data_2ms4_residue save_MolProbity _Software.Sf_category software _Software.Sf_framecode MolProbity _Software.Entry_ID ? _Software.ID 1 _Software.Name MolProbity _Software.Version 4.0 _Software.Details . save_ save_CYRANGE _Software.Sf_category software _Software.Sf_framecode CYRANGE _Software.Entry_ID ? _Software.ID 2 _Software.Name CYRANGE _Software.Version 2.0 _Software.Details . save_ save_Structure_validation_residue _Structure_validation_residue.Sf_category structure_validation _Structure_validation_residue.Sf_framecode Structure_validation_residue _Structure_validation_residue.Entry_ID ? _Structure_validation_residue.List_ID 1 _Structure_validation_residue.PDB_accession_code 2ms4 _Structure_validation_residue.Date_analyzed 2016-10-08 loop_ _Residue_analysis_software.Software_ID _Residue_analysis_software.Software_label _Residue_analysis_software.Method_ID _Residue_analysis_software.Method_label _Residue_analysis_software.Entry_ID _Residue_analysis_software.Structure_validation_oneline_list_ID 1 MolProbity . . ? 1 2 CYRANGE . . ? 1 stop_ loop_ _Residue_analysis.ID _Residue_analysis.PDB_model_num _Residue_analysis.Hydrogen_positions _Residue_analysis.MolProbity_flips _Residue_analysis.Cyrange_core_flag _Residue_analysis.Two_letter_chain_ID _Residue_analysis.PDB_strand_ID _Residue_analysis.PDB_residue_no _Residue_analysis.PDB_ins_code _Residue_analysis.PDB_residue_name _Residue_analysis.Assembly_ID _Residue_analysis.Entity_assembly_ID _Residue_analysis.Entity_ID _Residue_analysis.Comp_ID _Residue_analysis.Comp_index_ID _Residue_analysis.Clash_value _Residue_analysis.Clash_source_PDB_atom_name _Residue_analysis.Clash_destination_PDB_atom_name _Residue_analysis.Clash_destination_PDB_strand_ID _Residue_analysis.Clash_destination_PDB_residue_no _Residue_analysis.Clash_destination_PDB_ins_code _Residue_analysis.Clash_destination_PDB_residue_name _Residue_analysis.Cbeta_deviation_value _Residue_analysis.Rotamer_score _Residue_analysis.Rotamer_name _Residue_analysis.Ramachandran_phi _Residue_analysis.Ramachandran_psi _Residue_analysis.Ramachandran_score _Residue_analysis.Ramachandran_evaluation _Residue_analysis.Ramachandran_type _Residue_analysis.Bond_outlier_count _Residue_analysis.Worst_bond _Residue_analysis.Worst_bond_value _Residue_analysis.Worst_bond_sigma _Residue_analysis.Angle_outlier_count _Residue_analysis.Worst_angle _Residue_analysis.Worst_angle_value _Residue_analysis.Worst_angle_sigma _Residue_analysis.RNA_phosphate_perpendicular_outlier _Residue_analysis.RNA_suitness_score _Residue_analysis.RNA_suite_conformer _Residue_analysis.RNA_suite_triage _Residue_analysis.Max_b_factor _Residue_analysis.Tau_angle _Residue_analysis.Omega_dihedral _Residue_analysis.Disulfide_chi1 _Residue_analysis.Disulfide_chi2 _Residue_analysis.Disulfide_chi3 _Residue_analysis.Disulfide_ss_angle _Residue_analysis.Disulfide_ss _Residue_analysis.Disulfide_ss_angle_prime _Residue_analysis.Disulfide_chi2prime _Residue_analysis.Disulfide_chi1prime _Residue_analysis.Outlier_count_separate_geometry _Residue_analysis.Outlier_count _Residue_analysis.Entry_ID _Residue_analysis.Structure_validation_residue_list_ID . 001 nuclear orig core ' A' A ' 3' ' ' ASN . . . . . 0.481 ' ND2' ' HA ' ' A' ' 25' ' ' PHE . 20.1 m120 . . . . . 0 CA--C 1.549 0.917 0 N-CA-C 109.701 -0.481 . . . . 71.45 109.701 . . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 4' ' ' PRO . . . . . 0.502 ' HG2' ' HB2' ' A' ' 24' ' ' LEU . 52.8 Cg_endo -75.85 133.87 15.81 Favored 'Trans proline' 0 C--N 1.372 1.779 0 C-N-CA 122.078 1.852 . . . . 73.33 111.509 170.082 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 80.7 m -97.62 124.74 42.03 Favored 'General case' 0 CA--C 1.536 0.437 0 N-CA-C 108.524 -0.917 . . . . 73.14 108.524 172.631 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 7.4 m -100.87 123.47 53.89 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.81 0 N-CA-C 109.143 -0.688 . . . . 75.43 109.143 173.607 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 7' ' ' PHE . . . . . 0.571 ' H ' ' HA ' ' A' ' 163' ' ' GLN . 85.5 t80 -108.08 137.44 46.06 Favored 'General case' 0 C--O 1.241 0.608 0 C-N-CA 124.056 0.942 . . . . 73.0 109.236 -174.351 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 8' ' ' PHE . . . . . 0.505 ' HB3' HG23 ' A' ' 158' ' ' ILE . 62.8 m-85 -138.66 162.59 34.27 Favored 'General case' 0 N--CA 1.469 0.501 0 C-N-CA 123.889 0.875 . . . . 74.2 110.433 175.943 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 16.0 m-20 -110.35 117.88 34.82 Favored 'General case' 0 N--CA 1.467 0.394 0 N-CA-C 107.354 -1.35 . . . . 73.01 107.354 170.26 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 49.6 mm -89.4 124.94 42.38 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.559 0 N-CA-C 109.176 -0.676 . . . . 73.53 109.176 -179.809 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 11' ' ' ALA . . . . . 0.583 ' HB2' ' HB2' ' A' ' 159' ' ' ALA . . . -128.68 126.28 39.79 Favored 'General case' 0 N--CA 1.471 0.581 0 C-N-CA 123.34 0.656 . . . . 71.53 111.062 -173.177 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 12' ' ' VAL . . . . . 0.44 HG12 ' HB3' ' A' ' 154' ' ' LYS . 96.3 t -95.53 120.36 44.82 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.43 0 N-CA-C 108.077 -1.083 . . . . 74.42 108.077 174.801 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 31.4 m-20 60.37 24.48 13.99 Favored 'General case' 0 N--CA 1.482 1.126 0 C-N-CA 125.499 1.519 . . . . 73.53 111.767 -175.791 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 91.69 -18.61 52.26 Favored Glycine 0 C--N 1.354 1.559 0 CA-C-N 116.587 -0.279 . . . . 70.32 112.903 -175.554 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 15.8 mm-40 -82.15 114.2 49.21 Favored Pre-proline 0 CA--C 1.548 0.887 0 C-N-CA 124.213 1.005 . . . . 73.35 110.123 178.863 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 18.6 Cg_endo -56.18 108.79 0.36 Allowed 'Trans proline' 0 C--N 1.384 2.41 0 C-N-CA 123.262 2.642 . . . . 73.44 112.383 -178.077 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 48.4 tp -76.8 -29.52 56.04 Favored 'General case' 0 N--CA 1.475 0.776 0 CA-C-N 114.828 -1.078 . . . . 65.42 109.522 176.375 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 170.11 -159.65 32.24 Favored Glycine 0 N--CA 1.449 -0.5 0 CA-C-N 115.039 -0.982 . . . . 74.03 111.046 -176.109 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 2.0 ptp180 -149.08 142.93 25.68 Favored 'General case' 0 C--O 1.24 0.595 0 C-N-CA 123.282 0.633 . . . . 75.21 109.898 -177.408 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 50.7 t -132.09 129.07 59.98 Favored 'Isoleucine or valine' 0 C--O 1.24 0.582 0 C-N-CA 123.659 0.784 . . . . 74.54 109.453 -176.908 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 66.7 p -109.6 140.77 43.03 Favored 'General case' 0 C--O 1.252 1.189 0 N-CA-C 108.655 -0.869 . . . . 74.44 108.655 170.453 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 22' ' ' PHE . . . . . 0.44 ' HE1' ' HD2' ' A' ' 8' ' ' PHE . 45.2 m-85 -118.42 134.36 55.12 Favored 'General case' 0 N--CA 1.467 0.394 0 C-N-CA 123.908 0.883 . . . . 71.5 108.978 -178.113 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 7.7 tp10 -87.36 110.59 20.36 Favored 'General case' 0 CA--C 1.535 0.397 0 N-CA-C 109.35 -0.611 . . . . 75.53 109.35 174.026 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . 0.502 ' HB2' ' HG2' ' A' ' 4' ' ' PRO . 33.8 mt -83.92 121.28 27.15 Favored 'General case' 0 N--CA 1.469 0.482 0 N-CA-C 109.132 -0.692 . . . . 72.13 109.132 176.826 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 25' ' ' PHE . . . . . 0.481 ' HA ' ' ND2' ' A' ' 3' ' ' ASN . 65.6 m-85 -84.82 69.69 10.75 Favored 'General case' 0 CA--C 1.54 0.579 0 C-N-CA 123.746 0.818 . . . . 74.05 109.912 179.279 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -70.09 -20.14 63.22 Favored 'General case' 0 N--CA 1.478 0.975 0 CA-C-N 115.076 -0.966 . . . . 75.4 111.52 -179.579 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 11.5 p-10 -72.19 -19.16 61.79 Favored 'General case' 0 CA--C 1.55 0.98 0 C-N-CA 123.71 0.804 . . . . 74.13 111.188 175.579 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 47.0 mttm -108.57 -51.45 2.89 Favored 'General case' 0 N--CA 1.48 1.061 0 C-N-CA 123.46 0.704 . . . . 73.51 110.765 -176.698 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 29' ' ' VAL . . . . . 0.483 HG23 ' HA ' ' A' ' 129' ' ' PHE . 5.5 m -129.82 74.92 80.27 Favored Pre-proline 0 CA--C 1.56 1.334 0 C-N-CA 124.409 1.083 . . . . 73.44 109.741 -175.8 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 58.2 Cg_endo -65.8 -34.37 40.25 Favored 'Trans proline' 0 C--N 1.378 2.094 0 C-N-CA 122.98 2.453 . . . . 72.43 112.726 -168.468 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 31' ' ' LYS . . . . . 0.46 ' HB3' ' HB2' ' A' ' 86' ' ' GLU . 27.4 ttmt -64.55 -58.73 5.57 Favored 'General case' 0 CA--C 1.533 0.311 0 C-N-CA 124.226 1.01 . . . . 72.32 111.253 -177.561 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 3.8 m -72.39 -26.3 61.83 Favored 'General case' 0 CA--C 1.559 1.308 0 O-C-N 123.63 0.581 . . . . 73.43 111.191 -173.674 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 33' ' ' ALA . . . . . 0.471 ' HB1' ' HB3' ' A' ' 24' ' ' LEU . . . -73.47 -58.27 3.42 Favored 'General case' 0 N--CA 1.482 1.143 0 C-N-CA 123.025 0.53 . . . . 71.3 111.888 177.454 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . 0.467 ' HG3' HH21 ' A' ' 37' ' ' ARG . 43.0 tt0 -62.84 -29.49 70.78 Favored 'General case' 0 N--CA 1.488 1.447 0 C-N-CA 123.383 0.673 . . . . 75.31 111.192 -178.597 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 35' ' ' ASN . . . . . 0.452 ' ND2' ' SD ' ' A' ' 100' ' ' MET . 32.1 t30 -50.93 -60.02 3.53 Favored 'General case' 0 N--CA 1.476 0.83 0 C-N-CA 124.061 0.944 . . . . 72.43 110.527 174.506 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 84.1 t80 -66.48 -33.08 74.88 Favored 'General case' 0 CA--C 1.544 0.729 0 O-C-N 124.06 0.85 . . . . 63.43 111.237 -178.573 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 37' ' ' ARG . . . . . 0.467 HH21 ' HG3' ' A' ' 34' ' ' GLU . 17.4 ttp180 -62.48 -40.98 98.41 Favored 'General case' 0 N--CA 1.478 0.943 0 C-N-CA 123.204 0.602 . . . . 72.52 110.737 177.599 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 38' ' ' ALA . . . . . 0.418 ' HB2' HG21 ' A' ' 78' ' ' ILE . . . -80.47 -21.54 41.93 Favored 'General case' 0 N--CA 1.472 0.654 0 CA-C-N 115.386 -0.825 . . . . 65.44 111.321 -178.105 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 39' ' ' LEU . . . . . 0.443 ' HG ' ' O ' ' A' ' 35' ' ' ASN . 95.8 mt -72.15 -44.46 63.06 Favored 'General case' 0 N--CA 1.478 0.952 0 C-N-CA 123.203 0.601 . . . . 72.12 110.379 172.067 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 65.9 p -72.56 -40.2 66.86 Favored 'General case' 0 N--CA 1.475 0.823 0 C-N-CA 123.737 0.815 . . . . 73.3 111.484 -173.937 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 61.2 p -76.81 -31.55 57.01 Favored 'General case' 0 N--CA 1.474 0.726 0 O-C-N 123.343 0.402 . . . . 64.02 110.226 172.614 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 71.59 24.92 76.17 Favored Glycine 0 C--N 1.35 1.338 0 CA-C-N 115.659 -0.701 . . . . 72.21 114.312 175.226 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 20.9 mm-40 -68.24 -17.92 64.43 Favored 'General case' 0 N--CA 1.476 0.863 0 C-N-CA 123.203 0.601 . . . . 64.35 111.582 179.243 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 31.1 mmmt -92.18 13.5 18.87 Favored 'General case' 0 CA--C 1.552 1.024 0 C-N-CA 123.708 0.803 . . . . 72.23 111.384 177.169 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 84.76 37.84 10.04 Favored Glycine 0 C--N 1.353 1.511 0 N-CA-C 113.87 0.308 . . . . 71.44 113.87 171.229 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 23.0 m-85 -125.15 -46.84 1.79 Allowed 'General case' 0 N--CA 1.484 1.245 0 CA-C-N 117.058 0.429 . . . . 74.22 110.89 -174.257 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 53.89 58.5 12.36 Favored Glycine 0 C--N 1.349 1.297 0 O-C-N 124.161 0.913 . . . . 72.04 114.148 174.848 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 52.1 m-85 -63.86 89.84 0.05 Allowed 'General case' 0 N--CA 1.483 1.213 0 CA-C-O 121.851 0.834 . . . . 73.22 111.885 -179.153 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 38.7 tptt -112.96 142.77 45.26 Favored 'General case' 0 CA--C 1.538 0.49 0 CA-C-N 114.058 -1.428 . . . . 74.1 108.37 179.153 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 70.74 22.02 78.04 Favored Glycine 0 C--N 1.345 1.03 0 CA-C-O 119.568 -0.573 . . . . 54.21 113.923 175.438 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 24.3 t -58.87 114.51 2.58 Favored 'General case' 0 CA--C 1.549 0.92 0 C-N-CA 123.53 0.732 . . . . 74.24 111.05 -173.817 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 52' ' ' CYS . . . . . . . . . . . . . 15.5 p -87.25 118.1 26.44 Favored 'General case' 0 CA--C 1.54 0.564 0 C-N-CA 123.905 0.882 . . . . 74.13 111.873 -169.791 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 53' ' ' PHE . . . . . 0.678 ' HA ' ' HA2' ' A' ' 64' ' ' GLY . 88.4 m-85 -69.02 78.77 0.32 Allowed 'General case' 0 CA--C 1.539 0.541 0 C-N-CA 124.454 1.102 . . . . 74.24 109.671 165.405 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 15.2 p-80 -95.45 -8.4 35.52 Favored 'General case' 0 N--CA 1.479 0.999 0 CA-C-N 115.219 -0.9 . . . . 74.12 112.461 -173.652 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 59.0 ttt-85 -130.8 100.1 5.16 Favored 'General case' 0 N--CA 1.476 0.834 0 N-CA-C 109.133 -0.691 . . . . 71.25 109.133 179.364 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 56' ' ' ILE . . . . . 0.509 HD13 ' HB3' ' A' ' 53' ' ' PHE . 65.8 mt -134.39 133.21 55.2 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.117 0 C-N-CA 123.241 0.616 . . . . 72.53 109.97 -177.725 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 57' ' ' ILE . . . . . 0.495 HG21 ' HA ' ' A' ' 148' ' ' ARG . 66.6 mt -121.34 120.63 28.9 Favored Pre-proline 0 CA--C 1.558 1.25 0 C-N-CA 124.7 1.2 . . . . 73.32 109.229 175.871 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 35.6 Cg_endo -64.64 139.23 62.66 Favored 'Trans proline' 0 C--N 1.388 2.638 0 C-N-CA 123.078 2.519 . . . . 71.03 112.362 176.323 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 76.67 21.71 74.06 Favored Glycine 0 C--N 1.346 1.12 0 CA-C-N 115.009 -0.996 . . . . 60.44 113.134 -175.686 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 60' ' ' PHE . . . . . 0.4 ' HD2' ' HB ' ' A' ' 57' ' ' ILE . 19.9 t80 -149.57 -76.91 0.15 Allowed 'General case' 0 N--CA 1.478 0.936 0 CA-C-N 117.318 0.559 . . . . 74.14 111.349 -175.738 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 61' ' ' MET . . . . . 0.573 ' SD ' ' HB2' ' A' ' 113' ' ' PHE . 15.7 tmm? -168.07 142.94 3.59 Favored 'General case' 0 N--CA 1.481 1.077 0 N-CA-C 112.115 0.413 . . . . 72.41 112.115 -163.305 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 62' ' ' CYS . . . . . . . . . . . . . 22.7 p -111.53 113.21 25.47 Favored 'General case' 0 CA--C 1.551 0.985 0 C-N-CA 124.196 0.999 . . . . 63.01 109.908 173.18 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 63' ' ' GLN . . . . . 0.506 ' HA ' ' HA ' ' A' ' 113' ' ' PHE . 17.1 tt0 -108.53 127.05 53.59 Favored 'General case' 0 N--CA 1.487 1.384 0 C-N-CA 124.019 0.927 . . . . 72.33 111.745 -173.699 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 64' ' ' GLY . . . . . 0.678 ' HA2' ' HA ' ' A' ' 53' ' ' PHE . . . -102.35 167.34 17.85 Favored Glycine 0 C--N 1.351 1.385 0 CA-C-N 114.834 -1.076 . . . . 71.2 112.423 175.993 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -178.57 -174.97 45.27 Favored Glycine 0 C--N 1.339 0.701 0 N-CA-C 112.236 -0.346 . . . . 61.14 112.236 -179.432 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 28.2 t70 -126.1 168.04 14.55 Favored 'General case' 0 C--O 1.247 0.931 0 C-N-CA 124.185 0.994 . . . . 72.11 110.337 -170.608 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 51.9 t80 -88.04 -21.45 24.76 Favored 'General case' 0 CA--C 1.548 0.873 0 C-N-CA 123.799 0.84 . . . . 74.51 111.78 -176.959 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 67.5 m -63.48 108.57 1.39 Allowed 'General case' 0 N--CA 1.484 1.233 0 N-CA-C 109.792 -0.447 . . . . 72.2 109.792 179.9 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 70.0 ttt180 56.04 54.95 7.34 Favored 'General case' 0 CA--C 1.555 1.15 0 O-C-N 124.701 1.25 . . . . 74.3 110.473 -178.02 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 44.8 t-80 -57.13 -36.14 70.33 Favored 'General case' 0 N--CA 1.482 1.17 0 CA-C-N 115.462 -0.79 . . . . 71.44 111.988 -175.793 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 37.2 t30 -64.71 114.41 4.42 Favored 'General case' 0 N--CA 1.476 0.855 0 C-N-CA 123.398 0.679 . . . . 73.23 109.856 174.663 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 76.85 -6.77 38.52 Favored Glycine 0 CA--C 1.53 0.986 0 N-CA-C 116.019 1.168 . . . . 72.41 116.019 169.376 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 23.8 m -143.77 -82.36 0.17 Allowed 'General case' 0 CA--C 1.554 1.117 0 CA-C-N 117.922 0.861 . . . . 74.44 109.528 179.192 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 63.08 50.2 65.31 Favored Glycine 0 C--N 1.353 1.477 0 C-N-CA 123.559 0.599 . . . . 65.14 114.054 174.469 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 139.14 49.94 0.06 OUTLIER Glycine 0 C--N 1.345 1.053 0 CA-C-N 117.387 0.594 . . . . 72.41 111.682 -179.049 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 21.3 pttp -67.22 161.0 25.78 Favored 'General case' 0 CA--C 1.553 1.076 0 C-N-CA 123.341 0.656 . . . . 74.24 112.423 -174.122 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 80.6 p -90.11 -179.38 5.66 Favored 'General case' 0 CA--C 1.545 0.77 0 C-N-CA 124.259 1.023 . . . . 74.31 112.297 -171.106 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 78' ' ' ILE . . . . . 0.418 HG21 ' HB2' ' A' ' 38' ' ' ALA . 24.5 pt -73.47 -13.17 15.96 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.082 0 C-N-CA 123.197 0.599 . . . . 73.23 110.677 172.052 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 98.5 m-85 -91.53 7.46 41.25 Favored 'General case' 0 CA--C 1.545 0.782 0 C-N-CA 124.389 1.076 . . . . 73.12 110.626 171.213 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 91.61 -141.33 15.6 Favored Glycine 0 C--N 1.347 1.168 0 CA-C-O 119.532 -0.593 . . . . 75.41 112.422 176.829 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 31.3 tt0 -50.04 -56.81 9.27 Favored 'General case' 0 N--CA 1.481 1.11 0 C-N-CA 125.039 1.335 . . . . 64.51 111.829 -176.852 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 82' ' ' LYS . . . . . 0.512 ' HD2' ' HA ' ' A' ' 107' ' ' THR . 19.0 pttp -161.17 157.54 26.0 Favored 'General case' 0 C--O 1.239 0.514 0 O-C-N 123.873 0.733 . . . . 63.25 110.97 -179.447 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 24.5 p90 -144.42 172.33 13.1 Favored 'General case' 0 C--O 1.24 0.577 0 C-N-CA 124.915 1.286 . . . . 74.53 109.328 -179.514 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 12.0 pt-20 -99.79 150.27 22.51 Favored 'General case' 0 N--CA 1.473 0.676 0 C-N-CA 123.801 0.84 . . . . 74.34 109.675 176.972 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 26.8 m-20 -66.84 149.59 50.37 Favored 'General case' 0 N--CA 1.48 1.049 0 C-N-CA 123.664 0.786 . . . . 75.43 112.7 -176.203 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 86' ' ' GLU . . . . . 0.46 ' HB2' ' HB3' ' A' ' 31' ' ' LYS . 6.9 tp10 -69.13 -56.11 8.67 Favored 'General case' 0 CA--C 1.544 0.742 0 CA-C-N 115.035 -0.984 . . . . 71.13 110.475 178.782 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 16.8 p-10 -168.97 138.08 2.13 Favored 'General case' 0 N--CA 1.471 0.617 0 C-N-CA 123.771 0.828 . . . . 74.43 109.703 -172.953 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 88' ' ' PHE . . . . . 0.464 ' HD1' ' HB ' ' A' ' 127' ' ' VAL . 40.4 m-85 -90.98 68.23 6.15 Favored 'General case' 0 N--CA 1.479 0.995 0 C-N-CA 123.044 0.538 . . . . 73.54 110.902 -176.035 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 40.1 mt -80.24 -61.84 1.6 Allowed 'Isoleucine or valine' 0 N--CA 1.484 1.273 0 CA-C-O 120.933 0.397 . . . . 74.33 110.008 174.359 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 90' ' ' LEU . . . . . 0.443 HD13 ' HB2' ' A' ' 25' ' ' PHE . 96.0 mt -75.05 104.74 5.75 Favored 'General case' 0 CA--C 1.544 0.731 0 CA-C-N 115.49 -0.777 . . . . 70.34 110.878 -173.798 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 91' ' ' LYS . . . . . 0.675 ' HE3' ' HB ' ' A' ' 93' ' ' THR . 0.1 OUTLIER -83.96 158.49 21.52 Favored 'General case' 0 CA--C 1.545 0.786 0 CA-C-N 115.099 -0.955 . . . . 71.32 110.073 173.908 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 92' ' ' HIS . . . . . . . . . . . . . 25.2 m-70 -87.46 65.96 8.85 Favored 'General case' 0 N--CA 1.479 1.016 0 CA-C-O 121.493 0.663 . . . . 75.31 109.696 -177.293 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 93' ' ' THR . . . . . 0.675 ' HB ' ' HE3' ' A' ' 91' ' ' LYS . 15.3 t -105.04 15.21 28.04 Favored 'General case' 0 N--CA 1.483 1.176 0 CA-C-N 115.599 -0.728 . . . . 72.32 111.461 -174.088 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -155.35 174.84 33.44 Favored Glycine 0 C--N 1.345 1.044 0 C-N-CA 121.553 -0.356 . . . . 64.04 113.543 -176.225 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 95' ' ' PRO . . . . . 0.632 ' HB2' ' HE3' ' A' ' 136' ' ' MET . 53.6 Cg_endo -90.19 158.62 4.72 Favored 'Trans proline' 0 CA--C 1.553 1.459 0 C-N-CA 123.753 2.968 . . . . 65.51 111.919 175.656 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 77.23 17.95 78.87 Favored Glycine 0 C--N 1.344 0.999 0 CA-C-N 116.071 -0.513 . . . . 75.44 113.533 -179.117 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 97' ' ' ILE . . . . . 0.669 ' HB ' ' HB2' ' A' ' 115' ' ' CYS . 14.9 mm -66.5 103.09 0.52 Allowed 'Isoleucine or valine' 0 CA--C 1.555 1.169 0 C-N-CA 123.685 0.794 . . . . 62.33 111.009 -176.455 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 54.9 tp -88.71 118.1 28.15 Favored 'General case' 0 C--O 1.247 0.922 0 CA-C-O 121.893 0.854 . . . . 74.43 109.471 175.577 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 23.7 t -152.08 141.67 21.76 Favored 'General case' 0 CA--C 1.547 0.854 0 N-CA-C 107.893 -1.151 . . . . 74.14 107.893 -174.664 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 100' ' ' MET . . . . . 0.514 ' HA ' ' HA ' ' A' ' 112' ' ' PHE . 70.7 mtp -76.71 138.19 39.82 Favored 'General case' 0 N--CA 1.495 1.791 0 CA-C-N 119.622 1.101 . . . . 72.2 110.319 -175.294 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 101' ' ' ALA . . . . . 0.421 ' HB3' ' HB2' ' A' ' 111' ' ' GLN . . . -70.42 156.45 39.32 Favored 'General case' 0 C--O 1.247 0.932 0 CA-C-O 121.315 0.579 . . . . 70.31 111.235 -173.263 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 102' ' ' ASN . . . . . 0.405 ' HB3' ' HA ' ' A' ' 108' ' ' ASN . 25.6 p-10 -161.69 164.05 29.37 Favored 'General case' 0 C--O 1.238 0.454 0 CA-C-N 115.055 -0.975 . . . . 72.33 110.646 -173.328 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 103' ' ' ALA . . . . . 0.476 ' HB3' HG21 ' A' ' 107' ' ' THR . . . -97.21 -14.89 21.14 Favored 'General case' 0 CA--C 1.542 0.654 0 CA-C-N 115.521 -0.763 . . . . 74.43 110.361 169.546 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 166.35 -168.18 39.82 Favored Glycine 0 C--N 1.352 1.426 0 CA-C-O 119.406 -0.663 . . . . 75.54 112.517 178.602 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 46.7 Cg_exo -58.72 139.75 92.06 Favored 'Trans proline' 0 C--N 1.374 1.876 0 C-N-CA 123.155 2.57 . . . . 73.22 112.112 173.553 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 66.0 t30 65.53 11.4 7.4 Favored 'General case' 0 N--CA 1.487 1.4 0 C-N-CA 124.967 1.307 . . . . 63.42 111.877 -177.804 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 107' ' ' THR . . . . . 0.512 ' HA ' ' HD2' ' A' ' 82' ' ' LYS . 5.0 m -124.1 17.12 9.22 Favored 'General case' 0 CA--C 1.552 1.028 0 C-N-CA 124.0 0.92 . . . . 72.32 109.705 178.158 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 108' ' ' ASN . . . . . 0.405 ' HA ' ' HB3' ' A' ' 102' ' ' ASN . 32.8 t30 -80.85 150.89 28.94 Favored 'General case' 0 N--CA 1.477 0.9 0 C-N-CA 124.34 1.056 . . . . 74.23 110.112 176.759 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 106.82 25.52 6.18 Favored Glycine 0 N--CA 1.47 0.912 0 C-N-CA 121.488 -0.387 . . . . 74.3 113.297 176.171 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 12.9 p -131.78 118.19 19.59 Favored 'General case' 0 CA--C 1.537 0.447 0 N-CA-C 108.183 -1.043 . . . . 75.51 108.183 175.107 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 111' ' ' GLN . . . . . 0.461 HE21 ' HG2' ' B' ' 218' ' ' PRO . 48.9 mt-30 61.16 -173.68 0.13 Allowed 'General case' 0 N--CA 1.493 1.683 0 C-N-CA 124.097 0.959 . . . . 75.34 111.895 -172.536 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 112' ' ' PHE . . . . . 0.514 ' HA ' ' HA ' ' A' ' 100' ' ' MET . 42.0 p90 -146.31 159.37 43.44 Favored 'General case' 0 N--CA 1.476 0.856 0 C-N-CA 123.817 0.847 . . . . 75.44 109.153 171.968 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 113' ' ' PHE . . . . . 0.573 ' HB2' ' SD ' ' A' ' 61' ' ' MET . 50.6 p90 -138.1 146.78 43.3 Favored 'General case' 0 C--O 1.238 0.458 0 C-N-CA 123.631 0.772 . . . . 75.51 109.6 -179.47 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 114' ' ' ILE . . . . . 0.414 ' HA ' ' O ' ' A' ' 97' ' ' ILE . 17.2 mt -120.9 101.97 11.51 Favored 'Isoleucine or valine' 0 C--O 1.243 0.721 0 N-CA-C 107.517 -1.29 . . . . 74.31 107.517 176.419 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 115' ' ' CYS . . . . . 0.669 ' HB2' ' HB ' ' A' ' 97' ' ' ILE . 62.8 m -63.31 104.75 0.64 Allowed 'General case' 0 N--CA 1.469 0.511 0 N-CA-C 109.311 -0.626 . . . . 73.24 109.311 177.477 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 116' ' ' THR . . . . . 0.549 HG21 HG13 ' A' ' 139' ' ' VAL . 32.8 p -70.18 -32.8 70.9 Favored 'General case' 0 N--CA 1.472 0.656 0 C-N-CA 123.593 0.757 . . . . 72.0 109.859 -179.343 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -104.86 161.19 14.4 Favored 'General case' 0 C--O 1.241 0.62 0 C-N-CA 124.174 0.989 . . . . 75.32 109.505 172.27 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 9.4 ptmt -72.71 94.02 1.71 Allowed 'General case' 0 CA--C 1.546 0.826 0 CA-C-O 121.87 0.843 . . . . 75.21 109.874 174.828 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 119' ' ' THR . . . . . . . . . . . . . 75.0 p -87.22 83.99 7.31 Favored 'General case' 0 CA--C 1.545 0.771 0 CA-C-N 115.551 -0.75 . . . . 74.15 110.368 -175.354 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 8.3 pt-20 -80.36 -16.91 53.44 Favored 'General case' 0 N--CA 1.483 1.212 0 CA-C-O 121.137 0.494 . . . . 74.41 111.902 -172.426 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 121' ' ' TRP . . . . . . . . . . . . . 43.6 p90 -70.16 -9.86 56.99 Favored 'General case' 0 CA--C 1.546 0.813 0 C-N-CA 122.792 0.437 . . . . 74.24 111.58 173.971 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 122' ' ' LEU . . . . . 0.468 ' HA ' ' HE2' ' A' ' 125' ' ' LYS . 65.5 mt -89.17 4.91 47.0 Favored 'General case' 0 N--CA 1.477 0.882 0 C-N-CA 123.281 0.632 . . . . 74.44 111.936 174.723 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 78.5 m-20 -74.24 152.09 39.78 Favored 'General case' 0 N--CA 1.487 1.407 0 C-N-CA 122.482 0.313 . . . . 71.21 110.295 173.487 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 75.79 14.77 81.82 Favored Glycine 0 C--N 1.353 1.519 0 O-C-N 123.422 0.451 . . . . 43.02 112.802 -173.451 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 125' ' ' LYS . . . . . 0.468 ' HE2' ' HA ' ' A' ' 122' ' ' LEU . 30.0 mtmm -138.72 -162.09 1.27 Allowed 'General case' 0 N--CA 1.472 0.645 0 C-N-CA 125.683 1.593 . . . . 75.34 108.719 -174.95 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 126' ' ' HIS . . . . . . . . . . . . . 2.5 t60 -62.01 135.47 57.55 Favored 'General case' 0 CA--C 1.549 0.927 0 C-N-CA 123.938 0.895 . . . . 70.15 111.598 -165.715 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 127' ' ' VAL . . . . . 0.464 ' HB ' ' HD1' ' A' ' 88' ' ' PHE . 13.9 p -76.95 148.04 7.06 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.807 0 CA-C-N 114.526 -1.216 . . . . 63.33 112.317 -169.013 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 128' ' ' VAL . . . . . 0.441 ' HB ' ' HB3' ' A' ' 90' ' ' LEU . 18.9 t -72.56 156.07 6.96 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.818 0 C-N-CA 124.073 0.949 . . . . 74.34 108.884 171.619 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 129' ' ' PHE . . . . . 0.483 ' HA ' HG23 ' A' ' 29' ' ' VAL . 43.1 p90 -128.7 -23.84 3.08 Favored 'General case' 0 N--CA 1.485 1.324 0 CA-C-N 118.739 0.699 . . . . 73.42 111.661 175.4 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . -145.59 170.63 26.83 Favored Glycine 0 C--N 1.337 0.61 0 N-CA-C 111.454 -0.658 . . . . 73.53 111.454 -178.38 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 32.8 ttpt -150.07 147.27 27.6 Favored 'General case' 0 N--CA 1.472 0.646 0 N-CA-C 109.002 -0.74 . . . . 74.14 109.002 178.365 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 132' ' ' VAL . . . . . 0.482 HG23 HG22 ' A' ' 139' ' ' VAL . 58.1 t -62.43 112.32 0.97 Allowed 'Isoleucine or valine' 0 CA--C 1.538 0.49 0 C-N-CA 123.327 0.651 . . . . 74.24 109.771 174.838 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 21.9 ptmt -91.99 -33.98 14.62 Favored 'General case' 0 N--CA 1.471 0.606 0 N-CA-C 109.264 -0.643 . . . . 71.22 109.264 175.923 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 35.5 mt-10 -141.58 135.61 30.24 Favored 'General case' 0 N--CA 1.479 1.013 0 C-N-CA 124.513 1.125 . . . . 64.32 109.206 -179.072 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 95.63 24.72 15.04 Favored Glycine 0 C--N 1.349 1.301 0 O-C-N 123.381 0.426 . . . . 62.34 113.825 176.03 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 136' ' ' MET . . . . . 0.632 ' HE3' ' HB2' ' A' ' 95' ' ' PRO . 14.5 tpt -65.51 -32.09 73.5 Favored 'General case' 0 N--CA 1.485 1.293 0 CA-C-N 117.289 0.545 . . . . 72.24 111.119 179.787 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 137' ' ' ASN . . . . . . . . . . . . . 4.3 p-10 -61.26 -35.32 76.96 Favored 'General case' 0 CA--C 1.551 0.999 0 C-N-CA 123.941 0.897 . . . . 73.25 111.458 173.515 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 138' ' ' ILE . . . . . . . . . . . . . 50.6 mm -74.58 -32.93 30.81 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.001 0 C-N-CA 123.414 0.686 . . . . 74.41 110.532 177.51 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 139' ' ' VAL . . . . . 0.591 ' HA ' ' HE1' ' A' ' 142' ' ' MET . 87.7 t -66.52 -44.02 90.45 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.947 0 C-N-CA 123.733 0.813 . . . . 75.44 110.889 178.513 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 140' ' ' GLU . . . . . 0.414 ' O ' ' HG3' ' A' ' 144' ' ' ARG . 52.2 mt-10 -77.0 -19.41 57.31 Favored 'General case' 0 N--CA 1.475 0.795 0 CA-C-N 115.618 -0.719 . . . . 72.23 110.805 177.037 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -70.82 -37.55 73.23 Favored 'General case' 0 CA--C 1.543 0.687 0 C-N-CA 122.387 0.275 . . . . 75.31 110.295 169.068 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 142' ' ' MET . . . . . 0.591 ' HE1' ' HA ' ' A' ' 139' ' ' VAL . 70.6 mtm -63.24 -39.35 94.36 Favored 'General case' 0 N--CA 1.485 1.304 0 C-N-CA 123.065 0.546 . . . . 74.44 110.376 174.607 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 25.6 tt0 -55.61 -36.65 67.17 Favored 'General case' 0 CA--C 1.55 0.98 0 CA-C-N 114.539 -1.209 . . . . 72.51 111.784 178.252 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 144' ' ' ARG . . . . . 0.414 ' HG3' ' O ' ' A' ' 140' ' ' GLU . 29.2 mtm180 -73.82 -8.79 57.4 Favored 'General case' 0 N--CA 1.478 0.952 0 C-N-CA 123.837 0.855 . . . . 71.32 112.75 -176.952 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 145' ' ' PHE . . . . . 0.494 ' HB2' HD11 ' A' ' 156' ' ' ILE . 62.8 m-85 -97.63 -4.87 36.65 Favored 'General case' 0 N--CA 1.479 1.001 0 C-N-CA 122.674 0.389 . . . . 75.34 111.007 174.137 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . -92.92 171.36 32.8 Favored Glycine 0 C--N 1.347 1.158 0 CA-C-N 116.361 -0.381 . . . . 73.22 113.192 -179.632 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 147' ' ' SER . . . . . 0.479 ' HB2' ' HB3' ' A' ' 151' ' ' LYS . 18.3 m -133.6 156.99 46.85 Favored 'General case' 0 N--CA 1.475 0.8 0 C-N-CA 124.539 1.135 . . . . 73.11 109.566 -177.426 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 148' ' ' ARG . . . . . 0.495 ' HA ' HG21 ' A' ' 57' ' ' ILE . 18.9 mmt180 -59.12 -37.88 78.28 Favored 'General case' 0 N--CA 1.484 1.24 0 C-N-CA 123.858 0.863 . . . . 74.4 112.592 -172.219 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 149' ' ' ASN . . . . . . . . . . . . . 28.0 p-10 -72.0 -14.68 61.95 Favored 'General case' 0 N--CA 1.486 1.354 0 C-N-CA 123.518 0.727 . . . . 72.11 111.922 179.804 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . 112.89 -3.02 25.8 Favored Glycine 0 C--N 1.347 1.17 0 C-N-CA 123.428 0.537 . . . . 74.32 112.544 -178.644 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 151' ' ' LYS . . . . . 0.479 ' HB3' ' HB2' ' A' ' 147' ' ' SER . 87.9 tttt -67.82 146.47 53.66 Favored 'General case' 0 N--CA 1.478 0.938 0 C-N-CA 123.67 0.788 . . . . 75.3 111.092 -178.94 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 152' ' ' THR . . . . . . . . . . . . . 18.5 p -120.05 114.5 22.08 Favored 'General case' 0 N--CA 1.469 0.476 0 N-CA-C 109.204 -0.665 . . . . 70.42 109.204 173.062 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 153' ' ' SER . . . . . . . . . . . . . 37.8 t -67.34 -24.89 65.77 Favored 'General case' 0 CA--C 1.546 0.822 0 C-N-CA 124.242 1.017 . . . . 74.41 111.109 179.181 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 154' ' ' LYS . . . . . 0.44 ' HB3' HG12 ' A' ' 12' ' ' VAL . 69.7 mmtt -121.69 150.68 41.43 Favored 'General case' 0 N--CA 1.473 0.697 0 C-N-CA 123.951 0.901 . . . . 73.02 111.155 179.925 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 2.2 tppp? -93.37 91.16 7.05 Favored 'General case' 0 N--CA 1.474 0.773 0 CA-C-O 121.366 0.603 . . . . 74.42 110.251 -178.065 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 156' ' ' ILE . . . . . 0.517 ' HB ' ' HB2' ' A' ' 53' ' ' PHE . 48.4 mt -89.6 102.1 12.79 Favored 'Isoleucine or valine' 0 C--O 1.21 -1.009 0 N-CA-C 109.254 -0.647 . . . . 75.34 109.254 -177.05 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 157' ' ' THR . . . . . . . . . . . . . 42.3 p -108.54 145.19 35.17 Favored 'General case' 0 N--CA 1.472 0.652 0 C-N-CA 123.642 0.777 . . . . 75.21 110.151 178.841 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 158' ' ' ILE . . . . . 0.505 HG23 ' HB3' ' A' ' 8' ' ' PHE . 49.4 mt -70.47 95.86 0.47 Allowed 'Isoleucine or valine' 0 CA--C 1.547 0.839 0 N-CA-C 108.672 -0.862 . . . . 72.21 108.672 170.423 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 159' ' ' ALA . . . . . 0.583 ' HB2' ' HB2' ' A' ' 11' ' ' ALA . . . -51.72 -53.94 33.79 Favored 'General case' 0 N--CA 1.477 0.896 0 C-N-CA 124.402 1.081 . . . . 61.5 112.036 -177.599 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 160' ' ' ASP . . . . . . . . . . . . . 5.4 t70 -145.62 169.52 18.26 Favored 'General case' 0 CA--C 1.544 0.72 0 CA-C-N 116.195 -0.457 . . . . 73.12 110.583 -174.743 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 161' ' ' CYS . . . . . . . . . . . . . 12.7 p -135.16 -169.62 2.41 Favored 'General case' 0 N--CA 1.476 0.854 0 C-N-CA 125.048 1.339 . . . . 75.13 108.393 -177.822 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 162' ' ' GLY . . . . . . . . . . . . . . . 131.87 56.74 0.09 OUTLIER Glycine 0 N--CA 1.475 1.247 0 C-N-CA 120.635 -0.793 . . . . 74.24 111.922 -172.965 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 163' ' ' GLN . . . . . 0.571 ' HA ' ' H ' ' A' ' 7' ' ' PHE . 2.1 pt20 -46.93 135.54 9.21 Favored 'General case' 0 CA--C 1.552 1.022 0 C-N-CA 124.099 0.96 . . . . 73.41 113.478 -174.156 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 164' ' ' LEU . . . . . . . . . . . . . 86.6 mt . . . . . 0 CA--C 1.54 0.589 0 N-CA-C 108.751 -0.833 . . . . 74.02 108.751 178.249 . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' B' B ' 218' ' ' PRO . . . . . 0.461 ' HG2' HE21 ' A' ' 111' ' ' GLN . 42.1 Cg_endo . . . . . 0 CA--C 1.55 1.292 0 CA-C-O 121.143 0.393 . . . . 72.4 111.113 . . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 219' ' ' GLY . . . . . . . . . . . . . . . -179.86 147.84 7.69 Favored Glycine 0 CA--C 1.536 1.371 0 CA-C-N 115.534 -0.757 . . . . 74.21 111.927 -178.755 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 220' ' ' PRO . . . . . . . . . . . . . 21.5 Cg_exo -68.26 164.52 32.07 Favored 'Trans proline' 0 C--N 1.377 2.036 0 C-N-CA 123.796 2.997 . . . . 73.42 113.565 -178.07 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 221' ' ' TYR . . . . . . . . . . . . . 62.2 m-85 . . . . . 0 N--CA 1.481 1.123 0 C-N-CA 123.731 0.812 . . . . 70.53 111.157 -176.328 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 3' ' ' ASN . . . . . 0.428 ' ND2' ' HA ' ' A' ' 25' ' ' PHE . 21.5 m120 . . . . . 0 CA--C 1.543 0.696 0 N-CA-C 109.538 -0.542 . . . . 72.34 109.538 . . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 4' ' ' PRO . . . . . 0.476 ' HG2' ' HB2' ' A' ' 24' ' ' LEU . 57.6 Cg_endo -73.66 144.37 35.41 Favored 'Trans proline' 0 C--N 1.374 1.911 0 C-N-CA 122.414 2.076 . . . . 62.53 112.123 175.12 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 5' ' ' THR . . . . . 0.547 HG22 ' HD3' ' A' ' 133' ' ' LYS . 97.9 m -97.1 114.13 25.77 Favored 'General case' 0 C--O 1.223 -0.318 0 N-CA-C 108.325 -0.991 . . . . 73.24 108.325 177.475 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 43.1 t -99.7 119.17 47.38 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.852 0 N-CA-C 108.33 -0.989 . . . . 74.12 108.33 -178.721 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 75.1 t80 -99.58 132.81 44.66 Favored 'General case' 0 C--N 1.323 -0.572 0 N-CA-C 109.235 -0.654 . . . . 74.0 109.235 -173.125 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 8' ' ' PHE . . . . . 0.473 ' HD2' ' HE2' ' A' ' 22' ' ' PHE . 33.1 m-85 -136.57 161.16 36.65 Favored 'General case' 0 C--O 1.238 0.499 0 O-C-N 124.027 0.829 . . . . 74.31 110.975 170.295 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 6.4 m-20 -108.37 114.76 28.86 Favored 'General case' 0 N--CA 1.465 0.277 0 CA-C-N 113.749 -1.569 . . . . 73.35 107.652 168.389 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 10' ' ' ILE . . . . . 0.511 HG22 ' SD ' ' A' ' 142' ' ' MET . 44.5 mm -85.48 118.82 32.96 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.369 0 N-CA-C 108.707 -0.849 . . . . 74.32 108.707 174.502 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 11' ' ' ALA . . . . . 0.557 ' HB2' ' HB3' ' A' ' 159' ' ' ALA . . . -118.11 131.36 56.43 Favored 'General case' 0 N--CA 1.469 0.476 0 C-N-CA 123.37 0.668 . . . . 73.24 111.143 -176.657 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 71.1 t -96.65 112.85 29.6 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.454 0 N-CA-C 107.934 -1.136 . . . . 71.42 107.934 170.765 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 18.5 m-20 62.93 24.25 14.44 Favored 'General case' 0 N--CA 1.481 1.104 0 C-N-CA 125.12 1.368 . . . . 73.42 111.931 179.965 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 99.1 -21.24 46.75 Favored Glycine 0 C--N 1.348 1.227 0 CA-C-N 116.43 -0.35 . . . . 62.32 113.031 -177.805 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 36.7 mm-40 -83.27 114.73 55.02 Favored Pre-proline 0 CA--C 1.543 0.706 0 C-N-CA 123.529 0.731 . . . . 73.14 110.048 179.667 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 34.3 Cg_endo -60.72 109.27 0.64 Allowed 'Trans proline' 0 C--N 1.378 2.098 0 C-N-CA 122.844 2.363 . . . . 71.43 111.863 -177.265 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 66.0 tp -76.31 -35.46 58.81 Favored 'General case' 0 N--CA 1.471 0.621 0 CA-C-N 115.104 -0.953 . . . . 71.34 109.922 179.334 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -175.96 177.96 47.52 Favored Glycine 0 C--N 1.341 0.832 0 CA-C-N 115.57 -0.741 . . . . 73.1 112.882 177.338 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 80.7 mtt180 -115.16 116.91 29.14 Favored 'General case' 0 C--O 1.237 0.406 0 C-N-CA 124.219 1.008 . . . . 73.21 108.86 -179.299 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 67.5 t -114.65 118.33 58.33 Favored 'Isoleucine or valine' 0 C--O 1.238 0.498 0 C-N-CA 123.566 0.746 . . . . 71.4 109.417 -178.182 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 21' ' ' SER . . . . . 0.416 ' OG ' ' HB2' ' A' ' 134' ' ' GLU . 71.3 p -106.47 139.37 41.05 Favored 'General case' 0 C--O 1.246 0.878 0 N-CA-C 108.982 -0.748 . . . . 73.25 108.982 173.634 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 22' ' ' PHE . . . . . 0.473 ' HE2' ' HD2' ' A' ' 8' ' ' PHE . 85.2 m-85 -108.14 168.24 9.43 Favored 'General case' 0 C--N 1.331 -0.236 0 C-N-CA 124.544 1.138 . . . . 75.23 109.516 -179.886 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 23' ' ' GLU . . . . . 0.461 ' HB2' ' HD2' ' A' ' 133' ' ' LYS . 41.3 tt0 -129.95 106.9 8.96 Favored 'General case' 0 C--O 1.24 0.578 0 N-CA-C 107.979 -1.119 . . . . 74.02 107.979 179.007 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . 0.476 ' HB2' ' HG2' ' A' ' 4' ' ' PRO . 38.7 mt -82.44 124.72 30.31 Favored 'General case' 0 N--CA 1.467 0.414 0 N-CA-C 109.67 -0.493 . . . . 75.42 109.67 -179.456 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 25' ' ' PHE . . . . . 0.428 ' HA ' ' ND2' ' A' ' 3' ' ' ASN . 44.6 m-85 -86.48 66.57 9.57 Favored 'General case' 0 CA--C 1.535 0.403 0 C-N-CA 123.338 0.655 . . . . 74.32 109.236 177.632 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -62.35 -24.89 67.6 Favored 'General case' 0 N--CA 1.477 0.883 0 CA-C-N 115.282 -0.872 . . . . 43.3 111.703 -178.476 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 9.7 p-10 -71.42 -19.53 62.23 Favored 'General case' 0 N--CA 1.477 0.875 0 C-N-CA 124.097 0.959 . . . . 72.43 112.524 -179.905 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 61.2 mttp -110.58 -41.05 4.42 Favored 'General case' 0 N--CA 1.486 1.355 0 C-N-CA 123.729 0.812 . . . . 74.31 110.992 -178.76 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 29' ' ' VAL . . . . . 0.515 HG21 ' HA ' ' A' ' 129' ' ' PHE . 8.4 m -129.48 74.06 81.15 Favored Pre-proline 0 N--CA 1.478 0.966 0 C-N-CA 123.803 0.841 . . . . 72.41 109.947 -179.452 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 25.5 Cg_endo -60.09 -37.32 84.95 Favored 'Trans proline' 0 C--N 1.378 2.097 0 C-N-CA 122.797 2.331 . . . . 73.21 112.896 -175.982 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 36.6 ttmt -66.75 -52.0 49.33 Favored 'General case' 0 N--CA 1.482 1.136 0 C-N-CA 123.534 0.734 . . . . 75.02 112.043 -176.637 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 18.3 m -77.43 -31.25 53.83 Favored 'General case' 0 CA--C 1.55 0.978 0 CA-C-N 115.277 -0.874 . . . . 64.4 111.136 -170.617 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 33' ' ' ALA . . . . . 0.438 ' HB1' ' HB3' ' A' ' 24' ' ' LEU . . . -71.93 -47.18 54.31 Favored 'General case' 0 N--CA 1.473 0.718 0 C-N-CA 122.828 0.451 . . . . 75.13 110.057 174.327 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 11.4 tp10 -59.98 -35.63 75.41 Favored 'General case' 0 N--CA 1.485 1.308 0 C-N-CA 123.477 0.711 . . . . 73.52 111.141 178.684 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 35' ' ' ASN . . . . . 0.551 ' ND2' ' SD ' ' A' ' 100' ' ' MET . 32.7 t30 -56.12 -64.42 0.87 Allowed 'General case' 0 CA--C 1.539 0.523 0 CA-C-N 114.981 -1.009 . . . . 73.21 110.812 178.075 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 74.5 t80 -61.94 -35.38 78.25 Favored 'General case' 0 N--CA 1.474 0.74 0 C-N-CA 123.774 0.83 . . . . 72.54 111.41 -177.043 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 37' ' ' ARG . . . . . 0.425 ' HG3' HE22 ' A' ' 163' ' ' GLN . 20.7 ttt180 -58.82 -50.29 74.51 Favored 'General case' 0 N--CA 1.472 0.674 0 C-N-CA 124.046 0.938 . . . . 74.24 110.937 175.901 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 38' ' ' ALA . . . . . 0.539 ' HB1' HG21 ' A' ' 78' ' ' ILE . . . -75.69 -22.26 56.82 Favored 'General case' 0 CA--C 1.54 0.582 0 CA-C-N 115.587 -0.733 . . . . 72.12 111.727 -176.29 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 39' ' ' LEU . . . . . 0.482 HD23 ' CE1' ' A' ' 48' ' ' TYR . 96.6 mt -72.41 -42.27 65.3 Favored 'General case' 0 N--CA 1.479 1.008 0 C-N-CA 123.127 0.571 . . . . 73.42 109.86 172.214 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 48.0 t -68.63 -55.88 10.07 Favored 'General case' 0 N--CA 1.476 0.834 0 C-N-CA 124.238 1.015 . . . . 75.01 110.959 -176.139 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 71.3 p -73.41 -30.07 63.0 Favored 'General case' 0 CA--C 1.541 0.634 0 C-N-CA 123.659 0.783 . . . . 74.41 110.819 179.452 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 87.02 32.71 13.62 Favored Glycine 0 C--N 1.352 1.453 0 CA-C-O 119.909 -0.384 . . . . 63.52 113.021 176.129 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 50.9 mm-40 -54.89 -42.37 72.03 Favored 'General case' 0 N--CA 1.48 1.062 0 C-N-CA 123.551 0.741 . . . . 65.41 110.991 177.034 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 44' ' ' LYS . . . . . 0.562 ' HG3' ' HB ' ' A' ' 78' ' ' ILE . 29.6 mmmt -93.51 18.19 10.31 Favored 'General case' 0 CA--C 1.547 0.828 0 CA-C-N 115.044 -0.98 . . . . 74.23 111.683 -173.332 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 73.05 36.3 56.99 Favored Glycine 0 C--N 1.354 1.557 0 CA-C-N 116.301 -0.409 . . . . 63.41 114.068 171.722 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 46' ' ' PHE . . . . . 0.461 ' HE2' ' HA ' ' A' ' 78' ' ' ILE . 22.0 m-85 -120.25 -47.63 2.35 Favored 'General case' 0 N--CA 1.483 1.183 0 C-N-CA 122.811 0.444 . . . . 73.01 110.788 -177.391 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 53.27 62.12 6.3 Favored Glycine 0 C--N 1.356 1.644 0 O-C-N 123.92 0.763 . . . . 64.24 114.896 170.653 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 48' ' ' TYR . . . . . 0.482 ' CE1' HD23 ' A' ' 39' ' ' LEU . 66.8 m-85 -64.73 91.23 0.08 Allowed 'General case' 0 N--CA 1.48 1.042 0 CA-C-O 121.936 0.874 . . . . 73.14 111.67 -176.721 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 49' ' ' LYS . . . . . 0.549 ' HE2' ' HA ' ' A' ' 160' ' ' ASP . 28.0 tptp -109.7 130.88 55.47 Favored 'General case' 0 C--O 1.239 0.529 0 CA-C-N 113.913 -1.494 . . . . 73.04 108.726 178.985 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 80.83 21.24 63.92 Favored Glycine 0 C--N 1.348 1.248 0 CA-C-O 119.645 -0.531 . . . . 74.21 113.235 179.715 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 23.0 m -56.28 115.07 2.26 Favored 'General case' 0 C--N 1.355 0.806 0 C-N-CA 123.799 0.84 . . . . 73.3 110.885 -179.004 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 52' ' ' CYS . . . . . 0.685 ' SG ' ' HB3' ' A' ' 66' ' ' ASP . 6.3 p -96.76 130.11 44.06 Favored 'General case' 0 CA--C 1.548 0.888 0 C-N-CA 123.918 0.887 . . . . 73.41 112.261 -168.823 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 53' ' ' PHE . . . . . 0.713 ' HA ' ' HA2' ' A' ' 64' ' ' GLY . 11.8 m-85 -79.82 108.95 13.79 Favored 'General case' 0 CA--C 1.538 0.481 0 C-N-CA 125.155 1.382 . . . . 74.44 109.569 175.173 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 54' ' ' HIS . . . . . 0.545 ' HD1' ' HB2' ' A' ' 66' ' ' ASP . 53.1 p-80 -100.52 -30.58 11.72 Favored 'General case' 0 N--CA 1.487 1.416 0 C-N-CA 122.769 0.428 . . . . 62.15 111.018 178.964 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 27.9 ttt180 -112.38 99.98 8.43 Favored 'General case' 0 C--O 1.221 -0.445 0 N-CA-C 109.048 -0.723 . . . . 73.41 109.048 -173.278 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 56' ' ' ILE . . . . . 0.486 HG23 ' HA ' ' A' ' 143' ' ' GLU . 52.5 mt -134.63 134.68 54.12 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.801 0 N-CA-C 108.929 -0.767 . . . . 72.04 108.929 176.169 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 57' ' ' ILE . . . . . 0.626 HG22 ' HA ' ' A' ' 148' ' ' ARG . 58.1 mt -131.0 121.56 18.88 Favored Pre-proline 0 CA--C 1.554 1.12 0 C-N-CA 124.501 1.12 . . . . 75.23 108.037 179.357 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 58' ' ' PRO . . . . . 0.508 ' HA ' ' HG2' ' A' ' 143' ' ' GLU . 74.4 Cg_endo -70.89 139.58 36.63 Favored 'Trans proline' 0 C--N 1.378 2.084 0 C-N-CA 123.033 2.489 . . . . 61.4 112.577 -172.846 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 74.32 26.83 67.18 Favored Glycine 0 C--N 1.343 0.937 0 CA-C-N 115.552 -0.749 . . . . 74.43 112.569 -176.048 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 60' ' ' PHE . . . . . 0.4 ' HD2' ' HB ' ' A' ' 57' ' ' ILE . 28.3 t80 -148.47 -73.24 0.19 Allowed 'General case' 0 C--O 1.243 0.732 0 C-N-CA 123.659 0.784 . . . . 75.01 109.767 -175.188 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 61' ' ' MET . . . . . 0.628 ' HE2' ' HB3' ' A' ' 115' ' ' CYS . 44.7 ttm -171.69 140.46 1.33 Allowed 'General case' 0 C--N 1.353 0.722 0 CA-C-N 116.285 -0.416 . . . . 63.34 112.058 -163.215 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 62' ' ' CYS . . . . . 0.543 ' SG ' ' HB ' ' A' ' 114' ' ' ILE . 16.6 p -109.14 113.51 26.43 Favored 'General case' 0 CA--C 1.549 0.926 0 C-N-CA 124.031 0.932 . . . . 70.23 108.966 169.346 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 63' ' ' GLN . . . . . 0.472 ' HA ' ' HA ' ' A' ' 113' ' ' PHE . 50.7 tt0 -113.91 118.54 34.46 Favored 'General case' 0 N--CA 1.48 1.032 0 C-N-CA 123.574 0.75 . . . . 75.44 110.31 -170.875 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 64' ' ' GLY . . . . . 0.713 ' HA2' ' HA ' ' A' ' 53' ' ' PHE . . . -115.81 164.94 12.16 Favored Glycine 0 C--N 1.353 1.505 0 CA-C-N 115.736 -0.666 . . . . 71.2 113.622 -173.784 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 101.59 93.56 2.2 Favored Glycine 0 C--N 1.343 0.92 0 N-CA-C 110.096 -1.202 . . . . 63.54 110.096 -173.992 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 66' ' ' ASP . . . . . 0.685 ' HB3' ' SG ' ' A' ' 52' ' ' CYS . 38.9 t70 -122.6 -73.38 0.65 Allowed 'General case' 0 N--CA 1.476 0.838 0 C-N-CA 122.899 0.479 . . . . 61.31 110.588 -179.641 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 76.0 t80 -40.72 -49.84 3.09 Favored 'General case' 0 N--CA 1.483 1.206 0 C-N-CA 125.779 1.631 . . . . 74.43 114.048 -161.917 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 15.7 m -71.46 105.62 3.64 Favored 'General case' 0 CA--C 1.545 0.755 0 O-C-N 123.571 0.544 . . . . 74.14 110.551 -176.274 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 31.2 ttm180 51.82 47.66 24.33 Favored 'General case' 0 CA--C 1.553 1.095 0 C-N-CA 125.179 1.391 . . . . 74.02 111.379 -178.234 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 27.4 p80 -55.73 -28.15 54.3 Favored 'General case' 0 N--CA 1.492 1.654 0 C-N-CA 123.345 0.658 . . . . 72.41 111.773 179.302 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 6.3 t30 -80.98 103.53 10.87 Favored 'General case' 0 CA--C 1.544 0.72 0 C-N-CA 123.755 0.822 . . . . 74.25 109.217 170.008 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 97.22 -8.19 64.65 Favored Glycine 0 C--N 1.341 0.823 0 CA-C-O 119.132 -0.815 . . . . 43.43 115.09 168.597 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 73' ' ' THR . . . . . 0.484 HG23 ' HB3' ' A' ' 76' ' ' LYS . 25.6 m -149.51 -74.91 0.17 Allowed 'General case' 0 N--CA 1.484 1.271 0 CA-C-N 118.495 1.147 . . . . 75.41 110.491 178.894 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 81.75 60.19 2.23 Favored Glycine 0 C--N 1.35 1.334 0 CA-C-O 119.958 -0.356 . . . . 23.44 112.964 177.926 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 111.06 51.27 0.6 Allowed Glycine 0 N--CA 1.479 1.524 0 CA-C-N 117.329 0.564 . . . . 74.2 112.952 178.714 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 76' ' ' LYS . . . . . 0.484 ' HB3' HG23 ' A' ' 73' ' ' THR . 20.2 pttp -56.54 161.5 2.66 Favored 'General case' 0 N--CA 1.491 1.579 0 C-N-CA 124.55 1.14 . . . . 74.44 113.38 -178.997 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 46.1 p -101.59 179.7 4.27 Favored 'General case' 0 N--CA 1.484 1.247 0 C-N-CA 124.181 0.992 . . . . 70.25 112.698 -167.395 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 78' ' ' ILE . . . . . 0.562 ' HB ' ' HG3' ' A' ' 44' ' ' LYS . 29.1 pt -69.9 -16.82 20.63 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.907 0 C-N-CA 122.819 0.448 . . . . 73.42 111.441 177.553 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 86.0 m-85 -95.04 27.04 3.35 Favored 'General case' 0 CA--C 1.545 0.754 0 C-N-CA 124.112 0.965 . . . . 74.41 110.244 176.748 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 92.11 -128.62 9.46 Favored Glycine 0 C--N 1.351 1.381 0 N-CA-C 111.497 -0.641 . . . . 74.43 111.497 178.026 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 39.5 tt0 -66.05 -49.42 67.72 Favored 'General case' 0 N--CA 1.472 0.664 0 C-N-CA 123.548 0.739 . . . . 72.3 110.531 179.168 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 82' ' ' LYS . . . . . 0.712 ' HD2' ' HA ' ' A' ' 107' ' ' THR . 21.8 pttm -167.71 155.95 9.14 Favored 'General case' 0 CA--C 1.55 0.969 0 CA-C-N 115.501 -0.772 . . . . 72.04 111.054 -171.668 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 15.0 p90 -131.04 174.32 10.13 Favored 'General case' 0 N--CA 1.481 1.089 0 C-N-CA 125.176 1.39 . . . . 71.23 110.594 176.236 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 84' ' ' GLU . . . . . 0.418 ' HA ' ' HA ' ' A' ' 106' ' ' ASN . 9.8 pt-20 -84.37 157.26 21.51 Favored 'General case' 0 N--CA 1.483 1.22 0 C-N-CA 123.497 0.719 . . . . 73.13 111.278 177.203 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 40.6 m-20 -64.22 134.34 54.58 Favored 'General case' 0 N--CA 1.489 1.479 0 C-N-CA 124.047 0.939 . . . . 61.24 110.837 -176.278 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 6.2 tp10 -60.05 -58.88 6.62 Favored 'General case' 0 N--CA 1.486 1.358 0 C-N-CA 123.236 0.614 . . . . 74.52 111.091 -178.627 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 31.9 p30 -163.22 -157.18 0.41 Allowed 'General case' 0 N--CA 1.467 0.41 0 N-CA-C 107.521 -1.288 . . . . 64.44 107.521 -179.211 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 89.7 m-85 -142.43 34.1 1.47 Allowed 'General case' 0 N--CA 1.485 1.293 0 C-N-CA 123.311 0.644 . . . . 75.43 110.52 177.005 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 65.4 mt -61.94 -61.04 1.79 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.649 0 CA-C-O 121.506 0.669 . . . . 74.15 110.266 178.39 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 90' ' ' LEU . . . . . 0.454 ' HB3' ' HB ' ' A' ' 128' ' ' VAL . 59.3 mt -78.8 102.36 8.11 Favored 'General case' 0 C--O 1.242 0.665 0 CA-C-N 114.88 -1.054 . . . . 74.22 110.075 -177.305 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 91' ' ' LYS . . . . . 0.703 ' HE3' ' HB ' ' A' ' 93' ' ' THR . 0.1 OUTLIER -84.63 163.64 19.15 Favored 'General case' 0 C--O 1.24 0.586 0 CA-C-N 115.493 -0.776 . . . . 74.05 110.334 174.747 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 92' ' ' HIS . . . . . . . . . . . . . 19.0 m-70 -91.19 56.1 3.04 Favored 'General case' 0 N--CA 1.476 0.858 0 CA-C-O 122.033 0.921 . . . . 74.4 109.371 -176.699 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 93' ' ' THR . . . . . 0.703 ' HB ' ' HE3' ' A' ' 91' ' ' LYS . 12.6 t -91.33 -7.15 51.79 Favored 'General case' 0 N--CA 1.47 0.572 0 CA-C-N 114.61 -1.177 . . . . 72.02 111.385 -176.383 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -124.94 167.78 17.21 Favored Glycine 0 C--N 1.34 0.785 0 O-C-N 123.062 0.226 . . . . 71.3 113.241 -175.206 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 95' ' ' PRO . . . . . 0.436 ' HB3' ' O ' ' A' ' 116' ' ' THR . 1.1 Cg_endo -84.67 157.07 12.08 Favored 'Trans proline' 0 C--N 1.363 1.316 0 C-N-CA 123.519 2.812 . . . . 60.4 111.636 168.553 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 78.28 16.94 78.86 Favored Glycine 0 C--N 1.346 1.104 0 CA-C-N 116.203 -0.453 . . . . 74.51 113.206 179.948 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 97' ' ' ILE . . . . . 0.806 ' HB ' ' SG ' ' A' ' 115' ' ' CYS . 15.6 mm -73.14 109.42 5.33 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.921 0 C-N-CA 123.797 0.839 . . . . 73.11 111.201 -176.399 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 63.8 tp -94.21 111.86 23.62 Favored 'General case' 0 CA--C 1.552 1.037 0 C-N-CA 123.773 0.829 . . . . 75.25 109.95 174.35 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 99' ' ' SER . . . . . 0.471 ' HB2' ' HA ' ' A' ' 128' ' ' VAL . 29.8 t -137.14 147.89 46.27 Favored 'General case' 0 N--CA 1.474 0.766 0 C-N-CA 124.371 1.068 . . . . 73.32 108.743 177.059 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 100' ' ' MET . . . . . 0.556 ' HA ' ' HA ' ' A' ' 112' ' ' PHE . 67.5 mtp -77.47 146.39 36.49 Favored 'General case' 0 N--CA 1.483 1.216 0 CA-C-O 120.671 0.272 . . . . 63.51 110.657 179.918 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 101' ' ' ALA . . . . . 0.508 ' HB2' ' HB3' ' A' ' 111' ' ' GLN . . . -76.89 162.5 27.56 Favored 'General case' 0 C--O 1.245 0.844 0 CA-C-N 115.818 -0.628 . . . . 65.4 111.254 -176.469 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 102' ' ' ASN . . . . . 0.507 ' HB3' ' HA ' ' A' ' 108' ' ' ASN . 30.5 p-10 -168.47 171.1 9.26 Favored 'General case' 0 C--O 1.238 0.472 0 CA-C-N 114.823 -1.081 . . . . 54.15 109.522 179.503 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 103' ' ' ALA . . . . . 0.402 ' HB3' HG23 ' A' ' 107' ' ' THR . . . -119.59 13.41 12.52 Favored 'General case' 0 CA--C 1.543 0.695 0 CA-C-N 115.263 -0.88 . . . . 75.53 109.94 172.617 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 146.95 -166.86 28.36 Favored Glycine 0 C--N 1.352 1.438 0 CA-C-O 119.595 -0.559 . . . . 71.14 112.521 179.981 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 14.6 Cg_exo -67.34 140.79 54.15 Favored 'Trans proline' 0 C--N 1.372 1.808 0 C-N-CA 123.172 2.581 . . . . 73.52 111.433 178.957 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 106' ' ' ASN . . . . . 0.418 ' HA ' ' HA ' ' A' ' 84' ' ' GLU . 66.7 t30 66.4 9.72 6.69 Favored 'General case' 0 N--CA 1.491 1.606 0 C-N-CA 124.822 1.249 . . . . 73.31 111.979 -178.89 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 107' ' ' THR . . . . . 0.712 ' HA ' ' HD2' ' A' ' 82' ' ' LYS . 3.9 m -109.6 -6.47 15.35 Favored 'General case' 0 CA--C 1.552 1.049 0 C-N-CA 124.266 1.026 . . . . 73.2 109.669 177.025 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 108' ' ' ASN . . . . . 0.507 ' HA ' ' HB3' ' A' ' 102' ' ' ASN . 24.3 t30 -60.92 151.53 30.0 Favored 'General case' 0 N--CA 1.48 1.066 0 C-N-CA 125.046 1.339 . . . . 64.41 110.657 173.564 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 93.95 18.59 36.69 Favored Glycine 0 N--CA 1.465 0.628 0 C-N-CA 121.695 -0.288 . . . . 73.51 112.962 178.881 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 15.2 p -117.36 120.55 38.53 Favored 'General case' 0 C--N 1.328 -0.335 0 N-CA-C 106.938 -1.504 . . . . 73.33 106.938 167.093 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 111' ' ' GLN . . . . . 0.508 ' HB3' ' HB2' ' A' ' 101' ' ' ALA . 5.8 tt0 69.08 171.73 0.3 Allowed 'General case' 0 CA--C 1.557 1.23 0 C-N-CA 123.43 0.692 . . . . 73.31 111.341 171.609 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 112' ' ' PHE . . . . . 0.556 ' HA ' ' HA ' ' A' ' 100' ' ' MET . 52.5 p90 -143.8 155.0 43.99 Favored 'General case' 0 N--CA 1.48 1.026 0 O-C-N 121.748 -0.595 . . . . 74.22 109.695 176.364 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 113' ' ' PHE . . . . . 0.48 ' HB2' ' SD ' ' A' ' 61' ' ' MET . 40.5 p90 -140.57 151.3 44.6 Favored 'General case' 0 N--CA 1.47 0.536 0 C-N-CA 123.329 0.652 . . . . 73.21 111.277 -179.356 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 114' ' ' ILE . . . . . 0.543 ' HB ' ' SG ' ' A' ' 62' ' ' CYS . 19.3 mt -124.55 104.88 14.41 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.613 0 N-CA-C 108.067 -1.086 . . . . 75.54 108.067 177.029 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 115' ' ' CYS . . . . . 0.806 ' SG ' ' HB ' ' A' ' 97' ' ' ILE . 27.8 p -85.69 114.53 22.74 Favored 'General case' 0 C--O 1.241 0.643 0 CA-C-N 118.284 0.493 . . . . 73.02 109.728 178.968 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 116' ' ' THR . . . . . 0.436 ' O ' ' HB3' ' A' ' 95' ' ' PRO . 70.6 p -73.21 -20.88 60.77 Favored 'General case' 0 CA--C 1.54 0.579 0 C-N-CA 123.796 0.838 . . . . 72.24 110.603 176.863 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -101.94 155.89 17.88 Favored 'General case' 0 C--O 1.241 0.627 0 CA-C-N 115.383 -0.826 . . . . 74.14 109.76 171.893 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 19.2 ptmt -75.19 83.61 2.37 Favored 'General case' 0 CA--C 1.542 0.668 0 CA-C-O 121.765 0.793 . . . . 74.41 109.434 173.938 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 119' ' ' THR . . . . . 0.551 ' HB ' HD11 ' A' ' 122' ' ' LEU . 44.5 p -76.45 86.14 3.19 Favored 'General case' 0 CA--C 1.545 0.785 0 CA-C-O 121.948 0.88 . . . . 74.41 110.004 -175.984 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 11.1 pt-20 -78.51 -16.93 56.95 Favored 'General case' 0 N--CA 1.476 0.86 0 CA-C-N 114.825 -1.079 . . . . 74.53 112.127 -171.377 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 121' ' ' TRP . . . . . . . . . . . . . 35.7 p90 -74.18 -0.57 17.17 Favored 'General case' 0 CA--C 1.55 0.965 0 C-N-CA 123.027 0.531 . . . . 75.32 111.068 173.385 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 122' ' ' LEU . . . . . 0.551 HD11 ' HB ' ' A' ' 119' ' ' THR . 9.6 mp -97.42 -1.02 45.22 Favored 'General case' 0 N--CA 1.483 1.214 0 C-N-CA 124.275 1.03 . . . . 64.14 111.799 172.946 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 56.5 m-20 -71.06 129.51 39.14 Favored 'General case' 0 N--CA 1.477 0.898 0 N-CA-C 108.293 -1.003 . . . . 75.43 108.293 173.616 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 95.95 -25.08 26.98 Favored Glycine 0 N--CA 1.471 0.977 0 N-CA-C 111.573 -0.611 . . . . 70.3 111.573 -172.012 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 125' ' ' LYS . . . . . 0.578 ' HE2' ' HB3' ' B' ' 220' ' ' PRO . 16.3 ttpp -83.28 -168.46 2.1 Favored 'General case' 0 CA--C 1.555 1.144 0 N-CA-C 107.382 -1.34 . . . . 74.13 107.382 166.578 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 126' ' ' HIS . . . . . 0.508 ' H ' ' HG2' ' A' ' 125' ' ' LYS . 16.6 t-80 -65.0 131.65 47.15 Favored 'General case' 0 CA--C 1.548 0.887 0 CA-C-N 118.713 0.688 . . . . 74.11 112.082 -166.653 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 11.4 p -58.43 147.95 6.61 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.743 0 C-N-CA 125.906 1.682 . . . . 74.24 112.047 179.33 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 128' ' ' VAL . . . . . 0.471 ' HA ' ' HB2' ' A' ' 99' ' ' SER . 17.3 t -67.67 155.65 7.38 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.819 0 C-N-CA 123.927 0.891 . . . . 74.13 109.638 175.335 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 129' ' ' PHE . . . . . 0.515 ' HA ' HG21 ' A' ' 29' ' ' VAL . 50.5 p90 -133.5 -25.07 1.74 Allowed 'General case' 0 N--CA 1.477 0.908 0 O-C-N 122.269 -0.269 . . . . 73.15 111.363 173.843 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . -136.99 161.82 25.19 Favored Glycine 0 C--N 1.341 0.833 0 N-CA-C 111.588 -0.605 . . . . 70.44 111.588 -177.562 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 35.8 ttpt -144.29 138.61 28.05 Favored 'General case' 0 N--CA 1.468 0.461 0 N-CA-C 108.852 -0.795 . . . . 70.32 108.852 177.217 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 132' ' ' VAL . . . . . 0.4 HG11 ' HA ' ' A' ' 136' ' ' MET . 47.3 t -64.03 103.44 0.38 Allowed 'Isoleucine or valine' 0 C--O 1.24 0.562 0 N-CA-C 108.83 -0.804 . . . . 71.53 108.83 174.751 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 133' ' ' LYS . . . . . 0.547 ' HD3' HG22 ' A' ' 5' ' ' THR . 21.5 ptmt -85.67 -31.91 22.25 Favored 'General case' 0 CA--C 1.537 0.476 0 N-CA-C 109.371 -0.603 . . . . 73.12 109.371 179.941 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 134' ' ' GLU . . . . . 0.416 ' HB2' ' OG ' ' A' ' 21' ' ' SER . 17.0 mt-10 -143.87 149.05 36.35 Favored 'General case' 0 N--CA 1.479 1.023 0 C-N-CA 124.818 1.247 . . . . 75.13 109.222 179.02 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 84.31 22.55 54.06 Favored Glycine 0 C--N 1.345 1.048 0 O-C-N 123.379 0.424 . . . . 54.43 113.164 -179.716 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 136' ' ' MET . . . . . 0.4 ' HA ' HG11 ' A' ' 132' ' ' VAL . 16.5 tpt -62.76 -40.17 96.45 Favored 'General case' 0 N--CA 1.477 0.923 0 C-N-CA 123.239 0.616 . . . . 70.1 111.38 -179.913 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 137' ' ' ASN . . . . . . . . . . . . . 12.4 m120 -64.75 -26.61 68.43 Favored 'General case' 0 N--CA 1.478 0.973 0 C-N-CA 123.146 0.578 . . . . 72.25 111.271 179.255 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 138' ' ' ILE . . . . . . . . . . . . . 48.1 mm -76.48 -37.75 30.8 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.843 0 C-N-CA 123.444 0.698 . . . . 75.03 110.153 177.192 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 139' ' ' VAL . . . . . 0.47 HG12 ' SG ' ' A' ' 62' ' ' CYS . 95.4 t -62.26 -43.61 98.19 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.96 0 C-N-CA 123.471 0.708 . . . . 73.31 110.258 175.43 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 39.0 mt-10 -65.5 -42.37 92.17 Favored 'General case' 0 CA--C 1.544 0.734 0 CA-C-N 114.949 -1.023 . . . . 73.3 110.851 176.889 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -67.85 -39.21 83.82 Favored 'General case' 0 N--CA 1.48 1.034 0 C-N-CA 123.603 0.761 . . . . 72.23 111.884 -178.189 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 142' ' ' MET . . . . . 0.547 ' HB2' HD13 ' A' ' 156' ' ' ILE . 19.5 ptt? -75.95 -29.28 58.24 Favored 'General case' 0 N--CA 1.478 0.952 0 C-N-CA 122.644 0.378 . . . . 73.05 110.504 -178.912 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 143' ' ' GLU . . . . . 0.508 ' HG2' ' HA ' ' A' ' 58' ' ' PRO . 28.1 tt0 -65.61 -28.01 68.82 Favored 'General case' 0 CA--C 1.545 0.77 0 CA-C-N 115.711 -0.677 . . . . 74.03 111.68 178.677 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 144' ' ' ARG . . . . . . . . . . . . . 75.9 mtt180 -66.87 -13.22 61.4 Favored 'General case' 0 N--CA 1.479 0.992 0 C-N-CA 123.555 0.742 . . . . 73.41 111.921 177.699 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 145' ' ' PHE . . . . . . . . . . . . . 38.3 m-85 -88.68 -8.58 54.33 Favored 'General case' 0 N--CA 1.475 0.807 0 C-N-CA 123.379 0.672 . . . . 74.11 111.641 175.944 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . -87.3 171.53 42.23 Favored Glycine 0 C--N 1.346 1.095 0 CA-C-O 120.007 -0.33 . . . . 52.31 112.547 175.166 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 9.0 m -133.03 160.15 37.98 Favored 'General case' 0 N--CA 1.479 1.01 0 C-N-CA 123.565 0.746 . . . . 74.1 110.31 -175.525 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 148' ' ' ARG . . . . . 0.626 ' HA ' HG22 ' A' ' 57' ' ' ILE . 14.3 mmm180 -61.29 -31.64 71.47 Favored 'General case' 0 N--CA 1.483 1.22 0 C-N-CA 124.5 1.12 . . . . 74.43 113.407 -176.382 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 149' ' ' ASN . . . . . . . . . . . . . 31.2 p-10 -75.74 -13.1 60.3 Favored 'General case' 0 N--CA 1.483 1.2 0 C-N-CA 123.222 0.609 . . . . 63.33 111.467 178.573 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . 111.64 -17.15 25.85 Favored Glycine 0 C--N 1.348 1.208 0 CA-C-O 119.821 -0.433 . . . . 72.54 112.664 179.066 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 87.3 tttt -69.09 137.1 53.21 Favored 'General case' 0 CA--C 1.546 0.812 0 C-N-CA 122.853 0.461 . . . . 65.21 111.303 -175.214 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 152' ' ' THR . . . . . . . . . . . . . 6.8 p -92.18 121.44 33.72 Favored 'General case' 0 C--O 1.241 0.63 0 C-N-CA 123.826 0.85 . . . . 75.51 109.124 170.41 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 153' ' ' SER . . . . . . . . . . . . . 29.9 t -67.32 -36.21 81.01 Favored 'General case' 0 N--CA 1.472 0.665 0 C-N-CA 123.499 0.72 . . . . 65.41 109.995 174.042 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 69.5 mmtt -110.39 149.42 30.28 Favored 'General case' 0 N--CA 1.471 0.622 0 C-N-CA 124.256 1.023 . . . . 75.24 110.767 -178.28 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 16.2 tppt? -89.27 91.67 8.86 Favored 'General case' 0 C--N 1.345 0.376 0 N-CA-C 108.873 -0.788 . . . . 72.11 108.873 178.386 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 156' ' ' ILE . . . . . 0.547 HD13 ' HB2' ' A' ' 142' ' ' MET . 69.1 mt -91.75 126.05 44.39 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.416 0 N-CA-C 108.833 -0.802 . . . . 75.41 108.833 -179.054 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 157' ' ' THR . . . . . 0.445 HG23 ' HB3' ' A' ' 52' ' ' CYS . 21.1 p -134.11 157.47 46.09 Favored 'General case' 0 N--CA 1.477 0.915 0 C-N-CA 124.115 0.966 . . . . 60.3 109.708 -175.371 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 158' ' ' ILE . . . . . . . . . . . . . 46.4 mt -80.21 93.68 2.0 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.819 0 N-CA-C 109.261 -0.644 . . . . 72.31 109.261 170.601 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 159' ' ' ALA . . . . . 0.557 ' HB3' ' HB2' ' A' ' 11' ' ' ALA . . . -61.35 -34.16 74.84 Favored 'General case' 0 N--CA 1.472 0.626 0 C-N-CA 124.614 1.166 . . . . 73.11 113.404 -176.703 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 160' ' ' ASP . . . . . 0.549 ' HA ' ' HE2' ' A' ' 49' ' ' LYS . 26.3 t0 -159.98 162.76 34.4 Favored 'General case' 0 N--CA 1.475 0.814 0 C-N-CA 122.588 0.355 . . . . 73.1 110.375 -179.469 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 161' ' ' CYS . . . . . . . . . . . . . 28.0 p -127.74 -166.55 1.63 Allowed 'General case' 0 N--CA 1.474 0.731 0 C-N-CA 125.362 1.465 . . . . 73.44 108.812 -177.977 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 162' ' ' GLY . . . . . . . . . . . . . . . 134.17 54.51 0.07 OUTLIER Glycine 0 C--N 1.351 1.403 0 C-N-CA 121.406 -0.426 . . . . 75.3 112.885 -177.196 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 163' ' ' GLN . . . . . 0.425 HE22 ' HG3' ' A' ' 37' ' ' ARG . 8.1 tt0 -46.4 106.6 0.08 Allowed 'General case' 0 N--CA 1.483 1.18 0 C-N-CA 124.547 1.139 . . . . 75.42 111.629 178.515 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 164' ' ' LEU . . . . . . . . . . . . . 86.4 mt . . . . . 0 CA--C 1.542 0.671 0 CA-C-N 114.64 -1.164 . . . . 72.53 110.886 -177.402 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' B' B ' 218' ' ' PRO . . . . . . . . . . . . . 68.1 Cg_exo . . . . . 0 N--CA 1.491 1.348 0 CA-C-O 121.214 0.423 . . . . 73.55 111.9 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' B' B ' 219' ' ' GLY . . . . . . . . . . . . . . . 153.43 172.13 21.32 Favored Glycine 0 CA--C 1.529 0.928 0 CA-C-N 114.962 -1.017 . . . . 63.34 112.021 -174.213 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 220' ' ' PRO . . . . . 0.578 ' HB3' ' HE2' ' A' ' 125' ' ' LYS . 51.9 Cg_endo -86.48 165.49 9.32 Favored 'Trans proline' 0 C--N 1.364 1.355 0 C-N-CA 123.214 2.609 . . . . 74.45 114.22 179.689 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 221' ' ' TYR . . . . . . . . . . . . . 54.9 t80 . . . . . 0 N--CA 1.475 0.79 0 C-N-CA 123.002 0.521 . . . . 75.52 110.609 175.193 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 5.6 m120 . . . . . 0 CA--C 1.55 0.96 0 CA-C-O 119.087 -0.482 . . . . 71.55 110.043 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 31.5 Cg_endo -61.62 121.73 10.0 Favored 'Trans proline' 0 C--N 1.378 2.098 0 C-N-CA 122.957 2.438 . . . . 62.31 111.591 179.847 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 93.1 m -98.14 132.11 43.94 Favored 'General case' 0 CA--C 1.536 0.435 0 C-N-CA 122.756 0.422 . . . . 71.42 110.097 -177.972 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 6' ' ' VAL . . . . . 0.513 ' HA ' ' HB2' ' A' ' 163' ' ' GLN . 12.6 m -101.16 129.49 52.08 Favored 'Isoleucine or valine' 0 C--N 1.35 0.593 0 C-N-CA 123.53 0.732 . . . . 72.24 110.008 175.591 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 7' ' ' PHE . . . . . 0.612 ' HB2' ' HG ' ' A' ' 164' ' ' LEU . 37.7 t80 -119.61 134.23 55.31 Favored 'General case' 0 C--O 1.238 0.464 0 C-N-CA 123.886 0.875 . . . . 72.23 109.7 -170.684 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 8' ' ' PHE . . . . . 0.443 ' HB3' HG22 ' A' ' 158' ' ' ILE . 64.6 m-85 -139.89 161.37 37.75 Favored 'General case' 0 N--CA 1.47 0.536 0 O-C-N 123.801 0.688 . . . . 71.35 111.467 -174.705 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 7.6 m-20 -102.36 108.05 19.27 Favored 'General case' 0 N--CA 1.47 0.536 0 CA-C-N 114.005 -1.452 . . . . 65.45 107.58 166.017 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 10' ' ' ILE . . . . . 0.46 HG21 ' SD ' ' A' ' 142' ' ' MET . 49.2 mm -82.1 120.3 33.33 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.476 0 N-CA-C 108.852 -0.795 . . . . 73.21 108.852 175.323 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 11' ' ' ALA . . . . . 0.542 ' HB3' ' HB3' ' A' ' 159' ' ' ALA . . . -117.29 121.92 42.49 Favored 'General case' 0 N--CA 1.463 0.218 0 C-N-CA 123.529 0.732 . . . . 74.21 110.915 -173.638 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 12' ' ' VAL . . . . . 0.461 HG21 HD21 ' A' ' 17' ' ' LEU . 76.6 t -98.06 118.08 43.98 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.651 0 N-CA-C 108.334 -0.988 . . . . 75.21 108.334 173.454 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 35.8 m-20 61.9 31.2 18.25 Favored 'General case' 0 N--CA 1.486 1.364 0 C-N-CA 125.566 1.546 . . . . 72.25 111.249 -174.707 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 87.32 -15.78 52.24 Favored Glycine 0 C--N 1.352 1.428 0 CA-C-N 115.488 -0.778 . . . . 70.43 113.191 -177.499 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 21.8 mm-40 -90.81 115.72 64.86 Favored Pre-proline 0 N--CA 1.474 0.766 0 CA-C-O 118.606 -0.711 . . . . 73.15 110.514 -177.165 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 14.0 Cg_endo -53.52 104.88 0.11 Allowed 'Trans proline' 0 C--N 1.387 2.564 0 C-N-CA 123.228 2.619 . . . . 72.43 111.909 178.493 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 17' ' ' LEU . . . . . 0.461 HD21 HG21 ' A' ' 12' ' ' VAL . 21.3 tp -77.12 -24.93 51.65 Favored 'General case' 0 CA--C 1.541 0.632 0 CA-C-N 114.696 -1.138 . . . . 71.1 109.777 179.3 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 170.03 -178.62 42.78 Favored Glycine 0 C--N 1.342 0.894 0 CA-C-N 115.354 -0.839 . . . . 72.22 112.337 176.373 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 94.3 mtt180 -116.44 142.27 47.08 Favored 'General case' 0 N--CA 1.473 0.687 0 C-N-CA 123.771 0.828 . . . . 73.23 110.228 -178.49 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 45.0 t -131.35 141.11 46.76 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.69 0 C-N-CA 123.179 0.592 . . . . 73.22 110.247 -178.474 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 40.6 p -120.92 116.77 25.77 Favored 'General case' 0 CA--C 1.548 0.901 0 C-N-CA 124.596 1.158 . . . . 72.11 109.109 177.1 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 63.1 m-85 -103.36 113.47 26.99 Favored 'General case' 0 N--CA 1.472 0.647 0 C-N-CA 123.927 0.891 . . . . 71.45 109.377 177.158 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 23' ' ' GLU . . . . . 0.535 ' HB2' ' HD2' ' A' ' 133' ' ' LYS . 42.4 tt0 -74.88 103.56 5.16 Favored 'General case' 0 CA--C 1.553 1.083 0 C-N-CA 123.827 0.851 . . . . 72.51 109.934 175.759 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 21.0 mt -83.94 120.07 25.66 Favored 'General case' 0 N--CA 1.477 0.904 0 N-CA-C 109.352 -0.61 . . . . 73.14 109.352 178.454 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 25' ' ' PHE . . . . . 0.554 ' HB2' HD13 ' A' ' 90' ' ' LEU . 57.8 m-85 -84.46 70.44 10.68 Favored 'General case' 0 CA--C 1.544 0.716 0 C-N-CA 123.19 0.596 . . . . 74.4 110.117 177.809 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -60.97 -30.45 70.27 Favored 'General case' 0 N--CA 1.482 1.13 0 C-N-CA 123.247 0.619 . . . . 73.32 111.789 179.901 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 10.8 p-10 -62.03 -26.59 68.34 Favored 'General case' 0 CA--C 1.548 0.866 0 C-N-CA 124.169 0.988 . . . . 75.23 112.223 178.902 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 41.0 mttm -98.05 -49.69 4.66 Favored 'General case' 0 N--CA 1.479 0.991 0 C-N-CA 123.557 0.743 . . . . 65.13 110.476 -178.629 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 29' ' ' VAL . . . . . 0.553 HG22 ' HA ' ' A' ' 129' ' ' PHE . 26.7 m -120.05 83.67 31.52 Favored Pre-proline 0 CA--C 1.567 1.605 0 C-N-CA 123.844 0.858 . . . . 63.52 110.119 -174.285 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 32.7 Cg_endo -61.43 -49.84 6.79 Favored 'Trans proline' 0 C--N 1.382 2.33 0 C-N-CA 122.81 2.34 . . . . 74.34 112.337 -172.045 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 23.8 ttmm -60.5 -53.51 56.65 Favored 'General case' 0 N--CA 1.47 0.563 0 C-N-CA 124.049 0.94 . . . . 71.23 111.805 -175.247 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 7.3 m -75.85 -37.41 58.99 Favored 'General case' 0 CA--C 1.553 1.076 0 CA-C-N 115.339 -0.846 . . . . 75.15 111.912 -168.508 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -76.4 -43.37 40.76 Favored 'General case' 0 N--CA 1.479 0.998 0 C-N-CA 122.367 0.267 . . . . 63.41 111.327 -179.103 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 9.0 tp10 -62.75 -39.27 93.63 Favored 'General case' 0 N--CA 1.482 1.144 0 O-C-N 123.445 0.465 . . . . 73.32 110.878 178.134 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 35' ' ' ASN . . . . . 0.477 ' O ' ' HG ' ' A' ' 39' ' ' LEU . 35.6 t30 -50.2 -62.6 1.48 Allowed 'General case' 0 C--N 1.356 0.889 0 O-C-N 124.333 1.02 . . . . 74.13 110.885 176.865 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 36' ' ' PHE . . . . . 0.45 ' HE2' HG21 ' A' ' 6' ' ' VAL . 84.2 t80 -64.26 -34.03 77.19 Favored 'General case' 0 N--CA 1.471 0.613 0 O-C-N 124.172 0.92 . . . . 74.13 111.843 -175.544 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 41.9 ttp180 -64.71 -40.53 95.52 Favored 'General case' 0 CA--C 1.541 0.618 0 O-C-N 123.429 0.456 . . . . 70.51 110.682 178.969 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -75.88 -25.87 56.52 Favored 'General case' 0 N--CA 1.476 0.843 0 CA-C-N 115.881 -0.6 . . . . 74.02 111.432 179.226 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 39' ' ' LEU . . . . . 0.477 ' HG ' ' O ' ' A' ' 35' ' ' ASN . 85.5 mt -68.99 -40.1 78.96 Favored 'General case' 0 N--CA 1.48 1.037 0 C-N-CA 123.605 0.762 . . . . 73.04 109.868 172.544 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 37.1 t -68.38 -56.67 7.7 Favored 'General case' 0 N--CA 1.475 0.814 0 C-N-CA 124.584 1.154 . . . . 73.31 111.359 -177.151 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 18.1 p -71.87 -30.01 64.97 Favored 'General case' 0 N--CA 1.473 0.697 0 CA-C-N 115.625 -0.716 . . . . 75.4 111.587 -179.26 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 83.26 26.58 43.32 Favored Glycine 0 C--N 1.347 1.169 0 CA-C-N 116.093 -0.503 . . . . 74.34 112.805 -179.436 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 40.7 mm-40 -67.0 -21.01 65.97 Favored 'General case' 0 N--CA 1.476 0.874 0 C-N-CA 122.979 0.512 . . . . 75.12 111.873 177.887 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 3.3 mmpm? -100.61 18.31 19.55 Favored 'General case' 0 CA--C 1.548 0.866 0 C-N-CA 124.052 0.941 . . . . 74.11 111.159 175.443 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 87.43 -25.06 8.54 Favored Glycine 0 C--N 1.349 1.299 0 CA-C-O 119.437 -0.646 . . . . 73.1 114.304 175.034 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 17.4 m-85 -69.2 -48.78 61.11 Favored 'General case' 0 N--CA 1.478 0.928 0 CA-C-N 117.237 0.519 . . . . 72.14 111.655 -167.145 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 53.29 64.74 3.92 Favored Glycine 0 C--N 1.353 1.505 0 O-C-N 123.942 0.776 . . . . 75.12 114.212 170.692 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 48' ' ' TYR . . . . . 0.451 ' HB3' ' HB2' ' A' ' 51' ' ' SER . 59.3 m-85 -60.95 86.95 0.02 OUTLIER 'General case' 0 CA--C 1.551 1.006 0 CA-C-O 121.69 0.757 . . . . 73.45 111.044 178.209 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 27.7 tptp -112.68 125.28 54.13 Favored 'General case' 0 C--O 1.238 0.455 0 N-CA-C 107.306 -1.368 . . . . 74.11 107.306 177.086 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 73.92 21.62 78.99 Favored Glycine 0 CA--C 1.53 0.989 0 O-C-N 123.364 0.415 . . . . 73.44 112.097 -172.117 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 51' ' ' SER . . . . . 0.64 ' HA ' ' HB2' ' A' ' 67' ' ' PHE . 31.8 t -61.81 112.05 2.13 Favored 'General case' 0 C--N 1.358 0.944 0 C-N-CA 123.65 0.78 . . . . 73.12 111.042 -173.486 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 52' ' ' CYS . . . . . 0.596 ' SG ' ' HB3' ' A' ' 66' ' ' ASP . 5.1 p -82.06 161.76 22.8 Favored 'General case' 0 CA--C 1.537 0.446 0 CA-C-O 121.769 0.795 . . . . 64.45 111.914 -172.864 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 30.2 m-85 -113.72 133.36 55.39 Favored 'General case' 0 C--O 1.235 0.337 0 CA-C-N 114.613 -1.176 . . . . 75.13 108.136 177.164 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 54' ' ' HIS . . . . . 0.501 ' HD1' ' HB2' ' A' ' 66' ' ' ASP . 55.6 p-80 -115.9 -19.98 10.18 Favored 'General case' 0 N--CA 1.485 1.319 0 C-N-CA 122.871 0.468 . . . . 63.32 110.883 -179.351 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 55' ' ' ARG . . . . . 0.478 ' HA ' ' O ' ' A' ' 150' ' ' GLY . 27.9 ttt-85 -130.22 97.02 4.31 Favored 'General case' 0 C--O 1.215 -0.728 0 C-N-CA 123.116 0.566 . . . . 74.35 109.553 -172.158 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 33.2 mt -136.05 129.46 47.37 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.716 0 C-N-CA 123.488 0.715 . . . . 75.02 109.138 178.816 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 57' ' ' ILE . . . . . 0.436 HG23 ' HA ' ' A' ' 148' ' ' ARG . 56.8 mt -128.83 118.04 19.6 Favored Pre-proline 0 CA--C 1.552 1.02 0 C-N-CA 124.591 1.157 . . . . 75.22 109.153 -178.168 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 58' ' ' PRO . . . . . 0.694 ' HB3' ' HA ' ' A' ' 144' ' ' ARG . 38.7 Cg_endo -63.96 140.27 71.92 Favored 'Trans proline' 0 C--N 1.377 2.058 0 C-N-CA 123.563 2.842 . . . . 74.53 113.325 -175.966 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 73.4 20.45 79.88 Favored Glycine 0 C--N 1.346 1.115 0 CA-C-N 115.094 -0.957 . . . . 72.45 113.057 178.839 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 60' ' ' PHE . . . . . 0.417 ' CD2' ' HB3' ' A' ' 61' ' ' MET . 47.2 t80 -145.24 -73.68 0.24 Allowed 'General case' 0 C--O 1.244 0.782 0 C-N-CA 123.662 0.785 . . . . 73.21 109.717 -174.366 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 61' ' ' MET . . . . . 0.692 ' SD ' ' HB2' ' A' ' 63' ' ' GLN . 12.3 tmm? -169.15 137.03 1.9 Allowed 'General case' 0 N--CA 1.479 1.001 0 O-C-N 123.272 0.358 . . . . 74.33 111.686 -164.883 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 62' ' ' CYS . . . . . 0.463 ' SG ' ' HB ' ' A' ' 114' ' ' ILE . 3.9 p -112.89 121.32 44.32 Favored 'General case' 0 N--CA 1.484 1.228 0 C-N-CA 124.673 1.189 . . . . 74.12 110.585 174.334 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 63' ' ' GLN . . . . . 0.692 ' HB2' ' SD ' ' A' ' 61' ' ' MET . 53.7 tt0 -126.95 137.6 53.15 Favored 'General case' 0 N--CA 1.49 1.562 0 C-N-CA 124.163 0.985 . . . . 74.51 111.489 -168.596 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -154.86 -157.81 8.4 Favored Glycine 0 C--N 1.348 1.217 0 CA-C-N 115.975 -0.557 . . . . 51.01 113.311 -178.314 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 108.46 14.04 17.27 Favored Glycine 0 N--CA 1.476 1.344 0 N-CA-C 111.477 -0.649 . . . . 53.3 111.477 -169.789 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 66' ' ' ASP . . . . . 0.596 ' HB3' ' SG ' ' A' ' 52' ' ' CYS . 28.2 t70 -72.09 1.19 7.83 Favored 'General case' 0 CA--C 1.558 1.283 0 C-N-CA 125.242 1.417 . . . . 55.01 112.876 -167.409 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 67' ' ' PHE . . . . . 0.64 ' HB2' ' HA ' ' A' ' 51' ' ' SER . 56.6 t80 -73.36 -70.96 0.34 Allowed 'General case' 0 CA--C 1.549 0.932 0 C-N-CA 124.022 0.929 . . . . 73.31 111.41 -176.509 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 68' ' ' THR . . . . . 0.493 HG23 ' HD3' ' A' ' 76' ' ' LYS . 4.3 m -86.9 108.5 18.81 Favored 'General case' 0 N--CA 1.475 0.8 0 C-N-CA 122.949 0.5 . . . . 72.42 110.115 -171.999 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 34.8 ttt85 52.99 93.64 0.02 OUTLIER 'General case' 0 N--CA 1.481 1.116 0 C-N-CA 125.501 1.52 . . . . 72.53 111.618 -179.278 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 0.4 OUTLIER -110.69 11.73 22.67 Favored 'General case' 0 N--CA 1.481 1.088 0 N-CA-C 112.866 0.691 . . . . 73.33 112.866 -177.122 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 18.7 m120 -86.21 88.14 7.55 Favored 'General case' 0 N--CA 1.477 0.896 0 N-CA-C 108.928 -0.767 . . . . 72.44 108.928 171.467 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 69.96 29.39 70.82 Favored Glycine 0 C--N 1.35 1.334 0 CA-C-N 115.478 -0.783 . . . . 74.12 113.751 176.549 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 47.9 m -143.7 -64.55 0.38 Allowed 'General case' 0 CA--C 1.547 0.832 0 C-N-CA 124.015 0.926 . . . . 72.31 108.698 178.188 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 56.14 41.11 85.29 Favored Glycine 0 C--N 1.356 1.688 0 N-CA-C 115.234 0.853 . . . . 73.51 115.234 172.063 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 141.18 51.1 0.05 OUTLIER Glycine 0 C--N 1.346 1.12 0 CA-C-N 117.241 0.521 . . . . 71.32 111.872 -175.219 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 76' ' ' LYS . . . . . 0.6 ' HZ1' ' HB2' ' A' ' 76' ' ' LYS . 0.0 OUTLIER -58.87 147.81 32.44 Favored 'General case' 0 N--CA 1.475 0.82 0 C-N-CA 123.329 0.652 . . . . 75.15 112.151 -179.129 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 85.8 p -98.52 -178.37 3.98 Favored 'General case' 0 C--O 1.238 0.454 0 CA-C-N 115.325 -0.852 . . . . 72.44 111.953 -170.874 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 26.8 pt -75.58 -12.89 14.9 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.85 0 CA-C-N 114.999 -1.0 . . . . 75.45 111.003 175.426 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 99.2 m-85 -97.78 22.08 9.63 Favored 'General case' 0 N--CA 1.479 1.018 0 C-N-CA 124.133 0.973 . . . . 70.42 110.069 175.714 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 96.52 -111.71 4.29 Favored Glycine 0 C--N 1.346 1.128 0 N-CA-C 110.895 -0.882 . . . . 71.14 110.895 -177.694 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 41.5 tt0 -78.37 -59.63 2.7 Favored 'General case' 0 N--CA 1.472 0.628 0 C-N-CA 122.978 0.511 . . . . 73.34 110.378 -179.975 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 82' ' ' LYS . . . . . 0.759 ' HD2' ' HA ' ' A' ' 107' ' ' THR . 21.3 pttp -161.47 178.5 9.07 Favored 'General case' 0 N--CA 1.477 0.902 0 C-N-CA 123.88 0.872 . . . . 74.41 109.839 -171.055 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 35.7 p90 -152.07 174.36 13.78 Favored 'General case' 0 N--CA 1.474 0.765 0 C-N-CA 124.43 1.092 . . . . 74.43 111.459 -175.81 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 84' ' ' GLU . . . . . 0.498 ' HA ' ' HA ' ' A' ' 106' ' ' ASN . 13.7 pt-20 -82.92 160.28 22.13 Favored 'General case' 0 N--CA 1.474 0.734 0 CA-C-N 115.249 -0.887 . . . . 74.2 110.795 176.263 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 49.7 m-20 -63.04 133.98 55.39 Favored 'General case' 0 N--CA 1.47 0.56 0 C-N-CA 123.741 0.816 . . . . 72.23 110.832 179.232 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 9.9 tp10 -76.18 -61.79 1.82 Allowed 'General case' 0 CA--C 1.543 0.676 0 CA-C-N 116.074 -0.512 . . . . 73.41 109.846 179.261 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 87' ' ' ASN . . . . . 0.421 ' OD1' HG13 ' A' ' 29' ' ' VAL . 27.6 p-10 -169.36 155.39 6.27 Favored 'General case' 0 N--CA 1.477 0.899 0 C-N-CA 123.49 0.716 . . . . 62.44 110.265 -173.303 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 76.5 m-85 -109.11 33.26 4.37 Favored 'General case' 0 N--CA 1.479 1.0 0 C-N-CA 123.826 0.85 . . . . 75.54 111.442 -169.648 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 55.9 mt -60.25 -46.98 94.03 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.164 0 C-N-CA 123.311 0.644 . . . . 74.04 109.561 174.283 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 90' ' ' LEU . . . . . 0.554 HD13 ' HB2' ' A' ' 25' ' ' PHE . 95.9 mt -95.87 128.39 42.71 Favored 'General case' 0 CA--C 1.537 0.476 0 CA-C-N 115.047 -0.978 . . . . 73.13 109.803 179.067 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 17.8 ptpt -133.74 171.94 13.45 Favored 'General case' 0 N--CA 1.472 0.646 0 C-N-CA 124.305 1.042 . . . . 75.24 110.133 -179.444 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 92' ' ' HIS . . . . . . . . . . . . . 23.8 m-70 -85.49 50.28 1.93 Allowed 'General case' 0 N--CA 1.477 0.895 0 C-N-CA 124.277 1.031 . . . . 64.35 110.107 -175.909 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 8.8 t -89.28 4.92 47.19 Favored 'General case' 0 CA--C 1.549 0.929 0 C-N-CA 124.006 0.923 . . . . 62.25 111.576 -176.773 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -148.72 172.9 28.82 Favored Glycine 0 C--N 1.345 1.073 0 N-CA-C 111.93 -0.468 . . . . 64.2 111.93 178.779 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 89.9 Cg_endo -84.08 156.88 13.2 Favored 'Trans proline' 0 CA--C 1.551 1.367 0 C-N-CA 123.026 2.484 . . . . 74.11 111.921 172.363 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 78.61 19.95 72.48 Favored Glycine 0 N--CA 1.471 1.03 0 CA-C-N 116.418 -0.355 . . . . 73.14 113.86 -179.438 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 97' ' ' ILE . . . . . . . . . . . . . 22.1 mm -78.91 109.77 13.95 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.777 0 C-N-CA 123.954 0.902 . . . . 73.33 111.41 -175.483 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 98' ' ' LEU . . . . . 0.483 HD12 HG12 ' A' ' 114' ' ' ILE . 65.6 tp -90.09 118.46 29.65 Favored 'General case' 0 CA--C 1.551 1.004 0 C-N-CA 123.299 0.64 . . . . 72.4 109.661 176.35 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 99' ' ' SER . . . . . 0.464 ' HB2' HG21 ' A' ' 128' ' ' VAL . 33.5 t -137.39 155.85 48.89 Favored 'General case' 0 N--CA 1.476 0.875 0 C-N-CA 124.979 1.312 . . . . 75.35 108.911 -177.495 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 100' ' ' MET . . . . . 0.407 ' HA ' ' HA ' ' A' ' 112' ' ' PHE . 41.2 mtp -90.41 147.31 23.52 Favored 'General case' 0 N--CA 1.486 1.348 0 N-CA-C 110.069 -0.345 . . . . 72.34 110.069 178.123 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 101' ' ' ALA . . . . . 0.482 ' HB2' ' HA2' ' B' ' 219' ' ' GLY . . . -84.46 162.52 19.9 Favored 'General case' 0 N--CA 1.475 0.8 0 C-N-CA 123.443 0.697 . . . . 73.34 112.622 -169.873 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 26.1 p-10 -165.1 168.05 17.65 Favored 'General case' 0 C--N 1.352 0.714 0 CA-C-N 115.142 -0.936 . . . . 73.45 110.358 178.757 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -113.72 9.02 17.67 Favored 'General case' 0 CA--C 1.543 0.701 0 C-N-CA 123.606 0.762 . . . . 75.2 109.75 168.174 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 154.08 -173.73 32.64 Favored Glycine 0 C--N 1.354 1.548 0 CA-C-O 119.706 -0.497 . . . . 52.24 112.552 -178.887 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 48.9 Cg_exo -58.59 143.75 98.04 Favored 'Trans proline' 0 C--N 1.373 1.842 0 C-N-CA 123.43 2.753 . . . . 75.51 112.898 176.876 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 106' ' ' ASN . . . . . 0.498 ' HA ' ' HA ' ' A' ' 84' ' ' GLU . 61.6 t30 63.96 14.65 8.58 Favored 'General case' 0 N--CA 1.485 1.284 0 C-N-CA 125.267 1.427 . . . . 72.33 111.837 -178.034 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 107' ' ' THR . . . . . 0.759 ' HA ' ' HD2' ' A' ' 82' ' ' LYS . 2.8 m -115.55 -0.48 13.03 Favored 'General case' 0 CA--C 1.551 0.995 0 C-N-CA 123.766 0.827 . . . . 74.31 109.93 179.263 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 54.7 t30 -78.09 155.01 30.81 Favored 'General case' 0 N--CA 1.479 0.983 0 C-N-CA 123.363 0.665 . . . . 73.32 110.246 -178.016 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 96.37 -10.26 67.2 Favored Glycine 0 N--CA 1.468 0.801 0 CA-C-O 120.076 -0.291 . . . . 44.01 113.11 177.533 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 16.2 p -91.19 123.13 34.4 Favored 'General case' 0 CA--C 1.538 0.513 0 N-CA-C 107.539 -1.282 . . . . 71.01 107.539 167.322 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 111' ' ' GLN . . . . . 0.445 ' HB2' ' HB3' ' A' ' 101' ' ' ALA . 3.0 mt-30 69.76 165.23 0.27 Allowed 'General case' 0 N--CA 1.493 1.703 0 C-N-CA 125.852 1.661 . . . . 73.52 111.19 -178.594 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 112' ' ' PHE . . . . . 0.407 ' HA ' ' HA ' ' A' ' 100' ' ' MET . 54.3 p90 -139.43 155.6 47.5 Favored 'General case' 0 N--CA 1.482 1.134 0 N-CA-C 108.985 -0.746 . . . . 74.11 108.985 175.793 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 113' ' ' PHE . . . . . 0.55 ' HB2' ' SD ' ' A' ' 61' ' ' MET . 53.7 p90 -152.61 152.83 32.27 Favored 'General case' 0 N--CA 1.471 0.605 0 C-N-CA 122.963 0.505 . . . . 75.14 111.65 -176.337 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 114' ' ' ILE . . . . . 0.483 HG12 HD12 ' A' ' 98' ' ' LEU . 6.4 mt -119.93 108.05 22.46 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.761 0 N-CA-C 108.121 -1.066 . . . . 63.21 108.121 -176.724 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 115' ' ' CYS . . . . . . . . . . . . . 60.1 m -80.62 105.83 12.17 Favored 'General case' 0 N--CA 1.47 0.53 0 C-N-CA 123.129 0.572 . . . . 74.54 109.769 176.656 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 116' ' ' THR . . . . . 0.412 ' HA ' ' HE1' ' A' ' 136' ' ' MET . 40.5 p -71.85 -24.98 61.78 Favored 'General case' 0 N--CA 1.482 1.152 0 C-N-CA 122.612 0.365 . . . . 74.34 110.596 173.971 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -98.48 147.07 25.12 Favored 'General case' 0 C--O 1.239 0.545 0 CA-C-N 115.828 -0.624 . . . . 64.33 109.756 171.717 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 9.0 ptmm? -70.16 84.19 0.54 Allowed 'General case' 0 N--CA 1.477 0.899 0 CA-C-O 121.848 0.832 . . . . 74.1 110.021 171.847 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 119' ' ' THR . . . . . . . . . . . . . 35.8 p -79.92 85.31 5.56 Favored 'General case' 0 CA--C 1.548 0.866 0 CA-C-N 114.947 -1.024 . . . . 74.21 110.133 -175.546 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 9.3 pt-20 -68.39 -26.25 65.47 Favored 'General case' 0 N--CA 1.48 1.071 0 CA-C-N 114.737 -1.12 . . . . 71.42 112.125 -172.444 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 121' ' ' TRP . . . . . . . . . . . . . 47.0 p90 -72.57 1.08 8.83 Favored 'General case' 0 N--CA 1.473 0.715 0 C-N-CA 123.584 0.754 . . . . 74.4 112.265 178.546 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 122' ' ' LEU . . . . . 0.514 ' HB3' ' HE1' ' A' ' 126' ' ' HIS . 40.3 mt -104.12 5.3 35.01 Favored 'General case' 0 N--CA 1.475 0.815 0 C-N-CA 123.252 0.621 . . . . 74.22 111.897 176.355 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 40.4 m-20 -80.55 153.92 27.81 Favored 'General case' 0 N--CA 1.487 1.391 0 C-N-CA 122.812 0.445 . . . . 74.34 110.963 177.425 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 71.49 19.98 78.07 Favored Glycine 0 C--N 1.359 1.823 0 O-C-N 123.442 0.463 . . . . 64.2 112.304 -173.02 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 43.4 mtmt -145.22 -158.4 0.89 Allowed 'General case' 0 N--CA 1.47 0.533 0 C-N-CA 126.805 2.042 . . . . 74.01 107.884 -171.427 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 126' ' ' HIS . . . . . 0.514 ' HE1' ' HB3' ' A' ' 122' ' ' LEU . 0.0 OUTLIER -56.3 130.62 45.31 Favored 'General case' 0 N--CA 1.478 0.973 0 C-N-CA 123.8 0.84 . . . . 74.33 113.034 -159.119 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 99.3 t -61.45 130.14 25.22 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.615 0 CA-C-N 113.058 -1.883 . . . . 65.5 113.003 -166.517 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 128' ' ' VAL . . . . . 0.464 HG21 ' HB2' ' A' ' 99' ' ' SER . 92.8 t -81.05 145.26 9.18 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.313 0 CA-C-N 114.811 -1.086 . . . . 65.42 108.754 170.45 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 129' ' ' PHE . . . . . 0.553 ' HA ' HG22 ' A' ' 29' ' ' VAL . 21.6 p90 -138.27 -33.32 0.69 Allowed 'General case' 0 N--CA 1.469 0.503 0 C-N-CA 122.411 0.284 . . . . 73.52 110.984 -177.551 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . -115.66 165.14 12.15 Favored Glycine 0 C--N 1.337 0.588 0 O-C-N 123.709 0.631 . . . . 74.22 113.122 -175.591 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 30.2 ttpt -153.1 122.19 6.57 Favored 'General case' 0 C--N 1.324 -0.516 0 N-CA-C 107.207 -1.405 . . . . 74.4 107.207 177.867 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 3.9 p -65.92 105.36 0.62 Allowed 'Isoleucine or valine' 0 CA--C 1.553 1.078 0 CA-C-O 121.716 0.77 . . . . 61.33 109.651 175.56 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 133' ' ' LYS . . . . . 0.535 ' HD2' ' HB2' ' A' ' 23' ' ' GLU . 0.1 OUTLIER -78.5 -38.79 39.96 Favored 'General case' 0 N--CA 1.474 0.766 0 CA-C-N 114.901 -1.045 . . . . 75.2 109.903 -179.295 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 49.9 mt-10 -145.62 144.5 30.49 Favored 'General case' 0 N--CA 1.481 1.114 0 C-N-CA 124.599 1.16 . . . . 65.45 108.879 177.636 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 94.84 17.24 38.85 Favored Glycine 0 N--CA 1.472 1.059 0 N-CA-C 112.417 -0.273 . . . . 74.32 112.417 -176.409 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 136' ' ' MET . . . . . 0.412 ' HE1' ' HA ' ' A' ' 116' ' ' THR . 14.5 tpt -61.81 -35.19 77.48 Favored 'General case' 0 N--CA 1.482 1.167 0 C-N-CA 124.113 0.965 . . . . 75.34 111.683 179.374 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 137' ' ' ASN . . . . . . . . . . . . . 1.8 m-20 -61.68 -34.71 76.22 Favored 'General case' 0 CA--C 1.548 0.875 0 C-N-CA 123.589 0.756 . . . . 74.14 110.774 177.796 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 138' ' ' ILE . . . . . . . . . . . . . 43.9 mm -72.05 -35.76 54.78 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.854 0 C-N-CA 123.076 0.55 . . . . 72.52 110.389 179.477 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 98.7 t -63.12 -45.88 97.47 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.872 0 C-N-CA 123.18 0.592 . . . . 71.31 110.374 175.879 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 40.9 mt-10 -68.26 -26.76 65.83 Favored 'General case' 0 N--CA 1.476 0.837 0 CA-C-N 115.498 -0.774 . . . . 74.14 111.186 178.352 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -71.99 -56.69 5.21 Favored 'General case' 0 N--CA 1.475 0.782 0 C-N-CA 123.332 0.653 . . . . 71.12 111.185 176.69 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 142' ' ' MET . . . . . 0.537 ' HE1' HG23 ' A' ' 156' ' ' ILE . 26.8 ptm -61.12 -35.7 77.73 Favored 'General case' 0 N--CA 1.48 1.059 0 C-N-CA 123.718 0.807 . . . . 65.3 111.829 -177.753 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 33.4 tt0 -66.05 -32.14 73.44 Favored 'General case' 0 CA--C 1.543 0.709 0 CA-C-O 121.462 0.648 . . . . 65.5 112.219 -173.91 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 144' ' ' ARG . . . . . 0.694 ' HA ' ' HB3' ' A' ' 58' ' ' PRO . 96.4 mtt180 -80.54 -6.58 58.43 Favored 'General case' 0 N--CA 1.47 0.544 0 CA-C-N 115.855 -0.611 . . . . 74.1 111.866 -178.65 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 145' ' ' PHE . . . . . 0.491 ' HD2' ' HA ' ' A' ' 142' ' ' MET . 50.9 m-85 -85.12 5.47 29.68 Favored 'General case' 0 CA--C 1.552 1.025 0 C-N-CA 123.309 0.644 . . . . 72.15 111.131 167.647 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . -93.72 -170.97 38.93 Favored Glycine 0 C--N 1.35 1.359 0 N-CA-C 112.381 -0.287 . . . . 70.31 112.381 172.987 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 12.9 m -132.74 162.53 31.2 Favored 'General case' 0 N--CA 1.48 1.049 0 C-N-CA 123.545 0.738 . . . . 74.34 109.513 -179.322 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 148' ' ' ARG . . . . . 0.436 ' HA ' HG23 ' A' ' 57' ' ' ILE . 17.4 mmm180 -71.5 -18.89 62.26 Favored 'General case' 0 N--CA 1.483 1.18 0 C-N-CA 123.823 0.849 . . . . 73.22 112.946 -172.902 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 149' ' ' ASN . . . . . . . . . . . . . 30.6 p-10 -85.89 -21.47 27.98 Favored 'General case' 0 N--CA 1.481 1.085 0 C-N-CA 123.619 0.768 . . . . 73.41 110.8 174.198 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 150' ' ' GLY . . . . . 0.478 ' O ' ' HA ' ' A' ' 55' ' ' ARG . . . 119.45 -11.23 11.37 Favored Glycine 0 C--N 1.347 1.189 0 CA-C-N 115.915 -0.584 . . . . 53.13 113.187 -178.747 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 37.5 ttpt -64.56 137.55 57.91 Favored 'General case' 0 N--CA 1.476 0.844 0 CA-C-N 117.921 0.86 . . . . 73.1 110.799 -177.698 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 152' ' ' THR . . . . . . . . . . . . . 18.1 p -91.13 113.28 25.51 Favored 'General case' 0 CA--C 1.539 0.528 0 N-CA-C 109.117 -0.698 . . . . 70.13 109.117 176.079 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 153' ' ' SER . . . . . . . . . . . . . 32.1 t -67.39 -35.41 79.27 Favored 'General case' 0 N--CA 1.475 0.803 0 C-N-CA 123.208 0.603 . . . . 72.45 110.419 -179.318 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 75.6 mmtt -110.09 152.16 26.32 Favored 'General case' 0 C--O 1.243 0.714 0 CA-C-N 114.959 -1.019 . . . . 73.53 109.381 178.971 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 17.3 tppt? -79.23 88.88 4.89 Favored 'General case' 0 C--N 1.349 0.552 0 N-CA-C 108.558 -0.904 . . . . 73.21 108.558 177.338 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 156' ' ' ILE . . . . . 0.537 HG23 ' HE1' ' A' ' 142' ' ' MET . 58.0 mt -93.01 119.29 40.47 Favored 'Isoleucine or valine' 0 C--O 1.234 0.248 0 N-CA-C 108.821 -0.807 . . . . 71.22 108.821 -177.94 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 157' ' ' THR . . . . . . . . . . . . . 37.1 p -132.9 144.28 50.06 Favored 'General case' 0 C--O 1.238 0.481 0 C-N-CA 124.861 1.264 . . . . 74.54 109.099 -177.576 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 158' ' ' ILE . . . . . 0.443 HG22 ' HB3' ' A' ' 8' ' ' PHE . 62.2 mt -73.22 92.85 0.59 Allowed 'Isoleucine or valine' 0 CA--C 1.54 0.595 0 N-CA-C 107.526 -1.287 . . . . 72.42 107.526 166.874 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 159' ' ' ALA . . . . . 0.542 ' HB3' ' HB3' ' A' ' 11' ' ' ALA . . . -55.06 -57.32 12.18 Favored 'General case' 0 N--CA 1.47 0.549 0 C-N-CA 123.839 0.856 . . . . 72.33 110.892 -176.689 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 160' ' ' ASP . . . . . . . . . . . . . 13.2 m-20 -135.62 177.18 8.03 Favored 'General case' 0 N--CA 1.469 0.511 0 CA-C-O 121.698 0.761 . . . . 75.01 111.664 -175.18 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 161' ' ' CYS . . . . . . . . . . . . . 21.8 p -144.89 -169.35 3.16 Favored 'General case' 0 CA--C 1.542 0.644 0 C-N-CA 125.919 1.688 . . . . 74.32 107.768 -177.621 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 162' ' ' GLY . . . . . . . . . . . . . . . 130.27 53.06 0.1 Allowed Glycine 0 C--N 1.341 0.825 0 N-CA-C 109.92 -1.272 . . . . 65.13 109.92 -172.724 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 163' ' ' GLN . . . . . 0.513 ' HB2' ' HA ' ' A' ' 6' ' ' VAL . 15.6 pt20 -54.23 152.81 5.8 Favored 'General case' 0 CA--C 1.548 0.87 0 N-CA-C 114.512 1.301 . . . . 73.45 114.512 -170.927 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 164' ' ' LEU . . . . . 0.612 ' HG ' ' HB2' ' A' ' 7' ' ' PHE . 82.4 mt . . . . . 0 C--O 1.241 0.628 0 C-N-CA 124.462 1.105 . . . . 75.44 110.957 -169.874 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 218' ' ' PRO . . . . . . . . . . . . . 21.9 Cg_exo . . . . . 0 CA--C 1.545 1.052 0 N-CA-C 110.482 -0.622 . . . . 73.32 110.482 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' B' B ' 219' ' ' GLY . . . . . 0.482 ' HA2' ' HB2' ' A' ' 101' ' ' ALA . . . -173.14 147.81 9.92 Favored Glycine 0 C--N 1.347 1.184 0 CA-C-O 119.722 -0.488 . . . . 71.43 113.292 -178.943 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 220' ' ' PRO . . . . . 0.432 ' HB3' ' HE2' ' A' ' 126' ' ' HIS . 56.6 Cg_endo -67.55 153.46 76.32 Favored 'Trans proline' 0 C--N 1.377 2.075 0 C-N-CA 123.553 2.835 . . . . 65.04 112.748 177.923 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 221' ' ' TYR . . . . . . . . . . . . . 83.2 m-85 . . . . . 0 N--CA 1.477 0.908 0 C-N-CA 122.781 0.433 . . . . 74.3 110.709 -178.571 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 3' ' ' ASN . . . . . 0.502 HD21 ' HA ' ' A' ' 25' ' ' PHE . 13.4 m120 . . . . . 0 CA--C 1.545 0.775 0 CA-C-O 118.942 -0.551 . . . . 74.22 111.849 . . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 36.4 Cg_endo -64.58 122.1 9.88 Favored 'Trans proline' 0 C--N 1.382 2.306 0 C-N-CA 122.872 2.381 . . . . 73.12 111.076 173.973 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 50.6 m -97.88 129.52 44.82 Favored 'General case' 0 CA--C 1.534 0.352 0 C-N-CA 123.585 0.754 . . . . 75.03 109.441 -178.068 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 6' ' ' VAL . . . . . 0.537 ' HA ' ' HG3' ' A' ' 163' ' ' GLN . 27.2 m -99.26 126.1 52.63 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.364 0 N-CA-C 108.209 -1.034 . . . . 54.04 108.209 175.471 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 7' ' ' PHE . . . . . 0.524 ' H ' ' HA ' ' A' ' 163' ' ' GLN . 57.7 t80 -108.85 135.52 49.92 Favored 'General case' 0 C--O 1.237 0.404 0 N-CA-C 109.037 -0.727 . . . . 70.31 109.037 -175.932 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 72.6 m-85 -139.62 166.21 25.2 Favored 'General case' 0 C--O 1.24 0.604 0 C-N-CA 124.654 1.182 . . . . 72.31 109.8 178.471 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 43.4 m-20 -118.01 116.25 26.53 Favored 'General case' 0 C--N 1.328 -0.365 0 N-CA-C 106.389 -1.708 . . . . 75.5 106.389 166.163 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 33.8 mm -98.93 143.68 12.92 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.711 0 N-CA-C 108.916 -0.772 . . . . 74.43 108.916 -177.465 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 11' ' ' ALA . . . . . 0.507 ' HB1' ' HB2' ' A' ' 159' ' ' ALA . . . -136.99 140.36 42.1 Favored 'General case' 0 N--CA 1.467 0.417 0 C-N-CA 123.304 0.642 . . . . 60.12 111.818 -164.432 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 21.4 t -98.36 109.93 24.85 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.795 0 N-CA-C 107.796 -1.187 . . . . 72.41 107.796 171.418 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 45.4 m-20 68.25 20.63 8.73 Favored 'General case' 0 N--CA 1.497 1.904 0 C-N-CA 124.384 1.073 . . . . 73.35 111.766 -177.656 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 87.3 -3.19 86.75 Favored Glycine 0 C--N 1.349 1.278 0 CA-C-O 119.964 -0.353 . . . . 70.31 113.067 -174.666 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 40.0 mm-40 -84.18 113.71 49.96 Favored Pre-proline 0 CA--C 1.543 0.689 0 N-CA-C 108.902 -0.777 . . . . 71.35 108.902 175.235 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 21.1 Cg_endo -56.84 107.97 0.31 Allowed 'Trans proline' 0 C--N 1.383 2.354 0 C-N-CA 123.0 2.467 . . . . 75.24 111.749 -176.524 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 46.3 tp -78.92 -45.45 20.5 Favored 'General case' 0 N--CA 1.47 0.539 0 CA-C-N 115.538 -0.756 . . . . 73.24 109.36 178.535 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -176.1 -171.46 39.92 Favored Glycine 0 C--N 1.337 0.596 0 CA-C-N 115.742 -0.663 . . . . 73.11 112.688 179.944 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 40.3 ptt85 -106.21 144.78 32.43 Favored 'General case' 0 C--O 1.239 0.537 0 C-N-CA 123.875 0.87 . . . . 74.1 108.674 178.691 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 94.6 t -134.17 139.27 48.56 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.588 0 N-CA-C 108.683 -0.858 . . . . 73.2 108.683 176.887 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 24.8 m -133.12 118.38 18.64 Favored 'General case' 0 CA--C 1.545 0.777 0 C-N-CA 124.867 1.267 . . . . 54.53 108.414 -175.872 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 22' ' ' PHE . . . . . 0.462 ' HA ' ' HA ' ' A' ' 132' ' ' VAL . 41.0 m-85 -102.87 129.63 49.63 Favored 'General case' 0 N--CA 1.479 1.002 0 N-CA-C 109.435 -0.58 . . . . 71.54 109.435 177.512 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 35.7 tt0 -90.33 108.18 19.61 Favored 'General case' 0 CA--C 1.548 0.873 0 C-N-CA 124.183 0.993 . . . . 74.13 109.426 177.447 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . 0.501 ' HB3' ' HB2' ' A' ' 33' ' ' ALA . 40.6 mt -87.25 122.09 30.56 Favored 'General case' 0 N--CA 1.48 1.063 0 C-N-CA 123.031 0.532 . . . . 73.53 110.605 -177.008 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 25' ' ' PHE . . . . . 0.502 ' HA ' HD21 ' A' ' 3' ' ' ASN . 48.8 m-85 -84.91 65.26 9.1 Favored 'General case' 0 CA--C 1.548 0.879 0 C-N-CA 123.916 0.886 . . . . 74.22 110.805 -179.951 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -65.86 -25.88 67.39 Favored 'General case' 0 N--CA 1.482 1.131 0 CA-C-N 115.127 -0.942 . . . . 60.04 111.912 -177.766 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 9.2 p-10 -72.81 -6.64 46.24 Favored 'General case' 0 N--CA 1.48 1.041 0 C-N-CA 123.489 0.716 . . . . 75.52 111.341 -179.544 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 91.7 mttt -114.6 -48.94 2.84 Favored 'General case' 0 N--CA 1.476 0.857 0 C-N-CA 123.771 0.828 . . . . 75.44 109.872 177.242 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 29' ' ' VAL . . . . . 0.456 HG21 ' HA ' ' A' ' 129' ' ' PHE . 14.6 m -121.94 79.02 41.49 Favored Pre-proline 0 CA--C 1.566 1.56 0 C-N-CA 124.329 1.052 . . . . 73.24 109.293 -178.684 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 35.6 Cg_exo -60.03 -57.3 0.82 Allowed 'Trans proline' 0 C--N 1.391 2.766 0 C-N-CA 123.204 2.603 . . . . 75.3 112.953 -169.671 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 29.2 ttmt -58.43 -45.09 89.17 Favored 'General case' 0 N--CA 1.479 0.999 0 C-N-CA 124.564 1.146 . . . . 72.24 112.085 179.385 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 6.9 m -67.0 -40.1 87.28 Favored 'General case' 0 CA--C 1.548 0.894 0 CA-C-N 114.58 -1.191 . . . . 65.11 111.671 -170.459 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 33' ' ' ALA . . . . . 0.501 ' HB2' ' HB3' ' A' ' 24' ' ' LEU . . . -80.71 -36.18 32.55 Favored 'General case' 0 N--CA 1.475 0.798 0 C-N-CA 123.586 0.755 . . . . 74.42 110.702 178.381 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 14.7 tp10 -62.41 -32.04 72.81 Favored 'General case' 0 N--CA 1.486 1.37 0 C-N-CA 124.042 0.937 . . . . 73.1 111.144 -179.526 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 35' ' ' ASN . . . . . 0.555 ' ND2' ' SD ' ' A' ' 100' ' ' MET . 44.9 t30 -55.97 -64.35 0.88 Allowed 'General case' 0 CA--C 1.544 0.741 0 C-N-CA 123.823 0.849 . . . . 63.34 110.801 176.115 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 36' ' ' PHE . . . . . 0.517 ' HE2' HG22 ' A' ' 6' ' ' VAL . 65.7 t80 -65.5 -30.14 70.87 Favored 'General case' 0 N--CA 1.476 0.856 0 C-N-CA 123.603 0.761 . . . . 70.35 111.065 -176.264 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 44.8 ttp85 -64.76 -51.43 62.31 Favored 'General case' 0 CA--C 1.551 0.985 0 C-N-CA 124.015 0.926 . . . . 74.42 109.593 -179.415 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -78.44 -15.09 59.02 Favored 'General case' 0 CA--C 1.544 0.729 0 CA-C-N 115.037 -0.983 . . . . 75.43 112.26 -176.567 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 92.8 mt -79.59 -35.55 39.44 Favored 'General case' 0 N--CA 1.487 1.391 0 C-N-CA 122.96 0.504 . . . . 74.04 110.418 170.511 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 42.6 t -66.06 -54.39 26.48 Favored 'General case' 0 N--CA 1.477 0.897 0 C-N-CA 124.285 1.034 . . . . 74.42 110.592 179.892 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 10.9 p -75.67 -32.0 59.98 Favored 'General case' 0 N--CA 1.475 0.806 0 CA-C-N 115.878 -0.601 . . . . 72.42 111.52 175.87 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 81.5 34.96 24.2 Favored Glycine 0 C--N 1.348 1.221 0 CA-C-N 116.481 -0.327 . . . . 73.2 113.402 177.879 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 41.2 mm-40 -66.41 -20.47 66.07 Favored 'General case' 0 N--CA 1.476 0.867 0 C-N-CA 123.693 0.797 . . . . 74.21 111.991 -178.632 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 9.8 mmpt? -93.67 8.17 41.93 Favored 'General case' 0 CA--C 1.552 1.029 0 C-N-CA 124.193 0.997 . . . . 72.11 110.842 179.265 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 76.33 33.79 47.65 Favored Glycine 0 C--N 1.351 1.365 0 CA-C-O 119.774 -0.459 . . . . 71.14 113.384 179.995 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 23.4 m-85 -116.21 -49.35 2.69 Favored 'General case' 0 N--CA 1.484 1.266 0 CA-C-N 117.214 0.507 . . . . 74.23 110.797 -178.317 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 47.12 63.32 3.34 Favored Glycine 0 C--N 1.354 1.554 0 O-C-N 124.482 1.114 . . . . 73.33 115.371 169.609 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 32.0 m-85 -66.36 92.63 0.2 Allowed 'General case' 0 C--N 1.353 0.752 0 CA-C-O 121.869 0.842 . . . . 75.42 111.435 -173.71 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 27.9 tptp -109.33 94.8 5.23 Favored 'General case' 0 C--O 1.239 0.522 0 CA-C-N 113.991 -1.458 . . . . 74.42 108.591 -175.059 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 118.95 21.37 3.85 Favored Glycine 0 C--N 1.348 1.202 0 CA-C-O 119.781 -0.455 . . . . 53.32 113.395 -179.547 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 51' ' ' SER . . . . . 0.501 ' HB2' HD11 ' A' ' 158' ' ' ILE . 19.7 m -60.5 119.15 7.49 Favored 'General case' 0 N--CA 1.476 0.854 0 C-N-CA 123.577 0.751 . . . . 62.32 110.716 179.463 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 52' ' ' CYS . . . . . 0.414 ' HA ' ' HA ' ' A' ' 157' ' ' THR . 10.6 p -104.91 129.21 53.32 Favored 'General case' 0 N--CA 1.474 0.743 0 CA-C-O 121.637 0.732 . . . . 63.02 112.525 -170.415 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 53' ' ' PHE . . . . . 0.763 ' HA ' ' HA2' ' A' ' 64' ' ' GLY . 55.9 m-85 -70.52 109.71 4.99 Favored 'General case' 0 C--N 1.347 0.494 0 C-N-CA 124.842 1.257 . . . . 73.45 109.646 174.148 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 49.7 p-80 -120.28 -5.48 9.91 Favored 'General case' 0 N--CA 1.481 1.086 0 C-N-CA 123.815 0.846 . . . . 73.24 111.235 -176.454 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 55' ' ' ARG . . . . . 0.443 ' O ' ' HB3' ' A' ' 63' ' ' GLN . 53.2 ttt-85 -129.57 97.6 4.59 Favored 'General case' 0 N--CA 1.473 0.719 0 N-CA-C 108.891 -0.781 . . . . 73.32 108.891 175.604 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 56' ' ' ILE . . . . . 0.446 HG23 ' HA ' ' A' ' 143' ' ' GLU . 64.3 mt -130.55 127.18 61.9 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.943 0 N-CA-C 108.389 -0.967 . . . . 61.31 108.389 177.291 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 74.9 mt -124.85 118.16 25.84 Favored Pre-proline 0 CA--C 1.555 1.144 0 C-N-CA 123.974 0.909 . . . . 74.55 108.904 -177.884 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 52.7 Cg_exo -57.63 145.65 88.37 Favored 'Trans proline' 0 C--N 1.383 2.365 0 C-N-CA 124.229 3.286 . . . . 75.34 114.205 -179.237 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 66.1 24.19 71.69 Favored Glycine 0 C--N 1.352 1.451 0 O-C-N 124.291 0.994 . . . . 75.43 112.954 -179.272 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 36.3 t80 -145.09 -76.38 0.21 Allowed 'General case' 0 C--O 1.244 0.764 0 C-N-CA 123.886 0.875 . . . . 72.41 110.221 -173.744 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 61' ' ' MET . . . . . 0.698 ' SD ' ' HB2' ' A' ' 113' ' ' PHE . 12.1 tmm? -173.27 150.74 1.93 Allowed 'General case' 0 N--CA 1.484 1.272 0 CA-C-O 121.075 0.464 . . . . 75.14 112.19 -161.2 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 62' ' ' CYS . . . . . . . . . . . . . 36.7 t -114.45 111.92 22.19 Favored 'General case' 0 CA--C 1.558 1.287 0 C-N-CA 124.873 1.269 . . . . 72.54 109.752 175.687 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 63' ' ' GLN . . . . . 0.63 ' HB2' ' SD ' ' A' ' 61' ' ' MET . 49.6 tt0 -115.5 133.53 55.94 Favored 'General case' 0 N--CA 1.498 1.935 0 C-N-CA 124.017 0.927 . . . . 72.45 110.949 -172.209 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 64' ' ' GLY . . . . . 0.763 ' HA2' ' HA ' ' A' ' 53' ' ' PHE . . . -123.04 170.28 15.45 Favored Glycine 0 C--N 1.339 0.726 0 CA-C-N 115.259 -0.882 . . . . 63.15 112.83 179.032 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -164.54 156.99 29.21 Favored Glycine 0 C--N 1.33 0.241 0 N-CA-C 110.532 -1.027 . . . . 64.14 110.532 176.658 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 21.2 t70 -91.35 167.2 12.47 Favored 'General case' 0 C--O 1.244 0.798 0 CA-C-O 121.185 0.517 . . . . 62.41 110.34 -178.269 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 63.8 t80 -77.25 -29.08 53.81 Favored 'General case' 0 CA--C 1.552 1.035 0 C-N-CA 124.07 0.948 . . . . 75.51 111.18 -179.676 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 91.5 m -61.23 109.42 1.12 Allowed 'General case' 0 C--N 1.363 1.156 0 C-N-CA 123.922 0.889 . . . . 72.13 110.361 179.659 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 36.6 ttt180 52.98 82.89 0.07 Allowed 'General case' 0 CA--C 1.541 0.618 0 O-C-N 124.836 1.335 . . . . 75.23 110.461 -173.398 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 52.3 t60 -89.26 -19.94 24.74 Favored 'General case' 0 CA--C 1.549 0.911 0 CA-C-N 116.099 -0.501 . . . . 71.42 111.457 -174.601 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 3.5 m-20 -64.76 91.41 0.09 Allowed 'General case' 0 N--CA 1.489 1.516 0 C-N-CA 123.686 0.794 . . . . 71.51 111.214 -176.813 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 75.3 -6.19 30.88 Favored Glycine 0 C--N 1.349 1.27 0 CA-C-N 115.561 -0.745 . . . . 74.21 114.682 175.249 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -114.16 -67.03 1.03 Allowed 'General case' 0 CA--C 1.551 0.995 0 N-CA-C 109.187 -0.672 . . . . 75.13 109.187 -175.2 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 61.32 61.58 6.74 Favored Glycine 0 CA--C 1.534 1.24 0 CA-C-N 116.21 -0.45 . . . . 72.4 113.994 175.77 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 107.54 52.25 0.72 Allowed Glycine 0 N--CA 1.48 1.593 0 CA-C-N 117.674 0.737 . . . . 74.41 112.166 -177.5 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 76' ' ' LYS . . . . . 0.405 ' HA ' ' O ' ' A' ' 109' ' ' GLY . 21.5 pttp -53.77 170.58 0.11 Allowed 'General case' 0 CA--C 1.562 1.409 0 C-N-CA 125.076 1.35 . . . . 74.44 113.815 179.902 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 89.9 p -90.69 176.02 6.81 Favored 'General case' 0 N--CA 1.486 1.33 0 C-N-CA 123.689 0.796 . . . . 75.42 112.856 -165.885 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 25.5 pt -71.34 -17.95 20.05 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.225 0 C-N-CA 122.934 0.493 . . . . 74.35 110.784 174.327 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 69.7 m-85 -92.85 27.82 2.27 Favored 'General case' 0 CA--C 1.546 0.797 0 C-N-CA 124.058 0.943 . . . . 73.44 109.728 174.523 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 83.51 -119.38 4.89 Favored Glycine 0 C--N 1.354 1.551 0 CA-C-N 115.088 -0.96 . . . . 74.22 111.753 177.74 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 34.8 tt0 -61.74 -59.43 5.18 Favored 'General case' 0 C--O 1.241 0.625 0 C-N-CA 124.024 0.93 . . . . 64.43 110.723 -178.373 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 82' ' ' LYS . . . . . 0.745 ' HD2' ' HA ' ' A' ' 107' ' ' THR . 23.9 pttm -165.11 175.28 9.51 Favored 'General case' 0 CA--C 1.552 1.057 0 O-C-N 123.595 0.56 . . . . 74.2 111.742 -174.967 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 2.0 p90 -157.03 176.24 13.02 Favored 'General case' 0 N--CA 1.482 1.158 0 C-N-CA 125.83 1.652 . . . . 75.12 109.036 -179.884 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 12.5 pt-20 -93.02 -172.48 3.0 Favored 'General case' 0 N--CA 1.485 1.281 0 CA-C-O 121.255 0.55 . . . . 74.11 111.74 179.517 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 51.8 m-20 -80.42 136.74 36.41 Favored 'General case' 0 N--CA 1.471 0.614 0 C-N-CA 124.271 1.028 . . . . 70.21 109.148 173.22 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 12.6 tp10 -73.24 -52.53 13.68 Favored 'General case' 0 CA--C 1.544 0.728 0 O-C-N 123.472 0.482 . . . . 63.44 109.929 176.165 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 16.5 p-10 -170.14 134.79 1.27 Allowed 'General case' 0 N--CA 1.479 0.983 0 C-N-CA 123.595 0.758 . . . . 74.32 110.193 -174.58 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 73.7 m-85 -88.58 69.52 8.85 Favored 'General case' 0 N--CA 1.483 1.189 0 CA-C-O 121.096 0.474 . . . . 72.43 110.538 -178.053 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 37.0 mt -82.03 -58.25 3.87 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.77 0 N-CA-C 108.724 -0.843 . . . . 72.41 108.724 169.44 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 53.1 mt -92.78 119.52 32.22 Favored 'General case' 0 CA--C 1.541 0.598 0 CA-C-N 114.923 -1.035 . . . . 74.11 110.596 -171.006 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 9.8 mtmp? -121.98 171.48 8.91 Favored 'General case' 0 CA--C 1.543 0.708 0 C-N-CA 124.764 1.226 . . . . 72.31 109.814 175.086 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 92' ' ' HIS . . . . . . . . . . . . . 23.0 m-70 -78.09 80.62 4.51 Favored 'General case' 0 N--CA 1.477 0.886 0 C-N-CA 123.879 0.872 . . . . 74.34 110.16 -170.232 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 19.1 p -82.85 -57.31 3.36 Favored 'General case' 0 N--CA 1.473 0.714 0 C-N-CA 123.898 0.879 . . . . 74.45 111.212 -177.006 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -121.45 -176.64 15.34 Favored Glycine 0 C--N 1.346 1.129 0 O-C-N 123.466 0.479 . . . . 65.24 112.788 -176.374 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 8.4 Cg_exo -73.6 148.22 41.81 Favored 'Trans proline' 0 C--N 1.368 1.556 0 C-N-CA 122.987 2.458 . . . . 64.34 111.564 170.354 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 105.67 -2.6 39.17 Favored Glycine 0 N--CA 1.473 1.121 0 CA-C-N 116.391 -0.368 . . . . 65.33 113.213 -179.703 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 97' ' ' ILE . . . . . 0.458 ' HB ' ' HB2' ' A' ' 115' ' ' CYS . 18.1 mm -66.34 116.18 5.28 Favored 'Isoleucine or valine' 0 CA--C 1.555 1.167 0 C-N-CA 124.366 1.066 . . . . 74.12 111.862 -174.583 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 55.3 tp -100.29 122.43 43.07 Favored 'General case' 0 N--CA 1.479 0.994 0 C-N-CA 123.312 0.645 . . . . 70.12 110.063 173.624 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 44.9 t -142.89 144.36 32.42 Favored 'General case' 0 CA--C 1.539 0.525 0 C-N-CA 124.263 1.025 . . . . 73.21 108.254 176.944 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 100' ' ' MET . . . . . 0.555 ' SD ' ' ND2' ' A' ' 35' ' ' ASN . 13.4 ttt -79.45 141.97 36.31 Favored 'General case' 0 N--CA 1.483 1.18 0 C-N-CA 124.138 0.975 . . . . 73.12 109.073 -178.729 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 101' ' ' ALA . . . . . 0.416 ' HB1' ' HB2' ' A' ' 111' ' ' GLN . . . -77.24 160.9 28.55 Favored 'General case' 0 N--CA 1.479 1.019 0 CA-C-O 121.387 0.613 . . . . 75.43 111.616 -173.02 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 102' ' ' ASN . . . . . 0.516 ' HB3' ' HA ' ' A' ' 108' ' ' ASN . 25.7 p-10 -165.79 168.84 15.65 Favored 'General case' 0 N--CA 1.472 0.669 0 CA-C-N 114.581 -1.191 . . . . 71.55 109.711 -177.468 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -90.5 -47.28 7.8 Favored 'General case' 0 N--CA 1.469 0.503 0 N-CA-C 108.917 -0.771 . . . . 73.13 108.917 167.137 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -168.0 -152.71 7.72 Favored Glycine 0 CA--C 1.533 1.172 0 CA-C-O 119.096 -0.836 . . . . 72.41 112.561 179.485 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 37.5 Cg_exo -61.79 135.39 55.78 Favored 'Trans proline' 0 C--N 1.379 2.167 0 C-N-CA 123.116 2.544 . . . . 72.44 112.898 -178.275 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 67.1 t30 66.06 9.75 6.47 Favored 'General case' 0 N--CA 1.49 1.535 0 C-N-CA 125.211 1.404 . . . . 74.23 111.852 -179.736 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 107' ' ' THR . . . . . 0.745 ' HA ' ' HD2' ' A' ' 82' ' ' LYS . 2.2 m -111.35 8.68 21.43 Favored 'General case' 0 CA--C 1.555 1.167 0 C-N-CA 124.174 0.989 . . . . 62.21 109.857 179.415 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 108' ' ' ASN . . . . . 0.516 ' HA ' ' HB3' ' A' ' 102' ' ' ASN . 8.8 t30 -70.66 145.18 50.78 Favored 'General case' 0 N--CA 1.475 0.795 0 C-N-CA 124.599 1.16 . . . . 74.42 110.268 175.135 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 109' ' ' GLY . . . . . 0.415 ' HA2' ' SD ' ' A' ' 100' ' ' MET . . . 109.99 25.12 5.49 Favored Glycine 0 N--CA 1.468 0.778 0 C-N-CA 121.568 -0.349 . . . . 63.31 112.565 178.897 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 28.4 p -131.46 118.5 20.29 Favored 'General case' 0 CA--C 1.54 0.562 0 N-CA-C 108.735 -0.839 . . . . 75.2 108.735 177.46 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 111' ' ' GLN . . . . . 0.416 ' HB2' ' HB1' ' A' ' 101' ' ' ALA . 49.7 mt-30 59.15 -175.74 0.09 Allowed 'General case' 0 N--CA 1.497 1.898 0 C-N-CA 123.724 0.81 . . . . 64.1 112.14 -173.897 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 112' ' ' PHE . . . . . 0.432 ' HA ' ' HA ' ' A' ' 100' ' ' MET . 42.6 p90 -151.64 151.7 31.85 Favored 'General case' 0 N--CA 1.484 1.241 0 N-CA-C 108.284 -1.006 . . . . 73.22 108.284 176.748 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 113' ' ' PHE . . . . . 0.698 ' HB2' ' SD ' ' A' ' 61' ' ' MET . 51.0 p90 -140.16 137.77 34.66 Favored 'General case' 0 N--CA 1.478 0.946 0 CA-C-O 121.27 0.557 . . . . 71.52 111.803 -176.568 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 114' ' ' ILE . . . . . . . . . . . . . 11.0 mt -110.09 102.52 14.1 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.663 0 C-N-CA 124.904 1.282 . . . . 72.55 108.093 -178.358 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 115' ' ' CYS . . . . . 0.458 ' HB2' ' HB ' ' A' ' 97' ' ' ILE . 56.9 m -64.83 105.26 0.97 Allowed 'General case' 0 CA--C 1.548 0.894 0 C-N-CA 123.208 0.603 . . . . 72.12 109.765 177.125 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 116' ' ' THR . . . . . 0.549 ' HA ' ' HE2' ' A' ' 136' ' ' MET . 60.2 p -70.78 -32.01 68.99 Favored 'General case' 0 N--CA 1.476 0.844 0 C-N-CA 124.367 1.067 . . . . 72.12 110.803 -177.584 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -119.89 168.87 10.69 Favored 'General case' 0 C--O 1.247 0.946 0 C-N-CA 124.26 1.024 . . . . 60.32 108.824 169.499 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 17.5 ptmt -66.84 128.43 36.27 Favored 'General case' 0 N--CA 1.473 0.683 0 N-CA-C 109.268 -0.642 . . . . 74.53 109.268 173.462 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 119' ' ' THR . . . . . . . . . . . . . 27.0 p -131.9 84.17 2.14 Favored 'General case' 0 CA--C 1.541 0.606 0 CA-C-O 121.562 0.696 . . . . 72.05 109.15 -177.533 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 12.6 pt-20 -77.52 -15.45 59.27 Favored 'General case' 0 N--CA 1.481 1.115 0 CA-C-N 115.791 -0.64 . . . . 65.25 111.799 -172.275 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 121' ' ' TRP . . . . . . . . . . . . . 48.9 p90 -74.93 -5.05 41.71 Favored 'General case' 0 N--CA 1.478 0.928 0 C-N-CA 122.333 0.253 . . . . 74.21 111.146 174.709 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 23.0 mt -94.66 8.01 43.82 Favored 'General case' 0 N--CA 1.472 0.671 0 C-N-CA 123.169 0.588 . . . . 73.51 110.89 172.949 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 53.0 m-20 -77.25 122.75 25.5 Favored 'General case' 0 CA--C 1.537 0.471 0 N-CA-C 107.475 -1.305 . . . . 74.22 107.475 168.935 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 112.88 -25.26 11.85 Favored Glycine 0 C--N 1.343 0.917 0 N-CA-C 111.185 -0.766 . . . . 74.4 111.185 -165.703 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 32.4 mmmt -72.84 -164.24 0.16 Allowed 'General case' 0 N--CA 1.489 1.499 0 C-N-CA 123.848 0.859 . . . . 75.13 109.741 167.734 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 126' ' ' HIS . . . . . . . . . . . . . 50.8 t60 -66.77 144.67 56.19 Favored 'General case' 0 CA--C 1.551 1.014 0 CA-C-O 121.082 0.468 . . . . 74.33 110.817 178.543 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 26.1 t -62.72 139.06 21.73 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.838 0 CA-C-N 114.605 -1.18 . . . . 72.43 111.194 179.595 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 49.4 t -68.18 143.38 15.31 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.739 0 N-CA-C 109.17 -0.678 . . . . 73.14 109.17 172.687 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 129' ' ' PHE . . . . . 0.456 ' HA ' HG21 ' A' ' 29' ' ' VAL . 35.9 p90 -132.81 -8.3 3.14 Favored 'General case' 0 N--CA 1.478 0.963 0 O-C-N 121.987 -0.446 . . . . 75.51 111.43 179.46 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . -151.02 171.98 30.68 Favored Glycine 0 C--N 1.34 0.772 0 O-C-N 123.473 0.483 . . . . 65.44 112.557 -175.883 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 32.2 ttpt -154.88 122.41 5.69 Favored 'General case' 0 C--O 1.236 0.384 0 N-CA-C 108.161 -1.052 . . . . 74.41 108.161 177.423 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 132' ' ' VAL . . . . . 0.462 ' HA ' ' HA ' ' A' ' 22' ' ' PHE . 3.0 p -61.44 107.73 0.44 Allowed 'Isoleucine or valine' 0 CA--C 1.551 1.01 0 CA-C-O 121.885 0.85 . . . . 74.11 110.404 178.505 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 133' ' ' LYS . . . . . 0.533 ' HB2' ' HZ1' ' A' ' 133' ' ' LYS . 0.1 OUTLIER -80.9 -36.48 31.11 Favored 'General case' 0 CA--C 1.547 0.832 0 CA-C-N 114.821 -1.081 . . . . 72.31 110.385 -177.595 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 50.8 mt-10 -137.66 147.04 44.57 Favored 'General case' 0 N--CA 1.483 1.218 0 C-N-CA 124.766 1.226 . . . . 74.32 108.794 -178.734 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 80.15 14.92 79.78 Favored Glycine 0 C--N 1.344 0.982 0 O-C-N 123.208 0.318 . . . . 52.41 113.038 -177.602 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 136' ' ' MET . . . . . 0.549 ' HE2' ' HA ' ' A' ' 116' ' ' THR . 12.9 tpt -65.23 -40.83 94.6 Favored 'General case' 0 N--CA 1.473 0.683 0 C-N-CA 123.482 0.713 . . . . 71.41 110.198 174.339 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 137' ' ' ASN . . . . . . . . . . . . . 17.7 m120 -59.35 -35.34 73.69 Favored 'General case' 0 N--CA 1.481 1.081 0 C-N-CA 123.384 0.673 . . . . 74.2 111.427 176.246 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 138' ' ' ILE . . . . . 0.531 ' O ' ' HG3' ' A' ' 142' ' ' MET . 36.4 mm -60.25 -56.27 18.68 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.834 0 N-CA-C 109.277 -0.638 . . . . 75.01 109.277 172.998 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 91.3 t -54.81 -42.72 63.93 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.445 0 C-N-CA 124.21 1.004 . . . . 73.01 111.727 -175.857 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 46.1 mt-10 -67.38 -36.48 81.42 Favored 'General case' 0 N--CA 1.483 1.187 0 C-N-CA 123.824 0.849 . . . . 74.44 111.101 179.676 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -71.63 -25.05 61.99 Favored 'General case' 0 N--CA 1.478 0.973 0 CA-C-N 115.932 -0.577 . . . . 71.44 111.756 175.231 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 142' ' ' MET . . . . . 0.531 ' HG3' ' O ' ' A' ' 138' ' ' ILE . 35.4 mtp -83.52 -22.9 32.31 Favored 'General case' 0 N--CA 1.485 1.282 0 C-N-CA 122.701 0.4 . . . . 65.12 111.172 178.351 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 143' ' ' GLU . . . . . 0.446 ' HA ' HG23 ' A' ' 56' ' ' ILE . 37.5 tt0 -63.44 -25.46 68.28 Favored 'General case' 0 CA--C 1.547 0.852 0 O-C-N 123.786 0.679 . . . . 75.23 110.935 174.025 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 144' ' ' ARG . . . . . . . . . . . . . 51.2 mtp85 -67.82 -18.82 64.96 Favored 'General case' 0 CA--C 1.547 0.847 0 C-N-CA 123.944 0.898 . . . . 73.34 111.916 178.384 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 145' ' ' PHE . . . . . . . . . . . . . 89.9 m-85 -85.47 -21.22 28.8 Favored 'General case' 0 N--CA 1.48 1.037 0 C-N-CA 123.135 0.574 . . . . 71.32 110.793 175.003 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . -73.33 169.83 52.84 Favored Glycine 0 C--N 1.35 1.308 0 N-CA-C 114.135 0.414 . . . . 70.3 114.135 -177.439 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 15.2 m -131.68 165.32 23.97 Favored 'General case' 0 N--CA 1.484 1.242 0 C-N-CA 124.356 1.063 . . . . 75.32 110.418 -176.444 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 148' ' ' ARG . . . . . . . . . . . . . 15.2 mmm180 -60.6 -38.57 85.13 Favored 'General case' 0 N--CA 1.485 1.305 0 C-N-CA 124.135 0.974 . . . . 75.01 111.901 -177.435 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 149' ' ' ASN . . . . . . . . . . . . . 26.6 p-10 -80.08 -7.34 58.83 Favored 'General case' 0 N--CA 1.481 1.099 0 C-N-CA 123.629 0.772 . . . . 73.31 111.857 179.784 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 150' ' ' GLY . . . . . 0.435 ' O ' ' HA ' ' A' ' 55' ' ' ARG . . . 102.41 -4.06 50.92 Favored Glycine 0 C--N 1.348 1.202 0 CA-C-O 119.648 -0.529 . . . . 75.22 113.381 -179.434 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 87.0 tttt -64.54 134.62 54.77 Favored 'General case' 0 N--CA 1.476 0.87 0 CA-C-N 117.573 0.686 . . . . 73.22 110.607 -179.733 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 152' ' ' THR . . . . . . . . . . . . . 67.4 p -95.2 126.2 40.37 Favored 'General case' 0 C--O 1.242 0.669 0 N-CA-C 108.57 -0.9 . . . . 64.15 108.57 170.168 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 153' ' ' SER . . . . . . . . . . . . . 38.8 t -60.02 -42.34 94.13 Favored 'General case' 0 N--CA 1.477 0.893 0 C-N-CA 123.568 0.747 . . . . 74.41 109.766 178.152 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 28.6 mmtp -114.69 154.54 28.27 Favored 'General case' 0 C--O 1.242 0.687 0 CA-C-N 114.928 -1.033 . . . . 65.11 109.96 179.784 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 57.1 tptt -78.15 89.59 4.25 Favored 'General case' 0 CA--C 1.54 0.59 0 N-CA-C 109.04 -0.726 . . . . 75.43 109.04 179.879 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 156' ' ' ILE . . . . . . . . . . . . . 64.1 mt -84.37 116.12 27.56 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.488 0 N-CA-C 108.974 -0.75 . . . . 75.2 108.974 -176.034 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 157' ' ' THR . . . . . 0.414 ' HA ' ' HA ' ' A' ' 52' ' ' CYS . 50.5 p -120.41 159.97 24.03 Favored 'General case' 0 N--CA 1.479 1.018 0 C-N-CA 124.242 1.017 . . . . 64.12 110.288 -176.063 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 158' ' ' ILE . . . . . 0.501 HD11 ' HB2' ' A' ' 51' ' ' SER . 60.3 mt -87.82 100.05 9.64 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.647 0 N-CA-C 107.337 -1.357 . . . . 75.52 107.337 164.768 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 159' ' ' ALA . . . . . 0.507 ' HB2' ' HB1' ' A' ' 11' ' ' ALA . . . -57.56 -50.81 71.87 Favored 'General case' 0 N--CA 1.474 0.756 0 C-N-CA 124.193 0.997 . . . . 71.11 111.814 -177.686 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 160' ' ' ASP . . . . . . . . . . . . . 1.8 t70 -148.75 -179.15 6.77 Favored 'General case' 0 N--CA 1.48 1.049 0 CA-C-N 116.712 -0.222 . . . . 71.0 111.46 -174.049 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 161' ' ' CYS . . . . . . . . . . . . . 26.8 p -154.11 -169.07 3.14 Favored 'General case' 0 N--CA 1.475 0.816 0 C-N-CA 124.659 1.183 . . . . 62.41 108.992 -176.208 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 162' ' ' GLY . . . . . . . . . . . . . . . 136.46 53.11 0.06 OUTLIER Glycine 0 N--CA 1.475 1.287 0 N-CA-C 111.53 -0.628 . . . . 64.25 111.53 -166.056 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 163' ' ' GLN . . . . . 0.537 ' HG3' ' HA ' ' A' ' 6' ' ' VAL . 30.3 tt0 -45.8 117.43 1.48 Allowed 'General case' 0 N--CA 1.476 0.83 0 C-N-CA 126.588 1.955 . . . . 74.11 112.434 -179.869 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 164' ' ' LEU . . . . . . . . . . . . . 78.1 mt . . . . . 0 N--CA 1.466 0.343 0 N-CA-C 107.974 -1.121 . . . . 72.42 107.974 179.935 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' B' B ' 218' ' ' PRO . . . . . . . . . . . . . 86.3 Cg_endo . . . . . 0 CA--C 1.55 1.296 0 CA-C-O 121.626 0.594 . . . . 75.53 111.611 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' B' B ' 219' ' ' GLY . . . . . . . . . . . . . . . 171.73 -169.7 42.74 Favored Glycine 0 CA--C 1.531 1.093 0 CA-C-N 115.586 -0.734 . . . . 61.43 113.196 179.75 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 220' ' ' PRO . . . . . . . . . . . . . 87.4 Cg_endo -76.37 159.16 36.56 Favored 'Trans proline' 0 C--N 1.368 1.604 0 C-N-CA 123.999 3.133 . . . . 73.21 114.128 177.067 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 221' ' ' TYR . . . . . . . . . . . . . 66.3 m-85 . . . . . 0 N--CA 1.491 1.601 0 C-N-CA 123.49 0.716 . . . . 72.34 111.876 -176.907 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 15.2 m120 . . . . . 0 CA--C 1.549 0.928 0 N-CA-C 111.731 0.271 . . . . 74.1 111.731 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 4' ' ' PRO . . . . . 0.47 ' HG2' ' HB2' ' A' ' 24' ' ' LEU . 59.9 Cg_endo -73.69 146.41 38.49 Favored 'Trans proline' 0 C--N 1.374 1.871 0 C-N-CA 122.376 2.051 . . . . 73.45 111.403 166.232 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 5' ' ' THR . . . . . 0.459 ' HB ' ' O ' ' A' ' 164' ' ' LEU . 84.2 m -96.7 135.92 37.95 Favored 'General case' 0 CA--C 1.536 0.423 0 C-N-CA 123.344 0.658 . . . . 73.14 109.29 177.736 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 6' ' ' VAL . . . . . 0.486 ' HB ' ' HB2' ' A' ' 22' ' ' PHE . 23.3 t -100.19 147.08 7.96 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.485 0 N-CA-C 107.831 -1.174 . . . . 75.12 107.831 176.25 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 7' ' ' PHE . . . . . 0.482 ' H ' ' HA ' ' A' ' 163' ' ' GLN . 45.7 t80 -126.73 120.73 30.1 Favored 'General case' 0 C--O 1.237 0.412 0 N-CA-C 109.093 -0.706 . . . . 71.31 109.093 175.951 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 8' ' ' PHE . . . . . 0.415 ' HD2' ' HE2' ' A' ' 22' ' ' PHE . 30.6 m-85 -129.86 166.2 20.46 Favored 'General case' 0 N--CA 1.47 0.556 0 C-N-CA 123.864 0.865 . . . . 64.3 109.008 165.925 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 24.8 m-20 -117.82 122.9 44.6 Favored 'General case' 0 N--CA 1.466 0.349 0 N-CA-C 107.641 -1.244 . . . . 74.51 107.641 169.903 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 46.5 mm -87.2 124.41 40.63 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.509 0 N-CA-C 108.914 -0.772 . . . . 64.11 108.914 178.955 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 11' ' ' ALA . . . . . 0.826 ' HB3' ' HB2' ' A' ' 159' ' ' ALA . . . -118.82 128.13 54.17 Favored 'General case' 0 N--CA 1.469 0.483 0 C-N-CA 123.599 0.759 . . . . 75.12 110.695 -174.882 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 12' ' ' VAL . . . . . 0.455 HG11 ' HB3' ' A' ' 154' ' ' LYS . 96.0 t -95.81 107.91 20.33 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.48 0 N-CA-C 107.819 -1.178 . . . . 71.3 107.819 173.696 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 29.0 m-20 64.72 25.24 12.98 Favored 'General case' 0 N--CA 1.485 1.301 0 C-N-CA 125.284 1.434 . . . . 63.03 111.97 -175.926 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 87.24 1.36 84.22 Favored Glycine 0 C--N 1.348 1.249 0 CA-C-N 116.377 -0.374 . . . . 64.13 113.186 -177.061 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 17.5 mm-40 -94.46 113.49 61.07 Favored Pre-proline 0 CA--C 1.543 0.679 0 N-CA-C 108.584 -0.895 . . . . 64.34 108.584 175.125 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 26.4 Cg_endo -59.89 106.31 0.32 Allowed 'Trans proline' 0 C--N 1.38 2.197 0 C-N-CA 122.627 2.218 . . . . 73.42 112.181 -175.879 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 47.2 tp -75.49 -34.43 60.86 Favored 'General case' 0 N--CA 1.476 0.834 0 C-N-CA 124.178 0.991 . . . . 64.33 109.42 -179.348 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 178.47 177.44 47.15 Favored Glycine 0 C--N 1.343 0.919 0 CA-C-N 115.574 -0.739 . . . . 71.22 113.29 175.748 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 37.4 ptt85 -107.26 136.1 47.65 Favored 'General case' 0 C--O 1.24 0.584 0 C-N-CA 124.3 1.04 . . . . 75.2 108.998 177.05 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 20' ' ' VAL . . . . . 0.455 ' HA ' ' HA3' ' A' ' 135' ' ' GLY . 33.2 t -127.2 134.35 66.14 Favored 'Isoleucine or valine' 0 C--O 1.243 0.721 0 C-N-CA 123.122 0.569 . . . . 74.53 109.96 -178.856 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 21' ' ' SER . . . . . 0.434 ' HA ' ' O ' ' A' ' 6' ' ' VAL . 50.8 p -114.23 124.28 51.65 Favored 'General case' 0 CA--C 1.55 0.976 0 C-N-CA 123.83 0.852 . . . . 75.31 109.769 175.75 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 22' ' ' PHE . . . . . 0.486 ' HB2' ' HB ' ' A' ' 6' ' ' VAL . 60.7 m-85 -101.83 170.14 8.34 Favored 'General case' 0 N--CA 1.477 0.883 0 C-N-CA 123.903 0.881 . . . . 74.22 110.496 -179.962 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 35.0 tt0 -134.91 102.88 5.38 Favored 'General case' 0 N--CA 1.476 0.875 0 C-N-CA 123.649 0.78 . . . . 71.21 109.817 -175.225 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . 0.47 ' HB2' ' HG2' ' A' ' 4' ' ' PRO . 48.1 mt -82.02 131.78 35.25 Favored 'General case' 0 N--CA 1.478 0.97 0 C-N-CA 122.966 0.506 . . . . 73.32 110.423 -179.807 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 52.7 m-85 -86.93 69.06 10.24 Favored 'General case' 0 N--CA 1.469 0.506 0 N-CA-C 108.856 -0.794 . . . . 73.41 108.856 175.188 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -66.52 -12.89 59.8 Favored 'General case' 0 N--CA 1.483 1.184 0 CA-C-N 115.418 -0.81 . . . . 64.25 112.497 -175.114 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 11.1 p-10 -85.33 -34.85 21.75 Favored 'General case' 0 CA--C 1.545 0.756 0 C-N-CA 123.694 0.798 . . . . 74.11 111.482 175.323 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 96.7 mttt -93.83 -33.48 13.53 Favored 'General case' 0 N--CA 1.489 1.496 0 C-N-CA 123.099 0.56 . . . . 72.35 111.903 -172.709 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 29' ' ' VAL . . . . . 0.539 HG21 ' HA ' ' A' ' 129' ' ' PHE . 4.4 m -135.92 69.36 64.65 Favored Pre-proline 0 N--CA 1.481 1.103 0 C-N-CA 123.873 0.869 . . . . 71.41 109.07 177.45 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 37.1 Cg_exo -58.11 -35.28 98.87 Favored 'Trans proline' 0 C--N 1.381 2.26 0 C-N-CA 122.79 2.327 . . . . 74.42 113.42 -173.04 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 87.8 tttt -69.85 -50.27 44.27 Favored 'General case' 0 N--CA 1.472 0.664 0 C-N-CA 123.67 0.788 . . . . 72.11 111.776 -178.341 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 7.4 m -73.61 -29.6 62.48 Favored 'General case' 0 CA--C 1.556 1.211 0 C-N-CA 122.975 0.51 . . . . 73.41 111.113 -172.637 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -77.26 -36.01 54.8 Favored 'General case' 0 CA--C 1.547 0.855 0 C-N-CA 123.379 0.672 . . . . 74.14 110.875 175.46 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 12.2 tp10 -60.62 -42.87 97.71 Favored 'General case' 0 N--CA 1.488 1.46 0 C-N-CA 124.041 0.937 . . . . 72.01 109.942 175.102 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 35' ' ' ASN . . . . . 0.451 ' ND2' ' SD ' ' A' ' 100' ' ' MET . 43.3 t30 -55.58 -60.33 3.59 Favored 'General case' 0 C--N 1.347 0.498 0 CA-C-N 113.75 -1.568 . . . . 73.25 110.892 177.997 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 70.0 t80 -62.19 -34.12 75.83 Favored 'General case' 0 N--CA 1.471 0.618 0 O-C-N 124.361 1.038 . . . . 61.51 111.574 -174.838 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 42.1 ttp180 -64.99 -44.19 90.1 Favored 'General case' 0 C--N 1.348 0.512 0 O-C-N 123.605 0.566 . . . . 75.32 110.841 177.278 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 38' ' ' ALA . . . . . 0.521 ' HB2' HG23 ' A' ' 78' ' ' ILE . . . -73.65 -26.02 60.56 Favored 'General case' 0 N--CA 1.475 0.785 0 C-N-CA 122.896 0.479 . . . . 72.22 111.568 -178.875 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 39' ' ' LEU . . . . . 0.559 HD23 ' HE1' ' A' ' 48' ' ' TYR . 90.3 mt -68.78 -40.16 79.8 Favored 'General case' 0 CA--C 1.549 0.912 0 C-N-CA 123.705 0.802 . . . . 73.35 109.911 172.693 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 47.2 t -71.7 -51.29 23.73 Favored 'General case' 0 N--CA 1.476 0.856 0 C-N-CA 124.311 1.044 . . . . 73.13 111.329 -178.334 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 53.1 p -72.42 -31.4 65.46 Favored 'General case' 0 N--CA 1.471 0.612 0 C-N-CA 123.703 0.801 . . . . 60.11 111.652 -175.917 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 79.03 21.93 66.9 Favored Glycine 0 C--N 1.346 1.124 0 CA-C-N 115.895 -0.593 . . . . 63.14 113.794 178.151 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 30.9 mm-40 -62.08 -31.33 71.75 Favored 'General case' 0 N--CA 1.477 0.897 0 C-N-CA 123.302 0.641 . . . . 73.21 110.707 174.213 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 44' ' ' LYS . . . . . 0.423 ' HG2' ' HB1' ' A' ' 38' ' ' ALA . 30.5 mmmt -95.74 19.4 11.33 Favored 'General case' 0 CA--C 1.544 0.717 0 C-N-CA 123.896 0.878 . . . . 73.25 111.853 179.957 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 85.83 -9.65 68.01 Favored Glycine 0 C--N 1.353 1.508 0 N-CA-C 114.994 0.757 . . . . 73.35 114.994 170.802 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 22.3 m-85 -86.45 -50.23 7.03 Favored 'General case' 0 N--CA 1.478 0.956 0 CA-C-N 118.064 0.932 . . . . 74.42 111.473 -170.453 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 44.98 65.12 1.93 Allowed Glycine 0 C--N 1.361 1.946 0 O-C-N 124.634 1.209 . . . . 74.23 115.172 169.824 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 48' ' ' TYR . . . . . 0.559 ' HD2' ' HG ' ' A' ' 51' ' ' SER . 79.3 m-85 -60.07 86.09 0.01 OUTLIER 'General case' 0 N--CA 1.487 1.383 0 CA-C-O 122.241 1.019 . . . . 73.31 111.903 -173.731 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 27.6 tptp -114.72 128.49 56.34 Favored 'General case' 0 C--O 1.239 0.527 0 CA-C-N 113.376 -1.738 . . . . 74.13 108.515 -178.865 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 63.35 20.55 63.37 Favored Glycine 0 N--CA 1.476 1.317 0 O-C-N 123.255 0.347 . . . . 63.02 112.708 -173.321 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 51' ' ' SER . . . . . 0.559 ' HG ' ' HD2' ' A' ' 48' ' ' TYR . 27.0 t -76.12 123.73 26.28 Favored 'General case' 0 C--N 1.346 0.456 0 C-N-CA 123.119 0.567 . . . . 75.2 110.575 -171.137 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 52' ' ' CYS . . . . . 0.451 ' SG ' ' HD3' ' A' ' 155' ' ' LYS . 51.5 t -81.45 161.86 23.52 Favored 'General case' 0 CA--C 1.539 0.53 0 O-C-N 123.967 0.792 . . . . 73.4 112.537 -171.631 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 12.7 m-85 -111.67 131.47 55.27 Favored 'General case' 0 CA--C 1.537 0.465 0 N-CA-C 107.068 -1.456 . . . . 74.44 107.068 169.544 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 54' ' ' HIS . . . . . 0.43 ' HD1' ' HB2' ' A' ' 66' ' ' ASP . 47.9 p-80 -114.18 -29.35 6.98 Favored 'General case' 0 N--CA 1.496 1.866 0 CA-C-N 118.695 0.68 . . . . 74.21 112.348 -174.016 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 42.6 ttt-85 -119.62 98.29 6.05 Favored 'General case' 0 N--CA 1.473 0.724 0 N-CA-C 108.544 -0.91 . . . . 74.54 108.544 -176.603 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 59.5 mt -130.27 127.96 63.57 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.614 0 C-N-CA 123.807 0.843 . . . . 63.33 108.974 179.825 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 61.4 mt -127.83 118.88 21.12 Favored Pre-proline 0 CA--C 1.553 1.078 0 N-CA-C 108.189 -1.041 . . . . 75.42 108.189 176.848 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 58' ' ' PRO . . . . . 0.437 ' HB3' ' HA ' ' A' ' 144' ' ' ARG . 64.0 Cg_endo -70.35 139.02 37.24 Favored 'Trans proline' 0 C--N 1.379 2.154 0 C-N-CA 123.163 2.576 . . . . 75.42 111.98 -174.028 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 79.0 24.41 61.83 Favored Glycine 0 C--N 1.338 0.645 0 CA-C-N 115.204 -0.907 . . . . 34.0 112.325 -175.728 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 27.9 t80 -150.34 -76.87 0.14 Allowed 'General case' 0 CA--C 1.544 0.724 0 C-N-CA 123.778 0.831 . . . . 74.43 109.884 179.356 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 61' ' ' MET . . . . . 0.43 ' HG3' ' HG ' ' A' ' 115' ' ' CYS . 38.7 ttp -166.98 150.46 6.65 Favored 'General case' 0 N--CA 1.485 1.306 0 CA-C-O 120.912 0.386 . . . . 65.42 111.781 -164.412 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 62' ' ' CYS . . . . . . . . . . . . . 4.9 p -127.83 120.86 28.71 Favored 'General case' 0 N--CA 1.478 0.932 0 C-N-CA 124.829 1.251 . . . . 74.13 109.57 176.552 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 14.2 pt20 -128.26 144.97 51.18 Favored 'General case' 0 N--CA 1.491 1.62 0 CA-C-O 121.428 0.632 . . . . 73.01 112.375 -176.156 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -163.61 -147.27 5.01 Favored Glycine 0 C--N 1.348 1.227 0 CA-C-N 114.406 -1.27 . . . . 70.44 113.556 -174.609 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 90.66 12.32 61.01 Favored Glycine 0 C--N 1.345 1.062 0 N-CA-C 110.588 -1.005 . . . . 73.22 110.588 -161.878 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 66' ' ' ASP . . . . . 0.43 ' HB2' ' HD1' ' A' ' 54' ' ' HIS . 38.9 t70 -61.69 -43.64 98.47 Favored 'General case' 0 N--CA 1.472 0.66 0 C-N-CA 125.313 1.445 . . . . 74.53 112.543 -162.085 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 50.2 t80 -49.37 -36.77 22.61 Favored 'General case' 0 CA--C 1.552 1.042 0 O-C-N 124.598 1.186 . . . . 72.25 112.695 -170.236 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 54.3 m -88.11 108.23 19.15 Favored 'General case' 0 CA--C 1.545 0.782 0 C-N-CA 122.957 0.503 . . . . 71.31 110.522 176.147 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 31.8 mtp180 58.73 53.87 5.64 Favored 'General case' 0 N--CA 1.479 0.993 0 C-N-CA 124.963 1.305 . . . . 74.22 111.657 172.797 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 10.0 p80 -63.34 -13.17 36.16 Favored 'General case' 0 N--CA 1.482 1.172 0 N-CA-C 114.233 1.197 . . . . 74.35 114.233 -173.874 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 6.6 t30 -68.61 84.84 0.29 Allowed 'General case' 0 CA--C 1.552 1.049 0 C-N-CA 123.253 0.621 . . . . 71.23 110.159 179.163 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 64.47 13.95 56.19 Favored Glycine 0 C--N 1.353 1.506 0 N-CA-C 115.62 1.008 . . . . 75.24 115.62 176.397 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 6.9 m -125.0 -68.01 0.87 Allowed 'General case' 0 N--CA 1.476 0.851 0 N-CA-C 109.188 -0.671 . . . . 73.12 109.188 -178.228 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 57.3 50.45 64.59 Favored Glycine 0 C--N 1.353 1.515 0 O-C-N 124.559 1.162 . . . . 74.31 115.141 171.66 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 128.83 50.81 0.13 Allowed Glycine 0 C--N 1.35 1.335 0 CA-C-N 117.833 0.817 . . . . 64.23 113.281 178.837 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 14.1 ptmm? -64.27 165.6 9.26 Favored 'General case' 0 N--CA 1.482 1.15 0 C-N-CA 123.133 0.573 . . . . 73.43 112.338 -179.042 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 84.0 p -92.77 173.8 7.58 Favored 'General case' 0 N--CA 1.472 0.655 0 CA-C-N 115.893 -0.594 . . . . 73.35 111.392 -172.811 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 78' ' ' ILE . . . . . 0.521 HG23 ' HB2' ' A' ' 38' ' ' ALA . 23.1 pt -81.0 -20.99 11.13 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.609 0 CA-C-N 115.856 -0.611 . . . . 74.54 109.877 172.638 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 79' ' ' TYR . . . . . 0.418 ' HE2' ' HB2' ' A' ' 35' ' ' ASN . 64.0 m-85 -86.62 12.53 10.37 Favored 'General case' 0 CA--C 1.546 0.821 0 C-N-CA 123.767 0.827 . . . . 73.53 110.134 175.683 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 121.17 -152.5 16.79 Favored Glycine 0 C--N 1.354 1.549 0 C-N-CA 123.126 0.393 . . . . 64.44 112.784 171.203 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 34.3 tt0 -52.13 -53.24 45.21 Favored 'General case' 0 N--CA 1.471 0.597 0 C-N-CA 124.816 1.246 . . . . 72.45 109.396 171.993 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 82' ' ' LYS . . . . . 0.674 ' HD2' ' HA ' ' A' ' 107' ' ' THR . 20.7 pttp -169.52 156.06 6.46 Favored 'General case' 0 CA--C 1.548 0.888 0 CA-C-N 114.549 -1.205 . . . . 74.11 109.697 -178.319 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 9.7 p90 -131.68 174.78 9.77 Favored 'General case' 0 N--CA 1.48 1.029 0 C-N-CA 124.341 1.056 . . . . 70.35 110.57 -179.943 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 84' ' ' GLU . . . . . 0.555 ' HA ' ' HA ' ' A' ' 106' ' ' ASN . 0.0 OUTLIER -70.98 168.68 16.51 Favored 'General case' 0 N--CA 1.479 0.992 0 CA-C-N 115.759 -0.655 . . . . 75.12 111.582 -179.483 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 56.6 m-20 -80.58 111.39 16.95 Favored 'General case' 0 N--CA 1.47 0.571 0 N-CA-C 108.289 -1.004 . . . . 74.15 108.289 173.839 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 3.9 tp10 -46.98 -53.27 12.73 Favored 'General case' 0 N--CA 1.481 1.097 0 C-N-CA 124.895 1.278 . . . . 73.45 112.636 -175.0 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 87' ' ' ASN . . . . . 0.401 ' OD1' HG23 ' A' ' 127' ' ' VAL . 32.3 p30 -159.6 -165.62 1.58 Allowed 'General case' 0 N--CA 1.473 0.683 0 C-N-CA 123.62 0.768 . . . . 74.12 109.589 -176.17 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 93.7 m-85 -137.27 29.8 2.72 Favored 'General case' 0 N--CA 1.485 1.284 0 C-N-CA 123.868 0.867 . . . . 61.12 110.274 176.004 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 65.9 mt -60.07 -49.77 82.77 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.247 0 CA-C-O 121.866 0.841 . . . . 75.31 109.791 176.482 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 90' ' ' LEU . . . . . 0.615 ' HB3' ' HB ' ' A' ' 128' ' ' VAL . 92.3 mt -96.23 99.63 11.33 Favored 'General case' 0 C--O 1.237 0.436 0 CA-C-N 114.565 -1.198 . . . . 74.41 110.102 -175.969 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 91' ' ' LYS . . . . . 0.572 ' HB3' ' HZ1' ' A' ' 91' ' ' LYS . 8.7 mtpm? -76.31 149.7 37.02 Favored 'General case' 0 CA--C 1.543 0.69 0 C-N-CA 123.567 0.747 . . . . 75.1 110.204 176.771 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 92' ' ' HIS . . . . . . . . . . . . . 18.2 t-80 -87.43 28.45 0.97 Allowed 'General case' 0 N--CA 1.482 1.126 0 C-N-CA 124.21 1.004 . . . . 73.4 111.368 -169.412 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 14.5 t -99.87 16.46 23.69 Favored 'General case' 0 CA--C 1.552 1.051 0 C-N-CA 123.819 0.848 . . . . 75.24 111.628 -166.996 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -113.17 161.12 12.79 Favored Glycine 0 CA--C 1.534 1.255 0 CA-C-O 119.443 -0.643 . . . . 72.52 112.1 176.937 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 86.7 Cg_endo -83.4 154.2 14.04 Favored 'Trans proline' 0 C--N 1.367 1.544 0 C-N-CA 122.816 2.344 . . . . 75.2 111.957 171.408 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 71.12 19.76 77.49 Favored Glycine 0 C--N 1.35 1.312 0 N-CA-C 113.8 0.28 . . . . 54.35 113.8 -179.944 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 97' ' ' ILE . . . . . 0.435 HG21 HG11 ' A' ' 128' ' ' VAL . 24.6 mm -77.27 125.15 36.81 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.808 0 C-N-CA 123.231 0.612 . . . . 75.21 112.042 -175.65 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 98' ' ' LEU . . . . . 0.665 ' HG ' HG12 ' A' ' 114' ' ' ILE . 7.3 mp -93.11 123.2 36.21 Favored 'General case' 0 C--O 1.241 0.612 0 C-N-CA 123.709 0.804 . . . . 75.25 109.735 168.038 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 99' ' ' SER . . . . . 0.432 ' HG ' ' HA ' ' A' ' 128' ' ' VAL . 25.9 m -139.96 144.14 36.9 Favored 'General case' 0 N--CA 1.474 0.747 0 N-CA-C 107.737 -1.209 . . . . 72.12 107.737 168.876 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 100' ' ' MET . . . . . 0.54 ' HA ' ' HA ' ' A' ' 112' ' ' PHE . 72.1 mtp -75.44 142.28 43.02 Favored 'General case' 0 N--CA 1.482 1.157 0 N-CA-C 108.842 -0.799 . . . . 74.12 108.842 177.668 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 101' ' ' ALA . . . . . 0.541 ' HB1' ' HB2' ' A' ' 111' ' ' GLN . . . -73.97 140.32 45.45 Favored 'General case' 0 C--O 1.24 0.58 0 CA-C-O 121.362 0.601 . . . . 64.2 112.343 -166.805 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 28.6 p-10 -151.8 154.7 36.73 Favored 'General case' 0 C--O 1.237 0.398 0 CA-C-N 114.734 -1.121 . . . . 74.1 109.416 179.444 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -105.27 5.45 32.02 Favored 'General case' 0 CA--C 1.537 0.46 0 CA-C-N 115.538 -0.755 . . . . 75.15 110.261 170.589 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 162.07 -174.3 38.51 Favored Glycine 0 C--N 1.35 1.317 0 CA-C-O 119.661 -0.521 . . . . 54.44 112.387 179.577 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 77.5 Cg_exo -55.39 138.92 81.26 Favored 'Trans proline' 0 C--N 1.374 1.883 0 C-N-CA 123.663 2.909 . . . . 72.03 113.218 175.219 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 106' ' ' ASN . . . . . 0.555 ' HA ' ' HA ' ' A' ' 84' ' ' GLU . 63.9 t30 68.29 10.87 8.11 Favored 'General case' 0 N--CA 1.487 1.399 0 C-N-CA 125.277 1.431 . . . . 75.53 111.64 177.826 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 107' ' ' THR . . . . . 0.674 ' HA ' ' HD2' ' A' ' 82' ' ' LYS . 3.1 m -104.65 -11.64 16.8 Favored 'General case' 0 CA--C 1.552 1.051 0 C-N-CA 123.728 0.811 . . . . 72.14 110.129 176.99 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 10.5 t30 -56.15 139.77 46.36 Favored 'General case' 0 N--CA 1.48 1.043 0 C-N-CA 124.988 1.315 . . . . 74.24 111.651 172.428 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 112.52 3.05 25.74 Favored Glycine 0 N--CA 1.471 1.026 0 CA-C-O 119.924 -0.376 . . . . 71.23 113.137 176.197 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 15.3 p -114.19 122.35 46.54 Favored 'General case' 0 CA--C 1.542 0.648 0 N-CA-C 108.395 -0.965 . . . . 74.05 108.395 172.272 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 111' ' ' GLN . . . . . 0.541 ' HB2' ' HB1' ' A' ' 101' ' ' ALA . 41.0 mt-30 66.03 168.86 0.22 Allowed 'General case' 0 N--CA 1.496 1.846 0 C-N-CA 124.746 1.218 . . . . 73.33 112.416 -175.728 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 112' ' ' PHE . . . . . 0.54 ' HA ' ' HA ' ' A' ' 100' ' ' MET . 51.4 p90 -137.02 140.47 42.12 Favored 'General case' 0 N--CA 1.476 0.827 0 N-CA-C 108.153 -1.054 . . . . 74.42 108.153 168.341 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 113' ' ' PHE . . . . . 0.417 ' HE2' ' HA ' ' A' ' 101' ' ' ALA . 54.4 p90 -128.1 150.02 50.15 Favored 'General case' 0 N--CA 1.471 0.624 0 C-N-CA 122.899 0.48 . . . . 70.35 111.832 179.881 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 114' ' ' ILE . . . . . 0.665 HG12 ' HG ' ' A' ' 98' ' ' LEU . 14.0 mt -120.95 117.9 54.52 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.654 0 CA-C-N 115.12 -0.945 . . . . 75.01 108.666 173.943 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 115' ' ' CYS . . . . . 0.43 ' HG ' ' HG3' ' A' ' 61' ' ' MET . 58.8 m -94.77 110.41 22.27 Favored 'General case' 0 C--O 1.24 0.596 0 N-CA-C 108.311 -0.996 . . . . 73.41 108.311 173.891 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 116' ' ' THR . . . . . 0.463 HG21 ' HA ' ' A' ' 140' ' ' GLU . 72.5 p -71.03 -31.52 68.02 Favored 'General case' 0 N--CA 1.479 0.989 0 C-N-CA 122.51 0.324 . . . . 74.25 111.719 -175.28 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -97.25 163.67 12.81 Favored 'General case' 0 N--CA 1.479 1.004 0 N-CA-C 109.164 -0.68 . . . . 70.42 109.164 168.155 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 118' ' ' LYS . . . . . 0.442 ' HE2' ' HB3' ' A' ' 120' ' ' GLU . 0.0 OUTLIER -70.84 124.71 24.96 Favored 'General case' 0 C--N 1.347 0.466 0 N-CA-C 109.233 -0.654 . . . . 72.43 109.233 175.914 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 119' ' ' THR . . . . . 0.575 ' HB ' HD12 ' A' ' 122' ' ' LEU . 23.0 p -113.02 88.11 2.75 Favored 'General case' 0 C--O 1.238 0.462 0 CA-C-O 121.864 0.84 . . . . 73.24 109.055 179.138 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 120' ' ' GLU . . . . . 0.442 ' HB3' ' HE2' ' A' ' 118' ' ' LYS . 10.5 pt-20 -67.87 -27.16 66.44 Favored 'General case' 0 N--CA 1.478 0.965 0 CA-C-N 114.254 -1.339 . . . . 72.44 112.485 -178.009 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 121' ' ' TRP . . . . . . . . . . . . . 32.5 p90 -78.12 -1.02 30.49 Favored 'General case' 0 N--CA 1.479 1.014 0 C-N-CA 122.768 0.427 . . . . 74.32 111.113 178.49 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 122' ' ' LEU . . . . . 0.575 HD12 ' HB ' ' A' ' 119' ' ' THR . 9.3 mp -96.63 5.7 50.18 Favored 'General case' 0 N--CA 1.48 1.049 0 C-N-CA 123.904 0.882 . . . . 74.51 111.168 171.639 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 25.0 m-20 -72.62 141.12 48.33 Favored 'General case' 0 N--CA 1.481 1.09 0 N-CA-C 109.462 -0.57 . . . . 61.51 109.462 168.879 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 92.98 -28.31 9.68 Favored Glycine 0 N--CA 1.478 1.451 0 N-CA-C 111.759 -0.536 . . . . 74.45 111.759 -173.019 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 1.5 mppt? -73.65 -164.32 0.21 Allowed 'General case' 0 N--CA 1.481 1.084 0 C-N-CA 124.584 1.154 . . . . 74.4 109.538 168.585 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 126' ' ' HIS . . . . . . . . . . . . . 36.2 t60 -66.08 132.94 49.69 Favored 'General case' 0 CA--C 1.542 0.669 0 CA-C-O 121.638 0.733 . . . . 63.31 112.207 -170.853 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 127' ' ' VAL . . . . . 0.401 HG23 ' OD1' ' A' ' 87' ' ' ASN . 7.1 p -59.42 146.64 9.36 Favored 'Isoleucine or valine' 0 CA--C 1.554 1.103 0 CA-C-N 113.797 -1.547 . . . . 73.44 111.155 177.185 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 128' ' ' VAL . . . . . 0.615 ' HB ' ' HB3' ' A' ' 90' ' ' LEU . 42.1 t -62.44 147.05 11.97 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.795 0 C-N-CA 123.686 0.794 . . . . 71.03 110.333 179.625 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 129' ' ' PHE . . . . . 0.539 ' HA ' HG21 ' A' ' 29' ' ' VAL . 36.7 p90 -120.16 -28.83 5.01 Favored 'General case' 0 N--CA 1.476 0.87 0 C-N-CA 122.565 0.346 . . . . 75.23 110.277 170.575 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . -146.09 168.73 27.59 Favored Glycine 0 C--N 1.346 1.112 0 O-C-N 123.525 0.516 . . . . 74.45 112.798 -172.371 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 29.0 ttpt -152.76 134.6 14.69 Favored 'General case' 0 N--CA 1.47 0.541 0 N-CA-C 108.167 -1.049 . . . . 64.2 108.167 -177.611 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 132' ' ' VAL . . . . . 0.506 HG13 ' HA ' ' A' ' 136' ' ' MET . 7.3 t -66.62 109.95 1.36 Allowed 'Isoleucine or valine' 0 CA--C 1.542 0.671 0 N-CA-C 109.433 -0.58 . . . . 73.32 109.433 176.799 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 14.4 ptmm? -87.02 -39.52 15.57 Favored 'General case' 0 N--CA 1.481 1.104 0 N-CA-C 110.134 -0.321 . . . . 75.42 110.134 -178.269 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 134' ' ' GLU . . . . . 0.4 ' HB2' ' OG ' ' A' ' 21' ' ' SER . 20.6 mm-40 -144.53 162.13 37.35 Favored 'General case' 0 N--CA 1.488 1.471 0 C-N-CA 124.711 1.204 . . . . 73.05 108.693 173.316 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 135' ' ' GLY . . . . . 0.455 ' HA3' ' HA ' ' A' ' 20' ' ' VAL . . . 78.7 15.14 81.24 Favored Glycine 0 C--N 1.346 1.125 0 O-C-N 123.349 0.406 . . . . 71.32 112.177 -173.715 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 136' ' ' MET . . . . . 0.506 ' HA ' HG13 ' A' ' 132' ' ' VAL . 15.2 tpt -62.92 -34.38 77.32 Favored 'General case' 0 N--CA 1.472 0.626 0 C-N-CA 124.462 1.105 . . . . 73.42 111.808 -177.047 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 137' ' ' ASN . . . . . . . . . . . . . 27.3 t-20 -61.78 -35.84 79.34 Favored 'General case' 0 N--CA 1.48 1.069 0 C-N-CA 123.455 0.702 . . . . 73.22 111.164 177.571 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 138' ' ' ILE . . . . . . . . . . . . . 43.4 mm -71.12 -33.22 50.43 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.088 0 C-N-CA 123.402 0.681 . . . . 62.14 110.679 179.642 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 139' ' ' VAL . . . . . 0.483 HG13 ' HE3' ' A' ' 142' ' ' MET . 62.0 t -69.76 -44.87 78.79 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.999 0 C-N-CA 123.407 0.683 . . . . 74.22 110.518 176.306 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 140' ' ' GLU . . . . . 0.463 ' HA ' HG21 ' A' ' 116' ' ' THR . 40.0 mt-10 -63.82 -33.58 75.99 Favored 'General case' 0 N--CA 1.476 0.855 0 CA-C-N 115.476 -0.784 . . . . 75.45 110.534 176.882 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -70.37 -43.84 69.3 Favored 'General case' 0 C--O 1.24 0.594 0 C-N-CA 123.662 0.785 . . . . 75.31 111.307 178.124 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 142' ' ' MET . . . . . 0.497 ' HB2' HD12 ' A' ' 156' ' ' ILE . 22.4 ptt? -69.52 -34.09 73.75 Favored 'General case' 0 C--N 1.355 0.843 0 CA-C-N 116.84 -0.164 . . . . 75.11 110.929 -175.691 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 143' ' ' GLU . . . . . 0.421 ' HG2' ' HA ' ' A' ' 58' ' ' PRO . 30.9 tt0 -62.87 -28.99 70.42 Favored 'General case' 0 CA--C 1.559 1.294 0 C-N-CA 122.722 0.409 . . . . 72.45 111.462 -178.968 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 144' ' ' ARG . . . . . 0.437 ' HA ' ' HB3' ' A' ' 58' ' ' PRO . 58.6 mtp85 -68.72 -19.47 64.36 Favored 'General case' 0 N--CA 1.485 1.295 0 C-N-CA 123.589 0.756 . . . . 64.12 112.242 -179.091 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 145' ' ' PHE . . . . . 0.51 ' HB2' HD11 ' A' ' 156' ' ' ILE . 56.6 m-85 -79.95 -8.15 59.18 Favored 'General case' 0 N--CA 1.477 0.897 0 C-N-CA 122.807 0.443 . . . . 71.43 111.321 179.328 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . -78.14 179.59 51.47 Favored Glycine 0 C--N 1.345 1.029 0 O-C-N 123.348 0.405 . . . . 71.05 112.751 172.585 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 46.0 t -133.7 168.4 18.77 Favored 'General case' 0 N--CA 1.476 0.834 0 C-N-CA 123.773 0.829 . . . . 64.1 110.148 -176.893 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 148' ' ' ARG . . . . . . . . . . . . . 18.4 mmm180 -58.55 -37.01 74.82 Favored 'General case' 0 N--CA 1.481 1.107 0 C-N-CA 123.81 0.844 . . . . 73.23 111.863 178.527 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 149' ' ' ASN . . . . . . . . . . . . . 30.2 p-10 -89.78 11.69 19.36 Favored 'General case' 0 N--CA 1.483 1.203 0 C-N-CA 123.217 0.607 . . . . 75.03 112.201 -178.614 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . 86.08 -2.8 87.61 Favored Glycine 0 C--N 1.349 1.277 0 CA-C-O 119.732 -0.482 . . . . 62.41 114.031 177.421 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 35.7 ttmt -63.73 130.79 45.65 Favored 'General case' 0 N--CA 1.474 0.756 0 C-N-CA 123.792 0.837 . . . . 70.42 110.736 179.988 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 152' ' ' THR . . . . . . . . . . . . . 82.2 p -91.91 108.84 20.21 Favored 'General case' 0 C--O 1.239 0.504 0 N-CA-C 108.069 -1.085 . . . . 74.53 108.069 170.388 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 153' ' ' SER . . . . . . . . . . . . . 49.4 m -68.32 -28.92 67.58 Favored 'General case' 0 N--CA 1.473 0.712 0 C-N-CA 123.073 0.549 . . . . 75.22 110.532 177.789 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 154' ' ' LYS . . . . . 0.455 ' HB3' HG11 ' A' ' 12' ' ' VAL . 74.4 mmtt -117.11 139.83 50.26 Favored 'General case' 0 C--O 1.241 0.621 0 C-N-CA 124.155 0.982 . . . . 71.2 109.717 177.277 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 155' ' ' LYS . . . . . 0.451 ' HD3' ' SG ' ' A' ' 52' ' ' CYS . 17.4 tppt? -78.56 89.58 4.5 Favored 'General case' 0 CA--C 1.541 0.603 0 N-CA-C 109.016 -0.735 . . . . 74.31 109.016 179.926 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 156' ' ' ILE . . . . . 0.51 HD11 ' HB2' ' A' ' 145' ' ' PHE . 72.5 mt -86.58 117.53 31.16 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.321 0 CA-C-N 115.503 -0.771 . . . . 75.11 109.051 -177.422 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 157' ' ' THR . . . . . . . . . . . . . 25.1 p -130.88 153.62 48.94 Favored 'General case' 0 C--O 1.238 0.478 0 C-N-CA 124.8 1.24 . . . . 72.41 109.484 -171.898 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 158' ' ' ILE . . . . . 0.458 HD11 ' HZ ' ' A' ' 112' ' ' PHE . 67.7 mt -76.19 93.78 1.05 Allowed 'Isoleucine or valine' 0 CA--C 1.547 0.848 0 N-CA-C 108.633 -0.877 . . . . 64.35 108.633 172.094 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 159' ' ' ALA . . . . . 0.826 ' HB2' ' HB3' ' A' ' 11' ' ' ALA . . . -51.31 -53.03 39.95 Favored 'General case' 0 N--CA 1.483 1.185 0 C-N-CA 123.729 0.812 . . . . 34.43 111.707 -178.899 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 160' ' ' ASP . . . . . . . . . . . . . 1.5 t70 -151.18 176.61 11.02 Favored 'General case' 0 CA--C 1.548 0.897 0 CA-C-N 115.827 -0.624 . . . . 65.44 109.818 -178.557 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 161' ' ' CYS . . . . . . . . . . . . . 9.8 p -148.51 -171.69 3.91 Favored 'General case' 0 N--CA 1.477 0.905 0 C-N-CA 124.459 1.104 . . . . 74.23 109.9 -172.399 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 162' ' ' GLY . . . . . . . . . . . . . . . 131.23 53.39 0.09 OUTLIER Glycine 0 C--N 1.353 1.519 0 N-CA-C 112.238 -0.345 . . . . 72.0 112.238 -172.782 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 163' ' ' GLN . . . . . 0.482 ' HA ' ' H ' ' A' ' 7' ' ' PHE . 27.5 tt0 -46.74 107.08 0.1 Allowed 'General case' 0 CA--C 1.559 1.289 0 C-N-CA 125.234 1.414 . . . . 71.44 112.888 179.953 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 164' ' ' LEU . . . . . 0.459 ' O ' ' HB ' ' A' ' 5' ' ' THR . 84.5 mt . . . . . 0 N--CA 1.475 0.795 0 C-N-CA 123.898 0.879 . . . . 72.44 109.85 -175.246 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 218' ' ' PRO . . . . . . . . . . . . . 14.7 Cg_exo . . . . . 0 CA--C 1.539 0.763 0 N-CA-C 108.847 -1.251 . . . . 71.41 108.847 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' B' B ' 219' ' ' GLY . . . . . . . . . . . . . . . 160.18 156.91 8.37 Favored Glycine 0 CA--C 1.533 1.165 0 CA-C-N 115.753 -0.658 . . . . 74.21 112.057 -175.59 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 220' ' ' PRO . . . . . . . . . . . . . 36.3 Cg_endo -86.23 -179.22 3.07 Favored 'Trans proline' 0 C--N 1.365 1.433 0 C-N-CA 123.753 2.968 . . . . 74.14 113.86 -176.288 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 221' ' ' TYR . . . . . . . . . . . . . 97.0 m-85 . . . . . 0 N--CA 1.48 1.053 0 C-N-CA 123.333 0.653 . . . . 75.34 111.868 -175.14 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 3' ' ' ASN . . . . . 0.597 ' ND2' ' HA ' ' A' ' 25' ' ' PHE . 14.9 m120 . . . . . 0 CA--C 1.545 0.785 0 N-CA-C 110.066 -0.346 . . . . 74.34 110.066 . . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 4' ' ' PRO . . . . . 0.507 ' HG2' ' HB2' ' A' ' 24' ' ' LEU . 73.3 Cg_endo -77.48 150.35 28.19 Favored 'Trans proline' 0 C--N 1.374 1.907 0 C-N-CA 122.392 2.061 . . . . 75.22 111.575 170.559 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 5' ' ' THR . . . . . 0.425 ' HB ' ' O ' ' A' ' 164' ' ' LEU . 52.5 m -98.04 142.54 29.63 Favored 'General case' 0 CA--C 1.54 0.566 0 N-CA-C 108.932 -0.766 . . . . 71.54 108.932 175.168 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 6' ' ' VAL . . . . . 0.707 ' HA ' ' HG3' ' A' ' 163' ' ' GLN . 44.1 t -101.76 150.44 6.1 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.967 0 N-CA-C 107.689 -1.226 . . . . 74.31 107.689 171.125 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 7' ' ' PHE . . . . . 0.426 ' H ' ' HA ' ' A' ' 163' ' ' GLN . 74.2 t80 -133.55 130.77 38.9 Favored 'General case' 0 C--O 1.236 0.37 0 N-CA-C 109.531 -0.544 . . . . 74.51 109.531 175.962 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 8' ' ' PHE . . . . . 0.405 ' HD2' ' HE2' ' A' ' 22' ' ' PHE . 32.3 m-85 -138.2 166.49 24.03 Favored 'General case' 0 C--O 1.237 0.418 0 C-N-CA 124.808 1.243 . . . . 73.42 109.362 170.248 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 8.7 m-20 -117.27 112.19 20.43 Favored 'General case' 0 N--CA 1.468 0.463 0 CA-C-N 114.847 -1.069 . . . . 71.44 108.126 171.555 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 10' ' ' ILE . . . . . 0.42 HG23 ' SD ' ' A' ' 142' ' ' MET . 45.8 mm -83.33 128.57 38.64 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.453 0 N-CA-C 108.673 -0.862 . . . . 74.51 108.673 178.91 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 11' ' ' ALA . . . . . 0.654 ' HB2' ' HB3' ' A' ' 159' ' ' ALA . . . -129.97 141.1 50.81 Favored 'General case' 0 N--CA 1.471 0.614 0 C-N-CA 123.749 0.82 . . . . 63.21 110.58 -173.1 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 12' ' ' VAL . . . . . 0.518 HG11 ' HB3' ' A' ' 154' ' ' LYS . 86.2 t -97.17 110.89 25.93 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.435 0 C-N-CA 124.173 0.989 . . . . 72.52 108.848 173.533 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 9.9 m-20 58.98 24.29 12.47 Favored 'General case' 0 N--CA 1.485 1.31 0 C-N-CA 124.8 1.24 . . . . 75.4 112.651 179.919 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 106.13 -24.2 27.03 Favored Glycine 0 C--N 1.349 1.304 0 CA-C-O 119.681 -0.511 . . . . 72.12 113.006 179.658 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 24.7 mm-40 -81.78 120.28 77.35 Favored Pre-proline 0 N--CA 1.479 0.991 0 CA-C-O 118.449 -0.786 . . . . 75.2 109.327 179.994 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 19.1 Cg_endo -57.72 114.65 2.05 Favored 'Trans proline' 0 C--N 1.379 2.158 0 C-N-CA 123.107 2.538 . . . . 74.05 112.498 -177.114 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 17' ' ' LEU . . . . . 0.478 ' HB2' HG23 ' A' ' 12' ' ' VAL . 52.0 tp -79.43 -41.8 26.81 Favored 'General case' 0 N--CA 1.478 0.963 0 C-N-CA 123.735 0.814 . . . . 72.21 110.058 175.765 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -177.69 174.49 46.93 Favored Glycine 0 C--N 1.344 1.024 0 CA-C-N 115.711 -0.677 . . . . 63.5 113.395 179.955 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 19.9 mtp180 -111.2 117.5 33.39 Favored 'General case' 0 N--CA 1.471 0.611 0 N-CA-C 108.456 -0.942 . . . . 75.13 108.456 -175.925 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 86.2 t -113.37 138.48 42.82 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.733 0 C-N-CA 123.78 0.832 . . . . 73.45 110.12 -175.263 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 21' ' ' SER . . . . . 0.4 ' HB2' ' HB2' ' A' ' 134' ' ' GLU . 16.4 m -124.94 135.22 52.62 Favored 'General case' 0 C--O 1.242 0.67 0 C-N-CA 123.661 0.785 . . . . 75.45 110.114 174.901 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 22' ' ' PHE . . . . . 0.454 ' HB2' ' HB ' ' A' ' 6' ' ' VAL . 60.5 m-85 -105.78 170.0 8.15 Favored 'General case' 0 N--CA 1.474 0.765 0 C-N-CA 124.145 0.978 . . . . 64.23 109.912 179.079 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 23' ' ' GLU . . . . . 0.635 ' HB2' ' HD2' ' A' ' 133' ' ' LYS . 33.0 tt0 -130.76 108.89 10.2 Favored 'General case' 0 N--CA 1.473 0.692 0 C-N-CA 123.689 0.796 . . . . 75.52 109.233 177.948 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . 0.507 ' HB2' ' HG2' ' A' ' 4' ' ' PRO . 88.5 mt -78.54 121.0 24.04 Favored 'General case' 0 N--CA 1.469 0.481 0 C-N-CA 123.377 0.671 . . . . 75.44 109.961 179.149 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 25' ' ' PHE . . . . . 0.597 ' HA ' ' ND2' ' A' ' 3' ' ' ASN . 77.7 m-85 -83.85 68.25 9.88 Favored 'General case' 0 C--O 1.233 0.206 0 CA-C-O 121.65 0.738 . . . . 73.34 109.465 171.904 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -66.21 -21.92 66.32 Favored 'General case' 0 N--CA 1.473 0.704 0 CA-C-N 114.708 -1.133 . . . . 73.21 111.128 179.032 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 10.7 p-10 -72.71 -23.61 60.88 Favored 'General case' 0 CA--C 1.543 0.701 0 C-N-CA 124.029 0.932 . . . . 75.21 111.478 178.292 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 59.5 mttp -104.6 -51.29 3.11 Favored 'General case' 0 N--CA 1.482 1.169 0 C-N-CA 123.613 0.765 . . . . 73.04 110.965 -176.536 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 29' ' ' VAL . . . . . 0.562 ' HA ' ' HG2' ' A' ' 86' ' ' GLU . 5.4 m -124.33 72.92 58.55 Favored Pre-proline 0 CA--C 1.55 0.95 0 C-N-CA 124.099 0.96 . . . . 74.33 110.185 -178.195 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 20.7 Cg_endo -60.7 -29.64 88.76 Favored 'Trans proline' 0 C--N 1.38 2.222 0 C-N-CA 122.671 2.247 . . . . 74.11 113.107 -177.072 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 21.9 ttmm -65.33 -54.12 33.73 Favored 'General case' 0 N--CA 1.481 1.111 0 CA-C-O 121.715 0.769 . . . . 73.32 111.556 -179.428 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 32' ' ' THR . . . . . 0.444 HG21 ' HE2' ' A' ' 126' ' ' HIS . 20.5 m -80.16 -32.17 38.87 Favored 'General case' 0 CA--C 1.547 0.842 0 CA-C-N 114.723 -1.126 . . . . 75.42 111.138 -170.244 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 33' ' ' ALA . . . . . 0.481 ' HB3' ' HB3' ' A' ' 24' ' ' LEU . . . -70.1 -40.82 74.7 Favored 'General case' 0 N--CA 1.473 0.692 0 C-N-CA 122.787 0.435 . . . . 75.32 110.222 174.609 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 9.3 tp10 -62.77 -40.75 98.24 Favored 'General case' 0 N--CA 1.488 1.467 0 O-C-N 123.668 0.605 . . . . 74.52 110.752 176.54 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 35' ' ' ASN . . . . . 0.472 ' O ' ' HG ' ' A' ' 39' ' ' LEU . 40.0 t30 -53.57 -62.91 1.35 Allowed 'General case' 0 C--N 1.349 0.577 0 O-C-N 124.293 0.996 . . . . 75.4 110.433 178.643 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 65.6 t80 -65.53 -33.96 77.13 Favored 'General case' 0 N--CA 1.474 0.743 0 CA-C-N 115.338 -0.846 . . . . 72.52 111.805 -176.167 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 37' ' ' ARG . . . . . 0.547 ' HG3' HE22 ' A' ' 163' ' ' GLN . 32.7 ttt180 -55.21 -49.67 71.34 Favored 'General case' 0 N--CA 1.485 1.293 0 C-N-CA 124.262 1.025 . . . . 71.52 110.728 173.655 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 38' ' ' ALA . . . . . 0.443 ' HB2' HG23 ' A' ' 78' ' ' ILE . . . -76.92 -25.94 53.52 Favored 'General case' 0 CA--C 1.544 0.741 0 CA-C-N 114.314 -1.312 . . . . 61.14 112.07 -174.921 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 39' ' ' LEU . . . . . 0.472 ' HG ' ' O ' ' A' ' 35' ' ' ASN . 95.4 mt -73.39 -40.26 64.45 Favored 'General case' 0 N--CA 1.479 1.022 0 C-N-CA 123.536 0.734 . . . . 72.24 110.2 173.297 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 40.3 t -65.42 -54.74 24.29 Favored 'General case' 0 N--CA 1.479 0.984 0 CA-C-N 114.42 -1.264 . . . . 72.01 110.592 -176.144 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 82.6 p -73.3 -32.09 64.42 Favored 'General case' 0 N--CA 1.472 0.637 0 CA-C-O 121.29 0.567 . . . . 75.2 109.737 177.253 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . 0.447 ' HA3' ' HA2' ' A' ' 47' ' ' GLY . . . 75.39 8.22 83.5 Favored Glycine 0 C--N 1.347 1.186 0 CA-C-N 115.221 -0.899 . . . . 64.21 114.886 171.832 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 47.8 mm-40 -69.07 -4.59 17.69 Favored 'General case' 0 N--CA 1.482 1.146 0 C-N-CA 123.804 0.842 . . . . 64.13 113.046 -178.018 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 44' ' ' LYS . . . . . 0.435 ' HG3' ' HB1' ' A' ' 38' ' ' ALA . 32.3 mmmt -94.0 13.44 22.89 Favored 'General case' 0 CA--C 1.55 0.976 0 C-N-CA 123.565 0.746 . . . . 74.15 111.462 172.356 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 92.52 22.99 27.5 Favored Glycine 0 C--N 1.357 1.709 0 N-CA-C 114.559 0.584 . . . . 63.23 114.559 173.231 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 25.9 m-85 -114.88 -46.71 2.91 Favored 'General case' 0 N--CA 1.487 1.42 0 CA-C-N 117.507 0.654 . . . . 73.22 111.279 -172.069 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . 0.447 ' HA2' ' HA3' ' A' ' 42' ' ' GLY . . . 53.84 63.68 4.91 Favored Glycine 0 C--N 1.346 1.109 0 O-C-N 124.096 0.873 . . . . 71.24 114.64 173.084 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 50.7 m-85 -71.71 84.81 0.9 Allowed 'General case' 0 N--CA 1.485 1.282 0 CA-C-O 122.119 0.962 . . . . 75.01 111.167 177.387 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 49' ' ' LYS . . . . . 0.512 ' HE3' ' HA ' ' A' ' 160' ' ' ASP . 22.2 tptm -116.3 138.56 51.22 Favored 'General case' 0 CA--C 1.538 0.51 0 CA-C-N 113.601 -1.636 . . . . 70.02 107.603 171.851 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 69.45 19.99 74.99 Favored Glycine 0 N--CA 1.478 1.477 0 CA-C-N 118.069 0.395 . . . . 70.04 114.001 177.161 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 25.1 m -70.21 119.34 14.26 Favored 'General case' 0 N--CA 1.471 0.603 0 C-N-CA 123.614 0.765 . . . . 62.42 110.137 -176.436 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 52' ' ' CYS . . . . . . . . . . . . . 21.2 p -90.93 157.54 17.25 Favored 'General case' 0 N--CA 1.474 0.767 0 CA-C-O 121.714 0.769 . . . . 71.22 111.876 -171.518 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 29.1 m-85 -96.25 164.94 12.45 Favored 'General case' 0 C--O 1.24 0.605 0 C-N-CA 124.998 1.319 . . . . 73.45 108.741 175.515 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 19.5 p-80 -149.36 -43.09 0.14 Allowed 'General case' 0 N--CA 1.477 0.897 0 N-CA-C 110.451 -0.203 . . . . 74.44 110.451 -171.222 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 55' ' ' ARG . . . . . 0.472 ' HA ' ' O ' ' A' ' 150' ' ' GLY . 42.2 ttt-85 -121.06 98.81 6.16 Favored 'General case' 0 C--N 1.347 0.49 0 N-CA-C 109.089 -0.708 . . . . 74.23 109.089 -174.578 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 57.0 mt -127.39 127.19 68.75 Favored 'Isoleucine or valine' 0 C--O 1.239 0.527 0 N-CA-C 107.778 -1.193 . . . . 74.25 107.778 176.966 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 68.4 mt -122.44 116.41 29.52 Favored Pre-proline 0 CA--C 1.55 0.967 0 N-CA-C 108.278 -1.008 . . . . 70.13 108.278 -177.386 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 58' ' ' PRO . . . . . 0.415 ' HA ' ' HG2' ' A' ' 143' ' ' GLU . 31.0 Cg_exo -62.46 136.23 57.91 Favored 'Trans proline' 0 C--N 1.379 2.145 0 C-N-CA 123.313 2.675 . . . . 73.25 112.351 -179.346 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 78.86 22.72 65.66 Favored Glycine 0 C--N 1.344 1.019 0 O-C-N 123.78 0.675 . . . . 72.24 112.767 -176.202 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 60' ' ' PHE . . . . . 0.407 ' CD2' ' HB3' ' A' ' 61' ' ' MET . 55.3 t80 -148.01 -69.26 0.23 Allowed 'General case' 0 CA--C 1.55 0.958 0 C-N-CA 123.476 0.71 . . . . 71.4 111.054 -175.058 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 61' ' ' MET . . . . . 0.6 ' HE3' ' SG ' ' A' ' 115' ' ' CYS . 40.5 ttm -175.97 158.16 1.99 Allowed 'General case' 0 N--CA 1.49 1.542 0 N-CA-C 113.245 0.832 . . . . 73.33 113.245 -159.582 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 62' ' ' CYS . . . . . 0.442 ' SG ' ' HB ' ' A' ' 114' ' ' ILE . 24.9 p -122.94 113.75 19.51 Favored 'General case' 0 CA--C 1.549 0.94 0 C-N-CA 124.197 0.999 . . . . 72.14 109.647 168.579 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 57.8 tt0 -112.72 127.48 56.15 Favored 'General case' 0 N--CA 1.489 1.485 0 C-N-CA 124.125 0.97 . . . . 75.14 110.37 -176.145 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -151.47 -157.47 7.9 Favored Glycine 0 C--N 1.348 1.214 0 CA-C-N 115.698 -0.683 . . . . 60.23 113.715 -177.476 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 86.27 -8.13 75.48 Favored Glycine 0 C--N 1.35 1.35 0 N-CA-C 112.04 -0.424 . . . . 62.42 112.04 -167.722 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 38.9 t70 -75.66 86.98 2.72 Favored 'General case' 0 C--N 1.354 0.775 0 C-N-CA 124.638 1.175 . . . . 54.13 109.925 -174.221 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 91.2 t80 -144.42 -55.09 0.34 Allowed 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 114.547 -1.206 . . . . 74.14 108.697 -176.667 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 5.7 t -84.81 122.75 29.59 Favored 'General case' 0 C--O 1.246 0.873 0 C-N-CA 123.146 0.578 . . . . 72.24 109.998 178.804 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 86.0 mtt180 53.85 51.75 14.26 Favored 'General case' 0 N--CA 1.48 1.041 0 C-N-CA 124.369 1.068 . . . . 74.03 109.851 -179.251 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 20.8 p80 -78.4 66.75 4.03 Favored 'General case' 0 CA--C 1.555 1.164 0 CA-C-O 122.32 1.057 . . . . 73.02 112.046 -168.841 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 8.3 t30 -155.08 79.46 1.05 Allowed 'General case' 0 C--O 1.24 0.596 0 N-CA-C 107.289 -1.375 . . . . 75.44 107.289 -177.213 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 72' ' ' GLY . . . . . 0.552 ' HA2' ' HG3' ' B' ' 218' ' ' PRO . . . 79.65 -6.96 56.75 Favored Glycine 0 CA--C 1.533 1.163 0 CA-C-N 115.039 -0.982 . . . . 45.22 113.838 -179.006 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 7.3 m -115.51 -78.77 0.58 Allowed 'General case' 0 CA--C 1.546 0.804 0 N-CA-C 108.132 -1.062 . . . . 74.1 108.132 -179.822 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 54.67 60.61 8.37 Favored Glycine 0 C--N 1.359 1.851 0 N-CA-C 114.59 0.596 . . . . 71.42 114.59 172.199 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 119.95 52.5 0.27 Allowed Glycine 0 N--CA 1.476 1.307 0 CA-C-N 117.716 0.758 . . . . 71.33 111.289 -175.452 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 17.4 pttp -63.08 169.61 3.3 Favored 'General case' 0 CA--C 1.547 0.828 0 C-N-CA 124.186 0.995 . . . . 73.13 112.393 -174.768 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 76.1 p -93.16 179.23 5.49 Favored 'General case' 0 C--O 1.246 0.887 0 CA-C-O 121.525 0.679 . . . . 74.21 112.254 -171.134 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 78' ' ' ILE . . . . . 0.443 HG23 ' HB2' ' A' ' 38' ' ' ALA . 34.1 pt -75.23 -20.1 16.21 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.784 0 CA-C-N 115.294 -0.867 . . . . 74.41 110.187 168.735 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 82.7 m-85 -87.93 18.49 4.14 Favored 'General case' 0 CA--C 1.547 0.832 0 C-N-CA 124.57 1.148 . . . . 70.31 110.433 177.006 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 99.02 -120.79 6.98 Favored Glycine 0 C--N 1.354 1.565 0 N-CA-C 111.071 -0.812 . . . . 74.21 111.071 -179.842 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 36.8 tt0 -71.98 -59.42 2.75 Favored 'General case' 0 N--CA 1.47 0.544 0 C-N-CA 123.265 0.626 . . . . 75.22 110.057 178.057 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 82' ' ' LYS . . . . . 0.809 ' HD2' ' HA ' ' A' ' 107' ' ' THR . 21.4 pttp -155.62 175.98 13.2 Favored 'General case' 0 CA--C 1.544 0.741 0 CA-C-N 115.372 -0.831 . . . . 73.2 110.821 -172.41 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 12.1 p90 -159.15 173.72 15.97 Favored 'General case' 0 CA--C 1.538 0.507 0 C-N-CA 124.918 1.287 . . . . 74.4 110.035 -175.063 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 84' ' ' GLU . . . . . 0.548 ' HA ' ' HA ' ' A' ' 106' ' ' ASN . 7.4 pt-20 -83.84 169.85 14.71 Favored 'General case' 0 N--CA 1.475 0.803 0 C-N-CA 123.527 0.731 . . . . 72.05 111.753 -179.864 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 41.1 m-20 -74.9 143.55 43.74 Favored 'General case' 0 N--CA 1.472 0.641 0 C-N-CA 123.739 0.816 . . . . 63.44 109.677 -179.845 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 86' ' ' GLU . . . . . 0.562 ' HG2' ' HA ' ' A' ' 29' ' ' VAL . 7.9 tp10 -66.13 -59.53 3.68 Favored 'General case' 0 N--CA 1.472 0.654 0 CA-C-O 121.769 0.795 . . . . 64.35 110.107 176.202 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 32.4 p30 -163.32 -159.83 0.56 Allowed 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 113.974 -1.466 . . . . 72.21 107.909 -179.935 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 96.2 m-85 -138.35 42.74 2.19 Favored 'General case' 0 N--CA 1.482 1.158 0 C-N-CA 122.981 0.512 . . . . 71.02 110.307 179.45 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 61.9 mt -67.59 -48.43 76.69 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.488 0 CA-C-O 121.214 0.53 . . . . 75.41 110.062 175.998 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 90' ' ' LEU . . . . . 0.566 ' HB3' ' HB ' ' A' ' 128' ' ' VAL . 82.6 mt -88.99 153.08 21.31 Favored 'General case' 0 C--O 1.241 0.632 0 CA-C-N 115.556 -0.747 . . . . 71.3 110.653 179.035 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 21.1 ptmt -150.43 168.49 24.0 Favored 'General case' 0 N--CA 1.472 0.637 0 CA-C-N 115.529 -0.76 . . . . 74.23 110.62 -179.59 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 92' ' ' HIS . . . . . . . . . . . . . 27.2 m80 -87.31 68.36 9.78 Favored 'General case' 0 CA--C 1.546 0.802 0 C-N-CA 124.035 0.934 . . . . 75.54 109.454 -172.855 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 8.8 t -114.34 7.13 16.31 Favored 'General case' 0 N--CA 1.477 0.918 0 CA-C-N 114.972 -1.013 . . . . 75.52 111.338 -172.611 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -150.2 173.75 29.79 Favored Glycine 0 C--N 1.347 1.153 0 CA-C-O 119.993 -0.337 . . . . 52.13 113.137 -176.2 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 98.2 Cg_endo -85.15 155.96 11.14 Favored 'Trans proline' 0 C--N 1.368 1.579 0 C-N-CA 123.103 2.535 . . . . 72.53 112.379 174.066 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 76.18 19.09 78.87 Favored Glycine 0 N--CA 1.476 1.301 0 CA-C-N 116.481 -0.327 . . . . 63.23 113.581 178.613 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 97' ' ' ILE . . . . . 0.549 ' HB ' ' HB2' ' A' ' 115' ' ' CYS . 13.3 mm -76.34 105.45 5.26 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.907 0 C-N-CA 123.833 0.853 . . . . 74.31 111.42 -174.872 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 60.8 tp -90.62 119.42 30.85 Favored 'General case' 0 CA--C 1.549 0.941 0 C-N-CA 123.084 0.554 . . . . 75.33 110.002 176.694 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 47.2 t -143.91 148.9 36.05 Favored 'General case' 0 CA--C 1.545 0.778 0 C-N-CA 124.388 1.075 . . . . 74.22 108.576 179.126 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 100' ' ' MET . . . . . 0.444 ' HA ' ' HA ' ' A' ' 112' ' ' PHE . 57.0 mtp -82.84 147.24 28.45 Favored 'General case' 0 N--CA 1.488 1.432 0 CA-C-N 118.201 0.455 . . . . 72.31 110.535 179.819 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -76.41 145.55 39.28 Favored 'General case' 0 C--O 1.243 0.743 0 C-N-CA 122.888 0.475 . . . . 75.13 112.169 -172.248 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 20.4 p-10 -153.89 149.22 27.1 Favored 'General case' 0 C--O 1.241 0.616 0 C-N-CA 124.292 1.037 . . . . 71.41 108.7 177.894 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -87.37 -34.41 18.81 Favored 'General case' 0 N--CA 1.474 0.732 0 N-CA-C 109.477 -0.564 . . . . 74.34 109.477 169.895 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -158.71 -166.72 18.34 Favored Glycine 0 C--N 1.342 0.909 0 CA-C-N 115.387 -0.824 . . . . 64.2 111.292 174.236 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 33.7 Cg_exo -60.78 151.28 78.05 Favored 'Trans proline' 0 C--N 1.369 1.637 0 C-N-CA 122.797 2.331 . . . . 63.14 111.847 178.357 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 106' ' ' ASN . . . . . 0.548 ' HA ' ' HA ' ' A' ' 84' ' ' GLU . 65.0 t30 65.83 16.96 10.7 Favored 'General case' 0 CA--C 1.561 1.38 0 C-N-CA 124.758 1.223 . . . . 72.2 111.343 178.78 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 107' ' ' THR . . . . . 0.809 ' HA ' ' HD2' ' A' ' 82' ' ' LYS . 5.1 m -118.89 7.19 11.46 Favored 'General case' 0 N--CA 1.485 1.286 0 C-N-CA 123.968 0.907 . . . . 70.54 110.387 179.839 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 11.1 t30 -70.71 145.77 50.31 Favored 'General case' 0 C--O 1.213 -0.851 0 C-N-CA 124.696 1.198 . . . . 70.31 110.232 177.615 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 101.29 23.36 9.68 Favored Glycine 0 N--CA 1.472 1.089 0 C-N-CA 121.66 -0.305 . . . . 72.1 113.805 177.295 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 22.8 p -132.67 120.4 21.67 Favored 'General case' 0 N--CA 1.468 0.454 0 N-CA-C 107.881 -1.155 . . . . 73.22 107.881 174.249 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 111' ' ' GLN . . . . . 0.433 HE22 ' HG2' ' B' ' 218' ' ' PRO . 16.0 mt-30 62.71 161.77 0.09 Allowed 'General case' 0 N--CA 1.492 1.632 0 C-N-CA 124.114 0.966 . . . . 74.22 111.74 -171.778 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 112' ' ' PHE . . . . . 0.444 ' HA ' ' HA ' ' A' ' 100' ' ' MET . 49.1 p90 -133.72 143.14 48.31 Favored 'General case' 0 N--CA 1.472 0.645 0 N-CA-C 108.201 -1.037 . . . . 75.11 108.201 169.054 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 113' ' ' PHE . . . . . 0.438 ' HB2' ' SD ' ' A' ' 61' ' ' MET . 50.5 p90 -129.58 148.13 51.45 Favored 'General case' 0 C--O 1.236 0.391 0 C-N-CA 123.515 0.726 . . . . 74.31 110.091 179.574 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 114' ' ' ILE . . . . . 0.442 ' HB ' ' SG ' ' A' ' 62' ' ' CYS . 21.5 mt -112.63 104.61 17.31 Favored 'Isoleucine or valine' 0 C--O 1.241 0.61 0 N-CA-C 108.486 -0.931 . . . . 71.45 108.486 175.239 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 115' ' ' CYS . . . . . 0.6 ' SG ' ' HE3' ' A' ' 61' ' ' MET . 28.9 m -64.69 104.52 0.83 Allowed 'General case' 0 CA--C 1.542 0.656 0 N-CA-C 108.406 -0.961 . . . . 74.23 108.406 170.256 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 116' ' ' THR . . . . . 0.495 HG23 HG13 ' A' ' 139' ' ' VAL . 62.5 p -70.16 -31.78 69.43 Favored 'General case' 0 N--CA 1.472 0.632 0 C-N-CA 123.216 0.606 . . . . 71.01 110.296 -179.522 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -115.62 170.99 8.02 Favored 'General case' 0 C--O 1.243 0.745 0 C-N-CA 124.012 0.925 . . . . 74.23 109.72 175.292 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 19.3 ptmt -72.01 92.09 1.27 Allowed 'General case' 0 CA--C 1.554 1.11 0 CA-C-O 121.804 0.811 . . . . 73.25 110.019 175.253 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 119' ' ' THR . . . . . 0.541 ' HB ' HD11 ' A' ' 122' ' ' LEU . 46.7 p -85.64 83.63 7.83 Favored 'General case' 0 CA--C 1.546 0.817 0 CA-C-O 121.813 0.816 . . . . 75.54 109.182 179.766 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 10.2 pt-20 -75.91 -30.13 58.65 Favored 'General case' 0 N--CA 1.482 1.148 0 CA-C-N 115.524 -0.762 . . . . 75.22 112.38 -167.086 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 121' ' ' TRP . . . . . . . . . . . . . 39.0 p90 -69.19 -4.78 18.96 Favored 'General case' 0 CA--C 1.553 1.07 0 C-N-CA 123.713 0.805 . . . . 74.51 111.624 178.03 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 122' ' ' LEU . . . . . 0.541 HD11 ' HB ' ' A' ' 119' ' ' THR . 10.8 mp -87.27 2.39 50.29 Favored 'General case' 0 N--CA 1.482 1.169 0 C-N-CA 124.055 0.942 . . . . 72.53 112.485 174.695 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 78.4 m-20 -78.01 124.54 28.15 Favored 'General case' 0 N--CA 1.477 0.907 0 CA-C-N 118.427 0.558 . . . . 72.01 109.668 177.716 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 112.09 -11.11 26.93 Favored Glycine 0 C--N 1.351 1.369 0 CA-C-N 115.497 -0.774 . . . . 63.34 111.621 -165.027 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 28.7 mtpp -90.83 -165.09 1.28 Allowed 'General case' 0 N--CA 1.486 1.341 0 C-N-CA 124.19 0.996 . . . . 74.43 109.665 169.728 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 126' ' ' HIS . . . . . 0.444 ' HE2' HG21 ' A' ' 32' ' ' THR . 22.8 t60 -66.34 136.22 55.48 Favored 'General case' 0 CA--C 1.549 0.912 0 CA-C-O 121.35 0.595 . . . . 73.4 111.1 -178.815 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 7.1 p -59.15 147.97 7.43 Favored 'Isoleucine or valine' 0 CA--C 1.551 1.011 0 CA-C-N 113.976 -1.465 . . . . 63.15 111.726 178.03 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 128' ' ' VAL . . . . . 0.566 ' HB ' ' HB3' ' A' ' 90' ' ' LEU . 24.9 t -68.28 157.78 6.16 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.967 0 C-N-CA 123.482 0.713 . . . . 64.42 109.664 175.841 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 129' ' ' PHE . . . . . . . . . . . . . 49.1 p90 -138.9 -24.17 0.91 Allowed 'General case' 0 N--CA 1.478 0.971 0 C-N-CA 122.039 0.136 . . . . 74.22 111.127 174.189 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . -130.11 161.78 23.07 Favored Glycine 0 C--N 1.346 1.095 0 N-CA-C 112.242 -0.343 . . . . 61.24 112.242 -174.563 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 131' ' ' LYS . . . . . 0.426 ' HE2' ' HB3' ' A' ' 131' ' ' LYS . 31.2 ttpt -146.6 128.49 15.41 Favored 'General case' 0 N--CA 1.466 0.356 0 C-N-CA 123.689 0.796 . . . . 75.02 108.991 179.758 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 34.0 t -70.55 101.12 0.78 Allowed 'Isoleucine or valine' 0 CA--C 1.542 0.653 0 N-CA-C 109.282 -0.636 . . . . 63.04 109.282 177.807 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 133' ' ' LYS . . . . . 0.635 ' HD2' ' HB2' ' A' ' 23' ' ' GLU . 18.6 ptmt -87.81 -36.77 17.07 Favored 'General case' 0 N--CA 1.474 0.725 0 CA-C-N 115.615 -0.72 . . . . 74.23 109.781 -179.669 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 134' ' ' GLU . . . . . 0.515 ' HG2' ' HG3' ' A' ' 133' ' ' LYS . 30.8 mm-40 -124.23 144.93 49.67 Favored 'General case' 0 N--CA 1.472 0.648 0 C-N-CA 124.226 1.011 . . . . 75.23 108.8 176.706 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 78.47 21.45 69.58 Favored Glycine 0 N--CA 1.467 0.722 0 CA-C-O 119.582 -0.566 . . . . 53.34 113.375 175.037 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 136' ' ' MET . . . . . . . . . . . . . 16.3 tpt -62.34 -38.1 88.18 Favored 'General case' 0 N--CA 1.481 1.102 0 C-N-CA 123.042 0.537 . . . . 75.54 111.081 174.887 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 137' ' ' ASN . . . . . . . . . . . . . 16.3 m120 -64.29 -29.8 70.88 Favored 'General case' 0 CA--C 1.545 0.786 0 C-N-CA 122.937 0.495 . . . . 74.45 110.897 176.229 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 138' ' ' ILE . . . . . . . . . . . . . 46.8 mm -73.86 -36.1 44.73 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.039 0 C-N-CA 123.156 0.583 . . . . 73.21 110.153 175.797 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 139' ' ' VAL . . . . . 0.495 HG13 HG23 ' A' ' 116' ' ' THR . 91.8 t -65.91 -40.31 87.1 Favored 'Isoleucine or valine' 0 CA--C 1.555 1.149 0 C-N-CA 123.361 0.665 . . . . 73.13 110.674 178.112 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 44.1 mt-10 -74.03 -29.08 61.74 Favored 'General case' 0 N--CA 1.477 0.917 0 CA-C-N 115.64 -0.709 . . . . 75.15 110.622 177.209 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -70.86 -43.36 68.63 Favored 'General case' 0 N--CA 1.478 0.938 0 C-N-CA 122.902 0.481 . . . . 64.23 111.15 176.064 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 142' ' ' MET . . . . . 0.555 ' HB2' HD12 ' A' ' 156' ' ' ILE . 25.2 ptm -72.92 -28.05 62.22 Favored 'General case' 0 N--CA 1.477 0.878 0 C-N-CA 123.074 0.55 . . . . 73.35 111.315 -178.132 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 143' ' ' GLU . . . . . 0.415 ' HG2' ' HA ' ' A' ' 58' ' ' PRO . 34.0 tt0 -59.98 -32.55 70.94 Favored 'General case' 0 C--N 1.357 0.897 0 O-C-N 123.597 0.561 . . . . 72.42 111.937 178.352 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 144' ' ' ARG . . . . . . . . . . . . . 38.6 mtm-85 -67.45 -18.79 65.22 Favored 'General case' 0 N--CA 1.477 0.882 0 C-N-CA 123.038 0.535 . . . . 73.23 111.986 -178.363 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 145' ' ' PHE . . . . . 0.494 ' HB2' HD11 ' A' ' 156' ' ' ILE . 45.2 m-85 -83.01 -5.57 59.15 Favored 'General case' 0 N--CA 1.477 0.896 0 C-N-CA 122.871 0.469 . . . . 74.34 111.412 177.185 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . -87.23 175.15 46.04 Favored Glycine 0 C--N 1.347 1.188 0 O-C-N 123.444 0.465 . . . . 61.22 112.12 172.436 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 29.7 m -134.75 169.49 17.27 Favored 'General case' 0 N--CA 1.483 1.209 0 C-N-CA 123.392 0.677 . . . . 73.2 111.59 -174.445 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 148' ' ' ARG . . . . . . . . . . . . . 8.7 mmm180 -57.59 -41.26 80.82 Favored 'General case' 0 N--CA 1.487 1.383 0 C-N-CA 124.81 1.244 . . . . 73.01 113.065 179.927 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 149' ' ' ASN . . . . . . . . . . . . . 30.5 p-10 -75.24 -17.69 60.27 Favored 'General case' 0 N--CA 1.478 0.945 0 C-N-CA 122.958 0.503 . . . . 73.03 111.238 178.191 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 150' ' ' GLY . . . . . 0.472 ' O ' ' HA ' ' A' ' 55' ' ' ARG . . . 111.65 -10.2 28.0 Favored Glycine 0 C--N 1.348 1.222 0 O-C-N 123.706 0.629 . . . . 75.12 112.378 -179.554 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 25.1 ttmm -65.55 137.64 57.52 Favored 'General case' 0 N--CA 1.471 0.624 0 C-N-CA 122.875 0.47 . . . . 74.41 111.177 -175.765 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 152' ' ' THR . . . . . . . . . . . . . 41.1 p -90.42 109.76 20.88 Favored 'General case' 0 C--O 1.239 0.516 0 N-CA-C 108.198 -1.038 . . . . 73.0 108.198 174.493 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 153' ' ' SER . . . . . . . . . . . . . 19.3 m -62.56 -29.36 70.52 Favored 'General case' 0 CA--C 1.544 0.75 0 C-N-CA 124.039 0.936 . . . . 71.33 110.804 176.172 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 154' ' ' LYS . . . . . 0.518 ' HB3' HG11 ' A' ' 12' ' ' VAL . 48.1 mmtm -118.63 133.92 55.5 Favored 'General case' 0 CA--C 1.54 0.561 0 CA-C-N 114.609 -1.178 . . . . 65.53 108.832 175.281 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 16.9 tppt? -78.99 91.68 4.87 Favored 'General case' 0 N--CA 1.473 0.689 0 N-CA-C 109.627 -0.509 . . . . 74.55 109.627 -178.272 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 156' ' ' ILE . . . . . 0.555 HD12 ' HB2' ' A' ' 142' ' ' MET . 70.5 mt -84.92 117.14 29.66 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.357 0 N-CA-C 109.835 -0.431 . . . . 74.33 109.835 -175.242 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 157' ' ' THR . . . . . . . . . . . . . 54.8 p -115.91 156.34 26.36 Favored 'General case' 0 N--CA 1.473 0.707 0 C-N-CA 124.232 1.013 . . . . 63.13 110.015 -179.126 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 158' ' ' ILE . . . . . . . . . . . . . 63.7 mt -80.6 96.0 2.68 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.819 0 N-CA-C 108.283 -1.006 . . . . 73.42 108.283 169.786 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 159' ' ' ALA . . . . . 0.654 ' HB3' ' HB2' ' A' ' 11' ' ' ALA . . . -55.55 -53.14 60.09 Favored 'General case' 0 N--CA 1.478 0.939 0 C-N-CA 124.331 1.053 . . . . 62.42 111.784 -178.177 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 160' ' ' ASP . . . . . 0.512 ' HA ' ' HE3' ' A' ' 49' ' ' LYS . 0.9 OUTLIER -140.17 175.21 9.78 Favored 'General case' 0 N--CA 1.473 0.724 0 CA-C-N 115.798 -0.637 . . . . 71.51 110.405 -176.509 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 161' ' ' CYS . . . . . . . . . . . . . 63.2 m -146.23 -169.82 3.35 Favored 'General case' 0 CA--C 1.547 0.852 0 C-N-CA 125.147 1.379 . . . . 55.1 108.4 -172.674 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 162' ' ' GLY . . . . . . . . . . . . . . . 131.71 53.26 0.09 OUTLIER Glycine 0 C--N 1.348 1.216 0 N-CA-C 112.151 -0.38 . . . . 64.43 112.151 -177.836 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 163' ' ' GLN . . . . . 0.707 ' HG3' ' HA ' ' A' ' 6' ' ' VAL . 43.4 tt0 -46.21 110.53 0.28 Allowed 'General case' 0 N--CA 1.48 1.032 0 C-N-CA 125.035 1.334 . . . . 75.32 112.392 -177.349 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 164' ' ' LEU . . . . . 0.425 ' O ' ' HB ' ' A' ' 5' ' ' THR . 45.3 mt . . . . . 0 CA--C 1.543 0.704 0 N-CA-C 108.63 -0.878 . . . . 72.22 108.63 -179.357 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 218' ' ' PRO . . . . . 0.552 ' HG3' ' HA2' ' A' ' 72' ' ' GLY . 45.7 Cg_endo . . . . . 0 CA--C 1.544 0.977 0 N-CA-C 109.973 -0.818 . . . . 75.31 109.973 . . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 219' ' ' GLY . . . . . . . . . . . . . . . 147.16 -161.42 28.47 Favored Glycine 0 CA--C 1.527 0.791 0 CA-C-N 114.71 -1.132 . . . . 71.03 111.492 -171.489 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 220' ' ' PRO . . . . . . . . . . . . . 64.0 Cg_endo -91.03 168.87 3.56 Favored 'Trans proline' 0 C--N 1.363 1.298 0 C-N-CA 123.412 2.742 . . . . 70.21 114.677 -176.644 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 221' ' ' TYR . . . . . . . . . . . . . 88.0 t80 . . . . . 0 N--CA 1.484 1.248 0 C-N-CA 123.538 0.735 . . . . 74.41 109.184 169.921 . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 15.3 m120 . . . . . 0 CA--C 1.549 0.911 0 CA-C-O 119.181 -0.438 . . . . 73.54 111.429 . . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 4' ' ' PRO . . . . . 0.59 ' HG2' ' HB2' ' A' ' 24' ' ' LEU . 29.7 Cg_endo -65.06 123.42 11.55 Favored 'Trans proline' 0 C--N 1.379 2.18 0 C-N-CA 122.356 2.037 . . . . 65.51 110.298 170.694 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 5' ' ' THR . . . . . 0.585 HG21 ' HD3' ' A' ' 133' ' ' LYS . 99.3 m -96.48 119.39 34.89 Favored 'General case' 0 C--N 1.328 -0.351 0 N-CA-C 108.743 -0.836 . . . . 75.04 108.743 -174.811 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 32.1 m -102.77 123.66 56.28 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.646 0 N-CA-C 109.772 -0.455 . . . . 73.44 109.772 -177.694 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 7' ' ' PHE . . . . . 0.583 ' H ' ' HA ' ' A' ' 163' ' ' GLN . 76.7 t80 -109.89 130.16 55.56 Favored 'General case' 0 N--CA 1.47 0.543 0 C-N-CA 123.307 0.643 . . . . 73.13 109.849 -174.398 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 8' ' ' PHE . . . . . 0.471 ' HB3' HG22 ' A' ' 158' ' ' ILE . 36.9 m-85 -135.31 165.64 24.98 Favored 'General case' 0 N--CA 1.472 0.649 0 C-N-CA 124.604 1.162 . . . . 72.11 109.449 173.485 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 18.5 m-20 -120.15 115.08 22.94 Favored 'General case' 0 N--CA 1.467 0.423 0 C-N-CA 124.456 1.102 . . . . 71.0 108.544 171.532 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 10' ' ' ILE . . . . . 0.512 HG23 ' SD ' ' A' ' 142' ' ' MET . 44.3 mm -83.85 132.45 31.47 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.562 0 C-N-CA 123.611 0.764 . . . . 71.23 108.98 178.98 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 11' ' ' ALA . . . . . 0.407 ' O ' ' HA ' ' A' ' 156' ' ' ILE . . . -139.72 135.49 33.2 Favored 'General case' 0 N--CA 1.465 0.299 0 C-N-CA 122.561 0.345 . . . . 75.42 111.799 -171.984 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 14.6 m -96.03 113.77 31.2 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.682 0 C-N-CA 124.703 1.201 . . . . 63.12 109.487 179.752 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 54.8 m-20 63.35 20.43 12.26 Favored 'General case' 0 N--CA 1.489 1.521 0 C-N-CA 125.039 1.336 . . . . 71.35 110.987 -170.262 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 89.44 -6.4 83.29 Favored Glycine 0 C--N 1.348 1.244 0 CA-C-N 116.225 -0.443 . . . . 61.21 113.258 -174.774 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 27.2 mm-40 -86.51 125.99 65.7 Favored Pre-proline 0 CA--C 1.548 0.871 0 C-N-CA 123.39 0.676 . . . . 74.14 110.305 179.356 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 18.0 Cg_endo -52.64 101.85 0.06 OUTLIER 'Trans proline' 0 C--N 1.386 2.536 0 C-N-CA 124.168 3.245 . . . . 74.11 113.996 -170.475 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 53.1 tp -79.19 -35.87 41.14 Favored 'General case' 0 N--CA 1.479 1.003 0 N-CA-C 109.261 -0.644 . . . . 70.43 109.261 175.454 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 166.21 -173.82 41.73 Favored Glycine 0 C--N 1.337 0.614 0 CA-C-N 115.153 -0.93 . . . . 73.4 111.563 176.817 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 47.7 ptt85 -110.59 141.75 43.36 Favored 'General case' 0 C--O 1.239 0.51 0 C-N-CA 123.983 0.913 . . . . 75.54 109.255 177.51 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 93.7 t -134.88 121.2 33.32 Favored 'Isoleucine or valine' 0 C--O 1.239 0.504 0 C-N-CA 123.633 0.773 . . . . 62.42 109.253 175.202 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 21' ' ' SER . . . . . 0.466 ' HB3' ' HB2' ' A' ' 134' ' ' GLU . 22.8 t -115.1 136.99 52.52 Favored 'General case' 0 CA--C 1.539 0.548 0 N-CA-C 108.48 -0.933 . . . . 74.14 108.48 174.516 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 41.8 m-85 -109.69 169.14 8.9 Favored 'General case' 0 N--CA 1.472 0.668 0 C-N-CA 123.675 0.79 . . . . 72.42 110.235 177.684 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 23' ' ' GLU . . . . . 0.627 ' HB2' ' HD2' ' A' ' 133' ' ' LYS . 37.4 tt0 -122.22 103.7 8.95 Favored 'General case' 0 CA--C 1.538 0.503 0 C-N-CA 125.581 1.552 . . . . 75.01 107.938 -176.953 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . 0.59 ' HB2' ' HG2' ' A' ' 4' ' ' PRO . 18.4 mt -82.99 124.51 30.47 Favored 'General case' 0 N--CA 1.474 0.761 0 N-CA-C 109.454 -0.572 . . . . 71.1 109.454 -179.279 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 68.2 m-85 -86.6 69.37 10.35 Favored 'General case' 0 CA--C 1.534 0.357 0 C-N-CA 123.324 0.65 . . . . 74.0 109.38 179.292 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -64.65 -20.09 66.09 Favored 'General case' 0 N--CA 1.484 1.225 0 C-N-CA 123.553 0.741 . . . . 74.42 111.727 179.763 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 12.0 p-10 -74.67 -23.18 58.6 Favored 'General case' 0 CA--C 1.545 0.754 0 C-N-CA 124.308 1.043 . . . . 72.31 112.163 177.708 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 58.7 mttp -105.91 -41.54 5.38 Favored 'General case' 0 N--CA 1.486 1.328 0 C-N-CA 123.757 0.823 . . . . 62.15 111.245 -179.056 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 29' ' ' VAL . . . . . 0.548 HG13 ' HG2' ' A' ' 86' ' ' GLU . 10.7 m -138.26 74.25 42.3 Favored Pre-proline 0 CA--C 1.56 1.33 0 C-N-CA 124.445 1.098 . . . . 74.53 109.873 -172.552 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 59.2 Cg_endo -67.51 -37.97 15.76 Favored 'Trans proline' 0 C--N 1.377 2.067 0 C-N-CA 122.961 2.441 . . . . 73.04 113.383 -171.47 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 48.1 tttp -73.86 -42.09 61.3 Favored 'General case' 0 N--CA 1.478 0.95 0 C-N-CA 123.669 0.788 . . . . 73.22 110.907 -173.507 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 11.3 m -73.21 -36.98 66.59 Favored 'General case' 0 CA--C 1.547 0.832 0 CA-C-N 115.728 -0.669 . . . . 71.44 110.406 -177.707 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -67.11 -41.68 85.82 Favored 'General case' 0 CA--C 1.55 0.948 0 C-N-CA 123.053 0.541 . . . . 75.11 110.684 173.71 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 38.5 tt0 -59.92 -42.19 93.37 Favored 'General case' 0 N--CA 1.483 1.22 0 C-N-CA 124.655 1.182 . . . . 72.43 111.462 -179.428 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 35' ' ' ASN . . . . . 0.455 ' O ' ' HG ' ' A' ' 39' ' ' LEU . 47.7 t30 -56.92 -68.02 0.26 Allowed 'General case' 0 C--N 1.358 0.961 0 O-C-N 124.322 1.014 . . . . 75.31 110.266 -177.196 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 90.6 t80 -57.62 -40.7 79.74 Favored 'General case' 0 N--CA 1.474 0.734 0 O-C-N 124.315 1.009 . . . . 73.34 111.683 -175.683 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 71.5 ttt180 -58.3 -54.88 42.0 Favored 'General case' 0 C--N 1.354 0.802 0 O-C-N 123.719 0.637 . . . . 71.21 110.456 178.564 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 38' ' ' ALA . . . . . 0.469 ' HB3' HG22 ' A' ' 78' ' ' ILE . . . -64.76 -30.09 71.09 Favored 'General case' 0 N--CA 1.475 0.815 0 C-N-CA 123.616 0.766 . . . . 71.22 111.656 -175.099 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 39' ' ' LEU . . . . . 0.588 ' HB3' ' HD2' ' A' ' 48' ' ' TYR . 89.8 mt -63.11 -46.0 89.37 Favored 'General case' 0 N--CA 1.471 0.613 0 C-N-CA 123.545 0.738 . . . . 74.14 110.29 173.604 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 50.7 m -74.35 -39.1 63.01 Favored 'General case' 0 CA--C 1.547 0.843 0 C-N-CA 123.494 0.717 . . . . 72.14 112.018 -173.275 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -75.8 -30.81 59.2 Favored 'General case' 0 N--CA 1.482 1.15 0 C-N-CA 122.582 0.353 . . . . 74.22 110.581 178.195 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 84.87 32.45 21.19 Favored Glycine 0 C--N 1.347 1.152 0 CA-C-N 115.98 -0.555 . . . . 70.34 111.795 -174.432 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 5.2 mm-40 -63.65 -25.34 68.17 Favored 'General case' 0 N--CA 1.481 1.108 0 C-N-CA 123.565 0.746 . . . . 74.04 110.519 175.042 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 44' ' ' LYS . . . . . 0.486 ' HG3' ' HB ' ' A' ' 78' ' ' ILE . 29.2 mmmt -110.75 19.08 18.97 Favored 'General case' 0 CA--C 1.547 0.842 0 C-N-CA 124.2 1.0 . . . . 74.12 110.922 -178.999 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 78.88 -0.23 78.94 Favored Glycine 0 C--N 1.355 1.6 0 N-CA-C 115.05 0.78 . . . . 63.2 115.05 174.616 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 20.2 m-85 -85.62 -47.84 9.46 Favored 'General case' 0 N--CA 1.48 1.041 0 CA-C-N 117.785 0.793 . . . . 62.4 111.074 -174.181 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 49.66 62.64 4.7 Favored Glycine 0 C--N 1.355 1.619 0 O-C-N 124.358 1.036 . . . . 74.12 113.83 174.937 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 48' ' ' TYR . . . . . 0.588 ' HD2' ' HB3' ' A' ' 39' ' ' LEU . 35.5 m-85 -65.56 90.42 0.11 Allowed 'General case' 0 N--CA 1.474 0.759 0 CA-C-O 122.109 0.957 . . . . 73.41 111.773 -176.309 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 49' ' ' LYS . . . . . 0.586 ' HE3' ' HA ' ' A' ' 160' ' ' ASP . 24.1 tptm -109.88 131.25 55.23 Favored 'General case' 0 C--O 1.238 0.486 0 CA-C-N 113.686 -1.597 . . . . 74.43 108.53 179.939 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 79.95 20.36 68.05 Favored Glycine 0 C--N 1.346 1.137 0 CA-C-O 119.85 -0.417 . . . . 74.45 113.203 -179.464 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 39.0 t -60.69 126.75 28.57 Favored 'General case' 0 N--CA 1.479 1.021 0 C-N-CA 123.907 0.883 . . . . 73.21 110.243 179.39 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 52' ' ' CYS . . . . . . . . . . . . . 26.8 p -97.92 120.52 38.45 Favored 'General case' 0 N--CA 1.475 0.783 0 O-C-N 123.618 0.574 . . . . 74.44 111.933 -168.517 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 53' ' ' PHE . . . . . 0.735 ' HA ' ' HA2' ' A' ' 64' ' ' GLY . 82.3 m-85 -67.55 92.72 0.32 Allowed 'General case' 0 CA--C 1.536 0.442 0 C-N-CA 123.759 0.824 . . . . 72.11 108.884 166.894 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 26.2 p-80 -101.09 -9.81 21.04 Favored 'General case' 0 N--CA 1.475 0.795 0 CA-C-N 114.922 -1.035 . . . . 70.34 111.881 -172.215 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 37.8 ttt180 -132.28 98.99 4.55 Favored 'General case' 0 N--CA 1.472 0.628 0 N-CA-C 108.952 -0.759 . . . . 74.25 108.952 177.712 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 53.7 mt -128.12 130.95 69.75 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.82 0 N-CA-C 109.367 -0.605 . . . . 75.34 109.367 176.167 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 59.5 mt -125.12 124.85 25.33 Favored Pre-proline 0 CA--C 1.558 1.268 0 C-N-CA 124.172 0.989 . . . . 73.2 108.851 175.132 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 24.3 Cg_endo -60.37 151.13 76.55 Favored 'Trans proline' 0 C--N 1.385 2.499 0 C-N-CA 123.6 2.867 . . . . 73.33 113.795 -177.541 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 61.44 16.03 48.31 Favored Glycine 0 C--N 1.348 1.24 0 CA-C-N 114.963 -1.017 . . . . 62.44 114.086 179.715 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 36.3 t80 -137.28 -73.6 0.42 Allowed 'General case' 0 C--O 1.239 0.55 0 C-N-CA 123.274 0.63 . . . . 71.4 110.297 -171.735 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 61' ' ' MET . . . . . 0.453 ' HE1' ' HB2' ' A' ' 63' ' ' GLN . 51.4 ttp -171.05 138.43 1.28 Allowed 'General case' 0 N--CA 1.475 0.822 0 O-C-N 123.095 0.247 . . . . 65.31 111.567 -164.018 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 62' ' ' CYS . . . . . 0.554 ' SG ' ' HB ' ' A' ' 114' ' ' ILE . 21.9 p -108.03 110.85 22.65 Favored 'General case' 0 CA--C 1.548 0.881 0 C-N-CA 123.577 0.751 . . . . 71.45 109.266 168.017 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 63' ' ' GLN . . . . . 0.453 ' HB2' ' HE1' ' A' ' 61' ' ' MET . 52.0 tt0 -102.71 118.59 37.16 Favored 'General case' 0 N--CA 1.48 1.067 0 C-N-CA 124.353 1.061 . . . . 71.4 110.464 -175.172 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 64' ' ' GLY . . . . . 0.735 ' HA2' ' HA ' ' A' ' 53' ' ' PHE . . . -95.81 165.49 24.49 Favored Glycine 0 C--N 1.342 0.884 0 CA-C-N 115.262 -0.881 . . . . 52.43 112.842 177.292 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 177.19 133.04 1.76 Allowed Glycine 0 C--N 1.337 0.591 0 N-CA-C 111.922 -0.471 . . . . 44.33 111.922 179.286 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 22.6 t70 -75.78 170.3 16.47 Favored 'General case' 0 CA--C 1.551 0.993 0 C-N-CA 123.437 0.695 . . . . 74.11 110.867 -176.137 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 74.2 t80 -69.8 -25.78 63.95 Favored 'General case' 0 CA--C 1.553 1.071 0 C-N-CA 123.435 0.694 . . . . 73.33 111.285 176.547 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 63.4 m -63.37 109.48 1.61 Allowed 'General case' 0 N--CA 1.478 0.947 0 C-N-CA 123.415 0.686 . . . . 74.31 110.782 179.519 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 58.4 mtt180 59.63 34.52 22.27 Favored 'General case' 0 N--CA 1.479 0.997 0 C-N-CA 125.068 1.347 . . . . 75.23 111.435 -176.597 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 36.8 p-80 -55.42 -20.31 11.85 Favored 'General case' 0 N--CA 1.497 1.918 0 C-N-CA 123.558 0.743 . . . . 72.34 112.886 -172.43 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 5.1 t30 -66.08 87.28 0.1 Allowed 'General case' 0 CA--C 1.554 1.109 0 C-N-CA 124.257 1.023 . . . . 75.34 109.827 167.956 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 76.41 -7.2 32.8 Favored Glycine 0 CA--C 1.535 1.321 0 N-CA-C 115.805 1.082 . . . . 51.01 115.805 172.097 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 73' ' ' THR . . . . . 0.59 ' HA ' ' HB2' ' A' ' 110' ' ' SER . 79.2 m -118.09 -65.84 1.14 Allowed 'General case' 0 N--CA 1.479 0.997 0 CA-C-N 118.598 1.199 . . . . 73.44 110.843 -178.861 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 49.76 54.42 17.78 Favored Glycine 0 C--N 1.356 1.655 0 O-C-N 123.838 0.711 . . . . 64.41 114.379 172.967 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 127.07 55.37 0.14 Allowed Glycine 0 N--CA 1.469 0.895 0 C-N-CA 120.964 -0.636 . . . . 71.41 111.778 -172.449 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 76' ' ' LYS . . . . . 0.541 ' HG2' ' OH ' ' A' ' 48' ' ' TYR . 14.8 ptmm? -52.4 164.38 0.33 Allowed 'General case' 0 N--CA 1.49 1.54 0 C-N-CA 124.117 0.967 . . . . 74.43 111.915 178.584 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 94.9 p -88.95 175.38 7.45 Favored 'General case' 0 C--O 1.247 0.938 0 CA-C-O 121.214 0.53 . . . . 64.44 110.441 -171.981 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 78' ' ' ILE . . . . . 0.486 ' HB ' ' HG3' ' A' ' 44' ' ' LYS . 38.6 pt -74.64 -24.82 18.65 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.654 0 CA-C-N 115.344 -0.843 . . . . 74.43 110.757 179.726 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 51.0 m-85 -86.93 -43.34 12.47 Favored 'General case' 0 N--CA 1.476 0.865 0 C-N-CA 123.713 0.805 . . . . 75.31 110.337 -178.866 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -165.69 -134.79 1.73 Allowed Glycine 0 C--N 1.339 0.745 0 N-CA-C 110.539 -1.024 . . . . 74.15 110.539 -179.098 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 81' ' ' GLU . . . . . 0.523 ' HA ' ' HB2' ' A' ' 76' ' ' LYS . 36.6 tt0 -75.38 -36.8 60.86 Favored 'General case' 0 N--CA 1.477 0.879 0 CA-C-N 117.498 0.649 . . . . 64.33 109.734 175.293 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 82' ' ' LYS . . . . . 0.733 ' HD2' ' HA ' ' A' ' 107' ' ' THR . 19.7 pttp -159.62 166.58 30.37 Favored 'General case' 0 CA--C 1.544 0.732 0 C-N-CA 124.343 1.057 . . . . 63.44 109.309 -170.189 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 11.8 p90 -143.92 174.31 10.95 Favored 'General case' 0 N--CA 1.473 0.723 0 C-N-CA 124.064 0.945 . . . . 73.54 109.111 179.112 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 84' ' ' GLU . . . . . 0.457 ' HA ' ' HA ' ' A' ' 106' ' ' ASN . 11.7 pt-20 -79.19 -175.71 4.77 Favored 'General case' 0 CA--C 1.545 0.775 0 C-N-CA 123.519 0.728 . . . . 74.33 112.083 -178.521 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 30.5 m-20 -85.35 149.51 25.39 Favored 'General case' 0 N--CA 1.475 0.809 0 C-N-CA 123.428 0.691 . . . . 72.24 109.93 -176.672 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 86' ' ' GLU . . . . . 0.548 ' HG2' HG13 ' A' ' 29' ' ' VAL . 3.2 tp10 -77.53 -61.74 1.89 Allowed 'General case' 0 N--CA 1.478 0.957 0 C-N-CA 123.263 0.625 . . . . 74.34 110.54 175.594 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 29.9 p30 -173.57 -156.82 0.08 Allowed 'General case' 0 N--CA 1.475 0.806 0 C-N-CA 125.192 1.397 . . . . 74.22 107.413 -172.826 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 82.2 m-85 -142.04 39.18 1.62 Allowed 'General case' 0 N--CA 1.494 1.729 0 C-N-CA 123.245 0.618 . . . . 65.53 110.824 176.952 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 70.5 mt -65.01 -62.94 1.0 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.483 0 CA-C-O 121.312 0.577 . . . . 72.13 110.423 178.602 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 87.4 mt -86.9 135.82 33.18 Favored 'General case' 0 N--CA 1.47 0.547 0 C-N-CA 124.304 1.042 . . . . 74.54 110.643 -176.402 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 54.3 mtmt -118.89 160.02 22.71 Favored 'General case' 0 N--CA 1.473 0.723 0 C-N-CA 123.88 0.872 . . . . 75.25 111.072 -177.871 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 92' ' ' HIS . . . . . 0.538 ' HA ' HG21 ' A' ' 97' ' ' ILE . 13.6 m80 -83.25 21.14 1.16 Allowed 'General case' 0 N--CA 1.481 1.099 0 C-N-CA 124.777 1.231 . . . . 72.34 111.664 -174.436 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 11.4 t -86.74 31.32 0.69 Allowed 'General case' 0 CA--C 1.56 1.345 0 C-N-CA 124.259 1.024 . . . . 64.43 111.237 -170.562 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -151.14 162.38 29.44 Favored Glycine 0 C--N 1.348 1.208 0 N-CA-C 111.705 -0.558 . . . . 44.44 111.705 176.404 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 73.3 Cg_endo -75.96 145.53 28.37 Favored 'Trans proline' 0 C--N 1.369 1.615 0 C-N-CA 122.689 2.259 . . . . 75.44 112.292 173.757 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 96' ' ' GLY . . . . . 0.486 ' HA3' HG13 ' A' ' 132' ' ' VAL . . . 79.76 17.85 74.26 Favored Glycine 0 C--N 1.345 1.058 0 CA-C-N 116.078 -0.51 . . . . 53.31 114.334 177.475 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 97' ' ' ILE . . . . . 0.538 HG21 ' HA ' ' A' ' 92' ' ' HIS . 8.3 mm -71.41 124.25 27.43 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.893 0 C-N-CA 124.236 1.014 . . . . 73.03 110.757 178.963 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 63.2 tp -108.56 115.34 29.92 Favored 'General case' 0 N--CA 1.484 1.273 0 C-N-CA 123.53 0.732 . . . . 73.43 110.355 179.059 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 18.5 m -133.78 144.5 49.08 Favored 'General case' 0 N--CA 1.48 1.06 0 C-N-CA 124.632 1.173 . . . . 73.13 108.641 174.123 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 100' ' ' MET . . . . . 0.623 ' HA ' ' HA ' ' A' ' 112' ' ' PHE . 72.6 mtp -78.7 137.22 37.69 Favored 'General case' 0 N--CA 1.488 1.471 0 CA-C-N 118.412 0.551 . . . . 73.22 110.008 178.786 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 101' ' ' ALA . . . . . 0.461 ' HB1' ' HB2' ' A' ' 111' ' ' GLN . . . -72.32 168.78 17.64 Favored 'General case' 0 N--CA 1.481 1.088 0 C-N-CA 123.109 0.564 . . . . 55.15 111.981 -170.803 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 102' ' ' ASN . . . . . 0.575 ' HB3' ' HA ' ' A' ' 108' ' ' ASN . 29.4 p-10 -168.04 179.16 4.74 Favored 'General case' 0 CA--C 1.542 0.655 0 CA-C-N 115.646 -0.707 . . . . 74.21 111.278 -177.597 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -117.08 -5.41 11.4 Favored 'General case' 0 N--CA 1.479 0.999 0 C-N-CA 124.188 0.995 . . . . 70.44 110.726 169.165 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 163.7 -171.36 39.32 Favored Glycine 0 C--N 1.358 1.782 0 CA-C-O 119.507 -0.607 . . . . 75.34 112.901 179.695 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 52.7 Cg_exo -57.9 143.25 96.23 Favored 'Trans proline' 0 C--N 1.378 2.12 0 C-N-CA 123.419 2.746 . . . . 75.32 112.041 172.791 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 106' ' ' ASN . . . . . 0.457 ' HA ' ' HA ' ' A' ' 84' ' ' GLU . 65.6 t30 66.07 12.82 8.75 Favored 'General case' 0 N--CA 1.488 1.467 0 C-N-CA 124.135 0.974 . . . . 73.33 111.243 -178.617 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 107' ' ' THR . . . . . 0.733 ' HA ' ' HD2' ' A' ' 82' ' ' LYS . 6.4 m -123.72 1.48 8.8 Favored 'General case' 0 CA--C 1.556 1.188 0 C-N-CA 124.128 0.971 . . . . 63.41 110.017 179.665 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 108' ' ' ASN . . . . . 0.575 ' HA ' ' HB3' ' A' ' 102' ' ' ASN . 40.0 t30 -70.88 143.77 50.9 Favored 'General case' 0 N--CA 1.479 1.024 0 C-N-CA 124.26 1.024 . . . . 74.12 110.604 -178.626 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 94.93 20.66 27.79 Favored Glycine 0 N--CA 1.47 0.957 0 N-CA-C 113.847 0.299 . . . . 70.44 113.847 177.983 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 110' ' ' SER . . . . . 0.59 ' HB2' ' HA ' ' A' ' 73' ' ' THR . 27.5 p -112.42 118.37 34.99 Favored 'General case' 0 CA--C 1.54 0.591 0 N-CA-C 107.525 -1.287 . . . . 72.24 107.525 169.758 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 111' ' ' GLN . . . . . 0.514 ' HG3' ' O ' ' A' ' 73' ' ' THR . 38.3 mt-30 65.35 -177.94 0.18 Allowed 'General case' 0 N--CA 1.495 1.812 0 C-N-CA 124.183 0.993 . . . . 64.44 110.672 -168.284 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 112' ' ' PHE . . . . . 0.623 ' HA ' ' HA ' ' A' ' 100' ' ' MET . 30.0 p90 -147.99 158.58 44.13 Favored 'General case' 0 N--CA 1.472 0.667 0 C-N-CA 124.105 0.962 . . . . 73.31 108.805 175.685 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 113' ' ' PHE . . . . . 0.451 ' HA ' ' HA ' ' A' ' 63' ' ' GLN . 53.1 p90 -146.82 145.22 29.82 Favored 'General case' 0 C--O 1.235 0.326 0 CA-C-O 121.057 0.456 . . . . 74.25 110.701 -179.581 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 114' ' ' ILE . . . . . 0.554 ' HB ' ' SG ' ' A' ' 62' ' ' CYS . 10.7 mt -115.51 102.26 13.49 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.456 0 N-CA-C 107.066 -1.457 . . . . 73.24 107.066 177.512 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 115' ' ' CYS . . . . . 0.485 ' HB2' ' HB ' ' A' ' 97' ' ' ILE . 50.5 m -60.85 103.38 0.26 Allowed 'General case' 0 C--N 1.348 0.518 0 N-CA-C 108.432 -0.951 . . . . 64.45 108.432 172.044 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 116' ' ' THR . . . . . 0.533 HG22 HG13 ' A' ' 139' ' ' VAL . 34.6 p -71.51 -32.7 68.5 Favored 'General case' 0 N--CA 1.47 0.568 0 C-N-CA 123.833 0.853 . . . . 74.3 110.183 -175.195 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -115.35 169.16 9.35 Favored 'General case' 0 N--CA 1.472 0.663 0 C-N-CA 123.99 0.916 . . . . 74.24 109.857 172.39 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 15.0 ptmt -66.76 115.85 7.01 Favored 'General case' 0 CA--C 1.549 0.926 0 CA-C-O 121.269 0.557 . . . . 72.2 110.074 176.029 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 119' ' ' THR . . . . . 0.543 ' HB ' HD13 ' A' ' 122' ' ' LEU . 43.7 p -115.76 87.86 2.76 Favored 'General case' 0 CA--C 1.546 0.798 0 CA-C-O 121.712 0.767 . . . . 74.22 110.363 -178.76 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 11.9 pt-20 -80.22 -19.99 45.67 Favored 'General case' 0 N--CA 1.481 1.082 0 CA-C-N 115.744 -0.662 . . . . 74.44 111.278 -176.462 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 121' ' ' TRP . . . . . . . . . . . . . 33.5 p90 -77.64 -7.34 56.28 Favored 'General case' 0 N--CA 1.477 0.919 0 C-N-CA 122.999 0.52 . . . . 71.52 110.569 173.479 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 122' ' ' LEU . . . . . 0.543 HD13 ' HB ' ' A' ' 119' ' ' THR . 9.9 mp -88.86 -7.88 55.31 Favored 'General case' 0 N--CA 1.481 1.076 0 C-N-CA 123.638 0.775 . . . . 73.03 110.698 169.708 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 44.3 m-20 -79.06 150.77 31.77 Favored 'General case' 0 N--CA 1.478 0.969 0 N-CA-C 108.751 -0.833 . . . . 54.43 108.751 173.128 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 97.03 -28.31 14.43 Favored Glycine 0 CA--C 1.526 0.722 0 N-CA-C 110.48 -1.048 . . . . 74.01 110.48 -165.045 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 2.3 mppt? -85.37 -174.07 5.01 Favored 'General case' 0 N--CA 1.478 0.938 0 C-N-CA 124.139 0.976 . . . . 75.13 109.453 170.711 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 126' ' ' HIS . . . . . . . . . . . . . 49.9 p-80 -68.92 154.12 42.6 Favored 'General case' 0 N--CA 1.475 0.824 0 C-N-CA 123.756 0.822 . . . . 74.11 111.374 -166.204 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 127' ' ' VAL . . . . . 0.43 HG13 ' HB3' ' A' ' 86' ' ' GLU . 13.6 p -60.56 149.44 7.6 Favored 'Isoleucine or valine' 0 CA--C 1.552 1.035 0 C-N-CA 125.363 1.465 . . . . 75.14 113.569 -176.915 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 128' ' ' VAL . . . . . 0.418 HG12 HD12 ' A' ' 97' ' ' ILE . 46.5 t -76.94 153.64 5.62 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.82 0 C-N-CA 124.805 1.242 . . . . 74.22 109.688 171.661 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 129' ' ' PHE . . . . . 0.517 ' HA ' HG22 ' A' ' 29' ' ' VAL . 26.4 p90 -129.66 -19.73 3.32 Favored 'General case' 0 N--CA 1.482 1.173 0 CA-C-N 117.914 0.325 . . . . 75.22 111.572 178.256 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . -134.12 162.73 24.55 Favored Glycine 0 C--N 1.339 0.747 0 N-CA-C 112.297 -0.321 . . . . 73.45 112.297 -176.234 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 29.4 ttpt -150.14 134.34 17.13 Favored 'General case' 0 N--CA 1.472 0.626 0 N-CA-C 107.757 -1.201 . . . . 75.21 107.757 177.123 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 132' ' ' VAL . . . . . 0.486 HG13 ' HA3' ' A' ' 96' ' ' GLY . 12.1 p -64.7 131.23 30.44 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.876 0 CA-C-O 121.117 0.484 . . . . 72.3 109.81 178.105 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 133' ' ' LYS . . . . . 0.627 ' HD2' ' HB2' ' A' ' 23' ' ' GLU . 0.1 OUTLIER -118.52 -24.19 6.88 Favored 'General case' 0 N--CA 1.473 0.725 0 C-N-CA 123.736 0.814 . . . . 74.43 110.046 179.185 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 134' ' ' GLU . . . . . 0.466 ' HB2' ' HB3' ' A' ' 21' ' ' SER . 20.8 mm-40 -133.79 129.42 36.56 Favored 'General case' 0 N--CA 1.472 0.673 0 C-N-CA 124.224 1.01 . . . . 72.31 109.224 177.677 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 79.51 36.2 27.11 Favored Glycine 0 C--N 1.345 1.06 0 O-C-N 123.634 0.584 . . . . 64.32 113.945 174.676 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 136' ' ' MET . . . . . . . . . . . . . 5.3 tpt -57.23 -43.6 83.04 Favored 'General case' 0 N--CA 1.491 1.607 0 C-N-CA 123.669 0.787 . . . . 72.33 110.085 172.164 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 137' ' ' ASN . . . . . . . . . . . . . 2.8 t-20 -61.4 -35.08 76.52 Favored 'General case' 0 CA--C 1.548 0.886 0 C-N-CA 124.058 0.943 . . . . 73.1 111.476 177.427 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 138' ' ' ILE . . . . . . . . . . . . . 45.5 mm -69.48 -37.61 75.28 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.999 0 C-N-CA 122.835 0.454 . . . . 74.43 110.349 177.839 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 139' ' ' VAL . . . . . 0.533 HG13 HG22 ' A' ' 116' ' ' THR . 85.8 t -64.3 -37.01 78.82 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.3 0 C-N-CA 123.475 0.71 . . . . 75.5 110.471 174.738 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 44.9 mt-10 -78.6 -19.01 53.7 Favored 'General case' 0 CA--C 1.543 0.683 0 CA-C-N 115.595 -0.73 . . . . 73.41 111.345 178.016 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -78.86 -48.57 14.44 Favored 'General case' 0 N--CA 1.475 0.784 0 C-N-CA 122.987 0.515 . . . . 71.55 110.17 177.069 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 142' ' ' MET . . . . . 0.557 ' HA ' ' HD2' ' A' ' 145' ' ' PHE . 25.5 ptm -65.5 -31.43 72.49 Favored 'General case' 0 N--CA 1.479 0.977 0 C-N-CA 123.502 0.721 . . . . 71.2 110.841 177.429 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 23.6 tt0 -48.41 -45.41 36.09 Favored 'General case' 0 N--CA 1.481 1.089 0 C-N-CA 124.997 1.319 . . . . 64.41 111.426 171.309 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 144' ' ' ARG . . . . . . . . . . . . . 90.7 mtt180 -73.11 -18.78 61.26 Favored 'General case' 0 N--CA 1.474 0.739 0 CA-C-N 114.542 -1.208 . . . . 74.52 111.845 -174.701 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 145' ' ' PHE . . . . . 0.557 ' HD2' ' HA ' ' A' ' 142' ' ' MET . 54.1 m-85 -80.62 -19.65 44.97 Favored 'General case' 0 N--CA 1.475 0.812 0 N-CA-C 109.929 -0.396 . . . . 74.32 109.929 174.13 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . -77.01 165.04 53.29 Favored Glycine 0 C--N 1.344 1.016 0 N-CA-C 111.881 -0.488 . . . . 64.44 111.881 172.586 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 10.1 m -133.08 170.47 15.35 Favored 'General case' 0 N--CA 1.479 1.006 0 C-N-CA 123.255 0.622 . . . . 73.2 110.384 -173.929 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 148' ' ' ARG . . . . . . . . . . . . . 34.7 mmt180 -64.48 -32.57 74.25 Favored 'General case' 0 N--CA 1.487 1.404 0 C-N-CA 123.612 0.765 . . . . 74.31 111.809 -179.417 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 149' ' ' ASN . . . . . . . . . . . . . 25.5 p-10 -75.85 -5.09 44.32 Favored 'General case' 0 N--CA 1.481 1.11 0 C-N-CA 123.09 0.556 . . . . 74.32 111.476 177.781 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . 97.13 -19.52 54.44 Favored Glycine 0 C--N 1.35 1.348 0 C-N-CA 123.115 0.388 . . . . 74.33 113.28 176.507 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 61.0 tttm -78.1 146.93 34.9 Favored 'General case' 0 N--CA 1.474 0.749 0 CA-C-N 117.169 0.485 . . . . 74.11 110.476 -176.481 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 152' ' ' THR . . . . . . . . . . . . . 77.7 p -92.91 162.99 13.86 Favored 'General case' 0 CA--C 1.549 0.907 0 C-N-CA 123.972 0.909 . . . . 72.42 110.447 177.734 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 153' ' ' SER . . . . . . . . . . . . . 37.8 m -96.64 -27.34 14.85 Favored 'General case' 0 N--CA 1.477 0.907 0 C-N-CA 124.231 1.012 . . . . 74.44 109.675 178.149 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 74.9 mmtt -115.12 148.05 39.45 Favored 'General case' 0 C--O 1.239 0.541 0 C-N-CA 124.592 1.157 . . . . 73.43 108.974 176.276 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 44.7 mtmt -78.13 88.79 4.23 Favored 'General case' 0 N--CA 1.472 0.658 0 N-CA-C 107.828 -1.175 . . . . 73.42 107.828 171.673 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 156' ' ' ILE . . . . . 0.524 HG23 ' HE3' ' A' ' 142' ' ' MET . 65.8 mt -86.97 107.82 17.38 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.32 0 CA-C-N 115.805 -0.634 . . . . 75.31 109.459 -171.412 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 157' ' ' THR . . . . . . . . . . . . . 34.9 p -121.59 156.87 31.99 Favored 'General case' 0 C--O 1.243 0.722 0 C-N-CA 124.514 1.126 . . . . 72.04 110.587 -174.55 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 158' ' ' ILE . . . . . 0.471 HG22 ' HB3' ' A' ' 8' ' ' PHE . 58.6 mt -78.72 93.37 1.54 Allowed 'Isoleucine or valine' 0 CA--C 1.547 0.858 0 N-CA-C 108.766 -0.827 . . . . 74.32 108.766 171.779 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 159' ' ' ALA . . . . . . . . . . . . . . . -61.46 -39.83 92.31 Favored 'General case' 0 N--CA 1.479 1.009 0 C-N-CA 124.567 1.147 . . . . 72.52 113.066 -176.289 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 160' ' ' ASP . . . . . 0.586 ' HA ' ' HE3' ' A' ' 49' ' ' LYS . 16.2 t70 -150.67 168.59 23.88 Favored 'General case' 0 CA--C 1.551 0.99 0 O-C-N 123.528 0.517 . . . . 73.11 110.033 -174.595 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 161' ' ' CYS . . . . . . . . . . . . . 21.8 p -147.04 -170.46 3.55 Favored 'General case' 0 N--CA 1.478 0.953 0 C-N-CA 124.725 1.21 . . . . 75.44 109.234 -172.067 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 162' ' ' GLY . . . . . . . . . . . . . . . 132.12 52.72 0.09 OUTLIER Glycine 0 N--CA 1.476 1.344 0 O-C-N 122.016 -0.427 . . . . 73.25 112.097 -174.244 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 163' ' ' GLN . . . . . 0.583 ' HA ' ' H ' ' A' ' 7' ' ' PHE . 44.9 mt-30 -47.63 106.39 0.09 Allowed 'General case' 0 N--CA 1.48 1.039 0 C-N-CA 125.44 1.496 . . . . 73.1 111.887 -179.737 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 164' ' ' LEU . . . . . . . . . . . . . 74.1 mt . . . . . 0 CA--C 1.545 0.752 0 C-N-CA 125.005 1.322 . . . . 74.33 112.141 -171.393 . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' B' B ' 218' ' ' PRO . . . . . . . . . . . . . 57.9 Cg_endo . . . . . 0 CA--C 1.544 0.982 0 N-CA-C 111.248 -0.328 . . . . 63.41 111.248 . . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' B' B ' 219' ' ' GLY . . . . . . . . . . . . . . . 112.99 166.82 16.77 Favored Glycine 0 CA--C 1.526 0.732 0 CA-C-N 116.051 -0.522 . . . . 73.31 112.493 -178.79 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 220' ' ' PRO . . . . . . . . . . . . . 8.3 Cg_exo -74.76 154.82 43.98 Favored 'Trans proline' 0 CA--C 1.554 1.517 0 C-N-CA 123.76 2.974 . . . . 52.44 114.064 -172.605 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 221' ' ' TYR . . . . . . . . . . . . . 95.9 m-85 . . . . . 0 N--CA 1.483 1.204 0 C-N-CA 124.216 1.007 . . . . 60.25 111.277 -178.395 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 3' ' ' ASN . . . . . 0.454 ' ND2' ' HA ' ' A' ' 25' ' ' PHE . 15.9 m120 . . . . . 0 CA--C 1.556 1.176 0 CA-C-O 119.571 -0.252 . . . . 73.22 111.346 . . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 56.0 Cg_endo -70.8 123.31 9.64 Favored 'Trans proline' 0 C--N 1.379 2.178 0 C-N-CA 122.576 2.184 . . . . 75.21 110.652 175.159 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 5' ' ' THR . . . . . 0.463 ' HB ' ' O ' ' A' ' 164' ' ' LEU . 83.0 m -104.15 125.59 50.58 Favored 'General case' 0 CA--C 1.535 0.369 0 N-CA-C 109.703 -0.48 . . . . 55.15 109.703 -179.807 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 6' ' ' VAL . . . . . 0.593 ' HA ' ' HB2' ' A' ' 163' ' ' GLN . 6.7 m -100.51 122.94 53.09 Favored 'Isoleucine or valine' 0 C--N 1.347 0.457 0 CA-C-O 122.156 0.979 . . . . 73.31 109.732 -178.618 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 7' ' ' PHE . . . . . 0.643 ' H ' ' HA ' ' A' ' 163' ' ' GLN . 76.1 t80 -103.43 133.74 47.98 Favored 'General case' 0 C--O 1.243 0.734 0 CA-C-N 114.224 -1.353 . . . . 72.34 108.99 -174.877 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 8' ' ' PHE . . . . . 0.426 ' HD2' ' HE2' ' A' ' 22' ' ' PHE . 61.4 m-85 -135.23 162.08 33.56 Favored 'General case' 0 C--O 1.238 0.468 0 O-C-N 124.161 0.913 . . . . 74.2 109.702 172.258 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 24.9 m-20 -108.74 115.99 31.14 Favored 'General case' 0 C--N 1.322 -0.604 0 N-CA-C 106.975 -1.491 . . . . 74.54 106.975 170.235 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 51.3 mm -85.42 113.16 23.31 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.546 0 N-CA-C 108.707 -0.849 . . . . 71.12 108.707 178.068 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 11' ' ' ALA . . . . . 0.498 ' HB3' ' HB1' ' A' ' 159' ' ' ALA . . . -116.26 125.24 51.92 Favored 'General case' 0 N--CA 1.477 0.91 0 C-N-CA 122.974 0.51 . . . . 74.21 110.397 178.858 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 12' ' ' VAL . . . . . 0.403 ' HA ' ' HA ' ' A' ' 156' ' ' ILE . 48.7 t -95.34 107.18 19.19 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.626 0 N-CA-C 108.088 -1.079 . . . . 74.04 108.088 177.449 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 20.3 m-20 61.58 31.19 18.85 Favored 'General case' 0 N--CA 1.489 1.485 0 C-N-CA 124.662 1.185 . . . . 73.32 112.023 179.409 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 96.79 -19.55 54.28 Favored Glycine 0 C--N 1.344 0.977 0 CA-C-N 115.62 -0.718 . . . . 71.41 112.905 179.035 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 26.3 mm-40 -83.58 114.57 54.4 Favored Pre-proline 0 CA--C 1.542 0.653 0 N-CA-C 109.227 -0.657 . . . . 75.51 109.227 -179.928 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 47.2 Cg_endo -65.36 107.77 1.06 Allowed 'Trans proline' 0 C--N 1.376 2.018 0 C-N-CA 122.248 1.965 . . . . 73.13 111.285 -178.201 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 58.0 tp -75.89 -38.54 57.72 Favored 'General case' 0 C--O 1.241 0.635 0 CA-C-N 115.084 -0.962 . . . . 75.21 109.774 -177.827 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 173.0 -171.7 44.62 Favored Glycine 0 C--N 1.343 0.92 0 CA-C-N 116.159 -0.473 . . . . 63.4 113.875 176.52 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 19' ' ' ARG . . . . . 0.462 ' HB3' ' HE1' ' A' ' 7' ' ' PHE . 67.8 mtt85 -115.99 129.27 56.3 Favored 'General case' 0 N--CA 1.472 0.667 0 C-N-CA 124.312 1.045 . . . . 74.4 109.462 -173.843 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 20' ' ' VAL . . . . . 0.418 HG12 HG11 ' A' ' 132' ' ' VAL . 61.9 t -125.74 133.16 69.75 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.883 0 C-N-CA 123.106 0.563 . . . . 72.03 109.999 178.696 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 37.9 m -119.93 119.16 32.68 Favored 'General case' 0 CA--C 1.558 1.273 0 C-N-CA 124.389 1.075 . . . . 65.33 108.973 177.389 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 22' ' ' PHE . . . . . 0.426 ' HE2' ' HD2' ' A' ' 8' ' ' PHE . 52.7 m-85 -101.13 114.95 29.38 Favored 'General case' 0 N--CA 1.477 0.876 0 C-N-CA 124.22 1.008 . . . . 64.45 110.233 -179.255 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 23' ' ' GLU . . . . . 0.665 ' HB2' ' HD2' ' A' ' 133' ' ' LYS . 43.2 tt0 -76.06 105.06 6.89 Favored 'General case' 0 CA--C 1.549 0.933 0 C-N-CA 123.859 0.864 . . . . 61.34 109.799 176.601 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . 0.527 ' HB3' ' HB2' ' A' ' 33' ' ' ALA . 55.5 mt -82.99 128.06 34.12 Favored 'General case' 0 N--CA 1.478 0.954 0 C-N-CA 122.992 0.517 . . . . 72.33 110.66 -179.697 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 25' ' ' PHE . . . . . 0.454 ' HA ' ' ND2' ' A' ' 3' ' ' ASN . 54.1 m-85 -90.99 61.13 4.54 Favored 'General case' 0 CA--C 1.532 0.265 0 C-N-CA 123.787 0.835 . . . . 73.45 109.883 -179.295 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -67.9 -13.31 62.05 Favored 'General case' 0 N--CA 1.48 1.04 0 CA-C-N 115.849 -0.614 . . . . 51.45 112.042 179.371 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 11.2 p-10 -71.85 -31.83 66.88 Favored 'General case' 0 CA--C 1.55 0.944 0 C-N-CA 123.481 0.712 . . . . 74.21 110.829 173.848 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 58.0 mttp -96.88 -49.54 5.01 Favored 'General case' 0 N--CA 1.485 1.288 0 C-N-CA 123.948 0.899 . . . . 73.45 111.285 -178.317 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 29' ' ' VAL . . . . . 0.657 ' HB ' ' HB ' ' A' ' 32' ' ' THR . 11.8 m -117.77 76.14 10.53 Favored Pre-proline 0 CA--C 1.562 1.432 0 C-N-CA 124.165 0.986 . . . . 74.01 110.054 179.117 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 30' ' ' PRO . . . . . 0.453 ' HD2' ' HG2' ' A' ' 86' ' ' GLU . 7.2 Cg_endo -51.24 -59.59 1.1 Allowed 'Trans proline' 0 C--N 1.394 2.968 0 C-N-CA 123.381 2.721 . . . . 75.21 113.207 179.699 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 5.8 ttpm? -57.75 -50.2 74.03 Favored 'General case' 0 N--CA 1.482 1.172 0 C-N-CA 123.398 0.679 . . . . 74.44 112.098 -179.562 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 32' ' ' THR . . . . . 0.657 ' HB ' ' HB ' ' A' ' 29' ' ' VAL . 88.9 m -67.78 -35.6 78.97 Favored 'General case' 0 CA--C 1.56 1.357 0 C-N-CA 123.998 0.919 . . . . 74.14 112.593 -170.632 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 33' ' ' ALA . . . . . 0.527 ' HB2' ' HB3' ' A' ' 24' ' ' LEU . . . -90.47 -43.7 10.09 Favored 'General case' 0 N--CA 1.485 1.294 0 C-N-CA 123.019 0.528 . . . . 71.04 112.173 -176.985 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 39.3 tt0 -63.63 -31.73 72.99 Favored 'General case' 0 N--CA 1.484 1.255 0 C-N-CA 123.372 0.669 . . . . 73.15 110.733 179.754 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 35' ' ' ASN . . . . . 0.409 ' O ' ' HG ' ' A' ' 39' ' ' LEU . 35.8 t30 -49.01 -59.51 3.56 Favored 'General case' 0 C--N 1.36 1.029 0 O-C-N 124.566 1.166 . . . . 75.03 110.314 171.457 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 76.3 t80 -65.17 -40.55 94.44 Favored 'General case' 0 C--N 1.348 0.526 0 O-C-N 124.045 0.84 . . . . 70.25 111.249 -175.035 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 56.1 ttp180 -58.26 -44.98 88.62 Favored 'General case' 0 N--CA 1.48 1.044 0 O-C-N 123.723 0.639 . . . . 72.21 110.919 179.057 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 38' ' ' ALA . . . . . 0.539 ' HB3' HG23 ' A' ' 78' ' ' ILE . . . -69.38 -32.24 71.15 Favored 'General case' 0 N--CA 1.473 0.694 0 CA-C-N 115.274 -0.875 . . . . 74.24 111.487 -179.726 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 39' ' ' LEU . . . . . 0.409 ' HG ' ' O ' ' A' ' 35' ' ' ASN . 94.3 mt -69.74 -35.96 75.42 Favored 'General case' 0 N--CA 1.477 0.915 0 C-N-CA 123.87 0.868 . . . . 75.34 111.06 175.326 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 50.0 m -73.52 -54.81 7.34 Favored 'General case' 0 N--CA 1.474 0.75 0 C-N-CA 124.015 0.926 . . . . 75.55 111.284 -175.567 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 56.4 p -78.77 -31.51 46.16 Favored 'General case' 0 CA--C 1.538 0.519 0 CA-C-N 115.128 -0.942 . . . . 65.1 111.376 -175.188 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 92.09 37.68 5.92 Favored Glycine 0 C--N 1.347 1.168 0 CA-C-O 119.647 -0.529 . . . . 72.43 112.682 -178.204 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 68.1 mm-40 -61.1 -29.24 69.64 Favored 'General case' 0 N--CA 1.482 1.152 0 C-N-CA 123.089 0.555 . . . . 64.44 110.432 172.08 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 44' ' ' LYS . . . . . 0.579 ' HG3' ' HB ' ' A' ' 78' ' ' ILE . 32.0 mmmt -108.43 17.75 21.74 Favored 'General case' 0 CA--C 1.541 0.614 0 C-N-CA 124.696 1.199 . . . . 75.2 111.366 -178.965 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 80.23 -1.77 79.36 Favored Glycine 0 C--N 1.355 1.604 0 CA-C-O 119.118 -0.823 . . . . 73.35 114.923 173.353 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 19.7 m-85 -85.17 -48.15 9.43 Favored 'General case' 0 N--CA 1.477 0.924 0 CA-C-N 117.96 0.88 . . . . 64.14 111.05 -174.2 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 41.6 62.23 1.97 Allowed Glycine 0 N--CA 1.485 1.964 0 O-C-N 124.508 1.13 . . . . 74.52 114.816 171.517 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 48' ' ' TYR . . . . . 0.451 ' HB3' ' OG ' ' A' ' 51' ' ' SER . 34.5 m-85 -59.68 98.89 0.05 Allowed 'General case' 0 CA--C 1.548 0.898 0 CA-C-O 121.843 0.83 . . . . 72.52 112.191 -170.095 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 23.2 tptm -108.39 113.53 26.66 Favored 'General case' 0 CA--C 1.539 0.544 0 CA-C-N 113.941 -1.481 . . . . 75.24 108.841 -175.771 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 93.61 18.59 37.68 Favored Glycine 0 C--N 1.346 1.13 0 CA-C-O 119.267 -0.741 . . . . 75.45 113.078 179.823 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 51' ' ' SER . . . . . 0.451 ' OG ' ' HB3' ' A' ' 48' ' ' TYR . 19.6 m -59.95 118.62 6.47 Favored 'General case' 0 N--CA 1.476 0.853 0 C-N-CA 123.317 0.647 . . . . 73.33 111.177 -176.849 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 52' ' ' CYS . . . . . 0.622 ' SG ' ' HD2' ' A' ' 155' ' ' LYS . 36.0 t -86.28 125.15 33.39 Favored 'General case' 0 CA--C 1.533 0.306 0 CA-C-N 115.447 -0.797 . . . . 75.2 112.302 -167.539 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 53' ' ' PHE . . . . . 0.662 ' HA ' ' HA2' ' A' ' 64' ' ' GLY . 95.4 m-85 -73.08 109.33 6.54 Favored 'General case' 0 C--O 1.238 0.479 0 N-CA-C 108.756 -0.831 . . . . 74.15 108.756 166.27 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 19.2 p-80 -128.43 8.41 5.95 Favored 'General case' 0 N--CA 1.482 1.135 0 CA-C-N 115.611 -0.722 . . . . 74.43 111.856 -169.267 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 80.0 ttt-85 -152.25 99.31 2.5 Favored 'General case' 0 N--CA 1.472 0.67 0 N-CA-C 108.794 -0.817 . . . . 75.21 108.794 177.768 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 56' ' ' ILE . . . . . 0.46 HD12 ' HB3' ' A' ' 53' ' ' PHE . 58.3 mt -137.31 134.01 46.89 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.8 0 C-N-CA 123.181 0.592 . . . . 74.32 109.908 -174.688 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 41.8 mt -117.58 118.32 35.31 Favored Pre-proline 0 CA--C 1.554 1.109 0 C-N-CA 124.164 0.986 . . . . 71.31 108.549 174.229 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 58' ' ' PRO . . . . . 0.572 ' HA ' ' HG2' ' A' ' 143' ' ' GLU . 53.8 Cg_endo -67.3 135.95 38.57 Favored 'Trans proline' 0 C--N 1.38 2.206 0 C-N-CA 123.021 2.481 . . . . 74.45 111.508 179.847 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 77.35 30.01 54.97 Favored Glycine 0 CA--C 1.526 0.765 0 CA-C-N 115.345 -0.843 . . . . 71.13 113.091 -176.168 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 29.0 t80 -156.57 -67.04 0.11 Allowed 'General case' 0 C--O 1.247 0.96 0 C-N-CA 123.027 0.531 . . . . 74.14 110.715 -176.921 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 61' ' ' MET . . . . . 0.555 ' HE3' ' HB3' ' A' ' 115' ' ' CYS . 45.6 ttm -167.16 146.96 5.35 Favored 'General case' 0 N--CA 1.48 1.073 0 N-CA-C 112.188 0.44 . . . . 74.24 112.188 -165.654 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 62' ' ' CYS . . . . . 0.432 ' SG ' HG12 ' A' ' 139' ' ' VAL . 23.5 p -116.55 114.25 23.88 Favored 'General case' 0 CA--C 1.545 0.781 0 C-N-CA 123.726 0.81 . . . . 72.45 109.111 169.322 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 28.4 tt0 -112.63 140.96 46.96 Favored 'General case' 0 N--CA 1.479 0.995 0 C-N-CA 123.627 0.771 . . . . 74.25 110.66 -179.506 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 64' ' ' GLY . . . . . 0.662 ' HA2' ' HA ' ' A' ' 53' ' ' PHE . . . -130.81 -176.55 14.46 Favored Glycine 0 C--N 1.344 0.976 0 CA-C-N 115.306 -0.861 . . . . 72.24 112.754 176.669 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 176.22 155.07 12.41 Favored Glycine 0 C--N 1.335 0.486 0 N-CA-C 111.721 -0.552 . . . . 74.54 111.721 -179.262 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 21.2 t70 -83.06 179.79 7.65 Favored 'General case' 0 CA--C 1.552 1.031 0 C-N-CA 124.017 0.927 . . . . 74.42 110.593 -176.979 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 53.2 t80 -88.51 -15.68 34.65 Favored 'General case' 0 CA--C 1.548 0.89 0 C-N-CA 123.188 0.595 . . . . 62.22 111.538 177.635 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 42.5 m -65.01 107.79 1.61 Allowed 'General case' 0 C--N 1.357 0.93 0 N-CA-C 109.724 -0.472 . . . . 74.43 109.724 178.057 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 85.1 mtt85 58.64 47.66 12.8 Favored 'General case' 0 N--CA 1.479 1.002 0 C-N-CA 124.821 1.248 . . . . 73.05 110.633 -170.805 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 48.6 t-80 -49.82 -37.66 31.42 Favored 'General case' 0 N--CA 1.482 1.164 0 C-N-CA 124.754 1.222 . . . . 74.4 112.69 -172.297 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 53.1 t30 -68.26 96.47 0.65 Allowed 'General case' 0 CA--C 1.542 0.65 0 O-C-N 123.499 0.499 . . . . 65.34 109.991 175.233 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 67.56 16.15 67.2 Favored Glycine 0 C--N 1.345 1.06 0 N-CA-C 116.022 1.169 . . . . 73.24 116.022 168.805 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 73' ' ' THR . . . . . 0.583 ' HA ' ' HB2' ' A' ' 110' ' ' SER . 88.3 m -132.65 -75.93 0.5 Allowed 'General case' 0 N--CA 1.472 0.638 0 N-CA-C 108.426 -0.953 . . . . 72.12 108.426 168.871 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 53.95 60.26 8.67 Favored Glycine 0 C--N 1.355 1.59 0 O-C-N 123.781 0.675 . . . . 70.35 113.725 170.137 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 130.96 51.4 0.1 OUTLIER Glycine 0 C--N 1.344 1.026 0 N-CA-C 111.855 -0.498 . . . . 74.11 111.855 -176.716 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -52.36 166.09 0.2 Allowed 'General case' 0 N--CA 1.491 1.606 0 C-N-CA 124.369 1.068 . . . . 74.51 112.583 174.688 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 80.9 p -90.65 177.67 6.28 Favored 'General case' 0 N--CA 1.478 0.965 0 C-N-CA 122.994 0.518 . . . . 73.41 111.043 -175.699 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 78' ' ' ILE . . . . . 0.579 ' HB ' ' HG3' ' A' ' 44' ' ' LYS . 31.9 pt -79.02 -22.83 12.7 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.022 0 C-N-CA 123.275 0.63 . . . . 73.42 110.773 176.505 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 71.0 m-85 -79.42 -40.32 30.28 Favored 'General case' 0 N--CA 1.47 0.548 0 C-N-CA 124.19 0.996 . . . . 73.35 109.704 -179.724 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 177.45 -138.69 3.98 Favored Glycine 0 C--N 1.339 0.746 0 CA-C-N 115.152 -0.931 . . . . 63.03 111.528 177.734 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 36.0 tt0 -65.64 -44.44 86.39 Favored 'General case' 0 N--CA 1.471 0.604 0 C-N-CA 123.917 0.887 . . . . 73.44 109.855 177.025 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 82' ' ' LYS . . . . . 0.452 ' HD2' ' HA ' ' A' ' 107' ' ' THR . 20.8 pttp -154.07 175.31 13.58 Favored 'General case' 0 CA--C 1.55 0.977 0 CA-C-N 114.943 -1.026 . . . . 73.24 110.383 -175.219 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 2.2 p90 -159.42 170.48 21.67 Favored 'General case' 0 CA--C 1.554 1.104 0 C-N-CA 124.132 0.973 . . . . 74.14 110.311 -173.765 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 13.0 pt-20 -96.4 157.37 15.93 Favored 'General case' 0 N--CA 1.486 1.343 0 C-N-CA 123.664 0.785 . . . . 74.4 109.014 173.219 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 28.4 m-20 -77.53 150.85 34.77 Favored 'General case' 0 N--CA 1.483 1.206 0 N-CA-C 113.099 0.777 . . . . 74.32 113.099 178.1 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 86' ' ' GLU . . . . . 0.453 ' HG2' ' HD2' ' A' ' 30' ' ' PRO . 13.8 tp10 -61.95 -60.6 3.39 Favored 'General case' 0 CA--C 1.541 0.614 0 CA-C-N 114.044 -1.435 . . . . 73.41 111.158 -179.763 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 26.2 p30 -165.73 152.85 10.18 Favored 'General case' 0 N--CA 1.475 0.789 0 C-N-CA 123.556 0.743 . . . . 74.34 109.723 -176.973 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 89.9 m-85 -90.58 47.26 1.41 Allowed 'General case' 0 N--CA 1.48 1.055 0 C-N-CA 123.624 0.769 . . . . 74.45 111.267 -176.362 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 71.3 mt -69.87 -59.5 3.45 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.925 0 N-CA-C 108.926 -0.768 . . . . 71.34 108.926 173.209 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 90' ' ' LEU . . . . . 0.584 ' HB3' ' HB ' ' A' ' 128' ' ' VAL . 80.3 mt -86.69 104.92 16.54 Favored 'General case' 0 CA--C 1.539 0.542 0 CA-C-N 114.878 -1.055 . . . . 71.01 110.596 -172.057 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 20.4 ptmt -103.97 167.77 9.55 Favored 'General case' 0 N--CA 1.475 0.797 0 C-N-CA 123.278 0.631 . . . . 74.41 110.492 -179.617 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 92' ' ' HIS . . . . . . . . . . . . . 57.7 m-70 -83.53 69.38 10.07 Favored 'General case' 0 N--CA 1.48 1.028 0 C-N-CA 123.4 0.68 . . . . 71.4 110.799 -173.666 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 14.5 t -122.26 20.32 10.55 Favored 'General case' 0 N--CA 1.474 0.761 0 C-N-CA 123.338 0.655 . . . . 73.35 110.084 -176.546 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -143.99 172.27 25.22 Favored Glycine 0 C--N 1.348 1.197 0 CA-C-N 116.287 -0.415 . . . . 71.2 113.445 -176.336 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 58.4 Cg_endo -94.02 153.53 2.19 Favored 'Trans proline' 0 C--N 1.368 1.578 0 C-N-CA 123.676 2.918 . . . . 74.21 112.732 175.238 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 72.82 19.85 79.55 Favored Glycine 0 C--N 1.353 1.507 0 CA-C-N 116.244 -0.435 . . . . 60.0 112.827 177.008 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 97' ' ' ILE . . . . . 0.732 ' HB ' ' SG ' ' A' ' 115' ' ' CYS . 20.1 mm -68.84 108.36 1.6 Allowed 'Isoleucine or valine' 0 CA--C 1.541 0.625 0 C-N-CA 124.238 1.015 . . . . 75.33 111.257 -174.213 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 62.1 tp -90.06 120.55 31.35 Favored 'General case' 0 C--O 1.247 0.94 0 CA-C-N 115.581 -0.736 . . . . 75.25 109.95 172.575 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 99' ' ' SER . . . . . 0.468 ' HB3' ' HA ' ' A' ' 128' ' ' VAL . 7.9 p -149.62 147.67 28.4 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 114.483 -1.235 . . . . 72.35 107.902 171.81 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 100' ' ' MET . . . . . 0.715 ' HA ' ' HA ' ' A' ' 112' ' ' PHE . 96.9 mtp -77.29 149.14 35.39 Favored 'General case' 0 N--CA 1.493 1.68 0 C-N-CA 122.627 0.371 . . . . 71.13 110.276 -175.569 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 101' ' ' ALA . . . . . 0.503 ' HB3' ' HB2' ' A' ' 111' ' ' GLN . . . -73.57 162.71 28.93 Favored 'General case' 0 C--O 1.247 0.944 0 CA-C-O 121.535 0.683 . . . . 63.23 111.347 -176.851 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 102' ' ' ASN . . . . . 0.472 ' HB3' ' HA ' ' A' ' 108' ' ' ASN . 24.3 p-10 -167.24 168.4 13.41 Favored 'General case' 0 C--O 1.242 0.706 0 CA-C-N 114.583 -1.19 . . . . 52.43 109.903 -178.14 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 103' ' ' ALA . . . . . 0.405 ' HB1' HG21 ' A' ' 107' ' ' THR . . . -114.96 6.74 15.41 Favored 'General case' 0 CA--C 1.543 0.695 0 C-N-CA 123.802 0.841 . . . . 75.12 110.304 171.183 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 158.54 179.75 33.63 Favored Glycine 0 C--N 1.354 1.582 0 CA-C-O 119.468 -0.629 . . . . 73.42 112.408 178.094 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 26.0 Cg_exo -64.47 137.54 55.67 Favored 'Trans proline' 0 C--N 1.375 1.926 0 C-N-CA 122.933 2.422 . . . . 71.45 110.509 171.514 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 63.0 t30 68.8 8.79 7.0 Favored 'General case' 0 N--CA 1.49 1.528 0 C-N-CA 124.988 1.315 . . . . 74.41 111.116 -174.851 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 107' ' ' THR . . . . . 0.452 ' HA ' ' HD2' ' A' ' 82' ' ' LYS . 1.7 m -116.93 15.82 15.17 Favored 'General case' 0 CA--C 1.551 0.998 0 N-CA-C 108.359 -0.978 . . . . 71.12 108.359 171.6 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 108' ' ' ASN . . . . . 0.472 ' HA ' ' HB3' ' A' ' 102' ' ' ASN . 20.9 t30 -92.05 145.31 24.62 Favored 'General case' 0 C--O 1.202 -1.426 0 C-N-CA 124.832 1.253 . . . . 70.11 110.498 -176.317 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 113.3 26.99 3.8 Favored Glycine 0 N--CA 1.478 1.48 0 CA-C-N 118.303 0.501 . . . . 75.32 112.436 -178.787 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 110' ' ' SER . . . . . 0.583 ' HB2' ' HA ' ' A' ' 73' ' ' THR . 22.5 p -137.04 121.13 17.8 Favored 'General case' 0 CA--C 1.535 0.401 0 N-CA-C 108.675 -0.861 . . . . 62.44 108.675 -177.926 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 111' ' ' GLN . . . . . 0.503 ' HB2' ' HB3' ' A' ' 101' ' ' ALA . 47.4 mt-30 61.47 -177.25 0.12 Allowed 'General case' 0 N--CA 1.493 1.677 0 C-N-CA 123.898 0.879 . . . . 73.4 111.62 -174.551 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 112' ' ' PHE . . . . . 0.715 ' HA ' ' HA ' ' A' ' 100' ' ' MET . 35.5 p90 -151.75 152.92 33.34 Favored 'General case' 0 N--CA 1.475 0.804 0 C-N-CA 123.672 0.789 . . . . 65.54 109.348 176.698 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 113' ' ' PHE . . . . . . . . . . . . . 55.0 p90 -140.59 151.43 44.67 Favored 'General case' 0 N--CA 1.472 0.667 0 C-N-CA 122.963 0.505 . . . . 75.44 110.934 -178.803 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 114' ' ' ILE . . . . . . . . . . . . . 10.9 mt -125.92 107.77 18.22 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.705 0 N-CA-C 107.849 -1.167 . . . . 74.31 107.849 178.765 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 115' ' ' CYS . . . . . 0.732 ' SG ' ' HB ' ' A' ' 97' ' ' ILE . 28.5 p -89.3 113.68 24.97 Favored 'General case' 0 C--O 1.243 0.745 0 N-CA-C 108.964 -0.754 . . . . 71.51 108.964 175.601 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 71.6 p -70.84 -27.02 63.55 Favored 'General case' 0 N--CA 1.474 0.772 0 CA-C-N 115.253 -0.885 . . . . 72.33 111.291 -177.534 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -104.34 162.34 13.3 Favored 'General case' 0 C--O 1.248 0.977 0 C-N-CA 123.815 0.846 . . . . 75.41 110.058 174.826 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 18.1 ptmt -74.04 85.19 1.8 Allowed 'General case' 0 CA--C 1.546 0.825 0 CA-C-O 122.302 1.048 . . . . 74.42 110.248 175.329 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 119' ' ' THR . . . . . . . . . . . . . 50.8 p -82.04 84.39 7.0 Favored 'General case' 0 CA--C 1.546 0.793 0 CA-C-N 115.01 -0.996 . . . . 73.34 109.307 179.359 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 11.4 pt-20 -75.44 -23.36 56.9 Favored 'General case' 0 N--CA 1.484 1.257 0 CA-C-N 115.019 -0.991 . . . . 74.54 112.727 -167.628 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 121' ' ' TRP . . . . . . . . . . . . . 38.7 p90 -67.05 -8.72 32.41 Favored 'General case' 0 CA--C 1.551 1.0 0 C-N-CA 123.452 0.701 . . . . 74.23 112.201 176.79 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 31.9 mt -88.23 10.33 19.94 Favored 'General case' 0 CA--C 1.547 0.833 0 C-N-CA 122.947 0.499 . . . . 71.44 111.954 176.764 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 69.7 m-20 -72.4 121.18 19.11 Favored 'General case' 0 N--CA 1.483 1.207 0 N-CA-C 108.9 -0.778 . . . . 75.42 108.9 170.721 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 110.0 -17.94 29.21 Favored Glycine 0 N--CA 1.475 1.269 0 N-CA-C 111.04 -0.824 . . . . 71.54 111.04 -170.113 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 125' ' ' LYS . . . . . 0.595 ' HG2' ' H ' ' A' ' 126' ' ' HIS . 21.0 ttmm -86.72 -165.58 1.32 Allowed 'General case' 0 CA--C 1.559 1.3 0 N-CA-C 108.045 -1.094 . . . . 73.53 108.045 169.707 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 126' ' ' HIS . . . . . 0.595 ' H ' ' HG2' ' A' ' 125' ' ' LYS . 9.4 t-160 -65.59 130.08 42.02 Favored 'General case' 0 C--N 1.353 0.758 0 CA-C-N 118.583 0.628 . . . . 75.21 109.826 -173.71 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 57.6 t -58.68 143.7 12.69 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.835 0 CA-C-N 113.75 -1.568 . . . . 75.52 110.966 175.829 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 128' ' ' VAL . . . . . 0.584 ' HB ' ' HB3' ' A' ' 90' ' ' LEU . 21.8 t -66.94 149.01 11.83 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.583 0 N-CA-C 109.578 -0.527 . . . . 72.54 109.578 177.098 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 129' ' ' PHE . . . . . 0.513 ' HB3' HG23 ' A' ' 32' ' ' THR . 32.1 p90 -136.32 -23.89 1.26 Allowed 'General case' 0 N--CA 1.474 0.754 0 C-N-CA 122.243 0.217 . . . . 73.53 111.117 171.409 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . -127.09 157.75 20.78 Favored Glycine 0 C--N 1.338 0.689 0 N-CA-C 111.493 -0.643 . . . . 72.31 111.493 -177.552 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 31.3 ttpt -144.74 127.41 16.17 Favored 'General case' 0 C--N 1.324 -0.543 0 N-CA-C 108.616 -0.883 . . . . 72.23 108.616 179.967 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 132' ' ' VAL . . . . . 0.418 HG11 HG12 ' A' ' 20' ' ' VAL . 59.4 t -63.67 100.19 0.22 Allowed 'Isoleucine or valine' 0 CA--C 1.539 0.525 0 N-CA-C 108.589 -0.893 . . . . 71.33 108.589 171.902 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 133' ' ' LYS . . . . . 0.665 ' HD2' ' HB2' ' A' ' 23' ' ' GLU . 19.5 ptmt -87.65 -32.03 19.46 Favored 'General case' 0 N--CA 1.473 0.682 0 N-CA-C 109.581 -0.526 . . . . 75.01 109.581 178.315 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 44.8 mt-10 -139.41 146.29 39.95 Favored 'General case' 0 N--CA 1.473 0.7 0 C-N-CA 124.999 1.32 . . . . 61.33 108.936 176.728 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 87.83 21.76 45.43 Favored Glycine 0 C--N 1.342 0.868 0 O-C-N 123.541 0.526 . . . . 61.43 112.536 -175.89 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 136' ' ' MET . . . . . 0.417 ' HA ' HG13 ' A' ' 132' ' ' VAL . 7.1 tpt -58.88 -46.84 86.85 Favored 'General case' 0 C--N 1.359 1.004 0 C-N-CA 123.92 0.888 . . . . 74.4 111.337 -179.772 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 137' ' ' ASN . . . . . . . . . . . . . 20.1 m120 -65.03 -28.86 69.78 Favored 'General case' 0 N--CA 1.477 0.886 0 C-N-CA 123.228 0.611 . . . . 74.43 111.619 -179.394 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 138' ' ' ILE . . . . . . . . . . . . . 43.2 mm -70.41 -38.84 75.36 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.657 0 C-N-CA 123.329 0.652 . . . . 74.45 109.895 178.839 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 139' ' ' VAL . . . . . 0.467 ' HA ' ' HG2' ' A' ' 142' ' ' MET . 69.6 t -68.64 -39.78 80.84 Favored 'Isoleucine or valine' 0 CA--C 1.553 1.063 0 C-N-CA 123.481 0.713 . . . . 74.44 110.492 176.186 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 48.8 mt-10 -69.2 -27.53 65.58 Favored 'General case' 0 N--CA 1.476 0.872 0 C-N-CA 123.623 0.769 . . . . 75.11 111.224 177.92 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -80.35 -45.6 17.51 Favored 'General case' 0 N--CA 1.477 0.91 0 C-N-CA 123.639 0.776 . . . . 65.45 111.196 178.914 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 142' ' ' MET . . . . . 0.541 ' HA ' ' HD2' ' A' ' 145' ' ' PHE . 27.9 ptm -65.68 -31.71 72.87 Favored 'General case' 0 N--CA 1.478 0.969 0 C-N-CA 123.095 0.558 . . . . 64.31 111.22 -178.35 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 143' ' ' GLU . . . . . 0.572 ' HG2' ' HA ' ' A' ' 58' ' ' PRO . 39.1 tt0 -57.94 -32.22 67.58 Favored 'General case' 0 CA--C 1.552 1.037 0 C-N-CA 123.71 0.804 . . . . 75.21 111.969 177.957 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 144' ' ' ARG . . . . . . . . . . . . . 46.3 mtp85 -75.62 -16.98 60.15 Favored 'General case' 0 N--CA 1.473 0.705 0 CA-C-N 116.261 -0.427 . . . . 74.13 111.814 -175.782 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 145' ' ' PHE . . . . . 0.549 ' HB2' HD11 ' A' ' 156' ' ' ILE . 95.2 m-85 -79.88 2.09 24.62 Favored 'General case' 0 N--CA 1.479 0.994 0 C-N-CA 122.728 0.411 . . . . 71.03 110.844 175.38 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . -89.58 -174.75 45.92 Favored Glycine 0 C--N 1.352 1.426 0 O-C-N 123.199 0.312 . . . . 73.41 112.635 171.787 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 19.8 t -135.6 167.99 20.08 Favored 'General case' 0 N--CA 1.475 0.803 0 C-N-CA 123.796 0.838 . . . . 62.45 110.369 -177.869 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 148' ' ' ARG . . . . . . . . . . . . . 12.1 mmm180 -71.04 -29.84 65.87 Favored 'General case' 0 N--CA 1.477 0.907 0 C-N-CA 123.534 0.734 . . . . 74.23 112.09 -173.601 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 149' ' ' ASN . . . . . . . . . . . . . 28.7 p-10 -79.72 -3.05 45.75 Favored 'General case' 0 N--CA 1.484 1.237 0 C-N-CA 123.51 0.724 . . . . 73.42 111.451 176.141 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . 90.68 11.02 62.6 Favored Glycine 0 C--N 1.35 1.336 0 C-N-CA 123.052 0.358 . . . . 61.35 113.098 -179.522 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 56.1 tttm -84.77 158.67 20.65 Favored 'General case' 0 N--CA 1.474 0.761 0 C-N-CA 123.378 0.671 . . . . 73.34 109.458 177.384 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 152' ' ' THR . . . . . . . . . . . . . 24.8 p -101.58 128.72 47.71 Favored 'General case' 0 N--CA 1.475 0.821 0 C-N-CA 122.82 0.448 . . . . 53.11 109.905 171.86 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 153' ' ' SER . . . . . . . . . . . . . 42.4 t -70.25 -42.97 71.49 Favored 'General case' 0 N--CA 1.474 0.742 0 N-CA-C 109.245 -0.65 . . . . 72.25 109.245 168.851 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 154' ' ' LYS . . . . . 0.41 ' HB2' ' HB3' ' A' ' 145' ' ' PHE . 34.1 mmtp -118.4 140.68 49.48 Favored 'General case' 0 C--O 1.239 0.506 0 C-N-CA 123.614 0.766 . . . . 75.31 110.654 -179.338 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 155' ' ' LYS . . . . . 0.622 ' HD2' ' SG ' ' A' ' 52' ' ' CYS . 0.0 OUTLIER -87.03 93.24 9.3 Favored 'General case' 0 CA--C 1.535 0.374 0 O-C-N 123.944 0.778 . . . . 70.04 109.369 -172.271 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 156' ' ' ILE . . . . . 0.614 ' HB ' ' HB2' ' A' ' 53' ' ' PHE . 27.1 mt -87.63 149.27 4.13 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.591 0 CA-C-N 115.488 -0.778 . . . . 73.2 109.231 -177.685 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 157' ' ' THR . . . . . . . . . . . . . 71.9 p -146.25 170.41 16.82 Favored 'General case' 0 N--CA 1.482 1.153 0 C-N-CA 124.091 0.956 . . . . 73.22 109.951 -176.661 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 158' ' ' ILE . . . . . 0.408 HG23 ' HB3' ' A' ' 8' ' ' PHE . 67.8 mt -88.87 102.2 12.7 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.705 0 N-CA-C 107.954 -1.128 . . . . 75.24 107.954 165.05 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 159' ' ' ALA . . . . . 0.498 ' HB1' ' HB3' ' A' ' 11' ' ' ALA . . . -56.03 -49.66 73.08 Favored 'General case' 0 N--CA 1.476 0.835 0 C-N-CA 124.186 0.995 . . . . 72.12 112.115 179.048 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 160' ' ' ASP . . . . . . . . . . . . . 27.5 t70 -160.45 156.96 26.84 Favored 'General case' 0 N--CA 1.471 0.584 0 O-C-N 123.904 0.752 . . . . 70.35 110.685 -174.077 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 161' ' ' CYS . . . . . . . . . . . . . 14.9 p -110.8 -168.71 1.34 Allowed 'General case' 0 N--CA 1.475 0.811 0 C-N-CA 125.122 1.369 . . . . 72.52 108.839 175.851 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 162' ' ' GLY . . . . . . . . . . . . . . . 132.45 53.39 0.08 OUTLIER Glycine 0 C--N 1.346 1.1 0 N-CA-C 111.006 -0.838 . . . . 64.31 111.006 -171.274 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 163' ' ' GLN . . . . . 0.643 ' HA ' ' H ' ' A' ' 7' ' ' PHE . 16.2 pt20 -50.34 132.46 24.52 Favored 'General case' 0 C--N 1.357 0.915 0 C-N-CA 123.908 0.883 . . . . 73.4 113.034 -172.499 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 164' ' ' LEU . . . . . 0.463 ' O ' ' HB ' ' A' ' 5' ' ' THR . 96.7 mt . . . . . 0 CA--C 1.534 0.362 0 N-CA-C 107.92 -1.141 . . . . 73.4 107.92 177.44 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 218' ' ' PRO . . . . . . . . . . . . . 13.5 Cg_exo . . . . . 0 CA--C 1.544 0.987 0 CA-C-O 121.055 0.356 . . . . 71.12 111.223 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' B' B ' 219' ' ' GLY . . . . . 0.414 ' HA2' ' HD3' ' B' ' 220' ' ' PRO . . . 155.55 140.91 3.09 Favored Glycine 0 CA--C 1.53 1.006 0 CA-C-N 115.435 -0.802 . . . . 51.33 111.313 -176.5 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 220' ' ' PRO . . . . . 0.414 ' HD3' ' HA2' ' B' ' 219' ' ' GLY . 6.1 Cg_exo -77.13 173.25 14.7 Favored 'Trans proline' 0 C--N 1.369 1.634 0 C-N-CA 123.422 2.748 . . . . 75.22 114.108 -173.866 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 221' ' ' TYR . . . . . . . . . . . . . 43.0 p90 . . . . . 0 C--O 1.25 1.108 0 CA-C-N 114.697 -1.138 . . . . 74.42 109.776 -175.601 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 3' ' ' ASN . . . . . 0.487 HD21 ' HA ' ' A' ' 25' ' ' PHE . 19.6 m120 . . . . . 0 C--O 1.245 0.833 0 CA-C-O 119.052 -0.499 . . . . 74.12 110.911 . . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 26.5 Cg_endo -60.79 118.53 5.4 Favored 'Trans proline' 0 C--N 1.382 2.29 0 C-N-CA 122.422 2.081 . . . . 74.41 110.227 177.731 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 5' ' ' THR . . . . . 0.426 ' HB ' ' O ' ' A' ' 164' ' ' LEU . 40.1 m -95.56 130.2 42.49 Favored 'General case' 0 C--O 1.239 0.501 0 N-CA-C 108.95 -0.759 . . . . 75.23 108.95 -173.116 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 6' ' ' VAL . . . . . 0.815 ' HA ' ' HB2' ' A' ' 163' ' ' GLN . 48.5 t -99.6 152.53 4.57 Favored 'Isoleucine or valine' 0 C--O 1.215 -0.748 0 N-CA-C 108.513 -0.921 . . . . 65.14 108.513 -179.426 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 7' ' ' PHE . . . . . 0.438 ' HB3' ' HA ' ' A' ' 163' ' ' GLN . 56.2 t80 -139.6 133.62 30.96 Favored 'General case' 0 C--O 1.242 0.682 0 C-N-CA 123.336 0.654 . . . . 75.32 109.832 179.877 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 40.2 m-85 -135.62 164.39 27.95 Favored 'General case' 0 C--O 1.241 0.642 0 O-C-N 124.663 1.227 . . . . 75.14 109.0 171.808 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 9' ' ' ASP . . . . . 0.504 ' HB2' ' HB3' ' A' ' 159' ' ' ALA . 40.8 m-20 -108.02 114.2 27.93 Favored 'General case' 0 N--CA 1.468 0.434 0 N-CA-C 107.605 -1.257 . . . . 71.21 107.605 171.134 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 10' ' ' ILE . . . . . 0.495 HG23 ' SD ' ' A' ' 142' ' ' MET . 46.1 mm -81.42 129.88 36.76 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.593 0 N-CA-C 109.089 -0.708 . . . . 74.12 109.089 177.799 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 11' ' ' ALA . . . . . 0.589 ' HB3' ' HB1' ' A' ' 159' ' ' ALA . . . -132.3 133.51 44.14 Favored 'General case' 0 N--CA 1.468 0.454 0 C-N-CA 123.379 0.672 . . . . 71.13 111.613 -168.131 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 50.9 t -94.6 109.52 22.33 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.848 0 C-N-CA 124.607 1.163 . . . . 75.21 108.847 174.978 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 33.5 m-20 57.97 25.57 12.38 Favored 'General case' 0 N--CA 1.488 1.457 0 C-N-CA 125.449 1.5 . . . . 72.24 112.222 -172.96 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 100.45 -14.64 59.3 Favored Glycine 0 C--N 1.346 1.098 0 CA-C-O 119.475 -0.625 . . . . 73.45 113.326 179.129 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 17.6 mm-40 -87.72 114.25 58.14 Favored Pre-proline 0 N--CA 1.48 1.074 0 CA-C-N 117.559 0.679 . . . . 72.3 109.556 176.875 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 52.8 Cg_exo -50.26 108.64 0.23 Allowed 'Trans proline' 0 C--N 1.378 2.118 0 C-N-CA 123.649 2.9 . . . . 74.4 113.438 -178.795 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 59.4 tp -77.46 -40.49 42.99 Favored 'General case' 0 N--CA 1.472 0.648 0 C-N-CA 124.004 0.922 . . . . 71.02 109.546 175.459 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -167.43 170.38 41.6 Favored Glycine 0 C--N 1.342 0.904 0 CA-C-N 115.534 -0.757 . . . . 61.14 112.753 -178.823 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 19' ' ' ARG . . . . . 0.408 ' HB3' ' HE1' ' A' ' 7' ' ' PHE . 81.1 mtm180 -110.46 127.81 55.31 Favored 'General case' 0 N--CA 1.471 0.577 0 C-N-CA 124.299 1.04 . . . . 71.32 108.858 -178.587 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 76.5 t -129.17 122.16 55.54 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.723 0 C-N-CA 123.426 0.691 . . . . 74.31 110.67 -173.926 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 21' ' ' SER . . . . . 0.478 ' HB2' ' HB2' ' A' ' 134' ' ' GLU . 16.0 m -106.1 129.91 54.1 Favored 'General case' 0 CA--C 1.545 0.788 0 C-N-CA 123.58 0.752 . . . . 70.42 109.92 173.522 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 85.9 m-85 -100.64 170.23 8.5 Favored 'General case' 0 N--CA 1.474 0.768 0 C-N-CA 124.545 1.138 . . . . 65.45 110.038 175.022 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 23' ' ' GLU . . . . . 0.803 ' HB2' ' HD2' ' A' ' 133' ' ' LYS . 41.4 tt0 -135.35 118.75 16.79 Favored 'General case' 0 N--CA 1.472 0.648 0 C-N-CA 123.677 0.791 . . . . 74.25 109.261 -177.763 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . 0.473 ' HB3' ' HB3' ' A' ' 33' ' ' ALA . 36.3 mt -96.84 127.29 42.66 Favored 'General case' 0 N--CA 1.474 0.77 0 C-N-CA 122.747 0.419 . . . . 75.42 110.881 -177.062 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 25' ' ' PHE . . . . . 0.517 ' HB2' HD13 ' A' ' 90' ' ' LEU . 33.7 m-85 -86.15 65.85 9.28 Favored 'General case' 0 CA--C 1.537 0.466 0 C-N-CA 123.561 0.744 . . . . 75.42 109.188 175.851 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -65.47 -20.86 66.53 Favored 'General case' 0 N--CA 1.482 1.157 0 C-N-CA 124.193 0.997 . . . . 70.12 111.938 180.0 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 12.1 p-10 -77.15 -21.94 53.31 Favored 'General case' 0 CA--C 1.549 0.917 0 CA-C-N 114.924 -1.035 . . . . 73.13 111.589 178.668 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 60.2 mttp -106.11 -48.75 3.52 Favored 'General case' 0 N--CA 1.481 1.121 0 C-N-CA 123.392 0.677 . . . . 72.32 111.066 -176.207 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 29' ' ' VAL . . . . . 0.469 HG23 ' HA ' ' A' ' 129' ' ' PHE . 15.1 m -121.69 76.5 37.07 Favored Pre-proline 0 CA--C 1.552 1.054 0 C-N-CA 124.221 1.008 . . . . 74.41 109.613 -179.478 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 26.5 Cg_endo -61.45 -38.72 61.5 Favored 'Trans proline' 0 C--N 1.381 2.267 0 C-N-CA 122.492 2.128 . . . . 73.42 112.811 -173.194 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 31' ' ' LYS . . . . . 0.647 ' HZ3' ' HB2' ' A' ' 31' ' ' LYS . 4.7 ttmp? -65.21 -58.08 6.89 Favored 'General case' 0 N--CA 1.473 0.706 0 C-N-CA 122.971 0.509 . . . . 64.53 111.711 179.749 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 6.6 m -71.78 -28.46 63.64 Favored 'General case' 0 CA--C 1.555 1.168 0 CA-C-N 115.365 -0.834 . . . . 74.44 111.888 -168.79 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 33' ' ' ALA . . . . . 0.473 ' HB3' ' HB3' ' A' ' 24' ' ' LEU . . . -85.05 -45.79 11.78 Favored 'General case' 0 N--CA 1.478 0.942 0 C-N-CA 123.12 0.568 . . . . 71.02 111.275 179.793 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 8.5 tp10 -60.3 -34.73 74.19 Favored 'General case' 0 N--CA 1.487 1.386 0 C-N-CA 122.71 0.404 . . . . 54.45 110.988 178.96 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 35' ' ' ASN . . . . . 0.476 ' O ' ' HG ' ' A' ' 39' ' ' LEU . 36.2 t30 -49.44 -60.61 2.69 Favored 'General case' 0 C--N 1.351 0.651 0 O-C-N 124.514 1.134 . . . . 63.41 110.7 172.626 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 87.8 t80 -62.08 -40.91 97.42 Favored 'General case' 0 N--CA 1.466 0.371 0 CA-C-N 115.183 -0.917 . . . . 72.5 111.68 -176.307 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 37' ' ' ARG . . . . . 0.474 ' HG3' HE22 ' A' ' 163' ' ' GLN . 23.1 ttp180 -62.57 -42.99 99.89 Favored 'General case' 0 N--CA 1.477 0.9 0 C-N-CA 122.977 0.511 . . . . 73.43 110.909 -177.822 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 38' ' ' ALA . . . . . 0.484 ' HB3' ' HG2' ' A' ' 44' ' ' LYS . . . -69.1 -30.8 69.17 Favored 'General case' 0 CA--C 1.545 0.77 0 CA-C-N 115.341 -0.845 . . . . 65.31 111.508 179.754 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 39' ' ' LEU . . . . . 0.491 HD22 ' HE1' ' A' ' 48' ' ' TYR . 99.2 mt -72.48 -37.12 68.54 Favored 'General case' 0 CA--C 1.55 0.965 0 C-N-CA 123.582 0.753 . . . . 74.23 110.955 175.005 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 49.3 m -69.31 -46.2 67.69 Favored 'General case' 0 N--CA 1.479 1.006 0 C-N-CA 124.186 0.994 . . . . 75.24 111.284 -176.302 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 25.2 p -79.7 -30.01 40.9 Favored 'General case' 0 N--CA 1.472 0.668 0 C-N-CA 123.878 0.871 . . . . 61.31 111.288 178.587 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 83.03 28.82 36.09 Favored Glycine 0 C--N 1.346 1.119 0 CA-C-N 115.825 -0.625 . . . . 65.52 113.033 179.487 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 47.9 mm-40 -63.98 -23.06 67.19 Favored 'General case' 0 N--CA 1.477 0.887 0 C-N-CA 123.138 0.575 . . . . 73.43 111.604 177.024 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 44' ' ' LYS . . . . . 0.484 ' HG2' ' HB3' ' A' ' 38' ' ' ALA . 30.6 mmmt -99.77 19.83 15.27 Favored 'General case' 0 CA--C 1.541 0.631 0 C-N-CA 123.544 0.738 . . . . 73.53 111.985 -179.6 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 80.81 -21.99 5.19 Favored Glycine 0 C--N 1.355 1.607 0 N-CA-C 114.765 0.666 . . . . 63.12 114.765 173.224 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 46' ' ' PHE . . . . . 0.431 ' HE2' ' HA ' ' A' ' 78' ' ' ILE . 19.0 m-85 -69.84 -45.39 67.91 Favored 'General case' 0 C--N 1.348 0.534 0 C-N-CA 123.328 0.651 . . . . 63.51 110.684 -174.042 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 57.71 66.32 2.91 Favored Glycine 0 C--N 1.357 1.748 0 CA-C-O 119.008 -0.885 . . . . 74.34 113.927 168.544 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 48' ' ' TYR . . . . . 0.491 ' HE1' HD22 ' A' ' 39' ' ' LEU . 60.3 m-85 -66.21 85.59 0.1 Allowed 'General case' 0 N--CA 1.476 0.837 0 CA-C-O 122.71 1.243 . . . . 65.34 111.501 -176.494 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 29.0 tptp -113.32 109.21 18.35 Favored 'General case' 0 N--CA 1.451 -0.39 0 CA-C-N 112.662 -2.063 . . . . 73.14 107.975 179.439 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 89.8 19.89 45.9 Favored Glycine 0 N--CA 1.468 0.829 0 CA-C-O 119.657 -0.524 . . . . 74.03 113.695 -179.642 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 23.2 m -61.51 116.73 4.94 Favored 'General case' 0 C--O 1.243 0.745 0 C-N-CA 123.139 0.575 . . . . 70.14 109.572 174.228 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 52' ' ' CYS . . . . . 0.414 ' HA ' ' HA ' ' A' ' 157' ' ' THR . 20.1 p -102.03 128.96 48.24 Favored 'General case' 0 CA--C 1.538 0.487 0 CA-C-O 121.528 0.68 . . . . 73.43 112.19 -165.84 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 53' ' ' PHE . . . . . 0.576 ' HA ' ' HA2' ' A' ' 64' ' ' GLY . 77.7 m-85 -61.45 109.87 1.29 Allowed 'General case' 0 C--O 1.24 0.555 0 C-N-CA 124.804 1.241 . . . . 74.44 109.833 169.459 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 28.3 p-80 -124.15 2.42 8.57 Favored 'General case' 0 N--CA 1.475 0.791 0 CA-C-N 115.076 -0.965 . . . . 72.13 110.962 -175.532 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 55' ' ' ARG . . . . . 0.434 ' O ' ' HB3' ' A' ' 63' ' ' GLN . 53.4 ttt-85 -144.45 95.25 2.68 Favored 'General case' 0 C--O 1.218 -0.563 0 N-CA-C 108.396 -0.964 . . . . 73.11 108.396 177.046 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 56' ' ' ILE . . . . . 0.427 HG22 ' HA ' ' A' ' 143' ' ' GLU . 52.6 mt -130.4 133.68 63.49 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.088 0 N-CA-C 108.661 -0.866 . . . . 74.33 108.661 178.552 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 67.2 mt -126.65 118.61 22.75 Favored Pre-proline 0 CA--C 1.556 1.193 0 C-N-CA 123.606 0.762 . . . . 74.43 109.024 178.098 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 58' ' ' PRO . . . . . 0.407 ' HA ' ' HG2' ' A' ' 143' ' ' GLU . 51.6 Cg_exo -57.62 141.79 95.49 Favored 'Trans proline' 0 C--N 1.387 2.559 0 C-N-CA 124.067 3.178 . . . . 74.33 113.784 -178.363 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 67.98 31.43 75.27 Favored Glycine 0 C--N 1.348 1.215 0 O-C-N 124.03 0.831 . . . . 54.33 112.807 -179.273 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 49.1 t80 -152.73 -71.23 0.15 Allowed 'General case' 0 CA--C 1.546 0.808 0 C-N-CA 123.75 0.82 . . . . 75.42 110.364 -177.703 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 61' ' ' MET . . . . . 0.467 ' HE3' ' HB2' ' A' ' 63' ' ' GLN . 37.0 ttp -170.25 150.1 3.57 Favored 'General case' 0 N--CA 1.485 1.296 0 N-CA-C 112.432 0.531 . . . . 75.14 112.432 -163.532 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 62' ' ' CYS . . . . . 0.509 ' SG ' ' HB2' ' A' ' 143' ' ' GLU . 35.4 m -108.77 112.41 24.69 Favored 'General case' 0 N--CA 1.474 0.774 0 C-N-CA 123.806 0.842 . . . . 73.02 109.5 168.4 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 63' ' ' GLN . . . . . 0.467 ' HB2' ' HE3' ' A' ' 61' ' ' MET . 52.1 tt0 -112.57 134.74 53.94 Favored 'General case' 0 N--CA 1.486 1.365 0 CA-C-O 121.644 0.735 . . . . 73.2 110.115 179.975 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 64' ' ' GLY . . . . . 0.576 ' HA2' ' HA ' ' A' ' 53' ' ' PHE . . . -134.45 175.56 20.39 Favored Glycine 0 CA--C 1.499 -0.947 0 CA-C-N 115.238 -0.892 . . . . 75.32 112.478 178.697 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 178.6 170.99 41.39 Favored Glycine 0 N--CA 1.444 -0.833 0 N-CA-C 110.726 -0.95 . . . . 64.31 110.726 179.383 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 14.8 t70 -94.18 166.31 12.18 Favored 'General case' 0 C--O 1.241 0.654 0 N-CA-C 109.862 -0.421 . . . . 54.13 109.862 -172.366 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 37.7 t80 -70.83 -22.93 62.27 Favored 'General case' 0 CA--C 1.548 0.9 0 C-N-CA 122.742 0.417 . . . . 75.43 110.356 175.142 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 52.7 m -61.64 113.65 2.84 Favored 'General case' 0 C--O 1.247 0.922 0 C-N-CA 123.823 0.849 . . . . 75.35 110.994 176.417 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 69' ' ' ARG . . . . . 0.431 ' HB3' ' HB ' ' A' ' 73' ' ' THR . 53.5 mtt180 58.99 29.78 19.41 Favored 'General case' 0 C--N 1.361 1.103 0 C-N-CA 124.577 1.151 . . . . 65.11 112.353 -176.114 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 32.4 p80 -51.72 -33.79 36.08 Favored 'General case' 0 N--CA 1.495 1.811 0 C-N-CA 123.252 0.621 . . . . 75.32 111.381 -179.427 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 6.8 t30 -75.49 89.96 2.71 Favored 'General case' 0 CA--C 1.551 0.992 0 C-N-CA 124.104 0.962 . . . . 62.35 109.164 171.622 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 100.59 -7.24 57.76 Favored Glycine 0 C--N 1.347 1.176 0 N-CA-C 115.93 1.132 . . . . 74.21 115.93 171.089 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 73' ' ' THR . . . . . 0.431 ' HB ' ' HB3' ' A' ' 69' ' ' ARG . 15.0 m -142.92 -75.23 0.27 Allowed 'General case' 0 N--CA 1.483 1.198 0 CA-C-N 118.687 1.243 . . . . 74.4 109.792 179.763 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 72.07 40.29 56.87 Favored Glycine 0 C--N 1.354 1.546 0 C-N-CA 123.234 0.445 . . . . 72.44 113.634 173.975 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 142.45 52.79 0.04 OUTLIER Glycine 0 C--N 1.344 0.995 0 CA-C-N 117.402 0.601 . . . . 75.11 111.741 -173.236 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 76' ' ' LYS . . . . . 0.4 ' HG2' ' OH ' ' A' ' 48' ' ' TYR . 16.5 ptpt -56.55 162.78 2.05 Favored 'General case' 0 N--CA 1.477 0.913 0 C-N-CA 124.183 0.993 . . . . 74.31 112.165 -176.237 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 77.9 p -91.33 173.63 7.81 Favored 'General case' 0 C--O 1.241 0.634 0 CA-C-N 115.343 -0.844 . . . . 63.43 110.42 -179.991 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 78' ' ' ILE . . . . . 0.468 HG21 ' HB1' ' A' ' 38' ' ' ALA . 21.4 pt -74.7 -17.5 16.47 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.608 0 CA-C-N 116.067 -0.515 . . . . 71.23 109.96 173.133 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 49.5 m-85 -87.67 -13.23 43.15 Favored 'General case' 0 CA--C 1.541 0.619 0 C-N-CA 124.615 1.166 . . . . 75.05 110.795 -178.445 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 142.37 -133.02 5.41 Favored Glycine 0 C--N 1.348 1.228 0 N-CA-C 110.858 -0.897 . . . . 44.41 110.858 178.689 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 36.4 tt0 -65.51 -54.34 29.61 Favored 'General case' 0 CA--C 1.54 0.596 0 C-N-CA 123.365 0.666 . . . . 74.01 109.86 175.215 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 82' ' ' LYS . . . . . 0.814 ' HD2' ' HA ' ' A' ' 107' ' ' THR . 24.1 pttm -158.81 174.15 15.45 Favored 'General case' 0 C--O 1.243 0.73 0 CA-C-N 114.52 -1.218 . . . . 73.11 109.17 -172.787 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 12.5 p90 -155.39 172.56 18.01 Favored 'General case' 0 N--CA 1.478 0.939 0 C-N-CA 123.59 0.756 . . . . 64.41 110.245 -175.518 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 14.1 pt-20 -87.25 168.34 13.29 Favored 'General case' 0 CA--C 1.548 0.885 0 CA-C-N 115.897 -0.592 . . . . 74.43 110.614 179.23 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 85' ' ' ASP . . . . . 0.408 ' HB3' HG22 ' A' ' 127' ' ' VAL . 35.7 m-20 -80.31 150.36 29.98 Favored 'General case' 0 N--CA 1.478 0.971 0 C-N-CA 123.898 0.879 . . . . 65.32 112.199 -174.597 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 6.9 tp10 -78.26 -62.55 1.64 Allowed 'General case' 0 C--N 1.352 0.687 0 CA-C-N 115.425 -0.807 . . . . 73.15 111.403 -178.02 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 23.0 p30 -176.75 143.46 0.45 Allowed 'General case' 0 N--CA 1.48 1.056 0 C-N-CA 124.419 1.087 . . . . 63.24 109.159 -175.825 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 98.8 m-85 -89.3 50.11 1.87 Allowed 'General case' 0 N--CA 1.491 1.585 0 CA-C-O 121.607 0.718 . . . . 75.4 111.448 -168.073 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 70.9 mt -67.86 -48.16 76.46 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.695 0 C-N-CA 124.145 0.978 . . . . 74.31 109.885 174.202 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 90' ' ' LEU . . . . . 0.517 HD13 ' HB2' ' A' ' 25' ' ' PHE . 74.5 mt -99.89 122.69 43.2 Favored 'General case' 0 C--O 1.241 0.63 0 CA-C-N 115.462 -0.79 . . . . 74.43 110.585 -174.665 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 44.0 mtmt -119.89 171.71 8.23 Favored 'General case' 0 N--CA 1.475 0.807 0 C-N-CA 124.073 0.949 . . . . 73.52 110.4 177.098 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 92' ' ' HIS . . . . . 0.544 ' HA ' HG13 ' A' ' 97' ' ' ILE . 13.0 m-70 -87.59 41.65 1.0 Allowed 'General case' 0 N--CA 1.482 1.15 0 C-N-CA 124.223 1.009 . . . . 71.54 110.297 -176.115 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 13.0 t -84.92 1.49 47.05 Favored 'General case' 0 CA--C 1.555 1.16 0 C-N-CA 123.986 0.914 . . . . 75.24 111.679 -174.777 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -140.53 161.22 26.58 Favored Glycine 0 C--N 1.344 1.002 0 CA-C-O 119.552 -0.582 . . . . 72.32 111.709 179.601 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 7.3 Cg_exo -75.27 149.74 36.03 Favored 'Trans proline' 0 C--N 1.37 1.692 0 C-N-CA 123.135 2.557 . . . . 72.12 112.146 175.295 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 96' ' ' GLY . . . . . 0.414 ' HA3' HG12 ' A' ' 132' ' ' VAL . . . 84.61 19.45 59.99 Favored Glycine 0 C--N 1.343 0.957 0 N-CA-C 114.586 0.594 . . . . 73.51 114.586 177.357 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 97' ' ' ILE . . . . . 0.544 HG13 ' HA ' ' A' ' 92' ' ' HIS . 7.8 mm -70.54 122.49 22.48 Favored 'Isoleucine or valine' 0 CA--C 1.553 1.088 0 C-N-CA 124.061 0.944 . . . . 75.45 111.99 -177.199 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 56.8 tp -104.91 124.08 48.87 Favored 'General case' 0 N--CA 1.482 1.133 0 C-N-CA 123.266 0.626 . . . . 72.02 110.548 179.813 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 32.2 t -151.22 154.42 36.8 Favored 'General case' 0 CA--C 1.548 0.882 0 C-N-CA 123.627 0.771 . . . . 73.53 109.822 179.685 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 100' ' ' MET . . . . . 0.631 ' HA ' ' HA ' ' A' ' 112' ' ' PHE . 85.3 mtp -86.25 141.34 29.36 Favored 'General case' 0 N--CA 1.492 1.655 0 CA-C-N 118.272 0.487 . . . . 73.25 109.79 179.324 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 101' ' ' ALA . . . . . 0.401 ' HB3' ' HB2' ' A' ' 111' ' ' GLN . . . -73.07 162.41 29.49 Favored 'General case' 0 N--CA 1.487 1.401 0 N-CA-C 112.432 0.531 . . . . 74.33 112.432 -169.75 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 21.3 p-10 -161.71 170.16 20.17 Favored 'General case' 0 N--CA 1.474 0.753 0 CA-C-N 115.736 -0.665 . . . . 75.34 111.295 -174.28 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -103.73 -20.05 14.1 Favored 'General case' 0 N--CA 1.477 0.899 0 C-N-CA 124.124 0.97 . . . . 62.34 110.575 169.412 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 167.41 -151.38 18.96 Favored Glycine 0 CA--C 1.536 1.403 0 CA-C-O 119.269 -0.739 . . . . 73.31 111.439 -173.473 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 31.4 Cg_exo -62.46 144.07 94.21 Favored 'Trans proline' 0 C--N 1.37 1.709 0 C-N-CA 122.751 2.301 . . . . 73.22 112.671 175.108 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 64.4 t30 66.93 9.89 7.21 Favored 'General case' 0 N--CA 1.493 1.695 0 C-N-CA 124.745 1.218 . . . . 73.43 112.578 175.03 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 107' ' ' THR . . . . . 0.814 ' HA ' ' HD2' ' A' ' 82' ' ' LYS . 46.8 p -114.45 2.74 14.74 Favored 'General case' 0 N--CA 1.474 0.765 0 O-C-N 121.688 -0.632 . . . . 74.04 112.04 177.945 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 39.8 t30 -71.96 131.87 43.54 Favored 'General case' 0 N--CA 1.475 0.787 0 N-CA-C 108.925 -0.769 . . . . 74.22 108.925 174.924 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 112.43 22.15 5.91 Favored Glycine 0 N--CA 1.468 0.793 0 CA-C-O 120.239 -0.201 . . . . 44.13 113.08 -176.058 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 27.7 p -125.11 120.1 30.45 Favored 'General case' 0 N--CA 1.47 0.539 0 N-CA-C 107.745 -1.205 . . . . 74.02 107.745 169.21 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 111' ' ' GLN . . . . . 0.401 ' HB2' ' HB3' ' A' ' 101' ' ' ALA . 49.4 mt-30 63.41 176.95 0.16 Allowed 'General case' 0 N--CA 1.492 1.637 0 C-N-CA 124.133 0.973 . . . . 74.45 111.769 -171.897 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 112' ' ' PHE . . . . . 0.631 ' HA ' ' HA ' ' A' ' 100' ' ' MET . 44.9 p90 -139.88 159.46 42.13 Favored 'General case' 0 N--CA 1.476 0.87 0 C-N-CA 124.249 1.02 . . . . 74.24 108.461 175.478 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 113' ' ' PHE . . . . . . . . . . . . . 54.0 p90 -152.59 153.83 34.17 Favored 'General case' 0 N--CA 1.471 0.606 0 CA-C-O 121.004 0.431 . . . . 70.24 111.191 178.901 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 114' ' ' ILE . . . . . . . . . . . . . 9.3 mt -119.73 101.96 12.02 Favored 'Isoleucine or valine' 0 C--O 1.245 0.831 0 N-CA-C 107.663 -1.236 . . . . 71.22 107.663 176.468 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 115' ' ' CYS . . . . . . . . . . . . . 69.9 m -62.31 104.77 0.53 Allowed 'General case' 0 CA--C 1.537 0.46 0 N-CA-C 108.602 -0.888 . . . . 75.35 108.602 169.502 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 116' ' ' THR . . . . . 0.551 HG22 HG11 ' A' ' 139' ' ' VAL . 64.3 p -69.45 -35.15 75.37 Favored 'General case' 0 N--CA 1.473 0.725 0 C-N-CA 123.461 0.705 . . . . 74.45 110.334 -175.708 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -107.87 167.17 10.17 Favored 'General case' 0 C--O 1.246 0.887 0 CA-C-N 114.716 -1.129 . . . . 62.22 109.289 174.465 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 20.7 ptmt -73.73 91.23 1.89 Allowed 'General case' 0 CA--C 1.545 0.769 0 CA-C-O 122.013 0.911 . . . . 75.21 109.954 174.757 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 119' ' ' THR . . . . . . . . . . . . . 58.4 p -86.97 83.28 7.54 Favored 'General case' 0 CA--C 1.542 0.663 0 CA-C-O 121.997 0.904 . . . . 62.54 109.022 -179.242 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 15.9 pt-20 -79.72 -15.23 57.91 Favored 'General case' 0 N--CA 1.48 1.056 0 CA-C-N 115.129 -0.941 . . . . 71.13 112.406 -167.953 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 121' ' ' TRP . . . . . . . . . . . . . 44.2 p90 -71.97 -14.62 61.95 Favored 'General case' 0 N--CA 1.481 1.1 0 C-N-CA 122.977 0.511 . . . . 75.11 110.832 172.928 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 54.2 mt -88.37 6.47 37.2 Favored 'General case' 0 N--CA 1.474 0.729 0 C-N-CA 123.121 0.568 . . . . 74.22 111.092 174.238 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 30.7 m-20 -79.29 136.84 37.15 Favored 'General case' 0 N--CA 1.474 0.759 0 N-CA-C 107.905 -1.146 . . . . 72.41 107.905 167.546 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 95.42 -24.3 29.79 Favored Glycine 0 N--CA 1.472 1.067 0 N-CA-C 111.17 -0.772 . . . . 70.02 111.17 -168.408 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 125' ' ' LYS . . . . . 0.628 ' HG3' ' H ' ' A' ' 126' ' ' HIS . 12.2 tppt? -75.27 -169.45 0.97 Allowed 'General case' 0 CA--C 1.563 1.48 0 N-CA-C 107.913 -1.143 . . . . 73.53 107.913 169.274 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 126' ' ' HIS . . . . . 0.628 ' H ' ' HG3' ' A' ' 125' ' ' LYS . 43.2 p-80 -67.56 157.59 34.02 Favored 'General case' 0 CA--C 1.549 0.941 0 C-N-CA 123.919 0.887 . . . . 75.23 111.685 -173.347 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 127' ' ' VAL . . . . . 0.474 HG11 ' O ' ' A' ' 128' ' ' VAL . 43.1 t -67.86 140.45 19.16 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.85 0 CA-C-N 114.292 -1.322 . . . . 73.35 112.466 -173.033 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 128' ' ' VAL . . . . . 0.518 HG13 HD11 ' A' ' 97' ' ' ILE . 97.2 t -80.98 154.28 4.26 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.832 0 C-N-CA 124.803 1.241 . . . . 65.34 109.276 170.429 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 129' ' ' PHE . . . . . 0.507 ' CE2' ' HG3' ' A' ' 100' ' ' MET . 37.6 p90 -131.57 -17.41 2.91 Favored 'General case' 0 N--CA 1.484 1.239 0 O-C-N 121.626 -0.671 . . . . 74.2 111.663 177.938 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . -138.4 175.01 21.69 Favored Glycine 0 C--N 1.342 0.904 0 CA-C-O 121.431 0.462 . . . . 73.13 113.314 -169.283 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 31.3 ttpt -160.81 136.07 7.82 Favored 'General case' 0 CA--C 1.536 0.431 0 N-CA-C 108.205 -1.035 . . . . 71.44 108.205 -178.565 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 132' ' ' VAL . . . . . 0.414 HG12 ' HA3' ' A' ' 96' ' ' GLY . 13.3 p -72.25 130.97 35.31 Favored 'Isoleucine or valine' 0 CA--C 1.553 1.063 0 N-CA-C 109.251 -0.648 . . . . 73.21 109.251 173.239 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 133' ' ' LYS . . . . . 0.803 ' HD2' ' HB2' ' A' ' 23' ' ' GLU . 19.9 ptmt -116.15 -26.96 7.04 Favored 'General case' 0 N--CA 1.48 1.042 0 C-N-CA 123.582 0.753 . . . . 73.25 110.257 -179.721 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 134' ' ' GLU . . . . . 0.478 ' HB2' ' HB2' ' A' ' 21' ' ' SER . 71.3 mm-40 -131.24 130.22 42.62 Favored 'General case' 0 N--CA 1.471 0.617 0 C-N-CA 124.656 1.183 . . . . 63.33 108.558 175.308 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 90.89 27.71 18.19 Favored Glycine 0 N--CA 1.468 0.829 0 CA-C-O 119.569 -0.573 . . . . 62.05 113.688 175.444 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 136' ' ' MET . . . . . . . . . . . . . 6.4 tpt -58.76 -43.7 90.39 Favored 'General case' 0 N--CA 1.486 1.333 0 C-N-CA 123.561 0.745 . . . . 74.54 110.52 174.964 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 137' ' ' ASN . . . . . . . . . . . . . 18.7 m120 -60.61 -37.23 80.73 Favored 'General case' 0 N--CA 1.479 1.016 0 CA-C-N 115.625 -0.716 . . . . 73.54 111.283 178.29 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 138' ' ' ILE . . . . . . . . . . . . . 43.4 mm -67.78 -41.32 85.07 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.035 0 C-N-CA 123.555 0.742 . . . . 75.13 110.617 -179.566 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 139' ' ' VAL . . . . . 0.551 HG11 HG22 ' A' ' 116' ' ' THR . 96.1 t -61.5 -44.1 98.01 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.979 0 C-N-CA 123.503 0.721 . . . . 74.51 110.699 177.664 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 41.7 mt-10 -69.11 -34.24 74.76 Favored 'General case' 0 N--CA 1.477 0.914 0 CA-C-N 115.455 -0.793 . . . . 75.53 111.02 178.121 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -73.11 -33.8 65.78 Favored 'General case' 0 N--CA 1.475 0.822 0 C-N-CA 123.367 0.667 . . . . 72.33 111.669 -178.863 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 142' ' ' MET . . . . . 0.54 ' HB2' HD11 ' A' ' 156' ' ' ILE . 21.8 ptt? -79.38 -27.14 41.91 Favored 'General case' 0 N--CA 1.473 0.7 0 C-N-CA 122.423 0.289 . . . . 72.01 110.414 177.985 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 143' ' ' GLU . . . . . 0.509 ' HB2' ' SG ' ' A' ' 62' ' ' CYS . 33.4 tt0 -59.36 -29.3 67.58 Favored 'General case' 0 N--CA 1.482 1.144 0 C-N-CA 123.041 0.536 . . . . 73.05 111.609 176.134 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 144' ' ' ARG . . . . . . . . . . . . . 80.1 mtp180 -64.94 -21.45 66.83 Favored 'General case' 0 CA--C 1.543 0.707 0 C-N-CA 123.704 0.802 . . . . 72.44 112.365 -178.554 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 145' ' ' PHE . . . . . 0.47 ' HB2' HD13 ' A' ' 156' ' ' ILE . 77.6 m-85 -81.47 -12.7 58.79 Favored 'General case' 0 N--CA 1.478 0.933 0 C-N-CA 122.502 0.321 . . . . 71.12 111.337 175.554 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . -70.75 166.6 51.6 Favored Glycine 0 CA--C 1.531 1.034 0 N-CA-C 113.898 0.319 . . . . 55.41 113.898 179.347 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 14.7 m -134.86 161.27 35.7 Favored 'General case' 0 N--CA 1.479 0.994 0 C-N-CA 124.376 1.07 . . . . 74.3 109.749 -179.792 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 148' ' ' ARG . . . . . . . . . . . . . 22.8 mmt85 -68.3 -26.51 65.68 Favored 'General case' 0 N--CA 1.484 1.261 0 C-N-CA 123.557 0.743 . . . . 73.24 112.464 -176.714 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 149' ' ' ASN . . . . . . . . . . . . . 30.1 p-10 -84.33 0.47 49.09 Favored 'General case' 0 N--CA 1.486 1.33 0 C-N-CA 122.996 0.518 . . . . 70.24 111.452 175.682 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 150' ' ' GLY . . . . . 0.401 ' O ' ' HA ' ' A' ' 55' ' ' ARG . . . 95.29 -6.16 68.4 Favored Glycine 0 C--N 1.349 1.26 0 CA-C-O 119.683 -0.509 . . . . 55.01 112.982 179.445 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 53.8 tttp -62.94 141.31 58.77 Favored 'General case' 0 N--CA 1.475 0.823 0 C-N-CA 123.035 0.534 . . . . 71.34 111.072 179.987 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 152' ' ' THR . . . . . . . . . . . . . 26.4 p -102.74 131.8 49.33 Favored 'General case' 0 C--O 1.244 0.811 0 N-CA-C 108.776 -0.824 . . . . 71.42 108.776 166.686 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 153' ' ' SER . . . . . . . . . . . . . 16.4 m -72.49 -23.38 61.02 Favored 'General case' 0 N--CA 1.473 0.696 0 C-N-CA 123.834 0.854 . . . . 70.33 110.598 178.131 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 73.6 mmtt -134.88 143.38 46.94 Favored 'General case' 0 C--O 1.241 0.625 0 C-N-CA 125.338 1.455 . . . . 73.44 108.289 -178.678 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 3.8 tppp? -74.63 89.55 2.24 Favored 'General case' 0 C--N 1.345 0.373 0 N-CA-C 108.903 -0.777 . . . . 71.32 108.903 177.761 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 156' ' ' ILE . . . . . 0.54 HD11 ' HB2' ' A' ' 142' ' ' MET . 66.5 mt -84.02 130.17 36.36 Favored 'Isoleucine or valine' 0 C--O 1.222 -0.367 0 N-CA-C 106.967 -1.494 . . . . 74.35 106.967 179.989 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 157' ' ' THR . . . . . 0.414 ' HA ' ' HA ' ' A' ' 52' ' ' CYS . 4.8 t -154.44 156.54 36.95 Favored 'General case' 0 C--O 1.237 0.424 0 C-N-CA 122.74 0.416 . . . . 72.21 110.651 -167.166 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 158' ' ' ILE . . . . . . . . . . . . . 74.1 mt -75.2 98.33 1.39 Allowed 'Isoleucine or valine' 0 CA--C 1.539 0.553 0 N-CA-C 109.015 -0.735 . . . . 74.02 109.015 172.963 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 159' ' ' ALA . . . . . 0.589 ' HB1' ' HB3' ' A' ' 11' ' ' ALA . . . -53.6 -53.65 48.75 Favored 'General case' 0 N--CA 1.472 0.667 0 C-N-CA 123.629 0.772 . . . . 75.01 111.289 177.155 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 160' ' ' ASP . . . . . . . . . . . . . 25.9 t70 -156.33 152.87 28.16 Favored 'General case' 0 N--CA 1.476 0.834 0 CA-C-N 116.321 -0.399 . . . . 74.02 111.03 -177.77 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 161' ' ' CYS . . . . . . . . . . . . . 23.7 p -102.8 -171.45 1.95 Allowed 'General case' 0 N--CA 1.475 0.805 0 C-N-CA 124.888 1.275 . . . . 71.23 109.76 175.501 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 162' ' ' GLY . . . . . . . . . . . . . . . 130.49 52.25 0.1 Allowed Glycine 0 C--N 1.346 1.086 0 N-CA-C 111.176 -0.77 . . . . 74.04 111.176 -171.314 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 163' ' ' GLN . . . . . 0.815 ' HB2' ' HA ' ' A' ' 6' ' ' VAL . 3.6 pt20 -52.48 126.6 19.93 Favored 'General case' 0 CA--C 1.552 1.02 0 C-N-CA 124.527 1.131 . . . . 63.13 113.57 -169.82 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 164' ' ' LEU . . . . . 0.426 ' O ' ' HB ' ' A' ' 5' ' ' THR . 88.1 mt . . . . . 0 C--O 1.216 -0.706 0 CA-C-N 115.586 -0.734 . . . . 65.3 109.312 -175.114 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 218' ' ' PRO . . . . . . . . . . . . . 75.0 Cg_exo . . . . . 0 CA--C 1.547 1.139 0 CA-C-O 120.909 0.295 . . . . 73.05 111.516 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' B' B ' 219' ' ' GLY . . . . . . . . . . . . . . . 170.0 148.51 5.93 Favored Glycine 0 CA--C 1.534 1.264 0 CA-C-N 115.617 -0.719 . . . . 63.31 111.87 -178.006 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 220' ' ' PRO . . . . . . . . . . . . . 88.0 Cg_endo -76.85 169.75 21.11 Favored 'Trans proline' 0 C--N 1.37 1.688 0 C-N-CA 123.34 2.693 . . . . 73.35 114.823 -175.334 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 221' ' ' TYR . . . . . . . . . . . . . 91.4 m-85 . . . . . 0 N--CA 1.487 1.404 0 C-N-CA 124.175 0.99 . . . . 75.22 111.42 -176.44 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 3' ' ' ASN . . . . . 0.502 HD21 ' HA ' ' A' ' 25' ' ' PHE . 17.1 m120 . . . . . 0 CA--C 1.542 0.651 0 CA-C-O 119.236 -0.411 . . . . 73.11 111.234 . . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 4' ' ' PRO . . . . . 0.447 ' HG2' ' HB2' ' A' ' 24' ' ' LEU . 56.0 Cg_endo -68.28 153.19 74.93 Favored 'Trans proline' 0 C--N 1.369 1.634 0 C-N-CA 122.366 2.044 . . . . 74.41 110.517 170.216 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 5' ' ' THR . . . . . 0.494 ' HB ' ' O ' ' A' ' 164' ' ' LEU . 76.3 m -123.55 136.6 54.63 Favored 'General case' 0 C--O 1.236 0.374 0 N-CA-C 109.672 -0.492 . . . . 75.24 109.672 177.427 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 6' ' ' VAL . . . . . 0.47 ' HA ' ' HB2' ' A' ' 163' ' ' GLN . 17.3 m -102.67 145.99 11.3 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.36 0 C-N-CA 123.754 0.822 . . . . 75.34 109.653 174.813 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 7' ' ' PHE . . . . . 0.481 ' H ' ' HA ' ' A' ' 163' ' ' GLN . 84.3 t80 -121.47 133.53 55.05 Favored 'General case' 0 C--O 1.237 0.415 0 C-N-CA 123.896 0.879 . . . . 74.53 109.169 -176.342 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 8' ' ' PHE . . . . . 0.434 ' HD2' ' HE1' ' A' ' 22' ' ' PHE . 36.5 m-85 -133.43 164.87 26.17 Favored 'General case' 0 C--O 1.24 0.556 0 C-N-CA 124.11 0.964 . . . . 75.25 109.873 172.209 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 19.3 m-20 -118.2 112.89 20.72 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 114.209 -1.36 . . . . 74.31 107.819 173.039 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 10' ' ' ILE . . . . . 0.438 HG22 ' SD ' ' A' ' 142' ' ' MET . 40.3 mm -81.98 134.0 27.98 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.566 0 N-CA-C 108.853 -0.795 . . . . 75.41 108.853 177.906 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 11' ' ' ALA . . . . . 0.568 ' HB1' ' HB3' ' A' ' 159' ' ' ALA . . . -135.08 111.29 9.63 Favored 'General case' 0 N--CA 1.468 0.448 0 C-N-CA 123.482 0.713 . . . . 71.01 110.905 -173.064 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 12' ' ' VAL . . . . . 0.494 HG23 HG12 ' A' ' 156' ' ' ILE . 85.5 t -94.82 129.15 45.39 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.832 0 N-CA-C 108.14 -1.059 . . . . 74.14 108.14 178.708 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 22.9 m-20 68.92 13.96 8.85 Favored 'General case' 0 N--CA 1.493 1.684 0 C-N-CA 124.691 1.196 . . . . 74.42 110.481 -170.507 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 80.3 -2.62 76.14 Favored Glycine 0 C--N 1.354 1.55 0 CA-C-O 120.186 -0.23 . . . . 71.44 112.792 -168.972 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 18.3 mm-40 -93.17 117.73 67.55 Favored Pre-proline 0 C--O 1.243 0.751 0 C-N-CA 124.025 0.93 . . . . 74.5 109.454 178.722 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 92.5 Cg_exo -45.51 105.19 0.07 OUTLIER 'Trans proline' 0 C--N 1.378 2.13 0 C-N-CA 123.912 3.075 . . . . 74.15 113.681 179.302 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 31.9 tp -76.36 -35.54 58.65 Favored 'General case' 0 N--CA 1.477 0.915 0 C-N-CA 123.574 0.75 . . . . 74.41 109.411 179.219 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 166.52 -176.47 41.68 Favored Glycine 0 C--N 1.337 0.635 0 CA-C-N 115.617 -0.72 . . . . 72.22 111.662 178.244 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 19.9 ptt85 -106.58 148.13 28.64 Favored 'General case' 0 N--CA 1.472 0.644 0 C-N-CA 122.739 0.416 . . . . 74.33 110.088 -175.641 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 81.9 t -136.7 142.08 39.06 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.517 0 N-CA-C 108.635 -0.876 . . . . 73.31 108.635 176.788 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 15.7 m -130.21 132.79 46.16 Favored 'General case' 0 CA--C 1.542 0.662 0 N-CA-C 108.664 -0.865 . . . . 75.43 108.664 173.688 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 22' ' ' PHE . . . . . 0.434 ' HE1' ' HD2' ' A' ' 8' ' ' PHE . 40.8 m-85 -111.28 125.84 54.26 Favored 'General case' 0 N--CA 1.475 0.796 0 C-N-CA 123.516 0.726 . . . . 73.52 109.697 -179.524 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 37.0 tt0 -76.91 111.39 12.4 Favored 'General case' 0 CA--C 1.546 0.815 0 C-N-CA 123.252 0.621 . . . . 72.32 109.894 172.494 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . 0.447 ' HB2' ' HG2' ' A' ' 4' ' ' PRO . 76.1 mt -77.9 125.89 30.03 Favored 'General case' 0 N--CA 1.471 0.606 0 C-N-CA 123.325 0.65 . . . . 72.23 110.163 175.305 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 25' ' ' PHE . . . . . 0.502 ' HA ' HD21 ' A' ' 3' ' ' ASN . 90.8 m-85 -85.53 62.49 7.5 Favored 'General case' 0 CA--C 1.538 0.499 0 C-N-CA 123.777 0.831 . . . . 72.21 110.702 178.961 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -69.65 -8.56 48.68 Favored 'General case' 0 CA--C 1.547 0.845 0 CA-C-N 115.387 -0.824 . . . . 73.24 111.627 179.008 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 13.2 p-10 -76.23 -31.68 58.5 Favored 'General case' 0 CA--C 1.549 0.939 0 C-N-CA 123.427 0.691 . . . . 73.42 110.956 175.432 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 28' ' ' LYS . . . . . 0.483 ' HD2' HD23 ' A' ' 90' ' ' LEU . 62.0 mttp -106.18 -47.69 3.76 Favored 'General case' 0 N--CA 1.487 1.404 0 C-N-CA 123.261 0.624 . . . . 73.12 111.137 -176.211 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 21.1 m -122.6 67.58 29.55 Favored Pre-proline 0 CA--C 1.563 1.475 0 C-N-CA 123.803 0.841 . . . . 74.52 110.144 -179.914 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 38.4 Cg_endo -62.17 -30.74 82.45 Favored 'Trans proline' 0 C--N 1.384 2.399 0 C-N-CA 122.704 2.269 . . . . 71.24 112.264 -175.924 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 64.4 tttm -69.22 -51.14 40.72 Favored 'General case' 0 CA--C 1.543 0.7 0 C-N-CA 124.559 1.143 . . . . 74.15 111.223 -177.451 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 32' ' ' THR . . . . . 0.426 HG21 ' HE2' ' A' ' 126' ' ' HIS . 16.5 m -75.03 -30.15 61.01 Favored 'General case' 0 CA--C 1.551 1.009 0 CA-C-N 115.271 -0.877 . . . . 71.4 111.041 -175.264 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -72.81 -41.71 64.63 Favored 'General case' 0 CA--C 1.544 0.74 0 C-N-CA 123.18 0.592 . . . . 73.31 110.532 176.508 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 41.9 tt0 -61.16 -39.91 91.89 Favored 'General case' 0 N--CA 1.486 1.358 0 C-N-CA 124.002 0.921 . . . . 75.35 110.732 177.359 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 35' ' ' ASN . . . . . 0.417 ' O ' ' HG ' ' A' ' 39' ' ' LEU . 35.5 t30 -51.55 -67.28 0.26 Allowed 'General case' 0 CA--C 1.548 0.869 0 O-C-N 124.734 1.271 . . . . 64.31 111.034 178.083 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 85.0 t80 -62.23 -37.83 86.87 Favored 'General case' 0 N--CA 1.474 0.741 0 C-N-CA 123.156 0.582 . . . . 63.12 111.677 -176.161 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 73.8 ttt180 -59.03 -45.53 90.51 Favored 'General case' 0 CA--C 1.542 0.673 0 C-N-CA 123.419 0.687 . . . . 65.34 110.877 -179.936 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -69.95 -30.09 67.39 Favored 'General case' 0 N--CA 1.472 0.674 0 C-N-CA 123.453 0.701 . . . . 75.13 111.748 -179.869 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 39' ' ' LEU . . . . . 0.417 ' HG ' ' O ' ' A' ' 35' ' ' ASN . 90.2 mt -67.22 -37.46 83.62 Favored 'General case' 0 N--CA 1.477 0.903 0 C-N-CA 123.241 0.616 . . . . 74.43 110.684 173.667 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 36.9 m -77.77 -41.02 38.93 Favored 'General case' 0 N--CA 1.476 0.857 0 C-N-CA 123.641 0.776 . . . . 74.23 111.691 -175.493 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 41.1 p -82.21 -33.18 29.46 Favored 'General case' 0 N--CA 1.473 0.702 0 C-N-CA 123.54 0.736 . . . . 74.24 111.413 -176.344 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 92.77 24.59 22.81 Favored Glycine 0 C--N 1.342 0.909 0 CA-C-N 115.812 -0.631 . . . . 64.13 113.407 -176.86 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 45.6 mm-40 -60.99 -28.18 68.84 Favored 'General case' 0 N--CA 1.484 1.239 0 C-N-CA 122.865 0.466 . . . . 74.34 111.522 173.481 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 30.8 mmmt -106.49 15.67 25.62 Favored 'General case' 0 N--CA 1.47 0.531 0 C-N-CA 123.806 0.843 . . . . 73.21 111.298 -178.985 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 88.01 -34.53 3.73 Favored Glycine 0 C--N 1.35 1.311 0 CA-C-O 119.807 -0.44 . . . . 63.41 113.966 175.745 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 14.3 m-85 -62.42 -47.16 85.33 Favored 'General case' 0 N--CA 1.479 1.011 0 C-N-CA 123.44 0.696 . . . . 75.31 111.624 -169.463 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 47.2 56.85 7.57 Favored Glycine 0 C--N 1.356 1.665 0 O-C-N 124.521 1.138 . . . . 75.41 115.367 168.479 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 48' ' ' TYR . . . . . 0.497 ' OH ' ' HG2' ' A' ' 76' ' ' LYS . 56.7 m-85 -55.89 91.25 0.01 OUTLIER 'General case' 0 N--CA 1.479 1.006 0 C-N-CA 124.106 0.962 . . . . 74.32 112.933 -174.68 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 49' ' ' LYS . . . . . 0.509 ' HE2' ' HA ' ' A' ' 160' ' ' ASP . 29.5 tptp -110.09 120.79 43.56 Favored 'General case' 0 C--O 1.236 0.369 0 CA-C-N 113.99 -1.459 . . . . 63.3 108.582 -179.905 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 86.13 21.08 53.67 Favored Glycine 0 C--N 1.346 1.107 0 O-C-N 123.236 0.335 . . . . 60.25 112.79 -176.279 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 23.4 t -62.39 117.15 5.75 Favored 'General case' 0 CA--C 1.549 0.931 0 C-N-CA 124.075 0.95 . . . . 72.31 110.246 -178.357 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 52' ' ' CYS . . . . . . . . . . . . . 23.2 p -92.94 125.8 37.72 Favored 'General case' 0 C--O 1.24 0.566 0 C-N-CA 123.593 0.757 . . . . 74.33 112.573 -169.773 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 53' ' ' PHE . . . . . 0.738 ' HA ' ' HA2' ' A' ' 64' ' ' GLY . 64.1 m-85 -65.21 111.91 3.18 Favored 'General case' 0 CA--C 1.539 0.554 0 CA-C-N 115.035 -0.984 . . . . 74.23 108.956 164.404 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 21.8 p-80 -125.36 4.82 7.71 Favored 'General case' 0 N--CA 1.483 1.177 0 C-N-CA 123.447 0.699 . . . . 74.45 111.599 -175.983 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 65.5 ttt-85 -148.87 101.61 3.2 Favored 'General case' 0 N--CA 1.473 0.716 0 N-CA-C 109.431 -0.581 . . . . 75.24 109.431 176.648 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 56' ' ' ILE . . . . . 0.453 HG21 ' HA ' ' A' ' 143' ' ' GLU . 64.3 mt -133.7 134.12 56.55 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.098 0 C-N-CA 122.73 0.412 . . . . 75.22 110.007 -179.964 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 57' ' ' ILE . . . . . 0.409 ' HB ' ' HD2' ' A' ' 60' ' ' PHE . 71.7 mt -117.91 120.06 33.07 Favored Pre-proline 0 CA--C 1.55 0.964 0 N-CA-C 107.882 -1.155 . . . . 72.15 107.882 171.177 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 58' ' ' PRO . . . . . 0.55 ' HA ' ' HG2' ' A' ' 143' ' ' GLU . 28.0 Cg_endo -60.01 146.32 96.29 Favored 'Trans proline' 0 C--N 1.381 2.246 0 C-N-CA 123.043 2.495 . . . . 73.34 112.82 178.956 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 67.28 24.97 73.62 Favored Glycine 0 C--N 1.345 1.082 0 CA-C-N 115.74 -0.664 . . . . 74.15 113.935 179.446 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 60' ' ' PHE . . . . . 0.409 ' HD2' ' HB ' ' A' ' 57' ' ' ILE . 10.7 t80 -151.51 -72.4 0.16 Allowed 'General case' 0 N--CA 1.474 0.757 0 C-N-CA 122.978 0.511 . . . . 74.24 110.361 -175.173 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 47.1 ttp -160.04 135.05 7.91 Favored 'General case' 0 N--CA 1.474 0.728 0 CA-C-N 116.536 -0.302 . . . . 73.31 111.609 -167.112 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 62' ' ' CYS . . . . . 0.544 ' SG ' ' HB ' ' A' ' 114' ' ' ILE . 10.0 p -105.97 111.75 24.51 Favored 'General case' 0 CA--C 1.543 0.689 0 N-CA-C 108.764 -0.828 . . . . 73.11 108.764 167.898 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 63' ' ' GLN . . . . . 0.455 ' HA ' ' HA ' ' A' ' 113' ' ' PHE . 21.0 tt0 -109.13 133.76 52.59 Favored 'General case' 0 N--CA 1.48 1.062 0 C-N-CA 123.67 0.788 . . . . 71.21 110.933 -176.397 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 64' ' ' GLY . . . . . 0.738 ' HA2' ' HA ' ' A' ' 53' ' ' PHE . . . -122.52 175.24 16.42 Favored Glycine 0 C--N 1.345 1.078 0 CA-C-N 114.994 -1.003 . . . . 75.23 112.368 179.536 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 172.89 -166.26 38.81 Favored Glycine 0 C--N 1.331 0.291 0 N-CA-C 111.043 -0.823 . . . . 72.15 111.043 -179.792 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 38.8 t70 -126.32 160.8 29.38 Favored 'General case' 0 N--CA 1.476 0.863 0 C-N-CA 123.026 0.531 . . . . 74.51 110.55 -175.463 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 71.7 t80 -73.67 -32.43 63.96 Favored 'General case' 0 N--CA 1.472 0.669 0 C-N-CA 123.459 0.704 . . . . 74.43 111.211 -178.731 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 28.2 m -65.24 110.88 2.73 Favored 'General case' 0 N--CA 1.473 0.692 0 N-CA-C 109.925 -0.398 . . . . 74.25 109.925 -179.203 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 57.7 mtt85 66.99 30.52 7.49 Favored 'General case' 0 C--N 1.354 0.787 0 C-N-CA 125.052 1.341 . . . . 74.13 111.133 177.852 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 70' ' ' HIS . . . . . 0.413 ' HA ' ' HA3' ' A' ' 74' ' ' GLY . 27.5 p-80 -57.8 -23.69 53.69 Favored 'General case' 0 N--CA 1.49 1.537 0 C-N-CA 123.62 0.768 . . . . 71.23 111.774 -178.793 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 6.0 t30 -63.62 95.16 0.1 Allowed 'General case' 0 CA--C 1.543 0.694 0 C-N-CA 124.584 1.154 . . . . 74.31 109.339 168.376 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 79.05 -8.44 45.07 Favored Glycine 0 CA--C 1.529 0.92 0 N-CA-C 114.91 0.724 . . . . 72.13 114.91 174.258 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 18.0 m -135.47 -95.45 0.25 Allowed 'General case' 0 CA--C 1.558 1.279 0 CA-C-N 117.915 0.858 . . . . 71.5 110.179 -177.963 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 74' ' ' GLY . . . . . 0.413 ' HA3' ' HA ' ' A' ' 70' ' ' HIS . . . 59.51 56.15 26.61 Favored Glycine 0 C--N 1.359 1.855 0 CA-C-N 118.459 0.572 . . . . 65.05 113.626 177.776 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 134.76 49.41 0.08 OUTLIER Glycine 0 C--N 1.333 0.37 0 N-CA-C 109.443 -1.463 . . . . 70.55 109.443 -170.945 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 76' ' ' LYS . . . . . 0.497 ' HG2' ' OH ' ' A' ' 48' ' ' TYR . 22.7 ptmt -60.27 160.55 8.31 Favored 'General case' 0 N--CA 1.475 0.802 0 C-N-CA 124.113 0.965 . . . . 73.42 111.588 -177.548 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 79.1 p -90.27 174.22 7.71 Favored 'General case' 0 CA--C 1.54 0.58 0 CA-C-N 115.492 -0.776 . . . . 74.4 110.746 -178.486 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 24.8 pt -69.73 -17.54 21.38 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.818 0 C-N-CA 123.252 0.621 . . . . 74.32 110.806 176.611 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 36.5 m-85 -87.0 -16.2 36.45 Favored 'General case' 0 N--CA 1.47 0.563 0 C-N-CA 124.775 1.23 . . . . 72.31 110.643 -178.086 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 132.8 -134.04 7.35 Favored Glycine 0 C--N 1.345 1.064 0 N-CA-C 110.537 -1.025 . . . . 74.24 110.537 -177.179 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 37.1 tt0 -56.83 -54.6 44.52 Favored 'General case' 0 N--CA 1.473 0.707 0 C-N-CA 124.223 1.009 . . . . 74.41 111.427 179.453 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 82' ' ' LYS . . . . . 0.635 ' HD2' ' HA ' ' A' ' 107' ' ' THR . 21.6 pttp -168.19 177.35 5.52 Favored 'General case' 0 N--CA 1.474 0.742 0 C-N-CA 123.604 0.762 . . . . 74.32 110.69 -174.157 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 3.2 p90 -159.2 172.37 18.18 Favored 'General case' 0 CA--C 1.544 0.719 0 C-N-CA 124.73 1.212 . . . . 74.2 110.006 -174.68 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 84' ' ' GLU . . . . . 0.528 ' HA ' ' HA ' ' A' ' 106' ' ' ASN . 13.6 pt-20 -88.86 171.42 9.93 Favored 'General case' 0 N--CA 1.481 1.08 0 C-N-CA 123.094 0.558 . . . . 71.03 110.73 178.136 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 48.8 m-20 -80.63 148.71 30.14 Favored 'General case' 0 N--CA 1.478 0.928 0 N-CA-C 109.542 -0.54 . . . . 74.2 109.542 178.492 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 10.5 tp10 -86.98 -59.57 2.22 Favored 'General case' 0 N--CA 1.476 0.833 0 CA-C-O 120.606 0.241 . . . . 74.34 111.15 -179.659 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 13.0 p-10 -156.48 124.2 5.51 Favored 'General case' 0 N--CA 1.474 0.77 0 C-N-CA 123.015 0.526 . . . . 71.33 109.975 -169.603 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 79.1 m-85 -88.52 66.72 8.32 Favored 'General case' 0 N--CA 1.478 0.954 0 CA-C-O 121.683 0.754 . . . . 74.34 109.766 -174.53 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 55.0 mt -86.98 -51.6 12.74 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.587 0 CA-C-N 115.092 -0.958 . . . . 74.42 108.739 174.976 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 90' ' ' LEU . . . . . 0.543 ' HB3' ' HB ' ' A' ' 128' ' ' VAL . 94.6 mt -88.72 106.34 18.28 Favored 'General case' 0 C--O 1.24 0.57 0 CA-C-N 114.991 -1.004 . . . . 75.33 110.571 -175.789 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 50.0 mtmt -91.62 169.63 10.58 Favored 'General case' 0 C--O 1.24 0.593 0 CA-C-N 115.039 -0.982 . . . . 74.23 109.764 173.755 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 92' ' ' HIS . . . . . . . . . . . . . 20.8 m-70 -87.74 55.29 3.43 Favored 'General case' 0 N--CA 1.478 0.936 0 N-CA-C 108.826 -0.805 . . . . 73.2 108.826 -178.995 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 14.8 t -96.94 -2.67 43.2 Favored 'General case' 0 N--CA 1.475 0.776 0 CA-C-N 115.211 -0.904 . . . . 75.22 112.331 -169.707 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -131.77 178.65 17.74 Favored Glycine 0 C--N 1.342 0.912 0 CA-C-O 119.989 -0.34 . . . . 74.25 112.379 -179.564 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 95' ' ' PRO . . . . . 0.494 ' HB2' ' HE1' ' A' ' 136' ' ' MET . 76.9 Cg_endo -85.72 152.84 10.13 Favored 'Trans proline' 0 CA--C 1.551 1.373 0 C-N-CA 123.105 2.537 . . . . 73.34 112.37 172.16 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 80.66 19.96 67.1 Favored Glycine 0 C--N 1.343 0.954 0 CA-C-N 116.135 -0.484 . . . . 65.45 113.844 175.663 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 97' ' ' ILE . . . . . 0.658 ' HB ' ' HB2' ' A' ' 115' ' ' CYS . 25.8 mm -65.79 103.27 0.48 Allowed 'Isoleucine or valine' 0 CA--C 1.551 1.013 0 C-N-CA 124.138 0.975 . . . . 74.54 111.784 -175.606 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 58.5 tp -89.4 119.98 30.33 Favored 'General case' 0 C--O 1.247 0.972 0 CA-C-O 121.485 0.659 . . . . 73.33 109.819 174.264 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 46.0 t -149.55 146.38 27.32 Favored 'General case' 0 CA--C 1.549 0.929 0 C-N-CA 124.554 1.141 . . . . 63.24 108.119 -179.096 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 100' ' ' MET . . . . . 0.589 ' HA ' ' HA ' ' A' ' 112' ' ' PHE . 85.4 mtp -77.42 142.89 39.0 Favored 'General case' 0 N--CA 1.487 1.419 0 CA-C-N 118.216 0.462 . . . . 70.43 109.919 179.311 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 101' ' ' ALA . . . . . 0.496 ' HB3' ' HB2' ' A' ' 111' ' ' GLN . . . -75.04 155.52 37.17 Favored 'General case' 0 N--CA 1.474 0.731 0 CA-C-O 121.497 0.665 . . . . 74.31 112.083 -169.823 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 26.9 p-10 -167.49 166.32 14.34 Favored 'General case' 0 C--O 1.24 0.553 0 CA-C-N 114.421 -1.263 . . . . 73.03 109.744 -177.614 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -89.77 -50.98 5.74 Favored 'General case' 0 CA--C 1.537 0.452 0 N-CA-C 108.413 -0.958 . . . . 72.31 108.413 167.271 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -156.85 -156.11 7.74 Favored Glycine 0 C--N 1.347 1.193 0 CA-C-N 115.427 -0.806 . . . . 74.23 112.803 179.248 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 51.6 Cg_exo -55.7 139.62 83.49 Favored 'Trans proline' 0 C--N 1.375 1.932 0 C-N-CA 123.55 2.833 . . . . 71.24 113.165 178.134 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 106' ' ' ASN . . . . . 0.528 ' HA ' ' HA ' ' A' ' 84' ' ' GLU . 65.0 t30 66.24 8.51 5.64 Favored 'General case' 0 N--CA 1.483 1.217 0 C-N-CA 125.118 1.367 . . . . 74.33 112.487 177.215 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 107' ' ' THR . . . . . 0.635 ' HA ' ' HD2' ' A' ' 82' ' ' LYS . 3.8 m -100.72 -15.33 17.74 Favored 'General case' 0 CA--C 1.55 0.975 0 C-N-CA 123.749 0.82 . . . . 71.32 109.81 177.225 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 13.1 t30 -55.84 139.84 44.33 Favored 'General case' 0 C--O 1.208 -1.127 0 C-N-CA 125.658 1.583 . . . . 75.22 111.442 176.938 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 111.3 23.93 5.57 Favored Glycine 0 N--CA 1.469 0.886 0 N-CA-C 112.285 -0.326 . . . . 71.43 112.285 -178.872 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 13.6 p -136.98 120.8 17.46 Favored 'General case' 0 C--O 1.223 -0.311 0 C-N-CA 123.881 0.873 . . . . 72.4 108.645 178.126 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 111' ' ' GLN . . . . . 0.496 ' HB2' ' HB3' ' A' ' 101' ' ' ALA . 46.1 mt-30 59.51 -174.79 0.1 Allowed 'General case' 0 N--CA 1.489 1.489 0 C-N-CA 123.68 0.792 . . . . 74.33 111.563 -174.86 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 112' ' ' PHE . . . . . 0.589 ' HA ' ' HA ' ' A' ' 100' ' ' MET . 49.3 p90 -144.5 166.21 25.78 Favored 'General case' 0 N--CA 1.473 0.692 0 C-N-CA 123.953 0.901 . . . . 74.44 108.78 172.701 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 113' ' ' PHE . . . . . 0.455 ' HA ' ' HA ' ' A' ' 63' ' ' GLN . 51.8 p90 -152.64 154.94 36.35 Favored 'General case' 0 C--O 1.236 0.377 0 C-N-CA 122.969 0.508 . . . . 75.22 110.387 179.663 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 114' ' ' ILE . . . . . 0.544 ' HB ' ' SG ' ' A' ' 62' ' ' CYS . 16.2 mt -126.65 104.48 12.82 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.569 0 N-CA-C 108.698 -0.852 . . . . 60.01 108.698 178.492 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 115' ' ' CYS . . . . . 0.658 ' HB2' ' HB ' ' A' ' 97' ' ' ILE . 61.4 m -73.42 106.91 5.42 Favored 'General case' 0 CA--C 1.539 0.541 0 N-CA-C 109.016 -0.735 . . . . 65.24 109.016 172.772 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 116' ' ' THR . . . . . 0.415 HG22 HG11 ' A' ' 139' ' ' VAL . 75.1 p -71.39 -18.87 62.33 Favored 'General case' 0 N--CA 1.479 0.997 0 C-N-CA 123.261 0.624 . . . . 73.34 111.529 -177.273 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -124.72 169.52 11.9 Favored 'General case' 0 C--O 1.243 0.752 0 C-N-CA 123.682 0.793 . . . . 73.11 110.07 177.435 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 11.9 ptmm? -71.85 87.86 1.01 Allowed 'General case' 0 CA--C 1.55 0.95 0 CA-C-O 121.961 0.886 . . . . 73.33 110.92 176.173 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 119' ' ' THR . . . . . . . . . . . . . 52.9 p -85.34 87.89 7.44 Favored 'General case' 0 CA--C 1.544 0.734 0 CA-C-N 114.946 -1.025 . . . . 74.43 109.937 -176.894 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 7.9 pt-20 -73.07 -26.22 61.19 Favored 'General case' 0 N--CA 1.48 1.026 0 CA-C-N 114.535 -1.211 . . . . 75.21 112.934 -169.229 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 121' ' ' TRP . . . . . . . . . . . . . 39.5 p90 -70.72 -10.55 59.68 Favored 'General case' 0 N--CA 1.479 0.976 0 C-N-CA 123.732 0.813 . . . . 75.14 111.797 177.062 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 51.1 mt -95.05 0.07 54.13 Favored 'General case' 0 N--CA 1.477 0.904 0 C-N-CA 123.236 0.615 . . . . 74.45 111.673 177.514 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 32.9 m-20 -71.66 126.12 28.88 Favored 'General case' 0 N--CA 1.478 0.962 0 N-CA-C 108.801 -0.815 . . . . 73.51 108.801 172.762 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 106.82 -26.9 18.02 Favored Glycine 0 N--CA 1.471 1.02 0 N-CA-C 111.43 -0.668 . . . . 74.02 111.43 -171.933 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 125' ' ' LYS . . . . . 0.615 ' HG2' ' H ' ' A' ' 126' ' ' HIS . 20.9 ttmm -80.09 -164.96 0.75 Allowed 'General case' 0 CA--C 1.559 1.301 0 N-CA-C 107.979 -1.119 . . . . 74.51 107.979 170.907 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 126' ' ' HIS . . . . . 0.615 ' H ' ' HG2' ' A' ' 125' ' ' LYS . 8.9 t-80 -64.81 134.77 54.8 Favored 'General case' 0 C--N 1.353 0.76 0 CA-C-N 119.204 0.911 . . . . 74.12 111.132 -168.642 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 6.6 t -59.78 146.08 10.61 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.611 0 CA-C-N 112.787 -2.006 . . . . 74.33 111.091 -179.241 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 128' ' ' VAL . . . . . 0.543 ' HB ' ' HB3' ' A' ' 90' ' ' LEU . 18.9 t -74.8 156.1 6.28 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.789 0 N-CA-C 108.998 -0.742 . . . . 74.5 108.998 175.153 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 129' ' ' PHE . . . . . 0.427 ' CE2' ' HG3' ' A' ' 100' ' ' MET . 26.7 p90 -137.76 -11.72 1.54 Allowed 'General case' 0 N--CA 1.485 1.288 0 C-N-CA 122.189 0.195 . . . . 75.01 111.453 174.047 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . -148.14 159.11 27.92 Favored Glycine 0 C--N 1.341 0.84 0 N-CA-C 111.518 -0.633 . . . . 71.11 111.518 -177.056 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 35.1 ttpt -147.31 137.46 23.19 Favored 'General case' 0 N--CA 1.474 0.741 0 N-CA-C 109.39 -0.596 . . . . 75.24 109.39 178.728 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 132' ' ' VAL . . . . . 0.511 HG11 ' HA ' ' A' ' 136' ' ' MET . 37.5 t -63.91 111.89 1.18 Allowed 'Isoleucine or valine' 0 CA--C 1.543 0.705 0 O-C-N 123.658 0.599 . . . . 74.14 110.227 178.054 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 133' ' ' LYS . . . . . 0.593 ' HG3' ' HG2' ' A' ' 134' ' ' GLU . 0.0 OUTLIER -95.7 -42.42 8.39 Favored 'General case' 0 N--CA 1.474 0.751 0 C-N-CA 123.068 0.547 . . . . 74.32 109.569 172.457 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 134' ' ' GLU . . . . . 0.593 ' HG2' ' HG3' ' A' ' 133' ' ' LYS . 18.7 mm-40 -116.4 139.11 50.78 Favored 'General case' 0 N--CA 1.474 0.745 0 N-CA-C 108.674 -0.862 . . . . 74.21 108.674 -178.088 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 76.68 29.08 58.19 Favored Glycine 0 C--N 1.342 0.862 0 N-CA-C 114.156 0.422 . . . . 60.31 114.156 175.455 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 136' ' ' MET . . . . . 0.511 ' HA ' HG11 ' A' ' 132' ' ' VAL . 14.9 tpt -60.11 -38.08 81.93 Favored 'General case' 0 N--CA 1.477 0.908 0 C-N-CA 122.992 0.517 . . . . 74.3 111.216 177.647 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 137' ' ' ASN . . . . . . . . . . . . . 6.0 t30 -61.81 -39.23 91.01 Favored 'General case' 0 CA--C 1.543 0.679 0 CA-C-N 115.448 -0.796 . . . . 74.14 110.88 176.238 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 138' ' ' ILE . . . . . . . . . . . . . 49.2 mm -67.56 -35.57 73.51 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.089 0 C-N-CA 123.523 0.729 . . . . 73.2 110.868 -179.822 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 139' ' ' VAL . . . . . 0.472 ' HA ' ' HE1' ' A' ' 142' ' ' MET . 92.1 t -65.61 -47.26 86.93 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.939 0 C-N-CA 123.561 0.744 . . . . 75.33 110.648 177.203 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 41.6 mt-10 -66.83 -34.81 78.63 Favored 'General case' 0 CA--C 1.548 0.867 0 CA-C-N 115.396 -0.82 . . . . 73.43 110.964 177.739 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -69.01 -44.06 73.55 Favored 'General case' 0 N--CA 1.475 0.815 0 C-N-CA 123.309 0.644 . . . . 71.43 110.881 -178.984 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 142' ' ' MET . . . . . 0.551 ' HB2' HD12 ' A' ' 156' ' ' ILE . 19.7 ptt? -69.29 -31.16 69.47 Favored 'General case' 0 N--CA 1.477 0.88 0 O-C-N 123.429 0.456 . . . . 74.24 110.394 179.172 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 143' ' ' GLU . . . . . 0.55 ' HG2' ' HA ' ' A' ' 58' ' ' PRO . 36.9 tt0 -62.32 -31.76 72.43 Favored 'General case' 0 CA--C 1.549 0.907 0 C-N-CA 122.784 0.434 . . . . 70.12 112.009 178.868 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 144' ' ' ARG . . . . . . . . . . . . . 33.1 mtp85 -65.27 -20.57 66.48 Favored 'General case' 0 N--CA 1.48 1.035 0 C-N-CA 122.706 0.402 . . . . 72.41 111.863 178.607 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 145' ' ' PHE . . . . . 0.517 ' HD2' ' HA ' ' A' ' 142' ' ' MET . 66.3 m-85 -85.75 13.22 7.51 Favored 'General case' 0 N--CA 1.479 0.983 0 C-N-CA 123.388 0.675 . . . . 74.5 111.625 176.403 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . -98.45 -179.24 32.48 Favored Glycine 0 C--N 1.345 1.08 0 N-CA-C 111.743 -0.543 . . . . 63.31 111.743 169.838 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 10.8 m -133.45 163.09 30.14 Favored 'General case' 0 N--CA 1.478 0.944 0 C-N-CA 123.149 0.58 . . . . 73.33 111.203 -175.542 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 148' ' ' ARG . . . . . . . . . . . . . 7.3 mmm180 -67.82 -28.77 67.85 Favored 'General case' 0 N--CA 1.473 0.691 0 C-N-CA 124.383 1.073 . . . . 75.41 112.533 -177.511 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 149' ' ' ASN . . . . . . . . . . . . . 27.3 p-10 -84.58 -3.37 58.42 Favored 'General case' 0 N--CA 1.483 1.217 0 C-N-CA 123.349 0.659 . . . . 73.53 111.607 177.603 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . 100.25 -8.9 59.16 Favored Glycine 0 C--N 1.354 1.561 0 CA-C-O 119.975 -0.347 . . . . 73.12 113.188 179.028 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 59.6 tttp -65.44 143.08 57.93 Favored 'General case' 0 N--CA 1.478 0.956 0 C-N-CA 123.847 0.859 . . . . 74.25 110.408 178.336 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 152' ' ' THR . . . . . . . . . . . . . 16.5 p -92.92 114.21 26.71 Favored 'General case' 0 N--CA 1.467 0.398 0 N-CA-C 109.025 -0.732 . . . . 73.22 109.025 168.553 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 153' ' ' SER . . . . . . . . . . . . . 33.1 t -62.76 -29.02 70.38 Favored 'General case' 0 N--CA 1.475 0.784 0 C-N-CA 123.759 0.823 . . . . 72.42 110.719 177.063 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 154' ' ' LYS . . . . . 0.414 ' HB2' ' HB3' ' A' ' 145' ' ' PHE . 69.9 mmtt -124.93 145.06 50.03 Favored 'General case' 0 C--O 1.239 0.517 0 C-N-CA 123.942 0.897 . . . . 74.51 110.518 179.84 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 3.4 tppp? -79.23 99.41 7.03 Favored 'General case' 0 C--O 1.24 0.565 0 N-CA-C 109.031 -0.729 . . . . 75.32 109.031 172.651 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 156' ' ' ILE . . . . . 0.551 HD12 ' HB2' ' A' ' 142' ' ' MET . 52.3 mt -99.43 123.3 52.06 Favored 'Isoleucine or valine' 0 C--O 1.221 -0.406 0 CA-C-N 114.744 -1.116 . . . . 73.42 108.123 178.395 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 157' ' ' THR . . . . . . . . . . . . . 33.2 p -124.81 156.89 37.07 Favored 'General case' 0 N--CA 1.472 0.631 0 C-N-CA 124.13 0.972 . . . . 75.21 109.816 -177.521 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 158' ' ' ILE . . . . . . . . . . . . . 56.4 mt -82.25 93.73 2.7 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.719 0 N-CA-C 108.106 -1.072 . . . . 74.41 108.106 169.095 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 159' ' ' ALA . . . . . 0.568 ' HB3' ' HB1' ' A' ' 11' ' ' ALA . . . -54.54 -37.08 64.99 Favored 'General case' 0 N--CA 1.478 0.948 0 C-N-CA 124.759 1.224 . . . . 71.43 112.914 -177.736 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 160' ' ' ASP . . . . . 0.509 ' HA ' ' HE2' ' A' ' 49' ' ' LYS . 26.8 t0 -162.64 156.17 20.33 Favored 'General case' 0 N--CA 1.477 0.88 0 O-C-N 123.61 0.569 . . . . 74.15 111.214 -179.983 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 161' ' ' CYS . . . . . . . . . . . . . 6.9 p -123.15 -171.68 2.35 Favored 'General case' 0 N--CA 1.475 0.816 0 C-N-CA 125.255 1.422 . . . . 75.02 108.24 172.917 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 162' ' ' GLY . . . . . . . . . . . . . . . 131.42 57.93 0.09 OUTLIER Glycine 0 N--CA 1.475 1.266 0 O-C-N 121.473 -0.767 . . . . 31.53 111.507 -169.214 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 163' ' ' GLN . . . . . 0.481 ' HA ' ' H ' ' A' ' 7' ' ' PHE . 11.5 pt20 -45.36 132.71 7.65 Favored 'General case' 0 CA--C 1.547 0.838 0 C-N-CA 125.19 1.396 . . . . 74.21 114.031 -169.683 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 164' ' ' LEU . . . . . 0.494 ' O ' ' HB ' ' A' ' 5' ' ' THR . 85.1 mt . . . . . 0 N--CA 1.472 0.645 0 C-N-CA 123.976 0.911 . . . . 72.21 110.959 -179.731 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 218' ' ' PRO . . . . . . . . . . . . . 7.9 Cg_exo . . . . . 0 CA--C 1.545 1.052 0 N-CA-C 110.804 -0.499 . . . . 70.04 110.804 . . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' B' B ' 219' ' ' GLY . . . . . . . . . . . . . . . 166.37 141.91 3.28 Favored Glycine 0 CA--C 1.531 1.071 0 CA-C-O 119.471 -0.627 . . . . 72.3 112.277 -179.961 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 220' ' ' PRO . . . . . . . . . . . . . 52.4 Cg_exo -60.84 159.95 27.13 Favored 'Trans proline' 0 N--CA 1.498 1.788 0 C-N-CA 123.957 3.105 . . . . 72.34 114.698 178.308 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 221' ' ' TYR . . . . . . . . . . . . . 48.1 m-85 . . . . . 0 N--CA 1.484 1.247 0 C-N-CA 123.655 0.782 . . . . 73.53 110.704 -175.131 . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 13.3 m120 . . . . . 0 N--CA 1.478 0.956 0 CA-C-O 119.247 -0.406 . . . . 65.43 110.909 . . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 19.9 Cg_endo -57.12 118.43 5.3 Favored 'Trans proline' 0 C--N 1.379 2.184 0 C-N-CA 122.889 2.392 . . . . 74.35 111.448 -174.337 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 19.7 m -95.56 127.3 41.48 Favored 'General case' 0 N--CA 1.443 -0.794 0 N-CA-C 108.407 -0.96 . . . . 72.31 108.407 -176.757 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 6' ' ' VAL . . . . . 0.463 HG22 ' HB2' ' A' ' 22' ' ' PHE . 15.6 m -106.92 150.5 9.41 Favored 'Isoleucine or valine' 0 CA--C 1.522 -0.106 0 CA-C-N 115.536 -0.756 . . . . 74.42 109.096 -174.918 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 79.7 t80 -138.96 135.63 34.56 Favored 'General case' 0 C--O 1.239 0.531 0 C-N-CA 122.824 0.45 . . . . 73.31 110.389 -173.765 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 8' ' ' PHE . . . . . 0.415 ' HB3' HG22 ' A' ' 158' ' ' ILE . 61.2 m-85 -141.87 165.58 27.09 Favored 'General case' 0 N--CA 1.469 0.513 0 C-N-CA 123.998 0.919 . . . . 72.11 110.504 178.946 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 11.3 m-20 -106.74 119.01 38.18 Favored 'General case' 0 N--CA 1.468 0.454 0 N-CA-C 108.012 -1.107 . . . . 72.23 108.012 165.168 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 10' ' ' ILE . . . . . 0.517 HG22 ' SD ' ' A' ' 142' ' ' MET . 48.6 mm -86.49 118.5 32.91 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.559 0 N-CA-C 109.021 -0.733 . . . . 74.44 109.021 176.532 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 11' ' ' ALA . . . . . 0.752 ' HB1' ' HB2' ' A' ' 159' ' ' ALA . . . -109.32 133.09 53.48 Favored 'General case' 0 C--O 1.219 -0.538 0 C-N-CA 123.975 0.91 . . . . 63.22 111.383 -174.689 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 43.0 t -97.64 123.54 50.12 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.533 0 N-CA-C 108.437 -0.949 . . . . 74.22 108.437 170.532 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 13' ' ' ASP . . . . . 0.434 ' HA ' ' HB2' ' A' ' 155' ' ' LYS . 66.7 m-20 61.22 15.02 6.02 Favored 'General case' 0 N--CA 1.483 1.206 0 C-N-CA 125.55 1.54 . . . . 74.44 112.928 -178.036 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 108.42 -27.32 14.05 Favored Glycine 0 C--N 1.346 1.103 0 CA-C-O 119.679 -0.512 . . . . 74.24 112.825 -176.502 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 30.8 mm-40 -89.17 122.69 68.49 Favored Pre-proline 0 N--CA 1.487 1.379 0 CA-C-N 117.666 0.733 . . . . 71.42 110.427 -179.1 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 16' ' ' PRO . . . . . 0.462 ' HA ' ' HA ' ' A' ' 11' ' ' ALA . 19.2 Cg_endo -54.36 113.22 1.26 Allowed 'Trans proline' 0 C--N 1.386 2.55 0 C-N-CA 123.344 2.696 . . . . 70.34 112.974 -177.428 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 37.2 tp -77.03 -36.72 55.92 Favored 'General case' 0 N--CA 1.479 0.991 0 C-N-CA 124.041 0.936 . . . . 75.02 109.552 175.883 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -173.4 -161.78 24.23 Favored Glycine 0 C--N 1.335 0.479 0 CA-C-N 114.671 -1.149 . . . . 71.43 111.291 -178.741 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 3.5 ptp180 -144.31 140.82 29.38 Favored 'General case' 0 N--CA 1.469 0.516 0 C-N-CA 123.374 0.67 . . . . 74.14 109.858 -176.762 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 20' ' ' VAL . . . . . 0.424 ' HA ' ' HA3' ' A' ' 135' ' ' GLY . 60.8 t -128.54 135.89 61.32 Favored 'Isoleucine or valine' 0 C--O 1.24 0.599 0 C-N-CA 124.029 0.931 . . . . 64.13 109.464 -176.213 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 31.5 t -113.39 121.03 43.13 Favored 'General case' 0 CA--C 1.547 0.841 0 C-N-CA 123.864 0.865 . . . . 54.51 108.852 172.951 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 22' ' ' PHE . . . . . 0.463 ' HB2' HG22 ' A' ' 6' ' ' VAL . 12.2 m-85 -101.0 170.87 7.99 Favored 'General case' 0 CA--C 1.543 0.706 0 N-CA-C 108.731 -0.841 . . . . 73.35 108.731 175.458 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 23' ' ' GLU . . . . . 0.661 ' HB2' ' HD2' ' A' ' 133' ' ' LYS . 38.9 tt0 -134.08 108.5 8.36 Favored 'General case' 0 N--CA 1.472 0.663 0 C-N-CA 123.977 0.911 . . . . 65.21 109.094 -178.557 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 13.6 mt -91.48 121.09 32.87 Favored 'General case' 0 CA--C 1.542 0.663 0 C-N-CA 122.949 0.5 . . . . 72.33 110.09 -176.726 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 25' ' ' PHE . . . . . 0.506 ' HB2' HD13 ' A' ' 90' ' ' LEU . 31.4 m-85 -86.98 69.98 10.28 Favored 'General case' 0 N--CA 1.472 0.658 0 C-N-CA 123.631 0.772 . . . . 74.32 109.777 -177.766 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -64.53 -16.07 61.97 Favored 'General case' 0 N--CA 1.48 1.034 0 N-CA-C 112.929 0.714 . . . . 71.44 112.929 -178.085 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 10.3 p-10 -72.67 -29.72 63.65 Favored 'General case' 0 CA--C 1.553 1.073 0 C-N-CA 123.279 0.632 . . . . 72.44 111.431 177.281 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 54.5 mttp -98.54 -41.65 7.66 Favored 'General case' 0 N--CA 1.485 1.319 0 C-N-CA 123.833 0.853 . . . . 75.43 110.891 -176.407 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 29' ' ' VAL . . . . . 0.507 HG21 ' HA ' ' A' ' 129' ' ' PHE . 9.7 m -129.97 70.62 82.16 Favored Pre-proline 0 CA--C 1.561 1.39 0 C-N-CA 123.992 0.917 . . . . 73.31 109.815 -178.071 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 18.5 Cg_endo -57.73 -40.07 82.35 Favored 'Trans proline' 0 C--N 1.387 2.56 0 C-N-CA 123.221 2.614 . . . . 74.23 113.39 -175.28 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 31' ' ' LYS . . . . . 0.478 ' HG3' ' HH ' ' A' ' 79' ' ' TYR . 37.9 ttpt -66.87 -55.49 14.49 Favored 'General case' 0 N--CA 1.476 0.872 0 C-N-CA 123.539 0.735 . . . . 72.21 111.935 -179.587 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 5.8 m -68.74 -32.29 71.95 Favored 'General case' 0 CA--C 1.554 1.114 0 CA-C-N 115.591 -0.731 . . . . 70.4 111.455 -172.039 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -79.26 -45.5 19.63 Favored 'General case' 0 N--CA 1.477 0.878 0 C-N-CA 123.531 0.733 . . . . 74.44 111.115 179.745 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 32.3 tt0 -58.76 -35.07 72.15 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 123.604 0.565 . . . . 74.53 110.698 178.111 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 35' ' ' ASN . . . . . 0.519 ' ND2' ' SD ' ' A' ' 100' ' ' MET . 51.5 t30 -53.61 -69.25 0.12 Allowed 'General case' 0 C--N 1.353 0.751 0 O-C-N 124.267 0.98 . . . . 72.53 110.822 -179.175 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 91.4 t80 -62.83 -35.01 78.53 Favored 'General case' 0 N--CA 1.48 1.064 0 C-N-CA 123.493 0.717 . . . . 75.34 111.962 -176.128 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 56.2 ttt180 -61.74 -48.81 79.05 Favored 'General case' 0 N--CA 1.479 0.977 0 C-N-CA 123.535 0.734 . . . . 74.11 111.141 179.668 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -84.16 -19.45 34.1 Favored 'General case' 0 N--CA 1.475 0.808 0 CA-C-N 115.515 -0.766 . . . . 62.23 111.994 -174.832 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 39' ' ' LEU . . . . . 0.508 ' HG ' ' O ' ' A' ' 35' ' ' ASN . 66.4 mt -64.78 -46.1 83.52 Favored 'General case' 0 N--CA 1.474 0.752 0 N-CA-C 108.538 -0.912 . . . . 75.02 108.538 167.636 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 27.0 t -64.54 -56.21 15.54 Favored 'General case' 0 CA--C 1.543 0.683 0 C-N-CA 124.463 1.105 . . . . 72.41 112.047 -178.162 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 41' ' ' THR . . . . . 0.542 HG21 ' NE2' ' A' ' 163' ' ' GLN . 2.9 p -67.79 -30.71 70.21 Favored 'General case' 0 N--CA 1.477 0.901 0 C-N-CA 122.761 0.424 . . . . 75.44 111.541 179.652 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 84.09 29.01 32.31 Favored Glycine 0 C--N 1.345 1.069 0 CA-C-N 116.236 -0.438 . . . . 74.31 112.486 -179.06 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 21.2 mm-40 -64.49 -24.95 67.79 Favored 'General case' 0 N--CA 1.478 0.943 0 C-N-CA 123.437 0.695 . . . . 64.14 111.504 175.781 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 44' ' ' LYS . . . . . 0.488 ' HG3' HG22 ' A' ' 78' ' ' ILE . 70.8 mmtt -98.35 5.69 47.98 Favored 'General case' 0 CA--C 1.548 0.897 0 C-N-CA 124.088 0.955 . . . . 71.33 111.117 -179.936 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 79.08 39.21 20.44 Favored Glycine 0 C--N 1.348 1.218 0 CA-C-O 119.973 -0.348 . . . . 65.53 113.612 179.026 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 22.9 m-85 -123.98 -48.54 1.87 Allowed 'General case' 0 N--CA 1.485 1.3 0 CA-C-N 117.207 0.503 . . . . 74.21 111.309 -176.758 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 53.1 61.83 6.54 Favored Glycine 0 C--N 1.352 1.462 0 O-C-N 124.127 0.892 . . . . 73.14 114.461 171.009 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 48' ' ' TYR . . . . . 0.434 ' CE1' ' HA2' ' A' ' 75' ' ' GLY . 61.7 m-85 -67.51 97.94 0.63 Allowed 'General case' 0 N--CA 1.473 0.679 0 C-N-CA 123.499 0.72 . . . . 75.35 112.44 -176.289 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 3.0 tppp? -109.86 145.7 36.34 Favored 'General case' 0 CA--C 1.537 0.46 0 CA-C-N 114.532 -1.213 . . . . 74.33 108.938 172.26 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 71.01 20.63 77.99 Favored Glycine 0 C--N 1.343 0.953 0 CA-C-O 119.515 -0.603 . . . . 71.23 113.444 179.318 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 20.3 m -55.83 113.83 1.65 Allowed 'General case' 0 C--N 1.354 0.787 0 C-N-CA 123.595 0.758 . . . . 71.2 109.842 -179.324 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 52' ' ' CYS . . . . . 0.569 ' SG ' ' HB3' ' A' ' 66' ' ' ASP . 7.7 p -100.28 123.03 44.01 Favored 'General case' 0 CA--C 1.545 0.77 0 CA-C-N 115.277 -0.874 . . . . 73.54 112.505 -163.441 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 53' ' ' PHE . . . . . 0.723 ' HA ' ' HA2' ' A' ' 64' ' ' GLY . 33.3 m-85 -71.07 118.32 13.7 Favored 'General case' 0 C--O 1.239 0.504 0 C-N-CA 125.461 1.504 . . . . 73.02 109.79 171.874 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 54' ' ' HIS . . . . . 0.469 ' ND1' ' HB2' ' A' ' 66' ' ' ASP . 45.5 p-80 -115.96 -22.97 8.76 Favored 'General case' 0 N--CA 1.475 0.792 0 C-N-CA 123.772 0.829 . . . . 74.03 110.858 -176.675 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 47.9 ttt-85 -128.95 106.21 8.73 Favored 'General case' 0 C--N 1.359 1.005 0 N-CA-C 109.572 -0.529 . . . . 74.31 109.572 178.704 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 56' ' ' ILE . . . . . 0.535 HG23 ' HA ' ' A' ' 143' ' ' GLU . 56.5 mt -130.58 128.23 63.16 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.749 0 C-N-CA 123.72 0.808 . . . . 73.14 108.973 174.695 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 76.3 mt -108.02 117.66 54.57 Favored Pre-proline 0 CA--C 1.557 1.219 0 C-N-CA 124.281 1.032 . . . . 74.33 108.256 173.254 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 58' ' ' PRO . . . . . 0.54 ' HA ' ' HG2' ' A' ' 143' ' ' GLU . 32.0 Cg_exo -58.84 131.52 42.42 Favored 'Trans proline' 0 C--N 1.382 2.313 0 C-N-CA 123.64 2.893 . . . . 74.25 112.83 179.62 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 79.2 21.09 68.31 Favored Glycine 0 CA--C 1.529 0.928 0 O-C-N 124.018 0.824 . . . . 62.34 113.597 179.885 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 17.3 t80 -148.04 -73.42 0.2 Allowed 'General case' 0 N--CA 1.48 1.032 0 CA-C-N 117.659 0.73 . . . . 74.44 111.121 -173.888 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 61' ' ' MET . . . . . 0.411 ' SD ' ' CD1' ' A' ' 113' ' ' PHE . 58.5 ttp -159.75 142.56 13.83 Favored 'General case' 0 N--CA 1.483 1.221 0 N-CA-C 112.578 0.585 . . . . 75.32 112.578 -165.412 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 62' ' ' CYS . . . . . 0.513 ' SG ' ' HB2' ' A' ' 143' ' ' GLU . 52.2 m -117.18 116.92 28.23 Favored 'General case' 0 N--CA 1.474 0.74 0 C-N-CA 124.511 1.125 . . . . 73.41 110.179 175.145 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 15.0 pt20 -121.0 130.31 53.75 Favored 'General case' 0 N--CA 1.484 1.259 0 CA-C-O 122.103 0.954 . . . . 72.41 112.11 179.499 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 64' ' ' GLY . . . . . 0.723 ' HA2' ' HA ' ' A' ' 53' ' ' PHE . . . -113.49 -177.21 19.42 Favored Glycine 0 C--N 1.343 0.94 0 CA-C-N 113.79 -1.55 . . . . 62.34 112.758 178.27 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 98.83 73.66 1.11 Allowed Glycine 0 C--N 1.337 0.614 0 N-CA-C 110.871 -0.892 . . . . 72.44 110.871 -178.959 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 66' ' ' ASP . . . . . 0.569 ' HB3' ' SG ' ' A' ' 52' ' ' CYS . 32.6 t70 -127.56 30.29 5.36 Favored 'General case' 0 N--CA 1.482 1.141 0 C-N-CA 123.099 0.56 . . . . 70.03 109.916 172.124 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 57.0 t80 -93.8 -83.83 0.32 Allowed 'General case' 0 CA--C 1.555 1.148 0 O-C-N 122.055 -0.403 . . . . 74.44 111.044 -177.12 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 69.9 m -81.15 113.11 19.09 Favored 'General case' 0 N--CA 1.482 1.148 0 C-N-CA 123.407 0.683 . . . . 64.02 111.346 -171.307 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 60.7 ttt85 62.76 66.51 0.75 Allowed 'General case' 0 N--CA 1.476 0.856 0 C-N-CA 124.349 1.06 . . . . 75.22 109.522 -174.471 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 2.5 p-80 -74.63 74.85 2.02 Favored 'General case' 0 N--CA 1.482 1.161 0 CA-C-N 114.819 -1.082 . . . . 74.3 112.083 -175.272 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 64.5 t30 -154.72 77.98 1.05 Allowed 'General case' 0 N--CA 1.473 0.719 0 N-CA-C 108.085 -1.08 . . . . 73.44 108.085 177.163 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 63.98 22.81 67.08 Favored Glycine 0 CA--C 1.534 1.26 0 CA-C-N 115.67 -0.696 . . . . 75.33 114.044 -176.32 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 73' ' ' THR . . . . . 0.527 ' HA ' ' HB2' ' A' ' 110' ' ' SER . 46.9 m -142.53 -65.37 0.4 Allowed 'General case' 0 N--CA 1.476 0.854 0 C-N-CA 123.855 0.862 . . . . 74.43 109.492 -174.582 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 44.04 38.53 4.75 Favored Glycine 0 C--N 1.355 1.599 0 C-N-CA 124.517 1.056 . . . . 44.14 115.655 174.922 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 75' ' ' GLY . . . . . 0.434 ' HA2' ' CE1' ' A' ' 48' ' ' TYR . . . 149.78 54.05 0.01 OUTLIER Glycine 0 C--N 1.337 0.584 0 O-C-N 122.122 -0.634 . . . . 75.13 112.256 -161.281 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 76' ' ' LYS . . . . . 0.425 ' HZ2' ' HB2' ' A' ' 76' ' ' LYS . 0.0 OUTLIER -48.22 149.62 1.45 Allowed 'General case' 0 N--CA 1.481 1.108 0 C-N-CA 124.685 1.194 . . . . 72.22 111.621 169.909 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 94.3 p -90.03 -178.4 5.43 Favored 'General case' 0 C--O 1.24 0.59 0 CA-C-O 121.781 0.8 . . . . 73.34 112.244 -169.504 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 78' ' ' ILE . . . . . 0.488 HG22 ' HG3' ' A' ' 44' ' ' LYS . 27.7 pt -72.62 -19.48 19.11 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.941 0 CA-C-N 114.909 -1.041 . . . . 73.34 110.751 175.787 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 79' ' ' TYR . . . . . 0.478 ' HH ' ' HG3' ' A' ' 31' ' ' LYS . 92.8 m-85 -92.08 25.78 2.73 Favored 'General case' 0 N--CA 1.481 1.115 0 C-N-CA 123.701 0.8 . . . . 73.3 110.381 173.062 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 83.92 -105.15 2.74 Favored Glycine 0 C--N 1.343 0.939 0 N-CA-C 111.015 -0.834 . . . . 64.03 111.015 -178.243 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 43.0 tt0 -74.34 -61.26 1.92 Allowed 'General case' 0 C--O 1.242 0.7 0 C-N-CA 122.872 0.469 . . . . 75.1 110.493 -177.237 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 82' ' ' LYS . . . . . 0.716 ' HD2' ' HA ' ' A' ' 107' ' ' THR . 20.4 pttp -168.78 177.15 5.2 Favored 'General case' 0 CA--C 1.542 0.635 0 CA-C-N 115.465 -0.788 . . . . 74.44 110.475 -173.128 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 28.9 p90 -159.35 177.45 10.99 Favored 'General case' 0 CA--C 1.546 0.791 0 C-N-CA 125.467 1.507 . . . . 75.32 108.251 -174.714 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 11.5 pt-20 -94.97 167.6 11.3 Favored 'General case' 0 N--CA 1.485 1.283 0 O-C-N 121.926 -0.484 . . . . 74.4 111.552 179.224 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 25.9 m-20 -61.41 150.13 36.31 Favored 'General case' 0 N--CA 1.479 1.021 0 C-N-CA 123.82 0.848 . . . . 73.23 111.302 174.489 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 86' ' ' GLU . . . . . 0.499 ' HG2' ' HA ' ' A' ' 29' ' ' VAL . 6.3 tp10 -74.63 -61.82 1.74 Allowed 'General case' 0 N--CA 1.474 0.747 0 CA-C-N 116.55 -0.296 . . . . 73.02 111.329 -176.664 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 31.2 p-10 -174.32 143.97 0.9 Allowed 'General case' 0 N--CA 1.479 1.009 0 C-N-CA 123.85 0.86 . . . . 71.44 109.134 -174.643 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 92.7 m-85 -88.25 53.24 2.67 Favored 'General case' 0 N--CA 1.483 1.218 0 C-N-CA 123.819 0.848 . . . . 74.42 112.115 -166.565 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 63.3 mt -77.38 -57.5 5.67 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.855 0 C-N-CA 123.654 0.782 . . . . 71.23 108.946 173.298 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 90' ' ' LEU . . . . . 0.567 ' HB3' ' HB ' ' A' ' 128' ' ' VAL . 86.7 mt -85.03 121.58 28.01 Favored 'General case' 0 C--O 1.238 0.467 0 CA-C-N 114.672 -1.149 . . . . 73.44 110.619 -175.145 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 46.5 mtmt -117.5 169.39 9.57 Favored 'General case' 0 N--CA 1.474 0.756 0 C-N-CA 124.141 0.976 . . . . 73.24 110.193 -175.831 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 92' ' ' HIS . . . . . . . . . . . . . 28.1 m-70 -86.38 50.15 1.94 Allowed 'General case' 0 N--CA 1.48 1.068 0 C-N-CA 124.062 0.945 . . . . 74.35 109.942 -178.988 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 10.5 t -95.0 -2.45 50.32 Favored 'General case' 0 CA--C 1.547 0.84 0 CA-C-N 115.112 -0.949 . . . . 75.54 110.965 -175.281 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -131.66 170.33 21.62 Favored Glycine 0 CA--C 1.533 1.189 0 CA-C-O 119.735 -0.48 . . . . 60.01 112.272 179.07 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 83.8 Cg_endo -81.99 157.36 17.95 Favored 'Trans proline' 0 CA--C 1.554 1.519 0 C-N-CA 122.799 2.333 . . . . 71.31 112.209 170.83 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 79.3 21.17 67.87 Favored Glycine 0 C--N 1.35 1.306 0 CA-C-N 116.601 -0.272 . . . . 61.31 113.624 176.544 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 97' ' ' ILE . . . . . 0.618 ' HB ' ' HB2' ' A' ' 115' ' ' CYS . 24.9 mm -65.63 103.72 0.5 Allowed 'Isoleucine or valine' 0 CA--C 1.547 0.836 0 C-N-CA 123.603 0.761 . . . . 74.43 111.816 -175.559 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 63.0 tp -89.02 114.38 25.57 Favored 'General case' 0 CA--C 1.547 0.84 0 CA-C-O 121.586 0.708 . . . . 73.12 109.368 173.708 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 99' ' ' SER . . . . . 0.677 ' HB3' ' HA ' ' A' ' 128' ' ' VAL . 4.9 p -148.05 139.75 23.82 Favored 'General case' 0 CA--C 1.537 0.473 0 C-N-CA 124.801 1.24 . . . . 73.01 108.033 178.354 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 100' ' ' MET . . . . . 0.709 ' HA ' ' HA ' ' A' ' 112' ' ' PHE . 67.3 mtp -75.55 148.05 39.21 Favored 'General case' 0 N--CA 1.489 1.522 0 C-N-CA 122.625 0.37 . . . . 72.13 110.775 -173.187 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 101' ' ' ALA . . . . . 0.635 ' HB2' ' HB2' ' A' ' 111' ' ' GLN . . . -72.34 152.28 42.18 Favored 'General case' 0 N--CA 1.479 0.984 0 CA-C-O 121.196 0.522 . . . . 73.35 112.301 -171.928 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 102' ' ' ASN . . . . . 0.426 ' HB2' ' HB ' ' A' ' 107' ' ' THR . 30.1 p-10 -165.83 159.42 15.99 Favored 'General case' 0 CA--C 1.536 0.438 0 CA-C-N 114.821 -1.081 . . . . 75.34 109.774 -177.022 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -110.14 25.08 12.18 Favored 'General case' 0 N--CA 1.472 0.654 0 C-N-CA 123.356 0.662 . . . . 71.04 109.379 169.821 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 136.9 -174.1 21.81 Favored Glycine 0 CA--C 1.535 1.292 0 CA-C-N 115.484 -0.78 . . . . 70.51 112.029 -179.422 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 51.7 Cg_exo -57.22 152.24 46.7 Favored 'Trans proline' 0 C--N 1.37 1.671 0 C-N-CA 123.439 2.759 . . . . 63.51 112.595 175.316 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 65.1 t30 66.74 12.67 8.98 Favored 'General case' 0 N--CA 1.489 1.491 0 C-N-CA 124.347 1.059 . . . . 75.4 111.965 179.638 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 107' ' ' THR . . . . . 0.716 ' HA ' ' HD2' ' A' ' 82' ' ' LYS . 2.7 m -120.77 7.23 10.45 Favored 'General case' 0 N--CA 1.489 1.506 0 C-N-CA 123.451 0.701 . . . . 73.23 110.579 -179.504 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 12.4 t30 -76.89 139.93 40.4 Favored 'General case' 0 N--CA 1.478 0.965 0 C-N-CA 124.643 1.177 . . . . 73.52 110.26 179.181 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 112.59 -11.35 25.73 Favored Glycine 0 N--CA 1.471 1.003 0 CA-C-O 119.843 -0.42 . . . . 64.23 113.269 178.518 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 110' ' ' SER . . . . . 0.527 ' HB2' ' HA ' ' A' ' 73' ' ' THR . 33.9 p -99.87 121.61 41.57 Favored 'General case' 0 N--CA 1.474 0.773 0 N-CA-C 109.047 -0.723 . . . . 74.41 109.047 173.009 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 111' ' ' GLN . . . . . 0.635 ' HB2' ' HB2' ' A' ' 101' ' ' ALA . 38.5 mt-30 63.67 175.74 0.17 Allowed 'General case' 0 N--CA 1.498 1.969 0 C-N-CA 124.294 1.037 . . . . 74.32 111.848 -177.705 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 112' ' ' PHE . . . . . 0.709 ' HA ' ' HA ' ' A' ' 100' ' ' MET . 36.6 p90 -148.93 133.36 17.57 Favored 'General case' 0 N--CA 1.482 1.147 0 N-CA-C 109.427 -0.583 . . . . 71.23 109.427 177.133 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 113' ' ' PHE . . . . . 0.411 ' CD1' ' SD ' ' A' ' 61' ' ' MET . 51.7 p90 -118.98 149.83 40.96 Favored 'General case' 0 N--CA 1.478 0.935 0 C-N-CA 123.151 0.58 . . . . 71.33 111.592 179.627 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 114' ' ' ILE . . . . . . . . . . . . . 22.5 mt -123.0 103.8 13.59 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.611 0 C-N-CA 124.279 1.032 . . . . 74.31 108.698 -179.753 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 115' ' ' CYS . . . . . 0.618 ' HB2' ' HB ' ' A' ' 97' ' ' ILE . 62.2 m -75.71 106.22 7.16 Favored 'General case' 0 CA--C 1.541 0.623 0 N-CA-C 109.336 -0.616 . . . . 54.5 109.336 175.584 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 116' ' ' THR . . . . . 0.541 ' HA ' ' HE1' ' A' ' 136' ' ' MET . 39.5 p -70.63 -31.5 68.47 Favored 'General case' 0 N--CA 1.471 0.584 0 C-N-CA 123.534 0.734 . . . . 73.32 111.3 -179.104 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -99.06 159.04 15.25 Favored 'General case' 0 C--O 1.247 0.936 0 CA-C-N 115.462 -0.79 . . . . 71.5 109.478 171.69 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -72.36 88.89 1.2 Allowed 'General case' 0 CA--C 1.539 0.543 0 CA-C-O 121.765 0.793 . . . . 71.12 109.182 173.471 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 119' ' ' THR . . . . . . . . . . . . . 34.6 p -76.06 85.7 2.94 Favored 'General case' 0 CA--C 1.546 0.804 0 CA-C-O 122.276 1.036 . . . . 75.5 110.36 -174.381 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 11.5 pt-20 -71.29 -29.76 65.44 Favored 'General case' 0 N--CA 1.474 0.748 0 CA-C-N 114.158 -1.383 . . . . 75.41 111.38 -171.278 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 121' ' ' TRP . . . . . . . . . . . . . 43.6 p90 -67.94 -3.17 9.04 Favored 'General case' 0 N--CA 1.479 1.003 0 C-N-CA 123.367 0.667 . . . . 70.23 112.218 179.251 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 45.7 mt -96.24 26.32 4.35 Favored 'General case' 0 CA--C 1.555 1.141 0 C-N-CA 123.523 0.729 . . . . 62.41 111.535 174.037 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 56.7 m-20 -59.55 123.08 15.7 Favored 'General case' 0 N--CA 1.49 1.545 0 C-N-CA 122.758 0.423 . . . . 62.32 110.376 165.054 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 85.56 -9.1 69.03 Favored Glycine 0 N--CA 1.475 1.278 0 O-C-N 123.209 0.318 . . . . 61.44 113.27 -179.271 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 125' ' ' LYS . . . . . 0.631 ' HG3' ' H ' ' A' ' 126' ' ' HIS . 0.1 OUTLIER -82.74 -163.97 0.79 Allowed 'General case' 0 CA--C 1.561 1.371 0 C-N-CA 124.628 1.171 . . . . 74.22 108.412 177.511 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 126' ' ' HIS . . . . . 0.631 ' H ' ' HG3' ' A' ' 125' ' ' LYS . 57.3 t-80 -64.35 136.43 57.13 Favored 'General case' 0 N--CA 1.473 0.709 0 C-N-CA 124.119 0.968 . . . . 75.04 111.218 -166.38 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 45.1 t -71.76 140.33 18.32 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.536 0 CA-C-N 115.634 -0.712 . . . . 61.4 110.676 -176.466 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 128' ' ' VAL . . . . . 0.677 ' HA ' ' HB3' ' A' ' 99' ' ' SER . 25.1 t -73.37 148.0 9.14 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.558 0 N-CA-C 109.166 -0.679 . . . . 71.44 109.166 175.767 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 129' ' ' PHE . . . . . 0.507 ' HA ' HG21 ' A' ' 29' ' ' VAL . 39.5 p90 -129.2 -20.02 3.44 Favored 'General case' 0 N--CA 1.479 0.996 0 O-C-N 122.105 -0.372 . . . . 73.35 110.694 174.827 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . -140.23 164.18 26.25 Favored Glycine 0 C--N 1.34 0.761 0 O-C-N 123.717 0.636 . . . . 75.31 112.017 -175.87 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 34.6 ttpt -148.86 130.28 14.77 Favored 'General case' 0 N--CA 1.468 0.462 0 N-CA-C 109.271 -0.641 . . . . 74.21 109.271 -178.148 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 49.0 t -63.76 104.45 0.41 Allowed 'Isoleucine or valine' 0 C--O 1.238 0.496 0 N-CA-C 108.847 -0.797 . . . . 70.41 108.847 174.759 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 133' ' ' LYS . . . . . 0.661 ' HD2' ' HB2' ' A' ' 23' ' ' GLU . 19.4 ptmt -85.63 -33.4 21.63 Favored 'General case' 0 N--CA 1.471 0.618 0 N-CA-C 109.335 -0.617 . . . . 74.11 109.335 179.545 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 32.8 mt-10 -145.39 152.27 39.58 Favored 'General case' 0 N--CA 1.473 0.707 0 C-N-CA 125.033 1.333 . . . . 74.44 109.166 -178.135 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 135' ' ' GLY . . . . . 0.424 ' HA3' ' HA ' ' A' ' 20' ' ' VAL . . . 81.85 16.62 72.21 Favored Glycine 0 C--N 1.345 1.041 0 CA-C-N 116.534 -0.303 . . . . 74.02 112.729 -178.848 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 136' ' ' MET . . . . . 0.541 ' HE1' ' HA ' ' A' ' 116' ' ' THR . 14.5 tpt -62.6 -31.11 71.88 Favored 'General case' 0 N--CA 1.479 0.998 0 C-N-CA 124.232 1.013 . . . . 74.52 110.857 177.72 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 137' ' ' ASN . . . . . . . . . . . . . 45.3 t30 -56.53 -44.66 81.04 Favored 'General case' 0 N--CA 1.477 0.883 0 CA-C-N 114.51 -1.223 . . . . 75.44 110.779 171.824 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 138' ' ' ILE . . . . . . . . . . . . . 46.4 mm -73.72 -33.13 37.21 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.009 0 C-N-CA 123.682 0.793 . . . . 73.32 111.135 -178.199 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 70.2 t -63.27 -47.72 90.83 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.114 0 CA-C-O 121.32 0.581 . . . . 73.43 110.511 177.146 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 49.0 mt-10 -73.13 -29.29 62.78 Favored 'General case' 0 CA--C 1.548 0.884 0 CA-C-N 115.827 -0.624 . . . . 75.21 111.385 179.092 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -70.22 -40.17 74.67 Favored 'General case' 0 N--CA 1.479 0.991 0 C-N-CA 123.089 0.555 . . . . 75.54 111.269 177.503 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 142' ' ' MET . . . . . 0.517 ' SD ' HG22 ' A' ' 10' ' ' ILE . 22.9 ptt? -74.51 -27.03 60.37 Favored 'General case' 0 N--CA 1.484 1.271 0 C-N-CA 122.622 0.369 . . . . 61.34 110.107 178.501 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 143' ' ' GLU . . . . . 0.54 ' HG2' ' HA ' ' A' ' 58' ' ' PRO . 33.8 tt0 -65.41 -27.51 68.59 Favored 'General case' 0 CA--C 1.545 0.756 0 C-N-CA 123.202 0.601 . . . . 73.31 112.417 177.686 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 144' ' ' ARG . . . . . . . . . . . . . 74.3 mtp180 -65.7 -20.23 66.2 Favored 'General case' 0 CA--C 1.55 0.949 0 C-N-CA 123.48 0.712 . . . . 75.15 111.458 176.114 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 145' ' ' PHE . . . . . . . . . . . . . 43.6 m-85 -89.52 3.97 50.73 Favored 'General case' 0 CA--C 1.548 0.874 0 C-N-CA 123.607 0.763 . . . . 75.31 111.706 177.406 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . -85.52 177.26 50.07 Favored Glycine 0 C--N 1.347 1.167 0 N-CA-C 111.66 -0.576 . . . . 74.44 111.66 171.01 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 16.4 m -133.71 163.15 30.09 Favored 'General case' 0 N--CA 1.48 1.053 0 CA-C-N 117.587 0.694 . . . . 71.31 111.741 -175.895 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 148' ' ' ARG . . . . . . . . . . . . . 9.3 mmm180 -75.99 -15.31 60.17 Favored 'General case' 0 N--CA 1.475 0.798 0 C-N-CA 124.897 1.279 . . . . 73.32 112.879 -177.747 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 149' ' ' ASN . . . . . . . . . . . . . 34.3 p-10 -90.72 -3.51 57.41 Favored 'General case' 0 N--CA 1.481 1.117 0 C-N-CA 122.884 0.474 . . . . 73.31 110.333 171.982 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . 105.36 -27.33 18.69 Favored Glycine 0 C--N 1.351 1.393 0 CA-C-N 116.0 -0.546 . . . . 41.22 112.917 177.003 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 56.9 tttm -69.43 156.32 39.04 Favored 'General case' 0 N--CA 1.484 1.27 0 C-N-CA 123.217 0.607 . . . . 74.33 111.78 -173.358 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 152' ' ' THR . . . . . . . . . . . . . 69.2 p -94.39 130.63 40.65 Favored 'General case' 0 N--CA 1.474 0.765 0 CA-C-O 120.941 0.4 . . . . 75.42 110.428 172.304 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 153' ' ' SER . . . . . . . . . . . . . 15.0 m -69.47 -31.44 69.73 Favored 'General case' 0 N--CA 1.474 0.731 0 C-N-CA 123.928 0.891 . . . . 74.0 111.148 174.723 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 75.3 mmtt -115.13 153.63 30.42 Favored 'General case' 0 N--CA 1.473 0.723 0 C-N-CA 124.052 0.941 . . . . 72.23 109.972 -177.277 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 155' ' ' LYS . . . . . 0.434 ' HB2' ' HA ' ' A' ' 13' ' ' ASP . 30.3 mmmt -86.32 89.11 7.76 Favored 'General case' 0 N--CA 1.468 0.466 0 N-CA-C 109.244 -0.651 . . . . 75.52 109.244 175.626 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 156' ' ' ILE . . . . . 0.512 HD13 ' HB2' ' A' ' 142' ' ' MET . 59.2 mt -90.23 103.02 13.85 Favored 'Isoleucine or valine' 0 C--O 1.213 -0.837 0 N-CA-C 109.28 -0.637 . . . . 75.1 109.28 -174.706 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 157' ' ' THR . . . . . . . . . . . . . 44.7 p -114.45 147.99 38.47 Favored 'General case' 0 N--CA 1.476 0.868 0 C-N-CA 123.976 0.91 . . . . 75.32 109.972 -175.222 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 158' ' ' ILE . . . . . 0.415 HG22 ' HB3' ' A' ' 8' ' ' PHE . 47.2 mt -71.91 97.43 0.67 Allowed 'Isoleucine or valine' 0 CA--C 1.555 1.156 0 N-CA-C 109.546 -0.539 . . . . 74.12 109.546 170.638 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 159' ' ' ALA . . . . . 0.752 ' HB2' ' HB1' ' A' ' 11' ' ' ALA . . . -58.7 -48.57 80.67 Favored 'General case' 0 N--CA 1.482 1.136 0 C-N-CA 124.581 1.152 . . . . 62.12 112.757 -175.894 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 160' ' ' ASP . . . . . . . . . . . . . 25.4 t0 -148.86 166.16 29.36 Favored 'General case' 0 N--CA 1.478 0.974 0 CA-C-N 115.926 -0.579 . . . . 73.32 110.307 -175.734 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 161' ' ' CYS . . . . . . . . . . . . . 19.4 p -132.56 -170.91 2.53 Favored 'General case' 0 CA--C 1.548 0.888 0 C-N-CA 125.315 1.446 . . . . 74.22 109.056 179.85 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 162' ' ' GLY . . . . . . . . . . . . . . . 132.02 53.88 0.09 OUTLIER Glycine 0 N--CA 1.473 1.134 0 N-CA-C 111.265 -0.734 . . . . 73.41 111.265 -170.83 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 163' ' ' GLN . . . . . 0.542 ' NE2' HG21 ' A' ' 41' ' ' THR . 69.7 mt-30 -46.74 112.56 0.52 Allowed 'General case' 0 CA--C 1.55 0.952 0 C-N-CA 125.586 1.555 . . . . 74.34 112.762 -177.337 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 164' ' ' LEU . . . . . . . . . . . . . 88.0 mt . . . . . 0 N--CA 1.474 0.751 0 C-N-CA 124.045 0.938 . . . . 73.4 110.186 -175.646 . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' B' B ' 218' ' ' PRO . . . . . . . . . . . . . 10.8 Cg_endo . . . . . 0 CA--C 1.549 1.267 0 CA-C-O 121.216 0.423 . . . . 75.43 111.37 . . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' B' B ' 219' ' ' GLY . . . . . . . . . . . . . . . 137.0 126.95 2.57 Favored Glycine 0 CA--C 1.541 1.679 0 CA-C-N 114.931 -1.031 . . . . 73.13 110.585 -174.482 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 220' ' ' PRO . . . . . . . . . . . . . 57.5 Cg_endo -67.18 170.5 13.09 Favored 'Trans proline' 0 C--N 1.377 2.055 0 C-N-CA 123.178 2.585 . . . . 54.23 113.485 -177.163 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 221' ' ' TYR . . . . . . . . . . . . . 13.7 p90 . . . . . 0 C--O 1.252 1.192 0 CA-C-O 121.321 0.581 . . . . 72.32 111.265 -175.054 . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 3' ' ' ASN . . . . . 0.495 ' HB3' ' O ' ' A' ' 24' ' ' LEU . 13.2 m120 . . . . . 0 CA--C 1.552 1.046 0 CA-C-O 119.328 -0.367 . . . . 72.34 111.936 . . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 42.9 Cg_endo -66.71 119.36 6.38 Favored 'Trans proline' 0 C--N 1.384 2.443 0 C-N-CA 122.973 2.449 . . . . 74.53 111.049 175.572 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 5' ' ' THR . . . . . 0.425 ' O ' ' HB2' ' A' ' 163' ' ' GLN . 97.5 m -98.6 127.82 44.68 Favored 'General case' 0 CA--C 1.537 0.444 0 N-CA-C 109.239 -0.652 . . . . 74.13 109.239 -178.934 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 6' ' ' VAL . . . . . 0.493 ' HA ' ' HB2' ' A' ' 163' ' ' GLN . 14.1 m -102.13 123.13 55.17 Favored 'Isoleucine or valine' 0 C--N 1.351 0.652 0 C-N-CA 123.972 0.909 . . . . 74.23 109.563 178.252 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 7' ' ' PHE . . . . . 0.581 ' H ' ' HA ' ' A' ' 163' ' ' GLN . 57.5 t80 -102.79 137.27 41.22 Favored 'General case' 0 C--O 1.24 0.597 0 CA-C-N 115.058 -0.974 . . . . 72.24 108.905 -178.49 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 51.2 m-85 -136.59 164.78 27.4 Favored 'General case' 0 C--O 1.24 0.563 0 O-C-N 124.534 1.146 . . . . 74.31 109.971 174.32 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 24.6 m-20 -112.96 109.06 18.23 Favored 'General case' 0 C--N 1.324 -0.511 0 N-CA-C 106.263 -1.754 . . . . 72.11 106.263 169.976 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 10' ' ' ILE . . . . . 0.436 HG21 ' SD ' ' A' ' 142' ' ' MET . 46.7 mm -78.95 129.43 37.58 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.479 0 N-CA-C 108.013 -1.106 . . . . 73.5 108.013 177.555 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 11' ' ' ALA . . . . . 0.745 ' HB2' ' HB3' ' A' ' 159' ' ' ALA . . . -124.53 133.54 53.28 Favored 'General case' 0 C--O 1.217 -0.654 0 C-N-CA 123.849 0.86 . . . . 54.3 110.785 -171.782 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 12' ' ' VAL . . . . . 0.454 HG13 ' HB3' ' A' ' 154' ' ' LYS . 53.4 t -97.53 117.59 42.51 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.64 0 C-N-CA 124.236 1.014 . . . . 72.32 108.983 172.128 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 13' ' ' ASP . . . . . 0.463 ' HA ' ' HB3' ' A' ' 155' ' ' LYS . 31.6 m-20 54.97 38.93 31.29 Favored 'General case' 0 N--CA 1.484 1.257 0 C-N-CA 125.288 1.435 . . . . 64.14 111.211 -174.372 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 84.07 -14.51 43.6 Favored Glycine 0 C--N 1.353 1.508 0 CA-C-N 115.292 -0.867 . . . . 60.24 113.964 179.479 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 18.4 mm-40 -89.89 122.15 68.18 Favored Pre-proline 0 N--CA 1.474 0.756 0 CA-C-O 118.347 -0.835 . . . . 63.31 109.865 -178.896 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_exo -50.42 109.55 0.3 Allowed 'Trans proline' 0 C--N 1.378 2.119 0 C-N-CA 123.786 2.99 . . . . 65.35 113.397 -178.056 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 42.6 tp -77.11 -45.08 28.13 Favored 'General case' 0 N--CA 1.477 0.924 0 C-N-CA 123.647 0.779 . . . . 74.32 109.503 175.99 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -177.3 -172.45 41.86 Favored Glycine 0 C--N 1.343 0.961 0 CA-C-N 115.519 -0.764 . . . . 63.23 112.227 -179.933 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 19' ' ' ARG . . . . . 0.498 ' HB3' ' HE1' ' A' ' 7' ' ' PHE . 54.3 mtt180 -118.71 138.39 52.67 Favored 'General case' 0 N--CA 1.473 0.69 0 C-N-CA 124.185 0.994 . . . . 75.04 110.423 -174.02 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 36.7 t -135.29 144.23 34.77 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.819 0 C-N-CA 124.065 0.946 . . . . 75.14 109.09 178.328 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 75.1 m -128.94 126.41 39.58 Favored 'General case' 0 CA--C 1.549 0.933 0 C-N-CA 123.688 0.795 . . . . 62.21 108.931 172.185 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 70.4 m-85 -106.66 121.94 45.36 Favored 'General case' 0 N--CA 1.475 0.792 0 C-N-CA 123.909 0.884 . . . . 71.34 110.106 178.969 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 23' ' ' GLU . . . . . 0.455 ' HG3' ' HB2' ' A' ' 3' ' ' ASN . 39.7 tt0 -75.92 113.4 13.37 Favored 'General case' 0 CA--C 1.552 1.055 0 C-N-CA 123.764 0.825 . . . . 75.43 109.487 171.456 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . 0.495 ' O ' ' HB3' ' A' ' 3' ' ' ASN . 37.4 mt -91.39 123.5 34.86 Favored 'General case' 0 N--CA 1.482 1.127 0 C-N-CA 123.538 0.735 . . . . 74.32 110.305 179.452 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 25' ' ' PHE . . . . . 0.452 ' HD1' ' HZ3' ' A' ' 28' ' ' LYS . 79.3 m-85 -79.72 70.98 6.34 Favored 'General case' 0 N--CA 1.476 0.863 0 C-N-CA 123.688 0.795 . . . . 74.24 111.15 -178.506 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -74.99 1.44 12.92 Favored 'General case' 0 N--CA 1.483 1.196 0 C-N-CA 123.55 0.74 . . . . 74.43 112.172 -179.666 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 11.3 p-10 -89.55 -27.81 20.02 Favored 'General case' 0 CA--C 1.551 1.007 0 C-N-CA 123.537 0.735 . . . . 73.32 110.568 172.791 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 28' ' ' LYS . . . . . 0.452 ' HZ3' ' HD1' ' A' ' 25' ' ' PHE . 57.4 mttp -100.72 -39.33 7.9 Favored 'General case' 0 N--CA 1.485 1.3 0 C-N-CA 123.362 0.665 . . . . 74.2 110.845 -176.546 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 29' ' ' VAL . . . . . 0.517 HG22 ' HA ' ' A' ' 129' ' ' PHE . 12.0 m -137.44 61.82 33.65 Favored Pre-proline 0 CA--C 1.56 1.341 0 C-N-CA 124.341 1.056 . . . . 75.11 110.355 -176.367 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 20.7 Cg_endo -58.9 -23.81 69.54 Favored 'Trans proline' 0 C--N 1.387 2.561 0 C-N-CA 122.559 2.173 . . . . 72.0 113.733 -178.076 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 86.4 tttt -68.66 -56.47 8.07 Favored 'General case' 0 N--CA 1.477 0.912 0 C-N-CA 122.79 0.436 . . . . 73.1 110.688 179.662 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 5.7 m -74.06 -33.2 63.61 Favored 'General case' 0 CA--C 1.552 1.05 0 CA-C-N 115.418 -0.81 . . . . 74.31 111.177 -173.784 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -72.04 -46.62 56.35 Favored 'General case' 0 CA--C 1.546 0.816 0 C-N-CA 123.651 0.78 . . . . 75.35 111.056 179.948 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 34.4 tt0 -64.38 -37.31 87.06 Favored 'General case' 0 N--CA 1.487 1.419 0 C-N-CA 123.187 0.595 . . . . 74.14 110.652 178.497 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 35' ' ' ASN . . . . . 0.467 ' O ' ' HG ' ' A' ' 39' ' ' LEU . 38.8 t30 -51.61 -64.44 0.81 Allowed 'General case' 0 C--N 1.36 1.022 0 O-C-N 124.559 1.162 . . . . 74.11 110.14 177.232 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 86.9 t80 -61.09 -35.99 78.48 Favored 'General case' 0 CA--C 1.544 0.712 0 C-N-CA 123.92 0.888 . . . . 74.12 111.88 -177.808 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 77.3 ttt180 -64.93 -43.69 91.93 Favored 'General case' 0 N--CA 1.474 0.751 0 C-N-CA 123.715 0.806 . . . . 74.55 111.436 -177.922 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 38' ' ' ALA . . . . . 0.466 ' HB3' ' HG2' ' A' ' 44' ' ' LYS . . . -78.21 -27.84 47.86 Favored 'General case' 0 N--CA 1.474 0.755 0 C-N-CA 123.32 0.648 . . . . 73.43 111.209 -177.525 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 39' ' ' LEU . . . . . 0.467 ' HG ' ' O ' ' A' ' 35' ' ' ASN . 88.5 mt -66.02 -43.29 88.05 Favored 'General case' 0 CA--C 1.549 0.908 0 C-N-CA 123.437 0.695 . . . . 63.43 109.973 169.877 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 16.3 t -62.7 -51.88 65.47 Favored 'General case' 0 N--CA 1.476 0.855 0 C-N-CA 125.22 1.408 . . . . 74.12 111.336 -178.095 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 25.4 p -77.17 -32.95 56.5 Favored 'General case' 0 CA--C 1.536 0.424 0 CA-C-N 115.559 -0.746 . . . . 73.04 111.667 -176.167 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 88.42 26.97 26.39 Favored Glycine 0 C--N 1.346 1.116 0 O-C-N 123.406 0.441 . . . . 52.23 112.558 -175.33 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 22.8 mm-40 -63.59 -22.65 67.01 Favored 'General case' 0 N--CA 1.482 1.165 0 C-N-CA 123.471 0.708 . . . . 72.32 111.495 173.506 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 44' ' ' LYS . . . . . 0.466 ' HG2' ' HB3' ' A' ' 38' ' ' ALA . 31.0 mmmt -105.69 17.09 24.32 Favored 'General case' 0 CA--C 1.545 0.756 0 C-N-CA 123.998 0.919 . . . . 73.13 110.905 179.241 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 81.55 -25.86 3.74 Favored Glycine 0 C--N 1.355 1.593 0 N-CA-C 114.641 0.617 . . . . 72.32 114.641 175.661 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 16.4 m-85 -64.94 -44.03 90.79 Favored 'General case' 0 N--CA 1.48 1.055 0 C-N-CA 123.406 0.682 . . . . 72.53 111.186 -171.354 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 56.87 64.66 4.2 Favored Glycine 0 C--N 1.356 1.673 0 O-C-N 123.958 0.786 . . . . 62.22 114.34 166.049 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 51.4 m-85 -62.44 87.59 0.02 OUTLIER 'General case' 0 N--CA 1.48 1.075 0 CA-C-O 122.33 1.062 . . . . 75.54 111.426 -178.721 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 28.5 tptp -111.4 117.15 32.29 Favored 'General case' 0 C--O 1.235 0.33 0 CA-C-N 113.452 -1.703 . . . . 75.41 107.775 178.762 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 79.46 20.75 68.4 Favored Glycine 0 C--N 1.339 0.742 0 CA-C-O 119.698 -0.501 . . . . 72.1 112.877 -177.088 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 34.5 t -55.83 115.4 2.36 Favored 'General case' 0 C--N 1.357 0.921 0 C-N-CA 123.365 0.666 . . . . 73.33 109.387 178.078 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 52' ' ' CYS . . . . . 0.737 ' SG ' ' HB3' ' A' ' 66' ' ' ASP . 2.3 p -86.54 138.6 31.59 Favored 'General case' 0 C--O 1.242 0.685 0 O-C-N 124.255 0.972 . . . . 73.23 111.491 -172.495 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 53' ' ' PHE . . . . . 0.662 ' HA ' ' HA2' ' A' ' 64' ' ' GLY . 36.6 m-85 -89.29 99.09 12.15 Favored 'General case' 0 N--CA 1.451 -0.415 0 C-N-CA 125.338 1.455 . . . . 74.42 107.988 175.544 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 43.8 p-80 -82.49 -31.11 29.49 Favored 'General case' 0 N--CA 1.476 0.841 0 C-N-CA 123.608 0.763 . . . . 71.31 111.342 -177.098 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 55' ' ' ARG . . . . . 0.4 ' HA ' ' O ' ' A' ' 150' ' ' GLY . 52.5 ttt180 -122.92 98.43 5.9 Favored 'General case' 0 C--O 1.21 -0.979 0 C-N-CA 122.885 0.474 . . . . 75.22 109.85 -173.97 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 56' ' ' ILE . . . . . 0.467 HG22 ' HA ' ' A' ' 143' ' ' GLU . 38.8 mt -127.87 138.95 53.24 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.717 0 N-CA-C 109.296 -0.631 . . . . 75.51 109.296 173.139 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 57' ' ' ILE . . . . . 0.56 HG21 ' HA ' ' A' ' 148' ' ' ARG . 64.1 mt -134.08 113.71 12.57 Favored Pre-proline 0 CA--C 1.557 1.24 0 C-N-CA 125.133 1.373 . . . . 72.0 108.781 -174.694 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 58' ' ' PRO . . . . . 0.565 ' HA ' ' HG2' ' A' ' 143' ' ' GLU . 56.0 Cg_endo -66.17 131.46 26.9 Favored 'Trans proline' 0 C--N 1.386 2.516 0 C-N-CA 123.641 2.894 . . . . 73.45 113.357 -173.104 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 78.03 31.31 48.54 Favored Glycine 0 C--N 1.345 1.08 0 CA-C-N 115.387 -0.824 . . . . 72.55 112.696 -178.58 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 20.2 t80 -157.71 -73.73 0.09 Allowed 'General case' 0 CA--C 1.545 0.772 0 CA-C-N 116.781 0.291 . . . . 72.54 111.393 -174.533 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 43.6 ttp -159.59 138.8 11.13 Favored 'General case' 0 N--CA 1.481 1.09 0 C-N-CA 122.679 0.392 . . . . 72.22 111.299 -166.057 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 62' ' ' CYS . . . . . 0.638 ' SG ' ' HB ' ' A' ' 114' ' ' ILE . 5.4 p -116.31 111.65 20.42 Favored 'General case' 0 CA--C 1.554 1.099 0 C-N-CA 123.494 0.718 . . . . 53.21 109.429 169.572 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 63' ' ' GLN . . . . . 0.411 ' HA ' ' HA ' ' A' ' 113' ' ' PHE . 54.2 tt0 -109.34 117.71 34.77 Favored 'General case' 0 N--CA 1.487 1.379 0 C-N-CA 124.438 1.095 . . . . 72.44 110.897 -173.342 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 64' ' ' GLY . . . . . 0.662 ' HA2' ' HA ' ' A' ' 53' ' ' PHE . . . -106.73 -176.3 23.08 Favored Glycine 0 C--N 1.345 1.073 0 CA-C-N 115.713 -0.676 . . . . 62.11 113.34 179.621 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 84.4 91.5 0.76 Allowed Glycine 0 C--N 1.341 0.859 0 N-CA-C 110.446 -1.062 . . . . 54.02 110.446 -174.566 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 66' ' ' ASP . . . . . 0.737 ' HB3' ' SG ' ' A' ' 52' ' ' CYS . 32.9 t70 -128.56 -56.89 1.21 Allowed 'General case' 0 N--CA 1.473 0.718 0 C-N-CA 122.938 0.495 . . . . 65.44 110.532 176.019 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 65.7 t80 -40.25 -57.32 1.75 Allowed 'General case' 0 N--CA 1.485 1.307 0 C-N-CA 125.344 1.458 . . . . 75.34 114.196 -170.756 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 26.4 m -79.93 107.2 12.52 Favored 'General case' 0 C--O 1.243 0.738 0 CA-C-O 120.862 0.363 . . . . 72.12 110.992 -174.782 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 69' ' ' ARG . . . . . 0.413 ' HD2' ' HD2' ' A' ' 76' ' ' LYS . 62.6 mtt-85 54.29 71.67 0.51 Allowed 'General case' 0 N--CA 1.472 0.669 0 C-N-CA 125.929 1.692 . . . . 63.12 112.147 173.245 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 70' ' ' HIS . . . . . 0.43 ' HB3' ' O ' ' A' ' 66' ' ' ASP . 15.9 p-80 -85.34 17.5 3.09 Favored 'General case' 0 N--CA 1.481 1.118 0 N-CA-C 113.198 0.814 . . . . 73.15 113.198 -172.438 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 44.4 t30 -77.0 73.18 3.58 Favored 'General case' 0 N--CA 1.481 1.099 0 CA-C-O 121.561 0.696 . . . . 75.3 109.561 173.435 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 72' ' ' GLY . . . . . 0.54 ' HA2' ' HG2' ' B' ' 218' ' ' PRO . . . 63.68 20.79 64.36 Favored Glycine 0 C--N 1.346 1.092 0 CA-C-N 115.208 -0.905 . . . . 64.33 114.505 -179.071 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 37.1 m -125.03 -66.25 0.97 Allowed 'General case' 0 CA--C 1.542 0.669 0 C-N-CA 123.16 0.584 . . . . 73.34 109.459 -177.357 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 51.64 60.42 7.42 Favored Glycine 0 C--N 1.355 1.636 0 O-C-N 124.275 0.984 . . . . 51.52 113.543 177.589 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 132.21 53.03 0.08 OUTLIER Glycine 0 N--CA 1.469 0.899 0 CA-C-N 118.049 0.924 . . . . 64.4 112.35 -176.387 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 76' ' ' LYS . . . . . 0.661 ' HB2' ' HZ3' ' A' ' 76' ' ' LYS . 0.0 OUTLIER -51.57 149.47 4.4 Favored 'General case' 0 N--CA 1.481 1.125 0 C-N-CA 123.75 0.82 . . . . 74.42 111.49 177.242 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 92.0 p -91.45 176.01 6.71 Favored 'General case' 0 CA--C 1.538 0.509 0 CA-C-O 121.361 0.6 . . . . 74.33 111.163 -168.542 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 78' ' ' ILE . . . . . 0.432 HG23 ' HB1' ' A' ' 38' ' ' ALA . 25.5 pt -75.93 -18.05 15.44 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.615 0 CA-C-N 115.45 -0.795 . . . . 75.23 110.218 174.329 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 85.1 m-85 -87.76 -14.82 38.69 Favored 'General case' 0 N--CA 1.472 0.642 0 C-N-CA 124.291 1.036 . . . . 74.21 110.607 177.601 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 147.36 -112.39 0.59 Allowed Glycine 0 C--N 1.348 1.199 0 N-CA-C 110.612 -0.995 . . . . 72.52 110.612 178.817 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 32.1 tt0 -89.1 -50.72 5.99 Favored 'General case' 0 CA--C 1.539 0.533 0 CA-C-O 121.657 0.741 . . . . 75.1 109.358 176.017 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 82' ' ' LYS . . . . . 0.42 ' HD2' ' HA ' ' A' ' 107' ' ' THR . 23.7 pttm -151.88 177.46 10.41 Favored 'General case' 0 N--CA 1.47 0.541 0 CA-C-N 114.336 -1.302 . . . . 73.32 109.791 -169.335 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 45.7 p90 -158.43 170.7 21.62 Favored 'General case' 0 N--CA 1.476 0.836 0 C-N-CA 123.492 0.717 . . . . 71.24 110.362 176.468 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 84' ' ' GLU . . . . . 0.562 ' HA ' ' HA ' ' A' ' 106' ' ' ASN . 9.7 pt-20 -82.73 160.46 22.34 Favored 'General case' 0 N--CA 1.474 0.747 0 C-N-CA 122.899 0.48 . . . . 74.31 111.036 178.226 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 52.3 m-20 -65.23 131.73 47.25 Favored 'General case' 0 C--O 1.239 0.511 0 CA-C-N 114.802 -1.09 . . . . 73.24 110.298 177.509 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 10.9 tp10 -72.33 -58.13 3.65 Favored 'General case' 0 C--O 1.239 0.503 0 O-C-N 124.166 0.916 . . . . 74.1 109.323 175.224 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 32.3 p30 -159.02 -173.77 4.41 Favored 'General case' 0 C--O 1.237 0.405 0 CA-C-N 114.437 -1.256 . . . . 75.15 108.966 -175.97 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 89.0 m-85 -137.56 61.26 1.61 Allowed 'General case' 0 N--CA 1.477 0.886 0 C-N-CA 123.602 0.761 . . . . 74.21 108.982 173.193 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 62.5 mt -78.77 -54.32 12.09 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.151 0 CA-C-O 121.383 0.611 . . . . 75.21 109.909 177.495 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 90' ' ' LEU . . . . . 0.479 ' HB3' ' HB ' ' A' ' 128' ' ' VAL . 94.3 mt -89.05 140.88 28.99 Favored 'General case' 0 C--O 1.236 0.37 0 CA-C-N 115.067 -0.97 . . . . 70.53 111.389 -172.672 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 16.8 ptpt -139.63 170.56 15.68 Favored 'General case' 0 CA--C 1.541 0.612 0 C-N-CA 124.113 0.965 . . . . 74.13 110.83 -173.571 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 92' ' ' HIS . . . . . 0.568 ' HA ' HG21 ' A' ' 97' ' ' ILE . 13.2 m80 -92.12 53.72 2.22 Favored 'General case' 0 N--CA 1.48 1.041 0 C-N-CA 124.791 1.236 . . . . 72.24 110.78 -167.528 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 3.8 p -94.52 20.32 8.58 Favored 'General case' 0 N--CA 1.481 1.103 0 C-N-CA 124.196 0.998 . . . . 71.21 113.286 -174.125 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -163.93 178.92 39.17 Favored Glycine 0 C--N 1.344 0.974 0 C-N-CA 121.018 -0.611 . . . . 63.15 113.652 -178.214 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 95' ' ' PRO . . . . . 0.484 ' HB2' ' HE3' ' A' ' 136' ' ' MET . 85.0 Cg_endo -81.64 138.5 10.73 Favored 'Trans proline' 0 C--N 1.369 1.657 0 C-N-CA 123.046 2.497 . . . . 74.44 112.805 175.935 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 96' ' ' GLY . . . . . 0.486 ' HA3' HG11 ' A' ' 132' ' ' VAL . . . 80.28 20.12 67.75 Favored Glycine 0 C--N 1.35 1.316 0 CA-C-N 116.04 -0.527 . . . . 75.43 113.692 174.1 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 97' ' ' ILE . . . . . 0.568 HG21 ' HA ' ' A' ' 92' ' ' HIS . 21.7 mm -66.87 105.62 0.73 Allowed 'Isoleucine or valine' 0 CA--C 1.549 0.914 0 C-N-CA 124.518 1.127 . . . . 64.23 110.613 178.077 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 98' ' ' LEU . . . . . 0.43 HD11 HG12 ' A' ' 114' ' ' ILE . 59.2 tp -87.17 101.47 13.53 Favored 'General case' 0 CA--C 1.55 0.973 0 CA-C-O 121.894 0.855 . . . . 71.14 109.532 177.089 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 99' ' ' SER . . . . . 0.523 ' HB2' HG22 ' A' ' 128' ' ' VAL . 33.0 t -106.07 170.39 7.94 Favored 'General case' 0 N--CA 1.472 0.664 0 C-N-CA 124.965 1.306 . . . . 65.23 108.67 176.141 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 100' ' ' MET . . . . . 0.497 ' SD ' ' HA2' ' A' ' 109' ' ' GLY . 4.4 ttt -113.53 135.68 53.63 Favored 'General case' 0 N--CA 1.482 1.125 0 CA-C-N 118.356 0.525 . . . . 64.1 110.048 -178.175 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 101' ' ' ALA . . . . . 0.433 ' HB3' ' HB2' ' A' ' 111' ' ' GLN . . . -84.35 -178.95 7.07 Favored 'General case' 0 C--O 1.244 0.811 0 C-N-CA 123.764 0.826 . . . . 43.4 111.105 -173.79 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 25.8 p-10 -168.84 -178.83 3.49 Favored 'General case' 0 CA--C 1.539 0.552 0 CA-C-N 115.166 -0.925 . . . . 75.23 111.369 -168.322 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 103' ' ' ALA . . . . . 0.461 ' HB3' HG23 ' A' ' 107' ' ' THR . . . -124.46 13.2 8.78 Favored 'General case' 0 N--CA 1.479 1.002 0 C-N-CA 124.249 1.02 . . . . 71.22 109.496 161.94 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 145.39 178.07 20.64 Favored Glycine 0 C--N 1.352 1.424 0 CA-C-O 119.065 -0.853 . . . . 74.14 111.539 -179.556 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 32.5 Cg_exo -61.19 149.91 87.05 Favored 'Trans proline' 0 C--N 1.375 1.962 0 C-N-CA 123.198 2.599 . . . . 75.13 111.731 169.496 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 106' ' ' ASN . . . . . 0.562 ' HA ' ' HA ' ' A' ' 84' ' ' GLU . 65.6 t30 62.87 21.87 13.09 Favored 'General case' 0 CA--C 1.557 1.249 0 O-C-N 124.168 0.917 . . . . 62.11 110.325 -174.031 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 107' ' ' THR . . . . . 0.461 HG23 ' HB3' ' A' ' 103' ' ' ALA . 12.2 m -142.15 24.11 1.99 Allowed 'General case' 0 CA--C 1.555 1.137 0 C-N-CA 125.066 1.346 . . . . 74.54 109.094 178.154 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 61.1 t30 -80.27 147.95 30.97 Favored 'General case' 0 N--CA 1.476 0.851 0 C-N-CA 123.739 0.816 . . . . 74.32 109.46 176.534 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 109' ' ' GLY . . . . . 0.497 ' HA2' ' SD ' ' A' ' 100' ' ' MET . . . 106.49 -14.24 42.83 Favored Glycine 0 N--CA 1.472 1.04 0 CA-C-O 119.946 -0.363 . . . . 54.02 113.805 177.608 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 38.6 p -94.81 120.18 34.61 Favored 'General case' 0 CA--C 1.543 0.699 0 C-N-CA 123.382 0.673 . . . . 73.23 109.361 177.861 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 111' ' ' GLN . . . . . 0.638 HE22 ' HB2' ' B' ' 218' ' ' PRO . 27.8 mt-30 66.95 162.95 0.18 Allowed 'General case' 0 N--CA 1.497 1.906 0 C-N-CA 125.044 1.338 . . . . 75.31 111.408 -170.491 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 44.9 p90 -144.5 150.29 37.34 Favored 'General case' 0 N--CA 1.484 1.233 0 N-CA-C 108.362 -0.977 . . . . 73.12 108.362 178.19 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 113' ' ' PHE . . . . . 0.411 ' HA ' ' HA ' ' A' ' 63' ' ' GLN . 51.3 p90 -140.98 142.37 34.29 Favored 'General case' 0 N--CA 1.472 0.644 0 N-CA-C 111.969 0.359 . . . . 73.35 111.969 -175.895 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 114' ' ' ILE . . . . . 0.638 ' HB ' ' SG ' ' A' ' 62' ' ' CYS . 12.1 mt -111.98 105.02 17.98 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.733 0 C-N-CA 124.168 0.987 . . . . 73.44 109.127 -178.391 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 115' ' ' CYS . . . . . . . . . . . . . 69.5 m -75.71 107.89 8.19 Favored 'General case' 0 CA--C 1.541 0.597 0 N-CA-C 109.171 -0.677 . . . . 75.14 109.171 173.335 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 72.3 p -78.6 -10.71 59.84 Favored 'General case' 0 N--CA 1.481 1.078 0 C-N-CA 123.379 0.672 . . . . 63.41 111.681 -179.559 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -125.46 166.92 15.76 Favored 'General case' 0 C--O 1.243 0.746 0 C-N-CA 123.358 0.663 . . . . 73.42 109.741 176.37 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 11.3 ptmt -71.72 74.49 0.83 Allowed 'General case' 0 CA--C 1.548 0.893 0 C-N-CA 124.003 0.921 . . . . 72.22 110.097 174.829 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 119' ' ' THR . . . . . 0.543 ' HB ' HD23 ' A' ' 122' ' ' LEU . 41.1 p -76.53 90.66 3.32 Favored 'General case' 0 CA--C 1.546 0.821 0 CA-C-O 121.928 0.871 . . . . 74.32 109.588 -177.514 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 9.6 pt-20 -71.82 -32.11 67.23 Favored 'General case' 0 N--CA 1.472 0.648 0 CA-C-N 115.057 -0.974 . . . . 62.12 112.19 -173.987 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 121' ' ' TRP . . . . . . . . . . . . . 27.4 p90 -74.09 -4.82 37.94 Favored 'General case' 0 N--CA 1.479 0.99 0 C-N-CA 122.757 0.423 . . . . 75.33 111.058 176.793 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 122' ' ' LEU . . . . . 0.543 HD23 ' HB ' ' A' ' 119' ' ' THR . 3.8 mm? -86.88 -15.67 38.35 Favored 'General case' 0 N--CA 1.477 0.878 0 C-N-CA 123.761 0.824 . . . . 70.0 111.394 173.347 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 41.4 m-20 -72.41 149.39 44.32 Favored 'General case' 0 N--CA 1.482 1.134 0 N-CA-C 109.767 -0.457 . . . . 65.04 109.767 176.105 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 93.93 -26.9 14.4 Favored Glycine 0 N--CA 1.47 0.912 0 N-CA-C 111.628 -0.589 . . . . 60.25 111.628 -171.274 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 125' ' ' LYS . . . . . 0.508 ' HD2' ' HE2' ' B' ' 221' ' ' TYR . 1.8 mppt? -80.1 -169.89 2.24 Favored 'General case' 0 N--CA 1.478 0.951 0 C-N-CA 123.902 0.881 . . . . 75.54 109.709 172.387 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 126' ' ' HIS . . . . . . . . . . . . . 0.6 OUTLIER -69.34 145.68 52.77 Favored 'General case' 0 C--O 1.242 0.673 0 C-N-CA 123.372 0.669 . . . . 75.23 111.79 -167.51 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 11.1 p -65.32 145.19 14.12 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.726 0 CA-C-N 113.656 -1.611 . . . . 74.22 112.361 -165.521 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 128' ' ' VAL . . . . . 0.523 HG22 ' HB2' ' A' ' 99' ' ' SER . 60.2 t -74.25 150.22 7.43 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.53 0 CA-C-N 114.569 -1.196 . . . . 74.02 108.932 172.791 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 129' ' ' PHE . . . . . 0.517 ' HA ' HG22 ' A' ' 29' ' ' VAL . 45.5 p90 -133.59 -10.76 2.78 Favored 'General case' 0 N--CA 1.476 0.831 0 C-N-CA 122.202 0.201 . . . . 74.42 111.424 -179.396 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . -146.3 170.93 27.3 Favored Glycine 0 C--N 1.343 0.941 0 O-C-N 123.559 0.537 . . . . 75.33 112.751 -173.357 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 29.4 ttpt -161.19 134.21 6.34 Favored 'General case' 0 C--N 1.325 -0.46 0 C-N-CA 124.346 1.058 . . . . 74.32 108.235 -175.959 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 132' ' ' VAL . . . . . 0.486 HG11 ' HA3' ' A' ' 96' ' ' GLY . 13.7 p -68.41 131.02 33.82 Favored 'Isoleucine or valine' 0 CA--C 1.554 1.124 0 CA-C-N 118.329 0.513 . . . . 71.21 109.959 175.107 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -91.62 -48.82 6.63 Favored 'General case' 0 N--CA 1.48 1.061 0 N-CA-C 108.975 -0.75 . . . . 70.45 108.975 173.306 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 3.2 mp0 -146.63 155.85 42.76 Favored 'General case' 0 C--O 1.243 0.747 0 C-N-CA 124.983 1.313 . . . . 73.12 108.544 177.052 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 94.24 12.22 56.47 Favored Glycine 0 C--N 1.342 0.877 0 CA-C-N 115.926 -0.579 . . . . 51.42 112.376 -174.546 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 136' ' ' MET . . . . . 0.484 ' HE3' ' HB2' ' A' ' 95' ' ' PRO . 15.0 tpt -62.5 -31.1 71.8 Favored 'General case' 0 N--CA 1.48 1.031 0 C-N-CA 123.847 0.859 . . . . 75.32 111.192 178.522 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 137' ' ' ASN . . . . . . . . . . . . . 26.6 t-20 -55.51 -42.22 74.18 Favored 'General case' 0 N--CA 1.479 0.994 0 C-N-CA 123.964 0.906 . . . . 74.23 110.506 174.238 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 138' ' ' ILE . . . . . . . . . . . . . 44.9 mm -74.19 -32.85 33.24 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.73 0 CA-C-N 115.232 -0.895 . . . . 72.33 110.691 -178.95 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 69.3 t -64.55 -41.43 92.25 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.366 0 C-N-CA 123.471 0.709 . . . . 75.33 110.495 176.347 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 38.3 mt-10 -69.92 -39.22 76.29 Favored 'General case' 0 N--CA 1.473 0.722 0 CA-C-N 115.311 -0.859 . . . . 65.1 110.747 177.681 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -65.06 -52.45 55.67 Favored 'General case' 0 N--CA 1.475 0.784 0 O-C-N 123.681 0.613 . . . . 74.1 110.632 -179.568 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 142' ' ' MET . . . . . 0.575 ' HE2' HG22 ' A' ' 156' ' ' ILE . 27.6 ptm -59.73 -37.66 79.57 Favored 'General case' 0 N--CA 1.477 0.888 0 C-N-CA 123.055 0.542 . . . . 71.31 110.538 179.144 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 143' ' ' GLU . . . . . 0.565 ' HG2' ' HA ' ' A' ' 58' ' ' PRO . 39.4 tt0 -62.74 -35.76 80.8 Favored 'General case' 0 CA--C 1.546 0.822 0 CA-C-O 121.253 0.549 . . . . 74.02 112.144 -176.966 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 144' ' ' ARG . . . . . 0.546 ' HA ' ' HB3' ' A' ' 58' ' ' PRO . 62.3 mtt180 -73.58 -7.31 51.38 Favored 'General case' 0 CA--C 1.547 0.828 0 CA-C-N 115.769 -0.65 . . . . 73.15 112.711 -178.236 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 145' ' ' PHE . . . . . 0.517 ' HB2' HD11 ' A' ' 156' ' ' ILE . 55.0 m-85 -89.2 6.74 38.74 Favored 'General case' 0 CA--C 1.558 1.251 0 C-N-CA 123.07 0.548 . . . . 74.53 111.933 172.416 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . -102.5 -175.23 27.25 Favored Glycine 0 C--N 1.355 1.608 0 CA-C-N 117.646 0.203 . . . . 31.43 112.708 177.842 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 31.0 m -132.91 168.99 17.44 Favored 'General case' 0 N--CA 1.489 1.496 0 C-N-CA 124.202 1.001 . . . . 74.1 110.3 179.84 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 148' ' ' ARG . . . . . 0.56 ' HA ' HG21 ' A' ' 57' ' ' ILE . 21.9 mmt85 -65.98 -33.97 77.04 Favored 'General case' 0 N--CA 1.487 1.4 0 C-N-CA 123.845 0.858 . . . . 71.44 112.758 -175.143 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 149' ' ' ASN . . . . . . . . . . . . . 30.9 p-10 -74.7 -15.75 60.78 Favored 'General case' 0 N--CA 1.484 1.272 0 C-N-CA 123.411 0.684 . . . . 70.12 111.325 175.148 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 150' ' ' GLY . . . . . 0.4 ' O ' ' HA ' ' A' ' 55' ' ' ARG . . . 109.67 -17.06 30.86 Favored Glycine 0 C--N 1.344 1.004 0 CA-C-N 115.671 -0.695 . . . . 64.34 112.462 -179.962 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 66.2 tttp -60.3 124.01 19.0 Favored 'General case' 0 N--CA 1.474 0.769 0 CA-C-N 117.417 0.609 . . . . 72.51 110.918 -177.955 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 152' ' ' THR . . . . . 0.43 HG21 ' HB ' ' A' ' 56' ' ' ILE . 14.0 p -89.56 118.02 28.89 Favored 'General case' 0 CA--C 1.538 0.482 0 C-N-CA 123.235 0.614 . . . . 72.35 109.567 -177.897 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 153' ' ' SER . . . . . . . . . . . . . 19.8 m -66.89 -19.07 65.66 Favored 'General case' 0 CA--C 1.549 0.921 0 C-N-CA 124.153 0.981 . . . . 74.44 111.724 178.77 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 154' ' ' LYS . . . . . 0.454 ' HB3' HG13 ' A' ' 12' ' ' VAL . 74.6 mmtt -128.58 144.14 51.09 Favored 'General case' 0 N--CA 1.48 1.067 0 C-N-CA 124.478 1.111 . . . . 75.55 108.666 176.498 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 155' ' ' LYS . . . . . 0.483 ' HB2' ' HZ1' ' A' ' 155' ' ' LYS . 0.0 OUTLIER -81.47 90.13 6.2 Favored 'General case' 0 N--CA 1.477 0.882 0 CA-C-O 121.54 0.686 . . . . 74.13 109.743 -177.269 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 156' ' ' ILE . . . . . 0.575 HG22 ' HE2' ' A' ' 142' ' ' MET . 66.3 mt -88.74 118.48 34.22 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.432 0 CA-C-N 115.855 -0.611 . . . . 72.35 109.449 -176.206 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 157' ' ' THR . . . . . . . . . . . . . 30.7 p -131.15 156.09 45.88 Favored 'General case' 0 C--O 1.239 0.534 0 C-N-CA 124.469 1.108 . . . . 74.23 109.382 -174.931 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 158' ' ' ILE . . . . . . . . . . . . . 60.1 mt -77.96 94.15 1.46 Allowed 'Isoleucine or valine' 0 CA--C 1.55 0.946 0 N-CA-C 108.926 -0.768 . . . . 74.41 108.926 172.572 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 159' ' ' ALA . . . . . 0.745 ' HB3' ' HB2' ' A' ' 11' ' ' ALA . . . -51.9 -40.88 61.43 Favored 'General case' 0 N--CA 1.488 1.439 0 C-N-CA 124.551 1.14 . . . . 74.44 113.03 -177.932 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 160' ' ' ASP . . . . . . . . . . . . . 25.3 t0 -164.36 157.74 17.87 Favored 'General case' 0 N--CA 1.478 0.958 0 C-N-CA 122.946 0.498 . . . . 73.12 110.311 178.718 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 161' ' ' CYS . . . . . . . . . . . . . 29.2 p -119.82 -169.97 1.87 Allowed 'General case' 0 N--CA 1.475 0.779 0 C-N-CA 124.774 1.229 . . . . 75.42 108.36 175.398 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 162' ' ' GLY . . . . . . . . . . . . . . . 132.49 55.02 0.08 OUTLIER Glycine 0 C--N 1.347 1.156 0 N-CA-C 111.095 -0.802 . . . . 64.3 111.095 -170.393 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 163' ' ' GLN . . . . . 0.581 ' HA ' ' H ' ' A' ' 7' ' ' PHE . 3.0 pt20 -49.63 137.49 15.54 Favored 'General case' 0 CA--C 1.55 0.961 0 N-CA-C 114.357 1.243 . . . . 63.54 114.357 -169.296 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 164' ' ' LEU . . . . . 0.401 ' O ' ' HB ' ' A' ' 5' ' ' THR . 85.2 mt . . . . . 0 N--CA 1.472 0.644 0 CA-C-N 115.859 -0.61 . . . . 73.12 110.114 -176.502 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 218' ' ' PRO . . . . . 0.638 ' HB2' HE22 ' A' ' 111' ' ' GLN . 50.2 Cg_exo . . . . . 0 CA--C 1.543 0.94 0 CA-C-O 121.209 0.42 . . . . 61.52 112.484 . . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 219' ' ' GLY . . . . . . . . . . . . . . . 169.37 -176.47 43.36 Favored Glycine 0 CA--C 1.524 0.607 0 N-CA-C 110.164 -1.174 . . . . 51.33 110.164 -178.489 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 220' ' ' PRO . . . . . . . . . . . . . 82.4 Cg_endo -79.56 -177.59 3.97 Favored 'Trans proline' 0 CA--C 1.553 1.425 0 C-N-CA 122.519 2.146 . . . . 75.25 113.88 175.211 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 221' ' ' TYR . . . . . 0.508 ' HE2' ' HD2' ' A' ' 125' ' ' LYS . 64.4 m-85 . . . . . 0 N--CA 1.476 0.872 0 C-N-CA 123.852 0.861 . . . . 74.25 110.237 -178.051 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 3' ' ' ASN . . . . . 0.624 ' ND2' ' HA ' ' A' ' 25' ' ' PHE . 9.7 m120 . . . . . 0 N--CA 1.478 0.954 0 CA-C-O 118.888 -0.577 . . . . 75.1 110.838 . . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 4' ' ' PRO . . . . . 0.635 ' HG2' ' HB2' ' A' ' 24' ' ' LEU . 67.2 Cg_endo -72.66 136.74 26.24 Favored 'Trans proline' 0 C--N 1.374 1.872 0 C-N-CA 122.144 1.896 . . . . 74.22 111.653 176.37 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 5' ' ' THR . . . . . 0.586 HG23 ' HD3' ' A' ' 133' ' ' LYS . 85.5 m -95.99 113.56 25.19 Favored 'General case' 0 C--O 1.236 0.368 0 N-CA-C 107.893 -1.151 . . . . 73.13 107.893 176.002 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 6' ' ' VAL . . . . . 0.546 ' HA ' ' HB2' ' A' ' 163' ' ' GLN . 13.7 m -98.62 121.1 48.8 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.51 0 CA-C-O 121.956 0.884 . . . . 75.23 109.328 -178.22 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 7' ' ' PHE . . . . . 0.432 ' HZ ' ' HD2' ' A' ' 19' ' ' ARG . 77.3 t80 -105.08 135.09 47.08 Favored 'General case' 0 C--O 1.239 0.52 0 CA-C-N 114.423 -1.262 . . . . 73.32 109.237 -173.328 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 8' ' ' PHE . . . . . 0.46 ' HB3' HG22 ' A' ' 158' ' ' ILE . 64.4 m-85 -142.27 165.25 27.94 Favored 'General case' 0 C--O 1.24 0.578 0 O-C-N 124.398 1.061 . . . . 73.21 109.757 176.11 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 17.4 m-20 -113.91 108.51 17.15 Favored 'General case' 0 N--CA 1.465 0.314 0 N-CA-C 107.625 -1.25 . . . . 71.11 107.625 171.637 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 10' ' ' ILE . . . . . 0.432 HG21 ' SD ' ' A' ' 142' ' ' MET . 47.3 mm -80.7 116.82 25.61 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.351 0 N-CA-C 108.313 -0.995 . . . . 63.41 108.313 -179.545 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 11' ' ' ALA . . . . . 0.698 ' HB1' ' HB2' ' A' ' 159' ' ' ALA . . . -116.04 109.92 18.2 Favored 'General case' 0 N--CA 1.469 0.493 0 C-N-CA 123.684 0.794 . . . . 74.05 111.941 -168.586 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 12' ' ' VAL . . . . . 0.473 HG22 HD23 ' A' ' 17' ' ' LEU . 89.6 t -96.04 128.91 46.81 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.467 0 N-CA-C 108.057 -1.09 . . . . 75.01 108.057 176.684 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 25.0 m-20 70.24 15.94 7.4 Favored 'General case' 0 N--CA 1.493 1.688 0 C-N-CA 124.218 1.007 . . . . 74.55 110.484 -172.325 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 81.29 -5.89 65.92 Favored Glycine 0 C--N 1.353 1.507 0 CA-C-N 116.005 -0.543 . . . . 65.42 112.754 -170.505 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 25.7 mm-40 -98.32 120.81 58.68 Favored Pre-proline 0 N--CA 1.471 0.599 0 C-N-CA 123.823 0.849 . . . . 75.12 109.437 -178.213 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 52.3 Cg_exo -51.21 105.19 0.1 OUTLIER 'Trans proline' 0 C--N 1.375 1.963 0 C-N-CA 123.257 2.638 . . . . 60.42 112.344 178.536 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 17' ' ' LEU . . . . . 0.473 HD23 HG22 ' A' ' 12' ' ' VAL . 26.9 tp -75.08 -31.69 61.27 Favored 'General case' 0 N--CA 1.472 0.67 0 C-N-CA 124.126 0.97 . . . . 73.13 109.573 -179.892 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -175.66 173.15 46.07 Favored Glycine 0 C--N 1.341 0.814 0 CA-C-N 115.071 -0.968 . . . . 64.52 112.054 175.925 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 19' ' ' ARG . . . . . 0.432 ' HD2' ' HZ ' ' A' ' 7' ' ' PHE . 47.6 mtm180 -107.2 124.39 49.66 Favored 'General case' 0 N--CA 1.471 0.595 0 N-CA-C 108.541 -0.911 . . . . 74.21 108.541 -179.095 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 71.3 t -120.74 141.45 41.11 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.881 0 C-N-CA 123.1 0.56 . . . . 72.22 109.9 -176.945 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 21' ' ' SER . . . . . 0.547 ' HB2' ' HB2' ' A' ' 134' ' ' GLU . 60.6 m -127.39 132.14 50.2 Favored 'General case' 0 C--O 1.245 0.828 0 C-N-CA 123.878 0.871 . . . . 64.53 109.39 173.533 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 17.3 m-85 -107.42 153.67 22.45 Favored 'General case' 0 N--CA 1.469 0.513 0 N-CA-C 108.338 -0.986 . . . . 72.23 108.338 177.729 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 5.8 tp10 -104.75 109.64 21.67 Favored 'General case' 0 C--O 1.239 0.543 0 N-CA-C 108.598 -0.889 . . . . 73.45 108.598 176.954 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . 0.635 ' HB2' ' HG2' ' A' ' 4' ' ' PRO . 29.6 mt -81.11 122.77 27.77 Favored 'General case' 0 N--CA 1.465 0.285 0 N-CA-C 108.784 -0.821 . . . . 70.0 108.784 175.309 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 25' ' ' PHE . . . . . 0.624 ' HA ' ' ND2' ' A' ' 3' ' ' ASN . 86.9 m-85 -84.91 65.46 9.2 Favored 'General case' 0 N--CA 1.467 0.377 0 C-N-CA 123.166 0.586 . . . . 75.21 110.468 179.888 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -64.17 -24.16 67.58 Favored 'General case' 0 N--CA 1.477 0.877 0 C-N-CA 123.418 0.687 . . . . 65.15 111.876 -179.799 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 10.9 p-10 -66.09 -25.73 67.15 Favored 'General case' 0 N--CA 1.476 0.853 0 C-N-CA 123.535 0.734 . . . . 74.44 111.33 177.467 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 52.4 mttm -102.32 -43.93 5.55 Favored 'General case' 0 N--CA 1.478 0.962 0 C-N-CA 124.163 0.985 . . . . 73.13 110.238 -179.433 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 29' ' ' VAL . . . . . 0.45 HG21 ' HA ' ' A' ' 129' ' ' PHE . 16.0 m -127.31 78.85 74.03 Favored Pre-proline 0 CA--C 1.556 1.194 0 C-N-CA 124.128 0.971 . . . . 63.42 109.942 -177.11 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 11.3 Cg_endo -55.21 -48.02 23.09 Favored 'Trans proline' 0 C--N 1.383 2.373 0 C-N-CA 123.038 2.492 . . . . 74.44 112.89 -177.792 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 31' ' ' LYS . . . . . 0.44 ' HG3' ' OH ' ' A' ' 79' ' ' TYR . 23.4 ttmm -76.86 -43.48 35.96 Favored 'General case' 0 N--CA 1.474 0.771 0 C-N-CA 123.967 0.907 . . . . 74.35 112.344 -172.631 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 9.1 m -69.14 -33.36 73.33 Favored 'General case' 0 CA--C 1.549 0.94 0 CA-C-O 120.867 0.365 . . . . 75.14 110.273 -176.062 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 33' ' ' ALA . . . . . 0.402 ' HB3' ' HB3' ' A' ' 24' ' ' LEU . . . -78.43 -34.52 47.81 Favored 'General case' 0 CA--C 1.55 0.976 0 CA-C-N 116.112 -0.494 . . . . 75.44 111.533 174.03 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 29.7 tt0 -60.32 -41.58 93.8 Favored 'General case' 0 N--CA 1.49 1.555 0 C-N-CA 124.421 1.088 . . . . 64.41 111.077 178.536 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 35' ' ' ASN . . . . . 0.467 ' O ' ' HG ' ' A' ' 39' ' ' LEU . 40.9 t30 -54.15 -60.16 3.7 Favored 'General case' 0 CA--C 1.537 0.448 0 CA-C-N 114.297 -1.32 . . . . 75.32 110.191 178.635 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 63.1 t80 -65.48 -32.51 74.16 Favored 'General case' 0 CA--C 1.545 0.76 0 CA-C-N 115.225 -0.898 . . . . 71.52 111.613 -176.695 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 37.0 ttm-85 -57.02 -50.98 71.06 Favored 'General case' 0 N--CA 1.482 1.139 0 C-N-CA 124.028 0.931 . . . . 75.4 110.346 177.195 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 38' ' ' ALA . . . . . 0.541 ' HB2' HG22 ' A' ' 78' ' ' ILE . . . -79.26 -23.33 43.73 Favored 'General case' 0 CA--C 1.545 0.766 0 CA-C-N 115.029 -0.987 . . . . 73.34 112.22 -175.24 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 39' ' ' LEU . . . . . 0.467 ' HG ' ' O ' ' A' ' 35' ' ' ASN . 85.7 mt -71.78 -40.19 69.42 Favored 'General case' 0 N--CA 1.483 1.221 0 C-N-CA 123.004 0.522 . . . . 73.22 110.158 172.899 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 28.8 t -65.48 -55.05 20.03 Favored 'General case' 0 N--CA 1.475 0.805 0 C-N-CA 124.513 1.125 . . . . 61.2 110.682 -179.368 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 20.8 p -67.73 -32.07 72.43 Favored 'General case' 0 N--CA 1.477 0.894 0 CA-C-N 116.08 -0.509 . . . . 73.54 111.411 177.284 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 71.21 28.18 70.52 Favored Glycine 0 C--N 1.343 0.972 0 CA-C-N 115.686 -0.688 . . . . 53.32 112.838 -176.662 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 19.4 mm-40 -62.85 -31.07 72.01 Favored 'General case' 0 N--CA 1.479 0.992 0 C-N-CA 123.268 0.627 . . . . 75.33 111.461 177.62 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 75.7 mmtt -83.98 9.44 12.33 Favored 'General case' 0 CA--C 1.556 1.197 0 CA-C-N 115.706 -0.679 . . . . 74.42 111.592 178.062 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 76.1 32.51 52.39 Favored Glycine 0 C--N 1.352 1.455 0 C-N-CA 123.146 0.403 . . . . 64.31 113.706 175.711 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 17.9 m-85 -110.28 -47.23 3.32 Favored 'General case' 0 N--CA 1.483 1.182 0 N-CA-C 109.654 -0.498 . . . . 75.33 109.654 179.453 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 56.66 65.58 3.47 Favored Glycine 0 C--N 1.354 1.548 0 O-C-N 124.107 0.879 . . . . 64.03 114.21 168.627 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 48' ' ' TYR . . . . . 0.463 ' HE1' HD22 ' A' ' 39' ' ' LEU . 51.3 m-85 -65.25 87.33 0.07 Allowed 'General case' 0 N--CA 1.476 0.848 0 CA-C-O 122.644 1.212 . . . . 74.1 111.237 -179.378 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 49' ' ' LYS . . . . . 0.595 ' HZ1' ' HA ' ' A' ' 160' ' ' ASP . 50.6 tptt -111.13 134.83 52.42 Favored 'General case' 0 C--O 1.244 0.812 0 CA-C-N 112.698 -2.046 . . . . 73.35 107.655 -179.486 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 65.22 21.86 68.6 Favored Glycine 0 N--CA 1.468 0.823 0 CA-C-O 119.57 -0.572 . . . . 75.21 113.032 -179.321 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 28.1 t -57.98 114.24 2.25 Favored 'General case' 0 C--N 1.362 1.11 0 C-N-CA 123.688 0.795 . . . . 64.24 109.946 -176.379 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 52' ' ' CYS . . . . . . . . . . . . . 45.2 t -83.31 137.37 34.0 Favored 'General case' 0 C--O 1.241 0.619 0 CA-C-N 115.437 -0.802 . . . . 61.01 111.757 -166.872 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 53' ' ' PHE . . . . . 0.729 ' HA ' ' HA2' ' A' ' 64' ' ' GLY . 38.6 m-85 -87.2 115.65 24.75 Favored 'General case' 0 C--O 1.238 0.474 0 N-CA-C 107.886 -1.153 . . . . 75.25 107.886 169.647 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 47.3 p-80 -99.5 -29.71 12.58 Favored 'General case' 0 N--CA 1.48 1.072 0 C-N-CA 123.278 0.631 . . . . 74.1 111.153 -175.748 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 55' ' ' ARG . . . . . 0.518 ' HA ' ' O ' ' A' ' 150' ' ' GLY . 59.5 ttt180 -132.92 98.96 4.44 Favored 'General case' 0 C--O 1.218 -0.588 0 CA-C-N 115.78 -0.646 . . . . 75.22 109.412 -168.805 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 56' ' ' ILE . . . . . 0.448 HD12 HD11 ' A' ' 156' ' ' ILE . 47.5 mt -123.67 124.36 69.23 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.813 0 N-CA-C 109.162 -0.681 . . . . 73.14 109.162 178.564 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 57' ' ' ILE . . . . . 0.41 HG12 ' HA2' ' A' ' 150' ' ' GLY . 45.4 mt -126.61 112.16 22.83 Favored Pre-proline 0 CA--C 1.561 1.372 0 C-N-CA 124.87 1.268 . . . . 74.34 109.242 -170.985 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 71.0 Cg_exo -54.32 145.11 57.57 Favored 'Trans proline' 0 C--N 1.374 1.879 0 C-N-CA 123.924 3.083 . . . . 74.44 115.024 176.848 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 64.72 21.06 66.89 Favored Glycine 0 C--N 1.351 1.414 0 CA-C-N 114.643 -1.162 . . . . 54.25 113.71 -179.772 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 60' ' ' PHE . . . . . 0.413 ' HE1' ' HE1' ' A' ' 121' ' ' TRP . 33.1 t80 -144.42 -76.61 0.22 Allowed 'General case' 0 C--O 1.242 0.667 0 C-N-CA 123.099 0.559 . . . . 73.35 110.639 -171.09 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 61' ' ' MET . . . . . 0.652 ' SD ' ' HB2' ' A' ' 113' ' ' PHE . 12.3 tmm? -174.89 144.85 0.81 Allowed 'General case' 0 CA--C 1.543 0.711 0 O-C-N 123.457 0.473 . . . . 74.14 111.341 -162.187 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 62' ' ' CYS . . . . . 0.637 ' SG ' ' HE1' ' A' ' 142' ' ' MET . 8.1 p -113.78 112.66 23.78 Favored 'General case' 0 CA--C 1.552 1.054 0 C-N-CA 124.25 1.02 . . . . 65.11 109.653 172.827 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 63' ' ' GLN . . . . . 0.621 ' HB2' ' SD ' ' A' ' 61' ' ' MET . 49.6 tt0 -103.05 114.49 28.83 Favored 'General case' 0 N--CA 1.485 1.32 0 C-N-CA 124.248 1.019 . . . . 75.02 111.129 -171.145 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 64' ' ' GLY . . . . . 0.729 ' HA2' ' HA ' ' A' ' 53' ' ' PHE . . . -98.95 -169.62 30.93 Favored Glycine 0 C--O 1.244 0.72 0 CA-C-N 114.863 -1.062 . . . . 71.52 112.111 175.597 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 72.92 87.14 0.19 Allowed Glycine 0 C--N 1.337 0.632 0 N-CA-C 111.062 -0.815 . . . . 64.21 111.062 -178.178 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 38.8 t70 -128.04 -38.46 1.82 Allowed 'General case' 0 N--CA 1.469 0.525 0 C-N-CA 122.825 0.45 . . . . 74.23 111.474 -179.518 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 77.0 t80 -70.83 -68.56 0.42 Allowed 'General case' 0 CA--C 1.552 1.043 0 N-CA-C 113.505 0.928 . . . . 74.14 113.505 -164.812 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 48.9 m -60.04 109.37 0.94 Allowed 'General case' 0 N--CA 1.482 1.141 0 C-N-CA 123.62 0.768 . . . . 74.15 112.038 -168.797 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 69' ' ' ARG . . . . . 0.536 ' HD3' ' HD3' ' A' ' 76' ' ' LYS . 73.3 mtp180 57.93 69.18 0.76 Allowed 'General case' 0 C--N 1.352 0.686 0 C-N-CA 124.763 1.225 . . . . 74.44 110.637 -170.856 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 24.5 p-80 -79.89 66.71 5.45 Favored 'General case' 0 N--CA 1.476 0.854 0 CA-C-O 122.128 0.966 . . . . 72.03 111.939 -176.921 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 15.5 m120 -119.68 20.74 12.26 Favored 'General case' 0 N--CA 1.476 0.832 0 C-N-CA 124.51 1.124 . . . . 74.43 108.628 173.898 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 100.67 -8.1 58.05 Favored Glycine 0 C--N 1.349 1.26 0 CA-C-N 115.302 -0.863 . . . . 74.4 112.519 -170.747 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 10.2 m -81.59 -61.8 1.83 Allowed 'General case' 0 N--CA 1.475 0.78 0 CA-C-N 117.589 0.694 . . . . 73.53 109.286 179.376 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 48.37 47.61 28.18 Favored Glycine 0 C--N 1.351 1.368 0 O-C-N 124.146 0.904 . . . . 50.42 115.309 170.236 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 138.11 51.37 0.06 OUTLIER Glycine 0 N--CA 1.474 1.218 0 CA-C-N 118.532 1.166 . . . . 53.52 113.382 -178.388 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 76' ' ' LYS . . . . . 0.536 ' HD3' ' HD3' ' A' ' 69' ' ' ARG . 22.8 pttp -61.35 160.26 11.07 Favored 'General case' 0 CA--C 1.556 1.177 0 C-N-CA 123.71 0.804 . . . . 74.3 111.95 179.85 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 87.1 p -91.3 164.5 13.84 Favored 'General case' 0 N--CA 1.483 1.206 0 C-N-CA 123.693 0.797 . . . . 75.12 111.685 -171.266 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 78' ' ' ILE . . . . . 0.541 HG22 ' HB2' ' A' ' 38' ' ' ALA . 45.6 pt -65.18 -15.89 19.16 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.397 0 N-CA-C 112.396 0.517 . . . . 74.11 112.396 179.89 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 79' ' ' TYR . . . . . 0.44 ' OH ' ' HG3' ' A' ' 31' ' ' LYS . 32.3 m-85 -89.79 -32.4 16.96 Favored 'General case' 0 N--CA 1.472 0.629 0 C-N-CA 123.647 0.779 . . . . 73.02 110.833 179.216 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 171.79 -137.53 4.36 Favored Glycine 0 C--N 1.339 0.726 0 CA-C-N 116.046 -0.524 . . . . 64.31 112.141 179.43 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 35.3 tt0 -65.31 -40.39 93.7 Favored 'General case' 0 CA--C 1.544 0.715 0 C-N-CA 123.375 0.67 . . . . 73.22 110.617 176.249 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 82' ' ' LYS . . . . . 0.656 ' HD2' ' HA ' ' A' ' 107' ' ' THR . 23.3 pttm -170.97 178.68 3.34 Favored 'General case' 0 CA--C 1.549 0.932 0 C-N-CA 124.129 0.971 . . . . 75.25 110.125 -173.79 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 18.9 p90 -154.11 173.18 16.4 Favored 'General case' 0 N--CA 1.477 0.907 0 C-N-CA 124.682 1.193 . . . . 73.5 110.067 -177.026 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 84' ' ' GLU . . . . . 0.546 ' HA ' ' HA ' ' A' ' 106' ' ' ASN . 14.2 pt-20 -90.79 154.23 19.67 Favored 'General case' 0 C--O 1.24 0.575 0 CA-C-O 121.023 0.439 . . . . 74.34 110.875 -179.9 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 35.2 m-20 -64.83 130.61 44.1 Favored 'General case' 0 CA--C 1.536 0.436 0 CA-C-N 114.799 -1.091 . . . . 75.42 111.446 -175.185 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 28.3 tt0 -72.54 -60.83 2.04 Favored 'General case' 0 CA--C 1.54 0.592 0 C-N-CA 123.302 0.641 . . . . 64.03 111.972 -173.276 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 31.0 p30 -164.74 158.28 17.48 Favored 'General case' 0 N--CA 1.475 0.809 0 C-N-CA 122.679 0.392 . . . . 63.43 111.124 -179.069 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 93.1 m-85 -103.35 38.32 1.8 Allowed 'General case' 0 N--CA 1.479 0.975 0 C-N-CA 123.765 0.826 . . . . 73.51 111.217 -172.413 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 64.9 mt -66.02 -52.41 49.05 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.075 0 C-N-CA 123.039 0.535 . . . . 74.45 110.42 177.317 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 90' ' ' LEU . . . . . 0.517 HD12 ' HB2' ' A' ' 25' ' ' PHE . 62.0 mt -83.17 139.82 32.94 Favored 'General case' 0 N--CA 1.473 0.691 0 CA-C-N 115.894 -0.594 . . . . 64.32 111.846 -177.009 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 91' ' ' LYS . . . . . 0.58 ' HB3' ' HZ2' ' A' ' 91' ' ' LYS . 9.2 mtpm? -124.27 167.6 14.1 Favored 'General case' 0 N--CA 1.471 0.59 0 C-N-CA 124.377 1.071 . . . . 75.52 109.604 177.751 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 92' ' ' HIS . . . . . . . . . . . . . 24.9 m-70 -86.52 62.16 7.25 Favored 'General case' 0 CA--C 1.544 0.736 0 C-N-CA 124.173 0.989 . . . . 71.01 108.861 176.3 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 93' ' ' THR . . . . . 0.41 HG21 ' HB2' ' A' ' 91' ' ' LYS . 21.9 p -83.92 -33.97 24.61 Favored 'General case' 0 N--CA 1.473 0.709 0 CA-C-N 115.132 -0.94 . . . . 75.43 111.563 -175.112 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -121.11 -177.42 15.63 Favored Glycine 0 C--N 1.342 0.888 0 CA-C-N 116.07 -0.514 . . . . 65.42 112.876 -177.201 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 95' ' ' PRO . . . . . 0.527 ' HB2' ' HE1' ' A' ' 136' ' ' MET . 79.2 Cg_endo -85.26 158.1 11.15 Favored 'Trans proline' 0 CA--C 1.553 1.449 0 C-N-CA 123.281 2.654 . . . . 64.0 112.099 173.024 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 83.07 17.67 66.72 Favored Glycine 0 N--CA 1.47 0.911 0 CA-C-N 116.054 -0.521 . . . . 74.43 114.126 179.043 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 97' ' ' ILE . . . . . 0.588 ' HB ' ' HB2' ' A' ' 115' ' ' CYS . 31.6 mm -66.47 102.99 0.51 Allowed 'Isoleucine or valine' 0 CA--C 1.549 0.934 0 C-N-CA 123.64 0.776 . . . . 73.01 111.774 -174.6 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 98' ' ' LEU . . . . . 0.453 HD12 HG12 ' A' ' 114' ' ' ILE . 58.1 tp -85.74 105.73 16.48 Favored 'General case' 0 CA--C 1.551 0.991 0 C-N-CA 123.44 0.696 . . . . 74.54 109.68 177.598 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 47.8 t -126.66 135.39 51.11 Favored 'General case' 0 N--CA 1.468 0.467 0 C-N-CA 124.69 1.196 . . . . 74.14 108.78 178.308 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 100' ' ' MET . . . . . 0.492 ' SD ' ' HA2' ' A' ' 109' ' ' GLY . 14.3 ttt -78.8 135.77 37.17 Favored 'General case' 0 N--CA 1.474 0.761 0 N-CA-C 108.343 -0.984 . . . . 72.24 108.343 -179.357 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -74.5 158.16 34.27 Favored 'General case' 0 CA--C 1.545 0.783 0 N-CA-C 112.916 0.71 . . . . 64.01 112.916 -167.462 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 22.2 p-10 -158.09 169.07 25.36 Favored 'General case' 0 N--CA 1.476 0.868 0 CA-C-N 115.542 -0.754 . . . . 75.32 110.759 -179.692 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 103' ' ' ALA . . . . . 0.438 ' HB1' HG21 ' A' ' 107' ' ' THR . . . -113.96 -1.14 13.88 Favored 'General case' 0 N--CA 1.476 0.839 0 CA-C-N 115.492 -0.777 . . . . 74.43 110.758 171.721 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 160.22 -165.59 34.89 Favored Glycine 0 C--N 1.354 1.536 0 CA-C-O 119.668 -0.518 . . . . 71.24 113.056 178.891 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 26.6 Cg_exo -64.03 134.74 44.29 Favored 'Trans proline' 0 C--N 1.376 1.997 0 C-N-CA 123.529 2.819 . . . . 71.44 112.266 178.355 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 106' ' ' ASN . . . . . 0.546 ' HA ' ' HA ' ' A' ' 84' ' ' GLU . 65.0 t30 66.82 14.24 9.73 Favored 'General case' 0 N--CA 1.485 1.32 0 C-N-CA 124.534 1.134 . . . . 65.44 111.212 -179.102 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 107' ' ' THR . . . . . 0.656 ' HA ' ' HD2' ' A' ' 82' ' ' LYS . 2.3 m -115.11 7.26 15.36 Favored 'General case' 0 CA--C 1.549 0.923 0 C-N-CA 124.208 1.003 . . . . 73.2 109.918 -178.874 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 55.1 t30 -88.67 139.51 30.4 Favored 'General case' 0 N--CA 1.476 0.865 0 C-N-CA 123.248 0.619 . . . . 73.23 110.097 -177.397 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 109' ' ' GLY . . . . . 0.492 ' HA2' ' SD ' ' A' ' 100' ' ' MET . . . 113.07 25.35 4.49 Favored Glycine 0 N--CA 1.464 0.534 0 CA-C-O 120.204 -0.22 . . . . 64.44 112.772 -175.553 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 5.1 m -132.72 126.2 31.96 Favored 'General case' 0 CA--C 1.541 0.623 0 N-CA-C 108.013 -1.106 . . . . 65.24 108.013 170.206 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 10.5 mt-30 64.52 175.81 0.19 Allowed 'General case' 0 N--CA 1.504 2.23 0 C-N-CA 125.25 1.42 . . . . 65.22 110.82 -174.615 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 54.9 p90 -148.41 159.21 44.25 Favored 'General case' 0 N--CA 1.486 1.366 0 O-C-N 121.603 -0.686 . . . . 72.21 109.865 174.681 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 113' ' ' PHE . . . . . 0.652 ' HB2' ' SD ' ' A' ' 61' ' ' MET . 55.1 p90 -146.26 147.07 31.03 Favored 'General case' 0 N--CA 1.469 0.502 0 CA-C-O 121.109 0.481 . . . . 72.22 111.452 177.625 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 114' ' ' ILE . . . . . 0.512 ' HB ' ' SG ' ' A' ' 62' ' ' CYS . 13.9 mt -117.5 102.67 13.75 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.536 0 N-CA-C 108.071 -1.085 . . . . 73.55 108.071 -179.044 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 115' ' ' CYS . . . . . 0.588 ' HB2' ' HB ' ' A' ' 97' ' ' ILE . 33.7 m -68.16 105.23 2.02 Favored 'General case' 0 CA--C 1.539 0.544 0 C-N-CA 123.305 0.642 . . . . 64.33 109.601 -179.632 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 116' ' ' THR . . . . . 0.469 HG23 HG12 ' A' ' 139' ' ' VAL . 41.3 p -70.32 -30.4 67.37 Favored 'General case' 0 N--CA 1.475 0.797 0 C-N-CA 124.009 0.924 . . . . 62.22 110.822 -175.876 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -112.32 159.64 18.46 Favored 'General case' 0 C--O 1.243 0.725 0 N-CA-C 108.115 -1.069 . . . . 71.43 108.115 169.231 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -68.73 98.84 0.94 Allowed 'General case' 0 CA--C 1.542 0.661 0 CA-C-O 121.383 0.611 . . . . 73.22 109.491 176.669 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 119' ' ' THR . . . . . . . . . . . . . 33.9 p -81.66 85.35 6.58 Favored 'General case' 0 C--O 1.239 0.502 0 CA-C-O 121.778 0.799 . . . . 75.54 109.471 -179.183 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 12.1 pt-20 -72.25 -22.51 61.22 Favored 'General case' 0 N--CA 1.473 0.68 0 CA-C-N 114.805 -1.089 . . . . 74.5 112.001 -170.862 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 121' ' ' TRP . . . . . 0.413 ' HE1' ' HE1' ' A' ' 60' ' ' PHE . 26.8 p90 -69.79 -10.28 57.8 Favored 'General case' 0 N--CA 1.477 0.91 0 C-N-CA 123.261 0.624 . . . . 74.41 111.863 175.572 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 122' ' ' LEU . . . . . 0.535 ' HA ' ' HE2' ' A' ' 125' ' ' LYS . 79.3 mt -94.71 7.6 45.27 Favored 'General case' 0 N--CA 1.475 0.825 0 C-N-CA 122.952 0.501 . . . . 75.51 111.716 176.375 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 74.3 m-20 -80.59 148.38 30.33 Favored 'General case' 0 N--CA 1.478 0.945 0 N-CA-C 109.757 -0.46 . . . . 73.4 109.757 172.247 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 77.29 22.38 70.82 Favored Glycine 0 C--N 1.344 1.01 0 N-CA-C 111.992 -0.443 . . . . 52.22 111.992 -170.02 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 125' ' ' LYS . . . . . 0.535 ' HE2' ' HA ' ' A' ' 122' ' ' LEU . 27.1 mtmm -142.4 -167.47 2.5 Favored 'General case' 0 CA--C 1.545 0.759 0 C-N-CA 124.647 1.179 . . . . 72.55 110.356 -175.091 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 126' ' ' HIS . . . . . . . . . . . . . 2.3 p80 -64.72 157.67 26.81 Favored 'General case' 0 N--CA 1.475 0.785 0 C-N-CA 124.502 1.121 . . . . 71.31 113.955 -160.425 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 46.7 t -63.85 127.42 24.32 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.719 0 CA-C-N 113.337 -1.756 . . . . 72.03 113.627 -164.142 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 86.9 t -84.26 146.66 6.46 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.481 0 N-CA-C 108.034 -1.099 . . . . 74.53 108.034 164.196 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 129' ' ' PHE . . . . . 0.45 ' HA ' HG21 ' A' ' 29' ' ' VAL . 50.6 p90 -134.85 -6.38 2.42 Favored 'General case' 0 N--CA 1.478 0.965 0 CA-C-N 118.287 0.494 . . . . 74.25 111.721 -179.375 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . -150.02 168.44 30.07 Favored Glycine 0 C--N 1.342 0.869 0 C-N-CA 121.479 -0.391 . . . . 64.3 113.276 -175.402 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 32.2 ttpt -156.0 139.42 15.81 Favored 'General case' 0 N--CA 1.467 0.385 0 N-CA-C 107.861 -1.162 . . . . 75.02 107.861 175.04 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 132' ' ' VAL . . . . . 0.457 HG13 ' HA ' ' A' ' 136' ' ' MET . 21.8 t -64.0 114.48 2.11 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.717 0 CA-C-N 118.303 0.501 . . . . 74.21 109.871 179.733 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 133' ' ' LYS . . . . . 0.586 ' HD3' HG23 ' A' ' 5' ' ' THR . 21.6 ptmt -92.79 -30.62 15.39 Favored 'General case' 0 N--CA 1.478 0.944 0 C-N-CA 122.737 0.415 . . . . 70.23 109.884 178.861 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 134' ' ' GLU . . . . . 0.547 ' HB2' ' HB2' ' A' ' 21' ' ' SER . 41.4 mt-10 -142.49 135.8 28.74 Favored 'General case' 0 N--CA 1.473 0.725 0 C-N-CA 124.313 1.045 . . . . 71.54 109.657 -173.121 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 77.84 32.92 43.54 Favored Glycine 0 CA--C 1.531 1.076 0 O-C-N 123.327 0.392 . . . . 70.35 113.406 178.505 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 136' ' ' MET . . . . . 0.527 ' HE1' ' HB2' ' A' ' 95' ' ' PRO . 14.2 tpt -65.08 -35.31 80.75 Favored 'General case' 0 N--CA 1.482 1.148 0 C-N-CA 123.133 0.573 . . . . 63.32 111.643 -179.553 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 137' ' ' ASN . . . . . . . . . . . . . 18.2 m120 -67.1 -23.72 65.86 Favored 'General case' 0 N--CA 1.481 1.087 0 C-N-CA 123.294 0.638 . . . . 72.12 111.543 179.968 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 138' ' ' ILE . . . . . . . . . . . . . 36.7 mm -75.67 -37.96 37.09 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.063 0 C-N-CA 123.252 0.621 . . . . 72.41 109.61 175.913 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 139' ' ' VAL . . . . . 0.469 HG12 HG23 ' A' ' 116' ' ' THR . 95.9 t -63.5 -39.73 86.43 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.022 0 C-N-CA 123.592 0.757 . . . . 74.44 110.205 173.494 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 47.2 mt-10 -76.4 -20.68 56.88 Favored 'General case' 0 N--CA 1.474 0.774 0 CA-C-N 115.374 -0.83 . . . . 72.54 111.674 177.973 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -74.92 -50.66 16.07 Favored 'General case' 0 N--CA 1.471 0.594 0 C-N-CA 122.642 0.377 . . . . 55.34 110.387 173.939 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 142' ' ' MET . . . . . 0.637 ' HE1' ' SG ' ' A' ' 62' ' ' CYS . 18.3 ptt? -66.59 -28.15 68.28 Favored 'General case' 0 N--CA 1.483 1.182 0 C-N-CA 122.923 0.489 . . . . 75.31 111.63 -179.221 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 24.5 tt0 -47.46 -47.36 27.19 Favored 'General case' 0 N--CA 1.482 1.173 0 C-N-CA 125.28 1.432 . . . . 70.25 111.224 170.484 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 144' ' ' ARG . . . . . . . . . . . . . 88.6 mtt180 -85.78 -6.82 59.06 Favored 'General case' 0 CA--C 1.541 0.607 0 CA-C-N 114.123 -1.399 . . . . 74.32 111.678 -173.075 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 145' ' ' PHE . . . . . 0.513 ' HD2' ' HA ' ' A' ' 142' ' ' MET . 49.6 m-85 -89.48 2.5 54.47 Favored 'General case' 0 N--CA 1.479 1.005 0 C-N-CA 122.871 0.468 . . . . 74.31 110.448 168.149 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . -96.58 -170.55 34.42 Favored Glycine 0 C--N 1.349 1.267 0 CA-C-N 115.877 -0.602 . . . . 75.34 111.992 168.364 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 44.2 t -134.68 155.12 51.08 Favored 'General case' 0 N--CA 1.473 0.702 0 C-N-CA 124.191 0.996 . . . . 71.22 109.681 -177.833 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 148' ' ' ARG . . . . . . . . . . . . . 20.2 mmm-85 -62.24 -31.86 72.47 Favored 'General case' 0 N--CA 1.478 0.969 0 C-N-CA 123.916 0.886 . . . . 71.3 112.484 -173.055 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 149' ' ' ASN . . . . . . . . . . . . . 25.6 p-10 -76.97 -19.5 57.25 Favored 'General case' 0 N--CA 1.484 1.247 0 C-N-CA 123.021 0.528 . . . . 74.04 111.764 -179.464 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 150' ' ' GLY . . . . . 0.518 ' O ' ' HA ' ' A' ' 55' ' ' ARG . . . 119.64 -6.05 12.68 Favored Glycine 0 C--N 1.349 1.253 0 CA-C-O 119.702 -0.499 . . . . 74.4 113.367 -177.826 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 38.2 ttmt -66.62 141.15 57.91 Favored 'General case' 0 N--CA 1.474 0.747 0 CA-C-N 117.657 0.729 . . . . 74.31 110.553 177.041 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 152' ' ' THR . . . . . . . . . . . . . 18.1 p -92.46 115.26 27.93 Favored 'General case' 0 CA--C 1.538 0.488 0 N-CA-C 108.771 -0.825 . . . . 74.31 108.771 166.373 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 153' ' ' SER . . . . . . . . . . . . . 10.3 m -74.2 -21.03 59.99 Favored 'General case' 0 CA--C 1.545 0.758 0 CA-C-O 121.355 0.598 . . . . 60.41 110.295 179.624 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 71.7 mmtt -124.8 150.33 46.45 Favored 'General case' 0 N--CA 1.467 0.423 0 C-N-CA 124.537 1.135 . . . . 73.14 110.267 176.325 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 3.9 tppp? -79.92 94.96 5.96 Favored 'General case' 0 C--O 1.242 0.69 0 N-CA-C 108.927 -0.768 . . . . 74.33 108.927 173.478 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 156' ' ' ILE . . . . . 0.607 HD13 ' HB2' ' A' ' 142' ' ' MET . 60.8 mt -101.45 124.13 55.0 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.155 0 CA-C-N 114.972 -1.013 . . . . 74.15 108.621 -178.575 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 157' ' ' THR . . . . . . . . . . . . . 31.6 p -138.78 157.78 45.44 Favored 'General case' 0 N--CA 1.47 0.56 0 C-N-CA 124.567 1.147 . . . . 73.25 109.256 -173.686 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 158' ' ' ILE . . . . . 0.46 HG22 ' HB3' ' A' ' 8' ' ' PHE . 59.3 mt -80.24 94.28 2.12 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.72 0 N-CA-C 108.5 -0.926 . . . . 64.24 108.5 169.773 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 159' ' ' ALA . . . . . 0.698 ' HB2' ' HB1' ' A' ' 11' ' ' ALA . . . -52.76 -53.69 44.47 Favored 'General case' 0 N--CA 1.481 1.105 0 C-N-CA 124.114 0.966 . . . . 74.32 112.357 -177.852 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 160' ' ' ASP . . . . . 0.595 ' HA ' ' HZ1' ' A' ' 49' ' ' LYS . 26.9 t0 -148.54 157.66 43.61 Favored 'General case' 0 N--CA 1.471 0.618 0 CA-C-N 115.808 -0.633 . . . . 75.44 110.091 -173.557 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 161' ' ' CYS . . . . . . . . . . . . . 28.0 p -129.23 -170.62 2.31 Favored 'General case' 0 CA--C 1.539 0.543 0 C-N-CA 124.922 1.289 . . . . 71.12 108.513 176.888 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 162' ' ' GLY . . . . . . . . . . . . . . . 132.35 53.07 0.08 OUTLIER Glycine 0 C--N 1.342 0.906 0 N-CA-C 110.708 -0.957 . . . . 54.05 110.708 -168.442 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 163' ' ' GLN . . . . . 0.546 ' HB2' ' HA ' ' A' ' 6' ' ' VAL . 13.2 pt20 -55.99 143.73 31.22 Favored 'General case' 0 CA--C 1.544 0.749 0 C-N-CA 124.487 1.115 . . . . 72.43 113.097 -174.293 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 164' ' ' LEU . . . . . . . . . . . . . 77.5 mt . . . . . 0 CA--C 1.539 0.524 0 CA-C-N 115.404 -0.816 . . . . 74.14 110.277 -176.724 . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' B' B ' 218' ' ' PRO . . . . . . . . . . . . . 37.3 Cg_exo . . . . . 0 CA--C 1.542 0.924 0 N-CA-C 110.494 -0.618 . . . . 70.53 110.494 . . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' B' B ' 219' ' ' GLY . . . . . . . . . . . . . . . 171.1 171.49 36.39 Favored Glycine 0 CA--C 1.527 0.786 0 CA-C-N 116.283 -0.417 . . . . 42.03 112.776 -179.59 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 220' ' ' PRO . . . . . . . . . . . . . 97.6 Cg_endo -85.02 -169.17 0.59 Allowed 'Trans proline' 0 C--N 1.371 1.739 0 C-N-CA 123.429 2.752 . . . . 73.03 113.496 -178.785 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 221' ' ' TYR . . . . . . . . . . . . . 96.8 m-85 . . . . . 0 N--CA 1.483 1.177 0 C-N-CA 123.781 0.833 . . . . 73.24 109.742 179.111 . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 3' ' ' ASN . . . . . 0.5 ' ND2' ' HA ' ' A' ' 25' ' ' PHE . 11.8 m120 . . . . . 0 CA--C 1.545 0.757 0 CA-C-O 119.248 -0.406 . . . . 73.23 110.043 . . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 6.7 Cg_endo -80.73 152.68 19.7 Favored 'Trans proline' 0 C--N 1.371 1.755 0 C-N-CA 122.429 2.086 . . . . 65.01 110.963 173.872 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 5' ' ' THR . . . . . 0.42 ' HB ' ' O ' ' A' ' 164' ' ' LEU . 93.2 m -96.15 142.72 28.0 Favored 'General case' 0 CA--C 1.549 0.912 0 C-N-CA 123.096 0.558 . . . . 74.01 109.638 178.643 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 6' ' ' VAL . . . . . 0.654 ' HA ' ' HG3' ' A' ' 163' ' ' GLN . 29.1 t -110.37 147.12 14.8 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.436 0 N-CA-C 107.222 -1.399 . . . . 74.33 107.222 177.333 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 7' ' ' PHE . . . . . 0.533 ' H ' ' HA ' ' A' ' 163' ' ' GLN . 65.0 t80 -125.59 126.29 44.54 Favored 'General case' 0 C--O 1.238 0.468 0 N-CA-C 108.916 -0.772 . . . . 74.31 108.916 178.905 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 8' ' ' PHE . . . . . 0.531 ' HD2' ' HE2' ' A' ' 22' ' ' PHE . 33.9 m-85 -134.56 165.28 25.57 Favored 'General case' 0 N--CA 1.47 0.557 0 C-N-CA 124.074 0.95 . . . . 73.54 109.701 169.25 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 23.7 m-20 -118.27 117.33 28.83 Favored 'General case' 0 C--N 1.327 -0.406 0 N-CA-C 107.311 -1.366 . . . . 75.12 107.311 171.152 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 42.4 mm -90.05 136.12 24.61 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.823 0 N-CA-C 108.672 -0.862 . . . . 74.53 108.672 178.506 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 11' ' ' ALA . . . . . 0.678 ' HB1' ' HB2' ' A' ' 159' ' ' ALA . . . -135.47 122.27 21.07 Favored 'General case' 0 N--CA 1.478 0.951 0 C-N-CA 123.44 0.696 . . . . 74.44 111.666 -170.513 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 12' ' ' VAL . . . . . 0.43 HG22 HG12 ' A' ' 156' ' ' ILE . 62.4 t -95.94 122.99 47.95 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.709 0 C-N-CA 124.186 0.994 . . . . 71.02 108.962 176.846 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 42.3 m-20 64.1 23.09 13.11 Favored 'General case' 0 N--CA 1.491 1.616 0 C-N-CA 125.331 1.452 . . . . 74.12 110.836 -172.932 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 83.38 -13.21 47.41 Favored Glycine 0 C--N 1.351 1.384 0 CA-C-O 119.571 -0.572 . . . . 73.21 113.067 -173.079 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 37.8 mm-40 -83.49 117.23 68.04 Favored Pre-proline 0 C--N 1.353 0.759 0 C-N-CA 123.553 0.741 . . . . 71.22 109.981 177.863 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 93.1 Cg_exo -46.7 106.36 0.1 OUTLIER 'Trans proline' 0 C--N 1.379 2.134 0 C-N-CA 124.072 3.182 . . . . 71.25 113.891 -179.411 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 43.3 tp -76.08 -40.96 51.92 Favored 'General case' 0 N--CA 1.48 1.055 0 C-N-CA 123.705 0.802 . . . . 71.11 109.66 179.319 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -179.77 172.22 43.88 Favored Glycine 0 C--N 1.345 1.047 0 O-C-N 123.367 0.417 . . . . 60.12 112.957 178.386 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 13.2 ptm180 -105.82 124.47 49.61 Favored 'General case' 0 N--CA 1.473 0.71 0 N-CA-C 108.255 -1.017 . . . . 74.04 108.255 -177.988 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 51.8 t -120.89 137.91 53.08 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.407 0 C-N-CA 123.692 0.797 . . . . 74.25 109.382 -175.14 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 21' ' ' SER . . . . . 0.492 ' HB2' ' HB2' ' A' ' 134' ' ' GLU . 51.7 m -121.18 125.25 46.68 Favored 'General case' 0 C--O 1.248 1.004 0 C-N-CA 123.706 0.802 . . . . 73.42 109.519 176.677 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 22' ' ' PHE . . . . . 0.531 ' HE2' ' HD2' ' A' ' 8' ' ' PHE . 57.4 m-85 -100.81 169.95 8.65 Favored 'General case' 0 N--CA 1.474 0.735 0 C-N-CA 123.833 0.853 . . . . 75.51 109.358 178.47 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 23' ' ' GLU . . . . . 0.551 ' HB2' ' HD2' ' A' ' 133' ' ' LYS . 37.7 tt0 -138.32 112.31 8.48 Favored 'General case' 0 CA--C 1.543 0.684 0 C-N-CA 123.156 0.582 . . . . 74.02 109.632 -179.513 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . 0.417 HD21 ' HD1' ' A' ' 129' ' ' PHE . 62.1 mt -84.12 136.48 33.98 Favored 'General case' 0 N--CA 1.478 0.951 0 C-N-CA 123.692 0.797 . . . . 72.22 110.804 -176.784 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 25' ' ' PHE . . . . . 0.5 ' HA ' ' ND2' ' A' ' 3' ' ' ASN . 32.7 m-85 -85.65 64.29 8.54 Favored 'General case' 0 CA--C 1.546 0.805 0 CA-C-O 121.186 0.517 . . . . 73.44 109.642 175.886 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -72.91 1.03 9.52 Favored 'General case' 0 N--CA 1.486 1.364 0 N-CA-C 113.125 0.787 . . . . 74.01 113.125 -175.407 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 11.7 p-10 -87.33 -24.3 24.34 Favored 'General case' 0 CA--C 1.548 0.896 0 C-N-CA 123.555 0.742 . . . . 64.13 111.096 174.433 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 97.7 mttt -114.02 -35.02 5.21 Favored 'General case' 0 N--CA 1.489 1.489 0 C-N-CA 123.692 0.797 . . . . 73.23 111.12 -176.339 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 29' ' ' VAL . . . . . 0.502 HG21 ' HA ' ' A' ' 129' ' ' PHE . 6.7 m -128.85 71.15 81.46 Favored Pre-proline 0 CA--C 1.553 1.074 0 C-N-CA 123.927 0.891 . . . . 74.23 110.209 175.333 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 15.3 Cg_exo -66.03 -33.96 39.64 Favored 'Trans proline' 0 C--N 1.381 2.244 0 C-N-CA 122.567 2.178 . . . . 73.54 111.104 -179.13 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 87.7 tttt -63.51 -57.19 10.97 Favored 'General case' 0 CA--C 1.54 0.575 0 C-N-CA 124.796 1.238 . . . . 75.01 111.083 -179.17 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 6.5 m -68.98 -30.46 68.87 Favored 'General case' 0 CA--C 1.554 1.098 0 C-N-CA 123.613 0.765 . . . . 74.23 111.292 -174.964 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -71.81 -40.03 69.42 Favored 'General case' 0 CA--C 1.548 0.904 0 C-N-CA 123.403 0.681 . . . . 55.51 111.347 175.894 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 9.3 tp10 -71.81 -34.26 69.2 Favored 'General case' 0 N--CA 1.482 1.136 0 C-N-CA 123.436 0.695 . . . . 75.14 110.154 -178.458 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 35' ' ' ASN . . . . . 0.405 ' O ' ' HG ' ' A' ' 39' ' ' LEU . 40.1 t30 -57.98 -54.82 42.66 Favored 'General case' 0 N--CA 1.474 0.738 0 CA-C-N 114.527 -1.215 . . . . 64.22 109.766 173.526 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 74.2 t80 -58.91 -42.01 88.62 Favored 'General case' 0 CA--C 1.543 0.701 0 O-C-N 124.742 1.276 . . . . 73.1 111.096 -177.874 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 36.3 ttm180 -55.58 -57.14 13.18 Favored 'General case' 0 C--N 1.358 0.958 0 O-C-N 123.766 0.666 . . . . 63.14 110.394 175.629 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 38' ' ' ALA . . . . . 0.514 ' HB3' HG22 ' A' ' 78' ' ' ILE . . . -63.62 -32.96 74.6 Favored 'General case' 0 C--O 1.243 0.732 0 O-C-N 124.041 0.838 . . . . 60.02 112.129 -173.078 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 39' ' ' LEU . . . . . 0.556 HD23 ' HE2' ' A' ' 48' ' ' TYR . 74.2 mt -65.56 -45.0 85.02 Favored 'General case' 0 N--CA 1.475 0.792 0 O-C-N 124.147 0.904 . . . . 71.15 111.02 176.517 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 41.2 m -76.42 -49.45 16.67 Favored 'General case' 0 N--CA 1.475 0.814 0 C-N-CA 123.408 0.683 . . . . 42.04 112.01 -174.31 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 41' ' ' THR . . . . . 0.419 ' OG1' ' HG2' ' A' ' 43' ' ' GLU . 67.6 p -76.53 -31.48 57.67 Favored 'General case' 0 N--CA 1.471 0.609 0 C-N-CA 124.204 1.002 . . . . 71.12 111.647 -174.138 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 92.57 26.44 17.62 Favored Glycine 0 C--N 1.349 1.25 0 CA-C-O 119.683 -0.509 . . . . 74.35 113.071 -179.677 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 43' ' ' GLU . . . . . 0.419 ' HG2' ' OG1' ' A' ' 41' ' ' THR . 19.9 mm-40 -63.39 -22.97 67.2 Favored 'General case' 0 N--CA 1.483 1.213 0 C-N-CA 123.086 0.555 . . . . 63.32 111.69 174.31 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 44' ' ' LYS . . . . . 0.493 ' HG2' ' HB2' ' A' ' 38' ' ' ALA . 75.8 mmtt -114.38 16.43 17.81 Favored 'General case' 0 N--CA 1.482 1.149 0 C-N-CA 123.63 0.772 . . . . 73.53 111.022 177.242 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 93.41 -25.06 22.57 Favored Glycine 0 C--N 1.355 1.627 0 N-CA-C 114.794 0.677 . . . . 75.23 114.794 174.893 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 46' ' ' PHE . . . . . 0.416 ' HE2' ' HA ' ' A' ' 78' ' ' ILE . 21.8 m-85 -68.77 -48.22 64.22 Favored 'General case' 0 N--CA 1.479 0.992 0 C-N-CA 122.953 0.501 . . . . 75.12 111.846 -167.407 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 40.97 62.05 1.82 Allowed Glycine 0 C--N 1.358 1.786 0 O-C-N 124.975 1.422 . . . . 75.42 115.321 169.92 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 48' ' ' TYR . . . . . 0.556 ' HE2' HD23 ' A' ' 39' ' ' LEU . 97.3 m-85 -62.88 90.76 0.04 OUTLIER 'General case' 0 N--CA 1.476 0.859 0 CA-C-O 121.478 0.656 . . . . 74.41 111.52 -176.678 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 3.7 tppp? -105.24 125.81 51.4 Favored 'General case' 0 C--O 1.232 0.148 0 N-CA-C 108.328 -0.989 . . . . 72.3 108.328 175.05 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 80.96 20.23 65.72 Favored Glycine 0 CA--C 1.524 0.636 0 CA-C-O 119.681 -0.511 . . . . 63.03 112.742 -175.427 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 51' ' ' SER . . . . . 0.402 ' HB2' ' HB3' ' A' ' 48' ' ' TYR . 36.0 t -62.38 118.41 7.45 Favored 'General case' 0 C--N 1.354 0.786 0 N-CA-C 109.032 -0.729 . . . . 74.35 109.032 176.9 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 52' ' ' CYS . . . . . . . . . . . . . 25.6 p -86.75 129.48 34.86 Favored 'General case' 0 CA--C 1.536 0.425 0 C-N-CA 123.54 0.736 . . . . 64.01 111.645 -170.577 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 53' ' ' PHE . . . . . 0.636 ' HA ' ' HA2' ' A' ' 64' ' ' GLY . 46.5 m-85 -76.79 74.4 3.43 Favored 'General case' 0 CA--C 1.538 0.516 0 N-CA-C 108.353 -0.98 . . . . 73.25 108.353 168.415 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 27.1 p-80 -75.0 -22.84 58.27 Favored 'General case' 0 N--CA 1.476 0.868 0 CA-C-N 115.146 -0.934 . . . . 74.45 111.522 -174.674 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 55' ' ' ARG . . . . . 0.406 ' HA ' ' O ' ' A' ' 150' ' ' GLY . 38.4 ttt180 -112.96 99.41 7.84 Favored 'General case' 0 C--O 1.218 -0.601 0 N-CA-C 109.108 -0.701 . . . . 73.25 109.108 178.238 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 42.7 mt -127.63 137.86 56.44 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.643 0 N-CA-C 108.47 -0.937 . . . . 75.41 108.47 171.747 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 57' ' ' ILE . . . . . 0.667 HG23 ' HA ' ' A' ' 148' ' ' ARG . 70.2 mt -134.56 125.3 17.52 Favored Pre-proline 0 CA--C 1.553 1.08 0 C-N-CA 124.811 1.244 . . . . 73.43 108.621 -176.267 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 58' ' ' PRO . . . . . 0.451 ' HA ' ' HG2' ' A' ' 143' ' ' GLU . 84.3 Cg_endo -76.82 145.41 25.42 Favored 'Trans proline' 0 C--N 1.375 1.943 0 C-N-CA 122.687 2.258 . . . . 73.43 112.15 -177.606 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 70.04 25.48 75.55 Favored Glycine 0 C--N 1.342 0.868 0 CA-C-N 115.398 -0.819 . . . . 53.54 112.653 -175.486 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 36.5 t80 -151.57 -73.58 0.15 Allowed 'General case' 0 C--O 1.247 0.95 0 C-N-CA 122.835 0.454 . . . . 74.12 111.172 -171.646 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 61' ' ' MET . . . . . 0.616 ' HE1' ' SG ' ' A' ' 115' ' ' CYS . 38.8 ttm -176.79 143.9 0.46 Allowed 'General case' 0 N--CA 1.482 1.166 0 N-CA-C 112.445 0.535 . . . . 72.01 112.445 -159.06 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 62' ' ' CYS . . . . . 0.456 ' SG ' HG11 ' A' ' 139' ' ' VAL . 25.1 p -112.72 112.45 23.96 Favored 'General case' 0 CA--C 1.55 0.962 0 N-CA-C 109.018 -0.734 . . . . 75.3 109.018 169.344 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 63' ' ' GLN . . . . . 0.537 ' HA ' ' HA ' ' A' ' 113' ' ' PHE . 51.4 tt0 -105.43 120.68 42.21 Favored 'General case' 0 N--CA 1.485 1.284 0 C-N-CA 124.248 1.019 . . . . 74.33 111.503 -175.185 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 64' ' ' GLY . . . . . 0.636 ' HA2' ' HA ' ' A' ' 53' ' ' PHE . . . -91.84 148.75 19.38 Favored Glycine 0 C--N 1.347 1.16 0 CA-C-N 115.206 -0.906 . . . . 75.11 112.34 176.403 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 65' ' ' GLY . . . . . 0.501 ' HA3' ' HG2' ' A' ' 111' ' ' GLN . . . -176.84 131.25 1.8 Allowed Glycine 0 C--N 1.338 0.656 0 N-CA-C 111.984 -0.447 . . . . 73.2 111.984 179.511 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 33.2 t70 -75.99 165.35 25.09 Favored 'General case' 0 CA--C 1.547 0.846 0 C-N-CA 123.046 0.538 . . . . 74.43 111.31 -175.613 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 90.2 t80 -64.92 -32.88 74.81 Favored 'General case' 0 C--O 1.245 0.853 0 C-N-CA 123.665 0.786 . . . . 74.02 111.365 178.176 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 33.9 m -60.81 112.67 2.13 Favored 'General case' 0 C--N 1.354 0.772 0 C-N-CA 122.985 0.514 . . . . 73.34 111.254 -177.057 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 69' ' ' ARG . . . . . 0.42 ' HD3' ' HG3' ' A' ' 81' ' ' GLU . 81.1 mtt85 65.33 28.01 11.9 Favored 'General case' 0 CA--C 1.547 0.843 0 O-C-N 124.618 1.199 . . . . 74.52 112.02 178.381 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 15.4 p80 -55.18 -25.41 32.44 Favored 'General case' 0 N--CA 1.498 1.969 0 C-N-CA 123.529 0.732 . . . . 70.01 112.759 -174.571 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 11.2 m120 -77.5 87.84 3.84 Favored 'General case' 0 CA--C 1.544 0.747 0 C-N-CA 123.849 0.86 . . . . 74.33 109.373 174.353 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 91.25 -1.2 76.46 Favored Glycine 0 N--CA 1.474 1.213 0 CA-C-O 119.4 -0.667 . . . . 71.22 114.61 175.381 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 73' ' ' THR . . . . . 0.437 ' HA ' ' HB2' ' A' ' 110' ' ' SER . 96.2 m -140.31 -92.16 0.16 Allowed 'General case' 0 CA--C 1.558 1.277 0 CA-C-N 117.738 0.769 . . . . 73.2 110.046 172.951 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 81.67 43.66 8.27 Favored Glycine 0 C--N 1.359 1.84 0 CA-C-N 118.279 0.491 . . . . 73.51 113.985 176.684 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 140.79 53.46 0.04 OUTLIER Glycine 0 C--N 1.346 1.095 0 CA-C-N 117.552 0.676 . . . . 74.32 111.495 -176.482 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 76' ' ' LYS . . . . . 0.486 ' HB2' ' HA ' ' A' ' 81' ' ' GLU . 13.9 ptmm? -56.09 162.86 1.76 Allowed 'General case' 0 N--CA 1.483 1.182 0 C-N-CA 124.026 0.93 . . . . 73.22 112.749 -174.541 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 87.3 p -94.49 -177.77 4.35 Favored 'General case' 0 C--O 1.243 0.734 0 C-N-CA 122.995 0.518 . . . . 75.23 111.345 -170.775 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 78' ' ' ILE . . . . . 0.514 HG22 ' HB3' ' A' ' 38' ' ' ALA . 20.9 pt -88.59 -12.38 10.21 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.889 0 CA-C-N 115.56 -0.746 . . . . 65.42 110.668 173.985 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 42.9 m-85 -88.17 -24.62 23.27 Favored 'General case' 0 N--CA 1.472 0.646 0 C-N-CA 123.935 0.894 . . . . 74.41 109.662 178.476 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 167.86 -145.29 9.58 Favored Glycine 0 C--N 1.346 1.084 0 CA-C-N 115.365 -0.834 . . . . 72.05 111.095 176.827 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 81' ' ' GLU . . . . . 0.486 ' HA ' ' HB2' ' A' ' 76' ' ' LYS . 36.3 tt0 -69.16 -34.93 75.74 Favored 'General case' 0 CA--C 1.543 0.709 0 C-N-CA 123.293 0.637 . . . . 74.45 110.06 174.475 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 82' ' ' LYS . . . . . 0.695 ' HD2' ' HA ' ' A' ' 107' ' ' THR . 20.6 pttp -169.99 177.2 4.41 Favored 'General case' 0 N--CA 1.476 0.842 0 C-N-CA 124.733 1.213 . . . . 74.41 109.047 178.397 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 46.5 p90 -146.78 173.49 12.33 Favored 'General case' 0 N--CA 1.474 0.767 0 C-N-CA 123.651 0.78 . . . . 75.23 110.563 -179.208 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 13.5 pt-20 -88.34 158.99 18.26 Favored 'General case' 0 N--CA 1.475 0.821 0 C-N-CA 123.055 0.542 . . . . 73.21 110.208 177.917 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 27.0 m-20 -60.81 118.64 6.91 Favored 'General case' 0 N--CA 1.477 0.924 0 C-N-CA 124.376 1.071 . . . . 74.25 109.967 -179.337 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 20.6 tp10 -66.79 -59.01 3.92 Favored 'General case' 0 N--CA 1.479 0.983 0 C-N-CA 123.133 0.573 . . . . 65.42 111.198 -175.158 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 26.4 p30 -143.01 -174.46 4.19 Favored 'General case' 0 N--CA 1.47 0.543 0 C-N-CA 123.757 0.823 . . . . 74.43 109.593 179.966 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 79.8 m-85 -136.27 39.54 2.69 Favored 'General case' 0 N--CA 1.481 1.082 0 C-N-CA 123.591 0.756 . . . . 75.25 109.754 -179.325 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 60.5 mt -69.01 -62.07 1.42 Allowed 'Isoleucine or valine' 0 N--CA 1.477 0.9 0 CA-C-N 115.431 -0.804 . . . . 74.42 110.966 -178.806 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 90' ' ' LEU . . . . . 0.643 ' H ' HG23 ' A' ' 127' ' ' VAL . 66.1 mt -87.55 140.96 28.99 Favored 'General case' 0 C--O 1.238 0.492 0 CA-C-N 115.539 -0.755 . . . . 65.25 110.678 -171.748 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 55.3 mtpt -125.5 168.83 13.09 Favored 'General case' 0 N--CA 1.47 0.526 0 C-N-CA 124.152 0.981 . . . . 74.22 110.174 -174.285 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 92' ' ' HIS . . . . . 0.414 ' HD2' ' SG ' ' A' ' 115' ' ' CYS . 43.5 m80 -92.88 51.28 1.67 Allowed 'General case' 0 N--CA 1.48 1.026 0 C-N-CA 124.235 1.014 . . . . 70.43 109.503 -174.486 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 41.3 p -84.3 -7.12 59.42 Favored 'General case' 0 N--CA 1.472 0.632 0 CA-C-N 114.476 -1.238 . . . . 73.33 112.799 -171.371 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -143.5 -179.57 20.2 Favored Glycine 0 C--N 1.347 1.164 0 CA-C-O 120.117 -0.268 . . . . 71.31 113.057 -177.12 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 82.1 Cg_endo -82.4 158.21 17.06 Favored 'Trans proline' 0 C--N 1.367 1.523 0 C-N-CA 123.412 2.741 . . . . 74.55 112.561 175.241 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 73.83 18.83 79.69 Favored Glycine 0 CA--C 1.531 1.059 0 CA-C-N 115.524 -0.762 . . . . 72.44 114.467 178.867 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 97' ' ' ILE . . . . . 0.403 HG22 ' HA ' ' A' ' 92' ' ' HIS . 17.0 mm -78.93 108.28 12.33 Favored 'Isoleucine or valine' 0 CA--C 1.562 1.428 0 CA-C-N 117.533 0.666 . . . . 73.44 112.466 -171.824 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 98' ' ' LEU . . . . . 0.627 ' HG ' HG12 ' A' ' 114' ' ' ILE . 7.6 mp -87.21 117.93 26.29 Favored 'General case' 0 N--CA 1.488 1.468 0 C-N-CA 123.535 0.734 . . . . 75.04 111.033 175.923 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 99' ' ' SER . . . . . 0.651 ' HB3' ' HA ' ' A' ' 128' ' ' VAL . 2.7 p -139.78 143.5 36.93 Favored 'General case' 0 N--CA 1.476 0.874 0 N-CA-C 108.306 -0.998 . . . . 74.4 108.306 173.707 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 100' ' ' MET . . . . . 0.475 ' HA ' ' HA ' ' A' ' 112' ' ' PHE . 49.7 mtp -76.23 138.9 40.91 Favored 'General case' 0 N--CA 1.485 1.31 0 N-CA-C 109.689 -0.486 . . . . 75.14 109.689 -171.491 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 101' ' ' ALA . . . . . 0.503 ' HB1' ' HB2' ' A' ' 111' ' ' GLN . . . -75.69 158.25 32.57 Favored 'General case' 0 N--CA 1.481 1.082 0 CA-C-O 121.216 0.531 . . . . 75.13 111.635 -170.48 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 30.4 p-10 -162.67 163.13 27.13 Favored 'General case' 0 CA--C 1.537 0.453 0 CA-C-N 114.95 -1.023 . . . . 74.43 110.131 -179.361 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -103.91 1.67 31.61 Favored 'General case' 0 N--CA 1.473 0.707 0 C-N-CA 124.203 1.001 . . . . 75.54 110.196 169.686 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 149.45 -164.41 29.39 Favored Glycine 0 C--N 1.345 1.031 0 CA-C-O 119.273 -0.737 . . . . 61.14 111.466 -178.269 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 53.2 Cg_exo -56.89 141.73 93.14 Favored 'Trans proline' 0 C--N 1.368 1.6 0 C-N-CA 123.286 2.657 . . . . 75.14 112.795 175.978 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 63.9 t30 68.46 10.18 7.71 Favored 'General case' 0 N--CA 1.495 1.788 0 C-N-CA 125.102 1.361 . . . . 74.34 112.332 179.526 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 107' ' ' THR . . . . . 0.695 ' HA ' ' HD2' ' A' ' 82' ' ' LYS . 2.4 m -113.1 0.23 14.9 Favored 'General case' 0 CA--C 1.551 0.997 0 O-C-N 121.511 -0.743 . . . . 74.35 110.775 178.307 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 57.5 t30 -70.76 155.57 40.6 Favored 'General case' 0 N--CA 1.481 1.108 0 C-N-CA 123.784 0.834 . . . . 74.25 110.738 -178.034 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 89.76 0.73 78.13 Favored Glycine 0 N--CA 1.468 0.773 0 CA-C-N 116.713 -0.221 . . . . 73.22 113.55 179.026 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 110' ' ' SER . . . . . 0.437 ' HB2' ' HA ' ' A' ' 73' ' ' THR . 79.6 p -100.25 120.64 40.22 Favored 'General case' 0 CA--C 1.531 0.22 0 N-CA-C 108.012 -1.107 . . . . 72.34 108.012 173.731 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 111' ' ' GLN . . . . . 0.503 ' HB2' ' HB1' ' A' ' 101' ' ' ALA . 49.4 mt-30 62.53 176.57 0.14 Allowed 'General case' 0 N--CA 1.492 1.66 0 C-N-CA 123.609 0.764 . . . . 75.53 111.769 -174.839 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 112' ' ' PHE . . . . . 0.475 ' HA ' ' HA ' ' A' ' 100' ' ' MET . 29.1 p90 -147.13 133.71 19.85 Favored 'General case' 0 N--CA 1.471 0.622 0 N-CA-C 108.021 -1.103 . . . . 72.41 108.021 172.932 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 113' ' ' PHE . . . . . 0.548 ' HB2' ' SD ' ' A' ' 61' ' ' MET . 46.4 p90 -113.49 134.3 54.75 Favored 'General case' 0 C--O 1.239 0.539 0 CA-C-O 121.235 0.54 . . . . 71.34 110.751 178.349 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 114' ' ' ILE . . . . . 0.627 HG12 ' HG ' ' A' ' 98' ' ' LEU . 22.1 mt -99.96 101.04 11.56 Favored 'Isoleucine or valine' 0 C--O 1.239 0.532 0 N-CA-C 108.047 -1.094 . . . . 74.52 108.047 176.612 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 115' ' ' CYS . . . . . 0.616 ' SG ' ' HE1' ' A' ' 61' ' ' MET . 32.4 m -65.92 103.78 0.99 Allowed 'General case' 0 N--CA 1.467 0.388 0 N-CA-C 108.611 -0.885 . . . . 73.33 108.611 174.485 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 116' ' ' THR . . . . . 0.508 HG21 HG12 ' A' ' 139' ' ' VAL . 35.6 p -70.04 -28.86 65.81 Favored 'General case' 0 N--CA 1.48 1.05 0 C-N-CA 123.707 0.803 . . . . 75.14 110.675 -177.206 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -119.49 168.25 11.16 Favored 'General case' 0 C--O 1.243 0.72 0 C-N-CA 124.051 0.941 . . . . 63.21 109.279 171.159 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 13.3 ptmm? -72.55 89.3 1.28 Allowed 'General case' 0 C--O 1.246 0.89 0 CA-C-O 121.657 0.742 . . . . 74.34 110.3 178.1 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 119' ' ' THR . . . . . 0.504 ' HB ' HD13 ' A' ' 122' ' ' LEU . 37.6 p -71.22 89.2 0.85 Allowed 'General case' 0 CA--C 1.542 0.651 0 CA-C-O 122.0 0.905 . . . . 65.23 108.971 176.829 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 9.5 pt-20 -75.98 -21.44 56.95 Favored 'General case' 0 N--CA 1.475 0.788 0 CA-C-N 114.578 -1.192 . . . . 63.25 111.773 -171.486 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 121' ' ' TRP . . . . . . . . . . . . . 33.1 p90 -77.18 -0.84 26.58 Favored 'General case' 0 CA--C 1.549 0.937 0 C-N-CA 123.581 0.752 . . . . 72.14 110.829 172.35 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 122' ' ' LEU . . . . . 0.541 ' HA ' ' HE2' ' A' ' 125' ' ' LYS . 10.9 mp -101.97 7.04 41.5 Favored 'General case' 0 N--CA 1.474 0.727 0 C-N-CA 123.682 0.793 . . . . 74.41 110.879 170.832 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 93.8 m-20 -84.82 128.09 34.45 Favored 'General case' 0 N--CA 1.475 0.776 0 N-CA-C 109.588 -0.523 . . . . 53.51 109.588 173.558 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 94.42 7.41 60.55 Favored Glycine 0 C--N 1.345 1.043 0 N-CA-C 111.69 -0.564 . . . . 62.22 111.69 -168.454 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 125' ' ' LYS . . . . . 0.541 ' HE2' ' HA ' ' A' ' 122' ' ' LEU . 19.4 ttmm -104.26 -167.39 1.35 Allowed 'General case' 0 CA--C 1.552 1.049 0 C-N-CA 124.918 1.287 . . . . 73.35 108.375 179.021 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 126' ' ' HIS . . . . . 0.495 ' H ' ' HG2' ' A' ' 125' ' ' LYS . 42.5 p-80 -67.75 155.61 38.89 Favored 'General case' 0 C--O 1.244 0.769 0 CA-C-O 121.245 0.545 . . . . 74.35 111.672 -175.575 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 127' ' ' VAL . . . . . 0.643 HG23 ' H ' ' A' ' 90' ' ' LEU . 11.0 p -64.0 148.37 11.67 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.938 0 CA-C-N 113.988 -1.46 . . . . 70.32 112.99 -174.537 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 128' ' ' VAL . . . . . 0.651 ' HA ' ' HB3' ' A' ' 99' ' ' SER . 94.7 t -81.39 155.57 4.17 Favored 'Isoleucine or valine' 0 CA--C 1.551 1.0 0 C-N-CA 125.421 1.488 . . . . 71.25 109.23 172.055 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 129' ' ' PHE . . . . . 0.502 ' HA ' HG21 ' A' ' 29' ' ' VAL . 48.7 p90 -119.35 -24.33 6.41 Favored 'General case' 0 N--CA 1.487 1.383 0 CA-C-N 118.549 0.613 . . . . 75.11 111.603 177.416 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . -158.88 177.1 35.61 Favored Glycine 0 C--N 1.344 1.01 0 O-C-N 123.183 0.302 . . . . 45.2 112.468 -174.92 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 34.4 ttpt -153.33 147.41 25.58 Favored 'General case' 0 N--CA 1.472 0.671 0 C-N-CA 123.484 0.714 . . . . 74.45 109.3 -179.877 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 132' ' ' VAL . . . . . 0.428 HG21 ' HE1' ' A' ' 22' ' ' PHE . 16.9 t -68.29 120.33 15.55 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.552 0 N-CA-C 109.253 -0.647 . . . . 74.23 109.253 176.203 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 133' ' ' LYS . . . . . 0.551 ' HD2' ' HB2' ' A' ' 23' ' ' GLU . 20.6 ptmt -100.2 -33.54 10.39 Favored 'General case' 0 N--CA 1.477 0.895 0 N-CA-C 109.584 -0.524 . . . . 74.43 109.584 176.49 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 134' ' ' GLU . . . . . 0.492 ' HB2' ' HB2' ' A' ' 21' ' ' SER . 31.5 mt-10 -144.29 149.63 36.57 Favored 'General case' 0 N--CA 1.478 0.97 0 C-N-CA 125.166 1.387 . . . . 72.03 108.654 -178.516 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 83.43 17.44 66.47 Favored Glycine 0 C--N 1.339 0.742 0 N-CA-C 112.182 -0.367 . . . . 62.41 112.182 -177.701 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 136' ' ' MET . . . . . . . . . . . . . 15.7 tpt -64.01 -34.78 78.79 Favored 'General case' 0 C--N 1.354 0.796 0 C-N-CA 123.863 0.865 . . . . 73.11 110.913 -179.527 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 137' ' ' ASN . . . . . . . . . . . . . 27.3 t-20 -58.75 -42.31 88.57 Favored 'General case' 0 CA--C 1.542 0.644 0 C-N-CA 123.588 0.755 . . . . 73.24 110.568 174.049 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 138' ' ' ILE . . . . . . . . . . . . . 48.9 mm -67.67 -35.64 73.44 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.956 0 C-N-CA 123.331 0.652 . . . . 75.15 110.657 178.925 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 139' ' ' VAL . . . . . 0.508 HG12 HG21 ' A' ' 116' ' ' THR . 94.3 t -65.8 -37.98 81.15 Favored 'Isoleucine or valine' 0 CA--C 1.559 1.32 0 C-N-CA 123.941 0.896 . . . . 72.4 110.93 176.772 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 39.0 mt-10 -77.02 -27.55 54.63 Favored 'General case' 0 N--CA 1.48 1.04 0 C-N-CA 123.537 0.735 . . . . 74.42 111.186 177.625 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -72.65 -46.98 51.27 Favored 'General case' 0 N--CA 1.48 1.069 0 C-N-CA 123.338 0.655 . . . . 71.21 110.305 178.717 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 142' ' ' MET . . . . . 0.535 ' HA ' ' HD2' ' A' ' 145' ' ' PHE . 27.3 ptm -68.48 -30.34 69.16 Favored 'General case' 0 N--CA 1.475 0.81 0 CA-C-N 115.475 -0.784 . . . . 75.22 110.962 178.106 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 143' ' ' GLU . . . . . 0.451 ' HG2' ' HA ' ' A' ' 58' ' ' PRO . 35.8 tt0 -55.11 -42.26 72.69 Favored 'General case' 0 C--N 1.364 1.203 0 O-C-N 123.807 0.692 . . . . 74.55 111.361 174.71 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 144' ' ' ARG . . . . . . . . . . . . . 51.5 mtp180 -64.79 -22.91 67.09 Favored 'General case' 0 N--CA 1.473 0.715 0 CA-C-N 115.376 -0.829 . . . . 74.04 112.189 -178.233 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 145' ' ' PHE . . . . . 0.535 ' HD2' ' HA ' ' A' ' 142' ' ' MET . 47.7 m-85 -83.53 -1.02 52.79 Favored 'General case' 0 N--CA 1.479 0.987 0 C-N-CA 122.768 0.427 . . . . 74.24 111.876 179.426 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 146' ' ' GLY . . . . . 0.523 ' HA2' ' HA ' ' A' ' 152' ' ' THR . . . -96.71 172.06 28.17 Favored Glycine 0 C--N 1.342 0.867 0 N-CA-C 112.687 -0.165 . . . . 61.3 112.687 177.597 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 16.2 m -128.1 156.48 42.75 Favored 'General case' 0 N--CA 1.481 1.112 0 C-N-CA 123.845 0.858 . . . . 74.23 109.801 -178.332 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 148' ' ' ARG . . . . . 0.667 ' HA ' HG23 ' A' ' 57' ' ' ILE . 26.2 mmm-85 -58.53 -31.66 68.13 Favored 'General case' 0 N--CA 1.48 1.048 0 C-N-CA 124.595 1.158 . . . . 73.41 113.279 -174.359 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 149' ' ' ASN . . . . . . . . . . . . . 29.9 p-10 -77.7 -12.27 59.96 Favored 'General case' 0 N--CA 1.476 0.844 0 C-N-CA 123.364 0.666 . . . . 74.1 111.983 -178.279 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 150' ' ' GLY . . . . . 0.406 ' O ' ' HA ' ' A' ' 55' ' ' ARG . . . 106.45 6.05 36.27 Favored Glycine 0 C--N 1.348 1.2 0 CA-C-O 120.046 -0.308 . . . . 74.13 113.165 179.487 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 86.9 tttt -90.07 122.99 33.55 Favored 'General case' 0 N--CA 1.471 0.619 0 C-N-CA 123.08 0.552 . . . . 74.11 109.866 178.587 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 152' ' ' THR . . . . . 0.523 ' HA ' ' HA2' ' A' ' 146' ' ' GLY . 21.1 m -90.67 113.56 25.65 Favored 'General case' 0 CA--C 1.536 0.425 0 N-CA-C 108.82 -0.807 . . . . 73.43 108.82 174.978 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 153' ' ' SER . . . . . . . . . . . . . 9.1 m -52.8 -32.84 46.15 Favored 'General case' 0 N--CA 1.48 1.07 0 C-N-CA 124.646 1.178 . . . . 72.11 112.367 -178.394 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 70.7 mmtt -109.24 150.02 28.55 Favored 'General case' 0 N--CA 1.469 0.509 0 C-N-CA 124.358 1.063 . . . . 75.41 110.631 -175.731 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 75.0 mmtt -83.01 90.32 7.0 Favored 'General case' 0 N--CA 1.468 0.456 0 N-CA-C 108.527 -0.916 . . . . 71.42 108.527 172.542 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 156' ' ' ILE . . . . . 0.493 HG21 ' HE2' ' A' ' 142' ' ' MET . 54.0 mt -100.35 108.49 23.08 Favored 'Isoleucine or valine' 0 C--O 1.221 -0.43 0 CA-C-N 114.981 -1.009 . . . . 75.44 109.04 -175.693 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 157' ' ' THR . . . . . . . . . . . . . 56.9 p -118.47 159.71 23.01 Favored 'General case' 0 N--CA 1.473 0.713 0 C-N-CA 124.07 0.948 . . . . 72.32 110.53 -175.342 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 158' ' ' ILE . . . . . . . . . . . . . 62.5 mt -77.22 94.09 1.28 Allowed 'Isoleucine or valine' 0 CA--C 1.548 0.892 0 N-CA-C 108.988 -0.745 . . . . 71.44 108.988 170.398 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 159' ' ' ALA . . . . . 0.678 ' HB2' ' HB1' ' A' ' 11' ' ' ALA . . . -51.82 -49.56 62.55 Favored 'General case' 0 N--CA 1.483 1.21 0 C-N-CA 124.446 1.098 . . . . 64.21 112.411 -178.764 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 160' ' ' ASP . . . . . . . . . . . . . 19.7 t70 -152.92 169.94 21.6 Favored 'General case' 0 CA--C 1.546 0.805 0 CA-C-N 116.257 -0.428 . . . . 74.33 111.208 -179.351 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 161' ' ' CYS . . . . . . . . . . . . . 46.4 m -136.48 -168.93 2.34 Favored 'General case' 0 N--CA 1.47 0.56 0 C-N-CA 125.138 1.375 . . . . 73.31 108.623 -177.148 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 162' ' ' GLY . . . . . . . . . . . . . . . 132.44 53.52 0.08 OUTLIER Glycine 0 C--N 1.344 0.986 0 N-CA-C 111.025 -0.83 . . . . 72.32 111.025 -172.929 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 163' ' ' GLN . . . . . 0.654 ' HG3' ' HA ' ' A' ' 6' ' ' VAL . 46.8 tt0 -46.69 104.12 0.05 OUTLIER 'General case' 0 N--CA 1.481 1.086 0 C-N-CA 125.281 1.432 . . . . 71.2 112.312 -176.756 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 164' ' ' LEU . . . . . 0.42 ' O ' ' HB ' ' A' ' 5' ' ' THR . 64.9 mt . . . . . 0 N--CA 1.468 0.432 0 N-CA-C 107.272 -1.381 . . . . 73.23 107.272 -179.542 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 218' ' ' PRO . . . . . . . . . . . . . 15.4 Cg_exo . . . . . 0 CA--C 1.546 1.079 0 N-CA-C 111.234 -0.333 . . . . 71.33 111.234 . . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' B' B ' 219' ' ' GLY . . . . . . . . . . . . . . . 130.63 163.97 11.15 Favored Glycine 0 CA--C 1.531 1.065 0 CA-C-O 119.605 -0.553 . . . . 63.01 112.372 177.67 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 220' ' ' PRO . . . . . 0.441 ' HG3' HD23 ' A' ' 122' ' ' LEU . 96.3 Cg_endo -78.39 160.03 29.13 Favored 'Trans proline' 0 C--N 1.368 1.56 0 C-N-CA 123.669 2.912 . . . . 72.53 113.025 -175.394 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 221' ' ' TYR . . . . . . . . . . . . . 49.1 m-85 . . . . . 0 N--CA 1.475 0.783 0 C-N-CA 123.493 0.717 . . . . 72.25 111.651 -173.123 . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 13.7 m120 . . . . . 0 C--O 1.241 0.655 0 N-CA-C 107.498 -1.297 . . . . 74.23 107.498 . . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 4' ' ' PRO . . . . . 0.663 ' HB3' HH11 ' A' ' 37' ' ' ARG . 48.8 Cg_endo -69.18 119.76 6.7 Favored 'Trans proline' 0 C--N 1.371 1.745 0 C-N-CA 122.107 1.871 . . . . 72.53 110.917 177.35 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 86.6 m -96.84 117.85 31.98 Favored 'General case' 0 C--O 1.217 -0.61 0 N-CA-C 106.906 -1.516 . . . . 74.42 106.906 173.234 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 5.3 m -98.22 122.12 49.52 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.421 0 CA-C-O 121.782 0.801 . . . . 75.41 109.485 -176.537 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 7' ' ' PHE . . . . . 0.531 ' H ' ' HA ' ' A' ' 163' ' ' GLN . 73.2 t80 -100.75 131.79 46.47 Favored 'General case' 0 C--O 1.236 0.365 0 CA-C-N 114.485 -1.234 . . . . 75.03 108.893 -175.031 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 8' ' ' PHE . . . . . 0.475 ' HB3' HG23 ' A' ' 158' ' ' ILE . 44.2 m-85 -132.04 165.01 24.95 Favored 'General case' 0 C--O 1.24 0.566 0 C-N-CA 124.489 1.116 . . . . 70.43 109.125 170.566 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 49.5 m-20 -112.94 111.07 21.55 Favored 'General case' 0 C--N 1.326 -0.442 0 N-CA-C 107.564 -1.272 . . . . 72.15 107.564 169.281 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 10' ' ' ILE . . . . . 0.453 HG23 ' SD ' ' A' ' 142' ' ' MET . 41.3 mm -80.04 115.26 22.17 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.412 0 N-CA-C 108.518 -0.919 . . . . 75.3 108.518 179.154 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 11' ' ' ALA . . . . . 0.574 ' HB1' ' HB3' ' A' ' 159' ' ' ALA . . . -116.79 128.62 55.46 Favored 'General case' 0 N--CA 1.47 0.56 0 C-N-CA 123.793 0.837 . . . . 64.42 111.21 -173.761 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 73.2 t -95.8 113.64 30.66 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.616 0 N-CA-C 108.097 -1.075 . . . . 75.34 108.097 173.585 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 48.0 m-20 63.91 23.93 13.51 Favored 'General case' 0 N--CA 1.489 1.502 0 C-N-CA 125.567 1.547 . . . . 64.21 111.731 -178.676 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 96.85 -20.45 50.65 Favored Glycine 0 C--N 1.341 0.841 0 CA-C-O 119.569 -0.573 . . . . 63.21 112.838 -177.326 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 50.6 mm-40 -84.22 114.32 53.84 Favored Pre-proline 0 N--CA 1.476 0.841 0 CA-C-N 117.299 0.55 . . . . 73.23 110.215 178.353 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 76.5 Cg_exo -50.48 109.35 0.29 Allowed 'Trans proline' 0 C--N 1.382 2.309 0 C-N-CA 123.684 2.923 . . . . 74.02 112.802 177.875 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 44.3 tp -77.06 -45.01 28.54 Favored 'General case' 0 N--CA 1.473 0.701 0 N-CA-C 109.114 -0.698 . . . . 74.52 109.114 177.653 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -168.35 170.8 42.32 Favored Glycine 0 C--N 1.342 0.891 0 CA-C-N 115.873 -0.603 . . . . 74.25 112.543 179.694 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 69.3 mtt-85 -107.04 125.98 51.74 Favored 'General case' 0 N--CA 1.474 0.759 0 C-N-CA 123.718 0.807 . . . . 72.13 108.955 -176.466 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 93.1 t -121.76 144.92 29.36 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.769 0 C-N-CA 123.512 0.725 . . . . 73.22 110.11 -176.77 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 21' ' ' SER . . . . . 0.483 ' HB2' ' HB2' ' A' ' 134' ' ' GLU . 60.0 m -141.21 128.21 20.67 Favored 'General case' 0 CA--C 1.541 0.602 0 C-N-CA 124.733 1.213 . . . . 72.34 108.925 178.447 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 57.9 m-85 -109.59 121.35 45.01 Favored 'General case' 0 N--CA 1.476 0.83 0 C-N-CA 123.248 0.619 . . . . 73.01 110.02 -178.242 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 38.0 tt0 -74.53 104.23 5.16 Favored 'General case' 0 CA--C 1.547 0.854 0 C-N-CA 123.533 0.733 . . . . 74.52 109.192 171.36 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . 0.522 ' HB2' ' HG2' ' A' ' 4' ' ' PRO . 38.4 mt -85.6 123.83 31.46 Favored 'General case' 0 C--O 1.241 0.627 0 N-CA-C 109.114 -0.699 . . . . 75.01 109.114 175.971 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 25' ' ' PHE . . . . . 0.538 ' HD2' ' HZ1' ' A' ' 28' ' ' LYS . 58.0 m-85 -83.16 76.44 9.86 Favored 'General case' 0 CA--C 1.543 0.674 0 C-N-CA 123.498 0.719 . . . . 74.53 110.52 -177.043 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -71.14 -6.63 40.81 Favored 'General case' 0 N--CA 1.489 1.482 0 C-N-CA 122.913 0.485 . . . . 63.45 112.004 178.363 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 10.1 p-10 -89.07 -17.38 29.42 Favored 'General case' 0 CA--C 1.554 1.104 0 C-N-CA 123.746 0.819 . . . . 73.25 111.343 176.344 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 28' ' ' LYS . . . . . 0.538 ' HZ1' ' HD2' ' A' ' 25' ' ' PHE . 57.2 mttp -112.59 -44.78 3.3 Favored 'General case' 0 N--CA 1.494 1.758 0 C-N-CA 123.441 0.697 . . . . 73.22 111.033 -176.185 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 29' ' ' VAL . . . . . 0.496 HG23 ' HA ' ' A' ' 129' ' ' PHE . 12.0 m -127.91 62.97 59.49 Favored Pre-proline 0 CA--C 1.566 1.59 0 C-N-CA 124.448 1.099 . . . . 75.23 110.267 177.382 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 2.8 Cg_endo -49.83 -41.34 47.15 Favored 'Trans proline' 0 C--N 1.391 2.78 0 C-N-CA 123.41 2.74 . . . . 75.43 114.717 -172.994 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 31' ' ' LYS . . . . . 0.484 ' HG3' ' HH ' ' A' ' 79' ' ' TYR . 39.3 ttpt -64.46 -49.96 69.4 Favored 'General case' 0 N--CA 1.476 0.837 0 C-N-CA 123.449 0.699 . . . . 75.44 111.132 -177.496 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 7.1 m -76.01 -31.64 59.02 Favored 'General case' 0 CA--C 1.55 0.974 0 CA-C-N 115.115 -0.948 . . . . 73.33 111.504 -171.034 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -74.29 -46.93 38.08 Favored 'General case' 0 CA--C 1.543 0.704 0 C-N-CA 123.695 0.798 . . . . 72.4 110.336 177.976 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 11.6 tp10 -66.34 -29.66 69.89 Favored 'General case' 0 N--CA 1.482 1.134 0 C-N-CA 123.764 0.825 . . . . 71.41 110.979 178.852 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 35' ' ' ASN . . . . . 0.466 ' O ' ' HG ' ' A' ' 39' ' ' LEU . 25.8 t30 -54.06 -60.6 3.11 Favored 'General case' 0 N--CA 1.476 0.869 0 C-N-CA 123.826 0.85 . . . . 74.3 110.034 173.239 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 52.7 t80 -66.51 -34.84 78.83 Favored 'General case' 0 CA--C 1.541 0.598 0 O-C-N 124.224 0.953 . . . . 65.01 111.095 -175.094 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 37' ' ' ARG . . . . . 0.663 HH11 ' HB3' ' A' ' 4' ' ' PRO . 24.7 ttt180 -59.36 -45.56 91.05 Favored 'General case' 0 C--N 1.35 0.628 0 C-N-CA 123.541 0.736 . . . . 72.25 110.659 175.357 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 38' ' ' ALA . . . . . 0.556 ' HB2' ' HG2' ' A' ' 44' ' ' LYS . . . -73.3 -27.41 61.53 Favored 'General case' 0 CA--C 1.543 0.68 0 C-N-CA 123.434 0.694 . . . . 74.35 111.515 -177.956 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 39' ' ' LEU . . . . . 0.603 HD21 ' HE2' ' A' ' 48' ' ' TYR . 86.6 mt -72.97 -30.14 63.61 Favored 'General case' 0 N--CA 1.48 1.053 0 C-N-CA 123.462 0.705 . . . . 75.24 110.513 174.17 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 33.3 t -76.6 -53.95 7.35 Favored 'General case' 0 N--CA 1.478 0.946 0 C-N-CA 124.356 1.062 . . . . 75.2 110.898 179.452 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 44.0 p -76.83 -30.31 56.31 Favored 'General case' 0 N--CA 1.471 0.588 0 C-N-CA 124.401 1.08 . . . . 65.11 111.847 -174.523 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 79.86 30.89 41.6 Favored Glycine 0 C--N 1.341 0.851 0 CA-C-N 115.706 -0.679 . . . . 64.4 112.914 -179.076 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 55.7 mm-40 -58.33 -40.6 82.57 Favored 'General case' 0 N--CA 1.476 0.854 0 C-N-CA 123.079 0.551 . . . . 74.13 110.027 172.461 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 44' ' ' LYS . . . . . 0.556 ' HG2' ' HB2' ' A' ' 38' ' ' ALA . 28.4 mmmt -92.99 18.32 9.34 Favored 'General case' 0 CA--C 1.551 0.993 0 CA-C-N 115.315 -0.857 . . . . 72.41 111.379 -179.849 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 82.71 -8.87 61.02 Favored Glycine 0 C--N 1.35 1.335 0 N-CA-C 115.225 0.85 . . . . 72.54 115.225 172.872 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 46' ' ' PHE . . . . . 0.456 ' HE2' ' HA ' ' A' ' 78' ' ' ILE . 22.4 m-85 -82.09 -48.66 11.1 Favored 'General case' 0 N--CA 1.479 1.023 0 CA-C-N 117.713 0.756 . . . . 71.21 111.393 -170.224 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 38.04 62.6 1.02 Allowed Glycine 0 C--N 1.357 1.746 0 O-C-N 125.016 1.447 . . . . 42.31 116.186 168.278 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 48' ' ' TYR . . . . . 0.603 ' HE2' HD21 ' A' ' 39' ' ' LEU . 97.4 m-85 -62.18 92.85 0.04 OUTLIER 'General case' 0 N--CA 1.479 1.013 0 CA-C-O 121.908 0.861 . . . . 74.43 112.37 -170.736 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 49' ' ' LYS . . . . . 0.447 ' HE2' ' HA ' ' A' ' 160' ' ' ASP . 28.3 tptp -100.55 129.2 46.46 Favored 'General case' 0 C--O 1.237 0.436 0 C-N-CA 125.067 1.347 . . . . 74.04 107.954 179.593 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 73.63 20.5 79.82 Favored Glycine 0 C--N 1.345 1.045 0 O-C-N 123.33 0.394 . . . . 65.22 112.681 -176.007 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 51' ' ' SER . . . . . 0.451 ' HB2' ' HB3' ' A' ' 48' ' ' TYR . 22.7 t -64.92 119.83 11.43 Favored 'General case' 0 CA--C 1.546 0.819 0 C-N-CA 123.651 0.78 . . . . 74.11 109.901 -178.191 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 52' ' ' CYS . . . . . . . . . . . . . 37.6 t -93.36 153.79 18.33 Favored 'General case' 0 N--CA 1.472 0.642 0 C-N-CA 123.275 0.63 . . . . 71.11 111.959 -166.934 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 53' ' ' PHE . . . . . 0.474 ' HA ' ' HA2' ' A' ' 64' ' ' GLY . 45.9 m-85 -97.89 120.9 39.1 Favored 'General case' 0 C--O 1.237 0.412 0 C-N-CA 124.787 1.235 . . . . 74.55 108.04 172.724 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 19.5 p-80 -108.68 -36.71 6.09 Favored 'General case' 0 N--CA 1.479 0.996 0 C-N-CA 123.822 0.849 . . . . 71.43 110.146 -173.269 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 50.2 ttt180 -122.61 97.34 5.41 Favored 'General case' 0 C--O 1.217 -0.643 0 N-CA-C 108.703 -0.851 . . . . 73.24 108.703 -175.057 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 56' ' ' ILE . . . . . 0.488 HG23 ' HA ' ' A' ' 143' ' ' GLU . 44.9 mt -119.85 128.35 75.91 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.586 0 N-CA-C 108.192 -1.04 . . . . 70.21 108.192 172.931 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 57' ' ' ILE . . . . . 0.566 HG22 ' HA ' ' A' ' 148' ' ' ARG . 60.5 mt -120.68 124.86 27.37 Favored Pre-proline 0 CA--C 1.547 0.831 0 N-CA-C 108.34 -0.985 . . . . 74.22 108.34 175.436 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 58' ' ' PRO . . . . . 0.54 ' HA ' ' HG2' ' A' ' 143' ' ' GLU . 37.8 Cg_endo -63.1 141.69 84.22 Favored 'Trans proline' 0 C--N 1.383 2.352 0 C-N-CA 123.31 2.673 . . . . 71.43 112.505 -178.364 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 65.29 21.6 68.5 Favored Glycine 0 C--N 1.343 0.967 0 CA-C-N 115.326 -0.852 . . . . 73.51 113.717 -177.738 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 60' ' ' PHE . . . . . 0.439 ' HD2' ' HB ' ' A' ' 57' ' ' ILE . 27.8 t80 -138.01 -74.78 0.4 Allowed 'General case' 0 N--CA 1.468 0.447 0 N-CA-C 109.245 -0.65 . . . . 74.51 109.245 -172.42 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 61' ' ' MET . . . . . 0.59 ' HE3' ' HB3' ' A' ' 115' ' ' CYS . 11.9 ptp -175.31 154.1 1.66 Allowed 'General case' 0 N--CA 1.483 1.215 0 O-C-N 123.677 0.611 . . . . 75.15 112.501 -178.472 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 62' ' ' CYS . . . . . . . . . . . . . 56.7 m -102.94 109.74 21.4 Favored 'General case' 0 CA--C 1.539 0.539 0 CA-C-N 115.076 -0.965 . . . . 73.4 108.973 170.369 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 63' ' ' GLN . . . . . 0.472 ' HA ' ' HA ' ' A' ' 113' ' ' PHE . 53.1 tt0 -100.08 105.33 16.96 Favored 'General case' 0 C--O 1.248 0.977 0 CA-C-O 121.336 0.589 . . . . 71.54 109.901 -178.05 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 64' ' ' GLY . . . . . 0.474 ' HA2' ' HA ' ' A' ' 53' ' ' PHE . . . -110.79 -153.38 13.2 Favored Glycine 0 C--N 1.344 1.006 0 CA-C-N 114.466 -1.243 . . . . 72.11 111.31 174.931 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 86.05 -35.6 3.25 Favored Glycine 0 C--N 1.344 1.025 0 N-CA-C 111.856 -0.498 . . . . 62.54 111.856 -173.494 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 66' ' ' ASP . . . . . 0.546 ' HB2' ' HG2' ' A' ' 111' ' ' GLN . 35.5 t70 -66.54 103.1 0.99 Allowed 'General case' 0 N--CA 1.445 -0.688 0 C-N-CA 124.836 1.254 . . . . 74.42 110.686 -177.855 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 71.5 t80 -156.92 -68.83 0.1 Allowed 'General case' 0 C--O 1.239 0.521 0 N-CA-C 108.361 -0.978 . . . . 75.14 108.361 177.919 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 27.5 m -79.25 122.06 25.85 Favored 'General case' 0 C--O 1.24 0.57 0 CA-C-N 115.49 -0.777 . . . . 54.54 108.943 178.693 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 49.5 mtt85 65.94 36.06 6.16 Favored 'General case' 0 N--CA 1.482 1.159 0 C-N-CA 124.302 1.041 . . . . 73.01 111.538 177.787 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 1.2 t60 -41.1 -52.73 3.2 Favored 'General case' 0 N--CA 1.494 1.741 0 C-N-CA 125.804 1.642 . . . . 75.12 113.88 -175.273 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 93.2 m-20 -65.58 99.77 0.46 Allowed 'General case' 0 N--CA 1.477 0.887 0 C-N-CA 123.118 0.567 . . . . 72.44 110.777 -175.847 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 88.29 -7.05 82.73 Favored Glycine 0 C--N 1.345 1.044 0 CA-C-N 115.677 -0.692 . . . . 74.22 114.688 174.689 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 73' ' ' THR . . . . . 0.435 ' O ' ' HB3' ' A' ' 110' ' ' SER . 26.1 m -137.09 -83.02 0.35 Allowed 'General case' 0 N--CA 1.48 1.072 0 CA-C-N 118.076 0.938 . . . . 65.55 110.526 -178.049 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 74' ' ' GLY . . . . . 0.438 ' O ' ' HG3' ' A' ' 111' ' ' GLN . . . 71.95 64.12 2.78 Favored Glycine 0 C--N 1.354 1.535 0 N-CA-C 114.371 0.508 . . . . 71.53 114.371 173.171 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 97.43 54.53 1.24 Allowed Glycine 0 N--CA 1.472 1.052 0 C-N-CA 120.309 -0.948 . . . . 64.33 112.305 176.016 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 64.3 pttt -61.05 172.15 1.08 Allowed 'General case' 0 CA--C 1.551 1.001 0 C-N-CA 123.959 0.904 . . . . 74.35 113.283 -175.4 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 88.1 p -90.57 179.42 5.84 Favored 'General case' 0 C--O 1.242 0.684 0 CA-C-N 115.212 -0.904 . . . . 70.21 111.187 -176.146 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 78' ' ' ILE . . . . . 0.456 ' HA ' ' HE2' ' A' ' 46' ' ' PHE . 35.0 pt -74.56 -15.54 16.25 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.663 0 CA-C-N 115.72 -0.673 . . . . 71.41 111.359 177.608 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 79' ' ' TYR . . . . . 0.484 ' HH ' ' HG3' ' A' ' 31' ' ' LYS . 82.1 m-85 -95.0 11.27 32.57 Favored 'General case' 0 N--CA 1.475 0.821 0 C-N-CA 123.735 0.814 . . . . 74.22 111.35 177.287 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 105.88 -146.08 16.02 Favored Glycine 0 C--N 1.345 1.053 0 N-CA-C 111.244 -0.742 . . . . 71.12 111.244 -179.253 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 81' ' ' GLU . . . . . 0.407 ' HG2' ' HZ2' ' A' ' 82' ' ' LYS . 36.1 tt0 -57.81 -38.5 75.66 Favored 'General case' 0 N--CA 1.477 0.877 0 C-N-CA 124.08 0.952 . . . . 74.24 111.423 -178.227 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 82' ' ' LYS . . . . . 0.407 ' HZ2' ' HG2' ' A' ' 81' ' ' GLU . 3.8 ptpp? -160.15 172.48 17.36 Favored 'General case' 0 N--CA 1.474 0.743 0 C-N-CA 123.417 0.687 . . . . 74.0 111.805 -177.451 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 4.1 p90 -159.07 171.89 19.16 Favored 'General case' 0 CA--C 1.544 0.726 0 C-N-CA 125.012 1.325 . . . . 73.14 109.514 177.657 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 84' ' ' GLU . . . . . 0.506 ' HA ' ' HA ' ' A' ' 106' ' ' ASN . 12.6 pt-20 -81.67 158.4 24.29 Favored 'General case' 0 N--CA 1.475 0.776 0 C-N-CA 123.574 0.75 . . . . 74.32 111.758 -177.319 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 52.7 m-20 -81.85 143.74 31.51 Favored 'General case' 0 N--CA 1.476 0.875 0 C-N-CA 123.761 0.824 . . . . 75.33 109.269 173.294 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 12.5 tp10 -83.21 -59.38 2.48 Favored 'General case' 0 N--CA 1.477 0.883 0 CA-C-O 121.278 0.561 . . . . 71.4 111.051 -174.551 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 32.0 p30 -153.68 -167.5 2.7 Favored 'General case' 0 N--CA 1.472 0.673 0 C-N-CA 123.747 0.819 . . . . 70.12 109.157 -174.167 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 81.4 m-85 -138.58 39.49 2.22 Favored 'General case' 0 N--CA 1.482 1.166 0 C-N-CA 123.717 0.807 . . . . 73.54 110.451 178.046 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 67.8 mt -62.31 -38.18 80.49 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.324 0 CA-C-O 121.531 0.681 . . . . 73.33 109.904 174.612 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 90' ' ' LEU . . . . . 0.654 ' HB3' ' HB ' ' A' ' 128' ' ' VAL . 95.4 mt -98.9 150.62 21.73 Favored 'General case' 0 CA--C 1.543 0.705 0 C-N-CA 124.088 0.955 . . . . 74.45 110.893 179.379 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 47.2 pttt -158.77 163.87 36.35 Favored 'General case' 0 N--CA 1.482 1.172 0 C-N-CA 124.165 0.986 . . . . 75.21 110.294 -170.946 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 92' ' ' HIS . . . . . 0.4 ' HA ' HG13 ' A' ' 97' ' ' ILE . 13.3 m-70 -88.89 63.38 6.76 Favored 'General case' 0 N--CA 1.488 1.439 0 C-N-CA 123.63 0.772 . . . . 74.31 109.93 -175.196 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 15.3 p -90.8 2.57 55.97 Favored 'General case' 0 N--CA 1.48 1.064 0 C-N-CA 123.849 0.86 . . . . 74.12 111.811 178.508 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -157.27 173.36 34.79 Favored Glycine 0 C--N 1.343 0.926 0 CA-C-N 116.653 -0.248 . . . . 61.31 112.918 -178.644 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 86.2 Cg_endo -78.16 157.1 30.05 Favored 'Trans proline' 0 C--N 1.362 1.249 0 C-N-CA 123.276 2.651 . . . . 74.0 112.64 175.895 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 79.63 18.77 72.51 Favored Glycine 0 C--N 1.342 0.871 0 CA-C-N 115.694 -0.685 . . . . 61.1 114.476 175.396 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 97' ' ' ILE . . . . . 0.673 ' HB ' ' SG ' ' A' ' 115' ' ' CYS . 19.0 mm -73.03 128.54 35.85 Favored 'Isoleucine or valine' 0 CA--C 1.554 1.119 0 C-N-CA 123.967 0.907 . . . . 75.21 110.592 178.932 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 98' ' ' LEU . . . . . 0.486 HD11 HG12 ' A' ' 114' ' ' ILE . 67.7 tp -103.88 122.71 45.72 Favored 'General case' 0 C--O 1.252 1.207 0 C-N-CA 123.637 0.775 . . . . 73.52 110.13 176.139 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 99' ' ' SER . . . . . 0.416 ' HB3' ' HD2' ' A' ' 126' ' ' HIS . 50.7 m -145.34 139.68 27.18 Favored 'General case' 0 CA--C 1.555 1.155 0 C-N-CA 124.735 1.214 . . . . 72.24 109.418 179.744 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 100' ' ' MET . . . . . 0.654 ' HA ' ' HA ' ' A' ' 112' ' ' PHE . 85.9 mtp -76.57 147.54 37.61 Favored 'General case' 0 N--CA 1.491 1.605 0 C-N-CA 123.877 0.871 . . . . 74.31 111.647 178.48 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -75.25 145.77 41.66 Favored 'General case' 0 N--CA 1.479 0.995 0 C-N-CA 123.654 0.782 . . . . 65.53 111.843 -175.261 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 102' ' ' ASN . . . . . 0.405 ' HB3' ' HA ' ' A' ' 108' ' ' ASN . 26.9 p-10 -168.54 173.04 7.72 Favored 'General case' 0 N--CA 1.477 0.908 0 C-N-CA 123.958 0.903 . . . . 75.11 110.675 -178.902 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -91.45 -47.81 7.23 Favored 'General case' 0 N--CA 1.471 0.578 0 CA-C-N 115.7 -0.682 . . . . 65.21 109.551 168.636 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -163.1 -161.2 12.09 Favored Glycine 0 C--N 1.345 1.074 0 CA-C-N 115.512 -0.767 . . . . 62.22 111.973 178.111 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 51.9 Cg_exo -55.8 135.68 70.73 Favored 'Trans proline' 0 C--N 1.375 1.965 0 C-N-CA 123.417 2.745 . . . . 70.23 112.608 179.133 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 106' ' ' ASN . . . . . 0.506 ' HA ' ' HA ' ' A' ' 84' ' ' GLU . 64.9 t30 69.45 11.22 7.99 Favored 'General case' 0 N--CA 1.484 1.261 0 C-N-CA 124.982 1.313 . . . . 64.43 112.247 179.269 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 8.8 m -105.08 -12.98 15.89 Favored 'General case' 0 CA--C 1.552 1.057 0 C-N-CA 123.452 0.701 . . . . 71.21 109.576 171.549 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 108' ' ' ASN . . . . . 0.405 ' HA ' ' HB3' ' A' ' 102' ' ' ASN . 15.1 t30 -57.88 146.6 31.44 Favored 'General case' 0 N--CA 1.481 1.081 0 C-N-CA 125.609 1.563 . . . . 72.53 111.451 175.306 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 113.13 21.15 6.02 Favored Glycine 0 N--CA 1.471 1.02 0 N-CA-C 113.996 0.359 . . . . 51.32 113.996 175.944 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 110' ' ' SER . . . . . 0.435 ' HB3' ' O ' ' A' ' 73' ' ' THR . 69.0 m -138.36 122.62 18.16 Favored 'General case' 0 N--CA 1.474 0.765 0 N-CA-C 108.744 -0.836 . . . . 73.01 108.744 171.546 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 111' ' ' GLN . . . . . 0.546 ' HG2' ' HB2' ' A' ' 66' ' ' ASP . 18.1 mt-30 65.72 170.92 0.22 Allowed 'General case' 0 N--CA 1.498 1.953 0 C-N-CA 124.302 1.041 . . . . 75.11 111.802 -178.255 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 112' ' ' PHE . . . . . 0.654 ' HA ' ' HA ' ' A' ' 100' ' ' MET . 53.2 p90 -150.07 138.81 20.82 Favored 'General case' 0 N--CA 1.479 0.978 0 C-N-CA 123.118 0.567 . . . . 73.43 110.102 174.975 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 113' ' ' PHE . . . . . 0.472 ' HA ' ' HA ' ' A' ' 63' ' ' GLN . 42.9 p90 -111.84 144.99 40.24 Favored 'General case' 0 C--O 1.24 0.588 0 C-N-CA 123.753 0.821 . . . . 74.32 110.668 174.435 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 114' ' ' ILE . . . . . 0.486 HG12 HD11 ' A' ' 98' ' ' LEU . 8.2 mt -116.46 99.67 8.81 Favored 'Isoleucine or valine' 0 C--O 1.24 0.577 0 N-CA-C 106.919 -1.511 . . . . 74.11 106.919 178.232 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 115' ' ' CYS . . . . . 0.673 ' SG ' ' HB ' ' A' ' 97' ' ' ILE . 19.3 p -84.45 118.05 24.04 Favored 'General case' 0 N--CA 1.472 0.644 0 C-N-CA 122.404 0.282 . . . . 73.34 110.758 -175.768 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 59.5 p -78.65 1.17 23.69 Favored 'General case' 0 N--CA 1.481 1.075 0 C-N-CA 124.052 0.941 . . . . 74.42 111.902 -179.024 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -133.22 162.22 32.35 Favored 'General case' 0 C--O 1.244 0.787 0 C-N-CA 123.704 0.802 . . . . 71.01 109.966 -179.827 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 8.8 ptmt -71.82 81.51 0.89 Allowed 'General case' 0 CA--C 1.549 0.937 0 CA-C-O 121.846 0.831 . . . . 74.54 109.415 171.944 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 119' ' ' THR . . . . . 0.433 ' HB ' HD21 ' A' ' 122' ' ' LEU . 32.2 p -82.56 85.31 7.0 Favored 'General case' 0 CA--C 1.55 0.971 0 CA-C-O 122.147 0.975 . . . . 72.51 109.309 -177.331 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 12.8 pt-20 -74.57 -27.64 60.58 Favored 'General case' 0 N--CA 1.48 1.06 0 CA-C-N 114.67 -1.15 . . . . 71.04 112.318 -167.724 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 121' ' ' TRP . . . . . . . . . . . . . 46.5 p90 -67.49 -1.75 5.39 Favored 'General case' 0 N--CA 1.483 1.2 0 C-N-CA 123.747 0.819 . . . . 73.03 112.238 178.352 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 122' ' ' LEU . . . . . 0.438 HD13 ' HG3' ' B' ' 220' ' ' PRO . 3.2 mm? -78.06 -3.91 44.58 Favored 'General case' 0 CA--C 1.548 0.895 0 C-N-CA 124.454 1.102 . . . . 73.45 112.48 174.064 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 40.6 m-20 -65.22 128.38 35.58 Favored 'General case' 0 N--CA 1.487 1.384 0 CA-C-N 118.247 0.476 . . . . 63.1 111.164 176.592 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 104.23 -25.79 25.0 Favored Glycine 0 N--CA 1.477 1.378 0 N-CA-C 111.867 -0.493 . . . . 65.03 111.867 -174.665 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 12.5 ttmm -85.59 -164.46 1.02 Allowed 'General case' 0 CA--C 1.552 1.033 0 C-N-CA 124.329 1.052 . . . . 73.01 108.449 177.443 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 126' ' ' HIS . . . . . 0.416 ' HD2' ' HB3' ' A' ' 99' ' ' SER . 34.6 t60 -66.91 131.7 46.44 Favored 'General case' 0 CA--C 1.546 0.825 0 CA-C-O 121.183 0.516 . . . . 75.32 111.063 -175.343 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 7.4 p -62.42 147.4 11.62 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.808 0 CA-C-N 114.038 -1.437 . . . . 75.4 112.074 178.126 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 128' ' ' VAL . . . . . 0.654 ' HB ' ' HB3' ' A' ' 90' ' ' LEU . 46.3 t -64.43 149.98 10.61 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.721 0 C-N-CA 123.374 0.67 . . . . 74.21 110.3 174.699 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 129' ' ' PHE . . . . . 0.496 ' HA ' HG23 ' A' ' 29' ' ' VAL . 49.3 p90 -136.51 -27.95 1.03 Allowed 'General case' 0 N--CA 1.479 0.977 0 C-N-CA 122.378 0.271 . . . . 74.3 111.127 174.567 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . -123.54 167.13 15.84 Favored Glycine 0 C--N 1.343 0.942 0 O-C-N 123.424 0.452 . . . . 72.42 112.323 -177.719 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 30.2 ttpt -154.65 122.84 5.97 Favored 'General case' 0 N--CA 1.468 0.454 0 N-CA-C 107.997 -1.112 . . . . 74.11 107.997 179.092 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 12.7 p -67.0 122.39 17.94 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.959 0 CA-C-O 121.515 0.674 . . . . 65.01 109.98 177.468 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 21.2 ptmt -108.66 -22.98 12.01 Favored 'General case' 0 N--CA 1.476 0.844 0 C-N-CA 124.054 0.941 . . . . 63.12 110.251 179.009 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 134' ' ' GLU . . . . . 0.483 ' HB2' ' HB2' ' A' ' 21' ' ' SER . 34.6 mt-10 -136.71 134.03 36.74 Favored 'General case' 0 N--CA 1.475 0.817 0 C-N-CA 124.798 1.239 . . . . 75.44 108.17 179.863 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 80.1 26.66 54.94 Favored Glycine 0 CA--C 1.528 0.862 0 CA-C-O 119.837 -0.424 . . . . 73.25 113.235 -177.624 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 136' ' ' MET . . . . . . . . . . . . . 5.8 tpt -59.79 -53.17 61.1 Favored 'General case' 0 N--CA 1.485 1.288 0 C-N-CA 123.664 0.786 . . . . 70.32 110.471 175.103 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 137' ' ' ASN . . . . . . . . . . . . . 20.5 m120 -64.65 -25.79 68.11 Favored 'General case' 0 N--CA 1.477 0.884 0 CA-C-N 115.902 -0.59 . . . . 74.44 110.997 -179.537 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 138' ' ' ILE . . . . . . . . . . . . . 50.9 mm -69.52 -40.4 79.65 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.728 0 C-N-CA 123.393 0.677 . . . . 73.54 110.433 175.853 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 91.2 t -63.18 -40.33 88.62 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.131 0 C-N-CA 123.033 0.533 . . . . 74.41 109.888 174.987 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 40.3 mt-10 -65.46 -33.23 75.44 Favored 'General case' 0 CA--C 1.551 0.985 0 CA-C-N 115.541 -0.754 . . . . 75.31 111.329 175.808 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -75.2 -45.11 42.57 Favored 'General case' 0 N--CA 1.481 1.08 0 C-N-CA 123.753 0.821 . . . . 71.31 111.739 -177.667 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 142' ' ' MET . . . . . 0.533 ' HB2' HD13 ' A' ' 156' ' ' ILE . 25.4 ptm -69.48 -29.38 67.03 Favored 'General case' 0 N--CA 1.476 0.852 0 CA-C-N 115.823 -0.626 . . . . 74.1 110.66 179.031 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 143' ' ' GLU . . . . . 0.54 ' HG2' ' HA ' ' A' ' 58' ' ' PRO . 30.9 tt0 -64.88 -29.01 69.94 Favored 'General case' 0 C--N 1.353 0.731 0 C-N-CA 123.243 0.617 . . . . 70.02 111.531 -179.927 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 144' ' ' ARG . . . . . . . . . . . . . 24.3 mtp180 -63.15 -23.61 67.51 Favored 'General case' 0 N--CA 1.474 0.761 0 C-N-CA 123.572 0.749 . . . . 74.21 111.843 177.475 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 145' ' ' PHE . . . . . . . . . . . . . 65.7 m-85 -80.14 -13.82 58.97 Favored 'General case' 0 N--CA 1.481 1.111 0 C-N-CA 122.42 0.288 . . . . 73.4 111.506 179.68 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 146' ' ' GLY . . . . . 0.418 ' HA2' ' HA ' ' A' ' 152' ' ' THR . . . -84.4 171.09 47.41 Favored Glycine 0 C--N 1.343 0.949 0 O-C-N 122.979 0.174 . . . . 64.31 112.675 177.192 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 34.1 t -132.96 167.29 20.54 Favored 'General case' 0 N--CA 1.48 1.05 0 C-N-CA 123.966 0.906 . . . . 74.24 109.716 -176.229 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 148' ' ' ARG . . . . . 0.566 ' HA ' HG22 ' A' ' 57' ' ' ILE . 23.7 mmt85 -67.6 -23.39 65.38 Favored 'General case' 0 N--CA 1.488 1.46 0 C-N-CA 123.925 0.89 . . . . 75.55 112.591 -175.481 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 149' ' ' ASN . . . . . . . . . . . . . 27.8 p-10 -86.97 1.09 53.89 Favored 'General case' 0 N--CA 1.487 1.38 0 C-N-CA 123.363 0.665 . . . . 73.22 111.106 174.818 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . 95.32 -26.5 19.21 Favored Glycine 0 C--N 1.341 0.809 0 CA-C-O 119.692 -0.504 . . . . 73.13 113.169 179.282 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 65.0 tttp -63.69 118.14 7.84 Favored 'General case' 0 N--CA 1.476 0.827 0 CA-C-N 117.507 0.654 . . . . 70.44 110.921 -174.542 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 152' ' ' THR . . . . . 0.418 ' HA ' ' HA2' ' A' ' 146' ' ' GLY . 9.6 m -93.39 124.7 37.56 Favored 'General case' 0 CA--C 1.542 0.644 0 CA-C-N 114.763 -1.108 . . . . 74.4 109.062 179.269 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 153' ' ' SER . . . . . . . . . . . . . 66.2 p -63.77 -26.81 68.81 Favored 'General case' 0 N--CA 1.48 1.066 0 C-N-CA 124.13 0.972 . . . . 62.23 112.056 -178.655 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 72.1 mmtt -111.89 141.3 45.7 Favored 'General case' 0 C--O 1.238 0.472 0 C-N-CA 124.009 0.924 . . . . 75.34 111.252 -176.38 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 72.9 mmtt -83.16 91.23 7.2 Favored 'General case' 0 C--O 1.238 0.487 0 N-CA-C 108.369 -0.975 . . . . 74.01 108.369 172.798 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 156' ' ' ILE . . . . . 0.533 HD13 ' HB2' ' A' ' 142' ' ' MET . 62.6 mt -94.13 110.97 24.38 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.473 0 CA-C-N 114.84 -1.073 . . . . 64.34 108.955 -177.94 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 157' ' ' THR . . . . . . . . . . . . . 49.3 p -115.59 155.07 28.29 Favored 'General case' 0 C--O 1.243 0.743 0 C-N-CA 123.847 0.859 . . . . 75.13 110.454 -176.979 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 158' ' ' ILE . . . . . 0.475 HG23 ' HB3' ' A' ' 8' ' ' PHE . 62.6 mt -75.5 93.71 0.92 Allowed 'Isoleucine or valine' 0 CA--C 1.542 0.644 0 N-CA-C 108.205 -1.035 . . . . 73.03 108.205 171.199 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 159' ' ' ALA . . . . . 0.574 ' HB3' ' HB1' ' A' ' 11' ' ' ALA . . . -58.31 -35.62 72.13 Favored 'General case' 0 N--CA 1.474 0.744 0 C-N-CA 124.485 1.114 . . . . 71.1 112.834 -177.028 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 160' ' ' ASP . . . . . 0.447 ' HA ' ' HE2' ' A' ' 49' ' ' LYS . 23.7 t0 -161.16 157.39 25.8 Favored 'General case' 0 N--CA 1.477 0.906 0 O-C-N 123.358 0.411 . . . . 74.53 110.648 -174.986 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 161' ' ' CYS . . . . . . . . . . . . . 58.7 m -123.49 -172.59 2.55 Favored 'General case' 0 N--CA 1.485 1.299 0 C-N-CA 125.048 1.339 . . . . 74.33 108.473 177.281 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 162' ' ' GLY . . . . . . . . . . . . . . . 132.25 57.09 0.08 OUTLIER Glycine 0 C--N 1.354 1.572 0 CA-C-N 118.716 0.689 . . . . 61.15 112.977 -172.957 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 163' ' ' GLN . . . . . 0.531 ' HA ' ' H ' ' A' ' 7' ' ' PHE . 21.8 pt20 -47.84 137.46 9.77 Favored 'General case' 0 N--CA 1.485 1.288 0 C-N-CA 124.356 1.062 . . . . 72.3 113.708 -173.242 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 164' ' ' LEU . . . . . 0.468 ' HG ' ' HB2' ' A' ' 7' ' ' PHE . 41.2 mt . . . . . 0 CA--C 1.543 0.698 0 C-N-CA 124.005 0.922 . . . . 74.23 110.151 179.914 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 218' ' ' PRO . . . . . . . . . . . . . 93.4 Cg_endo . . . . . 0 CA--C 1.54 0.796 0 CA-C-O 121.215 0.423 . . . . 70.03 112.044 . . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' B' B ' 219' ' ' GLY . . . . . . . . . . . . . . . 112.38 177.55 19.88 Favored Glycine 0 CA--C 1.527 0.834 0 CA-C-N 115.186 -0.916 . . . . 75.52 111.909 -175.981 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 220' ' ' PRO . . . . . 0.438 ' HG3' HD13 ' A' ' 122' ' ' LEU . 91.7 Cg_endo -75.65 178.48 7.33 Favored 'Trans proline' 0 N--CA 1.489 1.254 0 C-N-CA 123.41 2.74 . . . . 63.54 113.419 -177.067 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 221' ' ' TYR . . . . . . . . . . . . . 99.7 m-85 . . . . . 0 N--CA 1.476 0.87 0 C-N-CA 124.464 1.105 . . . . 73.3 109.558 179.381 . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 3' ' ' ASN . . . . . 0.472 HD21 ' HA ' ' A' ' 25' ' ' PHE . 20.8 m120 . . . . . 0 N--CA 1.48 1.052 0 CA-C-O 119.288 -0.387 . . . . 73.15 111.723 . . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 4' ' ' PRO . . . . . 0.499 ' HG2' ' HB2' ' A' ' 24' ' ' LEU . 42.5 Cg_endo -65.42 135.34 42.26 Favored 'Trans proline' 0 C--N 1.378 2.1 0 C-N-CA 122.525 2.15 . . . . 73.31 110.816 178.522 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 55.9 m -122.3 123.26 41.01 Favored 'General case' 0 CA--C 1.54 0.568 0 N-CA-C 109.278 -0.638 . . . . 73.12 109.278 -172.882 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 6' ' ' VAL . . . . . 0.546 ' HA ' ' HB2' ' A' ' 163' ' ' GLN . 14.4 m -101.33 136.39 33.35 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.659 0 C-N-CA 123.965 0.906 . . . . 74.3 109.256 -175.915 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 7' ' ' PHE . . . . . 0.405 ' HB3' ' HA ' ' A' ' 163' ' ' GLN . 86.4 t80 -125.6 136.98 53.85 Favored 'General case' 0 C--O 1.238 0.47 0 C-N-CA 123.469 0.707 . . . . 73.1 109.683 -175.627 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 8' ' ' PHE . . . . . 0.441 ' HB3' HG23 ' A' ' 158' ' ' ILE . 53.3 m-85 -138.76 165.84 25.96 Favored 'General case' 0 CA--C 1.534 0.349 0 C-N-CA 124.809 1.243 . . . . 70.21 109.493 177.254 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 13.9 m-20 -111.67 118.23 35.07 Favored 'General case' 0 C--N 1.323 -0.565 0 N-CA-C 106.386 -1.709 . . . . 73.54 106.386 168.868 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 10' ' ' ILE . . . . . 0.443 HG22 ' SD ' ' A' ' 142' ' ' MET . 46.3 mm -84.98 129.53 37.58 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.56 0 N-CA-C 109.159 -0.682 . . . . 74.12 109.159 178.722 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 11' ' ' ALA . . . . . 0.766 ' HB2' ' HB1' ' A' ' 159' ' ' ALA . . . -124.59 126.98 46.69 Favored 'General case' 0 C--O 1.217 -0.642 0 C-N-CA 123.691 0.796 . . . . 65.0 110.496 -176.89 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 12' ' ' VAL . . . . . 0.446 HG21 ' HB2' ' A' ' 17' ' ' LEU . 89.1 t -96.14 116.38 37.85 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.759 0 N-CA-C 107.976 -1.12 . . . . 74.4 107.976 173.418 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 30.2 m-20 62.99 24.14 14.39 Favored 'General case' 0 N--CA 1.488 1.446 0 C-N-CA 125.59 1.556 . . . . 74.13 112.048 -177.288 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 97.24 -17.77 58.57 Favored Glycine 0 C--N 1.347 1.151 0 CA-C-O 119.951 -0.361 . . . . 75.12 113.037 -179.201 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 40.9 mm-40 -94.32 124.66 54.95 Favored Pre-proline 0 CA--C 1.545 0.755 0 CA-C-O 118.551 -0.738 . . . . 75.43 109.767 179.66 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 19.7 Cg_endo -56.06 118.07 4.81 Favored 'Trans proline' 0 C--N 1.381 2.274 0 C-N-CA 123.222 2.615 . . . . 74.21 113.111 -176.308 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 17' ' ' LEU . . . . . 0.446 ' HB2' HG21 ' A' ' 12' ' ' VAL . 49.3 tp -78.12 -38.55 43.63 Favored 'General case' 0 N--CA 1.476 0.871 0 C-N-CA 124.244 1.018 . . . . 73.41 109.407 171.371 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 177.39 -160.3 27.0 Favored Glycine 0 N--CA 1.449 -0.481 0 CA-C-N 114.317 -1.311 . . . . 63.11 110.707 -175.521 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 6.3 ptp180 -140.08 147.22 39.97 Favored 'General case' 0 N--CA 1.468 0.456 0 C-N-CA 123.934 0.893 . . . . 73.13 109.693 179.799 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 87.4 t -137.18 132.5 46.53 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.7 0 C-N-CA 124.092 0.957 . . . . 72.3 109.593 -175.24 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 7.9 t -120.1 122.62 41.45 Favored 'General case' 0 CA--C 1.547 0.855 0 N-CA-C 108.999 -0.741 . . . . 71.3 108.999 172.601 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 22' ' ' PHE . . . . . 0.534 ' HA ' ' HA ' ' A' ' 132' ' ' VAL . 11.1 m-85 -100.15 152.22 20.51 Favored 'General case' 0 N--CA 1.476 0.857 0 C-N-CA 124.027 0.931 . . . . 75.23 108.819 176.556 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 23' ' ' GLU . . . . . 0.636 ' HB2' ' HD2' ' A' ' 133' ' ' LYS . 39.7 tt0 -110.76 119.01 37.7 Favored 'General case' 0 CA--C 1.54 0.58 0 C-N-CA 123.318 0.647 . . . . 70.21 109.538 175.517 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . 0.499 ' HB2' ' HG2' ' A' ' 4' ' ' PRO . 18.5 mt -90.8 127.86 36.5 Favored 'General case' 0 N--CA 1.472 0.654 0 C-N-CA 124.462 1.105 . . . . 73.05 110.028 -178.301 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 25' ' ' PHE . . . . . 0.519 ' HB2' HD11 ' A' ' 90' ' ' LEU . 85.4 m-85 -88.92 71.9 8.52 Favored 'General case' 0 CA--C 1.536 0.427 0 C-N-CA 123.776 0.83 . . . . 70.52 110.34 -178.534 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -67.12 -15.59 63.81 Favored 'General case' 0 N--CA 1.481 1.122 0 CA-C-N 115.403 -0.817 . . . . 70.02 112.223 177.58 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 9.2 p-10 -76.3 -18.71 58.82 Favored 'General case' 0 CA--C 1.555 1.156 0 C-N-CA 123.409 0.683 . . . . 64.34 111.088 176.885 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 52.2 mttp -106.67 -45.65 4.17 Favored 'General case' 0 N--CA 1.483 1.201 0 C-N-CA 123.902 0.881 . . . . 75.34 110.37 -178.536 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 29' ' ' VAL . . . . . 0.563 HG21 ' HA ' ' A' ' 129' ' ' PHE . 4.6 m -134.68 69.98 71.8 Favored Pre-proline 0 CA--C 1.562 1.437 0 C-N-CA 124.36 1.064 . . . . 62.5 109.913 -175.748 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 18.8 Cg_endo -58.57 -29.54 89.26 Favored 'Trans proline' 0 C--N 1.382 2.324 0 C-N-CA 123.062 2.508 . . . . 64.51 113.985 -175.004 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 34.8 ttmt -72.63 -56.95 4.54 Favored 'General case' 0 N--CA 1.479 1.01 0 C-N-CA 123.668 0.787 . . . . 75.44 111.217 -179.648 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 6.6 m -69.31 -25.54 64.27 Favored 'General case' 0 CA--C 1.559 1.298 0 CA-C-N 115.081 -0.963 . . . . 75.1 111.074 -173.373 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -82.89 -42.4 17.77 Favored 'General case' 0 CA--C 1.548 0.898 0 C-N-CA 123.717 0.807 . . . . 74.44 111.085 177.254 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 38.8 tt0 -56.13 -39.44 72.25 Favored 'General case' 0 N--CA 1.493 1.675 0 C-N-CA 123.681 0.792 . . . . 62.42 110.57 177.192 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 35' ' ' ASN . . . . . 0.591 ' ND2' ' SD ' ' A' ' 100' ' ' MET . 41.4 t30 -50.95 -67.08 0.28 Allowed 'General case' 0 CA--C 1.538 0.488 0 O-C-N 125.149 1.531 . . . . 74.22 111.256 179.848 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 60.6 t80 -64.46 -36.02 82.82 Favored 'General case' 0 CA--C 1.543 0.707 0 O-C-N 124.016 0.822 . . . . 75.44 111.267 -173.62 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 62.2 ttt180 -60.63 -47.01 88.13 Favored 'General case' 0 N--CA 1.478 0.936 0 O-C-N 124.068 0.855 . . . . 75.43 111.042 178.906 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 38' ' ' ALA . . . . . 0.513 ' HB2' HG21 ' A' ' 78' ' ' ILE . . . -78.06 -19.92 53.35 Favored 'General case' 0 N--CA 1.475 0.811 0 CA-C-N 115.153 -0.93 . . . . 73.12 111.671 -177.416 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 39' ' ' LEU . . . . . 0.425 HD23 ' HE2' ' A' ' 48' ' ' TYR . 94.0 mt -73.94 -37.56 64.51 Favored 'General case' 0 N--CA 1.481 1.104 0 C-N-CA 123.162 0.585 . . . . 74.32 109.89 170.93 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 50.4 m -67.74 -49.4 62.74 Favored 'General case' 0 N--CA 1.48 1.041 0 C-N-CA 123.765 0.826 . . . . 75.5 110.831 -178.585 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 41' ' ' THR . . . . . 0.45 ' OG1' ' HG2' ' A' ' 43' ' ' GLU . 7.6 p -76.3 -33.78 59.07 Favored 'General case' 0 N--CA 1.477 0.895 0 C-N-CA 123.527 0.731 . . . . 74.22 111.619 178.344 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 76.99 37.9 31.78 Favored Glycine 0 C--N 1.34 0.756 0 CA-C-N 116.257 -0.429 . . . . 74.34 112.411 -172.525 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 43' ' ' GLU . . . . . 0.45 ' HG2' ' OG1' ' A' ' 41' ' ' THR . 22.7 mm-40 -64.67 -20.9 66.57 Favored 'General case' 0 N--CA 1.486 1.339 0 C-N-CA 123.159 0.584 . . . . 74.33 111.599 174.231 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 44' ' ' LYS . . . . . 0.544 ' HG3' ' HB ' ' A' ' 78' ' ' ILE . 71.1 mmtt -106.63 15.13 26.13 Favored 'General case' 0 CA--C 1.55 0.974 0 C-N-CA 124.296 1.038 . . . . 75.32 110.478 179.568 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 68.57 38.15 85.98 Favored Glycine 0 C--N 1.352 1.456 0 CA-C-N 116.103 -0.499 . . . . 73.03 114.227 177.466 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 46' ' ' PHE . . . . . 0.469 ' HE2' ' HA ' ' A' ' 78' ' ' ILE . 23.0 m-85 -117.49 -48.55 2.59 Favored 'General case' 0 N--CA 1.489 1.476 0 CA-C-N 117.432 0.616 . . . . 63.34 110.654 -179.246 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 48.14 61.51 4.88 Favored Glycine 0 C--N 1.356 1.672 0 O-C-N 124.415 1.072 . . . . 65.32 114.51 167.823 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 48' ' ' TYR . . . . . 0.425 ' HE2' HD23 ' A' ' 39' ' ' LEU . 64.0 m-85 -65.47 92.94 0.14 Allowed 'General case' 0 N--CA 1.477 0.903 0 CA-C-O 121.693 0.759 . . . . 75.15 112.339 -174.417 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 49' ' ' LYS . . . . . 0.438 ' NZ ' ' SG ' ' A' ' 161' ' ' CYS . 0.0 OUTLIER -105.77 135.78 46.59 Favored 'General case' 0 C--O 1.236 0.37 0 CA-C-N 114.006 -1.452 . . . . 72.41 108.658 175.238 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 78.34 21.59 69.65 Favored Glycine 0 C--N 1.341 0.853 0 CA-C-O 119.838 -0.423 . . . . 65.51 113.417 177.445 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 16.2 m -57.37 115.34 2.65 Favored 'General case' 0 N--CA 1.474 0.733 0 C-N-CA 123.586 0.754 . . . . 53.24 110.358 179.051 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 52' ' ' CYS . . . . . . . . . . . . . 23.8 p -81.36 114.55 20.2 Favored 'General case' 0 CA--C 1.538 0.5 0 C-N-CA 124.513 1.125 . . . . 71.34 111.459 -172.992 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 53' ' ' PHE . . . . . 0.709 ' HA ' ' HA2' ' A' ' 64' ' ' GLY . 38.6 m-85 -66.07 93.23 0.19 Allowed 'General case' 0 CA--C 1.539 0.539 0 C-N-CA 123.896 0.878 . . . . 74.41 108.784 164.715 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 17.0 p-80 -108.5 -0.34 20.49 Favored 'General case' 0 N--CA 1.479 0.977 0 CA-C-N 115.383 -0.826 . . . . 74.32 111.536 -176.498 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 55' ' ' ARG . . . . . 0.456 ' O ' ' HB3' ' A' ' 63' ' ' GLN . 53.2 ttt-85 -138.16 99.66 3.93 Favored 'General case' 0 C--O 1.21 -0.986 0 N-CA-C 109.228 -0.656 . . . . 75.5 109.228 173.796 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 56' ' ' ILE . . . . . 0.422 HD13 ' HB3' ' A' ' 53' ' ' PHE . 51.1 mt -131.33 134.35 61.11 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.935 0 N-CA-C 109.6 -0.519 . . . . 73.23 109.6 175.911 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 63.0 mt -128.82 113.38 18.96 Favored Pre-proline 0 CA--C 1.553 1.08 0 C-N-CA 124.694 1.197 . . . . 62.53 108.726 177.975 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 58' ' ' PRO . . . . . 0.55 ' HA ' ' HG2' ' A' ' 143' ' ' GLU . 41.4 Cg_endo -64.77 143.64 81.02 Favored 'Trans proline' 0 C--N 1.386 2.523 0 C-N-CA 123.415 2.743 . . . . 74.5 112.158 -177.322 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 72.36 27.47 69.73 Favored Glycine 0 C--N 1.344 1.013 0 CA-C-N 115.713 -0.676 . . . . 75.41 112.304 -176.888 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 20.5 t80 -153.59 -77.38 0.11 Allowed 'General case' 0 CA--C 1.543 0.685 0 C-N-CA 123.579 0.752 . . . . 75.03 109.644 -178.472 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 61' ' ' MET . . . . . 0.747 ' SD ' ' HB2' ' A' ' 113' ' ' PHE . 13.3 tmm? -167.86 137.75 2.67 Favored 'General case' 0 CA--C 1.548 0.88 0 C-N-CA 122.807 0.443 . . . . 72.12 111.585 -164.018 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 62' ' ' CYS . . . . . . . . . . . . . 4.3 p -106.94 113.56 27.12 Favored 'General case' 0 CA--C 1.552 1.057 0 C-N-CA 124.78 1.232 . . . . 71.35 109.923 172.343 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 63' ' ' GLN . . . . . 0.574 ' HB2' ' SD ' ' A' ' 61' ' ' MET . 49.2 tt0 -107.99 121.66 45.24 Favored 'General case' 0 N--CA 1.487 1.382 0 C-N-CA 124.155 0.982 . . . . 74.1 111.138 -174.65 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 64' ' ' GLY . . . . . 0.709 ' HA2' ' HA ' ' A' ' 53' ' ' PHE . . . -97.55 170.88 25.91 Favored Glycine 0 C--N 1.34 0.796 0 CA-C-N 114.721 -1.127 . . . . 73.31 112.0 172.755 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 176.7 179.43 47.11 Favored Glycine 0 C--O 1.224 -0.524 0 N-CA-C 111.77 -0.532 . . . . 74.22 111.77 178.704 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 6.9 t0 -102.73 151.75 22.03 Favored 'General case' 0 CA--C 1.546 0.803 0 C-N-CA 124.385 1.074 . . . . 72.5 110.434 -173.901 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 68.6 t80 -82.25 -30.28 30.81 Favored 'General case' 0 N--CA 1.478 0.929 0 C-N-CA 124.727 1.211 . . . . 72.34 110.46 -178.404 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 68' ' ' THR . . . . . 0.662 HG23 ' HG3' ' A' ' 69' ' ' ARG . 6.9 m -74.89 143.06 43.97 Favored 'General case' 0 CA--C 1.549 0.929 0 C-N-CA 123.661 0.784 . . . . 61.43 109.49 177.118 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 69' ' ' ARG . . . . . 0.662 ' HG3' HG23 ' A' ' 68' ' ' THR . 50.7 mtt180 60.68 26.09 15.85 Favored 'General case' 0 N--CA 1.491 1.611 0 C-N-CA 124.565 1.146 . . . . 73.15 111.798 175.627 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 20.3 t-80 -58.83 -40.59 84.63 Favored 'General case' 0 N--CA 1.474 0.742 0 C-N-CA 124.624 1.17 . . . . 65.14 113.241 -165.777 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 43.3 m-80 -67.35 103.81 1.36 Allowed 'General case' 0 N--CA 1.474 0.76 0 C-N-CA 122.785 0.434 . . . . 75.22 110.004 177.747 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 89.28 -7.93 80.97 Favored Glycine 0 CA--C 1.531 1.09 0 CA-C-N 115.643 -0.708 . . . . 71.21 114.602 173.869 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 18.3 m -144.48 -88.66 0.11 Allowed 'General case' 0 CA--C 1.556 1.211 0 CA-C-N 117.891 0.845 . . . . 74.5 110.297 -178.83 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 65.66 61.64 5.44 Favored Glycine 0 C--N 1.362 1.973 0 CA-C-O 119.593 -0.559 . . . . 65.42 113.718 176.999 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 121.22 51.96 0.24 Allowed Glycine 0 N--CA 1.479 1.508 0 CA-C-N 117.841 0.82 . . . . 64.35 111.736 -174.0 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 76' ' ' LYS . . . . . 0.435 ' HB2' ' O ' ' A' ' 80' ' ' GLY . 64.0 pttt -60.91 168.93 2.13 Favored 'General case' 0 CA--C 1.548 0.867 0 C-N-CA 123.799 0.84 . . . . 75.1 112.498 -175.518 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 80.9 p -91.23 176.16 6.68 Favored 'General case' 0 CA--C 1.542 0.639 0 CA-C-N 115.033 -0.985 . . . . 73.54 110.605 -177.671 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 78' ' ' ILE . . . . . 0.544 ' HB ' ' HG3' ' A' ' 44' ' ' LYS . 26.0 pt -74.5 -18.61 16.78 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.547 0 CA-C-N 115.939 -0.573 . . . . 75.45 110.026 172.145 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 55.0 m-85 -89.4 11.39 19.34 Favored 'General case' 0 CA--C 1.544 0.724 0 C-N-CA 124.764 1.225 . . . . 72.15 110.855 179.058 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 80' ' ' GLY . . . . . 0.435 ' O ' ' HB2' ' A' ' 76' ' ' LYS . . . 109.63 -133.8 11.84 Favored Glycine 0 C--N 1.351 1.396 0 N-CA-C 110.831 -0.908 . . . . 72.41 110.831 -179.82 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 35.9 tt0 -65.13 -41.11 95.13 Favored 'General case' 0 N--CA 1.478 0.934 0 C-N-CA 123.88 0.872 . . . . 73.41 111.114 -179.326 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 82' ' ' LYS . . . . . 0.714 ' HD2' ' HA ' ' A' ' 107' ' ' THR . 21.0 pttp -169.49 178.36 4.25 Favored 'General case' 0 CA--C 1.545 0.776 0 CA-C-N 115.065 -0.97 . . . . 75.25 109.836 -165.777 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 26.2 p90 -158.16 171.73 19.69 Favored 'General case' 0 N--CA 1.475 0.809 0 C-N-CA 123.479 0.712 . . . . 74.44 110.191 174.339 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 12.2 pt-20 -94.18 162.66 13.77 Favored 'General case' 0 N--CA 1.476 0.86 0 C-N-CA 123.204 0.602 . . . . 74.53 109.834 175.796 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 65.1 m-20 -68.45 148.23 50.92 Favored 'General case' 0 N--CA 1.475 0.815 0 C-N-CA 123.871 0.868 . . . . 74.54 112.562 -172.345 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 86' ' ' GLU . . . . . 0.557 ' HG2' ' HA ' ' A' ' 29' ' ' VAL . 5.2 tp10 -73.96 -62.99 1.31 Allowed 'General case' 0 CA--C 1.544 0.728 0 CA-C-N 115.447 -0.797 . . . . 74.11 110.097 179.083 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 25.5 p30 -175.05 150.54 1.21 Allowed 'General case' 0 N--CA 1.483 1.185 0 C-N-CA 124.338 1.055 . . . . 73.43 109.801 -177.518 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 91.5 m-85 -90.06 57.51 3.81 Favored 'General case' 0 N--CA 1.483 1.205 0 C-N-CA 123.783 0.833 . . . . 63.55 111.182 -171.248 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 72.8 mt -82.24 -53.8 11.06 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.76 0 CA-C-N 115.684 -0.689 . . . . 73.43 109.393 175.394 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 90' ' ' LEU . . . . . 0.519 HD11 ' HB2' ' A' ' 25' ' ' PHE . 87.0 mt -84.11 109.92 18.08 Favored 'General case' 0 CA--C 1.541 0.613 0 CA-C-N 115.197 -0.91 . . . . 72.41 110.84 -178.384 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 18.3 ptpt -102.27 171.29 7.56 Favored 'General case' 0 N--CA 1.473 0.685 0 C-N-CA 124.385 1.074 . . . . 64.54 109.884 175.566 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 92' ' ' HIS . . . . . . . . . . . . . 39.2 m80 -89.75 48.33 1.58 Allowed 'General case' 0 CA--C 1.551 1.009 0 C-N-CA 124.269 1.028 . . . . 75.44 110.266 -175.06 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 12.0 t -91.95 -16.3 26.79 Favored 'General case' 0 N--CA 1.481 1.102 0 C-N-CA 123.46 0.704 . . . . 74.31 111.108 -179.331 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -104.97 157.32 16.59 Favored Glycine 0 C--N 1.343 0.959 0 CA-C-O 119.603 -0.554 . . . . 64.32 112.245 178.51 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 71.9 Cg_endo -80.87 150.74 18.51 Favored 'Trans proline' 0 C--N 1.363 1.303 0 C-N-CA 122.505 2.137 . . . . 73.15 111.421 169.359 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 96' ' ' GLY . . . . . 0.441 ' HA3' HG11 ' A' ' 132' ' ' VAL . . . 84.22 22.89 53.49 Favored Glycine 0 C--N 1.344 0.992 0 N-CA-C 114.114 0.406 . . . . 63.34 114.114 176.993 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 97' ' ' ILE . . . . . . . . . . . . . 14.7 mm -63.0 115.71 2.37 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.897 0 C-N-CA 124.603 1.161 . . . . 75.22 112.093 -174.746 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 59.1 tp -97.8 114.22 26.2 Favored 'General case' 0 C--O 1.249 1.062 0 CA-C-O 121.77 0.795 . . . . 72.13 109.829 175.641 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 32.8 t -142.9 143.22 31.95 Favored 'General case' 0 CA--C 1.545 0.767 0 C-N-CA 124.771 1.229 . . . . 73.21 107.955 179.058 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 100' ' ' MET . . . . . 0.711 ' HA ' ' HA ' ' A' ' 112' ' ' PHE . 81.1 mtp -84.55 142.01 30.31 Favored 'General case' 0 N--CA 1.492 1.643 0 CA-C-N 118.496 0.589 . . . . 74.31 111.063 -176.329 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 101' ' ' ALA . . . . . 0.545 ' HB3' ' HB2' ' A' ' 111' ' ' GLN . . . -73.4 171.38 13.2 Favored 'General case' 0 N--CA 1.484 1.254 0 CA-C-O 121.102 0.477 . . . . 64.43 111.874 -171.504 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 102' ' ' ASN . . . . . 0.478 ' HB3' ' HA ' ' A' ' 108' ' ' ASN . 30.1 p-10 -168.39 167.25 12.01 Favored 'General case' 0 N--CA 1.472 0.67 0 CA-C-N 115.536 -0.757 . . . . 72.35 111.234 -173.499 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -105.89 6.21 31.3 Favored 'General case' 0 N--CA 1.477 0.908 0 C-N-CA 124.147 0.979 . . . . 64.11 110.544 169.182 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 152.91 -174.87 31.62 Favored Glycine 0 C--N 1.354 1.528 0 CA-C-O 119.244 -0.753 . . . . 63.23 112.167 179.665 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 44.0 Cg_exo -59.14 148.02 87.7 Favored 'Trans proline' 0 C--N 1.373 1.816 0 C-N-CA 123.041 2.494 . . . . 73.14 111.932 173.064 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 66.3 t30 68.01 9.55 7.23 Favored 'General case' 0 N--CA 1.483 1.212 0 C-N-CA 124.943 1.297 . . . . 64.52 111.128 -177.129 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 107' ' ' THR . . . . . 0.714 ' HA ' ' HD2' ' A' ' 82' ' ' LYS . 5.0 m -121.65 1.61 10.03 Favored 'General case' 0 CA--C 1.55 0.974 0 C-N-CA 123.857 0.863 . . . . 74.04 110.545 -178.907 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 108' ' ' ASN . . . . . 0.478 ' HA ' ' HB3' ' A' ' 102' ' ' ASN . 43.7 t30 -69.29 132.84 47.09 Favored 'General case' 0 N--CA 1.478 0.951 0 C-N-CA 123.72 0.808 . . . . 72.0 109.673 179.976 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 112.57 15.12 9.76 Favored Glycine 0 N--CA 1.472 1.076 0 N-CA-C 114.045 0.378 . . . . 43.44 114.045 -179.371 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 32.1 p -112.63 119.44 38.12 Favored 'General case' 0 CA--C 1.543 0.687 0 N-CA-C 107.626 -1.25 . . . . 73.33 107.626 167.78 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 111' ' ' GLN . . . . . 0.545 ' HB2' ' HB3' ' A' ' 101' ' ' ALA . 40.0 mt-30 66.18 178.18 0.21 Allowed 'General case' 0 N--CA 1.497 1.898 0 C-N-CA 124.458 1.103 . . . . 74.15 111.112 -169.741 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 112' ' ' PHE . . . . . 0.711 ' HA ' ' HA ' ' A' ' 100' ' ' MET . 45.1 p90 -145.54 154.2 41.92 Favored 'General case' 0 N--CA 1.48 1.057 0 C-N-CA 123.675 0.79 . . . . 74.44 108.951 177.959 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 113' ' ' PHE . . . . . 0.747 ' HB2' ' SD ' ' A' ' 61' ' ' MET . 51.4 p90 -144.65 154.61 42.97 Favored 'General case' 0 C--O 1.238 0.471 0 CA-C-O 120.823 0.344 . . . . 74.22 111.626 179.306 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 114' ' ' ILE . . . . . . . . . . . . . 5.7 mt -130.3 101.59 6.03 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.724 0 C-N-CA 124.077 0.951 . . . . 74.02 108.769 -174.236 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 115' ' ' CYS . . . . . . . . . . . . . 63.2 m -80.4 104.96 11.3 Favored 'General case' 0 N--CA 1.47 0.549 0 C-N-CA 123.507 0.723 . . . . 72.12 109.709 178.101 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 81.7 p -69.08 -27.62 65.78 Favored 'General case' 0 N--CA 1.488 1.434 0 CA-C-O 121.161 0.505 . . . . 72.23 111.257 -178.63 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -97.75 151.23 20.38 Favored 'General case' 0 C--O 1.24 0.591 0 CA-C-N 115.212 -0.903 . . . . 61.45 108.678 172.997 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 11.5 ptmm? -71.82 86.85 0.97 Allowed 'General case' 0 CA--C 1.552 1.029 0 CA-C-O 121.645 0.736 . . . . 74.53 109.396 174.325 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 119' ' ' THR . . . . . . . . . . . . . 40.6 p -76.21 86.7 3.04 Favored 'General case' 0 CA--C 1.543 0.678 0 CA-C-N 115.028 -0.987 . . . . 73.1 110.872 -172.607 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 12.4 pt-20 -65.24 -31.39 72.52 Favored 'General case' 0 CA--C 1.542 0.668 0 CA-C-N 114.545 -1.207 . . . . 74.54 111.866 -172.108 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 121' ' ' TRP . . . . . . . . . . . . . 42.6 p90 -70.83 -14.51 62.44 Favored 'General case' 0 N--CA 1.475 0.791 0 C-N-CA 123.543 0.737 . . . . 72.32 111.793 -178.794 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 42.7 mt -87.9 5.46 40.37 Favored 'General case' 0 N--CA 1.481 1.103 0 C-N-CA 122.828 0.451 . . . . 75.13 111.873 176.405 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 69.1 m-20 -80.39 140.33 36.09 Favored 'General case' 0 N--CA 1.482 1.144 0 C-N-CA 122.642 0.377 . . . . 65.44 110.451 172.275 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 94.35 -10.9 71.01 Favored Glycine 0 C--N 1.347 1.175 0 CA-C-N 115.602 -0.727 . . . . 71.11 112.183 -169.281 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 1.7 mppt? -94.6 -168.26 1.8 Allowed 'General case' 0 N--CA 1.472 0.662 0 C-N-CA 124.476 1.11 . . . . 72.2 109.535 173.722 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 126' ' ' HIS . . . . . . . . . . . . . 17.6 p80 -66.58 154.53 40.21 Favored 'General case' 0 CA--C 1.551 0.981 0 C-N-CA 124.179 0.991 . . . . 64.31 111.237 -172.146 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 17.6 m -78.81 147.54 6.76 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.813 0 CA-C-N 115.176 -0.92 . . . . 72.11 113.018 -163.262 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 128' ' ' VAL . . . . . 0.456 ' HB ' ' HB3' ' A' ' 90' ' ' LEU . 48.2 t -80.41 152.89 4.44 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.634 0 CA-C-N 114.159 -1.382 . . . . 74.21 108.537 172.576 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 129' ' ' PHE . . . . . 0.563 ' HA ' HG21 ' A' ' 29' ' ' VAL . 50.4 p90 -130.74 -15.81 3.42 Favored 'General case' 0 N--CA 1.482 1.173 0 N-CA-C 112.184 0.439 . . . . 74.22 112.184 179.187 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . -155.85 175.65 33.59 Favored Glycine 0 C--N 1.334 0.445 0 N-CA-C 112.109 -0.396 . . . . 64.22 112.109 -177.548 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 33.2 ttpt -156.23 140.51 16.6 Favored 'General case' 0 C--N 1.324 -0.519 0 N-CA-C 108.246 -1.02 . . . . 73.41 108.246 177.265 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 132' ' ' VAL . . . . . 0.534 ' HA ' ' HA ' ' A' ' 22' ' ' PHE . 6.7 p -61.1 134.23 26.57 Favored 'Isoleucine or valine' 0 CA--C 1.552 1.042 0 O-C-N 123.423 0.452 . . . . 73.34 111.279 177.336 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 133' ' ' LYS . . . . . 0.636 ' HD2' ' HB2' ' A' ' 23' ' ' GLU . 19.1 ptmt -111.52 -37.21 5.29 Favored 'General case' 0 N--CA 1.475 0.802 0 C-N-CA 123.472 0.709 . . . . 75.42 109.803 173.702 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 134' ' ' GLU . . . . . 0.54 ' HG2' ' HG3' ' A' ' 133' ' ' LYS . 40.9 mm-40 -119.91 133.94 55.4 Favored 'General case' 0 N--CA 1.48 1.06 0 C-N-CA 123.93 0.892 . . . . 74.11 109.728 -179.723 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 81.54 29.54 39.45 Favored Glycine 0 C--N 1.341 0.856 0 O-C-N 123.307 0.379 . . . . 62.44 113.421 176.965 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 136' ' ' MET . . . . . . . . . . . . . 15.8 tpt -59.43 -43.79 93.04 Favored 'General case' 0 N--CA 1.476 0.855 0 C-N-CA 123.487 0.715 . . . . 71.43 110.696 176.449 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 137' ' ' ASN . . . . . . . . . . . . . 17.0 m120 -63.55 -28.93 70.28 Favored 'General case' 0 N--CA 1.475 0.804 0 C-N-CA 123.607 0.763 . . . . 73.3 111.457 179.099 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 138' ' ' ILE . . . . . . . . . . . . . 43.4 mm -71.26 -39.03 72.28 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.119 0 C-N-CA 123.292 0.637 . . . . 72.42 110.255 176.316 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 50.8 t -64.12 -44.61 97.66 Favored 'Isoleucine or valine' 0 CA--C 1.552 1.054 0 C-N-CA 123.406 0.682 . . . . 74.43 110.189 177.982 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 43.5 mt-10 -67.99 -35.76 78.87 Favored 'General case' 0 N--CA 1.477 0.916 0 CA-C-N 115.149 -0.932 . . . . 74.45 110.908 178.956 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -68.4 -43.13 77.92 Favored 'General case' 0 N--CA 1.477 0.9 0 C-N-CA 123.479 0.712 . . . . 71.41 111.141 179.248 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 142' ' ' MET . . . . . 0.571 ' HB2' HD12 ' A' ' 156' ' ' ILE . 23.0 ptt? -73.68 -28.77 61.92 Favored 'General case' 0 N--CA 1.475 0.818 0 O-C-N 123.637 0.585 . . . . 75.41 110.793 -177.537 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 143' ' ' GLU . . . . . 0.55 ' HG2' ' HA ' ' A' ' 58' ' ' PRO . 33.0 tt0 -64.14 -28.93 70.1 Favored 'General case' 0 CA--C 1.553 1.083 0 CA-C-O 121.159 0.504 . . . . 63.43 111.555 -179.83 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 144' ' ' ARG . . . . . . . . . . . . . 48.1 mtm180 -70.67 -15.47 62.72 Favored 'General case' 0 N--CA 1.476 0.861 0 C-N-CA 123.191 0.596 . . . . 74.21 112.118 -179.957 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 145' ' ' PHE . . . . . 0.465 ' HB2' HD11 ' A' ' 156' ' ' ILE . 75.9 m-85 -82.87 -2.77 55.71 Favored 'General case' 0 N--CA 1.482 1.169 0 C-N-CA 122.592 0.357 . . . . 74.55 111.852 176.373 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . -95.42 -179.73 36.51 Favored Glycine 0 C--N 1.353 1.501 0 N-CA-C 112.331 -0.307 . . . . 71.04 112.331 176.193 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 16.5 m -132.58 169.44 16.6 Favored 'General case' 0 N--CA 1.487 1.376 0 C-N-CA 123.663 0.785 . . . . 74.52 110.842 -176.512 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 148' ' ' ARG . . . . . . . . . . . . . 10.6 mmt180 -65.65 -28.26 68.97 Favored 'General case' 0 N--CA 1.485 1.323 0 C-N-CA 123.926 0.891 . . . . 75.14 112.641 -174.255 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 149' ' ' ASN . . . . . . . . . . . . . 29.5 p-10 -81.88 -17.0 48.81 Favored 'General case' 0 N--CA 1.486 1.326 0 C-N-CA 123.444 0.698 . . . . 74.04 111.542 178.202 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 150' ' ' GLY . . . . . 0.449 ' O ' ' HA ' ' A' ' 55' ' ' ARG . . . 112.63 -17.01 23.55 Favored Glycine 0 C--N 1.348 1.205 0 CA-C-N 116.383 -0.371 . . . . 71.41 112.887 -178.831 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 62.7 tttp -67.21 133.98 50.8 Favored 'General case' 0 N--CA 1.473 0.695 0 CA-C-N 117.312 0.556 . . . . 73.04 110.603 -178.068 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 152' ' ' THR . . . . . . . . . . . . . 39.9 p -92.26 123.39 35.56 Favored 'General case' 0 CA--C 1.539 0.541 0 C-N-CA 123.301 0.64 . . . . 75.3 109.823 177.103 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 153' ' ' SER . . . . . . . . . . . . . 43.7 t -63.98 -36.22 83.28 Favored 'General case' 0 N--CA 1.475 0.813 0 C-N-CA 123.586 0.754 . . . . 74.11 110.176 174.148 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 45.4 mmtm -120.66 136.81 54.73 Favored 'General case' 0 N--CA 1.47 0.547 0 C-N-CA 124.205 1.002 . . . . 75.23 108.937 -179.046 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 33.4 mmtp -83.1 91.39 7.2 Favored 'General case' 0 N--CA 1.477 0.903 0 CA-C-O 121.513 0.673 . . . . 75.12 110.223 -174.568 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 156' ' ' ILE . . . . . 0.571 HD12 ' HB2' ' A' ' 142' ' ' MET . 68.2 mt -85.49 130.41 36.33 Favored 'Isoleucine or valine' 0 C--O 1.221 -0.397 0 CA-C-N 114.84 -1.073 . . . . 63.25 108.487 -178.349 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 157' ' ' THR . . . . . . . . . . . . . 35.9 p -138.68 156.4 47.44 Favored 'General case' 0 C--O 1.24 0.563 0 C-N-CA 124.444 1.098 . . . . 75.33 109.282 -175.536 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 158' ' ' ILE . . . . . 0.441 HG23 ' HB3' ' A' ' 8' ' ' PHE . 42.6 mt -74.43 95.26 0.86 Allowed 'Isoleucine or valine' 0 N--CA 1.475 0.822 0 N-CA-C 109.0 -0.741 . . . . 73.51 109.0 171.939 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 159' ' ' ALA . . . . . 0.766 ' HB1' ' HB2' ' A' ' 11' ' ' ALA . . . -51.7 -48.25 63.6 Favored 'General case' 0 N--CA 1.483 1.216 0 C-N-CA 124.585 1.154 . . . . 71.51 112.267 179.71 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 160' ' ' ASP . . . . . . . . . . . . . 35.6 t0 -154.23 162.11 41.39 Favored 'General case' 0 CA--C 1.54 0.567 0 CA-C-N 115.83 -0.623 . . . . 75.11 110.284 -175.639 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 161' ' ' CYS . . . . . 0.438 ' SG ' ' NZ ' ' A' ' 49' ' ' LYS . 27.6 p -136.53 -173.79 3.52 Favored 'General case' 0 N--CA 1.476 0.86 0 C-N-CA 124.274 1.03 . . . . 73.22 108.538 175.763 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 162' ' ' GLY . . . . . . . . . . . . . . . 131.08 55.24 0.09 OUTLIER Glycine 0 C--N 1.346 1.131 0 N-CA-C 111.007 -0.837 . . . . 71.42 111.007 -166.999 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 163' ' ' GLN . . . . . 0.546 ' HB2' ' HA ' ' A' ' 6' ' ' VAL . 13.8 pt20 -47.25 142.92 3.58 Favored 'General case' 0 CA--C 1.554 1.117 0 C-N-CA 125.056 1.342 . . . . 73.33 114.13 -170.956 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 164' ' ' LEU . . . . . . . . . . . . . 95.9 mt . . . . . 0 N--CA 1.477 0.876 0 C-N-CA 123.729 0.811 . . . . 74.43 111.034 -172.237 . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' B' B ' 218' ' ' PRO . . . . . 0.426 ' HB2' ' NE2' ' A' ' 111' ' ' GLN . 3.9 Cg_exo . . . . . 0 CA--C 1.547 1.16 0 N-CA-C 110.678 -0.547 . . . . 74.11 110.678 . . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 219' ' ' GLY . . . . . . . . . . . . . . . -178.88 164.87 33.51 Favored Glycine 0 CA--C 1.53 1.031 0 CA-C-N 114.765 -1.107 . . . . 72.35 111.435 -178.736 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 220' ' ' PRO . . . . . . . . . . . . . 62.0 Cg_endo -80.57 160.81 22.19 Favored 'Trans proline' 0 C--N 1.371 1.738 0 C-N-CA 123.09 2.527 . . . . 71.3 113.416 -178.043 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 221' ' ' TYR . . . . . . . . . . . . . 56.6 m-85 . . . . . 0 N--CA 1.486 1.348 0 C-N-CA 123.991 0.917 . . . . 73.43 111.106 -179.71 . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 3' ' ' ASN . . . . . 0.575 ' ND2' ' HA ' ' A' ' 25' ' ' PHE . 31.0 m120 . . . . . 0 CA--C 1.545 0.786 0 CA-C-O 119.565 -0.255 . . . . 75.25 111.088 . . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 4' ' ' PRO . . . . . 0.506 ' HG2' ' HB2' ' A' ' 24' ' ' LEU . 33.2 Cg_endo -63.63 119.53 6.62 Favored 'Trans proline' 0 C--N 1.38 2.219 0 C-N-CA 122.63 2.22 . . . . 74.31 112.043 176.368 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 5' ' ' THR . . . . . 0.558 HG22 ' HD3' ' A' ' 133' ' ' LYS . 61.1 m -97.42 110.71 23.22 Favored 'General case' 0 CA--C 1.539 0.556 0 C-N-CA 123.748 0.819 . . . . 72.34 108.807 178.703 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 10.0 m -97.83 123.31 50.21 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.155 0 N-CA-C 109.252 -0.647 . . . . 73.34 109.252 -175.588 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 7' ' ' PHE . . . . . 0.429 ' H ' ' HA ' ' A' ' 163' ' ' GLN . 82.3 t80 -103.82 142.39 34.46 Favored 'General case' 0 C--O 1.236 0.368 0 CA-C-N 115.706 -0.679 . . . . 73.32 109.946 -171.44 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 8' ' ' PHE . . . . . 0.443 ' HB3' HG23 ' A' ' 158' ' ' ILE . 72.5 m-85 -140.85 164.46 30.17 Favored 'General case' 0 C--O 1.239 0.508 0 C-N-CA 124.235 1.014 . . . . 75.41 109.494 174.535 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 24.5 m-20 -118.52 113.21 20.96 Favored 'General case' 0 N--CA 1.469 0.488 0 N-CA-C 107.134 -1.432 . . . . 54.14 107.134 168.551 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 37.8 mm -91.19 143.87 10.34 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.678 0 C-N-CA 123.137 0.575 . . . . 72.31 109.639 -175.965 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 11' ' ' ALA . . . . . 0.427 ' HB1' ' HB1' ' A' ' 159' ' ' ALA . . . -132.73 143.57 49.69 Favored 'General case' 0 CA--C 1.537 0.461 0 C-N-CA 123.831 0.852 . . . . 74.44 111.634 -167.624 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 12' ' ' VAL . . . . . 0.52 HG21 ' HB2' ' A' ' 17' ' ' LEU . 24.3 t -98.51 107.17 19.9 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.642 0 N-CA-C 108.256 -1.016 . . . . 74.43 108.256 172.439 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 27.5 m-20 62.03 32.01 17.77 Favored 'General case' 0 N--CA 1.488 1.461 0 C-N-CA 124.508 1.123 . . . . 74.31 111.78 179.338 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 99.27 -26.71 23.25 Favored Glycine 0 C--N 1.346 1.127 0 CA-C-N 115.424 -0.807 . . . . 75.35 112.87 -178.653 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 17.7 mm-40 -82.29 114.09 48.72 Favored Pre-proline 0 CA--C 1.547 0.853 0 CA-C-O 118.657 -0.687 . . . . 72.33 110.249 -174.349 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 21.7 Cg_endo -57.8 112.03 1.02 Allowed 'Trans proline' 0 C--N 1.382 2.304 0 C-N-CA 123.468 2.779 . . . . 74.11 112.52 -173.748 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 17' ' ' LEU . . . . . 0.52 ' HB2' HG21 ' A' ' 12' ' ' VAL . 61.6 tp -80.17 -46.49 16.28 Favored 'General case' 0 N--CA 1.472 0.642 0 C-N-CA 123.652 0.781 . . . . 73.24 110.551 -179.819 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -175.26 -163.88 28.96 Favored Glycine 0 C--N 1.34 0.761 0 CA-C-N 115.543 -0.753 . . . . 65.4 112.147 -177.768 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 8.9 ptp180 -107.13 150.59 26.42 Favored 'General case' 0 N--CA 1.479 1.004 0 C-N-CA 123.354 0.662 . . . . 74.02 109.927 -178.677 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 54.9 t -143.67 123.46 8.66 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.844 0 N-CA-C 108.275 -1.009 . . . . 74.43 108.275 169.04 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 11.1 t -126.9 138.41 53.3 Favored 'General case' 0 CA--C 1.546 0.821 0 C-N-CA 123.57 0.748 . . . . 65.33 109.618 178.128 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 22' ' ' PHE . . . . . 0.423 ' CG ' HD22 ' A' ' 98' ' ' LEU . 72.8 m-85 -109.69 150.18 28.65 Favored 'General case' 0 N--CA 1.476 0.826 0 C-N-CA 123.7 0.8 . . . . 74.01 111.012 -175.078 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 23' ' ' GLU . . . . . 0.55 ' HB2' ' HD2' ' A' ' 133' ' ' LYS . 5.2 tp10 -98.06 102.65 14.46 Favored 'General case' 0 N--CA 1.473 0.692 0 C-N-CA 124.462 1.105 . . . . 73.24 108.396 173.383 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . 0.506 ' HB2' ' HG2' ' A' ' 4' ' ' PRO . 26.5 mt -87.68 117.56 26.59 Favored 'General case' 0 N--CA 1.476 0.837 0 N-CA-C 109.598 -0.519 . . . . 72.33 109.598 179.972 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 25' ' ' PHE . . . . . 0.575 ' HA ' ' ND2' ' A' ' 3' ' ' ASN . 77.1 m-85 -86.45 65.35 9.01 Favored 'General case' 0 CA--C 1.539 0.533 0 CA-C-O 121.371 0.605 . . . . 74.45 110.701 -175.383 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -72.81 -4.99 35.02 Favored 'General case' 0 N--CA 1.481 1.11 0 C-N-CA 123.946 0.898 . . . . 75.0 112.961 -175.502 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 12.4 p-10 -78.58 -29.92 46.42 Favored 'General case' 0 N--CA 1.478 0.952 0 C-N-CA 123.049 0.54 . . . . 73.33 110.061 172.926 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 93.3 mttt -96.42 -42.26 8.2 Favored 'General case' 0 N--CA 1.474 0.752 0 C-N-CA 124.099 0.959 . . . . 73.14 110.34 -179.015 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 29' ' ' VAL . . . . . 0.541 HG22 ' HA ' ' A' ' 129' ' ' PHE . 4.1 m -126.85 76.19 75.45 Favored Pre-proline 0 CA--C 1.558 1.271 0 C-N-CA 123.887 0.875 . . . . 75.51 110.663 178.302 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 81.7 Cg_exo -49.09 -52.57 8.49 Favored 'Trans proline' 0 C--N 1.381 2.244 0 C-N-CA 123.388 2.725 . . . . 72.24 113.967 176.103 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 85.0 tttt -67.62 -54.48 19.4 Favored 'General case' 0 N--CA 1.478 0.929 0 C-N-CA 123.588 0.755 . . . . 75.44 111.66 -174.194 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 7.0 m -69.08 -33.12 73.04 Favored 'General case' 0 CA--C 1.551 0.983 0 C-N-CA 123.022 0.529 . . . . 74.34 111.642 -170.499 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 33' ' ' ALA . . . . . 0.504 ' HB2' ' HB3' ' A' ' 24' ' ' LEU . . . -79.58 -40.24 29.86 Favored 'General case' 0 CA--C 1.547 0.836 0 C-N-CA 122.619 0.367 . . . . 73.03 111.19 178.303 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 39.0 tt0 -59.86 -35.46 74.84 Favored 'General case' 0 N--CA 1.486 1.369 0 C-N-CA 123.324 0.65 . . . . 75.13 111.052 178.128 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 35' ' ' ASN . . . . . 0.516 ' ND2' ' SD ' ' A' ' 100' ' ' MET . 43.9 t30 -53.16 -65.87 0.49 Allowed 'General case' 0 C--N 1.35 0.618 0 O-C-N 124.552 1.157 . . . . 74.5 110.989 179.74 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 85.8 t80 -62.37 -34.03 75.89 Favored 'General case' 0 CA--C 1.542 0.649 0 O-C-N 124.332 1.02 . . . . 71.23 111.106 -177.008 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 37' ' ' ARG . . . . . 0.412 ' HG3' ' OE1' ' A' ' 163' ' ' GLN . 48.9 ttp180 -59.94 -45.88 91.19 Favored 'General case' 0 N--CA 1.473 0.676 0 O-C-N 123.926 0.766 . . . . 74.1 111.374 175.277 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -81.77 -18.84 42.75 Favored 'General case' 0 CA--C 1.537 0.477 0 CA-C-N 115.668 -0.696 . . . . 75.35 111.425 -174.374 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 39' ' ' LEU . . . . . 0.463 HD23 ' HE1' ' A' ' 48' ' ' TYR . 98.5 mt -74.26 -39.88 62.72 Favored 'General case' 0 CA--C 1.547 0.844 0 C-N-CA 123.312 0.645 . . . . 65.25 109.31 170.469 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 35.1 t -64.92 -55.03 21.71 Favored 'General case' 0 N--CA 1.477 0.877 0 C-N-CA 124.596 1.159 . . . . 70.44 111.155 -179.938 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 34.8 p -76.58 -31.37 57.46 Favored 'General case' 0 CA--C 1.541 0.607 0 CA-C-N 115.382 -0.826 . . . . 64.34 111.224 -178.289 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 79.23 22.1 66.05 Favored Glycine 0 C--N 1.346 1.139 0 CA-C-O 119.614 -0.548 . . . . 73.43 113.951 176.679 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 8.7 mm-40 -63.64 -22.41 66.88 Favored 'General case' 0 N--CA 1.483 1.221 0 C-N-CA 123.368 0.667 . . . . 74.15 111.728 179.857 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 30.6 mmmt -94.6 15.33 18.32 Favored 'General case' 0 CA--C 1.55 0.947 0 C-N-CA 124.035 0.934 . . . . 74.34 111.558 -179.962 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 76.98 36.71 35.1 Favored Glycine 0 C--N 1.35 1.335 0 N-CA-C 114.417 0.527 . . . . 75.45 114.417 174.843 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 46' ' ' PHE . . . . . 0.416 ' HE2' ' HA ' ' A' ' 78' ' ' ILE . 25.2 m-85 -122.6 -48.35 2.05 Favored 'General case' 0 N--CA 1.491 1.575 0 CA-C-N 117.758 0.779 . . . . 75.24 111.514 -177.457 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 54.18 63.83 4.82 Favored Glycine 0 C--N 1.35 1.312 0 O-C-N 124.077 0.86 . . . . 72.12 115.018 170.218 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 48' ' ' TYR . . . . . 0.686 ' HE2' ' HB2' ' A' ' 66' ' ' ASP . 54.6 m-85 -65.27 89.79 0.09 Allowed 'General case' 0 N--CA 1.481 1.118 0 CA-C-O 121.745 0.783 . . . . 75.34 111.731 179.885 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 27.6 tptp -111.23 107.0 16.16 Favored 'General case' 0 CA--C 1.535 0.377 0 CA-C-N 114.576 -1.193 . . . . 71.23 108.476 178.247 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 99.08 13.8 38.33 Favored Glycine 0 N--CA 1.471 0.999 0 CA-C-O 118.992 -0.893 . . . . 74.24 113.763 178.754 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 20.3 p -57.67 122.89 13.86 Favored 'General case' 0 N--CA 1.48 1.035 0 C-N-CA 123.414 0.686 . . . . 64.25 110.818 -178.482 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 52' ' ' CYS . . . . . . . . . . . . . 7.0 p -100.98 132.37 46.42 Favored 'General case' 0 CA--C 1.539 0.533 0 C-N-CA 123.721 0.808 . . . . 63.24 112.729 -164.058 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 53' ' ' PHE . . . . . 0.576 ' HA ' ' HA3' ' A' ' 64' ' ' GLY . 45.5 m-85 -72.04 140.22 48.9 Favored 'General case' 0 CA--C 1.54 0.559 0 C-N-CA 124.381 1.072 . . . . 73.24 110.151 168.899 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 15.8 p-80 -153.4 13.55 0.49 Allowed 'General case' 0 N--CA 1.478 0.959 0 CA-C-N 116.087 -0.506 . . . . 62.15 112.213 -173.82 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 55' ' ' ARG . . . . . 0.457 ' HA ' ' O ' ' A' ' 150' ' ' GLY . 33.4 ttt180 -155.8 98.29 1.9 Allowed 'General case' 0 N--CA 1.474 0.728 0 N-CA-C 109.732 -0.47 . . . . 74.14 109.732 174.342 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 29.3 mt -130.23 135.88 59.86 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.105 0 C-N-CA 123.053 0.541 . . . . 75.1 109.799 -178.449 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 61.7 mt -134.58 124.55 17.03 Favored Pre-proline 0 CA--C 1.553 1.072 0 C-N-CA 124.976 1.31 . . . . 75.43 109.497 -173.454 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 58' ' ' PRO . . . . . 0.428 ' HA ' ' HG2' ' A' ' 143' ' ' GLU . 31.0 Cg_endo -61.31 139.74 84.59 Favored 'Trans proline' 0 C--N 1.384 2.411 0 C-N-CA 123.609 2.873 . . . . 75.21 113.573 -179.452 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 60.22 24.55 61.24 Favored Glycine 0 C--N 1.353 1.504 0 CA-C-N 115.006 -0.997 . . . . 54.33 113.872 -179.813 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 40.5 t80 -139.76 -69.55 0.41 Allowed 'General case' 0 C--O 1.241 0.651 0 CA-C-N 116.973 0.386 . . . . 72.53 110.495 -174.583 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 53.3 ttp -171.44 148.34 2.53 Favored 'General case' 0 N--CA 1.482 1.151 0 N-CA-C 111.905 0.335 . . . . 65.45 111.905 -165.464 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 62' ' ' CYS . . . . . 0.603 ' SG ' ' HB ' ' A' ' 114' ' ' ILE . 21.9 p -119.81 117.58 28.57 Favored 'General case' 0 N--CA 1.477 0.89 0 C-N-CA 123.894 0.878 . . . . 74.22 108.974 169.591 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 63' ' ' GLN . . . . . 0.431 ' OE1' ' HD3' ' A' ' 55' ' ' ARG . 35.9 tt0 -123.24 143.92 49.73 Favored 'General case' 0 N--CA 1.487 1.42 0 C-N-CA 124.166 0.986 . . . . 75.2 111.781 -170.439 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 64' ' ' GLY . . . . . 0.576 ' HA3' ' HA ' ' A' ' 53' ' ' PHE . . . -161.78 -169.58 25.3 Favored Glycine 0 C--N 1.348 1.203 0 CA-C-N 115.039 -0.982 . . . . 52.33 113.011 176.403 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 166.4 -149.84 16.25 Favored Glycine 0 C--N 1.341 0.825 0 N-CA-C 112.242 -0.343 . . . . 65.05 112.242 -179.056 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 66' ' ' ASP . . . . . 0.686 ' HB2' ' HE2' ' A' ' 48' ' ' TYR . 41.2 t0 -74.94 146.4 41.8 Favored 'General case' 0 N--CA 1.477 0.919 0 C-N-CA 124.318 1.047 . . . . 73.21 110.601 -178.825 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 51.7 t80 -79.88 -33.69 39.8 Favored 'General case' 0 CA--C 1.542 0.673 0 C-N-CA 123.663 0.785 . . . . 62.51 109.46 178.043 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 68' ' ' THR . . . . . 0.63 HG22 ' HG3' ' A' ' 69' ' ' ARG . 14.1 m -72.56 150.59 43.01 Favored 'General case' 0 CA--C 1.544 0.748 0 CA-C-N 114.961 -1.018 . . . . 64.34 109.206 173.019 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 69' ' ' ARG . . . . . 0.63 ' HG3' HG22 ' A' ' 68' ' ' THR . 65.9 mtt85 66.71 13.68 9.46 Favored 'General case' 0 N--CA 1.488 1.438 0 C-N-CA 124.033 0.933 . . . . 75.14 112.296 174.921 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 15.9 t-80 -52.59 -29.1 24.06 Favored 'General case' 0 N--CA 1.484 1.253 0 C-N-CA 125.012 1.325 . . . . 74.44 112.007 -173.724 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 5.3 m-20 -69.28 88.2 0.44 Allowed 'General case' 0 CA--C 1.548 0.887 0 C-N-CA 123.987 0.915 . . . . 72.41 110.377 172.391 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 85.46 -1.2 88.47 Favored Glycine 0 CA--C 1.533 1.16 0 N-CA-C 115.195 0.838 . . . . 50.22 115.195 172.774 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 28.5 m -139.74 -90.74 0.18 Allowed 'General case' 0 N--CA 1.478 0.943 0 CA-C-N 118.06 0.93 . . . . 72.43 110.019 176.02 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 74' ' ' GLY . . . . . 0.453 ' HA2' ' O ' ' A' ' 68' ' ' THR . . . 61.32 60.65 7.93 Favored Glycine 0 C--N 1.356 1.668 0 O-C-N 123.577 0.548 . . . . 55.31 113.277 -176.905 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 141.36 52.19 0.04 OUTLIER Glycine 0 C--N 1.353 1.518 0 C-N-CA 121.101 -0.571 . . . . 73.22 113.055 -176.502 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 63.6 pttt -56.8 158.9 4.34 Favored 'General case' 0 N--CA 1.487 1.377 0 C-N-CA 123.406 0.682 . . . . 72.22 111.896 -179.881 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 71.8 p -98.29 -179.21 4.29 Favored 'General case' 0 CA--C 1.544 0.729 0 C-N-CA 123.338 0.655 . . . . 74.52 110.92 -176.214 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 78' ' ' ILE . . . . . 0.416 ' HA ' ' HE2' ' A' ' 46' ' ' PHE . 25.4 pt -84.96 -8.18 11.12 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.802 0 C-N-CA 122.936 0.494 . . . . 72.54 110.569 173.483 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 53.3 m-85 -103.87 12.42 34.44 Favored 'General case' 0 N--CA 1.472 0.669 0 C-N-CA 124.338 1.055 . . . . 64.43 110.361 -179.992 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 126.42 -134.62 8.62 Favored Glycine 0 C--N 1.348 1.211 0 N-CA-C 110.623 -0.991 . . . . 73.42 110.623 -179.113 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 36.7 tt0 -81.81 -45.66 15.26 Favored 'General case' 0 N--CA 1.47 0.53 0 N-CA-C 109.042 -0.725 . . . . 72.34 109.042 173.701 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 82' ' ' LYS . . . . . 0.786 ' HD2' ' HA ' ' A' ' 107' ' ' THR . 22.6 pttm -156.07 165.32 36.78 Favored 'General case' 0 CA--C 1.54 0.561 0 CA-C-N 114.217 -1.356 . . . . 74.4 110.096 -171.284 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 45.7 p90 -145.76 172.77 12.82 Favored 'General case' 0 N--CA 1.474 0.742 0 C-N-CA 124.177 0.991 . . . . 75.34 109.821 -178.663 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 12.2 pt-20 -91.9 159.73 15.62 Favored 'General case' 0 N--CA 1.472 0.666 0 C-N-CA 122.668 0.387 . . . . 75.34 110.614 178.722 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 62.5 m-20 -63.25 124.78 22.11 Favored 'General case' 0 N--CA 1.472 0.668 0 C-N-CA 123.621 0.768 . . . . 71.52 110.669 -179.767 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 62.1 tt0 -62.72 -48.28 79.91 Favored 'General case' 0 CA--C 1.54 0.566 0 CA-C-N 115.025 -0.989 . . . . 74.41 111.338 -178.95 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 31.9 p30 -161.65 -162.21 0.85 Allowed 'General case' 0 N--CA 1.474 0.759 0 C-N-CA 124.059 0.944 . . . . 75.24 108.517 -179.068 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 87.1 m-85 -142.16 46.14 1.64 Allowed 'General case' 0 N--CA 1.492 1.654 0 C-N-CA 123.043 0.537 . . . . 74.31 110.357 175.494 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 78.3 mt -69.59 -56.67 10.77 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.008 0 CA-C-N 115.764 -0.653 . . . . 62.3 109.882 176.111 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 90' ' ' LEU . . . . . 0.533 HD12 ' HB2' ' A' ' 25' ' ' PHE . 72.0 mt -87.42 126.69 35.03 Favored 'General case' 0 C--O 1.237 0.434 0 CA-C-N 115.045 -0.979 . . . . 64.32 109.751 -176.899 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 91' ' ' LYS . . . . . 0.557 ' HB3' ' HZ2' ' A' ' 91' ' ' LYS . 9.6 mtpm? -119.72 165.58 14.33 Favored 'General case' 0 CA--C 1.542 0.638 0 C-N-CA 124.194 0.998 . . . . 75.23 110.768 -175.291 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 92' ' ' HIS . . . . . . . . . . . . . 52.1 m-70 -83.73 51.31 1.99 Allowed 'General case' 0 N--CA 1.485 1.297 0 C-N-CA 124.478 1.111 . . . . 74.51 110.463 -177.326 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 11.6 t -95.94 13.39 27.06 Favored 'General case' 0 N--CA 1.48 1.036 0 C-N-CA 123.706 0.802 . . . . 73.35 112.242 -170.557 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -161.34 173.18 37.72 Favored Glycine 0 C--N 1.342 0.893 0 CA-C-O 120.027 -0.318 . . . . 64.53 112.524 179.618 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 98.6 Cg_endo -78.87 157.64 27.46 Favored 'Trans proline' 0 C--N 1.363 1.31 0 C-N-CA 122.68 2.253 . . . . 74.13 111.737 170.651 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 81.42 10.52 84.45 Favored Glycine 0 CA--C 1.533 1.171 0 CA-C-N 116.143 -0.481 . . . . 72.14 114.284 179.746 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 97' ' ' ILE . . . . . 0.55 ' HB ' ' HB2' ' A' ' 115' ' ' CYS . 9.8 mm -66.85 111.03 1.69 Allowed 'Isoleucine or valine' 0 CA--C 1.553 1.065 0 C-N-CA 124.36 1.064 . . . . 73.2 111.775 -176.56 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 98' ' ' LEU . . . . . 0.423 HD22 ' CG ' ' A' ' 22' ' ' PHE . 36.6 tp -92.09 113.98 26.39 Favored 'General case' 0 C--O 1.246 0.897 0 CA-C-O 121.257 0.551 . . . . 70.14 110.596 178.577 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 36.2 t -137.25 144.2 42.63 Favored 'General case' 0 CA--C 1.545 0.76 0 C-N-CA 124.395 1.078 . . . . 71.13 108.263 175.167 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 100' ' ' MET . . . . . 0.661 ' HA ' ' HA ' ' A' ' 112' ' ' PHE . 74.1 mtp -78.7 147.03 33.63 Favored 'General case' 0 N--CA 1.483 1.217 0 N-CA-C 109.168 -0.678 . . . . 75.43 109.168 175.316 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 101' ' ' ALA . . . . . 0.502 ' HA ' ' HE1' ' A' ' 126' ' ' HIS . . . -79.53 164.64 23.72 Favored 'General case' 0 N--CA 1.479 0.985 0 CA-C-O 121.399 0.619 . . . . 62.12 112.59 -169.875 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 24.2 p-10 -153.98 167.58 29.28 Favored 'General case' 0 N--CA 1.471 0.612 0 CA-C-N 114.82 -1.082 . . . . 71.35 110.071 -178.591 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -113.63 -7.12 13.35 Favored 'General case' 0 CA--C 1.544 0.747 0 C-N-CA 123.765 0.826 . . . . 72.41 110.02 167.56 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 171.5 -164.76 37.64 Favored Glycine 0 C--N 1.351 1.374 0 CA-C-O 119.399 -0.667 . . . . 44.33 111.555 -178.572 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 14.1 Cg_exo -70.69 143.06 45.35 Favored 'Trans proline' 0 C--N 1.37 1.658 0 C-N-CA 123.322 2.682 . . . . 73.2 111.856 177.952 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 64.4 t30 64.57 16.31 10.21 Favored 'General case' 0 N--CA 1.485 1.29 0 C-N-CA 125.131 1.372 . . . . 74.43 110.997 -177.174 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 107' ' ' THR . . . . . 0.786 ' HA ' ' HD2' ' A' ' 82' ' ' LYS . 4.6 m -117.26 5.48 12.66 Favored 'General case' 0 CA--C 1.547 0.828 0 C-N-CA 124.162 0.985 . . . . 73.13 110.042 -178.828 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 53.1 t30 -84.09 133.53 34.63 Favored 'General case' 0 N--CA 1.474 0.753 0 C-N-CA 123.867 0.867 . . . . 73.51 109.937 -176.842 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 113.12 10.39 15.84 Favored Glycine 0 N--CA 1.472 1.074 0 CA-C-O 120.203 -0.22 . . . . 72.23 113.181 -176.191 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 46.4 p -104.11 120.91 42.11 Favored 'General case' 0 CA--C 1.542 0.652 0 N-CA-C 107.48 -1.304 . . . . 74.03 107.48 166.383 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 111' ' ' GLN . . . . . 0.495 ' HB2' ' HB2' ' A' ' 101' ' ' ALA . 46.5 mt-30 66.9 178.01 0.23 Allowed 'General case' 0 N--CA 1.498 1.943 0 C-N-CA 124.567 1.147 . . . . 72.02 111.533 -172.929 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 112' ' ' PHE . . . . . 0.661 ' HA ' ' HA ' ' A' ' 100' ' ' MET . 45.2 p90 -143.74 161.45 38.56 Favored 'General case' 0 N--CA 1.473 0.708 0 C-N-CA 124.409 1.084 . . . . 71.2 108.874 173.273 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 113' ' ' PHE . . . . . 0.464 ' HE1' ' SG ' ' A' ' 115' ' ' CYS . 48.0 p90 -153.91 161.71 41.79 Favored 'General case' 0 N--CA 1.464 0.266 0 CA-C-O 121.354 0.597 . . . . 75.42 111.673 176.423 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 114' ' ' ILE . . . . . 0.603 ' HB ' ' SG ' ' A' ' 62' ' ' CYS . 15.6 mt -119.24 100.7 10.25 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.744 0 CA-C-N 114.31 -1.314 . . . . 71.41 107.577 175.184 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 115' ' ' CYS . . . . . 0.55 ' HB2' ' HB ' ' A' ' 97' ' ' ILE . 87.0 m -62.23 104.4 0.48 Allowed 'General case' 0 N--CA 1.474 0.769 0 N-CA-C 109.245 -0.65 . . . . 73.34 109.245 171.612 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 28.0 p -82.05 -0.19 43.33 Favored 'General case' 0 CA--C 1.547 0.853 0 C-N-CA 124.316 1.047 . . . . 74.22 111.609 -177.059 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -129.8 160.94 31.91 Favored 'General case' 0 C--O 1.245 0.834 0 C-N-CA 123.93 0.892 . . . . 74.44 109.608 169.471 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 10.3 ptmt -70.66 79.76 0.6 Allowed 'General case' 0 CA--C 1.546 0.82 0 CA-C-O 121.613 0.72 . . . . 73.13 109.418 171.123 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 119' ' ' THR . . . . . . . . . . . . . 36.6 p -72.35 87.05 1.13 Allowed 'General case' 0 CA--C 1.549 0.931 0 CA-C-O 122.013 0.911 . . . . 72.44 110.132 -176.161 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 9.5 pt-20 -72.8 -30.8 64.36 Favored 'General case' 0 N--CA 1.477 0.907 0 CA-C-N 114.611 -1.177 . . . . 75.3 112.307 -169.879 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 121' ' ' TRP . . . . . . . . . . . . . 41.4 p90 -68.39 -21.49 64.69 Favored 'General case' 0 CA--C 1.544 0.746 0 C-N-CA 122.965 0.506 . . . . 75.31 110.936 176.557 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 52.7 mt -83.41 0.36 46.45 Favored 'General case' 0 N--CA 1.482 1.139 0 C-N-CA 122.882 0.473 . . . . 72.02 112.254 177.768 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 62.7 m-20 -78.32 119.79 22.17 Favored 'General case' 0 CA--C 1.542 0.656 0 N-CA-C 109.082 -0.71 . . . . 74.35 109.082 172.728 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 111.02 -25.15 14.7 Favored Glycine 0 C--N 1.346 1.123 0 CA-C-N 115.589 -0.732 . . . . 74.43 111.279 -168.189 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 125' ' ' LYS . . . . . 0.652 ' HG3' ' H ' ' A' ' 126' ' ' HIS . 0.5 OUTLIER -77.32 -167.13 0.85 Allowed 'General case' 0 CA--C 1.568 1.641 0 C-N-CA 124.512 1.125 . . . . 65.15 107.984 170.997 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 126' ' ' HIS . . . . . 0.652 ' H ' ' HG3' ' A' ' 125' ' ' LYS . 0.4 OUTLIER -64.57 150.03 47.65 Favored 'General case' 0 C--O 1.248 0.996 0 C-N-CA 123.944 0.898 . . . . 74.24 112.93 -170.777 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 13.9 p -73.01 145.55 11.7 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.585 0 CA-C-N 114.354 -1.293 . . . . 64.54 111.906 -169.669 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 46.5 t -81.96 149.43 4.8 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.533 0 CA-C-N 114.379 -1.282 . . . . 75.52 108.616 172.41 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 129' ' ' PHE . . . . . 0.541 ' HA ' HG22 ' A' ' 29' ' ' VAL . 46.0 p90 -129.33 -9.1 4.7 Favored 'General case' 0 N--CA 1.481 1.086 0 CA-C-N 118.158 0.435 . . . . 72.41 111.753 179.611 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . -160.92 176.58 37.51 Favored Glycine 0 C--N 1.337 0.59 0 O-C-N 123.371 0.419 . . . . 73.23 112.67 -177.578 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 34.2 ttpt -151.47 135.86 16.89 Favored 'General case' 0 N--CA 1.467 0.415 0 N-CA-C 108.307 -0.997 . . . . 74.02 108.307 173.977 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 6.4 p -60.8 117.31 2.46 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.921 0 O-C-N 123.557 0.535 . . . . 75.35 110.661 178.568 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 133' ' ' LYS . . . . . 0.558 ' HD3' HG22 ' A' ' 5' ' ' THR . 22.3 ptmt -102.12 -14.93 16.87 Favored 'General case' 0 N--CA 1.481 1.124 0 C-N-CA 123.835 0.854 . . . . 75.31 110.609 -178.22 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 3.7 mm-40 -145.36 141.7 28.72 Favored 'General case' 0 N--CA 1.47 0.568 0 C-N-CA 123.11 0.564 . . . . 73.51 110.263 -177.808 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 71.75 26.47 72.78 Favored Glycine 0 C--N 1.338 0.645 0 O-C-N 123.797 0.686 . . . . 54.1 112.76 -174.384 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 136' ' ' MET . . . . . . . . . . . . . 7.0 tpt -60.58 -41.96 95.73 Favored 'General case' 0 N--CA 1.481 1.076 0 C-N-CA 123.379 0.672 . . . . 74.11 109.996 177.223 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 137' ' ' ASN . . . . . . . . . . . . . 12.4 m120 -62.95 -37.08 85.66 Favored 'General case' 0 N--CA 1.477 0.894 0 C-N-CA 123.68 0.792 . . . . 74.4 110.759 178.733 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 138' ' ' ILE . . . . . 0.517 ' O ' ' HG3' ' A' ' 142' ' ' MET . 49.6 mm -61.0 -51.16 76.43 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.809 0 C-N-CA 123.29 0.636 . . . . 74.51 109.663 175.922 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 139' ' ' VAL . . . . . 0.459 HG12 ' SG ' ' A' ' 62' ' ' CYS . 94.6 t -54.36 -47.0 70.06 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.138 0 C-N-CA 124.293 1.037 . . . . 74.42 111.454 179.859 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 38.2 mt-10 -67.24 -29.98 69.77 Favored 'General case' 0 N--CA 1.481 1.079 0 C-N-CA 123.689 0.796 . . . . 73.02 111.569 -179.222 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -77.59 -35.66 52.71 Favored 'General case' 0 N--CA 1.475 0.786 0 C-N-CA 122.938 0.495 . . . . 73.03 111.513 178.833 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 142' ' ' MET . . . . . 0.517 ' HG3' ' O ' ' A' ' 138' ' ' ILE . 45.3 mtp -80.52 -19.58 45.49 Favored 'General case' 0 N--CA 1.483 1.193 0 C-N-CA 122.693 0.397 . . . . 75.15 111.106 -178.935 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 143' ' ' GLU . . . . . 0.428 ' HG2' ' HA ' ' A' ' 58' ' ' PRO . 24.8 tt0 -54.15 -35.15 61.94 Favored 'General case' 0 CA--C 1.55 0.974 0 C-N-CA 124.445 1.098 . . . . 61.05 110.847 168.452 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 144' ' ' ARG . . . . . . . . . . . . . 71.9 mtp180 -74.42 -11.91 60.36 Favored 'General case' 0 CA--C 1.542 0.636 0 C-N-CA 124.69 1.196 . . . . 71.3 112.067 -175.833 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 145' ' ' PHE . . . . . 0.455 ' HD2' ' HA ' ' A' ' 142' ' ' MET . 67.2 m-85 -90.94 -4.89 56.14 Favored 'General case' 0 N--CA 1.479 0.986 0 C-N-CA 122.816 0.446 . . . . 74.15 110.962 173.541 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . -91.76 173.92 37.18 Favored Glycine 0 C--N 1.343 0.939 0 CA-C-N 116.827 -0.17 . . . . 75.41 112.714 176.614 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 20.0 m -132.0 167.92 18.84 Favored 'General case' 0 N--CA 1.484 1.259 0 C-N-CA 124.054 0.942 . . . . 75.03 110.434 -177.491 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 148' ' ' ARG . . . . . . . . . . . . . 19.7 mmm180 -61.77 -32.22 72.47 Favored 'General case' 0 N--CA 1.484 1.235 0 C-N-CA 123.852 0.861 . . . . 61.25 112.246 -173.071 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 149' ' ' ASN . . . . . . . . . . . . . 30.6 p-10 -88.61 -7.2 56.81 Favored 'General case' 0 N--CA 1.483 1.191 0 C-N-CA 123.716 0.806 . . . . 62.13 111.83 -179.457 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 150' ' ' GLY . . . . . 0.457 ' O ' ' HA ' ' A' ' 55' ' ' ARG . . . 105.29 -3.04 40.21 Favored Glycine 0 C--N 1.34 0.797 0 CA-C-O 119.85 -0.417 . . . . 74.13 113.421 -178.331 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 84.8 tttt -63.84 112.56 2.95 Favored 'General case' 0 N--CA 1.472 0.626 0 CA-C-O 121.229 0.537 . . . . 73.24 109.796 -179.212 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 152' ' ' THR . . . . . . . . . . . . . 9.1 m -94.21 109.51 21.31 Favored 'General case' 0 CA--C 1.541 0.604 0 N-CA-C 108.17 -1.048 . . . . 74.22 108.17 179.542 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 153' ' ' SER . . . . . . . . . . . . . 16.0 m -59.32 -35.5 73.93 Favored 'General case' 0 N--CA 1.478 0.941 0 C-N-CA 124.914 1.285 . . . . 71.43 112.164 -174.965 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 74.9 mmtt -109.98 137.04 48.31 Favored 'General case' 0 N--CA 1.467 0.379 0 C-N-CA 123.895 0.878 . . . . 74.35 109.236 -177.475 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 16.7 tppt? -77.52 91.03 3.9 Favored 'General case' 0 CA--C 1.534 0.341 0 N-CA-C 108.418 -0.956 . . . . 74.54 108.418 176.215 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 156' ' ' ILE . . . . . 0.525 ' HB ' ' HB2' ' A' ' 53' ' ' PHE . 85.6 mt -84.93 130.25 36.38 Favored 'Isoleucine or valine' 0 C--O 1.221 -0.446 0 CA-C-N 115.126 -0.943 . . . . 74.53 108.726 -175.383 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 157' ' ' THR . . . . . . . . . . . . . 32.3 p -130.55 155.39 46.59 Favored 'General case' 0 N--CA 1.476 0.867 0 C-N-CA 123.922 0.889 . . . . 72.21 109.934 -176.03 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 158' ' ' ILE . . . . . 0.443 HG23 ' HB3' ' A' ' 8' ' ' PHE . 23.3 mt -88.76 95.3 5.25 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.641 0 N-CA-C 108.598 -0.89 . . . . 72.43 108.598 171.643 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 159' ' ' ALA . . . . . 0.427 ' HB1' ' HB1' ' A' ' 11' ' ' ALA . . . -59.72 -33.37 71.55 Favored 'General case' 0 N--CA 1.474 0.729 0 C-N-CA 124.102 0.961 . . . . 75.32 113.023 -175.267 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 160' ' ' ASP . . . . . . . . . . . . . 1.7 t70 -159.34 170.83 20.97 Favored 'General case' 0 N--CA 1.483 1.206 0 CA-C-O 120.765 0.316 . . . . 75.41 111.496 -175.285 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 161' ' ' CYS . . . . . . . . . . . . . 19.9 p -139.02 -168.83 2.51 Favored 'General case' 0 N--CA 1.481 1.118 0 C-N-CA 125.305 1.442 . . . . 72.25 108.553 -179.463 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 162' ' ' GLY . . . . . . . . . . . . . . . 135.56 56.45 0.06 OUTLIER Glycine 0 N--CA 1.48 1.591 0 CA-C-N 119.294 0.952 . . . . 72.45 113.562 -170.735 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 163' ' ' GLN . . . . . 0.429 ' HA ' ' H ' ' A' ' 7' ' ' PHE . 49.3 tt0 -44.42 119.87 2.01 Favored 'General case' 0 N--CA 1.484 1.23 0 C-N-CA 125.336 1.454 . . . . 71.24 113.069 -178.44 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 164' ' ' LEU . . . . . 0.48 ' O ' ' HB ' ' A' ' 5' ' ' THR . 97.8 mt . . . . . 0 CA--C 1.536 0.43 0 CA-C-N 115.123 -0.944 . . . . 75.15 110.306 -176.591 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 218' ' ' PRO . . . . . . . . . . . . . 26.3 Cg_exo . . . . . 0 N--CA 1.485 0.989 0 CA-C-O 120.736 0.223 . . . . 75.45 111.732 . . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' B' B ' 219' ' ' GLY . . . . . . . . . . . . . . . 177.95 163.97 30.47 Favored Glycine 0 CA--C 1.525 0.674 0 CA-C-N 115.612 -0.722 . . . . 75.54 112.407 -179.844 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 220' ' ' PRO . . . . . . . . . . . . . 24.5 Cg_exo -68.09 157.65 60.87 Favored 'Trans proline' 0 N--CA 1.489 1.254 0 C-N-CA 123.5 2.8 . . . . 75.1 113.264 175.612 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 221' ' ' TYR . . . . . . . . . . . . . 78.4 m-85 . . . . . 0 N--CA 1.476 0.844 0 C-N-CA 123.365 0.666 . . . . 72.04 110.04 179.988 . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 3' ' ' ASN . . . . . 0.483 ' ND2' ' HA ' ' A' ' 25' ' ' PHE . 14.1 m120 . . . . . 0 CA--C 1.548 0.884 0 CA-C-O 118.727 -0.654 . . . . 74.23 110.895 . . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 4' ' ' PRO . . . . . 0.487 ' HG2' ' HB2' ' A' ' 24' ' ' LEU . 16.1 Cg_endo -56.39 147.12 69.78 Favored 'Trans proline' 0 C--N 1.386 2.504 0 C-N-CA 123.51 2.807 . . . . 64.41 114.276 179.111 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 5' ' ' THR . . . . . 0.507 HG22 ' HD3' ' A' ' 133' ' ' LYS . 86.6 m -98.52 116.82 31.58 Favored 'General case' 0 CA--C 1.542 0.637 0 C-N-CA 124.903 1.281 . . . . 73.42 108.56 178.271 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 6' ' ' VAL . . . . . 0.439 ' HA ' ' HG3' ' A' ' 163' ' ' GLN . 28.6 t -99.42 119.93 48.11 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.737 0 N-CA-C 108.358 -0.978 . . . . 72.33 108.358 178.784 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 7' ' ' PHE . . . . . 0.555 ' H ' ' HA ' ' A' ' 163' ' ' GLN . 75.7 t80 -100.76 131.17 46.78 Favored 'General case' 0 C--N 1.324 -0.539 0 N-CA-C 109.439 -0.578 . . . . 75.4 109.439 -176.712 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 8' ' ' PHE . . . . . 0.471 ' HD2' ' HE2' ' A' ' 22' ' ' PHE . 46.7 m-85 -133.74 165.07 25.81 Favored 'General case' 0 C--O 1.241 0.65 0 C-N-CA 124.584 1.153 . . . . 74.02 108.949 167.095 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 9' ' ' ASP . . . . . 0.462 ' HB2' ' HB3' ' A' ' 159' ' ' ALA . 27.9 m-20 -112.94 112.62 24.21 Favored 'General case' 0 C--N 1.318 -0.79 0 N-CA-C 106.337 -1.727 . . . . 70.34 106.337 170.422 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 10' ' ' ILE . . . . . 0.42 HG21 ' SD ' ' A' ' 142' ' ' MET . 43.5 mm -81.51 125.12 39.55 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.213 0 N-CA-C 108.695 -0.854 . . . . 73.03 108.695 -179.995 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 11' ' ' ALA . . . . . 0.639 ' HB3' ' HB1' ' A' ' 159' ' ' ALA . . . -121.76 123.54 42.07 Favored 'General case' 0 C--O 1.213 -0.847 0 C-N-CA 124.403 1.081 . . . . 73.43 110.247 -171.405 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 12' ' ' VAL . . . . . 0.422 HG22 HG12 ' A' ' 156' ' ' ILE . 67.9 t -99.24 131.36 46.68 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.653 0 N-CA-C 107.844 -1.169 . . . . 74.05 107.844 173.515 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 23.1 m-20 67.87 17.58 9.67 Favored 'General case' 0 N--CA 1.491 1.621 0 C-N-CA 124.418 1.087 . . . . 74.13 110.582 -173.577 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 82.75 -9.3 59.85 Favored Glycine 0 C--N 1.351 1.364 0 CA-C-O 119.907 -0.385 . . . . 72.23 113.131 -171.27 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 37.6 mm-40 -97.35 127.48 38.04 Favored Pre-proline 0 CA--C 1.548 0.888 0 C-N-CA 124.329 1.052 . . . . 73.43 110.209 -178.127 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 18.6 Cg_endo -55.28 112.5 1.06 Allowed 'Trans proline' 0 C--N 1.381 2.282 0 C-N-CA 123.75 2.967 . . . . 75.33 113.483 -172.995 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 17' ' ' LEU . . . . . 0.466 HD21 HG22 ' A' ' 138' ' ' ILE . 40.0 tp -79.33 -40.55 30.03 Favored 'General case' 0 N--CA 1.476 0.87 0 C-N-CA 123.469 0.708 . . . . 75.12 110.087 174.704 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -176.04 -179.36 46.48 Favored Glycine 0 C--N 1.348 1.206 0 CA-C-N 116.212 -0.449 . . . . 65.4 113.286 -179.813 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 30.5 mtp85 -107.69 125.48 51.42 Favored 'General case' 0 N--CA 1.475 0.792 0 C-N-CA 124.46 1.104 . . . . 74.32 109.142 -176.967 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 71.9 t -126.0 142.61 42.17 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.804 0 C-N-CA 124.13 0.972 . . . . 71.05 109.684 -177.903 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 21' ' ' SER . . . . . 0.493 ' HB2' ' HB2' ' A' ' 134' ' ' GLU . 49.4 m -130.64 134.69 47.17 Favored 'General case' 0 CA--C 1.539 0.539 0 C-N-CA 123.579 0.752 . . . . 62.33 109.556 173.447 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 22' ' ' PHE . . . . . 0.471 ' HE2' ' HD2' ' A' ' 8' ' ' PHE . 73.3 m-85 -100.49 170.28 8.5 Favored 'General case' 0 N--CA 1.467 0.389 0 C-N-CA 125.039 1.336 . . . . 72.22 108.945 175.32 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 23' ' ' GLU . . . . . 0.536 ' HB2' ' HD2' ' A' ' 133' ' ' LYS . 35.5 tt0 -137.07 107.15 6.33 Favored 'General case' 0 CA--C 1.539 0.523 0 C-N-CA 122.98 0.512 . . . . 71.14 109.674 -178.608 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . 0.487 ' HB2' ' HG2' ' A' ' 4' ' ' PRO . 25.5 mt -87.23 126.83 35.06 Favored 'General case' 0 N--CA 1.476 0.83 0 C-N-CA 123.347 0.659 . . . . 72.13 110.531 -175.734 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 25' ' ' PHE . . . . . 0.483 ' HA ' ' ND2' ' A' ' 3' ' ' ASN . 50.9 m-85 -86.21 67.17 9.87 Favored 'General case' 0 CA--C 1.54 0.594 0 C-N-CA 123.905 0.882 . . . . 75.32 109.267 178.51 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -66.83 -18.32 65.32 Favored 'General case' 0 N--CA 1.48 1.059 0 C-N-CA 124.323 1.049 . . . . 75.01 112.923 -173.271 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 12.9 p-10 -79.01 -32.01 44.92 Favored 'General case' 0 CA--C 1.546 0.804 0 C-N-CA 123.441 0.696 . . . . 74.32 110.672 176.258 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 97.9 mttt -89.94 -41.93 11.48 Favored 'General case' 0 N--CA 1.478 0.933 0 C-N-CA 123.69 0.796 . . . . 74.31 111.066 -175.703 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 29' ' ' VAL . . . . . 0.493 HG21 ' HA ' ' A' ' 129' ' ' PHE . 17.0 m -137.81 70.24 50.9 Favored Pre-proline 0 CA--C 1.561 1.374 0 C-N-CA 123.879 0.872 . . . . 73.41 110.096 -172.939 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 27.6 Cg_exo -60.93 -35.66 86.96 Favored 'Trans proline' 0 C--N 1.38 2.197 0 C-N-CA 123.169 2.58 . . . . 72.44 113.599 -170.727 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 22.9 ttmm -59.83 -61.11 2.85 Favored 'General case' 0 N--CA 1.475 0.782 0 C-N-CA 123.617 0.767 . . . . 71.33 111.725 -178.398 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 3.6 m -74.37 -27.53 60.7 Favored 'General case' 0 CA--C 1.553 1.077 0 CA-C-N 115.235 -0.893 . . . . 73.13 111.242 -171.059 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -74.2 -52.44 12.43 Favored 'General case' 0 CA--C 1.549 0.933 0 C-N-CA 122.774 0.43 . . . . 73.23 111.109 177.061 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 27.5 tt0 -61.14 -31.29 71.01 Favored 'General case' 0 N--CA 1.491 1.612 0 C-N-CA 123.305 0.642 . . . . 74.11 110.763 179.1 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 35' ' ' ASN . . . . . 0.501 ' O ' ' HG ' ' A' ' 39' ' ' LEU . 45.1 t30 -54.1 -66.55 0.38 Allowed 'General case' 0 C--N 1.354 0.797 0 O-C-N 123.97 0.794 . . . . 74.32 109.47 175.395 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 74.1 t80 -56.95 -38.2 72.62 Favored 'General case' 0 N--CA 1.479 1.011 0 C-N-CA 124.716 1.206 . . . . 73.25 111.51 -175.941 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 37' ' ' ARG . . . . . 0.501 ' HA ' HE22 ' A' ' 163' ' ' GLN . 14.0 ttm180 -55.24 -58.33 8.14 Favored 'General case' 0 C--N 1.353 0.759 0 CA-C-N 115.372 -0.831 . . . . 74.34 110.331 173.957 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 38' ' ' ALA . . . . . 0.433 ' HB3' ' HG2' ' A' ' 44' ' ' LYS . . . -74.11 -18.92 60.74 Favored 'General case' 0 N--CA 1.468 0.452 0 C-N-CA 123.785 0.834 . . . . 74.51 111.899 -171.782 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 39' ' ' LEU . . . . . 0.622 HD22 ' HE2' ' A' ' 48' ' ' TYR . 43.3 mt -71.58 -46.64 58.75 Favored 'General case' 0 CA--C 1.538 0.517 0 N-CA-C 109.371 -0.603 . . . . 72.02 109.371 173.229 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 33.7 t -68.5 -56.8 7.13 Favored 'General case' 0 CA--C 1.547 0.861 0 C-N-CA 123.797 0.839 . . . . 74.31 111.411 -179.433 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 41' ' ' THR . . . . . 0.4 ' OG1' ' HG2' ' A' ' 43' ' ' GLU . 71.6 p -76.62 -31.03 57.16 Favored 'General case' 0 N--CA 1.471 0.619 0 C-N-CA 124.075 0.95 . . . . 73.02 111.442 -174.012 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 85.74 31.92 19.85 Favored Glycine 0 C--N 1.349 1.261 0 CA-C-O 119.908 -0.384 . . . . 61.22 113.101 -179.022 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 43' ' ' GLU . . . . . 0.4 ' HG2' ' OG1' ' A' ' 41' ' ' THR . 24.5 mm-40 -66.12 -27.87 68.38 Favored 'General case' 0 N--CA 1.483 1.187 0 C-N-CA 122.706 0.402 . . . . 72.12 111.665 176.709 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 44' ' ' LYS . . . . . 0.433 ' HG2' ' HB3' ' A' ' 38' ' ' ALA . 33.3 mmtp -105.95 18.6 21.85 Favored 'General case' 0 N--CA 1.484 1.269 0 C-N-CA 122.992 0.517 . . . . 72.35 110.645 175.405 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 79.23 48.39 6.91 Favored Glycine 0 C--N 1.352 1.43 0 N-CA-C 114.803 0.681 . . . . 75.02 114.803 169.279 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 46' ' ' PHE . . . . . 0.462 ' CE2' ' HA ' ' A' ' 78' ' ' ILE . 25.1 m-85 -130.08 -50.79 1.12 Allowed 'General case' 0 N--CA 1.49 1.545 0 CA-C-N 118.021 0.911 . . . . 75.1 111.399 -178.557 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 47.87 53.97 12.76 Favored Glycine 0 C--N 1.354 1.547 0 O-C-N 124.593 1.183 . . . . 75.14 114.687 176.17 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 48' ' ' TYR . . . . . 0.622 ' HE2' HD22 ' A' ' 39' ' ' LEU . 33.5 m-85 -61.55 95.47 0.05 Allowed 'General case' 0 N--CA 1.479 1.001 0 C-N-CA 123.28 0.632 . . . . 72.12 111.487 -177.803 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 46.9 tptt -98.48 102.42 14.15 Favored 'General case' 0 CA--C 1.537 0.447 0 CA-C-N 114.866 -1.061 . . . . 74.33 108.925 -175.65 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 50' ' ' GLY . . . . . 0.422 ' HA2' ' O ' ' A' ' 158' ' ' ILE . . . 110.62 22.66 6.27 Favored Glycine 0 C--N 1.346 1.117 0 CA-C-O 119.362 -0.688 . . . . 74.32 114.651 173.647 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 19.3 m -53.43 128.35 28.35 Favored 'General case' 0 N--CA 1.484 1.268 0 C-N-CA 123.732 0.813 . . . . 74.43 111.175 178.005 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 52' ' ' CYS . . . . . 0.538 ' HA ' ' HA ' ' A' ' 157' ' ' THR . 19.4 p -103.25 133.83 47.67 Favored 'General case' 0 N--CA 1.478 0.937 0 N-CA-C 112.59 0.589 . . . . 73.55 112.59 -168.282 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 53' ' ' PHE . . . . . 0.684 ' HA ' ' HA2' ' A' ' 64' ' ' GLY . 79.4 m-85 -74.05 102.62 4.25 Favored 'General case' 0 N--CA 1.472 0.661 0 C-N-CA 124.069 0.948 . . . . 74.4 108.665 166.206 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 16.5 p-80 -114.82 -12.93 12.04 Favored 'General case' 0 N--CA 1.481 1.094 0 C-N-CA 123.603 0.761 . . . . 74.3 112.006 -173.316 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 36.1 ttt180 -128.39 100.82 5.95 Favored 'General case' 0 C--O 1.217 -0.618 0 C-N-CA 122.884 0.474 . . . . 73.44 109.75 179.13 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 57.9 mt -128.96 125.4 62.82 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.96 0 C-N-CA 122.905 0.482 . . . . 72.41 110.126 178.375 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 54.7 mt -116.48 114.25 40.38 Favored Pre-proline 0 CA--C 1.557 1.217 0 C-N-CA 124.367 1.067 . . . . 74.22 109.162 178.228 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 31.8 Cg_exo -60.32 129.88 31.66 Favored 'Trans proline' 0 C--N 1.387 2.582 0 C-N-CA 123.704 2.936 . . . . 73.3 112.61 178.103 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 81.26 26.17 52.82 Favored Glycine 0 C--N 1.341 0.807 0 O-C-N 123.778 0.674 . . . . 64.4 112.661 -176.113 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 23.1 t80 -151.88 -75.99 0.13 Allowed 'General case' 0 C--O 1.247 0.933 0 C-N-CA 123.016 0.526 . . . . 74.42 110.685 179.712 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 61' ' ' MET . . . . . 0.517 ' HE1' ' HD2' ' B' ' 220' ' ' PRO . 22.9 ptt? -165.35 163.62 19.87 Favored 'General case' 0 N--CA 1.485 1.305 0 N-CA-C 112.813 0.672 . . . . 73.01 112.813 -174.528 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 62' ' ' CYS . . . . . 0.465 ' SG ' ' HE1' ' A' ' 142' ' ' MET . 20.5 p -115.59 111.68 21.03 Favored 'General case' 0 CA--C 1.545 0.766 0 C-N-CA 124.253 1.021 . . . . 65.44 108.933 168.572 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 63' ' ' GLN . . . . . 0.554 ' HA ' ' HA ' ' A' ' 113' ' ' PHE . 52.1 tt0 -102.74 116.73 33.16 Favored 'General case' 0 N--CA 1.479 1.014 0 C-N-CA 124.019 0.928 . . . . 75.12 110.877 -174.955 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 64' ' ' GLY . . . . . 0.684 ' HA2' ' HA ' ' A' ' 53' ' ' PHE . . . -92.36 173.19 35.48 Favored Glycine 0 C--N 1.342 0.896 0 CA-C-N 115.221 -0.899 . . . . 72.13 112.284 171.362 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 174.29 150.46 7.69 Favored Glycine 0 C--O 1.238 0.344 0 N-CA-C 110.504 -1.038 . . . . 71.41 110.504 179.379 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 38.8 t70 -79.75 162.0 25.41 Favored 'General case' 0 CA--C 1.547 0.865 0 CA-C-O 121.608 0.718 . . . . 63.02 112.658 -169.804 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 55.0 t80 -79.95 -40.59 27.73 Favored 'General case' 0 CA--C 1.548 0.871 0 C-N-CA 124.701 1.2 . . . . 75.12 111.678 -177.281 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 25.3 m -61.16 112.68 2.21 Favored 'General case' 0 N--CA 1.479 0.979 0 C-N-CA 123.757 0.823 . . . . 71.44 111.681 -172.673 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 36.3 ttm180 55.83 77.03 0.25 Allowed 'General case' 0 N--CA 1.48 1.035 0 C-N-CA 124.852 1.261 . . . . 74.43 111.19 -178.877 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 12.2 t60 -79.16 -14.55 59.02 Favored 'General case' 0 CA--C 1.546 0.79 0 CA-C-N 115.261 -0.881 . . . . 71.23 110.806 -179.559 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 16.8 m120 -55.97 93.36 0.01 OUTLIER 'General case' 0 N--CA 1.485 1.279 0 C-N-CA 124.211 1.004 . . . . 74.44 110.723 178.18 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 70.18 11.25 67.05 Favored Glycine 0 C--N 1.351 1.4 0 CA-C-N 115.45 -0.795 . . . . 73.53 114.904 176.071 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 21.0 m -143.25 -83.62 0.16 Allowed 'General case' 0 CA--C 1.553 1.075 0 CA-C-N 117.663 0.731 . . . . 72.25 110.634 -178.578 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 64.4 59.22 8.6 Favored Glycine 0 C--N 1.357 1.731 0 O-C-N 123.301 0.376 . . . . 63.35 113.117 -177.008 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 134.6 49.07 0.08 OUTLIER Glycine 0 C--N 1.35 1.359 0 CA-C-N 117.05 0.425 . . . . 53.22 112.475 -176.135 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 14.0 ptmm? -65.59 159.91 23.66 Favored 'General case' 0 N--CA 1.484 1.243 0 C-N-CA 123.64 0.776 . . . . 75.24 111.454 -178.683 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 79.6 p -105.86 -175.65 2.85 Favored 'General case' 0 N--CA 1.481 1.095 0 N-CA-C 112.666 0.617 . . . . 65.44 112.666 -162.897 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 78' ' ' ILE . . . . . 0.462 ' HA ' ' CE2' ' A' ' 46' ' ' PHE . 44.3 pt -70.79 -21.08 22.38 Favored 'Isoleucine or valine' 0 C--N 1.358 0.971 0 CA-C-N 115.595 -0.73 . . . . 73.51 111.254 176.447 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 98.9 m-85 -88.66 33.83 0.77 Allowed 'General case' 0 N--CA 1.475 0.778 0 C-N-CA 123.83 0.852 . . . . 74.54 109.736 173.564 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 70.23 -99.16 0.69 Allowed Glycine 0 C--N 1.351 1.399 0 CA-C-N 115.403 -0.817 . . . . 74.03 111.604 -176.744 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 42.8 tt0 -73.03 -60.22 2.34 Favored 'General case' 0 CA--C 1.544 0.744 0 C-N-CA 123.956 0.902 . . . . 63.44 110.652 -176.498 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 82' ' ' LYS . . . . . 0.743 ' HD2' ' HA ' ' A' ' 107' ' ' THR . 18.8 pttp -169.2 177.37 4.83 Favored 'General case' 0 N--CA 1.482 1.148 0 C-N-CA 123.11 0.564 . . . . 71.44 111.162 -169.721 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 51.6 p90 -156.19 174.93 14.65 Favored 'General case' 0 N--CA 1.478 0.959 0 C-N-CA 124.204 1.002 . . . . 73.41 110.852 -177.574 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 13.5 pt-20 -102.76 162.96 12.5 Favored 'General case' 0 N--CA 1.481 1.117 0 C-N-CA 123.223 0.609 . . . . 74.04 110.872 177.233 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 85' ' ' ASP . . . . . 0.456 ' HB3' HG22 ' A' ' 127' ' ' VAL . 48.0 m-20 -64.71 130.63 44.29 Favored 'General case' 0 N--CA 1.478 0.926 0 CA-C-N 115.687 -0.688 . . . . 74.31 111.276 -179.993 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 9.3 tp10 -69.12 -61.36 1.82 Allowed 'General case' 0 N--CA 1.474 0.747 0 O-C-N 123.57 0.544 . . . . 72.13 111.102 -178.836 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 24.3 p-10 -161.2 127.89 3.98 Favored 'General case' 0 N--CA 1.477 0.887 0 C-N-CA 123.054 0.541 . . . . 75.12 110.325 -171.891 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 86.4 m-85 -88.58 74.11 8.52 Favored 'General case' 0 N--CA 1.476 0.85 0 CA-C-O 121.533 0.682 . . . . 74.15 110.18 -171.727 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 65.1 mt -88.87 -60.27 2.38 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.637 0 CA-C-N 115.221 -0.9 . . . . 70.12 108.998 173.453 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 67.4 mt -85.36 131.13 34.45 Favored 'General case' 0 C--O 1.241 0.626 0 CA-C-N 114.372 -1.286 . . . . 70.24 110.392 -173.05 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 32.2 mtmm -122.46 169.11 11.32 Favored 'General case' 0 N--CA 1.47 0.55 0 C-N-CA 124.933 1.293 . . . . 75.23 109.479 -174.485 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 92' ' ' HIS . . . . . . . . . . . . . 20.7 m-70 -91.95 36.83 0.97 Allowed 'General case' 0 N--CA 1.481 1.105 0 C-N-CA 123.992 0.917 . . . . 72.11 110.852 -170.79 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 80.7 p -67.92 -26.08 65.8 Favored 'General case' 0 N--CA 1.474 0.725 0 C-N-CA 124.387 1.075 . . . . 75.51 112.226 -170.935 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -124.88 175.6 17.17 Favored Glycine 0 C--N 1.344 1.007 0 O-C-N 123.232 0.332 . . . . 73.2 113.221 -177.067 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 93.0 Cg_endo -80.89 157.49 20.89 Favored 'Trans proline' 0 C--N 1.367 1.546 0 C-N-CA 123.046 2.498 . . . . 65.41 111.395 169.484 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 89.36 -0.71 81.34 Favored Glycine 0 N--CA 1.472 1.039 0 CA-C-N 116.27 -0.423 . . . . 52.54 112.971 -177.206 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 97' ' ' ILE . . . . . 0.442 ' HB ' ' HB2' ' A' ' 115' ' ' CYS . 13.9 mm -66.94 114.07 3.5 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.949 0 C-N-CA 124.041 0.936 . . . . 63.41 111.466 -176.591 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 98' ' ' LEU . . . . . 0.477 HD13 HG12 ' A' ' 114' ' ' ILE . 67.2 tp -102.28 113.11 26.13 Favored 'General case' 0 CA--C 1.551 0.999 0 C-N-CA 123.489 0.716 . . . . 74.51 109.761 177.827 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 42.6 t -131.44 168.77 17.04 Favored 'General case' 0 N--CA 1.479 0.978 0 C-N-CA 124.95 1.3 . . . . 71.41 108.296 176.533 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 100' ' ' MET . . . . . 0.507 ' HA ' ' HA ' ' A' ' 112' ' ' PHE . 44.4 mtp -101.62 146.59 27.49 Favored 'General case' 0 N--CA 1.491 1.604 0 CA-C-N 118.596 0.635 . . . . 65.11 110.482 -176.639 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 101' ' ' ALA . . . . . 0.519 ' HB2' ' HB2' ' A' ' 111' ' ' GLN . . . -85.49 167.58 15.32 Favored 'General case' 0 N--CA 1.482 1.151 0 C-N-CA 123.202 0.601 . . . . 65.44 111.174 -175.649 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 102' ' ' ASN . . . . . 0.583 ' HB3' ' HA ' ' A' ' 108' ' ' ASN . 29.4 p-10 -169.9 170.93 7.46 Favored 'General case' 0 N--CA 1.478 0.961 0 C-N-CA 122.829 0.451 . . . . 63.23 111.996 -177.111 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 103' ' ' ALA . . . . . 0.45 ' HB3' HG23 ' A' ' 107' ' ' THR . . . -99.59 -22.1 15.59 Favored 'General case' 0 CA--C 1.547 0.865 0 CA-C-N 115.377 -0.829 . . . . 74.3 111.142 171.55 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -178.15 -177.0 46.56 Favored Glycine 0 C--N 1.357 1.696 0 CA-C-O 119.467 -0.629 . . . . 65.23 113.053 -178.134 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 32.4 Cg_exo -58.62 136.52 74.55 Favored 'Trans proline' 0 C--N 1.375 1.948 0 C-N-CA 122.791 2.327 . . . . 75.42 112.908 175.002 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 66.6 t30 69.72 9.94 7.38 Favored 'General case' 0 N--CA 1.486 1.354 0 C-N-CA 124.805 1.242 . . . . 75.22 111.639 -176.459 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 107' ' ' THR . . . . . 0.743 ' HA ' ' HD2' ' A' ' 82' ' ' LYS . 3.9 m -109.96 5.16 22.11 Favored 'General case' 0 CA--C 1.553 1.087 0 C-N-CA 124.093 0.957 . . . . 73.01 110.305 178.301 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 108' ' ' ASN . . . . . 0.583 ' HA ' ' HB3' ' A' ' 102' ' ' ASN . 66.4 t30 -80.93 154.36 27.04 Favored 'General case' 0 N--CA 1.478 0.97 0 C-N-CA 123.467 0.707 . . . . 71.53 111.3 -173.772 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 106.36 -3.47 37.4 Favored Glycine 0 N--CA 1.467 0.725 0 CA-C-O 119.966 -0.352 . . . . 63.34 112.7 -178.394 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 41.1 p -91.29 119.23 31.16 Favored 'General case' 0 CA--C 1.54 0.563 0 N-CA-C 108.11 -1.07 . . . . 70.02 108.11 170.329 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 111' ' ' GLN . . . . . 0.565 HE22 ' HG2' ' B' ' 218' ' ' PRO . 35.7 mt-30 66.75 173.19 0.25 Allowed 'General case' 0 N--CA 1.496 1.857 0 C-N-CA 124.208 1.003 . . . . 74.32 112.093 -177.919 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 112' ' ' PHE . . . . . 0.507 ' HA ' ' HA ' ' A' ' 100' ' ' MET . 32.6 p90 -143.69 133.72 24.18 Favored 'General case' 0 N--CA 1.474 0.737 0 C-N-CA 123.879 0.871 . . . . 74.34 108.963 177.983 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 113' ' ' PHE . . . . . 0.554 ' HA ' ' HA ' ' A' ' 63' ' ' GLN . 52.2 p90 -116.52 142.06 47.37 Favored 'General case' 0 C--O 1.24 0.603 0 C-N-CA 123.342 0.657 . . . . 74.33 110.595 176.497 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 114' ' ' ILE . . . . . 0.477 HG12 HD13 ' A' ' 98' ' ' LEU . 15.3 mt -109.01 106.5 20.83 Favored 'Isoleucine or valine' 0 C--O 1.238 0.454 0 N-CA-C 108.066 -1.087 . . . . 74.34 108.066 175.39 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 115' ' ' CYS . . . . . 0.442 ' HB2' ' HB ' ' A' ' 97' ' ' ILE . 59.7 m -61.69 103.27 0.32 Allowed 'General case' 0 CA--C 1.546 0.823 0 C-N-CA 123.156 0.582 . . . . 64.44 109.607 173.554 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 116' ' ' THR . . . . . 0.542 HG22 HG12 ' A' ' 139' ' ' VAL . 35.2 p -74.56 -32.71 62.51 Favored 'General case' 0 N--CA 1.474 0.76 0 C-N-CA 124.29 1.036 . . . . 50.3 109.703 178.87 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -100.0 159.04 15.4 Favored 'General case' 0 C--O 1.243 0.761 0 C-N-CA 124.46 1.104 . . . . 31.34 108.561 171.051 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -71.88 111.98 7.59 Favored 'General case' 0 CA--C 1.543 0.693 0 N-CA-C 107.586 -1.264 . . . . 73.43 107.586 169.839 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 119' ' ' THR . . . . . . . . . . . . . 52.2 p -101.86 84.57 2.56 Favored 'General case' 0 CA--C 1.539 0.558 0 CA-C-O 122.319 1.057 . . . . 73.13 109.168 -175.974 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 11.1 pt-20 -77.0 -25.52 52.78 Favored 'General case' 0 N--CA 1.48 1.055 0 CA-C-N 114.543 -1.208 . . . . 73.01 110.903 -174.314 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 121' ' ' TRP . . . . . . . . . . . . . 43.8 p90 -70.19 -6.82 37.08 Favored 'General case' 0 CA--C 1.55 0.962 0 C-N-CA 123.914 0.886 . . . . 71.03 111.258 174.517 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 122' ' ' LEU . . . . . 0.431 HD22 ' HG2' ' A' ' 125' ' ' LYS . 42.7 mt -96.86 24.2 6.38 Favored 'General case' 0 CA--C 1.55 0.965 0 C-N-CA 123.32 0.648 . . . . 71.25 111.45 172.426 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 24.2 m-20 -71.79 133.9 45.83 Favored 'General case' 0 N--CA 1.484 1.247 0 N-CA-C 109.32 -0.622 . . . . 71.33 109.32 163.107 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 89.08 -13.84 62.22 Favored Glycine 0 C--N 1.345 1.056 0 CA-C-N 115.792 -0.64 . . . . 74.41 112.528 -173.26 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 125' ' ' LYS . . . . . 0.431 ' HG2' HD22 ' A' ' 122' ' ' LEU . 0.4 OUTLIER -81.63 -169.45 2.33 Favored 'General case' 0 N--CA 1.477 0.877 0 C-N-CA 123.657 0.783 . . . . 64.43 111.012 -179.02 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 126' ' ' HIS . . . . . 0.472 ' NE2' HD22 ' A' ' 102' ' ' ASN . 24.0 m80 -71.74 146.68 47.98 Favored 'General case' 0 N--CA 1.477 0.924 0 C-N-CA 124.481 1.112 . . . . 74.03 111.257 -163.059 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 127' ' ' VAL . . . . . 0.456 HG22 ' HB3' ' A' ' 85' ' ' ASP . 62.1 t -63.32 128.14 24.86 Favored 'Isoleucine or valine' 0 C--O 1.242 0.664 0 O-C-N 124.534 1.146 . . . . 75.21 112.108 -168.724 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 128' ' ' VAL . . . . . 0.402 HG11 HD12 ' A' ' 97' ' ' ILE . 47.6 t -75.5 140.39 17.46 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.356 0 CA-C-N 114.859 -1.064 . . . . 51.11 108.429 170.787 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 129' ' ' PHE . . . . . 0.493 ' HA ' HG21 ' A' ' 29' ' ' VAL . 41.1 p90 -128.13 -20.87 3.7 Favored 'General case' 0 N--CA 1.474 0.756 0 C-N-CA 122.623 0.369 . . . . 74.24 110.867 -177.475 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . -134.65 168.84 23.4 Favored Glycine 0 C--N 1.34 0.793 0 O-C-N 123.34 0.4 . . . . 62.12 112.188 -176.488 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 33.2 ttpt -152.26 137.11 17.12 Favored 'General case' 0 N--CA 1.47 0.569 0 C-N-CA 123.838 0.855 . . . . 74.34 109.091 176.568 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 17.1 t -70.95 111.71 5.03 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.528 0 N-CA-C 109.439 -0.578 . . . . 74.13 109.439 178.311 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 133' ' ' LYS . . . . . 0.536 ' HD2' ' HB2' ' A' ' 23' ' ' GLU . 20.2 ptmt -94.94 -37.63 11.07 Favored 'General case' 0 CA--C 1.541 0.605 0 C-N-CA 123.242 0.617 . . . . 75.32 110.19 178.193 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 134' ' ' GLU . . . . . 0.493 ' HB2' ' HB2' ' A' ' 21' ' ' SER . 17.9 mm-40 -124.4 136.4 54.03 Favored 'General case' 0 N--CA 1.474 0.757 0 C-N-CA 123.984 0.913 . . . . 73.11 109.274 -178.337 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 76.27 28.34 60.21 Favored Glycine 0 C--N 1.342 0.907 0 O-C-N 123.562 0.539 . . . . 63.55 113.913 175.245 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 136' ' ' MET . . . . . . . . . . . . . 15.3 tpt -63.91 -26.98 68.84 Favored 'General case' 0 N--CA 1.487 1.403 0 CA-C-N 117.418 0.609 . . . . 75.13 110.303 173.418 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 137' ' ' ASN . . . . . . . . . . . . . 1.7 m-20 -55.77 -46.69 77.84 Favored 'General case' 0 CA--C 1.549 0.927 0 C-N-CA 124.4 1.08 . . . . 74.14 110.291 171.502 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 138' ' ' ILE . . . . . 0.466 HG22 HD21 ' A' ' 17' ' ' LEU . 48.5 mm -68.17 -33.23 59.59 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.084 0 C-N-CA 123.876 0.871 . . . . 73.32 111.116 179.622 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 139' ' ' VAL . . . . . 0.542 HG12 HG22 ' A' ' 116' ' ' THR . 78.9 t -65.85 -44.5 92.78 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.072 0 C-N-CA 123.595 0.758 . . . . 74.35 111.12 178.839 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 45.1 mt-10 -74.34 -20.2 60.18 Favored 'General case' 0 N--CA 1.48 1.041 0 CA-C-N 115.747 -0.661 . . . . 74.01 110.99 176.919 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -72.16 -40.18 68.18 Favored 'General case' 0 CA--C 1.542 0.654 0 C-N-CA 122.895 0.478 . . . . 64.34 109.732 170.713 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 142' ' ' MET . . . . . 0.51 ' HE2' ' HA ' ' A' ' 139' ' ' VAL . 72.6 mtm -61.18 -38.81 87.82 Favored 'General case' 0 N--CA 1.484 1.26 0 C-N-CA 123.303 0.641 . . . . 72.14 110.289 176.744 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 42.7 tt0 -51.38 -40.31 58.95 Favored 'General case' 0 CA--C 1.552 1.041 0 O-C-N 124.402 1.064 . . . . 73.45 111.869 176.607 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 144' ' ' ARG . . . . . . . . . . . . . 53.6 mtp180 -71.81 -25.72 62.11 Favored 'General case' 0 CA--C 1.545 0.762 0 C-N-CA 123.47 0.708 . . . . 74.34 112.034 -178.279 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 145' ' ' PHE . . . . . . . . . . . . . 93.5 m-85 -82.77 2.4 34.09 Favored 'General case' 0 N--CA 1.481 1.118 0 C-N-CA 122.725 0.41 . . . . 74.12 111.223 175.749 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . -93.43 173.71 34.35 Favored Glycine 0 C--N 1.349 1.301 0 CA-C-N 117.741 0.246 . . . . 71.51 112.888 176.075 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 35.2 t -135.23 167.39 21.09 Favored 'General case' 0 N--CA 1.477 0.923 0 C-N-CA 123.911 0.884 . . . . 70.24 110.084 178.797 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 148' ' ' ARG . . . . . . . . . . . . . 23.2 mmt180 -73.6 -26.34 60.75 Favored 'General case' 0 N--CA 1.479 0.988 0 C-N-CA 123.725 0.81 . . . . 74.54 112.176 -173.352 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 149' ' ' ASN . . . . . . . . . . . . . 29.3 p-10 -77.06 -5.03 47.25 Favored 'General case' 0 N--CA 1.481 1.089 0 C-N-CA 123.17 0.588 . . . . 70.34 111.001 174.745 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . 101.54 -20.01 48.26 Favored Glycine 0 C--N 1.348 1.226 0 CA-C-O 119.959 -0.356 . . . . 63.41 112.474 177.936 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 34.9 ttpt -71.36 153.39 42.36 Favored 'General case' 0 N--CA 1.48 1.034 0 C-N-CA 122.802 0.441 . . . . 71.44 110.584 -176.894 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 152' ' ' THR . . . . . . . . . . . . . 72.2 p -94.82 134.05 37.86 Favored 'General case' 0 CA--C 1.543 0.696 0 C-N-CA 123.202 0.601 . . . . 71.15 109.452 172.484 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 153' ' ' SER . . . . . . . . . . . . . 36.5 m -65.84 -36.07 82.42 Favored 'General case' 0 CA--C 1.544 0.734 0 C-N-CA 123.641 0.776 . . . . 44.5 110.542 171.729 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 26.3 mmtp -122.87 139.47 54.0 Favored 'General case' 0 N--CA 1.479 0.985 0 C-N-CA 123.899 0.879 . . . . 72.11 109.505 175.222 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 11.7 tppt? -78.79 99.46 6.71 Favored 'General case' 0 CA--C 1.538 0.5 0 C-N-CA 123.101 0.56 . . . . 74.33 109.774 -178.127 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 156' ' ' ILE . . . . . 0.451 ' HB ' ' HB2' ' A' ' 53' ' ' PHE . 55.7 mt -89.24 126.08 42.24 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.482 0 CA-C-N 115.444 -0.798 . . . . 75.34 108.863 179.581 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 157' ' ' THR . . . . . 0.538 ' HA ' ' HA ' ' A' ' 52' ' ' CYS . 69.0 p -122.81 170.78 9.73 Favored 'General case' 0 CA--C 1.541 0.614 0 C-N-CA 125.276 1.43 . . . . 72.11 109.725 179.958 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 158' ' ' ILE . . . . . 0.422 ' O ' ' HA2' ' A' ' 50' ' ' GLY . 75.4 mt -90.83 113.51 26.74 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.685 0 N-CA-C 108.086 -1.079 . . . . 74.41 108.086 166.274 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 159' ' ' ALA . . . . . 0.639 ' HB1' ' HB3' ' A' ' 11' ' ' ALA . . . -63.84 -52.08 61.75 Favored 'General case' 0 N--CA 1.476 0.871 0 C-N-CA 123.9 0.88 . . . . 34.43 111.662 177.959 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 160' ' ' ASP . . . . . . . . . . . . . 14.7 t70 -157.36 173.27 17.17 Favored 'General case' 0 N--CA 1.48 1.043 0 C-N-CA 122.881 0.472 . . . . 73.51 109.823 -174.025 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 161' ' ' CYS . . . . . . . . . . . . . 19.4 p -134.55 -166.99 1.9 Allowed 'General case' 0 N--CA 1.475 0.817 0 C-N-CA 125.309 1.444 . . . . 52.23 109.101 -173.542 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 162' ' ' GLY . . . . . . . . . . . . . . . 134.92 53.17 0.07 OUTLIER Glycine 0 C--N 1.344 1.005 0 O-C-N 122.173 -0.33 . . . . 74.24 112.358 -173.163 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 163' ' ' GLN . . . . . 0.555 ' HA ' ' H ' ' A' ' 7' ' ' PHE . 6.6 tt0 -47.33 103.6 0.04 OUTLIER 'General case' 0 N--CA 1.48 1.035 0 C-N-CA 125.101 1.36 . . . . 74.35 111.614 -179.878 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 164' ' ' LEU . . . . . . . . . . . . . 85.2 mt . . . . . 0 CA--C 1.538 0.483 0 CA-C-N 114.765 -1.107 . . . . 65.14 110.882 -174.054 . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' B' B ' 218' ' ' PRO . . . . . 0.565 ' HG2' HE22 ' A' ' 111' ' ' GLN . 23.8 Cg_endo . . . . . 0 CA--C 1.554 1.503 0 CA-C-O 121.096 0.373 . . . . 65.3 111.216 . . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 219' ' ' GLY . . . . . . . . . . . . . . . 162.61 160.47 11.18 Favored Glycine 0 CA--C 1.533 1.162 0 CA-C-N 115.032 -0.985 . . . . 74.11 111.51 -178.197 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 220' ' ' PRO . . . . . 0.517 ' HD2' ' HE1' ' A' ' 61' ' ' MET . 27.5 Cg_exo -64.63 169.96 10.58 Favored 'Trans proline' 0 C--N 1.375 1.955 0 C-N-CA 123.492 2.794 . . . . 73.11 114.308 179.995 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' B' B ' 221' ' ' TYR . . . . . . . . . . . . . 73.1 m-85 . . . . . 0 N--CA 1.484 1.273 0 C-N-CA 123.949 0.9 . . . . 71.24 110.987 -174.938 . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 3' ' ' ASN . . . . . 0.484 HD21 ' HA ' ' A' ' 25' ' ' PHE . 16.3 m120 . . . . . 0 CA--C 1.549 0.935 0 CA-C-O 118.971 -0.538 . . . . 71.03 110.622 . . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 4' ' ' PRO . . . . . 0.618 ' HG2' ' HB2' ' A' ' 24' ' ' LEU . 32.7 Cg_endo -65.2 129.17 22.17 Favored 'Trans proline' 0 C--N 1.38 2.236 0 C-N-CA 122.696 2.264 . . . . 74.24 111.379 175.102 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 5' ' ' THR . . . . . 0.427 HG21 ' HD3' ' A' ' 133' ' ' LYS . 65.9 m -95.93 122.74 39.07 Favored 'General case' 0 N--CA 1.464 0.257 0 N-CA-C 108.112 -1.07 . . . . 72.4 108.112 177.44 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 34.7 m -107.15 128.6 61.95 Favored 'Isoleucine or valine' 0 C--O 1.22 -0.478 0 CA-C-O 121.432 0.634 . . . . 75.42 110.557 -179.018 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 7' ' ' PHE . . . . . 0.631 ' H ' ' HA ' ' A' ' 163' ' ' GLN . 74.6 t80 -116.03 138.79 50.9 Favored 'General case' 0 C--O 1.239 0.532 0 C-N-CA 124.792 1.237 . . . . 62.25 109.292 -171.579 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 8' ' ' PHE . . . . . 0.493 ' HB3' HG21 ' A' ' 158' ' ' ILE . 63.2 m-85 -141.02 162.68 34.92 Favored 'General case' 0 N--CA 1.47 0.568 0 O-C-N 124.375 1.047 . . . . 74.43 110.11 172.17 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 11.9 m-20 -108.67 106.8 17.01 Favored 'General case' 0 C--N 1.328 -0.341 0 C-N-CA 125.124 1.369 . . . . 64.23 107.359 171.523 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 49.5 mm -81.2 130.88 35.11 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.65 0 N-CA-C 108.664 -0.865 . . . . 74.44 108.664 177.863 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 11' ' ' ALA . . . . . 0.47 ' HB1' ' HB2' ' A' ' 159' ' ' ALA . . . -132.97 139.68 47.41 Favored 'General case' 0 N--CA 1.473 0.696 0 C-N-CA 123.754 0.822 . . . . 74.1 110.69 -174.256 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 12' ' ' VAL . . . . . 0.502 HG22 ' HB2' ' A' ' 17' ' ' LEU . 72.0 t -94.67 98.31 7.91 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.596 0 C-N-CA 124.899 1.28 . . . . 71.33 108.388 175.697 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 22.6 m-20 61.23 31.18 19.51 Favored 'General case' 0 N--CA 1.483 1.182 0 C-N-CA 124.702 1.201 . . . . 73.13 111.968 -177.993 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 96.14 -8.85 67.57 Favored Glycine 0 C--N 1.348 1.224 0 CA-C-O 119.749 -0.473 . . . . 63.31 113.302 179.215 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 39.1 mm-40 -85.56 113.38 50.65 Favored Pre-proline 0 N--CA 1.473 0.721 0 CA-C-O 118.418 -0.801 . . . . 75.44 109.223 173.321 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 19.2 Cg_endo -55.47 106.06 0.18 Allowed 'Trans proline' 0 C--N 1.385 2.491 0 C-N-CA 123.042 2.495 . . . . 74.44 112.249 -176.381 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 17' ' ' LEU . . . . . 0.502 ' HB2' HG22 ' A' ' 12' ' ' VAL . 68.9 tp -76.31 -41.37 48.81 Favored 'General case' 0 N--CA 1.476 0.858 0 C-N-CA 123.793 0.837 . . . . 72.11 109.115 -179.313 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 169.97 -172.98 44.03 Favored Glycine 0 C--N 1.341 0.836 0 CA-C-N 115.376 -0.829 . . . . 74.22 112.428 176.513 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 56.0 mtm180 -111.84 136.47 51.09 Favored 'General case' 0 C--O 1.239 0.529 0 C-N-CA 124.111 0.965 . . . . 72.01 109.766 -175.8 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 61.1 t -129.57 131.98 66.6 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.998 0 C-N-CA 123.644 0.778 . . . . 73.41 109.522 177.494 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 45.7 m -119.62 123.8 44.75 Favored 'General case' 0 CA--C 1.543 0.673 0 C-N-CA 124.139 0.975 . . . . 74.32 108.831 174.365 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 14.7 m-85 -99.85 169.09 9.47 Favored 'General case' 0 CA--C 1.541 0.618 0 C-N-CA 123.999 0.92 . . . . 75.43 109.007 174.886 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 23' ' ' GLU . . . . . 0.527 ' HB2' ' HD2' ' A' ' 133' ' ' LYS . 34.2 tt0 -125.86 108.58 11.59 Favored 'General case' 0 C--O 1.239 0.532 0 N-CA-C 107.697 -1.223 . . . . 73.24 107.697 179.404 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . 0.618 ' HB2' ' HG2' ' A' ' 4' ' ' PRO . 15.8 mt -84.89 124.5 31.7 Favored 'General case' 0 C--O 1.238 0.499 0 CA-C-O 120.935 0.398 . . . . 74.11 110.028 -179.884 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 25' ' ' PHE . . . . . 0.618 ' HB2' HD13 ' A' ' 90' ' ' LEU . 86.1 m-85 -86.04 64.86 8.82 Favored 'General case' 0 CA--C 1.535 0.375 0 CA-C-N 115.66 -0.7 . . . . 73.44 109.586 174.899 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -72.42 -16.06 61.83 Favored 'General case' 0 N--CA 1.479 0.989 0 CA-C-N 115.383 -0.826 . . . . 72.1 111.445 -179.11 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 9.8 p-10 -74.15 -23.0 59.21 Favored 'General case' 0 CA--C 1.553 1.068 0 C-N-CA 123.96 0.904 . . . . 64.21 110.782 173.851 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 28' ' ' LYS . . . . . 0.566 ' HZ1' ' HD2' ' A' ' 25' ' ' PHE . 58.2 mttp -101.52 -52.33 3.25 Favored 'General case' 0 N--CA 1.478 0.973 0 C-N-CA 123.874 0.87 . . . . 72.12 110.771 -177.618 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 30.0 m -122.85 74.37 46.57 Favored Pre-proline 0 CA--C 1.559 1.296 0 C-N-CA 124.308 1.043 . . . . 74.41 109.761 -173.884 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 24.8 Cg_exo -62.29 -43.36 23.62 Favored 'Trans proline' 0 C--N 1.38 2.206 0 C-N-CA 122.726 2.284 . . . . 74.05 113.136 -169.717 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 31' ' ' LYS . . . . . 0.414 ' HD2' ' HB2' ' A' ' 86' ' ' GLU . 1.5 ttmp? -57.05 -54.73 43.42 Favored 'General case' 0 N--CA 1.484 1.232 0 C-N-CA 123.472 0.709 . . . . 75.52 111.495 177.476 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 6.4 m -71.21 -36.3 71.84 Favored 'General case' 0 CA--C 1.551 0.993 0 C-N-CA 123.773 0.829 . . . . 71.52 111.776 -168.932 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 33' ' ' ALA . . . . . 0.43 ' HB2' ' HB3' ' A' ' 24' ' ' LEU . . . -79.85 -48.54 13.35 Favored 'General case' 0 N--CA 1.474 0.77 0 C-N-CA 123.447 0.699 . . . . 75.0 111.103 -177.792 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 12.6 tp10 -63.47 -28.48 69.99 Favored 'General case' 0 N--CA 1.482 1.141 0 C-N-CA 123.59 0.756 . . . . 72.44 111.099 -179.491 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 35' ' ' ASN . . . . . 0.543 ' ND2' ' SD ' ' A' ' 100' ' ' MET . 32.6 t30 -52.79 -69.37 0.12 Allowed 'General case' 0 C--N 1.353 0.721 0 O-C-N 123.948 0.78 . . . . 75.24 110.316 174.239 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 85.5 t80 -66.69 -32.41 73.71 Favored 'General case' 0 N--CA 1.476 0.875 0 C-N-CA 123.501 0.721 . . . . 71.15 111.296 -173.869 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 56.2 ttt-85 -55.4 -54.33 45.08 Favored 'General case' 0 N--CA 1.474 0.767 0 C-N-CA 124.192 0.997 . . . . 70.41 110.268 175.803 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -76.2 -24.15 54.67 Favored 'General case' 0 CA--C 1.541 0.623 0 CA-C-N 115.147 -0.933 . . . . 50.01 112.218 -174.941 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 39' ' ' LEU . . . . . 0.506 HD23 ' HE2' ' A' ' 48' ' ' TYR . 81.7 mt -66.03 -43.16 88.41 Favored 'General case' 0 N--CA 1.482 1.145 0 C-N-CA 123.329 0.651 . . . . 64.55 110.144 173.794 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 47.4 m -82.55 -37.37 25.25 Favored 'General case' 0 CA--C 1.547 0.838 0 CA-C-N 115.143 -0.935 . . . . 74.14 112.317 -172.718 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 41' ' ' THR . . . . . 0.411 ' OG1' ' HG2' ' A' ' 43' ' ' GLU . 3.7 p -72.79 -32.06 65.31 Favored 'General case' 0 N--CA 1.485 1.323 0 C-N-CA 122.519 0.328 . . . . 74.22 110.309 172.664 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 84.85 29.5 28.8 Favored Glycine 0 C--N 1.345 1.059 0 CA-C-N 116.025 -0.534 . . . . 72.15 112.558 -178.789 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 43' ' ' GLU . . . . . 0.411 ' HG2' ' OG1' ' A' ' 41' ' ' THR . 17.6 mm-40 -63.85 -31.41 72.59 Favored 'General case' 0 N--CA 1.48 1.058 0 C-N-CA 123.266 0.626 . . . . 64.21 110.793 176.606 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 71.6 mmtt -95.42 19.25 11.15 Favored 'General case' 0 N--CA 1.48 1.028 0 C-N-CA 123.719 0.807 . . . . 72.34 110.533 179.012 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 83.72 -15.97 33.77 Favored Glycine 0 C--N 1.353 1.482 0 CA-C-O 119.472 -0.627 . . . . 62.1 114.486 175.814 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 46' ' ' PHE . . . . . 0.418 ' HE2' ' HA ' ' A' ' 78' ' ' ILE . 23.6 m-85 -76.77 -51.24 11.75 Favored 'General case' 0 N--CA 1.476 0.853 0 CA-C-N 117.508 0.654 . . . . 65.11 112.686 -166.77 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 48.82 63.3 3.95 Favored Glycine 0 C--N 1.355 1.628 0 O-C-N 123.978 0.799 . . . . 54.33 114.653 176.302 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 48' ' ' TYR . . . . . 0.506 ' HE2' HD23 ' A' ' 39' ' ' LEU . 30.2 m-85 -70.04 100.2 1.58 Allowed 'General case' 0 N--CA 1.484 1.25 0 CA-C-N 117.763 0.782 . . . . 74.1 111.332 -175.511 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 49' ' ' LYS . . . . . 0.554 ' HE3' ' HA ' ' A' ' 160' ' ' ASP . 23.5 tptm -107.47 132.32 53.35 Favored 'General case' 0 CA--C 1.534 0.332 0 C-N-CA 124.951 1.301 . . . . 74.24 109.063 -176.004 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 83.2 21.38 58.93 Favored Glycine 0 C--N 1.348 1.196 0 CA-C-O 119.722 -0.488 . . . . 72.1 112.958 179.408 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 51' ' ' SER . . . . . 0.721 ' HA ' ' HB2' ' A' ' 67' ' ' PHE . 22.4 t -61.91 114.26 3.26 Favored 'General case' 0 C--N 1.358 0.959 0 C-N-CA 122.937 0.495 . . . . 74.52 110.601 -179.761 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 52' ' ' CYS . . . . . 0.592 ' HB3' ' HB3' ' A' ' 66' ' ' ASP . 53.5 t -89.89 157.95 17.65 Favored 'General case' 0 C--O 1.24 0.58 0 C-N-CA 123.352 0.661 . . . . 71.24 111.412 -173.349 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 53' ' ' PHE . . . . . 0.676 ' HA ' ' HA2' ' A' ' 64' ' ' GLY . 14.5 m-85 -105.85 98.0 7.75 Favored 'General case' 0 CA--C 1.535 0.402 0 C-N-CA 124.973 1.309 . . . . 73.53 107.64 176.263 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 54' ' ' HIS . . . . . 0.546 ' HD1' ' HB2' ' A' ' 66' ' ' ASP . 40.8 p-80 -88.22 -27.26 21.91 Favored 'General case' 0 N--CA 1.483 1.206 0 C-N-CA 122.464 0.306 . . . . 74.45 111.519 -178.068 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 55' ' ' ARG . . . . . 0.5 ' HA ' ' O ' ' A' ' 150' ' ' GLY . 42.4 ttt180 -116.1 104.86 11.97 Favored 'General case' 0 C--O 1.212 -0.917 0 N-CA-C 109.762 -0.458 . . . . 73.0 109.762 -175.583 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 63.5 mt -132.46 133.39 59.89 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.044 0 N-CA-C 108.963 -0.754 . . . . 74.55 108.963 174.066 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 57' ' ' ILE . . . . . 0.406 ' HB ' ' HD2' ' A' ' 60' ' ' PHE . 62.0 mt -123.15 123.18 26.73 Favored Pre-proline 0 CA--C 1.558 1.265 0 C-N-CA 124.41 1.084 . . . . 72.44 109.044 176.475 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 55.9 Cg_endo -67.31 144.7 69.22 Favored 'Trans proline' 0 C--N 1.383 2.392 0 C-N-CA 122.983 2.455 . . . . 75.54 111.798 178.706 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 73.56 13.48 80.15 Favored Glycine 0 CA--C 1.527 0.838 0 CA-C-N 115.46 -0.791 . . . . 73.11 114.027 -176.409 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 60' ' ' PHE . . . . . 0.427 ' CE2' ' HE2' ' A' ' 61' ' ' MET . 17.6 t80 -139.73 -75.06 0.35 Allowed 'General case' 0 C--O 1.245 0.859 0 C-N-CA 123.091 0.556 . . . . 71.01 110.495 -173.964 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 61' ' ' MET . . . . . 0.676 ' SD ' ' HB2' ' A' ' 113' ' ' PHE . 13.9 tmm? -174.62 147.26 1.06 Allowed 'General case' 0 CA--C 1.55 0.957 0 N-CA-C 112.064 0.394 . . . . 71.43 112.064 -164.827 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 62' ' ' CYS . . . . . 0.52 ' SG ' ' HB ' ' A' ' 114' ' ' ILE . 21.8 p -108.11 112.48 25.04 Favored 'General case' 0 CA--C 1.552 1.053 0 C-N-CA 124.182 0.993 . . . . 62.54 109.873 172.984 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 63' ' ' GLN . . . . . 0.601 ' HB2' ' SD ' ' A' ' 61' ' ' MET . 49.2 tt0 -104.87 111.33 24.05 Favored 'General case' 0 N--CA 1.487 1.404 0 C-N-CA 124.064 0.946 . . . . 71.15 111.465 -173.637 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 64' ' ' GLY . . . . . 0.676 ' HA2' ' HA ' ' A' ' 53' ' ' PHE . . . -89.51 -179.6 45.01 Favored Glycine 0 C--N 1.342 0.865 0 CA-C-N 114.952 -1.022 . . . . 55.2 112.583 173.483 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 99.42 72.22 1.02 Allowed Glycine 0 N--CA 1.444 -0.809 0 N-CA-C 110.491 -1.044 . . . . 64.34 110.491 -174.334 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 66' ' ' ASP . . . . . 0.592 ' HB3' ' HB3' ' A' ' 52' ' ' CYS . 38.2 t70 -123.88 -4.64 8.06 Favored 'General case' 0 N--CA 1.484 1.256 0 C-N-CA 123.735 0.814 . . . . 73.41 110.756 175.915 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 67' ' ' PHE . . . . . 0.721 ' HB2' ' HA ' ' A' ' 51' ' ' SER . 56.0 t80 -79.25 -70.58 0.5 Allowed 'General case' 0 CA--C 1.544 0.718 0 CA-C-N 116.082 -0.508 . . . . 74.1 111.315 -171.402 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 30.9 m -86.28 102.17 13.73 Favored 'General case' 0 N--CA 1.471 0.602 0 C-N-CA 122.484 0.313 . . . . 72.54 110.954 -171.136 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 81.5 mtp180 52.69 81.94 0.08 Allowed 'General case' 0 N--CA 1.476 0.844 0 C-N-CA 124.518 1.127 . . . . 75.31 111.335 -178.266 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 27.5 p80 -74.68 26.11 0.09 Allowed 'General case' 0 N--CA 1.495 1.78 0 N-CA-C 113.74 1.015 . . . . 74.4 113.74 -170.843 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 1.9 m-20 -86.65 45.06 1.21 Allowed 'General case' 0 CA--C 1.555 1.155 0 C-N-CA 124.344 1.058 . . . . 73.22 109.62 175.436 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 86.79 -7.9 77.99 Favored Glycine 0 C--N 1.353 1.515 0 CA-C-N 116.081 -0.509 . . . . 75.01 113.459 -176.811 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 73' ' ' THR . . . . . 0.491 ' HA ' ' HB2' ' A' ' 110' ' ' SER . 3.7 m -90.45 -61.57 1.65 Allowed 'General case' 0 N--CA 1.475 0.786 0 CA-C-N 117.499 0.65 . . . . 74.11 109.35 179.62 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 62.76 10.12 29.91 Favored Glycine 0 CA--C 1.538 1.525 0 N-CA-C 116.585 1.394 . . . . 72.02 116.585 164.772 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 145.44 55.4 0.02 OUTLIER Glycine 0 N--CA 1.471 1.012 0 CA-C-N 118.179 0.99 . . . . 72.23 111.451 -164.512 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 23.3 pttm -51.13 165.54 0.12 Allowed 'General case' 0 N--CA 1.488 1.428 0 C-N-CA 124.881 1.272 . . . . 75.24 112.658 179.8 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 77.0 p -90.65 178.59 6.03 Favored 'General case' 0 CA--C 1.545 0.767 0 C-N-CA 123.386 0.674 . . . . 71.1 112.446 -169.697 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 78' ' ' ILE . . . . . 0.418 ' HA ' ' HE2' ' A' ' 46' ' ' PHE . 34.7 pt -72.14 -14.57 17.43 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.074 0 C-N-CA 123.935 0.894 . . . . 73.43 110.663 175.207 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 89.6 m-85 -94.54 16.06 16.37 Favored 'General case' 0 CA--C 1.548 0.872 0 C-N-CA 124.458 1.103 . . . . 73.24 110.541 175.674 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 89.79 -121.76 6.26 Favored Glycine 0 C--N 1.355 1.587 0 N-CA-C 111.005 -0.838 . . . . 74.13 111.005 -179.35 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 42.3 tt0 -55.56 -56.4 20.74 Favored 'General case' 0 N--CA 1.48 1.059 0 C-N-CA 125.02 1.328 . . . . 73.3 111.321 -177.384 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 82' ' ' LYS . . . . . 0.826 ' HD2' ' HA ' ' A' ' 107' ' ' THR . 21.0 pttp -169.79 179.2 3.76 Favored 'General case' 0 N--CA 1.48 1.04 0 C-N-CA 124.322 1.049 . . . . 75.41 109.895 -174.999 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 53.5 p90 -148.79 173.66 13.03 Favored 'General case' 0 N--CA 1.475 0.817 0 C-N-CA 123.908 0.883 . . . . 75.25 111.269 -177.422 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 84' ' ' GLU . . . . . 0.417 ' HA ' ' HA ' ' A' ' 106' ' ' ASN . 13.9 pt-20 -94.8 151.43 19.25 Favored 'General case' 0 CA--C 1.541 0.603 0 CA-C-N 115.009 -0.996 . . . . 74.3 110.908 178.532 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 85' ' ' ASP . . . . . 0.433 ' HB3' HG22 ' A' ' 127' ' ' VAL . 44.7 m-20 -65.91 136.69 56.46 Favored 'General case' 0 N--CA 1.475 0.813 0 C-N-CA 124.375 1.07 . . . . 75.41 111.811 -176.93 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 86' ' ' GLU . . . . . 0.414 ' HB2' ' HD2' ' A' ' 31' ' ' LYS . 11.8 tp10 -86.06 -63.54 1.3 Allowed 'General case' 0 CA--C 1.548 0.895 0 CA-C-N 116.106 -0.497 . . . . 71.55 111.399 -173.144 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 26.0 p-10 -166.71 135.59 2.87 Favored 'General case' 0 N--CA 1.482 1.164 0 C-N-CA 122.936 0.494 . . . . 74.55 110.194 -173.944 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 25.9 m-85 -95.34 59.83 2.22 Favored 'General case' 0 N--CA 1.478 0.928 0 C-N-CA 123.841 0.856 . . . . 74.1 110.71 -170.797 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 34.0 mt -75.22 -35.32 33.61 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.17 0 CA-C-N 115.795 -0.639 . . . . 73.05 110.169 176.004 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 90' ' ' LEU . . . . . 0.618 HD13 ' HB2' ' A' ' 25' ' ' PHE . 78.8 mt -100.1 161.53 13.55 Favored 'General case' 0 N--CA 1.471 0.623 0 C-N-CA 123.798 0.839 . . . . 73.32 110.61 -179.125 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 91' ' ' LYS . . . . . 0.627 ' HG3' HG22 ' A' ' 93' ' ' THR . 49.3 pttt -159.17 160.37 35.42 Favored 'General case' 0 CA--C 1.547 0.864 0 CA-C-O 121.646 0.736 . . . . 70.2 111.931 -174.293 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 92' ' ' HIS . . . . . 0.4 ' HA ' HG23 ' A' ' 97' ' ' ILE . 22.9 m-70 -88.93 32.88 0.79 Allowed 'General case' 0 N--CA 1.483 1.195 0 C-N-CA 124.401 1.08 . . . . 73.13 112.434 -167.877 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 93' ' ' THR . . . . . 0.627 HG22 ' HG3' ' A' ' 91' ' ' LYS . 6.1 t -89.44 68.72 7.92 Favored 'General case' 0 N--CA 1.479 1.003 0 CA-C-O 122.52 1.152 . . . . 74.13 110.007 -179.217 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 153.12 164.51 12.59 Favored Glycine 0 C--N 1.338 0.64 0 CA-C-N 114.572 -1.195 . . . . 64.15 111.745 179.245 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 95' ' ' PRO . . . . . 0.498 ' HB2' ' HE3' ' A' ' 136' ' ' MET . 63.6 Cg_endo -76.82 157.37 35.16 Favored 'Trans proline' 0 CA--C 1.554 1.485 0 C-N-CA 122.308 2.006 . . . . 73.4 112.167 172.965 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 84.16 18.61 62.45 Favored Glycine 0 CA--C 1.532 1.145 0 N-CA-C 114.543 0.577 . . . . 74.32 114.543 177.506 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 97' ' ' ILE . . . . . 0.4 HG23 ' HA ' ' A' ' 92' ' ' HIS . 37.6 mm -86.48 106.93 16.19 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.311 0 CA-C-N 117.765 0.783 . . . . 74.24 111.689 -175.07 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 98' ' ' LEU . . . . . 0.43 HD13 HG12 ' A' ' 114' ' ' ILE . 67.2 tp -92.89 119.25 32.0 Favored 'General case' 0 CA--C 1.552 1.055 0 C-N-CA 123.582 0.753 . . . . 75.43 110.746 -178.614 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 13.5 m -138.0 143.28 40.56 Favored 'General case' 0 N--CA 1.482 1.134 0 C-N-CA 124.744 1.218 . . . . 73.41 108.774 177.492 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 100' ' ' MET . . . . . 0.64 ' HA ' ' HA ' ' A' ' 112' ' ' PHE . 73.3 mtp -77.95 138.95 39.13 Favored 'General case' 0 N--CA 1.488 1.433 0 CA-C-N 118.616 0.644 . . . . 73.44 109.335 176.144 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 101' ' ' ALA . . . . . 0.48 ' HB1' ' HB2' ' A' ' 111' ' ' GLN . . . -74.68 160.82 30.3 Favored 'General case' 0 N--CA 1.483 1.178 0 C-N-CA 123.106 0.562 . . . . 74.34 112.21 -168.281 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 102' ' ' ASN . . . . . 0.433 ' HB3' ' HA ' ' A' ' 108' ' ' ASN . 27.5 p-10 -165.28 164.3 19.94 Favored 'General case' 0 N--CA 1.476 0.839 0 CA-C-N 115.515 -0.766 . . . . 75.13 110.974 -176.383 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -107.85 10.34 28.63 Favored 'General case' 0 CA--C 1.549 0.91 0 C-N-CA 123.903 0.881 . . . . 75.03 110.615 171.676 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 148.65 -175.57 27.86 Favored Glycine 0 C--N 1.356 1.669 0 CA-C-O 119.543 -0.587 . . . . 62.02 112.373 179.666 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 40.4 Cg_exo -59.0 143.94 99.58 Favored 'Trans proline' 0 C--N 1.375 1.955 0 C-N-CA 123.358 2.705 . . . . 75.15 112.326 174.311 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 106' ' ' ASN . . . . . 0.417 ' HA ' ' HA ' ' A' ' 84' ' ' GLU . 65.1 t30 70.56 9.57 6.94 Favored 'General case' 0 N--CA 1.49 1.573 0 C-N-CA 125.27 1.428 . . . . 73.41 111.245 -177.914 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 107' ' ' THR . . . . . 0.826 ' HA ' ' HD2' ' A' ' 82' ' ' LYS . 4.0 m -121.88 4.65 9.95 Favored 'General case' 0 CA--C 1.556 1.18 0 C-N-CA 123.476 0.711 . . . . 73.43 110.945 -175.895 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 108' ' ' ASN . . . . . 0.433 ' HA ' ' HB3' ' A' ' 102' ' ' ASN . 48.5 t30 -84.7 140.74 31.08 Favored 'General case' 0 N--CA 1.485 1.324 0 C-N-CA 123.71 0.804 . . . . 73.04 110.68 -176.682 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 111.98 23.34 5.6 Favored Glycine 0 N--CA 1.474 1.206 0 C-N-CA 122.556 0.122 . . . . 61.22 113.354 -177.946 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 110' ' ' SER . . . . . 0.491 ' HB2' ' HA ' ' A' ' 73' ' ' THR . 12.2 p -127.77 120.33 27.66 Favored 'General case' 0 CA--C 1.536 0.433 0 N-CA-C 107.334 -1.358 . . . . 72.33 107.334 171.866 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 111' ' ' GLN . . . . . 0.48 ' HB2' ' HB1' ' A' ' 101' ' ' ALA . 49.4 mt-30 67.65 175.22 0.26 Allowed 'General case' 0 N--CA 1.488 1.436 0 C-N-CA 124.942 1.297 . . . . 74.33 111.051 -172.82 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 112' ' ' PHE . . . . . 0.64 ' HA ' ' HA ' ' A' ' 100' ' ' MET . 23.7 p90 -149.86 142.18 24.22 Favored 'General case' 0 N--CA 1.477 0.885 0 N-CA-C 108.12 -1.067 . . . . 74.34 108.12 176.209 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 113' ' ' PHE . . . . . 0.676 ' HB2' ' SD ' ' A' ' 61' ' ' MET . 54.3 p90 -135.27 139.02 44.07 Favored 'General case' 0 C--O 1.239 0.509 0 CA-C-O 121.198 0.523 . . . . 72.53 111.227 -177.649 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 114' ' ' ILE . . . . . 0.52 ' HB ' ' SG ' ' A' ' 62' ' ' CYS . 11.8 mt -103.17 108.36 24.19 Favored 'Isoleucine or valine' 0 C--O 1.241 0.629 0 N-CA-C 107.475 -1.306 . . . . 73.42 107.475 176.805 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 115' ' ' CYS . . . . . . . . . . . . . 58.6 m -67.87 103.72 1.52 Allowed 'General case' 0 N--CA 1.467 0.395 0 N-CA-C 109.059 -0.719 . . . . 71.42 109.059 177.01 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 116' ' ' THR . . . . . 0.575 HG22 HG11 ' A' ' 139' ' ' VAL . 36.6 p -70.9 -32.39 69.33 Favored 'General case' 0 CA--C 1.54 0.584 0 C-N-CA 124.361 1.065 . . . . 70.3 110.317 179.737 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -110.25 167.91 9.84 Favored 'General case' 0 CA--C 1.543 0.686 0 C-N-CA 124.339 1.056 . . . . 75.05 109.853 173.92 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 18.2 ptmt -76.83 85.08 3.41 Favored 'General case' 0 N--CA 1.479 0.98 0 C-N-CA 123.427 0.691 . . . . 74.22 110.568 179.309 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 119' ' ' THR . . . . . 0.58 ' HB ' HD23 ' A' ' 122' ' ' LEU . 73.5 p -77.44 85.33 3.84 Favored 'General case' 0 CA--C 1.552 1.034 0 CA-C-O 122.068 0.937 . . . . 75.14 110.168 -175.559 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 9.8 pt-20 -81.52 -20.88 39.12 Favored 'General case' 0 N--CA 1.486 1.34 0 C-N-CA 123.691 0.796 . . . . 73.41 112.247 -167.862 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 121' ' ' TRP . . . . . . . . . . . . . 28.5 p90 -73.06 -8.16 54.49 Favored 'General case' 0 N--CA 1.484 1.23 0 C-N-CA 123.525 0.73 . . . . 74.31 110.794 174.748 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 122' ' ' LEU . . . . . 0.58 HD23 ' HB ' ' A' ' 119' ' ' THR . 4.2 mm? -84.23 11.48 8.18 Favored 'General case' 0 CA--C 1.554 1.105 0 C-N-CA 124.16 0.984 . . . . 65.43 111.239 170.932 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 34.5 m-20 -75.92 150.84 37.46 Favored 'General case' 0 N--CA 1.491 1.602 0 CA-C-N 118.804 0.729 . . . . 72.12 110.744 171.228 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 64.45 13.45 54.88 Favored Glycine 0 C--N 1.352 1.43 0 O-C-N 123.877 0.735 . . . . 55.14 112.829 -173.827 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 125' ' ' LYS . . . . . 0.628 ' HB2' ' HZ2' ' A' ' 125' ' ' LYS . 0.0 OUTLIER -106.76 -166.21 1.15 Allowed 'General case' 0 CA--C 1.547 0.86 0 C-N-CA 124.941 1.296 . . . . 73.31 108.05 -173.108 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 126' ' ' HIS . . . . . . . . . . . . . 2.1 p80 -66.84 156.79 34.68 Favored 'General case' 0 N--CA 1.476 0.865 0 C-N-CA 124.48 1.112 . . . . 75.32 113.039 -173.68 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 127' ' ' VAL . . . . . 0.433 HG22 ' HB3' ' A' ' 85' ' ' ASP . 45.9 t -65.74 133.3 30.97 Favored 'Isoleucine or valine' 0 CA--C 1.553 1.084 0 C-N-CA 125.476 1.51 . . . . 73.44 112.955 -168.894 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 128' ' ' VAL . . . . . 0.494 ' HB ' ' HB2' ' A' ' 90' ' ' LEU . 47.3 t -85.19 158.57 3.41 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.148 0 C-N-CA 124.759 1.224 . . . . 72.32 108.701 168.813 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 129' ' ' PHE . . . . . . . . . . . . . 36.8 p90 -139.87 -32.53 0.62 Allowed 'General case' 0 N--CA 1.481 1.092 0 CA-C-N 118.422 0.556 . . . . 74.43 111.936 176.578 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . -117.84 162.41 13.07 Favored Glycine 0 C--N 1.341 0.855 0 CA-C-O 121.071 0.262 . . . . 62.21 113.427 -173.112 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 29.6 ttpt -149.51 120.06 7.46 Favored 'General case' 0 N--CA 1.469 0.489 0 C-N-CA 124.717 1.207 . . . . 75.24 108.796 -179.608 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 34.8 t -61.17 100.78 0.13 Allowed 'Isoleucine or valine' 0 N--CA 1.473 0.7 0 N-CA-C 109.567 -0.531 . . . . 74.12 109.567 177.266 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 133' ' ' LYS . . . . . 0.527 ' HD2' ' HB2' ' A' ' 23' ' ' GLU . 0.1 OUTLIER -86.25 -28.76 23.61 Favored 'General case' 0 N--CA 1.473 0.68 0 N-CA-C 109.454 -0.573 . . . . 73.31 109.454 -179.901 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 42.4 mt-10 -144.27 149.83 36.91 Favored 'General case' 0 N--CA 1.478 0.968 0 C-N-CA 124.937 1.295 . . . . 71.5 109.945 176.748 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 85.73 20.21 56.52 Favored Glycine 0 C--N 1.347 1.157 0 CA-C-O 119.822 -0.432 . . . . 54.4 113.687 176.749 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 136' ' ' MET . . . . . 0.498 ' HE3' ' HB2' ' A' ' 95' ' ' PRO . 14.4 tpt -67.24 -26.54 66.63 Favored 'General case' 0 N--CA 1.48 1.056 0 C-N-CA 123.156 0.582 . . . . 74.32 110.867 179.153 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 137' ' ' ASN . . . . . . . . . . . . . 52.9 t-20 -56.88 -44.39 82.22 Favored 'General case' 0 N--CA 1.48 1.07 0 C-N-CA 124.259 1.023 . . . . 65.15 109.812 172.164 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 138' ' ' ILE . . . . . . . . . . . . . 49.4 mm -71.47 -32.77 47.42 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.748 0 C-N-CA 123.861 0.864 . . . . 71.12 110.742 -179.08 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 139' ' ' VAL . . . . . 0.575 HG11 HG22 ' A' ' 116' ' ' THR . 93.5 t -67.09 -42.13 87.97 Favored 'Isoleucine or valine' 0 CA--C 1.559 1.317 0 C-N-CA 123.534 0.734 . . . . 72.31 110.837 177.904 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 39.3 mt-10 -73.92 -28.14 61.38 Favored 'General case' 0 N--CA 1.478 0.949 0 CA-C-N 115.563 -0.744 . . . . 71.34 110.804 176.747 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -70.43 -44.27 68.2 Favored 'General case' 0 N--CA 1.476 0.847 0 C-N-CA 123.688 0.795 . . . . 63.3 110.848 178.031 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 142' ' ' MET . . . . . 0.529 ' HE1' HG21 ' A' ' 156' ' ' ILE . 27.7 ptm -73.91 -29.36 62.01 Favored 'General case' 0 N--CA 1.473 0.679 0 CA-C-N 115.567 -0.742 . . . . 74.43 111.133 -177.975 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 143' ' ' GLU . . . . . 0.417 ' HB2' HG23 ' A' ' 116' ' ' THR . 41.2 tt0 -51.29 -38.44 52.87 Favored 'General case' 0 N--CA 1.478 0.97 0 C-N-CA 124.105 0.962 . . . . 71.54 111.707 174.189 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 144' ' ' ARG . . . . . . . . . . . . . 39.1 mtp85 -66.92 -22.1 65.97 Favored 'General case' 0 CA--C 1.542 0.667 0 CA-C-N 115.243 -0.889 . . . . 62.21 112.216 -173.432 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 145' ' ' PHE . . . . . . . . . . . . . 58.4 m-85 -82.35 -5.84 58.87 Favored 'General case' 0 N--CA 1.481 1.106 0 N-CA-C 112.088 0.403 . . . . 74.31 112.088 -178.181 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . -97.51 173.09 28.16 Favored Glycine 0 C--N 1.35 1.347 0 N-CA-C 112.52 -0.232 . . . . 73.04 112.52 177.655 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 46.1 m -134.25 172.37 12.96 Favored 'General case' 0 N--CA 1.486 1.328 0 C-N-CA 124.146 0.978 . . . . 72.44 111.106 -176.164 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 148' ' ' ARG . . . . . . . . . . . . . 11.0 mmt180 -57.14 -46.57 82.58 Favored 'General case' 0 N--CA 1.49 1.557 0 C-N-CA 124.697 1.199 . . . . 73.12 112.567 -178.553 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 149' ' ' ASN . . . . . . . . . . . . . 29.9 p-10 -67.34 -14.16 62.67 Favored 'General case' 0 N--CA 1.479 1.02 0 C-N-CA 123.801 0.841 . . . . 70.23 111.884 179.136 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 150' ' ' GLY . . . . . 0.5 ' O ' ' HA ' ' A' ' 55' ' ' ARG . . . 102.68 -4.34 50.2 Favored Glycine 0 C--N 1.351 1.372 0 CA-C-O 119.808 -0.44 . . . . 44.05 112.711 -179.732 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 62.3 tttp -69.93 133.56 47.44 Favored 'General case' 0 N--CA 1.475 0.778 0 CA-C-N 117.15 0.475 . . . . 74.44 110.408 -177.66 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 152' ' ' THR . . . . . . . . . . . . . 24.8 p -102.06 124.68 48.08 Favored 'General case' 0 C--O 1.236 0.38 0 C-N-CA 123.601 0.761 . . . . 75.21 109.468 174.165 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 153' ' ' SER . . . . . . . . . . . . . 47.7 t -75.15 -8.62 57.08 Favored 'General case' 0 CA--C 1.55 0.952 0 C-N-CA 123.419 0.688 . . . . 73.31 111.059 174.866 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 74.7 mmtt -133.96 132.42 40.16 Favored 'General case' 0 N--CA 1.475 0.777 0 C-N-CA 124.54 1.136 . . . . 71.3 109.424 178.489 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 46.1 mtmt -82.31 93.29 7.12 Favored 'General case' 0 N--CA 1.474 0.767 0 N-CA-C 108.085 -1.08 . . . . 74.25 108.085 173.757 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 156' ' ' ILE . . . . . 0.529 HG21 ' HE1' ' A' ' 142' ' ' MET . 62.6 mt -85.23 104.67 13.45 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.557 0 CA-C-N 115.707 -0.679 . . . . 74.21 109.886 -175.223 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 157' ' ' THR . . . . . . . . . . . . . 50.1 p -103.93 148.17 26.48 Favored 'General case' 0 N--CA 1.476 0.83 0 C-N-CA 124.44 1.096 . . . . 73.52 110.712 -173.393 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 158' ' ' ILE . . . . . 0.493 HG21 ' HB3' ' A' ' 8' ' ' PHE . 60.3 mt -74.93 93.43 0.8 Allowed 'Isoleucine or valine' 0 CA--C 1.543 0.706 0 N-CA-C 108.136 -1.061 . . . . 74.42 108.136 169.264 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 159' ' ' ALA . . . . . 0.47 ' HB2' ' HB1' ' A' ' 11' ' ' ALA . . . -57.29 -40.08 77.07 Favored 'General case' 0 N--CA 1.476 0.838 0 C-N-CA 124.585 1.154 . . . . 73.14 112.784 -177.335 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 160' ' ' ASP . . . . . 0.554 ' HA ' ' HE3' ' A' ' 49' ' ' LYS . 29.4 t70 -156.15 163.87 39.08 Favored 'General case' 0 N--CA 1.474 0.738 0 O-C-N 123.394 0.434 . . . . 61.32 111.06 -175.862 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 161' ' ' CYS . . . . . . . . . . . . . 18.6 p -131.39 -169.94 2.28 Favored 'General case' 0 CA--C 1.542 0.661 0 C-N-CA 124.976 1.311 . . . . 74.13 108.729 177.844 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 162' ' ' GLY . . . . . . . . . . . . . . . 131.22 51.69 0.1 OUTLIER Glycine 0 N--CA 1.471 1.008 0 N-CA-C 109.915 -1.274 . . . . 73.35 109.915 -170.225 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 163' ' ' GLN . . . . . 0.631 ' HA ' ' H ' ' A' ' 7' ' ' PHE . 36.7 mt-30 -54.33 122.19 9.87 Favored 'General case' 0 CA--C 1.546 0.821 0 CA-C-N 112.429 -1.885 . . . . 74.52 111.927 -175.836 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 164' ' ' LEU . . . . . . . . . . . . . 82.5 mt . . . . . 0 N--CA 1.475 0.806 0 C-N-CA 123.377 0.671 . . . . 75.41 111.377 -168.046 . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' B' B ' 218' ' ' PRO . . . . . . . . . . . . . 32.4 Cg_exo . . . . . 0 CA--C 1.547 1.168 0 CA-C-O 120.927 0.303 . . . . 72.43 111.787 . . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' B' B ' 219' ' ' GLY . . . . . . . . . . . . . . . 171.14 152.48 8.27 Favored Glycine 0 C--N 1.339 0.748 0 CA-C-N 115.827 -0.624 . . . . 72.42 111.865 178.4 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 220' ' ' PRO . . . . . 0.561 ' HB3' HD13 ' A' ' 122' ' ' LEU . 84.5 Cg_endo -77.72 155.52 31.13 Favored 'Trans proline' 0 C--N 1.373 1.852 0 C-N-CA 122.691 2.26 . . . . 71.54 112.395 179.888 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' B' B ' 221' ' ' TYR . . . . . . . . . . . . . 54.4 m-85 . . . . . 0 C--O 1.244 0.777 0 C-N-CA 123.306 0.642 . . . . 74.14 109.469 -174.799 . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 3' ' ' ASN . . . . . 0.4 ' ND2' ' HA ' ' A' ' 25' ' ' PHE . 16.6 m120 . . . . . 0 C--O 1.24 0.588 0 N-CA-C 110.024 -0.362 . . . . 73.35 110.024 . . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 4' ' ' PRO . . . . . 0.453 ' HG2' ' HB2' ' A' ' 24' ' ' LEU . 60.7 Cg_endo -80.04 141.02 14.54 Favored 'Trans proline' 0 C--N 1.362 1.283 0 C-N-CA 122.116 1.877 . . . . 75.34 111.003 164.518 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 50.6 m -96.54 134.0 40.31 Favored 'General case' 0 CA--C 1.533 0.302 0 N-CA-C 108.744 -0.835 . . . . 72.53 108.744 175.673 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 6' ' ' VAL . . . . . 0.594 ' HA ' ' HB2' ' A' ' 163' ' ' GLN . 58.2 t -100.47 145.84 10.27 Favored 'Isoleucine or valine' 0 C--O 1.217 -0.645 0 N-CA-C 107.869 -1.16 . . . . 73.44 107.869 174.593 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 7' ' ' PHE . . . . . 0.435 ' HB2' ' HG ' ' A' ' 164' ' ' LEU . 87.7 t80 -129.26 126.46 39.12 Favored 'General case' 0 C--O 1.239 0.552 0 N-CA-C 109.132 -0.692 . . . . 75.52 109.132 178.663 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 8' ' ' PHE . . . . . 0.446 ' HE2' ' HZ ' ' A' ' 36' ' ' PHE . 31.0 m-85 -128.16 166.0 19.35 Favored 'General case' 0 C--O 1.238 0.477 0 C-N-CA 124.253 1.021 . . . . 73.41 109.409 168.8 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 29.1 m-20 -115.16 111.96 21.8 Favored 'General case' 0 C--N 1.326 -0.419 0 N-CA-C 107.291 -1.374 . . . . 75.14 107.291 170.835 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 10' ' ' ILE . . . . . 0.458 HG21 ' SD ' ' A' ' 142' ' ' MET . 46.8 mm -80.89 125.76 39.5 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.473 0 N-CA-C 108.896 -0.779 . . . . 74.22 108.896 -179.461 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 11' ' ' ALA . . . . . 0.788 ' HB1' ' HB1' ' A' ' 159' ' ' ALA . . . -114.6 142.82 45.94 Favored 'General case' 0 C--O 1.217 -0.634 0 C-N-CA 124.556 1.142 . . . . 64.35 110.199 -173.839 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 12' ' ' VAL . . . . . 0.455 HG21 HG12 ' A' ' 156' ' ' ILE . 60.9 t -123.99 135.12 64.61 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.907 0 N-CA-C 107.237 -1.394 . . . . 72.24 107.237 172.097 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 25.4 m-20 65.49 20.32 11.68 Favored 'General case' 0 N--CA 1.494 1.73 0 C-N-CA 124.304 1.041 . . . . 75.21 110.424 -168.841 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 80.36 -5.7 62.93 Favored Glycine 0 C--N 1.358 1.753 0 CA-C-N 116.065 -0.516 . . . . 74.23 113.757 -173.849 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 30.8 mm-40 -104.77 126.94 29.9 Favored Pre-proline 0 N--CA 1.475 0.823 0 C-N-CA 123.882 0.873 . . . . 75.33 110.45 -175.52 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 14.8 Cg_endo -51.87 112.94 0.96 Allowed 'Trans proline' 0 C--N 1.385 2.494 0 C-N-CA 123.538 2.826 . . . . 63.52 112.647 -174.397 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 50.7 tp -76.42 -46.35 27.52 Favored 'General case' 0 N--CA 1.468 0.472 0 CA-C-N 115.007 -0.997 . . . . 52.41 108.859 175.535 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -169.57 -176.21 39.25 Favored Glycine 0 C--N 1.34 0.781 0 CA-C-N 115.169 -0.923 . . . . 72.34 112.258 179.777 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 13.5 ptp180 -109.79 144.44 38.21 Favored 'General case' 0 N--CA 1.475 0.786 0 C-N-CA 123.833 0.853 . . . . 70.12 110.256 -179.536 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 99.3 t -135.55 131.97 51.38 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.733 0 C-N-CA 124.058 0.943 . . . . 74.25 108.918 177.117 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 21' ' ' SER . . . . . 0.472 ' OG ' ' HB2' ' A' ' 134' ' ' GLU . 78.0 p -116.13 130.9 57.02 Favored 'General case' 0 CA--C 1.552 1.021 0 C-N-CA 123.388 0.675 . . . . 75.24 109.561 173.914 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 22' ' ' PHE . . . . . 0.418 ' CD1' HD22 ' A' ' 98' ' ' LEU . 44.9 m-85 -102.61 169.94 8.34 Favored 'General case' 0 N--CA 1.471 0.575 0 C-N-CA 124.785 1.234 . . . . 64.2 110.015 178.928 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 6.4 tp10 -130.95 106.31 8.33 Favored 'General case' 0 C--O 1.24 0.57 0 N-CA-C 108.593 -0.891 . . . . 73.32 108.593 -179.691 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . 0.453 ' HB2' ' HG2' ' A' ' 4' ' ' PRO . 52.1 mt -78.71 124.75 28.52 Favored 'General case' 0 N--CA 1.468 0.448 0 N-CA-C 109.962 -0.384 . . . . 75.15 109.962 178.383 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 25' ' ' PHE . . . . . 0.461 ' HB2' HD11 ' A' ' 90' ' ' LEU . 36.4 m-85 -85.34 60.0 5.98 Favored 'General case' 0 CA--C 1.545 0.771 0 N-CA-C 108.777 -0.823 . . . . 73.24 108.777 173.132 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -61.34 -33.41 73.57 Favored 'General case' 0 N--CA 1.483 1.21 0 C-N-CA 123.613 0.765 . . . . 75.42 111.666 -175.344 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 12.2 p-10 -59.98 -29.59 68.55 Favored 'General case' 0 CA--C 1.549 0.907 0 C-N-CA 124.372 1.069 . . . . 72.22 111.92 176.765 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 28' ' ' LYS . . . . . 0.559 ' HD2' HD23 ' A' ' 90' ' ' LEU . 40.0 mttm -94.72 -42.29 8.83 Favored 'General case' 0 N--CA 1.482 1.14 0 C-N-CA 123.548 0.739 . . . . 74.45 110.637 -178.114 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 29' ' ' VAL . . . . . 0.528 HG21 ' HA ' ' A' ' 129' ' ' PHE . 18.9 m -124.58 82.17 59.47 Favored Pre-proline 0 CA--C 1.563 1.473 0 C-N-CA 123.843 0.857 . . . . 74.33 110.867 -176.369 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 60.7 Cg_exo -53.77 -52.6 8.12 Favored 'Trans proline' 0 C--N 1.386 2.533 0 C-N-CA 123.183 2.589 . . . . 75.34 113.504 -177.83 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 31' ' ' LYS . . . . . 0.524 ' HZ2' ' HB2' ' A' ' 31' ' ' LYS . 4.0 ttmp? -66.47 -52.77 42.72 Favored 'General case' 0 N--CA 1.481 1.096 0 C-N-CA 124.252 1.021 . . . . 75.02 111.975 -177.301 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 32' ' ' THR . . . . . 0.648 HG21 ' HD2' ' A' ' 129' ' ' PHE . 1.4 m -64.55 -38.04 89.63 Favored 'General case' 0 CA--C 1.549 0.925 0 CA-C-N 115.23 -0.895 . . . . 73.52 110.94 -169.586 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -83.6 -36.44 23.92 Favored 'General case' 0 CA--C 1.548 0.885 0 C-N-CA 122.825 0.45 . . . . 75.44 112.2 -178.826 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 29.9 tt0 -57.03 -47.42 80.95 Favored 'General case' 0 N--CA 1.492 1.64 0 C-N-CA 123.371 0.668 . . . . 54.33 110.535 175.439 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 35' ' ' ASN . . . . . 0.487 ' O ' ' HG ' ' A' ' 39' ' ' LEU . 39.8 t30 -49.63 -57.38 7.27 Favored 'General case' 0 C--N 1.349 0.577 0 O-C-N 125.406 1.691 . . . . 75.13 110.474 179.209 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 36' ' ' PHE . . . . . 0.446 ' HZ ' ' HE2' ' A' ' 8' ' ' PHE . 72.3 t80 -62.24 -45.2 94.38 Favored 'General case' 0 CA--C 1.543 0.675 0 O-C-N 124.169 0.918 . . . . 73.13 112.051 -175.939 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 11.6 ttm180 -54.14 -47.72 71.59 Favored 'General case' 0 N--CA 1.482 1.143 0 O-C-N 123.843 0.714 . . . . 75.44 111.507 176.123 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 38' ' ' ALA . . . . . 0.512 ' HB1' ' HG2' ' A' ' 44' ' ' LYS . . . -70.44 -30.37 67.19 Favored 'General case' 0 CA--C 1.544 0.724 0 CA-C-N 115.578 -0.737 . . . . 74.03 111.809 -175.605 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 39' ' ' LEU . . . . . 0.52 HD21 ' HE2' ' A' ' 48' ' ' TYR . 99.7 mt -71.31 -43.64 66.7 Favored 'General case' 0 N--CA 1.477 0.883 0 C-N-CA 123.603 0.761 . . . . 72.13 110.593 175.161 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 34.9 t -64.56 -52.32 58.29 Favored 'General case' 0 N--CA 1.477 0.924 0 C-N-CA 124.979 1.312 . . . . 75.21 111.562 -174.843 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 41' ' ' THR . . . . . 0.44 ' OG1' ' HG2' ' A' ' 43' ' ' GLU . 67.4 p -85.18 -31.25 23.33 Favored 'General case' 0 C--O 1.24 0.587 0 CA-C-N 115.096 -0.956 . . . . 74.11 111.388 -176.054 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 85.99 35.72 10.92 Favored Glycine 0 C--N 1.347 1.16 0 CA-C-N 116.154 -0.476 . . . . 75.52 112.736 -177.803 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 43' ' ' GLU . . . . . 0.44 ' HG2' ' OG1' ' A' ' 41' ' ' THR . 26.7 mm-40 -62.89 -30.86 71.85 Favored 'General case' 0 N--CA 1.483 1.218 0 C-N-CA 122.92 0.488 . . . . 55.41 110.606 172.682 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 44' ' ' LYS . . . . . 0.512 ' HG2' ' HB1' ' A' ' 38' ' ' ALA . 31.5 mmmt -100.57 20.19 15.51 Favored 'General case' 0 CA--C 1.548 0.899 0 C-N-CA 123.707 0.803 . . . . 74.53 111.465 177.353 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 71.17 41.91 59.15 Favored Glycine 0 C--N 1.35 1.334 0 CA-C-O 119.528 -0.595 . . . . 74.32 114.562 171.896 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 24.1 m-85 -123.19 -48.33 1.98 Allowed 'General case' 0 N--CA 1.486 1.372 0 CA-C-N 117.596 0.698 . . . . 75.41 111.071 -176.876 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 48.58 62.64 4.3 Favored Glycine 0 C--N 1.356 1.685 0 O-C-N 124.169 0.918 . . . . 55.33 114.288 171.669 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 48' ' ' TYR . . . . . 0.571 ' CE1' ' HA2' ' A' ' 75' ' ' GLY . 66.1 m-85 -60.78 95.37 0.04 OUTLIER 'General case' 0 N--CA 1.48 1.065 0 CA-C-O 122.108 0.956 . . . . 74.51 112.751 -174.617 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 28.6 tptp -109.41 131.45 55.05 Favored 'General case' 0 CA--C 1.537 0.457 0 CA-C-N 113.337 -1.756 . . . . 74.32 109.149 -176.798 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 72.71 20.34 79.64 Favored Glycine 0 C--N 1.346 1.098 0 CA-C-O 119.665 -0.519 . . . . 70.04 113.793 177.412 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 51' ' ' SER . . . . . 0.477 ' HB3' ' HA2' ' A' ' 65' ' ' GLY . 49.0 m -61.14 114.56 3.2 Favored 'General case' 0 N--CA 1.476 0.858 0 C-N-CA 123.249 0.62 . . . . 72.3 110.368 -178.29 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 52' ' ' CYS . . . . . . . . . . . . . 53.5 t -92.14 121.44 33.69 Favored 'General case' 0 N--CA 1.474 0.727 0 N-CA-C 113.031 0.752 . . . . 75.21 113.031 -165.945 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 53' ' ' PHE . . . . . 0.565 ' HB2' ' HB ' ' A' ' 156' ' ' ILE . 76.4 m-85 -69.4 114.57 7.77 Favored 'General case' 0 C--O 1.239 0.517 0 C-N-CA 124.867 1.267 . . . . 75.5 109.816 167.803 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 17.4 p-80 -128.04 -4.5 5.66 Favored 'General case' 0 N--CA 1.481 1.079 0 C-N-CA 123.565 0.746 . . . . 75.4 112.031 -173.819 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 36.0 ttt180 -135.19 107.37 7.19 Favored 'General case' 0 C--N 1.357 0.928 0 N-CA-C 108.975 -0.75 . . . . 74.23 108.975 170.756 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 56' ' ' ILE . . . . . 0.486 HG22 ' SG ' ' A' ' 62' ' ' CYS . 71.8 mt -130.62 129.25 64.17 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.694 0 C-N-CA 123.721 0.808 . . . . 64.35 109.242 177.365 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 57' ' ' ILE . . . . . 0.442 HG12 ' HA2' ' A' ' 150' ' ' GLY . 52.2 mt -117.07 121.54 32.38 Favored Pre-proline 0 CA--C 1.556 1.186 0 C-N-CA 124.584 1.154 . . . . 71.51 108.725 176.903 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 58' ' ' PRO . . . . . 0.478 ' HA ' ' HG3' ' A' ' 143' ' ' GLU . 24.3 Cg_exo -64.01 146.85 91.67 Favored 'Trans proline' 0 C--N 1.375 1.954 0 C-N-CA 122.792 2.328 . . . . 65.2 112.63 173.388 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 63.99 31.22 80.08 Favored Glycine 0 C--N 1.345 1.033 0 CA-C-N 115.117 -0.947 . . . . 63.05 113.284 -176.306 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 40.0 t80 -158.46 -77.77 0.07 Allowed 'General case' 0 CA--C 1.549 0.923 0 CA-C-N 116.814 0.307 . . . . 75.43 111.653 -174.18 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 48.3 ttm -165.6 157.12 14.32 Favored 'General case' 0 N--CA 1.489 1.49 0 N-CA-C 112.01 0.374 . . . . 70.54 112.01 -163.433 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 62' ' ' CYS . . . . . 0.486 ' SG ' HG22 ' A' ' 56' ' ' ILE . 61.2 m -131.86 113.37 13.4 Favored 'General case' 0 N--CA 1.471 0.623 0 C-N-CA 124.299 1.04 . . . . 74.22 109.11 175.772 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 13.4 pt20 -117.6 149.55 40.48 Favored 'General case' 0 N--CA 1.488 1.448 0 CA-C-O 121.396 0.617 . . . . 75.24 111.556 -177.343 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 64' ' ' GLY . . . . . 0.462 ' CA ' ' HA ' ' A' ' 53' ' ' PHE . . . -162.1 179.4 37.46 Favored Glycine 0 C--N 1.343 0.951 0 CA-C-N 114.536 -1.211 . . . . 61.43 113.94 -176.492 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 65' ' ' GLY . . . . . 0.477 ' HA2' ' HB3' ' A' ' 51' ' ' SER . . . 110.04 98.31 2.5 Favored Glycine 0 N--CA 1.447 -0.581 0 N-CA-C 108.91 -1.676 . . . . 74.45 108.91 -167.277 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 23.7 t70 -124.69 19.95 8.6 Favored 'General case' 0 N--CA 1.483 1.21 0 CA-C-O 121.765 0.793 . . . . 71.13 109.132 179.353 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 49.1 t80 -81.54 -77.83 0.2 Allowed 'General case' 0 CA--C 1.551 1.004 0 CA-C-N 115.301 -0.863 . . . . 73.52 111.746 -169.55 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 89.6 m -85.54 107.74 17.61 Favored 'General case' 0 N--CA 1.48 1.068 0 C-N-CA 122.406 0.282 . . . . 73.31 110.442 -175.348 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 77.9 mtp180 66.44 80.86 0.21 Allowed 'General case' 0 N--CA 1.472 0.672 0 C-N-CA 125.177 1.391 . . . . 74.5 110.468 -179.85 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 7.8 p80 -70.98 73.87 0.61 Allowed 'General case' 0 CA--C 1.558 1.265 0 CA-C-O 122.343 1.068 . . . . 71.11 110.652 179.709 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 7.4 t30 -153.81 30.39 0.46 Allowed 'General case' 0 CA--C 1.553 1.073 0 C-N-CA 125.066 1.347 . . . . 65.51 107.587 -172.821 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 92.17 -8.67 77.48 Favored Glycine 0 C--N 1.353 1.507 0 CA-C-N 114.874 -1.057 . . . . 70.31 113.431 -177.235 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 73' ' ' THR . . . . . 0.591 ' HA ' ' HB2' ' A' ' 110' ' ' SER . 28.7 m -85.09 -67.12 0.82 Allowed 'General case' 0 CA--C 1.546 0.815 0 N-CA-C 108.525 -0.917 . . . . 63.32 108.525 174.458 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 54.92 18.58 11.87 Favored Glycine 0 C--N 1.348 1.242 0 N-CA-C 115.807 1.083 . . . . 71.34 115.807 167.248 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 75' ' ' GLY . . . . . 0.571 ' HA2' ' CE1' ' A' ' 48' ' ' TYR . . . 147.84 54.14 0.02 OUTLIER Glycine 0 CA--C 1.494 -1.233 0 O-C-N 121.537 -0.978 . . . . 53.0 111.826 -160.287 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 64.2 pttt -60.18 167.74 2.26 Favored 'General case' 0 CA--C 1.546 0.823 0 O-C-N 124.524 0.779 . . . . 74.41 111.173 173.782 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 87.1 p -88.78 174.16 8.15 Favored 'General case' 0 C--O 1.241 0.647 0 CA-C-N 115.68 -0.691 . . . . 63.24 110.607 -177.746 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 29.6 pt -69.77 -21.69 24.44 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.787 0 CA-C-N 115.846 -0.616 . . . . 74.04 110.557 173.244 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 56.4 m-85 -87.14 0.4 55.36 Favored 'General case' 0 N--CA 1.479 0.989 0 C-N-CA 124.134 0.974 . . . . 75.42 111.636 -178.166 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 125.6 -150.71 17.47 Favored Glycine 0 C--N 1.347 1.172 0 N-CA-C 111.135 -0.786 . . . . 73.13 111.135 -179.933 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 45.9 tt0 -63.02 -40.73 98.62 Favored 'General case' 0 N--CA 1.476 0.873 0 C-N-CA 123.392 0.677 . . . . 75.03 110.612 175.997 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 82' ' ' LYS . . . . . 0.482 ' HD3' ' HA ' ' A' ' 107' ' ' THR . 11.2 ptpp? -150.66 168.38 24.5 Favored 'General case' 0 CA--C 1.548 0.887 0 CA-C-N 115.637 -0.71 . . . . 73.23 110.963 -171.727 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 35.5 p90 -159.77 164.33 33.88 Favored 'General case' 0 N--CA 1.477 0.916 0 C-N-CA 124.797 1.239 . . . . 72.23 109.512 176.065 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 11.6 pt-20 -94.25 159.16 15.26 Favored 'General case' 0 N--CA 1.478 0.931 0 C-N-CA 123.158 0.583 . . . . 74.13 109.834 173.934 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 63.9 m-20 -67.08 151.36 47.75 Favored 'General case' 0 N--CA 1.475 0.809 0 C-N-CA 124.371 1.069 . . . . 74.13 113.814 -170.74 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 6.3 tp10 -69.59 -59.33 3.03 Favored 'General case' 0 CA--C 1.55 0.958 0 CA-C-N 114.953 -1.022 . . . . 75.21 111.12 177.567 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 87' ' ' ASN . . . . . 0.404 ' OD1' HG11 ' A' ' 29' ' ' VAL . 25.8 p-10 -174.2 137.51 0.54 Allowed 'General case' 0 N--CA 1.489 1.508 0 C-N-CA 123.88 0.872 . . . . 75.52 109.912 -171.639 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 91.9 m-85 -89.12 54.82 3.1 Favored 'General case' 0 N--CA 1.489 1.508 0 CA-C-O 121.468 0.652 . . . . 74.4 111.685 -171.492 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 49.3 mt -82.47 -46.72 19.26 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.812 0 CA-C-N 115.632 -0.713 . . . . 75.41 109.16 170.591 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 90' ' ' LEU . . . . . 0.559 HD23 ' HD2' ' A' ' 28' ' ' LYS . 90.2 mt -95.33 110.73 22.7 Favored 'General case' 0 C--O 1.241 0.641 0 CA-C-N 115.445 -0.798 . . . . 73.51 110.876 -174.728 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 23.5 pttm -107.84 169.52 8.55 Favored 'General case' 0 N--CA 1.474 0.769 0 C-N-CA 124.176 0.99 . . . . 74.41 109.409 173.503 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 92' ' ' HIS . . . . . 0.459 ' HA ' HG22 ' A' ' 97' ' ' ILE . 17.1 m-70 -87.68 47.07 1.45 Allowed 'General case' 0 N--CA 1.481 1.088 0 C-N-CA 124.045 0.938 . . . . 55.2 110.371 -173.688 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 9.5 t -83.71 5.32 25.11 Favored 'General case' 0 CA--C 1.552 1.028 0 C-N-CA 124.315 1.046 . . . . 75.45 111.971 -174.059 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -133.53 153.42 20.82 Favored Glycine 0 C--N 1.347 1.155 0 CA-C-O 119.713 -0.493 . . . . 74.11 112.067 179.091 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 73.5 Cg_endo -75.89 142.38 25.2 Favored 'Trans proline' 0 C--N 1.367 1.531 0 C-N-CA 122.538 2.158 . . . . 73.02 110.064 167.258 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 89.13 6.69 71.17 Favored Glycine 0 N--CA 1.467 0.75 0 CA-C-O 120.145 -0.253 . . . . 64.52 113.121 -175.931 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 97' ' ' ILE . . . . . 0.713 ' HB ' ' SG ' ' A' ' 115' ' ' CYS . 5.9 mm -68.63 120.18 15.67 Favored 'Isoleucine or valine' 0 CA--C 1.552 1.057 0 C-N-CA 123.181 0.593 . . . . 75.34 110.782 179.191 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 98' ' ' LEU . . . . . 0.418 HD22 ' CD1' ' A' ' 22' ' ' PHE . 56.8 tp -103.4 123.05 46.11 Favored 'General case' 0 CA--C 1.554 1.122 0 C-N-CA 124.4 1.08 . . . . 72.03 111.038 -177.657 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 99' ' ' SER . . . . . 0.686 ' HB3' ' HA ' ' A' ' 128' ' ' VAL . 11.3 p -152.88 158.39 42.08 Favored 'General case' 0 N--CA 1.473 0.687 0 C-N-CA 124.369 1.067 . . . . 71.41 109.514 176.212 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 100' ' ' MET . . . . . 0.644 ' HG3' ' HE2' ' A' ' 129' ' ' PHE . 79.7 mtp -77.25 145.83 37.28 Favored 'General case' 0 N--CA 1.487 1.398 0 N-CA-C 109.944 -0.391 . . . . 75.22 109.944 -179.898 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 101' ' ' ALA . . . . . 0.481 ' HB3' ' HB2' ' A' ' 111' ' ' GLN . . . -76.07 165.85 24.34 Favored 'General case' 0 C--O 1.247 0.943 0 CA-C-O 121.015 0.436 . . . . 65.44 111.236 -177.681 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 102' ' ' ASN . . . . . 0.453 ' HB3' ' HA ' ' A' ' 108' ' ' ASN . 27.1 p-10 -160.38 156.79 26.74 Favored 'General case' 0 N--CA 1.472 0.631 0 CA-C-N 115.809 -0.632 . . . . 73.42 111.007 -176.766 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -93.33 -17.23 23.82 Favored 'General case' 0 CA--C 1.545 0.773 0 CA-C-N 115.358 -0.837 . . . . 70.33 110.674 169.587 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 177.94 -178.75 48.51 Favored Glycine 0 C--N 1.352 1.437 0 CA-C-O 119.445 -0.642 . . . . 64.51 112.957 178.839 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 50.2 Cg_exo -58.85 141.22 97.82 Favored 'Trans proline' 0 C--N 1.374 1.917 0 C-N-CA 123.22 2.614 . . . . 75.03 112.439 171.554 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 64.4 t30 66.54 10.55 7.45 Favored 'General case' 0 N--CA 1.485 1.302 0 C-N-CA 125.48 1.512 . . . . 73.23 111.243 -176.301 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 107' ' ' THR . . . . . 0.482 ' HA ' ' HD3' ' A' ' 82' ' ' LYS . 16.7 m -126.57 18.76 7.42 Favored 'General case' 0 CA--C 1.558 1.273 0 C-N-CA 124.767 1.227 . . . . 73.14 108.769 -178.828 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 108' ' ' ASN . . . . . 0.453 ' HA ' ' HB3' ' A' ' 102' ' ' ASN . 48.1 t30 -86.13 143.74 27.87 Favored 'General case' 0 N--CA 1.48 1.026 0 C-N-CA 123.827 0.851 . . . . 61.45 109.206 177.33 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 112.69 26.29 4.24 Favored Glycine 0 N--CA 1.469 0.86 0 C-N-CA 121.18 -0.533 . . . . 65.52 113.481 -177.566 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 110' ' ' SER . . . . . 0.591 ' HB2' ' HA ' ' A' ' 73' ' ' THR . 31.6 p -129.17 121.06 26.91 Favored 'General case' 0 CA--C 1.539 0.551 0 N-CA-C 107.859 -1.163 . . . . 65.24 107.859 171.697 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 111' ' ' GLN . . . . . 0.481 ' HB2' ' HB3' ' A' ' 101' ' ' ALA . 48.8 mt-30 66.49 177.21 0.23 Allowed 'General case' 0 N--CA 1.491 1.583 0 C-N-CA 124.536 1.135 . . . . 70.13 111.271 -171.574 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 112' ' ' PHE . . . . . 0.637 ' HA ' ' HA ' ' A' ' 100' ' ' MET . 3.1 m-85 -131.75 166.92 20.45 Favored 'General case' 0 N--CA 1.477 0.882 0 N-CA-C 107.396 -1.335 . . . . 74.42 107.396 175.336 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 113' ' ' PHE . . . . . 0.416 ' O ' HD11 ' A' ' 98' ' ' LEU . 48.2 p90 -157.13 160.47 38.85 Favored 'General case' 0 N--CA 1.477 0.916 0 CA-C-O 121.393 0.616 . . . . 73.43 112.138 170.902 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 114' ' ' ILE . . . . . 0.465 HG21 HG12 ' A' ' 139' ' ' VAL . 20.2 mt -124.51 109.71 23.29 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.821 0 CA-C-N 114.024 -1.444 . . . . 74.53 107.443 171.845 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 115' ' ' CYS . . . . . 0.713 ' SG ' ' HB ' ' A' ' 97' ' ' ILE . 29.8 p -74.5 105.5 5.66 Favored 'General case' 0 N--CA 1.474 0.769 0 N-CA-C 108.836 -0.802 . . . . 74.04 108.836 177.464 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 116' ' ' THR . . . . . 0.403 HG23 HG11 ' A' ' 139' ' ' VAL . 24.2 p -71.27 -23.06 61.9 Favored 'General case' 0 N--CA 1.476 0.853 0 C-N-CA 124.396 1.078 . . . . 65.44 111.601 -174.015 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -107.39 152.89 23.57 Favored 'General case' 0 C--O 1.245 0.839 0 N-CA-C 108.794 -0.817 . . . . 71.3 108.794 166.775 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 20.3 ptmt -70.69 99.0 1.61 Allowed 'General case' 0 CA--C 1.543 0.676 0 CA-C-O 121.762 0.792 . . . . 75.51 109.033 172.851 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 119' ' ' THR . . . . . . . . . . . . . 82.2 p -81.7 86.32 6.44 Favored 'General case' 0 CA--C 1.547 0.858 0 CA-C-O 121.963 0.887 . . . . 72.33 109.656 -175.721 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 12.1 pt-20 -74.28 -29.99 61.9 Favored 'General case' 0 N--CA 1.48 1.057 0 CA-C-N 114.662 -1.153 . . . . 73.14 111.132 -175.092 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 121' ' ' TRP . . . . . . . . . . . . . 34.5 p90 -64.91 -13.4 56.76 Favored 'General case' 0 N--CA 1.48 1.03 0 C-N-CA 123.987 0.915 . . . . 75.35 111.57 175.347 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 64.7 mt -99.42 29.08 4.17 Favored 'General case' 0 CA--C 1.551 0.987 0 C-N-CA 123.75 0.82 . . . . 74.42 111.51 176.125 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 83.4 m-20 -69.45 134.95 49.56 Favored 'General case' 0 N--CA 1.484 1.254 0 N-CA-C 109.651 -0.5 . . . . 63.44 109.651 166.615 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 81.9 0.86 89.97 Favored Glycine 0 C--N 1.341 0.844 0 CA-C-N 116.223 -0.444 . . . . 52.03 113.056 -176.209 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 125' ' ' LYS . . . . . 0.465 ' HG3' ' H ' ' A' ' 126' ' ' HIS . 8.5 tppt? -78.43 -170.93 2.23 Favored 'General case' 0 N--CA 1.477 0.915 0 N-CA-C 108.641 -0.874 . . . . 75.41 108.641 176.96 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 126' ' ' HIS . . . . . 0.465 ' H ' ' HG3' ' A' ' 125' ' ' LYS . 44.7 p-80 -68.57 152.84 44.81 Favored 'General case' 0 CA--C 1.545 0.781 0 O-C-N 122.051 -0.406 . . . . 65.13 110.022 -175.826 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 48.5 t -79.37 147.42 6.7 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.697 0 C-N-CA 123.631 0.772 . . . . 75.34 112.452 -164.771 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 128' ' ' VAL . . . . . 0.686 ' HA ' ' HB3' ' A' ' 99' ' ' SER . 61.7 t -83.19 158.81 3.73 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.759 0 C-N-CA 125.103 1.361 . . . . 54.35 109.933 176.375 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 129' ' ' PHE . . . . . 0.648 ' HD2' HG21 ' A' ' 32' ' ' THR . 7.3 p90 -130.62 -24.13 2.51 Favored 'General case' 0 N--CA 1.479 1.023 0 N-CA-C 111.918 0.34 . . . . 74.53 111.918 173.509 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . -143.23 175.53 23.25 Favored Glycine 0 C--N 1.34 0.765 0 O-C-N 123.31 0.381 . . . . 64.03 112.588 -172.997 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 34.6 ttpt -161.08 137.9 8.71 Favored 'General case' 0 N--CA 1.466 0.365 0 N-CA-C 108.52 -0.919 . . . . 75.35 108.52 179.612 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 132' ' ' VAL . . . . . 0.466 HG13 ' HA ' ' A' ' 136' ' ' MET . 40.7 t -61.35 108.45 0.47 Allowed 'Isoleucine or valine' 0 CA--C 1.544 0.72 0 C-N-CA 123.418 0.687 . . . . 70.12 109.976 177.043 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 21.4 ptmt -85.74 -39.19 17.43 Favored 'General case' 0 CA--C 1.542 0.663 0 N-CA-C 109.689 -0.485 . . . . 75.35 109.689 177.006 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 134' ' ' GLU . . . . . 0.472 ' HB2' ' OG ' ' A' ' 21' ' ' SER . 53.4 mm-40 -137.81 149.61 46.5 Favored 'General case' 0 N--CA 1.483 1.195 0 C-N-CA 124.302 1.041 . . . . 64.34 109.253 177.573 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 85.03 20.38 57.67 Favored Glycine 0 N--CA 1.473 1.161 0 O-C-N 123.414 0.446 . . . . 75.34 112.649 -179.295 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 136' ' ' MET . . . . . 0.466 ' HA ' HG13 ' A' ' 132' ' ' VAL . 15.1 tpt -61.07 -33.89 74.04 Favored 'General case' 0 N--CA 1.483 1.211 0 C-N-CA 123.763 0.825 . . . . 73.21 110.943 179.662 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 137' ' ' ASN . . . . . . . . . . . . . 11.4 m120 -64.91 -32.67 74.49 Favored 'General case' 0 CA--C 1.546 0.797 0 C-N-CA 123.849 0.86 . . . . 72.4 111.82 -179.271 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 138' ' ' ILE . . . . . 0.41 ' O ' ' HG3' ' A' ' 142' ' ' MET . 46.8 mm -70.56 -37.8 71.16 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.966 0 C-N-CA 123.143 0.577 . . . . 72.05 109.868 177.355 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 139' ' ' VAL . . . . . 0.465 HG12 HG21 ' A' ' 114' ' ' ILE . 59.3 t -67.17 -37.39 79.1 Favored 'Isoleucine or valine' 0 CA--C 1.555 1.139 0 C-N-CA 123.829 0.852 . . . . 64.13 110.963 177.338 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 38.7 mt-10 -70.86 -28.4 64.54 Favored 'General case' 0 N--CA 1.478 0.934 0 CA-C-N 115.792 -0.64 . . . . 64.41 110.706 176.328 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -68.8 -39.52 80.07 Favored 'General case' 0 N--CA 1.475 0.814 0 C-N-CA 122.876 0.47 . . . . 73.45 110.278 172.38 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 142' ' ' MET . . . . . 0.458 ' SD ' HG21 ' A' ' 10' ' ' ILE . 76.6 mtp -58.25 -41.65 84.69 Favored 'General case' 0 N--CA 1.485 1.282 0 C-N-CA 123.983 0.913 . . . . 70.45 111.157 175.654 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 143' ' ' GLU . . . . . 0.478 ' HG3' ' HA ' ' A' ' 58' ' ' PRO . 37.8 tt0 -53.69 -43.3 68.81 Favored 'General case' 0 CA--C 1.546 0.79 0 CA-C-N 114.92 -1.036 . . . . 75.22 111.69 176.767 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 144' ' ' ARG . . . . . . . . . . . . . 56.2 mtt180 -72.53 -18.58 61.63 Favored 'General case' 0 N--CA 1.475 0.812 0 C-N-CA 124.155 0.982 . . . . 73.11 111.646 -177.263 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 145' ' ' PHE . . . . . 0.505 ' HB3' ' HB2' ' A' ' 154' ' ' LYS . 24.9 m-85 -86.56 -4.27 59.15 Favored 'General case' 0 N--CA 1.479 0.981 0 C-N-CA 123.398 0.679 . . . . 61.12 111.359 176.603 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . -97.24 -179.22 34.17 Favored Glycine 0 C--N 1.347 1.192 0 C-N-CA 123.053 0.358 . . . . 74.13 112.599 175.569 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 21.4 m -134.03 163.13 30.24 Favored 'General case' 0 N--CA 1.482 1.135 0 C-N-CA 124.114 0.966 . . . . 73.31 110.512 -176.121 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 148' ' ' ARG . . . . . . . . . . . . . 26.6 mmt180 -67.91 -28.18 67.28 Favored 'General case' 0 N--CA 1.486 1.364 0 C-N-CA 123.432 0.693 . . . . 73.24 112.037 -175.733 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 149' ' ' ASN . . . . . . . . . . . . . 30.8 p-10 -82.39 2.45 32.37 Favored 'General case' 0 N--CA 1.483 1.177 0 C-N-CA 123.644 0.778 . . . . 74.31 111.358 175.816 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 150' ' ' GLY . . . . . 0.442 ' HA2' HG12 ' A' ' 57' ' ' ILE . . . 93.06 -6.29 76.09 Favored Glycine 0 C--N 1.35 1.34 0 CA-C-O 119.722 -0.488 . . . . 62.53 113.674 177.02 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 40.7 ttmt -71.04 141.13 50.92 Favored 'General case' 0 N--CA 1.475 0.804 0 CA-C-N 117.315 0.557 . . . . 70.24 110.651 -177.719 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 152' ' ' THR . . . . . . . . . . . . . 12.5 p -90.35 117.08 28.8 Favored 'General case' 0 C--O 1.237 0.443 0 N-CA-C 108.824 -0.806 . . . . 75.35 108.824 169.062 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 153' ' ' SER . . . . . . . . . . . . . 22.8 m -66.46 -31.35 72.03 Favored 'General case' 0 CA--C 1.544 0.742 0 CA-C-N 115.679 -0.691 . . . . 73.23 110.036 171.92 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 154' ' ' LYS . . . . . 0.505 ' HB2' ' HB3' ' A' ' 145' ' ' PHE . 32.2 mmmt -121.13 129.97 53.52 Favored 'General case' 0 N--CA 1.472 0.627 0 CA-C-N 115.469 -0.787 . . . . 74.2 110.399 -178.96 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 83.3 tttt -67.76 106.36 2.22 Favored 'General case' 0 C--N 1.352 0.691 0 C-N-CA 123.737 0.815 . . . . 73.44 109.396 171.759 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 156' ' ' ILE . . . . . 0.565 ' HB ' ' HB2' ' A' ' 53' ' ' PHE . 62.0 mt -102.97 131.73 50.63 Favored 'Isoleucine or valine' 0 C--O 1.221 -0.422 0 N-CA-C 108.102 -1.073 . . . . 75.22 108.102 176.509 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 157' ' ' THR . . . . . . . . . . . . . 33.1 p -127.96 160.83 30.66 Favored 'General case' 0 N--CA 1.481 1.098 0 C-N-CA 123.935 0.894 . . . . 73.42 109.732 -179.75 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 158' ' ' ILE . . . . . . . . . . . . . 57.1 mt -82.98 97.08 4.17 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.838 0 N-CA-C 108.52 -0.918 . . . . 75.45 108.52 167.477 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 159' ' ' ALA . . . . . 0.788 ' HB1' ' HB1' ' A' ' 11' ' ' ALA . . . -55.99 -41.72 75.26 Favored 'General case' 0 N--CA 1.481 1.106 0 C-N-CA 124.067 0.947 . . . . 65.05 112.626 -177.262 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 160' ' ' ASP . . . . . . . . . . . . . 2.7 t70 -165.35 174.56 9.99 Favored 'General case' 0 CA--C 1.549 0.93 0 O-C-N 123.496 0.498 . . . . 62.4 110.527 -176.68 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 161' ' ' CYS . . . . . . . . . . . . . 24.5 p -130.96 -167.85 1.9 Allowed 'General case' 0 N--CA 1.478 0.959 0 C-N-CA 125.366 1.467 . . . . 72.04 109.41 -178.55 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 162' ' ' GLY . . . . . . . . . . . . . . . 132.62 53.32 0.08 OUTLIER Glycine 0 C--N 1.351 1.369 0 N-CA-C 112.137 -0.385 . . . . 74.11 112.137 -175.327 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 163' ' ' GLN . . . . . 0.594 ' HB2' ' HA ' ' A' ' 6' ' ' VAL . 21.2 pt20 -49.44 143.4 6.67 Favored 'General case' 0 N--CA 1.482 1.131 0 C-N-CA 124.421 1.088 . . . . 74.44 113.1 -174.379 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 164' ' ' LEU . . . . . 0.435 ' HG ' ' HB2' ' A' ' 7' ' ' PHE . 86.0 mt . . . . . 0 CA--C 1.547 0.843 0 C-N-CA 123.514 0.726 . . . . 74.2 110.14 -173.365 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 218' ' ' PRO . . . . . . . . . . . . . 11.7 Cg_endo . . . . . 0 CA--C 1.544 0.992 0 CA-C-O 121.651 0.605 . . . . 74.23 111.632 . . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' B' B ' 219' ' ' GLY . . . . . . . . . . . . . . . 176.08 156.04 14.32 Favored Glycine 0 CA--C 1.525 0.71 0 CA-C-N 114.593 -1.185 . . . . 74.43 111.542 177.711 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 220' ' ' PRO . . . . . . . . . . . . . 60.5 Cg_endo -85.38 -178.97 3.27 Favored 'Trans proline' 0 CA--C 1.553 1.472 0 C-N-CA 122.961 2.441 . . . . 74.3 112.209 175.459 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 221' ' ' TYR . . . . . . . . . . . . . 43.1 p90 . . . . . 0 N--CA 1.484 1.242 0 C-N-CA 123.632 0.773 . . . . 75.3 110.986 179.802 . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 56.3 mtt . . . . . 0 N--CA 1.477 0.912 0 N-CA-C 108.184 -1.043 . . . . 75.13 108.184 . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 12.8 m 48.71 35.08 0.24 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.855 0 C-N-CA 126.418 1.887 . . . . 74.55 112.848 -174.273 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 3' ' ' ASN . . . . . 0.481 ' ND2' ' HA ' ' A' ' 25' ' ' PHE . 20.1 m120 -88.26 113.81 56.76 Favored Pre-proline 0 CA--C 1.549 0.917 0 CA-C-N 115.012 -0.995 . . . . 71.45 109.701 177.703 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 4' ' ' PRO . . . . . 0.502 ' HG2' ' HB2' ' A' ' 24' ' ' LEU . 52.8 Cg_endo -75.85 133.87 15.81 Favored 'Trans proline' 0 C--N 1.372 1.779 0 C-N-CA 122.078 1.852 . . . . 73.33 111.509 170.082 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 80.7 m -97.62 124.74 42.03 Favored 'General case' 0 CA--C 1.536 0.437 0 N-CA-C 108.524 -0.917 . . . . 73.14 108.524 172.631 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 7.4 m -100.87 123.47 53.89 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.81 0 N-CA-C 109.143 -0.688 . . . . 75.43 109.143 173.607 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 7' ' ' PHE . . . . . 0.571 ' H ' ' HA ' ' A' ' 163' ' ' GLN . 85.5 t80 -108.08 137.44 46.06 Favored 'General case' 0 C--O 1.241 0.608 0 C-N-CA 124.056 0.942 . . . . 73.0 109.236 -174.351 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 8' ' ' PHE . . . . . 0.505 ' HB3' HG23 ' A' ' 158' ' ' ILE . 62.8 m-85 -138.66 162.59 34.27 Favored 'General case' 0 N--CA 1.469 0.501 0 C-N-CA 123.889 0.875 . . . . 74.2 110.433 175.943 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 16.0 m-20 -110.35 117.88 34.82 Favored 'General case' 0 N--CA 1.467 0.394 0 N-CA-C 107.354 -1.35 . . . . 73.01 107.354 170.26 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 49.6 mm -89.4 124.94 42.38 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.559 0 N-CA-C 109.176 -0.676 . . . . 73.53 109.176 -179.809 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 11' ' ' ALA . . . . . 0.583 ' HB2' ' HB2' ' A' ' 159' ' ' ALA . . . -128.68 126.28 39.79 Favored 'General case' 0 N--CA 1.471 0.581 0 C-N-CA 123.34 0.656 . . . . 71.53 111.062 -173.177 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . 0.44 HG12 ' HB3' ' A' ' 154' ' ' LYS . 96.3 t -95.53 120.36 44.82 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.43 0 N-CA-C 108.077 -1.083 . . . . 74.42 108.077 174.801 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 31.4 m-20 60.37 24.48 13.99 Favored 'General case' 0 N--CA 1.482 1.126 0 C-N-CA 125.499 1.519 . . . . 73.53 111.767 -175.791 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 91.69 -18.61 52.26 Favored Glycine 0 C--N 1.354 1.559 0 CA-C-N 116.587 -0.279 . . . . 70.32 112.903 -175.554 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 15.8 mm-40 -82.15 114.2 49.21 Favored Pre-proline 0 CA--C 1.548 0.887 0 C-N-CA 124.213 1.005 . . . . 73.35 110.123 178.863 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 18.6 Cg_endo -56.18 108.79 0.36 Allowed 'Trans proline' 0 C--N 1.384 2.41 0 C-N-CA 123.262 2.642 . . . . 73.44 112.383 -178.077 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 48.4 tp -76.8 -29.52 56.04 Favored 'General case' 0 N--CA 1.475 0.776 0 CA-C-N 114.828 -1.078 . . . . 65.42 109.522 176.375 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 170.11 -159.65 32.24 Favored Glycine 0 N--CA 1.449 -0.5 0 CA-C-N 115.039 -0.982 . . . . 74.03 111.046 -176.109 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 2.0 ptp180 -149.08 142.93 25.68 Favored 'General case' 0 C--O 1.24 0.595 0 C-N-CA 123.282 0.633 . . . . 75.21 109.898 -177.408 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 50.7 t -132.09 129.07 59.98 Favored 'Isoleucine or valine' 0 C--O 1.24 0.582 0 C-N-CA 123.659 0.784 . . . . 74.54 109.453 -176.908 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 66.7 p -109.6 140.77 43.03 Favored 'General case' 0 C--O 1.252 1.189 0 N-CA-C 108.655 -0.869 . . . . 74.44 108.655 170.453 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 22' ' ' PHE . . . . . 0.44 ' HE1' ' HD2' ' A' ' 8' ' ' PHE . 45.2 m-85 -118.42 134.36 55.12 Favored 'General case' 0 N--CA 1.467 0.394 0 C-N-CA 123.908 0.883 . . . . 71.5 108.978 -178.113 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 7.7 tp10 -87.36 110.59 20.36 Favored 'General case' 0 CA--C 1.535 0.397 0 N-CA-C 109.35 -0.611 . . . . 75.53 109.35 174.026 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . 0.502 ' HB2' ' HG2' ' A' ' 4' ' ' PRO . 33.8 mt -83.92 121.28 27.15 Favored 'General case' 0 N--CA 1.469 0.482 0 N-CA-C 109.132 -0.692 . . . . 72.13 109.132 176.826 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 25' ' ' PHE . . . . . 0.481 ' HA ' ' ND2' ' A' ' 3' ' ' ASN . 65.6 m-85 -84.82 69.69 10.75 Favored 'General case' 0 CA--C 1.54 0.579 0 C-N-CA 123.746 0.818 . . . . 74.05 109.912 179.279 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -70.09 -20.14 63.22 Favored 'General case' 0 N--CA 1.478 0.975 0 CA-C-N 115.076 -0.966 . . . . 75.4 111.52 -179.579 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 11.5 p-10 -72.19 -19.16 61.79 Favored 'General case' 0 CA--C 1.55 0.98 0 C-N-CA 123.71 0.804 . . . . 74.13 111.188 175.579 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 47.0 mttm -108.57 -51.45 2.89 Favored 'General case' 0 N--CA 1.48 1.061 0 C-N-CA 123.46 0.704 . . . . 73.51 110.765 -176.698 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 29' ' ' VAL . . . . . 0.483 HG23 ' HA ' ' A' ' 129' ' ' PHE . 5.5 m -129.82 74.92 80.27 Favored Pre-proline 0 CA--C 1.56 1.334 0 C-N-CA 124.409 1.083 . . . . 73.44 109.741 -175.8 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 58.2 Cg_endo -65.8 -34.37 40.25 Favored 'Trans proline' 0 C--N 1.378 2.094 0 C-N-CA 122.98 2.453 . . . . 72.43 112.726 -168.468 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 31' ' ' LYS . . . . . 0.46 ' HB3' ' HB2' ' A' ' 86' ' ' GLU . 27.4 ttmt -64.55 -58.73 5.57 Favored 'General case' 0 CA--C 1.533 0.311 0 C-N-CA 124.226 1.01 . . . . 72.32 111.253 -177.561 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 3.8 m -72.39 -26.3 61.83 Favored 'General case' 0 CA--C 1.559 1.308 0 O-C-N 123.63 0.581 . . . . 73.43 111.191 -173.674 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 33' ' ' ALA . . . . . 0.471 ' HB1' ' HB3' ' A' ' 24' ' ' LEU . . . -73.47 -58.27 3.42 Favored 'General case' 0 N--CA 1.482 1.143 0 C-N-CA 123.025 0.53 . . . . 71.3 111.888 177.454 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . 0.467 ' HG3' HH21 ' A' ' 37' ' ' ARG . 43.0 tt0 -62.84 -29.49 70.78 Favored 'General case' 0 N--CA 1.488 1.447 0 C-N-CA 123.383 0.673 . . . . 75.31 111.192 -178.597 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 35' ' ' ASN . . . . . 0.452 ' ND2' ' SD ' ' A' ' 100' ' ' MET . 32.1 t30 -50.93 -60.02 3.53 Favored 'General case' 0 N--CA 1.476 0.83 0 C-N-CA 124.061 0.944 . . . . 72.43 110.527 174.506 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 84.1 t80 -66.48 -33.08 74.88 Favored 'General case' 0 CA--C 1.544 0.729 0 O-C-N 124.06 0.85 . . . . 63.43 111.237 -178.573 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 37' ' ' ARG . . . . . 0.467 HH21 ' HG3' ' A' ' 34' ' ' GLU . 17.4 ttp180 -62.48 -40.98 98.41 Favored 'General case' 0 N--CA 1.478 0.943 0 C-N-CA 123.204 0.602 . . . . 72.52 110.737 177.599 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 38' ' ' ALA . . . . . 0.418 ' HB2' HG21 ' A' ' 78' ' ' ILE . . . -80.47 -21.54 41.93 Favored 'General case' 0 N--CA 1.472 0.654 0 CA-C-N 115.386 -0.825 . . . . 65.44 111.321 -178.105 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 39' ' ' LEU . . . . . 0.443 ' HG ' ' O ' ' A' ' 35' ' ' ASN . 95.8 mt -72.15 -44.46 63.06 Favored 'General case' 0 N--CA 1.478 0.952 0 C-N-CA 123.203 0.601 . . . . 72.12 110.379 172.067 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 65.9 p -72.56 -40.2 66.86 Favored 'General case' 0 N--CA 1.475 0.823 0 C-N-CA 123.737 0.815 . . . . 73.3 111.484 -173.937 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 61.2 p -76.81 -31.55 57.01 Favored 'General case' 0 N--CA 1.474 0.726 0 O-C-N 123.343 0.402 . . . . 64.02 110.226 172.614 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 71.59 24.92 76.17 Favored Glycine 0 C--N 1.35 1.338 0 CA-C-N 115.659 -0.701 . . . . 72.21 114.312 175.226 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 20.9 mm-40 -68.24 -17.92 64.43 Favored 'General case' 0 N--CA 1.476 0.863 0 C-N-CA 123.203 0.601 . . . . 64.35 111.582 179.243 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 31.1 mmmt -92.18 13.5 18.87 Favored 'General case' 0 CA--C 1.552 1.024 0 C-N-CA 123.708 0.803 . . . . 72.23 111.384 177.169 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 84.76 37.84 10.04 Favored Glycine 0 C--N 1.353 1.511 0 N-CA-C 113.87 0.308 . . . . 71.44 113.87 171.229 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 23.0 m-85 -125.15 -46.84 1.79 Allowed 'General case' 0 N--CA 1.484 1.245 0 CA-C-N 117.058 0.429 . . . . 74.22 110.89 -174.257 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 53.89 58.5 12.36 Favored Glycine 0 C--N 1.349 1.297 0 O-C-N 124.161 0.913 . . . . 72.04 114.148 174.848 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 52.1 m-85 -63.86 89.84 0.05 Allowed 'General case' 0 N--CA 1.483 1.213 0 CA-C-O 121.851 0.834 . . . . 73.22 111.885 -179.153 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 38.7 tptt -112.96 142.77 45.26 Favored 'General case' 0 CA--C 1.538 0.49 0 CA-C-N 114.058 -1.428 . . . . 74.1 108.37 179.153 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 70.74 22.02 78.04 Favored Glycine 0 C--N 1.345 1.03 0 CA-C-O 119.568 -0.573 . . . . 54.21 113.923 175.438 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 24.3 t -58.87 114.51 2.58 Favored 'General case' 0 CA--C 1.549 0.92 0 C-N-CA 123.53 0.732 . . . . 74.24 111.05 -173.817 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 52' ' ' CYS . . . . . . . . . . . . . 15.5 p -87.25 118.1 26.44 Favored 'General case' 0 CA--C 1.54 0.564 0 C-N-CA 123.905 0.882 . . . . 74.13 111.873 -169.791 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 53' ' ' PHE . . . . . 0.678 ' HA ' ' HA2' ' A' ' 64' ' ' GLY . 88.4 m-85 -69.02 78.77 0.32 Allowed 'General case' 0 CA--C 1.539 0.541 0 C-N-CA 124.454 1.102 . . . . 74.24 109.671 165.405 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 15.2 p-80 -95.45 -8.4 35.52 Favored 'General case' 0 N--CA 1.479 0.999 0 CA-C-N 115.219 -0.9 . . . . 74.12 112.461 -173.652 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 59.0 ttt-85 -130.8 100.1 5.16 Favored 'General case' 0 N--CA 1.476 0.834 0 N-CA-C 109.133 -0.691 . . . . 71.25 109.133 179.364 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 56' ' ' ILE . . . . . 0.509 HD13 ' HB3' ' A' ' 53' ' ' PHE . 65.8 mt -134.39 133.21 55.2 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.117 0 C-N-CA 123.241 0.616 . . . . 72.53 109.97 -177.725 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 57' ' ' ILE . . . . . 0.495 HG21 ' HA ' ' A' ' 148' ' ' ARG . 66.6 mt -121.34 120.63 28.9 Favored Pre-proline 0 CA--C 1.558 1.25 0 C-N-CA 124.7 1.2 . . . . 73.32 109.229 175.871 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 35.6 Cg_endo -64.64 139.23 62.66 Favored 'Trans proline' 0 C--N 1.388 2.638 0 C-N-CA 123.078 2.519 . . . . 71.03 112.362 176.323 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 76.67 21.71 74.06 Favored Glycine 0 C--N 1.346 1.12 0 CA-C-N 115.009 -0.996 . . . . 60.44 113.134 -175.686 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 60' ' ' PHE . . . . . 0.4 ' HD2' ' HB ' ' A' ' 57' ' ' ILE . 19.9 t80 -149.57 -76.91 0.15 Allowed 'General case' 0 N--CA 1.478 0.936 0 CA-C-N 117.318 0.559 . . . . 74.14 111.349 -175.738 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 61' ' ' MET . . . . . 0.573 ' SD ' ' HB2' ' A' ' 113' ' ' PHE . 15.7 tmm? -168.07 142.94 3.59 Favored 'General case' 0 N--CA 1.481 1.077 0 N-CA-C 112.115 0.413 . . . . 72.41 112.115 -163.305 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 62' ' ' CYS . . . . . . . . . . . . . 22.7 p -111.53 113.21 25.47 Favored 'General case' 0 CA--C 1.551 0.985 0 C-N-CA 124.196 0.999 . . . . 63.01 109.908 173.18 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 63' ' ' GLN . . . . . 0.506 ' HA ' ' HA ' ' A' ' 113' ' ' PHE . 17.1 tt0 -108.53 127.05 53.59 Favored 'General case' 0 N--CA 1.487 1.384 0 C-N-CA 124.019 0.927 . . . . 72.33 111.745 -173.699 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 64' ' ' GLY . . . . . 0.678 ' HA2' ' HA ' ' A' ' 53' ' ' PHE . . . -102.35 167.34 17.85 Favored Glycine 0 C--N 1.351 1.385 0 CA-C-N 114.834 -1.076 . . . . 71.2 112.423 175.993 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -178.57 -174.97 45.27 Favored Glycine 0 C--N 1.339 0.701 0 N-CA-C 112.236 -0.346 . . . . 61.14 112.236 -179.432 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 28.2 t70 -126.1 168.04 14.55 Favored 'General case' 0 C--O 1.247 0.931 0 C-N-CA 124.185 0.994 . . . . 72.11 110.337 -170.608 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 51.9 t80 -88.04 -21.45 24.76 Favored 'General case' 0 CA--C 1.548 0.873 0 C-N-CA 123.799 0.84 . . . . 74.51 111.78 -176.959 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 67.5 m -63.48 108.57 1.39 Allowed 'General case' 0 N--CA 1.484 1.233 0 N-CA-C 109.792 -0.447 . . . . 72.2 109.792 179.9 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 70.0 ttt180 56.04 54.95 7.34 Favored 'General case' 0 CA--C 1.555 1.15 0 O-C-N 124.701 1.25 . . . . 74.3 110.473 -178.02 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 44.8 t-80 -57.13 -36.14 70.33 Favored 'General case' 0 N--CA 1.482 1.17 0 CA-C-N 115.462 -0.79 . . . . 71.44 111.988 -175.793 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 37.2 t30 -64.71 114.41 4.42 Favored 'General case' 0 N--CA 1.476 0.855 0 C-N-CA 123.398 0.679 . . . . 73.23 109.856 174.663 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 76.85 -6.77 38.52 Favored Glycine 0 CA--C 1.53 0.986 0 N-CA-C 116.019 1.168 . . . . 72.41 116.019 169.376 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 23.8 m -143.77 -82.36 0.17 Allowed 'General case' 0 CA--C 1.554 1.117 0 CA-C-N 117.922 0.861 . . . . 74.44 109.528 179.192 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 63.08 50.2 65.31 Favored Glycine 0 C--N 1.353 1.477 0 C-N-CA 123.559 0.599 . . . . 65.14 114.054 174.469 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 139.14 49.94 0.06 OUTLIER Glycine 0 C--N 1.345 1.053 0 CA-C-N 117.387 0.594 . . . . 72.41 111.682 -179.049 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 21.3 pttp -67.22 161.0 25.78 Favored 'General case' 0 CA--C 1.553 1.076 0 C-N-CA 123.341 0.656 . . . . 74.24 112.423 -174.122 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 80.6 p -90.11 -179.38 5.66 Favored 'General case' 0 CA--C 1.545 0.77 0 C-N-CA 124.259 1.023 . . . . 74.31 112.297 -171.106 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 78' ' ' ILE . . . . . 0.418 HG21 ' HB2' ' A' ' 38' ' ' ALA . 24.5 pt -73.47 -13.17 15.96 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.082 0 C-N-CA 123.197 0.599 . . . . 73.23 110.677 172.052 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 98.5 m-85 -91.53 7.46 41.25 Favored 'General case' 0 CA--C 1.545 0.782 0 C-N-CA 124.389 1.076 . . . . 73.12 110.626 171.213 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 91.61 -141.33 15.6 Favored Glycine 0 C--N 1.347 1.168 0 CA-C-O 119.532 -0.593 . . . . 75.41 112.422 176.829 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 31.3 tt0 -50.04 -56.81 9.27 Favored 'General case' 0 N--CA 1.481 1.11 0 C-N-CA 125.039 1.335 . . . . 64.51 111.829 -176.852 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 82' ' ' LYS . . . . . 0.512 ' HD2' ' HA ' ' A' ' 107' ' ' THR . 19.0 pttp -161.17 157.54 26.0 Favored 'General case' 0 C--O 1.239 0.514 0 O-C-N 123.873 0.733 . . . . 63.25 110.97 -179.447 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 24.5 p90 -144.42 172.33 13.1 Favored 'General case' 0 C--O 1.24 0.577 0 C-N-CA 124.915 1.286 . . . . 74.53 109.328 -179.514 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 12.0 pt-20 -99.79 150.27 22.51 Favored 'General case' 0 N--CA 1.473 0.676 0 C-N-CA 123.801 0.84 . . . . 74.34 109.675 176.972 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 26.8 m-20 -66.84 149.59 50.37 Favored 'General case' 0 N--CA 1.48 1.049 0 C-N-CA 123.664 0.786 . . . . 75.43 112.7 -176.203 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 86' ' ' GLU . . . . . 0.46 ' HB2' ' HB3' ' A' ' 31' ' ' LYS . 6.9 tp10 -69.13 -56.11 8.67 Favored 'General case' 0 CA--C 1.544 0.742 0 CA-C-N 115.035 -0.984 . . . . 71.13 110.475 178.782 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 16.8 p-10 -168.97 138.08 2.13 Favored 'General case' 0 N--CA 1.471 0.617 0 C-N-CA 123.771 0.828 . . . . 74.43 109.703 -172.953 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 88' ' ' PHE . . . . . 0.464 ' HD1' ' HB ' ' A' ' 127' ' ' VAL . 40.4 m-85 -90.98 68.23 6.15 Favored 'General case' 0 N--CA 1.479 0.995 0 C-N-CA 123.044 0.538 . . . . 73.54 110.902 -176.035 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 40.1 mt -80.24 -61.84 1.6 Allowed 'Isoleucine or valine' 0 N--CA 1.484 1.273 0 CA-C-O 120.933 0.397 . . . . 74.33 110.008 174.359 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 90' ' ' LEU . . . . . 0.443 HD13 ' HB2' ' A' ' 25' ' ' PHE . 96.0 mt -75.05 104.74 5.75 Favored 'General case' 0 CA--C 1.544 0.731 0 CA-C-N 115.49 -0.777 . . . . 70.34 110.878 -173.798 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 91' ' ' LYS . . . . . 0.675 ' HE3' ' HB ' ' A' ' 93' ' ' THR . 0.1 OUTLIER -83.96 158.49 21.52 Favored 'General case' 0 CA--C 1.545 0.786 0 CA-C-N 115.099 -0.955 . . . . 71.32 110.073 173.908 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 92' ' ' HIS . . . . . . . . . . . . . 25.2 m-70 -87.46 65.96 8.85 Favored 'General case' 0 N--CA 1.479 1.016 0 CA-C-O 121.493 0.663 . . . . 75.31 109.696 -177.293 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 93' ' ' THR . . . . . 0.675 ' HB ' ' HE3' ' A' ' 91' ' ' LYS . 15.3 t -105.04 15.21 28.04 Favored 'General case' 0 N--CA 1.483 1.176 0 CA-C-N 115.599 -0.728 . . . . 72.32 111.461 -174.088 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -155.35 174.84 33.44 Favored Glycine 0 C--N 1.345 1.044 0 C-N-CA 121.553 -0.356 . . . . 64.04 113.543 -176.225 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 95' ' ' PRO . . . . . 0.632 ' HB2' ' HE3' ' A' ' 136' ' ' MET . 53.6 Cg_endo -90.19 158.62 4.72 Favored 'Trans proline' 0 CA--C 1.553 1.459 0 C-N-CA 123.753 2.968 . . . . 65.51 111.919 175.656 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 77.23 17.95 78.87 Favored Glycine 0 C--N 1.344 0.999 0 CA-C-N 116.071 -0.513 . . . . 75.44 113.533 -179.117 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 97' ' ' ILE . . . . . 0.669 ' HB ' ' HB2' ' A' ' 115' ' ' CYS . 14.9 mm -66.5 103.09 0.52 Allowed 'Isoleucine or valine' 0 CA--C 1.555 1.169 0 C-N-CA 123.685 0.794 . . . . 62.33 111.009 -176.455 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 54.9 tp -88.71 118.1 28.15 Favored 'General case' 0 C--O 1.247 0.922 0 CA-C-O 121.893 0.854 . . . . 74.43 109.471 175.577 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 23.7 t -152.08 141.67 21.76 Favored 'General case' 0 CA--C 1.547 0.854 0 N-CA-C 107.893 -1.151 . . . . 74.14 107.893 -174.664 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 100' ' ' MET . . . . . 0.514 ' HA ' ' HA ' ' A' ' 112' ' ' PHE . 70.7 mtp -76.71 138.19 39.82 Favored 'General case' 0 N--CA 1.495 1.791 0 CA-C-N 119.622 1.101 . . . . 72.2 110.319 -175.294 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 101' ' ' ALA . . . . . 0.421 ' HB3' ' HB2' ' A' ' 111' ' ' GLN . . . -70.42 156.45 39.32 Favored 'General case' 0 C--O 1.247 0.932 0 CA-C-O 121.315 0.579 . . . . 70.31 111.235 -173.263 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 102' ' ' ASN . . . . . 0.405 ' HB3' ' HA ' ' A' ' 108' ' ' ASN . 25.6 p-10 -161.69 164.05 29.37 Favored 'General case' 0 C--O 1.238 0.454 0 CA-C-N 115.055 -0.975 . . . . 72.33 110.646 -173.328 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 103' ' ' ALA . . . . . 0.476 ' HB3' HG21 ' A' ' 107' ' ' THR . . . -97.21 -14.89 21.14 Favored 'General case' 0 CA--C 1.542 0.654 0 CA-C-N 115.521 -0.763 . . . . 74.43 110.361 169.546 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 166.35 -168.18 39.82 Favored Glycine 0 C--N 1.352 1.426 0 CA-C-O 119.406 -0.663 . . . . 75.54 112.517 178.602 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 46.7 Cg_exo -58.72 139.75 92.06 Favored 'Trans proline' 0 C--N 1.374 1.876 0 C-N-CA 123.155 2.57 . . . . 73.22 112.112 173.553 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 66.0 t30 65.53 11.4 7.4 Favored 'General case' 0 N--CA 1.487 1.4 0 C-N-CA 124.967 1.307 . . . . 63.42 111.877 -177.804 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 107' ' ' THR . . . . . 0.512 ' HA ' ' HD2' ' A' ' 82' ' ' LYS . 5.0 m -124.1 17.12 9.22 Favored 'General case' 0 CA--C 1.552 1.028 0 C-N-CA 124.0 0.92 . . . . 72.32 109.705 178.158 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 108' ' ' ASN . . . . . 0.405 ' HA ' ' HB3' ' A' ' 102' ' ' ASN . 32.8 t30 -80.85 150.89 28.94 Favored 'General case' 0 N--CA 1.477 0.9 0 C-N-CA 124.34 1.056 . . . . 74.23 110.112 176.759 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 106.82 25.52 6.18 Favored Glycine 0 N--CA 1.47 0.912 0 C-N-CA 121.488 -0.387 . . . . 74.3 113.297 176.171 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 12.9 p -131.78 118.19 19.59 Favored 'General case' 0 CA--C 1.537 0.447 0 N-CA-C 108.183 -1.043 . . . . 75.51 108.183 175.107 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 111' ' ' GLN . . . . . 0.461 HE21 ' HG2' ' B' ' 218' ' ' PRO . 48.9 mt-30 61.16 -173.68 0.13 Allowed 'General case' 0 N--CA 1.493 1.683 0 C-N-CA 124.097 0.959 . . . . 75.34 111.895 -172.536 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 112' ' ' PHE . . . . . 0.514 ' HA ' ' HA ' ' A' ' 100' ' ' MET . 42.0 p90 -146.31 159.37 43.44 Favored 'General case' 0 N--CA 1.476 0.856 0 C-N-CA 123.817 0.847 . . . . 75.44 109.153 171.968 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 113' ' ' PHE . . . . . 0.573 ' HB2' ' SD ' ' A' ' 61' ' ' MET . 50.6 p90 -138.1 146.78 43.3 Favored 'General case' 0 C--O 1.238 0.458 0 C-N-CA 123.631 0.772 . . . . 75.51 109.6 -179.47 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 114' ' ' ILE . . . . . 0.414 ' HA ' ' O ' ' A' ' 97' ' ' ILE . 17.2 mt -120.9 101.97 11.51 Favored 'Isoleucine or valine' 0 C--O 1.243 0.721 0 N-CA-C 107.517 -1.29 . . . . 74.31 107.517 176.419 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 115' ' ' CYS . . . . . 0.669 ' HB2' ' HB ' ' A' ' 97' ' ' ILE . 62.8 m -63.31 104.75 0.64 Allowed 'General case' 0 N--CA 1.469 0.511 0 N-CA-C 109.311 -0.626 . . . . 73.24 109.311 177.477 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 116' ' ' THR . . . . . 0.549 HG21 HG13 ' A' ' 139' ' ' VAL . 32.8 p -70.18 -32.8 70.9 Favored 'General case' 0 N--CA 1.472 0.656 0 C-N-CA 123.593 0.757 . . . . 72.0 109.859 -179.343 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -104.86 161.19 14.4 Favored 'General case' 0 C--O 1.241 0.62 0 C-N-CA 124.174 0.989 . . . . 75.32 109.505 172.27 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 9.4 ptmt -72.71 94.02 1.71 Allowed 'General case' 0 CA--C 1.546 0.826 0 CA-C-O 121.87 0.843 . . . . 75.21 109.874 174.828 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 119' ' ' THR . . . . . . . . . . . . . 75.0 p -87.22 83.99 7.31 Favored 'General case' 0 CA--C 1.545 0.771 0 CA-C-N 115.551 -0.75 . . . . 74.15 110.368 -175.354 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 8.3 pt-20 -80.36 -16.91 53.44 Favored 'General case' 0 N--CA 1.483 1.212 0 CA-C-O 121.137 0.494 . . . . 74.41 111.902 -172.426 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 121' ' ' TRP . . . . . . . . . . . . . 43.6 p90 -70.16 -9.86 56.99 Favored 'General case' 0 CA--C 1.546 0.813 0 C-N-CA 122.792 0.437 . . . . 74.24 111.58 173.971 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 122' ' ' LEU . . . . . 0.468 ' HA ' ' HE2' ' A' ' 125' ' ' LYS . 65.5 mt -89.17 4.91 47.0 Favored 'General case' 0 N--CA 1.477 0.882 0 C-N-CA 123.281 0.632 . . . . 74.44 111.936 174.723 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 78.5 m-20 -74.24 152.09 39.78 Favored 'General case' 0 N--CA 1.487 1.407 0 C-N-CA 122.482 0.313 . . . . 71.21 110.295 173.487 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 75.79 14.77 81.82 Favored Glycine 0 C--N 1.353 1.519 0 O-C-N 123.422 0.451 . . . . 43.02 112.802 -173.451 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 125' ' ' LYS . . . . . 0.468 ' HE2' ' HA ' ' A' ' 122' ' ' LEU . 30.0 mtmm -138.72 -162.09 1.27 Allowed 'General case' 0 N--CA 1.472 0.645 0 C-N-CA 125.683 1.593 . . . . 75.34 108.719 -174.95 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 126' ' ' HIS . . . . . . . . . . . . . 2.5 t60 -62.01 135.47 57.55 Favored 'General case' 0 CA--C 1.549 0.927 0 C-N-CA 123.938 0.895 . . . . 70.15 111.598 -165.715 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 127' ' ' VAL . . . . . 0.464 ' HB ' ' HD1' ' A' ' 88' ' ' PHE . 13.9 p -76.95 148.04 7.06 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.807 0 CA-C-N 114.526 -1.216 . . . . 63.33 112.317 -169.013 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 128' ' ' VAL . . . . . 0.441 ' HB ' ' HB3' ' A' ' 90' ' ' LEU . 18.9 t -72.56 156.07 6.96 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.818 0 C-N-CA 124.073 0.949 . . . . 74.34 108.884 171.619 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 129' ' ' PHE . . . . . 0.483 ' HA ' HG23 ' A' ' 29' ' ' VAL . 43.1 p90 -128.7 -23.84 3.08 Favored 'General case' 0 N--CA 1.485 1.324 0 CA-C-N 118.739 0.699 . . . . 73.42 111.661 175.4 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . -145.59 170.63 26.83 Favored Glycine 0 C--N 1.337 0.61 0 N-CA-C 111.454 -0.658 . . . . 73.53 111.454 -178.38 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 32.8 ttpt -150.07 147.27 27.6 Favored 'General case' 0 N--CA 1.472 0.646 0 N-CA-C 109.002 -0.74 . . . . 74.14 109.002 178.365 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 132' ' ' VAL . . . . . 0.482 HG23 HG22 ' A' ' 139' ' ' VAL . 58.1 t -62.43 112.32 0.97 Allowed 'Isoleucine or valine' 0 CA--C 1.538 0.49 0 C-N-CA 123.327 0.651 . . . . 74.24 109.771 174.838 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 21.9 ptmt -91.99 -33.98 14.62 Favored 'General case' 0 N--CA 1.471 0.606 0 N-CA-C 109.264 -0.643 . . . . 71.22 109.264 175.923 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 35.5 mt-10 -141.58 135.61 30.24 Favored 'General case' 0 N--CA 1.479 1.013 0 C-N-CA 124.513 1.125 . . . . 64.32 109.206 -179.072 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 95.63 24.72 15.04 Favored Glycine 0 C--N 1.349 1.301 0 O-C-N 123.381 0.426 . . . . 62.34 113.825 176.03 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 136' ' ' MET . . . . . 0.632 ' HE3' ' HB2' ' A' ' 95' ' ' PRO . 14.5 tpt -65.51 -32.09 73.5 Favored 'General case' 0 N--CA 1.485 1.293 0 CA-C-N 117.289 0.545 . . . . 72.24 111.119 179.787 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 137' ' ' ASN . . . . . . . . . . . . . 4.3 p-10 -61.26 -35.32 76.96 Favored 'General case' 0 CA--C 1.551 0.999 0 C-N-CA 123.941 0.897 . . . . 73.25 111.458 173.515 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 138' ' ' ILE . . . . . . . . . . . . . 50.6 mm -74.58 -32.93 30.81 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.001 0 C-N-CA 123.414 0.686 . . . . 74.41 110.532 177.51 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 139' ' ' VAL . . . . . 0.591 ' HA ' ' HE1' ' A' ' 142' ' ' MET . 87.7 t -66.52 -44.02 90.45 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.947 0 C-N-CA 123.733 0.813 . . . . 75.44 110.889 178.513 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 140' ' ' GLU . . . . . 0.414 ' O ' ' HG3' ' A' ' 144' ' ' ARG . 52.2 mt-10 -77.0 -19.41 57.31 Favored 'General case' 0 N--CA 1.475 0.795 0 CA-C-N 115.618 -0.719 . . . . 72.23 110.805 177.037 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -70.82 -37.55 73.23 Favored 'General case' 0 CA--C 1.543 0.687 0 C-N-CA 122.387 0.275 . . . . 75.31 110.295 169.068 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 142' ' ' MET . . . . . 0.591 ' HE1' ' HA ' ' A' ' 139' ' ' VAL . 70.6 mtm -63.24 -39.35 94.36 Favored 'General case' 0 N--CA 1.485 1.304 0 C-N-CA 123.065 0.546 . . . . 74.44 110.376 174.607 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 25.6 tt0 -55.61 -36.65 67.17 Favored 'General case' 0 CA--C 1.55 0.98 0 CA-C-N 114.539 -1.209 . . . . 72.51 111.784 178.252 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 144' ' ' ARG . . . . . 0.414 ' HG3' ' O ' ' A' ' 140' ' ' GLU . 29.2 mtm180 -73.82 -8.79 57.4 Favored 'General case' 0 N--CA 1.478 0.952 0 C-N-CA 123.837 0.855 . . . . 71.32 112.75 -176.952 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 145' ' ' PHE . . . . . 0.494 ' HB2' HD11 ' A' ' 156' ' ' ILE . 62.8 m-85 -97.63 -4.87 36.65 Favored 'General case' 0 N--CA 1.479 1.001 0 C-N-CA 122.674 0.389 . . . . 75.34 111.007 174.137 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . -92.92 171.36 32.8 Favored Glycine 0 C--N 1.347 1.158 0 CA-C-N 116.361 -0.381 . . . . 73.22 113.192 -179.632 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 147' ' ' SER . . . . . 0.479 ' HB2' ' HB3' ' A' ' 151' ' ' LYS . 18.3 m -133.6 156.99 46.85 Favored 'General case' 0 N--CA 1.475 0.8 0 C-N-CA 124.539 1.135 . . . . 73.11 109.566 -177.426 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 148' ' ' ARG . . . . . 0.495 ' HA ' HG21 ' A' ' 57' ' ' ILE . 18.9 mmt180 -59.12 -37.88 78.28 Favored 'General case' 0 N--CA 1.484 1.24 0 C-N-CA 123.858 0.863 . . . . 74.4 112.592 -172.219 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 149' ' ' ASN . . . . . . . . . . . . . 28.0 p-10 -72.0 -14.68 61.95 Favored 'General case' 0 N--CA 1.486 1.354 0 C-N-CA 123.518 0.727 . . . . 72.11 111.922 179.804 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . 112.89 -3.02 25.8 Favored Glycine 0 C--N 1.347 1.17 0 C-N-CA 123.428 0.537 . . . . 74.32 112.544 -178.644 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 151' ' ' LYS . . . . . 0.479 ' HB3' ' HB2' ' A' ' 147' ' ' SER . 87.9 tttt -67.82 146.47 53.66 Favored 'General case' 0 N--CA 1.478 0.938 0 C-N-CA 123.67 0.788 . . . . 75.3 111.092 -178.94 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 152' ' ' THR . . . . . . . . . . . . . 18.5 p -120.05 114.5 22.08 Favored 'General case' 0 N--CA 1.469 0.476 0 N-CA-C 109.204 -0.665 . . . . 70.42 109.204 173.062 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 153' ' ' SER . . . . . . . . . . . . . 37.8 t -67.34 -24.89 65.77 Favored 'General case' 0 CA--C 1.546 0.822 0 C-N-CA 124.242 1.017 . . . . 74.41 111.109 179.181 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 154' ' ' LYS . . . . . 0.44 ' HB3' HG12 ' A' ' 12' ' ' VAL . 69.7 mmtt -121.69 150.68 41.43 Favored 'General case' 0 N--CA 1.473 0.697 0 C-N-CA 123.951 0.901 . . . . 73.02 111.155 179.925 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 2.2 tppp? -93.37 91.16 7.05 Favored 'General case' 0 N--CA 1.474 0.773 0 CA-C-O 121.366 0.603 . . . . 74.42 110.251 -178.065 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 156' ' ' ILE . . . . . 0.517 ' HB ' ' HB2' ' A' ' 53' ' ' PHE . 48.4 mt -89.6 102.1 12.79 Favored 'Isoleucine or valine' 0 C--O 1.21 -1.009 0 N-CA-C 109.254 -0.647 . . . . 75.34 109.254 -177.05 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 157' ' ' THR . . . . . . . . . . . . . 42.3 p -108.54 145.19 35.17 Favored 'General case' 0 N--CA 1.472 0.652 0 C-N-CA 123.642 0.777 . . . . 75.21 110.151 178.841 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 158' ' ' ILE . . . . . 0.505 HG23 ' HB3' ' A' ' 8' ' ' PHE . 49.4 mt -70.47 95.86 0.47 Allowed 'Isoleucine or valine' 0 CA--C 1.547 0.839 0 N-CA-C 108.672 -0.862 . . . . 72.21 108.672 170.423 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 159' ' ' ALA . . . . . 0.583 ' HB2' ' HB2' ' A' ' 11' ' ' ALA . . . -51.72 -53.94 33.79 Favored 'General case' 0 N--CA 1.477 0.896 0 C-N-CA 124.402 1.081 . . . . 61.5 112.036 -177.599 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 160' ' ' ASP . . . . . . . . . . . . . 5.4 t70 -145.62 169.52 18.26 Favored 'General case' 0 CA--C 1.544 0.72 0 CA-C-N 116.195 -0.457 . . . . 73.12 110.583 -174.743 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 161' ' ' CYS . . . . . . . . . . . . . 12.7 p -135.16 -169.62 2.41 Favored 'General case' 0 N--CA 1.476 0.854 0 C-N-CA 125.048 1.339 . . . . 75.13 108.393 -177.822 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 162' ' ' GLY . . . . . . . . . . . . . . . 131.87 56.74 0.09 OUTLIER Glycine 0 N--CA 1.475 1.247 0 C-N-CA 120.635 -0.793 . . . . 74.24 111.922 -172.965 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 163' ' ' GLN . . . . . 0.571 ' HA ' ' H ' ' A' ' 7' ' ' PHE . 2.1 pt20 -46.93 135.54 9.21 Favored 'General case' 0 CA--C 1.552 1.022 0 C-N-CA 124.099 0.96 . . . . 73.41 113.478 -174.156 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 164' ' ' LEU . . . . . . . . . . . . . 86.6 mt -82.17 99.76 9.44 Favored 'General case' 0 CA--C 1.54 0.589 0 N-CA-C 108.751 -0.833 . . . . 74.02 108.751 178.249 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 165' ' ' GLU . . . . . . . . . . . . . 28.4 tt0 . . . . . 0 CA--C 1.554 1.132 0 N-CA-C 107.56 -1.274 . . . . 64.02 107.56 -175.307 . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' B' B ' 216' ' ' PRO . . . . . . . . . . . . . 25.0 Cg_exo . . . . . 0 N--CA 1.493 1.458 0 N-CA-C 110.465 -0.629 . . . . 73.44 110.465 . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' B' B ' 217' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -163.07 163.3 17.36 Favored Pre-proline 0 CA--C 1.551 0.993 0 C-N-CA 124.469 1.107 . . . . 74.44 108.207 -176.395 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 218' ' ' PRO . . . . . 0.461 ' HG2' HE21 ' A' ' 111' ' ' GLN . 42.1 Cg_endo -67.33 94.18 0.36 Allowed 'Trans proline' 0 C--N 1.367 1.519 0 C-N-CA 121.746 1.63 . . . . 72.4 111.113 170.719 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 219' ' ' GLY . . . . . . . . . . . . . . . -179.86 147.84 7.69 Favored Glycine 0 CA--C 1.536 1.371 0 CA-C-N 115.534 -0.757 . . . . 74.21 111.927 -178.755 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 220' ' ' PRO . . . . . . . . . . . . . 21.5 Cg_exo -68.26 164.52 32.07 Favored 'Trans proline' 0 C--N 1.377 2.036 0 C-N-CA 123.796 2.997 . . . . 73.42 113.565 -178.07 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 221' ' ' TYR . . . . . . . . . . . . . 62.2 m-85 -129.05 157.14 42.55 Favored 'General case' 0 N--CA 1.481 1.123 0 C-N-CA 123.731 0.812 . . . . 70.53 111.157 -176.328 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 222' ' ' ALA . . . . . . . . . . . . . . . -171.96 173.53 4.4 Favored 'General case' 0 C--O 1.242 0.68 0 O-C-N 124.818 1.323 . . . . 72.41 109.672 174.753 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 223' ' ' GLN . . . . . . . . . . . . . 75.1 mt-30 63.62 86.95 0.13 Allowed Pre-proline 0 CA--C 1.551 0.994 0 O-C-N 124.365 1.04 . . . . 73.34 111.29 171.984 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 224' ' ' PRO . . . . . . . . . . . . . 31.4 Cg_exo . . . . . 0 C--N 1.378 2.083 0 C-N-CA 123.513 2.808 . . . . 72.53 113.079 -177.459 . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 76.6 mtp . . . . . 0 N--CA 1.479 1.004 0 N-CA-C 110.189 -0.3 . . . . 74.31 110.189 . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 47.1 t -77.09 88.7 0.91 Allowed 'Isoleucine or valine' 0 N--CA 1.476 0.864 0 N-CA-C 108.293 -1.002 . . . . 74.2 108.293 174.876 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 3' ' ' ASN . . . . . 0.428 ' ND2' ' HA ' ' A' ' 25' ' ' PHE . 21.5 m120 -97.87 103.92 19.35 Favored Pre-proline 0 CA--C 1.543 0.696 0 CA-C-N 115.336 -0.847 . . . . 72.34 109.538 177.587 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 4' ' ' PRO . . . . . 0.476 ' HG2' ' HB2' ' A' ' 24' ' ' LEU . 57.6 Cg_endo -73.66 144.37 35.41 Favored 'Trans proline' 0 C--N 1.374 1.911 0 C-N-CA 122.414 2.076 . . . . 62.53 112.123 175.12 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 5' ' ' THR . . . . . 0.547 HG22 ' HD3' ' A' ' 133' ' ' LYS . 97.9 m -97.1 114.13 25.77 Favored 'General case' 0 C--O 1.223 -0.318 0 N-CA-C 108.325 -0.991 . . . . 73.24 108.325 177.475 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 43.1 t -99.7 119.17 47.38 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.852 0 N-CA-C 108.33 -0.989 . . . . 74.12 108.33 -178.721 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 75.1 t80 -99.58 132.81 44.66 Favored 'General case' 0 C--N 1.323 -0.572 0 N-CA-C 109.235 -0.654 . . . . 74.0 109.235 -173.125 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 8' ' ' PHE . . . . . 0.473 ' HD2' ' HE2' ' A' ' 22' ' ' PHE . 33.1 m-85 -136.57 161.16 36.65 Favored 'General case' 0 C--O 1.238 0.499 0 O-C-N 124.027 0.829 . . . . 74.31 110.975 170.295 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 6.4 m-20 -108.37 114.76 28.86 Favored 'General case' 0 N--CA 1.465 0.277 0 CA-C-N 113.749 -1.569 . . . . 73.35 107.652 168.389 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 10' ' ' ILE . . . . . 0.511 HG22 ' SD ' ' A' ' 142' ' ' MET . 44.5 mm -85.48 118.82 32.96 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.369 0 N-CA-C 108.707 -0.849 . . . . 74.32 108.707 174.502 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 11' ' ' ALA . . . . . 0.557 ' HB2' ' HB3' ' A' ' 159' ' ' ALA . . . -118.11 131.36 56.43 Favored 'General case' 0 N--CA 1.469 0.476 0 C-N-CA 123.37 0.668 . . . . 73.24 111.143 -176.657 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 71.1 t -96.65 112.85 29.6 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.454 0 N-CA-C 107.934 -1.136 . . . . 71.42 107.934 170.765 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 18.5 m-20 62.93 24.25 14.44 Favored 'General case' 0 N--CA 1.481 1.104 0 C-N-CA 125.12 1.368 . . . . 73.42 111.931 179.965 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 99.1 -21.24 46.75 Favored Glycine 0 C--N 1.348 1.227 0 CA-C-N 116.43 -0.35 . . . . 62.32 113.031 -177.805 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 36.7 mm-40 -83.27 114.73 55.02 Favored Pre-proline 0 CA--C 1.543 0.706 0 C-N-CA 123.529 0.731 . . . . 73.14 110.048 179.667 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 34.3 Cg_endo -60.72 109.27 0.64 Allowed 'Trans proline' 0 C--N 1.378 2.098 0 C-N-CA 122.844 2.363 . . . . 71.43 111.863 -177.265 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 66.0 tp -76.31 -35.46 58.81 Favored 'General case' 0 N--CA 1.471 0.621 0 CA-C-N 115.104 -0.953 . . . . 71.34 109.922 179.334 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -175.96 177.96 47.52 Favored Glycine 0 C--N 1.341 0.832 0 CA-C-N 115.57 -0.741 . . . . 73.1 112.882 177.338 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 80.7 mtt180 -115.16 116.91 29.14 Favored 'General case' 0 C--O 1.237 0.406 0 C-N-CA 124.219 1.008 . . . . 73.21 108.86 -179.299 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 67.5 t -114.65 118.33 58.33 Favored 'Isoleucine or valine' 0 C--O 1.238 0.498 0 C-N-CA 123.566 0.746 . . . . 71.4 109.417 -178.182 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 21' ' ' SER . . . . . 0.416 ' OG ' ' HB2' ' A' ' 134' ' ' GLU . 71.3 p -106.47 139.37 41.05 Favored 'General case' 0 C--O 1.246 0.878 0 N-CA-C 108.982 -0.748 . . . . 73.25 108.982 173.634 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 22' ' ' PHE . . . . . 0.473 ' HE2' ' HD2' ' A' ' 8' ' ' PHE . 85.2 m-85 -108.14 168.24 9.43 Favored 'General case' 0 C--N 1.331 -0.236 0 C-N-CA 124.544 1.138 . . . . 75.23 109.516 -179.886 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . 0.461 ' HB2' ' HD2' ' A' ' 133' ' ' LYS . 41.3 tt0 -129.95 106.9 8.96 Favored 'General case' 0 C--O 1.24 0.578 0 N-CA-C 107.979 -1.119 . . . . 74.02 107.979 179.007 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . 0.476 ' HB2' ' HG2' ' A' ' 4' ' ' PRO . 38.7 mt -82.44 124.72 30.31 Favored 'General case' 0 N--CA 1.467 0.414 0 N-CA-C 109.67 -0.493 . . . . 75.42 109.67 -179.456 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 25' ' ' PHE . . . . . 0.428 ' HA ' ' ND2' ' A' ' 3' ' ' ASN . 44.6 m-85 -86.48 66.57 9.57 Favored 'General case' 0 CA--C 1.535 0.403 0 C-N-CA 123.338 0.655 . . . . 74.32 109.236 177.632 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -62.35 -24.89 67.6 Favored 'General case' 0 N--CA 1.477 0.883 0 CA-C-N 115.282 -0.872 . . . . 43.3 111.703 -178.476 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 9.7 p-10 -71.42 -19.53 62.23 Favored 'General case' 0 N--CA 1.477 0.875 0 C-N-CA 124.097 0.959 . . . . 72.43 112.524 -179.905 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 61.2 mttp -110.58 -41.05 4.42 Favored 'General case' 0 N--CA 1.486 1.355 0 C-N-CA 123.729 0.812 . . . . 74.31 110.992 -178.76 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 29' ' ' VAL . . . . . 0.515 HG21 ' HA ' ' A' ' 129' ' ' PHE . 8.4 m -129.48 74.06 81.15 Favored Pre-proline 0 N--CA 1.478 0.966 0 C-N-CA 123.803 0.841 . . . . 72.41 109.947 -179.452 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 25.5 Cg_endo -60.09 -37.32 84.95 Favored 'Trans proline' 0 C--N 1.378 2.097 0 C-N-CA 122.797 2.331 . . . . 73.21 112.896 -175.982 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 36.6 ttmt -66.75 -52.0 49.33 Favored 'General case' 0 N--CA 1.482 1.136 0 C-N-CA 123.534 0.734 . . . . 75.02 112.043 -176.637 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 18.3 m -77.43 -31.25 53.83 Favored 'General case' 0 CA--C 1.55 0.978 0 CA-C-N 115.277 -0.874 . . . . 64.4 111.136 -170.617 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 33' ' ' ALA . . . . . 0.438 ' HB1' ' HB3' ' A' ' 24' ' ' LEU . . . -71.93 -47.18 54.31 Favored 'General case' 0 N--CA 1.473 0.718 0 C-N-CA 122.828 0.451 . . . . 75.13 110.057 174.327 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 11.4 tp10 -59.98 -35.63 75.41 Favored 'General case' 0 N--CA 1.485 1.308 0 C-N-CA 123.477 0.711 . . . . 73.52 111.141 178.684 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 35' ' ' ASN . . . . . 0.551 ' ND2' ' SD ' ' A' ' 100' ' ' MET . 32.7 t30 -56.12 -64.42 0.87 Allowed 'General case' 0 CA--C 1.539 0.523 0 CA-C-N 114.981 -1.009 . . . . 73.21 110.812 178.075 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 74.5 t80 -61.94 -35.38 78.25 Favored 'General case' 0 N--CA 1.474 0.74 0 C-N-CA 123.774 0.83 . . . . 72.54 111.41 -177.043 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 37' ' ' ARG . . . . . 0.425 ' HG3' HE22 ' A' ' 163' ' ' GLN . 20.7 ttt180 -58.82 -50.29 74.51 Favored 'General case' 0 N--CA 1.472 0.674 0 C-N-CA 124.046 0.938 . . . . 74.24 110.937 175.901 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 38' ' ' ALA . . . . . 0.539 ' HB1' HG21 ' A' ' 78' ' ' ILE . . . -75.69 -22.26 56.82 Favored 'General case' 0 CA--C 1.54 0.582 0 CA-C-N 115.587 -0.733 . . . . 72.12 111.727 -176.29 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 39' ' ' LEU . . . . . 0.482 HD23 ' CE1' ' A' ' 48' ' ' TYR . 96.6 mt -72.41 -42.27 65.3 Favored 'General case' 0 N--CA 1.479 1.008 0 C-N-CA 123.127 0.571 . . . . 73.42 109.86 172.214 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 48.0 t -68.63 -55.88 10.07 Favored 'General case' 0 N--CA 1.476 0.834 0 C-N-CA 124.238 1.015 . . . . 75.01 110.959 -176.139 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 71.3 p -73.41 -30.07 63.0 Favored 'General case' 0 CA--C 1.541 0.634 0 C-N-CA 123.659 0.783 . . . . 74.41 110.819 179.452 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 87.02 32.71 13.62 Favored Glycine 0 C--N 1.352 1.453 0 CA-C-O 119.909 -0.384 . . . . 63.52 113.021 176.129 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 50.9 mm-40 -54.89 -42.37 72.03 Favored 'General case' 0 N--CA 1.48 1.062 0 C-N-CA 123.551 0.741 . . . . 65.41 110.991 177.034 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 44' ' ' LYS . . . . . 0.562 ' HG3' ' HB ' ' A' ' 78' ' ' ILE . 29.6 mmmt -93.51 18.19 10.31 Favored 'General case' 0 CA--C 1.547 0.828 0 CA-C-N 115.044 -0.98 . . . . 74.23 111.683 -173.332 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 73.05 36.3 56.99 Favored Glycine 0 C--N 1.354 1.557 0 CA-C-N 116.301 -0.409 . . . . 63.41 114.068 171.722 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 46' ' ' PHE . . . . . 0.461 ' HE2' ' HA ' ' A' ' 78' ' ' ILE . 22.0 m-85 -120.25 -47.63 2.35 Favored 'General case' 0 N--CA 1.483 1.183 0 C-N-CA 122.811 0.444 . . . . 73.01 110.788 -177.391 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 53.27 62.12 6.3 Favored Glycine 0 C--N 1.356 1.644 0 O-C-N 123.92 0.763 . . . . 64.24 114.896 170.653 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 48' ' ' TYR . . . . . 0.482 ' CE1' HD23 ' A' ' 39' ' ' LEU . 66.8 m-85 -64.73 91.23 0.08 Allowed 'General case' 0 N--CA 1.48 1.042 0 CA-C-O 121.936 0.874 . . . . 73.14 111.67 -176.721 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 49' ' ' LYS . . . . . 0.549 ' HE2' ' HA ' ' A' ' 160' ' ' ASP . 28.0 tptp -109.7 130.88 55.47 Favored 'General case' 0 C--O 1.239 0.529 0 CA-C-N 113.913 -1.494 . . . . 73.04 108.726 178.985 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 80.83 21.24 63.92 Favored Glycine 0 C--N 1.348 1.248 0 CA-C-O 119.645 -0.531 . . . . 74.21 113.235 179.715 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 23.0 m -56.28 115.07 2.26 Favored 'General case' 0 C--N 1.355 0.806 0 C-N-CA 123.799 0.84 . . . . 73.3 110.885 -179.004 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 52' ' ' CYS . . . . . 0.685 ' SG ' ' HB3' ' A' ' 66' ' ' ASP . 6.3 p -96.76 130.11 44.06 Favored 'General case' 0 CA--C 1.548 0.888 0 C-N-CA 123.918 0.887 . . . . 73.41 112.261 -168.823 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 53' ' ' PHE . . . . . 0.713 ' HA ' ' HA2' ' A' ' 64' ' ' GLY . 11.8 m-85 -79.82 108.95 13.79 Favored 'General case' 0 CA--C 1.538 0.481 0 C-N-CA 125.155 1.382 . . . . 74.44 109.569 175.173 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 54' ' ' HIS . . . . . 0.545 ' HD1' ' HB2' ' A' ' 66' ' ' ASP . 53.1 p-80 -100.52 -30.58 11.72 Favored 'General case' 0 N--CA 1.487 1.416 0 C-N-CA 122.769 0.428 . . . . 62.15 111.018 178.964 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 27.9 ttt180 -112.38 99.98 8.43 Favored 'General case' 0 C--O 1.221 -0.445 0 N-CA-C 109.048 -0.723 . . . . 73.41 109.048 -173.278 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 56' ' ' ILE . . . . . 0.486 HG23 ' HA ' ' A' ' 143' ' ' GLU . 52.5 mt -134.63 134.68 54.12 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.801 0 N-CA-C 108.929 -0.767 . . . . 72.04 108.929 176.169 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 57' ' ' ILE . . . . . 0.626 HG22 ' HA ' ' A' ' 148' ' ' ARG . 58.1 mt -131.0 121.56 18.88 Favored Pre-proline 0 CA--C 1.554 1.12 0 C-N-CA 124.501 1.12 . . . . 75.23 108.037 179.357 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 58' ' ' PRO . . . . . 0.508 ' HA ' ' HG2' ' A' ' 143' ' ' GLU . 74.4 Cg_endo -70.89 139.58 36.63 Favored 'Trans proline' 0 C--N 1.378 2.084 0 C-N-CA 123.033 2.489 . . . . 61.4 112.577 -172.846 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 74.32 26.83 67.18 Favored Glycine 0 C--N 1.343 0.937 0 CA-C-N 115.552 -0.749 . . . . 74.43 112.569 -176.048 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 60' ' ' PHE . . . . . 0.4 ' HD2' ' HB ' ' A' ' 57' ' ' ILE . 28.3 t80 -148.47 -73.24 0.19 Allowed 'General case' 0 C--O 1.243 0.732 0 C-N-CA 123.659 0.784 . . . . 75.01 109.767 -175.188 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 61' ' ' MET . . . . . 0.628 ' HE2' ' HB3' ' A' ' 115' ' ' CYS . 44.7 ttm -171.69 140.46 1.33 Allowed 'General case' 0 C--N 1.353 0.722 0 CA-C-N 116.285 -0.416 . . . . 63.34 112.058 -163.215 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 62' ' ' CYS . . . . . 0.543 ' SG ' ' HB ' ' A' ' 114' ' ' ILE . 16.6 p -109.14 113.51 26.43 Favored 'General case' 0 CA--C 1.549 0.926 0 C-N-CA 124.031 0.932 . . . . 70.23 108.966 169.346 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 63' ' ' GLN . . . . . 0.472 ' HA ' ' HA ' ' A' ' 113' ' ' PHE . 50.7 tt0 -113.91 118.54 34.46 Favored 'General case' 0 N--CA 1.48 1.032 0 C-N-CA 123.574 0.75 . . . . 75.44 110.31 -170.875 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 64' ' ' GLY . . . . . 0.713 ' HA2' ' HA ' ' A' ' 53' ' ' PHE . . . -115.81 164.94 12.16 Favored Glycine 0 C--N 1.353 1.505 0 CA-C-N 115.736 -0.666 . . . . 71.2 113.622 -173.784 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 101.59 93.56 2.2 Favored Glycine 0 C--N 1.343 0.92 0 N-CA-C 110.096 -1.202 . . . . 63.54 110.096 -173.992 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 66' ' ' ASP . . . . . 0.685 ' HB3' ' SG ' ' A' ' 52' ' ' CYS . 38.9 t70 -122.6 -73.38 0.65 Allowed 'General case' 0 N--CA 1.476 0.838 0 C-N-CA 122.899 0.479 . . . . 61.31 110.588 -179.641 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 76.0 t80 -40.72 -49.84 3.09 Favored 'General case' 0 N--CA 1.483 1.206 0 C-N-CA 125.779 1.631 . . . . 74.43 114.048 -161.917 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 15.7 m -71.46 105.62 3.64 Favored 'General case' 0 CA--C 1.545 0.755 0 O-C-N 123.571 0.544 . . . . 74.14 110.551 -176.274 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 31.2 ttm180 51.82 47.66 24.33 Favored 'General case' 0 CA--C 1.553 1.095 0 C-N-CA 125.179 1.391 . . . . 74.02 111.379 -178.234 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 27.4 p80 -55.73 -28.15 54.3 Favored 'General case' 0 N--CA 1.492 1.654 0 C-N-CA 123.345 0.658 . . . . 72.41 111.773 179.302 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 6.3 t30 -80.98 103.53 10.87 Favored 'General case' 0 CA--C 1.544 0.72 0 C-N-CA 123.755 0.822 . . . . 74.25 109.217 170.008 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 97.22 -8.19 64.65 Favored Glycine 0 C--N 1.341 0.823 0 CA-C-O 119.132 -0.815 . . . . 43.43 115.09 168.597 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 73' ' ' THR . . . . . 0.484 HG23 ' HB3' ' A' ' 76' ' ' LYS . 25.6 m -149.51 -74.91 0.17 Allowed 'General case' 0 N--CA 1.484 1.271 0 CA-C-N 118.495 1.147 . . . . 75.41 110.491 178.894 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 81.75 60.19 2.23 Favored Glycine 0 C--N 1.35 1.334 0 CA-C-O 119.958 -0.356 . . . . 23.44 112.964 177.926 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 111.06 51.27 0.6 Allowed Glycine 0 N--CA 1.479 1.524 0 CA-C-N 117.329 0.564 . . . . 74.2 112.952 178.714 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 76' ' ' LYS . . . . . 0.484 ' HB3' HG23 ' A' ' 73' ' ' THR . 20.2 pttp -56.54 161.5 2.66 Favored 'General case' 0 N--CA 1.491 1.579 0 C-N-CA 124.55 1.14 . . . . 74.44 113.38 -178.997 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 46.1 p -101.59 179.7 4.27 Favored 'General case' 0 N--CA 1.484 1.247 0 C-N-CA 124.181 0.992 . . . . 70.25 112.698 -167.395 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 78' ' ' ILE . . . . . 0.562 ' HB ' ' HG3' ' A' ' 44' ' ' LYS . 29.1 pt -69.9 -16.82 20.63 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.907 0 C-N-CA 122.819 0.448 . . . . 73.42 111.441 177.553 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 86.0 m-85 -95.04 27.04 3.35 Favored 'General case' 0 CA--C 1.545 0.754 0 C-N-CA 124.112 0.965 . . . . 74.41 110.244 176.748 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 92.11 -128.62 9.46 Favored Glycine 0 C--N 1.351 1.381 0 N-CA-C 111.497 -0.641 . . . . 74.43 111.497 178.026 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 39.5 tt0 -66.05 -49.42 67.72 Favored 'General case' 0 N--CA 1.472 0.664 0 C-N-CA 123.548 0.739 . . . . 72.3 110.531 179.168 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 82' ' ' LYS . . . . . 0.712 ' HD2' ' HA ' ' A' ' 107' ' ' THR . 21.8 pttm -167.71 155.95 9.14 Favored 'General case' 0 CA--C 1.55 0.969 0 CA-C-N 115.501 -0.772 . . . . 72.04 111.054 -171.668 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 15.0 p90 -131.04 174.32 10.13 Favored 'General case' 0 N--CA 1.481 1.089 0 C-N-CA 125.176 1.39 . . . . 71.23 110.594 176.236 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 84' ' ' GLU . . . . . 0.418 ' HA ' ' HA ' ' A' ' 106' ' ' ASN . 9.8 pt-20 -84.37 157.26 21.51 Favored 'General case' 0 N--CA 1.483 1.22 0 C-N-CA 123.497 0.719 . . . . 73.13 111.278 177.203 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 40.6 m-20 -64.22 134.34 54.58 Favored 'General case' 0 N--CA 1.489 1.479 0 C-N-CA 124.047 0.939 . . . . 61.24 110.837 -176.278 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 6.2 tp10 -60.05 -58.88 6.62 Favored 'General case' 0 N--CA 1.486 1.358 0 C-N-CA 123.236 0.614 . . . . 74.52 111.091 -178.627 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 31.9 p30 -163.22 -157.18 0.41 Allowed 'General case' 0 N--CA 1.467 0.41 0 N-CA-C 107.521 -1.288 . . . . 64.44 107.521 -179.211 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 89.7 m-85 -142.43 34.1 1.47 Allowed 'General case' 0 N--CA 1.485 1.293 0 C-N-CA 123.311 0.644 . . . . 75.43 110.52 177.005 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 65.4 mt -61.94 -61.04 1.79 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.649 0 CA-C-O 121.506 0.669 . . . . 74.15 110.266 178.39 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 90' ' ' LEU . . . . . 0.454 ' HB3' ' HB ' ' A' ' 128' ' ' VAL . 59.3 mt -78.8 102.36 8.11 Favored 'General case' 0 C--O 1.242 0.665 0 CA-C-N 114.88 -1.054 . . . . 74.22 110.075 -177.305 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 91' ' ' LYS . . . . . 0.703 ' HE3' ' HB ' ' A' ' 93' ' ' THR . 0.1 OUTLIER -84.63 163.64 19.15 Favored 'General case' 0 C--O 1.24 0.586 0 CA-C-N 115.493 -0.776 . . . . 74.05 110.334 174.747 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 92' ' ' HIS . . . . . . . . . . . . . 19.0 m-70 -91.19 56.1 3.04 Favored 'General case' 0 N--CA 1.476 0.858 0 CA-C-O 122.033 0.921 . . . . 74.4 109.371 -176.699 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 93' ' ' THR . . . . . 0.703 ' HB ' ' HE3' ' A' ' 91' ' ' LYS . 12.6 t -91.33 -7.15 51.79 Favored 'General case' 0 N--CA 1.47 0.572 0 CA-C-N 114.61 -1.177 . . . . 72.02 111.385 -176.383 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -124.94 167.78 17.21 Favored Glycine 0 C--N 1.34 0.785 0 O-C-N 123.062 0.226 . . . . 71.3 113.241 -175.206 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 95' ' ' PRO . . . . . 0.436 ' HB3' ' O ' ' A' ' 116' ' ' THR . 1.1 Cg_endo -84.67 157.07 12.08 Favored 'Trans proline' 0 C--N 1.363 1.316 0 C-N-CA 123.519 2.812 . . . . 60.4 111.636 168.553 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 78.28 16.94 78.86 Favored Glycine 0 C--N 1.346 1.104 0 CA-C-N 116.203 -0.453 . . . . 74.51 113.206 179.948 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 97' ' ' ILE . . . . . 0.806 ' HB ' ' SG ' ' A' ' 115' ' ' CYS . 15.6 mm -73.14 109.42 5.33 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.921 0 C-N-CA 123.797 0.839 . . . . 73.11 111.201 -176.399 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 63.8 tp -94.21 111.86 23.62 Favored 'General case' 0 CA--C 1.552 1.037 0 C-N-CA 123.773 0.829 . . . . 75.25 109.95 174.35 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 99' ' ' SER . . . . . 0.471 ' HB2' ' HA ' ' A' ' 128' ' ' VAL . 29.8 t -137.14 147.89 46.27 Favored 'General case' 0 N--CA 1.474 0.766 0 C-N-CA 124.371 1.068 . . . . 73.32 108.743 177.059 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 100' ' ' MET . . . . . 0.556 ' HA ' ' HA ' ' A' ' 112' ' ' PHE . 67.5 mtp -77.47 146.39 36.49 Favored 'General case' 0 N--CA 1.483 1.216 0 CA-C-O 120.671 0.272 . . . . 63.51 110.657 179.918 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 101' ' ' ALA . . . . . 0.508 ' HB2' ' HB3' ' A' ' 111' ' ' GLN . . . -76.89 162.5 27.56 Favored 'General case' 0 C--O 1.245 0.844 0 CA-C-N 115.818 -0.628 . . . . 65.4 111.254 -176.469 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 102' ' ' ASN . . . . . 0.507 ' HB3' ' HA ' ' A' ' 108' ' ' ASN . 30.5 p-10 -168.47 171.1 9.26 Favored 'General case' 0 C--O 1.238 0.472 0 CA-C-N 114.823 -1.081 . . . . 54.15 109.522 179.503 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 103' ' ' ALA . . . . . 0.402 ' HB3' HG23 ' A' ' 107' ' ' THR . . . -119.59 13.41 12.52 Favored 'General case' 0 CA--C 1.543 0.695 0 CA-C-N 115.263 -0.88 . . . . 75.53 109.94 172.617 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 146.95 -166.86 28.36 Favored Glycine 0 C--N 1.352 1.438 0 CA-C-O 119.595 -0.559 . . . . 71.14 112.521 179.981 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 14.6 Cg_exo -67.34 140.79 54.15 Favored 'Trans proline' 0 C--N 1.372 1.808 0 C-N-CA 123.172 2.581 . . . . 73.52 111.433 178.957 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 106' ' ' ASN . . . . . 0.418 ' HA ' ' HA ' ' A' ' 84' ' ' GLU . 66.7 t30 66.4 9.72 6.69 Favored 'General case' 0 N--CA 1.491 1.606 0 C-N-CA 124.822 1.249 . . . . 73.31 111.979 -178.89 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 107' ' ' THR . . . . . 0.712 ' HA ' ' HD2' ' A' ' 82' ' ' LYS . 3.9 m -109.6 -6.47 15.35 Favored 'General case' 0 CA--C 1.552 1.049 0 C-N-CA 124.266 1.026 . . . . 73.2 109.669 177.025 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 108' ' ' ASN . . . . . 0.507 ' HA ' ' HB3' ' A' ' 102' ' ' ASN . 24.3 t30 -60.92 151.53 30.0 Favored 'General case' 0 N--CA 1.48 1.066 0 C-N-CA 125.046 1.339 . . . . 64.41 110.657 173.564 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 93.95 18.59 36.69 Favored Glycine 0 N--CA 1.465 0.628 0 C-N-CA 121.695 -0.288 . . . . 73.51 112.962 178.881 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 15.2 p -117.36 120.55 38.53 Favored 'General case' 0 C--N 1.328 -0.335 0 N-CA-C 106.938 -1.504 . . . . 73.33 106.938 167.093 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 111' ' ' GLN . . . . . 0.508 ' HB3' ' HB2' ' A' ' 101' ' ' ALA . 5.8 tt0 69.08 171.73 0.3 Allowed 'General case' 0 CA--C 1.557 1.23 0 C-N-CA 123.43 0.692 . . . . 73.31 111.341 171.609 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 112' ' ' PHE . . . . . 0.556 ' HA ' ' HA ' ' A' ' 100' ' ' MET . 52.5 p90 -143.8 155.0 43.99 Favored 'General case' 0 N--CA 1.48 1.026 0 O-C-N 121.748 -0.595 . . . . 74.22 109.695 176.364 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 113' ' ' PHE . . . . . 0.48 ' HB2' ' SD ' ' A' ' 61' ' ' MET . 40.5 p90 -140.57 151.3 44.6 Favored 'General case' 0 N--CA 1.47 0.536 0 C-N-CA 123.329 0.652 . . . . 73.21 111.277 -179.356 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 114' ' ' ILE . . . . . 0.543 ' HB ' ' SG ' ' A' ' 62' ' ' CYS . 19.3 mt -124.55 104.88 14.41 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.613 0 N-CA-C 108.067 -1.086 . . . . 75.54 108.067 177.029 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 115' ' ' CYS . . . . . 0.806 ' SG ' ' HB ' ' A' ' 97' ' ' ILE . 27.8 p -85.69 114.53 22.74 Favored 'General case' 0 C--O 1.241 0.643 0 CA-C-N 118.284 0.493 . . . . 73.02 109.728 178.968 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 116' ' ' THR . . . . . 0.436 ' O ' ' HB3' ' A' ' 95' ' ' PRO . 70.6 p -73.21 -20.88 60.77 Favored 'General case' 0 CA--C 1.54 0.579 0 C-N-CA 123.796 0.838 . . . . 72.24 110.603 176.863 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -101.94 155.89 17.88 Favored 'General case' 0 C--O 1.241 0.627 0 CA-C-N 115.383 -0.826 . . . . 74.14 109.76 171.893 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 19.2 ptmt -75.19 83.61 2.37 Favored 'General case' 0 CA--C 1.542 0.668 0 CA-C-O 121.765 0.793 . . . . 74.41 109.434 173.938 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 119' ' ' THR . . . . . 0.551 ' HB ' HD11 ' A' ' 122' ' ' LEU . 44.5 p -76.45 86.14 3.19 Favored 'General case' 0 CA--C 1.545 0.785 0 CA-C-O 121.948 0.88 . . . . 74.41 110.004 -175.984 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 11.1 pt-20 -78.51 -16.93 56.95 Favored 'General case' 0 N--CA 1.476 0.86 0 CA-C-N 114.825 -1.079 . . . . 74.53 112.127 -171.377 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 121' ' ' TRP . . . . . . . . . . . . . 35.7 p90 -74.18 -0.57 17.17 Favored 'General case' 0 CA--C 1.55 0.965 0 C-N-CA 123.027 0.531 . . . . 75.32 111.068 173.385 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 122' ' ' LEU . . . . . 0.551 HD11 ' HB ' ' A' ' 119' ' ' THR . 9.6 mp -97.42 -1.02 45.22 Favored 'General case' 0 N--CA 1.483 1.214 0 C-N-CA 124.275 1.03 . . . . 64.14 111.799 172.946 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 56.5 m-20 -71.06 129.51 39.14 Favored 'General case' 0 N--CA 1.477 0.898 0 N-CA-C 108.293 -1.003 . . . . 75.43 108.293 173.616 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 95.95 -25.08 26.98 Favored Glycine 0 N--CA 1.471 0.977 0 N-CA-C 111.573 -0.611 . . . . 70.3 111.573 -172.012 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 125' ' ' LYS . . . . . 0.578 ' HE2' ' HB3' ' B' ' 220' ' ' PRO . 16.3 ttpp -83.28 -168.46 2.1 Favored 'General case' 0 CA--C 1.555 1.144 0 N-CA-C 107.382 -1.34 . . . . 74.13 107.382 166.578 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 126' ' ' HIS . . . . . 0.508 ' H ' ' HG2' ' A' ' 125' ' ' LYS . 16.6 t-80 -65.0 131.65 47.15 Favored 'General case' 0 CA--C 1.548 0.887 0 CA-C-N 118.713 0.688 . . . . 74.11 112.082 -166.653 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 11.4 p -58.43 147.95 6.61 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.743 0 C-N-CA 125.906 1.682 . . . . 74.24 112.047 179.33 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 128' ' ' VAL . . . . . 0.471 ' HA ' ' HB2' ' A' ' 99' ' ' SER . 17.3 t -67.67 155.65 7.38 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.819 0 C-N-CA 123.927 0.891 . . . . 74.13 109.638 175.335 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 129' ' ' PHE . . . . . 0.515 ' HA ' HG21 ' A' ' 29' ' ' VAL . 50.5 p90 -133.5 -25.07 1.74 Allowed 'General case' 0 N--CA 1.477 0.908 0 O-C-N 122.269 -0.269 . . . . 73.15 111.363 173.843 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . -136.99 161.82 25.19 Favored Glycine 0 C--N 1.341 0.833 0 N-CA-C 111.588 -0.605 . . . . 70.44 111.588 -177.562 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 35.8 ttpt -144.29 138.61 28.05 Favored 'General case' 0 N--CA 1.468 0.461 0 N-CA-C 108.852 -0.795 . . . . 70.32 108.852 177.217 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 132' ' ' VAL . . . . . 0.4 HG11 ' HA ' ' A' ' 136' ' ' MET . 47.3 t -64.03 103.44 0.38 Allowed 'Isoleucine or valine' 0 C--O 1.24 0.562 0 N-CA-C 108.83 -0.804 . . . . 71.53 108.83 174.751 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 133' ' ' LYS . . . . . 0.547 ' HD3' HG22 ' A' ' 5' ' ' THR . 21.5 ptmt -85.67 -31.91 22.25 Favored 'General case' 0 CA--C 1.537 0.476 0 N-CA-C 109.371 -0.603 . . . . 73.12 109.371 179.941 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 134' ' ' GLU . . . . . 0.416 ' HB2' ' OG ' ' A' ' 21' ' ' SER . 17.0 mt-10 -143.87 149.05 36.35 Favored 'General case' 0 N--CA 1.479 1.023 0 C-N-CA 124.818 1.247 . . . . 75.13 109.222 179.02 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 84.31 22.55 54.06 Favored Glycine 0 C--N 1.345 1.048 0 O-C-N 123.379 0.424 . . . . 54.43 113.164 -179.716 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 136' ' ' MET . . . . . 0.4 ' HA ' HG11 ' A' ' 132' ' ' VAL . 16.5 tpt -62.76 -40.17 96.45 Favored 'General case' 0 N--CA 1.477 0.923 0 C-N-CA 123.239 0.616 . . . . 70.1 111.38 -179.913 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 137' ' ' ASN . . . . . . . . . . . . . 12.4 m120 -64.75 -26.61 68.43 Favored 'General case' 0 N--CA 1.478 0.973 0 C-N-CA 123.146 0.578 . . . . 72.25 111.271 179.255 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 138' ' ' ILE . . . . . . . . . . . . . 48.1 mm -76.48 -37.75 30.8 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.843 0 C-N-CA 123.444 0.698 . . . . 75.03 110.153 177.192 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 139' ' ' VAL . . . . . 0.47 HG12 ' SG ' ' A' ' 62' ' ' CYS . 95.4 t -62.26 -43.61 98.19 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.96 0 C-N-CA 123.471 0.708 . . . . 73.31 110.258 175.43 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 39.0 mt-10 -65.5 -42.37 92.17 Favored 'General case' 0 CA--C 1.544 0.734 0 CA-C-N 114.949 -1.023 . . . . 73.3 110.851 176.889 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -67.85 -39.21 83.82 Favored 'General case' 0 N--CA 1.48 1.034 0 C-N-CA 123.603 0.761 . . . . 72.23 111.884 -178.189 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 142' ' ' MET . . . . . 0.547 ' HB2' HD13 ' A' ' 156' ' ' ILE . 19.5 ptt? -75.95 -29.28 58.24 Favored 'General case' 0 N--CA 1.478 0.952 0 C-N-CA 122.644 0.378 . . . . 73.05 110.504 -178.912 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 143' ' ' GLU . . . . . 0.508 ' HG2' ' HA ' ' A' ' 58' ' ' PRO . 28.1 tt0 -65.61 -28.01 68.82 Favored 'General case' 0 CA--C 1.545 0.77 0 CA-C-N 115.711 -0.677 . . . . 74.03 111.68 178.677 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 144' ' ' ARG . . . . . . . . . . . . . 75.9 mtt180 -66.87 -13.22 61.4 Favored 'General case' 0 N--CA 1.479 0.992 0 C-N-CA 123.555 0.742 . . . . 73.41 111.921 177.699 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 145' ' ' PHE . . . . . . . . . . . . . 38.3 m-85 -88.68 -8.58 54.33 Favored 'General case' 0 N--CA 1.475 0.807 0 C-N-CA 123.379 0.672 . . . . 74.11 111.641 175.944 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . -87.3 171.53 42.23 Favored Glycine 0 C--N 1.346 1.095 0 CA-C-O 120.007 -0.33 . . . . 52.31 112.547 175.166 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 9.0 m -133.03 160.15 37.98 Favored 'General case' 0 N--CA 1.479 1.01 0 C-N-CA 123.565 0.746 . . . . 74.1 110.31 -175.525 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 148' ' ' ARG . . . . . 0.626 ' HA ' HG22 ' A' ' 57' ' ' ILE . 14.3 mmm180 -61.29 -31.64 71.47 Favored 'General case' 0 N--CA 1.483 1.22 0 C-N-CA 124.5 1.12 . . . . 74.43 113.407 -176.382 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 149' ' ' ASN . . . . . . . . . . . . . 31.2 p-10 -75.74 -13.1 60.3 Favored 'General case' 0 N--CA 1.483 1.2 0 C-N-CA 123.222 0.609 . . . . 63.33 111.467 178.573 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . 111.64 -17.15 25.85 Favored Glycine 0 C--N 1.348 1.208 0 CA-C-O 119.821 -0.433 . . . . 72.54 112.664 179.066 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 87.3 tttt -69.09 137.1 53.21 Favored 'General case' 0 CA--C 1.546 0.812 0 C-N-CA 122.853 0.461 . . . . 65.21 111.303 -175.214 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 152' ' ' THR . . . . . . . . . . . . . 6.8 p -92.18 121.44 33.72 Favored 'General case' 0 C--O 1.241 0.63 0 C-N-CA 123.826 0.85 . . . . 75.51 109.124 170.41 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 153' ' ' SER . . . . . . . . . . . . . 29.9 t -67.32 -36.21 81.01 Favored 'General case' 0 N--CA 1.472 0.665 0 C-N-CA 123.499 0.72 . . . . 65.41 109.995 174.042 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 69.5 mmtt -110.39 149.42 30.28 Favored 'General case' 0 N--CA 1.471 0.622 0 C-N-CA 124.256 1.023 . . . . 75.24 110.767 -178.28 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 16.2 tppt? -89.27 91.67 8.86 Favored 'General case' 0 C--N 1.345 0.376 0 N-CA-C 108.873 -0.788 . . . . 72.11 108.873 178.386 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 156' ' ' ILE . . . . . 0.547 HD13 ' HB2' ' A' ' 142' ' ' MET . 69.1 mt -91.75 126.05 44.39 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.416 0 N-CA-C 108.833 -0.802 . . . . 75.41 108.833 -179.054 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 157' ' ' THR . . . . . 0.445 HG23 ' HB3' ' A' ' 52' ' ' CYS . 21.1 p -134.11 157.47 46.09 Favored 'General case' 0 N--CA 1.477 0.915 0 C-N-CA 124.115 0.966 . . . . 60.3 109.708 -175.371 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 158' ' ' ILE . . . . . . . . . . . . . 46.4 mt -80.21 93.68 2.0 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.819 0 N-CA-C 109.261 -0.644 . . . . 72.31 109.261 170.601 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 159' ' ' ALA . . . . . 0.557 ' HB3' ' HB2' ' A' ' 11' ' ' ALA . . . -61.35 -34.16 74.84 Favored 'General case' 0 N--CA 1.472 0.626 0 C-N-CA 124.614 1.166 . . . . 73.11 113.404 -176.703 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 160' ' ' ASP . . . . . 0.549 ' HA ' ' HE2' ' A' ' 49' ' ' LYS . 26.3 t0 -159.98 162.76 34.4 Favored 'General case' 0 N--CA 1.475 0.814 0 C-N-CA 122.588 0.355 . . . . 73.1 110.375 -179.469 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 161' ' ' CYS . . . . . . . . . . . . . 28.0 p -127.74 -166.55 1.63 Allowed 'General case' 0 N--CA 1.474 0.731 0 C-N-CA 125.362 1.465 . . . . 73.44 108.812 -177.977 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 162' ' ' GLY . . . . . . . . . . . . . . . 134.17 54.51 0.07 OUTLIER Glycine 0 C--N 1.351 1.403 0 C-N-CA 121.406 -0.426 . . . . 75.3 112.885 -177.196 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 163' ' ' GLN . . . . . 0.425 HE22 ' HG3' ' A' ' 37' ' ' ARG . 8.1 tt0 -46.4 106.6 0.08 Allowed 'General case' 0 N--CA 1.483 1.18 0 C-N-CA 124.547 1.139 . . . . 75.42 111.629 178.515 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 164' ' ' LEU . . . . . . . . . . . . . 86.4 mt -73.39 113.09 10.08 Favored 'General case' 0 CA--C 1.542 0.671 0 CA-C-N 114.64 -1.164 . . . . 72.53 110.886 -177.402 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 165' ' ' GLU . . . . . . . . . . . . . 36.4 tt0 . . . . . 0 C--O 1.251 1.184 0 N-CA-C 108.448 -0.945 . . . . 74.51 108.448 172.512 . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' B' B ' 216' ' ' PRO . . . . . . . . . . . . . 5.3 Cg_exo . . . . . 0 N--CA 1.482 0.821 0 N-CA-C 110.247 -0.713 . . . . 74.52 110.247 . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' B' B ' 217' ' ' GLU . . . . . . . . . . . . . 80.7 tt0 -63.48 133.79 95.63 Favored Pre-proline 0 CA--C 1.552 1.021 0 C-N-CA 124.328 1.051 . . . . 74.23 110.679 -179.529 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 218' ' ' PRO . . . . . . . . . . . . . 68.1 Cg_exo -52.96 95.15 0.04 OUTLIER 'Trans proline' 0 C--N 1.388 2.647 0 C-N-CA 122.848 2.365 . . . . 73.55 111.9 175.172 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 219' ' ' GLY . . . . . . . . . . . . . . . 153.43 172.13 21.32 Favored Glycine 0 CA--C 1.529 0.928 0 CA-C-N 114.962 -1.017 . . . . 63.34 112.021 -174.213 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 220' ' ' PRO . . . . . 0.578 ' HB3' ' HE2' ' A' ' 125' ' ' LYS . 51.9 Cg_endo -86.48 165.49 9.32 Favored 'Trans proline' 0 C--N 1.364 1.355 0 C-N-CA 123.214 2.609 . . . . 74.45 114.22 179.689 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 221' ' ' TYR . . . . . 0.515 ' HH ' ' HA ' ' B' ' 224' ' ' PRO . 54.9 t80 -78.99 141.25 37.66 Favored 'General case' 0 N--CA 1.475 0.79 0 C-N-CA 123.002 0.521 . . . . 75.52 110.609 175.193 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 222' ' ' ALA . . . . . . . . . . . . . . . -85.01 -164.61 1.01 Allowed 'General case' 0 N--CA 1.475 0.806 0 C-N-CA 124.293 1.037 . . . . 64.3 111.893 -179.155 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 223' ' ' GLN . . . . . . . . . . . . . 14.3 mp0 -59.1 147.59 74.06 Favored Pre-proline 0 CA--C 1.557 1.219 0 C-N-CA 123.414 0.686 . . . . 71.3 109.555 172.968 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 224' ' ' PRO . . . . . 0.515 ' HA ' ' HH ' ' B' ' 221' ' ' TYR . 18.7 Cg_endo . . . . . 0 C--N 1.376 2.01 0 C-N-CA 122.781 2.321 . . . . 73.31 112.288 177.597 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 34.5 mmt . . . . . 0 N--CA 1.482 1.17 0 N-CA-C 109.371 -0.603 . . . . 75.33 109.371 . . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 11.8 p -92.95 -2.95 10.78 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.49 0 CA-C-O 121.774 0.797 . . . . 71.2 110.801 175.08 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 5.6 m120 -83.44 118.13 70.64 Favored Pre-proline 0 CA--C 1.55 0.96 0 C-N-CA 123.794 0.838 . . . . 71.55 110.043 -168.245 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 31.5 Cg_endo -61.62 121.73 10.0 Favored 'Trans proline' 0 C--N 1.378 2.098 0 C-N-CA 122.957 2.438 . . . . 62.31 111.591 179.847 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 93.1 m -98.14 132.11 43.94 Favored 'General case' 0 CA--C 1.536 0.435 0 C-N-CA 122.756 0.422 . . . . 71.42 110.097 -177.972 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . 0.513 ' HA ' ' HB2' ' A' ' 163' ' ' GLN . 12.6 m -101.16 129.49 52.08 Favored 'Isoleucine or valine' 0 C--N 1.35 0.593 0 C-N-CA 123.53 0.732 . . . . 72.24 110.008 175.591 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 7' ' ' PHE . . . . . 0.612 ' HB2' ' HG ' ' A' ' 164' ' ' LEU . 37.7 t80 -119.61 134.23 55.31 Favored 'General case' 0 C--O 1.238 0.464 0 C-N-CA 123.886 0.875 . . . . 72.23 109.7 -170.684 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 8' ' ' PHE . . . . . 0.443 ' HB3' HG22 ' A' ' 158' ' ' ILE . 64.6 m-85 -139.89 161.37 37.75 Favored 'General case' 0 N--CA 1.47 0.536 0 O-C-N 123.801 0.688 . . . . 71.35 111.467 -174.705 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 7.6 m-20 -102.36 108.05 19.27 Favored 'General case' 0 N--CA 1.47 0.536 0 CA-C-N 114.005 -1.452 . . . . 65.45 107.58 166.017 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 10' ' ' ILE . . . . . 0.46 HG21 ' SD ' ' A' ' 142' ' ' MET . 49.2 mm -82.1 120.3 33.33 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.476 0 N-CA-C 108.852 -0.795 . . . . 73.21 108.852 175.323 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 11' ' ' ALA . . . . . 0.542 ' HB3' ' HB3' ' A' ' 159' ' ' ALA . . . -117.29 121.92 42.49 Favored 'General case' 0 N--CA 1.463 0.218 0 C-N-CA 123.529 0.732 . . . . 74.21 110.915 -173.638 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . 0.461 HG21 HD21 ' A' ' 17' ' ' LEU . 76.6 t -98.06 118.08 43.98 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.651 0 N-CA-C 108.334 -0.988 . . . . 75.21 108.334 173.454 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 35.8 m-20 61.9 31.2 18.25 Favored 'General case' 0 N--CA 1.486 1.364 0 C-N-CA 125.566 1.546 . . . . 72.25 111.249 -174.707 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 87.32 -15.78 52.24 Favored Glycine 0 C--N 1.352 1.428 0 CA-C-N 115.488 -0.778 . . . . 70.43 113.191 -177.499 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 21.8 mm-40 -90.81 115.72 64.86 Favored Pre-proline 0 N--CA 1.474 0.766 0 CA-C-O 118.606 -0.711 . . . . 73.15 110.514 -177.165 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 14.0 Cg_endo -53.52 104.88 0.11 Allowed 'Trans proline' 0 C--N 1.387 2.564 0 C-N-CA 123.228 2.619 . . . . 72.43 111.909 178.493 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . 0.461 HD21 HG21 ' A' ' 12' ' ' VAL . 21.3 tp -77.12 -24.93 51.65 Favored 'General case' 0 CA--C 1.541 0.632 0 CA-C-N 114.696 -1.138 . . . . 71.1 109.777 179.3 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 170.03 -178.62 42.78 Favored Glycine 0 C--N 1.342 0.894 0 CA-C-N 115.354 -0.839 . . . . 72.22 112.337 176.373 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 94.3 mtt180 -116.44 142.27 47.08 Favored 'General case' 0 N--CA 1.473 0.687 0 C-N-CA 123.771 0.828 . . . . 73.23 110.228 -178.49 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 45.0 t -131.35 141.11 46.76 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.69 0 C-N-CA 123.179 0.592 . . . . 73.22 110.247 -178.474 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 40.6 p -120.92 116.77 25.77 Favored 'General case' 0 CA--C 1.548 0.901 0 C-N-CA 124.596 1.158 . . . . 72.11 109.109 177.1 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 63.1 m-85 -103.36 113.47 26.99 Favored 'General case' 0 N--CA 1.472 0.647 0 C-N-CA 123.927 0.891 . . . . 71.45 109.377 177.158 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . 0.535 ' HB2' ' HD2' ' A' ' 133' ' ' LYS . 42.4 tt0 -74.88 103.56 5.16 Favored 'General case' 0 CA--C 1.553 1.083 0 C-N-CA 123.827 0.851 . . . . 72.51 109.934 175.759 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 21.0 mt -83.94 120.07 25.66 Favored 'General case' 0 N--CA 1.477 0.904 0 N-CA-C 109.352 -0.61 . . . . 73.14 109.352 178.454 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 25' ' ' PHE . . . . . 0.554 ' HB2' HD13 ' A' ' 90' ' ' LEU . 57.8 m-85 -84.46 70.44 10.68 Favored 'General case' 0 CA--C 1.544 0.716 0 C-N-CA 123.19 0.596 . . . . 74.4 110.117 177.809 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -60.97 -30.45 70.27 Favored 'General case' 0 N--CA 1.482 1.13 0 C-N-CA 123.247 0.619 . . . . 73.32 111.789 179.901 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 10.8 p-10 -62.03 -26.59 68.34 Favored 'General case' 0 CA--C 1.548 0.866 0 C-N-CA 124.169 0.988 . . . . 75.23 112.223 178.902 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 41.0 mttm -98.05 -49.69 4.66 Favored 'General case' 0 N--CA 1.479 0.991 0 C-N-CA 123.557 0.743 . . . . 65.13 110.476 -178.629 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 29' ' ' VAL . . . . . 0.553 HG22 ' HA ' ' A' ' 129' ' ' PHE . 26.7 m -120.05 83.67 31.52 Favored Pre-proline 0 CA--C 1.567 1.605 0 C-N-CA 123.844 0.858 . . . . 63.52 110.119 -174.285 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 32.7 Cg_endo -61.43 -49.84 6.79 Favored 'Trans proline' 0 C--N 1.382 2.33 0 C-N-CA 122.81 2.34 . . . . 74.34 112.337 -172.045 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 23.8 ttmm -60.5 -53.51 56.65 Favored 'General case' 0 N--CA 1.47 0.563 0 C-N-CA 124.049 0.94 . . . . 71.23 111.805 -175.247 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 7.3 m -75.85 -37.41 58.99 Favored 'General case' 0 CA--C 1.553 1.076 0 CA-C-N 115.339 -0.846 . . . . 75.15 111.912 -168.508 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -76.4 -43.37 40.76 Favored 'General case' 0 N--CA 1.479 0.998 0 C-N-CA 122.367 0.267 . . . . 63.41 111.327 -179.103 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 9.0 tp10 -62.75 -39.27 93.63 Favored 'General case' 0 N--CA 1.482 1.144 0 O-C-N 123.445 0.465 . . . . 73.32 110.878 178.134 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 35' ' ' ASN . . . . . 0.477 ' O ' ' HG ' ' A' ' 39' ' ' LEU . 35.6 t30 -50.2 -62.6 1.48 Allowed 'General case' 0 C--N 1.356 0.889 0 O-C-N 124.333 1.02 . . . . 74.13 110.885 176.865 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 36' ' ' PHE . . . . . 0.45 ' HE2' HG21 ' A' ' 6' ' ' VAL . 84.2 t80 -64.26 -34.03 77.19 Favored 'General case' 0 N--CA 1.471 0.613 0 O-C-N 124.172 0.92 . . . . 74.13 111.843 -175.544 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 41.9 ttp180 -64.71 -40.53 95.52 Favored 'General case' 0 CA--C 1.541 0.618 0 O-C-N 123.429 0.456 . . . . 70.51 110.682 178.969 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -75.88 -25.87 56.52 Favored 'General case' 0 N--CA 1.476 0.843 0 CA-C-N 115.881 -0.6 . . . . 74.02 111.432 179.226 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 39' ' ' LEU . . . . . 0.477 ' HG ' ' O ' ' A' ' 35' ' ' ASN . 85.5 mt -68.99 -40.1 78.96 Favored 'General case' 0 N--CA 1.48 1.037 0 C-N-CA 123.605 0.762 . . . . 73.04 109.868 172.544 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 37.1 t -68.38 -56.67 7.7 Favored 'General case' 0 N--CA 1.475 0.814 0 C-N-CA 124.584 1.154 . . . . 73.31 111.359 -177.151 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 18.1 p -71.87 -30.01 64.97 Favored 'General case' 0 N--CA 1.473 0.697 0 CA-C-N 115.625 -0.716 . . . . 75.4 111.587 -179.26 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 83.26 26.58 43.32 Favored Glycine 0 C--N 1.347 1.169 0 CA-C-N 116.093 -0.503 . . . . 74.34 112.805 -179.436 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 40.7 mm-40 -67.0 -21.01 65.97 Favored 'General case' 0 N--CA 1.476 0.874 0 C-N-CA 122.979 0.512 . . . . 75.12 111.873 177.887 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 3.3 mmpm? -100.61 18.31 19.55 Favored 'General case' 0 CA--C 1.548 0.866 0 C-N-CA 124.052 0.941 . . . . 74.11 111.159 175.443 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 87.43 -25.06 8.54 Favored Glycine 0 C--N 1.349 1.299 0 CA-C-O 119.437 -0.646 . . . . 73.1 114.304 175.034 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 17.4 m-85 -69.2 -48.78 61.11 Favored 'General case' 0 N--CA 1.478 0.928 0 CA-C-N 117.237 0.519 . . . . 72.14 111.655 -167.145 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 53.29 64.74 3.92 Favored Glycine 0 C--N 1.353 1.505 0 O-C-N 123.942 0.776 . . . . 75.12 114.212 170.692 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 48' ' ' TYR . . . . . 0.451 ' HB3' ' HB2' ' A' ' 51' ' ' SER . 59.3 m-85 -60.95 86.95 0.02 OUTLIER 'General case' 0 CA--C 1.551 1.006 0 CA-C-O 121.69 0.757 . . . . 73.45 111.044 178.209 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 27.7 tptp -112.68 125.28 54.13 Favored 'General case' 0 C--O 1.238 0.455 0 N-CA-C 107.306 -1.368 . . . . 74.11 107.306 177.086 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 73.92 21.62 78.99 Favored Glycine 0 CA--C 1.53 0.989 0 O-C-N 123.364 0.415 . . . . 73.44 112.097 -172.117 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 51' ' ' SER . . . . . 0.64 ' HA ' ' HB2' ' A' ' 67' ' ' PHE . 31.8 t -61.81 112.05 2.13 Favored 'General case' 0 C--N 1.358 0.944 0 C-N-CA 123.65 0.78 . . . . 73.12 111.042 -173.486 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 52' ' ' CYS . . . . . 0.596 ' SG ' ' HB3' ' A' ' 66' ' ' ASP . 5.1 p -82.06 161.76 22.8 Favored 'General case' 0 CA--C 1.537 0.446 0 CA-C-O 121.769 0.795 . . . . 64.45 111.914 -172.864 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 30.2 m-85 -113.72 133.36 55.39 Favored 'General case' 0 C--O 1.235 0.337 0 CA-C-N 114.613 -1.176 . . . . 75.13 108.136 177.164 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 54' ' ' HIS . . . . . 0.501 ' HD1' ' HB2' ' A' ' 66' ' ' ASP . 55.6 p-80 -115.9 -19.98 10.18 Favored 'General case' 0 N--CA 1.485 1.319 0 C-N-CA 122.871 0.468 . . . . 63.32 110.883 -179.351 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 55' ' ' ARG . . . . . 0.478 ' HA ' ' O ' ' A' ' 150' ' ' GLY . 27.9 ttt-85 -130.22 97.02 4.31 Favored 'General case' 0 C--O 1.215 -0.728 0 C-N-CA 123.116 0.566 . . . . 74.35 109.553 -172.158 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 33.2 mt -136.05 129.46 47.37 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.716 0 C-N-CA 123.488 0.715 . . . . 75.02 109.138 178.816 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 57' ' ' ILE . . . . . 0.436 HG23 ' HA ' ' A' ' 148' ' ' ARG . 56.8 mt -128.83 118.04 19.6 Favored Pre-proline 0 CA--C 1.552 1.02 0 C-N-CA 124.591 1.157 . . . . 75.22 109.153 -178.168 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 58' ' ' PRO . . . . . 0.694 ' HB3' ' HA ' ' A' ' 144' ' ' ARG . 38.7 Cg_endo -63.96 140.27 71.92 Favored 'Trans proline' 0 C--N 1.377 2.058 0 C-N-CA 123.563 2.842 . . . . 74.53 113.325 -175.966 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 73.4 20.45 79.88 Favored Glycine 0 C--N 1.346 1.115 0 CA-C-N 115.094 -0.957 . . . . 72.45 113.057 178.839 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 60' ' ' PHE . . . . . 0.417 ' CD2' ' HB3' ' A' ' 61' ' ' MET . 47.2 t80 -145.24 -73.68 0.24 Allowed 'General case' 0 C--O 1.244 0.782 0 C-N-CA 123.662 0.785 . . . . 73.21 109.717 -174.366 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 61' ' ' MET . . . . . 0.692 ' SD ' ' HB2' ' A' ' 63' ' ' GLN . 12.3 tmm? -169.15 137.03 1.9 Allowed 'General case' 0 N--CA 1.479 1.001 0 O-C-N 123.272 0.358 . . . . 74.33 111.686 -164.883 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 62' ' ' CYS . . . . . 0.463 ' SG ' ' HB ' ' A' ' 114' ' ' ILE . 3.9 p -112.89 121.32 44.32 Favored 'General case' 0 N--CA 1.484 1.228 0 C-N-CA 124.673 1.189 . . . . 74.12 110.585 174.334 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 63' ' ' GLN . . . . . 0.692 ' HB2' ' SD ' ' A' ' 61' ' ' MET . 53.7 tt0 -126.95 137.6 53.15 Favored 'General case' 0 N--CA 1.49 1.562 0 C-N-CA 124.163 0.985 . . . . 74.51 111.489 -168.596 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -154.86 -157.81 8.4 Favored Glycine 0 C--N 1.348 1.217 0 CA-C-N 115.975 -0.557 . . . . 51.01 113.311 -178.314 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 108.46 14.04 17.27 Favored Glycine 0 N--CA 1.476 1.344 0 N-CA-C 111.477 -0.649 . . . . 53.3 111.477 -169.789 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 66' ' ' ASP . . . . . 0.596 ' HB3' ' SG ' ' A' ' 52' ' ' CYS . 28.2 t70 -72.09 1.19 7.83 Favored 'General case' 0 CA--C 1.558 1.283 0 C-N-CA 125.242 1.417 . . . . 55.01 112.876 -167.409 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 67' ' ' PHE . . . . . 0.64 ' HB2' ' HA ' ' A' ' 51' ' ' SER . 56.6 t80 -73.36 -70.96 0.34 Allowed 'General case' 0 CA--C 1.549 0.932 0 C-N-CA 124.022 0.929 . . . . 73.31 111.41 -176.509 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 68' ' ' THR . . . . . 0.493 HG23 ' HD3' ' A' ' 76' ' ' LYS . 4.3 m -86.9 108.5 18.81 Favored 'General case' 0 N--CA 1.475 0.8 0 C-N-CA 122.949 0.5 . . . . 72.42 110.115 -171.999 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 34.8 ttt85 52.99 93.64 0.02 OUTLIER 'General case' 0 N--CA 1.481 1.116 0 C-N-CA 125.501 1.52 . . . . 72.53 111.618 -179.278 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 0.4 OUTLIER -110.69 11.73 22.67 Favored 'General case' 0 N--CA 1.481 1.088 0 N-CA-C 112.866 0.691 . . . . 73.33 112.866 -177.122 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 18.7 m120 -86.21 88.14 7.55 Favored 'General case' 0 N--CA 1.477 0.896 0 N-CA-C 108.928 -0.767 . . . . 72.44 108.928 171.467 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 69.96 29.39 70.82 Favored Glycine 0 C--N 1.35 1.334 0 CA-C-N 115.478 -0.783 . . . . 74.12 113.751 176.549 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 47.9 m -143.7 -64.55 0.38 Allowed 'General case' 0 CA--C 1.547 0.832 0 C-N-CA 124.015 0.926 . . . . 72.31 108.698 178.188 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 56.14 41.11 85.29 Favored Glycine 0 C--N 1.356 1.688 0 N-CA-C 115.234 0.853 . . . . 73.51 115.234 172.063 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 141.18 51.1 0.05 OUTLIER Glycine 0 C--N 1.346 1.12 0 CA-C-N 117.241 0.521 . . . . 71.32 111.872 -175.219 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 76' ' ' LYS . . . . . 0.6 ' HZ1' ' HB2' ' A' ' 76' ' ' LYS . 0.0 OUTLIER -58.87 147.81 32.44 Favored 'General case' 0 N--CA 1.475 0.82 0 C-N-CA 123.329 0.652 . . . . 75.15 112.151 -179.129 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 85.8 p -98.52 -178.37 3.98 Favored 'General case' 0 C--O 1.238 0.454 0 CA-C-N 115.325 -0.852 . . . . 72.44 111.953 -170.874 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 26.8 pt -75.58 -12.89 14.9 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.85 0 CA-C-N 114.999 -1.0 . . . . 75.45 111.003 175.426 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 99.2 m-85 -97.78 22.08 9.63 Favored 'General case' 0 N--CA 1.479 1.018 0 C-N-CA 124.133 0.973 . . . . 70.42 110.069 175.714 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 96.52 -111.71 4.29 Favored Glycine 0 C--N 1.346 1.128 0 N-CA-C 110.895 -0.882 . . . . 71.14 110.895 -177.694 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 41.5 tt0 -78.37 -59.63 2.7 Favored 'General case' 0 N--CA 1.472 0.628 0 C-N-CA 122.978 0.511 . . . . 73.34 110.378 -179.975 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 82' ' ' LYS . . . . . 0.759 ' HD2' ' HA ' ' A' ' 107' ' ' THR . 21.3 pttp -161.47 178.5 9.07 Favored 'General case' 0 N--CA 1.477 0.902 0 C-N-CA 123.88 0.872 . . . . 74.41 109.839 -171.055 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 35.7 p90 -152.07 174.36 13.78 Favored 'General case' 0 N--CA 1.474 0.765 0 C-N-CA 124.43 1.092 . . . . 74.43 111.459 -175.81 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 84' ' ' GLU . . . . . 0.498 ' HA ' ' HA ' ' A' ' 106' ' ' ASN . 13.7 pt-20 -82.92 160.28 22.13 Favored 'General case' 0 N--CA 1.474 0.734 0 CA-C-N 115.249 -0.887 . . . . 74.2 110.795 176.263 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 49.7 m-20 -63.04 133.98 55.39 Favored 'General case' 0 N--CA 1.47 0.56 0 C-N-CA 123.741 0.816 . . . . 72.23 110.832 179.232 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 9.9 tp10 -76.18 -61.79 1.82 Allowed 'General case' 0 CA--C 1.543 0.676 0 CA-C-N 116.074 -0.512 . . . . 73.41 109.846 179.261 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 87' ' ' ASN . . . . . 0.421 ' OD1' HG13 ' A' ' 29' ' ' VAL . 27.6 p-10 -169.36 155.39 6.27 Favored 'General case' 0 N--CA 1.477 0.899 0 C-N-CA 123.49 0.716 . . . . 62.44 110.265 -173.303 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 76.5 m-85 -109.11 33.26 4.37 Favored 'General case' 0 N--CA 1.479 1.0 0 C-N-CA 123.826 0.85 . . . . 75.54 111.442 -169.648 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 55.9 mt -60.25 -46.98 94.03 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.164 0 C-N-CA 123.311 0.644 . . . . 74.04 109.561 174.283 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 90' ' ' LEU . . . . . 0.554 HD13 ' HB2' ' A' ' 25' ' ' PHE . 95.9 mt -95.87 128.39 42.71 Favored 'General case' 0 CA--C 1.537 0.476 0 CA-C-N 115.047 -0.978 . . . . 73.13 109.803 179.067 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 17.8 ptpt -133.74 171.94 13.45 Favored 'General case' 0 N--CA 1.472 0.646 0 C-N-CA 124.305 1.042 . . . . 75.24 110.133 -179.444 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 92' ' ' HIS . . . . . . . . . . . . . 23.8 m-70 -85.49 50.28 1.93 Allowed 'General case' 0 N--CA 1.477 0.895 0 C-N-CA 124.277 1.031 . . . . 64.35 110.107 -175.909 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 8.8 t -89.28 4.92 47.19 Favored 'General case' 0 CA--C 1.549 0.929 0 C-N-CA 124.006 0.923 . . . . 62.25 111.576 -176.773 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -148.72 172.9 28.82 Favored Glycine 0 C--N 1.345 1.073 0 N-CA-C 111.93 -0.468 . . . . 64.2 111.93 178.779 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 89.9 Cg_endo -84.08 156.88 13.2 Favored 'Trans proline' 0 CA--C 1.551 1.367 0 C-N-CA 123.026 2.484 . . . . 74.11 111.921 172.363 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 78.61 19.95 72.48 Favored Glycine 0 N--CA 1.471 1.03 0 CA-C-N 116.418 -0.355 . . . . 73.14 113.86 -179.438 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 97' ' ' ILE . . . . . . . . . . . . . 22.1 mm -78.91 109.77 13.95 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.777 0 C-N-CA 123.954 0.902 . . . . 73.33 111.41 -175.483 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 98' ' ' LEU . . . . . 0.483 HD12 HG12 ' A' ' 114' ' ' ILE . 65.6 tp -90.09 118.46 29.65 Favored 'General case' 0 CA--C 1.551 1.004 0 C-N-CA 123.299 0.64 . . . . 72.4 109.661 176.35 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 99' ' ' SER . . . . . 0.464 ' HB2' HG21 ' A' ' 128' ' ' VAL . 33.5 t -137.39 155.85 48.89 Favored 'General case' 0 N--CA 1.476 0.875 0 C-N-CA 124.979 1.312 . . . . 75.35 108.911 -177.495 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 100' ' ' MET . . . . . 0.407 ' HA ' ' HA ' ' A' ' 112' ' ' PHE . 41.2 mtp -90.41 147.31 23.52 Favored 'General case' 0 N--CA 1.486 1.348 0 N-CA-C 110.069 -0.345 . . . . 72.34 110.069 178.123 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 101' ' ' ALA . . . . . 0.482 ' HB2' ' HA2' ' B' ' 219' ' ' GLY . . . -84.46 162.52 19.9 Favored 'General case' 0 N--CA 1.475 0.8 0 C-N-CA 123.443 0.697 . . . . 73.34 112.622 -169.873 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 26.1 p-10 -165.1 168.05 17.65 Favored 'General case' 0 C--N 1.352 0.714 0 CA-C-N 115.142 -0.936 . . . . 73.45 110.358 178.757 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -113.72 9.02 17.67 Favored 'General case' 0 CA--C 1.543 0.701 0 C-N-CA 123.606 0.762 . . . . 75.2 109.75 168.174 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 154.08 -173.73 32.64 Favored Glycine 0 C--N 1.354 1.548 0 CA-C-O 119.706 -0.497 . . . . 52.24 112.552 -178.887 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 48.9 Cg_exo -58.59 143.75 98.04 Favored 'Trans proline' 0 C--N 1.373 1.842 0 C-N-CA 123.43 2.753 . . . . 75.51 112.898 176.876 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 106' ' ' ASN . . . . . 0.498 ' HA ' ' HA ' ' A' ' 84' ' ' GLU . 61.6 t30 63.96 14.65 8.58 Favored 'General case' 0 N--CA 1.485 1.284 0 C-N-CA 125.267 1.427 . . . . 72.33 111.837 -178.034 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 107' ' ' THR . . . . . 0.759 ' HA ' ' HD2' ' A' ' 82' ' ' LYS . 2.8 m -115.55 -0.48 13.03 Favored 'General case' 0 CA--C 1.551 0.995 0 C-N-CA 123.766 0.827 . . . . 74.31 109.93 179.263 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 54.7 t30 -78.09 155.01 30.81 Favored 'General case' 0 N--CA 1.479 0.983 0 C-N-CA 123.363 0.665 . . . . 73.32 110.246 -178.016 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 96.37 -10.26 67.2 Favored Glycine 0 N--CA 1.468 0.801 0 CA-C-O 120.076 -0.291 . . . . 44.01 113.11 177.533 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 16.2 p -91.19 123.13 34.4 Favored 'General case' 0 CA--C 1.538 0.513 0 N-CA-C 107.539 -1.282 . . . . 71.01 107.539 167.322 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 111' ' ' GLN . . . . . 0.445 ' HB2' ' HB3' ' A' ' 101' ' ' ALA . 3.0 mt-30 69.76 165.23 0.27 Allowed 'General case' 0 N--CA 1.493 1.703 0 C-N-CA 125.852 1.661 . . . . 73.52 111.19 -178.594 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 112' ' ' PHE . . . . . 0.407 ' HA ' ' HA ' ' A' ' 100' ' ' MET . 54.3 p90 -139.43 155.6 47.5 Favored 'General case' 0 N--CA 1.482 1.134 0 N-CA-C 108.985 -0.746 . . . . 74.11 108.985 175.793 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 113' ' ' PHE . . . . . 0.55 ' HB2' ' SD ' ' A' ' 61' ' ' MET . 53.7 p90 -152.61 152.83 32.27 Favored 'General case' 0 N--CA 1.471 0.605 0 C-N-CA 122.963 0.505 . . . . 75.14 111.65 -176.337 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 114' ' ' ILE . . . . . 0.483 HG12 HD12 ' A' ' 98' ' ' LEU . 6.4 mt -119.93 108.05 22.46 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.761 0 N-CA-C 108.121 -1.066 . . . . 63.21 108.121 -176.724 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 115' ' ' CYS . . . . . . . . . . . . . 60.1 m -80.62 105.83 12.17 Favored 'General case' 0 N--CA 1.47 0.53 0 C-N-CA 123.129 0.572 . . . . 74.54 109.769 176.656 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 116' ' ' THR . . . . . 0.412 ' HA ' ' HE1' ' A' ' 136' ' ' MET . 40.5 p -71.85 -24.98 61.78 Favored 'General case' 0 N--CA 1.482 1.152 0 C-N-CA 122.612 0.365 . . . . 74.34 110.596 173.971 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -98.48 147.07 25.12 Favored 'General case' 0 C--O 1.239 0.545 0 CA-C-N 115.828 -0.624 . . . . 64.33 109.756 171.717 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 9.0 ptmm? -70.16 84.19 0.54 Allowed 'General case' 0 N--CA 1.477 0.899 0 CA-C-O 121.848 0.832 . . . . 74.1 110.021 171.847 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 119' ' ' THR . . . . . . . . . . . . . 35.8 p -79.92 85.31 5.56 Favored 'General case' 0 CA--C 1.548 0.866 0 CA-C-N 114.947 -1.024 . . . . 74.21 110.133 -175.546 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 9.3 pt-20 -68.39 -26.25 65.47 Favored 'General case' 0 N--CA 1.48 1.071 0 CA-C-N 114.737 -1.12 . . . . 71.42 112.125 -172.444 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 121' ' ' TRP . . . . . . . . . . . . . 47.0 p90 -72.57 1.08 8.83 Favored 'General case' 0 N--CA 1.473 0.715 0 C-N-CA 123.584 0.754 . . . . 74.4 112.265 178.546 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 122' ' ' LEU . . . . . 0.514 ' HB3' ' HE1' ' A' ' 126' ' ' HIS . 40.3 mt -104.12 5.3 35.01 Favored 'General case' 0 N--CA 1.475 0.815 0 C-N-CA 123.252 0.621 . . . . 74.22 111.897 176.355 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 40.4 m-20 -80.55 153.92 27.81 Favored 'General case' 0 N--CA 1.487 1.391 0 C-N-CA 122.812 0.445 . . . . 74.34 110.963 177.425 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 71.49 19.98 78.07 Favored Glycine 0 C--N 1.359 1.823 0 O-C-N 123.442 0.463 . . . . 64.2 112.304 -173.02 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 43.4 mtmt -145.22 -158.4 0.89 Allowed 'General case' 0 N--CA 1.47 0.533 0 C-N-CA 126.805 2.042 . . . . 74.01 107.884 -171.427 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 126' ' ' HIS . . . . . 0.514 ' HE1' ' HB3' ' A' ' 122' ' ' LEU . 0.0 OUTLIER -56.3 130.62 45.31 Favored 'General case' 0 N--CA 1.478 0.973 0 C-N-CA 123.8 0.84 . . . . 74.33 113.034 -159.119 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 99.3 t -61.45 130.14 25.22 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.615 0 CA-C-N 113.058 -1.883 . . . . 65.5 113.003 -166.517 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 128' ' ' VAL . . . . . 0.464 HG21 ' HB2' ' A' ' 99' ' ' SER . 92.8 t -81.05 145.26 9.18 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.313 0 CA-C-N 114.811 -1.086 . . . . 65.42 108.754 170.45 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 129' ' ' PHE . . . . . 0.553 ' HA ' HG22 ' A' ' 29' ' ' VAL . 21.6 p90 -138.27 -33.32 0.69 Allowed 'General case' 0 N--CA 1.469 0.503 0 C-N-CA 122.411 0.284 . . . . 73.52 110.984 -177.551 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . -115.66 165.14 12.15 Favored Glycine 0 C--N 1.337 0.588 0 O-C-N 123.709 0.631 . . . . 74.22 113.122 -175.591 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 30.2 ttpt -153.1 122.19 6.57 Favored 'General case' 0 C--N 1.324 -0.516 0 N-CA-C 107.207 -1.405 . . . . 74.4 107.207 177.867 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 3.9 p -65.92 105.36 0.62 Allowed 'Isoleucine or valine' 0 CA--C 1.553 1.078 0 CA-C-O 121.716 0.77 . . . . 61.33 109.651 175.56 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 133' ' ' LYS . . . . . 0.535 ' HD2' ' HB2' ' A' ' 23' ' ' GLU . 0.1 OUTLIER -78.5 -38.79 39.96 Favored 'General case' 0 N--CA 1.474 0.766 0 CA-C-N 114.901 -1.045 . . . . 75.2 109.903 -179.295 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 49.9 mt-10 -145.62 144.5 30.49 Favored 'General case' 0 N--CA 1.481 1.114 0 C-N-CA 124.599 1.16 . . . . 65.45 108.879 177.636 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 94.84 17.24 38.85 Favored Glycine 0 N--CA 1.472 1.059 0 N-CA-C 112.417 -0.273 . . . . 74.32 112.417 -176.409 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 136' ' ' MET . . . . . 0.412 ' HE1' ' HA ' ' A' ' 116' ' ' THR . 14.5 tpt -61.81 -35.19 77.48 Favored 'General case' 0 N--CA 1.482 1.167 0 C-N-CA 124.113 0.965 . . . . 75.34 111.683 179.374 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 137' ' ' ASN . . . . . . . . . . . . . 1.8 m-20 -61.68 -34.71 76.22 Favored 'General case' 0 CA--C 1.548 0.875 0 C-N-CA 123.589 0.756 . . . . 74.14 110.774 177.796 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 138' ' ' ILE . . . . . . . . . . . . . 43.9 mm -72.05 -35.76 54.78 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.854 0 C-N-CA 123.076 0.55 . . . . 72.52 110.389 179.477 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 98.7 t -63.12 -45.88 97.47 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.872 0 C-N-CA 123.18 0.592 . . . . 71.31 110.374 175.879 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 40.9 mt-10 -68.26 -26.76 65.83 Favored 'General case' 0 N--CA 1.476 0.837 0 CA-C-N 115.498 -0.774 . . . . 74.14 111.186 178.352 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -71.99 -56.69 5.21 Favored 'General case' 0 N--CA 1.475 0.782 0 C-N-CA 123.332 0.653 . . . . 71.12 111.185 176.69 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 142' ' ' MET . . . . . 0.537 ' HE1' HG23 ' A' ' 156' ' ' ILE . 26.8 ptm -61.12 -35.7 77.73 Favored 'General case' 0 N--CA 1.48 1.059 0 C-N-CA 123.718 0.807 . . . . 65.3 111.829 -177.753 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 33.4 tt0 -66.05 -32.14 73.44 Favored 'General case' 0 CA--C 1.543 0.709 0 CA-C-O 121.462 0.648 . . . . 65.5 112.219 -173.91 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 144' ' ' ARG . . . . . 0.694 ' HA ' ' HB3' ' A' ' 58' ' ' PRO . 96.4 mtt180 -80.54 -6.58 58.43 Favored 'General case' 0 N--CA 1.47 0.544 0 CA-C-N 115.855 -0.611 . . . . 74.1 111.866 -178.65 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 145' ' ' PHE . . . . . 0.491 ' HD2' ' HA ' ' A' ' 142' ' ' MET . 50.9 m-85 -85.12 5.47 29.68 Favored 'General case' 0 CA--C 1.552 1.025 0 C-N-CA 123.309 0.644 . . . . 72.15 111.131 167.647 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . -93.72 -170.97 38.93 Favored Glycine 0 C--N 1.35 1.359 0 N-CA-C 112.381 -0.287 . . . . 70.31 112.381 172.987 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 12.9 m -132.74 162.53 31.2 Favored 'General case' 0 N--CA 1.48 1.049 0 C-N-CA 123.545 0.738 . . . . 74.34 109.513 -179.322 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 148' ' ' ARG . . . . . 0.436 ' HA ' HG23 ' A' ' 57' ' ' ILE . 17.4 mmm180 -71.5 -18.89 62.26 Favored 'General case' 0 N--CA 1.483 1.18 0 C-N-CA 123.823 0.849 . . . . 73.22 112.946 -172.902 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 149' ' ' ASN . . . . . . . . . . . . . 30.6 p-10 -85.89 -21.47 27.98 Favored 'General case' 0 N--CA 1.481 1.085 0 C-N-CA 123.619 0.768 . . . . 73.41 110.8 174.198 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 150' ' ' GLY . . . . . 0.478 ' O ' ' HA ' ' A' ' 55' ' ' ARG . . . 119.45 -11.23 11.37 Favored Glycine 0 C--N 1.347 1.189 0 CA-C-N 115.915 -0.584 . . . . 53.13 113.187 -178.747 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 37.5 ttpt -64.56 137.55 57.91 Favored 'General case' 0 N--CA 1.476 0.844 0 CA-C-N 117.921 0.86 . . . . 73.1 110.799 -177.698 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 152' ' ' THR . . . . . . . . . . . . . 18.1 p -91.13 113.28 25.51 Favored 'General case' 0 CA--C 1.539 0.528 0 N-CA-C 109.117 -0.698 . . . . 70.13 109.117 176.079 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 153' ' ' SER . . . . . . . . . . . . . 32.1 t -67.39 -35.41 79.27 Favored 'General case' 0 N--CA 1.475 0.803 0 C-N-CA 123.208 0.603 . . . . 72.45 110.419 -179.318 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 75.6 mmtt -110.09 152.16 26.32 Favored 'General case' 0 C--O 1.243 0.714 0 CA-C-N 114.959 -1.019 . . . . 73.53 109.381 178.971 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 17.3 tppt? -79.23 88.88 4.89 Favored 'General case' 0 C--N 1.349 0.552 0 N-CA-C 108.558 -0.904 . . . . 73.21 108.558 177.338 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 156' ' ' ILE . . . . . 0.537 HG23 ' HE1' ' A' ' 142' ' ' MET . 58.0 mt -93.01 119.29 40.47 Favored 'Isoleucine or valine' 0 C--O 1.234 0.248 0 N-CA-C 108.821 -0.807 . . . . 71.22 108.821 -177.94 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 157' ' ' THR . . . . . . . . . . . . . 37.1 p -132.9 144.28 50.06 Favored 'General case' 0 C--O 1.238 0.481 0 C-N-CA 124.861 1.264 . . . . 74.54 109.099 -177.576 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 158' ' ' ILE . . . . . 0.443 HG22 ' HB3' ' A' ' 8' ' ' PHE . 62.2 mt -73.22 92.85 0.59 Allowed 'Isoleucine or valine' 0 CA--C 1.54 0.595 0 N-CA-C 107.526 -1.287 . . . . 72.42 107.526 166.874 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 159' ' ' ALA . . . . . 0.542 ' HB3' ' HB3' ' A' ' 11' ' ' ALA . . . -55.06 -57.32 12.18 Favored 'General case' 0 N--CA 1.47 0.549 0 C-N-CA 123.839 0.856 . . . . 72.33 110.892 -176.689 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 160' ' ' ASP . . . . . . . . . . . . . 13.2 m-20 -135.62 177.18 8.03 Favored 'General case' 0 N--CA 1.469 0.511 0 CA-C-O 121.698 0.761 . . . . 75.01 111.664 -175.18 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 161' ' ' CYS . . . . . . . . . . . . . 21.8 p -144.89 -169.35 3.16 Favored 'General case' 0 CA--C 1.542 0.644 0 C-N-CA 125.919 1.688 . . . . 74.32 107.768 -177.621 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 162' ' ' GLY . . . . . . . . . . . . . . . 130.27 53.06 0.1 Allowed Glycine 0 C--N 1.341 0.825 0 N-CA-C 109.92 -1.272 . . . . 65.13 109.92 -172.724 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 163' ' ' GLN . . . . . 0.513 ' HB2' ' HA ' ' A' ' 6' ' ' VAL . 15.6 pt20 -54.23 152.81 5.8 Favored 'General case' 0 CA--C 1.548 0.87 0 N-CA-C 114.512 1.301 . . . . 73.45 114.512 -170.927 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 164' ' ' LEU . . . . . 0.612 ' HG ' ' HB2' ' A' ' 7' ' ' PHE . 82.4 mt -88.51 118.2 28.0 Favored 'General case' 0 C--O 1.241 0.628 0 C-N-CA 124.462 1.105 . . . . 75.44 110.957 -169.874 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 165' ' ' GLU . . . . . . . . . . . . . 8.9 pt-20 . . . . . 0 CA--C 1.556 1.201 0 C-N-CA 124.181 0.992 . . . . 71.03 109.815 179.676 . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' B' B ' 216' ' ' PRO . . . . . . . . . . . . . 17.0 Cg_endo . . . . . 0 N--CA 1.487 1.111 0 N-CA-C 110.081 -0.777 . . . . 75.45 110.081 . . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' B' B ' 217' ' ' GLU . . . . . . . . . . . . . 16.9 pt-20 -79.17 159.34 73.11 Favored Pre-proline 0 CA--C 1.554 1.12 0 C-N-CA 123.318 0.647 . . . . 72.42 110.041 178.198 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 218' ' ' PRO . . . . . . . . . . . . . 21.9 Cg_exo -65.33 99.18 0.35 Allowed 'Trans proline' 0 C--N 1.375 1.971 0 C-N-CA 121.985 1.79 . . . . 73.32 110.482 169.994 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 219' ' ' GLY . . . . . 0.482 ' HA2' ' HB2' ' A' ' 101' ' ' ALA . . . -173.14 147.81 9.92 Favored Glycine 0 C--N 1.347 1.184 0 CA-C-O 119.722 -0.488 . . . . 71.43 113.292 -178.943 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 220' ' ' PRO . . . . . 0.432 ' HB3' ' HE2' ' A' ' 126' ' ' HIS . 56.6 Cg_endo -67.55 153.46 76.32 Favored 'Trans proline' 0 C--N 1.377 2.075 0 C-N-CA 123.553 2.835 . . . . 65.04 112.748 177.923 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 221' ' ' TYR . . . . . . . . . . . . . 83.2 m-85 -79.95 138.62 37.14 Favored 'General case' 0 N--CA 1.477 0.908 0 C-N-CA 122.781 0.433 . . . . 74.3 110.709 -178.571 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 222' ' ' ALA . . . . . . . . . . . . . . . -112.15 179.88 3.87 Favored 'General case' 0 N--CA 1.468 0.435 0 N-CA-C 113.791 1.034 . . . . 73.01 113.791 -162.964 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 223' ' ' GLN . . . . . . . . . . . . . 27.6 pt20 -94.84 121.81 61.91 Favored Pre-proline 0 CA--C 1.56 1.358 0 CA-C-N 114.318 -1.31 . . . . 74.34 109.604 178.1 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 224' ' ' PRO . . . . . . . . . . . . . 13.6 Cg_exo . . . . . 0 C--N 1.376 2.014 0 C-N-CA 122.834 2.356 . . . . 73.45 111.16 172.031 . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 92.2 mmm . . . . . 0 N--CA 1.49 1.559 0 N-CA-C 110.023 -0.362 . . . . 75.4 110.023 . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 13.5 p -80.33 -20.05 11.88 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.222 0 CA-C-O 121.685 0.755 . . . . 74.05 109.584 168.012 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 3' ' ' ASN . . . . . 0.502 HD21 ' HA ' ' A' ' 25' ' ' PHE . 13.4 m120 -77.06 124.47 87.32 Favored Pre-proline 0 CA--C 1.545 0.775 0 C-N-CA 124.442 1.097 . . . . 74.22 111.849 -171.888 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 36.4 Cg_endo -64.58 122.1 9.88 Favored 'Trans proline' 0 C--N 1.382 2.306 0 C-N-CA 122.872 2.381 . . . . 73.12 111.076 173.973 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 50.6 m -97.88 129.52 44.82 Favored 'General case' 0 CA--C 1.534 0.352 0 C-N-CA 123.585 0.754 . . . . 75.03 109.441 -178.068 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . 0.537 ' HA ' ' HG3' ' A' ' 163' ' ' GLN . 27.2 m -99.26 126.1 52.63 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.364 0 N-CA-C 108.209 -1.034 . . . . 54.04 108.209 175.471 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 7' ' ' PHE . . . . . 0.524 ' H ' ' HA ' ' A' ' 163' ' ' GLN . 57.7 t80 -108.85 135.52 49.92 Favored 'General case' 0 C--O 1.237 0.404 0 N-CA-C 109.037 -0.727 . . . . 70.31 109.037 -175.932 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 72.6 m-85 -139.62 166.21 25.2 Favored 'General case' 0 C--O 1.24 0.604 0 C-N-CA 124.654 1.182 . . . . 72.31 109.8 178.471 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 43.4 m-20 -118.01 116.25 26.53 Favored 'General case' 0 C--N 1.328 -0.365 0 N-CA-C 106.389 -1.708 . . . . 75.5 106.389 166.163 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 33.8 mm -98.93 143.68 12.92 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.711 0 N-CA-C 108.916 -0.772 . . . . 74.43 108.916 -177.465 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 11' ' ' ALA . . . . . 0.507 ' HB1' ' HB2' ' A' ' 159' ' ' ALA . . . -136.99 140.36 42.1 Favored 'General case' 0 N--CA 1.467 0.417 0 C-N-CA 123.304 0.642 . . . . 60.12 111.818 -164.432 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 21.4 t -98.36 109.93 24.85 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.795 0 N-CA-C 107.796 -1.187 . . . . 72.41 107.796 171.418 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 45.4 m-20 68.25 20.63 8.73 Favored 'General case' 0 N--CA 1.497 1.904 0 C-N-CA 124.384 1.073 . . . . 73.35 111.766 -177.656 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 87.3 -3.19 86.75 Favored Glycine 0 C--N 1.349 1.278 0 CA-C-O 119.964 -0.353 . . . . 70.31 113.067 -174.666 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 40.0 mm-40 -84.18 113.71 49.96 Favored Pre-proline 0 CA--C 1.543 0.689 0 N-CA-C 108.902 -0.777 . . . . 71.35 108.902 175.235 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 21.1 Cg_endo -56.84 107.97 0.31 Allowed 'Trans proline' 0 C--N 1.383 2.354 0 C-N-CA 123.0 2.467 . . . . 75.24 111.749 -176.524 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 46.3 tp -78.92 -45.45 20.5 Favored 'General case' 0 N--CA 1.47 0.539 0 CA-C-N 115.538 -0.756 . . . . 73.24 109.36 178.535 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -176.1 -171.46 39.92 Favored Glycine 0 C--N 1.337 0.596 0 CA-C-N 115.742 -0.663 . . . . 73.11 112.688 179.944 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 40.3 ptt85 -106.21 144.78 32.43 Favored 'General case' 0 C--O 1.239 0.537 0 C-N-CA 123.875 0.87 . . . . 74.1 108.674 178.691 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 94.6 t -134.17 139.27 48.56 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.588 0 N-CA-C 108.683 -0.858 . . . . 73.2 108.683 176.887 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 24.8 m -133.12 118.38 18.64 Favored 'General case' 0 CA--C 1.545 0.777 0 C-N-CA 124.867 1.267 . . . . 54.53 108.414 -175.872 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 22' ' ' PHE . . . . . 0.462 ' HA ' ' HA ' ' A' ' 132' ' ' VAL . 41.0 m-85 -102.87 129.63 49.63 Favored 'General case' 0 N--CA 1.479 1.002 0 N-CA-C 109.435 -0.58 . . . . 71.54 109.435 177.512 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 35.7 tt0 -90.33 108.18 19.61 Favored 'General case' 0 CA--C 1.548 0.873 0 C-N-CA 124.183 0.993 . . . . 74.13 109.426 177.447 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . 0.501 ' HB3' ' HB2' ' A' ' 33' ' ' ALA . 40.6 mt -87.25 122.09 30.56 Favored 'General case' 0 N--CA 1.48 1.063 0 C-N-CA 123.031 0.532 . . . . 73.53 110.605 -177.008 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 25' ' ' PHE . . . . . 0.502 ' HA ' HD21 ' A' ' 3' ' ' ASN . 48.8 m-85 -84.91 65.26 9.1 Favored 'General case' 0 CA--C 1.548 0.879 0 C-N-CA 123.916 0.886 . . . . 74.22 110.805 -179.951 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -65.86 -25.88 67.39 Favored 'General case' 0 N--CA 1.482 1.131 0 CA-C-N 115.127 -0.942 . . . . 60.04 111.912 -177.766 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 9.2 p-10 -72.81 -6.64 46.24 Favored 'General case' 0 N--CA 1.48 1.041 0 C-N-CA 123.489 0.716 . . . . 75.52 111.341 -179.544 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 91.7 mttt -114.6 -48.94 2.84 Favored 'General case' 0 N--CA 1.476 0.857 0 C-N-CA 123.771 0.828 . . . . 75.44 109.872 177.242 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 29' ' ' VAL . . . . . 0.456 HG21 ' HA ' ' A' ' 129' ' ' PHE . 14.6 m -121.94 79.02 41.49 Favored Pre-proline 0 CA--C 1.566 1.56 0 C-N-CA 124.329 1.052 . . . . 73.24 109.293 -178.684 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 35.6 Cg_exo -60.03 -57.3 0.82 Allowed 'Trans proline' 0 C--N 1.391 2.766 0 C-N-CA 123.204 2.603 . . . . 75.3 112.953 -169.671 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 29.2 ttmt -58.43 -45.09 89.17 Favored 'General case' 0 N--CA 1.479 0.999 0 C-N-CA 124.564 1.146 . . . . 72.24 112.085 179.385 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 6.9 m -67.0 -40.1 87.28 Favored 'General case' 0 CA--C 1.548 0.894 0 CA-C-N 114.58 -1.191 . . . . 65.11 111.671 -170.459 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 33' ' ' ALA . . . . . 0.501 ' HB2' ' HB3' ' A' ' 24' ' ' LEU . . . -80.71 -36.18 32.55 Favored 'General case' 0 N--CA 1.475 0.798 0 C-N-CA 123.586 0.755 . . . . 74.42 110.702 178.381 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 14.7 tp10 -62.41 -32.04 72.81 Favored 'General case' 0 N--CA 1.486 1.37 0 C-N-CA 124.042 0.937 . . . . 73.1 111.144 -179.526 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 35' ' ' ASN . . . . . 0.555 ' ND2' ' SD ' ' A' ' 100' ' ' MET . 44.9 t30 -55.97 -64.35 0.88 Allowed 'General case' 0 CA--C 1.544 0.741 0 C-N-CA 123.823 0.849 . . . . 63.34 110.801 176.115 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 36' ' ' PHE . . . . . 0.517 ' HE2' HG22 ' A' ' 6' ' ' VAL . 65.7 t80 -65.5 -30.14 70.87 Favored 'General case' 0 N--CA 1.476 0.856 0 C-N-CA 123.603 0.761 . . . . 70.35 111.065 -176.264 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 44.8 ttp85 -64.76 -51.43 62.31 Favored 'General case' 0 CA--C 1.551 0.985 0 C-N-CA 124.015 0.926 . . . . 74.42 109.593 -179.415 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -78.44 -15.09 59.02 Favored 'General case' 0 CA--C 1.544 0.729 0 CA-C-N 115.037 -0.983 . . . . 75.43 112.26 -176.567 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 92.8 mt -79.59 -35.55 39.44 Favored 'General case' 0 N--CA 1.487 1.391 0 C-N-CA 122.96 0.504 . . . . 74.04 110.418 170.511 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 42.6 t -66.06 -54.39 26.48 Favored 'General case' 0 N--CA 1.477 0.897 0 C-N-CA 124.285 1.034 . . . . 74.42 110.592 179.892 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 10.9 p -75.67 -32.0 59.98 Favored 'General case' 0 N--CA 1.475 0.806 0 CA-C-N 115.878 -0.601 . . . . 72.42 111.52 175.87 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 81.5 34.96 24.2 Favored Glycine 0 C--N 1.348 1.221 0 CA-C-N 116.481 -0.327 . . . . 73.2 113.402 177.879 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 41.2 mm-40 -66.41 -20.47 66.07 Favored 'General case' 0 N--CA 1.476 0.867 0 C-N-CA 123.693 0.797 . . . . 74.21 111.991 -178.632 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 9.8 mmpt? -93.67 8.17 41.93 Favored 'General case' 0 CA--C 1.552 1.029 0 C-N-CA 124.193 0.997 . . . . 72.11 110.842 179.265 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 76.33 33.79 47.65 Favored Glycine 0 C--N 1.351 1.365 0 CA-C-O 119.774 -0.459 . . . . 71.14 113.384 179.995 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 23.4 m-85 -116.21 -49.35 2.69 Favored 'General case' 0 N--CA 1.484 1.266 0 CA-C-N 117.214 0.507 . . . . 74.23 110.797 -178.317 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 47.12 63.32 3.34 Favored Glycine 0 C--N 1.354 1.554 0 O-C-N 124.482 1.114 . . . . 73.33 115.371 169.609 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 32.0 m-85 -66.36 92.63 0.2 Allowed 'General case' 0 C--N 1.353 0.752 0 CA-C-O 121.869 0.842 . . . . 75.42 111.435 -173.71 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 27.9 tptp -109.33 94.8 5.23 Favored 'General case' 0 C--O 1.239 0.522 0 CA-C-N 113.991 -1.458 . . . . 74.42 108.591 -175.059 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 118.95 21.37 3.85 Favored Glycine 0 C--N 1.348 1.202 0 CA-C-O 119.781 -0.455 . . . . 53.32 113.395 -179.547 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 51' ' ' SER . . . . . 0.501 ' HB2' HD11 ' A' ' 158' ' ' ILE . 19.7 m -60.5 119.15 7.49 Favored 'General case' 0 N--CA 1.476 0.854 0 C-N-CA 123.577 0.751 . . . . 62.32 110.716 179.463 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 52' ' ' CYS . . . . . 0.414 ' HA ' ' HA ' ' A' ' 157' ' ' THR . 10.6 p -104.91 129.21 53.32 Favored 'General case' 0 N--CA 1.474 0.743 0 CA-C-O 121.637 0.732 . . . . 63.02 112.525 -170.415 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 53' ' ' PHE . . . . . 0.763 ' HA ' ' HA2' ' A' ' 64' ' ' GLY . 55.9 m-85 -70.52 109.71 4.99 Favored 'General case' 0 C--N 1.347 0.494 0 C-N-CA 124.842 1.257 . . . . 73.45 109.646 174.148 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 49.7 p-80 -120.28 -5.48 9.91 Favored 'General case' 0 N--CA 1.481 1.086 0 C-N-CA 123.815 0.846 . . . . 73.24 111.235 -176.454 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 55' ' ' ARG . . . . . 0.443 ' O ' ' HB3' ' A' ' 63' ' ' GLN . 53.2 ttt-85 -129.57 97.6 4.59 Favored 'General case' 0 N--CA 1.473 0.719 0 N-CA-C 108.891 -0.781 . . . . 73.32 108.891 175.604 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 56' ' ' ILE . . . . . 0.446 HG23 ' HA ' ' A' ' 143' ' ' GLU . 64.3 mt -130.55 127.18 61.9 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.943 0 N-CA-C 108.389 -0.967 . . . . 61.31 108.389 177.291 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 74.9 mt -124.85 118.16 25.84 Favored Pre-proline 0 CA--C 1.555 1.144 0 C-N-CA 123.974 0.909 . . . . 74.55 108.904 -177.884 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 52.7 Cg_exo -57.63 145.65 88.37 Favored 'Trans proline' 0 C--N 1.383 2.365 0 C-N-CA 124.229 3.286 . . . . 75.34 114.205 -179.237 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 66.1 24.19 71.69 Favored Glycine 0 C--N 1.352 1.451 0 O-C-N 124.291 0.994 . . . . 75.43 112.954 -179.272 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 60' ' ' PHE . . . . . 0.599 ' HB2' HE22 ' B' ' 223' ' ' GLN . 36.3 t80 -145.09 -76.38 0.21 Allowed 'General case' 0 C--O 1.244 0.764 0 C-N-CA 123.886 0.875 . . . . 72.41 110.221 -173.744 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 61' ' ' MET . . . . . 0.698 ' SD ' ' HB2' ' A' ' 113' ' ' PHE . 12.1 tmm? -173.27 150.74 1.93 Allowed 'General case' 0 N--CA 1.484 1.272 0 CA-C-O 121.075 0.464 . . . . 75.14 112.19 -161.2 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 62' ' ' CYS . . . . . . . . . . . . . 36.7 t -114.45 111.92 22.19 Favored 'General case' 0 CA--C 1.558 1.287 0 C-N-CA 124.873 1.269 . . . . 72.54 109.752 175.687 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 63' ' ' GLN . . . . . 0.63 ' HB2' ' SD ' ' A' ' 61' ' ' MET . 49.6 tt0 -115.5 133.53 55.94 Favored 'General case' 0 N--CA 1.498 1.935 0 C-N-CA 124.017 0.927 . . . . 72.45 110.949 -172.209 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 64' ' ' GLY . . . . . 0.763 ' HA2' ' HA ' ' A' ' 53' ' ' PHE . . . -123.04 170.28 15.45 Favored Glycine 0 C--N 1.339 0.726 0 CA-C-N 115.259 -0.882 . . . . 63.15 112.83 179.032 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -164.54 156.99 29.21 Favored Glycine 0 C--N 1.33 0.241 0 N-CA-C 110.532 -1.027 . . . . 64.14 110.532 176.658 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 21.2 t70 -91.35 167.2 12.47 Favored 'General case' 0 C--O 1.244 0.798 0 CA-C-O 121.185 0.517 . . . . 62.41 110.34 -178.269 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 63.8 t80 -77.25 -29.08 53.81 Favored 'General case' 0 CA--C 1.552 1.035 0 C-N-CA 124.07 0.948 . . . . 75.51 111.18 -179.676 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 91.5 m -61.23 109.42 1.12 Allowed 'General case' 0 C--N 1.363 1.156 0 C-N-CA 123.922 0.889 . . . . 72.13 110.361 179.659 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 36.6 ttt180 52.98 82.89 0.07 Allowed 'General case' 0 CA--C 1.541 0.618 0 O-C-N 124.836 1.335 . . . . 75.23 110.461 -173.398 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 52.3 t60 -89.26 -19.94 24.74 Favored 'General case' 0 CA--C 1.549 0.911 0 CA-C-N 116.099 -0.501 . . . . 71.42 111.457 -174.601 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 3.5 m-20 -64.76 91.41 0.09 Allowed 'General case' 0 N--CA 1.489 1.516 0 C-N-CA 123.686 0.794 . . . . 71.51 111.214 -176.813 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 75.3 -6.19 30.88 Favored Glycine 0 C--N 1.349 1.27 0 CA-C-N 115.561 -0.745 . . . . 74.21 114.682 175.249 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -114.16 -67.03 1.03 Allowed 'General case' 0 CA--C 1.551 0.995 0 N-CA-C 109.187 -0.672 . . . . 75.13 109.187 -175.2 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 61.32 61.58 6.74 Favored Glycine 0 CA--C 1.534 1.24 0 CA-C-N 116.21 -0.45 . . . . 72.4 113.994 175.77 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 107.54 52.25 0.72 Allowed Glycine 0 N--CA 1.48 1.593 0 CA-C-N 117.674 0.737 . . . . 74.41 112.166 -177.5 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 76' ' ' LYS . . . . . 0.405 ' HA ' ' O ' ' A' ' 109' ' ' GLY . 21.5 pttp -53.77 170.58 0.11 Allowed 'General case' 0 CA--C 1.562 1.409 0 C-N-CA 125.076 1.35 . . . . 74.44 113.815 179.902 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 89.9 p -90.69 176.02 6.81 Favored 'General case' 0 N--CA 1.486 1.33 0 C-N-CA 123.689 0.796 . . . . 75.42 112.856 -165.885 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 25.5 pt -71.34 -17.95 20.05 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.225 0 C-N-CA 122.934 0.493 . . . . 74.35 110.784 174.327 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 69.7 m-85 -92.85 27.82 2.27 Favored 'General case' 0 CA--C 1.546 0.797 0 C-N-CA 124.058 0.943 . . . . 73.44 109.728 174.523 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 83.51 -119.38 4.89 Favored Glycine 0 C--N 1.354 1.551 0 CA-C-N 115.088 -0.96 . . . . 74.22 111.753 177.74 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 34.8 tt0 -61.74 -59.43 5.18 Favored 'General case' 0 C--O 1.241 0.625 0 C-N-CA 124.024 0.93 . . . . 64.43 110.723 -178.373 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 82' ' ' LYS . . . . . 0.745 ' HD2' ' HA ' ' A' ' 107' ' ' THR . 23.9 pttm -165.11 175.28 9.51 Favored 'General case' 0 CA--C 1.552 1.057 0 O-C-N 123.595 0.56 . . . . 74.2 111.742 -174.967 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 2.0 p90 -157.03 176.24 13.02 Favored 'General case' 0 N--CA 1.482 1.158 0 C-N-CA 125.83 1.652 . . . . 75.12 109.036 -179.884 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 12.5 pt-20 -93.02 -172.48 3.0 Favored 'General case' 0 N--CA 1.485 1.281 0 CA-C-O 121.255 0.55 . . . . 74.11 111.74 179.517 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 51.8 m-20 -80.42 136.74 36.41 Favored 'General case' 0 N--CA 1.471 0.614 0 C-N-CA 124.271 1.028 . . . . 70.21 109.148 173.22 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 12.6 tp10 -73.24 -52.53 13.68 Favored 'General case' 0 CA--C 1.544 0.728 0 O-C-N 123.472 0.482 . . . . 63.44 109.929 176.165 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 16.5 p-10 -170.14 134.79 1.27 Allowed 'General case' 0 N--CA 1.479 0.983 0 C-N-CA 123.595 0.758 . . . . 74.32 110.193 -174.58 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 73.7 m-85 -88.58 69.52 8.85 Favored 'General case' 0 N--CA 1.483 1.189 0 CA-C-O 121.096 0.474 . . . . 72.43 110.538 -178.053 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 37.0 mt -82.03 -58.25 3.87 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.77 0 N-CA-C 108.724 -0.843 . . . . 72.41 108.724 169.44 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 53.1 mt -92.78 119.52 32.22 Favored 'General case' 0 CA--C 1.541 0.598 0 CA-C-N 114.923 -1.035 . . . . 74.11 110.596 -171.006 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 9.8 mtmp? -121.98 171.48 8.91 Favored 'General case' 0 CA--C 1.543 0.708 0 C-N-CA 124.764 1.226 . . . . 72.31 109.814 175.086 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 92' ' ' HIS . . . . . . . . . . . . . 23.0 m-70 -78.09 80.62 4.51 Favored 'General case' 0 N--CA 1.477 0.886 0 C-N-CA 123.879 0.872 . . . . 74.34 110.16 -170.232 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 19.1 p -82.85 -57.31 3.36 Favored 'General case' 0 N--CA 1.473 0.714 0 C-N-CA 123.898 0.879 . . . . 74.45 111.212 -177.006 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -121.45 -176.64 15.34 Favored Glycine 0 C--N 1.346 1.129 0 O-C-N 123.466 0.479 . . . . 65.24 112.788 -176.374 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 8.4 Cg_exo -73.6 148.22 41.81 Favored 'Trans proline' 0 C--N 1.368 1.556 0 C-N-CA 122.987 2.458 . . . . 64.34 111.564 170.354 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 105.67 -2.6 39.17 Favored Glycine 0 N--CA 1.473 1.121 0 CA-C-N 116.391 -0.368 . . . . 65.33 113.213 -179.703 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 97' ' ' ILE . . . . . 0.458 ' HB ' ' HB2' ' A' ' 115' ' ' CYS . 18.1 mm -66.34 116.18 5.28 Favored 'Isoleucine or valine' 0 CA--C 1.555 1.167 0 C-N-CA 124.366 1.066 . . . . 74.12 111.862 -174.583 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 55.3 tp -100.29 122.43 43.07 Favored 'General case' 0 N--CA 1.479 0.994 0 C-N-CA 123.312 0.645 . . . . 70.12 110.063 173.624 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 44.9 t -142.89 144.36 32.42 Favored 'General case' 0 CA--C 1.539 0.525 0 C-N-CA 124.263 1.025 . . . . 73.21 108.254 176.944 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 100' ' ' MET . . . . . 0.555 ' SD ' ' ND2' ' A' ' 35' ' ' ASN . 13.4 ttt -79.45 141.97 36.31 Favored 'General case' 0 N--CA 1.483 1.18 0 C-N-CA 124.138 0.975 . . . . 73.12 109.073 -178.729 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 101' ' ' ALA . . . . . 0.416 ' HB1' ' HB2' ' A' ' 111' ' ' GLN . . . -77.24 160.9 28.55 Favored 'General case' 0 N--CA 1.479 1.019 0 CA-C-O 121.387 0.613 . . . . 75.43 111.616 -173.02 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 102' ' ' ASN . . . . . 0.516 ' HB3' ' HA ' ' A' ' 108' ' ' ASN . 25.7 p-10 -165.79 168.84 15.65 Favored 'General case' 0 N--CA 1.472 0.669 0 CA-C-N 114.581 -1.191 . . . . 71.55 109.711 -177.468 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -90.5 -47.28 7.8 Favored 'General case' 0 N--CA 1.469 0.503 0 N-CA-C 108.917 -0.771 . . . . 73.13 108.917 167.137 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -168.0 -152.71 7.72 Favored Glycine 0 CA--C 1.533 1.172 0 CA-C-O 119.096 -0.836 . . . . 72.41 112.561 179.485 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 37.5 Cg_exo -61.79 135.39 55.78 Favored 'Trans proline' 0 C--N 1.379 2.167 0 C-N-CA 123.116 2.544 . . . . 72.44 112.898 -178.275 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 67.1 t30 66.06 9.75 6.47 Favored 'General case' 0 N--CA 1.49 1.535 0 C-N-CA 125.211 1.404 . . . . 74.23 111.852 -179.736 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 107' ' ' THR . . . . . 0.745 ' HA ' ' HD2' ' A' ' 82' ' ' LYS . 2.2 m -111.35 8.68 21.43 Favored 'General case' 0 CA--C 1.555 1.167 0 C-N-CA 124.174 0.989 . . . . 62.21 109.857 179.415 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 108' ' ' ASN . . . . . 0.516 ' HA ' ' HB3' ' A' ' 102' ' ' ASN . 8.8 t30 -70.66 145.18 50.78 Favored 'General case' 0 N--CA 1.475 0.795 0 C-N-CA 124.599 1.16 . . . . 74.42 110.268 175.135 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 109' ' ' GLY . . . . . 0.415 ' HA2' ' SD ' ' A' ' 100' ' ' MET . . . 109.99 25.12 5.49 Favored Glycine 0 N--CA 1.468 0.778 0 C-N-CA 121.568 -0.349 . . . . 63.31 112.565 178.897 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 28.4 p -131.46 118.5 20.29 Favored 'General case' 0 CA--C 1.54 0.562 0 N-CA-C 108.735 -0.839 . . . . 75.2 108.735 177.46 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 111' ' ' GLN . . . . . 0.416 ' HB2' ' HB1' ' A' ' 101' ' ' ALA . 49.7 mt-30 59.15 -175.74 0.09 Allowed 'General case' 0 N--CA 1.497 1.898 0 C-N-CA 123.724 0.81 . . . . 64.1 112.14 -173.897 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 112' ' ' PHE . . . . . 0.432 ' HA ' ' HA ' ' A' ' 100' ' ' MET . 42.6 p90 -151.64 151.7 31.85 Favored 'General case' 0 N--CA 1.484 1.241 0 N-CA-C 108.284 -1.006 . . . . 73.22 108.284 176.748 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 113' ' ' PHE . . . . . 0.698 ' HB2' ' SD ' ' A' ' 61' ' ' MET . 51.0 p90 -140.16 137.77 34.66 Favored 'General case' 0 N--CA 1.478 0.946 0 CA-C-O 121.27 0.557 . . . . 71.52 111.803 -176.568 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 114' ' ' ILE . . . . . . . . . . . . . 11.0 mt -110.09 102.52 14.1 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.663 0 C-N-CA 124.904 1.282 . . . . 72.55 108.093 -178.358 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 115' ' ' CYS . . . . . 0.458 ' HB2' ' HB ' ' A' ' 97' ' ' ILE . 56.9 m -64.83 105.26 0.97 Allowed 'General case' 0 CA--C 1.548 0.894 0 C-N-CA 123.208 0.603 . . . . 72.12 109.765 177.125 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 116' ' ' THR . . . . . 0.549 ' HA ' ' HE2' ' A' ' 136' ' ' MET . 60.2 p -70.78 -32.01 68.99 Favored 'General case' 0 N--CA 1.476 0.844 0 C-N-CA 124.367 1.067 . . . . 72.12 110.803 -177.584 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -119.89 168.87 10.69 Favored 'General case' 0 C--O 1.247 0.946 0 C-N-CA 124.26 1.024 . . . . 60.32 108.824 169.499 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 17.5 ptmt -66.84 128.43 36.27 Favored 'General case' 0 N--CA 1.473 0.683 0 N-CA-C 109.268 -0.642 . . . . 74.53 109.268 173.462 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 119' ' ' THR . . . . . . . . . . . . . 27.0 p -131.9 84.17 2.14 Favored 'General case' 0 CA--C 1.541 0.606 0 CA-C-O 121.562 0.696 . . . . 72.05 109.15 -177.533 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 12.6 pt-20 -77.52 -15.45 59.27 Favored 'General case' 0 N--CA 1.481 1.115 0 CA-C-N 115.791 -0.64 . . . . 65.25 111.799 -172.275 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 121' ' ' TRP . . . . . . . . . . . . . 48.9 p90 -74.93 -5.05 41.71 Favored 'General case' 0 N--CA 1.478 0.928 0 C-N-CA 122.333 0.253 . . . . 74.21 111.146 174.709 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 23.0 mt -94.66 8.01 43.82 Favored 'General case' 0 N--CA 1.472 0.671 0 C-N-CA 123.169 0.588 . . . . 73.51 110.89 172.949 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 53.0 m-20 -77.25 122.75 25.5 Favored 'General case' 0 CA--C 1.537 0.471 0 N-CA-C 107.475 -1.305 . . . . 74.22 107.475 168.935 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 112.88 -25.26 11.85 Favored Glycine 0 C--N 1.343 0.917 0 N-CA-C 111.185 -0.766 . . . . 74.4 111.185 -165.703 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 32.4 mmmt -72.84 -164.24 0.16 Allowed 'General case' 0 N--CA 1.489 1.499 0 C-N-CA 123.848 0.859 . . . . 75.13 109.741 167.734 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 126' ' ' HIS . . . . . . . . . . . . . 50.8 t60 -66.77 144.67 56.19 Favored 'General case' 0 CA--C 1.551 1.014 0 CA-C-O 121.082 0.468 . . . . 74.33 110.817 178.543 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 26.1 t -62.72 139.06 21.73 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.838 0 CA-C-N 114.605 -1.18 . . . . 72.43 111.194 179.595 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 49.4 t -68.18 143.38 15.31 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.739 0 N-CA-C 109.17 -0.678 . . . . 73.14 109.17 172.687 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 129' ' ' PHE . . . . . 0.456 ' HA ' HG21 ' A' ' 29' ' ' VAL . 35.9 p90 -132.81 -8.3 3.14 Favored 'General case' 0 N--CA 1.478 0.963 0 O-C-N 121.987 -0.446 . . . . 75.51 111.43 179.46 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . -151.02 171.98 30.68 Favored Glycine 0 C--N 1.34 0.772 0 O-C-N 123.473 0.483 . . . . 65.44 112.557 -175.883 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 32.2 ttpt -154.88 122.41 5.69 Favored 'General case' 0 C--O 1.236 0.384 0 N-CA-C 108.161 -1.052 . . . . 74.41 108.161 177.423 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 132' ' ' VAL . . . . . 0.462 ' HA ' ' HA ' ' A' ' 22' ' ' PHE . 3.0 p -61.44 107.73 0.44 Allowed 'Isoleucine or valine' 0 CA--C 1.551 1.01 0 CA-C-O 121.885 0.85 . . . . 74.11 110.404 178.505 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 133' ' ' LYS . . . . . 0.533 ' HB2' ' HZ1' ' A' ' 133' ' ' LYS . 0.1 OUTLIER -80.9 -36.48 31.11 Favored 'General case' 0 CA--C 1.547 0.832 0 CA-C-N 114.821 -1.081 . . . . 72.31 110.385 -177.595 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 50.8 mt-10 -137.66 147.04 44.57 Favored 'General case' 0 N--CA 1.483 1.218 0 C-N-CA 124.766 1.226 . . . . 74.32 108.794 -178.734 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 80.15 14.92 79.78 Favored Glycine 0 C--N 1.344 0.982 0 O-C-N 123.208 0.318 . . . . 52.41 113.038 -177.602 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 136' ' ' MET . . . . . 0.549 ' HE2' ' HA ' ' A' ' 116' ' ' THR . 12.9 tpt -65.23 -40.83 94.6 Favored 'General case' 0 N--CA 1.473 0.683 0 C-N-CA 123.482 0.713 . . . . 71.41 110.198 174.339 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 137' ' ' ASN . . . . . . . . . . . . . 17.7 m120 -59.35 -35.34 73.69 Favored 'General case' 0 N--CA 1.481 1.081 0 C-N-CA 123.384 0.673 . . . . 74.2 111.427 176.246 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 138' ' ' ILE . . . . . 0.531 ' O ' ' HG3' ' A' ' 142' ' ' MET . 36.4 mm -60.25 -56.27 18.68 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.834 0 N-CA-C 109.277 -0.638 . . . . 75.01 109.277 172.998 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 91.3 t -54.81 -42.72 63.93 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.445 0 C-N-CA 124.21 1.004 . . . . 73.01 111.727 -175.857 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 46.1 mt-10 -67.38 -36.48 81.42 Favored 'General case' 0 N--CA 1.483 1.187 0 C-N-CA 123.824 0.849 . . . . 74.44 111.101 179.676 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -71.63 -25.05 61.99 Favored 'General case' 0 N--CA 1.478 0.973 0 CA-C-N 115.932 -0.577 . . . . 71.44 111.756 175.231 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 142' ' ' MET . . . . . 0.531 ' HG3' ' O ' ' A' ' 138' ' ' ILE . 35.4 mtp -83.52 -22.9 32.31 Favored 'General case' 0 N--CA 1.485 1.282 0 C-N-CA 122.701 0.4 . . . . 65.12 111.172 178.351 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 143' ' ' GLU . . . . . 0.446 ' HA ' HG23 ' A' ' 56' ' ' ILE . 37.5 tt0 -63.44 -25.46 68.28 Favored 'General case' 0 CA--C 1.547 0.852 0 O-C-N 123.786 0.679 . . . . 75.23 110.935 174.025 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 144' ' ' ARG . . . . . . . . . . . . . 51.2 mtp85 -67.82 -18.82 64.96 Favored 'General case' 0 CA--C 1.547 0.847 0 C-N-CA 123.944 0.898 . . . . 73.34 111.916 178.384 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 145' ' ' PHE . . . . . . . . . . . . . 89.9 m-85 -85.47 -21.22 28.8 Favored 'General case' 0 N--CA 1.48 1.037 0 C-N-CA 123.135 0.574 . . . . 71.32 110.793 175.003 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . -73.33 169.83 52.84 Favored Glycine 0 C--N 1.35 1.308 0 N-CA-C 114.135 0.414 . . . . 70.3 114.135 -177.439 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 15.2 m -131.68 165.32 23.97 Favored 'General case' 0 N--CA 1.484 1.242 0 C-N-CA 124.356 1.063 . . . . 75.32 110.418 -176.444 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 148' ' ' ARG . . . . . . . . . . . . . 15.2 mmm180 -60.6 -38.57 85.13 Favored 'General case' 0 N--CA 1.485 1.305 0 C-N-CA 124.135 0.974 . . . . 75.01 111.901 -177.435 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 149' ' ' ASN . . . . . . . . . . . . . 26.6 p-10 -80.08 -7.34 58.83 Favored 'General case' 0 N--CA 1.481 1.099 0 C-N-CA 123.629 0.772 . . . . 73.31 111.857 179.784 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 150' ' ' GLY . . . . . 0.435 ' O ' ' HA ' ' A' ' 55' ' ' ARG . . . 102.41 -4.06 50.92 Favored Glycine 0 C--N 1.348 1.202 0 CA-C-O 119.648 -0.529 . . . . 75.22 113.381 -179.434 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 87.0 tttt -64.54 134.62 54.77 Favored 'General case' 0 N--CA 1.476 0.87 0 CA-C-N 117.573 0.686 . . . . 73.22 110.607 -179.733 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 152' ' ' THR . . . . . . . . . . . . . 67.4 p -95.2 126.2 40.37 Favored 'General case' 0 C--O 1.242 0.669 0 N-CA-C 108.57 -0.9 . . . . 64.15 108.57 170.168 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 153' ' ' SER . . . . . . . . . . . . . 38.8 t -60.02 -42.34 94.13 Favored 'General case' 0 N--CA 1.477 0.893 0 C-N-CA 123.568 0.747 . . . . 74.41 109.766 178.152 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 28.6 mmtp -114.69 154.54 28.27 Favored 'General case' 0 C--O 1.242 0.687 0 CA-C-N 114.928 -1.033 . . . . 65.11 109.96 179.784 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 57.1 tptt -78.15 89.59 4.25 Favored 'General case' 0 CA--C 1.54 0.59 0 N-CA-C 109.04 -0.726 . . . . 75.43 109.04 179.879 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 156' ' ' ILE . . . . . . . . . . . . . 64.1 mt -84.37 116.12 27.56 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.488 0 N-CA-C 108.974 -0.75 . . . . 75.2 108.974 -176.034 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 157' ' ' THR . . . . . 0.414 ' HA ' ' HA ' ' A' ' 52' ' ' CYS . 50.5 p -120.41 159.97 24.03 Favored 'General case' 0 N--CA 1.479 1.018 0 C-N-CA 124.242 1.017 . . . . 64.12 110.288 -176.063 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 158' ' ' ILE . . . . . 0.501 HD11 ' HB2' ' A' ' 51' ' ' SER . 60.3 mt -87.82 100.05 9.64 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.647 0 N-CA-C 107.337 -1.357 . . . . 75.52 107.337 164.768 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 159' ' ' ALA . . . . . 0.507 ' HB2' ' HB1' ' A' ' 11' ' ' ALA . . . -57.56 -50.81 71.87 Favored 'General case' 0 N--CA 1.474 0.756 0 C-N-CA 124.193 0.997 . . . . 71.11 111.814 -177.686 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 160' ' ' ASP . . . . . . . . . . . . . 1.8 t70 -148.75 -179.15 6.77 Favored 'General case' 0 N--CA 1.48 1.049 0 CA-C-N 116.712 -0.222 . . . . 71.0 111.46 -174.049 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 161' ' ' CYS . . . . . . . . . . . . . 26.8 p -154.11 -169.07 3.14 Favored 'General case' 0 N--CA 1.475 0.816 0 C-N-CA 124.659 1.183 . . . . 62.41 108.992 -176.208 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 162' ' ' GLY . . . . . . . . . . . . . . . 136.46 53.11 0.06 OUTLIER Glycine 0 N--CA 1.475 1.287 0 N-CA-C 111.53 -0.628 . . . . 64.25 111.53 -166.056 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 163' ' ' GLN . . . . . 0.537 ' HG3' ' HA ' ' A' ' 6' ' ' VAL . 30.3 tt0 -45.8 117.43 1.48 Allowed 'General case' 0 N--CA 1.476 0.83 0 C-N-CA 126.588 1.955 . . . . 74.11 112.434 -179.869 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 164' ' ' LEU . . . . . . . . . . . . . 78.1 mt -89.3 98.48 11.79 Favored 'General case' 0 N--CA 1.466 0.343 0 N-CA-C 107.974 -1.121 . . . . 72.42 107.974 179.935 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 165' ' ' GLU . . . . . . . . . . . . . 11.3 pt-20 . . . . . 0 C--O 1.254 1.324 0 C-N-CA 123.946 0.898 . . . . 72.53 110.096 -172.922 . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' B' B ' 216' ' ' PRO . . . . . . . . . . . . . 2.6 Cg_exo . . . . . 0 N--CA 1.489 1.221 0 N-CA-C 110.264 -0.706 . . . . 71.01 110.264 . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' B' B ' 217' ' ' GLU . . . . . . . . . . . . . 5.7 tp10 -102.89 101.03 18.54 Favored Pre-proline 0 CA--C 1.554 1.121 0 N-CA-C 108.968 -0.753 . . . . 75.15 108.968 176.144 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 218' ' ' PRO . . . . . . . . . . . . . 86.3 Cg_endo -90.03 79.72 0.7 Allowed 'Trans proline' 0 C--N 1.382 2.291 0 C-N-CA 122.923 2.415 . . . . 75.53 111.611 179.312 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 219' ' ' GLY . . . . . . . . . . . . . . . 171.73 -169.7 42.74 Favored Glycine 0 CA--C 1.531 1.093 0 CA-C-N 115.586 -0.734 . . . . 61.43 113.196 179.75 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 220' ' ' PRO . . . . . . . . . . . . . 87.4 Cg_endo -76.37 159.16 36.56 Favored 'Trans proline' 0 C--N 1.368 1.604 0 C-N-CA 123.999 3.133 . . . . 73.21 114.128 177.067 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 221' ' ' TYR . . . . . . . . . . . . . 66.3 m-85 -84.06 140.59 31.73 Favored 'General case' 0 N--CA 1.491 1.601 0 C-N-CA 123.49 0.716 . . . . 72.34 111.876 -176.907 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 222' ' ' ALA . . . . . . . . . . . . . . . -127.37 -176.17 3.66 Favored 'General case' 0 N--CA 1.481 1.081 0 C-N-CA 124.065 0.946 . . . . 70.1 112.711 -173.281 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 223' ' ' GLN . . . . . 0.599 HE22 ' HB2' ' A' ' 60' ' ' PHE . 0.9 OUTLIER -74.77 126.99 87.87 Favored Pre-proline 0 CA--C 1.551 0.995 0 CA-C-N 114.853 -1.067 . . . . 73.15 109.314 176.128 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' B' B ' 224' ' ' PRO . . . . . . . . . . . . . 36.5 Cg_endo . . . . . 0 C--N 1.379 2.161 0 C-N-CA 123.046 2.497 . . . . 73.12 112.821 -176.7 . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 1' ' ' MET . . . . . 0.565 ' SD ' ' HE3' ' A' ' 28' ' ' LYS . 93.7 mmm . . . . . 0 N--CA 1.483 1.188 0 N-CA-C 110.179 -0.304 . . . . 64.13 110.179 . . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 2' ' ' VAL . . . . . 0.5 HG13 ' HB3' ' A' ' 27' ' ' ASP . 3.4 p -143.69 87.79 0.32 Allowed 'Isoleucine or valine' 0 N--CA 1.477 0.89 0 CA-C-O 122.542 1.163 . . . . 75.42 108.405 172.844 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 15.2 m120 -99.62 108.67 52.11 Favored Pre-proline 0 CA--C 1.549 0.928 0 CA-C-N 113.915 -1.493 . . . . 74.1 111.731 -175.663 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 4' ' ' PRO . . . . . 0.47 ' HG2' ' HB2' ' A' ' 24' ' ' LEU . 59.9 Cg_endo -73.69 146.41 38.49 Favored 'Trans proline' 0 C--N 1.374 1.871 0 C-N-CA 122.376 2.051 . . . . 73.45 111.403 166.232 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 5' ' ' THR . . . . . 0.459 ' HB ' ' O ' ' A' ' 164' ' ' LEU . 84.2 m -96.7 135.92 37.95 Favored 'General case' 0 CA--C 1.536 0.423 0 C-N-CA 123.344 0.658 . . . . 73.14 109.29 177.736 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . 0.486 ' HB ' ' HB2' ' A' ' 22' ' ' PHE . 23.3 t -100.19 147.08 7.96 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.485 0 N-CA-C 107.831 -1.174 . . . . 75.12 107.831 176.25 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 7' ' ' PHE . . . . . 0.482 ' H ' ' HA ' ' A' ' 163' ' ' GLN . 45.7 t80 -126.73 120.73 30.1 Favored 'General case' 0 C--O 1.237 0.412 0 N-CA-C 109.093 -0.706 . . . . 71.31 109.093 175.951 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 8' ' ' PHE . . . . . 0.415 ' HD2' ' HE2' ' A' ' 22' ' ' PHE . 30.6 m-85 -129.86 166.2 20.46 Favored 'General case' 0 N--CA 1.47 0.556 0 C-N-CA 123.864 0.865 . . . . 64.3 109.008 165.925 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 24.8 m-20 -117.82 122.9 44.6 Favored 'General case' 0 N--CA 1.466 0.349 0 N-CA-C 107.641 -1.244 . . . . 74.51 107.641 169.903 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 46.5 mm -87.2 124.41 40.63 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.509 0 N-CA-C 108.914 -0.772 . . . . 64.11 108.914 178.955 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 11' ' ' ALA . . . . . 0.826 ' HB3' ' HB2' ' A' ' 159' ' ' ALA . . . -118.82 128.13 54.17 Favored 'General case' 0 N--CA 1.469 0.483 0 C-N-CA 123.599 0.759 . . . . 75.12 110.695 -174.882 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . 0.455 HG11 ' HB3' ' A' ' 154' ' ' LYS . 96.0 t -95.81 107.91 20.33 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.48 0 N-CA-C 107.819 -1.178 . . . . 71.3 107.819 173.696 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 29.0 m-20 64.72 25.24 12.98 Favored 'General case' 0 N--CA 1.485 1.301 0 C-N-CA 125.284 1.434 . . . . 63.03 111.97 -175.926 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 87.24 1.36 84.22 Favored Glycine 0 C--N 1.348 1.249 0 CA-C-N 116.377 -0.374 . . . . 64.13 113.186 -177.061 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 17.5 mm-40 -94.46 113.49 61.07 Favored Pre-proline 0 CA--C 1.543 0.679 0 N-CA-C 108.584 -0.895 . . . . 64.34 108.584 175.125 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 26.4 Cg_endo -59.89 106.31 0.32 Allowed 'Trans proline' 0 C--N 1.38 2.197 0 C-N-CA 122.627 2.218 . . . . 73.42 112.181 -175.879 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 47.2 tp -75.49 -34.43 60.86 Favored 'General case' 0 N--CA 1.476 0.834 0 C-N-CA 124.178 0.991 . . . . 64.33 109.42 -179.348 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 178.47 177.44 47.15 Favored Glycine 0 C--N 1.343 0.919 0 CA-C-N 115.574 -0.739 . . . . 71.22 113.29 175.748 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 37.4 ptt85 -107.26 136.1 47.65 Favored 'General case' 0 C--O 1.24 0.584 0 C-N-CA 124.3 1.04 . . . . 75.2 108.998 177.05 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 20' ' ' VAL . . . . . 0.455 ' HA ' ' HA3' ' A' ' 135' ' ' GLY . 33.2 t -127.2 134.35 66.14 Favored 'Isoleucine or valine' 0 C--O 1.243 0.721 0 C-N-CA 123.122 0.569 . . . . 74.53 109.96 -178.856 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 21' ' ' SER . . . . . 0.434 ' HA ' ' O ' ' A' ' 6' ' ' VAL . 50.8 p -114.23 124.28 51.65 Favored 'General case' 0 CA--C 1.55 0.976 0 C-N-CA 123.83 0.852 . . . . 75.31 109.769 175.75 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 22' ' ' PHE . . . . . 0.486 ' HB2' ' HB ' ' A' ' 6' ' ' VAL . 60.7 m-85 -101.83 170.14 8.34 Favored 'General case' 0 N--CA 1.477 0.883 0 C-N-CA 123.903 0.881 . . . . 74.22 110.496 -179.962 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 35.0 tt0 -134.91 102.88 5.38 Favored 'General case' 0 N--CA 1.476 0.875 0 C-N-CA 123.649 0.78 . . . . 71.21 109.817 -175.225 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . 0.47 ' HB2' ' HG2' ' A' ' 4' ' ' PRO . 48.1 mt -82.02 131.78 35.25 Favored 'General case' 0 N--CA 1.478 0.97 0 C-N-CA 122.966 0.506 . . . . 73.32 110.423 -179.807 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 52.7 m-85 -86.93 69.06 10.24 Favored 'General case' 0 N--CA 1.469 0.506 0 N-CA-C 108.856 -0.794 . . . . 73.41 108.856 175.188 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -66.52 -12.89 59.8 Favored 'General case' 0 N--CA 1.483 1.184 0 CA-C-N 115.418 -0.81 . . . . 64.25 112.497 -175.114 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 27' ' ' ASP . . . . . 0.5 ' HB3' HG13 ' A' ' 2' ' ' VAL . 11.1 p-10 -85.33 -34.85 21.75 Favored 'General case' 0 CA--C 1.545 0.756 0 C-N-CA 123.694 0.798 . . . . 74.11 111.482 175.323 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 28' ' ' LYS . . . . . 0.565 ' HE3' ' SD ' ' A' ' 1' ' ' MET . 96.7 mttt -93.83 -33.48 13.53 Favored 'General case' 0 N--CA 1.489 1.496 0 C-N-CA 123.099 0.56 . . . . 72.35 111.903 -172.709 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 29' ' ' VAL . . . . . 0.539 HG21 ' HA ' ' A' ' 129' ' ' PHE . 4.4 m -135.92 69.36 64.65 Favored Pre-proline 0 N--CA 1.481 1.103 0 C-N-CA 123.873 0.869 . . . . 71.41 109.07 177.45 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 37.1 Cg_exo -58.11 -35.28 98.87 Favored 'Trans proline' 0 C--N 1.381 2.26 0 C-N-CA 122.79 2.327 . . . . 74.42 113.42 -173.04 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 87.8 tttt -69.85 -50.27 44.27 Favored 'General case' 0 N--CA 1.472 0.664 0 C-N-CA 123.67 0.788 . . . . 72.11 111.776 -178.341 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 7.4 m -73.61 -29.6 62.48 Favored 'General case' 0 CA--C 1.556 1.211 0 C-N-CA 122.975 0.51 . . . . 73.41 111.113 -172.637 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -77.26 -36.01 54.8 Favored 'General case' 0 CA--C 1.547 0.855 0 C-N-CA 123.379 0.672 . . . . 74.14 110.875 175.46 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 12.2 tp10 -60.62 -42.87 97.71 Favored 'General case' 0 N--CA 1.488 1.46 0 C-N-CA 124.041 0.937 . . . . 72.01 109.942 175.102 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 35' ' ' ASN . . . . . 0.451 ' ND2' ' SD ' ' A' ' 100' ' ' MET . 43.3 t30 -55.58 -60.33 3.59 Favored 'General case' 0 C--N 1.347 0.498 0 CA-C-N 113.75 -1.568 . . . . 73.25 110.892 177.997 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 70.0 t80 -62.19 -34.12 75.83 Favored 'General case' 0 N--CA 1.471 0.618 0 O-C-N 124.361 1.038 . . . . 61.51 111.574 -174.838 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 42.1 ttp180 -64.99 -44.19 90.1 Favored 'General case' 0 C--N 1.348 0.512 0 O-C-N 123.605 0.566 . . . . 75.32 110.841 177.278 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 38' ' ' ALA . . . . . 0.521 ' HB2' HG23 ' A' ' 78' ' ' ILE . . . -73.65 -26.02 60.56 Favored 'General case' 0 N--CA 1.475 0.785 0 C-N-CA 122.896 0.479 . . . . 72.22 111.568 -178.875 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 39' ' ' LEU . . . . . 0.559 HD23 ' HE1' ' A' ' 48' ' ' TYR . 90.3 mt -68.78 -40.16 79.8 Favored 'General case' 0 CA--C 1.549 0.912 0 C-N-CA 123.705 0.802 . . . . 73.35 109.911 172.693 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 47.2 t -71.7 -51.29 23.73 Favored 'General case' 0 N--CA 1.476 0.856 0 C-N-CA 124.311 1.044 . . . . 73.13 111.329 -178.334 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 53.1 p -72.42 -31.4 65.46 Favored 'General case' 0 N--CA 1.471 0.612 0 C-N-CA 123.703 0.801 . . . . 60.11 111.652 -175.917 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 79.03 21.93 66.9 Favored Glycine 0 C--N 1.346 1.124 0 CA-C-N 115.895 -0.593 . . . . 63.14 113.794 178.151 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 30.9 mm-40 -62.08 -31.33 71.75 Favored 'General case' 0 N--CA 1.477 0.897 0 C-N-CA 123.302 0.641 . . . . 73.21 110.707 174.213 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 44' ' ' LYS . . . . . 0.423 ' HG2' ' HB1' ' A' ' 38' ' ' ALA . 30.5 mmmt -95.74 19.4 11.33 Favored 'General case' 0 CA--C 1.544 0.717 0 C-N-CA 123.896 0.878 . . . . 73.25 111.853 179.957 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 85.83 -9.65 68.01 Favored Glycine 0 C--N 1.353 1.508 0 N-CA-C 114.994 0.757 . . . . 73.35 114.994 170.802 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 22.3 m-85 -86.45 -50.23 7.03 Favored 'General case' 0 N--CA 1.478 0.956 0 CA-C-N 118.064 0.932 . . . . 74.42 111.473 -170.453 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 44.98 65.12 1.93 Allowed Glycine 0 C--N 1.361 1.946 0 O-C-N 124.634 1.209 . . . . 74.23 115.172 169.824 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 48' ' ' TYR . . . . . 0.559 ' HD2' ' HG ' ' A' ' 51' ' ' SER . 79.3 m-85 -60.07 86.09 0.01 OUTLIER 'General case' 0 N--CA 1.487 1.383 0 CA-C-O 122.241 1.019 . . . . 73.31 111.903 -173.731 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 27.6 tptp -114.72 128.49 56.34 Favored 'General case' 0 C--O 1.239 0.527 0 CA-C-N 113.376 -1.738 . . . . 74.13 108.515 -178.865 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 63.35 20.55 63.37 Favored Glycine 0 N--CA 1.476 1.317 0 O-C-N 123.255 0.347 . . . . 63.02 112.708 -173.321 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 51' ' ' SER . . . . . 0.559 ' HG ' ' HD2' ' A' ' 48' ' ' TYR . 27.0 t -76.12 123.73 26.28 Favored 'General case' 0 C--N 1.346 0.456 0 C-N-CA 123.119 0.567 . . . . 75.2 110.575 -171.137 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 52' ' ' CYS . . . . . 0.451 ' SG ' ' HD3' ' A' ' 155' ' ' LYS . 51.5 t -81.45 161.86 23.52 Favored 'General case' 0 CA--C 1.539 0.53 0 O-C-N 123.967 0.792 . . . . 73.4 112.537 -171.631 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 12.7 m-85 -111.67 131.47 55.27 Favored 'General case' 0 CA--C 1.537 0.465 0 N-CA-C 107.068 -1.456 . . . . 74.44 107.068 169.544 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 54' ' ' HIS . . . . . 0.43 ' HD1' ' HB2' ' A' ' 66' ' ' ASP . 47.9 p-80 -114.18 -29.35 6.98 Favored 'General case' 0 N--CA 1.496 1.866 0 CA-C-N 118.695 0.68 . . . . 74.21 112.348 -174.016 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 42.6 ttt-85 -119.62 98.29 6.05 Favored 'General case' 0 N--CA 1.473 0.724 0 N-CA-C 108.544 -0.91 . . . . 74.54 108.544 -176.603 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 59.5 mt -130.27 127.96 63.57 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.614 0 C-N-CA 123.807 0.843 . . . . 63.33 108.974 179.825 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 61.4 mt -127.83 118.88 21.12 Favored Pre-proline 0 CA--C 1.553 1.078 0 N-CA-C 108.189 -1.041 . . . . 75.42 108.189 176.848 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 58' ' ' PRO . . . . . 0.437 ' HB3' ' HA ' ' A' ' 144' ' ' ARG . 64.0 Cg_endo -70.35 139.02 37.24 Favored 'Trans proline' 0 C--N 1.379 2.154 0 C-N-CA 123.163 2.576 . . . . 75.42 111.98 -174.028 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 79.0 24.41 61.83 Favored Glycine 0 C--N 1.338 0.645 0 CA-C-N 115.204 -0.907 . . . . 34.0 112.325 -175.728 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 27.9 t80 -150.34 -76.87 0.14 Allowed 'General case' 0 CA--C 1.544 0.724 0 C-N-CA 123.778 0.831 . . . . 74.43 109.884 179.356 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 61' ' ' MET . . . . . 0.43 ' HG3' ' HG ' ' A' ' 115' ' ' CYS . 38.7 ttp -166.98 150.46 6.65 Favored 'General case' 0 N--CA 1.485 1.306 0 CA-C-O 120.912 0.386 . . . . 65.42 111.781 -164.412 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 62' ' ' CYS . . . . . . . . . . . . . 4.9 p -127.83 120.86 28.71 Favored 'General case' 0 N--CA 1.478 0.932 0 C-N-CA 124.829 1.251 . . . . 74.13 109.57 176.552 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 14.2 pt20 -128.26 144.97 51.18 Favored 'General case' 0 N--CA 1.491 1.62 0 CA-C-O 121.428 0.632 . . . . 73.01 112.375 -176.156 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -163.61 -147.27 5.01 Favored Glycine 0 C--N 1.348 1.227 0 CA-C-N 114.406 -1.27 . . . . 70.44 113.556 -174.609 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 90.66 12.32 61.01 Favored Glycine 0 C--N 1.345 1.062 0 N-CA-C 110.588 -1.005 . . . . 73.22 110.588 -161.878 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 66' ' ' ASP . . . . . 0.43 ' HB2' ' HD1' ' A' ' 54' ' ' HIS . 38.9 t70 -61.69 -43.64 98.47 Favored 'General case' 0 N--CA 1.472 0.66 0 C-N-CA 125.313 1.445 . . . . 74.53 112.543 -162.085 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 50.2 t80 -49.37 -36.77 22.61 Favored 'General case' 0 CA--C 1.552 1.042 0 O-C-N 124.598 1.186 . . . . 72.25 112.695 -170.236 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 54.3 m -88.11 108.23 19.15 Favored 'General case' 0 CA--C 1.545 0.782 0 C-N-CA 122.957 0.503 . . . . 71.31 110.522 176.147 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 31.8 mtp180 58.73 53.87 5.64 Favored 'General case' 0 N--CA 1.479 0.993 0 C-N-CA 124.963 1.305 . . . . 74.22 111.657 172.797 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 10.0 p80 -63.34 -13.17 36.16 Favored 'General case' 0 N--CA 1.482 1.172 0 N-CA-C 114.233 1.197 . . . . 74.35 114.233 -173.874 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 6.6 t30 -68.61 84.84 0.29 Allowed 'General case' 0 CA--C 1.552 1.049 0 C-N-CA 123.253 0.621 . . . . 71.23 110.159 179.163 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 64.47 13.95 56.19 Favored Glycine 0 C--N 1.353 1.506 0 N-CA-C 115.62 1.008 . . . . 75.24 115.62 176.397 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 6.9 m -125.0 -68.01 0.87 Allowed 'General case' 0 N--CA 1.476 0.851 0 N-CA-C 109.188 -0.671 . . . . 73.12 109.188 -178.228 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 57.3 50.45 64.59 Favored Glycine 0 C--N 1.353 1.515 0 O-C-N 124.559 1.162 . . . . 74.31 115.141 171.66 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 128.83 50.81 0.13 Allowed Glycine 0 C--N 1.35 1.335 0 CA-C-N 117.833 0.817 . . . . 64.23 113.281 178.837 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 14.1 ptmm? -64.27 165.6 9.26 Favored 'General case' 0 N--CA 1.482 1.15 0 C-N-CA 123.133 0.573 . . . . 73.43 112.338 -179.042 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 84.0 p -92.77 173.8 7.58 Favored 'General case' 0 N--CA 1.472 0.655 0 CA-C-N 115.893 -0.594 . . . . 73.35 111.392 -172.811 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 78' ' ' ILE . . . . . 0.521 HG23 ' HB2' ' A' ' 38' ' ' ALA . 23.1 pt -81.0 -20.99 11.13 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.609 0 CA-C-N 115.856 -0.611 . . . . 74.54 109.877 172.638 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 79' ' ' TYR . . . . . 0.418 ' HE2' ' HB2' ' A' ' 35' ' ' ASN . 64.0 m-85 -86.62 12.53 10.37 Favored 'General case' 0 CA--C 1.546 0.821 0 C-N-CA 123.767 0.827 . . . . 73.53 110.134 175.683 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 121.17 -152.5 16.79 Favored Glycine 0 C--N 1.354 1.549 0 C-N-CA 123.126 0.393 . . . . 64.44 112.784 171.203 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 34.3 tt0 -52.13 -53.24 45.21 Favored 'General case' 0 N--CA 1.471 0.597 0 C-N-CA 124.816 1.246 . . . . 72.45 109.396 171.993 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 82' ' ' LYS . . . . . 0.674 ' HD2' ' HA ' ' A' ' 107' ' ' THR . 20.7 pttp -169.52 156.06 6.46 Favored 'General case' 0 CA--C 1.548 0.888 0 CA-C-N 114.549 -1.205 . . . . 74.11 109.697 -178.319 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 9.7 p90 -131.68 174.78 9.77 Favored 'General case' 0 N--CA 1.48 1.029 0 C-N-CA 124.341 1.056 . . . . 70.35 110.57 -179.943 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 84' ' ' GLU . . . . . 0.555 ' HA ' ' HA ' ' A' ' 106' ' ' ASN . 0.0 OUTLIER -70.98 168.68 16.51 Favored 'General case' 0 N--CA 1.479 0.992 0 CA-C-N 115.759 -0.655 . . . . 75.12 111.582 -179.483 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 56.6 m-20 -80.58 111.39 16.95 Favored 'General case' 0 N--CA 1.47 0.571 0 N-CA-C 108.289 -1.004 . . . . 74.15 108.289 173.839 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 3.9 tp10 -46.98 -53.27 12.73 Favored 'General case' 0 N--CA 1.481 1.097 0 C-N-CA 124.895 1.278 . . . . 73.45 112.636 -175.0 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 87' ' ' ASN . . . . . 0.401 ' OD1' HG23 ' A' ' 127' ' ' VAL . 32.3 p30 -159.6 -165.62 1.58 Allowed 'General case' 0 N--CA 1.473 0.683 0 C-N-CA 123.62 0.768 . . . . 74.12 109.589 -176.17 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 93.7 m-85 -137.27 29.8 2.72 Favored 'General case' 0 N--CA 1.485 1.284 0 C-N-CA 123.868 0.867 . . . . 61.12 110.274 176.004 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 65.9 mt -60.07 -49.77 82.77 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.247 0 CA-C-O 121.866 0.841 . . . . 75.31 109.791 176.482 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 90' ' ' LEU . . . . . 0.615 ' HB3' ' HB ' ' A' ' 128' ' ' VAL . 92.3 mt -96.23 99.63 11.33 Favored 'General case' 0 C--O 1.237 0.436 0 CA-C-N 114.565 -1.198 . . . . 74.41 110.102 -175.969 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 91' ' ' LYS . . . . . 0.572 ' HB3' ' HZ1' ' A' ' 91' ' ' LYS . 8.7 mtpm? -76.31 149.7 37.02 Favored 'General case' 0 CA--C 1.543 0.69 0 C-N-CA 123.567 0.747 . . . . 75.1 110.204 176.771 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 92' ' ' HIS . . . . . . . . . . . . . 18.2 t-80 -87.43 28.45 0.97 Allowed 'General case' 0 N--CA 1.482 1.126 0 C-N-CA 124.21 1.004 . . . . 73.4 111.368 -169.412 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 14.5 t -99.87 16.46 23.69 Favored 'General case' 0 CA--C 1.552 1.051 0 C-N-CA 123.819 0.848 . . . . 75.24 111.628 -166.996 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -113.17 161.12 12.79 Favored Glycine 0 CA--C 1.534 1.255 0 CA-C-O 119.443 -0.643 . . . . 72.52 112.1 176.937 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 86.7 Cg_endo -83.4 154.2 14.04 Favored 'Trans proline' 0 C--N 1.367 1.544 0 C-N-CA 122.816 2.344 . . . . 75.2 111.957 171.408 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 71.12 19.76 77.49 Favored Glycine 0 C--N 1.35 1.312 0 N-CA-C 113.8 0.28 . . . . 54.35 113.8 -179.944 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 97' ' ' ILE . . . . . 0.435 HG21 HG11 ' A' ' 128' ' ' VAL . 24.6 mm -77.27 125.15 36.81 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.808 0 C-N-CA 123.231 0.612 . . . . 75.21 112.042 -175.65 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 98' ' ' LEU . . . . . 0.665 ' HG ' HG12 ' A' ' 114' ' ' ILE . 7.3 mp -93.11 123.2 36.21 Favored 'General case' 0 C--O 1.241 0.612 0 C-N-CA 123.709 0.804 . . . . 75.25 109.735 168.038 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 99' ' ' SER . . . . . 0.432 ' HG ' ' HA ' ' A' ' 128' ' ' VAL . 25.9 m -139.96 144.14 36.9 Favored 'General case' 0 N--CA 1.474 0.747 0 N-CA-C 107.737 -1.209 . . . . 72.12 107.737 168.876 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 100' ' ' MET . . . . . 0.54 ' HA ' ' HA ' ' A' ' 112' ' ' PHE . 72.1 mtp -75.44 142.28 43.02 Favored 'General case' 0 N--CA 1.482 1.157 0 N-CA-C 108.842 -0.799 . . . . 74.12 108.842 177.668 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 101' ' ' ALA . . . . . 0.541 ' HB1' ' HB2' ' A' ' 111' ' ' GLN . . . -73.97 140.32 45.45 Favored 'General case' 0 C--O 1.24 0.58 0 CA-C-O 121.362 0.601 . . . . 64.2 112.343 -166.805 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 28.6 p-10 -151.8 154.7 36.73 Favored 'General case' 0 C--O 1.237 0.398 0 CA-C-N 114.734 -1.121 . . . . 74.1 109.416 179.444 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -105.27 5.45 32.02 Favored 'General case' 0 CA--C 1.537 0.46 0 CA-C-N 115.538 -0.755 . . . . 75.15 110.261 170.589 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 162.07 -174.3 38.51 Favored Glycine 0 C--N 1.35 1.317 0 CA-C-O 119.661 -0.521 . . . . 54.44 112.387 179.577 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 77.5 Cg_exo -55.39 138.92 81.26 Favored 'Trans proline' 0 C--N 1.374 1.883 0 C-N-CA 123.663 2.909 . . . . 72.03 113.218 175.219 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 106' ' ' ASN . . . . . 0.555 ' HA ' ' HA ' ' A' ' 84' ' ' GLU . 63.9 t30 68.29 10.87 8.11 Favored 'General case' 0 N--CA 1.487 1.399 0 C-N-CA 125.277 1.431 . . . . 75.53 111.64 177.826 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 107' ' ' THR . . . . . 0.674 ' HA ' ' HD2' ' A' ' 82' ' ' LYS . 3.1 m -104.65 -11.64 16.8 Favored 'General case' 0 CA--C 1.552 1.051 0 C-N-CA 123.728 0.811 . . . . 72.14 110.129 176.99 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 10.5 t30 -56.15 139.77 46.36 Favored 'General case' 0 N--CA 1.48 1.043 0 C-N-CA 124.988 1.315 . . . . 74.24 111.651 172.428 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 112.52 3.05 25.74 Favored Glycine 0 N--CA 1.471 1.026 0 CA-C-O 119.924 -0.376 . . . . 71.23 113.137 176.197 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 15.3 p -114.19 122.35 46.54 Favored 'General case' 0 CA--C 1.542 0.648 0 N-CA-C 108.395 -0.965 . . . . 74.05 108.395 172.272 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 111' ' ' GLN . . . . . 0.541 ' HB2' ' HB1' ' A' ' 101' ' ' ALA . 41.0 mt-30 66.03 168.86 0.22 Allowed 'General case' 0 N--CA 1.496 1.846 0 C-N-CA 124.746 1.218 . . . . 73.33 112.416 -175.728 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 112' ' ' PHE . . . . . 0.54 ' HA ' ' HA ' ' A' ' 100' ' ' MET . 51.4 p90 -137.02 140.47 42.12 Favored 'General case' 0 N--CA 1.476 0.827 0 N-CA-C 108.153 -1.054 . . . . 74.42 108.153 168.341 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 113' ' ' PHE . . . . . 0.417 ' HE2' ' HA ' ' A' ' 101' ' ' ALA . 54.4 p90 -128.1 150.02 50.15 Favored 'General case' 0 N--CA 1.471 0.624 0 C-N-CA 122.899 0.48 . . . . 70.35 111.832 179.881 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 114' ' ' ILE . . . . . 0.665 HG12 ' HG ' ' A' ' 98' ' ' LEU . 14.0 mt -120.95 117.9 54.52 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.654 0 CA-C-N 115.12 -0.945 . . . . 75.01 108.666 173.943 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 115' ' ' CYS . . . . . 0.43 ' HG ' ' HG3' ' A' ' 61' ' ' MET . 58.8 m -94.77 110.41 22.27 Favored 'General case' 0 C--O 1.24 0.596 0 N-CA-C 108.311 -0.996 . . . . 73.41 108.311 173.891 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 116' ' ' THR . . . . . 0.463 HG21 ' HA ' ' A' ' 140' ' ' GLU . 72.5 p -71.03 -31.52 68.02 Favored 'General case' 0 N--CA 1.479 0.989 0 C-N-CA 122.51 0.324 . . . . 74.25 111.719 -175.28 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -97.25 163.67 12.81 Favored 'General case' 0 N--CA 1.479 1.004 0 N-CA-C 109.164 -0.68 . . . . 70.42 109.164 168.155 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 118' ' ' LYS . . . . . 0.442 ' HE2' ' HB3' ' A' ' 120' ' ' GLU . 0.0 OUTLIER -70.84 124.71 24.96 Favored 'General case' 0 C--N 1.347 0.466 0 N-CA-C 109.233 -0.654 . . . . 72.43 109.233 175.914 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 119' ' ' THR . . . . . 0.575 ' HB ' HD12 ' A' ' 122' ' ' LEU . 23.0 p -113.02 88.11 2.75 Favored 'General case' 0 C--O 1.238 0.462 0 CA-C-O 121.864 0.84 . . . . 73.24 109.055 179.138 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 120' ' ' GLU . . . . . 0.442 ' HB3' ' HE2' ' A' ' 118' ' ' LYS . 10.5 pt-20 -67.87 -27.16 66.44 Favored 'General case' 0 N--CA 1.478 0.965 0 CA-C-N 114.254 -1.339 . . . . 72.44 112.485 -178.009 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 121' ' ' TRP . . . . . . . . . . . . . 32.5 p90 -78.12 -1.02 30.49 Favored 'General case' 0 N--CA 1.479 1.014 0 C-N-CA 122.768 0.427 . . . . 74.32 111.113 178.49 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 122' ' ' LEU . . . . . 0.575 HD12 ' HB ' ' A' ' 119' ' ' THR . 9.3 mp -96.63 5.7 50.18 Favored 'General case' 0 N--CA 1.48 1.049 0 C-N-CA 123.904 0.882 . . . . 74.51 111.168 171.639 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 25.0 m-20 -72.62 141.12 48.33 Favored 'General case' 0 N--CA 1.481 1.09 0 N-CA-C 109.462 -0.57 . . . . 61.51 109.462 168.879 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 92.98 -28.31 9.68 Favored Glycine 0 N--CA 1.478 1.451 0 N-CA-C 111.759 -0.536 . . . . 74.45 111.759 -173.019 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 1.5 mppt? -73.65 -164.32 0.21 Allowed 'General case' 0 N--CA 1.481 1.084 0 C-N-CA 124.584 1.154 . . . . 74.4 109.538 168.585 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 126' ' ' HIS . . . . . . . . . . . . . 36.2 t60 -66.08 132.94 49.69 Favored 'General case' 0 CA--C 1.542 0.669 0 CA-C-O 121.638 0.733 . . . . 63.31 112.207 -170.853 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 127' ' ' VAL . . . . . 0.401 HG23 ' OD1' ' A' ' 87' ' ' ASN . 7.1 p -59.42 146.64 9.36 Favored 'Isoleucine or valine' 0 CA--C 1.554 1.103 0 CA-C-N 113.797 -1.547 . . . . 73.44 111.155 177.185 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 128' ' ' VAL . . . . . 0.615 ' HB ' ' HB3' ' A' ' 90' ' ' LEU . 42.1 t -62.44 147.05 11.97 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.795 0 C-N-CA 123.686 0.794 . . . . 71.03 110.333 179.625 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 129' ' ' PHE . . . . . 0.539 ' HA ' HG21 ' A' ' 29' ' ' VAL . 36.7 p90 -120.16 -28.83 5.01 Favored 'General case' 0 N--CA 1.476 0.87 0 C-N-CA 122.565 0.346 . . . . 75.23 110.277 170.575 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . -146.09 168.73 27.59 Favored Glycine 0 C--N 1.346 1.112 0 O-C-N 123.525 0.516 . . . . 74.45 112.798 -172.371 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 29.0 ttpt -152.76 134.6 14.69 Favored 'General case' 0 N--CA 1.47 0.541 0 N-CA-C 108.167 -1.049 . . . . 64.2 108.167 -177.611 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 132' ' ' VAL . . . . . 0.506 HG13 ' HA ' ' A' ' 136' ' ' MET . 7.3 t -66.62 109.95 1.36 Allowed 'Isoleucine or valine' 0 CA--C 1.542 0.671 0 N-CA-C 109.433 -0.58 . . . . 73.32 109.433 176.799 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 14.4 ptmm? -87.02 -39.52 15.57 Favored 'General case' 0 N--CA 1.481 1.104 0 N-CA-C 110.134 -0.321 . . . . 75.42 110.134 -178.269 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 134' ' ' GLU . . . . . 0.4 ' HB2' ' OG ' ' A' ' 21' ' ' SER . 20.6 mm-40 -144.53 162.13 37.35 Favored 'General case' 0 N--CA 1.488 1.471 0 C-N-CA 124.711 1.204 . . . . 73.05 108.693 173.316 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 135' ' ' GLY . . . . . 0.455 ' HA3' ' HA ' ' A' ' 20' ' ' VAL . . . 78.7 15.14 81.24 Favored Glycine 0 C--N 1.346 1.125 0 O-C-N 123.349 0.406 . . . . 71.32 112.177 -173.715 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 136' ' ' MET . . . . . 0.506 ' HA ' HG13 ' A' ' 132' ' ' VAL . 15.2 tpt -62.92 -34.38 77.32 Favored 'General case' 0 N--CA 1.472 0.626 0 C-N-CA 124.462 1.105 . . . . 73.42 111.808 -177.047 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 137' ' ' ASN . . . . . . . . . . . . . 27.3 t-20 -61.78 -35.84 79.34 Favored 'General case' 0 N--CA 1.48 1.069 0 C-N-CA 123.455 0.702 . . . . 73.22 111.164 177.571 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 138' ' ' ILE . . . . . . . . . . . . . 43.4 mm -71.12 -33.22 50.43 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.088 0 C-N-CA 123.402 0.681 . . . . 62.14 110.679 179.642 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 139' ' ' VAL . . . . . 0.483 HG13 ' HE3' ' A' ' 142' ' ' MET . 62.0 t -69.76 -44.87 78.79 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.999 0 C-N-CA 123.407 0.683 . . . . 74.22 110.518 176.306 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 140' ' ' GLU . . . . . 0.463 ' HA ' HG21 ' A' ' 116' ' ' THR . 40.0 mt-10 -63.82 -33.58 75.99 Favored 'General case' 0 N--CA 1.476 0.855 0 CA-C-N 115.476 -0.784 . . . . 75.45 110.534 176.882 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -70.37 -43.84 69.3 Favored 'General case' 0 C--O 1.24 0.594 0 C-N-CA 123.662 0.785 . . . . 75.31 111.307 178.124 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 142' ' ' MET . . . . . 0.497 ' HB2' HD12 ' A' ' 156' ' ' ILE . 22.4 ptt? -69.52 -34.09 73.75 Favored 'General case' 0 C--N 1.355 0.843 0 CA-C-N 116.84 -0.164 . . . . 75.11 110.929 -175.691 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 143' ' ' GLU . . . . . 0.421 ' HG2' ' HA ' ' A' ' 58' ' ' PRO . 30.9 tt0 -62.87 -28.99 70.42 Favored 'General case' 0 CA--C 1.559 1.294 0 C-N-CA 122.722 0.409 . . . . 72.45 111.462 -178.968 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 144' ' ' ARG . . . . . 0.437 ' HA ' ' HB3' ' A' ' 58' ' ' PRO . 58.6 mtp85 -68.72 -19.47 64.36 Favored 'General case' 0 N--CA 1.485 1.295 0 C-N-CA 123.589 0.756 . . . . 64.12 112.242 -179.091 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 145' ' ' PHE . . . . . 0.51 ' HB2' HD11 ' A' ' 156' ' ' ILE . 56.6 m-85 -79.95 -8.15 59.18 Favored 'General case' 0 N--CA 1.477 0.897 0 C-N-CA 122.807 0.443 . . . . 71.43 111.321 179.328 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . -78.14 179.59 51.47 Favored Glycine 0 C--N 1.345 1.029 0 O-C-N 123.348 0.405 . . . . 71.05 112.751 172.585 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 46.0 t -133.7 168.4 18.77 Favored 'General case' 0 N--CA 1.476 0.834 0 C-N-CA 123.773 0.829 . . . . 64.1 110.148 -176.893 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 148' ' ' ARG . . . . . . . . . . . . . 18.4 mmm180 -58.55 -37.01 74.82 Favored 'General case' 0 N--CA 1.481 1.107 0 C-N-CA 123.81 0.844 . . . . 73.23 111.863 178.527 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 149' ' ' ASN . . . . . . . . . . . . . 30.2 p-10 -89.78 11.69 19.36 Favored 'General case' 0 N--CA 1.483 1.203 0 C-N-CA 123.217 0.607 . . . . 75.03 112.201 -178.614 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . 86.08 -2.8 87.61 Favored Glycine 0 C--N 1.349 1.277 0 CA-C-O 119.732 -0.482 . . . . 62.41 114.031 177.421 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 35.7 ttmt -63.73 130.79 45.65 Favored 'General case' 0 N--CA 1.474 0.756 0 C-N-CA 123.792 0.837 . . . . 70.42 110.736 179.988 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 152' ' ' THR . . . . . . . . . . . . . 82.2 p -91.91 108.84 20.21 Favored 'General case' 0 C--O 1.239 0.504 0 N-CA-C 108.069 -1.085 . . . . 74.53 108.069 170.388 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 153' ' ' SER . . . . . . . . . . . . . 49.4 m -68.32 -28.92 67.58 Favored 'General case' 0 N--CA 1.473 0.712 0 C-N-CA 123.073 0.549 . . . . 75.22 110.532 177.789 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 154' ' ' LYS . . . . . 0.455 ' HB3' HG11 ' A' ' 12' ' ' VAL . 74.4 mmtt -117.11 139.83 50.26 Favored 'General case' 0 C--O 1.241 0.621 0 C-N-CA 124.155 0.982 . . . . 71.2 109.717 177.277 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 155' ' ' LYS . . . . . 0.451 ' HD3' ' SG ' ' A' ' 52' ' ' CYS . 17.4 tppt? -78.56 89.58 4.5 Favored 'General case' 0 CA--C 1.541 0.603 0 N-CA-C 109.016 -0.735 . . . . 74.31 109.016 179.926 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 156' ' ' ILE . . . . . 0.51 HD11 ' HB2' ' A' ' 145' ' ' PHE . 72.5 mt -86.58 117.53 31.16 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.321 0 CA-C-N 115.503 -0.771 . . . . 75.11 109.051 -177.422 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 157' ' ' THR . . . . . . . . . . . . . 25.1 p -130.88 153.62 48.94 Favored 'General case' 0 C--O 1.238 0.478 0 C-N-CA 124.8 1.24 . . . . 72.41 109.484 -171.898 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 158' ' ' ILE . . . . . 0.458 HD11 ' HZ ' ' A' ' 112' ' ' PHE . 67.7 mt -76.19 93.78 1.05 Allowed 'Isoleucine or valine' 0 CA--C 1.547 0.848 0 N-CA-C 108.633 -0.877 . . . . 64.35 108.633 172.094 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 159' ' ' ALA . . . . . 0.826 ' HB2' ' HB3' ' A' ' 11' ' ' ALA . . . -51.31 -53.03 39.95 Favored 'General case' 0 N--CA 1.483 1.185 0 C-N-CA 123.729 0.812 . . . . 34.43 111.707 -178.899 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 160' ' ' ASP . . . . . . . . . . . . . 1.5 t70 -151.18 176.61 11.02 Favored 'General case' 0 CA--C 1.548 0.897 0 CA-C-N 115.827 -0.624 . . . . 65.44 109.818 -178.557 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 161' ' ' CYS . . . . . . . . . . . . . 9.8 p -148.51 -171.69 3.91 Favored 'General case' 0 N--CA 1.477 0.905 0 C-N-CA 124.459 1.104 . . . . 74.23 109.9 -172.399 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 162' ' ' GLY . . . . . . . . . . . . . . . 131.23 53.39 0.09 OUTLIER Glycine 0 C--N 1.353 1.519 0 N-CA-C 112.238 -0.345 . . . . 72.0 112.238 -172.782 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 163' ' ' GLN . . . . . 0.482 ' HA ' ' H ' ' A' ' 7' ' ' PHE . 27.5 tt0 -46.74 107.08 0.1 Allowed 'General case' 0 CA--C 1.559 1.289 0 C-N-CA 125.234 1.414 . . . . 71.44 112.888 179.953 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 164' ' ' LEU . . . . . 0.459 ' O ' ' HB ' ' A' ' 5' ' ' THR . 84.5 mt -87.37 100.54 12.81 Favored 'General case' 0 N--CA 1.475 0.795 0 C-N-CA 123.898 0.879 . . . . 72.44 109.85 -175.246 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 165' ' ' GLU . . . . . . . . . . . . . 11.4 pt-20 . . . . . 0 N--CA 1.486 1.34 0 CA-C-O 118.945 -0.55 . . . . 75.43 110.68 177.947 . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' B' B ' 216' ' ' PRO . . . . . . . . . . . . . 2.1 Cg_endo . . . . . 0 CA--C 1.542 0.9 0 N-CA-C 110.255 -0.71 . . . . 75.02 110.255 . . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' B' B ' 217' ' ' GLU . . . . . . . . . . . . . 42.9 mt-10 -115.84 162.93 22.97 Favored Pre-proline 0 CA--C 1.545 0.779 0 C-N-CA 124.867 1.267 . . . . 74.42 109.196 178.647 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 218' ' ' PRO . . . . . . . . . . . . . 14.7 Cg_exo -68.54 92.03 0.41 Allowed 'Trans proline' 0 C--N 1.376 2.015 0 C-N-CA 121.818 1.679 . . . . 71.41 108.847 163.865 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 219' ' ' GLY . . . . . . . . . . . . . . . 160.18 156.91 8.37 Favored Glycine 0 CA--C 1.533 1.165 0 CA-C-N 115.753 -0.658 . . . . 74.21 112.057 -175.59 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 220' ' ' PRO . . . . . . . . . . . . . 36.3 Cg_endo -86.23 -179.22 3.07 Favored 'Trans proline' 0 C--N 1.365 1.433 0 C-N-CA 123.753 2.968 . . . . 74.14 113.86 -176.288 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 221' ' ' TYR . . . . . . . . . . . . . 97.0 m-85 -100.38 138.01 38.04 Favored 'General case' 0 N--CA 1.48 1.053 0 C-N-CA 123.333 0.653 . . . . 75.34 111.868 -175.14 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 222' ' ' ALA . . . . . . . . . . . . . . . -81.5 -169.96 2.56 Favored 'General case' 0 N--CA 1.477 0.911 0 C-N-CA 124.829 1.252 . . . . 72.44 112.44 175.791 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 223' ' ' GLN . . . . . . . . . . . . . 9.9 mp0 -53.38 116.23 9.23 Favored Pre-proline 0 CA--C 1.556 1.176 0 C-N-CA 123.934 0.894 . . . . 72.23 108.952 170.871 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 224' ' ' PRO . . . . . . . . . . . . . 5.7 Cg_exo . . . . . 0 C--N 1.38 2.187 0 C-N-CA 122.486 2.124 . . . . 73.31 112.036 -176.009 . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 51.3 ttp . . . . . 0 N--CA 1.478 0.939 0 N-CA-C 109.791 -0.448 . . . . 72.24 109.791 . . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 27.0 m -83.75 -19.68 9.43 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.19 0 C-N-CA 123.82 0.848 . . . . 64.15 111.542 -179.113 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 3' ' ' ASN . . . . . 0.597 ' ND2' ' HA ' ' A' ' 25' ' ' PHE . 14.9 m120 -84.38 118.48 71.25 Favored Pre-proline 0 CA--C 1.545 0.785 0 C-N-CA 123.852 0.861 . . . . 74.34 110.066 -177.66 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 4' ' ' PRO . . . . . 0.507 ' HG2' ' HB2' ' A' ' 24' ' ' LEU . 73.3 Cg_endo -77.48 150.35 28.19 Favored 'Trans proline' 0 C--N 1.374 1.907 0 C-N-CA 122.392 2.061 . . . . 75.22 111.575 170.559 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 5' ' ' THR . . . . . 0.425 ' HB ' ' O ' ' A' ' 164' ' ' LEU . 52.5 m -98.04 142.54 29.63 Favored 'General case' 0 CA--C 1.54 0.566 0 N-CA-C 108.932 -0.766 . . . . 71.54 108.932 175.168 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . 0.707 ' HA ' ' HG3' ' A' ' 163' ' ' GLN . 44.1 t -101.76 150.44 6.1 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.967 0 N-CA-C 107.689 -1.226 . . . . 74.31 107.689 171.125 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 7' ' ' PHE . . . . . 0.426 ' H ' ' HA ' ' A' ' 163' ' ' GLN . 74.2 t80 -133.55 130.77 38.9 Favored 'General case' 0 C--O 1.236 0.37 0 N-CA-C 109.531 -0.544 . . . . 74.51 109.531 175.962 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 8' ' ' PHE . . . . . 0.405 ' HD2' ' HE2' ' A' ' 22' ' ' PHE . 32.3 m-85 -138.2 166.49 24.03 Favored 'General case' 0 C--O 1.237 0.418 0 C-N-CA 124.808 1.243 . . . . 73.42 109.362 170.248 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 8.7 m-20 -117.27 112.19 20.43 Favored 'General case' 0 N--CA 1.468 0.463 0 CA-C-N 114.847 -1.069 . . . . 71.44 108.126 171.555 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 10' ' ' ILE . . . . . 0.42 HG23 ' SD ' ' A' ' 142' ' ' MET . 45.8 mm -83.33 128.57 38.64 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.453 0 N-CA-C 108.673 -0.862 . . . . 74.51 108.673 178.91 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 11' ' ' ALA . . . . . 0.654 ' HB2' ' HB3' ' A' ' 159' ' ' ALA . . . -129.97 141.1 50.81 Favored 'General case' 0 N--CA 1.471 0.614 0 C-N-CA 123.749 0.82 . . . . 63.21 110.58 -173.1 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . 0.518 HG11 ' HB3' ' A' ' 154' ' ' LYS . 86.2 t -97.17 110.89 25.93 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.435 0 C-N-CA 124.173 0.989 . . . . 72.52 108.848 173.533 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 9.9 m-20 58.98 24.29 12.47 Favored 'General case' 0 N--CA 1.485 1.31 0 C-N-CA 124.8 1.24 . . . . 75.4 112.651 179.919 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 106.13 -24.2 27.03 Favored Glycine 0 C--N 1.349 1.304 0 CA-C-O 119.681 -0.511 . . . . 72.12 113.006 179.658 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 24.7 mm-40 -81.78 120.28 77.35 Favored Pre-proline 0 N--CA 1.479 0.991 0 CA-C-O 118.449 -0.786 . . . . 75.2 109.327 179.994 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 19.1 Cg_endo -57.72 114.65 2.05 Favored 'Trans proline' 0 C--N 1.379 2.158 0 C-N-CA 123.107 2.538 . . . . 74.05 112.498 -177.114 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . 0.478 ' HB2' HG23 ' A' ' 12' ' ' VAL . 52.0 tp -79.43 -41.8 26.81 Favored 'General case' 0 N--CA 1.478 0.963 0 C-N-CA 123.735 0.814 . . . . 72.21 110.058 175.765 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -177.69 174.49 46.93 Favored Glycine 0 C--N 1.344 1.024 0 CA-C-N 115.711 -0.677 . . . . 63.5 113.395 179.955 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 19.9 mtp180 -111.2 117.5 33.39 Favored 'General case' 0 N--CA 1.471 0.611 0 N-CA-C 108.456 -0.942 . . . . 75.13 108.456 -175.925 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 86.2 t -113.37 138.48 42.82 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.733 0 C-N-CA 123.78 0.832 . . . . 73.45 110.12 -175.263 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 21' ' ' SER . . . . . 0.4 ' HB2' ' HB2' ' A' ' 134' ' ' GLU . 16.4 m -124.94 135.22 52.62 Favored 'General case' 0 C--O 1.242 0.67 0 C-N-CA 123.661 0.785 . . . . 75.45 110.114 174.901 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 22' ' ' PHE . . . . . 0.454 ' HB2' ' HB ' ' A' ' 6' ' ' VAL . 60.5 m-85 -105.78 170.0 8.15 Favored 'General case' 0 N--CA 1.474 0.765 0 C-N-CA 124.145 0.978 . . . . 64.23 109.912 179.079 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . 0.635 ' HB2' ' HD2' ' A' ' 133' ' ' LYS . 33.0 tt0 -130.76 108.89 10.2 Favored 'General case' 0 N--CA 1.473 0.692 0 C-N-CA 123.689 0.796 . . . . 75.52 109.233 177.948 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . 0.507 ' HB2' ' HG2' ' A' ' 4' ' ' PRO . 88.5 mt -78.54 121.0 24.04 Favored 'General case' 0 N--CA 1.469 0.481 0 C-N-CA 123.377 0.671 . . . . 75.44 109.961 179.149 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 25' ' ' PHE . . . . . 0.597 ' HA ' ' ND2' ' A' ' 3' ' ' ASN . 77.7 m-85 -83.85 68.25 9.88 Favored 'General case' 0 C--O 1.233 0.206 0 CA-C-O 121.65 0.738 . . . . 73.34 109.465 171.904 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -66.21 -21.92 66.32 Favored 'General case' 0 N--CA 1.473 0.704 0 CA-C-N 114.708 -1.133 . . . . 73.21 111.128 179.032 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 10.7 p-10 -72.71 -23.61 60.88 Favored 'General case' 0 CA--C 1.543 0.701 0 C-N-CA 124.029 0.932 . . . . 75.21 111.478 178.292 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 59.5 mttp -104.6 -51.29 3.11 Favored 'General case' 0 N--CA 1.482 1.169 0 C-N-CA 123.613 0.765 . . . . 73.04 110.965 -176.536 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 29' ' ' VAL . . . . . 0.562 ' HA ' ' HG2' ' A' ' 86' ' ' GLU . 5.4 m -124.33 72.92 58.55 Favored Pre-proline 0 CA--C 1.55 0.95 0 C-N-CA 124.099 0.96 . . . . 74.33 110.185 -178.195 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 20.7 Cg_endo -60.7 -29.64 88.76 Favored 'Trans proline' 0 C--N 1.38 2.222 0 C-N-CA 122.671 2.247 . . . . 74.11 113.107 -177.072 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 21.9 ttmm -65.33 -54.12 33.73 Favored 'General case' 0 N--CA 1.481 1.111 0 CA-C-O 121.715 0.769 . . . . 73.32 111.556 -179.428 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 32' ' ' THR . . . . . 0.444 HG21 ' HE2' ' A' ' 126' ' ' HIS . 20.5 m -80.16 -32.17 38.87 Favored 'General case' 0 CA--C 1.547 0.842 0 CA-C-N 114.723 -1.126 . . . . 75.42 111.138 -170.244 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 33' ' ' ALA . . . . . 0.481 ' HB3' ' HB3' ' A' ' 24' ' ' LEU . . . -70.1 -40.82 74.7 Favored 'General case' 0 N--CA 1.473 0.692 0 C-N-CA 122.787 0.435 . . . . 75.32 110.222 174.609 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 9.3 tp10 -62.77 -40.75 98.24 Favored 'General case' 0 N--CA 1.488 1.467 0 O-C-N 123.668 0.605 . . . . 74.52 110.752 176.54 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 35' ' ' ASN . . . . . 0.472 ' O ' ' HG ' ' A' ' 39' ' ' LEU . 40.0 t30 -53.57 -62.91 1.35 Allowed 'General case' 0 C--N 1.349 0.577 0 O-C-N 124.293 0.996 . . . . 75.4 110.433 178.643 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 65.6 t80 -65.53 -33.96 77.13 Favored 'General case' 0 N--CA 1.474 0.743 0 CA-C-N 115.338 -0.846 . . . . 72.52 111.805 -176.167 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 37' ' ' ARG . . . . . 0.547 ' HG3' HE22 ' A' ' 163' ' ' GLN . 32.7 ttt180 -55.21 -49.67 71.34 Favored 'General case' 0 N--CA 1.485 1.293 0 C-N-CA 124.262 1.025 . . . . 71.52 110.728 173.655 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 38' ' ' ALA . . . . . 0.443 ' HB2' HG23 ' A' ' 78' ' ' ILE . . . -76.92 -25.94 53.52 Favored 'General case' 0 CA--C 1.544 0.741 0 CA-C-N 114.314 -1.312 . . . . 61.14 112.07 -174.921 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 39' ' ' LEU . . . . . 0.472 ' HG ' ' O ' ' A' ' 35' ' ' ASN . 95.4 mt -73.39 -40.26 64.45 Favored 'General case' 0 N--CA 1.479 1.022 0 C-N-CA 123.536 0.734 . . . . 72.24 110.2 173.297 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 40.3 t -65.42 -54.74 24.29 Favored 'General case' 0 N--CA 1.479 0.984 0 CA-C-N 114.42 -1.264 . . . . 72.01 110.592 -176.144 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 82.6 p -73.3 -32.09 64.42 Favored 'General case' 0 N--CA 1.472 0.637 0 CA-C-O 121.29 0.567 . . . . 75.2 109.737 177.253 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . 0.447 ' HA3' ' HA2' ' A' ' 47' ' ' GLY . . . 75.39 8.22 83.5 Favored Glycine 0 C--N 1.347 1.186 0 CA-C-N 115.221 -0.899 . . . . 64.21 114.886 171.832 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 47.8 mm-40 -69.07 -4.59 17.69 Favored 'General case' 0 N--CA 1.482 1.146 0 C-N-CA 123.804 0.842 . . . . 64.13 113.046 -178.018 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 44' ' ' LYS . . . . . 0.435 ' HG3' ' HB1' ' A' ' 38' ' ' ALA . 32.3 mmmt -94.0 13.44 22.89 Favored 'General case' 0 CA--C 1.55 0.976 0 C-N-CA 123.565 0.746 . . . . 74.15 111.462 172.356 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 92.52 22.99 27.5 Favored Glycine 0 C--N 1.357 1.709 0 N-CA-C 114.559 0.584 . . . . 63.23 114.559 173.231 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 25.9 m-85 -114.88 -46.71 2.91 Favored 'General case' 0 N--CA 1.487 1.42 0 CA-C-N 117.507 0.654 . . . . 73.22 111.279 -172.069 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . 0.447 ' HA2' ' HA3' ' A' ' 42' ' ' GLY . . . 53.84 63.68 4.91 Favored Glycine 0 C--N 1.346 1.109 0 O-C-N 124.096 0.873 . . . . 71.24 114.64 173.084 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 50.7 m-85 -71.71 84.81 0.9 Allowed 'General case' 0 N--CA 1.485 1.282 0 CA-C-O 122.119 0.962 . . . . 75.01 111.167 177.387 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 49' ' ' LYS . . . . . 0.512 ' HE3' ' HA ' ' A' ' 160' ' ' ASP . 22.2 tptm -116.3 138.56 51.22 Favored 'General case' 0 CA--C 1.538 0.51 0 CA-C-N 113.601 -1.636 . . . . 70.02 107.603 171.851 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 69.45 19.99 74.99 Favored Glycine 0 N--CA 1.478 1.477 0 CA-C-N 118.069 0.395 . . . . 70.04 114.001 177.161 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 25.1 m -70.21 119.34 14.26 Favored 'General case' 0 N--CA 1.471 0.603 0 C-N-CA 123.614 0.765 . . . . 62.42 110.137 -176.436 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 52' ' ' CYS . . . . . . . . . . . . . 21.2 p -90.93 157.54 17.25 Favored 'General case' 0 N--CA 1.474 0.767 0 CA-C-O 121.714 0.769 . . . . 71.22 111.876 -171.518 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 29.1 m-85 -96.25 164.94 12.45 Favored 'General case' 0 C--O 1.24 0.605 0 C-N-CA 124.998 1.319 . . . . 73.45 108.741 175.515 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 19.5 p-80 -149.36 -43.09 0.14 Allowed 'General case' 0 N--CA 1.477 0.897 0 N-CA-C 110.451 -0.203 . . . . 74.44 110.451 -171.222 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 55' ' ' ARG . . . . . 0.472 ' HA ' ' O ' ' A' ' 150' ' ' GLY . 42.2 ttt-85 -121.06 98.81 6.16 Favored 'General case' 0 C--N 1.347 0.49 0 N-CA-C 109.089 -0.708 . . . . 74.23 109.089 -174.578 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 57.0 mt -127.39 127.19 68.75 Favored 'Isoleucine or valine' 0 C--O 1.239 0.527 0 N-CA-C 107.778 -1.193 . . . . 74.25 107.778 176.966 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 68.4 mt -122.44 116.41 29.52 Favored Pre-proline 0 CA--C 1.55 0.967 0 N-CA-C 108.278 -1.008 . . . . 70.13 108.278 -177.386 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 58' ' ' PRO . . . . . 0.415 ' HA ' ' HG2' ' A' ' 143' ' ' GLU . 31.0 Cg_exo -62.46 136.23 57.91 Favored 'Trans proline' 0 C--N 1.379 2.145 0 C-N-CA 123.313 2.675 . . . . 73.25 112.351 -179.346 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 78.86 22.72 65.66 Favored Glycine 0 C--N 1.344 1.019 0 O-C-N 123.78 0.675 . . . . 72.24 112.767 -176.202 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 60' ' ' PHE . . . . . 0.407 ' CD2' ' HB3' ' A' ' 61' ' ' MET . 55.3 t80 -148.01 -69.26 0.23 Allowed 'General case' 0 CA--C 1.55 0.958 0 C-N-CA 123.476 0.71 . . . . 71.4 111.054 -175.058 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 61' ' ' MET . . . . . 0.6 ' HE3' ' SG ' ' A' ' 115' ' ' CYS . 40.5 ttm -175.97 158.16 1.99 Allowed 'General case' 0 N--CA 1.49 1.542 0 N-CA-C 113.245 0.832 . . . . 73.33 113.245 -159.582 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 62' ' ' CYS . . . . . 0.442 ' SG ' ' HB ' ' A' ' 114' ' ' ILE . 24.9 p -122.94 113.75 19.51 Favored 'General case' 0 CA--C 1.549 0.94 0 C-N-CA 124.197 0.999 . . . . 72.14 109.647 168.579 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 57.8 tt0 -112.72 127.48 56.15 Favored 'General case' 0 N--CA 1.489 1.485 0 C-N-CA 124.125 0.97 . . . . 75.14 110.37 -176.145 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -151.47 -157.47 7.9 Favored Glycine 0 C--N 1.348 1.214 0 CA-C-N 115.698 -0.683 . . . . 60.23 113.715 -177.476 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 86.27 -8.13 75.48 Favored Glycine 0 C--N 1.35 1.35 0 N-CA-C 112.04 -0.424 . . . . 62.42 112.04 -167.722 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 38.9 t70 -75.66 86.98 2.72 Favored 'General case' 0 C--N 1.354 0.775 0 C-N-CA 124.638 1.175 . . . . 54.13 109.925 -174.221 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 91.2 t80 -144.42 -55.09 0.34 Allowed 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 114.547 -1.206 . . . . 74.14 108.697 -176.667 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 5.7 t -84.81 122.75 29.59 Favored 'General case' 0 C--O 1.246 0.873 0 C-N-CA 123.146 0.578 . . . . 72.24 109.998 178.804 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 86.0 mtt180 53.85 51.75 14.26 Favored 'General case' 0 N--CA 1.48 1.041 0 C-N-CA 124.369 1.068 . . . . 74.03 109.851 -179.251 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 20.8 p80 -78.4 66.75 4.03 Favored 'General case' 0 CA--C 1.555 1.164 0 CA-C-O 122.32 1.057 . . . . 73.02 112.046 -168.841 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 8.3 t30 -155.08 79.46 1.05 Allowed 'General case' 0 C--O 1.24 0.596 0 N-CA-C 107.289 -1.375 . . . . 75.44 107.289 -177.213 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 72' ' ' GLY . . . . . 0.552 ' HA2' ' HG3' ' B' ' 218' ' ' PRO . . . 79.65 -6.96 56.75 Favored Glycine 0 CA--C 1.533 1.163 0 CA-C-N 115.039 -0.982 . . . . 45.22 113.838 -179.006 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 7.3 m -115.51 -78.77 0.58 Allowed 'General case' 0 CA--C 1.546 0.804 0 N-CA-C 108.132 -1.062 . . . . 74.1 108.132 -179.822 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 54.67 60.61 8.37 Favored Glycine 0 C--N 1.359 1.851 0 N-CA-C 114.59 0.596 . . . . 71.42 114.59 172.199 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 119.95 52.5 0.27 Allowed Glycine 0 N--CA 1.476 1.307 0 CA-C-N 117.716 0.758 . . . . 71.33 111.289 -175.452 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 17.4 pttp -63.08 169.61 3.3 Favored 'General case' 0 CA--C 1.547 0.828 0 C-N-CA 124.186 0.995 . . . . 73.13 112.393 -174.768 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 76.1 p -93.16 179.23 5.49 Favored 'General case' 0 C--O 1.246 0.887 0 CA-C-O 121.525 0.679 . . . . 74.21 112.254 -171.134 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 78' ' ' ILE . . . . . 0.443 HG23 ' HB2' ' A' ' 38' ' ' ALA . 34.1 pt -75.23 -20.1 16.21 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.784 0 CA-C-N 115.294 -0.867 . . . . 74.41 110.187 168.735 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 82.7 m-85 -87.93 18.49 4.14 Favored 'General case' 0 CA--C 1.547 0.832 0 C-N-CA 124.57 1.148 . . . . 70.31 110.433 177.006 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 99.02 -120.79 6.98 Favored Glycine 0 C--N 1.354 1.565 0 N-CA-C 111.071 -0.812 . . . . 74.21 111.071 -179.842 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 36.8 tt0 -71.98 -59.42 2.75 Favored 'General case' 0 N--CA 1.47 0.544 0 C-N-CA 123.265 0.626 . . . . 75.22 110.057 178.057 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 82' ' ' LYS . . . . . 0.809 ' HD2' ' HA ' ' A' ' 107' ' ' THR . 21.4 pttp -155.62 175.98 13.2 Favored 'General case' 0 CA--C 1.544 0.741 0 CA-C-N 115.372 -0.831 . . . . 73.2 110.821 -172.41 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 12.1 p90 -159.15 173.72 15.97 Favored 'General case' 0 CA--C 1.538 0.507 0 C-N-CA 124.918 1.287 . . . . 74.4 110.035 -175.063 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 84' ' ' GLU . . . . . 0.548 ' HA ' ' HA ' ' A' ' 106' ' ' ASN . 7.4 pt-20 -83.84 169.85 14.71 Favored 'General case' 0 N--CA 1.475 0.803 0 C-N-CA 123.527 0.731 . . . . 72.05 111.753 -179.864 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 41.1 m-20 -74.9 143.55 43.74 Favored 'General case' 0 N--CA 1.472 0.641 0 C-N-CA 123.739 0.816 . . . . 63.44 109.677 -179.845 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 86' ' ' GLU . . . . . 0.562 ' HG2' ' HA ' ' A' ' 29' ' ' VAL . 7.9 tp10 -66.13 -59.53 3.68 Favored 'General case' 0 N--CA 1.472 0.654 0 CA-C-O 121.769 0.795 . . . . 64.35 110.107 176.202 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 32.4 p30 -163.32 -159.83 0.56 Allowed 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 113.974 -1.466 . . . . 72.21 107.909 -179.935 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 96.2 m-85 -138.35 42.74 2.19 Favored 'General case' 0 N--CA 1.482 1.158 0 C-N-CA 122.981 0.512 . . . . 71.02 110.307 179.45 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 61.9 mt -67.59 -48.43 76.69 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.488 0 CA-C-O 121.214 0.53 . . . . 75.41 110.062 175.998 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 90' ' ' LEU . . . . . 0.566 ' HB3' ' HB ' ' A' ' 128' ' ' VAL . 82.6 mt -88.99 153.08 21.31 Favored 'General case' 0 C--O 1.241 0.632 0 CA-C-N 115.556 -0.747 . . . . 71.3 110.653 179.035 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 21.1 ptmt -150.43 168.49 24.0 Favored 'General case' 0 N--CA 1.472 0.637 0 CA-C-N 115.529 -0.76 . . . . 74.23 110.62 -179.59 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 92' ' ' HIS . . . . . . . . . . . . . 27.2 m80 -87.31 68.36 9.78 Favored 'General case' 0 CA--C 1.546 0.802 0 C-N-CA 124.035 0.934 . . . . 75.54 109.454 -172.855 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 8.8 t -114.34 7.13 16.31 Favored 'General case' 0 N--CA 1.477 0.918 0 CA-C-N 114.972 -1.013 . . . . 75.52 111.338 -172.611 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -150.2 173.75 29.79 Favored Glycine 0 C--N 1.347 1.153 0 CA-C-O 119.993 -0.337 . . . . 52.13 113.137 -176.2 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 98.2 Cg_endo -85.15 155.96 11.14 Favored 'Trans proline' 0 C--N 1.368 1.579 0 C-N-CA 123.103 2.535 . . . . 72.53 112.379 174.066 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 76.18 19.09 78.87 Favored Glycine 0 N--CA 1.476 1.301 0 CA-C-N 116.481 -0.327 . . . . 63.23 113.581 178.613 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 97' ' ' ILE . . . . . 0.549 ' HB ' ' HB2' ' A' ' 115' ' ' CYS . 13.3 mm -76.34 105.45 5.26 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.907 0 C-N-CA 123.833 0.853 . . . . 74.31 111.42 -174.872 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 60.8 tp -90.62 119.42 30.85 Favored 'General case' 0 CA--C 1.549 0.941 0 C-N-CA 123.084 0.554 . . . . 75.33 110.002 176.694 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 47.2 t -143.91 148.9 36.05 Favored 'General case' 0 CA--C 1.545 0.778 0 C-N-CA 124.388 1.075 . . . . 74.22 108.576 179.126 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 100' ' ' MET . . . . . 0.444 ' HA ' ' HA ' ' A' ' 112' ' ' PHE . 57.0 mtp -82.84 147.24 28.45 Favored 'General case' 0 N--CA 1.488 1.432 0 CA-C-N 118.201 0.455 . . . . 72.31 110.535 179.819 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -76.41 145.55 39.28 Favored 'General case' 0 C--O 1.243 0.743 0 C-N-CA 122.888 0.475 . . . . 75.13 112.169 -172.248 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 20.4 p-10 -153.89 149.22 27.1 Favored 'General case' 0 C--O 1.241 0.616 0 C-N-CA 124.292 1.037 . . . . 71.41 108.7 177.894 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -87.37 -34.41 18.81 Favored 'General case' 0 N--CA 1.474 0.732 0 N-CA-C 109.477 -0.564 . . . . 74.34 109.477 169.895 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -158.71 -166.72 18.34 Favored Glycine 0 C--N 1.342 0.909 0 CA-C-N 115.387 -0.824 . . . . 64.2 111.292 174.236 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 33.7 Cg_exo -60.78 151.28 78.05 Favored 'Trans proline' 0 C--N 1.369 1.637 0 C-N-CA 122.797 2.331 . . . . 63.14 111.847 178.357 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 106' ' ' ASN . . . . . 0.548 ' HA ' ' HA ' ' A' ' 84' ' ' GLU . 65.0 t30 65.83 16.96 10.7 Favored 'General case' 0 CA--C 1.561 1.38 0 C-N-CA 124.758 1.223 . . . . 72.2 111.343 178.78 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 107' ' ' THR . . . . . 0.809 ' HA ' ' HD2' ' A' ' 82' ' ' LYS . 5.1 m -118.89 7.19 11.46 Favored 'General case' 0 N--CA 1.485 1.286 0 C-N-CA 123.968 0.907 . . . . 70.54 110.387 179.839 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 11.1 t30 -70.71 145.77 50.31 Favored 'General case' 0 C--O 1.213 -0.851 0 C-N-CA 124.696 1.198 . . . . 70.31 110.232 177.615 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 101.29 23.36 9.68 Favored Glycine 0 N--CA 1.472 1.089 0 C-N-CA 121.66 -0.305 . . . . 72.1 113.805 177.295 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 22.8 p -132.67 120.4 21.67 Favored 'General case' 0 N--CA 1.468 0.454 0 N-CA-C 107.881 -1.155 . . . . 73.22 107.881 174.249 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 111' ' ' GLN . . . . . 0.433 HE22 ' HG2' ' B' ' 218' ' ' PRO . 16.0 mt-30 62.71 161.77 0.09 Allowed 'General case' 0 N--CA 1.492 1.632 0 C-N-CA 124.114 0.966 . . . . 74.22 111.74 -171.778 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 112' ' ' PHE . . . . . 0.444 ' HA ' ' HA ' ' A' ' 100' ' ' MET . 49.1 p90 -133.72 143.14 48.31 Favored 'General case' 0 N--CA 1.472 0.645 0 N-CA-C 108.201 -1.037 . . . . 75.11 108.201 169.054 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 113' ' ' PHE . . . . . 0.438 ' HB2' ' SD ' ' A' ' 61' ' ' MET . 50.5 p90 -129.58 148.13 51.45 Favored 'General case' 0 C--O 1.236 0.391 0 C-N-CA 123.515 0.726 . . . . 74.31 110.091 179.574 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 114' ' ' ILE . . . . . 0.442 ' HB ' ' SG ' ' A' ' 62' ' ' CYS . 21.5 mt -112.63 104.61 17.31 Favored 'Isoleucine or valine' 0 C--O 1.241 0.61 0 N-CA-C 108.486 -0.931 . . . . 71.45 108.486 175.239 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 115' ' ' CYS . . . . . 0.6 ' SG ' ' HE3' ' A' ' 61' ' ' MET . 28.9 m -64.69 104.52 0.83 Allowed 'General case' 0 CA--C 1.542 0.656 0 N-CA-C 108.406 -0.961 . . . . 74.23 108.406 170.256 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 116' ' ' THR . . . . . 0.495 HG23 HG13 ' A' ' 139' ' ' VAL . 62.5 p -70.16 -31.78 69.43 Favored 'General case' 0 N--CA 1.472 0.632 0 C-N-CA 123.216 0.606 . . . . 71.01 110.296 -179.522 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -115.62 170.99 8.02 Favored 'General case' 0 C--O 1.243 0.745 0 C-N-CA 124.012 0.925 . . . . 74.23 109.72 175.292 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 19.3 ptmt -72.01 92.09 1.27 Allowed 'General case' 0 CA--C 1.554 1.11 0 CA-C-O 121.804 0.811 . . . . 73.25 110.019 175.253 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 119' ' ' THR . . . . . 0.541 ' HB ' HD11 ' A' ' 122' ' ' LEU . 46.7 p -85.64 83.63 7.83 Favored 'General case' 0 CA--C 1.546 0.817 0 CA-C-O 121.813 0.816 . . . . 75.54 109.182 179.766 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 10.2 pt-20 -75.91 -30.13 58.65 Favored 'General case' 0 N--CA 1.482 1.148 0 CA-C-N 115.524 -0.762 . . . . 75.22 112.38 -167.086 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 121' ' ' TRP . . . . . . . . . . . . . 39.0 p90 -69.19 -4.78 18.96 Favored 'General case' 0 CA--C 1.553 1.07 0 C-N-CA 123.713 0.805 . . . . 74.51 111.624 178.03 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 122' ' ' LEU . . . . . 0.541 HD11 ' HB ' ' A' ' 119' ' ' THR . 10.8 mp -87.27 2.39 50.29 Favored 'General case' 0 N--CA 1.482 1.169 0 C-N-CA 124.055 0.942 . . . . 72.53 112.485 174.695 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 78.4 m-20 -78.01 124.54 28.15 Favored 'General case' 0 N--CA 1.477 0.907 0 CA-C-N 118.427 0.558 . . . . 72.01 109.668 177.716 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 112.09 -11.11 26.93 Favored Glycine 0 C--N 1.351 1.369 0 CA-C-N 115.497 -0.774 . . . . 63.34 111.621 -165.027 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 28.7 mtpp -90.83 -165.09 1.28 Allowed 'General case' 0 N--CA 1.486 1.341 0 C-N-CA 124.19 0.996 . . . . 74.43 109.665 169.728 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 126' ' ' HIS . . . . . 0.444 ' HE2' HG21 ' A' ' 32' ' ' THR . 22.8 t60 -66.34 136.22 55.48 Favored 'General case' 0 CA--C 1.549 0.912 0 CA-C-O 121.35 0.595 . . . . 73.4 111.1 -178.815 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 7.1 p -59.15 147.97 7.43 Favored 'Isoleucine or valine' 0 CA--C 1.551 1.011 0 CA-C-N 113.976 -1.465 . . . . 63.15 111.726 178.03 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 128' ' ' VAL . . . . . 0.566 ' HB ' ' HB3' ' A' ' 90' ' ' LEU . 24.9 t -68.28 157.78 6.16 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.967 0 C-N-CA 123.482 0.713 . . . . 64.42 109.664 175.841 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 129' ' ' PHE . . . . . . . . . . . . . 49.1 p90 -138.9 -24.17 0.91 Allowed 'General case' 0 N--CA 1.478 0.971 0 C-N-CA 122.039 0.136 . . . . 74.22 111.127 174.189 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . -130.11 161.78 23.07 Favored Glycine 0 C--N 1.346 1.095 0 N-CA-C 112.242 -0.343 . . . . 61.24 112.242 -174.563 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 131' ' ' LYS . . . . . 0.426 ' HE2' ' HB3' ' A' ' 131' ' ' LYS . 31.2 ttpt -146.6 128.49 15.41 Favored 'General case' 0 N--CA 1.466 0.356 0 C-N-CA 123.689 0.796 . . . . 75.02 108.991 179.758 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 34.0 t -70.55 101.12 0.78 Allowed 'Isoleucine or valine' 0 CA--C 1.542 0.653 0 N-CA-C 109.282 -0.636 . . . . 63.04 109.282 177.807 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 133' ' ' LYS . . . . . 0.635 ' HD2' ' HB2' ' A' ' 23' ' ' GLU . 18.6 ptmt -87.81 -36.77 17.07 Favored 'General case' 0 N--CA 1.474 0.725 0 CA-C-N 115.615 -0.72 . . . . 74.23 109.781 -179.669 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 134' ' ' GLU . . . . . 0.515 ' HG2' ' HG3' ' A' ' 133' ' ' LYS . 30.8 mm-40 -124.23 144.93 49.67 Favored 'General case' 0 N--CA 1.472 0.648 0 C-N-CA 124.226 1.011 . . . . 75.23 108.8 176.706 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 78.47 21.45 69.58 Favored Glycine 0 N--CA 1.467 0.722 0 CA-C-O 119.582 -0.566 . . . . 53.34 113.375 175.037 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 136' ' ' MET . . . . . . . . . . . . . 16.3 tpt -62.34 -38.1 88.18 Favored 'General case' 0 N--CA 1.481 1.102 0 C-N-CA 123.042 0.537 . . . . 75.54 111.081 174.887 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 137' ' ' ASN . . . . . . . . . . . . . 16.3 m120 -64.29 -29.8 70.88 Favored 'General case' 0 CA--C 1.545 0.786 0 C-N-CA 122.937 0.495 . . . . 74.45 110.897 176.229 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 138' ' ' ILE . . . . . . . . . . . . . 46.8 mm -73.86 -36.1 44.73 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.039 0 C-N-CA 123.156 0.583 . . . . 73.21 110.153 175.797 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 139' ' ' VAL . . . . . 0.495 HG13 HG23 ' A' ' 116' ' ' THR . 91.8 t -65.91 -40.31 87.1 Favored 'Isoleucine or valine' 0 CA--C 1.555 1.149 0 C-N-CA 123.361 0.665 . . . . 73.13 110.674 178.112 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 44.1 mt-10 -74.03 -29.08 61.74 Favored 'General case' 0 N--CA 1.477 0.917 0 CA-C-N 115.64 -0.709 . . . . 75.15 110.622 177.209 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -70.86 -43.36 68.63 Favored 'General case' 0 N--CA 1.478 0.938 0 C-N-CA 122.902 0.481 . . . . 64.23 111.15 176.064 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 142' ' ' MET . . . . . 0.555 ' HB2' HD12 ' A' ' 156' ' ' ILE . 25.2 ptm -72.92 -28.05 62.22 Favored 'General case' 0 N--CA 1.477 0.878 0 C-N-CA 123.074 0.55 . . . . 73.35 111.315 -178.132 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 143' ' ' GLU . . . . . 0.415 ' HG2' ' HA ' ' A' ' 58' ' ' PRO . 34.0 tt0 -59.98 -32.55 70.94 Favored 'General case' 0 C--N 1.357 0.897 0 O-C-N 123.597 0.561 . . . . 72.42 111.937 178.352 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 144' ' ' ARG . . . . . . . . . . . . . 38.6 mtm-85 -67.45 -18.79 65.22 Favored 'General case' 0 N--CA 1.477 0.882 0 C-N-CA 123.038 0.535 . . . . 73.23 111.986 -178.363 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 145' ' ' PHE . . . . . 0.494 ' HB2' HD11 ' A' ' 156' ' ' ILE . 45.2 m-85 -83.01 -5.57 59.15 Favored 'General case' 0 N--CA 1.477 0.896 0 C-N-CA 122.871 0.469 . . . . 74.34 111.412 177.185 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . -87.23 175.15 46.04 Favored Glycine 0 C--N 1.347 1.188 0 O-C-N 123.444 0.465 . . . . 61.22 112.12 172.436 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 29.7 m -134.75 169.49 17.27 Favored 'General case' 0 N--CA 1.483 1.209 0 C-N-CA 123.392 0.677 . . . . 73.2 111.59 -174.445 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 148' ' ' ARG . . . . . . . . . . . . . 8.7 mmm180 -57.59 -41.26 80.82 Favored 'General case' 0 N--CA 1.487 1.383 0 C-N-CA 124.81 1.244 . . . . 73.01 113.065 179.927 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 149' ' ' ASN . . . . . . . . . . . . . 30.5 p-10 -75.24 -17.69 60.27 Favored 'General case' 0 N--CA 1.478 0.945 0 C-N-CA 122.958 0.503 . . . . 73.03 111.238 178.191 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 150' ' ' GLY . . . . . 0.472 ' O ' ' HA ' ' A' ' 55' ' ' ARG . . . 111.65 -10.2 28.0 Favored Glycine 0 C--N 1.348 1.222 0 O-C-N 123.706 0.629 . . . . 75.12 112.378 -179.554 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 25.1 ttmm -65.55 137.64 57.52 Favored 'General case' 0 N--CA 1.471 0.624 0 C-N-CA 122.875 0.47 . . . . 74.41 111.177 -175.765 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 152' ' ' THR . . . . . . . . . . . . . 41.1 p -90.42 109.76 20.88 Favored 'General case' 0 C--O 1.239 0.516 0 N-CA-C 108.198 -1.038 . . . . 73.0 108.198 174.493 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 153' ' ' SER . . . . . . . . . . . . . 19.3 m -62.56 -29.36 70.52 Favored 'General case' 0 CA--C 1.544 0.75 0 C-N-CA 124.039 0.936 . . . . 71.33 110.804 176.172 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 154' ' ' LYS . . . . . 0.518 ' HB3' HG11 ' A' ' 12' ' ' VAL . 48.1 mmtm -118.63 133.92 55.5 Favored 'General case' 0 CA--C 1.54 0.561 0 CA-C-N 114.609 -1.178 . . . . 65.53 108.832 175.281 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 16.9 tppt? -78.99 91.68 4.87 Favored 'General case' 0 N--CA 1.473 0.689 0 N-CA-C 109.627 -0.509 . . . . 74.55 109.627 -178.272 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 156' ' ' ILE . . . . . 0.555 HD12 ' HB2' ' A' ' 142' ' ' MET . 70.5 mt -84.92 117.14 29.66 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.357 0 N-CA-C 109.835 -0.431 . . . . 74.33 109.835 -175.242 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 157' ' ' THR . . . . . . . . . . . . . 54.8 p -115.91 156.34 26.36 Favored 'General case' 0 N--CA 1.473 0.707 0 C-N-CA 124.232 1.013 . . . . 63.13 110.015 -179.126 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 158' ' ' ILE . . . . . . . . . . . . . 63.7 mt -80.6 96.0 2.68 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.819 0 N-CA-C 108.283 -1.006 . . . . 73.42 108.283 169.786 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 159' ' ' ALA . . . . . 0.654 ' HB3' ' HB2' ' A' ' 11' ' ' ALA . . . -55.55 -53.14 60.09 Favored 'General case' 0 N--CA 1.478 0.939 0 C-N-CA 124.331 1.053 . . . . 62.42 111.784 -178.177 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 160' ' ' ASP . . . . . 0.512 ' HA ' ' HE3' ' A' ' 49' ' ' LYS . 0.9 OUTLIER -140.17 175.21 9.78 Favored 'General case' 0 N--CA 1.473 0.724 0 CA-C-N 115.798 -0.637 . . . . 71.51 110.405 -176.509 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 161' ' ' CYS . . . . . . . . . . . . . 63.2 m -146.23 -169.82 3.35 Favored 'General case' 0 CA--C 1.547 0.852 0 C-N-CA 125.147 1.379 . . . . 55.1 108.4 -172.674 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 162' ' ' GLY . . . . . . . . . . . . . . . 131.71 53.26 0.09 OUTLIER Glycine 0 C--N 1.348 1.216 0 N-CA-C 112.151 -0.38 . . . . 64.43 112.151 -177.836 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 163' ' ' GLN . . . . . 0.707 ' HG3' ' HA ' ' A' ' 6' ' ' VAL . 43.4 tt0 -46.21 110.53 0.28 Allowed 'General case' 0 N--CA 1.48 1.032 0 C-N-CA 125.035 1.334 . . . . 75.32 112.392 -177.349 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 164' ' ' LEU . . . . . 0.425 ' O ' ' HB ' ' A' ' 5' ' ' THR . 45.3 mt -79.62 94.7 5.72 Favored 'General case' 0 CA--C 1.543 0.704 0 N-CA-C 108.63 -0.878 . . . . 72.22 108.63 -179.357 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 165' ' ' GLU . . . . . . . . . . . . . 41.6 mt-10 . . . . . 0 C--O 1.25 1.096 0 CA-C-O 118.862 -0.589 . . . . 74.24 110.553 -173.114 . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' B' B ' 216' ' ' PRO . . . . . . . . . . . . . 5.5 Cg_endo . . . . . 0 CA--C 1.545 1.054 0 N-CA-C 110.421 -0.646 . . . . 72.32 110.421 . . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' B' B ' 217' ' ' GLU . . . . . . . . . . . . . 42.9 mt-10 -90.65 162.69 32.94 Favored Pre-proline 0 N--CA 1.481 1.1 0 C-N-CA 123.853 0.861 . . . . 71.31 110.585 -177.045 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 218' ' ' PRO . . . . . 0.552 ' HG3' ' HA2' ' A' ' 72' ' ' GLY . 45.7 Cg_endo -66.23 93.58 0.29 Allowed 'Trans proline' 0 C--N 1.383 2.368 0 C-N-CA 122.448 2.099 . . . . 75.31 109.973 173.344 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 219' ' ' GLY . . . . . . . . . . . . . . . 147.16 -161.42 28.47 Favored Glycine 0 CA--C 1.527 0.791 0 CA-C-N 114.71 -1.132 . . . . 71.03 111.492 -171.489 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 220' ' ' PRO . . . . . . . . . . . . . 64.0 Cg_endo -91.03 168.87 3.56 Favored 'Trans proline' 0 C--N 1.363 1.298 0 C-N-CA 123.412 2.742 . . . . 70.21 114.677 -176.644 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 221' ' ' TYR . . . . . . . . . . . . . 88.0 t80 -99.56 155.95 17.31 Favored 'General case' 0 N--CA 1.484 1.248 0 C-N-CA 123.538 0.735 . . . . 74.41 109.184 169.921 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 222' ' ' ALA . . . . . . . . . . . . . . . -147.7 139.55 24.07 Favored 'General case' 0 N--CA 1.476 0.828 0 C-N-CA 123.925 0.89 . . . . 75.43 112.294 -173.519 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 223' ' ' GLN . . . . . . . . . . . . . 2.0 mp0 67.61 153.85 0.13 Allowed Pre-proline 0 CA--C 1.561 1.383 0 O-C-N 125.135 1.522 . . . . 73.55 113.393 163.087 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 224' ' ' PRO . . . . . . . . . . . . . 55.4 Cg_endo . . . . . 0 C--N 1.381 2.259 0 C-N-CA 122.165 1.91 . . . . 73.34 111.319 172.374 . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 64.1 mtt . . . . . 0 N--CA 1.475 0.784 0 N-CA-C 109.179 -0.675 . . . . 74.44 109.179 . . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 14.8 p -116.1 -10.97 12.05 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.267 0 C-N-CA 124.517 1.127 . . . . 74.41 110.237 -179.764 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 15.3 m120 -71.52 114.93 32.31 Favored Pre-proline 0 CA--C 1.549 0.911 0 C-N-CA 124.51 1.124 . . . . 73.54 111.429 -176.022 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 4' ' ' PRO . . . . . 0.59 ' HG2' ' HB2' ' A' ' 24' ' ' LEU . 29.7 Cg_endo -65.06 123.42 11.55 Favored 'Trans proline' 0 C--N 1.379 2.18 0 C-N-CA 122.356 2.037 . . . . 65.51 110.298 170.694 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 5' ' ' THR . . . . . 0.585 HG21 ' HD3' ' A' ' 133' ' ' LYS . 99.3 m -96.48 119.39 34.89 Favored 'General case' 0 C--N 1.328 -0.351 0 N-CA-C 108.743 -0.836 . . . . 75.04 108.743 -174.811 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 32.1 m -102.77 123.66 56.28 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.646 0 N-CA-C 109.772 -0.455 . . . . 73.44 109.772 -177.694 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 7' ' ' PHE . . . . . 0.583 ' H ' ' HA ' ' A' ' 163' ' ' GLN . 76.7 t80 -109.89 130.16 55.56 Favored 'General case' 0 N--CA 1.47 0.543 0 C-N-CA 123.307 0.643 . . . . 73.13 109.849 -174.398 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 8' ' ' PHE . . . . . 0.471 ' HB3' HG22 ' A' ' 158' ' ' ILE . 36.9 m-85 -135.31 165.64 24.98 Favored 'General case' 0 N--CA 1.472 0.649 0 C-N-CA 124.604 1.162 . . . . 72.11 109.449 173.485 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 18.5 m-20 -120.15 115.08 22.94 Favored 'General case' 0 N--CA 1.467 0.423 0 C-N-CA 124.456 1.102 . . . . 71.0 108.544 171.532 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 10' ' ' ILE . . . . . 0.512 HG23 ' SD ' ' A' ' 142' ' ' MET . 44.3 mm -83.85 132.45 31.47 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.562 0 C-N-CA 123.611 0.764 . . . . 71.23 108.98 178.98 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 11' ' ' ALA . . . . . 0.407 ' O ' ' HA ' ' A' ' 156' ' ' ILE . . . -139.72 135.49 33.2 Favored 'General case' 0 N--CA 1.465 0.299 0 C-N-CA 122.561 0.345 . . . . 75.42 111.799 -171.984 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 14.6 m -96.03 113.77 31.2 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.682 0 C-N-CA 124.703 1.201 . . . . 63.12 109.487 179.752 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 54.8 m-20 63.35 20.43 12.26 Favored 'General case' 0 N--CA 1.489 1.521 0 C-N-CA 125.039 1.336 . . . . 71.35 110.987 -170.262 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 89.44 -6.4 83.29 Favored Glycine 0 C--N 1.348 1.244 0 CA-C-N 116.225 -0.443 . . . . 61.21 113.258 -174.774 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 27.2 mm-40 -86.51 125.99 65.7 Favored Pre-proline 0 CA--C 1.548 0.871 0 C-N-CA 123.39 0.676 . . . . 74.14 110.305 179.356 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 18.0 Cg_endo -52.64 101.85 0.06 OUTLIER 'Trans proline' 0 C--N 1.386 2.536 0 C-N-CA 124.168 3.245 . . . . 74.11 113.996 -170.475 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 53.1 tp -79.19 -35.87 41.14 Favored 'General case' 0 N--CA 1.479 1.003 0 N-CA-C 109.261 -0.644 . . . . 70.43 109.261 175.454 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 166.21 -173.82 41.73 Favored Glycine 0 C--N 1.337 0.614 0 CA-C-N 115.153 -0.93 . . . . 73.4 111.563 176.817 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 47.7 ptt85 -110.59 141.75 43.36 Favored 'General case' 0 C--O 1.239 0.51 0 C-N-CA 123.983 0.913 . . . . 75.54 109.255 177.51 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 93.7 t -134.88 121.2 33.32 Favored 'Isoleucine or valine' 0 C--O 1.239 0.504 0 C-N-CA 123.633 0.773 . . . . 62.42 109.253 175.202 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 21' ' ' SER . . . . . 0.466 ' HB3' ' HB2' ' A' ' 134' ' ' GLU . 22.8 t -115.1 136.99 52.52 Favored 'General case' 0 CA--C 1.539 0.548 0 N-CA-C 108.48 -0.933 . . . . 74.14 108.48 174.516 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 41.8 m-85 -109.69 169.14 8.9 Favored 'General case' 0 N--CA 1.472 0.668 0 C-N-CA 123.675 0.79 . . . . 72.42 110.235 177.684 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . 0.627 ' HB2' ' HD2' ' A' ' 133' ' ' LYS . 37.4 tt0 -122.22 103.7 8.95 Favored 'General case' 0 CA--C 1.538 0.503 0 C-N-CA 125.581 1.552 . . . . 75.01 107.938 -176.953 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . 0.59 ' HB2' ' HG2' ' A' ' 4' ' ' PRO . 18.4 mt -82.99 124.51 30.47 Favored 'General case' 0 N--CA 1.474 0.761 0 N-CA-C 109.454 -0.572 . . . . 71.1 109.454 -179.279 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 68.2 m-85 -86.6 69.37 10.35 Favored 'General case' 0 CA--C 1.534 0.357 0 C-N-CA 123.324 0.65 . . . . 74.0 109.38 179.292 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -64.65 -20.09 66.09 Favored 'General case' 0 N--CA 1.484 1.225 0 C-N-CA 123.553 0.741 . . . . 74.42 111.727 179.763 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 12.0 p-10 -74.67 -23.18 58.6 Favored 'General case' 0 CA--C 1.545 0.754 0 C-N-CA 124.308 1.043 . . . . 72.31 112.163 177.708 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 58.7 mttp -105.91 -41.54 5.38 Favored 'General case' 0 N--CA 1.486 1.328 0 C-N-CA 123.757 0.823 . . . . 62.15 111.245 -179.056 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 29' ' ' VAL . . . . . 0.548 HG13 ' HG2' ' A' ' 86' ' ' GLU . 10.7 m -138.26 74.25 42.3 Favored Pre-proline 0 CA--C 1.56 1.33 0 C-N-CA 124.445 1.098 . . . . 74.53 109.873 -172.552 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 59.2 Cg_endo -67.51 -37.97 15.76 Favored 'Trans proline' 0 C--N 1.377 2.067 0 C-N-CA 122.961 2.441 . . . . 73.04 113.383 -171.47 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 48.1 tttp -73.86 -42.09 61.3 Favored 'General case' 0 N--CA 1.478 0.95 0 C-N-CA 123.669 0.788 . . . . 73.22 110.907 -173.507 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 11.3 m -73.21 -36.98 66.59 Favored 'General case' 0 CA--C 1.547 0.832 0 CA-C-N 115.728 -0.669 . . . . 71.44 110.406 -177.707 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -67.11 -41.68 85.82 Favored 'General case' 0 CA--C 1.55 0.948 0 C-N-CA 123.053 0.541 . . . . 75.11 110.684 173.71 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 38.5 tt0 -59.92 -42.19 93.37 Favored 'General case' 0 N--CA 1.483 1.22 0 C-N-CA 124.655 1.182 . . . . 72.43 111.462 -179.428 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 35' ' ' ASN . . . . . 0.455 ' O ' ' HG ' ' A' ' 39' ' ' LEU . 47.7 t30 -56.92 -68.02 0.26 Allowed 'General case' 0 C--N 1.358 0.961 0 O-C-N 124.322 1.014 . . . . 75.31 110.266 -177.196 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 90.6 t80 -57.62 -40.7 79.74 Favored 'General case' 0 N--CA 1.474 0.734 0 O-C-N 124.315 1.009 . . . . 73.34 111.683 -175.683 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 71.5 ttt180 -58.3 -54.88 42.0 Favored 'General case' 0 C--N 1.354 0.802 0 O-C-N 123.719 0.637 . . . . 71.21 110.456 178.564 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 38' ' ' ALA . . . . . 0.469 ' HB3' HG22 ' A' ' 78' ' ' ILE . . . -64.76 -30.09 71.09 Favored 'General case' 0 N--CA 1.475 0.815 0 C-N-CA 123.616 0.766 . . . . 71.22 111.656 -175.099 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 39' ' ' LEU . . . . . 0.588 ' HB3' ' HD2' ' A' ' 48' ' ' TYR . 89.8 mt -63.11 -46.0 89.37 Favored 'General case' 0 N--CA 1.471 0.613 0 C-N-CA 123.545 0.738 . . . . 74.14 110.29 173.604 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 50.7 m -74.35 -39.1 63.01 Favored 'General case' 0 CA--C 1.547 0.843 0 C-N-CA 123.494 0.717 . . . . 72.14 112.018 -173.275 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -75.8 -30.81 59.2 Favored 'General case' 0 N--CA 1.482 1.15 0 C-N-CA 122.582 0.353 . . . . 74.22 110.581 178.195 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 84.87 32.45 21.19 Favored Glycine 0 C--N 1.347 1.152 0 CA-C-N 115.98 -0.555 . . . . 70.34 111.795 -174.432 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 5.2 mm-40 -63.65 -25.34 68.17 Favored 'General case' 0 N--CA 1.481 1.108 0 C-N-CA 123.565 0.746 . . . . 74.04 110.519 175.042 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 44' ' ' LYS . . . . . 0.486 ' HG3' ' HB ' ' A' ' 78' ' ' ILE . 29.2 mmmt -110.75 19.08 18.97 Favored 'General case' 0 CA--C 1.547 0.842 0 C-N-CA 124.2 1.0 . . . . 74.12 110.922 -178.999 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 78.88 -0.23 78.94 Favored Glycine 0 C--N 1.355 1.6 0 N-CA-C 115.05 0.78 . . . . 63.2 115.05 174.616 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 20.2 m-85 -85.62 -47.84 9.46 Favored 'General case' 0 N--CA 1.48 1.041 0 CA-C-N 117.785 0.793 . . . . 62.4 111.074 -174.181 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 49.66 62.64 4.7 Favored Glycine 0 C--N 1.355 1.619 0 O-C-N 124.358 1.036 . . . . 74.12 113.83 174.937 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 48' ' ' TYR . . . . . 0.588 ' HD2' ' HB3' ' A' ' 39' ' ' LEU . 35.5 m-85 -65.56 90.42 0.11 Allowed 'General case' 0 N--CA 1.474 0.759 0 CA-C-O 122.109 0.957 . . . . 73.41 111.773 -176.309 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 49' ' ' LYS . . . . . 0.586 ' HE3' ' HA ' ' A' ' 160' ' ' ASP . 24.1 tptm -109.88 131.25 55.23 Favored 'General case' 0 C--O 1.238 0.486 0 CA-C-N 113.686 -1.597 . . . . 74.43 108.53 179.939 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 79.95 20.36 68.05 Favored Glycine 0 C--N 1.346 1.137 0 CA-C-O 119.85 -0.417 . . . . 74.45 113.203 -179.464 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 39.0 t -60.69 126.75 28.57 Favored 'General case' 0 N--CA 1.479 1.021 0 C-N-CA 123.907 0.883 . . . . 73.21 110.243 179.39 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 52' ' ' CYS . . . . . . . . . . . . . 26.8 p -97.92 120.52 38.45 Favored 'General case' 0 N--CA 1.475 0.783 0 O-C-N 123.618 0.574 . . . . 74.44 111.933 -168.517 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 53' ' ' PHE . . . . . 0.735 ' HA ' ' HA2' ' A' ' 64' ' ' GLY . 82.3 m-85 -67.55 92.72 0.32 Allowed 'General case' 0 CA--C 1.536 0.442 0 C-N-CA 123.759 0.824 . . . . 72.11 108.884 166.894 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 26.2 p-80 -101.09 -9.81 21.04 Favored 'General case' 0 N--CA 1.475 0.795 0 CA-C-N 114.922 -1.035 . . . . 70.34 111.881 -172.215 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 37.8 ttt180 -132.28 98.99 4.55 Favored 'General case' 0 N--CA 1.472 0.628 0 N-CA-C 108.952 -0.759 . . . . 74.25 108.952 177.712 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 53.7 mt -128.12 130.95 69.75 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.82 0 N-CA-C 109.367 -0.605 . . . . 75.34 109.367 176.167 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 59.5 mt -125.12 124.85 25.33 Favored Pre-proline 0 CA--C 1.558 1.268 0 C-N-CA 124.172 0.989 . . . . 73.2 108.851 175.132 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 24.3 Cg_endo -60.37 151.13 76.55 Favored 'Trans proline' 0 C--N 1.385 2.499 0 C-N-CA 123.6 2.867 . . . . 73.33 113.795 -177.541 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 61.44 16.03 48.31 Favored Glycine 0 C--N 1.348 1.24 0 CA-C-N 114.963 -1.017 . . . . 62.44 114.086 179.715 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 36.3 t80 -137.28 -73.6 0.42 Allowed 'General case' 0 C--O 1.239 0.55 0 C-N-CA 123.274 0.63 . . . . 71.4 110.297 -171.735 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 61' ' ' MET . . . . . 0.453 ' HE1' ' HB2' ' A' ' 63' ' ' GLN . 51.4 ttp -171.05 138.43 1.28 Allowed 'General case' 0 N--CA 1.475 0.822 0 O-C-N 123.095 0.247 . . . . 65.31 111.567 -164.018 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 62' ' ' CYS . . . . . 0.554 ' SG ' ' HB ' ' A' ' 114' ' ' ILE . 21.9 p -108.03 110.85 22.65 Favored 'General case' 0 CA--C 1.548 0.881 0 C-N-CA 123.577 0.751 . . . . 71.45 109.266 168.017 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 63' ' ' GLN . . . . . 0.453 ' HB2' ' HE1' ' A' ' 61' ' ' MET . 52.0 tt0 -102.71 118.59 37.16 Favored 'General case' 0 N--CA 1.48 1.067 0 C-N-CA 124.353 1.061 . . . . 71.4 110.464 -175.172 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 64' ' ' GLY . . . . . 0.735 ' HA2' ' HA ' ' A' ' 53' ' ' PHE . . . -95.81 165.49 24.49 Favored Glycine 0 C--N 1.342 0.884 0 CA-C-N 115.262 -0.881 . . . . 52.43 112.842 177.292 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 177.19 133.04 1.76 Allowed Glycine 0 C--N 1.337 0.591 0 N-CA-C 111.922 -0.471 . . . . 44.33 111.922 179.286 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 22.6 t70 -75.78 170.3 16.47 Favored 'General case' 0 CA--C 1.551 0.993 0 C-N-CA 123.437 0.695 . . . . 74.11 110.867 -176.137 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 74.2 t80 -69.8 -25.78 63.95 Favored 'General case' 0 CA--C 1.553 1.071 0 C-N-CA 123.435 0.694 . . . . 73.33 111.285 176.547 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 63.4 m -63.37 109.48 1.61 Allowed 'General case' 0 N--CA 1.478 0.947 0 C-N-CA 123.415 0.686 . . . . 74.31 110.782 179.519 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 58.4 mtt180 59.63 34.52 22.27 Favored 'General case' 0 N--CA 1.479 0.997 0 C-N-CA 125.068 1.347 . . . . 75.23 111.435 -176.597 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 36.8 p-80 -55.42 -20.31 11.85 Favored 'General case' 0 N--CA 1.497 1.918 0 C-N-CA 123.558 0.743 . . . . 72.34 112.886 -172.43 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 5.1 t30 -66.08 87.28 0.1 Allowed 'General case' 0 CA--C 1.554 1.109 0 C-N-CA 124.257 1.023 . . . . 75.34 109.827 167.956 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 76.41 -7.2 32.8 Favored Glycine 0 CA--C 1.535 1.321 0 N-CA-C 115.805 1.082 . . . . 51.01 115.805 172.097 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 73' ' ' THR . . . . . 0.59 ' HA ' ' HB2' ' A' ' 110' ' ' SER . 79.2 m -118.09 -65.84 1.14 Allowed 'General case' 0 N--CA 1.479 0.997 0 CA-C-N 118.598 1.199 . . . . 73.44 110.843 -178.861 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 49.76 54.42 17.78 Favored Glycine 0 C--N 1.356 1.655 0 O-C-N 123.838 0.711 . . . . 64.41 114.379 172.967 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 127.07 55.37 0.14 Allowed Glycine 0 N--CA 1.469 0.895 0 C-N-CA 120.964 -0.636 . . . . 71.41 111.778 -172.449 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 76' ' ' LYS . . . . . 0.541 ' HG2' ' OH ' ' A' ' 48' ' ' TYR . 14.8 ptmm? -52.4 164.38 0.33 Allowed 'General case' 0 N--CA 1.49 1.54 0 C-N-CA 124.117 0.967 . . . . 74.43 111.915 178.584 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 94.9 p -88.95 175.38 7.45 Favored 'General case' 0 C--O 1.247 0.938 0 CA-C-O 121.214 0.53 . . . . 64.44 110.441 -171.981 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 78' ' ' ILE . . . . . 0.486 ' HB ' ' HG3' ' A' ' 44' ' ' LYS . 38.6 pt -74.64 -24.82 18.65 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.654 0 CA-C-N 115.344 -0.843 . . . . 74.43 110.757 179.726 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 51.0 m-85 -86.93 -43.34 12.47 Favored 'General case' 0 N--CA 1.476 0.865 0 C-N-CA 123.713 0.805 . . . . 75.31 110.337 -178.866 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -165.69 -134.79 1.73 Allowed Glycine 0 C--N 1.339 0.745 0 N-CA-C 110.539 -1.024 . . . . 74.15 110.539 -179.098 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 81' ' ' GLU . . . . . 0.523 ' HA ' ' HB2' ' A' ' 76' ' ' LYS . 36.6 tt0 -75.38 -36.8 60.86 Favored 'General case' 0 N--CA 1.477 0.879 0 CA-C-N 117.498 0.649 . . . . 64.33 109.734 175.293 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 82' ' ' LYS . . . . . 0.733 ' HD2' ' HA ' ' A' ' 107' ' ' THR . 19.7 pttp -159.62 166.58 30.37 Favored 'General case' 0 CA--C 1.544 0.732 0 C-N-CA 124.343 1.057 . . . . 63.44 109.309 -170.189 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 11.8 p90 -143.92 174.31 10.95 Favored 'General case' 0 N--CA 1.473 0.723 0 C-N-CA 124.064 0.945 . . . . 73.54 109.111 179.112 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 84' ' ' GLU . . . . . 0.457 ' HA ' ' HA ' ' A' ' 106' ' ' ASN . 11.7 pt-20 -79.19 -175.71 4.77 Favored 'General case' 0 CA--C 1.545 0.775 0 C-N-CA 123.519 0.728 . . . . 74.33 112.083 -178.521 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 30.5 m-20 -85.35 149.51 25.39 Favored 'General case' 0 N--CA 1.475 0.809 0 C-N-CA 123.428 0.691 . . . . 72.24 109.93 -176.672 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 86' ' ' GLU . . . . . 0.548 ' HG2' HG13 ' A' ' 29' ' ' VAL . 3.2 tp10 -77.53 -61.74 1.89 Allowed 'General case' 0 N--CA 1.478 0.957 0 C-N-CA 123.263 0.625 . . . . 74.34 110.54 175.594 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 29.9 p30 -173.57 -156.82 0.08 Allowed 'General case' 0 N--CA 1.475 0.806 0 C-N-CA 125.192 1.397 . . . . 74.22 107.413 -172.826 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 82.2 m-85 -142.04 39.18 1.62 Allowed 'General case' 0 N--CA 1.494 1.729 0 C-N-CA 123.245 0.618 . . . . 65.53 110.824 176.952 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 70.5 mt -65.01 -62.94 1.0 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.483 0 CA-C-O 121.312 0.577 . . . . 72.13 110.423 178.602 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 87.4 mt -86.9 135.82 33.18 Favored 'General case' 0 N--CA 1.47 0.547 0 C-N-CA 124.304 1.042 . . . . 74.54 110.643 -176.402 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 54.3 mtmt -118.89 160.02 22.71 Favored 'General case' 0 N--CA 1.473 0.723 0 C-N-CA 123.88 0.872 . . . . 75.25 111.072 -177.871 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 92' ' ' HIS . . . . . 0.538 ' HA ' HG21 ' A' ' 97' ' ' ILE . 13.6 m80 -83.25 21.14 1.16 Allowed 'General case' 0 N--CA 1.481 1.099 0 C-N-CA 124.777 1.231 . . . . 72.34 111.664 -174.436 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 11.4 t -86.74 31.32 0.69 Allowed 'General case' 0 CA--C 1.56 1.345 0 C-N-CA 124.259 1.024 . . . . 64.43 111.237 -170.562 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -151.14 162.38 29.44 Favored Glycine 0 C--N 1.348 1.208 0 N-CA-C 111.705 -0.558 . . . . 44.44 111.705 176.404 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 73.3 Cg_endo -75.96 145.53 28.37 Favored 'Trans proline' 0 C--N 1.369 1.615 0 C-N-CA 122.689 2.259 . . . . 75.44 112.292 173.757 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 96' ' ' GLY . . . . . 0.486 ' HA3' HG13 ' A' ' 132' ' ' VAL . . . 79.76 17.85 74.26 Favored Glycine 0 C--N 1.345 1.058 0 CA-C-N 116.078 -0.51 . . . . 53.31 114.334 177.475 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 97' ' ' ILE . . . . . 0.538 HG21 ' HA ' ' A' ' 92' ' ' HIS . 8.3 mm -71.41 124.25 27.43 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.893 0 C-N-CA 124.236 1.014 . . . . 73.03 110.757 178.963 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 63.2 tp -108.56 115.34 29.92 Favored 'General case' 0 N--CA 1.484 1.273 0 C-N-CA 123.53 0.732 . . . . 73.43 110.355 179.059 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 18.5 m -133.78 144.5 49.08 Favored 'General case' 0 N--CA 1.48 1.06 0 C-N-CA 124.632 1.173 . . . . 73.13 108.641 174.123 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 100' ' ' MET . . . . . 0.623 ' HA ' ' HA ' ' A' ' 112' ' ' PHE . 72.6 mtp -78.7 137.22 37.69 Favored 'General case' 0 N--CA 1.488 1.471 0 CA-C-N 118.412 0.551 . . . . 73.22 110.008 178.786 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 101' ' ' ALA . . . . . 0.461 ' HB1' ' HB2' ' A' ' 111' ' ' GLN . . . -72.32 168.78 17.64 Favored 'General case' 0 N--CA 1.481 1.088 0 C-N-CA 123.109 0.564 . . . . 55.15 111.981 -170.803 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 102' ' ' ASN . . . . . 0.575 ' HB3' ' HA ' ' A' ' 108' ' ' ASN . 29.4 p-10 -168.04 179.16 4.74 Favored 'General case' 0 CA--C 1.542 0.655 0 CA-C-N 115.646 -0.707 . . . . 74.21 111.278 -177.597 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -117.08 -5.41 11.4 Favored 'General case' 0 N--CA 1.479 0.999 0 C-N-CA 124.188 0.995 . . . . 70.44 110.726 169.165 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 163.7 -171.36 39.32 Favored Glycine 0 C--N 1.358 1.782 0 CA-C-O 119.507 -0.607 . . . . 75.34 112.901 179.695 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 52.7 Cg_exo -57.9 143.25 96.23 Favored 'Trans proline' 0 C--N 1.378 2.12 0 C-N-CA 123.419 2.746 . . . . 75.32 112.041 172.791 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 106' ' ' ASN . . . . . 0.457 ' HA ' ' HA ' ' A' ' 84' ' ' GLU . 65.6 t30 66.07 12.82 8.75 Favored 'General case' 0 N--CA 1.488 1.467 0 C-N-CA 124.135 0.974 . . . . 73.33 111.243 -178.617 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 107' ' ' THR . . . . . 0.733 ' HA ' ' HD2' ' A' ' 82' ' ' LYS . 6.4 m -123.72 1.48 8.8 Favored 'General case' 0 CA--C 1.556 1.188 0 C-N-CA 124.128 0.971 . . . . 63.41 110.017 179.665 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 108' ' ' ASN . . . . . 0.575 ' HA ' ' HB3' ' A' ' 102' ' ' ASN . 40.0 t30 -70.88 143.77 50.9 Favored 'General case' 0 N--CA 1.479 1.024 0 C-N-CA 124.26 1.024 . . . . 74.12 110.604 -178.626 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 94.93 20.66 27.79 Favored Glycine 0 N--CA 1.47 0.957 0 N-CA-C 113.847 0.299 . . . . 70.44 113.847 177.983 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 110' ' ' SER . . . . . 0.59 ' HB2' ' HA ' ' A' ' 73' ' ' THR . 27.5 p -112.42 118.37 34.99 Favored 'General case' 0 CA--C 1.54 0.591 0 N-CA-C 107.525 -1.287 . . . . 72.24 107.525 169.758 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 111' ' ' GLN . . . . . 0.514 ' HG3' ' O ' ' A' ' 73' ' ' THR . 38.3 mt-30 65.35 -177.94 0.18 Allowed 'General case' 0 N--CA 1.495 1.812 0 C-N-CA 124.183 0.993 . . . . 64.44 110.672 -168.284 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 112' ' ' PHE . . . . . 0.623 ' HA ' ' HA ' ' A' ' 100' ' ' MET . 30.0 p90 -147.99 158.58 44.13 Favored 'General case' 0 N--CA 1.472 0.667 0 C-N-CA 124.105 0.962 . . . . 73.31 108.805 175.685 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 113' ' ' PHE . . . . . 0.451 ' HA ' ' HA ' ' A' ' 63' ' ' GLN . 53.1 p90 -146.82 145.22 29.82 Favored 'General case' 0 C--O 1.235 0.326 0 CA-C-O 121.057 0.456 . . . . 74.25 110.701 -179.581 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 114' ' ' ILE . . . . . 0.554 ' HB ' ' SG ' ' A' ' 62' ' ' CYS . 10.7 mt -115.51 102.26 13.49 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.456 0 N-CA-C 107.066 -1.457 . . . . 73.24 107.066 177.512 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 115' ' ' CYS . . . . . 0.485 ' HB2' ' HB ' ' A' ' 97' ' ' ILE . 50.5 m -60.85 103.38 0.26 Allowed 'General case' 0 C--N 1.348 0.518 0 N-CA-C 108.432 -0.951 . . . . 64.45 108.432 172.044 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 116' ' ' THR . . . . . 0.533 HG22 HG13 ' A' ' 139' ' ' VAL . 34.6 p -71.51 -32.7 68.5 Favored 'General case' 0 N--CA 1.47 0.568 0 C-N-CA 123.833 0.853 . . . . 74.3 110.183 -175.195 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -115.35 169.16 9.35 Favored 'General case' 0 N--CA 1.472 0.663 0 C-N-CA 123.99 0.916 . . . . 74.24 109.857 172.39 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 15.0 ptmt -66.76 115.85 7.01 Favored 'General case' 0 CA--C 1.549 0.926 0 CA-C-O 121.269 0.557 . . . . 72.2 110.074 176.029 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 119' ' ' THR . . . . . 0.543 ' HB ' HD13 ' A' ' 122' ' ' LEU . 43.7 p -115.76 87.86 2.76 Favored 'General case' 0 CA--C 1.546 0.798 0 CA-C-O 121.712 0.767 . . . . 74.22 110.363 -178.76 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 11.9 pt-20 -80.22 -19.99 45.67 Favored 'General case' 0 N--CA 1.481 1.082 0 CA-C-N 115.744 -0.662 . . . . 74.44 111.278 -176.462 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 121' ' ' TRP . . . . . . . . . . . . . 33.5 p90 -77.64 -7.34 56.28 Favored 'General case' 0 N--CA 1.477 0.919 0 C-N-CA 122.999 0.52 . . . . 71.52 110.569 173.479 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 122' ' ' LEU . . . . . 0.543 HD13 ' HB ' ' A' ' 119' ' ' THR . 9.9 mp -88.86 -7.88 55.31 Favored 'General case' 0 N--CA 1.481 1.076 0 C-N-CA 123.638 0.775 . . . . 73.03 110.698 169.708 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 44.3 m-20 -79.06 150.77 31.77 Favored 'General case' 0 N--CA 1.478 0.969 0 N-CA-C 108.751 -0.833 . . . . 54.43 108.751 173.128 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 97.03 -28.31 14.43 Favored Glycine 0 CA--C 1.526 0.722 0 N-CA-C 110.48 -1.048 . . . . 74.01 110.48 -165.045 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 2.3 mppt? -85.37 -174.07 5.01 Favored 'General case' 0 N--CA 1.478 0.938 0 C-N-CA 124.139 0.976 . . . . 75.13 109.453 170.711 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 126' ' ' HIS . . . . . . . . . . . . . 49.9 p-80 -68.92 154.12 42.6 Favored 'General case' 0 N--CA 1.475 0.824 0 C-N-CA 123.756 0.822 . . . . 74.11 111.374 -166.204 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 127' ' ' VAL . . . . . 0.43 HG13 ' HB3' ' A' ' 86' ' ' GLU . 13.6 p -60.56 149.44 7.6 Favored 'Isoleucine or valine' 0 CA--C 1.552 1.035 0 C-N-CA 125.363 1.465 . . . . 75.14 113.569 -176.915 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 128' ' ' VAL . . . . . 0.418 HG12 HD12 ' A' ' 97' ' ' ILE . 46.5 t -76.94 153.64 5.62 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.82 0 C-N-CA 124.805 1.242 . . . . 74.22 109.688 171.661 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 129' ' ' PHE . . . . . 0.517 ' HA ' HG22 ' A' ' 29' ' ' VAL . 26.4 p90 -129.66 -19.73 3.32 Favored 'General case' 0 N--CA 1.482 1.173 0 CA-C-N 117.914 0.325 . . . . 75.22 111.572 178.256 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . -134.12 162.73 24.55 Favored Glycine 0 C--N 1.339 0.747 0 N-CA-C 112.297 -0.321 . . . . 73.45 112.297 -176.234 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 29.4 ttpt -150.14 134.34 17.13 Favored 'General case' 0 N--CA 1.472 0.626 0 N-CA-C 107.757 -1.201 . . . . 75.21 107.757 177.123 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 132' ' ' VAL . . . . . 0.486 HG13 ' HA3' ' A' ' 96' ' ' GLY . 12.1 p -64.7 131.23 30.44 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.876 0 CA-C-O 121.117 0.484 . . . . 72.3 109.81 178.105 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 133' ' ' LYS . . . . . 0.627 ' HD2' ' HB2' ' A' ' 23' ' ' GLU . 0.1 OUTLIER -118.52 -24.19 6.88 Favored 'General case' 0 N--CA 1.473 0.725 0 C-N-CA 123.736 0.814 . . . . 74.43 110.046 179.185 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 134' ' ' GLU . . . . . 0.466 ' HB2' ' HB3' ' A' ' 21' ' ' SER . 20.8 mm-40 -133.79 129.42 36.56 Favored 'General case' 0 N--CA 1.472 0.673 0 C-N-CA 124.224 1.01 . . . . 72.31 109.224 177.677 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 79.51 36.2 27.11 Favored Glycine 0 C--N 1.345 1.06 0 O-C-N 123.634 0.584 . . . . 64.32 113.945 174.676 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 136' ' ' MET . . . . . . . . . . . . . 5.3 tpt -57.23 -43.6 83.04 Favored 'General case' 0 N--CA 1.491 1.607 0 C-N-CA 123.669 0.787 . . . . 72.33 110.085 172.164 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 137' ' ' ASN . . . . . . . . . . . . . 2.8 t-20 -61.4 -35.08 76.52 Favored 'General case' 0 CA--C 1.548 0.886 0 C-N-CA 124.058 0.943 . . . . 73.1 111.476 177.427 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 138' ' ' ILE . . . . . . . . . . . . . 45.5 mm -69.48 -37.61 75.28 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.999 0 C-N-CA 122.835 0.454 . . . . 74.43 110.349 177.839 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 139' ' ' VAL . . . . . 0.533 HG13 HG22 ' A' ' 116' ' ' THR . 85.8 t -64.3 -37.01 78.82 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.3 0 C-N-CA 123.475 0.71 . . . . 75.5 110.471 174.738 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 44.9 mt-10 -78.6 -19.01 53.7 Favored 'General case' 0 CA--C 1.543 0.683 0 CA-C-N 115.595 -0.73 . . . . 73.41 111.345 178.016 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -78.86 -48.57 14.44 Favored 'General case' 0 N--CA 1.475 0.784 0 C-N-CA 122.987 0.515 . . . . 71.55 110.17 177.069 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 142' ' ' MET . . . . . 0.557 ' HA ' ' HD2' ' A' ' 145' ' ' PHE . 25.5 ptm -65.5 -31.43 72.49 Favored 'General case' 0 N--CA 1.479 0.977 0 C-N-CA 123.502 0.721 . . . . 71.2 110.841 177.429 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 23.6 tt0 -48.41 -45.41 36.09 Favored 'General case' 0 N--CA 1.481 1.089 0 C-N-CA 124.997 1.319 . . . . 64.41 111.426 171.309 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 144' ' ' ARG . . . . . . . . . . . . . 90.7 mtt180 -73.11 -18.78 61.26 Favored 'General case' 0 N--CA 1.474 0.739 0 CA-C-N 114.542 -1.208 . . . . 74.52 111.845 -174.701 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 145' ' ' PHE . . . . . 0.557 ' HD2' ' HA ' ' A' ' 142' ' ' MET . 54.1 m-85 -80.62 -19.65 44.97 Favored 'General case' 0 N--CA 1.475 0.812 0 N-CA-C 109.929 -0.396 . . . . 74.32 109.929 174.13 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . -77.01 165.04 53.29 Favored Glycine 0 C--N 1.344 1.016 0 N-CA-C 111.881 -0.488 . . . . 64.44 111.881 172.586 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 10.1 m -133.08 170.47 15.35 Favored 'General case' 0 N--CA 1.479 1.006 0 C-N-CA 123.255 0.622 . . . . 73.2 110.384 -173.929 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 148' ' ' ARG . . . . . . . . . . . . . 34.7 mmt180 -64.48 -32.57 74.25 Favored 'General case' 0 N--CA 1.487 1.404 0 C-N-CA 123.612 0.765 . . . . 74.31 111.809 -179.417 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 149' ' ' ASN . . . . . . . . . . . . . 25.5 p-10 -75.85 -5.09 44.32 Favored 'General case' 0 N--CA 1.481 1.11 0 C-N-CA 123.09 0.556 . . . . 74.32 111.476 177.781 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . 97.13 -19.52 54.44 Favored Glycine 0 C--N 1.35 1.348 0 C-N-CA 123.115 0.388 . . . . 74.33 113.28 176.507 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 61.0 tttm -78.1 146.93 34.9 Favored 'General case' 0 N--CA 1.474 0.749 0 CA-C-N 117.169 0.485 . . . . 74.11 110.476 -176.481 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 152' ' ' THR . . . . . . . . . . . . . 77.7 p -92.91 162.99 13.86 Favored 'General case' 0 CA--C 1.549 0.907 0 C-N-CA 123.972 0.909 . . . . 72.42 110.447 177.734 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 153' ' ' SER . . . . . . . . . . . . . 37.8 m -96.64 -27.34 14.85 Favored 'General case' 0 N--CA 1.477 0.907 0 C-N-CA 124.231 1.012 . . . . 74.44 109.675 178.149 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 74.9 mmtt -115.12 148.05 39.45 Favored 'General case' 0 C--O 1.239 0.541 0 C-N-CA 124.592 1.157 . . . . 73.43 108.974 176.276 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 44.7 mtmt -78.13 88.79 4.23 Favored 'General case' 0 N--CA 1.472 0.658 0 N-CA-C 107.828 -1.175 . . . . 73.42 107.828 171.673 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 156' ' ' ILE . . . . . 0.524 HG23 ' HE3' ' A' ' 142' ' ' MET . 65.8 mt -86.97 107.82 17.38 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.32 0 CA-C-N 115.805 -0.634 . . . . 75.31 109.459 -171.412 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 157' ' ' THR . . . . . . . . . . . . . 34.9 p -121.59 156.87 31.99 Favored 'General case' 0 C--O 1.243 0.722 0 C-N-CA 124.514 1.126 . . . . 72.04 110.587 -174.55 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 158' ' ' ILE . . . . . 0.471 HG22 ' HB3' ' A' ' 8' ' ' PHE . 58.6 mt -78.72 93.37 1.54 Allowed 'Isoleucine or valine' 0 CA--C 1.547 0.858 0 N-CA-C 108.766 -0.827 . . . . 74.32 108.766 171.779 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 159' ' ' ALA . . . . . . . . . . . . . . . -61.46 -39.83 92.31 Favored 'General case' 0 N--CA 1.479 1.009 0 C-N-CA 124.567 1.147 . . . . 72.52 113.066 -176.289 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 160' ' ' ASP . . . . . 0.586 ' HA ' ' HE3' ' A' ' 49' ' ' LYS . 16.2 t70 -150.67 168.59 23.88 Favored 'General case' 0 CA--C 1.551 0.99 0 O-C-N 123.528 0.517 . . . . 73.11 110.033 -174.595 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 161' ' ' CYS . . . . . . . . . . . . . 21.8 p -147.04 -170.46 3.55 Favored 'General case' 0 N--CA 1.478 0.953 0 C-N-CA 124.725 1.21 . . . . 75.44 109.234 -172.067 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 162' ' ' GLY . . . . . . . . . . . . . . . 132.12 52.72 0.09 OUTLIER Glycine 0 N--CA 1.476 1.344 0 O-C-N 122.016 -0.427 . . . . 73.25 112.097 -174.244 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 163' ' ' GLN . . . . . 0.583 ' HA ' ' H ' ' A' ' 7' ' ' PHE . 44.9 mt-30 -47.63 106.39 0.09 Allowed 'General case' 0 N--CA 1.48 1.039 0 C-N-CA 125.44 1.496 . . . . 73.1 111.887 -179.737 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 164' ' ' LEU . . . . . . . . . . . . . 74.1 mt -63.61 105.29 0.77 Allowed 'General case' 0 CA--C 1.545 0.752 0 C-N-CA 125.005 1.322 . . . . 74.33 112.141 -171.393 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 165' ' ' GLU . . . . . . . . . . . . . 33.2 tt0 . . . . . 0 CA--C 1.554 1.114 0 N-CA-C 108.057 -1.09 . . . . 72.5 108.057 170.373 . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' B' B ' 216' ' ' PRO . . . . . . . . . . . . . 5.7 Cg_endo . . . . . 0 CA--C 1.543 0.959 0 N-CA-C 110.506 -0.613 . . . . 71.3 110.506 . . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' B' B ' 217' ' ' GLU . . . . . . . . . . . . . 28.7 tt0 -123.62 105.3 33.1 Favored Pre-proline 0 N--CA 1.475 0.82 0 C-N-CA 123.734 0.813 . . . . 71.31 109.714 -178.061 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 218' ' ' PRO . . . . . . . . . . . . . 57.9 Cg_endo -86.09 170.88 8.18 Favored 'Trans proline' 0 C--N 1.369 1.616 0 C-N-CA 122.462 2.108 . . . . 63.41 111.248 169.457 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 219' ' ' GLY . . . . . . . . . . . . . . . 112.99 166.82 16.77 Favored Glycine 0 CA--C 1.526 0.732 0 CA-C-N 116.051 -0.522 . . . . 73.31 112.493 -178.79 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 220' ' ' PRO . . . . . . . . . . . . . 8.3 Cg_exo -74.76 154.82 43.98 Favored 'Trans proline' 0 CA--C 1.554 1.517 0 C-N-CA 123.76 2.974 . . . . 52.44 114.064 -172.605 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 221' ' ' TYR . . . . . . . . . . . . . 95.9 m-85 -89.5 151.05 22.18 Favored 'General case' 0 N--CA 1.483 1.204 0 C-N-CA 124.216 1.007 . . . . 60.25 111.277 -178.395 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 222' ' ' ALA . . . . . . . . . . . . . . . -104.24 -168.04 1.44 Allowed 'General case' 0 N--CA 1.475 0.819 0 C-N-CA 124.417 1.087 . . . . 65.02 112.805 -169.34 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 223' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -84.29 139.6 39.03 Favored Pre-proline 0 CA--C 1.557 1.233 0 CA-C-N 114.752 -1.113 . . . . 71.53 108.669 166.919 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 224' ' ' PRO . . . . . . . . . . . . . 60.8 Cg_endo . . . . . 0 C--N 1.378 2.092 0 C-N-CA 122.692 2.261 . . . . 70.12 111.863 -179.423 . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 24.8 mmt . . . . . 0 N--CA 1.478 0.946 0 N-CA-C 109.458 -0.571 . . . . 72.15 109.458 . . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 14.7 p -77.0 -26.18 15.82 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.942 0 C-N-CA 123.669 0.788 . . . . 61.44 110.817 179.762 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 3' ' ' ASN . . . . . 0.454 ' ND2' ' HA ' ' A' ' 25' ' ' PHE . 15.9 m120 -66.03 113.32 11.76 Favored Pre-proline 0 CA--C 1.556 1.176 0 C-N-CA 124.097 0.959 . . . . 73.22 111.346 -178.131 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 56.0 Cg_endo -70.8 123.31 9.64 Favored 'Trans proline' 0 C--N 1.379 2.178 0 C-N-CA 122.576 2.184 . . . . 75.21 110.652 175.159 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 5' ' ' THR . . . . . 0.463 ' HB ' ' O ' ' A' ' 164' ' ' LEU . 83.0 m -104.15 125.59 50.58 Favored 'General case' 0 CA--C 1.535 0.369 0 N-CA-C 109.703 -0.48 . . . . 55.15 109.703 -179.807 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . 0.593 ' HA ' ' HB2' ' A' ' 163' ' ' GLN . 6.7 m -100.51 122.94 53.09 Favored 'Isoleucine or valine' 0 C--N 1.347 0.457 0 CA-C-O 122.156 0.979 . . . . 73.31 109.732 -178.618 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 7' ' ' PHE . . . . . 0.643 ' H ' ' HA ' ' A' ' 163' ' ' GLN . 76.1 t80 -103.43 133.74 47.98 Favored 'General case' 0 C--O 1.243 0.734 0 CA-C-N 114.224 -1.353 . . . . 72.34 108.99 -174.877 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 8' ' ' PHE . . . . . 0.426 ' HD2' ' HE2' ' A' ' 22' ' ' PHE . 61.4 m-85 -135.23 162.08 33.56 Favored 'General case' 0 C--O 1.238 0.468 0 O-C-N 124.161 0.913 . . . . 74.2 109.702 172.258 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 24.9 m-20 -108.74 115.99 31.14 Favored 'General case' 0 C--N 1.322 -0.604 0 N-CA-C 106.975 -1.491 . . . . 74.54 106.975 170.235 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 51.3 mm -85.42 113.16 23.31 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.546 0 N-CA-C 108.707 -0.849 . . . . 71.12 108.707 178.068 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 11' ' ' ALA . . . . . 0.498 ' HB3' ' HB1' ' A' ' 159' ' ' ALA . . . -116.26 125.24 51.92 Favored 'General case' 0 N--CA 1.477 0.91 0 C-N-CA 122.974 0.51 . . . . 74.21 110.397 178.858 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . 0.403 ' HA ' ' HA ' ' A' ' 156' ' ' ILE . 48.7 t -95.34 107.18 19.19 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.626 0 N-CA-C 108.088 -1.079 . . . . 74.04 108.088 177.449 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 20.3 m-20 61.58 31.19 18.85 Favored 'General case' 0 N--CA 1.489 1.485 0 C-N-CA 124.662 1.185 . . . . 73.32 112.023 179.409 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 96.79 -19.55 54.28 Favored Glycine 0 C--N 1.344 0.977 0 CA-C-N 115.62 -0.718 . . . . 71.41 112.905 179.035 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 26.3 mm-40 -83.58 114.57 54.4 Favored Pre-proline 0 CA--C 1.542 0.653 0 N-CA-C 109.227 -0.657 . . . . 75.51 109.227 -179.928 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 47.2 Cg_endo -65.36 107.77 1.06 Allowed 'Trans proline' 0 C--N 1.376 2.018 0 C-N-CA 122.248 1.965 . . . . 73.13 111.285 -178.201 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 58.0 tp -75.89 -38.54 57.72 Favored 'General case' 0 C--O 1.241 0.635 0 CA-C-N 115.084 -0.962 . . . . 75.21 109.774 -177.827 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 173.0 -171.7 44.62 Favored Glycine 0 C--N 1.343 0.92 0 CA-C-N 116.159 -0.473 . . . . 63.4 113.875 176.52 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 19' ' ' ARG . . . . . 0.462 ' HB3' ' HE1' ' A' ' 7' ' ' PHE . 67.8 mtt85 -115.99 129.27 56.3 Favored 'General case' 0 N--CA 1.472 0.667 0 C-N-CA 124.312 1.045 . . . . 74.4 109.462 -173.843 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 20' ' ' VAL . . . . . 0.418 HG12 HG11 ' A' ' 132' ' ' VAL . 61.9 t -125.74 133.16 69.75 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.883 0 C-N-CA 123.106 0.563 . . . . 72.03 109.999 178.696 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 37.9 m -119.93 119.16 32.68 Favored 'General case' 0 CA--C 1.558 1.273 0 C-N-CA 124.389 1.075 . . . . 65.33 108.973 177.389 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 22' ' ' PHE . . . . . 0.426 ' HE2' ' HD2' ' A' ' 8' ' ' PHE . 52.7 m-85 -101.13 114.95 29.38 Favored 'General case' 0 N--CA 1.477 0.876 0 C-N-CA 124.22 1.008 . . . . 64.45 110.233 -179.255 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . 0.665 ' HB2' ' HD2' ' A' ' 133' ' ' LYS . 43.2 tt0 -76.06 105.06 6.89 Favored 'General case' 0 CA--C 1.549 0.933 0 C-N-CA 123.859 0.864 . . . . 61.34 109.799 176.601 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . 0.527 ' HB3' ' HB2' ' A' ' 33' ' ' ALA . 55.5 mt -82.99 128.06 34.12 Favored 'General case' 0 N--CA 1.478 0.954 0 C-N-CA 122.992 0.517 . . . . 72.33 110.66 -179.697 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 25' ' ' PHE . . . . . 0.454 ' HA ' ' ND2' ' A' ' 3' ' ' ASN . 54.1 m-85 -90.99 61.13 4.54 Favored 'General case' 0 CA--C 1.532 0.265 0 C-N-CA 123.787 0.835 . . . . 73.45 109.883 -179.295 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -67.9 -13.31 62.05 Favored 'General case' 0 N--CA 1.48 1.04 0 CA-C-N 115.849 -0.614 . . . . 51.45 112.042 179.371 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 11.2 p-10 -71.85 -31.83 66.88 Favored 'General case' 0 CA--C 1.55 0.944 0 C-N-CA 123.481 0.712 . . . . 74.21 110.829 173.848 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 58.0 mttp -96.88 -49.54 5.01 Favored 'General case' 0 N--CA 1.485 1.288 0 C-N-CA 123.948 0.899 . . . . 73.45 111.285 -178.317 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 29' ' ' VAL . . . . . 0.657 ' HB ' ' HB ' ' A' ' 32' ' ' THR . 11.8 m -117.77 76.14 10.53 Favored Pre-proline 0 CA--C 1.562 1.432 0 C-N-CA 124.165 0.986 . . . . 74.01 110.054 179.117 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 30' ' ' PRO . . . . . 0.453 ' HD2' ' HG2' ' A' ' 86' ' ' GLU . 7.2 Cg_endo -51.24 -59.59 1.1 Allowed 'Trans proline' 0 C--N 1.394 2.968 0 C-N-CA 123.381 2.721 . . . . 75.21 113.207 179.699 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 5.8 ttpm? -57.75 -50.2 74.03 Favored 'General case' 0 N--CA 1.482 1.172 0 C-N-CA 123.398 0.679 . . . . 74.44 112.098 -179.562 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 32' ' ' THR . . . . . 0.657 ' HB ' ' HB ' ' A' ' 29' ' ' VAL . 88.9 m -67.78 -35.6 78.97 Favored 'General case' 0 CA--C 1.56 1.357 0 C-N-CA 123.998 0.919 . . . . 74.14 112.593 -170.632 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 33' ' ' ALA . . . . . 0.527 ' HB2' ' HB3' ' A' ' 24' ' ' LEU . . . -90.47 -43.7 10.09 Favored 'General case' 0 N--CA 1.485 1.294 0 C-N-CA 123.019 0.528 . . . . 71.04 112.173 -176.985 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 39.3 tt0 -63.63 -31.73 72.99 Favored 'General case' 0 N--CA 1.484 1.255 0 C-N-CA 123.372 0.669 . . . . 73.15 110.733 179.754 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 35' ' ' ASN . . . . . 0.409 ' O ' ' HG ' ' A' ' 39' ' ' LEU . 35.8 t30 -49.01 -59.51 3.56 Favored 'General case' 0 C--N 1.36 1.029 0 O-C-N 124.566 1.166 . . . . 75.03 110.314 171.457 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 76.3 t80 -65.17 -40.55 94.44 Favored 'General case' 0 C--N 1.348 0.526 0 O-C-N 124.045 0.84 . . . . 70.25 111.249 -175.035 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 56.1 ttp180 -58.26 -44.98 88.62 Favored 'General case' 0 N--CA 1.48 1.044 0 O-C-N 123.723 0.639 . . . . 72.21 110.919 179.057 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 38' ' ' ALA . . . . . 0.539 ' HB3' HG23 ' A' ' 78' ' ' ILE . . . -69.38 -32.24 71.15 Favored 'General case' 0 N--CA 1.473 0.694 0 CA-C-N 115.274 -0.875 . . . . 74.24 111.487 -179.726 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 39' ' ' LEU . . . . . 0.409 ' HG ' ' O ' ' A' ' 35' ' ' ASN . 94.3 mt -69.74 -35.96 75.42 Favored 'General case' 0 N--CA 1.477 0.915 0 C-N-CA 123.87 0.868 . . . . 75.34 111.06 175.326 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 50.0 m -73.52 -54.81 7.34 Favored 'General case' 0 N--CA 1.474 0.75 0 C-N-CA 124.015 0.926 . . . . 75.55 111.284 -175.567 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 56.4 p -78.77 -31.51 46.16 Favored 'General case' 0 CA--C 1.538 0.519 0 CA-C-N 115.128 -0.942 . . . . 65.1 111.376 -175.188 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 92.09 37.68 5.92 Favored Glycine 0 C--N 1.347 1.168 0 CA-C-O 119.647 -0.529 . . . . 72.43 112.682 -178.204 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 68.1 mm-40 -61.1 -29.24 69.64 Favored 'General case' 0 N--CA 1.482 1.152 0 C-N-CA 123.089 0.555 . . . . 64.44 110.432 172.08 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 44' ' ' LYS . . . . . 0.579 ' HG3' ' HB ' ' A' ' 78' ' ' ILE . 32.0 mmmt -108.43 17.75 21.74 Favored 'General case' 0 CA--C 1.541 0.614 0 C-N-CA 124.696 1.199 . . . . 75.2 111.366 -178.965 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 80.23 -1.77 79.36 Favored Glycine 0 C--N 1.355 1.604 0 CA-C-O 119.118 -0.823 . . . . 73.35 114.923 173.353 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 19.7 m-85 -85.17 -48.15 9.43 Favored 'General case' 0 N--CA 1.477 0.924 0 CA-C-N 117.96 0.88 . . . . 64.14 111.05 -174.2 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 41.6 62.23 1.97 Allowed Glycine 0 N--CA 1.485 1.964 0 O-C-N 124.508 1.13 . . . . 74.52 114.816 171.517 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 48' ' ' TYR . . . . . 0.451 ' HB3' ' OG ' ' A' ' 51' ' ' SER . 34.5 m-85 -59.68 98.89 0.05 Allowed 'General case' 0 CA--C 1.548 0.898 0 CA-C-O 121.843 0.83 . . . . 72.52 112.191 -170.095 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 23.2 tptm -108.39 113.53 26.66 Favored 'General case' 0 CA--C 1.539 0.544 0 CA-C-N 113.941 -1.481 . . . . 75.24 108.841 -175.771 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 93.61 18.59 37.68 Favored Glycine 0 C--N 1.346 1.13 0 CA-C-O 119.267 -0.741 . . . . 75.45 113.078 179.823 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 51' ' ' SER . . . . . 0.451 ' OG ' ' HB3' ' A' ' 48' ' ' TYR . 19.6 m -59.95 118.62 6.47 Favored 'General case' 0 N--CA 1.476 0.853 0 C-N-CA 123.317 0.647 . . . . 73.33 111.177 -176.849 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 52' ' ' CYS . . . . . 0.622 ' SG ' ' HD2' ' A' ' 155' ' ' LYS . 36.0 t -86.28 125.15 33.39 Favored 'General case' 0 CA--C 1.533 0.306 0 CA-C-N 115.447 -0.797 . . . . 75.2 112.302 -167.539 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 53' ' ' PHE . . . . . 0.662 ' HA ' ' HA2' ' A' ' 64' ' ' GLY . 95.4 m-85 -73.08 109.33 6.54 Favored 'General case' 0 C--O 1.238 0.479 0 N-CA-C 108.756 -0.831 . . . . 74.15 108.756 166.27 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 19.2 p-80 -128.43 8.41 5.95 Favored 'General case' 0 N--CA 1.482 1.135 0 CA-C-N 115.611 -0.722 . . . . 74.43 111.856 -169.267 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 80.0 ttt-85 -152.25 99.31 2.5 Favored 'General case' 0 N--CA 1.472 0.67 0 N-CA-C 108.794 -0.817 . . . . 75.21 108.794 177.768 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 56' ' ' ILE . . . . . 0.46 HD12 ' HB3' ' A' ' 53' ' ' PHE . 58.3 mt -137.31 134.01 46.89 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.8 0 C-N-CA 123.181 0.592 . . . . 74.32 109.908 -174.688 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 41.8 mt -117.58 118.32 35.31 Favored Pre-proline 0 CA--C 1.554 1.109 0 C-N-CA 124.164 0.986 . . . . 71.31 108.549 174.229 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 58' ' ' PRO . . . . . 0.572 ' HA ' ' HG2' ' A' ' 143' ' ' GLU . 53.8 Cg_endo -67.3 135.95 38.57 Favored 'Trans proline' 0 C--N 1.38 2.206 0 C-N-CA 123.021 2.481 . . . . 74.45 111.508 179.847 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 77.35 30.01 54.97 Favored Glycine 0 CA--C 1.526 0.765 0 CA-C-N 115.345 -0.843 . . . . 71.13 113.091 -176.168 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 29.0 t80 -156.57 -67.04 0.11 Allowed 'General case' 0 C--O 1.247 0.96 0 C-N-CA 123.027 0.531 . . . . 74.14 110.715 -176.921 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 61' ' ' MET . . . . . 0.555 ' HE3' ' HB3' ' A' ' 115' ' ' CYS . 45.6 ttm -167.16 146.96 5.35 Favored 'General case' 0 N--CA 1.48 1.073 0 N-CA-C 112.188 0.44 . . . . 74.24 112.188 -165.654 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 62' ' ' CYS . . . . . 0.432 ' SG ' HG12 ' A' ' 139' ' ' VAL . 23.5 p -116.55 114.25 23.88 Favored 'General case' 0 CA--C 1.545 0.781 0 C-N-CA 123.726 0.81 . . . . 72.45 109.111 169.322 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 28.4 tt0 -112.63 140.96 46.96 Favored 'General case' 0 N--CA 1.479 0.995 0 C-N-CA 123.627 0.771 . . . . 74.25 110.66 -179.506 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 64' ' ' GLY . . . . . 0.662 ' HA2' ' HA ' ' A' ' 53' ' ' PHE . . . -130.81 -176.55 14.46 Favored Glycine 0 C--N 1.344 0.976 0 CA-C-N 115.306 -0.861 . . . . 72.24 112.754 176.669 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 176.22 155.07 12.41 Favored Glycine 0 C--N 1.335 0.486 0 N-CA-C 111.721 -0.552 . . . . 74.54 111.721 -179.262 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 21.2 t70 -83.06 179.79 7.65 Favored 'General case' 0 CA--C 1.552 1.031 0 C-N-CA 124.017 0.927 . . . . 74.42 110.593 -176.979 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 53.2 t80 -88.51 -15.68 34.65 Favored 'General case' 0 CA--C 1.548 0.89 0 C-N-CA 123.188 0.595 . . . . 62.22 111.538 177.635 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 42.5 m -65.01 107.79 1.61 Allowed 'General case' 0 C--N 1.357 0.93 0 N-CA-C 109.724 -0.472 . . . . 74.43 109.724 178.057 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 85.1 mtt85 58.64 47.66 12.8 Favored 'General case' 0 N--CA 1.479 1.002 0 C-N-CA 124.821 1.248 . . . . 73.05 110.633 -170.805 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 48.6 t-80 -49.82 -37.66 31.42 Favored 'General case' 0 N--CA 1.482 1.164 0 C-N-CA 124.754 1.222 . . . . 74.4 112.69 -172.297 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 53.1 t30 -68.26 96.47 0.65 Allowed 'General case' 0 CA--C 1.542 0.65 0 O-C-N 123.499 0.499 . . . . 65.34 109.991 175.233 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 67.56 16.15 67.2 Favored Glycine 0 C--N 1.345 1.06 0 N-CA-C 116.022 1.169 . . . . 73.24 116.022 168.805 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 73' ' ' THR . . . . . 0.583 ' HA ' ' HB2' ' A' ' 110' ' ' SER . 88.3 m -132.65 -75.93 0.5 Allowed 'General case' 0 N--CA 1.472 0.638 0 N-CA-C 108.426 -0.953 . . . . 72.12 108.426 168.871 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 53.95 60.26 8.67 Favored Glycine 0 C--N 1.355 1.59 0 O-C-N 123.781 0.675 . . . . 70.35 113.725 170.137 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 130.96 51.4 0.1 OUTLIER Glycine 0 C--N 1.344 1.026 0 N-CA-C 111.855 -0.498 . . . . 74.11 111.855 -176.716 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -52.36 166.09 0.2 Allowed 'General case' 0 N--CA 1.491 1.606 0 C-N-CA 124.369 1.068 . . . . 74.51 112.583 174.688 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 80.9 p -90.65 177.67 6.28 Favored 'General case' 0 N--CA 1.478 0.965 0 C-N-CA 122.994 0.518 . . . . 73.41 111.043 -175.699 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 78' ' ' ILE . . . . . 0.579 ' HB ' ' HG3' ' A' ' 44' ' ' LYS . 31.9 pt -79.02 -22.83 12.7 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.022 0 C-N-CA 123.275 0.63 . . . . 73.42 110.773 176.505 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 71.0 m-85 -79.42 -40.32 30.28 Favored 'General case' 0 N--CA 1.47 0.548 0 C-N-CA 124.19 0.996 . . . . 73.35 109.704 -179.724 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 177.45 -138.69 3.98 Favored Glycine 0 C--N 1.339 0.746 0 CA-C-N 115.152 -0.931 . . . . 63.03 111.528 177.734 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 36.0 tt0 -65.64 -44.44 86.39 Favored 'General case' 0 N--CA 1.471 0.604 0 C-N-CA 123.917 0.887 . . . . 73.44 109.855 177.025 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 82' ' ' LYS . . . . . 0.452 ' HD2' ' HA ' ' A' ' 107' ' ' THR . 20.8 pttp -154.07 175.31 13.58 Favored 'General case' 0 CA--C 1.55 0.977 0 CA-C-N 114.943 -1.026 . . . . 73.24 110.383 -175.219 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 2.2 p90 -159.42 170.48 21.67 Favored 'General case' 0 CA--C 1.554 1.104 0 C-N-CA 124.132 0.973 . . . . 74.14 110.311 -173.765 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 13.0 pt-20 -96.4 157.37 15.93 Favored 'General case' 0 N--CA 1.486 1.343 0 C-N-CA 123.664 0.785 . . . . 74.4 109.014 173.219 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 28.4 m-20 -77.53 150.85 34.77 Favored 'General case' 0 N--CA 1.483 1.206 0 N-CA-C 113.099 0.777 . . . . 74.32 113.099 178.1 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 86' ' ' GLU . . . . . 0.453 ' HG2' ' HD2' ' A' ' 30' ' ' PRO . 13.8 tp10 -61.95 -60.6 3.39 Favored 'General case' 0 CA--C 1.541 0.614 0 CA-C-N 114.044 -1.435 . . . . 73.41 111.158 -179.763 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 26.2 p30 -165.73 152.85 10.18 Favored 'General case' 0 N--CA 1.475 0.789 0 C-N-CA 123.556 0.743 . . . . 74.34 109.723 -176.973 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 89.9 m-85 -90.58 47.26 1.41 Allowed 'General case' 0 N--CA 1.48 1.055 0 C-N-CA 123.624 0.769 . . . . 74.45 111.267 -176.362 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 71.3 mt -69.87 -59.5 3.45 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.925 0 N-CA-C 108.926 -0.768 . . . . 71.34 108.926 173.209 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 90' ' ' LEU . . . . . 0.584 ' HB3' ' HB ' ' A' ' 128' ' ' VAL . 80.3 mt -86.69 104.92 16.54 Favored 'General case' 0 CA--C 1.539 0.542 0 CA-C-N 114.878 -1.055 . . . . 71.01 110.596 -172.057 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 20.4 ptmt -103.97 167.77 9.55 Favored 'General case' 0 N--CA 1.475 0.797 0 C-N-CA 123.278 0.631 . . . . 74.41 110.492 -179.617 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 92' ' ' HIS . . . . . . . . . . . . . 57.7 m-70 -83.53 69.38 10.07 Favored 'General case' 0 N--CA 1.48 1.028 0 C-N-CA 123.4 0.68 . . . . 71.4 110.799 -173.666 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 14.5 t -122.26 20.32 10.55 Favored 'General case' 0 N--CA 1.474 0.761 0 C-N-CA 123.338 0.655 . . . . 73.35 110.084 -176.546 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -143.99 172.27 25.22 Favored Glycine 0 C--N 1.348 1.197 0 CA-C-N 116.287 -0.415 . . . . 71.2 113.445 -176.336 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 58.4 Cg_endo -94.02 153.53 2.19 Favored 'Trans proline' 0 C--N 1.368 1.578 0 C-N-CA 123.676 2.918 . . . . 74.21 112.732 175.238 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 72.82 19.85 79.55 Favored Glycine 0 C--N 1.353 1.507 0 CA-C-N 116.244 -0.435 . . . . 60.0 112.827 177.008 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 97' ' ' ILE . . . . . 0.732 ' HB ' ' SG ' ' A' ' 115' ' ' CYS . 20.1 mm -68.84 108.36 1.6 Allowed 'Isoleucine or valine' 0 CA--C 1.541 0.625 0 C-N-CA 124.238 1.015 . . . . 75.33 111.257 -174.213 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 62.1 tp -90.06 120.55 31.35 Favored 'General case' 0 C--O 1.247 0.94 0 CA-C-N 115.581 -0.736 . . . . 75.25 109.95 172.575 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 99' ' ' SER . . . . . 0.468 ' HB3' ' HA ' ' A' ' 128' ' ' VAL . 7.9 p -149.62 147.67 28.4 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 114.483 -1.235 . . . . 72.35 107.902 171.81 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 100' ' ' MET . . . . . 0.715 ' HA ' ' HA ' ' A' ' 112' ' ' PHE . 96.9 mtp -77.29 149.14 35.39 Favored 'General case' 0 N--CA 1.493 1.68 0 C-N-CA 122.627 0.371 . . . . 71.13 110.276 -175.569 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 101' ' ' ALA . . . . . 0.503 ' HB3' ' HB2' ' A' ' 111' ' ' GLN . . . -73.57 162.71 28.93 Favored 'General case' 0 C--O 1.247 0.944 0 CA-C-O 121.535 0.683 . . . . 63.23 111.347 -176.851 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 102' ' ' ASN . . . . . 0.472 ' HB3' ' HA ' ' A' ' 108' ' ' ASN . 24.3 p-10 -167.24 168.4 13.41 Favored 'General case' 0 C--O 1.242 0.706 0 CA-C-N 114.583 -1.19 . . . . 52.43 109.903 -178.14 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 103' ' ' ALA . . . . . 0.602 ' HB3' ' HB2' ' B' ' 216' ' ' PRO . . . -114.96 6.74 15.41 Favored 'General case' 0 CA--C 1.543 0.695 0 C-N-CA 123.802 0.841 . . . . 75.12 110.304 171.183 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 158.54 179.75 33.63 Favored Glycine 0 C--N 1.354 1.582 0 CA-C-O 119.468 -0.629 . . . . 73.42 112.408 178.094 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 26.0 Cg_exo -64.47 137.54 55.67 Favored 'Trans proline' 0 C--N 1.375 1.926 0 C-N-CA 122.933 2.422 . . . . 71.45 110.509 171.514 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 63.0 t30 68.8 8.79 7.0 Favored 'General case' 0 N--CA 1.49 1.528 0 C-N-CA 124.988 1.315 . . . . 74.41 111.116 -174.851 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 107' ' ' THR . . . . . 0.452 ' HA ' ' HD2' ' A' ' 82' ' ' LYS . 1.7 m -116.93 15.82 15.17 Favored 'General case' 0 CA--C 1.551 0.998 0 N-CA-C 108.359 -0.978 . . . . 71.12 108.359 171.6 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 108' ' ' ASN . . . . . 0.472 ' HA ' ' HB3' ' A' ' 102' ' ' ASN . 20.9 t30 -92.05 145.31 24.62 Favored 'General case' 0 C--O 1.202 -1.426 0 C-N-CA 124.832 1.253 . . . . 70.11 110.498 -176.317 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 113.3 26.99 3.8 Favored Glycine 0 N--CA 1.478 1.48 0 CA-C-N 118.303 0.501 . . . . 75.32 112.436 -178.787 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 110' ' ' SER . . . . . 0.583 ' HB2' ' HA ' ' A' ' 73' ' ' THR . 22.5 p -137.04 121.13 17.8 Favored 'General case' 0 CA--C 1.535 0.401 0 N-CA-C 108.675 -0.861 . . . . 62.44 108.675 -177.926 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 111' ' ' GLN . . . . . 0.503 ' HB2' ' HB3' ' A' ' 101' ' ' ALA . 47.4 mt-30 61.47 -177.25 0.12 Allowed 'General case' 0 N--CA 1.493 1.677 0 C-N-CA 123.898 0.879 . . . . 73.4 111.62 -174.551 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 112' ' ' PHE . . . . . 0.715 ' HA ' ' HA ' ' A' ' 100' ' ' MET . 35.5 p90 -151.75 152.92 33.34 Favored 'General case' 0 N--CA 1.475 0.804 0 C-N-CA 123.672 0.789 . . . . 65.54 109.348 176.698 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 113' ' ' PHE . . . . . . . . . . . . . 55.0 p90 -140.59 151.43 44.67 Favored 'General case' 0 N--CA 1.472 0.667 0 C-N-CA 122.963 0.505 . . . . 75.44 110.934 -178.803 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 114' ' ' ILE . . . . . . . . . . . . . 10.9 mt -125.92 107.77 18.22 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.705 0 N-CA-C 107.849 -1.167 . . . . 74.31 107.849 178.765 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 115' ' ' CYS . . . . . 0.732 ' SG ' ' HB ' ' A' ' 97' ' ' ILE . 28.5 p -89.3 113.68 24.97 Favored 'General case' 0 C--O 1.243 0.745 0 N-CA-C 108.964 -0.754 . . . . 71.51 108.964 175.601 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 71.6 p -70.84 -27.02 63.55 Favored 'General case' 0 N--CA 1.474 0.772 0 CA-C-N 115.253 -0.885 . . . . 72.33 111.291 -177.534 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -104.34 162.34 13.3 Favored 'General case' 0 C--O 1.248 0.977 0 C-N-CA 123.815 0.846 . . . . 75.41 110.058 174.826 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 18.1 ptmt -74.04 85.19 1.8 Allowed 'General case' 0 CA--C 1.546 0.825 0 CA-C-O 122.302 1.048 . . . . 74.42 110.248 175.329 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 119' ' ' THR . . . . . . . . . . . . . 50.8 p -82.04 84.39 7.0 Favored 'General case' 0 CA--C 1.546 0.793 0 CA-C-N 115.01 -0.996 . . . . 73.34 109.307 179.359 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 11.4 pt-20 -75.44 -23.36 56.9 Favored 'General case' 0 N--CA 1.484 1.257 0 CA-C-N 115.019 -0.991 . . . . 74.54 112.727 -167.628 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 121' ' ' TRP . . . . . . . . . . . . . 38.7 p90 -67.05 -8.72 32.41 Favored 'General case' 0 CA--C 1.551 1.0 0 C-N-CA 123.452 0.701 . . . . 74.23 112.201 176.79 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 31.9 mt -88.23 10.33 19.94 Favored 'General case' 0 CA--C 1.547 0.833 0 C-N-CA 122.947 0.499 . . . . 71.44 111.954 176.764 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 69.7 m-20 -72.4 121.18 19.11 Favored 'General case' 0 N--CA 1.483 1.207 0 N-CA-C 108.9 -0.778 . . . . 75.42 108.9 170.721 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 110.0 -17.94 29.21 Favored Glycine 0 N--CA 1.475 1.269 0 N-CA-C 111.04 -0.824 . . . . 71.54 111.04 -170.113 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 125' ' ' LYS . . . . . 0.595 ' HG2' ' H ' ' A' ' 126' ' ' HIS . 21.0 ttmm -86.72 -165.58 1.32 Allowed 'General case' 0 CA--C 1.559 1.3 0 N-CA-C 108.045 -1.094 . . . . 73.53 108.045 169.707 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 126' ' ' HIS . . . . . 0.595 ' H ' ' HG2' ' A' ' 125' ' ' LYS . 9.4 t-160 -65.59 130.08 42.02 Favored 'General case' 0 C--N 1.353 0.758 0 CA-C-N 118.583 0.628 . . . . 75.21 109.826 -173.71 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 57.6 t -58.68 143.7 12.69 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.835 0 CA-C-N 113.75 -1.568 . . . . 75.52 110.966 175.829 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 128' ' ' VAL . . . . . 0.584 ' HB ' ' HB3' ' A' ' 90' ' ' LEU . 21.8 t -66.94 149.01 11.83 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.583 0 N-CA-C 109.578 -0.527 . . . . 72.54 109.578 177.098 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 129' ' ' PHE . . . . . 0.513 ' HB3' HG23 ' A' ' 32' ' ' THR . 32.1 p90 -136.32 -23.89 1.26 Allowed 'General case' 0 N--CA 1.474 0.754 0 C-N-CA 122.243 0.217 . . . . 73.53 111.117 171.409 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . -127.09 157.75 20.78 Favored Glycine 0 C--N 1.338 0.689 0 N-CA-C 111.493 -0.643 . . . . 72.31 111.493 -177.552 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 31.3 ttpt -144.74 127.41 16.17 Favored 'General case' 0 C--N 1.324 -0.543 0 N-CA-C 108.616 -0.883 . . . . 72.23 108.616 179.967 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 132' ' ' VAL . . . . . 0.418 HG11 HG12 ' A' ' 20' ' ' VAL . 59.4 t -63.67 100.19 0.22 Allowed 'Isoleucine or valine' 0 CA--C 1.539 0.525 0 N-CA-C 108.589 -0.893 . . . . 71.33 108.589 171.902 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 133' ' ' LYS . . . . . 0.665 ' HD2' ' HB2' ' A' ' 23' ' ' GLU . 19.5 ptmt -87.65 -32.03 19.46 Favored 'General case' 0 N--CA 1.473 0.682 0 N-CA-C 109.581 -0.526 . . . . 75.01 109.581 178.315 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 44.8 mt-10 -139.41 146.29 39.95 Favored 'General case' 0 N--CA 1.473 0.7 0 C-N-CA 124.999 1.32 . . . . 61.33 108.936 176.728 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 87.83 21.76 45.43 Favored Glycine 0 C--N 1.342 0.868 0 O-C-N 123.541 0.526 . . . . 61.43 112.536 -175.89 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 136' ' ' MET . . . . . 0.417 ' HA ' HG13 ' A' ' 132' ' ' VAL . 7.1 tpt -58.88 -46.84 86.85 Favored 'General case' 0 C--N 1.359 1.004 0 C-N-CA 123.92 0.888 . . . . 74.4 111.337 -179.772 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 137' ' ' ASN . . . . . . . . . . . . . 20.1 m120 -65.03 -28.86 69.78 Favored 'General case' 0 N--CA 1.477 0.886 0 C-N-CA 123.228 0.611 . . . . 74.43 111.619 -179.394 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 138' ' ' ILE . . . . . . . . . . . . . 43.2 mm -70.41 -38.84 75.36 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.657 0 C-N-CA 123.329 0.652 . . . . 74.45 109.895 178.839 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 139' ' ' VAL . . . . . 0.467 ' HA ' ' HG2' ' A' ' 142' ' ' MET . 69.6 t -68.64 -39.78 80.84 Favored 'Isoleucine or valine' 0 CA--C 1.553 1.063 0 C-N-CA 123.481 0.713 . . . . 74.44 110.492 176.186 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 48.8 mt-10 -69.2 -27.53 65.58 Favored 'General case' 0 N--CA 1.476 0.872 0 C-N-CA 123.623 0.769 . . . . 75.11 111.224 177.92 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -80.35 -45.6 17.51 Favored 'General case' 0 N--CA 1.477 0.91 0 C-N-CA 123.639 0.776 . . . . 65.45 111.196 178.914 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 142' ' ' MET . . . . . 0.541 ' HA ' ' HD2' ' A' ' 145' ' ' PHE . 27.9 ptm -65.68 -31.71 72.87 Favored 'General case' 0 N--CA 1.478 0.969 0 C-N-CA 123.095 0.558 . . . . 64.31 111.22 -178.35 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 143' ' ' GLU . . . . . 0.572 ' HG2' ' HA ' ' A' ' 58' ' ' PRO . 39.1 tt0 -57.94 -32.22 67.58 Favored 'General case' 0 CA--C 1.552 1.037 0 C-N-CA 123.71 0.804 . . . . 75.21 111.969 177.957 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 144' ' ' ARG . . . . . . . . . . . . . 46.3 mtp85 -75.62 -16.98 60.15 Favored 'General case' 0 N--CA 1.473 0.705 0 CA-C-N 116.261 -0.427 . . . . 74.13 111.814 -175.782 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 145' ' ' PHE . . . . . 0.549 ' HB2' HD11 ' A' ' 156' ' ' ILE . 95.2 m-85 -79.88 2.09 24.62 Favored 'General case' 0 N--CA 1.479 0.994 0 C-N-CA 122.728 0.411 . . . . 71.03 110.844 175.38 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . -89.58 -174.75 45.92 Favored Glycine 0 C--N 1.352 1.426 0 O-C-N 123.199 0.312 . . . . 73.41 112.635 171.787 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 19.8 t -135.6 167.99 20.08 Favored 'General case' 0 N--CA 1.475 0.803 0 C-N-CA 123.796 0.838 . . . . 62.45 110.369 -177.869 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 148' ' ' ARG . . . . . . . . . . . . . 12.1 mmm180 -71.04 -29.84 65.87 Favored 'General case' 0 N--CA 1.477 0.907 0 C-N-CA 123.534 0.734 . . . . 74.23 112.09 -173.601 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 149' ' ' ASN . . . . . . . . . . . . . 28.7 p-10 -79.72 -3.05 45.75 Favored 'General case' 0 N--CA 1.484 1.237 0 C-N-CA 123.51 0.724 . . . . 73.42 111.451 176.141 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . 90.68 11.02 62.6 Favored Glycine 0 C--N 1.35 1.336 0 C-N-CA 123.052 0.358 . . . . 61.35 113.098 -179.522 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 56.1 tttm -84.77 158.67 20.65 Favored 'General case' 0 N--CA 1.474 0.761 0 C-N-CA 123.378 0.671 . . . . 73.34 109.458 177.384 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 152' ' ' THR . . . . . . . . . . . . . 24.8 p -101.58 128.72 47.71 Favored 'General case' 0 N--CA 1.475 0.821 0 C-N-CA 122.82 0.448 . . . . 53.11 109.905 171.86 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 153' ' ' SER . . . . . . . . . . . . . 42.4 t -70.25 -42.97 71.49 Favored 'General case' 0 N--CA 1.474 0.742 0 N-CA-C 109.245 -0.65 . . . . 72.25 109.245 168.851 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 154' ' ' LYS . . . . . 0.41 ' HB2' ' HB3' ' A' ' 145' ' ' PHE . 34.1 mmtp -118.4 140.68 49.48 Favored 'General case' 0 C--O 1.239 0.506 0 C-N-CA 123.614 0.766 . . . . 75.31 110.654 -179.338 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 155' ' ' LYS . . . . . 0.622 ' HD2' ' SG ' ' A' ' 52' ' ' CYS . 0.0 OUTLIER -87.03 93.24 9.3 Favored 'General case' 0 CA--C 1.535 0.374 0 O-C-N 123.944 0.778 . . . . 70.04 109.369 -172.271 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 156' ' ' ILE . . . . . 0.614 ' HB ' ' HB2' ' A' ' 53' ' ' PHE . 27.1 mt -87.63 149.27 4.13 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.591 0 CA-C-N 115.488 -0.778 . . . . 73.2 109.231 -177.685 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 157' ' ' THR . . . . . . . . . . . . . 71.9 p -146.25 170.41 16.82 Favored 'General case' 0 N--CA 1.482 1.153 0 C-N-CA 124.091 0.956 . . . . 73.22 109.951 -176.661 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 158' ' ' ILE . . . . . 0.408 HG23 ' HB3' ' A' ' 8' ' ' PHE . 67.8 mt -88.87 102.2 12.7 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.705 0 N-CA-C 107.954 -1.128 . . . . 75.24 107.954 165.05 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 159' ' ' ALA . . . . . 0.498 ' HB1' ' HB3' ' A' ' 11' ' ' ALA . . . -56.03 -49.66 73.08 Favored 'General case' 0 N--CA 1.476 0.835 0 C-N-CA 124.186 0.995 . . . . 72.12 112.115 179.048 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 160' ' ' ASP . . . . . . . . . . . . . 27.5 t70 -160.45 156.96 26.84 Favored 'General case' 0 N--CA 1.471 0.584 0 O-C-N 123.904 0.752 . . . . 70.35 110.685 -174.077 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 161' ' ' CYS . . . . . . . . . . . . . 14.9 p -110.8 -168.71 1.34 Allowed 'General case' 0 N--CA 1.475 0.811 0 C-N-CA 125.122 1.369 . . . . 72.52 108.839 175.851 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 162' ' ' GLY . . . . . . . . . . . . . . . 132.45 53.39 0.08 OUTLIER Glycine 0 C--N 1.346 1.1 0 N-CA-C 111.006 -0.838 . . . . 64.31 111.006 -171.274 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 163' ' ' GLN . . . . . 0.643 ' HA ' ' H ' ' A' ' 7' ' ' PHE . 16.2 pt20 -50.34 132.46 24.52 Favored 'General case' 0 C--N 1.357 0.915 0 C-N-CA 123.908 0.883 . . . . 73.4 113.034 -172.499 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 164' ' ' LEU . . . . . 0.463 ' O ' ' HB ' ' A' ' 5' ' ' THR . 96.7 mt -92.87 97.3 10.66 Favored 'General case' 0 CA--C 1.534 0.362 0 N-CA-C 107.92 -1.141 . . . . 73.4 107.92 177.44 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 165' ' ' GLU . . . . . . . . . . . . . 38.0 tt0 . . . . . 0 CA--C 1.547 0.831 0 C-N-CA 123.994 0.918 . . . . 73.31 108.738 -173.966 . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' B' B ' 216' ' ' PRO . . . . . 0.602 ' HB2' ' HB3' ' A' ' 103' ' ' ALA . 1.5 Cg_endo . . . . . 0 CA--C 1.541 0.83 0 N-CA-C 110.482 -0.622 . . . . 64.02 110.482 . . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 217' ' ' GLU . . . . . . . . . . . . . 40.9 tt0 -94.8 133.11 27.1 Favored Pre-proline 0 CA--C 1.549 0.941 0 C-N-CA 123.761 0.824 . . . . 75.11 109.612 178.44 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 218' ' ' PRO . . . . . . . . . . . . . 13.5 Cg_exo -70.17 86.6 0.63 Allowed 'Trans proline' 0 C--N 1.383 2.385 0 C-N-CA 122.958 2.438 . . . . 71.12 111.223 175.81 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 219' ' ' GLY . . . . . 0.414 ' HA2' ' HD3' ' B' ' 220' ' ' PRO . . . 155.55 140.91 3.09 Favored Glycine 0 CA--C 1.53 1.006 0 CA-C-N 115.435 -0.802 . . . . 51.33 111.313 -176.5 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 220' ' ' PRO . . . . . 0.414 ' HD3' ' HA2' ' B' ' 219' ' ' GLY . 6.1 Cg_exo -77.13 173.25 14.7 Favored 'Trans proline' 0 C--N 1.369 1.634 0 C-N-CA 123.422 2.748 . . . . 75.22 114.108 -173.866 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 221' ' ' TYR . . . . . . . . . . . . . 43.0 p90 -155.81 170.36 22.25 Favored 'General case' 0 C--O 1.25 1.108 0 CA-C-N 114.697 -1.138 . . . . 74.42 109.776 -175.601 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 222' ' ' ALA . . . . . . . . . . . . . . . -172.94 -70.79 0.01 OUTLIER 'General case' 0 N--CA 1.474 0.739 0 C-N-CA 123.82 0.848 . . . . 73.12 109.952 -179.951 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 223' ' ' GLN . . . . . . . . . . . . . 13.5 pt20 -100.78 143.42 26.54 Favored Pre-proline 0 CA--C 1.54 0.58 0 CA-C-N 114.142 -1.39 . . . . 74.52 108.932 -177.347 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 224' ' ' PRO . . . . . . . . . . . . . 60.0 Cg_endo . . . . . 0 C--N 1.371 1.752 0 C-N-CA 122.15 1.9 . . . . 65.41 110.261 172.528 . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 26.7 ptt? . . . . . 0 N--CA 1.475 0.785 0 N-CA-C 111.555 0.205 . . . . 62.32 111.555 . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 9.7 p -92.52 13.0 2.36 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.681 0 CA-C-O 122.06 0.933 . . . . 70.33 110.748 -178.441 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 3' ' ' ASN . . . . . 0.487 HD21 ' HA ' ' A' ' 25' ' ' PHE . 19.6 m120 -69.2 122.28 84.84 Favored Pre-proline 0 C--O 1.245 0.833 0 C-N-CA 124.06 0.944 . . . . 74.12 110.911 -173.414 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 26.5 Cg_endo -60.79 118.53 5.4 Favored 'Trans proline' 0 C--N 1.382 2.29 0 C-N-CA 122.422 2.081 . . . . 74.41 110.227 177.731 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 5' ' ' THR . . . . . 0.426 ' HB ' ' O ' ' A' ' 164' ' ' LEU . 40.1 m -95.56 130.2 42.49 Favored 'General case' 0 C--O 1.239 0.501 0 N-CA-C 108.95 -0.759 . . . . 75.23 108.95 -173.116 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . 0.815 ' HA ' ' HB2' ' A' ' 163' ' ' GLN . 48.5 t -99.6 152.53 4.57 Favored 'Isoleucine or valine' 0 C--O 1.215 -0.748 0 N-CA-C 108.513 -0.921 . . . . 65.14 108.513 -179.426 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 7' ' ' PHE . . . . . 0.438 ' HB3' ' HA ' ' A' ' 163' ' ' GLN . 56.2 t80 -139.6 133.62 30.96 Favored 'General case' 0 C--O 1.242 0.682 0 C-N-CA 123.336 0.654 . . . . 75.32 109.832 179.877 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 40.2 m-85 -135.62 164.39 27.95 Favored 'General case' 0 C--O 1.241 0.642 0 O-C-N 124.663 1.227 . . . . 75.14 109.0 171.808 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 9' ' ' ASP . . . . . 0.504 ' HB2' ' HB3' ' A' ' 159' ' ' ALA . 40.8 m-20 -108.02 114.2 27.93 Favored 'General case' 0 N--CA 1.468 0.434 0 N-CA-C 107.605 -1.257 . . . . 71.21 107.605 171.134 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 10' ' ' ILE . . . . . 0.495 HG23 ' SD ' ' A' ' 142' ' ' MET . 46.1 mm -81.42 129.88 36.76 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.593 0 N-CA-C 109.089 -0.708 . . . . 74.12 109.089 177.799 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 11' ' ' ALA . . . . . 0.589 ' HB3' ' HB1' ' A' ' 159' ' ' ALA . . . -132.3 133.51 44.14 Favored 'General case' 0 N--CA 1.468 0.454 0 C-N-CA 123.379 0.672 . . . . 71.13 111.613 -168.131 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 50.9 t -94.6 109.52 22.33 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.848 0 C-N-CA 124.607 1.163 . . . . 75.21 108.847 174.978 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 33.5 m-20 57.97 25.57 12.38 Favored 'General case' 0 N--CA 1.488 1.457 0 C-N-CA 125.449 1.5 . . . . 72.24 112.222 -172.96 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 100.45 -14.64 59.3 Favored Glycine 0 C--N 1.346 1.098 0 CA-C-O 119.475 -0.625 . . . . 73.45 113.326 179.129 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 17.6 mm-40 -87.72 114.25 58.14 Favored Pre-proline 0 N--CA 1.48 1.074 0 CA-C-N 117.559 0.679 . . . . 72.3 109.556 176.875 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 52.8 Cg_exo -50.26 108.64 0.23 Allowed 'Trans proline' 0 C--N 1.378 2.118 0 C-N-CA 123.649 2.9 . . . . 74.4 113.438 -178.795 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 59.4 tp -77.46 -40.49 42.99 Favored 'General case' 0 N--CA 1.472 0.648 0 C-N-CA 124.004 0.922 . . . . 71.02 109.546 175.459 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -167.43 170.38 41.6 Favored Glycine 0 C--N 1.342 0.904 0 CA-C-N 115.534 -0.757 . . . . 61.14 112.753 -178.823 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 19' ' ' ARG . . . . . 0.408 ' HB3' ' HE1' ' A' ' 7' ' ' PHE . 81.1 mtm180 -110.46 127.81 55.31 Favored 'General case' 0 N--CA 1.471 0.577 0 C-N-CA 124.299 1.04 . . . . 71.32 108.858 -178.587 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 76.5 t -129.17 122.16 55.54 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.723 0 C-N-CA 123.426 0.691 . . . . 74.31 110.67 -173.926 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 21' ' ' SER . . . . . 0.478 ' HB2' ' HB2' ' A' ' 134' ' ' GLU . 16.0 m -106.1 129.91 54.1 Favored 'General case' 0 CA--C 1.545 0.788 0 C-N-CA 123.58 0.752 . . . . 70.42 109.92 173.522 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 85.9 m-85 -100.64 170.23 8.5 Favored 'General case' 0 N--CA 1.474 0.768 0 C-N-CA 124.545 1.138 . . . . 65.45 110.038 175.022 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . 0.803 ' HB2' ' HD2' ' A' ' 133' ' ' LYS . 41.4 tt0 -135.35 118.75 16.79 Favored 'General case' 0 N--CA 1.472 0.648 0 C-N-CA 123.677 0.791 . . . . 74.25 109.261 -177.763 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . 0.473 ' HB3' ' HB3' ' A' ' 33' ' ' ALA . 36.3 mt -96.84 127.29 42.66 Favored 'General case' 0 N--CA 1.474 0.77 0 C-N-CA 122.747 0.419 . . . . 75.42 110.881 -177.062 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 25' ' ' PHE . . . . . 0.517 ' HB2' HD13 ' A' ' 90' ' ' LEU . 33.7 m-85 -86.15 65.85 9.28 Favored 'General case' 0 CA--C 1.537 0.466 0 C-N-CA 123.561 0.744 . . . . 75.42 109.188 175.851 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -65.47 -20.86 66.53 Favored 'General case' 0 N--CA 1.482 1.157 0 C-N-CA 124.193 0.997 . . . . 70.12 111.938 180.0 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 12.1 p-10 -77.15 -21.94 53.31 Favored 'General case' 0 CA--C 1.549 0.917 0 CA-C-N 114.924 -1.035 . . . . 73.13 111.589 178.668 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 60.2 mttp -106.11 -48.75 3.52 Favored 'General case' 0 N--CA 1.481 1.121 0 C-N-CA 123.392 0.677 . . . . 72.32 111.066 -176.207 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 29' ' ' VAL . . . . . 0.469 HG23 ' HA ' ' A' ' 129' ' ' PHE . 15.1 m -121.69 76.5 37.07 Favored Pre-proline 0 CA--C 1.552 1.054 0 C-N-CA 124.221 1.008 . . . . 74.41 109.613 -179.478 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 26.5 Cg_endo -61.45 -38.72 61.5 Favored 'Trans proline' 0 C--N 1.381 2.267 0 C-N-CA 122.492 2.128 . . . . 73.42 112.811 -173.194 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 31' ' ' LYS . . . . . 0.647 ' HZ3' ' HB2' ' A' ' 31' ' ' LYS . 4.7 ttmp? -65.21 -58.08 6.89 Favored 'General case' 0 N--CA 1.473 0.706 0 C-N-CA 122.971 0.509 . . . . 64.53 111.711 179.749 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 6.6 m -71.78 -28.46 63.64 Favored 'General case' 0 CA--C 1.555 1.168 0 CA-C-N 115.365 -0.834 . . . . 74.44 111.888 -168.79 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 33' ' ' ALA . . . . . 0.473 ' HB3' ' HB3' ' A' ' 24' ' ' LEU . . . -85.05 -45.79 11.78 Favored 'General case' 0 N--CA 1.478 0.942 0 C-N-CA 123.12 0.568 . . . . 71.02 111.275 179.793 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 8.5 tp10 -60.3 -34.73 74.19 Favored 'General case' 0 N--CA 1.487 1.386 0 C-N-CA 122.71 0.404 . . . . 54.45 110.988 178.96 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 35' ' ' ASN . . . . . 0.476 ' O ' ' HG ' ' A' ' 39' ' ' LEU . 36.2 t30 -49.44 -60.61 2.69 Favored 'General case' 0 C--N 1.351 0.651 0 O-C-N 124.514 1.134 . . . . 63.41 110.7 172.626 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 87.8 t80 -62.08 -40.91 97.42 Favored 'General case' 0 N--CA 1.466 0.371 0 CA-C-N 115.183 -0.917 . . . . 72.5 111.68 -176.307 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 37' ' ' ARG . . . . . 0.474 ' HG3' HE22 ' A' ' 163' ' ' GLN . 23.1 ttp180 -62.57 -42.99 99.89 Favored 'General case' 0 N--CA 1.477 0.9 0 C-N-CA 122.977 0.511 . . . . 73.43 110.909 -177.822 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 38' ' ' ALA . . . . . 0.484 ' HB3' ' HG2' ' A' ' 44' ' ' LYS . . . -69.1 -30.8 69.17 Favored 'General case' 0 CA--C 1.545 0.77 0 CA-C-N 115.341 -0.845 . . . . 65.31 111.508 179.754 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 39' ' ' LEU . . . . . 0.491 HD22 ' HE1' ' A' ' 48' ' ' TYR . 99.2 mt -72.48 -37.12 68.54 Favored 'General case' 0 CA--C 1.55 0.965 0 C-N-CA 123.582 0.753 . . . . 74.23 110.955 175.005 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 49.3 m -69.31 -46.2 67.69 Favored 'General case' 0 N--CA 1.479 1.006 0 C-N-CA 124.186 0.994 . . . . 75.24 111.284 -176.302 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 25.2 p -79.7 -30.01 40.9 Favored 'General case' 0 N--CA 1.472 0.668 0 C-N-CA 123.878 0.871 . . . . 61.31 111.288 178.587 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 83.03 28.82 36.09 Favored Glycine 0 C--N 1.346 1.119 0 CA-C-N 115.825 -0.625 . . . . 65.52 113.033 179.487 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 47.9 mm-40 -63.98 -23.06 67.19 Favored 'General case' 0 N--CA 1.477 0.887 0 C-N-CA 123.138 0.575 . . . . 73.43 111.604 177.024 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 44' ' ' LYS . . . . . 0.484 ' HG2' ' HB3' ' A' ' 38' ' ' ALA . 30.6 mmmt -99.77 19.83 15.27 Favored 'General case' 0 CA--C 1.541 0.631 0 C-N-CA 123.544 0.738 . . . . 73.53 111.985 -179.6 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 80.81 -21.99 5.19 Favored Glycine 0 C--N 1.355 1.607 0 N-CA-C 114.765 0.666 . . . . 63.12 114.765 173.224 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 46' ' ' PHE . . . . . 0.431 ' HE2' ' HA ' ' A' ' 78' ' ' ILE . 19.0 m-85 -69.84 -45.39 67.91 Favored 'General case' 0 C--N 1.348 0.534 0 C-N-CA 123.328 0.651 . . . . 63.51 110.684 -174.042 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 57.71 66.32 2.91 Favored Glycine 0 C--N 1.357 1.748 0 CA-C-O 119.008 -0.885 . . . . 74.34 113.927 168.544 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 48' ' ' TYR . . . . . 0.491 ' HE1' HD22 ' A' ' 39' ' ' LEU . 60.3 m-85 -66.21 85.59 0.1 Allowed 'General case' 0 N--CA 1.476 0.837 0 CA-C-O 122.71 1.243 . . . . 65.34 111.501 -176.494 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 29.0 tptp -113.32 109.21 18.35 Favored 'General case' 0 N--CA 1.451 -0.39 0 CA-C-N 112.662 -2.063 . . . . 73.14 107.975 179.439 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 89.8 19.89 45.9 Favored Glycine 0 N--CA 1.468 0.829 0 CA-C-O 119.657 -0.524 . . . . 74.03 113.695 -179.642 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 23.2 m -61.51 116.73 4.94 Favored 'General case' 0 C--O 1.243 0.745 0 C-N-CA 123.139 0.575 . . . . 70.14 109.572 174.228 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 52' ' ' CYS . . . . . 0.414 ' HA ' ' HA ' ' A' ' 157' ' ' THR . 20.1 p -102.03 128.96 48.24 Favored 'General case' 0 CA--C 1.538 0.487 0 CA-C-O 121.528 0.68 . . . . 73.43 112.19 -165.84 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 53' ' ' PHE . . . . . 0.576 ' HA ' ' HA2' ' A' ' 64' ' ' GLY . 77.7 m-85 -61.45 109.87 1.29 Allowed 'General case' 0 C--O 1.24 0.555 0 C-N-CA 124.804 1.241 . . . . 74.44 109.833 169.459 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 28.3 p-80 -124.15 2.42 8.57 Favored 'General case' 0 N--CA 1.475 0.791 0 CA-C-N 115.076 -0.965 . . . . 72.13 110.962 -175.532 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 55' ' ' ARG . . . . . 0.434 ' O ' ' HB3' ' A' ' 63' ' ' GLN . 53.4 ttt-85 -144.45 95.25 2.68 Favored 'General case' 0 C--O 1.218 -0.563 0 N-CA-C 108.396 -0.964 . . . . 73.11 108.396 177.046 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 56' ' ' ILE . . . . . 0.427 HG22 ' HA ' ' A' ' 143' ' ' GLU . 52.6 mt -130.4 133.68 63.49 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.088 0 N-CA-C 108.661 -0.866 . . . . 74.33 108.661 178.552 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 67.2 mt -126.65 118.61 22.75 Favored Pre-proline 0 CA--C 1.556 1.193 0 C-N-CA 123.606 0.762 . . . . 74.43 109.024 178.098 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 58' ' ' PRO . . . . . 0.407 ' HA ' ' HG2' ' A' ' 143' ' ' GLU . 51.6 Cg_exo -57.62 141.79 95.49 Favored 'Trans proline' 0 C--N 1.387 2.559 0 C-N-CA 124.067 3.178 . . . . 74.33 113.784 -178.363 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 67.98 31.43 75.27 Favored Glycine 0 C--N 1.348 1.215 0 O-C-N 124.03 0.831 . . . . 54.33 112.807 -179.273 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 49.1 t80 -152.73 -71.23 0.15 Allowed 'General case' 0 CA--C 1.546 0.808 0 C-N-CA 123.75 0.82 . . . . 75.42 110.364 -177.703 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 61' ' ' MET . . . . . 0.467 ' HE3' ' HB2' ' A' ' 63' ' ' GLN . 37.0 ttp -170.25 150.1 3.57 Favored 'General case' 0 N--CA 1.485 1.296 0 N-CA-C 112.432 0.531 . . . . 75.14 112.432 -163.532 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 62' ' ' CYS . . . . . 0.509 ' SG ' ' HB2' ' A' ' 143' ' ' GLU . 35.4 m -108.77 112.41 24.69 Favored 'General case' 0 N--CA 1.474 0.774 0 C-N-CA 123.806 0.842 . . . . 73.02 109.5 168.4 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 63' ' ' GLN . . . . . 0.467 ' HB2' ' HE3' ' A' ' 61' ' ' MET . 52.1 tt0 -112.57 134.74 53.94 Favored 'General case' 0 N--CA 1.486 1.365 0 CA-C-O 121.644 0.735 . . . . 73.2 110.115 179.975 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 64' ' ' GLY . . . . . 0.576 ' HA2' ' HA ' ' A' ' 53' ' ' PHE . . . -134.45 175.56 20.39 Favored Glycine 0 CA--C 1.499 -0.947 0 CA-C-N 115.238 -0.892 . . . . 75.32 112.478 178.697 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 178.6 170.99 41.39 Favored Glycine 0 N--CA 1.444 -0.833 0 N-CA-C 110.726 -0.95 . . . . 64.31 110.726 179.383 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 14.8 t70 -94.18 166.31 12.18 Favored 'General case' 0 C--O 1.241 0.654 0 N-CA-C 109.862 -0.421 . . . . 54.13 109.862 -172.366 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 37.7 t80 -70.83 -22.93 62.27 Favored 'General case' 0 CA--C 1.548 0.9 0 C-N-CA 122.742 0.417 . . . . 75.43 110.356 175.142 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 52.7 m -61.64 113.65 2.84 Favored 'General case' 0 C--O 1.247 0.922 0 C-N-CA 123.823 0.849 . . . . 75.35 110.994 176.417 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 69' ' ' ARG . . . . . 0.431 ' HB3' ' HB ' ' A' ' 73' ' ' THR . 53.5 mtt180 58.99 29.78 19.41 Favored 'General case' 0 C--N 1.361 1.103 0 C-N-CA 124.577 1.151 . . . . 65.11 112.353 -176.114 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 32.4 p80 -51.72 -33.79 36.08 Favored 'General case' 0 N--CA 1.495 1.811 0 C-N-CA 123.252 0.621 . . . . 75.32 111.381 -179.427 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 6.8 t30 -75.49 89.96 2.71 Favored 'General case' 0 CA--C 1.551 0.992 0 C-N-CA 124.104 0.962 . . . . 62.35 109.164 171.622 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 100.59 -7.24 57.76 Favored Glycine 0 C--N 1.347 1.176 0 N-CA-C 115.93 1.132 . . . . 74.21 115.93 171.089 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 73' ' ' THR . . . . . 0.431 ' HB ' ' HB3' ' A' ' 69' ' ' ARG . 15.0 m -142.92 -75.23 0.27 Allowed 'General case' 0 N--CA 1.483 1.198 0 CA-C-N 118.687 1.243 . . . . 74.4 109.792 179.763 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 72.07 40.29 56.87 Favored Glycine 0 C--N 1.354 1.546 0 C-N-CA 123.234 0.445 . . . . 72.44 113.634 173.975 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 142.45 52.79 0.04 OUTLIER Glycine 0 C--N 1.344 0.995 0 CA-C-N 117.402 0.601 . . . . 75.11 111.741 -173.236 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 76' ' ' LYS . . . . . 0.4 ' HG2' ' OH ' ' A' ' 48' ' ' TYR . 16.5 ptpt -56.55 162.78 2.05 Favored 'General case' 0 N--CA 1.477 0.913 0 C-N-CA 124.183 0.993 . . . . 74.31 112.165 -176.237 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 77.9 p -91.33 173.63 7.81 Favored 'General case' 0 C--O 1.241 0.634 0 CA-C-N 115.343 -0.844 . . . . 63.43 110.42 -179.991 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 78' ' ' ILE . . . . . 0.468 HG21 ' HB1' ' A' ' 38' ' ' ALA . 21.4 pt -74.7 -17.5 16.47 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.608 0 CA-C-N 116.067 -0.515 . . . . 71.23 109.96 173.133 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 49.5 m-85 -87.67 -13.23 43.15 Favored 'General case' 0 CA--C 1.541 0.619 0 C-N-CA 124.615 1.166 . . . . 75.05 110.795 -178.445 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 142.37 -133.02 5.41 Favored Glycine 0 C--N 1.348 1.228 0 N-CA-C 110.858 -0.897 . . . . 44.41 110.858 178.689 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 36.4 tt0 -65.51 -54.34 29.61 Favored 'General case' 0 CA--C 1.54 0.596 0 C-N-CA 123.365 0.666 . . . . 74.01 109.86 175.215 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 82' ' ' LYS . . . . . 0.814 ' HD2' ' HA ' ' A' ' 107' ' ' THR . 24.1 pttm -158.81 174.15 15.45 Favored 'General case' 0 C--O 1.243 0.73 0 CA-C-N 114.52 -1.218 . . . . 73.11 109.17 -172.787 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 12.5 p90 -155.39 172.56 18.01 Favored 'General case' 0 N--CA 1.478 0.939 0 C-N-CA 123.59 0.756 . . . . 64.41 110.245 -175.518 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 14.1 pt-20 -87.25 168.34 13.29 Favored 'General case' 0 CA--C 1.548 0.885 0 CA-C-N 115.897 -0.592 . . . . 74.43 110.614 179.23 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 85' ' ' ASP . . . . . 0.408 ' HB3' HG22 ' A' ' 127' ' ' VAL . 35.7 m-20 -80.31 150.36 29.98 Favored 'General case' 0 N--CA 1.478 0.971 0 C-N-CA 123.898 0.879 . . . . 65.32 112.199 -174.597 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 6.9 tp10 -78.26 -62.55 1.64 Allowed 'General case' 0 C--N 1.352 0.687 0 CA-C-N 115.425 -0.807 . . . . 73.15 111.403 -178.02 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 23.0 p30 -176.75 143.46 0.45 Allowed 'General case' 0 N--CA 1.48 1.056 0 C-N-CA 124.419 1.087 . . . . 63.24 109.159 -175.825 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 98.8 m-85 -89.3 50.11 1.87 Allowed 'General case' 0 N--CA 1.491 1.585 0 CA-C-O 121.607 0.718 . . . . 75.4 111.448 -168.073 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 70.9 mt -67.86 -48.16 76.46 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.695 0 C-N-CA 124.145 0.978 . . . . 74.31 109.885 174.202 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 90' ' ' LEU . . . . . 0.517 HD13 ' HB2' ' A' ' 25' ' ' PHE . 74.5 mt -99.89 122.69 43.2 Favored 'General case' 0 C--O 1.241 0.63 0 CA-C-N 115.462 -0.79 . . . . 74.43 110.585 -174.665 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 44.0 mtmt -119.89 171.71 8.23 Favored 'General case' 0 N--CA 1.475 0.807 0 C-N-CA 124.073 0.949 . . . . 73.52 110.4 177.098 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 92' ' ' HIS . . . . . 0.544 ' HA ' HG13 ' A' ' 97' ' ' ILE . 13.0 m-70 -87.59 41.65 1.0 Allowed 'General case' 0 N--CA 1.482 1.15 0 C-N-CA 124.223 1.009 . . . . 71.54 110.297 -176.115 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 13.0 t -84.92 1.49 47.05 Favored 'General case' 0 CA--C 1.555 1.16 0 C-N-CA 123.986 0.914 . . . . 75.24 111.679 -174.777 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -140.53 161.22 26.58 Favored Glycine 0 C--N 1.344 1.002 0 CA-C-O 119.552 -0.582 . . . . 72.32 111.709 179.601 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 7.3 Cg_exo -75.27 149.74 36.03 Favored 'Trans proline' 0 C--N 1.37 1.692 0 C-N-CA 123.135 2.557 . . . . 72.12 112.146 175.295 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 96' ' ' GLY . . . . . 0.414 ' HA3' HG12 ' A' ' 132' ' ' VAL . . . 84.61 19.45 59.99 Favored Glycine 0 C--N 1.343 0.957 0 N-CA-C 114.586 0.594 . . . . 73.51 114.586 177.357 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 97' ' ' ILE . . . . . 0.544 HG13 ' HA ' ' A' ' 92' ' ' HIS . 7.8 mm -70.54 122.49 22.48 Favored 'Isoleucine or valine' 0 CA--C 1.553 1.088 0 C-N-CA 124.061 0.944 . . . . 75.45 111.99 -177.199 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 56.8 tp -104.91 124.08 48.87 Favored 'General case' 0 N--CA 1.482 1.133 0 C-N-CA 123.266 0.626 . . . . 72.02 110.548 179.813 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 32.2 t -151.22 154.42 36.8 Favored 'General case' 0 CA--C 1.548 0.882 0 C-N-CA 123.627 0.771 . . . . 73.53 109.822 179.685 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 100' ' ' MET . . . . . 0.631 ' HA ' ' HA ' ' A' ' 112' ' ' PHE . 85.3 mtp -86.25 141.34 29.36 Favored 'General case' 0 N--CA 1.492 1.655 0 CA-C-N 118.272 0.487 . . . . 73.25 109.79 179.324 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 101' ' ' ALA . . . . . 0.401 ' HB3' ' HB2' ' A' ' 111' ' ' GLN . . . -73.07 162.41 29.49 Favored 'General case' 0 N--CA 1.487 1.401 0 N-CA-C 112.432 0.531 . . . . 74.33 112.432 -169.75 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 21.3 p-10 -161.71 170.16 20.17 Favored 'General case' 0 N--CA 1.474 0.753 0 CA-C-N 115.736 -0.665 . . . . 75.34 111.295 -174.28 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -103.73 -20.05 14.1 Favored 'General case' 0 N--CA 1.477 0.899 0 C-N-CA 124.124 0.97 . . . . 62.34 110.575 169.412 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 167.41 -151.38 18.96 Favored Glycine 0 CA--C 1.536 1.403 0 CA-C-O 119.269 -0.739 . . . . 73.31 111.439 -173.473 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 31.4 Cg_exo -62.46 144.07 94.21 Favored 'Trans proline' 0 C--N 1.37 1.709 0 C-N-CA 122.751 2.301 . . . . 73.22 112.671 175.108 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 64.4 t30 66.93 9.89 7.21 Favored 'General case' 0 N--CA 1.493 1.695 0 C-N-CA 124.745 1.218 . . . . 73.43 112.578 175.03 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 107' ' ' THR . . . . . 0.814 ' HA ' ' HD2' ' A' ' 82' ' ' LYS . 46.8 p -114.45 2.74 14.74 Favored 'General case' 0 N--CA 1.474 0.765 0 O-C-N 121.688 -0.632 . . . . 74.04 112.04 177.945 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 39.8 t30 -71.96 131.87 43.54 Favored 'General case' 0 N--CA 1.475 0.787 0 N-CA-C 108.925 -0.769 . . . . 74.22 108.925 174.924 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 112.43 22.15 5.91 Favored Glycine 0 N--CA 1.468 0.793 0 CA-C-O 120.239 -0.201 . . . . 44.13 113.08 -176.058 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 27.7 p -125.11 120.1 30.45 Favored 'General case' 0 N--CA 1.47 0.539 0 N-CA-C 107.745 -1.205 . . . . 74.02 107.745 169.21 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 111' ' ' GLN . . . . . 0.401 ' HB2' ' HB3' ' A' ' 101' ' ' ALA . 49.4 mt-30 63.41 176.95 0.16 Allowed 'General case' 0 N--CA 1.492 1.637 0 C-N-CA 124.133 0.973 . . . . 74.45 111.769 -171.897 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 112' ' ' PHE . . . . . 0.631 ' HA ' ' HA ' ' A' ' 100' ' ' MET . 44.9 p90 -139.88 159.46 42.13 Favored 'General case' 0 N--CA 1.476 0.87 0 C-N-CA 124.249 1.02 . . . . 74.24 108.461 175.478 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 113' ' ' PHE . . . . . . . . . . . . . 54.0 p90 -152.59 153.83 34.17 Favored 'General case' 0 N--CA 1.471 0.606 0 CA-C-O 121.004 0.431 . . . . 70.24 111.191 178.901 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 114' ' ' ILE . . . . . . . . . . . . . 9.3 mt -119.73 101.96 12.02 Favored 'Isoleucine or valine' 0 C--O 1.245 0.831 0 N-CA-C 107.663 -1.236 . . . . 71.22 107.663 176.468 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 115' ' ' CYS . . . . . . . . . . . . . 69.9 m -62.31 104.77 0.53 Allowed 'General case' 0 CA--C 1.537 0.46 0 N-CA-C 108.602 -0.888 . . . . 75.35 108.602 169.502 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 116' ' ' THR . . . . . 0.551 HG22 HG11 ' A' ' 139' ' ' VAL . 64.3 p -69.45 -35.15 75.37 Favored 'General case' 0 N--CA 1.473 0.725 0 C-N-CA 123.461 0.705 . . . . 74.45 110.334 -175.708 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -107.87 167.17 10.17 Favored 'General case' 0 C--O 1.246 0.887 0 CA-C-N 114.716 -1.129 . . . . 62.22 109.289 174.465 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 20.7 ptmt -73.73 91.23 1.89 Allowed 'General case' 0 CA--C 1.545 0.769 0 CA-C-O 122.013 0.911 . . . . 75.21 109.954 174.757 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 119' ' ' THR . . . . . . . . . . . . . 58.4 p -86.97 83.28 7.54 Favored 'General case' 0 CA--C 1.542 0.663 0 CA-C-O 121.997 0.904 . . . . 62.54 109.022 -179.242 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 15.9 pt-20 -79.72 -15.23 57.91 Favored 'General case' 0 N--CA 1.48 1.056 0 CA-C-N 115.129 -0.941 . . . . 71.13 112.406 -167.953 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 121' ' ' TRP . . . . . . . . . . . . . 44.2 p90 -71.97 -14.62 61.95 Favored 'General case' 0 N--CA 1.481 1.1 0 C-N-CA 122.977 0.511 . . . . 75.11 110.832 172.928 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 54.2 mt -88.37 6.47 37.2 Favored 'General case' 0 N--CA 1.474 0.729 0 C-N-CA 123.121 0.568 . . . . 74.22 111.092 174.238 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 30.7 m-20 -79.29 136.84 37.15 Favored 'General case' 0 N--CA 1.474 0.759 0 N-CA-C 107.905 -1.146 . . . . 72.41 107.905 167.546 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 95.42 -24.3 29.79 Favored Glycine 0 N--CA 1.472 1.067 0 N-CA-C 111.17 -0.772 . . . . 70.02 111.17 -168.408 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 125' ' ' LYS . . . . . 0.628 ' HG3' ' H ' ' A' ' 126' ' ' HIS . 12.2 tppt? -75.27 -169.45 0.97 Allowed 'General case' 0 CA--C 1.563 1.48 0 N-CA-C 107.913 -1.143 . . . . 73.53 107.913 169.274 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 126' ' ' HIS . . . . . 0.628 ' H ' ' HG3' ' A' ' 125' ' ' LYS . 43.2 p-80 -67.56 157.59 34.02 Favored 'General case' 0 CA--C 1.549 0.941 0 C-N-CA 123.919 0.887 . . . . 75.23 111.685 -173.347 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 127' ' ' VAL . . . . . 0.474 HG11 ' O ' ' A' ' 128' ' ' VAL . 43.1 t -67.86 140.45 19.16 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.85 0 CA-C-N 114.292 -1.322 . . . . 73.35 112.466 -173.033 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 128' ' ' VAL . . . . . 0.518 HG13 HD11 ' A' ' 97' ' ' ILE . 97.2 t -80.98 154.28 4.26 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.832 0 C-N-CA 124.803 1.241 . . . . 65.34 109.276 170.429 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 129' ' ' PHE . . . . . 0.507 ' CE2' ' HG3' ' A' ' 100' ' ' MET . 37.6 p90 -131.57 -17.41 2.91 Favored 'General case' 0 N--CA 1.484 1.239 0 O-C-N 121.626 -0.671 . . . . 74.2 111.663 177.938 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . -138.4 175.01 21.69 Favored Glycine 0 C--N 1.342 0.904 0 CA-C-O 121.431 0.462 . . . . 73.13 113.314 -169.283 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 31.3 ttpt -160.81 136.07 7.82 Favored 'General case' 0 CA--C 1.536 0.431 0 N-CA-C 108.205 -1.035 . . . . 71.44 108.205 -178.565 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 132' ' ' VAL . . . . . 0.414 HG12 ' HA3' ' A' ' 96' ' ' GLY . 13.3 p -72.25 130.97 35.31 Favored 'Isoleucine or valine' 0 CA--C 1.553 1.063 0 N-CA-C 109.251 -0.648 . . . . 73.21 109.251 173.239 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 133' ' ' LYS . . . . . 0.803 ' HD2' ' HB2' ' A' ' 23' ' ' GLU . 19.9 ptmt -116.15 -26.96 7.04 Favored 'General case' 0 N--CA 1.48 1.042 0 C-N-CA 123.582 0.753 . . . . 73.25 110.257 -179.721 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 134' ' ' GLU . . . . . 0.478 ' HB2' ' HB2' ' A' ' 21' ' ' SER . 71.3 mm-40 -131.24 130.22 42.62 Favored 'General case' 0 N--CA 1.471 0.617 0 C-N-CA 124.656 1.183 . . . . 63.33 108.558 175.308 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 90.89 27.71 18.19 Favored Glycine 0 N--CA 1.468 0.829 0 CA-C-O 119.569 -0.573 . . . . 62.05 113.688 175.444 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 136' ' ' MET . . . . . . . . . . . . . 6.4 tpt -58.76 -43.7 90.39 Favored 'General case' 0 N--CA 1.486 1.333 0 C-N-CA 123.561 0.745 . . . . 74.54 110.52 174.964 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 137' ' ' ASN . . . . . . . . . . . . . 18.7 m120 -60.61 -37.23 80.73 Favored 'General case' 0 N--CA 1.479 1.016 0 CA-C-N 115.625 -0.716 . . . . 73.54 111.283 178.29 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 138' ' ' ILE . . . . . . . . . . . . . 43.4 mm -67.78 -41.32 85.07 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.035 0 C-N-CA 123.555 0.742 . . . . 75.13 110.617 -179.566 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 139' ' ' VAL . . . . . 0.551 HG11 HG22 ' A' ' 116' ' ' THR . 96.1 t -61.5 -44.1 98.01 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.979 0 C-N-CA 123.503 0.721 . . . . 74.51 110.699 177.664 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 41.7 mt-10 -69.11 -34.24 74.76 Favored 'General case' 0 N--CA 1.477 0.914 0 CA-C-N 115.455 -0.793 . . . . 75.53 111.02 178.121 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -73.11 -33.8 65.78 Favored 'General case' 0 N--CA 1.475 0.822 0 C-N-CA 123.367 0.667 . . . . 72.33 111.669 -178.863 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 142' ' ' MET . . . . . 0.54 ' HB2' HD11 ' A' ' 156' ' ' ILE . 21.8 ptt? -79.38 -27.14 41.91 Favored 'General case' 0 N--CA 1.473 0.7 0 C-N-CA 122.423 0.289 . . . . 72.01 110.414 177.985 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 143' ' ' GLU . . . . . 0.509 ' HB2' ' SG ' ' A' ' 62' ' ' CYS . 33.4 tt0 -59.36 -29.3 67.58 Favored 'General case' 0 N--CA 1.482 1.144 0 C-N-CA 123.041 0.536 . . . . 73.05 111.609 176.134 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 144' ' ' ARG . . . . . . . . . . . . . 80.1 mtp180 -64.94 -21.45 66.83 Favored 'General case' 0 CA--C 1.543 0.707 0 C-N-CA 123.704 0.802 . . . . 72.44 112.365 -178.554 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 145' ' ' PHE . . . . . 0.47 ' HB2' HD13 ' A' ' 156' ' ' ILE . 77.6 m-85 -81.47 -12.7 58.79 Favored 'General case' 0 N--CA 1.478 0.933 0 C-N-CA 122.502 0.321 . . . . 71.12 111.337 175.554 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . -70.75 166.6 51.6 Favored Glycine 0 CA--C 1.531 1.034 0 N-CA-C 113.898 0.319 . . . . 55.41 113.898 179.347 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 14.7 m -134.86 161.27 35.7 Favored 'General case' 0 N--CA 1.479 0.994 0 C-N-CA 124.376 1.07 . . . . 74.3 109.749 -179.792 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 148' ' ' ARG . . . . . . . . . . . . . 22.8 mmt85 -68.3 -26.51 65.68 Favored 'General case' 0 N--CA 1.484 1.261 0 C-N-CA 123.557 0.743 . . . . 73.24 112.464 -176.714 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 149' ' ' ASN . . . . . . . . . . . . . 30.1 p-10 -84.33 0.47 49.09 Favored 'General case' 0 N--CA 1.486 1.33 0 C-N-CA 122.996 0.518 . . . . 70.24 111.452 175.682 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 150' ' ' GLY . . . . . 0.401 ' O ' ' HA ' ' A' ' 55' ' ' ARG . . . 95.29 -6.16 68.4 Favored Glycine 0 C--N 1.349 1.26 0 CA-C-O 119.683 -0.509 . . . . 55.01 112.982 179.445 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 53.8 tttp -62.94 141.31 58.77 Favored 'General case' 0 N--CA 1.475 0.823 0 C-N-CA 123.035 0.534 . . . . 71.34 111.072 179.987 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 152' ' ' THR . . . . . . . . . . . . . 26.4 p -102.74 131.8 49.33 Favored 'General case' 0 C--O 1.244 0.811 0 N-CA-C 108.776 -0.824 . . . . 71.42 108.776 166.686 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 153' ' ' SER . . . . . . . . . . . . . 16.4 m -72.49 -23.38 61.02 Favored 'General case' 0 N--CA 1.473 0.696 0 C-N-CA 123.834 0.854 . . . . 70.33 110.598 178.131 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 73.6 mmtt -134.88 143.38 46.94 Favored 'General case' 0 C--O 1.241 0.625 0 C-N-CA 125.338 1.455 . . . . 73.44 108.289 -178.678 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 3.8 tppp? -74.63 89.55 2.24 Favored 'General case' 0 C--N 1.345 0.373 0 N-CA-C 108.903 -0.777 . . . . 71.32 108.903 177.761 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 156' ' ' ILE . . . . . 0.54 HD11 ' HB2' ' A' ' 142' ' ' MET . 66.5 mt -84.02 130.17 36.36 Favored 'Isoleucine or valine' 0 C--O 1.222 -0.367 0 N-CA-C 106.967 -1.494 . . . . 74.35 106.967 179.989 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 157' ' ' THR . . . . . 0.414 ' HA ' ' HA ' ' A' ' 52' ' ' CYS . 4.8 t -154.44 156.54 36.95 Favored 'General case' 0 C--O 1.237 0.424 0 C-N-CA 122.74 0.416 . . . . 72.21 110.651 -167.166 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 158' ' ' ILE . . . . . . . . . . . . . 74.1 mt -75.2 98.33 1.39 Allowed 'Isoleucine or valine' 0 CA--C 1.539 0.553 0 N-CA-C 109.015 -0.735 . . . . 74.02 109.015 172.963 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 159' ' ' ALA . . . . . 0.589 ' HB1' ' HB3' ' A' ' 11' ' ' ALA . . . -53.6 -53.65 48.75 Favored 'General case' 0 N--CA 1.472 0.667 0 C-N-CA 123.629 0.772 . . . . 75.01 111.289 177.155 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 160' ' ' ASP . . . . . . . . . . . . . 25.9 t70 -156.33 152.87 28.16 Favored 'General case' 0 N--CA 1.476 0.834 0 CA-C-N 116.321 -0.399 . . . . 74.02 111.03 -177.77 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 161' ' ' CYS . . . . . . . . . . . . . 23.7 p -102.8 -171.45 1.95 Allowed 'General case' 0 N--CA 1.475 0.805 0 C-N-CA 124.888 1.275 . . . . 71.23 109.76 175.501 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 162' ' ' GLY . . . . . . . . . . . . . . . 130.49 52.25 0.1 Allowed Glycine 0 C--N 1.346 1.086 0 N-CA-C 111.176 -0.77 . . . . 74.04 111.176 -171.314 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 163' ' ' GLN . . . . . 0.815 ' HB2' ' HA ' ' A' ' 6' ' ' VAL . 3.6 pt20 -52.48 126.6 19.93 Favored 'General case' 0 CA--C 1.552 1.02 0 C-N-CA 124.527 1.131 . . . . 63.13 113.57 -169.82 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 164' ' ' LEU . . . . . 0.426 ' O ' ' HB ' ' A' ' 5' ' ' THR . 88.1 mt -85.57 99.77 11.48 Favored 'General case' 0 C--O 1.216 -0.706 0 CA-C-N 115.586 -0.734 . . . . 65.3 109.312 -175.114 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 165' ' ' GLU . . . . . . . . . . . . . 12.7 pt-20 . . . . . 0 C--O 1.252 1.208 0 CA-C-O 119.279 -0.391 . . . . 71.21 110.006 -178.308 . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' B' B ' 216' ' ' PRO . . . . . . . . . . . . . 17.1 Cg_exo . . . . . 0 N--CA 1.49 1.311 0 N-CA-C 109.882 -0.853 . . . . 73.01 109.882 . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' B' B ' 217' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -101.33 174.22 3.08 Favored Pre-proline 0 CA--C 1.554 1.133 0 C-N-CA 124.508 1.123 . . . . 63.15 109.036 176.205 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 218' ' ' PRO . . . . . . . . . . . . . 75.0 Cg_exo -54.26 95.34 0.04 OUTLIER 'Trans proline' 0 C--N 1.384 2.438 0 C-N-CA 122.114 1.876 . . . . 73.05 111.516 164.609 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 219' ' ' GLY . . . . . . . . . . . . . . . 170.0 148.51 5.93 Favored Glycine 0 CA--C 1.534 1.264 0 CA-C-N 115.617 -0.719 . . . . 63.31 111.87 -178.006 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 220' ' ' PRO . . . . . . . . . . . . . 88.0 Cg_endo -76.85 169.75 21.11 Favored 'Trans proline' 0 C--N 1.37 1.688 0 C-N-CA 123.34 2.693 . . . . 73.35 114.823 -175.334 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 221' ' ' TYR . . . . . . . . . . . . . 91.4 m-85 -89.52 137.93 31.9 Favored 'General case' 0 N--CA 1.487 1.404 0 C-N-CA 124.175 0.99 . . . . 75.22 111.42 -176.44 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 222' ' ' ALA . . . . . . . . . . . . . . . -120.58 -170.59 2.02 Favored 'General case' 0 N--CA 1.477 0.925 0 C-N-CA 124.932 1.293 . . . . 71.23 112.586 -170.045 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 223' ' ' GLN . . . . . . . . . . . . . 34.8 mt-30 -72.42 115.57 40.51 Favored Pre-proline 0 CA--C 1.549 0.938 0 N-CA-C 108.57 -0.9 . . . . 72.5 108.57 171.07 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 224' ' ' PRO . . . . . . . . . . . . . 13.8 Cg_exo . . . . . 0 C--N 1.372 1.805 0 C-N-CA 122.61 2.207 . . . . 73.24 111.043 177.779 . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 3.8 mpp? . . . . . 0 N--CA 1.482 1.15 0 N-CA-C 110.196 -0.298 . . . . 75.23 110.196 . . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 6.9 p -60.82 -32.67 52.7 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.271 0 C-N-CA 124.346 1.059 . . . . 75.01 110.761 173.159 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 3' ' ' ASN . . . . . 0.502 HD21 ' HA ' ' A' ' 25' ' ' PHE . 17.1 m120 -68.45 122.86 86.09 Favored Pre-proline 0 CA--C 1.542 0.651 0 C-N-CA 124.795 1.238 . . . . 73.11 111.234 -175.877 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 4' ' ' PRO . . . . . 0.447 ' HG2' ' HB2' ' A' ' 24' ' ' LEU . 56.0 Cg_endo -68.28 153.19 74.93 Favored 'Trans proline' 0 C--N 1.369 1.634 0 C-N-CA 122.366 2.044 . . . . 74.41 110.517 170.216 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 5' ' ' THR . . . . . 0.494 ' HB ' ' O ' ' A' ' 164' ' ' LEU . 76.3 m -123.55 136.6 54.63 Favored 'General case' 0 C--O 1.236 0.374 0 N-CA-C 109.672 -0.492 . . . . 75.24 109.672 177.427 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . 0.47 ' HA ' ' HB2' ' A' ' 163' ' ' GLN . 17.3 m -102.67 145.99 11.3 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.36 0 C-N-CA 123.754 0.822 . . . . 75.34 109.653 174.813 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 7' ' ' PHE . . . . . 0.481 ' H ' ' HA ' ' A' ' 163' ' ' GLN . 84.3 t80 -121.47 133.53 55.05 Favored 'General case' 0 C--O 1.237 0.415 0 C-N-CA 123.896 0.879 . . . . 74.53 109.169 -176.342 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 8' ' ' PHE . . . . . 0.434 ' HD2' ' HE1' ' A' ' 22' ' ' PHE . 36.5 m-85 -133.43 164.87 26.17 Favored 'General case' 0 C--O 1.24 0.556 0 C-N-CA 124.11 0.964 . . . . 75.25 109.873 172.209 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 19.3 m-20 -118.2 112.89 20.72 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 114.209 -1.36 . . . . 74.31 107.819 173.039 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 10' ' ' ILE . . . . . 0.438 HG22 ' SD ' ' A' ' 142' ' ' MET . 40.3 mm -81.98 134.0 27.98 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.566 0 N-CA-C 108.853 -0.795 . . . . 75.41 108.853 177.906 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 11' ' ' ALA . . . . . 0.568 ' HB1' ' HB3' ' A' ' 159' ' ' ALA . . . -135.08 111.29 9.63 Favored 'General case' 0 N--CA 1.468 0.448 0 C-N-CA 123.482 0.713 . . . . 71.01 110.905 -173.064 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . 0.494 HG23 HG12 ' A' ' 156' ' ' ILE . 85.5 t -94.82 129.15 45.39 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.832 0 N-CA-C 108.14 -1.059 . . . . 74.14 108.14 178.708 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 22.9 m-20 68.92 13.96 8.85 Favored 'General case' 0 N--CA 1.493 1.684 0 C-N-CA 124.691 1.196 . . . . 74.42 110.481 -170.507 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 80.3 -2.62 76.14 Favored Glycine 0 C--N 1.354 1.55 0 CA-C-O 120.186 -0.23 . . . . 71.44 112.792 -168.972 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 18.3 mm-40 -93.17 117.73 67.55 Favored Pre-proline 0 C--O 1.243 0.751 0 C-N-CA 124.025 0.93 . . . . 74.5 109.454 178.722 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 92.5 Cg_exo -45.51 105.19 0.07 OUTLIER 'Trans proline' 0 C--N 1.378 2.13 0 C-N-CA 123.912 3.075 . . . . 74.15 113.681 179.302 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 31.9 tp -76.36 -35.54 58.65 Favored 'General case' 0 N--CA 1.477 0.915 0 C-N-CA 123.574 0.75 . . . . 74.41 109.411 179.219 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 166.52 -176.47 41.68 Favored Glycine 0 C--N 1.337 0.635 0 CA-C-N 115.617 -0.72 . . . . 72.22 111.662 178.244 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 19.9 ptt85 -106.58 148.13 28.64 Favored 'General case' 0 N--CA 1.472 0.644 0 C-N-CA 122.739 0.416 . . . . 74.33 110.088 -175.641 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 81.9 t -136.7 142.08 39.06 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.517 0 N-CA-C 108.635 -0.876 . . . . 73.31 108.635 176.788 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 15.7 m -130.21 132.79 46.16 Favored 'General case' 0 CA--C 1.542 0.662 0 N-CA-C 108.664 -0.865 . . . . 75.43 108.664 173.688 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 22' ' ' PHE . . . . . 0.434 ' HE1' ' HD2' ' A' ' 8' ' ' PHE . 40.8 m-85 -111.28 125.84 54.26 Favored 'General case' 0 N--CA 1.475 0.796 0 C-N-CA 123.516 0.726 . . . . 73.52 109.697 -179.524 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 37.0 tt0 -76.91 111.39 12.4 Favored 'General case' 0 CA--C 1.546 0.815 0 C-N-CA 123.252 0.621 . . . . 72.32 109.894 172.494 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . 0.447 ' HB2' ' HG2' ' A' ' 4' ' ' PRO . 76.1 mt -77.9 125.89 30.03 Favored 'General case' 0 N--CA 1.471 0.606 0 C-N-CA 123.325 0.65 . . . . 72.23 110.163 175.305 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 25' ' ' PHE . . . . . 0.502 ' HA ' HD21 ' A' ' 3' ' ' ASN . 90.8 m-85 -85.53 62.49 7.5 Favored 'General case' 0 CA--C 1.538 0.499 0 C-N-CA 123.777 0.831 . . . . 72.21 110.702 178.961 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -69.65 -8.56 48.68 Favored 'General case' 0 CA--C 1.547 0.845 0 CA-C-N 115.387 -0.824 . . . . 73.24 111.627 179.008 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 13.2 p-10 -76.23 -31.68 58.5 Favored 'General case' 0 CA--C 1.549 0.939 0 C-N-CA 123.427 0.691 . . . . 73.42 110.956 175.432 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 28' ' ' LYS . . . . . 0.483 ' HD2' HD23 ' A' ' 90' ' ' LEU . 62.0 mttp -106.18 -47.69 3.76 Favored 'General case' 0 N--CA 1.487 1.404 0 C-N-CA 123.261 0.624 . . . . 73.12 111.137 -176.211 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 21.1 m -122.6 67.58 29.55 Favored Pre-proline 0 CA--C 1.563 1.475 0 C-N-CA 123.803 0.841 . . . . 74.52 110.144 -179.914 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 38.4 Cg_endo -62.17 -30.74 82.45 Favored 'Trans proline' 0 C--N 1.384 2.399 0 C-N-CA 122.704 2.269 . . . . 71.24 112.264 -175.924 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 64.4 tttm -69.22 -51.14 40.72 Favored 'General case' 0 CA--C 1.543 0.7 0 C-N-CA 124.559 1.143 . . . . 74.15 111.223 -177.451 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 32' ' ' THR . . . . . 0.426 HG21 ' HE2' ' A' ' 126' ' ' HIS . 16.5 m -75.03 -30.15 61.01 Favored 'General case' 0 CA--C 1.551 1.009 0 CA-C-N 115.271 -0.877 . . . . 71.4 111.041 -175.264 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -72.81 -41.71 64.63 Favored 'General case' 0 CA--C 1.544 0.74 0 C-N-CA 123.18 0.592 . . . . 73.31 110.532 176.508 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 41.9 tt0 -61.16 -39.91 91.89 Favored 'General case' 0 N--CA 1.486 1.358 0 C-N-CA 124.002 0.921 . . . . 75.35 110.732 177.359 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 35' ' ' ASN . . . . . 0.417 ' O ' ' HG ' ' A' ' 39' ' ' LEU . 35.5 t30 -51.55 -67.28 0.26 Allowed 'General case' 0 CA--C 1.548 0.869 0 O-C-N 124.734 1.271 . . . . 64.31 111.034 178.083 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 85.0 t80 -62.23 -37.83 86.87 Favored 'General case' 0 N--CA 1.474 0.741 0 C-N-CA 123.156 0.582 . . . . 63.12 111.677 -176.161 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 73.8 ttt180 -59.03 -45.53 90.51 Favored 'General case' 0 CA--C 1.542 0.673 0 C-N-CA 123.419 0.687 . . . . 65.34 110.877 -179.936 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -69.95 -30.09 67.39 Favored 'General case' 0 N--CA 1.472 0.674 0 C-N-CA 123.453 0.701 . . . . 75.13 111.748 -179.869 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 39' ' ' LEU . . . . . 0.417 ' HG ' ' O ' ' A' ' 35' ' ' ASN . 90.2 mt -67.22 -37.46 83.62 Favored 'General case' 0 N--CA 1.477 0.903 0 C-N-CA 123.241 0.616 . . . . 74.43 110.684 173.667 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 36.9 m -77.77 -41.02 38.93 Favored 'General case' 0 N--CA 1.476 0.857 0 C-N-CA 123.641 0.776 . . . . 74.23 111.691 -175.493 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 41.1 p -82.21 -33.18 29.46 Favored 'General case' 0 N--CA 1.473 0.702 0 C-N-CA 123.54 0.736 . . . . 74.24 111.413 -176.344 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 92.77 24.59 22.81 Favored Glycine 0 C--N 1.342 0.909 0 CA-C-N 115.812 -0.631 . . . . 64.13 113.407 -176.86 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 45.6 mm-40 -60.99 -28.18 68.84 Favored 'General case' 0 N--CA 1.484 1.239 0 C-N-CA 122.865 0.466 . . . . 74.34 111.522 173.481 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 30.8 mmmt -106.49 15.67 25.62 Favored 'General case' 0 N--CA 1.47 0.531 0 C-N-CA 123.806 0.843 . . . . 73.21 111.298 -178.985 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 88.01 -34.53 3.73 Favored Glycine 0 C--N 1.35 1.311 0 CA-C-O 119.807 -0.44 . . . . 63.41 113.966 175.745 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 14.3 m-85 -62.42 -47.16 85.33 Favored 'General case' 0 N--CA 1.479 1.011 0 C-N-CA 123.44 0.696 . . . . 75.31 111.624 -169.463 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 47.2 56.85 7.57 Favored Glycine 0 C--N 1.356 1.665 0 O-C-N 124.521 1.138 . . . . 75.41 115.367 168.479 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 48' ' ' TYR . . . . . 0.497 ' OH ' ' HG2' ' A' ' 76' ' ' LYS . 56.7 m-85 -55.89 91.25 0.01 OUTLIER 'General case' 0 N--CA 1.479 1.006 0 C-N-CA 124.106 0.962 . . . . 74.32 112.933 -174.68 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 49' ' ' LYS . . . . . 0.509 ' HE2' ' HA ' ' A' ' 160' ' ' ASP . 29.5 tptp -110.09 120.79 43.56 Favored 'General case' 0 C--O 1.236 0.369 0 CA-C-N 113.99 -1.459 . . . . 63.3 108.582 -179.905 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 86.13 21.08 53.67 Favored Glycine 0 C--N 1.346 1.107 0 O-C-N 123.236 0.335 . . . . 60.25 112.79 -176.279 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 23.4 t -62.39 117.15 5.75 Favored 'General case' 0 CA--C 1.549 0.931 0 C-N-CA 124.075 0.95 . . . . 72.31 110.246 -178.357 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 52' ' ' CYS . . . . . . . . . . . . . 23.2 p -92.94 125.8 37.72 Favored 'General case' 0 C--O 1.24 0.566 0 C-N-CA 123.593 0.757 . . . . 74.33 112.573 -169.773 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 53' ' ' PHE . . . . . 0.738 ' HA ' ' HA2' ' A' ' 64' ' ' GLY . 64.1 m-85 -65.21 111.91 3.18 Favored 'General case' 0 CA--C 1.539 0.554 0 CA-C-N 115.035 -0.984 . . . . 74.23 108.956 164.404 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 21.8 p-80 -125.36 4.82 7.71 Favored 'General case' 0 N--CA 1.483 1.177 0 C-N-CA 123.447 0.699 . . . . 74.45 111.599 -175.983 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 65.5 ttt-85 -148.87 101.61 3.2 Favored 'General case' 0 N--CA 1.473 0.716 0 N-CA-C 109.431 -0.581 . . . . 75.24 109.431 176.648 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 56' ' ' ILE . . . . . 0.453 HG21 ' HA ' ' A' ' 143' ' ' GLU . 64.3 mt -133.7 134.12 56.55 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.098 0 C-N-CA 122.73 0.412 . . . . 75.22 110.007 -179.964 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 57' ' ' ILE . . . . . 0.409 ' HB ' ' HD2' ' A' ' 60' ' ' PHE . 71.7 mt -117.91 120.06 33.07 Favored Pre-proline 0 CA--C 1.55 0.964 0 N-CA-C 107.882 -1.155 . . . . 72.15 107.882 171.177 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 58' ' ' PRO . . . . . 0.55 ' HA ' ' HG2' ' A' ' 143' ' ' GLU . 28.0 Cg_endo -60.01 146.32 96.29 Favored 'Trans proline' 0 C--N 1.381 2.246 0 C-N-CA 123.043 2.495 . . . . 73.34 112.82 178.956 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 67.28 24.97 73.62 Favored Glycine 0 C--N 1.345 1.082 0 CA-C-N 115.74 -0.664 . . . . 74.15 113.935 179.446 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 60' ' ' PHE . . . . . 0.409 ' HD2' ' HB ' ' A' ' 57' ' ' ILE . 10.7 t80 -151.51 -72.4 0.16 Allowed 'General case' 0 N--CA 1.474 0.757 0 C-N-CA 122.978 0.511 . . . . 74.24 110.361 -175.173 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 47.1 ttp -160.04 135.05 7.91 Favored 'General case' 0 N--CA 1.474 0.728 0 CA-C-N 116.536 -0.302 . . . . 73.31 111.609 -167.112 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 62' ' ' CYS . . . . . 0.544 ' SG ' ' HB ' ' A' ' 114' ' ' ILE . 10.0 p -105.97 111.75 24.51 Favored 'General case' 0 CA--C 1.543 0.689 0 N-CA-C 108.764 -0.828 . . . . 73.11 108.764 167.898 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 63' ' ' GLN . . . . . 0.455 ' HA ' ' HA ' ' A' ' 113' ' ' PHE . 21.0 tt0 -109.13 133.76 52.59 Favored 'General case' 0 N--CA 1.48 1.062 0 C-N-CA 123.67 0.788 . . . . 71.21 110.933 -176.397 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 64' ' ' GLY . . . . . 0.738 ' HA2' ' HA ' ' A' ' 53' ' ' PHE . . . -122.52 175.24 16.42 Favored Glycine 0 C--N 1.345 1.078 0 CA-C-N 114.994 -1.003 . . . . 75.23 112.368 179.536 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 172.89 -166.26 38.81 Favored Glycine 0 C--N 1.331 0.291 0 N-CA-C 111.043 -0.823 . . . . 72.15 111.043 -179.792 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 38.8 t70 -126.32 160.8 29.38 Favored 'General case' 0 N--CA 1.476 0.863 0 C-N-CA 123.026 0.531 . . . . 74.51 110.55 -175.463 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 71.7 t80 -73.67 -32.43 63.96 Favored 'General case' 0 N--CA 1.472 0.669 0 C-N-CA 123.459 0.704 . . . . 74.43 111.211 -178.731 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 28.2 m -65.24 110.88 2.73 Favored 'General case' 0 N--CA 1.473 0.692 0 N-CA-C 109.925 -0.398 . . . . 74.25 109.925 -179.203 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 57.7 mtt85 66.99 30.52 7.49 Favored 'General case' 0 C--N 1.354 0.787 0 C-N-CA 125.052 1.341 . . . . 74.13 111.133 177.852 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 70' ' ' HIS . . . . . 0.413 ' HA ' ' HA3' ' A' ' 74' ' ' GLY . 27.5 p-80 -57.8 -23.69 53.69 Favored 'General case' 0 N--CA 1.49 1.537 0 C-N-CA 123.62 0.768 . . . . 71.23 111.774 -178.793 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 6.0 t30 -63.62 95.16 0.1 Allowed 'General case' 0 CA--C 1.543 0.694 0 C-N-CA 124.584 1.154 . . . . 74.31 109.339 168.376 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 79.05 -8.44 45.07 Favored Glycine 0 CA--C 1.529 0.92 0 N-CA-C 114.91 0.724 . . . . 72.13 114.91 174.258 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 18.0 m -135.47 -95.45 0.25 Allowed 'General case' 0 CA--C 1.558 1.279 0 CA-C-N 117.915 0.858 . . . . 71.5 110.179 -177.963 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 74' ' ' GLY . . . . . 0.413 ' HA3' ' HA ' ' A' ' 70' ' ' HIS . . . 59.51 56.15 26.61 Favored Glycine 0 C--N 1.359 1.855 0 CA-C-N 118.459 0.572 . . . . 65.05 113.626 177.776 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 134.76 49.41 0.08 OUTLIER Glycine 0 C--N 1.333 0.37 0 N-CA-C 109.443 -1.463 . . . . 70.55 109.443 -170.945 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 76' ' ' LYS . . . . . 0.497 ' HG2' ' OH ' ' A' ' 48' ' ' TYR . 22.7 ptmt -60.27 160.55 8.31 Favored 'General case' 0 N--CA 1.475 0.802 0 C-N-CA 124.113 0.965 . . . . 73.42 111.588 -177.548 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 79.1 p -90.27 174.22 7.71 Favored 'General case' 0 CA--C 1.54 0.58 0 CA-C-N 115.492 -0.776 . . . . 74.4 110.746 -178.486 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 24.8 pt -69.73 -17.54 21.38 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.818 0 C-N-CA 123.252 0.621 . . . . 74.32 110.806 176.611 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 36.5 m-85 -87.0 -16.2 36.45 Favored 'General case' 0 N--CA 1.47 0.563 0 C-N-CA 124.775 1.23 . . . . 72.31 110.643 -178.086 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 132.8 -134.04 7.35 Favored Glycine 0 C--N 1.345 1.064 0 N-CA-C 110.537 -1.025 . . . . 74.24 110.537 -177.179 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 37.1 tt0 -56.83 -54.6 44.52 Favored 'General case' 0 N--CA 1.473 0.707 0 C-N-CA 124.223 1.009 . . . . 74.41 111.427 179.453 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 82' ' ' LYS . . . . . 0.635 ' HD2' ' HA ' ' A' ' 107' ' ' THR . 21.6 pttp -168.19 177.35 5.52 Favored 'General case' 0 N--CA 1.474 0.742 0 C-N-CA 123.604 0.762 . . . . 74.32 110.69 -174.157 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 3.2 p90 -159.2 172.37 18.18 Favored 'General case' 0 CA--C 1.544 0.719 0 C-N-CA 124.73 1.212 . . . . 74.2 110.006 -174.68 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 84' ' ' GLU . . . . . 0.528 ' HA ' ' HA ' ' A' ' 106' ' ' ASN . 13.6 pt-20 -88.86 171.42 9.93 Favored 'General case' 0 N--CA 1.481 1.08 0 C-N-CA 123.094 0.558 . . . . 71.03 110.73 178.136 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 48.8 m-20 -80.63 148.71 30.14 Favored 'General case' 0 N--CA 1.478 0.928 0 N-CA-C 109.542 -0.54 . . . . 74.2 109.542 178.492 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 10.5 tp10 -86.98 -59.57 2.22 Favored 'General case' 0 N--CA 1.476 0.833 0 CA-C-O 120.606 0.241 . . . . 74.34 111.15 -179.659 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 13.0 p-10 -156.48 124.2 5.51 Favored 'General case' 0 N--CA 1.474 0.77 0 C-N-CA 123.015 0.526 . . . . 71.33 109.975 -169.603 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 79.1 m-85 -88.52 66.72 8.32 Favored 'General case' 0 N--CA 1.478 0.954 0 CA-C-O 121.683 0.754 . . . . 74.34 109.766 -174.53 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 55.0 mt -86.98 -51.6 12.74 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.587 0 CA-C-N 115.092 -0.958 . . . . 74.42 108.739 174.976 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 90' ' ' LEU . . . . . 0.543 ' HB3' ' HB ' ' A' ' 128' ' ' VAL . 94.6 mt -88.72 106.34 18.28 Favored 'General case' 0 C--O 1.24 0.57 0 CA-C-N 114.991 -1.004 . . . . 75.33 110.571 -175.789 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 50.0 mtmt -91.62 169.63 10.58 Favored 'General case' 0 C--O 1.24 0.593 0 CA-C-N 115.039 -0.982 . . . . 74.23 109.764 173.755 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 92' ' ' HIS . . . . . . . . . . . . . 20.8 m-70 -87.74 55.29 3.43 Favored 'General case' 0 N--CA 1.478 0.936 0 N-CA-C 108.826 -0.805 . . . . 73.2 108.826 -178.995 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 14.8 t -96.94 -2.67 43.2 Favored 'General case' 0 N--CA 1.475 0.776 0 CA-C-N 115.211 -0.904 . . . . 75.22 112.331 -169.707 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -131.77 178.65 17.74 Favored Glycine 0 C--N 1.342 0.912 0 CA-C-O 119.989 -0.34 . . . . 74.25 112.379 -179.564 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 95' ' ' PRO . . . . . 0.494 ' HB2' ' HE1' ' A' ' 136' ' ' MET . 76.9 Cg_endo -85.72 152.84 10.13 Favored 'Trans proline' 0 CA--C 1.551 1.373 0 C-N-CA 123.105 2.537 . . . . 73.34 112.37 172.16 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 80.66 19.96 67.1 Favored Glycine 0 C--N 1.343 0.954 0 CA-C-N 116.135 -0.484 . . . . 65.45 113.844 175.663 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 97' ' ' ILE . . . . . 0.658 ' HB ' ' HB2' ' A' ' 115' ' ' CYS . 25.8 mm -65.79 103.27 0.48 Allowed 'Isoleucine or valine' 0 CA--C 1.551 1.013 0 C-N-CA 124.138 0.975 . . . . 74.54 111.784 -175.606 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 58.5 tp -89.4 119.98 30.33 Favored 'General case' 0 C--O 1.247 0.972 0 CA-C-O 121.485 0.659 . . . . 73.33 109.819 174.264 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 46.0 t -149.55 146.38 27.32 Favored 'General case' 0 CA--C 1.549 0.929 0 C-N-CA 124.554 1.141 . . . . 63.24 108.119 -179.096 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 100' ' ' MET . . . . . 0.589 ' HA ' ' HA ' ' A' ' 112' ' ' PHE . 85.4 mtp -77.42 142.89 39.0 Favored 'General case' 0 N--CA 1.487 1.419 0 CA-C-N 118.216 0.462 . . . . 70.43 109.919 179.311 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 101' ' ' ALA . . . . . 0.496 ' HB3' ' HB2' ' A' ' 111' ' ' GLN . . . -75.04 155.52 37.17 Favored 'General case' 0 N--CA 1.474 0.731 0 CA-C-O 121.497 0.665 . . . . 74.31 112.083 -169.823 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 26.9 p-10 -167.49 166.32 14.34 Favored 'General case' 0 C--O 1.24 0.553 0 CA-C-N 114.421 -1.263 . . . . 73.03 109.744 -177.614 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -89.77 -50.98 5.74 Favored 'General case' 0 CA--C 1.537 0.452 0 N-CA-C 108.413 -0.958 . . . . 72.31 108.413 167.271 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -156.85 -156.11 7.74 Favored Glycine 0 C--N 1.347 1.193 0 CA-C-N 115.427 -0.806 . . . . 74.23 112.803 179.248 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 51.6 Cg_exo -55.7 139.62 83.49 Favored 'Trans proline' 0 C--N 1.375 1.932 0 C-N-CA 123.55 2.833 . . . . 71.24 113.165 178.134 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 106' ' ' ASN . . . . . 0.528 ' HA ' ' HA ' ' A' ' 84' ' ' GLU . 65.0 t30 66.24 8.51 5.64 Favored 'General case' 0 N--CA 1.483 1.217 0 C-N-CA 125.118 1.367 . . . . 74.33 112.487 177.215 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 107' ' ' THR . . . . . 0.635 ' HA ' ' HD2' ' A' ' 82' ' ' LYS . 3.8 m -100.72 -15.33 17.74 Favored 'General case' 0 CA--C 1.55 0.975 0 C-N-CA 123.749 0.82 . . . . 71.32 109.81 177.225 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 13.1 t30 -55.84 139.84 44.33 Favored 'General case' 0 C--O 1.208 -1.127 0 C-N-CA 125.658 1.583 . . . . 75.22 111.442 176.938 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 111.3 23.93 5.57 Favored Glycine 0 N--CA 1.469 0.886 0 N-CA-C 112.285 -0.326 . . . . 71.43 112.285 -178.872 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 13.6 p -136.98 120.8 17.46 Favored 'General case' 0 C--O 1.223 -0.311 0 C-N-CA 123.881 0.873 . . . . 72.4 108.645 178.126 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 111' ' ' GLN . . . . . 0.496 ' HB2' ' HB3' ' A' ' 101' ' ' ALA . 46.1 mt-30 59.51 -174.79 0.1 Allowed 'General case' 0 N--CA 1.489 1.489 0 C-N-CA 123.68 0.792 . . . . 74.33 111.563 -174.86 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 112' ' ' PHE . . . . . 0.589 ' HA ' ' HA ' ' A' ' 100' ' ' MET . 49.3 p90 -144.5 166.21 25.78 Favored 'General case' 0 N--CA 1.473 0.692 0 C-N-CA 123.953 0.901 . . . . 74.44 108.78 172.701 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 113' ' ' PHE . . . . . 0.455 ' HA ' ' HA ' ' A' ' 63' ' ' GLN . 51.8 p90 -152.64 154.94 36.35 Favored 'General case' 0 C--O 1.236 0.377 0 C-N-CA 122.969 0.508 . . . . 75.22 110.387 179.663 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 114' ' ' ILE . . . . . 0.544 ' HB ' ' SG ' ' A' ' 62' ' ' CYS . 16.2 mt -126.65 104.48 12.82 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.569 0 N-CA-C 108.698 -0.852 . . . . 60.01 108.698 178.492 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 115' ' ' CYS . . . . . 0.658 ' HB2' ' HB ' ' A' ' 97' ' ' ILE . 61.4 m -73.42 106.91 5.42 Favored 'General case' 0 CA--C 1.539 0.541 0 N-CA-C 109.016 -0.735 . . . . 65.24 109.016 172.772 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 116' ' ' THR . . . . . 0.415 HG22 HG11 ' A' ' 139' ' ' VAL . 75.1 p -71.39 -18.87 62.33 Favored 'General case' 0 N--CA 1.479 0.997 0 C-N-CA 123.261 0.624 . . . . 73.34 111.529 -177.273 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -124.72 169.52 11.9 Favored 'General case' 0 C--O 1.243 0.752 0 C-N-CA 123.682 0.793 . . . . 73.11 110.07 177.435 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 11.9 ptmm? -71.85 87.86 1.01 Allowed 'General case' 0 CA--C 1.55 0.95 0 CA-C-O 121.961 0.886 . . . . 73.33 110.92 176.173 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 119' ' ' THR . . . . . . . . . . . . . 52.9 p -85.34 87.89 7.44 Favored 'General case' 0 CA--C 1.544 0.734 0 CA-C-N 114.946 -1.025 . . . . 74.43 109.937 -176.894 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 7.9 pt-20 -73.07 -26.22 61.19 Favored 'General case' 0 N--CA 1.48 1.026 0 CA-C-N 114.535 -1.211 . . . . 75.21 112.934 -169.229 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 121' ' ' TRP . . . . . . . . . . . . . 39.5 p90 -70.72 -10.55 59.68 Favored 'General case' 0 N--CA 1.479 0.976 0 C-N-CA 123.732 0.813 . . . . 75.14 111.797 177.062 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 51.1 mt -95.05 0.07 54.13 Favored 'General case' 0 N--CA 1.477 0.904 0 C-N-CA 123.236 0.615 . . . . 74.45 111.673 177.514 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 32.9 m-20 -71.66 126.12 28.88 Favored 'General case' 0 N--CA 1.478 0.962 0 N-CA-C 108.801 -0.815 . . . . 73.51 108.801 172.762 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 106.82 -26.9 18.02 Favored Glycine 0 N--CA 1.471 1.02 0 N-CA-C 111.43 -0.668 . . . . 74.02 111.43 -171.933 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 125' ' ' LYS . . . . . 0.615 ' HG2' ' H ' ' A' ' 126' ' ' HIS . 20.9 ttmm -80.09 -164.96 0.75 Allowed 'General case' 0 CA--C 1.559 1.301 0 N-CA-C 107.979 -1.119 . . . . 74.51 107.979 170.907 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 126' ' ' HIS . . . . . 0.615 ' H ' ' HG2' ' A' ' 125' ' ' LYS . 8.9 t-80 -64.81 134.77 54.8 Favored 'General case' 0 C--N 1.353 0.76 0 CA-C-N 119.204 0.911 . . . . 74.12 111.132 -168.642 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 6.6 t -59.78 146.08 10.61 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.611 0 CA-C-N 112.787 -2.006 . . . . 74.33 111.091 -179.241 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 128' ' ' VAL . . . . . 0.543 ' HB ' ' HB3' ' A' ' 90' ' ' LEU . 18.9 t -74.8 156.1 6.28 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.789 0 N-CA-C 108.998 -0.742 . . . . 74.5 108.998 175.153 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 129' ' ' PHE . . . . . 0.427 ' CE2' ' HG3' ' A' ' 100' ' ' MET . 26.7 p90 -137.76 -11.72 1.54 Allowed 'General case' 0 N--CA 1.485 1.288 0 C-N-CA 122.189 0.195 . . . . 75.01 111.453 174.047 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . -148.14 159.11 27.92 Favored Glycine 0 C--N 1.341 0.84 0 N-CA-C 111.518 -0.633 . . . . 71.11 111.518 -177.056 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 35.1 ttpt -147.31 137.46 23.19 Favored 'General case' 0 N--CA 1.474 0.741 0 N-CA-C 109.39 -0.596 . . . . 75.24 109.39 178.728 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 132' ' ' VAL . . . . . 0.511 HG11 ' HA ' ' A' ' 136' ' ' MET . 37.5 t -63.91 111.89 1.18 Allowed 'Isoleucine or valine' 0 CA--C 1.543 0.705 0 O-C-N 123.658 0.599 . . . . 74.14 110.227 178.054 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 133' ' ' LYS . . . . . 0.593 ' HG3' ' HG2' ' A' ' 134' ' ' GLU . 0.0 OUTLIER -95.7 -42.42 8.39 Favored 'General case' 0 N--CA 1.474 0.751 0 C-N-CA 123.068 0.547 . . . . 74.32 109.569 172.457 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 134' ' ' GLU . . . . . 0.593 ' HG2' ' HG3' ' A' ' 133' ' ' LYS . 18.7 mm-40 -116.4 139.11 50.78 Favored 'General case' 0 N--CA 1.474 0.745 0 N-CA-C 108.674 -0.862 . . . . 74.21 108.674 -178.088 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 76.68 29.08 58.19 Favored Glycine 0 C--N 1.342 0.862 0 N-CA-C 114.156 0.422 . . . . 60.31 114.156 175.455 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 136' ' ' MET . . . . . 0.511 ' HA ' HG11 ' A' ' 132' ' ' VAL . 14.9 tpt -60.11 -38.08 81.93 Favored 'General case' 0 N--CA 1.477 0.908 0 C-N-CA 122.992 0.517 . . . . 74.3 111.216 177.647 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 137' ' ' ASN . . . . . . . . . . . . . 6.0 t30 -61.81 -39.23 91.01 Favored 'General case' 0 CA--C 1.543 0.679 0 CA-C-N 115.448 -0.796 . . . . 74.14 110.88 176.238 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 138' ' ' ILE . . . . . . . . . . . . . 49.2 mm -67.56 -35.57 73.51 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.089 0 C-N-CA 123.523 0.729 . . . . 73.2 110.868 -179.822 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 139' ' ' VAL . . . . . 0.472 ' HA ' ' HE1' ' A' ' 142' ' ' MET . 92.1 t -65.61 -47.26 86.93 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.939 0 C-N-CA 123.561 0.744 . . . . 75.33 110.648 177.203 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 41.6 mt-10 -66.83 -34.81 78.63 Favored 'General case' 0 CA--C 1.548 0.867 0 CA-C-N 115.396 -0.82 . . . . 73.43 110.964 177.739 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -69.01 -44.06 73.55 Favored 'General case' 0 N--CA 1.475 0.815 0 C-N-CA 123.309 0.644 . . . . 71.43 110.881 -178.984 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 142' ' ' MET . . . . . 0.551 ' HB2' HD12 ' A' ' 156' ' ' ILE . 19.7 ptt? -69.29 -31.16 69.47 Favored 'General case' 0 N--CA 1.477 0.88 0 O-C-N 123.429 0.456 . . . . 74.24 110.394 179.172 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 143' ' ' GLU . . . . . 0.55 ' HG2' ' HA ' ' A' ' 58' ' ' PRO . 36.9 tt0 -62.32 -31.76 72.43 Favored 'General case' 0 CA--C 1.549 0.907 0 C-N-CA 122.784 0.434 . . . . 70.12 112.009 178.868 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 144' ' ' ARG . . . . . . . . . . . . . 33.1 mtp85 -65.27 -20.57 66.48 Favored 'General case' 0 N--CA 1.48 1.035 0 C-N-CA 122.706 0.402 . . . . 72.41 111.863 178.607 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 145' ' ' PHE . . . . . 0.517 ' HD2' ' HA ' ' A' ' 142' ' ' MET . 66.3 m-85 -85.75 13.22 7.51 Favored 'General case' 0 N--CA 1.479 0.983 0 C-N-CA 123.388 0.675 . . . . 74.5 111.625 176.403 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . -98.45 -179.24 32.48 Favored Glycine 0 C--N 1.345 1.08 0 N-CA-C 111.743 -0.543 . . . . 63.31 111.743 169.838 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 10.8 m -133.45 163.09 30.14 Favored 'General case' 0 N--CA 1.478 0.944 0 C-N-CA 123.149 0.58 . . . . 73.33 111.203 -175.542 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 148' ' ' ARG . . . . . . . . . . . . . 7.3 mmm180 -67.82 -28.77 67.85 Favored 'General case' 0 N--CA 1.473 0.691 0 C-N-CA 124.383 1.073 . . . . 75.41 112.533 -177.511 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 149' ' ' ASN . . . . . . . . . . . . . 27.3 p-10 -84.58 -3.37 58.42 Favored 'General case' 0 N--CA 1.483 1.217 0 C-N-CA 123.349 0.659 . . . . 73.53 111.607 177.603 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . 100.25 -8.9 59.16 Favored Glycine 0 C--N 1.354 1.561 0 CA-C-O 119.975 -0.347 . . . . 73.12 113.188 179.028 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 59.6 tttp -65.44 143.08 57.93 Favored 'General case' 0 N--CA 1.478 0.956 0 C-N-CA 123.847 0.859 . . . . 74.25 110.408 178.336 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 152' ' ' THR . . . . . . . . . . . . . 16.5 p -92.92 114.21 26.71 Favored 'General case' 0 N--CA 1.467 0.398 0 N-CA-C 109.025 -0.732 . . . . 73.22 109.025 168.553 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 153' ' ' SER . . . . . . . . . . . . . 33.1 t -62.76 -29.02 70.38 Favored 'General case' 0 N--CA 1.475 0.784 0 C-N-CA 123.759 0.823 . . . . 72.42 110.719 177.063 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 154' ' ' LYS . . . . . 0.414 ' HB2' ' HB3' ' A' ' 145' ' ' PHE . 69.9 mmtt -124.93 145.06 50.03 Favored 'General case' 0 C--O 1.239 0.517 0 C-N-CA 123.942 0.897 . . . . 74.51 110.518 179.84 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 3.4 tppp? -79.23 99.41 7.03 Favored 'General case' 0 C--O 1.24 0.565 0 N-CA-C 109.031 -0.729 . . . . 75.32 109.031 172.651 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 156' ' ' ILE . . . . . 0.551 HD12 ' HB2' ' A' ' 142' ' ' MET . 52.3 mt -99.43 123.3 52.06 Favored 'Isoleucine or valine' 0 C--O 1.221 -0.406 0 CA-C-N 114.744 -1.116 . . . . 73.42 108.123 178.395 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 157' ' ' THR . . . . . . . . . . . . . 33.2 p -124.81 156.89 37.07 Favored 'General case' 0 N--CA 1.472 0.631 0 C-N-CA 124.13 0.972 . . . . 75.21 109.816 -177.521 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 158' ' ' ILE . . . . . . . . . . . . . 56.4 mt -82.25 93.73 2.7 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.719 0 N-CA-C 108.106 -1.072 . . . . 74.41 108.106 169.095 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 159' ' ' ALA . . . . . 0.568 ' HB3' ' HB1' ' A' ' 11' ' ' ALA . . . -54.54 -37.08 64.99 Favored 'General case' 0 N--CA 1.478 0.948 0 C-N-CA 124.759 1.224 . . . . 71.43 112.914 -177.736 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 160' ' ' ASP . . . . . 0.509 ' HA ' ' HE2' ' A' ' 49' ' ' LYS . 26.8 t0 -162.64 156.17 20.33 Favored 'General case' 0 N--CA 1.477 0.88 0 O-C-N 123.61 0.569 . . . . 74.15 111.214 -179.983 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 161' ' ' CYS . . . . . . . . . . . . . 6.9 p -123.15 -171.68 2.35 Favored 'General case' 0 N--CA 1.475 0.816 0 C-N-CA 125.255 1.422 . . . . 75.02 108.24 172.917 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 162' ' ' GLY . . . . . . . . . . . . . . . 131.42 57.93 0.09 OUTLIER Glycine 0 N--CA 1.475 1.266 0 O-C-N 121.473 -0.767 . . . . 31.53 111.507 -169.214 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 163' ' ' GLN . . . . . 0.481 ' HA ' ' H ' ' A' ' 7' ' ' PHE . 11.5 pt20 -45.36 132.71 7.65 Favored 'General case' 0 CA--C 1.547 0.838 0 C-N-CA 125.19 1.396 . . . . 74.21 114.031 -169.683 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 164' ' ' LEU . . . . . 0.494 ' O ' ' HB ' ' A' ' 5' ' ' THR . 85.1 mt -103.4 101.48 11.38 Favored 'General case' 0 N--CA 1.472 0.645 0 C-N-CA 123.976 0.911 . . . . 72.21 110.959 -179.731 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 165' ' ' GLU . . . . . . . . . . . . . 46.9 mt-10 . . . . . 0 CA--C 1.553 1.066 0 N-CA-C 108.974 -0.75 . . . . 63.02 108.974 171.701 . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' B' B ' 216' ' ' PRO . . . . . . . . . . . . . 10.0 Cg_endo . . . . . 0 CA--C 1.554 1.5 0 CA-C-O 119.46 -0.308 . . . . 72.41 111.873 . . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' B' B ' 217' ' ' GLU . . . . . . . . . . . . . 16.1 pt-20 -171.73 154.8 3.74 Favored Pre-proline 0 N--CA 1.487 1.409 0 C-N-CA 123.487 0.715 . . . . 75.34 110.916 -175.861 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 218' ' ' PRO . . . . . . . . . . . . . 7.9 Cg_exo -70.77 90.8 0.62 Allowed 'Trans proline' 0 C--N 1.379 2.176 0 C-N-CA 122.618 2.212 . . . . 70.04 110.804 173.089 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 219' ' ' GLY . . . . . . . . . . . . . . . 166.37 141.91 3.28 Favored Glycine 0 CA--C 1.531 1.071 0 CA-C-O 119.471 -0.627 . . . . 72.3 112.277 -179.961 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 220' ' ' PRO . . . . . . . . . . . . . 52.4 Cg_exo -60.84 159.95 27.13 Favored 'Trans proline' 0 N--CA 1.498 1.788 0 C-N-CA 123.957 3.105 . . . . 72.34 114.698 178.308 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 221' ' ' TYR . . . . . . . . . . . . . 48.1 m-85 -128.2 150.16 50.13 Favored 'General case' 0 N--CA 1.484 1.247 0 C-N-CA 123.655 0.782 . . . . 73.53 110.704 -175.131 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 222' ' ' ALA . . . . . . . . . . . . . . . -173.07 178.79 2.4 Favored 'General case' 0 N--CA 1.474 0.753 0 O-C-N 124.367 1.042 . . . . 73.42 110.543 174.003 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 223' ' ' GLN . . . . . . . . . . . . . 4.2 mp0 51.77 56.8 16.29 Favored Pre-proline 0 CA--C 1.565 1.532 0 C-N-CA 124.448 1.099 . . . . 75.21 110.535 -172.776 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 224' ' ' PRO . . . . . . . . . . . . . 2.0 Cg_endo . . . . . 0 C--N 1.381 2.24 0 C-N-CA 123.49 2.793 . . . . 72.42 111.529 -172.65 . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 97.2 mmm . . . . . 0 N--CA 1.48 1.043 0 CA-C-O 121.291 0.567 . . . . 75.32 109.617 . . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 11.8 p -78.0 -17.88 13.88 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.928 0 C-N-CA 123.939 0.896 . . . . 71.22 111.108 -179.007 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 13.3 m120 -55.26 113.38 5.41 Favored Pre-proline 0 C--N 1.36 1.056 0 C-N-CA 123.572 0.749 . . . . 65.43 110.909 179.504 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 19.9 Cg_endo -57.12 118.43 5.3 Favored 'Trans proline' 0 C--N 1.379 2.184 0 C-N-CA 122.889 2.392 . . . . 74.35 111.448 -174.337 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 19.7 m -95.56 127.3 41.48 Favored 'General case' 0 N--CA 1.443 -0.794 0 N-CA-C 108.407 -0.96 . . . . 72.31 108.407 -176.757 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . 0.463 HG22 ' HB2' ' A' ' 22' ' ' PHE . 15.6 m -106.92 150.5 9.41 Favored 'Isoleucine or valine' 0 CA--C 1.522 -0.106 0 CA-C-N 115.536 -0.756 . . . . 74.42 109.096 -174.918 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 79.7 t80 -138.96 135.63 34.56 Favored 'General case' 0 C--O 1.239 0.531 0 C-N-CA 122.824 0.45 . . . . 73.31 110.389 -173.765 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 8' ' ' PHE . . . . . 0.415 ' HB3' HG22 ' A' ' 158' ' ' ILE . 61.2 m-85 -141.87 165.58 27.09 Favored 'General case' 0 N--CA 1.469 0.513 0 C-N-CA 123.998 0.919 . . . . 72.11 110.504 178.946 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 11.3 m-20 -106.74 119.01 38.18 Favored 'General case' 0 N--CA 1.468 0.454 0 N-CA-C 108.012 -1.107 . . . . 72.23 108.012 165.168 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 10' ' ' ILE . . . . . 0.517 HG22 ' SD ' ' A' ' 142' ' ' MET . 48.6 mm -86.49 118.5 32.91 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.559 0 N-CA-C 109.021 -0.733 . . . . 74.44 109.021 176.532 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 11' ' ' ALA . . . . . 0.752 ' HB1' ' HB2' ' A' ' 159' ' ' ALA . . . -109.32 133.09 53.48 Favored 'General case' 0 C--O 1.219 -0.538 0 C-N-CA 123.975 0.91 . . . . 63.22 111.383 -174.689 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 43.0 t -97.64 123.54 50.12 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.533 0 N-CA-C 108.437 -0.949 . . . . 74.22 108.437 170.532 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 13' ' ' ASP . . . . . 0.434 ' HA ' ' HB2' ' A' ' 155' ' ' LYS . 66.7 m-20 61.22 15.02 6.02 Favored 'General case' 0 N--CA 1.483 1.206 0 C-N-CA 125.55 1.54 . . . . 74.44 112.928 -178.036 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 108.42 -27.32 14.05 Favored Glycine 0 C--N 1.346 1.103 0 CA-C-O 119.679 -0.512 . . . . 74.24 112.825 -176.502 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 30.8 mm-40 -89.17 122.69 68.49 Favored Pre-proline 0 N--CA 1.487 1.379 0 CA-C-N 117.666 0.733 . . . . 71.42 110.427 -179.1 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 16' ' ' PRO . . . . . 0.462 ' HA ' ' HA ' ' A' ' 11' ' ' ALA . 19.2 Cg_endo -54.36 113.22 1.26 Allowed 'Trans proline' 0 C--N 1.386 2.55 0 C-N-CA 123.344 2.696 . . . . 70.34 112.974 -177.428 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 37.2 tp -77.03 -36.72 55.92 Favored 'General case' 0 N--CA 1.479 0.991 0 C-N-CA 124.041 0.936 . . . . 75.02 109.552 175.883 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -173.4 -161.78 24.23 Favored Glycine 0 C--N 1.335 0.479 0 CA-C-N 114.671 -1.149 . . . . 71.43 111.291 -178.741 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 3.5 ptp180 -144.31 140.82 29.38 Favored 'General case' 0 N--CA 1.469 0.516 0 C-N-CA 123.374 0.67 . . . . 74.14 109.858 -176.762 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 20' ' ' VAL . . . . . 0.424 ' HA ' ' HA3' ' A' ' 135' ' ' GLY . 60.8 t -128.54 135.89 61.32 Favored 'Isoleucine or valine' 0 C--O 1.24 0.599 0 C-N-CA 124.029 0.931 . . . . 64.13 109.464 -176.213 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 31.5 t -113.39 121.03 43.13 Favored 'General case' 0 CA--C 1.547 0.841 0 C-N-CA 123.864 0.865 . . . . 54.51 108.852 172.951 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 22' ' ' PHE . . . . . 0.463 ' HB2' HG22 ' A' ' 6' ' ' VAL . 12.2 m-85 -101.0 170.87 7.99 Favored 'General case' 0 CA--C 1.543 0.706 0 N-CA-C 108.731 -0.841 . . . . 73.35 108.731 175.458 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . 0.661 ' HB2' ' HD2' ' A' ' 133' ' ' LYS . 38.9 tt0 -134.08 108.5 8.36 Favored 'General case' 0 N--CA 1.472 0.663 0 C-N-CA 123.977 0.911 . . . . 65.21 109.094 -178.557 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 13.6 mt -91.48 121.09 32.87 Favored 'General case' 0 CA--C 1.542 0.663 0 C-N-CA 122.949 0.5 . . . . 72.33 110.09 -176.726 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 25' ' ' PHE . . . . . 0.506 ' HB2' HD13 ' A' ' 90' ' ' LEU . 31.4 m-85 -86.98 69.98 10.28 Favored 'General case' 0 N--CA 1.472 0.658 0 C-N-CA 123.631 0.772 . . . . 74.32 109.777 -177.766 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -64.53 -16.07 61.97 Favored 'General case' 0 N--CA 1.48 1.034 0 N-CA-C 112.929 0.714 . . . . 71.44 112.929 -178.085 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 10.3 p-10 -72.67 -29.72 63.65 Favored 'General case' 0 CA--C 1.553 1.073 0 C-N-CA 123.279 0.632 . . . . 72.44 111.431 177.281 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 54.5 mttp -98.54 -41.65 7.66 Favored 'General case' 0 N--CA 1.485 1.319 0 C-N-CA 123.833 0.853 . . . . 75.43 110.891 -176.407 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 29' ' ' VAL . . . . . 0.507 HG21 ' HA ' ' A' ' 129' ' ' PHE . 9.7 m -129.97 70.62 82.16 Favored Pre-proline 0 CA--C 1.561 1.39 0 C-N-CA 123.992 0.917 . . . . 73.31 109.815 -178.071 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 18.5 Cg_endo -57.73 -40.07 82.35 Favored 'Trans proline' 0 C--N 1.387 2.56 0 C-N-CA 123.221 2.614 . . . . 74.23 113.39 -175.28 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 31' ' ' LYS . . . . . 0.478 ' HG3' ' HH ' ' A' ' 79' ' ' TYR . 37.9 ttpt -66.87 -55.49 14.49 Favored 'General case' 0 N--CA 1.476 0.872 0 C-N-CA 123.539 0.735 . . . . 72.21 111.935 -179.587 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 5.8 m -68.74 -32.29 71.95 Favored 'General case' 0 CA--C 1.554 1.114 0 CA-C-N 115.591 -0.731 . . . . 70.4 111.455 -172.039 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -79.26 -45.5 19.63 Favored 'General case' 0 N--CA 1.477 0.878 0 C-N-CA 123.531 0.733 . . . . 74.44 111.115 179.745 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 32.3 tt0 -58.76 -35.07 72.15 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 123.604 0.565 . . . . 74.53 110.698 178.111 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 35' ' ' ASN . . . . . 0.519 ' ND2' ' SD ' ' A' ' 100' ' ' MET . 51.5 t30 -53.61 -69.25 0.12 Allowed 'General case' 0 C--N 1.353 0.751 0 O-C-N 124.267 0.98 . . . . 72.53 110.822 -179.175 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 91.4 t80 -62.83 -35.01 78.53 Favored 'General case' 0 N--CA 1.48 1.064 0 C-N-CA 123.493 0.717 . . . . 75.34 111.962 -176.128 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 56.2 ttt180 -61.74 -48.81 79.05 Favored 'General case' 0 N--CA 1.479 0.977 0 C-N-CA 123.535 0.734 . . . . 74.11 111.141 179.668 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -84.16 -19.45 34.1 Favored 'General case' 0 N--CA 1.475 0.808 0 CA-C-N 115.515 -0.766 . . . . 62.23 111.994 -174.832 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 39' ' ' LEU . . . . . 0.508 ' HG ' ' O ' ' A' ' 35' ' ' ASN . 66.4 mt -64.78 -46.1 83.52 Favored 'General case' 0 N--CA 1.474 0.752 0 N-CA-C 108.538 -0.912 . . . . 75.02 108.538 167.636 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 27.0 t -64.54 -56.21 15.54 Favored 'General case' 0 CA--C 1.543 0.683 0 C-N-CA 124.463 1.105 . . . . 72.41 112.047 -178.162 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 41' ' ' THR . . . . . 0.542 HG21 ' NE2' ' A' ' 163' ' ' GLN . 2.9 p -67.79 -30.71 70.21 Favored 'General case' 0 N--CA 1.477 0.901 0 C-N-CA 122.761 0.424 . . . . 75.44 111.541 179.652 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 84.09 29.01 32.31 Favored Glycine 0 C--N 1.345 1.069 0 CA-C-N 116.236 -0.438 . . . . 74.31 112.486 -179.06 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 21.2 mm-40 -64.49 -24.95 67.79 Favored 'General case' 0 N--CA 1.478 0.943 0 C-N-CA 123.437 0.695 . . . . 64.14 111.504 175.781 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 44' ' ' LYS . . . . . 0.488 ' HG3' HG22 ' A' ' 78' ' ' ILE . 70.8 mmtt -98.35 5.69 47.98 Favored 'General case' 0 CA--C 1.548 0.897 0 C-N-CA 124.088 0.955 . . . . 71.33 111.117 -179.936 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 79.08 39.21 20.44 Favored Glycine 0 C--N 1.348 1.218 0 CA-C-O 119.973 -0.348 . . . . 65.53 113.612 179.026 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 22.9 m-85 -123.98 -48.54 1.87 Allowed 'General case' 0 N--CA 1.485 1.3 0 CA-C-N 117.207 0.503 . . . . 74.21 111.309 -176.758 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 53.1 61.83 6.54 Favored Glycine 0 C--N 1.352 1.462 0 O-C-N 124.127 0.892 . . . . 73.14 114.461 171.009 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 48' ' ' TYR . . . . . 0.434 ' CE1' ' HA2' ' A' ' 75' ' ' GLY . 61.7 m-85 -67.51 97.94 0.63 Allowed 'General case' 0 N--CA 1.473 0.679 0 C-N-CA 123.499 0.72 . . . . 75.35 112.44 -176.289 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 3.0 tppp? -109.86 145.7 36.34 Favored 'General case' 0 CA--C 1.537 0.46 0 CA-C-N 114.532 -1.213 . . . . 74.33 108.938 172.26 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 71.01 20.63 77.99 Favored Glycine 0 C--N 1.343 0.953 0 CA-C-O 119.515 -0.603 . . . . 71.23 113.444 179.318 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 20.3 m -55.83 113.83 1.65 Allowed 'General case' 0 C--N 1.354 0.787 0 C-N-CA 123.595 0.758 . . . . 71.2 109.842 -179.324 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 52' ' ' CYS . . . . . 0.569 ' SG ' ' HB3' ' A' ' 66' ' ' ASP . 7.7 p -100.28 123.03 44.01 Favored 'General case' 0 CA--C 1.545 0.77 0 CA-C-N 115.277 -0.874 . . . . 73.54 112.505 -163.441 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 53' ' ' PHE . . . . . 0.723 ' HA ' ' HA2' ' A' ' 64' ' ' GLY . 33.3 m-85 -71.07 118.32 13.7 Favored 'General case' 0 C--O 1.239 0.504 0 C-N-CA 125.461 1.504 . . . . 73.02 109.79 171.874 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 54' ' ' HIS . . . . . 0.469 ' ND1' ' HB2' ' A' ' 66' ' ' ASP . 45.5 p-80 -115.96 -22.97 8.76 Favored 'General case' 0 N--CA 1.475 0.792 0 C-N-CA 123.772 0.829 . . . . 74.03 110.858 -176.675 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 47.9 ttt-85 -128.95 106.21 8.73 Favored 'General case' 0 C--N 1.359 1.005 0 N-CA-C 109.572 -0.529 . . . . 74.31 109.572 178.704 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 56' ' ' ILE . . . . . 0.535 HG23 ' HA ' ' A' ' 143' ' ' GLU . 56.5 mt -130.58 128.23 63.16 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.749 0 C-N-CA 123.72 0.808 . . . . 73.14 108.973 174.695 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 76.3 mt -108.02 117.66 54.57 Favored Pre-proline 0 CA--C 1.557 1.219 0 C-N-CA 124.281 1.032 . . . . 74.33 108.256 173.254 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 58' ' ' PRO . . . . . 0.54 ' HA ' ' HG2' ' A' ' 143' ' ' GLU . 32.0 Cg_exo -58.84 131.52 42.42 Favored 'Trans proline' 0 C--N 1.382 2.313 0 C-N-CA 123.64 2.893 . . . . 74.25 112.83 179.62 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 79.2 21.09 68.31 Favored Glycine 0 CA--C 1.529 0.928 0 O-C-N 124.018 0.824 . . . . 62.34 113.597 179.885 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 17.3 t80 -148.04 -73.42 0.2 Allowed 'General case' 0 N--CA 1.48 1.032 0 CA-C-N 117.659 0.73 . . . . 74.44 111.121 -173.888 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 61' ' ' MET . . . . . 0.411 ' SD ' ' CD1' ' A' ' 113' ' ' PHE . 58.5 ttp -159.75 142.56 13.83 Favored 'General case' 0 N--CA 1.483 1.221 0 N-CA-C 112.578 0.585 . . . . 75.32 112.578 -165.412 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 62' ' ' CYS . . . . . 0.513 ' SG ' ' HB2' ' A' ' 143' ' ' GLU . 52.2 m -117.18 116.92 28.23 Favored 'General case' 0 N--CA 1.474 0.74 0 C-N-CA 124.511 1.125 . . . . 73.41 110.179 175.145 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 15.0 pt20 -121.0 130.31 53.75 Favored 'General case' 0 N--CA 1.484 1.259 0 CA-C-O 122.103 0.954 . . . . 72.41 112.11 179.499 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 64' ' ' GLY . . . . . 0.723 ' HA2' ' HA ' ' A' ' 53' ' ' PHE . . . -113.49 -177.21 19.42 Favored Glycine 0 C--N 1.343 0.94 0 CA-C-N 113.79 -1.55 . . . . 62.34 112.758 178.27 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 98.83 73.66 1.11 Allowed Glycine 0 C--N 1.337 0.614 0 N-CA-C 110.871 -0.892 . . . . 72.44 110.871 -178.959 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 66' ' ' ASP . . . . . 0.569 ' HB3' ' SG ' ' A' ' 52' ' ' CYS . 32.6 t70 -127.56 30.29 5.36 Favored 'General case' 0 N--CA 1.482 1.141 0 C-N-CA 123.099 0.56 . . . . 70.03 109.916 172.124 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 57.0 t80 -93.8 -83.83 0.32 Allowed 'General case' 0 CA--C 1.555 1.148 0 O-C-N 122.055 -0.403 . . . . 74.44 111.044 -177.12 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 69.9 m -81.15 113.11 19.09 Favored 'General case' 0 N--CA 1.482 1.148 0 C-N-CA 123.407 0.683 . . . . 64.02 111.346 -171.307 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 60.7 ttt85 62.76 66.51 0.75 Allowed 'General case' 0 N--CA 1.476 0.856 0 C-N-CA 124.349 1.06 . . . . 75.22 109.522 -174.471 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 2.5 p-80 -74.63 74.85 2.02 Favored 'General case' 0 N--CA 1.482 1.161 0 CA-C-N 114.819 -1.082 . . . . 74.3 112.083 -175.272 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 64.5 t30 -154.72 77.98 1.05 Allowed 'General case' 0 N--CA 1.473 0.719 0 N-CA-C 108.085 -1.08 . . . . 73.44 108.085 177.163 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 63.98 22.81 67.08 Favored Glycine 0 CA--C 1.534 1.26 0 CA-C-N 115.67 -0.696 . . . . 75.33 114.044 -176.32 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 73' ' ' THR . . . . . 0.527 ' HA ' ' HB2' ' A' ' 110' ' ' SER . 46.9 m -142.53 -65.37 0.4 Allowed 'General case' 0 N--CA 1.476 0.854 0 C-N-CA 123.855 0.862 . . . . 74.43 109.492 -174.582 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 44.04 38.53 4.75 Favored Glycine 0 C--N 1.355 1.599 0 C-N-CA 124.517 1.056 . . . . 44.14 115.655 174.922 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . 0.434 ' HA2' ' CE1' ' A' ' 48' ' ' TYR . . . 149.78 54.05 0.01 OUTLIER Glycine 0 C--N 1.337 0.584 0 O-C-N 122.122 -0.634 . . . . 75.13 112.256 -161.281 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 76' ' ' LYS . . . . . 0.425 ' HZ2' ' HB2' ' A' ' 76' ' ' LYS . 0.0 OUTLIER -48.22 149.62 1.45 Allowed 'General case' 0 N--CA 1.481 1.108 0 C-N-CA 124.685 1.194 . . . . 72.22 111.621 169.909 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 94.3 p -90.03 -178.4 5.43 Favored 'General case' 0 C--O 1.24 0.59 0 CA-C-O 121.781 0.8 . . . . 73.34 112.244 -169.504 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 78' ' ' ILE . . . . . 0.488 HG22 ' HG3' ' A' ' 44' ' ' LYS . 27.7 pt -72.62 -19.48 19.11 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.941 0 CA-C-N 114.909 -1.041 . . . . 73.34 110.751 175.787 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 79' ' ' TYR . . . . . 0.478 ' HH ' ' HG3' ' A' ' 31' ' ' LYS . 92.8 m-85 -92.08 25.78 2.73 Favored 'General case' 0 N--CA 1.481 1.115 0 C-N-CA 123.701 0.8 . . . . 73.3 110.381 173.062 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 83.92 -105.15 2.74 Favored Glycine 0 C--N 1.343 0.939 0 N-CA-C 111.015 -0.834 . . . . 64.03 111.015 -178.243 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 43.0 tt0 -74.34 -61.26 1.92 Allowed 'General case' 0 C--O 1.242 0.7 0 C-N-CA 122.872 0.469 . . . . 75.1 110.493 -177.237 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 82' ' ' LYS . . . . . 0.716 ' HD2' ' HA ' ' A' ' 107' ' ' THR . 20.4 pttp -168.78 177.15 5.2 Favored 'General case' 0 CA--C 1.542 0.635 0 CA-C-N 115.465 -0.788 . . . . 74.44 110.475 -173.128 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 28.9 p90 -159.35 177.45 10.99 Favored 'General case' 0 CA--C 1.546 0.791 0 C-N-CA 125.467 1.507 . . . . 75.32 108.251 -174.714 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 11.5 pt-20 -94.97 167.6 11.3 Favored 'General case' 0 N--CA 1.485 1.283 0 O-C-N 121.926 -0.484 . . . . 74.4 111.552 179.224 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 25.9 m-20 -61.41 150.13 36.31 Favored 'General case' 0 N--CA 1.479 1.021 0 C-N-CA 123.82 0.848 . . . . 73.23 111.302 174.489 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 86' ' ' GLU . . . . . 0.499 ' HG2' ' HA ' ' A' ' 29' ' ' VAL . 6.3 tp10 -74.63 -61.82 1.74 Allowed 'General case' 0 N--CA 1.474 0.747 0 CA-C-N 116.55 -0.296 . . . . 73.02 111.329 -176.664 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 31.2 p-10 -174.32 143.97 0.9 Allowed 'General case' 0 N--CA 1.479 1.009 0 C-N-CA 123.85 0.86 . . . . 71.44 109.134 -174.643 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 92.7 m-85 -88.25 53.24 2.67 Favored 'General case' 0 N--CA 1.483 1.218 0 C-N-CA 123.819 0.848 . . . . 74.42 112.115 -166.565 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 63.3 mt -77.38 -57.5 5.67 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.855 0 C-N-CA 123.654 0.782 . . . . 71.23 108.946 173.298 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 90' ' ' LEU . . . . . 0.567 ' HB3' ' HB ' ' A' ' 128' ' ' VAL . 86.7 mt -85.03 121.58 28.01 Favored 'General case' 0 C--O 1.238 0.467 0 CA-C-N 114.672 -1.149 . . . . 73.44 110.619 -175.145 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 46.5 mtmt -117.5 169.39 9.57 Favored 'General case' 0 N--CA 1.474 0.756 0 C-N-CA 124.141 0.976 . . . . 73.24 110.193 -175.831 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 92' ' ' HIS . . . . . . . . . . . . . 28.1 m-70 -86.38 50.15 1.94 Allowed 'General case' 0 N--CA 1.48 1.068 0 C-N-CA 124.062 0.945 . . . . 74.35 109.942 -178.988 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 10.5 t -95.0 -2.45 50.32 Favored 'General case' 0 CA--C 1.547 0.84 0 CA-C-N 115.112 -0.949 . . . . 75.54 110.965 -175.281 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -131.66 170.33 21.62 Favored Glycine 0 CA--C 1.533 1.189 0 CA-C-O 119.735 -0.48 . . . . 60.01 112.272 179.07 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 83.8 Cg_endo -81.99 157.36 17.95 Favored 'Trans proline' 0 CA--C 1.554 1.519 0 C-N-CA 122.799 2.333 . . . . 71.31 112.209 170.83 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 79.3 21.17 67.87 Favored Glycine 0 C--N 1.35 1.306 0 CA-C-N 116.601 -0.272 . . . . 61.31 113.624 176.544 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 97' ' ' ILE . . . . . 0.618 ' HB ' ' HB2' ' A' ' 115' ' ' CYS . 24.9 mm -65.63 103.72 0.5 Allowed 'Isoleucine or valine' 0 CA--C 1.547 0.836 0 C-N-CA 123.603 0.761 . . . . 74.43 111.816 -175.559 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 63.0 tp -89.02 114.38 25.57 Favored 'General case' 0 CA--C 1.547 0.84 0 CA-C-O 121.586 0.708 . . . . 73.12 109.368 173.708 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 99' ' ' SER . . . . . 0.677 ' HB3' ' HA ' ' A' ' 128' ' ' VAL . 4.9 p -148.05 139.75 23.82 Favored 'General case' 0 CA--C 1.537 0.473 0 C-N-CA 124.801 1.24 . . . . 73.01 108.033 178.354 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 100' ' ' MET . . . . . 0.709 ' HA ' ' HA ' ' A' ' 112' ' ' PHE . 67.3 mtp -75.55 148.05 39.21 Favored 'General case' 0 N--CA 1.489 1.522 0 C-N-CA 122.625 0.37 . . . . 72.13 110.775 -173.187 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 101' ' ' ALA . . . . . 0.635 ' HB2' ' HB2' ' A' ' 111' ' ' GLN . . . -72.34 152.28 42.18 Favored 'General case' 0 N--CA 1.479 0.984 0 CA-C-O 121.196 0.522 . . . . 73.35 112.301 -171.928 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 102' ' ' ASN . . . . . 0.426 ' HB2' ' HB ' ' A' ' 107' ' ' THR . 30.1 p-10 -165.83 159.42 15.99 Favored 'General case' 0 CA--C 1.536 0.438 0 CA-C-N 114.821 -1.081 . . . . 75.34 109.774 -177.022 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -110.14 25.08 12.18 Favored 'General case' 0 N--CA 1.472 0.654 0 C-N-CA 123.356 0.662 . . . . 71.04 109.379 169.821 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 136.9 -174.1 21.81 Favored Glycine 0 CA--C 1.535 1.292 0 CA-C-N 115.484 -0.78 . . . . 70.51 112.029 -179.422 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 51.7 Cg_exo -57.22 152.24 46.7 Favored 'Trans proline' 0 C--N 1.37 1.671 0 C-N-CA 123.439 2.759 . . . . 63.51 112.595 175.316 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 65.1 t30 66.74 12.67 8.98 Favored 'General case' 0 N--CA 1.489 1.491 0 C-N-CA 124.347 1.059 . . . . 75.4 111.965 179.638 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 107' ' ' THR . . . . . 0.716 ' HA ' ' HD2' ' A' ' 82' ' ' LYS . 2.7 m -120.77 7.23 10.45 Favored 'General case' 0 N--CA 1.489 1.506 0 C-N-CA 123.451 0.701 . . . . 73.23 110.579 -179.504 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 12.4 t30 -76.89 139.93 40.4 Favored 'General case' 0 N--CA 1.478 0.965 0 C-N-CA 124.643 1.177 . . . . 73.52 110.26 179.181 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 112.59 -11.35 25.73 Favored Glycine 0 N--CA 1.471 1.003 0 CA-C-O 119.843 -0.42 . . . . 64.23 113.269 178.518 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 110' ' ' SER . . . . . 0.527 ' HB2' ' HA ' ' A' ' 73' ' ' THR . 33.9 p -99.87 121.61 41.57 Favored 'General case' 0 N--CA 1.474 0.773 0 N-CA-C 109.047 -0.723 . . . . 74.41 109.047 173.009 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 111' ' ' GLN . . . . . 0.635 ' HB2' ' HB2' ' A' ' 101' ' ' ALA . 38.5 mt-30 63.67 175.74 0.17 Allowed 'General case' 0 N--CA 1.498 1.969 0 C-N-CA 124.294 1.037 . . . . 74.32 111.848 -177.705 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 112' ' ' PHE . . . . . 0.709 ' HA ' ' HA ' ' A' ' 100' ' ' MET . 36.6 p90 -148.93 133.36 17.57 Favored 'General case' 0 N--CA 1.482 1.147 0 N-CA-C 109.427 -0.583 . . . . 71.23 109.427 177.133 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 113' ' ' PHE . . . . . 0.411 ' CD1' ' SD ' ' A' ' 61' ' ' MET . 51.7 p90 -118.98 149.83 40.96 Favored 'General case' 0 N--CA 1.478 0.935 0 C-N-CA 123.151 0.58 . . . . 71.33 111.592 179.627 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 114' ' ' ILE . . . . . . . . . . . . . 22.5 mt -123.0 103.8 13.59 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.611 0 C-N-CA 124.279 1.032 . . . . 74.31 108.698 -179.753 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 115' ' ' CYS . . . . . 0.618 ' HB2' ' HB ' ' A' ' 97' ' ' ILE . 62.2 m -75.71 106.22 7.16 Favored 'General case' 0 CA--C 1.541 0.623 0 N-CA-C 109.336 -0.616 . . . . 54.5 109.336 175.584 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 116' ' ' THR . . . . . 0.541 ' HA ' ' HE1' ' A' ' 136' ' ' MET . 39.5 p -70.63 -31.5 68.47 Favored 'General case' 0 N--CA 1.471 0.584 0 C-N-CA 123.534 0.734 . . . . 73.32 111.3 -179.104 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -99.06 159.04 15.25 Favored 'General case' 0 C--O 1.247 0.936 0 CA-C-N 115.462 -0.79 . . . . 71.5 109.478 171.69 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -72.36 88.89 1.2 Allowed 'General case' 0 CA--C 1.539 0.543 0 CA-C-O 121.765 0.793 . . . . 71.12 109.182 173.471 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 119' ' ' THR . . . . . . . . . . . . . 34.6 p -76.06 85.7 2.94 Favored 'General case' 0 CA--C 1.546 0.804 0 CA-C-O 122.276 1.036 . . . . 75.5 110.36 -174.381 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 11.5 pt-20 -71.29 -29.76 65.44 Favored 'General case' 0 N--CA 1.474 0.748 0 CA-C-N 114.158 -1.383 . . . . 75.41 111.38 -171.278 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 121' ' ' TRP . . . . . . . . . . . . . 43.6 p90 -67.94 -3.17 9.04 Favored 'General case' 0 N--CA 1.479 1.003 0 C-N-CA 123.367 0.667 . . . . 70.23 112.218 179.251 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 45.7 mt -96.24 26.32 4.35 Favored 'General case' 0 CA--C 1.555 1.141 0 C-N-CA 123.523 0.729 . . . . 62.41 111.535 174.037 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 56.7 m-20 -59.55 123.08 15.7 Favored 'General case' 0 N--CA 1.49 1.545 0 C-N-CA 122.758 0.423 . . . . 62.32 110.376 165.054 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 85.56 -9.1 69.03 Favored Glycine 0 N--CA 1.475 1.278 0 O-C-N 123.209 0.318 . . . . 61.44 113.27 -179.271 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 125' ' ' LYS . . . . . 0.631 ' HG3' ' H ' ' A' ' 126' ' ' HIS . 0.1 OUTLIER -82.74 -163.97 0.79 Allowed 'General case' 0 CA--C 1.561 1.371 0 C-N-CA 124.628 1.171 . . . . 74.22 108.412 177.511 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 126' ' ' HIS . . . . . 0.631 ' H ' ' HG3' ' A' ' 125' ' ' LYS . 57.3 t-80 -64.35 136.43 57.13 Favored 'General case' 0 N--CA 1.473 0.709 0 C-N-CA 124.119 0.968 . . . . 75.04 111.218 -166.38 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 45.1 t -71.76 140.33 18.32 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.536 0 CA-C-N 115.634 -0.712 . . . . 61.4 110.676 -176.466 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 128' ' ' VAL . . . . . 0.677 ' HA ' ' HB3' ' A' ' 99' ' ' SER . 25.1 t -73.37 148.0 9.14 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.558 0 N-CA-C 109.166 -0.679 . . . . 71.44 109.166 175.767 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 129' ' ' PHE . . . . . 0.507 ' HA ' HG21 ' A' ' 29' ' ' VAL . 39.5 p90 -129.2 -20.02 3.44 Favored 'General case' 0 N--CA 1.479 0.996 0 O-C-N 122.105 -0.372 . . . . 73.35 110.694 174.827 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . -140.23 164.18 26.25 Favored Glycine 0 C--N 1.34 0.761 0 O-C-N 123.717 0.636 . . . . 75.31 112.017 -175.87 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 34.6 ttpt -148.86 130.28 14.77 Favored 'General case' 0 N--CA 1.468 0.462 0 N-CA-C 109.271 -0.641 . . . . 74.21 109.271 -178.148 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 49.0 t -63.76 104.45 0.41 Allowed 'Isoleucine or valine' 0 C--O 1.238 0.496 0 N-CA-C 108.847 -0.797 . . . . 70.41 108.847 174.759 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 133' ' ' LYS . . . . . 0.661 ' HD2' ' HB2' ' A' ' 23' ' ' GLU . 19.4 ptmt -85.63 -33.4 21.63 Favored 'General case' 0 N--CA 1.471 0.618 0 N-CA-C 109.335 -0.617 . . . . 74.11 109.335 179.545 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 32.8 mt-10 -145.39 152.27 39.58 Favored 'General case' 0 N--CA 1.473 0.707 0 C-N-CA 125.033 1.333 . . . . 74.44 109.166 -178.135 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 135' ' ' GLY . . . . . 0.424 ' HA3' ' HA ' ' A' ' 20' ' ' VAL . . . 81.85 16.62 72.21 Favored Glycine 0 C--N 1.345 1.041 0 CA-C-N 116.534 -0.303 . . . . 74.02 112.729 -178.848 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 136' ' ' MET . . . . . 0.541 ' HE1' ' HA ' ' A' ' 116' ' ' THR . 14.5 tpt -62.6 -31.11 71.88 Favored 'General case' 0 N--CA 1.479 0.998 0 C-N-CA 124.232 1.013 . . . . 74.52 110.857 177.72 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 137' ' ' ASN . . . . . . . . . . . . . 45.3 t30 -56.53 -44.66 81.04 Favored 'General case' 0 N--CA 1.477 0.883 0 CA-C-N 114.51 -1.223 . . . . 75.44 110.779 171.824 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 138' ' ' ILE . . . . . . . . . . . . . 46.4 mm -73.72 -33.13 37.21 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.009 0 C-N-CA 123.682 0.793 . . . . 73.32 111.135 -178.199 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 70.2 t -63.27 -47.72 90.83 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.114 0 CA-C-O 121.32 0.581 . . . . 73.43 110.511 177.146 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 49.0 mt-10 -73.13 -29.29 62.78 Favored 'General case' 0 CA--C 1.548 0.884 0 CA-C-N 115.827 -0.624 . . . . 75.21 111.385 179.092 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -70.22 -40.17 74.67 Favored 'General case' 0 N--CA 1.479 0.991 0 C-N-CA 123.089 0.555 . . . . 75.54 111.269 177.503 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 142' ' ' MET . . . . . 0.517 ' SD ' HG22 ' A' ' 10' ' ' ILE . 22.9 ptt? -74.51 -27.03 60.37 Favored 'General case' 0 N--CA 1.484 1.271 0 C-N-CA 122.622 0.369 . . . . 61.34 110.107 178.501 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 143' ' ' GLU . . . . . 0.54 ' HG2' ' HA ' ' A' ' 58' ' ' PRO . 33.8 tt0 -65.41 -27.51 68.59 Favored 'General case' 0 CA--C 1.545 0.756 0 C-N-CA 123.202 0.601 . . . . 73.31 112.417 177.686 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 144' ' ' ARG . . . . . . . . . . . . . 74.3 mtp180 -65.7 -20.23 66.2 Favored 'General case' 0 CA--C 1.55 0.949 0 C-N-CA 123.48 0.712 . . . . 75.15 111.458 176.114 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 145' ' ' PHE . . . . . . . . . . . . . 43.6 m-85 -89.52 3.97 50.73 Favored 'General case' 0 CA--C 1.548 0.874 0 C-N-CA 123.607 0.763 . . . . 75.31 111.706 177.406 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . -85.52 177.26 50.07 Favored Glycine 0 C--N 1.347 1.167 0 N-CA-C 111.66 -0.576 . . . . 74.44 111.66 171.01 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 16.4 m -133.71 163.15 30.09 Favored 'General case' 0 N--CA 1.48 1.053 0 CA-C-N 117.587 0.694 . . . . 71.31 111.741 -175.895 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 148' ' ' ARG . . . . . . . . . . . . . 9.3 mmm180 -75.99 -15.31 60.17 Favored 'General case' 0 N--CA 1.475 0.798 0 C-N-CA 124.897 1.279 . . . . 73.32 112.879 -177.747 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 149' ' ' ASN . . . . . . . . . . . . . 34.3 p-10 -90.72 -3.51 57.41 Favored 'General case' 0 N--CA 1.481 1.117 0 C-N-CA 122.884 0.474 . . . . 73.31 110.333 171.982 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . 105.36 -27.33 18.69 Favored Glycine 0 C--N 1.351 1.393 0 CA-C-N 116.0 -0.546 . . . . 41.22 112.917 177.003 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 56.9 tttm -69.43 156.32 39.04 Favored 'General case' 0 N--CA 1.484 1.27 0 C-N-CA 123.217 0.607 . . . . 74.33 111.78 -173.358 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 152' ' ' THR . . . . . . . . . . . . . 69.2 p -94.39 130.63 40.65 Favored 'General case' 0 N--CA 1.474 0.765 0 CA-C-O 120.941 0.4 . . . . 75.42 110.428 172.304 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 153' ' ' SER . . . . . . . . . . . . . 15.0 m -69.47 -31.44 69.73 Favored 'General case' 0 N--CA 1.474 0.731 0 C-N-CA 123.928 0.891 . . . . 74.0 111.148 174.723 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 75.3 mmtt -115.13 153.63 30.42 Favored 'General case' 0 N--CA 1.473 0.723 0 C-N-CA 124.052 0.941 . . . . 72.23 109.972 -177.277 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 155' ' ' LYS . . . . . 0.434 ' HB2' ' HA ' ' A' ' 13' ' ' ASP . 30.3 mmmt -86.32 89.11 7.76 Favored 'General case' 0 N--CA 1.468 0.466 0 N-CA-C 109.244 -0.651 . . . . 75.52 109.244 175.626 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 156' ' ' ILE . . . . . 0.512 HD13 ' HB2' ' A' ' 142' ' ' MET . 59.2 mt -90.23 103.02 13.85 Favored 'Isoleucine or valine' 0 C--O 1.213 -0.837 0 N-CA-C 109.28 -0.637 . . . . 75.1 109.28 -174.706 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 157' ' ' THR . . . . . . . . . . . . . 44.7 p -114.45 147.99 38.47 Favored 'General case' 0 N--CA 1.476 0.868 0 C-N-CA 123.976 0.91 . . . . 75.32 109.972 -175.222 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 158' ' ' ILE . . . . . 0.415 HG22 ' HB3' ' A' ' 8' ' ' PHE . 47.2 mt -71.91 97.43 0.67 Allowed 'Isoleucine or valine' 0 CA--C 1.555 1.156 0 N-CA-C 109.546 -0.539 . . . . 74.12 109.546 170.638 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 159' ' ' ALA . . . . . 0.752 ' HB2' ' HB1' ' A' ' 11' ' ' ALA . . . -58.7 -48.57 80.67 Favored 'General case' 0 N--CA 1.482 1.136 0 C-N-CA 124.581 1.152 . . . . 62.12 112.757 -175.894 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 160' ' ' ASP . . . . . . . . . . . . . 25.4 t0 -148.86 166.16 29.36 Favored 'General case' 0 N--CA 1.478 0.974 0 CA-C-N 115.926 -0.579 . . . . 73.32 110.307 -175.734 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 161' ' ' CYS . . . . . . . . . . . . . 19.4 p -132.56 -170.91 2.53 Favored 'General case' 0 CA--C 1.548 0.888 0 C-N-CA 125.315 1.446 . . . . 74.22 109.056 179.85 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 162' ' ' GLY . . . . . . . . . . . . . . . 132.02 53.88 0.09 OUTLIER Glycine 0 N--CA 1.473 1.134 0 N-CA-C 111.265 -0.734 . . . . 73.41 111.265 -170.83 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 163' ' ' GLN . . . . . 0.542 ' NE2' HG21 ' A' ' 41' ' ' THR . 69.7 mt-30 -46.74 112.56 0.52 Allowed 'General case' 0 CA--C 1.55 0.952 0 C-N-CA 125.586 1.555 . . . . 74.34 112.762 -177.337 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 164' ' ' LEU . . . . . . . . . . . . . 88.0 mt -80.24 102.72 9.64 Favored 'General case' 0 N--CA 1.474 0.751 0 C-N-CA 124.045 0.938 . . . . 73.4 110.186 -175.646 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 165' ' ' GLU . . . . . . . . . . . . . 5.6 pt-20 . . . . . 0 C--O 1.252 1.225 0 C-N-CA 122.697 0.399 . . . . 74.11 110.2 -174.991 . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' B' B ' 216' ' ' PRO . . . . . . . . . . . . . 5.2 Cg_exo . . . . . 0 CA--C 1.547 1.147 0 N-CA-C 109.751 -0.904 . . . . 73.41 109.751 . . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' B' B ' 217' ' ' GLU . . . . . 0.423 ' HB2' ' HD2' ' B' ' 218' ' ' PRO . 1.0 OUTLIER -146.41 -178.84 0.84 Allowed Pre-proline 0 CA--C 1.556 1.208 0 C-N-CA 125.247 1.419 . . . . 75.24 108.59 -175.119 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' B' B ' 218' ' ' PRO . . . . . 0.423 ' HD2' ' HB2' ' B' ' 217' ' ' GLU . 10.8 Cg_endo -55.92 92.63 0.05 OUTLIER 'Trans proline' 0 C--N 1.38 2.226 0 C-N-CA 121.44 1.427 . . . . 75.43 111.37 163.55 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 219' ' ' GLY . . . . . . . . . . . . . . . 137.0 126.95 2.57 Favored Glycine 0 CA--C 1.541 1.679 0 CA-C-N 114.931 -1.031 . . . . 73.13 110.585 -174.482 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 220' ' ' PRO . . . . . . . . . . . . . 57.5 Cg_endo -67.18 170.5 13.09 Favored 'Trans proline' 0 C--N 1.377 2.055 0 C-N-CA 123.178 2.585 . . . . 54.23 113.485 -177.163 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 221' ' ' TYR . . . . . . . . . . . . . 13.7 p90 -128.97 161.87 28.9 Favored 'General case' 0 C--O 1.252 1.192 0 CA-C-O 121.321 0.581 . . . . 72.32 111.265 -175.054 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 222' ' ' ALA . . . . . . . . . . . . . . . -172.5 177.27 3.06 Favored 'General case' 0 CA--C 1.543 0.706 0 C-N-CA 125.704 1.602 . . . . 70.15 108.938 172.931 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 223' ' ' GLN . . . . . . . . . . . . . 2.7 mp0 67.78 94.84 0.05 OUTLIER Pre-proline 0 N--CA 1.484 1.235 0 C-N-CA 124.424 1.09 . . . . 74.35 110.232 -176.109 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 224' ' ' PRO . . . . . . . . . . . . . 33.4 Cg_endo . . . . . 0 C--N 1.382 2.316 0 C-N-CA 123.659 2.906 . . . . 75.34 113.382 -178.185 . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 29.3 mmt . . . . . 0 N--CA 1.485 1.302 0 N-CA-C 110.165 -0.309 . . . . 75.11 110.165 . . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 11.2 p -64.55 -18.96 24.25 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.467 0 C-N-CA 123.825 0.85 . . . . 74.12 111.486 178.199 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 3' ' ' ASN . . . . . 0.495 ' HB3' ' O ' ' A' ' 24' ' ' LEU . 13.2 m120 -68.48 140.38 92.41 Favored Pre-proline 0 CA--C 1.552 1.046 0 C-N-CA 124.995 1.318 . . . . 72.34 111.936 -173.868 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 42.9 Cg_endo -66.71 119.36 6.38 Favored 'Trans proline' 0 C--N 1.384 2.443 0 C-N-CA 122.973 2.449 . . . . 74.53 111.049 175.572 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 5' ' ' THR . . . . . 0.425 ' O ' ' HB2' ' A' ' 163' ' ' GLN . 97.5 m -98.6 127.82 44.68 Favored 'General case' 0 CA--C 1.537 0.444 0 N-CA-C 109.239 -0.652 . . . . 74.13 109.239 -178.934 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . 0.493 ' HA ' ' HB2' ' A' ' 163' ' ' GLN . 14.1 m -102.13 123.13 55.17 Favored 'Isoleucine or valine' 0 C--N 1.351 0.652 0 C-N-CA 123.972 0.909 . . . . 74.23 109.563 178.252 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 7' ' ' PHE . . . . . 0.581 ' H ' ' HA ' ' A' ' 163' ' ' GLN . 57.5 t80 -102.79 137.27 41.22 Favored 'General case' 0 C--O 1.24 0.597 0 CA-C-N 115.058 -0.974 . . . . 72.24 108.905 -178.49 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 51.2 m-85 -136.59 164.78 27.4 Favored 'General case' 0 C--O 1.24 0.563 0 O-C-N 124.534 1.146 . . . . 74.31 109.971 174.32 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 24.6 m-20 -112.96 109.06 18.23 Favored 'General case' 0 C--N 1.324 -0.511 0 N-CA-C 106.263 -1.754 . . . . 72.11 106.263 169.976 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 10' ' ' ILE . . . . . 0.436 HG21 ' SD ' ' A' ' 142' ' ' MET . 46.7 mm -78.95 129.43 37.58 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.479 0 N-CA-C 108.013 -1.106 . . . . 73.5 108.013 177.555 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 11' ' ' ALA . . . . . 0.745 ' HB2' ' HB3' ' A' ' 159' ' ' ALA . . . -124.53 133.54 53.28 Favored 'General case' 0 C--O 1.217 -0.654 0 C-N-CA 123.849 0.86 . . . . 54.3 110.785 -171.782 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . 0.454 HG13 ' HB3' ' A' ' 154' ' ' LYS . 53.4 t -97.53 117.59 42.51 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.64 0 C-N-CA 124.236 1.014 . . . . 72.32 108.983 172.128 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 13' ' ' ASP . . . . . 0.463 ' HA ' ' HB3' ' A' ' 155' ' ' LYS . 31.6 m-20 54.97 38.93 31.29 Favored 'General case' 0 N--CA 1.484 1.257 0 C-N-CA 125.288 1.435 . . . . 64.14 111.211 -174.372 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 84.07 -14.51 43.6 Favored Glycine 0 C--N 1.353 1.508 0 CA-C-N 115.292 -0.867 . . . . 60.24 113.964 179.479 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 18.4 mm-40 -89.89 122.15 68.18 Favored Pre-proline 0 N--CA 1.474 0.756 0 CA-C-O 118.347 -0.835 . . . . 63.31 109.865 -178.896 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_exo -50.42 109.55 0.3 Allowed 'Trans proline' 0 C--N 1.378 2.119 0 C-N-CA 123.786 2.99 . . . . 65.35 113.397 -178.056 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 42.6 tp -77.11 -45.08 28.13 Favored 'General case' 0 N--CA 1.477 0.924 0 C-N-CA 123.647 0.779 . . . . 74.32 109.503 175.99 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -177.3 -172.45 41.86 Favored Glycine 0 C--N 1.343 0.961 0 CA-C-N 115.519 -0.764 . . . . 63.23 112.227 -179.933 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 19' ' ' ARG . . . . . 0.498 ' HB3' ' HE1' ' A' ' 7' ' ' PHE . 54.3 mtt180 -118.71 138.39 52.67 Favored 'General case' 0 N--CA 1.473 0.69 0 C-N-CA 124.185 0.994 . . . . 75.04 110.423 -174.02 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 36.7 t -135.29 144.23 34.77 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.819 0 C-N-CA 124.065 0.946 . . . . 75.14 109.09 178.328 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 75.1 m -128.94 126.41 39.58 Favored 'General case' 0 CA--C 1.549 0.933 0 C-N-CA 123.688 0.795 . . . . 62.21 108.931 172.185 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 70.4 m-85 -106.66 121.94 45.36 Favored 'General case' 0 N--CA 1.475 0.792 0 C-N-CA 123.909 0.884 . . . . 71.34 110.106 178.969 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . 0.455 ' HG3' ' HB2' ' A' ' 3' ' ' ASN . 39.7 tt0 -75.92 113.4 13.37 Favored 'General case' 0 CA--C 1.552 1.055 0 C-N-CA 123.764 0.825 . . . . 75.43 109.487 171.456 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . 0.495 ' O ' ' HB3' ' A' ' 3' ' ' ASN . 37.4 mt -91.39 123.5 34.86 Favored 'General case' 0 N--CA 1.482 1.127 0 C-N-CA 123.538 0.735 . . . . 74.32 110.305 179.452 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 25' ' ' PHE . . . . . 0.452 ' HD1' ' HZ3' ' A' ' 28' ' ' LYS . 79.3 m-85 -79.72 70.98 6.34 Favored 'General case' 0 N--CA 1.476 0.863 0 C-N-CA 123.688 0.795 . . . . 74.24 111.15 -178.506 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -74.99 1.44 12.92 Favored 'General case' 0 N--CA 1.483 1.196 0 C-N-CA 123.55 0.74 . . . . 74.43 112.172 -179.666 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 11.3 p-10 -89.55 -27.81 20.02 Favored 'General case' 0 CA--C 1.551 1.007 0 C-N-CA 123.537 0.735 . . . . 73.32 110.568 172.791 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 28' ' ' LYS . . . . . 0.452 ' HZ3' ' HD1' ' A' ' 25' ' ' PHE . 57.4 mttp -100.72 -39.33 7.9 Favored 'General case' 0 N--CA 1.485 1.3 0 C-N-CA 123.362 0.665 . . . . 74.2 110.845 -176.546 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 29' ' ' VAL . . . . . 0.517 HG22 ' HA ' ' A' ' 129' ' ' PHE . 12.0 m -137.44 61.82 33.65 Favored Pre-proline 0 CA--C 1.56 1.341 0 C-N-CA 124.341 1.056 . . . . 75.11 110.355 -176.367 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 20.7 Cg_endo -58.9 -23.81 69.54 Favored 'Trans proline' 0 C--N 1.387 2.561 0 C-N-CA 122.559 2.173 . . . . 72.0 113.733 -178.076 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 86.4 tttt -68.66 -56.47 8.07 Favored 'General case' 0 N--CA 1.477 0.912 0 C-N-CA 122.79 0.436 . . . . 73.1 110.688 179.662 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 5.7 m -74.06 -33.2 63.61 Favored 'General case' 0 CA--C 1.552 1.05 0 CA-C-N 115.418 -0.81 . . . . 74.31 111.177 -173.784 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -72.04 -46.62 56.35 Favored 'General case' 0 CA--C 1.546 0.816 0 C-N-CA 123.651 0.78 . . . . 75.35 111.056 179.948 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 34.4 tt0 -64.38 -37.31 87.06 Favored 'General case' 0 N--CA 1.487 1.419 0 C-N-CA 123.187 0.595 . . . . 74.14 110.652 178.497 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 35' ' ' ASN . . . . . 0.467 ' O ' ' HG ' ' A' ' 39' ' ' LEU . 38.8 t30 -51.61 -64.44 0.81 Allowed 'General case' 0 C--N 1.36 1.022 0 O-C-N 124.559 1.162 . . . . 74.11 110.14 177.232 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 86.9 t80 -61.09 -35.99 78.48 Favored 'General case' 0 CA--C 1.544 0.712 0 C-N-CA 123.92 0.888 . . . . 74.12 111.88 -177.808 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 77.3 ttt180 -64.93 -43.69 91.93 Favored 'General case' 0 N--CA 1.474 0.751 0 C-N-CA 123.715 0.806 . . . . 74.55 111.436 -177.922 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 38' ' ' ALA . . . . . 0.466 ' HB3' ' HG2' ' A' ' 44' ' ' LYS . . . -78.21 -27.84 47.86 Favored 'General case' 0 N--CA 1.474 0.755 0 C-N-CA 123.32 0.648 . . . . 73.43 111.209 -177.525 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 39' ' ' LEU . . . . . 0.467 ' HG ' ' O ' ' A' ' 35' ' ' ASN . 88.5 mt -66.02 -43.29 88.05 Favored 'General case' 0 CA--C 1.549 0.908 0 C-N-CA 123.437 0.695 . . . . 63.43 109.973 169.877 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 16.3 t -62.7 -51.88 65.47 Favored 'General case' 0 N--CA 1.476 0.855 0 C-N-CA 125.22 1.408 . . . . 74.12 111.336 -178.095 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 25.4 p -77.17 -32.95 56.5 Favored 'General case' 0 CA--C 1.536 0.424 0 CA-C-N 115.559 -0.746 . . . . 73.04 111.667 -176.167 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 88.42 26.97 26.39 Favored Glycine 0 C--N 1.346 1.116 0 O-C-N 123.406 0.441 . . . . 52.23 112.558 -175.33 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 22.8 mm-40 -63.59 -22.65 67.01 Favored 'General case' 0 N--CA 1.482 1.165 0 C-N-CA 123.471 0.708 . . . . 72.32 111.495 173.506 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 44' ' ' LYS . . . . . 0.466 ' HG2' ' HB3' ' A' ' 38' ' ' ALA . 31.0 mmmt -105.69 17.09 24.32 Favored 'General case' 0 CA--C 1.545 0.756 0 C-N-CA 123.998 0.919 . . . . 73.13 110.905 179.241 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 81.55 -25.86 3.74 Favored Glycine 0 C--N 1.355 1.593 0 N-CA-C 114.641 0.617 . . . . 72.32 114.641 175.661 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 16.4 m-85 -64.94 -44.03 90.79 Favored 'General case' 0 N--CA 1.48 1.055 0 C-N-CA 123.406 0.682 . . . . 72.53 111.186 -171.354 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 56.87 64.66 4.2 Favored Glycine 0 C--N 1.356 1.673 0 O-C-N 123.958 0.786 . . . . 62.22 114.34 166.049 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 51.4 m-85 -62.44 87.59 0.02 OUTLIER 'General case' 0 N--CA 1.48 1.075 0 CA-C-O 122.33 1.062 . . . . 75.54 111.426 -178.721 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 28.5 tptp -111.4 117.15 32.29 Favored 'General case' 0 C--O 1.235 0.33 0 CA-C-N 113.452 -1.703 . . . . 75.41 107.775 178.762 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 79.46 20.75 68.4 Favored Glycine 0 C--N 1.339 0.742 0 CA-C-O 119.698 -0.501 . . . . 72.1 112.877 -177.088 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 34.5 t -55.83 115.4 2.36 Favored 'General case' 0 C--N 1.357 0.921 0 C-N-CA 123.365 0.666 . . . . 73.33 109.387 178.078 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 52' ' ' CYS . . . . . 0.737 ' SG ' ' HB3' ' A' ' 66' ' ' ASP . 2.3 p -86.54 138.6 31.59 Favored 'General case' 0 C--O 1.242 0.685 0 O-C-N 124.255 0.972 . . . . 73.23 111.491 -172.495 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 53' ' ' PHE . . . . . 0.662 ' HA ' ' HA2' ' A' ' 64' ' ' GLY . 36.6 m-85 -89.29 99.09 12.15 Favored 'General case' 0 N--CA 1.451 -0.415 0 C-N-CA 125.338 1.455 . . . . 74.42 107.988 175.544 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 43.8 p-80 -82.49 -31.11 29.49 Favored 'General case' 0 N--CA 1.476 0.841 0 C-N-CA 123.608 0.763 . . . . 71.31 111.342 -177.098 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 55' ' ' ARG . . . . . 0.4 ' HA ' ' O ' ' A' ' 150' ' ' GLY . 52.5 ttt180 -122.92 98.43 5.9 Favored 'General case' 0 C--O 1.21 -0.979 0 C-N-CA 122.885 0.474 . . . . 75.22 109.85 -173.97 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 56' ' ' ILE . . . . . 0.467 HG22 ' HA ' ' A' ' 143' ' ' GLU . 38.8 mt -127.87 138.95 53.24 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.717 0 N-CA-C 109.296 -0.631 . . . . 75.51 109.296 173.139 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 57' ' ' ILE . . . . . 0.56 HG21 ' HA ' ' A' ' 148' ' ' ARG . 64.1 mt -134.08 113.71 12.57 Favored Pre-proline 0 CA--C 1.557 1.24 0 C-N-CA 125.133 1.373 . . . . 72.0 108.781 -174.694 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 58' ' ' PRO . . . . . 0.565 ' HA ' ' HG2' ' A' ' 143' ' ' GLU . 56.0 Cg_endo -66.17 131.46 26.9 Favored 'Trans proline' 0 C--N 1.386 2.516 0 C-N-CA 123.641 2.894 . . . . 73.45 113.357 -173.104 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 78.03 31.31 48.54 Favored Glycine 0 C--N 1.345 1.08 0 CA-C-N 115.387 -0.824 . . . . 72.55 112.696 -178.58 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 60' ' ' PHE . . . . . 0.446 ' CE2' ' HA ' ' B' ' 222' ' ' ALA . 20.2 t80 -157.71 -73.73 0.09 Allowed 'General case' 0 CA--C 1.545 0.772 0 CA-C-N 116.781 0.291 . . . . 72.54 111.393 -174.533 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 43.6 ttp -159.59 138.8 11.13 Favored 'General case' 0 N--CA 1.481 1.09 0 C-N-CA 122.679 0.392 . . . . 72.22 111.299 -166.057 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 62' ' ' CYS . . . . . 0.638 ' SG ' ' HB ' ' A' ' 114' ' ' ILE . 5.4 p -116.31 111.65 20.42 Favored 'General case' 0 CA--C 1.554 1.099 0 C-N-CA 123.494 0.718 . . . . 53.21 109.429 169.572 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 63' ' ' GLN . . . . . 0.411 ' HA ' ' HA ' ' A' ' 113' ' ' PHE . 54.2 tt0 -109.34 117.71 34.77 Favored 'General case' 0 N--CA 1.487 1.379 0 C-N-CA 124.438 1.095 . . . . 72.44 110.897 -173.342 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 64' ' ' GLY . . . . . 0.662 ' HA2' ' HA ' ' A' ' 53' ' ' PHE . . . -106.73 -176.3 23.08 Favored Glycine 0 C--N 1.345 1.073 0 CA-C-N 115.713 -0.676 . . . . 62.11 113.34 179.621 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 84.4 91.5 0.76 Allowed Glycine 0 C--N 1.341 0.859 0 N-CA-C 110.446 -1.062 . . . . 54.02 110.446 -174.566 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 66' ' ' ASP . . . . . 0.737 ' HB3' ' SG ' ' A' ' 52' ' ' CYS . 32.9 t70 -128.56 -56.89 1.21 Allowed 'General case' 0 N--CA 1.473 0.718 0 C-N-CA 122.938 0.495 . . . . 65.44 110.532 176.019 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 65.7 t80 -40.25 -57.32 1.75 Allowed 'General case' 0 N--CA 1.485 1.307 0 C-N-CA 125.344 1.458 . . . . 75.34 114.196 -170.756 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 26.4 m -79.93 107.2 12.52 Favored 'General case' 0 C--O 1.243 0.738 0 CA-C-O 120.862 0.363 . . . . 72.12 110.992 -174.782 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 69' ' ' ARG . . . . . 0.413 ' HD2' ' HD2' ' A' ' 76' ' ' LYS . 62.6 mtt-85 54.29 71.67 0.51 Allowed 'General case' 0 N--CA 1.472 0.669 0 C-N-CA 125.929 1.692 . . . . 63.12 112.147 173.245 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 70' ' ' HIS . . . . . 0.43 ' HB3' ' O ' ' A' ' 66' ' ' ASP . 15.9 p-80 -85.34 17.5 3.09 Favored 'General case' 0 N--CA 1.481 1.118 0 N-CA-C 113.198 0.814 . . . . 73.15 113.198 -172.438 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 44.4 t30 -77.0 73.18 3.58 Favored 'General case' 0 N--CA 1.481 1.099 0 CA-C-O 121.561 0.696 . . . . 75.3 109.561 173.435 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 72' ' ' GLY . . . . . 0.54 ' HA2' ' HG2' ' B' ' 218' ' ' PRO . . . 63.68 20.79 64.36 Favored Glycine 0 C--N 1.346 1.092 0 CA-C-N 115.208 -0.905 . . . . 64.33 114.505 -179.071 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 37.1 m -125.03 -66.25 0.97 Allowed 'General case' 0 CA--C 1.542 0.669 0 C-N-CA 123.16 0.584 . . . . 73.34 109.459 -177.357 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 51.64 60.42 7.42 Favored Glycine 0 C--N 1.355 1.636 0 O-C-N 124.275 0.984 . . . . 51.52 113.543 177.589 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 132.21 53.03 0.08 OUTLIER Glycine 0 N--CA 1.469 0.899 0 CA-C-N 118.049 0.924 . . . . 64.4 112.35 -176.387 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 76' ' ' LYS . . . . . 0.661 ' HB2' ' HZ3' ' A' ' 76' ' ' LYS . 0.0 OUTLIER -51.57 149.47 4.4 Favored 'General case' 0 N--CA 1.481 1.125 0 C-N-CA 123.75 0.82 . . . . 74.42 111.49 177.242 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 92.0 p -91.45 176.01 6.71 Favored 'General case' 0 CA--C 1.538 0.509 0 CA-C-O 121.361 0.6 . . . . 74.33 111.163 -168.542 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 78' ' ' ILE . . . . . 0.432 HG23 ' HB1' ' A' ' 38' ' ' ALA . 25.5 pt -75.93 -18.05 15.44 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.615 0 CA-C-N 115.45 -0.795 . . . . 75.23 110.218 174.329 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 85.1 m-85 -87.76 -14.82 38.69 Favored 'General case' 0 N--CA 1.472 0.642 0 C-N-CA 124.291 1.036 . . . . 74.21 110.607 177.601 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 147.36 -112.39 0.59 Allowed Glycine 0 C--N 1.348 1.199 0 N-CA-C 110.612 -0.995 . . . . 72.52 110.612 178.817 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 32.1 tt0 -89.1 -50.72 5.99 Favored 'General case' 0 CA--C 1.539 0.533 0 CA-C-O 121.657 0.741 . . . . 75.1 109.358 176.017 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 82' ' ' LYS . . . . . 0.42 ' HD2' ' HA ' ' A' ' 107' ' ' THR . 23.7 pttm -151.88 177.46 10.41 Favored 'General case' 0 N--CA 1.47 0.541 0 CA-C-N 114.336 -1.302 . . . . 73.32 109.791 -169.335 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 45.7 p90 -158.43 170.7 21.62 Favored 'General case' 0 N--CA 1.476 0.836 0 C-N-CA 123.492 0.717 . . . . 71.24 110.362 176.468 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 84' ' ' GLU . . . . . 0.562 ' HA ' ' HA ' ' A' ' 106' ' ' ASN . 9.7 pt-20 -82.73 160.46 22.34 Favored 'General case' 0 N--CA 1.474 0.747 0 C-N-CA 122.899 0.48 . . . . 74.31 111.036 178.226 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 52.3 m-20 -65.23 131.73 47.25 Favored 'General case' 0 C--O 1.239 0.511 0 CA-C-N 114.802 -1.09 . . . . 73.24 110.298 177.509 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 10.9 tp10 -72.33 -58.13 3.65 Favored 'General case' 0 C--O 1.239 0.503 0 O-C-N 124.166 0.916 . . . . 74.1 109.323 175.224 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 32.3 p30 -159.02 -173.77 4.41 Favored 'General case' 0 C--O 1.237 0.405 0 CA-C-N 114.437 -1.256 . . . . 75.15 108.966 -175.97 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 89.0 m-85 -137.56 61.26 1.61 Allowed 'General case' 0 N--CA 1.477 0.886 0 C-N-CA 123.602 0.761 . . . . 74.21 108.982 173.193 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 62.5 mt -78.77 -54.32 12.09 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.151 0 CA-C-O 121.383 0.611 . . . . 75.21 109.909 177.495 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 90' ' ' LEU . . . . . 0.479 ' HB3' ' HB ' ' A' ' 128' ' ' VAL . 94.3 mt -89.05 140.88 28.99 Favored 'General case' 0 C--O 1.236 0.37 0 CA-C-N 115.067 -0.97 . . . . 70.53 111.389 -172.672 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 16.8 ptpt -139.63 170.56 15.68 Favored 'General case' 0 CA--C 1.541 0.612 0 C-N-CA 124.113 0.965 . . . . 74.13 110.83 -173.571 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 92' ' ' HIS . . . . . 0.568 ' HA ' HG21 ' A' ' 97' ' ' ILE . 13.2 m80 -92.12 53.72 2.22 Favored 'General case' 0 N--CA 1.48 1.041 0 C-N-CA 124.791 1.236 . . . . 72.24 110.78 -167.528 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 3.8 p -94.52 20.32 8.58 Favored 'General case' 0 N--CA 1.481 1.103 0 C-N-CA 124.196 0.998 . . . . 71.21 113.286 -174.125 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -163.93 178.92 39.17 Favored Glycine 0 C--N 1.344 0.974 0 C-N-CA 121.018 -0.611 . . . . 63.15 113.652 -178.214 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 95' ' ' PRO . . . . . 0.484 ' HB2' ' HE3' ' A' ' 136' ' ' MET . 85.0 Cg_endo -81.64 138.5 10.73 Favored 'Trans proline' 0 C--N 1.369 1.657 0 C-N-CA 123.046 2.497 . . . . 74.44 112.805 175.935 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 96' ' ' GLY . . . . . 0.486 ' HA3' HG11 ' A' ' 132' ' ' VAL . . . 80.28 20.12 67.75 Favored Glycine 0 C--N 1.35 1.316 0 CA-C-N 116.04 -0.527 . . . . 75.43 113.692 174.1 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 97' ' ' ILE . . . . . 0.568 HG21 ' HA ' ' A' ' 92' ' ' HIS . 21.7 mm -66.87 105.62 0.73 Allowed 'Isoleucine or valine' 0 CA--C 1.549 0.914 0 C-N-CA 124.518 1.127 . . . . 64.23 110.613 178.077 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 98' ' ' LEU . . . . . 0.43 HD11 HG12 ' A' ' 114' ' ' ILE . 59.2 tp -87.17 101.47 13.53 Favored 'General case' 0 CA--C 1.55 0.973 0 CA-C-O 121.894 0.855 . . . . 71.14 109.532 177.089 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 99' ' ' SER . . . . . 0.523 ' HB2' HG22 ' A' ' 128' ' ' VAL . 33.0 t -106.07 170.39 7.94 Favored 'General case' 0 N--CA 1.472 0.664 0 C-N-CA 124.965 1.306 . . . . 65.23 108.67 176.141 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 100' ' ' MET . . . . . 0.497 ' SD ' ' HA2' ' A' ' 109' ' ' GLY . 4.4 ttt -113.53 135.68 53.63 Favored 'General case' 0 N--CA 1.482 1.125 0 CA-C-N 118.356 0.525 . . . . 64.1 110.048 -178.175 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 101' ' ' ALA . . . . . 0.433 ' HB3' ' HB2' ' A' ' 111' ' ' GLN . . . -84.35 -178.95 7.07 Favored 'General case' 0 C--O 1.244 0.811 0 C-N-CA 123.764 0.826 . . . . 43.4 111.105 -173.79 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 25.8 p-10 -168.84 -178.83 3.49 Favored 'General case' 0 CA--C 1.539 0.552 0 CA-C-N 115.166 -0.925 . . . . 75.23 111.369 -168.322 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 103' ' ' ALA . . . . . 0.461 ' HB3' HG23 ' A' ' 107' ' ' THR . . . -124.46 13.2 8.78 Favored 'General case' 0 N--CA 1.479 1.002 0 C-N-CA 124.249 1.02 . . . . 71.22 109.496 161.94 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 145.39 178.07 20.64 Favored Glycine 0 C--N 1.352 1.424 0 CA-C-O 119.065 -0.853 . . . . 74.14 111.539 -179.556 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 32.5 Cg_exo -61.19 149.91 87.05 Favored 'Trans proline' 0 C--N 1.375 1.962 0 C-N-CA 123.198 2.599 . . . . 75.13 111.731 169.496 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 106' ' ' ASN . . . . . 0.562 ' HA ' ' HA ' ' A' ' 84' ' ' GLU . 65.6 t30 62.87 21.87 13.09 Favored 'General case' 0 CA--C 1.557 1.249 0 O-C-N 124.168 0.917 . . . . 62.11 110.325 -174.031 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 107' ' ' THR . . . . . 0.461 HG23 ' HB3' ' A' ' 103' ' ' ALA . 12.2 m -142.15 24.11 1.99 Allowed 'General case' 0 CA--C 1.555 1.137 0 C-N-CA 125.066 1.346 . . . . 74.54 109.094 178.154 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 61.1 t30 -80.27 147.95 30.97 Favored 'General case' 0 N--CA 1.476 0.851 0 C-N-CA 123.739 0.816 . . . . 74.32 109.46 176.534 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 109' ' ' GLY . . . . . 0.497 ' HA2' ' SD ' ' A' ' 100' ' ' MET . . . 106.49 -14.24 42.83 Favored Glycine 0 N--CA 1.472 1.04 0 CA-C-O 119.946 -0.363 . . . . 54.02 113.805 177.608 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 38.6 p -94.81 120.18 34.61 Favored 'General case' 0 CA--C 1.543 0.699 0 C-N-CA 123.382 0.673 . . . . 73.23 109.361 177.861 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 111' ' ' GLN . . . . . 0.638 HE22 ' HB2' ' B' ' 218' ' ' PRO . 27.8 mt-30 66.95 162.95 0.18 Allowed 'General case' 0 N--CA 1.497 1.906 0 C-N-CA 125.044 1.338 . . . . 75.31 111.408 -170.491 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 44.9 p90 -144.5 150.29 37.34 Favored 'General case' 0 N--CA 1.484 1.233 0 N-CA-C 108.362 -0.977 . . . . 73.12 108.362 178.19 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 113' ' ' PHE . . . . . 0.411 ' HA ' ' HA ' ' A' ' 63' ' ' GLN . 51.3 p90 -140.98 142.37 34.29 Favored 'General case' 0 N--CA 1.472 0.644 0 N-CA-C 111.969 0.359 . . . . 73.35 111.969 -175.895 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 114' ' ' ILE . . . . . 0.638 ' HB ' ' SG ' ' A' ' 62' ' ' CYS . 12.1 mt -111.98 105.02 17.98 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.733 0 C-N-CA 124.168 0.987 . . . . 73.44 109.127 -178.391 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 115' ' ' CYS . . . . . . . . . . . . . 69.5 m -75.71 107.89 8.19 Favored 'General case' 0 CA--C 1.541 0.597 0 N-CA-C 109.171 -0.677 . . . . 75.14 109.171 173.335 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 72.3 p -78.6 -10.71 59.84 Favored 'General case' 0 N--CA 1.481 1.078 0 C-N-CA 123.379 0.672 . . . . 63.41 111.681 -179.559 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -125.46 166.92 15.76 Favored 'General case' 0 C--O 1.243 0.746 0 C-N-CA 123.358 0.663 . . . . 73.42 109.741 176.37 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 11.3 ptmt -71.72 74.49 0.83 Allowed 'General case' 0 CA--C 1.548 0.893 0 C-N-CA 124.003 0.921 . . . . 72.22 110.097 174.829 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 119' ' ' THR . . . . . 0.543 ' HB ' HD23 ' A' ' 122' ' ' LEU . 41.1 p -76.53 90.66 3.32 Favored 'General case' 0 CA--C 1.546 0.821 0 CA-C-O 121.928 0.871 . . . . 74.32 109.588 -177.514 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 9.6 pt-20 -71.82 -32.11 67.23 Favored 'General case' 0 N--CA 1.472 0.648 0 CA-C-N 115.057 -0.974 . . . . 62.12 112.19 -173.987 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 121' ' ' TRP . . . . . . . . . . . . . 27.4 p90 -74.09 -4.82 37.94 Favored 'General case' 0 N--CA 1.479 0.99 0 C-N-CA 122.757 0.423 . . . . 75.33 111.058 176.793 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 122' ' ' LEU . . . . . 0.543 HD23 ' HB ' ' A' ' 119' ' ' THR . 3.8 mm? -86.88 -15.67 38.35 Favored 'General case' 0 N--CA 1.477 0.878 0 C-N-CA 123.761 0.824 . . . . 70.0 111.394 173.347 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 41.4 m-20 -72.41 149.39 44.32 Favored 'General case' 0 N--CA 1.482 1.134 0 N-CA-C 109.767 -0.457 . . . . 65.04 109.767 176.105 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 93.93 -26.9 14.4 Favored Glycine 0 N--CA 1.47 0.912 0 N-CA-C 111.628 -0.589 . . . . 60.25 111.628 -171.274 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 125' ' ' LYS . . . . . 0.508 ' HD2' ' HE2' ' B' ' 221' ' ' TYR . 1.8 mppt? -80.1 -169.89 2.24 Favored 'General case' 0 N--CA 1.478 0.951 0 C-N-CA 123.902 0.881 . . . . 75.54 109.709 172.387 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 126' ' ' HIS . . . . . . . . . . . . . 0.6 OUTLIER -69.34 145.68 52.77 Favored 'General case' 0 C--O 1.242 0.673 0 C-N-CA 123.372 0.669 . . . . 75.23 111.79 -167.51 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 11.1 p -65.32 145.19 14.12 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.726 0 CA-C-N 113.656 -1.611 . . . . 74.22 112.361 -165.521 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 128' ' ' VAL . . . . . 0.523 HG22 ' HB2' ' A' ' 99' ' ' SER . 60.2 t -74.25 150.22 7.43 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.53 0 CA-C-N 114.569 -1.196 . . . . 74.02 108.932 172.791 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 129' ' ' PHE . . . . . 0.517 ' HA ' HG22 ' A' ' 29' ' ' VAL . 45.5 p90 -133.59 -10.76 2.78 Favored 'General case' 0 N--CA 1.476 0.831 0 C-N-CA 122.202 0.201 . . . . 74.42 111.424 -179.396 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . -146.3 170.93 27.3 Favored Glycine 0 C--N 1.343 0.941 0 O-C-N 123.559 0.537 . . . . 75.33 112.751 -173.357 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 29.4 ttpt -161.19 134.21 6.34 Favored 'General case' 0 C--N 1.325 -0.46 0 C-N-CA 124.346 1.058 . . . . 74.32 108.235 -175.959 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 132' ' ' VAL . . . . . 0.486 HG11 ' HA3' ' A' ' 96' ' ' GLY . 13.7 p -68.41 131.02 33.82 Favored 'Isoleucine or valine' 0 CA--C 1.554 1.124 0 CA-C-N 118.329 0.513 . . . . 71.21 109.959 175.107 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -91.62 -48.82 6.63 Favored 'General case' 0 N--CA 1.48 1.061 0 N-CA-C 108.975 -0.75 . . . . 70.45 108.975 173.306 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 3.2 mp0 -146.63 155.85 42.76 Favored 'General case' 0 C--O 1.243 0.747 0 C-N-CA 124.983 1.313 . . . . 73.12 108.544 177.052 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 94.24 12.22 56.47 Favored Glycine 0 C--N 1.342 0.877 0 CA-C-N 115.926 -0.579 . . . . 51.42 112.376 -174.546 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 136' ' ' MET . . . . . 0.484 ' HE3' ' HB2' ' A' ' 95' ' ' PRO . 15.0 tpt -62.5 -31.1 71.8 Favored 'General case' 0 N--CA 1.48 1.031 0 C-N-CA 123.847 0.859 . . . . 75.32 111.192 178.522 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 137' ' ' ASN . . . . . . . . . . . . . 26.6 t-20 -55.51 -42.22 74.18 Favored 'General case' 0 N--CA 1.479 0.994 0 C-N-CA 123.964 0.906 . . . . 74.23 110.506 174.238 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 138' ' ' ILE . . . . . . . . . . . . . 44.9 mm -74.19 -32.85 33.24 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.73 0 CA-C-N 115.232 -0.895 . . . . 72.33 110.691 -178.95 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 69.3 t -64.55 -41.43 92.25 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.366 0 C-N-CA 123.471 0.709 . . . . 75.33 110.495 176.347 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 38.3 mt-10 -69.92 -39.22 76.29 Favored 'General case' 0 N--CA 1.473 0.722 0 CA-C-N 115.311 -0.859 . . . . 65.1 110.747 177.681 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -65.06 -52.45 55.67 Favored 'General case' 0 N--CA 1.475 0.784 0 O-C-N 123.681 0.613 . . . . 74.1 110.632 -179.568 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 142' ' ' MET . . . . . 0.575 ' HE2' HG22 ' A' ' 156' ' ' ILE . 27.6 ptm -59.73 -37.66 79.57 Favored 'General case' 0 N--CA 1.477 0.888 0 C-N-CA 123.055 0.542 . . . . 71.31 110.538 179.144 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 143' ' ' GLU . . . . . 0.565 ' HG2' ' HA ' ' A' ' 58' ' ' PRO . 39.4 tt0 -62.74 -35.76 80.8 Favored 'General case' 0 CA--C 1.546 0.822 0 CA-C-O 121.253 0.549 . . . . 74.02 112.144 -176.966 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 144' ' ' ARG . . . . . 0.546 ' HA ' ' HB3' ' A' ' 58' ' ' PRO . 62.3 mtt180 -73.58 -7.31 51.38 Favored 'General case' 0 CA--C 1.547 0.828 0 CA-C-N 115.769 -0.65 . . . . 73.15 112.711 -178.236 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 145' ' ' PHE . . . . . 0.517 ' HB2' HD11 ' A' ' 156' ' ' ILE . 55.0 m-85 -89.2 6.74 38.74 Favored 'General case' 0 CA--C 1.558 1.251 0 C-N-CA 123.07 0.548 . . . . 74.53 111.933 172.416 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . -102.5 -175.23 27.25 Favored Glycine 0 C--N 1.355 1.608 0 CA-C-N 117.646 0.203 . . . . 31.43 112.708 177.842 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 31.0 m -132.91 168.99 17.44 Favored 'General case' 0 N--CA 1.489 1.496 0 C-N-CA 124.202 1.001 . . . . 74.1 110.3 179.84 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 148' ' ' ARG . . . . . 0.56 ' HA ' HG21 ' A' ' 57' ' ' ILE . 21.9 mmt85 -65.98 -33.97 77.04 Favored 'General case' 0 N--CA 1.487 1.4 0 C-N-CA 123.845 0.858 . . . . 71.44 112.758 -175.143 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 149' ' ' ASN . . . . . . . . . . . . . 30.9 p-10 -74.7 -15.75 60.78 Favored 'General case' 0 N--CA 1.484 1.272 0 C-N-CA 123.411 0.684 . . . . 70.12 111.325 175.148 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 150' ' ' GLY . . . . . 0.4 ' O ' ' HA ' ' A' ' 55' ' ' ARG . . . 109.67 -17.06 30.86 Favored Glycine 0 C--N 1.344 1.004 0 CA-C-N 115.671 -0.695 . . . . 64.34 112.462 -179.962 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 66.2 tttp -60.3 124.01 19.0 Favored 'General case' 0 N--CA 1.474 0.769 0 CA-C-N 117.417 0.609 . . . . 72.51 110.918 -177.955 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 152' ' ' THR . . . . . 0.43 HG21 ' HB ' ' A' ' 56' ' ' ILE . 14.0 p -89.56 118.02 28.89 Favored 'General case' 0 CA--C 1.538 0.482 0 C-N-CA 123.235 0.614 . . . . 72.35 109.567 -177.897 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 153' ' ' SER . . . . . . . . . . . . . 19.8 m -66.89 -19.07 65.66 Favored 'General case' 0 CA--C 1.549 0.921 0 C-N-CA 124.153 0.981 . . . . 74.44 111.724 178.77 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 154' ' ' LYS . . . . . 0.454 ' HB3' HG13 ' A' ' 12' ' ' VAL . 74.6 mmtt -128.58 144.14 51.09 Favored 'General case' 0 N--CA 1.48 1.067 0 C-N-CA 124.478 1.111 . . . . 75.55 108.666 176.498 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 155' ' ' LYS . . . . . 0.483 ' HB2' ' HZ1' ' A' ' 155' ' ' LYS . 0.0 OUTLIER -81.47 90.13 6.2 Favored 'General case' 0 N--CA 1.477 0.882 0 CA-C-O 121.54 0.686 . . . . 74.13 109.743 -177.269 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 156' ' ' ILE . . . . . 0.575 HG22 ' HE2' ' A' ' 142' ' ' MET . 66.3 mt -88.74 118.48 34.22 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.432 0 CA-C-N 115.855 -0.611 . . . . 72.35 109.449 -176.206 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 157' ' ' THR . . . . . . . . . . . . . 30.7 p -131.15 156.09 45.88 Favored 'General case' 0 C--O 1.239 0.534 0 C-N-CA 124.469 1.108 . . . . 74.23 109.382 -174.931 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 158' ' ' ILE . . . . . . . . . . . . . 60.1 mt -77.96 94.15 1.46 Allowed 'Isoleucine or valine' 0 CA--C 1.55 0.946 0 N-CA-C 108.926 -0.768 . . . . 74.41 108.926 172.572 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 159' ' ' ALA . . . . . 0.745 ' HB3' ' HB2' ' A' ' 11' ' ' ALA . . . -51.9 -40.88 61.43 Favored 'General case' 0 N--CA 1.488 1.439 0 C-N-CA 124.551 1.14 . . . . 74.44 113.03 -177.932 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 160' ' ' ASP . . . . . . . . . . . . . 25.3 t0 -164.36 157.74 17.87 Favored 'General case' 0 N--CA 1.478 0.958 0 C-N-CA 122.946 0.498 . . . . 73.12 110.311 178.718 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 161' ' ' CYS . . . . . . . . . . . . . 29.2 p -119.82 -169.97 1.87 Allowed 'General case' 0 N--CA 1.475 0.779 0 C-N-CA 124.774 1.229 . . . . 75.42 108.36 175.398 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 162' ' ' GLY . . . . . . . . . . . . . . . 132.49 55.02 0.08 OUTLIER Glycine 0 C--N 1.347 1.156 0 N-CA-C 111.095 -0.802 . . . . 64.3 111.095 -170.393 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 163' ' ' GLN . . . . . 0.581 ' HA ' ' H ' ' A' ' 7' ' ' PHE . 3.0 pt20 -49.63 137.49 15.54 Favored 'General case' 0 CA--C 1.55 0.961 0 N-CA-C 114.357 1.243 . . . . 63.54 114.357 -169.296 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 164' ' ' LEU . . . . . 0.401 ' O ' ' HB ' ' A' ' 5' ' ' THR . 85.2 mt -89.96 116.67 28.19 Favored 'General case' 0 N--CA 1.472 0.644 0 CA-C-N 115.859 -0.61 . . . . 73.12 110.114 -176.502 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 165' ' ' GLU . . . . . . . . . . . . . 9.3 pt-20 . . . . . 0 C--O 1.256 1.415 0 C-N-CA 123.458 0.703 . . . . 71.31 110.322 -179.019 . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' B' B ' 216' ' ' PRO . . . . . . . . . . . . . 1.2 Cg_endo . . . . . 0 N--CA 1.486 1.061 0 N-CA-C 110.601 -0.577 . . . . 65.41 110.601 . . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' B' B ' 217' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -89.71 151.44 45.7 Favored Pre-proline 0 N--CA 1.481 1.11 0 C-N-CA 123.069 0.548 . . . . 75.41 110.034 -179.602 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 218' ' ' PRO . . . . . 0.638 ' HB2' HE22 ' A' ' 111' ' ' GLN . 50.2 Cg_exo -56.18 113.78 1.6 Allowed 'Trans proline' 0 C--N 1.385 2.492 0 C-N-CA 123.09 2.527 . . . . 61.52 112.484 178.9 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 219' ' ' GLY . . . . . . . . . . . . . . . 169.37 -176.47 43.36 Favored Glycine 0 CA--C 1.524 0.607 0 N-CA-C 110.164 -1.174 . . . . 51.33 110.164 -178.489 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 220' ' ' PRO . . . . . . . . . . . . . 82.4 Cg_endo -79.56 -177.59 3.97 Favored 'Trans proline' 0 CA--C 1.553 1.425 0 C-N-CA 122.519 2.146 . . . . 75.25 113.88 175.211 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 221' ' ' TYR . . . . . 0.508 ' HE2' ' HD2' ' A' ' 125' ' ' LYS . 64.4 m-85 -82.12 123.54 29.06 Favored 'General case' 0 N--CA 1.476 0.872 0 C-N-CA 123.852 0.861 . . . . 74.25 110.237 -178.051 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 222' ' ' ALA . . . . . 0.446 ' HA ' ' CE2' ' A' ' 60' ' ' PHE . . . -90.24 166.44 13.35 Favored 'General case' 0 N--CA 1.476 0.834 0 N-CA-C 113.255 0.835 . . . . 60.11 113.255 -175.131 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 223' ' ' GLN . . . . . 0.423 HE21 HG22 ' A' ' 57' ' ' ILE . 28.4 pt20 -75.18 140.39 73.13 Favored Pre-proline 0 CA--C 1.556 1.176 0 CA-C-N 115.408 -0.815 . . . . 73.54 108.904 171.204 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 224' ' ' PRO . . . . . . . . . . . . . 56.2 Cg_endo . . . . . 0 CA--C 1.564 2.012 0 C-N-CA 122.72 2.28 . . . . 62.53 111.827 174.851 . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 1' ' ' MET . . . . . 0.403 ' SD ' ' HB2' ' A' ' 3' ' ' ASN . 23.7 ptp . . . . . 0 N--CA 1.484 1.236 0 CA-C-O 120.404 0.145 . . . . 75.24 110.693 . . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 5.9 p -83.88 -19.13 9.62 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.99 0 C-N-CA 122.996 0.518 . . . . 74.35 110.575 179.604 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 3' ' ' ASN . . . . . 0.624 ' ND2' ' HA ' ' A' ' 25' ' ' PHE . 9.7 m120 -56.21 115.69 10.54 Favored Pre-proline 0 N--CA 1.478 0.954 0 C-N-CA 124.524 1.13 . . . . 75.1 110.838 175.79 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 4' ' ' PRO . . . . . 0.635 ' HG2' ' HB2' ' A' ' 24' ' ' LEU . 67.2 Cg_endo -72.66 136.74 26.24 Favored 'Trans proline' 0 C--N 1.374 1.872 0 C-N-CA 122.144 1.896 . . . . 74.22 111.653 176.37 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 5' ' ' THR . . . . . 0.586 HG23 ' HD3' ' A' ' 133' ' ' LYS . 85.5 m -95.99 113.56 25.19 Favored 'General case' 0 C--O 1.236 0.368 0 N-CA-C 107.893 -1.151 . . . . 73.13 107.893 176.002 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . 0.546 ' HA ' ' HB2' ' A' ' 163' ' ' GLN . 13.7 m -98.62 121.1 48.8 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.51 0 CA-C-O 121.956 0.884 . . . . 75.23 109.328 -178.22 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 7' ' ' PHE . . . . . 0.432 ' HZ ' ' HD2' ' A' ' 19' ' ' ARG . 77.3 t80 -105.08 135.09 47.08 Favored 'General case' 0 C--O 1.239 0.52 0 CA-C-N 114.423 -1.262 . . . . 73.32 109.237 -173.328 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 8' ' ' PHE . . . . . 0.46 ' HB3' HG22 ' A' ' 158' ' ' ILE . 64.4 m-85 -142.27 165.25 27.94 Favored 'General case' 0 C--O 1.24 0.578 0 O-C-N 124.398 1.061 . . . . 73.21 109.757 176.11 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 17.4 m-20 -113.91 108.51 17.15 Favored 'General case' 0 N--CA 1.465 0.314 0 N-CA-C 107.625 -1.25 . . . . 71.11 107.625 171.637 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 10' ' ' ILE . . . . . 0.432 HG21 ' SD ' ' A' ' 142' ' ' MET . 47.3 mm -80.7 116.82 25.61 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.351 0 N-CA-C 108.313 -0.995 . . . . 63.41 108.313 -179.545 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 11' ' ' ALA . . . . . 0.698 ' HB1' ' HB2' ' A' ' 159' ' ' ALA . . . -116.04 109.92 18.2 Favored 'General case' 0 N--CA 1.469 0.493 0 C-N-CA 123.684 0.794 . . . . 74.05 111.941 -168.586 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . 0.473 HG22 HD23 ' A' ' 17' ' ' LEU . 89.6 t -96.04 128.91 46.81 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.467 0 N-CA-C 108.057 -1.09 . . . . 75.01 108.057 176.684 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 25.0 m-20 70.24 15.94 7.4 Favored 'General case' 0 N--CA 1.493 1.688 0 C-N-CA 124.218 1.007 . . . . 74.55 110.484 -172.325 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 81.29 -5.89 65.92 Favored Glycine 0 C--N 1.353 1.507 0 CA-C-N 116.005 -0.543 . . . . 65.42 112.754 -170.505 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 25.7 mm-40 -98.32 120.81 58.68 Favored Pre-proline 0 N--CA 1.471 0.599 0 C-N-CA 123.823 0.849 . . . . 75.12 109.437 -178.213 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 52.3 Cg_exo -51.21 105.19 0.1 OUTLIER 'Trans proline' 0 C--N 1.375 1.963 0 C-N-CA 123.257 2.638 . . . . 60.42 112.344 178.536 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . 0.473 HD23 HG22 ' A' ' 12' ' ' VAL . 26.9 tp -75.08 -31.69 61.27 Favored 'General case' 0 N--CA 1.472 0.67 0 C-N-CA 124.126 0.97 . . . . 73.13 109.573 -179.892 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -175.66 173.15 46.07 Favored Glycine 0 C--N 1.341 0.814 0 CA-C-N 115.071 -0.968 . . . . 64.52 112.054 175.925 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 19' ' ' ARG . . . . . 0.432 ' HD2' ' HZ ' ' A' ' 7' ' ' PHE . 47.6 mtm180 -107.2 124.39 49.66 Favored 'General case' 0 N--CA 1.471 0.595 0 N-CA-C 108.541 -0.911 . . . . 74.21 108.541 -179.095 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 71.3 t -120.74 141.45 41.11 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.881 0 C-N-CA 123.1 0.56 . . . . 72.22 109.9 -176.945 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 21' ' ' SER . . . . . 0.547 ' HB2' ' HB2' ' A' ' 134' ' ' GLU . 60.6 m -127.39 132.14 50.2 Favored 'General case' 0 C--O 1.245 0.828 0 C-N-CA 123.878 0.871 . . . . 64.53 109.39 173.533 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 17.3 m-85 -107.42 153.67 22.45 Favored 'General case' 0 N--CA 1.469 0.513 0 N-CA-C 108.338 -0.986 . . . . 72.23 108.338 177.729 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 5.8 tp10 -104.75 109.64 21.67 Favored 'General case' 0 C--O 1.239 0.543 0 N-CA-C 108.598 -0.889 . . . . 73.45 108.598 176.954 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . 0.635 ' HB2' ' HG2' ' A' ' 4' ' ' PRO . 29.6 mt -81.11 122.77 27.77 Favored 'General case' 0 N--CA 1.465 0.285 0 N-CA-C 108.784 -0.821 . . . . 70.0 108.784 175.309 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 25' ' ' PHE . . . . . 0.624 ' HA ' ' ND2' ' A' ' 3' ' ' ASN . 86.9 m-85 -84.91 65.46 9.2 Favored 'General case' 0 N--CA 1.467 0.377 0 C-N-CA 123.166 0.586 . . . . 75.21 110.468 179.888 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -64.17 -24.16 67.58 Favored 'General case' 0 N--CA 1.477 0.877 0 C-N-CA 123.418 0.687 . . . . 65.15 111.876 -179.799 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 10.9 p-10 -66.09 -25.73 67.15 Favored 'General case' 0 N--CA 1.476 0.853 0 C-N-CA 123.535 0.734 . . . . 74.44 111.33 177.467 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 52.4 mttm -102.32 -43.93 5.55 Favored 'General case' 0 N--CA 1.478 0.962 0 C-N-CA 124.163 0.985 . . . . 73.13 110.238 -179.433 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 29' ' ' VAL . . . . . 0.45 HG21 ' HA ' ' A' ' 129' ' ' PHE . 16.0 m -127.31 78.85 74.03 Favored Pre-proline 0 CA--C 1.556 1.194 0 C-N-CA 124.128 0.971 . . . . 63.42 109.942 -177.11 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 11.3 Cg_endo -55.21 -48.02 23.09 Favored 'Trans proline' 0 C--N 1.383 2.373 0 C-N-CA 123.038 2.492 . . . . 74.44 112.89 -177.792 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 31' ' ' LYS . . . . . 0.44 ' HG3' ' OH ' ' A' ' 79' ' ' TYR . 23.4 ttmm -76.86 -43.48 35.96 Favored 'General case' 0 N--CA 1.474 0.771 0 C-N-CA 123.967 0.907 . . . . 74.35 112.344 -172.631 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 9.1 m -69.14 -33.36 73.33 Favored 'General case' 0 CA--C 1.549 0.94 0 CA-C-O 120.867 0.365 . . . . 75.14 110.273 -176.062 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 33' ' ' ALA . . . . . 0.402 ' HB3' ' HB3' ' A' ' 24' ' ' LEU . . . -78.43 -34.52 47.81 Favored 'General case' 0 CA--C 1.55 0.976 0 CA-C-N 116.112 -0.494 . . . . 75.44 111.533 174.03 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 29.7 tt0 -60.32 -41.58 93.8 Favored 'General case' 0 N--CA 1.49 1.555 0 C-N-CA 124.421 1.088 . . . . 64.41 111.077 178.536 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 35' ' ' ASN . . . . . 0.467 ' O ' ' HG ' ' A' ' 39' ' ' LEU . 40.9 t30 -54.15 -60.16 3.7 Favored 'General case' 0 CA--C 1.537 0.448 0 CA-C-N 114.297 -1.32 . . . . 75.32 110.191 178.635 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 63.1 t80 -65.48 -32.51 74.16 Favored 'General case' 0 CA--C 1.545 0.76 0 CA-C-N 115.225 -0.898 . . . . 71.52 111.613 -176.695 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 37.0 ttm-85 -57.02 -50.98 71.06 Favored 'General case' 0 N--CA 1.482 1.139 0 C-N-CA 124.028 0.931 . . . . 75.4 110.346 177.195 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 38' ' ' ALA . . . . . 0.541 ' HB2' HG22 ' A' ' 78' ' ' ILE . . . -79.26 -23.33 43.73 Favored 'General case' 0 CA--C 1.545 0.766 0 CA-C-N 115.029 -0.987 . . . . 73.34 112.22 -175.24 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 39' ' ' LEU . . . . . 0.467 ' HG ' ' O ' ' A' ' 35' ' ' ASN . 85.7 mt -71.78 -40.19 69.42 Favored 'General case' 0 N--CA 1.483 1.221 0 C-N-CA 123.004 0.522 . . . . 73.22 110.158 172.899 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 28.8 t -65.48 -55.05 20.03 Favored 'General case' 0 N--CA 1.475 0.805 0 C-N-CA 124.513 1.125 . . . . 61.2 110.682 -179.368 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 20.8 p -67.73 -32.07 72.43 Favored 'General case' 0 N--CA 1.477 0.894 0 CA-C-N 116.08 -0.509 . . . . 73.54 111.411 177.284 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 71.21 28.18 70.52 Favored Glycine 0 C--N 1.343 0.972 0 CA-C-N 115.686 -0.688 . . . . 53.32 112.838 -176.662 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 19.4 mm-40 -62.85 -31.07 72.01 Favored 'General case' 0 N--CA 1.479 0.992 0 C-N-CA 123.268 0.627 . . . . 75.33 111.461 177.62 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 75.7 mmtt -83.98 9.44 12.33 Favored 'General case' 0 CA--C 1.556 1.197 0 CA-C-N 115.706 -0.679 . . . . 74.42 111.592 178.062 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 76.1 32.51 52.39 Favored Glycine 0 C--N 1.352 1.455 0 C-N-CA 123.146 0.403 . . . . 64.31 113.706 175.711 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 17.9 m-85 -110.28 -47.23 3.32 Favored 'General case' 0 N--CA 1.483 1.182 0 N-CA-C 109.654 -0.498 . . . . 75.33 109.654 179.453 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 56.66 65.58 3.47 Favored Glycine 0 C--N 1.354 1.548 0 O-C-N 124.107 0.879 . . . . 64.03 114.21 168.627 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 48' ' ' TYR . . . . . 0.463 ' HE1' HD22 ' A' ' 39' ' ' LEU . 51.3 m-85 -65.25 87.33 0.07 Allowed 'General case' 0 N--CA 1.476 0.848 0 CA-C-O 122.644 1.212 . . . . 74.1 111.237 -179.378 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 49' ' ' LYS . . . . . 0.595 ' HZ1' ' HA ' ' A' ' 160' ' ' ASP . 50.6 tptt -111.13 134.83 52.42 Favored 'General case' 0 C--O 1.244 0.812 0 CA-C-N 112.698 -2.046 . . . . 73.35 107.655 -179.486 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 65.22 21.86 68.6 Favored Glycine 0 N--CA 1.468 0.823 0 CA-C-O 119.57 -0.572 . . . . 75.21 113.032 -179.321 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 28.1 t -57.98 114.24 2.25 Favored 'General case' 0 C--N 1.362 1.11 0 C-N-CA 123.688 0.795 . . . . 64.24 109.946 -176.379 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 52' ' ' CYS . . . . . . . . . . . . . 45.2 t -83.31 137.37 34.0 Favored 'General case' 0 C--O 1.241 0.619 0 CA-C-N 115.437 -0.802 . . . . 61.01 111.757 -166.872 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 53' ' ' PHE . . . . . 0.729 ' HA ' ' HA2' ' A' ' 64' ' ' GLY . 38.6 m-85 -87.2 115.65 24.75 Favored 'General case' 0 C--O 1.238 0.474 0 N-CA-C 107.886 -1.153 . . . . 75.25 107.886 169.647 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 47.3 p-80 -99.5 -29.71 12.58 Favored 'General case' 0 N--CA 1.48 1.072 0 C-N-CA 123.278 0.631 . . . . 74.1 111.153 -175.748 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 55' ' ' ARG . . . . . 0.518 ' HA ' ' O ' ' A' ' 150' ' ' GLY . 59.5 ttt180 -132.92 98.96 4.44 Favored 'General case' 0 C--O 1.218 -0.588 0 CA-C-N 115.78 -0.646 . . . . 75.22 109.412 -168.805 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 56' ' ' ILE . . . . . 0.448 HD12 HD11 ' A' ' 156' ' ' ILE . 47.5 mt -123.67 124.36 69.23 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.813 0 N-CA-C 109.162 -0.681 . . . . 73.14 109.162 178.564 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 57' ' ' ILE . . . . . 0.428 HD12 ' HB1' ' B' ' 222' ' ' ALA . 45.4 mt -126.61 112.16 22.83 Favored Pre-proline 0 CA--C 1.561 1.372 0 C-N-CA 124.87 1.268 . . . . 74.34 109.242 -170.985 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 71.0 Cg_exo -54.32 145.11 57.57 Favored 'Trans proline' 0 C--N 1.374 1.879 0 C-N-CA 123.924 3.083 . . . . 74.44 115.024 176.848 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 64.72 21.06 66.89 Favored Glycine 0 C--N 1.351 1.414 0 CA-C-N 114.643 -1.162 . . . . 54.25 113.71 -179.772 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 60' ' ' PHE . . . . . 0.413 ' HE1' ' HE1' ' A' ' 121' ' ' TRP . 33.1 t80 -144.42 -76.61 0.22 Allowed 'General case' 0 C--O 1.242 0.667 0 C-N-CA 123.099 0.559 . . . . 73.35 110.639 -171.09 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 61' ' ' MET . . . . . 0.652 ' SD ' ' HB2' ' A' ' 113' ' ' PHE . 12.3 tmm? -174.89 144.85 0.81 Allowed 'General case' 0 CA--C 1.543 0.711 0 O-C-N 123.457 0.473 . . . . 74.14 111.341 -162.187 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 62' ' ' CYS . . . . . 0.637 ' SG ' ' HE1' ' A' ' 142' ' ' MET . 8.1 p -113.78 112.66 23.78 Favored 'General case' 0 CA--C 1.552 1.054 0 C-N-CA 124.25 1.02 . . . . 65.11 109.653 172.827 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 63' ' ' GLN . . . . . 0.621 ' HB2' ' SD ' ' A' ' 61' ' ' MET . 49.6 tt0 -103.05 114.49 28.83 Favored 'General case' 0 N--CA 1.485 1.32 0 C-N-CA 124.248 1.019 . . . . 75.02 111.129 -171.145 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 64' ' ' GLY . . . . . 0.729 ' HA2' ' HA ' ' A' ' 53' ' ' PHE . . . -98.95 -169.62 30.93 Favored Glycine 0 C--O 1.244 0.72 0 CA-C-N 114.863 -1.062 . . . . 71.52 112.111 175.597 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 72.92 87.14 0.19 Allowed Glycine 0 C--N 1.337 0.632 0 N-CA-C 111.062 -0.815 . . . . 64.21 111.062 -178.178 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 38.8 t70 -128.04 -38.46 1.82 Allowed 'General case' 0 N--CA 1.469 0.525 0 C-N-CA 122.825 0.45 . . . . 74.23 111.474 -179.518 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 77.0 t80 -70.83 -68.56 0.42 Allowed 'General case' 0 CA--C 1.552 1.043 0 N-CA-C 113.505 0.928 . . . . 74.14 113.505 -164.812 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 48.9 m -60.04 109.37 0.94 Allowed 'General case' 0 N--CA 1.482 1.141 0 C-N-CA 123.62 0.768 . . . . 74.15 112.038 -168.797 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 69' ' ' ARG . . . . . 0.536 ' HD3' ' HD3' ' A' ' 76' ' ' LYS . 73.3 mtp180 57.93 69.18 0.76 Allowed 'General case' 0 C--N 1.352 0.686 0 C-N-CA 124.763 1.225 . . . . 74.44 110.637 -170.856 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 24.5 p-80 -79.89 66.71 5.45 Favored 'General case' 0 N--CA 1.476 0.854 0 CA-C-O 122.128 0.966 . . . . 72.03 111.939 -176.921 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 15.5 m120 -119.68 20.74 12.26 Favored 'General case' 0 N--CA 1.476 0.832 0 C-N-CA 124.51 1.124 . . . . 74.43 108.628 173.898 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 100.67 -8.1 58.05 Favored Glycine 0 C--N 1.349 1.26 0 CA-C-N 115.302 -0.863 . . . . 74.4 112.519 -170.747 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 10.2 m -81.59 -61.8 1.83 Allowed 'General case' 0 N--CA 1.475 0.78 0 CA-C-N 117.589 0.694 . . . . 73.53 109.286 179.376 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 48.37 47.61 28.18 Favored Glycine 0 C--N 1.351 1.368 0 O-C-N 124.146 0.904 . . . . 50.42 115.309 170.236 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 138.11 51.37 0.06 OUTLIER Glycine 0 N--CA 1.474 1.218 0 CA-C-N 118.532 1.166 . . . . 53.52 113.382 -178.388 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 76' ' ' LYS . . . . . 0.536 ' HD3' ' HD3' ' A' ' 69' ' ' ARG . 22.8 pttp -61.35 160.26 11.07 Favored 'General case' 0 CA--C 1.556 1.177 0 C-N-CA 123.71 0.804 . . . . 74.3 111.95 179.85 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 87.1 p -91.3 164.5 13.84 Favored 'General case' 0 N--CA 1.483 1.206 0 C-N-CA 123.693 0.797 . . . . 75.12 111.685 -171.266 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 78' ' ' ILE . . . . . 0.541 HG22 ' HB2' ' A' ' 38' ' ' ALA . 45.6 pt -65.18 -15.89 19.16 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.397 0 N-CA-C 112.396 0.517 . . . . 74.11 112.396 179.89 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 79' ' ' TYR . . . . . 0.44 ' OH ' ' HG3' ' A' ' 31' ' ' LYS . 32.3 m-85 -89.79 -32.4 16.96 Favored 'General case' 0 N--CA 1.472 0.629 0 C-N-CA 123.647 0.779 . . . . 73.02 110.833 179.216 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 171.79 -137.53 4.36 Favored Glycine 0 C--N 1.339 0.726 0 CA-C-N 116.046 -0.524 . . . . 64.31 112.141 179.43 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 35.3 tt0 -65.31 -40.39 93.7 Favored 'General case' 0 CA--C 1.544 0.715 0 C-N-CA 123.375 0.67 . . . . 73.22 110.617 176.249 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 82' ' ' LYS . . . . . 0.656 ' HD2' ' HA ' ' A' ' 107' ' ' THR . 23.3 pttm -170.97 178.68 3.34 Favored 'General case' 0 CA--C 1.549 0.932 0 C-N-CA 124.129 0.971 . . . . 75.25 110.125 -173.79 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 18.9 p90 -154.11 173.18 16.4 Favored 'General case' 0 N--CA 1.477 0.907 0 C-N-CA 124.682 1.193 . . . . 73.5 110.067 -177.026 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 84' ' ' GLU . . . . . 0.546 ' HA ' ' HA ' ' A' ' 106' ' ' ASN . 14.2 pt-20 -90.79 154.23 19.67 Favored 'General case' 0 C--O 1.24 0.575 0 CA-C-O 121.023 0.439 . . . . 74.34 110.875 -179.9 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 35.2 m-20 -64.83 130.61 44.1 Favored 'General case' 0 CA--C 1.536 0.436 0 CA-C-N 114.799 -1.091 . . . . 75.42 111.446 -175.185 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 28.3 tt0 -72.54 -60.83 2.04 Favored 'General case' 0 CA--C 1.54 0.592 0 C-N-CA 123.302 0.641 . . . . 64.03 111.972 -173.276 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 31.0 p30 -164.74 158.28 17.48 Favored 'General case' 0 N--CA 1.475 0.809 0 C-N-CA 122.679 0.392 . . . . 63.43 111.124 -179.069 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 93.1 m-85 -103.35 38.32 1.8 Allowed 'General case' 0 N--CA 1.479 0.975 0 C-N-CA 123.765 0.826 . . . . 73.51 111.217 -172.413 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 64.9 mt -66.02 -52.41 49.05 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.075 0 C-N-CA 123.039 0.535 . . . . 74.45 110.42 177.317 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 90' ' ' LEU . . . . . 0.517 HD12 ' HB2' ' A' ' 25' ' ' PHE . 62.0 mt -83.17 139.82 32.94 Favored 'General case' 0 N--CA 1.473 0.691 0 CA-C-N 115.894 -0.594 . . . . 64.32 111.846 -177.009 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 91' ' ' LYS . . . . . 0.58 ' HB3' ' HZ2' ' A' ' 91' ' ' LYS . 9.2 mtpm? -124.27 167.6 14.1 Favored 'General case' 0 N--CA 1.471 0.59 0 C-N-CA 124.377 1.071 . . . . 75.52 109.604 177.751 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 92' ' ' HIS . . . . . . . . . . . . . 24.9 m-70 -86.52 62.16 7.25 Favored 'General case' 0 CA--C 1.544 0.736 0 C-N-CA 124.173 0.989 . . . . 71.01 108.861 176.3 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 93' ' ' THR . . . . . 0.41 HG21 ' HB2' ' A' ' 91' ' ' LYS . 21.9 p -83.92 -33.97 24.61 Favored 'General case' 0 N--CA 1.473 0.709 0 CA-C-N 115.132 -0.94 . . . . 75.43 111.563 -175.112 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -121.11 -177.42 15.63 Favored Glycine 0 C--N 1.342 0.888 0 CA-C-N 116.07 -0.514 . . . . 65.42 112.876 -177.201 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 95' ' ' PRO . . . . . 0.527 ' HB2' ' HE1' ' A' ' 136' ' ' MET . 79.2 Cg_endo -85.26 158.1 11.15 Favored 'Trans proline' 0 CA--C 1.553 1.449 0 C-N-CA 123.281 2.654 . . . . 64.0 112.099 173.024 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 83.07 17.67 66.72 Favored Glycine 0 N--CA 1.47 0.911 0 CA-C-N 116.054 -0.521 . . . . 74.43 114.126 179.043 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 97' ' ' ILE . . . . . 0.588 ' HB ' ' HB2' ' A' ' 115' ' ' CYS . 31.6 mm -66.47 102.99 0.51 Allowed 'Isoleucine or valine' 0 CA--C 1.549 0.934 0 C-N-CA 123.64 0.776 . . . . 73.01 111.774 -174.6 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 98' ' ' LEU . . . . . 0.453 HD12 HG12 ' A' ' 114' ' ' ILE . 58.1 tp -85.74 105.73 16.48 Favored 'General case' 0 CA--C 1.551 0.991 0 C-N-CA 123.44 0.696 . . . . 74.54 109.68 177.598 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 47.8 t -126.66 135.39 51.11 Favored 'General case' 0 N--CA 1.468 0.467 0 C-N-CA 124.69 1.196 . . . . 74.14 108.78 178.308 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 100' ' ' MET . . . . . 0.492 ' SD ' ' HA2' ' A' ' 109' ' ' GLY . 14.3 ttt -78.8 135.77 37.17 Favored 'General case' 0 N--CA 1.474 0.761 0 N-CA-C 108.343 -0.984 . . . . 72.24 108.343 -179.357 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -74.5 158.16 34.27 Favored 'General case' 0 CA--C 1.545 0.783 0 N-CA-C 112.916 0.71 . . . . 64.01 112.916 -167.462 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 22.2 p-10 -158.09 169.07 25.36 Favored 'General case' 0 N--CA 1.476 0.868 0 CA-C-N 115.542 -0.754 . . . . 75.32 110.759 -179.692 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 103' ' ' ALA . . . . . 0.438 ' HB1' HG21 ' A' ' 107' ' ' THR . . . -113.96 -1.14 13.88 Favored 'General case' 0 N--CA 1.476 0.839 0 CA-C-N 115.492 -0.777 . . . . 74.43 110.758 171.721 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 160.22 -165.59 34.89 Favored Glycine 0 C--N 1.354 1.536 0 CA-C-O 119.668 -0.518 . . . . 71.24 113.056 178.891 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 26.6 Cg_exo -64.03 134.74 44.29 Favored 'Trans proline' 0 C--N 1.376 1.997 0 C-N-CA 123.529 2.819 . . . . 71.44 112.266 178.355 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 106' ' ' ASN . . . . . 0.546 ' HA ' ' HA ' ' A' ' 84' ' ' GLU . 65.0 t30 66.82 14.24 9.73 Favored 'General case' 0 N--CA 1.485 1.32 0 C-N-CA 124.534 1.134 . . . . 65.44 111.212 -179.102 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 107' ' ' THR . . . . . 0.656 ' HA ' ' HD2' ' A' ' 82' ' ' LYS . 2.3 m -115.11 7.26 15.36 Favored 'General case' 0 CA--C 1.549 0.923 0 C-N-CA 124.208 1.003 . . . . 73.2 109.918 -178.874 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 55.1 t30 -88.67 139.51 30.4 Favored 'General case' 0 N--CA 1.476 0.865 0 C-N-CA 123.248 0.619 . . . . 73.23 110.097 -177.397 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 109' ' ' GLY . . . . . 0.492 ' HA2' ' SD ' ' A' ' 100' ' ' MET . . . 113.07 25.35 4.49 Favored Glycine 0 N--CA 1.464 0.534 0 CA-C-O 120.204 -0.22 . . . . 64.44 112.772 -175.553 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 5.1 m -132.72 126.2 31.96 Favored 'General case' 0 CA--C 1.541 0.623 0 N-CA-C 108.013 -1.106 . . . . 65.24 108.013 170.206 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 10.5 mt-30 64.52 175.81 0.19 Allowed 'General case' 0 N--CA 1.504 2.23 0 C-N-CA 125.25 1.42 . . . . 65.22 110.82 -174.615 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 54.9 p90 -148.41 159.21 44.25 Favored 'General case' 0 N--CA 1.486 1.366 0 O-C-N 121.603 -0.686 . . . . 72.21 109.865 174.681 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 113' ' ' PHE . . . . . 0.652 ' HB2' ' SD ' ' A' ' 61' ' ' MET . 55.1 p90 -146.26 147.07 31.03 Favored 'General case' 0 N--CA 1.469 0.502 0 CA-C-O 121.109 0.481 . . . . 72.22 111.452 177.625 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 114' ' ' ILE . . . . . 0.512 ' HB ' ' SG ' ' A' ' 62' ' ' CYS . 13.9 mt -117.5 102.67 13.75 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.536 0 N-CA-C 108.071 -1.085 . . . . 73.55 108.071 -179.044 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 115' ' ' CYS . . . . . 0.588 ' HB2' ' HB ' ' A' ' 97' ' ' ILE . 33.7 m -68.16 105.23 2.02 Favored 'General case' 0 CA--C 1.539 0.544 0 C-N-CA 123.305 0.642 . . . . 64.33 109.601 -179.632 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 116' ' ' THR . . . . . 0.469 HG23 HG12 ' A' ' 139' ' ' VAL . 41.3 p -70.32 -30.4 67.37 Favored 'General case' 0 N--CA 1.475 0.797 0 C-N-CA 124.009 0.924 . . . . 62.22 110.822 -175.876 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -112.32 159.64 18.46 Favored 'General case' 0 C--O 1.243 0.725 0 N-CA-C 108.115 -1.069 . . . . 71.43 108.115 169.231 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -68.73 98.84 0.94 Allowed 'General case' 0 CA--C 1.542 0.661 0 CA-C-O 121.383 0.611 . . . . 73.22 109.491 176.669 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 119' ' ' THR . . . . . . . . . . . . . 33.9 p -81.66 85.35 6.58 Favored 'General case' 0 C--O 1.239 0.502 0 CA-C-O 121.778 0.799 . . . . 75.54 109.471 -179.183 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 12.1 pt-20 -72.25 -22.51 61.22 Favored 'General case' 0 N--CA 1.473 0.68 0 CA-C-N 114.805 -1.089 . . . . 74.5 112.001 -170.862 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 121' ' ' TRP . . . . . 0.413 ' HE1' ' HE1' ' A' ' 60' ' ' PHE . 26.8 p90 -69.79 -10.28 57.8 Favored 'General case' 0 N--CA 1.477 0.91 0 C-N-CA 123.261 0.624 . . . . 74.41 111.863 175.572 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 122' ' ' LEU . . . . . 0.535 ' HA ' ' HE2' ' A' ' 125' ' ' LYS . 79.3 mt -94.71 7.6 45.27 Favored 'General case' 0 N--CA 1.475 0.825 0 C-N-CA 122.952 0.501 . . . . 75.51 111.716 176.375 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 74.3 m-20 -80.59 148.38 30.33 Favored 'General case' 0 N--CA 1.478 0.945 0 N-CA-C 109.757 -0.46 . . . . 73.4 109.757 172.247 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 77.29 22.38 70.82 Favored Glycine 0 C--N 1.344 1.01 0 N-CA-C 111.992 -0.443 . . . . 52.22 111.992 -170.02 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 125' ' ' LYS . . . . . 0.535 ' HE2' ' HA ' ' A' ' 122' ' ' LEU . 27.1 mtmm -142.4 -167.47 2.5 Favored 'General case' 0 CA--C 1.545 0.759 0 C-N-CA 124.647 1.179 . . . . 72.55 110.356 -175.091 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 126' ' ' HIS . . . . . . . . . . . . . 2.3 p80 -64.72 157.67 26.81 Favored 'General case' 0 N--CA 1.475 0.785 0 C-N-CA 124.502 1.121 . . . . 71.31 113.955 -160.425 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 46.7 t -63.85 127.42 24.32 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.719 0 CA-C-N 113.337 -1.756 . . . . 72.03 113.627 -164.142 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 86.9 t -84.26 146.66 6.46 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.481 0 N-CA-C 108.034 -1.099 . . . . 74.53 108.034 164.196 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 129' ' ' PHE . . . . . 0.45 ' HA ' HG21 ' A' ' 29' ' ' VAL . 50.6 p90 -134.85 -6.38 2.42 Favored 'General case' 0 N--CA 1.478 0.965 0 CA-C-N 118.287 0.494 . . . . 74.25 111.721 -179.375 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . -150.02 168.44 30.07 Favored Glycine 0 C--N 1.342 0.869 0 C-N-CA 121.479 -0.391 . . . . 64.3 113.276 -175.402 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 32.2 ttpt -156.0 139.42 15.81 Favored 'General case' 0 N--CA 1.467 0.385 0 N-CA-C 107.861 -1.162 . . . . 75.02 107.861 175.04 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 132' ' ' VAL . . . . . 0.457 HG13 ' HA ' ' A' ' 136' ' ' MET . 21.8 t -64.0 114.48 2.11 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.717 0 CA-C-N 118.303 0.501 . . . . 74.21 109.871 179.733 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 133' ' ' LYS . . . . . 0.586 ' HD3' HG23 ' A' ' 5' ' ' THR . 21.6 ptmt -92.79 -30.62 15.39 Favored 'General case' 0 N--CA 1.478 0.944 0 C-N-CA 122.737 0.415 . . . . 70.23 109.884 178.861 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 134' ' ' GLU . . . . . 0.547 ' HB2' ' HB2' ' A' ' 21' ' ' SER . 41.4 mt-10 -142.49 135.8 28.74 Favored 'General case' 0 N--CA 1.473 0.725 0 C-N-CA 124.313 1.045 . . . . 71.54 109.657 -173.121 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 77.84 32.92 43.54 Favored Glycine 0 CA--C 1.531 1.076 0 O-C-N 123.327 0.392 . . . . 70.35 113.406 178.505 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 136' ' ' MET . . . . . 0.527 ' HE1' ' HB2' ' A' ' 95' ' ' PRO . 14.2 tpt -65.08 -35.31 80.75 Favored 'General case' 0 N--CA 1.482 1.148 0 C-N-CA 123.133 0.573 . . . . 63.32 111.643 -179.553 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 137' ' ' ASN . . . . . . . . . . . . . 18.2 m120 -67.1 -23.72 65.86 Favored 'General case' 0 N--CA 1.481 1.087 0 C-N-CA 123.294 0.638 . . . . 72.12 111.543 179.968 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 138' ' ' ILE . . . . . . . . . . . . . 36.7 mm -75.67 -37.96 37.09 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.063 0 C-N-CA 123.252 0.621 . . . . 72.41 109.61 175.913 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 139' ' ' VAL . . . . . 0.469 HG12 HG23 ' A' ' 116' ' ' THR . 95.9 t -63.5 -39.73 86.43 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.022 0 C-N-CA 123.592 0.757 . . . . 74.44 110.205 173.494 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 47.2 mt-10 -76.4 -20.68 56.88 Favored 'General case' 0 N--CA 1.474 0.774 0 CA-C-N 115.374 -0.83 . . . . 72.54 111.674 177.973 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -74.92 -50.66 16.07 Favored 'General case' 0 N--CA 1.471 0.594 0 C-N-CA 122.642 0.377 . . . . 55.34 110.387 173.939 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 142' ' ' MET . . . . . 0.637 ' HE1' ' SG ' ' A' ' 62' ' ' CYS . 18.3 ptt? -66.59 -28.15 68.28 Favored 'General case' 0 N--CA 1.483 1.182 0 C-N-CA 122.923 0.489 . . . . 75.31 111.63 -179.221 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 24.5 tt0 -47.46 -47.36 27.19 Favored 'General case' 0 N--CA 1.482 1.173 0 C-N-CA 125.28 1.432 . . . . 70.25 111.224 170.484 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 144' ' ' ARG . . . . . . . . . . . . . 88.6 mtt180 -85.78 -6.82 59.06 Favored 'General case' 0 CA--C 1.541 0.607 0 CA-C-N 114.123 -1.399 . . . . 74.32 111.678 -173.075 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 145' ' ' PHE . . . . . 0.513 ' HD2' ' HA ' ' A' ' 142' ' ' MET . 49.6 m-85 -89.48 2.5 54.47 Favored 'General case' 0 N--CA 1.479 1.005 0 C-N-CA 122.871 0.468 . . . . 74.31 110.448 168.149 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . -96.58 -170.55 34.42 Favored Glycine 0 C--N 1.349 1.267 0 CA-C-N 115.877 -0.602 . . . . 75.34 111.992 168.364 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 44.2 t -134.68 155.12 51.08 Favored 'General case' 0 N--CA 1.473 0.702 0 C-N-CA 124.191 0.996 . . . . 71.22 109.681 -177.833 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 148' ' ' ARG . . . . . . . . . . . . . 20.2 mmm-85 -62.24 -31.86 72.47 Favored 'General case' 0 N--CA 1.478 0.969 0 C-N-CA 123.916 0.886 . . . . 71.3 112.484 -173.055 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 149' ' ' ASN . . . . . . . . . . . . . 25.6 p-10 -76.97 -19.5 57.25 Favored 'General case' 0 N--CA 1.484 1.247 0 C-N-CA 123.021 0.528 . . . . 74.04 111.764 -179.464 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 150' ' ' GLY . . . . . 0.518 ' O ' ' HA ' ' A' ' 55' ' ' ARG . . . 119.64 -6.05 12.68 Favored Glycine 0 C--N 1.349 1.253 0 CA-C-O 119.702 -0.499 . . . . 74.4 113.367 -177.826 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 38.2 ttmt -66.62 141.15 57.91 Favored 'General case' 0 N--CA 1.474 0.747 0 CA-C-N 117.657 0.729 . . . . 74.31 110.553 177.041 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 152' ' ' THR . . . . . . . . . . . . . 18.1 p -92.46 115.26 27.93 Favored 'General case' 0 CA--C 1.538 0.488 0 N-CA-C 108.771 -0.825 . . . . 74.31 108.771 166.373 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 153' ' ' SER . . . . . . . . . . . . . 10.3 m -74.2 -21.03 59.99 Favored 'General case' 0 CA--C 1.545 0.758 0 CA-C-O 121.355 0.598 . . . . 60.41 110.295 179.624 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 71.7 mmtt -124.8 150.33 46.45 Favored 'General case' 0 N--CA 1.467 0.423 0 C-N-CA 124.537 1.135 . . . . 73.14 110.267 176.325 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 3.9 tppp? -79.92 94.96 5.96 Favored 'General case' 0 C--O 1.242 0.69 0 N-CA-C 108.927 -0.768 . . . . 74.33 108.927 173.478 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 156' ' ' ILE . . . . . 0.607 HD13 ' HB2' ' A' ' 142' ' ' MET . 60.8 mt -101.45 124.13 55.0 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.155 0 CA-C-N 114.972 -1.013 . . . . 74.15 108.621 -178.575 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 157' ' ' THR . . . . . . . . . . . . . 31.6 p -138.78 157.78 45.44 Favored 'General case' 0 N--CA 1.47 0.56 0 C-N-CA 124.567 1.147 . . . . 73.25 109.256 -173.686 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 158' ' ' ILE . . . . . 0.46 HG22 ' HB3' ' A' ' 8' ' ' PHE . 59.3 mt -80.24 94.28 2.12 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.72 0 N-CA-C 108.5 -0.926 . . . . 64.24 108.5 169.773 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 159' ' ' ALA . . . . . 0.698 ' HB2' ' HB1' ' A' ' 11' ' ' ALA . . . -52.76 -53.69 44.47 Favored 'General case' 0 N--CA 1.481 1.105 0 C-N-CA 124.114 0.966 . . . . 74.32 112.357 -177.852 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 160' ' ' ASP . . . . . 0.595 ' HA ' ' HZ1' ' A' ' 49' ' ' LYS . 26.9 t0 -148.54 157.66 43.61 Favored 'General case' 0 N--CA 1.471 0.618 0 CA-C-N 115.808 -0.633 . . . . 75.44 110.091 -173.557 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 161' ' ' CYS . . . . . . . . . . . . . 28.0 p -129.23 -170.62 2.31 Favored 'General case' 0 CA--C 1.539 0.543 0 C-N-CA 124.922 1.289 . . . . 71.12 108.513 176.888 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 162' ' ' GLY . . . . . . . . . . . . . . . 132.35 53.07 0.08 OUTLIER Glycine 0 C--N 1.342 0.906 0 N-CA-C 110.708 -0.957 . . . . 54.05 110.708 -168.442 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 163' ' ' GLN . . . . . 0.546 ' HB2' ' HA ' ' A' ' 6' ' ' VAL . 13.2 pt20 -55.99 143.73 31.22 Favored 'General case' 0 CA--C 1.544 0.749 0 C-N-CA 124.487 1.115 . . . . 72.43 113.097 -174.293 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 164' ' ' LEU . . . . . . . . . . . . . 77.5 mt -82.1 105.64 13.36 Favored 'General case' 0 CA--C 1.539 0.524 0 CA-C-N 115.404 -0.816 . . . . 74.14 110.277 -176.724 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 165' ' ' GLU . . . . . . . . . . . . . 7.5 pt-20 . . . . . 0 CA--C 1.558 1.258 0 C-N-CA 123.836 0.855 . . . . 75.21 109.426 169.363 . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' B' B ' 216' ' ' PRO . . . . . . . . . . . . . 18.1 Cg_exo . . . . . 0 N--CA 1.485 1.0 0 N-CA-C 109.821 -0.876 . . . . 71.44 109.821 . . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' B' B ' 217' ' ' GLU . . . . . . . . . . . . . 28.9 tt0 -145.44 140.69 16.16 Favored Pre-proline 0 C--O 1.245 0.817 0 C-N-CA 124.185 0.994 . . . . 72.12 108.454 179.773 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 218' ' ' PRO . . . . . . . . . . . . . 37.3 Cg_exo -62.74 101.08 0.25 Allowed 'Trans proline' 0 C--N 1.37 1.665 0 C-N-CA 122.04 1.827 . . . . 70.53 110.494 161.485 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 219' ' ' GLY . . . . . . . . . . . . . . . 171.1 171.49 36.39 Favored Glycine 0 CA--C 1.527 0.786 0 CA-C-N 116.283 -0.417 . . . . 42.03 112.776 -179.59 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 220' ' ' PRO . . . . . . . . . . . . . 97.6 Cg_endo -85.02 -169.17 0.59 Allowed 'Trans proline' 0 C--N 1.371 1.739 0 C-N-CA 123.429 2.752 . . . . 73.03 113.496 -178.785 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 221' ' ' TYR . . . . . . . . . . . . . 96.8 m-85 -117.92 125.47 50.52 Favored 'General case' 0 N--CA 1.483 1.177 0 C-N-CA 123.781 0.833 . . . . 73.24 109.742 179.111 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 222' ' ' ALA . . . . . 0.428 ' HB1' HD12 ' A' ' 57' ' ' ILE . . . -68.94 105.04 2.24 Favored 'General case' 0 N--CA 1.475 0.809 0 C-N-CA 124.219 1.008 . . . . 73.11 111.671 -175.724 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 223' ' ' GLN . . . . . . . . . . . . . 23.0 mp0 38.81 73.54 0.78 Allowed Pre-proline 0 CA--C 1.56 1.361 0 O-C-N 125.093 1.495 . . . . 74.2 112.383 178.976 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 224' ' ' PRO . . . . . . . . . . . . . 50.2 Cg_exo . . . . . 0 C--N 1.373 1.829 0 C-N-CA 123.611 2.874 . . . . 63.31 112.811 -176.482 . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 74.5 mtp . . . . . 0 N--CA 1.48 1.059 0 N-CA-C 109.288 -0.634 . . . . 63.22 109.288 . . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 15.4 m -77.11 78.72 0.68 Allowed 'Isoleucine or valine' 0 N--CA 1.478 0.966 0 CA-C-O 122.521 1.153 . . . . 72.34 110.294 178.263 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 3' ' ' ASN . . . . . 0.5 ' ND2' ' HA ' ' A' ' 25' ' ' PHE . 11.8 m120 -98.04 107.71 42.46 Favored Pre-proline 0 CA--C 1.545 0.757 0 CA-C-N 114.413 -1.267 . . . . 73.23 110.043 -179.813 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 6.7 Cg_endo -80.73 152.68 19.7 Favored 'Trans proline' 0 C--N 1.371 1.755 0 C-N-CA 122.429 2.086 . . . . 65.01 110.963 173.872 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 5' ' ' THR . . . . . 0.42 ' HB ' ' O ' ' A' ' 164' ' ' LEU . 93.2 m -96.15 142.72 28.0 Favored 'General case' 0 CA--C 1.549 0.912 0 C-N-CA 123.096 0.558 . . . . 74.01 109.638 178.643 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . 0.654 ' HA ' ' HG3' ' A' ' 163' ' ' GLN . 29.1 t -110.37 147.12 14.8 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.436 0 N-CA-C 107.222 -1.399 . . . . 74.33 107.222 177.333 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 7' ' ' PHE . . . . . 0.533 ' H ' ' HA ' ' A' ' 163' ' ' GLN . 65.0 t80 -125.59 126.29 44.54 Favored 'General case' 0 C--O 1.238 0.468 0 N-CA-C 108.916 -0.772 . . . . 74.31 108.916 178.905 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 8' ' ' PHE . . . . . 0.531 ' HD2' ' HE2' ' A' ' 22' ' ' PHE . 33.9 m-85 -134.56 165.28 25.57 Favored 'General case' 0 N--CA 1.47 0.557 0 C-N-CA 124.074 0.95 . . . . 73.54 109.701 169.25 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 23.7 m-20 -118.27 117.33 28.83 Favored 'General case' 0 C--N 1.327 -0.406 0 N-CA-C 107.311 -1.366 . . . . 75.12 107.311 171.152 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 42.4 mm -90.05 136.12 24.61 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.823 0 N-CA-C 108.672 -0.862 . . . . 74.53 108.672 178.506 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 11' ' ' ALA . . . . . 0.678 ' HB1' ' HB2' ' A' ' 159' ' ' ALA . . . -135.47 122.27 21.07 Favored 'General case' 0 N--CA 1.478 0.951 0 C-N-CA 123.44 0.696 . . . . 74.44 111.666 -170.513 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . 0.43 HG22 HG12 ' A' ' 156' ' ' ILE . 62.4 t -95.94 122.99 47.95 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.709 0 C-N-CA 124.186 0.994 . . . . 71.02 108.962 176.846 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 42.3 m-20 64.1 23.09 13.11 Favored 'General case' 0 N--CA 1.491 1.616 0 C-N-CA 125.331 1.452 . . . . 74.12 110.836 -172.932 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 83.38 -13.21 47.41 Favored Glycine 0 C--N 1.351 1.384 0 CA-C-O 119.571 -0.572 . . . . 73.21 113.067 -173.079 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 37.8 mm-40 -83.49 117.23 68.04 Favored Pre-proline 0 C--N 1.353 0.759 0 C-N-CA 123.553 0.741 . . . . 71.22 109.981 177.863 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 93.1 Cg_exo -46.7 106.36 0.1 OUTLIER 'Trans proline' 0 C--N 1.379 2.134 0 C-N-CA 124.072 3.182 . . . . 71.25 113.891 -179.411 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 43.3 tp -76.08 -40.96 51.92 Favored 'General case' 0 N--CA 1.48 1.055 0 C-N-CA 123.705 0.802 . . . . 71.11 109.66 179.319 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -179.77 172.22 43.88 Favored Glycine 0 C--N 1.345 1.047 0 O-C-N 123.367 0.417 . . . . 60.12 112.957 178.386 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 13.2 ptm180 -105.82 124.47 49.61 Favored 'General case' 0 N--CA 1.473 0.71 0 N-CA-C 108.255 -1.017 . . . . 74.04 108.255 -177.988 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 51.8 t -120.89 137.91 53.08 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.407 0 C-N-CA 123.692 0.797 . . . . 74.25 109.382 -175.14 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 21' ' ' SER . . . . . 0.492 ' HB2' ' HB2' ' A' ' 134' ' ' GLU . 51.7 m -121.18 125.25 46.68 Favored 'General case' 0 C--O 1.248 1.004 0 C-N-CA 123.706 0.802 . . . . 73.42 109.519 176.677 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 22' ' ' PHE . . . . . 0.531 ' HE2' ' HD2' ' A' ' 8' ' ' PHE . 57.4 m-85 -100.81 169.95 8.65 Favored 'General case' 0 N--CA 1.474 0.735 0 C-N-CA 123.833 0.853 . . . . 75.51 109.358 178.47 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . 0.551 ' HB2' ' HD2' ' A' ' 133' ' ' LYS . 37.7 tt0 -138.32 112.31 8.48 Favored 'General case' 0 CA--C 1.543 0.684 0 C-N-CA 123.156 0.582 . . . . 74.02 109.632 -179.513 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . 0.417 HD21 ' HD1' ' A' ' 129' ' ' PHE . 62.1 mt -84.12 136.48 33.98 Favored 'General case' 0 N--CA 1.478 0.951 0 C-N-CA 123.692 0.797 . . . . 72.22 110.804 -176.784 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 25' ' ' PHE . . . . . 0.5 ' HA ' ' ND2' ' A' ' 3' ' ' ASN . 32.7 m-85 -85.65 64.29 8.54 Favored 'General case' 0 CA--C 1.546 0.805 0 CA-C-O 121.186 0.517 . . . . 73.44 109.642 175.886 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -72.91 1.03 9.52 Favored 'General case' 0 N--CA 1.486 1.364 0 N-CA-C 113.125 0.787 . . . . 74.01 113.125 -175.407 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 11.7 p-10 -87.33 -24.3 24.34 Favored 'General case' 0 CA--C 1.548 0.896 0 C-N-CA 123.555 0.742 . . . . 64.13 111.096 174.433 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 97.7 mttt -114.02 -35.02 5.21 Favored 'General case' 0 N--CA 1.489 1.489 0 C-N-CA 123.692 0.797 . . . . 73.23 111.12 -176.339 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 29' ' ' VAL . . . . . 0.502 HG21 ' HA ' ' A' ' 129' ' ' PHE . 6.7 m -128.85 71.15 81.46 Favored Pre-proline 0 CA--C 1.553 1.074 0 C-N-CA 123.927 0.891 . . . . 74.23 110.209 175.333 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 15.3 Cg_exo -66.03 -33.96 39.64 Favored 'Trans proline' 0 C--N 1.381 2.244 0 C-N-CA 122.567 2.178 . . . . 73.54 111.104 -179.13 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 87.7 tttt -63.51 -57.19 10.97 Favored 'General case' 0 CA--C 1.54 0.575 0 C-N-CA 124.796 1.238 . . . . 75.01 111.083 -179.17 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 6.5 m -68.98 -30.46 68.87 Favored 'General case' 0 CA--C 1.554 1.098 0 C-N-CA 123.613 0.765 . . . . 74.23 111.292 -174.964 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -71.81 -40.03 69.42 Favored 'General case' 0 CA--C 1.548 0.904 0 C-N-CA 123.403 0.681 . . . . 55.51 111.347 175.894 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 9.3 tp10 -71.81 -34.26 69.2 Favored 'General case' 0 N--CA 1.482 1.136 0 C-N-CA 123.436 0.695 . . . . 75.14 110.154 -178.458 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 35' ' ' ASN . . . . . 0.405 ' O ' ' HG ' ' A' ' 39' ' ' LEU . 40.1 t30 -57.98 -54.82 42.66 Favored 'General case' 0 N--CA 1.474 0.738 0 CA-C-N 114.527 -1.215 . . . . 64.22 109.766 173.526 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 74.2 t80 -58.91 -42.01 88.62 Favored 'General case' 0 CA--C 1.543 0.701 0 O-C-N 124.742 1.276 . . . . 73.1 111.096 -177.874 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 36.3 ttm180 -55.58 -57.14 13.18 Favored 'General case' 0 C--N 1.358 0.958 0 O-C-N 123.766 0.666 . . . . 63.14 110.394 175.629 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 38' ' ' ALA . . . . . 0.514 ' HB3' HG22 ' A' ' 78' ' ' ILE . . . -63.62 -32.96 74.6 Favored 'General case' 0 C--O 1.243 0.732 0 O-C-N 124.041 0.838 . . . . 60.02 112.129 -173.078 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 39' ' ' LEU . . . . . 0.556 HD23 ' HE2' ' A' ' 48' ' ' TYR . 74.2 mt -65.56 -45.0 85.02 Favored 'General case' 0 N--CA 1.475 0.792 0 O-C-N 124.147 0.904 . . . . 71.15 111.02 176.517 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 41.2 m -76.42 -49.45 16.67 Favored 'General case' 0 N--CA 1.475 0.814 0 C-N-CA 123.408 0.683 . . . . 42.04 112.01 -174.31 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 41' ' ' THR . . . . . 0.419 ' OG1' ' HG2' ' A' ' 43' ' ' GLU . 67.6 p -76.53 -31.48 57.67 Favored 'General case' 0 N--CA 1.471 0.609 0 C-N-CA 124.204 1.002 . . . . 71.12 111.647 -174.138 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 92.57 26.44 17.62 Favored Glycine 0 C--N 1.349 1.25 0 CA-C-O 119.683 -0.509 . . . . 74.35 113.071 -179.677 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 43' ' ' GLU . . . . . 0.419 ' HG2' ' OG1' ' A' ' 41' ' ' THR . 19.9 mm-40 -63.39 -22.97 67.2 Favored 'General case' 0 N--CA 1.483 1.213 0 C-N-CA 123.086 0.555 . . . . 63.32 111.69 174.31 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 44' ' ' LYS . . . . . 0.493 ' HG2' ' HB2' ' A' ' 38' ' ' ALA . 75.8 mmtt -114.38 16.43 17.81 Favored 'General case' 0 N--CA 1.482 1.149 0 C-N-CA 123.63 0.772 . . . . 73.53 111.022 177.242 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 93.41 -25.06 22.57 Favored Glycine 0 C--N 1.355 1.627 0 N-CA-C 114.794 0.677 . . . . 75.23 114.794 174.893 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 46' ' ' PHE . . . . . 0.416 ' HE2' ' HA ' ' A' ' 78' ' ' ILE . 21.8 m-85 -68.77 -48.22 64.22 Favored 'General case' 0 N--CA 1.479 0.992 0 C-N-CA 122.953 0.501 . . . . 75.12 111.846 -167.407 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 40.97 62.05 1.82 Allowed Glycine 0 C--N 1.358 1.786 0 O-C-N 124.975 1.422 . . . . 75.42 115.321 169.92 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 48' ' ' TYR . . . . . 0.556 ' HE2' HD23 ' A' ' 39' ' ' LEU . 97.3 m-85 -62.88 90.76 0.04 OUTLIER 'General case' 0 N--CA 1.476 0.859 0 CA-C-O 121.478 0.656 . . . . 74.41 111.52 -176.678 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 3.7 tppp? -105.24 125.81 51.4 Favored 'General case' 0 C--O 1.232 0.148 0 N-CA-C 108.328 -0.989 . . . . 72.3 108.328 175.05 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 80.96 20.23 65.72 Favored Glycine 0 CA--C 1.524 0.636 0 CA-C-O 119.681 -0.511 . . . . 63.03 112.742 -175.427 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 51' ' ' SER . . . . . 0.402 ' HB2' ' HB3' ' A' ' 48' ' ' TYR . 36.0 t -62.38 118.41 7.45 Favored 'General case' 0 C--N 1.354 0.786 0 N-CA-C 109.032 -0.729 . . . . 74.35 109.032 176.9 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 52' ' ' CYS . . . . . . . . . . . . . 25.6 p -86.75 129.48 34.86 Favored 'General case' 0 CA--C 1.536 0.425 0 C-N-CA 123.54 0.736 . . . . 64.01 111.645 -170.577 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 53' ' ' PHE . . . . . 0.636 ' HA ' ' HA2' ' A' ' 64' ' ' GLY . 46.5 m-85 -76.79 74.4 3.43 Favored 'General case' 0 CA--C 1.538 0.516 0 N-CA-C 108.353 -0.98 . . . . 73.25 108.353 168.415 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 27.1 p-80 -75.0 -22.84 58.27 Favored 'General case' 0 N--CA 1.476 0.868 0 CA-C-N 115.146 -0.934 . . . . 74.45 111.522 -174.674 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 55' ' ' ARG . . . . . 0.406 ' HA ' ' O ' ' A' ' 150' ' ' GLY . 38.4 ttt180 -112.96 99.41 7.84 Favored 'General case' 0 C--O 1.218 -0.601 0 N-CA-C 109.108 -0.701 . . . . 73.25 109.108 178.238 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 42.7 mt -127.63 137.86 56.44 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.643 0 N-CA-C 108.47 -0.937 . . . . 75.41 108.47 171.747 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 57' ' ' ILE . . . . . 0.667 HG23 ' HA ' ' A' ' 148' ' ' ARG . 70.2 mt -134.56 125.3 17.52 Favored Pre-proline 0 CA--C 1.553 1.08 0 C-N-CA 124.811 1.244 . . . . 73.43 108.621 -176.267 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 58' ' ' PRO . . . . . 0.451 ' HA ' ' HG2' ' A' ' 143' ' ' GLU . 84.3 Cg_endo -76.82 145.41 25.42 Favored 'Trans proline' 0 C--N 1.375 1.943 0 C-N-CA 122.687 2.258 . . . . 73.43 112.15 -177.606 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 70.04 25.48 75.55 Favored Glycine 0 C--N 1.342 0.868 0 CA-C-N 115.398 -0.819 . . . . 53.54 112.653 -175.486 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 36.5 t80 -151.57 -73.58 0.15 Allowed 'General case' 0 C--O 1.247 0.95 0 C-N-CA 122.835 0.454 . . . . 74.12 111.172 -171.646 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 61' ' ' MET . . . . . 0.616 ' HE1' ' SG ' ' A' ' 115' ' ' CYS . 38.8 ttm -176.79 143.9 0.46 Allowed 'General case' 0 N--CA 1.482 1.166 0 N-CA-C 112.445 0.535 . . . . 72.01 112.445 -159.06 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 62' ' ' CYS . . . . . 0.456 ' SG ' HG11 ' A' ' 139' ' ' VAL . 25.1 p -112.72 112.45 23.96 Favored 'General case' 0 CA--C 1.55 0.962 0 N-CA-C 109.018 -0.734 . . . . 75.3 109.018 169.344 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 63' ' ' GLN . . . . . 0.537 ' HA ' ' HA ' ' A' ' 113' ' ' PHE . 51.4 tt0 -105.43 120.68 42.21 Favored 'General case' 0 N--CA 1.485 1.284 0 C-N-CA 124.248 1.019 . . . . 74.33 111.503 -175.185 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 64' ' ' GLY . . . . . 0.636 ' HA2' ' HA ' ' A' ' 53' ' ' PHE . . . -91.84 148.75 19.38 Favored Glycine 0 C--N 1.347 1.16 0 CA-C-N 115.206 -0.906 . . . . 75.11 112.34 176.403 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . 0.501 ' HA3' ' HG2' ' A' ' 111' ' ' GLN . . . -176.84 131.25 1.8 Allowed Glycine 0 C--N 1.338 0.656 0 N-CA-C 111.984 -0.447 . . . . 73.2 111.984 179.511 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 33.2 t70 -75.99 165.35 25.09 Favored 'General case' 0 CA--C 1.547 0.846 0 C-N-CA 123.046 0.538 . . . . 74.43 111.31 -175.613 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 90.2 t80 -64.92 -32.88 74.81 Favored 'General case' 0 C--O 1.245 0.853 0 C-N-CA 123.665 0.786 . . . . 74.02 111.365 178.176 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 33.9 m -60.81 112.67 2.13 Favored 'General case' 0 C--N 1.354 0.772 0 C-N-CA 122.985 0.514 . . . . 73.34 111.254 -177.057 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 69' ' ' ARG . . . . . 0.42 ' HD3' ' HG3' ' A' ' 81' ' ' GLU . 81.1 mtt85 65.33 28.01 11.9 Favored 'General case' 0 CA--C 1.547 0.843 0 O-C-N 124.618 1.199 . . . . 74.52 112.02 178.381 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 15.4 p80 -55.18 -25.41 32.44 Favored 'General case' 0 N--CA 1.498 1.969 0 C-N-CA 123.529 0.732 . . . . 70.01 112.759 -174.571 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 11.2 m120 -77.5 87.84 3.84 Favored 'General case' 0 CA--C 1.544 0.747 0 C-N-CA 123.849 0.86 . . . . 74.33 109.373 174.353 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 91.25 -1.2 76.46 Favored Glycine 0 N--CA 1.474 1.213 0 CA-C-O 119.4 -0.667 . . . . 71.22 114.61 175.381 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 73' ' ' THR . . . . . 0.437 ' HA ' ' HB2' ' A' ' 110' ' ' SER . 96.2 m -140.31 -92.16 0.16 Allowed 'General case' 0 CA--C 1.558 1.277 0 CA-C-N 117.738 0.769 . . . . 73.2 110.046 172.951 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 81.67 43.66 8.27 Favored Glycine 0 C--N 1.359 1.84 0 CA-C-N 118.279 0.491 . . . . 73.51 113.985 176.684 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 140.79 53.46 0.04 OUTLIER Glycine 0 C--N 1.346 1.095 0 CA-C-N 117.552 0.676 . . . . 74.32 111.495 -176.482 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 76' ' ' LYS . . . . . 0.486 ' HB2' ' HA ' ' A' ' 81' ' ' GLU . 13.9 ptmm? -56.09 162.86 1.76 Allowed 'General case' 0 N--CA 1.483 1.182 0 C-N-CA 124.026 0.93 . . . . 73.22 112.749 -174.541 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 87.3 p -94.49 -177.77 4.35 Favored 'General case' 0 C--O 1.243 0.734 0 C-N-CA 122.995 0.518 . . . . 75.23 111.345 -170.775 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 78' ' ' ILE . . . . . 0.514 HG22 ' HB3' ' A' ' 38' ' ' ALA . 20.9 pt -88.59 -12.38 10.21 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.889 0 CA-C-N 115.56 -0.746 . . . . 65.42 110.668 173.985 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 42.9 m-85 -88.17 -24.62 23.27 Favored 'General case' 0 N--CA 1.472 0.646 0 C-N-CA 123.935 0.894 . . . . 74.41 109.662 178.476 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 167.86 -145.29 9.58 Favored Glycine 0 C--N 1.346 1.084 0 CA-C-N 115.365 -0.834 . . . . 72.05 111.095 176.827 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 81' ' ' GLU . . . . . 0.486 ' HA ' ' HB2' ' A' ' 76' ' ' LYS . 36.3 tt0 -69.16 -34.93 75.74 Favored 'General case' 0 CA--C 1.543 0.709 0 C-N-CA 123.293 0.637 . . . . 74.45 110.06 174.475 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 82' ' ' LYS . . . . . 0.695 ' HD2' ' HA ' ' A' ' 107' ' ' THR . 20.6 pttp -169.99 177.2 4.41 Favored 'General case' 0 N--CA 1.476 0.842 0 C-N-CA 124.733 1.213 . . . . 74.41 109.047 178.397 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 46.5 p90 -146.78 173.49 12.33 Favored 'General case' 0 N--CA 1.474 0.767 0 C-N-CA 123.651 0.78 . . . . 75.23 110.563 -179.208 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 13.5 pt-20 -88.34 158.99 18.26 Favored 'General case' 0 N--CA 1.475 0.821 0 C-N-CA 123.055 0.542 . . . . 73.21 110.208 177.917 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 27.0 m-20 -60.81 118.64 6.91 Favored 'General case' 0 N--CA 1.477 0.924 0 C-N-CA 124.376 1.071 . . . . 74.25 109.967 -179.337 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 20.6 tp10 -66.79 -59.01 3.92 Favored 'General case' 0 N--CA 1.479 0.983 0 C-N-CA 123.133 0.573 . . . . 65.42 111.198 -175.158 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 26.4 p30 -143.01 -174.46 4.19 Favored 'General case' 0 N--CA 1.47 0.543 0 C-N-CA 123.757 0.823 . . . . 74.43 109.593 179.966 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 79.8 m-85 -136.27 39.54 2.69 Favored 'General case' 0 N--CA 1.481 1.082 0 C-N-CA 123.591 0.756 . . . . 75.25 109.754 -179.325 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 60.5 mt -69.01 -62.07 1.42 Allowed 'Isoleucine or valine' 0 N--CA 1.477 0.9 0 CA-C-N 115.431 -0.804 . . . . 74.42 110.966 -178.806 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 90' ' ' LEU . . . . . 0.643 ' H ' HG23 ' A' ' 127' ' ' VAL . 66.1 mt -87.55 140.96 28.99 Favored 'General case' 0 C--O 1.238 0.492 0 CA-C-N 115.539 -0.755 . . . . 65.25 110.678 -171.748 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 55.3 mtpt -125.5 168.83 13.09 Favored 'General case' 0 N--CA 1.47 0.526 0 C-N-CA 124.152 0.981 . . . . 74.22 110.174 -174.285 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 92' ' ' HIS . . . . . 0.414 ' HD2' ' SG ' ' A' ' 115' ' ' CYS . 43.5 m80 -92.88 51.28 1.67 Allowed 'General case' 0 N--CA 1.48 1.026 0 C-N-CA 124.235 1.014 . . . . 70.43 109.503 -174.486 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 41.3 p -84.3 -7.12 59.42 Favored 'General case' 0 N--CA 1.472 0.632 0 CA-C-N 114.476 -1.238 . . . . 73.33 112.799 -171.371 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -143.5 -179.57 20.2 Favored Glycine 0 C--N 1.347 1.164 0 CA-C-O 120.117 -0.268 . . . . 71.31 113.057 -177.12 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 82.1 Cg_endo -82.4 158.21 17.06 Favored 'Trans proline' 0 C--N 1.367 1.523 0 C-N-CA 123.412 2.741 . . . . 74.55 112.561 175.241 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 73.83 18.83 79.69 Favored Glycine 0 CA--C 1.531 1.059 0 CA-C-N 115.524 -0.762 . . . . 72.44 114.467 178.867 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 97' ' ' ILE . . . . . 0.403 HG22 ' HA ' ' A' ' 92' ' ' HIS . 17.0 mm -78.93 108.28 12.33 Favored 'Isoleucine or valine' 0 CA--C 1.562 1.428 0 CA-C-N 117.533 0.666 . . . . 73.44 112.466 -171.824 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 98' ' ' LEU . . . . . 0.627 ' HG ' HG12 ' A' ' 114' ' ' ILE . 7.6 mp -87.21 117.93 26.29 Favored 'General case' 0 N--CA 1.488 1.468 0 C-N-CA 123.535 0.734 . . . . 75.04 111.033 175.923 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 99' ' ' SER . . . . . 0.651 ' HB3' ' HA ' ' A' ' 128' ' ' VAL . 2.7 p -139.78 143.5 36.93 Favored 'General case' 0 N--CA 1.476 0.874 0 N-CA-C 108.306 -0.998 . . . . 74.4 108.306 173.707 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 100' ' ' MET . . . . . 0.475 ' HA ' ' HA ' ' A' ' 112' ' ' PHE . 49.7 mtp -76.23 138.9 40.91 Favored 'General case' 0 N--CA 1.485 1.31 0 N-CA-C 109.689 -0.486 . . . . 75.14 109.689 -171.491 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 101' ' ' ALA . . . . . 0.503 ' HB1' ' HB2' ' A' ' 111' ' ' GLN . . . -75.69 158.25 32.57 Favored 'General case' 0 N--CA 1.481 1.082 0 CA-C-O 121.216 0.531 . . . . 75.13 111.635 -170.48 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 30.4 p-10 -162.67 163.13 27.13 Favored 'General case' 0 CA--C 1.537 0.453 0 CA-C-N 114.95 -1.023 . . . . 74.43 110.131 -179.361 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -103.91 1.67 31.61 Favored 'General case' 0 N--CA 1.473 0.707 0 C-N-CA 124.203 1.001 . . . . 75.54 110.196 169.686 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 149.45 -164.41 29.39 Favored Glycine 0 C--N 1.345 1.031 0 CA-C-O 119.273 -0.737 . . . . 61.14 111.466 -178.269 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 53.2 Cg_exo -56.89 141.73 93.14 Favored 'Trans proline' 0 C--N 1.368 1.6 0 C-N-CA 123.286 2.657 . . . . 75.14 112.795 175.978 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 63.9 t30 68.46 10.18 7.71 Favored 'General case' 0 N--CA 1.495 1.788 0 C-N-CA 125.102 1.361 . . . . 74.34 112.332 179.526 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 107' ' ' THR . . . . . 0.695 ' HA ' ' HD2' ' A' ' 82' ' ' LYS . 2.4 m -113.1 0.23 14.9 Favored 'General case' 0 CA--C 1.551 0.997 0 O-C-N 121.511 -0.743 . . . . 74.35 110.775 178.307 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 57.5 t30 -70.76 155.57 40.6 Favored 'General case' 0 N--CA 1.481 1.108 0 C-N-CA 123.784 0.834 . . . . 74.25 110.738 -178.034 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 89.76 0.73 78.13 Favored Glycine 0 N--CA 1.468 0.773 0 CA-C-N 116.713 -0.221 . . . . 73.22 113.55 179.026 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 110' ' ' SER . . . . . 0.437 ' HB2' ' HA ' ' A' ' 73' ' ' THR . 79.6 p -100.25 120.64 40.22 Favored 'General case' 0 CA--C 1.531 0.22 0 N-CA-C 108.012 -1.107 . . . . 72.34 108.012 173.731 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 111' ' ' GLN . . . . . 0.503 ' HB2' ' HB1' ' A' ' 101' ' ' ALA . 49.4 mt-30 62.53 176.57 0.14 Allowed 'General case' 0 N--CA 1.492 1.66 0 C-N-CA 123.609 0.764 . . . . 75.53 111.769 -174.839 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 112' ' ' PHE . . . . . 0.475 ' HA ' ' HA ' ' A' ' 100' ' ' MET . 29.1 p90 -147.13 133.71 19.85 Favored 'General case' 0 N--CA 1.471 0.622 0 N-CA-C 108.021 -1.103 . . . . 72.41 108.021 172.932 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 113' ' ' PHE . . . . . 0.548 ' HB2' ' SD ' ' A' ' 61' ' ' MET . 46.4 p90 -113.49 134.3 54.75 Favored 'General case' 0 C--O 1.239 0.539 0 CA-C-O 121.235 0.54 . . . . 71.34 110.751 178.349 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 114' ' ' ILE . . . . . 0.627 HG12 ' HG ' ' A' ' 98' ' ' LEU . 22.1 mt -99.96 101.04 11.56 Favored 'Isoleucine or valine' 0 C--O 1.239 0.532 0 N-CA-C 108.047 -1.094 . . . . 74.52 108.047 176.612 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 115' ' ' CYS . . . . . 0.616 ' SG ' ' HE1' ' A' ' 61' ' ' MET . 32.4 m -65.92 103.78 0.99 Allowed 'General case' 0 N--CA 1.467 0.388 0 N-CA-C 108.611 -0.885 . . . . 73.33 108.611 174.485 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 116' ' ' THR . . . . . 0.508 HG21 HG12 ' A' ' 139' ' ' VAL . 35.6 p -70.04 -28.86 65.81 Favored 'General case' 0 N--CA 1.48 1.05 0 C-N-CA 123.707 0.803 . . . . 75.14 110.675 -177.206 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -119.49 168.25 11.16 Favored 'General case' 0 C--O 1.243 0.72 0 C-N-CA 124.051 0.941 . . . . 63.21 109.279 171.159 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 13.3 ptmm? -72.55 89.3 1.28 Allowed 'General case' 0 C--O 1.246 0.89 0 CA-C-O 121.657 0.742 . . . . 74.34 110.3 178.1 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 119' ' ' THR . . . . . 0.504 ' HB ' HD13 ' A' ' 122' ' ' LEU . 37.6 p -71.22 89.2 0.85 Allowed 'General case' 0 CA--C 1.542 0.651 0 CA-C-O 122.0 0.905 . . . . 65.23 108.971 176.829 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 9.5 pt-20 -75.98 -21.44 56.95 Favored 'General case' 0 N--CA 1.475 0.788 0 CA-C-N 114.578 -1.192 . . . . 63.25 111.773 -171.486 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 121' ' ' TRP . . . . . . . . . . . . . 33.1 p90 -77.18 -0.84 26.58 Favored 'General case' 0 CA--C 1.549 0.937 0 C-N-CA 123.581 0.752 . . . . 72.14 110.829 172.35 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 122' ' ' LEU . . . . . 0.541 ' HA ' ' HE2' ' A' ' 125' ' ' LYS . 10.9 mp -101.97 7.04 41.5 Favored 'General case' 0 N--CA 1.474 0.727 0 C-N-CA 123.682 0.793 . . . . 74.41 110.879 170.832 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 93.8 m-20 -84.82 128.09 34.45 Favored 'General case' 0 N--CA 1.475 0.776 0 N-CA-C 109.588 -0.523 . . . . 53.51 109.588 173.558 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 94.42 7.41 60.55 Favored Glycine 0 C--N 1.345 1.043 0 N-CA-C 111.69 -0.564 . . . . 62.22 111.69 -168.454 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 125' ' ' LYS . . . . . 0.541 ' HE2' ' HA ' ' A' ' 122' ' ' LEU . 19.4 ttmm -104.26 -167.39 1.35 Allowed 'General case' 0 CA--C 1.552 1.049 0 C-N-CA 124.918 1.287 . . . . 73.35 108.375 179.021 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 126' ' ' HIS . . . . . 0.495 ' H ' ' HG2' ' A' ' 125' ' ' LYS . 42.5 p-80 -67.75 155.61 38.89 Favored 'General case' 0 C--O 1.244 0.769 0 CA-C-O 121.245 0.545 . . . . 74.35 111.672 -175.575 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 127' ' ' VAL . . . . . 0.643 HG23 ' H ' ' A' ' 90' ' ' LEU . 11.0 p -64.0 148.37 11.67 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.938 0 CA-C-N 113.988 -1.46 . . . . 70.32 112.99 -174.537 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 128' ' ' VAL . . . . . 0.651 ' HA ' ' HB3' ' A' ' 99' ' ' SER . 94.7 t -81.39 155.57 4.17 Favored 'Isoleucine or valine' 0 CA--C 1.551 1.0 0 C-N-CA 125.421 1.488 . . . . 71.25 109.23 172.055 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 129' ' ' PHE . . . . . 0.502 ' HA ' HG21 ' A' ' 29' ' ' VAL . 48.7 p90 -119.35 -24.33 6.41 Favored 'General case' 0 N--CA 1.487 1.383 0 CA-C-N 118.549 0.613 . . . . 75.11 111.603 177.416 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . -158.88 177.1 35.61 Favored Glycine 0 C--N 1.344 1.01 0 O-C-N 123.183 0.302 . . . . 45.2 112.468 -174.92 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 34.4 ttpt -153.33 147.41 25.58 Favored 'General case' 0 N--CA 1.472 0.671 0 C-N-CA 123.484 0.714 . . . . 74.45 109.3 -179.877 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 132' ' ' VAL . . . . . 0.428 HG21 ' HE1' ' A' ' 22' ' ' PHE . 16.9 t -68.29 120.33 15.55 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.552 0 N-CA-C 109.253 -0.647 . . . . 74.23 109.253 176.203 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 133' ' ' LYS . . . . . 0.551 ' HD2' ' HB2' ' A' ' 23' ' ' GLU . 20.6 ptmt -100.2 -33.54 10.39 Favored 'General case' 0 N--CA 1.477 0.895 0 N-CA-C 109.584 -0.524 . . . . 74.43 109.584 176.49 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 134' ' ' GLU . . . . . 0.492 ' HB2' ' HB2' ' A' ' 21' ' ' SER . 31.5 mt-10 -144.29 149.63 36.57 Favored 'General case' 0 N--CA 1.478 0.97 0 C-N-CA 125.166 1.387 . . . . 72.03 108.654 -178.516 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 83.43 17.44 66.47 Favored Glycine 0 C--N 1.339 0.742 0 N-CA-C 112.182 -0.367 . . . . 62.41 112.182 -177.701 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 136' ' ' MET . . . . . . . . . . . . . 15.7 tpt -64.01 -34.78 78.79 Favored 'General case' 0 C--N 1.354 0.796 0 C-N-CA 123.863 0.865 . . . . 73.11 110.913 -179.527 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 137' ' ' ASN . . . . . . . . . . . . . 27.3 t-20 -58.75 -42.31 88.57 Favored 'General case' 0 CA--C 1.542 0.644 0 C-N-CA 123.588 0.755 . . . . 73.24 110.568 174.049 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 138' ' ' ILE . . . . . . . . . . . . . 48.9 mm -67.67 -35.64 73.44 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.956 0 C-N-CA 123.331 0.652 . . . . 75.15 110.657 178.925 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 139' ' ' VAL . . . . . 0.508 HG12 HG21 ' A' ' 116' ' ' THR . 94.3 t -65.8 -37.98 81.15 Favored 'Isoleucine or valine' 0 CA--C 1.559 1.32 0 C-N-CA 123.941 0.896 . . . . 72.4 110.93 176.772 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 39.0 mt-10 -77.02 -27.55 54.63 Favored 'General case' 0 N--CA 1.48 1.04 0 C-N-CA 123.537 0.735 . . . . 74.42 111.186 177.625 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -72.65 -46.98 51.27 Favored 'General case' 0 N--CA 1.48 1.069 0 C-N-CA 123.338 0.655 . . . . 71.21 110.305 178.717 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 142' ' ' MET . . . . . 0.535 ' HA ' ' HD2' ' A' ' 145' ' ' PHE . 27.3 ptm -68.48 -30.34 69.16 Favored 'General case' 0 N--CA 1.475 0.81 0 CA-C-N 115.475 -0.784 . . . . 75.22 110.962 178.106 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 143' ' ' GLU . . . . . 0.451 ' HG2' ' HA ' ' A' ' 58' ' ' PRO . 35.8 tt0 -55.11 -42.26 72.69 Favored 'General case' 0 C--N 1.364 1.203 0 O-C-N 123.807 0.692 . . . . 74.55 111.361 174.71 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 144' ' ' ARG . . . . . . . . . . . . . 51.5 mtp180 -64.79 -22.91 67.09 Favored 'General case' 0 N--CA 1.473 0.715 0 CA-C-N 115.376 -0.829 . . . . 74.04 112.189 -178.233 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 145' ' ' PHE . . . . . 0.535 ' HD2' ' HA ' ' A' ' 142' ' ' MET . 47.7 m-85 -83.53 -1.02 52.79 Favored 'General case' 0 N--CA 1.479 0.987 0 C-N-CA 122.768 0.427 . . . . 74.24 111.876 179.426 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 146' ' ' GLY . . . . . 0.523 ' HA2' ' HA ' ' A' ' 152' ' ' THR . . . -96.71 172.06 28.17 Favored Glycine 0 C--N 1.342 0.867 0 N-CA-C 112.687 -0.165 . . . . 61.3 112.687 177.597 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 16.2 m -128.1 156.48 42.75 Favored 'General case' 0 N--CA 1.481 1.112 0 C-N-CA 123.845 0.858 . . . . 74.23 109.801 -178.332 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 148' ' ' ARG . . . . . 0.667 ' HA ' HG23 ' A' ' 57' ' ' ILE . 26.2 mmm-85 -58.53 -31.66 68.13 Favored 'General case' 0 N--CA 1.48 1.048 0 C-N-CA 124.595 1.158 . . . . 73.41 113.279 -174.359 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 149' ' ' ASN . . . . . . . . . . . . . 29.9 p-10 -77.7 -12.27 59.96 Favored 'General case' 0 N--CA 1.476 0.844 0 C-N-CA 123.364 0.666 . . . . 74.1 111.983 -178.279 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 150' ' ' GLY . . . . . 0.406 ' O ' ' HA ' ' A' ' 55' ' ' ARG . . . 106.45 6.05 36.27 Favored Glycine 0 C--N 1.348 1.2 0 CA-C-O 120.046 -0.308 . . . . 74.13 113.165 179.487 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 86.9 tttt -90.07 122.99 33.55 Favored 'General case' 0 N--CA 1.471 0.619 0 C-N-CA 123.08 0.552 . . . . 74.11 109.866 178.587 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 152' ' ' THR . . . . . 0.523 ' HA ' ' HA2' ' A' ' 146' ' ' GLY . 21.1 m -90.67 113.56 25.65 Favored 'General case' 0 CA--C 1.536 0.425 0 N-CA-C 108.82 -0.807 . . . . 73.43 108.82 174.978 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 153' ' ' SER . . . . . . . . . . . . . 9.1 m -52.8 -32.84 46.15 Favored 'General case' 0 N--CA 1.48 1.07 0 C-N-CA 124.646 1.178 . . . . 72.11 112.367 -178.394 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 70.7 mmtt -109.24 150.02 28.55 Favored 'General case' 0 N--CA 1.469 0.509 0 C-N-CA 124.358 1.063 . . . . 75.41 110.631 -175.731 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 75.0 mmtt -83.01 90.32 7.0 Favored 'General case' 0 N--CA 1.468 0.456 0 N-CA-C 108.527 -0.916 . . . . 71.42 108.527 172.542 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 156' ' ' ILE . . . . . 0.493 HG21 ' HE2' ' A' ' 142' ' ' MET . 54.0 mt -100.35 108.49 23.08 Favored 'Isoleucine or valine' 0 C--O 1.221 -0.43 0 CA-C-N 114.981 -1.009 . . . . 75.44 109.04 -175.693 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 157' ' ' THR . . . . . . . . . . . . . 56.9 p -118.47 159.71 23.01 Favored 'General case' 0 N--CA 1.473 0.713 0 C-N-CA 124.07 0.948 . . . . 72.32 110.53 -175.342 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 158' ' ' ILE . . . . . . . . . . . . . 62.5 mt -77.22 94.09 1.28 Allowed 'Isoleucine or valine' 0 CA--C 1.548 0.892 0 N-CA-C 108.988 -0.745 . . . . 71.44 108.988 170.398 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 159' ' ' ALA . . . . . 0.678 ' HB2' ' HB1' ' A' ' 11' ' ' ALA . . . -51.82 -49.56 62.55 Favored 'General case' 0 N--CA 1.483 1.21 0 C-N-CA 124.446 1.098 . . . . 64.21 112.411 -178.764 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 160' ' ' ASP . . . . . . . . . . . . . 19.7 t70 -152.92 169.94 21.6 Favored 'General case' 0 CA--C 1.546 0.805 0 CA-C-N 116.257 -0.428 . . . . 74.33 111.208 -179.351 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 161' ' ' CYS . . . . . . . . . . . . . 46.4 m -136.48 -168.93 2.34 Favored 'General case' 0 N--CA 1.47 0.56 0 C-N-CA 125.138 1.375 . . . . 73.31 108.623 -177.148 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 162' ' ' GLY . . . . . . . . . . . . . . . 132.44 53.52 0.08 OUTLIER Glycine 0 C--N 1.344 0.986 0 N-CA-C 111.025 -0.83 . . . . 72.32 111.025 -172.929 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 163' ' ' GLN . . . . . 0.654 ' HG3' ' HA ' ' A' ' 6' ' ' VAL . 46.8 tt0 -46.69 104.12 0.05 OUTLIER 'General case' 0 N--CA 1.481 1.086 0 C-N-CA 125.281 1.432 . . . . 71.2 112.312 -176.756 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 164' ' ' LEU . . . . . 0.42 ' O ' ' HB ' ' A' ' 5' ' ' THR . 64.9 mt -91.17 97.22 11.01 Favored 'General case' 0 N--CA 1.468 0.432 0 N-CA-C 107.272 -1.381 . . . . 73.23 107.272 -179.542 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 165' ' ' GLU . . . . . . . . . . . . . 7.2 pt-20 . . . . . 0 C--O 1.253 1.248 0 CA-C-O 119.387 -0.339 . . . . 73.12 111.097 -172.533 . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' B' B ' 216' ' ' PRO . . . . . . . . . . . . . 35.0 Cg_endo . . . . . 0 CA--C 1.547 1.138 0 N-CA-C 110.081 -0.777 . . . . 64.34 110.081 . . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' B' B ' 217' ' ' GLU . . . . . . . . . . . . . 40.8 tt0 -122.53 102.95 38.55 Favored Pre-proline 0 CA--C 1.549 0.94 0 C-N-CA 124.13 0.972 . . . . 73.54 109.531 -177.272 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 218' ' ' PRO . . . . . . . . . . . . . 15.4 Cg_exo -69.58 151.02 70.03 Favored 'Trans proline' 0 C--N 1.377 2.036 0 C-N-CA 122.615 2.21 . . . . 71.33 111.234 168.001 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 219' ' ' GLY . . . . . . . . . . . . . . . 130.63 163.97 11.15 Favored Glycine 0 CA--C 1.531 1.065 0 CA-C-O 119.605 -0.553 . . . . 63.01 112.372 177.67 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 220' ' ' PRO . . . . . 0.441 ' HG3' HD23 ' A' ' 122' ' ' LEU . 96.3 Cg_endo -78.39 160.03 29.13 Favored 'Trans proline' 0 C--N 1.368 1.56 0 C-N-CA 123.669 2.912 . . . . 72.53 113.025 -175.394 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 221' ' ' TYR . . . . . . . . . . . . . 49.1 m-85 -85.69 139.11 31.64 Favored 'General case' 0 N--CA 1.475 0.783 0 C-N-CA 123.493 0.717 . . . . 72.25 111.651 -173.123 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 222' ' ' ALA . . . . . 0.463 ' HB1' HD11 ' A' ' 57' ' ' ILE . . . -82.13 102.26 10.95 Favored 'General case' 0 C--N 1.348 0.504 0 CA-C-N 115.198 -0.91 . . . . 74.32 112.451 -171.87 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 223' ' ' GLN . . . . . . . . . . . . . 55.7 mt-30 58.42 90.45 0.09 OUTLIER Pre-proline 0 CA--C 1.562 1.419 0 O-C-N 124.713 1.258 . . . . 75.45 111.345 169.507 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 224' ' ' PRO . . . . . . . . . . . . . 11.4 Cg_exo . . . . . 0 C--N 1.373 1.853 0 C-N-CA 123.036 2.491 . . . . 72.21 111.954 -178.896 . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 17.7 ptp . . . . . 0 N--CA 1.473 0.711 0 CA-C-O 120.805 0.336 . . . . 71.33 110.27 . . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 5.3 p -77.93 94.96 1.54 Allowed 'Isoleucine or valine' 0 CA--C 1.55 0.946 0 CA-C-O 122.073 0.94 . . . . 72.52 110.744 -179.234 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 13.7 m120 -94.88 106.08 22.83 Favored Pre-proline 0 C--O 1.241 0.655 0 N-CA-C 107.498 -1.297 . . . . 74.23 107.498 169.291 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 4' ' ' PRO . . . . . 0.663 ' HB3' HH11 ' A' ' 37' ' ' ARG . 48.8 Cg_endo -69.18 119.76 6.7 Favored 'Trans proline' 0 C--N 1.371 1.745 0 C-N-CA 122.107 1.871 . . . . 72.53 110.917 177.35 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 86.6 m -96.84 117.85 31.98 Favored 'General case' 0 C--O 1.217 -0.61 0 N-CA-C 106.906 -1.516 . . . . 74.42 106.906 173.234 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 5.3 m -98.22 122.12 49.52 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.421 0 CA-C-O 121.782 0.801 . . . . 75.41 109.485 -176.537 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 7' ' ' PHE . . . . . 0.531 ' H ' ' HA ' ' A' ' 163' ' ' GLN . 73.2 t80 -100.75 131.79 46.47 Favored 'General case' 0 C--O 1.236 0.365 0 CA-C-N 114.485 -1.234 . . . . 75.03 108.893 -175.031 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 8' ' ' PHE . . . . . 0.475 ' HB3' HG23 ' A' ' 158' ' ' ILE . 44.2 m-85 -132.04 165.01 24.95 Favored 'General case' 0 C--O 1.24 0.566 0 C-N-CA 124.489 1.116 . . . . 70.43 109.125 170.566 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 49.5 m-20 -112.94 111.07 21.55 Favored 'General case' 0 C--N 1.326 -0.442 0 N-CA-C 107.564 -1.272 . . . . 72.15 107.564 169.281 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 10' ' ' ILE . . . . . 0.453 HG23 ' SD ' ' A' ' 142' ' ' MET . 41.3 mm -80.04 115.26 22.17 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.412 0 N-CA-C 108.518 -0.919 . . . . 75.3 108.518 179.154 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 11' ' ' ALA . . . . . 0.574 ' HB1' ' HB3' ' A' ' 159' ' ' ALA . . . -116.79 128.62 55.46 Favored 'General case' 0 N--CA 1.47 0.56 0 C-N-CA 123.793 0.837 . . . . 64.42 111.21 -173.761 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 73.2 t -95.8 113.64 30.66 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.616 0 N-CA-C 108.097 -1.075 . . . . 75.34 108.097 173.585 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 48.0 m-20 63.91 23.93 13.51 Favored 'General case' 0 N--CA 1.489 1.502 0 C-N-CA 125.567 1.547 . . . . 64.21 111.731 -178.676 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 96.85 -20.45 50.65 Favored Glycine 0 C--N 1.341 0.841 0 CA-C-O 119.569 -0.573 . . . . 63.21 112.838 -177.326 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 50.6 mm-40 -84.22 114.32 53.84 Favored Pre-proline 0 N--CA 1.476 0.841 0 CA-C-N 117.299 0.55 . . . . 73.23 110.215 178.353 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 76.5 Cg_exo -50.48 109.35 0.29 Allowed 'Trans proline' 0 C--N 1.382 2.309 0 C-N-CA 123.684 2.923 . . . . 74.02 112.802 177.875 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 44.3 tp -77.06 -45.01 28.54 Favored 'General case' 0 N--CA 1.473 0.701 0 N-CA-C 109.114 -0.698 . . . . 74.52 109.114 177.653 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -168.35 170.8 42.32 Favored Glycine 0 C--N 1.342 0.891 0 CA-C-N 115.873 -0.603 . . . . 74.25 112.543 179.694 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 69.3 mtt-85 -107.04 125.98 51.74 Favored 'General case' 0 N--CA 1.474 0.759 0 C-N-CA 123.718 0.807 . . . . 72.13 108.955 -176.466 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 93.1 t -121.76 144.92 29.36 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.769 0 C-N-CA 123.512 0.725 . . . . 73.22 110.11 -176.77 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 21' ' ' SER . . . . . 0.483 ' HB2' ' HB2' ' A' ' 134' ' ' GLU . 60.0 m -141.21 128.21 20.67 Favored 'General case' 0 CA--C 1.541 0.602 0 C-N-CA 124.733 1.213 . . . . 72.34 108.925 178.447 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 57.9 m-85 -109.59 121.35 45.01 Favored 'General case' 0 N--CA 1.476 0.83 0 C-N-CA 123.248 0.619 . . . . 73.01 110.02 -178.242 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 38.0 tt0 -74.53 104.23 5.16 Favored 'General case' 0 CA--C 1.547 0.854 0 C-N-CA 123.533 0.733 . . . . 74.52 109.192 171.36 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . 0.522 ' HB2' ' HG2' ' A' ' 4' ' ' PRO . 38.4 mt -85.6 123.83 31.46 Favored 'General case' 0 C--O 1.241 0.627 0 N-CA-C 109.114 -0.699 . . . . 75.01 109.114 175.971 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 25' ' ' PHE . . . . . 0.538 ' HD2' ' HZ1' ' A' ' 28' ' ' LYS . 58.0 m-85 -83.16 76.44 9.86 Favored 'General case' 0 CA--C 1.543 0.674 0 C-N-CA 123.498 0.719 . . . . 74.53 110.52 -177.043 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -71.14 -6.63 40.81 Favored 'General case' 0 N--CA 1.489 1.482 0 C-N-CA 122.913 0.485 . . . . 63.45 112.004 178.363 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 10.1 p-10 -89.07 -17.38 29.42 Favored 'General case' 0 CA--C 1.554 1.104 0 C-N-CA 123.746 0.819 . . . . 73.25 111.343 176.344 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 28' ' ' LYS . . . . . 0.538 ' HZ1' ' HD2' ' A' ' 25' ' ' PHE . 57.2 mttp -112.59 -44.78 3.3 Favored 'General case' 0 N--CA 1.494 1.758 0 C-N-CA 123.441 0.697 . . . . 73.22 111.033 -176.185 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 29' ' ' VAL . . . . . 0.496 HG23 ' HA ' ' A' ' 129' ' ' PHE . 12.0 m -127.91 62.97 59.49 Favored Pre-proline 0 CA--C 1.566 1.59 0 C-N-CA 124.448 1.099 . . . . 75.23 110.267 177.382 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 2.8 Cg_endo -49.83 -41.34 47.15 Favored 'Trans proline' 0 C--N 1.391 2.78 0 C-N-CA 123.41 2.74 . . . . 75.43 114.717 -172.994 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 31' ' ' LYS . . . . . 0.484 ' HG3' ' HH ' ' A' ' 79' ' ' TYR . 39.3 ttpt -64.46 -49.96 69.4 Favored 'General case' 0 N--CA 1.476 0.837 0 C-N-CA 123.449 0.699 . . . . 75.44 111.132 -177.496 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 7.1 m -76.01 -31.64 59.02 Favored 'General case' 0 CA--C 1.55 0.974 0 CA-C-N 115.115 -0.948 . . . . 73.33 111.504 -171.034 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -74.29 -46.93 38.08 Favored 'General case' 0 CA--C 1.543 0.704 0 C-N-CA 123.695 0.798 . . . . 72.4 110.336 177.976 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 11.6 tp10 -66.34 -29.66 69.89 Favored 'General case' 0 N--CA 1.482 1.134 0 C-N-CA 123.764 0.825 . . . . 71.41 110.979 178.852 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 35' ' ' ASN . . . . . 0.466 ' O ' ' HG ' ' A' ' 39' ' ' LEU . 25.8 t30 -54.06 -60.6 3.11 Favored 'General case' 0 N--CA 1.476 0.869 0 C-N-CA 123.826 0.85 . . . . 74.3 110.034 173.239 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 52.7 t80 -66.51 -34.84 78.83 Favored 'General case' 0 CA--C 1.541 0.598 0 O-C-N 124.224 0.953 . . . . 65.01 111.095 -175.094 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 37' ' ' ARG . . . . . 0.663 HH11 ' HB3' ' A' ' 4' ' ' PRO . 24.7 ttt180 -59.36 -45.56 91.05 Favored 'General case' 0 C--N 1.35 0.628 0 C-N-CA 123.541 0.736 . . . . 72.25 110.659 175.357 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 38' ' ' ALA . . . . . 0.556 ' HB2' ' HG2' ' A' ' 44' ' ' LYS . . . -73.3 -27.41 61.53 Favored 'General case' 0 CA--C 1.543 0.68 0 C-N-CA 123.434 0.694 . . . . 74.35 111.515 -177.956 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 39' ' ' LEU . . . . . 0.603 HD21 ' HE2' ' A' ' 48' ' ' TYR . 86.6 mt -72.97 -30.14 63.61 Favored 'General case' 0 N--CA 1.48 1.053 0 C-N-CA 123.462 0.705 . . . . 75.24 110.513 174.17 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 33.3 t -76.6 -53.95 7.35 Favored 'General case' 0 N--CA 1.478 0.946 0 C-N-CA 124.356 1.062 . . . . 75.2 110.898 179.452 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 44.0 p -76.83 -30.31 56.31 Favored 'General case' 0 N--CA 1.471 0.588 0 C-N-CA 124.401 1.08 . . . . 65.11 111.847 -174.523 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 79.86 30.89 41.6 Favored Glycine 0 C--N 1.341 0.851 0 CA-C-N 115.706 -0.679 . . . . 64.4 112.914 -179.076 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 55.7 mm-40 -58.33 -40.6 82.57 Favored 'General case' 0 N--CA 1.476 0.854 0 C-N-CA 123.079 0.551 . . . . 74.13 110.027 172.461 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 44' ' ' LYS . . . . . 0.556 ' HG2' ' HB2' ' A' ' 38' ' ' ALA . 28.4 mmmt -92.99 18.32 9.34 Favored 'General case' 0 CA--C 1.551 0.993 0 CA-C-N 115.315 -0.857 . . . . 72.41 111.379 -179.849 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 82.71 -8.87 61.02 Favored Glycine 0 C--N 1.35 1.335 0 N-CA-C 115.225 0.85 . . . . 72.54 115.225 172.872 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 46' ' ' PHE . . . . . 0.456 ' HE2' ' HA ' ' A' ' 78' ' ' ILE . 22.4 m-85 -82.09 -48.66 11.1 Favored 'General case' 0 N--CA 1.479 1.023 0 CA-C-N 117.713 0.756 . . . . 71.21 111.393 -170.224 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 38.04 62.6 1.02 Allowed Glycine 0 C--N 1.357 1.746 0 O-C-N 125.016 1.447 . . . . 42.31 116.186 168.278 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 48' ' ' TYR . . . . . 0.603 ' HE2' HD21 ' A' ' 39' ' ' LEU . 97.4 m-85 -62.18 92.85 0.04 OUTLIER 'General case' 0 N--CA 1.479 1.013 0 CA-C-O 121.908 0.861 . . . . 74.43 112.37 -170.736 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 49' ' ' LYS . . . . . 0.447 ' HE2' ' HA ' ' A' ' 160' ' ' ASP . 28.3 tptp -100.55 129.2 46.46 Favored 'General case' 0 C--O 1.237 0.436 0 C-N-CA 125.067 1.347 . . . . 74.04 107.954 179.593 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 73.63 20.5 79.82 Favored Glycine 0 C--N 1.345 1.045 0 O-C-N 123.33 0.394 . . . . 65.22 112.681 -176.007 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 51' ' ' SER . . . . . 0.451 ' HB2' ' HB3' ' A' ' 48' ' ' TYR . 22.7 t -64.92 119.83 11.43 Favored 'General case' 0 CA--C 1.546 0.819 0 C-N-CA 123.651 0.78 . . . . 74.11 109.901 -178.191 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 52' ' ' CYS . . . . . . . . . . . . . 37.6 t -93.36 153.79 18.33 Favored 'General case' 0 N--CA 1.472 0.642 0 C-N-CA 123.275 0.63 . . . . 71.11 111.959 -166.934 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 53' ' ' PHE . . . . . 0.474 ' HA ' ' HA2' ' A' ' 64' ' ' GLY . 45.9 m-85 -97.89 120.9 39.1 Favored 'General case' 0 C--O 1.237 0.412 0 C-N-CA 124.787 1.235 . . . . 74.55 108.04 172.724 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 19.5 p-80 -108.68 -36.71 6.09 Favored 'General case' 0 N--CA 1.479 0.996 0 C-N-CA 123.822 0.849 . . . . 71.43 110.146 -173.269 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 50.2 ttt180 -122.61 97.34 5.41 Favored 'General case' 0 C--O 1.217 -0.643 0 N-CA-C 108.703 -0.851 . . . . 73.24 108.703 -175.057 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 56' ' ' ILE . . . . . 0.488 HG23 ' HA ' ' A' ' 143' ' ' GLU . 44.9 mt -119.85 128.35 75.91 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.586 0 N-CA-C 108.192 -1.04 . . . . 70.21 108.192 172.931 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 57' ' ' ILE . . . . . 0.566 HG22 ' HA ' ' A' ' 148' ' ' ARG . 60.5 mt -120.68 124.86 27.37 Favored Pre-proline 0 CA--C 1.547 0.831 0 N-CA-C 108.34 -0.985 . . . . 74.22 108.34 175.436 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 58' ' ' PRO . . . . . 0.54 ' HA ' ' HG2' ' A' ' 143' ' ' GLU . 37.8 Cg_endo -63.1 141.69 84.22 Favored 'Trans proline' 0 C--N 1.383 2.352 0 C-N-CA 123.31 2.673 . . . . 71.43 112.505 -178.364 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 65.29 21.6 68.5 Favored Glycine 0 C--N 1.343 0.967 0 CA-C-N 115.326 -0.852 . . . . 73.51 113.717 -177.738 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 60' ' ' PHE . . . . . 0.723 ' HB2' ' HG3' ' B' ' 223' ' ' GLN . 27.8 t80 -138.01 -74.78 0.4 Allowed 'General case' 0 N--CA 1.468 0.447 0 N-CA-C 109.245 -0.65 . . . . 74.51 109.245 -172.42 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 61' ' ' MET . . . . . 0.59 ' HE3' ' HB3' ' A' ' 115' ' ' CYS . 11.9 ptp -175.31 154.1 1.66 Allowed 'General case' 0 N--CA 1.483 1.215 0 O-C-N 123.677 0.611 . . . . 75.15 112.501 -178.472 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 62' ' ' CYS . . . . . . . . . . . . . 56.7 m -102.94 109.74 21.4 Favored 'General case' 0 CA--C 1.539 0.539 0 CA-C-N 115.076 -0.965 . . . . 73.4 108.973 170.369 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 63' ' ' GLN . . . . . 0.472 ' HA ' ' HA ' ' A' ' 113' ' ' PHE . 53.1 tt0 -100.08 105.33 16.96 Favored 'General case' 0 C--O 1.248 0.977 0 CA-C-O 121.336 0.589 . . . . 71.54 109.901 -178.05 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 64' ' ' GLY . . . . . 0.474 ' HA2' ' HA ' ' A' ' 53' ' ' PHE . . . -110.79 -153.38 13.2 Favored Glycine 0 C--N 1.344 1.006 0 CA-C-N 114.466 -1.243 . . . . 72.11 111.31 174.931 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 86.05 -35.6 3.25 Favored Glycine 0 C--N 1.344 1.025 0 N-CA-C 111.856 -0.498 . . . . 62.54 111.856 -173.494 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 66' ' ' ASP . . . . . 0.546 ' HB2' ' HG2' ' A' ' 111' ' ' GLN . 35.5 t70 -66.54 103.1 0.99 Allowed 'General case' 0 N--CA 1.445 -0.688 0 C-N-CA 124.836 1.254 . . . . 74.42 110.686 -177.855 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 71.5 t80 -156.92 -68.83 0.1 Allowed 'General case' 0 C--O 1.239 0.521 0 N-CA-C 108.361 -0.978 . . . . 75.14 108.361 177.919 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 27.5 m -79.25 122.06 25.85 Favored 'General case' 0 C--O 1.24 0.57 0 CA-C-N 115.49 -0.777 . . . . 54.54 108.943 178.693 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 49.5 mtt85 65.94 36.06 6.16 Favored 'General case' 0 N--CA 1.482 1.159 0 C-N-CA 124.302 1.041 . . . . 73.01 111.538 177.787 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 1.2 t60 -41.1 -52.73 3.2 Favored 'General case' 0 N--CA 1.494 1.741 0 C-N-CA 125.804 1.642 . . . . 75.12 113.88 -175.273 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 93.2 m-20 -65.58 99.77 0.46 Allowed 'General case' 0 N--CA 1.477 0.887 0 C-N-CA 123.118 0.567 . . . . 72.44 110.777 -175.847 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 72' ' ' GLY . . . . . 0.61 ' HA2' ' HG2' ' B' ' 216' ' ' PRO . . . 88.29 -7.05 82.73 Favored Glycine 0 C--N 1.345 1.044 0 CA-C-N 115.677 -0.692 . . . . 74.22 114.688 174.689 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 73' ' ' THR . . . . . 0.435 ' O ' ' HB3' ' A' ' 110' ' ' SER . 26.1 m -137.09 -83.02 0.35 Allowed 'General case' 0 N--CA 1.48 1.072 0 CA-C-N 118.076 0.938 . . . . 65.55 110.526 -178.049 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 74' ' ' GLY . . . . . 0.438 ' O ' ' HG3' ' A' ' 111' ' ' GLN . . . 71.95 64.12 2.78 Favored Glycine 0 C--N 1.354 1.535 0 N-CA-C 114.371 0.508 . . . . 71.53 114.371 173.171 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 97.43 54.53 1.24 Allowed Glycine 0 N--CA 1.472 1.052 0 C-N-CA 120.309 -0.948 . . . . 64.33 112.305 176.016 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 64.3 pttt -61.05 172.15 1.08 Allowed 'General case' 0 CA--C 1.551 1.001 0 C-N-CA 123.959 0.904 . . . . 74.35 113.283 -175.4 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 88.1 p -90.57 179.42 5.84 Favored 'General case' 0 C--O 1.242 0.684 0 CA-C-N 115.212 -0.904 . . . . 70.21 111.187 -176.146 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 78' ' ' ILE . . . . . 0.456 ' HA ' ' HE2' ' A' ' 46' ' ' PHE . 35.0 pt -74.56 -15.54 16.25 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.663 0 CA-C-N 115.72 -0.673 . . . . 71.41 111.359 177.608 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 79' ' ' TYR . . . . . 0.484 ' HH ' ' HG3' ' A' ' 31' ' ' LYS . 82.1 m-85 -95.0 11.27 32.57 Favored 'General case' 0 N--CA 1.475 0.821 0 C-N-CA 123.735 0.814 . . . . 74.22 111.35 177.287 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 105.88 -146.08 16.02 Favored Glycine 0 C--N 1.345 1.053 0 N-CA-C 111.244 -0.742 . . . . 71.12 111.244 -179.253 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 81' ' ' GLU . . . . . 0.407 ' HG2' ' HZ2' ' A' ' 82' ' ' LYS . 36.1 tt0 -57.81 -38.5 75.66 Favored 'General case' 0 N--CA 1.477 0.877 0 C-N-CA 124.08 0.952 . . . . 74.24 111.423 -178.227 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 82' ' ' LYS . . . . . 0.407 ' HZ2' ' HG2' ' A' ' 81' ' ' GLU . 3.8 ptpp? -160.15 172.48 17.36 Favored 'General case' 0 N--CA 1.474 0.743 0 C-N-CA 123.417 0.687 . . . . 74.0 111.805 -177.451 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 4.1 p90 -159.07 171.89 19.16 Favored 'General case' 0 CA--C 1.544 0.726 0 C-N-CA 125.012 1.325 . . . . 73.14 109.514 177.657 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 84' ' ' GLU . . . . . 0.506 ' HA ' ' HA ' ' A' ' 106' ' ' ASN . 12.6 pt-20 -81.67 158.4 24.29 Favored 'General case' 0 N--CA 1.475 0.776 0 C-N-CA 123.574 0.75 . . . . 74.32 111.758 -177.319 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 52.7 m-20 -81.85 143.74 31.51 Favored 'General case' 0 N--CA 1.476 0.875 0 C-N-CA 123.761 0.824 . . . . 75.33 109.269 173.294 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 12.5 tp10 -83.21 -59.38 2.48 Favored 'General case' 0 N--CA 1.477 0.883 0 CA-C-O 121.278 0.561 . . . . 71.4 111.051 -174.551 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 32.0 p30 -153.68 -167.5 2.7 Favored 'General case' 0 N--CA 1.472 0.673 0 C-N-CA 123.747 0.819 . . . . 70.12 109.157 -174.167 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 81.4 m-85 -138.58 39.49 2.22 Favored 'General case' 0 N--CA 1.482 1.166 0 C-N-CA 123.717 0.807 . . . . 73.54 110.451 178.046 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 67.8 mt -62.31 -38.18 80.49 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.324 0 CA-C-O 121.531 0.681 . . . . 73.33 109.904 174.612 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 90' ' ' LEU . . . . . 0.654 ' HB3' ' HB ' ' A' ' 128' ' ' VAL . 95.4 mt -98.9 150.62 21.73 Favored 'General case' 0 CA--C 1.543 0.705 0 C-N-CA 124.088 0.955 . . . . 74.45 110.893 179.379 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 47.2 pttt -158.77 163.87 36.35 Favored 'General case' 0 N--CA 1.482 1.172 0 C-N-CA 124.165 0.986 . . . . 75.21 110.294 -170.946 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 92' ' ' HIS . . . . . 0.4 ' HA ' HG13 ' A' ' 97' ' ' ILE . 13.3 m-70 -88.89 63.38 6.76 Favored 'General case' 0 N--CA 1.488 1.439 0 C-N-CA 123.63 0.772 . . . . 74.31 109.93 -175.196 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 15.3 p -90.8 2.57 55.97 Favored 'General case' 0 N--CA 1.48 1.064 0 C-N-CA 123.849 0.86 . . . . 74.12 111.811 178.508 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -157.27 173.36 34.79 Favored Glycine 0 C--N 1.343 0.926 0 CA-C-N 116.653 -0.248 . . . . 61.31 112.918 -178.644 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 86.2 Cg_endo -78.16 157.1 30.05 Favored 'Trans proline' 0 C--N 1.362 1.249 0 C-N-CA 123.276 2.651 . . . . 74.0 112.64 175.895 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 79.63 18.77 72.51 Favored Glycine 0 C--N 1.342 0.871 0 CA-C-N 115.694 -0.685 . . . . 61.1 114.476 175.396 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 97' ' ' ILE . . . . . 0.673 ' HB ' ' SG ' ' A' ' 115' ' ' CYS . 19.0 mm -73.03 128.54 35.85 Favored 'Isoleucine or valine' 0 CA--C 1.554 1.119 0 C-N-CA 123.967 0.907 . . . . 75.21 110.592 178.932 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 98' ' ' LEU . . . . . 0.486 HD11 HG12 ' A' ' 114' ' ' ILE . 67.7 tp -103.88 122.71 45.72 Favored 'General case' 0 C--O 1.252 1.207 0 C-N-CA 123.637 0.775 . . . . 73.52 110.13 176.139 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 99' ' ' SER . . . . . 0.416 ' HB3' ' HD2' ' A' ' 126' ' ' HIS . 50.7 m -145.34 139.68 27.18 Favored 'General case' 0 CA--C 1.555 1.155 0 C-N-CA 124.735 1.214 . . . . 72.24 109.418 179.744 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 100' ' ' MET . . . . . 0.654 ' HA ' ' HA ' ' A' ' 112' ' ' PHE . 85.9 mtp -76.57 147.54 37.61 Favored 'General case' 0 N--CA 1.491 1.605 0 C-N-CA 123.877 0.871 . . . . 74.31 111.647 178.48 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -75.25 145.77 41.66 Favored 'General case' 0 N--CA 1.479 0.995 0 C-N-CA 123.654 0.782 . . . . 65.53 111.843 -175.261 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 102' ' ' ASN . . . . . 0.405 ' HB3' ' HA ' ' A' ' 108' ' ' ASN . 26.9 p-10 -168.54 173.04 7.72 Favored 'General case' 0 N--CA 1.477 0.908 0 C-N-CA 123.958 0.903 . . . . 75.11 110.675 -178.902 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -91.45 -47.81 7.23 Favored 'General case' 0 N--CA 1.471 0.578 0 CA-C-N 115.7 -0.682 . . . . 65.21 109.551 168.636 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -163.1 -161.2 12.09 Favored Glycine 0 C--N 1.345 1.074 0 CA-C-N 115.512 -0.767 . . . . 62.22 111.973 178.111 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 51.9 Cg_exo -55.8 135.68 70.73 Favored 'Trans proline' 0 C--N 1.375 1.965 0 C-N-CA 123.417 2.745 . . . . 70.23 112.608 179.133 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 106' ' ' ASN . . . . . 0.506 ' HA ' ' HA ' ' A' ' 84' ' ' GLU . 64.9 t30 69.45 11.22 7.99 Favored 'General case' 0 N--CA 1.484 1.261 0 C-N-CA 124.982 1.313 . . . . 64.43 112.247 179.269 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 8.8 m -105.08 -12.98 15.89 Favored 'General case' 0 CA--C 1.552 1.057 0 C-N-CA 123.452 0.701 . . . . 71.21 109.576 171.549 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 108' ' ' ASN . . . . . 0.405 ' HA ' ' HB3' ' A' ' 102' ' ' ASN . 15.1 t30 -57.88 146.6 31.44 Favored 'General case' 0 N--CA 1.481 1.081 0 C-N-CA 125.609 1.563 . . . . 72.53 111.451 175.306 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 113.13 21.15 6.02 Favored Glycine 0 N--CA 1.471 1.02 0 N-CA-C 113.996 0.359 . . . . 51.32 113.996 175.944 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 110' ' ' SER . . . . . 0.435 ' HB3' ' O ' ' A' ' 73' ' ' THR . 69.0 m -138.36 122.62 18.16 Favored 'General case' 0 N--CA 1.474 0.765 0 N-CA-C 108.744 -0.836 . . . . 73.01 108.744 171.546 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 111' ' ' GLN . . . . . 0.546 ' HG2' ' HB2' ' A' ' 66' ' ' ASP . 18.1 mt-30 65.72 170.92 0.22 Allowed 'General case' 0 N--CA 1.498 1.953 0 C-N-CA 124.302 1.041 . . . . 75.11 111.802 -178.255 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 112' ' ' PHE . . . . . 0.654 ' HA ' ' HA ' ' A' ' 100' ' ' MET . 53.2 p90 -150.07 138.81 20.82 Favored 'General case' 0 N--CA 1.479 0.978 0 C-N-CA 123.118 0.567 . . . . 73.43 110.102 174.975 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 113' ' ' PHE . . . . . 0.472 ' HA ' ' HA ' ' A' ' 63' ' ' GLN . 42.9 p90 -111.84 144.99 40.24 Favored 'General case' 0 C--O 1.24 0.588 0 C-N-CA 123.753 0.821 . . . . 74.32 110.668 174.435 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 114' ' ' ILE . . . . . 0.486 HG12 HD11 ' A' ' 98' ' ' LEU . 8.2 mt -116.46 99.67 8.81 Favored 'Isoleucine or valine' 0 C--O 1.24 0.577 0 N-CA-C 106.919 -1.511 . . . . 74.11 106.919 178.232 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 115' ' ' CYS . . . . . 0.673 ' SG ' ' HB ' ' A' ' 97' ' ' ILE . 19.3 p -84.45 118.05 24.04 Favored 'General case' 0 N--CA 1.472 0.644 0 C-N-CA 122.404 0.282 . . . . 73.34 110.758 -175.768 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 59.5 p -78.65 1.17 23.69 Favored 'General case' 0 N--CA 1.481 1.075 0 C-N-CA 124.052 0.941 . . . . 74.42 111.902 -179.024 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -133.22 162.22 32.35 Favored 'General case' 0 C--O 1.244 0.787 0 C-N-CA 123.704 0.802 . . . . 71.01 109.966 -179.827 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 8.8 ptmt -71.82 81.51 0.89 Allowed 'General case' 0 CA--C 1.549 0.937 0 CA-C-O 121.846 0.831 . . . . 74.54 109.415 171.944 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 119' ' ' THR . . . . . 0.433 ' HB ' HD21 ' A' ' 122' ' ' LEU . 32.2 p -82.56 85.31 7.0 Favored 'General case' 0 CA--C 1.55 0.971 0 CA-C-O 122.147 0.975 . . . . 72.51 109.309 -177.331 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 12.8 pt-20 -74.57 -27.64 60.58 Favored 'General case' 0 N--CA 1.48 1.06 0 CA-C-N 114.67 -1.15 . . . . 71.04 112.318 -167.724 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 121' ' ' TRP . . . . . . . . . . . . . 46.5 p90 -67.49 -1.75 5.39 Favored 'General case' 0 N--CA 1.483 1.2 0 C-N-CA 123.747 0.819 . . . . 73.03 112.238 178.352 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 122' ' ' LEU . . . . . 0.438 HD13 ' HG3' ' B' ' 220' ' ' PRO . 3.2 mm? -78.06 -3.91 44.58 Favored 'General case' 0 CA--C 1.548 0.895 0 C-N-CA 124.454 1.102 . . . . 73.45 112.48 174.064 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 40.6 m-20 -65.22 128.38 35.58 Favored 'General case' 0 N--CA 1.487 1.384 0 CA-C-N 118.247 0.476 . . . . 63.1 111.164 176.592 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 104.23 -25.79 25.0 Favored Glycine 0 N--CA 1.477 1.378 0 N-CA-C 111.867 -0.493 . . . . 65.03 111.867 -174.665 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 12.5 ttmm -85.59 -164.46 1.02 Allowed 'General case' 0 CA--C 1.552 1.033 0 C-N-CA 124.329 1.052 . . . . 73.01 108.449 177.443 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 126' ' ' HIS . . . . . 0.416 ' HD2' ' HB3' ' A' ' 99' ' ' SER . 34.6 t60 -66.91 131.7 46.44 Favored 'General case' 0 CA--C 1.546 0.825 0 CA-C-O 121.183 0.516 . . . . 75.32 111.063 -175.343 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 7.4 p -62.42 147.4 11.62 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.808 0 CA-C-N 114.038 -1.437 . . . . 75.4 112.074 178.126 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 128' ' ' VAL . . . . . 0.654 ' HB ' ' HB3' ' A' ' 90' ' ' LEU . 46.3 t -64.43 149.98 10.61 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.721 0 C-N-CA 123.374 0.67 . . . . 74.21 110.3 174.699 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 129' ' ' PHE . . . . . 0.496 ' HA ' HG23 ' A' ' 29' ' ' VAL . 49.3 p90 -136.51 -27.95 1.03 Allowed 'General case' 0 N--CA 1.479 0.977 0 C-N-CA 122.378 0.271 . . . . 74.3 111.127 174.567 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . -123.54 167.13 15.84 Favored Glycine 0 C--N 1.343 0.942 0 O-C-N 123.424 0.452 . . . . 72.42 112.323 -177.719 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 30.2 ttpt -154.65 122.84 5.97 Favored 'General case' 0 N--CA 1.468 0.454 0 N-CA-C 107.997 -1.112 . . . . 74.11 107.997 179.092 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 12.7 p -67.0 122.39 17.94 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.959 0 CA-C-O 121.515 0.674 . . . . 65.01 109.98 177.468 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 21.2 ptmt -108.66 -22.98 12.01 Favored 'General case' 0 N--CA 1.476 0.844 0 C-N-CA 124.054 0.941 . . . . 63.12 110.251 179.009 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 134' ' ' GLU . . . . . 0.483 ' HB2' ' HB2' ' A' ' 21' ' ' SER . 34.6 mt-10 -136.71 134.03 36.74 Favored 'General case' 0 N--CA 1.475 0.817 0 C-N-CA 124.798 1.239 . . . . 75.44 108.17 179.863 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 80.1 26.66 54.94 Favored Glycine 0 CA--C 1.528 0.862 0 CA-C-O 119.837 -0.424 . . . . 73.25 113.235 -177.624 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 136' ' ' MET . . . . . . . . . . . . . 5.8 tpt -59.79 -53.17 61.1 Favored 'General case' 0 N--CA 1.485 1.288 0 C-N-CA 123.664 0.786 . . . . 70.32 110.471 175.103 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 137' ' ' ASN . . . . . . . . . . . . . 20.5 m120 -64.65 -25.79 68.11 Favored 'General case' 0 N--CA 1.477 0.884 0 CA-C-N 115.902 -0.59 . . . . 74.44 110.997 -179.537 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 138' ' ' ILE . . . . . . . . . . . . . 50.9 mm -69.52 -40.4 79.65 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.728 0 C-N-CA 123.393 0.677 . . . . 73.54 110.433 175.853 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 91.2 t -63.18 -40.33 88.62 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.131 0 C-N-CA 123.033 0.533 . . . . 74.41 109.888 174.987 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 40.3 mt-10 -65.46 -33.23 75.44 Favored 'General case' 0 CA--C 1.551 0.985 0 CA-C-N 115.541 -0.754 . . . . 75.31 111.329 175.808 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -75.2 -45.11 42.57 Favored 'General case' 0 N--CA 1.481 1.08 0 C-N-CA 123.753 0.821 . . . . 71.31 111.739 -177.667 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 142' ' ' MET . . . . . 0.533 ' HB2' HD13 ' A' ' 156' ' ' ILE . 25.4 ptm -69.48 -29.38 67.03 Favored 'General case' 0 N--CA 1.476 0.852 0 CA-C-N 115.823 -0.626 . . . . 74.1 110.66 179.031 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 143' ' ' GLU . . . . . 0.54 ' HG2' ' HA ' ' A' ' 58' ' ' PRO . 30.9 tt0 -64.88 -29.01 69.94 Favored 'General case' 0 C--N 1.353 0.731 0 C-N-CA 123.243 0.617 . . . . 70.02 111.531 -179.927 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 144' ' ' ARG . . . . . . . . . . . . . 24.3 mtp180 -63.15 -23.61 67.51 Favored 'General case' 0 N--CA 1.474 0.761 0 C-N-CA 123.572 0.749 . . . . 74.21 111.843 177.475 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 145' ' ' PHE . . . . . . . . . . . . . 65.7 m-85 -80.14 -13.82 58.97 Favored 'General case' 0 N--CA 1.481 1.111 0 C-N-CA 122.42 0.288 . . . . 73.4 111.506 179.68 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 146' ' ' GLY . . . . . 0.418 ' HA2' ' HA ' ' A' ' 152' ' ' THR . . . -84.4 171.09 47.41 Favored Glycine 0 C--N 1.343 0.949 0 O-C-N 122.979 0.174 . . . . 64.31 112.675 177.192 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 34.1 t -132.96 167.29 20.54 Favored 'General case' 0 N--CA 1.48 1.05 0 C-N-CA 123.966 0.906 . . . . 74.24 109.716 -176.229 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 148' ' ' ARG . . . . . 0.566 ' HA ' HG22 ' A' ' 57' ' ' ILE . 23.7 mmt85 -67.6 -23.39 65.38 Favored 'General case' 0 N--CA 1.488 1.46 0 C-N-CA 123.925 0.89 . . . . 75.55 112.591 -175.481 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 149' ' ' ASN . . . . . . . . . . . . . 27.8 p-10 -86.97 1.09 53.89 Favored 'General case' 0 N--CA 1.487 1.38 0 C-N-CA 123.363 0.665 . . . . 73.22 111.106 174.818 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . 95.32 -26.5 19.21 Favored Glycine 0 C--N 1.341 0.809 0 CA-C-O 119.692 -0.504 . . . . 73.13 113.169 179.282 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 65.0 tttp -63.69 118.14 7.84 Favored 'General case' 0 N--CA 1.476 0.827 0 CA-C-N 117.507 0.654 . . . . 70.44 110.921 -174.542 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 152' ' ' THR . . . . . 0.418 ' HA ' ' HA2' ' A' ' 146' ' ' GLY . 9.6 m -93.39 124.7 37.56 Favored 'General case' 0 CA--C 1.542 0.644 0 CA-C-N 114.763 -1.108 . . . . 74.4 109.062 179.269 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 153' ' ' SER . . . . . . . . . . . . . 66.2 p -63.77 -26.81 68.81 Favored 'General case' 0 N--CA 1.48 1.066 0 C-N-CA 124.13 0.972 . . . . 62.23 112.056 -178.655 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 72.1 mmtt -111.89 141.3 45.7 Favored 'General case' 0 C--O 1.238 0.472 0 C-N-CA 124.009 0.924 . . . . 75.34 111.252 -176.38 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 72.9 mmtt -83.16 91.23 7.2 Favored 'General case' 0 C--O 1.238 0.487 0 N-CA-C 108.369 -0.975 . . . . 74.01 108.369 172.798 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 156' ' ' ILE . . . . . 0.533 HD13 ' HB2' ' A' ' 142' ' ' MET . 62.6 mt -94.13 110.97 24.38 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.473 0 CA-C-N 114.84 -1.073 . . . . 64.34 108.955 -177.94 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 157' ' ' THR . . . . . . . . . . . . . 49.3 p -115.59 155.07 28.29 Favored 'General case' 0 C--O 1.243 0.743 0 C-N-CA 123.847 0.859 . . . . 75.13 110.454 -176.979 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 158' ' ' ILE . . . . . 0.475 HG23 ' HB3' ' A' ' 8' ' ' PHE . 62.6 mt -75.5 93.71 0.92 Allowed 'Isoleucine or valine' 0 CA--C 1.542 0.644 0 N-CA-C 108.205 -1.035 . . . . 73.03 108.205 171.199 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 159' ' ' ALA . . . . . 0.574 ' HB3' ' HB1' ' A' ' 11' ' ' ALA . . . -58.31 -35.62 72.13 Favored 'General case' 0 N--CA 1.474 0.744 0 C-N-CA 124.485 1.114 . . . . 71.1 112.834 -177.028 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 160' ' ' ASP . . . . . 0.447 ' HA ' ' HE2' ' A' ' 49' ' ' LYS . 23.7 t0 -161.16 157.39 25.8 Favored 'General case' 0 N--CA 1.477 0.906 0 O-C-N 123.358 0.411 . . . . 74.53 110.648 -174.986 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 161' ' ' CYS . . . . . . . . . . . . . 58.7 m -123.49 -172.59 2.55 Favored 'General case' 0 N--CA 1.485 1.299 0 C-N-CA 125.048 1.339 . . . . 74.33 108.473 177.281 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 162' ' ' GLY . . . . . . . . . . . . . . . 132.25 57.09 0.08 OUTLIER Glycine 0 C--N 1.354 1.572 0 CA-C-N 118.716 0.689 . . . . 61.15 112.977 -172.957 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 163' ' ' GLN . . . . . 0.531 ' HA ' ' H ' ' A' ' 7' ' ' PHE . 21.8 pt20 -47.84 137.46 9.77 Favored 'General case' 0 N--CA 1.485 1.288 0 C-N-CA 124.356 1.062 . . . . 72.3 113.708 -173.242 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 164' ' ' LEU . . . . . 0.468 ' HG ' ' HB2' ' A' ' 7' ' ' PHE . 41.2 mt -84.08 125.1 31.8 Favored 'General case' 0 CA--C 1.543 0.698 0 C-N-CA 124.005 0.922 . . . . 74.23 110.151 179.914 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 165' ' ' GLU . . . . . . . . . . . . . 29.0 tt0 . . . . . 0 C--O 1.253 1.245 0 C-N-CA 123.39 0.676 . . . . 74.13 109.602 176.971 . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' B' B ' 216' ' ' PRO . . . . . 0.61 ' HG2' ' HA2' ' A' ' 72' ' ' GLY . 24.2 Cg_exo . . . . . 0 N--CA 1.492 1.415 0 N-CA-C 111.527 -0.22 . . . . 72.41 111.527 . . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 217' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER 55.74 64.39 5.38 Favored Pre-proline 0 CA--C 1.558 1.261 0 C-N-CA 124.775 1.23 . . . . 71.41 110.68 -176.331 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 218' ' ' PRO . . . . . . . . . . . . . 93.4 Cg_endo -78.7 146.97 21.57 Favored 'Trans proline' 0 C--N 1.378 2.128 0 C-N-CA 122.28 1.986 . . . . 70.03 112.044 -178.634 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 219' ' ' GLY . . . . . . . . . . . . . . . 112.38 177.55 19.88 Favored Glycine 0 CA--C 1.527 0.834 0 CA-C-N 115.186 -0.916 . . . . 75.52 111.909 -175.981 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 220' ' ' PRO . . . . . 0.438 ' HG3' HD13 ' A' ' 122' ' ' LEU . 91.7 Cg_endo -75.65 178.48 7.33 Favored 'Trans proline' 0 N--CA 1.489 1.254 0 C-N-CA 123.41 2.74 . . . . 63.54 113.419 -177.067 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 221' ' ' TYR . . . . . . . . . . . . . 99.7 m-85 -129.62 -166.13 1.62 Allowed 'General case' 0 N--CA 1.476 0.87 0 C-N-CA 124.464 1.105 . . . . 73.3 109.558 179.381 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 222' ' ' ALA . . . . . . . . . . . . . . . 86.31 179.65 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.533 0 C-N-CA 126.513 1.925 . . . . 63.15 110.03 -167.908 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 223' ' ' GLN . . . . . 0.723 ' HG3' ' HB2' ' A' ' 60' ' ' PHE . 18.2 mm-40 64.84 68.18 0.77 Allowed Pre-proline 0 N--CA 1.481 1.091 0 C-N-CA 124.794 1.238 . . . . 74.1 110.787 -171.954 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 224' ' ' PRO . . . . . . . . . . . . . 17.3 Cg_endo . . . . . 0 C--N 1.379 2.182 0 C-N-CA 123.023 2.482 . . . . 72.12 111.006 -177.65 . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 26.3 mmt . . . . . 0 N--CA 1.475 0.813 0 CA-C-O 121.285 0.565 . . . . 75.34 110.112 . . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 9.4 p -99.67 9.83 7.51 Favored 'Isoleucine or valine' 0 CA--C 1.561 1.388 0 C-N-CA 124.123 0.969 . . . . 71.52 109.492 173.055 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 3' ' ' ASN . . . . . 0.472 HD21 ' HA ' ' A' ' 25' ' ' PHE . 20.8 m120 -57.93 120.77 45.17 Favored Pre-proline 0 C--N 1.362 1.114 0 C-N-CA 123.908 0.883 . . . . 73.15 111.723 -176.836 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 4' ' ' PRO . . . . . 0.499 ' HG2' ' HB2' ' A' ' 24' ' ' LEU . 42.5 Cg_endo -65.42 135.34 42.26 Favored 'Trans proline' 0 C--N 1.378 2.1 0 C-N-CA 122.525 2.15 . . . . 73.31 110.816 178.522 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 55.9 m -122.3 123.26 41.01 Favored 'General case' 0 CA--C 1.54 0.568 0 N-CA-C 109.278 -0.638 . . . . 73.12 109.278 -172.882 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . 0.546 ' HA ' ' HB2' ' A' ' 163' ' ' GLN . 14.4 m -101.33 136.39 33.35 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.659 0 C-N-CA 123.965 0.906 . . . . 74.3 109.256 -175.915 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 7' ' ' PHE . . . . . 0.405 ' HB3' ' HA ' ' A' ' 163' ' ' GLN . 86.4 t80 -125.6 136.98 53.85 Favored 'General case' 0 C--O 1.238 0.47 0 C-N-CA 123.469 0.707 . . . . 73.1 109.683 -175.627 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 8' ' ' PHE . . . . . 0.441 ' HB3' HG23 ' A' ' 158' ' ' ILE . 53.3 m-85 -138.76 165.84 25.96 Favored 'General case' 0 CA--C 1.534 0.349 0 C-N-CA 124.809 1.243 . . . . 70.21 109.493 177.254 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 13.9 m-20 -111.67 118.23 35.07 Favored 'General case' 0 C--N 1.323 -0.565 0 N-CA-C 106.386 -1.709 . . . . 73.54 106.386 168.868 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 10' ' ' ILE . . . . . 0.443 HG22 ' SD ' ' A' ' 142' ' ' MET . 46.3 mm -84.98 129.53 37.58 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.56 0 N-CA-C 109.159 -0.682 . . . . 74.12 109.159 178.722 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 11' ' ' ALA . . . . . 0.766 ' HB2' ' HB1' ' A' ' 159' ' ' ALA . . . -124.59 126.98 46.69 Favored 'General case' 0 C--O 1.217 -0.642 0 C-N-CA 123.691 0.796 . . . . 65.0 110.496 -176.89 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . 0.446 HG21 ' HB2' ' A' ' 17' ' ' LEU . 89.1 t -96.14 116.38 37.85 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.759 0 N-CA-C 107.976 -1.12 . . . . 74.4 107.976 173.418 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 30.2 m-20 62.99 24.14 14.39 Favored 'General case' 0 N--CA 1.488 1.446 0 C-N-CA 125.59 1.556 . . . . 74.13 112.048 -177.288 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 97.24 -17.77 58.57 Favored Glycine 0 C--N 1.347 1.151 0 CA-C-O 119.951 -0.361 . . . . 75.12 113.037 -179.201 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 40.9 mm-40 -94.32 124.66 54.95 Favored Pre-proline 0 CA--C 1.545 0.755 0 CA-C-O 118.551 -0.738 . . . . 75.43 109.767 179.66 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 19.7 Cg_endo -56.06 118.07 4.81 Favored 'Trans proline' 0 C--N 1.381 2.274 0 C-N-CA 123.222 2.615 . . . . 74.21 113.111 -176.308 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . 0.446 ' HB2' HG21 ' A' ' 12' ' ' VAL . 49.3 tp -78.12 -38.55 43.63 Favored 'General case' 0 N--CA 1.476 0.871 0 C-N-CA 124.244 1.018 . . . . 73.41 109.407 171.371 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 177.39 -160.3 27.0 Favored Glycine 0 N--CA 1.449 -0.481 0 CA-C-N 114.317 -1.311 . . . . 63.11 110.707 -175.521 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 6.3 ptp180 -140.08 147.22 39.97 Favored 'General case' 0 N--CA 1.468 0.456 0 C-N-CA 123.934 0.893 . . . . 73.13 109.693 179.799 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 87.4 t -137.18 132.5 46.53 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.7 0 C-N-CA 124.092 0.957 . . . . 72.3 109.593 -175.24 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 7.9 t -120.1 122.62 41.45 Favored 'General case' 0 CA--C 1.547 0.855 0 N-CA-C 108.999 -0.741 . . . . 71.3 108.999 172.601 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 22' ' ' PHE . . . . . 0.534 ' HA ' ' HA ' ' A' ' 132' ' ' VAL . 11.1 m-85 -100.15 152.22 20.51 Favored 'General case' 0 N--CA 1.476 0.857 0 C-N-CA 124.027 0.931 . . . . 75.23 108.819 176.556 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . 0.636 ' HB2' ' HD2' ' A' ' 133' ' ' LYS . 39.7 tt0 -110.76 119.01 37.7 Favored 'General case' 0 CA--C 1.54 0.58 0 C-N-CA 123.318 0.647 . . . . 70.21 109.538 175.517 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . 0.499 ' HB2' ' HG2' ' A' ' 4' ' ' PRO . 18.5 mt -90.8 127.86 36.5 Favored 'General case' 0 N--CA 1.472 0.654 0 C-N-CA 124.462 1.105 . . . . 73.05 110.028 -178.301 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 25' ' ' PHE . . . . . 0.519 ' HB2' HD11 ' A' ' 90' ' ' LEU . 85.4 m-85 -88.92 71.9 8.52 Favored 'General case' 0 CA--C 1.536 0.427 0 C-N-CA 123.776 0.83 . . . . 70.52 110.34 -178.534 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -67.12 -15.59 63.81 Favored 'General case' 0 N--CA 1.481 1.122 0 CA-C-N 115.403 -0.817 . . . . 70.02 112.223 177.58 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 9.2 p-10 -76.3 -18.71 58.82 Favored 'General case' 0 CA--C 1.555 1.156 0 C-N-CA 123.409 0.683 . . . . 64.34 111.088 176.885 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 52.2 mttp -106.67 -45.65 4.17 Favored 'General case' 0 N--CA 1.483 1.201 0 C-N-CA 123.902 0.881 . . . . 75.34 110.37 -178.536 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 29' ' ' VAL . . . . . 0.563 HG21 ' HA ' ' A' ' 129' ' ' PHE . 4.6 m -134.68 69.98 71.8 Favored Pre-proline 0 CA--C 1.562 1.437 0 C-N-CA 124.36 1.064 . . . . 62.5 109.913 -175.748 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 18.8 Cg_endo -58.57 -29.54 89.26 Favored 'Trans proline' 0 C--N 1.382 2.324 0 C-N-CA 123.062 2.508 . . . . 64.51 113.985 -175.004 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 34.8 ttmt -72.63 -56.95 4.54 Favored 'General case' 0 N--CA 1.479 1.01 0 C-N-CA 123.668 0.787 . . . . 75.44 111.217 -179.648 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 6.6 m -69.31 -25.54 64.27 Favored 'General case' 0 CA--C 1.559 1.298 0 CA-C-N 115.081 -0.963 . . . . 75.1 111.074 -173.373 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -82.89 -42.4 17.77 Favored 'General case' 0 CA--C 1.548 0.898 0 C-N-CA 123.717 0.807 . . . . 74.44 111.085 177.254 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 38.8 tt0 -56.13 -39.44 72.25 Favored 'General case' 0 N--CA 1.493 1.675 0 C-N-CA 123.681 0.792 . . . . 62.42 110.57 177.192 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 35' ' ' ASN . . . . . 0.591 ' ND2' ' SD ' ' A' ' 100' ' ' MET . 41.4 t30 -50.95 -67.08 0.28 Allowed 'General case' 0 CA--C 1.538 0.488 0 O-C-N 125.149 1.531 . . . . 74.22 111.256 179.848 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 60.6 t80 -64.46 -36.02 82.82 Favored 'General case' 0 CA--C 1.543 0.707 0 O-C-N 124.016 0.822 . . . . 75.44 111.267 -173.62 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 62.2 ttt180 -60.63 -47.01 88.13 Favored 'General case' 0 N--CA 1.478 0.936 0 O-C-N 124.068 0.855 . . . . 75.43 111.042 178.906 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 38' ' ' ALA . . . . . 0.513 ' HB2' HG21 ' A' ' 78' ' ' ILE . . . -78.06 -19.92 53.35 Favored 'General case' 0 N--CA 1.475 0.811 0 CA-C-N 115.153 -0.93 . . . . 73.12 111.671 -177.416 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 39' ' ' LEU . . . . . 0.425 HD23 ' HE2' ' A' ' 48' ' ' TYR . 94.0 mt -73.94 -37.56 64.51 Favored 'General case' 0 N--CA 1.481 1.104 0 C-N-CA 123.162 0.585 . . . . 74.32 109.89 170.93 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 50.4 m -67.74 -49.4 62.74 Favored 'General case' 0 N--CA 1.48 1.041 0 C-N-CA 123.765 0.826 . . . . 75.5 110.831 -178.585 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 41' ' ' THR . . . . . 0.45 ' OG1' ' HG2' ' A' ' 43' ' ' GLU . 7.6 p -76.3 -33.78 59.07 Favored 'General case' 0 N--CA 1.477 0.895 0 C-N-CA 123.527 0.731 . . . . 74.22 111.619 178.344 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 76.99 37.9 31.78 Favored Glycine 0 C--N 1.34 0.756 0 CA-C-N 116.257 -0.429 . . . . 74.34 112.411 -172.525 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 43' ' ' GLU . . . . . 0.45 ' HG2' ' OG1' ' A' ' 41' ' ' THR . 22.7 mm-40 -64.67 -20.9 66.57 Favored 'General case' 0 N--CA 1.486 1.339 0 C-N-CA 123.159 0.584 . . . . 74.33 111.599 174.231 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 44' ' ' LYS . . . . . 0.544 ' HG3' ' HB ' ' A' ' 78' ' ' ILE . 71.1 mmtt -106.63 15.13 26.13 Favored 'General case' 0 CA--C 1.55 0.974 0 C-N-CA 124.296 1.038 . . . . 75.32 110.478 179.568 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 68.57 38.15 85.98 Favored Glycine 0 C--N 1.352 1.456 0 CA-C-N 116.103 -0.499 . . . . 73.03 114.227 177.466 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 46' ' ' PHE . . . . . 0.469 ' HE2' ' HA ' ' A' ' 78' ' ' ILE . 23.0 m-85 -117.49 -48.55 2.59 Favored 'General case' 0 N--CA 1.489 1.476 0 CA-C-N 117.432 0.616 . . . . 63.34 110.654 -179.246 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 48.14 61.51 4.88 Favored Glycine 0 C--N 1.356 1.672 0 O-C-N 124.415 1.072 . . . . 65.32 114.51 167.823 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 48' ' ' TYR . . . . . 0.425 ' HE2' HD23 ' A' ' 39' ' ' LEU . 64.0 m-85 -65.47 92.94 0.14 Allowed 'General case' 0 N--CA 1.477 0.903 0 CA-C-O 121.693 0.759 . . . . 75.15 112.339 -174.417 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 49' ' ' LYS . . . . . 0.438 ' NZ ' ' SG ' ' A' ' 161' ' ' CYS . 0.0 OUTLIER -105.77 135.78 46.59 Favored 'General case' 0 C--O 1.236 0.37 0 CA-C-N 114.006 -1.452 . . . . 72.41 108.658 175.238 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 78.34 21.59 69.65 Favored Glycine 0 C--N 1.341 0.853 0 CA-C-O 119.838 -0.423 . . . . 65.51 113.417 177.445 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 16.2 m -57.37 115.34 2.65 Favored 'General case' 0 N--CA 1.474 0.733 0 C-N-CA 123.586 0.754 . . . . 53.24 110.358 179.051 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 52' ' ' CYS . . . . . . . . . . . . . 23.8 p -81.36 114.55 20.2 Favored 'General case' 0 CA--C 1.538 0.5 0 C-N-CA 124.513 1.125 . . . . 71.34 111.459 -172.992 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 53' ' ' PHE . . . . . 0.709 ' HA ' ' HA2' ' A' ' 64' ' ' GLY . 38.6 m-85 -66.07 93.23 0.19 Allowed 'General case' 0 CA--C 1.539 0.539 0 C-N-CA 123.896 0.878 . . . . 74.41 108.784 164.715 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 17.0 p-80 -108.5 -0.34 20.49 Favored 'General case' 0 N--CA 1.479 0.977 0 CA-C-N 115.383 -0.826 . . . . 74.32 111.536 -176.498 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 55' ' ' ARG . . . . . 0.456 ' O ' ' HB3' ' A' ' 63' ' ' GLN . 53.2 ttt-85 -138.16 99.66 3.93 Favored 'General case' 0 C--O 1.21 -0.986 0 N-CA-C 109.228 -0.656 . . . . 75.5 109.228 173.796 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 56' ' ' ILE . . . . . 0.422 HD13 ' HB3' ' A' ' 53' ' ' PHE . 51.1 mt -131.33 134.35 61.11 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.935 0 N-CA-C 109.6 -0.519 . . . . 73.23 109.6 175.911 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 63.0 mt -128.82 113.38 18.96 Favored Pre-proline 0 CA--C 1.553 1.08 0 C-N-CA 124.694 1.197 . . . . 62.53 108.726 177.975 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 58' ' ' PRO . . . . . 0.55 ' HA ' ' HG2' ' A' ' 143' ' ' GLU . 41.4 Cg_endo -64.77 143.64 81.02 Favored 'Trans proline' 0 C--N 1.386 2.523 0 C-N-CA 123.415 2.743 . . . . 74.5 112.158 -177.322 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 72.36 27.47 69.73 Favored Glycine 0 C--N 1.344 1.013 0 CA-C-N 115.713 -0.676 . . . . 75.41 112.304 -176.888 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 20.5 t80 -153.59 -77.38 0.11 Allowed 'General case' 0 CA--C 1.543 0.685 0 C-N-CA 123.579 0.752 . . . . 75.03 109.644 -178.472 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 61' ' ' MET . . . . . 0.747 ' SD ' ' HB2' ' A' ' 113' ' ' PHE . 13.3 tmm? -167.86 137.75 2.67 Favored 'General case' 0 CA--C 1.548 0.88 0 C-N-CA 122.807 0.443 . . . . 72.12 111.585 -164.018 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 62' ' ' CYS . . . . . . . . . . . . . 4.3 p -106.94 113.56 27.12 Favored 'General case' 0 CA--C 1.552 1.057 0 C-N-CA 124.78 1.232 . . . . 71.35 109.923 172.343 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 63' ' ' GLN . . . . . 0.574 ' HB2' ' SD ' ' A' ' 61' ' ' MET . 49.2 tt0 -107.99 121.66 45.24 Favored 'General case' 0 N--CA 1.487 1.382 0 C-N-CA 124.155 0.982 . . . . 74.1 111.138 -174.65 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 64' ' ' GLY . . . . . 0.709 ' HA2' ' HA ' ' A' ' 53' ' ' PHE . . . -97.55 170.88 25.91 Favored Glycine 0 C--N 1.34 0.796 0 CA-C-N 114.721 -1.127 . . . . 73.31 112.0 172.755 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 176.7 179.43 47.11 Favored Glycine 0 C--O 1.224 -0.524 0 N-CA-C 111.77 -0.532 . . . . 74.22 111.77 178.704 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 6.9 t0 -102.73 151.75 22.03 Favored 'General case' 0 CA--C 1.546 0.803 0 C-N-CA 124.385 1.074 . . . . 72.5 110.434 -173.901 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 68.6 t80 -82.25 -30.28 30.81 Favored 'General case' 0 N--CA 1.478 0.929 0 C-N-CA 124.727 1.211 . . . . 72.34 110.46 -178.404 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 68' ' ' THR . . . . . 0.662 HG23 ' HG3' ' A' ' 69' ' ' ARG . 6.9 m -74.89 143.06 43.97 Favored 'General case' 0 CA--C 1.549 0.929 0 C-N-CA 123.661 0.784 . . . . 61.43 109.49 177.118 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 69' ' ' ARG . . . . . 0.662 ' HG3' HG23 ' A' ' 68' ' ' THR . 50.7 mtt180 60.68 26.09 15.85 Favored 'General case' 0 N--CA 1.491 1.611 0 C-N-CA 124.565 1.146 . . . . 73.15 111.798 175.627 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 20.3 t-80 -58.83 -40.59 84.63 Favored 'General case' 0 N--CA 1.474 0.742 0 C-N-CA 124.624 1.17 . . . . 65.14 113.241 -165.777 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 43.3 m-80 -67.35 103.81 1.36 Allowed 'General case' 0 N--CA 1.474 0.76 0 C-N-CA 122.785 0.434 . . . . 75.22 110.004 177.747 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 89.28 -7.93 80.97 Favored Glycine 0 CA--C 1.531 1.09 0 CA-C-N 115.643 -0.708 . . . . 71.21 114.602 173.869 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 18.3 m -144.48 -88.66 0.11 Allowed 'General case' 0 CA--C 1.556 1.211 0 CA-C-N 117.891 0.845 . . . . 74.5 110.297 -178.83 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 65.66 61.64 5.44 Favored Glycine 0 C--N 1.362 1.973 0 CA-C-O 119.593 -0.559 . . . . 65.42 113.718 176.999 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 121.22 51.96 0.24 Allowed Glycine 0 N--CA 1.479 1.508 0 CA-C-N 117.841 0.82 . . . . 64.35 111.736 -174.0 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 76' ' ' LYS . . . . . 0.435 ' HB2' ' O ' ' A' ' 80' ' ' GLY . 64.0 pttt -60.91 168.93 2.13 Favored 'General case' 0 CA--C 1.548 0.867 0 C-N-CA 123.799 0.84 . . . . 75.1 112.498 -175.518 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 80.9 p -91.23 176.16 6.68 Favored 'General case' 0 CA--C 1.542 0.639 0 CA-C-N 115.033 -0.985 . . . . 73.54 110.605 -177.671 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 78' ' ' ILE . . . . . 0.544 ' HB ' ' HG3' ' A' ' 44' ' ' LYS . 26.0 pt -74.5 -18.61 16.78 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.547 0 CA-C-N 115.939 -0.573 . . . . 75.45 110.026 172.145 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 55.0 m-85 -89.4 11.39 19.34 Favored 'General case' 0 CA--C 1.544 0.724 0 C-N-CA 124.764 1.225 . . . . 72.15 110.855 179.058 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 80' ' ' GLY . . . . . 0.435 ' O ' ' HB2' ' A' ' 76' ' ' LYS . . . 109.63 -133.8 11.84 Favored Glycine 0 C--N 1.351 1.396 0 N-CA-C 110.831 -0.908 . . . . 72.41 110.831 -179.82 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 35.9 tt0 -65.13 -41.11 95.13 Favored 'General case' 0 N--CA 1.478 0.934 0 C-N-CA 123.88 0.872 . . . . 73.41 111.114 -179.326 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 82' ' ' LYS . . . . . 0.714 ' HD2' ' HA ' ' A' ' 107' ' ' THR . 21.0 pttp -169.49 178.36 4.25 Favored 'General case' 0 CA--C 1.545 0.776 0 CA-C-N 115.065 -0.97 . . . . 75.25 109.836 -165.777 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 26.2 p90 -158.16 171.73 19.69 Favored 'General case' 0 N--CA 1.475 0.809 0 C-N-CA 123.479 0.712 . . . . 74.44 110.191 174.339 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 12.2 pt-20 -94.18 162.66 13.77 Favored 'General case' 0 N--CA 1.476 0.86 0 C-N-CA 123.204 0.602 . . . . 74.53 109.834 175.796 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 65.1 m-20 -68.45 148.23 50.92 Favored 'General case' 0 N--CA 1.475 0.815 0 C-N-CA 123.871 0.868 . . . . 74.54 112.562 -172.345 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 86' ' ' GLU . . . . . 0.557 ' HG2' ' HA ' ' A' ' 29' ' ' VAL . 5.2 tp10 -73.96 -62.99 1.31 Allowed 'General case' 0 CA--C 1.544 0.728 0 CA-C-N 115.447 -0.797 . . . . 74.11 110.097 179.083 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 25.5 p30 -175.05 150.54 1.21 Allowed 'General case' 0 N--CA 1.483 1.185 0 C-N-CA 124.338 1.055 . . . . 73.43 109.801 -177.518 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 91.5 m-85 -90.06 57.51 3.81 Favored 'General case' 0 N--CA 1.483 1.205 0 C-N-CA 123.783 0.833 . . . . 63.55 111.182 -171.248 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 72.8 mt -82.24 -53.8 11.06 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.76 0 CA-C-N 115.684 -0.689 . . . . 73.43 109.393 175.394 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 90' ' ' LEU . . . . . 0.519 HD11 ' HB2' ' A' ' 25' ' ' PHE . 87.0 mt -84.11 109.92 18.08 Favored 'General case' 0 CA--C 1.541 0.613 0 CA-C-N 115.197 -0.91 . . . . 72.41 110.84 -178.384 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 18.3 ptpt -102.27 171.29 7.56 Favored 'General case' 0 N--CA 1.473 0.685 0 C-N-CA 124.385 1.074 . . . . 64.54 109.884 175.566 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 92' ' ' HIS . . . . . . . . . . . . . 39.2 m80 -89.75 48.33 1.58 Allowed 'General case' 0 CA--C 1.551 1.009 0 C-N-CA 124.269 1.028 . . . . 75.44 110.266 -175.06 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 12.0 t -91.95 -16.3 26.79 Favored 'General case' 0 N--CA 1.481 1.102 0 C-N-CA 123.46 0.704 . . . . 74.31 111.108 -179.331 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -104.97 157.32 16.59 Favored Glycine 0 C--N 1.343 0.959 0 CA-C-O 119.603 -0.554 . . . . 64.32 112.245 178.51 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 71.9 Cg_endo -80.87 150.74 18.51 Favored 'Trans proline' 0 C--N 1.363 1.303 0 C-N-CA 122.505 2.137 . . . . 73.15 111.421 169.359 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 96' ' ' GLY . . . . . 0.441 ' HA3' HG11 ' A' ' 132' ' ' VAL . . . 84.22 22.89 53.49 Favored Glycine 0 C--N 1.344 0.992 0 N-CA-C 114.114 0.406 . . . . 63.34 114.114 176.993 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 97' ' ' ILE . . . . . . . . . . . . . 14.7 mm -63.0 115.71 2.37 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.897 0 C-N-CA 124.603 1.161 . . . . 75.22 112.093 -174.746 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 59.1 tp -97.8 114.22 26.2 Favored 'General case' 0 C--O 1.249 1.062 0 CA-C-O 121.77 0.795 . . . . 72.13 109.829 175.641 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 32.8 t -142.9 143.22 31.95 Favored 'General case' 0 CA--C 1.545 0.767 0 C-N-CA 124.771 1.229 . . . . 73.21 107.955 179.058 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 100' ' ' MET . . . . . 0.711 ' HA ' ' HA ' ' A' ' 112' ' ' PHE . 81.1 mtp -84.55 142.01 30.31 Favored 'General case' 0 N--CA 1.492 1.643 0 CA-C-N 118.496 0.589 . . . . 74.31 111.063 -176.329 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 101' ' ' ALA . . . . . 0.545 ' HB3' ' HB2' ' A' ' 111' ' ' GLN . . . -73.4 171.38 13.2 Favored 'General case' 0 N--CA 1.484 1.254 0 CA-C-O 121.102 0.477 . . . . 64.43 111.874 -171.504 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 102' ' ' ASN . . . . . 0.478 ' HB3' ' HA ' ' A' ' 108' ' ' ASN . 30.1 p-10 -168.39 167.25 12.01 Favored 'General case' 0 N--CA 1.472 0.67 0 CA-C-N 115.536 -0.757 . . . . 72.35 111.234 -173.499 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -105.89 6.21 31.3 Favored 'General case' 0 N--CA 1.477 0.908 0 C-N-CA 124.147 0.979 . . . . 64.11 110.544 169.182 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 152.91 -174.87 31.62 Favored Glycine 0 C--N 1.354 1.528 0 CA-C-O 119.244 -0.753 . . . . 63.23 112.167 179.665 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 44.0 Cg_exo -59.14 148.02 87.7 Favored 'Trans proline' 0 C--N 1.373 1.816 0 C-N-CA 123.041 2.494 . . . . 73.14 111.932 173.064 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 66.3 t30 68.01 9.55 7.23 Favored 'General case' 0 N--CA 1.483 1.212 0 C-N-CA 124.943 1.297 . . . . 64.52 111.128 -177.129 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 107' ' ' THR . . . . . 0.714 ' HA ' ' HD2' ' A' ' 82' ' ' LYS . 5.0 m -121.65 1.61 10.03 Favored 'General case' 0 CA--C 1.55 0.974 0 C-N-CA 123.857 0.863 . . . . 74.04 110.545 -178.907 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 108' ' ' ASN . . . . . 0.478 ' HA ' ' HB3' ' A' ' 102' ' ' ASN . 43.7 t30 -69.29 132.84 47.09 Favored 'General case' 0 N--CA 1.478 0.951 0 C-N-CA 123.72 0.808 . . . . 72.0 109.673 179.976 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 112.57 15.12 9.76 Favored Glycine 0 N--CA 1.472 1.076 0 N-CA-C 114.045 0.378 . . . . 43.44 114.045 -179.371 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 32.1 p -112.63 119.44 38.12 Favored 'General case' 0 CA--C 1.543 0.687 0 N-CA-C 107.626 -1.25 . . . . 73.33 107.626 167.78 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 111' ' ' GLN . . . . . 0.545 ' HB2' ' HB3' ' A' ' 101' ' ' ALA . 40.0 mt-30 66.18 178.18 0.21 Allowed 'General case' 0 N--CA 1.497 1.898 0 C-N-CA 124.458 1.103 . . . . 74.15 111.112 -169.741 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 112' ' ' PHE . . . . . 0.711 ' HA ' ' HA ' ' A' ' 100' ' ' MET . 45.1 p90 -145.54 154.2 41.92 Favored 'General case' 0 N--CA 1.48 1.057 0 C-N-CA 123.675 0.79 . . . . 74.44 108.951 177.959 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 113' ' ' PHE . . . . . 0.747 ' HB2' ' SD ' ' A' ' 61' ' ' MET . 51.4 p90 -144.65 154.61 42.97 Favored 'General case' 0 C--O 1.238 0.471 0 CA-C-O 120.823 0.344 . . . . 74.22 111.626 179.306 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 114' ' ' ILE . . . . . . . . . . . . . 5.7 mt -130.3 101.59 6.03 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.724 0 C-N-CA 124.077 0.951 . . . . 74.02 108.769 -174.236 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 115' ' ' CYS . . . . . . . . . . . . . 63.2 m -80.4 104.96 11.3 Favored 'General case' 0 N--CA 1.47 0.549 0 C-N-CA 123.507 0.723 . . . . 72.12 109.709 178.101 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 81.7 p -69.08 -27.62 65.78 Favored 'General case' 0 N--CA 1.488 1.434 0 CA-C-O 121.161 0.505 . . . . 72.23 111.257 -178.63 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -97.75 151.23 20.38 Favored 'General case' 0 C--O 1.24 0.591 0 CA-C-N 115.212 -0.903 . . . . 61.45 108.678 172.997 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 11.5 ptmm? -71.82 86.85 0.97 Allowed 'General case' 0 CA--C 1.552 1.029 0 CA-C-O 121.645 0.736 . . . . 74.53 109.396 174.325 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 119' ' ' THR . . . . . . . . . . . . . 40.6 p -76.21 86.7 3.04 Favored 'General case' 0 CA--C 1.543 0.678 0 CA-C-N 115.028 -0.987 . . . . 73.1 110.872 -172.607 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 12.4 pt-20 -65.24 -31.39 72.52 Favored 'General case' 0 CA--C 1.542 0.668 0 CA-C-N 114.545 -1.207 . . . . 74.54 111.866 -172.108 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 121' ' ' TRP . . . . . . . . . . . . . 42.6 p90 -70.83 -14.51 62.44 Favored 'General case' 0 N--CA 1.475 0.791 0 C-N-CA 123.543 0.737 . . . . 72.32 111.793 -178.794 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 42.7 mt -87.9 5.46 40.37 Favored 'General case' 0 N--CA 1.481 1.103 0 C-N-CA 122.828 0.451 . . . . 75.13 111.873 176.405 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 69.1 m-20 -80.39 140.33 36.09 Favored 'General case' 0 N--CA 1.482 1.144 0 C-N-CA 122.642 0.377 . . . . 65.44 110.451 172.275 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 94.35 -10.9 71.01 Favored Glycine 0 C--N 1.347 1.175 0 CA-C-N 115.602 -0.727 . . . . 71.11 112.183 -169.281 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 1.7 mppt? -94.6 -168.26 1.8 Allowed 'General case' 0 N--CA 1.472 0.662 0 C-N-CA 124.476 1.11 . . . . 72.2 109.535 173.722 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 126' ' ' HIS . . . . . . . . . . . . . 17.6 p80 -66.58 154.53 40.21 Favored 'General case' 0 CA--C 1.551 0.981 0 C-N-CA 124.179 0.991 . . . . 64.31 111.237 -172.146 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 17.6 m -78.81 147.54 6.76 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.813 0 CA-C-N 115.176 -0.92 . . . . 72.11 113.018 -163.262 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 128' ' ' VAL . . . . . 0.456 ' HB ' ' HB3' ' A' ' 90' ' ' LEU . 48.2 t -80.41 152.89 4.44 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.634 0 CA-C-N 114.159 -1.382 . . . . 74.21 108.537 172.576 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 129' ' ' PHE . . . . . 0.563 ' HA ' HG21 ' A' ' 29' ' ' VAL . 50.4 p90 -130.74 -15.81 3.42 Favored 'General case' 0 N--CA 1.482 1.173 0 N-CA-C 112.184 0.439 . . . . 74.22 112.184 179.187 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . -155.85 175.65 33.59 Favored Glycine 0 C--N 1.334 0.445 0 N-CA-C 112.109 -0.396 . . . . 64.22 112.109 -177.548 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 33.2 ttpt -156.23 140.51 16.6 Favored 'General case' 0 C--N 1.324 -0.519 0 N-CA-C 108.246 -1.02 . . . . 73.41 108.246 177.265 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 132' ' ' VAL . . . . . 0.534 ' HA ' ' HA ' ' A' ' 22' ' ' PHE . 6.7 p -61.1 134.23 26.57 Favored 'Isoleucine or valine' 0 CA--C 1.552 1.042 0 O-C-N 123.423 0.452 . . . . 73.34 111.279 177.336 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 133' ' ' LYS . . . . . 0.636 ' HD2' ' HB2' ' A' ' 23' ' ' GLU . 19.1 ptmt -111.52 -37.21 5.29 Favored 'General case' 0 N--CA 1.475 0.802 0 C-N-CA 123.472 0.709 . . . . 75.42 109.803 173.702 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 134' ' ' GLU . . . . . 0.54 ' HG2' ' HG3' ' A' ' 133' ' ' LYS . 40.9 mm-40 -119.91 133.94 55.4 Favored 'General case' 0 N--CA 1.48 1.06 0 C-N-CA 123.93 0.892 . . . . 74.11 109.728 -179.723 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 81.54 29.54 39.45 Favored Glycine 0 C--N 1.341 0.856 0 O-C-N 123.307 0.379 . . . . 62.44 113.421 176.965 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 136' ' ' MET . . . . . . . . . . . . . 15.8 tpt -59.43 -43.79 93.04 Favored 'General case' 0 N--CA 1.476 0.855 0 C-N-CA 123.487 0.715 . . . . 71.43 110.696 176.449 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 137' ' ' ASN . . . . . . . . . . . . . 17.0 m120 -63.55 -28.93 70.28 Favored 'General case' 0 N--CA 1.475 0.804 0 C-N-CA 123.607 0.763 . . . . 73.3 111.457 179.099 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 138' ' ' ILE . . . . . . . . . . . . . 43.4 mm -71.26 -39.03 72.28 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.119 0 C-N-CA 123.292 0.637 . . . . 72.42 110.255 176.316 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 50.8 t -64.12 -44.61 97.66 Favored 'Isoleucine or valine' 0 CA--C 1.552 1.054 0 C-N-CA 123.406 0.682 . . . . 74.43 110.189 177.982 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 43.5 mt-10 -67.99 -35.76 78.87 Favored 'General case' 0 N--CA 1.477 0.916 0 CA-C-N 115.149 -0.932 . . . . 74.45 110.908 178.956 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -68.4 -43.13 77.92 Favored 'General case' 0 N--CA 1.477 0.9 0 C-N-CA 123.479 0.712 . . . . 71.41 111.141 179.248 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 142' ' ' MET . . . . . 0.571 ' HB2' HD12 ' A' ' 156' ' ' ILE . 23.0 ptt? -73.68 -28.77 61.92 Favored 'General case' 0 N--CA 1.475 0.818 0 O-C-N 123.637 0.585 . . . . 75.41 110.793 -177.537 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 143' ' ' GLU . . . . . 0.55 ' HG2' ' HA ' ' A' ' 58' ' ' PRO . 33.0 tt0 -64.14 -28.93 70.1 Favored 'General case' 0 CA--C 1.553 1.083 0 CA-C-O 121.159 0.504 . . . . 63.43 111.555 -179.83 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 144' ' ' ARG . . . . . . . . . . . . . 48.1 mtm180 -70.67 -15.47 62.72 Favored 'General case' 0 N--CA 1.476 0.861 0 C-N-CA 123.191 0.596 . . . . 74.21 112.118 -179.957 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 145' ' ' PHE . . . . . 0.465 ' HB2' HD11 ' A' ' 156' ' ' ILE . 75.9 m-85 -82.87 -2.77 55.71 Favored 'General case' 0 N--CA 1.482 1.169 0 C-N-CA 122.592 0.357 . . . . 74.55 111.852 176.373 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . -95.42 -179.73 36.51 Favored Glycine 0 C--N 1.353 1.501 0 N-CA-C 112.331 -0.307 . . . . 71.04 112.331 176.193 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 16.5 m -132.58 169.44 16.6 Favored 'General case' 0 N--CA 1.487 1.376 0 C-N-CA 123.663 0.785 . . . . 74.52 110.842 -176.512 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 148' ' ' ARG . . . . . . . . . . . . . 10.6 mmt180 -65.65 -28.26 68.97 Favored 'General case' 0 N--CA 1.485 1.323 0 C-N-CA 123.926 0.891 . . . . 75.14 112.641 -174.255 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 149' ' ' ASN . . . . . . . . . . . . . 29.5 p-10 -81.88 -17.0 48.81 Favored 'General case' 0 N--CA 1.486 1.326 0 C-N-CA 123.444 0.698 . . . . 74.04 111.542 178.202 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 150' ' ' GLY . . . . . 0.449 ' O ' ' HA ' ' A' ' 55' ' ' ARG . . . 112.63 -17.01 23.55 Favored Glycine 0 C--N 1.348 1.205 0 CA-C-N 116.383 -0.371 . . . . 71.41 112.887 -178.831 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 62.7 tttp -67.21 133.98 50.8 Favored 'General case' 0 N--CA 1.473 0.695 0 CA-C-N 117.312 0.556 . . . . 73.04 110.603 -178.068 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 152' ' ' THR . . . . . . . . . . . . . 39.9 p -92.26 123.39 35.56 Favored 'General case' 0 CA--C 1.539 0.541 0 C-N-CA 123.301 0.64 . . . . 75.3 109.823 177.103 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 153' ' ' SER . . . . . . . . . . . . . 43.7 t -63.98 -36.22 83.28 Favored 'General case' 0 N--CA 1.475 0.813 0 C-N-CA 123.586 0.754 . . . . 74.11 110.176 174.148 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 45.4 mmtm -120.66 136.81 54.73 Favored 'General case' 0 N--CA 1.47 0.547 0 C-N-CA 124.205 1.002 . . . . 75.23 108.937 -179.046 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 33.4 mmtp -83.1 91.39 7.2 Favored 'General case' 0 N--CA 1.477 0.903 0 CA-C-O 121.513 0.673 . . . . 75.12 110.223 -174.568 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 156' ' ' ILE . . . . . 0.571 HD12 ' HB2' ' A' ' 142' ' ' MET . 68.2 mt -85.49 130.41 36.33 Favored 'Isoleucine or valine' 0 C--O 1.221 -0.397 0 CA-C-N 114.84 -1.073 . . . . 63.25 108.487 -178.349 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 157' ' ' THR . . . . . . . . . . . . . 35.9 p -138.68 156.4 47.44 Favored 'General case' 0 C--O 1.24 0.563 0 C-N-CA 124.444 1.098 . . . . 75.33 109.282 -175.536 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 158' ' ' ILE . . . . . 0.441 HG23 ' HB3' ' A' ' 8' ' ' PHE . 42.6 mt -74.43 95.26 0.86 Allowed 'Isoleucine or valine' 0 N--CA 1.475 0.822 0 N-CA-C 109.0 -0.741 . . . . 73.51 109.0 171.939 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 159' ' ' ALA . . . . . 0.766 ' HB1' ' HB2' ' A' ' 11' ' ' ALA . . . -51.7 -48.25 63.6 Favored 'General case' 0 N--CA 1.483 1.216 0 C-N-CA 124.585 1.154 . . . . 71.51 112.267 179.71 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 160' ' ' ASP . . . . . . . . . . . . . 35.6 t0 -154.23 162.11 41.39 Favored 'General case' 0 CA--C 1.54 0.567 0 CA-C-N 115.83 -0.623 . . . . 75.11 110.284 -175.639 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 161' ' ' CYS . . . . . 0.438 ' SG ' ' NZ ' ' A' ' 49' ' ' LYS . 27.6 p -136.53 -173.79 3.52 Favored 'General case' 0 N--CA 1.476 0.86 0 C-N-CA 124.274 1.03 . . . . 73.22 108.538 175.763 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 162' ' ' GLY . . . . . . . . . . . . . . . 131.08 55.24 0.09 OUTLIER Glycine 0 C--N 1.346 1.131 0 N-CA-C 111.007 -0.837 . . . . 71.42 111.007 -166.999 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 163' ' ' GLN . . . . . 0.546 ' HB2' ' HA ' ' A' ' 6' ' ' VAL . 13.8 pt20 -47.25 142.92 3.58 Favored 'General case' 0 CA--C 1.554 1.117 0 C-N-CA 125.056 1.342 . . . . 73.33 114.13 -170.956 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 164' ' ' LEU . . . . . . . . . . . . . 95.9 mt -98.81 106.14 18.37 Favored 'General case' 0 N--CA 1.477 0.876 0 C-N-CA 123.729 0.811 . . . . 74.43 111.034 -172.237 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 165' ' ' GLU . . . . . . . . . . . . . 48.7 mt-10 . . . . . 0 C--O 1.252 1.203 0 N-CA-C 108.341 -0.985 . . . . 73.21 108.341 173.88 . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' B' B ' 216' ' ' PRO . . . . . . . . . . . . . 6.2 Cg_exo . . . . . 0 CA--C 1.545 1.061 0 N-CA-C 109.989 -0.812 . . . . 71.52 109.989 . . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' B' B ' 217' ' ' GLU . . . . . . . . . . . . . 44.7 tt0 -167.33 110.12 0.62 Allowed Pre-proline 0 CA--C 1.549 0.929 0 C-N-CA 124.281 1.033 . . . . 75.14 108.695 -179.688 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 218' ' ' PRO . . . . . 0.426 ' HB2' ' NE2' ' A' ' 111' ' ' GLN . 3.9 Cg_exo -79.42 77.62 4.02 Favored 'Trans proline' 0 C--N 1.376 2.003 0 C-N-CA 122.7 2.267 . . . . 74.11 110.678 176.333 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 219' ' ' GLY . . . . . . . . . . . . . . . -178.88 164.87 33.51 Favored Glycine 0 CA--C 1.53 1.031 0 CA-C-N 114.765 -1.107 . . . . 72.35 111.435 -178.736 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 220' ' ' PRO . . . . . . . . . . . . . 62.0 Cg_endo -80.57 160.81 22.19 Favored 'Trans proline' 0 C--N 1.371 1.738 0 C-N-CA 123.09 2.527 . . . . 71.3 113.416 -178.043 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 221' ' ' TYR . . . . . . . . . . . . . 56.6 m-85 -68.0 135.39 52.25 Favored 'General case' 0 N--CA 1.486 1.348 0 C-N-CA 123.991 0.917 . . . . 73.43 111.106 -179.71 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 222' ' ' ALA . . . . . . . . . . . . . . . -88.2 -85.59 0.18 Allowed 'General case' 0 N--CA 1.468 0.436 0 C-N-CA 123.987 0.915 . . . . 75.24 112.921 -172.185 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 223' ' ' GLN . . . . . 0.452 ' HB2' ' HD3' ' B' ' 224' ' ' PRO . 72.6 mt-30 -142.0 -45.12 0.02 OUTLIER Pre-proline 0 CA--C 1.562 1.416 0 C-N-CA 125.029 1.332 . . . . 73.42 109.179 -167.733 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 224' ' ' PRO . . . . . 0.452 ' HD3' ' HB2' ' B' ' 223' ' ' GLN . 31.9 Cg_exo . . . . . 0 C--N 1.403 3.432 0 C-N-CA 122.26 1.973 . . . . 74.13 111.739 165.044 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 1' ' ' MET . . . . . 0.448 ' SD ' ' NZ ' ' A' ' 133' ' ' LYS . 61.0 mtt . . . . . 0 N--CA 1.481 1.109 0 N-CA-C 109.828 -0.434 . . . . 74.51 109.828 . . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 11.9 p -78.46 -13.43 13.75 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.093 0 C-N-CA 123.994 0.918 . . . . 74.52 110.499 175.298 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 3' ' ' ASN . . . . . 0.575 ' ND2' ' HA ' ' A' ' 25' ' ' PHE . 31.0 m120 -75.99 130.13 79.06 Favored Pre-proline 0 CA--C 1.545 0.786 0 C-N-CA 123.64 0.776 . . . . 75.25 111.088 -178.507 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 4' ' ' PRO . . . . . 0.506 ' HG2' ' HB2' ' A' ' 24' ' ' LEU . 33.2 Cg_endo -63.63 119.53 6.62 Favored 'Trans proline' 0 C--N 1.38 2.219 0 C-N-CA 122.63 2.22 . . . . 74.31 112.043 176.368 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 5' ' ' THR . . . . . 0.558 HG22 ' HD3' ' A' ' 133' ' ' LYS . 61.1 m -97.42 110.71 23.22 Favored 'General case' 0 CA--C 1.539 0.556 0 C-N-CA 123.748 0.819 . . . . 72.34 108.807 178.703 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 10.0 m -97.83 123.31 50.21 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.155 0 N-CA-C 109.252 -0.647 . . . . 73.34 109.252 -175.588 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 7' ' ' PHE . . . . . 0.429 ' H ' ' HA ' ' A' ' 163' ' ' GLN . 82.3 t80 -103.82 142.39 34.46 Favored 'General case' 0 C--O 1.236 0.368 0 CA-C-N 115.706 -0.679 . . . . 73.32 109.946 -171.44 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 8' ' ' PHE . . . . . 0.443 ' HB3' HG23 ' A' ' 158' ' ' ILE . 72.5 m-85 -140.85 164.46 30.17 Favored 'General case' 0 C--O 1.239 0.508 0 C-N-CA 124.235 1.014 . . . . 75.41 109.494 174.535 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 24.5 m-20 -118.52 113.21 20.96 Favored 'General case' 0 N--CA 1.469 0.488 0 N-CA-C 107.134 -1.432 . . . . 54.14 107.134 168.551 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 37.8 mm -91.19 143.87 10.34 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.678 0 C-N-CA 123.137 0.575 . . . . 72.31 109.639 -175.965 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 11' ' ' ALA . . . . . 0.427 ' HB1' ' HB1' ' A' ' 159' ' ' ALA . . . -132.73 143.57 49.69 Favored 'General case' 0 CA--C 1.537 0.461 0 C-N-CA 123.831 0.852 . . . . 74.44 111.634 -167.624 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . 0.52 HG21 ' HB2' ' A' ' 17' ' ' LEU . 24.3 t -98.51 107.17 19.9 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.642 0 N-CA-C 108.256 -1.016 . . . . 74.43 108.256 172.439 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 27.5 m-20 62.03 32.01 17.77 Favored 'General case' 0 N--CA 1.488 1.461 0 C-N-CA 124.508 1.123 . . . . 74.31 111.78 179.338 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 99.27 -26.71 23.25 Favored Glycine 0 C--N 1.346 1.127 0 CA-C-N 115.424 -0.807 . . . . 75.35 112.87 -178.653 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 17.7 mm-40 -82.29 114.09 48.72 Favored Pre-proline 0 CA--C 1.547 0.853 0 CA-C-O 118.657 -0.687 . . . . 72.33 110.249 -174.349 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 21.7 Cg_endo -57.8 112.03 1.02 Allowed 'Trans proline' 0 C--N 1.382 2.304 0 C-N-CA 123.468 2.779 . . . . 74.11 112.52 -173.748 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . 0.52 ' HB2' HG21 ' A' ' 12' ' ' VAL . 61.6 tp -80.17 -46.49 16.28 Favored 'General case' 0 N--CA 1.472 0.642 0 C-N-CA 123.652 0.781 . . . . 73.24 110.551 -179.819 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -175.26 -163.88 28.96 Favored Glycine 0 C--N 1.34 0.761 0 CA-C-N 115.543 -0.753 . . . . 65.4 112.147 -177.768 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 8.9 ptp180 -107.13 150.59 26.42 Favored 'General case' 0 N--CA 1.479 1.004 0 C-N-CA 123.354 0.662 . . . . 74.02 109.927 -178.677 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 54.9 t -143.67 123.46 8.66 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.844 0 N-CA-C 108.275 -1.009 . . . . 74.43 108.275 169.04 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 11.1 t -126.9 138.41 53.3 Favored 'General case' 0 CA--C 1.546 0.821 0 C-N-CA 123.57 0.748 . . . . 65.33 109.618 178.128 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 22' ' ' PHE . . . . . 0.423 ' CG ' HD22 ' A' ' 98' ' ' LEU . 72.8 m-85 -109.69 150.18 28.65 Favored 'General case' 0 N--CA 1.476 0.826 0 C-N-CA 123.7 0.8 . . . . 74.01 111.012 -175.078 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . 0.55 ' HB2' ' HD2' ' A' ' 133' ' ' LYS . 5.2 tp10 -98.06 102.65 14.46 Favored 'General case' 0 N--CA 1.473 0.692 0 C-N-CA 124.462 1.105 . . . . 73.24 108.396 173.383 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . 0.506 ' HB2' ' HG2' ' A' ' 4' ' ' PRO . 26.5 mt -87.68 117.56 26.59 Favored 'General case' 0 N--CA 1.476 0.837 0 N-CA-C 109.598 -0.519 . . . . 72.33 109.598 179.972 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 25' ' ' PHE . . . . . 0.575 ' HA ' ' ND2' ' A' ' 3' ' ' ASN . 77.1 m-85 -86.45 65.35 9.01 Favored 'General case' 0 CA--C 1.539 0.533 0 CA-C-O 121.371 0.605 . . . . 74.45 110.701 -175.383 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -72.81 -4.99 35.02 Favored 'General case' 0 N--CA 1.481 1.11 0 C-N-CA 123.946 0.898 . . . . 75.0 112.961 -175.502 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 12.4 p-10 -78.58 -29.92 46.42 Favored 'General case' 0 N--CA 1.478 0.952 0 C-N-CA 123.049 0.54 . . . . 73.33 110.061 172.926 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 93.3 mttt -96.42 -42.26 8.2 Favored 'General case' 0 N--CA 1.474 0.752 0 C-N-CA 124.099 0.959 . . . . 73.14 110.34 -179.015 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 29' ' ' VAL . . . . . 0.541 HG22 ' HA ' ' A' ' 129' ' ' PHE . 4.1 m -126.85 76.19 75.45 Favored Pre-proline 0 CA--C 1.558 1.271 0 C-N-CA 123.887 0.875 . . . . 75.51 110.663 178.302 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 81.7 Cg_exo -49.09 -52.57 8.49 Favored 'Trans proline' 0 C--N 1.381 2.244 0 C-N-CA 123.388 2.725 . . . . 72.24 113.967 176.103 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 85.0 tttt -67.62 -54.48 19.4 Favored 'General case' 0 N--CA 1.478 0.929 0 C-N-CA 123.588 0.755 . . . . 75.44 111.66 -174.194 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 7.0 m -69.08 -33.12 73.04 Favored 'General case' 0 CA--C 1.551 0.983 0 C-N-CA 123.022 0.529 . . . . 74.34 111.642 -170.499 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 33' ' ' ALA . . . . . 0.504 ' HB2' ' HB3' ' A' ' 24' ' ' LEU . . . -79.58 -40.24 29.86 Favored 'General case' 0 CA--C 1.547 0.836 0 C-N-CA 122.619 0.367 . . . . 73.03 111.19 178.303 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 39.0 tt0 -59.86 -35.46 74.84 Favored 'General case' 0 N--CA 1.486 1.369 0 C-N-CA 123.324 0.65 . . . . 75.13 111.052 178.128 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 35' ' ' ASN . . . . . 0.516 ' ND2' ' SD ' ' A' ' 100' ' ' MET . 43.9 t30 -53.16 -65.87 0.49 Allowed 'General case' 0 C--N 1.35 0.618 0 O-C-N 124.552 1.157 . . . . 74.5 110.989 179.74 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 85.8 t80 -62.37 -34.03 75.89 Favored 'General case' 0 CA--C 1.542 0.649 0 O-C-N 124.332 1.02 . . . . 71.23 111.106 -177.008 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 37' ' ' ARG . . . . . 0.412 ' HG3' ' OE1' ' A' ' 163' ' ' GLN . 48.9 ttp180 -59.94 -45.88 91.19 Favored 'General case' 0 N--CA 1.473 0.676 0 O-C-N 123.926 0.766 . . . . 74.1 111.374 175.277 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -81.77 -18.84 42.75 Favored 'General case' 0 CA--C 1.537 0.477 0 CA-C-N 115.668 -0.696 . . . . 75.35 111.425 -174.374 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 39' ' ' LEU . . . . . 0.463 HD23 ' HE1' ' A' ' 48' ' ' TYR . 98.5 mt -74.26 -39.88 62.72 Favored 'General case' 0 CA--C 1.547 0.844 0 C-N-CA 123.312 0.645 . . . . 65.25 109.31 170.469 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 35.1 t -64.92 -55.03 21.71 Favored 'General case' 0 N--CA 1.477 0.877 0 C-N-CA 124.596 1.159 . . . . 70.44 111.155 -179.938 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 34.8 p -76.58 -31.37 57.46 Favored 'General case' 0 CA--C 1.541 0.607 0 CA-C-N 115.382 -0.826 . . . . 64.34 111.224 -178.289 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 79.23 22.1 66.05 Favored Glycine 0 C--N 1.346 1.139 0 CA-C-O 119.614 -0.548 . . . . 73.43 113.951 176.679 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 8.7 mm-40 -63.64 -22.41 66.88 Favored 'General case' 0 N--CA 1.483 1.221 0 C-N-CA 123.368 0.667 . . . . 74.15 111.728 179.857 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 30.6 mmmt -94.6 15.33 18.32 Favored 'General case' 0 CA--C 1.55 0.947 0 C-N-CA 124.035 0.934 . . . . 74.34 111.558 -179.962 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 76.98 36.71 35.1 Favored Glycine 0 C--N 1.35 1.335 0 N-CA-C 114.417 0.527 . . . . 75.45 114.417 174.843 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 46' ' ' PHE . . . . . 0.416 ' HE2' ' HA ' ' A' ' 78' ' ' ILE . 25.2 m-85 -122.6 -48.35 2.05 Favored 'General case' 0 N--CA 1.491 1.575 0 CA-C-N 117.758 0.779 . . . . 75.24 111.514 -177.457 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 54.18 63.83 4.82 Favored Glycine 0 C--N 1.35 1.312 0 O-C-N 124.077 0.86 . . . . 72.12 115.018 170.218 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 48' ' ' TYR . . . . . 0.686 ' HE2' ' HB2' ' A' ' 66' ' ' ASP . 54.6 m-85 -65.27 89.79 0.09 Allowed 'General case' 0 N--CA 1.481 1.118 0 CA-C-O 121.745 0.783 . . . . 75.34 111.731 179.885 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 27.6 tptp -111.23 107.0 16.16 Favored 'General case' 0 CA--C 1.535 0.377 0 CA-C-N 114.576 -1.193 . . . . 71.23 108.476 178.247 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 99.08 13.8 38.33 Favored Glycine 0 N--CA 1.471 0.999 0 CA-C-O 118.992 -0.893 . . . . 74.24 113.763 178.754 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 20.3 p -57.67 122.89 13.86 Favored 'General case' 0 N--CA 1.48 1.035 0 C-N-CA 123.414 0.686 . . . . 64.25 110.818 -178.482 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 52' ' ' CYS . . . . . . . . . . . . . 7.0 p -100.98 132.37 46.42 Favored 'General case' 0 CA--C 1.539 0.533 0 C-N-CA 123.721 0.808 . . . . 63.24 112.729 -164.058 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 53' ' ' PHE . . . . . 0.576 ' HA ' ' HA3' ' A' ' 64' ' ' GLY . 45.5 m-85 -72.04 140.22 48.9 Favored 'General case' 0 CA--C 1.54 0.559 0 C-N-CA 124.381 1.072 . . . . 73.24 110.151 168.899 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 15.8 p-80 -153.4 13.55 0.49 Allowed 'General case' 0 N--CA 1.478 0.959 0 CA-C-N 116.087 -0.506 . . . . 62.15 112.213 -173.82 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 55' ' ' ARG . . . . . 0.457 ' HA ' ' O ' ' A' ' 150' ' ' GLY . 33.4 ttt180 -155.8 98.29 1.9 Allowed 'General case' 0 N--CA 1.474 0.728 0 N-CA-C 109.732 -0.47 . . . . 74.14 109.732 174.342 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 29.3 mt -130.23 135.88 59.86 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.105 0 C-N-CA 123.053 0.541 . . . . 75.1 109.799 -178.449 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 61.7 mt -134.58 124.55 17.03 Favored Pre-proline 0 CA--C 1.553 1.072 0 C-N-CA 124.976 1.31 . . . . 75.43 109.497 -173.454 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 58' ' ' PRO . . . . . 0.428 ' HA ' ' HG2' ' A' ' 143' ' ' GLU . 31.0 Cg_endo -61.31 139.74 84.59 Favored 'Trans proline' 0 C--N 1.384 2.411 0 C-N-CA 123.609 2.873 . . . . 75.21 113.573 -179.452 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 60.22 24.55 61.24 Favored Glycine 0 C--N 1.353 1.504 0 CA-C-N 115.006 -0.997 . . . . 54.33 113.872 -179.813 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 40.5 t80 -139.76 -69.55 0.41 Allowed 'General case' 0 C--O 1.241 0.651 0 CA-C-N 116.973 0.386 . . . . 72.53 110.495 -174.583 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 53.3 ttp -171.44 148.34 2.53 Favored 'General case' 0 N--CA 1.482 1.151 0 N-CA-C 111.905 0.335 . . . . 65.45 111.905 -165.464 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 62' ' ' CYS . . . . . 0.603 ' SG ' ' HB ' ' A' ' 114' ' ' ILE . 21.9 p -119.81 117.58 28.57 Favored 'General case' 0 N--CA 1.477 0.89 0 C-N-CA 123.894 0.878 . . . . 74.22 108.974 169.591 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 63' ' ' GLN . . . . . 0.431 ' OE1' ' HD3' ' A' ' 55' ' ' ARG . 35.9 tt0 -123.24 143.92 49.73 Favored 'General case' 0 N--CA 1.487 1.42 0 C-N-CA 124.166 0.986 . . . . 75.2 111.781 -170.439 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 64' ' ' GLY . . . . . 0.576 ' HA3' ' HA ' ' A' ' 53' ' ' PHE . . . -161.78 -169.58 25.3 Favored Glycine 0 C--N 1.348 1.203 0 CA-C-N 115.039 -0.982 . . . . 52.33 113.011 176.403 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 166.4 -149.84 16.25 Favored Glycine 0 C--N 1.341 0.825 0 N-CA-C 112.242 -0.343 . . . . 65.05 112.242 -179.056 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 66' ' ' ASP . . . . . 0.686 ' HB2' ' HE2' ' A' ' 48' ' ' TYR . 41.2 t0 -74.94 146.4 41.8 Favored 'General case' 0 N--CA 1.477 0.919 0 C-N-CA 124.318 1.047 . . . . 73.21 110.601 -178.825 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 51.7 t80 -79.88 -33.69 39.8 Favored 'General case' 0 CA--C 1.542 0.673 0 C-N-CA 123.663 0.785 . . . . 62.51 109.46 178.043 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 68' ' ' THR . . . . . 0.63 HG22 ' HG3' ' A' ' 69' ' ' ARG . 14.1 m -72.56 150.59 43.01 Favored 'General case' 0 CA--C 1.544 0.748 0 CA-C-N 114.961 -1.018 . . . . 64.34 109.206 173.019 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 69' ' ' ARG . . . . . 0.63 ' HG3' HG22 ' A' ' 68' ' ' THR . 65.9 mtt85 66.71 13.68 9.46 Favored 'General case' 0 N--CA 1.488 1.438 0 C-N-CA 124.033 0.933 . . . . 75.14 112.296 174.921 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 15.9 t-80 -52.59 -29.1 24.06 Favored 'General case' 0 N--CA 1.484 1.253 0 C-N-CA 125.012 1.325 . . . . 74.44 112.007 -173.724 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 5.3 m-20 -69.28 88.2 0.44 Allowed 'General case' 0 CA--C 1.548 0.887 0 C-N-CA 123.987 0.915 . . . . 72.41 110.377 172.391 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 85.46 -1.2 88.47 Favored Glycine 0 CA--C 1.533 1.16 0 N-CA-C 115.195 0.838 . . . . 50.22 115.195 172.774 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 28.5 m -139.74 -90.74 0.18 Allowed 'General case' 0 N--CA 1.478 0.943 0 CA-C-N 118.06 0.93 . . . . 72.43 110.019 176.02 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 74' ' ' GLY . . . . . 0.453 ' HA2' ' O ' ' A' ' 68' ' ' THR . . . 61.32 60.65 7.93 Favored Glycine 0 C--N 1.356 1.668 0 O-C-N 123.577 0.548 . . . . 55.31 113.277 -176.905 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 141.36 52.19 0.04 OUTLIER Glycine 0 C--N 1.353 1.518 0 C-N-CA 121.101 -0.571 . . . . 73.22 113.055 -176.502 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 63.6 pttt -56.8 158.9 4.34 Favored 'General case' 0 N--CA 1.487 1.377 0 C-N-CA 123.406 0.682 . . . . 72.22 111.896 -179.881 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 71.8 p -98.29 -179.21 4.29 Favored 'General case' 0 CA--C 1.544 0.729 0 C-N-CA 123.338 0.655 . . . . 74.52 110.92 -176.214 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 78' ' ' ILE . . . . . 0.416 ' HA ' ' HE2' ' A' ' 46' ' ' PHE . 25.4 pt -84.96 -8.18 11.12 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.802 0 C-N-CA 122.936 0.494 . . . . 72.54 110.569 173.483 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 53.3 m-85 -103.87 12.42 34.44 Favored 'General case' 0 N--CA 1.472 0.669 0 C-N-CA 124.338 1.055 . . . . 64.43 110.361 -179.992 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 126.42 -134.62 8.62 Favored Glycine 0 C--N 1.348 1.211 0 N-CA-C 110.623 -0.991 . . . . 73.42 110.623 -179.113 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 36.7 tt0 -81.81 -45.66 15.26 Favored 'General case' 0 N--CA 1.47 0.53 0 N-CA-C 109.042 -0.725 . . . . 72.34 109.042 173.701 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 82' ' ' LYS . . . . . 0.786 ' HD2' ' HA ' ' A' ' 107' ' ' THR . 22.6 pttm -156.07 165.32 36.78 Favored 'General case' 0 CA--C 1.54 0.561 0 CA-C-N 114.217 -1.356 . . . . 74.4 110.096 -171.284 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 45.7 p90 -145.76 172.77 12.82 Favored 'General case' 0 N--CA 1.474 0.742 0 C-N-CA 124.177 0.991 . . . . 75.34 109.821 -178.663 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 12.2 pt-20 -91.9 159.73 15.62 Favored 'General case' 0 N--CA 1.472 0.666 0 C-N-CA 122.668 0.387 . . . . 75.34 110.614 178.722 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 62.5 m-20 -63.25 124.78 22.11 Favored 'General case' 0 N--CA 1.472 0.668 0 C-N-CA 123.621 0.768 . . . . 71.52 110.669 -179.767 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 62.1 tt0 -62.72 -48.28 79.91 Favored 'General case' 0 CA--C 1.54 0.566 0 CA-C-N 115.025 -0.989 . . . . 74.41 111.338 -178.95 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 31.9 p30 -161.65 -162.21 0.85 Allowed 'General case' 0 N--CA 1.474 0.759 0 C-N-CA 124.059 0.944 . . . . 75.24 108.517 -179.068 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 87.1 m-85 -142.16 46.14 1.64 Allowed 'General case' 0 N--CA 1.492 1.654 0 C-N-CA 123.043 0.537 . . . . 74.31 110.357 175.494 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 78.3 mt -69.59 -56.67 10.77 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.008 0 CA-C-N 115.764 -0.653 . . . . 62.3 109.882 176.111 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 90' ' ' LEU . . . . . 0.533 HD12 ' HB2' ' A' ' 25' ' ' PHE . 72.0 mt -87.42 126.69 35.03 Favored 'General case' 0 C--O 1.237 0.434 0 CA-C-N 115.045 -0.979 . . . . 64.32 109.751 -176.899 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 91' ' ' LYS . . . . . 0.557 ' HB3' ' HZ2' ' A' ' 91' ' ' LYS . 9.6 mtpm? -119.72 165.58 14.33 Favored 'General case' 0 CA--C 1.542 0.638 0 C-N-CA 124.194 0.998 . . . . 75.23 110.768 -175.291 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 92' ' ' HIS . . . . . . . . . . . . . 52.1 m-70 -83.73 51.31 1.99 Allowed 'General case' 0 N--CA 1.485 1.297 0 C-N-CA 124.478 1.111 . . . . 74.51 110.463 -177.326 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 11.6 t -95.94 13.39 27.06 Favored 'General case' 0 N--CA 1.48 1.036 0 C-N-CA 123.706 0.802 . . . . 73.35 112.242 -170.557 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -161.34 173.18 37.72 Favored Glycine 0 C--N 1.342 0.893 0 CA-C-O 120.027 -0.318 . . . . 64.53 112.524 179.618 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 98.6 Cg_endo -78.87 157.64 27.46 Favored 'Trans proline' 0 C--N 1.363 1.31 0 C-N-CA 122.68 2.253 . . . . 74.13 111.737 170.651 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 81.42 10.52 84.45 Favored Glycine 0 CA--C 1.533 1.171 0 CA-C-N 116.143 -0.481 . . . . 72.14 114.284 179.746 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 97' ' ' ILE . . . . . 0.55 ' HB ' ' HB2' ' A' ' 115' ' ' CYS . 9.8 mm -66.85 111.03 1.69 Allowed 'Isoleucine or valine' 0 CA--C 1.553 1.065 0 C-N-CA 124.36 1.064 . . . . 73.2 111.775 -176.56 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 98' ' ' LEU . . . . . 0.423 HD22 ' CG ' ' A' ' 22' ' ' PHE . 36.6 tp -92.09 113.98 26.39 Favored 'General case' 0 C--O 1.246 0.897 0 CA-C-O 121.257 0.551 . . . . 70.14 110.596 178.577 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 36.2 t -137.25 144.2 42.63 Favored 'General case' 0 CA--C 1.545 0.76 0 C-N-CA 124.395 1.078 . . . . 71.13 108.263 175.167 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 100' ' ' MET . . . . . 0.661 ' HA ' ' HA ' ' A' ' 112' ' ' PHE . 74.1 mtp -78.7 147.03 33.63 Favored 'General case' 0 N--CA 1.483 1.217 0 N-CA-C 109.168 -0.678 . . . . 75.43 109.168 175.316 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 101' ' ' ALA . . . . . 0.502 ' HA ' ' HE1' ' A' ' 126' ' ' HIS . . . -79.53 164.64 23.72 Favored 'General case' 0 N--CA 1.479 0.985 0 CA-C-O 121.399 0.619 . . . . 62.12 112.59 -169.875 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 24.2 p-10 -153.98 167.58 29.28 Favored 'General case' 0 N--CA 1.471 0.612 0 CA-C-N 114.82 -1.082 . . . . 71.35 110.071 -178.591 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -113.63 -7.12 13.35 Favored 'General case' 0 CA--C 1.544 0.747 0 C-N-CA 123.765 0.826 . . . . 72.41 110.02 167.56 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 171.5 -164.76 37.64 Favored Glycine 0 C--N 1.351 1.374 0 CA-C-O 119.399 -0.667 . . . . 44.33 111.555 -178.572 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 14.1 Cg_exo -70.69 143.06 45.35 Favored 'Trans proline' 0 C--N 1.37 1.658 0 C-N-CA 123.322 2.682 . . . . 73.2 111.856 177.952 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 64.4 t30 64.57 16.31 10.21 Favored 'General case' 0 N--CA 1.485 1.29 0 C-N-CA 125.131 1.372 . . . . 74.43 110.997 -177.174 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 107' ' ' THR . . . . . 0.786 ' HA ' ' HD2' ' A' ' 82' ' ' LYS . 4.6 m -117.26 5.48 12.66 Favored 'General case' 0 CA--C 1.547 0.828 0 C-N-CA 124.162 0.985 . . . . 73.13 110.042 -178.828 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 53.1 t30 -84.09 133.53 34.63 Favored 'General case' 0 N--CA 1.474 0.753 0 C-N-CA 123.867 0.867 . . . . 73.51 109.937 -176.842 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 113.12 10.39 15.84 Favored Glycine 0 N--CA 1.472 1.074 0 CA-C-O 120.203 -0.22 . . . . 72.23 113.181 -176.191 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 46.4 p -104.11 120.91 42.11 Favored 'General case' 0 CA--C 1.542 0.652 0 N-CA-C 107.48 -1.304 . . . . 74.03 107.48 166.383 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 111' ' ' GLN . . . . . 0.495 ' HB2' ' HB2' ' A' ' 101' ' ' ALA . 46.5 mt-30 66.9 178.01 0.23 Allowed 'General case' 0 N--CA 1.498 1.943 0 C-N-CA 124.567 1.147 . . . . 72.02 111.533 -172.929 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 112' ' ' PHE . . . . . 0.661 ' HA ' ' HA ' ' A' ' 100' ' ' MET . 45.2 p90 -143.74 161.45 38.56 Favored 'General case' 0 N--CA 1.473 0.708 0 C-N-CA 124.409 1.084 . . . . 71.2 108.874 173.273 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 113' ' ' PHE . . . . . 0.464 ' HE1' ' SG ' ' A' ' 115' ' ' CYS . 48.0 p90 -153.91 161.71 41.79 Favored 'General case' 0 N--CA 1.464 0.266 0 CA-C-O 121.354 0.597 . . . . 75.42 111.673 176.423 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 114' ' ' ILE . . . . . 0.603 ' HB ' ' SG ' ' A' ' 62' ' ' CYS . 15.6 mt -119.24 100.7 10.25 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.744 0 CA-C-N 114.31 -1.314 . . . . 71.41 107.577 175.184 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 115' ' ' CYS . . . . . 0.55 ' HB2' ' HB ' ' A' ' 97' ' ' ILE . 87.0 m -62.23 104.4 0.48 Allowed 'General case' 0 N--CA 1.474 0.769 0 N-CA-C 109.245 -0.65 . . . . 73.34 109.245 171.612 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 28.0 p -82.05 -0.19 43.33 Favored 'General case' 0 CA--C 1.547 0.853 0 C-N-CA 124.316 1.047 . . . . 74.22 111.609 -177.059 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -129.8 160.94 31.91 Favored 'General case' 0 C--O 1.245 0.834 0 C-N-CA 123.93 0.892 . . . . 74.44 109.608 169.471 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 10.3 ptmt -70.66 79.76 0.6 Allowed 'General case' 0 CA--C 1.546 0.82 0 CA-C-O 121.613 0.72 . . . . 73.13 109.418 171.123 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 119' ' ' THR . . . . . . . . . . . . . 36.6 p -72.35 87.05 1.13 Allowed 'General case' 0 CA--C 1.549 0.931 0 CA-C-O 122.013 0.911 . . . . 72.44 110.132 -176.161 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 9.5 pt-20 -72.8 -30.8 64.36 Favored 'General case' 0 N--CA 1.477 0.907 0 CA-C-N 114.611 -1.177 . . . . 75.3 112.307 -169.879 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 121' ' ' TRP . . . . . . . . . . . . . 41.4 p90 -68.39 -21.49 64.69 Favored 'General case' 0 CA--C 1.544 0.746 0 C-N-CA 122.965 0.506 . . . . 75.31 110.936 176.557 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 52.7 mt -83.41 0.36 46.45 Favored 'General case' 0 N--CA 1.482 1.139 0 C-N-CA 122.882 0.473 . . . . 72.02 112.254 177.768 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 62.7 m-20 -78.32 119.79 22.17 Favored 'General case' 0 CA--C 1.542 0.656 0 N-CA-C 109.082 -0.71 . . . . 74.35 109.082 172.728 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 111.02 -25.15 14.7 Favored Glycine 0 C--N 1.346 1.123 0 CA-C-N 115.589 -0.732 . . . . 74.43 111.279 -168.189 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 125' ' ' LYS . . . . . 0.652 ' HG3' ' H ' ' A' ' 126' ' ' HIS . 0.5 OUTLIER -77.32 -167.13 0.85 Allowed 'General case' 0 CA--C 1.568 1.641 0 C-N-CA 124.512 1.125 . . . . 65.15 107.984 170.997 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 126' ' ' HIS . . . . . 0.652 ' H ' ' HG3' ' A' ' 125' ' ' LYS . 0.4 OUTLIER -64.57 150.03 47.65 Favored 'General case' 0 C--O 1.248 0.996 0 C-N-CA 123.944 0.898 . . . . 74.24 112.93 -170.777 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 13.9 p -73.01 145.55 11.7 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.585 0 CA-C-N 114.354 -1.293 . . . . 64.54 111.906 -169.669 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 46.5 t -81.96 149.43 4.8 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.533 0 CA-C-N 114.379 -1.282 . . . . 75.52 108.616 172.41 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 129' ' ' PHE . . . . . 0.541 ' HA ' HG22 ' A' ' 29' ' ' VAL . 46.0 p90 -129.33 -9.1 4.7 Favored 'General case' 0 N--CA 1.481 1.086 0 CA-C-N 118.158 0.435 . . . . 72.41 111.753 179.611 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . -160.92 176.58 37.51 Favored Glycine 0 C--N 1.337 0.59 0 O-C-N 123.371 0.419 . . . . 73.23 112.67 -177.578 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 34.2 ttpt -151.47 135.86 16.89 Favored 'General case' 0 N--CA 1.467 0.415 0 N-CA-C 108.307 -0.997 . . . . 74.02 108.307 173.977 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 6.4 p -60.8 117.31 2.46 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.921 0 O-C-N 123.557 0.535 . . . . 75.35 110.661 178.568 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 133' ' ' LYS . . . . . 0.558 ' HD3' HG22 ' A' ' 5' ' ' THR . 22.3 ptmt -102.12 -14.93 16.87 Favored 'General case' 0 N--CA 1.481 1.124 0 C-N-CA 123.835 0.854 . . . . 75.31 110.609 -178.22 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 3.7 mm-40 -145.36 141.7 28.72 Favored 'General case' 0 N--CA 1.47 0.568 0 C-N-CA 123.11 0.564 . . . . 73.51 110.263 -177.808 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 71.75 26.47 72.78 Favored Glycine 0 C--N 1.338 0.645 0 O-C-N 123.797 0.686 . . . . 54.1 112.76 -174.384 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 136' ' ' MET . . . . . . . . . . . . . 7.0 tpt -60.58 -41.96 95.73 Favored 'General case' 0 N--CA 1.481 1.076 0 C-N-CA 123.379 0.672 . . . . 74.11 109.996 177.223 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 137' ' ' ASN . . . . . . . . . . . . . 12.4 m120 -62.95 -37.08 85.66 Favored 'General case' 0 N--CA 1.477 0.894 0 C-N-CA 123.68 0.792 . . . . 74.4 110.759 178.733 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 138' ' ' ILE . . . . . 0.517 ' O ' ' HG3' ' A' ' 142' ' ' MET . 49.6 mm -61.0 -51.16 76.43 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.809 0 C-N-CA 123.29 0.636 . . . . 74.51 109.663 175.922 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 139' ' ' VAL . . . . . 0.459 HG12 ' SG ' ' A' ' 62' ' ' CYS . 94.6 t -54.36 -47.0 70.06 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.138 0 C-N-CA 124.293 1.037 . . . . 74.42 111.454 179.859 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 38.2 mt-10 -67.24 -29.98 69.77 Favored 'General case' 0 N--CA 1.481 1.079 0 C-N-CA 123.689 0.796 . . . . 73.02 111.569 -179.222 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -77.59 -35.66 52.71 Favored 'General case' 0 N--CA 1.475 0.786 0 C-N-CA 122.938 0.495 . . . . 73.03 111.513 178.833 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 142' ' ' MET . . . . . 0.517 ' HG3' ' O ' ' A' ' 138' ' ' ILE . 45.3 mtp -80.52 -19.58 45.49 Favored 'General case' 0 N--CA 1.483 1.193 0 C-N-CA 122.693 0.397 . . . . 75.15 111.106 -178.935 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 143' ' ' GLU . . . . . 0.428 ' HG2' ' HA ' ' A' ' 58' ' ' PRO . 24.8 tt0 -54.15 -35.15 61.94 Favored 'General case' 0 CA--C 1.55 0.974 0 C-N-CA 124.445 1.098 . . . . 61.05 110.847 168.452 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 144' ' ' ARG . . . . . . . . . . . . . 71.9 mtp180 -74.42 -11.91 60.36 Favored 'General case' 0 CA--C 1.542 0.636 0 C-N-CA 124.69 1.196 . . . . 71.3 112.067 -175.833 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 145' ' ' PHE . . . . . 0.455 ' HD2' ' HA ' ' A' ' 142' ' ' MET . 67.2 m-85 -90.94 -4.89 56.14 Favored 'General case' 0 N--CA 1.479 0.986 0 C-N-CA 122.816 0.446 . . . . 74.15 110.962 173.541 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . -91.76 173.92 37.18 Favored Glycine 0 C--N 1.343 0.939 0 CA-C-N 116.827 -0.17 . . . . 75.41 112.714 176.614 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 20.0 m -132.0 167.92 18.84 Favored 'General case' 0 N--CA 1.484 1.259 0 C-N-CA 124.054 0.942 . . . . 75.03 110.434 -177.491 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 148' ' ' ARG . . . . . . . . . . . . . 19.7 mmm180 -61.77 -32.22 72.47 Favored 'General case' 0 N--CA 1.484 1.235 0 C-N-CA 123.852 0.861 . . . . 61.25 112.246 -173.071 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 149' ' ' ASN . . . . . . . . . . . . . 30.6 p-10 -88.61 -7.2 56.81 Favored 'General case' 0 N--CA 1.483 1.191 0 C-N-CA 123.716 0.806 . . . . 62.13 111.83 -179.457 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 150' ' ' GLY . . . . . 0.457 ' O ' ' HA ' ' A' ' 55' ' ' ARG . . . 105.29 -3.04 40.21 Favored Glycine 0 C--N 1.34 0.797 0 CA-C-O 119.85 -0.417 . . . . 74.13 113.421 -178.331 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 84.8 tttt -63.84 112.56 2.95 Favored 'General case' 0 N--CA 1.472 0.626 0 CA-C-O 121.229 0.537 . . . . 73.24 109.796 -179.212 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 152' ' ' THR . . . . . . . . . . . . . 9.1 m -94.21 109.51 21.31 Favored 'General case' 0 CA--C 1.541 0.604 0 N-CA-C 108.17 -1.048 . . . . 74.22 108.17 179.542 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 153' ' ' SER . . . . . . . . . . . . . 16.0 m -59.32 -35.5 73.93 Favored 'General case' 0 N--CA 1.478 0.941 0 C-N-CA 124.914 1.285 . . . . 71.43 112.164 -174.965 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 74.9 mmtt -109.98 137.04 48.31 Favored 'General case' 0 N--CA 1.467 0.379 0 C-N-CA 123.895 0.878 . . . . 74.35 109.236 -177.475 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 16.7 tppt? -77.52 91.03 3.9 Favored 'General case' 0 CA--C 1.534 0.341 0 N-CA-C 108.418 -0.956 . . . . 74.54 108.418 176.215 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 156' ' ' ILE . . . . . 0.525 ' HB ' ' HB2' ' A' ' 53' ' ' PHE . 85.6 mt -84.93 130.25 36.38 Favored 'Isoleucine or valine' 0 C--O 1.221 -0.446 0 CA-C-N 115.126 -0.943 . . . . 74.53 108.726 -175.383 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 157' ' ' THR . . . . . . . . . . . . . 32.3 p -130.55 155.39 46.59 Favored 'General case' 0 N--CA 1.476 0.867 0 C-N-CA 123.922 0.889 . . . . 72.21 109.934 -176.03 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 158' ' ' ILE . . . . . 0.443 HG23 ' HB3' ' A' ' 8' ' ' PHE . 23.3 mt -88.76 95.3 5.25 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.641 0 N-CA-C 108.598 -0.89 . . . . 72.43 108.598 171.643 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 159' ' ' ALA . . . . . 0.427 ' HB1' ' HB1' ' A' ' 11' ' ' ALA . . . -59.72 -33.37 71.55 Favored 'General case' 0 N--CA 1.474 0.729 0 C-N-CA 124.102 0.961 . . . . 75.32 113.023 -175.267 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 160' ' ' ASP . . . . . . . . . . . . . 1.7 t70 -159.34 170.83 20.97 Favored 'General case' 0 N--CA 1.483 1.206 0 CA-C-O 120.765 0.316 . . . . 75.41 111.496 -175.285 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 161' ' ' CYS . . . . . . . . . . . . . 19.9 p -139.02 -168.83 2.51 Favored 'General case' 0 N--CA 1.481 1.118 0 C-N-CA 125.305 1.442 . . . . 72.25 108.553 -179.463 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 162' ' ' GLY . . . . . . . . . . . . . . . 135.56 56.45 0.06 OUTLIER Glycine 0 N--CA 1.48 1.591 0 CA-C-N 119.294 0.952 . . . . 72.45 113.562 -170.735 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 163' ' ' GLN . . . . . 0.429 ' HA ' ' H ' ' A' ' 7' ' ' PHE . 49.3 tt0 -44.42 119.87 2.01 Favored 'General case' 0 N--CA 1.484 1.23 0 C-N-CA 125.336 1.454 . . . . 71.24 113.069 -178.44 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 164' ' ' LEU . . . . . 0.48 ' O ' ' HB ' ' A' ' 5' ' ' THR . 97.8 mt -91.24 107.96 19.56 Favored 'General case' 0 CA--C 1.536 0.43 0 CA-C-N 115.123 -0.944 . . . . 75.15 110.306 -176.591 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 165' ' ' GLU . . . . . . . . . . . . . 4.4 pt-20 . . . . . 0 CA--C 1.552 1.049 0 N-CA-C 109.196 -0.668 . . . . 74.1 109.196 175.63 . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' B' B ' 216' ' ' PRO . . . . . . . . . . . . . 16.6 Cg_exo . . . . . 0 N--CA 1.489 1.249 0 N-CA-C 110.784 -0.506 . . . . 75.15 110.784 . . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' B' B ' 217' ' ' GLU . . . . . . . . . . . . . 39.3 tt0 -142.25 105.88 5.61 Favored Pre-proline 0 CA--C 1.546 0.798 0 N-CA-C 108.272 -1.01 . . . . 61.42 108.272 -175.291 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 218' ' ' PRO . . . . . . . . . . . . . 26.3 Cg_exo -63.2 105.37 0.47 Allowed 'Trans proline' 0 C--N 1.381 2.278 0 C-N-CA 122.73 2.287 . . . . 75.45 111.732 -179.906 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 219' ' ' GLY . . . . . . . . . . . . . . . 177.95 163.97 30.47 Favored Glycine 0 CA--C 1.525 0.674 0 CA-C-N 115.612 -0.722 . . . . 75.54 112.407 -179.844 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 220' ' ' PRO . . . . . . . . . . . . . 24.5 Cg_exo -68.09 157.65 60.87 Favored 'Trans proline' 0 N--CA 1.489 1.254 0 C-N-CA 123.5 2.8 . . . . 75.1 113.264 175.612 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 221' ' ' TYR . . . . . . . . . . . . . 78.4 m-85 -86.59 139.2 31.05 Favored 'General case' 0 N--CA 1.476 0.844 0 C-N-CA 123.365 0.666 . . . . 72.04 110.04 179.988 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 222' ' ' ALA . . . . . . . . . . . . . . . -103.83 -173.31 2.28 Favored 'General case' 0 N--CA 1.473 0.717 0 C-N-CA 123.934 0.894 . . . . 63.45 113.15 -167.734 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 223' ' ' GLN . . . . . . . . . . . . . 24.2 pt20 -95.71 108.38 39.76 Favored Pre-proline 0 CA--C 1.56 1.36 0 CA-C-N 114.121 -1.4 . . . . 75.2 108.974 170.14 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 224' ' ' PRO . . . . . . . . . . . . . 24.0 Cg_exo . . . . . 0 C--N 1.373 1.849 0 C-N-CA 122.863 2.376 . . . . 74.54 112.131 177.524 . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 1' ' ' MET . . . . . 0.45 ' SD ' ' N ' ' A' ' 1' ' ' MET . 0.8 OUTLIER . . . . . 0 N--CA 1.476 0.863 0 N-CA-C 109.165 -0.68 . . . . 73.41 109.165 . . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 9.9 p -79.46 -25.58 12.54 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.948 0 C-N-CA 123.752 0.821 . . . . 74.21 111.759 -170.9 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 3' ' ' ASN . . . . . 0.483 ' ND2' ' HA ' ' A' ' 25' ' ' PHE . 14.1 m120 -95.79 109.28 45.41 Favored Pre-proline 0 CA--C 1.548 0.884 0 C-N-CA 123.544 0.738 . . . . 74.23 110.895 -175.123 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 4' ' ' PRO . . . . . 0.487 ' HG2' ' HB2' ' A' ' 24' ' ' LEU . 16.1 Cg_endo -56.39 147.12 69.78 Favored 'Trans proline' 0 C--N 1.386 2.504 0 C-N-CA 123.51 2.807 . . . . 64.41 114.276 179.111 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 5' ' ' THR . . . . . 0.507 HG22 ' HD3' ' A' ' 133' ' ' LYS . 86.6 m -98.52 116.82 31.58 Favored 'General case' 0 CA--C 1.542 0.637 0 C-N-CA 124.903 1.281 . . . . 73.42 108.56 178.271 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . 0.439 ' HA ' ' HG3' ' A' ' 163' ' ' GLN . 28.6 t -99.42 119.93 48.11 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.737 0 N-CA-C 108.358 -0.978 . . . . 72.33 108.358 178.784 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 7' ' ' PHE . . . . . 0.555 ' H ' ' HA ' ' A' ' 163' ' ' GLN . 75.7 t80 -100.76 131.17 46.78 Favored 'General case' 0 C--N 1.324 -0.539 0 N-CA-C 109.439 -0.578 . . . . 75.4 109.439 -176.712 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 8' ' ' PHE . . . . . 0.471 ' HD2' ' HE2' ' A' ' 22' ' ' PHE . 46.7 m-85 -133.74 165.07 25.81 Favored 'General case' 0 C--O 1.241 0.65 0 C-N-CA 124.584 1.153 . . . . 74.02 108.949 167.095 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 9' ' ' ASP . . . . . 0.462 ' HB2' ' HB3' ' A' ' 159' ' ' ALA . 27.9 m-20 -112.94 112.62 24.21 Favored 'General case' 0 C--N 1.318 -0.79 0 N-CA-C 106.337 -1.727 . . . . 70.34 106.337 170.422 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 10' ' ' ILE . . . . . 0.42 HG21 ' SD ' ' A' ' 142' ' ' MET . 43.5 mm -81.51 125.12 39.55 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.213 0 N-CA-C 108.695 -0.854 . . . . 73.03 108.695 -179.995 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 11' ' ' ALA . . . . . 0.639 ' HB3' ' HB1' ' A' ' 159' ' ' ALA . . . -121.76 123.54 42.07 Favored 'General case' 0 C--O 1.213 -0.847 0 C-N-CA 124.403 1.081 . . . . 73.43 110.247 -171.405 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . 0.422 HG22 HG12 ' A' ' 156' ' ' ILE . 67.9 t -99.24 131.36 46.68 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.653 0 N-CA-C 107.844 -1.169 . . . . 74.05 107.844 173.515 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 23.1 m-20 67.87 17.58 9.67 Favored 'General case' 0 N--CA 1.491 1.621 0 C-N-CA 124.418 1.087 . . . . 74.13 110.582 -173.577 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 82.75 -9.3 59.85 Favored Glycine 0 C--N 1.351 1.364 0 CA-C-O 119.907 -0.385 . . . . 72.23 113.131 -171.27 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 37.6 mm-40 -97.35 127.48 38.04 Favored Pre-proline 0 CA--C 1.548 0.888 0 C-N-CA 124.329 1.052 . . . . 73.43 110.209 -178.127 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 18.6 Cg_endo -55.28 112.5 1.06 Allowed 'Trans proline' 0 C--N 1.381 2.282 0 C-N-CA 123.75 2.967 . . . . 75.33 113.483 -172.995 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . 0.466 HD21 HG22 ' A' ' 138' ' ' ILE . 40.0 tp -79.33 -40.55 30.03 Favored 'General case' 0 N--CA 1.476 0.87 0 C-N-CA 123.469 0.708 . . . . 75.12 110.087 174.704 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -176.04 -179.36 46.48 Favored Glycine 0 C--N 1.348 1.206 0 CA-C-N 116.212 -0.449 . . . . 65.4 113.286 -179.813 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 30.5 mtp85 -107.69 125.48 51.42 Favored 'General case' 0 N--CA 1.475 0.792 0 C-N-CA 124.46 1.104 . . . . 74.32 109.142 -176.967 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 71.9 t -126.0 142.61 42.17 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.804 0 C-N-CA 124.13 0.972 . . . . 71.05 109.684 -177.903 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 21' ' ' SER . . . . . 0.493 ' HB2' ' HB2' ' A' ' 134' ' ' GLU . 49.4 m -130.64 134.69 47.17 Favored 'General case' 0 CA--C 1.539 0.539 0 C-N-CA 123.579 0.752 . . . . 62.33 109.556 173.447 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 22' ' ' PHE . . . . . 0.471 ' HE2' ' HD2' ' A' ' 8' ' ' PHE . 73.3 m-85 -100.49 170.28 8.5 Favored 'General case' 0 N--CA 1.467 0.389 0 C-N-CA 125.039 1.336 . . . . 72.22 108.945 175.32 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . 0.536 ' HB2' ' HD2' ' A' ' 133' ' ' LYS . 35.5 tt0 -137.07 107.15 6.33 Favored 'General case' 0 CA--C 1.539 0.523 0 C-N-CA 122.98 0.512 . . . . 71.14 109.674 -178.608 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . 0.487 ' HB2' ' HG2' ' A' ' 4' ' ' PRO . 25.5 mt -87.23 126.83 35.06 Favored 'General case' 0 N--CA 1.476 0.83 0 C-N-CA 123.347 0.659 . . . . 72.13 110.531 -175.734 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 25' ' ' PHE . . . . . 0.483 ' HA ' ' ND2' ' A' ' 3' ' ' ASN . 50.9 m-85 -86.21 67.17 9.87 Favored 'General case' 0 CA--C 1.54 0.594 0 C-N-CA 123.905 0.882 . . . . 75.32 109.267 178.51 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -66.83 -18.32 65.32 Favored 'General case' 0 N--CA 1.48 1.059 0 C-N-CA 124.323 1.049 . . . . 75.01 112.923 -173.271 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 12.9 p-10 -79.01 -32.01 44.92 Favored 'General case' 0 CA--C 1.546 0.804 0 C-N-CA 123.441 0.696 . . . . 74.32 110.672 176.258 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 97.9 mttt -89.94 -41.93 11.48 Favored 'General case' 0 N--CA 1.478 0.933 0 C-N-CA 123.69 0.796 . . . . 74.31 111.066 -175.703 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 29' ' ' VAL . . . . . 0.493 HG21 ' HA ' ' A' ' 129' ' ' PHE . 17.0 m -137.81 70.24 50.9 Favored Pre-proline 0 CA--C 1.561 1.374 0 C-N-CA 123.879 0.872 . . . . 73.41 110.096 -172.939 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 27.6 Cg_exo -60.93 -35.66 86.96 Favored 'Trans proline' 0 C--N 1.38 2.197 0 C-N-CA 123.169 2.58 . . . . 72.44 113.599 -170.727 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 22.9 ttmm -59.83 -61.11 2.85 Favored 'General case' 0 N--CA 1.475 0.782 0 C-N-CA 123.617 0.767 . . . . 71.33 111.725 -178.398 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 3.6 m -74.37 -27.53 60.7 Favored 'General case' 0 CA--C 1.553 1.077 0 CA-C-N 115.235 -0.893 . . . . 73.13 111.242 -171.059 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -74.2 -52.44 12.43 Favored 'General case' 0 CA--C 1.549 0.933 0 C-N-CA 122.774 0.43 . . . . 73.23 111.109 177.061 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 27.5 tt0 -61.14 -31.29 71.01 Favored 'General case' 0 N--CA 1.491 1.612 0 C-N-CA 123.305 0.642 . . . . 74.11 110.763 179.1 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 35' ' ' ASN . . . . . 0.501 ' O ' ' HG ' ' A' ' 39' ' ' LEU . 45.1 t30 -54.1 -66.55 0.38 Allowed 'General case' 0 C--N 1.354 0.797 0 O-C-N 123.97 0.794 . . . . 74.32 109.47 175.395 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 74.1 t80 -56.95 -38.2 72.62 Favored 'General case' 0 N--CA 1.479 1.011 0 C-N-CA 124.716 1.206 . . . . 73.25 111.51 -175.941 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 37' ' ' ARG . . . . . 0.501 ' HA ' HE22 ' A' ' 163' ' ' GLN . 14.0 ttm180 -55.24 -58.33 8.14 Favored 'General case' 0 C--N 1.353 0.759 0 CA-C-N 115.372 -0.831 . . . . 74.34 110.331 173.957 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 38' ' ' ALA . . . . . 0.433 ' HB3' ' HG2' ' A' ' 44' ' ' LYS . . . -74.11 -18.92 60.74 Favored 'General case' 0 N--CA 1.468 0.452 0 C-N-CA 123.785 0.834 . . . . 74.51 111.899 -171.782 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 39' ' ' LEU . . . . . 0.622 HD22 ' HE2' ' A' ' 48' ' ' TYR . 43.3 mt -71.58 -46.64 58.75 Favored 'General case' 0 CA--C 1.538 0.517 0 N-CA-C 109.371 -0.603 . . . . 72.02 109.371 173.229 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 33.7 t -68.5 -56.8 7.13 Favored 'General case' 0 CA--C 1.547 0.861 0 C-N-CA 123.797 0.839 . . . . 74.31 111.411 -179.433 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 41' ' ' THR . . . . . 0.4 ' OG1' ' HG2' ' A' ' 43' ' ' GLU . 71.6 p -76.62 -31.03 57.16 Favored 'General case' 0 N--CA 1.471 0.619 0 C-N-CA 124.075 0.95 . . . . 73.02 111.442 -174.012 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 85.74 31.92 19.85 Favored Glycine 0 C--N 1.349 1.261 0 CA-C-O 119.908 -0.384 . . . . 61.22 113.101 -179.022 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 43' ' ' GLU . . . . . 0.4 ' HG2' ' OG1' ' A' ' 41' ' ' THR . 24.5 mm-40 -66.12 -27.87 68.38 Favored 'General case' 0 N--CA 1.483 1.187 0 C-N-CA 122.706 0.402 . . . . 72.12 111.665 176.709 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 44' ' ' LYS . . . . . 0.433 ' HG2' ' HB3' ' A' ' 38' ' ' ALA . 33.3 mmtp -105.95 18.6 21.85 Favored 'General case' 0 N--CA 1.484 1.269 0 C-N-CA 122.992 0.517 . . . . 72.35 110.645 175.405 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 79.23 48.39 6.91 Favored Glycine 0 C--N 1.352 1.43 0 N-CA-C 114.803 0.681 . . . . 75.02 114.803 169.279 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 46' ' ' PHE . . . . . 0.462 ' CE2' ' HA ' ' A' ' 78' ' ' ILE . 25.1 m-85 -130.08 -50.79 1.12 Allowed 'General case' 0 N--CA 1.49 1.545 0 CA-C-N 118.021 0.911 . . . . 75.1 111.399 -178.557 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 47.87 53.97 12.76 Favored Glycine 0 C--N 1.354 1.547 0 O-C-N 124.593 1.183 . . . . 75.14 114.687 176.17 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 48' ' ' TYR . . . . . 0.622 ' HE2' HD22 ' A' ' 39' ' ' LEU . 33.5 m-85 -61.55 95.47 0.05 Allowed 'General case' 0 N--CA 1.479 1.001 0 C-N-CA 123.28 0.632 . . . . 72.12 111.487 -177.803 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 46.9 tptt -98.48 102.42 14.15 Favored 'General case' 0 CA--C 1.537 0.447 0 CA-C-N 114.866 -1.061 . . . . 74.33 108.925 -175.65 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 50' ' ' GLY . . . . . 0.422 ' HA2' ' O ' ' A' ' 158' ' ' ILE . . . 110.62 22.66 6.27 Favored Glycine 0 C--N 1.346 1.117 0 CA-C-O 119.362 -0.688 . . . . 74.32 114.651 173.647 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 19.3 m -53.43 128.35 28.35 Favored 'General case' 0 N--CA 1.484 1.268 0 C-N-CA 123.732 0.813 . . . . 74.43 111.175 178.005 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 52' ' ' CYS . . . . . 0.538 ' HA ' ' HA ' ' A' ' 157' ' ' THR . 19.4 p -103.25 133.83 47.67 Favored 'General case' 0 N--CA 1.478 0.937 0 N-CA-C 112.59 0.589 . . . . 73.55 112.59 -168.282 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 53' ' ' PHE . . . . . 0.684 ' HA ' ' HA2' ' A' ' 64' ' ' GLY . 79.4 m-85 -74.05 102.62 4.25 Favored 'General case' 0 N--CA 1.472 0.661 0 C-N-CA 124.069 0.948 . . . . 74.4 108.665 166.206 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 16.5 p-80 -114.82 -12.93 12.04 Favored 'General case' 0 N--CA 1.481 1.094 0 C-N-CA 123.603 0.761 . . . . 74.3 112.006 -173.316 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 36.1 ttt180 -128.39 100.82 5.95 Favored 'General case' 0 C--O 1.217 -0.618 0 C-N-CA 122.884 0.474 . . . . 73.44 109.75 179.13 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 57.9 mt -128.96 125.4 62.82 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.96 0 C-N-CA 122.905 0.482 . . . . 72.41 110.126 178.375 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 54.7 mt -116.48 114.25 40.38 Favored Pre-proline 0 CA--C 1.557 1.217 0 C-N-CA 124.367 1.067 . . . . 74.22 109.162 178.228 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 31.8 Cg_exo -60.32 129.88 31.66 Favored 'Trans proline' 0 C--N 1.387 2.582 0 C-N-CA 123.704 2.936 . . . . 73.3 112.61 178.103 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 81.26 26.17 52.82 Favored Glycine 0 C--N 1.341 0.807 0 O-C-N 123.778 0.674 . . . . 64.4 112.661 -176.113 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 60' ' ' PHE . . . . . 0.442 ' HB2' HE21 ' B' ' 223' ' ' GLN . 23.1 t80 -151.88 -75.99 0.13 Allowed 'General case' 0 C--O 1.247 0.933 0 C-N-CA 123.016 0.526 . . . . 74.42 110.685 179.712 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 61' ' ' MET . . . . . 0.517 ' HE1' ' HD2' ' B' ' 220' ' ' PRO . 22.9 ptt? -165.35 163.62 19.87 Favored 'General case' 0 N--CA 1.485 1.305 0 N-CA-C 112.813 0.672 . . . . 73.01 112.813 -174.528 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 62' ' ' CYS . . . . . 0.465 ' SG ' ' HE1' ' A' ' 142' ' ' MET . 20.5 p -115.59 111.68 21.03 Favored 'General case' 0 CA--C 1.545 0.766 0 C-N-CA 124.253 1.021 . . . . 65.44 108.933 168.572 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 63' ' ' GLN . . . . . 0.554 ' HA ' ' HA ' ' A' ' 113' ' ' PHE . 52.1 tt0 -102.74 116.73 33.16 Favored 'General case' 0 N--CA 1.479 1.014 0 C-N-CA 124.019 0.928 . . . . 75.12 110.877 -174.955 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 64' ' ' GLY . . . . . 0.684 ' HA2' ' HA ' ' A' ' 53' ' ' PHE . . . -92.36 173.19 35.48 Favored Glycine 0 C--N 1.342 0.896 0 CA-C-N 115.221 -0.899 . . . . 72.13 112.284 171.362 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 174.29 150.46 7.69 Favored Glycine 0 C--O 1.238 0.344 0 N-CA-C 110.504 -1.038 . . . . 71.41 110.504 179.379 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 38.8 t70 -79.75 162.0 25.41 Favored 'General case' 0 CA--C 1.547 0.865 0 CA-C-O 121.608 0.718 . . . . 63.02 112.658 -169.804 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 55.0 t80 -79.95 -40.59 27.73 Favored 'General case' 0 CA--C 1.548 0.871 0 C-N-CA 124.701 1.2 . . . . 75.12 111.678 -177.281 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 25.3 m -61.16 112.68 2.21 Favored 'General case' 0 N--CA 1.479 0.979 0 C-N-CA 123.757 0.823 . . . . 71.44 111.681 -172.673 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 36.3 ttm180 55.83 77.03 0.25 Allowed 'General case' 0 N--CA 1.48 1.035 0 C-N-CA 124.852 1.261 . . . . 74.43 111.19 -178.877 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 12.2 t60 -79.16 -14.55 59.02 Favored 'General case' 0 CA--C 1.546 0.79 0 CA-C-N 115.261 -0.881 . . . . 71.23 110.806 -179.559 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 16.8 m120 -55.97 93.36 0.01 OUTLIER 'General case' 0 N--CA 1.485 1.279 0 C-N-CA 124.211 1.004 . . . . 74.44 110.723 178.18 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 70.18 11.25 67.05 Favored Glycine 0 C--N 1.351 1.4 0 CA-C-N 115.45 -0.795 . . . . 73.53 114.904 176.071 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 21.0 m -143.25 -83.62 0.16 Allowed 'General case' 0 CA--C 1.553 1.075 0 CA-C-N 117.663 0.731 . . . . 72.25 110.634 -178.578 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 64.4 59.22 8.6 Favored Glycine 0 C--N 1.357 1.731 0 O-C-N 123.301 0.376 . . . . 63.35 113.117 -177.008 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 134.6 49.07 0.08 OUTLIER Glycine 0 C--N 1.35 1.359 0 CA-C-N 117.05 0.425 . . . . 53.22 112.475 -176.135 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 14.0 ptmm? -65.59 159.91 23.66 Favored 'General case' 0 N--CA 1.484 1.243 0 C-N-CA 123.64 0.776 . . . . 75.24 111.454 -178.683 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 79.6 p -105.86 -175.65 2.85 Favored 'General case' 0 N--CA 1.481 1.095 0 N-CA-C 112.666 0.617 . . . . 65.44 112.666 -162.897 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 78' ' ' ILE . . . . . 0.462 ' HA ' ' CE2' ' A' ' 46' ' ' PHE . 44.3 pt -70.79 -21.08 22.38 Favored 'Isoleucine or valine' 0 C--N 1.358 0.971 0 CA-C-N 115.595 -0.73 . . . . 73.51 111.254 176.447 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 98.9 m-85 -88.66 33.83 0.77 Allowed 'General case' 0 N--CA 1.475 0.778 0 C-N-CA 123.83 0.852 . . . . 74.54 109.736 173.564 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 70.23 -99.16 0.69 Allowed Glycine 0 C--N 1.351 1.399 0 CA-C-N 115.403 -0.817 . . . . 74.03 111.604 -176.744 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 42.8 tt0 -73.03 -60.22 2.34 Favored 'General case' 0 CA--C 1.544 0.744 0 C-N-CA 123.956 0.902 . . . . 63.44 110.652 -176.498 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 82' ' ' LYS . . . . . 0.743 ' HD2' ' HA ' ' A' ' 107' ' ' THR . 18.8 pttp -169.2 177.37 4.83 Favored 'General case' 0 N--CA 1.482 1.148 0 C-N-CA 123.11 0.564 . . . . 71.44 111.162 -169.721 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 51.6 p90 -156.19 174.93 14.65 Favored 'General case' 0 N--CA 1.478 0.959 0 C-N-CA 124.204 1.002 . . . . 73.41 110.852 -177.574 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 13.5 pt-20 -102.76 162.96 12.5 Favored 'General case' 0 N--CA 1.481 1.117 0 C-N-CA 123.223 0.609 . . . . 74.04 110.872 177.233 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 85' ' ' ASP . . . . . 0.456 ' HB3' HG22 ' A' ' 127' ' ' VAL . 48.0 m-20 -64.71 130.63 44.29 Favored 'General case' 0 N--CA 1.478 0.926 0 CA-C-N 115.687 -0.688 . . . . 74.31 111.276 -179.993 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 9.3 tp10 -69.12 -61.36 1.82 Allowed 'General case' 0 N--CA 1.474 0.747 0 O-C-N 123.57 0.544 . . . . 72.13 111.102 -178.836 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 24.3 p-10 -161.2 127.89 3.98 Favored 'General case' 0 N--CA 1.477 0.887 0 C-N-CA 123.054 0.541 . . . . 75.12 110.325 -171.891 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 86.4 m-85 -88.58 74.11 8.52 Favored 'General case' 0 N--CA 1.476 0.85 0 CA-C-O 121.533 0.682 . . . . 74.15 110.18 -171.727 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 65.1 mt -88.87 -60.27 2.38 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.637 0 CA-C-N 115.221 -0.9 . . . . 70.12 108.998 173.453 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 67.4 mt -85.36 131.13 34.45 Favored 'General case' 0 C--O 1.241 0.626 0 CA-C-N 114.372 -1.286 . . . . 70.24 110.392 -173.05 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 32.2 mtmm -122.46 169.11 11.32 Favored 'General case' 0 N--CA 1.47 0.55 0 C-N-CA 124.933 1.293 . . . . 75.23 109.479 -174.485 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 92' ' ' HIS . . . . . . . . . . . . . 20.7 m-70 -91.95 36.83 0.97 Allowed 'General case' 0 N--CA 1.481 1.105 0 C-N-CA 123.992 0.917 . . . . 72.11 110.852 -170.79 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 80.7 p -67.92 -26.08 65.8 Favored 'General case' 0 N--CA 1.474 0.725 0 C-N-CA 124.387 1.075 . . . . 75.51 112.226 -170.935 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -124.88 175.6 17.17 Favored Glycine 0 C--N 1.344 1.007 0 O-C-N 123.232 0.332 . . . . 73.2 113.221 -177.067 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 93.0 Cg_endo -80.89 157.49 20.89 Favored 'Trans proline' 0 C--N 1.367 1.546 0 C-N-CA 123.046 2.498 . . . . 65.41 111.395 169.484 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 89.36 -0.71 81.34 Favored Glycine 0 N--CA 1.472 1.039 0 CA-C-N 116.27 -0.423 . . . . 52.54 112.971 -177.206 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 97' ' ' ILE . . . . . 0.442 ' HB ' ' HB2' ' A' ' 115' ' ' CYS . 13.9 mm -66.94 114.07 3.5 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.949 0 C-N-CA 124.041 0.936 . . . . 63.41 111.466 -176.591 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 98' ' ' LEU . . . . . 0.477 HD13 HG12 ' A' ' 114' ' ' ILE . 67.2 tp -102.28 113.11 26.13 Favored 'General case' 0 CA--C 1.551 0.999 0 C-N-CA 123.489 0.716 . . . . 74.51 109.761 177.827 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 42.6 t -131.44 168.77 17.04 Favored 'General case' 0 N--CA 1.479 0.978 0 C-N-CA 124.95 1.3 . . . . 71.41 108.296 176.533 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 100' ' ' MET . . . . . 0.507 ' HA ' ' HA ' ' A' ' 112' ' ' PHE . 44.4 mtp -101.62 146.59 27.49 Favored 'General case' 0 N--CA 1.491 1.604 0 CA-C-N 118.596 0.635 . . . . 65.11 110.482 -176.639 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 101' ' ' ALA . . . . . 0.519 ' HB2' ' HB2' ' A' ' 111' ' ' GLN . . . -85.49 167.58 15.32 Favored 'General case' 0 N--CA 1.482 1.151 0 C-N-CA 123.202 0.601 . . . . 65.44 111.174 -175.649 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 102' ' ' ASN . . . . . 0.583 ' HB3' ' HA ' ' A' ' 108' ' ' ASN . 29.4 p-10 -169.9 170.93 7.46 Favored 'General case' 0 N--CA 1.478 0.961 0 C-N-CA 122.829 0.451 . . . . 63.23 111.996 -177.111 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 103' ' ' ALA . . . . . 0.45 ' HB3' HG23 ' A' ' 107' ' ' THR . . . -99.59 -22.1 15.59 Favored 'General case' 0 CA--C 1.547 0.865 0 CA-C-N 115.377 -0.829 . . . . 74.3 111.142 171.55 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -178.15 -177.0 46.56 Favored Glycine 0 C--N 1.357 1.696 0 CA-C-O 119.467 -0.629 . . . . 65.23 113.053 -178.134 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 32.4 Cg_exo -58.62 136.52 74.55 Favored 'Trans proline' 0 C--N 1.375 1.948 0 C-N-CA 122.791 2.327 . . . . 75.42 112.908 175.002 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 66.6 t30 69.72 9.94 7.38 Favored 'General case' 0 N--CA 1.486 1.354 0 C-N-CA 124.805 1.242 . . . . 75.22 111.639 -176.459 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 107' ' ' THR . . . . . 0.743 ' HA ' ' HD2' ' A' ' 82' ' ' LYS . 3.9 m -109.96 5.16 22.11 Favored 'General case' 0 CA--C 1.553 1.087 0 C-N-CA 124.093 0.957 . . . . 73.01 110.305 178.301 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 108' ' ' ASN . . . . . 0.583 ' HA ' ' HB3' ' A' ' 102' ' ' ASN . 66.4 t30 -80.93 154.36 27.04 Favored 'General case' 0 N--CA 1.478 0.97 0 C-N-CA 123.467 0.707 . . . . 71.53 111.3 -173.772 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 106.36 -3.47 37.4 Favored Glycine 0 N--CA 1.467 0.725 0 CA-C-O 119.966 -0.352 . . . . 63.34 112.7 -178.394 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 41.1 p -91.29 119.23 31.16 Favored 'General case' 0 CA--C 1.54 0.563 0 N-CA-C 108.11 -1.07 . . . . 70.02 108.11 170.329 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 111' ' ' GLN . . . . . 0.565 HE22 ' HG2' ' B' ' 218' ' ' PRO . 35.7 mt-30 66.75 173.19 0.25 Allowed 'General case' 0 N--CA 1.496 1.857 0 C-N-CA 124.208 1.003 . . . . 74.32 112.093 -177.919 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 112' ' ' PHE . . . . . 0.507 ' HA ' ' HA ' ' A' ' 100' ' ' MET . 32.6 p90 -143.69 133.72 24.18 Favored 'General case' 0 N--CA 1.474 0.737 0 C-N-CA 123.879 0.871 . . . . 74.34 108.963 177.983 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 113' ' ' PHE . . . . . 0.554 ' HA ' ' HA ' ' A' ' 63' ' ' GLN . 52.2 p90 -116.52 142.06 47.37 Favored 'General case' 0 C--O 1.24 0.603 0 C-N-CA 123.342 0.657 . . . . 74.33 110.595 176.497 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 114' ' ' ILE . . . . . 0.477 HG12 HD13 ' A' ' 98' ' ' LEU . 15.3 mt -109.01 106.5 20.83 Favored 'Isoleucine or valine' 0 C--O 1.238 0.454 0 N-CA-C 108.066 -1.087 . . . . 74.34 108.066 175.39 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 115' ' ' CYS . . . . . 0.442 ' HB2' ' HB ' ' A' ' 97' ' ' ILE . 59.7 m -61.69 103.27 0.32 Allowed 'General case' 0 CA--C 1.546 0.823 0 C-N-CA 123.156 0.582 . . . . 64.44 109.607 173.554 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 116' ' ' THR . . . . . 0.542 HG22 HG12 ' A' ' 139' ' ' VAL . 35.2 p -74.56 -32.71 62.51 Favored 'General case' 0 N--CA 1.474 0.76 0 C-N-CA 124.29 1.036 . . . . 50.3 109.703 178.87 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -100.0 159.04 15.4 Favored 'General case' 0 C--O 1.243 0.761 0 C-N-CA 124.46 1.104 . . . . 31.34 108.561 171.051 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -71.88 111.98 7.59 Favored 'General case' 0 CA--C 1.543 0.693 0 N-CA-C 107.586 -1.264 . . . . 73.43 107.586 169.839 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 119' ' ' THR . . . . . . . . . . . . . 52.2 p -101.86 84.57 2.56 Favored 'General case' 0 CA--C 1.539 0.558 0 CA-C-O 122.319 1.057 . . . . 73.13 109.168 -175.974 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 11.1 pt-20 -77.0 -25.52 52.78 Favored 'General case' 0 N--CA 1.48 1.055 0 CA-C-N 114.543 -1.208 . . . . 73.01 110.903 -174.314 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 121' ' ' TRP . . . . . . . . . . . . . 43.8 p90 -70.19 -6.82 37.08 Favored 'General case' 0 CA--C 1.55 0.962 0 C-N-CA 123.914 0.886 . . . . 71.03 111.258 174.517 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 122' ' ' LEU . . . . . 0.431 HD22 ' HG2' ' A' ' 125' ' ' LYS . 42.7 mt -96.86 24.2 6.38 Favored 'General case' 0 CA--C 1.55 0.965 0 C-N-CA 123.32 0.648 . . . . 71.25 111.45 172.426 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 24.2 m-20 -71.79 133.9 45.83 Favored 'General case' 0 N--CA 1.484 1.247 0 N-CA-C 109.32 -0.622 . . . . 71.33 109.32 163.107 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 89.08 -13.84 62.22 Favored Glycine 0 C--N 1.345 1.056 0 CA-C-N 115.792 -0.64 . . . . 74.41 112.528 -173.26 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 125' ' ' LYS . . . . . 0.431 ' HG2' HD22 ' A' ' 122' ' ' LEU . 0.4 OUTLIER -81.63 -169.45 2.33 Favored 'General case' 0 N--CA 1.477 0.877 0 C-N-CA 123.657 0.783 . . . . 64.43 111.012 -179.02 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 126' ' ' HIS . . . . . 0.472 ' NE2' HD22 ' A' ' 102' ' ' ASN . 24.0 m80 -71.74 146.68 47.98 Favored 'General case' 0 N--CA 1.477 0.924 0 C-N-CA 124.481 1.112 . . . . 74.03 111.257 -163.059 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 127' ' ' VAL . . . . . 0.456 HG22 ' HB3' ' A' ' 85' ' ' ASP . 62.1 t -63.32 128.14 24.86 Favored 'Isoleucine or valine' 0 C--O 1.242 0.664 0 O-C-N 124.534 1.146 . . . . 75.21 112.108 -168.724 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 128' ' ' VAL . . . . . 0.402 HG11 HD12 ' A' ' 97' ' ' ILE . 47.6 t -75.5 140.39 17.46 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.356 0 CA-C-N 114.859 -1.064 . . . . 51.11 108.429 170.787 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 129' ' ' PHE . . . . . 0.493 ' HA ' HG21 ' A' ' 29' ' ' VAL . 41.1 p90 -128.13 -20.87 3.7 Favored 'General case' 0 N--CA 1.474 0.756 0 C-N-CA 122.623 0.369 . . . . 74.24 110.867 -177.475 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . -134.65 168.84 23.4 Favored Glycine 0 C--N 1.34 0.793 0 O-C-N 123.34 0.4 . . . . 62.12 112.188 -176.488 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 33.2 ttpt -152.26 137.11 17.12 Favored 'General case' 0 N--CA 1.47 0.569 0 C-N-CA 123.838 0.855 . . . . 74.34 109.091 176.568 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 17.1 t -70.95 111.71 5.03 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.528 0 N-CA-C 109.439 -0.578 . . . . 74.13 109.439 178.311 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 133' ' ' LYS . . . . . 0.536 ' HD2' ' HB2' ' A' ' 23' ' ' GLU . 20.2 ptmt -94.94 -37.63 11.07 Favored 'General case' 0 CA--C 1.541 0.605 0 C-N-CA 123.242 0.617 . . . . 75.32 110.19 178.193 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 134' ' ' GLU . . . . . 0.493 ' HB2' ' HB2' ' A' ' 21' ' ' SER . 17.9 mm-40 -124.4 136.4 54.03 Favored 'General case' 0 N--CA 1.474 0.757 0 C-N-CA 123.984 0.913 . . . . 73.11 109.274 -178.337 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 76.27 28.34 60.21 Favored Glycine 0 C--N 1.342 0.907 0 O-C-N 123.562 0.539 . . . . 63.55 113.913 175.245 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 136' ' ' MET . . . . . . . . . . . . . 15.3 tpt -63.91 -26.98 68.84 Favored 'General case' 0 N--CA 1.487 1.403 0 CA-C-N 117.418 0.609 . . . . 75.13 110.303 173.418 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 137' ' ' ASN . . . . . . . . . . . . . 1.7 m-20 -55.77 -46.69 77.84 Favored 'General case' 0 CA--C 1.549 0.927 0 C-N-CA 124.4 1.08 . . . . 74.14 110.291 171.502 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 138' ' ' ILE . . . . . 0.466 HG22 HD21 ' A' ' 17' ' ' LEU . 48.5 mm -68.17 -33.23 59.59 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.084 0 C-N-CA 123.876 0.871 . . . . 73.32 111.116 179.622 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 139' ' ' VAL . . . . . 0.542 HG12 HG22 ' A' ' 116' ' ' THR . 78.9 t -65.85 -44.5 92.78 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.072 0 C-N-CA 123.595 0.758 . . . . 74.35 111.12 178.839 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 45.1 mt-10 -74.34 -20.2 60.18 Favored 'General case' 0 N--CA 1.48 1.041 0 CA-C-N 115.747 -0.661 . . . . 74.01 110.99 176.919 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -72.16 -40.18 68.18 Favored 'General case' 0 CA--C 1.542 0.654 0 C-N-CA 122.895 0.478 . . . . 64.34 109.732 170.713 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 142' ' ' MET . . . . . 0.51 ' HE2' ' HA ' ' A' ' 139' ' ' VAL . 72.6 mtm -61.18 -38.81 87.82 Favored 'General case' 0 N--CA 1.484 1.26 0 C-N-CA 123.303 0.641 . . . . 72.14 110.289 176.744 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 42.7 tt0 -51.38 -40.31 58.95 Favored 'General case' 0 CA--C 1.552 1.041 0 O-C-N 124.402 1.064 . . . . 73.45 111.869 176.607 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 144' ' ' ARG . . . . . . . . . . . . . 53.6 mtp180 -71.81 -25.72 62.11 Favored 'General case' 0 CA--C 1.545 0.762 0 C-N-CA 123.47 0.708 . . . . 74.34 112.034 -178.279 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 145' ' ' PHE . . . . . . . . . . . . . 93.5 m-85 -82.77 2.4 34.09 Favored 'General case' 0 N--CA 1.481 1.118 0 C-N-CA 122.725 0.41 . . . . 74.12 111.223 175.749 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . -93.43 173.71 34.35 Favored Glycine 0 C--N 1.349 1.301 0 CA-C-N 117.741 0.246 . . . . 71.51 112.888 176.075 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 35.2 t -135.23 167.39 21.09 Favored 'General case' 0 N--CA 1.477 0.923 0 C-N-CA 123.911 0.884 . . . . 70.24 110.084 178.797 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 148' ' ' ARG . . . . . . . . . . . . . 23.2 mmt180 -73.6 -26.34 60.75 Favored 'General case' 0 N--CA 1.479 0.988 0 C-N-CA 123.725 0.81 . . . . 74.54 112.176 -173.352 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 149' ' ' ASN . . . . . . . . . . . . . 29.3 p-10 -77.06 -5.03 47.25 Favored 'General case' 0 N--CA 1.481 1.089 0 C-N-CA 123.17 0.588 . . . . 70.34 111.001 174.745 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . 101.54 -20.01 48.26 Favored Glycine 0 C--N 1.348 1.226 0 CA-C-O 119.959 -0.356 . . . . 63.41 112.474 177.936 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 34.9 ttpt -71.36 153.39 42.36 Favored 'General case' 0 N--CA 1.48 1.034 0 C-N-CA 122.802 0.441 . . . . 71.44 110.584 -176.894 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 152' ' ' THR . . . . . . . . . . . . . 72.2 p -94.82 134.05 37.86 Favored 'General case' 0 CA--C 1.543 0.696 0 C-N-CA 123.202 0.601 . . . . 71.15 109.452 172.484 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 153' ' ' SER . . . . . . . . . . . . . 36.5 m -65.84 -36.07 82.42 Favored 'General case' 0 CA--C 1.544 0.734 0 C-N-CA 123.641 0.776 . . . . 44.5 110.542 171.729 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 26.3 mmtp -122.87 139.47 54.0 Favored 'General case' 0 N--CA 1.479 0.985 0 C-N-CA 123.899 0.879 . . . . 72.11 109.505 175.222 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 11.7 tppt? -78.79 99.46 6.71 Favored 'General case' 0 CA--C 1.538 0.5 0 C-N-CA 123.101 0.56 . . . . 74.33 109.774 -178.127 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 156' ' ' ILE . . . . . 0.451 ' HB ' ' HB2' ' A' ' 53' ' ' PHE . 55.7 mt -89.24 126.08 42.24 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.482 0 CA-C-N 115.444 -0.798 . . . . 75.34 108.863 179.581 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 157' ' ' THR . . . . . 0.538 ' HA ' ' HA ' ' A' ' 52' ' ' CYS . 69.0 p -122.81 170.78 9.73 Favored 'General case' 0 CA--C 1.541 0.614 0 C-N-CA 125.276 1.43 . . . . 72.11 109.725 179.958 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 158' ' ' ILE . . . . . 0.422 ' O ' ' HA2' ' A' ' 50' ' ' GLY . 75.4 mt -90.83 113.51 26.74 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.685 0 N-CA-C 108.086 -1.079 . . . . 74.41 108.086 166.274 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 159' ' ' ALA . . . . . 0.639 ' HB1' ' HB3' ' A' ' 11' ' ' ALA . . . -63.84 -52.08 61.75 Favored 'General case' 0 N--CA 1.476 0.871 0 C-N-CA 123.9 0.88 . . . . 34.43 111.662 177.959 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 160' ' ' ASP . . . . . . . . . . . . . 14.7 t70 -157.36 173.27 17.17 Favored 'General case' 0 N--CA 1.48 1.043 0 C-N-CA 122.881 0.472 . . . . 73.51 109.823 -174.025 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 161' ' ' CYS . . . . . . . . . . . . . 19.4 p -134.55 -166.99 1.9 Allowed 'General case' 0 N--CA 1.475 0.817 0 C-N-CA 125.309 1.444 . . . . 52.23 109.101 -173.542 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 162' ' ' GLY . . . . . . . . . . . . . . . 134.92 53.17 0.07 OUTLIER Glycine 0 C--N 1.344 1.005 0 O-C-N 122.173 -0.33 . . . . 74.24 112.358 -173.163 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 163' ' ' GLN . . . . . 0.555 ' HA ' ' H ' ' A' ' 7' ' ' PHE . 6.6 tt0 -47.33 103.6 0.04 OUTLIER 'General case' 0 N--CA 1.48 1.035 0 C-N-CA 125.101 1.36 . . . . 74.35 111.614 -179.878 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 164' ' ' LEU . . . . . . . . . . . . . 85.2 mt -71.27 121.85 19.19 Favored 'General case' 0 CA--C 1.538 0.483 0 CA-C-N 114.765 -1.107 . . . . 65.14 110.882 -174.054 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 165' ' ' GLU . . . . . . . . . . . . . 19.0 pt-20 . . . . . 0 C--O 1.249 1.04 0 C-N-CA 124.114 0.965 . . . . 75.12 109.756 171.89 . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' B' B ' 216' ' ' PRO . . . . . . . . . . . . . 10.9 Cg_endo . . . . . 0 N--CA 1.486 1.048 0 N-CA-C 110.449 -0.635 . . . . 64.33 110.449 . . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' B' B ' 217' ' ' GLU . . . . . . . . . . . . . 40.6 mt-10 -131.79 142.08 43.91 Favored Pre-proline 0 N--CA 1.483 1.183 0 C-N-CA 123.507 0.723 . . . . 75.14 110.379 -172.994 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 218' ' ' PRO . . . . . 0.565 ' HG2' HE22 ' A' ' 111' ' ' GLN . 23.8 Cg_endo -62.37 102.69 0.28 Allowed 'Trans proline' 0 C--N 1.381 2.242 0 C-N-CA 122.386 2.058 . . . . 65.3 111.216 175.845 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 219' ' ' GLY . . . . . . . . . . . . . . . 162.61 160.47 11.18 Favored Glycine 0 CA--C 1.533 1.162 0 CA-C-N 115.032 -0.985 . . . . 74.11 111.51 -178.197 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 220' ' ' PRO . . . . . 0.517 ' HD2' ' HE1' ' A' ' 61' ' ' MET . 27.5 Cg_exo -64.63 169.96 10.58 Favored 'Trans proline' 0 C--N 1.375 1.955 0 C-N-CA 123.492 2.794 . . . . 73.11 114.308 179.995 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 221' ' ' TYR . . . . . . . . . . . . . 73.1 m-85 -132.66 173.94 10.82 Favored 'General case' 0 N--CA 1.484 1.273 0 C-N-CA 123.949 0.9 . . . . 71.24 110.987 -174.938 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 222' ' ' ALA . . . . . . . . . . . . . . . -172.29 -175.37 1.39 Allowed 'General case' 0 N--CA 1.477 0.894 0 C-N-CA 124.23 1.012 . . . . 73.33 111.055 -178.93 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 223' ' ' GLN . . . . . 0.442 HE21 ' HB2' ' A' ' 60' ' ' PHE . 75.3 mt-30 61.71 91.73 0.07 OUTLIER Pre-proline 0 N--CA 1.479 0.997 0 C-N-CA 125.08 1.352 . . . . 72.41 112.546 168.06 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 224' ' ' PRO . . . . . . . . . . . . . 33.0 Cg_exo . . . . . 0 C--N 1.376 2.021 0 C-N-CA 123.219 2.612 . . . . 74.1 111.936 175.607 . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 96.0 mmm . . . . . 0 N--CA 1.472 0.672 0 N-CA-C 110.119 -0.326 . . . . 73.52 110.119 . . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 9.1 p -68.03 -21.99 27.39 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.169 0 C-N-CA 123.744 0.818 . . . . 75.21 110.086 174.064 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 3' ' ' ASN . . . . . 0.484 HD21 ' HA ' ' A' ' 25' ' ' PHE . 16.3 m120 -59.23 119.31 37.73 Favored Pre-proline 0 CA--C 1.549 0.935 0 C-N-CA 124.914 1.286 . . . . 71.03 110.622 174.402 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 4' ' ' PRO . . . . . 0.618 ' HG2' ' HB2' ' A' ' 24' ' ' LEU . 32.7 Cg_endo -65.2 129.17 22.17 Favored 'Trans proline' 0 C--N 1.38 2.236 0 C-N-CA 122.696 2.264 . . . . 74.24 111.379 175.102 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 5' ' ' THR . . . . . 0.427 HG21 ' HD3' ' A' ' 133' ' ' LYS . 65.9 m -95.93 122.74 39.07 Favored 'General case' 0 N--CA 1.464 0.257 0 N-CA-C 108.112 -1.07 . . . . 72.4 108.112 177.44 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 34.7 m -107.15 128.6 61.95 Favored 'Isoleucine or valine' 0 C--O 1.22 -0.478 0 CA-C-O 121.432 0.634 . . . . 75.42 110.557 -179.018 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 7' ' ' PHE . . . . . 0.631 ' H ' ' HA ' ' A' ' 163' ' ' GLN . 74.6 t80 -116.03 138.79 50.9 Favored 'General case' 0 C--O 1.239 0.532 0 C-N-CA 124.792 1.237 . . . . 62.25 109.292 -171.579 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 8' ' ' PHE . . . . . 0.493 ' HB3' HG21 ' A' ' 158' ' ' ILE . 63.2 m-85 -141.02 162.68 34.92 Favored 'General case' 0 N--CA 1.47 0.568 0 O-C-N 124.375 1.047 . . . . 74.43 110.11 172.17 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 11.9 m-20 -108.67 106.8 17.01 Favored 'General case' 0 C--N 1.328 -0.341 0 C-N-CA 125.124 1.369 . . . . 64.23 107.359 171.523 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 49.5 mm -81.2 130.88 35.11 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.65 0 N-CA-C 108.664 -0.865 . . . . 74.44 108.664 177.863 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 11' ' ' ALA . . . . . 0.47 ' HB1' ' HB2' ' A' ' 159' ' ' ALA . . . -132.97 139.68 47.41 Favored 'General case' 0 N--CA 1.473 0.696 0 C-N-CA 123.754 0.822 . . . . 74.1 110.69 -174.256 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . 0.502 HG22 ' HB2' ' A' ' 17' ' ' LEU . 72.0 t -94.67 98.31 7.91 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.596 0 C-N-CA 124.899 1.28 . . . . 71.33 108.388 175.697 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 22.6 m-20 61.23 31.18 19.51 Favored 'General case' 0 N--CA 1.483 1.182 0 C-N-CA 124.702 1.201 . . . . 73.13 111.968 -177.993 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 96.14 -8.85 67.57 Favored Glycine 0 C--N 1.348 1.224 0 CA-C-O 119.749 -0.473 . . . . 63.31 113.302 179.215 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 39.1 mm-40 -85.56 113.38 50.65 Favored Pre-proline 0 N--CA 1.473 0.721 0 CA-C-O 118.418 -0.801 . . . . 75.44 109.223 173.321 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 19.2 Cg_endo -55.47 106.06 0.18 Allowed 'Trans proline' 0 C--N 1.385 2.491 0 C-N-CA 123.042 2.495 . . . . 74.44 112.249 -176.381 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . 0.502 ' HB2' HG22 ' A' ' 12' ' ' VAL . 68.9 tp -76.31 -41.37 48.81 Favored 'General case' 0 N--CA 1.476 0.858 0 C-N-CA 123.793 0.837 . . . . 72.11 109.115 -179.313 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 169.97 -172.98 44.03 Favored Glycine 0 C--N 1.341 0.836 0 CA-C-N 115.376 -0.829 . . . . 74.22 112.428 176.513 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 56.0 mtm180 -111.84 136.47 51.09 Favored 'General case' 0 C--O 1.239 0.529 0 C-N-CA 124.111 0.965 . . . . 72.01 109.766 -175.8 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 61.1 t -129.57 131.98 66.6 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.998 0 C-N-CA 123.644 0.778 . . . . 73.41 109.522 177.494 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 45.7 m -119.62 123.8 44.75 Favored 'General case' 0 CA--C 1.543 0.673 0 C-N-CA 124.139 0.975 . . . . 74.32 108.831 174.365 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 14.7 m-85 -99.85 169.09 9.47 Favored 'General case' 0 CA--C 1.541 0.618 0 C-N-CA 123.999 0.92 . . . . 75.43 109.007 174.886 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . 0.527 ' HB2' ' HD2' ' A' ' 133' ' ' LYS . 34.2 tt0 -125.86 108.58 11.59 Favored 'General case' 0 C--O 1.239 0.532 0 N-CA-C 107.697 -1.223 . . . . 73.24 107.697 179.404 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . 0.618 ' HB2' ' HG2' ' A' ' 4' ' ' PRO . 15.8 mt -84.89 124.5 31.7 Favored 'General case' 0 C--O 1.238 0.499 0 CA-C-O 120.935 0.398 . . . . 74.11 110.028 -179.884 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 25' ' ' PHE . . . . . 0.618 ' HB2' HD13 ' A' ' 90' ' ' LEU . 86.1 m-85 -86.04 64.86 8.82 Favored 'General case' 0 CA--C 1.535 0.375 0 CA-C-N 115.66 -0.7 . . . . 73.44 109.586 174.899 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -72.42 -16.06 61.83 Favored 'General case' 0 N--CA 1.479 0.989 0 CA-C-N 115.383 -0.826 . . . . 72.1 111.445 -179.11 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 9.8 p-10 -74.15 -23.0 59.21 Favored 'General case' 0 CA--C 1.553 1.068 0 C-N-CA 123.96 0.904 . . . . 64.21 110.782 173.851 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 28' ' ' LYS . . . . . 0.566 ' HZ1' ' HD2' ' A' ' 25' ' ' PHE . 58.2 mttp -101.52 -52.33 3.25 Favored 'General case' 0 N--CA 1.478 0.973 0 C-N-CA 123.874 0.87 . . . . 72.12 110.771 -177.618 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 30.0 m -122.85 74.37 46.57 Favored Pre-proline 0 CA--C 1.559 1.296 0 C-N-CA 124.308 1.043 . . . . 74.41 109.761 -173.884 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 24.8 Cg_exo -62.29 -43.36 23.62 Favored 'Trans proline' 0 C--N 1.38 2.206 0 C-N-CA 122.726 2.284 . . . . 74.05 113.136 -169.717 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 31' ' ' LYS . . . . . 0.414 ' HD2' ' HB2' ' A' ' 86' ' ' GLU . 1.5 ttmp? -57.05 -54.73 43.42 Favored 'General case' 0 N--CA 1.484 1.232 0 C-N-CA 123.472 0.709 . . . . 75.52 111.495 177.476 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 6.4 m -71.21 -36.3 71.84 Favored 'General case' 0 CA--C 1.551 0.993 0 C-N-CA 123.773 0.829 . . . . 71.52 111.776 -168.932 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 33' ' ' ALA . . . . . 0.43 ' HB2' ' HB3' ' A' ' 24' ' ' LEU . . . -79.85 -48.54 13.35 Favored 'General case' 0 N--CA 1.474 0.77 0 C-N-CA 123.447 0.699 . . . . 75.0 111.103 -177.792 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 12.6 tp10 -63.47 -28.48 69.99 Favored 'General case' 0 N--CA 1.482 1.141 0 C-N-CA 123.59 0.756 . . . . 72.44 111.099 -179.491 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 35' ' ' ASN . . . . . 0.543 ' ND2' ' SD ' ' A' ' 100' ' ' MET . 32.6 t30 -52.79 -69.37 0.12 Allowed 'General case' 0 C--N 1.353 0.721 0 O-C-N 123.948 0.78 . . . . 75.24 110.316 174.239 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 85.5 t80 -66.69 -32.41 73.71 Favored 'General case' 0 N--CA 1.476 0.875 0 C-N-CA 123.501 0.721 . . . . 71.15 111.296 -173.869 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 56.2 ttt-85 -55.4 -54.33 45.08 Favored 'General case' 0 N--CA 1.474 0.767 0 C-N-CA 124.192 0.997 . . . . 70.41 110.268 175.803 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -76.2 -24.15 54.67 Favored 'General case' 0 CA--C 1.541 0.623 0 CA-C-N 115.147 -0.933 . . . . 50.01 112.218 -174.941 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 39' ' ' LEU . . . . . 0.506 HD23 ' HE2' ' A' ' 48' ' ' TYR . 81.7 mt -66.03 -43.16 88.41 Favored 'General case' 0 N--CA 1.482 1.145 0 C-N-CA 123.329 0.651 . . . . 64.55 110.144 173.794 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 47.4 m -82.55 -37.37 25.25 Favored 'General case' 0 CA--C 1.547 0.838 0 CA-C-N 115.143 -0.935 . . . . 74.14 112.317 -172.718 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 41' ' ' THR . . . . . 0.411 ' OG1' ' HG2' ' A' ' 43' ' ' GLU . 3.7 p -72.79 -32.06 65.31 Favored 'General case' 0 N--CA 1.485 1.323 0 C-N-CA 122.519 0.328 . . . . 74.22 110.309 172.664 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 84.85 29.5 28.8 Favored Glycine 0 C--N 1.345 1.059 0 CA-C-N 116.025 -0.534 . . . . 72.15 112.558 -178.789 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 43' ' ' GLU . . . . . 0.411 ' HG2' ' OG1' ' A' ' 41' ' ' THR . 17.6 mm-40 -63.85 -31.41 72.59 Favored 'General case' 0 N--CA 1.48 1.058 0 C-N-CA 123.266 0.626 . . . . 64.21 110.793 176.606 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 71.6 mmtt -95.42 19.25 11.15 Favored 'General case' 0 N--CA 1.48 1.028 0 C-N-CA 123.719 0.807 . . . . 72.34 110.533 179.012 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 83.72 -15.97 33.77 Favored Glycine 0 C--N 1.353 1.482 0 CA-C-O 119.472 -0.627 . . . . 62.1 114.486 175.814 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 46' ' ' PHE . . . . . 0.418 ' HE2' ' HA ' ' A' ' 78' ' ' ILE . 23.6 m-85 -76.77 -51.24 11.75 Favored 'General case' 0 N--CA 1.476 0.853 0 CA-C-N 117.508 0.654 . . . . 65.11 112.686 -166.77 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 48.82 63.3 3.95 Favored Glycine 0 C--N 1.355 1.628 0 O-C-N 123.978 0.799 . . . . 54.33 114.653 176.302 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 48' ' ' TYR . . . . . 0.506 ' HE2' HD23 ' A' ' 39' ' ' LEU . 30.2 m-85 -70.04 100.2 1.58 Allowed 'General case' 0 N--CA 1.484 1.25 0 CA-C-N 117.763 0.782 . . . . 74.1 111.332 -175.511 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 49' ' ' LYS . . . . . 0.554 ' HE3' ' HA ' ' A' ' 160' ' ' ASP . 23.5 tptm -107.47 132.32 53.35 Favored 'General case' 0 CA--C 1.534 0.332 0 C-N-CA 124.951 1.301 . . . . 74.24 109.063 -176.004 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 83.2 21.38 58.93 Favored Glycine 0 C--N 1.348 1.196 0 CA-C-O 119.722 -0.488 . . . . 72.1 112.958 179.408 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 51' ' ' SER . . . . . 0.721 ' HA ' ' HB2' ' A' ' 67' ' ' PHE . 22.4 t -61.91 114.26 3.26 Favored 'General case' 0 C--N 1.358 0.959 0 C-N-CA 122.937 0.495 . . . . 74.52 110.601 -179.761 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 52' ' ' CYS . . . . . 0.592 ' HB3' ' HB3' ' A' ' 66' ' ' ASP . 53.5 t -89.89 157.95 17.65 Favored 'General case' 0 C--O 1.24 0.58 0 C-N-CA 123.352 0.661 . . . . 71.24 111.412 -173.349 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 53' ' ' PHE . . . . . 0.676 ' HA ' ' HA2' ' A' ' 64' ' ' GLY . 14.5 m-85 -105.85 98.0 7.75 Favored 'General case' 0 CA--C 1.535 0.402 0 C-N-CA 124.973 1.309 . . . . 73.53 107.64 176.263 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 54' ' ' HIS . . . . . 0.546 ' HD1' ' HB2' ' A' ' 66' ' ' ASP . 40.8 p-80 -88.22 -27.26 21.91 Favored 'General case' 0 N--CA 1.483 1.206 0 C-N-CA 122.464 0.306 . . . . 74.45 111.519 -178.068 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 55' ' ' ARG . . . . . 0.5 ' HA ' ' O ' ' A' ' 150' ' ' GLY . 42.4 ttt180 -116.1 104.86 11.97 Favored 'General case' 0 C--O 1.212 -0.917 0 N-CA-C 109.762 -0.458 . . . . 73.0 109.762 -175.583 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 63.5 mt -132.46 133.39 59.89 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.044 0 N-CA-C 108.963 -0.754 . . . . 74.55 108.963 174.066 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 57' ' ' ILE . . . . . 0.406 ' HB ' ' HD2' ' A' ' 60' ' ' PHE . 62.0 mt -123.15 123.18 26.73 Favored Pre-proline 0 CA--C 1.558 1.265 0 C-N-CA 124.41 1.084 . . . . 72.44 109.044 176.475 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 55.9 Cg_endo -67.31 144.7 69.22 Favored 'Trans proline' 0 C--N 1.383 2.392 0 C-N-CA 122.983 2.455 . . . . 75.54 111.798 178.706 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 73.56 13.48 80.15 Favored Glycine 0 CA--C 1.527 0.838 0 CA-C-N 115.46 -0.791 . . . . 73.11 114.027 -176.409 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 60' ' ' PHE . . . . . 0.427 ' CE2' ' HE2' ' A' ' 61' ' ' MET . 17.6 t80 -139.73 -75.06 0.35 Allowed 'General case' 0 C--O 1.245 0.859 0 C-N-CA 123.091 0.556 . . . . 71.01 110.495 -173.964 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 61' ' ' MET . . . . . 0.676 ' SD ' ' HB2' ' A' ' 113' ' ' PHE . 13.9 tmm? -174.62 147.26 1.06 Allowed 'General case' 0 CA--C 1.55 0.957 0 N-CA-C 112.064 0.394 . . . . 71.43 112.064 -164.827 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 62' ' ' CYS . . . . . 0.52 ' SG ' ' HB ' ' A' ' 114' ' ' ILE . 21.8 p -108.11 112.48 25.04 Favored 'General case' 0 CA--C 1.552 1.053 0 C-N-CA 124.182 0.993 . . . . 62.54 109.873 172.984 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 63' ' ' GLN . . . . . 0.601 ' HB2' ' SD ' ' A' ' 61' ' ' MET . 49.2 tt0 -104.87 111.33 24.05 Favored 'General case' 0 N--CA 1.487 1.404 0 C-N-CA 124.064 0.946 . . . . 71.15 111.465 -173.637 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 64' ' ' GLY . . . . . 0.676 ' HA2' ' HA ' ' A' ' 53' ' ' PHE . . . -89.51 -179.6 45.01 Favored Glycine 0 C--N 1.342 0.865 0 CA-C-N 114.952 -1.022 . . . . 55.2 112.583 173.483 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 99.42 72.22 1.02 Allowed Glycine 0 N--CA 1.444 -0.809 0 N-CA-C 110.491 -1.044 . . . . 64.34 110.491 -174.334 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 66' ' ' ASP . . . . . 0.592 ' HB3' ' HB3' ' A' ' 52' ' ' CYS . 38.2 t70 -123.88 -4.64 8.06 Favored 'General case' 0 N--CA 1.484 1.256 0 C-N-CA 123.735 0.814 . . . . 73.41 110.756 175.915 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 67' ' ' PHE . . . . . 0.721 ' HB2' ' HA ' ' A' ' 51' ' ' SER . 56.0 t80 -79.25 -70.58 0.5 Allowed 'General case' 0 CA--C 1.544 0.718 0 CA-C-N 116.082 -0.508 . . . . 74.1 111.315 -171.402 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 30.9 m -86.28 102.17 13.73 Favored 'General case' 0 N--CA 1.471 0.602 0 C-N-CA 122.484 0.313 . . . . 72.54 110.954 -171.136 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 81.5 mtp180 52.69 81.94 0.08 Allowed 'General case' 0 N--CA 1.476 0.844 0 C-N-CA 124.518 1.127 . . . . 75.31 111.335 -178.266 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 27.5 p80 -74.68 26.11 0.09 Allowed 'General case' 0 N--CA 1.495 1.78 0 N-CA-C 113.74 1.015 . . . . 74.4 113.74 -170.843 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 1.9 m-20 -86.65 45.06 1.21 Allowed 'General case' 0 CA--C 1.555 1.155 0 C-N-CA 124.344 1.058 . . . . 73.22 109.62 175.436 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 86.79 -7.9 77.99 Favored Glycine 0 C--N 1.353 1.515 0 CA-C-N 116.081 -0.509 . . . . 75.01 113.459 -176.811 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 73' ' ' THR . . . . . 0.491 ' HA ' ' HB2' ' A' ' 110' ' ' SER . 3.7 m -90.45 -61.57 1.65 Allowed 'General case' 0 N--CA 1.475 0.786 0 CA-C-N 117.499 0.65 . . . . 74.11 109.35 179.62 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 62.76 10.12 29.91 Favored Glycine 0 CA--C 1.538 1.525 0 N-CA-C 116.585 1.394 . . . . 72.02 116.585 164.772 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 145.44 55.4 0.02 OUTLIER Glycine 0 N--CA 1.471 1.012 0 CA-C-N 118.179 0.99 . . . . 72.23 111.451 -164.512 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 23.3 pttm -51.13 165.54 0.12 Allowed 'General case' 0 N--CA 1.488 1.428 0 C-N-CA 124.881 1.272 . . . . 75.24 112.658 179.8 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 77.0 p -90.65 178.59 6.03 Favored 'General case' 0 CA--C 1.545 0.767 0 C-N-CA 123.386 0.674 . . . . 71.1 112.446 -169.697 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 78' ' ' ILE . . . . . 0.418 ' HA ' ' HE2' ' A' ' 46' ' ' PHE . 34.7 pt -72.14 -14.57 17.43 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.074 0 C-N-CA 123.935 0.894 . . . . 73.43 110.663 175.207 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 89.6 m-85 -94.54 16.06 16.37 Favored 'General case' 0 CA--C 1.548 0.872 0 C-N-CA 124.458 1.103 . . . . 73.24 110.541 175.674 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 89.79 -121.76 6.26 Favored Glycine 0 C--N 1.355 1.587 0 N-CA-C 111.005 -0.838 . . . . 74.13 111.005 -179.35 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 42.3 tt0 -55.56 -56.4 20.74 Favored 'General case' 0 N--CA 1.48 1.059 0 C-N-CA 125.02 1.328 . . . . 73.3 111.321 -177.384 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 82' ' ' LYS . . . . . 0.826 ' HD2' ' HA ' ' A' ' 107' ' ' THR . 21.0 pttp -169.79 179.2 3.76 Favored 'General case' 0 N--CA 1.48 1.04 0 C-N-CA 124.322 1.049 . . . . 75.41 109.895 -174.999 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 53.5 p90 -148.79 173.66 13.03 Favored 'General case' 0 N--CA 1.475 0.817 0 C-N-CA 123.908 0.883 . . . . 75.25 111.269 -177.422 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 84' ' ' GLU . . . . . 0.417 ' HA ' ' HA ' ' A' ' 106' ' ' ASN . 13.9 pt-20 -94.8 151.43 19.25 Favored 'General case' 0 CA--C 1.541 0.603 0 CA-C-N 115.009 -0.996 . . . . 74.3 110.908 178.532 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 85' ' ' ASP . . . . . 0.433 ' HB3' HG22 ' A' ' 127' ' ' VAL . 44.7 m-20 -65.91 136.69 56.46 Favored 'General case' 0 N--CA 1.475 0.813 0 C-N-CA 124.375 1.07 . . . . 75.41 111.811 -176.93 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 86' ' ' GLU . . . . . 0.414 ' HB2' ' HD2' ' A' ' 31' ' ' LYS . 11.8 tp10 -86.06 -63.54 1.3 Allowed 'General case' 0 CA--C 1.548 0.895 0 CA-C-N 116.106 -0.497 . . . . 71.55 111.399 -173.144 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 26.0 p-10 -166.71 135.59 2.87 Favored 'General case' 0 N--CA 1.482 1.164 0 C-N-CA 122.936 0.494 . . . . 74.55 110.194 -173.944 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 25.9 m-85 -95.34 59.83 2.22 Favored 'General case' 0 N--CA 1.478 0.928 0 C-N-CA 123.841 0.856 . . . . 74.1 110.71 -170.797 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 34.0 mt -75.22 -35.32 33.61 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.17 0 CA-C-N 115.795 -0.639 . . . . 73.05 110.169 176.004 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 90' ' ' LEU . . . . . 0.618 HD13 ' HB2' ' A' ' 25' ' ' PHE . 78.8 mt -100.1 161.53 13.55 Favored 'General case' 0 N--CA 1.471 0.623 0 C-N-CA 123.798 0.839 . . . . 73.32 110.61 -179.125 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 91' ' ' LYS . . . . . 0.627 ' HG3' HG22 ' A' ' 93' ' ' THR . 49.3 pttt -159.17 160.37 35.42 Favored 'General case' 0 CA--C 1.547 0.864 0 CA-C-O 121.646 0.736 . . . . 70.2 111.931 -174.293 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 92' ' ' HIS . . . . . 0.4 ' HA ' HG23 ' A' ' 97' ' ' ILE . 22.9 m-70 -88.93 32.88 0.79 Allowed 'General case' 0 N--CA 1.483 1.195 0 C-N-CA 124.401 1.08 . . . . 73.13 112.434 -167.877 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 93' ' ' THR . . . . . 0.627 HG22 ' HG3' ' A' ' 91' ' ' LYS . 6.1 t -89.44 68.72 7.92 Favored 'General case' 0 N--CA 1.479 1.003 0 CA-C-O 122.52 1.152 . . . . 74.13 110.007 -179.217 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 153.12 164.51 12.59 Favored Glycine 0 C--N 1.338 0.64 0 CA-C-N 114.572 -1.195 . . . . 64.15 111.745 179.245 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 95' ' ' PRO . . . . . 0.498 ' HB2' ' HE3' ' A' ' 136' ' ' MET . 63.6 Cg_endo -76.82 157.37 35.16 Favored 'Trans proline' 0 CA--C 1.554 1.485 0 C-N-CA 122.308 2.006 . . . . 73.4 112.167 172.965 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 84.16 18.61 62.45 Favored Glycine 0 CA--C 1.532 1.145 0 N-CA-C 114.543 0.577 . . . . 74.32 114.543 177.506 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 97' ' ' ILE . . . . . 0.4 HG23 ' HA ' ' A' ' 92' ' ' HIS . 37.6 mm -86.48 106.93 16.19 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.311 0 CA-C-N 117.765 0.783 . . . . 74.24 111.689 -175.07 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 98' ' ' LEU . . . . . 0.43 HD13 HG12 ' A' ' 114' ' ' ILE . 67.2 tp -92.89 119.25 32.0 Favored 'General case' 0 CA--C 1.552 1.055 0 C-N-CA 123.582 0.753 . . . . 75.43 110.746 -178.614 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 13.5 m -138.0 143.28 40.56 Favored 'General case' 0 N--CA 1.482 1.134 0 C-N-CA 124.744 1.218 . . . . 73.41 108.774 177.492 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 100' ' ' MET . . . . . 0.64 ' HA ' ' HA ' ' A' ' 112' ' ' PHE . 73.3 mtp -77.95 138.95 39.13 Favored 'General case' 0 N--CA 1.488 1.433 0 CA-C-N 118.616 0.644 . . . . 73.44 109.335 176.144 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 101' ' ' ALA . . . . . 0.48 ' HB1' ' HB2' ' A' ' 111' ' ' GLN . . . -74.68 160.82 30.3 Favored 'General case' 0 N--CA 1.483 1.178 0 C-N-CA 123.106 0.562 . . . . 74.34 112.21 -168.281 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 102' ' ' ASN . . . . . 0.433 ' HB3' ' HA ' ' A' ' 108' ' ' ASN . 27.5 p-10 -165.28 164.3 19.94 Favored 'General case' 0 N--CA 1.476 0.839 0 CA-C-N 115.515 -0.766 . . . . 75.13 110.974 -176.383 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -107.85 10.34 28.63 Favored 'General case' 0 CA--C 1.549 0.91 0 C-N-CA 123.903 0.881 . . . . 75.03 110.615 171.676 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 148.65 -175.57 27.86 Favored Glycine 0 C--N 1.356 1.669 0 CA-C-O 119.543 -0.587 . . . . 62.02 112.373 179.666 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 40.4 Cg_exo -59.0 143.94 99.58 Favored 'Trans proline' 0 C--N 1.375 1.955 0 C-N-CA 123.358 2.705 . . . . 75.15 112.326 174.311 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 106' ' ' ASN . . . . . 0.417 ' HA ' ' HA ' ' A' ' 84' ' ' GLU . 65.1 t30 70.56 9.57 6.94 Favored 'General case' 0 N--CA 1.49 1.573 0 C-N-CA 125.27 1.428 . . . . 73.41 111.245 -177.914 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 107' ' ' THR . . . . . 0.826 ' HA ' ' HD2' ' A' ' 82' ' ' LYS . 4.0 m -121.88 4.65 9.95 Favored 'General case' 0 CA--C 1.556 1.18 0 C-N-CA 123.476 0.711 . . . . 73.43 110.945 -175.895 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 108' ' ' ASN . . . . . 0.433 ' HA ' ' HB3' ' A' ' 102' ' ' ASN . 48.5 t30 -84.7 140.74 31.08 Favored 'General case' 0 N--CA 1.485 1.324 0 C-N-CA 123.71 0.804 . . . . 73.04 110.68 -176.682 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 111.98 23.34 5.6 Favored Glycine 0 N--CA 1.474 1.206 0 C-N-CA 122.556 0.122 . . . . 61.22 113.354 -177.946 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 110' ' ' SER . . . . . 0.491 ' HB2' ' HA ' ' A' ' 73' ' ' THR . 12.2 p -127.77 120.33 27.66 Favored 'General case' 0 CA--C 1.536 0.433 0 N-CA-C 107.334 -1.358 . . . . 72.33 107.334 171.866 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 111' ' ' GLN . . . . . 0.48 ' HB2' ' HB1' ' A' ' 101' ' ' ALA . 49.4 mt-30 67.65 175.22 0.26 Allowed 'General case' 0 N--CA 1.488 1.436 0 C-N-CA 124.942 1.297 . . . . 74.33 111.051 -172.82 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 112' ' ' PHE . . . . . 0.64 ' HA ' ' HA ' ' A' ' 100' ' ' MET . 23.7 p90 -149.86 142.18 24.22 Favored 'General case' 0 N--CA 1.477 0.885 0 N-CA-C 108.12 -1.067 . . . . 74.34 108.12 176.209 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 113' ' ' PHE . . . . . 0.676 ' HB2' ' SD ' ' A' ' 61' ' ' MET . 54.3 p90 -135.27 139.02 44.07 Favored 'General case' 0 C--O 1.239 0.509 0 CA-C-O 121.198 0.523 . . . . 72.53 111.227 -177.649 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 114' ' ' ILE . . . . . 0.52 ' HB ' ' SG ' ' A' ' 62' ' ' CYS . 11.8 mt -103.17 108.36 24.19 Favored 'Isoleucine or valine' 0 C--O 1.241 0.629 0 N-CA-C 107.475 -1.306 . . . . 73.42 107.475 176.805 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 115' ' ' CYS . . . . . . . . . . . . . 58.6 m -67.87 103.72 1.52 Allowed 'General case' 0 N--CA 1.467 0.395 0 N-CA-C 109.059 -0.719 . . . . 71.42 109.059 177.01 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 116' ' ' THR . . . . . 0.575 HG22 HG11 ' A' ' 139' ' ' VAL . 36.6 p -70.9 -32.39 69.33 Favored 'General case' 0 CA--C 1.54 0.584 0 C-N-CA 124.361 1.065 . . . . 70.3 110.317 179.737 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -110.25 167.91 9.84 Favored 'General case' 0 CA--C 1.543 0.686 0 C-N-CA 124.339 1.056 . . . . 75.05 109.853 173.92 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 18.2 ptmt -76.83 85.08 3.41 Favored 'General case' 0 N--CA 1.479 0.98 0 C-N-CA 123.427 0.691 . . . . 74.22 110.568 179.309 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 119' ' ' THR . . . . . 0.58 ' HB ' HD23 ' A' ' 122' ' ' LEU . 73.5 p -77.44 85.33 3.84 Favored 'General case' 0 CA--C 1.552 1.034 0 CA-C-O 122.068 0.937 . . . . 75.14 110.168 -175.559 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 9.8 pt-20 -81.52 -20.88 39.12 Favored 'General case' 0 N--CA 1.486 1.34 0 C-N-CA 123.691 0.796 . . . . 73.41 112.247 -167.862 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 121' ' ' TRP . . . . . . . . . . . . . 28.5 p90 -73.06 -8.16 54.49 Favored 'General case' 0 N--CA 1.484 1.23 0 C-N-CA 123.525 0.73 . . . . 74.31 110.794 174.748 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 122' ' ' LEU . . . . . 0.58 HD23 ' HB ' ' A' ' 119' ' ' THR . 4.2 mm? -84.23 11.48 8.18 Favored 'General case' 0 CA--C 1.554 1.105 0 C-N-CA 124.16 0.984 . . . . 65.43 111.239 170.932 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 34.5 m-20 -75.92 150.84 37.46 Favored 'General case' 0 N--CA 1.491 1.602 0 CA-C-N 118.804 0.729 . . . . 72.12 110.744 171.228 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 64.45 13.45 54.88 Favored Glycine 0 C--N 1.352 1.43 0 O-C-N 123.877 0.735 . . . . 55.14 112.829 -173.827 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 125' ' ' LYS . . . . . 0.628 ' HB2' ' HZ2' ' A' ' 125' ' ' LYS . 0.0 OUTLIER -106.76 -166.21 1.15 Allowed 'General case' 0 CA--C 1.547 0.86 0 C-N-CA 124.941 1.296 . . . . 73.31 108.05 -173.108 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 126' ' ' HIS . . . . . . . . . . . . . 2.1 p80 -66.84 156.79 34.68 Favored 'General case' 0 N--CA 1.476 0.865 0 C-N-CA 124.48 1.112 . . . . 75.32 113.039 -173.68 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 127' ' ' VAL . . . . . 0.433 HG22 ' HB3' ' A' ' 85' ' ' ASP . 45.9 t -65.74 133.3 30.97 Favored 'Isoleucine or valine' 0 CA--C 1.553 1.084 0 C-N-CA 125.476 1.51 . . . . 73.44 112.955 -168.894 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 128' ' ' VAL . . . . . 0.494 ' HB ' ' HB2' ' A' ' 90' ' ' LEU . 47.3 t -85.19 158.57 3.41 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.148 0 C-N-CA 124.759 1.224 . . . . 72.32 108.701 168.813 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 129' ' ' PHE . . . . . . . . . . . . . 36.8 p90 -139.87 -32.53 0.62 Allowed 'General case' 0 N--CA 1.481 1.092 0 CA-C-N 118.422 0.556 . . . . 74.43 111.936 176.578 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . -117.84 162.41 13.07 Favored Glycine 0 C--N 1.341 0.855 0 CA-C-O 121.071 0.262 . . . . 62.21 113.427 -173.112 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 29.6 ttpt -149.51 120.06 7.46 Favored 'General case' 0 N--CA 1.469 0.489 0 C-N-CA 124.717 1.207 . . . . 75.24 108.796 -179.608 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 34.8 t -61.17 100.78 0.13 Allowed 'Isoleucine or valine' 0 N--CA 1.473 0.7 0 N-CA-C 109.567 -0.531 . . . . 74.12 109.567 177.266 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 133' ' ' LYS . . . . . 0.527 ' HD2' ' HB2' ' A' ' 23' ' ' GLU . 0.1 OUTLIER -86.25 -28.76 23.61 Favored 'General case' 0 N--CA 1.473 0.68 0 N-CA-C 109.454 -0.573 . . . . 73.31 109.454 -179.901 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 42.4 mt-10 -144.27 149.83 36.91 Favored 'General case' 0 N--CA 1.478 0.968 0 C-N-CA 124.937 1.295 . . . . 71.5 109.945 176.748 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 85.73 20.21 56.52 Favored Glycine 0 C--N 1.347 1.157 0 CA-C-O 119.822 -0.432 . . . . 54.4 113.687 176.749 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 136' ' ' MET . . . . . 0.498 ' HE3' ' HB2' ' A' ' 95' ' ' PRO . 14.4 tpt -67.24 -26.54 66.63 Favored 'General case' 0 N--CA 1.48 1.056 0 C-N-CA 123.156 0.582 . . . . 74.32 110.867 179.153 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 137' ' ' ASN . . . . . . . . . . . . . 52.9 t-20 -56.88 -44.39 82.22 Favored 'General case' 0 N--CA 1.48 1.07 0 C-N-CA 124.259 1.023 . . . . 65.15 109.812 172.164 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 138' ' ' ILE . . . . . . . . . . . . . 49.4 mm -71.47 -32.77 47.42 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.748 0 C-N-CA 123.861 0.864 . . . . 71.12 110.742 -179.08 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 139' ' ' VAL . . . . . 0.575 HG11 HG22 ' A' ' 116' ' ' THR . 93.5 t -67.09 -42.13 87.97 Favored 'Isoleucine or valine' 0 CA--C 1.559 1.317 0 C-N-CA 123.534 0.734 . . . . 72.31 110.837 177.904 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 39.3 mt-10 -73.92 -28.14 61.38 Favored 'General case' 0 N--CA 1.478 0.949 0 CA-C-N 115.563 -0.744 . . . . 71.34 110.804 176.747 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -70.43 -44.27 68.2 Favored 'General case' 0 N--CA 1.476 0.847 0 C-N-CA 123.688 0.795 . . . . 63.3 110.848 178.031 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 142' ' ' MET . . . . . 0.529 ' HE1' HG21 ' A' ' 156' ' ' ILE . 27.7 ptm -73.91 -29.36 62.01 Favored 'General case' 0 N--CA 1.473 0.679 0 CA-C-N 115.567 -0.742 . . . . 74.43 111.133 -177.975 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 143' ' ' GLU . . . . . 0.417 ' HB2' HG23 ' A' ' 116' ' ' THR . 41.2 tt0 -51.29 -38.44 52.87 Favored 'General case' 0 N--CA 1.478 0.97 0 C-N-CA 124.105 0.962 . . . . 71.54 111.707 174.189 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 144' ' ' ARG . . . . . . . . . . . . . 39.1 mtp85 -66.92 -22.1 65.97 Favored 'General case' 0 CA--C 1.542 0.667 0 CA-C-N 115.243 -0.889 . . . . 62.21 112.216 -173.432 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 145' ' ' PHE . . . . . . . . . . . . . 58.4 m-85 -82.35 -5.84 58.87 Favored 'General case' 0 N--CA 1.481 1.106 0 N-CA-C 112.088 0.403 . . . . 74.31 112.088 -178.181 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . -97.51 173.09 28.16 Favored Glycine 0 C--N 1.35 1.347 0 N-CA-C 112.52 -0.232 . . . . 73.04 112.52 177.655 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 46.1 m -134.25 172.37 12.96 Favored 'General case' 0 N--CA 1.486 1.328 0 C-N-CA 124.146 0.978 . . . . 72.44 111.106 -176.164 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 148' ' ' ARG . . . . . 0.421 ' NH1' ' HB3' ' B' ' 223' ' ' GLN . 11.0 mmt180 -57.14 -46.57 82.58 Favored 'General case' 0 N--CA 1.49 1.557 0 C-N-CA 124.697 1.199 . . . . 73.12 112.567 -178.553 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 149' ' ' ASN . . . . . . . . . . . . . 29.9 p-10 -67.34 -14.16 62.67 Favored 'General case' 0 N--CA 1.479 1.02 0 C-N-CA 123.801 0.841 . . . . 70.23 111.884 179.136 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 150' ' ' GLY . . . . . 0.5 ' O ' ' HA ' ' A' ' 55' ' ' ARG . . . 102.68 -4.34 50.2 Favored Glycine 0 C--N 1.351 1.372 0 CA-C-O 119.808 -0.44 . . . . 44.05 112.711 -179.732 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 62.3 tttp -69.93 133.56 47.44 Favored 'General case' 0 N--CA 1.475 0.778 0 CA-C-N 117.15 0.475 . . . . 74.44 110.408 -177.66 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 152' ' ' THR . . . . . . . . . . . . . 24.8 p -102.06 124.68 48.08 Favored 'General case' 0 C--O 1.236 0.38 0 C-N-CA 123.601 0.761 . . . . 75.21 109.468 174.165 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 153' ' ' SER . . . . . . . . . . . . . 47.7 t -75.15 -8.62 57.08 Favored 'General case' 0 CA--C 1.55 0.952 0 C-N-CA 123.419 0.688 . . . . 73.31 111.059 174.866 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 74.7 mmtt -133.96 132.42 40.16 Favored 'General case' 0 N--CA 1.475 0.777 0 C-N-CA 124.54 1.136 . . . . 71.3 109.424 178.489 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 46.1 mtmt -82.31 93.29 7.12 Favored 'General case' 0 N--CA 1.474 0.767 0 N-CA-C 108.085 -1.08 . . . . 74.25 108.085 173.757 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 156' ' ' ILE . . . . . 0.529 HG21 ' HE1' ' A' ' 142' ' ' MET . 62.6 mt -85.23 104.67 13.45 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.557 0 CA-C-N 115.707 -0.679 . . . . 74.21 109.886 -175.223 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 157' ' ' THR . . . . . . . . . . . . . 50.1 p -103.93 148.17 26.48 Favored 'General case' 0 N--CA 1.476 0.83 0 C-N-CA 124.44 1.096 . . . . 73.52 110.712 -173.393 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 158' ' ' ILE . . . . . 0.493 HG21 ' HB3' ' A' ' 8' ' ' PHE . 60.3 mt -74.93 93.43 0.8 Allowed 'Isoleucine or valine' 0 CA--C 1.543 0.706 0 N-CA-C 108.136 -1.061 . . . . 74.42 108.136 169.264 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 159' ' ' ALA . . . . . 0.47 ' HB2' ' HB1' ' A' ' 11' ' ' ALA . . . -57.29 -40.08 77.07 Favored 'General case' 0 N--CA 1.476 0.838 0 C-N-CA 124.585 1.154 . . . . 73.14 112.784 -177.335 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 160' ' ' ASP . . . . . 0.554 ' HA ' ' HE3' ' A' ' 49' ' ' LYS . 29.4 t70 -156.15 163.87 39.08 Favored 'General case' 0 N--CA 1.474 0.738 0 O-C-N 123.394 0.434 . . . . 61.32 111.06 -175.862 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 161' ' ' CYS . . . . . . . . . . . . . 18.6 p -131.39 -169.94 2.28 Favored 'General case' 0 CA--C 1.542 0.661 0 C-N-CA 124.976 1.311 . . . . 74.13 108.729 177.844 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 162' ' ' GLY . . . . . . . . . . . . . . . 131.22 51.69 0.1 OUTLIER Glycine 0 N--CA 1.471 1.008 0 N-CA-C 109.915 -1.274 . . . . 73.35 109.915 -170.225 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 163' ' ' GLN . . . . . 0.631 ' HA ' ' H ' ' A' ' 7' ' ' PHE . 36.7 mt-30 -54.33 122.19 9.87 Favored 'General case' 0 CA--C 1.546 0.821 0 CA-C-N 112.429 -1.885 . . . . 74.52 111.927 -175.836 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 164' ' ' LEU . . . . . . . . . . . . . 82.5 mt -71.62 98.8 1.96 Allowed 'General case' 0 N--CA 1.475 0.806 0 C-N-CA 123.377 0.671 . . . . 75.41 111.377 -168.046 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 165' ' ' GLU . . . . . . . . . . . . . 42.5 mt-10 . . . . . 0 C--O 1.252 1.189 0 N-CA-C 107.742 -1.207 . . . . 73.23 107.742 173.77 . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' B' B ' 216' ' ' PRO . . . . . . . . . . . . . 24.0 Cg_exo . . . . . 0 N--CA 1.486 1.068 0 N-CA-C 110.361 -0.669 . . . . 64.24 110.361 . . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' B' B ' 217' ' ' GLU . . . . . . . . . . . . . 11.2 pt-20 -59.89 145.08 85.03 Favored Pre-proline 0 CA--C 1.554 1.097 0 CA-C-N 114.543 -1.208 . . . . 72.11 112.259 -178.503 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 218' ' ' PRO . . . . . . . . . . . . . 32.4 Cg_exo -61.89 98.17 0.16 Allowed 'Trans proline' 0 C--N 1.374 1.9 0 C-N-CA 122.63 2.22 . . . . 72.43 111.787 167.861 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 219' ' ' GLY . . . . . . . . . . . . . . . 171.14 152.48 8.27 Favored Glycine 0 C--N 1.339 0.748 0 CA-C-N 115.827 -0.624 . . . . 72.42 111.865 178.4 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 220' ' ' PRO . . . . . 0.561 ' HB3' HD13 ' A' ' 122' ' ' LEU . 84.5 Cg_endo -77.72 155.52 31.13 Favored 'Trans proline' 0 C--N 1.373 1.852 0 C-N-CA 122.691 2.26 . . . . 71.54 112.395 179.888 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 221' ' ' TYR . . . . . . . . . . . . . 54.4 m-85 -114.08 142.88 45.64 Favored 'General case' 0 C--O 1.244 0.777 0 C-N-CA 123.306 0.642 . . . . 74.14 109.469 -174.799 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 222' ' ' ALA . . . . . . . . . . . . . . . -171.08 161.13 6.71 Favored 'General case' 0 C--O 1.243 0.742 0 C-N-CA 124.457 1.103 . . . . 75.04 110.198 175.086 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 223' ' ' GLN . . . . . 0.421 ' HB3' ' NH1' ' A' ' 148' ' ' ARG . 76.4 mt-30 60.19 64.31 2.7 Favored Pre-proline 0 CA--C 1.553 1.085 0 C-N-CA 124.725 1.21 . . . . 73.44 111.572 174.748 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 224' ' ' PRO . . . . . . . . . . . . . 22.1 Cg_exo . . . . . 0 C--N 1.379 2.178 0 C-N-CA 123.411 2.741 . . . . 60.31 112.399 -176.535 . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 60.7 mtt . . . . . 0 N--CA 1.482 1.157 0 N-CA-C 109.075 -0.713 . . . . 65.11 109.075 . . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 24.0 t -77.54 72.24 0.5 Allowed 'Isoleucine or valine' 0 N--CA 1.483 1.21 0 CA-C-O 121.915 0.864 . . . . 70.42 109.099 179.185 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 3' ' ' ASN . . . . . 0.4 ' ND2' ' HA ' ' A' ' 25' ' ' PHE . 16.6 m120 -101.92 105.5 42.14 Favored Pre-proline 0 C--O 1.24 0.588 0 CA-C-N 114.267 -1.333 . . . . 73.35 110.024 177.179 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 4' ' ' PRO . . . . . 0.453 ' HG2' ' HB2' ' A' ' 24' ' ' LEU . 60.7 Cg_endo -80.04 141.02 14.54 Favored 'Trans proline' 0 C--N 1.362 1.283 0 C-N-CA 122.116 1.877 . . . . 75.34 111.003 164.518 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 50.6 m -96.54 134.0 40.31 Favored 'General case' 0 CA--C 1.533 0.302 0 N-CA-C 108.744 -0.835 . . . . 72.53 108.744 175.673 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . 0.594 ' HA ' ' HB2' ' A' ' 163' ' ' GLN . 58.2 t -100.47 145.84 10.27 Favored 'Isoleucine or valine' 0 C--O 1.217 -0.645 0 N-CA-C 107.869 -1.16 . . . . 73.44 107.869 174.593 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 7' ' ' PHE . . . . . 0.435 ' HB2' ' HG ' ' A' ' 164' ' ' LEU . 87.7 t80 -129.26 126.46 39.12 Favored 'General case' 0 C--O 1.239 0.552 0 N-CA-C 109.132 -0.692 . . . . 75.52 109.132 178.663 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 8' ' ' PHE . . . . . 0.446 ' HE2' ' HZ ' ' A' ' 36' ' ' PHE . 31.0 m-85 -128.16 166.0 19.35 Favored 'General case' 0 C--O 1.238 0.477 0 C-N-CA 124.253 1.021 . . . . 73.41 109.409 168.8 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 29.1 m-20 -115.16 111.96 21.8 Favored 'General case' 0 C--N 1.326 -0.419 0 N-CA-C 107.291 -1.374 . . . . 75.14 107.291 170.835 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 10' ' ' ILE . . . . . 0.458 HG21 ' SD ' ' A' ' 142' ' ' MET . 46.8 mm -80.89 125.76 39.5 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.473 0 N-CA-C 108.896 -0.779 . . . . 74.22 108.896 -179.461 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 11' ' ' ALA . . . . . 0.788 ' HB1' ' HB1' ' A' ' 159' ' ' ALA . . . -114.6 142.82 45.94 Favored 'General case' 0 C--O 1.217 -0.634 0 C-N-CA 124.556 1.142 . . . . 64.35 110.199 -173.839 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . 0.455 HG21 HG12 ' A' ' 156' ' ' ILE . 60.9 t -123.99 135.12 64.61 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.907 0 N-CA-C 107.237 -1.394 . . . . 72.24 107.237 172.097 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 25.4 m-20 65.49 20.32 11.68 Favored 'General case' 0 N--CA 1.494 1.73 0 C-N-CA 124.304 1.041 . . . . 75.21 110.424 -168.841 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 80.36 -5.7 62.93 Favored Glycine 0 C--N 1.358 1.753 0 CA-C-N 116.065 -0.516 . . . . 74.23 113.757 -173.849 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 30.8 mm-40 -104.77 126.94 29.9 Favored Pre-proline 0 N--CA 1.475 0.823 0 C-N-CA 123.882 0.873 . . . . 75.33 110.45 -175.52 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 14.8 Cg_endo -51.87 112.94 0.96 Allowed 'Trans proline' 0 C--N 1.385 2.494 0 C-N-CA 123.538 2.826 . . . . 63.52 112.647 -174.397 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 50.7 tp -76.42 -46.35 27.52 Favored 'General case' 0 N--CA 1.468 0.472 0 CA-C-N 115.007 -0.997 . . . . 52.41 108.859 175.535 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -169.57 -176.21 39.25 Favored Glycine 0 C--N 1.34 0.781 0 CA-C-N 115.169 -0.923 . . . . 72.34 112.258 179.777 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 13.5 ptp180 -109.79 144.44 38.21 Favored 'General case' 0 N--CA 1.475 0.786 0 C-N-CA 123.833 0.853 . . . . 70.12 110.256 -179.536 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 99.3 t -135.55 131.97 51.38 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.733 0 C-N-CA 124.058 0.943 . . . . 74.25 108.918 177.117 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 21' ' ' SER . . . . . 0.472 ' OG ' ' HB2' ' A' ' 134' ' ' GLU . 78.0 p -116.13 130.9 57.02 Favored 'General case' 0 CA--C 1.552 1.021 0 C-N-CA 123.388 0.675 . . . . 75.24 109.561 173.914 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 22' ' ' PHE . . . . . 0.418 ' CD1' HD22 ' A' ' 98' ' ' LEU . 44.9 m-85 -102.61 169.94 8.34 Favored 'General case' 0 N--CA 1.471 0.575 0 C-N-CA 124.785 1.234 . . . . 64.2 110.015 178.928 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 6.4 tp10 -130.95 106.31 8.33 Favored 'General case' 0 C--O 1.24 0.57 0 N-CA-C 108.593 -0.891 . . . . 73.32 108.593 -179.691 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . 0.453 ' HB2' ' HG2' ' A' ' 4' ' ' PRO . 52.1 mt -78.71 124.75 28.52 Favored 'General case' 0 N--CA 1.468 0.448 0 N-CA-C 109.962 -0.384 . . . . 75.15 109.962 178.383 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 25' ' ' PHE . . . . . 0.461 ' HB2' HD11 ' A' ' 90' ' ' LEU . 36.4 m-85 -85.34 60.0 5.98 Favored 'General case' 0 CA--C 1.545 0.771 0 N-CA-C 108.777 -0.823 . . . . 73.24 108.777 173.132 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -61.34 -33.41 73.57 Favored 'General case' 0 N--CA 1.483 1.21 0 C-N-CA 123.613 0.765 . . . . 75.42 111.666 -175.344 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 12.2 p-10 -59.98 -29.59 68.55 Favored 'General case' 0 CA--C 1.549 0.907 0 C-N-CA 124.372 1.069 . . . . 72.22 111.92 176.765 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 28' ' ' LYS . . . . . 0.559 ' HD2' HD23 ' A' ' 90' ' ' LEU . 40.0 mttm -94.72 -42.29 8.83 Favored 'General case' 0 N--CA 1.482 1.14 0 C-N-CA 123.548 0.739 . . . . 74.45 110.637 -178.114 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 29' ' ' VAL . . . . . 0.528 HG21 ' HA ' ' A' ' 129' ' ' PHE . 18.9 m -124.58 82.17 59.47 Favored Pre-proline 0 CA--C 1.563 1.473 0 C-N-CA 123.843 0.857 . . . . 74.33 110.867 -176.369 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 60.7 Cg_exo -53.77 -52.6 8.12 Favored 'Trans proline' 0 C--N 1.386 2.533 0 C-N-CA 123.183 2.589 . . . . 75.34 113.504 -177.83 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 31' ' ' LYS . . . . . 0.524 ' HZ2' ' HB2' ' A' ' 31' ' ' LYS . 4.0 ttmp? -66.47 -52.77 42.72 Favored 'General case' 0 N--CA 1.481 1.096 0 C-N-CA 124.252 1.021 . . . . 75.02 111.975 -177.301 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 32' ' ' THR . . . . . 0.648 HG21 ' HD2' ' A' ' 129' ' ' PHE . 1.4 m -64.55 -38.04 89.63 Favored 'General case' 0 CA--C 1.549 0.925 0 CA-C-N 115.23 -0.895 . . . . 73.52 110.94 -169.586 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -83.6 -36.44 23.92 Favored 'General case' 0 CA--C 1.548 0.885 0 C-N-CA 122.825 0.45 . . . . 75.44 112.2 -178.826 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 29.9 tt0 -57.03 -47.42 80.95 Favored 'General case' 0 N--CA 1.492 1.64 0 C-N-CA 123.371 0.668 . . . . 54.33 110.535 175.439 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 35' ' ' ASN . . . . . 0.487 ' O ' ' HG ' ' A' ' 39' ' ' LEU . 39.8 t30 -49.63 -57.38 7.27 Favored 'General case' 0 C--N 1.349 0.577 0 O-C-N 125.406 1.691 . . . . 75.13 110.474 179.209 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 36' ' ' PHE . . . . . 0.446 ' HZ ' ' HE2' ' A' ' 8' ' ' PHE . 72.3 t80 -62.24 -45.2 94.38 Favored 'General case' 0 CA--C 1.543 0.675 0 O-C-N 124.169 0.918 . . . . 73.13 112.051 -175.939 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 11.6 ttm180 -54.14 -47.72 71.59 Favored 'General case' 0 N--CA 1.482 1.143 0 O-C-N 123.843 0.714 . . . . 75.44 111.507 176.123 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 38' ' ' ALA . . . . . 0.512 ' HB1' ' HG2' ' A' ' 44' ' ' LYS . . . -70.44 -30.37 67.19 Favored 'General case' 0 CA--C 1.544 0.724 0 CA-C-N 115.578 -0.737 . . . . 74.03 111.809 -175.605 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 39' ' ' LEU . . . . . 0.52 HD21 ' HE2' ' A' ' 48' ' ' TYR . 99.7 mt -71.31 -43.64 66.7 Favored 'General case' 0 N--CA 1.477 0.883 0 C-N-CA 123.603 0.761 . . . . 72.13 110.593 175.161 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 34.9 t -64.56 -52.32 58.29 Favored 'General case' 0 N--CA 1.477 0.924 0 C-N-CA 124.979 1.312 . . . . 75.21 111.562 -174.843 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 41' ' ' THR . . . . . 0.44 ' OG1' ' HG2' ' A' ' 43' ' ' GLU . 67.4 p -85.18 -31.25 23.33 Favored 'General case' 0 C--O 1.24 0.587 0 CA-C-N 115.096 -0.956 . . . . 74.11 111.388 -176.054 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 85.99 35.72 10.92 Favored Glycine 0 C--N 1.347 1.16 0 CA-C-N 116.154 -0.476 . . . . 75.52 112.736 -177.803 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 43' ' ' GLU . . . . . 0.44 ' HG2' ' OG1' ' A' ' 41' ' ' THR . 26.7 mm-40 -62.89 -30.86 71.85 Favored 'General case' 0 N--CA 1.483 1.218 0 C-N-CA 122.92 0.488 . . . . 55.41 110.606 172.682 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 44' ' ' LYS . . . . . 0.512 ' HG2' ' HB1' ' A' ' 38' ' ' ALA . 31.5 mmmt -100.57 20.19 15.51 Favored 'General case' 0 CA--C 1.548 0.899 0 C-N-CA 123.707 0.803 . . . . 74.53 111.465 177.353 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 71.17 41.91 59.15 Favored Glycine 0 C--N 1.35 1.334 0 CA-C-O 119.528 -0.595 . . . . 74.32 114.562 171.896 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 24.1 m-85 -123.19 -48.33 1.98 Allowed 'General case' 0 N--CA 1.486 1.372 0 CA-C-N 117.596 0.698 . . . . 75.41 111.071 -176.876 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 48.58 62.64 4.3 Favored Glycine 0 C--N 1.356 1.685 0 O-C-N 124.169 0.918 . . . . 55.33 114.288 171.669 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 48' ' ' TYR . . . . . 0.571 ' CE1' ' HA2' ' A' ' 75' ' ' GLY . 66.1 m-85 -60.78 95.37 0.04 OUTLIER 'General case' 0 N--CA 1.48 1.065 0 CA-C-O 122.108 0.956 . . . . 74.51 112.751 -174.617 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 28.6 tptp -109.41 131.45 55.05 Favored 'General case' 0 CA--C 1.537 0.457 0 CA-C-N 113.337 -1.756 . . . . 74.32 109.149 -176.798 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 72.71 20.34 79.64 Favored Glycine 0 C--N 1.346 1.098 0 CA-C-O 119.665 -0.519 . . . . 70.04 113.793 177.412 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 51' ' ' SER . . . . . 0.477 ' HB3' ' HA2' ' A' ' 65' ' ' GLY . 49.0 m -61.14 114.56 3.2 Favored 'General case' 0 N--CA 1.476 0.858 0 C-N-CA 123.249 0.62 . . . . 72.3 110.368 -178.29 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 52' ' ' CYS . . . . . . . . . . . . . 53.5 t -92.14 121.44 33.69 Favored 'General case' 0 N--CA 1.474 0.727 0 N-CA-C 113.031 0.752 . . . . 75.21 113.031 -165.945 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 53' ' ' PHE . . . . . 0.565 ' HB2' ' HB ' ' A' ' 156' ' ' ILE . 76.4 m-85 -69.4 114.57 7.77 Favored 'General case' 0 C--O 1.239 0.517 0 C-N-CA 124.867 1.267 . . . . 75.5 109.816 167.803 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 17.4 p-80 -128.04 -4.5 5.66 Favored 'General case' 0 N--CA 1.481 1.079 0 C-N-CA 123.565 0.746 . . . . 75.4 112.031 -173.819 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 36.0 ttt180 -135.19 107.37 7.19 Favored 'General case' 0 C--N 1.357 0.928 0 N-CA-C 108.975 -0.75 . . . . 74.23 108.975 170.756 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 56' ' ' ILE . . . . . 0.486 HG22 ' SG ' ' A' ' 62' ' ' CYS . 71.8 mt -130.62 129.25 64.17 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.694 0 C-N-CA 123.721 0.808 . . . . 64.35 109.242 177.365 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 57' ' ' ILE . . . . . 0.442 HG12 ' HA2' ' A' ' 150' ' ' GLY . 52.2 mt -117.07 121.54 32.38 Favored Pre-proline 0 CA--C 1.556 1.186 0 C-N-CA 124.584 1.154 . . . . 71.51 108.725 176.903 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 58' ' ' PRO . . . . . 0.478 ' HA ' ' HG3' ' A' ' 143' ' ' GLU . 24.3 Cg_exo -64.01 146.85 91.67 Favored 'Trans proline' 0 C--N 1.375 1.954 0 C-N-CA 122.792 2.328 . . . . 65.2 112.63 173.388 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 63.99 31.22 80.08 Favored Glycine 0 C--N 1.345 1.033 0 CA-C-N 115.117 -0.947 . . . . 63.05 113.284 -176.306 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 40.0 t80 -158.46 -77.77 0.07 Allowed 'General case' 0 CA--C 1.549 0.923 0 CA-C-N 116.814 0.307 . . . . 75.43 111.653 -174.18 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 48.3 ttm -165.6 157.12 14.32 Favored 'General case' 0 N--CA 1.489 1.49 0 N-CA-C 112.01 0.374 . . . . 70.54 112.01 -163.433 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 62' ' ' CYS . . . . . 0.486 ' SG ' HG22 ' A' ' 56' ' ' ILE . 61.2 m -131.86 113.37 13.4 Favored 'General case' 0 N--CA 1.471 0.623 0 C-N-CA 124.299 1.04 . . . . 74.22 109.11 175.772 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 13.4 pt20 -117.6 149.55 40.48 Favored 'General case' 0 N--CA 1.488 1.448 0 CA-C-O 121.396 0.617 . . . . 75.24 111.556 -177.343 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 64' ' ' GLY . . . . . 0.462 ' CA ' ' HA ' ' A' ' 53' ' ' PHE . . . -162.1 179.4 37.46 Favored Glycine 0 C--N 1.343 0.951 0 CA-C-N 114.536 -1.211 . . . . 61.43 113.94 -176.492 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . 0.477 ' HA2' ' HB3' ' A' ' 51' ' ' SER . . . 110.04 98.31 2.5 Favored Glycine 0 N--CA 1.447 -0.581 0 N-CA-C 108.91 -1.676 . . . . 74.45 108.91 -167.277 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 23.7 t70 -124.69 19.95 8.6 Favored 'General case' 0 N--CA 1.483 1.21 0 CA-C-O 121.765 0.793 . . . . 71.13 109.132 179.353 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 49.1 t80 -81.54 -77.83 0.2 Allowed 'General case' 0 CA--C 1.551 1.004 0 CA-C-N 115.301 -0.863 . . . . 73.52 111.746 -169.55 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 89.6 m -85.54 107.74 17.61 Favored 'General case' 0 N--CA 1.48 1.068 0 C-N-CA 122.406 0.282 . . . . 73.31 110.442 -175.348 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 77.9 mtp180 66.44 80.86 0.21 Allowed 'General case' 0 N--CA 1.472 0.672 0 C-N-CA 125.177 1.391 . . . . 74.5 110.468 -179.85 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 7.8 p80 -70.98 73.87 0.61 Allowed 'General case' 0 CA--C 1.558 1.265 0 CA-C-O 122.343 1.068 . . . . 71.11 110.652 179.709 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 7.4 t30 -153.81 30.39 0.46 Allowed 'General case' 0 CA--C 1.553 1.073 0 C-N-CA 125.066 1.347 . . . . 65.51 107.587 -172.821 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 92.17 -8.67 77.48 Favored Glycine 0 C--N 1.353 1.507 0 CA-C-N 114.874 -1.057 . . . . 70.31 113.431 -177.235 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 73' ' ' THR . . . . . 0.591 ' HA ' ' HB2' ' A' ' 110' ' ' SER . 28.7 m -85.09 -67.12 0.82 Allowed 'General case' 0 CA--C 1.546 0.815 0 N-CA-C 108.525 -0.917 . . . . 63.32 108.525 174.458 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 54.92 18.58 11.87 Favored Glycine 0 C--N 1.348 1.242 0 N-CA-C 115.807 1.083 . . . . 71.34 115.807 167.248 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . 0.571 ' HA2' ' CE1' ' A' ' 48' ' ' TYR . . . 147.84 54.14 0.02 OUTLIER Glycine 0 CA--C 1.494 -1.233 0 O-C-N 121.537 -0.978 . . . . 53.0 111.826 -160.287 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 64.2 pttt -60.18 167.74 2.26 Favored 'General case' 0 CA--C 1.546 0.823 0 O-C-N 124.524 0.779 . . . . 74.41 111.173 173.782 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 87.1 p -88.78 174.16 8.15 Favored 'General case' 0 C--O 1.241 0.647 0 CA-C-N 115.68 -0.691 . . . . 63.24 110.607 -177.746 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 29.6 pt -69.77 -21.69 24.44 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.787 0 CA-C-N 115.846 -0.616 . . . . 74.04 110.557 173.244 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 56.4 m-85 -87.14 0.4 55.36 Favored 'General case' 0 N--CA 1.479 0.989 0 C-N-CA 124.134 0.974 . . . . 75.42 111.636 -178.166 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 125.6 -150.71 17.47 Favored Glycine 0 C--N 1.347 1.172 0 N-CA-C 111.135 -0.786 . . . . 73.13 111.135 -179.933 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 45.9 tt0 -63.02 -40.73 98.62 Favored 'General case' 0 N--CA 1.476 0.873 0 C-N-CA 123.392 0.677 . . . . 75.03 110.612 175.997 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 82' ' ' LYS . . . . . 0.482 ' HD3' ' HA ' ' A' ' 107' ' ' THR . 11.2 ptpp? -150.66 168.38 24.5 Favored 'General case' 0 CA--C 1.548 0.887 0 CA-C-N 115.637 -0.71 . . . . 73.23 110.963 -171.727 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 35.5 p90 -159.77 164.33 33.88 Favored 'General case' 0 N--CA 1.477 0.916 0 C-N-CA 124.797 1.239 . . . . 72.23 109.512 176.065 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 11.6 pt-20 -94.25 159.16 15.26 Favored 'General case' 0 N--CA 1.478 0.931 0 C-N-CA 123.158 0.583 . . . . 74.13 109.834 173.934 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 63.9 m-20 -67.08 151.36 47.75 Favored 'General case' 0 N--CA 1.475 0.809 0 C-N-CA 124.371 1.069 . . . . 74.13 113.814 -170.74 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 6.3 tp10 -69.59 -59.33 3.03 Favored 'General case' 0 CA--C 1.55 0.958 0 CA-C-N 114.953 -1.022 . . . . 75.21 111.12 177.567 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 87' ' ' ASN . . . . . 0.404 ' OD1' HG11 ' A' ' 29' ' ' VAL . 25.8 p-10 -174.2 137.51 0.54 Allowed 'General case' 0 N--CA 1.489 1.508 0 C-N-CA 123.88 0.872 . . . . 75.52 109.912 -171.639 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 91.9 m-85 -89.12 54.82 3.1 Favored 'General case' 0 N--CA 1.489 1.508 0 CA-C-O 121.468 0.652 . . . . 74.4 111.685 -171.492 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 49.3 mt -82.47 -46.72 19.26 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.812 0 CA-C-N 115.632 -0.713 . . . . 75.41 109.16 170.591 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 90' ' ' LEU . . . . . 0.559 HD23 ' HD2' ' A' ' 28' ' ' LYS . 90.2 mt -95.33 110.73 22.7 Favored 'General case' 0 C--O 1.241 0.641 0 CA-C-N 115.445 -0.798 . . . . 73.51 110.876 -174.728 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 23.5 pttm -107.84 169.52 8.55 Favored 'General case' 0 N--CA 1.474 0.769 0 C-N-CA 124.176 0.99 . . . . 74.41 109.409 173.503 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 92' ' ' HIS . . . . . 0.459 ' HA ' HG22 ' A' ' 97' ' ' ILE . 17.1 m-70 -87.68 47.07 1.45 Allowed 'General case' 0 N--CA 1.481 1.088 0 C-N-CA 124.045 0.938 . . . . 55.2 110.371 -173.688 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 9.5 t -83.71 5.32 25.11 Favored 'General case' 0 CA--C 1.552 1.028 0 C-N-CA 124.315 1.046 . . . . 75.45 111.971 -174.059 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -133.53 153.42 20.82 Favored Glycine 0 C--N 1.347 1.155 0 CA-C-O 119.713 -0.493 . . . . 74.11 112.067 179.091 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 73.5 Cg_endo -75.89 142.38 25.2 Favored 'Trans proline' 0 C--N 1.367 1.531 0 C-N-CA 122.538 2.158 . . . . 73.02 110.064 167.258 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 89.13 6.69 71.17 Favored Glycine 0 N--CA 1.467 0.75 0 CA-C-O 120.145 -0.253 . . . . 64.52 113.121 -175.931 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 97' ' ' ILE . . . . . 0.713 ' HB ' ' SG ' ' A' ' 115' ' ' CYS . 5.9 mm -68.63 120.18 15.67 Favored 'Isoleucine or valine' 0 CA--C 1.552 1.057 0 C-N-CA 123.181 0.593 . . . . 75.34 110.782 179.191 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 98' ' ' LEU . . . . . 0.418 HD22 ' CD1' ' A' ' 22' ' ' PHE . 56.8 tp -103.4 123.05 46.11 Favored 'General case' 0 CA--C 1.554 1.122 0 C-N-CA 124.4 1.08 . . . . 72.03 111.038 -177.657 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 99' ' ' SER . . . . . 0.686 ' HB3' ' HA ' ' A' ' 128' ' ' VAL . 11.3 p -152.88 158.39 42.08 Favored 'General case' 0 N--CA 1.473 0.687 0 C-N-CA 124.369 1.067 . . . . 71.41 109.514 176.212 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 100' ' ' MET . . . . . 0.644 ' HG3' ' HE2' ' A' ' 129' ' ' PHE . 79.7 mtp -77.25 145.83 37.28 Favored 'General case' 0 N--CA 1.487 1.398 0 N-CA-C 109.944 -0.391 . . . . 75.22 109.944 -179.898 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 101' ' ' ALA . . . . . 0.481 ' HB3' ' HB2' ' A' ' 111' ' ' GLN . . . -76.07 165.85 24.34 Favored 'General case' 0 C--O 1.247 0.943 0 CA-C-O 121.015 0.436 . . . . 65.44 111.236 -177.681 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 102' ' ' ASN . . . . . 0.453 ' HB3' ' HA ' ' A' ' 108' ' ' ASN . 27.1 p-10 -160.38 156.79 26.74 Favored 'General case' 0 N--CA 1.472 0.631 0 CA-C-N 115.809 -0.632 . . . . 73.42 111.007 -176.766 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -93.33 -17.23 23.82 Favored 'General case' 0 CA--C 1.545 0.773 0 CA-C-N 115.358 -0.837 . . . . 70.33 110.674 169.587 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 177.94 -178.75 48.51 Favored Glycine 0 C--N 1.352 1.437 0 CA-C-O 119.445 -0.642 . . . . 64.51 112.957 178.839 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 50.2 Cg_exo -58.85 141.22 97.82 Favored 'Trans proline' 0 C--N 1.374 1.917 0 C-N-CA 123.22 2.614 . . . . 75.03 112.439 171.554 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 64.4 t30 66.54 10.55 7.45 Favored 'General case' 0 N--CA 1.485 1.302 0 C-N-CA 125.48 1.512 . . . . 73.23 111.243 -176.301 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 107' ' ' THR . . . . . 0.482 ' HA ' ' HD3' ' A' ' 82' ' ' LYS . 16.7 m -126.57 18.76 7.42 Favored 'General case' 0 CA--C 1.558 1.273 0 C-N-CA 124.767 1.227 . . . . 73.14 108.769 -178.828 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 108' ' ' ASN . . . . . 0.453 ' HA ' ' HB3' ' A' ' 102' ' ' ASN . 48.1 t30 -86.13 143.74 27.87 Favored 'General case' 0 N--CA 1.48 1.026 0 C-N-CA 123.827 0.851 . . . . 61.45 109.206 177.33 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 112.69 26.29 4.24 Favored Glycine 0 N--CA 1.469 0.86 0 C-N-CA 121.18 -0.533 . . . . 65.52 113.481 -177.566 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 110' ' ' SER . . . . . 0.591 ' HB2' ' HA ' ' A' ' 73' ' ' THR . 31.6 p -129.17 121.06 26.91 Favored 'General case' 0 CA--C 1.539 0.551 0 N-CA-C 107.859 -1.163 . . . . 65.24 107.859 171.697 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 111' ' ' GLN . . . . . 0.481 ' HB2' ' HB3' ' A' ' 101' ' ' ALA . 48.8 mt-30 66.49 177.21 0.23 Allowed 'General case' 0 N--CA 1.491 1.583 0 C-N-CA 124.536 1.135 . . . . 70.13 111.271 -171.574 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 112' ' ' PHE . . . . . 0.637 ' HA ' ' HA ' ' A' ' 100' ' ' MET . 3.1 m-85 -131.75 166.92 20.45 Favored 'General case' 0 N--CA 1.477 0.882 0 N-CA-C 107.396 -1.335 . . . . 74.42 107.396 175.336 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 113' ' ' PHE . . . . . 0.416 ' O ' HD11 ' A' ' 98' ' ' LEU . 48.2 p90 -157.13 160.47 38.85 Favored 'General case' 0 N--CA 1.477 0.916 0 CA-C-O 121.393 0.616 . . . . 73.43 112.138 170.902 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 114' ' ' ILE . . . . . 0.465 HG21 HG12 ' A' ' 139' ' ' VAL . 20.2 mt -124.51 109.71 23.29 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.821 0 CA-C-N 114.024 -1.444 . . . . 74.53 107.443 171.845 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 115' ' ' CYS . . . . . 0.713 ' SG ' ' HB ' ' A' ' 97' ' ' ILE . 29.8 p -74.5 105.5 5.66 Favored 'General case' 0 N--CA 1.474 0.769 0 N-CA-C 108.836 -0.802 . . . . 74.04 108.836 177.464 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 116' ' ' THR . . . . . 0.403 HG23 HG11 ' A' ' 139' ' ' VAL . 24.2 p -71.27 -23.06 61.9 Favored 'General case' 0 N--CA 1.476 0.853 0 C-N-CA 124.396 1.078 . . . . 65.44 111.601 -174.015 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -107.39 152.89 23.57 Favored 'General case' 0 C--O 1.245 0.839 0 N-CA-C 108.794 -0.817 . . . . 71.3 108.794 166.775 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 20.3 ptmt -70.69 99.0 1.61 Allowed 'General case' 0 CA--C 1.543 0.676 0 CA-C-O 121.762 0.792 . . . . 75.51 109.033 172.851 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 119' ' ' THR . . . . . . . . . . . . . 82.2 p -81.7 86.32 6.44 Favored 'General case' 0 CA--C 1.547 0.858 0 CA-C-O 121.963 0.887 . . . . 72.33 109.656 -175.721 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 12.1 pt-20 -74.28 -29.99 61.9 Favored 'General case' 0 N--CA 1.48 1.057 0 CA-C-N 114.662 -1.153 . . . . 73.14 111.132 -175.092 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 121' ' ' TRP . . . . . . . . . . . . . 34.5 p90 -64.91 -13.4 56.76 Favored 'General case' 0 N--CA 1.48 1.03 0 C-N-CA 123.987 0.915 . . . . 75.35 111.57 175.347 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 64.7 mt -99.42 29.08 4.17 Favored 'General case' 0 CA--C 1.551 0.987 0 C-N-CA 123.75 0.82 . . . . 74.42 111.51 176.125 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 83.4 m-20 -69.45 134.95 49.56 Favored 'General case' 0 N--CA 1.484 1.254 0 N-CA-C 109.651 -0.5 . . . . 63.44 109.651 166.615 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 81.9 0.86 89.97 Favored Glycine 0 C--N 1.341 0.844 0 CA-C-N 116.223 -0.444 . . . . 52.03 113.056 -176.209 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 125' ' ' LYS . . . . . 0.465 ' HG3' ' H ' ' A' ' 126' ' ' HIS . 8.5 tppt? -78.43 -170.93 2.23 Favored 'General case' 0 N--CA 1.477 0.915 0 N-CA-C 108.641 -0.874 . . . . 75.41 108.641 176.96 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 126' ' ' HIS . . . . . 0.465 ' H ' ' HG3' ' A' ' 125' ' ' LYS . 44.7 p-80 -68.57 152.84 44.81 Favored 'General case' 0 CA--C 1.545 0.781 0 O-C-N 122.051 -0.406 . . . . 65.13 110.022 -175.826 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 48.5 t -79.37 147.42 6.7 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.697 0 C-N-CA 123.631 0.772 . . . . 75.34 112.452 -164.771 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 128' ' ' VAL . . . . . 0.686 ' HA ' ' HB3' ' A' ' 99' ' ' SER . 61.7 t -83.19 158.81 3.73 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.759 0 C-N-CA 125.103 1.361 . . . . 54.35 109.933 176.375 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 129' ' ' PHE . . . . . 0.648 ' HD2' HG21 ' A' ' 32' ' ' THR . 7.3 p90 -130.62 -24.13 2.51 Favored 'General case' 0 N--CA 1.479 1.023 0 N-CA-C 111.918 0.34 . . . . 74.53 111.918 173.509 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . -143.23 175.53 23.25 Favored Glycine 0 C--N 1.34 0.765 0 O-C-N 123.31 0.381 . . . . 64.03 112.588 -172.997 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 34.6 ttpt -161.08 137.9 8.71 Favored 'General case' 0 N--CA 1.466 0.365 0 N-CA-C 108.52 -0.919 . . . . 75.35 108.52 179.612 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 132' ' ' VAL . . . . . 0.466 HG13 ' HA ' ' A' ' 136' ' ' MET . 40.7 t -61.35 108.45 0.47 Allowed 'Isoleucine or valine' 0 CA--C 1.544 0.72 0 C-N-CA 123.418 0.687 . . . . 70.12 109.976 177.043 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 21.4 ptmt -85.74 -39.19 17.43 Favored 'General case' 0 CA--C 1.542 0.663 0 N-CA-C 109.689 -0.485 . . . . 75.35 109.689 177.006 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 134' ' ' GLU . . . . . 0.472 ' HB2' ' OG ' ' A' ' 21' ' ' SER . 53.4 mm-40 -137.81 149.61 46.5 Favored 'General case' 0 N--CA 1.483 1.195 0 C-N-CA 124.302 1.041 . . . . 64.34 109.253 177.573 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 85.03 20.38 57.67 Favored Glycine 0 N--CA 1.473 1.161 0 O-C-N 123.414 0.446 . . . . 75.34 112.649 -179.295 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 136' ' ' MET . . . . . 0.466 ' HA ' HG13 ' A' ' 132' ' ' VAL . 15.1 tpt -61.07 -33.89 74.04 Favored 'General case' 0 N--CA 1.483 1.211 0 C-N-CA 123.763 0.825 . . . . 73.21 110.943 179.662 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 137' ' ' ASN . . . . . . . . . . . . . 11.4 m120 -64.91 -32.67 74.49 Favored 'General case' 0 CA--C 1.546 0.797 0 C-N-CA 123.849 0.86 . . . . 72.4 111.82 -179.271 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 138' ' ' ILE . . . . . 0.41 ' O ' ' HG3' ' A' ' 142' ' ' MET . 46.8 mm -70.56 -37.8 71.16 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.966 0 C-N-CA 123.143 0.577 . . . . 72.05 109.868 177.355 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 139' ' ' VAL . . . . . 0.465 HG12 HG21 ' A' ' 114' ' ' ILE . 59.3 t -67.17 -37.39 79.1 Favored 'Isoleucine or valine' 0 CA--C 1.555 1.139 0 C-N-CA 123.829 0.852 . . . . 64.13 110.963 177.338 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 38.7 mt-10 -70.86 -28.4 64.54 Favored 'General case' 0 N--CA 1.478 0.934 0 CA-C-N 115.792 -0.64 . . . . 64.41 110.706 176.328 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -68.8 -39.52 80.07 Favored 'General case' 0 N--CA 1.475 0.814 0 C-N-CA 122.876 0.47 . . . . 73.45 110.278 172.38 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 142' ' ' MET . . . . . 0.458 ' SD ' HG21 ' A' ' 10' ' ' ILE . 76.6 mtp -58.25 -41.65 84.69 Favored 'General case' 0 N--CA 1.485 1.282 0 C-N-CA 123.983 0.913 . . . . 70.45 111.157 175.654 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 143' ' ' GLU . . . . . 0.478 ' HG3' ' HA ' ' A' ' 58' ' ' PRO . 37.8 tt0 -53.69 -43.3 68.81 Favored 'General case' 0 CA--C 1.546 0.79 0 CA-C-N 114.92 -1.036 . . . . 75.22 111.69 176.767 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 144' ' ' ARG . . . . . . . . . . . . . 56.2 mtt180 -72.53 -18.58 61.63 Favored 'General case' 0 N--CA 1.475 0.812 0 C-N-CA 124.155 0.982 . . . . 73.11 111.646 -177.263 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 145' ' ' PHE . . . . . 0.505 ' HB3' ' HB2' ' A' ' 154' ' ' LYS . 24.9 m-85 -86.56 -4.27 59.15 Favored 'General case' 0 N--CA 1.479 0.981 0 C-N-CA 123.398 0.679 . . . . 61.12 111.359 176.603 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . -97.24 -179.22 34.17 Favored Glycine 0 C--N 1.347 1.192 0 C-N-CA 123.053 0.358 . . . . 74.13 112.599 175.569 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 21.4 m -134.03 163.13 30.24 Favored 'General case' 0 N--CA 1.482 1.135 0 C-N-CA 124.114 0.966 . . . . 73.31 110.512 -176.121 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 148' ' ' ARG . . . . . . . . . . . . . 26.6 mmt180 -67.91 -28.18 67.28 Favored 'General case' 0 N--CA 1.486 1.364 0 C-N-CA 123.432 0.693 . . . . 73.24 112.037 -175.733 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 149' ' ' ASN . . . . . . . . . . . . . 30.8 p-10 -82.39 2.45 32.37 Favored 'General case' 0 N--CA 1.483 1.177 0 C-N-CA 123.644 0.778 . . . . 74.31 111.358 175.816 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 150' ' ' GLY . . . . . 0.442 ' HA2' HG12 ' A' ' 57' ' ' ILE . . . 93.06 -6.29 76.09 Favored Glycine 0 C--N 1.35 1.34 0 CA-C-O 119.722 -0.488 . . . . 62.53 113.674 177.02 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 40.7 ttmt -71.04 141.13 50.92 Favored 'General case' 0 N--CA 1.475 0.804 0 CA-C-N 117.315 0.557 . . . . 70.24 110.651 -177.719 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 152' ' ' THR . . . . . . . . . . . . . 12.5 p -90.35 117.08 28.8 Favored 'General case' 0 C--O 1.237 0.443 0 N-CA-C 108.824 -0.806 . . . . 75.35 108.824 169.062 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 153' ' ' SER . . . . . . . . . . . . . 22.8 m -66.46 -31.35 72.03 Favored 'General case' 0 CA--C 1.544 0.742 0 CA-C-N 115.679 -0.691 . . . . 73.23 110.036 171.92 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 154' ' ' LYS . . . . . 0.505 ' HB2' ' HB3' ' A' ' 145' ' ' PHE . 32.2 mmmt -121.13 129.97 53.52 Favored 'General case' 0 N--CA 1.472 0.627 0 CA-C-N 115.469 -0.787 . . . . 74.2 110.399 -178.96 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 83.3 tttt -67.76 106.36 2.22 Favored 'General case' 0 C--N 1.352 0.691 0 C-N-CA 123.737 0.815 . . . . 73.44 109.396 171.759 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 156' ' ' ILE . . . . . 0.565 ' HB ' ' HB2' ' A' ' 53' ' ' PHE . 62.0 mt -102.97 131.73 50.63 Favored 'Isoleucine or valine' 0 C--O 1.221 -0.422 0 N-CA-C 108.102 -1.073 . . . . 75.22 108.102 176.509 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 157' ' ' THR . . . . . . . . . . . . . 33.1 p -127.96 160.83 30.66 Favored 'General case' 0 N--CA 1.481 1.098 0 C-N-CA 123.935 0.894 . . . . 73.42 109.732 -179.75 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 158' ' ' ILE . . . . . . . . . . . . . 57.1 mt -82.98 97.08 4.17 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.838 0 N-CA-C 108.52 -0.918 . . . . 75.45 108.52 167.477 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 159' ' ' ALA . . . . . 0.788 ' HB1' ' HB1' ' A' ' 11' ' ' ALA . . . -55.99 -41.72 75.26 Favored 'General case' 0 N--CA 1.481 1.106 0 C-N-CA 124.067 0.947 . . . . 65.05 112.626 -177.262 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 160' ' ' ASP . . . . . . . . . . . . . 2.7 t70 -165.35 174.56 9.99 Favored 'General case' 0 CA--C 1.549 0.93 0 O-C-N 123.496 0.498 . . . . 62.4 110.527 -176.68 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 161' ' ' CYS . . . . . . . . . . . . . 24.5 p -130.96 -167.85 1.9 Allowed 'General case' 0 N--CA 1.478 0.959 0 C-N-CA 125.366 1.467 . . . . 72.04 109.41 -178.55 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 162' ' ' GLY . . . . . . . . . . . . . . . 132.62 53.32 0.08 OUTLIER Glycine 0 C--N 1.351 1.369 0 N-CA-C 112.137 -0.385 . . . . 74.11 112.137 -175.327 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 163' ' ' GLN . . . . . 0.594 ' HB2' ' HA ' ' A' ' 6' ' ' VAL . 21.2 pt20 -49.44 143.4 6.67 Favored 'General case' 0 N--CA 1.482 1.131 0 C-N-CA 124.421 1.088 . . . . 74.44 113.1 -174.379 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 164' ' ' LEU . . . . . 0.435 ' HG ' ' HB2' ' A' ' 7' ' ' PHE . 86.0 mt -95.42 116.93 29.48 Favored 'General case' 0 CA--C 1.547 0.843 0 C-N-CA 123.514 0.726 . . . . 74.2 110.14 -173.365 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 165' ' ' GLU . . . . . . . . . . . . . 14.0 pt-20 . . . . . 0 C--O 1.252 1.226 0 C-N-CA 123.646 0.778 . . . . 73.15 108.938 179.406 . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' B' B ' 216' ' ' PRO . . . . . . . . . . . . . 32.8 Cg_endo . . . . . 0 CA--C 1.546 1.09 0 N-CA-C 110.014 -0.802 . . . . 75.43 110.014 . . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' B' B ' 217' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -145.93 94.11 5.06 Favored Pre-proline 0 CA--C 1.554 1.101 0 N-CA-C 106.781 -1.563 . . . . 72.02 106.781 177.217 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 218' ' ' PRO . . . . . . . . . . . . . 11.7 Cg_endo -91.23 77.87 0.55 Allowed 'Trans proline' 0 C--N 1.378 2.082 0 C-N-CA 123.424 2.75 . . . . 74.23 111.632 -178.098 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 219' ' ' GLY . . . . . . . . . . . . . . . 176.08 156.04 14.32 Favored Glycine 0 CA--C 1.525 0.71 0 CA-C-N 114.593 -1.185 . . . . 74.43 111.542 177.711 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 220' ' ' PRO . . . . . . . . . . . . . 60.5 Cg_endo -85.38 -178.97 3.27 Favored 'Trans proline' 0 CA--C 1.553 1.472 0 C-N-CA 122.961 2.441 . . . . 74.3 112.209 175.459 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 221' ' ' TYR . . . . . . . . . . . . . 43.1 p90 -147.05 178.52 8.3 Favored 'General case' 0 N--CA 1.484 1.242 0 C-N-CA 123.632 0.773 . . . . 75.3 110.986 179.802 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 222' ' ' ALA . . . . . . . . . . . . . . . 170.21 91.02 0.0 OUTLIER 'General case' 0 N--CA 1.486 1.369 0 C-N-CA 125.683 1.593 . . . . 72.23 109.976 166.072 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 223' ' ' GLN . . . . . 0.52 ' H ' ' HD2' ' B' ' 224' ' ' PRO . 35.1 mm-40 -120.66 -50.61 0.04 OUTLIER Pre-proline 0 CA--C 1.563 1.446 0 C-N-CA 124.137 0.975 . . . . 74.54 109.948 168.624 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 224' ' ' PRO . . . . . 0.52 ' HD2' ' H ' ' B' ' 223' ' ' GLN . 52.7 Cg_endo . . . . . 0 C--N 1.394 2.971 0 C-N-CA 121.6 1.533 . . . . 71.53 111.133 170.181 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 44.5 m-80 . . . . . 0 CA--C 1.549 0.917 0 N-CA-C 109.701 -0.481 . . . . 64.31 109.701 . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 4' ' ' PRO . . . . . 0.493 ' HG2' ' HB2' ' A' ' 24' ' ' LEU . 52.8 Cg_endo -75.85 133.87 15.81 Favored 'Trans proline' 0 C--N 1.372 1.779 0 C-N-CA 122.078 1.852 . . . . 73.33 111.509 170.082 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 5' ' ' THR . . . . . 0.405 ' HB ' ' O ' ' A' ' 164' ' ' LEU . 80.7 m -97.62 124.74 42.03 Favored 'General case' 0 CA--C 1.536 0.437 0 N-CA-C 108.524 -0.917 . . . . 73.14 108.524 172.631 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 7.4 m -100.87 123.47 53.89 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.81 0 N-CA-C 109.143 -0.688 . . . . 75.43 109.143 173.607 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 7' ' ' PHE . . . . . 0.621 ' H ' ' HA ' ' A' ' 163' ' ' GLN . 85.5 t80 -108.08 137.44 46.06 Favored 'General case' 0 C--O 1.241 0.608 0 C-N-CA 124.056 0.942 . . . . 73.0 109.236 -174.351 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 8' ' ' PHE . . . . . 0.497 ' HB3' HG23 ' A' ' 158' ' ' ILE . 62.8 m-85 -138.66 162.59 34.27 Favored 'General case' 0 N--CA 1.469 0.501 0 C-N-CA 123.889 0.875 . . . . 74.2 110.433 175.943 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 16.0 m-20 -110.35 117.88 34.82 Favored 'General case' 0 N--CA 1.467 0.394 0 N-CA-C 107.354 -1.35 . . . . 72.32 107.354 170.26 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 49.6 mm -89.4 124.94 42.38 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.559 0 N-CA-C 109.176 -0.676 . . . . 73.53 109.176 -179.809 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 11' ' ' ALA . . . . . 0.553 ' HB2' ' HB2' ' A' ' 159' ' ' ALA . . . -128.68 126.28 39.79 Favored 'General case' 0 N--CA 1.471 0.581 0 C-N-CA 123.34 0.656 . . . . 51.33 111.062 -173.177 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 12' ' ' VAL . . . . . 0.438 HG13 ' HB3' ' A' ' 154' ' ' LYS . 96.3 t -95.53 120.36 44.82 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.43 0 N-CA-C 108.077 -1.083 . . . . 74.42 108.077 174.801 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 31.4 m-20 60.37 24.48 13.99 Favored 'General case' 0 N--CA 1.482 1.126 0 C-N-CA 125.499 1.519 . . . . 73.53 111.767 -175.791 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 91.69 -18.61 52.26 Favored Glycine 0 C--N 1.354 1.559 0 CA-C-N 116.587 -0.279 . . . . 64.23 112.903 -175.554 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 15.8 mm-40 -82.15 114.2 49.21 Favored Pre-proline 0 CA--C 1.548 0.887 0 C-N-CA 124.213 1.005 . . . . 72.43 110.123 178.863 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 18.6 Cg_endo -56.18 108.79 0.36 Allowed 'Trans proline' 0 C--N 1.384 2.41 0 C-N-CA 123.262 2.642 . . . . 73.44 112.383 -178.077 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 48.4 tp -76.8 -29.52 56.04 Favored 'General case' 0 N--CA 1.475 0.776 0 CA-C-N 114.828 -1.078 . . . . 62.25 109.522 176.375 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 170.11 -159.65 32.24 Favored Glycine 0 N--CA 1.449 -0.5 0 CA-C-N 115.039 -0.982 . . . . 72.32 111.046 -176.109 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 2.0 ptp180 -149.08 142.93 25.68 Favored 'General case' 0 C--O 1.24 0.595 0 C-N-CA 123.282 0.633 . . . . 73.53 109.898 -177.408 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 50.7 t -132.09 129.07 59.98 Favored 'Isoleucine or valine' 0 C--O 1.24 0.582 0 C-N-CA 123.659 0.784 . . . . 74.54 109.453 -176.908 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 66.7 p -109.6 140.77 43.03 Favored 'General case' 0 C--O 1.252 1.189 0 N-CA-C 108.655 -0.869 . . . . 74.44 108.655 170.453 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 22' ' ' PHE . . . . . 0.438 ' HE1' ' HD2' ' A' ' 8' ' ' PHE . 45.2 m-85 -118.42 134.36 55.12 Favored 'General case' 0 N--CA 1.467 0.394 0 C-N-CA 123.908 0.883 . . . . 71.5 108.978 -178.113 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 7.7 tp10 -87.36 110.59 20.36 Favored 'General case' 0 CA--C 1.535 0.397 0 N-CA-C 109.35 -0.611 . . . . 75.53 109.35 174.026 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 24' ' ' LEU . . . . . 0.493 ' HB2' ' HG2' ' A' ' 4' ' ' PRO . 33.8 mt -83.92 121.28 27.15 Favored 'General case' 0 N--CA 1.469 0.482 0 N-CA-C 109.132 -0.692 . . . . 64.34 109.132 176.826 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 25' ' ' PHE . . . . . 0.441 ' HB2' HD11 ' A' ' 90' ' ' LEU . 65.6 m-85 -84.82 69.69 10.75 Favored 'General case' 0 CA--C 1.54 0.579 0 C-N-CA 123.746 0.818 . . . . 73.13 109.912 179.279 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -70.09 -20.14 63.22 Favored 'General case' 0 N--CA 1.478 0.975 0 CA-C-N 115.076 -0.966 . . . . 75.25 111.52 -179.579 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 11.5 p-10 -72.19 -19.16 61.79 Favored 'General case' 0 CA--C 1.55 0.98 0 C-N-CA 123.71 0.804 . . . . 71.31 111.188 175.579 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 28' ' ' LYS . . . . . 0.422 ' HD2' HD21 ' A' ' 90' ' ' LEU . 47.0 mttm -108.57 -51.45 2.89 Favored 'General case' 0 N--CA 1.48 1.061 0 C-N-CA 123.46 0.704 . . . . 73.51 110.765 -176.698 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 29' ' ' VAL . . . . . 0.499 HG21 ' HA ' ' A' ' 129' ' ' PHE . 5.5 m -129.82 74.92 80.27 Favored Pre-proline 0 CA--C 1.56 1.334 0 C-N-CA 124.409 1.083 . . . . 45.12 109.741 -175.8 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 58.2 Cg_endo -65.8 -34.37 40.25 Favored 'Trans proline' 0 C--N 1.378 2.094 0 C-N-CA 122.98 2.453 . . . . 72.43 112.726 -168.468 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 31' ' ' LYS . . . . . 0.469 ' HB3' ' HB2' ' A' ' 86' ' ' GLU . 27.4 ttmt -64.55 -58.73 5.57 Favored 'General case' 0 CA--C 1.533 0.311 0 C-N-CA 124.226 1.01 . . . . 70.51 111.253 -177.561 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 3.8 m -72.39 -26.3 61.83 Favored 'General case' 0 CA--C 1.559 1.308 0 O-C-N 123.63 0.581 . . . . 73.43 111.191 -173.674 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 33' ' ' ALA . . . . . 0.448 ' HB1' ' HB3' ' A' ' 24' ' ' LEU . . . -73.47 -58.27 3.42 Favored 'General case' 0 N--CA 1.482 1.143 0 C-N-CA 123.025 0.53 . . . . 71.3 111.888 177.454 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 34' ' ' GLU . . . . . 0.499 ' HG3' HH21 ' A' ' 37' ' ' ARG . 43.0 tt0 -62.84 -29.49 70.78 Favored 'General case' 0 N--CA 1.488 1.447 0 C-N-CA 123.383 0.673 . . . . 75.31 111.192 -178.597 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 35' ' ' ASN . . . . . 0.456 ' O ' ' HG ' ' A' ' 39' ' ' LEU . 32.1 t30 -50.93 -60.02 3.53 Favored 'General case' 0 N--CA 1.476 0.83 0 C-N-CA 124.061 0.944 . . . . 70.23 110.527 174.506 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 84.1 t80 -66.48 -33.08 74.88 Favored 'General case' 0 CA--C 1.544 0.729 0 O-C-N 124.06 0.85 . . . . 63.43 111.237 -178.573 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 37' ' ' ARG . . . . . 0.499 HH21 ' HG3' ' A' ' 34' ' ' GLU . 17.4 ttp180 -62.48 -40.98 98.41 Favored 'General case' 0 N--CA 1.478 0.943 0 C-N-CA 123.204 0.602 . . . . 72.52 110.737 177.599 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -80.47 -21.54 41.93 Favored 'General case' 0 N--CA 1.472 0.654 0 CA-C-N 115.386 -0.825 . . . . 64.05 111.321 -178.105 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 39' ' ' LEU . . . . . 0.456 ' HG ' ' O ' ' A' ' 35' ' ' ASN . 95.8 mt -72.15 -44.46 63.06 Favored 'General case' 0 N--CA 1.478 0.952 0 C-N-CA 123.203 0.601 . . . . 55.31 110.379 172.067 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 65.9 p -72.56 -40.2 66.86 Favored 'General case' 0 N--CA 1.475 0.823 0 C-N-CA 123.737 0.815 . . . . 42.42 111.484 -173.937 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 61.2 p -76.81 -31.55 57.01 Favored 'General case' 0 N--CA 1.474 0.726 0 O-C-N 123.343 0.402 . . . . 62.14 110.226 172.614 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 71.59 24.92 76.17 Favored Glycine 0 C--N 1.35 1.338 0 CA-C-N 115.659 -0.701 . . . . 72.21 114.312 175.226 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 20.9 mm-40 -68.24 -17.92 64.43 Favored 'General case' 0 N--CA 1.476 0.863 0 C-N-CA 123.203 0.601 . . . . 64.35 111.582 179.243 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 31.1 mmmt -92.18 13.5 18.87 Favored 'General case' 0 CA--C 1.552 1.024 0 C-N-CA 123.708 0.803 . . . . 72.23 111.384 177.169 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 84.76 37.84 10.04 Favored Glycine 0 C--N 1.353 1.511 0 N-CA-C 113.87 0.308 . . . . 71.44 113.87 171.229 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 23.0 m-85 -125.15 -46.84 1.79 Allowed 'General case' 0 N--CA 1.484 1.245 0 CA-C-N 117.058 0.429 . . . . 74.22 110.89 -174.257 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 53.89 58.5 12.36 Favored Glycine 0 C--N 1.349 1.297 0 O-C-N 124.161 0.913 . . . . 72.04 114.148 174.848 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 48' ' ' TYR . . . . . 0.413 ' HE2' ' HA2' ' A' ' 75' ' ' GLY . 52.1 m-85 -63.86 89.84 0.05 Allowed 'General case' 0 N--CA 1.483 1.213 0 CA-C-O 121.851 0.834 . . . . 73.22 111.885 -179.153 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 38.7 tptt -112.96 142.77 45.26 Favored 'General case' 0 CA--C 1.538 0.49 0 CA-C-N 114.058 -1.428 . . . . 65.42 108.37 179.153 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 70.74 22.02 78.04 Favored Glycine 0 C--N 1.345 1.03 0 CA-C-O 119.568 -0.573 . . . . 50.51 113.923 175.438 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 24.3 t -58.87 114.51 2.58 Favored 'General case' 0 CA--C 1.549 0.92 0 C-N-CA 123.53 0.732 . . . . 74.24 111.05 -173.817 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 52' ' ' CYS . . . . . . . . . . . . . 15.5 p -87.25 118.1 26.44 Favored 'General case' 0 CA--C 1.54 0.564 0 C-N-CA 123.905 0.882 . . . . 74.13 111.873 -169.791 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 53' ' ' PHE . . . . . 0.677 ' HA ' ' HA2' ' A' ' 64' ' ' GLY . 88.4 m-85 -69.02 78.77 0.32 Allowed 'General case' 0 CA--C 1.539 0.541 0 C-N-CA 124.454 1.102 . . . . 71.12 109.671 165.405 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 15.2 p-80 -95.45 -8.4 35.52 Favored 'General case' 0 N--CA 1.479 0.999 0 CA-C-N 115.219 -0.9 . . . . 73.1 112.461 -173.652 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 59.0 ttt-85 -130.8 100.1 5.16 Favored 'General case' 0 N--CA 1.476 0.834 0 N-CA-C 109.133 -0.691 . . . . 71.14 109.133 179.364 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 56' ' ' ILE . . . . . 0.527 HD11 ' HB3' ' A' ' 53' ' ' PHE . 65.8 mt -134.39 133.21 55.2 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.117 0 C-N-CA 123.241 0.616 . . . . 60.04 109.97 -177.725 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 57' ' ' ILE . . . . . 0.518 HG23 ' HA ' ' A' ' 148' ' ' ARG . 66.6 mt -121.34 120.63 28.9 Favored Pre-proline 0 CA--C 1.558 1.25 0 C-N-CA 124.7 1.2 . . . . 73.32 109.229 175.871 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 35.6 Cg_endo -64.64 139.23 62.66 Favored 'Trans proline' 0 C--N 1.388 2.638 0 C-N-CA 123.078 2.519 . . . . 71.03 112.362 176.323 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 76.67 21.71 74.06 Favored Glycine 0 C--N 1.346 1.12 0 CA-C-N 115.009 -0.996 . . . . 51.14 113.134 -175.686 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 60' ' ' PHE . . . . . 0.406 ' HD2' ' HB ' ' A' ' 57' ' ' ILE . 19.9 t80 -149.57 -76.91 0.15 Allowed 'General case' 0 N--CA 1.478 0.936 0 CA-C-N 117.318 0.559 . . . . 74.14 111.349 -175.738 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 61' ' ' MET . . . . . 0.586 ' SD ' ' HB2' ' A' ' 113' ' ' PHE . 15.7 tmm? -168.07 142.94 3.59 Favored 'General case' 0 N--CA 1.481 1.077 0 N-CA-C 112.115 0.413 . . . . 63.41 112.115 -163.305 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 62' ' ' CYS . . . . . . . . . . . . . 22.7 p -111.53 113.21 25.47 Favored 'General case' 0 CA--C 1.551 0.985 0 C-N-CA 124.196 0.999 . . . . 63.01 109.908 173.18 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 63' ' ' GLN . . . . . 0.498 ' HA ' ' HA ' ' A' ' 113' ' ' PHE . 17.1 tt0 -108.53 127.05 53.59 Favored 'General case' 0 N--CA 1.487 1.384 0 C-N-CA 124.019 0.927 . . . . 61.42 111.745 -173.699 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 64' ' ' GLY . . . . . 0.677 ' HA2' ' HA ' ' A' ' 53' ' ' PHE . . . -102.35 167.34 17.85 Favored Glycine 0 C--N 1.351 1.385 0 CA-C-N 114.834 -1.076 . . . . 71.2 112.423 175.993 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -178.57 -174.97 45.27 Favored Glycine 0 C--N 1.339 0.701 0 N-CA-C 112.236 -0.346 . . . . 61.14 112.236 -179.432 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 28.2 t70 -126.1 168.04 14.55 Favored 'General case' 0 C--O 1.247 0.931 0 C-N-CA 124.185 0.994 . . . . 72.11 110.337 -170.608 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 51.9 t80 -88.04 -21.45 24.76 Favored 'General case' 0 CA--C 1.548 0.873 0 C-N-CA 123.799 0.84 . . . . 74.11 111.78 -176.959 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 67.5 m -63.48 108.57 1.39 Allowed 'General case' 0 N--CA 1.484 1.233 0 N-CA-C 109.792 -0.447 . . . . 70.33 109.792 179.9 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 70.0 ttt180 56.04 54.95 7.34 Favored 'General case' 0 CA--C 1.555 1.15 0 O-C-N 124.701 1.25 . . . . 73.43 110.473 -178.02 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 44.8 t-80 -57.13 -36.14 70.33 Favored 'General case' 0 N--CA 1.482 1.17 0 CA-C-N 115.462 -0.79 . . . . 71.44 111.988 -175.793 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 37.2 t30 -64.71 114.41 4.42 Favored 'General case' 0 N--CA 1.476 0.855 0 C-N-CA 123.398 0.679 . . . . 60.4 109.856 174.663 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 76.85 -6.77 38.52 Favored Glycine 0 CA--C 1.53 0.986 0 N-CA-C 116.019 1.168 . . . . 72.41 116.019 169.376 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 23.8 m -143.77 -82.36 0.17 Allowed 'General case' 0 CA--C 1.554 1.117 0 CA-C-N 117.922 0.861 . . . . 74.44 109.528 179.192 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 63.08 50.2 65.31 Favored Glycine 0 C--N 1.353 1.477 0 C-N-CA 123.559 0.599 . . . . 43.42 114.054 174.469 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 75' ' ' GLY . . . . . 0.413 ' HA2' ' HE2' ' A' ' 48' ' ' TYR . . . 139.14 49.94 0.06 OUTLIER Glycine 0 C--N 1.345 1.053 0 CA-C-N 117.387 0.594 . . . . 72.41 111.682 -179.049 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 21.3 pttp -67.22 161.0 25.78 Favored 'General case' 0 CA--C 1.553 1.076 0 C-N-CA 123.341 0.656 . . . . 52.14 112.423 -174.122 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 80.6 p -90.11 -179.38 5.66 Favored 'General case' 0 CA--C 1.545 0.77 0 C-N-CA 124.259 1.023 . . . . 74.31 112.297 -171.106 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 24.5 pt -73.47 -13.17 15.96 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.082 0 C-N-CA 123.197 0.599 . . . . 73.23 110.677 172.052 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 98.5 m-85 -91.53 7.46 41.25 Favored 'General case' 0 CA--C 1.545 0.782 0 C-N-CA 124.389 1.076 . . . . 73.12 110.626 171.213 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 91.61 -141.33 15.6 Favored Glycine 0 C--N 1.347 1.168 0 CA-C-O 119.532 -0.593 . . . . 62.52 112.422 176.829 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 31.3 tt0 -50.04 -56.81 9.27 Favored 'General case' 0 N--CA 1.481 1.11 0 C-N-CA 125.039 1.335 . . . . 64.51 111.829 -176.852 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 82' ' ' LYS . . . . . 0.529 ' HD2' ' HA ' ' A' ' 107' ' ' THR . 19.0 pttp -161.17 157.54 26.0 Favored 'General case' 0 C--O 1.239 0.514 0 O-C-N 123.873 0.733 . . . . 62.45 110.97 -179.447 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 24.5 p90 -144.42 172.33 13.1 Favored 'General case' 0 C--O 1.24 0.577 0 C-N-CA 124.915 1.286 . . . . 74.53 109.328 -179.514 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 12.0 pt-20 -99.79 150.27 22.51 Favored 'General case' 0 N--CA 1.473 0.676 0 C-N-CA 123.801 0.84 . . . . 74.34 109.675 176.972 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 26.8 m-20 -66.84 149.59 50.37 Favored 'General case' 0 N--CA 1.48 1.049 0 C-N-CA 123.664 0.786 . . . . 75.35 112.7 -176.203 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 86' ' ' GLU . . . . . 0.469 ' HB2' ' HB3' ' A' ' 31' ' ' LYS . 6.9 tp10 -69.13 -56.11 8.67 Favored 'General case' 0 CA--C 1.544 0.742 0 CA-C-N 115.035 -0.984 . . . . 70.2 110.475 178.782 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 16.8 p-10 -168.97 138.08 2.13 Favored 'General case' 0 N--CA 1.471 0.617 0 C-N-CA 123.771 0.828 . . . . 64.23 109.703 -172.953 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 88' ' ' PHE . . . . . 0.464 ' HD1' ' HB ' ' A' ' 127' ' ' VAL . 40.4 m-85 -90.98 68.23 6.15 Favored 'General case' 0 N--CA 1.479 0.995 0 C-N-CA 123.044 0.538 . . . . 73.54 110.902 -176.035 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 40.1 mt -80.24 -61.84 1.6 Allowed 'Isoleucine or valine' 0 N--CA 1.484 1.273 0 CA-C-O 120.933 0.397 . . . . 62.14 110.008 174.359 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 90' ' ' LEU . . . . . 0.443 ' HB3' ' HB ' ' A' ' 128' ' ' VAL . 96.0 mt -75.05 104.74 5.75 Favored 'General case' 0 CA--C 1.544 0.731 0 CA-C-N 115.49 -0.777 . . . . 61.43 110.878 -173.798 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 91' ' ' LYS . . . . . 0.668 ' HE3' ' HB ' ' A' ' 93' ' ' THR . 0.1 OUTLIER -83.96 158.49 21.52 Favored 'General case' 0 CA--C 1.545 0.786 0 CA-C-N 115.099 -0.955 . . . . 71.32 110.073 173.908 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 92' ' ' HIS . . . . . . . . . . . . . 25.2 m-70 -87.46 65.96 8.85 Favored 'General case' 0 N--CA 1.479 1.016 0 CA-C-O 121.493 0.663 . . . . 75.31 109.696 -177.293 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 93' ' ' THR . . . . . 0.668 ' HB ' ' HE3' ' A' ' 91' ' ' LYS . 15.3 t -105.04 15.21 28.04 Favored 'General case' 0 N--CA 1.483 1.176 0 CA-C-N 115.599 -0.728 . . . . 61.23 111.461 -174.088 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -155.35 174.84 33.44 Favored Glycine 0 C--N 1.345 1.044 0 C-N-CA 121.553 -0.356 . . . . 62.14 113.543 -176.225 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -90.19 158.62 4.72 Favored 'Trans proline' 0 CA--C 1.553 1.459 0 C-N-CA 123.753 2.968 . . . . 65.51 111.919 175.656 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 77.23 17.95 78.87 Favored Glycine 0 C--N 1.344 0.999 0 CA-C-N 116.071 -0.513 . . . . 61.11 113.533 -179.117 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 97' ' ' ILE . . . . . 0.671 ' HB ' ' HB2' ' A' ' 115' ' ' CYS . 14.9 mm -66.5 103.09 0.52 Allowed 'Isoleucine or valine' 0 CA--C 1.555 1.169 0 C-N-CA 123.685 0.794 . . . . 62.33 111.009 -176.455 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 98' ' ' LEU . . . . . 0.417 HD22 ' CG ' ' A' ' 22' ' ' PHE . 54.9 tp -88.71 118.1 28.15 Favored 'General case' 0 C--O 1.247 0.922 0 CA-C-O 121.893 0.854 . . . . 74.43 109.471 175.577 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 23.7 t -152.08 141.67 21.76 Favored 'General case' 0 CA--C 1.547 0.854 0 N-CA-C 107.893 -1.151 . . . . 60.31 107.893 -174.664 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 100' ' ' MET . . . . . 0.527 ' HA ' ' HA ' ' A' ' 112' ' ' PHE . 70.7 mtp -76.71 138.19 39.82 Favored 'General case' 0 N--CA 1.495 1.791 0 CA-C-N 119.622 1.101 . . . . 72.2 110.319 -175.294 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 101' ' ' ALA . . . . . 0.437 ' HB3' ' HB2' ' A' ' 111' ' ' GLN . . . -70.42 156.45 39.32 Favored 'General case' 0 C--O 1.247 0.932 0 CA-C-O 121.315 0.579 . . . . 62.33 111.235 -173.263 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 102' ' ' ASN . . . . . 0.423 ' HB3' ' HA ' ' A' ' 108' ' ' ASN . 25.6 p-10 -161.69 164.05 29.37 Favored 'General case' 0 C--O 1.238 0.454 0 CA-C-N 115.055 -0.975 . . . . 72.33 110.646 -173.328 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 103' ' ' ALA . . . . . 0.503 ' HB3' HG21 ' A' ' 107' ' ' THR . . . -97.21 -14.89 21.14 Favored 'General case' 0 CA--C 1.542 0.654 0 CA-C-N 115.521 -0.763 . . . . 73.14 110.361 169.546 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 166.35 -168.18 39.82 Favored Glycine 0 C--N 1.352 1.426 0 CA-C-O 119.406 -0.663 . . . . 75.54 112.517 178.602 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 46.7 Cg_exo -58.72 139.75 92.06 Favored 'Trans proline' 0 C--N 1.374 1.876 0 C-N-CA 123.155 2.57 . . . . 73.22 112.112 173.553 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 66.0 t30 65.53 11.4 7.4 Favored 'General case' 0 N--CA 1.487 1.4 0 C-N-CA 124.967 1.307 . . . . 63.42 111.877 -177.804 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 107' ' ' THR . . . . . 0.529 ' HA ' ' HD2' ' A' ' 82' ' ' LYS . 5.0 m -124.1 17.12 9.22 Favored 'General case' 0 CA--C 1.552 1.028 0 C-N-CA 124.0 0.92 . . . . 72.21 109.705 178.158 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 108' ' ' ASN . . . . . 0.423 ' HA ' ' HB3' ' A' ' 102' ' ' ASN . 32.8 t30 -80.85 150.89 28.94 Favored 'General case' 0 N--CA 1.477 0.9 0 C-N-CA 124.34 1.056 . . . . 73.12 110.112 176.759 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 106.82 25.52 6.18 Favored Glycine 0 N--CA 1.47 0.912 0 C-N-CA 121.488 -0.387 . . . . 74.3 113.297 176.171 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 12.9 p -131.78 118.19 19.59 Favored 'General case' 0 CA--C 1.537 0.447 0 N-CA-C 108.183 -1.043 . . . . 75.51 108.183 175.107 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 111' ' ' GLN . . . . . 0.507 HE21 ' HG2' ' B' ' 218' ' ' PRO . 48.9 mt-30 61.16 -173.68 0.13 Allowed 'General case' 0 N--CA 1.493 1.683 0 C-N-CA 124.097 0.959 . . . . 75.34 111.895 -172.536 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 112' ' ' PHE . . . . . 0.527 ' HA ' ' HA ' ' A' ' 100' ' ' MET . 42.0 p90 -146.31 159.37 43.44 Favored 'General case' 0 N--CA 1.476 0.856 0 C-N-CA 123.817 0.847 . . . . 62.25 109.153 171.968 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 113' ' ' PHE . . . . . 0.586 ' HB2' ' SD ' ' A' ' 61' ' ' MET . 50.6 p90 -138.1 146.78 43.3 Favored 'General case' 0 C--O 1.238 0.458 0 C-N-CA 123.631 0.772 . . . . 75.12 109.6 -179.47 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 114' ' ' ILE . . . . . . . . . . . . . 17.2 mt -120.9 101.97 11.51 Favored 'Isoleucine or valine' 0 C--O 1.243 0.721 0 N-CA-C 107.517 -1.29 . . . . 63.25 107.517 176.419 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 115' ' ' CYS . . . . . 0.671 ' HB2' ' HB ' ' A' ' 97' ' ' ILE . 62.8 m -63.31 104.75 0.64 Allowed 'General case' 0 N--CA 1.469 0.511 0 N-CA-C 109.311 -0.626 . . . . 73.24 109.311 177.477 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 116' ' ' THR . . . . . 0.576 HG22 HG12 ' A' ' 139' ' ' VAL . 32.8 p -70.18 -32.8 70.9 Favored 'General case' 0 N--CA 1.472 0.656 0 C-N-CA 123.593 0.757 . . . . 72.0 109.859 -179.343 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -104.86 161.19 14.4 Favored 'General case' 0 C--O 1.241 0.62 0 C-N-CA 124.174 0.989 . . . . 75.32 109.505 172.27 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 9.4 ptmt -72.71 94.02 1.71 Allowed 'General case' 0 CA--C 1.546 0.826 0 CA-C-O 121.87 0.843 . . . . 75.21 109.874 174.828 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 119' ' ' THR . . . . . . . . . . . . . 75.0 p -87.22 83.99 7.31 Favored 'General case' 0 CA--C 1.545 0.771 0 CA-C-N 115.551 -0.75 . . . . 74.15 110.368 -175.354 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 8.3 pt-20 -80.36 -16.91 53.44 Favored 'General case' 0 N--CA 1.483 1.212 0 CA-C-O 121.137 0.494 . . . . 64.31 111.902 -172.426 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 121' ' ' TRP . . . . . . . . . . . . . 43.6 p90 -70.16 -9.86 56.99 Favored 'General case' 0 CA--C 1.546 0.813 0 C-N-CA 122.792 0.437 . . . . 71.32 111.58 173.971 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 122' ' ' LEU . . . . . 0.479 ' HA ' ' HE2' ' A' ' 125' ' ' LYS . 65.5 mt -89.17 4.91 47.0 Favored 'General case' 0 N--CA 1.477 0.882 0 C-N-CA 123.281 0.632 . . . . 63.33 111.936 174.723 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 78.5 m-20 -74.24 152.09 39.78 Favored 'General case' 0 N--CA 1.487 1.407 0 C-N-CA 122.482 0.313 . . . . 71.21 110.295 173.487 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 75.79 14.77 81.82 Favored Glycine 0 C--N 1.353 1.519 0 O-C-N 123.422 0.451 . . . . 41.02 112.802 -173.451 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 125' ' ' LYS . . . . . 0.479 ' HE2' ' HA ' ' A' ' 122' ' ' LEU . 30.0 mtmm -138.72 -162.09 1.27 Allowed 'General case' 0 N--CA 1.472 0.645 0 C-N-CA 125.683 1.593 . . . . 75.34 108.719 -174.95 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 126' ' ' HIS . . . . . . . . . . . . . 2.5 t60 -62.01 135.47 57.55 Favored 'General case' 0 CA--C 1.549 0.927 0 C-N-CA 123.938 0.895 . . . . 64.14 111.598 -165.715 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 127' ' ' VAL . . . . . 0.464 ' HB ' ' HD1' ' A' ' 88' ' ' PHE . 13.9 p -76.95 148.04 7.06 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.807 0 CA-C-N 114.526 -1.216 . . . . 62.11 112.317 -169.013 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 128' ' ' VAL . . . . . 0.443 ' HB ' ' HB3' ' A' ' 90' ' ' LEU . 18.9 t -72.56 156.07 6.96 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.818 0 C-N-CA 124.073 0.949 . . . . 74.34 108.884 171.619 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 129' ' ' PHE . . . . . 0.499 ' HA ' HG21 ' A' ' 29' ' ' VAL . 43.1 p90 -128.7 -23.84 3.08 Favored 'General case' 0 N--CA 1.485 1.324 0 CA-C-N 118.739 0.699 . . . . 64.42 111.661 175.4 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . -145.59 170.63 26.83 Favored Glycine 0 C--N 1.337 0.61 0 N-CA-C 111.454 -0.658 . . . . 70.23 111.454 -178.38 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 32.8 ttpt -150.07 147.27 27.6 Favored 'General case' 0 N--CA 1.472 0.646 0 N-CA-C 109.002 -0.74 . . . . 74.14 109.002 178.365 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 132' ' ' VAL . . . . . 0.573 HG21 HG21 ' A' ' 139' ' ' VAL . 58.1 t -62.43 112.32 0.97 Allowed 'Isoleucine or valine' 0 CA--C 1.538 0.49 0 C-N-CA 123.327 0.651 . . . . 74.24 109.771 174.838 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 21.9 ptmt -91.99 -33.98 14.62 Favored 'General case' 0 N--CA 1.471 0.606 0 N-CA-C 109.264 -0.643 . . . . 61.13 109.264 175.923 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 35.5 mt-10 -141.58 135.61 30.24 Favored 'General case' 0 N--CA 1.479 1.013 0 C-N-CA 124.513 1.125 . . . . 64.32 109.206 -179.072 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 95.63 24.72 15.04 Favored Glycine 0 C--N 1.349 1.301 0 O-C-N 123.381 0.426 . . . . 62.34 113.825 176.03 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 136' ' ' MET . . . . . . . . . . . . . 14.5 tpt -65.51 -32.09 73.5 Favored 'General case' 0 N--CA 1.485 1.293 0 CA-C-N 117.289 0.545 . . . . 72.24 111.119 179.787 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 137' ' ' ASN . . . . . . . . . . . . . 4.3 p-10 -61.26 -35.32 76.96 Favored 'General case' 0 CA--C 1.551 0.999 0 C-N-CA 123.941 0.897 . . . . 64.14 111.458 173.515 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 138' ' ' ILE . . . . . . . . . . . . . 50.6 mm -74.58 -32.93 30.81 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.001 0 C-N-CA 123.414 0.686 . . . . 73.44 110.532 177.51 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 139' ' ' VAL . . . . . 0.576 HG12 HG22 ' A' ' 116' ' ' THR . 87.7 t -66.52 -44.02 90.45 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.947 0 C-N-CA 123.733 0.813 . . . . 41.34 110.889 178.513 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 140' ' ' GLU . . . . . 0.419 ' O ' ' HG3' ' A' ' 144' ' ' ARG . 52.2 mt-10 -77.0 -19.41 57.31 Favored 'General case' 0 N--CA 1.475 0.795 0 CA-C-N 115.618 -0.719 . . . . 72.23 110.805 177.037 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -70.82 -37.55 73.23 Favored 'General case' 0 CA--C 1.543 0.687 0 C-N-CA 122.387 0.275 . . . . 42.54 110.295 169.068 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 142' ' ' MET . . . . . . . . . . . . . 70.6 mtm -63.24 -39.35 94.36 Favored 'General case' 0 N--CA 1.485 1.304 0 C-N-CA 123.065 0.546 . . . . 74.44 110.376 174.607 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 143' ' ' GLU . . . . . 0.412 ' HB2' HG21 ' A' ' 116' ' ' THR . 25.6 tt0 -55.61 -36.65 67.17 Favored 'General case' 0 CA--C 1.55 0.98 0 CA-C-N 114.539 -1.209 . . . . 61.24 111.784 178.252 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 144' ' ' ARG . . . . . 0.419 ' HG3' ' O ' ' A' ' 140' ' ' GLU . 29.2 mtm180 -73.82 -8.79 57.4 Favored 'General case' 0 N--CA 1.478 0.952 0 C-N-CA 123.837 0.855 . . . . 71.32 112.75 -176.952 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 145' ' ' PHE . . . . . 0.503 ' HB2' HD11 ' A' ' 156' ' ' ILE . 62.8 m-85 -97.63 -4.87 36.65 Favored 'General case' 0 N--CA 1.479 1.001 0 C-N-CA 122.674 0.389 . . . . 74.51 111.007 174.137 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . -92.92 171.36 32.8 Favored Glycine 0 C--N 1.347 1.158 0 CA-C-N 116.361 -0.381 . . . . 73.22 113.192 -179.632 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 147' ' ' SER . . . . . 0.471 ' HB2' ' HB3' ' A' ' 151' ' ' LYS . 18.3 m -133.6 156.99 46.85 Favored 'General case' 0 N--CA 1.475 0.8 0 C-N-CA 124.539 1.135 . . . . 73.11 109.566 -177.426 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 148' ' ' ARG . . . . . 0.518 ' HA ' HG23 ' A' ' 57' ' ' ILE . 18.9 mmt180 -59.12 -37.88 78.28 Favored 'General case' 0 N--CA 1.484 1.24 0 C-N-CA 123.858 0.863 . . . . 74.4 112.592 -172.219 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 149' ' ' ASN . . . . . . . . . . . . . 28.0 p-10 -72.0 -14.68 61.95 Favored 'General case' 0 N--CA 1.486 1.354 0 C-N-CA 123.518 0.727 . . . . 72.0 111.922 179.804 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . 112.89 -3.02 25.8 Favored Glycine 0 C--N 1.347 1.17 0 C-N-CA 123.428 0.537 . . . . 64.2 112.544 -178.644 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 151' ' ' LYS . . . . . 0.471 ' HB3' ' HB2' ' A' ' 147' ' ' SER . 87.9 tttt -67.82 146.47 53.66 Favored 'General case' 0 N--CA 1.478 0.938 0 C-N-CA 123.67 0.788 . . . . 73.34 111.092 -178.94 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 152' ' ' THR . . . . . . . . . . . . . 18.5 p -120.05 114.5 22.08 Favored 'General case' 0 N--CA 1.469 0.476 0 N-CA-C 109.204 -0.665 . . . . 70.42 109.204 173.062 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 153' ' ' SER . . . . . . . . . . . . . 37.8 t -67.34 -24.89 65.77 Favored 'General case' 0 CA--C 1.546 0.822 0 C-N-CA 124.242 1.017 . . . . 74.11 111.109 179.181 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 154' ' ' LYS . . . . . 0.438 ' HB3' HG13 ' A' ' 12' ' ' VAL . 69.7 mmtt -121.69 150.68 41.43 Favored 'General case' 0 N--CA 1.473 0.697 0 C-N-CA 123.951 0.901 . . . . 71.54 111.155 179.925 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 2.2 tppp? -93.37 91.16 7.05 Favored 'General case' 0 N--CA 1.474 0.773 0 CA-C-O 121.366 0.603 . . . . 74.12 110.251 -178.065 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 156' ' ' ILE . . . . . 0.527 ' HB ' ' HB2' ' A' ' 53' ' ' PHE . 48.4 mt -89.6 102.1 12.79 Favored 'Isoleucine or valine' 0 C--O 1.21 -1.009 0 N-CA-C 109.254 -0.647 . . . . 75.34 109.254 -177.05 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 157' ' ' THR . . . . . . . . . . . . . 42.3 p -108.54 145.19 35.17 Favored 'General case' 0 N--CA 1.472 0.652 0 C-N-CA 123.642 0.777 . . . . 73.31 110.151 178.841 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 158' ' ' ILE . . . . . 0.497 HG23 ' HB3' ' A' ' 8' ' ' PHE . 49.4 mt -70.47 95.86 0.47 Allowed 'Isoleucine or valine' 0 CA--C 1.547 0.839 0 N-CA-C 108.672 -0.862 . . . . 72.21 108.672 170.423 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 159' ' ' ALA . . . . . 0.553 ' HB2' ' HB2' ' A' ' 11' ' ' ALA . . . -51.72 -53.94 33.79 Favored 'General case' 0 N--CA 1.477 0.896 0 C-N-CA 124.402 1.081 . . . . 50.3 112.036 -177.599 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 160' ' ' ASP . . . . . . . . . . . . . 5.4 t70 -145.62 169.52 18.26 Favored 'General case' 0 CA--C 1.544 0.72 0 CA-C-N 116.195 -0.457 . . . . 73.12 110.583 -174.743 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 161' ' ' CYS . . . . . . . . . . . . . 12.7 p -135.16 -169.62 2.41 Favored 'General case' 0 N--CA 1.476 0.854 0 C-N-CA 125.048 1.339 . . . . 75.13 108.393 -177.822 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 162' ' ' GLY . . . . . . . . . . . . . . . 131.87 56.74 0.09 OUTLIER Glycine 0 N--CA 1.475 1.247 0 C-N-CA 120.635 -0.793 . . . . 74.24 111.922 -172.965 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 163' ' ' GLN . . . . . 0.621 ' HA ' ' H ' ' A' ' 7' ' ' PHE . 19.5 pt20 -46.93 135.54 9.21 Favored 'General case' 0 CA--C 1.552 1.022 0 C-N-CA 124.099 0.96 . . . . 72.14 113.478 -174.156 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 164' ' ' LEU . . . . . 0.405 ' O ' ' HB ' ' A' ' 5' ' ' THR . 86.6 mt . . . . . 0 CA--C 1.54 0.589 0 N-CA-C 108.751 -0.833 . . . . 44.12 108.751 178.249 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 218' ' ' PRO . . . . . 0.507 ' HG2' HE21 ' A' ' 111' ' ' GLN . 42.1 Cg_endo . . . . . 0 CA--C 1.55 1.292 0 CA-C-O 121.143 0.393 . . . . 71.33 111.113 . . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 219' ' ' GLY . . . . . . . . . . . . . . . -179.86 147.84 7.69 Favored Glycine 0 CA--C 1.536 1.371 0 CA-C-N 115.534 -0.757 . . . . 74.21 111.927 -178.755 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 220' ' ' PRO . . . . . . . . . . . . . 21.5 Cg_exo -68.26 164.52 32.07 Favored 'Trans proline' 0 C--N 1.377 2.036 0 C-N-CA 123.796 2.997 . . . . 71.54 113.565 -178.07 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 221' ' ' TYR . . . . . . . . . . . . . 62.2 m-85 . . . . . 0 N--CA 1.481 1.123 0 C-N-CA 123.731 0.812 . . . . 70.1 111.157 -176.328 . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 82.0 m-20 . . . . . 0 CA--C 1.543 0.696 0 N-CA-C 109.538 -0.542 . . . . 62.52 109.538 . . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 4' ' ' PRO . . . . . 0.485 ' HG2' ' HB2' ' A' ' 24' ' ' LEU . 57.6 Cg_endo -73.66 144.37 35.41 Favored 'Trans proline' 0 C--N 1.374 1.911 0 C-N-CA 122.414 2.076 . . . . 62.53 112.123 175.12 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 5' ' ' THR . . . . . 0.569 HG23 ' HD3' ' A' ' 133' ' ' LYS . 97.9 m -97.1 114.13 25.77 Favored 'General case' 0 C--O 1.223 -0.318 0 N-CA-C 108.325 -0.991 . . . . 53.21 108.325 177.475 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 43.1 t -99.7 119.17 47.38 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.852 0 N-CA-C 108.33 -0.989 . . . . 74.12 108.33 -178.721 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 75.1 t80 -99.58 132.81 44.66 Favored 'General case' 0 C--N 1.323 -0.572 0 N-CA-C 109.235 -0.654 . . . . 74.0 109.235 -173.125 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 8' ' ' PHE . . . . . 0.475 ' HD2' ' HE2' ' A' ' 22' ' ' PHE . 33.1 m-85 -136.57 161.16 36.65 Favored 'General case' 0 C--O 1.238 0.499 0 O-C-N 124.027 0.829 . . . . 74.31 110.975 170.295 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 6.4 m-20 -108.37 114.76 28.86 Favored 'General case' 0 N--CA 1.465 0.277 0 CA-C-N 113.749 -1.569 . . . . 73.35 107.652 168.389 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 10' ' ' ILE . . . . . 0.542 HG21 ' SD ' ' A' ' 142' ' ' MET . 44.5 mm -85.48 118.82 32.96 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.369 0 N-CA-C 108.707 -0.849 . . . . 74.32 108.707 174.502 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 11' ' ' ALA . . . . . 0.554 ' HB2' ' HB2' ' A' ' 159' ' ' ALA . . . -118.11 131.36 56.43 Favored 'General case' 0 N--CA 1.469 0.476 0 C-N-CA 123.37 0.668 . . . . 63.22 111.143 -176.657 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 71.1 t -96.65 112.85 29.6 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.454 0 N-CA-C 107.934 -1.136 . . . . 64.31 107.934 170.765 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 18.5 m-20 62.93 24.25 14.44 Favored 'General case' 0 N--CA 1.481 1.104 0 C-N-CA 125.12 1.368 . . . . 64.05 111.931 179.965 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 99.1 -21.24 46.75 Favored Glycine 0 C--N 1.348 1.227 0 CA-C-N 116.43 -0.35 . . . . 62.32 113.031 -177.805 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 36.7 mm-40 -83.27 114.73 55.02 Favored Pre-proline 0 CA--C 1.543 0.706 0 C-N-CA 123.529 0.731 . . . . 73.14 110.048 179.667 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 34.3 Cg_endo -60.72 109.27 0.64 Allowed 'Trans proline' 0 C--N 1.378 2.098 0 C-N-CA 122.844 2.363 . . . . 71.12 111.863 -177.265 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 66.0 tp -76.31 -35.46 58.81 Favored 'General case' 0 N--CA 1.471 0.621 0 CA-C-N 115.104 -0.953 . . . . 55.21 109.922 179.334 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -175.96 177.96 47.52 Favored Glycine 0 C--N 1.341 0.832 0 CA-C-N 115.57 -0.741 . . . . 73.1 112.882 177.338 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 80.7 mtt180 -115.16 116.91 29.14 Favored 'General case' 0 C--O 1.237 0.406 0 C-N-CA 124.219 1.008 . . . . 73.21 108.86 -179.299 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 20' ' ' VAL . . . . . 0.414 HG13 HG13 ' A' ' 132' ' ' VAL . 67.5 t -114.65 118.33 58.33 Favored 'Isoleucine or valine' 0 C--O 1.238 0.498 0 C-N-CA 123.566 0.746 . . . . 64.21 109.417 -178.182 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 21' ' ' SER . . . . . 0.413 ' OG ' ' HB2' ' A' ' 134' ' ' GLU . 71.3 p -106.47 139.37 41.05 Favored 'General case' 0 C--O 1.246 0.878 0 N-CA-C 108.982 -0.748 . . . . 65.01 108.982 173.634 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 22' ' ' PHE . . . . . 0.475 ' HE2' ' HD2' ' A' ' 8' ' ' PHE . 85.2 m-85 -108.14 168.24 9.43 Favored 'General case' 0 C--N 1.331 -0.236 0 C-N-CA 124.544 1.138 . . . . 73.41 109.516 -179.886 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 23' ' ' GLU . . . . . 0.461 ' HB2' ' HD2' ' A' ' 133' ' ' LYS . 41.3 tt0 -129.95 106.9 8.96 Favored 'General case' 0 C--O 1.24 0.578 0 N-CA-C 107.979 -1.119 . . . . 53.53 107.979 179.007 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 24' ' ' LEU . . . . . 0.485 ' HB2' ' HG2' ' A' ' 4' ' ' PRO . 38.7 mt -82.44 124.72 30.31 Favored 'General case' 0 N--CA 1.467 0.414 0 N-CA-C 109.67 -0.493 . . . . 72.31 109.67 -179.456 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 44.6 m-85 -86.48 66.57 9.57 Favored 'General case' 0 CA--C 1.535 0.403 0 C-N-CA 123.338 0.655 . . . . 74.32 109.236 177.632 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -62.35 -24.89 67.6 Favored 'General case' 0 N--CA 1.477 0.883 0 CA-C-N 115.282 -0.872 . . . . 43.3 111.703 -178.476 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 9.7 p-10 -71.42 -19.53 62.23 Favored 'General case' 0 N--CA 1.477 0.875 0 C-N-CA 124.097 0.959 . . . . 71.51 112.524 -179.905 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 61.2 mttp -110.58 -41.05 4.42 Favored 'General case' 0 N--CA 1.486 1.355 0 C-N-CA 123.729 0.812 . . . . 63.13 110.992 -178.76 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 29' ' ' VAL . . . . . 0.523 HG21 ' HA ' ' A' ' 129' ' ' PHE . 8.4 m -129.48 74.06 81.15 Favored Pre-proline 0 N--CA 1.478 0.966 0 C-N-CA 123.803 0.841 . . . . 72.41 109.947 -179.452 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 25.5 Cg_endo -60.09 -37.32 84.95 Favored 'Trans proline' 0 C--N 1.378 2.097 0 C-N-CA 122.797 2.331 . . . . 71.01 112.896 -175.982 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 31' ' ' LYS . . . . . 0.408 ' HE3' ' HB2' ' A' ' 31' ' ' LYS . 36.6 ttmt -66.75 -52.0 49.33 Favored 'General case' 0 N--CA 1.482 1.136 0 C-N-CA 123.534 0.734 . . . . 75.02 112.043 -176.637 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 18.3 m -77.43 -31.25 53.83 Favored 'General case' 0 CA--C 1.55 0.978 0 CA-C-N 115.277 -0.874 . . . . 51.42 111.136 -170.617 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 33' ' ' ALA . . . . . 0.447 ' HB1' ' HB3' ' A' ' 24' ' ' LEU . . . -71.93 -47.18 54.31 Favored 'General case' 0 N--CA 1.473 0.718 0 C-N-CA 122.828 0.451 . . . . 75.13 110.057 174.327 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 11.4 tp10 -59.98 -35.63 75.41 Favored 'General case' 0 N--CA 1.485 1.308 0 C-N-CA 123.477 0.711 . . . . 73.52 111.141 178.684 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 35' ' ' ASN . . . . . 0.551 ' ND2' ' SD ' ' A' ' 100' ' ' MET . 32.7 t30 -56.12 -64.42 0.87 Allowed 'General case' 0 CA--C 1.539 0.523 0 CA-C-N 114.981 -1.009 . . . . 64.22 110.812 178.075 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 74.5 t80 -61.94 -35.38 78.25 Favored 'General case' 0 N--CA 1.474 0.74 0 C-N-CA 123.774 0.83 . . . . 72.54 111.41 -177.043 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 37' ' ' ARG . . . . . 0.417 ' HG3' HE22 ' A' ' 163' ' ' GLN . 20.7 ttt180 -58.82 -50.29 74.51 Favored 'General case' 0 N--CA 1.472 0.674 0 C-N-CA 124.046 0.938 . . . . 70.35 110.937 175.901 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 38' ' ' ALA . . . . . 0.543 ' HB3' HG21 ' A' ' 78' ' ' ILE . . . -75.69 -22.26 56.82 Favored 'General case' 0 CA--C 1.54 0.582 0 CA-C-N 115.587 -0.733 . . . . 53.41 111.727 -176.29 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 39' ' ' LEU . . . . . 0.515 HD22 ' CE1' ' A' ' 48' ' ' TYR . 96.6 mt -72.41 -42.27 65.3 Favored 'General case' 0 N--CA 1.479 1.008 0 C-N-CA 123.127 0.571 . . . . 73.42 109.86 172.214 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 48.0 t -68.63 -55.88 10.07 Favored 'General case' 0 N--CA 1.476 0.834 0 C-N-CA 124.238 1.015 . . . . 54.21 110.959 -176.139 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 71.3 p -73.41 -30.07 63.0 Favored 'General case' 0 CA--C 1.541 0.634 0 C-N-CA 123.659 0.783 . . . . 74.41 110.819 179.452 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 87.02 32.71 13.62 Favored Glycine 0 C--N 1.352 1.453 0 CA-C-O 119.909 -0.384 . . . . 63.52 113.021 176.129 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 50.9 mm-40 -54.89 -42.37 72.03 Favored 'General case' 0 N--CA 1.48 1.062 0 C-N-CA 123.551 0.741 . . . . 65.41 110.991 177.034 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 44' ' ' LYS . . . . . 0.547 ' HG3' ' HB ' ' A' ' 78' ' ' ILE . 29.6 mmmt -93.51 18.19 10.31 Favored 'General case' 0 CA--C 1.547 0.828 0 CA-C-N 115.044 -0.98 . . . . 74.23 111.683 -173.332 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 73.05 36.3 56.99 Favored Glycine 0 C--N 1.354 1.557 0 CA-C-N 116.301 -0.409 . . . . 63.41 114.068 171.722 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 46' ' ' PHE . . . . . 0.461 ' HE2' ' HA ' ' A' ' 78' ' ' ILE . 22.0 m-85 -120.25 -47.63 2.35 Favored 'General case' 0 N--CA 1.483 1.183 0 C-N-CA 122.811 0.444 . . . . 62.12 110.788 -177.391 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 53.27 62.12 6.3 Favored Glycine 0 C--N 1.356 1.644 0 O-C-N 123.92 0.763 . . . . 64.24 114.896 170.653 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 48' ' ' TYR . . . . . 0.515 ' CE1' HD22 ' A' ' 39' ' ' LEU . 66.8 m-85 -64.73 91.23 0.08 Allowed 'General case' 0 N--CA 1.48 1.042 0 CA-C-O 121.936 0.874 . . . . 65.33 111.67 -176.721 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 49' ' ' LYS . . . . . 0.548 ' HE2' ' HA ' ' A' ' 160' ' ' ASP . 28.0 tptp -109.7 130.88 55.47 Favored 'General case' 0 C--O 1.239 0.529 0 CA-C-N 113.913 -1.494 . . . . 71.23 108.726 178.985 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 80.83 21.24 63.92 Favored Glycine 0 C--N 1.348 1.248 0 CA-C-O 119.645 -0.531 . . . . 73.43 113.235 179.715 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 51' ' ' SER . . . . . 0.43 ' HB2' HD12 ' A' ' 158' ' ' ILE . 23.0 m -56.28 115.07 2.26 Favored 'General case' 0 C--N 1.355 0.806 0 C-N-CA 123.799 0.84 . . . . 73.3 110.885 -179.004 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 52' ' ' CYS . . . . . 0.69 ' SG ' ' HB3' ' A' ' 66' ' ' ASP . 6.3 p -96.76 130.11 44.06 Favored 'General case' 0 CA--C 1.548 0.888 0 C-N-CA 123.918 0.887 . . . . 73.22 112.261 -168.823 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 53' ' ' PHE . . . . . 0.722 ' HA ' ' HA2' ' A' ' 64' ' ' GLY . 11.8 m-85 -79.82 108.95 13.79 Favored 'General case' 0 CA--C 1.538 0.481 0 C-N-CA 125.155 1.382 . . . . 53.53 109.569 175.173 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 53.1 p-80 -100.52 -30.58 11.72 Favored 'General case' 0 N--CA 1.487 1.416 0 C-N-CA 122.769 0.428 . . . . 62.15 111.018 178.964 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 27.9 ttt180 -112.38 99.98 8.43 Favored 'General case' 0 C--O 1.221 -0.445 0 N-CA-C 109.048 -0.723 . . . . 64.32 109.048 -173.278 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 56' ' ' ILE . . . . . 0.497 HG21 ' HA ' ' A' ' 143' ' ' GLU . 52.5 mt -134.63 134.68 54.12 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.801 0 N-CA-C 108.929 -0.767 . . . . 72.04 108.929 176.169 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 57' ' ' ILE . . . . . 0.641 HG23 ' HA ' ' A' ' 148' ' ' ARG . 58.1 mt -131.0 121.56 18.88 Favored Pre-proline 0 CA--C 1.554 1.12 0 C-N-CA 124.501 1.12 . . . . 74.41 108.037 179.357 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 58' ' ' PRO . . . . . 0.481 ' HA ' ' HG2' ' A' ' 143' ' ' GLU . 74.4 Cg_endo -70.89 139.58 36.63 Favored 'Trans proline' 0 C--N 1.378 2.084 0 C-N-CA 123.033 2.489 . . . . 61.4 112.577 -172.846 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 74.32 26.83 67.18 Favored Glycine 0 C--N 1.343 0.937 0 CA-C-N 115.552 -0.749 . . . . 63.21 112.569 -176.048 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 60' ' ' PHE . . . . . 0.412 ' HD2' ' HB ' ' A' ' 57' ' ' ILE . 28.3 t80 -148.47 -73.24 0.19 Allowed 'General case' 0 C--O 1.243 0.732 0 C-N-CA 123.659 0.784 . . . . 73.33 109.767 -175.188 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 61' ' ' MET . . . . . 0.475 ' SD ' ' HB2' ' A' ' 113' ' ' PHE . 44.7 ttm -171.69 140.46 1.33 Allowed 'General case' 0 C--N 1.353 0.722 0 CA-C-N 116.285 -0.416 . . . . 63.34 112.058 -163.215 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 62' ' ' CYS . . . . . 0.546 ' SG ' ' HB ' ' A' ' 114' ' ' ILE . 16.6 p -109.14 113.51 26.43 Favored 'General case' 0 CA--C 1.549 0.926 0 C-N-CA 124.031 0.932 . . . . 70.23 108.966 169.346 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 63' ' ' GLN . . . . . 0.475 ' HA ' ' HA ' ' A' ' 113' ' ' PHE . 50.7 tt0 -113.91 118.54 34.46 Favored 'General case' 0 N--CA 1.48 1.032 0 C-N-CA 123.574 0.75 . . . . 75.44 110.31 -170.875 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 64' ' ' GLY . . . . . 0.722 ' HA2' ' HA ' ' A' ' 53' ' ' PHE . . . -115.81 164.94 12.16 Favored Glycine 0 C--N 1.353 1.505 0 CA-C-N 115.736 -0.666 . . . . 71.2 113.622 -173.784 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 101.59 93.56 2.2 Favored Glycine 0 C--N 1.343 0.92 0 N-CA-C 110.096 -1.202 . . . . 61.45 110.096 -173.992 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 66' ' ' ASP . . . . . 0.69 ' HB3' ' SG ' ' A' ' 52' ' ' CYS . 38.9 t70 -122.6 -73.38 0.65 Allowed 'General case' 0 N--CA 1.476 0.838 0 C-N-CA 122.899 0.479 . . . . 51.13 110.588 -179.641 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 76.0 t80 -40.72 -49.84 3.09 Favored 'General case' 0 N--CA 1.483 1.206 0 C-N-CA 125.779 1.631 . . . . 74.43 114.048 -161.917 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 15.7 m -71.46 105.62 3.64 Favored 'General case' 0 CA--C 1.545 0.755 0 O-C-N 123.571 0.544 . . . . 74.14 110.551 -176.274 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 31.2 ttm180 51.82 47.66 24.33 Favored 'General case' 0 CA--C 1.553 1.095 0 C-N-CA 125.179 1.391 . . . . 72.31 111.379 -178.234 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 27.4 p80 -55.73 -28.15 54.3 Favored 'General case' 0 N--CA 1.492 1.654 0 C-N-CA 123.345 0.658 . . . . 72.41 111.773 179.302 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 6.3 t30 -80.98 103.53 10.87 Favored 'General case' 0 CA--C 1.544 0.72 0 C-N-CA 123.755 0.822 . . . . 74.25 109.217 170.008 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 97.22 -8.19 64.65 Favored Glycine 0 C--N 1.341 0.823 0 CA-C-O 119.132 -0.815 . . . . 43.43 115.09 168.597 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 73' ' ' THR . . . . . 0.517 HG21 ' HB3' ' A' ' 76' ' ' LYS . 25.6 m -149.51 -74.91 0.17 Allowed 'General case' 0 N--CA 1.484 1.271 0 CA-C-N 118.495 1.147 . . . . 75.41 110.491 178.894 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 81.75 60.19 2.23 Favored Glycine 0 C--N 1.35 1.334 0 CA-C-O 119.958 -0.356 . . . . 23.44 112.964 177.926 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 111.06 51.27 0.6 Allowed Glycine 0 N--CA 1.479 1.524 0 CA-C-N 117.329 0.564 . . . . 74.2 112.952 178.714 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 76' ' ' LYS . . . . . 0.517 ' HB3' HG21 ' A' ' 73' ' ' THR . 20.2 pttp -56.54 161.5 2.66 Favored 'General case' 0 N--CA 1.491 1.579 0 C-N-CA 124.55 1.14 . . . . 72.11 113.38 -178.997 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 46.1 p -101.59 179.7 4.27 Favored 'General case' 0 N--CA 1.484 1.247 0 C-N-CA 124.181 0.992 . . . . 70.25 112.698 -167.395 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 78' ' ' ILE . . . . . 0.547 ' HB ' ' HG3' ' A' ' 44' ' ' LYS . 29.1 pt -69.9 -16.82 20.63 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.907 0 C-N-CA 122.819 0.448 . . . . 71.12 111.441 177.553 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 86.0 m-85 -95.04 27.04 3.35 Favored 'General case' 0 CA--C 1.545 0.754 0 C-N-CA 124.112 0.965 . . . . 74.41 110.244 176.748 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 92.11 -128.62 9.46 Favored Glycine 0 C--N 1.351 1.381 0 N-CA-C 111.497 -0.641 . . . . 74.43 111.497 178.026 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 39.5 tt0 -66.05 -49.42 67.72 Favored 'General case' 0 N--CA 1.472 0.664 0 C-N-CA 123.548 0.739 . . . . 72.3 110.531 179.168 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 82' ' ' LYS . . . . . 0.713 ' HD2' ' HA ' ' A' ' 107' ' ' THR . 21.8 pttm -167.71 155.95 9.14 Favored 'General case' 0 CA--C 1.55 0.969 0 CA-C-N 115.501 -0.772 . . . . 63.42 111.054 -171.668 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 15.0 p90 -131.04 174.32 10.13 Favored 'General case' 0 N--CA 1.481 1.089 0 C-N-CA 125.176 1.39 . . . . 71.23 110.594 176.236 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 9.8 pt-20 -84.37 157.26 21.51 Favored 'General case' 0 N--CA 1.483 1.22 0 C-N-CA 123.497 0.719 . . . . 73.13 111.278 177.203 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 40.6 m-20 -64.22 134.34 54.58 Favored 'General case' 0 N--CA 1.489 1.479 0 C-N-CA 124.047 0.939 . . . . 61.24 110.837 -176.278 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 6.2 tp10 -60.05 -58.88 6.62 Favored 'General case' 0 N--CA 1.486 1.358 0 C-N-CA 123.236 0.614 . . . . 74.52 111.091 -178.627 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 31.9 p30 -163.22 -157.18 0.41 Allowed 'General case' 0 N--CA 1.467 0.41 0 N-CA-C 107.521 -1.288 . . . . 64.44 107.521 -179.211 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 89.7 m-85 -142.43 34.1 1.47 Allowed 'General case' 0 N--CA 1.485 1.293 0 C-N-CA 123.311 0.644 . . . . 75.43 110.52 177.005 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 65.4 mt -61.94 -61.04 1.79 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.649 0 CA-C-O 121.506 0.669 . . . . 74.15 110.266 178.39 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 90' ' ' LEU . . . . . 0.451 ' HB3' ' HB ' ' A' ' 128' ' ' VAL . 59.3 mt -78.8 102.36 8.11 Favored 'General case' 0 C--O 1.242 0.665 0 CA-C-N 114.88 -1.054 . . . . 64.11 110.075 -177.305 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 91' ' ' LYS . . . . . 0.691 ' HE3' ' HB ' ' A' ' 93' ' ' THR . 0.1 OUTLIER -84.63 163.64 19.15 Favored 'General case' 0 C--O 1.24 0.586 0 CA-C-N 115.493 -0.776 . . . . 70.14 110.334 174.747 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 92' ' ' HIS . . . . . . . . . . . . . 19.0 m-70 -91.19 56.1 3.04 Favored 'General case' 0 N--CA 1.476 0.858 0 CA-C-O 122.033 0.921 . . . . 74.4 109.371 -176.699 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 93' ' ' THR . . . . . 0.691 ' HB ' ' HE3' ' A' ' 91' ' ' LYS . 12.6 t -91.33 -7.15 51.79 Favored 'General case' 0 N--CA 1.47 0.572 0 CA-C-N 114.61 -1.177 . . . . 71.3 111.385 -176.383 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -124.94 167.78 17.21 Favored Glycine 0 C--N 1.34 0.785 0 O-C-N 123.062 0.226 . . . . 62.0 113.241 -175.206 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 95' ' ' PRO . . . . . 0.445 ' HB3' ' O ' ' A' ' 116' ' ' THR . 1.1 Cg_endo -84.67 157.07 12.08 Favored 'Trans proline' 0 C--N 1.363 1.316 0 C-N-CA 123.519 2.812 . . . . 60.4 111.636 168.553 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 78.28 16.94 78.86 Favored Glycine 0 C--N 1.346 1.104 0 CA-C-N 116.203 -0.453 . . . . 74.51 113.206 179.948 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 97' ' ' ILE . . . . . 0.813 ' HB ' ' SG ' ' A' ' 115' ' ' CYS . 15.6 mm -73.14 109.42 5.33 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.921 0 C-N-CA 123.797 0.839 . . . . 70.35 111.201 -176.399 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 63.8 tp -94.21 111.86 23.62 Favored 'General case' 0 CA--C 1.552 1.037 0 C-N-CA 123.773 0.829 . . . . 74.25 109.95 174.35 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 99' ' ' SER . . . . . 0.462 ' HB2' ' HA ' ' A' ' 128' ' ' VAL . 29.8 t -137.14 147.89 46.27 Favored 'General case' 0 N--CA 1.474 0.766 0 C-N-CA 124.371 1.068 . . . . 61.21 108.743 177.059 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 100' ' ' MET . . . . . 0.565 ' HA ' ' HA ' ' A' ' 112' ' ' PHE . 67.5 mtp -77.47 146.39 36.49 Favored 'General case' 0 N--CA 1.483 1.216 0 CA-C-O 120.671 0.272 . . . . 63.51 110.657 179.918 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 101' ' ' ALA . . . . . 0.55 ' HB3' ' HB3' ' A' ' 111' ' ' GLN . . . -76.89 162.5 27.56 Favored 'General case' 0 C--O 1.245 0.844 0 CA-C-N 115.818 -0.628 . . . . 64.33 111.254 -176.469 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 102' ' ' ASN . . . . . 0.498 ' HB3' ' HA ' ' A' ' 108' ' ' ASN . 30.5 p-10 -168.47 171.1 9.26 Favored 'General case' 0 C--O 1.238 0.472 0 CA-C-N 114.823 -1.081 . . . . 54.15 109.522 179.503 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 103' ' ' ALA . . . . . 0.426 ' HB3' HG21 ' A' ' 107' ' ' THR . . . -119.59 13.41 12.52 Favored 'General case' 0 CA--C 1.543 0.695 0 CA-C-N 115.263 -0.88 . . . . 75.53 109.94 172.617 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 146.95 -166.86 28.36 Favored Glycine 0 C--N 1.352 1.438 0 CA-C-O 119.595 -0.559 . . . . 71.14 112.521 179.981 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 14.6 Cg_exo -67.34 140.79 54.15 Favored 'Trans proline' 0 C--N 1.372 1.808 0 C-N-CA 123.172 2.581 . . . . 72.43 111.433 178.957 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 66.7 t30 66.4 9.72 6.69 Favored 'General case' 0 N--CA 1.491 1.606 0 C-N-CA 124.822 1.249 . . . . 73.31 111.979 -178.89 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 107' ' ' THR . . . . . 0.713 ' HA ' ' HD2' ' A' ' 82' ' ' LYS . 3.9 m -109.6 -6.47 15.35 Favored 'General case' 0 CA--C 1.552 1.049 0 C-N-CA 124.266 1.026 . . . . 73.2 109.669 177.025 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 108' ' ' ASN . . . . . 0.498 ' HA ' ' HB3' ' A' ' 102' ' ' ASN . 24.3 t30 -60.92 151.53 30.0 Favored 'General case' 0 N--CA 1.48 1.066 0 C-N-CA 125.046 1.339 . . . . 62.52 110.657 173.564 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 93.95 18.59 36.69 Favored Glycine 0 N--CA 1.465 0.628 0 C-N-CA 121.695 -0.288 . . . . 73.51 112.962 178.881 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 15.2 p -117.36 120.55 38.53 Favored 'General case' 0 C--N 1.328 -0.335 0 N-CA-C 106.938 -1.504 . . . . 73.33 106.938 167.093 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 111' ' ' GLN . . . . . 0.55 ' HB3' ' HB3' ' A' ' 101' ' ' ALA . 5.8 tt0 69.08 171.73 0.3 Allowed 'General case' 0 CA--C 1.557 1.23 0 C-N-CA 123.43 0.692 . . . . 64.03 111.341 171.609 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 112' ' ' PHE . . . . . 0.565 ' HA ' ' HA ' ' A' ' 100' ' ' MET . 52.5 p90 -143.8 155.0 43.99 Favored 'General case' 0 N--CA 1.48 1.026 0 O-C-N 121.748 -0.595 . . . . 74.22 109.695 176.364 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 113' ' ' PHE . . . . . 0.475 ' HB2' ' SD ' ' A' ' 61' ' ' MET . 40.5 p90 -140.57 151.3 44.6 Favored 'General case' 0 N--CA 1.47 0.536 0 C-N-CA 123.329 0.652 . . . . 73.21 111.277 -179.356 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 114' ' ' ILE . . . . . 0.546 ' HB ' ' SG ' ' A' ' 62' ' ' CYS . 19.3 mt -124.55 104.88 14.41 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.613 0 N-CA-C 108.067 -1.086 . . . . 75.43 108.067 177.029 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 115' ' ' CYS . . . . . 0.813 ' SG ' ' HB ' ' A' ' 97' ' ' ILE . 27.8 p -85.69 114.53 22.74 Favored 'General case' 0 C--O 1.241 0.643 0 CA-C-N 118.284 0.493 . . . . 73.02 109.728 178.968 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 116' ' ' THR . . . . . 0.445 ' O ' ' HB3' ' A' ' 95' ' ' PRO . 70.6 p -73.21 -20.88 60.77 Favored 'General case' 0 CA--C 1.54 0.579 0 C-N-CA 123.796 0.838 . . . . 72.24 110.603 176.863 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -101.94 155.89 17.88 Favored 'General case' 0 C--O 1.241 0.627 0 CA-C-N 115.383 -0.826 . . . . 74.14 109.76 171.893 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 19.2 ptmt -75.19 83.61 2.37 Favored 'General case' 0 CA--C 1.542 0.668 0 CA-C-O 121.765 0.793 . . . . 70.14 109.434 173.938 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 119' ' ' THR . . . . . 0.582 ' HB ' HD13 ' A' ' 122' ' ' LEU . 44.5 p -76.45 86.14 3.19 Favored 'General case' 0 CA--C 1.545 0.785 0 CA-C-O 121.948 0.88 . . . . 74.41 110.004 -175.984 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 11.1 pt-20 -78.51 -16.93 56.95 Favored 'General case' 0 N--CA 1.476 0.86 0 CA-C-N 114.825 -1.079 . . . . 74.53 112.127 -171.377 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 121' ' ' TRP . . . . . . . . . . . . . 35.7 p90 -74.18 -0.57 17.17 Favored 'General case' 0 CA--C 1.55 0.965 0 C-N-CA 123.027 0.531 . . . . 75.32 111.068 173.385 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 122' ' ' LEU . . . . . 0.582 HD13 ' HB ' ' A' ' 119' ' ' THR . 9.6 mp -97.42 -1.02 45.22 Favored 'General case' 0 N--CA 1.483 1.214 0 C-N-CA 124.275 1.03 . . . . 63.34 111.799 172.946 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 56.5 m-20 -71.06 129.51 39.14 Favored 'General case' 0 N--CA 1.477 0.898 0 N-CA-C 108.293 -1.003 . . . . 75.43 108.293 173.616 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 95.95 -25.08 26.98 Favored Glycine 0 N--CA 1.471 0.977 0 N-CA-C 111.573 -0.611 . . . . 55.2 111.573 -172.012 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 125' ' ' LYS . . . . . 0.578 ' HE2' ' HB3' ' B' ' 220' ' ' PRO . 16.3 ttpp -83.28 -168.46 2.1 Favored 'General case' 0 CA--C 1.555 1.144 0 N-CA-C 107.382 -1.34 . . . . 74.13 107.382 166.578 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 126' ' ' HIS . . . . . 0.498 ' H ' ' HG2' ' A' ' 125' ' ' LYS . 16.6 t-80 -65.0 131.65 47.15 Favored 'General case' 0 CA--C 1.548 0.887 0 CA-C-N 118.713 0.688 . . . . 74.11 112.082 -166.653 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 11.4 p -58.43 147.95 6.61 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.743 0 C-N-CA 125.906 1.682 . . . . 62.44 112.047 179.33 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 128' ' ' VAL . . . . . 0.462 ' HA ' ' HB2' ' A' ' 99' ' ' SER . 17.3 t -67.67 155.65 7.38 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.819 0 C-N-CA 123.927 0.891 . . . . 74.13 109.638 175.335 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 129' ' ' PHE . . . . . 0.523 ' HA ' HG21 ' A' ' 29' ' ' VAL . 50.5 p90 -133.5 -25.07 1.74 Allowed 'General case' 0 N--CA 1.477 0.908 0 O-C-N 122.269 -0.269 . . . . 65.51 111.363 173.843 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . -136.99 161.82 25.19 Favored Glycine 0 C--N 1.341 0.833 0 N-CA-C 111.588 -0.605 . . . . 70.44 111.588 -177.562 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 35.8 ttpt -144.29 138.61 28.05 Favored 'General case' 0 N--CA 1.468 0.461 0 N-CA-C 108.852 -0.795 . . . . 64.54 108.852 177.217 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 132' ' ' VAL . . . . . 0.414 HG13 HG13 ' A' ' 20' ' ' VAL . 47.3 t -64.03 103.44 0.38 Allowed 'Isoleucine or valine' 0 C--O 1.24 0.562 0 N-CA-C 108.83 -0.804 . . . . 71.42 108.83 174.751 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 133' ' ' LYS . . . . . 0.569 ' HD3' HG23 ' A' ' 5' ' ' THR . 21.5 ptmt -85.67 -31.91 22.25 Favored 'General case' 0 CA--C 1.537 0.476 0 N-CA-C 109.371 -0.603 . . . . 73.12 109.371 179.941 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 134' ' ' GLU . . . . . 0.413 ' HB2' ' OG ' ' A' ' 21' ' ' SER . 17.0 mt-10 -143.87 149.05 36.35 Favored 'General case' 0 N--CA 1.479 1.023 0 C-N-CA 124.818 1.247 . . . . 75.13 109.222 179.02 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 84.31 22.55 54.06 Favored Glycine 0 C--N 1.345 1.048 0 O-C-N 123.379 0.424 . . . . 54.43 113.164 -179.716 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 136' ' ' MET . . . . . 0.403 ' HA ' HG11 ' A' ' 132' ' ' VAL . 16.5 tpt -62.76 -40.17 96.45 Favored 'General case' 0 N--CA 1.477 0.923 0 C-N-CA 123.239 0.616 . . . . 70.1 111.38 -179.913 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 137' ' ' ASN . . . . . . . . . . . . . 12.4 m120 -64.75 -26.61 68.43 Favored 'General case' 0 N--CA 1.478 0.973 0 C-N-CA 123.146 0.578 . . . . 70.53 111.271 179.255 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 138' ' ' ILE . . . . . . . . . . . . . 48.1 mm -76.48 -37.75 30.8 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.843 0 C-N-CA 123.444 0.698 . . . . 55.1 110.153 177.192 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 139' ' ' VAL . . . . . 0.475 HG13 ' SG ' ' A' ' 62' ' ' CYS . 95.4 t -62.26 -43.61 98.19 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.96 0 C-N-CA 123.471 0.708 . . . . 63.51 110.258 175.43 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 39.0 mt-10 -65.5 -42.37 92.17 Favored 'General case' 0 CA--C 1.544 0.734 0 CA-C-N 114.949 -1.023 . . . . 73.3 110.851 176.889 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -67.85 -39.21 83.82 Favored 'General case' 0 N--CA 1.48 1.034 0 C-N-CA 123.603 0.761 . . . . 63.04 111.884 -178.189 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 142' ' ' MET . . . . . 0.594 ' HB2' HD13 ' A' ' 156' ' ' ILE . 19.5 ptt? -75.95 -29.28 58.24 Favored 'General case' 0 N--CA 1.478 0.952 0 C-N-CA 122.644 0.378 . . . . 64.25 110.504 -178.912 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 143' ' ' GLU . . . . . 0.497 ' HA ' HG21 ' A' ' 56' ' ' ILE . 28.1 tt0 -65.61 -28.01 68.82 Favored 'General case' 0 CA--C 1.545 0.77 0 CA-C-N 115.711 -0.677 . . . . 74.03 111.68 178.677 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 144' ' ' ARG . . . . . . . . . . . . . 75.9 mtt180 -66.87 -13.22 61.4 Favored 'General case' 0 N--CA 1.479 0.992 0 C-N-CA 123.555 0.742 . . . . 72.31 111.921 177.699 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 145' ' ' PHE . . . . . . . . . . . . . 38.3 m-85 -88.68 -8.58 54.33 Favored 'General case' 0 N--CA 1.475 0.807 0 C-N-CA 123.379 0.672 . . . . 73.54 111.641 175.944 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . -87.3 171.53 42.23 Favored Glycine 0 C--N 1.346 1.095 0 CA-C-O 120.007 -0.33 . . . . 42.04 112.547 175.166 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 9.0 m -133.03 160.15 37.98 Favored 'General case' 0 N--CA 1.479 1.01 0 C-N-CA 123.565 0.746 . . . . 72.25 110.31 -175.525 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 148' ' ' ARG . . . . . 0.641 ' HA ' HG23 ' A' ' 57' ' ' ILE . 14.3 mmm180 -61.29 -31.64 71.47 Favored 'General case' 0 N--CA 1.483 1.22 0 C-N-CA 124.5 1.12 . . . . 74.43 113.407 -176.382 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 149' ' ' ASN . . . . . . . . . . . . . 31.2 p-10 -75.74 -13.1 60.3 Favored 'General case' 0 N--CA 1.483 1.2 0 C-N-CA 123.222 0.609 . . . . 63.33 111.467 178.573 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . 111.64 -17.15 25.85 Favored Glycine 0 C--N 1.348 1.208 0 CA-C-O 119.821 -0.433 . . . . 72.54 112.664 179.066 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 87.3 tttt -69.09 137.1 53.21 Favored 'General case' 0 CA--C 1.546 0.812 0 C-N-CA 122.853 0.461 . . . . 63.54 111.303 -175.214 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 152' ' ' THR . . . . . . . . . . . . . 6.8 p -92.18 121.44 33.72 Favored 'General case' 0 C--O 1.241 0.63 0 C-N-CA 123.826 0.85 . . . . 75.51 109.124 170.41 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 153' ' ' SER . . . . . . . . . . . . . 29.9 t -67.32 -36.21 81.01 Favored 'General case' 0 N--CA 1.472 0.665 0 C-N-CA 123.499 0.72 . . . . 42.33 109.995 174.042 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 69.5 mmtt -110.39 149.42 30.28 Favored 'General case' 0 N--CA 1.471 0.622 0 C-N-CA 124.256 1.023 . . . . 74.32 110.767 -178.28 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 16.2 tppt? -89.27 91.67 8.86 Favored 'General case' 0 C--N 1.345 0.376 0 N-CA-C 108.873 -0.788 . . . . 71.44 108.873 178.386 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 156' ' ' ILE . . . . . 0.594 HD13 ' HB2' ' A' ' 142' ' ' MET . 69.1 mt -91.75 126.05 44.39 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.416 0 N-CA-C 108.833 -0.802 . . . . 72.35 108.833 -179.054 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 157' ' ' THR . . . . . 0.473 HG22 ' HB3' ' A' ' 52' ' ' CYS . 21.1 p -134.11 157.47 46.09 Favored 'General case' 0 N--CA 1.477 0.915 0 C-N-CA 124.115 0.966 . . . . 60.3 109.708 -175.371 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 158' ' ' ILE . . . . . 0.43 HD12 ' HB2' ' A' ' 51' ' ' SER . 46.4 mt -80.21 93.68 2.0 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.819 0 N-CA-C 109.261 -0.644 . . . . 71.41 109.261 170.601 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 159' ' ' ALA . . . . . 0.554 ' HB2' ' HB2' ' A' ' 11' ' ' ALA . . . -61.35 -34.16 74.84 Favored 'General case' 0 N--CA 1.472 0.626 0 C-N-CA 124.614 1.166 . . . . 73.11 113.404 -176.703 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 160' ' ' ASP . . . . . 0.548 ' HA ' ' HE2' ' A' ' 49' ' ' LYS . 26.3 t0 -159.98 162.76 34.4 Favored 'General case' 0 N--CA 1.475 0.814 0 C-N-CA 122.588 0.355 . . . . 70.44 110.375 -179.469 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 161' ' ' CYS . . . . . . . . . . . . . 28.0 p -127.74 -166.55 1.63 Allowed 'General case' 0 N--CA 1.474 0.731 0 C-N-CA 125.362 1.465 . . . . 73.44 108.812 -177.977 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 162' ' ' GLY . . . . . . . . . . . . . . . 134.17 54.51 0.07 OUTLIER Glycine 0 C--N 1.351 1.403 0 C-N-CA 121.406 -0.426 . . . . 75.3 112.885 -177.196 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 163' ' ' GLN . . . . . 0.417 HE22 ' HG3' ' A' ' 37' ' ' ARG . 8.1 tt0 -46.4 106.6 0.08 Allowed 'General case' 0 N--CA 1.483 1.18 0 C-N-CA 124.547 1.139 . . . . 52.1 111.629 178.515 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 164' ' ' LEU . . . . . . . . . . . . . 86.4 mt . . . . . 0 CA--C 1.542 0.671 0 CA-C-N 114.64 -1.164 . . . . 72.53 110.886 -177.402 . . . . . . . . 0 0 . 1 . 002 nuclear build core ' B' B ' 218' ' ' PRO . . . . . . . . . . . . . 68.1 Cg_exo . . . . . 0 N--CA 1.491 1.348 0 CA-C-O 121.214 0.423 . . . . 73.55 111.9 . . . . . . . . . 0 0 . 1 . 002 nuclear build core ' B' B ' 219' ' ' GLY . . . . . . . . . . . . . . . 153.43 172.13 21.32 Favored Glycine 0 CA--C 1.529 0.928 0 CA-C-N 114.962 -1.017 . . . . 60.14 112.021 -174.213 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 220' ' ' PRO . . . . . 0.578 ' HB3' ' HE2' ' A' ' 125' ' ' LYS . 51.9 Cg_endo -86.48 165.49 9.32 Favored 'Trans proline' 0 C--N 1.364 1.355 0 C-N-CA 123.214 2.609 . . . . 74.45 114.22 179.689 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 221' ' ' TYR . . . . . . . . . . . . . 54.9 t80 . . . . . 0 N--CA 1.475 0.79 0 C-N-CA 123.002 0.521 . . . . 44.14 110.609 175.193 . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 8.2 m-80 . . . . . 0 CA--C 1.55 0.96 0 CA-C-O 119.087 -0.482 . . . . 71.55 110.043 . . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 31.5 Cg_endo -61.62 121.73 10.0 Favored 'Trans proline' 0 C--N 1.378 2.098 0 C-N-CA 122.957 2.438 . . . . 62.31 111.591 179.847 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 5' ' ' THR . . . . . 0.401 ' HB ' ' HB2' ' A' ' 164' ' ' LEU . 93.1 m -98.14 132.11 43.94 Favored 'General case' 0 CA--C 1.536 0.435 0 C-N-CA 122.756 0.422 . . . . 71.42 110.097 -177.972 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 6' ' ' VAL . . . . . 0.521 ' HA ' ' HB2' ' A' ' 163' ' ' GLN . 12.6 m -101.16 129.49 52.08 Favored 'Isoleucine or valine' 0 C--N 1.35 0.593 0 C-N-CA 123.53 0.732 . . . . 72.24 110.008 175.591 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 7' ' ' PHE . . . . . 0.621 ' HB2' ' HG ' ' A' ' 164' ' ' LEU . 37.7 t80 -119.61 134.23 55.31 Favored 'General case' 0 C--O 1.238 0.464 0 C-N-CA 123.886 0.875 . . . . 72.04 109.7 -170.684 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 8' ' ' PHE . . . . . 0.437 ' HB3' HG23 ' A' ' 158' ' ' ILE . 64.6 m-85 -139.89 161.37 37.75 Favored 'General case' 0 N--CA 1.47 0.536 0 O-C-N 123.801 0.688 . . . . 71.35 111.467 -174.705 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 7.6 m-20 -102.36 108.05 19.27 Favored 'General case' 0 N--CA 1.47 0.536 0 CA-C-N 114.005 -1.452 . . . . 65.45 107.58 166.017 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 10' ' ' ILE . . . . . 0.475 HG21 ' SD ' ' A' ' 142' ' ' MET . 49.2 mm -82.1 120.3 33.33 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.476 0 N-CA-C 108.852 -0.795 . . . . 73.21 108.852 175.323 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 11' ' ' ALA . . . . . 0.537 ' HB2' ' HB2' ' A' ' 159' ' ' ALA . . . -117.29 121.92 42.49 Favored 'General case' 0 N--CA 1.463 0.218 0 C-N-CA 123.529 0.732 . . . . 65.55 110.915 -173.638 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 12' ' ' VAL . . . . . 0.488 HG21 HD22 ' A' ' 17' ' ' LEU . 76.6 t -98.06 118.08 43.98 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.651 0 N-CA-C 108.334 -0.988 . . . . 72.34 108.334 173.454 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 35.8 m-20 61.9 31.2 18.25 Favored 'General case' 0 N--CA 1.486 1.364 0 C-N-CA 125.566 1.546 . . . . 72.25 111.249 -174.707 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 87.32 -15.78 52.24 Favored Glycine 0 C--N 1.352 1.428 0 CA-C-N 115.488 -0.778 . . . . 43.33 113.191 -177.499 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 21.8 mm-40 -90.81 115.72 64.86 Favored Pre-proline 0 N--CA 1.474 0.766 0 CA-C-O 118.606 -0.711 . . . . 73.15 110.514 -177.165 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 14.0 Cg_endo -53.52 104.88 0.11 Allowed 'Trans proline' 0 C--N 1.387 2.564 0 C-N-CA 123.228 2.619 . . . . 72.43 111.909 178.493 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 17' ' ' LEU . . . . . 0.488 HD22 HG21 ' A' ' 12' ' ' VAL . 21.3 tp -77.12 -24.93 51.65 Favored 'General case' 0 CA--C 1.541 0.632 0 CA-C-N 114.696 -1.138 . . . . 71.1 109.777 179.3 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 170.03 -178.62 42.78 Favored Glycine 0 C--N 1.342 0.894 0 CA-C-N 115.354 -0.839 . . . . 51.14 112.337 176.373 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 94.3 mtt180 -116.44 142.27 47.08 Favored 'General case' 0 N--CA 1.473 0.687 0 C-N-CA 123.771 0.828 . . . . 72.44 110.228 -178.49 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 45.0 t -131.35 141.11 46.76 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.69 0 C-N-CA 123.179 0.592 . . . . 73.22 110.247 -178.474 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 40.6 p -120.92 116.77 25.77 Favored 'General case' 0 CA--C 1.548 0.901 0 C-N-CA 124.596 1.158 . . . . 72.11 109.109 177.1 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 63.1 m-85 -103.36 113.47 26.99 Favored 'General case' 0 N--CA 1.472 0.647 0 C-N-CA 123.927 0.891 . . . . 62.42 109.377 177.158 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 23' ' ' GLU . . . . . 0.537 ' HB2' ' HD2' ' A' ' 133' ' ' LYS . 42.4 tt0 -74.88 103.56 5.16 Favored 'General case' 0 CA--C 1.553 1.083 0 C-N-CA 123.827 0.851 . . . . 71.23 109.934 175.759 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 21.0 mt -83.94 120.07 25.66 Favored 'General case' 0 N--CA 1.477 0.904 0 N-CA-C 109.352 -0.61 . . . . 73.14 109.352 178.454 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 25' ' ' PHE . . . . . 0.585 ' HB2' HD11 ' A' ' 90' ' ' LEU . 57.8 m-85 -84.46 70.44 10.68 Favored 'General case' 0 CA--C 1.544 0.716 0 C-N-CA 123.19 0.596 . . . . 73.32 110.117 177.809 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -60.97 -30.45 70.27 Favored 'General case' 0 N--CA 1.482 1.13 0 C-N-CA 123.247 0.619 . . . . 73.32 111.789 179.901 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 10.8 p-10 -62.03 -26.59 68.34 Favored 'General case' 0 CA--C 1.548 0.866 0 C-N-CA 124.169 0.988 . . . . 75.23 112.223 178.902 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 28' ' ' LYS . . . . . 0.406 ' HD2' HD21 ' A' ' 90' ' ' LEU . 41.0 mttm -98.05 -49.69 4.66 Favored 'General case' 0 N--CA 1.479 0.991 0 C-N-CA 123.557 0.743 . . . . 52.01 110.476 -178.629 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 29' ' ' VAL . . . . . 0.569 HG21 ' HA ' ' A' ' 129' ' ' PHE . 26.7 m -120.05 83.67 31.52 Favored Pre-proline 0 CA--C 1.567 1.605 0 C-N-CA 123.844 0.858 . . . . 63.52 110.119 -174.285 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 32.7 Cg_endo -61.43 -49.84 6.79 Favored 'Trans proline' 0 C--N 1.382 2.33 0 C-N-CA 122.81 2.34 . . . . 73.11 112.337 -172.045 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 23.8 ttmm -60.5 -53.51 56.65 Favored 'General case' 0 N--CA 1.47 0.563 0 C-N-CA 124.049 0.94 . . . . 71.23 111.805 -175.247 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 7.3 m -75.85 -37.41 58.99 Favored 'General case' 0 CA--C 1.553 1.076 0 CA-C-N 115.339 -0.846 . . . . 74.22 111.912 -168.508 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -76.4 -43.37 40.76 Favored 'General case' 0 N--CA 1.479 0.998 0 C-N-CA 122.367 0.267 . . . . 61.03 111.327 -179.103 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 9.0 tp10 -62.75 -39.27 93.63 Favored 'General case' 0 N--CA 1.482 1.144 0 O-C-N 123.445 0.465 . . . . 54.02 110.878 178.134 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 35' ' ' ASN . . . . . 0.492 ' O ' ' HG ' ' A' ' 39' ' ' LEU . 35.6 t30 -50.2 -62.6 1.48 Allowed 'General case' 0 C--N 1.356 0.889 0 O-C-N 124.333 1.02 . . . . 74.13 110.885 176.865 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 36' ' ' PHE . . . . . 0.46 ' HE2' HG21 ' A' ' 6' ' ' VAL . 84.2 t80 -64.26 -34.03 77.19 Favored 'General case' 0 N--CA 1.471 0.613 0 O-C-N 124.172 0.92 . . . . 74.13 111.843 -175.544 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 41.9 ttp180 -64.71 -40.53 95.52 Favored 'General case' 0 CA--C 1.541 0.618 0 O-C-N 123.429 0.456 . . . . 65.05 110.682 178.969 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -75.88 -25.87 56.52 Favored 'General case' 0 N--CA 1.476 0.843 0 CA-C-N 115.881 -0.6 . . . . 42.45 111.432 179.226 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 39' ' ' LEU . . . . . 0.492 ' HG ' ' O ' ' A' ' 35' ' ' ASN . 85.5 mt -68.99 -40.1 78.96 Favored 'General case' 0 N--CA 1.48 1.037 0 C-N-CA 123.605 0.762 . . . . 73.04 109.868 172.544 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 37.1 t -68.38 -56.67 7.7 Favored 'General case' 0 N--CA 1.475 0.814 0 C-N-CA 124.584 1.154 . . . . 73.31 111.359 -177.151 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 18.1 p -71.87 -30.01 64.97 Favored 'General case' 0 N--CA 1.473 0.697 0 CA-C-N 115.625 -0.716 . . . . 63.12 111.587 -179.26 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 83.26 26.58 43.32 Favored Glycine 0 C--N 1.347 1.169 0 CA-C-N 116.093 -0.503 . . . . 74.34 112.805 -179.436 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 40.7 mm-40 -67.0 -21.01 65.97 Favored 'General case' 0 N--CA 1.476 0.874 0 C-N-CA 122.979 0.512 . . . . 75.12 111.873 177.887 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 3.3 mmpm? -100.61 18.31 19.55 Favored 'General case' 0 CA--C 1.548 0.866 0 C-N-CA 124.052 0.941 . . . . 73.15 111.159 175.443 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 87.43 -25.06 8.54 Favored Glycine 0 C--N 1.349 1.299 0 CA-C-O 119.437 -0.646 . . . . 73.1 114.304 175.034 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 17.4 m-85 -69.2 -48.78 61.11 Favored 'General case' 0 N--CA 1.478 0.928 0 CA-C-N 117.237 0.519 . . . . 72.14 111.655 -167.145 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 53.29 64.74 3.92 Favored Glycine 0 C--N 1.353 1.505 0 O-C-N 123.942 0.776 . . . . 75.12 114.212 170.692 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 48' ' ' TYR . . . . . 0.453 ' HB3' ' HB2' ' A' ' 51' ' ' SER . 59.3 m-85 -60.95 86.95 0.02 OUTLIER 'General case' 0 CA--C 1.551 1.006 0 CA-C-O 121.69 0.757 . . . . 73.45 111.044 178.209 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 27.7 tptp -112.68 125.28 54.13 Favored 'General case' 0 C--O 1.238 0.455 0 N-CA-C 107.306 -1.368 . . . . 73.15 107.306 177.086 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 73.92 21.62 78.99 Favored Glycine 0 CA--C 1.53 0.989 0 O-C-N 123.364 0.415 . . . . 50.21 112.097 -172.117 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 51' ' ' SER . . . . . 0.653 ' HA ' ' HB2' ' A' ' 67' ' ' PHE . 31.8 t -61.81 112.05 2.13 Favored 'General case' 0 C--N 1.358 0.944 0 C-N-CA 123.65 0.78 . . . . 73.12 111.042 -173.486 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 52' ' ' CYS . . . . . 0.605 ' SG ' ' HB3' ' A' ' 66' ' ' ASP . 5.1 p -82.06 161.76 22.8 Favored 'General case' 0 CA--C 1.537 0.446 0 CA-C-O 121.769 0.795 . . . . 62.13 111.914 -172.864 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 30.2 m-85 -113.72 133.36 55.39 Favored 'General case' 0 C--O 1.235 0.337 0 CA-C-N 114.613 -1.176 . . . . 72.11 108.136 177.164 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 55.6 p-80 -115.9 -19.98 10.18 Favored 'General case' 0 N--CA 1.485 1.319 0 C-N-CA 122.871 0.468 . . . . 63.32 110.883 -179.351 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 55' ' ' ARG . . . . . 0.472 ' HA ' ' O ' ' A' ' 150' ' ' GLY . 27.9 ttt-85 -130.22 97.02 4.31 Favored 'General case' 0 C--O 1.215 -0.728 0 C-N-CA 123.116 0.566 . . . . 74.35 109.553 -172.158 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 33.2 mt -136.05 129.46 47.37 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.716 0 C-N-CA 123.488 0.715 . . . . 75.02 109.138 178.816 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 57' ' ' ILE . . . . . 0.45 HG23 ' HA ' ' A' ' 148' ' ' ARG . 56.8 mt -128.83 118.04 19.6 Favored Pre-proline 0 CA--C 1.552 1.02 0 C-N-CA 124.591 1.157 . . . . 75.22 109.153 -178.168 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 58' ' ' PRO . . . . . 0.709 ' HB3' ' HA ' ' A' ' 144' ' ' ARG . 38.7 Cg_endo -63.96 140.27 71.92 Favored 'Trans proline' 0 C--N 1.377 2.058 0 C-N-CA 123.563 2.842 . . . . 74.53 113.325 -175.966 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 73.4 20.45 79.88 Favored Glycine 0 C--N 1.346 1.115 0 CA-C-N 115.094 -0.957 . . . . 72.45 113.057 178.839 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 60' ' ' PHE . . . . . 0.427 ' CD2' ' HB3' ' A' ' 61' ' ' MET . 47.2 t80 -145.24 -73.68 0.24 Allowed 'General case' 0 C--O 1.244 0.782 0 C-N-CA 123.662 0.785 . . . . 73.21 109.717 -174.366 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 61' ' ' MET . . . . . 0.704 ' SD ' ' HB2' ' A' ' 63' ' ' GLN . 12.3 tmm? -169.15 137.03 1.9 Allowed 'General case' 0 N--CA 1.479 1.001 0 O-C-N 123.272 0.358 . . . . 71.14 111.686 -164.883 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 62' ' ' CYS . . . . . 0.486 ' SG ' ' HB ' ' A' ' 114' ' ' ILE . 3.9 p -112.89 121.32 44.32 Favored 'General case' 0 N--CA 1.484 1.228 0 C-N-CA 124.673 1.189 . . . . 74.12 110.585 174.334 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 63' ' ' GLN . . . . . 0.704 ' HB2' ' SD ' ' A' ' 61' ' ' MET . 53.7 tt0 -126.95 137.6 53.15 Favored 'General case' 0 N--CA 1.49 1.562 0 C-N-CA 124.163 0.985 . . . . 61.44 111.489 -168.596 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -154.86 -157.81 8.4 Favored Glycine 0 C--N 1.348 1.217 0 CA-C-N 115.975 -0.557 . . . . 51.01 113.311 -178.314 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 108.46 14.04 17.27 Favored Glycine 0 N--CA 1.476 1.344 0 N-CA-C 111.477 -0.649 . . . . 53.3 111.477 -169.789 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 66' ' ' ASP . . . . . 0.605 ' HB3' ' SG ' ' A' ' 52' ' ' CYS . 28.2 t70 -72.09 1.19 7.83 Favored 'General case' 0 CA--C 1.558 1.283 0 C-N-CA 125.242 1.417 . . . . 53.02 112.876 -167.409 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 67' ' ' PHE . . . . . 0.653 ' HB2' ' HA ' ' A' ' 51' ' ' SER . 56.6 t80 -73.36 -70.96 0.34 Allowed 'General case' 0 CA--C 1.549 0.932 0 C-N-CA 124.022 0.929 . . . . 73.31 111.41 -176.509 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 68' ' ' THR . . . . . 0.511 HG22 ' HD3' ' A' ' 76' ' ' LYS . 4.3 m -86.9 108.5 18.81 Favored 'General case' 0 N--CA 1.475 0.8 0 C-N-CA 122.949 0.5 . . . . 35.3 110.115 -171.999 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 34.8 ttt85 52.99 93.64 0.02 OUTLIER 'General case' 0 N--CA 1.481 1.116 0 C-N-CA 125.501 1.52 . . . . 65.41 111.618 -179.278 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 0.4 OUTLIER -110.69 11.73 22.67 Favored 'General case' 0 N--CA 1.481 1.088 0 N-CA-C 112.866 0.691 . . . . 73.33 112.866 -177.122 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 18.7 m120 -86.21 88.14 7.55 Favored 'General case' 0 N--CA 1.477 0.896 0 N-CA-C 108.928 -0.767 . . . . 64.11 108.928 171.467 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 69.96 29.39 70.82 Favored Glycine 0 C--N 1.35 1.334 0 CA-C-N 115.478 -0.783 . . . . 74.12 113.751 176.549 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 47.9 m -143.7 -64.55 0.38 Allowed 'General case' 0 CA--C 1.547 0.832 0 C-N-CA 124.015 0.926 . . . . 65.24 108.698 178.188 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 56.14 41.11 85.29 Favored Glycine 0 C--N 1.356 1.688 0 N-CA-C 115.234 0.853 . . . . 73.51 115.234 172.063 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 141.18 51.1 0.05 OUTLIER Glycine 0 C--N 1.346 1.12 0 CA-C-N 117.241 0.521 . . . . 24.3 111.872 -175.219 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 76' ' ' LYS . . . . . 0.511 ' HD3' HG22 ' A' ' 68' ' ' THR . 0.0 OUTLIER -58.87 147.81 32.44 Favored 'General case' 0 N--CA 1.475 0.82 0 C-N-CA 123.329 0.652 . . . . 74.33 112.151 -179.129 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 85.8 p -98.52 -178.37 3.98 Favored 'General case' 0 C--O 1.238 0.454 0 CA-C-N 115.325 -0.852 . . . . 72.44 111.953 -170.874 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 26.8 pt -75.58 -12.89 14.9 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.85 0 CA-C-N 114.999 -1.0 . . . . 75.45 111.003 175.426 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 99.2 m-85 -97.78 22.08 9.63 Favored 'General case' 0 N--CA 1.479 1.018 0 C-N-CA 124.133 0.973 . . . . 70.42 110.069 175.714 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 96.52 -111.71 4.29 Favored Glycine 0 C--N 1.346 1.128 0 N-CA-C 110.895 -0.882 . . . . 71.14 110.895 -177.694 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 41.5 tt0 -78.37 -59.63 2.7 Favored 'General case' 0 N--CA 1.472 0.628 0 C-N-CA 122.978 0.511 . . . . 72.31 110.378 -179.975 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 82' ' ' LYS . . . . . 0.759 ' HD2' ' HA ' ' A' ' 107' ' ' THR . 21.3 pttp -161.47 178.5 9.07 Favored 'General case' 0 N--CA 1.477 0.902 0 C-N-CA 123.88 0.872 . . . . 74.41 109.839 -171.055 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 35.7 p90 -152.07 174.36 13.78 Favored 'General case' 0 N--CA 1.474 0.765 0 C-N-CA 124.43 1.092 . . . . 72.13 111.459 -175.81 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 84' ' ' GLU . . . . . 0.46 ' HA ' ' HA ' ' A' ' 106' ' ' ASN . 13.7 pt-20 -82.92 160.28 22.13 Favored 'General case' 0 N--CA 1.474 0.734 0 CA-C-N 115.249 -0.887 . . . . 74.2 110.795 176.263 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 85' ' ' ASP . . . . . 0.404 ' OD1' ' HA ' ' A' ' 126' ' ' HIS . 49.7 m-20 -63.04 133.98 55.39 Favored 'General case' 0 N--CA 1.47 0.56 0 C-N-CA 123.741 0.816 . . . . 72.23 110.832 179.232 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 9.9 tp10 -76.18 -61.79 1.82 Allowed 'General case' 0 CA--C 1.543 0.676 0 CA-C-N 116.074 -0.512 . . . . 73.41 109.846 179.261 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 87' ' ' ASN . . . . . 0.433 ' OD1' HG12 ' A' ' 29' ' ' VAL . 27.6 p-10 -169.36 155.39 6.27 Favored 'General case' 0 N--CA 1.477 0.899 0 C-N-CA 123.49 0.716 . . . . 60.21 110.265 -173.303 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 76.5 m-85 -109.11 33.26 4.37 Favored 'General case' 0 N--CA 1.479 1.0 0 C-N-CA 123.826 0.85 . . . . 75.54 111.442 -169.648 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 55.9 mt -60.25 -46.98 94.03 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.164 0 C-N-CA 123.311 0.644 . . . . 65.1 109.561 174.283 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 90' ' ' LEU . . . . . 0.585 HD11 ' HB2' ' A' ' 25' ' ' PHE . 95.9 mt -95.87 128.39 42.71 Favored 'General case' 0 CA--C 1.537 0.476 0 CA-C-N 115.047 -0.978 . . . . 73.13 109.803 179.067 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 17.8 ptpt -133.74 171.94 13.45 Favored 'General case' 0 N--CA 1.472 0.646 0 C-N-CA 124.305 1.042 . . . . 75.24 110.133 -179.444 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 92' ' ' HIS . . . . . . . . . . . . . 23.8 m-70 -85.49 50.28 1.93 Allowed 'General case' 0 N--CA 1.477 0.895 0 C-N-CA 124.277 1.031 . . . . 64.35 110.107 -175.909 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 8.8 t -89.28 4.92 47.19 Favored 'General case' 0 CA--C 1.549 0.929 0 C-N-CA 124.006 0.923 . . . . 54.15 111.576 -176.773 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -148.72 172.9 28.82 Favored Glycine 0 C--N 1.345 1.073 0 N-CA-C 111.93 -0.468 . . . . 62.34 111.93 178.779 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 89.9 Cg_endo -84.08 156.88 13.2 Favored 'Trans proline' 0 CA--C 1.551 1.367 0 C-N-CA 123.026 2.484 . . . . 73.34 111.921 172.363 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 78.61 19.95 72.48 Favored Glycine 0 N--CA 1.471 1.03 0 CA-C-N 116.418 -0.355 . . . . 73.14 113.86 -179.438 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 97' ' ' ILE . . . . . . . . . . . . . 22.1 mm -78.91 109.77 13.95 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.777 0 C-N-CA 123.954 0.902 . . . . 63.22 111.41 -175.483 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 98' ' ' LEU . . . . . 0.492 HD13 HG12 ' A' ' 114' ' ' ILE . 65.6 tp -90.09 118.46 29.65 Favored 'General case' 0 CA--C 1.551 1.004 0 C-N-CA 123.299 0.64 . . . . 72.4 109.661 176.35 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 99' ' ' SER . . . . . 0.486 ' HB2' HG22 ' A' ' 128' ' ' VAL . 33.5 t -137.39 155.85 48.89 Favored 'General case' 0 N--CA 1.476 0.875 0 C-N-CA 124.979 1.312 . . . . 75.35 108.911 -177.495 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 100' ' ' MET . . . . . 0.41 ' HA ' ' HA ' ' A' ' 112' ' ' PHE . 41.2 mtp -90.41 147.31 23.52 Favored 'General case' 0 N--CA 1.486 1.348 0 N-CA-C 110.069 -0.345 . . . . 72.34 110.069 178.123 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 101' ' ' ALA . . . . . 0.475 ' HB3' ' HB2' ' A' ' 111' ' ' GLN . . . -84.46 162.52 19.9 Favored 'General case' 0 N--CA 1.475 0.8 0 C-N-CA 123.443 0.697 . . . . 44.53 112.622 -169.873 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 26.1 p-10 -165.1 168.05 17.65 Favored 'General case' 0 C--N 1.352 0.714 0 CA-C-N 115.142 -0.936 . . . . 73.45 110.358 178.757 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -113.72 9.02 17.67 Favored 'General case' 0 CA--C 1.543 0.701 0 C-N-CA 123.606 0.762 . . . . 75.2 109.75 168.174 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 154.08 -173.73 32.64 Favored Glycine 0 C--N 1.354 1.548 0 CA-C-O 119.706 -0.497 . . . . 52.13 112.552 -178.887 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 48.9 Cg_exo -58.59 143.75 98.04 Favored 'Trans proline' 0 C--N 1.373 1.842 0 C-N-CA 123.43 2.753 . . . . 75.51 112.898 176.876 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 106' ' ' ASN . . . . . 0.46 ' HA ' ' HA ' ' A' ' 84' ' ' GLU . 61.6 t30 63.96 14.65 8.58 Favored 'General case' 0 N--CA 1.485 1.284 0 C-N-CA 125.267 1.427 . . . . 72.33 111.837 -178.034 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 107' ' ' THR . . . . . 0.759 ' HA ' ' HD2' ' A' ' 82' ' ' LYS . 2.8 m -115.55 -0.48 13.03 Favored 'General case' 0 CA--C 1.551 0.995 0 C-N-CA 123.766 0.827 . . . . 61.35 109.93 179.263 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 54.7 t30 -78.09 155.01 30.81 Favored 'General case' 0 N--CA 1.479 0.983 0 C-N-CA 123.363 0.665 . . . . 64.51 110.246 -178.016 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 96.37 -10.26 67.2 Favored Glycine 0 N--CA 1.468 0.801 0 CA-C-O 120.076 -0.291 . . . . 33.23 113.11 177.533 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 16.2 p -91.19 123.13 34.4 Favored 'General case' 0 CA--C 1.538 0.513 0 N-CA-C 107.539 -1.282 . . . . 62.35 107.539 167.322 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 111' ' ' GLN . . . . . 0.475 ' HB2' ' HB3' ' A' ' 101' ' ' ALA . 3.0 mt-30 69.76 165.23 0.27 Allowed 'General case' 0 N--CA 1.493 1.703 0 C-N-CA 125.852 1.661 . . . . 73.34 111.19 -178.594 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 112' ' ' PHE . . . . . 0.41 ' HA ' ' HA ' ' A' ' 100' ' ' MET . 54.3 p90 -139.43 155.6 47.5 Favored 'General case' 0 N--CA 1.482 1.134 0 N-CA-C 108.985 -0.746 . . . . 74.11 108.985 175.793 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 113' ' ' PHE . . . . . 0.557 ' HB2' ' SD ' ' A' ' 61' ' ' MET . 53.7 p90 -152.61 152.83 32.27 Favored 'General case' 0 N--CA 1.471 0.605 0 C-N-CA 122.963 0.505 . . . . 60.55 111.65 -176.337 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 114' ' ' ILE . . . . . 0.492 HG12 HD13 ' A' ' 98' ' ' LEU . 6.4 mt -119.93 108.05 22.46 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.761 0 N-CA-C 108.121 -1.066 . . . . 63.21 108.121 -176.724 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 115' ' ' CYS . . . . . . . . . . . . . 60.1 m -80.62 105.83 12.17 Favored 'General case' 0 N--CA 1.47 0.53 0 C-N-CA 123.129 0.572 . . . . 74.23 109.769 176.656 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 40.5 p -71.85 -24.98 61.78 Favored 'General case' 0 N--CA 1.482 1.152 0 C-N-CA 122.612 0.365 . . . . 71.5 110.596 173.971 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -98.48 147.07 25.12 Favored 'General case' 0 C--O 1.239 0.545 0 CA-C-N 115.828 -0.624 . . . . 64.33 109.756 171.717 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 9.0 ptmm? -70.16 84.19 0.54 Allowed 'General case' 0 N--CA 1.477 0.899 0 CA-C-O 121.848 0.832 . . . . 70.24 110.021 171.847 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 119' ' ' THR . . . . . . . . . . . . . 35.8 p -79.92 85.31 5.56 Favored 'General case' 0 CA--C 1.548 0.866 0 CA-C-N 114.947 -1.024 . . . . 71.42 110.133 -175.546 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 9.3 pt-20 -68.39 -26.25 65.47 Favored 'General case' 0 N--CA 1.48 1.071 0 CA-C-N 114.737 -1.12 . . . . 71.42 112.125 -172.444 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 121' ' ' TRP . . . . . . . . . . . . . 47.0 p90 -72.57 1.08 8.83 Favored 'General case' 0 N--CA 1.473 0.715 0 C-N-CA 123.584 0.754 . . . . 74.31 112.265 178.546 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 122' ' ' LEU . . . . . 0.523 ' HB3' ' HE1' ' A' ' 126' ' ' HIS . 40.3 mt -104.12 5.3 35.01 Favored 'General case' 0 N--CA 1.475 0.815 0 C-N-CA 123.252 0.621 . . . . 74.2 111.897 176.355 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 40.4 m-20 -80.55 153.92 27.81 Favored 'General case' 0 N--CA 1.487 1.391 0 C-N-CA 122.812 0.445 . . . . 74.34 110.963 177.425 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 71.49 19.98 78.07 Favored Glycine 0 C--N 1.359 1.823 0 O-C-N 123.442 0.463 . . . . 54.45 112.304 -173.02 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 43.4 mtmt -145.22 -158.4 0.89 Allowed 'General case' 0 N--CA 1.47 0.533 0 C-N-CA 126.805 2.042 . . . . 72.42 107.884 -171.427 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 126' ' ' HIS . . . . . 0.523 ' HE1' ' HB3' ' A' ' 122' ' ' LEU . 0.0 OUTLIER -56.3 130.62 45.31 Favored 'General case' 0 N--CA 1.478 0.973 0 C-N-CA 123.8 0.84 . . . . 74.33 113.034 -159.119 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 99.3 t -61.45 130.14 25.22 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.615 0 CA-C-N 113.058 -1.883 . . . . 65.5 113.003 -166.517 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 128' ' ' VAL . . . . . 0.486 HG22 ' HB2' ' A' ' 99' ' ' SER . 92.8 t -81.05 145.26 9.18 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.313 0 CA-C-N 114.811 -1.086 . . . . 61.2 108.754 170.45 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 129' ' ' PHE . . . . . 0.569 ' HA ' HG21 ' A' ' 29' ' ' VAL . 21.6 p90 -138.27 -33.32 0.69 Allowed 'General case' 0 N--CA 1.469 0.503 0 C-N-CA 122.411 0.284 . . . . 54.52 110.984 -177.551 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . -115.66 165.14 12.15 Favored Glycine 0 C--N 1.337 0.588 0 O-C-N 123.709 0.631 . . . . 74.22 113.122 -175.591 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 30.2 ttpt -153.1 122.19 6.57 Favored 'General case' 0 C--N 1.324 -0.516 0 N-CA-C 107.207 -1.405 . . . . 71.14 107.207 177.867 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 3.9 p -65.92 105.36 0.62 Allowed 'Isoleucine or valine' 0 CA--C 1.553 1.078 0 CA-C-O 121.716 0.77 . . . . 61.33 109.651 175.56 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 133' ' ' LYS . . . . . 0.537 ' HD2' ' HB2' ' A' ' 23' ' ' GLU . 0.1 OUTLIER -78.5 -38.79 39.96 Favored 'General case' 0 N--CA 1.474 0.766 0 CA-C-N 114.901 -1.045 . . . . 74.35 109.903 -179.295 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 49.9 mt-10 -145.62 144.5 30.49 Favored 'General case' 0 N--CA 1.481 1.114 0 C-N-CA 124.599 1.16 . . . . 65.45 108.879 177.636 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 94.84 17.24 38.85 Favored Glycine 0 N--CA 1.472 1.059 0 N-CA-C 112.417 -0.273 . . . . 74.32 112.417 -176.409 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 136' ' ' MET . . . . . . . . . . . . . 14.5 tpt -61.81 -35.19 77.48 Favored 'General case' 0 N--CA 1.482 1.167 0 C-N-CA 124.113 0.965 . . . . 74.21 111.683 179.374 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 137' ' ' ASN . . . . . . . . . . . . . 1.8 m-20 -61.68 -34.71 76.22 Favored 'General case' 0 CA--C 1.548 0.875 0 C-N-CA 123.589 0.756 . . . . 74.14 110.774 177.796 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 138' ' ' ILE . . . . . . . . . . . . . 43.9 mm -72.05 -35.76 54.78 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.854 0 C-N-CA 123.076 0.55 . . . . 64.23 110.389 179.477 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 98.7 t -63.12 -45.88 97.47 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.872 0 C-N-CA 123.18 0.592 . . . . 71.31 110.374 175.879 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 40.9 mt-10 -68.26 -26.76 65.83 Favored 'General case' 0 N--CA 1.476 0.837 0 CA-C-N 115.498 -0.774 . . . . 74.14 111.186 178.352 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -71.99 -56.69 5.21 Favored 'General case' 0 N--CA 1.475 0.782 0 C-N-CA 123.332 0.653 . . . . 71.12 111.185 176.69 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 142' ' ' MET . . . . . 0.499 ' HA ' ' HD2' ' A' ' 145' ' ' PHE . 26.8 ptm -61.12 -35.7 77.73 Favored 'General case' 0 N--CA 1.48 1.059 0 C-N-CA 123.718 0.807 . . . . 65.3 111.829 -177.753 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 33.4 tt0 -66.05 -32.14 73.44 Favored 'General case' 0 CA--C 1.543 0.709 0 CA-C-O 121.462 0.648 . . . . 65.5 112.219 -173.91 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 144' ' ' ARG . . . . . 0.709 ' HA ' ' HB3' ' A' ' 58' ' ' PRO . 96.4 mtt180 -80.54 -6.58 58.43 Favored 'General case' 0 N--CA 1.47 0.544 0 CA-C-N 115.855 -0.611 . . . . 63.21 111.866 -178.65 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 145' ' ' PHE . . . . . 0.499 ' HD2' ' HA ' ' A' ' 142' ' ' MET . 50.9 m-85 -85.12 5.47 29.68 Favored 'General case' 0 CA--C 1.552 1.025 0 C-N-CA 123.309 0.644 . . . . 72.15 111.131 167.647 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . -93.72 -170.97 38.93 Favored Glycine 0 C--N 1.35 1.359 0 N-CA-C 112.381 -0.287 . . . . 70.31 112.381 172.987 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 12.9 m -132.74 162.53 31.2 Favored 'General case' 0 N--CA 1.48 1.049 0 C-N-CA 123.545 0.738 . . . . 71.02 109.513 -179.322 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 148' ' ' ARG . . . . . 0.45 ' HA ' HG23 ' A' ' 57' ' ' ILE . 17.4 mmm180 -71.5 -18.89 62.26 Favored 'General case' 0 N--CA 1.483 1.18 0 C-N-CA 123.823 0.849 . . . . 72.51 112.946 -172.902 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 149' ' ' ASN . . . . . . . . . . . . . 30.6 p-10 -85.89 -21.47 27.98 Favored 'General case' 0 N--CA 1.481 1.085 0 C-N-CA 123.619 0.768 . . . . 72.13 110.8 174.198 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 150' ' ' GLY . . . . . 0.472 ' O ' ' HA ' ' A' ' 55' ' ' ARG . . . 119.45 -11.23 11.37 Favored Glycine 0 C--N 1.347 1.189 0 CA-C-N 115.915 -0.584 . . . . 32.33 113.187 -178.747 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 37.5 ttpt -64.56 137.55 57.91 Favored 'General case' 0 N--CA 1.476 0.844 0 CA-C-N 117.921 0.86 . . . . 73.1 110.799 -177.698 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 152' ' ' THR . . . . . . . . . . . . . 18.1 p -91.13 113.28 25.51 Favored 'General case' 0 CA--C 1.539 0.528 0 N-CA-C 109.117 -0.698 . . . . 70.13 109.117 176.079 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 153' ' ' SER . . . . . . . . . . . . . 32.1 t -67.39 -35.41 79.27 Favored 'General case' 0 N--CA 1.475 0.803 0 C-N-CA 123.208 0.603 . . . . 72.1 110.419 -179.318 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 75.6 mmtt -110.09 152.16 26.32 Favored 'General case' 0 C--O 1.243 0.714 0 CA-C-N 114.959 -1.019 . . . . 73.53 109.381 178.971 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 17.3 tppt? -79.23 88.88 4.89 Favored 'General case' 0 C--N 1.349 0.552 0 N-CA-C 108.558 -0.904 . . . . 71.13 108.558 177.338 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 156' ' ' ILE . . . . . 0.486 HD11 ' HB2' ' A' ' 145' ' ' PHE . 58.0 mt -93.01 119.29 40.47 Favored 'Isoleucine or valine' 0 C--O 1.234 0.248 0 N-CA-C 108.821 -0.807 . . . . 62.51 108.821 -177.94 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 157' ' ' THR . . . . . . . . . . . . . 37.1 p -132.9 144.28 50.06 Favored 'General case' 0 C--O 1.238 0.481 0 C-N-CA 124.861 1.264 . . . . 74.42 109.099 -177.576 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 158' ' ' ILE . . . . . 0.437 HG23 ' HB3' ' A' ' 8' ' ' PHE . 62.2 mt -73.22 92.85 0.59 Allowed 'Isoleucine or valine' 0 CA--C 1.54 0.595 0 N-CA-C 107.526 -1.287 . . . . 62.23 107.526 166.874 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 159' ' ' ALA . . . . . 0.537 ' HB2' ' HB2' ' A' ' 11' ' ' ALA . . . -55.06 -57.32 12.18 Favored 'General case' 0 N--CA 1.47 0.549 0 C-N-CA 123.839 0.856 . . . . 72.33 110.892 -176.689 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 160' ' ' ASP . . . . . . . . . . . . . 13.2 m-20 -135.62 177.18 8.03 Favored 'General case' 0 N--CA 1.469 0.511 0 CA-C-O 121.698 0.761 . . . . 75.01 111.664 -175.18 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 161' ' ' CYS . . . . . . . . . . . . . 21.8 p -144.89 -169.35 3.16 Favored 'General case' 0 CA--C 1.542 0.644 0 C-N-CA 125.919 1.688 . . . . 74.32 107.768 -177.621 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 162' ' ' GLY . . . . . . . . . . . . . . . 130.27 53.06 0.1 Allowed Glycine 0 C--N 1.341 0.825 0 N-CA-C 109.92 -1.272 . . . . 65.13 109.92 -172.724 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 163' ' ' GLN . . . . . 0.521 ' HB2' ' HA ' ' A' ' 6' ' ' VAL . 15.6 pt20 -54.23 152.81 5.8 Favored 'General case' 0 CA--C 1.548 0.87 0 N-CA-C 114.512 1.301 . . . . 73.45 114.512 -170.927 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 164' ' ' LEU . . . . . 0.621 ' HG ' ' HB2' ' A' ' 7' ' ' PHE . 82.4 mt . . . . . 0 C--O 1.241 0.628 0 C-N-CA 124.462 1.105 . . . . 75.44 110.957 -169.874 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 218' ' ' PRO . . . . . . . . . . . . . 21.9 Cg_exo . . . . . 0 CA--C 1.545 1.052 0 N-CA-C 110.482 -0.622 . . . . 73.32 110.482 . . . . . . . . . 0 0 . 1 . 003 nuclear build core ' B' B ' 219' ' ' GLY . . . . . 0.443 ' HA2' ' HB1' ' A' ' 101' ' ' ALA . . . -173.14 147.81 9.92 Favored Glycine 0 C--N 1.347 1.184 0 CA-C-O 119.722 -0.488 . . . . 71.43 113.292 -178.943 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 220' ' ' PRO . . . . . . . . . . . . . 56.6 Cg_endo -67.55 153.46 76.32 Favored 'Trans proline' 0 C--N 1.377 2.075 0 C-N-CA 123.553 2.835 . . . . 62.11 112.748 177.923 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 221' ' ' TYR . . . . . . . . . . . . . 83.2 m-85 . . . . . 0 N--CA 1.477 0.908 0 C-N-CA 122.781 0.433 . . . . 74.3 110.709 -178.571 . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 30.2 m-80 . . . . . 0 CA--C 1.545 0.775 0 CA-C-O 118.942 -0.551 . . . . 53.2 111.849 . . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 36.4 Cg_endo -64.58 122.1 9.88 Favored 'Trans proline' 0 C--N 1.382 2.306 0 C-N-CA 122.872 2.381 . . . . 61.12 111.076 173.973 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 50.6 m -97.88 129.52 44.82 Favored 'General case' 0 CA--C 1.534 0.352 0 C-N-CA 123.585 0.754 . . . . 75.03 109.441 -178.068 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 6' ' ' VAL . . . . . 0.56 ' HA ' ' HG3' ' A' ' 163' ' ' GLN . 27.2 m -99.26 126.1 52.63 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.364 0 N-CA-C 108.209 -1.034 . . . . 54.04 108.209 175.471 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 7' ' ' PHE . . . . . 0.556 ' H ' ' HA ' ' A' ' 163' ' ' GLN . 57.7 t80 -108.85 135.52 49.92 Favored 'General case' 0 C--O 1.237 0.404 0 N-CA-C 109.037 -0.727 . . . . 70.31 109.037 -175.932 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 72.6 m-85 -139.62 166.21 25.2 Favored 'General case' 0 C--O 1.24 0.604 0 C-N-CA 124.654 1.182 . . . . 72.31 109.8 178.471 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 43.4 m-20 -118.01 116.25 26.53 Favored 'General case' 0 C--N 1.328 -0.365 0 N-CA-C 106.389 -1.708 . . . . 75.5 106.389 166.163 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 33.8 mm -98.93 143.68 12.92 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.711 0 N-CA-C 108.916 -0.772 . . . . 65.12 108.916 -177.465 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 11' ' ' ALA . . . . . 0.495 ' HB2' ' HB2' ' A' ' 159' ' ' ALA . . . -136.99 140.36 42.1 Favored 'General case' 0 N--CA 1.467 0.417 0 C-N-CA 123.304 0.642 . . . . 60.12 111.818 -164.432 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 12' ' ' VAL . . . . . 0.404 HG23 ' HB2' ' A' ' 17' ' ' LEU . 21.4 t -98.36 109.93 24.85 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.795 0 N-CA-C 107.796 -1.187 . . . . 71.41 107.796 171.418 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 45.4 m-20 68.25 20.63 8.73 Favored 'General case' 0 N--CA 1.497 1.904 0 C-N-CA 124.384 1.073 . . . . 73.35 111.766 -177.656 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 87.3 -3.19 86.75 Favored Glycine 0 C--N 1.349 1.278 0 CA-C-O 119.964 -0.353 . . . . 70.31 113.067 -174.666 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 40.0 mm-40 -84.18 113.71 49.96 Favored Pre-proline 0 CA--C 1.543 0.689 0 N-CA-C 108.902 -0.777 . . . . 71.35 108.902 175.235 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 21.1 Cg_endo -56.84 107.97 0.31 Allowed 'Trans proline' 0 C--N 1.383 2.354 0 C-N-CA 123.0 2.467 . . . . 75.24 111.749 -176.524 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 17' ' ' LEU . . . . . 0.404 ' HB2' HG23 ' A' ' 12' ' ' VAL . 46.3 tp -78.92 -45.45 20.5 Favored 'General case' 0 N--CA 1.47 0.539 0 CA-C-N 115.538 -0.756 . . . . 73.24 109.36 178.535 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -176.1 -171.46 39.92 Favored Glycine 0 C--N 1.337 0.596 0 CA-C-N 115.742 -0.663 . . . . 72.41 112.688 179.944 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 40.3 ptt85 -106.21 144.78 32.43 Favored 'General case' 0 C--O 1.239 0.537 0 C-N-CA 123.875 0.87 . . . . 74.1 108.674 178.691 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 94.6 t -134.17 139.27 48.56 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.588 0 N-CA-C 108.683 -0.858 . . . . 70.22 108.683 176.887 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 24.8 m -133.12 118.38 18.64 Favored 'General case' 0 CA--C 1.545 0.777 0 C-N-CA 124.867 1.267 . . . . 54.53 108.414 -175.872 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 22' ' ' PHE . . . . . 0.451 ' HA ' ' HA ' ' A' ' 132' ' ' VAL . 41.0 m-85 -102.87 129.63 49.63 Favored 'General case' 0 N--CA 1.479 1.002 0 N-CA-C 109.435 -0.58 . . . . 62.31 109.435 177.512 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 35.7 tt0 -90.33 108.18 19.61 Favored 'General case' 0 CA--C 1.548 0.873 0 C-N-CA 124.183 0.993 . . . . 71.34 109.426 177.447 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 24' ' ' LEU . . . . . 0.513 ' HB3' ' HB1' ' A' ' 33' ' ' ALA . 40.6 mt -87.25 122.09 30.56 Favored 'General case' 0 N--CA 1.48 1.063 0 C-N-CA 123.031 0.532 . . . . 65.32 110.605 -177.008 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 48.8 m-85 -84.91 65.26 9.1 Favored 'General case' 0 CA--C 1.548 0.879 0 C-N-CA 123.916 0.886 . . . . 74.22 110.805 -179.951 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -65.86 -25.88 67.39 Favored 'General case' 0 N--CA 1.482 1.131 0 CA-C-N 115.127 -0.942 . . . . 41.3 111.912 -177.766 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 9.2 p-10 -72.81 -6.64 46.24 Favored 'General case' 0 N--CA 1.48 1.041 0 C-N-CA 123.489 0.716 . . . . 75.52 111.341 -179.544 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 91.7 mttt -114.6 -48.94 2.84 Favored 'General case' 0 N--CA 1.476 0.857 0 C-N-CA 123.771 0.828 . . . . 75.44 109.872 177.242 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 29' ' ' VAL . . . . . 0.451 HG21 ' HA ' ' A' ' 129' ' ' PHE . 14.6 m -121.94 79.02 41.49 Favored Pre-proline 0 CA--C 1.566 1.56 0 C-N-CA 124.329 1.052 . . . . 73.21 109.293 -178.684 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 35.6 Cg_exo -60.03 -57.3 0.82 Allowed 'Trans proline' 0 C--N 1.391 2.766 0 C-N-CA 123.204 2.603 . . . . 75.3 112.953 -169.671 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 29.2 ttmt -58.43 -45.09 89.17 Favored 'General case' 0 N--CA 1.479 0.999 0 C-N-CA 124.564 1.146 . . . . 72.24 112.085 179.385 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 6.9 m -67.0 -40.1 87.28 Favored 'General case' 0 CA--C 1.548 0.894 0 CA-C-N 114.58 -1.191 . . . . 60.02 111.671 -170.459 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 33' ' ' ALA . . . . . 0.513 ' HB1' ' HB3' ' A' ' 24' ' ' LEU . . . -80.71 -36.18 32.55 Favored 'General case' 0 N--CA 1.475 0.798 0 C-N-CA 123.586 0.755 . . . . 71.24 110.702 178.381 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 14.7 tp10 -62.41 -32.04 72.81 Favored 'General case' 0 N--CA 1.486 1.37 0 C-N-CA 124.042 0.937 . . . . 73.1 111.144 -179.526 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 35' ' ' ASN . . . . . 0.555 ' ND2' ' SD ' ' A' ' 100' ' ' MET . 44.9 t30 -55.97 -64.35 0.88 Allowed 'General case' 0 CA--C 1.544 0.741 0 C-N-CA 123.823 0.849 . . . . 63.34 110.801 176.115 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 36' ' ' PHE . . . . . 0.524 ' HE2' HG21 ' A' ' 6' ' ' VAL . 65.7 t80 -65.5 -30.14 70.87 Favored 'General case' 0 N--CA 1.476 0.856 0 C-N-CA 123.603 0.761 . . . . 55.1 111.065 -176.264 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 44.8 ttp85 -64.76 -51.43 62.31 Favored 'General case' 0 CA--C 1.551 0.985 0 C-N-CA 124.015 0.926 . . . . 64.24 109.593 -179.415 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -78.44 -15.09 59.02 Favored 'General case' 0 CA--C 1.544 0.729 0 CA-C-N 115.037 -0.983 . . . . 75.43 112.26 -176.567 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 39' ' ' LEU . . . . . 0.403 HD22 ' CE2' ' A' ' 48' ' ' TYR . 92.8 mt -79.59 -35.55 39.44 Favored 'General case' 0 N--CA 1.487 1.391 0 C-N-CA 122.96 0.504 . . . . 65.41 110.418 170.511 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 42.6 t -66.06 -54.39 26.48 Favored 'General case' 0 N--CA 1.477 0.897 0 C-N-CA 124.285 1.034 . . . . 65.53 110.592 179.892 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 10.9 p -75.67 -32.0 59.98 Favored 'General case' 0 N--CA 1.475 0.806 0 CA-C-N 115.878 -0.601 . . . . 65.34 111.52 175.87 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 81.5 34.96 24.2 Favored Glycine 0 C--N 1.348 1.221 0 CA-C-N 116.481 -0.327 . . . . 64.41 113.402 177.879 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 41.2 mm-40 -66.41 -20.47 66.07 Favored 'General case' 0 N--CA 1.476 0.867 0 C-N-CA 123.693 0.797 . . . . 74.21 111.991 -178.632 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 9.8 mmpt? -93.67 8.17 41.93 Favored 'General case' 0 CA--C 1.552 1.029 0 C-N-CA 124.193 0.997 . . . . 65.41 110.842 179.265 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 76.33 33.79 47.65 Favored Glycine 0 C--N 1.351 1.365 0 CA-C-O 119.774 -0.459 . . . . 71.14 113.384 179.995 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 23.4 m-85 -116.21 -49.35 2.69 Favored 'General case' 0 N--CA 1.484 1.266 0 CA-C-N 117.214 0.507 . . . . 74.23 110.797 -178.317 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 47.12 63.32 3.34 Favored Glycine 0 C--N 1.354 1.554 0 O-C-N 124.482 1.114 . . . . 73.33 115.371 169.609 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 48' ' ' TYR . . . . . 0.403 ' CE2' HD22 ' A' ' 39' ' ' LEU . 32.0 m-85 -66.36 92.63 0.2 Allowed 'General case' 0 C--N 1.353 0.752 0 CA-C-O 121.869 0.842 . . . . 75.42 111.435 -173.71 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 27.9 tptp -109.33 94.8 5.23 Favored 'General case' 0 C--O 1.239 0.522 0 CA-C-N 113.991 -1.458 . . . . 53.24 108.591 -175.059 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 118.95 21.37 3.85 Favored Glycine 0 C--N 1.348 1.202 0 CA-C-O 119.781 -0.455 . . . . 44.02 113.395 -179.547 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 51' ' ' SER . . . . . 0.514 ' HB2' HD12 ' A' ' 158' ' ' ILE . 19.7 m -60.5 119.15 7.49 Favored 'General case' 0 N--CA 1.476 0.854 0 C-N-CA 123.577 0.751 . . . . 62.32 110.716 179.463 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 52' ' ' CYS . . . . . . . . . . . . . 10.6 p -104.91 129.21 53.32 Favored 'General case' 0 N--CA 1.474 0.743 0 CA-C-O 121.637 0.732 . . . . 63.02 112.525 -170.415 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 53' ' ' PHE . . . . . 0.776 ' HA ' ' HA2' ' A' ' 64' ' ' GLY . 55.9 m-85 -70.52 109.71 4.99 Favored 'General case' 0 C--N 1.347 0.494 0 C-N-CA 124.842 1.257 . . . . 73.45 109.646 174.148 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 49.7 p-80 -120.28 -5.48 9.91 Favored 'General case' 0 N--CA 1.481 1.086 0 C-N-CA 123.815 0.846 . . . . 73.24 111.235 -176.454 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 55' ' ' ARG . . . . . 0.454 ' O ' ' HB3' ' A' ' 63' ' ' GLN . 53.2 ttt-85 -129.57 97.6 4.59 Favored 'General case' 0 N--CA 1.473 0.719 0 N-CA-C 108.891 -0.781 . . . . 51.44 108.891 175.604 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 56' ' ' ILE . . . . . 0.456 HG21 ' HA ' ' A' ' 143' ' ' GLU . 64.3 mt -130.55 127.18 61.9 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.943 0 N-CA-C 108.389 -0.967 . . . . 61.31 108.389 177.291 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 74.9 mt -124.85 118.16 25.84 Favored Pre-proline 0 CA--C 1.555 1.144 0 C-N-CA 123.974 0.909 . . . . 60.33 108.904 -177.884 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 52.7 Cg_exo -57.63 145.65 88.37 Favored 'Trans proline' 0 C--N 1.383 2.365 0 C-N-CA 124.229 3.286 . . . . 73.15 114.205 -179.237 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 66.1 24.19 71.69 Favored Glycine 0 C--N 1.352 1.451 0 O-C-N 124.291 0.994 . . . . 74.43 112.954 -179.272 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 60' ' ' PHE . . . . . 0.403 ' CD2' ' HB3' ' A' ' 61' ' ' MET . 36.3 t80 -145.09 -76.38 0.21 Allowed 'General case' 0 C--O 1.244 0.764 0 C-N-CA 123.886 0.875 . . . . 72.41 110.221 -173.744 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 61' ' ' MET . . . . . 0.708 ' SD ' ' HB2' ' A' ' 113' ' ' PHE . 12.1 tmm? -173.27 150.74 1.93 Allowed 'General case' 0 N--CA 1.484 1.272 0 CA-C-O 121.075 0.464 . . . . 75.14 112.19 -161.2 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 62' ' ' CYS . . . . . . . . . . . . . 36.7 t -114.45 111.92 22.19 Favored 'General case' 0 CA--C 1.558 1.287 0 C-N-CA 124.873 1.269 . . . . 72.54 109.752 175.687 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 63' ' ' GLN . . . . . 0.644 ' HB2' ' SD ' ' A' ' 61' ' ' MET . 49.6 tt0 -115.5 133.53 55.94 Favored 'General case' 0 N--CA 1.498 1.935 0 C-N-CA 124.017 0.927 . . . . 72.45 110.949 -172.209 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 64' ' ' GLY . . . . . 0.776 ' HA2' ' HA ' ' A' ' 53' ' ' PHE . . . -123.04 170.28 15.45 Favored Glycine 0 C--N 1.339 0.726 0 CA-C-N 115.259 -0.882 . . . . 63.15 112.83 179.032 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -164.54 156.99 29.21 Favored Glycine 0 C--N 1.33 0.241 0 N-CA-C 110.532 -1.027 . . . . 64.14 110.532 176.658 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 21.2 t70 -91.35 167.2 12.47 Favored 'General case' 0 C--O 1.244 0.798 0 CA-C-O 121.185 0.517 . . . . 62.41 110.34 -178.269 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 63.8 t80 -77.25 -29.08 53.81 Favored 'General case' 0 CA--C 1.552 1.035 0 C-N-CA 124.07 0.948 . . . . 73.51 111.18 -179.676 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 91.5 m -61.23 109.42 1.12 Allowed 'General case' 0 C--N 1.363 1.156 0 C-N-CA 123.922 0.889 . . . . 61.03 110.361 179.659 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 36.6 ttt180 52.98 82.89 0.07 Allowed 'General case' 0 CA--C 1.541 0.618 0 O-C-N 124.836 1.335 . . . . 75.23 110.461 -173.398 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 52.3 t60 -89.26 -19.94 24.74 Favored 'General case' 0 CA--C 1.549 0.911 0 CA-C-N 116.099 -0.501 . . . . 71.42 111.457 -174.601 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 3.5 m-20 -64.76 91.41 0.09 Allowed 'General case' 0 N--CA 1.489 1.516 0 C-N-CA 123.686 0.794 . . . . 71.31 111.214 -176.813 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 75.3 -6.19 30.88 Favored Glycine 0 C--N 1.349 1.27 0 CA-C-N 115.561 -0.745 . . . . 74.21 114.682 175.249 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -114.16 -67.03 1.03 Allowed 'General case' 0 CA--C 1.551 0.995 0 N-CA-C 109.187 -0.672 . . . . 75.13 109.187 -175.2 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 61.32 61.58 6.74 Favored Glycine 0 CA--C 1.534 1.24 0 CA-C-N 116.21 -0.45 . . . . 72.4 113.994 175.77 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 107.54 52.25 0.72 Allowed Glycine 0 N--CA 1.48 1.593 0 CA-C-N 117.674 0.737 . . . . 63.2 112.166 -177.5 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 76' ' ' LYS . . . . . 0.437 ' HA ' ' O ' ' A' ' 109' ' ' GLY . 21.5 pttp -53.77 170.58 0.11 Allowed 'General case' 0 CA--C 1.562 1.409 0 C-N-CA 125.076 1.35 . . . . 71.45 113.815 179.902 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 89.9 p -90.69 176.02 6.81 Favored 'General case' 0 N--CA 1.486 1.33 0 C-N-CA 123.689 0.796 . . . . 75.21 112.856 -165.885 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 25.5 pt -71.34 -17.95 20.05 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.225 0 C-N-CA 122.934 0.493 . . . . 74.35 110.784 174.327 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 69.7 m-85 -92.85 27.82 2.27 Favored 'General case' 0 CA--C 1.546 0.797 0 C-N-CA 124.058 0.943 . . . . 73.44 109.728 174.523 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 83.51 -119.38 4.89 Favored Glycine 0 C--N 1.354 1.551 0 CA-C-N 115.088 -0.96 . . . . 74.22 111.753 177.74 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 34.8 tt0 -61.74 -59.43 5.18 Favored 'General case' 0 C--O 1.241 0.625 0 C-N-CA 124.024 0.93 . . . . 61.2 110.723 -178.373 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 82' ' ' LYS . . . . . 0.749 ' HD2' ' HA ' ' A' ' 107' ' ' THR . 23.9 pttm -165.11 175.28 9.51 Favored 'General case' 0 CA--C 1.552 1.057 0 O-C-N 123.595 0.56 . . . . 74.2 111.742 -174.967 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 2.0 p90 -157.03 176.24 13.02 Favored 'General case' 0 N--CA 1.482 1.158 0 C-N-CA 125.83 1.652 . . . . 75.12 109.036 -179.884 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 12.5 pt-20 -93.02 -172.48 3.0 Favored 'General case' 0 N--CA 1.485 1.281 0 CA-C-O 121.255 0.55 . . . . 74.11 111.74 179.517 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 51.8 m-20 -80.42 136.74 36.41 Favored 'General case' 0 N--CA 1.471 0.614 0 C-N-CA 124.271 1.028 . . . . 70.21 109.148 173.22 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 12.6 tp10 -73.24 -52.53 13.68 Favored 'General case' 0 CA--C 1.544 0.728 0 O-C-N 123.472 0.482 . . . . 63.44 109.929 176.165 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 87' ' ' ASN . . . . . 0.402 ' OD1' HG12 ' A' ' 29' ' ' VAL . 16.5 p-10 -170.14 134.79 1.27 Allowed 'General case' 0 N--CA 1.479 0.983 0 C-N-CA 123.595 0.758 . . . . 74.32 110.193 -174.58 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 73.7 m-85 -88.58 69.52 8.85 Favored 'General case' 0 N--CA 1.483 1.189 0 CA-C-O 121.096 0.474 . . . . 72.43 110.538 -178.053 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 37.0 mt -82.03 -58.25 3.87 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.77 0 N-CA-C 108.724 -0.843 . . . . 72.03 108.724 169.44 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 53.1 mt -92.78 119.52 32.22 Favored 'General case' 0 CA--C 1.541 0.598 0 CA-C-N 114.923 -1.035 . . . . 74.11 110.596 -171.006 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 9.8 mtmp? -121.98 171.48 8.91 Favored 'General case' 0 CA--C 1.543 0.708 0 C-N-CA 124.764 1.226 . . . . 71.21 109.814 175.086 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 92' ' ' HIS . . . . . . . . . . . . . 23.0 m-70 -78.09 80.62 4.51 Favored 'General case' 0 N--CA 1.477 0.886 0 C-N-CA 123.879 0.872 . . . . 74.34 110.16 -170.232 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 19.1 p -82.85 -57.31 3.36 Favored 'General case' 0 N--CA 1.473 0.714 0 C-N-CA 123.898 0.879 . . . . 74.45 111.212 -177.006 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -121.45 -176.64 15.34 Favored Glycine 0 C--N 1.346 1.129 0 O-C-N 123.466 0.479 . . . . 23.33 112.788 -176.374 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 8.4 Cg_exo -73.6 148.22 41.81 Favored 'Trans proline' 0 C--N 1.368 1.556 0 C-N-CA 122.987 2.458 . . . . 64.15 111.564 170.354 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 105.67 -2.6 39.17 Favored Glycine 0 N--CA 1.473 1.121 0 CA-C-N 116.391 -0.368 . . . . 65.33 113.213 -179.703 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 97' ' ' ILE . . . . . 0.453 ' HB ' ' HB2' ' A' ' 115' ' ' CYS . 18.1 mm -66.34 116.18 5.28 Favored 'Isoleucine or valine' 0 CA--C 1.555 1.167 0 C-N-CA 124.366 1.066 . . . . 70.33 111.862 -174.583 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 55.3 tp -100.29 122.43 43.07 Favored 'General case' 0 N--CA 1.479 0.994 0 C-N-CA 123.312 0.645 . . . . 70.12 110.063 173.624 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 44.9 t -142.89 144.36 32.42 Favored 'General case' 0 CA--C 1.539 0.525 0 C-N-CA 124.263 1.025 . . . . 73.21 108.254 176.944 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 100' ' ' MET . . . . . 0.555 ' SD ' ' ND2' ' A' ' 35' ' ' ASN . 13.4 ttt -79.45 141.97 36.31 Favored 'General case' 0 N--CA 1.483 1.18 0 C-N-CA 124.138 0.975 . . . . 73.12 109.073 -178.729 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 101' ' ' ALA . . . . . 0.437 ' HB3' ' HB2' ' A' ' 111' ' ' GLN . . . -77.24 160.9 28.55 Favored 'General case' 0 N--CA 1.479 1.019 0 CA-C-O 121.387 0.613 . . . . 72.23 111.616 -173.02 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 102' ' ' ASN . . . . . 0.51 ' HB3' ' HA ' ' A' ' 108' ' ' ASN . 25.7 p-10 -165.79 168.84 15.65 Favored 'General case' 0 N--CA 1.472 0.669 0 CA-C-N 114.581 -1.191 . . . . 53.44 109.711 -177.468 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -90.5 -47.28 7.8 Favored 'General case' 0 N--CA 1.469 0.503 0 N-CA-C 108.917 -0.771 . . . . 73.13 108.917 167.137 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -168.0 -152.71 7.72 Favored Glycine 0 CA--C 1.533 1.172 0 CA-C-O 119.096 -0.836 . . . . 72.41 112.561 179.485 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 37.5 Cg_exo -61.79 135.39 55.78 Favored 'Trans proline' 0 C--N 1.379 2.167 0 C-N-CA 123.116 2.544 . . . . 63.45 112.898 -178.275 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 67.1 t30 66.06 9.75 6.47 Favored 'General case' 0 N--CA 1.49 1.535 0 C-N-CA 125.211 1.404 . . . . 73.54 111.852 -179.736 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 107' ' ' THR . . . . . 0.749 ' HA ' ' HD2' ' A' ' 82' ' ' LYS . 2.2 m -111.35 8.68 21.43 Favored 'General case' 0 CA--C 1.555 1.167 0 C-N-CA 124.174 0.989 . . . . 50.24 109.857 179.415 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 108' ' ' ASN . . . . . 0.51 ' HA ' ' HB3' ' A' ' 102' ' ' ASN . 8.8 t30 -70.66 145.18 50.78 Favored 'General case' 0 N--CA 1.475 0.795 0 C-N-CA 124.599 1.16 . . . . 74.42 110.268 175.135 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 109' ' ' GLY . . . . . 0.437 ' O ' ' HA ' ' A' ' 76' ' ' LYS . . . 109.99 25.12 5.49 Favored Glycine 0 N--CA 1.468 0.778 0 C-N-CA 121.568 -0.349 . . . . 50.24 112.565 178.897 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 28.4 p -131.46 118.5 20.29 Favored 'General case' 0 CA--C 1.54 0.562 0 N-CA-C 108.735 -0.839 . . . . 75.2 108.735 177.46 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 111' ' ' GLN . . . . . 0.437 ' HB2' ' HB3' ' A' ' 101' ' ' ALA . 49.7 mt-30 59.15 -175.74 0.09 Allowed 'General case' 0 N--CA 1.497 1.898 0 C-N-CA 123.724 0.81 . . . . 53.02 112.14 -173.897 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 112' ' ' PHE . . . . . 0.475 ' HA ' ' HA ' ' A' ' 100' ' ' MET . 42.6 p90 -151.64 151.7 31.85 Favored 'General case' 0 N--CA 1.484 1.241 0 N-CA-C 108.284 -1.006 . . . . 73.22 108.284 176.748 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 113' ' ' PHE . . . . . 0.708 ' HB2' ' SD ' ' A' ' 61' ' ' MET . 51.0 p90 -140.16 137.77 34.66 Favored 'General case' 0 N--CA 1.478 0.946 0 CA-C-O 121.27 0.557 . . . . 71.52 111.803 -176.568 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 114' ' ' ILE . . . . . . . . . . . . . 11.0 mt -110.09 102.52 14.1 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.663 0 C-N-CA 124.904 1.282 . . . . 72.55 108.093 -178.358 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 115' ' ' CYS . . . . . 0.453 ' HB2' ' HB ' ' A' ' 97' ' ' ILE . 56.9 m -64.83 105.26 0.97 Allowed 'General case' 0 CA--C 1.548 0.894 0 C-N-CA 123.208 0.603 . . . . 72.12 109.765 177.125 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 60.2 p -70.78 -32.01 68.99 Favored 'General case' 0 N--CA 1.476 0.844 0 C-N-CA 124.367 1.067 . . . . 65.43 110.803 -177.584 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -119.89 168.87 10.69 Favored 'General case' 0 C--O 1.247 0.946 0 C-N-CA 124.26 1.024 . . . . 30.42 108.824 169.499 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 17.5 ptmt -66.84 128.43 36.27 Favored 'General case' 0 N--CA 1.473 0.683 0 N-CA-C 109.268 -0.642 . . . . 74.53 109.268 173.462 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 119' ' ' THR . . . . . . . . . . . . . 27.0 p -131.9 84.17 2.14 Favored 'General case' 0 CA--C 1.541 0.606 0 CA-C-O 121.562 0.696 . . . . 72.05 109.15 -177.533 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 12.6 pt-20 -77.52 -15.45 59.27 Favored 'General case' 0 N--CA 1.481 1.115 0 CA-C-N 115.791 -0.64 . . . . 65.25 111.799 -172.275 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 121' ' ' TRP . . . . . . . . . . . . . 48.9 p90 -74.93 -5.05 41.71 Favored 'General case' 0 N--CA 1.478 0.928 0 C-N-CA 122.333 0.253 . . . . 73.11 111.146 174.709 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 122' ' ' LEU . . . . . 0.413 HD22 ' HB2' ' B' ' 220' ' ' PRO . 23.0 mt -94.66 8.01 43.82 Favored 'General case' 0 N--CA 1.472 0.671 0 C-N-CA 123.169 0.588 . . . . 73.51 110.89 172.949 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 53.0 m-20 -77.25 122.75 25.5 Favored 'General case' 0 CA--C 1.537 0.471 0 N-CA-C 107.475 -1.305 . . . . 64.34 107.475 168.935 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 112.88 -25.26 11.85 Favored Glycine 0 C--N 1.343 0.917 0 N-CA-C 111.185 -0.766 . . . . 74.4 111.185 -165.703 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 32.4 mmmt -72.84 -164.24 0.16 Allowed 'General case' 0 N--CA 1.489 1.499 0 C-N-CA 123.848 0.859 . . . . 65.13 109.741 167.734 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 126' ' ' HIS . . . . . . . . . . . . . 50.8 t60 -66.77 144.67 56.19 Favored 'General case' 0 CA--C 1.551 1.014 0 CA-C-O 121.082 0.468 . . . . 73.31 110.817 178.543 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 26.1 t -62.72 139.06 21.73 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.838 0 CA-C-N 114.605 -1.18 . . . . 72.43 111.194 179.595 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 49.4 t -68.18 143.38 15.31 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.739 0 N-CA-C 109.17 -0.678 . . . . 64.21 109.17 172.687 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 129' ' ' PHE . . . . . 0.451 ' HA ' HG21 ' A' ' 29' ' ' VAL . 35.9 p90 -132.81 -8.3 3.14 Favored 'General case' 0 N--CA 1.478 0.963 0 O-C-N 121.987 -0.446 . . . . 75.51 111.43 179.46 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . -151.02 171.98 30.68 Favored Glycine 0 C--N 1.34 0.772 0 O-C-N 123.473 0.483 . . . . 65.44 112.557 -175.883 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 32.2 ttpt -154.88 122.41 5.69 Favored 'General case' 0 C--O 1.236 0.384 0 N-CA-C 108.161 -1.052 . . . . 74.41 108.161 177.423 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 132' ' ' VAL . . . . . 0.451 ' HA ' ' HA ' ' A' ' 22' ' ' PHE . 3.0 p -61.44 107.73 0.44 Allowed 'Isoleucine or valine' 0 CA--C 1.551 1.01 0 CA-C-O 121.885 0.85 . . . . 74.11 110.404 178.505 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -80.9 -36.48 31.11 Favored 'General case' 0 CA--C 1.547 0.832 0 CA-C-N 114.821 -1.081 . . . . 72.31 110.385 -177.595 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 50.8 mt-10 -137.66 147.04 44.57 Favored 'General case' 0 N--CA 1.483 1.218 0 C-N-CA 124.766 1.226 . . . . 74.32 108.794 -178.734 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 80.15 14.92 79.78 Favored Glycine 0 C--N 1.344 0.982 0 O-C-N 123.208 0.318 . . . . 52.41 113.038 -177.602 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 136' ' ' MET . . . . . . . . . . . . . 12.9 tpt -65.23 -40.83 94.6 Favored 'General case' 0 N--CA 1.473 0.683 0 C-N-CA 123.482 0.713 . . . . 71.41 110.198 174.339 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 137' ' ' ASN . . . . . . . . . . . . . 17.7 m120 -59.35 -35.34 73.69 Favored 'General case' 0 N--CA 1.481 1.081 0 C-N-CA 123.384 0.673 . . . . 74.2 111.427 176.246 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 138' ' ' ILE . . . . . 0.554 ' O ' ' HG3' ' A' ' 142' ' ' MET . 36.4 mm -60.25 -56.27 18.68 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.834 0 N-CA-C 109.277 -0.638 . . . . 74.24 109.277 172.998 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 91.3 t -54.81 -42.72 63.93 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.445 0 C-N-CA 124.21 1.004 . . . . 73.01 111.727 -175.857 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 46.1 mt-10 -67.38 -36.48 81.42 Favored 'General case' 0 N--CA 1.483 1.187 0 C-N-CA 123.824 0.849 . . . . 73.32 111.101 179.676 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -71.63 -25.05 61.99 Favored 'General case' 0 N--CA 1.478 0.973 0 CA-C-N 115.932 -0.577 . . . . 65.32 111.756 175.231 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 142' ' ' MET . . . . . 0.554 ' HG3' ' O ' ' A' ' 138' ' ' ILE . 35.4 mtp -83.52 -22.9 32.31 Favored 'General case' 0 N--CA 1.485 1.282 0 C-N-CA 122.701 0.4 . . . . 63.32 111.172 178.351 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 143' ' ' GLU . . . . . 0.456 ' HA ' HG21 ' A' ' 56' ' ' ILE . 37.5 tt0 -63.44 -25.46 68.28 Favored 'General case' 0 CA--C 1.547 0.852 0 O-C-N 123.786 0.679 . . . . 75.23 110.935 174.025 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 144' ' ' ARG . . . . . . . . . . . . . 51.2 mtp85 -67.82 -18.82 64.96 Favored 'General case' 0 CA--C 1.547 0.847 0 C-N-CA 123.944 0.898 . . . . 73.34 111.916 178.384 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 145' ' ' PHE . . . . . . . . . . . . . 89.9 m-85 -85.47 -21.22 28.8 Favored 'General case' 0 N--CA 1.48 1.037 0 C-N-CA 123.135 0.574 . . . . 71.32 110.793 175.003 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . -73.33 169.83 52.84 Favored Glycine 0 C--N 1.35 1.308 0 N-CA-C 114.135 0.414 . . . . 70.3 114.135 -177.439 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 15.2 m -131.68 165.32 23.97 Favored 'General case' 0 N--CA 1.484 1.242 0 C-N-CA 124.356 1.063 . . . . 75.32 110.418 -176.444 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 148' ' ' ARG . . . . . . . . . . . . . 15.2 mmm180 -60.6 -38.57 85.13 Favored 'General case' 0 N--CA 1.485 1.305 0 C-N-CA 124.135 0.974 . . . . 75.01 111.901 -177.435 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 149' ' ' ASN . . . . . . . . . . . . . 26.6 p-10 -80.08 -7.34 58.83 Favored 'General case' 0 N--CA 1.481 1.099 0 C-N-CA 123.629 0.772 . . . . 73.31 111.857 179.784 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 150' ' ' GLY . . . . . 0.414 ' O ' ' HA ' ' A' ' 55' ' ' ARG . . . 102.41 -4.06 50.92 Favored Glycine 0 C--N 1.348 1.202 0 CA-C-O 119.648 -0.529 . . . . 75.22 113.381 -179.434 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 87.0 tttt -64.54 134.62 54.77 Favored 'General case' 0 N--CA 1.476 0.87 0 CA-C-N 117.573 0.686 . . . . 73.22 110.607 -179.733 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 152' ' ' THR . . . . . . . . . . . . . 67.4 p -95.2 126.2 40.37 Favored 'General case' 0 C--O 1.242 0.669 0 N-CA-C 108.57 -0.9 . . . . 64.15 108.57 170.168 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 153' ' ' SER . . . . . . . . . . . . . 38.8 t -60.02 -42.34 94.13 Favored 'General case' 0 N--CA 1.477 0.893 0 C-N-CA 123.568 0.747 . . . . 74.41 109.766 178.152 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 28.6 mmtp -114.69 154.54 28.27 Favored 'General case' 0 C--O 1.242 0.687 0 CA-C-N 114.928 -1.033 . . . . 53.41 109.96 179.784 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 57.1 tptt -78.15 89.59 4.25 Favored 'General case' 0 CA--C 1.54 0.59 0 N-CA-C 109.04 -0.726 . . . . 75.33 109.04 179.879 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 156' ' ' ILE . . . . . 0.423 HG23 ' HE1' ' A' ' 142' ' ' MET . 64.1 mt -84.37 116.12 27.56 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.488 0 N-CA-C 108.974 -0.75 . . . . 63.45 108.974 -176.034 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 157' ' ' THR . . . . . . . . . . . . . 50.5 p -120.41 159.97 24.03 Favored 'General case' 0 N--CA 1.479 1.018 0 C-N-CA 124.242 1.017 . . . . 64.12 110.288 -176.063 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 158' ' ' ILE . . . . . 0.514 HD12 ' HB2' ' A' ' 51' ' ' SER . 60.3 mt -87.82 100.05 9.64 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.647 0 N-CA-C 107.337 -1.357 . . . . 75.23 107.337 164.768 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 159' ' ' ALA . . . . . 0.495 ' HB2' ' HB2' ' A' ' 11' ' ' ALA . . . -57.56 -50.81 71.87 Favored 'General case' 0 N--CA 1.474 0.756 0 C-N-CA 124.193 0.997 . . . . 71.11 111.814 -177.686 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 160' ' ' ASP . . . . . . . . . . . . . 1.8 t70 -148.75 -179.15 6.77 Favored 'General case' 0 N--CA 1.48 1.049 0 CA-C-N 116.712 -0.222 . . . . 65.42 111.46 -174.049 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 161' ' ' CYS . . . . . . . . . . . . . 26.8 p -154.11 -169.07 3.14 Favored 'General case' 0 N--CA 1.475 0.816 0 C-N-CA 124.659 1.183 . . . . 62.41 108.992 -176.208 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 162' ' ' GLY . . . . . . . . . . . . . . . 136.46 53.11 0.06 OUTLIER Glycine 0 N--CA 1.475 1.287 0 N-CA-C 111.53 -0.628 . . . . 55.2 111.53 -166.056 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 163' ' ' GLN . . . . . 0.56 ' HG3' ' HA ' ' A' ' 6' ' ' VAL . 30.3 tt0 -45.8 117.43 1.48 Allowed 'General case' 0 N--CA 1.476 0.83 0 C-N-CA 126.588 1.955 . . . . 74.11 112.434 -179.869 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 164' ' ' LEU . . . . . . . . . . . . . 78.1 mt . . . . . 0 N--CA 1.466 0.343 0 N-CA-C 107.974 -1.121 . . . . 72.42 107.974 179.935 . . . . . . . . 0 0 . 1 . 004 nuclear build core ' B' B ' 218' ' ' PRO . . . . . . . . . . . . . 86.3 Cg_endo . . . . . 0 CA--C 1.55 1.296 0 CA-C-O 121.626 0.594 . . . . 71.12 111.611 . . . . . . . . . 0 0 . 1 . 004 nuclear build core ' B' B ' 219' ' ' GLY . . . . . . . . . . . . . . . 171.73 -169.7 42.74 Favored Glycine 0 CA--C 1.531 1.093 0 CA-C-N 115.586 -0.734 . . . . 61.43 113.196 179.75 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 220' ' ' PRO . . . . . 0.413 ' HB2' HD22 ' A' ' 122' ' ' LEU . 87.4 Cg_endo -76.37 159.16 36.56 Favored 'Trans proline' 0 C--N 1.368 1.604 0 C-N-CA 123.999 3.133 . . . . 73.21 114.128 177.067 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 221' ' ' TYR . . . . . . . . . . . . . 66.3 m-85 . . . . . 0 N--CA 1.491 1.601 0 C-N-CA 123.49 0.716 . . . . 62.45 111.876 -176.907 . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 15.2 m120 . . . . . 0 CA--C 1.549 0.928 0 N-CA-C 111.731 0.271 . . . . 62.32 111.731 . . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 4' ' ' PRO . . . . . 0.474 ' HG2' ' HB2' ' A' ' 24' ' ' LEU . 59.9 Cg_endo -73.69 146.41 38.49 Favored 'Trans proline' 0 C--N 1.374 1.871 0 C-N-CA 122.376 2.051 . . . . 62.11 111.403 166.232 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 5' ' ' THR . . . . . 0.486 ' HB ' ' O ' ' A' ' 164' ' ' LEU . 84.2 m -96.7 135.92 37.95 Favored 'General case' 0 CA--C 1.536 0.423 0 C-N-CA 123.344 0.658 . . . . 73.14 109.29 177.736 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 6' ' ' VAL . . . . . 0.475 ' HB ' ' HB2' ' A' ' 22' ' ' PHE . 23.3 t -100.19 147.08 7.96 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.485 0 N-CA-C 107.831 -1.174 . . . . 75.12 107.831 176.25 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 7' ' ' PHE . . . . . 0.439 ' H ' ' HA ' ' A' ' 163' ' ' GLN . 45.7 t80 -126.73 120.73 30.1 Favored 'General case' 0 C--O 1.237 0.412 0 N-CA-C 109.093 -0.706 . . . . 71.31 109.093 175.951 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 8' ' ' PHE . . . . . 0.402 ' HD2' ' HE2' ' A' ' 22' ' ' PHE . 30.6 m-85 -129.86 166.2 20.46 Favored 'General case' 0 N--CA 1.47 0.556 0 C-N-CA 123.864 0.865 . . . . 63.53 109.008 165.925 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 24.8 m-20 -117.82 122.9 44.6 Favored 'General case' 0 N--CA 1.466 0.349 0 N-CA-C 107.641 -1.244 . . . . 74.51 107.641 169.903 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 46.5 mm -87.2 124.41 40.63 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.509 0 N-CA-C 108.914 -0.772 . . . . 50.43 108.914 178.955 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 11' ' ' ALA . . . . . 0.851 ' HB2' ' HB2' ' A' ' 159' ' ' ALA . . . -118.82 128.13 54.17 Favored 'General case' 0 N--CA 1.469 0.483 0 C-N-CA 123.599 0.759 . . . . 63.14 110.695 -174.882 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 12' ' ' VAL . . . . . 0.467 HG13 ' HB3' ' A' ' 154' ' ' LYS . 96.0 t -95.81 107.91 20.33 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.48 0 N-CA-C 107.819 -1.178 . . . . 71.3 107.819 173.696 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 29.0 m-20 64.72 25.24 12.98 Favored 'General case' 0 N--CA 1.485 1.301 0 C-N-CA 125.284 1.434 . . . . 63.03 111.97 -175.926 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 87.24 1.36 84.22 Favored Glycine 0 C--N 1.348 1.249 0 CA-C-N 116.377 -0.374 . . . . 64.13 113.186 -177.061 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 17.5 mm-40 -94.46 113.49 61.07 Favored Pre-proline 0 CA--C 1.543 0.679 0 N-CA-C 108.584 -0.895 . . . . 54.42 108.584 175.125 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 26.4 Cg_endo -59.89 106.31 0.32 Allowed 'Trans proline' 0 C--N 1.38 2.197 0 C-N-CA 122.627 2.218 . . . . 73.31 112.181 -175.879 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 47.2 tp -75.49 -34.43 60.86 Favored 'General case' 0 N--CA 1.476 0.834 0 C-N-CA 124.178 0.991 . . . . 60.03 109.42 -179.348 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 178.47 177.44 47.15 Favored Glycine 0 C--N 1.343 0.919 0 CA-C-N 115.574 -0.739 . . . . 62.43 113.29 175.748 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 37.4 ptt85 -107.26 136.1 47.65 Favored 'General case' 0 C--O 1.24 0.584 0 C-N-CA 124.3 1.04 . . . . 75.2 108.998 177.05 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 20' ' ' VAL . . . . . 0.467 ' HA ' ' HA3' ' A' ' 135' ' ' GLY . 33.2 t -127.2 134.35 66.14 Favored 'Isoleucine or valine' 0 C--O 1.243 0.721 0 C-N-CA 123.122 0.569 . . . . 54.41 109.96 -178.856 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 21' ' ' SER . . . . . 0.453 ' HA ' ' O ' ' A' ' 6' ' ' VAL . 50.8 p -114.23 124.28 51.65 Favored 'General case' 0 CA--C 1.55 0.976 0 C-N-CA 123.83 0.852 . . . . 75.31 109.769 175.75 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 22' ' ' PHE . . . . . 0.475 ' HB2' ' HB ' ' A' ' 6' ' ' VAL . 60.7 m-85 -101.83 170.14 8.34 Favored 'General case' 0 N--CA 1.477 0.883 0 C-N-CA 123.903 0.881 . . . . 74.22 110.496 -179.962 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 35.0 tt0 -134.91 102.88 5.38 Favored 'General case' 0 N--CA 1.476 0.875 0 C-N-CA 123.649 0.78 . . . . 71.21 109.817 -175.225 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 24' ' ' LEU . . . . . 0.474 ' HB2' ' HG2' ' A' ' 4' ' ' PRO . 48.1 mt -82.02 131.78 35.25 Favored 'General case' 0 N--CA 1.478 0.97 0 C-N-CA 122.966 0.506 . . . . 73.32 110.423 -179.807 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 52.7 m-85 -86.93 69.06 10.24 Favored 'General case' 0 N--CA 1.469 0.506 0 N-CA-C 108.856 -0.794 . . . . 65.44 108.856 175.188 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -66.52 -12.89 59.8 Favored 'General case' 0 N--CA 1.483 1.184 0 CA-C-N 115.418 -0.81 . . . . 64.25 112.497 -175.114 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 11.1 p-10 -85.33 -34.85 21.75 Favored 'General case' 0 CA--C 1.545 0.756 0 C-N-CA 123.694 0.798 . . . . 74.11 111.482 175.323 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 96.7 mttt -93.83 -33.48 13.53 Favored 'General case' 0 N--CA 1.489 1.496 0 C-N-CA 123.099 0.56 . . . . 72.35 111.903 -172.709 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 29' ' ' VAL . . . . . 0.566 HG21 ' HA ' ' A' ' 129' ' ' PHE . 4.4 m -135.92 69.36 64.65 Favored Pre-proline 0 N--CA 1.481 1.103 0 C-N-CA 123.873 0.869 . . . . 71.41 109.07 177.45 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 37.1 Cg_exo -58.11 -35.28 98.87 Favored 'Trans proline' 0 C--N 1.381 2.26 0 C-N-CA 122.79 2.327 . . . . 73.2 113.42 -173.04 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 87.8 tttt -69.85 -50.27 44.27 Favored 'General case' 0 N--CA 1.472 0.664 0 C-N-CA 123.67 0.788 . . . . 52.21 111.776 -178.341 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 7.4 m -73.61 -29.6 62.48 Favored 'General case' 0 CA--C 1.556 1.211 0 C-N-CA 122.975 0.51 . . . . 73.41 111.113 -172.637 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -77.26 -36.01 54.8 Favored 'General case' 0 CA--C 1.547 0.855 0 C-N-CA 123.379 0.672 . . . . 74.14 110.875 175.46 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 12.2 tp10 -60.62 -42.87 97.71 Favored 'General case' 0 N--CA 1.488 1.46 0 C-N-CA 124.041 0.937 . . . . 63.43 109.942 175.102 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 35' ' ' ASN . . . . . 0.461 ' O ' ' HG ' ' A' ' 39' ' ' LEU . 43.3 t30 -55.58 -60.33 3.59 Favored 'General case' 0 C--N 1.347 0.498 0 CA-C-N 113.75 -1.568 . . . . 73.25 110.892 177.997 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 70.0 t80 -62.19 -34.12 75.83 Favored 'General case' 0 N--CA 1.471 0.618 0 O-C-N 124.361 1.038 . . . . 61.51 111.574 -174.838 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 42.1 ttp180 -64.99 -44.19 90.1 Favored 'General case' 0 C--N 1.348 0.512 0 O-C-N 123.605 0.566 . . . . 70.35 110.841 177.278 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 38' ' ' ALA . . . . . 0.541 ' HB3' HG21 ' A' ' 78' ' ' ILE . . . -73.65 -26.02 60.56 Favored 'General case' 0 N--CA 1.475 0.785 0 C-N-CA 122.896 0.479 . . . . 51.55 111.568 -178.875 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 39' ' ' LEU . . . . . 0.577 HD22 ' HE1' ' A' ' 48' ' ' TYR . 90.3 mt -68.78 -40.16 79.8 Favored 'General case' 0 CA--C 1.549 0.912 0 C-N-CA 123.705 0.802 . . . . 73.22 109.911 172.693 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 47.2 t -71.7 -51.29 23.73 Favored 'General case' 0 N--CA 1.476 0.856 0 C-N-CA 124.311 1.044 . . . . 73.13 111.329 -178.334 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 53.1 p -72.42 -31.4 65.46 Favored 'General case' 0 N--CA 1.471 0.612 0 C-N-CA 123.703 0.801 . . . . 44.04 111.652 -175.917 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 79.03 21.93 66.9 Favored Glycine 0 C--N 1.346 1.124 0 CA-C-N 115.895 -0.593 . . . . 63.14 113.794 178.151 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 30.9 mm-40 -62.08 -31.33 71.75 Favored 'General case' 0 N--CA 1.477 0.897 0 C-N-CA 123.302 0.641 . . . . 73.21 110.707 174.213 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 44' ' ' LYS . . . . . 0.444 ' HG2' ' HB1' ' A' ' 38' ' ' ALA . 30.5 mmmt -95.74 19.4 11.33 Favored 'General case' 0 CA--C 1.544 0.717 0 C-N-CA 123.896 0.878 . . . . 72.04 111.853 179.957 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 85.83 -9.65 68.01 Favored Glycine 0 C--N 1.353 1.508 0 N-CA-C 114.994 0.757 . . . . 73.35 114.994 170.802 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 46' ' ' PHE . . . . . 0.411 ' HE2' ' HA ' ' A' ' 78' ' ' ILE . 22.3 m-85 -86.45 -50.23 7.03 Favored 'General case' 0 N--CA 1.478 0.956 0 CA-C-N 118.064 0.932 . . . . 74.42 111.473 -170.453 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 44.98 65.12 1.93 Allowed Glycine 0 C--N 1.361 1.946 0 O-C-N 124.634 1.209 . . . . 64.13 115.172 169.824 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 48' ' ' TYR . . . . . 0.577 ' HE1' HD22 ' A' ' 39' ' ' LEU . 79.3 m-85 -60.07 86.09 0.01 OUTLIER 'General case' 0 N--CA 1.487 1.383 0 CA-C-O 122.241 1.019 . . . . 72.34 111.903 -173.731 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 27.6 tptp -114.72 128.49 56.34 Favored 'General case' 0 C--O 1.239 0.527 0 CA-C-N 113.376 -1.738 . . . . 74.13 108.515 -178.865 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 63.35 20.55 63.37 Favored Glycine 0 N--CA 1.476 1.317 0 O-C-N 123.255 0.347 . . . . 63.02 112.708 -173.321 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 27.0 t -76.12 123.73 26.28 Favored 'General case' 0 C--N 1.346 0.456 0 C-N-CA 123.119 0.567 . . . . 75.2 110.575 -171.137 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 52' ' ' CYS . . . . . 0.457 ' SG ' ' HD3' ' A' ' 155' ' ' LYS . 51.5 t -81.45 161.86 23.52 Favored 'General case' 0 CA--C 1.539 0.53 0 O-C-N 123.967 0.792 . . . . 70.5 112.537 -171.631 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 12.7 m-85 -111.67 131.47 55.27 Favored 'General case' 0 CA--C 1.537 0.465 0 N-CA-C 107.068 -1.456 . . . . 74.44 107.068 169.544 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 47.9 p-80 -114.18 -29.35 6.98 Favored 'General case' 0 N--CA 1.496 1.866 0 CA-C-N 118.695 0.68 . . . . 74.21 112.348 -174.016 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 55' ' ' ARG . . . . . 0.413 ' HB3' ' HG2' ' A' ' 63' ' ' GLN . 42.6 ttt-85 -119.62 98.29 6.05 Favored 'General case' 0 N--CA 1.473 0.724 0 N-CA-C 108.544 -0.91 . . . . 74.54 108.544 -176.603 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 59.5 mt -130.27 127.96 63.57 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.614 0 C-N-CA 123.807 0.843 . . . . 63.33 108.974 179.825 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 61.4 mt -127.83 118.88 21.12 Favored Pre-proline 0 CA--C 1.553 1.078 0 N-CA-C 108.189 -1.041 . . . . 72.14 108.189 176.848 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 58' ' ' PRO . . . . . 0.482 ' HB3' ' HA ' ' A' ' 144' ' ' ARG . 64.0 Cg_endo -70.35 139.02 37.24 Favored 'Trans proline' 0 C--N 1.379 2.154 0 C-N-CA 123.163 2.576 . . . . 73.24 111.98 -174.028 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 79.0 24.41 61.83 Favored Glycine 0 C--N 1.338 0.645 0 CA-C-N 115.204 -0.907 . . . . 31.14 112.325 -175.728 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 27.9 t80 -150.34 -76.87 0.14 Allowed 'General case' 0 CA--C 1.544 0.724 0 C-N-CA 123.778 0.831 . . . . 72.4 109.884 179.356 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 38.7 ttp -166.98 150.46 6.65 Favored 'General case' 0 N--CA 1.485 1.306 0 CA-C-O 120.912 0.386 . . . . 65.42 111.781 -164.412 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 62' ' ' CYS . . . . . . . . . . . . . 4.9 p -127.83 120.86 28.71 Favored 'General case' 0 N--CA 1.478 0.932 0 C-N-CA 124.829 1.251 . . . . 64.55 109.57 176.552 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 63' ' ' GLN . . . . . 0.413 ' HG2' ' HB3' ' A' ' 55' ' ' ARG . 14.2 pt20 -128.26 144.97 51.18 Favored 'General case' 0 N--CA 1.491 1.62 0 CA-C-O 121.428 0.632 . . . . 73.01 112.375 -176.156 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -163.61 -147.27 5.01 Favored Glycine 0 C--N 1.348 1.227 0 CA-C-N 114.406 -1.27 . . . . 52.14 113.556 -174.609 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 90.66 12.32 61.01 Favored Glycine 0 C--N 1.345 1.062 0 N-CA-C 110.588 -1.005 . . . . 52.14 110.588 -161.878 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 38.9 t70 -61.69 -43.64 98.47 Favored 'General case' 0 N--CA 1.472 0.66 0 C-N-CA 125.313 1.445 . . . . 74.53 112.543 -162.085 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 50.2 t80 -49.37 -36.77 22.61 Favored 'General case' 0 CA--C 1.552 1.042 0 O-C-N 124.598 1.186 . . . . 72.25 112.695 -170.236 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 54.3 m -88.11 108.23 19.15 Favored 'General case' 0 CA--C 1.545 0.782 0 C-N-CA 122.957 0.503 . . . . 71.31 110.522 176.147 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 31.8 mtp180 58.73 53.87 5.64 Favored 'General case' 0 N--CA 1.479 0.993 0 C-N-CA 124.963 1.305 . . . . 73.32 111.657 172.797 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 10.0 p80 -63.34 -13.17 36.16 Favored 'General case' 0 N--CA 1.482 1.172 0 N-CA-C 114.233 1.197 . . . . 74.35 114.233 -173.874 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 6.6 t30 -68.61 84.84 0.29 Allowed 'General case' 0 CA--C 1.552 1.049 0 C-N-CA 123.253 0.621 . . . . 65.14 110.159 179.163 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 64.47 13.95 56.19 Favored Glycine 0 C--N 1.353 1.506 0 N-CA-C 115.62 1.008 . . . . 54.31 115.62 176.397 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 73' ' ' THR . . . . . 0.406 ' O ' ' HG3' ' A' ' 111' ' ' GLN . 6.9 m -125.0 -68.01 0.87 Allowed 'General case' 0 N--CA 1.476 0.851 0 N-CA-C 109.188 -0.671 . . . . 72.24 109.188 -178.228 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 57.3 50.45 64.59 Favored Glycine 0 C--N 1.353 1.515 0 O-C-N 124.559 1.162 . . . . 74.31 115.141 171.66 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 128.83 50.81 0.13 Allowed Glycine 0 C--N 1.35 1.335 0 CA-C-N 117.833 0.817 . . . . 54.44 113.281 178.837 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 14.1 ptmm? -64.27 165.6 9.26 Favored 'General case' 0 N--CA 1.482 1.15 0 C-N-CA 123.133 0.573 . . . . 73.43 112.338 -179.042 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 84.0 p -92.77 173.8 7.58 Favored 'General case' 0 N--CA 1.472 0.655 0 CA-C-N 115.893 -0.594 . . . . 72.44 111.392 -172.811 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 78' ' ' ILE . . . . . 0.541 HG21 ' HB3' ' A' ' 38' ' ' ALA . 23.1 pt -81.0 -20.99 11.13 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.609 0 CA-C-N 115.856 -0.611 . . . . 74.54 109.877 172.638 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 79' ' ' TYR . . . . . 0.427 ' HE2' ' HB2' ' A' ' 35' ' ' ASN . 64.0 m-85 -86.62 12.53 10.37 Favored 'General case' 0 CA--C 1.546 0.821 0 C-N-CA 123.767 0.827 . . . . 71.22 110.134 175.683 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 121.17 -152.5 16.79 Favored Glycine 0 C--N 1.354 1.549 0 C-N-CA 123.126 0.393 . . . . 62.02 112.784 171.203 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 34.3 tt0 -52.13 -53.24 45.21 Favored 'General case' 0 N--CA 1.471 0.597 0 C-N-CA 124.816 1.246 . . . . 72.45 109.396 171.993 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 82' ' ' LYS . . . . . 0.676 ' HD2' ' HA ' ' A' ' 107' ' ' THR . 20.7 pttp -169.52 156.06 6.46 Favored 'General case' 0 CA--C 1.548 0.888 0 CA-C-N 114.549 -1.205 . . . . 62.13 109.697 -178.319 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 9.7 p90 -131.68 174.78 9.77 Favored 'General case' 0 N--CA 1.48 1.029 0 C-N-CA 124.341 1.056 . . . . 65.21 110.57 -179.943 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 84' ' ' GLU . . . . . 0.542 ' HA ' ' HA ' ' A' ' 106' ' ' ASN . 0.0 OUTLIER -70.98 168.68 16.51 Favored 'General case' 0 N--CA 1.479 0.992 0 CA-C-N 115.759 -0.655 . . . . 73.14 111.582 -179.483 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 56.6 m-20 -80.58 111.39 16.95 Favored 'General case' 0 N--CA 1.47 0.571 0 N-CA-C 108.289 -1.004 . . . . 74.15 108.289 173.839 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 3.9 tp10 -46.98 -53.27 12.73 Favored 'General case' 0 N--CA 1.481 1.097 0 C-N-CA 124.895 1.278 . . . . 73.45 112.636 -175.0 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 87' ' ' ASN . . . . . 0.409 ' OD1' HG21 ' A' ' 127' ' ' VAL . 32.3 p30 -159.6 -165.62 1.58 Allowed 'General case' 0 N--CA 1.473 0.683 0 C-N-CA 123.62 0.768 . . . . 73.13 109.589 -176.17 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 93.7 m-85 -137.27 29.8 2.72 Favored 'General case' 0 N--CA 1.485 1.284 0 C-N-CA 123.868 0.867 . . . . 52.53 110.274 176.004 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 65.9 mt -60.07 -49.77 82.77 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.247 0 CA-C-O 121.866 0.841 . . . . 75.31 109.791 176.482 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 90' ' ' LEU . . . . . 0.622 ' HB3' ' HB ' ' A' ' 128' ' ' VAL . 92.3 mt -96.23 99.63 11.33 Favored 'General case' 0 C--O 1.237 0.436 0 CA-C-N 114.565 -1.198 . . . . 63.45 110.102 -175.969 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 8.7 mtpm? -76.31 149.7 37.02 Favored 'General case' 0 CA--C 1.543 0.69 0 C-N-CA 123.567 0.747 . . . . 75.1 110.204 176.771 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 92' ' ' HIS . . . . . . . . . . . . . 18.2 t-80 -87.43 28.45 0.97 Allowed 'General case' 0 N--CA 1.482 1.126 0 C-N-CA 124.21 1.004 . . . . 70.53 111.368 -169.412 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 14.5 t -99.87 16.46 23.69 Favored 'General case' 0 CA--C 1.552 1.051 0 C-N-CA 123.819 0.848 . . . . 60.21 111.628 -166.996 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -113.17 161.12 12.79 Favored Glycine 0 CA--C 1.534 1.255 0 CA-C-O 119.443 -0.643 . . . . 72.52 112.1 176.937 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 86.7 Cg_endo -83.4 154.2 14.04 Favored 'Trans proline' 0 C--N 1.367 1.544 0 C-N-CA 122.816 2.344 . . . . 74.54 111.957 171.408 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 71.12 19.76 77.49 Favored Glycine 0 C--N 1.35 1.312 0 N-CA-C 113.8 0.28 . . . . 50.33 113.8 -179.944 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 97' ' ' ILE . . . . . 0.429 HG23 HG13 ' A' ' 128' ' ' VAL . 24.6 mm -77.27 125.15 36.81 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.808 0 C-N-CA 123.231 0.612 . . . . 75.21 112.042 -175.65 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 98' ' ' LEU . . . . . 0.68 ' HG ' HG12 ' A' ' 114' ' ' ILE . 7.3 mp -93.11 123.2 36.21 Favored 'General case' 0 C--O 1.241 0.612 0 C-N-CA 123.709 0.804 . . . . 72.44 109.735 168.038 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 25.9 m -139.96 144.14 36.9 Favored 'General case' 0 N--CA 1.474 0.747 0 N-CA-C 107.737 -1.209 . . . . 61.33 107.737 168.876 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 100' ' ' MET . . . . . 0.549 ' HA ' ' HA ' ' A' ' 112' ' ' PHE . 72.1 mtp -75.44 142.28 43.02 Favored 'General case' 0 N--CA 1.482 1.157 0 N-CA-C 108.842 -0.799 . . . . 74.12 108.842 177.668 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 101' ' ' ALA . . . . . 0.631 ' HB3' ' HB2' ' A' ' 111' ' ' GLN . . . -73.97 140.32 45.45 Favored 'General case' 0 C--O 1.24 0.58 0 CA-C-O 121.362 0.601 . . . . 63.11 112.343 -166.805 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 28.6 p-10 -151.8 154.7 36.73 Favored 'General case' 0 C--O 1.237 0.398 0 CA-C-N 114.734 -1.121 . . . . 65.14 109.416 179.444 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -105.27 5.45 32.02 Favored 'General case' 0 CA--C 1.537 0.46 0 CA-C-N 115.538 -0.755 . . . . 75.15 110.261 170.589 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 162.07 -174.3 38.51 Favored Glycine 0 C--N 1.35 1.317 0 CA-C-O 119.661 -0.521 . . . . 53.44 112.387 179.577 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 77.5 Cg_exo -55.39 138.92 81.26 Favored 'Trans proline' 0 C--N 1.374 1.883 0 C-N-CA 123.663 2.909 . . . . 72.03 113.218 175.219 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 106' ' ' ASN . . . . . 0.542 ' HA ' ' HA ' ' A' ' 84' ' ' GLU . 63.9 t30 68.29 10.87 8.11 Favored 'General case' 0 N--CA 1.487 1.399 0 C-N-CA 125.277 1.431 . . . . 64.52 111.64 177.826 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 107' ' ' THR . . . . . 0.676 ' HA ' ' HD2' ' A' ' 82' ' ' LYS . 3.1 m -104.65 -11.64 16.8 Favored 'General case' 0 CA--C 1.552 1.051 0 C-N-CA 123.728 0.811 . . . . 71.42 110.129 176.99 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 10.5 t30 -56.15 139.77 46.36 Favored 'General case' 0 N--CA 1.48 1.043 0 C-N-CA 124.988 1.315 . . . . 65.03 111.651 172.428 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 112.52 3.05 25.74 Favored Glycine 0 N--CA 1.471 1.026 0 CA-C-O 119.924 -0.376 . . . . 60.32 113.137 176.197 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 15.3 p -114.19 122.35 46.54 Favored 'General case' 0 CA--C 1.542 0.648 0 N-CA-C 108.395 -0.965 . . . . 73.51 108.395 172.272 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 111' ' ' GLN . . . . . 0.631 ' HB2' ' HB3' ' A' ' 101' ' ' ALA . 41.0 mt-30 66.03 168.86 0.22 Allowed 'General case' 0 N--CA 1.496 1.846 0 C-N-CA 124.746 1.218 . . . . 73.33 112.416 -175.728 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 112' ' ' PHE . . . . . 0.549 ' HA ' ' HA ' ' A' ' 100' ' ' MET . 51.4 p90 -137.02 140.47 42.12 Favored 'General case' 0 N--CA 1.476 0.827 0 N-CA-C 108.153 -1.054 . . . . 74.42 108.153 168.341 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 113' ' ' PHE . . . . . 0.409 ' HE2' ' HA ' ' A' ' 101' ' ' ALA . 54.4 p90 -128.1 150.02 50.15 Favored 'General case' 0 N--CA 1.471 0.624 0 C-N-CA 122.899 0.48 . . . . 70.35 111.832 179.881 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 114' ' ' ILE . . . . . 0.68 HG12 ' HG ' ' A' ' 98' ' ' LEU . 14.0 mt -120.95 117.9 54.52 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.654 0 CA-C-N 115.12 -0.945 . . . . 72.42 108.666 173.943 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 115' ' ' CYS . . . . . . . . . . . . . 58.8 m -94.77 110.41 22.27 Favored 'General case' 0 C--O 1.24 0.596 0 N-CA-C 108.311 -0.996 . . . . 73.41 108.311 173.891 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 116' ' ' THR . . . . . 0.459 HG21 ' HA ' ' A' ' 140' ' ' GLU . 72.5 p -71.03 -31.52 68.02 Favored 'General case' 0 N--CA 1.479 0.989 0 C-N-CA 122.51 0.324 . . . . 74.25 111.719 -175.28 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -97.25 163.67 12.81 Favored 'General case' 0 N--CA 1.479 1.004 0 N-CA-C 109.164 -0.68 . . . . 70.42 109.164 168.155 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 118' ' ' LYS . . . . . 0.47 ' HE2' ' HB3' ' A' ' 120' ' ' GLU . 0.0 OUTLIER -70.84 124.71 24.96 Favored 'General case' 0 C--N 1.347 0.466 0 N-CA-C 109.233 -0.654 . . . . 72.43 109.233 175.914 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 119' ' ' THR . . . . . 0.6 ' HB ' HD13 ' A' ' 122' ' ' LEU . 23.0 p -113.02 88.11 2.75 Favored 'General case' 0 C--O 1.238 0.462 0 CA-C-O 121.864 0.84 . . . . 73.24 109.055 179.138 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 120' ' ' GLU . . . . . 0.47 ' HB3' ' HE2' ' A' ' 118' ' ' LYS . 10.5 pt-20 -67.87 -27.16 66.44 Favored 'General case' 0 N--CA 1.478 0.965 0 CA-C-N 114.254 -1.339 . . . . 72.44 112.485 -178.009 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 121' ' ' TRP . . . . . . . . . . . . . 32.5 p90 -78.12 -1.02 30.49 Favored 'General case' 0 N--CA 1.479 1.014 0 C-N-CA 122.768 0.427 . . . . 74.32 111.113 178.49 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 122' ' ' LEU . . . . . 0.6 HD13 ' HB ' ' A' ' 119' ' ' THR . 9.3 mp -96.63 5.7 50.18 Favored 'General case' 0 N--CA 1.48 1.049 0 C-N-CA 123.904 0.882 . . . . 64.13 111.168 171.639 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 25.0 m-20 -72.62 141.12 48.33 Favored 'General case' 0 N--CA 1.481 1.09 0 N-CA-C 109.462 -0.57 . . . . 61.51 109.462 168.879 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 92.98 -28.31 9.68 Favored Glycine 0 N--CA 1.478 1.451 0 N-CA-C 111.759 -0.536 . . . . 71.3 111.759 -173.019 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 1.5 mppt? -73.65 -164.32 0.21 Allowed 'General case' 0 N--CA 1.481 1.084 0 C-N-CA 124.584 1.154 . . . . 65.25 109.538 168.585 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 126' ' ' HIS . . . . . . . . . . . . . 36.2 t60 -66.08 132.94 49.69 Favored 'General case' 0 CA--C 1.542 0.669 0 CA-C-O 121.638 0.733 . . . . 63.31 112.207 -170.853 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 127' ' ' VAL . . . . . 0.409 HG21 ' OD1' ' A' ' 87' ' ' ASN . 7.1 p -59.42 146.64 9.36 Favored 'Isoleucine or valine' 0 CA--C 1.554 1.103 0 CA-C-N 113.797 -1.547 . . . . 73.44 111.155 177.185 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 128' ' ' VAL . . . . . 0.622 ' HB ' ' HB3' ' A' ' 90' ' ' LEU . 42.1 t -62.44 147.05 11.97 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.795 0 C-N-CA 123.686 0.794 . . . . 45.34 110.333 179.625 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 129' ' ' PHE . . . . . 0.566 ' HA ' HG21 ' A' ' 29' ' ' VAL . 36.7 p90 -120.16 -28.83 5.01 Favored 'General case' 0 N--CA 1.476 0.87 0 C-N-CA 122.565 0.346 . . . . 74.05 110.277 170.575 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . -146.09 168.73 27.59 Favored Glycine 0 C--N 1.346 1.112 0 O-C-N 123.525 0.516 . . . . 74.45 112.798 -172.371 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 29.0 ttpt -152.76 134.6 14.69 Favored 'General case' 0 N--CA 1.47 0.541 0 N-CA-C 108.167 -1.049 . . . . 62.34 108.167 -177.611 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 132' ' ' VAL . . . . . 0.486 HG11 ' HA ' ' A' ' 136' ' ' MET . 7.3 t -66.62 109.95 1.36 Allowed 'Isoleucine or valine' 0 CA--C 1.542 0.671 0 N-CA-C 109.433 -0.58 . . . . 65.22 109.433 176.799 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 14.4 ptmm? -87.02 -39.52 15.57 Favored 'General case' 0 N--CA 1.481 1.104 0 N-CA-C 110.134 -0.321 . . . . 73.33 110.134 -178.269 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 134' ' ' GLU . . . . . 0.403 ' HB2' ' OG ' ' A' ' 21' ' ' SER . 20.6 mm-40 -144.53 162.13 37.35 Favored 'General case' 0 N--CA 1.488 1.471 0 C-N-CA 124.711 1.204 . . . . 61.32 108.693 173.316 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 135' ' ' GLY . . . . . 0.467 ' HA3' ' HA ' ' A' ' 20' ' ' VAL . . . 78.7 15.14 81.24 Favored Glycine 0 C--N 1.346 1.125 0 O-C-N 123.349 0.406 . . . . 71.32 112.177 -173.715 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 136' ' ' MET . . . . . 0.486 ' HA ' HG11 ' A' ' 132' ' ' VAL . 15.2 tpt -62.92 -34.38 77.32 Favored 'General case' 0 N--CA 1.472 0.626 0 C-N-CA 124.462 1.105 . . . . 72.12 111.808 -177.047 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 137' ' ' ASN . . . . . . . . . . . . . 27.3 t-20 -61.78 -35.84 79.34 Favored 'General case' 0 N--CA 1.48 1.069 0 C-N-CA 123.455 0.702 . . . . 73.22 111.164 177.571 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 138' ' ' ILE . . . . . . . . . . . . . 43.4 mm -71.12 -33.22 50.43 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.088 0 C-N-CA 123.402 0.681 . . . . 62.14 110.679 179.642 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 139' ' ' VAL . . . . . 0.422 HG11 HG21 ' A' ' 114' ' ' ILE . 62.0 t -69.76 -44.87 78.79 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.999 0 C-N-CA 123.407 0.683 . . . . 72.12 110.518 176.306 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 140' ' ' GLU . . . . . 0.459 ' HA ' HG21 ' A' ' 116' ' ' THR . 40.0 mt-10 -63.82 -33.58 75.99 Favored 'General case' 0 N--CA 1.476 0.855 0 CA-C-N 115.476 -0.784 . . . . 73.31 110.534 176.882 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -70.37 -43.84 69.3 Favored 'General case' 0 C--O 1.24 0.594 0 C-N-CA 123.662 0.785 . . . . 75.31 111.307 178.124 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 142' ' ' MET . . . . . 0.515 ' HB2' HD13 ' A' ' 156' ' ' ILE . 22.4 ptt? -69.52 -34.09 73.75 Favored 'General case' 0 C--N 1.355 0.843 0 CA-C-N 116.84 -0.164 . . . . 65.3 110.929 -175.691 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 143' ' ' GLU . . . . . 0.413 ' HG2' ' HA ' ' A' ' 58' ' ' PRO . 30.9 tt0 -62.87 -28.99 70.42 Favored 'General case' 0 CA--C 1.559 1.294 0 C-N-CA 122.722 0.409 . . . . 72.45 111.462 -178.968 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 144' ' ' ARG . . . . . 0.482 ' HA ' ' HB3' ' A' ' 58' ' ' PRO . 58.6 mtp85 -68.72 -19.47 64.36 Favored 'General case' 0 N--CA 1.485 1.295 0 C-N-CA 123.589 0.756 . . . . 61.13 112.242 -179.091 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 145' ' ' PHE . . . . . 0.529 ' HB2' HD11 ' A' ' 156' ' ' ILE . 56.6 m-85 -79.95 -8.15 59.18 Favored 'General case' 0 N--CA 1.477 0.897 0 C-N-CA 122.807 0.443 . . . . 71.43 111.321 179.328 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . -78.14 179.59 51.47 Favored Glycine 0 C--N 1.345 1.029 0 O-C-N 123.348 0.405 . . . . 53.44 112.751 172.585 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 46.0 t -133.7 168.4 18.77 Favored 'General case' 0 N--CA 1.476 0.834 0 C-N-CA 123.773 0.829 . . . . 60.45 110.148 -176.893 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 148' ' ' ARG . . . . . . . . . . . . . 18.4 mmm180 -58.55 -37.01 74.82 Favored 'General case' 0 N--CA 1.481 1.107 0 C-N-CA 123.81 0.844 . . . . 73.23 111.863 178.527 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 149' ' ' ASN . . . . . . . . . . . . . 30.2 p-10 -89.78 11.69 19.36 Favored 'General case' 0 N--CA 1.483 1.203 0 C-N-CA 123.217 0.607 . . . . 74.32 112.201 -178.614 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . 86.08 -2.8 87.61 Favored Glycine 0 C--N 1.349 1.277 0 CA-C-O 119.732 -0.482 . . . . 45.04 114.031 177.421 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 35.7 ttmt -63.73 130.79 45.65 Favored 'General case' 0 N--CA 1.474 0.756 0 C-N-CA 123.792 0.837 . . . . 70.14 110.736 179.988 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 152' ' ' THR . . . . . . . . . . . . . 82.2 p -91.91 108.84 20.21 Favored 'General case' 0 C--O 1.239 0.504 0 N-CA-C 108.069 -1.085 . . . . 72.2 108.069 170.388 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 153' ' ' SER . . . . . . . . . . . . . 49.4 m -68.32 -28.92 67.58 Favored 'General case' 0 N--CA 1.473 0.712 0 C-N-CA 123.073 0.549 . . . . 75.22 110.532 177.789 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 154' ' ' LYS . . . . . 0.467 ' HB3' HG13 ' A' ' 12' ' ' VAL . 74.4 mmtt -117.11 139.83 50.26 Favored 'General case' 0 C--O 1.241 0.621 0 C-N-CA 124.155 0.982 . . . . 71.2 109.717 177.277 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 155' ' ' LYS . . . . . 0.457 ' HD3' ' SG ' ' A' ' 52' ' ' CYS . 17.4 tppt? -78.56 89.58 4.5 Favored 'General case' 0 CA--C 1.541 0.603 0 N-CA-C 109.016 -0.735 . . . . 71.42 109.016 179.926 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 156' ' ' ILE . . . . . 0.529 HD11 ' HB2' ' A' ' 145' ' ' PHE . 72.5 mt -86.58 117.53 31.16 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.321 0 CA-C-N 115.503 -0.771 . . . . 75.11 109.051 -177.422 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 157' ' ' THR . . . . . . . . . . . . . 25.1 p -130.88 153.62 48.94 Favored 'General case' 0 C--O 1.238 0.478 0 C-N-CA 124.8 1.24 . . . . 61.23 109.484 -171.898 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 158' ' ' ILE . . . . . 0.46 HD11 ' HZ ' ' A' ' 112' ' ' PHE . 67.7 mt -76.19 93.78 1.05 Allowed 'Isoleucine or valine' 0 CA--C 1.547 0.848 0 N-CA-C 108.633 -0.877 . . . . 64.35 108.633 172.094 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 159' ' ' ALA . . . . . 0.851 ' HB2' ' HB2' ' A' ' 11' ' ' ALA . . . -51.31 -53.03 39.95 Favored 'General case' 0 N--CA 1.483 1.185 0 C-N-CA 123.729 0.812 . . . . 34.43 111.707 -178.899 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 160' ' ' ASP . . . . . . . . . . . . . 1.5 t70 -151.18 176.61 11.02 Favored 'General case' 0 CA--C 1.548 0.897 0 CA-C-N 115.827 -0.624 . . . . 65.44 109.818 -178.557 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 161' ' ' CYS . . . . . . . . . . . . . 9.8 p -148.51 -171.69 3.91 Favored 'General case' 0 N--CA 1.477 0.905 0 C-N-CA 124.459 1.104 . . . . 74.23 109.9 -172.399 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 162' ' ' GLY . . . . . . . . . . . . . . . 131.23 53.39 0.09 OUTLIER Glycine 0 C--N 1.353 1.519 0 N-CA-C 112.238 -0.345 . . . . 52.25 112.238 -172.782 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 163' ' ' GLN . . . . . 0.439 ' HA ' ' H ' ' A' ' 7' ' ' PHE . 27.5 tt0 -46.74 107.08 0.1 Allowed 'General case' 0 CA--C 1.559 1.289 0 C-N-CA 125.234 1.414 . . . . 71.44 112.888 179.953 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 164' ' ' LEU . . . . . 0.486 ' O ' ' HB ' ' A' ' 5' ' ' THR . 84.5 mt . . . . . 0 N--CA 1.475 0.795 0 C-N-CA 123.898 0.879 . . . . 72.44 109.85 -175.246 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 218' ' ' PRO . . . . . . . . . . . . . 14.7 Cg_exo . . . . . 0 CA--C 1.539 0.763 0 N-CA-C 108.847 -1.251 . . . . 71.14 108.847 . . . . . . . . . 0 0 . 1 . 005 nuclear build core ' B' B ' 219' ' ' GLY . . . . . . . . . . . . . . . 160.18 156.91 8.37 Favored Glycine 0 CA--C 1.533 1.165 0 CA-C-N 115.753 -0.658 . . . . 74.21 112.057 -175.59 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 220' ' ' PRO . . . . . . . . . . . . . 36.3 Cg_endo -86.23 -179.22 3.07 Favored 'Trans proline' 0 C--N 1.365 1.433 0 C-N-CA 123.753 2.968 . . . . 74.14 113.86 -176.288 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 221' ' ' TYR . . . . . . . . . . . . . 97.0 m-85 . . . . . 0 N--CA 1.48 1.053 0 C-N-CA 123.333 0.653 . . . . 75.34 111.868 -175.14 . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 3' ' ' ASN . . . . . 0.445 ' OD1' ' HA ' ' A' ' 25' ' ' PHE . 21.1 m-80 . . . . . 0 CA--C 1.545 0.785 0 N-CA-C 110.066 -0.346 . . . . 74.34 110.066 . . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 4' ' ' PRO . . . . . 0.51 ' HG2' ' HB2' ' A' ' 24' ' ' LEU . 73.3 Cg_endo -77.48 150.35 28.19 Favored 'Trans proline' 0 C--N 1.374 1.907 0 C-N-CA 122.392 2.061 . . . . 75.11 111.575 170.559 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 5' ' ' THR . . . . . 0.445 ' HB ' ' O ' ' A' ' 164' ' ' LEU . 52.5 m -98.04 142.54 29.63 Favored 'General case' 0 CA--C 1.54 0.566 0 N-CA-C 108.932 -0.766 . . . . 71.54 108.932 175.168 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 6' ' ' VAL . . . . . 0.706 ' HA ' ' HG3' ' A' ' 163' ' ' GLN . 44.1 t -101.76 150.44 6.1 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.967 0 N-CA-C 107.689 -1.226 . . . . 74.31 107.689 171.125 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 7' ' ' PHE . . . . . 0.433 ' H ' ' HA ' ' A' ' 163' ' ' GLN . 74.2 t80 -133.55 130.77 38.9 Favored 'General case' 0 C--O 1.236 0.37 0 N-CA-C 109.531 -0.544 . . . . 74.51 109.531 175.962 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 8' ' ' PHE . . . . . 0.401 ' HD2' ' HE2' ' A' ' 22' ' ' PHE . 32.3 m-85 -138.2 166.49 24.03 Favored 'General case' 0 C--O 1.237 0.418 0 C-N-CA 124.808 1.243 . . . . 73.31 109.362 170.248 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 9' ' ' ASP . . . . . 0.401 ' HB2' ' H ' ' A' ' 160' ' ' ASP . 8.7 m-20 -117.27 112.19 20.43 Favored 'General case' 0 N--CA 1.468 0.463 0 CA-C-N 114.847 -1.069 . . . . 64.44 108.126 171.555 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 10' ' ' ILE . . . . . 0.447 HG21 ' SD ' ' A' ' 142' ' ' MET . 45.8 mm -83.33 128.57 38.64 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.453 0 N-CA-C 108.673 -0.862 . . . . 74.42 108.673 178.91 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 11' ' ' ALA . . . . . 0.655 ' HB2' ' HB2' ' A' ' 159' ' ' ALA . . . -129.97 141.1 50.81 Favored 'General case' 0 N--CA 1.471 0.614 0 C-N-CA 123.749 0.82 . . . . 50.32 110.58 -173.1 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 12' ' ' VAL . . . . . 0.541 HG13 ' HB3' ' A' ' 154' ' ' LYS . 86.2 t -97.17 110.89 25.93 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.435 0 C-N-CA 124.173 0.989 . . . . 63.34 108.848 173.533 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 9.9 m-20 58.98 24.29 12.47 Favored 'General case' 0 N--CA 1.485 1.31 0 C-N-CA 124.8 1.24 . . . . 75.4 112.651 179.919 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 106.13 -24.2 27.03 Favored Glycine 0 C--N 1.349 1.304 0 CA-C-O 119.681 -0.511 . . . . 64.22 113.006 179.658 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 24.7 mm-40 -81.78 120.28 77.35 Favored Pre-proline 0 N--CA 1.479 0.991 0 CA-C-O 118.449 -0.786 . . . . 74.44 109.327 179.994 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 19.1 Cg_endo -57.72 114.65 2.05 Favored 'Trans proline' 0 C--N 1.379 2.158 0 C-N-CA 123.107 2.538 . . . . 73.44 112.498 -177.114 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 17' ' ' LEU . . . . . 0.5 ' HB2' HG23 ' A' ' 12' ' ' VAL . 52.0 tp -79.43 -41.8 26.81 Favored 'General case' 0 N--CA 1.478 0.963 0 C-N-CA 123.735 0.814 . . . . 72.21 110.058 175.765 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -177.69 174.49 46.93 Favored Glycine 0 C--N 1.344 1.024 0 CA-C-N 115.711 -0.677 . . . . 63.5 113.395 179.955 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 19.9 mtp180 -111.2 117.5 33.39 Favored 'General case' 0 N--CA 1.471 0.611 0 N-CA-C 108.456 -0.942 . . . . 75.13 108.456 -175.925 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 86.2 t -113.37 138.48 42.82 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.733 0 C-N-CA 123.78 0.832 . . . . 73.45 110.12 -175.263 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 16.4 m -124.94 135.22 52.62 Favored 'General case' 0 C--O 1.242 0.67 0 C-N-CA 123.661 0.785 . . . . 75.45 110.114 174.901 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 22' ' ' PHE . . . . . 0.431 ' HB2' ' HB ' ' A' ' 6' ' ' VAL . 60.5 m-85 -105.78 170.0 8.15 Favored 'General case' 0 N--CA 1.474 0.765 0 C-N-CA 124.145 0.978 . . . . 64.23 109.912 179.079 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 23' ' ' GLU . . . . . 0.631 ' HB2' ' HD2' ' A' ' 133' ' ' LYS . 33.0 tt0 -130.76 108.89 10.2 Favored 'General case' 0 N--CA 1.473 0.692 0 C-N-CA 123.689 0.796 . . . . 74.35 109.233 177.948 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 24' ' ' LEU . . . . . 0.51 ' HB2' ' HG2' ' A' ' 4' ' ' PRO . 88.5 mt -78.54 121.0 24.04 Favored 'General case' 0 N--CA 1.469 0.481 0 C-N-CA 123.377 0.671 . . . . 75.34 109.961 179.149 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 25' ' ' PHE . . . . . 0.445 ' HA ' ' OD1' ' A' ' 3' ' ' ASN . 77.7 m-85 -83.85 68.25 9.88 Favored 'General case' 0 C--O 1.233 0.206 0 CA-C-O 121.65 0.738 . . . . 62.11 109.465 171.904 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -66.21 -21.92 66.32 Favored 'General case' 0 N--CA 1.473 0.704 0 CA-C-N 114.708 -1.133 . . . . 44.15 111.128 179.032 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 10.7 p-10 -72.71 -23.61 60.88 Favored 'General case' 0 CA--C 1.543 0.701 0 C-N-CA 124.029 0.932 . . . . 63.33 111.478 178.292 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 59.5 mttp -104.6 -51.29 3.11 Favored 'General case' 0 N--CA 1.482 1.169 0 C-N-CA 123.613 0.765 . . . . 64.33 110.965 -176.536 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 29' ' ' VAL . . . . . 0.564 ' HA ' ' HG2' ' A' ' 86' ' ' GLU . 5.4 m -124.33 72.92 58.55 Favored Pre-proline 0 CA--C 1.55 0.95 0 C-N-CA 124.099 0.96 . . . . 72.33 110.185 -178.195 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 20.7 Cg_endo -60.7 -29.64 88.76 Favored 'Trans proline' 0 C--N 1.38 2.222 0 C-N-CA 122.671 2.247 . . . . 52.51 113.107 -177.072 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 21.9 ttmm -65.33 -54.12 33.73 Favored 'General case' 0 N--CA 1.481 1.111 0 CA-C-O 121.715 0.769 . . . . 62.44 111.556 -179.428 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 20.5 m -80.16 -32.17 38.87 Favored 'General case' 0 CA--C 1.547 0.842 0 CA-C-N 114.723 -1.126 . . . . 75.42 111.138 -170.244 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 33' ' ' ALA . . . . . 0.472 ' HB1' ' HB3' ' A' ' 24' ' ' LEU . . . -70.1 -40.82 74.7 Favored 'General case' 0 N--CA 1.473 0.692 0 C-N-CA 122.787 0.435 . . . . 73.3 110.222 174.609 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 9.3 tp10 -62.77 -40.75 98.24 Favored 'General case' 0 N--CA 1.488 1.467 0 O-C-N 123.668 0.605 . . . . 61.24 110.752 176.54 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 35' ' ' ASN . . . . . 0.484 ' O ' ' HG ' ' A' ' 39' ' ' LEU . 40.0 t30 -53.57 -62.91 1.35 Allowed 'General case' 0 C--N 1.349 0.577 0 O-C-N 124.293 0.996 . . . . 75.4 110.433 178.643 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 65.6 t80 -65.53 -33.96 77.13 Favored 'General case' 0 N--CA 1.474 0.743 0 CA-C-N 115.338 -0.846 . . . . 72.52 111.805 -176.167 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 37' ' ' ARG . . . . . 0.556 ' HG3' HE22 ' A' ' 163' ' ' GLN . 32.7 ttt180 -55.21 -49.67 71.34 Favored 'General case' 0 N--CA 1.485 1.293 0 C-N-CA 124.262 1.025 . . . . 62.43 110.728 173.655 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 38' ' ' ALA . . . . . 0.457 ' HB3' HG21 ' A' ' 78' ' ' ILE . . . -76.92 -25.94 53.52 Favored 'General case' 0 CA--C 1.544 0.741 0 CA-C-N 114.314 -1.312 . . . . 61.14 112.07 -174.921 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 39' ' ' LEU . . . . . 0.484 ' HG ' ' O ' ' A' ' 35' ' ' ASN . 95.4 mt -73.39 -40.26 64.45 Favored 'General case' 0 N--CA 1.479 1.022 0 C-N-CA 123.536 0.734 . . . . 65.4 110.2 173.297 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 40.3 t -65.42 -54.74 24.29 Favored 'General case' 0 N--CA 1.479 0.984 0 CA-C-N 114.42 -1.264 . . . . 71.21 110.592 -176.144 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 82.6 p -73.3 -32.09 64.42 Favored 'General case' 0 N--CA 1.472 0.637 0 CA-C-O 121.29 0.567 . . . . 70.1 109.737 177.253 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 42' ' ' GLY . . . . . 0.446 ' HA3' ' HA2' ' A' ' 47' ' ' GLY . . . 75.39 8.22 83.5 Favored Glycine 0 C--N 1.347 1.186 0 CA-C-N 115.221 -0.899 . . . . 64.21 114.886 171.832 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 47.8 mm-40 -69.07 -4.59 17.69 Favored 'General case' 0 N--CA 1.482 1.146 0 C-N-CA 123.804 0.842 . . . . 64.13 113.046 -178.018 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 44' ' ' LYS . . . . . 0.451 ' HG3' ' HB1' ' A' ' 38' ' ' ALA . 32.3 mmmt -94.0 13.44 22.89 Favored 'General case' 0 CA--C 1.55 0.976 0 C-N-CA 123.565 0.746 . . . . 72.14 111.462 172.356 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 92.52 22.99 27.5 Favored Glycine 0 C--N 1.357 1.709 0 N-CA-C 114.559 0.584 . . . . 32.5 114.559 173.231 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 25.9 m-85 -114.88 -46.71 2.91 Favored 'General case' 0 N--CA 1.487 1.42 0 CA-C-N 117.507 0.654 . . . . 70.42 111.279 -172.069 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 47' ' ' GLY . . . . . 0.446 ' HA2' ' HA3' ' A' ' 42' ' ' GLY . . . 53.84 63.68 4.91 Favored Glycine 0 C--N 1.346 1.109 0 O-C-N 124.096 0.873 . . . . 14.42 114.64 173.084 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 50.7 m-85 -71.71 84.81 0.9 Allowed 'General case' 0 N--CA 1.485 1.282 0 CA-C-O 122.119 0.962 . . . . 74.32 111.167 177.387 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 49' ' ' LYS . . . . . 0.558 ' HE3' ' HA ' ' A' ' 160' ' ' ASP . 22.2 tptm -116.3 138.56 51.22 Favored 'General case' 0 CA--C 1.538 0.51 0 CA-C-N 113.601 -1.636 . . . . 62.14 107.603 171.851 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 69.45 19.99 74.99 Favored Glycine 0 N--CA 1.478 1.477 0 CA-C-N 118.069 0.395 . . . . 70.04 114.001 177.161 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 25.1 m -70.21 119.34 14.26 Favored 'General case' 0 N--CA 1.471 0.603 0 C-N-CA 123.614 0.765 . . . . 62.42 110.137 -176.436 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 52' ' ' CYS . . . . . . . . . . . . . 21.2 p -90.93 157.54 17.25 Favored 'General case' 0 N--CA 1.474 0.767 0 CA-C-O 121.714 0.769 . . . . 61.15 111.876 -171.518 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 29.1 m-85 -96.25 164.94 12.45 Favored 'General case' 0 C--O 1.24 0.605 0 C-N-CA 124.998 1.319 . . . . 73.45 108.741 175.515 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 19.5 p-80 -149.36 -43.09 0.14 Allowed 'General case' 0 N--CA 1.477 0.897 0 N-CA-C 110.451 -0.203 . . . . 74.44 110.451 -171.222 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 55' ' ' ARG . . . . . 0.464 ' HA ' ' O ' ' A' ' 150' ' ' GLY . 42.2 ttt-85 -121.06 98.81 6.16 Favored 'General case' 0 C--N 1.347 0.49 0 N-CA-C 109.089 -0.708 . . . . 74.23 109.089 -174.578 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 57.0 mt -127.39 127.19 68.75 Favored 'Isoleucine or valine' 0 C--O 1.239 0.527 0 N-CA-C 107.778 -1.193 . . . . 74.25 107.778 176.966 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 68.4 mt -122.44 116.41 29.52 Favored Pre-proline 0 CA--C 1.55 0.967 0 N-CA-C 108.278 -1.008 . . . . 64.13 108.278 -177.386 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 31.0 Cg_exo -62.46 136.23 57.91 Favored 'Trans proline' 0 C--N 1.379 2.145 0 C-N-CA 123.313 2.675 . . . . 73.25 112.351 -179.346 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 78.86 22.72 65.66 Favored Glycine 0 C--N 1.344 1.019 0 O-C-N 123.78 0.675 . . . . 65.11 112.767 -176.202 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 60' ' ' PHE . . . . . 0.404 ' CD2' ' HB3' ' A' ' 61' ' ' MET . 55.3 t80 -148.01 -69.26 0.23 Allowed 'General case' 0 CA--C 1.55 0.958 0 C-N-CA 123.476 0.71 . . . . 43.44 111.054 -175.058 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 61' ' ' MET . . . . . 0.433 ' SD ' ' HB2' ' A' ' 113' ' ' PHE . 40.5 ttm -175.97 158.16 1.99 Allowed 'General case' 0 N--CA 1.49 1.542 0 N-CA-C 113.245 0.832 . . . . 72.05 113.245 -159.582 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 62' ' ' CYS . . . . . 0.458 ' SG ' ' HB ' ' A' ' 114' ' ' ILE . 24.9 p -122.94 113.75 19.51 Favored 'General case' 0 CA--C 1.549 0.94 0 C-N-CA 124.197 0.999 . . . . 72.14 109.647 168.579 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 57.8 tt0 -112.72 127.48 56.15 Favored 'General case' 0 N--CA 1.489 1.485 0 C-N-CA 124.125 0.97 . . . . 75.14 110.37 -176.145 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -151.47 -157.47 7.9 Favored Glycine 0 C--N 1.348 1.214 0 CA-C-N 115.698 -0.683 . . . . 43.11 113.715 -177.476 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 86.27 -8.13 75.48 Favored Glycine 0 C--N 1.35 1.35 0 N-CA-C 112.04 -0.424 . . . . 53.22 112.04 -167.722 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 38.9 t70 -75.66 86.98 2.72 Favored 'General case' 0 C--N 1.354 0.775 0 C-N-CA 124.638 1.175 . . . . 52.23 109.925 -174.221 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 91.2 t80 -144.42 -55.09 0.34 Allowed 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 114.547 -1.206 . . . . 72.45 108.697 -176.667 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 5.7 t -84.81 122.75 29.59 Favored 'General case' 0 C--O 1.246 0.873 0 C-N-CA 123.146 0.578 . . . . 72.24 109.998 178.804 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 86.0 mtt180 53.85 51.75 14.26 Favored 'General case' 0 N--CA 1.48 1.041 0 C-N-CA 124.369 1.068 . . . . 73.01 109.851 -179.251 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 20.8 p80 -78.4 66.75 4.03 Favored 'General case' 0 CA--C 1.555 1.164 0 CA-C-O 122.32 1.057 . . . . 65.12 112.046 -168.841 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 8.3 t30 -155.08 79.46 1.05 Allowed 'General case' 0 C--O 1.24 0.596 0 N-CA-C 107.289 -1.375 . . . . 72.24 107.289 -177.213 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 72' ' ' GLY . . . . . 0.568 ' HA2' ' HG3' ' B' ' 218' ' ' PRO . . . 79.65 -6.96 56.75 Favored Glycine 0 CA--C 1.533 1.163 0 CA-C-N 115.039 -0.982 . . . . 45.22 113.838 -179.006 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 7.3 m -115.51 -78.77 0.58 Allowed 'General case' 0 CA--C 1.546 0.804 0 N-CA-C 108.132 -1.062 . . . . 71.22 108.132 -179.822 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 54.67 60.61 8.37 Favored Glycine 0 C--N 1.359 1.851 0 N-CA-C 114.59 0.596 . . . . 51.34 114.59 172.199 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 119.95 52.5 0.27 Allowed Glycine 0 N--CA 1.476 1.307 0 CA-C-N 117.716 0.758 . . . . 54.12 111.289 -175.452 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 17.4 pttp -63.08 169.61 3.3 Favored 'General case' 0 CA--C 1.547 0.828 0 C-N-CA 124.186 0.995 . . . . 73.13 112.393 -174.768 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 76.1 p -93.16 179.23 5.49 Favored 'General case' 0 C--O 1.246 0.887 0 CA-C-O 121.525 0.679 . . . . 74.21 112.254 -171.134 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 78' ' ' ILE . . . . . 0.457 HG21 ' HB3' ' A' ' 38' ' ' ALA . 34.1 pt -75.23 -20.1 16.21 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.784 0 CA-C-N 115.294 -0.867 . . . . 74.31 110.187 168.735 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 82.7 m-85 -87.93 18.49 4.14 Favored 'General case' 0 CA--C 1.547 0.832 0 C-N-CA 124.57 1.148 . . . . 64.25 110.433 177.006 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 99.02 -120.79 6.98 Favored Glycine 0 C--N 1.354 1.565 0 N-CA-C 111.071 -0.812 . . . . 74.21 111.071 -179.842 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 36.8 tt0 -71.98 -59.42 2.75 Favored 'General case' 0 N--CA 1.47 0.544 0 C-N-CA 123.265 0.626 . . . . 72.41 110.057 178.057 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 82' ' ' LYS . . . . . 0.825 ' HD2' ' HA ' ' A' ' 107' ' ' THR . 21.4 pttp -155.62 175.98 13.2 Favored 'General case' 0 CA--C 1.544 0.741 0 CA-C-N 115.372 -0.831 . . . . 73.2 110.821 -172.41 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 12.1 p90 -159.15 173.72 15.97 Favored 'General case' 0 CA--C 1.538 0.507 0 C-N-CA 124.918 1.287 . . . . 74.4 110.035 -175.063 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 84' ' ' GLU . . . . . 0.511 ' HA ' ' HA ' ' A' ' 106' ' ' ASN . 7.4 pt-20 -83.84 169.85 14.71 Favored 'General case' 0 N--CA 1.475 0.803 0 C-N-CA 123.527 0.731 . . . . 72.05 111.753 -179.864 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 41.1 m-20 -74.9 143.55 43.74 Favored 'General case' 0 N--CA 1.472 0.641 0 C-N-CA 123.739 0.816 . . . . 54.43 109.677 -179.845 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 86' ' ' GLU . . . . . 0.564 ' HG2' ' HA ' ' A' ' 29' ' ' VAL . 7.9 tp10 -66.13 -59.53 3.68 Favored 'General case' 0 N--CA 1.472 0.654 0 CA-C-O 121.769 0.795 . . . . 60.51 110.107 176.202 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 32.4 p30 -163.32 -159.83 0.56 Allowed 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 113.974 -1.466 . . . . 62.25 107.909 -179.935 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 96.2 m-85 -138.35 42.74 2.19 Favored 'General case' 0 N--CA 1.482 1.158 0 C-N-CA 122.981 0.512 . . . . 70.43 110.307 179.45 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 61.9 mt -67.59 -48.43 76.69 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.488 0 CA-C-O 121.214 0.53 . . . . 75.41 110.062 175.998 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 90' ' ' LEU . . . . . 0.561 ' HB3' ' HB ' ' A' ' 128' ' ' VAL . 82.6 mt -88.99 153.08 21.31 Favored 'General case' 0 C--O 1.241 0.632 0 CA-C-N 115.556 -0.747 . . . . 63.35 110.653 179.035 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 21.1 ptmt -150.43 168.49 24.0 Favored 'General case' 0 N--CA 1.472 0.637 0 CA-C-N 115.529 -0.76 . . . . 73.31 110.62 -179.59 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 92' ' ' HIS . . . . . . . . . . . . . 27.2 m80 -87.31 68.36 9.78 Favored 'General case' 0 CA--C 1.546 0.802 0 C-N-CA 124.035 0.934 . . . . 75.54 109.454 -172.855 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 8.8 t -114.34 7.13 16.31 Favored 'General case' 0 N--CA 1.477 0.918 0 CA-C-N 114.972 -1.013 . . . . 73.45 111.338 -172.611 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -150.2 173.75 29.79 Favored Glycine 0 C--N 1.347 1.153 0 CA-C-O 119.993 -0.337 . . . . 52.13 113.137 -176.2 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 98.2 Cg_endo -85.15 155.96 11.14 Favored 'Trans proline' 0 C--N 1.368 1.579 0 C-N-CA 123.103 2.535 . . . . 63.14 112.379 174.066 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 76.18 19.09 78.87 Favored Glycine 0 N--CA 1.476 1.301 0 CA-C-N 116.481 -0.327 . . . . 63.23 113.581 178.613 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 97' ' ' ILE . . . . . 0.555 ' HB ' ' HB2' ' A' ' 115' ' ' CYS . 13.3 mm -76.34 105.45 5.26 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.907 0 C-N-CA 123.833 0.853 . . . . 74.31 111.42 -174.872 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 60.8 tp -90.62 119.42 30.85 Favored 'General case' 0 CA--C 1.549 0.941 0 C-N-CA 123.084 0.554 . . . . 74.43 110.002 176.694 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 47.2 t -143.91 148.9 36.05 Favored 'General case' 0 CA--C 1.545 0.778 0 C-N-CA 124.388 1.075 . . . . 74.22 108.576 179.126 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 100' ' ' MET . . . . . 0.451 ' HA ' ' HA ' ' A' ' 112' ' ' PHE . 57.0 mtp -82.84 147.24 28.45 Favored 'General case' 0 N--CA 1.488 1.432 0 CA-C-N 118.201 0.455 . . . . 72.31 110.535 179.819 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -76.41 145.55 39.28 Favored 'General case' 0 C--O 1.243 0.743 0 C-N-CA 122.888 0.475 . . . . 75.13 112.169 -172.248 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 20.4 p-10 -153.89 149.22 27.1 Favored 'General case' 0 C--O 1.241 0.616 0 C-N-CA 124.292 1.037 . . . . 71.41 108.7 177.894 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -87.37 -34.41 18.81 Favored 'General case' 0 N--CA 1.474 0.732 0 N-CA-C 109.477 -0.564 . . . . 74.34 109.477 169.895 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -158.71 -166.72 18.34 Favored Glycine 0 C--N 1.342 0.909 0 CA-C-N 115.387 -0.824 . . . . 24.24 111.292 174.236 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 33.7 Cg_exo -60.78 151.28 78.05 Favored 'Trans proline' 0 C--N 1.369 1.637 0 C-N-CA 122.797 2.331 . . . . 62.4 111.847 178.357 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 106' ' ' ASN . . . . . 0.511 ' HA ' ' HA ' ' A' ' 84' ' ' GLU . 65.0 t30 65.83 16.96 10.7 Favored 'General case' 0 CA--C 1.561 1.38 0 C-N-CA 124.758 1.223 . . . . 72.2 111.343 178.78 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 107' ' ' THR . . . . . 0.825 ' HA ' ' HD2' ' A' ' 82' ' ' LYS . 5.1 m -118.89 7.19 11.46 Favored 'General case' 0 N--CA 1.485 1.286 0 C-N-CA 123.968 0.907 . . . . 70.54 110.387 179.839 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 11.1 t30 -70.71 145.77 50.31 Favored 'General case' 0 C--O 1.213 -0.851 0 C-N-CA 124.696 1.198 . . . . 70.31 110.232 177.615 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 101.29 23.36 9.68 Favored Glycine 0 N--CA 1.472 1.089 0 C-N-CA 121.66 -0.305 . . . . 72.1 113.805 177.295 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 22.8 p -132.67 120.4 21.67 Favored 'General case' 0 N--CA 1.468 0.454 0 N-CA-C 107.881 -1.155 . . . . 34.11 107.881 174.249 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 111' ' ' GLN . . . . . 0.49 HE22 ' HG2' ' B' ' 218' ' ' PRO . 16.0 mt-30 62.71 161.77 0.09 Allowed 'General case' 0 N--CA 1.492 1.632 0 C-N-CA 124.114 0.966 . . . . 74.22 111.74 -171.778 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 112' ' ' PHE . . . . . 0.451 ' HA ' ' HA ' ' A' ' 100' ' ' MET . 49.1 p90 -133.72 143.14 48.31 Favored 'General case' 0 N--CA 1.472 0.645 0 N-CA-C 108.201 -1.037 . . . . 75.11 108.201 169.054 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 113' ' ' PHE . . . . . 0.433 ' HB2' ' SD ' ' A' ' 61' ' ' MET . 50.5 p90 -129.58 148.13 51.45 Favored 'General case' 0 C--O 1.236 0.391 0 C-N-CA 123.515 0.726 . . . . 64.53 110.091 179.574 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 114' ' ' ILE . . . . . 0.458 ' HB ' ' SG ' ' A' ' 62' ' ' CYS . 21.5 mt -112.63 104.61 17.31 Favored 'Isoleucine or valine' 0 C--O 1.241 0.61 0 N-CA-C 108.486 -0.931 . . . . 55.41 108.486 175.239 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 115' ' ' CYS . . . . . 0.555 ' HB2' ' HB ' ' A' ' 97' ' ' ILE . 28.9 m -64.69 104.52 0.83 Allowed 'General case' 0 CA--C 1.542 0.656 0 N-CA-C 108.406 -0.961 . . . . 74.23 108.406 170.256 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 116' ' ' THR . . . . . 0.523 HG22 HG12 ' A' ' 139' ' ' VAL . 62.5 p -70.16 -31.78 69.43 Favored 'General case' 0 N--CA 1.472 0.632 0 C-N-CA 123.216 0.606 . . . . 71.01 110.296 -179.522 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -115.62 170.99 8.02 Favored 'General case' 0 C--O 1.243 0.745 0 C-N-CA 124.012 0.925 . . . . 74.23 109.72 175.292 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 19.3 ptmt -72.01 92.09 1.27 Allowed 'General case' 0 CA--C 1.554 1.11 0 CA-C-O 121.804 0.811 . . . . 65.13 110.019 175.253 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 119' ' ' THR . . . . . 0.574 ' HB ' HD13 ' A' ' 122' ' ' LEU . 46.7 p -85.64 83.63 7.83 Favored 'General case' 0 CA--C 1.546 0.817 0 CA-C-O 121.813 0.816 . . . . 73.45 109.182 179.766 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 10.2 pt-20 -75.91 -30.13 58.65 Favored 'General case' 0 N--CA 1.482 1.148 0 CA-C-N 115.524 -0.762 . . . . 75.22 112.38 -167.086 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 121' ' ' TRP . . . . . . . . . . . . . 39.0 p90 -69.19 -4.78 18.96 Favored 'General case' 0 CA--C 1.553 1.07 0 C-N-CA 123.713 0.805 . . . . 74.51 111.624 178.03 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 122' ' ' LEU . . . . . 0.574 HD13 ' HB ' ' A' ' 119' ' ' THR . 10.8 mp -87.27 2.39 50.29 Favored 'General case' 0 N--CA 1.482 1.169 0 C-N-CA 124.055 0.942 . . . . 43.45 112.485 174.695 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 78.4 m-20 -78.01 124.54 28.15 Favored 'General case' 0 N--CA 1.477 0.907 0 CA-C-N 118.427 0.558 . . . . 72.01 109.668 177.716 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 112.09 -11.11 26.93 Favored Glycine 0 C--N 1.351 1.369 0 CA-C-N 115.497 -0.774 . . . . 63.34 111.621 -165.027 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 28.7 mtpp -90.83 -165.09 1.28 Allowed 'General case' 0 N--CA 1.486 1.341 0 C-N-CA 124.19 0.996 . . . . 74.43 109.665 169.728 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 126' ' ' HIS . . . . . . . . . . . . . 22.8 t60 -66.34 136.22 55.48 Favored 'General case' 0 CA--C 1.549 0.912 0 CA-C-O 121.35 0.595 . . . . 62.41 111.1 -178.815 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 7.1 p -59.15 147.97 7.43 Favored 'Isoleucine or valine' 0 CA--C 1.551 1.011 0 CA-C-N 113.976 -1.465 . . . . 54.05 111.726 178.03 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 128' ' ' VAL . . . . . 0.561 ' HB ' ' HB3' ' A' ' 90' ' ' LEU . 24.9 t -68.28 157.78 6.16 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.967 0 C-N-CA 123.482 0.713 . . . . 42.11 109.664 175.841 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 129' ' ' PHE . . . . . . . . . . . . . 49.1 p90 -138.9 -24.17 0.91 Allowed 'General case' 0 N--CA 1.478 0.971 0 C-N-CA 122.039 0.136 . . . . 74.22 111.127 174.189 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . -130.11 161.78 23.07 Favored Glycine 0 C--N 1.346 1.095 0 N-CA-C 112.242 -0.343 . . . . 31.1 112.242 -174.563 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 131' ' ' LYS . . . . . 0.432 ' HB3' ' HE2' ' A' ' 131' ' ' LYS . 31.2 ttpt -146.6 128.49 15.41 Favored 'General case' 0 N--CA 1.466 0.356 0 C-N-CA 123.689 0.796 . . . . 74.53 108.991 179.758 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 34.0 t -70.55 101.12 0.78 Allowed 'Isoleucine or valine' 0 CA--C 1.542 0.653 0 N-CA-C 109.282 -0.636 . . . . 63.04 109.282 177.807 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 133' ' ' LYS . . . . . 0.631 ' HD2' ' HB2' ' A' ' 23' ' ' GLU . 18.6 ptmt -87.81 -36.77 17.07 Favored 'General case' 0 N--CA 1.474 0.725 0 CA-C-N 115.615 -0.72 . . . . 74.23 109.781 -179.669 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 134' ' ' GLU . . . . . 0.524 ' HG2' ' HG3' ' A' ' 133' ' ' LYS . 30.8 mm-40 -124.23 144.93 49.67 Favored 'General case' 0 N--CA 1.472 0.648 0 C-N-CA 124.226 1.011 . . . . 75.23 108.8 176.706 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 78.47 21.45 69.58 Favored Glycine 0 N--CA 1.467 0.722 0 CA-C-O 119.582 -0.566 . . . . 53.34 113.375 175.037 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 136' ' ' MET . . . . . . . . . . . . . 16.3 tpt -62.34 -38.1 88.18 Favored 'General case' 0 N--CA 1.481 1.102 0 C-N-CA 123.042 0.537 . . . . 75.54 111.081 174.887 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 137' ' ' ASN . . . . . . . . . . . . . 16.3 m120 -64.29 -29.8 70.88 Favored 'General case' 0 CA--C 1.545 0.786 0 C-N-CA 122.937 0.495 . . . . 70.32 110.897 176.229 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 138' ' ' ILE . . . . . . . . . . . . . 46.8 mm -73.86 -36.1 44.73 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.039 0 C-N-CA 123.156 0.583 . . . . 73.21 110.153 175.797 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 139' ' ' VAL . . . . . 0.523 HG12 HG22 ' A' ' 116' ' ' THR . 91.8 t -65.91 -40.31 87.1 Favored 'Isoleucine or valine' 0 CA--C 1.555 1.149 0 C-N-CA 123.361 0.665 . . . . 73.13 110.674 178.112 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 44.1 mt-10 -74.03 -29.08 61.74 Favored 'General case' 0 N--CA 1.477 0.917 0 CA-C-N 115.64 -0.709 . . . . 75.15 110.622 177.209 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -70.86 -43.36 68.63 Favored 'General case' 0 N--CA 1.478 0.938 0 C-N-CA 122.902 0.481 . . . . 64.23 111.15 176.064 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 142' ' ' MET . . . . . 0.581 ' HB2' HD13 ' A' ' 156' ' ' ILE . 25.2 ptm -72.92 -28.05 62.22 Favored 'General case' 0 N--CA 1.477 0.878 0 C-N-CA 123.074 0.55 . . . . 72.51 111.315 -178.132 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 34.0 tt0 -59.98 -32.55 70.94 Favored 'General case' 0 C--N 1.357 0.897 0 O-C-N 123.597 0.561 . . . . 72.42 111.937 178.352 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 144' ' ' ARG . . . . . . . . . . . . . 38.6 mtm-85 -67.45 -18.79 65.22 Favored 'General case' 0 N--CA 1.477 0.882 0 C-N-CA 123.038 0.535 . . . . 73.23 111.986 -178.363 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 145' ' ' PHE . . . . . 0.522 ' HB2' HD11 ' A' ' 156' ' ' ILE . 45.2 m-85 -83.01 -5.57 59.15 Favored 'General case' 0 N--CA 1.477 0.896 0 C-N-CA 122.871 0.469 . . . . 74.34 111.412 177.185 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . -87.23 175.15 46.04 Favored Glycine 0 C--N 1.347 1.188 0 O-C-N 123.444 0.465 . . . . 61.22 112.12 172.436 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 29.7 m -134.75 169.49 17.27 Favored 'General case' 0 N--CA 1.483 1.209 0 C-N-CA 123.392 0.677 . . . . 73.2 111.59 -174.445 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 148' ' ' ARG . . . . . . . . . . . . . 8.7 mmm180 -57.59 -41.26 80.82 Favored 'General case' 0 N--CA 1.487 1.383 0 C-N-CA 124.81 1.244 . . . . 73.01 113.065 179.927 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 149' ' ' ASN . . . . . . . . . . . . . 30.5 p-10 -75.24 -17.69 60.27 Favored 'General case' 0 N--CA 1.478 0.945 0 C-N-CA 122.958 0.503 . . . . 73.03 111.238 178.191 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 150' ' ' GLY . . . . . 0.464 ' O ' ' HA ' ' A' ' 55' ' ' ARG . . . 111.65 -10.2 28.0 Favored Glycine 0 C--N 1.348 1.222 0 O-C-N 123.706 0.629 . . . . 64.45 112.378 -179.554 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 25.1 ttmm -65.55 137.64 57.52 Favored 'General case' 0 N--CA 1.471 0.624 0 C-N-CA 122.875 0.47 . . . . 74.41 111.177 -175.765 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 152' ' ' THR . . . . . . . . . . . . . 41.1 p -90.42 109.76 20.88 Favored 'General case' 0 C--O 1.239 0.516 0 N-CA-C 108.198 -1.038 . . . . 63.45 108.198 174.493 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 153' ' ' SER . . . . . . . . . . . . . 19.3 m -62.56 -29.36 70.52 Favored 'General case' 0 CA--C 1.544 0.75 0 C-N-CA 124.039 0.936 . . . . 71.33 110.804 176.172 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 154' ' ' LYS . . . . . 0.541 ' HB3' HG13 ' A' ' 12' ' ' VAL . 48.1 mmtm -118.63 133.92 55.5 Favored 'General case' 0 CA--C 1.54 0.561 0 CA-C-N 114.609 -1.178 . . . . 64.33 108.832 175.281 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 16.9 tppt? -78.99 91.68 4.87 Favored 'General case' 0 N--CA 1.473 0.689 0 N-CA-C 109.627 -0.509 . . . . 71.13 109.627 -178.272 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 156' ' ' ILE . . . . . 0.581 HD13 ' HB2' ' A' ' 142' ' ' MET . 70.5 mt -84.92 117.14 29.66 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.357 0 N-CA-C 109.835 -0.431 . . . . 74.33 109.835 -175.242 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 157' ' ' THR . . . . . . . . . . . . . 54.8 p -115.91 156.34 26.36 Favored 'General case' 0 N--CA 1.473 0.707 0 C-N-CA 124.232 1.013 . . . . 55.35 110.015 -179.126 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 158' ' ' ILE . . . . . . . . . . . . . 63.7 mt -80.6 96.0 2.68 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.819 0 N-CA-C 108.283 -1.006 . . . . 73.42 108.283 169.786 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 159' ' ' ALA . . . . . 0.655 ' HB2' ' HB2' ' A' ' 11' ' ' ALA . . . -55.55 -53.14 60.09 Favored 'General case' 0 N--CA 1.478 0.939 0 C-N-CA 124.331 1.053 . . . . 62.42 111.784 -178.177 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 160' ' ' ASP . . . . . 0.558 ' HA ' ' HE3' ' A' ' 49' ' ' LYS . 0.9 OUTLIER -140.17 175.21 9.78 Favored 'General case' 0 N--CA 1.473 0.724 0 CA-C-N 115.798 -0.637 . . . . 71.51 110.405 -176.509 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 161' ' ' CYS . . . . . . . . . . . . . 63.2 m -146.23 -169.82 3.35 Favored 'General case' 0 CA--C 1.547 0.852 0 C-N-CA 125.147 1.379 . . . . 55.1 108.4 -172.674 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 162' ' ' GLY . . . . . . . . . . . . . . . 131.71 53.26 0.09 OUTLIER Glycine 0 C--N 1.348 1.216 0 N-CA-C 112.151 -0.38 . . . . 64.43 112.151 -177.836 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 163' ' ' GLN . . . . . 0.706 ' HG3' ' HA ' ' A' ' 6' ' ' VAL . 43.4 tt0 -46.21 110.53 0.28 Allowed 'General case' 0 N--CA 1.48 1.032 0 C-N-CA 125.035 1.334 . . . . 75.32 112.392 -177.349 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 164' ' ' LEU . . . . . 0.445 ' O ' ' HB ' ' A' ' 5' ' ' THR . 45.3 mt . . . . . 0 CA--C 1.543 0.704 0 N-CA-C 108.63 -0.878 . . . . 71.25 108.63 -179.357 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 218' ' ' PRO . . . . . 0.568 ' HG3' ' HA2' ' A' ' 72' ' ' GLY . 45.7 Cg_endo . . . . . 0 CA--C 1.544 0.977 0 N-CA-C 109.973 -0.818 . . . . 72.41 109.973 . . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 219' ' ' GLY . . . . . . . . . . . . . . . 147.16 -161.42 28.47 Favored Glycine 0 CA--C 1.527 0.791 0 CA-C-N 114.71 -1.132 . . . . 71.03 111.492 -171.489 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 220' ' ' PRO . . . . . . . . . . . . . 64.0 Cg_endo -91.03 168.87 3.56 Favored 'Trans proline' 0 C--N 1.363 1.298 0 C-N-CA 123.412 2.742 . . . . 63.4 114.677 -176.644 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 221' ' ' TYR . . . . . . . . . . . . . 88.0 t80 . . . . . 0 N--CA 1.484 1.248 0 C-N-CA 123.538 0.735 . . . . 74.41 109.184 169.921 . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 24.2 m-80 . . . . . 0 CA--C 1.549 0.911 0 CA-C-O 119.181 -0.438 . . . . 73.54 111.429 . . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 4' ' ' PRO . . . . . 0.589 ' HG2' ' HB2' ' A' ' 24' ' ' LEU . 29.7 Cg_endo -65.06 123.42 11.55 Favored 'Trans proline' 0 C--N 1.379 2.18 0 C-N-CA 122.356 2.037 . . . . 65.51 110.298 170.694 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 5' ' ' THR . . . . . 0.62 HG23 ' HD3' ' A' ' 133' ' ' LYS . 99.3 m -96.48 119.39 34.89 Favored 'General case' 0 C--N 1.328 -0.351 0 N-CA-C 108.743 -0.836 . . . . 70.31 108.743 -174.811 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 32.1 m -102.77 123.66 56.28 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.646 0 N-CA-C 109.772 -0.455 . . . . 73.31 109.772 -177.694 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 7' ' ' PHE . . . . . 0.589 ' H ' ' HA ' ' A' ' 163' ' ' GLN . 76.7 t80 -109.89 130.16 55.56 Favored 'General case' 0 N--CA 1.47 0.543 0 C-N-CA 123.307 0.643 . . . . 73.13 109.849 -174.398 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 8' ' ' PHE . . . . . 0.456 ' HB3' HG23 ' A' ' 158' ' ' ILE . 36.9 m-85 -135.31 165.64 24.98 Favored 'General case' 0 N--CA 1.472 0.649 0 C-N-CA 124.604 1.162 . . . . 71.21 109.449 173.485 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 18.5 m-20 -120.15 115.08 22.94 Favored 'General case' 0 N--CA 1.467 0.423 0 C-N-CA 124.456 1.102 . . . . 71.0 108.544 171.532 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 10' ' ' ILE . . . . . 0.531 HG21 ' SD ' ' A' ' 142' ' ' MET . 44.3 mm -83.85 132.45 31.47 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.562 0 C-N-CA 123.611 0.764 . . . . 64.11 108.98 178.98 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 11' ' ' ALA . . . . . 0.408 ' O ' ' HA ' ' A' ' 156' ' ' ILE . . . -139.72 135.49 33.2 Favored 'General case' 0 N--CA 1.465 0.299 0 C-N-CA 122.561 0.345 . . . . 73.22 111.799 -171.984 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 14.6 m -96.03 113.77 31.2 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.682 0 C-N-CA 124.703 1.201 . . . . 61.23 109.487 179.752 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 54.8 m-20 63.35 20.43 12.26 Favored 'General case' 0 N--CA 1.489 1.521 0 C-N-CA 125.039 1.336 . . . . 71.35 110.987 -170.262 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 89.44 -6.4 83.29 Favored Glycine 0 C--N 1.348 1.244 0 CA-C-N 116.225 -0.443 . . . . 61.21 113.258 -174.774 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 27.2 mm-40 -86.51 125.99 65.7 Favored Pre-proline 0 CA--C 1.548 0.871 0 C-N-CA 123.39 0.676 . . . . 74.14 110.305 179.356 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 18.0 Cg_endo -52.64 101.85 0.06 OUTLIER 'Trans proline' 0 C--N 1.386 2.536 0 C-N-CA 124.168 3.245 . . . . 74.11 113.996 -170.475 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 53.1 tp -79.19 -35.87 41.14 Favored 'General case' 0 N--CA 1.479 1.003 0 N-CA-C 109.261 -0.644 . . . . 52.4 109.261 175.454 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 166.21 -173.82 41.73 Favored Glycine 0 C--N 1.337 0.614 0 CA-C-N 115.153 -0.93 . . . . 61.43 111.563 176.817 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 47.7 ptt85 -110.59 141.75 43.36 Favored 'General case' 0 C--O 1.239 0.51 0 C-N-CA 123.983 0.913 . . . . 75.54 109.255 177.51 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 93.7 t -134.88 121.2 33.32 Favored 'Isoleucine or valine' 0 C--O 1.239 0.504 0 C-N-CA 123.633 0.773 . . . . 52.22 109.253 175.202 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 21' ' ' SER . . . . . 0.478 ' HB3' ' HB2' ' A' ' 134' ' ' GLU . 22.8 t -115.1 136.99 52.52 Favored 'General case' 0 CA--C 1.539 0.548 0 N-CA-C 108.48 -0.933 . . . . 72.45 108.48 174.516 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 41.8 m-85 -109.69 169.14 8.9 Favored 'General case' 0 N--CA 1.472 0.668 0 C-N-CA 123.675 0.79 . . . . 61.22 110.235 177.684 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 23' ' ' GLU . . . . . 0.624 ' HB2' ' HD2' ' A' ' 133' ' ' LYS . 37.4 tt0 -122.22 103.7 8.95 Favored 'General case' 0 CA--C 1.538 0.503 0 C-N-CA 125.581 1.552 . . . . 75.01 107.938 -176.953 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 24' ' ' LEU . . . . . 0.589 ' HB2' ' HG2' ' A' ' 4' ' ' PRO . 18.4 mt -82.99 124.51 30.47 Favored 'General case' 0 N--CA 1.474 0.761 0 N-CA-C 109.454 -0.572 . . . . 61.32 109.454 -179.279 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 68.2 m-85 -86.6 69.37 10.35 Favored 'General case' 0 CA--C 1.534 0.357 0 C-N-CA 123.324 0.65 . . . . 74.0 109.38 179.292 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -64.65 -20.09 66.09 Favored 'General case' 0 N--CA 1.484 1.225 0 C-N-CA 123.553 0.741 . . . . 53.34 111.727 179.763 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 12.0 p-10 -74.67 -23.18 58.6 Favored 'General case' 0 CA--C 1.545 0.754 0 C-N-CA 124.308 1.043 . . . . 72.31 112.163 177.708 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 58.7 mttp -105.91 -41.54 5.38 Favored 'General case' 0 N--CA 1.486 1.328 0 C-N-CA 123.757 0.823 . . . . 62.15 111.245 -179.056 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 29' ' ' VAL . . . . . 0.585 HG12 ' HG2' ' A' ' 86' ' ' GLU . 10.7 m -138.26 74.25 42.3 Favored Pre-proline 0 CA--C 1.56 1.33 0 C-N-CA 124.445 1.098 . . . . 74.02 109.873 -172.552 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 59.2 Cg_endo -67.51 -37.97 15.76 Favored 'Trans proline' 0 C--N 1.377 2.067 0 C-N-CA 122.961 2.441 . . . . 73.04 113.383 -171.47 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 48.1 tttp -73.86 -42.09 61.3 Favored 'General case' 0 N--CA 1.478 0.95 0 C-N-CA 123.669 0.788 . . . . 73.22 110.907 -173.507 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 11.3 m -73.21 -36.98 66.59 Favored 'General case' 0 CA--C 1.547 0.832 0 CA-C-N 115.728 -0.669 . . . . 65.35 110.406 -177.707 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -67.11 -41.68 85.82 Favored 'General case' 0 CA--C 1.55 0.948 0 C-N-CA 123.053 0.541 . . . . 75.11 110.684 173.71 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 38.5 tt0 -59.92 -42.19 93.37 Favored 'General case' 0 N--CA 1.483 1.22 0 C-N-CA 124.655 1.182 . . . . 72.43 111.462 -179.428 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 35' ' ' ASN . . . . . 0.469 ' O ' ' HG ' ' A' ' 39' ' ' LEU . 47.7 t30 -56.92 -68.02 0.26 Allowed 'General case' 0 C--N 1.358 0.961 0 O-C-N 124.322 1.014 . . . . 64.24 110.266 -177.196 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 90.6 t80 -57.62 -40.7 79.74 Favored 'General case' 0 N--CA 1.474 0.734 0 O-C-N 124.315 1.009 . . . . 73.34 111.683 -175.683 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 71.5 ttt180 -58.3 -54.88 42.0 Favored 'General case' 0 C--N 1.354 0.802 0 O-C-N 123.719 0.637 . . . . 70.24 110.456 178.564 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 38' ' ' ALA . . . . . 0.448 ' HB3' HG21 ' A' ' 78' ' ' ILE . . . -64.76 -30.09 71.09 Favored 'General case' 0 N--CA 1.475 0.815 0 C-N-CA 123.616 0.766 . . . . 34.44 111.656 -175.099 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 39' ' ' LEU . . . . . 0.588 ' HB3' ' HD2' ' A' ' 48' ' ' TYR . 89.8 mt -63.11 -46.0 89.37 Favored 'General case' 0 N--CA 1.471 0.613 0 C-N-CA 123.545 0.738 . . . . 74.14 110.29 173.604 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 50.7 m -74.35 -39.1 63.01 Favored 'General case' 0 CA--C 1.547 0.843 0 C-N-CA 123.494 0.717 . . . . 72.14 112.018 -173.275 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -75.8 -30.81 59.2 Favored 'General case' 0 N--CA 1.482 1.15 0 C-N-CA 122.582 0.353 . . . . 62.21 110.581 178.195 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 84.87 32.45 21.19 Favored Glycine 0 C--N 1.347 1.152 0 CA-C-N 115.98 -0.555 . . . . 70.34 111.795 -174.432 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 5.2 mm-40 -63.65 -25.34 68.17 Favored 'General case' 0 N--CA 1.481 1.108 0 C-N-CA 123.565 0.746 . . . . 72.14 110.519 175.042 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 44' ' ' LYS . . . . . 0.458 ' HG3' ' HB ' ' A' ' 78' ' ' ILE . 29.2 mmmt -110.75 19.08 18.97 Favored 'General case' 0 CA--C 1.547 0.842 0 C-N-CA 124.2 1.0 . . . . 53.52 110.922 -178.999 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 78.88 -0.23 78.94 Favored Glycine 0 C--N 1.355 1.6 0 N-CA-C 115.05 0.78 . . . . 61.24 115.05 174.616 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 20.2 m-85 -85.62 -47.84 9.46 Favored 'General case' 0 N--CA 1.48 1.041 0 CA-C-N 117.785 0.793 . . . . 53.24 111.074 -174.181 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 49.66 62.64 4.7 Favored Glycine 0 C--N 1.355 1.619 0 O-C-N 124.358 1.036 . . . . 74.12 113.83 174.937 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 48' ' ' TYR . . . . . 0.588 ' HD2' ' HB3' ' A' ' 39' ' ' LEU . 35.5 m-85 -65.56 90.42 0.11 Allowed 'General case' 0 N--CA 1.474 0.759 0 CA-C-O 122.109 0.957 . . . . 73.41 111.773 -176.309 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 49' ' ' LYS . . . . . 0.595 ' HE3' ' HA ' ' A' ' 160' ' ' ASP . 24.1 tptm -109.88 131.25 55.23 Favored 'General case' 0 C--O 1.238 0.486 0 CA-C-N 113.686 -1.597 . . . . 64.21 108.53 179.939 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 79.95 20.36 68.05 Favored Glycine 0 C--N 1.346 1.137 0 CA-C-O 119.85 -0.417 . . . . 60.11 113.203 -179.464 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 39.0 t -60.69 126.75 28.57 Favored 'General case' 0 N--CA 1.479 1.021 0 C-N-CA 123.907 0.883 . . . . 72.14 110.243 179.39 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 52' ' ' CYS . . . . . . . . . . . . . 26.8 p -97.92 120.52 38.45 Favored 'General case' 0 N--CA 1.475 0.783 0 O-C-N 123.618 0.574 . . . . 74.44 111.933 -168.517 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 53' ' ' PHE . . . . . 0.749 ' HA ' ' HA2' ' A' ' 64' ' ' GLY . 82.3 m-85 -67.55 92.72 0.32 Allowed 'General case' 0 CA--C 1.536 0.442 0 C-N-CA 123.759 0.824 . . . . 61.1 108.884 166.894 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 26.2 p-80 -101.09 -9.81 21.04 Favored 'General case' 0 N--CA 1.475 0.795 0 CA-C-N 114.922 -1.035 . . . . 63.05 111.881 -172.215 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 37.8 ttt180 -132.28 98.99 4.55 Favored 'General case' 0 N--CA 1.472 0.628 0 N-CA-C 108.952 -0.759 . . . . 71.03 108.952 177.712 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 53.7 mt -128.12 130.95 69.75 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.82 0 N-CA-C 109.367 -0.605 . . . . 73.34 109.367 176.167 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 59.5 mt -125.12 124.85 25.33 Favored Pre-proline 0 CA--C 1.558 1.268 0 C-N-CA 124.172 0.989 . . . . 71.31 108.851 175.132 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 24.3 Cg_endo -60.37 151.13 76.55 Favored 'Trans proline' 0 C--N 1.385 2.499 0 C-N-CA 123.6 2.867 . . . . 73.33 113.795 -177.541 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 61.44 16.03 48.31 Favored Glycine 0 C--N 1.348 1.24 0 CA-C-N 114.963 -1.017 . . . . 62.44 114.086 179.715 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 36.3 t80 -137.28 -73.6 0.42 Allowed 'General case' 0 C--O 1.239 0.55 0 C-N-CA 123.274 0.63 . . . . 71.4 110.297 -171.735 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 51.4 ttp -171.05 138.43 1.28 Allowed 'General case' 0 N--CA 1.475 0.822 0 O-C-N 123.095 0.247 . . . . 54.23 111.567 -164.018 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 62' ' ' CYS . . . . . 0.563 ' SG ' ' HB ' ' A' ' 114' ' ' ILE . 21.9 p -108.03 110.85 22.65 Favored 'General case' 0 CA--C 1.548 0.881 0 C-N-CA 123.577 0.751 . . . . 71.45 109.266 168.017 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 63' ' ' GLN . . . . . 0.464 ' HA ' ' HA ' ' A' ' 113' ' ' PHE . 52.0 tt0 -102.71 118.59 37.16 Favored 'General case' 0 N--CA 1.48 1.067 0 C-N-CA 124.353 1.061 . . . . 64.32 110.464 -175.172 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 64' ' ' GLY . . . . . 0.749 ' HA2' ' HA ' ' A' ' 53' ' ' PHE . . . -95.81 165.49 24.49 Favored Glycine 0 C--N 1.342 0.884 0 CA-C-N 115.262 -0.881 . . . . 43.25 112.842 177.292 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 65' ' ' GLY . . . . . 0.419 ' HA3' ' HG2' ' A' ' 111' ' ' GLN . . . 177.19 133.04 1.76 Allowed Glycine 0 C--N 1.337 0.591 0 N-CA-C 111.922 -0.471 . . . . 44.33 111.922 179.286 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 22.6 t70 -75.78 170.3 16.47 Favored 'General case' 0 CA--C 1.551 0.993 0 C-N-CA 123.437 0.695 . . . . 74.11 110.867 -176.137 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 74.2 t80 -69.8 -25.78 63.95 Favored 'General case' 0 CA--C 1.553 1.071 0 C-N-CA 123.435 0.694 . . . . 71.31 111.285 176.547 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 63.4 m -63.37 109.48 1.61 Allowed 'General case' 0 N--CA 1.478 0.947 0 C-N-CA 123.415 0.686 . . . . 74.31 110.782 179.519 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 58.4 mtt180 59.63 34.52 22.27 Favored 'General case' 0 N--CA 1.479 0.997 0 C-N-CA 125.068 1.347 . . . . 73.14 111.435 -176.597 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 36.8 p-80 -55.42 -20.31 11.85 Favored 'General case' 0 N--CA 1.497 1.918 0 C-N-CA 123.558 0.743 . . . . 72.34 112.886 -172.43 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 5.1 t30 -66.08 87.28 0.1 Allowed 'General case' 0 CA--C 1.554 1.109 0 C-N-CA 124.257 1.023 . . . . 75.34 109.827 167.956 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 76.41 -7.2 32.8 Favored Glycine 0 CA--C 1.535 1.321 0 N-CA-C 115.805 1.082 . . . . 34.25 115.805 172.097 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 73' ' ' THR . . . . . 0.6 ' HA ' ' HB2' ' A' ' 110' ' ' SER . 79.2 m -118.09 -65.84 1.14 Allowed 'General case' 0 N--CA 1.479 0.997 0 CA-C-N 118.598 1.199 . . . . 73.44 110.843 -178.861 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 49.76 54.42 17.78 Favored Glycine 0 C--N 1.356 1.655 0 O-C-N 123.838 0.711 . . . . 31.43 114.379 172.967 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 127.07 55.37 0.14 Allowed Glycine 0 N--CA 1.469 0.895 0 C-N-CA 120.964 -0.636 . . . . 71.41 111.778 -172.449 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 76' ' ' LYS . . . . . 0.557 ' HG2' ' OH ' ' A' ' 48' ' ' TYR . 14.8 ptmm? -52.4 164.38 0.33 Allowed 'General case' 0 N--CA 1.49 1.54 0 C-N-CA 124.117 0.967 . . . . 74.43 111.915 178.584 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 94.9 p -88.95 175.38 7.45 Favored 'General case' 0 C--O 1.247 0.938 0 CA-C-O 121.214 0.53 . . . . 53.01 110.441 -171.981 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 78' ' ' ILE . . . . . 0.458 ' HB ' ' HG3' ' A' ' 44' ' ' LYS . 38.6 pt -74.64 -24.82 18.65 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.654 0 CA-C-N 115.344 -0.843 . . . . 60.42 110.757 179.726 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 51.0 m-85 -86.93 -43.34 12.47 Favored 'General case' 0 N--CA 1.476 0.865 0 C-N-CA 123.713 0.805 . . . . 71.44 110.337 -178.866 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -165.69 -134.79 1.73 Allowed Glycine 0 C--N 1.339 0.745 0 N-CA-C 110.539 -1.024 . . . . 74.15 110.539 -179.098 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 81' ' ' GLU . . . . . 0.529 ' HA ' ' HB2' ' A' ' 76' ' ' LYS . 36.6 tt0 -75.38 -36.8 60.86 Favored 'General case' 0 N--CA 1.477 0.879 0 CA-C-N 117.498 0.649 . . . . 64.33 109.734 175.293 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 82' ' ' LYS . . . . . 0.749 ' HD2' ' HA ' ' A' ' 107' ' ' THR . 19.7 pttp -159.62 166.58 30.37 Favored 'General case' 0 CA--C 1.544 0.732 0 C-N-CA 124.343 1.057 . . . . 62.12 109.309 -170.189 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 11.8 p90 -143.92 174.31 10.95 Favored 'General case' 0 N--CA 1.473 0.723 0 C-N-CA 124.064 0.945 . . . . 73.54 109.111 179.112 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 84' ' ' GLU . . . . . 0.414 ' HA ' ' HA ' ' A' ' 106' ' ' ASN . 11.7 pt-20 -79.19 -175.71 4.77 Favored 'General case' 0 CA--C 1.545 0.775 0 C-N-CA 123.519 0.728 . . . . 74.33 112.083 -178.521 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 30.5 m-20 -85.35 149.51 25.39 Favored 'General case' 0 N--CA 1.475 0.809 0 C-N-CA 123.428 0.691 . . . . 62.13 109.93 -176.672 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 86' ' ' GLU . . . . . 0.585 ' HG2' HG12 ' A' ' 29' ' ' VAL . 3.2 tp10 -77.53 -61.74 1.89 Allowed 'General case' 0 N--CA 1.478 0.957 0 C-N-CA 123.263 0.625 . . . . 54.44 110.54 175.594 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 29.9 p30 -173.57 -156.82 0.08 Allowed 'General case' 0 N--CA 1.475 0.806 0 C-N-CA 125.192 1.397 . . . . 74.22 107.413 -172.826 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 82.2 m-85 -142.04 39.18 1.62 Allowed 'General case' 0 N--CA 1.494 1.729 0 C-N-CA 123.245 0.618 . . . . 65.53 110.824 176.952 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 70.5 mt -65.01 -62.94 1.0 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.483 0 CA-C-O 121.312 0.577 . . . . 64.03 110.423 178.602 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 90' ' ' LEU . . . . . 0.409 ' H ' HG23 ' A' ' 127' ' ' VAL . 87.4 mt -86.9 135.82 33.18 Favored 'General case' 0 N--CA 1.47 0.547 0 C-N-CA 124.304 1.042 . . . . 74.4 110.643 -176.402 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 54.3 mtmt -118.89 160.02 22.71 Favored 'General case' 0 N--CA 1.473 0.723 0 C-N-CA 123.88 0.872 . . . . 71.14 111.072 -177.871 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 92' ' ' HIS . . . . . 0.534 ' HA ' HG21 ' A' ' 97' ' ' ILE . 13.6 m80 -83.25 21.14 1.16 Allowed 'General case' 0 N--CA 1.481 1.099 0 C-N-CA 124.777 1.231 . . . . 70.22 111.664 -174.436 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 11.4 t -86.74 31.32 0.69 Allowed 'General case' 0 CA--C 1.56 1.345 0 C-N-CA 124.259 1.024 . . . . 64.43 111.237 -170.562 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -151.14 162.38 29.44 Favored Glycine 0 C--N 1.348 1.208 0 N-CA-C 111.705 -0.558 . . . . 33.11 111.705 176.404 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 73.3 Cg_endo -75.96 145.53 28.37 Favored 'Trans proline' 0 C--N 1.369 1.615 0 C-N-CA 122.689 2.259 . . . . 71.33 112.292 173.757 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 96' ' ' GLY . . . . . 0.523 ' HA3' HG12 ' A' ' 132' ' ' VAL . . . 79.76 17.85 74.26 Favored Glycine 0 C--N 1.345 1.058 0 CA-C-N 116.078 -0.51 . . . . 53.31 114.334 177.475 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 97' ' ' ILE . . . . . 0.534 HG21 ' HA ' ' A' ' 92' ' ' HIS . 8.3 mm -71.41 124.25 27.43 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.893 0 C-N-CA 124.236 1.014 . . . . 63.21 110.757 178.963 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 63.2 tp -108.56 115.34 29.92 Favored 'General case' 0 N--CA 1.484 1.273 0 C-N-CA 123.53 0.732 . . . . 62.42 110.355 179.059 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 18.5 m -133.78 144.5 49.08 Favored 'General case' 0 N--CA 1.48 1.06 0 C-N-CA 124.632 1.173 . . . . 73.13 108.641 174.123 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 100' ' ' MET . . . . . 0.647 ' HA ' ' HA ' ' A' ' 112' ' ' PHE . 72.6 mtp -78.7 137.22 37.69 Favored 'General case' 0 N--CA 1.488 1.471 0 CA-C-N 118.412 0.551 . . . . 73.22 110.008 178.786 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 101' ' ' ALA . . . . . 0.477 ' HB3' ' HB2' ' A' ' 111' ' ' GLN . . . -72.32 168.78 17.64 Favored 'General case' 0 N--CA 1.481 1.088 0 C-N-CA 123.109 0.564 . . . . 55.15 111.981 -170.803 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 102' ' ' ASN . . . . . 0.57 ' HB3' ' HA ' ' A' ' 108' ' ' ASN . 29.4 p-10 -168.04 179.16 4.74 Favored 'General case' 0 CA--C 1.542 0.655 0 CA-C-N 115.646 -0.707 . . . . 62.23 111.278 -177.597 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -117.08 -5.41 11.4 Favored 'General case' 0 N--CA 1.479 0.999 0 C-N-CA 124.188 0.995 . . . . 70.44 110.726 169.165 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 163.7 -171.36 39.32 Favored Glycine 0 C--N 1.358 1.782 0 CA-C-O 119.507 -0.607 . . . . 75.34 112.901 179.695 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 52.7 Cg_exo -57.9 143.25 96.23 Favored 'Trans proline' 0 C--N 1.378 2.12 0 C-N-CA 123.419 2.746 . . . . 73.31 112.041 172.791 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 106' ' ' ASN . . . . . 0.414 ' HA ' ' HA ' ' A' ' 84' ' ' GLU . 65.6 t30 66.07 12.82 8.75 Favored 'General case' 0 N--CA 1.488 1.467 0 C-N-CA 124.135 0.974 . . . . 73.33 111.243 -178.617 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 107' ' ' THR . . . . . 0.749 ' HA ' ' HD2' ' A' ' 82' ' ' LYS . 6.4 m -123.72 1.48 8.8 Favored 'General case' 0 CA--C 1.556 1.188 0 C-N-CA 124.128 0.971 . . . . 63.41 110.017 179.665 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 108' ' ' ASN . . . . . 0.57 ' HA ' ' HB3' ' A' ' 102' ' ' ASN . 40.0 t30 -70.88 143.77 50.9 Favored 'General case' 0 N--CA 1.479 1.024 0 C-N-CA 124.26 1.024 . . . . 73.22 110.604 -178.626 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 94.93 20.66 27.79 Favored Glycine 0 N--CA 1.47 0.957 0 N-CA-C 113.847 0.299 . . . . 64.03 113.847 177.983 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 110' ' ' SER . . . . . 0.6 ' HB2' ' HA ' ' A' ' 73' ' ' THR . 27.5 p -112.42 118.37 34.99 Favored 'General case' 0 CA--C 1.54 0.591 0 N-CA-C 107.525 -1.287 . . . . 41.05 107.525 169.758 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 111' ' ' GLN . . . . . 0.524 ' HG3' ' O ' ' A' ' 73' ' ' THR . 38.3 mt-30 65.35 -177.94 0.18 Allowed 'General case' 0 N--CA 1.495 1.812 0 C-N-CA 124.183 0.993 . . . . 62.34 110.672 -168.284 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 112' ' ' PHE . . . . . 0.647 ' HA ' ' HA ' ' A' ' 100' ' ' MET . 30.0 p90 -147.99 158.58 44.13 Favored 'General case' 0 N--CA 1.472 0.667 0 C-N-CA 124.105 0.962 . . . . 73.31 108.805 175.685 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 113' ' ' PHE . . . . . 0.464 ' HA ' ' HA ' ' A' ' 63' ' ' GLN . 53.1 p90 -146.82 145.22 29.82 Favored 'General case' 0 C--O 1.235 0.326 0 CA-C-O 121.057 0.456 . . . . 74.25 110.701 -179.581 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 114' ' ' ILE . . . . . 0.563 ' HB ' ' SG ' ' A' ' 62' ' ' CYS . 10.7 mt -115.51 102.26 13.49 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.456 0 N-CA-C 107.066 -1.457 . . . . 73.24 107.066 177.512 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 115' ' ' CYS . . . . . 0.493 ' HB2' ' HB ' ' A' ' 97' ' ' ILE . 50.5 m -60.85 103.38 0.26 Allowed 'General case' 0 C--N 1.348 0.518 0 N-CA-C 108.432 -0.951 . . . . 62.22 108.432 172.044 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 116' ' ' THR . . . . . 0.545 HG22 HG12 ' A' ' 139' ' ' VAL . 34.6 p -71.51 -32.7 68.5 Favored 'General case' 0 N--CA 1.47 0.568 0 C-N-CA 123.833 0.853 . . . . 74.3 110.183 -175.195 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -115.35 169.16 9.35 Favored 'General case' 0 N--CA 1.472 0.663 0 C-N-CA 123.99 0.916 . . . . 74.24 109.857 172.39 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 15.0 ptmt -66.76 115.85 7.01 Favored 'General case' 0 CA--C 1.549 0.926 0 CA-C-O 121.269 0.557 . . . . 72.2 110.074 176.029 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 119' ' ' THR . . . . . 0.559 ' HB ' HD13 ' A' ' 122' ' ' LEU . 43.7 p -115.76 87.86 2.76 Favored 'General case' 0 CA--C 1.546 0.798 0 CA-C-O 121.712 0.767 . . . . 74.22 110.363 -178.76 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 11.9 pt-20 -80.22 -19.99 45.67 Favored 'General case' 0 N--CA 1.481 1.082 0 CA-C-N 115.744 -0.662 . . . . 73.13 111.278 -176.462 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 121' ' ' TRP . . . . . . . . . . . . . 33.5 p90 -77.64 -7.34 56.28 Favored 'General case' 0 N--CA 1.477 0.919 0 C-N-CA 122.999 0.52 . . . . 71.52 110.569 173.479 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 122' ' ' LEU . . . . . 0.559 HD13 ' HB ' ' A' ' 119' ' ' THR . 9.9 mp -88.86 -7.88 55.31 Favored 'General case' 0 N--CA 1.481 1.076 0 C-N-CA 123.638 0.775 . . . . 72.5 110.698 169.708 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 44.3 m-20 -79.06 150.77 31.77 Favored 'General case' 0 N--CA 1.478 0.969 0 N-CA-C 108.751 -0.833 . . . . 54.43 108.751 173.128 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 97.03 -28.31 14.43 Favored Glycine 0 CA--C 1.526 0.722 0 N-CA-C 110.48 -1.048 . . . . 65.43 110.48 -165.045 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 2.3 mppt? -85.37 -174.07 5.01 Favored 'General case' 0 N--CA 1.478 0.938 0 C-N-CA 124.139 0.976 . . . . 75.13 109.453 170.711 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 126' ' ' HIS . . . . . . . . . . . . . 49.9 p-80 -68.92 154.12 42.6 Favored 'General case' 0 N--CA 1.475 0.824 0 C-N-CA 123.756 0.822 . . . . 73.42 111.374 -166.204 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 127' ' ' VAL . . . . . 0.409 HG23 ' H ' ' A' ' 90' ' ' LEU . 13.6 p -60.56 149.44 7.6 Favored 'Isoleucine or valine' 0 CA--C 1.552 1.035 0 C-N-CA 125.363 1.465 . . . . 71.24 113.569 -176.915 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 128' ' ' VAL . . . . . 0.41 HG11 HD12 ' A' ' 97' ' ' ILE . 46.5 t -76.94 153.64 5.62 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.82 0 C-N-CA 124.805 1.242 . . . . 74.15 109.688 171.661 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 129' ' ' PHE . . . . . 0.544 ' HA ' HG21 ' A' ' 29' ' ' VAL . 26.4 p90 -129.66 -19.73 3.32 Favored 'General case' 0 N--CA 1.482 1.173 0 CA-C-N 117.914 0.325 . . . . 75.22 111.572 178.256 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . -134.12 162.73 24.55 Favored Glycine 0 C--N 1.339 0.747 0 N-CA-C 112.297 -0.321 . . . . 73.45 112.297 -176.234 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 131' ' ' LYS . . . . . 0.42 ' HE2' ' HB3' ' A' ' 131' ' ' LYS . 29.4 ttpt -150.14 134.34 17.13 Favored 'General case' 0 N--CA 1.472 0.626 0 N-CA-C 107.757 -1.201 . . . . 62.21 107.757 177.123 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 132' ' ' VAL . . . . . 0.523 HG12 ' HA3' ' A' ' 96' ' ' GLY . 12.1 p -64.7 131.23 30.44 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.876 0 CA-C-O 121.117 0.484 . . . . 72.3 109.81 178.105 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 133' ' ' LYS . . . . . 0.624 ' HD2' ' HB2' ' A' ' 23' ' ' GLU . 0.1 OUTLIER -118.52 -24.19 6.88 Favored 'General case' 0 N--CA 1.473 0.725 0 C-N-CA 123.736 0.814 . . . . 74.14 110.046 179.185 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 134' ' ' GLU . . . . . 0.478 ' HB2' ' HB3' ' A' ' 21' ' ' SER . 20.8 mm-40 -133.79 129.42 36.56 Favored 'General case' 0 N--CA 1.472 0.673 0 C-N-CA 124.224 1.01 . . . . 72.31 109.224 177.677 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 79.51 36.2 27.11 Favored Glycine 0 C--N 1.345 1.06 0 O-C-N 123.634 0.584 . . . . 43.04 113.945 174.676 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 136' ' ' MET . . . . . . . . . . . . . 5.3 tpt -57.23 -43.6 83.04 Favored 'General case' 0 N--CA 1.491 1.607 0 C-N-CA 123.669 0.787 . . . . 61.44 110.085 172.164 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 137' ' ' ASN . . . . . . . . . . . . . 2.8 t-20 -61.4 -35.08 76.52 Favored 'General case' 0 CA--C 1.548 0.886 0 C-N-CA 124.058 0.943 . . . . 73.1 111.476 177.427 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 138' ' ' ILE . . . . . . . . . . . . . 45.5 mm -69.48 -37.61 75.28 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.999 0 C-N-CA 122.835 0.454 . . . . 72.21 110.349 177.839 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 139' ' ' VAL . . . . . 0.545 HG12 HG22 ' A' ' 116' ' ' THR . 85.8 t -64.3 -37.01 78.82 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.3 0 C-N-CA 123.475 0.71 . . . . 75.5 110.471 174.738 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 44.9 mt-10 -78.6 -19.01 53.7 Favored 'General case' 0 CA--C 1.543 0.683 0 CA-C-N 115.595 -0.73 . . . . 62.2 111.345 178.016 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -78.86 -48.57 14.44 Favored 'General case' 0 N--CA 1.475 0.784 0 C-N-CA 122.987 0.515 . . . . 52.24 110.17 177.069 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 142' ' ' MET . . . . . 0.558 ' HA ' ' HD2' ' A' ' 145' ' ' PHE . 25.5 ptm -65.5 -31.43 72.49 Favored 'General case' 0 N--CA 1.479 0.977 0 C-N-CA 123.502 0.721 . . . . 71.2 110.841 177.429 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 23.6 tt0 -48.41 -45.41 36.09 Favored 'General case' 0 N--CA 1.481 1.089 0 C-N-CA 124.997 1.319 . . . . 64.41 111.426 171.309 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 144' ' ' ARG . . . . . . . . . . . . . 90.7 mtt180 -73.11 -18.78 61.26 Favored 'General case' 0 N--CA 1.474 0.739 0 CA-C-N 114.542 -1.208 . . . . 74.52 111.845 -174.701 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 145' ' ' PHE . . . . . 0.558 ' HD2' ' HA ' ' A' ' 142' ' ' MET . 54.1 m-85 -80.62 -19.65 44.97 Favored 'General case' 0 N--CA 1.475 0.812 0 N-CA-C 109.929 -0.396 . . . . 72.34 109.929 174.13 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . -77.01 165.04 53.29 Favored Glycine 0 C--N 1.344 1.016 0 N-CA-C 111.881 -0.488 . . . . 64.44 111.881 172.586 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 10.1 m -133.08 170.47 15.35 Favored 'General case' 0 N--CA 1.479 1.006 0 C-N-CA 123.255 0.622 . . . . 73.2 110.384 -173.929 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 148' ' ' ARG . . . . . . . . . . . . . 34.7 mmt180 -64.48 -32.57 74.25 Favored 'General case' 0 N--CA 1.487 1.404 0 C-N-CA 123.612 0.765 . . . . 74.31 111.809 -179.417 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 149' ' ' ASN . . . . . . . . . . . . . 25.5 p-10 -75.85 -5.09 44.32 Favored 'General case' 0 N--CA 1.481 1.11 0 C-N-CA 123.09 0.556 . . . . 74.32 111.476 177.781 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . 97.13 -19.52 54.44 Favored Glycine 0 C--N 1.35 1.348 0 C-N-CA 123.115 0.388 . . . . 74.33 113.28 176.507 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 61.0 tttm -78.1 146.93 34.9 Favored 'General case' 0 N--CA 1.474 0.749 0 CA-C-N 117.169 0.485 . . . . 63.11 110.476 -176.481 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 152' ' ' THR . . . . . . . . . . . . . 77.7 p -92.91 162.99 13.86 Favored 'General case' 0 CA--C 1.549 0.907 0 C-N-CA 123.972 0.909 . . . . 52.43 110.447 177.734 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 153' ' ' SER . . . . . . . . . . . . . 37.8 m -96.64 -27.34 14.85 Favored 'General case' 0 N--CA 1.477 0.907 0 C-N-CA 124.231 1.012 . . . . 74.44 109.675 178.149 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 74.9 mmtt -115.12 148.05 39.45 Favored 'General case' 0 C--O 1.239 0.541 0 C-N-CA 124.592 1.157 . . . . 71.22 108.974 176.276 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 44.7 mtmt -78.13 88.79 4.23 Favored 'General case' 0 N--CA 1.472 0.658 0 N-CA-C 107.828 -1.175 . . . . 73.42 107.828 171.673 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 156' ' ' ILE . . . . . 0.503 HD13 ' HB2' ' A' ' 142' ' ' MET . 65.8 mt -86.97 107.82 17.38 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.32 0 CA-C-N 115.805 -0.634 . . . . 71.25 109.459 -171.412 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 157' ' ' THR . . . . . . . . . . . . . 34.9 p -121.59 156.87 31.99 Favored 'General case' 0 C--O 1.243 0.722 0 C-N-CA 124.514 1.126 . . . . 72.04 110.587 -174.55 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 158' ' ' ILE . . . . . 0.456 HG23 ' HB3' ' A' ' 8' ' ' PHE . 58.6 mt -78.72 93.37 1.54 Allowed 'Isoleucine or valine' 0 CA--C 1.547 0.858 0 N-CA-C 108.766 -0.827 . . . . 54.1 108.766 171.779 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 159' ' ' ALA . . . . . . . . . . . . . . . -61.46 -39.83 92.31 Favored 'General case' 0 N--CA 1.479 1.009 0 C-N-CA 124.567 1.147 . . . . 71.01 113.066 -176.289 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 160' ' ' ASP . . . . . 0.595 ' HA ' ' HE3' ' A' ' 49' ' ' LYS . 16.2 t70 -150.67 168.59 23.88 Favored 'General case' 0 CA--C 1.551 0.99 0 O-C-N 123.528 0.517 . . . . 73.11 110.033 -174.595 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 161' ' ' CYS . . . . . . . . . . . . . 21.8 p -147.04 -170.46 3.55 Favored 'General case' 0 N--CA 1.478 0.953 0 C-N-CA 124.725 1.21 . . . . 60.24 109.234 -172.067 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 162' ' ' GLY . . . . . . . . . . . . . . . 132.12 52.72 0.09 OUTLIER Glycine 0 N--CA 1.476 1.344 0 O-C-N 122.016 -0.427 . . . . 55.11 112.097 -174.244 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 163' ' ' GLN . . . . . 0.589 ' HA ' ' H ' ' A' ' 7' ' ' PHE . 44.9 mt-30 -47.63 106.39 0.09 Allowed 'General case' 0 N--CA 1.48 1.039 0 C-N-CA 125.44 1.496 . . . . 70.01 111.887 -179.737 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 164' ' ' LEU . . . . . . . . . . . . . 74.1 mt . . . . . 0 CA--C 1.545 0.752 0 C-N-CA 125.005 1.322 . . . . 72.42 112.141 -171.393 . . . . . . . . 0 0 . 1 . 007 nuclear build core ' B' B ' 218' ' ' PRO . . . . . . . . . . . . . 57.9 Cg_endo . . . . . 0 CA--C 1.544 0.982 0 N-CA-C 111.248 -0.328 . . . . 52.4 111.248 . . . . . . . . . 0 0 . 1 . 007 nuclear build core ' B' B ' 219' ' ' GLY . . . . . . . . . . . . . . . 112.99 166.82 16.77 Favored Glycine 0 CA--C 1.526 0.732 0 CA-C-N 116.051 -0.522 . . . . 73.31 112.493 -178.79 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 220' ' ' PRO . . . . . . . . . . . . . 8.3 Cg_exo -74.76 154.82 43.98 Favored 'Trans proline' 0 CA--C 1.554 1.517 0 C-N-CA 123.76 2.974 . . . . 22.33 114.064 -172.605 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 221' ' ' TYR . . . . . . . . . . . . . 95.9 m-85 . . . . . 0 N--CA 1.483 1.204 0 C-N-CA 124.216 1.007 . . . . 60.25 111.277 -178.395 . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 29.5 m-80 . . . . . 0 CA--C 1.556 1.176 0 CA-C-O 119.571 -0.252 . . . . 73.22 111.346 . . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 56.0 Cg_endo -70.8 123.31 9.64 Favored 'Trans proline' 0 C--N 1.379 2.178 0 C-N-CA 122.576 2.184 . . . . 70.31 110.652 175.159 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 5' ' ' THR . . . . . 0.476 ' HB ' ' O ' ' A' ' 164' ' ' LEU . 83.0 m -104.15 125.59 50.58 Favored 'General case' 0 CA--C 1.535 0.369 0 N-CA-C 109.703 -0.48 . . . . 55.15 109.703 -179.807 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 6' ' ' VAL . . . . . 0.616 ' HA ' ' HB2' ' A' ' 163' ' ' GLN . 6.7 m -100.51 122.94 53.09 Favored 'Isoleucine or valine' 0 C--N 1.347 0.457 0 CA-C-O 122.156 0.979 . . . . 73.31 109.732 -178.618 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 7' ' ' PHE . . . . . 0.708 ' H ' ' HA ' ' A' ' 163' ' ' GLN . 76.1 t80 -103.43 133.74 47.98 Favored 'General case' 0 C--O 1.243 0.734 0 CA-C-N 114.224 -1.353 . . . . 72.34 108.99 -174.877 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 8' ' ' PHE . . . . . 0.428 ' HD2' ' HE2' ' A' ' 22' ' ' PHE . 61.4 m-85 -135.23 162.08 33.56 Favored 'General case' 0 C--O 1.238 0.468 0 O-C-N 124.161 0.913 . . . . 74.2 109.702 172.258 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 24.9 m-20 -108.74 115.99 31.14 Favored 'General case' 0 C--N 1.322 -0.604 0 N-CA-C 106.975 -1.491 . . . . 74.54 106.975 170.235 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 51.3 mm -85.42 113.16 23.31 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.546 0 N-CA-C 108.707 -0.849 . . . . 63.21 108.707 178.068 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 11' ' ' ALA . . . . . 0.502 ' HB2' ' HB2' ' A' ' 159' ' ' ALA . . . -116.26 125.24 51.92 Favored 'General case' 0 N--CA 1.477 0.91 0 C-N-CA 122.974 0.51 . . . . 72.45 110.397 178.858 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 48.7 t -95.34 107.18 19.19 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.626 0 N-CA-C 108.088 -1.079 . . . . 53.33 108.088 177.449 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 20.3 m-20 61.58 31.19 18.85 Favored 'General case' 0 N--CA 1.489 1.485 0 C-N-CA 124.662 1.185 . . . . 72.31 112.023 179.409 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 96.79 -19.55 54.28 Favored Glycine 0 C--N 1.344 0.977 0 CA-C-N 115.62 -0.718 . . . . 71.41 112.905 179.035 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 26.3 mm-40 -83.58 114.57 54.4 Favored Pre-proline 0 CA--C 1.542 0.653 0 N-CA-C 109.227 -0.657 . . . . 75.51 109.227 -179.928 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 47.2 Cg_endo -65.36 107.77 1.06 Allowed 'Trans proline' 0 C--N 1.376 2.018 0 C-N-CA 122.248 1.965 . . . . 73.13 111.285 -178.201 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 58.0 tp -75.89 -38.54 57.72 Favored 'General case' 0 C--O 1.241 0.635 0 CA-C-N 115.084 -0.962 . . . . 63.54 109.774 -177.827 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 173.0 -171.7 44.62 Favored Glycine 0 C--N 1.343 0.92 0 CA-C-N 116.159 -0.473 . . . . 63.4 113.875 176.52 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 19' ' ' ARG . . . . . 0.458 ' HB3' ' HE1' ' A' ' 7' ' ' PHE . 67.8 mtt85 -115.99 129.27 56.3 Favored 'General case' 0 N--CA 1.472 0.667 0 C-N-CA 124.312 1.045 . . . . 74.4 109.462 -173.843 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 20' ' ' VAL . . . . . 0.44 HG13 HG13 ' A' ' 132' ' ' VAL . 61.9 t -125.74 133.16 69.75 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.883 0 C-N-CA 123.106 0.563 . . . . 72.03 109.999 178.696 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 37.9 m -119.93 119.16 32.68 Favored 'General case' 0 CA--C 1.558 1.273 0 C-N-CA 124.389 1.075 . . . . 65.33 108.973 177.389 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 22' ' ' PHE . . . . . 0.428 ' HE2' ' HD2' ' A' ' 8' ' ' PHE . 52.7 m-85 -101.13 114.95 29.38 Favored 'General case' 0 N--CA 1.477 0.876 0 C-N-CA 124.22 1.008 . . . . 52.42 110.233 -179.255 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 23' ' ' GLU . . . . . 0.662 ' HB2' ' HD2' ' A' ' 133' ' ' LYS . 43.2 tt0 -76.06 105.06 6.89 Favored 'General case' 0 CA--C 1.549 0.933 0 C-N-CA 123.859 0.864 . . . . 61.34 109.799 176.601 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 24' ' ' LEU . . . . . 0.521 ' HB3' ' HB1' ' A' ' 33' ' ' ALA . 55.5 mt -82.99 128.06 34.12 Favored 'General case' 0 N--CA 1.478 0.954 0 C-N-CA 122.992 0.517 . . . . 72.33 110.66 -179.697 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 54.1 m-85 -90.99 61.13 4.54 Favored 'General case' 0 CA--C 1.532 0.265 0 C-N-CA 123.787 0.835 . . . . 73.33 109.883 -179.295 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -67.9 -13.31 62.05 Favored 'General case' 0 N--CA 1.48 1.04 0 CA-C-N 115.849 -0.614 . . . . 51.45 112.042 179.371 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 11.2 p-10 -71.85 -31.83 66.88 Favored 'General case' 0 CA--C 1.55 0.944 0 C-N-CA 123.481 0.712 . . . . 74.21 110.829 173.848 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 58.0 mttp -96.88 -49.54 5.01 Favored 'General case' 0 N--CA 1.485 1.288 0 C-N-CA 123.948 0.899 . . . . 73.45 111.285 -178.317 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 29' ' ' VAL . . . . . 0.642 ' HB ' ' HB ' ' A' ' 32' ' ' THR . 11.8 m -117.77 76.14 10.53 Favored Pre-proline 0 CA--C 1.562 1.432 0 C-N-CA 124.165 0.986 . . . . 52.35 110.054 179.117 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 30' ' ' PRO . . . . . 0.449 ' HD2' ' HG2' ' A' ' 86' ' ' GLU . 7.2 Cg_endo -51.24 -59.59 1.1 Allowed 'Trans proline' 0 C--N 1.394 2.968 0 C-N-CA 123.381 2.721 . . . . 70.31 113.207 179.699 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 5.8 ttpm? -57.75 -50.2 74.03 Favored 'General case' 0 N--CA 1.482 1.172 0 C-N-CA 123.398 0.679 . . . . 72.34 112.098 -179.562 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 32' ' ' THR . . . . . 0.642 ' HB ' ' HB ' ' A' ' 29' ' ' VAL . 88.9 m -67.78 -35.6 78.97 Favored 'General case' 0 CA--C 1.56 1.357 0 C-N-CA 123.998 0.919 . . . . 71.32 112.593 -170.632 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 33' ' ' ALA . . . . . 0.521 ' HB1' ' HB3' ' A' ' 24' ' ' LEU . . . -90.47 -43.7 10.09 Favored 'General case' 0 N--CA 1.485 1.294 0 C-N-CA 123.019 0.528 . . . . 54.24 112.173 -176.985 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 39.3 tt0 -63.63 -31.73 72.99 Favored 'General case' 0 N--CA 1.484 1.255 0 C-N-CA 123.372 0.669 . . . . 73.15 110.733 179.754 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 35' ' ' ASN . . . . . 0.421 ' O ' ' HG ' ' A' ' 39' ' ' LEU . 35.8 t30 -49.01 -59.51 3.56 Favored 'General case' 0 C--N 1.36 1.029 0 O-C-N 124.566 1.166 . . . . 75.03 110.314 171.457 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 76.3 t80 -65.17 -40.55 94.44 Favored 'General case' 0 C--N 1.348 0.526 0 O-C-N 124.045 0.84 . . . . 70.21 111.249 -175.035 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 56.1 ttp180 -58.26 -44.98 88.62 Favored 'General case' 0 N--CA 1.48 1.044 0 O-C-N 123.723 0.639 . . . . 72.21 110.919 179.057 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 38' ' ' ALA . . . . . 0.547 ' HB3' HG21 ' A' ' 78' ' ' ILE . . . -69.38 -32.24 71.15 Favored 'General case' 0 N--CA 1.473 0.694 0 CA-C-N 115.274 -0.875 . . . . 74.24 111.487 -179.726 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 39' ' ' LEU . . . . . 0.421 ' HG ' ' O ' ' A' ' 35' ' ' ASN . 94.3 mt -69.74 -35.96 75.42 Favored 'General case' 0 N--CA 1.477 0.915 0 C-N-CA 123.87 0.868 . . . . 75.34 111.06 175.326 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 50.0 m -73.52 -54.81 7.34 Favored 'General case' 0 N--CA 1.474 0.75 0 C-N-CA 124.015 0.926 . . . . 75.55 111.284 -175.567 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 56.4 p -78.77 -31.51 46.16 Favored 'General case' 0 CA--C 1.538 0.519 0 CA-C-N 115.128 -0.942 . . . . 32.41 111.376 -175.188 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 92.09 37.68 5.92 Favored Glycine 0 C--N 1.347 1.168 0 CA-C-O 119.647 -0.529 . . . . 60.33 112.682 -178.204 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 68.1 mm-40 -61.1 -29.24 69.64 Favored 'General case' 0 N--CA 1.482 1.152 0 C-N-CA 123.089 0.555 . . . . 64.44 110.432 172.08 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 44' ' ' LYS . . . . . 0.547 ' HG3' ' HB ' ' A' ' 78' ' ' ILE . 32.0 mmmt -108.43 17.75 21.74 Favored 'General case' 0 CA--C 1.541 0.614 0 C-N-CA 124.696 1.199 . . . . 75.2 111.366 -178.965 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 80.23 -1.77 79.36 Favored Glycine 0 C--N 1.355 1.604 0 CA-C-O 119.118 -0.823 . . . . 73.35 114.923 173.353 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 19.7 m-85 -85.17 -48.15 9.43 Favored 'General case' 0 N--CA 1.477 0.924 0 CA-C-N 117.96 0.88 . . . . 64.13 111.05 -174.2 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 41.6 62.23 1.97 Allowed Glycine 0 N--CA 1.485 1.964 0 O-C-N 124.508 1.13 . . . . 61.14 114.816 171.517 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 48' ' ' TYR . . . . . 0.471 ' HB3' ' OG ' ' A' ' 51' ' ' SER . 34.5 m-85 -59.68 98.89 0.05 Allowed 'General case' 0 CA--C 1.548 0.898 0 CA-C-O 121.843 0.83 . . . . 72.3 112.191 -170.095 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 23.2 tptm -108.39 113.53 26.66 Favored 'General case' 0 CA--C 1.539 0.544 0 CA-C-N 113.941 -1.481 . . . . 72.02 108.841 -175.771 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 93.61 18.59 37.68 Favored Glycine 0 C--N 1.346 1.13 0 CA-C-O 119.267 -0.741 . . . . 63.41 113.078 179.823 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 51' ' ' SER . . . . . 0.471 ' OG ' ' HB3' ' A' ' 48' ' ' TYR . 19.6 m -59.95 118.62 6.47 Favored 'General case' 0 N--CA 1.476 0.853 0 C-N-CA 123.317 0.647 . . . . 73.22 111.177 -176.849 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 52' ' ' CYS . . . . . 0.642 ' SG ' ' HD2' ' A' ' 155' ' ' LYS . 36.0 t -86.28 125.15 33.39 Favored 'General case' 0 CA--C 1.533 0.306 0 CA-C-N 115.447 -0.797 . . . . 73.41 112.302 -167.539 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 53' ' ' PHE . . . . . 0.667 ' HA ' ' HA2' ' A' ' 64' ' ' GLY . 95.4 m-85 -73.08 109.33 6.54 Favored 'General case' 0 C--O 1.238 0.479 0 N-CA-C 108.756 -0.831 . . . . 72.54 108.756 166.27 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 19.2 p-80 -128.43 8.41 5.95 Favored 'General case' 0 N--CA 1.482 1.135 0 CA-C-N 115.611 -0.722 . . . . 74.43 111.856 -169.267 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 80.0 ttt-85 -152.25 99.31 2.5 Favored 'General case' 0 N--CA 1.472 0.67 0 N-CA-C 108.794 -0.817 . . . . 75.21 108.794 177.768 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 56' ' ' ILE . . . . . 0.463 HD11 ' HB3' ' A' ' 53' ' ' PHE . 58.3 mt -137.31 134.01 46.89 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.8 0 C-N-CA 123.181 0.592 . . . . 71.13 109.908 -174.688 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 41.8 mt -117.58 118.32 35.31 Favored Pre-proline 0 CA--C 1.554 1.109 0 C-N-CA 124.164 0.986 . . . . 51.1 108.549 174.229 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 58' ' ' PRO . . . . . 0.574 ' HA ' ' HG2' ' A' ' 143' ' ' GLU . 53.8 Cg_endo -67.3 135.95 38.57 Favored 'Trans proline' 0 C--N 1.38 2.206 0 C-N-CA 123.021 2.481 . . . . 74.45 111.508 179.847 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 77.35 30.01 54.97 Favored Glycine 0 CA--C 1.526 0.765 0 CA-C-N 115.345 -0.843 . . . . 71.13 113.091 -176.168 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 29.0 t80 -156.57 -67.04 0.11 Allowed 'General case' 0 C--O 1.247 0.96 0 C-N-CA 123.027 0.531 . . . . 73.32 110.715 -176.921 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 61' ' ' MET . . . . . 0.4 ' HE2' ' HB2' ' A' ' 61' ' ' MET . 45.6 ttm -167.16 146.96 5.35 Favored 'General case' 0 N--CA 1.48 1.073 0 N-CA-C 112.188 0.44 . . . . 74.24 112.188 -165.654 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 62' ' ' CYS . . . . . 0.456 ' SG ' HG13 ' A' ' 139' ' ' VAL . 23.5 p -116.55 114.25 23.88 Favored 'General case' 0 CA--C 1.545 0.781 0 C-N-CA 123.726 0.81 . . . . 72.45 109.111 169.322 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 28.4 tt0 -112.63 140.96 46.96 Favored 'General case' 0 N--CA 1.479 0.995 0 C-N-CA 123.627 0.771 . . . . 74.25 110.66 -179.506 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 64' ' ' GLY . . . . . 0.667 ' HA2' ' HA ' ' A' ' 53' ' ' PHE . . . -130.81 -176.55 14.46 Favored Glycine 0 C--N 1.344 0.976 0 CA-C-N 115.306 -0.861 . . . . 72.24 112.754 176.669 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 176.22 155.07 12.41 Favored Glycine 0 C--N 1.335 0.486 0 N-CA-C 111.721 -0.552 . . . . 74.54 111.721 -179.262 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 21.2 t70 -83.06 179.79 7.65 Favored 'General case' 0 CA--C 1.552 1.031 0 C-N-CA 124.017 0.927 . . . . 74.42 110.593 -176.979 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 53.2 t80 -88.51 -15.68 34.65 Favored 'General case' 0 CA--C 1.548 0.89 0 C-N-CA 123.188 0.595 . . . . 52.35 111.538 177.635 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 42.5 m -65.01 107.79 1.61 Allowed 'General case' 0 C--N 1.357 0.93 0 N-CA-C 109.724 -0.472 . . . . 74.43 109.724 178.057 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 85.1 mtt85 58.64 47.66 12.8 Favored 'General case' 0 N--CA 1.479 1.002 0 C-N-CA 124.821 1.248 . . . . 73.05 110.633 -170.805 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 48.6 t-80 -49.82 -37.66 31.42 Favored 'General case' 0 N--CA 1.482 1.164 0 C-N-CA 124.754 1.222 . . . . 74.4 112.69 -172.297 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 53.1 t30 -68.26 96.47 0.65 Allowed 'General case' 0 CA--C 1.542 0.65 0 O-C-N 123.499 0.499 . . . . 50.11 109.991 175.233 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 67.56 16.15 67.2 Favored Glycine 0 C--N 1.345 1.06 0 N-CA-C 116.022 1.169 . . . . 73.24 116.022 168.805 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 73' ' ' THR . . . . . 0.58 ' HA ' ' HB2' ' A' ' 110' ' ' SER . 88.3 m -132.65 -75.93 0.5 Allowed 'General case' 0 N--CA 1.472 0.638 0 N-CA-C 108.426 -0.953 . . . . 72.12 108.426 168.871 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 53.95 60.26 8.67 Favored Glycine 0 C--N 1.355 1.59 0 O-C-N 123.781 0.675 . . . . 70.35 113.725 170.137 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 130.96 51.4 0.1 OUTLIER Glycine 0 C--N 1.344 1.026 0 N-CA-C 111.855 -0.498 . . . . 74.11 111.855 -176.716 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -52.36 166.09 0.2 Allowed 'General case' 0 N--CA 1.491 1.606 0 C-N-CA 124.369 1.068 . . . . 62.44 112.583 174.688 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 80.9 p -90.65 177.67 6.28 Favored 'General case' 0 N--CA 1.478 0.965 0 C-N-CA 122.994 0.518 . . . . 72.35 111.043 -175.699 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 78' ' ' ILE . . . . . 0.547 ' HB ' ' HG3' ' A' ' 44' ' ' LYS . 31.9 pt -79.02 -22.83 12.7 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.022 0 C-N-CA 123.275 0.63 . . . . 54.35 110.773 176.505 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 71.0 m-85 -79.42 -40.32 30.28 Favored 'General case' 0 N--CA 1.47 0.548 0 C-N-CA 124.19 0.996 . . . . 73.35 109.704 -179.724 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 177.45 -138.69 3.98 Favored Glycine 0 C--N 1.339 0.746 0 CA-C-N 115.152 -0.931 . . . . 63.03 111.528 177.734 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 36.0 tt0 -65.64 -44.44 86.39 Favored 'General case' 0 N--CA 1.471 0.604 0 C-N-CA 123.917 0.887 . . . . 51.44 109.855 177.025 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 82' ' ' LYS . . . . . 0.447 ' HD2' ' HA ' ' A' ' 107' ' ' THR . 20.8 pttp -154.07 175.31 13.58 Favored 'General case' 0 CA--C 1.55 0.977 0 CA-C-N 114.943 -1.026 . . . . 72.53 110.383 -175.219 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 2.2 p90 -159.42 170.48 21.67 Favored 'General case' 0 CA--C 1.554 1.104 0 C-N-CA 124.132 0.973 . . . . 53.21 110.311 -173.765 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 13.0 pt-20 -96.4 157.37 15.93 Favored 'General case' 0 N--CA 1.486 1.343 0 C-N-CA 123.664 0.785 . . . . 74.4 109.014 173.219 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 28.4 m-20 -77.53 150.85 34.77 Favored 'General case' 0 N--CA 1.483 1.206 0 N-CA-C 113.099 0.777 . . . . 74.12 113.099 178.1 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 86' ' ' GLU . . . . . 0.449 ' HG2' ' HD2' ' A' ' 30' ' ' PRO . 13.8 tp10 -61.95 -60.6 3.39 Favored 'General case' 0 CA--C 1.541 0.614 0 CA-C-N 114.044 -1.435 . . . . 73.41 111.158 -179.763 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 26.2 p30 -165.73 152.85 10.18 Favored 'General case' 0 N--CA 1.475 0.789 0 C-N-CA 123.556 0.743 . . . . 74.34 109.723 -176.973 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 89.9 m-85 -90.58 47.26 1.41 Allowed 'General case' 0 N--CA 1.48 1.055 0 C-N-CA 123.624 0.769 . . . . 74.31 111.267 -176.362 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 71.3 mt -69.87 -59.5 3.45 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.925 0 N-CA-C 108.926 -0.768 . . . . 71.34 108.926 173.209 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 90' ' ' LEU . . . . . 0.59 ' HB3' ' HB ' ' A' ' 128' ' ' VAL . 80.3 mt -86.69 104.92 16.54 Favored 'General case' 0 CA--C 1.539 0.542 0 CA-C-N 114.878 -1.055 . . . . 61.21 110.596 -172.057 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 20.4 ptmt -103.97 167.77 9.55 Favored 'General case' 0 N--CA 1.475 0.797 0 C-N-CA 123.278 0.631 . . . . 60.45 110.492 -179.617 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 92' ' ' HIS . . . . . . . . . . . . . 57.7 m-70 -83.53 69.38 10.07 Favored 'General case' 0 N--CA 1.48 1.028 0 C-N-CA 123.4 0.68 . . . . 71.4 110.799 -173.666 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 14.5 t -122.26 20.32 10.55 Favored 'General case' 0 N--CA 1.474 0.761 0 C-N-CA 123.338 0.655 . . . . 64.31 110.084 -176.546 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -143.99 172.27 25.22 Favored Glycine 0 C--N 1.348 1.197 0 CA-C-N 116.287 -0.415 . . . . 71.2 113.445 -176.336 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 58.4 Cg_endo -94.02 153.53 2.19 Favored 'Trans proline' 0 C--N 1.368 1.578 0 C-N-CA 123.676 2.918 . . . . 74.21 112.732 175.238 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 72.82 19.85 79.55 Favored Glycine 0 C--N 1.353 1.507 0 CA-C-N 116.244 -0.435 . . . . 42.25 112.827 177.008 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 97' ' ' ILE . . . . . 0.737 ' HB ' ' SG ' ' A' ' 115' ' ' CYS . 20.1 mm -68.84 108.36 1.6 Allowed 'Isoleucine or valine' 0 CA--C 1.541 0.625 0 C-N-CA 124.238 1.015 . . . . 70.12 111.257 -174.213 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 62.1 tp -90.06 120.55 31.35 Favored 'General case' 0 C--O 1.247 0.94 0 CA-C-N 115.581 -0.736 . . . . 75.12 109.95 172.575 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 99' ' ' SER . . . . . 0.467 ' HB3' ' HA ' ' A' ' 128' ' ' VAL . 7.9 p -149.62 147.67 28.4 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 114.483 -1.235 . . . . 72.35 107.902 171.81 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 100' ' ' MET . . . . . 0.734 ' HA ' ' HA ' ' A' ' 112' ' ' PHE . 96.9 mtp -77.29 149.14 35.39 Favored 'General case' 0 N--CA 1.493 1.68 0 C-N-CA 122.627 0.371 . . . . 63.13 110.276 -175.569 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 101' ' ' ALA . . . . . 0.533 ' HB3' ' HB2' ' A' ' 111' ' ' GLN . . . -73.57 162.71 28.93 Favored 'General case' 0 C--O 1.247 0.944 0 CA-C-O 121.535 0.683 . . . . 63.23 111.347 -176.851 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 102' ' ' ASN . . . . . 0.47 ' HB3' ' HA ' ' A' ' 108' ' ' ASN . 24.3 p-10 -167.24 168.4 13.41 Favored 'General case' 0 C--O 1.242 0.706 0 CA-C-N 114.583 -1.19 . . . . 52.43 109.903 -178.14 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -114.96 6.74 15.41 Favored 'General case' 0 CA--C 1.543 0.695 0 C-N-CA 123.802 0.841 . . . . 54.14 110.304 171.183 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 158.54 179.75 33.63 Favored Glycine 0 C--N 1.354 1.582 0 CA-C-O 119.468 -0.629 . . . . 73.34 112.408 178.094 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 26.0 Cg_exo -64.47 137.54 55.67 Favored 'Trans proline' 0 C--N 1.375 1.926 0 C-N-CA 122.933 2.422 . . . . 71.45 110.509 171.514 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 63.0 t30 68.8 8.79 7.0 Favored 'General case' 0 N--CA 1.49 1.528 0 C-N-CA 124.988 1.315 . . . . 72.53 111.116 -174.851 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 107' ' ' THR . . . . . 0.447 ' HA ' ' HD2' ' A' ' 82' ' ' LYS . 1.7 m -116.93 15.82 15.17 Favored 'General case' 0 CA--C 1.551 0.998 0 N-CA-C 108.359 -0.978 . . . . 65.33 108.359 171.6 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 108' ' ' ASN . . . . . 0.47 ' HA ' ' HB3' ' A' ' 102' ' ' ASN . 20.9 t30 -92.05 145.31 24.62 Favored 'General case' 0 C--O 1.202 -1.426 0 C-N-CA 124.832 1.253 . . . . 70.11 110.498 -176.317 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 113.3 26.99 3.8 Favored Glycine 0 N--CA 1.478 1.48 0 CA-C-N 118.303 0.501 . . . . 75.32 112.436 -178.787 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 110' ' ' SER . . . . . 0.58 ' HB2' ' HA ' ' A' ' 73' ' ' THR . 22.5 p -137.04 121.13 17.8 Favored 'General case' 0 CA--C 1.535 0.401 0 N-CA-C 108.675 -0.861 . . . . 62.44 108.675 -177.926 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 111' ' ' GLN . . . . . 0.533 ' HB2' ' HB3' ' A' ' 101' ' ' ALA . 47.4 mt-30 61.47 -177.25 0.12 Allowed 'General case' 0 N--CA 1.493 1.677 0 C-N-CA 123.898 0.879 . . . . 73.4 111.62 -174.551 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 112' ' ' PHE . . . . . 0.734 ' HA ' ' HA ' ' A' ' 100' ' ' MET . 35.5 p90 -151.75 152.92 33.34 Favored 'General case' 0 N--CA 1.475 0.804 0 C-N-CA 123.672 0.789 . . . . 65.54 109.348 176.698 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 113' ' ' PHE . . . . . . . . . . . . . 55.0 p90 -140.59 151.43 44.67 Favored 'General case' 0 N--CA 1.472 0.667 0 C-N-CA 122.963 0.505 . . . . 75.44 110.934 -178.803 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 114' ' ' ILE . . . . . . . . . . . . . 10.9 mt -125.92 107.77 18.22 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.705 0 N-CA-C 107.849 -1.167 . . . . 74.31 107.849 178.765 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 115' ' ' CYS . . . . . 0.737 ' SG ' ' HB ' ' A' ' 97' ' ' ILE . 28.5 p -89.3 113.68 24.97 Favored 'General case' 0 C--O 1.243 0.745 0 N-CA-C 108.964 -0.754 . . . . 71.12 108.964 175.601 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 71.6 p -70.84 -27.02 63.55 Favored 'General case' 0 N--CA 1.474 0.772 0 CA-C-N 115.253 -0.885 . . . . 63.3 111.291 -177.534 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -104.34 162.34 13.3 Favored 'General case' 0 C--O 1.248 0.977 0 C-N-CA 123.815 0.846 . . . . 75.41 110.058 174.826 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 18.1 ptmt -74.04 85.19 1.8 Allowed 'General case' 0 CA--C 1.546 0.825 0 CA-C-O 122.302 1.048 . . . . 74.42 110.248 175.329 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 119' ' ' THR . . . . . . . . . . . . . 50.8 p -82.04 84.39 7.0 Favored 'General case' 0 CA--C 1.546 0.793 0 CA-C-N 115.01 -0.996 . . . . 60.35 109.307 179.359 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 11.4 pt-20 -75.44 -23.36 56.9 Favored 'General case' 0 N--CA 1.484 1.257 0 CA-C-N 115.019 -0.991 . . . . 74.52 112.727 -167.628 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 121' ' ' TRP . . . . . . . . . . . . . 38.7 p90 -67.05 -8.72 32.41 Favored 'General case' 0 CA--C 1.551 1.0 0 C-N-CA 123.452 0.701 . . . . 74.23 112.201 176.79 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 31.9 mt -88.23 10.33 19.94 Favored 'General case' 0 CA--C 1.547 0.833 0 C-N-CA 122.947 0.499 . . . . 64.54 111.954 176.764 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 69.7 m-20 -72.4 121.18 19.11 Favored 'General case' 0 N--CA 1.483 1.207 0 N-CA-C 108.9 -0.778 . . . . 74.42 108.9 170.721 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 110.0 -17.94 29.21 Favored Glycine 0 N--CA 1.475 1.269 0 N-CA-C 111.04 -0.824 . . . . 53.03 111.04 -170.113 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 125' ' ' LYS . . . . . 0.602 ' HG2' ' H ' ' A' ' 126' ' ' HIS . 21.0 ttmm -86.72 -165.58 1.32 Allowed 'General case' 0 CA--C 1.559 1.3 0 N-CA-C 108.045 -1.094 . . . . 63.53 108.045 169.707 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 126' ' ' HIS . . . . . 0.602 ' H ' ' HG2' ' A' ' 125' ' ' LYS . 9.4 t-160 -65.59 130.08 42.02 Favored 'General case' 0 C--N 1.353 0.758 0 CA-C-N 118.583 0.628 . . . . 73.05 109.826 -173.71 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 127' ' ' VAL . . . . . 0.4 ' N ' ' HD2' ' A' ' 126' ' ' HIS . 57.6 t -58.68 143.7 12.69 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.835 0 CA-C-N 113.75 -1.568 . . . . 75.52 110.966 175.829 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 128' ' ' VAL . . . . . 0.59 ' HB ' ' HB3' ' A' ' 90' ' ' LEU . 21.8 t -66.94 149.01 11.83 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.583 0 N-CA-C 109.578 -0.527 . . . . 61.41 109.578 177.098 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 129' ' ' PHE . . . . . 0.545 ' HB3' HG22 ' A' ' 32' ' ' THR . 32.1 p90 -136.32 -23.89 1.26 Allowed 'General case' 0 N--CA 1.474 0.754 0 C-N-CA 122.243 0.217 . . . . 73.53 111.117 171.409 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . -127.09 157.75 20.78 Favored Glycine 0 C--N 1.338 0.689 0 N-CA-C 111.493 -0.643 . . . . 72.2 111.493 -177.552 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 131' ' ' LYS . . . . . 0.407 ' HE2' ' HB3' ' A' ' 131' ' ' LYS . 31.3 ttpt -144.74 127.41 16.17 Favored 'General case' 0 C--N 1.324 -0.543 0 N-CA-C 108.616 -0.883 . . . . 63.15 108.616 179.967 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 132' ' ' VAL . . . . . 0.478 HG21 HG21 ' A' ' 139' ' ' VAL . 59.4 t -63.67 100.19 0.22 Allowed 'Isoleucine or valine' 0 CA--C 1.539 0.525 0 N-CA-C 108.589 -0.893 . . . . 71.33 108.589 171.902 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 133' ' ' LYS . . . . . 0.662 ' HD2' ' HB2' ' A' ' 23' ' ' GLU . 19.5 ptmt -87.65 -32.03 19.46 Favored 'General case' 0 N--CA 1.473 0.682 0 N-CA-C 109.581 -0.526 . . . . 71.43 109.581 178.315 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 44.8 mt-10 -139.41 146.29 39.95 Favored 'General case' 0 N--CA 1.473 0.7 0 C-N-CA 124.999 1.32 . . . . 61.03 108.936 176.728 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 87.83 21.76 45.43 Favored Glycine 0 C--N 1.342 0.868 0 O-C-N 123.541 0.526 . . . . 51.43 112.536 -175.89 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 136' ' ' MET . . . . . 0.428 ' HA ' HG11 ' A' ' 132' ' ' VAL . 7.1 tpt -58.88 -46.84 86.85 Favored 'General case' 0 C--N 1.359 1.004 0 C-N-CA 123.92 0.888 . . . . 71.43 111.337 -179.772 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 137' ' ' ASN . . . . . . . . . . . . . 20.1 m120 -65.03 -28.86 69.78 Favored 'General case' 0 N--CA 1.477 0.886 0 C-N-CA 123.228 0.611 . . . . 74.43 111.619 -179.394 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 138' ' ' ILE . . . . . . . . . . . . . 43.2 mm -70.41 -38.84 75.36 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.657 0 C-N-CA 123.329 0.652 . . . . 74.45 109.895 178.839 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 139' ' ' VAL . . . . . 0.478 HG21 HG21 ' A' ' 132' ' ' VAL . 69.6 t -68.64 -39.78 80.84 Favored 'Isoleucine or valine' 0 CA--C 1.553 1.063 0 C-N-CA 123.481 0.713 . . . . 74.44 110.492 176.186 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 48.8 mt-10 -69.2 -27.53 65.58 Favored 'General case' 0 N--CA 1.476 0.872 0 C-N-CA 123.623 0.769 . . . . 71.55 111.224 177.92 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -80.35 -45.6 17.51 Favored 'General case' 0 N--CA 1.477 0.91 0 C-N-CA 123.639 0.776 . . . . 63.14 111.196 178.914 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 142' ' ' MET . . . . . 0.544 ' HA ' ' HD2' ' A' ' 145' ' ' PHE . 27.9 ptm -65.68 -31.71 72.87 Favored 'General case' 0 N--CA 1.478 0.969 0 C-N-CA 123.095 0.558 . . . . 64.31 111.22 -178.35 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 143' ' ' GLU . . . . . 0.574 ' HG2' ' HA ' ' A' ' 58' ' ' PRO . 39.1 tt0 -57.94 -32.22 67.58 Favored 'General case' 0 CA--C 1.552 1.037 0 C-N-CA 123.71 0.804 . . . . 75.21 111.969 177.957 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 144' ' ' ARG . . . . . . . . . . . . . 46.3 mtp85 -75.62 -16.98 60.15 Favored 'General case' 0 N--CA 1.473 0.705 0 CA-C-N 116.261 -0.427 . . . . 74.13 111.814 -175.782 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 145' ' ' PHE . . . . . 0.596 ' HB2' HD11 ' A' ' 156' ' ' ILE . 95.2 m-85 -79.88 2.09 24.62 Favored 'General case' 0 N--CA 1.479 0.994 0 C-N-CA 122.728 0.411 . . . . 71.03 110.844 175.38 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . -89.58 -174.75 45.92 Favored Glycine 0 C--N 1.352 1.426 0 O-C-N 123.199 0.312 . . . . 73.41 112.635 171.787 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 19.8 t -135.6 167.99 20.08 Favored 'General case' 0 N--CA 1.475 0.803 0 C-N-CA 123.796 0.838 . . . . 62.45 110.369 -177.869 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 148' ' ' ARG . . . . . . . . . . . . . 12.1 mmm180 -71.04 -29.84 65.87 Favored 'General case' 0 N--CA 1.477 0.907 0 C-N-CA 123.534 0.734 . . . . 74.11 112.09 -173.601 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 149' ' ' ASN . . . . . . . . . . . . . 28.7 p-10 -79.72 -3.05 45.75 Favored 'General case' 0 N--CA 1.484 1.237 0 C-N-CA 123.51 0.724 . . . . 73.14 111.451 176.141 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . 90.68 11.02 62.6 Favored Glycine 0 C--N 1.35 1.336 0 C-N-CA 123.052 0.358 . . . . 55.23 113.098 -179.522 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 56.1 tttm -84.77 158.67 20.65 Favored 'General case' 0 N--CA 1.474 0.761 0 C-N-CA 123.378 0.671 . . . . 72.43 109.458 177.384 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 152' ' ' THR . . . . . . . . . . . . . 24.8 p -101.58 128.72 47.71 Favored 'General case' 0 N--CA 1.475 0.821 0 C-N-CA 122.82 0.448 . . . . 53.11 109.905 171.86 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 153' ' ' SER . . . . . . . . . . . . . 42.4 t -70.25 -42.97 71.49 Favored 'General case' 0 N--CA 1.474 0.742 0 N-CA-C 109.245 -0.65 . . . . 63.04 109.245 168.851 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 154' ' ' LYS . . . . . 0.4 ' HB2' ' HB3' ' A' ' 145' ' ' PHE . 34.1 mmtp -118.4 140.68 49.48 Favored 'General case' 0 C--O 1.239 0.506 0 C-N-CA 123.614 0.766 . . . . 75.31 110.654 -179.338 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 155' ' ' LYS . . . . . 0.642 ' HD2' ' SG ' ' A' ' 52' ' ' CYS . 0.0 OUTLIER -87.03 93.24 9.3 Favored 'General case' 0 CA--C 1.535 0.374 0 O-C-N 123.944 0.778 . . . . 70.04 109.369 -172.271 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 156' ' ' ILE . . . . . 0.624 ' HB ' ' HB2' ' A' ' 53' ' ' PHE . 27.1 mt -87.63 149.27 4.13 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.591 0 CA-C-N 115.488 -0.778 . . . . 61.43 109.231 -177.685 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 157' ' ' THR . . . . . . . . . . . . . 71.9 p -146.25 170.41 16.82 Favored 'General case' 0 N--CA 1.482 1.153 0 C-N-CA 124.091 0.956 . . . . 72.31 109.951 -176.661 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 158' ' ' ILE . . . . . 0.4 HG23 ' HB3' ' A' ' 8' ' ' PHE . 67.8 mt -88.87 102.2 12.7 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.705 0 N-CA-C 107.954 -1.128 . . . . 72.41 107.954 165.05 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 159' ' ' ALA . . . . . 0.502 ' HB2' ' HB2' ' A' ' 11' ' ' ALA . . . -56.03 -49.66 73.08 Favored 'General case' 0 N--CA 1.476 0.835 0 C-N-CA 124.186 0.995 . . . . 71.52 112.115 179.048 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 160' ' ' ASP . . . . . . . . . . . . . 27.5 t70 -160.45 156.96 26.84 Favored 'General case' 0 N--CA 1.471 0.584 0 O-C-N 123.904 0.752 . . . . 62.04 110.685 -174.077 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 161' ' ' CYS . . . . . . . . . . . . . 14.9 p -110.8 -168.71 1.34 Allowed 'General case' 0 N--CA 1.475 0.811 0 C-N-CA 125.122 1.369 . . . . 62.33 108.839 175.851 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 162' ' ' GLY . . . . . . . . . . . . . . . 132.45 53.39 0.08 OUTLIER Glycine 0 C--N 1.346 1.1 0 N-CA-C 111.006 -0.838 . . . . 60.23 111.006 -171.274 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 163' ' ' GLN . . . . . 0.708 ' HA ' ' H ' ' A' ' 7' ' ' PHE . 16.2 pt20 -50.34 132.46 24.52 Favored 'General case' 0 C--N 1.357 0.915 0 C-N-CA 123.908 0.883 . . . . 71.43 113.034 -172.499 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 164' ' ' LEU . . . . . 0.476 ' O ' ' HB ' ' A' ' 5' ' ' THR . 96.7 mt . . . . . 0 CA--C 1.534 0.362 0 N-CA-C 107.92 -1.141 . . . . 73.4 107.92 177.44 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 218' ' ' PRO . . . . . . . . . . . . . 13.5 Cg_exo . . . . . 0 CA--C 1.544 0.987 0 CA-C-O 121.055 0.356 . . . . 71.12 111.223 . . . . . . . . . 0 0 . 1 . 008 nuclear build core ' B' B ' 219' ' ' GLY . . . . . 0.429 ' HA2' ' HD3' ' B' ' 220' ' ' PRO . . . 155.55 140.91 3.09 Favored Glycine 0 CA--C 1.53 1.006 0 CA-C-N 115.435 -0.802 . . . . 51.13 111.313 -176.5 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 220' ' ' PRO . . . . . 0.429 ' HD3' ' HA2' ' B' ' 219' ' ' GLY . 6.1 Cg_exo -77.13 173.25 14.7 Favored 'Trans proline' 0 C--N 1.369 1.634 0 C-N-CA 123.422 2.748 . . . . 71.22 114.108 -173.866 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 221' ' ' TYR . . . . . . . . . . . . . 43.0 p90 . . . . . 0 C--O 1.25 1.108 0 CA-C-N 114.697 -1.138 . . . . 74.42 109.776 -175.601 . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 46.2 m-80 . . . . . 0 C--O 1.245 0.833 0 CA-C-O 119.052 -0.499 . . . . 63.3 110.911 . . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 26.5 Cg_endo -60.79 118.53 5.4 Favored 'Trans proline' 0 C--N 1.382 2.29 0 C-N-CA 122.422 2.081 . . . . 74.41 110.227 177.731 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 5' ' ' THR . . . . . 0.459 ' HB ' ' O ' ' A' ' 164' ' ' LEU . 40.1 m -95.56 130.2 42.49 Favored 'General case' 0 C--O 1.239 0.501 0 N-CA-C 108.95 -0.759 . . . . 75.23 108.95 -173.116 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 6' ' ' VAL . . . . . 0.837 ' HA ' ' HB2' ' A' ' 163' ' ' GLN . 48.5 t -99.6 152.53 4.57 Favored 'Isoleucine or valine' 0 C--O 1.215 -0.748 0 N-CA-C 108.513 -0.921 . . . . 55.32 108.513 -179.426 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 7' ' ' PHE . . . . . 0.466 ' HB3' ' HA ' ' A' ' 163' ' ' GLN . 56.2 t80 -139.6 133.62 30.96 Favored 'General case' 0 C--O 1.242 0.682 0 C-N-CA 123.336 0.654 . . . . 72.13 109.832 179.877 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 40.2 m-85 -135.62 164.39 27.95 Favored 'General case' 0 C--O 1.241 0.642 0 O-C-N 124.663 1.227 . . . . 72.25 109.0 171.808 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 9' ' ' ASP . . . . . 0.522 ' HB2' ' HB3' ' A' ' 159' ' ' ALA . 40.8 m-20 -108.02 114.2 27.93 Favored 'General case' 0 N--CA 1.468 0.434 0 N-CA-C 107.605 -1.257 . . . . 71.21 107.605 171.134 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 10' ' ' ILE . . . . . 0.514 HG21 ' SD ' ' A' ' 142' ' ' MET . 46.1 mm -81.42 129.88 36.76 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.593 0 N-CA-C 109.089 -0.708 . . . . 64.32 109.089 177.799 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 11' ' ' ALA . . . . . 0.568 ' HB2' ' HB2' ' A' ' 159' ' ' ALA . . . -132.3 133.51 44.14 Favored 'General case' 0 N--CA 1.468 0.454 0 C-N-CA 123.379 0.672 . . . . 71.13 111.613 -168.131 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 12' ' ' VAL . . . . . 0.404 HG13 ' HB3' ' A' ' 154' ' ' LYS . 50.9 t -94.6 109.52 22.33 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.848 0 C-N-CA 124.607 1.163 . . . . 64.11 108.847 174.978 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 33.5 m-20 57.97 25.57 12.38 Favored 'General case' 0 N--CA 1.488 1.457 0 C-N-CA 125.449 1.5 . . . . 70.42 112.222 -172.96 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 100.45 -14.64 59.3 Favored Glycine 0 C--N 1.346 1.098 0 CA-C-O 119.475 -0.625 . . . . 73.45 113.326 179.129 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 17.6 mm-40 -87.72 114.25 58.14 Favored Pre-proline 0 N--CA 1.48 1.074 0 CA-C-N 117.559 0.679 . . . . 72.3 109.556 176.875 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 52.8 Cg_exo -50.26 108.64 0.23 Allowed 'Trans proline' 0 C--N 1.378 2.118 0 C-N-CA 123.649 2.9 . . . . 74.4 113.438 -178.795 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 59.4 tp -77.46 -40.49 42.99 Favored 'General case' 0 N--CA 1.472 0.648 0 C-N-CA 124.004 0.922 . . . . 25.14 109.546 175.459 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -167.43 170.38 41.6 Favored Glycine 0 C--N 1.342 0.904 0 CA-C-N 115.534 -0.757 . . . . 33.34 112.753 -178.823 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 19' ' ' ARG . . . . . 0.415 ' HB3' ' HE1' ' A' ' 7' ' ' PHE . 81.1 mtm180 -110.46 127.81 55.31 Favored 'General case' 0 N--CA 1.471 0.577 0 C-N-CA 124.299 1.04 . . . . 71.32 108.858 -178.587 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 76.5 t -129.17 122.16 55.54 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.723 0 C-N-CA 123.426 0.691 . . . . 71.53 110.67 -173.926 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 21' ' ' SER . . . . . 0.456 ' HB2' ' HB2' ' A' ' 134' ' ' GLU . 16.0 m -106.1 129.91 54.1 Favored 'General case' 0 CA--C 1.545 0.788 0 C-N-CA 123.58 0.752 . . . . 53.21 109.92 173.522 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 85.9 m-85 -100.64 170.23 8.5 Favored 'General case' 0 N--CA 1.474 0.768 0 C-N-CA 124.545 1.138 . . . . 65.45 110.038 175.022 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 23' ' ' GLU . . . . . 0.802 ' HB2' ' HD2' ' A' ' 133' ' ' LYS . 41.4 tt0 -135.35 118.75 16.79 Favored 'General case' 0 N--CA 1.472 0.648 0 C-N-CA 123.677 0.791 . . . . 72.4 109.261 -177.763 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 24' ' ' LEU . . . . . 0.471 ' HB3' ' HB1' ' A' ' 33' ' ' ALA . 36.3 mt -96.84 127.29 42.66 Favored 'General case' 0 N--CA 1.474 0.77 0 C-N-CA 122.747 0.419 . . . . 75.42 110.881 -177.062 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 25' ' ' PHE . . . . . 0.532 ' HB2' HD11 ' A' ' 90' ' ' LEU . 33.7 m-85 -86.15 65.85 9.28 Favored 'General case' 0 CA--C 1.537 0.466 0 C-N-CA 123.561 0.744 . . . . 75.42 109.188 175.851 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -65.47 -20.86 66.53 Favored 'General case' 0 N--CA 1.482 1.157 0 C-N-CA 124.193 0.997 . . . . 62.44 111.938 180.0 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 12.1 p-10 -77.15 -21.94 53.31 Favored 'General case' 0 CA--C 1.549 0.917 0 CA-C-N 114.924 -1.035 . . . . 72.05 111.589 178.668 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 60.2 mttp -106.11 -48.75 3.52 Favored 'General case' 0 N--CA 1.481 1.121 0 C-N-CA 123.392 0.677 . . . . 72.12 111.066 -176.207 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 29' ' ' VAL . . . . . 0.461 HG21 ' HA ' ' A' ' 129' ' ' PHE . 15.1 m -121.69 76.5 37.07 Favored Pre-proline 0 CA--C 1.552 1.054 0 C-N-CA 124.221 1.008 . . . . 74.12 109.613 -179.478 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 26.5 Cg_endo -61.45 -38.72 61.5 Favored 'Trans proline' 0 C--N 1.381 2.267 0 C-N-CA 122.492 2.128 . . . . 73.42 112.811 -173.194 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 4.7 ttmp? -65.21 -58.08 6.89 Favored 'General case' 0 N--CA 1.473 0.706 0 C-N-CA 122.971 0.509 . . . . 64.53 111.711 179.749 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 6.6 m -71.78 -28.46 63.64 Favored 'General case' 0 CA--C 1.555 1.168 0 CA-C-N 115.365 -0.834 . . . . 74.44 111.888 -168.79 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 33' ' ' ALA . . . . . 0.471 ' HB1' ' HB3' ' A' ' 24' ' ' LEU . . . -85.05 -45.79 11.78 Favored 'General case' 0 N--CA 1.478 0.942 0 C-N-CA 123.12 0.568 . . . . 55.54 111.275 179.793 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 8.5 tp10 -60.3 -34.73 74.19 Favored 'General case' 0 N--CA 1.487 1.386 0 C-N-CA 122.71 0.404 . . . . 43.52 110.988 178.96 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 35' ' ' ASN . . . . . 0.485 ' O ' ' HG ' ' A' ' 39' ' ' LEU . 36.2 t30 -49.44 -60.61 2.69 Favored 'General case' 0 C--N 1.351 0.651 0 O-C-N 124.514 1.134 . . . . 62.41 110.7 172.626 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 87.8 t80 -62.08 -40.91 97.42 Favored 'General case' 0 N--CA 1.466 0.371 0 CA-C-N 115.183 -0.917 . . . . 72.23 111.68 -176.307 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 23.1 ttp180 -62.57 -42.99 99.89 Favored 'General case' 0 N--CA 1.477 0.9 0 C-N-CA 122.977 0.511 . . . . 73.43 110.909 -177.822 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 38' ' ' ALA . . . . . 0.547 ' HB1' ' HG2' ' A' ' 44' ' ' LYS . . . -69.1 -30.8 69.17 Favored 'General case' 0 CA--C 1.545 0.77 0 CA-C-N 115.341 -0.845 . . . . 62.11 111.508 179.754 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 39' ' ' LEU . . . . . 0.505 HD22 ' HE1' ' A' ' 48' ' ' TYR . 99.2 mt -72.48 -37.12 68.54 Favored 'General case' 0 CA--C 1.55 0.965 0 C-N-CA 123.582 0.753 . . . . 74.23 110.955 175.005 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 49.3 m -69.31 -46.2 67.69 Favored 'General case' 0 N--CA 1.479 1.006 0 C-N-CA 124.186 0.994 . . . . 74.43 111.284 -176.302 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 25.2 p -79.7 -30.01 40.9 Favored 'General case' 0 N--CA 1.472 0.668 0 C-N-CA 123.878 0.871 . . . . 40.3 111.288 178.587 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 83.03 28.82 36.09 Favored Glycine 0 C--N 1.346 1.119 0 CA-C-N 115.825 -0.625 . . . . 65.52 113.033 179.487 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 47.9 mm-40 -63.98 -23.06 67.19 Favored 'General case' 0 N--CA 1.477 0.887 0 C-N-CA 123.138 0.575 . . . . 73.43 111.604 177.024 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 44' ' ' LYS . . . . . 0.547 ' HG2' ' HB1' ' A' ' 38' ' ' ALA . 30.6 mmmt -99.77 19.83 15.27 Favored 'General case' 0 CA--C 1.541 0.631 0 C-N-CA 123.544 0.738 . . . . 73.53 111.985 -179.6 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 80.81 -21.99 5.19 Favored Glycine 0 C--N 1.355 1.607 0 N-CA-C 114.765 0.666 . . . . 63.12 114.765 173.224 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 46' ' ' PHE . . . . . 0.43 ' HE2' ' HA ' ' A' ' 78' ' ' ILE . 19.0 m-85 -69.84 -45.39 67.91 Favored 'General case' 0 C--N 1.348 0.534 0 C-N-CA 123.328 0.651 . . . . 63.51 110.684 -174.042 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 57.71 66.32 2.91 Favored Glycine 0 C--N 1.357 1.748 0 CA-C-O 119.008 -0.885 . . . . 74.34 113.927 168.544 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 48' ' ' TYR . . . . . 0.505 ' HE1' HD22 ' A' ' 39' ' ' LEU . 60.3 m-85 -66.21 85.59 0.1 Allowed 'General case' 0 N--CA 1.476 0.837 0 CA-C-O 122.71 1.243 . . . . 65.34 111.501 -176.494 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 29.0 tptp -113.32 109.21 18.35 Favored 'General case' 0 N--CA 1.451 -0.39 0 CA-C-N 112.662 -2.063 . . . . 73.14 107.975 179.439 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 89.8 19.89 45.9 Favored Glycine 0 N--CA 1.468 0.829 0 CA-C-O 119.657 -0.524 . . . . 73.33 113.695 -179.642 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 23.2 m -61.51 116.73 4.94 Favored 'General case' 0 C--O 1.243 0.745 0 C-N-CA 123.139 0.575 . . . . 70.14 109.572 174.228 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 52' ' ' CYS . . . . . 0.406 ' HA ' ' HA ' ' A' ' 157' ' ' THR . 20.1 p -102.03 128.96 48.24 Favored 'General case' 0 CA--C 1.538 0.487 0 CA-C-O 121.528 0.68 . . . . 71.31 112.19 -165.84 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 53' ' ' PHE . . . . . 0.585 ' HA ' ' HA2' ' A' ' 64' ' ' GLY . 77.7 m-85 -61.45 109.87 1.29 Allowed 'General case' 0 C--O 1.24 0.555 0 C-N-CA 124.804 1.241 . . . . 74.44 109.833 169.459 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 28.3 p-80 -124.15 2.42 8.57 Favored 'General case' 0 N--CA 1.475 0.791 0 CA-C-N 115.076 -0.965 . . . . 72.13 110.962 -175.532 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 55' ' ' ARG . . . . . 0.445 ' O ' ' HB3' ' A' ' 63' ' ' GLN . 53.4 ttt-85 -144.45 95.25 2.68 Favored 'General case' 0 C--O 1.218 -0.563 0 N-CA-C 108.396 -0.964 . . . . 73.11 108.396 177.046 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 56' ' ' ILE . . . . . 0.43 HG21 ' HA ' ' A' ' 143' ' ' GLU . 52.6 mt -130.4 133.68 63.49 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.088 0 N-CA-C 108.661 -0.866 . . . . 71.3 108.661 178.552 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 67.2 mt -126.65 118.61 22.75 Favored Pre-proline 0 CA--C 1.556 1.193 0 C-N-CA 123.606 0.762 . . . . 64.54 109.024 178.098 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 51.6 Cg_exo -57.62 141.79 95.49 Favored 'Trans proline' 0 C--N 1.387 2.559 0 C-N-CA 124.067 3.178 . . . . 74.33 113.784 -178.363 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 67.98 31.43 75.27 Favored Glycine 0 C--N 1.348 1.215 0 O-C-N 124.03 0.831 . . . . 50.3 112.807 -179.273 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 49.1 t80 -152.73 -71.23 0.15 Allowed 'General case' 0 CA--C 1.546 0.808 0 C-N-CA 123.75 0.82 . . . . 65.3 110.364 -177.703 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 37.0 ttp -170.25 150.1 3.57 Favored 'General case' 0 N--CA 1.485 1.296 0 N-CA-C 112.432 0.531 . . . . 75.14 112.432 -163.532 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 62' ' ' CYS . . . . . 0.497 ' SG ' ' HB2' ' A' ' 143' ' ' GLU . 35.4 m -108.77 112.41 24.69 Favored 'General case' 0 N--CA 1.474 0.774 0 C-N-CA 123.806 0.842 . . . . 73.02 109.5 168.4 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 63' ' ' GLN . . . . . 0.445 ' HB3' ' O ' ' A' ' 55' ' ' ARG . 52.1 tt0 -112.57 134.74 53.94 Favored 'General case' 0 N--CA 1.486 1.365 0 CA-C-O 121.644 0.735 . . . . 63.34 110.115 179.975 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 64' ' ' GLY . . . . . 0.585 ' HA2' ' HA ' ' A' ' 53' ' ' PHE . . . -134.45 175.56 20.39 Favored Glycine 0 CA--C 1.499 -0.947 0 CA-C-N 115.238 -0.892 . . . . 52.32 112.478 178.697 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 178.6 170.99 41.39 Favored Glycine 0 N--CA 1.444 -0.833 0 N-CA-C 110.726 -0.95 . . . . 64.31 110.726 179.383 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 14.8 t70 -94.18 166.31 12.18 Favored 'General case' 0 C--O 1.241 0.654 0 N-CA-C 109.862 -0.421 . . . . 54.13 109.862 -172.366 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 37.7 t80 -70.83 -22.93 62.27 Favored 'General case' 0 CA--C 1.548 0.9 0 C-N-CA 122.742 0.417 . . . . 64.44 110.356 175.142 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 52.7 m -61.64 113.65 2.84 Favored 'General case' 0 C--O 1.247 0.922 0 C-N-CA 123.823 0.849 . . . . 72.5 110.994 176.417 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 69' ' ' ARG . . . . . 0.415 ' HB3' ' HB ' ' A' ' 73' ' ' THR . 53.5 mtt180 58.99 29.78 19.41 Favored 'General case' 0 C--N 1.361 1.103 0 C-N-CA 124.577 1.151 . . . . 65.11 112.353 -176.114 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 32.4 p80 -51.72 -33.79 36.08 Favored 'General case' 0 N--CA 1.495 1.811 0 C-N-CA 123.252 0.621 . . . . 75.32 111.381 -179.427 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 6.8 t30 -75.49 89.96 2.71 Favored 'General case' 0 CA--C 1.551 0.992 0 C-N-CA 124.104 0.962 . . . . 62.35 109.164 171.622 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 100.59 -7.24 57.76 Favored Glycine 0 C--N 1.347 1.176 0 N-CA-C 115.93 1.132 . . . . 44.32 115.93 171.089 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 73' ' ' THR . . . . . 0.415 ' HB ' ' HB3' ' A' ' 69' ' ' ARG . 15.0 m -142.92 -75.23 0.27 Allowed 'General case' 0 N--CA 1.483 1.198 0 CA-C-N 118.687 1.243 . . . . 62.12 109.792 179.763 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 72.07 40.29 56.87 Favored Glycine 0 C--N 1.354 1.546 0 C-N-CA 123.234 0.445 . . . . 35.11 113.634 173.975 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 142.45 52.79 0.04 OUTLIER Glycine 0 C--N 1.344 0.995 0 CA-C-N 117.402 0.601 . . . . 75.11 111.741 -173.236 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 76' ' ' LYS . . . . . 0.407 ' HG2' ' OH ' ' A' ' 48' ' ' TYR . 16.5 ptpt -56.55 162.78 2.05 Favored 'General case' 0 N--CA 1.477 0.913 0 C-N-CA 124.183 0.993 . . . . 71.44 112.165 -176.237 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 77.9 p -91.33 173.63 7.81 Favored 'General case' 0 C--O 1.241 0.634 0 CA-C-N 115.343 -0.844 . . . . 63.43 110.42 -179.991 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 78' ' ' ILE . . . . . 0.441 HG21 ' HB3' ' A' ' 38' ' ' ALA . 21.4 pt -74.7 -17.5 16.47 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.608 0 CA-C-N 116.067 -0.515 . . . . 64.4 109.96 173.133 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 49.5 m-85 -87.67 -13.23 43.15 Favored 'General case' 0 CA--C 1.541 0.619 0 C-N-CA 124.615 1.166 . . . . 75.05 110.795 -178.445 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 142.37 -133.02 5.41 Favored Glycine 0 C--N 1.348 1.228 0 N-CA-C 110.858 -0.897 . . . . 44.41 110.858 178.689 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 36.4 tt0 -65.51 -54.34 29.61 Favored 'General case' 0 CA--C 1.54 0.596 0 C-N-CA 123.365 0.666 . . . . 74.01 109.86 175.215 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 82' ' ' LYS . . . . . 0.805 ' HD2' ' HA ' ' A' ' 107' ' ' THR . 24.1 pttm -158.81 174.15 15.45 Favored 'General case' 0 C--O 1.243 0.73 0 CA-C-N 114.52 -1.218 . . . . 62.35 109.17 -172.787 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 12.5 p90 -155.39 172.56 18.01 Favored 'General case' 0 N--CA 1.478 0.939 0 C-N-CA 123.59 0.756 . . . . 64.41 110.245 -175.518 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 14.1 pt-20 -87.25 168.34 13.29 Favored 'General case' 0 CA--C 1.548 0.885 0 CA-C-N 115.897 -0.592 . . . . 73.45 110.614 179.23 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 85' ' ' ASP . . . . . 0.432 ' HB3' HG23 ' A' ' 127' ' ' VAL . 35.7 m-20 -80.31 150.36 29.98 Favored 'General case' 0 N--CA 1.478 0.971 0 C-N-CA 123.898 0.879 . . . . 65.32 112.199 -174.597 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 6.9 tp10 -78.26 -62.55 1.64 Allowed 'General case' 0 C--N 1.352 0.687 0 CA-C-N 115.425 -0.807 . . . . 73.15 111.403 -178.02 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 23.0 p30 -176.75 143.46 0.45 Allowed 'General case' 0 N--CA 1.48 1.056 0 C-N-CA 124.419 1.087 . . . . 63.24 109.159 -175.825 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 98.8 m-85 -89.3 50.11 1.87 Allowed 'General case' 0 N--CA 1.491 1.585 0 CA-C-O 121.607 0.718 . . . . 63.55 111.448 -168.073 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 70.9 mt -67.86 -48.16 76.46 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.695 0 C-N-CA 124.145 0.978 . . . . 62.25 109.885 174.202 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 90' ' ' LEU . . . . . 0.532 HD11 ' HB2' ' A' ' 25' ' ' PHE . 74.5 mt -99.89 122.69 43.2 Favored 'General case' 0 C--O 1.241 0.63 0 CA-C-N 115.462 -0.79 . . . . 64.41 110.585 -174.665 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 44.0 mtmt -119.89 171.71 8.23 Favored 'General case' 0 N--CA 1.475 0.807 0 C-N-CA 124.073 0.949 . . . . 70.04 110.4 177.098 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 92' ' ' HIS . . . . . 0.559 ' HA ' HG13 ' A' ' 97' ' ' ILE . 13.0 m-70 -87.59 41.65 1.0 Allowed 'General case' 0 N--CA 1.482 1.15 0 C-N-CA 124.223 1.009 . . . . 64.53 110.297 -176.115 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 13.0 t -84.92 1.49 47.05 Favored 'General case' 0 CA--C 1.555 1.16 0 C-N-CA 123.986 0.914 . . . . 72.44 111.679 -174.777 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -140.53 161.22 26.58 Favored Glycine 0 C--N 1.344 1.002 0 CA-C-O 119.552 -0.582 . . . . 72.32 111.709 179.601 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 7.3 Cg_exo -75.27 149.74 36.03 Favored 'Trans proline' 0 C--N 1.37 1.692 0 C-N-CA 123.135 2.557 . . . . 72.12 112.146 175.295 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 96' ' ' GLY . . . . . 0.43 ' HA3' HG12 ' A' ' 132' ' ' VAL . . . 84.61 19.45 59.99 Favored Glycine 0 C--N 1.343 0.957 0 N-CA-C 114.586 0.594 . . . . 73.51 114.586 177.357 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 97' ' ' ILE . . . . . 0.559 HG13 ' HA ' ' A' ' 92' ' ' HIS . 7.8 mm -70.54 122.49 22.48 Favored 'Isoleucine or valine' 0 CA--C 1.553 1.088 0 C-N-CA 124.061 0.944 . . . . 64.34 111.99 -177.199 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 56.8 tp -104.91 124.08 48.87 Favored 'General case' 0 N--CA 1.482 1.133 0 C-N-CA 123.266 0.626 . . . . 64.41 110.548 179.813 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 32.2 t -151.22 154.42 36.8 Favored 'General case' 0 CA--C 1.548 0.882 0 C-N-CA 123.627 0.771 . . . . 71.33 109.822 179.685 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 100' ' ' MET . . . . . 0.632 ' HA ' ' HA ' ' A' ' 112' ' ' PHE . 85.3 mtp -86.25 141.34 29.36 Favored 'General case' 0 N--CA 1.492 1.655 0 CA-C-N 118.272 0.487 . . . . 62.41 109.79 179.324 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 101' ' ' ALA . . . . . 0.432 ' HB3' ' HB2' ' A' ' 111' ' ' GLN . . . -73.07 162.41 29.49 Favored 'General case' 0 N--CA 1.487 1.401 0 N-CA-C 112.432 0.531 . . . . 41.22 112.432 -169.75 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 21.3 p-10 -161.71 170.16 20.17 Favored 'General case' 0 N--CA 1.474 0.753 0 CA-C-N 115.736 -0.665 . . . . 64.44 111.295 -174.28 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -103.73 -20.05 14.1 Favored 'General case' 0 N--CA 1.477 0.899 0 C-N-CA 124.124 0.97 . . . . 62.34 110.575 169.412 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 167.41 -151.38 18.96 Favored Glycine 0 CA--C 1.536 1.403 0 CA-C-O 119.269 -0.739 . . . . 52.13 111.439 -173.473 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 31.4 Cg_exo -62.46 144.07 94.21 Favored 'Trans proline' 0 C--N 1.37 1.709 0 C-N-CA 122.751 2.301 . . . . 73.14 112.671 175.108 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 64.4 t30 66.93 9.89 7.21 Favored 'General case' 0 N--CA 1.493 1.695 0 C-N-CA 124.745 1.218 . . . . 73.43 112.578 175.03 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 107' ' ' THR . . . . . 0.805 ' HA ' ' HD2' ' A' ' 82' ' ' LYS . 46.8 p -114.45 2.74 14.74 Favored 'General case' 0 N--CA 1.474 0.765 0 O-C-N 121.688 -0.632 . . . . 71.42 112.04 177.945 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 39.8 t30 -71.96 131.87 43.54 Favored 'General case' 0 N--CA 1.475 0.787 0 N-CA-C 108.925 -0.769 . . . . 74.22 108.925 174.924 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 112.43 22.15 5.91 Favored Glycine 0 N--CA 1.468 0.793 0 CA-C-O 120.239 -0.201 . . . . 44.13 113.08 -176.058 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 27.7 p -125.11 120.1 30.45 Favored 'General case' 0 N--CA 1.47 0.539 0 N-CA-C 107.745 -1.205 . . . . 74.02 107.745 169.21 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 111' ' ' GLN . . . . . 0.432 ' HB2' ' HB3' ' A' ' 101' ' ' ALA . 49.4 mt-30 63.41 176.95 0.16 Allowed 'General case' 0 N--CA 1.492 1.637 0 C-N-CA 124.133 0.973 . . . . 74.45 111.769 -171.897 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 112' ' ' PHE . . . . . 0.632 ' HA ' ' HA ' ' A' ' 100' ' ' MET . 44.9 p90 -139.88 159.46 42.13 Favored 'General case' 0 N--CA 1.476 0.87 0 C-N-CA 124.249 1.02 . . . . 74.24 108.461 175.478 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 113' ' ' PHE . . . . . . . . . . . . . 54.0 p90 -152.59 153.83 34.17 Favored 'General case' 0 N--CA 1.471 0.606 0 CA-C-O 121.004 0.431 . . . . 70.24 111.191 178.901 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 114' ' ' ILE . . . . . . . . . . . . . 9.3 mt -119.73 101.96 12.02 Favored 'Isoleucine or valine' 0 C--O 1.245 0.831 0 N-CA-C 107.663 -1.236 . . . . 44.21 107.663 176.468 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 115' ' ' CYS . . . . . 0.407 ' HB2' ' HB ' ' A' ' 97' ' ' ILE . 69.9 m -62.31 104.77 0.53 Allowed 'General case' 0 CA--C 1.537 0.46 0 N-CA-C 108.602 -0.888 . . . . 63.53 108.602 169.502 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 116' ' ' THR . . . . . 0.604 HG22 HG12 ' A' ' 139' ' ' VAL . 64.3 p -69.45 -35.15 75.37 Favored 'General case' 0 N--CA 1.473 0.725 0 C-N-CA 123.461 0.705 . . . . 73.31 110.334 -175.708 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -107.87 167.17 10.17 Favored 'General case' 0 C--O 1.246 0.887 0 CA-C-N 114.716 -1.129 . . . . 44.31 109.289 174.465 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 20.7 ptmt -73.73 91.23 1.89 Allowed 'General case' 0 CA--C 1.545 0.769 0 CA-C-O 122.013 0.911 . . . . 75.21 109.954 174.757 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 119' ' ' THR . . . . . . . . . . . . . 58.4 p -86.97 83.28 7.54 Favored 'General case' 0 CA--C 1.542 0.663 0 CA-C-O 121.997 0.904 . . . . 62.54 109.022 -179.242 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 15.9 pt-20 -79.72 -15.23 57.91 Favored 'General case' 0 N--CA 1.48 1.056 0 CA-C-N 115.129 -0.941 . . . . 44.24 112.406 -167.953 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 121' ' ' TRP . . . . . . . . . . . . . 44.2 p90 -71.97 -14.62 61.95 Favored 'General case' 0 N--CA 1.481 1.1 0 C-N-CA 122.977 0.511 . . . . 64.32 110.832 172.928 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 54.2 mt -88.37 6.47 37.2 Favored 'General case' 0 N--CA 1.474 0.729 0 C-N-CA 123.121 0.568 . . . . 71.14 111.092 174.238 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 30.7 m-20 -79.29 136.84 37.15 Favored 'General case' 0 N--CA 1.474 0.759 0 N-CA-C 107.905 -1.146 . . . . 52.24 107.905 167.546 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 95.42 -24.3 29.79 Favored Glycine 0 N--CA 1.472 1.067 0 N-CA-C 111.17 -0.772 . . . . 64.02 111.17 -168.408 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 125' ' ' LYS . . . . . 0.631 ' HG3' ' H ' ' A' ' 126' ' ' HIS . 12.2 tppt? -75.27 -169.45 0.97 Allowed 'General case' 0 CA--C 1.563 1.48 0 N-CA-C 107.913 -1.143 . . . . 73.53 107.913 169.274 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 126' ' ' HIS . . . . . 0.631 ' H ' ' HG3' ' A' ' 125' ' ' LYS . 43.2 p-80 -67.56 157.59 34.02 Favored 'General case' 0 CA--C 1.549 0.941 0 C-N-CA 123.919 0.887 . . . . 75.14 111.685 -173.347 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 127' ' ' VAL . . . . . 0.491 HG12 ' O ' ' A' ' 128' ' ' VAL . 43.1 t -67.86 140.45 19.16 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.85 0 CA-C-N 114.292 -1.322 . . . . 73.35 112.466 -173.033 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 128' ' ' VAL . . . . . 0.501 HG11 HD12 ' A' ' 97' ' ' ILE . 97.2 t -80.98 154.28 4.26 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.832 0 C-N-CA 124.803 1.241 . . . . 62.13 109.276 170.429 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 129' ' ' PHE . . . . . 0.523 ' CE2' ' HG3' ' A' ' 100' ' ' MET . 37.6 p90 -131.57 -17.41 2.91 Favored 'General case' 0 N--CA 1.484 1.239 0 O-C-N 121.626 -0.671 . . . . 63.52 111.663 177.938 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . -138.4 175.01 21.69 Favored Glycine 0 C--N 1.342 0.904 0 CA-C-O 121.431 0.462 . . . . 73.13 113.314 -169.283 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 31.3 ttpt -160.81 136.07 7.82 Favored 'General case' 0 CA--C 1.536 0.431 0 N-CA-C 108.205 -1.035 . . . . 71.41 108.205 -178.565 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 132' ' ' VAL . . . . . 0.43 HG12 ' HA3' ' A' ' 96' ' ' GLY . 13.3 p -72.25 130.97 35.31 Favored 'Isoleucine or valine' 0 CA--C 1.553 1.063 0 N-CA-C 109.251 -0.648 . . . . 62.14 109.251 173.239 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 133' ' ' LYS . . . . . 0.802 ' HD2' ' HB2' ' A' ' 23' ' ' GLU . 19.9 ptmt -116.15 -26.96 7.04 Favored 'General case' 0 N--CA 1.48 1.042 0 C-N-CA 123.582 0.753 . . . . 73.25 110.257 -179.721 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 134' ' ' GLU . . . . . 0.456 ' HB2' ' HB2' ' A' ' 21' ' ' SER . 71.3 mm-40 -131.24 130.22 42.62 Favored 'General case' 0 N--CA 1.471 0.617 0 C-N-CA 124.656 1.183 . . . . 54.15 108.558 175.308 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 135' ' ' GLY . . . . . 0.414 ' O ' HG23 ' A' ' 139' ' ' VAL . . . 90.89 27.71 18.19 Favored Glycine 0 N--CA 1.468 0.829 0 CA-C-O 119.569 -0.573 . . . . 62.05 113.688 175.444 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 136' ' ' MET . . . . . . . . . . . . . 6.4 tpt -58.76 -43.7 90.39 Favored 'General case' 0 N--CA 1.486 1.333 0 C-N-CA 123.561 0.745 . . . . 74.54 110.52 174.964 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 137' ' ' ASN . . . . . . . . . . . . . 18.7 m120 -60.61 -37.23 80.73 Favored 'General case' 0 N--CA 1.479 1.016 0 CA-C-N 115.625 -0.716 . . . . 73.54 111.283 178.29 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 138' ' ' ILE . . . . . . . . . . . . . 43.4 mm -67.78 -41.32 85.07 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.035 0 C-N-CA 123.555 0.742 . . . . 75.13 110.617 -179.566 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 139' ' ' VAL . . . . . 0.604 HG12 HG22 ' A' ' 116' ' ' THR . 96.1 t -61.5 -44.1 98.01 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.979 0 C-N-CA 123.503 0.721 . . . . 73.34 110.699 177.664 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 41.7 mt-10 -69.11 -34.24 74.76 Favored 'General case' 0 N--CA 1.477 0.914 0 CA-C-N 115.455 -0.793 . . . . 75.53 111.02 178.121 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -73.11 -33.8 65.78 Favored 'General case' 0 N--CA 1.475 0.822 0 C-N-CA 123.367 0.667 . . . . 72.33 111.669 -178.863 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 142' ' ' MET . . . . . 0.561 ' HB2' HD13 ' A' ' 156' ' ' ILE . 21.8 ptt? -79.38 -27.14 41.91 Favored 'General case' 0 N--CA 1.473 0.7 0 C-N-CA 122.423 0.289 . . . . 72.01 110.414 177.985 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 143' ' ' GLU . . . . . 0.497 ' HB2' ' SG ' ' A' ' 62' ' ' CYS . 33.4 tt0 -59.36 -29.3 67.58 Favored 'General case' 0 N--CA 1.482 1.144 0 C-N-CA 123.041 0.536 . . . . 73.05 111.609 176.134 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 144' ' ' ARG . . . . . . . . . . . . . 80.1 mtp180 -64.94 -21.45 66.83 Favored 'General case' 0 CA--C 1.543 0.707 0 C-N-CA 123.704 0.802 . . . . 72.44 112.365 -178.554 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 145' ' ' PHE . . . . . 0.499 ' HB2' HD11 ' A' ' 156' ' ' ILE . 77.6 m-85 -81.47 -12.7 58.79 Favored 'General case' 0 N--CA 1.478 0.933 0 C-N-CA 122.502 0.321 . . . . 71.12 111.337 175.554 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . -70.75 166.6 51.6 Favored Glycine 0 CA--C 1.531 1.034 0 N-CA-C 113.898 0.319 . . . . 55.41 113.898 179.347 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 14.7 m -134.86 161.27 35.7 Favored 'General case' 0 N--CA 1.479 0.994 0 C-N-CA 124.376 1.07 . . . . 74.3 109.749 -179.792 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 148' ' ' ARG . . . . . . . . . . . . . 22.8 mmt85 -68.3 -26.51 65.68 Favored 'General case' 0 N--CA 1.484 1.261 0 C-N-CA 123.557 0.743 . . . . 70.54 112.464 -176.714 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 149' ' ' ASN . . . . . . . . . . . . . 30.1 p-10 -84.33 0.47 49.09 Favored 'General case' 0 N--CA 1.486 1.33 0 C-N-CA 122.996 0.518 . . . . 70.24 111.452 175.682 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . 95.29 -6.16 68.4 Favored Glycine 0 C--N 1.349 1.26 0 CA-C-O 119.683 -0.509 . . . . 55.01 112.982 179.445 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 53.8 tttp -62.94 141.31 58.77 Favored 'General case' 0 N--CA 1.475 0.823 0 C-N-CA 123.035 0.534 . . . . 64.31 111.072 179.987 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 152' ' ' THR . . . . . . . . . . . . . 26.4 p -102.74 131.8 49.33 Favored 'General case' 0 C--O 1.244 0.811 0 N-CA-C 108.776 -0.824 . . . . 71.42 108.776 166.686 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 153' ' ' SER . . . . . . . . . . . . . 16.4 m -72.49 -23.38 61.02 Favored 'General case' 0 N--CA 1.473 0.696 0 C-N-CA 123.834 0.854 . . . . 45.02 110.598 178.131 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 154' ' ' LYS . . . . . 0.404 ' HB3' HG13 ' A' ' 12' ' ' VAL . 73.6 mmtt -134.88 143.38 46.94 Favored 'General case' 0 C--O 1.241 0.625 0 C-N-CA 125.338 1.455 . . . . 73.44 108.289 -178.678 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 3.8 tppp? -74.63 89.55 2.24 Favored 'General case' 0 C--N 1.345 0.373 0 N-CA-C 108.903 -0.777 . . . . 71.32 108.903 177.761 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 156' ' ' ILE . . . . . 0.561 HD13 ' HB2' ' A' ' 142' ' ' MET . 66.5 mt -84.02 130.17 36.36 Favored 'Isoleucine or valine' 0 C--O 1.222 -0.367 0 N-CA-C 106.967 -1.494 . . . . 72.24 106.967 179.989 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 157' ' ' THR . . . . . 0.406 ' HA ' ' HA ' ' A' ' 52' ' ' CYS . 4.8 t -154.44 156.54 36.95 Favored 'General case' 0 C--O 1.237 0.424 0 C-N-CA 122.74 0.416 . . . . 72.21 110.651 -167.166 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 158' ' ' ILE . . . . . . . . . . . . . 74.1 mt -75.2 98.33 1.39 Allowed 'Isoleucine or valine' 0 CA--C 1.539 0.553 0 N-CA-C 109.015 -0.735 . . . . 74.02 109.015 172.963 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 159' ' ' ALA . . . . . 0.568 ' HB2' ' HB2' ' A' ' 11' ' ' ALA . . . -53.6 -53.65 48.75 Favored 'General case' 0 N--CA 1.472 0.667 0 C-N-CA 123.629 0.772 . . . . 75.01 111.289 177.155 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 160' ' ' ASP . . . . . . . . . . . . . 25.9 t70 -156.33 152.87 28.16 Favored 'General case' 0 N--CA 1.476 0.834 0 CA-C-N 116.321 -0.399 . . . . 74.02 111.03 -177.77 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 161' ' ' CYS . . . . . . . . . . . . . 23.7 p -102.8 -171.45 1.95 Allowed 'General case' 0 N--CA 1.475 0.805 0 C-N-CA 124.888 1.275 . . . . 42.23 109.76 175.501 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 162' ' ' GLY . . . . . . . . . . . . . . . 130.49 52.25 0.1 Allowed Glycine 0 C--N 1.346 1.086 0 N-CA-C 111.176 -0.77 . . . . 71.23 111.176 -171.314 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 163' ' ' GLN . . . . . 0.837 ' HB2' ' HA ' ' A' ' 6' ' ' VAL . 12.8 pt20 -52.48 126.6 19.93 Favored 'General case' 0 CA--C 1.552 1.02 0 C-N-CA 124.527 1.131 . . . . 54.2 113.57 -169.82 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 164' ' ' LEU . . . . . 0.459 ' O ' ' HB ' ' A' ' 5' ' ' THR . 88.1 mt . . . . . 0 C--O 1.216 -0.706 0 CA-C-N 115.586 -0.734 . . . . 63.24 109.312 -175.114 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 218' ' ' PRO . . . . . . . . . . . . . 75.0 Cg_exo . . . . . 0 CA--C 1.547 1.139 0 CA-C-O 120.909 0.295 . . . . 73.05 111.516 . . . . . . . . . 0 0 . 1 . 009 nuclear build core ' B' B ' 219' ' ' GLY . . . . . . . . . . . . . . . 170.0 148.51 5.93 Favored Glycine 0 CA--C 1.534 1.264 0 CA-C-N 115.617 -0.719 . . . . 63.31 111.87 -178.006 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 220' ' ' PRO . . . . . . . . . . . . . 88.0 Cg_endo -76.85 169.75 21.11 Favored 'Trans proline' 0 C--N 1.37 1.688 0 C-N-CA 123.34 2.693 . . . . 73.35 114.823 -175.334 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 221' ' ' TYR . . . . . . . . . . . . . 91.4 m-85 . . . . . 0 N--CA 1.487 1.404 0 C-N-CA 124.175 0.99 . . . . 75.22 111.42 -176.44 . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 38.7 m-80 . . . . . 0 CA--C 1.542 0.651 0 CA-C-O 119.236 -0.411 . . . . 73.11 111.234 . . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 4' ' ' PRO . . . . . 0.449 ' HG2' ' HB2' ' A' ' 24' ' ' LEU . 56.0 Cg_endo -68.28 153.19 74.93 Favored 'Trans proline' 0 C--N 1.369 1.634 0 C-N-CA 122.366 2.044 . . . . 74.41 110.517 170.216 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 5' ' ' THR . . . . . 0.515 ' HB ' ' O ' ' A' ' 164' ' ' LEU . 76.3 m -123.55 136.6 54.63 Favored 'General case' 0 C--O 1.236 0.374 0 N-CA-C 109.672 -0.492 . . . . 75.24 109.672 177.427 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 6' ' ' VAL . . . . . 0.49 ' HA ' ' HB2' ' A' ' 163' ' ' GLN . 17.3 m -102.67 145.99 11.3 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.36 0 C-N-CA 123.754 0.822 . . . . 72.51 109.653 174.813 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 7' ' ' PHE . . . . . 0.497 ' H ' ' HA ' ' A' ' 163' ' ' GLN . 84.3 t80 -121.47 133.53 55.05 Favored 'General case' 0 C--O 1.237 0.415 0 C-N-CA 123.896 0.879 . . . . 72.01 109.169 -176.342 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 8' ' ' PHE . . . . . 0.431 ' HD2' ' HE1' ' A' ' 22' ' ' PHE . 36.5 m-85 -133.43 164.87 26.17 Favored 'General case' 0 C--O 1.24 0.556 0 C-N-CA 124.11 0.964 . . . . 71.23 109.873 172.209 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 19.3 m-20 -118.2 112.89 20.72 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 114.209 -1.36 . . . . 73.21 107.819 173.039 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 10' ' ' ILE . . . . . 0.464 HG21 ' SD ' ' A' ' 142' ' ' MET . 40.3 mm -81.98 134.0 27.98 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.566 0 N-CA-C 108.853 -0.795 . . . . 75.41 108.853 177.906 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 11' ' ' ALA . . . . . 0.551 ' HB2' ' HB2' ' A' ' 159' ' ' ALA . . . -135.08 111.29 9.63 Favored 'General case' 0 N--CA 1.468 0.448 0 C-N-CA 123.482 0.713 . . . . 70.12 110.905 -173.064 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 12' ' ' VAL . . . . . 0.503 HG22 HG12 ' A' ' 156' ' ' ILE . 85.5 t -94.82 129.15 45.39 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.832 0 N-CA-C 108.14 -1.059 . . . . 74.14 108.14 178.708 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 22.9 m-20 68.92 13.96 8.85 Favored 'General case' 0 N--CA 1.493 1.684 0 C-N-CA 124.691 1.196 . . . . 74.42 110.481 -170.507 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 80.3 -2.62 76.14 Favored Glycine 0 C--N 1.354 1.55 0 CA-C-O 120.186 -0.23 . . . . 71.44 112.792 -168.972 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 18.3 mm-40 -93.17 117.73 67.55 Favored Pre-proline 0 C--O 1.243 0.751 0 C-N-CA 124.025 0.93 . . . . 74.5 109.454 178.722 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 92.5 Cg_exo -45.51 105.19 0.07 OUTLIER 'Trans proline' 0 C--N 1.378 2.13 0 C-N-CA 123.912 3.075 . . . . 70.31 113.681 179.302 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 31.9 tp -76.36 -35.54 58.65 Favored 'General case' 0 N--CA 1.477 0.915 0 C-N-CA 123.574 0.75 . . . . 74.41 109.411 179.219 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 166.52 -176.47 41.68 Favored Glycine 0 C--N 1.337 0.635 0 CA-C-N 115.617 -0.72 . . . . 72.22 111.662 178.244 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 19.9 ptt85 -106.58 148.13 28.64 Favored 'General case' 0 N--CA 1.472 0.644 0 C-N-CA 122.739 0.416 . . . . 74.03 110.088 -175.641 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 20' ' ' VAL . . . . . 0.401 HG13 HG13 ' A' ' 132' ' ' VAL . 81.9 t -136.7 142.08 39.06 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.517 0 N-CA-C 108.635 -0.876 . . . . 72.04 108.635 176.788 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 15.7 m -130.21 132.79 46.16 Favored 'General case' 0 CA--C 1.542 0.662 0 N-CA-C 108.664 -0.865 . . . . 50.44 108.664 173.688 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 22' ' ' PHE . . . . . 0.431 ' HE1' ' HD2' ' A' ' 8' ' ' PHE . 40.8 m-85 -111.28 125.84 54.26 Favored 'General case' 0 N--CA 1.475 0.796 0 C-N-CA 123.516 0.726 . . . . 73.52 109.697 -179.524 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 37.0 tt0 -76.91 111.39 12.4 Favored 'General case' 0 CA--C 1.546 0.815 0 C-N-CA 123.252 0.621 . . . . 72.32 109.894 172.494 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 24' ' ' LEU . . . . . 0.449 ' HB2' ' HG2' ' A' ' 4' ' ' PRO . 76.1 mt -77.9 125.89 30.03 Favored 'General case' 0 N--CA 1.471 0.606 0 C-N-CA 123.325 0.65 . . . . 72.13 110.163 175.305 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 90.8 m-85 -85.53 62.49 7.5 Favored 'General case' 0 CA--C 1.538 0.499 0 C-N-CA 123.777 0.831 . . . . 72.21 110.702 178.961 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -69.65 -8.56 48.68 Favored 'General case' 0 CA--C 1.547 0.845 0 CA-C-N 115.387 -0.824 . . . . 73.24 111.627 179.008 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 13.2 p-10 -76.23 -31.68 58.5 Favored 'General case' 0 CA--C 1.549 0.939 0 C-N-CA 123.427 0.691 . . . . 73.23 110.956 175.432 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 28' ' ' LYS . . . . . 0.513 ' HD2' HD21 ' A' ' 90' ' ' LEU . 62.0 mttp -106.18 -47.69 3.76 Favored 'General case' 0 N--CA 1.487 1.404 0 C-N-CA 123.261 0.624 . . . . 65.1 111.137 -176.211 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 21.1 m -122.6 67.58 29.55 Favored Pre-proline 0 CA--C 1.563 1.475 0 C-N-CA 123.803 0.841 . . . . 73.55 110.144 -179.914 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 38.4 Cg_endo -62.17 -30.74 82.45 Favored 'Trans proline' 0 C--N 1.384 2.399 0 C-N-CA 122.704 2.269 . . . . 71.1 112.264 -175.924 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 64.4 tttm -69.22 -51.14 40.72 Favored 'General case' 0 CA--C 1.543 0.7 0 C-N-CA 124.559 1.143 . . . . 74.04 111.223 -177.451 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 16.5 m -75.03 -30.15 61.01 Favored 'General case' 0 CA--C 1.551 1.009 0 CA-C-N 115.271 -0.877 . . . . 71.4 111.041 -175.264 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -72.81 -41.71 64.63 Favored 'General case' 0 CA--C 1.544 0.74 0 C-N-CA 123.18 0.592 . . . . 73.31 110.532 176.508 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 41.9 tt0 -61.16 -39.91 91.89 Favored 'General case' 0 N--CA 1.486 1.358 0 C-N-CA 124.002 0.921 . . . . 53.02 110.732 177.359 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 35' ' ' ASN . . . . . 0.426 ' O ' ' HG ' ' A' ' 39' ' ' LEU . 35.5 t30 -51.55 -67.28 0.26 Allowed 'General case' 0 CA--C 1.548 0.869 0 O-C-N 124.734 1.271 . . . . 54.42 111.034 178.083 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 85.0 t80 -62.23 -37.83 86.87 Favored 'General case' 0 N--CA 1.474 0.741 0 C-N-CA 123.156 0.582 . . . . 54.52 111.677 -176.161 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 73.8 ttt180 -59.03 -45.53 90.51 Favored 'General case' 0 CA--C 1.542 0.673 0 C-N-CA 123.419 0.687 . . . . 64.01 110.877 -179.936 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 38' ' ' ALA . . . . . 0.416 ' HB1' ' HG2' ' A' ' 44' ' ' LYS . . . -69.95 -30.09 67.39 Favored 'General case' 0 N--CA 1.472 0.674 0 C-N-CA 123.453 0.701 . . . . 75.13 111.748 -179.869 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 39' ' ' LEU . . . . . 0.426 ' HG ' ' O ' ' A' ' 35' ' ' ASN . 90.2 mt -67.22 -37.46 83.62 Favored 'General case' 0 N--CA 1.477 0.903 0 C-N-CA 123.241 0.616 . . . . 44.03 110.684 173.667 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 36.9 m -77.77 -41.02 38.93 Favored 'General case' 0 N--CA 1.476 0.857 0 C-N-CA 123.641 0.776 . . . . 63.04 111.691 -175.493 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 41.1 p -82.21 -33.18 29.46 Favored 'General case' 0 N--CA 1.473 0.702 0 C-N-CA 123.54 0.736 . . . . 61.43 111.413 -176.344 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 92.77 24.59 22.81 Favored Glycine 0 C--N 1.342 0.909 0 CA-C-N 115.812 -0.631 . . . . 64.13 113.407 -176.86 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 45.6 mm-40 -60.99 -28.18 68.84 Favored 'General case' 0 N--CA 1.484 1.239 0 C-N-CA 122.865 0.466 . . . . 65.24 111.522 173.481 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 44' ' ' LYS . . . . . 0.416 ' HG2' ' HB1' ' A' ' 38' ' ' ALA . 30.8 mmmt -106.49 15.67 25.62 Favored 'General case' 0 N--CA 1.47 0.531 0 C-N-CA 123.806 0.843 . . . . 73.21 111.298 -178.985 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 88.01 -34.53 3.73 Favored Glycine 0 C--N 1.35 1.311 0 CA-C-O 119.807 -0.44 . . . . 63.3 113.966 175.745 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 14.3 m-85 -62.42 -47.16 85.33 Favored 'General case' 0 N--CA 1.479 1.011 0 C-N-CA 123.44 0.696 . . . . 75.31 111.624 -169.463 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 47.2 56.85 7.57 Favored Glycine 0 C--N 1.356 1.665 0 O-C-N 124.521 1.138 . . . . 75.41 115.367 168.479 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 48' ' ' TYR . . . . . 0.511 ' OH ' ' HG2' ' A' ' 76' ' ' LYS . 56.7 m-85 -55.89 91.25 0.01 OUTLIER 'General case' 0 N--CA 1.479 1.006 0 C-N-CA 124.106 0.962 . . . . 74.32 112.933 -174.68 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 49' ' ' LYS . . . . . 0.507 ' HE2' ' HA ' ' A' ' 160' ' ' ASP . 29.5 tptp -110.09 120.79 43.56 Favored 'General case' 0 C--O 1.236 0.369 0 CA-C-N 113.99 -1.459 . . . . 61.55 108.582 -179.905 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 86.13 21.08 53.67 Favored Glycine 0 C--N 1.346 1.107 0 O-C-N 123.236 0.335 . . . . 50.44 112.79 -176.279 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 23.4 t -62.39 117.15 5.75 Favored 'General case' 0 CA--C 1.549 0.931 0 C-N-CA 124.075 0.95 . . . . 72.31 110.246 -178.357 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 52' ' ' CYS . . . . . . . . . . . . . 23.2 p -92.94 125.8 37.72 Favored 'General case' 0 C--O 1.24 0.566 0 C-N-CA 123.593 0.757 . . . . 74.33 112.573 -169.773 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 53' ' ' PHE . . . . . 0.745 ' HA ' ' HA2' ' A' ' 64' ' ' GLY . 64.1 m-85 -65.21 111.91 3.18 Favored 'General case' 0 CA--C 1.539 0.554 0 CA-C-N 115.035 -0.984 . . . . 73.24 108.956 164.404 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 21.8 p-80 -125.36 4.82 7.71 Favored 'General case' 0 N--CA 1.483 1.177 0 C-N-CA 123.447 0.699 . . . . 73.22 111.599 -175.983 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 65.5 ttt-85 -148.87 101.61 3.2 Favored 'General case' 0 N--CA 1.473 0.716 0 N-CA-C 109.431 -0.581 . . . . 75.24 109.431 176.648 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 56' ' ' ILE . . . . . 0.467 HG21 ' HA ' ' A' ' 143' ' ' GLU . 64.3 mt -133.7 134.12 56.55 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.098 0 C-N-CA 122.73 0.412 . . . . 71.04 110.007 -179.964 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 57' ' ' ILE . . . . . 0.414 ' HB ' ' HD2' ' A' ' 60' ' ' PHE . 71.7 mt -117.91 120.06 33.07 Favored Pre-proline 0 CA--C 1.55 0.964 0 N-CA-C 107.882 -1.155 . . . . 72.15 107.882 171.177 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 58' ' ' PRO . . . . . 0.525 ' HA ' ' HG2' ' A' ' 143' ' ' GLU . 28.0 Cg_endo -60.01 146.32 96.29 Favored 'Trans proline' 0 C--N 1.381 2.246 0 C-N-CA 123.043 2.495 . . . . 63.43 112.82 178.956 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 67.28 24.97 73.62 Favored Glycine 0 C--N 1.345 1.082 0 CA-C-N 115.74 -0.664 . . . . 74.15 113.935 179.446 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 60' ' ' PHE . . . . . 0.414 ' HD2' ' HB ' ' A' ' 57' ' ' ILE . 10.7 t80 -151.51 -72.4 0.16 Allowed 'General case' 0 N--CA 1.474 0.757 0 C-N-CA 122.978 0.511 . . . . 54.41 110.361 -175.173 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 47.1 ttp -160.04 135.05 7.91 Favored 'General case' 0 N--CA 1.474 0.728 0 CA-C-N 116.536 -0.302 . . . . 52.51 111.609 -167.112 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 62' ' ' CYS . . . . . 0.555 ' SG ' ' HB ' ' A' ' 114' ' ' ILE . 10.0 p -105.97 111.75 24.51 Favored 'General case' 0 CA--C 1.543 0.689 0 N-CA-C 108.764 -0.828 . . . . 73.11 108.764 167.898 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 63' ' ' GLN . . . . . 0.463 ' HA ' ' HA ' ' A' ' 113' ' ' PHE . 21.0 tt0 -109.13 133.76 52.59 Favored 'General case' 0 N--CA 1.48 1.062 0 C-N-CA 123.67 0.788 . . . . 54.4 110.933 -176.397 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 64' ' ' GLY . . . . . 0.745 ' HA2' ' HA ' ' A' ' 53' ' ' PHE . . . -122.52 175.24 16.42 Favored Glycine 0 C--N 1.345 1.078 0 CA-C-N 114.994 -1.003 . . . . 70.04 112.368 179.536 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 172.89 -166.26 38.81 Favored Glycine 0 C--N 1.331 0.291 0 N-CA-C 111.043 -0.823 . . . . 72.15 111.043 -179.792 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 38.8 t70 -126.32 160.8 29.38 Favored 'General case' 0 N--CA 1.476 0.863 0 C-N-CA 123.026 0.531 . . . . 74.51 110.55 -175.463 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 71.7 t80 -73.67 -32.43 63.96 Favored 'General case' 0 N--CA 1.472 0.669 0 C-N-CA 123.459 0.704 . . . . 74.43 111.211 -178.731 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 28.2 m -65.24 110.88 2.73 Favored 'General case' 0 N--CA 1.473 0.692 0 N-CA-C 109.925 -0.398 . . . . 74.25 109.925 -179.203 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 57.7 mtt85 66.99 30.52 7.49 Favored 'General case' 0 C--N 1.354 0.787 0 C-N-CA 125.052 1.341 . . . . 74.13 111.133 177.852 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 70' ' ' HIS . . . . . 0.413 ' HA ' ' HA3' ' A' ' 74' ' ' GLY . 27.5 p-80 -57.8 -23.69 53.69 Favored 'General case' 0 N--CA 1.49 1.537 0 C-N-CA 123.62 0.768 . . . . 71.23 111.774 -178.793 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 6.0 t30 -63.62 95.16 0.1 Allowed 'General case' 0 CA--C 1.543 0.694 0 C-N-CA 124.584 1.154 . . . . 73.34 109.339 168.376 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 79.05 -8.44 45.07 Favored Glycine 0 CA--C 1.529 0.92 0 N-CA-C 114.91 0.724 . . . . 72.13 114.91 174.258 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 18.0 m -135.47 -95.45 0.25 Allowed 'General case' 0 CA--C 1.558 1.279 0 CA-C-N 117.915 0.858 . . . . 71.24 110.179 -177.963 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 74' ' ' GLY . . . . . 0.413 ' HA3' ' HA ' ' A' ' 70' ' ' HIS . . . 59.51 56.15 26.61 Favored Glycine 0 C--N 1.359 1.855 0 CA-C-N 118.459 0.572 . . . . 65.05 113.626 177.776 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 134.76 49.41 0.08 OUTLIER Glycine 0 C--N 1.333 0.37 0 N-CA-C 109.443 -1.463 . . . . 70.55 109.443 -170.945 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 76' ' ' LYS . . . . . 0.511 ' HG2' ' OH ' ' A' ' 48' ' ' TYR . 22.7 ptmt -60.27 160.55 8.31 Favored 'General case' 0 N--CA 1.475 0.802 0 C-N-CA 124.113 0.965 . . . . 51.22 111.588 -177.548 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 79.1 p -90.27 174.22 7.71 Favored 'General case' 0 CA--C 1.54 0.58 0 CA-C-N 115.492 -0.776 . . . . 44.34 110.746 -178.486 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 24.8 pt -69.73 -17.54 21.38 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.818 0 C-N-CA 123.252 0.621 . . . . 74.32 110.806 176.611 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 36.5 m-85 -87.0 -16.2 36.45 Favored 'General case' 0 N--CA 1.47 0.563 0 C-N-CA 124.775 1.23 . . . . 72.31 110.643 -178.086 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 132.8 -134.04 7.35 Favored Glycine 0 C--N 1.345 1.064 0 N-CA-C 110.537 -1.025 . . . . 74.24 110.537 -177.179 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 37.1 tt0 -56.83 -54.6 44.52 Favored 'General case' 0 N--CA 1.473 0.707 0 C-N-CA 124.223 1.009 . . . . 74.41 111.427 179.453 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 82' ' ' LYS . . . . . 0.645 ' HD2' ' HA ' ' A' ' 107' ' ' THR . 21.6 pttp -168.19 177.35 5.52 Favored 'General case' 0 N--CA 1.474 0.742 0 C-N-CA 123.604 0.762 . . . . 74.32 110.69 -174.157 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 3.2 p90 -159.2 172.37 18.18 Favored 'General case' 0 CA--C 1.544 0.719 0 C-N-CA 124.73 1.212 . . . . 74.12 110.006 -174.68 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 84' ' ' GLU . . . . . 0.499 ' HA ' ' HA ' ' A' ' 106' ' ' ASN . 13.6 pt-20 -88.86 171.42 9.93 Favored 'General case' 0 N--CA 1.481 1.08 0 C-N-CA 123.094 0.558 . . . . 71.03 110.73 178.136 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 48.8 m-20 -80.63 148.71 30.14 Favored 'General case' 0 N--CA 1.478 0.928 0 N-CA-C 109.542 -0.54 . . . . 74.2 109.542 178.492 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 10.5 tp10 -86.98 -59.57 2.22 Favored 'General case' 0 N--CA 1.476 0.833 0 CA-C-O 120.606 0.241 . . . . 74.34 111.15 -179.659 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 13.0 p-10 -156.48 124.2 5.51 Favored 'General case' 0 N--CA 1.474 0.77 0 C-N-CA 123.015 0.526 . . . . 71.33 109.975 -169.603 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 79.1 m-85 -88.52 66.72 8.32 Favored 'General case' 0 N--CA 1.478 0.954 0 CA-C-O 121.683 0.754 . . . . 74.34 109.766 -174.53 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 55.0 mt -86.98 -51.6 12.74 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.587 0 CA-C-N 115.092 -0.958 . . . . 74.42 108.739 174.976 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 90' ' ' LEU . . . . . 0.543 ' HB3' ' HB ' ' A' ' 128' ' ' VAL . 94.6 mt -88.72 106.34 18.28 Favored 'General case' 0 C--O 1.24 0.57 0 CA-C-N 114.991 -1.004 . . . . 75.33 110.571 -175.789 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 50.0 mtmt -91.62 169.63 10.58 Favored 'General case' 0 C--O 1.24 0.593 0 CA-C-N 115.039 -0.982 . . . . 64.4 109.764 173.755 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 92' ' ' HIS . . . . . . . . . . . . . 20.8 m-70 -87.74 55.29 3.43 Favored 'General case' 0 N--CA 1.478 0.936 0 N-CA-C 108.826 -0.805 . . . . 72.53 108.826 -178.995 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 14.8 t -96.94 -2.67 43.2 Favored 'General case' 0 N--CA 1.475 0.776 0 CA-C-N 115.211 -0.904 . . . . 44.31 112.331 -169.707 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -131.77 178.65 17.74 Favored Glycine 0 C--N 1.342 0.912 0 CA-C-O 119.989 -0.34 . . . . 74.25 112.379 -179.564 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 76.9 Cg_endo -85.72 152.84 10.13 Favored 'Trans proline' 0 CA--C 1.551 1.373 0 C-N-CA 123.105 2.537 . . . . 73.34 112.37 172.16 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 80.66 19.96 67.1 Favored Glycine 0 C--N 1.343 0.954 0 CA-C-N 116.135 -0.484 . . . . 41.3 113.844 175.663 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 97' ' ' ILE . . . . . 0.668 ' HB ' ' HB2' ' A' ' 115' ' ' CYS . 25.8 mm -65.79 103.27 0.48 Allowed 'Isoleucine or valine' 0 CA--C 1.551 1.013 0 C-N-CA 124.138 0.975 . . . . 74.54 111.784 -175.606 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 58.5 tp -89.4 119.98 30.33 Favored 'General case' 0 C--O 1.247 0.972 0 CA-C-O 121.485 0.659 . . . . 61.4 109.819 174.264 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 46.0 t -149.55 146.38 27.32 Favored 'General case' 0 CA--C 1.549 0.929 0 C-N-CA 124.554 1.141 . . . . 63.24 108.119 -179.096 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 100' ' ' MET . . . . . 0.596 ' HA ' ' HA ' ' A' ' 112' ' ' PHE . 85.4 mtp -77.42 142.89 39.0 Favored 'General case' 0 N--CA 1.487 1.419 0 CA-C-N 118.216 0.462 . . . . 70.43 109.919 179.311 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 101' ' ' ALA . . . . . 0.538 ' HB3' ' HB2' ' A' ' 111' ' ' GLN . . . -75.04 155.52 37.17 Favored 'General case' 0 N--CA 1.474 0.731 0 CA-C-O 121.497 0.665 . . . . 72.31 112.083 -169.823 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 102' ' ' ASN . . . . . 0.423 ' HB2' ' HB ' ' A' ' 107' ' ' THR . 26.9 p-10 -167.49 166.32 14.34 Favored 'General case' 0 C--O 1.24 0.553 0 CA-C-N 114.421 -1.263 . . . . 73.03 109.744 -177.614 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -89.77 -50.98 5.74 Favored 'General case' 0 CA--C 1.537 0.452 0 N-CA-C 108.413 -0.958 . . . . 52.33 108.413 167.271 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -156.85 -156.11 7.74 Favored Glycine 0 C--N 1.347 1.193 0 CA-C-N 115.427 -0.806 . . . . 74.23 112.803 179.248 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 51.6 Cg_exo -55.7 139.62 83.49 Favored 'Trans proline' 0 C--N 1.375 1.932 0 C-N-CA 123.55 2.833 . . . . 50.11 113.165 178.134 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 106' ' ' ASN . . . . . 0.499 ' HA ' ' HA ' ' A' ' 84' ' ' GLU . 65.0 t30 66.24 8.51 5.64 Favored 'General case' 0 N--CA 1.483 1.217 0 C-N-CA 125.118 1.367 . . . . 62.42 112.487 177.215 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 107' ' ' THR . . . . . 0.645 ' HA ' ' HD2' ' A' ' 82' ' ' LYS . 3.8 m -100.72 -15.33 17.74 Favored 'General case' 0 CA--C 1.55 0.975 0 C-N-CA 123.749 0.82 . . . . 71.32 109.81 177.225 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 13.1 t30 -55.84 139.84 44.33 Favored 'General case' 0 C--O 1.208 -1.127 0 C-N-CA 125.658 1.583 . . . . 73.12 111.442 176.938 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 111.3 23.93 5.57 Favored Glycine 0 N--CA 1.469 0.886 0 N-CA-C 112.285 -0.326 . . . . 50.13 112.285 -178.872 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 13.6 p -136.98 120.8 17.46 Favored 'General case' 0 C--O 1.223 -0.311 0 C-N-CA 123.881 0.873 . . . . 72.4 108.645 178.126 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 111' ' ' GLN . . . . . 0.538 ' HB2' ' HB3' ' A' ' 101' ' ' ALA . 46.1 mt-30 59.51 -174.79 0.1 Allowed 'General case' 0 N--CA 1.489 1.489 0 C-N-CA 123.68 0.792 . . . . 74.33 111.563 -174.86 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 112' ' ' PHE . . . . . 0.596 ' HA ' ' HA ' ' A' ' 100' ' ' MET . 49.3 p90 -144.5 166.21 25.78 Favored 'General case' 0 N--CA 1.473 0.692 0 C-N-CA 123.953 0.901 . . . . 71.54 108.78 172.701 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 113' ' ' PHE . . . . . 0.463 ' HA ' ' HA ' ' A' ' 63' ' ' GLN . 51.8 p90 -152.64 154.94 36.35 Favored 'General case' 0 C--O 1.236 0.377 0 C-N-CA 122.969 0.508 . . . . 74.3 110.387 179.663 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 114' ' ' ILE . . . . . 0.555 ' HB ' ' SG ' ' A' ' 62' ' ' CYS . 16.2 mt -126.65 104.48 12.82 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.569 0 N-CA-C 108.698 -0.852 . . . . 45.5 108.698 178.492 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 115' ' ' CYS . . . . . 0.668 ' HB2' ' HB ' ' A' ' 97' ' ' ILE . 61.4 m -73.42 106.91 5.42 Favored 'General case' 0 CA--C 1.539 0.541 0 N-CA-C 109.016 -0.735 . . . . 52.45 109.016 172.772 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 116' ' ' THR . . . . . 0.426 HG22 HG12 ' A' ' 139' ' ' VAL . 75.1 p -71.39 -18.87 62.33 Favored 'General case' 0 N--CA 1.479 0.997 0 C-N-CA 123.261 0.624 . . . . 73.34 111.529 -177.273 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -124.72 169.52 11.9 Favored 'General case' 0 C--O 1.243 0.752 0 C-N-CA 123.682 0.793 . . . . 73.11 110.07 177.435 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 11.9 ptmm? -71.85 87.86 1.01 Allowed 'General case' 0 CA--C 1.55 0.95 0 CA-C-O 121.961 0.886 . . . . 73.33 110.92 176.173 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 119' ' ' THR . . . . . . . . . . . . . 52.9 p -85.34 87.89 7.44 Favored 'General case' 0 CA--C 1.544 0.734 0 CA-C-N 114.946 -1.025 . . . . 74.43 109.937 -176.894 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 120' ' ' GLU . . . . . 0.4 ' H ' ' HG2' ' A' ' 120' ' ' GLU . 7.9 pt-20 -73.07 -26.22 61.19 Favored 'General case' 0 N--CA 1.48 1.026 0 CA-C-N 114.535 -1.211 . . . . 75.21 112.934 -169.229 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 121' ' ' TRP . . . . . . . . . . . . . 39.5 p90 -70.72 -10.55 59.68 Favored 'General case' 0 N--CA 1.479 0.976 0 C-N-CA 123.732 0.813 . . . . 75.14 111.797 177.062 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 51.1 mt -95.05 0.07 54.13 Favored 'General case' 0 N--CA 1.477 0.904 0 C-N-CA 123.236 0.615 . . . . 74.45 111.673 177.514 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 32.9 m-20 -71.66 126.12 28.88 Favored 'General case' 0 N--CA 1.478 0.962 0 N-CA-C 108.801 -0.815 . . . . 73.51 108.801 172.762 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 106.82 -26.9 18.02 Favored Glycine 0 N--CA 1.471 1.02 0 N-CA-C 111.43 -0.668 . . . . 63.03 111.43 -171.933 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 125' ' ' LYS . . . . . 0.62 ' HG2' ' H ' ' A' ' 126' ' ' HIS . 20.9 ttmm -80.09 -164.96 0.75 Allowed 'General case' 0 CA--C 1.559 1.301 0 N-CA-C 107.979 -1.119 . . . . 73.02 107.979 170.907 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 126' ' ' HIS . . . . . 0.62 ' H ' ' HG2' ' A' ' 125' ' ' LYS . 8.9 t-80 -64.81 134.77 54.8 Favored 'General case' 0 C--N 1.353 0.76 0 CA-C-N 119.204 0.911 . . . . 64.1 111.132 -168.642 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 6.6 t -59.78 146.08 10.61 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.611 0 CA-C-N 112.787 -2.006 . . . . 74.33 111.091 -179.241 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 128' ' ' VAL . . . . . 0.543 ' HB ' ' HB3' ' A' ' 90' ' ' LEU . 18.9 t -74.8 156.1 6.28 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.789 0 N-CA-C 108.998 -0.742 . . . . 74.5 108.998 175.153 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 129' ' ' PHE . . . . . 0.441 ' CE2' ' HG3' ' A' ' 100' ' ' MET . 26.7 p90 -137.76 -11.72 1.54 Allowed 'General case' 0 N--CA 1.485 1.288 0 C-N-CA 122.189 0.195 . . . . 75.01 111.453 174.047 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . -148.14 159.11 27.92 Favored Glycine 0 C--N 1.341 0.84 0 N-CA-C 111.518 -0.633 . . . . 45.34 111.518 -177.056 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 35.1 ttpt -147.31 137.46 23.19 Favored 'General case' 0 N--CA 1.474 0.741 0 N-CA-C 109.39 -0.596 . . . . 75.24 109.39 178.728 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 132' ' ' VAL . . . . . 0.513 HG11 ' HA ' ' A' ' 136' ' ' MET . 37.5 t -63.91 111.89 1.18 Allowed 'Isoleucine or valine' 0 CA--C 1.543 0.705 0 O-C-N 123.658 0.599 . . . . 74.14 110.227 178.054 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 133' ' ' LYS . . . . . 0.593 ' HG3' ' HG2' ' A' ' 134' ' ' GLU . 0.0 OUTLIER -95.7 -42.42 8.39 Favored 'General case' 0 N--CA 1.474 0.751 0 C-N-CA 123.068 0.547 . . . . 60.42 109.569 172.457 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 134' ' ' GLU . . . . . 0.593 ' HG2' ' HG3' ' A' ' 133' ' ' LYS . 18.7 mm-40 -116.4 139.11 50.78 Favored 'General case' 0 N--CA 1.474 0.745 0 N-CA-C 108.674 -0.862 . . . . 74.21 108.674 -178.088 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 76.68 29.08 58.19 Favored Glycine 0 C--N 1.342 0.862 0 N-CA-C 114.156 0.422 . . . . 60.31 114.156 175.455 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 136' ' ' MET . . . . . 0.513 ' HA ' HG11 ' A' ' 132' ' ' VAL . 14.9 tpt -60.11 -38.08 81.93 Favored 'General case' 0 N--CA 1.477 0.908 0 C-N-CA 122.992 0.517 . . . . 74.3 111.216 177.647 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 137' ' ' ASN . . . . . . . . . . . . . 6.0 t30 -61.81 -39.23 91.01 Favored 'General case' 0 CA--C 1.543 0.679 0 CA-C-N 115.448 -0.796 . . . . 74.14 110.88 176.238 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 138' ' ' ILE . . . . . . . . . . . . . 49.2 mm -67.56 -35.57 73.51 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.089 0 C-N-CA 123.523 0.729 . . . . 62.33 110.868 -179.822 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 139' ' ' VAL . . . . . 0.446 HG21 HG21 ' A' ' 132' ' ' VAL . 92.1 t -65.61 -47.26 86.93 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.939 0 C-N-CA 123.561 0.744 . . . . 55.2 110.648 177.203 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 41.6 mt-10 -66.83 -34.81 78.63 Favored 'General case' 0 CA--C 1.548 0.867 0 CA-C-N 115.396 -0.82 . . . . 71.44 110.964 177.739 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -69.01 -44.06 73.55 Favored 'General case' 0 N--CA 1.475 0.815 0 C-N-CA 123.309 0.644 . . . . 51.45 110.881 -178.984 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 142' ' ' MET . . . . . 0.567 ' HB2' HD13 ' A' ' 156' ' ' ILE . 19.7 ptt? -69.29 -31.16 69.47 Favored 'General case' 0 N--CA 1.477 0.88 0 O-C-N 123.429 0.456 . . . . 73.52 110.394 179.172 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 143' ' ' GLU . . . . . 0.525 ' HG2' ' HA ' ' A' ' 58' ' ' PRO . 36.9 tt0 -62.32 -31.76 72.43 Favored 'General case' 0 CA--C 1.549 0.907 0 C-N-CA 122.784 0.434 . . . . 70.12 112.009 178.868 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 144' ' ' ARG . . . . . . . . . . . . . 33.1 mtp85 -65.27 -20.57 66.48 Favored 'General case' 0 N--CA 1.48 1.035 0 C-N-CA 122.706 0.402 . . . . 72.41 111.863 178.607 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 145' ' ' PHE . . . . . 0.534 ' HB2' HD11 ' A' ' 156' ' ' ILE . 66.3 m-85 -85.75 13.22 7.51 Favored 'General case' 0 N--CA 1.479 0.983 0 C-N-CA 123.388 0.675 . . . . 74.5 111.625 176.403 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . -98.45 -179.24 32.48 Favored Glycine 0 C--N 1.345 1.08 0 N-CA-C 111.743 -0.543 . . . . 63.12 111.743 169.838 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 10.8 m -133.45 163.09 30.14 Favored 'General case' 0 N--CA 1.478 0.944 0 C-N-CA 123.149 0.58 . . . . 73.33 111.203 -175.542 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 148' ' ' ARG . . . . . . . . . . . . . 7.3 mmm180 -67.82 -28.77 67.85 Favored 'General case' 0 N--CA 1.473 0.691 0 C-N-CA 124.383 1.073 . . . . 75.41 112.533 -177.511 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 149' ' ' ASN . . . . . . . . . . . . . 27.3 p-10 -84.58 -3.37 58.42 Favored 'General case' 0 N--CA 1.483 1.217 0 C-N-CA 123.349 0.659 . . . . 72.43 111.607 177.603 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . 100.25 -8.9 59.16 Favored Glycine 0 C--N 1.354 1.561 0 CA-C-O 119.975 -0.347 . . . . 55.41 113.188 179.028 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 59.6 tttp -65.44 143.08 57.93 Favored 'General case' 0 N--CA 1.478 0.956 0 C-N-CA 123.847 0.859 . . . . 74.25 110.408 178.336 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 152' ' ' THR . . . . . . . . . . . . . 16.5 p -92.92 114.21 26.71 Favored 'General case' 0 N--CA 1.467 0.398 0 N-CA-C 109.025 -0.732 . . . . 73.22 109.025 168.553 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 153' ' ' SER . . . . . . . . . . . . . 33.1 t -62.76 -29.02 70.38 Favored 'General case' 0 N--CA 1.475 0.784 0 C-N-CA 123.759 0.823 . . . . 72.23 110.719 177.063 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 154' ' ' LYS . . . . . 0.407 ' HB2' ' HB3' ' A' ' 145' ' ' PHE . 69.9 mmtt -124.93 145.06 50.03 Favored 'General case' 0 C--O 1.239 0.517 0 C-N-CA 123.942 0.897 . . . . 71.32 110.518 179.84 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 3.4 tppp? -79.23 99.41 7.03 Favored 'General case' 0 C--O 1.24 0.565 0 N-CA-C 109.031 -0.729 . . . . 75.32 109.031 172.651 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 156' ' ' ILE . . . . . 0.567 HD13 ' HB2' ' A' ' 142' ' ' MET . 52.3 mt -99.43 123.3 52.06 Favored 'Isoleucine or valine' 0 C--O 1.221 -0.406 0 CA-C-N 114.744 -1.116 . . . . 72.2 108.123 178.395 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 157' ' ' THR . . . . . . . . . . . . . 33.2 p -124.81 156.89 37.07 Favored 'General case' 0 N--CA 1.472 0.631 0 C-N-CA 124.13 0.972 . . . . 75.21 109.816 -177.521 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 158' ' ' ILE . . . . . . . . . . . . . 56.4 mt -82.25 93.73 2.7 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.719 0 N-CA-C 108.106 -1.072 . . . . 72.0 108.106 169.095 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 159' ' ' ALA . . . . . 0.551 ' HB2' ' HB2' ' A' ' 11' ' ' ALA . . . -54.54 -37.08 64.99 Favored 'General case' 0 N--CA 1.478 0.948 0 C-N-CA 124.759 1.224 . . . . 71.43 112.914 -177.736 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 160' ' ' ASP . . . . . 0.507 ' HA ' ' HE2' ' A' ' 49' ' ' LYS . 26.8 t0 -162.64 156.17 20.33 Favored 'General case' 0 N--CA 1.477 0.88 0 O-C-N 123.61 0.569 . . . . 74.15 111.214 -179.983 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 161' ' ' CYS . . . . . . . . . . . . . 6.9 p -123.15 -171.68 2.35 Favored 'General case' 0 N--CA 1.475 0.816 0 C-N-CA 125.255 1.422 . . . . 75.02 108.24 172.917 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 162' ' ' GLY . . . . . . . . . . . . . . . 131.42 57.93 0.09 OUTLIER Glycine 0 N--CA 1.475 1.266 0 O-C-N 121.473 -0.767 . . . . 14.22 111.507 -169.214 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 163' ' ' GLN . . . . . 0.497 ' HA ' ' H ' ' A' ' 7' ' ' PHE . 11.5 pt20 -45.36 132.71 7.65 Favored 'General case' 0 CA--C 1.547 0.838 0 C-N-CA 125.19 1.396 . . . . 74.21 114.031 -169.683 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 164' ' ' LEU . . . . . 0.515 ' O ' ' HB ' ' A' ' 5' ' ' THR . 85.1 mt . . . . . 0 N--CA 1.472 0.645 0 C-N-CA 123.976 0.911 . . . . 72.21 110.959 -179.731 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 218' ' ' PRO . . . . . . . . . . . . . 7.9 Cg_exo . . . . . 0 CA--C 1.545 1.052 0 N-CA-C 110.804 -0.499 . . . . 70.04 110.804 . . . . . . . . . 0 0 . 1 . 010 nuclear build core ' B' B ' 219' ' ' GLY . . . . . . . . . . . . . . . 166.37 141.91 3.28 Favored Glycine 0 CA--C 1.531 1.071 0 CA-C-O 119.471 -0.627 . . . . 72.3 112.277 -179.961 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 220' ' ' PRO . . . . . . . . . . . . . 52.4 Cg_exo -60.84 159.95 27.13 Favored 'Trans proline' 0 N--CA 1.498 1.788 0 C-N-CA 123.957 3.105 . . . . 72.34 114.698 178.308 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 221' ' ' TYR . . . . . . . . . . . . . 48.1 m-85 . . . . . 0 N--CA 1.484 1.247 0 C-N-CA 123.655 0.782 . . . . 70.24 110.704 -175.131 . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 89.2 m-20 . . . . . 0 N--CA 1.478 0.956 0 CA-C-O 119.247 -0.406 . . . . 65.43 110.909 . . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 19.9 Cg_endo -57.12 118.43 5.3 Favored 'Trans proline' 0 C--N 1.379 2.184 0 C-N-CA 122.889 2.392 . . . . 74.03 111.448 -174.337 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 5' ' ' THR . . . . . 0.421 ' HB ' ' O ' ' A' ' 164' ' ' LEU . 19.7 m -95.56 127.3 41.48 Favored 'General case' 0 N--CA 1.443 -0.794 0 N-CA-C 108.407 -0.96 . . . . 70.24 108.407 -176.757 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 6' ' ' VAL . . . . . 0.472 HG22 ' HB2' ' A' ' 22' ' ' PHE . 15.6 m -106.92 150.5 9.41 Favored 'Isoleucine or valine' 0 CA--C 1.522 -0.106 0 CA-C-N 115.536 -0.756 . . . . 71.32 109.096 -174.918 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 79.7 t80 -138.96 135.63 34.56 Favored 'General case' 0 C--O 1.239 0.531 0 C-N-CA 122.824 0.45 . . . . 73.31 110.389 -173.765 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 8' ' ' PHE . . . . . 0.448 ' HE1' ' HG ' ' A' ' 40' ' ' SER . 61.2 m-85 -141.87 165.58 27.09 Favored 'General case' 0 N--CA 1.469 0.513 0 C-N-CA 123.998 0.919 . . . . 61.21 110.504 178.946 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 11.3 m-20 -106.74 119.01 38.18 Favored 'General case' 0 N--CA 1.468 0.454 0 N-CA-C 108.012 -1.107 . . . . 61.02 108.012 165.168 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 10' ' ' ILE . . . . . 0.539 HG21 ' SD ' ' A' ' 142' ' ' MET . 48.6 mm -86.49 118.5 32.91 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.559 0 N-CA-C 109.021 -0.733 . . . . 73.42 109.021 176.532 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 11' ' ' ALA . . . . . 0.757 ' HB2' ' HB2' ' A' ' 159' ' ' ALA . . . -109.32 133.09 53.48 Favored 'General case' 0 C--O 1.219 -0.538 0 C-N-CA 123.975 0.91 . . . . 60.54 111.383 -174.689 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 43.0 t -97.64 123.54 50.12 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.533 0 N-CA-C 108.437 -0.949 . . . . 74.22 108.437 170.532 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 13' ' ' ASP . . . . . 0.454 ' HA ' ' HB2' ' A' ' 155' ' ' LYS . 66.7 m-20 61.22 15.02 6.02 Favored 'General case' 0 N--CA 1.483 1.206 0 C-N-CA 125.55 1.54 . . . . 74.44 112.928 -178.036 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 108.42 -27.32 14.05 Favored Glycine 0 C--N 1.346 1.103 0 CA-C-O 119.679 -0.512 . . . . 74.24 112.825 -176.502 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 30.8 mm-40 -89.17 122.69 68.49 Favored Pre-proline 0 N--CA 1.487 1.379 0 CA-C-N 117.666 0.733 . . . . 64.15 110.427 -179.1 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 16' ' ' PRO . . . . . 0.477 ' HA ' ' HA ' ' A' ' 11' ' ' ALA . 19.2 Cg_endo -54.36 113.22 1.26 Allowed 'Trans proline' 0 C--N 1.386 2.55 0 C-N-CA 123.344 2.696 . . . . 65.0 112.974 -177.428 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 37.2 tp -77.03 -36.72 55.92 Favored 'General case' 0 N--CA 1.479 0.991 0 C-N-CA 124.041 0.936 . . . . 72.02 109.552 175.883 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -173.4 -161.78 24.23 Favored Glycine 0 C--N 1.335 0.479 0 CA-C-N 114.671 -1.149 . . . . 32.44 111.291 -178.741 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 3.5 ptp180 -144.31 140.82 29.38 Favored 'General case' 0 N--CA 1.469 0.516 0 C-N-CA 123.374 0.67 . . . . 62.34 109.858 -176.762 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 20' ' ' VAL . . . . . 0.436 ' HA ' ' HA3' ' A' ' 135' ' ' GLY . 60.8 t -128.54 135.89 61.32 Favored 'Isoleucine or valine' 0 C--O 1.24 0.599 0 C-N-CA 124.029 0.931 . . . . 43.52 109.464 -176.213 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 31.5 t -113.39 121.03 43.13 Favored 'General case' 0 CA--C 1.547 0.841 0 C-N-CA 123.864 0.865 . . . . 54.51 108.852 172.951 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 22' ' ' PHE . . . . . 0.472 ' HB2' HG22 ' A' ' 6' ' ' VAL . 12.2 m-85 -101.0 170.87 7.99 Favored 'General case' 0 CA--C 1.543 0.706 0 N-CA-C 108.731 -0.841 . . . . 73.35 108.731 175.458 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 23' ' ' GLU . . . . . 0.66 ' HB2' ' HD2' ' A' ' 133' ' ' LYS . 38.9 tt0 -134.08 108.5 8.36 Favored 'General case' 0 N--CA 1.472 0.663 0 C-N-CA 123.977 0.911 . . . . 61.44 109.094 -178.557 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 13.6 mt -91.48 121.09 32.87 Favored 'General case' 0 CA--C 1.542 0.663 0 C-N-CA 122.949 0.5 . . . . 72.33 110.09 -176.726 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 25' ' ' PHE . . . . . 0.52 ' HB2' HD11 ' A' ' 90' ' ' LEU . 31.4 m-85 -86.98 69.98 10.28 Favored 'General case' 0 N--CA 1.472 0.658 0 C-N-CA 123.631 0.772 . . . . 74.32 109.777 -177.766 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -64.53 -16.07 61.97 Favored 'General case' 0 N--CA 1.48 1.034 0 N-CA-C 112.929 0.714 . . . . 60.41 112.929 -178.085 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 10.3 p-10 -72.67 -29.72 63.65 Favored 'General case' 0 CA--C 1.553 1.073 0 C-N-CA 123.279 0.632 . . . . 72.43 111.431 177.281 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 54.5 mttp -98.54 -41.65 7.66 Favored 'General case' 0 N--CA 1.485 1.319 0 C-N-CA 123.833 0.853 . . . . 75.43 110.891 -176.407 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 29' ' ' VAL . . . . . 0.517 HG21 ' HA ' ' A' ' 129' ' ' PHE . 9.7 m -129.97 70.62 82.16 Favored Pre-proline 0 CA--C 1.561 1.39 0 C-N-CA 123.992 0.917 . . . . 54.41 109.815 -178.071 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 18.5 Cg_endo -57.73 -40.07 82.35 Favored 'Trans proline' 0 C--N 1.387 2.56 0 C-N-CA 123.221 2.614 . . . . 70.15 113.39 -175.28 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 37.9 ttpt -66.87 -55.49 14.49 Favored 'General case' 0 N--CA 1.476 0.872 0 C-N-CA 123.539 0.735 . . . . 72.21 111.935 -179.587 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 5.8 m -68.74 -32.29 71.95 Favored 'General case' 0 CA--C 1.554 1.114 0 CA-C-N 115.591 -0.731 . . . . 70.4 111.455 -172.039 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -79.26 -45.5 19.63 Favored 'General case' 0 N--CA 1.477 0.878 0 C-N-CA 123.531 0.733 . . . . 64.32 111.115 179.745 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 32.3 tt0 -58.76 -35.07 72.15 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 123.604 0.565 . . . . 74.53 110.698 178.111 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 35' ' ' ASN . . . . . 0.527 ' O ' ' HG ' ' A' ' 39' ' ' LEU . 51.5 t30 -53.61 -69.25 0.12 Allowed 'General case' 0 C--N 1.353 0.751 0 O-C-N 124.267 0.98 . . . . 62.24 110.822 -179.175 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 91.4 t80 -62.83 -35.01 78.53 Favored 'General case' 0 N--CA 1.48 1.064 0 C-N-CA 123.493 0.717 . . . . 75.34 111.962 -176.128 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 56.2 ttt180 -61.74 -48.81 79.05 Favored 'General case' 0 N--CA 1.479 0.977 0 C-N-CA 123.535 0.734 . . . . 72.41 111.141 179.668 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -84.16 -19.45 34.1 Favored 'General case' 0 N--CA 1.475 0.808 0 CA-C-N 115.515 -0.766 . . . . 62.23 111.994 -174.832 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 39' ' ' LEU . . . . . 0.527 ' HG ' ' O ' ' A' ' 35' ' ' ASN . 66.4 mt -64.78 -46.1 83.52 Favored 'General case' 0 N--CA 1.474 0.752 0 N-CA-C 108.538 -0.912 . . . . 63.45 108.538 167.636 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 40' ' ' SER . . . . . 0.448 ' HG ' ' HE1' ' A' ' 8' ' ' PHE . 27.0 t -64.54 -56.21 15.54 Favored 'General case' 0 CA--C 1.543 0.683 0 C-N-CA 124.463 1.105 . . . . 71.1 112.047 -178.162 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 41' ' ' THR . . . . . 0.553 HG23 ' NE2' ' A' ' 163' ' ' GLN . 2.9 p -67.79 -30.71 70.21 Favored 'General case' 0 N--CA 1.477 0.901 0 C-N-CA 122.761 0.424 . . . . 75.44 111.541 179.652 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 42' ' ' GLY . . . . . 0.421 ' HA2' ' H ' ' A' ' 47' ' ' GLY . . . 84.09 29.01 32.31 Favored Glycine 0 C--N 1.345 1.069 0 CA-C-N 116.236 -0.438 . . . . 74.31 112.486 -179.06 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 21.2 mm-40 -64.49 -24.95 67.79 Favored 'General case' 0 N--CA 1.478 0.943 0 C-N-CA 123.437 0.695 . . . . 63.11 111.504 175.781 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 44' ' ' LYS . . . . . 0.548 ' HG3' HG22 ' A' ' 78' ' ' ILE . 70.8 mmtt -98.35 5.69 47.98 Favored 'General case' 0 CA--C 1.548 0.897 0 C-N-CA 124.088 0.955 . . . . 71.33 111.117 -179.936 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 79.08 39.21 20.44 Favored Glycine 0 C--N 1.348 1.218 0 CA-C-O 119.973 -0.348 . . . . 65.53 113.612 179.026 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 22.9 m-85 -123.98 -48.54 1.87 Allowed 'General case' 0 N--CA 1.485 1.3 0 CA-C-N 117.207 0.503 . . . . 64.41 111.309 -176.758 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 47' ' ' GLY . . . . . 0.421 ' H ' ' HA2' ' A' ' 42' ' ' GLY . . . 53.1 61.83 6.54 Favored Glycine 0 C--N 1.352 1.462 0 O-C-N 124.127 0.892 . . . . 73.14 114.461 171.009 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 48' ' ' TYR . . . . . 0.46 ' CE1' ' HA2' ' A' ' 75' ' ' GLY . 61.7 m-85 -67.51 97.94 0.63 Allowed 'General case' 0 N--CA 1.473 0.679 0 C-N-CA 123.499 0.72 . . . . 65.01 112.44 -176.289 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 3.0 tppp? -109.86 145.7 36.34 Favored 'General case' 0 CA--C 1.537 0.46 0 CA-C-N 114.532 -1.213 . . . . 62.52 108.938 172.26 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 71.01 20.63 77.99 Favored Glycine 0 C--N 1.343 0.953 0 CA-C-O 119.515 -0.603 . . . . 53.24 113.444 179.318 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 20.3 m -55.83 113.83 1.65 Allowed 'General case' 0 C--N 1.354 0.787 0 C-N-CA 123.595 0.758 . . . . 70.12 109.842 -179.324 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 52' ' ' CYS . . . . . 0.569 ' SG ' ' HB3' ' A' ' 66' ' ' ASP . 7.7 p -100.28 123.03 44.01 Favored 'General case' 0 CA--C 1.545 0.77 0 CA-C-N 115.277 -0.874 . . . . 73.54 112.505 -163.441 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 53' ' ' PHE . . . . . 0.734 ' HA ' ' HA2' ' A' ' 64' ' ' GLY . 33.3 m-85 -71.07 118.32 13.7 Favored 'General case' 0 C--O 1.239 0.504 0 C-N-CA 125.461 1.504 . . . . 73.02 109.79 171.874 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 54' ' ' HIS . . . . . 0.477 ' ND1' ' HB2' ' A' ' 66' ' ' ASP . 45.5 p-80 -115.96 -22.97 8.76 Favored 'General case' 0 N--CA 1.475 0.792 0 C-N-CA 123.772 0.829 . . . . 74.03 110.858 -176.675 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 47.9 ttt-85 -128.95 106.21 8.73 Favored 'General case' 0 C--N 1.359 1.005 0 N-CA-C 109.572 -0.529 . . . . 73.34 109.572 178.704 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 56' ' ' ILE . . . . . 0.55 HG21 ' HA ' ' A' ' 143' ' ' GLU . 56.5 mt -130.58 128.23 63.16 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.749 0 C-N-CA 123.72 0.808 . . . . 73.14 108.973 174.695 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 57' ' ' ILE . . . . . 0.409 ' HB ' ' HD2' ' A' ' 60' ' ' PHE . 76.3 mt -108.02 117.66 54.57 Favored Pre-proline 0 CA--C 1.557 1.219 0 C-N-CA 124.281 1.032 . . . . 74.33 108.256 173.254 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 58' ' ' PRO . . . . . 0.565 ' HA ' ' HG2' ' A' ' 143' ' ' GLU . 32.0 Cg_exo -58.84 131.52 42.42 Favored 'Trans proline' 0 C--N 1.382 2.313 0 C-N-CA 123.64 2.893 . . . . 64.04 112.83 179.62 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 79.2 21.09 68.31 Favored Glycine 0 CA--C 1.529 0.928 0 O-C-N 124.018 0.824 . . . . 53.33 113.597 179.885 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 60' ' ' PHE . . . . . 0.409 ' HD2' ' HB ' ' A' ' 57' ' ' ILE . 17.3 t80 -148.04 -73.42 0.2 Allowed 'General case' 0 N--CA 1.48 1.032 0 CA-C-N 117.659 0.73 . . . . 74.44 111.121 -173.888 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 61' ' ' MET . . . . . 0.411 ' SD ' ' CD1' ' A' ' 113' ' ' PHE . 58.5 ttp -159.75 142.56 13.83 Favored 'General case' 0 N--CA 1.483 1.221 0 N-CA-C 112.578 0.585 . . . . 72.15 112.578 -165.412 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 62' ' ' CYS . . . . . 0.501 ' SG ' ' HB2' ' A' ' 143' ' ' GLU . 52.2 m -117.18 116.92 28.23 Favored 'General case' 0 N--CA 1.474 0.74 0 C-N-CA 124.511 1.125 . . . . 73.41 110.179 175.145 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 15.0 pt20 -121.0 130.31 53.75 Favored 'General case' 0 N--CA 1.484 1.259 0 CA-C-O 122.103 0.954 . . . . 72.41 112.11 179.499 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 64' ' ' GLY . . . . . 0.734 ' HA2' ' HA ' ' A' ' 53' ' ' PHE . . . -113.49 -177.21 19.42 Favored Glycine 0 C--N 1.343 0.94 0 CA-C-N 113.79 -1.55 . . . . 43.11 112.758 178.27 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 98.83 73.66 1.11 Allowed Glycine 0 C--N 1.337 0.614 0 N-CA-C 110.871 -0.892 . . . . 52.04 110.871 -178.959 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 66' ' ' ASP . . . . . 0.569 ' HB3' ' SG ' ' A' ' 52' ' ' CYS . 32.6 t70 -127.56 30.29 5.36 Favored 'General case' 0 N--CA 1.482 1.141 0 C-N-CA 123.099 0.56 . . . . 70.03 109.916 172.124 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 57.0 t80 -93.8 -83.83 0.32 Allowed 'General case' 0 CA--C 1.555 1.148 0 O-C-N 122.055 -0.403 . . . . 71.3 111.044 -177.12 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 69.9 m -81.15 113.11 19.09 Favored 'General case' 0 N--CA 1.482 1.148 0 C-N-CA 123.407 0.683 . . . . 43.11 111.346 -171.307 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 60.7 ttt85 62.76 66.51 0.75 Allowed 'General case' 0 N--CA 1.476 0.856 0 C-N-CA 124.349 1.06 . . . . 52.43 109.522 -174.471 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 2.5 p-80 -74.63 74.85 2.02 Favored 'General case' 0 N--CA 1.482 1.161 0 CA-C-N 114.819 -1.082 . . . . 74.3 112.083 -175.272 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 64.5 t30 -154.72 77.98 1.05 Allowed 'General case' 0 N--CA 1.473 0.719 0 N-CA-C 108.085 -1.08 . . . . 71.24 108.085 177.163 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 63.98 22.81 67.08 Favored Glycine 0 CA--C 1.534 1.26 0 CA-C-N 115.67 -0.696 . . . . 75.33 114.044 -176.32 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 73' ' ' THR . . . . . 0.551 ' HA ' ' HB2' ' A' ' 110' ' ' SER . 46.9 m -142.53 -65.37 0.4 Allowed 'General case' 0 N--CA 1.476 0.854 0 C-N-CA 123.855 0.862 . . . . 72.52 109.492 -174.582 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 44.04 38.53 4.75 Favored Glycine 0 C--N 1.355 1.599 0 C-N-CA 124.517 1.056 . . . . 44.14 115.655 174.922 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 75' ' ' GLY . . . . . 0.46 ' HA2' ' CE1' ' A' ' 48' ' ' TYR . . . 149.78 54.05 0.01 OUTLIER Glycine 0 C--N 1.337 0.584 0 O-C-N 122.122 -0.634 . . . . 75.13 112.256 -161.281 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -48.22 149.62 1.45 Allowed 'General case' 0 N--CA 1.481 1.108 0 C-N-CA 124.685 1.194 . . . . 71.11 111.621 169.909 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 94.3 p -90.03 -178.4 5.43 Favored 'General case' 0 C--O 1.24 0.59 0 CA-C-O 121.781 0.8 . . . . 64.24 112.244 -169.504 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 78' ' ' ILE . . . . . 0.548 HG22 ' HG3' ' A' ' 44' ' ' LYS . 27.7 pt -72.62 -19.48 19.11 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.941 0 CA-C-N 114.909 -1.041 . . . . 65.12 110.751 175.787 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 92.8 m-85 -92.08 25.78 2.73 Favored 'General case' 0 N--CA 1.481 1.115 0 C-N-CA 123.701 0.8 . . . . 73.11 110.381 173.062 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 83.92 -105.15 2.74 Favored Glycine 0 C--N 1.343 0.939 0 N-CA-C 111.015 -0.834 . . . . 62.35 111.015 -178.243 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 43.0 tt0 -74.34 -61.26 1.92 Allowed 'General case' 0 C--O 1.242 0.7 0 C-N-CA 122.872 0.469 . . . . 75.1 110.493 -177.237 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 82' ' ' LYS . . . . . 0.729 ' HD2' ' HA ' ' A' ' 107' ' ' THR . 20.4 pttp -168.78 177.15 5.2 Favored 'General case' 0 CA--C 1.542 0.635 0 CA-C-N 115.465 -0.788 . . . . 74.44 110.475 -173.128 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 28.9 p90 -159.35 177.45 10.99 Favored 'General case' 0 CA--C 1.546 0.791 0 C-N-CA 125.467 1.507 . . . . 75.32 108.251 -174.714 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 11.5 pt-20 -94.97 167.6 11.3 Favored 'General case' 0 N--CA 1.485 1.283 0 O-C-N 121.926 -0.484 . . . . 74.4 111.552 179.224 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 25.9 m-20 -61.41 150.13 36.31 Favored 'General case' 0 N--CA 1.479 1.021 0 C-N-CA 123.82 0.848 . . . . 54.03 111.302 174.489 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 86' ' ' GLU . . . . . 0.505 ' HG2' ' HA ' ' A' ' 29' ' ' VAL . 6.3 tp10 -74.63 -61.82 1.74 Allowed 'General case' 0 N--CA 1.474 0.747 0 CA-C-N 116.55 -0.296 . . . . 73.02 111.329 -176.664 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 87' ' ' ASN . . . . . 0.425 ' O ' HG11 ' A' ' 127' ' ' VAL . 31.2 p-10 -174.32 143.97 0.9 Allowed 'General case' 0 N--CA 1.479 1.009 0 C-N-CA 123.85 0.86 . . . . 64.02 109.134 -174.643 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 92.7 m-85 -88.25 53.24 2.67 Favored 'General case' 0 N--CA 1.483 1.218 0 C-N-CA 123.819 0.848 . . . . 74.42 112.115 -166.565 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 63.3 mt -77.38 -57.5 5.67 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.855 0 C-N-CA 123.654 0.782 . . . . 52.25 108.946 173.298 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 90' ' ' LEU . . . . . 0.575 ' HB3' ' HB ' ' A' ' 128' ' ' VAL . 86.7 mt -85.03 121.58 28.01 Favored 'General case' 0 C--O 1.238 0.467 0 CA-C-N 114.672 -1.149 . . . . 73.43 110.619 -175.145 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 46.5 mtmt -117.5 169.39 9.57 Favored 'General case' 0 N--CA 1.474 0.756 0 C-N-CA 124.141 0.976 . . . . 73.24 110.193 -175.831 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 92' ' ' HIS . . . . . 0.404 ' HA ' HG13 ' A' ' 97' ' ' ILE . 28.1 m-70 -86.38 50.15 1.94 Allowed 'General case' 0 N--CA 1.48 1.068 0 C-N-CA 124.062 0.945 . . . . 72.24 109.942 -178.988 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 10.5 t -95.0 -2.45 50.32 Favored 'General case' 0 CA--C 1.547 0.84 0 CA-C-N 115.112 -0.949 . . . . 75.54 110.965 -175.281 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -131.66 170.33 21.62 Favored Glycine 0 CA--C 1.533 1.189 0 CA-C-O 119.735 -0.48 . . . . 60.01 112.272 179.07 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 83.8 Cg_endo -81.99 157.36 17.95 Favored 'Trans proline' 0 CA--C 1.554 1.519 0 C-N-CA 122.799 2.333 . . . . 71.31 112.209 170.83 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 79.3 21.17 67.87 Favored Glycine 0 C--N 1.35 1.306 0 CA-C-N 116.601 -0.272 . . . . 54.13 113.624 176.544 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 97' ' ' ILE . . . . . 0.623 ' HB ' ' HB2' ' A' ' 115' ' ' CYS . 24.9 mm -65.63 103.72 0.5 Allowed 'Isoleucine or valine' 0 CA--C 1.547 0.836 0 C-N-CA 123.603 0.761 . . . . 74.43 111.816 -175.559 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 63.0 tp -89.02 114.38 25.57 Favored 'General case' 0 CA--C 1.547 0.84 0 CA-C-O 121.586 0.708 . . . . 72.13 109.368 173.708 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 99' ' ' SER . . . . . 0.692 ' HB3' ' HA ' ' A' ' 128' ' ' VAL . 4.9 p -148.05 139.75 23.82 Favored 'General case' 0 CA--C 1.537 0.473 0 C-N-CA 124.801 1.24 . . . . 61.3 108.033 178.354 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 100' ' ' MET . . . . . 0.736 ' HA ' ' HA ' ' A' ' 112' ' ' PHE . 67.3 mtp -75.55 148.05 39.21 Favored 'General case' 0 N--CA 1.489 1.522 0 C-N-CA 122.625 0.37 . . . . 63.23 110.775 -173.187 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 101' ' ' ALA . . . . . 0.71 ' HB3' ' HB2' ' A' ' 111' ' ' GLN . . . -72.34 152.28 42.18 Favored 'General case' 0 N--CA 1.479 0.984 0 CA-C-O 121.196 0.522 . . . . 73.32 112.301 -171.928 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 102' ' ' ASN . . . . . 0.459 ' HB2' ' HB ' ' A' ' 107' ' ' THR . 30.1 p-10 -165.83 159.42 15.99 Favored 'General case' 0 CA--C 1.536 0.438 0 CA-C-N 114.821 -1.081 . . . . 75.34 109.774 -177.022 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -110.14 25.08 12.18 Favored 'General case' 0 N--CA 1.472 0.654 0 C-N-CA 123.356 0.662 . . . . 63.23 109.379 169.821 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 136.9 -174.1 21.81 Favored Glycine 0 CA--C 1.535 1.292 0 CA-C-N 115.484 -0.78 . . . . 54.1 112.029 -179.422 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 51.7 Cg_exo -57.22 152.24 46.7 Favored 'Trans proline' 0 C--N 1.37 1.671 0 C-N-CA 123.439 2.759 . . . . 62.21 112.595 175.316 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 65.1 t30 66.74 12.67 8.98 Favored 'General case' 0 N--CA 1.489 1.491 0 C-N-CA 124.347 1.059 . . . . 75.4 111.965 179.638 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 107' ' ' THR . . . . . 0.729 ' HA ' ' HD2' ' A' ' 82' ' ' LYS . 2.7 m -120.77 7.23 10.45 Favored 'General case' 0 N--CA 1.489 1.506 0 C-N-CA 123.451 0.701 . . . . 72.24 110.579 -179.504 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 12.4 t30 -76.89 139.93 40.4 Favored 'General case' 0 N--CA 1.478 0.965 0 C-N-CA 124.643 1.177 . . . . 73.52 110.26 179.181 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 112.59 -11.35 25.73 Favored Glycine 0 N--CA 1.471 1.003 0 CA-C-O 119.843 -0.42 . . . . 64.22 113.269 178.518 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 110' ' ' SER . . . . . 0.551 ' HB2' ' HA ' ' A' ' 73' ' ' THR . 33.9 p -99.87 121.61 41.57 Favored 'General case' 0 N--CA 1.474 0.773 0 N-CA-C 109.047 -0.723 . . . . 74.41 109.047 173.009 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 111' ' ' GLN . . . . . 0.71 ' HB2' ' HB3' ' A' ' 101' ' ' ALA . 38.5 mt-30 63.67 175.74 0.17 Allowed 'General case' 0 N--CA 1.498 1.969 0 C-N-CA 124.294 1.037 . . . . 70.01 111.848 -177.705 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 112' ' ' PHE . . . . . 0.736 ' HA ' ' HA ' ' A' ' 100' ' ' MET . 36.6 p90 -148.93 133.36 17.57 Favored 'General case' 0 N--CA 1.482 1.147 0 N-CA-C 109.427 -0.583 . . . . 62.4 109.427 177.133 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 113' ' ' PHE . . . . . 0.411 ' CD1' ' SD ' ' A' ' 61' ' ' MET . 51.7 p90 -118.98 149.83 40.96 Favored 'General case' 0 N--CA 1.478 0.935 0 C-N-CA 123.151 0.58 . . . . 64.12 111.592 179.627 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 114' ' ' ILE . . . . . . . . . . . . . 22.5 mt -123.0 103.8 13.59 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.611 0 C-N-CA 124.279 1.032 . . . . 52.04 108.698 -179.753 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 115' ' ' CYS . . . . . 0.623 ' HB2' ' HB ' ' A' ' 97' ' ' ILE . 62.2 m -75.71 106.22 7.16 Favored 'General case' 0 CA--C 1.541 0.623 0 N-CA-C 109.336 -0.616 . . . . 52.22 109.336 175.584 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 39.5 p -70.63 -31.5 68.47 Favored 'General case' 0 N--CA 1.471 0.584 0 C-N-CA 123.534 0.734 . . . . 72.51 111.3 -179.104 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -99.06 159.04 15.25 Favored 'General case' 0 C--O 1.247 0.936 0 CA-C-N 115.462 -0.79 . . . . 44.05 109.478 171.69 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -72.36 88.89 1.2 Allowed 'General case' 0 CA--C 1.539 0.543 0 CA-C-O 121.765 0.793 . . . . 61.33 109.182 173.471 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 119' ' ' THR . . . . . . . . . . . . . 34.6 p -76.06 85.7 2.94 Favored 'General case' 0 CA--C 1.546 0.804 0 CA-C-O 122.276 1.036 . . . . 75.5 110.36 -174.381 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 11.5 pt-20 -71.29 -29.76 65.44 Favored 'General case' 0 N--CA 1.474 0.748 0 CA-C-N 114.158 -1.383 . . . . 75.41 111.38 -171.278 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 121' ' ' TRP . . . . . . . . . . . . . 43.6 p90 -67.94 -3.17 9.04 Favored 'General case' 0 N--CA 1.479 1.003 0 C-N-CA 123.367 0.667 . . . . 63.14 112.218 179.251 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 45.7 mt -96.24 26.32 4.35 Favored 'General case' 0 CA--C 1.555 1.141 0 C-N-CA 123.523 0.729 . . . . 62.41 111.535 174.037 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 56.7 m-20 -59.55 123.08 15.7 Favored 'General case' 0 N--CA 1.49 1.545 0 C-N-CA 122.758 0.423 . . . . 62.32 110.376 165.054 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 85.56 -9.1 69.03 Favored Glycine 0 N--CA 1.475 1.278 0 O-C-N 123.209 0.318 . . . . 61.44 113.27 -179.271 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 125' ' ' LYS . . . . . 0.641 ' HG3' ' H ' ' A' ' 126' ' ' HIS . 0.1 OUTLIER -82.74 -163.97 0.79 Allowed 'General case' 0 CA--C 1.561 1.371 0 C-N-CA 124.628 1.171 . . . . 73.43 108.412 177.511 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 126' ' ' HIS . . . . . 0.641 ' H ' ' HG3' ' A' ' 125' ' ' LYS . 57.3 t-80 -64.35 136.43 57.13 Favored 'General case' 0 N--CA 1.473 0.709 0 C-N-CA 124.119 0.968 . . . . 75.04 111.218 -166.38 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 127' ' ' VAL . . . . . 0.425 HG11 ' O ' ' A' ' 87' ' ' ASN . 45.1 t -71.76 140.33 18.32 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.536 0 CA-C-N 115.634 -0.712 . . . . 61.4 110.676 -176.466 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 128' ' ' VAL . . . . . 0.692 ' HA ' ' HB3' ' A' ' 99' ' ' SER . 25.1 t -73.37 148.0 9.14 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.558 0 N-CA-C 109.166 -0.679 . . . . 71.44 109.166 175.767 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 129' ' ' PHE . . . . . 0.517 ' HA ' HG21 ' A' ' 29' ' ' VAL . 39.5 p90 -129.2 -20.02 3.44 Favored 'General case' 0 N--CA 1.479 0.996 0 O-C-N 122.105 -0.372 . . . . 73.35 110.694 174.827 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . -140.23 164.18 26.25 Favored Glycine 0 C--N 1.34 0.761 0 O-C-N 123.717 0.636 . . . . 75.31 112.017 -175.87 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 34.6 ttpt -148.86 130.28 14.77 Favored 'General case' 0 N--CA 1.468 0.462 0 N-CA-C 109.271 -0.641 . . . . 74.21 109.271 -178.148 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 49.0 t -63.76 104.45 0.41 Allowed 'Isoleucine or valine' 0 C--O 1.238 0.496 0 N-CA-C 108.847 -0.797 . . . . 65.22 108.847 174.759 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 133' ' ' LYS . . . . . 0.66 ' HD2' ' HB2' ' A' ' 23' ' ' GLU . 19.4 ptmt -85.63 -33.4 21.63 Favored 'General case' 0 N--CA 1.471 0.618 0 N-CA-C 109.335 -0.617 . . . . 71.34 109.335 179.545 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 32.8 mt-10 -145.39 152.27 39.58 Favored 'General case' 0 N--CA 1.473 0.707 0 C-N-CA 125.033 1.333 . . . . 74.44 109.166 -178.135 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 135' ' ' GLY . . . . . 0.436 ' HA3' ' HA ' ' A' ' 20' ' ' VAL . . . 81.85 16.62 72.21 Favored Glycine 0 C--N 1.345 1.041 0 CA-C-N 116.534 -0.303 . . . . 74.02 112.729 -178.848 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 136' ' ' MET . . . . . . . . . . . . . 14.5 tpt -62.6 -31.11 71.88 Favored 'General case' 0 N--CA 1.479 0.998 0 C-N-CA 124.232 1.013 . . . . 73.0 110.857 177.72 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 137' ' ' ASN . . . . . . . . . . . . . 45.3 t30 -56.53 -44.66 81.04 Favored 'General case' 0 N--CA 1.477 0.883 0 CA-C-N 114.51 -1.223 . . . . 75.44 110.779 171.824 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 138' ' ' ILE . . . . . . . . . . . . . 46.4 mm -73.72 -33.13 37.21 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.009 0 C-N-CA 123.682 0.793 . . . . 64.42 111.135 -178.199 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 70.2 t -63.27 -47.72 90.83 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.114 0 CA-C-O 121.32 0.581 . . . . 73.43 110.511 177.146 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 49.0 mt-10 -73.13 -29.29 62.78 Favored 'General case' 0 CA--C 1.548 0.884 0 CA-C-N 115.827 -0.624 . . . . 75.21 111.385 179.092 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -70.22 -40.17 74.67 Favored 'General case' 0 N--CA 1.479 0.991 0 C-N-CA 123.089 0.555 . . . . 75.54 111.269 177.503 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 142' ' ' MET . . . . . 0.539 ' SD ' HG21 ' A' ' 10' ' ' ILE . 22.9 ptt? -74.51 -27.03 60.37 Favored 'General case' 0 N--CA 1.484 1.271 0 C-N-CA 122.622 0.369 . . . . 53.04 110.107 178.501 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 143' ' ' GLU . . . . . 0.565 ' HG2' ' HA ' ' A' ' 58' ' ' PRO . 33.8 tt0 -65.41 -27.51 68.59 Favored 'General case' 0 CA--C 1.545 0.756 0 C-N-CA 123.202 0.601 . . . . 73.31 112.417 177.686 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 144' ' ' ARG . . . . . . . . . . . . . 74.3 mtp180 -65.7 -20.23 66.2 Favored 'General case' 0 CA--C 1.55 0.949 0 C-N-CA 123.48 0.712 . . . . 75.15 111.458 176.114 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 145' ' ' PHE . . . . . 0.407 ' HB2' HD11 ' A' ' 156' ' ' ILE . 43.6 m-85 -89.52 3.97 50.73 Favored 'General case' 0 CA--C 1.548 0.874 0 C-N-CA 123.607 0.763 . . . . 74.13 111.706 177.406 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . -85.52 177.26 50.07 Favored Glycine 0 C--N 1.347 1.167 0 N-CA-C 111.66 -0.576 . . . . 74.44 111.66 171.01 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 16.4 m -133.71 163.15 30.09 Favored 'General case' 0 N--CA 1.48 1.053 0 CA-C-N 117.587 0.694 . . . . 51.43 111.741 -175.895 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 148' ' ' ARG . . . . . . . . . . . . . 9.3 mmm180 -75.99 -15.31 60.17 Favored 'General case' 0 N--CA 1.475 0.798 0 C-N-CA 124.897 1.279 . . . . 52.12 112.879 -177.747 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 149' ' ' ASN . . . . . . . . . . . . . 34.3 p-10 -90.72 -3.51 57.41 Favored 'General case' 0 N--CA 1.481 1.117 0 C-N-CA 122.884 0.474 . . . . 73.31 110.333 171.982 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . 105.36 -27.33 18.69 Favored Glycine 0 C--N 1.351 1.393 0 CA-C-N 116.0 -0.546 . . . . 41.15 112.917 177.003 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 56.9 tttm -69.43 156.32 39.04 Favored 'General case' 0 N--CA 1.484 1.27 0 C-N-CA 123.217 0.607 . . . . 74.33 111.78 -173.358 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 152' ' ' THR . . . . . . . . . . . . . 69.2 p -94.39 130.63 40.65 Favored 'General case' 0 N--CA 1.474 0.765 0 CA-C-O 120.941 0.4 . . . . 75.42 110.428 172.304 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 153' ' ' SER . . . . . . . . . . . . . 15.0 m -69.47 -31.44 69.73 Favored 'General case' 0 N--CA 1.474 0.731 0 C-N-CA 123.928 0.891 . . . . 72.3 111.148 174.723 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 75.3 mmtt -115.13 153.63 30.42 Favored 'General case' 0 N--CA 1.473 0.723 0 C-N-CA 124.052 0.941 . . . . 70.2 109.972 -177.277 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 155' ' ' LYS . . . . . 0.454 ' HB2' ' HA ' ' A' ' 13' ' ' ASP . 30.3 mmmt -86.32 89.11 7.76 Favored 'General case' 0 N--CA 1.468 0.466 0 N-CA-C 109.244 -0.651 . . . . 75.52 109.244 175.626 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 156' ' ' ILE . . . . . 0.526 HD13 ' HB2' ' A' ' 142' ' ' MET . 59.2 mt -90.23 103.02 13.85 Favored 'Isoleucine or valine' 0 C--O 1.213 -0.837 0 N-CA-C 109.28 -0.637 . . . . 75.1 109.28 -174.706 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 157' ' ' THR . . . . . . . . . . . . . 44.7 p -114.45 147.99 38.47 Favored 'General case' 0 N--CA 1.476 0.868 0 C-N-CA 123.976 0.91 . . . . 73.11 109.972 -175.222 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 158' ' ' ILE . . . . . 0.408 HG23 ' HB3' ' A' ' 8' ' ' PHE . 47.2 mt -71.91 97.43 0.67 Allowed 'Isoleucine or valine' 0 CA--C 1.555 1.156 0 N-CA-C 109.546 -0.539 . . . . 74.12 109.546 170.638 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 159' ' ' ALA . . . . . 0.757 ' HB2' ' HB2' ' A' ' 11' ' ' ALA . . . -58.7 -48.57 80.67 Favored 'General case' 0 N--CA 1.482 1.136 0 C-N-CA 124.581 1.152 . . . . 45.43 112.757 -175.894 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 160' ' ' ASP . . . . . . . . . . . . . 25.4 t0 -148.86 166.16 29.36 Favored 'General case' 0 N--CA 1.478 0.974 0 CA-C-N 115.926 -0.579 . . . . 73.32 110.307 -175.734 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 161' ' ' CYS . . . . . . . . . . . . . 19.4 p -132.56 -170.91 2.53 Favored 'General case' 0 CA--C 1.548 0.888 0 C-N-CA 125.315 1.446 . . . . 52.21 109.056 179.85 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 162' ' ' GLY . . . . . . . . . . . . . . . 132.02 53.88 0.09 OUTLIER Glycine 0 N--CA 1.473 1.134 0 N-CA-C 111.265 -0.734 . . . . 73.41 111.265 -170.83 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 163' ' ' GLN . . . . . 0.553 ' NE2' HG23 ' A' ' 41' ' ' THR . 69.7 mt-30 -46.74 112.56 0.52 Allowed 'General case' 0 CA--C 1.55 0.952 0 C-N-CA 125.586 1.555 . . . . 60.22 112.762 -177.337 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 164' ' ' LEU . . . . . 0.421 ' O ' ' HB ' ' A' ' 5' ' ' THR . 88.0 mt . . . . . 0 N--CA 1.474 0.751 0 C-N-CA 124.045 0.938 . . . . 73.4 110.186 -175.646 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 218' ' ' PRO . . . . . . . . . . . . . 10.8 Cg_endo . . . . . 0 CA--C 1.549 1.267 0 CA-C-O 121.216 0.423 . . . . 73.04 111.37 . . . . . . . . . 0 0 . 1 . 011 nuclear build core ' B' B ' 219' ' ' GLY . . . . . . . . . . . . . . . 137.0 126.95 2.57 Favored Glycine 0 CA--C 1.541 1.679 0 CA-C-N 114.931 -1.031 . . . . 72.34 110.585 -174.482 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 220' ' ' PRO . . . . . . . . . . . . . 57.5 Cg_endo -67.18 170.5 13.09 Favored 'Trans proline' 0 C--N 1.377 2.055 0 C-N-CA 123.178 2.585 . . . . 53.01 113.485 -177.163 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 221' ' ' TYR . . . . . . . . . . . . . 13.7 p90 . . . . . 0 C--O 1.252 1.192 0 CA-C-O 121.321 0.581 . . . . 72.32 111.265 -175.054 . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 3' ' ' ASN . . . . . 0.502 ' HB3' ' O ' ' A' ' 24' ' ' LEU . 27.3 m-80 . . . . . 0 CA--C 1.552 1.046 0 CA-C-O 119.328 -0.367 . . . . 72.34 111.936 . . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 42.9 Cg_endo -66.71 119.36 6.38 Favored 'Trans proline' 0 C--N 1.384 2.443 0 C-N-CA 122.973 2.449 . . . . 65.32 111.049 175.572 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 5' ' ' THR . . . . . 0.428 ' O ' ' HB2' ' A' ' 163' ' ' GLN . 97.5 m -98.6 127.82 44.68 Favored 'General case' 0 CA--C 1.537 0.444 0 N-CA-C 109.239 -0.652 . . . . 74.13 109.239 -178.934 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 6' ' ' VAL . . . . . 0.501 ' HA ' ' HB2' ' A' ' 163' ' ' GLN . 14.1 m -102.13 123.13 55.17 Favored 'Isoleucine or valine' 0 C--N 1.351 0.652 0 C-N-CA 123.972 0.909 . . . . 73.04 109.563 178.252 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 7' ' ' PHE . . . . . 0.635 ' H ' ' HA ' ' A' ' 163' ' ' GLN . 57.5 t80 -102.79 137.27 41.22 Favored 'General case' 0 C--O 1.24 0.597 0 CA-C-N 115.058 -0.974 . . . . 72.24 108.905 -178.49 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 51.2 m-85 -136.59 164.78 27.4 Favored 'General case' 0 C--O 1.24 0.563 0 O-C-N 124.534 1.146 . . . . 74.31 109.971 174.32 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 24.6 m-20 -112.96 109.06 18.23 Favored 'General case' 0 C--N 1.324 -0.511 0 N-CA-C 106.263 -1.754 . . . . 72.11 106.263 169.976 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 10' ' ' ILE . . . . . 0.453 HG21 ' SD ' ' A' ' 142' ' ' MET . 46.7 mm -78.95 129.43 37.58 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.479 0 N-CA-C 108.013 -1.106 . . . . 44.12 108.013 177.555 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 11' ' ' ALA . . . . . 0.75 ' HB2' ' HB2' ' A' ' 159' ' ' ALA . . . -124.53 133.54 53.28 Favored 'General case' 0 C--O 1.217 -0.654 0 C-N-CA 123.849 0.86 . . . . 53.53 110.785 -171.782 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 12' ' ' VAL . . . . . 0.453 HG13 ' HB3' ' A' ' 154' ' ' LYS . 53.4 t -97.53 117.59 42.51 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.64 0 C-N-CA 124.236 1.014 . . . . 63.14 108.983 172.128 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 13' ' ' ASP . . . . . 0.47 ' HA ' ' HB3' ' A' ' 155' ' ' LYS . 31.6 m-20 54.97 38.93 31.29 Favored 'General case' 0 N--CA 1.484 1.257 0 C-N-CA 125.288 1.435 . . . . 64.14 111.211 -174.372 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 84.07 -14.51 43.6 Favored Glycine 0 C--N 1.353 1.508 0 CA-C-N 115.292 -0.867 . . . . 53.05 113.964 179.479 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 18.4 mm-40 -89.89 122.15 68.18 Favored Pre-proline 0 N--CA 1.474 0.756 0 CA-C-O 118.347 -0.835 . . . . 53.31 109.865 -178.896 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_exo -50.42 109.55 0.3 Allowed 'Trans proline' 0 C--N 1.378 2.119 0 C-N-CA 123.786 2.99 . . . . 53.2 113.397 -178.056 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 42.6 tp -77.11 -45.08 28.13 Favored 'General case' 0 N--CA 1.477 0.924 0 C-N-CA 123.647 0.779 . . . . 73.41 109.503 175.99 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -177.3 -172.45 41.86 Favored Glycine 0 C--N 1.343 0.961 0 CA-C-N 115.519 -0.764 . . . . 43.34 112.227 -179.933 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 19' ' ' ARG . . . . . 0.497 ' HB3' ' HE1' ' A' ' 7' ' ' PHE . 54.3 mtt180 -118.71 138.39 52.67 Favored 'General case' 0 N--CA 1.473 0.69 0 C-N-CA 124.185 0.994 . . . . 75.04 110.423 -174.02 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 36.7 t -135.29 144.23 34.77 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.819 0 C-N-CA 124.065 0.946 . . . . 71.43 109.09 178.328 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 75.1 m -128.94 126.41 39.58 Favored 'General case' 0 CA--C 1.549 0.933 0 C-N-CA 123.688 0.795 . . . . 62.21 108.931 172.185 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 70.4 m-85 -106.66 121.94 45.36 Favored 'General case' 0 N--CA 1.475 0.792 0 C-N-CA 123.909 0.884 . . . . 71.34 110.106 178.969 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 23' ' ' GLU . . . . . 0.477 ' HG3' ' HB2' ' A' ' 3' ' ' ASN . 39.7 tt0 -75.92 113.4 13.37 Favored 'General case' 0 CA--C 1.552 1.055 0 C-N-CA 123.764 0.825 . . . . 75.43 109.487 171.456 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 24' ' ' LEU . . . . . 0.502 ' O ' ' HB3' ' A' ' 3' ' ' ASN . 37.4 mt -91.39 123.5 34.86 Favored 'General case' 0 N--CA 1.482 1.127 0 C-N-CA 123.538 0.735 . . . . 62.13 110.305 179.452 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 79.3 m-85 -79.72 70.98 6.34 Favored 'General case' 0 N--CA 1.476 0.863 0 C-N-CA 123.688 0.795 . . . . 73.53 111.15 -178.506 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -74.99 1.44 12.92 Favored 'General case' 0 N--CA 1.483 1.196 0 C-N-CA 123.55 0.74 . . . . 74.43 112.172 -179.666 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 11.3 p-10 -89.55 -27.81 20.02 Favored 'General case' 0 CA--C 1.551 1.007 0 C-N-CA 123.537 0.735 . . . . 73.32 110.568 172.791 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 57.4 mttp -100.72 -39.33 7.9 Favored 'General case' 0 N--CA 1.485 1.3 0 C-N-CA 123.362 0.665 . . . . 74.2 110.845 -176.546 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 29' ' ' VAL . . . . . 0.519 HG21 ' HA ' ' A' ' 129' ' ' PHE . 12.0 m -137.44 61.82 33.65 Favored Pre-proline 0 CA--C 1.56 1.341 0 C-N-CA 124.341 1.056 . . . . 75.11 110.355 -176.367 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 20.7 Cg_endo -58.9 -23.81 69.54 Favored 'Trans proline' 0 C--N 1.387 2.561 0 C-N-CA 122.559 2.173 . . . . 71.23 113.733 -178.076 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 86.4 tttt -68.66 -56.47 8.07 Favored 'General case' 0 N--CA 1.477 0.912 0 C-N-CA 122.79 0.436 . . . . 71.24 110.688 179.662 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 5.7 m -74.06 -33.2 63.61 Favored 'General case' 0 CA--C 1.552 1.05 0 CA-C-N 115.418 -0.81 . . . . 74.31 111.177 -173.784 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -72.04 -46.62 56.35 Favored 'General case' 0 CA--C 1.546 0.816 0 C-N-CA 123.651 0.78 . . . . 75.35 111.056 179.948 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 34.4 tt0 -64.38 -37.31 87.06 Favored 'General case' 0 N--CA 1.487 1.419 0 C-N-CA 123.187 0.595 . . . . 74.14 110.652 178.497 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 35' ' ' ASN . . . . . 0.477 ' O ' ' HG ' ' A' ' 39' ' ' LEU . 38.8 t30 -51.61 -64.44 0.81 Allowed 'General case' 0 C--N 1.36 1.022 0 O-C-N 124.559 1.162 . . . . 72.1 110.14 177.232 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 86.9 t80 -61.09 -35.99 78.48 Favored 'General case' 0 CA--C 1.544 0.712 0 C-N-CA 123.92 0.888 . . . . 74.12 111.88 -177.808 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 77.3 ttt180 -64.93 -43.69 91.93 Favored 'General case' 0 N--CA 1.474 0.751 0 C-N-CA 123.715 0.806 . . . . 65.52 111.436 -177.922 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 38' ' ' ALA . . . . . 0.513 ' HB1' ' HG2' ' A' ' 44' ' ' LYS . . . -78.21 -27.84 47.86 Favored 'General case' 0 N--CA 1.474 0.755 0 C-N-CA 123.32 0.648 . . . . 73.43 111.209 -177.525 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 39' ' ' LEU . . . . . 0.477 ' HG ' ' O ' ' A' ' 35' ' ' ASN . 88.5 mt -66.02 -43.29 88.05 Favored 'General case' 0 CA--C 1.549 0.908 0 C-N-CA 123.437 0.695 . . . . 62.24 109.973 169.877 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 16.3 t -62.7 -51.88 65.47 Favored 'General case' 0 N--CA 1.476 0.855 0 C-N-CA 125.22 1.408 . . . . 74.12 111.336 -178.095 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 25.4 p -77.17 -32.95 56.5 Favored 'General case' 0 CA--C 1.536 0.424 0 CA-C-N 115.559 -0.746 . . . . 73.04 111.667 -176.167 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 88.42 26.97 26.39 Favored Glycine 0 C--N 1.346 1.116 0 O-C-N 123.406 0.441 . . . . 52.23 112.558 -175.33 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 22.8 mm-40 -63.59 -22.65 67.01 Favored 'General case' 0 N--CA 1.482 1.165 0 C-N-CA 123.471 0.708 . . . . 72.32 111.495 173.506 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 44' ' ' LYS . . . . . 0.513 ' HG2' ' HB1' ' A' ' 38' ' ' ALA . 31.0 mmmt -105.69 17.09 24.32 Favored 'General case' 0 CA--C 1.545 0.756 0 C-N-CA 123.998 0.919 . . . . 72.43 110.905 179.241 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 81.55 -25.86 3.74 Favored Glycine 0 C--N 1.355 1.593 0 N-CA-C 114.641 0.617 . . . . 72.32 114.641 175.661 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 16.4 m-85 -64.94 -44.03 90.79 Favored 'General case' 0 N--CA 1.48 1.055 0 C-N-CA 123.406 0.682 . . . . 51.24 111.186 -171.354 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 56.87 64.66 4.2 Favored Glycine 0 C--N 1.356 1.673 0 O-C-N 123.958 0.786 . . . . 62.22 114.34 166.049 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 48' ' ' TYR . . . . . 0.401 ' HE1' HD22 ' A' ' 39' ' ' LEU . 51.4 m-85 -62.44 87.59 0.02 OUTLIER 'General case' 0 N--CA 1.48 1.075 0 CA-C-O 122.33 1.062 . . . . 75.54 111.426 -178.721 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 28.5 tptp -111.4 117.15 32.29 Favored 'General case' 0 C--O 1.235 0.33 0 CA-C-N 113.452 -1.703 . . . . 71.21 107.775 178.762 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 79.46 20.75 68.4 Favored Glycine 0 C--N 1.339 0.742 0 CA-C-O 119.698 -0.501 . . . . 50.35 112.877 -177.088 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 34.5 t -55.83 115.4 2.36 Favored 'General case' 0 C--N 1.357 0.921 0 C-N-CA 123.365 0.666 . . . . 73.13 109.387 178.078 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 52' ' ' CYS . . . . . 0.742 ' SG ' ' HB3' ' A' ' 66' ' ' ASP . 2.3 p -86.54 138.6 31.59 Favored 'General case' 0 C--O 1.242 0.685 0 O-C-N 124.255 0.972 . . . . 73.23 111.491 -172.495 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 53' ' ' PHE . . . . . 0.667 ' HA ' ' HA2' ' A' ' 64' ' ' GLY . 36.6 m-85 -89.29 99.09 12.15 Favored 'General case' 0 N--CA 1.451 -0.415 0 C-N-CA 125.338 1.455 . . . . 74.42 107.988 175.544 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 43.8 p-80 -82.49 -31.11 29.49 Favored 'General case' 0 N--CA 1.476 0.841 0 C-N-CA 123.608 0.763 . . . . 71.31 111.342 -177.098 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 55' ' ' ARG . . . . . 0.403 ' HA ' ' O ' ' A' ' 150' ' ' GLY . 52.5 ttt180 -122.92 98.43 5.9 Favored 'General case' 0 C--O 1.21 -0.979 0 C-N-CA 122.885 0.474 . . . . 65.34 109.85 -173.97 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 56' ' ' ILE . . . . . 0.484 HG21 ' HA ' ' A' ' 143' ' ' GLU . 38.8 mt -127.87 138.95 53.24 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.717 0 N-CA-C 109.296 -0.631 . . . . 74.12 109.296 173.139 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 57' ' ' ILE . . . . . 0.565 HG23 ' HA ' ' A' ' 148' ' ' ARG . 64.1 mt -134.08 113.71 12.57 Favored Pre-proline 0 CA--C 1.557 1.24 0 C-N-CA 125.133 1.373 . . . . 70.21 108.781 -174.694 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 58' ' ' PRO . . . . . 0.578 ' HA ' ' HG2' ' A' ' 143' ' ' GLU . 56.0 Cg_endo -66.17 131.46 26.9 Favored 'Trans proline' 0 C--N 1.386 2.516 0 C-N-CA 123.641 2.894 . . . . 43.23 113.357 -173.104 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 78.03 31.31 48.54 Favored Glycine 0 C--N 1.345 1.08 0 CA-C-N 115.387 -0.824 . . . . 72.55 112.696 -178.58 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 20.2 t80 -157.71 -73.73 0.09 Allowed 'General case' 0 CA--C 1.545 0.772 0 CA-C-N 116.781 0.291 . . . . 72.54 111.393 -174.533 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 43.6 ttp -159.59 138.8 11.13 Favored 'General case' 0 N--CA 1.481 1.09 0 C-N-CA 122.679 0.392 . . . . 55.01 111.299 -166.057 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 62' ' ' CYS . . . . . 0.648 ' SG ' ' HB ' ' A' ' 114' ' ' ILE . 5.4 p -116.31 111.65 20.42 Favored 'General case' 0 CA--C 1.554 1.099 0 C-N-CA 123.494 0.718 . . . . 53.21 109.429 169.572 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 63' ' ' GLN . . . . . 0.4 ' HA ' ' HA ' ' A' ' 113' ' ' PHE . 54.2 tt0 -109.34 117.71 34.77 Favored 'General case' 0 N--CA 1.487 1.379 0 C-N-CA 124.438 1.095 . . . . 63.04 110.897 -173.342 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 64' ' ' GLY . . . . . 0.667 ' HA2' ' HA ' ' A' ' 53' ' ' PHE . . . -106.73 -176.3 23.08 Favored Glycine 0 C--N 1.345 1.073 0 CA-C-N 115.713 -0.676 . . . . 62.11 113.34 179.621 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 84.4 91.5 0.76 Allowed Glycine 0 C--N 1.341 0.859 0 N-CA-C 110.446 -1.062 . . . . 32.45 110.446 -174.566 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 66' ' ' ASP . . . . . 0.742 ' HB3' ' SG ' ' A' ' 52' ' ' CYS . 32.9 t70 -128.56 -56.89 1.21 Allowed 'General case' 0 N--CA 1.473 0.718 0 C-N-CA 122.938 0.495 . . . . 65.44 110.532 176.019 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 65.7 t80 -40.25 -57.32 1.75 Allowed 'General case' 0 N--CA 1.485 1.307 0 C-N-CA 125.344 1.458 . . . . 75.34 114.196 -170.756 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 26.4 m -79.93 107.2 12.52 Favored 'General case' 0 C--O 1.243 0.738 0 CA-C-O 120.862 0.363 . . . . 72.12 110.992 -174.782 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 62.6 mtt-85 54.29 71.67 0.51 Allowed 'General case' 0 N--CA 1.472 0.669 0 C-N-CA 125.929 1.692 . . . . 61.24 112.147 173.245 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 70' ' ' HIS . . . . . 0.439 ' HB3' ' O ' ' A' ' 66' ' ' ASP . 15.9 p-80 -85.34 17.5 3.09 Favored 'General case' 0 N--CA 1.481 1.118 0 N-CA-C 113.198 0.814 . . . . 73.15 113.198 -172.438 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 44.4 t30 -77.0 73.18 3.58 Favored 'General case' 0 N--CA 1.481 1.099 0 CA-C-O 121.561 0.696 . . . . 72.34 109.561 173.435 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 72' ' ' GLY . . . . . 0.563 ' HA2' ' HG2' ' B' ' 218' ' ' PRO . . . 63.68 20.79 64.36 Favored Glycine 0 C--N 1.346 1.092 0 CA-C-N 115.208 -0.905 . . . . 64.33 114.505 -179.071 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 37.1 m -125.03 -66.25 0.97 Allowed 'General case' 0 CA--C 1.542 0.669 0 C-N-CA 123.16 0.584 . . . . 63.42 109.459 -177.357 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 51.64 60.42 7.42 Favored Glycine 0 C--N 1.355 1.636 0 O-C-N 124.275 0.984 . . . . 35.31 113.543 177.589 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 132.21 53.03 0.08 OUTLIER Glycine 0 N--CA 1.469 0.899 0 CA-C-N 118.049 0.924 . . . . 64.4 112.35 -176.387 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -51.57 149.47 4.4 Favored 'General case' 0 N--CA 1.481 1.125 0 C-N-CA 123.75 0.82 . . . . 74.42 111.49 177.242 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 92.0 p -91.45 176.01 6.71 Favored 'General case' 0 CA--C 1.538 0.509 0 CA-C-O 121.361 0.6 . . . . 73.51 111.163 -168.542 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 78' ' ' ILE . . . . . 0.407 HG21 ' HB3' ' A' ' 38' ' ' ALA . 25.5 pt -75.93 -18.05 15.44 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.615 0 CA-C-N 115.45 -0.795 . . . . 61.33 110.218 174.329 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 85.1 m-85 -87.76 -14.82 38.69 Favored 'General case' 0 N--CA 1.472 0.642 0 C-N-CA 124.291 1.036 . . . . 74.21 110.607 177.601 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 147.36 -112.39 0.59 Allowed Glycine 0 C--N 1.348 1.199 0 N-CA-C 110.612 -0.995 . . . . 72.52 110.612 178.817 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 32.1 tt0 -89.1 -50.72 5.99 Favored 'General case' 0 CA--C 1.539 0.533 0 CA-C-O 121.657 0.741 . . . . 75.1 109.358 176.017 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 82' ' ' LYS . . . . . 0.438 ' HD2' ' HA ' ' A' ' 107' ' ' THR . 23.7 pttm -151.88 177.46 10.41 Favored 'General case' 0 N--CA 1.47 0.541 0 CA-C-N 114.336 -1.302 . . . . 73.12 109.791 -169.335 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 45.7 p90 -158.43 170.7 21.62 Favored 'General case' 0 N--CA 1.476 0.836 0 C-N-CA 123.492 0.717 . . . . 71.24 110.362 176.468 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 84' ' ' GLU . . . . . 0.534 ' HA ' ' HA ' ' A' ' 106' ' ' ASN . 9.7 pt-20 -82.73 160.46 22.34 Favored 'General case' 0 N--CA 1.474 0.747 0 C-N-CA 122.899 0.48 . . . . 74.31 111.036 178.226 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 52.3 m-20 -65.23 131.73 47.25 Favored 'General case' 0 C--O 1.239 0.511 0 CA-C-N 114.802 -1.09 . . . . 73.24 110.298 177.509 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 10.9 tp10 -72.33 -58.13 3.65 Favored 'General case' 0 C--O 1.239 0.503 0 O-C-N 124.166 0.916 . . . . 63.4 109.323 175.224 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 32.3 p30 -159.02 -173.77 4.41 Favored 'General case' 0 C--O 1.237 0.405 0 CA-C-N 114.437 -1.256 . . . . 75.15 108.966 -175.97 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 89.0 m-85 -137.56 61.26 1.61 Allowed 'General case' 0 N--CA 1.477 0.886 0 C-N-CA 123.602 0.761 . . . . 74.13 108.982 173.193 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 62.5 mt -78.77 -54.32 12.09 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.151 0 CA-C-O 121.383 0.611 . . . . 73.42 109.909 177.495 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 90' ' ' LEU . . . . . 0.499 ' HB3' ' HB ' ' A' ' 128' ' ' VAL . 94.3 mt -89.05 140.88 28.99 Favored 'General case' 0 C--O 1.236 0.37 0 CA-C-N 115.067 -0.97 . . . . 61.25 111.389 -172.672 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 16.8 ptpt -139.63 170.56 15.68 Favored 'General case' 0 CA--C 1.541 0.612 0 C-N-CA 124.113 0.965 . . . . 63.45 110.83 -173.571 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 92' ' ' HIS . . . . . 0.574 ' HA ' HG21 ' A' ' 97' ' ' ILE . 13.2 m80 -92.12 53.72 2.22 Favored 'General case' 0 N--CA 1.48 1.041 0 C-N-CA 124.791 1.236 . . . . 72.24 110.78 -167.528 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 3.8 p -94.52 20.32 8.58 Favored 'General case' 0 N--CA 1.481 1.103 0 C-N-CA 124.196 0.998 . . . . 32.55 113.286 -174.125 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -163.93 178.92 39.17 Favored Glycine 0 C--N 1.344 0.974 0 C-N-CA 121.018 -0.611 . . . . 43.33 113.652 -178.214 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 85.0 Cg_endo -81.64 138.5 10.73 Favored 'Trans proline' 0 C--N 1.369 1.657 0 C-N-CA 123.046 2.497 . . . . 74.44 112.805 175.935 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 96' ' ' GLY . . . . . 0.551 ' HA3' HG12 ' A' ' 132' ' ' VAL . . . 80.28 20.12 67.75 Favored Glycine 0 C--N 1.35 1.316 0 CA-C-N 116.04 -0.527 . . . . 75.43 113.692 174.1 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 97' ' ' ILE . . . . . 0.574 HG21 ' HA ' ' A' ' 92' ' ' HIS . 21.7 mm -66.87 105.62 0.73 Allowed 'Isoleucine or valine' 0 CA--C 1.549 0.914 0 C-N-CA 124.518 1.127 . . . . 61.53 110.613 178.077 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 98' ' ' LEU . . . . . 0.451 HD13 HG12 ' A' ' 114' ' ' ILE . 59.2 tp -87.17 101.47 13.53 Favored 'General case' 0 CA--C 1.55 0.973 0 CA-C-O 121.894 0.855 . . . . 71.14 109.532 177.089 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 99' ' ' SER . . . . . 0.522 ' HB2' HG22 ' A' ' 128' ' ' VAL . 33.0 t -106.07 170.39 7.94 Favored 'General case' 0 N--CA 1.472 0.664 0 C-N-CA 124.965 1.306 . . . . 44.33 108.67 176.141 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 100' ' ' MET . . . . . 0.5 ' SD ' ' HA2' ' A' ' 109' ' ' GLY . 4.4 ttt -113.53 135.68 53.63 Favored 'General case' 0 N--CA 1.482 1.125 0 CA-C-N 118.356 0.525 . . . . 64.1 110.048 -178.175 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 101' ' ' ALA . . . . . 0.441 ' HB3' ' HB2' ' A' ' 111' ' ' GLN . . . -84.35 -178.95 7.07 Favored 'General case' 0 C--O 1.244 0.811 0 C-N-CA 123.764 0.826 . . . . 43.4 111.105 -173.79 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 25.8 p-10 -168.84 -178.83 3.49 Favored 'General case' 0 CA--C 1.539 0.552 0 CA-C-N 115.166 -0.925 . . . . 72.24 111.369 -168.322 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 103' ' ' ALA . . . . . 0.495 ' HB3' HG21 ' A' ' 107' ' ' THR . . . -124.46 13.2 8.78 Favored 'General case' 0 N--CA 1.479 1.002 0 C-N-CA 124.249 1.02 . . . . 71.22 109.496 161.94 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 145.39 178.07 20.64 Favored Glycine 0 C--N 1.352 1.424 0 CA-C-O 119.065 -0.853 . . . . 74.14 111.539 -179.556 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 32.5 Cg_exo -61.19 149.91 87.05 Favored 'Trans proline' 0 C--N 1.375 1.962 0 C-N-CA 123.198 2.599 . . . . 75.13 111.731 169.496 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 106' ' ' ASN . . . . . 0.534 ' HA ' ' HA ' ' A' ' 84' ' ' GLU . 65.6 t30 62.87 21.87 13.09 Favored 'General case' 0 CA--C 1.557 1.249 0 O-C-N 124.168 0.917 . . . . 62.11 110.325 -174.031 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 107' ' ' THR . . . . . 0.495 HG21 ' HB3' ' A' ' 103' ' ' ALA . 12.2 m -142.15 24.11 1.99 Allowed 'General case' 0 CA--C 1.555 1.137 0 C-N-CA 125.066 1.346 . . . . 73.33 109.094 178.154 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 61.1 t30 -80.27 147.95 30.97 Favored 'General case' 0 N--CA 1.476 0.851 0 C-N-CA 123.739 0.816 . . . . 73.44 109.46 176.534 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 109' ' ' GLY . . . . . 0.5 ' HA2' ' SD ' ' A' ' 100' ' ' MET . . . 106.49 -14.24 42.83 Favored Glycine 0 N--CA 1.472 1.04 0 CA-C-O 119.946 -0.363 . . . . 54.02 113.805 177.608 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 38.6 p -94.81 120.18 34.61 Favored 'General case' 0 CA--C 1.543 0.699 0 C-N-CA 123.382 0.673 . . . . 71.23 109.361 177.861 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 111' ' ' GLN . . . . . 0.693 HE22 ' HB2' ' B' ' 218' ' ' PRO . 27.8 mt-30 66.95 162.95 0.18 Allowed 'General case' 0 N--CA 1.497 1.906 0 C-N-CA 125.044 1.338 . . . . 75.31 111.408 -170.491 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 44.9 p90 -144.5 150.29 37.34 Favored 'General case' 0 N--CA 1.484 1.233 0 N-CA-C 108.362 -0.977 . . . . 64.13 108.362 178.19 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 113' ' ' PHE . . . . . 0.4 ' HA ' ' HA ' ' A' ' 63' ' ' GLN . 51.3 p90 -140.98 142.37 34.29 Favored 'General case' 0 N--CA 1.472 0.644 0 N-CA-C 111.969 0.359 . . . . 63.34 111.969 -175.895 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 114' ' ' ILE . . . . . 0.648 ' HB ' ' SG ' ' A' ' 62' ' ' CYS . 12.1 mt -111.98 105.02 17.98 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.733 0 C-N-CA 124.168 0.987 . . . . 65.11 109.127 -178.391 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 115' ' ' CYS . . . . . . . . . . . . . 69.5 m -75.71 107.89 8.19 Favored 'General case' 0 CA--C 1.541 0.597 0 N-CA-C 109.171 -0.677 . . . . 75.14 109.171 173.335 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 116' ' ' THR . . . . . 0.468 ' HA ' ' H ' ' A' ' 96' ' ' GLY . 72.3 p -78.6 -10.71 59.84 Favored 'General case' 0 N--CA 1.481 1.078 0 C-N-CA 123.379 0.672 . . . . 52.34 111.681 -179.559 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -125.46 166.92 15.76 Favored 'General case' 0 C--O 1.243 0.746 0 C-N-CA 123.358 0.663 . . . . 45.44 109.741 176.37 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 11.3 ptmt -71.72 74.49 0.83 Allowed 'General case' 0 CA--C 1.548 0.893 0 C-N-CA 124.003 0.921 . . . . 64.3 110.097 174.829 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 119' ' ' THR . . . . . 0.547 ' HB ' HD23 ' A' ' 122' ' ' LEU . 41.1 p -76.53 90.66 3.32 Favored 'General case' 0 CA--C 1.546 0.821 0 CA-C-O 121.928 0.871 . . . . 71.2 109.588 -177.514 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 9.6 pt-20 -71.82 -32.11 67.23 Favored 'General case' 0 N--CA 1.472 0.648 0 CA-C-N 115.057 -0.974 . . . . 62.12 112.19 -173.987 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 121' ' ' TRP . . . . . . . . . . . . . 27.4 p90 -74.09 -4.82 37.94 Favored 'General case' 0 N--CA 1.479 0.99 0 C-N-CA 122.757 0.423 . . . . 73.44 111.058 176.793 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 122' ' ' LEU . . . . . 0.547 HD23 ' HB ' ' A' ' 119' ' ' THR . 3.8 mm? -86.88 -15.67 38.35 Favored 'General case' 0 N--CA 1.477 0.878 0 C-N-CA 123.761 0.824 . . . . 70.0 111.394 173.347 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 41.4 m-20 -72.41 149.39 44.32 Favored 'General case' 0 N--CA 1.482 1.134 0 N-CA-C 109.767 -0.457 . . . . 65.04 109.767 176.105 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 93.93 -26.9 14.4 Favored Glycine 0 N--CA 1.47 0.912 0 N-CA-C 111.628 -0.589 . . . . 51.13 111.628 -171.274 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 125' ' ' LYS . . . . . 0.504 ' HD2' ' HE2' ' B' ' 221' ' ' TYR . 1.8 mppt? -80.1 -169.89 2.24 Favored 'General case' 0 N--CA 1.478 0.951 0 C-N-CA 123.902 0.881 . . . . 74.55 109.709 172.387 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 126' ' ' HIS . . . . . . . . . . . . . 0.6 OUTLIER -69.34 145.68 52.77 Favored 'General case' 0 C--O 1.242 0.673 0 C-N-CA 123.372 0.669 . . . . 75.23 111.79 -167.51 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 11.1 p -65.32 145.19 14.12 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.726 0 CA-C-N 113.656 -1.611 . . . . 63.12 112.361 -165.521 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 128' ' ' VAL . . . . . 0.522 HG22 ' HB2' ' A' ' 99' ' ' SER . 60.2 t -74.25 150.22 7.43 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.53 0 CA-C-N 114.569 -1.196 . . . . 73.0 108.932 172.791 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 129' ' ' PHE . . . . . 0.519 ' HA ' HG21 ' A' ' 29' ' ' VAL . 45.5 p90 -133.59 -10.76 2.78 Favored 'General case' 0 N--CA 1.476 0.831 0 C-N-CA 122.202 0.201 . . . . 74.42 111.424 -179.396 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . -146.3 170.93 27.3 Favored Glycine 0 C--N 1.343 0.941 0 O-C-N 123.559 0.537 . . . . 75.33 112.751 -173.357 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 29.4 ttpt -161.19 134.21 6.34 Favored 'General case' 0 C--N 1.325 -0.46 0 C-N-CA 124.346 1.058 . . . . 63.21 108.235 -175.959 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 132' ' ' VAL . . . . . 0.551 HG12 ' HA3' ' A' ' 96' ' ' GLY . 13.7 p -68.41 131.02 33.82 Favored 'Isoleucine or valine' 0 CA--C 1.554 1.124 0 CA-C-N 118.329 0.513 . . . . 71.21 109.959 175.107 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -91.62 -48.82 6.63 Favored 'General case' 0 N--CA 1.48 1.061 0 N-CA-C 108.975 -0.75 . . . . 61.41 108.975 173.306 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 3.2 mp0 -146.63 155.85 42.76 Favored 'General case' 0 C--O 1.243 0.747 0 C-N-CA 124.983 1.313 . . . . 71.44 108.544 177.052 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 94.24 12.22 56.47 Favored Glycine 0 C--N 1.342 0.877 0 CA-C-N 115.926 -0.579 . . . . 51.42 112.376 -174.546 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 136' ' ' MET . . . . . 0.423 ' SD ' HG11 ' A' ' 132' ' ' VAL . 15.0 tpt -62.5 -31.1 71.8 Favored 'General case' 0 N--CA 1.48 1.031 0 C-N-CA 123.847 0.859 . . . . 60.33 111.192 178.522 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 137' ' ' ASN . . . . . . . . . . . . . 26.6 t-20 -55.51 -42.22 74.18 Favored 'General case' 0 N--CA 1.479 0.994 0 C-N-CA 123.964 0.906 . . . . 74.23 110.506 174.238 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 138' ' ' ILE . . . . . . . . . . . . . 44.9 mm -74.19 -32.85 33.24 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.73 0 CA-C-N 115.232 -0.895 . . . . 72.33 110.691 -178.95 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 69.3 t -64.55 -41.43 92.25 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.366 0 C-N-CA 123.471 0.709 . . . . 62.01 110.495 176.347 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 38.3 mt-10 -69.92 -39.22 76.29 Favored 'General case' 0 N--CA 1.473 0.722 0 CA-C-N 115.311 -0.859 . . . . 62.5 110.747 177.681 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -65.06 -52.45 55.67 Favored 'General case' 0 N--CA 1.475 0.784 0 O-C-N 123.681 0.613 . . . . 74.1 110.632 -179.568 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 142' ' ' MET . . . . . 0.459 ' HB2' HD13 ' A' ' 156' ' ' ILE . 27.6 ptm -59.73 -37.66 79.57 Favored 'General case' 0 N--CA 1.477 0.888 0 C-N-CA 123.055 0.542 . . . . 71.31 110.538 179.144 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 143' ' ' GLU . . . . . 0.578 ' HG2' ' HA ' ' A' ' 58' ' ' PRO . 39.4 tt0 -62.74 -35.76 80.8 Favored 'General case' 0 CA--C 1.546 0.822 0 CA-C-O 121.253 0.549 . . . . 74.02 112.144 -176.966 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 144' ' ' ARG . . . . . 0.557 ' HA ' ' HB3' ' A' ' 58' ' ' PRO . 62.3 mtt180 -73.58 -7.31 51.38 Favored 'General case' 0 CA--C 1.547 0.828 0 CA-C-N 115.769 -0.65 . . . . 73.15 112.711 -178.236 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 145' ' ' PHE . . . . . 0.546 ' HB2' HD11 ' A' ' 156' ' ' ILE . 55.0 m-85 -89.2 6.74 38.74 Favored 'General case' 0 CA--C 1.558 1.251 0 C-N-CA 123.07 0.548 . . . . 74.53 111.933 172.416 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . -102.5 -175.23 27.25 Favored Glycine 0 C--N 1.355 1.608 0 CA-C-N 117.646 0.203 . . . . 21.24 112.708 177.842 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 31.0 m -132.91 168.99 17.44 Favored 'General case' 0 N--CA 1.489 1.496 0 C-N-CA 124.202 1.001 . . . . 71.43 110.3 179.84 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 148' ' ' ARG . . . . . 0.565 ' HA ' HG23 ' A' ' 57' ' ' ILE . 21.9 mmt85 -65.98 -33.97 77.04 Favored 'General case' 0 N--CA 1.487 1.4 0 C-N-CA 123.845 0.858 . . . . 64.52 112.758 -175.143 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 149' ' ' ASN . . . . . . . . . . . . . 30.9 p-10 -74.7 -15.75 60.78 Favored 'General case' 0 N--CA 1.484 1.272 0 C-N-CA 123.411 0.684 . . . . 70.12 111.325 175.148 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 150' ' ' GLY . . . . . 0.403 ' O ' ' HA ' ' A' ' 55' ' ' ARG . . . 109.67 -17.06 30.86 Favored Glycine 0 C--N 1.344 1.004 0 CA-C-N 115.671 -0.695 . . . . 64.05 112.462 -179.962 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 66.2 tttp -60.3 124.01 19.0 Favored 'General case' 0 N--CA 1.474 0.769 0 CA-C-N 117.417 0.609 . . . . 71.01 110.918 -177.955 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 152' ' ' THR . . . . . 0.432 HG22 ' HB ' ' A' ' 56' ' ' ILE . 14.0 p -89.56 118.02 28.89 Favored 'General case' 0 CA--C 1.538 0.482 0 C-N-CA 123.235 0.614 . . . . 70.44 109.567 -177.897 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 153' ' ' SER . . . . . . . . . . . . . 19.8 m -66.89 -19.07 65.66 Favored 'General case' 0 CA--C 1.549 0.921 0 C-N-CA 124.153 0.981 . . . . 74.44 111.724 178.77 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 154' ' ' LYS . . . . . 0.453 ' HB3' HG13 ' A' ' 12' ' ' VAL . 74.6 mmtt -128.58 144.14 51.09 Favored 'General case' 0 N--CA 1.48 1.067 0 C-N-CA 124.478 1.111 . . . . 75.55 108.666 176.498 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 155' ' ' LYS . . . . . 0.47 ' HB3' ' HA ' ' A' ' 13' ' ' ASP . 0.0 OUTLIER -81.47 90.13 6.2 Favored 'General case' 0 N--CA 1.477 0.882 0 CA-C-O 121.54 0.686 . . . . 71.3 109.743 -177.269 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 156' ' ' ILE . . . . . 0.546 HD11 ' HB2' ' A' ' 145' ' ' PHE . 66.3 mt -88.74 118.48 34.22 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.432 0 CA-C-N 115.855 -0.611 . . . . 72.35 109.449 -176.206 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 157' ' ' THR . . . . . . . . . . . . . 30.7 p -131.15 156.09 45.88 Favored 'General case' 0 C--O 1.239 0.534 0 C-N-CA 124.469 1.108 . . . . 74.04 109.382 -174.931 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 158' ' ' ILE . . . . . . . . . . . . . 60.1 mt -77.96 94.15 1.46 Allowed 'Isoleucine or valine' 0 CA--C 1.55 0.946 0 N-CA-C 108.926 -0.768 . . . . 64.02 108.926 172.572 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 159' ' ' ALA . . . . . 0.75 ' HB2' ' HB2' ' A' ' 11' ' ' ALA . . . -51.9 -40.88 61.43 Favored 'General case' 0 N--CA 1.488 1.439 0 C-N-CA 124.551 1.14 . . . . 61.34 113.03 -177.932 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 160' ' ' ASP . . . . . . . . . . . . . 25.3 t0 -164.36 157.74 17.87 Favored 'General case' 0 N--CA 1.478 0.958 0 C-N-CA 122.946 0.498 . . . . 73.12 110.311 178.718 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 161' ' ' CYS . . . . . . . . . . . . . 29.2 p -119.82 -169.97 1.87 Allowed 'General case' 0 N--CA 1.475 0.779 0 C-N-CA 124.774 1.229 . . . . 75.42 108.36 175.398 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 162' ' ' GLY . . . . . . . . . . . . . . . 132.49 55.02 0.08 OUTLIER Glycine 0 C--N 1.347 1.156 0 N-CA-C 111.095 -0.802 . . . . 54.33 111.095 -170.393 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 163' ' ' GLN . . . . . 0.635 ' HA ' ' H ' ' A' ' 7' ' ' PHE . 3.0 pt20 -49.63 137.49 15.54 Favored 'General case' 0 CA--C 1.55 0.961 0 N-CA-C 114.357 1.243 . . . . 63.54 114.357 -169.296 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 164' ' ' LEU . . . . . 0.415 ' O ' ' HB ' ' A' ' 5' ' ' THR . 85.2 mt . . . . . 0 N--CA 1.472 0.644 0 CA-C-N 115.859 -0.61 . . . . 62.34 110.114 -176.502 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 218' ' ' PRO . . . . . 0.693 ' HB2' HE22 ' A' ' 111' ' ' GLN . 50.2 Cg_exo . . . . . 0 CA--C 1.543 0.94 0 CA-C-O 121.209 0.42 . . . . 61.52 112.484 . . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 219' ' ' GLY . . . . . . . . . . . . . . . 169.37 -176.47 43.36 Favored Glycine 0 CA--C 1.524 0.607 0 N-CA-C 110.164 -1.174 . . . . 43.52 110.164 -178.489 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 220' ' ' PRO . . . . . . . . . . . . . 82.4 Cg_endo -79.56 -177.59 3.97 Favored 'Trans proline' 0 CA--C 1.553 1.425 0 C-N-CA 122.519 2.146 . . . . 75.25 113.88 175.211 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 221' ' ' TYR . . . . . 0.504 ' HE2' ' HD2' ' A' ' 125' ' ' LYS . 64.4 m-85 . . . . . 0 N--CA 1.476 0.872 0 C-N-CA 123.852 0.861 . . . . 71.4 110.237 -178.051 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 3' ' ' ASN . . . . . 0.477 ' OD1' ' HA ' ' A' ' 25' ' ' PHE . 4.3 m-80 . . . . . 0 N--CA 1.478 0.954 0 CA-C-O 118.888 -0.577 . . . . 75.1 110.838 . . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 4' ' ' PRO . . . . . 0.645 ' HG2' ' HB2' ' A' ' 24' ' ' LEU . 67.2 Cg_endo -72.66 136.74 26.24 Favored 'Trans proline' 0 C--N 1.374 1.872 0 C-N-CA 122.144 1.896 . . . . 64.21 111.653 176.37 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 5' ' ' THR . . . . . 0.608 HG23 ' HD3' ' A' ' 133' ' ' LYS . 85.5 m -95.99 113.56 25.19 Favored 'General case' 0 C--O 1.236 0.368 0 N-CA-C 107.893 -1.151 . . . . 73.13 107.893 176.002 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 6' ' ' VAL . . . . . 0.556 ' HA ' ' HB2' ' A' ' 163' ' ' GLN . 13.7 m -98.62 121.1 48.8 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.51 0 CA-C-O 121.956 0.884 . . . . 75.23 109.328 -178.22 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 7' ' ' PHE . . . . . 0.436 ' H ' ' HA ' ' A' ' 163' ' ' GLN . 77.3 t80 -105.08 135.09 47.08 Favored 'General case' 0 C--O 1.239 0.52 0 CA-C-N 114.423 -1.262 . . . . 70.21 109.237 -173.328 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 8' ' ' PHE . . . . . 0.44 ' HB3' HG23 ' A' ' 158' ' ' ILE . 64.4 m-85 -142.27 165.25 27.94 Favored 'General case' 0 C--O 1.24 0.578 0 O-C-N 124.398 1.061 . . . . 64.24 109.757 176.11 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 17.4 m-20 -113.91 108.51 17.15 Favored 'General case' 0 N--CA 1.465 0.314 0 N-CA-C 107.625 -1.25 . . . . 71.11 107.625 171.637 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 10' ' ' ILE . . . . . 0.441 HG21 ' SD ' ' A' ' 142' ' ' MET . 47.3 mm -80.7 116.82 25.61 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.351 0 N-CA-C 108.313 -0.995 . . . . 52.01 108.313 -179.545 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 11' ' ' ALA . . . . . 0.688 ' HB2' ' HB2' ' A' ' 159' ' ' ALA . . . -116.04 109.92 18.2 Favored 'General case' 0 N--CA 1.469 0.493 0 C-N-CA 123.684 0.794 . . . . 70.42 111.941 -168.586 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 12' ' ' VAL . . . . . 0.502 HG21 HD22 ' A' ' 17' ' ' LEU . 89.6 t -96.04 128.91 46.81 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.467 0 N-CA-C 108.057 -1.09 . . . . 75.01 108.057 176.684 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 25.0 m-20 70.24 15.94 7.4 Favored 'General case' 0 N--CA 1.493 1.688 0 C-N-CA 124.218 1.007 . . . . 74.55 110.484 -172.325 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 81.29 -5.89 65.92 Favored Glycine 0 C--N 1.353 1.507 0 CA-C-N 116.005 -0.543 . . . . 65.42 112.754 -170.505 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 25.7 mm-40 -98.32 120.81 58.68 Favored Pre-proline 0 N--CA 1.471 0.599 0 C-N-CA 123.823 0.849 . . . . 64.24 109.437 -178.213 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 52.3 Cg_exo -51.21 105.19 0.1 OUTLIER 'Trans proline' 0 C--N 1.375 1.963 0 C-N-CA 123.257 2.638 . . . . 60.14 112.344 178.536 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 17' ' ' LEU . . . . . 0.502 HD22 HG21 ' A' ' 12' ' ' VAL . 26.9 tp -75.08 -31.69 61.27 Favored 'General case' 0 N--CA 1.472 0.67 0 C-N-CA 124.126 0.97 . . . . 61.21 109.573 -179.892 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -175.66 173.15 46.07 Favored Glycine 0 C--N 1.341 0.814 0 CA-C-N 115.071 -0.968 . . . . 64.52 112.054 175.925 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 19' ' ' ARG . . . . . 0.428 ' HD2' ' HZ ' ' A' ' 7' ' ' PHE . 47.6 mtm180 -107.2 124.39 49.66 Favored 'General case' 0 N--CA 1.471 0.595 0 N-CA-C 108.541 -0.911 . . . . 74.21 108.541 -179.095 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 71.3 t -120.74 141.45 41.11 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.881 0 C-N-CA 123.1 0.56 . . . . 71.52 109.9 -176.945 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 21' ' ' SER . . . . . 0.551 ' HB2' ' HB2' ' A' ' 134' ' ' GLU . 60.6 m -127.39 132.14 50.2 Favored 'General case' 0 C--O 1.245 0.828 0 C-N-CA 123.878 0.871 . . . . 64.35 109.39 173.533 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 17.3 m-85 -107.42 153.67 22.45 Favored 'General case' 0 N--CA 1.469 0.513 0 N-CA-C 108.338 -0.986 . . . . 72.23 108.338 177.729 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 5.8 tp10 -104.75 109.64 21.67 Favored 'General case' 0 C--O 1.239 0.543 0 N-CA-C 108.598 -0.889 . . . . 73.45 108.598 176.954 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 24' ' ' LEU . . . . . 0.645 ' HB2' ' HG2' ' A' ' 4' ' ' PRO . 29.6 mt -81.11 122.77 27.77 Favored 'General case' 0 N--CA 1.465 0.285 0 N-CA-C 108.784 -0.821 . . . . 53.05 108.784 175.309 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 25' ' ' PHE . . . . . 0.508 ' HB2' HD11 ' A' ' 90' ' ' LEU . 86.9 m-85 -84.91 65.46 9.2 Favored 'General case' 0 N--CA 1.467 0.377 0 C-N-CA 123.166 0.586 . . . . 75.21 110.468 179.888 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -64.17 -24.16 67.58 Favored 'General case' 0 N--CA 1.477 0.877 0 C-N-CA 123.418 0.687 . . . . 65.15 111.876 -179.799 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 10.9 p-10 -66.09 -25.73 67.15 Favored 'General case' 0 N--CA 1.476 0.853 0 C-N-CA 123.535 0.734 . . . . 73.33 111.33 177.467 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 52.4 mttm -102.32 -43.93 5.55 Favored 'General case' 0 N--CA 1.478 0.962 0 C-N-CA 124.163 0.985 . . . . 63.14 110.238 -179.433 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 29' ' ' VAL . . . . . 0.443 HG21 ' HA ' ' A' ' 129' ' ' PHE . 16.0 m -127.31 78.85 74.03 Favored Pre-proline 0 CA--C 1.556 1.194 0 C-N-CA 124.128 0.971 . . . . 43.23 109.942 -177.11 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 11.3 Cg_endo -55.21 -48.02 23.09 Favored 'Trans proline' 0 C--N 1.383 2.373 0 C-N-CA 123.038 2.492 . . . . 74.44 112.89 -177.792 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 31' ' ' LYS . . . . . 0.446 ' HG3' ' OH ' ' A' ' 79' ' ' TYR . 23.4 ttmm -76.86 -43.48 35.96 Favored 'General case' 0 N--CA 1.474 0.771 0 C-N-CA 123.967 0.907 . . . . 74.35 112.344 -172.631 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 9.1 m -69.14 -33.36 73.33 Favored 'General case' 0 CA--C 1.549 0.94 0 CA-C-O 120.867 0.365 . . . . 51.53 110.273 -176.062 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -78.43 -34.52 47.81 Favored 'General case' 0 CA--C 1.55 0.976 0 CA-C-N 116.112 -0.494 . . . . 64.32 111.533 174.03 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 29.7 tt0 -60.32 -41.58 93.8 Favored 'General case' 0 N--CA 1.49 1.555 0 C-N-CA 124.421 1.088 . . . . 64.04 111.077 178.536 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 35' ' ' ASN . . . . . 0.478 ' O ' ' HG ' ' A' ' 39' ' ' LEU . 40.9 t30 -54.15 -60.16 3.7 Favored 'General case' 0 CA--C 1.537 0.448 0 CA-C-N 114.297 -1.32 . . . . 75.32 110.191 178.635 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 63.1 t80 -65.48 -32.51 74.16 Favored 'General case' 0 CA--C 1.545 0.76 0 CA-C-N 115.225 -0.898 . . . . 71.52 111.613 -176.695 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 37.0 ttm-85 -57.02 -50.98 71.06 Favored 'General case' 0 N--CA 1.482 1.139 0 C-N-CA 124.028 0.931 . . . . 75.4 110.346 177.195 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 38' ' ' ALA . . . . . 0.538 ' HB3' HG21 ' A' ' 78' ' ' ILE . . . -79.26 -23.33 43.73 Favored 'General case' 0 CA--C 1.545 0.766 0 CA-C-N 115.029 -0.987 . . . . 73.34 112.22 -175.24 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 39' ' ' LEU . . . . . 0.478 ' HG ' ' O ' ' A' ' 35' ' ' ASN . 85.7 mt -71.78 -40.19 69.42 Favored 'General case' 0 N--CA 1.483 1.221 0 C-N-CA 123.004 0.522 . . . . 52.21 110.158 172.899 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 28.8 t -65.48 -55.05 20.03 Favored 'General case' 0 N--CA 1.475 0.805 0 C-N-CA 124.513 1.125 . . . . 54.44 110.682 -179.368 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 20.8 p -67.73 -32.07 72.43 Favored 'General case' 0 N--CA 1.477 0.894 0 CA-C-N 116.08 -0.509 . . . . 73.54 111.411 177.284 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 71.21 28.18 70.52 Favored Glycine 0 C--N 1.343 0.972 0 CA-C-N 115.686 -0.688 . . . . 53.32 112.838 -176.662 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 19.4 mm-40 -62.85 -31.07 72.01 Favored 'General case' 0 N--CA 1.479 0.992 0 C-N-CA 123.268 0.627 . . . . 75.33 111.461 177.62 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 44' ' ' LYS . . . . . 0.403 ' HG2' ' HB1' ' A' ' 38' ' ' ALA . 75.7 mmtt -83.98 9.44 12.33 Favored 'General case' 0 CA--C 1.556 1.197 0 CA-C-N 115.706 -0.679 . . . . 74.42 111.592 178.062 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 76.1 32.51 52.39 Favored Glycine 0 C--N 1.352 1.455 0 C-N-CA 123.146 0.403 . . . . 64.31 113.706 175.711 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 17.9 m-85 -110.28 -47.23 3.32 Favored 'General case' 0 N--CA 1.483 1.182 0 N-CA-C 109.654 -0.498 . . . . 75.33 109.654 179.453 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 56.66 65.58 3.47 Favored Glycine 0 C--N 1.354 1.548 0 O-C-N 124.107 0.879 . . . . 53.03 114.21 168.627 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 48' ' ' TYR . . . . . 0.472 ' HE1' HD22 ' A' ' 39' ' ' LEU . 51.3 m-85 -65.25 87.33 0.07 Allowed 'General case' 0 N--CA 1.476 0.848 0 CA-C-O 122.644 1.212 . . . . 74.1 111.237 -179.378 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 50.6 tptt -111.13 134.83 52.42 Favored 'General case' 0 C--O 1.244 0.812 0 CA-C-N 112.698 -2.046 . . . . 73.35 107.655 -179.486 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 65.22 21.86 68.6 Favored Glycine 0 N--CA 1.468 0.823 0 CA-C-O 119.57 -0.572 . . . . 75.21 113.032 -179.321 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 28.1 t -57.98 114.24 2.25 Favored 'General case' 0 C--N 1.362 1.11 0 C-N-CA 123.688 0.795 . . . . 64.12 109.946 -176.379 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 52' ' ' CYS . . . . . . . . . . . . . 45.2 t -83.31 137.37 34.0 Favored 'General case' 0 C--O 1.241 0.619 0 CA-C-N 115.437 -0.802 . . . . 60.13 111.757 -166.872 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 53' ' ' PHE . . . . . 0.747 ' HA ' ' HA2' ' A' ' 64' ' ' GLY . 38.6 m-85 -87.2 115.65 24.75 Favored 'General case' 0 C--O 1.238 0.474 0 N-CA-C 107.886 -1.153 . . . . 75.25 107.886 169.647 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 47.3 p-80 -99.5 -29.71 12.58 Favored 'General case' 0 N--CA 1.48 1.072 0 C-N-CA 123.278 0.631 . . . . 74.1 111.153 -175.748 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 55' ' ' ARG . . . . . 0.527 ' HA ' ' O ' ' A' ' 150' ' ' GLY . 59.5 ttt180 -132.92 98.96 4.44 Favored 'General case' 0 C--O 1.218 -0.588 0 CA-C-N 115.78 -0.646 . . . . 73.43 109.412 -168.805 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 56' ' ' ILE . . . . . 0.504 HD12 HD12 ' A' ' 156' ' ' ILE . 47.5 mt -123.67 124.36 69.23 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.813 0 N-CA-C 109.162 -0.681 . . . . 73.14 109.162 178.564 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 57' ' ' ILE . . . . . 0.414 HG12 ' HA2' ' A' ' 150' ' ' GLY . 45.4 mt -126.61 112.16 22.83 Favored Pre-proline 0 CA--C 1.561 1.372 0 C-N-CA 124.87 1.268 . . . . 63.43 109.242 -170.985 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 71.0 Cg_exo -54.32 145.11 57.57 Favored 'Trans proline' 0 C--N 1.374 1.879 0 C-N-CA 123.924 3.083 . . . . 74.44 115.024 176.848 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 64.72 21.06 66.89 Favored Glycine 0 C--N 1.351 1.414 0 CA-C-N 114.643 -1.162 . . . . 54.22 113.71 -179.772 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 60' ' ' PHE . . . . . 0.441 ' HE1' ' HE1' ' A' ' 121' ' ' TRP . 33.1 t80 -144.42 -76.61 0.22 Allowed 'General case' 0 C--O 1.242 0.667 0 C-N-CA 123.099 0.559 . . . . 63.33 110.639 -171.09 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 61' ' ' MET . . . . . 0.664 ' SD ' ' HB2' ' A' ' 113' ' ' PHE . 12.3 tmm? -174.89 144.85 0.81 Allowed 'General case' 0 CA--C 1.543 0.711 0 O-C-N 123.457 0.473 . . . . 73.1 111.341 -162.187 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 62' ' ' CYS . . . . . 0.513 ' SG ' ' HB ' ' A' ' 114' ' ' ILE . 8.1 p -113.78 112.66 23.78 Favored 'General case' 0 CA--C 1.552 1.054 0 C-N-CA 124.25 1.02 . . . . 65.11 109.653 172.827 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 63' ' ' GLN . . . . . 0.63 ' HB2' ' SD ' ' A' ' 61' ' ' MET . 49.6 tt0 -103.05 114.49 28.83 Favored 'General case' 0 N--CA 1.485 1.32 0 C-N-CA 124.248 1.019 . . . . 75.02 111.129 -171.145 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 64' ' ' GLY . . . . . 0.747 ' HA2' ' HA ' ' A' ' 53' ' ' PHE . . . -98.95 -169.62 30.93 Favored Glycine 0 C--O 1.244 0.72 0 CA-C-N 114.863 -1.062 . . . . 71.52 112.111 175.597 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 72.92 87.14 0.19 Allowed Glycine 0 C--N 1.337 0.632 0 N-CA-C 111.062 -0.815 . . . . 64.21 111.062 -178.178 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 38.8 t70 -128.04 -38.46 1.82 Allowed 'General case' 0 N--CA 1.469 0.525 0 C-N-CA 122.825 0.45 . . . . 74.23 111.474 -179.518 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 77.0 t80 -70.83 -68.56 0.42 Allowed 'General case' 0 CA--C 1.552 1.043 0 N-CA-C 113.505 0.928 . . . . 61.45 113.505 -164.812 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 48.9 m -60.04 109.37 0.94 Allowed 'General case' 0 N--CA 1.482 1.141 0 C-N-CA 123.62 0.768 . . . . 65.12 112.038 -168.797 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 69' ' ' ARG . . . . . 0.557 ' HD3' ' HD3' ' A' ' 76' ' ' LYS . 73.3 mtp180 57.93 69.18 0.76 Allowed 'General case' 0 C--N 1.352 0.686 0 C-N-CA 124.763 1.225 . . . . 72.43 110.637 -170.856 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 24.5 p-80 -79.89 66.71 5.45 Favored 'General case' 0 N--CA 1.476 0.854 0 CA-C-O 122.128 0.966 . . . . 72.03 111.939 -176.921 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 15.5 m120 -119.68 20.74 12.26 Favored 'General case' 0 N--CA 1.476 0.832 0 C-N-CA 124.51 1.124 . . . . 74.43 108.628 173.898 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 100.67 -8.1 58.05 Favored Glycine 0 C--N 1.349 1.26 0 CA-C-N 115.302 -0.863 . . . . 72.32 112.519 -170.747 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 10.2 m -81.59 -61.8 1.83 Allowed 'General case' 0 N--CA 1.475 0.78 0 CA-C-N 117.589 0.694 . . . . 73.53 109.286 179.376 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 48.37 47.61 28.18 Favored Glycine 0 C--N 1.351 1.368 0 O-C-N 124.146 0.904 . . . . 43.5 115.309 170.236 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 138.11 51.37 0.06 OUTLIER Glycine 0 N--CA 1.474 1.218 0 CA-C-N 118.532 1.166 . . . . 53.52 113.382 -178.388 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 76' ' ' LYS . . . . . 0.557 ' HD3' ' HD3' ' A' ' 69' ' ' ARG . 22.8 pttp -61.35 160.26 11.07 Favored 'General case' 0 CA--C 1.556 1.177 0 C-N-CA 123.71 0.804 . . . . 74.3 111.95 179.85 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 87.1 p -91.3 164.5 13.84 Favored 'General case' 0 N--CA 1.483 1.206 0 C-N-CA 123.693 0.797 . . . . 75.12 111.685 -171.266 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 78' ' ' ILE . . . . . 0.538 HG21 ' HB3' ' A' ' 38' ' ' ALA . 45.6 pt -65.18 -15.89 19.16 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.397 0 N-CA-C 112.396 0.517 . . . . 72.03 112.396 179.89 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 79' ' ' TYR . . . . . 0.446 ' OH ' ' HG3' ' A' ' 31' ' ' LYS . 32.3 m-85 -89.79 -32.4 16.96 Favored 'General case' 0 N--CA 1.472 0.629 0 C-N-CA 123.647 0.779 . . . . 73.02 110.833 179.216 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 171.79 -137.53 4.36 Favored Glycine 0 C--N 1.339 0.726 0 CA-C-N 116.046 -0.524 . . . . 61.33 112.141 179.43 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 35.3 tt0 -65.31 -40.39 93.7 Favored 'General case' 0 CA--C 1.544 0.715 0 C-N-CA 123.375 0.67 . . . . 73.22 110.617 176.249 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 82' ' ' LYS . . . . . 0.652 ' HD2' ' HA ' ' A' ' 107' ' ' THR . 23.3 pttm -170.97 178.68 3.34 Favored 'General case' 0 CA--C 1.549 0.932 0 C-N-CA 124.129 0.971 . . . . 74.43 110.125 -173.79 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 18.9 p90 -154.11 173.18 16.4 Favored 'General case' 0 N--CA 1.477 0.907 0 C-N-CA 124.682 1.193 . . . . 71.23 110.067 -177.026 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 84' ' ' GLU . . . . . 0.512 ' HA ' ' HA ' ' A' ' 106' ' ' ASN . 14.2 pt-20 -90.79 154.23 19.67 Favored 'General case' 0 C--O 1.24 0.575 0 CA-C-O 121.023 0.439 . . . . 74.01 110.875 -179.9 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 35.2 m-20 -64.83 130.61 44.1 Favored 'General case' 0 CA--C 1.536 0.436 0 CA-C-N 114.799 -1.091 . . . . 75.42 111.446 -175.185 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 28.3 tt0 -72.54 -60.83 2.04 Favored 'General case' 0 CA--C 1.54 0.592 0 C-N-CA 123.302 0.641 . . . . 64.03 111.972 -173.276 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 31.0 p30 -164.74 158.28 17.48 Favored 'General case' 0 N--CA 1.475 0.809 0 C-N-CA 122.679 0.392 . . . . 43.3 111.124 -179.069 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 93.1 m-85 -103.35 38.32 1.8 Allowed 'General case' 0 N--CA 1.479 0.975 0 C-N-CA 123.765 0.826 . . . . 62.11 111.217 -172.413 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 64.9 mt -66.02 -52.41 49.05 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.075 0 C-N-CA 123.039 0.535 . . . . 74.45 110.42 177.317 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 90' ' ' LEU . . . . . 0.508 HD11 ' HB2' ' A' ' 25' ' ' PHE . 62.0 mt -83.17 139.82 32.94 Favored 'General case' 0 N--CA 1.473 0.691 0 CA-C-N 115.894 -0.594 . . . . 64.32 111.846 -177.009 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 91' ' ' LYS . . . . . 0.479 ' HZ3' ' HB3' ' A' ' 91' ' ' LYS . 9.2 mtpm? -124.27 167.6 14.1 Favored 'General case' 0 N--CA 1.471 0.59 0 C-N-CA 124.377 1.071 . . . . 75.12 109.604 177.751 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 92' ' ' HIS . . . . . . . . . . . . . 24.9 m-70 -86.52 62.16 7.25 Favored 'General case' 0 CA--C 1.544 0.736 0 C-N-CA 124.173 0.989 . . . . 71.01 108.861 176.3 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 93' ' ' THR . . . . . 0.435 HG23 ' HB2' ' A' ' 91' ' ' LYS . 21.9 p -83.92 -33.97 24.61 Favored 'General case' 0 N--CA 1.473 0.709 0 CA-C-N 115.132 -0.94 . . . . 75.43 111.563 -175.112 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -121.11 -177.42 15.63 Favored Glycine 0 C--N 1.342 0.888 0 CA-C-N 116.07 -0.514 . . . . 65.42 112.876 -177.201 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 79.2 Cg_endo -85.26 158.1 11.15 Favored 'Trans proline' 0 CA--C 1.553 1.449 0 C-N-CA 123.281 2.654 . . . . 64.0 112.099 173.024 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 83.07 17.67 66.72 Favored Glycine 0 N--CA 1.47 0.911 0 CA-C-N 116.054 -0.521 . . . . 74.43 114.126 179.043 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 97' ' ' ILE . . . . . 0.58 ' HB ' ' HB2' ' A' ' 115' ' ' CYS . 31.6 mm -66.47 102.99 0.51 Allowed 'Isoleucine or valine' 0 CA--C 1.549 0.934 0 C-N-CA 123.64 0.776 . . . . 73.01 111.774 -174.6 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 98' ' ' LEU . . . . . 0.467 HD13 HG12 ' A' ' 114' ' ' ILE . 58.1 tp -85.74 105.73 16.48 Favored 'General case' 0 CA--C 1.551 0.991 0 C-N-CA 123.44 0.696 . . . . 74.54 109.68 177.598 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 47.8 t -126.66 135.39 51.11 Favored 'General case' 0 N--CA 1.468 0.467 0 C-N-CA 124.69 1.196 . . . . 74.14 108.78 178.308 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 100' ' ' MET . . . . . 0.502 ' SD ' ' HA2' ' A' ' 109' ' ' GLY . 14.3 ttt -78.8 135.77 37.17 Favored 'General case' 0 N--CA 1.474 0.761 0 N-CA-C 108.343 -0.984 . . . . 72.24 108.343 -179.357 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -74.5 158.16 34.27 Favored 'General case' 0 CA--C 1.545 0.783 0 N-CA-C 112.916 0.71 . . . . 61.4 112.916 -167.462 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 22.2 p-10 -158.09 169.07 25.36 Favored 'General case' 0 N--CA 1.476 0.868 0 CA-C-N 115.542 -0.754 . . . . 75.32 110.759 -179.692 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 103' ' ' ALA . . . . . 0.453 ' HB3' HG21 ' A' ' 107' ' ' THR . . . -113.96 -1.14 13.88 Favored 'General case' 0 N--CA 1.476 0.839 0 CA-C-N 115.492 -0.777 . . . . 74.33 110.758 171.721 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 160.22 -165.59 34.89 Favored Glycine 0 C--N 1.354 1.536 0 CA-C-O 119.668 -0.518 . . . . 71.24 113.056 178.891 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 26.6 Cg_exo -64.03 134.74 44.29 Favored 'Trans proline' 0 C--N 1.376 1.997 0 C-N-CA 123.529 2.819 . . . . 71.44 112.266 178.355 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 106' ' ' ASN . . . . . 0.512 ' HA ' ' HA ' ' A' ' 84' ' ' GLU . 65.0 t30 66.82 14.24 9.73 Favored 'General case' 0 N--CA 1.485 1.32 0 C-N-CA 124.534 1.134 . . . . 41.43 111.212 -179.102 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 107' ' ' THR . . . . . 0.652 ' HA ' ' HD2' ' A' ' 82' ' ' LYS . 2.3 m -115.11 7.26 15.36 Favored 'General case' 0 CA--C 1.549 0.923 0 C-N-CA 124.208 1.003 . . . . 73.2 109.918 -178.874 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 55.1 t30 -88.67 139.51 30.4 Favored 'General case' 0 N--CA 1.476 0.865 0 C-N-CA 123.248 0.619 . . . . 73.23 110.097 -177.397 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 109' ' ' GLY . . . . . 0.502 ' HA2' ' SD ' ' A' ' 100' ' ' MET . . . 113.07 25.35 4.49 Favored Glycine 0 N--CA 1.464 0.534 0 CA-C-O 120.204 -0.22 . . . . 64.44 112.772 -175.553 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 5.1 m -132.72 126.2 31.96 Favored 'General case' 0 CA--C 1.541 0.623 0 N-CA-C 108.013 -1.106 . . . . 65.24 108.013 170.206 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 10.5 mt-30 64.52 175.81 0.19 Allowed 'General case' 0 N--CA 1.504 2.23 0 C-N-CA 125.25 1.42 . . . . 65.22 110.82 -174.615 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 54.9 p90 -148.41 159.21 44.25 Favored 'General case' 0 N--CA 1.486 1.366 0 O-C-N 121.603 -0.686 . . . . 71.45 109.865 174.681 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 113' ' ' PHE . . . . . 0.664 ' HB2' ' SD ' ' A' ' 61' ' ' MET . 55.1 p90 -146.26 147.07 31.03 Favored 'General case' 0 N--CA 1.469 0.502 0 CA-C-O 121.109 0.481 . . . . 71.11 111.452 177.625 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 114' ' ' ILE . . . . . 0.513 ' HB ' ' SG ' ' A' ' 62' ' ' CYS . 13.9 mt -117.5 102.67 13.75 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.536 0 N-CA-C 108.071 -1.085 . . . . 72.4 108.071 -179.044 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 115' ' ' CYS . . . . . 0.58 ' HB2' ' HB ' ' A' ' 97' ' ' ILE . 33.7 m -68.16 105.23 2.02 Favored 'General case' 0 CA--C 1.539 0.544 0 C-N-CA 123.305 0.642 . . . . 61.01 109.601 -179.632 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 116' ' ' THR . . . . . 0.477 HG22 HG12 ' A' ' 139' ' ' VAL . 41.3 p -70.32 -30.4 67.37 Favored 'General case' 0 N--CA 1.475 0.797 0 C-N-CA 124.009 0.924 . . . . 51.34 110.822 -175.876 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -112.32 159.64 18.46 Favored 'General case' 0 C--O 1.243 0.725 0 N-CA-C 108.115 -1.069 . . . . 71.1 108.115 169.231 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -68.73 98.84 0.94 Allowed 'General case' 0 CA--C 1.542 0.661 0 CA-C-O 121.383 0.611 . . . . 73.22 109.491 176.669 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 119' ' ' THR . . . . . . . . . . . . . 33.9 p -81.66 85.35 6.58 Favored 'General case' 0 C--O 1.239 0.502 0 CA-C-O 121.778 0.799 . . . . 75.54 109.471 -179.183 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 12.1 pt-20 -72.25 -22.51 61.22 Favored 'General case' 0 N--CA 1.473 0.68 0 CA-C-N 114.805 -1.089 . . . . 74.5 112.001 -170.862 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 121' ' ' TRP . . . . . 0.441 ' HE1' ' HE1' ' A' ' 60' ' ' PHE . 26.8 p90 -69.79 -10.28 57.8 Favored 'General case' 0 N--CA 1.477 0.91 0 C-N-CA 123.261 0.624 . . . . 72.04 111.863 175.572 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 122' ' ' LEU . . . . . 0.547 ' HA ' ' HE2' ' A' ' 125' ' ' LYS . 79.3 mt -94.71 7.6 45.27 Favored 'General case' 0 N--CA 1.475 0.825 0 C-N-CA 122.952 0.501 . . . . 75.51 111.716 176.375 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 74.3 m-20 -80.59 148.38 30.33 Favored 'General case' 0 N--CA 1.478 0.945 0 N-CA-C 109.757 -0.46 . . . . 41.13 109.757 172.247 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 77.29 22.38 70.82 Favored Glycine 0 C--N 1.344 1.01 0 N-CA-C 111.992 -0.443 . . . . 42.44 111.992 -170.02 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 125' ' ' LYS . . . . . 0.547 ' HE2' ' HA ' ' A' ' 122' ' ' LEU . 27.1 mtmm -142.4 -167.47 2.5 Favored 'General case' 0 CA--C 1.545 0.759 0 C-N-CA 124.647 1.179 . . . . 72.55 110.356 -175.091 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 126' ' ' HIS . . . . . . . . . . . . . 14.7 p-80 -64.72 157.67 26.81 Favored 'General case' 0 N--CA 1.475 0.785 0 C-N-CA 124.502 1.121 . . . . 62.12 113.955 -160.425 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 46.7 t -63.85 127.42 24.32 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.719 0 CA-C-N 113.337 -1.756 . . . . 72.03 113.627 -164.142 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 86.9 t -84.26 146.66 6.46 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.481 0 N-CA-C 108.034 -1.099 . . . . 73.2 108.034 164.196 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 129' ' ' PHE . . . . . 0.443 ' HA ' HG21 ' A' ' 29' ' ' VAL . 50.6 p90 -134.85 -6.38 2.42 Favored 'General case' 0 N--CA 1.478 0.965 0 CA-C-N 118.287 0.494 . . . . 73.55 111.721 -179.375 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . -150.02 168.44 30.07 Favored Glycine 0 C--N 1.342 0.869 0 C-N-CA 121.479 -0.391 . . . . 41.4 113.276 -175.402 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 32.2 ttpt -156.0 139.42 15.81 Favored 'General case' 0 N--CA 1.467 0.385 0 N-CA-C 107.861 -1.162 . . . . 74.55 107.861 175.04 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 132' ' ' VAL . . . . . 0.462 HG11 ' HA ' ' A' ' 136' ' ' MET . 21.8 t -64.0 114.48 2.11 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.717 0 CA-C-N 118.303 0.501 . . . . 74.21 109.871 179.733 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 133' ' ' LYS . . . . . 0.608 ' HD3' HG23 ' A' ' 5' ' ' THR . 21.6 ptmt -92.79 -30.62 15.39 Favored 'General case' 0 N--CA 1.478 0.944 0 C-N-CA 122.737 0.415 . . . . 70.23 109.884 178.861 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 134' ' ' GLU . . . . . 0.551 ' HB2' ' HB2' ' A' ' 21' ' ' SER . 41.4 mt-10 -142.49 135.8 28.74 Favored 'General case' 0 N--CA 1.473 0.725 0 C-N-CA 124.313 1.045 . . . . 63.31 109.657 -173.121 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 77.84 32.92 43.54 Favored Glycine 0 CA--C 1.531 1.076 0 O-C-N 123.327 0.392 . . . . 70.35 113.406 178.505 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 136' ' ' MET . . . . . 0.462 ' HA ' HG11 ' A' ' 132' ' ' VAL . 14.2 tpt -65.08 -35.31 80.75 Favored 'General case' 0 N--CA 1.482 1.148 0 C-N-CA 123.133 0.573 . . . . 63.32 111.643 -179.553 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 137' ' ' ASN . . . . . . . . . . . . . 18.2 m120 -67.1 -23.72 65.86 Favored 'General case' 0 N--CA 1.481 1.087 0 C-N-CA 123.294 0.638 . . . . 70.24 111.543 179.968 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 138' ' ' ILE . . . . . . . . . . . . . 36.7 mm -75.67 -37.96 37.09 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.063 0 C-N-CA 123.252 0.621 . . . . 72.41 109.61 175.913 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 139' ' ' VAL . . . . . 0.477 HG12 HG22 ' A' ' 116' ' ' THR . 95.9 t -63.5 -39.73 86.43 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.022 0 C-N-CA 123.592 0.757 . . . . 73.31 110.205 173.494 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 47.2 mt-10 -76.4 -20.68 56.88 Favored 'General case' 0 N--CA 1.474 0.774 0 CA-C-N 115.374 -0.83 . . . . 72.54 111.674 177.973 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -74.92 -50.66 16.07 Favored 'General case' 0 N--CA 1.471 0.594 0 C-N-CA 122.642 0.377 . . . . 55.34 110.387 173.939 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 142' ' ' MET . . . . . 0.652 ' HB2' HD13 ' A' ' 156' ' ' ILE . 18.3 ptt? -66.59 -28.15 68.28 Favored 'General case' 0 N--CA 1.483 1.182 0 C-N-CA 122.923 0.489 . . . . 71.24 111.63 -179.221 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 24.5 tt0 -47.46 -47.36 27.19 Favored 'General case' 0 N--CA 1.482 1.173 0 C-N-CA 125.28 1.432 . . . . 70.25 111.224 170.484 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 144' ' ' ARG . . . . . . . . . . . . . 88.6 mtt180 -85.78 -6.82 59.06 Favored 'General case' 0 CA--C 1.541 0.607 0 CA-C-N 114.123 -1.399 . . . . 74.32 111.678 -173.075 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 145' ' ' PHE . . . . . 0.51 ' HD2' ' HA ' ' A' ' 142' ' ' MET . 49.6 m-85 -89.48 2.5 54.47 Favored 'General case' 0 N--CA 1.479 1.005 0 C-N-CA 122.871 0.468 . . . . 64.11 110.448 168.149 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . -96.58 -170.55 34.42 Favored Glycine 0 C--N 1.349 1.267 0 CA-C-N 115.877 -0.602 . . . . 62.34 111.992 168.364 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 44.2 t -134.68 155.12 51.08 Favored 'General case' 0 N--CA 1.473 0.702 0 C-N-CA 124.191 0.996 . . . . 61.15 109.681 -177.833 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 148' ' ' ARG . . . . . . . . . . . . . 20.2 mmm-85 -62.24 -31.86 72.47 Favored 'General case' 0 N--CA 1.478 0.969 0 C-N-CA 123.916 0.886 . . . . 71.3 112.484 -173.055 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 149' ' ' ASN . . . . . . . . . . . . . 25.6 p-10 -76.97 -19.5 57.25 Favored 'General case' 0 N--CA 1.484 1.247 0 C-N-CA 123.021 0.528 . . . . 61.43 111.764 -179.464 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 150' ' ' GLY . . . . . 0.527 ' O ' ' HA ' ' A' ' 55' ' ' ARG . . . 119.64 -6.05 12.68 Favored Glycine 0 C--N 1.349 1.253 0 CA-C-O 119.702 -0.499 . . . . 74.4 113.367 -177.826 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 38.2 ttmt -66.62 141.15 57.91 Favored 'General case' 0 N--CA 1.474 0.747 0 CA-C-N 117.657 0.729 . . . . 65.24 110.553 177.041 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 152' ' ' THR . . . . . . . . . . . . . 18.1 p -92.46 115.26 27.93 Favored 'General case' 0 CA--C 1.538 0.488 0 N-CA-C 108.771 -0.825 . . . . 70.12 108.771 166.373 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 153' ' ' SER . . . . . . . . . . . . . 10.3 m -74.2 -21.03 59.99 Favored 'General case' 0 CA--C 1.545 0.758 0 CA-C-O 121.355 0.598 . . . . 60.41 110.295 179.624 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 71.7 mmtt -124.8 150.33 46.45 Favored 'General case' 0 N--CA 1.467 0.423 0 C-N-CA 124.537 1.135 . . . . 73.14 110.267 176.325 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 3.9 tppp? -79.92 94.96 5.96 Favored 'General case' 0 C--O 1.242 0.69 0 N-CA-C 108.927 -0.768 . . . . 74.33 108.927 173.478 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 156' ' ' ILE . . . . . 0.652 HD13 ' HB2' ' A' ' 142' ' ' MET . 60.8 mt -101.45 124.13 55.0 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.155 0 CA-C-N 114.972 -1.013 . . . . 70.15 108.621 -178.575 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 157' ' ' THR . . . . . . . . . . . . . 31.6 p -138.78 157.78 45.44 Favored 'General case' 0 N--CA 1.47 0.56 0 C-N-CA 124.567 1.147 . . . . 73.25 109.256 -173.686 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 158' ' ' ILE . . . . . 0.44 HG23 ' HB3' ' A' ' 8' ' ' PHE . 59.3 mt -80.24 94.28 2.12 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.72 0 N-CA-C 108.5 -0.926 . . . . 52.14 108.5 169.773 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 159' ' ' ALA . . . . . 0.688 ' HB2' ' HB2' ' A' ' 11' ' ' ALA . . . -52.76 -53.69 44.47 Favored 'General case' 0 N--CA 1.481 1.105 0 C-N-CA 124.114 0.966 . . . . 64.13 112.357 -177.852 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 160' ' ' ASP . . . . . . . . . . . . . 26.9 t0 -148.54 157.66 43.61 Favored 'General case' 0 N--CA 1.471 0.618 0 CA-C-N 115.808 -0.633 . . . . 75.44 110.091 -173.557 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 161' ' ' CYS . . . . . . . . . . . . . 28.0 p -129.23 -170.62 2.31 Favored 'General case' 0 CA--C 1.539 0.543 0 C-N-CA 124.922 1.289 . . . . 71.12 108.513 176.888 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 162' ' ' GLY . . . . . . . . . . . . . . . 132.35 53.07 0.08 OUTLIER Glycine 0 C--N 1.342 0.906 0 N-CA-C 110.708 -0.957 . . . . 44.3 110.708 -168.442 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 163' ' ' GLN . . . . . 0.556 ' HB2' ' HA ' ' A' ' 6' ' ' VAL . 13.2 pt20 -55.99 143.73 31.22 Favored 'General case' 0 CA--C 1.544 0.749 0 C-N-CA 124.487 1.115 . . . . 72.43 113.097 -174.293 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 164' ' ' LEU . . . . . . . . . . . . . 77.5 mt . . . . . 0 CA--C 1.539 0.524 0 CA-C-N 115.404 -0.816 . . . . 74.14 110.277 -176.724 . . . . . . . . 0 0 . 1 . 013 nuclear build core ' B' B ' 218' ' ' PRO . . . . . . . . . . . . . 37.3 Cg_exo . . . . . 0 CA--C 1.542 0.924 0 N-CA-C 110.494 -0.618 . . . . 70.53 110.494 . . . . . . . . . 0 0 . 1 . 013 nuclear build core ' B' B ' 219' ' ' GLY . . . . . . . . . . . . . . . 171.1 171.49 36.39 Favored Glycine 0 CA--C 1.527 0.786 0 CA-C-N 116.283 -0.417 . . . . 24.42 112.776 -179.59 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 220' ' ' PRO . . . . . . . . . . . . . 97.6 Cg_endo -85.02 -169.17 0.59 Allowed 'Trans proline' 0 C--N 1.371 1.739 0 C-N-CA 123.429 2.752 . . . . 62.51 113.496 -178.785 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 221' ' ' TYR . . . . . . . . . . . . . 96.8 m-85 . . . . . 0 N--CA 1.483 1.177 0 C-N-CA 123.781 0.833 . . . . 61.2 109.742 179.111 . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 70.0 m-20 . . . . . 0 CA--C 1.545 0.757 0 CA-C-O 119.248 -0.406 . . . . 72.34 110.043 . . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 6.7 Cg_endo -80.73 152.68 19.7 Favored 'Trans proline' 0 C--N 1.371 1.755 0 C-N-CA 122.429 2.086 . . . . 65.01 110.963 173.872 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 5' ' ' THR . . . . . 0.46 ' HB ' ' O ' ' A' ' 164' ' ' LEU . 93.2 m -96.15 142.72 28.0 Favored 'General case' 0 CA--C 1.549 0.912 0 C-N-CA 123.096 0.558 . . . . 74.01 109.638 178.643 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 6' ' ' VAL . . . . . 0.665 ' HA ' ' HG3' ' A' ' 163' ' ' GLN . 29.1 t -110.37 147.12 14.8 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.436 0 N-CA-C 107.222 -1.399 . . . . 74.33 107.222 177.333 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 7' ' ' PHE . . . . . 0.536 ' H ' ' HA ' ' A' ' 163' ' ' GLN . 65.0 t80 -125.59 126.29 44.54 Favored 'General case' 0 C--O 1.238 0.468 0 N-CA-C 108.916 -0.772 . . . . 74.31 108.916 178.905 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 8' ' ' PHE . . . . . 0.541 ' HD2' ' HE2' ' A' ' 22' ' ' PHE . 33.9 m-85 -134.56 165.28 25.57 Favored 'General case' 0 N--CA 1.47 0.557 0 C-N-CA 124.074 0.95 . . . . 73.54 109.701 169.25 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 23.7 m-20 -118.27 117.33 28.83 Favored 'General case' 0 C--N 1.327 -0.406 0 N-CA-C 107.311 -1.366 . . . . 75.12 107.311 171.152 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 42.4 mm -90.05 136.12 24.61 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.823 0 N-CA-C 108.672 -0.862 . . . . 71.31 108.672 178.506 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 11' ' ' ALA . . . . . 0.662 ' HB2' ' HB2' ' A' ' 159' ' ' ALA . . . -135.47 122.27 21.07 Favored 'General case' 0 N--CA 1.478 0.951 0 C-N-CA 123.44 0.696 . . . . 65.24 111.666 -170.513 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 12' ' ' VAL . . . . . 0.442 HG22 HG12 ' A' ' 156' ' ' ILE . 62.4 t -95.94 122.99 47.95 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.709 0 C-N-CA 124.186 0.994 . . . . 71.02 108.962 176.846 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 42.3 m-20 64.1 23.09 13.11 Favored 'General case' 0 N--CA 1.491 1.616 0 C-N-CA 125.331 1.452 . . . . 74.12 110.836 -172.932 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 83.38 -13.21 47.41 Favored Glycine 0 C--N 1.351 1.384 0 CA-C-O 119.571 -0.572 . . . . 73.21 113.067 -173.079 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 37.8 mm-40 -83.49 117.23 68.04 Favored Pre-proline 0 C--N 1.353 0.759 0 C-N-CA 123.553 0.741 . . . . 63.13 109.981 177.863 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 93.1 Cg_exo -46.7 106.36 0.1 OUTLIER 'Trans proline' 0 C--N 1.379 2.134 0 C-N-CA 124.072 3.182 . . . . 61.03 113.891 -179.411 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 43.3 tp -76.08 -40.96 51.92 Favored 'General case' 0 N--CA 1.48 1.055 0 C-N-CA 123.705 0.802 . . . . 71.11 109.66 179.319 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -179.77 172.22 43.88 Favored Glycine 0 C--N 1.345 1.047 0 O-C-N 123.367 0.417 . . . . 24.11 112.957 178.386 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 13.2 ptm180 -105.82 124.47 49.61 Favored 'General case' 0 N--CA 1.473 0.71 0 N-CA-C 108.255 -1.017 . . . . 74.04 108.255 -177.988 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 51.8 t -120.89 137.91 53.08 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.407 0 C-N-CA 123.692 0.797 . . . . 74.25 109.382 -175.14 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 21' ' ' SER . . . . . 0.497 ' HB2' ' HB2' ' A' ' 134' ' ' GLU . 51.7 m -121.18 125.25 46.68 Favored 'General case' 0 C--O 1.248 1.004 0 C-N-CA 123.706 0.802 . . . . 73.42 109.519 176.677 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 22' ' ' PHE . . . . . 0.541 ' HE2' ' HD2' ' A' ' 8' ' ' PHE . 57.4 m-85 -100.81 169.95 8.65 Favored 'General case' 0 N--CA 1.474 0.735 0 C-N-CA 123.833 0.853 . . . . 72.21 109.358 178.47 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 23' ' ' GLU . . . . . 0.545 ' HB2' ' HD2' ' A' ' 133' ' ' LYS . 37.7 tt0 -138.32 112.31 8.48 Favored 'General case' 0 CA--C 1.543 0.684 0 C-N-CA 123.156 0.582 . . . . 74.02 109.632 -179.513 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 24' ' ' LEU . . . . . 0.414 HD22 ' HD1' ' A' ' 129' ' ' PHE . 62.1 mt -84.12 136.48 33.98 Favored 'General case' 0 N--CA 1.478 0.951 0 C-N-CA 123.692 0.797 . . . . 65.1 110.804 -176.784 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 32.7 m-85 -85.65 64.29 8.54 Favored 'General case' 0 CA--C 1.546 0.805 0 CA-C-O 121.186 0.517 . . . . 73.35 109.642 175.886 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -72.91 1.03 9.52 Favored 'General case' 0 N--CA 1.486 1.364 0 N-CA-C 113.125 0.787 . . . . 55.4 113.125 -175.407 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 11.7 p-10 -87.33 -24.3 24.34 Favored 'General case' 0 CA--C 1.548 0.896 0 C-N-CA 123.555 0.742 . . . . 64.13 111.096 174.433 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 97.7 mttt -114.02 -35.02 5.21 Favored 'General case' 0 N--CA 1.489 1.489 0 C-N-CA 123.692 0.797 . . . . 70.21 111.12 -176.339 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 29' ' ' VAL . . . . . 0.505 HG21 ' HA ' ' A' ' 129' ' ' PHE . 6.7 m -128.85 71.15 81.46 Favored Pre-proline 0 CA--C 1.553 1.074 0 C-N-CA 123.927 0.891 . . . . 73.0 110.209 175.333 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 15.3 Cg_exo -66.03 -33.96 39.64 Favored 'Trans proline' 0 C--N 1.381 2.244 0 C-N-CA 122.567 2.178 . . . . 73.54 111.104 -179.13 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 87.7 tttt -63.51 -57.19 10.97 Favored 'General case' 0 CA--C 1.54 0.575 0 C-N-CA 124.796 1.238 . . . . 75.01 111.083 -179.17 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 6.5 m -68.98 -30.46 68.87 Favored 'General case' 0 CA--C 1.554 1.098 0 C-N-CA 123.613 0.765 . . . . 61.33 111.292 -174.964 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -71.81 -40.03 69.42 Favored 'General case' 0 CA--C 1.548 0.904 0 C-N-CA 123.403 0.681 . . . . 45.03 111.347 175.894 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 9.3 tp10 -71.81 -34.26 69.2 Favored 'General case' 0 N--CA 1.482 1.136 0 C-N-CA 123.436 0.695 . . . . 75.14 110.154 -178.458 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 35' ' ' ASN . . . . . 0.419 ' O ' ' HG ' ' A' ' 39' ' ' LEU . 40.1 t30 -57.98 -54.82 42.66 Favored 'General case' 0 N--CA 1.474 0.738 0 CA-C-N 114.527 -1.215 . . . . 64.22 109.766 173.526 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 74.2 t80 -58.91 -42.01 88.62 Favored 'General case' 0 CA--C 1.543 0.701 0 O-C-N 124.742 1.276 . . . . 73.1 111.096 -177.874 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 36.3 ttm180 -55.58 -57.14 13.18 Favored 'General case' 0 C--N 1.358 0.958 0 O-C-N 123.766 0.666 . . . . 63.14 110.394 175.629 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 38' ' ' ALA . . . . . 0.515 ' HB1' ' HG2' ' A' ' 44' ' ' LYS . . . -63.62 -32.96 74.6 Favored 'General case' 0 C--O 1.243 0.732 0 O-C-N 124.041 0.838 . . . . 60.02 112.129 -173.078 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 39' ' ' LEU . . . . . 0.566 HD22 ' HE2' ' A' ' 48' ' ' TYR . 74.2 mt -65.56 -45.0 85.02 Favored 'General case' 0 N--CA 1.475 0.792 0 O-C-N 124.147 0.904 . . . . 70.53 111.02 176.517 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 41.2 m -76.42 -49.45 16.67 Favored 'General case' 0 N--CA 1.475 0.814 0 C-N-CA 123.408 0.683 . . . . 41.24 112.01 -174.31 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 41' ' ' THR . . . . . 0.426 ' OG1' ' HG2' ' A' ' 43' ' ' GLU . 67.6 p -76.53 -31.48 57.67 Favored 'General case' 0 N--CA 1.471 0.609 0 C-N-CA 124.204 1.002 . . . . 71.12 111.647 -174.138 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 92.57 26.44 17.62 Favored Glycine 0 C--N 1.349 1.25 0 CA-C-O 119.683 -0.509 . . . . 74.35 113.071 -179.677 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 43' ' ' GLU . . . . . 0.426 ' HG2' ' OG1' ' A' ' 41' ' ' THR . 19.9 mm-40 -63.39 -22.97 67.2 Favored 'General case' 0 N--CA 1.483 1.213 0 C-N-CA 123.086 0.555 . . . . 63.32 111.69 174.31 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 44' ' ' LYS . . . . . 0.515 ' HG2' ' HB1' ' A' ' 38' ' ' ALA . 75.8 mmtt -114.38 16.43 17.81 Favored 'General case' 0 N--CA 1.482 1.149 0 C-N-CA 123.63 0.772 . . . . 73.53 111.022 177.242 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 93.41 -25.06 22.57 Favored Glycine 0 C--N 1.355 1.627 0 N-CA-C 114.794 0.677 . . . . 75.23 114.794 174.893 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 46' ' ' PHE . . . . . 0.424 ' HE2' ' HA ' ' A' ' 78' ' ' ILE . 21.8 m-85 -68.77 -48.22 64.22 Favored 'General case' 0 N--CA 1.479 0.992 0 C-N-CA 122.953 0.501 . . . . 75.12 111.846 -167.407 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 40.97 62.05 1.82 Allowed Glycine 0 C--N 1.358 1.786 0 O-C-N 124.975 1.422 . . . . 75.42 115.321 169.92 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 48' ' ' TYR . . . . . 0.566 ' HE2' HD22 ' A' ' 39' ' ' LEU . 97.3 m-85 -62.88 90.76 0.04 OUTLIER 'General case' 0 N--CA 1.476 0.859 0 CA-C-O 121.478 0.656 . . . . 74.41 111.52 -176.678 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 3.7 tppp? -105.24 125.81 51.4 Favored 'General case' 0 C--O 1.232 0.148 0 N-CA-C 108.328 -0.989 . . . . 72.3 108.328 175.05 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 80.96 20.23 65.72 Favored Glycine 0 CA--C 1.524 0.636 0 CA-C-O 119.681 -0.511 . . . . 51.14 112.742 -175.427 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 51' ' ' SER . . . . . 0.414 ' HB2' ' HB3' ' A' ' 48' ' ' TYR . 36.0 t -62.38 118.41 7.45 Favored 'General case' 0 C--N 1.354 0.786 0 N-CA-C 109.032 -0.729 . . . . 70.42 109.032 176.9 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 52' ' ' CYS . . . . . . . . . . . . . 25.6 p -86.75 129.48 34.86 Favored 'General case' 0 CA--C 1.536 0.425 0 C-N-CA 123.54 0.736 . . . . 64.01 111.645 -170.577 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 53' ' ' PHE . . . . . 0.65 ' HA ' ' HA2' ' A' ' 64' ' ' GLY . 46.5 m-85 -76.79 74.4 3.43 Favored 'General case' 0 CA--C 1.538 0.516 0 N-CA-C 108.353 -0.98 . . . . 73.25 108.353 168.415 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 27.1 p-80 -75.0 -22.84 58.27 Favored 'General case' 0 N--CA 1.476 0.868 0 CA-C-N 115.146 -0.934 . . . . 74.45 111.522 -174.674 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 55' ' ' ARG . . . . . 0.41 ' HA ' ' O ' ' A' ' 150' ' ' GLY . 38.4 ttt180 -112.96 99.41 7.84 Favored 'General case' 0 C--O 1.218 -0.601 0 N-CA-C 109.108 -0.701 . . . . 72.03 109.108 178.238 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 42.7 mt -127.63 137.86 56.44 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.643 0 N-CA-C 108.47 -0.937 . . . . 75.41 108.47 171.747 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 57' ' ' ILE . . . . . 0.687 HG23 ' HA ' ' A' ' 148' ' ' ARG . 70.2 mt -134.56 125.3 17.52 Favored Pre-proline 0 CA--C 1.553 1.08 0 C-N-CA 124.811 1.244 . . . . 72.43 108.621 -176.267 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 58' ' ' PRO . . . . . 0.411 ' HA ' ' HG2' ' A' ' 143' ' ' GLU . 84.3 Cg_endo -76.82 145.41 25.42 Favored 'Trans proline' 0 C--N 1.375 1.943 0 C-N-CA 122.687 2.258 . . . . 73.43 112.15 -177.606 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 70.04 25.48 75.55 Favored Glycine 0 C--N 1.342 0.868 0 CA-C-N 115.398 -0.819 . . . . 53.54 112.653 -175.486 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 60' ' ' PHE . . . . . 0.4 ' HD2' ' HB ' ' A' ' 57' ' ' ILE . 36.5 t80 -151.57 -73.58 0.15 Allowed 'General case' 0 C--O 1.247 0.95 0 C-N-CA 122.835 0.454 . . . . 74.12 111.172 -171.646 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 61' ' ' MET . . . . . 0.543 ' SD ' ' HB2' ' A' ' 113' ' ' PHE . 38.8 ttm -176.79 143.9 0.46 Allowed 'General case' 0 N--CA 1.482 1.166 0 N-CA-C 112.445 0.535 . . . . 63.02 112.445 -159.06 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 62' ' ' CYS . . . . . 0.472 ' SG ' HG13 ' A' ' 139' ' ' VAL . 25.1 p -112.72 112.45 23.96 Favored 'General case' 0 CA--C 1.55 0.962 0 N-CA-C 109.018 -0.734 . . . . 75.3 109.018 169.344 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 63' ' ' GLN . . . . . 0.528 ' HA ' ' HA ' ' A' ' 113' ' ' PHE . 51.4 tt0 -105.43 120.68 42.21 Favored 'General case' 0 N--CA 1.485 1.284 0 C-N-CA 124.248 1.019 . . . . 74.33 111.503 -175.185 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 64' ' ' GLY . . . . . 0.65 ' HA2' ' HA ' ' A' ' 53' ' ' PHE . . . -91.84 148.75 19.38 Favored Glycine 0 C--N 1.347 1.16 0 CA-C-N 115.206 -0.906 . . . . 75.11 112.34 176.403 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 65' ' ' GLY . . . . . 0.517 ' HA3' ' HG2' ' A' ' 111' ' ' GLN . . . -176.84 131.25 1.8 Allowed Glycine 0 C--N 1.338 0.656 0 N-CA-C 111.984 -0.447 . . . . 73.2 111.984 179.511 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 33.2 t70 -75.99 165.35 25.09 Favored 'General case' 0 CA--C 1.547 0.846 0 C-N-CA 123.046 0.538 . . . . 72.45 111.31 -175.613 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 90.2 t80 -64.92 -32.88 74.81 Favored 'General case' 0 C--O 1.245 0.853 0 C-N-CA 123.665 0.786 . . . . 72.34 111.365 178.176 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 33.9 m -60.81 112.67 2.13 Favored 'General case' 0 C--N 1.354 0.772 0 C-N-CA 122.985 0.514 . . . . 73.34 111.254 -177.057 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 69' ' ' ARG . . . . . 0.43 ' HD3' ' HG3' ' A' ' 81' ' ' GLU . 81.1 mtt85 65.33 28.01 11.9 Favored 'General case' 0 CA--C 1.547 0.843 0 O-C-N 124.618 1.199 . . . . 74.44 112.02 178.381 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 15.4 p80 -55.18 -25.41 32.44 Favored 'General case' 0 N--CA 1.498 1.969 0 C-N-CA 123.529 0.732 . . . . 70.01 112.759 -174.571 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 11.2 m120 -77.5 87.84 3.84 Favored 'General case' 0 CA--C 1.544 0.747 0 C-N-CA 123.849 0.86 . . . . 64.31 109.373 174.353 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 91.25 -1.2 76.46 Favored Glycine 0 N--CA 1.474 1.213 0 CA-C-O 119.4 -0.667 . . . . 63.45 114.61 175.381 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 73' ' ' THR . . . . . 0.461 ' HA ' ' HB2' ' A' ' 110' ' ' SER . 96.2 m -140.31 -92.16 0.16 Allowed 'General case' 0 CA--C 1.558 1.277 0 CA-C-N 117.738 0.769 . . . . 71.23 110.046 172.951 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 81.67 43.66 8.27 Favored Glycine 0 C--N 1.359 1.84 0 CA-C-N 118.279 0.491 . . . . 73.51 113.985 176.684 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 140.79 53.46 0.04 OUTLIER Glycine 0 C--N 1.346 1.095 0 CA-C-N 117.552 0.676 . . . . 74.32 111.495 -176.482 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 76' ' ' LYS . . . . . 0.503 ' HB2' ' HA ' ' A' ' 81' ' ' GLU . 13.9 ptmm? -56.09 162.86 1.76 Allowed 'General case' 0 N--CA 1.483 1.182 0 C-N-CA 124.026 0.93 . . . . 73.22 112.749 -174.541 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 87.3 p -94.49 -177.77 4.35 Favored 'General case' 0 C--O 1.243 0.734 0 C-N-CA 122.995 0.518 . . . . 63.03 111.345 -170.775 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 78' ' ' ILE . . . . . 0.51 HG21 ' HB3' ' A' ' 38' ' ' ALA . 20.9 pt -88.59 -12.38 10.21 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.889 0 CA-C-N 115.56 -0.746 . . . . 65.42 110.668 173.985 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 42.9 m-85 -88.17 -24.62 23.27 Favored 'General case' 0 N--CA 1.472 0.646 0 C-N-CA 123.935 0.894 . . . . 73.3 109.662 178.476 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 167.86 -145.29 9.58 Favored Glycine 0 C--N 1.346 1.084 0 CA-C-N 115.365 -0.834 . . . . 72.05 111.095 176.827 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 81' ' ' GLU . . . . . 0.503 ' HA ' ' HB2' ' A' ' 76' ' ' LYS . 36.3 tt0 -69.16 -34.93 75.74 Favored 'General case' 0 CA--C 1.543 0.709 0 C-N-CA 123.293 0.637 . . . . 71.54 110.06 174.475 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 82' ' ' LYS . . . . . 0.706 ' HD2' ' HA ' ' A' ' 107' ' ' THR . 20.6 pttp -169.99 177.2 4.41 Favored 'General case' 0 N--CA 1.476 0.842 0 C-N-CA 124.733 1.213 . . . . 71.33 109.047 178.397 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 46.5 p90 -146.78 173.49 12.33 Favored 'General case' 0 N--CA 1.474 0.767 0 C-N-CA 123.651 0.78 . . . . 71.13 110.563 -179.208 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 13.5 pt-20 -88.34 158.99 18.26 Favored 'General case' 0 N--CA 1.475 0.821 0 C-N-CA 123.055 0.542 . . . . 73.21 110.208 177.917 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 27.0 m-20 -60.81 118.64 6.91 Favored 'General case' 0 N--CA 1.477 0.924 0 C-N-CA 124.376 1.071 . . . . 74.25 109.967 -179.337 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 20.6 tp10 -66.79 -59.01 3.92 Favored 'General case' 0 N--CA 1.479 0.983 0 C-N-CA 123.133 0.573 . . . . 63.31 111.198 -175.158 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 26.4 p30 -143.01 -174.46 4.19 Favored 'General case' 0 N--CA 1.47 0.543 0 C-N-CA 123.757 0.823 . . . . 74.32 109.593 179.966 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 79.8 m-85 -136.27 39.54 2.69 Favored 'General case' 0 N--CA 1.481 1.082 0 C-N-CA 123.591 0.756 . . . . 75.25 109.754 -179.325 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 60.5 mt -69.01 -62.07 1.42 Allowed 'Isoleucine or valine' 0 N--CA 1.477 0.9 0 CA-C-N 115.431 -0.804 . . . . 74.42 110.966 -178.806 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 90' ' ' LEU . . . . . 0.696 ' H ' HG23 ' A' ' 127' ' ' VAL . 66.1 mt -87.55 140.96 28.99 Favored 'General case' 0 C--O 1.238 0.492 0 CA-C-N 115.539 -0.755 . . . . 65.25 110.678 -171.748 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 55.3 mtpt -125.5 168.83 13.09 Favored 'General case' 0 N--CA 1.47 0.526 0 C-N-CA 124.152 0.981 . . . . 53.12 110.174 -174.285 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 92' ' ' HIS . . . . . 0.415 ' HA ' HG21 ' A' ' 97' ' ' ILE . 43.5 m80 -92.88 51.28 1.67 Allowed 'General case' 0 N--CA 1.48 1.026 0 C-N-CA 124.235 1.014 . . . . 62.24 109.503 -174.486 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 41.3 p -84.3 -7.12 59.42 Favored 'General case' 0 N--CA 1.472 0.632 0 CA-C-N 114.476 -1.238 . . . . 73.33 112.799 -171.371 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -143.5 -179.57 20.2 Favored Glycine 0 C--N 1.347 1.164 0 CA-C-O 120.117 -0.268 . . . . 41.44 113.057 -177.12 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 82.1 Cg_endo -82.4 158.21 17.06 Favored 'Trans proline' 0 C--N 1.367 1.523 0 C-N-CA 123.412 2.741 . . . . 73.31 112.561 175.241 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 73.83 18.83 79.69 Favored Glycine 0 CA--C 1.531 1.059 0 CA-C-N 115.524 -0.762 . . . . 71.21 114.467 178.867 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 97' ' ' ILE . . . . . 0.415 HG21 ' HA ' ' A' ' 92' ' ' HIS . 17.0 mm -78.93 108.28 12.33 Favored 'Isoleucine or valine' 0 CA--C 1.562 1.428 0 CA-C-N 117.533 0.666 . . . . 71.1 112.466 -171.824 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 98' ' ' LEU . . . . . 0.636 ' HG ' HG12 ' A' ' 114' ' ' ILE . 7.6 mp -87.21 117.93 26.29 Favored 'General case' 0 N--CA 1.488 1.468 0 C-N-CA 123.535 0.734 . . . . 74.2 111.033 175.923 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 99' ' ' SER . . . . . 0.644 ' HB3' ' HA ' ' A' ' 128' ' ' VAL . 2.7 p -139.78 143.5 36.93 Favored 'General case' 0 N--CA 1.476 0.874 0 N-CA-C 108.306 -0.998 . . . . 74.4 108.306 173.707 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 100' ' ' MET . . . . . 0.473 ' HA ' ' HA ' ' A' ' 112' ' ' PHE . 49.7 mtp -76.23 138.9 40.91 Favored 'General case' 0 N--CA 1.485 1.31 0 N-CA-C 109.689 -0.486 . . . . 75.14 109.689 -171.491 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 101' ' ' ALA . . . . . 0.549 ' HB3' ' HB2' ' A' ' 111' ' ' GLN . . . -75.69 158.25 32.57 Favored 'General case' 0 N--CA 1.481 1.082 0 CA-C-O 121.216 0.531 . . . . 75.13 111.635 -170.48 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 30.4 p-10 -162.67 163.13 27.13 Favored 'General case' 0 CA--C 1.537 0.453 0 CA-C-N 114.95 -1.023 . . . . 74.43 110.131 -179.361 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -103.91 1.67 31.61 Favored 'General case' 0 N--CA 1.473 0.707 0 C-N-CA 124.203 1.001 . . . . 75.54 110.196 169.686 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 149.45 -164.41 29.39 Favored Glycine 0 C--N 1.345 1.031 0 CA-C-O 119.273 -0.737 . . . . 61.14 111.466 -178.269 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 53.2 Cg_exo -56.89 141.73 93.14 Favored 'Trans proline' 0 C--N 1.368 1.6 0 C-N-CA 123.286 2.657 . . . . 75.14 112.795 175.978 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 63.9 t30 68.46 10.18 7.71 Favored 'General case' 0 N--CA 1.495 1.788 0 C-N-CA 125.102 1.361 . . . . 73.24 112.332 179.526 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 107' ' ' THR . . . . . 0.706 ' HA ' ' HD2' ' A' ' 82' ' ' LYS . 2.4 m -113.1 0.23 14.9 Favored 'General case' 0 CA--C 1.551 0.997 0 O-C-N 121.511 -0.743 . . . . 74.35 110.775 178.307 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 57.5 t30 -70.76 155.57 40.6 Favored 'General case' 0 N--CA 1.481 1.108 0 C-N-CA 123.784 0.834 . . . . 74.25 110.738 -178.034 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 89.76 0.73 78.13 Favored Glycine 0 N--CA 1.468 0.773 0 CA-C-N 116.713 -0.221 . . . . 52.34 113.55 179.026 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 110' ' ' SER . . . . . 0.461 ' HB2' ' HA ' ' A' ' 73' ' ' THR . 79.6 p -100.25 120.64 40.22 Favored 'General case' 0 CA--C 1.531 0.22 0 N-CA-C 108.012 -1.107 . . . . 65.23 108.012 173.731 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 111' ' ' GLN . . . . . 0.549 ' HB2' ' HB3' ' A' ' 101' ' ' ALA . 49.4 mt-30 62.53 176.57 0.14 Allowed 'General case' 0 N--CA 1.492 1.66 0 C-N-CA 123.609 0.764 . . . . 75.53 111.769 -174.839 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 112' ' ' PHE . . . . . 0.473 ' HA ' ' HA ' ' A' ' 100' ' ' MET . 29.1 p90 -147.13 133.71 19.85 Favored 'General case' 0 N--CA 1.471 0.622 0 N-CA-C 108.021 -1.103 . . . . 72.41 108.021 172.932 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 113' ' ' PHE . . . . . 0.543 ' HB2' ' SD ' ' A' ' 61' ' ' MET . 46.4 p90 -113.49 134.3 54.75 Favored 'General case' 0 C--O 1.239 0.539 0 CA-C-O 121.235 0.54 . . . . 71.34 110.751 178.349 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 114' ' ' ILE . . . . . 0.636 HG12 ' HG ' ' A' ' 98' ' ' LEU . 22.1 mt -99.96 101.04 11.56 Favored 'Isoleucine or valine' 0 C--O 1.239 0.532 0 N-CA-C 108.047 -1.094 . . . . 70.42 108.047 176.612 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 115' ' ' CYS . . . . . 0.414 ' SG ' ' HD2' ' A' ' 92' ' ' HIS . 32.4 m -65.92 103.78 0.99 Allowed 'General case' 0 N--CA 1.467 0.388 0 N-CA-C 108.611 -0.885 . . . . 73.33 108.611 174.485 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 116' ' ' THR . . . . . 0.521 HG22 HG12 ' A' ' 139' ' ' VAL . 35.6 p -70.04 -28.86 65.81 Favored 'General case' 0 N--CA 1.48 1.05 0 C-N-CA 123.707 0.803 . . . . 61.42 110.675 -177.206 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -119.49 168.25 11.16 Favored 'General case' 0 C--O 1.243 0.72 0 C-N-CA 124.051 0.941 . . . . 63.21 109.279 171.159 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 13.3 ptmm? -72.55 89.3 1.28 Allowed 'General case' 0 C--O 1.246 0.89 0 CA-C-O 121.657 0.742 . . . . 74.34 110.3 178.1 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 119' ' ' THR . . . . . 0.506 ' HB ' HD13 ' A' ' 122' ' ' LEU . 37.6 p -71.22 89.2 0.85 Allowed 'General case' 0 CA--C 1.542 0.651 0 CA-C-O 122.0 0.905 . . . . 54.33 108.971 176.829 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 9.5 pt-20 -75.98 -21.44 56.95 Favored 'General case' 0 N--CA 1.475 0.788 0 CA-C-N 114.578 -1.192 . . . . 63.04 111.773 -171.486 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 121' ' ' TRP . . . . . . . . . . . . . 33.1 p90 -77.18 -0.84 26.58 Favored 'General case' 0 CA--C 1.549 0.937 0 C-N-CA 123.581 0.752 . . . . 64.11 110.829 172.35 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 122' ' ' LEU . . . . . 0.564 ' HA ' ' HE2' ' A' ' 125' ' ' LYS . 10.9 mp -101.97 7.04 41.5 Favored 'General case' 0 N--CA 1.474 0.727 0 C-N-CA 123.682 0.793 . . . . 74.05 110.879 170.832 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 93.8 m-20 -84.82 128.09 34.45 Favored 'General case' 0 N--CA 1.475 0.776 0 N-CA-C 109.588 -0.523 . . . . 53.51 109.588 173.558 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 94.42 7.41 60.55 Favored Glycine 0 C--N 1.345 1.043 0 N-CA-C 111.69 -0.564 . . . . 62.22 111.69 -168.454 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 125' ' ' LYS . . . . . 0.564 ' HE2' ' HA ' ' A' ' 122' ' ' LEU . 19.4 ttmm -104.26 -167.39 1.35 Allowed 'General case' 0 CA--C 1.552 1.049 0 C-N-CA 124.918 1.287 . . . . 73.35 108.375 179.021 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 126' ' ' HIS . . . . . 0.508 ' H ' ' HG2' ' A' ' 125' ' ' LYS . 42.5 p-80 -67.75 155.61 38.89 Favored 'General case' 0 C--O 1.244 0.769 0 CA-C-O 121.245 0.545 . . . . 74.35 111.672 -175.575 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 127' ' ' VAL . . . . . 0.696 HG23 ' H ' ' A' ' 90' ' ' LEU . 11.0 p -64.0 148.37 11.67 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.938 0 CA-C-N 113.988 -1.46 . . . . 53.42 112.99 -174.537 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 128' ' ' VAL . . . . . 0.644 ' HA ' ' HB3' ' A' ' 99' ' ' SER . 94.7 t -81.39 155.57 4.17 Favored 'Isoleucine or valine' 0 CA--C 1.551 1.0 0 C-N-CA 125.421 1.488 . . . . 71.25 109.23 172.055 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 129' ' ' PHE . . . . . 0.505 ' HA ' HG21 ' A' ' 29' ' ' VAL . 48.7 p90 -119.35 -24.33 6.41 Favored 'General case' 0 N--CA 1.487 1.383 0 CA-C-N 118.549 0.613 . . . . 71.01 111.603 177.416 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . -158.88 177.1 35.61 Favored Glycine 0 C--N 1.344 1.01 0 O-C-N 123.183 0.302 . . . . 45.2 112.468 -174.92 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 34.4 ttpt -153.33 147.41 25.58 Favored 'General case' 0 N--CA 1.472 0.671 0 C-N-CA 123.484 0.714 . . . . 74.45 109.3 -179.877 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 132' ' ' VAL . . . . . 0.442 HG22 ' HE1' ' A' ' 22' ' ' PHE . 16.9 t -68.29 120.33 15.55 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.552 0 N-CA-C 109.253 -0.647 . . . . 74.23 109.253 176.203 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 133' ' ' LYS . . . . . 0.545 ' HD2' ' HB2' ' A' ' 23' ' ' GLU . 20.6 ptmt -100.2 -33.54 10.39 Favored 'General case' 0 N--CA 1.477 0.895 0 N-CA-C 109.584 -0.524 . . . . 61.23 109.584 176.49 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 134' ' ' GLU . . . . . 0.497 ' HB2' ' HB2' ' A' ' 21' ' ' SER . 31.5 mt-10 -144.29 149.63 36.57 Favored 'General case' 0 N--CA 1.478 0.97 0 C-N-CA 125.166 1.387 . . . . 71.53 108.654 -178.516 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 83.43 17.44 66.47 Favored Glycine 0 C--N 1.339 0.742 0 N-CA-C 112.182 -0.367 . . . . 61.12 112.182 -177.701 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 136' ' ' MET . . . . . . . . . . . . . 15.7 tpt -64.01 -34.78 78.79 Favored 'General case' 0 C--N 1.354 0.796 0 C-N-CA 123.863 0.865 . . . . 73.11 110.913 -179.527 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 137' ' ' ASN . . . . . . . . . . . . . 27.3 t-20 -58.75 -42.31 88.57 Favored 'General case' 0 CA--C 1.542 0.644 0 C-N-CA 123.588 0.755 . . . . 73.21 110.568 174.049 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 138' ' ' ILE . . . . . . . . . . . . . 48.9 mm -67.67 -35.64 73.44 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.956 0 C-N-CA 123.331 0.652 . . . . 74.25 110.657 178.925 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 139' ' ' VAL . . . . . 0.521 HG12 HG22 ' A' ' 116' ' ' THR . 94.3 t -65.8 -37.98 81.15 Favored 'Isoleucine or valine' 0 CA--C 1.559 1.32 0 C-N-CA 123.941 0.896 . . . . 51.24 110.93 176.772 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 39.0 mt-10 -77.02 -27.55 54.63 Favored 'General case' 0 N--CA 1.48 1.04 0 C-N-CA 123.537 0.735 . . . . 74.42 111.186 177.625 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -72.65 -46.98 51.27 Favored 'General case' 0 N--CA 1.48 1.069 0 C-N-CA 123.338 0.655 . . . . 51.44 110.305 178.717 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 142' ' ' MET . . . . . 0.538 ' HA ' ' HD2' ' A' ' 145' ' ' PHE . 27.3 ptm -68.48 -30.34 69.16 Favored 'General case' 0 N--CA 1.475 0.81 0 CA-C-N 115.475 -0.784 . . . . 73.43 110.962 178.106 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 143' ' ' GLU . . . . . 0.411 ' HG2' ' HA ' ' A' ' 58' ' ' PRO . 35.8 tt0 -55.11 -42.26 72.69 Favored 'General case' 0 C--N 1.364 1.203 0 O-C-N 123.807 0.692 . . . . 74.43 111.361 174.71 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 144' ' ' ARG . . . . . . . . . . . . . 51.5 mtp180 -64.79 -22.91 67.09 Favored 'General case' 0 N--CA 1.473 0.715 0 CA-C-N 115.376 -0.829 . . . . 74.04 112.189 -178.233 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 145' ' ' PHE . . . . . 0.538 ' HD2' ' HA ' ' A' ' 142' ' ' MET . 47.7 m-85 -83.53 -1.02 52.79 Favored 'General case' 0 N--CA 1.479 0.987 0 C-N-CA 122.768 0.427 . . . . 54.42 111.876 179.426 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 146' ' ' GLY . . . . . 0.522 ' HA2' ' HA ' ' A' ' 152' ' ' THR . . . -96.71 172.06 28.17 Favored Glycine 0 C--N 1.342 0.867 0 N-CA-C 112.687 -0.165 . . . . 61.21 112.687 177.597 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 16.2 m -128.1 156.48 42.75 Favored 'General case' 0 N--CA 1.481 1.112 0 C-N-CA 123.845 0.858 . . . . 74.23 109.801 -178.332 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 148' ' ' ARG . . . . . 0.687 ' HA ' HG23 ' A' ' 57' ' ' ILE . 26.2 mmm-85 -58.53 -31.66 68.13 Favored 'General case' 0 N--CA 1.48 1.048 0 C-N-CA 124.595 1.158 . . . . 72.15 113.279 -174.359 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 149' ' ' ASN . . . . . . . . . . . . . 29.9 p-10 -77.7 -12.27 59.96 Favored 'General case' 0 N--CA 1.476 0.844 0 C-N-CA 123.364 0.666 . . . . 74.1 111.983 -178.279 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 150' ' ' GLY . . . . . 0.41 ' O ' ' HA ' ' A' ' 55' ' ' ARG . . . 106.45 6.05 36.27 Favored Glycine 0 C--N 1.348 1.2 0 CA-C-O 120.046 -0.308 . . . . 71.11 113.165 179.487 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 86.9 tttt -90.07 122.99 33.55 Favored 'General case' 0 N--CA 1.471 0.619 0 C-N-CA 123.08 0.552 . . . . 70.23 109.866 178.587 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 152' ' ' THR . . . . . 0.522 ' HA ' ' HA2' ' A' ' 146' ' ' GLY . 21.1 m -90.67 113.56 25.65 Favored 'General case' 0 CA--C 1.536 0.425 0 N-CA-C 108.82 -0.807 . . . . 63.14 108.82 174.978 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 153' ' ' SER . . . . . . . . . . . . . 9.1 m -52.8 -32.84 46.15 Favored 'General case' 0 N--CA 1.48 1.07 0 C-N-CA 124.646 1.178 . . . . 72.11 112.367 -178.394 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 70.7 mmtt -109.24 150.02 28.55 Favored 'General case' 0 N--CA 1.469 0.509 0 C-N-CA 124.358 1.063 . . . . 64.22 110.631 -175.731 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 75.0 mmtt -83.01 90.32 7.0 Favored 'General case' 0 N--CA 1.468 0.456 0 N-CA-C 108.527 -0.916 . . . . 71.42 108.527 172.542 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 156' ' ' ILE . . . . . 0.484 ' HA ' ' O ' ' A' ' 11' ' ' ALA . 54.0 mt -100.35 108.49 23.08 Favored 'Isoleucine or valine' 0 C--O 1.221 -0.43 0 CA-C-N 114.981 -1.009 . . . . 74.51 109.04 -175.693 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 157' ' ' THR . . . . . . . . . . . . . 56.9 p -118.47 159.71 23.01 Favored 'General case' 0 N--CA 1.473 0.713 0 C-N-CA 124.07 0.948 . . . . 72.32 110.53 -175.342 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 158' ' ' ILE . . . . . . . . . . . . . 62.5 mt -77.22 94.09 1.28 Allowed 'Isoleucine or valine' 0 CA--C 1.548 0.892 0 N-CA-C 108.988 -0.745 . . . . 55.31 108.988 170.398 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 159' ' ' ALA . . . . . 0.662 ' HB2' ' HB2' ' A' ' 11' ' ' ALA . . . -51.82 -49.56 62.55 Favored 'General case' 0 N--CA 1.483 1.21 0 C-N-CA 124.446 1.098 . . . . 64.21 112.411 -178.764 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 160' ' ' ASP . . . . . . . . . . . . . 19.7 t70 -152.92 169.94 21.6 Favored 'General case' 0 CA--C 1.546 0.805 0 CA-C-N 116.257 -0.428 . . . . 64.3 111.208 -179.351 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 161' ' ' CYS . . . . . . . . . . . . . 46.4 m -136.48 -168.93 2.34 Favored 'General case' 0 N--CA 1.47 0.56 0 C-N-CA 125.138 1.375 . . . . 73.31 108.623 -177.148 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 162' ' ' GLY . . . . . . . . . . . . . . . 132.44 53.52 0.08 OUTLIER Glycine 0 C--N 1.344 0.986 0 N-CA-C 111.025 -0.83 . . . . 72.32 111.025 -172.929 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 163' ' ' GLN . . . . . 0.665 ' HG3' ' HA ' ' A' ' 6' ' ' VAL . 46.8 tt0 -46.69 104.12 0.05 OUTLIER 'General case' 0 N--CA 1.481 1.086 0 C-N-CA 125.281 1.432 . . . . 71.2 112.312 -176.756 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 164' ' ' LEU . . . . . 0.46 ' O ' ' HB ' ' A' ' 5' ' ' THR . 64.9 mt . . . . . 0 N--CA 1.468 0.432 0 N-CA-C 107.272 -1.381 . . . . 73.23 107.272 -179.542 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 218' ' ' PRO . . . . . . . . . . . . . 15.4 Cg_exo . . . . . 0 CA--C 1.546 1.079 0 N-CA-C 111.234 -0.333 . . . . 53.52 111.234 . . . . . . . . . 0 0 . 1 . 014 nuclear build core ' B' B ' 219' ' ' GLY . . . . . . . . . . . . . . . 130.63 163.97 11.15 Favored Glycine 0 CA--C 1.531 1.065 0 CA-C-O 119.605 -0.553 . . . . 63.01 112.372 177.67 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 220' ' ' PRO . . . . . 0.461 ' HG3' HD21 ' A' ' 122' ' ' LEU . 96.3 Cg_endo -78.39 160.03 29.13 Favored 'Trans proline' 0 C--N 1.368 1.56 0 C-N-CA 123.669 2.912 . . . . 72.53 113.025 -175.394 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 221' ' ' TYR . . . . . . . . . . . . . 49.1 m-85 . . . . . 0 N--CA 1.475 0.783 0 C-N-CA 123.493 0.717 . . . . 72.25 111.651 -173.123 . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 18.2 m-80 . . . . . 0 C--O 1.241 0.655 0 N-CA-C 107.498 -1.297 . . . . 74.23 107.498 . . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 4' ' ' PRO . . . . . 0.687 ' HB3' HH11 ' A' ' 37' ' ' ARG . 48.8 Cg_endo -69.18 119.76 6.7 Favored 'Trans proline' 0 C--N 1.371 1.745 0 C-N-CA 122.107 1.871 . . . . 72.53 110.917 177.35 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 86.6 m -96.84 117.85 31.98 Favored 'General case' 0 C--O 1.217 -0.61 0 N-CA-C 106.906 -1.516 . . . . 72.31 106.906 173.234 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 5.3 m -98.22 122.12 49.52 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.421 0 CA-C-O 121.782 0.801 . . . . 75.41 109.485 -176.537 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 7' ' ' PHE . . . . . 0.57 ' H ' ' HA ' ' A' ' 163' ' ' GLN . 73.2 t80 -100.75 131.79 46.47 Favored 'General case' 0 C--O 1.236 0.365 0 CA-C-N 114.485 -1.234 . . . . 73.15 108.893 -175.031 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 8' ' ' PHE . . . . . 0.461 ' HB3' HG23 ' A' ' 158' ' ' ILE . 44.2 m-85 -132.04 165.01 24.95 Favored 'General case' 0 C--O 1.24 0.566 0 C-N-CA 124.489 1.116 . . . . 70.43 109.125 170.566 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 49.5 m-20 -112.94 111.07 21.55 Favored 'General case' 0 C--N 1.326 -0.442 0 N-CA-C 107.564 -1.272 . . . . 72.15 107.564 169.281 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 10' ' ' ILE . . . . . 0.475 HG21 ' SD ' ' A' ' 142' ' ' MET . 41.3 mm -80.04 115.26 22.17 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.412 0 N-CA-C 108.518 -0.919 . . . . 73.25 108.518 179.154 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 11' ' ' ALA . . . . . 0.566 ' HB2' ' HB2' ' A' ' 159' ' ' ALA . . . -116.79 128.62 55.46 Favored 'General case' 0 N--CA 1.47 0.56 0 C-N-CA 123.793 0.837 . . . . 64.42 111.21 -173.761 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 73.2 t -95.8 113.64 30.66 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.616 0 N-CA-C 108.097 -1.075 . . . . 75.34 108.097 173.585 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 48.0 m-20 63.91 23.93 13.51 Favored 'General case' 0 N--CA 1.489 1.502 0 C-N-CA 125.567 1.547 . . . . 64.21 111.731 -178.676 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 96.85 -20.45 50.65 Favored Glycine 0 C--N 1.341 0.841 0 CA-C-O 119.569 -0.573 . . . . 63.21 112.838 -177.326 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 50.6 mm-40 -84.22 114.32 53.84 Favored Pre-proline 0 N--CA 1.476 0.841 0 CA-C-N 117.299 0.55 . . . . 73.23 110.215 178.353 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 76.5 Cg_exo -50.48 109.35 0.29 Allowed 'Trans proline' 0 C--N 1.382 2.309 0 C-N-CA 123.684 2.923 . . . . 74.02 112.802 177.875 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 44.3 tp -77.06 -45.01 28.54 Favored 'General case' 0 N--CA 1.473 0.701 0 N-CA-C 109.114 -0.698 . . . . 74.52 109.114 177.653 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -168.35 170.8 42.32 Favored Glycine 0 C--N 1.342 0.891 0 CA-C-N 115.873 -0.603 . . . . 74.25 112.543 179.694 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 69.3 mtt-85 -107.04 125.98 51.74 Favored 'General case' 0 N--CA 1.474 0.759 0 C-N-CA 123.718 0.807 . . . . 72.13 108.955 -176.466 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 93.1 t -121.76 144.92 29.36 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.769 0 C-N-CA 123.512 0.725 . . . . 71.12 110.11 -176.77 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 21' ' ' SER . . . . . 0.473 ' HB2' ' HB2' ' A' ' 134' ' ' GLU . 60.0 m -141.21 128.21 20.67 Favored 'General case' 0 CA--C 1.541 0.602 0 C-N-CA 124.733 1.213 . . . . 72.34 108.925 178.447 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 57.9 m-85 -109.59 121.35 45.01 Favored 'General case' 0 N--CA 1.476 0.83 0 C-N-CA 123.248 0.619 . . . . 73.01 110.02 -178.242 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 38.0 tt0 -74.53 104.23 5.16 Favored 'General case' 0 CA--C 1.547 0.854 0 C-N-CA 123.533 0.733 . . . . 74.52 109.192 171.36 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 24' ' ' LEU . . . . . 0.522 ' HB2' ' HG2' ' A' ' 4' ' ' PRO . 38.4 mt -85.6 123.83 31.46 Favored 'General case' 0 C--O 1.241 0.627 0 N-CA-C 109.114 -0.699 . . . . 61.41 109.114 175.971 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 58.0 m-85 -83.16 76.44 9.86 Favored 'General case' 0 CA--C 1.543 0.674 0 C-N-CA 123.498 0.719 . . . . 74.53 110.52 -177.043 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -71.14 -6.63 40.81 Favored 'General case' 0 N--CA 1.489 1.482 0 C-N-CA 122.913 0.485 . . . . 63.45 112.004 178.363 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 10.1 p-10 -89.07 -17.38 29.42 Favored 'General case' 0 CA--C 1.554 1.104 0 C-N-CA 123.746 0.819 . . . . 64.54 111.343 176.344 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 57.2 mttp -112.59 -44.78 3.3 Favored 'General case' 0 N--CA 1.494 1.758 0 C-N-CA 123.441 0.697 . . . . 73.22 111.033 -176.185 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 29' ' ' VAL . . . . . 0.503 HG21 ' HA ' ' A' ' 129' ' ' PHE . 12.0 m -127.91 62.97 59.49 Favored Pre-proline 0 CA--C 1.566 1.59 0 C-N-CA 124.448 1.099 . . . . 75.23 110.267 177.382 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 2.8 Cg_endo -49.83 -41.34 47.15 Favored 'Trans proline' 0 C--N 1.391 2.78 0 C-N-CA 123.41 2.74 . . . . 75.43 114.717 -172.994 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 39.3 ttpt -64.46 -49.96 69.4 Favored 'General case' 0 N--CA 1.476 0.837 0 C-N-CA 123.449 0.699 . . . . 74.3 111.132 -177.496 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 7.1 m -76.01 -31.64 59.02 Favored 'General case' 0 CA--C 1.55 0.974 0 CA-C-N 115.115 -0.948 . . . . 71.35 111.504 -171.034 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -74.29 -46.93 38.08 Favored 'General case' 0 CA--C 1.543 0.704 0 C-N-CA 123.695 0.798 . . . . 43.55 110.336 177.976 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 11.6 tp10 -66.34 -29.66 69.89 Favored 'General case' 0 N--CA 1.482 1.134 0 C-N-CA 123.764 0.825 . . . . 71.32 110.979 178.852 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 35' ' ' ASN . . . . . 0.479 ' O ' ' HG ' ' A' ' 39' ' ' LEU . 25.8 t30 -54.06 -60.6 3.11 Favored 'General case' 0 N--CA 1.476 0.869 0 C-N-CA 123.826 0.85 . . . . 74.3 110.034 173.239 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 52.7 t80 -66.51 -34.84 78.83 Favored 'General case' 0 CA--C 1.541 0.598 0 O-C-N 124.224 0.953 . . . . 65.01 111.095 -175.094 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 37' ' ' ARG . . . . . 0.687 HH11 ' HB3' ' A' ' 4' ' ' PRO . 24.7 ttt180 -59.36 -45.56 91.05 Favored 'General case' 0 C--N 1.35 0.628 0 C-N-CA 123.541 0.736 . . . . 63.34 110.659 175.357 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 38' ' ' ALA . . . . . 0.592 ' HB1' ' HG2' ' A' ' 44' ' ' LYS . . . -73.3 -27.41 61.53 Favored 'General case' 0 CA--C 1.543 0.68 0 C-N-CA 123.434 0.694 . . . . 74.35 111.515 -177.956 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 39' ' ' LEU . . . . . 0.621 HD22 ' HE2' ' A' ' 48' ' ' TYR . 86.6 mt -72.97 -30.14 63.61 Favored 'General case' 0 N--CA 1.48 1.053 0 C-N-CA 123.462 0.705 . . . . 75.24 110.513 174.17 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 33.3 t -76.6 -53.95 7.35 Favored 'General case' 0 N--CA 1.478 0.946 0 C-N-CA 124.356 1.062 . . . . 73.43 110.898 179.452 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 41' ' ' THR . . . . . 0.4 ' OG1' ' HG2' ' A' ' 43' ' ' GLU . 44.0 p -76.83 -30.31 56.31 Favored 'General case' 0 N--CA 1.471 0.588 0 C-N-CA 124.401 1.08 . . . . 53.31 111.847 -174.523 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 79.86 30.89 41.6 Favored Glycine 0 C--N 1.341 0.851 0 CA-C-N 115.706 -0.679 . . . . 41.45 112.914 -179.076 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 43' ' ' GLU . . . . . 0.4 ' HG2' ' OG1' ' A' ' 41' ' ' THR . 55.7 mm-40 -58.33 -40.6 82.57 Favored 'General case' 0 N--CA 1.476 0.854 0 C-N-CA 123.079 0.551 . . . . 74.13 110.027 172.461 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 44' ' ' LYS . . . . . 0.592 ' HG2' ' HB1' ' A' ' 38' ' ' ALA . 28.4 mmmt -92.99 18.32 9.34 Favored 'General case' 0 CA--C 1.551 0.993 0 CA-C-N 115.315 -0.857 . . . . 72.41 111.379 -179.849 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 82.71 -8.87 61.02 Favored Glycine 0 C--N 1.35 1.335 0 N-CA-C 115.225 0.85 . . . . 72.54 115.225 172.872 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 46' ' ' PHE . . . . . 0.465 ' HE2' ' HA ' ' A' ' 78' ' ' ILE . 22.4 m-85 -82.09 -48.66 11.1 Favored 'General case' 0 N--CA 1.479 1.023 0 CA-C-N 117.713 0.756 . . . . 71.21 111.393 -170.224 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 38.04 62.6 1.02 Allowed Glycine 0 C--N 1.357 1.746 0 O-C-N 125.016 1.447 . . . . 42.31 116.186 168.278 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 48' ' ' TYR . . . . . 0.621 ' HE2' HD22 ' A' ' 39' ' ' LEU . 97.4 m-85 -62.18 92.85 0.04 OUTLIER 'General case' 0 N--CA 1.479 1.013 0 CA-C-O 121.908 0.861 . . . . 73.32 112.37 -170.736 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 49' ' ' LYS . . . . . 0.441 ' HE2' ' HA ' ' A' ' 160' ' ' ASP . 28.3 tptp -100.55 129.2 46.46 Favored 'General case' 0 C--O 1.237 0.436 0 C-N-CA 125.067 1.347 . . . . 74.04 107.954 179.593 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 73.63 20.5 79.82 Favored Glycine 0 C--N 1.345 1.045 0 O-C-N 123.33 0.394 . . . . 65.22 112.681 -176.007 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 51' ' ' SER . . . . . 0.464 ' HB2' ' HB3' ' A' ' 48' ' ' TYR . 22.7 t -64.92 119.83 11.43 Favored 'General case' 0 CA--C 1.546 0.819 0 C-N-CA 123.651 0.78 . . . . 72.54 109.901 -178.191 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 52' ' ' CYS . . . . . 0.417 ' H ' ' HB2' ' A' ' 67' ' ' PHE . 37.6 t -93.36 153.79 18.33 Favored 'General case' 0 N--CA 1.472 0.642 0 C-N-CA 123.275 0.63 . . . . 70.03 111.959 -166.934 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 53' ' ' PHE . . . . . 0.487 ' HA ' ' HA2' ' A' ' 64' ' ' GLY . 45.9 m-85 -97.89 120.9 39.1 Favored 'General case' 0 C--O 1.237 0.412 0 C-N-CA 124.787 1.235 . . . . 71.51 108.04 172.724 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 19.5 p-80 -108.68 -36.71 6.09 Favored 'General case' 0 N--CA 1.479 0.996 0 C-N-CA 123.822 0.849 . . . . 71.43 110.146 -173.269 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 50.2 ttt180 -122.61 97.34 5.41 Favored 'General case' 0 C--O 1.217 -0.643 0 N-CA-C 108.703 -0.851 . . . . 73.24 108.703 -175.057 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 56' ' ' ILE . . . . . 0.511 HG21 ' HA ' ' A' ' 143' ' ' GLU . 44.9 mt -119.85 128.35 75.91 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.586 0 N-CA-C 108.192 -1.04 . . . . 63.52 108.192 172.931 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 57' ' ' ILE . . . . . 0.574 HG23 ' HA ' ' A' ' 148' ' ' ARG . 60.5 mt -120.68 124.86 27.37 Favored Pre-proline 0 CA--C 1.547 0.831 0 N-CA-C 108.34 -0.985 . . . . 61.2 108.34 175.436 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 58' ' ' PRO . . . . . 0.526 ' HA ' ' HG2' ' A' ' 143' ' ' GLU . 37.8 Cg_endo -63.1 141.69 84.22 Favored 'Trans proline' 0 C--N 1.383 2.352 0 C-N-CA 123.31 2.673 . . . . 71.43 112.505 -178.364 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 65.29 21.6 68.5 Favored Glycine 0 C--N 1.343 0.967 0 CA-C-N 115.326 -0.852 . . . . 73.51 113.717 -177.738 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 60' ' ' PHE . . . . . 0.453 ' HD2' ' HB ' ' A' ' 57' ' ' ILE . 27.8 t80 -138.01 -74.78 0.4 Allowed 'General case' 0 N--CA 1.468 0.447 0 N-CA-C 109.245 -0.65 . . . . 74.51 109.245 -172.42 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 11.9 ptp -175.31 154.1 1.66 Allowed 'General case' 0 N--CA 1.483 1.215 0 O-C-N 123.677 0.611 . . . . 62.41 112.501 -178.472 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 62' ' ' CYS . . . . . . . . . . . . . 56.7 m -102.94 109.74 21.4 Favored 'General case' 0 CA--C 1.539 0.539 0 CA-C-N 115.076 -0.965 . . . . 73.4 108.973 170.369 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 63' ' ' GLN . . . . . 0.46 ' HA ' ' HA ' ' A' ' 113' ' ' PHE . 53.1 tt0 -100.08 105.33 16.96 Favored 'General case' 0 C--O 1.248 0.977 0 CA-C-O 121.336 0.589 . . . . 71.54 109.901 -178.05 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 64' ' ' GLY . . . . . 0.487 ' HA2' ' HA ' ' A' ' 53' ' ' PHE . . . -110.79 -153.38 13.2 Favored Glycine 0 C--N 1.344 1.006 0 CA-C-N 114.466 -1.243 . . . . 72.11 111.31 174.931 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 86.05 -35.6 3.25 Favored Glycine 0 C--N 1.344 1.025 0 N-CA-C 111.856 -0.498 . . . . 62.54 111.856 -173.494 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 66' ' ' ASP . . . . . 0.554 ' HB2' ' HG2' ' A' ' 111' ' ' GLN . 35.5 t70 -66.54 103.1 0.99 Allowed 'General case' 0 N--CA 1.445 -0.688 0 C-N-CA 124.836 1.254 . . . . 74.32 110.686 -177.855 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 67' ' ' PHE . . . . . 0.417 ' HB2' ' H ' ' A' ' 52' ' ' CYS . 71.5 t80 -156.92 -68.83 0.1 Allowed 'General case' 0 C--O 1.239 0.521 0 N-CA-C 108.361 -0.978 . . . . 74.53 108.361 177.919 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 27.5 m -79.25 122.06 25.85 Favored 'General case' 0 C--O 1.24 0.57 0 CA-C-N 115.49 -0.777 . . . . 54.54 108.943 178.693 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 49.5 mtt85 65.94 36.06 6.16 Favored 'General case' 0 N--CA 1.482 1.159 0 C-N-CA 124.302 1.041 . . . . 64.31 111.538 177.787 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 1.2 t60 -41.1 -52.73 3.2 Favored 'General case' 0 N--CA 1.494 1.741 0 C-N-CA 125.804 1.642 . . . . 74.22 113.88 -175.273 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 93.2 m-20 -65.58 99.77 0.46 Allowed 'General case' 0 N--CA 1.477 0.887 0 C-N-CA 123.118 0.567 . . . . 53.53 110.777 -175.847 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 88.29 -7.05 82.73 Favored Glycine 0 C--N 1.345 1.044 0 CA-C-N 115.677 -0.692 . . . . 74.22 114.688 174.689 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 73' ' ' THR . . . . . 0.439 ' O ' ' HB3' ' A' ' 110' ' ' SER . 26.1 m -137.09 -83.02 0.35 Allowed 'General case' 0 N--CA 1.48 1.072 0 CA-C-N 118.076 0.938 . . . . 65.55 110.526 -178.049 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 74' ' ' GLY . . . . . 0.448 ' O ' ' HG3' ' A' ' 111' ' ' GLN . . . 71.95 64.12 2.78 Favored Glycine 0 C--N 1.354 1.535 0 N-CA-C 114.371 0.508 . . . . 70.01 114.371 173.171 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 97.43 54.53 1.24 Allowed Glycine 0 N--CA 1.472 1.052 0 C-N-CA 120.309 -0.948 . . . . 64.33 112.305 176.016 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 64.3 pttt -61.05 172.15 1.08 Allowed 'General case' 0 CA--C 1.551 1.001 0 C-N-CA 123.959 0.904 . . . . 71.33 113.283 -175.4 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 88.1 p -90.57 179.42 5.84 Favored 'General case' 0 C--O 1.242 0.684 0 CA-C-N 115.212 -0.904 . . . . 70.21 111.187 -176.146 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 78' ' ' ILE . . . . . 0.465 ' HA ' ' HE2' ' A' ' 46' ' ' PHE . 35.0 pt -74.56 -15.54 16.25 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.663 0 CA-C-N 115.72 -0.673 . . . . 71.21 111.359 177.608 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 82.1 m-85 -95.0 11.27 32.57 Favored 'General case' 0 N--CA 1.475 0.821 0 C-N-CA 123.735 0.814 . . . . 74.22 111.35 177.287 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 105.88 -146.08 16.02 Favored Glycine 0 C--N 1.345 1.053 0 N-CA-C 111.244 -0.742 . . . . 71.12 111.244 -179.253 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 36.1 tt0 -57.81 -38.5 75.66 Favored 'General case' 0 N--CA 1.477 0.877 0 C-N-CA 124.08 0.952 . . . . 74.24 111.423 -178.227 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 3.8 ptpp? -160.15 172.48 17.36 Favored 'General case' 0 N--CA 1.474 0.743 0 C-N-CA 123.417 0.687 . . . . 74.0 111.805 -177.451 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 4.1 p90 -159.07 171.89 19.16 Favored 'General case' 0 CA--C 1.544 0.726 0 C-N-CA 125.012 1.325 . . . . 73.14 109.514 177.657 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 84' ' ' GLU . . . . . 0.486 ' HA ' ' HA ' ' A' ' 106' ' ' ASN . 12.6 pt-20 -81.67 158.4 24.29 Favored 'General case' 0 N--CA 1.475 0.776 0 C-N-CA 123.574 0.75 . . . . 74.32 111.758 -177.319 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 52.7 m-20 -81.85 143.74 31.51 Favored 'General case' 0 N--CA 1.476 0.875 0 C-N-CA 123.761 0.824 . . . . 75.33 109.269 173.294 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 12.5 tp10 -83.21 -59.38 2.48 Favored 'General case' 0 N--CA 1.477 0.883 0 CA-C-O 121.278 0.561 . . . . 63.31 111.051 -174.551 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 32.0 p30 -153.68 -167.5 2.7 Favored 'General case' 0 N--CA 1.472 0.673 0 C-N-CA 123.747 0.819 . . . . 63.51 109.157 -174.167 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 81.4 m-85 -138.58 39.49 2.22 Favored 'General case' 0 N--CA 1.482 1.166 0 C-N-CA 123.717 0.807 . . . . 73.54 110.451 178.046 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 67.8 mt -62.31 -38.18 80.49 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.324 0 CA-C-O 121.531 0.681 . . . . 71.44 109.904 174.612 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 90' ' ' LEU . . . . . 0.67 ' HB3' ' HB ' ' A' ' 128' ' ' VAL . 95.4 mt -98.9 150.62 21.73 Favored 'General case' 0 CA--C 1.543 0.705 0 C-N-CA 124.088 0.955 . . . . 74.45 110.893 179.379 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 47.2 pttt -158.77 163.87 36.35 Favored 'General case' 0 N--CA 1.482 1.172 0 C-N-CA 124.165 0.986 . . . . 75.21 110.294 -170.946 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 92' ' ' HIS . . . . . 0.402 ' HA ' HG13 ' A' ' 97' ' ' ILE . 13.3 m-70 -88.89 63.38 6.76 Favored 'General case' 0 N--CA 1.488 1.439 0 C-N-CA 123.63 0.772 . . . . 74.31 109.93 -175.196 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 15.3 p -90.8 2.57 55.97 Favored 'General case' 0 N--CA 1.48 1.064 0 C-N-CA 123.849 0.86 . . . . 74.12 111.811 178.508 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -157.27 173.36 34.79 Favored Glycine 0 C--N 1.343 0.926 0 CA-C-N 116.653 -0.248 . . . . 61.31 112.918 -178.644 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 86.2 Cg_endo -78.16 157.1 30.05 Favored 'Trans proline' 0 C--N 1.362 1.249 0 C-N-CA 123.276 2.651 . . . . 74.0 112.64 175.895 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 79.63 18.77 72.51 Favored Glycine 0 C--N 1.342 0.871 0 CA-C-N 115.694 -0.685 . . . . 54.32 114.476 175.396 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 97' ' ' ILE . . . . . 0.67 ' HB ' ' SG ' ' A' ' 115' ' ' CYS . 19.0 mm -73.03 128.54 35.85 Favored 'Isoleucine or valine' 0 CA--C 1.554 1.119 0 C-N-CA 123.967 0.907 . . . . 62.52 110.592 178.932 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 98' ' ' LEU . . . . . 0.501 HD13 HG12 ' A' ' 114' ' ' ILE . 67.7 tp -103.88 122.71 45.72 Favored 'General case' 0 C--O 1.252 1.207 0 C-N-CA 123.637 0.775 . . . . 72.25 110.13 176.139 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 99' ' ' SER . . . . . 0.422 ' HB3' ' HD2' ' A' ' 126' ' ' HIS . 50.7 m -145.34 139.68 27.18 Favored 'General case' 0 CA--C 1.555 1.155 0 C-N-CA 124.735 1.214 . . . . 72.12 109.418 179.744 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 100' ' ' MET . . . . . 0.675 ' HA ' ' HA ' ' A' ' 112' ' ' PHE . 85.9 mtp -76.57 147.54 37.61 Favored 'General case' 0 N--CA 1.491 1.605 0 C-N-CA 123.877 0.871 . . . . 74.31 111.647 178.48 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 101' ' ' ALA . . . . . 0.4 ' HB3' ' HB2' ' A' ' 111' ' ' GLN . . . -75.25 145.77 41.66 Favored 'General case' 0 N--CA 1.479 0.995 0 C-N-CA 123.654 0.782 . . . . 54.14 111.843 -175.261 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 26.9 p-10 -168.54 173.04 7.72 Favored 'General case' 0 N--CA 1.477 0.908 0 C-N-CA 123.958 0.903 . . . . 71.2 110.675 -178.902 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -91.45 -47.81 7.23 Favored 'General case' 0 N--CA 1.471 0.578 0 CA-C-N 115.7 -0.682 . . . . 42.15 109.551 168.636 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -163.1 -161.2 12.09 Favored Glycine 0 C--N 1.345 1.074 0 CA-C-N 115.512 -0.767 . . . . 42.11 111.973 178.111 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 51.9 Cg_exo -55.8 135.68 70.73 Favored 'Trans proline' 0 C--N 1.375 1.965 0 C-N-CA 123.417 2.745 . . . . 70.23 112.608 179.133 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 106' ' ' ASN . . . . . 0.486 ' HA ' ' HA ' ' A' ' 84' ' ' GLU . 64.9 t30 69.45 11.22 7.99 Favored 'General case' 0 N--CA 1.484 1.261 0 C-N-CA 124.982 1.313 . . . . 64.43 112.247 179.269 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 8.8 m -105.08 -12.98 15.89 Favored 'General case' 0 CA--C 1.552 1.057 0 C-N-CA 123.452 0.701 . . . . 61.03 109.576 171.549 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 15.1 t30 -57.88 146.6 31.44 Favored 'General case' 0 N--CA 1.481 1.081 0 C-N-CA 125.609 1.563 . . . . 72.53 111.451 175.306 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 113.13 21.15 6.02 Favored Glycine 0 N--CA 1.471 1.02 0 N-CA-C 113.996 0.359 . . . . 23.54 113.996 175.944 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 110' ' ' SER . . . . . 0.439 ' HB3' ' O ' ' A' ' 73' ' ' THR . 69.0 m -138.36 122.62 18.16 Favored 'General case' 0 N--CA 1.474 0.765 0 N-CA-C 108.744 -0.836 . . . . 73.01 108.744 171.546 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 111' ' ' GLN . . . . . 0.554 ' HG2' ' HB2' ' A' ' 66' ' ' ASP . 18.1 mt-30 65.72 170.92 0.22 Allowed 'General case' 0 N--CA 1.498 1.953 0 C-N-CA 124.302 1.041 . . . . 74.41 111.802 -178.255 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 112' ' ' PHE . . . . . 0.675 ' HA ' ' HA ' ' A' ' 100' ' ' MET . 53.2 p90 -150.07 138.81 20.82 Favored 'General case' 0 N--CA 1.479 0.978 0 C-N-CA 123.118 0.567 . . . . 73.43 110.102 174.975 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 113' ' ' PHE . . . . . 0.46 ' HA ' ' HA ' ' A' ' 63' ' ' GLN . 42.9 p90 -111.84 144.99 40.24 Favored 'General case' 0 C--O 1.24 0.588 0 C-N-CA 123.753 0.821 . . . . 74.32 110.668 174.435 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 114' ' ' ILE . . . . . 0.501 HG12 HD13 ' A' ' 98' ' ' LEU . 8.2 mt -116.46 99.67 8.81 Favored 'Isoleucine or valine' 0 C--O 1.24 0.577 0 N-CA-C 106.919 -1.511 . . . . 74.11 106.919 178.232 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 115' ' ' CYS . . . . . 0.67 ' SG ' ' HB ' ' A' ' 97' ' ' ILE . 19.3 p -84.45 118.05 24.04 Favored 'General case' 0 N--CA 1.472 0.644 0 C-N-CA 122.404 0.282 . . . . 72.43 110.758 -175.768 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 59.5 p -78.65 1.17 23.69 Favored 'General case' 0 N--CA 1.481 1.075 0 C-N-CA 124.052 0.941 . . . . 74.42 111.902 -179.024 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -133.22 162.22 32.35 Favored 'General case' 0 C--O 1.244 0.787 0 C-N-CA 123.704 0.802 . . . . 71.01 109.966 -179.827 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 8.8 ptmt -71.82 81.51 0.89 Allowed 'General case' 0 CA--C 1.549 0.937 0 CA-C-O 121.846 0.831 . . . . 74.54 109.415 171.944 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 119' ' ' THR . . . . . 0.491 ' HB ' HD23 ' A' ' 122' ' ' LEU . 32.2 p -82.56 85.31 7.0 Favored 'General case' 0 CA--C 1.55 0.971 0 CA-C-O 122.147 0.975 . . . . 71.32 109.309 -177.331 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 12.8 pt-20 -74.57 -27.64 60.58 Favored 'General case' 0 N--CA 1.48 1.06 0 CA-C-N 114.67 -1.15 . . . . 61.05 112.318 -167.724 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 121' ' ' TRP . . . . . . . . . . . . . 46.5 p90 -67.49 -1.75 5.39 Favored 'General case' 0 N--CA 1.483 1.2 0 C-N-CA 123.747 0.819 . . . . 73.03 112.238 178.352 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 122' ' ' LEU . . . . . 0.491 HD23 ' HB ' ' A' ' 119' ' ' THR . 3.2 mm? -78.06 -3.91 44.58 Favored 'General case' 0 CA--C 1.548 0.895 0 C-N-CA 124.454 1.102 . . . . 73.45 112.48 174.064 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 40.6 m-20 -65.22 128.38 35.58 Favored 'General case' 0 N--CA 1.487 1.384 0 CA-C-N 118.247 0.476 . . . . 63.1 111.164 176.592 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 104.23 -25.79 25.0 Favored Glycine 0 N--CA 1.477 1.378 0 N-CA-C 111.867 -0.493 . . . . 60.12 111.867 -174.665 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 12.5 ttmm -85.59 -164.46 1.02 Allowed 'General case' 0 CA--C 1.552 1.033 0 C-N-CA 124.329 1.052 . . . . 60.11 108.449 177.443 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 126' ' ' HIS . . . . . 0.422 ' HD2' ' HB3' ' A' ' 99' ' ' SER . 34.6 t60 -66.91 131.7 46.44 Favored 'General case' 0 CA--C 1.546 0.825 0 CA-C-O 121.183 0.516 . . . . 71.04 111.063 -175.343 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 7.4 p -62.42 147.4 11.62 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.808 0 CA-C-N 114.038 -1.437 . . . . 75.4 112.074 178.126 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 128' ' ' VAL . . . . . 0.67 ' HB ' ' HB3' ' A' ' 90' ' ' LEU . 46.3 t -64.43 149.98 10.61 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.721 0 C-N-CA 123.374 0.67 . . . . 72.12 110.3 174.699 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 129' ' ' PHE . . . . . 0.503 ' HA ' HG21 ' A' ' 29' ' ' VAL . 49.3 p90 -136.51 -27.95 1.03 Allowed 'General case' 0 N--CA 1.479 0.977 0 C-N-CA 122.378 0.271 . . . . 74.3 111.127 174.567 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . -123.54 167.13 15.84 Favored Glycine 0 C--N 1.343 0.942 0 O-C-N 123.424 0.452 . . . . 61.01 112.323 -177.719 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 30.2 ttpt -154.65 122.84 5.97 Favored 'General case' 0 N--CA 1.468 0.454 0 N-CA-C 107.997 -1.112 . . . . 74.11 107.997 179.092 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 12.7 p -67.0 122.39 17.94 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.959 0 CA-C-O 121.515 0.674 . . . . 52.45 109.98 177.468 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 21.2 ptmt -108.66 -22.98 12.01 Favored 'General case' 0 N--CA 1.476 0.844 0 C-N-CA 124.054 0.941 . . . . 63.12 110.251 179.009 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 134' ' ' GLU . . . . . 0.473 ' HB2' ' HB2' ' A' ' 21' ' ' SER . 34.6 mt-10 -136.71 134.03 36.74 Favored 'General case' 0 N--CA 1.475 0.817 0 C-N-CA 124.798 1.239 . . . . 75.44 108.17 179.863 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 135' ' ' GLY . . . . . 0.411 ' O ' HG23 ' A' ' 139' ' ' VAL . . . 80.1 26.66 54.94 Favored Glycine 0 CA--C 1.528 0.862 0 CA-C-O 119.837 -0.424 . . . . 41.41 113.235 -177.624 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 136' ' ' MET . . . . . . . . . . . . . 5.8 tpt -59.79 -53.17 61.1 Favored 'General case' 0 N--CA 1.485 1.288 0 C-N-CA 123.664 0.786 . . . . 70.32 110.471 175.103 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 137' ' ' ASN . . . . . . . . . . . . . 20.5 m120 -64.65 -25.79 68.11 Favored 'General case' 0 N--CA 1.477 0.884 0 CA-C-N 115.902 -0.59 . . . . 74.44 110.997 -179.537 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 138' ' ' ILE . . . . . . . . . . . . . 50.9 mm -69.52 -40.4 79.65 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.728 0 C-N-CA 123.393 0.677 . . . . 73.54 110.433 175.853 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 139' ' ' VAL . . . . . 0.411 HG23 ' O ' ' A' ' 135' ' ' GLY . 91.2 t -63.18 -40.33 88.62 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.131 0 C-N-CA 123.033 0.533 . . . . 74.41 109.888 174.987 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 40.3 mt-10 -65.46 -33.23 75.44 Favored 'General case' 0 CA--C 1.551 0.985 0 CA-C-N 115.541 -0.754 . . . . 75.31 111.329 175.808 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -75.2 -45.11 42.57 Favored 'General case' 0 N--CA 1.481 1.08 0 C-N-CA 123.753 0.821 . . . . 71.31 111.739 -177.667 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 142' ' ' MET . . . . . 0.551 ' HB2' HD13 ' A' ' 156' ' ' ILE . 25.4 ptm -69.48 -29.38 67.03 Favored 'General case' 0 N--CA 1.476 0.852 0 CA-C-N 115.823 -0.626 . . . . 74.1 110.66 179.031 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 143' ' ' GLU . . . . . 0.526 ' HG2' ' HA ' ' A' ' 58' ' ' PRO . 30.9 tt0 -64.88 -29.01 69.94 Favored 'General case' 0 C--N 1.353 0.731 0 C-N-CA 123.243 0.617 . . . . 70.02 111.531 -179.927 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 144' ' ' ARG . . . . . . . . . . . . . 24.3 mtp180 -63.15 -23.61 67.51 Favored 'General case' 0 N--CA 1.474 0.761 0 C-N-CA 123.572 0.749 . . . . 73.34 111.843 177.475 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 145' ' ' PHE . . . . . . . . . . . . . 65.7 m-85 -80.14 -13.82 58.97 Favored 'General case' 0 N--CA 1.481 1.111 0 C-N-CA 122.42 0.288 . . . . 73.4 111.506 179.68 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 146' ' ' GLY . . . . . 0.411 ' HA2' ' HA ' ' A' ' 152' ' ' THR . . . -84.4 171.09 47.41 Favored Glycine 0 C--N 1.343 0.949 0 O-C-N 122.979 0.174 . . . . 64.31 112.675 177.192 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 34.1 t -132.96 167.29 20.54 Favored 'General case' 0 N--CA 1.48 1.05 0 C-N-CA 123.966 0.906 . . . . 74.24 109.716 -176.229 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 148' ' ' ARG . . . . . 0.574 ' HA ' HG23 ' A' ' 57' ' ' ILE . 23.7 mmt85 -67.6 -23.39 65.38 Favored 'General case' 0 N--CA 1.488 1.46 0 C-N-CA 123.925 0.89 . . . . 75.55 112.591 -175.481 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 149' ' ' ASN . . . . . . . . . . . . . 27.8 p-10 -86.97 1.09 53.89 Favored 'General case' 0 N--CA 1.487 1.38 0 C-N-CA 123.363 0.665 . . . . 60.52 111.106 174.818 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . 95.32 -26.5 19.21 Favored Glycine 0 C--N 1.341 0.809 0 CA-C-O 119.692 -0.504 . . . . 73.13 113.169 179.282 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 65.0 tttp -63.69 118.14 7.84 Favored 'General case' 0 N--CA 1.476 0.827 0 CA-C-N 117.507 0.654 . . . . 70.44 110.921 -174.542 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 152' ' ' THR . . . . . 0.411 ' HA ' ' HA2' ' A' ' 146' ' ' GLY . 9.6 m -93.39 124.7 37.56 Favored 'General case' 0 CA--C 1.542 0.644 0 CA-C-N 114.763 -1.108 . . . . 74.4 109.062 179.269 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 153' ' ' SER . . . . . . . . . . . . . 66.2 p -63.77 -26.81 68.81 Favored 'General case' 0 N--CA 1.48 1.066 0 C-N-CA 124.13 0.972 . . . . 35.31 112.056 -178.655 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 72.1 mmtt -111.89 141.3 45.7 Favored 'General case' 0 C--O 1.238 0.472 0 C-N-CA 124.009 0.924 . . . . 60.44 111.252 -176.38 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 72.9 mmtt -83.16 91.23 7.2 Favored 'General case' 0 C--O 1.238 0.487 0 N-CA-C 108.369 -0.975 . . . . 60.54 108.369 172.798 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 156' ' ' ILE . . . . . 0.551 HD13 ' HB2' ' A' ' 142' ' ' MET . 62.6 mt -94.13 110.97 24.38 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.473 0 CA-C-N 114.84 -1.073 . . . . 52.13 108.955 -177.94 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 157' ' ' THR . . . . . . . . . . . . . 49.3 p -115.59 155.07 28.29 Favored 'General case' 0 C--O 1.243 0.743 0 C-N-CA 123.847 0.859 . . . . 74.22 110.454 -176.979 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 158' ' ' ILE . . . . . 0.461 HG23 ' HB3' ' A' ' 8' ' ' PHE . 62.6 mt -75.5 93.71 0.92 Allowed 'Isoleucine or valine' 0 CA--C 1.542 0.644 0 N-CA-C 108.205 -1.035 . . . . 73.03 108.205 171.199 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 159' ' ' ALA . . . . . 0.566 ' HB2' ' HB2' ' A' ' 11' ' ' ALA . . . -58.31 -35.62 72.13 Favored 'General case' 0 N--CA 1.474 0.744 0 C-N-CA 124.485 1.114 . . . . 71.1 112.834 -177.028 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 160' ' ' ASP . . . . . 0.441 ' HA ' ' HE2' ' A' ' 49' ' ' LYS . 23.7 t0 -161.16 157.39 25.8 Favored 'General case' 0 N--CA 1.477 0.906 0 O-C-N 123.358 0.411 . . . . 70.14 110.648 -174.986 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 161' ' ' CYS . . . . . . . . . . . . . 58.7 m -123.49 -172.59 2.55 Favored 'General case' 0 N--CA 1.485 1.299 0 C-N-CA 125.048 1.339 . . . . 71.2 108.473 177.281 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 162' ' ' GLY . . . . . . . . . . . . . . . 132.25 57.09 0.08 OUTLIER Glycine 0 C--N 1.354 1.572 0 CA-C-N 118.716 0.689 . . . . 61.15 112.977 -172.957 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 163' ' ' GLN . . . . . 0.57 ' HA ' ' H ' ' A' ' 7' ' ' PHE . 2.0 pt20 -47.84 137.46 9.77 Favored 'General case' 0 N--CA 1.485 1.288 0 C-N-CA 124.356 1.062 . . . . 72.3 113.708 -173.242 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 164' ' ' LEU . . . . . 0.473 ' HG ' ' HB2' ' A' ' 7' ' ' PHE . 41.2 mt . . . . . 0 CA--C 1.543 0.698 0 C-N-CA 124.005 0.922 . . . . 74.23 110.151 179.914 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 218' ' ' PRO . . . . . . . . . . . . . 93.4 Cg_endo . . . . . 0 CA--C 1.54 0.796 0 CA-C-O 121.215 0.423 . . . . 70.03 112.044 . . . . . . . . . 0 0 . 1 . 015 nuclear build core ' B' B ' 219' ' ' GLY . . . . . . . . . . . . . . . 112.38 177.55 19.88 Favored Glycine 0 CA--C 1.527 0.834 0 CA-C-N 115.186 -0.916 . . . . 75.52 111.909 -175.981 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 220' ' ' PRO . . . . . 0.436 ' HG3' HD11 ' A' ' 122' ' ' LEU . 91.7 Cg_endo -75.65 178.48 7.33 Favored 'Trans proline' 0 N--CA 1.489 1.254 0 C-N-CA 123.41 2.74 . . . . 63.54 113.419 -177.067 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 221' ' ' TYR . . . . . . . . . . . . . 99.7 m-85 . . . . . 0 N--CA 1.476 0.87 0 C-N-CA 124.464 1.105 . . . . 73.3 109.558 179.381 . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 55.5 m-80 . . . . . 0 N--CA 1.48 1.052 0 CA-C-O 119.288 -0.387 . . . . 73.15 111.723 . . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 4' ' ' PRO . . . . . 0.497 ' HG2' ' HB2' ' A' ' 24' ' ' LEU . 42.5 Cg_endo -65.42 135.34 42.26 Favored 'Trans proline' 0 C--N 1.378 2.1 0 C-N-CA 122.525 2.15 . . . . 73.31 110.816 178.522 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 5' ' ' THR . . . . . 0.408 ' HB ' ' O ' ' A' ' 164' ' ' LEU . 55.9 m -122.3 123.26 41.01 Favored 'General case' 0 CA--C 1.54 0.568 0 N-CA-C 109.278 -0.638 . . . . 71.22 109.278 -172.882 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 6' ' ' VAL . . . . . 0.552 ' HA ' ' HB2' ' A' ' 163' ' ' GLN . 14.4 m -101.33 136.39 33.35 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.659 0 C-N-CA 123.965 0.906 . . . . 74.23 109.256 -175.915 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 7' ' ' PHE . . . . . 0.438 ' HB3' ' HA ' ' A' ' 163' ' ' GLN . 86.4 t80 -125.6 136.98 53.85 Favored 'General case' 0 C--O 1.238 0.47 0 C-N-CA 123.469 0.707 . . . . 73.1 109.683 -175.627 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 8' ' ' PHE . . . . . 0.427 ' HB3' HG23 ' A' ' 158' ' ' ILE . 53.3 m-85 -138.76 165.84 25.96 Favored 'General case' 0 CA--C 1.534 0.349 0 C-N-CA 124.809 1.243 . . . . 70.21 109.493 177.254 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 13.9 m-20 -111.67 118.23 35.07 Favored 'General case' 0 C--N 1.323 -0.565 0 N-CA-C 106.386 -1.709 . . . . 73.54 106.386 168.868 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 10' ' ' ILE . . . . . 0.459 HG21 ' SD ' ' A' ' 142' ' ' MET . 46.3 mm -84.98 129.53 37.58 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.56 0 N-CA-C 109.159 -0.682 . . . . 52.53 109.159 178.722 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 11' ' ' ALA . . . . . 0.792 ' HB2' ' HB2' ' A' ' 159' ' ' ALA . . . -124.59 126.98 46.69 Favored 'General case' 0 C--O 1.217 -0.642 0 C-N-CA 123.691 0.796 . . . . 65.0 110.496 -176.89 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 12' ' ' VAL . . . . . 0.497 HG23 ' HB2' ' A' ' 17' ' ' LEU . 89.1 t -96.14 116.38 37.85 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.759 0 N-CA-C 107.976 -1.12 . . . . 41.14 107.976 173.418 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 30.2 m-20 62.99 24.14 14.39 Favored 'General case' 0 N--CA 1.488 1.446 0 C-N-CA 125.59 1.556 . . . . 74.13 112.048 -177.288 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 97.24 -17.77 58.57 Favored Glycine 0 C--N 1.347 1.151 0 CA-C-O 119.951 -0.361 . . . . 75.12 113.037 -179.201 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 40.9 mm-40 -94.32 124.66 54.95 Favored Pre-proline 0 CA--C 1.545 0.755 0 CA-C-O 118.551 -0.738 . . . . 51.41 109.767 179.66 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 19.7 Cg_endo -56.06 118.07 4.81 Favored 'Trans proline' 0 C--N 1.381 2.274 0 C-N-CA 123.222 2.615 . . . . 74.21 113.111 -176.308 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 17' ' ' LEU . . . . . 0.497 ' HB2' HG23 ' A' ' 12' ' ' VAL . 49.3 tp -78.12 -38.55 43.63 Favored 'General case' 0 N--CA 1.476 0.871 0 C-N-CA 124.244 1.018 . . . . 73.41 109.407 171.371 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 177.39 -160.3 27.0 Favored Glycine 0 N--CA 1.449 -0.481 0 CA-C-N 114.317 -1.311 . . . . 63.11 110.707 -175.521 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 6.3 ptp180 -140.08 147.22 39.97 Favored 'General case' 0 N--CA 1.468 0.456 0 C-N-CA 123.934 0.893 . . . . 72.14 109.693 179.799 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 87.4 t -137.18 132.5 46.53 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.7 0 C-N-CA 124.092 0.957 . . . . 64.21 109.593 -175.24 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 7.9 t -120.1 122.62 41.45 Favored 'General case' 0 CA--C 1.547 0.855 0 N-CA-C 108.999 -0.741 . . . . 71.3 108.999 172.601 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 22' ' ' PHE . . . . . 0.549 ' HA ' ' HA ' ' A' ' 132' ' ' VAL . 11.1 m-85 -100.15 152.22 20.51 Favored 'General case' 0 N--CA 1.476 0.857 0 C-N-CA 124.027 0.931 . . . . 71.42 108.819 176.556 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 23' ' ' GLU . . . . . 0.649 ' HB2' ' HD2' ' A' ' 133' ' ' LYS . 39.7 tt0 -110.76 119.01 37.7 Favored 'General case' 0 CA--C 1.54 0.58 0 C-N-CA 123.318 0.647 . . . . 70.21 109.538 175.517 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 24' ' ' LEU . . . . . 0.497 ' HB2' ' HG2' ' A' ' 4' ' ' PRO . 18.5 mt -90.8 127.86 36.5 Favored 'General case' 0 N--CA 1.472 0.654 0 C-N-CA 124.462 1.105 . . . . 73.05 110.028 -178.301 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 25' ' ' PHE . . . . . 0.536 ' HB2' HD11 ' A' ' 90' ' ' LEU . 85.4 m-85 -88.92 71.9 8.52 Favored 'General case' 0 CA--C 1.536 0.427 0 C-N-CA 123.776 0.83 . . . . 64.35 110.34 -178.534 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -67.12 -15.59 63.81 Favored 'General case' 0 N--CA 1.481 1.122 0 CA-C-N 115.403 -0.817 . . . . 63.35 112.223 177.58 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 9.2 p-10 -76.3 -18.71 58.82 Favored 'General case' 0 CA--C 1.555 1.156 0 C-N-CA 123.409 0.683 . . . . 64.34 111.088 176.885 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 52.2 mttp -106.67 -45.65 4.17 Favored 'General case' 0 N--CA 1.483 1.201 0 C-N-CA 123.902 0.881 . . . . 75.34 110.37 -178.536 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 29' ' ' VAL . . . . . 0.586 HG21 ' HA ' ' A' ' 129' ' ' PHE . 4.6 m -134.68 69.98 71.8 Favored Pre-proline 0 CA--C 1.562 1.437 0 C-N-CA 124.36 1.064 . . . . 62.5 109.913 -175.748 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 18.8 Cg_endo -58.57 -29.54 89.26 Favored 'Trans proline' 0 C--N 1.382 2.324 0 C-N-CA 123.062 2.508 . . . . 64.51 113.985 -175.004 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 34.8 ttmt -72.63 -56.95 4.54 Favored 'General case' 0 N--CA 1.479 1.01 0 C-N-CA 123.668 0.787 . . . . 74.52 111.217 -179.648 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 6.6 m -69.31 -25.54 64.27 Favored 'General case' 0 CA--C 1.559 1.298 0 CA-C-N 115.081 -0.963 . . . . 52.5 111.074 -173.373 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -82.89 -42.4 17.77 Favored 'General case' 0 CA--C 1.548 0.898 0 C-N-CA 123.717 0.807 . . . . 63.42 111.085 177.254 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 38.8 tt0 -56.13 -39.44 72.25 Favored 'General case' 0 N--CA 1.493 1.675 0 C-N-CA 123.681 0.792 . . . . 52.42 110.57 177.192 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 35' ' ' ASN . . . . . 0.591 ' ND2' ' SD ' ' A' ' 100' ' ' MET . 41.4 t30 -50.95 -67.08 0.28 Allowed 'General case' 0 CA--C 1.538 0.488 0 O-C-N 125.149 1.531 . . . . 74.22 111.256 179.848 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 60.6 t80 -64.46 -36.02 82.82 Favored 'General case' 0 CA--C 1.543 0.707 0 O-C-N 124.016 0.822 . . . . 75.44 111.267 -173.62 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 62.2 ttt180 -60.63 -47.01 88.13 Favored 'General case' 0 N--CA 1.478 0.936 0 O-C-N 124.068 0.855 . . . . 75.43 111.042 178.906 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 38' ' ' ALA . . . . . 0.486 ' HB3' HG21 ' A' ' 78' ' ' ILE . . . -78.06 -19.92 53.35 Favored 'General case' 0 N--CA 1.475 0.811 0 CA-C-N 115.153 -0.93 . . . . 73.12 111.671 -177.416 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 39' ' ' LEU . . . . . 0.422 ' HG ' ' O ' ' A' ' 35' ' ' ASN . 94.0 mt -73.94 -37.56 64.51 Favored 'General case' 0 N--CA 1.481 1.104 0 C-N-CA 123.162 0.585 . . . . 74.32 109.89 170.93 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 50.4 m -67.74 -49.4 62.74 Favored 'General case' 0 N--CA 1.48 1.041 0 C-N-CA 123.765 0.826 . . . . 75.5 110.831 -178.585 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 41' ' ' THR . . . . . 0.461 ' OG1' ' HG2' ' A' ' 43' ' ' GLU . 7.6 p -76.3 -33.78 59.07 Favored 'General case' 0 N--CA 1.477 0.895 0 C-N-CA 123.527 0.731 . . . . 72.13 111.619 178.344 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 76.99 37.9 31.78 Favored Glycine 0 C--N 1.34 0.756 0 CA-C-N 116.257 -0.429 . . . . 74.34 112.411 -172.525 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 43' ' ' GLU . . . . . 0.461 ' HG2' ' OG1' ' A' ' 41' ' ' THR . 22.7 mm-40 -64.67 -20.9 66.57 Favored 'General case' 0 N--CA 1.486 1.339 0 C-N-CA 123.159 0.584 . . . . 74.33 111.599 174.231 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 44' ' ' LYS . . . . . 0.514 ' HG3' ' HB ' ' A' ' 78' ' ' ILE . 71.1 mmtt -106.63 15.13 26.13 Favored 'General case' 0 CA--C 1.55 0.974 0 C-N-CA 124.296 1.038 . . . . 74.11 110.478 179.568 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 68.57 38.15 85.98 Favored Glycine 0 C--N 1.352 1.456 0 CA-C-N 116.103 -0.499 . . . . 73.03 114.227 177.466 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 46' ' ' PHE . . . . . 0.474 ' HE2' ' HA ' ' A' ' 78' ' ' ILE . 23.0 m-85 -117.49 -48.55 2.59 Favored 'General case' 0 N--CA 1.489 1.476 0 CA-C-N 117.432 0.616 . . . . 63.34 110.654 -179.246 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 48.14 61.51 4.88 Favored Glycine 0 C--N 1.356 1.672 0 O-C-N 124.415 1.072 . . . . 65.32 114.51 167.823 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 48' ' ' TYR . . . . . 0.418 ' HE2' HD22 ' A' ' 39' ' ' LEU . 64.0 m-85 -65.47 92.94 0.14 Allowed 'General case' 0 N--CA 1.477 0.903 0 CA-C-O 121.693 0.759 . . . . 75.15 112.339 -174.417 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 49' ' ' LYS . . . . . 0.558 ' HZ3' ' HB2' ' A' ' 49' ' ' LYS . 0.0 OUTLIER -105.77 135.78 46.59 Favored 'General case' 0 C--O 1.236 0.37 0 CA-C-N 114.006 -1.452 . . . . 63.01 108.658 175.238 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 78.34 21.59 69.65 Favored Glycine 0 C--N 1.341 0.853 0 CA-C-O 119.838 -0.423 . . . . 55.32 113.417 177.445 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 16.2 m -57.37 115.34 2.65 Favored 'General case' 0 N--CA 1.474 0.733 0 C-N-CA 123.586 0.754 . . . . 53.24 110.358 179.051 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 52' ' ' CYS . . . . . . . . . . . . . 23.8 p -81.36 114.55 20.2 Favored 'General case' 0 CA--C 1.538 0.5 0 C-N-CA 124.513 1.125 . . . . 71.34 111.459 -172.992 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 53' ' ' PHE . . . . . 0.718 ' HA ' ' HA2' ' A' ' 64' ' ' GLY . 38.6 m-85 -66.07 93.23 0.19 Allowed 'General case' 0 CA--C 1.539 0.539 0 C-N-CA 123.896 0.878 . . . . 74.41 108.784 164.715 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 17.0 p-80 -108.5 -0.34 20.49 Favored 'General case' 0 N--CA 1.479 0.977 0 CA-C-N 115.383 -0.826 . . . . 73.14 111.536 -176.498 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 55' ' ' ARG . . . . . 0.464 ' O ' ' HB3' ' A' ' 63' ' ' GLN . 53.2 ttt-85 -138.16 99.66 3.93 Favored 'General case' 0 C--O 1.21 -0.986 0 N-CA-C 109.228 -0.656 . . . . 50.11 109.228 173.796 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 56' ' ' ILE . . . . . 0.442 HG21 ' HA ' ' A' ' 143' ' ' GLU . 51.1 mt -131.33 134.35 61.11 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.935 0 N-CA-C 109.6 -0.519 . . . . 53.43 109.6 175.911 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 57' ' ' ILE . . . . . 0.415 HG23 ' HA ' ' A' ' 148' ' ' ARG . 63.0 mt -128.82 113.38 18.96 Favored Pre-proline 0 CA--C 1.553 1.08 0 C-N-CA 124.694 1.197 . . . . 61.41 108.726 177.975 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 58' ' ' PRO . . . . . 0.556 ' HA ' ' HG2' ' A' ' 143' ' ' GLU . 41.4 Cg_endo -64.77 143.64 81.02 Favored 'Trans proline' 0 C--N 1.386 2.523 0 C-N-CA 123.415 2.743 . . . . 73.02 112.158 -177.322 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 72.36 27.47 69.73 Favored Glycine 0 C--N 1.344 1.013 0 CA-C-N 115.713 -0.676 . . . . 50.1 112.304 -176.888 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 20.5 t80 -153.59 -77.38 0.11 Allowed 'General case' 0 CA--C 1.543 0.685 0 C-N-CA 123.579 0.752 . . . . 75.03 109.644 -178.472 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 61' ' ' MET . . . . . 0.761 ' SD ' ' HB2' ' A' ' 113' ' ' PHE . 13.3 tmm? -167.86 137.75 2.67 Favored 'General case' 0 CA--C 1.548 0.88 0 C-N-CA 122.807 0.443 . . . . 72.12 111.585 -164.018 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 62' ' ' CYS . . . . . . . . . . . . . 4.3 p -106.94 113.56 27.12 Favored 'General case' 0 CA--C 1.552 1.057 0 C-N-CA 124.78 1.232 . . . . 63.41 109.923 172.343 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 63' ' ' GLN . . . . . 0.586 ' HB2' ' SD ' ' A' ' 61' ' ' MET . 49.2 tt0 -107.99 121.66 45.24 Favored 'General case' 0 N--CA 1.487 1.382 0 C-N-CA 124.155 0.982 . . . . 74.1 111.138 -174.65 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 64' ' ' GLY . . . . . 0.718 ' HA2' ' HA ' ' A' ' 53' ' ' PHE . . . -97.55 170.88 25.91 Favored Glycine 0 C--N 1.34 0.796 0 CA-C-N 114.721 -1.127 . . . . 73.31 112.0 172.755 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 176.7 179.43 47.11 Favored Glycine 0 C--O 1.224 -0.524 0 N-CA-C 111.77 -0.532 . . . . 74.22 111.77 178.704 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 6.9 t0 -102.73 151.75 22.03 Favored 'General case' 0 CA--C 1.546 0.803 0 C-N-CA 124.385 1.074 . . . . 72.5 110.434 -173.901 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 68.6 t80 -82.25 -30.28 30.81 Favored 'General case' 0 N--CA 1.478 0.929 0 C-N-CA 124.727 1.211 . . . . 72.34 110.46 -178.404 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 68' ' ' THR . . . . . 0.684 HG22 ' HG3' ' A' ' 69' ' ' ARG . 6.9 m -74.89 143.06 43.97 Favored 'General case' 0 CA--C 1.549 0.929 0 C-N-CA 123.661 0.784 . . . . 61.43 109.49 177.118 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 69' ' ' ARG . . . . . 0.684 ' HG3' HG22 ' A' ' 68' ' ' THR . 50.7 mtt180 60.68 26.09 15.85 Favored 'General case' 0 N--CA 1.491 1.611 0 C-N-CA 124.565 1.146 . . . . 73.15 111.798 175.627 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 20.3 t-80 -58.83 -40.59 84.63 Favored 'General case' 0 N--CA 1.474 0.742 0 C-N-CA 124.624 1.17 . . . . 54.31 113.241 -165.777 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 43.3 m-80 -67.35 103.81 1.36 Allowed 'General case' 0 N--CA 1.474 0.76 0 C-N-CA 122.785 0.434 . . . . 75.22 110.004 177.747 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 89.28 -7.93 80.97 Favored Glycine 0 CA--C 1.531 1.09 0 CA-C-N 115.643 -0.708 . . . . 31.11 114.602 173.869 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 18.3 m -144.48 -88.66 0.11 Allowed 'General case' 0 CA--C 1.556 1.211 0 CA-C-N 117.891 0.845 . . . . 74.5 110.297 -178.83 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 65.66 61.64 5.44 Favored Glycine 0 C--N 1.362 1.973 0 CA-C-O 119.593 -0.559 . . . . 65.14 113.718 176.999 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 121.22 51.96 0.24 Allowed Glycine 0 N--CA 1.479 1.508 0 CA-C-N 117.841 0.82 . . . . 43.33 111.736 -174.0 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 76' ' ' LYS . . . . . 0.432 ' HB2' ' O ' ' A' ' 80' ' ' GLY . 64.0 pttt -60.91 168.93 2.13 Favored 'General case' 0 CA--C 1.548 0.867 0 C-N-CA 123.799 0.84 . . . . 73.14 112.498 -175.518 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 80.9 p -91.23 176.16 6.68 Favored 'General case' 0 CA--C 1.542 0.639 0 CA-C-N 115.033 -0.985 . . . . 62.1 110.605 -177.671 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 78' ' ' ILE . . . . . 0.514 ' HB ' ' HG3' ' A' ' 44' ' ' LYS . 26.0 pt -74.5 -18.61 16.78 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.547 0 CA-C-N 115.939 -0.573 . . . . 75.45 110.026 172.145 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 55.0 m-85 -89.4 11.39 19.34 Favored 'General case' 0 CA--C 1.544 0.724 0 C-N-CA 124.764 1.225 . . . . 71.32 110.855 179.058 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 80' ' ' GLY . . . . . 0.432 ' O ' ' HB2' ' A' ' 76' ' ' LYS . . . 109.63 -133.8 11.84 Favored Glycine 0 C--N 1.351 1.396 0 N-CA-C 110.831 -0.908 . . . . 72.41 110.831 -179.82 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 35.9 tt0 -65.13 -41.11 95.13 Favored 'General case' 0 N--CA 1.478 0.934 0 C-N-CA 123.88 0.872 . . . . 65.03 111.114 -179.326 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 82' ' ' LYS . . . . . 0.727 ' HD2' ' HA ' ' A' ' 107' ' ' THR . 21.0 pttp -169.49 178.36 4.25 Favored 'General case' 0 CA--C 1.545 0.776 0 CA-C-N 115.065 -0.97 . . . . 75.25 109.836 -165.777 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 26.2 p90 -158.16 171.73 19.69 Favored 'General case' 0 N--CA 1.475 0.809 0 C-N-CA 123.479 0.712 . . . . 74.11 110.191 174.339 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 12.2 pt-20 -94.18 162.66 13.77 Favored 'General case' 0 N--CA 1.476 0.86 0 C-N-CA 123.204 0.602 . . . . 74.53 109.834 175.796 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 65.1 m-20 -68.45 148.23 50.92 Favored 'General case' 0 N--CA 1.475 0.815 0 C-N-CA 123.871 0.868 . . . . 74.54 112.562 -172.345 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 86' ' ' GLU . . . . . 0.561 ' HG2' ' HA ' ' A' ' 29' ' ' VAL . 5.2 tp10 -73.96 -62.99 1.31 Allowed 'General case' 0 CA--C 1.544 0.728 0 CA-C-N 115.447 -0.797 . . . . 74.11 110.097 179.083 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 25.5 p30 -175.05 150.54 1.21 Allowed 'General case' 0 N--CA 1.483 1.185 0 C-N-CA 124.338 1.055 . . . . 60.43 109.801 -177.518 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 91.5 m-85 -90.06 57.51 3.81 Favored 'General case' 0 N--CA 1.483 1.205 0 C-N-CA 123.783 0.833 . . . . 63.22 111.182 -171.248 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 72.8 mt -82.24 -53.8 11.06 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.76 0 CA-C-N 115.684 -0.689 . . . . 54.4 109.393 175.394 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 90' ' ' LEU . . . . . 0.536 HD11 ' HB2' ' A' ' 25' ' ' PHE . 87.0 mt -84.11 109.92 18.08 Favored 'General case' 0 CA--C 1.541 0.613 0 CA-C-N 115.197 -0.91 . . . . 72.41 110.84 -178.384 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 18.3 ptpt -102.27 171.29 7.56 Favored 'General case' 0 N--CA 1.473 0.685 0 C-N-CA 124.385 1.074 . . . . 64.54 109.884 175.566 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 92' ' ' HIS . . . . . . . . . . . . . 39.2 m80 -89.75 48.33 1.58 Allowed 'General case' 0 CA--C 1.551 1.009 0 C-N-CA 124.269 1.028 . . . . 75.44 110.266 -175.06 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 12.0 t -91.95 -16.3 26.79 Favored 'General case' 0 N--CA 1.481 1.102 0 C-N-CA 123.46 0.704 . . . . 71.23 111.108 -179.331 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -104.97 157.32 16.59 Favored Glycine 0 C--N 1.343 0.959 0 CA-C-O 119.603 -0.554 . . . . 64.32 112.245 178.51 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 71.9 Cg_endo -80.87 150.74 18.51 Favored 'Trans proline' 0 C--N 1.363 1.303 0 C-N-CA 122.505 2.137 . . . . 64.01 111.421 169.359 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 96' ' ' GLY . . . . . 0.431 ' HA3' HG12 ' A' ' 132' ' ' VAL . . . 84.22 22.89 53.49 Favored Glycine 0 C--N 1.344 0.992 0 N-CA-C 114.114 0.406 . . . . 63.34 114.114 176.993 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 97' ' ' ILE . . . . . . . . . . . . . 14.7 mm -63.0 115.71 2.37 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.897 0 C-N-CA 124.603 1.161 . . . . 75.22 112.093 -174.746 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 59.1 tp -97.8 114.22 26.2 Favored 'General case' 0 C--O 1.249 1.062 0 CA-C-O 121.77 0.795 . . . . 71.14 109.829 175.641 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 32.8 t -142.9 143.22 31.95 Favored 'General case' 0 CA--C 1.545 0.767 0 C-N-CA 124.771 1.229 . . . . 70.51 107.955 179.058 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 100' ' ' MET . . . . . 0.72 ' HA ' ' HA ' ' A' ' 112' ' ' PHE . 81.1 mtp -84.55 142.01 30.31 Favored 'General case' 0 N--CA 1.492 1.643 0 CA-C-N 118.496 0.589 . . . . 73.35 111.063 -176.329 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 101' ' ' ALA . . . . . 0.582 ' HB3' ' HB2' ' A' ' 111' ' ' GLN . . . -73.4 171.38 13.2 Favored 'General case' 0 N--CA 1.484 1.254 0 CA-C-O 121.102 0.477 . . . . 64.43 111.874 -171.504 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 102' ' ' ASN . . . . . 0.466 ' HB3' ' HA ' ' A' ' 108' ' ' ASN . 30.1 p-10 -168.39 167.25 12.01 Favored 'General case' 0 N--CA 1.472 0.67 0 CA-C-N 115.536 -0.757 . . . . 72.35 111.234 -173.499 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -105.89 6.21 31.3 Favored 'General case' 0 N--CA 1.477 0.908 0 C-N-CA 124.147 0.979 . . . . 62.32 110.544 169.182 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 152.91 -174.87 31.62 Favored Glycine 0 C--N 1.354 1.528 0 CA-C-O 119.244 -0.753 . . . . 50.33 112.167 179.665 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 44.0 Cg_exo -59.14 148.02 87.7 Favored 'Trans proline' 0 C--N 1.373 1.816 0 C-N-CA 123.041 2.494 . . . . 70.21 111.932 173.064 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 66.3 t30 68.01 9.55 7.23 Favored 'General case' 0 N--CA 1.483 1.212 0 C-N-CA 124.943 1.297 . . . . 64.52 111.128 -177.129 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 107' ' ' THR . . . . . 0.727 ' HA ' ' HD2' ' A' ' 82' ' ' LYS . 5.0 m -121.65 1.61 10.03 Favored 'General case' 0 CA--C 1.55 0.974 0 C-N-CA 123.857 0.863 . . . . 64.31 110.545 -178.907 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 108' ' ' ASN . . . . . 0.466 ' HA ' ' HB3' ' A' ' 102' ' ' ASN . 43.7 t30 -69.29 132.84 47.09 Favored 'General case' 0 N--CA 1.478 0.951 0 C-N-CA 123.72 0.808 . . . . 72.0 109.673 179.976 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 112.57 15.12 9.76 Favored Glycine 0 N--CA 1.472 1.076 0 N-CA-C 114.045 0.378 . . . . 43.44 114.045 -179.371 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 32.1 p -112.63 119.44 38.12 Favored 'General case' 0 CA--C 1.543 0.687 0 N-CA-C 107.626 -1.25 . . . . 73.33 107.626 167.78 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 111' ' ' GLN . . . . . 0.582 ' HB2' ' HB3' ' A' ' 101' ' ' ALA . 40.0 mt-30 66.18 178.18 0.21 Allowed 'General case' 0 N--CA 1.497 1.898 0 C-N-CA 124.458 1.103 . . . . 74.15 111.112 -169.741 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 112' ' ' PHE . . . . . 0.72 ' HA ' ' HA ' ' A' ' 100' ' ' MET . 45.1 p90 -145.54 154.2 41.92 Favored 'General case' 0 N--CA 1.48 1.057 0 C-N-CA 123.675 0.79 . . . . 72.02 108.951 177.959 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 113' ' ' PHE . . . . . 0.761 ' HB2' ' SD ' ' A' ' 61' ' ' MET . 51.4 p90 -144.65 154.61 42.97 Favored 'General case' 0 C--O 1.238 0.471 0 CA-C-O 120.823 0.344 . . . . 63.13 111.626 179.306 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 114' ' ' ILE . . . . . . . . . . . . . 5.7 mt -130.3 101.59 6.03 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.724 0 C-N-CA 124.077 0.951 . . . . 65.41 108.769 -174.236 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 115' ' ' CYS . . . . . . . . . . . . . 63.2 m -80.4 104.96 11.3 Favored 'General case' 0 N--CA 1.47 0.549 0 C-N-CA 123.507 0.723 . . . . 72.12 109.709 178.101 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 81.7 p -69.08 -27.62 65.78 Favored 'General case' 0 N--CA 1.488 1.434 0 CA-C-O 121.161 0.505 . . . . 64.24 111.257 -178.63 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -97.75 151.23 20.38 Favored 'General case' 0 C--O 1.24 0.591 0 CA-C-N 115.212 -0.903 . . . . 61.03 108.678 172.997 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 11.5 ptmm? -71.82 86.85 0.97 Allowed 'General case' 0 CA--C 1.552 1.029 0 CA-C-O 121.645 0.736 . . . . 72.44 109.396 174.325 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 119' ' ' THR . . . . . . . . . . . . . 40.6 p -76.21 86.7 3.04 Favored 'General case' 0 CA--C 1.543 0.678 0 CA-C-N 115.028 -0.987 . . . . 73.1 110.872 -172.607 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 12.4 pt-20 -65.24 -31.39 72.52 Favored 'General case' 0 CA--C 1.542 0.668 0 CA-C-N 114.545 -1.207 . . . . 74.54 111.866 -172.108 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 121' ' ' TRP . . . . . . . . . . . . . 42.6 p90 -70.83 -14.51 62.44 Favored 'General case' 0 N--CA 1.475 0.791 0 C-N-CA 123.543 0.737 . . . . 71.3 111.793 -178.794 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 42.7 mt -87.9 5.46 40.37 Favored 'General case' 0 N--CA 1.481 1.103 0 C-N-CA 122.828 0.451 . . . . 74.52 111.873 176.405 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 69.1 m-20 -80.39 140.33 36.09 Favored 'General case' 0 N--CA 1.482 1.144 0 C-N-CA 122.642 0.377 . . . . 61.01 110.451 172.275 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 94.35 -10.9 71.01 Favored Glycine 0 C--N 1.347 1.175 0 CA-C-N 115.602 -0.727 . . . . 71.11 112.183 -169.281 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 1.7 mppt? -94.6 -168.26 1.8 Allowed 'General case' 0 N--CA 1.472 0.662 0 C-N-CA 124.476 1.11 . . . . 71.01 109.535 173.722 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 126' ' ' HIS . . . . . . . . . . . . . 53.9 p-80 -66.58 154.53 40.21 Favored 'General case' 0 CA--C 1.551 0.981 0 C-N-CA 124.179 0.991 . . . . 64.31 111.237 -172.146 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 17.6 m -78.81 147.54 6.76 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.813 0 CA-C-N 115.176 -0.92 . . . . 72.03 113.018 -163.262 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 128' ' ' VAL . . . . . 0.469 ' HB ' ' HB3' ' A' ' 90' ' ' LEU . 48.2 t -80.41 152.89 4.44 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.634 0 CA-C-N 114.159 -1.382 . . . . 52.33 108.537 172.576 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 129' ' ' PHE . . . . . 0.586 ' HA ' HG21 ' A' ' 29' ' ' VAL . 50.4 p90 -130.74 -15.81 3.42 Favored 'General case' 0 N--CA 1.482 1.173 0 N-CA-C 112.184 0.439 . . . . 73.41 112.184 179.187 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . -155.85 175.65 33.59 Favored Glycine 0 C--N 1.334 0.445 0 N-CA-C 112.109 -0.396 . . . . 53.13 112.109 -177.548 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 33.2 ttpt -156.23 140.51 16.6 Favored 'General case' 0 C--N 1.324 -0.519 0 N-CA-C 108.246 -1.02 . . . . 73.41 108.246 177.265 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 132' ' ' VAL . . . . . 0.549 ' HA ' ' HA ' ' A' ' 22' ' ' PHE . 6.7 p -61.1 134.23 26.57 Favored 'Isoleucine or valine' 0 CA--C 1.552 1.042 0 O-C-N 123.423 0.452 . . . . 73.04 111.279 177.336 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 133' ' ' LYS . . . . . 0.649 ' HD2' ' HB2' ' A' ' 23' ' ' GLU . 19.1 ptmt -111.52 -37.21 5.29 Favored 'General case' 0 N--CA 1.475 0.802 0 C-N-CA 123.472 0.709 . . . . 75.42 109.803 173.702 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 134' ' ' GLU . . . . . 0.546 ' HG2' ' HG3' ' A' ' 133' ' ' LYS . 40.9 mm-40 -119.91 133.94 55.4 Favored 'General case' 0 N--CA 1.48 1.06 0 C-N-CA 123.93 0.892 . . . . 53.11 109.728 -179.723 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 81.54 29.54 39.45 Favored Glycine 0 C--N 1.341 0.856 0 O-C-N 123.307 0.379 . . . . 61.34 113.421 176.965 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 136' ' ' MET . . . . . . . . . . . . . 15.8 tpt -59.43 -43.79 93.04 Favored 'General case' 0 N--CA 1.476 0.855 0 C-N-CA 123.487 0.715 . . . . 70.23 110.696 176.449 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 137' ' ' ASN . . . . . . . . . . . . . 17.0 m120 -63.55 -28.93 70.28 Favored 'General case' 0 N--CA 1.475 0.804 0 C-N-CA 123.607 0.763 . . . . 73.3 111.457 179.099 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 138' ' ' ILE . . . . . . . . . . . . . 43.4 mm -71.26 -39.03 72.28 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.119 0 C-N-CA 123.292 0.637 . . . . 62.12 110.255 176.316 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 50.8 t -64.12 -44.61 97.66 Favored 'Isoleucine or valine' 0 CA--C 1.552 1.054 0 C-N-CA 123.406 0.682 . . . . 74.43 110.189 177.982 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 43.5 mt-10 -67.99 -35.76 78.87 Favored 'General case' 0 N--CA 1.477 0.916 0 CA-C-N 115.149 -0.932 . . . . 74.45 110.908 178.956 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -68.4 -43.13 77.92 Favored 'General case' 0 N--CA 1.477 0.9 0 C-N-CA 123.479 0.712 . . . . 71.41 111.141 179.248 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 142' ' ' MET . . . . . 0.603 ' HB2' HD13 ' A' ' 156' ' ' ILE . 23.0 ptt? -73.68 -28.77 61.92 Favored 'General case' 0 N--CA 1.475 0.818 0 O-C-N 123.637 0.585 . . . . 75.41 110.793 -177.537 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 143' ' ' GLU . . . . . 0.556 ' HG2' ' HA ' ' A' ' 58' ' ' PRO . 33.0 tt0 -64.14 -28.93 70.1 Favored 'General case' 0 CA--C 1.553 1.083 0 CA-C-O 121.159 0.504 . . . . 62.24 111.555 -179.83 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 144' ' ' ARG . . . . . . . . . . . . . 48.1 mtm180 -70.67 -15.47 62.72 Favored 'General case' 0 N--CA 1.476 0.861 0 C-N-CA 123.191 0.596 . . . . 74.21 112.118 -179.957 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 145' ' ' PHE . . . . . 0.513 ' HB2' HD11 ' A' ' 156' ' ' ILE . 75.9 m-85 -82.87 -2.77 55.71 Favored 'General case' 0 N--CA 1.482 1.169 0 C-N-CA 122.592 0.357 . . . . 74.55 111.852 176.373 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . -95.42 -179.73 36.51 Favored Glycine 0 C--N 1.353 1.501 0 N-CA-C 112.331 -0.307 . . . . 45.13 112.331 176.193 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 16.5 m -132.58 169.44 16.6 Favored 'General case' 0 N--CA 1.487 1.376 0 C-N-CA 123.663 0.785 . . . . 74.52 110.842 -176.512 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 148' ' ' ARG . . . . . 0.415 ' HA ' HG23 ' A' ' 57' ' ' ILE . 10.6 mmt180 -65.65 -28.26 68.97 Favored 'General case' 0 N--CA 1.485 1.323 0 C-N-CA 123.926 0.891 . . . . 74.52 112.641 -174.255 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 149' ' ' ASN . . . . . . . . . . . . . 29.5 p-10 -81.88 -17.0 48.81 Favored 'General case' 0 N--CA 1.486 1.326 0 C-N-CA 123.444 0.698 . . . . 73.42 111.542 178.202 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 150' ' ' GLY . . . . . 0.441 ' O ' ' HA ' ' A' ' 55' ' ' ARG . . . 112.63 -17.01 23.55 Favored Glycine 0 C--N 1.348 1.205 0 CA-C-N 116.383 -0.371 . . . . 71.41 112.887 -178.831 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 62.7 tttp -67.21 133.98 50.8 Favored 'General case' 0 N--CA 1.473 0.695 0 CA-C-N 117.312 0.556 . . . . 70.31 110.603 -178.068 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 152' ' ' THR . . . . . . . . . . . . . 39.9 p -92.26 123.39 35.56 Favored 'General case' 0 CA--C 1.539 0.541 0 C-N-CA 123.301 0.64 . . . . 73.22 109.823 177.103 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 153' ' ' SER . . . . . . . . . . . . . 43.7 t -63.98 -36.22 83.28 Favored 'General case' 0 N--CA 1.475 0.813 0 C-N-CA 123.586 0.754 . . . . 74.11 110.176 174.148 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 45.4 mmtm -120.66 136.81 54.73 Favored 'General case' 0 N--CA 1.47 0.547 0 C-N-CA 124.205 1.002 . . . . 75.23 108.937 -179.046 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 33.4 mmtp -83.1 91.39 7.2 Favored 'General case' 0 N--CA 1.477 0.903 0 CA-C-O 121.513 0.673 . . . . 74.31 110.223 -174.568 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 156' ' ' ILE . . . . . 0.603 HD13 ' HB2' ' A' ' 142' ' ' MET . 68.2 mt -85.49 130.41 36.33 Favored 'Isoleucine or valine' 0 C--O 1.221 -0.397 0 CA-C-N 114.84 -1.073 . . . . 63.25 108.487 -178.349 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 157' ' ' THR . . . . . . . . . . . . . 35.9 p -138.68 156.4 47.44 Favored 'General case' 0 C--O 1.24 0.563 0 C-N-CA 124.444 1.098 . . . . 73.23 109.282 -175.536 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 158' ' ' ILE . . . . . 0.427 HG23 ' HB3' ' A' ' 8' ' ' PHE . 42.6 mt -74.43 95.26 0.86 Allowed 'Isoleucine or valine' 0 N--CA 1.475 0.822 0 N-CA-C 109.0 -0.741 . . . . 73.51 109.0 171.939 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 159' ' ' ALA . . . . . 0.792 ' HB2' ' HB2' ' A' ' 11' ' ' ALA . . . -51.7 -48.25 63.6 Favored 'General case' 0 N--CA 1.483 1.216 0 C-N-CA 124.585 1.154 . . . . 43.13 112.267 179.71 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 160' ' ' ASP . . . . . . . . . . . . . 35.6 t0 -154.23 162.11 41.39 Favored 'General case' 0 CA--C 1.54 0.567 0 CA-C-N 115.83 -0.623 . . . . 73.5 110.284 -175.639 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 161' ' ' CYS . . . . . . . . . . . . . 27.6 p -136.53 -173.79 3.52 Favored 'General case' 0 N--CA 1.476 0.86 0 C-N-CA 124.274 1.03 . . . . 73.22 108.538 175.763 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 162' ' ' GLY . . . . . . . . . . . . . . . 131.08 55.24 0.09 OUTLIER Glycine 0 C--N 1.346 1.131 0 N-CA-C 111.007 -0.837 . . . . 52.45 111.007 -166.999 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 163' ' ' GLN . . . . . 0.552 ' HB2' ' HA ' ' A' ' 6' ' ' VAL . 13.8 pt20 -47.25 142.92 3.58 Favored 'General case' 0 CA--C 1.554 1.117 0 C-N-CA 125.056 1.342 . . . . 64.02 114.13 -170.956 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 164' ' ' LEU . . . . . 0.408 ' O ' ' HB ' ' A' ' 5' ' ' THR . 95.9 mt . . . . . 0 N--CA 1.477 0.876 0 C-N-CA 123.729 0.811 . . . . 74.43 111.034 -172.237 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 218' ' ' PRO . . . . . 0.428 ' HB2' ' NE2' ' A' ' 111' ' ' GLN . 3.9 Cg_exo . . . . . 0 CA--C 1.547 1.16 0 N-CA-C 110.678 -0.547 . . . . 62.34 110.678 . . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 219' ' ' GLY . . . . . . . . . . . . . . . -178.88 164.87 33.51 Favored Glycine 0 CA--C 1.53 1.031 0 CA-C-N 114.765 -1.107 . . . . 70.41 111.435 -178.736 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 220' ' ' PRO . . . . . . . . . . . . . 62.0 Cg_endo -80.57 160.81 22.19 Favored 'Trans proline' 0 C--N 1.371 1.738 0 C-N-CA 123.09 2.527 . . . . 71.01 113.416 -178.043 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 221' ' ' TYR . . . . . . . . . . . . . 56.6 m-85 . . . . . 0 N--CA 1.486 1.348 0 C-N-CA 123.991 0.917 . . . . 73.43 111.106 -179.71 . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 3' ' ' ASN . . . . . 0.437 ' OD1' ' HA ' ' A' ' 25' ' ' PHE . 68.7 m-80 . . . . . 0 CA--C 1.545 0.786 0 CA-C-O 119.565 -0.255 . . . . 75.25 111.088 . . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 4' ' ' PRO . . . . . 0.498 ' HG2' ' HB2' ' A' ' 24' ' ' LEU . 33.2 Cg_endo -63.63 119.53 6.62 Favored 'Trans proline' 0 C--N 1.38 2.219 0 C-N-CA 122.63 2.22 . . . . 61.22 112.043 176.368 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 5' ' ' THR . . . . . 0.601 HG23 ' HD3' ' A' ' 133' ' ' LYS . 61.1 m -97.42 110.71 23.22 Favored 'General case' 0 CA--C 1.539 0.556 0 C-N-CA 123.748 0.819 . . . . 65.24 108.807 178.703 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 10.0 m -97.83 123.31 50.21 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.155 0 N-CA-C 109.252 -0.647 . . . . 64.31 109.252 -175.588 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 7' ' ' PHE . . . . . 0.45 ' H ' ' HA ' ' A' ' 163' ' ' GLN . 82.3 t80 -103.82 142.39 34.46 Favored 'General case' 0 C--O 1.236 0.368 0 CA-C-N 115.706 -0.679 . . . . 63.12 109.946 -171.44 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 8' ' ' PHE . . . . . 0.429 ' HB3' HG23 ' A' ' 158' ' ' ILE . 72.5 m-85 -140.85 164.46 30.17 Favored 'General case' 0 C--O 1.239 0.508 0 C-N-CA 124.235 1.014 . . . . 75.41 109.494 174.535 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 24.5 m-20 -118.52 113.21 20.96 Favored 'General case' 0 N--CA 1.469 0.488 0 N-CA-C 107.134 -1.432 . . . . 54.14 107.134 168.551 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 37.8 mm -91.19 143.87 10.34 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.678 0 C-N-CA 123.137 0.575 . . . . 65.3 109.639 -175.965 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 11' ' ' ALA . . . . . 0.407 ' HB2' ' HB2' ' A' ' 159' ' ' ALA . . . -132.73 143.57 49.69 Favored 'General case' 0 CA--C 1.537 0.461 0 C-N-CA 123.831 0.852 . . . . 74.44 111.634 -167.624 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 12' ' ' VAL . . . . . 0.54 HG23 ' HB2' ' A' ' 17' ' ' LEU . 24.3 t -98.51 107.17 19.9 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.642 0 N-CA-C 108.256 -1.016 . . . . 73.23 108.256 172.439 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 27.5 m-20 62.03 32.01 17.77 Favored 'General case' 0 N--CA 1.488 1.461 0 C-N-CA 124.508 1.123 . . . . 74.31 111.78 179.338 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 99.27 -26.71 23.25 Favored Glycine 0 C--N 1.346 1.127 0 CA-C-N 115.424 -0.807 . . . . 63.23 112.87 -178.653 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 17.7 mm-40 -82.29 114.09 48.72 Favored Pre-proline 0 CA--C 1.547 0.853 0 CA-C-O 118.657 -0.687 . . . . 72.33 110.249 -174.349 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 21.7 Cg_endo -57.8 112.03 1.02 Allowed 'Trans proline' 0 C--N 1.382 2.304 0 C-N-CA 123.468 2.779 . . . . 72.22 112.52 -173.748 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 17' ' ' LEU . . . . . 0.54 ' HB2' HG23 ' A' ' 12' ' ' VAL . 61.6 tp -80.17 -46.49 16.28 Favored 'General case' 0 N--CA 1.472 0.642 0 C-N-CA 123.652 0.781 . . . . 62.05 110.551 -179.819 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -175.26 -163.88 28.96 Favored Glycine 0 C--N 1.34 0.761 0 CA-C-N 115.543 -0.753 . . . . 65.4 112.147 -177.768 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 8.9 ptp180 -107.13 150.59 26.42 Favored 'General case' 0 N--CA 1.479 1.004 0 C-N-CA 123.354 0.662 . . . . 71.13 109.927 -178.677 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 54.9 t -143.67 123.46 8.66 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.844 0 N-CA-C 108.275 -1.009 . . . . 74.43 108.275 169.04 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 11.1 t -126.9 138.41 53.3 Favored 'General case' 0 CA--C 1.546 0.821 0 C-N-CA 123.57 0.748 . . . . 41.25 109.618 178.128 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 22' ' ' PHE . . . . . 0.426 ' CG ' HD22 ' A' ' 98' ' ' LEU . 72.8 m-85 -109.69 150.18 28.65 Favored 'General case' 0 N--CA 1.476 0.826 0 C-N-CA 123.7 0.8 . . . . 63.52 111.012 -175.078 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 23' ' ' GLU . . . . . 0.544 ' HB2' ' HD2' ' A' ' 133' ' ' LYS . 5.2 tp10 -98.06 102.65 14.46 Favored 'General case' 0 N--CA 1.473 0.692 0 C-N-CA 124.462 1.105 . . . . 62.25 108.396 173.383 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 24' ' ' LEU . . . . . 0.512 ' HB3' ' HB1' ' A' ' 33' ' ' ALA . 26.5 mt -87.68 117.56 26.59 Favored 'General case' 0 N--CA 1.476 0.837 0 N-CA-C 109.598 -0.519 . . . . 64.41 109.598 179.972 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 25' ' ' PHE . . . . . 0.57 ' HB2' HD11 ' A' ' 90' ' ' LEU . 77.1 m-85 -86.45 65.35 9.01 Favored 'General case' 0 CA--C 1.539 0.533 0 CA-C-O 121.371 0.605 . . . . 74.45 110.701 -175.383 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -72.81 -4.99 35.02 Favored 'General case' 0 N--CA 1.481 1.11 0 C-N-CA 123.946 0.898 . . . . 75.0 112.961 -175.502 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 12.4 p-10 -78.58 -29.92 46.42 Favored 'General case' 0 N--CA 1.478 0.952 0 C-N-CA 123.049 0.54 . . . . 73.33 110.061 172.926 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 93.3 mttt -96.42 -42.26 8.2 Favored 'General case' 0 N--CA 1.474 0.752 0 C-N-CA 124.099 0.959 . . . . 53.42 110.34 -179.015 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 29' ' ' VAL . . . . . 0.549 HG21 ' HA ' ' A' ' 129' ' ' PHE . 4.1 m -126.85 76.19 75.45 Favored Pre-proline 0 CA--C 1.558 1.271 0 C-N-CA 123.887 0.875 . . . . 75.51 110.663 178.302 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 81.7 Cg_exo -49.09 -52.57 8.49 Favored 'Trans proline' 0 C--N 1.381 2.244 0 C-N-CA 123.388 2.725 . . . . 51.42 113.967 176.103 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 85.0 tttt -67.62 -54.48 19.4 Favored 'General case' 0 N--CA 1.478 0.929 0 C-N-CA 123.588 0.755 . . . . 74.42 111.66 -174.194 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 7.0 m -69.08 -33.12 73.04 Favored 'General case' 0 CA--C 1.551 0.983 0 C-N-CA 123.022 0.529 . . . . 41.11 111.642 -170.499 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 33' ' ' ALA . . . . . 0.512 ' HB1' ' HB3' ' A' ' 24' ' ' LEU . . . -79.58 -40.24 29.86 Favored 'General case' 0 CA--C 1.547 0.836 0 C-N-CA 122.619 0.367 . . . . 64.53 111.19 178.303 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 39.0 tt0 -59.86 -35.46 74.84 Favored 'General case' 0 N--CA 1.486 1.369 0 C-N-CA 123.324 0.65 . . . . 75.13 111.052 178.128 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 35' ' ' ASN . . . . . 0.516 ' ND2' ' SD ' ' A' ' 100' ' ' MET . 43.9 t30 -53.16 -65.87 0.49 Allowed 'General case' 0 C--N 1.35 0.618 0 O-C-N 124.552 1.157 . . . . 73.33 110.989 179.74 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 85.8 t80 -62.37 -34.03 75.89 Favored 'General case' 0 CA--C 1.542 0.649 0 O-C-N 124.332 1.02 . . . . 65.13 111.106 -177.008 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 37' ' ' ARG . . . . . 0.423 ' HG3' ' OE1' ' A' ' 163' ' ' GLN . 48.9 ttp180 -59.94 -45.88 91.19 Favored 'General case' 0 N--CA 1.473 0.676 0 O-C-N 123.926 0.766 . . . . 73.31 111.374 175.277 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 38' ' ' ALA . . . . . 0.411 ' HB1' ' HG2' ' A' ' 44' ' ' LYS . . . -81.77 -18.84 42.75 Favored 'General case' 0 CA--C 1.537 0.477 0 CA-C-N 115.668 -0.696 . . . . 74.42 111.425 -174.374 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 39' ' ' LEU . . . . . 0.481 HD22 ' HE1' ' A' ' 48' ' ' TYR . 98.5 mt -74.26 -39.88 62.72 Favored 'General case' 0 CA--C 1.547 0.844 0 C-N-CA 123.312 0.645 . . . . 65.25 109.31 170.469 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 35.1 t -64.92 -55.03 21.71 Favored 'General case' 0 N--CA 1.477 0.877 0 C-N-CA 124.596 1.159 . . . . 54.5 111.155 -179.938 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 34.8 p -76.58 -31.37 57.46 Favored 'General case' 0 CA--C 1.541 0.607 0 CA-C-N 115.382 -0.826 . . . . 51.13 111.224 -178.289 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 79.23 22.1 66.05 Favored Glycine 0 C--N 1.346 1.139 0 CA-C-O 119.614 -0.548 . . . . 64.24 113.951 176.679 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 8.7 mm-40 -63.64 -22.41 66.88 Favored 'General case' 0 N--CA 1.483 1.221 0 C-N-CA 123.368 0.667 . . . . 72.01 111.728 179.857 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 44' ' ' LYS . . . . . 0.411 ' HG2' ' HB1' ' A' ' 38' ' ' ALA . 30.6 mmmt -94.6 15.33 18.32 Favored 'General case' 0 CA--C 1.55 0.947 0 C-N-CA 124.035 0.934 . . . . 74.34 111.558 -179.962 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 76.98 36.71 35.1 Favored Glycine 0 C--N 1.35 1.335 0 N-CA-C 114.417 0.527 . . . . 75.45 114.417 174.843 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 46' ' ' PHE . . . . . 0.435 ' HE2' ' HA ' ' A' ' 78' ' ' ILE . 25.2 m-85 -122.6 -48.35 2.05 Favored 'General case' 0 N--CA 1.491 1.575 0 CA-C-N 117.758 0.779 . . . . 75.02 111.514 -177.457 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 54.18 63.83 4.82 Favored Glycine 0 C--N 1.35 1.312 0 O-C-N 124.077 0.86 . . . . 54.51 115.018 170.218 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 48' ' ' TYR . . . . . 0.688 ' HE2' ' HB2' ' A' ' 66' ' ' ASP . 54.6 m-85 -65.27 89.79 0.09 Allowed 'General case' 0 N--CA 1.481 1.118 0 CA-C-O 121.745 0.783 . . . . 75.34 111.731 179.885 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 27.6 tptp -111.23 107.0 16.16 Favored 'General case' 0 CA--C 1.535 0.377 0 CA-C-N 114.576 -1.193 . . . . 62.14 108.476 178.247 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 99.08 13.8 38.33 Favored Glycine 0 N--CA 1.471 0.999 0 CA-C-O 118.992 -0.893 . . . . 54.41 113.763 178.754 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 20.3 p -57.67 122.89 13.86 Favored 'General case' 0 N--CA 1.48 1.035 0 C-N-CA 123.414 0.686 . . . . 60.21 110.818 -178.482 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 52' ' ' CYS . . . . . . . . . . . . . 7.0 p -100.98 132.37 46.42 Favored 'General case' 0 CA--C 1.539 0.533 0 C-N-CA 123.721 0.808 . . . . 55.13 112.729 -164.058 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 53' ' ' PHE . . . . . 0.604 ' HA ' ' HA3' ' A' ' 64' ' ' GLY . 45.5 m-85 -72.04 140.22 48.9 Favored 'General case' 0 CA--C 1.54 0.559 0 C-N-CA 124.381 1.072 . . . . 73.24 110.151 168.899 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 15.8 p-80 -153.4 13.55 0.49 Allowed 'General case' 0 N--CA 1.478 0.959 0 CA-C-N 116.087 -0.506 . . . . 62.15 112.213 -173.82 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 55' ' ' ARG . . . . . 0.451 ' HA ' ' O ' ' A' ' 150' ' ' GLY . 33.4 ttt180 -155.8 98.29 1.9 Allowed 'General case' 0 N--CA 1.474 0.728 0 N-CA-C 109.732 -0.47 . . . . 74.14 109.732 174.342 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 29.3 mt -130.23 135.88 59.86 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.105 0 C-N-CA 123.053 0.541 . . . . 75.1 109.799 -178.449 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 61.7 mt -134.58 124.55 17.03 Favored Pre-proline 0 CA--C 1.553 1.072 0 C-N-CA 124.976 1.31 . . . . 74.42 109.497 -173.454 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 31.0 Cg_endo -61.31 139.74 84.59 Favored 'Trans proline' 0 C--N 1.384 2.411 0 C-N-CA 123.609 2.873 . . . . 73.44 113.573 -179.452 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 60.22 24.55 61.24 Favored Glycine 0 C--N 1.353 1.504 0 CA-C-N 115.006 -0.997 . . . . 41.11 113.872 -179.813 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 40.5 t80 -139.76 -69.55 0.41 Allowed 'General case' 0 C--O 1.241 0.651 0 CA-C-N 116.973 0.386 . . . . 72.53 110.495 -174.583 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 53.3 ttp -171.44 148.34 2.53 Favored 'General case' 0 N--CA 1.482 1.151 0 N-CA-C 111.905 0.335 . . . . 65.45 111.905 -165.464 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 62' ' ' CYS . . . . . 0.611 ' SG ' ' HB ' ' A' ' 114' ' ' ILE . 21.9 p -119.81 117.58 28.57 Favored 'General case' 0 N--CA 1.477 0.89 0 C-N-CA 123.894 0.878 . . . . 65.23 108.974 169.591 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 63' ' ' GLN . . . . . 0.442 ' OE1' ' HD3' ' A' ' 55' ' ' ARG . 35.9 tt0 -123.24 143.92 49.73 Favored 'General case' 0 N--CA 1.487 1.42 0 C-N-CA 124.166 0.986 . . . . 73.03 111.781 -170.439 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 64' ' ' GLY . . . . . 0.604 ' HA3' ' HA ' ' A' ' 53' ' ' PHE . . . -161.78 -169.58 25.3 Favored Glycine 0 C--N 1.348 1.203 0 CA-C-N 115.039 -0.982 . . . . 52.33 113.011 176.403 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 166.4 -149.84 16.25 Favored Glycine 0 C--N 1.341 0.825 0 N-CA-C 112.242 -0.343 . . . . 44.21 112.242 -179.056 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 66' ' ' ASP . . . . . 0.688 ' HB2' ' HE2' ' A' ' 48' ' ' TYR . 41.2 t0 -74.94 146.4 41.8 Favored 'General case' 0 N--CA 1.477 0.919 0 C-N-CA 124.318 1.047 . . . . 64.22 110.601 -178.825 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 51.7 t80 -79.88 -33.69 39.8 Favored 'General case' 0 CA--C 1.542 0.673 0 C-N-CA 123.663 0.785 . . . . 61.21 109.46 178.043 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 68' ' ' THR . . . . . 0.637 HG22 ' HG3' ' A' ' 69' ' ' ARG . 14.1 m -72.56 150.59 43.01 Favored 'General case' 0 CA--C 1.544 0.748 0 CA-C-N 114.961 -1.018 . . . . 63.32 109.206 173.019 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 69' ' ' ARG . . . . . 0.637 ' HG3' HG22 ' A' ' 68' ' ' THR . 65.9 mtt85 66.71 13.68 9.46 Favored 'General case' 0 N--CA 1.488 1.438 0 C-N-CA 124.033 0.933 . . . . 73.32 112.296 174.921 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 15.9 t-80 -52.59 -29.1 24.06 Favored 'General case' 0 N--CA 1.484 1.253 0 C-N-CA 125.012 1.325 . . . . 74.44 112.007 -173.724 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 5.3 m-20 -69.28 88.2 0.44 Allowed 'General case' 0 CA--C 1.548 0.887 0 C-N-CA 123.987 0.915 . . . . 62.35 110.377 172.391 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 85.46 -1.2 88.47 Favored Glycine 0 CA--C 1.533 1.16 0 N-CA-C 115.195 0.838 . . . . 13.14 115.195 172.774 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 28.5 m -139.74 -90.74 0.18 Allowed 'General case' 0 N--CA 1.478 0.943 0 CA-C-N 118.06 0.93 . . . . 53.4 110.019 176.02 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 74' ' ' GLY . . . . . 0.464 ' HA2' ' O ' ' A' ' 68' ' ' THR . . . 61.32 60.65 7.93 Favored Glycine 0 C--N 1.356 1.668 0 O-C-N 123.577 0.548 . . . . 24.24 113.277 -176.905 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 141.36 52.19 0.04 OUTLIER Glycine 0 C--N 1.353 1.518 0 C-N-CA 121.101 -0.571 . . . . 73.22 113.055 -176.502 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 63.6 pttt -56.8 158.9 4.34 Favored 'General case' 0 N--CA 1.487 1.377 0 C-N-CA 123.406 0.682 . . . . 72.1 111.896 -179.881 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 71.8 p -98.29 -179.21 4.29 Favored 'General case' 0 CA--C 1.544 0.729 0 C-N-CA 123.338 0.655 . . . . 74.52 110.92 -176.214 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 78' ' ' ILE . . . . . 0.435 ' HA ' ' HE2' ' A' ' 46' ' ' PHE . 25.4 pt -84.96 -8.18 11.12 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.802 0 C-N-CA 122.936 0.494 . . . . 72.24 110.569 173.483 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 53.3 m-85 -103.87 12.42 34.44 Favored 'General case' 0 N--CA 1.472 0.669 0 C-N-CA 124.338 1.055 . . . . 64.43 110.361 -179.992 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 126.42 -134.62 8.62 Favored Glycine 0 C--N 1.348 1.211 0 N-CA-C 110.623 -0.991 . . . . 62.35 110.623 -179.113 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 36.7 tt0 -81.81 -45.66 15.26 Favored 'General case' 0 N--CA 1.47 0.53 0 N-CA-C 109.042 -0.725 . . . . 72.34 109.042 173.701 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 82' ' ' LYS . . . . . 0.799 ' HD2' ' HA ' ' A' ' 107' ' ' THR . 22.6 pttm -156.07 165.32 36.78 Favored 'General case' 0 CA--C 1.54 0.561 0 CA-C-N 114.217 -1.356 . . . . 74.4 110.096 -171.284 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 45.7 p90 -145.76 172.77 12.82 Favored 'General case' 0 N--CA 1.474 0.742 0 C-N-CA 124.177 0.991 . . . . 75.34 109.821 -178.663 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 12.2 pt-20 -91.9 159.73 15.62 Favored 'General case' 0 N--CA 1.472 0.666 0 C-N-CA 122.668 0.387 . . . . 62.45 110.614 178.722 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 62.5 m-20 -63.25 124.78 22.11 Favored 'General case' 0 N--CA 1.472 0.668 0 C-N-CA 123.621 0.768 . . . . 71.52 110.669 -179.767 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 62.1 tt0 -62.72 -48.28 79.91 Favored 'General case' 0 CA--C 1.54 0.566 0 CA-C-N 115.025 -0.989 . . . . 74.41 111.338 -178.95 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 31.9 p30 -161.65 -162.21 0.85 Allowed 'General case' 0 N--CA 1.474 0.759 0 C-N-CA 124.059 0.944 . . . . 75.24 108.517 -179.068 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 87.1 m-85 -142.16 46.14 1.64 Allowed 'General case' 0 N--CA 1.492 1.654 0 C-N-CA 123.043 0.537 . . . . 71.4 110.357 175.494 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 78.3 mt -69.59 -56.67 10.77 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.008 0 CA-C-N 115.764 -0.653 . . . . 42.14 109.882 176.111 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 90' ' ' LEU . . . . . 0.57 HD11 ' HB2' ' A' ' 25' ' ' PHE . 72.0 mt -87.42 126.69 35.03 Favored 'General case' 0 C--O 1.237 0.434 0 CA-C-N 115.045 -0.979 . . . . 54.12 109.751 -176.899 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 9.6 mtpm? -119.72 165.58 14.33 Favored 'General case' 0 CA--C 1.542 0.638 0 C-N-CA 124.194 0.998 . . . . 64.13 110.768 -175.291 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 92' ' ' HIS . . . . . . . . . . . . . 52.1 m-70 -83.73 51.31 1.99 Allowed 'General case' 0 N--CA 1.485 1.297 0 C-N-CA 124.478 1.111 . . . . 74.03 110.463 -177.326 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 11.6 t -95.94 13.39 27.06 Favored 'General case' 0 N--CA 1.48 1.036 0 C-N-CA 123.706 0.802 . . . . 73.35 112.242 -170.557 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -161.34 173.18 37.72 Favored Glycine 0 C--N 1.342 0.893 0 CA-C-O 120.027 -0.318 . . . . 64.43 112.524 179.618 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 98.6 Cg_endo -78.87 157.64 27.46 Favored 'Trans proline' 0 C--N 1.363 1.31 0 C-N-CA 122.68 2.253 . . . . 70.1 111.737 170.651 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 81.42 10.52 84.45 Favored Glycine 0 CA--C 1.533 1.171 0 CA-C-N 116.143 -0.481 . . . . 72.14 114.284 179.746 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 97' ' ' ILE . . . . . 0.579 ' HB ' ' HB2' ' A' ' 115' ' ' CYS . 9.8 mm -66.85 111.03 1.69 Allowed 'Isoleucine or valine' 0 CA--C 1.553 1.065 0 C-N-CA 124.36 1.064 . . . . 73.2 111.775 -176.56 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 98' ' ' LEU . . . . . 0.426 HD22 ' CG ' ' A' ' 22' ' ' PHE . 36.6 tp -92.09 113.98 26.39 Favored 'General case' 0 C--O 1.246 0.897 0 CA-C-O 121.257 0.551 . . . . 70.14 110.596 178.577 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 36.2 t -137.25 144.2 42.63 Favored 'General case' 0 CA--C 1.545 0.76 0 C-N-CA 124.395 1.078 . . . . 63.13 108.263 175.167 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 100' ' ' MET . . . . . 0.656 ' HA ' ' HA ' ' A' ' 112' ' ' PHE . 74.1 mtp -78.7 147.03 33.63 Favored 'General case' 0 N--CA 1.483 1.217 0 N-CA-C 109.168 -0.678 . . . . 53.21 109.168 175.316 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 101' ' ' ALA . . . . . 0.548 ' HB3' ' HB2' ' A' ' 111' ' ' GLN . . . -79.53 164.64 23.72 Favored 'General case' 0 N--CA 1.479 0.985 0 CA-C-O 121.399 0.619 . . . . 54.45 112.59 -169.875 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 24.2 p-10 -153.98 167.58 29.28 Favored 'General case' 0 N--CA 1.471 0.612 0 CA-C-N 114.82 -1.082 . . . . 71.35 110.071 -178.591 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -113.63 -7.12 13.35 Favored 'General case' 0 CA--C 1.544 0.747 0 C-N-CA 123.765 0.826 . . . . 72.41 110.02 167.56 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 171.5 -164.76 37.64 Favored Glycine 0 C--N 1.351 1.374 0 CA-C-O 119.399 -0.667 . . . . 44.33 111.555 -178.572 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 14.1 Cg_exo -70.69 143.06 45.35 Favored 'Trans proline' 0 C--N 1.37 1.658 0 C-N-CA 123.322 2.682 . . . . 73.2 111.856 177.952 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 64.4 t30 64.57 16.31 10.21 Favored 'General case' 0 N--CA 1.485 1.29 0 C-N-CA 125.131 1.372 . . . . 73.35 110.997 -177.174 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 107' ' ' THR . . . . . 0.799 ' HA ' ' HD2' ' A' ' 82' ' ' LYS . 4.6 m -117.26 5.48 12.66 Favored 'General case' 0 CA--C 1.547 0.828 0 C-N-CA 124.162 0.985 . . . . 70.23 110.042 -178.828 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 53.1 t30 -84.09 133.53 34.63 Favored 'General case' 0 N--CA 1.474 0.753 0 C-N-CA 123.867 0.867 . . . . 71.52 109.937 -176.842 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 113.12 10.39 15.84 Favored Glycine 0 N--CA 1.472 1.074 0 CA-C-O 120.203 -0.22 . . . . 72.23 113.181 -176.191 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 46.4 p -104.11 120.91 42.11 Favored 'General case' 0 CA--C 1.542 0.652 0 N-CA-C 107.48 -1.304 . . . . 72.3 107.48 166.383 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 111' ' ' GLN . . . . . 0.548 ' HB2' ' HB3' ' A' ' 101' ' ' ALA . 46.5 mt-30 66.9 178.01 0.23 Allowed 'General case' 0 N--CA 1.498 1.943 0 C-N-CA 124.567 1.147 . . . . 64.32 111.533 -172.929 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 112' ' ' PHE . . . . . 0.656 ' HA ' ' HA ' ' A' ' 100' ' ' MET . 45.2 p90 -143.74 161.45 38.56 Favored 'General case' 0 N--CA 1.473 0.708 0 C-N-CA 124.409 1.084 . . . . 64.04 108.874 173.273 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 113' ' ' PHE . . . . . 0.462 ' HE1' ' SG ' ' A' ' 115' ' ' CYS . 48.0 p90 -153.91 161.71 41.79 Favored 'General case' 0 N--CA 1.464 0.266 0 CA-C-O 121.354 0.597 . . . . 75.42 111.673 176.423 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 114' ' ' ILE . . . . . 0.611 ' HB ' ' SG ' ' A' ' 62' ' ' CYS . 15.6 mt -119.24 100.7 10.25 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.744 0 CA-C-N 114.31 -1.314 . . . . 64.41 107.577 175.184 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 115' ' ' CYS . . . . . 0.579 ' HB2' ' HB ' ' A' ' 97' ' ' ILE . 87.0 m -62.23 104.4 0.48 Allowed 'General case' 0 N--CA 1.474 0.769 0 N-CA-C 109.245 -0.65 . . . . 51.33 109.245 171.612 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 28.0 p -82.05 -0.19 43.33 Favored 'General case' 0 CA--C 1.547 0.853 0 C-N-CA 124.316 1.047 . . . . 73.11 111.609 -177.059 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -129.8 160.94 31.91 Favored 'General case' 0 C--O 1.245 0.834 0 C-N-CA 123.93 0.892 . . . . 41.34 109.608 169.471 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 10.3 ptmt -70.66 79.76 0.6 Allowed 'General case' 0 CA--C 1.546 0.82 0 CA-C-O 121.613 0.72 . . . . 50.23 109.418 171.123 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 119' ' ' THR . . . . . . . . . . . . . 36.6 p -72.35 87.05 1.13 Allowed 'General case' 0 CA--C 1.549 0.931 0 CA-C-O 122.013 0.911 . . . . 72.44 110.132 -176.161 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 9.5 pt-20 -72.8 -30.8 64.36 Favored 'General case' 0 N--CA 1.477 0.907 0 CA-C-N 114.611 -1.177 . . . . 73.05 112.307 -169.879 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 121' ' ' TRP . . . . . . . . . . . . . 41.4 p90 -68.39 -21.49 64.69 Favored 'General case' 0 CA--C 1.544 0.746 0 C-N-CA 122.965 0.506 . . . . 75.31 110.936 176.557 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 52.7 mt -83.41 0.36 46.45 Favored 'General case' 0 N--CA 1.482 1.139 0 C-N-CA 122.882 0.473 . . . . 42.23 112.254 177.768 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 62.7 m-20 -78.32 119.79 22.17 Favored 'General case' 0 CA--C 1.542 0.656 0 N-CA-C 109.082 -0.71 . . . . 74.35 109.082 172.728 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 111.02 -25.15 14.7 Favored Glycine 0 C--N 1.346 1.123 0 CA-C-N 115.589 -0.732 . . . . 74.43 111.279 -168.189 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 125' ' ' LYS . . . . . 0.655 ' HG3' ' H ' ' A' ' 126' ' ' HIS . 0.5 OUTLIER -77.32 -167.13 0.85 Allowed 'General case' 0 CA--C 1.568 1.641 0 C-N-CA 124.512 1.125 . . . . 61.14 107.984 170.997 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 126' ' ' HIS . . . . . 0.655 ' H ' ' HG3' ' A' ' 125' ' ' LYS . 0.0 OUTLIER -64.57 150.03 47.65 Favored 'General case' 0 C--O 1.248 0.996 0 C-N-CA 123.944 0.898 . . . . 74.24 112.93 -170.777 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 13.9 p -73.01 145.55 11.7 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.585 0 CA-C-N 114.354 -1.293 . . . . 64.54 111.906 -169.669 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 46.5 t -81.96 149.43 4.8 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.533 0 CA-C-N 114.379 -1.282 . . . . 74.12 108.616 172.41 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 129' ' ' PHE . . . . . 0.549 ' HA ' HG21 ' A' ' 29' ' ' VAL . 46.0 p90 -129.33 -9.1 4.7 Favored 'General case' 0 N--CA 1.481 1.086 0 CA-C-N 118.158 0.435 . . . . 72.41 111.753 179.611 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . -160.92 176.58 37.51 Favored Glycine 0 C--N 1.337 0.59 0 O-C-N 123.371 0.419 . . . . 73.23 112.67 -177.578 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 34.2 ttpt -151.47 135.86 16.89 Favored 'General case' 0 N--CA 1.467 0.415 0 N-CA-C 108.307 -0.997 . . . . 63.0 108.307 173.977 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 6.4 p -60.8 117.31 2.46 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.921 0 O-C-N 123.557 0.535 . . . . 74.44 110.661 178.568 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 133' ' ' LYS . . . . . 0.601 ' HD3' HG23 ' A' ' 5' ' ' THR . 22.3 ptmt -102.12 -14.93 16.87 Favored 'General case' 0 N--CA 1.481 1.124 0 C-N-CA 123.835 0.854 . . . . 75.31 110.609 -178.22 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 3.7 mm-40 -145.36 141.7 28.72 Favored 'General case' 0 N--CA 1.47 0.568 0 C-N-CA 123.11 0.564 . . . . 73.51 110.263 -177.808 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 135' ' ' GLY . . . . . 0.405 ' O ' HG23 ' A' ' 139' ' ' VAL . . . 71.75 26.47 72.78 Favored Glycine 0 C--N 1.338 0.645 0 O-C-N 123.797 0.686 . . . . 54.1 112.76 -174.384 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 136' ' ' MET . . . . . . . . . . . . . 7.0 tpt -60.58 -41.96 95.73 Favored 'General case' 0 N--CA 1.481 1.076 0 C-N-CA 123.379 0.672 . . . . 74.11 109.996 177.223 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 137' ' ' ASN . . . . . . . . . . . . . 12.4 m120 -62.95 -37.08 85.66 Favored 'General case' 0 N--CA 1.477 0.894 0 C-N-CA 123.68 0.792 . . . . 74.4 110.759 178.733 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 138' ' ' ILE . . . . . 0.53 ' O ' ' HG3' ' A' ' 142' ' ' MET . 49.6 mm -61.0 -51.16 76.43 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.809 0 C-N-CA 123.29 0.636 . . . . 74.51 109.663 175.922 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 139' ' ' VAL . . . . . 0.463 HG13 ' SG ' ' A' ' 62' ' ' CYS . 94.6 t -54.36 -47.0 70.06 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.138 0 C-N-CA 124.293 1.037 . . . . 74.42 111.454 179.859 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 38.2 mt-10 -67.24 -29.98 69.77 Favored 'General case' 0 N--CA 1.481 1.079 0 C-N-CA 123.689 0.796 . . . . 73.02 111.569 -179.222 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -77.59 -35.66 52.71 Favored 'General case' 0 N--CA 1.475 0.786 0 C-N-CA 122.938 0.495 . . . . 42.0 111.513 178.833 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 142' ' ' MET . . . . . 0.53 ' HG3' ' O ' ' A' ' 138' ' ' ILE . 45.3 mtp -80.52 -19.58 45.49 Favored 'General case' 0 N--CA 1.483 1.193 0 C-N-CA 122.693 0.397 . . . . 75.15 111.106 -178.935 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 24.8 tt0 -54.15 -35.15 61.94 Favored 'General case' 0 CA--C 1.55 0.974 0 C-N-CA 124.445 1.098 . . . . 52.14 110.847 168.452 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 144' ' ' ARG . . . . . . . . . . . . . 71.9 mtp180 -74.42 -11.91 60.36 Favored 'General case' 0 CA--C 1.542 0.636 0 C-N-CA 124.69 1.196 . . . . 63.44 112.067 -175.833 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 145' ' ' PHE . . . . . 0.46 ' HD2' ' HA ' ' A' ' 142' ' ' MET . 67.2 m-85 -90.94 -4.89 56.14 Favored 'General case' 0 N--CA 1.479 0.986 0 C-N-CA 122.816 0.446 . . . . 64.04 110.962 173.541 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . -91.76 173.92 37.18 Favored Glycine 0 C--N 1.343 0.939 0 CA-C-N 116.827 -0.17 . . . . 75.41 112.714 176.614 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 20.0 m -132.0 167.92 18.84 Favored 'General case' 0 N--CA 1.484 1.259 0 C-N-CA 124.054 0.942 . . . . 73.43 110.434 -177.491 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 148' ' ' ARG . . . . . . . . . . . . . 19.7 mmm180 -61.77 -32.22 72.47 Favored 'General case' 0 N--CA 1.484 1.235 0 C-N-CA 123.852 0.861 . . . . 52.32 112.246 -173.071 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 149' ' ' ASN . . . . . . . . . . . . . 30.6 p-10 -88.61 -7.2 56.81 Favored 'General case' 0 N--CA 1.483 1.191 0 C-N-CA 123.716 0.806 . . . . 62.13 111.83 -179.457 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 150' ' ' GLY . . . . . 0.451 ' O ' ' HA ' ' A' ' 55' ' ' ARG . . . 105.29 -3.04 40.21 Favored Glycine 0 C--N 1.34 0.797 0 CA-C-O 119.85 -0.417 . . . . 74.13 113.421 -178.331 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 84.8 tttt -63.84 112.56 2.95 Favored 'General case' 0 N--CA 1.472 0.626 0 CA-C-O 121.229 0.537 . . . . 73.24 109.796 -179.212 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 152' ' ' THR . . . . . . . . . . . . . 9.1 m -94.21 109.51 21.31 Favored 'General case' 0 CA--C 1.541 0.604 0 N-CA-C 108.17 -1.048 . . . . 74.22 108.17 179.542 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 153' ' ' SER . . . . . . . . . . . . . 16.0 m -59.32 -35.5 73.93 Favored 'General case' 0 N--CA 1.478 0.941 0 C-N-CA 124.914 1.285 . . . . 71.43 112.164 -174.965 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 74.9 mmtt -109.98 137.04 48.31 Favored 'General case' 0 N--CA 1.467 0.379 0 C-N-CA 123.895 0.878 . . . . 74.3 109.236 -177.475 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 16.7 tppt? -77.52 91.03 3.9 Favored 'General case' 0 CA--C 1.534 0.341 0 N-CA-C 108.418 -0.956 . . . . 73.35 108.418 176.215 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 156' ' ' ILE . . . . . 0.539 ' HB ' ' HB2' ' A' ' 53' ' ' PHE . 85.6 mt -84.93 130.25 36.38 Favored 'Isoleucine or valine' 0 C--O 1.221 -0.446 0 CA-C-N 115.126 -0.943 . . . . 71.55 108.726 -175.383 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 157' ' ' THR . . . . . . . . . . . . . 32.3 p -130.55 155.39 46.59 Favored 'General case' 0 N--CA 1.476 0.867 0 C-N-CA 123.922 0.889 . . . . 52.44 109.934 -176.03 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 158' ' ' ILE . . . . . 0.429 HG23 ' HB3' ' A' ' 8' ' ' PHE . 23.3 mt -88.76 95.3 5.25 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.641 0 N-CA-C 108.598 -0.89 . . . . 72.43 108.598 171.643 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 159' ' ' ALA . . . . . 0.407 ' HB2' ' HB2' ' A' ' 11' ' ' ALA . . . -59.72 -33.37 71.55 Favored 'General case' 0 N--CA 1.474 0.729 0 C-N-CA 124.102 0.961 . . . . 75.32 113.023 -175.267 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 160' ' ' ASP . . . . . . . . . . . . . 1.7 t70 -159.34 170.83 20.97 Favored 'General case' 0 N--CA 1.483 1.206 0 CA-C-O 120.765 0.316 . . . . 75.41 111.496 -175.285 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 161' ' ' CYS . . . . . . . . . . . . . 19.9 p -139.02 -168.83 2.51 Favored 'General case' 0 N--CA 1.481 1.118 0 C-N-CA 125.305 1.442 . . . . 72.25 108.553 -179.463 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 162' ' ' GLY . . . . . . . . . . . . . . . 135.56 56.45 0.06 OUTLIER Glycine 0 N--CA 1.48 1.591 0 CA-C-N 119.294 0.952 . . . . 72.45 113.562 -170.735 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 163' ' ' GLN . . . . . 0.45 ' HA ' ' H ' ' A' ' 7' ' ' PHE . 49.3 tt0 -44.42 119.87 2.01 Favored 'General case' 0 N--CA 1.484 1.23 0 C-N-CA 125.336 1.454 . . . . 53.31 113.069 -178.44 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 164' ' ' LEU . . . . . 0.489 ' O ' ' HB ' ' A' ' 5' ' ' THR . 97.8 mt . . . . . 0 CA--C 1.536 0.43 0 CA-C-N 115.123 -0.944 . . . . 75.15 110.306 -176.591 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 218' ' ' PRO . . . . . . . . . . . . . 26.3 Cg_exo . . . . . 0 N--CA 1.485 0.989 0 CA-C-O 120.736 0.223 . . . . 65.22 111.732 . . . . . . . . . 0 0 . 1 . 017 nuclear build core ' B' B ' 219' ' ' GLY . . . . . . . . . . . . . . . 177.95 163.97 30.47 Favored Glycine 0 CA--C 1.525 0.674 0 CA-C-N 115.612 -0.722 . . . . 75.54 112.407 -179.844 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 220' ' ' PRO . . . . . . . . . . . . . 24.5 Cg_exo -68.09 157.65 60.87 Favored 'Trans proline' 0 N--CA 1.489 1.254 0 C-N-CA 123.5 2.8 . . . . 75.1 113.264 175.612 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 221' ' ' TYR . . . . . . . . . . . . . 78.4 m-85 . . . . . 0 N--CA 1.476 0.844 0 C-N-CA 123.365 0.666 . . . . 72.04 110.04 179.988 . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 79.2 m-20 . . . . . 0 CA--C 1.548 0.884 0 CA-C-O 118.727 -0.654 . . . . 74.23 110.895 . . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 4' ' ' PRO . . . . . 0.49 ' HG2' ' HB2' ' A' ' 24' ' ' LEU . 16.1 Cg_endo -56.39 147.12 69.78 Favored 'Trans proline' 0 C--N 1.386 2.504 0 C-N-CA 123.51 2.807 . . . . 64.41 114.276 179.111 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 5' ' ' THR . . . . . 0.521 HG23 ' HD3' ' A' ' 133' ' ' LYS . 86.6 m -98.52 116.82 31.58 Favored 'General case' 0 CA--C 1.542 0.637 0 C-N-CA 124.903 1.281 . . . . 73.42 108.56 178.271 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 6' ' ' VAL . . . . . 0.454 ' HA ' ' HG3' ' A' ' 163' ' ' GLN . 28.6 t -99.42 119.93 48.11 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.737 0 N-CA-C 108.358 -0.978 . . . . 60.41 108.358 178.784 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 7' ' ' PHE . . . . . 0.573 ' H ' ' HA ' ' A' ' 163' ' ' GLN . 75.7 t80 -100.76 131.17 46.78 Favored 'General case' 0 C--N 1.324 -0.539 0 N-CA-C 109.439 -0.578 . . . . 75.4 109.439 -176.712 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 8' ' ' PHE . . . . . 0.48 ' HD2' ' HE2' ' A' ' 22' ' ' PHE . 46.7 m-85 -133.74 165.07 25.81 Favored 'General case' 0 C--O 1.241 0.65 0 C-N-CA 124.584 1.153 . . . . 74.02 108.949 167.095 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 9' ' ' ASP . . . . . 0.47 ' HB2' ' HB3' ' A' ' 159' ' ' ALA . 27.9 m-20 -112.94 112.62 24.21 Favored 'General case' 0 C--N 1.318 -0.79 0 N-CA-C 106.337 -1.727 . . . . 70.34 106.337 170.422 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 10' ' ' ILE . . . . . 0.425 HG21 ' SD ' ' A' ' 142' ' ' MET . 43.5 mm -81.51 125.12 39.55 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.213 0 N-CA-C 108.695 -0.854 . . . . 71.42 108.695 -179.995 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 11' ' ' ALA . . . . . 0.641 ' HB2' ' HB2' ' A' ' 159' ' ' ALA . . . -121.76 123.54 42.07 Favored 'General case' 0 C--O 1.213 -0.847 0 C-N-CA 124.403 1.081 . . . . 73.43 110.247 -171.405 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 12' ' ' VAL . . . . . 0.42 HG22 HG12 ' A' ' 156' ' ' ILE . 67.9 t -99.24 131.36 46.68 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.653 0 N-CA-C 107.844 -1.169 . . . . 65.11 107.844 173.515 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 23.1 m-20 67.87 17.58 9.67 Favored 'General case' 0 N--CA 1.491 1.621 0 C-N-CA 124.418 1.087 . . . . 71.11 110.582 -173.577 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 82.75 -9.3 59.85 Favored Glycine 0 C--N 1.351 1.364 0 CA-C-O 119.907 -0.385 . . . . 72.23 113.131 -171.27 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 37.6 mm-40 -97.35 127.48 38.04 Favored Pre-proline 0 CA--C 1.548 0.888 0 C-N-CA 124.329 1.052 . . . . 73.43 110.209 -178.127 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 18.6 Cg_endo -55.28 112.5 1.06 Allowed 'Trans proline' 0 C--N 1.381 2.282 0 C-N-CA 123.75 2.967 . . . . 70.23 113.483 -172.995 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 17' ' ' LEU . . . . . 0.506 HD23 HG23 ' A' ' 138' ' ' ILE . 40.0 tp -79.33 -40.55 30.03 Favored 'General case' 0 N--CA 1.476 0.87 0 C-N-CA 123.469 0.708 . . . . 64.15 110.087 174.704 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -176.04 -179.36 46.48 Favored Glycine 0 C--N 1.348 1.206 0 CA-C-N 116.212 -0.449 . . . . 52.11 113.286 -179.813 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 30.5 mtp85 -107.69 125.48 51.42 Favored 'General case' 0 N--CA 1.475 0.792 0 C-N-CA 124.46 1.104 . . . . 74.13 109.142 -176.967 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 71.9 t -126.0 142.61 42.17 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.804 0 C-N-CA 124.13 0.972 . . . . 71.05 109.684 -177.903 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 21' ' ' SER . . . . . 0.48 ' HB2' ' HB2' ' A' ' 134' ' ' GLU . 49.4 m -130.64 134.69 47.17 Favored 'General case' 0 CA--C 1.539 0.539 0 C-N-CA 123.579 0.752 . . . . 55.02 109.556 173.447 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 22' ' ' PHE . . . . . 0.48 ' HE2' ' HD2' ' A' ' 8' ' ' PHE . 73.3 m-85 -100.49 170.28 8.5 Favored 'General case' 0 N--CA 1.467 0.389 0 C-N-CA 125.039 1.336 . . . . 72.22 108.945 175.32 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 23' ' ' GLU . . . . . 0.531 ' HB2' ' HD2' ' A' ' 133' ' ' LYS . 35.5 tt0 -137.07 107.15 6.33 Favored 'General case' 0 CA--C 1.539 0.523 0 C-N-CA 122.98 0.512 . . . . 71.14 109.674 -178.608 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 24' ' ' LEU . . . . . 0.49 ' HB2' ' HG2' ' A' ' 4' ' ' PRO . 25.5 mt -87.23 126.83 35.06 Favored 'General case' 0 N--CA 1.476 0.83 0 C-N-CA 123.347 0.659 . . . . 64.41 110.531 -175.734 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 50.9 m-85 -86.21 67.17 9.87 Favored 'General case' 0 CA--C 1.54 0.594 0 C-N-CA 123.905 0.882 . . . . 75.32 109.267 178.51 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -66.83 -18.32 65.32 Favored 'General case' 0 N--CA 1.48 1.059 0 C-N-CA 124.323 1.049 . . . . 75.01 112.923 -173.271 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 12.9 p-10 -79.01 -32.01 44.92 Favored 'General case' 0 CA--C 1.546 0.804 0 C-N-CA 123.441 0.696 . . . . 74.32 110.672 176.258 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 97.9 mttt -89.94 -41.93 11.48 Favored 'General case' 0 N--CA 1.478 0.933 0 C-N-CA 123.69 0.796 . . . . 65.23 111.066 -175.703 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 29' ' ' VAL . . . . . 0.499 HG21 ' HA ' ' A' ' 129' ' ' PHE . 17.0 m -137.81 70.24 50.9 Favored Pre-proline 0 CA--C 1.561 1.374 0 C-N-CA 123.879 0.872 . . . . 52.43 110.096 -172.939 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 27.6 Cg_exo -60.93 -35.66 86.96 Favored 'Trans proline' 0 C--N 1.38 2.197 0 C-N-CA 123.169 2.58 . . . . 72.44 113.599 -170.727 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 22.9 ttmm -59.83 -61.11 2.85 Favored 'General case' 0 N--CA 1.475 0.782 0 C-N-CA 123.617 0.767 . . . . 65.43 111.725 -178.398 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 3.6 m -74.37 -27.53 60.7 Favored 'General case' 0 CA--C 1.553 1.077 0 CA-C-N 115.235 -0.893 . . . . 73.13 111.242 -171.059 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -74.2 -52.44 12.43 Favored 'General case' 0 CA--C 1.549 0.933 0 C-N-CA 122.774 0.43 . . . . 73.23 111.109 177.061 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 27.5 tt0 -61.14 -31.29 71.01 Favored 'General case' 0 N--CA 1.491 1.612 0 C-N-CA 123.305 0.642 . . . . 73.3 110.763 179.1 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 35' ' ' ASN . . . . . 0.519 ' O ' ' HG ' ' A' ' 39' ' ' LEU . 45.1 t30 -54.1 -66.55 0.38 Allowed 'General case' 0 C--N 1.354 0.797 0 O-C-N 123.97 0.794 . . . . 54.24 109.47 175.395 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 74.1 t80 -56.95 -38.2 72.62 Favored 'General case' 0 N--CA 1.479 1.011 0 C-N-CA 124.716 1.206 . . . . 70.4 111.51 -175.941 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 14.0 ttm180 -55.24 -58.33 8.14 Favored 'General case' 0 C--N 1.353 0.759 0 CA-C-N 115.372 -0.831 . . . . 74.34 110.331 173.957 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 38' ' ' ALA . . . . . 0.435 ' HB1' ' HG2' ' A' ' 44' ' ' LYS . . . -74.11 -18.92 60.74 Favored 'General case' 0 N--CA 1.468 0.452 0 C-N-CA 123.785 0.834 . . . . 74.51 111.899 -171.782 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 39' ' ' LEU . . . . . 0.639 HD22 ' HE2' ' A' ' 48' ' ' TYR . 43.3 mt -71.58 -46.64 58.75 Favored 'General case' 0 CA--C 1.538 0.517 0 N-CA-C 109.371 -0.603 . . . . 72.02 109.371 173.229 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 33.7 t -68.5 -56.8 7.13 Favored 'General case' 0 CA--C 1.547 0.861 0 C-N-CA 123.797 0.839 . . . . 74.31 111.411 -179.433 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 41' ' ' THR . . . . . 0.406 ' OG1' ' HG2' ' A' ' 43' ' ' GLU . 71.6 p -76.62 -31.03 57.16 Favored 'General case' 0 N--CA 1.471 0.619 0 C-N-CA 124.075 0.95 . . . . 73.02 111.442 -174.012 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 85.74 31.92 19.85 Favored Glycine 0 C--N 1.349 1.261 0 CA-C-O 119.908 -0.384 . . . . 50.31 113.101 -179.022 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 43' ' ' GLU . . . . . 0.406 ' HG2' ' OG1' ' A' ' 41' ' ' THR . 24.5 mm-40 -66.12 -27.87 68.38 Favored 'General case' 0 N--CA 1.483 1.187 0 C-N-CA 122.706 0.402 . . . . 64.33 111.665 176.709 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 44' ' ' LYS . . . . . 0.435 ' HG2' ' HB1' ' A' ' 38' ' ' ALA . 33.3 mmtp -105.95 18.6 21.85 Favored 'General case' 0 N--CA 1.484 1.269 0 C-N-CA 122.992 0.517 . . . . 72.35 110.645 175.405 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 79.23 48.39 6.91 Favored Glycine 0 C--N 1.352 1.43 0 N-CA-C 114.803 0.681 . . . . 75.02 114.803 169.279 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 46' ' ' PHE . . . . . 0.493 ' HE2' ' HA ' ' A' ' 78' ' ' ILE . 25.1 m-85 -130.08 -50.79 1.12 Allowed 'General case' 0 N--CA 1.49 1.545 0 CA-C-N 118.021 0.911 . . . . 75.1 111.399 -178.557 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 47.87 53.97 12.76 Favored Glycine 0 C--N 1.354 1.547 0 O-C-N 124.593 1.183 . . . . 75.14 114.687 176.17 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 48' ' ' TYR . . . . . 0.639 ' HE2' HD22 ' A' ' 39' ' ' LEU . 33.5 m-85 -61.55 95.47 0.05 Allowed 'General case' 0 N--CA 1.479 1.001 0 C-N-CA 123.28 0.632 . . . . 65.31 111.487 -177.803 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 46.9 tptt -98.48 102.42 14.15 Favored 'General case' 0 CA--C 1.537 0.447 0 CA-C-N 114.866 -1.061 . . . . 55.11 108.925 -175.65 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 50' ' ' GLY . . . . . 0.43 ' HA2' ' O ' ' A' ' 158' ' ' ILE . . . 110.62 22.66 6.27 Favored Glycine 0 C--N 1.346 1.117 0 CA-C-O 119.362 -0.688 . . . . 74.32 114.651 173.647 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 51' ' ' SER . . . . . 0.42 ' HB2' HD12 ' A' ' 158' ' ' ILE . 19.3 m -53.43 128.35 28.35 Favored 'General case' 0 N--CA 1.484 1.268 0 C-N-CA 123.732 0.813 . . . . 72.12 111.175 178.005 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 52' ' ' CYS . . . . . 0.53 ' HA ' ' HA ' ' A' ' 157' ' ' THR . 19.4 p -103.25 133.83 47.67 Favored 'General case' 0 N--CA 1.478 0.937 0 N-CA-C 112.59 0.589 . . . . 63.23 112.59 -168.282 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 53' ' ' PHE . . . . . 0.684 ' HA ' ' HA2' ' A' ' 64' ' ' GLY . 79.4 m-85 -74.05 102.62 4.25 Favored 'General case' 0 N--CA 1.472 0.661 0 C-N-CA 124.069 0.948 . . . . 74.4 108.665 166.206 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 16.5 p-80 -114.82 -12.93 12.04 Favored 'General case' 0 N--CA 1.481 1.094 0 C-N-CA 123.603 0.761 . . . . 61.23 112.006 -173.316 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 36.1 ttt180 -128.39 100.82 5.95 Favored 'General case' 0 C--O 1.217 -0.618 0 C-N-CA 122.884 0.474 . . . . 65.21 109.75 179.13 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 57.9 mt -128.96 125.4 62.82 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.96 0 C-N-CA 122.905 0.482 . . . . 65.53 110.126 178.375 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 54.7 mt -116.48 114.25 40.38 Favored Pre-proline 0 CA--C 1.557 1.217 0 C-N-CA 124.367 1.067 . . . . 52.1 109.162 178.228 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 31.8 Cg_exo -60.32 129.88 31.66 Favored 'Trans proline' 0 C--N 1.387 2.582 0 C-N-CA 123.704 2.936 . . . . 71.24 112.61 178.103 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 81.26 26.17 52.82 Favored Glycine 0 C--N 1.341 0.807 0 O-C-N 123.778 0.674 . . . . 52.44 112.661 -176.113 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 23.1 t80 -151.88 -75.99 0.13 Allowed 'General case' 0 C--O 1.247 0.933 0 C-N-CA 123.016 0.526 . . . . 74.42 110.685 179.712 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 61' ' ' MET . . . . . 0.481 ' HA ' ' H ' ' A' ' 116' ' ' THR . 22.9 ptt? -165.35 163.62 19.87 Favored 'General case' 0 N--CA 1.485 1.305 0 N-CA-C 112.813 0.672 . . . . 70.31 112.813 -174.528 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 62' ' ' CYS . . . . . 0.464 ' SG ' ' HB ' ' A' ' 114' ' ' ILE . 20.5 p -115.59 111.68 21.03 Favored 'General case' 0 CA--C 1.545 0.766 0 C-N-CA 124.253 1.021 . . . . 65.44 108.933 168.572 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 63' ' ' GLN . . . . . 0.561 ' HA ' ' HA ' ' A' ' 113' ' ' PHE . 52.1 tt0 -102.74 116.73 33.16 Favored 'General case' 0 N--CA 1.479 1.014 0 C-N-CA 124.019 0.928 . . . . 74.11 110.877 -174.955 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 64' ' ' GLY . . . . . 0.684 ' HA2' ' HA ' ' A' ' 53' ' ' PHE . . . -92.36 173.19 35.48 Favored Glycine 0 C--N 1.342 0.896 0 CA-C-N 115.221 -0.899 . . . . 72.13 112.284 171.362 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 174.29 150.46 7.69 Favored Glycine 0 C--O 1.238 0.344 0 N-CA-C 110.504 -1.038 . . . . 71.41 110.504 179.379 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 38.8 t70 -79.75 162.0 25.41 Favored 'General case' 0 CA--C 1.547 0.865 0 CA-C-O 121.608 0.718 . . . . 63.02 112.658 -169.804 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 55.0 t80 -79.95 -40.59 27.73 Favored 'General case' 0 CA--C 1.548 0.871 0 C-N-CA 124.701 1.2 . . . . 73.3 111.678 -177.281 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 25.3 m -61.16 112.68 2.21 Favored 'General case' 0 N--CA 1.479 0.979 0 C-N-CA 123.757 0.823 . . . . 71.44 111.681 -172.673 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 36.3 ttm180 55.83 77.03 0.25 Allowed 'General case' 0 N--CA 1.48 1.035 0 C-N-CA 124.852 1.261 . . . . 74.43 111.19 -178.877 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 12.2 t60 -79.16 -14.55 59.02 Favored 'General case' 0 CA--C 1.546 0.79 0 CA-C-N 115.261 -0.881 . . . . 71.23 110.806 -179.559 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 16.8 m120 -55.97 93.36 0.01 OUTLIER 'General case' 0 N--CA 1.485 1.279 0 C-N-CA 124.211 1.004 . . . . 74.44 110.723 178.18 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 70.18 11.25 67.05 Favored Glycine 0 C--N 1.351 1.4 0 CA-C-N 115.45 -0.795 . . . . 73.53 114.904 176.071 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 21.0 m -143.25 -83.62 0.16 Allowed 'General case' 0 CA--C 1.553 1.075 0 CA-C-N 117.663 0.731 . . . . 63.34 110.634 -178.578 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 64.4 59.22 8.6 Favored Glycine 0 C--N 1.357 1.731 0 O-C-N 123.301 0.376 . . . . 63.35 113.117 -177.008 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 134.6 49.07 0.08 OUTLIER Glycine 0 C--N 1.35 1.359 0 CA-C-N 117.05 0.425 . . . . 43.2 112.475 -176.135 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 14.0 ptmm? -65.59 159.91 23.66 Favored 'General case' 0 N--CA 1.484 1.243 0 C-N-CA 123.64 0.776 . . . . 75.04 111.454 -178.683 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 79.6 p -105.86 -175.65 2.85 Favored 'General case' 0 N--CA 1.481 1.095 0 N-CA-C 112.666 0.617 . . . . 65.44 112.666 -162.897 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 78' ' ' ILE . . . . . 0.493 ' HA ' ' HE2' ' A' ' 46' ' ' PHE . 44.3 pt -70.79 -21.08 22.38 Favored 'Isoleucine or valine' 0 C--N 1.358 0.971 0 CA-C-N 115.595 -0.73 . . . . 65.34 111.254 176.447 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 98.9 m-85 -88.66 33.83 0.77 Allowed 'General case' 0 N--CA 1.475 0.778 0 C-N-CA 123.83 0.852 . . . . 52.34 109.736 173.564 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 70.23 -99.16 0.69 Allowed Glycine 0 C--N 1.351 1.399 0 CA-C-N 115.403 -0.817 . . . . 74.03 111.604 -176.744 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 42.8 tt0 -73.03 -60.22 2.34 Favored 'General case' 0 CA--C 1.544 0.744 0 C-N-CA 123.956 0.902 . . . . 63.44 110.652 -176.498 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 82' ' ' LYS . . . . . 0.75 ' HD2' ' HA ' ' A' ' 107' ' ' THR . 18.8 pttp -169.2 177.37 4.83 Favored 'General case' 0 N--CA 1.482 1.148 0 C-N-CA 123.11 0.564 . . . . 64.14 111.162 -169.721 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 51.6 p90 -156.19 174.93 14.65 Favored 'General case' 0 N--CA 1.478 0.959 0 C-N-CA 124.204 1.002 . . . . 72.11 110.852 -177.574 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 13.5 pt-20 -102.76 162.96 12.5 Favored 'General case' 0 N--CA 1.481 1.117 0 C-N-CA 123.223 0.609 . . . . 71.35 110.872 177.233 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 85' ' ' ASP . . . . . 0.469 ' HB3' HG23 ' A' ' 127' ' ' VAL . 48.0 m-20 -64.71 130.63 44.29 Favored 'General case' 0 N--CA 1.478 0.926 0 CA-C-N 115.687 -0.688 . . . . 74.31 111.276 -179.993 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 9.3 tp10 -69.12 -61.36 1.82 Allowed 'General case' 0 N--CA 1.474 0.747 0 O-C-N 123.57 0.544 . . . . 72.13 111.102 -178.836 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 24.3 p-10 -161.2 127.89 3.98 Favored 'General case' 0 N--CA 1.477 0.887 0 C-N-CA 123.054 0.541 . . . . 75.12 110.325 -171.891 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 86.4 m-85 -88.58 74.11 8.52 Favored 'General case' 0 N--CA 1.476 0.85 0 CA-C-O 121.533 0.682 . . . . 74.15 110.18 -171.727 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 65.1 mt -88.87 -60.27 2.38 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.637 0 CA-C-N 115.221 -0.9 . . . . 70.12 108.998 173.453 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 67.4 mt -85.36 131.13 34.45 Favored 'General case' 0 C--O 1.241 0.626 0 CA-C-N 114.372 -1.286 . . . . 60.54 110.392 -173.05 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 32.2 mtmm -122.46 169.11 11.32 Favored 'General case' 0 N--CA 1.47 0.55 0 C-N-CA 124.933 1.293 . . . . 75.23 109.479 -174.485 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 92' ' ' HIS . . . . . . . . . . . . . 20.7 m-70 -91.95 36.83 0.97 Allowed 'General case' 0 N--CA 1.481 1.105 0 C-N-CA 123.992 0.917 . . . . 72.11 110.852 -170.79 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 80.7 p -67.92 -26.08 65.8 Favored 'General case' 0 N--CA 1.474 0.725 0 C-N-CA 124.387 1.075 . . . . 75.51 112.226 -170.935 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -124.88 175.6 17.17 Favored Glycine 0 C--N 1.344 1.007 0 O-C-N 123.232 0.332 . . . . 72.31 113.221 -177.067 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 93.0 Cg_endo -80.89 157.49 20.89 Favored 'Trans proline' 0 C--N 1.367 1.546 0 C-N-CA 123.046 2.498 . . . . 53.41 111.395 169.484 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 89.36 -0.71 81.34 Favored Glycine 0 N--CA 1.472 1.039 0 CA-C-N 116.27 -0.423 . . . . 34.4 112.971 -177.206 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 97' ' ' ILE . . . . . 0.44 ' HB ' ' HB2' ' A' ' 115' ' ' CYS . 13.9 mm -66.94 114.07 3.5 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.949 0 C-N-CA 124.041 0.936 . . . . 60.32 111.466 -176.591 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 98' ' ' LEU . . . . . 0.489 HD13 HG12 ' A' ' 114' ' ' ILE . 67.2 tp -102.28 113.11 26.13 Favored 'General case' 0 CA--C 1.551 0.999 0 C-N-CA 123.489 0.716 . . . . 74.51 109.761 177.827 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 42.6 t -131.44 168.77 17.04 Favored 'General case' 0 N--CA 1.479 0.978 0 C-N-CA 124.95 1.3 . . . . 71.14 108.296 176.533 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 100' ' ' MET . . . . . 0.505 ' HA ' ' HA ' ' A' ' 112' ' ' PHE . 44.4 mtp -101.62 146.59 27.49 Favored 'General case' 0 N--CA 1.491 1.604 0 CA-C-N 118.596 0.635 . . . . 62.12 110.482 -176.639 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 101' ' ' ALA . . . . . 0.553 ' HB3' ' HB2' ' A' ' 111' ' ' GLN . . . -85.49 167.58 15.32 Favored 'General case' 0 N--CA 1.482 1.151 0 C-N-CA 123.202 0.601 . . . . 64.33 111.174 -175.649 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 102' ' ' ASN . . . . . 0.593 ' HB3' ' HA ' ' A' ' 108' ' ' ASN . 29.4 p-10 -169.9 170.93 7.46 Favored 'General case' 0 N--CA 1.478 0.961 0 C-N-CA 122.829 0.451 . . . . 63.23 111.996 -177.111 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 103' ' ' ALA . . . . . 0.476 ' HB3' HG21 ' A' ' 107' ' ' THR . . . -99.59 -22.1 15.59 Favored 'General case' 0 CA--C 1.547 0.865 0 CA-C-N 115.377 -0.829 . . . . 44.03 111.142 171.55 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -178.15 -177.0 46.56 Favored Glycine 0 C--N 1.357 1.696 0 CA-C-O 119.467 -0.629 . . . . 53.55 113.053 -178.134 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 32.4 Cg_exo -58.62 136.52 74.55 Favored 'Trans proline' 0 C--N 1.375 1.948 0 C-N-CA 122.791 2.327 . . . . 75.42 112.908 175.002 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 66.6 t30 69.72 9.94 7.38 Favored 'General case' 0 N--CA 1.486 1.354 0 C-N-CA 124.805 1.242 . . . . 75.13 111.639 -176.459 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 107' ' ' THR . . . . . 0.75 ' HA ' ' HD2' ' A' ' 82' ' ' LYS . 3.9 m -109.96 5.16 22.11 Favored 'General case' 0 CA--C 1.553 1.087 0 C-N-CA 124.093 0.957 . . . . 71.34 110.305 178.301 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 108' ' ' ASN . . . . . 0.593 ' HA ' ' HB3' ' A' ' 102' ' ' ASN . 66.4 t30 -80.93 154.36 27.04 Favored 'General case' 0 N--CA 1.478 0.97 0 C-N-CA 123.467 0.707 . . . . 71.53 111.3 -173.772 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 106.36 -3.47 37.4 Favored Glycine 0 N--CA 1.467 0.725 0 CA-C-O 119.966 -0.352 . . . . 54.14 112.7 -178.394 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 41.1 p -91.29 119.23 31.16 Favored 'General case' 0 CA--C 1.54 0.563 0 N-CA-C 108.11 -1.07 . . . . 70.02 108.11 170.329 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 111' ' ' GLN . . . . . 0.572 HE22 ' HG2' ' B' ' 218' ' ' PRO . 35.7 mt-30 66.75 173.19 0.25 Allowed 'General case' 0 N--CA 1.496 1.857 0 C-N-CA 124.208 1.003 . . . . 73.53 112.093 -177.919 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 112' ' ' PHE . . . . . 0.505 ' HA ' ' HA ' ' A' ' 100' ' ' MET . 32.6 p90 -143.69 133.72 24.18 Favored 'General case' 0 N--CA 1.474 0.737 0 C-N-CA 123.879 0.871 . . . . 72.15 108.963 177.983 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 113' ' ' PHE . . . . . 0.561 ' HA ' ' HA ' ' A' ' 63' ' ' GLN . 52.2 p90 -116.52 142.06 47.37 Favored 'General case' 0 C--O 1.24 0.603 0 C-N-CA 123.342 0.657 . . . . 74.33 110.595 176.497 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 114' ' ' ILE . . . . . 0.489 HG12 HD13 ' A' ' 98' ' ' LEU . 15.3 mt -109.01 106.5 20.83 Favored 'Isoleucine or valine' 0 C--O 1.238 0.454 0 N-CA-C 108.066 -1.087 . . . . 74.34 108.066 175.39 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 115' ' ' CYS . . . . . 0.44 ' HB2' ' HB ' ' A' ' 97' ' ' ILE . 59.7 m -61.69 103.27 0.32 Allowed 'General case' 0 CA--C 1.546 0.823 0 C-N-CA 123.156 0.582 . . . . 64.44 109.607 173.554 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 116' ' ' THR . . . . . 0.567 HG22 HG12 ' A' ' 139' ' ' VAL . 35.2 p -74.56 -32.71 62.51 Favored 'General case' 0 N--CA 1.474 0.76 0 C-N-CA 124.29 1.036 . . . . 50.12 109.703 178.87 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -100.0 159.04 15.4 Favored 'General case' 0 C--O 1.243 0.761 0 C-N-CA 124.46 1.104 . . . . 31.34 108.561 171.051 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -71.88 111.98 7.59 Favored 'General case' 0 CA--C 1.543 0.693 0 N-CA-C 107.586 -1.264 . . . . 72.31 107.586 169.839 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 119' ' ' THR . . . . . . . . . . . . . 52.2 p -101.86 84.57 2.56 Favored 'General case' 0 CA--C 1.539 0.558 0 CA-C-O 122.319 1.057 . . . . 73.13 109.168 -175.974 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 11.1 pt-20 -77.0 -25.52 52.78 Favored 'General case' 0 N--CA 1.48 1.055 0 CA-C-N 114.543 -1.208 . . . . 71.22 110.903 -174.314 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 121' ' ' TRP . . . . . . . . . . . . . 43.8 p90 -70.19 -6.82 37.08 Favored 'General case' 0 CA--C 1.55 0.962 0 C-N-CA 123.914 0.886 . . . . 62.11 111.258 174.517 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 122' ' ' LEU . . . . . 0.422 HD22 ' HG2' ' A' ' 125' ' ' LYS . 42.7 mt -96.86 24.2 6.38 Favored 'General case' 0 CA--C 1.55 0.965 0 C-N-CA 123.32 0.648 . . . . 63.1 111.45 172.426 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 24.2 m-20 -71.79 133.9 45.83 Favored 'General case' 0 N--CA 1.484 1.247 0 N-CA-C 109.32 -0.622 . . . . 63.44 109.32 163.107 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 89.08 -13.84 62.22 Favored Glycine 0 C--N 1.345 1.056 0 CA-C-N 115.792 -0.64 . . . . 74.41 112.528 -173.26 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 125' ' ' LYS . . . . . 0.422 ' HG2' HD22 ' A' ' 122' ' ' LEU . 0.4 OUTLIER -81.63 -169.45 2.33 Favored 'General case' 0 N--CA 1.477 0.877 0 C-N-CA 123.657 0.783 . . . . 64.43 111.012 -179.02 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 126' ' ' HIS . . . . . . . . . . . . . 24.0 m80 -71.74 146.68 47.98 Favored 'General case' 0 N--CA 1.477 0.924 0 C-N-CA 124.481 1.112 . . . . 63.34 111.257 -163.059 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 127' ' ' VAL . . . . . 0.469 HG23 ' HB3' ' A' ' 85' ' ' ASP . 62.1 t -63.32 128.14 24.86 Favored 'Isoleucine or valine' 0 C--O 1.242 0.664 0 O-C-N 124.534 1.146 . . . . 75.21 112.108 -168.724 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 128' ' ' VAL . . . . . 0.408 HG11 HD12 ' A' ' 97' ' ' ILE . 47.6 t -75.5 140.39 17.46 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.356 0 CA-C-N 114.859 -1.064 . . . . 31.52 108.429 170.787 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 129' ' ' PHE . . . . . 0.499 ' HA ' HG21 ' A' ' 29' ' ' VAL . 41.1 p90 -128.13 -20.87 3.7 Favored 'General case' 0 N--CA 1.474 0.756 0 C-N-CA 122.623 0.369 . . . . 74.24 110.867 -177.475 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . -134.65 168.84 23.4 Favored Glycine 0 C--N 1.34 0.793 0 O-C-N 123.34 0.4 . . . . 62.12 112.188 -176.488 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 33.2 ttpt -152.26 137.11 17.12 Favored 'General case' 0 N--CA 1.47 0.569 0 C-N-CA 123.838 0.855 . . . . 63.51 109.091 176.568 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 17.1 t -70.95 111.71 5.03 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.528 0 N-CA-C 109.439 -0.578 . . . . 74.13 109.439 178.311 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 133' ' ' LYS . . . . . 0.531 ' HD2' ' HB2' ' A' ' 23' ' ' GLU . 20.2 ptmt -94.94 -37.63 11.07 Favored 'General case' 0 CA--C 1.541 0.605 0 C-N-CA 123.242 0.617 . . . . 75.32 110.19 178.193 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 134' ' ' GLU . . . . . 0.48 ' HB2' ' HB2' ' A' ' 21' ' ' SER . 17.9 mm-40 -124.4 136.4 54.03 Favored 'General case' 0 N--CA 1.474 0.757 0 C-N-CA 123.984 0.913 . . . . 65.24 109.274 -178.337 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 76.27 28.34 60.21 Favored Glycine 0 C--N 1.342 0.907 0 O-C-N 123.562 0.539 . . . . 42.3 113.913 175.245 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 136' ' ' MET . . . . . . . . . . . . . 15.3 tpt -63.91 -26.98 68.84 Favored 'General case' 0 N--CA 1.487 1.403 0 CA-C-N 117.418 0.609 . . . . 75.13 110.303 173.418 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 137' ' ' ASN . . . . . . . . . . . . . 1.7 m-20 -55.77 -46.69 77.84 Favored 'General case' 0 CA--C 1.549 0.927 0 C-N-CA 124.4 1.08 . . . . 74.14 110.291 171.502 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 138' ' ' ILE . . . . . 0.506 HG23 HD23 ' A' ' 17' ' ' LEU . 48.5 mm -68.17 -33.23 59.59 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.084 0 C-N-CA 123.876 0.871 . . . . 64.4 111.116 179.622 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 139' ' ' VAL . . . . . 0.567 HG12 HG22 ' A' ' 116' ' ' THR . 78.9 t -65.85 -44.5 92.78 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.072 0 C-N-CA 123.595 0.758 . . . . 71.35 111.12 178.839 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 45.1 mt-10 -74.34 -20.2 60.18 Favored 'General case' 0 N--CA 1.48 1.041 0 CA-C-N 115.747 -0.661 . . . . 74.01 110.99 176.919 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -72.16 -40.18 68.18 Favored 'General case' 0 CA--C 1.542 0.654 0 C-N-CA 122.895 0.478 . . . . 63.43 109.732 170.713 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 142' ' ' MET . . . . . 0.425 ' SD ' HG21 ' A' ' 10' ' ' ILE . 72.6 mtm -61.18 -38.81 87.82 Favored 'General case' 0 N--CA 1.484 1.26 0 C-N-CA 123.303 0.641 . . . . 72.14 110.289 176.744 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 143' ' ' GLU . . . . . 0.408 ' HB2' HG21 ' A' ' 116' ' ' THR . 42.7 tt0 -51.38 -40.31 58.95 Favored 'General case' 0 CA--C 1.552 1.041 0 O-C-N 124.402 1.064 . . . . 72.21 111.869 176.607 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 144' ' ' ARG . . . . . . . . . . . . . 53.6 mtp180 -71.81 -25.72 62.11 Favored 'General case' 0 CA--C 1.545 0.762 0 C-N-CA 123.47 0.708 . . . . 72.03 112.034 -178.279 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 145' ' ' PHE . . . . . . . . . . . . . 93.5 m-85 -82.77 2.4 34.09 Favored 'General case' 0 N--CA 1.481 1.118 0 C-N-CA 122.725 0.41 . . . . 74.12 111.223 175.749 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . -93.43 173.71 34.35 Favored Glycine 0 C--N 1.349 1.301 0 CA-C-N 117.741 0.246 . . . . 63.45 112.888 176.075 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 35.2 t -135.23 167.39 21.09 Favored 'General case' 0 N--CA 1.477 0.923 0 C-N-CA 123.911 0.884 . . . . 32.51 110.084 178.797 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 148' ' ' ARG . . . . . . . . . . . . . 23.2 mmt180 -73.6 -26.34 60.75 Favored 'General case' 0 N--CA 1.479 0.988 0 C-N-CA 123.725 0.81 . . . . 65.53 112.176 -173.352 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 149' ' ' ASN . . . . . . . . . . . . . 29.3 p-10 -77.06 -5.03 47.25 Favored 'General case' 0 N--CA 1.481 1.089 0 C-N-CA 123.17 0.588 . . . . 54.25 111.001 174.745 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . 101.54 -20.01 48.26 Favored Glycine 0 C--N 1.348 1.226 0 CA-C-O 119.959 -0.356 . . . . 63.41 112.474 177.936 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 34.9 ttpt -71.36 153.39 42.36 Favored 'General case' 0 N--CA 1.48 1.034 0 C-N-CA 122.802 0.441 . . . . 71.44 110.584 -176.894 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 152' ' ' THR . . . . . . . . . . . . . 72.2 p -94.82 134.05 37.86 Favored 'General case' 0 CA--C 1.543 0.696 0 C-N-CA 123.202 0.601 . . . . 71.15 109.452 172.484 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 153' ' ' SER . . . . . . . . . . . . . 36.5 m -65.84 -36.07 82.42 Favored 'General case' 0 CA--C 1.544 0.734 0 C-N-CA 123.641 0.776 . . . . 42.0 110.542 171.729 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 26.3 mmtp -122.87 139.47 54.0 Favored 'General case' 0 N--CA 1.479 0.985 0 C-N-CA 123.899 0.879 . . . . 72.11 109.505 175.222 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 11.7 tppt? -78.79 99.46 6.71 Favored 'General case' 0 CA--C 1.538 0.5 0 C-N-CA 123.101 0.56 . . . . 71.54 109.774 -178.127 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 156' ' ' ILE . . . . . 0.476 ' HB ' ' HB2' ' A' ' 53' ' ' PHE . 55.7 mt -89.24 126.08 42.24 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.482 0 CA-C-N 115.444 -0.798 . . . . 75.12 108.863 179.581 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 157' ' ' THR . . . . . 0.53 ' HA ' ' HA ' ' A' ' 52' ' ' CYS . 69.0 p -122.81 170.78 9.73 Favored 'General case' 0 CA--C 1.541 0.614 0 C-N-CA 125.276 1.43 . . . . 72.11 109.725 179.958 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 158' ' ' ILE . . . . . 0.43 ' O ' ' HA2' ' A' ' 50' ' ' GLY . 75.4 mt -90.83 113.51 26.74 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.685 0 N-CA-C 108.086 -1.079 . . . . 71.32 108.086 166.274 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 159' ' ' ALA . . . . . 0.641 ' HB2' ' HB2' ' A' ' 11' ' ' ALA . . . -63.84 -52.08 61.75 Favored 'General case' 0 N--CA 1.476 0.871 0 C-N-CA 123.9 0.88 . . . . 32.3 111.662 177.959 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 160' ' ' ASP . . . . . . . . . . . . . 14.7 t70 -157.36 173.27 17.17 Favored 'General case' 0 N--CA 1.48 1.043 0 C-N-CA 122.881 0.472 . . . . 73.51 109.823 -174.025 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 161' ' ' CYS . . . . . . . . . . . . . 19.4 p -134.55 -166.99 1.9 Allowed 'General case' 0 N--CA 1.475 0.817 0 C-N-CA 125.309 1.444 . . . . 45.54 109.101 -173.542 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 162' ' ' GLY . . . . . . . . . . . . . . . 134.92 53.17 0.07 OUTLIER Glycine 0 C--N 1.344 1.005 0 O-C-N 122.173 -0.33 . . . . 71.01 112.358 -173.163 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 163' ' ' GLN . . . . . 0.573 ' HA ' ' H ' ' A' ' 7' ' ' PHE . 46.4 tt0 -47.33 103.6 0.04 OUTLIER 'General case' 0 N--CA 1.48 1.035 0 C-N-CA 125.101 1.36 . . . . 64.35 111.614 -179.878 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 164' ' ' LEU . . . . . . . . . . . . . 85.2 mt . . . . . 0 CA--C 1.538 0.483 0 CA-C-N 114.765 -1.107 . . . . 42.25 110.882 -174.054 . . . . . . . . 0 0 . 1 . 018 nuclear build core ' B' B ' 218' ' ' PRO . . . . . 0.572 ' HG2' HE22 ' A' ' 111' ' ' GLN . 23.8 Cg_endo . . . . . 0 CA--C 1.554 1.503 0 CA-C-O 121.096 0.373 . . . . 65.3 111.216 . . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 219' ' ' GLY . . . . . . . . . . . . . . . 162.61 160.47 11.18 Favored Glycine 0 CA--C 1.533 1.162 0 CA-C-N 115.032 -0.985 . . . . 74.11 111.51 -178.197 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 220' ' ' PRO . . . . . . . . . . . . . 27.5 Cg_exo -64.63 169.96 10.58 Favored 'Trans proline' 0 C--N 1.375 1.955 0 C-N-CA 123.492 2.794 . . . . 73.11 114.308 179.995 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 221' ' ' TYR . . . . . . . . . . . . . 73.1 m-85 . . . . . 0 N--CA 1.484 1.273 0 C-N-CA 123.949 0.9 . . . . 71.24 110.987 -174.938 . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 33.1 m-80 . . . . . 0 CA--C 1.549 0.935 0 CA-C-O 118.971 -0.538 . . . . 31.55 110.622 . . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 4' ' ' PRO . . . . . 0.62 ' HG2' ' HB2' ' A' ' 24' ' ' LEU . 32.7 Cg_endo -65.2 129.17 22.17 Favored 'Trans proline' 0 C--N 1.38 2.236 0 C-N-CA 122.696 2.264 . . . . 74.24 111.379 175.102 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 5' ' ' THR . . . . . 0.467 HG23 ' HD3' ' A' ' 133' ' ' LYS . 65.9 m -95.93 122.74 39.07 Favored 'General case' 0 N--CA 1.464 0.257 0 N-CA-C 108.112 -1.07 . . . . 63.24 108.112 177.44 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 34.7 m -107.15 128.6 61.95 Favored 'Isoleucine or valine' 0 C--O 1.22 -0.478 0 CA-C-O 121.432 0.634 . . . . 75.42 110.557 -179.018 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 7' ' ' PHE . . . . . 0.664 ' H ' ' HA ' ' A' ' 163' ' ' GLN . 74.6 t80 -116.03 138.79 50.9 Favored 'General case' 0 C--O 1.239 0.532 0 C-N-CA 124.792 1.237 . . . . 52.22 109.292 -171.579 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 8' ' ' PHE . . . . . 0.483 ' HB3' HG23 ' A' ' 158' ' ' ILE . 63.2 m-85 -141.02 162.68 34.92 Favored 'General case' 0 N--CA 1.47 0.568 0 O-C-N 124.375 1.047 . . . . 74.43 110.11 172.17 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 11.9 m-20 -108.67 106.8 17.01 Favored 'General case' 0 C--N 1.328 -0.341 0 C-N-CA 125.124 1.369 . . . . 62.21 107.359 171.523 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 49.5 mm -81.2 130.88 35.11 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.65 0 N-CA-C 108.664 -0.865 . . . . 73.34 108.664 177.863 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 11' ' ' ALA . . . . . 0.451 ' HB2' ' HB2' ' A' ' 159' ' ' ALA . . . -132.97 139.68 47.41 Favored 'General case' 0 N--CA 1.473 0.696 0 C-N-CA 123.754 0.822 . . . . 73.44 110.69 -174.256 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 12' ' ' VAL . . . . . 0.538 HG23 ' HB2' ' A' ' 17' ' ' LEU . 72.0 t -94.67 98.31 7.91 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.596 0 C-N-CA 124.899 1.28 . . . . 70.33 108.388 175.697 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 22.6 m-20 61.23 31.18 19.51 Favored 'General case' 0 N--CA 1.483 1.182 0 C-N-CA 124.702 1.201 . . . . 73.13 111.968 -177.993 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 96.14 -8.85 67.57 Favored Glycine 0 C--N 1.348 1.224 0 CA-C-O 119.749 -0.473 . . . . 63.31 113.302 179.215 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 39.1 mm-40 -85.56 113.38 50.65 Favored Pre-proline 0 N--CA 1.473 0.721 0 CA-C-O 118.418 -0.801 . . . . 73.04 109.223 173.321 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 19.2 Cg_endo -55.47 106.06 0.18 Allowed 'Trans proline' 0 C--N 1.385 2.491 0 C-N-CA 123.042 2.495 . . . . 50.22 112.249 -176.381 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 17' ' ' LEU . . . . . 0.538 ' HB2' HG23 ' A' ' 12' ' ' VAL . 68.9 tp -76.31 -41.37 48.81 Favored 'General case' 0 N--CA 1.476 0.858 0 C-N-CA 123.793 0.837 . . . . 51.05 109.115 -179.313 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 169.97 -172.98 44.03 Favored Glycine 0 C--N 1.341 0.836 0 CA-C-N 115.376 -0.829 . . . . 55.33 112.428 176.513 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 56.0 mtm180 -111.84 136.47 51.09 Favored 'General case' 0 C--O 1.239 0.529 0 C-N-CA 124.111 0.965 . . . . 72.01 109.766 -175.8 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 20' ' ' VAL . . . . . 0.413 ' HA ' ' HA3' ' A' ' 135' ' ' GLY . 61.1 t -129.57 131.98 66.6 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.998 0 C-N-CA 123.644 0.778 . . . . 34.14 109.522 177.494 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 45.7 m -119.62 123.8 44.75 Favored 'General case' 0 CA--C 1.543 0.673 0 C-N-CA 124.139 0.975 . . . . 74.32 108.831 174.365 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 14.7 m-85 -99.85 169.09 9.47 Favored 'General case' 0 CA--C 1.541 0.618 0 C-N-CA 123.999 0.92 . . . . 75.43 109.007 174.886 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 23' ' ' GLU . . . . . 0.527 ' HB2' ' HD2' ' A' ' 133' ' ' LYS . 34.2 tt0 -125.86 108.58 11.59 Favored 'General case' 0 C--O 1.239 0.532 0 N-CA-C 107.697 -1.223 . . . . 73.24 107.697 179.404 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 24' ' ' LEU . . . . . 0.62 ' HB2' ' HG2' ' A' ' 4' ' ' PRO . 15.8 mt -84.89 124.5 31.7 Favored 'General case' 0 C--O 1.238 0.499 0 CA-C-O 120.935 0.398 . . . . 72.31 110.028 -179.884 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 25' ' ' PHE . . . . . 0.635 ' HB2' HD11 ' A' ' 90' ' ' LEU . 86.1 m-85 -86.04 64.86 8.82 Favored 'General case' 0 CA--C 1.535 0.375 0 CA-C-N 115.66 -0.7 . . . . 61.23 109.586 174.899 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -72.42 -16.06 61.83 Favored 'General case' 0 N--CA 1.479 0.989 0 CA-C-N 115.383 -0.826 . . . . 72.1 111.445 -179.11 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 9.8 p-10 -74.15 -23.0 59.21 Favored 'General case' 0 CA--C 1.553 1.068 0 C-N-CA 123.96 0.904 . . . . 51.53 110.782 173.851 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 58.2 mttp -101.52 -52.33 3.25 Favored 'General case' 0 N--CA 1.478 0.973 0 C-N-CA 123.874 0.87 . . . . 71.21 110.771 -177.618 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 30.0 m -122.85 74.37 46.57 Favored Pre-proline 0 CA--C 1.559 1.296 0 C-N-CA 124.308 1.043 . . . . 72.3 109.761 -173.884 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 24.8 Cg_exo -62.29 -43.36 23.62 Favored 'Trans proline' 0 C--N 1.38 2.206 0 C-N-CA 122.726 2.284 . . . . 74.05 113.136 -169.717 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 31' ' ' LYS . . . . . 0.416 ' HD2' ' HB2' ' A' ' 86' ' ' GLU . 1.5 ttmp? -57.05 -54.73 43.42 Favored 'General case' 0 N--CA 1.484 1.232 0 C-N-CA 123.472 0.709 . . . . 64.13 111.495 177.476 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 6.4 m -71.21 -36.3 71.84 Favored 'General case' 0 CA--C 1.551 0.993 0 C-N-CA 123.773 0.829 . . . . 71.52 111.776 -168.932 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 33' ' ' ALA . . . . . 0.414 ' HB1' ' HB3' ' A' ' 24' ' ' LEU . . . -79.85 -48.54 13.35 Favored 'General case' 0 N--CA 1.474 0.77 0 C-N-CA 123.447 0.699 . . . . 41.35 111.103 -177.792 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 12.6 tp10 -63.47 -28.48 69.99 Favored 'General case' 0 N--CA 1.482 1.141 0 C-N-CA 123.59 0.756 . . . . 63.21 111.099 -179.491 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 35' ' ' ASN . . . . . 0.543 ' ND2' ' SD ' ' A' ' 100' ' ' MET . 32.6 t30 -52.79 -69.37 0.12 Allowed 'General case' 0 C--N 1.353 0.721 0 O-C-N 123.948 0.78 . . . . 75.24 110.316 174.239 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 85.5 t80 -66.69 -32.41 73.71 Favored 'General case' 0 N--CA 1.476 0.875 0 C-N-CA 123.501 0.721 . . . . 71.15 111.296 -173.869 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 56.2 ttt-85 -55.4 -54.33 45.08 Favored 'General case' 0 N--CA 1.474 0.767 0 C-N-CA 124.192 0.997 . . . . 64.15 110.268 175.803 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 38' ' ' ALA . . . . . 0.426 ' HB1' ' HG2' ' A' ' 44' ' ' LYS . . . -76.2 -24.15 54.67 Favored 'General case' 0 CA--C 1.541 0.623 0 CA-C-N 115.147 -0.933 . . . . 35.41 112.218 -174.941 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 39' ' ' LEU . . . . . 0.525 HD22 ' HE2' ' A' ' 48' ' ' TYR . 81.7 mt -66.03 -43.16 88.41 Favored 'General case' 0 N--CA 1.482 1.145 0 C-N-CA 123.329 0.651 . . . . 64.55 110.144 173.794 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 47.4 m -82.55 -37.37 25.25 Favored 'General case' 0 CA--C 1.547 0.838 0 CA-C-N 115.143 -0.935 . . . . 64.44 112.317 -172.718 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 41' ' ' THR . . . . . 0.421 ' OG1' ' HG2' ' A' ' 43' ' ' GLU . 3.7 p -72.79 -32.06 65.31 Favored 'General case' 0 N--CA 1.485 1.323 0 C-N-CA 122.519 0.328 . . . . 73.24 110.309 172.664 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 84.85 29.5 28.8 Favored Glycine 0 C--N 1.345 1.059 0 CA-C-N 116.025 -0.534 . . . . 70.05 112.558 -178.789 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 43' ' ' GLU . . . . . 0.421 ' HG2' ' OG1' ' A' ' 41' ' ' THR . 17.6 mm-40 -63.85 -31.41 72.59 Favored 'General case' 0 N--CA 1.48 1.058 0 C-N-CA 123.266 0.626 . . . . 64.21 110.793 176.606 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 44' ' ' LYS . . . . . 0.426 ' HG2' ' HB1' ' A' ' 38' ' ' ALA . 71.6 mmtt -95.42 19.25 11.15 Favored 'General case' 0 N--CA 1.48 1.028 0 C-N-CA 123.719 0.807 . . . . 64.44 110.533 179.012 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 83.72 -15.97 33.77 Favored Glycine 0 C--N 1.353 1.482 0 CA-C-O 119.472 -0.627 . . . . 62.1 114.486 175.814 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 46' ' ' PHE . . . . . 0.421 ' HE2' ' HA ' ' A' ' 78' ' ' ILE . 23.6 m-85 -76.77 -51.24 11.75 Favored 'General case' 0 N--CA 1.476 0.853 0 CA-C-N 117.508 0.654 . . . . 61.34 112.686 -166.77 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 48.82 63.3 3.95 Favored Glycine 0 C--N 1.355 1.628 0 O-C-N 123.978 0.799 . . . . 54.33 114.653 176.302 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 48' ' ' TYR . . . . . 0.525 ' HE2' HD22 ' A' ' 39' ' ' LEU . 30.2 m-85 -70.04 100.2 1.58 Allowed 'General case' 0 N--CA 1.484 1.25 0 CA-C-N 117.763 0.782 . . . . 74.1 111.332 -175.511 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 49' ' ' LYS . . . . . 0.582 ' HE3' ' HA ' ' A' ' 160' ' ' ASP . 23.5 tptm -107.47 132.32 53.35 Favored 'General case' 0 CA--C 1.534 0.332 0 C-N-CA 124.951 1.301 . . . . 71.43 109.063 -176.004 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 83.2 21.38 58.93 Favored Glycine 0 C--N 1.348 1.196 0 CA-C-O 119.722 -0.488 . . . . 72.1 112.958 179.408 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 51' ' ' SER . . . . . 0.73 ' HA ' ' HB2' ' A' ' 67' ' ' PHE . 22.4 t -61.91 114.26 3.26 Favored 'General case' 0 C--N 1.358 0.959 0 C-N-CA 122.937 0.495 . . . . 74.52 110.601 -179.761 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 52' ' ' CYS . . . . . 0.609 ' HB3' ' HB3' ' A' ' 66' ' ' ASP . 53.5 t -89.89 157.95 17.65 Favored 'General case' 0 C--O 1.24 0.58 0 C-N-CA 123.352 0.661 . . . . 52.52 111.412 -173.349 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 53' ' ' PHE . . . . . 0.7 ' HA ' ' HA2' ' A' ' 64' ' ' GLY . 14.5 m-85 -105.85 98.0 7.75 Favored 'General case' 0 CA--C 1.535 0.402 0 C-N-CA 124.973 1.309 . . . . 70.24 107.64 176.263 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 40.8 p-80 -88.22 -27.26 21.91 Favored 'General case' 0 N--CA 1.483 1.206 0 C-N-CA 122.464 0.306 . . . . 74.45 111.519 -178.068 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 55' ' ' ARG . . . . . 0.501 ' HA ' ' O ' ' A' ' 150' ' ' GLY . 42.4 ttt180 -116.1 104.86 11.97 Favored 'General case' 0 C--O 1.212 -0.917 0 N-CA-C 109.762 -0.458 . . . . 71.33 109.762 -175.583 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 63.5 mt -132.46 133.39 59.89 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.044 0 N-CA-C 108.963 -0.754 . . . . 74.55 108.963 174.066 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 57' ' ' ILE . . . . . 0.409 ' HB ' ' HD2' ' A' ' 60' ' ' PHE . 62.0 mt -123.15 123.18 26.73 Favored Pre-proline 0 CA--C 1.558 1.265 0 C-N-CA 124.41 1.084 . . . . 71.0 109.044 176.475 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 55.9 Cg_endo -67.31 144.7 69.22 Favored 'Trans proline' 0 C--N 1.383 2.392 0 C-N-CA 122.983 2.455 . . . . 75.54 111.798 178.706 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 73.56 13.48 80.15 Favored Glycine 0 CA--C 1.527 0.838 0 CA-C-N 115.46 -0.791 . . . . 71.1 114.027 -176.409 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 60' ' ' PHE . . . . . 0.409 ' HD2' ' HB ' ' A' ' 57' ' ' ILE . 17.6 t80 -139.73 -75.06 0.35 Allowed 'General case' 0 C--O 1.245 0.859 0 C-N-CA 123.091 0.556 . . . . 65.21 110.495 -173.964 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 61' ' ' MET . . . . . 0.68 ' SD ' ' HB2' ' A' ' 113' ' ' PHE . 13.9 tmm? -174.62 147.26 1.06 Allowed 'General case' 0 CA--C 1.55 0.957 0 N-CA-C 112.064 0.394 . . . . 71.43 112.064 -164.827 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 62' ' ' CYS . . . . . 0.527 ' SG ' ' HB ' ' A' ' 114' ' ' ILE . 21.8 p -108.11 112.48 25.04 Favored 'General case' 0 CA--C 1.552 1.053 0 C-N-CA 124.182 0.993 . . . . 51.4 109.873 172.984 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 63' ' ' GLN . . . . . 0.607 ' HB2' ' SD ' ' A' ' 61' ' ' MET . 49.2 tt0 -104.87 111.33 24.05 Favored 'General case' 0 N--CA 1.487 1.404 0 C-N-CA 124.064 0.946 . . . . 71.15 111.465 -173.637 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 64' ' ' GLY . . . . . 0.7 ' HA2' ' HA ' ' A' ' 53' ' ' PHE . . . -89.51 -179.6 45.01 Favored Glycine 0 C--N 1.342 0.865 0 CA-C-N 114.952 -1.022 . . . . 55.2 112.583 173.483 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 99.42 72.22 1.02 Allowed Glycine 0 N--CA 1.444 -0.809 0 N-CA-C 110.491 -1.044 . . . . 45.31 110.491 -174.334 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 66' ' ' ASP . . . . . 0.609 ' HB3' ' HB3' ' A' ' 52' ' ' CYS . 38.2 t70 -123.88 -4.64 8.06 Favored 'General case' 0 N--CA 1.484 1.256 0 C-N-CA 123.735 0.814 . . . . 72.35 110.756 175.915 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 67' ' ' PHE . . . . . 0.73 ' HB2' ' HA ' ' A' ' 51' ' ' SER . 56.0 t80 -79.25 -70.58 0.5 Allowed 'General case' 0 CA--C 1.544 0.718 0 CA-C-N 116.082 -0.508 . . . . 74.1 111.315 -171.402 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 30.9 m -86.28 102.17 13.73 Favored 'General case' 0 N--CA 1.471 0.602 0 C-N-CA 122.484 0.313 . . . . 72.54 110.954 -171.136 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 81.5 mtp180 52.69 81.94 0.08 Allowed 'General case' 0 N--CA 1.476 0.844 0 C-N-CA 124.518 1.127 . . . . 74.52 111.335 -178.266 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 27.5 p80 -74.68 26.11 0.09 Allowed 'General case' 0 N--CA 1.495 1.78 0 N-CA-C 113.74 1.015 . . . . 74.4 113.74 -170.843 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 1.9 m-20 -86.65 45.06 1.21 Allowed 'General case' 0 CA--C 1.555 1.155 0 C-N-CA 124.344 1.058 . . . . 73.22 109.62 175.436 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 86.79 -7.9 77.99 Favored Glycine 0 C--N 1.353 1.515 0 CA-C-N 116.081 -0.509 . . . . 63.14 113.459 -176.811 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 73' ' ' THR . . . . . 0.507 ' HA ' ' HB2' ' A' ' 110' ' ' SER . 3.7 m -90.45 -61.57 1.65 Allowed 'General case' 0 N--CA 1.475 0.786 0 CA-C-N 117.499 0.65 . . . . 64.1 109.35 179.62 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 62.76 10.12 29.91 Favored Glycine 0 CA--C 1.538 1.525 0 N-CA-C 116.585 1.394 . . . . 62.32 116.585 164.772 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 145.44 55.4 0.02 OUTLIER Glycine 0 N--CA 1.471 1.012 0 CA-C-N 118.179 0.99 . . . . 72.23 111.451 -164.512 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 23.3 pttm -51.13 165.54 0.12 Allowed 'General case' 0 N--CA 1.488 1.428 0 C-N-CA 124.881 1.272 . . . . 75.24 112.658 179.8 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 77' ' ' SER . . . . . 0.428 ' HA ' HD11 ' A' ' 39' ' ' LEU . 77.0 p -90.65 178.59 6.03 Favored 'General case' 0 CA--C 1.545 0.767 0 C-N-CA 123.386 0.674 . . . . 71.1 112.446 -169.697 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 78' ' ' ILE . . . . . 0.421 ' HA ' ' HE2' ' A' ' 46' ' ' PHE . 34.7 pt -72.14 -14.57 17.43 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.074 0 C-N-CA 123.935 0.894 . . . . 73.43 110.663 175.207 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 89.6 m-85 -94.54 16.06 16.37 Favored 'General case' 0 CA--C 1.548 0.872 0 C-N-CA 124.458 1.103 . . . . 73.23 110.541 175.674 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 89.79 -121.76 6.26 Favored Glycine 0 C--N 1.355 1.587 0 N-CA-C 111.005 -0.838 . . . . 74.13 111.005 -179.35 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 42.3 tt0 -55.56 -56.4 20.74 Favored 'General case' 0 N--CA 1.48 1.059 0 C-N-CA 125.02 1.328 . . . . 73.11 111.321 -177.384 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 82' ' ' LYS . . . . . 0.842 ' HD2' ' HA ' ' A' ' 107' ' ' THR . 21.0 pttp -169.79 179.2 3.76 Favored 'General case' 0 N--CA 1.48 1.04 0 C-N-CA 124.322 1.049 . . . . 75.41 109.895 -174.999 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 53.5 p90 -148.79 173.66 13.03 Favored 'General case' 0 N--CA 1.475 0.817 0 C-N-CA 123.908 0.883 . . . . 75.25 111.269 -177.422 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 13.9 pt-20 -94.8 151.43 19.25 Favored 'General case' 0 CA--C 1.541 0.603 0 CA-C-N 115.009 -0.996 . . . . 74.3 110.908 178.532 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 85' ' ' ASP . . . . . 0.424 ' HB3' HG23 ' A' ' 127' ' ' VAL . 44.7 m-20 -65.91 136.69 56.46 Favored 'General case' 0 N--CA 1.475 0.813 0 C-N-CA 124.375 1.07 . . . . 75.41 111.811 -176.93 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 86' ' ' GLU . . . . . 0.416 ' HB2' ' HD2' ' A' ' 31' ' ' LYS . 11.8 tp10 -86.06 -63.54 1.3 Allowed 'General case' 0 CA--C 1.548 0.895 0 CA-C-N 116.106 -0.497 . . . . 63.23 111.399 -173.144 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 26.0 p-10 -166.71 135.59 2.87 Favored 'General case' 0 N--CA 1.482 1.164 0 C-N-CA 122.936 0.494 . . . . 74.55 110.194 -173.944 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 25.9 m-85 -95.34 59.83 2.22 Favored 'General case' 0 N--CA 1.478 0.928 0 C-N-CA 123.841 0.856 . . . . 74.1 110.71 -170.797 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 34.0 mt -75.22 -35.32 33.61 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.17 0 CA-C-N 115.795 -0.639 . . . . 73.05 110.169 176.004 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 90' ' ' LEU . . . . . 0.635 HD11 ' HB2' ' A' ' 25' ' ' PHE . 78.8 mt -100.1 161.53 13.55 Favored 'General case' 0 N--CA 1.471 0.623 0 C-N-CA 123.798 0.839 . . . . 73.32 110.61 -179.125 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 91' ' ' LYS . . . . . 0.659 ' HG3' HG22 ' A' ' 93' ' ' THR . 49.3 pttt -159.17 160.37 35.42 Favored 'General case' 0 CA--C 1.547 0.864 0 CA-C-O 121.646 0.736 . . . . 43.04 111.931 -174.293 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 92' ' ' HIS . . . . . . . . . . . . . 22.9 m-70 -88.93 32.88 0.79 Allowed 'General case' 0 N--CA 1.483 1.195 0 C-N-CA 124.401 1.08 . . . . 73.13 112.434 -167.877 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 93' ' ' THR . . . . . 0.659 HG22 ' HG3' ' A' ' 91' ' ' LYS . 6.1 t -89.44 68.72 7.92 Favored 'General case' 0 N--CA 1.479 1.003 0 CA-C-O 122.52 1.152 . . . . 74.13 110.007 -179.217 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 153.12 164.51 12.59 Favored Glycine 0 C--N 1.338 0.64 0 CA-C-N 114.572 -1.195 . . . . 63.13 111.745 179.245 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 63.6 Cg_endo -76.82 157.37 35.16 Favored 'Trans proline' 0 CA--C 1.554 1.485 0 C-N-CA 122.308 2.006 . . . . 73.4 112.167 172.965 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 84.16 18.61 62.45 Favored Glycine 0 CA--C 1.532 1.145 0 N-CA-C 114.543 0.577 . . . . 60.33 114.543 177.506 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 97' ' ' ILE . . . . . . . . . . . . . 37.6 mm -86.48 106.93 16.19 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.311 0 CA-C-N 117.765 0.783 . . . . 71.22 111.689 -175.07 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 98' ' ' LEU . . . . . 0.449 HD13 HG12 ' A' ' 114' ' ' ILE . 67.2 tp -92.89 119.25 32.0 Favored 'General case' 0 CA--C 1.552 1.055 0 C-N-CA 123.582 0.753 . . . . 73.23 110.746 -178.614 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 13.5 m -138.0 143.28 40.56 Favored 'General case' 0 N--CA 1.482 1.134 0 C-N-CA 124.744 1.218 . . . . 62.51 108.774 177.492 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 100' ' ' MET . . . . . 0.649 ' HA ' ' HA ' ' A' ' 112' ' ' PHE . 73.3 mtp -77.95 138.95 39.13 Favored 'General case' 0 N--CA 1.488 1.433 0 CA-C-N 118.616 0.644 . . . . 73.44 109.335 176.144 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 101' ' ' ALA . . . . . 0.53 ' HB3' ' HB2' ' A' ' 111' ' ' GLN . . . -74.68 160.82 30.3 Favored 'General case' 0 N--CA 1.483 1.178 0 C-N-CA 123.106 0.562 . . . . 74.34 112.21 -168.281 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 102' ' ' ASN . . . . . 0.439 ' HB3' ' HA ' ' A' ' 108' ' ' ASN . 27.5 p-10 -165.28 164.3 19.94 Favored 'General case' 0 N--CA 1.476 0.839 0 CA-C-N 115.515 -0.766 . . . . 70.3 110.974 -176.383 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -107.85 10.34 28.63 Favored 'General case' 0 CA--C 1.549 0.91 0 C-N-CA 123.903 0.881 . . . . 64.23 110.615 171.676 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 148.65 -175.57 27.86 Favored Glycine 0 C--N 1.356 1.669 0 CA-C-O 119.543 -0.587 . . . . 40.52 112.373 179.666 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 40.4 Cg_exo -59.0 143.94 99.58 Favored 'Trans proline' 0 C--N 1.375 1.955 0 C-N-CA 123.358 2.705 . . . . 64.15 112.326 174.311 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 65.1 t30 70.56 9.57 6.94 Favored 'General case' 0 N--CA 1.49 1.573 0 C-N-CA 125.27 1.428 . . . . 73.41 111.245 -177.914 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 107' ' ' THR . . . . . 0.842 ' HA ' ' HD2' ' A' ' 82' ' ' LYS . 4.0 m -121.88 4.65 9.95 Favored 'General case' 0 CA--C 1.556 1.18 0 C-N-CA 123.476 0.711 . . . . 73.43 110.945 -175.895 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 108' ' ' ASN . . . . . 0.439 ' HA ' ' HB3' ' A' ' 102' ' ' ASN . 48.5 t30 -84.7 140.74 31.08 Favored 'General case' 0 N--CA 1.485 1.324 0 C-N-CA 123.71 0.804 . . . . 72.21 110.68 -176.682 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 111.98 23.34 5.6 Favored Glycine 0 N--CA 1.474 1.206 0 C-N-CA 122.556 0.122 . . . . 55.03 113.354 -177.946 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 110' ' ' SER . . . . . 0.507 ' HB2' ' HA ' ' A' ' 73' ' ' THR . 12.2 p -127.77 120.33 27.66 Favored 'General case' 0 CA--C 1.536 0.433 0 N-CA-C 107.334 -1.358 . . . . 62.51 107.334 171.866 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 111' ' ' GLN . . . . . 0.53 ' HB2' ' HB3' ' A' ' 101' ' ' ALA . 49.4 mt-30 67.65 175.22 0.26 Allowed 'General case' 0 N--CA 1.488 1.436 0 C-N-CA 124.942 1.297 . . . . 74.33 111.051 -172.82 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 112' ' ' PHE . . . . . 0.649 ' HA ' ' HA ' ' A' ' 100' ' ' MET . 23.7 p90 -149.86 142.18 24.22 Favored 'General case' 0 N--CA 1.477 0.885 0 N-CA-C 108.12 -1.067 . . . . 74.34 108.12 176.209 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 113' ' ' PHE . . . . . 0.68 ' HB2' ' SD ' ' A' ' 61' ' ' MET . 54.3 p90 -135.27 139.02 44.07 Favored 'General case' 0 C--O 1.239 0.509 0 CA-C-O 121.198 0.523 . . . . 72.53 111.227 -177.649 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 114' ' ' ILE . . . . . 0.527 ' HB ' ' SG ' ' A' ' 62' ' ' CYS . 11.8 mt -103.17 108.36 24.19 Favored 'Isoleucine or valine' 0 C--O 1.241 0.629 0 N-CA-C 107.475 -1.306 . . . . 73.42 107.475 176.805 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 115' ' ' CYS . . . . . . . . . . . . . 58.6 m -67.87 103.72 1.52 Allowed 'General case' 0 N--CA 1.467 0.395 0 N-CA-C 109.059 -0.719 . . . . 71.42 109.059 177.01 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 116' ' ' THR . . . . . 0.609 HG22 HG12 ' A' ' 139' ' ' VAL . 36.6 p -70.9 -32.39 69.33 Favored 'General case' 0 CA--C 1.54 0.584 0 C-N-CA 124.361 1.065 . . . . 64.1 110.317 179.737 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -110.25 167.91 9.84 Favored 'General case' 0 CA--C 1.543 0.686 0 C-N-CA 124.339 1.056 . . . . 72.33 109.853 173.92 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 18.2 ptmt -76.83 85.08 3.41 Favored 'General case' 0 N--CA 1.479 0.98 0 C-N-CA 123.427 0.691 . . . . 70.44 110.568 179.309 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 119' ' ' THR . . . . . 0.656 ' HB ' HD23 ' A' ' 122' ' ' LEU . 73.5 p -77.44 85.33 3.84 Favored 'General case' 0 CA--C 1.552 1.034 0 CA-C-O 122.068 0.937 . . . . 75.14 110.168 -175.559 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 9.8 pt-20 -81.52 -20.88 39.12 Favored 'General case' 0 N--CA 1.486 1.34 0 C-N-CA 123.691 0.796 . . . . 73.41 112.247 -167.862 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 121' ' ' TRP . . . . . . . . . . . . . 28.5 p90 -73.06 -8.16 54.49 Favored 'General case' 0 N--CA 1.484 1.23 0 C-N-CA 123.525 0.73 . . . . 74.31 110.794 174.748 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 122' ' ' LEU . . . . . 0.656 HD23 ' HB ' ' A' ' 119' ' ' THR . 4.2 mm? -84.23 11.48 8.18 Favored 'General case' 0 CA--C 1.554 1.105 0 C-N-CA 124.16 0.984 . . . . 64.13 111.239 170.932 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 34.5 m-20 -75.92 150.84 37.46 Favored 'General case' 0 N--CA 1.491 1.602 0 CA-C-N 118.804 0.729 . . . . 72.12 110.744 171.228 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 64.45 13.45 54.88 Favored Glycine 0 C--N 1.352 1.43 0 O-C-N 123.877 0.735 . . . . 55.14 112.829 -173.827 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -106.76 -166.21 1.15 Allowed 'General case' 0 CA--C 1.547 0.86 0 C-N-CA 124.941 1.296 . . . . 73.31 108.05 -173.108 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 126' ' ' HIS . . . . . . . . . . . . . 14.0 p-80 -66.84 156.79 34.68 Favored 'General case' 0 N--CA 1.476 0.865 0 C-N-CA 124.48 1.112 . . . . 75.32 113.039 -173.68 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 127' ' ' VAL . . . . . 0.424 HG23 ' HB3' ' A' ' 85' ' ' ASP . 45.9 t -65.74 133.3 30.97 Favored 'Isoleucine or valine' 0 CA--C 1.553 1.084 0 C-N-CA 125.476 1.51 . . . . 73.44 112.955 -168.894 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 128' ' ' VAL . . . . . 0.509 ' HB ' ' HB2' ' A' ' 90' ' ' LEU . 47.3 t -85.19 158.57 3.41 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.148 0 C-N-CA 124.759 1.224 . . . . 71.13 108.701 168.813 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 129' ' ' PHE . . . . . 0.417 ' HD2' HD22 ' A' ' 24' ' ' LEU . 36.8 p90 -139.87 -32.53 0.62 Allowed 'General case' 0 N--CA 1.481 1.092 0 CA-C-N 118.422 0.556 . . . . 74.43 111.936 176.578 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . -117.84 162.41 13.07 Favored Glycine 0 C--N 1.341 0.855 0 CA-C-O 121.071 0.262 . . . . 62.01 113.427 -173.112 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 131' ' ' LYS . . . . . 0.404 ' HB3' ' HE2' ' A' ' 131' ' ' LYS . 29.6 ttpt -149.51 120.06 7.46 Favored 'General case' 0 N--CA 1.469 0.489 0 C-N-CA 124.717 1.207 . . . . 71.04 108.796 -179.608 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 34.8 t -61.17 100.78 0.13 Allowed 'Isoleucine or valine' 0 N--CA 1.473 0.7 0 N-CA-C 109.567 -0.531 . . . . 74.12 109.567 177.266 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 133' ' ' LYS . . . . . 0.527 ' HD2' ' HB2' ' A' ' 23' ' ' GLU . 0.1 OUTLIER -86.25 -28.76 23.61 Favored 'General case' 0 N--CA 1.473 0.68 0 N-CA-C 109.454 -0.573 . . . . 73.31 109.454 -179.901 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 42.4 mt-10 -144.27 149.83 36.91 Favored 'General case' 0 N--CA 1.478 0.968 0 C-N-CA 124.937 1.295 . . . . 71.5 109.945 176.748 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 135' ' ' GLY . . . . . 0.413 ' HA3' ' HA ' ' A' ' 20' ' ' VAL . . . 85.73 20.21 56.52 Favored Glycine 0 C--N 1.347 1.157 0 CA-C-O 119.822 -0.432 . . . . 51.3 113.687 176.749 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 136' ' ' MET . . . . . . . . . . . . . 14.4 tpt -67.24 -26.54 66.63 Favored 'General case' 0 N--CA 1.48 1.056 0 C-N-CA 123.156 0.582 . . . . 74.32 110.867 179.153 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 137' ' ' ASN . . . . . . . . . . . . . 52.9 t-20 -56.88 -44.39 82.22 Favored 'General case' 0 N--CA 1.48 1.07 0 C-N-CA 124.259 1.023 . . . . 65.15 109.812 172.164 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 138' ' ' ILE . . . . . . . . . . . . . 49.4 mm -71.47 -32.77 47.42 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.748 0 C-N-CA 123.861 0.864 . . . . 71.12 110.742 -179.08 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 139' ' ' VAL . . . . . 0.609 HG12 HG22 ' A' ' 116' ' ' THR . 93.5 t -67.09 -42.13 87.97 Favored 'Isoleucine or valine' 0 CA--C 1.559 1.317 0 C-N-CA 123.534 0.734 . . . . 54.12 110.837 177.904 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 39.3 mt-10 -73.92 -28.14 61.38 Favored 'General case' 0 N--CA 1.478 0.949 0 CA-C-N 115.563 -0.744 . . . . 62.51 110.804 176.747 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -70.43 -44.27 68.2 Favored 'General case' 0 N--CA 1.476 0.847 0 C-N-CA 123.688 0.795 . . . . 63.3 110.848 178.031 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 142' ' ' MET . . . . . 0.522 ' HB2' HD13 ' A' ' 156' ' ' ILE . 27.7 ptm -73.91 -29.36 62.01 Favored 'General case' 0 N--CA 1.473 0.679 0 CA-C-N 115.567 -0.742 . . . . 74.43 111.133 -177.975 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 143' ' ' GLU . . . . . 0.447 ' HB2' HG21 ' A' ' 116' ' ' THR . 41.2 tt0 -51.29 -38.44 52.87 Favored 'General case' 0 N--CA 1.478 0.97 0 C-N-CA 124.105 0.962 . . . . 71.54 111.707 174.189 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 144' ' ' ARG . . . . . . . . . . . . . 39.1 mtp85 -66.92 -22.1 65.97 Favored 'General case' 0 CA--C 1.542 0.667 0 CA-C-N 115.243 -0.889 . . . . 55.13 112.216 -173.432 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 145' ' ' PHE . . . . . . . . . . . . . 58.4 m-85 -82.35 -5.84 58.87 Favored 'General case' 0 N--CA 1.481 1.106 0 N-CA-C 112.088 0.403 . . . . 74.31 112.088 -178.181 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . -97.51 173.09 28.16 Favored Glycine 0 C--N 1.35 1.347 0 N-CA-C 112.52 -0.232 . . . . 73.04 112.52 177.655 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 46.1 m -134.25 172.37 12.96 Favored 'General case' 0 N--CA 1.486 1.328 0 C-N-CA 124.146 0.978 . . . . 72.44 111.106 -176.164 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 148' ' ' ARG . . . . . . . . . . . . . 11.0 mmt180 -57.14 -46.57 82.58 Favored 'General case' 0 N--CA 1.49 1.557 0 C-N-CA 124.697 1.199 . . . . 64.43 112.567 -178.553 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 149' ' ' ASN . . . . . . . . . . . . . 29.9 p-10 -67.34 -14.16 62.67 Favored 'General case' 0 N--CA 1.479 1.02 0 C-N-CA 123.801 0.841 . . . . 70.23 111.884 179.136 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 150' ' ' GLY . . . . . 0.501 ' O ' ' HA ' ' A' ' 55' ' ' ARG . . . 102.68 -4.34 50.2 Favored Glycine 0 C--N 1.351 1.372 0 CA-C-O 119.808 -0.44 . . . . 25.34 112.711 -179.732 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 62.3 tttp -69.93 133.56 47.44 Favored 'General case' 0 N--CA 1.475 0.778 0 CA-C-N 117.15 0.475 . . . . 72.01 110.408 -177.66 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 152' ' ' THR . . . . . . . . . . . . . 24.8 p -102.06 124.68 48.08 Favored 'General case' 0 C--O 1.236 0.38 0 C-N-CA 123.601 0.761 . . . . 73.43 109.468 174.165 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 153' ' ' SER . . . . . . . . . . . . . 47.7 t -75.15 -8.62 57.08 Favored 'General case' 0 CA--C 1.55 0.952 0 C-N-CA 123.419 0.688 . . . . 71.42 111.059 174.866 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 74.7 mmtt -133.96 132.42 40.16 Favored 'General case' 0 N--CA 1.475 0.777 0 C-N-CA 124.54 1.136 . . . . 71.3 109.424 178.489 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 46.1 mtmt -82.31 93.29 7.12 Favored 'General case' 0 N--CA 1.474 0.767 0 N-CA-C 108.085 -1.08 . . . . 73.4 108.085 173.757 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 156' ' ' ILE . . . . . 0.522 HD13 ' HB2' ' A' ' 142' ' ' MET . 62.6 mt -85.23 104.67 13.45 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.557 0 CA-C-N 115.707 -0.679 . . . . 74.21 109.886 -175.223 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 157' ' ' THR . . . . . . . . . . . . . 50.1 p -103.93 148.17 26.48 Favored 'General case' 0 N--CA 1.476 0.83 0 C-N-CA 124.44 1.096 . . . . 73.52 110.712 -173.393 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 158' ' ' ILE . . . . . 0.483 HG23 ' HB3' ' A' ' 8' ' ' PHE . 60.3 mt -74.93 93.43 0.8 Allowed 'Isoleucine or valine' 0 CA--C 1.543 0.706 0 N-CA-C 108.136 -1.061 . . . . 74.34 108.136 169.264 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 159' ' ' ALA . . . . . 0.451 ' HB2' ' HB2' ' A' ' 11' ' ' ALA . . . -57.29 -40.08 77.07 Favored 'General case' 0 N--CA 1.476 0.838 0 C-N-CA 124.585 1.154 . . . . 73.14 112.784 -177.335 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 160' ' ' ASP . . . . . 0.582 ' HA ' ' HE3' ' A' ' 49' ' ' LYS . 29.4 t70 -156.15 163.87 39.08 Favored 'General case' 0 N--CA 1.474 0.738 0 O-C-N 123.394 0.434 . . . . 61.32 111.06 -175.862 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 161' ' ' CYS . . . . . . . . . . . . . 18.6 p -131.39 -169.94 2.28 Favored 'General case' 0 CA--C 1.542 0.661 0 C-N-CA 124.976 1.311 . . . . 72.3 108.729 177.844 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 162' ' ' GLY . . . . . . . . . . . . . . . 131.22 51.69 0.1 OUTLIER Glycine 0 N--CA 1.471 1.008 0 N-CA-C 109.915 -1.274 . . . . 73.35 109.915 -170.225 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 163' ' ' GLN . . . . . 0.664 ' HA ' ' H ' ' A' ' 7' ' ' PHE . 36.7 mt-30 -54.33 122.19 9.87 Favored 'General case' 0 CA--C 1.546 0.821 0 CA-C-N 112.429 -1.885 . . . . 74.52 111.927 -175.836 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 164' ' ' LEU . . . . . . . . . . . . . 82.5 mt . . . . . 0 N--CA 1.475 0.806 0 C-N-CA 123.377 0.671 . . . . 70.31 111.377 -168.046 . . . . . . . . 0 0 . 1 . 019 nuclear build core ' B' B ' 218' ' ' PRO . . . . . . . . . . . . . 32.4 Cg_exo . . . . . 0 CA--C 1.547 1.168 0 CA-C-O 120.927 0.303 . . . . 63.2 111.787 . . . . . . . . . 0 0 . 1 . 019 nuclear build core ' B' B ' 219' ' ' GLY . . . . . . . . . . . . . . . 171.14 152.48 8.27 Favored Glycine 0 C--N 1.339 0.748 0 CA-C-N 115.827 -0.624 . . . . 72.42 111.865 178.4 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 220' ' ' PRO . . . . . 0.623 ' HB3' HD11 ' A' ' 122' ' ' LEU . 84.5 Cg_endo -77.72 155.52 31.13 Favored 'Trans proline' 0 C--N 1.373 1.852 0 C-N-CA 122.691 2.26 . . . . 61.21 112.395 179.888 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 221' ' ' TYR . . . . . . . . . . . . . 54.4 m-85 . . . . . 0 C--O 1.244 0.777 0 C-N-CA 123.306 0.642 . . . . 74.14 109.469 -174.799 . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 88.1 m-20 . . . . . 0 C--O 1.24 0.588 0 N-CA-C 110.024 -0.362 . . . . 73.35 110.024 . . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 4' ' ' PRO . . . . . 0.451 ' HG2' ' HB2' ' A' ' 24' ' ' LEU . 60.7 Cg_endo -80.04 141.02 14.54 Favored 'Trans proline' 0 C--N 1.362 1.283 0 C-N-CA 122.116 1.877 . . . . 75.34 111.003 164.518 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 5' ' ' THR . . . . . 0.402 ' HB ' ' O ' ' A' ' 164' ' ' LEU . 50.6 m -96.54 134.0 40.31 Favored 'General case' 0 CA--C 1.533 0.302 0 N-CA-C 108.744 -0.835 . . . . 72.53 108.744 175.673 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 6' ' ' VAL . . . . . 0.6 ' HA ' ' HB2' ' A' ' 163' ' ' GLN . 58.2 t -100.47 145.84 10.27 Favored 'Isoleucine or valine' 0 C--O 1.217 -0.645 0 N-CA-C 107.869 -1.16 . . . . 63.21 107.869 174.593 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 7' ' ' PHE . . . . . 0.443 ' HB2' ' HG ' ' A' ' 164' ' ' LEU . 87.7 t80 -129.26 126.46 39.12 Favored 'General case' 0 C--O 1.239 0.552 0 N-CA-C 109.132 -0.692 . . . . 75.52 109.132 178.663 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 8' ' ' PHE . . . . . 0.441 ' HE2' ' HZ ' ' A' ' 36' ' ' PHE . 31.0 m-85 -128.16 166.0 19.35 Favored 'General case' 0 C--O 1.238 0.477 0 C-N-CA 124.253 1.021 . . . . 73.41 109.409 168.8 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 29.1 m-20 -115.16 111.96 21.8 Favored 'General case' 0 C--N 1.326 -0.419 0 N-CA-C 107.291 -1.374 . . . . 75.14 107.291 170.835 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 10' ' ' ILE . . . . . 0.482 HG21 ' SD ' ' A' ' 142' ' ' MET . 46.8 mm -80.89 125.76 39.5 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.473 0 N-CA-C 108.896 -0.779 . . . . 60.1 108.896 -179.461 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 11' ' ' ALA . . . . . 0.821 ' HB2' ' HB2' ' A' ' 159' ' ' ALA . . . -114.6 142.82 45.94 Favored 'General case' 0 C--O 1.217 -0.634 0 C-N-CA 124.556 1.142 . . . . 52.21 110.199 -173.839 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 12' ' ' VAL . . . . . 0.46 HG22 HG12 ' A' ' 156' ' ' ILE . 60.9 t -123.99 135.12 64.61 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.907 0 N-CA-C 107.237 -1.394 . . . . 64.21 107.237 172.097 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 25.4 m-20 65.49 20.32 11.68 Favored 'General case' 0 N--CA 1.494 1.73 0 C-N-CA 124.304 1.041 . . . . 75.21 110.424 -168.841 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 80.36 -5.7 62.93 Favored Glycine 0 C--N 1.358 1.753 0 CA-C-N 116.065 -0.516 . . . . 60.11 113.757 -173.849 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 30.8 mm-40 -104.77 126.94 29.9 Favored Pre-proline 0 N--CA 1.475 0.823 0 C-N-CA 123.882 0.873 . . . . 75.33 110.45 -175.52 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 14.8 Cg_endo -51.87 112.94 0.96 Allowed 'Trans proline' 0 C--N 1.385 2.494 0 C-N-CA 123.538 2.826 . . . . 63.52 112.647 -174.397 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 50.7 tp -76.42 -46.35 27.52 Favored 'General case' 0 N--CA 1.468 0.472 0 CA-C-N 115.007 -0.997 . . . . 52.41 108.859 175.535 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -169.57 -176.21 39.25 Favored Glycine 0 C--N 1.34 0.781 0 CA-C-N 115.169 -0.923 . . . . 72.34 112.258 179.777 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 13.5 ptp180 -109.79 144.44 38.21 Favored 'General case' 0 N--CA 1.475 0.786 0 C-N-CA 123.833 0.853 . . . . 54.34 110.256 -179.536 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 99.3 t -135.55 131.97 51.38 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.733 0 C-N-CA 124.058 0.943 . . . . 74.25 108.918 177.117 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 21' ' ' SER . . . . . 0.473 ' OG ' ' HB2' ' A' ' 134' ' ' GLU . 78.0 p -116.13 130.9 57.02 Favored 'General case' 0 CA--C 1.552 1.021 0 C-N-CA 123.388 0.675 . . . . 75.24 109.561 173.914 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 22' ' ' PHE . . . . . 0.452 ' CD1' HD22 ' A' ' 98' ' ' LEU . 44.9 m-85 -102.61 169.94 8.34 Favored 'General case' 0 N--CA 1.471 0.575 0 C-N-CA 124.785 1.234 . . . . 64.2 110.015 178.928 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 6.4 tp10 -130.95 106.31 8.33 Favored 'General case' 0 C--O 1.24 0.57 0 N-CA-C 108.593 -0.891 . . . . 54.44 108.593 -179.691 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 24' ' ' LEU . . . . . 0.451 ' HB2' ' HG2' ' A' ' 4' ' ' PRO . 52.1 mt -78.71 124.75 28.52 Favored 'General case' 0 N--CA 1.468 0.448 0 N-CA-C 109.962 -0.384 . . . . 75.15 109.962 178.383 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 25' ' ' PHE . . . . . 0.483 ' HB2' HD11 ' A' ' 90' ' ' LEU . 36.4 m-85 -85.34 60.0 5.98 Favored 'General case' 0 CA--C 1.545 0.771 0 N-CA-C 108.777 -0.823 . . . . 73.24 108.777 173.132 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -61.34 -33.41 73.57 Favored 'General case' 0 N--CA 1.483 1.21 0 C-N-CA 123.613 0.765 . . . . 75.42 111.666 -175.344 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 12.2 p-10 -59.98 -29.59 68.55 Favored 'General case' 0 CA--C 1.549 0.907 0 C-N-CA 124.372 1.069 . . . . 70.04 111.92 176.765 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 28' ' ' LYS . . . . . 0.579 ' HD2' HD21 ' A' ' 90' ' ' LEU . 40.0 mttm -94.72 -42.29 8.83 Favored 'General case' 0 N--CA 1.482 1.14 0 C-N-CA 123.548 0.739 . . . . 74.24 110.637 -178.114 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 29' ' ' VAL . . . . . 0.532 HG21 ' HA ' ' A' ' 129' ' ' PHE . 18.9 m -124.58 82.17 59.47 Favored Pre-proline 0 CA--C 1.563 1.473 0 C-N-CA 123.843 0.857 . . . . 74.33 110.867 -176.369 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 60.7 Cg_exo -53.77 -52.6 8.12 Favored 'Trans proline' 0 C--N 1.386 2.533 0 C-N-CA 123.183 2.589 . . . . 75.03 113.504 -177.83 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 4.0 ttmp? -66.47 -52.77 42.72 Favored 'General case' 0 N--CA 1.481 1.096 0 C-N-CA 124.252 1.021 . . . . 75.02 111.975 -177.301 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 32' ' ' THR . . . . . 0.66 HG22 ' HD2' ' A' ' 129' ' ' PHE . 1.4 m -64.55 -38.04 89.63 Favored 'General case' 0 CA--C 1.549 0.925 0 CA-C-N 115.23 -0.895 . . . . 73.03 110.94 -169.586 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -83.6 -36.44 23.92 Favored 'General case' 0 CA--C 1.548 0.885 0 C-N-CA 122.825 0.45 . . . . 75.44 112.2 -178.826 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 29.9 tt0 -57.03 -47.42 80.95 Favored 'General case' 0 N--CA 1.492 1.64 0 C-N-CA 123.371 0.668 . . . . 53.11 110.535 175.439 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 35' ' ' ASN . . . . . 0.499 ' O ' ' HG ' ' A' ' 39' ' ' LEU . 39.8 t30 -49.63 -57.38 7.27 Favored 'General case' 0 C--N 1.349 0.577 0 O-C-N 125.406 1.691 . . . . 73.5 110.474 179.209 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 36' ' ' PHE . . . . . 0.441 ' HZ ' ' HE2' ' A' ' 8' ' ' PHE . 72.3 t80 -62.24 -45.2 94.38 Favored 'General case' 0 CA--C 1.543 0.675 0 O-C-N 124.169 0.918 . . . . 73.13 112.051 -175.939 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 11.6 ttm180 -54.14 -47.72 71.59 Favored 'General case' 0 N--CA 1.482 1.143 0 O-C-N 123.843 0.714 . . . . 75.44 111.507 176.123 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 38' ' ' ALA . . . . . 0.522 ' HB1' ' HG2' ' A' ' 44' ' ' LYS . . . -70.44 -30.37 67.19 Favored 'General case' 0 CA--C 1.544 0.724 0 CA-C-N 115.578 -0.737 . . . . 74.03 111.809 -175.605 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 39' ' ' LEU . . . . . 0.552 HD22 ' HE2' ' A' ' 48' ' ' TYR . 99.7 mt -71.31 -43.64 66.7 Favored 'General case' 0 N--CA 1.477 0.883 0 C-N-CA 123.603 0.761 . . . . 71.13 110.593 175.161 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 34.9 t -64.56 -52.32 58.29 Favored 'General case' 0 N--CA 1.477 0.924 0 C-N-CA 124.979 1.312 . . . . 70.2 111.562 -174.843 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 41' ' ' THR . . . . . 0.446 ' OG1' ' HG2' ' A' ' 43' ' ' GLU . 67.4 p -85.18 -31.25 23.33 Favored 'General case' 0 C--O 1.24 0.587 0 CA-C-N 115.096 -0.956 . . . . 74.11 111.388 -176.054 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 85.99 35.72 10.92 Favored Glycine 0 C--N 1.347 1.16 0 CA-C-N 116.154 -0.476 . . . . 53.24 112.736 -177.803 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 43' ' ' GLU . . . . . 0.446 ' HG2' ' OG1' ' A' ' 41' ' ' THR . 26.7 mm-40 -62.89 -30.86 71.85 Favored 'General case' 0 N--CA 1.483 1.218 0 C-N-CA 122.92 0.488 . . . . 55.41 110.606 172.682 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 44' ' ' LYS . . . . . 0.522 ' HG2' ' HB1' ' A' ' 38' ' ' ALA . 31.5 mmmt -100.57 20.19 15.51 Favored 'General case' 0 CA--C 1.548 0.899 0 C-N-CA 123.707 0.803 . . . . 74.53 111.465 177.353 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 71.17 41.91 59.15 Favored Glycine 0 C--N 1.35 1.334 0 CA-C-O 119.528 -0.595 . . . . 71.23 114.562 171.896 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 24.1 m-85 -123.19 -48.33 1.98 Allowed 'General case' 0 N--CA 1.486 1.372 0 CA-C-N 117.596 0.698 . . . . 71.42 111.071 -176.876 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 48.58 62.64 4.3 Favored Glycine 0 C--N 1.356 1.685 0 O-C-N 124.169 0.918 . . . . 15.11 114.288 171.669 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 48' ' ' TYR . . . . . 0.589 ' CE1' ' HA2' ' A' ' 75' ' ' GLY . 66.1 m-85 -60.78 95.37 0.04 OUTLIER 'General case' 0 N--CA 1.48 1.065 0 CA-C-O 122.108 0.956 . . . . 72.1 112.751 -174.617 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 28.6 tptp -109.41 131.45 55.05 Favored 'General case' 0 CA--C 1.537 0.457 0 CA-C-N 113.337 -1.756 . . . . 51.53 109.149 -176.798 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 72.71 20.34 79.64 Favored Glycine 0 C--N 1.346 1.098 0 CA-C-O 119.665 -0.519 . . . . 70.04 113.793 177.412 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 51' ' ' SER . . . . . 0.485 ' HB3' ' HA2' ' A' ' 65' ' ' GLY . 49.0 m -61.14 114.56 3.2 Favored 'General case' 0 N--CA 1.476 0.858 0 C-N-CA 123.249 0.62 . . . . 63.04 110.368 -178.29 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 52' ' ' CYS . . . . . . . . . . . . . 53.5 t -92.14 121.44 33.69 Favored 'General case' 0 N--CA 1.474 0.727 0 N-CA-C 113.031 0.752 . . . . 75.21 113.031 -165.945 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 53' ' ' PHE . . . . . 0.584 ' HB2' ' HB ' ' A' ' 156' ' ' ILE . 76.4 m-85 -69.4 114.57 7.77 Favored 'General case' 0 C--O 1.239 0.517 0 C-N-CA 124.867 1.267 . . . . 75.5 109.816 167.803 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 17.4 p-80 -128.04 -4.5 5.66 Favored 'General case' 0 N--CA 1.481 1.079 0 C-N-CA 123.565 0.746 . . . . 75.4 112.031 -173.819 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 36.0 ttt180 -135.19 107.37 7.19 Favored 'General case' 0 C--N 1.357 0.928 0 N-CA-C 108.975 -0.75 . . . . 74.23 108.975 170.756 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 56' ' ' ILE . . . . . 0.494 HG23 ' SG ' ' A' ' 62' ' ' CYS . 71.8 mt -130.62 129.25 64.17 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.694 0 C-N-CA 123.721 0.808 . . . . 64.35 109.242 177.365 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 57' ' ' ILE . . . . . 0.468 HG12 ' HA2' ' A' ' 150' ' ' GLY . 52.2 mt -117.07 121.54 32.38 Favored Pre-proline 0 CA--C 1.556 1.186 0 C-N-CA 124.584 1.154 . . . . 61.04 108.725 176.903 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 58' ' ' PRO . . . . . 0.503 ' HA ' ' HG3' ' A' ' 143' ' ' GLU . 24.3 Cg_exo -64.01 146.85 91.67 Favored 'Trans proline' 0 C--N 1.375 1.954 0 C-N-CA 122.792 2.328 . . . . 65.2 112.63 173.388 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 63.99 31.22 80.08 Favored Glycine 0 C--N 1.345 1.033 0 CA-C-N 115.117 -0.947 . . . . 63.05 113.284 -176.306 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 40.0 t80 -158.46 -77.77 0.07 Allowed 'General case' 0 CA--C 1.549 0.923 0 CA-C-N 116.814 0.307 . . . . 74.41 111.653 -174.18 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 48.3 ttm -165.6 157.12 14.32 Favored 'General case' 0 N--CA 1.489 1.49 0 N-CA-C 112.01 0.374 . . . . 70.54 112.01 -163.433 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 62' ' ' CYS . . . . . 0.494 ' SG ' HG23 ' A' ' 56' ' ' ILE . 61.2 m -131.86 113.37 13.4 Favored 'General case' 0 N--CA 1.471 0.623 0 C-N-CA 124.299 1.04 . . . . 54.22 109.11 175.772 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 13.4 pt20 -117.6 149.55 40.48 Favored 'General case' 0 N--CA 1.488 1.448 0 CA-C-O 121.396 0.617 . . . . 75.24 111.556 -177.343 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 64' ' ' GLY . . . . . 0.459 ' CA ' ' HA ' ' A' ' 53' ' ' PHE . . . -162.1 179.4 37.46 Favored Glycine 0 C--N 1.343 0.951 0 CA-C-N 114.536 -1.211 . . . . 60.11 113.94 -176.492 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 65' ' ' GLY . . . . . 0.485 ' HA2' ' HB3' ' A' ' 51' ' ' SER . . . 110.04 98.31 2.5 Favored Glycine 0 N--CA 1.447 -0.581 0 N-CA-C 108.91 -1.676 . . . . 74.45 108.91 -167.277 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 23.7 t70 -124.69 19.95 8.6 Favored 'General case' 0 N--CA 1.483 1.21 0 CA-C-O 121.765 0.793 . . . . 53.41 109.132 179.353 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 49.1 t80 -81.54 -77.83 0.2 Allowed 'General case' 0 CA--C 1.551 1.004 0 CA-C-N 115.301 -0.863 . . . . 61.42 111.746 -169.55 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 89.6 m -85.54 107.74 17.61 Favored 'General case' 0 N--CA 1.48 1.068 0 C-N-CA 122.406 0.282 . . . . 73.31 110.442 -175.348 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 77.9 mtp180 66.44 80.86 0.21 Allowed 'General case' 0 N--CA 1.472 0.672 0 C-N-CA 125.177 1.391 . . . . 74.5 110.468 -179.85 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 7.8 p80 -70.98 73.87 0.61 Allowed 'General case' 0 CA--C 1.558 1.265 0 CA-C-O 122.343 1.068 . . . . 70.31 110.652 179.709 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 7.4 t30 -153.81 30.39 0.46 Allowed 'General case' 0 CA--C 1.553 1.073 0 C-N-CA 125.066 1.347 . . . . 65.44 107.587 -172.821 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 92.17 -8.67 77.48 Favored Glycine 0 C--N 1.353 1.507 0 CA-C-N 114.874 -1.057 . . . . 53.41 113.431 -177.235 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 73' ' ' THR . . . . . 0.608 ' HA ' ' HB2' ' A' ' 110' ' ' SER . 28.7 m -85.09 -67.12 0.82 Allowed 'General case' 0 CA--C 1.546 0.815 0 N-CA-C 108.525 -0.917 . . . . 63.32 108.525 174.458 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 54.92 18.58 11.87 Favored Glycine 0 C--N 1.348 1.242 0 N-CA-C 115.807 1.083 . . . . 71.34 115.807 167.248 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 75' ' ' GLY . . . . . 0.589 ' HA2' ' CE1' ' A' ' 48' ' ' TYR . . . 147.84 54.14 0.02 OUTLIER Glycine 0 CA--C 1.494 -1.233 0 O-C-N 121.537 -0.978 . . . . 53.0 111.826 -160.287 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 64.2 pttt -60.18 167.74 2.26 Favored 'General case' 0 CA--C 1.546 0.823 0 O-C-N 124.524 0.779 . . . . 44.14 111.173 173.782 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 87.1 p -88.78 174.16 8.15 Favored 'General case' 0 C--O 1.241 0.647 0 CA-C-N 115.68 -0.691 . . . . 51.21 110.607 -177.746 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 29.6 pt -69.77 -21.69 24.44 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.787 0 CA-C-N 115.846 -0.616 . . . . 74.04 110.557 173.244 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 56.4 m-85 -87.14 0.4 55.36 Favored 'General case' 0 N--CA 1.479 0.989 0 C-N-CA 124.134 0.974 . . . . 63.43 111.636 -178.166 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 125.6 -150.71 17.47 Favored Glycine 0 C--N 1.347 1.172 0 N-CA-C 111.135 -0.786 . . . . 73.13 111.135 -179.933 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 45.9 tt0 -63.02 -40.73 98.62 Favored 'General case' 0 N--CA 1.476 0.873 0 C-N-CA 123.392 0.677 . . . . 72.25 110.612 175.997 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 82' ' ' LYS . . . . . 0.476 ' HD3' ' HA ' ' A' ' 107' ' ' THR . 11.2 ptpp? -150.66 168.38 24.5 Favored 'General case' 0 CA--C 1.548 0.887 0 CA-C-N 115.637 -0.71 . . . . 73.23 110.963 -171.727 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 35.5 p90 -159.77 164.33 33.88 Favored 'General case' 0 N--CA 1.477 0.916 0 C-N-CA 124.797 1.239 . . . . 72.23 109.512 176.065 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 11.6 pt-20 -94.25 159.16 15.26 Favored 'General case' 0 N--CA 1.478 0.931 0 C-N-CA 123.158 0.583 . . . . 74.13 109.834 173.934 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 63.9 m-20 -67.08 151.36 47.75 Favored 'General case' 0 N--CA 1.475 0.809 0 C-N-CA 124.371 1.069 . . . . 74.13 113.814 -170.74 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 6.3 tp10 -69.59 -59.33 3.03 Favored 'General case' 0 CA--C 1.55 0.958 0 CA-C-N 114.953 -1.022 . . . . 75.21 111.12 177.567 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 87' ' ' ASN . . . . . 0.417 ' OD1' HG12 ' A' ' 29' ' ' VAL . 25.8 p-10 -174.2 137.51 0.54 Allowed 'General case' 0 N--CA 1.489 1.508 0 C-N-CA 123.88 0.872 . . . . 75.52 109.912 -171.639 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 91.9 m-85 -89.12 54.82 3.1 Favored 'General case' 0 N--CA 1.489 1.508 0 CA-C-O 121.468 0.652 . . . . 74.4 111.685 -171.492 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 49.3 mt -82.47 -46.72 19.26 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.812 0 CA-C-N 115.632 -0.713 . . . . 75.41 109.16 170.591 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 90' ' ' LEU . . . . . 0.579 HD21 ' HD2' ' A' ' 28' ' ' LYS . 90.2 mt -95.33 110.73 22.7 Favored 'General case' 0 C--O 1.241 0.641 0 CA-C-N 115.445 -0.798 . . . . 53.11 110.876 -174.728 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 23.5 pttm -107.84 169.52 8.55 Favored 'General case' 0 N--CA 1.474 0.769 0 C-N-CA 124.176 0.99 . . . . 74.41 109.409 173.503 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 92' ' ' HIS . . . . . 0.463 ' HA ' HG21 ' A' ' 97' ' ' ILE . 17.1 m-70 -87.68 47.07 1.45 Allowed 'General case' 0 N--CA 1.481 1.088 0 C-N-CA 124.045 0.938 . . . . 55.2 110.371 -173.688 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 9.5 t -83.71 5.32 25.11 Favored 'General case' 0 CA--C 1.552 1.028 0 C-N-CA 124.315 1.046 . . . . 75.45 111.971 -174.059 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -133.53 153.42 20.82 Favored Glycine 0 C--N 1.347 1.155 0 CA-C-O 119.713 -0.493 . . . . 74.11 112.067 179.091 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 73.5 Cg_endo -75.89 142.38 25.2 Favored 'Trans proline' 0 C--N 1.367 1.531 0 C-N-CA 122.538 2.158 . . . . 73.02 110.064 167.258 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 89.13 6.69 71.17 Favored Glycine 0 N--CA 1.467 0.75 0 CA-C-O 120.145 -0.253 . . . . 62.42 113.121 -175.931 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 97' ' ' ILE . . . . . 0.717 ' HB ' ' SG ' ' A' ' 115' ' ' CYS . 5.9 mm -68.63 120.18 15.67 Favored 'Isoleucine or valine' 0 CA--C 1.552 1.057 0 C-N-CA 123.181 0.593 . . . . 75.34 110.782 179.191 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 98' ' ' LEU . . . . . 0.452 HD22 ' CD1' ' A' ' 22' ' ' PHE . 56.8 tp -103.4 123.05 46.11 Favored 'General case' 0 CA--C 1.554 1.122 0 C-N-CA 124.4 1.08 . . . . 54.34 111.038 -177.657 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 99' ' ' SER . . . . . 0.712 ' HB3' ' HA ' ' A' ' 128' ' ' VAL . 11.3 p -152.88 158.39 42.08 Favored 'General case' 0 N--CA 1.473 0.687 0 C-N-CA 124.369 1.067 . . . . 71.41 109.514 176.212 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 100' ' ' MET . . . . . 0.661 ' HG3' ' HE2' ' A' ' 129' ' ' PHE . 79.7 mtp -77.25 145.83 37.28 Favored 'General case' 0 N--CA 1.487 1.398 0 N-CA-C 109.944 -0.391 . . . . 75.22 109.944 -179.898 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 101' ' ' ALA . . . . . 0.518 ' HB3' ' HB2' ' A' ' 111' ' ' GLN . . . -76.07 165.85 24.34 Favored 'General case' 0 C--O 1.247 0.943 0 CA-C-O 121.015 0.436 . . . . 65.44 111.236 -177.681 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 102' ' ' ASN . . . . . 0.475 ' HB3' ' HA ' ' A' ' 108' ' ' ASN . 27.1 p-10 -160.38 156.79 26.74 Favored 'General case' 0 N--CA 1.472 0.631 0 CA-C-N 115.809 -0.632 . . . . 72.41 111.007 -176.766 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -93.33 -17.23 23.82 Favored 'General case' 0 CA--C 1.545 0.773 0 CA-C-N 115.358 -0.837 . . . . 54.31 110.674 169.587 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 177.94 -178.75 48.51 Favored Glycine 0 C--N 1.352 1.437 0 CA-C-O 119.445 -0.642 . . . . 64.51 112.957 178.839 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 50.2 Cg_exo -58.85 141.22 97.82 Favored 'Trans proline' 0 C--N 1.374 1.917 0 C-N-CA 123.22 2.614 . . . . 75.03 112.439 171.554 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 64.4 t30 66.54 10.55 7.45 Favored 'General case' 0 N--CA 1.485 1.302 0 C-N-CA 125.48 1.512 . . . . 73.23 111.243 -176.301 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 107' ' ' THR . . . . . 0.476 ' HA ' ' HD3' ' A' ' 82' ' ' LYS . 16.7 m -126.57 18.76 7.42 Favored 'General case' 0 CA--C 1.558 1.273 0 C-N-CA 124.767 1.227 . . . . 60.12 108.769 -178.828 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 108' ' ' ASN . . . . . 0.475 ' HA ' ' HB3' ' A' ' 102' ' ' ASN . 48.1 t30 -86.13 143.74 27.87 Favored 'General case' 0 N--CA 1.48 1.026 0 C-N-CA 123.827 0.851 . . . . 61.45 109.206 177.33 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 112.69 26.29 4.24 Favored Glycine 0 N--CA 1.469 0.86 0 C-N-CA 121.18 -0.533 . . . . 40.02 113.481 -177.566 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 110' ' ' SER . . . . . 0.608 ' HB2' ' HA ' ' A' ' 73' ' ' THR . 31.6 p -129.17 121.06 26.91 Favored 'General case' 0 CA--C 1.539 0.551 0 N-CA-C 107.859 -1.163 . . . . 65.24 107.859 171.697 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 111' ' ' GLN . . . . . 0.518 ' HB2' ' HB3' ' A' ' 101' ' ' ALA . 48.8 mt-30 66.49 177.21 0.23 Allowed 'General case' 0 N--CA 1.491 1.583 0 C-N-CA 124.536 1.135 . . . . 70.13 111.271 -171.574 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 112' ' ' PHE . . . . . 0.638 ' HA ' ' HA ' ' A' ' 100' ' ' MET . 3.1 m-85 -131.75 166.92 20.45 Favored 'General case' 0 N--CA 1.477 0.882 0 N-CA-C 107.396 -1.335 . . . . 72.44 107.396 175.336 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 113' ' ' PHE . . . . . 0.424 ' O ' HD12 ' A' ' 98' ' ' LEU . 48.2 p90 -157.13 160.47 38.85 Favored 'General case' 0 N--CA 1.477 0.916 0 CA-C-O 121.393 0.616 . . . . 73.43 112.138 170.902 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 114' ' ' ILE . . . . . 0.483 HG21 HG11 ' A' ' 139' ' ' VAL . 20.2 mt -124.51 109.71 23.29 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.821 0 CA-C-N 114.024 -1.444 . . . . 71.32 107.443 171.845 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 115' ' ' CYS . . . . . 0.717 ' SG ' ' HB ' ' A' ' 97' ' ' ILE . 29.8 p -74.5 105.5 5.66 Favored 'General case' 0 N--CA 1.474 0.769 0 N-CA-C 108.836 -0.802 . . . . 74.04 108.836 177.464 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 116' ' ' THR . . . . . 0.421 HG22 HG12 ' A' ' 139' ' ' VAL . 24.2 p -71.27 -23.06 61.9 Favored 'General case' 0 N--CA 1.476 0.853 0 C-N-CA 124.396 1.078 . . . . 62.14 111.601 -174.015 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -107.39 152.89 23.57 Favored 'General case' 0 C--O 1.245 0.839 0 N-CA-C 108.794 -0.817 . . . . 71.3 108.794 166.775 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 20.3 ptmt -70.69 99.0 1.61 Allowed 'General case' 0 CA--C 1.543 0.676 0 CA-C-O 121.762 0.792 . . . . 75.51 109.033 172.851 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 119' ' ' THR . . . . . . . . . . . . . 82.2 p -81.7 86.32 6.44 Favored 'General case' 0 CA--C 1.547 0.858 0 CA-C-O 121.963 0.887 . . . . 63.23 109.656 -175.721 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 12.1 pt-20 -74.28 -29.99 61.9 Favored 'General case' 0 N--CA 1.48 1.057 0 CA-C-N 114.662 -1.153 . . . . 73.14 111.132 -175.092 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 121' ' ' TRP . . . . . . . . . . . . . 34.5 p90 -64.91 -13.4 56.76 Favored 'General case' 0 N--CA 1.48 1.03 0 C-N-CA 123.987 0.915 . . . . 75.35 111.57 175.347 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 64.7 mt -99.42 29.08 4.17 Favored 'General case' 0 CA--C 1.551 0.987 0 C-N-CA 123.75 0.82 . . . . 45.12 111.51 176.125 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 83.4 m-20 -69.45 134.95 49.56 Favored 'General case' 0 N--CA 1.484 1.254 0 N-CA-C 109.651 -0.5 . . . . 63.44 109.651 166.615 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 81.9 0.86 89.97 Favored Glycine 0 C--N 1.341 0.844 0 CA-C-N 116.223 -0.444 . . . . 34.42 113.056 -176.209 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 125' ' ' LYS . . . . . 0.46 ' HG3' ' H ' ' A' ' 126' ' ' HIS . 8.5 tppt? -78.43 -170.93 2.23 Favored 'General case' 0 N--CA 1.477 0.915 0 N-CA-C 108.641 -0.874 . . . . 63.44 108.641 176.96 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 126' ' ' HIS . . . . . 0.46 ' H ' ' HG3' ' A' ' 125' ' ' LYS . 44.7 p-80 -68.57 152.84 44.81 Favored 'General case' 0 CA--C 1.545 0.781 0 O-C-N 122.051 -0.406 . . . . 65.13 110.022 -175.826 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 48.5 t -79.37 147.42 6.7 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.697 0 C-N-CA 123.631 0.772 . . . . 75.34 112.452 -164.771 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 128' ' ' VAL . . . . . 0.712 ' HA ' ' HB3' ' A' ' 99' ' ' SER . 61.7 t -83.19 158.81 3.73 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.759 0 C-N-CA 125.103 1.361 . . . . 54.35 109.933 176.375 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 129' ' ' PHE . . . . . 0.661 ' HE2' ' HG3' ' A' ' 100' ' ' MET . 7.3 p90 -130.62 -24.13 2.51 Favored 'General case' 0 N--CA 1.479 1.023 0 N-CA-C 111.918 0.34 . . . . 72.2 111.918 173.509 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . -143.23 175.53 23.25 Favored Glycine 0 C--N 1.34 0.765 0 O-C-N 123.31 0.381 . . . . 63.31 112.588 -172.997 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 34.6 ttpt -161.08 137.9 8.71 Favored 'General case' 0 N--CA 1.466 0.365 0 N-CA-C 108.52 -0.919 . . . . 74.22 108.52 179.612 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 132' ' ' VAL . . . . . 0.467 HG11 ' HA ' ' A' ' 136' ' ' MET . 40.7 t -61.35 108.45 0.47 Allowed 'Isoleucine or valine' 0 CA--C 1.544 0.72 0 C-N-CA 123.418 0.687 . . . . 64.53 109.976 177.043 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 21.4 ptmt -85.74 -39.19 17.43 Favored 'General case' 0 CA--C 1.542 0.663 0 N-CA-C 109.689 -0.485 . . . . 53.24 109.689 177.006 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 134' ' ' GLU . . . . . 0.473 ' HB2' ' OG ' ' A' ' 21' ' ' SER . 53.4 mm-40 -137.81 149.61 46.5 Favored 'General case' 0 N--CA 1.483 1.195 0 C-N-CA 124.302 1.041 . . . . 64.34 109.253 177.573 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 85.03 20.38 57.67 Favored Glycine 0 N--CA 1.473 1.161 0 O-C-N 123.414 0.446 . . . . 75.34 112.649 -179.295 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 136' ' ' MET . . . . . 0.467 ' HA ' HG11 ' A' ' 132' ' ' VAL . 15.1 tpt -61.07 -33.89 74.04 Favored 'General case' 0 N--CA 1.483 1.211 0 C-N-CA 123.763 0.825 . . . . 73.21 110.943 179.662 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 137' ' ' ASN . . . . . . . . . . . . . 11.4 m120 -64.91 -32.67 74.49 Favored 'General case' 0 CA--C 1.546 0.797 0 C-N-CA 123.849 0.86 . . . . 72.4 111.82 -179.271 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 138' ' ' ILE . . . . . 0.408 ' O ' ' HG3' ' A' ' 142' ' ' MET . 46.8 mm -70.56 -37.8 71.16 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.966 0 C-N-CA 123.143 0.577 . . . . 64.32 109.868 177.355 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 139' ' ' VAL . . . . . 0.483 HG11 HG21 ' A' ' 114' ' ' ILE . 59.3 t -67.17 -37.39 79.1 Favored 'Isoleucine or valine' 0 CA--C 1.555 1.139 0 C-N-CA 123.829 0.852 . . . . 62.3 110.963 177.338 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 38.7 mt-10 -70.86 -28.4 64.54 Favored 'General case' 0 N--CA 1.478 0.934 0 CA-C-N 115.792 -0.64 . . . . 54.05 110.706 176.328 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -68.8 -39.52 80.07 Favored 'General case' 0 N--CA 1.475 0.814 0 C-N-CA 122.876 0.47 . . . . 73.45 110.278 172.38 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 142' ' ' MET . . . . . 0.482 ' SD ' HG21 ' A' ' 10' ' ' ILE . 76.6 mtp -58.25 -41.65 84.69 Favored 'General case' 0 N--CA 1.485 1.282 0 C-N-CA 123.983 0.913 . . . . 70.45 111.157 175.654 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 143' ' ' GLU . . . . . 0.503 ' HG3' ' HA ' ' A' ' 58' ' ' PRO . 37.8 tt0 -53.69 -43.3 68.81 Favored 'General case' 0 CA--C 1.546 0.79 0 CA-C-N 114.92 -1.036 . . . . 60.42 111.69 176.767 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 144' ' ' ARG . . . . . . . . . . . . . 56.2 mtt180 -72.53 -18.58 61.63 Favored 'General case' 0 N--CA 1.475 0.812 0 C-N-CA 124.155 0.982 . . . . 53.01 111.646 -177.263 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 145' ' ' PHE . . . . . 0.494 ' HB3' ' HB2' ' A' ' 154' ' ' LYS . 24.9 m-85 -86.56 -4.27 59.15 Favored 'General case' 0 N--CA 1.479 0.981 0 C-N-CA 123.398 0.679 . . . . 61.12 111.359 176.603 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . -97.24 -179.22 34.17 Favored Glycine 0 C--N 1.347 1.192 0 C-N-CA 123.053 0.358 . . . . 74.13 112.599 175.569 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 21.4 m -134.03 163.13 30.24 Favored 'General case' 0 N--CA 1.482 1.135 0 C-N-CA 124.114 0.966 . . . . 73.31 110.512 -176.121 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 148' ' ' ARG . . . . . . . . . . . . . 26.6 mmt180 -67.91 -28.18 67.28 Favored 'General case' 0 N--CA 1.486 1.364 0 C-N-CA 123.432 0.693 . . . . 72.21 112.037 -175.733 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 149' ' ' ASN . . . . . . . . . . . . . 30.8 p-10 -82.39 2.45 32.37 Favored 'General case' 0 N--CA 1.483 1.177 0 C-N-CA 123.644 0.778 . . . . 74.31 111.358 175.816 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 150' ' ' GLY . . . . . 0.468 ' HA2' HG12 ' A' ' 57' ' ' ILE . . . 93.06 -6.29 76.09 Favored Glycine 0 C--N 1.35 1.34 0 CA-C-O 119.722 -0.488 . . . . 41.12 113.674 177.02 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 40.7 ttmt -71.04 141.13 50.92 Favored 'General case' 0 N--CA 1.475 0.804 0 CA-C-N 117.315 0.557 . . . . 70.24 110.651 -177.719 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 152' ' ' THR . . . . . . . . . . . . . 12.5 p -90.35 117.08 28.8 Favored 'General case' 0 C--O 1.237 0.443 0 N-CA-C 108.824 -0.806 . . . . 75.35 108.824 169.062 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 153' ' ' SER . . . . . . . . . . . . . 22.8 m -66.46 -31.35 72.03 Favored 'General case' 0 CA--C 1.544 0.742 0 CA-C-N 115.679 -0.691 . . . . 73.23 110.036 171.92 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 154' ' ' LYS . . . . . 0.494 ' HB2' ' HB3' ' A' ' 145' ' ' PHE . 32.2 mmmt -121.13 129.97 53.52 Favored 'General case' 0 N--CA 1.472 0.627 0 CA-C-N 115.469 -0.787 . . . . 74.2 110.399 -178.96 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 83.3 tttt -67.76 106.36 2.22 Favored 'General case' 0 C--N 1.352 0.691 0 C-N-CA 123.737 0.815 . . . . 73.14 109.396 171.759 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 156' ' ' ILE . . . . . 0.584 ' HB ' ' HB2' ' A' ' 53' ' ' PHE . 62.0 mt -102.97 131.73 50.63 Favored 'Isoleucine or valine' 0 C--O 1.221 -0.422 0 N-CA-C 108.102 -1.073 . . . . 75.22 108.102 176.509 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 157' ' ' THR . . . . . . . . . . . . . 33.1 p -127.96 160.83 30.66 Favored 'General case' 0 N--CA 1.481 1.098 0 C-N-CA 123.935 0.894 . . . . 62.23 109.732 -179.75 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 158' ' ' ILE . . . . . . . . . . . . . 57.1 mt -82.98 97.08 4.17 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.838 0 N-CA-C 108.52 -0.918 . . . . 74.14 108.52 167.477 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 159' ' ' ALA . . . . . 0.821 ' HB2' ' HB2' ' A' ' 11' ' ' ALA . . . -55.99 -41.72 75.26 Favored 'General case' 0 N--CA 1.481 1.106 0 C-N-CA 124.067 0.947 . . . . 53.02 112.626 -177.262 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 160' ' ' ASP . . . . . . . . . . . . . 2.7 t70 -165.35 174.56 9.99 Favored 'General case' 0 CA--C 1.549 0.93 0 O-C-N 123.496 0.498 . . . . 62.4 110.527 -176.68 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 161' ' ' CYS . . . . . . . . . . . . . 24.5 p -130.96 -167.85 1.9 Allowed 'General case' 0 N--CA 1.478 0.959 0 C-N-CA 125.366 1.467 . . . . 65.35 109.41 -178.55 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 162' ' ' GLY . . . . . . . . . . . . . . . 132.62 53.32 0.08 OUTLIER Glycine 0 C--N 1.351 1.369 0 N-CA-C 112.137 -0.385 . . . . 74.11 112.137 -175.327 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 163' ' ' GLN . . . . . 0.6 ' HB2' ' HA ' ' A' ' 6' ' ' VAL . 21.2 pt20 -49.44 143.4 6.67 Favored 'General case' 0 N--CA 1.482 1.131 0 C-N-CA 124.421 1.088 . . . . 73.41 113.1 -174.379 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 164' ' ' LEU . . . . . 0.443 ' HG ' ' HB2' ' A' ' 7' ' ' PHE . 86.0 mt . . . . . 0 CA--C 1.547 0.843 0 C-N-CA 123.514 0.726 . . . . 74.2 110.14 -173.365 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 218' ' ' PRO . . . . . . . . . . . . . 11.7 Cg_endo . . . . . 0 CA--C 1.544 0.992 0 CA-C-O 121.651 0.605 . . . . 74.23 111.632 . . . . . . . . . 0 0 . 1 . 020 nuclear build core ' B' B ' 219' ' ' GLY . . . . . . . . . . . . . . . 176.08 156.04 14.32 Favored Glycine 0 CA--C 1.525 0.71 0 CA-C-N 114.593 -1.185 . . . . 74.43 111.542 177.711 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 220' ' ' PRO . . . . . . . . . . . . . 60.5 Cg_endo -85.38 -178.97 3.27 Favored 'Trans proline' 0 CA--C 1.553 1.472 0 C-N-CA 122.961 2.441 . . . . 65.14 112.209 175.459 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 221' ' ' TYR . . . . . . . . . . . . . 43.1 p90 . . . . . 0 N--CA 1.484 1.242 0 C-N-CA 123.632 0.773 . . . . 75.3 110.986 179.802 . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 56.3 mtt . . . . . 0 N--CA 1.477 0.912 0 N-CA-C 108.184 -1.043 . . . . 65.32 108.184 . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 12.8 m 48.71 35.08 0.24 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.855 0 C-N-CA 126.418 1.887 . . . . 73.31 112.848 -174.273 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 3' ' ' ASN . . . . . 0.485 ' ND2' ' HA ' ' A' ' 25' ' ' PHE . 20.1 m120 -88.26 113.81 56.76 Favored Pre-proline 0 CA--C 1.549 0.917 0 CA-C-N 115.012 -0.995 . . . . 64.31 109.701 177.703 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 4' ' ' PRO . . . . . 0.493 ' HG2' ' HB2' ' A' ' 24' ' ' LEU . 52.8 Cg_endo -75.85 133.87 15.81 Favored 'Trans proline' 0 C--N 1.372 1.779 0 C-N-CA 122.078 1.852 . . . . 73.33 111.509 170.082 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 5' ' ' THR . . . . . 0.405 ' HB ' ' O ' ' A' ' 164' ' ' LEU . 80.7 m -97.62 124.74 42.03 Favored 'General case' 0 CA--C 1.536 0.437 0 N-CA-C 108.524 -0.917 . . . . 73.14 108.524 172.631 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 7.4 m -100.87 123.47 53.89 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.81 0 N-CA-C 109.143 -0.688 . . . . 75.43 109.143 173.607 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 7' ' ' PHE . . . . . 0.621 ' H ' ' HA ' ' A' ' 163' ' ' GLN . 85.5 t80 -108.08 137.44 46.06 Favored 'General case' 0 C--O 1.241 0.608 0 C-N-CA 124.056 0.942 . . . . 73.0 109.236 -174.351 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 8' ' ' PHE . . . . . 0.497 ' HB3' HG23 ' A' ' 158' ' ' ILE . 62.8 m-85 -138.66 162.59 34.27 Favored 'General case' 0 N--CA 1.469 0.501 0 C-N-CA 123.889 0.875 . . . . 74.2 110.433 175.943 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 16.0 m-20 -110.35 117.88 34.82 Favored 'General case' 0 N--CA 1.467 0.394 0 N-CA-C 107.354 -1.35 . . . . 72.32 107.354 170.26 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 49.6 mm -89.4 124.94 42.38 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.559 0 N-CA-C 109.176 -0.676 . . . . 73.53 109.176 -179.809 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 11' ' ' ALA . . . . . 0.553 ' HB2' ' HB2' ' A' ' 159' ' ' ALA . . . -128.68 126.28 39.79 Favored 'General case' 0 N--CA 1.471 0.581 0 C-N-CA 123.34 0.656 . . . . 51.33 111.062 -173.177 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 12' ' ' VAL . . . . . 0.438 HG13 ' HB3' ' A' ' 154' ' ' LYS . 96.3 t -95.53 120.36 44.82 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.43 0 N-CA-C 108.077 -1.083 . . . . 74.42 108.077 174.801 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 31.4 m-20 60.37 24.48 13.99 Favored 'General case' 0 N--CA 1.482 1.126 0 C-N-CA 125.499 1.519 . . . . 73.53 111.767 -175.791 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 91.69 -18.61 52.26 Favored Glycine 0 C--N 1.354 1.559 0 CA-C-N 116.587 -0.279 . . . . 64.23 112.903 -175.554 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 15.8 mm-40 -82.15 114.2 49.21 Favored Pre-proline 0 CA--C 1.548 0.887 0 C-N-CA 124.213 1.005 . . . . 72.43 110.123 178.863 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 18.6 Cg_endo -56.18 108.79 0.36 Allowed 'Trans proline' 0 C--N 1.384 2.41 0 C-N-CA 123.262 2.642 . . . . 73.44 112.383 -178.077 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 48.4 tp -76.8 -29.52 56.04 Favored 'General case' 0 N--CA 1.475 0.776 0 CA-C-N 114.828 -1.078 . . . . 62.25 109.522 176.375 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 170.11 -159.65 32.24 Favored Glycine 0 N--CA 1.449 -0.5 0 CA-C-N 115.039 -0.982 . . . . 72.32 111.046 -176.109 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 2.0 ptp180 -149.08 142.93 25.68 Favored 'General case' 0 C--O 1.24 0.595 0 C-N-CA 123.282 0.633 . . . . 73.53 109.898 -177.408 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 50.7 t -132.09 129.07 59.98 Favored 'Isoleucine or valine' 0 C--O 1.24 0.582 0 C-N-CA 123.659 0.784 . . . . 74.54 109.453 -176.908 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 66.7 p -109.6 140.77 43.03 Favored 'General case' 0 C--O 1.252 1.189 0 N-CA-C 108.655 -0.869 . . . . 74.44 108.655 170.453 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 22' ' ' PHE . . . . . 0.438 ' HE1' ' HD2' ' A' ' 8' ' ' PHE . 45.2 m-85 -118.42 134.36 55.12 Favored 'General case' 0 N--CA 1.467 0.394 0 C-N-CA 123.908 0.883 . . . . 71.5 108.978 -178.113 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 7.7 tp10 -87.36 110.59 20.36 Favored 'General case' 0 CA--C 1.535 0.397 0 N-CA-C 109.35 -0.611 . . . . 75.53 109.35 174.026 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 24' ' ' LEU . . . . . 0.493 ' HB2' ' HG2' ' A' ' 4' ' ' PRO . 33.8 mt -83.92 121.28 27.15 Favored 'General case' 0 N--CA 1.469 0.482 0 N-CA-C 109.132 -0.692 . . . . 64.34 109.132 176.826 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 25' ' ' PHE . . . . . 0.485 ' HA ' ' ND2' ' A' ' 3' ' ' ASN . 65.6 m-85 -84.82 69.69 10.75 Favored 'General case' 0 CA--C 1.54 0.579 0 C-N-CA 123.746 0.818 . . . . 73.13 109.912 179.279 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -70.09 -20.14 63.22 Favored 'General case' 0 N--CA 1.478 0.975 0 CA-C-N 115.076 -0.966 . . . . 75.25 111.52 -179.579 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 11.5 p-10 -72.19 -19.16 61.79 Favored 'General case' 0 CA--C 1.55 0.98 0 C-N-CA 123.71 0.804 . . . . 71.31 111.188 175.579 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 28' ' ' LYS . . . . . 0.422 ' HD2' HD21 ' A' ' 90' ' ' LEU . 47.0 mttm -108.57 -51.45 2.89 Favored 'General case' 0 N--CA 1.48 1.061 0 C-N-CA 123.46 0.704 . . . . 73.51 110.765 -176.698 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 29' ' ' VAL . . . . . 0.499 HG21 ' HA ' ' A' ' 129' ' ' PHE . 5.5 m -129.82 74.92 80.27 Favored Pre-proline 0 CA--C 1.56 1.334 0 C-N-CA 124.409 1.083 . . . . 45.12 109.741 -175.8 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 58.2 Cg_endo -65.8 -34.37 40.25 Favored 'Trans proline' 0 C--N 1.378 2.094 0 C-N-CA 122.98 2.453 . . . . 72.43 112.726 -168.468 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 31' ' ' LYS . . . . . 0.469 ' HB3' ' HB2' ' A' ' 86' ' ' GLU . 27.4 ttmt -64.55 -58.73 5.57 Favored 'General case' 0 CA--C 1.533 0.311 0 C-N-CA 124.226 1.01 . . . . 70.51 111.253 -177.561 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 3.8 m -72.39 -26.3 61.83 Favored 'General case' 0 CA--C 1.559 1.308 0 O-C-N 123.63 0.581 . . . . 73.43 111.191 -173.674 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 33' ' ' ALA . . . . . 0.448 ' HB1' ' HB3' ' A' ' 24' ' ' LEU . . . -73.47 -58.27 3.42 Favored 'General case' 0 N--CA 1.482 1.143 0 C-N-CA 123.025 0.53 . . . . 71.3 111.888 177.454 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 34' ' ' GLU . . . . . 0.499 ' HG3' HH21 ' A' ' 37' ' ' ARG . 43.0 tt0 -62.84 -29.49 70.78 Favored 'General case' 0 N--CA 1.488 1.447 0 C-N-CA 123.383 0.673 . . . . 75.31 111.192 -178.597 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 35' ' ' ASN . . . . . 0.456 ' O ' ' HG ' ' A' ' 39' ' ' LEU . 32.1 t30 -50.93 -60.02 3.53 Favored 'General case' 0 N--CA 1.476 0.83 0 C-N-CA 124.061 0.944 . . . . 70.23 110.527 174.506 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 84.1 t80 -66.48 -33.08 74.88 Favored 'General case' 0 CA--C 1.544 0.729 0 O-C-N 124.06 0.85 . . . . 63.43 111.237 -178.573 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 37' ' ' ARG . . . . . 0.499 HH21 ' HG3' ' A' ' 34' ' ' GLU . 17.4 ttp180 -62.48 -40.98 98.41 Favored 'General case' 0 N--CA 1.478 0.943 0 C-N-CA 123.204 0.602 . . . . 72.52 110.737 177.599 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -80.47 -21.54 41.93 Favored 'General case' 0 N--CA 1.472 0.654 0 CA-C-N 115.386 -0.825 . . . . 64.05 111.321 -178.105 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 39' ' ' LEU . . . . . 0.456 ' HG ' ' O ' ' A' ' 35' ' ' ASN . 95.8 mt -72.15 -44.46 63.06 Favored 'General case' 0 N--CA 1.478 0.952 0 C-N-CA 123.203 0.601 . . . . 55.31 110.379 172.067 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 65.9 p -72.56 -40.2 66.86 Favored 'General case' 0 N--CA 1.475 0.823 0 C-N-CA 123.737 0.815 . . . . 42.42 111.484 -173.937 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 61.2 p -76.81 -31.55 57.01 Favored 'General case' 0 N--CA 1.474 0.726 0 O-C-N 123.343 0.402 . . . . 62.14 110.226 172.614 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 71.59 24.92 76.17 Favored Glycine 0 C--N 1.35 1.338 0 CA-C-N 115.659 -0.701 . . . . 72.21 114.312 175.226 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 20.9 mm-40 -68.24 -17.92 64.43 Favored 'General case' 0 N--CA 1.476 0.863 0 C-N-CA 123.203 0.601 . . . . 64.35 111.582 179.243 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 31.1 mmmt -92.18 13.5 18.87 Favored 'General case' 0 CA--C 1.552 1.024 0 C-N-CA 123.708 0.803 . . . . 72.23 111.384 177.169 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 84.76 37.84 10.04 Favored Glycine 0 C--N 1.353 1.511 0 N-CA-C 113.87 0.308 . . . . 71.44 113.87 171.229 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 23.0 m-85 -125.15 -46.84 1.79 Allowed 'General case' 0 N--CA 1.484 1.245 0 CA-C-N 117.058 0.429 . . . . 74.22 110.89 -174.257 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 53.89 58.5 12.36 Favored Glycine 0 C--N 1.349 1.297 0 O-C-N 124.161 0.913 . . . . 72.04 114.148 174.848 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 48' ' ' TYR . . . . . 0.413 ' HE2' ' HA2' ' A' ' 75' ' ' GLY . 52.1 m-85 -63.86 89.84 0.05 Allowed 'General case' 0 N--CA 1.483 1.213 0 CA-C-O 121.851 0.834 . . . . 73.22 111.885 -179.153 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 38.7 tptt -112.96 142.77 45.26 Favored 'General case' 0 CA--C 1.538 0.49 0 CA-C-N 114.058 -1.428 . . . . 65.42 108.37 179.153 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 70.74 22.02 78.04 Favored Glycine 0 C--N 1.345 1.03 0 CA-C-O 119.568 -0.573 . . . . 50.51 113.923 175.438 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 24.3 t -58.87 114.51 2.58 Favored 'General case' 0 CA--C 1.549 0.92 0 C-N-CA 123.53 0.732 . . . . 74.24 111.05 -173.817 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 52' ' ' CYS . . . . . . . . . . . . . 15.5 p -87.25 118.1 26.44 Favored 'General case' 0 CA--C 1.54 0.564 0 C-N-CA 123.905 0.882 . . . . 74.13 111.873 -169.791 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 53' ' ' PHE . . . . . 0.677 ' HA ' ' HA2' ' A' ' 64' ' ' GLY . 88.4 m-85 -69.02 78.77 0.32 Allowed 'General case' 0 CA--C 1.539 0.541 0 C-N-CA 124.454 1.102 . . . . 71.12 109.671 165.405 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 15.2 p-80 -95.45 -8.4 35.52 Favored 'General case' 0 N--CA 1.479 0.999 0 CA-C-N 115.219 -0.9 . . . . 73.1 112.461 -173.652 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 59.0 ttt-85 -130.8 100.1 5.16 Favored 'General case' 0 N--CA 1.476 0.834 0 N-CA-C 109.133 -0.691 . . . . 71.14 109.133 179.364 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 56' ' ' ILE . . . . . 0.527 HD11 ' HB3' ' A' ' 53' ' ' PHE . 65.8 mt -134.39 133.21 55.2 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.117 0 C-N-CA 123.241 0.616 . . . . 60.04 109.97 -177.725 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 57' ' ' ILE . . . . . 0.518 HG23 ' HA ' ' A' ' 148' ' ' ARG . 66.6 mt -121.34 120.63 28.9 Favored Pre-proline 0 CA--C 1.558 1.25 0 C-N-CA 124.7 1.2 . . . . 73.32 109.229 175.871 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 35.6 Cg_endo -64.64 139.23 62.66 Favored 'Trans proline' 0 C--N 1.388 2.638 0 C-N-CA 123.078 2.519 . . . . 71.03 112.362 176.323 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 76.67 21.71 74.06 Favored Glycine 0 C--N 1.346 1.12 0 CA-C-N 115.009 -0.996 . . . . 51.14 113.134 -175.686 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 60' ' ' PHE . . . . . 0.406 ' HD2' ' HB ' ' A' ' 57' ' ' ILE . 19.9 t80 -149.57 -76.91 0.15 Allowed 'General case' 0 N--CA 1.478 0.936 0 CA-C-N 117.318 0.559 . . . . 74.14 111.349 -175.738 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 61' ' ' MET . . . . . 0.586 ' SD ' ' HB2' ' A' ' 113' ' ' PHE . 15.7 tmm? -168.07 142.94 3.59 Favored 'General case' 0 N--CA 1.481 1.077 0 N-CA-C 112.115 0.413 . . . . 63.41 112.115 -163.305 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 62' ' ' CYS . . . . . . . . . . . . . 22.7 p -111.53 113.21 25.47 Favored 'General case' 0 CA--C 1.551 0.985 0 C-N-CA 124.196 0.999 . . . . 63.01 109.908 173.18 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 63' ' ' GLN . . . . . 0.498 ' HA ' ' HA ' ' A' ' 113' ' ' PHE . 17.1 tt0 -108.53 127.05 53.59 Favored 'General case' 0 N--CA 1.487 1.384 0 C-N-CA 124.019 0.927 . . . . 61.42 111.745 -173.699 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 64' ' ' GLY . . . . . 0.677 ' HA2' ' HA ' ' A' ' 53' ' ' PHE . . . -102.35 167.34 17.85 Favored Glycine 0 C--N 1.351 1.385 0 CA-C-N 114.834 -1.076 . . . . 71.2 112.423 175.993 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -178.57 -174.97 45.27 Favored Glycine 0 C--N 1.339 0.701 0 N-CA-C 112.236 -0.346 . . . . 61.14 112.236 -179.432 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 28.2 t70 -126.1 168.04 14.55 Favored 'General case' 0 C--O 1.247 0.931 0 C-N-CA 124.185 0.994 . . . . 72.11 110.337 -170.608 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 51.9 t80 -88.04 -21.45 24.76 Favored 'General case' 0 CA--C 1.548 0.873 0 C-N-CA 123.799 0.84 . . . . 74.11 111.78 -176.959 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 67.5 m -63.48 108.57 1.39 Allowed 'General case' 0 N--CA 1.484 1.233 0 N-CA-C 109.792 -0.447 . . . . 70.33 109.792 179.9 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 70.0 ttt180 56.04 54.95 7.34 Favored 'General case' 0 CA--C 1.555 1.15 0 O-C-N 124.701 1.25 . . . . 73.43 110.473 -178.02 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 44.8 t-80 -57.13 -36.14 70.33 Favored 'General case' 0 N--CA 1.482 1.17 0 CA-C-N 115.462 -0.79 . . . . 71.44 111.988 -175.793 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 37.2 t30 -64.71 114.41 4.42 Favored 'General case' 0 N--CA 1.476 0.855 0 C-N-CA 123.398 0.679 . . . . 60.4 109.856 174.663 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 76.85 -6.77 38.52 Favored Glycine 0 CA--C 1.53 0.986 0 N-CA-C 116.019 1.168 . . . . 72.41 116.019 169.376 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 23.8 m -143.77 -82.36 0.17 Allowed 'General case' 0 CA--C 1.554 1.117 0 CA-C-N 117.922 0.861 . . . . 74.44 109.528 179.192 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 63.08 50.2 65.31 Favored Glycine 0 C--N 1.353 1.477 0 C-N-CA 123.559 0.599 . . . . 43.42 114.054 174.469 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 75' ' ' GLY . . . . . 0.413 ' HA2' ' HE2' ' A' ' 48' ' ' TYR . . . 139.14 49.94 0.06 OUTLIER Glycine 0 C--N 1.345 1.053 0 CA-C-N 117.387 0.594 . . . . 72.41 111.682 -179.049 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 21.3 pttp -67.22 161.0 25.78 Favored 'General case' 0 CA--C 1.553 1.076 0 C-N-CA 123.341 0.656 . . . . 52.14 112.423 -174.122 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 80.6 p -90.11 -179.38 5.66 Favored 'General case' 0 CA--C 1.545 0.77 0 C-N-CA 124.259 1.023 . . . . 74.31 112.297 -171.106 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 24.5 pt -73.47 -13.17 15.96 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.082 0 C-N-CA 123.197 0.599 . . . . 73.23 110.677 172.052 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 98.5 m-85 -91.53 7.46 41.25 Favored 'General case' 0 CA--C 1.545 0.782 0 C-N-CA 124.389 1.076 . . . . 73.12 110.626 171.213 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 91.61 -141.33 15.6 Favored Glycine 0 C--N 1.347 1.168 0 CA-C-O 119.532 -0.593 . . . . 62.52 112.422 176.829 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 31.3 tt0 -50.04 -56.81 9.27 Favored 'General case' 0 N--CA 1.481 1.11 0 C-N-CA 125.039 1.335 . . . . 64.51 111.829 -176.852 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 82' ' ' LYS . . . . . 0.529 ' HD2' ' HA ' ' A' ' 107' ' ' THR . 19.0 pttp -161.17 157.54 26.0 Favored 'General case' 0 C--O 1.239 0.514 0 O-C-N 123.873 0.733 . . . . 62.45 110.97 -179.447 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 24.5 p90 -144.42 172.33 13.1 Favored 'General case' 0 C--O 1.24 0.577 0 C-N-CA 124.915 1.286 . . . . 74.53 109.328 -179.514 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 12.0 pt-20 -99.79 150.27 22.51 Favored 'General case' 0 N--CA 1.473 0.676 0 C-N-CA 123.801 0.84 . . . . 74.34 109.675 176.972 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 26.8 m-20 -66.84 149.59 50.37 Favored 'General case' 0 N--CA 1.48 1.049 0 C-N-CA 123.664 0.786 . . . . 75.35 112.7 -176.203 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 86' ' ' GLU . . . . . 0.469 ' HB2' ' HB3' ' A' ' 31' ' ' LYS . 6.9 tp10 -69.13 -56.11 8.67 Favored 'General case' 0 CA--C 1.544 0.742 0 CA-C-N 115.035 -0.984 . . . . 70.2 110.475 178.782 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 16.8 p-10 -168.97 138.08 2.13 Favored 'General case' 0 N--CA 1.471 0.617 0 C-N-CA 123.771 0.828 . . . . 64.23 109.703 -172.953 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 88' ' ' PHE . . . . . 0.464 ' HD1' ' HB ' ' A' ' 127' ' ' VAL . 40.4 m-85 -90.98 68.23 6.15 Favored 'General case' 0 N--CA 1.479 0.995 0 C-N-CA 123.044 0.538 . . . . 73.54 110.902 -176.035 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 40.1 mt -80.24 -61.84 1.6 Allowed 'Isoleucine or valine' 0 N--CA 1.484 1.273 0 CA-C-O 120.933 0.397 . . . . 62.14 110.008 174.359 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 90' ' ' LEU . . . . . 0.443 ' HB3' ' HB ' ' A' ' 128' ' ' VAL . 96.0 mt -75.05 104.74 5.75 Favored 'General case' 0 CA--C 1.544 0.731 0 CA-C-N 115.49 -0.777 . . . . 61.43 110.878 -173.798 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 91' ' ' LYS . . . . . 0.668 ' HE3' ' HB ' ' A' ' 93' ' ' THR . 0.1 OUTLIER -83.96 158.49 21.52 Favored 'General case' 0 CA--C 1.545 0.786 0 CA-C-N 115.099 -0.955 . . . . 71.32 110.073 173.908 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 92' ' ' HIS . . . . . . . . . . . . . 25.2 m-70 -87.46 65.96 8.85 Favored 'General case' 0 N--CA 1.479 1.016 0 CA-C-O 121.493 0.663 . . . . 75.31 109.696 -177.293 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 93' ' ' THR . . . . . 0.668 ' HB ' ' HE3' ' A' ' 91' ' ' LYS . 15.3 t -105.04 15.21 28.04 Favored 'General case' 0 N--CA 1.483 1.176 0 CA-C-N 115.599 -0.728 . . . . 61.23 111.461 -174.088 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -155.35 174.84 33.44 Favored Glycine 0 C--N 1.345 1.044 0 C-N-CA 121.553 -0.356 . . . . 62.14 113.543 -176.225 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -90.19 158.62 4.72 Favored 'Trans proline' 0 CA--C 1.553 1.459 0 C-N-CA 123.753 2.968 . . . . 65.51 111.919 175.656 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 77.23 17.95 78.87 Favored Glycine 0 C--N 1.344 0.999 0 CA-C-N 116.071 -0.513 . . . . 61.11 113.533 -179.117 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 97' ' ' ILE . . . . . 0.671 ' HB ' ' HB2' ' A' ' 115' ' ' CYS . 14.9 mm -66.5 103.09 0.52 Allowed 'Isoleucine or valine' 0 CA--C 1.555 1.169 0 C-N-CA 123.685 0.794 . . . . 62.33 111.009 -176.455 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 98' ' ' LEU . . . . . 0.417 HD22 ' CG ' ' A' ' 22' ' ' PHE . 54.9 tp -88.71 118.1 28.15 Favored 'General case' 0 C--O 1.247 0.922 0 CA-C-O 121.893 0.854 . . . . 74.43 109.471 175.577 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 23.7 t -152.08 141.67 21.76 Favored 'General case' 0 CA--C 1.547 0.854 0 N-CA-C 107.893 -1.151 . . . . 60.31 107.893 -174.664 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 100' ' ' MET . . . . . 0.527 ' HA ' ' HA ' ' A' ' 112' ' ' PHE . 70.7 mtp -76.71 138.19 39.82 Favored 'General case' 0 N--CA 1.495 1.791 0 CA-C-N 119.622 1.101 . . . . 72.2 110.319 -175.294 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 101' ' ' ALA . . . . . 0.437 ' HB3' ' HB2' ' A' ' 111' ' ' GLN . . . -70.42 156.45 39.32 Favored 'General case' 0 C--O 1.247 0.932 0 CA-C-O 121.315 0.579 . . . . 62.33 111.235 -173.263 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 102' ' ' ASN . . . . . 0.423 ' HB3' ' HA ' ' A' ' 108' ' ' ASN . 25.6 p-10 -161.69 164.05 29.37 Favored 'General case' 0 C--O 1.238 0.454 0 CA-C-N 115.055 -0.975 . . . . 72.33 110.646 -173.328 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 103' ' ' ALA . . . . . 0.503 ' HB3' HG21 ' A' ' 107' ' ' THR . . . -97.21 -14.89 21.14 Favored 'General case' 0 CA--C 1.542 0.654 0 CA-C-N 115.521 -0.763 . . . . 73.14 110.361 169.546 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 166.35 -168.18 39.82 Favored Glycine 0 C--N 1.352 1.426 0 CA-C-O 119.406 -0.663 . . . . 75.54 112.517 178.602 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 46.7 Cg_exo -58.72 139.75 92.06 Favored 'Trans proline' 0 C--N 1.374 1.876 0 C-N-CA 123.155 2.57 . . . . 73.22 112.112 173.553 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 66.0 t30 65.53 11.4 7.4 Favored 'General case' 0 N--CA 1.487 1.4 0 C-N-CA 124.967 1.307 . . . . 63.42 111.877 -177.804 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 107' ' ' THR . . . . . 0.529 ' HA ' ' HD2' ' A' ' 82' ' ' LYS . 5.0 m -124.1 17.12 9.22 Favored 'General case' 0 CA--C 1.552 1.028 0 C-N-CA 124.0 0.92 . . . . 72.21 109.705 178.158 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 108' ' ' ASN . . . . . 0.423 ' HA ' ' HB3' ' A' ' 102' ' ' ASN . 32.8 t30 -80.85 150.89 28.94 Favored 'General case' 0 N--CA 1.477 0.9 0 C-N-CA 124.34 1.056 . . . . 73.12 110.112 176.759 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 106.82 25.52 6.18 Favored Glycine 0 N--CA 1.47 0.912 0 C-N-CA 121.488 -0.387 . . . . 74.3 113.297 176.171 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 12.9 p -131.78 118.19 19.59 Favored 'General case' 0 CA--C 1.537 0.447 0 N-CA-C 108.183 -1.043 . . . . 75.51 108.183 175.107 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 111' ' ' GLN . . . . . 0.507 HE21 ' HG2' ' B' ' 218' ' ' PRO . 48.9 mt-30 61.16 -173.68 0.13 Allowed 'General case' 0 N--CA 1.493 1.683 0 C-N-CA 124.097 0.959 . . . . 75.34 111.895 -172.536 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 112' ' ' PHE . . . . . 0.527 ' HA ' ' HA ' ' A' ' 100' ' ' MET . 42.0 p90 -146.31 159.37 43.44 Favored 'General case' 0 N--CA 1.476 0.856 0 C-N-CA 123.817 0.847 . . . . 62.25 109.153 171.968 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 113' ' ' PHE . . . . . 0.586 ' HB2' ' SD ' ' A' ' 61' ' ' MET . 50.6 p90 -138.1 146.78 43.3 Favored 'General case' 0 C--O 1.238 0.458 0 C-N-CA 123.631 0.772 . . . . 75.12 109.6 -179.47 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 114' ' ' ILE . . . . . . . . . . . . . 17.2 mt -120.9 101.97 11.51 Favored 'Isoleucine or valine' 0 C--O 1.243 0.721 0 N-CA-C 107.517 -1.29 . . . . 63.25 107.517 176.419 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 115' ' ' CYS . . . . . 0.671 ' HB2' ' HB ' ' A' ' 97' ' ' ILE . 62.8 m -63.31 104.75 0.64 Allowed 'General case' 0 N--CA 1.469 0.511 0 N-CA-C 109.311 -0.626 . . . . 73.24 109.311 177.477 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 116' ' ' THR . . . . . 0.576 HG22 HG12 ' A' ' 139' ' ' VAL . 32.8 p -70.18 -32.8 70.9 Favored 'General case' 0 N--CA 1.472 0.656 0 C-N-CA 123.593 0.757 . . . . 72.0 109.859 -179.343 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -104.86 161.19 14.4 Favored 'General case' 0 C--O 1.241 0.62 0 C-N-CA 124.174 0.989 . . . . 75.32 109.505 172.27 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 9.4 ptmt -72.71 94.02 1.71 Allowed 'General case' 0 CA--C 1.546 0.826 0 CA-C-O 121.87 0.843 . . . . 75.21 109.874 174.828 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 119' ' ' THR . . . . . . . . . . . . . 75.0 p -87.22 83.99 7.31 Favored 'General case' 0 CA--C 1.545 0.771 0 CA-C-N 115.551 -0.75 . . . . 74.15 110.368 -175.354 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 8.3 pt-20 -80.36 -16.91 53.44 Favored 'General case' 0 N--CA 1.483 1.212 0 CA-C-O 121.137 0.494 . . . . 64.31 111.902 -172.426 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 121' ' ' TRP . . . . . . . . . . . . . 43.6 p90 -70.16 -9.86 56.99 Favored 'General case' 0 CA--C 1.546 0.813 0 C-N-CA 122.792 0.437 . . . . 71.32 111.58 173.971 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 122' ' ' LEU . . . . . 0.479 ' HA ' ' HE2' ' A' ' 125' ' ' LYS . 65.5 mt -89.17 4.91 47.0 Favored 'General case' 0 N--CA 1.477 0.882 0 C-N-CA 123.281 0.632 . . . . 63.33 111.936 174.723 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 78.5 m-20 -74.24 152.09 39.78 Favored 'General case' 0 N--CA 1.487 1.407 0 C-N-CA 122.482 0.313 . . . . 71.21 110.295 173.487 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 75.79 14.77 81.82 Favored Glycine 0 C--N 1.353 1.519 0 O-C-N 123.422 0.451 . . . . 41.02 112.802 -173.451 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 125' ' ' LYS . . . . . 0.479 ' HE2' ' HA ' ' A' ' 122' ' ' LEU . 30.0 mtmm -138.72 -162.09 1.27 Allowed 'General case' 0 N--CA 1.472 0.645 0 C-N-CA 125.683 1.593 . . . . 75.34 108.719 -174.95 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 126' ' ' HIS . . . . . . . . . . . . . 2.5 t60 -62.01 135.47 57.55 Favored 'General case' 0 CA--C 1.549 0.927 0 C-N-CA 123.938 0.895 . . . . 64.14 111.598 -165.715 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 127' ' ' VAL . . . . . 0.464 ' HB ' ' HD1' ' A' ' 88' ' ' PHE . 13.9 p -76.95 148.04 7.06 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.807 0 CA-C-N 114.526 -1.216 . . . . 62.11 112.317 -169.013 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 128' ' ' VAL . . . . . 0.443 ' HB ' ' HB3' ' A' ' 90' ' ' LEU . 18.9 t -72.56 156.07 6.96 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.818 0 C-N-CA 124.073 0.949 . . . . 74.34 108.884 171.619 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 129' ' ' PHE . . . . . 0.499 ' HA ' HG21 ' A' ' 29' ' ' VAL . 43.1 p90 -128.7 -23.84 3.08 Favored 'General case' 0 N--CA 1.485 1.324 0 CA-C-N 118.739 0.699 . . . . 64.42 111.661 175.4 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . -145.59 170.63 26.83 Favored Glycine 0 C--N 1.337 0.61 0 N-CA-C 111.454 -0.658 . . . . 70.23 111.454 -178.38 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 32.8 ttpt -150.07 147.27 27.6 Favored 'General case' 0 N--CA 1.472 0.646 0 N-CA-C 109.002 -0.74 . . . . 74.14 109.002 178.365 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 132' ' ' VAL . . . . . 0.573 HG21 HG21 ' A' ' 139' ' ' VAL . 58.1 t -62.43 112.32 0.97 Allowed 'Isoleucine or valine' 0 CA--C 1.538 0.49 0 C-N-CA 123.327 0.651 . . . . 74.24 109.771 174.838 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 21.9 ptmt -91.99 -33.98 14.62 Favored 'General case' 0 N--CA 1.471 0.606 0 N-CA-C 109.264 -0.643 . . . . 61.13 109.264 175.923 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 35.5 mt-10 -141.58 135.61 30.24 Favored 'General case' 0 N--CA 1.479 1.013 0 C-N-CA 124.513 1.125 . . . . 64.32 109.206 -179.072 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 95.63 24.72 15.04 Favored Glycine 0 C--N 1.349 1.301 0 O-C-N 123.381 0.426 . . . . 62.34 113.825 176.03 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 136' ' ' MET . . . . . . . . . . . . . 14.5 tpt -65.51 -32.09 73.5 Favored 'General case' 0 N--CA 1.485 1.293 0 CA-C-N 117.289 0.545 . . . . 72.24 111.119 179.787 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 137' ' ' ASN . . . . . . . . . . . . . 4.3 p-10 -61.26 -35.32 76.96 Favored 'General case' 0 CA--C 1.551 0.999 0 C-N-CA 123.941 0.897 . . . . 64.14 111.458 173.515 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 138' ' ' ILE . . . . . . . . . . . . . 50.6 mm -74.58 -32.93 30.81 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.001 0 C-N-CA 123.414 0.686 . . . . 73.44 110.532 177.51 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 139' ' ' VAL . . . . . 0.576 HG12 HG22 ' A' ' 116' ' ' THR . 87.7 t -66.52 -44.02 90.45 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.947 0 C-N-CA 123.733 0.813 . . . . 41.34 110.889 178.513 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 140' ' ' GLU . . . . . 0.419 ' O ' ' HG3' ' A' ' 144' ' ' ARG . 52.2 mt-10 -77.0 -19.41 57.31 Favored 'General case' 0 N--CA 1.475 0.795 0 CA-C-N 115.618 -0.719 . . . . 72.23 110.805 177.037 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -70.82 -37.55 73.23 Favored 'General case' 0 CA--C 1.543 0.687 0 C-N-CA 122.387 0.275 . . . . 42.54 110.295 169.068 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 142' ' ' MET . . . . . . . . . . . . . 70.6 mtm -63.24 -39.35 94.36 Favored 'General case' 0 N--CA 1.485 1.304 0 C-N-CA 123.065 0.546 . . . . 74.44 110.376 174.607 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 143' ' ' GLU . . . . . 0.412 ' HB2' HG21 ' A' ' 116' ' ' THR . 25.6 tt0 -55.61 -36.65 67.17 Favored 'General case' 0 CA--C 1.55 0.98 0 CA-C-N 114.539 -1.209 . . . . 61.24 111.784 178.252 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 144' ' ' ARG . . . . . 0.419 ' HG3' ' O ' ' A' ' 140' ' ' GLU . 29.2 mtm180 -73.82 -8.79 57.4 Favored 'General case' 0 N--CA 1.478 0.952 0 C-N-CA 123.837 0.855 . . . . 71.32 112.75 -176.952 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 145' ' ' PHE . . . . . 0.503 ' HB2' HD11 ' A' ' 156' ' ' ILE . 62.8 m-85 -97.63 -4.87 36.65 Favored 'General case' 0 N--CA 1.479 1.001 0 C-N-CA 122.674 0.389 . . . . 74.51 111.007 174.137 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . -92.92 171.36 32.8 Favored Glycine 0 C--N 1.347 1.158 0 CA-C-N 116.361 -0.381 . . . . 73.22 113.192 -179.632 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 147' ' ' SER . . . . . 0.471 ' HB2' ' HB3' ' A' ' 151' ' ' LYS . 18.3 m -133.6 156.99 46.85 Favored 'General case' 0 N--CA 1.475 0.8 0 C-N-CA 124.539 1.135 . . . . 73.11 109.566 -177.426 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 148' ' ' ARG . . . . . 0.518 ' HA ' HG23 ' A' ' 57' ' ' ILE . 18.9 mmt180 -59.12 -37.88 78.28 Favored 'General case' 0 N--CA 1.484 1.24 0 C-N-CA 123.858 0.863 . . . . 74.4 112.592 -172.219 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 149' ' ' ASN . . . . . . . . . . . . . 28.0 p-10 -72.0 -14.68 61.95 Favored 'General case' 0 N--CA 1.486 1.354 0 C-N-CA 123.518 0.727 . . . . 72.0 111.922 179.804 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . 112.89 -3.02 25.8 Favored Glycine 0 C--N 1.347 1.17 0 C-N-CA 123.428 0.537 . . . . 64.2 112.544 -178.644 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 151' ' ' LYS . . . . . 0.471 ' HB3' ' HB2' ' A' ' 147' ' ' SER . 87.9 tttt -67.82 146.47 53.66 Favored 'General case' 0 N--CA 1.478 0.938 0 C-N-CA 123.67 0.788 . . . . 73.34 111.092 -178.94 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 152' ' ' THR . . . . . . . . . . . . . 18.5 p -120.05 114.5 22.08 Favored 'General case' 0 N--CA 1.469 0.476 0 N-CA-C 109.204 -0.665 . . . . 70.42 109.204 173.062 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 153' ' ' SER . . . . . . . . . . . . . 37.8 t -67.34 -24.89 65.77 Favored 'General case' 0 CA--C 1.546 0.822 0 C-N-CA 124.242 1.017 . . . . 74.11 111.109 179.181 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 154' ' ' LYS . . . . . 0.438 ' HB3' HG13 ' A' ' 12' ' ' VAL . 69.7 mmtt -121.69 150.68 41.43 Favored 'General case' 0 N--CA 1.473 0.697 0 C-N-CA 123.951 0.901 . . . . 71.54 111.155 179.925 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 2.2 tppp? -93.37 91.16 7.05 Favored 'General case' 0 N--CA 1.474 0.773 0 CA-C-O 121.366 0.603 . . . . 74.12 110.251 -178.065 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 156' ' ' ILE . . . . . 0.527 ' HB ' ' HB2' ' A' ' 53' ' ' PHE . 48.4 mt -89.6 102.1 12.79 Favored 'Isoleucine or valine' 0 C--O 1.21 -1.009 0 N-CA-C 109.254 -0.647 . . . . 75.34 109.254 -177.05 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 157' ' ' THR . . . . . . . . . . . . . 42.3 p -108.54 145.19 35.17 Favored 'General case' 0 N--CA 1.472 0.652 0 C-N-CA 123.642 0.777 . . . . 73.31 110.151 178.841 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 158' ' ' ILE . . . . . 0.497 HG23 ' HB3' ' A' ' 8' ' ' PHE . 49.4 mt -70.47 95.86 0.47 Allowed 'Isoleucine or valine' 0 CA--C 1.547 0.839 0 N-CA-C 108.672 -0.862 . . . . 72.21 108.672 170.423 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 159' ' ' ALA . . . . . 0.553 ' HB2' ' HB2' ' A' ' 11' ' ' ALA . . . -51.72 -53.94 33.79 Favored 'General case' 0 N--CA 1.477 0.896 0 C-N-CA 124.402 1.081 . . . . 50.3 112.036 -177.599 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 160' ' ' ASP . . . . . . . . . . . . . 5.4 t70 -145.62 169.52 18.26 Favored 'General case' 0 CA--C 1.544 0.72 0 CA-C-N 116.195 -0.457 . . . . 73.12 110.583 -174.743 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 161' ' ' CYS . . . . . . . . . . . . . 12.7 p -135.16 -169.62 2.41 Favored 'General case' 0 N--CA 1.476 0.854 0 C-N-CA 125.048 1.339 . . . . 75.13 108.393 -177.822 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 162' ' ' GLY . . . . . . . . . . . . . . . 131.87 56.74 0.09 OUTLIER Glycine 0 N--CA 1.475 1.247 0 C-N-CA 120.635 -0.793 . . . . 74.24 111.922 -172.965 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 163' ' ' GLN . . . . . 0.621 ' HA ' ' H ' ' A' ' 7' ' ' PHE . 19.5 pt20 -46.93 135.54 9.21 Favored 'General case' 0 CA--C 1.552 1.022 0 C-N-CA 124.099 0.96 . . . . 72.14 113.478 -174.156 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 164' ' ' LEU . . . . . 0.405 ' O ' ' HB ' ' A' ' 5' ' ' THR . 86.6 mt -82.17 99.76 9.44 Favored 'General case' 0 CA--C 1.54 0.589 0 N-CA-C 108.751 -0.833 . . . . 44.12 108.751 178.249 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 165' ' ' GLU . . . . . . . . . . . . . 28.4 tt0 . . . . . 0 CA--C 1.554 1.132 0 N-CA-C 107.56 -1.274 . . . . 64.02 107.56 -175.307 . . . . . . . . 0 0 . 1 . 001 nuclear build full ' B' B ' 216' ' ' PRO . . . . . 0.612 ' N ' ' HH ' ' B' ' 221' ' ' TYR . 25.0 Cg_exo . . . . . 0 N--CA 1.493 1.458 0 N-CA-C 110.465 -0.629 . . . . 73.44 110.465 . . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 217' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -163.07 163.3 17.36 Favored Pre-proline 0 CA--C 1.551 0.993 0 C-N-CA 124.469 1.107 . . . . 74.44 108.207 -176.395 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 218' ' ' PRO . . . . . 0.507 ' HG2' HE21 ' A' ' 111' ' ' GLN . 42.1 Cg_endo -67.33 94.18 0.36 Allowed 'Trans proline' 0 C--N 1.367 1.519 0 C-N-CA 121.746 1.63 . . . . 71.33 111.113 170.719 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 219' ' ' GLY . . . . . . . . . . . . . . . -179.86 147.84 7.69 Favored Glycine 0 CA--C 1.536 1.371 0 CA-C-N 115.534 -0.757 . . . . 74.21 111.927 -178.755 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 220' ' ' PRO . . . . . . . . . . . . . 21.5 Cg_exo -68.26 164.52 32.07 Favored 'Trans proline' 0 C--N 1.377 2.036 0 C-N-CA 123.796 2.997 . . . . 71.54 113.565 -178.07 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 221' ' ' TYR . . . . . 0.612 ' HH ' ' N ' ' B' ' 216' ' ' PRO . 62.2 m-85 -129.05 157.14 42.55 Favored 'General case' 0 N--CA 1.481 1.123 0 C-N-CA 123.731 0.812 . . . . 70.1 111.157 -176.328 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 222' ' ' ALA . . . . . . . . . . . . . . . -171.96 173.53 4.4 Favored 'General case' 0 C--O 1.242 0.68 0 O-C-N 124.818 1.323 . . . . 72.32 109.672 174.753 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 223' ' ' GLN . . . . . . . . . . . . . 75.1 mt-30 63.62 86.95 0.13 Allowed Pre-proline 0 CA--C 1.551 0.994 0 O-C-N 124.365 1.04 . . . . 73.34 111.29 171.984 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 224' ' ' PRO . . . . . . . . . . . . . 31.4 Cg_exo . . . . . 0 C--N 1.378 2.083 0 C-N-CA 123.513 2.808 . . . . 72.53 113.079 -177.459 . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 76.6 mtp . . . . . 0 N--CA 1.479 1.004 0 N-CA-C 110.189 -0.3 . . . . 62.21 110.189 . . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 47.1 t -77.09 88.7 0.91 Allowed 'Isoleucine or valine' 0 N--CA 1.476 0.864 0 N-CA-C 108.293 -1.002 . . . . 74.05 108.293 174.876 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 82.0 m-20 -97.87 103.92 19.35 Favored Pre-proline 0 CA--C 1.543 0.696 0 CA-C-N 115.336 -0.847 . . . . 62.52 109.538 177.587 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 4' ' ' PRO . . . . . 0.485 ' HG2' ' HB2' ' A' ' 24' ' ' LEU . 57.6 Cg_endo -73.66 144.37 35.41 Favored 'Trans proline' 0 C--N 1.374 1.911 0 C-N-CA 122.414 2.076 . . . . 62.53 112.123 175.12 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 5' ' ' THR . . . . . 0.569 HG23 ' HD3' ' A' ' 133' ' ' LYS . 97.9 m -97.1 114.13 25.77 Favored 'General case' 0 C--O 1.223 -0.318 0 N-CA-C 108.325 -0.991 . . . . 53.21 108.325 177.475 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 43.1 t -99.7 119.17 47.38 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.852 0 N-CA-C 108.33 -0.989 . . . . 74.12 108.33 -178.721 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 75.1 t80 -99.58 132.81 44.66 Favored 'General case' 0 C--N 1.323 -0.572 0 N-CA-C 109.235 -0.654 . . . . 74.0 109.235 -173.125 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 8' ' ' PHE . . . . . 0.475 ' HD2' ' HE2' ' A' ' 22' ' ' PHE . 33.1 m-85 -136.57 161.16 36.65 Favored 'General case' 0 C--O 1.238 0.499 0 O-C-N 124.027 0.829 . . . . 74.31 110.975 170.295 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 6.4 m-20 -108.37 114.76 28.86 Favored 'General case' 0 N--CA 1.465 0.277 0 CA-C-N 113.749 -1.569 . . . . 73.35 107.652 168.389 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 10' ' ' ILE . . . . . 0.542 HG21 ' SD ' ' A' ' 142' ' ' MET . 44.5 mm -85.48 118.82 32.96 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.369 0 N-CA-C 108.707 -0.849 . . . . 74.32 108.707 174.502 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 11' ' ' ALA . . . . . 0.554 ' HB2' ' HB2' ' A' ' 159' ' ' ALA . . . -118.11 131.36 56.43 Favored 'General case' 0 N--CA 1.469 0.476 0 C-N-CA 123.37 0.668 . . . . 63.22 111.143 -176.657 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 71.1 t -96.65 112.85 29.6 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.454 0 N-CA-C 107.934 -1.136 . . . . 64.31 107.934 170.765 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 18.5 m-20 62.93 24.25 14.44 Favored 'General case' 0 N--CA 1.481 1.104 0 C-N-CA 125.12 1.368 . . . . 64.05 111.931 179.965 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 99.1 -21.24 46.75 Favored Glycine 0 C--N 1.348 1.227 0 CA-C-N 116.43 -0.35 . . . . 62.32 113.031 -177.805 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 36.7 mm-40 -83.27 114.73 55.02 Favored Pre-proline 0 CA--C 1.543 0.706 0 C-N-CA 123.529 0.731 . . . . 73.14 110.048 179.667 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 34.3 Cg_endo -60.72 109.27 0.64 Allowed 'Trans proline' 0 C--N 1.378 2.098 0 C-N-CA 122.844 2.363 . . . . 71.12 111.863 -177.265 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 66.0 tp -76.31 -35.46 58.81 Favored 'General case' 0 N--CA 1.471 0.621 0 CA-C-N 115.104 -0.953 . . . . 55.21 109.922 179.334 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -175.96 177.96 47.52 Favored Glycine 0 C--N 1.341 0.832 0 CA-C-N 115.57 -0.741 . . . . 73.1 112.882 177.338 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 80.7 mtt180 -115.16 116.91 29.14 Favored 'General case' 0 C--O 1.237 0.406 0 C-N-CA 124.219 1.008 . . . . 73.21 108.86 -179.299 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 20' ' ' VAL . . . . . 0.414 HG13 HG13 ' A' ' 132' ' ' VAL . 67.5 t -114.65 118.33 58.33 Favored 'Isoleucine or valine' 0 C--O 1.238 0.498 0 C-N-CA 123.566 0.746 . . . . 64.21 109.417 -178.182 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 21' ' ' SER . . . . . 0.413 ' OG ' ' HB2' ' A' ' 134' ' ' GLU . 71.3 p -106.47 139.37 41.05 Favored 'General case' 0 C--O 1.246 0.878 0 N-CA-C 108.982 -0.748 . . . . 65.01 108.982 173.634 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 22' ' ' PHE . . . . . 0.475 ' HE2' ' HD2' ' A' ' 8' ' ' PHE . 85.2 m-85 -108.14 168.24 9.43 Favored 'General case' 0 C--N 1.331 -0.236 0 C-N-CA 124.544 1.138 . . . . 73.41 109.516 -179.886 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 23' ' ' GLU . . . . . 0.461 ' HB2' ' HD2' ' A' ' 133' ' ' LYS . 41.3 tt0 -129.95 106.9 8.96 Favored 'General case' 0 C--O 1.24 0.578 0 N-CA-C 107.979 -1.119 . . . . 53.53 107.979 179.007 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 24' ' ' LEU . . . . . 0.485 ' HB2' ' HG2' ' A' ' 4' ' ' PRO . 38.7 mt -82.44 124.72 30.31 Favored 'General case' 0 N--CA 1.467 0.414 0 N-CA-C 109.67 -0.493 . . . . 72.31 109.67 -179.456 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 44.6 m-85 -86.48 66.57 9.57 Favored 'General case' 0 CA--C 1.535 0.403 0 C-N-CA 123.338 0.655 . . . . 74.32 109.236 177.632 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -62.35 -24.89 67.6 Favored 'General case' 0 N--CA 1.477 0.883 0 CA-C-N 115.282 -0.872 . . . . 43.3 111.703 -178.476 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 9.7 p-10 -71.42 -19.53 62.23 Favored 'General case' 0 N--CA 1.477 0.875 0 C-N-CA 124.097 0.959 . . . . 71.51 112.524 -179.905 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 61.2 mttp -110.58 -41.05 4.42 Favored 'General case' 0 N--CA 1.486 1.355 0 C-N-CA 123.729 0.812 . . . . 63.13 110.992 -178.76 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 29' ' ' VAL . . . . . 0.523 HG21 ' HA ' ' A' ' 129' ' ' PHE . 8.4 m -129.48 74.06 81.15 Favored Pre-proline 0 N--CA 1.478 0.966 0 C-N-CA 123.803 0.841 . . . . 72.41 109.947 -179.452 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 25.5 Cg_endo -60.09 -37.32 84.95 Favored 'Trans proline' 0 C--N 1.378 2.097 0 C-N-CA 122.797 2.331 . . . . 71.01 112.896 -175.982 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 31' ' ' LYS . . . . . 0.408 ' HE3' ' HB2' ' A' ' 31' ' ' LYS . 36.6 ttmt -66.75 -52.0 49.33 Favored 'General case' 0 N--CA 1.482 1.136 0 C-N-CA 123.534 0.734 . . . . 75.02 112.043 -176.637 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 18.3 m -77.43 -31.25 53.83 Favored 'General case' 0 CA--C 1.55 0.978 0 CA-C-N 115.277 -0.874 . . . . 51.42 111.136 -170.617 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 33' ' ' ALA . . . . . 0.447 ' HB1' ' HB3' ' A' ' 24' ' ' LEU . . . -71.93 -47.18 54.31 Favored 'General case' 0 N--CA 1.473 0.718 0 C-N-CA 122.828 0.451 . . . . 75.13 110.057 174.327 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 11.4 tp10 -59.98 -35.63 75.41 Favored 'General case' 0 N--CA 1.485 1.308 0 C-N-CA 123.477 0.711 . . . . 73.52 111.141 178.684 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 35' ' ' ASN . . . . . 0.551 ' ND2' ' SD ' ' A' ' 100' ' ' MET . 32.7 t30 -56.12 -64.42 0.87 Allowed 'General case' 0 CA--C 1.539 0.523 0 CA-C-N 114.981 -1.009 . . . . 64.22 110.812 178.075 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 74.5 t80 -61.94 -35.38 78.25 Favored 'General case' 0 N--CA 1.474 0.74 0 C-N-CA 123.774 0.83 . . . . 72.54 111.41 -177.043 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 37' ' ' ARG . . . . . 0.417 ' HG3' HE22 ' A' ' 163' ' ' GLN . 20.7 ttt180 -58.82 -50.29 74.51 Favored 'General case' 0 N--CA 1.472 0.674 0 C-N-CA 124.046 0.938 . . . . 70.35 110.937 175.901 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 38' ' ' ALA . . . . . 0.543 ' HB3' HG21 ' A' ' 78' ' ' ILE . . . -75.69 -22.26 56.82 Favored 'General case' 0 CA--C 1.54 0.582 0 CA-C-N 115.587 -0.733 . . . . 53.41 111.727 -176.29 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 39' ' ' LEU . . . . . 0.515 HD22 ' CE1' ' A' ' 48' ' ' TYR . 96.6 mt -72.41 -42.27 65.3 Favored 'General case' 0 N--CA 1.479 1.008 0 C-N-CA 123.127 0.571 . . . . 73.42 109.86 172.214 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 48.0 t -68.63 -55.88 10.07 Favored 'General case' 0 N--CA 1.476 0.834 0 C-N-CA 124.238 1.015 . . . . 54.21 110.959 -176.139 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 71.3 p -73.41 -30.07 63.0 Favored 'General case' 0 CA--C 1.541 0.634 0 C-N-CA 123.659 0.783 . . . . 74.41 110.819 179.452 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 87.02 32.71 13.62 Favored Glycine 0 C--N 1.352 1.453 0 CA-C-O 119.909 -0.384 . . . . 63.52 113.021 176.129 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 50.9 mm-40 -54.89 -42.37 72.03 Favored 'General case' 0 N--CA 1.48 1.062 0 C-N-CA 123.551 0.741 . . . . 65.41 110.991 177.034 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 44' ' ' LYS . . . . . 0.547 ' HG3' ' HB ' ' A' ' 78' ' ' ILE . 29.6 mmmt -93.51 18.19 10.31 Favored 'General case' 0 CA--C 1.547 0.828 0 CA-C-N 115.044 -0.98 . . . . 74.23 111.683 -173.332 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 73.05 36.3 56.99 Favored Glycine 0 C--N 1.354 1.557 0 CA-C-N 116.301 -0.409 . . . . 63.41 114.068 171.722 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 46' ' ' PHE . . . . . 0.461 ' HE2' ' HA ' ' A' ' 78' ' ' ILE . 22.0 m-85 -120.25 -47.63 2.35 Favored 'General case' 0 N--CA 1.483 1.183 0 C-N-CA 122.811 0.444 . . . . 62.12 110.788 -177.391 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 53.27 62.12 6.3 Favored Glycine 0 C--N 1.356 1.644 0 O-C-N 123.92 0.763 . . . . 64.24 114.896 170.653 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 48' ' ' TYR . . . . . 0.515 ' CE1' HD22 ' A' ' 39' ' ' LEU . 66.8 m-85 -64.73 91.23 0.08 Allowed 'General case' 0 N--CA 1.48 1.042 0 CA-C-O 121.936 0.874 . . . . 65.33 111.67 -176.721 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 49' ' ' LYS . . . . . 0.548 ' HE2' ' HA ' ' A' ' 160' ' ' ASP . 28.0 tptp -109.7 130.88 55.47 Favored 'General case' 0 C--O 1.239 0.529 0 CA-C-N 113.913 -1.494 . . . . 71.23 108.726 178.985 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 80.83 21.24 63.92 Favored Glycine 0 C--N 1.348 1.248 0 CA-C-O 119.645 -0.531 . . . . 73.43 113.235 179.715 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 51' ' ' SER . . . . . 0.43 ' HB2' HD12 ' A' ' 158' ' ' ILE . 23.0 m -56.28 115.07 2.26 Favored 'General case' 0 C--N 1.355 0.806 0 C-N-CA 123.799 0.84 . . . . 73.3 110.885 -179.004 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 52' ' ' CYS . . . . . 0.69 ' SG ' ' HB3' ' A' ' 66' ' ' ASP . 6.3 p -96.76 130.11 44.06 Favored 'General case' 0 CA--C 1.548 0.888 0 C-N-CA 123.918 0.887 . . . . 73.22 112.261 -168.823 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 53' ' ' PHE . . . . . 0.722 ' HA ' ' HA2' ' A' ' 64' ' ' GLY . 11.8 m-85 -79.82 108.95 13.79 Favored 'General case' 0 CA--C 1.538 0.481 0 C-N-CA 125.155 1.382 . . . . 53.53 109.569 175.173 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 53.1 p-80 -100.52 -30.58 11.72 Favored 'General case' 0 N--CA 1.487 1.416 0 C-N-CA 122.769 0.428 . . . . 62.15 111.018 178.964 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 27.9 ttt180 -112.38 99.98 8.43 Favored 'General case' 0 C--O 1.221 -0.445 0 N-CA-C 109.048 -0.723 . . . . 64.32 109.048 -173.278 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 56' ' ' ILE . . . . . 0.497 HG21 ' HA ' ' A' ' 143' ' ' GLU . 52.5 mt -134.63 134.68 54.12 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.801 0 N-CA-C 108.929 -0.767 . . . . 72.04 108.929 176.169 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 57' ' ' ILE . . . . . 0.641 HG23 ' HA ' ' A' ' 148' ' ' ARG . 58.1 mt -131.0 121.56 18.88 Favored Pre-proline 0 CA--C 1.554 1.12 0 C-N-CA 124.501 1.12 . . . . 74.41 108.037 179.357 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 58' ' ' PRO . . . . . 0.481 ' HA ' ' HG2' ' A' ' 143' ' ' GLU . 74.4 Cg_endo -70.89 139.58 36.63 Favored 'Trans proline' 0 C--N 1.378 2.084 0 C-N-CA 123.033 2.489 . . . . 61.4 112.577 -172.846 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 74.32 26.83 67.18 Favored Glycine 0 C--N 1.343 0.937 0 CA-C-N 115.552 -0.749 . . . . 63.21 112.569 -176.048 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 60' ' ' PHE . . . . . 0.412 ' HD2' ' HB ' ' A' ' 57' ' ' ILE . 28.3 t80 -148.47 -73.24 0.19 Allowed 'General case' 0 C--O 1.243 0.732 0 C-N-CA 123.659 0.784 . . . . 73.33 109.767 -175.188 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 61' ' ' MET . . . . . 0.475 ' SD ' ' HB2' ' A' ' 113' ' ' PHE . 44.7 ttm -171.69 140.46 1.33 Allowed 'General case' 0 C--N 1.353 0.722 0 CA-C-N 116.285 -0.416 . . . . 63.34 112.058 -163.215 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 62' ' ' CYS . . . . . 0.546 ' SG ' ' HB ' ' A' ' 114' ' ' ILE . 16.6 p -109.14 113.51 26.43 Favored 'General case' 0 CA--C 1.549 0.926 0 C-N-CA 124.031 0.932 . . . . 70.23 108.966 169.346 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 63' ' ' GLN . . . . . 0.475 ' HA ' ' HA ' ' A' ' 113' ' ' PHE . 50.7 tt0 -113.91 118.54 34.46 Favored 'General case' 0 N--CA 1.48 1.032 0 C-N-CA 123.574 0.75 . . . . 75.44 110.31 -170.875 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 64' ' ' GLY . . . . . 0.722 ' HA2' ' HA ' ' A' ' 53' ' ' PHE . . . -115.81 164.94 12.16 Favored Glycine 0 C--N 1.353 1.505 0 CA-C-N 115.736 -0.666 . . . . 71.2 113.622 -173.784 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 101.59 93.56 2.2 Favored Glycine 0 C--N 1.343 0.92 0 N-CA-C 110.096 -1.202 . . . . 61.45 110.096 -173.992 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 66' ' ' ASP . . . . . 0.69 ' HB3' ' SG ' ' A' ' 52' ' ' CYS . 38.9 t70 -122.6 -73.38 0.65 Allowed 'General case' 0 N--CA 1.476 0.838 0 C-N-CA 122.899 0.479 . . . . 51.13 110.588 -179.641 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 76.0 t80 -40.72 -49.84 3.09 Favored 'General case' 0 N--CA 1.483 1.206 0 C-N-CA 125.779 1.631 . . . . 74.43 114.048 -161.917 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 15.7 m -71.46 105.62 3.64 Favored 'General case' 0 CA--C 1.545 0.755 0 O-C-N 123.571 0.544 . . . . 74.14 110.551 -176.274 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 31.2 ttm180 51.82 47.66 24.33 Favored 'General case' 0 CA--C 1.553 1.095 0 C-N-CA 125.179 1.391 . . . . 72.31 111.379 -178.234 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 27.4 p80 -55.73 -28.15 54.3 Favored 'General case' 0 N--CA 1.492 1.654 0 C-N-CA 123.345 0.658 . . . . 72.41 111.773 179.302 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 6.3 t30 -80.98 103.53 10.87 Favored 'General case' 0 CA--C 1.544 0.72 0 C-N-CA 123.755 0.822 . . . . 74.25 109.217 170.008 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 97.22 -8.19 64.65 Favored Glycine 0 C--N 1.341 0.823 0 CA-C-O 119.132 -0.815 . . . . 43.43 115.09 168.597 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 73' ' ' THR . . . . . 0.517 HG21 ' HB3' ' A' ' 76' ' ' LYS . 25.6 m -149.51 -74.91 0.17 Allowed 'General case' 0 N--CA 1.484 1.271 0 CA-C-N 118.495 1.147 . . . . 75.41 110.491 178.894 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 81.75 60.19 2.23 Favored Glycine 0 C--N 1.35 1.334 0 CA-C-O 119.958 -0.356 . . . . 23.44 112.964 177.926 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 111.06 51.27 0.6 Allowed Glycine 0 N--CA 1.479 1.524 0 CA-C-N 117.329 0.564 . . . . 74.2 112.952 178.714 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 76' ' ' LYS . . . . . 0.517 ' HB3' HG21 ' A' ' 73' ' ' THR . 20.2 pttp -56.54 161.5 2.66 Favored 'General case' 0 N--CA 1.491 1.579 0 C-N-CA 124.55 1.14 . . . . 72.11 113.38 -178.997 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 46.1 p -101.59 179.7 4.27 Favored 'General case' 0 N--CA 1.484 1.247 0 C-N-CA 124.181 0.992 . . . . 70.25 112.698 -167.395 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 78' ' ' ILE . . . . . 0.547 ' HB ' ' HG3' ' A' ' 44' ' ' LYS . 29.1 pt -69.9 -16.82 20.63 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.907 0 C-N-CA 122.819 0.448 . . . . 71.12 111.441 177.553 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 86.0 m-85 -95.04 27.04 3.35 Favored 'General case' 0 CA--C 1.545 0.754 0 C-N-CA 124.112 0.965 . . . . 74.41 110.244 176.748 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 92.11 -128.62 9.46 Favored Glycine 0 C--N 1.351 1.381 0 N-CA-C 111.497 -0.641 . . . . 74.43 111.497 178.026 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 39.5 tt0 -66.05 -49.42 67.72 Favored 'General case' 0 N--CA 1.472 0.664 0 C-N-CA 123.548 0.739 . . . . 72.3 110.531 179.168 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 82' ' ' LYS . . . . . 0.713 ' HD2' ' HA ' ' A' ' 107' ' ' THR . 21.8 pttm -167.71 155.95 9.14 Favored 'General case' 0 CA--C 1.55 0.969 0 CA-C-N 115.501 -0.772 . . . . 63.42 111.054 -171.668 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 15.0 p90 -131.04 174.32 10.13 Favored 'General case' 0 N--CA 1.481 1.089 0 C-N-CA 125.176 1.39 . . . . 71.23 110.594 176.236 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 9.8 pt-20 -84.37 157.26 21.51 Favored 'General case' 0 N--CA 1.483 1.22 0 C-N-CA 123.497 0.719 . . . . 73.13 111.278 177.203 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 40.6 m-20 -64.22 134.34 54.58 Favored 'General case' 0 N--CA 1.489 1.479 0 C-N-CA 124.047 0.939 . . . . 61.24 110.837 -176.278 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 6.2 tp10 -60.05 -58.88 6.62 Favored 'General case' 0 N--CA 1.486 1.358 0 C-N-CA 123.236 0.614 . . . . 74.52 111.091 -178.627 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 31.9 p30 -163.22 -157.18 0.41 Allowed 'General case' 0 N--CA 1.467 0.41 0 N-CA-C 107.521 -1.288 . . . . 64.44 107.521 -179.211 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 89.7 m-85 -142.43 34.1 1.47 Allowed 'General case' 0 N--CA 1.485 1.293 0 C-N-CA 123.311 0.644 . . . . 75.43 110.52 177.005 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 65.4 mt -61.94 -61.04 1.79 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.649 0 CA-C-O 121.506 0.669 . . . . 74.15 110.266 178.39 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 90' ' ' LEU . . . . . 0.451 ' HB3' ' HB ' ' A' ' 128' ' ' VAL . 59.3 mt -78.8 102.36 8.11 Favored 'General case' 0 C--O 1.242 0.665 0 CA-C-N 114.88 -1.054 . . . . 64.11 110.075 -177.305 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 91' ' ' LYS . . . . . 0.691 ' HE3' ' HB ' ' A' ' 93' ' ' THR . 0.1 OUTLIER -84.63 163.64 19.15 Favored 'General case' 0 C--O 1.24 0.586 0 CA-C-N 115.493 -0.776 . . . . 70.14 110.334 174.747 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 92' ' ' HIS . . . . . . . . . . . . . 19.0 m-70 -91.19 56.1 3.04 Favored 'General case' 0 N--CA 1.476 0.858 0 CA-C-O 122.033 0.921 . . . . 74.4 109.371 -176.699 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 93' ' ' THR . . . . . 0.691 ' HB ' ' HE3' ' A' ' 91' ' ' LYS . 12.6 t -91.33 -7.15 51.79 Favored 'General case' 0 N--CA 1.47 0.572 0 CA-C-N 114.61 -1.177 . . . . 71.3 111.385 -176.383 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -124.94 167.78 17.21 Favored Glycine 0 C--N 1.34 0.785 0 O-C-N 123.062 0.226 . . . . 62.0 113.241 -175.206 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 95' ' ' PRO . . . . . 0.445 ' HB3' ' O ' ' A' ' 116' ' ' THR . 1.1 Cg_endo -84.67 157.07 12.08 Favored 'Trans proline' 0 C--N 1.363 1.316 0 C-N-CA 123.519 2.812 . . . . 60.4 111.636 168.553 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 78.28 16.94 78.86 Favored Glycine 0 C--N 1.346 1.104 0 CA-C-N 116.203 -0.453 . . . . 74.51 113.206 179.948 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 97' ' ' ILE . . . . . 0.813 ' HB ' ' SG ' ' A' ' 115' ' ' CYS . 15.6 mm -73.14 109.42 5.33 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.921 0 C-N-CA 123.797 0.839 . . . . 70.35 111.201 -176.399 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 63.8 tp -94.21 111.86 23.62 Favored 'General case' 0 CA--C 1.552 1.037 0 C-N-CA 123.773 0.829 . . . . 74.25 109.95 174.35 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 99' ' ' SER . . . . . 0.462 ' HB2' ' HA ' ' A' ' 128' ' ' VAL . 29.8 t -137.14 147.89 46.27 Favored 'General case' 0 N--CA 1.474 0.766 0 C-N-CA 124.371 1.068 . . . . 61.21 108.743 177.059 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 100' ' ' MET . . . . . 0.565 ' HA ' ' HA ' ' A' ' 112' ' ' PHE . 67.5 mtp -77.47 146.39 36.49 Favored 'General case' 0 N--CA 1.483 1.216 0 CA-C-O 120.671 0.272 . . . . 63.51 110.657 179.918 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 101' ' ' ALA . . . . . 0.55 ' HB3' ' HB3' ' A' ' 111' ' ' GLN . . . -76.89 162.5 27.56 Favored 'General case' 0 C--O 1.245 0.844 0 CA-C-N 115.818 -0.628 . . . . 64.33 111.254 -176.469 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 102' ' ' ASN . . . . . 0.498 ' HB3' ' HA ' ' A' ' 108' ' ' ASN . 30.5 p-10 -168.47 171.1 9.26 Favored 'General case' 0 C--O 1.238 0.472 0 CA-C-N 114.823 -1.081 . . . . 54.15 109.522 179.503 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 103' ' ' ALA . . . . . 0.426 ' HB3' HG21 ' A' ' 107' ' ' THR . . . -119.59 13.41 12.52 Favored 'General case' 0 CA--C 1.543 0.695 0 CA-C-N 115.263 -0.88 . . . . 75.53 109.94 172.617 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 146.95 -166.86 28.36 Favored Glycine 0 C--N 1.352 1.438 0 CA-C-O 119.595 -0.559 . . . . 71.14 112.521 179.981 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 14.6 Cg_exo -67.34 140.79 54.15 Favored 'Trans proline' 0 C--N 1.372 1.808 0 C-N-CA 123.172 2.581 . . . . 72.43 111.433 178.957 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 66.7 t30 66.4 9.72 6.69 Favored 'General case' 0 N--CA 1.491 1.606 0 C-N-CA 124.822 1.249 . . . . 73.31 111.979 -178.89 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 107' ' ' THR . . . . . 0.713 ' HA ' ' HD2' ' A' ' 82' ' ' LYS . 3.9 m -109.6 -6.47 15.35 Favored 'General case' 0 CA--C 1.552 1.049 0 C-N-CA 124.266 1.026 . . . . 73.2 109.669 177.025 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 108' ' ' ASN . . . . . 0.498 ' HA ' ' HB3' ' A' ' 102' ' ' ASN . 24.3 t30 -60.92 151.53 30.0 Favored 'General case' 0 N--CA 1.48 1.066 0 C-N-CA 125.046 1.339 . . . . 62.52 110.657 173.564 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 93.95 18.59 36.69 Favored Glycine 0 N--CA 1.465 0.628 0 C-N-CA 121.695 -0.288 . . . . 73.51 112.962 178.881 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 15.2 p -117.36 120.55 38.53 Favored 'General case' 0 C--N 1.328 -0.335 0 N-CA-C 106.938 -1.504 . . . . 73.33 106.938 167.093 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 111' ' ' GLN . . . . . 0.55 ' HB3' ' HB3' ' A' ' 101' ' ' ALA . 5.8 tt0 69.08 171.73 0.3 Allowed 'General case' 0 CA--C 1.557 1.23 0 C-N-CA 123.43 0.692 . . . . 64.03 111.341 171.609 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 112' ' ' PHE . . . . . 0.565 ' HA ' ' HA ' ' A' ' 100' ' ' MET . 52.5 p90 -143.8 155.0 43.99 Favored 'General case' 0 N--CA 1.48 1.026 0 O-C-N 121.748 -0.595 . . . . 74.22 109.695 176.364 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 113' ' ' PHE . . . . . 0.475 ' HB2' ' SD ' ' A' ' 61' ' ' MET . 40.5 p90 -140.57 151.3 44.6 Favored 'General case' 0 N--CA 1.47 0.536 0 C-N-CA 123.329 0.652 . . . . 73.21 111.277 -179.356 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 114' ' ' ILE . . . . . 0.546 ' HB ' ' SG ' ' A' ' 62' ' ' CYS . 19.3 mt -124.55 104.88 14.41 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.613 0 N-CA-C 108.067 -1.086 . . . . 75.43 108.067 177.029 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 115' ' ' CYS . . . . . 0.813 ' SG ' ' HB ' ' A' ' 97' ' ' ILE . 27.8 p -85.69 114.53 22.74 Favored 'General case' 0 C--O 1.241 0.643 0 CA-C-N 118.284 0.493 . . . . 73.02 109.728 178.968 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 116' ' ' THR . . . . . 0.445 ' O ' ' HB3' ' A' ' 95' ' ' PRO . 70.6 p -73.21 -20.88 60.77 Favored 'General case' 0 CA--C 1.54 0.579 0 C-N-CA 123.796 0.838 . . . . 72.24 110.603 176.863 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -101.94 155.89 17.88 Favored 'General case' 0 C--O 1.241 0.627 0 CA-C-N 115.383 -0.826 . . . . 74.14 109.76 171.893 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 19.2 ptmt -75.19 83.61 2.37 Favored 'General case' 0 CA--C 1.542 0.668 0 CA-C-O 121.765 0.793 . . . . 70.14 109.434 173.938 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 119' ' ' THR . . . . . 0.582 ' HB ' HD13 ' A' ' 122' ' ' LEU . 44.5 p -76.45 86.14 3.19 Favored 'General case' 0 CA--C 1.545 0.785 0 CA-C-O 121.948 0.88 . . . . 74.41 110.004 -175.984 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 11.1 pt-20 -78.51 -16.93 56.95 Favored 'General case' 0 N--CA 1.476 0.86 0 CA-C-N 114.825 -1.079 . . . . 74.53 112.127 -171.377 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 121' ' ' TRP . . . . . . . . . . . . . 35.7 p90 -74.18 -0.57 17.17 Favored 'General case' 0 CA--C 1.55 0.965 0 C-N-CA 123.027 0.531 . . . . 75.32 111.068 173.385 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 122' ' ' LEU . . . . . 0.582 HD13 ' HB ' ' A' ' 119' ' ' THR . 9.6 mp -97.42 -1.02 45.22 Favored 'General case' 0 N--CA 1.483 1.214 0 C-N-CA 124.275 1.03 . . . . 63.34 111.799 172.946 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 56.5 m-20 -71.06 129.51 39.14 Favored 'General case' 0 N--CA 1.477 0.898 0 N-CA-C 108.293 -1.003 . . . . 75.43 108.293 173.616 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 95.95 -25.08 26.98 Favored Glycine 0 N--CA 1.471 0.977 0 N-CA-C 111.573 -0.611 . . . . 55.2 111.573 -172.012 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 125' ' ' LYS . . . . . 0.578 ' HE2' ' HB3' ' B' ' 220' ' ' PRO . 16.3 ttpp -83.28 -168.46 2.1 Favored 'General case' 0 CA--C 1.555 1.144 0 N-CA-C 107.382 -1.34 . . . . 74.13 107.382 166.578 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 126' ' ' HIS . . . . . 0.498 ' H ' ' HG2' ' A' ' 125' ' ' LYS . 16.6 t-80 -65.0 131.65 47.15 Favored 'General case' 0 CA--C 1.548 0.887 0 CA-C-N 118.713 0.688 . . . . 74.11 112.082 -166.653 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 11.4 p -58.43 147.95 6.61 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.743 0 C-N-CA 125.906 1.682 . . . . 62.44 112.047 179.33 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 128' ' ' VAL . . . . . 0.462 ' HA ' ' HB2' ' A' ' 99' ' ' SER . 17.3 t -67.67 155.65 7.38 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.819 0 C-N-CA 123.927 0.891 . . . . 74.13 109.638 175.335 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 129' ' ' PHE . . . . . 0.523 ' HA ' HG21 ' A' ' 29' ' ' VAL . 50.5 p90 -133.5 -25.07 1.74 Allowed 'General case' 0 N--CA 1.477 0.908 0 O-C-N 122.269 -0.269 . . . . 65.51 111.363 173.843 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . -136.99 161.82 25.19 Favored Glycine 0 C--N 1.341 0.833 0 N-CA-C 111.588 -0.605 . . . . 70.44 111.588 -177.562 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 35.8 ttpt -144.29 138.61 28.05 Favored 'General case' 0 N--CA 1.468 0.461 0 N-CA-C 108.852 -0.795 . . . . 64.54 108.852 177.217 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 132' ' ' VAL . . . . . 0.414 HG13 HG13 ' A' ' 20' ' ' VAL . 47.3 t -64.03 103.44 0.38 Allowed 'Isoleucine or valine' 0 C--O 1.24 0.562 0 N-CA-C 108.83 -0.804 . . . . 71.42 108.83 174.751 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 133' ' ' LYS . . . . . 0.569 ' HD3' HG23 ' A' ' 5' ' ' THR . 21.5 ptmt -85.67 -31.91 22.25 Favored 'General case' 0 CA--C 1.537 0.476 0 N-CA-C 109.371 -0.603 . . . . 73.12 109.371 179.941 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 134' ' ' GLU . . . . . 0.413 ' HB2' ' OG ' ' A' ' 21' ' ' SER . 17.0 mt-10 -143.87 149.05 36.35 Favored 'General case' 0 N--CA 1.479 1.023 0 C-N-CA 124.818 1.247 . . . . 75.13 109.222 179.02 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 84.31 22.55 54.06 Favored Glycine 0 C--N 1.345 1.048 0 O-C-N 123.379 0.424 . . . . 54.43 113.164 -179.716 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 136' ' ' MET . . . . . 0.403 ' HA ' HG11 ' A' ' 132' ' ' VAL . 16.5 tpt -62.76 -40.17 96.45 Favored 'General case' 0 N--CA 1.477 0.923 0 C-N-CA 123.239 0.616 . . . . 70.1 111.38 -179.913 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 137' ' ' ASN . . . . . . . . . . . . . 12.4 m120 -64.75 -26.61 68.43 Favored 'General case' 0 N--CA 1.478 0.973 0 C-N-CA 123.146 0.578 . . . . 70.53 111.271 179.255 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 138' ' ' ILE . . . . . . . . . . . . . 48.1 mm -76.48 -37.75 30.8 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.843 0 C-N-CA 123.444 0.698 . . . . 55.1 110.153 177.192 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 139' ' ' VAL . . . . . 0.475 HG13 ' SG ' ' A' ' 62' ' ' CYS . 95.4 t -62.26 -43.61 98.19 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.96 0 C-N-CA 123.471 0.708 . . . . 63.51 110.258 175.43 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 39.0 mt-10 -65.5 -42.37 92.17 Favored 'General case' 0 CA--C 1.544 0.734 0 CA-C-N 114.949 -1.023 . . . . 73.3 110.851 176.889 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -67.85 -39.21 83.82 Favored 'General case' 0 N--CA 1.48 1.034 0 C-N-CA 123.603 0.761 . . . . 63.04 111.884 -178.189 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 142' ' ' MET . . . . . 0.594 ' HB2' HD13 ' A' ' 156' ' ' ILE . 19.5 ptt? -75.95 -29.28 58.24 Favored 'General case' 0 N--CA 1.478 0.952 0 C-N-CA 122.644 0.378 . . . . 64.25 110.504 -178.912 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 143' ' ' GLU . . . . . 0.497 ' HA ' HG21 ' A' ' 56' ' ' ILE . 28.1 tt0 -65.61 -28.01 68.82 Favored 'General case' 0 CA--C 1.545 0.77 0 CA-C-N 115.711 -0.677 . . . . 74.03 111.68 178.677 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 144' ' ' ARG . . . . . . . . . . . . . 75.9 mtt180 -66.87 -13.22 61.4 Favored 'General case' 0 N--CA 1.479 0.992 0 C-N-CA 123.555 0.742 . . . . 72.31 111.921 177.699 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 145' ' ' PHE . . . . . . . . . . . . . 38.3 m-85 -88.68 -8.58 54.33 Favored 'General case' 0 N--CA 1.475 0.807 0 C-N-CA 123.379 0.672 . . . . 73.54 111.641 175.944 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . -87.3 171.53 42.23 Favored Glycine 0 C--N 1.346 1.095 0 CA-C-O 120.007 -0.33 . . . . 42.04 112.547 175.166 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 9.0 m -133.03 160.15 37.98 Favored 'General case' 0 N--CA 1.479 1.01 0 C-N-CA 123.565 0.746 . . . . 72.25 110.31 -175.525 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 148' ' ' ARG . . . . . 0.641 ' HA ' HG23 ' A' ' 57' ' ' ILE . 14.3 mmm180 -61.29 -31.64 71.47 Favored 'General case' 0 N--CA 1.483 1.22 0 C-N-CA 124.5 1.12 . . . . 74.43 113.407 -176.382 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 149' ' ' ASN . . . . . . . . . . . . . 31.2 p-10 -75.74 -13.1 60.3 Favored 'General case' 0 N--CA 1.483 1.2 0 C-N-CA 123.222 0.609 . . . . 63.33 111.467 178.573 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . 111.64 -17.15 25.85 Favored Glycine 0 C--N 1.348 1.208 0 CA-C-O 119.821 -0.433 . . . . 72.54 112.664 179.066 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 87.3 tttt -69.09 137.1 53.21 Favored 'General case' 0 CA--C 1.546 0.812 0 C-N-CA 122.853 0.461 . . . . 63.54 111.303 -175.214 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 152' ' ' THR . . . . . . . . . . . . . 6.8 p -92.18 121.44 33.72 Favored 'General case' 0 C--O 1.241 0.63 0 C-N-CA 123.826 0.85 . . . . 75.51 109.124 170.41 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 153' ' ' SER . . . . . . . . . . . . . 29.9 t -67.32 -36.21 81.01 Favored 'General case' 0 N--CA 1.472 0.665 0 C-N-CA 123.499 0.72 . . . . 42.33 109.995 174.042 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 69.5 mmtt -110.39 149.42 30.28 Favored 'General case' 0 N--CA 1.471 0.622 0 C-N-CA 124.256 1.023 . . . . 74.32 110.767 -178.28 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 16.2 tppt? -89.27 91.67 8.86 Favored 'General case' 0 C--N 1.345 0.376 0 N-CA-C 108.873 -0.788 . . . . 71.44 108.873 178.386 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 156' ' ' ILE . . . . . 0.594 HD13 ' HB2' ' A' ' 142' ' ' MET . 69.1 mt -91.75 126.05 44.39 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.416 0 N-CA-C 108.833 -0.802 . . . . 72.35 108.833 -179.054 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 157' ' ' THR . . . . . 0.473 HG22 ' HB3' ' A' ' 52' ' ' CYS . 21.1 p -134.11 157.47 46.09 Favored 'General case' 0 N--CA 1.477 0.915 0 C-N-CA 124.115 0.966 . . . . 60.3 109.708 -175.371 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 158' ' ' ILE . . . . . 0.43 HD12 ' HB2' ' A' ' 51' ' ' SER . 46.4 mt -80.21 93.68 2.0 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.819 0 N-CA-C 109.261 -0.644 . . . . 71.41 109.261 170.601 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 159' ' ' ALA . . . . . 0.554 ' HB2' ' HB2' ' A' ' 11' ' ' ALA . . . -61.35 -34.16 74.84 Favored 'General case' 0 N--CA 1.472 0.626 0 C-N-CA 124.614 1.166 . . . . 73.11 113.404 -176.703 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 160' ' ' ASP . . . . . 0.548 ' HA ' ' HE2' ' A' ' 49' ' ' LYS . 26.3 t0 -159.98 162.76 34.4 Favored 'General case' 0 N--CA 1.475 0.814 0 C-N-CA 122.588 0.355 . . . . 70.44 110.375 -179.469 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 161' ' ' CYS . . . . . . . . . . . . . 28.0 p -127.74 -166.55 1.63 Allowed 'General case' 0 N--CA 1.474 0.731 0 C-N-CA 125.362 1.465 . . . . 73.44 108.812 -177.977 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 162' ' ' GLY . . . . . . . . . . . . . . . 134.17 54.51 0.07 OUTLIER Glycine 0 C--N 1.351 1.403 0 C-N-CA 121.406 -0.426 . . . . 75.3 112.885 -177.196 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 163' ' ' GLN . . . . . 0.417 HE22 ' HG3' ' A' ' 37' ' ' ARG . 8.1 tt0 -46.4 106.6 0.08 Allowed 'General case' 0 N--CA 1.483 1.18 0 C-N-CA 124.547 1.139 . . . . 52.1 111.629 178.515 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 164' ' ' LEU . . . . . . . . . . . . . 86.4 mt -73.39 113.09 10.08 Favored 'General case' 0 CA--C 1.542 0.671 0 CA-C-N 114.64 -1.164 . . . . 72.53 110.886 -177.402 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 165' ' ' GLU . . . . . . . . . . . . . 36.4 tt0 . . . . . 0 C--O 1.251 1.184 0 N-CA-C 108.448 -0.945 . . . . 74.51 108.448 172.512 . . . . . . . . 0 0 . 1 . 002 nuclear build full ' B' B ' 216' ' ' PRO . . . . . . . . . . . . . 5.3 Cg_exo . . . . . 0 N--CA 1.482 0.821 0 N-CA-C 110.247 -0.713 . . . . 74.52 110.247 . . . . . . . . . 0 0 . 1 . 002 nuclear build full ' B' B ' 217' ' ' GLU . . . . . . . . . . . . . 80.7 tt0 -63.48 133.79 95.63 Favored Pre-proline 0 CA--C 1.552 1.021 0 C-N-CA 124.328 1.051 . . . . 74.23 110.679 -179.529 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 218' ' ' PRO . . . . . . . . . . . . . 68.1 Cg_exo -52.96 95.15 0.04 OUTLIER 'Trans proline' 0 C--N 1.388 2.647 0 C-N-CA 122.848 2.365 . . . . 73.55 111.9 175.172 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 219' ' ' GLY . . . . . . . . . . . . . . . 153.43 172.13 21.32 Favored Glycine 0 CA--C 1.529 0.928 0 CA-C-N 114.962 -1.017 . . . . 60.14 112.021 -174.213 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 220' ' ' PRO . . . . . 0.578 ' HB3' ' HE2' ' A' ' 125' ' ' LYS . 51.9 Cg_endo -86.48 165.49 9.32 Favored 'Trans proline' 0 C--N 1.364 1.355 0 C-N-CA 123.214 2.609 . . . . 74.45 114.22 179.689 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 221' ' ' TYR . . . . . . . . . . . . . 54.9 t80 -78.99 141.25 37.66 Favored 'General case' 0 N--CA 1.475 0.79 0 C-N-CA 123.002 0.521 . . . . 44.14 110.609 175.193 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 222' ' ' ALA . . . . . . . . . . . . . . . -85.01 -164.61 1.01 Allowed 'General case' 0 N--CA 1.475 0.806 0 C-N-CA 124.293 1.037 . . . . 64.3 111.893 -179.155 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 223' ' ' GLN . . . . . 0.409 ' NE2' ' HB2' ' A' ' 60' ' ' PHE . 14.3 mp0 -59.1 147.59 74.06 Favored Pre-proline 0 CA--C 1.557 1.219 0 C-N-CA 123.414 0.686 . . . . 71.3 109.555 172.968 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 224' ' ' PRO . . . . . . . . . . . . . 18.7 Cg_endo . . . . . 0 C--N 1.376 2.01 0 C-N-CA 122.781 2.321 . . . . 73.31 112.288 177.597 . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 34.5 mmt . . . . . 0 N--CA 1.482 1.17 0 N-CA-C 109.371 -0.603 . . . . 75.33 109.371 . . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 11.8 p -92.95 -2.95 10.78 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.49 0 CA-C-O 121.774 0.797 . . . . 35.35 110.801 175.08 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 5.6 m120 -83.44 118.13 70.64 Favored Pre-proline 0 CA--C 1.55 0.96 0 C-N-CA 123.794 0.838 . . . . 71.55 110.043 -168.245 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 31.5 Cg_endo -61.62 121.73 10.0 Favored 'Trans proline' 0 C--N 1.378 2.098 0 C-N-CA 122.957 2.438 . . . . 62.31 111.591 179.847 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 5' ' ' THR . . . . . 0.401 ' HB ' ' HB2' ' A' ' 164' ' ' LEU . 93.1 m -98.14 132.11 43.94 Favored 'General case' 0 CA--C 1.536 0.435 0 C-N-CA 122.756 0.422 . . . . 71.42 110.097 -177.972 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 6' ' ' VAL . . . . . 0.521 ' HA ' ' HB2' ' A' ' 163' ' ' GLN . 12.6 m -101.16 129.49 52.08 Favored 'Isoleucine or valine' 0 C--N 1.35 0.593 0 C-N-CA 123.53 0.732 . . . . 72.24 110.008 175.591 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 7' ' ' PHE . . . . . 0.621 ' HB2' ' HG ' ' A' ' 164' ' ' LEU . 37.7 t80 -119.61 134.23 55.31 Favored 'General case' 0 C--O 1.238 0.464 0 C-N-CA 123.886 0.875 . . . . 72.04 109.7 -170.684 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 8' ' ' PHE . . . . . 0.437 ' HB3' HG23 ' A' ' 158' ' ' ILE . 64.6 m-85 -139.89 161.37 37.75 Favored 'General case' 0 N--CA 1.47 0.536 0 O-C-N 123.801 0.688 . . . . 71.35 111.467 -174.705 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 7.6 m-20 -102.36 108.05 19.27 Favored 'General case' 0 N--CA 1.47 0.536 0 CA-C-N 114.005 -1.452 . . . . 65.45 107.58 166.017 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 10' ' ' ILE . . . . . 0.475 HG21 ' SD ' ' A' ' 142' ' ' MET . 49.2 mm -82.1 120.3 33.33 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.476 0 N-CA-C 108.852 -0.795 . . . . 73.21 108.852 175.323 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 11' ' ' ALA . . . . . 0.537 ' HB2' ' HB2' ' A' ' 159' ' ' ALA . . . -117.29 121.92 42.49 Favored 'General case' 0 N--CA 1.463 0.218 0 C-N-CA 123.529 0.732 . . . . 65.55 110.915 -173.638 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 12' ' ' VAL . . . . . 0.488 HG21 HD22 ' A' ' 17' ' ' LEU . 76.6 t -98.06 118.08 43.98 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.651 0 N-CA-C 108.334 -0.988 . . . . 72.34 108.334 173.454 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 35.8 m-20 61.9 31.2 18.25 Favored 'General case' 0 N--CA 1.486 1.364 0 C-N-CA 125.566 1.546 . . . . 72.25 111.249 -174.707 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 87.32 -15.78 52.24 Favored Glycine 0 C--N 1.352 1.428 0 CA-C-N 115.488 -0.778 . . . . 43.33 113.191 -177.499 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 21.8 mm-40 -90.81 115.72 64.86 Favored Pre-proline 0 N--CA 1.474 0.766 0 CA-C-O 118.606 -0.711 . . . . 73.15 110.514 -177.165 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 14.0 Cg_endo -53.52 104.88 0.11 Allowed 'Trans proline' 0 C--N 1.387 2.564 0 C-N-CA 123.228 2.619 . . . . 72.43 111.909 178.493 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 17' ' ' LEU . . . . . 0.488 HD22 HG21 ' A' ' 12' ' ' VAL . 21.3 tp -77.12 -24.93 51.65 Favored 'General case' 0 CA--C 1.541 0.632 0 CA-C-N 114.696 -1.138 . . . . 71.1 109.777 179.3 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 170.03 -178.62 42.78 Favored Glycine 0 C--N 1.342 0.894 0 CA-C-N 115.354 -0.839 . . . . 51.14 112.337 176.373 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 94.3 mtt180 -116.44 142.27 47.08 Favored 'General case' 0 N--CA 1.473 0.687 0 C-N-CA 123.771 0.828 . . . . 72.44 110.228 -178.49 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 45.0 t -131.35 141.11 46.76 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.69 0 C-N-CA 123.179 0.592 . . . . 73.22 110.247 -178.474 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 40.6 p -120.92 116.77 25.77 Favored 'General case' 0 CA--C 1.548 0.901 0 C-N-CA 124.596 1.158 . . . . 72.11 109.109 177.1 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 63.1 m-85 -103.36 113.47 26.99 Favored 'General case' 0 N--CA 1.472 0.647 0 C-N-CA 123.927 0.891 . . . . 62.42 109.377 177.158 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 23' ' ' GLU . . . . . 0.537 ' HB2' ' HD2' ' A' ' 133' ' ' LYS . 42.4 tt0 -74.88 103.56 5.16 Favored 'General case' 0 CA--C 1.553 1.083 0 C-N-CA 123.827 0.851 . . . . 71.23 109.934 175.759 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 21.0 mt -83.94 120.07 25.66 Favored 'General case' 0 N--CA 1.477 0.904 0 N-CA-C 109.352 -0.61 . . . . 73.14 109.352 178.454 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 25' ' ' PHE . . . . . 0.585 ' HB2' HD11 ' A' ' 90' ' ' LEU . 57.8 m-85 -84.46 70.44 10.68 Favored 'General case' 0 CA--C 1.544 0.716 0 C-N-CA 123.19 0.596 . . . . 73.32 110.117 177.809 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -60.97 -30.45 70.27 Favored 'General case' 0 N--CA 1.482 1.13 0 C-N-CA 123.247 0.619 . . . . 73.32 111.789 179.901 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 10.8 p-10 -62.03 -26.59 68.34 Favored 'General case' 0 CA--C 1.548 0.866 0 C-N-CA 124.169 0.988 . . . . 75.23 112.223 178.902 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 28' ' ' LYS . . . . . 0.406 ' HD2' HD21 ' A' ' 90' ' ' LEU . 41.0 mttm -98.05 -49.69 4.66 Favored 'General case' 0 N--CA 1.479 0.991 0 C-N-CA 123.557 0.743 . . . . 52.01 110.476 -178.629 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 29' ' ' VAL . . . . . 0.569 HG21 ' HA ' ' A' ' 129' ' ' PHE . 26.7 m -120.05 83.67 31.52 Favored Pre-proline 0 CA--C 1.567 1.605 0 C-N-CA 123.844 0.858 . . . . 63.52 110.119 -174.285 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 32.7 Cg_endo -61.43 -49.84 6.79 Favored 'Trans proline' 0 C--N 1.382 2.33 0 C-N-CA 122.81 2.34 . . . . 73.11 112.337 -172.045 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 23.8 ttmm -60.5 -53.51 56.65 Favored 'General case' 0 N--CA 1.47 0.563 0 C-N-CA 124.049 0.94 . . . . 71.23 111.805 -175.247 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 7.3 m -75.85 -37.41 58.99 Favored 'General case' 0 CA--C 1.553 1.076 0 CA-C-N 115.339 -0.846 . . . . 74.22 111.912 -168.508 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -76.4 -43.37 40.76 Favored 'General case' 0 N--CA 1.479 0.998 0 C-N-CA 122.367 0.267 . . . . 61.03 111.327 -179.103 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 9.0 tp10 -62.75 -39.27 93.63 Favored 'General case' 0 N--CA 1.482 1.144 0 O-C-N 123.445 0.465 . . . . 54.02 110.878 178.134 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 35' ' ' ASN . . . . . 0.492 ' O ' ' HG ' ' A' ' 39' ' ' LEU . 35.6 t30 -50.2 -62.6 1.48 Allowed 'General case' 0 C--N 1.356 0.889 0 O-C-N 124.333 1.02 . . . . 74.13 110.885 176.865 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 36' ' ' PHE . . . . . 0.46 ' HE2' HG21 ' A' ' 6' ' ' VAL . 84.2 t80 -64.26 -34.03 77.19 Favored 'General case' 0 N--CA 1.471 0.613 0 O-C-N 124.172 0.92 . . . . 74.13 111.843 -175.544 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 41.9 ttp180 -64.71 -40.53 95.52 Favored 'General case' 0 CA--C 1.541 0.618 0 O-C-N 123.429 0.456 . . . . 65.05 110.682 178.969 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -75.88 -25.87 56.52 Favored 'General case' 0 N--CA 1.476 0.843 0 CA-C-N 115.881 -0.6 . . . . 42.45 111.432 179.226 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 39' ' ' LEU . . . . . 0.492 ' HG ' ' O ' ' A' ' 35' ' ' ASN . 85.5 mt -68.99 -40.1 78.96 Favored 'General case' 0 N--CA 1.48 1.037 0 C-N-CA 123.605 0.762 . . . . 73.04 109.868 172.544 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 37.1 t -68.38 -56.67 7.7 Favored 'General case' 0 N--CA 1.475 0.814 0 C-N-CA 124.584 1.154 . . . . 73.31 111.359 -177.151 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 18.1 p -71.87 -30.01 64.97 Favored 'General case' 0 N--CA 1.473 0.697 0 CA-C-N 115.625 -0.716 . . . . 63.12 111.587 -179.26 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 83.26 26.58 43.32 Favored Glycine 0 C--N 1.347 1.169 0 CA-C-N 116.093 -0.503 . . . . 74.34 112.805 -179.436 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 40.7 mm-40 -67.0 -21.01 65.97 Favored 'General case' 0 N--CA 1.476 0.874 0 C-N-CA 122.979 0.512 . . . . 75.12 111.873 177.887 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 3.3 mmpm? -100.61 18.31 19.55 Favored 'General case' 0 CA--C 1.548 0.866 0 C-N-CA 124.052 0.941 . . . . 73.15 111.159 175.443 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 87.43 -25.06 8.54 Favored Glycine 0 C--N 1.349 1.299 0 CA-C-O 119.437 -0.646 . . . . 73.1 114.304 175.034 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 17.4 m-85 -69.2 -48.78 61.11 Favored 'General case' 0 N--CA 1.478 0.928 0 CA-C-N 117.237 0.519 . . . . 72.14 111.655 -167.145 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 53.29 64.74 3.92 Favored Glycine 0 C--N 1.353 1.505 0 O-C-N 123.942 0.776 . . . . 75.12 114.212 170.692 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 48' ' ' TYR . . . . . 0.453 ' HB3' ' HB2' ' A' ' 51' ' ' SER . 59.3 m-85 -60.95 86.95 0.02 OUTLIER 'General case' 0 CA--C 1.551 1.006 0 CA-C-O 121.69 0.757 . . . . 73.45 111.044 178.209 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 27.7 tptp -112.68 125.28 54.13 Favored 'General case' 0 C--O 1.238 0.455 0 N-CA-C 107.306 -1.368 . . . . 73.15 107.306 177.086 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 73.92 21.62 78.99 Favored Glycine 0 CA--C 1.53 0.989 0 O-C-N 123.364 0.415 . . . . 50.21 112.097 -172.117 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 51' ' ' SER . . . . . 0.653 ' HA ' ' HB2' ' A' ' 67' ' ' PHE . 31.8 t -61.81 112.05 2.13 Favored 'General case' 0 C--N 1.358 0.944 0 C-N-CA 123.65 0.78 . . . . 73.12 111.042 -173.486 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 52' ' ' CYS . . . . . 0.605 ' SG ' ' HB3' ' A' ' 66' ' ' ASP . 5.1 p -82.06 161.76 22.8 Favored 'General case' 0 CA--C 1.537 0.446 0 CA-C-O 121.769 0.795 . . . . 62.13 111.914 -172.864 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 30.2 m-85 -113.72 133.36 55.39 Favored 'General case' 0 C--O 1.235 0.337 0 CA-C-N 114.613 -1.176 . . . . 72.11 108.136 177.164 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 55.6 p-80 -115.9 -19.98 10.18 Favored 'General case' 0 N--CA 1.485 1.319 0 C-N-CA 122.871 0.468 . . . . 63.32 110.883 -179.351 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 55' ' ' ARG . . . . . 0.472 ' HA ' ' O ' ' A' ' 150' ' ' GLY . 27.9 ttt-85 -130.22 97.02 4.31 Favored 'General case' 0 C--O 1.215 -0.728 0 C-N-CA 123.116 0.566 . . . . 74.35 109.553 -172.158 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 33.2 mt -136.05 129.46 47.37 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.716 0 C-N-CA 123.488 0.715 . . . . 75.02 109.138 178.816 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 57' ' ' ILE . . . . . 0.45 HG23 ' HA ' ' A' ' 148' ' ' ARG . 56.8 mt -128.83 118.04 19.6 Favored Pre-proline 0 CA--C 1.552 1.02 0 C-N-CA 124.591 1.157 . . . . 75.22 109.153 -178.168 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 58' ' ' PRO . . . . . 0.709 ' HB3' ' HA ' ' A' ' 144' ' ' ARG . 38.7 Cg_endo -63.96 140.27 71.92 Favored 'Trans proline' 0 C--N 1.377 2.058 0 C-N-CA 123.563 2.842 . . . . 74.53 113.325 -175.966 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 73.4 20.45 79.88 Favored Glycine 0 C--N 1.346 1.115 0 CA-C-N 115.094 -0.957 . . . . 72.45 113.057 178.839 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 60' ' ' PHE . . . . . 0.427 ' CD2' ' HB3' ' A' ' 61' ' ' MET . 47.2 t80 -145.24 -73.68 0.24 Allowed 'General case' 0 C--O 1.244 0.782 0 C-N-CA 123.662 0.785 . . . . 73.21 109.717 -174.366 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 61' ' ' MET . . . . . 0.704 ' SD ' ' HB2' ' A' ' 63' ' ' GLN . 12.3 tmm? -169.15 137.03 1.9 Allowed 'General case' 0 N--CA 1.479 1.001 0 O-C-N 123.272 0.358 . . . . 71.14 111.686 -164.883 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 62' ' ' CYS . . . . . 0.486 ' SG ' ' HB ' ' A' ' 114' ' ' ILE . 3.9 p -112.89 121.32 44.32 Favored 'General case' 0 N--CA 1.484 1.228 0 C-N-CA 124.673 1.189 . . . . 74.12 110.585 174.334 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 63' ' ' GLN . . . . . 0.704 ' HB2' ' SD ' ' A' ' 61' ' ' MET . 53.7 tt0 -126.95 137.6 53.15 Favored 'General case' 0 N--CA 1.49 1.562 0 C-N-CA 124.163 0.985 . . . . 61.44 111.489 -168.596 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -154.86 -157.81 8.4 Favored Glycine 0 C--N 1.348 1.217 0 CA-C-N 115.975 -0.557 . . . . 51.01 113.311 -178.314 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 108.46 14.04 17.27 Favored Glycine 0 N--CA 1.476 1.344 0 N-CA-C 111.477 -0.649 . . . . 53.3 111.477 -169.789 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 66' ' ' ASP . . . . . 0.605 ' HB3' ' SG ' ' A' ' 52' ' ' CYS . 28.2 t70 -72.09 1.19 7.83 Favored 'General case' 0 CA--C 1.558 1.283 0 C-N-CA 125.242 1.417 . . . . 53.02 112.876 -167.409 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 67' ' ' PHE . . . . . 0.653 ' HB2' ' HA ' ' A' ' 51' ' ' SER . 56.6 t80 -73.36 -70.96 0.34 Allowed 'General case' 0 CA--C 1.549 0.932 0 C-N-CA 124.022 0.929 . . . . 73.31 111.41 -176.509 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 68' ' ' THR . . . . . 0.511 HG22 ' HD3' ' A' ' 76' ' ' LYS . 4.3 m -86.9 108.5 18.81 Favored 'General case' 0 N--CA 1.475 0.8 0 C-N-CA 122.949 0.5 . . . . 35.3 110.115 -171.999 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 34.8 ttt85 52.99 93.64 0.02 OUTLIER 'General case' 0 N--CA 1.481 1.116 0 C-N-CA 125.501 1.52 . . . . 65.41 111.618 -179.278 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 0.4 OUTLIER -110.69 11.73 22.67 Favored 'General case' 0 N--CA 1.481 1.088 0 N-CA-C 112.866 0.691 . . . . 73.33 112.866 -177.122 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 18.7 m120 -86.21 88.14 7.55 Favored 'General case' 0 N--CA 1.477 0.896 0 N-CA-C 108.928 -0.767 . . . . 64.11 108.928 171.467 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 69.96 29.39 70.82 Favored Glycine 0 C--N 1.35 1.334 0 CA-C-N 115.478 -0.783 . . . . 74.12 113.751 176.549 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 47.9 m -143.7 -64.55 0.38 Allowed 'General case' 0 CA--C 1.547 0.832 0 C-N-CA 124.015 0.926 . . . . 65.24 108.698 178.188 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 56.14 41.11 85.29 Favored Glycine 0 C--N 1.356 1.688 0 N-CA-C 115.234 0.853 . . . . 73.51 115.234 172.063 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 141.18 51.1 0.05 OUTLIER Glycine 0 C--N 1.346 1.12 0 CA-C-N 117.241 0.521 . . . . 24.3 111.872 -175.219 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 76' ' ' LYS . . . . . 0.511 ' HD3' HG22 ' A' ' 68' ' ' THR . 0.0 OUTLIER -58.87 147.81 32.44 Favored 'General case' 0 N--CA 1.475 0.82 0 C-N-CA 123.329 0.652 . . . . 74.33 112.151 -179.129 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 85.8 p -98.52 -178.37 3.98 Favored 'General case' 0 C--O 1.238 0.454 0 CA-C-N 115.325 -0.852 . . . . 72.44 111.953 -170.874 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 26.8 pt -75.58 -12.89 14.9 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.85 0 CA-C-N 114.999 -1.0 . . . . 75.45 111.003 175.426 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 99.2 m-85 -97.78 22.08 9.63 Favored 'General case' 0 N--CA 1.479 1.018 0 C-N-CA 124.133 0.973 . . . . 70.42 110.069 175.714 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 96.52 -111.71 4.29 Favored Glycine 0 C--N 1.346 1.128 0 N-CA-C 110.895 -0.882 . . . . 71.14 110.895 -177.694 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 41.5 tt0 -78.37 -59.63 2.7 Favored 'General case' 0 N--CA 1.472 0.628 0 C-N-CA 122.978 0.511 . . . . 72.31 110.378 -179.975 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 82' ' ' LYS . . . . . 0.759 ' HD2' ' HA ' ' A' ' 107' ' ' THR . 21.3 pttp -161.47 178.5 9.07 Favored 'General case' 0 N--CA 1.477 0.902 0 C-N-CA 123.88 0.872 . . . . 74.41 109.839 -171.055 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 35.7 p90 -152.07 174.36 13.78 Favored 'General case' 0 N--CA 1.474 0.765 0 C-N-CA 124.43 1.092 . . . . 72.13 111.459 -175.81 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 84' ' ' GLU . . . . . 0.46 ' HA ' ' HA ' ' A' ' 106' ' ' ASN . 13.7 pt-20 -82.92 160.28 22.13 Favored 'General case' 0 N--CA 1.474 0.734 0 CA-C-N 115.249 -0.887 . . . . 74.2 110.795 176.263 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 85' ' ' ASP . . . . . 0.404 ' OD1' ' HA ' ' A' ' 126' ' ' HIS . 49.7 m-20 -63.04 133.98 55.39 Favored 'General case' 0 N--CA 1.47 0.56 0 C-N-CA 123.741 0.816 . . . . 72.23 110.832 179.232 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 9.9 tp10 -76.18 -61.79 1.82 Allowed 'General case' 0 CA--C 1.543 0.676 0 CA-C-N 116.074 -0.512 . . . . 73.41 109.846 179.261 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 87' ' ' ASN . . . . . 0.433 ' OD1' HG12 ' A' ' 29' ' ' VAL . 27.6 p-10 -169.36 155.39 6.27 Favored 'General case' 0 N--CA 1.477 0.899 0 C-N-CA 123.49 0.716 . . . . 60.21 110.265 -173.303 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 76.5 m-85 -109.11 33.26 4.37 Favored 'General case' 0 N--CA 1.479 1.0 0 C-N-CA 123.826 0.85 . . . . 75.54 111.442 -169.648 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 55.9 mt -60.25 -46.98 94.03 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.164 0 C-N-CA 123.311 0.644 . . . . 65.1 109.561 174.283 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 90' ' ' LEU . . . . . 0.585 HD11 ' HB2' ' A' ' 25' ' ' PHE . 95.9 mt -95.87 128.39 42.71 Favored 'General case' 0 CA--C 1.537 0.476 0 CA-C-N 115.047 -0.978 . . . . 73.13 109.803 179.067 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 17.8 ptpt -133.74 171.94 13.45 Favored 'General case' 0 N--CA 1.472 0.646 0 C-N-CA 124.305 1.042 . . . . 75.24 110.133 -179.444 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 92' ' ' HIS . . . . . . . . . . . . . 23.8 m-70 -85.49 50.28 1.93 Allowed 'General case' 0 N--CA 1.477 0.895 0 C-N-CA 124.277 1.031 . . . . 64.35 110.107 -175.909 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 8.8 t -89.28 4.92 47.19 Favored 'General case' 0 CA--C 1.549 0.929 0 C-N-CA 124.006 0.923 . . . . 54.15 111.576 -176.773 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -148.72 172.9 28.82 Favored Glycine 0 C--N 1.345 1.073 0 N-CA-C 111.93 -0.468 . . . . 62.34 111.93 178.779 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 89.9 Cg_endo -84.08 156.88 13.2 Favored 'Trans proline' 0 CA--C 1.551 1.367 0 C-N-CA 123.026 2.484 . . . . 73.34 111.921 172.363 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 78.61 19.95 72.48 Favored Glycine 0 N--CA 1.471 1.03 0 CA-C-N 116.418 -0.355 . . . . 73.14 113.86 -179.438 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 97' ' ' ILE . . . . . . . . . . . . . 22.1 mm -78.91 109.77 13.95 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.777 0 C-N-CA 123.954 0.902 . . . . 63.22 111.41 -175.483 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 98' ' ' LEU . . . . . 0.492 HD13 HG12 ' A' ' 114' ' ' ILE . 65.6 tp -90.09 118.46 29.65 Favored 'General case' 0 CA--C 1.551 1.004 0 C-N-CA 123.299 0.64 . . . . 72.4 109.661 176.35 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 99' ' ' SER . . . . . 0.486 ' HB2' HG22 ' A' ' 128' ' ' VAL . 33.5 t -137.39 155.85 48.89 Favored 'General case' 0 N--CA 1.476 0.875 0 C-N-CA 124.979 1.312 . . . . 75.35 108.911 -177.495 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 100' ' ' MET . . . . . 0.41 ' HA ' ' HA ' ' A' ' 112' ' ' PHE . 41.2 mtp -90.41 147.31 23.52 Favored 'General case' 0 N--CA 1.486 1.348 0 N-CA-C 110.069 -0.345 . . . . 72.34 110.069 178.123 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 101' ' ' ALA . . . . . 0.475 ' HB3' ' HB2' ' A' ' 111' ' ' GLN . . . -84.46 162.52 19.9 Favored 'General case' 0 N--CA 1.475 0.8 0 C-N-CA 123.443 0.697 . . . . 44.53 112.622 -169.873 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 26.1 p-10 -165.1 168.05 17.65 Favored 'General case' 0 C--N 1.352 0.714 0 CA-C-N 115.142 -0.936 . . . . 73.45 110.358 178.757 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -113.72 9.02 17.67 Favored 'General case' 0 CA--C 1.543 0.701 0 C-N-CA 123.606 0.762 . . . . 75.2 109.75 168.174 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 154.08 -173.73 32.64 Favored Glycine 0 C--N 1.354 1.548 0 CA-C-O 119.706 -0.497 . . . . 52.13 112.552 -178.887 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 48.9 Cg_exo -58.59 143.75 98.04 Favored 'Trans proline' 0 C--N 1.373 1.842 0 C-N-CA 123.43 2.753 . . . . 75.51 112.898 176.876 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 106' ' ' ASN . . . . . 0.46 ' HA ' ' HA ' ' A' ' 84' ' ' GLU . 61.6 t30 63.96 14.65 8.58 Favored 'General case' 0 N--CA 1.485 1.284 0 C-N-CA 125.267 1.427 . . . . 72.33 111.837 -178.034 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 107' ' ' THR . . . . . 0.759 ' HA ' ' HD2' ' A' ' 82' ' ' LYS . 2.8 m -115.55 -0.48 13.03 Favored 'General case' 0 CA--C 1.551 0.995 0 C-N-CA 123.766 0.827 . . . . 61.35 109.93 179.263 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 54.7 t30 -78.09 155.01 30.81 Favored 'General case' 0 N--CA 1.479 0.983 0 C-N-CA 123.363 0.665 . . . . 64.51 110.246 -178.016 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 96.37 -10.26 67.2 Favored Glycine 0 N--CA 1.468 0.801 0 CA-C-O 120.076 -0.291 . . . . 33.23 113.11 177.533 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 16.2 p -91.19 123.13 34.4 Favored 'General case' 0 CA--C 1.538 0.513 0 N-CA-C 107.539 -1.282 . . . . 62.35 107.539 167.322 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 111' ' ' GLN . . . . . 0.475 ' HB2' ' HB3' ' A' ' 101' ' ' ALA . 3.0 mt-30 69.76 165.23 0.27 Allowed 'General case' 0 N--CA 1.493 1.703 0 C-N-CA 125.852 1.661 . . . . 73.34 111.19 -178.594 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 112' ' ' PHE . . . . . 0.41 ' HA ' ' HA ' ' A' ' 100' ' ' MET . 54.3 p90 -139.43 155.6 47.5 Favored 'General case' 0 N--CA 1.482 1.134 0 N-CA-C 108.985 -0.746 . . . . 74.11 108.985 175.793 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 113' ' ' PHE . . . . . 0.557 ' HB2' ' SD ' ' A' ' 61' ' ' MET . 53.7 p90 -152.61 152.83 32.27 Favored 'General case' 0 N--CA 1.471 0.605 0 C-N-CA 122.963 0.505 . . . . 60.55 111.65 -176.337 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 114' ' ' ILE . . . . . 0.492 HG12 HD13 ' A' ' 98' ' ' LEU . 6.4 mt -119.93 108.05 22.46 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.761 0 N-CA-C 108.121 -1.066 . . . . 63.21 108.121 -176.724 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 115' ' ' CYS . . . . . . . . . . . . . 60.1 m -80.62 105.83 12.17 Favored 'General case' 0 N--CA 1.47 0.53 0 C-N-CA 123.129 0.572 . . . . 74.23 109.769 176.656 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 40.5 p -71.85 -24.98 61.78 Favored 'General case' 0 N--CA 1.482 1.152 0 C-N-CA 122.612 0.365 . . . . 71.5 110.596 173.971 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -98.48 147.07 25.12 Favored 'General case' 0 C--O 1.239 0.545 0 CA-C-N 115.828 -0.624 . . . . 64.33 109.756 171.717 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 9.0 ptmm? -70.16 84.19 0.54 Allowed 'General case' 0 N--CA 1.477 0.899 0 CA-C-O 121.848 0.832 . . . . 70.24 110.021 171.847 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 119' ' ' THR . . . . . . . . . . . . . 35.8 p -79.92 85.31 5.56 Favored 'General case' 0 CA--C 1.548 0.866 0 CA-C-N 114.947 -1.024 . . . . 71.42 110.133 -175.546 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 9.3 pt-20 -68.39 -26.25 65.47 Favored 'General case' 0 N--CA 1.48 1.071 0 CA-C-N 114.737 -1.12 . . . . 71.42 112.125 -172.444 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 121' ' ' TRP . . . . . . . . . . . . . 47.0 p90 -72.57 1.08 8.83 Favored 'General case' 0 N--CA 1.473 0.715 0 C-N-CA 123.584 0.754 . . . . 74.31 112.265 178.546 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 122' ' ' LEU . . . . . 0.523 ' HB3' ' HE1' ' A' ' 126' ' ' HIS . 40.3 mt -104.12 5.3 35.01 Favored 'General case' 0 N--CA 1.475 0.815 0 C-N-CA 123.252 0.621 . . . . 74.2 111.897 176.355 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 40.4 m-20 -80.55 153.92 27.81 Favored 'General case' 0 N--CA 1.487 1.391 0 C-N-CA 122.812 0.445 . . . . 74.34 110.963 177.425 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 71.49 19.98 78.07 Favored Glycine 0 C--N 1.359 1.823 0 O-C-N 123.442 0.463 . . . . 54.45 112.304 -173.02 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 43.4 mtmt -145.22 -158.4 0.89 Allowed 'General case' 0 N--CA 1.47 0.533 0 C-N-CA 126.805 2.042 . . . . 72.42 107.884 -171.427 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 126' ' ' HIS . . . . . 0.523 ' HE1' ' HB3' ' A' ' 122' ' ' LEU . 0.0 OUTLIER -56.3 130.62 45.31 Favored 'General case' 0 N--CA 1.478 0.973 0 C-N-CA 123.8 0.84 . . . . 74.33 113.034 -159.119 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 99.3 t -61.45 130.14 25.22 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.615 0 CA-C-N 113.058 -1.883 . . . . 65.5 113.003 -166.517 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 128' ' ' VAL . . . . . 0.486 HG22 ' HB2' ' A' ' 99' ' ' SER . 92.8 t -81.05 145.26 9.18 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.313 0 CA-C-N 114.811 -1.086 . . . . 61.2 108.754 170.45 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 129' ' ' PHE . . . . . 0.569 ' HA ' HG21 ' A' ' 29' ' ' VAL . 21.6 p90 -138.27 -33.32 0.69 Allowed 'General case' 0 N--CA 1.469 0.503 0 C-N-CA 122.411 0.284 . . . . 54.52 110.984 -177.551 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . -115.66 165.14 12.15 Favored Glycine 0 C--N 1.337 0.588 0 O-C-N 123.709 0.631 . . . . 74.22 113.122 -175.591 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 30.2 ttpt -153.1 122.19 6.57 Favored 'General case' 0 C--N 1.324 -0.516 0 N-CA-C 107.207 -1.405 . . . . 71.14 107.207 177.867 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 3.9 p -65.92 105.36 0.62 Allowed 'Isoleucine or valine' 0 CA--C 1.553 1.078 0 CA-C-O 121.716 0.77 . . . . 61.33 109.651 175.56 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 133' ' ' LYS . . . . . 0.537 ' HD2' ' HB2' ' A' ' 23' ' ' GLU . 0.1 OUTLIER -78.5 -38.79 39.96 Favored 'General case' 0 N--CA 1.474 0.766 0 CA-C-N 114.901 -1.045 . . . . 74.35 109.903 -179.295 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 49.9 mt-10 -145.62 144.5 30.49 Favored 'General case' 0 N--CA 1.481 1.114 0 C-N-CA 124.599 1.16 . . . . 65.45 108.879 177.636 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 94.84 17.24 38.85 Favored Glycine 0 N--CA 1.472 1.059 0 N-CA-C 112.417 -0.273 . . . . 74.32 112.417 -176.409 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 136' ' ' MET . . . . . . . . . . . . . 14.5 tpt -61.81 -35.19 77.48 Favored 'General case' 0 N--CA 1.482 1.167 0 C-N-CA 124.113 0.965 . . . . 74.21 111.683 179.374 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 137' ' ' ASN . . . . . . . . . . . . . 1.8 m-20 -61.68 -34.71 76.22 Favored 'General case' 0 CA--C 1.548 0.875 0 C-N-CA 123.589 0.756 . . . . 74.14 110.774 177.796 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 138' ' ' ILE . . . . . . . . . . . . . 43.9 mm -72.05 -35.76 54.78 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.854 0 C-N-CA 123.076 0.55 . . . . 64.23 110.389 179.477 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 98.7 t -63.12 -45.88 97.47 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.872 0 C-N-CA 123.18 0.592 . . . . 71.31 110.374 175.879 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 40.9 mt-10 -68.26 -26.76 65.83 Favored 'General case' 0 N--CA 1.476 0.837 0 CA-C-N 115.498 -0.774 . . . . 74.14 111.186 178.352 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -71.99 -56.69 5.21 Favored 'General case' 0 N--CA 1.475 0.782 0 C-N-CA 123.332 0.653 . . . . 71.12 111.185 176.69 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 142' ' ' MET . . . . . 0.499 ' HA ' ' HD2' ' A' ' 145' ' ' PHE . 26.8 ptm -61.12 -35.7 77.73 Favored 'General case' 0 N--CA 1.48 1.059 0 C-N-CA 123.718 0.807 . . . . 65.3 111.829 -177.753 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 33.4 tt0 -66.05 -32.14 73.44 Favored 'General case' 0 CA--C 1.543 0.709 0 CA-C-O 121.462 0.648 . . . . 65.5 112.219 -173.91 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 144' ' ' ARG . . . . . 0.709 ' HA ' ' HB3' ' A' ' 58' ' ' PRO . 96.4 mtt180 -80.54 -6.58 58.43 Favored 'General case' 0 N--CA 1.47 0.544 0 CA-C-N 115.855 -0.611 . . . . 63.21 111.866 -178.65 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 145' ' ' PHE . . . . . 0.499 ' HD2' ' HA ' ' A' ' 142' ' ' MET . 50.9 m-85 -85.12 5.47 29.68 Favored 'General case' 0 CA--C 1.552 1.025 0 C-N-CA 123.309 0.644 . . . . 72.15 111.131 167.647 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . -93.72 -170.97 38.93 Favored Glycine 0 C--N 1.35 1.359 0 N-CA-C 112.381 -0.287 . . . . 70.31 112.381 172.987 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 12.9 m -132.74 162.53 31.2 Favored 'General case' 0 N--CA 1.48 1.049 0 C-N-CA 123.545 0.738 . . . . 71.02 109.513 -179.322 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 148' ' ' ARG . . . . . 0.45 ' HA ' HG23 ' A' ' 57' ' ' ILE . 17.4 mmm180 -71.5 -18.89 62.26 Favored 'General case' 0 N--CA 1.483 1.18 0 C-N-CA 123.823 0.849 . . . . 72.51 112.946 -172.902 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 149' ' ' ASN . . . . . . . . . . . . . 30.6 p-10 -85.89 -21.47 27.98 Favored 'General case' 0 N--CA 1.481 1.085 0 C-N-CA 123.619 0.768 . . . . 72.13 110.8 174.198 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 150' ' ' GLY . . . . . 0.472 ' O ' ' HA ' ' A' ' 55' ' ' ARG . . . 119.45 -11.23 11.37 Favored Glycine 0 C--N 1.347 1.189 0 CA-C-N 115.915 -0.584 . . . . 32.33 113.187 -178.747 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 37.5 ttpt -64.56 137.55 57.91 Favored 'General case' 0 N--CA 1.476 0.844 0 CA-C-N 117.921 0.86 . . . . 73.1 110.799 -177.698 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 152' ' ' THR . . . . . . . . . . . . . 18.1 p -91.13 113.28 25.51 Favored 'General case' 0 CA--C 1.539 0.528 0 N-CA-C 109.117 -0.698 . . . . 70.13 109.117 176.079 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 153' ' ' SER . . . . . . . . . . . . . 32.1 t -67.39 -35.41 79.27 Favored 'General case' 0 N--CA 1.475 0.803 0 C-N-CA 123.208 0.603 . . . . 72.1 110.419 -179.318 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 75.6 mmtt -110.09 152.16 26.32 Favored 'General case' 0 C--O 1.243 0.714 0 CA-C-N 114.959 -1.019 . . . . 73.53 109.381 178.971 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 17.3 tppt? -79.23 88.88 4.89 Favored 'General case' 0 C--N 1.349 0.552 0 N-CA-C 108.558 -0.904 . . . . 71.13 108.558 177.338 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 156' ' ' ILE . . . . . 0.486 HD11 ' HB2' ' A' ' 145' ' ' PHE . 58.0 mt -93.01 119.29 40.47 Favored 'Isoleucine or valine' 0 C--O 1.234 0.248 0 N-CA-C 108.821 -0.807 . . . . 62.51 108.821 -177.94 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 157' ' ' THR . . . . . . . . . . . . . 37.1 p -132.9 144.28 50.06 Favored 'General case' 0 C--O 1.238 0.481 0 C-N-CA 124.861 1.264 . . . . 74.42 109.099 -177.576 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 158' ' ' ILE . . . . . 0.437 HG23 ' HB3' ' A' ' 8' ' ' PHE . 62.2 mt -73.22 92.85 0.59 Allowed 'Isoleucine or valine' 0 CA--C 1.54 0.595 0 N-CA-C 107.526 -1.287 . . . . 62.23 107.526 166.874 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 159' ' ' ALA . . . . . 0.537 ' HB2' ' HB2' ' A' ' 11' ' ' ALA . . . -55.06 -57.32 12.18 Favored 'General case' 0 N--CA 1.47 0.549 0 C-N-CA 123.839 0.856 . . . . 72.33 110.892 -176.689 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 160' ' ' ASP . . . . . . . . . . . . . 13.2 m-20 -135.62 177.18 8.03 Favored 'General case' 0 N--CA 1.469 0.511 0 CA-C-O 121.698 0.761 . . . . 75.01 111.664 -175.18 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 161' ' ' CYS . . . . . . . . . . . . . 21.8 p -144.89 -169.35 3.16 Favored 'General case' 0 CA--C 1.542 0.644 0 C-N-CA 125.919 1.688 . . . . 74.32 107.768 -177.621 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 162' ' ' GLY . . . . . . . . . . . . . . . 130.27 53.06 0.1 Allowed Glycine 0 C--N 1.341 0.825 0 N-CA-C 109.92 -1.272 . . . . 65.13 109.92 -172.724 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 163' ' ' GLN . . . . . 0.521 ' HB2' ' HA ' ' A' ' 6' ' ' VAL . 15.6 pt20 -54.23 152.81 5.8 Favored 'General case' 0 CA--C 1.548 0.87 0 N-CA-C 114.512 1.301 . . . . 73.45 114.512 -170.927 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 164' ' ' LEU . . . . . 0.621 ' HG ' ' HB2' ' A' ' 7' ' ' PHE . 82.4 mt -88.51 118.2 28.0 Favored 'General case' 0 C--O 1.241 0.628 0 C-N-CA 124.462 1.105 . . . . 75.44 110.957 -169.874 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 165' ' ' GLU . . . . . . . . . . . . . 8.9 pt-20 . . . . . 0 CA--C 1.556 1.201 0 C-N-CA 124.181 0.992 . . . . 71.03 109.815 179.676 . . . . . . . . 0 0 . 1 . 003 nuclear build full ' B' B ' 216' ' ' PRO . . . . . . . . . . . . . 17.0 Cg_endo . . . . . 0 N--CA 1.487 1.111 0 N-CA-C 110.081 -0.777 . . . . 75.45 110.081 . . . . . . . . . 0 0 . 1 . 003 nuclear build full ' B' B ' 217' ' ' GLU . . . . . . . . . . . . . 16.9 pt-20 -79.17 159.34 73.11 Favored Pre-proline 0 CA--C 1.554 1.12 0 C-N-CA 123.318 0.647 . . . . 72.42 110.041 178.198 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 218' ' ' PRO . . . . . . . . . . . . . 21.9 Cg_exo -65.33 99.18 0.35 Allowed 'Trans proline' 0 C--N 1.375 1.971 0 C-N-CA 121.985 1.79 . . . . 73.32 110.482 169.994 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 219' ' ' GLY . . . . . 0.443 ' HA2' ' HB1' ' A' ' 101' ' ' ALA . . . -173.14 147.81 9.92 Favored Glycine 0 C--N 1.347 1.184 0 CA-C-O 119.722 -0.488 . . . . 71.43 113.292 -178.943 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 220' ' ' PRO . . . . . . . . . . . . . 56.6 Cg_endo -67.55 153.46 76.32 Favored 'Trans proline' 0 C--N 1.377 2.075 0 C-N-CA 123.553 2.835 . . . . 62.11 112.748 177.923 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 221' ' ' TYR . . . . . . . . . . . . . 83.2 m-85 -79.95 138.62 37.14 Favored 'General case' 0 N--CA 1.477 0.908 0 C-N-CA 122.781 0.433 . . . . 74.3 110.709 -178.571 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 222' ' ' ALA . . . . . . . . . . . . . . . -112.15 179.88 3.87 Favored 'General case' 0 N--CA 1.468 0.435 0 N-CA-C 113.791 1.034 . . . . 73.01 113.791 -162.964 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 223' ' ' GLN . . . . . . . . . . . . . 2.3 pt20 -94.84 121.81 61.91 Favored Pre-proline 0 CA--C 1.56 1.358 0 CA-C-N 114.318 -1.31 . . . . 74.34 109.604 178.1 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 224' ' ' PRO . . . . . . . . . . . . . 13.6 Cg_exo . . . . . 0 C--N 1.376 2.014 0 C-N-CA 122.834 2.356 . . . . 73.4 111.16 172.031 . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 92.2 mmm . . . . . 0 N--CA 1.49 1.559 0 N-CA-C 110.023 -0.362 . . . . 74.3 110.023 . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 13.5 p -80.33 -20.05 11.88 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.222 0 CA-C-O 121.685 0.755 . . . . 74.05 109.584 168.012 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 3' ' ' ASN . . . . . 0.583 HD22 ' HA ' ' A' ' 25' ' ' PHE . 13.4 m120 -77.06 124.47 87.32 Favored Pre-proline 0 CA--C 1.545 0.775 0 C-N-CA 124.442 1.097 . . . . 53.2 111.849 -171.888 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 36.4 Cg_endo -64.58 122.1 9.88 Favored 'Trans proline' 0 C--N 1.382 2.306 0 C-N-CA 122.872 2.381 . . . . 61.12 111.076 173.973 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 50.6 m -97.88 129.52 44.82 Favored 'General case' 0 CA--C 1.534 0.352 0 C-N-CA 123.585 0.754 . . . . 75.03 109.441 -178.068 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 6' ' ' VAL . . . . . 0.56 ' HA ' ' HG3' ' A' ' 163' ' ' GLN . 27.2 m -99.26 126.1 52.63 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.364 0 N-CA-C 108.209 -1.034 . . . . 54.04 108.209 175.471 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 7' ' ' PHE . . . . . 0.556 ' H ' ' HA ' ' A' ' 163' ' ' GLN . 57.7 t80 -108.85 135.52 49.92 Favored 'General case' 0 C--O 1.237 0.404 0 N-CA-C 109.037 -0.727 . . . . 70.31 109.037 -175.932 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 72.6 m-85 -139.62 166.21 25.2 Favored 'General case' 0 C--O 1.24 0.604 0 C-N-CA 124.654 1.182 . . . . 72.31 109.8 178.471 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 43.4 m-20 -118.01 116.25 26.53 Favored 'General case' 0 C--N 1.328 -0.365 0 N-CA-C 106.389 -1.708 . . . . 75.5 106.389 166.163 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 33.8 mm -98.93 143.68 12.92 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.711 0 N-CA-C 108.916 -0.772 . . . . 65.12 108.916 -177.465 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 11' ' ' ALA . . . . . 0.495 ' HB2' ' HB2' ' A' ' 159' ' ' ALA . . . -136.99 140.36 42.1 Favored 'General case' 0 N--CA 1.467 0.417 0 C-N-CA 123.304 0.642 . . . . 60.12 111.818 -164.432 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 12' ' ' VAL . . . . . 0.404 HG23 ' HB2' ' A' ' 17' ' ' LEU . 21.4 t -98.36 109.93 24.85 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.795 0 N-CA-C 107.796 -1.187 . . . . 71.41 107.796 171.418 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 45.4 m-20 68.25 20.63 8.73 Favored 'General case' 0 N--CA 1.497 1.904 0 C-N-CA 124.384 1.073 . . . . 73.35 111.766 -177.656 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 87.3 -3.19 86.75 Favored Glycine 0 C--N 1.349 1.278 0 CA-C-O 119.964 -0.353 . . . . 70.31 113.067 -174.666 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 40.0 mm-40 -84.18 113.71 49.96 Favored Pre-proline 0 CA--C 1.543 0.689 0 N-CA-C 108.902 -0.777 . . . . 71.35 108.902 175.235 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 21.1 Cg_endo -56.84 107.97 0.31 Allowed 'Trans proline' 0 C--N 1.383 2.354 0 C-N-CA 123.0 2.467 . . . . 75.24 111.749 -176.524 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 17' ' ' LEU . . . . . 0.404 ' HB2' HG23 ' A' ' 12' ' ' VAL . 46.3 tp -78.92 -45.45 20.5 Favored 'General case' 0 N--CA 1.47 0.539 0 CA-C-N 115.538 -0.756 . . . . 73.24 109.36 178.535 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -176.1 -171.46 39.92 Favored Glycine 0 C--N 1.337 0.596 0 CA-C-N 115.742 -0.663 . . . . 72.41 112.688 179.944 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 40.3 ptt85 -106.21 144.78 32.43 Favored 'General case' 0 C--O 1.239 0.537 0 C-N-CA 123.875 0.87 . . . . 74.1 108.674 178.691 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 94.6 t -134.17 139.27 48.56 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.588 0 N-CA-C 108.683 -0.858 . . . . 70.22 108.683 176.887 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 24.8 m -133.12 118.38 18.64 Favored 'General case' 0 CA--C 1.545 0.777 0 C-N-CA 124.867 1.267 . . . . 54.53 108.414 -175.872 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 22' ' ' PHE . . . . . 0.451 ' HA ' ' HA ' ' A' ' 132' ' ' VAL . 41.0 m-85 -102.87 129.63 49.63 Favored 'General case' 0 N--CA 1.479 1.002 0 N-CA-C 109.435 -0.58 . . . . 62.31 109.435 177.512 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 35.7 tt0 -90.33 108.18 19.61 Favored 'General case' 0 CA--C 1.548 0.873 0 C-N-CA 124.183 0.993 . . . . 71.34 109.426 177.447 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 24' ' ' LEU . . . . . 0.513 ' HB3' ' HB1' ' A' ' 33' ' ' ALA . 40.6 mt -87.25 122.09 30.56 Favored 'General case' 0 N--CA 1.48 1.063 0 C-N-CA 123.031 0.532 . . . . 65.32 110.605 -177.008 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 25' ' ' PHE . . . . . 0.583 ' HA ' HD22 ' A' ' 3' ' ' ASN . 48.8 m-85 -84.91 65.26 9.1 Favored 'General case' 0 CA--C 1.548 0.879 0 C-N-CA 123.916 0.886 . . . . 74.22 110.805 -179.951 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -65.86 -25.88 67.39 Favored 'General case' 0 N--CA 1.482 1.131 0 CA-C-N 115.127 -0.942 . . . . 41.3 111.912 -177.766 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 9.2 p-10 -72.81 -6.64 46.24 Favored 'General case' 0 N--CA 1.48 1.041 0 C-N-CA 123.489 0.716 . . . . 75.52 111.341 -179.544 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 91.7 mttt -114.6 -48.94 2.84 Favored 'General case' 0 N--CA 1.476 0.857 0 C-N-CA 123.771 0.828 . . . . 75.44 109.872 177.242 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 29' ' ' VAL . . . . . 0.451 HG21 ' HA ' ' A' ' 129' ' ' PHE . 14.6 m -121.94 79.02 41.49 Favored Pre-proline 0 CA--C 1.566 1.56 0 C-N-CA 124.329 1.052 . . . . 73.21 109.293 -178.684 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 35.6 Cg_exo -60.03 -57.3 0.82 Allowed 'Trans proline' 0 C--N 1.391 2.766 0 C-N-CA 123.204 2.603 . . . . 75.3 112.953 -169.671 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 29.2 ttmt -58.43 -45.09 89.17 Favored 'General case' 0 N--CA 1.479 0.999 0 C-N-CA 124.564 1.146 . . . . 72.24 112.085 179.385 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 6.9 m -67.0 -40.1 87.28 Favored 'General case' 0 CA--C 1.548 0.894 0 CA-C-N 114.58 -1.191 . . . . 60.02 111.671 -170.459 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 33' ' ' ALA . . . . . 0.513 ' HB1' ' HB3' ' A' ' 24' ' ' LEU . . . -80.71 -36.18 32.55 Favored 'General case' 0 N--CA 1.475 0.798 0 C-N-CA 123.586 0.755 . . . . 71.24 110.702 178.381 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 14.7 tp10 -62.41 -32.04 72.81 Favored 'General case' 0 N--CA 1.486 1.37 0 C-N-CA 124.042 0.937 . . . . 73.1 111.144 -179.526 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 35' ' ' ASN . . . . . 0.555 ' ND2' ' SD ' ' A' ' 100' ' ' MET . 44.9 t30 -55.97 -64.35 0.88 Allowed 'General case' 0 CA--C 1.544 0.741 0 C-N-CA 123.823 0.849 . . . . 63.34 110.801 176.115 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 36' ' ' PHE . . . . . 0.524 ' HE2' HG21 ' A' ' 6' ' ' VAL . 65.7 t80 -65.5 -30.14 70.87 Favored 'General case' 0 N--CA 1.476 0.856 0 C-N-CA 123.603 0.761 . . . . 55.1 111.065 -176.264 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 44.8 ttp85 -64.76 -51.43 62.31 Favored 'General case' 0 CA--C 1.551 0.985 0 C-N-CA 124.015 0.926 . . . . 64.24 109.593 -179.415 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -78.44 -15.09 59.02 Favored 'General case' 0 CA--C 1.544 0.729 0 CA-C-N 115.037 -0.983 . . . . 75.43 112.26 -176.567 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 39' ' ' LEU . . . . . 0.403 HD22 ' CE2' ' A' ' 48' ' ' TYR . 92.8 mt -79.59 -35.55 39.44 Favored 'General case' 0 N--CA 1.487 1.391 0 C-N-CA 122.96 0.504 . . . . 65.41 110.418 170.511 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 42.6 t -66.06 -54.39 26.48 Favored 'General case' 0 N--CA 1.477 0.897 0 C-N-CA 124.285 1.034 . . . . 65.53 110.592 179.892 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 10.9 p -75.67 -32.0 59.98 Favored 'General case' 0 N--CA 1.475 0.806 0 CA-C-N 115.878 -0.601 . . . . 65.34 111.52 175.87 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 81.5 34.96 24.2 Favored Glycine 0 C--N 1.348 1.221 0 CA-C-N 116.481 -0.327 . . . . 64.41 113.402 177.879 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 41.2 mm-40 -66.41 -20.47 66.07 Favored 'General case' 0 N--CA 1.476 0.867 0 C-N-CA 123.693 0.797 . . . . 74.21 111.991 -178.632 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 9.8 mmpt? -93.67 8.17 41.93 Favored 'General case' 0 CA--C 1.552 1.029 0 C-N-CA 124.193 0.997 . . . . 65.41 110.842 179.265 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 76.33 33.79 47.65 Favored Glycine 0 C--N 1.351 1.365 0 CA-C-O 119.774 -0.459 . . . . 71.14 113.384 179.995 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 23.4 m-85 -116.21 -49.35 2.69 Favored 'General case' 0 N--CA 1.484 1.266 0 CA-C-N 117.214 0.507 . . . . 74.23 110.797 -178.317 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 47.12 63.32 3.34 Favored Glycine 0 C--N 1.354 1.554 0 O-C-N 124.482 1.114 . . . . 73.33 115.371 169.609 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 48' ' ' TYR . . . . . 0.403 ' CE2' HD22 ' A' ' 39' ' ' LEU . 32.0 m-85 -66.36 92.63 0.2 Allowed 'General case' 0 C--N 1.353 0.752 0 CA-C-O 121.869 0.842 . . . . 75.42 111.435 -173.71 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 27.9 tptp -109.33 94.8 5.23 Favored 'General case' 0 C--O 1.239 0.522 0 CA-C-N 113.991 -1.458 . . . . 53.24 108.591 -175.059 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 118.95 21.37 3.85 Favored Glycine 0 C--N 1.348 1.202 0 CA-C-O 119.781 -0.455 . . . . 44.02 113.395 -179.547 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 51' ' ' SER . . . . . 0.514 ' HB2' HD12 ' A' ' 158' ' ' ILE . 19.7 m -60.5 119.15 7.49 Favored 'General case' 0 N--CA 1.476 0.854 0 C-N-CA 123.577 0.751 . . . . 62.32 110.716 179.463 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 52' ' ' CYS . . . . . . . . . . . . . 10.6 p -104.91 129.21 53.32 Favored 'General case' 0 N--CA 1.474 0.743 0 CA-C-O 121.637 0.732 . . . . 63.02 112.525 -170.415 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 53' ' ' PHE . . . . . 0.776 ' HA ' ' HA2' ' A' ' 64' ' ' GLY . 55.9 m-85 -70.52 109.71 4.99 Favored 'General case' 0 C--N 1.347 0.494 0 C-N-CA 124.842 1.257 . . . . 73.45 109.646 174.148 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 49.7 p-80 -120.28 -5.48 9.91 Favored 'General case' 0 N--CA 1.481 1.086 0 C-N-CA 123.815 0.846 . . . . 73.24 111.235 -176.454 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 55' ' ' ARG . . . . . 0.454 ' O ' ' HB3' ' A' ' 63' ' ' GLN . 53.2 ttt-85 -129.57 97.6 4.59 Favored 'General case' 0 N--CA 1.473 0.719 0 N-CA-C 108.891 -0.781 . . . . 51.44 108.891 175.604 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 56' ' ' ILE . . . . . 0.456 HG21 ' HA ' ' A' ' 143' ' ' GLU . 64.3 mt -130.55 127.18 61.9 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.943 0 N-CA-C 108.389 -0.967 . . . . 61.31 108.389 177.291 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 74.9 mt -124.85 118.16 25.84 Favored Pre-proline 0 CA--C 1.555 1.144 0 C-N-CA 123.974 0.909 . . . . 60.33 108.904 -177.884 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 52.7 Cg_exo -57.63 145.65 88.37 Favored 'Trans proline' 0 C--N 1.383 2.365 0 C-N-CA 124.229 3.286 . . . . 73.15 114.205 -179.237 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 66.1 24.19 71.69 Favored Glycine 0 C--N 1.352 1.451 0 O-C-N 124.291 0.994 . . . . 74.43 112.954 -179.272 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 60' ' ' PHE . . . . . 0.403 ' CD2' ' HB3' ' A' ' 61' ' ' MET . 36.3 t80 -145.09 -76.38 0.21 Allowed 'General case' 0 C--O 1.244 0.764 0 C-N-CA 123.886 0.875 . . . . 72.41 110.221 -173.744 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 61' ' ' MET . . . . . 0.708 ' SD ' ' HB2' ' A' ' 113' ' ' PHE . 12.1 tmm? -173.27 150.74 1.93 Allowed 'General case' 0 N--CA 1.484 1.272 0 CA-C-O 121.075 0.464 . . . . 75.14 112.19 -161.2 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 62' ' ' CYS . . . . . . . . . . . . . 36.7 t -114.45 111.92 22.19 Favored 'General case' 0 CA--C 1.558 1.287 0 C-N-CA 124.873 1.269 . . . . 72.54 109.752 175.687 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 63' ' ' GLN . . . . . 0.644 ' HB2' ' SD ' ' A' ' 61' ' ' MET . 49.6 tt0 -115.5 133.53 55.94 Favored 'General case' 0 N--CA 1.498 1.935 0 C-N-CA 124.017 0.927 . . . . 72.45 110.949 -172.209 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 64' ' ' GLY . . . . . 0.776 ' HA2' ' HA ' ' A' ' 53' ' ' PHE . . . -123.04 170.28 15.45 Favored Glycine 0 C--N 1.339 0.726 0 CA-C-N 115.259 -0.882 . . . . 63.15 112.83 179.032 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -164.54 156.99 29.21 Favored Glycine 0 C--N 1.33 0.241 0 N-CA-C 110.532 -1.027 . . . . 64.14 110.532 176.658 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 21.2 t70 -91.35 167.2 12.47 Favored 'General case' 0 C--O 1.244 0.798 0 CA-C-O 121.185 0.517 . . . . 62.41 110.34 -178.269 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 63.8 t80 -77.25 -29.08 53.81 Favored 'General case' 0 CA--C 1.552 1.035 0 C-N-CA 124.07 0.948 . . . . 73.51 111.18 -179.676 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 91.5 m -61.23 109.42 1.12 Allowed 'General case' 0 C--N 1.363 1.156 0 C-N-CA 123.922 0.889 . . . . 61.03 110.361 179.659 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 36.6 ttt180 52.98 82.89 0.07 Allowed 'General case' 0 CA--C 1.541 0.618 0 O-C-N 124.836 1.335 . . . . 75.23 110.461 -173.398 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 52.3 t60 -89.26 -19.94 24.74 Favored 'General case' 0 CA--C 1.549 0.911 0 CA-C-N 116.099 -0.501 . . . . 71.42 111.457 -174.601 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 3.5 m-20 -64.76 91.41 0.09 Allowed 'General case' 0 N--CA 1.489 1.516 0 C-N-CA 123.686 0.794 . . . . 71.31 111.214 -176.813 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 75.3 -6.19 30.88 Favored Glycine 0 C--N 1.349 1.27 0 CA-C-N 115.561 -0.745 . . . . 74.21 114.682 175.249 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -114.16 -67.03 1.03 Allowed 'General case' 0 CA--C 1.551 0.995 0 N-CA-C 109.187 -0.672 . . . . 75.13 109.187 -175.2 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 61.32 61.58 6.74 Favored Glycine 0 CA--C 1.534 1.24 0 CA-C-N 116.21 -0.45 . . . . 72.4 113.994 175.77 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 107.54 52.25 0.72 Allowed Glycine 0 N--CA 1.48 1.593 0 CA-C-N 117.674 0.737 . . . . 63.2 112.166 -177.5 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 76' ' ' LYS . . . . . 0.437 ' HA ' ' O ' ' A' ' 109' ' ' GLY . 21.5 pttp -53.77 170.58 0.11 Allowed 'General case' 0 CA--C 1.562 1.409 0 C-N-CA 125.076 1.35 . . . . 71.45 113.815 179.902 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 89.9 p -90.69 176.02 6.81 Favored 'General case' 0 N--CA 1.486 1.33 0 C-N-CA 123.689 0.796 . . . . 75.21 112.856 -165.885 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 25.5 pt -71.34 -17.95 20.05 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.225 0 C-N-CA 122.934 0.493 . . . . 74.35 110.784 174.327 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 69.7 m-85 -92.85 27.82 2.27 Favored 'General case' 0 CA--C 1.546 0.797 0 C-N-CA 124.058 0.943 . . . . 73.44 109.728 174.523 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 83.51 -119.38 4.89 Favored Glycine 0 C--N 1.354 1.551 0 CA-C-N 115.088 -0.96 . . . . 74.22 111.753 177.74 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 34.8 tt0 -61.74 -59.43 5.18 Favored 'General case' 0 C--O 1.241 0.625 0 C-N-CA 124.024 0.93 . . . . 61.2 110.723 -178.373 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 82' ' ' LYS . . . . . 0.749 ' HD2' ' HA ' ' A' ' 107' ' ' THR . 23.9 pttm -165.11 175.28 9.51 Favored 'General case' 0 CA--C 1.552 1.057 0 O-C-N 123.595 0.56 . . . . 74.2 111.742 -174.967 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 2.0 p90 -157.03 176.24 13.02 Favored 'General case' 0 N--CA 1.482 1.158 0 C-N-CA 125.83 1.652 . . . . 75.12 109.036 -179.884 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 12.5 pt-20 -93.02 -172.48 3.0 Favored 'General case' 0 N--CA 1.485 1.281 0 CA-C-O 121.255 0.55 . . . . 74.11 111.74 179.517 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 51.8 m-20 -80.42 136.74 36.41 Favored 'General case' 0 N--CA 1.471 0.614 0 C-N-CA 124.271 1.028 . . . . 70.21 109.148 173.22 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 12.6 tp10 -73.24 -52.53 13.68 Favored 'General case' 0 CA--C 1.544 0.728 0 O-C-N 123.472 0.482 . . . . 63.44 109.929 176.165 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 87' ' ' ASN . . . . . 0.402 ' OD1' HG12 ' A' ' 29' ' ' VAL . 16.5 p-10 -170.14 134.79 1.27 Allowed 'General case' 0 N--CA 1.479 0.983 0 C-N-CA 123.595 0.758 . . . . 74.32 110.193 -174.58 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 73.7 m-85 -88.58 69.52 8.85 Favored 'General case' 0 N--CA 1.483 1.189 0 CA-C-O 121.096 0.474 . . . . 72.43 110.538 -178.053 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 37.0 mt -82.03 -58.25 3.87 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.77 0 N-CA-C 108.724 -0.843 . . . . 72.03 108.724 169.44 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 53.1 mt -92.78 119.52 32.22 Favored 'General case' 0 CA--C 1.541 0.598 0 CA-C-N 114.923 -1.035 . . . . 74.11 110.596 -171.006 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 9.8 mtmp? -121.98 171.48 8.91 Favored 'General case' 0 CA--C 1.543 0.708 0 C-N-CA 124.764 1.226 . . . . 71.21 109.814 175.086 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 92' ' ' HIS . . . . . . . . . . . . . 23.0 m-70 -78.09 80.62 4.51 Favored 'General case' 0 N--CA 1.477 0.886 0 C-N-CA 123.879 0.872 . . . . 74.34 110.16 -170.232 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 19.1 p -82.85 -57.31 3.36 Favored 'General case' 0 N--CA 1.473 0.714 0 C-N-CA 123.898 0.879 . . . . 74.45 111.212 -177.006 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -121.45 -176.64 15.34 Favored Glycine 0 C--N 1.346 1.129 0 O-C-N 123.466 0.479 . . . . 23.33 112.788 -176.374 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 8.4 Cg_exo -73.6 148.22 41.81 Favored 'Trans proline' 0 C--N 1.368 1.556 0 C-N-CA 122.987 2.458 . . . . 64.15 111.564 170.354 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 105.67 -2.6 39.17 Favored Glycine 0 N--CA 1.473 1.121 0 CA-C-N 116.391 -0.368 . . . . 65.33 113.213 -179.703 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 97' ' ' ILE . . . . . 0.453 ' HB ' ' HB2' ' A' ' 115' ' ' CYS . 18.1 mm -66.34 116.18 5.28 Favored 'Isoleucine or valine' 0 CA--C 1.555 1.167 0 C-N-CA 124.366 1.066 . . . . 70.33 111.862 -174.583 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 55.3 tp -100.29 122.43 43.07 Favored 'General case' 0 N--CA 1.479 0.994 0 C-N-CA 123.312 0.645 . . . . 70.12 110.063 173.624 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 44.9 t -142.89 144.36 32.42 Favored 'General case' 0 CA--C 1.539 0.525 0 C-N-CA 124.263 1.025 . . . . 73.21 108.254 176.944 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 100' ' ' MET . . . . . 0.555 ' SD ' ' ND2' ' A' ' 35' ' ' ASN . 13.4 ttt -79.45 141.97 36.31 Favored 'General case' 0 N--CA 1.483 1.18 0 C-N-CA 124.138 0.975 . . . . 73.12 109.073 -178.729 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 101' ' ' ALA . . . . . 0.437 ' HB3' ' HB2' ' A' ' 111' ' ' GLN . . . -77.24 160.9 28.55 Favored 'General case' 0 N--CA 1.479 1.019 0 CA-C-O 121.387 0.613 . . . . 72.23 111.616 -173.02 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 102' ' ' ASN . . . . . 0.51 ' HB3' ' HA ' ' A' ' 108' ' ' ASN . 25.7 p-10 -165.79 168.84 15.65 Favored 'General case' 0 N--CA 1.472 0.669 0 CA-C-N 114.581 -1.191 . . . . 53.44 109.711 -177.468 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -90.5 -47.28 7.8 Favored 'General case' 0 N--CA 1.469 0.503 0 N-CA-C 108.917 -0.771 . . . . 73.13 108.917 167.137 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -168.0 -152.71 7.72 Favored Glycine 0 CA--C 1.533 1.172 0 CA-C-O 119.096 -0.836 . . . . 72.41 112.561 179.485 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 37.5 Cg_exo -61.79 135.39 55.78 Favored 'Trans proline' 0 C--N 1.379 2.167 0 C-N-CA 123.116 2.544 . . . . 63.45 112.898 -178.275 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 67.1 t30 66.06 9.75 6.47 Favored 'General case' 0 N--CA 1.49 1.535 0 C-N-CA 125.211 1.404 . . . . 73.54 111.852 -179.736 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 107' ' ' THR . . . . . 0.749 ' HA ' ' HD2' ' A' ' 82' ' ' LYS . 2.2 m -111.35 8.68 21.43 Favored 'General case' 0 CA--C 1.555 1.167 0 C-N-CA 124.174 0.989 . . . . 50.24 109.857 179.415 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 108' ' ' ASN . . . . . 0.51 ' HA ' ' HB3' ' A' ' 102' ' ' ASN . 8.8 t30 -70.66 145.18 50.78 Favored 'General case' 0 N--CA 1.475 0.795 0 C-N-CA 124.599 1.16 . . . . 74.42 110.268 175.135 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 109' ' ' GLY . . . . . 0.437 ' O ' ' HA ' ' A' ' 76' ' ' LYS . . . 109.99 25.12 5.49 Favored Glycine 0 N--CA 1.468 0.778 0 C-N-CA 121.568 -0.349 . . . . 50.24 112.565 178.897 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 28.4 p -131.46 118.5 20.29 Favored 'General case' 0 CA--C 1.54 0.562 0 N-CA-C 108.735 -0.839 . . . . 75.2 108.735 177.46 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 111' ' ' GLN . . . . . 0.437 ' HB2' ' HB3' ' A' ' 101' ' ' ALA . 49.7 mt-30 59.15 -175.74 0.09 Allowed 'General case' 0 N--CA 1.497 1.898 0 C-N-CA 123.724 0.81 . . . . 53.02 112.14 -173.897 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 112' ' ' PHE . . . . . 0.475 ' HA ' ' HA ' ' A' ' 100' ' ' MET . 42.6 p90 -151.64 151.7 31.85 Favored 'General case' 0 N--CA 1.484 1.241 0 N-CA-C 108.284 -1.006 . . . . 73.22 108.284 176.748 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 113' ' ' PHE . . . . . 0.708 ' HB2' ' SD ' ' A' ' 61' ' ' MET . 51.0 p90 -140.16 137.77 34.66 Favored 'General case' 0 N--CA 1.478 0.946 0 CA-C-O 121.27 0.557 . . . . 71.52 111.803 -176.568 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 114' ' ' ILE . . . . . . . . . . . . . 11.0 mt -110.09 102.52 14.1 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.663 0 C-N-CA 124.904 1.282 . . . . 72.55 108.093 -178.358 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 115' ' ' CYS . . . . . 0.453 ' HB2' ' HB ' ' A' ' 97' ' ' ILE . 56.9 m -64.83 105.26 0.97 Allowed 'General case' 0 CA--C 1.548 0.894 0 C-N-CA 123.208 0.603 . . . . 72.12 109.765 177.125 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 60.2 p -70.78 -32.01 68.99 Favored 'General case' 0 N--CA 1.476 0.844 0 C-N-CA 124.367 1.067 . . . . 65.43 110.803 -177.584 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -119.89 168.87 10.69 Favored 'General case' 0 C--O 1.247 0.946 0 C-N-CA 124.26 1.024 . . . . 30.42 108.824 169.499 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 17.5 ptmt -66.84 128.43 36.27 Favored 'General case' 0 N--CA 1.473 0.683 0 N-CA-C 109.268 -0.642 . . . . 74.53 109.268 173.462 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 119' ' ' THR . . . . . . . . . . . . . 27.0 p -131.9 84.17 2.14 Favored 'General case' 0 CA--C 1.541 0.606 0 CA-C-O 121.562 0.696 . . . . 72.05 109.15 -177.533 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 12.6 pt-20 -77.52 -15.45 59.27 Favored 'General case' 0 N--CA 1.481 1.115 0 CA-C-N 115.791 -0.64 . . . . 65.25 111.799 -172.275 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 121' ' ' TRP . . . . . . . . . . . . . 48.9 p90 -74.93 -5.05 41.71 Favored 'General case' 0 N--CA 1.478 0.928 0 C-N-CA 122.333 0.253 . . . . 73.11 111.146 174.709 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 122' ' ' LEU . . . . . 0.413 HD22 ' HB2' ' B' ' 220' ' ' PRO . 23.0 mt -94.66 8.01 43.82 Favored 'General case' 0 N--CA 1.472 0.671 0 C-N-CA 123.169 0.588 . . . . 73.51 110.89 172.949 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 53.0 m-20 -77.25 122.75 25.5 Favored 'General case' 0 CA--C 1.537 0.471 0 N-CA-C 107.475 -1.305 . . . . 64.34 107.475 168.935 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 112.88 -25.26 11.85 Favored Glycine 0 C--N 1.343 0.917 0 N-CA-C 111.185 -0.766 . . . . 74.4 111.185 -165.703 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 32.4 mmmt -72.84 -164.24 0.16 Allowed 'General case' 0 N--CA 1.489 1.499 0 C-N-CA 123.848 0.859 . . . . 65.13 109.741 167.734 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 126' ' ' HIS . . . . . . . . . . . . . 50.8 t60 -66.77 144.67 56.19 Favored 'General case' 0 CA--C 1.551 1.014 0 CA-C-O 121.082 0.468 . . . . 73.31 110.817 178.543 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 26.1 t -62.72 139.06 21.73 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.838 0 CA-C-N 114.605 -1.18 . . . . 72.43 111.194 179.595 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 49.4 t -68.18 143.38 15.31 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.739 0 N-CA-C 109.17 -0.678 . . . . 64.21 109.17 172.687 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 129' ' ' PHE . . . . . 0.451 ' HA ' HG21 ' A' ' 29' ' ' VAL . 35.9 p90 -132.81 -8.3 3.14 Favored 'General case' 0 N--CA 1.478 0.963 0 O-C-N 121.987 -0.446 . . . . 75.51 111.43 179.46 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . -151.02 171.98 30.68 Favored Glycine 0 C--N 1.34 0.772 0 O-C-N 123.473 0.483 . . . . 65.44 112.557 -175.883 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 32.2 ttpt -154.88 122.41 5.69 Favored 'General case' 0 C--O 1.236 0.384 0 N-CA-C 108.161 -1.052 . . . . 74.41 108.161 177.423 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 132' ' ' VAL . . . . . 0.451 ' HA ' ' HA ' ' A' ' 22' ' ' PHE . 3.0 p -61.44 107.73 0.44 Allowed 'Isoleucine or valine' 0 CA--C 1.551 1.01 0 CA-C-O 121.885 0.85 . . . . 74.11 110.404 178.505 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -80.9 -36.48 31.11 Favored 'General case' 0 CA--C 1.547 0.832 0 CA-C-N 114.821 -1.081 . . . . 72.31 110.385 -177.595 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 50.8 mt-10 -137.66 147.04 44.57 Favored 'General case' 0 N--CA 1.483 1.218 0 C-N-CA 124.766 1.226 . . . . 74.32 108.794 -178.734 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 80.15 14.92 79.78 Favored Glycine 0 C--N 1.344 0.982 0 O-C-N 123.208 0.318 . . . . 52.41 113.038 -177.602 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 136' ' ' MET . . . . . . . . . . . . . 12.9 tpt -65.23 -40.83 94.6 Favored 'General case' 0 N--CA 1.473 0.683 0 C-N-CA 123.482 0.713 . . . . 71.41 110.198 174.339 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 137' ' ' ASN . . . . . . . . . . . . . 17.7 m120 -59.35 -35.34 73.69 Favored 'General case' 0 N--CA 1.481 1.081 0 C-N-CA 123.384 0.673 . . . . 74.2 111.427 176.246 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 138' ' ' ILE . . . . . 0.554 ' O ' ' HG3' ' A' ' 142' ' ' MET . 36.4 mm -60.25 -56.27 18.68 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.834 0 N-CA-C 109.277 -0.638 . . . . 74.24 109.277 172.998 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 91.3 t -54.81 -42.72 63.93 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.445 0 C-N-CA 124.21 1.004 . . . . 73.01 111.727 -175.857 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 46.1 mt-10 -67.38 -36.48 81.42 Favored 'General case' 0 N--CA 1.483 1.187 0 C-N-CA 123.824 0.849 . . . . 73.32 111.101 179.676 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -71.63 -25.05 61.99 Favored 'General case' 0 N--CA 1.478 0.973 0 CA-C-N 115.932 -0.577 . . . . 65.32 111.756 175.231 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 142' ' ' MET . . . . . 0.554 ' HG3' ' O ' ' A' ' 138' ' ' ILE . 35.4 mtp -83.52 -22.9 32.31 Favored 'General case' 0 N--CA 1.485 1.282 0 C-N-CA 122.701 0.4 . . . . 63.32 111.172 178.351 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 143' ' ' GLU . . . . . 0.456 ' HA ' HG21 ' A' ' 56' ' ' ILE . 37.5 tt0 -63.44 -25.46 68.28 Favored 'General case' 0 CA--C 1.547 0.852 0 O-C-N 123.786 0.679 . . . . 75.23 110.935 174.025 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 144' ' ' ARG . . . . . . . . . . . . . 51.2 mtp85 -67.82 -18.82 64.96 Favored 'General case' 0 CA--C 1.547 0.847 0 C-N-CA 123.944 0.898 . . . . 73.34 111.916 178.384 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 145' ' ' PHE . . . . . . . . . . . . . 89.9 m-85 -85.47 -21.22 28.8 Favored 'General case' 0 N--CA 1.48 1.037 0 C-N-CA 123.135 0.574 . . . . 71.32 110.793 175.003 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . -73.33 169.83 52.84 Favored Glycine 0 C--N 1.35 1.308 0 N-CA-C 114.135 0.414 . . . . 70.3 114.135 -177.439 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 15.2 m -131.68 165.32 23.97 Favored 'General case' 0 N--CA 1.484 1.242 0 C-N-CA 124.356 1.063 . . . . 75.32 110.418 -176.444 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 148' ' ' ARG . . . . . . . . . . . . . 15.2 mmm180 -60.6 -38.57 85.13 Favored 'General case' 0 N--CA 1.485 1.305 0 C-N-CA 124.135 0.974 . . . . 75.01 111.901 -177.435 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 149' ' ' ASN . . . . . . . . . . . . . 26.6 p-10 -80.08 -7.34 58.83 Favored 'General case' 0 N--CA 1.481 1.099 0 C-N-CA 123.629 0.772 . . . . 73.31 111.857 179.784 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 150' ' ' GLY . . . . . 0.414 ' O ' ' HA ' ' A' ' 55' ' ' ARG . . . 102.41 -4.06 50.92 Favored Glycine 0 C--N 1.348 1.202 0 CA-C-O 119.648 -0.529 . . . . 75.22 113.381 -179.434 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 87.0 tttt -64.54 134.62 54.77 Favored 'General case' 0 N--CA 1.476 0.87 0 CA-C-N 117.573 0.686 . . . . 73.22 110.607 -179.733 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 152' ' ' THR . . . . . . . . . . . . . 67.4 p -95.2 126.2 40.37 Favored 'General case' 0 C--O 1.242 0.669 0 N-CA-C 108.57 -0.9 . . . . 64.15 108.57 170.168 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 153' ' ' SER . . . . . . . . . . . . . 38.8 t -60.02 -42.34 94.13 Favored 'General case' 0 N--CA 1.477 0.893 0 C-N-CA 123.568 0.747 . . . . 74.41 109.766 178.152 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 28.6 mmtp -114.69 154.54 28.27 Favored 'General case' 0 C--O 1.242 0.687 0 CA-C-N 114.928 -1.033 . . . . 53.41 109.96 179.784 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 57.1 tptt -78.15 89.59 4.25 Favored 'General case' 0 CA--C 1.54 0.59 0 N-CA-C 109.04 -0.726 . . . . 75.33 109.04 179.879 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 156' ' ' ILE . . . . . 0.423 HG23 ' HE1' ' A' ' 142' ' ' MET . 64.1 mt -84.37 116.12 27.56 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.488 0 N-CA-C 108.974 -0.75 . . . . 63.45 108.974 -176.034 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 157' ' ' THR . . . . . . . . . . . . . 50.5 p -120.41 159.97 24.03 Favored 'General case' 0 N--CA 1.479 1.018 0 C-N-CA 124.242 1.017 . . . . 64.12 110.288 -176.063 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 158' ' ' ILE . . . . . 0.514 HD12 ' HB2' ' A' ' 51' ' ' SER . 60.3 mt -87.82 100.05 9.64 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.647 0 N-CA-C 107.337 -1.357 . . . . 75.23 107.337 164.768 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 159' ' ' ALA . . . . . 0.495 ' HB2' ' HB2' ' A' ' 11' ' ' ALA . . . -57.56 -50.81 71.87 Favored 'General case' 0 N--CA 1.474 0.756 0 C-N-CA 124.193 0.997 . . . . 71.11 111.814 -177.686 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 160' ' ' ASP . . . . . . . . . . . . . 1.8 t70 -148.75 -179.15 6.77 Favored 'General case' 0 N--CA 1.48 1.049 0 CA-C-N 116.712 -0.222 . . . . 65.42 111.46 -174.049 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 161' ' ' CYS . . . . . . . . . . . . . 26.8 p -154.11 -169.07 3.14 Favored 'General case' 0 N--CA 1.475 0.816 0 C-N-CA 124.659 1.183 . . . . 62.41 108.992 -176.208 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 162' ' ' GLY . . . . . . . . . . . . . . . 136.46 53.11 0.06 OUTLIER Glycine 0 N--CA 1.475 1.287 0 N-CA-C 111.53 -0.628 . . . . 55.2 111.53 -166.056 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 163' ' ' GLN . . . . . 0.56 ' HG3' ' HA ' ' A' ' 6' ' ' VAL . 30.3 tt0 -45.8 117.43 1.48 Allowed 'General case' 0 N--CA 1.476 0.83 0 C-N-CA 126.588 1.955 . . . . 74.11 112.434 -179.869 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 164' ' ' LEU . . . . . . . . . . . . . 78.1 mt -89.3 98.48 11.79 Favored 'General case' 0 N--CA 1.466 0.343 0 N-CA-C 107.974 -1.121 . . . . 72.42 107.974 179.935 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 165' ' ' GLU . . . . . . . . . . . . . 11.3 pt-20 . . . . . 0 C--O 1.254 1.324 0 C-N-CA 123.946 0.898 . . . . 72.53 110.096 -172.922 . . . . . . . . 0 0 . 1 . 004 nuclear build full ' B' B ' 216' ' ' PRO . . . . . . . . . . . . . 2.6 Cg_exo . . . . . 0 N--CA 1.489 1.221 0 N-CA-C 110.264 -0.706 . . . . 62.14 110.264 . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' B' B ' 217' ' ' GLU . . . . . . . . . . . . . 5.7 tp10 -102.89 101.03 18.54 Favored Pre-proline 0 CA--C 1.554 1.121 0 N-CA-C 108.968 -0.753 . . . . 74.04 108.968 176.144 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 218' ' ' PRO . . . . . . . . . . . . . 86.3 Cg_endo -90.03 79.72 0.7 Allowed 'Trans proline' 0 C--N 1.382 2.291 0 C-N-CA 122.923 2.415 . . . . 71.12 111.611 179.312 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 219' ' ' GLY . . . . . . . . . . . . . . . 171.73 -169.7 42.74 Favored Glycine 0 CA--C 1.531 1.093 0 CA-C-N 115.586 -0.734 . . . . 61.43 113.196 179.75 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 220' ' ' PRO . . . . . 0.413 ' HB2' HD22 ' A' ' 122' ' ' LEU . 87.4 Cg_endo -76.37 159.16 36.56 Favored 'Trans proline' 0 C--N 1.368 1.604 0 C-N-CA 123.999 3.133 . . . . 73.21 114.128 177.067 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 221' ' ' TYR . . . . . . . . . . . . . 66.3 m-85 -84.06 140.59 31.73 Favored 'General case' 0 N--CA 1.491 1.601 0 C-N-CA 123.49 0.716 . . . . 62.45 111.876 -176.907 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 222' ' ' ALA . . . . . . . . . . . . . . . -127.37 -176.17 3.66 Favored 'General case' 0 N--CA 1.481 1.081 0 C-N-CA 124.065 0.946 . . . . 70.1 112.711 -173.281 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 223' ' ' GLN . . . . . . . . . . . . . 1.6 mp0 -74.77 126.99 87.87 Favored Pre-proline 0 CA--C 1.551 0.995 0 CA-C-N 114.853 -1.067 . . . . 73.15 109.314 176.128 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 224' ' ' PRO . . . . . . . . . . . . . 36.5 Cg_endo . . . . . 0 C--N 1.379 2.161 0 C-N-CA 123.046 2.497 . . . . 72.32 112.821 -176.7 . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 1' ' ' MET . . . . . 0.574 ' SD ' ' HE3' ' A' ' 28' ' ' LYS . 93.7 mmm . . . . . 0 N--CA 1.483 1.188 0 N-CA-C 110.179 -0.304 . . . . 64.13 110.179 . . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 2' ' ' VAL . . . . . 0.487 HG12 ' HB3' ' A' ' 27' ' ' ASP . 3.4 p -143.69 87.79 0.32 Allowed 'Isoleucine or valine' 0 N--CA 1.477 0.89 0 CA-C-O 122.542 1.163 . . . . 75.42 108.405 172.844 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 15.2 m120 -99.62 108.67 52.11 Favored Pre-proline 0 CA--C 1.549 0.928 0 CA-C-N 113.915 -1.493 . . . . 62.32 111.731 -175.663 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 4' ' ' PRO . . . . . 0.474 ' HG2' ' HB2' ' A' ' 24' ' ' LEU . 59.9 Cg_endo -73.69 146.41 38.49 Favored 'Trans proline' 0 C--N 1.374 1.871 0 C-N-CA 122.376 2.051 . . . . 62.11 111.403 166.232 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 5' ' ' THR . . . . . 0.486 ' HB ' ' O ' ' A' ' 164' ' ' LEU . 84.2 m -96.7 135.92 37.95 Favored 'General case' 0 CA--C 1.536 0.423 0 C-N-CA 123.344 0.658 . . . . 73.14 109.29 177.736 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 6' ' ' VAL . . . . . 0.475 ' HB ' ' HB2' ' A' ' 22' ' ' PHE . 23.3 t -100.19 147.08 7.96 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.485 0 N-CA-C 107.831 -1.174 . . . . 75.12 107.831 176.25 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 7' ' ' PHE . . . . . 0.439 ' H ' ' HA ' ' A' ' 163' ' ' GLN . 45.7 t80 -126.73 120.73 30.1 Favored 'General case' 0 C--O 1.237 0.412 0 N-CA-C 109.093 -0.706 . . . . 71.31 109.093 175.951 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 8' ' ' PHE . . . . . 0.402 ' HD2' ' HE2' ' A' ' 22' ' ' PHE . 30.6 m-85 -129.86 166.2 20.46 Favored 'General case' 0 N--CA 1.47 0.556 0 C-N-CA 123.864 0.865 . . . . 63.53 109.008 165.925 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 24.8 m-20 -117.82 122.9 44.6 Favored 'General case' 0 N--CA 1.466 0.349 0 N-CA-C 107.641 -1.244 . . . . 74.51 107.641 169.903 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 46.5 mm -87.2 124.41 40.63 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.509 0 N-CA-C 108.914 -0.772 . . . . 50.43 108.914 178.955 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 11' ' ' ALA . . . . . 0.851 ' HB2' ' HB2' ' A' ' 159' ' ' ALA . . . -118.82 128.13 54.17 Favored 'General case' 0 N--CA 1.469 0.483 0 C-N-CA 123.599 0.759 . . . . 63.14 110.695 -174.882 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 12' ' ' VAL . . . . . 0.467 HG13 ' HB3' ' A' ' 154' ' ' LYS . 96.0 t -95.81 107.91 20.33 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.48 0 N-CA-C 107.819 -1.178 . . . . 71.3 107.819 173.696 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 29.0 m-20 64.72 25.24 12.98 Favored 'General case' 0 N--CA 1.485 1.301 0 C-N-CA 125.284 1.434 . . . . 63.03 111.97 -175.926 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 87.24 1.36 84.22 Favored Glycine 0 C--N 1.348 1.249 0 CA-C-N 116.377 -0.374 . . . . 64.13 113.186 -177.061 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 17.5 mm-40 -94.46 113.49 61.07 Favored Pre-proline 0 CA--C 1.543 0.679 0 N-CA-C 108.584 -0.895 . . . . 54.42 108.584 175.125 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 26.4 Cg_endo -59.89 106.31 0.32 Allowed 'Trans proline' 0 C--N 1.38 2.197 0 C-N-CA 122.627 2.218 . . . . 73.31 112.181 -175.879 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 47.2 tp -75.49 -34.43 60.86 Favored 'General case' 0 N--CA 1.476 0.834 0 C-N-CA 124.178 0.991 . . . . 60.03 109.42 -179.348 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 178.47 177.44 47.15 Favored Glycine 0 C--N 1.343 0.919 0 CA-C-N 115.574 -0.739 . . . . 62.43 113.29 175.748 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 37.4 ptt85 -107.26 136.1 47.65 Favored 'General case' 0 C--O 1.24 0.584 0 C-N-CA 124.3 1.04 . . . . 75.2 108.998 177.05 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 20' ' ' VAL . . . . . 0.467 ' HA ' ' HA3' ' A' ' 135' ' ' GLY . 33.2 t -127.2 134.35 66.14 Favored 'Isoleucine or valine' 0 C--O 1.243 0.721 0 C-N-CA 123.122 0.569 . . . . 54.41 109.96 -178.856 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 21' ' ' SER . . . . . 0.453 ' HA ' ' O ' ' A' ' 6' ' ' VAL . 50.8 p -114.23 124.28 51.65 Favored 'General case' 0 CA--C 1.55 0.976 0 C-N-CA 123.83 0.852 . . . . 75.31 109.769 175.75 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 22' ' ' PHE . . . . . 0.475 ' HB2' ' HB ' ' A' ' 6' ' ' VAL . 60.7 m-85 -101.83 170.14 8.34 Favored 'General case' 0 N--CA 1.477 0.883 0 C-N-CA 123.903 0.881 . . . . 74.22 110.496 -179.962 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 35.0 tt0 -134.91 102.88 5.38 Favored 'General case' 0 N--CA 1.476 0.875 0 C-N-CA 123.649 0.78 . . . . 71.21 109.817 -175.225 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 24' ' ' LEU . . . . . 0.474 ' HB2' ' HG2' ' A' ' 4' ' ' PRO . 48.1 mt -82.02 131.78 35.25 Favored 'General case' 0 N--CA 1.478 0.97 0 C-N-CA 122.966 0.506 . . . . 73.32 110.423 -179.807 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 52.7 m-85 -86.93 69.06 10.24 Favored 'General case' 0 N--CA 1.469 0.506 0 N-CA-C 108.856 -0.794 . . . . 65.44 108.856 175.188 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -66.52 -12.89 59.8 Favored 'General case' 0 N--CA 1.483 1.184 0 CA-C-N 115.418 -0.81 . . . . 64.25 112.497 -175.114 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 27' ' ' ASP . . . . . 0.487 ' HB3' HG12 ' A' ' 2' ' ' VAL . 11.1 p-10 -85.33 -34.85 21.75 Favored 'General case' 0 CA--C 1.545 0.756 0 C-N-CA 123.694 0.798 . . . . 74.11 111.482 175.323 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 28' ' ' LYS . . . . . 0.574 ' HE3' ' SD ' ' A' ' 1' ' ' MET . 96.7 mttt -93.83 -33.48 13.53 Favored 'General case' 0 N--CA 1.489 1.496 0 C-N-CA 123.099 0.56 . . . . 72.35 111.903 -172.709 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 29' ' ' VAL . . . . . 0.566 HG21 ' HA ' ' A' ' 129' ' ' PHE . 4.4 m -135.92 69.36 64.65 Favored Pre-proline 0 N--CA 1.481 1.103 0 C-N-CA 123.873 0.869 . . . . 71.41 109.07 177.45 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 37.1 Cg_exo -58.11 -35.28 98.87 Favored 'Trans proline' 0 C--N 1.381 2.26 0 C-N-CA 122.79 2.327 . . . . 73.2 113.42 -173.04 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 87.8 tttt -69.85 -50.27 44.27 Favored 'General case' 0 N--CA 1.472 0.664 0 C-N-CA 123.67 0.788 . . . . 52.21 111.776 -178.341 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 7.4 m -73.61 -29.6 62.48 Favored 'General case' 0 CA--C 1.556 1.211 0 C-N-CA 122.975 0.51 . . . . 73.41 111.113 -172.637 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -77.26 -36.01 54.8 Favored 'General case' 0 CA--C 1.547 0.855 0 C-N-CA 123.379 0.672 . . . . 74.14 110.875 175.46 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 12.2 tp10 -60.62 -42.87 97.71 Favored 'General case' 0 N--CA 1.488 1.46 0 C-N-CA 124.041 0.937 . . . . 63.43 109.942 175.102 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 35' ' ' ASN . . . . . 0.461 ' O ' ' HG ' ' A' ' 39' ' ' LEU . 43.3 t30 -55.58 -60.33 3.59 Favored 'General case' 0 C--N 1.347 0.498 0 CA-C-N 113.75 -1.568 . . . . 73.25 110.892 177.997 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 70.0 t80 -62.19 -34.12 75.83 Favored 'General case' 0 N--CA 1.471 0.618 0 O-C-N 124.361 1.038 . . . . 61.51 111.574 -174.838 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 42.1 ttp180 -64.99 -44.19 90.1 Favored 'General case' 0 C--N 1.348 0.512 0 O-C-N 123.605 0.566 . . . . 70.35 110.841 177.278 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 38' ' ' ALA . . . . . 0.541 ' HB3' HG21 ' A' ' 78' ' ' ILE . . . -73.65 -26.02 60.56 Favored 'General case' 0 N--CA 1.475 0.785 0 C-N-CA 122.896 0.479 . . . . 51.55 111.568 -178.875 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 39' ' ' LEU . . . . . 0.577 HD22 ' HE1' ' A' ' 48' ' ' TYR . 90.3 mt -68.78 -40.16 79.8 Favored 'General case' 0 CA--C 1.549 0.912 0 C-N-CA 123.705 0.802 . . . . 73.22 109.911 172.693 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 47.2 t -71.7 -51.29 23.73 Favored 'General case' 0 N--CA 1.476 0.856 0 C-N-CA 124.311 1.044 . . . . 73.13 111.329 -178.334 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 53.1 p -72.42 -31.4 65.46 Favored 'General case' 0 N--CA 1.471 0.612 0 C-N-CA 123.703 0.801 . . . . 44.04 111.652 -175.917 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 79.03 21.93 66.9 Favored Glycine 0 C--N 1.346 1.124 0 CA-C-N 115.895 -0.593 . . . . 63.14 113.794 178.151 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 30.9 mm-40 -62.08 -31.33 71.75 Favored 'General case' 0 N--CA 1.477 0.897 0 C-N-CA 123.302 0.641 . . . . 73.21 110.707 174.213 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 44' ' ' LYS . . . . . 0.444 ' HG2' ' HB1' ' A' ' 38' ' ' ALA . 30.5 mmmt -95.74 19.4 11.33 Favored 'General case' 0 CA--C 1.544 0.717 0 C-N-CA 123.896 0.878 . . . . 72.04 111.853 179.957 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 85.83 -9.65 68.01 Favored Glycine 0 C--N 1.353 1.508 0 N-CA-C 114.994 0.757 . . . . 73.35 114.994 170.802 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 46' ' ' PHE . . . . . 0.411 ' HE2' ' HA ' ' A' ' 78' ' ' ILE . 22.3 m-85 -86.45 -50.23 7.03 Favored 'General case' 0 N--CA 1.478 0.956 0 CA-C-N 118.064 0.932 . . . . 74.42 111.473 -170.453 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 44.98 65.12 1.93 Allowed Glycine 0 C--N 1.361 1.946 0 O-C-N 124.634 1.209 . . . . 64.13 115.172 169.824 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 48' ' ' TYR . . . . . 0.577 ' HE1' HD22 ' A' ' 39' ' ' LEU . 79.3 m-85 -60.07 86.09 0.01 OUTLIER 'General case' 0 N--CA 1.487 1.383 0 CA-C-O 122.241 1.019 . . . . 72.34 111.903 -173.731 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 27.6 tptp -114.72 128.49 56.34 Favored 'General case' 0 C--O 1.239 0.527 0 CA-C-N 113.376 -1.738 . . . . 74.13 108.515 -178.865 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 63.35 20.55 63.37 Favored Glycine 0 N--CA 1.476 1.317 0 O-C-N 123.255 0.347 . . . . 63.02 112.708 -173.321 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 27.0 t -76.12 123.73 26.28 Favored 'General case' 0 C--N 1.346 0.456 0 C-N-CA 123.119 0.567 . . . . 75.2 110.575 -171.137 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 52' ' ' CYS . . . . . 0.457 ' SG ' ' HD3' ' A' ' 155' ' ' LYS . 51.5 t -81.45 161.86 23.52 Favored 'General case' 0 CA--C 1.539 0.53 0 O-C-N 123.967 0.792 . . . . 70.5 112.537 -171.631 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 12.7 m-85 -111.67 131.47 55.27 Favored 'General case' 0 CA--C 1.537 0.465 0 N-CA-C 107.068 -1.456 . . . . 74.44 107.068 169.544 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 47.9 p-80 -114.18 -29.35 6.98 Favored 'General case' 0 N--CA 1.496 1.866 0 CA-C-N 118.695 0.68 . . . . 74.21 112.348 -174.016 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 55' ' ' ARG . . . . . 0.413 ' HB3' ' HG2' ' A' ' 63' ' ' GLN . 42.6 ttt-85 -119.62 98.29 6.05 Favored 'General case' 0 N--CA 1.473 0.724 0 N-CA-C 108.544 -0.91 . . . . 74.54 108.544 -176.603 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 59.5 mt -130.27 127.96 63.57 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.614 0 C-N-CA 123.807 0.843 . . . . 63.33 108.974 179.825 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 61.4 mt -127.83 118.88 21.12 Favored Pre-proline 0 CA--C 1.553 1.078 0 N-CA-C 108.189 -1.041 . . . . 72.14 108.189 176.848 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 58' ' ' PRO . . . . . 0.482 ' HB3' ' HA ' ' A' ' 144' ' ' ARG . 64.0 Cg_endo -70.35 139.02 37.24 Favored 'Trans proline' 0 C--N 1.379 2.154 0 C-N-CA 123.163 2.576 . . . . 73.24 111.98 -174.028 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 79.0 24.41 61.83 Favored Glycine 0 C--N 1.338 0.645 0 CA-C-N 115.204 -0.907 . . . . 31.14 112.325 -175.728 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 27.9 t80 -150.34 -76.87 0.14 Allowed 'General case' 0 CA--C 1.544 0.724 0 C-N-CA 123.778 0.831 . . . . 72.4 109.884 179.356 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 38.7 ttp -166.98 150.46 6.65 Favored 'General case' 0 N--CA 1.485 1.306 0 CA-C-O 120.912 0.386 . . . . 65.42 111.781 -164.412 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 62' ' ' CYS . . . . . . . . . . . . . 4.9 p -127.83 120.86 28.71 Favored 'General case' 0 N--CA 1.478 0.932 0 C-N-CA 124.829 1.251 . . . . 64.55 109.57 176.552 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 63' ' ' GLN . . . . . 0.413 ' HG2' ' HB3' ' A' ' 55' ' ' ARG . 14.2 pt20 -128.26 144.97 51.18 Favored 'General case' 0 N--CA 1.491 1.62 0 CA-C-O 121.428 0.632 . . . . 73.01 112.375 -176.156 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -163.61 -147.27 5.01 Favored Glycine 0 C--N 1.348 1.227 0 CA-C-N 114.406 -1.27 . . . . 52.14 113.556 -174.609 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 90.66 12.32 61.01 Favored Glycine 0 C--N 1.345 1.062 0 N-CA-C 110.588 -1.005 . . . . 52.14 110.588 -161.878 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 38.9 t70 -61.69 -43.64 98.47 Favored 'General case' 0 N--CA 1.472 0.66 0 C-N-CA 125.313 1.445 . . . . 74.53 112.543 -162.085 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 50.2 t80 -49.37 -36.77 22.61 Favored 'General case' 0 CA--C 1.552 1.042 0 O-C-N 124.598 1.186 . . . . 72.25 112.695 -170.236 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 54.3 m -88.11 108.23 19.15 Favored 'General case' 0 CA--C 1.545 0.782 0 C-N-CA 122.957 0.503 . . . . 71.31 110.522 176.147 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 31.8 mtp180 58.73 53.87 5.64 Favored 'General case' 0 N--CA 1.479 0.993 0 C-N-CA 124.963 1.305 . . . . 73.32 111.657 172.797 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 10.0 p80 -63.34 -13.17 36.16 Favored 'General case' 0 N--CA 1.482 1.172 0 N-CA-C 114.233 1.197 . . . . 74.35 114.233 -173.874 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 6.6 t30 -68.61 84.84 0.29 Allowed 'General case' 0 CA--C 1.552 1.049 0 C-N-CA 123.253 0.621 . . . . 65.14 110.159 179.163 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 64.47 13.95 56.19 Favored Glycine 0 C--N 1.353 1.506 0 N-CA-C 115.62 1.008 . . . . 54.31 115.62 176.397 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 73' ' ' THR . . . . . 0.406 ' O ' ' HG3' ' A' ' 111' ' ' GLN . 6.9 m -125.0 -68.01 0.87 Allowed 'General case' 0 N--CA 1.476 0.851 0 N-CA-C 109.188 -0.671 . . . . 72.24 109.188 -178.228 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 57.3 50.45 64.59 Favored Glycine 0 C--N 1.353 1.515 0 O-C-N 124.559 1.162 . . . . 74.31 115.141 171.66 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 128.83 50.81 0.13 Allowed Glycine 0 C--N 1.35 1.335 0 CA-C-N 117.833 0.817 . . . . 54.44 113.281 178.837 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 14.1 ptmm? -64.27 165.6 9.26 Favored 'General case' 0 N--CA 1.482 1.15 0 C-N-CA 123.133 0.573 . . . . 73.43 112.338 -179.042 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 84.0 p -92.77 173.8 7.58 Favored 'General case' 0 N--CA 1.472 0.655 0 CA-C-N 115.893 -0.594 . . . . 72.44 111.392 -172.811 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 78' ' ' ILE . . . . . 0.541 HG21 ' HB3' ' A' ' 38' ' ' ALA . 23.1 pt -81.0 -20.99 11.13 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.609 0 CA-C-N 115.856 -0.611 . . . . 74.54 109.877 172.638 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 79' ' ' TYR . . . . . 0.427 ' HE2' ' HB2' ' A' ' 35' ' ' ASN . 64.0 m-85 -86.62 12.53 10.37 Favored 'General case' 0 CA--C 1.546 0.821 0 C-N-CA 123.767 0.827 . . . . 71.22 110.134 175.683 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 121.17 -152.5 16.79 Favored Glycine 0 C--N 1.354 1.549 0 C-N-CA 123.126 0.393 . . . . 62.02 112.784 171.203 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 34.3 tt0 -52.13 -53.24 45.21 Favored 'General case' 0 N--CA 1.471 0.597 0 C-N-CA 124.816 1.246 . . . . 72.45 109.396 171.993 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 82' ' ' LYS . . . . . 0.676 ' HD2' ' HA ' ' A' ' 107' ' ' THR . 20.7 pttp -169.52 156.06 6.46 Favored 'General case' 0 CA--C 1.548 0.888 0 CA-C-N 114.549 -1.205 . . . . 62.13 109.697 -178.319 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 9.7 p90 -131.68 174.78 9.77 Favored 'General case' 0 N--CA 1.48 1.029 0 C-N-CA 124.341 1.056 . . . . 65.21 110.57 -179.943 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 84' ' ' GLU . . . . . 0.542 ' HA ' ' HA ' ' A' ' 106' ' ' ASN . 0.0 OUTLIER -70.98 168.68 16.51 Favored 'General case' 0 N--CA 1.479 0.992 0 CA-C-N 115.759 -0.655 . . . . 73.14 111.582 -179.483 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 56.6 m-20 -80.58 111.39 16.95 Favored 'General case' 0 N--CA 1.47 0.571 0 N-CA-C 108.289 -1.004 . . . . 74.15 108.289 173.839 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 3.9 tp10 -46.98 -53.27 12.73 Favored 'General case' 0 N--CA 1.481 1.097 0 C-N-CA 124.895 1.278 . . . . 73.45 112.636 -175.0 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 87' ' ' ASN . . . . . 0.409 ' OD1' HG21 ' A' ' 127' ' ' VAL . 32.3 p30 -159.6 -165.62 1.58 Allowed 'General case' 0 N--CA 1.473 0.683 0 C-N-CA 123.62 0.768 . . . . 73.13 109.589 -176.17 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 93.7 m-85 -137.27 29.8 2.72 Favored 'General case' 0 N--CA 1.485 1.284 0 C-N-CA 123.868 0.867 . . . . 52.53 110.274 176.004 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 65.9 mt -60.07 -49.77 82.77 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.247 0 CA-C-O 121.866 0.841 . . . . 75.31 109.791 176.482 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 90' ' ' LEU . . . . . 0.622 ' HB3' ' HB ' ' A' ' 128' ' ' VAL . 92.3 mt -96.23 99.63 11.33 Favored 'General case' 0 C--O 1.237 0.436 0 CA-C-N 114.565 -1.198 . . . . 63.45 110.102 -175.969 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 8.7 mtpm? -76.31 149.7 37.02 Favored 'General case' 0 CA--C 1.543 0.69 0 C-N-CA 123.567 0.747 . . . . 75.1 110.204 176.771 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 92' ' ' HIS . . . . . . . . . . . . . 18.2 t-80 -87.43 28.45 0.97 Allowed 'General case' 0 N--CA 1.482 1.126 0 C-N-CA 124.21 1.004 . . . . 70.53 111.368 -169.412 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 14.5 t -99.87 16.46 23.69 Favored 'General case' 0 CA--C 1.552 1.051 0 C-N-CA 123.819 0.848 . . . . 60.21 111.628 -166.996 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -113.17 161.12 12.79 Favored Glycine 0 CA--C 1.534 1.255 0 CA-C-O 119.443 -0.643 . . . . 72.52 112.1 176.937 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 86.7 Cg_endo -83.4 154.2 14.04 Favored 'Trans proline' 0 C--N 1.367 1.544 0 C-N-CA 122.816 2.344 . . . . 74.54 111.957 171.408 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 71.12 19.76 77.49 Favored Glycine 0 C--N 1.35 1.312 0 N-CA-C 113.8 0.28 . . . . 50.33 113.8 -179.944 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 97' ' ' ILE . . . . . 0.429 HG23 HG13 ' A' ' 128' ' ' VAL . 24.6 mm -77.27 125.15 36.81 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.808 0 C-N-CA 123.231 0.612 . . . . 75.21 112.042 -175.65 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 98' ' ' LEU . . . . . 0.68 ' HG ' HG12 ' A' ' 114' ' ' ILE . 7.3 mp -93.11 123.2 36.21 Favored 'General case' 0 C--O 1.241 0.612 0 C-N-CA 123.709 0.804 . . . . 72.44 109.735 168.038 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 25.9 m -139.96 144.14 36.9 Favored 'General case' 0 N--CA 1.474 0.747 0 N-CA-C 107.737 -1.209 . . . . 61.33 107.737 168.876 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 100' ' ' MET . . . . . 0.549 ' HA ' ' HA ' ' A' ' 112' ' ' PHE . 72.1 mtp -75.44 142.28 43.02 Favored 'General case' 0 N--CA 1.482 1.157 0 N-CA-C 108.842 -0.799 . . . . 74.12 108.842 177.668 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 101' ' ' ALA . . . . . 0.631 ' HB3' ' HB2' ' A' ' 111' ' ' GLN . . . -73.97 140.32 45.45 Favored 'General case' 0 C--O 1.24 0.58 0 CA-C-O 121.362 0.601 . . . . 63.11 112.343 -166.805 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 28.6 p-10 -151.8 154.7 36.73 Favored 'General case' 0 C--O 1.237 0.398 0 CA-C-N 114.734 -1.121 . . . . 65.14 109.416 179.444 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -105.27 5.45 32.02 Favored 'General case' 0 CA--C 1.537 0.46 0 CA-C-N 115.538 -0.755 . . . . 75.15 110.261 170.589 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 162.07 -174.3 38.51 Favored Glycine 0 C--N 1.35 1.317 0 CA-C-O 119.661 -0.521 . . . . 53.44 112.387 179.577 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 77.5 Cg_exo -55.39 138.92 81.26 Favored 'Trans proline' 0 C--N 1.374 1.883 0 C-N-CA 123.663 2.909 . . . . 72.03 113.218 175.219 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 106' ' ' ASN . . . . . 0.542 ' HA ' ' HA ' ' A' ' 84' ' ' GLU . 63.9 t30 68.29 10.87 8.11 Favored 'General case' 0 N--CA 1.487 1.399 0 C-N-CA 125.277 1.431 . . . . 64.52 111.64 177.826 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 107' ' ' THR . . . . . 0.676 ' HA ' ' HD2' ' A' ' 82' ' ' LYS . 3.1 m -104.65 -11.64 16.8 Favored 'General case' 0 CA--C 1.552 1.051 0 C-N-CA 123.728 0.811 . . . . 71.42 110.129 176.99 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 10.5 t30 -56.15 139.77 46.36 Favored 'General case' 0 N--CA 1.48 1.043 0 C-N-CA 124.988 1.315 . . . . 65.03 111.651 172.428 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 112.52 3.05 25.74 Favored Glycine 0 N--CA 1.471 1.026 0 CA-C-O 119.924 -0.376 . . . . 60.32 113.137 176.197 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 15.3 p -114.19 122.35 46.54 Favored 'General case' 0 CA--C 1.542 0.648 0 N-CA-C 108.395 -0.965 . . . . 73.51 108.395 172.272 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 111' ' ' GLN . . . . . 0.631 ' HB2' ' HB3' ' A' ' 101' ' ' ALA . 41.0 mt-30 66.03 168.86 0.22 Allowed 'General case' 0 N--CA 1.496 1.846 0 C-N-CA 124.746 1.218 . . . . 73.33 112.416 -175.728 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 112' ' ' PHE . . . . . 0.549 ' HA ' ' HA ' ' A' ' 100' ' ' MET . 51.4 p90 -137.02 140.47 42.12 Favored 'General case' 0 N--CA 1.476 0.827 0 N-CA-C 108.153 -1.054 . . . . 74.42 108.153 168.341 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 113' ' ' PHE . . . . . 0.409 ' HE2' ' HA ' ' A' ' 101' ' ' ALA . 54.4 p90 -128.1 150.02 50.15 Favored 'General case' 0 N--CA 1.471 0.624 0 C-N-CA 122.899 0.48 . . . . 70.35 111.832 179.881 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 114' ' ' ILE . . . . . 0.68 HG12 ' HG ' ' A' ' 98' ' ' LEU . 14.0 mt -120.95 117.9 54.52 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.654 0 CA-C-N 115.12 -0.945 . . . . 72.42 108.666 173.943 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 115' ' ' CYS . . . . . . . . . . . . . 58.8 m -94.77 110.41 22.27 Favored 'General case' 0 C--O 1.24 0.596 0 N-CA-C 108.311 -0.996 . . . . 73.41 108.311 173.891 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 116' ' ' THR . . . . . 0.459 HG21 ' HA ' ' A' ' 140' ' ' GLU . 72.5 p -71.03 -31.52 68.02 Favored 'General case' 0 N--CA 1.479 0.989 0 C-N-CA 122.51 0.324 . . . . 74.25 111.719 -175.28 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -97.25 163.67 12.81 Favored 'General case' 0 N--CA 1.479 1.004 0 N-CA-C 109.164 -0.68 . . . . 70.42 109.164 168.155 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 118' ' ' LYS . . . . . 0.47 ' HE2' ' HB3' ' A' ' 120' ' ' GLU . 0.0 OUTLIER -70.84 124.71 24.96 Favored 'General case' 0 C--N 1.347 0.466 0 N-CA-C 109.233 -0.654 . . . . 72.43 109.233 175.914 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 119' ' ' THR . . . . . 0.6 ' HB ' HD13 ' A' ' 122' ' ' LEU . 23.0 p -113.02 88.11 2.75 Favored 'General case' 0 C--O 1.238 0.462 0 CA-C-O 121.864 0.84 . . . . 73.24 109.055 179.138 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 120' ' ' GLU . . . . . 0.47 ' HB3' ' HE2' ' A' ' 118' ' ' LYS . 10.5 pt-20 -67.87 -27.16 66.44 Favored 'General case' 0 N--CA 1.478 0.965 0 CA-C-N 114.254 -1.339 . . . . 72.44 112.485 -178.009 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 121' ' ' TRP . . . . . . . . . . . . . 32.5 p90 -78.12 -1.02 30.49 Favored 'General case' 0 N--CA 1.479 1.014 0 C-N-CA 122.768 0.427 . . . . 74.32 111.113 178.49 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 122' ' ' LEU . . . . . 0.6 HD13 ' HB ' ' A' ' 119' ' ' THR . 9.3 mp -96.63 5.7 50.18 Favored 'General case' 0 N--CA 1.48 1.049 0 C-N-CA 123.904 0.882 . . . . 64.13 111.168 171.639 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 25.0 m-20 -72.62 141.12 48.33 Favored 'General case' 0 N--CA 1.481 1.09 0 N-CA-C 109.462 -0.57 . . . . 61.51 109.462 168.879 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 92.98 -28.31 9.68 Favored Glycine 0 N--CA 1.478 1.451 0 N-CA-C 111.759 -0.536 . . . . 71.3 111.759 -173.019 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 1.5 mppt? -73.65 -164.32 0.21 Allowed 'General case' 0 N--CA 1.481 1.084 0 C-N-CA 124.584 1.154 . . . . 65.25 109.538 168.585 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 126' ' ' HIS . . . . . . . . . . . . . 36.2 t60 -66.08 132.94 49.69 Favored 'General case' 0 CA--C 1.542 0.669 0 CA-C-O 121.638 0.733 . . . . 63.31 112.207 -170.853 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 127' ' ' VAL . . . . . 0.409 HG21 ' OD1' ' A' ' 87' ' ' ASN . 7.1 p -59.42 146.64 9.36 Favored 'Isoleucine or valine' 0 CA--C 1.554 1.103 0 CA-C-N 113.797 -1.547 . . . . 73.44 111.155 177.185 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 128' ' ' VAL . . . . . 0.622 ' HB ' ' HB3' ' A' ' 90' ' ' LEU . 42.1 t -62.44 147.05 11.97 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.795 0 C-N-CA 123.686 0.794 . . . . 45.34 110.333 179.625 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 129' ' ' PHE . . . . . 0.566 ' HA ' HG21 ' A' ' 29' ' ' VAL . 36.7 p90 -120.16 -28.83 5.01 Favored 'General case' 0 N--CA 1.476 0.87 0 C-N-CA 122.565 0.346 . . . . 74.05 110.277 170.575 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . -146.09 168.73 27.59 Favored Glycine 0 C--N 1.346 1.112 0 O-C-N 123.525 0.516 . . . . 74.45 112.798 -172.371 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 29.0 ttpt -152.76 134.6 14.69 Favored 'General case' 0 N--CA 1.47 0.541 0 N-CA-C 108.167 -1.049 . . . . 62.34 108.167 -177.611 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 132' ' ' VAL . . . . . 0.486 HG11 ' HA ' ' A' ' 136' ' ' MET . 7.3 t -66.62 109.95 1.36 Allowed 'Isoleucine or valine' 0 CA--C 1.542 0.671 0 N-CA-C 109.433 -0.58 . . . . 65.22 109.433 176.799 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 14.4 ptmm? -87.02 -39.52 15.57 Favored 'General case' 0 N--CA 1.481 1.104 0 N-CA-C 110.134 -0.321 . . . . 73.33 110.134 -178.269 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 134' ' ' GLU . . . . . 0.403 ' HB2' ' OG ' ' A' ' 21' ' ' SER . 20.6 mm-40 -144.53 162.13 37.35 Favored 'General case' 0 N--CA 1.488 1.471 0 C-N-CA 124.711 1.204 . . . . 61.32 108.693 173.316 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 135' ' ' GLY . . . . . 0.467 ' HA3' ' HA ' ' A' ' 20' ' ' VAL . . . 78.7 15.14 81.24 Favored Glycine 0 C--N 1.346 1.125 0 O-C-N 123.349 0.406 . . . . 71.32 112.177 -173.715 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 136' ' ' MET . . . . . 0.486 ' HA ' HG11 ' A' ' 132' ' ' VAL . 15.2 tpt -62.92 -34.38 77.32 Favored 'General case' 0 N--CA 1.472 0.626 0 C-N-CA 124.462 1.105 . . . . 72.12 111.808 -177.047 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 137' ' ' ASN . . . . . . . . . . . . . 27.3 t-20 -61.78 -35.84 79.34 Favored 'General case' 0 N--CA 1.48 1.069 0 C-N-CA 123.455 0.702 . . . . 73.22 111.164 177.571 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 138' ' ' ILE . . . . . . . . . . . . . 43.4 mm -71.12 -33.22 50.43 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.088 0 C-N-CA 123.402 0.681 . . . . 62.14 110.679 179.642 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 139' ' ' VAL . . . . . 0.422 HG11 HG21 ' A' ' 114' ' ' ILE . 62.0 t -69.76 -44.87 78.79 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.999 0 C-N-CA 123.407 0.683 . . . . 72.12 110.518 176.306 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 140' ' ' GLU . . . . . 0.459 ' HA ' HG21 ' A' ' 116' ' ' THR . 40.0 mt-10 -63.82 -33.58 75.99 Favored 'General case' 0 N--CA 1.476 0.855 0 CA-C-N 115.476 -0.784 . . . . 73.31 110.534 176.882 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -70.37 -43.84 69.3 Favored 'General case' 0 C--O 1.24 0.594 0 C-N-CA 123.662 0.785 . . . . 75.31 111.307 178.124 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 142' ' ' MET . . . . . 0.515 ' HB2' HD13 ' A' ' 156' ' ' ILE . 22.4 ptt? -69.52 -34.09 73.75 Favored 'General case' 0 C--N 1.355 0.843 0 CA-C-N 116.84 -0.164 . . . . 65.3 110.929 -175.691 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 143' ' ' GLU . . . . . 0.413 ' HG2' ' HA ' ' A' ' 58' ' ' PRO . 30.9 tt0 -62.87 -28.99 70.42 Favored 'General case' 0 CA--C 1.559 1.294 0 C-N-CA 122.722 0.409 . . . . 72.45 111.462 -178.968 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 144' ' ' ARG . . . . . 0.482 ' HA ' ' HB3' ' A' ' 58' ' ' PRO . 58.6 mtp85 -68.72 -19.47 64.36 Favored 'General case' 0 N--CA 1.485 1.295 0 C-N-CA 123.589 0.756 . . . . 61.13 112.242 -179.091 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 145' ' ' PHE . . . . . 0.529 ' HB2' HD11 ' A' ' 156' ' ' ILE . 56.6 m-85 -79.95 -8.15 59.18 Favored 'General case' 0 N--CA 1.477 0.897 0 C-N-CA 122.807 0.443 . . . . 71.43 111.321 179.328 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . -78.14 179.59 51.47 Favored Glycine 0 C--N 1.345 1.029 0 O-C-N 123.348 0.405 . . . . 53.44 112.751 172.585 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 46.0 t -133.7 168.4 18.77 Favored 'General case' 0 N--CA 1.476 0.834 0 C-N-CA 123.773 0.829 . . . . 60.45 110.148 -176.893 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 148' ' ' ARG . . . . . . . . . . . . . 18.4 mmm180 -58.55 -37.01 74.82 Favored 'General case' 0 N--CA 1.481 1.107 0 C-N-CA 123.81 0.844 . . . . 73.23 111.863 178.527 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 149' ' ' ASN . . . . . . . . . . . . . 30.2 p-10 -89.78 11.69 19.36 Favored 'General case' 0 N--CA 1.483 1.203 0 C-N-CA 123.217 0.607 . . . . 74.32 112.201 -178.614 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . 86.08 -2.8 87.61 Favored Glycine 0 C--N 1.349 1.277 0 CA-C-O 119.732 -0.482 . . . . 45.04 114.031 177.421 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 35.7 ttmt -63.73 130.79 45.65 Favored 'General case' 0 N--CA 1.474 0.756 0 C-N-CA 123.792 0.837 . . . . 70.14 110.736 179.988 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 152' ' ' THR . . . . . . . . . . . . . 82.2 p -91.91 108.84 20.21 Favored 'General case' 0 C--O 1.239 0.504 0 N-CA-C 108.069 -1.085 . . . . 72.2 108.069 170.388 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 153' ' ' SER . . . . . . . . . . . . . 49.4 m -68.32 -28.92 67.58 Favored 'General case' 0 N--CA 1.473 0.712 0 C-N-CA 123.073 0.549 . . . . 75.22 110.532 177.789 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 154' ' ' LYS . . . . . 0.467 ' HB3' HG13 ' A' ' 12' ' ' VAL . 74.4 mmtt -117.11 139.83 50.26 Favored 'General case' 0 C--O 1.241 0.621 0 C-N-CA 124.155 0.982 . . . . 71.2 109.717 177.277 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 155' ' ' LYS . . . . . 0.457 ' HD3' ' SG ' ' A' ' 52' ' ' CYS . 17.4 tppt? -78.56 89.58 4.5 Favored 'General case' 0 CA--C 1.541 0.603 0 N-CA-C 109.016 -0.735 . . . . 71.42 109.016 179.926 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 156' ' ' ILE . . . . . 0.529 HD11 ' HB2' ' A' ' 145' ' ' PHE . 72.5 mt -86.58 117.53 31.16 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.321 0 CA-C-N 115.503 -0.771 . . . . 75.11 109.051 -177.422 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 157' ' ' THR . . . . . . . . . . . . . 25.1 p -130.88 153.62 48.94 Favored 'General case' 0 C--O 1.238 0.478 0 C-N-CA 124.8 1.24 . . . . 61.23 109.484 -171.898 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 158' ' ' ILE . . . . . 0.46 HD11 ' HZ ' ' A' ' 112' ' ' PHE . 67.7 mt -76.19 93.78 1.05 Allowed 'Isoleucine or valine' 0 CA--C 1.547 0.848 0 N-CA-C 108.633 -0.877 . . . . 64.35 108.633 172.094 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 159' ' ' ALA . . . . . 0.851 ' HB2' ' HB2' ' A' ' 11' ' ' ALA . . . -51.31 -53.03 39.95 Favored 'General case' 0 N--CA 1.483 1.185 0 C-N-CA 123.729 0.812 . . . . 34.43 111.707 -178.899 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 160' ' ' ASP . . . . . . . . . . . . . 1.5 t70 -151.18 176.61 11.02 Favored 'General case' 0 CA--C 1.548 0.897 0 CA-C-N 115.827 -0.624 . . . . 65.44 109.818 -178.557 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 161' ' ' CYS . . . . . . . . . . . . . 9.8 p -148.51 -171.69 3.91 Favored 'General case' 0 N--CA 1.477 0.905 0 C-N-CA 124.459 1.104 . . . . 74.23 109.9 -172.399 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 162' ' ' GLY . . . . . . . . . . . . . . . 131.23 53.39 0.09 OUTLIER Glycine 0 C--N 1.353 1.519 0 N-CA-C 112.238 -0.345 . . . . 52.25 112.238 -172.782 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 163' ' ' GLN . . . . . 0.439 ' HA ' ' H ' ' A' ' 7' ' ' PHE . 27.5 tt0 -46.74 107.08 0.1 Allowed 'General case' 0 CA--C 1.559 1.289 0 C-N-CA 125.234 1.414 . . . . 71.44 112.888 179.953 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 164' ' ' LEU . . . . . 0.486 ' O ' ' HB ' ' A' ' 5' ' ' THR . 84.5 mt -87.37 100.54 12.81 Favored 'General case' 0 N--CA 1.475 0.795 0 C-N-CA 123.898 0.879 . . . . 72.44 109.85 -175.246 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 165' ' ' GLU . . . . . . . . . . . . . 11.4 pt-20 . . . . . 0 N--CA 1.486 1.34 0 CA-C-O 118.945 -0.55 . . . . 75.43 110.68 177.947 . . . . . . . . 0 0 . 1 . 005 nuclear build full ' B' B ' 216' ' ' PRO . . . . . . . . . . . . . 2.1 Cg_endo . . . . . 0 CA--C 1.542 0.9 0 N-CA-C 110.255 -0.71 . . . . 75.02 110.255 . . . . . . . . . 0 0 . 1 . 005 nuclear build full ' B' B ' 217' ' ' GLU . . . . . . . . . . . . . 42.9 mt-10 -115.84 162.93 22.97 Favored Pre-proline 0 CA--C 1.545 0.779 0 C-N-CA 124.867 1.267 . . . . 73.54 109.196 178.647 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 218' ' ' PRO . . . . . . . . . . . . . 14.7 Cg_exo -68.54 92.03 0.41 Allowed 'Trans proline' 0 C--N 1.376 2.015 0 C-N-CA 121.818 1.679 . . . . 71.14 108.847 163.865 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 219' ' ' GLY . . . . . . . . . . . . . . . 160.18 156.91 8.37 Favored Glycine 0 CA--C 1.533 1.165 0 CA-C-N 115.753 -0.658 . . . . 74.21 112.057 -175.59 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 220' ' ' PRO . . . . . . . . . . . . . 36.3 Cg_endo -86.23 -179.22 3.07 Favored 'Trans proline' 0 C--N 1.365 1.433 0 C-N-CA 123.753 2.968 . . . . 74.14 113.86 -176.288 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 221' ' ' TYR . . . . . . . . . . . . . 97.0 m-85 -100.38 138.01 38.04 Favored 'General case' 0 N--CA 1.48 1.053 0 C-N-CA 123.333 0.653 . . . . 75.34 111.868 -175.14 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 222' ' ' ALA . . . . . . . . . . . . . . . -81.5 -169.96 2.56 Favored 'General case' 0 N--CA 1.477 0.911 0 C-N-CA 124.829 1.252 . . . . 72.11 112.44 175.791 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 223' ' ' GLN . . . . . . . . . . . . . 9.9 mp0 -53.38 116.23 9.23 Favored Pre-proline 0 CA--C 1.556 1.176 0 C-N-CA 123.934 0.894 . . . . 72.23 108.952 170.871 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 224' ' ' PRO . . . . . . . . . . . . . 5.7 Cg_exo . . . . . 0 C--N 1.38 2.187 0 C-N-CA 122.486 2.124 . . . . 73.31 112.036 -176.009 . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 51.3 ttp . . . . . 0 N--CA 1.478 0.939 0 N-CA-C 109.791 -0.448 . . . . 64.41 109.791 . . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 27.0 m -83.75 -19.68 9.43 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.19 0 C-N-CA 123.82 0.848 . . . . 64.15 111.542 -179.113 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 3' ' ' ASN . . . . . 0.445 ' OD1' ' HA ' ' A' ' 25' ' ' PHE . 21.1 m-80 -84.38 118.48 71.25 Favored Pre-proline 0 CA--C 1.545 0.785 0 C-N-CA 123.852 0.861 . . . . 74.34 110.066 -177.66 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 4' ' ' PRO . . . . . 0.51 ' HG2' ' HB2' ' A' ' 24' ' ' LEU . 73.3 Cg_endo -77.48 150.35 28.19 Favored 'Trans proline' 0 C--N 1.374 1.907 0 C-N-CA 122.392 2.061 . . . . 75.11 111.575 170.559 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 5' ' ' THR . . . . . 0.445 ' HB ' ' O ' ' A' ' 164' ' ' LEU . 52.5 m -98.04 142.54 29.63 Favored 'General case' 0 CA--C 1.54 0.566 0 N-CA-C 108.932 -0.766 . . . . 71.54 108.932 175.168 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 6' ' ' VAL . . . . . 0.706 ' HA ' ' HG3' ' A' ' 163' ' ' GLN . 44.1 t -101.76 150.44 6.1 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.967 0 N-CA-C 107.689 -1.226 . . . . 74.31 107.689 171.125 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 7' ' ' PHE . . . . . 0.433 ' H ' ' HA ' ' A' ' 163' ' ' GLN . 74.2 t80 -133.55 130.77 38.9 Favored 'General case' 0 C--O 1.236 0.37 0 N-CA-C 109.531 -0.544 . . . . 74.51 109.531 175.962 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 8' ' ' PHE . . . . . 0.401 ' HD2' ' HE2' ' A' ' 22' ' ' PHE . 32.3 m-85 -138.2 166.49 24.03 Favored 'General case' 0 C--O 1.237 0.418 0 C-N-CA 124.808 1.243 . . . . 73.31 109.362 170.248 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 9' ' ' ASP . . . . . 0.401 ' HB2' ' H ' ' A' ' 160' ' ' ASP . 8.7 m-20 -117.27 112.19 20.43 Favored 'General case' 0 N--CA 1.468 0.463 0 CA-C-N 114.847 -1.069 . . . . 64.44 108.126 171.555 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 10' ' ' ILE . . . . . 0.447 HG21 ' SD ' ' A' ' 142' ' ' MET . 45.8 mm -83.33 128.57 38.64 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.453 0 N-CA-C 108.673 -0.862 . . . . 74.42 108.673 178.91 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 11' ' ' ALA . . . . . 0.655 ' HB2' ' HB2' ' A' ' 159' ' ' ALA . . . -129.97 141.1 50.81 Favored 'General case' 0 N--CA 1.471 0.614 0 C-N-CA 123.749 0.82 . . . . 50.32 110.58 -173.1 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 12' ' ' VAL . . . . . 0.541 HG13 ' HB3' ' A' ' 154' ' ' LYS . 86.2 t -97.17 110.89 25.93 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.435 0 C-N-CA 124.173 0.989 . . . . 63.34 108.848 173.533 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 9.9 m-20 58.98 24.29 12.47 Favored 'General case' 0 N--CA 1.485 1.31 0 C-N-CA 124.8 1.24 . . . . 75.4 112.651 179.919 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 106.13 -24.2 27.03 Favored Glycine 0 C--N 1.349 1.304 0 CA-C-O 119.681 -0.511 . . . . 64.22 113.006 179.658 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 24.7 mm-40 -81.78 120.28 77.35 Favored Pre-proline 0 N--CA 1.479 0.991 0 CA-C-O 118.449 -0.786 . . . . 74.44 109.327 179.994 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 19.1 Cg_endo -57.72 114.65 2.05 Favored 'Trans proline' 0 C--N 1.379 2.158 0 C-N-CA 123.107 2.538 . . . . 73.44 112.498 -177.114 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 17' ' ' LEU . . . . . 0.5 ' HB2' HG23 ' A' ' 12' ' ' VAL . 52.0 tp -79.43 -41.8 26.81 Favored 'General case' 0 N--CA 1.478 0.963 0 C-N-CA 123.735 0.814 . . . . 72.21 110.058 175.765 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -177.69 174.49 46.93 Favored Glycine 0 C--N 1.344 1.024 0 CA-C-N 115.711 -0.677 . . . . 63.5 113.395 179.955 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 19.9 mtp180 -111.2 117.5 33.39 Favored 'General case' 0 N--CA 1.471 0.611 0 N-CA-C 108.456 -0.942 . . . . 75.13 108.456 -175.925 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 86.2 t -113.37 138.48 42.82 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.733 0 C-N-CA 123.78 0.832 . . . . 73.45 110.12 -175.263 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 16.4 m -124.94 135.22 52.62 Favored 'General case' 0 C--O 1.242 0.67 0 C-N-CA 123.661 0.785 . . . . 75.45 110.114 174.901 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 22' ' ' PHE . . . . . 0.431 ' HB2' ' HB ' ' A' ' 6' ' ' VAL . 60.5 m-85 -105.78 170.0 8.15 Favored 'General case' 0 N--CA 1.474 0.765 0 C-N-CA 124.145 0.978 . . . . 64.23 109.912 179.079 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 23' ' ' GLU . . . . . 0.631 ' HB2' ' HD2' ' A' ' 133' ' ' LYS . 33.0 tt0 -130.76 108.89 10.2 Favored 'General case' 0 N--CA 1.473 0.692 0 C-N-CA 123.689 0.796 . . . . 74.35 109.233 177.948 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 24' ' ' LEU . . . . . 0.51 ' HB2' ' HG2' ' A' ' 4' ' ' PRO . 88.5 mt -78.54 121.0 24.04 Favored 'General case' 0 N--CA 1.469 0.481 0 C-N-CA 123.377 0.671 . . . . 75.34 109.961 179.149 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 25' ' ' PHE . . . . . 0.445 ' HA ' ' OD1' ' A' ' 3' ' ' ASN . 77.7 m-85 -83.85 68.25 9.88 Favored 'General case' 0 C--O 1.233 0.206 0 CA-C-O 121.65 0.738 . . . . 62.11 109.465 171.904 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -66.21 -21.92 66.32 Favored 'General case' 0 N--CA 1.473 0.704 0 CA-C-N 114.708 -1.133 . . . . 44.15 111.128 179.032 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 10.7 p-10 -72.71 -23.61 60.88 Favored 'General case' 0 CA--C 1.543 0.701 0 C-N-CA 124.029 0.932 . . . . 63.33 111.478 178.292 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 59.5 mttp -104.6 -51.29 3.11 Favored 'General case' 0 N--CA 1.482 1.169 0 C-N-CA 123.613 0.765 . . . . 64.33 110.965 -176.536 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 29' ' ' VAL . . . . . 0.564 ' HA ' ' HG2' ' A' ' 86' ' ' GLU . 5.4 m -124.33 72.92 58.55 Favored Pre-proline 0 CA--C 1.55 0.95 0 C-N-CA 124.099 0.96 . . . . 72.33 110.185 -178.195 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 20.7 Cg_endo -60.7 -29.64 88.76 Favored 'Trans proline' 0 C--N 1.38 2.222 0 C-N-CA 122.671 2.247 . . . . 52.51 113.107 -177.072 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 21.9 ttmm -65.33 -54.12 33.73 Favored 'General case' 0 N--CA 1.481 1.111 0 CA-C-O 121.715 0.769 . . . . 62.44 111.556 -179.428 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 20.5 m -80.16 -32.17 38.87 Favored 'General case' 0 CA--C 1.547 0.842 0 CA-C-N 114.723 -1.126 . . . . 75.42 111.138 -170.244 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 33' ' ' ALA . . . . . 0.472 ' HB1' ' HB3' ' A' ' 24' ' ' LEU . . . -70.1 -40.82 74.7 Favored 'General case' 0 N--CA 1.473 0.692 0 C-N-CA 122.787 0.435 . . . . 73.3 110.222 174.609 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 9.3 tp10 -62.77 -40.75 98.24 Favored 'General case' 0 N--CA 1.488 1.467 0 O-C-N 123.668 0.605 . . . . 61.24 110.752 176.54 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 35' ' ' ASN . . . . . 0.484 ' O ' ' HG ' ' A' ' 39' ' ' LEU . 40.0 t30 -53.57 -62.91 1.35 Allowed 'General case' 0 C--N 1.349 0.577 0 O-C-N 124.293 0.996 . . . . 75.4 110.433 178.643 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 65.6 t80 -65.53 -33.96 77.13 Favored 'General case' 0 N--CA 1.474 0.743 0 CA-C-N 115.338 -0.846 . . . . 72.52 111.805 -176.167 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 37' ' ' ARG . . . . . 0.556 ' HG3' HE22 ' A' ' 163' ' ' GLN . 32.7 ttt180 -55.21 -49.67 71.34 Favored 'General case' 0 N--CA 1.485 1.293 0 C-N-CA 124.262 1.025 . . . . 62.43 110.728 173.655 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 38' ' ' ALA . . . . . 0.457 ' HB3' HG21 ' A' ' 78' ' ' ILE . . . -76.92 -25.94 53.52 Favored 'General case' 0 CA--C 1.544 0.741 0 CA-C-N 114.314 -1.312 . . . . 61.14 112.07 -174.921 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 39' ' ' LEU . . . . . 0.484 ' HG ' ' O ' ' A' ' 35' ' ' ASN . 95.4 mt -73.39 -40.26 64.45 Favored 'General case' 0 N--CA 1.479 1.022 0 C-N-CA 123.536 0.734 . . . . 65.4 110.2 173.297 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 40.3 t -65.42 -54.74 24.29 Favored 'General case' 0 N--CA 1.479 0.984 0 CA-C-N 114.42 -1.264 . . . . 71.21 110.592 -176.144 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 82.6 p -73.3 -32.09 64.42 Favored 'General case' 0 N--CA 1.472 0.637 0 CA-C-O 121.29 0.567 . . . . 70.1 109.737 177.253 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 42' ' ' GLY . . . . . 0.446 ' HA3' ' HA2' ' A' ' 47' ' ' GLY . . . 75.39 8.22 83.5 Favored Glycine 0 C--N 1.347 1.186 0 CA-C-N 115.221 -0.899 . . . . 64.21 114.886 171.832 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 47.8 mm-40 -69.07 -4.59 17.69 Favored 'General case' 0 N--CA 1.482 1.146 0 C-N-CA 123.804 0.842 . . . . 64.13 113.046 -178.018 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 44' ' ' LYS . . . . . 0.451 ' HG3' ' HB1' ' A' ' 38' ' ' ALA . 32.3 mmmt -94.0 13.44 22.89 Favored 'General case' 0 CA--C 1.55 0.976 0 C-N-CA 123.565 0.746 . . . . 72.14 111.462 172.356 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 92.52 22.99 27.5 Favored Glycine 0 C--N 1.357 1.709 0 N-CA-C 114.559 0.584 . . . . 32.5 114.559 173.231 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 25.9 m-85 -114.88 -46.71 2.91 Favored 'General case' 0 N--CA 1.487 1.42 0 CA-C-N 117.507 0.654 . . . . 70.42 111.279 -172.069 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 47' ' ' GLY . . . . . 0.446 ' HA2' ' HA3' ' A' ' 42' ' ' GLY . . . 53.84 63.68 4.91 Favored Glycine 0 C--N 1.346 1.109 0 O-C-N 124.096 0.873 . . . . 14.42 114.64 173.084 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 50.7 m-85 -71.71 84.81 0.9 Allowed 'General case' 0 N--CA 1.485 1.282 0 CA-C-O 122.119 0.962 . . . . 74.32 111.167 177.387 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 49' ' ' LYS . . . . . 0.558 ' HE3' ' HA ' ' A' ' 160' ' ' ASP . 22.2 tptm -116.3 138.56 51.22 Favored 'General case' 0 CA--C 1.538 0.51 0 CA-C-N 113.601 -1.636 . . . . 62.14 107.603 171.851 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 69.45 19.99 74.99 Favored Glycine 0 N--CA 1.478 1.477 0 CA-C-N 118.069 0.395 . . . . 70.04 114.001 177.161 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 25.1 m -70.21 119.34 14.26 Favored 'General case' 0 N--CA 1.471 0.603 0 C-N-CA 123.614 0.765 . . . . 62.42 110.137 -176.436 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 52' ' ' CYS . . . . . . . . . . . . . 21.2 p -90.93 157.54 17.25 Favored 'General case' 0 N--CA 1.474 0.767 0 CA-C-O 121.714 0.769 . . . . 61.15 111.876 -171.518 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 29.1 m-85 -96.25 164.94 12.45 Favored 'General case' 0 C--O 1.24 0.605 0 C-N-CA 124.998 1.319 . . . . 73.45 108.741 175.515 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 19.5 p-80 -149.36 -43.09 0.14 Allowed 'General case' 0 N--CA 1.477 0.897 0 N-CA-C 110.451 -0.203 . . . . 74.44 110.451 -171.222 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 55' ' ' ARG . . . . . 0.464 ' HA ' ' O ' ' A' ' 150' ' ' GLY . 42.2 ttt-85 -121.06 98.81 6.16 Favored 'General case' 0 C--N 1.347 0.49 0 N-CA-C 109.089 -0.708 . . . . 74.23 109.089 -174.578 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 57.0 mt -127.39 127.19 68.75 Favored 'Isoleucine or valine' 0 C--O 1.239 0.527 0 N-CA-C 107.778 -1.193 . . . . 74.25 107.778 176.966 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 68.4 mt -122.44 116.41 29.52 Favored Pre-proline 0 CA--C 1.55 0.967 0 N-CA-C 108.278 -1.008 . . . . 64.13 108.278 -177.386 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 31.0 Cg_exo -62.46 136.23 57.91 Favored 'Trans proline' 0 C--N 1.379 2.145 0 C-N-CA 123.313 2.675 . . . . 73.25 112.351 -179.346 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 78.86 22.72 65.66 Favored Glycine 0 C--N 1.344 1.019 0 O-C-N 123.78 0.675 . . . . 65.11 112.767 -176.202 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 60' ' ' PHE . . . . . 0.435 ' HB2' HE22 ' B' ' 223' ' ' GLN . 55.3 t80 -148.01 -69.26 0.23 Allowed 'General case' 0 CA--C 1.55 0.958 0 C-N-CA 123.476 0.71 . . . . 43.44 111.054 -175.058 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 61' ' ' MET . . . . . 0.433 ' SD ' ' HB2' ' A' ' 113' ' ' PHE . 40.5 ttm -175.97 158.16 1.99 Allowed 'General case' 0 N--CA 1.49 1.542 0 N-CA-C 113.245 0.832 . . . . 72.05 113.245 -159.582 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 62' ' ' CYS . . . . . 0.458 ' SG ' ' HB ' ' A' ' 114' ' ' ILE . 24.9 p -122.94 113.75 19.51 Favored 'General case' 0 CA--C 1.549 0.94 0 C-N-CA 124.197 0.999 . . . . 72.14 109.647 168.579 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 57.8 tt0 -112.72 127.48 56.15 Favored 'General case' 0 N--CA 1.489 1.485 0 C-N-CA 124.125 0.97 . . . . 75.14 110.37 -176.145 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -151.47 -157.47 7.9 Favored Glycine 0 C--N 1.348 1.214 0 CA-C-N 115.698 -0.683 . . . . 43.11 113.715 -177.476 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 86.27 -8.13 75.48 Favored Glycine 0 C--N 1.35 1.35 0 N-CA-C 112.04 -0.424 . . . . 53.22 112.04 -167.722 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 38.9 t70 -75.66 86.98 2.72 Favored 'General case' 0 C--N 1.354 0.775 0 C-N-CA 124.638 1.175 . . . . 52.23 109.925 -174.221 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 91.2 t80 -144.42 -55.09 0.34 Allowed 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 114.547 -1.206 . . . . 72.45 108.697 -176.667 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 5.7 t -84.81 122.75 29.59 Favored 'General case' 0 C--O 1.246 0.873 0 C-N-CA 123.146 0.578 . . . . 72.24 109.998 178.804 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 86.0 mtt180 53.85 51.75 14.26 Favored 'General case' 0 N--CA 1.48 1.041 0 C-N-CA 124.369 1.068 . . . . 73.01 109.851 -179.251 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 20.8 p80 -78.4 66.75 4.03 Favored 'General case' 0 CA--C 1.555 1.164 0 CA-C-O 122.32 1.057 . . . . 65.12 112.046 -168.841 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 8.3 t30 -155.08 79.46 1.05 Allowed 'General case' 0 C--O 1.24 0.596 0 N-CA-C 107.289 -1.375 . . . . 72.24 107.289 -177.213 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 72' ' ' GLY . . . . . 0.568 ' HA2' ' HG3' ' B' ' 218' ' ' PRO . . . 79.65 -6.96 56.75 Favored Glycine 0 CA--C 1.533 1.163 0 CA-C-N 115.039 -0.982 . . . . 45.22 113.838 -179.006 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 7.3 m -115.51 -78.77 0.58 Allowed 'General case' 0 CA--C 1.546 0.804 0 N-CA-C 108.132 -1.062 . . . . 71.22 108.132 -179.822 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 54.67 60.61 8.37 Favored Glycine 0 C--N 1.359 1.851 0 N-CA-C 114.59 0.596 . . . . 51.34 114.59 172.199 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 119.95 52.5 0.27 Allowed Glycine 0 N--CA 1.476 1.307 0 CA-C-N 117.716 0.758 . . . . 54.12 111.289 -175.452 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 17.4 pttp -63.08 169.61 3.3 Favored 'General case' 0 CA--C 1.547 0.828 0 C-N-CA 124.186 0.995 . . . . 73.13 112.393 -174.768 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 76.1 p -93.16 179.23 5.49 Favored 'General case' 0 C--O 1.246 0.887 0 CA-C-O 121.525 0.679 . . . . 74.21 112.254 -171.134 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 78' ' ' ILE . . . . . 0.457 HG21 ' HB3' ' A' ' 38' ' ' ALA . 34.1 pt -75.23 -20.1 16.21 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.784 0 CA-C-N 115.294 -0.867 . . . . 74.31 110.187 168.735 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 82.7 m-85 -87.93 18.49 4.14 Favored 'General case' 0 CA--C 1.547 0.832 0 C-N-CA 124.57 1.148 . . . . 64.25 110.433 177.006 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 99.02 -120.79 6.98 Favored Glycine 0 C--N 1.354 1.565 0 N-CA-C 111.071 -0.812 . . . . 74.21 111.071 -179.842 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 36.8 tt0 -71.98 -59.42 2.75 Favored 'General case' 0 N--CA 1.47 0.544 0 C-N-CA 123.265 0.626 . . . . 72.41 110.057 178.057 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 82' ' ' LYS . . . . . 0.825 ' HD2' ' HA ' ' A' ' 107' ' ' THR . 21.4 pttp -155.62 175.98 13.2 Favored 'General case' 0 CA--C 1.544 0.741 0 CA-C-N 115.372 -0.831 . . . . 73.2 110.821 -172.41 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 12.1 p90 -159.15 173.72 15.97 Favored 'General case' 0 CA--C 1.538 0.507 0 C-N-CA 124.918 1.287 . . . . 74.4 110.035 -175.063 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 84' ' ' GLU . . . . . 0.511 ' HA ' ' HA ' ' A' ' 106' ' ' ASN . 7.4 pt-20 -83.84 169.85 14.71 Favored 'General case' 0 N--CA 1.475 0.803 0 C-N-CA 123.527 0.731 . . . . 72.05 111.753 -179.864 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 41.1 m-20 -74.9 143.55 43.74 Favored 'General case' 0 N--CA 1.472 0.641 0 C-N-CA 123.739 0.816 . . . . 54.43 109.677 -179.845 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 86' ' ' GLU . . . . . 0.564 ' HG2' ' HA ' ' A' ' 29' ' ' VAL . 7.9 tp10 -66.13 -59.53 3.68 Favored 'General case' 0 N--CA 1.472 0.654 0 CA-C-O 121.769 0.795 . . . . 60.51 110.107 176.202 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 32.4 p30 -163.32 -159.83 0.56 Allowed 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 113.974 -1.466 . . . . 62.25 107.909 -179.935 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 96.2 m-85 -138.35 42.74 2.19 Favored 'General case' 0 N--CA 1.482 1.158 0 C-N-CA 122.981 0.512 . . . . 70.43 110.307 179.45 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 61.9 mt -67.59 -48.43 76.69 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.488 0 CA-C-O 121.214 0.53 . . . . 75.41 110.062 175.998 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 90' ' ' LEU . . . . . 0.561 ' HB3' ' HB ' ' A' ' 128' ' ' VAL . 82.6 mt -88.99 153.08 21.31 Favored 'General case' 0 C--O 1.241 0.632 0 CA-C-N 115.556 -0.747 . . . . 63.35 110.653 179.035 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 21.1 ptmt -150.43 168.49 24.0 Favored 'General case' 0 N--CA 1.472 0.637 0 CA-C-N 115.529 -0.76 . . . . 73.31 110.62 -179.59 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 92' ' ' HIS . . . . . . . . . . . . . 27.2 m80 -87.31 68.36 9.78 Favored 'General case' 0 CA--C 1.546 0.802 0 C-N-CA 124.035 0.934 . . . . 75.54 109.454 -172.855 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 8.8 t -114.34 7.13 16.31 Favored 'General case' 0 N--CA 1.477 0.918 0 CA-C-N 114.972 -1.013 . . . . 73.45 111.338 -172.611 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -150.2 173.75 29.79 Favored Glycine 0 C--N 1.347 1.153 0 CA-C-O 119.993 -0.337 . . . . 52.13 113.137 -176.2 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 98.2 Cg_endo -85.15 155.96 11.14 Favored 'Trans proline' 0 C--N 1.368 1.579 0 C-N-CA 123.103 2.535 . . . . 63.14 112.379 174.066 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 76.18 19.09 78.87 Favored Glycine 0 N--CA 1.476 1.301 0 CA-C-N 116.481 -0.327 . . . . 63.23 113.581 178.613 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 97' ' ' ILE . . . . . 0.555 ' HB ' ' HB2' ' A' ' 115' ' ' CYS . 13.3 mm -76.34 105.45 5.26 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.907 0 C-N-CA 123.833 0.853 . . . . 74.31 111.42 -174.872 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 60.8 tp -90.62 119.42 30.85 Favored 'General case' 0 CA--C 1.549 0.941 0 C-N-CA 123.084 0.554 . . . . 74.43 110.002 176.694 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 47.2 t -143.91 148.9 36.05 Favored 'General case' 0 CA--C 1.545 0.778 0 C-N-CA 124.388 1.075 . . . . 74.22 108.576 179.126 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 100' ' ' MET . . . . . 0.451 ' HA ' ' HA ' ' A' ' 112' ' ' PHE . 57.0 mtp -82.84 147.24 28.45 Favored 'General case' 0 N--CA 1.488 1.432 0 CA-C-N 118.201 0.455 . . . . 72.31 110.535 179.819 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -76.41 145.55 39.28 Favored 'General case' 0 C--O 1.243 0.743 0 C-N-CA 122.888 0.475 . . . . 75.13 112.169 -172.248 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 20.4 p-10 -153.89 149.22 27.1 Favored 'General case' 0 C--O 1.241 0.616 0 C-N-CA 124.292 1.037 . . . . 71.41 108.7 177.894 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -87.37 -34.41 18.81 Favored 'General case' 0 N--CA 1.474 0.732 0 N-CA-C 109.477 -0.564 . . . . 74.34 109.477 169.895 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -158.71 -166.72 18.34 Favored Glycine 0 C--N 1.342 0.909 0 CA-C-N 115.387 -0.824 . . . . 24.24 111.292 174.236 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 33.7 Cg_exo -60.78 151.28 78.05 Favored 'Trans proline' 0 C--N 1.369 1.637 0 C-N-CA 122.797 2.331 . . . . 62.4 111.847 178.357 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 106' ' ' ASN . . . . . 0.511 ' HA ' ' HA ' ' A' ' 84' ' ' GLU . 65.0 t30 65.83 16.96 10.7 Favored 'General case' 0 CA--C 1.561 1.38 0 C-N-CA 124.758 1.223 . . . . 72.2 111.343 178.78 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 107' ' ' THR . . . . . 0.825 ' HA ' ' HD2' ' A' ' 82' ' ' LYS . 5.1 m -118.89 7.19 11.46 Favored 'General case' 0 N--CA 1.485 1.286 0 C-N-CA 123.968 0.907 . . . . 70.54 110.387 179.839 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 11.1 t30 -70.71 145.77 50.31 Favored 'General case' 0 C--O 1.213 -0.851 0 C-N-CA 124.696 1.198 . . . . 70.31 110.232 177.615 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 101.29 23.36 9.68 Favored Glycine 0 N--CA 1.472 1.089 0 C-N-CA 121.66 -0.305 . . . . 72.1 113.805 177.295 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 22.8 p -132.67 120.4 21.67 Favored 'General case' 0 N--CA 1.468 0.454 0 N-CA-C 107.881 -1.155 . . . . 34.11 107.881 174.249 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 111' ' ' GLN . . . . . 0.49 HE22 ' HG2' ' B' ' 218' ' ' PRO . 16.0 mt-30 62.71 161.77 0.09 Allowed 'General case' 0 N--CA 1.492 1.632 0 C-N-CA 124.114 0.966 . . . . 74.22 111.74 -171.778 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 112' ' ' PHE . . . . . 0.451 ' HA ' ' HA ' ' A' ' 100' ' ' MET . 49.1 p90 -133.72 143.14 48.31 Favored 'General case' 0 N--CA 1.472 0.645 0 N-CA-C 108.201 -1.037 . . . . 75.11 108.201 169.054 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 113' ' ' PHE . . . . . 0.433 ' HB2' ' SD ' ' A' ' 61' ' ' MET . 50.5 p90 -129.58 148.13 51.45 Favored 'General case' 0 C--O 1.236 0.391 0 C-N-CA 123.515 0.726 . . . . 64.53 110.091 179.574 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 114' ' ' ILE . . . . . 0.458 ' HB ' ' SG ' ' A' ' 62' ' ' CYS . 21.5 mt -112.63 104.61 17.31 Favored 'Isoleucine or valine' 0 C--O 1.241 0.61 0 N-CA-C 108.486 -0.931 . . . . 55.41 108.486 175.239 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 115' ' ' CYS . . . . . 0.555 ' HB2' ' HB ' ' A' ' 97' ' ' ILE . 28.9 m -64.69 104.52 0.83 Allowed 'General case' 0 CA--C 1.542 0.656 0 N-CA-C 108.406 -0.961 . . . . 74.23 108.406 170.256 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 116' ' ' THR . . . . . 0.523 HG22 HG12 ' A' ' 139' ' ' VAL . 62.5 p -70.16 -31.78 69.43 Favored 'General case' 0 N--CA 1.472 0.632 0 C-N-CA 123.216 0.606 . . . . 71.01 110.296 -179.522 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -115.62 170.99 8.02 Favored 'General case' 0 C--O 1.243 0.745 0 C-N-CA 124.012 0.925 . . . . 74.23 109.72 175.292 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 19.3 ptmt -72.01 92.09 1.27 Allowed 'General case' 0 CA--C 1.554 1.11 0 CA-C-O 121.804 0.811 . . . . 65.13 110.019 175.253 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 119' ' ' THR . . . . . 0.574 ' HB ' HD13 ' A' ' 122' ' ' LEU . 46.7 p -85.64 83.63 7.83 Favored 'General case' 0 CA--C 1.546 0.817 0 CA-C-O 121.813 0.816 . . . . 73.45 109.182 179.766 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 10.2 pt-20 -75.91 -30.13 58.65 Favored 'General case' 0 N--CA 1.482 1.148 0 CA-C-N 115.524 -0.762 . . . . 75.22 112.38 -167.086 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 121' ' ' TRP . . . . . . . . . . . . . 39.0 p90 -69.19 -4.78 18.96 Favored 'General case' 0 CA--C 1.553 1.07 0 C-N-CA 123.713 0.805 . . . . 74.51 111.624 178.03 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 122' ' ' LEU . . . . . 0.574 HD13 ' HB ' ' A' ' 119' ' ' THR . 10.8 mp -87.27 2.39 50.29 Favored 'General case' 0 N--CA 1.482 1.169 0 C-N-CA 124.055 0.942 . . . . 43.45 112.485 174.695 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 78.4 m-20 -78.01 124.54 28.15 Favored 'General case' 0 N--CA 1.477 0.907 0 CA-C-N 118.427 0.558 . . . . 72.01 109.668 177.716 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 112.09 -11.11 26.93 Favored Glycine 0 C--N 1.351 1.369 0 CA-C-N 115.497 -0.774 . . . . 63.34 111.621 -165.027 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 28.7 mtpp -90.83 -165.09 1.28 Allowed 'General case' 0 N--CA 1.486 1.341 0 C-N-CA 124.19 0.996 . . . . 74.43 109.665 169.728 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 126' ' ' HIS . . . . . . . . . . . . . 22.8 t60 -66.34 136.22 55.48 Favored 'General case' 0 CA--C 1.549 0.912 0 CA-C-O 121.35 0.595 . . . . 62.41 111.1 -178.815 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 7.1 p -59.15 147.97 7.43 Favored 'Isoleucine or valine' 0 CA--C 1.551 1.011 0 CA-C-N 113.976 -1.465 . . . . 54.05 111.726 178.03 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 128' ' ' VAL . . . . . 0.561 ' HB ' ' HB3' ' A' ' 90' ' ' LEU . 24.9 t -68.28 157.78 6.16 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.967 0 C-N-CA 123.482 0.713 . . . . 42.11 109.664 175.841 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 129' ' ' PHE . . . . . . . . . . . . . 49.1 p90 -138.9 -24.17 0.91 Allowed 'General case' 0 N--CA 1.478 0.971 0 C-N-CA 122.039 0.136 . . . . 74.22 111.127 174.189 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . -130.11 161.78 23.07 Favored Glycine 0 C--N 1.346 1.095 0 N-CA-C 112.242 -0.343 . . . . 31.1 112.242 -174.563 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 131' ' ' LYS . . . . . 0.432 ' HB3' ' HE2' ' A' ' 131' ' ' LYS . 31.2 ttpt -146.6 128.49 15.41 Favored 'General case' 0 N--CA 1.466 0.356 0 C-N-CA 123.689 0.796 . . . . 74.53 108.991 179.758 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 34.0 t -70.55 101.12 0.78 Allowed 'Isoleucine or valine' 0 CA--C 1.542 0.653 0 N-CA-C 109.282 -0.636 . . . . 63.04 109.282 177.807 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 133' ' ' LYS . . . . . 0.631 ' HD2' ' HB2' ' A' ' 23' ' ' GLU . 18.6 ptmt -87.81 -36.77 17.07 Favored 'General case' 0 N--CA 1.474 0.725 0 CA-C-N 115.615 -0.72 . . . . 74.23 109.781 -179.669 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 134' ' ' GLU . . . . . 0.524 ' HG2' ' HG3' ' A' ' 133' ' ' LYS . 30.8 mm-40 -124.23 144.93 49.67 Favored 'General case' 0 N--CA 1.472 0.648 0 C-N-CA 124.226 1.011 . . . . 75.23 108.8 176.706 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 78.47 21.45 69.58 Favored Glycine 0 N--CA 1.467 0.722 0 CA-C-O 119.582 -0.566 . . . . 53.34 113.375 175.037 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 136' ' ' MET . . . . . . . . . . . . . 16.3 tpt -62.34 -38.1 88.18 Favored 'General case' 0 N--CA 1.481 1.102 0 C-N-CA 123.042 0.537 . . . . 75.54 111.081 174.887 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 137' ' ' ASN . . . . . . . . . . . . . 16.3 m120 -64.29 -29.8 70.88 Favored 'General case' 0 CA--C 1.545 0.786 0 C-N-CA 122.937 0.495 . . . . 70.32 110.897 176.229 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 138' ' ' ILE . . . . . . . . . . . . . 46.8 mm -73.86 -36.1 44.73 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.039 0 C-N-CA 123.156 0.583 . . . . 73.21 110.153 175.797 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 139' ' ' VAL . . . . . 0.523 HG12 HG22 ' A' ' 116' ' ' THR . 91.8 t -65.91 -40.31 87.1 Favored 'Isoleucine or valine' 0 CA--C 1.555 1.149 0 C-N-CA 123.361 0.665 . . . . 73.13 110.674 178.112 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 44.1 mt-10 -74.03 -29.08 61.74 Favored 'General case' 0 N--CA 1.477 0.917 0 CA-C-N 115.64 -0.709 . . . . 75.15 110.622 177.209 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -70.86 -43.36 68.63 Favored 'General case' 0 N--CA 1.478 0.938 0 C-N-CA 122.902 0.481 . . . . 64.23 111.15 176.064 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 142' ' ' MET . . . . . 0.581 ' HB2' HD13 ' A' ' 156' ' ' ILE . 25.2 ptm -72.92 -28.05 62.22 Favored 'General case' 0 N--CA 1.477 0.878 0 C-N-CA 123.074 0.55 . . . . 72.51 111.315 -178.132 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 34.0 tt0 -59.98 -32.55 70.94 Favored 'General case' 0 C--N 1.357 0.897 0 O-C-N 123.597 0.561 . . . . 72.42 111.937 178.352 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 144' ' ' ARG . . . . . . . . . . . . . 38.6 mtm-85 -67.45 -18.79 65.22 Favored 'General case' 0 N--CA 1.477 0.882 0 C-N-CA 123.038 0.535 . . . . 73.23 111.986 -178.363 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 145' ' ' PHE . . . . . 0.522 ' HB2' HD11 ' A' ' 156' ' ' ILE . 45.2 m-85 -83.01 -5.57 59.15 Favored 'General case' 0 N--CA 1.477 0.896 0 C-N-CA 122.871 0.469 . . . . 74.34 111.412 177.185 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . -87.23 175.15 46.04 Favored Glycine 0 C--N 1.347 1.188 0 O-C-N 123.444 0.465 . . . . 61.22 112.12 172.436 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 29.7 m -134.75 169.49 17.27 Favored 'General case' 0 N--CA 1.483 1.209 0 C-N-CA 123.392 0.677 . . . . 73.2 111.59 -174.445 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 148' ' ' ARG . . . . . . . . . . . . . 8.7 mmm180 -57.59 -41.26 80.82 Favored 'General case' 0 N--CA 1.487 1.383 0 C-N-CA 124.81 1.244 . . . . 73.01 113.065 179.927 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 149' ' ' ASN . . . . . . . . . . . . . 30.5 p-10 -75.24 -17.69 60.27 Favored 'General case' 0 N--CA 1.478 0.945 0 C-N-CA 122.958 0.503 . . . . 73.03 111.238 178.191 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 150' ' ' GLY . . . . . 0.464 ' O ' ' HA ' ' A' ' 55' ' ' ARG . . . 111.65 -10.2 28.0 Favored Glycine 0 C--N 1.348 1.222 0 O-C-N 123.706 0.629 . . . . 64.45 112.378 -179.554 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 25.1 ttmm -65.55 137.64 57.52 Favored 'General case' 0 N--CA 1.471 0.624 0 C-N-CA 122.875 0.47 . . . . 74.41 111.177 -175.765 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 152' ' ' THR . . . . . . . . . . . . . 41.1 p -90.42 109.76 20.88 Favored 'General case' 0 C--O 1.239 0.516 0 N-CA-C 108.198 -1.038 . . . . 63.45 108.198 174.493 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 153' ' ' SER . . . . . . . . . . . . . 19.3 m -62.56 -29.36 70.52 Favored 'General case' 0 CA--C 1.544 0.75 0 C-N-CA 124.039 0.936 . . . . 71.33 110.804 176.172 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 154' ' ' LYS . . . . . 0.541 ' HB3' HG13 ' A' ' 12' ' ' VAL . 48.1 mmtm -118.63 133.92 55.5 Favored 'General case' 0 CA--C 1.54 0.561 0 CA-C-N 114.609 -1.178 . . . . 64.33 108.832 175.281 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 16.9 tppt? -78.99 91.68 4.87 Favored 'General case' 0 N--CA 1.473 0.689 0 N-CA-C 109.627 -0.509 . . . . 71.13 109.627 -178.272 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 156' ' ' ILE . . . . . 0.581 HD13 ' HB2' ' A' ' 142' ' ' MET . 70.5 mt -84.92 117.14 29.66 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.357 0 N-CA-C 109.835 -0.431 . . . . 74.33 109.835 -175.242 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 157' ' ' THR . . . . . . . . . . . . . 54.8 p -115.91 156.34 26.36 Favored 'General case' 0 N--CA 1.473 0.707 0 C-N-CA 124.232 1.013 . . . . 55.35 110.015 -179.126 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 158' ' ' ILE . . . . . . . . . . . . . 63.7 mt -80.6 96.0 2.68 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.819 0 N-CA-C 108.283 -1.006 . . . . 73.42 108.283 169.786 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 159' ' ' ALA . . . . . 0.655 ' HB2' ' HB2' ' A' ' 11' ' ' ALA . . . -55.55 -53.14 60.09 Favored 'General case' 0 N--CA 1.478 0.939 0 C-N-CA 124.331 1.053 . . . . 62.42 111.784 -178.177 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 160' ' ' ASP . . . . . 0.558 ' HA ' ' HE3' ' A' ' 49' ' ' LYS . 0.9 OUTLIER -140.17 175.21 9.78 Favored 'General case' 0 N--CA 1.473 0.724 0 CA-C-N 115.798 -0.637 . . . . 71.51 110.405 -176.509 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 161' ' ' CYS . . . . . . . . . . . . . 63.2 m -146.23 -169.82 3.35 Favored 'General case' 0 CA--C 1.547 0.852 0 C-N-CA 125.147 1.379 . . . . 55.1 108.4 -172.674 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 162' ' ' GLY . . . . . . . . . . . . . . . 131.71 53.26 0.09 OUTLIER Glycine 0 C--N 1.348 1.216 0 N-CA-C 112.151 -0.38 . . . . 64.43 112.151 -177.836 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 163' ' ' GLN . . . . . 0.706 ' HG3' ' HA ' ' A' ' 6' ' ' VAL . 43.4 tt0 -46.21 110.53 0.28 Allowed 'General case' 0 N--CA 1.48 1.032 0 C-N-CA 125.035 1.334 . . . . 75.32 112.392 -177.349 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 164' ' ' LEU . . . . . 0.445 ' O ' ' HB ' ' A' ' 5' ' ' THR . 45.3 mt -79.62 94.7 5.72 Favored 'General case' 0 CA--C 1.543 0.704 0 N-CA-C 108.63 -0.878 . . . . 71.25 108.63 -179.357 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 165' ' ' GLU . . . . . . . . . . . . . 41.6 mt-10 . . . . . 0 C--O 1.25 1.096 0 CA-C-O 118.862 -0.589 . . . . 74.24 110.553 -173.114 . . . . . . . . 0 0 . 1 . 006 nuclear build full ' B' B ' 216' ' ' PRO . . . . . . . . . . . . . 5.5 Cg_endo . . . . . 0 CA--C 1.545 1.054 0 N-CA-C 110.421 -0.646 . . . . 72.12 110.421 . . . . . . . . . 0 0 . 1 . 006 nuclear build full ' B' B ' 217' ' ' GLU . . . . . . . . . . . . . 42.9 mt-10 -90.65 162.69 32.94 Favored Pre-proline 0 N--CA 1.481 1.1 0 C-N-CA 123.853 0.861 . . . . 63.12 110.585 -177.045 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 218' ' ' PRO . . . . . 0.568 ' HG3' ' HA2' ' A' ' 72' ' ' GLY . 45.7 Cg_endo -66.23 93.58 0.29 Allowed 'Trans proline' 0 C--N 1.383 2.368 0 C-N-CA 122.448 2.099 . . . . 72.41 109.973 173.344 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 219' ' ' GLY . . . . . . . . . . . . . . . 147.16 -161.42 28.47 Favored Glycine 0 CA--C 1.527 0.791 0 CA-C-N 114.71 -1.132 . . . . 71.03 111.492 -171.489 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 220' ' ' PRO . . . . . . . . . . . . . 64.0 Cg_endo -91.03 168.87 3.56 Favored 'Trans proline' 0 C--N 1.363 1.298 0 C-N-CA 123.412 2.742 . . . . 63.4 114.677 -176.644 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 221' ' ' TYR . . . . . . . . . . . . . 88.0 t80 -99.56 155.95 17.31 Favored 'General case' 0 N--CA 1.484 1.248 0 C-N-CA 123.538 0.735 . . . . 74.41 109.184 169.921 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 222' ' ' ALA . . . . . 0.401 ' HB2' ' CE2' ' A' ' 60' ' ' PHE . . . -147.7 139.55 24.07 Favored 'General case' 0 N--CA 1.476 0.828 0 C-N-CA 123.925 0.89 . . . . 54.11 112.294 -173.519 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 223' ' ' GLN . . . . . 0.435 HE22 ' HB2' ' A' ' 60' ' ' PHE . 2.0 mp0 67.61 153.85 0.13 Allowed Pre-proline 0 CA--C 1.561 1.383 0 O-C-N 125.135 1.522 . . . . 73.55 113.393 163.087 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 224' ' ' PRO . . . . . . . . . . . . . 55.4 Cg_endo . . . . . 0 C--N 1.381 2.259 0 C-N-CA 122.165 1.91 . . . . 73.34 111.319 172.374 . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 64.1 mtt . . . . . 0 N--CA 1.475 0.784 0 N-CA-C 109.179 -0.675 . . . . 74.44 109.179 . . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 14.8 p -116.1 -10.97 12.05 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.267 0 C-N-CA 124.517 1.127 . . . . 62.15 110.237 -179.764 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 24.2 m-80 -71.52 114.93 32.31 Favored Pre-proline 0 CA--C 1.549 0.911 0 C-N-CA 124.51 1.124 . . . . 73.54 111.429 -176.022 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 4' ' ' PRO . . . . . 0.589 ' HG2' ' HB2' ' A' ' 24' ' ' LEU . 29.7 Cg_endo -65.06 123.42 11.55 Favored 'Trans proline' 0 C--N 1.379 2.18 0 C-N-CA 122.356 2.037 . . . . 65.51 110.298 170.694 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 5' ' ' THR . . . . . 0.62 HG23 ' HD3' ' A' ' 133' ' ' LYS . 99.3 m -96.48 119.39 34.89 Favored 'General case' 0 C--N 1.328 -0.351 0 N-CA-C 108.743 -0.836 . . . . 70.31 108.743 -174.811 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 32.1 m -102.77 123.66 56.28 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.646 0 N-CA-C 109.772 -0.455 . . . . 73.31 109.772 -177.694 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 7' ' ' PHE . . . . . 0.589 ' H ' ' HA ' ' A' ' 163' ' ' GLN . 76.7 t80 -109.89 130.16 55.56 Favored 'General case' 0 N--CA 1.47 0.543 0 C-N-CA 123.307 0.643 . . . . 73.13 109.849 -174.398 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 8' ' ' PHE . . . . . 0.456 ' HB3' HG23 ' A' ' 158' ' ' ILE . 36.9 m-85 -135.31 165.64 24.98 Favored 'General case' 0 N--CA 1.472 0.649 0 C-N-CA 124.604 1.162 . . . . 71.21 109.449 173.485 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 18.5 m-20 -120.15 115.08 22.94 Favored 'General case' 0 N--CA 1.467 0.423 0 C-N-CA 124.456 1.102 . . . . 71.0 108.544 171.532 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 10' ' ' ILE . . . . . 0.531 HG21 ' SD ' ' A' ' 142' ' ' MET . 44.3 mm -83.85 132.45 31.47 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.562 0 C-N-CA 123.611 0.764 . . . . 64.11 108.98 178.98 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 11' ' ' ALA . . . . . 0.408 ' O ' ' HA ' ' A' ' 156' ' ' ILE . . . -139.72 135.49 33.2 Favored 'General case' 0 N--CA 1.465 0.299 0 C-N-CA 122.561 0.345 . . . . 73.22 111.799 -171.984 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 14.6 m -96.03 113.77 31.2 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.682 0 C-N-CA 124.703 1.201 . . . . 61.23 109.487 179.752 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 54.8 m-20 63.35 20.43 12.26 Favored 'General case' 0 N--CA 1.489 1.521 0 C-N-CA 125.039 1.336 . . . . 71.35 110.987 -170.262 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 89.44 -6.4 83.29 Favored Glycine 0 C--N 1.348 1.244 0 CA-C-N 116.225 -0.443 . . . . 61.21 113.258 -174.774 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 27.2 mm-40 -86.51 125.99 65.7 Favored Pre-proline 0 CA--C 1.548 0.871 0 C-N-CA 123.39 0.676 . . . . 74.14 110.305 179.356 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 18.0 Cg_endo -52.64 101.85 0.06 OUTLIER 'Trans proline' 0 C--N 1.386 2.536 0 C-N-CA 124.168 3.245 . . . . 74.11 113.996 -170.475 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 53.1 tp -79.19 -35.87 41.14 Favored 'General case' 0 N--CA 1.479 1.003 0 N-CA-C 109.261 -0.644 . . . . 52.4 109.261 175.454 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 166.21 -173.82 41.73 Favored Glycine 0 C--N 1.337 0.614 0 CA-C-N 115.153 -0.93 . . . . 61.43 111.563 176.817 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 47.7 ptt85 -110.59 141.75 43.36 Favored 'General case' 0 C--O 1.239 0.51 0 C-N-CA 123.983 0.913 . . . . 75.54 109.255 177.51 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 93.7 t -134.88 121.2 33.32 Favored 'Isoleucine or valine' 0 C--O 1.239 0.504 0 C-N-CA 123.633 0.773 . . . . 52.22 109.253 175.202 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 21' ' ' SER . . . . . 0.478 ' HB3' ' HB2' ' A' ' 134' ' ' GLU . 22.8 t -115.1 136.99 52.52 Favored 'General case' 0 CA--C 1.539 0.548 0 N-CA-C 108.48 -0.933 . . . . 72.45 108.48 174.516 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 41.8 m-85 -109.69 169.14 8.9 Favored 'General case' 0 N--CA 1.472 0.668 0 C-N-CA 123.675 0.79 . . . . 61.22 110.235 177.684 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 23' ' ' GLU . . . . . 0.624 ' HB2' ' HD2' ' A' ' 133' ' ' LYS . 37.4 tt0 -122.22 103.7 8.95 Favored 'General case' 0 CA--C 1.538 0.503 0 C-N-CA 125.581 1.552 . . . . 75.01 107.938 -176.953 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 24' ' ' LEU . . . . . 0.589 ' HB2' ' HG2' ' A' ' 4' ' ' PRO . 18.4 mt -82.99 124.51 30.47 Favored 'General case' 0 N--CA 1.474 0.761 0 N-CA-C 109.454 -0.572 . . . . 61.32 109.454 -179.279 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 68.2 m-85 -86.6 69.37 10.35 Favored 'General case' 0 CA--C 1.534 0.357 0 C-N-CA 123.324 0.65 . . . . 74.0 109.38 179.292 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -64.65 -20.09 66.09 Favored 'General case' 0 N--CA 1.484 1.225 0 C-N-CA 123.553 0.741 . . . . 53.34 111.727 179.763 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 12.0 p-10 -74.67 -23.18 58.6 Favored 'General case' 0 CA--C 1.545 0.754 0 C-N-CA 124.308 1.043 . . . . 72.31 112.163 177.708 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 58.7 mttp -105.91 -41.54 5.38 Favored 'General case' 0 N--CA 1.486 1.328 0 C-N-CA 123.757 0.823 . . . . 62.15 111.245 -179.056 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 29' ' ' VAL . . . . . 0.585 HG12 ' HG2' ' A' ' 86' ' ' GLU . 10.7 m -138.26 74.25 42.3 Favored Pre-proline 0 CA--C 1.56 1.33 0 C-N-CA 124.445 1.098 . . . . 74.02 109.873 -172.552 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 59.2 Cg_endo -67.51 -37.97 15.76 Favored 'Trans proline' 0 C--N 1.377 2.067 0 C-N-CA 122.961 2.441 . . . . 73.04 113.383 -171.47 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 48.1 tttp -73.86 -42.09 61.3 Favored 'General case' 0 N--CA 1.478 0.95 0 C-N-CA 123.669 0.788 . . . . 73.22 110.907 -173.507 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 11.3 m -73.21 -36.98 66.59 Favored 'General case' 0 CA--C 1.547 0.832 0 CA-C-N 115.728 -0.669 . . . . 65.35 110.406 -177.707 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -67.11 -41.68 85.82 Favored 'General case' 0 CA--C 1.55 0.948 0 C-N-CA 123.053 0.541 . . . . 75.11 110.684 173.71 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 38.5 tt0 -59.92 -42.19 93.37 Favored 'General case' 0 N--CA 1.483 1.22 0 C-N-CA 124.655 1.182 . . . . 72.43 111.462 -179.428 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 35' ' ' ASN . . . . . 0.469 ' O ' ' HG ' ' A' ' 39' ' ' LEU . 47.7 t30 -56.92 -68.02 0.26 Allowed 'General case' 0 C--N 1.358 0.961 0 O-C-N 124.322 1.014 . . . . 64.24 110.266 -177.196 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 90.6 t80 -57.62 -40.7 79.74 Favored 'General case' 0 N--CA 1.474 0.734 0 O-C-N 124.315 1.009 . . . . 73.34 111.683 -175.683 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 71.5 ttt180 -58.3 -54.88 42.0 Favored 'General case' 0 C--N 1.354 0.802 0 O-C-N 123.719 0.637 . . . . 70.24 110.456 178.564 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 38' ' ' ALA . . . . . 0.448 ' HB3' HG21 ' A' ' 78' ' ' ILE . . . -64.76 -30.09 71.09 Favored 'General case' 0 N--CA 1.475 0.815 0 C-N-CA 123.616 0.766 . . . . 34.44 111.656 -175.099 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 39' ' ' LEU . . . . . 0.588 ' HB3' ' HD2' ' A' ' 48' ' ' TYR . 89.8 mt -63.11 -46.0 89.37 Favored 'General case' 0 N--CA 1.471 0.613 0 C-N-CA 123.545 0.738 . . . . 74.14 110.29 173.604 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 50.7 m -74.35 -39.1 63.01 Favored 'General case' 0 CA--C 1.547 0.843 0 C-N-CA 123.494 0.717 . . . . 72.14 112.018 -173.275 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -75.8 -30.81 59.2 Favored 'General case' 0 N--CA 1.482 1.15 0 C-N-CA 122.582 0.353 . . . . 62.21 110.581 178.195 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 84.87 32.45 21.19 Favored Glycine 0 C--N 1.347 1.152 0 CA-C-N 115.98 -0.555 . . . . 70.34 111.795 -174.432 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 5.2 mm-40 -63.65 -25.34 68.17 Favored 'General case' 0 N--CA 1.481 1.108 0 C-N-CA 123.565 0.746 . . . . 72.14 110.519 175.042 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 44' ' ' LYS . . . . . 0.458 ' HG3' ' HB ' ' A' ' 78' ' ' ILE . 29.2 mmmt -110.75 19.08 18.97 Favored 'General case' 0 CA--C 1.547 0.842 0 C-N-CA 124.2 1.0 . . . . 53.52 110.922 -178.999 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 78.88 -0.23 78.94 Favored Glycine 0 C--N 1.355 1.6 0 N-CA-C 115.05 0.78 . . . . 61.24 115.05 174.616 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 20.2 m-85 -85.62 -47.84 9.46 Favored 'General case' 0 N--CA 1.48 1.041 0 CA-C-N 117.785 0.793 . . . . 53.24 111.074 -174.181 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 49.66 62.64 4.7 Favored Glycine 0 C--N 1.355 1.619 0 O-C-N 124.358 1.036 . . . . 74.12 113.83 174.937 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 48' ' ' TYR . . . . . 0.588 ' HD2' ' HB3' ' A' ' 39' ' ' LEU . 35.5 m-85 -65.56 90.42 0.11 Allowed 'General case' 0 N--CA 1.474 0.759 0 CA-C-O 122.109 0.957 . . . . 73.41 111.773 -176.309 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 49' ' ' LYS . . . . . 0.595 ' HE3' ' HA ' ' A' ' 160' ' ' ASP . 24.1 tptm -109.88 131.25 55.23 Favored 'General case' 0 C--O 1.238 0.486 0 CA-C-N 113.686 -1.597 . . . . 64.21 108.53 179.939 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 79.95 20.36 68.05 Favored Glycine 0 C--N 1.346 1.137 0 CA-C-O 119.85 -0.417 . . . . 60.11 113.203 -179.464 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 39.0 t -60.69 126.75 28.57 Favored 'General case' 0 N--CA 1.479 1.021 0 C-N-CA 123.907 0.883 . . . . 72.14 110.243 179.39 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 52' ' ' CYS . . . . . . . . . . . . . 26.8 p -97.92 120.52 38.45 Favored 'General case' 0 N--CA 1.475 0.783 0 O-C-N 123.618 0.574 . . . . 74.44 111.933 -168.517 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 53' ' ' PHE . . . . . 0.749 ' HA ' ' HA2' ' A' ' 64' ' ' GLY . 82.3 m-85 -67.55 92.72 0.32 Allowed 'General case' 0 CA--C 1.536 0.442 0 C-N-CA 123.759 0.824 . . . . 61.1 108.884 166.894 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 26.2 p-80 -101.09 -9.81 21.04 Favored 'General case' 0 N--CA 1.475 0.795 0 CA-C-N 114.922 -1.035 . . . . 63.05 111.881 -172.215 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 37.8 ttt180 -132.28 98.99 4.55 Favored 'General case' 0 N--CA 1.472 0.628 0 N-CA-C 108.952 -0.759 . . . . 71.03 108.952 177.712 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 53.7 mt -128.12 130.95 69.75 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.82 0 N-CA-C 109.367 -0.605 . . . . 73.34 109.367 176.167 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 59.5 mt -125.12 124.85 25.33 Favored Pre-proline 0 CA--C 1.558 1.268 0 C-N-CA 124.172 0.989 . . . . 71.31 108.851 175.132 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 24.3 Cg_endo -60.37 151.13 76.55 Favored 'Trans proline' 0 C--N 1.385 2.499 0 C-N-CA 123.6 2.867 . . . . 73.33 113.795 -177.541 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 61.44 16.03 48.31 Favored Glycine 0 C--N 1.348 1.24 0 CA-C-N 114.963 -1.017 . . . . 62.44 114.086 179.715 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 36.3 t80 -137.28 -73.6 0.42 Allowed 'General case' 0 C--O 1.239 0.55 0 C-N-CA 123.274 0.63 . . . . 71.4 110.297 -171.735 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 51.4 ttp -171.05 138.43 1.28 Allowed 'General case' 0 N--CA 1.475 0.822 0 O-C-N 123.095 0.247 . . . . 54.23 111.567 -164.018 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 62' ' ' CYS . . . . . 0.563 ' SG ' ' HB ' ' A' ' 114' ' ' ILE . 21.9 p -108.03 110.85 22.65 Favored 'General case' 0 CA--C 1.548 0.881 0 C-N-CA 123.577 0.751 . . . . 71.45 109.266 168.017 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 63' ' ' GLN . . . . . 0.464 ' HA ' ' HA ' ' A' ' 113' ' ' PHE . 52.0 tt0 -102.71 118.59 37.16 Favored 'General case' 0 N--CA 1.48 1.067 0 C-N-CA 124.353 1.061 . . . . 64.32 110.464 -175.172 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 64' ' ' GLY . . . . . 0.749 ' HA2' ' HA ' ' A' ' 53' ' ' PHE . . . -95.81 165.49 24.49 Favored Glycine 0 C--N 1.342 0.884 0 CA-C-N 115.262 -0.881 . . . . 43.25 112.842 177.292 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 65' ' ' GLY . . . . . 0.419 ' HA3' ' HG2' ' A' ' 111' ' ' GLN . . . 177.19 133.04 1.76 Allowed Glycine 0 C--N 1.337 0.591 0 N-CA-C 111.922 -0.471 . . . . 44.33 111.922 179.286 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 22.6 t70 -75.78 170.3 16.47 Favored 'General case' 0 CA--C 1.551 0.993 0 C-N-CA 123.437 0.695 . . . . 74.11 110.867 -176.137 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 74.2 t80 -69.8 -25.78 63.95 Favored 'General case' 0 CA--C 1.553 1.071 0 C-N-CA 123.435 0.694 . . . . 71.31 111.285 176.547 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 63.4 m -63.37 109.48 1.61 Allowed 'General case' 0 N--CA 1.478 0.947 0 C-N-CA 123.415 0.686 . . . . 74.31 110.782 179.519 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 58.4 mtt180 59.63 34.52 22.27 Favored 'General case' 0 N--CA 1.479 0.997 0 C-N-CA 125.068 1.347 . . . . 73.14 111.435 -176.597 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 36.8 p-80 -55.42 -20.31 11.85 Favored 'General case' 0 N--CA 1.497 1.918 0 C-N-CA 123.558 0.743 . . . . 72.34 112.886 -172.43 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 5.1 t30 -66.08 87.28 0.1 Allowed 'General case' 0 CA--C 1.554 1.109 0 C-N-CA 124.257 1.023 . . . . 75.34 109.827 167.956 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 76.41 -7.2 32.8 Favored Glycine 0 CA--C 1.535 1.321 0 N-CA-C 115.805 1.082 . . . . 34.25 115.805 172.097 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 73' ' ' THR . . . . . 0.6 ' HA ' ' HB2' ' A' ' 110' ' ' SER . 79.2 m -118.09 -65.84 1.14 Allowed 'General case' 0 N--CA 1.479 0.997 0 CA-C-N 118.598 1.199 . . . . 73.44 110.843 -178.861 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 49.76 54.42 17.78 Favored Glycine 0 C--N 1.356 1.655 0 O-C-N 123.838 0.711 . . . . 31.43 114.379 172.967 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 127.07 55.37 0.14 Allowed Glycine 0 N--CA 1.469 0.895 0 C-N-CA 120.964 -0.636 . . . . 71.41 111.778 -172.449 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 76' ' ' LYS . . . . . 0.557 ' HG2' ' OH ' ' A' ' 48' ' ' TYR . 14.8 ptmm? -52.4 164.38 0.33 Allowed 'General case' 0 N--CA 1.49 1.54 0 C-N-CA 124.117 0.967 . . . . 74.43 111.915 178.584 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 94.9 p -88.95 175.38 7.45 Favored 'General case' 0 C--O 1.247 0.938 0 CA-C-O 121.214 0.53 . . . . 53.01 110.441 -171.981 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 78' ' ' ILE . . . . . 0.458 ' HB ' ' HG3' ' A' ' 44' ' ' LYS . 38.6 pt -74.64 -24.82 18.65 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.654 0 CA-C-N 115.344 -0.843 . . . . 60.42 110.757 179.726 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 51.0 m-85 -86.93 -43.34 12.47 Favored 'General case' 0 N--CA 1.476 0.865 0 C-N-CA 123.713 0.805 . . . . 71.44 110.337 -178.866 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -165.69 -134.79 1.73 Allowed Glycine 0 C--N 1.339 0.745 0 N-CA-C 110.539 -1.024 . . . . 74.15 110.539 -179.098 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 81' ' ' GLU . . . . . 0.529 ' HA ' ' HB2' ' A' ' 76' ' ' LYS . 36.6 tt0 -75.38 -36.8 60.86 Favored 'General case' 0 N--CA 1.477 0.879 0 CA-C-N 117.498 0.649 . . . . 64.33 109.734 175.293 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 82' ' ' LYS . . . . . 0.749 ' HD2' ' HA ' ' A' ' 107' ' ' THR . 19.7 pttp -159.62 166.58 30.37 Favored 'General case' 0 CA--C 1.544 0.732 0 C-N-CA 124.343 1.057 . . . . 62.12 109.309 -170.189 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 11.8 p90 -143.92 174.31 10.95 Favored 'General case' 0 N--CA 1.473 0.723 0 C-N-CA 124.064 0.945 . . . . 73.54 109.111 179.112 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 84' ' ' GLU . . . . . 0.414 ' HA ' ' HA ' ' A' ' 106' ' ' ASN . 11.7 pt-20 -79.19 -175.71 4.77 Favored 'General case' 0 CA--C 1.545 0.775 0 C-N-CA 123.519 0.728 . . . . 74.33 112.083 -178.521 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 30.5 m-20 -85.35 149.51 25.39 Favored 'General case' 0 N--CA 1.475 0.809 0 C-N-CA 123.428 0.691 . . . . 62.13 109.93 -176.672 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 86' ' ' GLU . . . . . 0.585 ' HG2' HG12 ' A' ' 29' ' ' VAL . 3.2 tp10 -77.53 -61.74 1.89 Allowed 'General case' 0 N--CA 1.478 0.957 0 C-N-CA 123.263 0.625 . . . . 54.44 110.54 175.594 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 29.9 p30 -173.57 -156.82 0.08 Allowed 'General case' 0 N--CA 1.475 0.806 0 C-N-CA 125.192 1.397 . . . . 74.22 107.413 -172.826 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 82.2 m-85 -142.04 39.18 1.62 Allowed 'General case' 0 N--CA 1.494 1.729 0 C-N-CA 123.245 0.618 . . . . 65.53 110.824 176.952 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 70.5 mt -65.01 -62.94 1.0 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.483 0 CA-C-O 121.312 0.577 . . . . 64.03 110.423 178.602 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 90' ' ' LEU . . . . . 0.409 ' H ' HG23 ' A' ' 127' ' ' VAL . 87.4 mt -86.9 135.82 33.18 Favored 'General case' 0 N--CA 1.47 0.547 0 C-N-CA 124.304 1.042 . . . . 74.4 110.643 -176.402 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 54.3 mtmt -118.89 160.02 22.71 Favored 'General case' 0 N--CA 1.473 0.723 0 C-N-CA 123.88 0.872 . . . . 71.14 111.072 -177.871 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 92' ' ' HIS . . . . . 0.534 ' HA ' HG21 ' A' ' 97' ' ' ILE . 13.6 m80 -83.25 21.14 1.16 Allowed 'General case' 0 N--CA 1.481 1.099 0 C-N-CA 124.777 1.231 . . . . 70.22 111.664 -174.436 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 11.4 t -86.74 31.32 0.69 Allowed 'General case' 0 CA--C 1.56 1.345 0 C-N-CA 124.259 1.024 . . . . 64.43 111.237 -170.562 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -151.14 162.38 29.44 Favored Glycine 0 C--N 1.348 1.208 0 N-CA-C 111.705 -0.558 . . . . 33.11 111.705 176.404 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 73.3 Cg_endo -75.96 145.53 28.37 Favored 'Trans proline' 0 C--N 1.369 1.615 0 C-N-CA 122.689 2.259 . . . . 71.33 112.292 173.757 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 96' ' ' GLY . . . . . 0.523 ' HA3' HG12 ' A' ' 132' ' ' VAL . . . 79.76 17.85 74.26 Favored Glycine 0 C--N 1.345 1.058 0 CA-C-N 116.078 -0.51 . . . . 53.31 114.334 177.475 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 97' ' ' ILE . . . . . 0.534 HG21 ' HA ' ' A' ' 92' ' ' HIS . 8.3 mm -71.41 124.25 27.43 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.893 0 C-N-CA 124.236 1.014 . . . . 63.21 110.757 178.963 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 63.2 tp -108.56 115.34 29.92 Favored 'General case' 0 N--CA 1.484 1.273 0 C-N-CA 123.53 0.732 . . . . 62.42 110.355 179.059 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 18.5 m -133.78 144.5 49.08 Favored 'General case' 0 N--CA 1.48 1.06 0 C-N-CA 124.632 1.173 . . . . 73.13 108.641 174.123 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 100' ' ' MET . . . . . 0.647 ' HA ' ' HA ' ' A' ' 112' ' ' PHE . 72.6 mtp -78.7 137.22 37.69 Favored 'General case' 0 N--CA 1.488 1.471 0 CA-C-N 118.412 0.551 . . . . 73.22 110.008 178.786 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 101' ' ' ALA . . . . . 0.477 ' HB3' ' HB2' ' A' ' 111' ' ' GLN . . . -72.32 168.78 17.64 Favored 'General case' 0 N--CA 1.481 1.088 0 C-N-CA 123.109 0.564 . . . . 55.15 111.981 -170.803 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 102' ' ' ASN . . . . . 0.57 ' HB3' ' HA ' ' A' ' 108' ' ' ASN . 29.4 p-10 -168.04 179.16 4.74 Favored 'General case' 0 CA--C 1.542 0.655 0 CA-C-N 115.646 -0.707 . . . . 62.23 111.278 -177.597 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -117.08 -5.41 11.4 Favored 'General case' 0 N--CA 1.479 0.999 0 C-N-CA 124.188 0.995 . . . . 70.44 110.726 169.165 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 163.7 -171.36 39.32 Favored Glycine 0 C--N 1.358 1.782 0 CA-C-O 119.507 -0.607 . . . . 75.34 112.901 179.695 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 52.7 Cg_exo -57.9 143.25 96.23 Favored 'Trans proline' 0 C--N 1.378 2.12 0 C-N-CA 123.419 2.746 . . . . 73.31 112.041 172.791 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 106' ' ' ASN . . . . . 0.414 ' HA ' ' HA ' ' A' ' 84' ' ' GLU . 65.6 t30 66.07 12.82 8.75 Favored 'General case' 0 N--CA 1.488 1.467 0 C-N-CA 124.135 0.974 . . . . 73.33 111.243 -178.617 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 107' ' ' THR . . . . . 0.749 ' HA ' ' HD2' ' A' ' 82' ' ' LYS . 6.4 m -123.72 1.48 8.8 Favored 'General case' 0 CA--C 1.556 1.188 0 C-N-CA 124.128 0.971 . . . . 63.41 110.017 179.665 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 108' ' ' ASN . . . . . 0.57 ' HA ' ' HB3' ' A' ' 102' ' ' ASN . 40.0 t30 -70.88 143.77 50.9 Favored 'General case' 0 N--CA 1.479 1.024 0 C-N-CA 124.26 1.024 . . . . 73.22 110.604 -178.626 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 94.93 20.66 27.79 Favored Glycine 0 N--CA 1.47 0.957 0 N-CA-C 113.847 0.299 . . . . 64.03 113.847 177.983 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 110' ' ' SER . . . . . 0.6 ' HB2' ' HA ' ' A' ' 73' ' ' THR . 27.5 p -112.42 118.37 34.99 Favored 'General case' 0 CA--C 1.54 0.591 0 N-CA-C 107.525 -1.287 . . . . 41.05 107.525 169.758 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 111' ' ' GLN . . . . . 0.524 ' HG3' ' O ' ' A' ' 73' ' ' THR . 38.3 mt-30 65.35 -177.94 0.18 Allowed 'General case' 0 N--CA 1.495 1.812 0 C-N-CA 124.183 0.993 . . . . 62.34 110.672 -168.284 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 112' ' ' PHE . . . . . 0.647 ' HA ' ' HA ' ' A' ' 100' ' ' MET . 30.0 p90 -147.99 158.58 44.13 Favored 'General case' 0 N--CA 1.472 0.667 0 C-N-CA 124.105 0.962 . . . . 73.31 108.805 175.685 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 113' ' ' PHE . . . . . 0.464 ' HA ' ' HA ' ' A' ' 63' ' ' GLN . 53.1 p90 -146.82 145.22 29.82 Favored 'General case' 0 C--O 1.235 0.326 0 CA-C-O 121.057 0.456 . . . . 74.25 110.701 -179.581 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 114' ' ' ILE . . . . . 0.563 ' HB ' ' SG ' ' A' ' 62' ' ' CYS . 10.7 mt -115.51 102.26 13.49 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.456 0 N-CA-C 107.066 -1.457 . . . . 73.24 107.066 177.512 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 115' ' ' CYS . . . . . 0.493 ' HB2' ' HB ' ' A' ' 97' ' ' ILE . 50.5 m -60.85 103.38 0.26 Allowed 'General case' 0 C--N 1.348 0.518 0 N-CA-C 108.432 -0.951 . . . . 62.22 108.432 172.044 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 116' ' ' THR . . . . . 0.545 HG22 HG12 ' A' ' 139' ' ' VAL . 34.6 p -71.51 -32.7 68.5 Favored 'General case' 0 N--CA 1.47 0.568 0 C-N-CA 123.833 0.853 . . . . 74.3 110.183 -175.195 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -115.35 169.16 9.35 Favored 'General case' 0 N--CA 1.472 0.663 0 C-N-CA 123.99 0.916 . . . . 74.24 109.857 172.39 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 15.0 ptmt -66.76 115.85 7.01 Favored 'General case' 0 CA--C 1.549 0.926 0 CA-C-O 121.269 0.557 . . . . 72.2 110.074 176.029 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 119' ' ' THR . . . . . 0.559 ' HB ' HD13 ' A' ' 122' ' ' LEU . 43.7 p -115.76 87.86 2.76 Favored 'General case' 0 CA--C 1.546 0.798 0 CA-C-O 121.712 0.767 . . . . 74.22 110.363 -178.76 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 11.9 pt-20 -80.22 -19.99 45.67 Favored 'General case' 0 N--CA 1.481 1.082 0 CA-C-N 115.744 -0.662 . . . . 73.13 111.278 -176.462 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 121' ' ' TRP . . . . . . . . . . . . . 33.5 p90 -77.64 -7.34 56.28 Favored 'General case' 0 N--CA 1.477 0.919 0 C-N-CA 122.999 0.52 . . . . 71.52 110.569 173.479 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 122' ' ' LEU . . . . . 0.559 HD13 ' HB ' ' A' ' 119' ' ' THR . 9.9 mp -88.86 -7.88 55.31 Favored 'General case' 0 N--CA 1.481 1.076 0 C-N-CA 123.638 0.775 . . . . 72.5 110.698 169.708 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 44.3 m-20 -79.06 150.77 31.77 Favored 'General case' 0 N--CA 1.478 0.969 0 N-CA-C 108.751 -0.833 . . . . 54.43 108.751 173.128 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 97.03 -28.31 14.43 Favored Glycine 0 CA--C 1.526 0.722 0 N-CA-C 110.48 -1.048 . . . . 65.43 110.48 -165.045 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 2.3 mppt? -85.37 -174.07 5.01 Favored 'General case' 0 N--CA 1.478 0.938 0 C-N-CA 124.139 0.976 . . . . 75.13 109.453 170.711 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 126' ' ' HIS . . . . . . . . . . . . . 49.9 p-80 -68.92 154.12 42.6 Favored 'General case' 0 N--CA 1.475 0.824 0 C-N-CA 123.756 0.822 . . . . 73.42 111.374 -166.204 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 127' ' ' VAL . . . . . 0.409 HG23 ' H ' ' A' ' 90' ' ' LEU . 13.6 p -60.56 149.44 7.6 Favored 'Isoleucine or valine' 0 CA--C 1.552 1.035 0 C-N-CA 125.363 1.465 . . . . 71.24 113.569 -176.915 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 128' ' ' VAL . . . . . 0.41 HG11 HD12 ' A' ' 97' ' ' ILE . 46.5 t -76.94 153.64 5.62 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.82 0 C-N-CA 124.805 1.242 . . . . 74.15 109.688 171.661 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 129' ' ' PHE . . . . . 0.544 ' HA ' HG21 ' A' ' 29' ' ' VAL . 26.4 p90 -129.66 -19.73 3.32 Favored 'General case' 0 N--CA 1.482 1.173 0 CA-C-N 117.914 0.325 . . . . 75.22 111.572 178.256 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . -134.12 162.73 24.55 Favored Glycine 0 C--N 1.339 0.747 0 N-CA-C 112.297 -0.321 . . . . 73.45 112.297 -176.234 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 131' ' ' LYS . . . . . 0.42 ' HE2' ' HB3' ' A' ' 131' ' ' LYS . 29.4 ttpt -150.14 134.34 17.13 Favored 'General case' 0 N--CA 1.472 0.626 0 N-CA-C 107.757 -1.201 . . . . 62.21 107.757 177.123 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 132' ' ' VAL . . . . . 0.523 HG12 ' HA3' ' A' ' 96' ' ' GLY . 12.1 p -64.7 131.23 30.44 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.876 0 CA-C-O 121.117 0.484 . . . . 72.3 109.81 178.105 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 133' ' ' LYS . . . . . 0.624 ' HD2' ' HB2' ' A' ' 23' ' ' GLU . 0.1 OUTLIER -118.52 -24.19 6.88 Favored 'General case' 0 N--CA 1.473 0.725 0 C-N-CA 123.736 0.814 . . . . 74.14 110.046 179.185 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 134' ' ' GLU . . . . . 0.478 ' HB2' ' HB3' ' A' ' 21' ' ' SER . 20.8 mm-40 -133.79 129.42 36.56 Favored 'General case' 0 N--CA 1.472 0.673 0 C-N-CA 124.224 1.01 . . . . 72.31 109.224 177.677 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 79.51 36.2 27.11 Favored Glycine 0 C--N 1.345 1.06 0 O-C-N 123.634 0.584 . . . . 43.04 113.945 174.676 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 136' ' ' MET . . . . . . . . . . . . . 5.3 tpt -57.23 -43.6 83.04 Favored 'General case' 0 N--CA 1.491 1.607 0 C-N-CA 123.669 0.787 . . . . 61.44 110.085 172.164 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 137' ' ' ASN . . . . . . . . . . . . . 2.8 t-20 -61.4 -35.08 76.52 Favored 'General case' 0 CA--C 1.548 0.886 0 C-N-CA 124.058 0.943 . . . . 73.1 111.476 177.427 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 138' ' ' ILE . . . . . . . . . . . . . 45.5 mm -69.48 -37.61 75.28 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.999 0 C-N-CA 122.835 0.454 . . . . 72.21 110.349 177.839 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 139' ' ' VAL . . . . . 0.545 HG12 HG22 ' A' ' 116' ' ' THR . 85.8 t -64.3 -37.01 78.82 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.3 0 C-N-CA 123.475 0.71 . . . . 75.5 110.471 174.738 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 44.9 mt-10 -78.6 -19.01 53.7 Favored 'General case' 0 CA--C 1.543 0.683 0 CA-C-N 115.595 -0.73 . . . . 62.2 111.345 178.016 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -78.86 -48.57 14.44 Favored 'General case' 0 N--CA 1.475 0.784 0 C-N-CA 122.987 0.515 . . . . 52.24 110.17 177.069 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 142' ' ' MET . . . . . 0.558 ' HA ' ' HD2' ' A' ' 145' ' ' PHE . 25.5 ptm -65.5 -31.43 72.49 Favored 'General case' 0 N--CA 1.479 0.977 0 C-N-CA 123.502 0.721 . . . . 71.2 110.841 177.429 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 23.6 tt0 -48.41 -45.41 36.09 Favored 'General case' 0 N--CA 1.481 1.089 0 C-N-CA 124.997 1.319 . . . . 64.41 111.426 171.309 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 144' ' ' ARG . . . . . . . . . . . . . 90.7 mtt180 -73.11 -18.78 61.26 Favored 'General case' 0 N--CA 1.474 0.739 0 CA-C-N 114.542 -1.208 . . . . 74.52 111.845 -174.701 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 145' ' ' PHE . . . . . 0.558 ' HD2' ' HA ' ' A' ' 142' ' ' MET . 54.1 m-85 -80.62 -19.65 44.97 Favored 'General case' 0 N--CA 1.475 0.812 0 N-CA-C 109.929 -0.396 . . . . 72.34 109.929 174.13 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . -77.01 165.04 53.29 Favored Glycine 0 C--N 1.344 1.016 0 N-CA-C 111.881 -0.488 . . . . 64.44 111.881 172.586 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 10.1 m -133.08 170.47 15.35 Favored 'General case' 0 N--CA 1.479 1.006 0 C-N-CA 123.255 0.622 . . . . 73.2 110.384 -173.929 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 148' ' ' ARG . . . . . . . . . . . . . 34.7 mmt180 -64.48 -32.57 74.25 Favored 'General case' 0 N--CA 1.487 1.404 0 C-N-CA 123.612 0.765 . . . . 74.31 111.809 -179.417 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 149' ' ' ASN . . . . . . . . . . . . . 25.5 p-10 -75.85 -5.09 44.32 Favored 'General case' 0 N--CA 1.481 1.11 0 C-N-CA 123.09 0.556 . . . . 74.32 111.476 177.781 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . 97.13 -19.52 54.44 Favored Glycine 0 C--N 1.35 1.348 0 C-N-CA 123.115 0.388 . . . . 74.33 113.28 176.507 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 61.0 tttm -78.1 146.93 34.9 Favored 'General case' 0 N--CA 1.474 0.749 0 CA-C-N 117.169 0.485 . . . . 63.11 110.476 -176.481 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 152' ' ' THR . . . . . . . . . . . . . 77.7 p -92.91 162.99 13.86 Favored 'General case' 0 CA--C 1.549 0.907 0 C-N-CA 123.972 0.909 . . . . 52.43 110.447 177.734 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 153' ' ' SER . . . . . . . . . . . . . 37.8 m -96.64 -27.34 14.85 Favored 'General case' 0 N--CA 1.477 0.907 0 C-N-CA 124.231 1.012 . . . . 74.44 109.675 178.149 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 74.9 mmtt -115.12 148.05 39.45 Favored 'General case' 0 C--O 1.239 0.541 0 C-N-CA 124.592 1.157 . . . . 71.22 108.974 176.276 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 44.7 mtmt -78.13 88.79 4.23 Favored 'General case' 0 N--CA 1.472 0.658 0 N-CA-C 107.828 -1.175 . . . . 73.42 107.828 171.673 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 156' ' ' ILE . . . . . 0.503 HD13 ' HB2' ' A' ' 142' ' ' MET . 65.8 mt -86.97 107.82 17.38 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.32 0 CA-C-N 115.805 -0.634 . . . . 71.25 109.459 -171.412 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 157' ' ' THR . . . . . . . . . . . . . 34.9 p -121.59 156.87 31.99 Favored 'General case' 0 C--O 1.243 0.722 0 C-N-CA 124.514 1.126 . . . . 72.04 110.587 -174.55 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 158' ' ' ILE . . . . . 0.456 HG23 ' HB3' ' A' ' 8' ' ' PHE . 58.6 mt -78.72 93.37 1.54 Allowed 'Isoleucine or valine' 0 CA--C 1.547 0.858 0 N-CA-C 108.766 -0.827 . . . . 54.1 108.766 171.779 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 159' ' ' ALA . . . . . . . . . . . . . . . -61.46 -39.83 92.31 Favored 'General case' 0 N--CA 1.479 1.009 0 C-N-CA 124.567 1.147 . . . . 71.01 113.066 -176.289 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 160' ' ' ASP . . . . . 0.595 ' HA ' ' HE3' ' A' ' 49' ' ' LYS . 16.2 t70 -150.67 168.59 23.88 Favored 'General case' 0 CA--C 1.551 0.99 0 O-C-N 123.528 0.517 . . . . 73.11 110.033 -174.595 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 161' ' ' CYS . . . . . . . . . . . . . 21.8 p -147.04 -170.46 3.55 Favored 'General case' 0 N--CA 1.478 0.953 0 C-N-CA 124.725 1.21 . . . . 60.24 109.234 -172.067 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 162' ' ' GLY . . . . . . . . . . . . . . . 132.12 52.72 0.09 OUTLIER Glycine 0 N--CA 1.476 1.344 0 O-C-N 122.016 -0.427 . . . . 55.11 112.097 -174.244 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 163' ' ' GLN . . . . . 0.589 ' HA ' ' H ' ' A' ' 7' ' ' PHE . 44.9 mt-30 -47.63 106.39 0.09 Allowed 'General case' 0 N--CA 1.48 1.039 0 C-N-CA 125.44 1.496 . . . . 70.01 111.887 -179.737 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 164' ' ' LEU . . . . . . . . . . . . . 74.1 mt -63.61 105.29 0.77 Allowed 'General case' 0 CA--C 1.545 0.752 0 C-N-CA 125.005 1.322 . . . . 72.42 112.141 -171.393 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 165' ' ' GLU . . . . . . . . . . . . . 33.2 tt0 . . . . . 0 CA--C 1.554 1.114 0 N-CA-C 108.057 -1.09 . . . . 72.5 108.057 170.373 . . . . . . . . 0 0 . 1 . 007 nuclear build full ' B' B ' 216' ' ' PRO . . . . . . . . . . . . . 5.7 Cg_endo . . . . . 0 CA--C 1.543 0.959 0 N-CA-C 110.506 -0.613 . . . . 70.52 110.506 . . . . . . . . . 0 0 . 1 . 007 nuclear build full ' B' B ' 217' ' ' GLU . . . . . . . . . . . . . 28.7 tt0 -123.62 105.3 33.1 Favored Pre-proline 0 N--CA 1.475 0.82 0 C-N-CA 123.734 0.813 . . . . 54.42 109.714 -178.061 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 218' ' ' PRO . . . . . . . . . . . . . 57.9 Cg_endo -86.09 170.88 8.18 Favored 'Trans proline' 0 C--N 1.369 1.616 0 C-N-CA 122.462 2.108 . . . . 52.4 111.248 169.457 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 219' ' ' GLY . . . . . . . . . . . . . . . 112.99 166.82 16.77 Favored Glycine 0 CA--C 1.526 0.732 0 CA-C-N 116.051 -0.522 . . . . 73.31 112.493 -178.79 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 220' ' ' PRO . . . . . . . . . . . . . 8.3 Cg_exo -74.76 154.82 43.98 Favored 'Trans proline' 0 CA--C 1.554 1.517 0 C-N-CA 123.76 2.974 . . . . 22.33 114.064 -172.605 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 221' ' ' TYR . . . . . . . . . . . . . 95.9 m-85 -89.5 151.05 22.18 Favored 'General case' 0 N--CA 1.483 1.204 0 C-N-CA 124.216 1.007 . . . . 60.25 111.277 -178.395 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 222' ' ' ALA . . . . . . . . . . . . . . . -104.24 -168.04 1.44 Allowed 'General case' 0 N--CA 1.475 0.819 0 C-N-CA 124.417 1.087 . . . . 65.02 112.805 -169.34 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 223' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -84.29 139.6 39.03 Favored Pre-proline 0 CA--C 1.557 1.233 0 CA-C-N 114.752 -1.113 . . . . 71.53 108.669 166.919 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 224' ' ' PRO . . . . . . . . . . . . . 60.8 Cg_endo . . . . . 0 C--N 1.378 2.092 0 C-N-CA 122.692 2.261 . . . . 70.12 111.863 -179.423 . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 24.8 mmt . . . . . 0 N--CA 1.478 0.946 0 N-CA-C 109.458 -0.571 . . . . 64.25 109.458 . . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 14.7 p -77.0 -26.18 15.82 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.942 0 C-N-CA 123.669 0.788 . . . . 61.44 110.817 179.762 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 29.5 m-80 -66.03 113.32 11.76 Favored Pre-proline 0 CA--C 1.556 1.176 0 C-N-CA 124.097 0.959 . . . . 73.22 111.346 -178.131 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 56.0 Cg_endo -70.8 123.31 9.64 Favored 'Trans proline' 0 C--N 1.379 2.178 0 C-N-CA 122.576 2.184 . . . . 70.31 110.652 175.159 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 5' ' ' THR . . . . . 0.476 ' HB ' ' O ' ' A' ' 164' ' ' LEU . 83.0 m -104.15 125.59 50.58 Favored 'General case' 0 CA--C 1.535 0.369 0 N-CA-C 109.703 -0.48 . . . . 55.15 109.703 -179.807 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 6' ' ' VAL . . . . . 0.616 ' HA ' ' HB2' ' A' ' 163' ' ' GLN . 6.7 m -100.51 122.94 53.09 Favored 'Isoleucine or valine' 0 C--N 1.347 0.457 0 CA-C-O 122.156 0.979 . . . . 73.31 109.732 -178.618 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 7' ' ' PHE . . . . . 0.708 ' H ' ' HA ' ' A' ' 163' ' ' GLN . 76.1 t80 -103.43 133.74 47.98 Favored 'General case' 0 C--O 1.243 0.734 0 CA-C-N 114.224 -1.353 . . . . 72.34 108.99 -174.877 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 8' ' ' PHE . . . . . 0.428 ' HD2' ' HE2' ' A' ' 22' ' ' PHE . 61.4 m-85 -135.23 162.08 33.56 Favored 'General case' 0 C--O 1.238 0.468 0 O-C-N 124.161 0.913 . . . . 74.2 109.702 172.258 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 24.9 m-20 -108.74 115.99 31.14 Favored 'General case' 0 C--N 1.322 -0.604 0 N-CA-C 106.975 -1.491 . . . . 74.54 106.975 170.235 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 51.3 mm -85.42 113.16 23.31 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.546 0 N-CA-C 108.707 -0.849 . . . . 63.21 108.707 178.068 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 11' ' ' ALA . . . . . 0.502 ' HB2' ' HB2' ' A' ' 159' ' ' ALA . . . -116.26 125.24 51.92 Favored 'General case' 0 N--CA 1.477 0.91 0 C-N-CA 122.974 0.51 . . . . 72.45 110.397 178.858 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 48.7 t -95.34 107.18 19.19 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.626 0 N-CA-C 108.088 -1.079 . . . . 53.33 108.088 177.449 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 20.3 m-20 61.58 31.19 18.85 Favored 'General case' 0 N--CA 1.489 1.485 0 C-N-CA 124.662 1.185 . . . . 72.31 112.023 179.409 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 96.79 -19.55 54.28 Favored Glycine 0 C--N 1.344 0.977 0 CA-C-N 115.62 -0.718 . . . . 71.41 112.905 179.035 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 26.3 mm-40 -83.58 114.57 54.4 Favored Pre-proline 0 CA--C 1.542 0.653 0 N-CA-C 109.227 -0.657 . . . . 75.51 109.227 -179.928 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 47.2 Cg_endo -65.36 107.77 1.06 Allowed 'Trans proline' 0 C--N 1.376 2.018 0 C-N-CA 122.248 1.965 . . . . 73.13 111.285 -178.201 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 58.0 tp -75.89 -38.54 57.72 Favored 'General case' 0 C--O 1.241 0.635 0 CA-C-N 115.084 -0.962 . . . . 63.54 109.774 -177.827 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 173.0 -171.7 44.62 Favored Glycine 0 C--N 1.343 0.92 0 CA-C-N 116.159 -0.473 . . . . 63.4 113.875 176.52 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 19' ' ' ARG . . . . . 0.458 ' HB3' ' HE1' ' A' ' 7' ' ' PHE . 67.8 mtt85 -115.99 129.27 56.3 Favored 'General case' 0 N--CA 1.472 0.667 0 C-N-CA 124.312 1.045 . . . . 74.4 109.462 -173.843 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 20' ' ' VAL . . . . . 0.44 HG13 HG13 ' A' ' 132' ' ' VAL . 61.9 t -125.74 133.16 69.75 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.883 0 C-N-CA 123.106 0.563 . . . . 72.03 109.999 178.696 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 37.9 m -119.93 119.16 32.68 Favored 'General case' 0 CA--C 1.558 1.273 0 C-N-CA 124.389 1.075 . . . . 65.33 108.973 177.389 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 22' ' ' PHE . . . . . 0.428 ' HE2' ' HD2' ' A' ' 8' ' ' PHE . 52.7 m-85 -101.13 114.95 29.38 Favored 'General case' 0 N--CA 1.477 0.876 0 C-N-CA 124.22 1.008 . . . . 52.42 110.233 -179.255 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 23' ' ' GLU . . . . . 0.662 ' HB2' ' HD2' ' A' ' 133' ' ' LYS . 43.2 tt0 -76.06 105.06 6.89 Favored 'General case' 0 CA--C 1.549 0.933 0 C-N-CA 123.859 0.864 . . . . 61.34 109.799 176.601 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 24' ' ' LEU . . . . . 0.521 ' HB3' ' HB1' ' A' ' 33' ' ' ALA . 55.5 mt -82.99 128.06 34.12 Favored 'General case' 0 N--CA 1.478 0.954 0 C-N-CA 122.992 0.517 . . . . 72.33 110.66 -179.697 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 54.1 m-85 -90.99 61.13 4.54 Favored 'General case' 0 CA--C 1.532 0.265 0 C-N-CA 123.787 0.835 . . . . 73.33 109.883 -179.295 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -67.9 -13.31 62.05 Favored 'General case' 0 N--CA 1.48 1.04 0 CA-C-N 115.849 -0.614 . . . . 51.45 112.042 179.371 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 11.2 p-10 -71.85 -31.83 66.88 Favored 'General case' 0 CA--C 1.55 0.944 0 C-N-CA 123.481 0.712 . . . . 74.21 110.829 173.848 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 58.0 mttp -96.88 -49.54 5.01 Favored 'General case' 0 N--CA 1.485 1.288 0 C-N-CA 123.948 0.899 . . . . 73.45 111.285 -178.317 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 29' ' ' VAL . . . . . 0.642 ' HB ' ' HB ' ' A' ' 32' ' ' THR . 11.8 m -117.77 76.14 10.53 Favored Pre-proline 0 CA--C 1.562 1.432 0 C-N-CA 124.165 0.986 . . . . 52.35 110.054 179.117 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 30' ' ' PRO . . . . . 0.449 ' HD2' ' HG2' ' A' ' 86' ' ' GLU . 7.2 Cg_endo -51.24 -59.59 1.1 Allowed 'Trans proline' 0 C--N 1.394 2.968 0 C-N-CA 123.381 2.721 . . . . 70.31 113.207 179.699 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 5.8 ttpm? -57.75 -50.2 74.03 Favored 'General case' 0 N--CA 1.482 1.172 0 C-N-CA 123.398 0.679 . . . . 72.34 112.098 -179.562 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 32' ' ' THR . . . . . 0.642 ' HB ' ' HB ' ' A' ' 29' ' ' VAL . 88.9 m -67.78 -35.6 78.97 Favored 'General case' 0 CA--C 1.56 1.357 0 C-N-CA 123.998 0.919 . . . . 71.32 112.593 -170.632 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 33' ' ' ALA . . . . . 0.521 ' HB1' ' HB3' ' A' ' 24' ' ' LEU . . . -90.47 -43.7 10.09 Favored 'General case' 0 N--CA 1.485 1.294 0 C-N-CA 123.019 0.528 . . . . 54.24 112.173 -176.985 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 39.3 tt0 -63.63 -31.73 72.99 Favored 'General case' 0 N--CA 1.484 1.255 0 C-N-CA 123.372 0.669 . . . . 73.15 110.733 179.754 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 35' ' ' ASN . . . . . 0.421 ' O ' ' HG ' ' A' ' 39' ' ' LEU . 35.8 t30 -49.01 -59.51 3.56 Favored 'General case' 0 C--N 1.36 1.029 0 O-C-N 124.566 1.166 . . . . 75.03 110.314 171.457 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 76.3 t80 -65.17 -40.55 94.44 Favored 'General case' 0 C--N 1.348 0.526 0 O-C-N 124.045 0.84 . . . . 70.21 111.249 -175.035 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 56.1 ttp180 -58.26 -44.98 88.62 Favored 'General case' 0 N--CA 1.48 1.044 0 O-C-N 123.723 0.639 . . . . 72.21 110.919 179.057 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 38' ' ' ALA . . . . . 0.547 ' HB3' HG21 ' A' ' 78' ' ' ILE . . . -69.38 -32.24 71.15 Favored 'General case' 0 N--CA 1.473 0.694 0 CA-C-N 115.274 -0.875 . . . . 74.24 111.487 -179.726 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 39' ' ' LEU . . . . . 0.421 ' HG ' ' O ' ' A' ' 35' ' ' ASN . 94.3 mt -69.74 -35.96 75.42 Favored 'General case' 0 N--CA 1.477 0.915 0 C-N-CA 123.87 0.868 . . . . 75.34 111.06 175.326 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 50.0 m -73.52 -54.81 7.34 Favored 'General case' 0 N--CA 1.474 0.75 0 C-N-CA 124.015 0.926 . . . . 75.55 111.284 -175.567 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 56.4 p -78.77 -31.51 46.16 Favored 'General case' 0 CA--C 1.538 0.519 0 CA-C-N 115.128 -0.942 . . . . 32.41 111.376 -175.188 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 92.09 37.68 5.92 Favored Glycine 0 C--N 1.347 1.168 0 CA-C-O 119.647 -0.529 . . . . 60.33 112.682 -178.204 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 68.1 mm-40 -61.1 -29.24 69.64 Favored 'General case' 0 N--CA 1.482 1.152 0 C-N-CA 123.089 0.555 . . . . 64.44 110.432 172.08 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 44' ' ' LYS . . . . . 0.547 ' HG3' ' HB ' ' A' ' 78' ' ' ILE . 32.0 mmmt -108.43 17.75 21.74 Favored 'General case' 0 CA--C 1.541 0.614 0 C-N-CA 124.696 1.199 . . . . 75.2 111.366 -178.965 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 80.23 -1.77 79.36 Favored Glycine 0 C--N 1.355 1.604 0 CA-C-O 119.118 -0.823 . . . . 73.35 114.923 173.353 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 19.7 m-85 -85.17 -48.15 9.43 Favored 'General case' 0 N--CA 1.477 0.924 0 CA-C-N 117.96 0.88 . . . . 64.13 111.05 -174.2 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 41.6 62.23 1.97 Allowed Glycine 0 N--CA 1.485 1.964 0 O-C-N 124.508 1.13 . . . . 61.14 114.816 171.517 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 48' ' ' TYR . . . . . 0.471 ' HB3' ' OG ' ' A' ' 51' ' ' SER . 34.5 m-85 -59.68 98.89 0.05 Allowed 'General case' 0 CA--C 1.548 0.898 0 CA-C-O 121.843 0.83 . . . . 72.3 112.191 -170.095 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 23.2 tptm -108.39 113.53 26.66 Favored 'General case' 0 CA--C 1.539 0.544 0 CA-C-N 113.941 -1.481 . . . . 72.02 108.841 -175.771 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 93.61 18.59 37.68 Favored Glycine 0 C--N 1.346 1.13 0 CA-C-O 119.267 -0.741 . . . . 63.41 113.078 179.823 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 51' ' ' SER . . . . . 0.471 ' OG ' ' HB3' ' A' ' 48' ' ' TYR . 19.6 m -59.95 118.62 6.47 Favored 'General case' 0 N--CA 1.476 0.853 0 C-N-CA 123.317 0.647 . . . . 73.22 111.177 -176.849 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 52' ' ' CYS . . . . . 0.642 ' SG ' ' HD2' ' A' ' 155' ' ' LYS . 36.0 t -86.28 125.15 33.39 Favored 'General case' 0 CA--C 1.533 0.306 0 CA-C-N 115.447 -0.797 . . . . 73.41 112.302 -167.539 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 53' ' ' PHE . . . . . 0.667 ' HA ' ' HA2' ' A' ' 64' ' ' GLY . 95.4 m-85 -73.08 109.33 6.54 Favored 'General case' 0 C--O 1.238 0.479 0 N-CA-C 108.756 -0.831 . . . . 72.54 108.756 166.27 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 19.2 p-80 -128.43 8.41 5.95 Favored 'General case' 0 N--CA 1.482 1.135 0 CA-C-N 115.611 -0.722 . . . . 74.43 111.856 -169.267 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 80.0 ttt-85 -152.25 99.31 2.5 Favored 'General case' 0 N--CA 1.472 0.67 0 N-CA-C 108.794 -0.817 . . . . 75.21 108.794 177.768 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 56' ' ' ILE . . . . . 0.463 HD11 ' HB3' ' A' ' 53' ' ' PHE . 58.3 mt -137.31 134.01 46.89 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.8 0 C-N-CA 123.181 0.592 . . . . 71.13 109.908 -174.688 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 41.8 mt -117.58 118.32 35.31 Favored Pre-proline 0 CA--C 1.554 1.109 0 C-N-CA 124.164 0.986 . . . . 51.1 108.549 174.229 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 58' ' ' PRO . . . . . 0.574 ' HA ' ' HG2' ' A' ' 143' ' ' GLU . 53.8 Cg_endo -67.3 135.95 38.57 Favored 'Trans proline' 0 C--N 1.38 2.206 0 C-N-CA 123.021 2.481 . . . . 74.45 111.508 179.847 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 77.35 30.01 54.97 Favored Glycine 0 CA--C 1.526 0.765 0 CA-C-N 115.345 -0.843 . . . . 71.13 113.091 -176.168 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 29.0 t80 -156.57 -67.04 0.11 Allowed 'General case' 0 C--O 1.247 0.96 0 C-N-CA 123.027 0.531 . . . . 73.32 110.715 -176.921 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 61' ' ' MET . . . . . 0.4 ' HE2' ' HB2' ' A' ' 61' ' ' MET . 45.6 ttm -167.16 146.96 5.35 Favored 'General case' 0 N--CA 1.48 1.073 0 N-CA-C 112.188 0.44 . . . . 74.24 112.188 -165.654 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 62' ' ' CYS . . . . . 0.456 ' SG ' HG13 ' A' ' 139' ' ' VAL . 23.5 p -116.55 114.25 23.88 Favored 'General case' 0 CA--C 1.545 0.781 0 C-N-CA 123.726 0.81 . . . . 72.45 109.111 169.322 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 28.4 tt0 -112.63 140.96 46.96 Favored 'General case' 0 N--CA 1.479 0.995 0 C-N-CA 123.627 0.771 . . . . 74.25 110.66 -179.506 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 64' ' ' GLY . . . . . 0.667 ' HA2' ' HA ' ' A' ' 53' ' ' PHE . . . -130.81 -176.55 14.46 Favored Glycine 0 C--N 1.344 0.976 0 CA-C-N 115.306 -0.861 . . . . 72.24 112.754 176.669 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 176.22 155.07 12.41 Favored Glycine 0 C--N 1.335 0.486 0 N-CA-C 111.721 -0.552 . . . . 74.54 111.721 -179.262 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 21.2 t70 -83.06 179.79 7.65 Favored 'General case' 0 CA--C 1.552 1.031 0 C-N-CA 124.017 0.927 . . . . 74.42 110.593 -176.979 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 53.2 t80 -88.51 -15.68 34.65 Favored 'General case' 0 CA--C 1.548 0.89 0 C-N-CA 123.188 0.595 . . . . 52.35 111.538 177.635 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 42.5 m -65.01 107.79 1.61 Allowed 'General case' 0 C--N 1.357 0.93 0 N-CA-C 109.724 -0.472 . . . . 74.43 109.724 178.057 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 85.1 mtt85 58.64 47.66 12.8 Favored 'General case' 0 N--CA 1.479 1.002 0 C-N-CA 124.821 1.248 . . . . 73.05 110.633 -170.805 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 48.6 t-80 -49.82 -37.66 31.42 Favored 'General case' 0 N--CA 1.482 1.164 0 C-N-CA 124.754 1.222 . . . . 74.4 112.69 -172.297 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 53.1 t30 -68.26 96.47 0.65 Allowed 'General case' 0 CA--C 1.542 0.65 0 O-C-N 123.499 0.499 . . . . 50.11 109.991 175.233 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 67.56 16.15 67.2 Favored Glycine 0 C--N 1.345 1.06 0 N-CA-C 116.022 1.169 . . . . 73.24 116.022 168.805 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 73' ' ' THR . . . . . 0.58 ' HA ' ' HB2' ' A' ' 110' ' ' SER . 88.3 m -132.65 -75.93 0.5 Allowed 'General case' 0 N--CA 1.472 0.638 0 N-CA-C 108.426 -0.953 . . . . 72.12 108.426 168.871 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 53.95 60.26 8.67 Favored Glycine 0 C--N 1.355 1.59 0 O-C-N 123.781 0.675 . . . . 70.35 113.725 170.137 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 130.96 51.4 0.1 OUTLIER Glycine 0 C--N 1.344 1.026 0 N-CA-C 111.855 -0.498 . . . . 74.11 111.855 -176.716 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -52.36 166.09 0.2 Allowed 'General case' 0 N--CA 1.491 1.606 0 C-N-CA 124.369 1.068 . . . . 62.44 112.583 174.688 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 80.9 p -90.65 177.67 6.28 Favored 'General case' 0 N--CA 1.478 0.965 0 C-N-CA 122.994 0.518 . . . . 72.35 111.043 -175.699 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 78' ' ' ILE . . . . . 0.547 ' HB ' ' HG3' ' A' ' 44' ' ' LYS . 31.9 pt -79.02 -22.83 12.7 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.022 0 C-N-CA 123.275 0.63 . . . . 54.35 110.773 176.505 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 71.0 m-85 -79.42 -40.32 30.28 Favored 'General case' 0 N--CA 1.47 0.548 0 C-N-CA 124.19 0.996 . . . . 73.35 109.704 -179.724 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 177.45 -138.69 3.98 Favored Glycine 0 C--N 1.339 0.746 0 CA-C-N 115.152 -0.931 . . . . 63.03 111.528 177.734 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 36.0 tt0 -65.64 -44.44 86.39 Favored 'General case' 0 N--CA 1.471 0.604 0 C-N-CA 123.917 0.887 . . . . 51.44 109.855 177.025 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 82' ' ' LYS . . . . . 0.447 ' HD2' ' HA ' ' A' ' 107' ' ' THR . 20.8 pttp -154.07 175.31 13.58 Favored 'General case' 0 CA--C 1.55 0.977 0 CA-C-N 114.943 -1.026 . . . . 72.53 110.383 -175.219 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 2.2 p90 -159.42 170.48 21.67 Favored 'General case' 0 CA--C 1.554 1.104 0 C-N-CA 124.132 0.973 . . . . 53.21 110.311 -173.765 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 13.0 pt-20 -96.4 157.37 15.93 Favored 'General case' 0 N--CA 1.486 1.343 0 C-N-CA 123.664 0.785 . . . . 74.4 109.014 173.219 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 28.4 m-20 -77.53 150.85 34.77 Favored 'General case' 0 N--CA 1.483 1.206 0 N-CA-C 113.099 0.777 . . . . 74.12 113.099 178.1 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 86' ' ' GLU . . . . . 0.449 ' HG2' ' HD2' ' A' ' 30' ' ' PRO . 13.8 tp10 -61.95 -60.6 3.39 Favored 'General case' 0 CA--C 1.541 0.614 0 CA-C-N 114.044 -1.435 . . . . 73.41 111.158 -179.763 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 26.2 p30 -165.73 152.85 10.18 Favored 'General case' 0 N--CA 1.475 0.789 0 C-N-CA 123.556 0.743 . . . . 74.34 109.723 -176.973 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 89.9 m-85 -90.58 47.26 1.41 Allowed 'General case' 0 N--CA 1.48 1.055 0 C-N-CA 123.624 0.769 . . . . 74.31 111.267 -176.362 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 71.3 mt -69.87 -59.5 3.45 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.925 0 N-CA-C 108.926 -0.768 . . . . 71.34 108.926 173.209 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 90' ' ' LEU . . . . . 0.59 ' HB3' ' HB ' ' A' ' 128' ' ' VAL . 80.3 mt -86.69 104.92 16.54 Favored 'General case' 0 CA--C 1.539 0.542 0 CA-C-N 114.878 -1.055 . . . . 61.21 110.596 -172.057 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 20.4 ptmt -103.97 167.77 9.55 Favored 'General case' 0 N--CA 1.475 0.797 0 C-N-CA 123.278 0.631 . . . . 60.45 110.492 -179.617 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 92' ' ' HIS . . . . . . . . . . . . . 57.7 m-70 -83.53 69.38 10.07 Favored 'General case' 0 N--CA 1.48 1.028 0 C-N-CA 123.4 0.68 . . . . 71.4 110.799 -173.666 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 14.5 t -122.26 20.32 10.55 Favored 'General case' 0 N--CA 1.474 0.761 0 C-N-CA 123.338 0.655 . . . . 64.31 110.084 -176.546 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -143.99 172.27 25.22 Favored Glycine 0 C--N 1.348 1.197 0 CA-C-N 116.287 -0.415 . . . . 71.2 113.445 -176.336 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 58.4 Cg_endo -94.02 153.53 2.19 Favored 'Trans proline' 0 C--N 1.368 1.578 0 C-N-CA 123.676 2.918 . . . . 74.21 112.732 175.238 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 72.82 19.85 79.55 Favored Glycine 0 C--N 1.353 1.507 0 CA-C-N 116.244 -0.435 . . . . 42.25 112.827 177.008 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 97' ' ' ILE . . . . . 0.737 ' HB ' ' SG ' ' A' ' 115' ' ' CYS . 20.1 mm -68.84 108.36 1.6 Allowed 'Isoleucine or valine' 0 CA--C 1.541 0.625 0 C-N-CA 124.238 1.015 . . . . 70.12 111.257 -174.213 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 62.1 tp -90.06 120.55 31.35 Favored 'General case' 0 C--O 1.247 0.94 0 CA-C-N 115.581 -0.736 . . . . 75.12 109.95 172.575 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 99' ' ' SER . . . . . 0.467 ' HB3' ' HA ' ' A' ' 128' ' ' VAL . 7.9 p -149.62 147.67 28.4 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 114.483 -1.235 . . . . 72.35 107.902 171.81 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 100' ' ' MET . . . . . 0.734 ' HA ' ' HA ' ' A' ' 112' ' ' PHE . 96.9 mtp -77.29 149.14 35.39 Favored 'General case' 0 N--CA 1.493 1.68 0 C-N-CA 122.627 0.371 . . . . 63.13 110.276 -175.569 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 101' ' ' ALA . . . . . 0.533 ' HB3' ' HB2' ' A' ' 111' ' ' GLN . . . -73.57 162.71 28.93 Favored 'General case' 0 C--O 1.247 0.944 0 CA-C-O 121.535 0.683 . . . . 63.23 111.347 -176.851 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 102' ' ' ASN . . . . . 0.47 ' HB3' ' HA ' ' A' ' 108' ' ' ASN . 24.3 p-10 -167.24 168.4 13.41 Favored 'General case' 0 C--O 1.242 0.706 0 CA-C-N 114.583 -1.19 . . . . 52.43 109.903 -178.14 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 103' ' ' ALA . . . . . 0.591 ' HB1' ' HB2' ' B' ' 216' ' ' PRO . . . -114.96 6.74 15.41 Favored 'General case' 0 CA--C 1.543 0.695 0 C-N-CA 123.802 0.841 . . . . 54.14 110.304 171.183 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 158.54 179.75 33.63 Favored Glycine 0 C--N 1.354 1.582 0 CA-C-O 119.468 -0.629 . . . . 73.34 112.408 178.094 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 26.0 Cg_exo -64.47 137.54 55.67 Favored 'Trans proline' 0 C--N 1.375 1.926 0 C-N-CA 122.933 2.422 . . . . 71.45 110.509 171.514 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 63.0 t30 68.8 8.79 7.0 Favored 'General case' 0 N--CA 1.49 1.528 0 C-N-CA 124.988 1.315 . . . . 72.53 111.116 -174.851 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 107' ' ' THR . . . . . 0.447 ' HA ' ' HD2' ' A' ' 82' ' ' LYS . 1.7 m -116.93 15.82 15.17 Favored 'General case' 0 CA--C 1.551 0.998 0 N-CA-C 108.359 -0.978 . . . . 65.33 108.359 171.6 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 108' ' ' ASN . . . . . 0.47 ' HA ' ' HB3' ' A' ' 102' ' ' ASN . 20.9 t30 -92.05 145.31 24.62 Favored 'General case' 0 C--O 1.202 -1.426 0 C-N-CA 124.832 1.253 . . . . 70.11 110.498 -176.317 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 113.3 26.99 3.8 Favored Glycine 0 N--CA 1.478 1.48 0 CA-C-N 118.303 0.501 . . . . 75.32 112.436 -178.787 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 110' ' ' SER . . . . . 0.58 ' HB2' ' HA ' ' A' ' 73' ' ' THR . 22.5 p -137.04 121.13 17.8 Favored 'General case' 0 CA--C 1.535 0.401 0 N-CA-C 108.675 -0.861 . . . . 62.44 108.675 -177.926 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 111' ' ' GLN . . . . . 0.533 ' HB2' ' HB3' ' A' ' 101' ' ' ALA . 47.4 mt-30 61.47 -177.25 0.12 Allowed 'General case' 0 N--CA 1.493 1.677 0 C-N-CA 123.898 0.879 . . . . 73.4 111.62 -174.551 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 112' ' ' PHE . . . . . 0.734 ' HA ' ' HA ' ' A' ' 100' ' ' MET . 35.5 p90 -151.75 152.92 33.34 Favored 'General case' 0 N--CA 1.475 0.804 0 C-N-CA 123.672 0.789 . . . . 65.54 109.348 176.698 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 113' ' ' PHE . . . . . . . . . . . . . 55.0 p90 -140.59 151.43 44.67 Favored 'General case' 0 N--CA 1.472 0.667 0 C-N-CA 122.963 0.505 . . . . 75.44 110.934 -178.803 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 114' ' ' ILE . . . . . . . . . . . . . 10.9 mt -125.92 107.77 18.22 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.705 0 N-CA-C 107.849 -1.167 . . . . 74.31 107.849 178.765 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 115' ' ' CYS . . . . . 0.737 ' SG ' ' HB ' ' A' ' 97' ' ' ILE . 28.5 p -89.3 113.68 24.97 Favored 'General case' 0 C--O 1.243 0.745 0 N-CA-C 108.964 -0.754 . . . . 71.12 108.964 175.601 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 71.6 p -70.84 -27.02 63.55 Favored 'General case' 0 N--CA 1.474 0.772 0 CA-C-N 115.253 -0.885 . . . . 63.3 111.291 -177.534 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -104.34 162.34 13.3 Favored 'General case' 0 C--O 1.248 0.977 0 C-N-CA 123.815 0.846 . . . . 75.41 110.058 174.826 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 18.1 ptmt -74.04 85.19 1.8 Allowed 'General case' 0 CA--C 1.546 0.825 0 CA-C-O 122.302 1.048 . . . . 74.42 110.248 175.329 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 119' ' ' THR . . . . . . . . . . . . . 50.8 p -82.04 84.39 7.0 Favored 'General case' 0 CA--C 1.546 0.793 0 CA-C-N 115.01 -0.996 . . . . 60.35 109.307 179.359 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 11.4 pt-20 -75.44 -23.36 56.9 Favored 'General case' 0 N--CA 1.484 1.257 0 CA-C-N 115.019 -0.991 . . . . 74.52 112.727 -167.628 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 121' ' ' TRP . . . . . . . . . . . . . 38.7 p90 -67.05 -8.72 32.41 Favored 'General case' 0 CA--C 1.551 1.0 0 C-N-CA 123.452 0.701 . . . . 74.23 112.201 176.79 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 31.9 mt -88.23 10.33 19.94 Favored 'General case' 0 CA--C 1.547 0.833 0 C-N-CA 122.947 0.499 . . . . 64.54 111.954 176.764 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 69.7 m-20 -72.4 121.18 19.11 Favored 'General case' 0 N--CA 1.483 1.207 0 N-CA-C 108.9 -0.778 . . . . 74.42 108.9 170.721 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 110.0 -17.94 29.21 Favored Glycine 0 N--CA 1.475 1.269 0 N-CA-C 111.04 -0.824 . . . . 53.03 111.04 -170.113 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 125' ' ' LYS . . . . . 0.602 ' HG2' ' H ' ' A' ' 126' ' ' HIS . 21.0 ttmm -86.72 -165.58 1.32 Allowed 'General case' 0 CA--C 1.559 1.3 0 N-CA-C 108.045 -1.094 . . . . 63.53 108.045 169.707 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 126' ' ' HIS . . . . . 0.602 ' H ' ' HG2' ' A' ' 125' ' ' LYS . 9.4 t-160 -65.59 130.08 42.02 Favored 'General case' 0 C--N 1.353 0.758 0 CA-C-N 118.583 0.628 . . . . 73.05 109.826 -173.71 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 127' ' ' VAL . . . . . 0.4 ' N ' ' HD2' ' A' ' 126' ' ' HIS . 57.6 t -58.68 143.7 12.69 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.835 0 CA-C-N 113.75 -1.568 . . . . 75.52 110.966 175.829 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 128' ' ' VAL . . . . . 0.59 ' HB ' ' HB3' ' A' ' 90' ' ' LEU . 21.8 t -66.94 149.01 11.83 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.583 0 N-CA-C 109.578 -0.527 . . . . 61.41 109.578 177.098 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 129' ' ' PHE . . . . . 0.545 ' HB3' HG22 ' A' ' 32' ' ' THR . 32.1 p90 -136.32 -23.89 1.26 Allowed 'General case' 0 N--CA 1.474 0.754 0 C-N-CA 122.243 0.217 . . . . 73.53 111.117 171.409 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . -127.09 157.75 20.78 Favored Glycine 0 C--N 1.338 0.689 0 N-CA-C 111.493 -0.643 . . . . 72.2 111.493 -177.552 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 131' ' ' LYS . . . . . 0.407 ' HE2' ' HB3' ' A' ' 131' ' ' LYS . 31.3 ttpt -144.74 127.41 16.17 Favored 'General case' 0 C--N 1.324 -0.543 0 N-CA-C 108.616 -0.883 . . . . 63.15 108.616 179.967 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 132' ' ' VAL . . . . . 0.478 HG21 HG21 ' A' ' 139' ' ' VAL . 59.4 t -63.67 100.19 0.22 Allowed 'Isoleucine or valine' 0 CA--C 1.539 0.525 0 N-CA-C 108.589 -0.893 . . . . 71.33 108.589 171.902 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 133' ' ' LYS . . . . . 0.662 ' HD2' ' HB2' ' A' ' 23' ' ' GLU . 19.5 ptmt -87.65 -32.03 19.46 Favored 'General case' 0 N--CA 1.473 0.682 0 N-CA-C 109.581 -0.526 . . . . 71.43 109.581 178.315 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 44.8 mt-10 -139.41 146.29 39.95 Favored 'General case' 0 N--CA 1.473 0.7 0 C-N-CA 124.999 1.32 . . . . 61.03 108.936 176.728 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 87.83 21.76 45.43 Favored Glycine 0 C--N 1.342 0.868 0 O-C-N 123.541 0.526 . . . . 51.43 112.536 -175.89 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 136' ' ' MET . . . . . 0.428 ' HA ' HG11 ' A' ' 132' ' ' VAL . 7.1 tpt -58.88 -46.84 86.85 Favored 'General case' 0 C--N 1.359 1.004 0 C-N-CA 123.92 0.888 . . . . 71.43 111.337 -179.772 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 137' ' ' ASN . . . . . . . . . . . . . 20.1 m120 -65.03 -28.86 69.78 Favored 'General case' 0 N--CA 1.477 0.886 0 C-N-CA 123.228 0.611 . . . . 74.43 111.619 -179.394 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 138' ' ' ILE . . . . . . . . . . . . . 43.2 mm -70.41 -38.84 75.36 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.657 0 C-N-CA 123.329 0.652 . . . . 74.45 109.895 178.839 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 139' ' ' VAL . . . . . 0.478 HG21 HG21 ' A' ' 132' ' ' VAL . 69.6 t -68.64 -39.78 80.84 Favored 'Isoleucine or valine' 0 CA--C 1.553 1.063 0 C-N-CA 123.481 0.713 . . . . 74.44 110.492 176.186 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 48.8 mt-10 -69.2 -27.53 65.58 Favored 'General case' 0 N--CA 1.476 0.872 0 C-N-CA 123.623 0.769 . . . . 71.55 111.224 177.92 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -80.35 -45.6 17.51 Favored 'General case' 0 N--CA 1.477 0.91 0 C-N-CA 123.639 0.776 . . . . 63.14 111.196 178.914 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 142' ' ' MET . . . . . 0.544 ' HA ' ' HD2' ' A' ' 145' ' ' PHE . 27.9 ptm -65.68 -31.71 72.87 Favored 'General case' 0 N--CA 1.478 0.969 0 C-N-CA 123.095 0.558 . . . . 64.31 111.22 -178.35 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 143' ' ' GLU . . . . . 0.574 ' HG2' ' HA ' ' A' ' 58' ' ' PRO . 39.1 tt0 -57.94 -32.22 67.58 Favored 'General case' 0 CA--C 1.552 1.037 0 C-N-CA 123.71 0.804 . . . . 75.21 111.969 177.957 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 144' ' ' ARG . . . . . . . . . . . . . 46.3 mtp85 -75.62 -16.98 60.15 Favored 'General case' 0 N--CA 1.473 0.705 0 CA-C-N 116.261 -0.427 . . . . 74.13 111.814 -175.782 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 145' ' ' PHE . . . . . 0.596 ' HB2' HD11 ' A' ' 156' ' ' ILE . 95.2 m-85 -79.88 2.09 24.62 Favored 'General case' 0 N--CA 1.479 0.994 0 C-N-CA 122.728 0.411 . . . . 71.03 110.844 175.38 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . -89.58 -174.75 45.92 Favored Glycine 0 C--N 1.352 1.426 0 O-C-N 123.199 0.312 . . . . 73.41 112.635 171.787 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 19.8 t -135.6 167.99 20.08 Favored 'General case' 0 N--CA 1.475 0.803 0 C-N-CA 123.796 0.838 . . . . 62.45 110.369 -177.869 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 148' ' ' ARG . . . . . . . . . . . . . 12.1 mmm180 -71.04 -29.84 65.87 Favored 'General case' 0 N--CA 1.477 0.907 0 C-N-CA 123.534 0.734 . . . . 74.11 112.09 -173.601 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 149' ' ' ASN . . . . . . . . . . . . . 28.7 p-10 -79.72 -3.05 45.75 Favored 'General case' 0 N--CA 1.484 1.237 0 C-N-CA 123.51 0.724 . . . . 73.14 111.451 176.141 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . 90.68 11.02 62.6 Favored Glycine 0 C--N 1.35 1.336 0 C-N-CA 123.052 0.358 . . . . 55.23 113.098 -179.522 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 56.1 tttm -84.77 158.67 20.65 Favored 'General case' 0 N--CA 1.474 0.761 0 C-N-CA 123.378 0.671 . . . . 72.43 109.458 177.384 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 152' ' ' THR . . . . . . . . . . . . . 24.8 p -101.58 128.72 47.71 Favored 'General case' 0 N--CA 1.475 0.821 0 C-N-CA 122.82 0.448 . . . . 53.11 109.905 171.86 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 153' ' ' SER . . . . . . . . . . . . . 42.4 t -70.25 -42.97 71.49 Favored 'General case' 0 N--CA 1.474 0.742 0 N-CA-C 109.245 -0.65 . . . . 63.04 109.245 168.851 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 154' ' ' LYS . . . . . 0.4 ' HB2' ' HB3' ' A' ' 145' ' ' PHE . 34.1 mmtp -118.4 140.68 49.48 Favored 'General case' 0 C--O 1.239 0.506 0 C-N-CA 123.614 0.766 . . . . 75.31 110.654 -179.338 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 155' ' ' LYS . . . . . 0.642 ' HD2' ' SG ' ' A' ' 52' ' ' CYS . 0.0 OUTLIER -87.03 93.24 9.3 Favored 'General case' 0 CA--C 1.535 0.374 0 O-C-N 123.944 0.778 . . . . 70.04 109.369 -172.271 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 156' ' ' ILE . . . . . 0.624 ' HB ' ' HB2' ' A' ' 53' ' ' PHE . 27.1 mt -87.63 149.27 4.13 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.591 0 CA-C-N 115.488 -0.778 . . . . 61.43 109.231 -177.685 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 157' ' ' THR . . . . . . . . . . . . . 71.9 p -146.25 170.41 16.82 Favored 'General case' 0 N--CA 1.482 1.153 0 C-N-CA 124.091 0.956 . . . . 72.31 109.951 -176.661 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 158' ' ' ILE . . . . . 0.4 HG23 ' HB3' ' A' ' 8' ' ' PHE . 67.8 mt -88.87 102.2 12.7 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.705 0 N-CA-C 107.954 -1.128 . . . . 72.41 107.954 165.05 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 159' ' ' ALA . . . . . 0.502 ' HB2' ' HB2' ' A' ' 11' ' ' ALA . . . -56.03 -49.66 73.08 Favored 'General case' 0 N--CA 1.476 0.835 0 C-N-CA 124.186 0.995 . . . . 71.52 112.115 179.048 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 160' ' ' ASP . . . . . . . . . . . . . 27.5 t70 -160.45 156.96 26.84 Favored 'General case' 0 N--CA 1.471 0.584 0 O-C-N 123.904 0.752 . . . . 62.04 110.685 -174.077 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 161' ' ' CYS . . . . . . . . . . . . . 14.9 p -110.8 -168.71 1.34 Allowed 'General case' 0 N--CA 1.475 0.811 0 C-N-CA 125.122 1.369 . . . . 62.33 108.839 175.851 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 162' ' ' GLY . . . . . . . . . . . . . . . 132.45 53.39 0.08 OUTLIER Glycine 0 C--N 1.346 1.1 0 N-CA-C 111.006 -0.838 . . . . 60.23 111.006 -171.274 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 163' ' ' GLN . . . . . 0.708 ' HA ' ' H ' ' A' ' 7' ' ' PHE . 16.2 pt20 -50.34 132.46 24.52 Favored 'General case' 0 C--N 1.357 0.915 0 C-N-CA 123.908 0.883 . . . . 71.43 113.034 -172.499 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 164' ' ' LEU . . . . . 0.476 ' O ' ' HB ' ' A' ' 5' ' ' THR . 96.7 mt -92.87 97.3 10.66 Favored 'General case' 0 CA--C 1.534 0.362 0 N-CA-C 107.92 -1.141 . . . . 73.4 107.92 177.44 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 165' ' ' GLU . . . . . . . . . . . . . 38.0 tt0 . . . . . 0 CA--C 1.547 0.831 0 C-N-CA 123.994 0.918 . . . . 71.34 108.738 -173.966 . . . . . . . . 0 0 . 1 . 008 nuclear build full ' B' B ' 216' ' ' PRO . . . . . 0.591 ' HB2' ' HB1' ' A' ' 103' ' ' ALA . 1.5 Cg_endo . . . . . 0 CA--C 1.541 0.83 0 N-CA-C 110.482 -0.622 . . . . 61.44 110.482 . . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 217' ' ' GLU . . . . . 0.416 ' HA ' ' HD3' ' B' ' 218' ' ' PRO . 40.9 tt0 -94.8 133.11 27.1 Favored Pre-proline 0 CA--C 1.549 0.941 0 C-N-CA 123.761 0.824 . . . . 75.11 109.612 178.44 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 218' ' ' PRO . . . . . 0.416 ' HD3' ' HA ' ' B' ' 217' ' ' GLU . 13.5 Cg_exo -70.17 86.6 0.63 Allowed 'Trans proline' 0 C--N 1.383 2.385 0 C-N-CA 122.958 2.438 . . . . 71.12 111.223 175.81 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 219' ' ' GLY . . . . . 0.429 ' HA2' ' HD3' ' B' ' 220' ' ' PRO . . . 155.55 140.91 3.09 Favored Glycine 0 CA--C 1.53 1.006 0 CA-C-N 115.435 -0.802 . . . . 51.13 111.313 -176.5 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 220' ' ' PRO . . . . . 0.429 ' HD3' ' HA2' ' B' ' 219' ' ' GLY . 6.1 Cg_exo -77.13 173.25 14.7 Favored 'Trans proline' 0 C--N 1.369 1.634 0 C-N-CA 123.422 2.748 . . . . 71.22 114.108 -173.866 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 221' ' ' TYR . . . . . . . . . . . . . 43.0 p90 -155.81 170.36 22.25 Favored 'General case' 0 C--O 1.25 1.108 0 CA-C-N 114.697 -1.138 . . . . 74.42 109.776 -175.601 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 222' ' ' ALA . . . . . . . . . . . . . . . -172.94 -70.79 0.01 OUTLIER 'General case' 0 N--CA 1.474 0.739 0 C-N-CA 123.82 0.848 . . . . 72.12 109.952 -179.951 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 223' ' ' GLN . . . . . . . . . . . . . 4.0 pt20 -100.78 143.42 26.54 Favored Pre-proline 0 CA--C 1.54 0.58 0 CA-C-N 114.142 -1.39 . . . . 74.52 108.932 -177.347 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 224' ' ' PRO . . . . . . . . . . . . . 60.0 Cg_endo . . . . . 0 C--N 1.371 1.752 0 C-N-CA 122.15 1.9 . . . . 65.41 110.261 172.528 . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 26.7 ptt? . . . . . 0 N--CA 1.475 0.785 0 N-CA-C 111.555 0.205 . . . . 62.32 111.555 . . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 9.7 p -92.52 13.0 2.36 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.681 0 CA-C-O 122.06 0.933 . . . . 45.43 110.748 -178.441 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 3' ' ' ASN . . . . . 0.553 HD22 ' HA ' ' A' ' 25' ' ' PHE . 19.6 m120 -69.2 122.28 84.84 Favored Pre-proline 0 C--O 1.245 0.833 0 C-N-CA 124.06 0.944 . . . . 63.3 110.911 -173.414 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 26.5 Cg_endo -60.79 118.53 5.4 Favored 'Trans proline' 0 C--N 1.382 2.29 0 C-N-CA 122.422 2.081 . . . . 74.41 110.227 177.731 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 5' ' ' THR . . . . . 0.459 ' HB ' ' O ' ' A' ' 164' ' ' LEU . 40.1 m -95.56 130.2 42.49 Favored 'General case' 0 C--O 1.239 0.501 0 N-CA-C 108.95 -0.759 . . . . 75.23 108.95 -173.116 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 6' ' ' VAL . . . . . 0.837 ' HA ' ' HB2' ' A' ' 163' ' ' GLN . 48.5 t -99.6 152.53 4.57 Favored 'Isoleucine or valine' 0 C--O 1.215 -0.748 0 N-CA-C 108.513 -0.921 . . . . 55.32 108.513 -179.426 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 7' ' ' PHE . . . . . 0.466 ' HB3' ' HA ' ' A' ' 163' ' ' GLN . 56.2 t80 -139.6 133.62 30.96 Favored 'General case' 0 C--O 1.242 0.682 0 C-N-CA 123.336 0.654 . . . . 72.13 109.832 179.877 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 40.2 m-85 -135.62 164.39 27.95 Favored 'General case' 0 C--O 1.241 0.642 0 O-C-N 124.663 1.227 . . . . 72.25 109.0 171.808 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 9' ' ' ASP . . . . . 0.522 ' HB2' ' HB3' ' A' ' 159' ' ' ALA . 40.8 m-20 -108.02 114.2 27.93 Favored 'General case' 0 N--CA 1.468 0.434 0 N-CA-C 107.605 -1.257 . . . . 71.21 107.605 171.134 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 10' ' ' ILE . . . . . 0.514 HG21 ' SD ' ' A' ' 142' ' ' MET . 46.1 mm -81.42 129.88 36.76 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.593 0 N-CA-C 109.089 -0.708 . . . . 64.32 109.089 177.799 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 11' ' ' ALA . . . . . 0.568 ' HB2' ' HB2' ' A' ' 159' ' ' ALA . . . -132.3 133.51 44.14 Favored 'General case' 0 N--CA 1.468 0.454 0 C-N-CA 123.379 0.672 . . . . 71.13 111.613 -168.131 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 12' ' ' VAL . . . . . 0.404 HG13 ' HB3' ' A' ' 154' ' ' LYS . 50.9 t -94.6 109.52 22.33 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.848 0 C-N-CA 124.607 1.163 . . . . 64.11 108.847 174.978 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 33.5 m-20 57.97 25.57 12.38 Favored 'General case' 0 N--CA 1.488 1.457 0 C-N-CA 125.449 1.5 . . . . 70.42 112.222 -172.96 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 100.45 -14.64 59.3 Favored Glycine 0 C--N 1.346 1.098 0 CA-C-O 119.475 -0.625 . . . . 73.45 113.326 179.129 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 17.6 mm-40 -87.72 114.25 58.14 Favored Pre-proline 0 N--CA 1.48 1.074 0 CA-C-N 117.559 0.679 . . . . 72.3 109.556 176.875 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 52.8 Cg_exo -50.26 108.64 0.23 Allowed 'Trans proline' 0 C--N 1.378 2.118 0 C-N-CA 123.649 2.9 . . . . 74.4 113.438 -178.795 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 59.4 tp -77.46 -40.49 42.99 Favored 'General case' 0 N--CA 1.472 0.648 0 C-N-CA 124.004 0.922 . . . . 25.14 109.546 175.459 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -167.43 170.38 41.6 Favored Glycine 0 C--N 1.342 0.904 0 CA-C-N 115.534 -0.757 . . . . 33.34 112.753 -178.823 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 19' ' ' ARG . . . . . 0.415 ' HB3' ' HE1' ' A' ' 7' ' ' PHE . 81.1 mtm180 -110.46 127.81 55.31 Favored 'General case' 0 N--CA 1.471 0.577 0 C-N-CA 124.299 1.04 . . . . 71.32 108.858 -178.587 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 76.5 t -129.17 122.16 55.54 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.723 0 C-N-CA 123.426 0.691 . . . . 71.53 110.67 -173.926 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 21' ' ' SER . . . . . 0.456 ' HB2' ' HB2' ' A' ' 134' ' ' GLU . 16.0 m -106.1 129.91 54.1 Favored 'General case' 0 CA--C 1.545 0.788 0 C-N-CA 123.58 0.752 . . . . 53.21 109.92 173.522 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 85.9 m-85 -100.64 170.23 8.5 Favored 'General case' 0 N--CA 1.474 0.768 0 C-N-CA 124.545 1.138 . . . . 65.45 110.038 175.022 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 23' ' ' GLU . . . . . 0.802 ' HB2' ' HD2' ' A' ' 133' ' ' LYS . 41.4 tt0 -135.35 118.75 16.79 Favored 'General case' 0 N--CA 1.472 0.648 0 C-N-CA 123.677 0.791 . . . . 72.4 109.261 -177.763 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 24' ' ' LEU . . . . . 0.471 ' HB3' ' HB1' ' A' ' 33' ' ' ALA . 36.3 mt -96.84 127.29 42.66 Favored 'General case' 0 N--CA 1.474 0.77 0 C-N-CA 122.747 0.419 . . . . 75.42 110.881 -177.062 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 25' ' ' PHE . . . . . 0.553 ' HA ' HD22 ' A' ' 3' ' ' ASN . 33.7 m-85 -86.15 65.85 9.28 Favored 'General case' 0 CA--C 1.537 0.466 0 C-N-CA 123.561 0.744 . . . . 75.42 109.188 175.851 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -65.47 -20.86 66.53 Favored 'General case' 0 N--CA 1.482 1.157 0 C-N-CA 124.193 0.997 . . . . 62.44 111.938 180.0 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 12.1 p-10 -77.15 -21.94 53.31 Favored 'General case' 0 CA--C 1.549 0.917 0 CA-C-N 114.924 -1.035 . . . . 72.05 111.589 178.668 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 60.2 mttp -106.11 -48.75 3.52 Favored 'General case' 0 N--CA 1.481 1.121 0 C-N-CA 123.392 0.677 . . . . 72.12 111.066 -176.207 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 29' ' ' VAL . . . . . 0.461 HG21 ' HA ' ' A' ' 129' ' ' PHE . 15.1 m -121.69 76.5 37.07 Favored Pre-proline 0 CA--C 1.552 1.054 0 C-N-CA 124.221 1.008 . . . . 74.12 109.613 -179.478 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 26.5 Cg_endo -61.45 -38.72 61.5 Favored 'Trans proline' 0 C--N 1.381 2.267 0 C-N-CA 122.492 2.128 . . . . 73.42 112.811 -173.194 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 4.7 ttmp? -65.21 -58.08 6.89 Favored 'General case' 0 N--CA 1.473 0.706 0 C-N-CA 122.971 0.509 . . . . 64.53 111.711 179.749 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 6.6 m -71.78 -28.46 63.64 Favored 'General case' 0 CA--C 1.555 1.168 0 CA-C-N 115.365 -0.834 . . . . 74.44 111.888 -168.79 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 33' ' ' ALA . . . . . 0.471 ' HB1' ' HB3' ' A' ' 24' ' ' LEU . . . -85.05 -45.79 11.78 Favored 'General case' 0 N--CA 1.478 0.942 0 C-N-CA 123.12 0.568 . . . . 55.54 111.275 179.793 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 8.5 tp10 -60.3 -34.73 74.19 Favored 'General case' 0 N--CA 1.487 1.386 0 C-N-CA 122.71 0.404 . . . . 43.52 110.988 178.96 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 35' ' ' ASN . . . . . 0.485 ' O ' ' HG ' ' A' ' 39' ' ' LEU . 36.2 t30 -49.44 -60.61 2.69 Favored 'General case' 0 C--N 1.351 0.651 0 O-C-N 124.514 1.134 . . . . 62.41 110.7 172.626 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 87.8 t80 -62.08 -40.91 97.42 Favored 'General case' 0 N--CA 1.466 0.371 0 CA-C-N 115.183 -0.917 . . . . 72.23 111.68 -176.307 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 23.1 ttp180 -62.57 -42.99 99.89 Favored 'General case' 0 N--CA 1.477 0.9 0 C-N-CA 122.977 0.511 . . . . 73.43 110.909 -177.822 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 38' ' ' ALA . . . . . 0.547 ' HB1' ' HG2' ' A' ' 44' ' ' LYS . . . -69.1 -30.8 69.17 Favored 'General case' 0 CA--C 1.545 0.77 0 CA-C-N 115.341 -0.845 . . . . 62.11 111.508 179.754 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 39' ' ' LEU . . . . . 0.505 HD22 ' HE1' ' A' ' 48' ' ' TYR . 99.2 mt -72.48 -37.12 68.54 Favored 'General case' 0 CA--C 1.55 0.965 0 C-N-CA 123.582 0.753 . . . . 74.23 110.955 175.005 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 49.3 m -69.31 -46.2 67.69 Favored 'General case' 0 N--CA 1.479 1.006 0 C-N-CA 124.186 0.994 . . . . 74.43 111.284 -176.302 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 25.2 p -79.7 -30.01 40.9 Favored 'General case' 0 N--CA 1.472 0.668 0 C-N-CA 123.878 0.871 . . . . 40.3 111.288 178.587 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 83.03 28.82 36.09 Favored Glycine 0 C--N 1.346 1.119 0 CA-C-N 115.825 -0.625 . . . . 65.52 113.033 179.487 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 47.9 mm-40 -63.98 -23.06 67.19 Favored 'General case' 0 N--CA 1.477 0.887 0 C-N-CA 123.138 0.575 . . . . 73.43 111.604 177.024 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 44' ' ' LYS . . . . . 0.547 ' HG2' ' HB1' ' A' ' 38' ' ' ALA . 30.6 mmmt -99.77 19.83 15.27 Favored 'General case' 0 CA--C 1.541 0.631 0 C-N-CA 123.544 0.738 . . . . 73.53 111.985 -179.6 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 80.81 -21.99 5.19 Favored Glycine 0 C--N 1.355 1.607 0 N-CA-C 114.765 0.666 . . . . 63.12 114.765 173.224 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 46' ' ' PHE . . . . . 0.43 ' HE2' ' HA ' ' A' ' 78' ' ' ILE . 19.0 m-85 -69.84 -45.39 67.91 Favored 'General case' 0 C--N 1.348 0.534 0 C-N-CA 123.328 0.651 . . . . 63.51 110.684 -174.042 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 57.71 66.32 2.91 Favored Glycine 0 C--N 1.357 1.748 0 CA-C-O 119.008 -0.885 . . . . 74.34 113.927 168.544 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 48' ' ' TYR . . . . . 0.505 ' HE1' HD22 ' A' ' 39' ' ' LEU . 60.3 m-85 -66.21 85.59 0.1 Allowed 'General case' 0 N--CA 1.476 0.837 0 CA-C-O 122.71 1.243 . . . . 65.34 111.501 -176.494 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 29.0 tptp -113.32 109.21 18.35 Favored 'General case' 0 N--CA 1.451 -0.39 0 CA-C-N 112.662 -2.063 . . . . 73.14 107.975 179.439 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 89.8 19.89 45.9 Favored Glycine 0 N--CA 1.468 0.829 0 CA-C-O 119.657 -0.524 . . . . 73.33 113.695 -179.642 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 23.2 m -61.51 116.73 4.94 Favored 'General case' 0 C--O 1.243 0.745 0 C-N-CA 123.139 0.575 . . . . 70.14 109.572 174.228 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 52' ' ' CYS . . . . . 0.406 ' HA ' ' HA ' ' A' ' 157' ' ' THR . 20.1 p -102.03 128.96 48.24 Favored 'General case' 0 CA--C 1.538 0.487 0 CA-C-O 121.528 0.68 . . . . 71.31 112.19 -165.84 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 53' ' ' PHE . . . . . 0.585 ' HA ' ' HA2' ' A' ' 64' ' ' GLY . 77.7 m-85 -61.45 109.87 1.29 Allowed 'General case' 0 C--O 1.24 0.555 0 C-N-CA 124.804 1.241 . . . . 74.44 109.833 169.459 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 28.3 p-80 -124.15 2.42 8.57 Favored 'General case' 0 N--CA 1.475 0.791 0 CA-C-N 115.076 -0.965 . . . . 72.13 110.962 -175.532 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 55' ' ' ARG . . . . . 0.445 ' O ' ' HB3' ' A' ' 63' ' ' GLN . 53.4 ttt-85 -144.45 95.25 2.68 Favored 'General case' 0 C--O 1.218 -0.563 0 N-CA-C 108.396 -0.964 . . . . 73.11 108.396 177.046 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 56' ' ' ILE . . . . . 0.43 HG21 ' HA ' ' A' ' 143' ' ' GLU . 52.6 mt -130.4 133.68 63.49 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.088 0 N-CA-C 108.661 -0.866 . . . . 71.3 108.661 178.552 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 67.2 mt -126.65 118.61 22.75 Favored Pre-proline 0 CA--C 1.556 1.193 0 C-N-CA 123.606 0.762 . . . . 64.54 109.024 178.098 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 51.6 Cg_exo -57.62 141.79 95.49 Favored 'Trans proline' 0 C--N 1.387 2.559 0 C-N-CA 124.067 3.178 . . . . 74.33 113.784 -178.363 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 67.98 31.43 75.27 Favored Glycine 0 C--N 1.348 1.215 0 O-C-N 124.03 0.831 . . . . 50.3 112.807 -179.273 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 49.1 t80 -152.73 -71.23 0.15 Allowed 'General case' 0 CA--C 1.546 0.808 0 C-N-CA 123.75 0.82 . . . . 65.3 110.364 -177.703 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 37.0 ttp -170.25 150.1 3.57 Favored 'General case' 0 N--CA 1.485 1.296 0 N-CA-C 112.432 0.531 . . . . 75.14 112.432 -163.532 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 62' ' ' CYS . . . . . 0.497 ' SG ' ' HB2' ' A' ' 143' ' ' GLU . 35.4 m -108.77 112.41 24.69 Favored 'General case' 0 N--CA 1.474 0.774 0 C-N-CA 123.806 0.842 . . . . 73.02 109.5 168.4 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 63' ' ' GLN . . . . . 0.445 ' HB3' ' O ' ' A' ' 55' ' ' ARG . 52.1 tt0 -112.57 134.74 53.94 Favored 'General case' 0 N--CA 1.486 1.365 0 CA-C-O 121.644 0.735 . . . . 63.34 110.115 179.975 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 64' ' ' GLY . . . . . 0.585 ' HA2' ' HA ' ' A' ' 53' ' ' PHE . . . -134.45 175.56 20.39 Favored Glycine 0 CA--C 1.499 -0.947 0 CA-C-N 115.238 -0.892 . . . . 52.32 112.478 178.697 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 178.6 170.99 41.39 Favored Glycine 0 N--CA 1.444 -0.833 0 N-CA-C 110.726 -0.95 . . . . 64.31 110.726 179.383 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 14.8 t70 -94.18 166.31 12.18 Favored 'General case' 0 C--O 1.241 0.654 0 N-CA-C 109.862 -0.421 . . . . 54.13 109.862 -172.366 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 37.7 t80 -70.83 -22.93 62.27 Favored 'General case' 0 CA--C 1.548 0.9 0 C-N-CA 122.742 0.417 . . . . 64.44 110.356 175.142 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 52.7 m -61.64 113.65 2.84 Favored 'General case' 0 C--O 1.247 0.922 0 C-N-CA 123.823 0.849 . . . . 72.5 110.994 176.417 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 69' ' ' ARG . . . . . 0.415 ' HB3' ' HB ' ' A' ' 73' ' ' THR . 53.5 mtt180 58.99 29.78 19.41 Favored 'General case' 0 C--N 1.361 1.103 0 C-N-CA 124.577 1.151 . . . . 65.11 112.353 -176.114 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 32.4 p80 -51.72 -33.79 36.08 Favored 'General case' 0 N--CA 1.495 1.811 0 C-N-CA 123.252 0.621 . . . . 75.32 111.381 -179.427 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 6.8 t30 -75.49 89.96 2.71 Favored 'General case' 0 CA--C 1.551 0.992 0 C-N-CA 124.104 0.962 . . . . 62.35 109.164 171.622 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 100.59 -7.24 57.76 Favored Glycine 0 C--N 1.347 1.176 0 N-CA-C 115.93 1.132 . . . . 44.32 115.93 171.089 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 73' ' ' THR . . . . . 0.415 ' HB ' ' HB3' ' A' ' 69' ' ' ARG . 15.0 m -142.92 -75.23 0.27 Allowed 'General case' 0 N--CA 1.483 1.198 0 CA-C-N 118.687 1.243 . . . . 62.12 109.792 179.763 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 72.07 40.29 56.87 Favored Glycine 0 C--N 1.354 1.546 0 C-N-CA 123.234 0.445 . . . . 35.11 113.634 173.975 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 142.45 52.79 0.04 OUTLIER Glycine 0 C--N 1.344 0.995 0 CA-C-N 117.402 0.601 . . . . 75.11 111.741 -173.236 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 76' ' ' LYS . . . . . 0.407 ' HG2' ' OH ' ' A' ' 48' ' ' TYR . 16.5 ptpt -56.55 162.78 2.05 Favored 'General case' 0 N--CA 1.477 0.913 0 C-N-CA 124.183 0.993 . . . . 71.44 112.165 -176.237 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 77.9 p -91.33 173.63 7.81 Favored 'General case' 0 C--O 1.241 0.634 0 CA-C-N 115.343 -0.844 . . . . 63.43 110.42 -179.991 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 78' ' ' ILE . . . . . 0.441 HG21 ' HB3' ' A' ' 38' ' ' ALA . 21.4 pt -74.7 -17.5 16.47 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.608 0 CA-C-N 116.067 -0.515 . . . . 64.4 109.96 173.133 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 49.5 m-85 -87.67 -13.23 43.15 Favored 'General case' 0 CA--C 1.541 0.619 0 C-N-CA 124.615 1.166 . . . . 75.05 110.795 -178.445 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 142.37 -133.02 5.41 Favored Glycine 0 C--N 1.348 1.228 0 N-CA-C 110.858 -0.897 . . . . 44.41 110.858 178.689 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 36.4 tt0 -65.51 -54.34 29.61 Favored 'General case' 0 CA--C 1.54 0.596 0 C-N-CA 123.365 0.666 . . . . 74.01 109.86 175.215 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 82' ' ' LYS . . . . . 0.805 ' HD2' ' HA ' ' A' ' 107' ' ' THR . 24.1 pttm -158.81 174.15 15.45 Favored 'General case' 0 C--O 1.243 0.73 0 CA-C-N 114.52 -1.218 . . . . 62.35 109.17 -172.787 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 12.5 p90 -155.39 172.56 18.01 Favored 'General case' 0 N--CA 1.478 0.939 0 C-N-CA 123.59 0.756 . . . . 64.41 110.245 -175.518 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 14.1 pt-20 -87.25 168.34 13.29 Favored 'General case' 0 CA--C 1.548 0.885 0 CA-C-N 115.897 -0.592 . . . . 73.45 110.614 179.23 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 85' ' ' ASP . . . . . 0.432 ' HB3' HG23 ' A' ' 127' ' ' VAL . 35.7 m-20 -80.31 150.36 29.98 Favored 'General case' 0 N--CA 1.478 0.971 0 C-N-CA 123.898 0.879 . . . . 65.32 112.199 -174.597 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 6.9 tp10 -78.26 -62.55 1.64 Allowed 'General case' 0 C--N 1.352 0.687 0 CA-C-N 115.425 -0.807 . . . . 73.15 111.403 -178.02 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 23.0 p30 -176.75 143.46 0.45 Allowed 'General case' 0 N--CA 1.48 1.056 0 C-N-CA 124.419 1.087 . . . . 63.24 109.159 -175.825 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 98.8 m-85 -89.3 50.11 1.87 Allowed 'General case' 0 N--CA 1.491 1.585 0 CA-C-O 121.607 0.718 . . . . 63.55 111.448 -168.073 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 70.9 mt -67.86 -48.16 76.46 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.695 0 C-N-CA 124.145 0.978 . . . . 62.25 109.885 174.202 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 90' ' ' LEU . . . . . 0.532 HD11 ' HB2' ' A' ' 25' ' ' PHE . 74.5 mt -99.89 122.69 43.2 Favored 'General case' 0 C--O 1.241 0.63 0 CA-C-N 115.462 -0.79 . . . . 64.41 110.585 -174.665 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 44.0 mtmt -119.89 171.71 8.23 Favored 'General case' 0 N--CA 1.475 0.807 0 C-N-CA 124.073 0.949 . . . . 70.04 110.4 177.098 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 92' ' ' HIS . . . . . 0.559 ' HA ' HG13 ' A' ' 97' ' ' ILE . 13.0 m-70 -87.59 41.65 1.0 Allowed 'General case' 0 N--CA 1.482 1.15 0 C-N-CA 124.223 1.009 . . . . 64.53 110.297 -176.115 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 13.0 t -84.92 1.49 47.05 Favored 'General case' 0 CA--C 1.555 1.16 0 C-N-CA 123.986 0.914 . . . . 72.44 111.679 -174.777 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -140.53 161.22 26.58 Favored Glycine 0 C--N 1.344 1.002 0 CA-C-O 119.552 -0.582 . . . . 72.32 111.709 179.601 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 7.3 Cg_exo -75.27 149.74 36.03 Favored 'Trans proline' 0 C--N 1.37 1.692 0 C-N-CA 123.135 2.557 . . . . 72.12 112.146 175.295 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 96' ' ' GLY . . . . . 0.43 ' HA3' HG12 ' A' ' 132' ' ' VAL . . . 84.61 19.45 59.99 Favored Glycine 0 C--N 1.343 0.957 0 N-CA-C 114.586 0.594 . . . . 73.51 114.586 177.357 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 97' ' ' ILE . . . . . 0.559 HG13 ' HA ' ' A' ' 92' ' ' HIS . 7.8 mm -70.54 122.49 22.48 Favored 'Isoleucine or valine' 0 CA--C 1.553 1.088 0 C-N-CA 124.061 0.944 . . . . 64.34 111.99 -177.199 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 56.8 tp -104.91 124.08 48.87 Favored 'General case' 0 N--CA 1.482 1.133 0 C-N-CA 123.266 0.626 . . . . 64.41 110.548 179.813 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 32.2 t -151.22 154.42 36.8 Favored 'General case' 0 CA--C 1.548 0.882 0 C-N-CA 123.627 0.771 . . . . 71.33 109.822 179.685 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 100' ' ' MET . . . . . 0.632 ' HA ' ' HA ' ' A' ' 112' ' ' PHE . 85.3 mtp -86.25 141.34 29.36 Favored 'General case' 0 N--CA 1.492 1.655 0 CA-C-N 118.272 0.487 . . . . 62.41 109.79 179.324 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 101' ' ' ALA . . . . . 0.432 ' HB3' ' HB2' ' A' ' 111' ' ' GLN . . . -73.07 162.41 29.49 Favored 'General case' 0 N--CA 1.487 1.401 0 N-CA-C 112.432 0.531 . . . . 41.22 112.432 -169.75 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 21.3 p-10 -161.71 170.16 20.17 Favored 'General case' 0 N--CA 1.474 0.753 0 CA-C-N 115.736 -0.665 . . . . 64.44 111.295 -174.28 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -103.73 -20.05 14.1 Favored 'General case' 0 N--CA 1.477 0.899 0 C-N-CA 124.124 0.97 . . . . 62.34 110.575 169.412 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 167.41 -151.38 18.96 Favored Glycine 0 CA--C 1.536 1.403 0 CA-C-O 119.269 -0.739 . . . . 52.13 111.439 -173.473 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 31.4 Cg_exo -62.46 144.07 94.21 Favored 'Trans proline' 0 C--N 1.37 1.709 0 C-N-CA 122.751 2.301 . . . . 73.14 112.671 175.108 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 64.4 t30 66.93 9.89 7.21 Favored 'General case' 0 N--CA 1.493 1.695 0 C-N-CA 124.745 1.218 . . . . 73.43 112.578 175.03 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 107' ' ' THR . . . . . 0.805 ' HA ' ' HD2' ' A' ' 82' ' ' LYS . 46.8 p -114.45 2.74 14.74 Favored 'General case' 0 N--CA 1.474 0.765 0 O-C-N 121.688 -0.632 . . . . 71.42 112.04 177.945 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 39.8 t30 -71.96 131.87 43.54 Favored 'General case' 0 N--CA 1.475 0.787 0 N-CA-C 108.925 -0.769 . . . . 74.22 108.925 174.924 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 112.43 22.15 5.91 Favored Glycine 0 N--CA 1.468 0.793 0 CA-C-O 120.239 -0.201 . . . . 44.13 113.08 -176.058 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 27.7 p -125.11 120.1 30.45 Favored 'General case' 0 N--CA 1.47 0.539 0 N-CA-C 107.745 -1.205 . . . . 74.02 107.745 169.21 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 111' ' ' GLN . . . . . 0.432 ' HB2' ' HB3' ' A' ' 101' ' ' ALA . 49.4 mt-30 63.41 176.95 0.16 Allowed 'General case' 0 N--CA 1.492 1.637 0 C-N-CA 124.133 0.973 . . . . 74.45 111.769 -171.897 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 112' ' ' PHE . . . . . 0.632 ' HA ' ' HA ' ' A' ' 100' ' ' MET . 44.9 p90 -139.88 159.46 42.13 Favored 'General case' 0 N--CA 1.476 0.87 0 C-N-CA 124.249 1.02 . . . . 74.24 108.461 175.478 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 113' ' ' PHE . . . . . . . . . . . . . 54.0 p90 -152.59 153.83 34.17 Favored 'General case' 0 N--CA 1.471 0.606 0 CA-C-O 121.004 0.431 . . . . 70.24 111.191 178.901 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 114' ' ' ILE . . . . . . . . . . . . . 9.3 mt -119.73 101.96 12.02 Favored 'Isoleucine or valine' 0 C--O 1.245 0.831 0 N-CA-C 107.663 -1.236 . . . . 44.21 107.663 176.468 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 115' ' ' CYS . . . . . 0.407 ' HB2' ' HB ' ' A' ' 97' ' ' ILE . 69.9 m -62.31 104.77 0.53 Allowed 'General case' 0 CA--C 1.537 0.46 0 N-CA-C 108.602 -0.888 . . . . 63.53 108.602 169.502 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 116' ' ' THR . . . . . 0.604 HG22 HG12 ' A' ' 139' ' ' VAL . 64.3 p -69.45 -35.15 75.37 Favored 'General case' 0 N--CA 1.473 0.725 0 C-N-CA 123.461 0.705 . . . . 73.31 110.334 -175.708 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -107.87 167.17 10.17 Favored 'General case' 0 C--O 1.246 0.887 0 CA-C-N 114.716 -1.129 . . . . 44.31 109.289 174.465 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 20.7 ptmt -73.73 91.23 1.89 Allowed 'General case' 0 CA--C 1.545 0.769 0 CA-C-O 122.013 0.911 . . . . 75.21 109.954 174.757 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 119' ' ' THR . . . . . . . . . . . . . 58.4 p -86.97 83.28 7.54 Favored 'General case' 0 CA--C 1.542 0.663 0 CA-C-O 121.997 0.904 . . . . 62.54 109.022 -179.242 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 15.9 pt-20 -79.72 -15.23 57.91 Favored 'General case' 0 N--CA 1.48 1.056 0 CA-C-N 115.129 -0.941 . . . . 44.24 112.406 -167.953 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 121' ' ' TRP . . . . . . . . . . . . . 44.2 p90 -71.97 -14.62 61.95 Favored 'General case' 0 N--CA 1.481 1.1 0 C-N-CA 122.977 0.511 . . . . 64.32 110.832 172.928 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 54.2 mt -88.37 6.47 37.2 Favored 'General case' 0 N--CA 1.474 0.729 0 C-N-CA 123.121 0.568 . . . . 71.14 111.092 174.238 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 30.7 m-20 -79.29 136.84 37.15 Favored 'General case' 0 N--CA 1.474 0.759 0 N-CA-C 107.905 -1.146 . . . . 52.24 107.905 167.546 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 95.42 -24.3 29.79 Favored Glycine 0 N--CA 1.472 1.067 0 N-CA-C 111.17 -0.772 . . . . 64.02 111.17 -168.408 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 125' ' ' LYS . . . . . 0.631 ' HG3' ' H ' ' A' ' 126' ' ' HIS . 12.2 tppt? -75.27 -169.45 0.97 Allowed 'General case' 0 CA--C 1.563 1.48 0 N-CA-C 107.913 -1.143 . . . . 73.53 107.913 169.274 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 126' ' ' HIS . . . . . 0.631 ' H ' ' HG3' ' A' ' 125' ' ' LYS . 43.2 p-80 -67.56 157.59 34.02 Favored 'General case' 0 CA--C 1.549 0.941 0 C-N-CA 123.919 0.887 . . . . 75.14 111.685 -173.347 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 127' ' ' VAL . . . . . 0.491 HG12 ' O ' ' A' ' 128' ' ' VAL . 43.1 t -67.86 140.45 19.16 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.85 0 CA-C-N 114.292 -1.322 . . . . 73.35 112.466 -173.033 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 128' ' ' VAL . . . . . 0.501 HG11 HD12 ' A' ' 97' ' ' ILE . 97.2 t -80.98 154.28 4.26 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.832 0 C-N-CA 124.803 1.241 . . . . 62.13 109.276 170.429 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 129' ' ' PHE . . . . . 0.523 ' CE2' ' HG3' ' A' ' 100' ' ' MET . 37.6 p90 -131.57 -17.41 2.91 Favored 'General case' 0 N--CA 1.484 1.239 0 O-C-N 121.626 -0.671 . . . . 63.52 111.663 177.938 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . -138.4 175.01 21.69 Favored Glycine 0 C--N 1.342 0.904 0 CA-C-O 121.431 0.462 . . . . 73.13 113.314 -169.283 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 31.3 ttpt -160.81 136.07 7.82 Favored 'General case' 0 CA--C 1.536 0.431 0 N-CA-C 108.205 -1.035 . . . . 71.41 108.205 -178.565 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 132' ' ' VAL . . . . . 0.43 HG12 ' HA3' ' A' ' 96' ' ' GLY . 13.3 p -72.25 130.97 35.31 Favored 'Isoleucine or valine' 0 CA--C 1.553 1.063 0 N-CA-C 109.251 -0.648 . . . . 62.14 109.251 173.239 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 133' ' ' LYS . . . . . 0.802 ' HD2' ' HB2' ' A' ' 23' ' ' GLU . 19.9 ptmt -116.15 -26.96 7.04 Favored 'General case' 0 N--CA 1.48 1.042 0 C-N-CA 123.582 0.753 . . . . 73.25 110.257 -179.721 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 134' ' ' GLU . . . . . 0.456 ' HB2' ' HB2' ' A' ' 21' ' ' SER . 71.3 mm-40 -131.24 130.22 42.62 Favored 'General case' 0 N--CA 1.471 0.617 0 C-N-CA 124.656 1.183 . . . . 54.15 108.558 175.308 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 135' ' ' GLY . . . . . 0.414 ' O ' HG23 ' A' ' 139' ' ' VAL . . . 90.89 27.71 18.19 Favored Glycine 0 N--CA 1.468 0.829 0 CA-C-O 119.569 -0.573 . . . . 62.05 113.688 175.444 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 136' ' ' MET . . . . . . . . . . . . . 6.4 tpt -58.76 -43.7 90.39 Favored 'General case' 0 N--CA 1.486 1.333 0 C-N-CA 123.561 0.745 . . . . 74.54 110.52 174.964 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 137' ' ' ASN . . . . . . . . . . . . . 18.7 m120 -60.61 -37.23 80.73 Favored 'General case' 0 N--CA 1.479 1.016 0 CA-C-N 115.625 -0.716 . . . . 73.54 111.283 178.29 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 138' ' ' ILE . . . . . . . . . . . . . 43.4 mm -67.78 -41.32 85.07 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.035 0 C-N-CA 123.555 0.742 . . . . 75.13 110.617 -179.566 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 139' ' ' VAL . . . . . 0.604 HG12 HG22 ' A' ' 116' ' ' THR . 96.1 t -61.5 -44.1 98.01 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.979 0 C-N-CA 123.503 0.721 . . . . 73.34 110.699 177.664 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 41.7 mt-10 -69.11 -34.24 74.76 Favored 'General case' 0 N--CA 1.477 0.914 0 CA-C-N 115.455 -0.793 . . . . 75.53 111.02 178.121 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -73.11 -33.8 65.78 Favored 'General case' 0 N--CA 1.475 0.822 0 C-N-CA 123.367 0.667 . . . . 72.33 111.669 -178.863 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 142' ' ' MET . . . . . 0.561 ' HB2' HD13 ' A' ' 156' ' ' ILE . 21.8 ptt? -79.38 -27.14 41.91 Favored 'General case' 0 N--CA 1.473 0.7 0 C-N-CA 122.423 0.289 . . . . 72.01 110.414 177.985 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 143' ' ' GLU . . . . . 0.497 ' HB2' ' SG ' ' A' ' 62' ' ' CYS . 33.4 tt0 -59.36 -29.3 67.58 Favored 'General case' 0 N--CA 1.482 1.144 0 C-N-CA 123.041 0.536 . . . . 73.05 111.609 176.134 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 144' ' ' ARG . . . . . . . . . . . . . 80.1 mtp180 -64.94 -21.45 66.83 Favored 'General case' 0 CA--C 1.543 0.707 0 C-N-CA 123.704 0.802 . . . . 72.44 112.365 -178.554 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 145' ' ' PHE . . . . . 0.499 ' HB2' HD11 ' A' ' 156' ' ' ILE . 77.6 m-85 -81.47 -12.7 58.79 Favored 'General case' 0 N--CA 1.478 0.933 0 C-N-CA 122.502 0.321 . . . . 71.12 111.337 175.554 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . -70.75 166.6 51.6 Favored Glycine 0 CA--C 1.531 1.034 0 N-CA-C 113.898 0.319 . . . . 55.41 113.898 179.347 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 14.7 m -134.86 161.27 35.7 Favored 'General case' 0 N--CA 1.479 0.994 0 C-N-CA 124.376 1.07 . . . . 74.3 109.749 -179.792 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 148' ' ' ARG . . . . . . . . . . . . . 22.8 mmt85 -68.3 -26.51 65.68 Favored 'General case' 0 N--CA 1.484 1.261 0 C-N-CA 123.557 0.743 . . . . 70.54 112.464 -176.714 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 149' ' ' ASN . . . . . . . . . . . . . 30.1 p-10 -84.33 0.47 49.09 Favored 'General case' 0 N--CA 1.486 1.33 0 C-N-CA 122.996 0.518 . . . . 70.24 111.452 175.682 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . 95.29 -6.16 68.4 Favored Glycine 0 C--N 1.349 1.26 0 CA-C-O 119.683 -0.509 . . . . 55.01 112.982 179.445 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 53.8 tttp -62.94 141.31 58.77 Favored 'General case' 0 N--CA 1.475 0.823 0 C-N-CA 123.035 0.534 . . . . 64.31 111.072 179.987 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 152' ' ' THR . . . . . . . . . . . . . 26.4 p -102.74 131.8 49.33 Favored 'General case' 0 C--O 1.244 0.811 0 N-CA-C 108.776 -0.824 . . . . 71.42 108.776 166.686 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 153' ' ' SER . . . . . . . . . . . . . 16.4 m -72.49 -23.38 61.02 Favored 'General case' 0 N--CA 1.473 0.696 0 C-N-CA 123.834 0.854 . . . . 45.02 110.598 178.131 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 154' ' ' LYS . . . . . 0.404 ' HB3' HG13 ' A' ' 12' ' ' VAL . 73.6 mmtt -134.88 143.38 46.94 Favored 'General case' 0 C--O 1.241 0.625 0 C-N-CA 125.338 1.455 . . . . 73.44 108.289 -178.678 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 3.8 tppp? -74.63 89.55 2.24 Favored 'General case' 0 C--N 1.345 0.373 0 N-CA-C 108.903 -0.777 . . . . 71.32 108.903 177.761 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 156' ' ' ILE . . . . . 0.561 HD13 ' HB2' ' A' ' 142' ' ' MET . 66.5 mt -84.02 130.17 36.36 Favored 'Isoleucine or valine' 0 C--O 1.222 -0.367 0 N-CA-C 106.967 -1.494 . . . . 72.24 106.967 179.989 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 157' ' ' THR . . . . . 0.406 ' HA ' ' HA ' ' A' ' 52' ' ' CYS . 4.8 t -154.44 156.54 36.95 Favored 'General case' 0 C--O 1.237 0.424 0 C-N-CA 122.74 0.416 . . . . 72.21 110.651 -167.166 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 158' ' ' ILE . . . . . . . . . . . . . 74.1 mt -75.2 98.33 1.39 Allowed 'Isoleucine or valine' 0 CA--C 1.539 0.553 0 N-CA-C 109.015 -0.735 . . . . 74.02 109.015 172.963 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 159' ' ' ALA . . . . . 0.568 ' HB2' ' HB2' ' A' ' 11' ' ' ALA . . . -53.6 -53.65 48.75 Favored 'General case' 0 N--CA 1.472 0.667 0 C-N-CA 123.629 0.772 . . . . 75.01 111.289 177.155 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 160' ' ' ASP . . . . . . . . . . . . . 25.9 t70 -156.33 152.87 28.16 Favored 'General case' 0 N--CA 1.476 0.834 0 CA-C-N 116.321 -0.399 . . . . 74.02 111.03 -177.77 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 161' ' ' CYS . . . . . . . . . . . . . 23.7 p -102.8 -171.45 1.95 Allowed 'General case' 0 N--CA 1.475 0.805 0 C-N-CA 124.888 1.275 . . . . 42.23 109.76 175.501 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 162' ' ' GLY . . . . . . . . . . . . . . . 130.49 52.25 0.1 Allowed Glycine 0 C--N 1.346 1.086 0 N-CA-C 111.176 -0.77 . . . . 71.23 111.176 -171.314 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 163' ' ' GLN . . . . . 0.837 ' HB2' ' HA ' ' A' ' 6' ' ' VAL . 12.8 pt20 -52.48 126.6 19.93 Favored 'General case' 0 CA--C 1.552 1.02 0 C-N-CA 124.527 1.131 . . . . 54.2 113.57 -169.82 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 164' ' ' LEU . . . . . 0.459 ' O ' ' HB ' ' A' ' 5' ' ' THR . 88.1 mt -85.57 99.77 11.48 Favored 'General case' 0 C--O 1.216 -0.706 0 CA-C-N 115.586 -0.734 . . . . 63.24 109.312 -175.114 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 165' ' ' GLU . . . . . . . . . . . . . 12.7 pt-20 . . . . . 0 C--O 1.252 1.208 0 CA-C-O 119.279 -0.391 . . . . 71.21 110.006 -178.308 . . . . . . . . 0 0 . 1 . 009 nuclear build full ' B' B ' 216' ' ' PRO . . . . . . . . . . . . . 17.1 Cg_exo . . . . . 0 N--CA 1.49 1.311 0 N-CA-C 109.882 -0.853 . . . . 72.31 109.882 . . . . . . . . . 0 0 . 1 . 009 nuclear build full ' B' B ' 217' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -101.33 174.22 3.08 Favored Pre-proline 0 CA--C 1.554 1.133 0 C-N-CA 124.508 1.123 . . . . 63.15 109.036 176.205 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 218' ' ' PRO . . . . . . . . . . . . . 75.0 Cg_exo -54.26 95.34 0.04 OUTLIER 'Trans proline' 0 C--N 1.384 2.438 0 C-N-CA 122.114 1.876 . . . . 73.05 111.516 164.609 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 219' ' ' GLY . . . . . . . . . . . . . . . 170.0 148.51 5.93 Favored Glycine 0 CA--C 1.534 1.264 0 CA-C-N 115.617 -0.719 . . . . 63.31 111.87 -178.006 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 220' ' ' PRO . . . . . . . . . . . . . 88.0 Cg_endo -76.85 169.75 21.11 Favored 'Trans proline' 0 C--N 1.37 1.688 0 C-N-CA 123.34 2.693 . . . . 73.35 114.823 -175.334 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 221' ' ' TYR . . . . . . . . . . . . . 91.4 m-85 -89.52 137.93 31.9 Favored 'General case' 0 N--CA 1.487 1.404 0 C-N-CA 124.175 0.99 . . . . 75.22 111.42 -176.44 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 222' ' ' ALA . . . . . . . . . . . . . . . -120.58 -170.59 2.02 Favored 'General case' 0 N--CA 1.477 0.925 0 C-N-CA 124.932 1.293 . . . . 52.24 112.586 -170.045 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 223' ' ' GLN . . . . . . . . . . . . . 34.8 mt-30 -72.42 115.57 40.51 Favored Pre-proline 0 CA--C 1.549 0.938 0 N-CA-C 108.57 -0.9 . . . . 72.5 108.57 171.07 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 224' ' ' PRO . . . . . . . . . . . . . 13.8 Cg_exo . . . . . 0 C--N 1.372 1.805 0 C-N-CA 122.61 2.207 . . . . 72.31 111.043 177.779 . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 3.8 mpp? . . . . . 0 N--CA 1.482 1.15 0 N-CA-C 110.196 -0.298 . . . . 72.44 110.196 . . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 6.9 p -60.82 -32.67 52.7 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.271 0 C-N-CA 124.346 1.059 . . . . 53.13 110.761 173.159 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 38.7 m-80 -68.45 122.86 86.09 Favored Pre-proline 0 CA--C 1.542 0.651 0 C-N-CA 124.795 1.238 . . . . 73.11 111.234 -175.877 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 4' ' ' PRO . . . . . 0.449 ' HG2' ' HB2' ' A' ' 24' ' ' LEU . 56.0 Cg_endo -68.28 153.19 74.93 Favored 'Trans proline' 0 C--N 1.369 1.634 0 C-N-CA 122.366 2.044 . . . . 74.41 110.517 170.216 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 5' ' ' THR . . . . . 0.515 ' HB ' ' O ' ' A' ' 164' ' ' LEU . 76.3 m -123.55 136.6 54.63 Favored 'General case' 0 C--O 1.236 0.374 0 N-CA-C 109.672 -0.492 . . . . 75.24 109.672 177.427 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 6' ' ' VAL . . . . . 0.49 ' HA ' ' HB2' ' A' ' 163' ' ' GLN . 17.3 m -102.67 145.99 11.3 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.36 0 C-N-CA 123.754 0.822 . . . . 72.51 109.653 174.813 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 7' ' ' PHE . . . . . 0.497 ' H ' ' HA ' ' A' ' 163' ' ' GLN . 84.3 t80 -121.47 133.53 55.05 Favored 'General case' 0 C--O 1.237 0.415 0 C-N-CA 123.896 0.879 . . . . 72.01 109.169 -176.342 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 8' ' ' PHE . . . . . 0.431 ' HD2' ' HE1' ' A' ' 22' ' ' PHE . 36.5 m-85 -133.43 164.87 26.17 Favored 'General case' 0 C--O 1.24 0.556 0 C-N-CA 124.11 0.964 . . . . 71.23 109.873 172.209 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 19.3 m-20 -118.2 112.89 20.72 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 114.209 -1.36 . . . . 73.21 107.819 173.039 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 10' ' ' ILE . . . . . 0.464 HG21 ' SD ' ' A' ' 142' ' ' MET . 40.3 mm -81.98 134.0 27.98 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.566 0 N-CA-C 108.853 -0.795 . . . . 75.41 108.853 177.906 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 11' ' ' ALA . . . . . 0.551 ' HB2' ' HB2' ' A' ' 159' ' ' ALA . . . -135.08 111.29 9.63 Favored 'General case' 0 N--CA 1.468 0.448 0 C-N-CA 123.482 0.713 . . . . 70.12 110.905 -173.064 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 12' ' ' VAL . . . . . 0.503 HG22 HG12 ' A' ' 156' ' ' ILE . 85.5 t -94.82 129.15 45.39 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.832 0 N-CA-C 108.14 -1.059 . . . . 74.14 108.14 178.708 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 22.9 m-20 68.92 13.96 8.85 Favored 'General case' 0 N--CA 1.493 1.684 0 C-N-CA 124.691 1.196 . . . . 74.42 110.481 -170.507 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 80.3 -2.62 76.14 Favored Glycine 0 C--N 1.354 1.55 0 CA-C-O 120.186 -0.23 . . . . 71.44 112.792 -168.972 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 18.3 mm-40 -93.17 117.73 67.55 Favored Pre-proline 0 C--O 1.243 0.751 0 C-N-CA 124.025 0.93 . . . . 74.5 109.454 178.722 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 92.5 Cg_exo -45.51 105.19 0.07 OUTLIER 'Trans proline' 0 C--N 1.378 2.13 0 C-N-CA 123.912 3.075 . . . . 70.31 113.681 179.302 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 31.9 tp -76.36 -35.54 58.65 Favored 'General case' 0 N--CA 1.477 0.915 0 C-N-CA 123.574 0.75 . . . . 74.41 109.411 179.219 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 166.52 -176.47 41.68 Favored Glycine 0 C--N 1.337 0.635 0 CA-C-N 115.617 -0.72 . . . . 72.22 111.662 178.244 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 19.9 ptt85 -106.58 148.13 28.64 Favored 'General case' 0 N--CA 1.472 0.644 0 C-N-CA 122.739 0.416 . . . . 74.03 110.088 -175.641 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 20' ' ' VAL . . . . . 0.401 HG13 HG13 ' A' ' 132' ' ' VAL . 81.9 t -136.7 142.08 39.06 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.517 0 N-CA-C 108.635 -0.876 . . . . 72.04 108.635 176.788 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 15.7 m -130.21 132.79 46.16 Favored 'General case' 0 CA--C 1.542 0.662 0 N-CA-C 108.664 -0.865 . . . . 50.44 108.664 173.688 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 22' ' ' PHE . . . . . 0.431 ' HE1' ' HD2' ' A' ' 8' ' ' PHE . 40.8 m-85 -111.28 125.84 54.26 Favored 'General case' 0 N--CA 1.475 0.796 0 C-N-CA 123.516 0.726 . . . . 73.52 109.697 -179.524 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 37.0 tt0 -76.91 111.39 12.4 Favored 'General case' 0 CA--C 1.546 0.815 0 C-N-CA 123.252 0.621 . . . . 72.32 109.894 172.494 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 24' ' ' LEU . . . . . 0.449 ' HB2' ' HG2' ' A' ' 4' ' ' PRO . 76.1 mt -77.9 125.89 30.03 Favored 'General case' 0 N--CA 1.471 0.606 0 C-N-CA 123.325 0.65 . . . . 72.13 110.163 175.305 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 90.8 m-85 -85.53 62.49 7.5 Favored 'General case' 0 CA--C 1.538 0.499 0 C-N-CA 123.777 0.831 . . . . 72.21 110.702 178.961 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -69.65 -8.56 48.68 Favored 'General case' 0 CA--C 1.547 0.845 0 CA-C-N 115.387 -0.824 . . . . 73.24 111.627 179.008 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 13.2 p-10 -76.23 -31.68 58.5 Favored 'General case' 0 CA--C 1.549 0.939 0 C-N-CA 123.427 0.691 . . . . 73.23 110.956 175.432 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 28' ' ' LYS . . . . . 0.513 ' HD2' HD21 ' A' ' 90' ' ' LEU . 62.0 mttp -106.18 -47.69 3.76 Favored 'General case' 0 N--CA 1.487 1.404 0 C-N-CA 123.261 0.624 . . . . 65.1 111.137 -176.211 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 21.1 m -122.6 67.58 29.55 Favored Pre-proline 0 CA--C 1.563 1.475 0 C-N-CA 123.803 0.841 . . . . 73.55 110.144 -179.914 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 38.4 Cg_endo -62.17 -30.74 82.45 Favored 'Trans proline' 0 C--N 1.384 2.399 0 C-N-CA 122.704 2.269 . . . . 71.1 112.264 -175.924 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 64.4 tttm -69.22 -51.14 40.72 Favored 'General case' 0 CA--C 1.543 0.7 0 C-N-CA 124.559 1.143 . . . . 74.04 111.223 -177.451 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 16.5 m -75.03 -30.15 61.01 Favored 'General case' 0 CA--C 1.551 1.009 0 CA-C-N 115.271 -0.877 . . . . 71.4 111.041 -175.264 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -72.81 -41.71 64.63 Favored 'General case' 0 CA--C 1.544 0.74 0 C-N-CA 123.18 0.592 . . . . 73.31 110.532 176.508 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 41.9 tt0 -61.16 -39.91 91.89 Favored 'General case' 0 N--CA 1.486 1.358 0 C-N-CA 124.002 0.921 . . . . 53.02 110.732 177.359 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 35' ' ' ASN . . . . . 0.426 ' O ' ' HG ' ' A' ' 39' ' ' LEU . 35.5 t30 -51.55 -67.28 0.26 Allowed 'General case' 0 CA--C 1.548 0.869 0 O-C-N 124.734 1.271 . . . . 54.42 111.034 178.083 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 85.0 t80 -62.23 -37.83 86.87 Favored 'General case' 0 N--CA 1.474 0.741 0 C-N-CA 123.156 0.582 . . . . 54.52 111.677 -176.161 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 73.8 ttt180 -59.03 -45.53 90.51 Favored 'General case' 0 CA--C 1.542 0.673 0 C-N-CA 123.419 0.687 . . . . 64.01 110.877 -179.936 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 38' ' ' ALA . . . . . 0.416 ' HB1' ' HG2' ' A' ' 44' ' ' LYS . . . -69.95 -30.09 67.39 Favored 'General case' 0 N--CA 1.472 0.674 0 C-N-CA 123.453 0.701 . . . . 75.13 111.748 -179.869 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 39' ' ' LEU . . . . . 0.426 ' HG ' ' O ' ' A' ' 35' ' ' ASN . 90.2 mt -67.22 -37.46 83.62 Favored 'General case' 0 N--CA 1.477 0.903 0 C-N-CA 123.241 0.616 . . . . 44.03 110.684 173.667 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 36.9 m -77.77 -41.02 38.93 Favored 'General case' 0 N--CA 1.476 0.857 0 C-N-CA 123.641 0.776 . . . . 63.04 111.691 -175.493 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 41.1 p -82.21 -33.18 29.46 Favored 'General case' 0 N--CA 1.473 0.702 0 C-N-CA 123.54 0.736 . . . . 61.43 111.413 -176.344 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 92.77 24.59 22.81 Favored Glycine 0 C--N 1.342 0.909 0 CA-C-N 115.812 -0.631 . . . . 64.13 113.407 -176.86 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 45.6 mm-40 -60.99 -28.18 68.84 Favored 'General case' 0 N--CA 1.484 1.239 0 C-N-CA 122.865 0.466 . . . . 65.24 111.522 173.481 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 44' ' ' LYS . . . . . 0.416 ' HG2' ' HB1' ' A' ' 38' ' ' ALA . 30.8 mmmt -106.49 15.67 25.62 Favored 'General case' 0 N--CA 1.47 0.531 0 C-N-CA 123.806 0.843 . . . . 73.21 111.298 -178.985 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 88.01 -34.53 3.73 Favored Glycine 0 C--N 1.35 1.311 0 CA-C-O 119.807 -0.44 . . . . 63.3 113.966 175.745 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 14.3 m-85 -62.42 -47.16 85.33 Favored 'General case' 0 N--CA 1.479 1.011 0 C-N-CA 123.44 0.696 . . . . 75.31 111.624 -169.463 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 47.2 56.85 7.57 Favored Glycine 0 C--N 1.356 1.665 0 O-C-N 124.521 1.138 . . . . 75.41 115.367 168.479 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 48' ' ' TYR . . . . . 0.511 ' OH ' ' HG2' ' A' ' 76' ' ' LYS . 56.7 m-85 -55.89 91.25 0.01 OUTLIER 'General case' 0 N--CA 1.479 1.006 0 C-N-CA 124.106 0.962 . . . . 74.32 112.933 -174.68 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 49' ' ' LYS . . . . . 0.507 ' HE2' ' HA ' ' A' ' 160' ' ' ASP . 29.5 tptp -110.09 120.79 43.56 Favored 'General case' 0 C--O 1.236 0.369 0 CA-C-N 113.99 -1.459 . . . . 61.55 108.582 -179.905 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 86.13 21.08 53.67 Favored Glycine 0 C--N 1.346 1.107 0 O-C-N 123.236 0.335 . . . . 50.44 112.79 -176.279 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 23.4 t -62.39 117.15 5.75 Favored 'General case' 0 CA--C 1.549 0.931 0 C-N-CA 124.075 0.95 . . . . 72.31 110.246 -178.357 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 52' ' ' CYS . . . . . . . . . . . . . 23.2 p -92.94 125.8 37.72 Favored 'General case' 0 C--O 1.24 0.566 0 C-N-CA 123.593 0.757 . . . . 74.33 112.573 -169.773 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 53' ' ' PHE . . . . . 0.745 ' HA ' ' HA2' ' A' ' 64' ' ' GLY . 64.1 m-85 -65.21 111.91 3.18 Favored 'General case' 0 CA--C 1.539 0.554 0 CA-C-N 115.035 -0.984 . . . . 73.24 108.956 164.404 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 21.8 p-80 -125.36 4.82 7.71 Favored 'General case' 0 N--CA 1.483 1.177 0 C-N-CA 123.447 0.699 . . . . 73.22 111.599 -175.983 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 65.5 ttt-85 -148.87 101.61 3.2 Favored 'General case' 0 N--CA 1.473 0.716 0 N-CA-C 109.431 -0.581 . . . . 75.24 109.431 176.648 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 56' ' ' ILE . . . . . 0.467 HG21 ' HA ' ' A' ' 143' ' ' GLU . 64.3 mt -133.7 134.12 56.55 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.098 0 C-N-CA 122.73 0.412 . . . . 71.04 110.007 -179.964 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 57' ' ' ILE . . . . . 0.414 ' HB ' ' HD2' ' A' ' 60' ' ' PHE . 71.7 mt -117.91 120.06 33.07 Favored Pre-proline 0 CA--C 1.55 0.964 0 N-CA-C 107.882 -1.155 . . . . 72.15 107.882 171.177 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 58' ' ' PRO . . . . . 0.525 ' HA ' ' HG2' ' A' ' 143' ' ' GLU . 28.0 Cg_endo -60.01 146.32 96.29 Favored 'Trans proline' 0 C--N 1.381 2.246 0 C-N-CA 123.043 2.495 . . . . 63.43 112.82 178.956 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 67.28 24.97 73.62 Favored Glycine 0 C--N 1.345 1.082 0 CA-C-N 115.74 -0.664 . . . . 74.15 113.935 179.446 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 60' ' ' PHE . . . . . 0.414 ' HD2' ' HB ' ' A' ' 57' ' ' ILE . 10.7 t80 -151.51 -72.4 0.16 Allowed 'General case' 0 N--CA 1.474 0.757 0 C-N-CA 122.978 0.511 . . . . 54.41 110.361 -175.173 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 47.1 ttp -160.04 135.05 7.91 Favored 'General case' 0 N--CA 1.474 0.728 0 CA-C-N 116.536 -0.302 . . . . 52.51 111.609 -167.112 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 62' ' ' CYS . . . . . 0.555 ' SG ' ' HB ' ' A' ' 114' ' ' ILE . 10.0 p -105.97 111.75 24.51 Favored 'General case' 0 CA--C 1.543 0.689 0 N-CA-C 108.764 -0.828 . . . . 73.11 108.764 167.898 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 63' ' ' GLN . . . . . 0.463 ' HA ' ' HA ' ' A' ' 113' ' ' PHE . 21.0 tt0 -109.13 133.76 52.59 Favored 'General case' 0 N--CA 1.48 1.062 0 C-N-CA 123.67 0.788 . . . . 54.4 110.933 -176.397 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 64' ' ' GLY . . . . . 0.745 ' HA2' ' HA ' ' A' ' 53' ' ' PHE . . . -122.52 175.24 16.42 Favored Glycine 0 C--N 1.345 1.078 0 CA-C-N 114.994 -1.003 . . . . 70.04 112.368 179.536 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 172.89 -166.26 38.81 Favored Glycine 0 C--N 1.331 0.291 0 N-CA-C 111.043 -0.823 . . . . 72.15 111.043 -179.792 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 38.8 t70 -126.32 160.8 29.38 Favored 'General case' 0 N--CA 1.476 0.863 0 C-N-CA 123.026 0.531 . . . . 74.51 110.55 -175.463 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 71.7 t80 -73.67 -32.43 63.96 Favored 'General case' 0 N--CA 1.472 0.669 0 C-N-CA 123.459 0.704 . . . . 74.43 111.211 -178.731 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 28.2 m -65.24 110.88 2.73 Favored 'General case' 0 N--CA 1.473 0.692 0 N-CA-C 109.925 -0.398 . . . . 74.25 109.925 -179.203 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 57.7 mtt85 66.99 30.52 7.49 Favored 'General case' 0 C--N 1.354 0.787 0 C-N-CA 125.052 1.341 . . . . 74.13 111.133 177.852 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 70' ' ' HIS . . . . . 0.413 ' HA ' ' HA3' ' A' ' 74' ' ' GLY . 27.5 p-80 -57.8 -23.69 53.69 Favored 'General case' 0 N--CA 1.49 1.537 0 C-N-CA 123.62 0.768 . . . . 71.23 111.774 -178.793 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 6.0 t30 -63.62 95.16 0.1 Allowed 'General case' 0 CA--C 1.543 0.694 0 C-N-CA 124.584 1.154 . . . . 73.34 109.339 168.376 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 79.05 -8.44 45.07 Favored Glycine 0 CA--C 1.529 0.92 0 N-CA-C 114.91 0.724 . . . . 72.13 114.91 174.258 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 18.0 m -135.47 -95.45 0.25 Allowed 'General case' 0 CA--C 1.558 1.279 0 CA-C-N 117.915 0.858 . . . . 71.24 110.179 -177.963 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 74' ' ' GLY . . . . . 0.413 ' HA3' ' HA ' ' A' ' 70' ' ' HIS . . . 59.51 56.15 26.61 Favored Glycine 0 C--N 1.359 1.855 0 CA-C-N 118.459 0.572 . . . . 65.05 113.626 177.776 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 134.76 49.41 0.08 OUTLIER Glycine 0 C--N 1.333 0.37 0 N-CA-C 109.443 -1.463 . . . . 70.55 109.443 -170.945 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 76' ' ' LYS . . . . . 0.511 ' HG2' ' OH ' ' A' ' 48' ' ' TYR . 22.7 ptmt -60.27 160.55 8.31 Favored 'General case' 0 N--CA 1.475 0.802 0 C-N-CA 124.113 0.965 . . . . 51.22 111.588 -177.548 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 79.1 p -90.27 174.22 7.71 Favored 'General case' 0 CA--C 1.54 0.58 0 CA-C-N 115.492 -0.776 . . . . 44.34 110.746 -178.486 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 24.8 pt -69.73 -17.54 21.38 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.818 0 C-N-CA 123.252 0.621 . . . . 74.32 110.806 176.611 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 36.5 m-85 -87.0 -16.2 36.45 Favored 'General case' 0 N--CA 1.47 0.563 0 C-N-CA 124.775 1.23 . . . . 72.31 110.643 -178.086 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 132.8 -134.04 7.35 Favored Glycine 0 C--N 1.345 1.064 0 N-CA-C 110.537 -1.025 . . . . 74.24 110.537 -177.179 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 37.1 tt0 -56.83 -54.6 44.52 Favored 'General case' 0 N--CA 1.473 0.707 0 C-N-CA 124.223 1.009 . . . . 74.41 111.427 179.453 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 82' ' ' LYS . . . . . 0.645 ' HD2' ' HA ' ' A' ' 107' ' ' THR . 21.6 pttp -168.19 177.35 5.52 Favored 'General case' 0 N--CA 1.474 0.742 0 C-N-CA 123.604 0.762 . . . . 74.32 110.69 -174.157 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 3.2 p90 -159.2 172.37 18.18 Favored 'General case' 0 CA--C 1.544 0.719 0 C-N-CA 124.73 1.212 . . . . 74.12 110.006 -174.68 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 84' ' ' GLU . . . . . 0.499 ' HA ' ' HA ' ' A' ' 106' ' ' ASN . 13.6 pt-20 -88.86 171.42 9.93 Favored 'General case' 0 N--CA 1.481 1.08 0 C-N-CA 123.094 0.558 . . . . 71.03 110.73 178.136 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 48.8 m-20 -80.63 148.71 30.14 Favored 'General case' 0 N--CA 1.478 0.928 0 N-CA-C 109.542 -0.54 . . . . 74.2 109.542 178.492 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 10.5 tp10 -86.98 -59.57 2.22 Favored 'General case' 0 N--CA 1.476 0.833 0 CA-C-O 120.606 0.241 . . . . 74.34 111.15 -179.659 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 13.0 p-10 -156.48 124.2 5.51 Favored 'General case' 0 N--CA 1.474 0.77 0 C-N-CA 123.015 0.526 . . . . 71.33 109.975 -169.603 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 79.1 m-85 -88.52 66.72 8.32 Favored 'General case' 0 N--CA 1.478 0.954 0 CA-C-O 121.683 0.754 . . . . 74.34 109.766 -174.53 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 55.0 mt -86.98 -51.6 12.74 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.587 0 CA-C-N 115.092 -0.958 . . . . 74.42 108.739 174.976 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 90' ' ' LEU . . . . . 0.543 ' HB3' ' HB ' ' A' ' 128' ' ' VAL . 94.6 mt -88.72 106.34 18.28 Favored 'General case' 0 C--O 1.24 0.57 0 CA-C-N 114.991 -1.004 . . . . 75.33 110.571 -175.789 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 50.0 mtmt -91.62 169.63 10.58 Favored 'General case' 0 C--O 1.24 0.593 0 CA-C-N 115.039 -0.982 . . . . 64.4 109.764 173.755 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 92' ' ' HIS . . . . . . . . . . . . . 20.8 m-70 -87.74 55.29 3.43 Favored 'General case' 0 N--CA 1.478 0.936 0 N-CA-C 108.826 -0.805 . . . . 72.53 108.826 -178.995 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 14.8 t -96.94 -2.67 43.2 Favored 'General case' 0 N--CA 1.475 0.776 0 CA-C-N 115.211 -0.904 . . . . 44.31 112.331 -169.707 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -131.77 178.65 17.74 Favored Glycine 0 C--N 1.342 0.912 0 CA-C-O 119.989 -0.34 . . . . 74.25 112.379 -179.564 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 76.9 Cg_endo -85.72 152.84 10.13 Favored 'Trans proline' 0 CA--C 1.551 1.373 0 C-N-CA 123.105 2.537 . . . . 73.34 112.37 172.16 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 80.66 19.96 67.1 Favored Glycine 0 C--N 1.343 0.954 0 CA-C-N 116.135 -0.484 . . . . 41.3 113.844 175.663 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 97' ' ' ILE . . . . . 0.668 ' HB ' ' HB2' ' A' ' 115' ' ' CYS . 25.8 mm -65.79 103.27 0.48 Allowed 'Isoleucine or valine' 0 CA--C 1.551 1.013 0 C-N-CA 124.138 0.975 . . . . 74.54 111.784 -175.606 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 58.5 tp -89.4 119.98 30.33 Favored 'General case' 0 C--O 1.247 0.972 0 CA-C-O 121.485 0.659 . . . . 61.4 109.819 174.264 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 46.0 t -149.55 146.38 27.32 Favored 'General case' 0 CA--C 1.549 0.929 0 C-N-CA 124.554 1.141 . . . . 63.24 108.119 -179.096 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 100' ' ' MET . . . . . 0.596 ' HA ' ' HA ' ' A' ' 112' ' ' PHE . 85.4 mtp -77.42 142.89 39.0 Favored 'General case' 0 N--CA 1.487 1.419 0 CA-C-N 118.216 0.462 . . . . 70.43 109.919 179.311 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 101' ' ' ALA . . . . . 0.538 ' HB3' ' HB2' ' A' ' 111' ' ' GLN . . . -75.04 155.52 37.17 Favored 'General case' 0 N--CA 1.474 0.731 0 CA-C-O 121.497 0.665 . . . . 72.31 112.083 -169.823 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 102' ' ' ASN . . . . . 0.423 ' HB2' ' HB ' ' A' ' 107' ' ' THR . 26.9 p-10 -167.49 166.32 14.34 Favored 'General case' 0 C--O 1.24 0.553 0 CA-C-N 114.421 -1.263 . . . . 73.03 109.744 -177.614 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -89.77 -50.98 5.74 Favored 'General case' 0 CA--C 1.537 0.452 0 N-CA-C 108.413 -0.958 . . . . 52.33 108.413 167.271 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -156.85 -156.11 7.74 Favored Glycine 0 C--N 1.347 1.193 0 CA-C-N 115.427 -0.806 . . . . 74.23 112.803 179.248 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 51.6 Cg_exo -55.7 139.62 83.49 Favored 'Trans proline' 0 C--N 1.375 1.932 0 C-N-CA 123.55 2.833 . . . . 50.11 113.165 178.134 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 106' ' ' ASN . . . . . 0.499 ' HA ' ' HA ' ' A' ' 84' ' ' GLU . 65.0 t30 66.24 8.51 5.64 Favored 'General case' 0 N--CA 1.483 1.217 0 C-N-CA 125.118 1.367 . . . . 62.42 112.487 177.215 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 107' ' ' THR . . . . . 0.645 ' HA ' ' HD2' ' A' ' 82' ' ' LYS . 3.8 m -100.72 -15.33 17.74 Favored 'General case' 0 CA--C 1.55 0.975 0 C-N-CA 123.749 0.82 . . . . 71.32 109.81 177.225 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 13.1 t30 -55.84 139.84 44.33 Favored 'General case' 0 C--O 1.208 -1.127 0 C-N-CA 125.658 1.583 . . . . 73.12 111.442 176.938 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 111.3 23.93 5.57 Favored Glycine 0 N--CA 1.469 0.886 0 N-CA-C 112.285 -0.326 . . . . 50.13 112.285 -178.872 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 13.6 p -136.98 120.8 17.46 Favored 'General case' 0 C--O 1.223 -0.311 0 C-N-CA 123.881 0.873 . . . . 72.4 108.645 178.126 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 111' ' ' GLN . . . . . 0.538 ' HB2' ' HB3' ' A' ' 101' ' ' ALA . 46.1 mt-30 59.51 -174.79 0.1 Allowed 'General case' 0 N--CA 1.489 1.489 0 C-N-CA 123.68 0.792 . . . . 74.33 111.563 -174.86 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 112' ' ' PHE . . . . . 0.596 ' HA ' ' HA ' ' A' ' 100' ' ' MET . 49.3 p90 -144.5 166.21 25.78 Favored 'General case' 0 N--CA 1.473 0.692 0 C-N-CA 123.953 0.901 . . . . 71.54 108.78 172.701 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 113' ' ' PHE . . . . . 0.463 ' HA ' ' HA ' ' A' ' 63' ' ' GLN . 51.8 p90 -152.64 154.94 36.35 Favored 'General case' 0 C--O 1.236 0.377 0 C-N-CA 122.969 0.508 . . . . 74.3 110.387 179.663 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 114' ' ' ILE . . . . . 0.555 ' HB ' ' SG ' ' A' ' 62' ' ' CYS . 16.2 mt -126.65 104.48 12.82 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.569 0 N-CA-C 108.698 -0.852 . . . . 45.5 108.698 178.492 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 115' ' ' CYS . . . . . 0.668 ' HB2' ' HB ' ' A' ' 97' ' ' ILE . 61.4 m -73.42 106.91 5.42 Favored 'General case' 0 CA--C 1.539 0.541 0 N-CA-C 109.016 -0.735 . . . . 52.45 109.016 172.772 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 116' ' ' THR . . . . . 0.426 HG22 HG12 ' A' ' 139' ' ' VAL . 75.1 p -71.39 -18.87 62.33 Favored 'General case' 0 N--CA 1.479 0.997 0 C-N-CA 123.261 0.624 . . . . 73.34 111.529 -177.273 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -124.72 169.52 11.9 Favored 'General case' 0 C--O 1.243 0.752 0 C-N-CA 123.682 0.793 . . . . 73.11 110.07 177.435 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 11.9 ptmm? -71.85 87.86 1.01 Allowed 'General case' 0 CA--C 1.55 0.95 0 CA-C-O 121.961 0.886 . . . . 73.33 110.92 176.173 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 119' ' ' THR . . . . . . . . . . . . . 52.9 p -85.34 87.89 7.44 Favored 'General case' 0 CA--C 1.544 0.734 0 CA-C-N 114.946 -1.025 . . . . 74.43 109.937 -176.894 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 120' ' ' GLU . . . . . 0.4 ' H ' ' HG2' ' A' ' 120' ' ' GLU . 7.9 pt-20 -73.07 -26.22 61.19 Favored 'General case' 0 N--CA 1.48 1.026 0 CA-C-N 114.535 -1.211 . . . . 75.21 112.934 -169.229 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 121' ' ' TRP . . . . . . . . . . . . . 39.5 p90 -70.72 -10.55 59.68 Favored 'General case' 0 N--CA 1.479 0.976 0 C-N-CA 123.732 0.813 . . . . 75.14 111.797 177.062 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 51.1 mt -95.05 0.07 54.13 Favored 'General case' 0 N--CA 1.477 0.904 0 C-N-CA 123.236 0.615 . . . . 74.45 111.673 177.514 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 32.9 m-20 -71.66 126.12 28.88 Favored 'General case' 0 N--CA 1.478 0.962 0 N-CA-C 108.801 -0.815 . . . . 73.51 108.801 172.762 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 106.82 -26.9 18.02 Favored Glycine 0 N--CA 1.471 1.02 0 N-CA-C 111.43 -0.668 . . . . 63.03 111.43 -171.933 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 125' ' ' LYS . . . . . 0.62 ' HG2' ' H ' ' A' ' 126' ' ' HIS . 20.9 ttmm -80.09 -164.96 0.75 Allowed 'General case' 0 CA--C 1.559 1.301 0 N-CA-C 107.979 -1.119 . . . . 73.02 107.979 170.907 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 126' ' ' HIS . . . . . 0.62 ' H ' ' HG2' ' A' ' 125' ' ' LYS . 8.9 t-80 -64.81 134.77 54.8 Favored 'General case' 0 C--N 1.353 0.76 0 CA-C-N 119.204 0.911 . . . . 64.1 111.132 -168.642 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 6.6 t -59.78 146.08 10.61 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.611 0 CA-C-N 112.787 -2.006 . . . . 74.33 111.091 -179.241 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 128' ' ' VAL . . . . . 0.543 ' HB ' ' HB3' ' A' ' 90' ' ' LEU . 18.9 t -74.8 156.1 6.28 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.789 0 N-CA-C 108.998 -0.742 . . . . 74.5 108.998 175.153 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 129' ' ' PHE . . . . . 0.441 ' CE2' ' HG3' ' A' ' 100' ' ' MET . 26.7 p90 -137.76 -11.72 1.54 Allowed 'General case' 0 N--CA 1.485 1.288 0 C-N-CA 122.189 0.195 . . . . 75.01 111.453 174.047 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . -148.14 159.11 27.92 Favored Glycine 0 C--N 1.341 0.84 0 N-CA-C 111.518 -0.633 . . . . 45.34 111.518 -177.056 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 35.1 ttpt -147.31 137.46 23.19 Favored 'General case' 0 N--CA 1.474 0.741 0 N-CA-C 109.39 -0.596 . . . . 75.24 109.39 178.728 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 132' ' ' VAL . . . . . 0.513 HG11 ' HA ' ' A' ' 136' ' ' MET . 37.5 t -63.91 111.89 1.18 Allowed 'Isoleucine or valine' 0 CA--C 1.543 0.705 0 O-C-N 123.658 0.599 . . . . 74.14 110.227 178.054 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 133' ' ' LYS . . . . . 0.593 ' HG3' ' HG2' ' A' ' 134' ' ' GLU . 0.0 OUTLIER -95.7 -42.42 8.39 Favored 'General case' 0 N--CA 1.474 0.751 0 C-N-CA 123.068 0.547 . . . . 60.42 109.569 172.457 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 134' ' ' GLU . . . . . 0.593 ' HG2' ' HG3' ' A' ' 133' ' ' LYS . 18.7 mm-40 -116.4 139.11 50.78 Favored 'General case' 0 N--CA 1.474 0.745 0 N-CA-C 108.674 -0.862 . . . . 74.21 108.674 -178.088 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 76.68 29.08 58.19 Favored Glycine 0 C--N 1.342 0.862 0 N-CA-C 114.156 0.422 . . . . 60.31 114.156 175.455 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 136' ' ' MET . . . . . 0.513 ' HA ' HG11 ' A' ' 132' ' ' VAL . 14.9 tpt -60.11 -38.08 81.93 Favored 'General case' 0 N--CA 1.477 0.908 0 C-N-CA 122.992 0.517 . . . . 74.3 111.216 177.647 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 137' ' ' ASN . . . . . . . . . . . . . 6.0 t30 -61.81 -39.23 91.01 Favored 'General case' 0 CA--C 1.543 0.679 0 CA-C-N 115.448 -0.796 . . . . 74.14 110.88 176.238 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 138' ' ' ILE . . . . . . . . . . . . . 49.2 mm -67.56 -35.57 73.51 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.089 0 C-N-CA 123.523 0.729 . . . . 62.33 110.868 -179.822 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 139' ' ' VAL . . . . . 0.446 HG21 HG21 ' A' ' 132' ' ' VAL . 92.1 t -65.61 -47.26 86.93 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.939 0 C-N-CA 123.561 0.744 . . . . 55.2 110.648 177.203 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 41.6 mt-10 -66.83 -34.81 78.63 Favored 'General case' 0 CA--C 1.548 0.867 0 CA-C-N 115.396 -0.82 . . . . 71.44 110.964 177.739 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -69.01 -44.06 73.55 Favored 'General case' 0 N--CA 1.475 0.815 0 C-N-CA 123.309 0.644 . . . . 51.45 110.881 -178.984 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 142' ' ' MET . . . . . 0.567 ' HB2' HD13 ' A' ' 156' ' ' ILE . 19.7 ptt? -69.29 -31.16 69.47 Favored 'General case' 0 N--CA 1.477 0.88 0 O-C-N 123.429 0.456 . . . . 73.52 110.394 179.172 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 143' ' ' GLU . . . . . 0.525 ' HG2' ' HA ' ' A' ' 58' ' ' PRO . 36.9 tt0 -62.32 -31.76 72.43 Favored 'General case' 0 CA--C 1.549 0.907 0 C-N-CA 122.784 0.434 . . . . 70.12 112.009 178.868 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 144' ' ' ARG . . . . . . . . . . . . . 33.1 mtp85 -65.27 -20.57 66.48 Favored 'General case' 0 N--CA 1.48 1.035 0 C-N-CA 122.706 0.402 . . . . 72.41 111.863 178.607 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 145' ' ' PHE . . . . . 0.534 ' HB2' HD11 ' A' ' 156' ' ' ILE . 66.3 m-85 -85.75 13.22 7.51 Favored 'General case' 0 N--CA 1.479 0.983 0 C-N-CA 123.388 0.675 . . . . 74.5 111.625 176.403 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . -98.45 -179.24 32.48 Favored Glycine 0 C--N 1.345 1.08 0 N-CA-C 111.743 -0.543 . . . . 63.12 111.743 169.838 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 10.8 m -133.45 163.09 30.14 Favored 'General case' 0 N--CA 1.478 0.944 0 C-N-CA 123.149 0.58 . . . . 73.33 111.203 -175.542 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 148' ' ' ARG . . . . . . . . . . . . . 7.3 mmm180 -67.82 -28.77 67.85 Favored 'General case' 0 N--CA 1.473 0.691 0 C-N-CA 124.383 1.073 . . . . 75.41 112.533 -177.511 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 149' ' ' ASN . . . . . . . . . . . . . 27.3 p-10 -84.58 -3.37 58.42 Favored 'General case' 0 N--CA 1.483 1.217 0 C-N-CA 123.349 0.659 . . . . 72.43 111.607 177.603 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . 100.25 -8.9 59.16 Favored Glycine 0 C--N 1.354 1.561 0 CA-C-O 119.975 -0.347 . . . . 55.41 113.188 179.028 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 59.6 tttp -65.44 143.08 57.93 Favored 'General case' 0 N--CA 1.478 0.956 0 C-N-CA 123.847 0.859 . . . . 74.25 110.408 178.336 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 152' ' ' THR . . . . . . . . . . . . . 16.5 p -92.92 114.21 26.71 Favored 'General case' 0 N--CA 1.467 0.398 0 N-CA-C 109.025 -0.732 . . . . 73.22 109.025 168.553 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 153' ' ' SER . . . . . . . . . . . . . 33.1 t -62.76 -29.02 70.38 Favored 'General case' 0 N--CA 1.475 0.784 0 C-N-CA 123.759 0.823 . . . . 72.23 110.719 177.063 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 154' ' ' LYS . . . . . 0.407 ' HB2' ' HB3' ' A' ' 145' ' ' PHE . 69.9 mmtt -124.93 145.06 50.03 Favored 'General case' 0 C--O 1.239 0.517 0 C-N-CA 123.942 0.897 . . . . 71.32 110.518 179.84 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 3.4 tppp? -79.23 99.41 7.03 Favored 'General case' 0 C--O 1.24 0.565 0 N-CA-C 109.031 -0.729 . . . . 75.32 109.031 172.651 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 156' ' ' ILE . . . . . 0.567 HD13 ' HB2' ' A' ' 142' ' ' MET . 52.3 mt -99.43 123.3 52.06 Favored 'Isoleucine or valine' 0 C--O 1.221 -0.406 0 CA-C-N 114.744 -1.116 . . . . 72.2 108.123 178.395 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 157' ' ' THR . . . . . . . . . . . . . 33.2 p -124.81 156.89 37.07 Favored 'General case' 0 N--CA 1.472 0.631 0 C-N-CA 124.13 0.972 . . . . 75.21 109.816 -177.521 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 158' ' ' ILE . . . . . . . . . . . . . 56.4 mt -82.25 93.73 2.7 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.719 0 N-CA-C 108.106 -1.072 . . . . 72.0 108.106 169.095 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 159' ' ' ALA . . . . . 0.551 ' HB2' ' HB2' ' A' ' 11' ' ' ALA . . . -54.54 -37.08 64.99 Favored 'General case' 0 N--CA 1.478 0.948 0 C-N-CA 124.759 1.224 . . . . 71.43 112.914 -177.736 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 160' ' ' ASP . . . . . 0.507 ' HA ' ' HE2' ' A' ' 49' ' ' LYS . 26.8 t0 -162.64 156.17 20.33 Favored 'General case' 0 N--CA 1.477 0.88 0 O-C-N 123.61 0.569 . . . . 74.15 111.214 -179.983 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 161' ' ' CYS . . . . . . . . . . . . . 6.9 p -123.15 -171.68 2.35 Favored 'General case' 0 N--CA 1.475 0.816 0 C-N-CA 125.255 1.422 . . . . 75.02 108.24 172.917 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 162' ' ' GLY . . . . . . . . . . . . . . . 131.42 57.93 0.09 OUTLIER Glycine 0 N--CA 1.475 1.266 0 O-C-N 121.473 -0.767 . . . . 14.22 111.507 -169.214 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 163' ' ' GLN . . . . . 0.497 ' HA ' ' H ' ' A' ' 7' ' ' PHE . 11.5 pt20 -45.36 132.71 7.65 Favored 'General case' 0 CA--C 1.547 0.838 0 C-N-CA 125.19 1.396 . . . . 74.21 114.031 -169.683 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 164' ' ' LEU . . . . . 0.515 ' O ' ' HB ' ' A' ' 5' ' ' THR . 85.1 mt -103.4 101.48 11.38 Favored 'General case' 0 N--CA 1.472 0.645 0 C-N-CA 123.976 0.911 . . . . 72.21 110.959 -179.731 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 165' ' ' GLU . . . . . . . . . . . . . 46.9 mt-10 . . . . . 0 CA--C 1.553 1.066 0 N-CA-C 108.974 -0.75 . . . . 63.02 108.974 171.701 . . . . . . . . 0 0 . 1 . 010 nuclear build full ' B' B ' 216' ' ' PRO . . . . . 0.635 ' N ' ' HH ' ' B' ' 221' ' ' TYR . 10.0 Cg_endo . . . . . 0 CA--C 1.554 1.5 0 CA-C-O 119.46 -0.308 . . . . 54.54 111.873 . . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 217' ' ' GLU . . . . . . . . . . . . . 16.1 pt-20 -171.73 154.8 3.74 Favored Pre-proline 0 N--CA 1.487 1.409 0 C-N-CA 123.487 0.715 . . . . 75.34 110.916 -175.861 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 218' ' ' PRO . . . . . . . . . . . . . 7.9 Cg_exo -70.77 90.8 0.62 Allowed 'Trans proline' 0 C--N 1.379 2.176 0 C-N-CA 122.618 2.212 . . . . 70.04 110.804 173.089 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 219' ' ' GLY . . . . . . . . . . . . . . . 166.37 141.91 3.28 Favored Glycine 0 CA--C 1.531 1.071 0 CA-C-O 119.471 -0.627 . . . . 72.3 112.277 -179.961 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 220' ' ' PRO . . . . . . . . . . . . . 52.4 Cg_exo -60.84 159.95 27.13 Favored 'Trans proline' 0 N--CA 1.498 1.788 0 C-N-CA 123.957 3.105 . . . . 72.34 114.698 178.308 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 221' ' ' TYR . . . . . 0.635 ' HH ' ' N ' ' B' ' 216' ' ' PRO . 48.1 m-85 -128.2 150.16 50.13 Favored 'General case' 0 N--CA 1.484 1.247 0 C-N-CA 123.655 0.782 . . . . 70.24 110.704 -175.131 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 222' ' ' ALA . . . . . . . . . . . . . . . -173.07 178.79 2.4 Favored 'General case' 0 N--CA 1.474 0.753 0 O-C-N 124.367 1.042 . . . . 61.23 110.543 174.003 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 223' ' ' GLN . . . . . . . . . . . . . 4.2 mp0 51.77 56.8 16.29 Favored Pre-proline 0 CA--C 1.565 1.532 0 C-N-CA 124.448 1.099 . . . . 74.43 110.535 -172.776 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 224' ' ' PRO . . . . . . . . . . . . . 2.0 Cg_endo . . . . . 0 C--N 1.381 2.24 0 C-N-CA 123.49 2.793 . . . . 71.54 111.529 -172.65 . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 97.2 mmm . . . . . 0 N--CA 1.48 1.043 0 CA-C-O 121.291 0.567 . . . . 73.33 109.617 . . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 11.8 p -78.0 -17.88 13.88 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.928 0 C-N-CA 123.939 0.896 . . . . 71.22 111.108 -179.007 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 89.2 m-20 -55.26 113.38 5.41 Favored Pre-proline 0 C--N 1.36 1.056 0 C-N-CA 123.572 0.749 . . . . 65.43 110.909 179.504 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 19.9 Cg_endo -57.12 118.43 5.3 Favored 'Trans proline' 0 C--N 1.379 2.184 0 C-N-CA 122.889 2.392 . . . . 74.03 111.448 -174.337 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 5' ' ' THR . . . . . 0.421 ' HB ' ' O ' ' A' ' 164' ' ' LEU . 19.7 m -95.56 127.3 41.48 Favored 'General case' 0 N--CA 1.443 -0.794 0 N-CA-C 108.407 -0.96 . . . . 70.24 108.407 -176.757 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 6' ' ' VAL . . . . . 0.472 HG22 ' HB2' ' A' ' 22' ' ' PHE . 15.6 m -106.92 150.5 9.41 Favored 'Isoleucine or valine' 0 CA--C 1.522 -0.106 0 CA-C-N 115.536 -0.756 . . . . 71.32 109.096 -174.918 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 79.7 t80 -138.96 135.63 34.56 Favored 'General case' 0 C--O 1.239 0.531 0 C-N-CA 122.824 0.45 . . . . 73.31 110.389 -173.765 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 8' ' ' PHE . . . . . 0.448 ' HE1' ' HG ' ' A' ' 40' ' ' SER . 61.2 m-85 -141.87 165.58 27.09 Favored 'General case' 0 N--CA 1.469 0.513 0 C-N-CA 123.998 0.919 . . . . 61.21 110.504 178.946 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 11.3 m-20 -106.74 119.01 38.18 Favored 'General case' 0 N--CA 1.468 0.454 0 N-CA-C 108.012 -1.107 . . . . 61.02 108.012 165.168 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 10' ' ' ILE . . . . . 0.539 HG21 ' SD ' ' A' ' 142' ' ' MET . 48.6 mm -86.49 118.5 32.91 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.559 0 N-CA-C 109.021 -0.733 . . . . 73.42 109.021 176.532 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 11' ' ' ALA . . . . . 0.757 ' HB2' ' HB2' ' A' ' 159' ' ' ALA . . . -109.32 133.09 53.48 Favored 'General case' 0 C--O 1.219 -0.538 0 C-N-CA 123.975 0.91 . . . . 60.54 111.383 -174.689 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 43.0 t -97.64 123.54 50.12 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.533 0 N-CA-C 108.437 -0.949 . . . . 74.22 108.437 170.532 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 13' ' ' ASP . . . . . 0.454 ' HA ' ' HB2' ' A' ' 155' ' ' LYS . 66.7 m-20 61.22 15.02 6.02 Favored 'General case' 0 N--CA 1.483 1.206 0 C-N-CA 125.55 1.54 . . . . 74.44 112.928 -178.036 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 108.42 -27.32 14.05 Favored Glycine 0 C--N 1.346 1.103 0 CA-C-O 119.679 -0.512 . . . . 74.24 112.825 -176.502 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 30.8 mm-40 -89.17 122.69 68.49 Favored Pre-proline 0 N--CA 1.487 1.379 0 CA-C-N 117.666 0.733 . . . . 64.15 110.427 -179.1 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 16' ' ' PRO . . . . . 0.477 ' HA ' ' HA ' ' A' ' 11' ' ' ALA . 19.2 Cg_endo -54.36 113.22 1.26 Allowed 'Trans proline' 0 C--N 1.386 2.55 0 C-N-CA 123.344 2.696 . . . . 65.0 112.974 -177.428 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 37.2 tp -77.03 -36.72 55.92 Favored 'General case' 0 N--CA 1.479 0.991 0 C-N-CA 124.041 0.936 . . . . 72.02 109.552 175.883 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -173.4 -161.78 24.23 Favored Glycine 0 C--N 1.335 0.479 0 CA-C-N 114.671 -1.149 . . . . 32.44 111.291 -178.741 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 3.5 ptp180 -144.31 140.82 29.38 Favored 'General case' 0 N--CA 1.469 0.516 0 C-N-CA 123.374 0.67 . . . . 62.34 109.858 -176.762 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 20' ' ' VAL . . . . . 0.436 ' HA ' ' HA3' ' A' ' 135' ' ' GLY . 60.8 t -128.54 135.89 61.32 Favored 'Isoleucine or valine' 0 C--O 1.24 0.599 0 C-N-CA 124.029 0.931 . . . . 43.52 109.464 -176.213 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 31.5 t -113.39 121.03 43.13 Favored 'General case' 0 CA--C 1.547 0.841 0 C-N-CA 123.864 0.865 . . . . 54.51 108.852 172.951 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 22' ' ' PHE . . . . . 0.472 ' HB2' HG22 ' A' ' 6' ' ' VAL . 12.2 m-85 -101.0 170.87 7.99 Favored 'General case' 0 CA--C 1.543 0.706 0 N-CA-C 108.731 -0.841 . . . . 73.35 108.731 175.458 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 23' ' ' GLU . . . . . 0.66 ' HB2' ' HD2' ' A' ' 133' ' ' LYS . 38.9 tt0 -134.08 108.5 8.36 Favored 'General case' 0 N--CA 1.472 0.663 0 C-N-CA 123.977 0.911 . . . . 61.44 109.094 -178.557 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 13.6 mt -91.48 121.09 32.87 Favored 'General case' 0 CA--C 1.542 0.663 0 C-N-CA 122.949 0.5 . . . . 72.33 110.09 -176.726 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 25' ' ' PHE . . . . . 0.52 ' HB2' HD11 ' A' ' 90' ' ' LEU . 31.4 m-85 -86.98 69.98 10.28 Favored 'General case' 0 N--CA 1.472 0.658 0 C-N-CA 123.631 0.772 . . . . 74.32 109.777 -177.766 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -64.53 -16.07 61.97 Favored 'General case' 0 N--CA 1.48 1.034 0 N-CA-C 112.929 0.714 . . . . 60.41 112.929 -178.085 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 10.3 p-10 -72.67 -29.72 63.65 Favored 'General case' 0 CA--C 1.553 1.073 0 C-N-CA 123.279 0.632 . . . . 72.43 111.431 177.281 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 54.5 mttp -98.54 -41.65 7.66 Favored 'General case' 0 N--CA 1.485 1.319 0 C-N-CA 123.833 0.853 . . . . 75.43 110.891 -176.407 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 29' ' ' VAL . . . . . 0.517 HG21 ' HA ' ' A' ' 129' ' ' PHE . 9.7 m -129.97 70.62 82.16 Favored Pre-proline 0 CA--C 1.561 1.39 0 C-N-CA 123.992 0.917 . . . . 54.41 109.815 -178.071 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 18.5 Cg_endo -57.73 -40.07 82.35 Favored 'Trans proline' 0 C--N 1.387 2.56 0 C-N-CA 123.221 2.614 . . . . 70.15 113.39 -175.28 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 37.9 ttpt -66.87 -55.49 14.49 Favored 'General case' 0 N--CA 1.476 0.872 0 C-N-CA 123.539 0.735 . . . . 72.21 111.935 -179.587 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 5.8 m -68.74 -32.29 71.95 Favored 'General case' 0 CA--C 1.554 1.114 0 CA-C-N 115.591 -0.731 . . . . 70.4 111.455 -172.039 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -79.26 -45.5 19.63 Favored 'General case' 0 N--CA 1.477 0.878 0 C-N-CA 123.531 0.733 . . . . 64.32 111.115 179.745 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 32.3 tt0 -58.76 -35.07 72.15 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 123.604 0.565 . . . . 74.53 110.698 178.111 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 35' ' ' ASN . . . . . 0.527 ' O ' ' HG ' ' A' ' 39' ' ' LEU . 51.5 t30 -53.61 -69.25 0.12 Allowed 'General case' 0 C--N 1.353 0.751 0 O-C-N 124.267 0.98 . . . . 62.24 110.822 -179.175 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 91.4 t80 -62.83 -35.01 78.53 Favored 'General case' 0 N--CA 1.48 1.064 0 C-N-CA 123.493 0.717 . . . . 75.34 111.962 -176.128 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 56.2 ttt180 -61.74 -48.81 79.05 Favored 'General case' 0 N--CA 1.479 0.977 0 C-N-CA 123.535 0.734 . . . . 72.41 111.141 179.668 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -84.16 -19.45 34.1 Favored 'General case' 0 N--CA 1.475 0.808 0 CA-C-N 115.515 -0.766 . . . . 62.23 111.994 -174.832 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 39' ' ' LEU . . . . . 0.527 ' HG ' ' O ' ' A' ' 35' ' ' ASN . 66.4 mt -64.78 -46.1 83.52 Favored 'General case' 0 N--CA 1.474 0.752 0 N-CA-C 108.538 -0.912 . . . . 63.45 108.538 167.636 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 40' ' ' SER . . . . . 0.448 ' HG ' ' HE1' ' A' ' 8' ' ' PHE . 27.0 t -64.54 -56.21 15.54 Favored 'General case' 0 CA--C 1.543 0.683 0 C-N-CA 124.463 1.105 . . . . 71.1 112.047 -178.162 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 41' ' ' THR . . . . . 0.553 HG23 ' NE2' ' A' ' 163' ' ' GLN . 2.9 p -67.79 -30.71 70.21 Favored 'General case' 0 N--CA 1.477 0.901 0 C-N-CA 122.761 0.424 . . . . 75.44 111.541 179.652 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 42' ' ' GLY . . . . . 0.421 ' HA2' ' H ' ' A' ' 47' ' ' GLY . . . 84.09 29.01 32.31 Favored Glycine 0 C--N 1.345 1.069 0 CA-C-N 116.236 -0.438 . . . . 74.31 112.486 -179.06 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 21.2 mm-40 -64.49 -24.95 67.79 Favored 'General case' 0 N--CA 1.478 0.943 0 C-N-CA 123.437 0.695 . . . . 63.11 111.504 175.781 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 44' ' ' LYS . . . . . 0.548 ' HG3' HG22 ' A' ' 78' ' ' ILE . 70.8 mmtt -98.35 5.69 47.98 Favored 'General case' 0 CA--C 1.548 0.897 0 C-N-CA 124.088 0.955 . . . . 71.33 111.117 -179.936 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 79.08 39.21 20.44 Favored Glycine 0 C--N 1.348 1.218 0 CA-C-O 119.973 -0.348 . . . . 65.53 113.612 179.026 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 22.9 m-85 -123.98 -48.54 1.87 Allowed 'General case' 0 N--CA 1.485 1.3 0 CA-C-N 117.207 0.503 . . . . 64.41 111.309 -176.758 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 47' ' ' GLY . . . . . 0.421 ' H ' ' HA2' ' A' ' 42' ' ' GLY . . . 53.1 61.83 6.54 Favored Glycine 0 C--N 1.352 1.462 0 O-C-N 124.127 0.892 . . . . 73.14 114.461 171.009 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 48' ' ' TYR . . . . . 0.46 ' CE1' ' HA2' ' A' ' 75' ' ' GLY . 61.7 m-85 -67.51 97.94 0.63 Allowed 'General case' 0 N--CA 1.473 0.679 0 C-N-CA 123.499 0.72 . . . . 65.01 112.44 -176.289 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 3.0 tppp? -109.86 145.7 36.34 Favored 'General case' 0 CA--C 1.537 0.46 0 CA-C-N 114.532 -1.213 . . . . 62.52 108.938 172.26 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 71.01 20.63 77.99 Favored Glycine 0 C--N 1.343 0.953 0 CA-C-O 119.515 -0.603 . . . . 53.24 113.444 179.318 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 20.3 m -55.83 113.83 1.65 Allowed 'General case' 0 C--N 1.354 0.787 0 C-N-CA 123.595 0.758 . . . . 70.12 109.842 -179.324 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 52' ' ' CYS . . . . . 0.569 ' SG ' ' HB3' ' A' ' 66' ' ' ASP . 7.7 p -100.28 123.03 44.01 Favored 'General case' 0 CA--C 1.545 0.77 0 CA-C-N 115.277 -0.874 . . . . 73.54 112.505 -163.441 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 53' ' ' PHE . . . . . 0.734 ' HA ' ' HA2' ' A' ' 64' ' ' GLY . 33.3 m-85 -71.07 118.32 13.7 Favored 'General case' 0 C--O 1.239 0.504 0 C-N-CA 125.461 1.504 . . . . 73.02 109.79 171.874 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 54' ' ' HIS . . . . . 0.477 ' ND1' ' HB2' ' A' ' 66' ' ' ASP . 45.5 p-80 -115.96 -22.97 8.76 Favored 'General case' 0 N--CA 1.475 0.792 0 C-N-CA 123.772 0.829 . . . . 74.03 110.858 -176.675 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 47.9 ttt-85 -128.95 106.21 8.73 Favored 'General case' 0 C--N 1.359 1.005 0 N-CA-C 109.572 -0.529 . . . . 73.34 109.572 178.704 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 56' ' ' ILE . . . . . 0.55 HG21 ' HA ' ' A' ' 143' ' ' GLU . 56.5 mt -130.58 128.23 63.16 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.749 0 C-N-CA 123.72 0.808 . . . . 73.14 108.973 174.695 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 57' ' ' ILE . . . . . 0.409 ' HB ' ' HD2' ' A' ' 60' ' ' PHE . 76.3 mt -108.02 117.66 54.57 Favored Pre-proline 0 CA--C 1.557 1.219 0 C-N-CA 124.281 1.032 . . . . 74.33 108.256 173.254 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 58' ' ' PRO . . . . . 0.565 ' HA ' ' HG2' ' A' ' 143' ' ' GLU . 32.0 Cg_exo -58.84 131.52 42.42 Favored 'Trans proline' 0 C--N 1.382 2.313 0 C-N-CA 123.64 2.893 . . . . 64.04 112.83 179.62 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 79.2 21.09 68.31 Favored Glycine 0 CA--C 1.529 0.928 0 O-C-N 124.018 0.824 . . . . 53.33 113.597 179.885 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 60' ' ' PHE . . . . . 0.409 ' HD2' ' HB ' ' A' ' 57' ' ' ILE . 17.3 t80 -148.04 -73.42 0.2 Allowed 'General case' 0 N--CA 1.48 1.032 0 CA-C-N 117.659 0.73 . . . . 74.44 111.121 -173.888 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 61' ' ' MET . . . . . 0.411 ' SD ' ' CD1' ' A' ' 113' ' ' PHE . 58.5 ttp -159.75 142.56 13.83 Favored 'General case' 0 N--CA 1.483 1.221 0 N-CA-C 112.578 0.585 . . . . 72.15 112.578 -165.412 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 62' ' ' CYS . . . . . 0.501 ' SG ' ' HB2' ' A' ' 143' ' ' GLU . 52.2 m -117.18 116.92 28.23 Favored 'General case' 0 N--CA 1.474 0.74 0 C-N-CA 124.511 1.125 . . . . 73.41 110.179 175.145 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 15.0 pt20 -121.0 130.31 53.75 Favored 'General case' 0 N--CA 1.484 1.259 0 CA-C-O 122.103 0.954 . . . . 72.41 112.11 179.499 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 64' ' ' GLY . . . . . 0.734 ' HA2' ' HA ' ' A' ' 53' ' ' PHE . . . -113.49 -177.21 19.42 Favored Glycine 0 C--N 1.343 0.94 0 CA-C-N 113.79 -1.55 . . . . 43.11 112.758 178.27 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 98.83 73.66 1.11 Allowed Glycine 0 C--N 1.337 0.614 0 N-CA-C 110.871 -0.892 . . . . 52.04 110.871 -178.959 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 66' ' ' ASP . . . . . 0.569 ' HB3' ' SG ' ' A' ' 52' ' ' CYS . 32.6 t70 -127.56 30.29 5.36 Favored 'General case' 0 N--CA 1.482 1.141 0 C-N-CA 123.099 0.56 . . . . 70.03 109.916 172.124 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 57.0 t80 -93.8 -83.83 0.32 Allowed 'General case' 0 CA--C 1.555 1.148 0 O-C-N 122.055 -0.403 . . . . 71.3 111.044 -177.12 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 69.9 m -81.15 113.11 19.09 Favored 'General case' 0 N--CA 1.482 1.148 0 C-N-CA 123.407 0.683 . . . . 43.11 111.346 -171.307 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 60.7 ttt85 62.76 66.51 0.75 Allowed 'General case' 0 N--CA 1.476 0.856 0 C-N-CA 124.349 1.06 . . . . 52.43 109.522 -174.471 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 2.5 p-80 -74.63 74.85 2.02 Favored 'General case' 0 N--CA 1.482 1.161 0 CA-C-N 114.819 -1.082 . . . . 74.3 112.083 -175.272 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 64.5 t30 -154.72 77.98 1.05 Allowed 'General case' 0 N--CA 1.473 0.719 0 N-CA-C 108.085 -1.08 . . . . 71.24 108.085 177.163 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 63.98 22.81 67.08 Favored Glycine 0 CA--C 1.534 1.26 0 CA-C-N 115.67 -0.696 . . . . 75.33 114.044 -176.32 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 73' ' ' THR . . . . . 0.551 ' HA ' ' HB2' ' A' ' 110' ' ' SER . 46.9 m -142.53 -65.37 0.4 Allowed 'General case' 0 N--CA 1.476 0.854 0 C-N-CA 123.855 0.862 . . . . 72.52 109.492 -174.582 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 44.04 38.53 4.75 Favored Glycine 0 C--N 1.355 1.599 0 C-N-CA 124.517 1.056 . . . . 44.14 115.655 174.922 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 75' ' ' GLY . . . . . 0.46 ' HA2' ' CE1' ' A' ' 48' ' ' TYR . . . 149.78 54.05 0.01 OUTLIER Glycine 0 C--N 1.337 0.584 0 O-C-N 122.122 -0.634 . . . . 75.13 112.256 -161.281 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -48.22 149.62 1.45 Allowed 'General case' 0 N--CA 1.481 1.108 0 C-N-CA 124.685 1.194 . . . . 71.11 111.621 169.909 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 94.3 p -90.03 -178.4 5.43 Favored 'General case' 0 C--O 1.24 0.59 0 CA-C-O 121.781 0.8 . . . . 64.24 112.244 -169.504 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 78' ' ' ILE . . . . . 0.548 HG22 ' HG3' ' A' ' 44' ' ' LYS . 27.7 pt -72.62 -19.48 19.11 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.941 0 CA-C-N 114.909 -1.041 . . . . 65.12 110.751 175.787 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 92.8 m-85 -92.08 25.78 2.73 Favored 'General case' 0 N--CA 1.481 1.115 0 C-N-CA 123.701 0.8 . . . . 73.11 110.381 173.062 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 83.92 -105.15 2.74 Favored Glycine 0 C--N 1.343 0.939 0 N-CA-C 111.015 -0.834 . . . . 62.35 111.015 -178.243 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 43.0 tt0 -74.34 -61.26 1.92 Allowed 'General case' 0 C--O 1.242 0.7 0 C-N-CA 122.872 0.469 . . . . 75.1 110.493 -177.237 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 82' ' ' LYS . . . . . 0.729 ' HD2' ' HA ' ' A' ' 107' ' ' THR . 20.4 pttp -168.78 177.15 5.2 Favored 'General case' 0 CA--C 1.542 0.635 0 CA-C-N 115.465 -0.788 . . . . 74.44 110.475 -173.128 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 28.9 p90 -159.35 177.45 10.99 Favored 'General case' 0 CA--C 1.546 0.791 0 C-N-CA 125.467 1.507 . . . . 75.32 108.251 -174.714 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 11.5 pt-20 -94.97 167.6 11.3 Favored 'General case' 0 N--CA 1.485 1.283 0 O-C-N 121.926 -0.484 . . . . 74.4 111.552 179.224 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 25.9 m-20 -61.41 150.13 36.31 Favored 'General case' 0 N--CA 1.479 1.021 0 C-N-CA 123.82 0.848 . . . . 54.03 111.302 174.489 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 86' ' ' GLU . . . . . 0.505 ' HG2' ' HA ' ' A' ' 29' ' ' VAL . 6.3 tp10 -74.63 -61.82 1.74 Allowed 'General case' 0 N--CA 1.474 0.747 0 CA-C-N 116.55 -0.296 . . . . 73.02 111.329 -176.664 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 87' ' ' ASN . . . . . 0.425 ' O ' HG11 ' A' ' 127' ' ' VAL . 31.2 p-10 -174.32 143.97 0.9 Allowed 'General case' 0 N--CA 1.479 1.009 0 C-N-CA 123.85 0.86 . . . . 64.02 109.134 -174.643 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 92.7 m-85 -88.25 53.24 2.67 Favored 'General case' 0 N--CA 1.483 1.218 0 C-N-CA 123.819 0.848 . . . . 74.42 112.115 -166.565 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 63.3 mt -77.38 -57.5 5.67 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.855 0 C-N-CA 123.654 0.782 . . . . 52.25 108.946 173.298 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 90' ' ' LEU . . . . . 0.575 ' HB3' ' HB ' ' A' ' 128' ' ' VAL . 86.7 mt -85.03 121.58 28.01 Favored 'General case' 0 C--O 1.238 0.467 0 CA-C-N 114.672 -1.149 . . . . 73.43 110.619 -175.145 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 46.5 mtmt -117.5 169.39 9.57 Favored 'General case' 0 N--CA 1.474 0.756 0 C-N-CA 124.141 0.976 . . . . 73.24 110.193 -175.831 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 92' ' ' HIS . . . . . 0.404 ' HA ' HG13 ' A' ' 97' ' ' ILE . 28.1 m-70 -86.38 50.15 1.94 Allowed 'General case' 0 N--CA 1.48 1.068 0 C-N-CA 124.062 0.945 . . . . 72.24 109.942 -178.988 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 10.5 t -95.0 -2.45 50.32 Favored 'General case' 0 CA--C 1.547 0.84 0 CA-C-N 115.112 -0.949 . . . . 75.54 110.965 -175.281 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -131.66 170.33 21.62 Favored Glycine 0 CA--C 1.533 1.189 0 CA-C-O 119.735 -0.48 . . . . 60.01 112.272 179.07 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 83.8 Cg_endo -81.99 157.36 17.95 Favored 'Trans proline' 0 CA--C 1.554 1.519 0 C-N-CA 122.799 2.333 . . . . 71.31 112.209 170.83 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 79.3 21.17 67.87 Favored Glycine 0 C--N 1.35 1.306 0 CA-C-N 116.601 -0.272 . . . . 54.13 113.624 176.544 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 97' ' ' ILE . . . . . 0.623 ' HB ' ' HB2' ' A' ' 115' ' ' CYS . 24.9 mm -65.63 103.72 0.5 Allowed 'Isoleucine or valine' 0 CA--C 1.547 0.836 0 C-N-CA 123.603 0.761 . . . . 74.43 111.816 -175.559 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 63.0 tp -89.02 114.38 25.57 Favored 'General case' 0 CA--C 1.547 0.84 0 CA-C-O 121.586 0.708 . . . . 72.13 109.368 173.708 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 99' ' ' SER . . . . . 0.692 ' HB3' ' HA ' ' A' ' 128' ' ' VAL . 4.9 p -148.05 139.75 23.82 Favored 'General case' 0 CA--C 1.537 0.473 0 C-N-CA 124.801 1.24 . . . . 61.3 108.033 178.354 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 100' ' ' MET . . . . . 0.736 ' HA ' ' HA ' ' A' ' 112' ' ' PHE . 67.3 mtp -75.55 148.05 39.21 Favored 'General case' 0 N--CA 1.489 1.522 0 C-N-CA 122.625 0.37 . . . . 63.23 110.775 -173.187 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 101' ' ' ALA . . . . . 0.71 ' HB3' ' HB2' ' A' ' 111' ' ' GLN . . . -72.34 152.28 42.18 Favored 'General case' 0 N--CA 1.479 0.984 0 CA-C-O 121.196 0.522 . . . . 73.32 112.301 -171.928 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 102' ' ' ASN . . . . . 0.459 ' HB2' ' HB ' ' A' ' 107' ' ' THR . 30.1 p-10 -165.83 159.42 15.99 Favored 'General case' 0 CA--C 1.536 0.438 0 CA-C-N 114.821 -1.081 . . . . 75.34 109.774 -177.022 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -110.14 25.08 12.18 Favored 'General case' 0 N--CA 1.472 0.654 0 C-N-CA 123.356 0.662 . . . . 63.23 109.379 169.821 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 136.9 -174.1 21.81 Favored Glycine 0 CA--C 1.535 1.292 0 CA-C-N 115.484 -0.78 . . . . 54.1 112.029 -179.422 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 51.7 Cg_exo -57.22 152.24 46.7 Favored 'Trans proline' 0 C--N 1.37 1.671 0 C-N-CA 123.439 2.759 . . . . 62.21 112.595 175.316 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 65.1 t30 66.74 12.67 8.98 Favored 'General case' 0 N--CA 1.489 1.491 0 C-N-CA 124.347 1.059 . . . . 75.4 111.965 179.638 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 107' ' ' THR . . . . . 0.729 ' HA ' ' HD2' ' A' ' 82' ' ' LYS . 2.7 m -120.77 7.23 10.45 Favored 'General case' 0 N--CA 1.489 1.506 0 C-N-CA 123.451 0.701 . . . . 72.24 110.579 -179.504 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 12.4 t30 -76.89 139.93 40.4 Favored 'General case' 0 N--CA 1.478 0.965 0 C-N-CA 124.643 1.177 . . . . 73.52 110.26 179.181 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 112.59 -11.35 25.73 Favored Glycine 0 N--CA 1.471 1.003 0 CA-C-O 119.843 -0.42 . . . . 64.22 113.269 178.518 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 110' ' ' SER . . . . . 0.551 ' HB2' ' HA ' ' A' ' 73' ' ' THR . 33.9 p -99.87 121.61 41.57 Favored 'General case' 0 N--CA 1.474 0.773 0 N-CA-C 109.047 -0.723 . . . . 74.41 109.047 173.009 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 111' ' ' GLN . . . . . 0.71 ' HB2' ' HB3' ' A' ' 101' ' ' ALA . 38.5 mt-30 63.67 175.74 0.17 Allowed 'General case' 0 N--CA 1.498 1.969 0 C-N-CA 124.294 1.037 . . . . 70.01 111.848 -177.705 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 112' ' ' PHE . . . . . 0.736 ' HA ' ' HA ' ' A' ' 100' ' ' MET . 36.6 p90 -148.93 133.36 17.57 Favored 'General case' 0 N--CA 1.482 1.147 0 N-CA-C 109.427 -0.583 . . . . 62.4 109.427 177.133 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 113' ' ' PHE . . . . . 0.411 ' CD1' ' SD ' ' A' ' 61' ' ' MET . 51.7 p90 -118.98 149.83 40.96 Favored 'General case' 0 N--CA 1.478 0.935 0 C-N-CA 123.151 0.58 . . . . 64.12 111.592 179.627 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 114' ' ' ILE . . . . . . . . . . . . . 22.5 mt -123.0 103.8 13.59 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.611 0 C-N-CA 124.279 1.032 . . . . 52.04 108.698 -179.753 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 115' ' ' CYS . . . . . 0.623 ' HB2' ' HB ' ' A' ' 97' ' ' ILE . 62.2 m -75.71 106.22 7.16 Favored 'General case' 0 CA--C 1.541 0.623 0 N-CA-C 109.336 -0.616 . . . . 52.22 109.336 175.584 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 39.5 p -70.63 -31.5 68.47 Favored 'General case' 0 N--CA 1.471 0.584 0 C-N-CA 123.534 0.734 . . . . 72.51 111.3 -179.104 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -99.06 159.04 15.25 Favored 'General case' 0 C--O 1.247 0.936 0 CA-C-N 115.462 -0.79 . . . . 44.05 109.478 171.69 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -72.36 88.89 1.2 Allowed 'General case' 0 CA--C 1.539 0.543 0 CA-C-O 121.765 0.793 . . . . 61.33 109.182 173.471 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 119' ' ' THR . . . . . . . . . . . . . 34.6 p -76.06 85.7 2.94 Favored 'General case' 0 CA--C 1.546 0.804 0 CA-C-O 122.276 1.036 . . . . 75.5 110.36 -174.381 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 11.5 pt-20 -71.29 -29.76 65.44 Favored 'General case' 0 N--CA 1.474 0.748 0 CA-C-N 114.158 -1.383 . . . . 75.41 111.38 -171.278 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 121' ' ' TRP . . . . . . . . . . . . . 43.6 p90 -67.94 -3.17 9.04 Favored 'General case' 0 N--CA 1.479 1.003 0 C-N-CA 123.367 0.667 . . . . 63.14 112.218 179.251 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 45.7 mt -96.24 26.32 4.35 Favored 'General case' 0 CA--C 1.555 1.141 0 C-N-CA 123.523 0.729 . . . . 62.41 111.535 174.037 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 56.7 m-20 -59.55 123.08 15.7 Favored 'General case' 0 N--CA 1.49 1.545 0 C-N-CA 122.758 0.423 . . . . 62.32 110.376 165.054 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 85.56 -9.1 69.03 Favored Glycine 0 N--CA 1.475 1.278 0 O-C-N 123.209 0.318 . . . . 61.44 113.27 -179.271 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 125' ' ' LYS . . . . . 0.641 ' HG3' ' H ' ' A' ' 126' ' ' HIS . 0.1 OUTLIER -82.74 -163.97 0.79 Allowed 'General case' 0 CA--C 1.561 1.371 0 C-N-CA 124.628 1.171 . . . . 73.43 108.412 177.511 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 126' ' ' HIS . . . . . 0.641 ' H ' ' HG3' ' A' ' 125' ' ' LYS . 57.3 t-80 -64.35 136.43 57.13 Favored 'General case' 0 N--CA 1.473 0.709 0 C-N-CA 124.119 0.968 . . . . 75.04 111.218 -166.38 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 127' ' ' VAL . . . . . 0.425 HG11 ' O ' ' A' ' 87' ' ' ASN . 45.1 t -71.76 140.33 18.32 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.536 0 CA-C-N 115.634 -0.712 . . . . 61.4 110.676 -176.466 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 128' ' ' VAL . . . . . 0.692 ' HA ' ' HB3' ' A' ' 99' ' ' SER . 25.1 t -73.37 148.0 9.14 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.558 0 N-CA-C 109.166 -0.679 . . . . 71.44 109.166 175.767 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 129' ' ' PHE . . . . . 0.517 ' HA ' HG21 ' A' ' 29' ' ' VAL . 39.5 p90 -129.2 -20.02 3.44 Favored 'General case' 0 N--CA 1.479 0.996 0 O-C-N 122.105 -0.372 . . . . 73.35 110.694 174.827 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . -140.23 164.18 26.25 Favored Glycine 0 C--N 1.34 0.761 0 O-C-N 123.717 0.636 . . . . 75.31 112.017 -175.87 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 34.6 ttpt -148.86 130.28 14.77 Favored 'General case' 0 N--CA 1.468 0.462 0 N-CA-C 109.271 -0.641 . . . . 74.21 109.271 -178.148 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 49.0 t -63.76 104.45 0.41 Allowed 'Isoleucine or valine' 0 C--O 1.238 0.496 0 N-CA-C 108.847 -0.797 . . . . 65.22 108.847 174.759 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 133' ' ' LYS . . . . . 0.66 ' HD2' ' HB2' ' A' ' 23' ' ' GLU . 19.4 ptmt -85.63 -33.4 21.63 Favored 'General case' 0 N--CA 1.471 0.618 0 N-CA-C 109.335 -0.617 . . . . 71.34 109.335 179.545 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 32.8 mt-10 -145.39 152.27 39.58 Favored 'General case' 0 N--CA 1.473 0.707 0 C-N-CA 125.033 1.333 . . . . 74.44 109.166 -178.135 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 135' ' ' GLY . . . . . 0.436 ' HA3' ' HA ' ' A' ' 20' ' ' VAL . . . 81.85 16.62 72.21 Favored Glycine 0 C--N 1.345 1.041 0 CA-C-N 116.534 -0.303 . . . . 74.02 112.729 -178.848 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 136' ' ' MET . . . . . . . . . . . . . 14.5 tpt -62.6 -31.11 71.88 Favored 'General case' 0 N--CA 1.479 0.998 0 C-N-CA 124.232 1.013 . . . . 73.0 110.857 177.72 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 137' ' ' ASN . . . . . . . . . . . . . 45.3 t30 -56.53 -44.66 81.04 Favored 'General case' 0 N--CA 1.477 0.883 0 CA-C-N 114.51 -1.223 . . . . 75.44 110.779 171.824 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 138' ' ' ILE . . . . . . . . . . . . . 46.4 mm -73.72 -33.13 37.21 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.009 0 C-N-CA 123.682 0.793 . . . . 64.42 111.135 -178.199 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 70.2 t -63.27 -47.72 90.83 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.114 0 CA-C-O 121.32 0.581 . . . . 73.43 110.511 177.146 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 49.0 mt-10 -73.13 -29.29 62.78 Favored 'General case' 0 CA--C 1.548 0.884 0 CA-C-N 115.827 -0.624 . . . . 75.21 111.385 179.092 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -70.22 -40.17 74.67 Favored 'General case' 0 N--CA 1.479 0.991 0 C-N-CA 123.089 0.555 . . . . 75.54 111.269 177.503 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 142' ' ' MET . . . . . 0.539 ' SD ' HG21 ' A' ' 10' ' ' ILE . 22.9 ptt? -74.51 -27.03 60.37 Favored 'General case' 0 N--CA 1.484 1.271 0 C-N-CA 122.622 0.369 . . . . 53.04 110.107 178.501 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 143' ' ' GLU . . . . . 0.565 ' HG2' ' HA ' ' A' ' 58' ' ' PRO . 33.8 tt0 -65.41 -27.51 68.59 Favored 'General case' 0 CA--C 1.545 0.756 0 C-N-CA 123.202 0.601 . . . . 73.31 112.417 177.686 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 144' ' ' ARG . . . . . . . . . . . . . 74.3 mtp180 -65.7 -20.23 66.2 Favored 'General case' 0 CA--C 1.55 0.949 0 C-N-CA 123.48 0.712 . . . . 75.15 111.458 176.114 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 145' ' ' PHE . . . . . 0.407 ' HB2' HD11 ' A' ' 156' ' ' ILE . 43.6 m-85 -89.52 3.97 50.73 Favored 'General case' 0 CA--C 1.548 0.874 0 C-N-CA 123.607 0.763 . . . . 74.13 111.706 177.406 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . -85.52 177.26 50.07 Favored Glycine 0 C--N 1.347 1.167 0 N-CA-C 111.66 -0.576 . . . . 74.44 111.66 171.01 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 16.4 m -133.71 163.15 30.09 Favored 'General case' 0 N--CA 1.48 1.053 0 CA-C-N 117.587 0.694 . . . . 51.43 111.741 -175.895 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 148' ' ' ARG . . . . . . . . . . . . . 9.3 mmm180 -75.99 -15.31 60.17 Favored 'General case' 0 N--CA 1.475 0.798 0 C-N-CA 124.897 1.279 . . . . 52.12 112.879 -177.747 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 149' ' ' ASN . . . . . . . . . . . . . 34.3 p-10 -90.72 -3.51 57.41 Favored 'General case' 0 N--CA 1.481 1.117 0 C-N-CA 122.884 0.474 . . . . 73.31 110.333 171.982 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . 105.36 -27.33 18.69 Favored Glycine 0 C--N 1.351 1.393 0 CA-C-N 116.0 -0.546 . . . . 41.15 112.917 177.003 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 56.9 tttm -69.43 156.32 39.04 Favored 'General case' 0 N--CA 1.484 1.27 0 C-N-CA 123.217 0.607 . . . . 74.33 111.78 -173.358 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 152' ' ' THR . . . . . . . . . . . . . 69.2 p -94.39 130.63 40.65 Favored 'General case' 0 N--CA 1.474 0.765 0 CA-C-O 120.941 0.4 . . . . 75.42 110.428 172.304 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 153' ' ' SER . . . . . . . . . . . . . 15.0 m -69.47 -31.44 69.73 Favored 'General case' 0 N--CA 1.474 0.731 0 C-N-CA 123.928 0.891 . . . . 72.3 111.148 174.723 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 75.3 mmtt -115.13 153.63 30.42 Favored 'General case' 0 N--CA 1.473 0.723 0 C-N-CA 124.052 0.941 . . . . 70.2 109.972 -177.277 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 155' ' ' LYS . . . . . 0.454 ' HB2' ' HA ' ' A' ' 13' ' ' ASP . 30.3 mmmt -86.32 89.11 7.76 Favored 'General case' 0 N--CA 1.468 0.466 0 N-CA-C 109.244 -0.651 . . . . 75.52 109.244 175.626 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 156' ' ' ILE . . . . . 0.526 HD13 ' HB2' ' A' ' 142' ' ' MET . 59.2 mt -90.23 103.02 13.85 Favored 'Isoleucine or valine' 0 C--O 1.213 -0.837 0 N-CA-C 109.28 -0.637 . . . . 75.1 109.28 -174.706 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 157' ' ' THR . . . . . . . . . . . . . 44.7 p -114.45 147.99 38.47 Favored 'General case' 0 N--CA 1.476 0.868 0 C-N-CA 123.976 0.91 . . . . 73.11 109.972 -175.222 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 158' ' ' ILE . . . . . 0.408 HG23 ' HB3' ' A' ' 8' ' ' PHE . 47.2 mt -71.91 97.43 0.67 Allowed 'Isoleucine or valine' 0 CA--C 1.555 1.156 0 N-CA-C 109.546 -0.539 . . . . 74.12 109.546 170.638 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 159' ' ' ALA . . . . . 0.757 ' HB2' ' HB2' ' A' ' 11' ' ' ALA . . . -58.7 -48.57 80.67 Favored 'General case' 0 N--CA 1.482 1.136 0 C-N-CA 124.581 1.152 . . . . 45.43 112.757 -175.894 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 160' ' ' ASP . . . . . . . . . . . . . 25.4 t0 -148.86 166.16 29.36 Favored 'General case' 0 N--CA 1.478 0.974 0 CA-C-N 115.926 -0.579 . . . . 73.32 110.307 -175.734 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 161' ' ' CYS . . . . . . . . . . . . . 19.4 p -132.56 -170.91 2.53 Favored 'General case' 0 CA--C 1.548 0.888 0 C-N-CA 125.315 1.446 . . . . 52.21 109.056 179.85 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 162' ' ' GLY . . . . . . . . . . . . . . . 132.02 53.88 0.09 OUTLIER Glycine 0 N--CA 1.473 1.134 0 N-CA-C 111.265 -0.734 . . . . 73.41 111.265 -170.83 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 163' ' ' GLN . . . . . 0.553 ' NE2' HG23 ' A' ' 41' ' ' THR . 69.7 mt-30 -46.74 112.56 0.52 Allowed 'General case' 0 CA--C 1.55 0.952 0 C-N-CA 125.586 1.555 . . . . 60.22 112.762 -177.337 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 164' ' ' LEU . . . . . 0.421 ' O ' ' HB ' ' A' ' 5' ' ' THR . 88.0 mt -80.24 102.72 9.64 Favored 'General case' 0 N--CA 1.474 0.751 0 C-N-CA 124.045 0.938 . . . . 73.4 110.186 -175.646 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 165' ' ' GLU . . . . . . . . . . . . . 5.6 pt-20 . . . . . 0 C--O 1.252 1.225 0 C-N-CA 122.697 0.399 . . . . 74.11 110.2 -174.991 . . . . . . . . 0 0 . 1 . 011 nuclear build full ' B' B ' 216' ' ' PRO . . . . . . . . . . . . . 5.2 Cg_exo . . . . . 0 CA--C 1.547 1.147 0 N-CA-C 109.751 -0.904 . . . . 73.41 109.751 . . . . . . . . . 0 0 . 1 . 011 nuclear build full ' B' B ' 217' ' ' GLU . . . . . 0.421 ' HB2' ' HD2' ' B' ' 218' ' ' PRO . 1.0 OUTLIER -146.41 -178.84 0.84 Allowed Pre-proline 0 CA--C 1.556 1.208 0 C-N-CA 125.247 1.419 . . . . 73.22 108.59 -175.119 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' B' B ' 218' ' ' PRO . . . . . 0.421 ' HD2' ' HB2' ' B' ' 217' ' ' GLU . 10.8 Cg_endo -55.92 92.63 0.05 OUTLIER 'Trans proline' 0 C--N 1.38 2.226 0 C-N-CA 121.44 1.427 . . . . 73.04 111.37 163.55 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 219' ' ' GLY . . . . . . . . . . . . . . . 137.0 126.95 2.57 Favored Glycine 0 CA--C 1.541 1.679 0 CA-C-N 114.931 -1.031 . . . . 72.34 110.585 -174.482 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 220' ' ' PRO . . . . . . . . . . . . . 57.5 Cg_endo -67.18 170.5 13.09 Favored 'Trans proline' 0 C--N 1.377 2.055 0 C-N-CA 123.178 2.585 . . . . 53.01 113.485 -177.163 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 221' ' ' TYR . . . . . . . . . . . . . 13.7 p90 -128.97 161.87 28.9 Favored 'General case' 0 C--O 1.252 1.192 0 CA-C-O 121.321 0.581 . . . . 72.32 111.265 -175.054 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 222' ' ' ALA . . . . . . . . . . . . . . . -172.5 177.27 3.06 Favored 'General case' 0 CA--C 1.543 0.706 0 C-N-CA 125.704 1.602 . . . . 63.22 108.938 172.931 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 223' ' ' GLN . . . . . . . . . . . . . 2.7 mp0 67.78 94.84 0.05 OUTLIER Pre-proline 0 N--CA 1.484 1.235 0 C-N-CA 124.424 1.09 . . . . 74.35 110.232 -176.109 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 224' ' ' PRO . . . . . . . . . . . . . 33.4 Cg_endo . . . . . 0 C--N 1.382 2.316 0 C-N-CA 123.659 2.906 . . . . 75.34 113.382 -178.185 . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 29.3 mmt . . . . . 0 N--CA 1.485 1.302 0 N-CA-C 110.165 -0.309 . . . . 71.03 110.165 . . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 11.2 p -64.55 -18.96 24.25 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.467 0 C-N-CA 123.825 0.85 . . . . 72.15 111.486 178.199 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 3' ' ' ASN . . . . . 0.502 ' HB3' ' O ' ' A' ' 24' ' ' LEU . 13.2 m120 -68.48 140.38 92.41 Favored Pre-proline 0 CA--C 1.552 1.046 0 C-N-CA 124.995 1.318 . . . . 72.34 111.936 -173.868 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 42.9 Cg_endo -66.71 119.36 6.38 Favored 'Trans proline' 0 C--N 1.384 2.443 0 C-N-CA 122.973 2.449 . . . . 65.32 111.049 175.572 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 5' ' ' THR . . . . . 0.428 ' O ' ' HB2' ' A' ' 163' ' ' GLN . 97.5 m -98.6 127.82 44.68 Favored 'General case' 0 CA--C 1.537 0.444 0 N-CA-C 109.239 -0.652 . . . . 74.13 109.239 -178.934 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 6' ' ' VAL . . . . . 0.501 ' HA ' ' HB2' ' A' ' 163' ' ' GLN . 14.1 m -102.13 123.13 55.17 Favored 'Isoleucine or valine' 0 C--N 1.351 0.652 0 C-N-CA 123.972 0.909 . . . . 73.04 109.563 178.252 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 7' ' ' PHE . . . . . 0.635 ' H ' ' HA ' ' A' ' 163' ' ' GLN . 57.5 t80 -102.79 137.27 41.22 Favored 'General case' 0 C--O 1.24 0.597 0 CA-C-N 115.058 -0.974 . . . . 72.24 108.905 -178.49 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 51.2 m-85 -136.59 164.78 27.4 Favored 'General case' 0 C--O 1.24 0.563 0 O-C-N 124.534 1.146 . . . . 74.31 109.971 174.32 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 24.6 m-20 -112.96 109.06 18.23 Favored 'General case' 0 C--N 1.324 -0.511 0 N-CA-C 106.263 -1.754 . . . . 72.11 106.263 169.976 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 10' ' ' ILE . . . . . 0.453 HG21 ' SD ' ' A' ' 142' ' ' MET . 46.7 mm -78.95 129.43 37.58 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.479 0 N-CA-C 108.013 -1.106 . . . . 44.12 108.013 177.555 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 11' ' ' ALA . . . . . 0.75 ' HB2' ' HB2' ' A' ' 159' ' ' ALA . . . -124.53 133.54 53.28 Favored 'General case' 0 C--O 1.217 -0.654 0 C-N-CA 123.849 0.86 . . . . 53.53 110.785 -171.782 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 12' ' ' VAL . . . . . 0.453 HG13 ' HB3' ' A' ' 154' ' ' LYS . 53.4 t -97.53 117.59 42.51 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.64 0 C-N-CA 124.236 1.014 . . . . 63.14 108.983 172.128 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 13' ' ' ASP . . . . . 0.47 ' HA ' ' HB3' ' A' ' 155' ' ' LYS . 31.6 m-20 54.97 38.93 31.29 Favored 'General case' 0 N--CA 1.484 1.257 0 C-N-CA 125.288 1.435 . . . . 64.14 111.211 -174.372 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 84.07 -14.51 43.6 Favored Glycine 0 C--N 1.353 1.508 0 CA-C-N 115.292 -0.867 . . . . 53.05 113.964 179.479 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 18.4 mm-40 -89.89 122.15 68.18 Favored Pre-proline 0 N--CA 1.474 0.756 0 CA-C-O 118.347 -0.835 . . . . 53.31 109.865 -178.896 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_exo -50.42 109.55 0.3 Allowed 'Trans proline' 0 C--N 1.378 2.119 0 C-N-CA 123.786 2.99 . . . . 53.2 113.397 -178.056 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 42.6 tp -77.11 -45.08 28.13 Favored 'General case' 0 N--CA 1.477 0.924 0 C-N-CA 123.647 0.779 . . . . 73.41 109.503 175.99 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -177.3 -172.45 41.86 Favored Glycine 0 C--N 1.343 0.961 0 CA-C-N 115.519 -0.764 . . . . 43.34 112.227 -179.933 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 19' ' ' ARG . . . . . 0.497 ' HB3' ' HE1' ' A' ' 7' ' ' PHE . 54.3 mtt180 -118.71 138.39 52.67 Favored 'General case' 0 N--CA 1.473 0.69 0 C-N-CA 124.185 0.994 . . . . 75.04 110.423 -174.02 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 36.7 t -135.29 144.23 34.77 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.819 0 C-N-CA 124.065 0.946 . . . . 71.43 109.09 178.328 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 75.1 m -128.94 126.41 39.58 Favored 'General case' 0 CA--C 1.549 0.933 0 C-N-CA 123.688 0.795 . . . . 62.21 108.931 172.185 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 70.4 m-85 -106.66 121.94 45.36 Favored 'General case' 0 N--CA 1.475 0.792 0 C-N-CA 123.909 0.884 . . . . 71.34 110.106 178.969 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 23' ' ' GLU . . . . . 0.477 ' HG3' ' HB2' ' A' ' 3' ' ' ASN . 39.7 tt0 -75.92 113.4 13.37 Favored 'General case' 0 CA--C 1.552 1.055 0 C-N-CA 123.764 0.825 . . . . 75.43 109.487 171.456 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 24' ' ' LEU . . . . . 0.502 ' O ' ' HB3' ' A' ' 3' ' ' ASN . 37.4 mt -91.39 123.5 34.86 Favored 'General case' 0 N--CA 1.482 1.127 0 C-N-CA 123.538 0.735 . . . . 62.13 110.305 179.452 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 25' ' ' PHE . . . . . 0.412 ' HA ' HD22 ' A' ' 3' ' ' ASN . 79.3 m-85 -79.72 70.98 6.34 Favored 'General case' 0 N--CA 1.476 0.863 0 C-N-CA 123.688 0.795 . . . . 73.53 111.15 -178.506 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -74.99 1.44 12.92 Favored 'General case' 0 N--CA 1.483 1.196 0 C-N-CA 123.55 0.74 . . . . 74.43 112.172 -179.666 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 11.3 p-10 -89.55 -27.81 20.02 Favored 'General case' 0 CA--C 1.551 1.007 0 C-N-CA 123.537 0.735 . . . . 73.32 110.568 172.791 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 57.4 mttp -100.72 -39.33 7.9 Favored 'General case' 0 N--CA 1.485 1.3 0 C-N-CA 123.362 0.665 . . . . 74.2 110.845 -176.546 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 29' ' ' VAL . . . . . 0.519 HG21 ' HA ' ' A' ' 129' ' ' PHE . 12.0 m -137.44 61.82 33.65 Favored Pre-proline 0 CA--C 1.56 1.341 0 C-N-CA 124.341 1.056 . . . . 75.11 110.355 -176.367 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 20.7 Cg_endo -58.9 -23.81 69.54 Favored 'Trans proline' 0 C--N 1.387 2.561 0 C-N-CA 122.559 2.173 . . . . 71.23 113.733 -178.076 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 86.4 tttt -68.66 -56.47 8.07 Favored 'General case' 0 N--CA 1.477 0.912 0 C-N-CA 122.79 0.436 . . . . 71.24 110.688 179.662 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 5.7 m -74.06 -33.2 63.61 Favored 'General case' 0 CA--C 1.552 1.05 0 CA-C-N 115.418 -0.81 . . . . 74.31 111.177 -173.784 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -72.04 -46.62 56.35 Favored 'General case' 0 CA--C 1.546 0.816 0 C-N-CA 123.651 0.78 . . . . 75.35 111.056 179.948 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 34.4 tt0 -64.38 -37.31 87.06 Favored 'General case' 0 N--CA 1.487 1.419 0 C-N-CA 123.187 0.595 . . . . 74.14 110.652 178.497 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 35' ' ' ASN . . . . . 0.477 ' O ' ' HG ' ' A' ' 39' ' ' LEU . 38.8 t30 -51.61 -64.44 0.81 Allowed 'General case' 0 C--N 1.36 1.022 0 O-C-N 124.559 1.162 . . . . 72.1 110.14 177.232 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 86.9 t80 -61.09 -35.99 78.48 Favored 'General case' 0 CA--C 1.544 0.712 0 C-N-CA 123.92 0.888 . . . . 74.12 111.88 -177.808 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 77.3 ttt180 -64.93 -43.69 91.93 Favored 'General case' 0 N--CA 1.474 0.751 0 C-N-CA 123.715 0.806 . . . . 65.52 111.436 -177.922 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 38' ' ' ALA . . . . . 0.513 ' HB1' ' HG2' ' A' ' 44' ' ' LYS . . . -78.21 -27.84 47.86 Favored 'General case' 0 N--CA 1.474 0.755 0 C-N-CA 123.32 0.648 . . . . 73.43 111.209 -177.525 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 39' ' ' LEU . . . . . 0.477 ' HG ' ' O ' ' A' ' 35' ' ' ASN . 88.5 mt -66.02 -43.29 88.05 Favored 'General case' 0 CA--C 1.549 0.908 0 C-N-CA 123.437 0.695 . . . . 62.24 109.973 169.877 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 16.3 t -62.7 -51.88 65.47 Favored 'General case' 0 N--CA 1.476 0.855 0 C-N-CA 125.22 1.408 . . . . 74.12 111.336 -178.095 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 25.4 p -77.17 -32.95 56.5 Favored 'General case' 0 CA--C 1.536 0.424 0 CA-C-N 115.559 -0.746 . . . . 73.04 111.667 -176.167 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 88.42 26.97 26.39 Favored Glycine 0 C--N 1.346 1.116 0 O-C-N 123.406 0.441 . . . . 52.23 112.558 -175.33 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 22.8 mm-40 -63.59 -22.65 67.01 Favored 'General case' 0 N--CA 1.482 1.165 0 C-N-CA 123.471 0.708 . . . . 72.32 111.495 173.506 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 44' ' ' LYS . . . . . 0.513 ' HG2' ' HB1' ' A' ' 38' ' ' ALA . 31.0 mmmt -105.69 17.09 24.32 Favored 'General case' 0 CA--C 1.545 0.756 0 C-N-CA 123.998 0.919 . . . . 72.43 110.905 179.241 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 81.55 -25.86 3.74 Favored Glycine 0 C--N 1.355 1.593 0 N-CA-C 114.641 0.617 . . . . 72.32 114.641 175.661 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 16.4 m-85 -64.94 -44.03 90.79 Favored 'General case' 0 N--CA 1.48 1.055 0 C-N-CA 123.406 0.682 . . . . 51.24 111.186 -171.354 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 56.87 64.66 4.2 Favored Glycine 0 C--N 1.356 1.673 0 O-C-N 123.958 0.786 . . . . 62.22 114.34 166.049 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 48' ' ' TYR . . . . . 0.401 ' HE1' HD22 ' A' ' 39' ' ' LEU . 51.4 m-85 -62.44 87.59 0.02 OUTLIER 'General case' 0 N--CA 1.48 1.075 0 CA-C-O 122.33 1.062 . . . . 75.54 111.426 -178.721 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 28.5 tptp -111.4 117.15 32.29 Favored 'General case' 0 C--O 1.235 0.33 0 CA-C-N 113.452 -1.703 . . . . 71.21 107.775 178.762 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 79.46 20.75 68.4 Favored Glycine 0 C--N 1.339 0.742 0 CA-C-O 119.698 -0.501 . . . . 50.35 112.877 -177.088 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 34.5 t -55.83 115.4 2.36 Favored 'General case' 0 C--N 1.357 0.921 0 C-N-CA 123.365 0.666 . . . . 73.13 109.387 178.078 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 52' ' ' CYS . . . . . 0.742 ' SG ' ' HB3' ' A' ' 66' ' ' ASP . 2.3 p -86.54 138.6 31.59 Favored 'General case' 0 C--O 1.242 0.685 0 O-C-N 124.255 0.972 . . . . 73.23 111.491 -172.495 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 53' ' ' PHE . . . . . 0.667 ' HA ' ' HA2' ' A' ' 64' ' ' GLY . 36.6 m-85 -89.29 99.09 12.15 Favored 'General case' 0 N--CA 1.451 -0.415 0 C-N-CA 125.338 1.455 . . . . 74.42 107.988 175.544 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 43.8 p-80 -82.49 -31.11 29.49 Favored 'General case' 0 N--CA 1.476 0.841 0 C-N-CA 123.608 0.763 . . . . 71.31 111.342 -177.098 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 55' ' ' ARG . . . . . 0.403 ' HA ' ' O ' ' A' ' 150' ' ' GLY . 52.5 ttt180 -122.92 98.43 5.9 Favored 'General case' 0 C--O 1.21 -0.979 0 C-N-CA 122.885 0.474 . . . . 65.34 109.85 -173.97 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 56' ' ' ILE . . . . . 0.484 HG21 ' HA ' ' A' ' 143' ' ' GLU . 38.8 mt -127.87 138.95 53.24 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.717 0 N-CA-C 109.296 -0.631 . . . . 74.12 109.296 173.139 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 57' ' ' ILE . . . . . 0.565 HG23 ' HA ' ' A' ' 148' ' ' ARG . 64.1 mt -134.08 113.71 12.57 Favored Pre-proline 0 CA--C 1.557 1.24 0 C-N-CA 125.133 1.373 . . . . 70.21 108.781 -174.694 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 58' ' ' PRO . . . . . 0.578 ' HA ' ' HG2' ' A' ' 143' ' ' GLU . 56.0 Cg_endo -66.17 131.46 26.9 Favored 'Trans proline' 0 C--N 1.386 2.516 0 C-N-CA 123.641 2.894 . . . . 43.23 113.357 -173.104 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 78.03 31.31 48.54 Favored Glycine 0 C--N 1.345 1.08 0 CA-C-N 115.387 -0.824 . . . . 72.55 112.696 -178.58 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 60' ' ' PHE . . . . . 0.43 ' CE2' ' HA ' ' B' ' 222' ' ' ALA . 20.2 t80 -157.71 -73.73 0.09 Allowed 'General case' 0 CA--C 1.545 0.772 0 CA-C-N 116.781 0.291 . . . . 72.54 111.393 -174.533 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 43.6 ttp -159.59 138.8 11.13 Favored 'General case' 0 N--CA 1.481 1.09 0 C-N-CA 122.679 0.392 . . . . 55.01 111.299 -166.057 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 62' ' ' CYS . . . . . 0.648 ' SG ' ' HB ' ' A' ' 114' ' ' ILE . 5.4 p -116.31 111.65 20.42 Favored 'General case' 0 CA--C 1.554 1.099 0 C-N-CA 123.494 0.718 . . . . 53.21 109.429 169.572 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 63' ' ' GLN . . . . . 0.4 ' HA ' ' HA ' ' A' ' 113' ' ' PHE . 54.2 tt0 -109.34 117.71 34.77 Favored 'General case' 0 N--CA 1.487 1.379 0 C-N-CA 124.438 1.095 . . . . 63.04 110.897 -173.342 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 64' ' ' GLY . . . . . 0.667 ' HA2' ' HA ' ' A' ' 53' ' ' PHE . . . -106.73 -176.3 23.08 Favored Glycine 0 C--N 1.345 1.073 0 CA-C-N 115.713 -0.676 . . . . 62.11 113.34 179.621 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 84.4 91.5 0.76 Allowed Glycine 0 C--N 1.341 0.859 0 N-CA-C 110.446 -1.062 . . . . 32.45 110.446 -174.566 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 66' ' ' ASP . . . . . 0.742 ' HB3' ' SG ' ' A' ' 52' ' ' CYS . 32.9 t70 -128.56 -56.89 1.21 Allowed 'General case' 0 N--CA 1.473 0.718 0 C-N-CA 122.938 0.495 . . . . 65.44 110.532 176.019 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 65.7 t80 -40.25 -57.32 1.75 Allowed 'General case' 0 N--CA 1.485 1.307 0 C-N-CA 125.344 1.458 . . . . 75.34 114.196 -170.756 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 26.4 m -79.93 107.2 12.52 Favored 'General case' 0 C--O 1.243 0.738 0 CA-C-O 120.862 0.363 . . . . 72.12 110.992 -174.782 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 62.6 mtt-85 54.29 71.67 0.51 Allowed 'General case' 0 N--CA 1.472 0.669 0 C-N-CA 125.929 1.692 . . . . 61.24 112.147 173.245 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 70' ' ' HIS . . . . . 0.439 ' HB3' ' O ' ' A' ' 66' ' ' ASP . 15.9 p-80 -85.34 17.5 3.09 Favored 'General case' 0 N--CA 1.481 1.118 0 N-CA-C 113.198 0.814 . . . . 73.15 113.198 -172.438 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 44.4 t30 -77.0 73.18 3.58 Favored 'General case' 0 N--CA 1.481 1.099 0 CA-C-O 121.561 0.696 . . . . 72.34 109.561 173.435 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 72' ' ' GLY . . . . . 0.563 ' HA2' ' HG2' ' B' ' 218' ' ' PRO . . . 63.68 20.79 64.36 Favored Glycine 0 C--N 1.346 1.092 0 CA-C-N 115.208 -0.905 . . . . 64.33 114.505 -179.071 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 37.1 m -125.03 -66.25 0.97 Allowed 'General case' 0 CA--C 1.542 0.669 0 C-N-CA 123.16 0.584 . . . . 63.42 109.459 -177.357 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 51.64 60.42 7.42 Favored Glycine 0 C--N 1.355 1.636 0 O-C-N 124.275 0.984 . . . . 35.31 113.543 177.589 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 132.21 53.03 0.08 OUTLIER Glycine 0 N--CA 1.469 0.899 0 CA-C-N 118.049 0.924 . . . . 64.4 112.35 -176.387 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -51.57 149.47 4.4 Favored 'General case' 0 N--CA 1.481 1.125 0 C-N-CA 123.75 0.82 . . . . 74.42 111.49 177.242 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 92.0 p -91.45 176.01 6.71 Favored 'General case' 0 CA--C 1.538 0.509 0 CA-C-O 121.361 0.6 . . . . 73.51 111.163 -168.542 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 78' ' ' ILE . . . . . 0.407 HG21 ' HB3' ' A' ' 38' ' ' ALA . 25.5 pt -75.93 -18.05 15.44 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.615 0 CA-C-N 115.45 -0.795 . . . . 61.33 110.218 174.329 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 85.1 m-85 -87.76 -14.82 38.69 Favored 'General case' 0 N--CA 1.472 0.642 0 C-N-CA 124.291 1.036 . . . . 74.21 110.607 177.601 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 147.36 -112.39 0.59 Allowed Glycine 0 C--N 1.348 1.199 0 N-CA-C 110.612 -0.995 . . . . 72.52 110.612 178.817 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 32.1 tt0 -89.1 -50.72 5.99 Favored 'General case' 0 CA--C 1.539 0.533 0 CA-C-O 121.657 0.741 . . . . 75.1 109.358 176.017 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 82' ' ' LYS . . . . . 0.438 ' HD2' ' HA ' ' A' ' 107' ' ' THR . 23.7 pttm -151.88 177.46 10.41 Favored 'General case' 0 N--CA 1.47 0.541 0 CA-C-N 114.336 -1.302 . . . . 73.12 109.791 -169.335 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 45.7 p90 -158.43 170.7 21.62 Favored 'General case' 0 N--CA 1.476 0.836 0 C-N-CA 123.492 0.717 . . . . 71.24 110.362 176.468 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 84' ' ' GLU . . . . . 0.534 ' HA ' ' HA ' ' A' ' 106' ' ' ASN . 9.7 pt-20 -82.73 160.46 22.34 Favored 'General case' 0 N--CA 1.474 0.747 0 C-N-CA 122.899 0.48 . . . . 74.31 111.036 178.226 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 52.3 m-20 -65.23 131.73 47.25 Favored 'General case' 0 C--O 1.239 0.511 0 CA-C-N 114.802 -1.09 . . . . 73.24 110.298 177.509 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 10.9 tp10 -72.33 -58.13 3.65 Favored 'General case' 0 C--O 1.239 0.503 0 O-C-N 124.166 0.916 . . . . 63.4 109.323 175.224 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 32.3 p30 -159.02 -173.77 4.41 Favored 'General case' 0 C--O 1.237 0.405 0 CA-C-N 114.437 -1.256 . . . . 75.15 108.966 -175.97 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 89.0 m-85 -137.56 61.26 1.61 Allowed 'General case' 0 N--CA 1.477 0.886 0 C-N-CA 123.602 0.761 . . . . 74.13 108.982 173.193 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 62.5 mt -78.77 -54.32 12.09 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.151 0 CA-C-O 121.383 0.611 . . . . 73.42 109.909 177.495 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 90' ' ' LEU . . . . . 0.499 ' HB3' ' HB ' ' A' ' 128' ' ' VAL . 94.3 mt -89.05 140.88 28.99 Favored 'General case' 0 C--O 1.236 0.37 0 CA-C-N 115.067 -0.97 . . . . 61.25 111.389 -172.672 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 16.8 ptpt -139.63 170.56 15.68 Favored 'General case' 0 CA--C 1.541 0.612 0 C-N-CA 124.113 0.965 . . . . 63.45 110.83 -173.571 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 92' ' ' HIS . . . . . 0.574 ' HA ' HG21 ' A' ' 97' ' ' ILE . 13.2 m80 -92.12 53.72 2.22 Favored 'General case' 0 N--CA 1.48 1.041 0 C-N-CA 124.791 1.236 . . . . 72.24 110.78 -167.528 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 3.8 p -94.52 20.32 8.58 Favored 'General case' 0 N--CA 1.481 1.103 0 C-N-CA 124.196 0.998 . . . . 32.55 113.286 -174.125 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -163.93 178.92 39.17 Favored Glycine 0 C--N 1.344 0.974 0 C-N-CA 121.018 -0.611 . . . . 43.33 113.652 -178.214 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 85.0 Cg_endo -81.64 138.5 10.73 Favored 'Trans proline' 0 C--N 1.369 1.657 0 C-N-CA 123.046 2.497 . . . . 74.44 112.805 175.935 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 96' ' ' GLY . . . . . 0.551 ' HA3' HG12 ' A' ' 132' ' ' VAL . . . 80.28 20.12 67.75 Favored Glycine 0 C--N 1.35 1.316 0 CA-C-N 116.04 -0.527 . . . . 75.43 113.692 174.1 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 97' ' ' ILE . . . . . 0.574 HG21 ' HA ' ' A' ' 92' ' ' HIS . 21.7 mm -66.87 105.62 0.73 Allowed 'Isoleucine or valine' 0 CA--C 1.549 0.914 0 C-N-CA 124.518 1.127 . . . . 61.53 110.613 178.077 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 98' ' ' LEU . . . . . 0.451 HD13 HG12 ' A' ' 114' ' ' ILE . 59.2 tp -87.17 101.47 13.53 Favored 'General case' 0 CA--C 1.55 0.973 0 CA-C-O 121.894 0.855 . . . . 71.14 109.532 177.089 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 99' ' ' SER . . . . . 0.522 ' HB2' HG22 ' A' ' 128' ' ' VAL . 33.0 t -106.07 170.39 7.94 Favored 'General case' 0 N--CA 1.472 0.664 0 C-N-CA 124.965 1.306 . . . . 44.33 108.67 176.141 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 100' ' ' MET . . . . . 0.5 ' SD ' ' HA2' ' A' ' 109' ' ' GLY . 4.4 ttt -113.53 135.68 53.63 Favored 'General case' 0 N--CA 1.482 1.125 0 CA-C-N 118.356 0.525 . . . . 64.1 110.048 -178.175 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 101' ' ' ALA . . . . . 0.441 ' HB3' ' HB2' ' A' ' 111' ' ' GLN . . . -84.35 -178.95 7.07 Favored 'General case' 0 C--O 1.244 0.811 0 C-N-CA 123.764 0.826 . . . . 43.4 111.105 -173.79 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 25.8 p-10 -168.84 -178.83 3.49 Favored 'General case' 0 CA--C 1.539 0.552 0 CA-C-N 115.166 -0.925 . . . . 72.24 111.369 -168.322 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 103' ' ' ALA . . . . . 0.495 ' HB3' HG21 ' A' ' 107' ' ' THR . . . -124.46 13.2 8.78 Favored 'General case' 0 N--CA 1.479 1.002 0 C-N-CA 124.249 1.02 . . . . 71.22 109.496 161.94 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 145.39 178.07 20.64 Favored Glycine 0 C--N 1.352 1.424 0 CA-C-O 119.065 -0.853 . . . . 74.14 111.539 -179.556 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 32.5 Cg_exo -61.19 149.91 87.05 Favored 'Trans proline' 0 C--N 1.375 1.962 0 C-N-CA 123.198 2.599 . . . . 75.13 111.731 169.496 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 106' ' ' ASN . . . . . 0.534 ' HA ' ' HA ' ' A' ' 84' ' ' GLU . 65.6 t30 62.87 21.87 13.09 Favored 'General case' 0 CA--C 1.557 1.249 0 O-C-N 124.168 0.917 . . . . 62.11 110.325 -174.031 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 107' ' ' THR . . . . . 0.495 HG21 ' HB3' ' A' ' 103' ' ' ALA . 12.2 m -142.15 24.11 1.99 Allowed 'General case' 0 CA--C 1.555 1.137 0 C-N-CA 125.066 1.346 . . . . 73.33 109.094 178.154 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 61.1 t30 -80.27 147.95 30.97 Favored 'General case' 0 N--CA 1.476 0.851 0 C-N-CA 123.739 0.816 . . . . 73.44 109.46 176.534 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 109' ' ' GLY . . . . . 0.5 ' HA2' ' SD ' ' A' ' 100' ' ' MET . . . 106.49 -14.24 42.83 Favored Glycine 0 N--CA 1.472 1.04 0 CA-C-O 119.946 -0.363 . . . . 54.02 113.805 177.608 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 38.6 p -94.81 120.18 34.61 Favored 'General case' 0 CA--C 1.543 0.699 0 C-N-CA 123.382 0.673 . . . . 71.23 109.361 177.861 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 111' ' ' GLN . . . . . 0.693 HE22 ' HB2' ' B' ' 218' ' ' PRO . 27.8 mt-30 66.95 162.95 0.18 Allowed 'General case' 0 N--CA 1.497 1.906 0 C-N-CA 125.044 1.338 . . . . 75.31 111.408 -170.491 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 44.9 p90 -144.5 150.29 37.34 Favored 'General case' 0 N--CA 1.484 1.233 0 N-CA-C 108.362 -0.977 . . . . 64.13 108.362 178.19 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 113' ' ' PHE . . . . . 0.4 ' HA ' ' HA ' ' A' ' 63' ' ' GLN . 51.3 p90 -140.98 142.37 34.29 Favored 'General case' 0 N--CA 1.472 0.644 0 N-CA-C 111.969 0.359 . . . . 63.34 111.969 -175.895 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 114' ' ' ILE . . . . . 0.648 ' HB ' ' SG ' ' A' ' 62' ' ' CYS . 12.1 mt -111.98 105.02 17.98 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.733 0 C-N-CA 124.168 0.987 . . . . 65.11 109.127 -178.391 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 115' ' ' CYS . . . . . . . . . . . . . 69.5 m -75.71 107.89 8.19 Favored 'General case' 0 CA--C 1.541 0.597 0 N-CA-C 109.171 -0.677 . . . . 75.14 109.171 173.335 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 116' ' ' THR . . . . . 0.468 ' HA ' ' H ' ' A' ' 96' ' ' GLY . 72.3 p -78.6 -10.71 59.84 Favored 'General case' 0 N--CA 1.481 1.078 0 C-N-CA 123.379 0.672 . . . . 52.34 111.681 -179.559 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -125.46 166.92 15.76 Favored 'General case' 0 C--O 1.243 0.746 0 C-N-CA 123.358 0.663 . . . . 45.44 109.741 176.37 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 11.3 ptmt -71.72 74.49 0.83 Allowed 'General case' 0 CA--C 1.548 0.893 0 C-N-CA 124.003 0.921 . . . . 64.3 110.097 174.829 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 119' ' ' THR . . . . . 0.547 ' HB ' HD23 ' A' ' 122' ' ' LEU . 41.1 p -76.53 90.66 3.32 Favored 'General case' 0 CA--C 1.546 0.821 0 CA-C-O 121.928 0.871 . . . . 71.2 109.588 -177.514 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 9.6 pt-20 -71.82 -32.11 67.23 Favored 'General case' 0 N--CA 1.472 0.648 0 CA-C-N 115.057 -0.974 . . . . 62.12 112.19 -173.987 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 121' ' ' TRP . . . . . . . . . . . . . 27.4 p90 -74.09 -4.82 37.94 Favored 'General case' 0 N--CA 1.479 0.99 0 C-N-CA 122.757 0.423 . . . . 73.44 111.058 176.793 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 122' ' ' LEU . . . . . 0.547 HD23 ' HB ' ' A' ' 119' ' ' THR . 3.8 mm? -86.88 -15.67 38.35 Favored 'General case' 0 N--CA 1.477 0.878 0 C-N-CA 123.761 0.824 . . . . 70.0 111.394 173.347 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 41.4 m-20 -72.41 149.39 44.32 Favored 'General case' 0 N--CA 1.482 1.134 0 N-CA-C 109.767 -0.457 . . . . 65.04 109.767 176.105 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 93.93 -26.9 14.4 Favored Glycine 0 N--CA 1.47 0.912 0 N-CA-C 111.628 -0.589 . . . . 51.13 111.628 -171.274 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 125' ' ' LYS . . . . . 0.504 ' HD2' ' HE2' ' B' ' 221' ' ' TYR . 1.8 mppt? -80.1 -169.89 2.24 Favored 'General case' 0 N--CA 1.478 0.951 0 C-N-CA 123.902 0.881 . . . . 74.55 109.709 172.387 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 126' ' ' HIS . . . . . . . . . . . . . 0.6 OUTLIER -69.34 145.68 52.77 Favored 'General case' 0 C--O 1.242 0.673 0 C-N-CA 123.372 0.669 . . . . 75.23 111.79 -167.51 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 11.1 p -65.32 145.19 14.12 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.726 0 CA-C-N 113.656 -1.611 . . . . 63.12 112.361 -165.521 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 128' ' ' VAL . . . . . 0.522 HG22 ' HB2' ' A' ' 99' ' ' SER . 60.2 t -74.25 150.22 7.43 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.53 0 CA-C-N 114.569 -1.196 . . . . 73.0 108.932 172.791 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 129' ' ' PHE . . . . . 0.519 ' HA ' HG21 ' A' ' 29' ' ' VAL . 45.5 p90 -133.59 -10.76 2.78 Favored 'General case' 0 N--CA 1.476 0.831 0 C-N-CA 122.202 0.201 . . . . 74.42 111.424 -179.396 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . -146.3 170.93 27.3 Favored Glycine 0 C--N 1.343 0.941 0 O-C-N 123.559 0.537 . . . . 75.33 112.751 -173.357 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 29.4 ttpt -161.19 134.21 6.34 Favored 'General case' 0 C--N 1.325 -0.46 0 C-N-CA 124.346 1.058 . . . . 63.21 108.235 -175.959 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 132' ' ' VAL . . . . . 0.551 HG12 ' HA3' ' A' ' 96' ' ' GLY . 13.7 p -68.41 131.02 33.82 Favored 'Isoleucine or valine' 0 CA--C 1.554 1.124 0 CA-C-N 118.329 0.513 . . . . 71.21 109.959 175.107 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -91.62 -48.82 6.63 Favored 'General case' 0 N--CA 1.48 1.061 0 N-CA-C 108.975 -0.75 . . . . 61.41 108.975 173.306 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 3.2 mp0 -146.63 155.85 42.76 Favored 'General case' 0 C--O 1.243 0.747 0 C-N-CA 124.983 1.313 . . . . 71.44 108.544 177.052 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 94.24 12.22 56.47 Favored Glycine 0 C--N 1.342 0.877 0 CA-C-N 115.926 -0.579 . . . . 51.42 112.376 -174.546 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 136' ' ' MET . . . . . 0.423 ' SD ' HG11 ' A' ' 132' ' ' VAL . 15.0 tpt -62.5 -31.1 71.8 Favored 'General case' 0 N--CA 1.48 1.031 0 C-N-CA 123.847 0.859 . . . . 60.33 111.192 178.522 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 137' ' ' ASN . . . . . . . . . . . . . 26.6 t-20 -55.51 -42.22 74.18 Favored 'General case' 0 N--CA 1.479 0.994 0 C-N-CA 123.964 0.906 . . . . 74.23 110.506 174.238 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 138' ' ' ILE . . . . . . . . . . . . . 44.9 mm -74.19 -32.85 33.24 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.73 0 CA-C-N 115.232 -0.895 . . . . 72.33 110.691 -178.95 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 69.3 t -64.55 -41.43 92.25 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.366 0 C-N-CA 123.471 0.709 . . . . 62.01 110.495 176.347 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 38.3 mt-10 -69.92 -39.22 76.29 Favored 'General case' 0 N--CA 1.473 0.722 0 CA-C-N 115.311 -0.859 . . . . 62.5 110.747 177.681 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -65.06 -52.45 55.67 Favored 'General case' 0 N--CA 1.475 0.784 0 O-C-N 123.681 0.613 . . . . 74.1 110.632 -179.568 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 142' ' ' MET . . . . . 0.459 ' HB2' HD13 ' A' ' 156' ' ' ILE . 27.6 ptm -59.73 -37.66 79.57 Favored 'General case' 0 N--CA 1.477 0.888 0 C-N-CA 123.055 0.542 . . . . 71.31 110.538 179.144 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 143' ' ' GLU . . . . . 0.578 ' HG2' ' HA ' ' A' ' 58' ' ' PRO . 39.4 tt0 -62.74 -35.76 80.8 Favored 'General case' 0 CA--C 1.546 0.822 0 CA-C-O 121.253 0.549 . . . . 74.02 112.144 -176.966 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 144' ' ' ARG . . . . . 0.557 ' HA ' ' HB3' ' A' ' 58' ' ' PRO . 62.3 mtt180 -73.58 -7.31 51.38 Favored 'General case' 0 CA--C 1.547 0.828 0 CA-C-N 115.769 -0.65 . . . . 73.15 112.711 -178.236 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 145' ' ' PHE . . . . . 0.546 ' HB2' HD11 ' A' ' 156' ' ' ILE . 55.0 m-85 -89.2 6.74 38.74 Favored 'General case' 0 CA--C 1.558 1.251 0 C-N-CA 123.07 0.548 . . . . 74.53 111.933 172.416 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . -102.5 -175.23 27.25 Favored Glycine 0 C--N 1.355 1.608 0 CA-C-N 117.646 0.203 . . . . 21.24 112.708 177.842 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 31.0 m -132.91 168.99 17.44 Favored 'General case' 0 N--CA 1.489 1.496 0 C-N-CA 124.202 1.001 . . . . 71.43 110.3 179.84 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 148' ' ' ARG . . . . . 0.565 ' HA ' HG23 ' A' ' 57' ' ' ILE . 21.9 mmt85 -65.98 -33.97 77.04 Favored 'General case' 0 N--CA 1.487 1.4 0 C-N-CA 123.845 0.858 . . . . 64.52 112.758 -175.143 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 149' ' ' ASN . . . . . . . . . . . . . 30.9 p-10 -74.7 -15.75 60.78 Favored 'General case' 0 N--CA 1.484 1.272 0 C-N-CA 123.411 0.684 . . . . 70.12 111.325 175.148 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 150' ' ' GLY . . . . . 0.403 ' O ' ' HA ' ' A' ' 55' ' ' ARG . . . 109.67 -17.06 30.86 Favored Glycine 0 C--N 1.344 1.004 0 CA-C-N 115.671 -0.695 . . . . 64.05 112.462 -179.962 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 66.2 tttp -60.3 124.01 19.0 Favored 'General case' 0 N--CA 1.474 0.769 0 CA-C-N 117.417 0.609 . . . . 71.01 110.918 -177.955 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 152' ' ' THR . . . . . 0.432 HG22 ' HB ' ' A' ' 56' ' ' ILE . 14.0 p -89.56 118.02 28.89 Favored 'General case' 0 CA--C 1.538 0.482 0 C-N-CA 123.235 0.614 . . . . 70.44 109.567 -177.897 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 153' ' ' SER . . . . . . . . . . . . . 19.8 m -66.89 -19.07 65.66 Favored 'General case' 0 CA--C 1.549 0.921 0 C-N-CA 124.153 0.981 . . . . 74.44 111.724 178.77 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 154' ' ' LYS . . . . . 0.453 ' HB3' HG13 ' A' ' 12' ' ' VAL . 74.6 mmtt -128.58 144.14 51.09 Favored 'General case' 0 N--CA 1.48 1.067 0 C-N-CA 124.478 1.111 . . . . 75.55 108.666 176.498 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 155' ' ' LYS . . . . . 0.47 ' HB3' ' HA ' ' A' ' 13' ' ' ASP . 0.0 OUTLIER -81.47 90.13 6.2 Favored 'General case' 0 N--CA 1.477 0.882 0 CA-C-O 121.54 0.686 . . . . 71.3 109.743 -177.269 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 156' ' ' ILE . . . . . 0.546 HD11 ' HB2' ' A' ' 145' ' ' PHE . 66.3 mt -88.74 118.48 34.22 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.432 0 CA-C-N 115.855 -0.611 . . . . 72.35 109.449 -176.206 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 157' ' ' THR . . . . . . . . . . . . . 30.7 p -131.15 156.09 45.88 Favored 'General case' 0 C--O 1.239 0.534 0 C-N-CA 124.469 1.108 . . . . 74.04 109.382 -174.931 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 158' ' ' ILE . . . . . . . . . . . . . 60.1 mt -77.96 94.15 1.46 Allowed 'Isoleucine or valine' 0 CA--C 1.55 0.946 0 N-CA-C 108.926 -0.768 . . . . 64.02 108.926 172.572 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 159' ' ' ALA . . . . . 0.75 ' HB2' ' HB2' ' A' ' 11' ' ' ALA . . . -51.9 -40.88 61.43 Favored 'General case' 0 N--CA 1.488 1.439 0 C-N-CA 124.551 1.14 . . . . 61.34 113.03 -177.932 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 160' ' ' ASP . . . . . . . . . . . . . 25.3 t0 -164.36 157.74 17.87 Favored 'General case' 0 N--CA 1.478 0.958 0 C-N-CA 122.946 0.498 . . . . 73.12 110.311 178.718 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 161' ' ' CYS . . . . . . . . . . . . . 29.2 p -119.82 -169.97 1.87 Allowed 'General case' 0 N--CA 1.475 0.779 0 C-N-CA 124.774 1.229 . . . . 75.42 108.36 175.398 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 162' ' ' GLY . . . . . . . . . . . . . . . 132.49 55.02 0.08 OUTLIER Glycine 0 C--N 1.347 1.156 0 N-CA-C 111.095 -0.802 . . . . 54.33 111.095 -170.393 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 163' ' ' GLN . . . . . 0.635 ' HA ' ' H ' ' A' ' 7' ' ' PHE . 3.0 pt20 -49.63 137.49 15.54 Favored 'General case' 0 CA--C 1.55 0.961 0 N-CA-C 114.357 1.243 . . . . 63.54 114.357 -169.296 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 164' ' ' LEU . . . . . 0.415 ' O ' ' HB ' ' A' ' 5' ' ' THR . 85.2 mt -89.96 116.67 28.19 Favored 'General case' 0 N--CA 1.472 0.644 0 CA-C-N 115.859 -0.61 . . . . 62.34 110.114 -176.502 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 165' ' ' GLU . . . . . . . . . . . . . 9.3 pt-20 . . . . . 0 C--O 1.256 1.415 0 C-N-CA 123.458 0.703 . . . . 71.31 110.322 -179.019 . . . . . . . . 0 0 . 1 . 012 nuclear build full ' B' B ' 216' ' ' PRO . . . . . . . . . . . . . 1.2 Cg_endo . . . . . 0 N--CA 1.486 1.061 0 N-CA-C 110.601 -0.577 . . . . 65.41 110.601 . . . . . . . . . 0 0 . 1 . 012 nuclear build full ' B' B ' 217' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -89.71 151.44 45.7 Favored Pre-proline 0 N--CA 1.481 1.11 0 C-N-CA 123.069 0.548 . . . . 75.41 110.034 -179.602 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 218' ' ' PRO . . . . . 0.693 ' HB2' HE22 ' A' ' 111' ' ' GLN . 50.2 Cg_exo -56.18 113.78 1.6 Allowed 'Trans proline' 0 C--N 1.385 2.492 0 C-N-CA 123.09 2.527 . . . . 61.52 112.484 178.9 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 219' ' ' GLY . . . . . . . . . . . . . . . 169.37 -176.47 43.36 Favored Glycine 0 CA--C 1.524 0.607 0 N-CA-C 110.164 -1.174 . . . . 43.52 110.164 -178.489 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 220' ' ' PRO . . . . . . . . . . . . . 82.4 Cg_endo -79.56 -177.59 3.97 Favored 'Trans proline' 0 CA--C 1.553 1.425 0 C-N-CA 122.519 2.146 . . . . 75.25 113.88 175.211 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 221' ' ' TYR . . . . . 0.504 ' HE2' ' HD2' ' A' ' 125' ' ' LYS . 64.4 m-85 -82.12 123.54 29.06 Favored 'General case' 0 N--CA 1.476 0.872 0 C-N-CA 123.852 0.861 . . . . 71.4 110.237 -178.051 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 222' ' ' ALA . . . . . 0.43 ' HA ' ' CE2' ' A' ' 60' ' ' PHE . . . -90.24 166.44 13.35 Favored 'General case' 0 N--CA 1.476 0.834 0 N-CA-C 113.255 0.835 . . . . 53.14 113.255 -175.131 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 223' ' ' GLN . . . . . . . . . . . . . 2.9 pt20 -75.18 140.39 73.13 Favored Pre-proline 0 CA--C 1.556 1.176 0 CA-C-N 115.408 -0.815 . . . . 54.42 108.904 171.204 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 224' ' ' PRO . . . . . . . . . . . . . 56.2 Cg_endo . . . . . 0 CA--C 1.564 2.012 0 C-N-CA 122.72 2.28 . . . . 62.53 111.827 174.851 . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 1' ' ' MET . . . . . 0.405 ' SD ' ' HB2' ' A' ' 3' ' ' ASN . 23.7 ptp . . . . . 0 N--CA 1.484 1.236 0 CA-C-O 120.404 0.145 . . . . 72.43 110.693 . . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 5.9 p -83.88 -19.13 9.62 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.99 0 C-N-CA 122.996 0.518 . . . . 74.35 110.575 179.604 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 3' ' ' ASN . . . . . 0.477 ' OD1' ' HA ' ' A' ' 25' ' ' PHE . 4.3 m-80 -56.21 115.69 10.54 Favored Pre-proline 0 N--CA 1.478 0.954 0 C-N-CA 124.524 1.13 . . . . 75.1 110.838 175.79 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 4' ' ' PRO . . . . . 0.645 ' HG2' ' HB2' ' A' ' 24' ' ' LEU . 67.2 Cg_endo -72.66 136.74 26.24 Favored 'Trans proline' 0 C--N 1.374 1.872 0 C-N-CA 122.144 1.896 . . . . 64.21 111.653 176.37 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 5' ' ' THR . . . . . 0.608 HG23 ' HD3' ' A' ' 133' ' ' LYS . 85.5 m -95.99 113.56 25.19 Favored 'General case' 0 C--O 1.236 0.368 0 N-CA-C 107.893 -1.151 . . . . 73.13 107.893 176.002 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 6' ' ' VAL . . . . . 0.556 ' HA ' ' HB2' ' A' ' 163' ' ' GLN . 13.7 m -98.62 121.1 48.8 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.51 0 CA-C-O 121.956 0.884 . . . . 75.23 109.328 -178.22 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 7' ' ' PHE . . . . . 0.436 ' H ' ' HA ' ' A' ' 163' ' ' GLN . 77.3 t80 -105.08 135.09 47.08 Favored 'General case' 0 C--O 1.239 0.52 0 CA-C-N 114.423 -1.262 . . . . 70.21 109.237 -173.328 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 8' ' ' PHE . . . . . 0.44 ' HB3' HG23 ' A' ' 158' ' ' ILE . 64.4 m-85 -142.27 165.25 27.94 Favored 'General case' 0 C--O 1.24 0.578 0 O-C-N 124.398 1.061 . . . . 64.24 109.757 176.11 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 17.4 m-20 -113.91 108.51 17.15 Favored 'General case' 0 N--CA 1.465 0.314 0 N-CA-C 107.625 -1.25 . . . . 71.11 107.625 171.637 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 10' ' ' ILE . . . . . 0.441 HG21 ' SD ' ' A' ' 142' ' ' MET . 47.3 mm -80.7 116.82 25.61 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.351 0 N-CA-C 108.313 -0.995 . . . . 52.01 108.313 -179.545 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 11' ' ' ALA . . . . . 0.688 ' HB2' ' HB2' ' A' ' 159' ' ' ALA . . . -116.04 109.92 18.2 Favored 'General case' 0 N--CA 1.469 0.493 0 C-N-CA 123.684 0.794 . . . . 70.42 111.941 -168.586 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 12' ' ' VAL . . . . . 0.502 HG21 HD22 ' A' ' 17' ' ' LEU . 89.6 t -96.04 128.91 46.81 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.467 0 N-CA-C 108.057 -1.09 . . . . 75.01 108.057 176.684 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 25.0 m-20 70.24 15.94 7.4 Favored 'General case' 0 N--CA 1.493 1.688 0 C-N-CA 124.218 1.007 . . . . 74.55 110.484 -172.325 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 81.29 -5.89 65.92 Favored Glycine 0 C--N 1.353 1.507 0 CA-C-N 116.005 -0.543 . . . . 65.42 112.754 -170.505 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 25.7 mm-40 -98.32 120.81 58.68 Favored Pre-proline 0 N--CA 1.471 0.599 0 C-N-CA 123.823 0.849 . . . . 64.24 109.437 -178.213 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 52.3 Cg_exo -51.21 105.19 0.1 OUTLIER 'Trans proline' 0 C--N 1.375 1.963 0 C-N-CA 123.257 2.638 . . . . 60.14 112.344 178.536 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 17' ' ' LEU . . . . . 0.502 HD22 HG21 ' A' ' 12' ' ' VAL . 26.9 tp -75.08 -31.69 61.27 Favored 'General case' 0 N--CA 1.472 0.67 0 C-N-CA 124.126 0.97 . . . . 61.21 109.573 -179.892 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -175.66 173.15 46.07 Favored Glycine 0 C--N 1.341 0.814 0 CA-C-N 115.071 -0.968 . . . . 64.52 112.054 175.925 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 19' ' ' ARG . . . . . 0.428 ' HD2' ' HZ ' ' A' ' 7' ' ' PHE . 47.6 mtm180 -107.2 124.39 49.66 Favored 'General case' 0 N--CA 1.471 0.595 0 N-CA-C 108.541 -0.911 . . . . 74.21 108.541 -179.095 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 71.3 t -120.74 141.45 41.11 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.881 0 C-N-CA 123.1 0.56 . . . . 71.52 109.9 -176.945 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 21' ' ' SER . . . . . 0.551 ' HB2' ' HB2' ' A' ' 134' ' ' GLU . 60.6 m -127.39 132.14 50.2 Favored 'General case' 0 C--O 1.245 0.828 0 C-N-CA 123.878 0.871 . . . . 64.35 109.39 173.533 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 17.3 m-85 -107.42 153.67 22.45 Favored 'General case' 0 N--CA 1.469 0.513 0 N-CA-C 108.338 -0.986 . . . . 72.23 108.338 177.729 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 5.8 tp10 -104.75 109.64 21.67 Favored 'General case' 0 C--O 1.239 0.543 0 N-CA-C 108.598 -0.889 . . . . 73.45 108.598 176.954 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 24' ' ' LEU . . . . . 0.645 ' HB2' ' HG2' ' A' ' 4' ' ' PRO . 29.6 mt -81.11 122.77 27.77 Favored 'General case' 0 N--CA 1.465 0.285 0 N-CA-C 108.784 -0.821 . . . . 53.05 108.784 175.309 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 25' ' ' PHE . . . . . 0.508 ' HB2' HD11 ' A' ' 90' ' ' LEU . 86.9 m-85 -84.91 65.46 9.2 Favored 'General case' 0 N--CA 1.467 0.377 0 C-N-CA 123.166 0.586 . . . . 75.21 110.468 179.888 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -64.17 -24.16 67.58 Favored 'General case' 0 N--CA 1.477 0.877 0 C-N-CA 123.418 0.687 . . . . 65.15 111.876 -179.799 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 10.9 p-10 -66.09 -25.73 67.15 Favored 'General case' 0 N--CA 1.476 0.853 0 C-N-CA 123.535 0.734 . . . . 73.33 111.33 177.467 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 52.4 mttm -102.32 -43.93 5.55 Favored 'General case' 0 N--CA 1.478 0.962 0 C-N-CA 124.163 0.985 . . . . 63.14 110.238 -179.433 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 29' ' ' VAL . . . . . 0.443 HG21 ' HA ' ' A' ' 129' ' ' PHE . 16.0 m -127.31 78.85 74.03 Favored Pre-proline 0 CA--C 1.556 1.194 0 C-N-CA 124.128 0.971 . . . . 43.23 109.942 -177.11 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 11.3 Cg_endo -55.21 -48.02 23.09 Favored 'Trans proline' 0 C--N 1.383 2.373 0 C-N-CA 123.038 2.492 . . . . 74.44 112.89 -177.792 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 31' ' ' LYS . . . . . 0.446 ' HG3' ' OH ' ' A' ' 79' ' ' TYR . 23.4 ttmm -76.86 -43.48 35.96 Favored 'General case' 0 N--CA 1.474 0.771 0 C-N-CA 123.967 0.907 . . . . 74.35 112.344 -172.631 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 9.1 m -69.14 -33.36 73.33 Favored 'General case' 0 CA--C 1.549 0.94 0 CA-C-O 120.867 0.365 . . . . 51.53 110.273 -176.062 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -78.43 -34.52 47.81 Favored 'General case' 0 CA--C 1.55 0.976 0 CA-C-N 116.112 -0.494 . . . . 64.32 111.533 174.03 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 29.7 tt0 -60.32 -41.58 93.8 Favored 'General case' 0 N--CA 1.49 1.555 0 C-N-CA 124.421 1.088 . . . . 64.04 111.077 178.536 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 35' ' ' ASN . . . . . 0.478 ' O ' ' HG ' ' A' ' 39' ' ' LEU . 40.9 t30 -54.15 -60.16 3.7 Favored 'General case' 0 CA--C 1.537 0.448 0 CA-C-N 114.297 -1.32 . . . . 75.32 110.191 178.635 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 63.1 t80 -65.48 -32.51 74.16 Favored 'General case' 0 CA--C 1.545 0.76 0 CA-C-N 115.225 -0.898 . . . . 71.52 111.613 -176.695 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 37.0 ttm-85 -57.02 -50.98 71.06 Favored 'General case' 0 N--CA 1.482 1.139 0 C-N-CA 124.028 0.931 . . . . 75.4 110.346 177.195 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 38' ' ' ALA . . . . . 0.538 ' HB3' HG21 ' A' ' 78' ' ' ILE . . . -79.26 -23.33 43.73 Favored 'General case' 0 CA--C 1.545 0.766 0 CA-C-N 115.029 -0.987 . . . . 73.34 112.22 -175.24 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 39' ' ' LEU . . . . . 0.478 ' HG ' ' O ' ' A' ' 35' ' ' ASN . 85.7 mt -71.78 -40.19 69.42 Favored 'General case' 0 N--CA 1.483 1.221 0 C-N-CA 123.004 0.522 . . . . 52.21 110.158 172.899 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 28.8 t -65.48 -55.05 20.03 Favored 'General case' 0 N--CA 1.475 0.805 0 C-N-CA 124.513 1.125 . . . . 54.44 110.682 -179.368 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 20.8 p -67.73 -32.07 72.43 Favored 'General case' 0 N--CA 1.477 0.894 0 CA-C-N 116.08 -0.509 . . . . 73.54 111.411 177.284 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 71.21 28.18 70.52 Favored Glycine 0 C--N 1.343 0.972 0 CA-C-N 115.686 -0.688 . . . . 53.32 112.838 -176.662 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 19.4 mm-40 -62.85 -31.07 72.01 Favored 'General case' 0 N--CA 1.479 0.992 0 C-N-CA 123.268 0.627 . . . . 75.33 111.461 177.62 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 44' ' ' LYS . . . . . 0.403 ' HG2' ' HB1' ' A' ' 38' ' ' ALA . 75.7 mmtt -83.98 9.44 12.33 Favored 'General case' 0 CA--C 1.556 1.197 0 CA-C-N 115.706 -0.679 . . . . 74.42 111.592 178.062 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 76.1 32.51 52.39 Favored Glycine 0 C--N 1.352 1.455 0 C-N-CA 123.146 0.403 . . . . 64.31 113.706 175.711 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 17.9 m-85 -110.28 -47.23 3.32 Favored 'General case' 0 N--CA 1.483 1.182 0 N-CA-C 109.654 -0.498 . . . . 75.33 109.654 179.453 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 56.66 65.58 3.47 Favored Glycine 0 C--N 1.354 1.548 0 O-C-N 124.107 0.879 . . . . 53.03 114.21 168.627 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 48' ' ' TYR . . . . . 0.472 ' HE1' HD22 ' A' ' 39' ' ' LEU . 51.3 m-85 -65.25 87.33 0.07 Allowed 'General case' 0 N--CA 1.476 0.848 0 CA-C-O 122.644 1.212 . . . . 74.1 111.237 -179.378 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 50.6 tptt -111.13 134.83 52.42 Favored 'General case' 0 C--O 1.244 0.812 0 CA-C-N 112.698 -2.046 . . . . 73.35 107.655 -179.486 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 65.22 21.86 68.6 Favored Glycine 0 N--CA 1.468 0.823 0 CA-C-O 119.57 -0.572 . . . . 75.21 113.032 -179.321 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 28.1 t -57.98 114.24 2.25 Favored 'General case' 0 C--N 1.362 1.11 0 C-N-CA 123.688 0.795 . . . . 64.12 109.946 -176.379 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 52' ' ' CYS . . . . . . . . . . . . . 45.2 t -83.31 137.37 34.0 Favored 'General case' 0 C--O 1.241 0.619 0 CA-C-N 115.437 -0.802 . . . . 60.13 111.757 -166.872 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 53' ' ' PHE . . . . . 0.747 ' HA ' ' HA2' ' A' ' 64' ' ' GLY . 38.6 m-85 -87.2 115.65 24.75 Favored 'General case' 0 C--O 1.238 0.474 0 N-CA-C 107.886 -1.153 . . . . 75.25 107.886 169.647 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 47.3 p-80 -99.5 -29.71 12.58 Favored 'General case' 0 N--CA 1.48 1.072 0 C-N-CA 123.278 0.631 . . . . 74.1 111.153 -175.748 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 55' ' ' ARG . . . . . 0.527 ' HA ' ' O ' ' A' ' 150' ' ' GLY . 59.5 ttt180 -132.92 98.96 4.44 Favored 'General case' 0 C--O 1.218 -0.588 0 CA-C-N 115.78 -0.646 . . . . 73.43 109.412 -168.805 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 56' ' ' ILE . . . . . 0.504 HD12 HD12 ' A' ' 156' ' ' ILE . 47.5 mt -123.67 124.36 69.23 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.813 0 N-CA-C 109.162 -0.681 . . . . 73.14 109.162 178.564 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 57' ' ' ILE . . . . . 0.488 HD13 ' HB2' ' B' ' 222' ' ' ALA . 45.4 mt -126.61 112.16 22.83 Favored Pre-proline 0 CA--C 1.561 1.372 0 C-N-CA 124.87 1.268 . . . . 63.43 109.242 -170.985 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 71.0 Cg_exo -54.32 145.11 57.57 Favored 'Trans proline' 0 C--N 1.374 1.879 0 C-N-CA 123.924 3.083 . . . . 74.44 115.024 176.848 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 64.72 21.06 66.89 Favored Glycine 0 C--N 1.351 1.414 0 CA-C-N 114.643 -1.162 . . . . 54.22 113.71 -179.772 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 60' ' ' PHE . . . . . 0.441 ' HE1' ' HE1' ' A' ' 121' ' ' TRP . 33.1 t80 -144.42 -76.61 0.22 Allowed 'General case' 0 C--O 1.242 0.667 0 C-N-CA 123.099 0.559 . . . . 63.33 110.639 -171.09 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 61' ' ' MET . . . . . 0.664 ' SD ' ' HB2' ' A' ' 113' ' ' PHE . 12.3 tmm? -174.89 144.85 0.81 Allowed 'General case' 0 CA--C 1.543 0.711 0 O-C-N 123.457 0.473 . . . . 73.1 111.341 -162.187 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 62' ' ' CYS . . . . . 0.513 ' SG ' ' HB ' ' A' ' 114' ' ' ILE . 8.1 p -113.78 112.66 23.78 Favored 'General case' 0 CA--C 1.552 1.054 0 C-N-CA 124.25 1.02 . . . . 65.11 109.653 172.827 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 63' ' ' GLN . . . . . 0.63 ' HB2' ' SD ' ' A' ' 61' ' ' MET . 49.6 tt0 -103.05 114.49 28.83 Favored 'General case' 0 N--CA 1.485 1.32 0 C-N-CA 124.248 1.019 . . . . 75.02 111.129 -171.145 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 64' ' ' GLY . . . . . 0.747 ' HA2' ' HA ' ' A' ' 53' ' ' PHE . . . -98.95 -169.62 30.93 Favored Glycine 0 C--O 1.244 0.72 0 CA-C-N 114.863 -1.062 . . . . 71.52 112.111 175.597 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 72.92 87.14 0.19 Allowed Glycine 0 C--N 1.337 0.632 0 N-CA-C 111.062 -0.815 . . . . 64.21 111.062 -178.178 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 38.8 t70 -128.04 -38.46 1.82 Allowed 'General case' 0 N--CA 1.469 0.525 0 C-N-CA 122.825 0.45 . . . . 74.23 111.474 -179.518 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 77.0 t80 -70.83 -68.56 0.42 Allowed 'General case' 0 CA--C 1.552 1.043 0 N-CA-C 113.505 0.928 . . . . 61.45 113.505 -164.812 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 48.9 m -60.04 109.37 0.94 Allowed 'General case' 0 N--CA 1.482 1.141 0 C-N-CA 123.62 0.768 . . . . 65.12 112.038 -168.797 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 69' ' ' ARG . . . . . 0.557 ' HD3' ' HD3' ' A' ' 76' ' ' LYS . 73.3 mtp180 57.93 69.18 0.76 Allowed 'General case' 0 C--N 1.352 0.686 0 C-N-CA 124.763 1.225 . . . . 72.43 110.637 -170.856 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 24.5 p-80 -79.89 66.71 5.45 Favored 'General case' 0 N--CA 1.476 0.854 0 CA-C-O 122.128 0.966 . . . . 72.03 111.939 -176.921 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 15.5 m120 -119.68 20.74 12.26 Favored 'General case' 0 N--CA 1.476 0.832 0 C-N-CA 124.51 1.124 . . . . 74.43 108.628 173.898 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 100.67 -8.1 58.05 Favored Glycine 0 C--N 1.349 1.26 0 CA-C-N 115.302 -0.863 . . . . 72.32 112.519 -170.747 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 10.2 m -81.59 -61.8 1.83 Allowed 'General case' 0 N--CA 1.475 0.78 0 CA-C-N 117.589 0.694 . . . . 73.53 109.286 179.376 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 48.37 47.61 28.18 Favored Glycine 0 C--N 1.351 1.368 0 O-C-N 124.146 0.904 . . . . 43.5 115.309 170.236 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 138.11 51.37 0.06 OUTLIER Glycine 0 N--CA 1.474 1.218 0 CA-C-N 118.532 1.166 . . . . 53.52 113.382 -178.388 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 76' ' ' LYS . . . . . 0.557 ' HD3' ' HD3' ' A' ' 69' ' ' ARG . 22.8 pttp -61.35 160.26 11.07 Favored 'General case' 0 CA--C 1.556 1.177 0 C-N-CA 123.71 0.804 . . . . 74.3 111.95 179.85 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 87.1 p -91.3 164.5 13.84 Favored 'General case' 0 N--CA 1.483 1.206 0 C-N-CA 123.693 0.797 . . . . 75.12 111.685 -171.266 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 78' ' ' ILE . . . . . 0.538 HG21 ' HB3' ' A' ' 38' ' ' ALA . 45.6 pt -65.18 -15.89 19.16 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.397 0 N-CA-C 112.396 0.517 . . . . 72.03 112.396 179.89 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 79' ' ' TYR . . . . . 0.446 ' OH ' ' HG3' ' A' ' 31' ' ' LYS . 32.3 m-85 -89.79 -32.4 16.96 Favored 'General case' 0 N--CA 1.472 0.629 0 C-N-CA 123.647 0.779 . . . . 73.02 110.833 179.216 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 171.79 -137.53 4.36 Favored Glycine 0 C--N 1.339 0.726 0 CA-C-N 116.046 -0.524 . . . . 61.33 112.141 179.43 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 35.3 tt0 -65.31 -40.39 93.7 Favored 'General case' 0 CA--C 1.544 0.715 0 C-N-CA 123.375 0.67 . . . . 73.22 110.617 176.249 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 82' ' ' LYS . . . . . 0.652 ' HD2' ' HA ' ' A' ' 107' ' ' THR . 23.3 pttm -170.97 178.68 3.34 Favored 'General case' 0 CA--C 1.549 0.932 0 C-N-CA 124.129 0.971 . . . . 74.43 110.125 -173.79 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 18.9 p90 -154.11 173.18 16.4 Favored 'General case' 0 N--CA 1.477 0.907 0 C-N-CA 124.682 1.193 . . . . 71.23 110.067 -177.026 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 84' ' ' GLU . . . . . 0.512 ' HA ' ' HA ' ' A' ' 106' ' ' ASN . 14.2 pt-20 -90.79 154.23 19.67 Favored 'General case' 0 C--O 1.24 0.575 0 CA-C-O 121.023 0.439 . . . . 74.01 110.875 -179.9 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 35.2 m-20 -64.83 130.61 44.1 Favored 'General case' 0 CA--C 1.536 0.436 0 CA-C-N 114.799 -1.091 . . . . 75.42 111.446 -175.185 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 28.3 tt0 -72.54 -60.83 2.04 Favored 'General case' 0 CA--C 1.54 0.592 0 C-N-CA 123.302 0.641 . . . . 64.03 111.972 -173.276 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 31.0 p30 -164.74 158.28 17.48 Favored 'General case' 0 N--CA 1.475 0.809 0 C-N-CA 122.679 0.392 . . . . 43.3 111.124 -179.069 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 93.1 m-85 -103.35 38.32 1.8 Allowed 'General case' 0 N--CA 1.479 0.975 0 C-N-CA 123.765 0.826 . . . . 62.11 111.217 -172.413 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 64.9 mt -66.02 -52.41 49.05 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.075 0 C-N-CA 123.039 0.535 . . . . 74.45 110.42 177.317 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 90' ' ' LEU . . . . . 0.508 HD11 ' HB2' ' A' ' 25' ' ' PHE . 62.0 mt -83.17 139.82 32.94 Favored 'General case' 0 N--CA 1.473 0.691 0 CA-C-N 115.894 -0.594 . . . . 64.32 111.846 -177.009 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 91' ' ' LYS . . . . . 0.479 ' HZ3' ' HB3' ' A' ' 91' ' ' LYS . 9.2 mtpm? -124.27 167.6 14.1 Favored 'General case' 0 N--CA 1.471 0.59 0 C-N-CA 124.377 1.071 . . . . 75.12 109.604 177.751 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 92' ' ' HIS . . . . . . . . . . . . . 24.9 m-70 -86.52 62.16 7.25 Favored 'General case' 0 CA--C 1.544 0.736 0 C-N-CA 124.173 0.989 . . . . 71.01 108.861 176.3 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 93' ' ' THR . . . . . 0.435 HG23 ' HB2' ' A' ' 91' ' ' LYS . 21.9 p -83.92 -33.97 24.61 Favored 'General case' 0 N--CA 1.473 0.709 0 CA-C-N 115.132 -0.94 . . . . 75.43 111.563 -175.112 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -121.11 -177.42 15.63 Favored Glycine 0 C--N 1.342 0.888 0 CA-C-N 116.07 -0.514 . . . . 65.42 112.876 -177.201 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 79.2 Cg_endo -85.26 158.1 11.15 Favored 'Trans proline' 0 CA--C 1.553 1.449 0 C-N-CA 123.281 2.654 . . . . 64.0 112.099 173.024 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 83.07 17.67 66.72 Favored Glycine 0 N--CA 1.47 0.911 0 CA-C-N 116.054 -0.521 . . . . 74.43 114.126 179.043 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 97' ' ' ILE . . . . . 0.58 ' HB ' ' HB2' ' A' ' 115' ' ' CYS . 31.6 mm -66.47 102.99 0.51 Allowed 'Isoleucine or valine' 0 CA--C 1.549 0.934 0 C-N-CA 123.64 0.776 . . . . 73.01 111.774 -174.6 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 98' ' ' LEU . . . . . 0.467 HD13 HG12 ' A' ' 114' ' ' ILE . 58.1 tp -85.74 105.73 16.48 Favored 'General case' 0 CA--C 1.551 0.991 0 C-N-CA 123.44 0.696 . . . . 74.54 109.68 177.598 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 47.8 t -126.66 135.39 51.11 Favored 'General case' 0 N--CA 1.468 0.467 0 C-N-CA 124.69 1.196 . . . . 74.14 108.78 178.308 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 100' ' ' MET . . . . . 0.502 ' SD ' ' HA2' ' A' ' 109' ' ' GLY . 14.3 ttt -78.8 135.77 37.17 Favored 'General case' 0 N--CA 1.474 0.761 0 N-CA-C 108.343 -0.984 . . . . 72.24 108.343 -179.357 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -74.5 158.16 34.27 Favored 'General case' 0 CA--C 1.545 0.783 0 N-CA-C 112.916 0.71 . . . . 61.4 112.916 -167.462 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 22.2 p-10 -158.09 169.07 25.36 Favored 'General case' 0 N--CA 1.476 0.868 0 CA-C-N 115.542 -0.754 . . . . 75.32 110.759 -179.692 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 103' ' ' ALA . . . . . 0.453 ' HB3' HG21 ' A' ' 107' ' ' THR . . . -113.96 -1.14 13.88 Favored 'General case' 0 N--CA 1.476 0.839 0 CA-C-N 115.492 -0.777 . . . . 74.33 110.758 171.721 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 160.22 -165.59 34.89 Favored Glycine 0 C--N 1.354 1.536 0 CA-C-O 119.668 -0.518 . . . . 71.24 113.056 178.891 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 26.6 Cg_exo -64.03 134.74 44.29 Favored 'Trans proline' 0 C--N 1.376 1.997 0 C-N-CA 123.529 2.819 . . . . 71.44 112.266 178.355 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 106' ' ' ASN . . . . . 0.512 ' HA ' ' HA ' ' A' ' 84' ' ' GLU . 65.0 t30 66.82 14.24 9.73 Favored 'General case' 0 N--CA 1.485 1.32 0 C-N-CA 124.534 1.134 . . . . 41.43 111.212 -179.102 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 107' ' ' THR . . . . . 0.652 ' HA ' ' HD2' ' A' ' 82' ' ' LYS . 2.3 m -115.11 7.26 15.36 Favored 'General case' 0 CA--C 1.549 0.923 0 C-N-CA 124.208 1.003 . . . . 73.2 109.918 -178.874 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 55.1 t30 -88.67 139.51 30.4 Favored 'General case' 0 N--CA 1.476 0.865 0 C-N-CA 123.248 0.619 . . . . 73.23 110.097 -177.397 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 109' ' ' GLY . . . . . 0.502 ' HA2' ' SD ' ' A' ' 100' ' ' MET . . . 113.07 25.35 4.49 Favored Glycine 0 N--CA 1.464 0.534 0 CA-C-O 120.204 -0.22 . . . . 64.44 112.772 -175.553 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 5.1 m -132.72 126.2 31.96 Favored 'General case' 0 CA--C 1.541 0.623 0 N-CA-C 108.013 -1.106 . . . . 65.24 108.013 170.206 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 10.5 mt-30 64.52 175.81 0.19 Allowed 'General case' 0 N--CA 1.504 2.23 0 C-N-CA 125.25 1.42 . . . . 65.22 110.82 -174.615 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 54.9 p90 -148.41 159.21 44.25 Favored 'General case' 0 N--CA 1.486 1.366 0 O-C-N 121.603 -0.686 . . . . 71.45 109.865 174.681 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 113' ' ' PHE . . . . . 0.664 ' HB2' ' SD ' ' A' ' 61' ' ' MET . 55.1 p90 -146.26 147.07 31.03 Favored 'General case' 0 N--CA 1.469 0.502 0 CA-C-O 121.109 0.481 . . . . 71.11 111.452 177.625 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 114' ' ' ILE . . . . . 0.513 ' HB ' ' SG ' ' A' ' 62' ' ' CYS . 13.9 mt -117.5 102.67 13.75 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.536 0 N-CA-C 108.071 -1.085 . . . . 72.4 108.071 -179.044 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 115' ' ' CYS . . . . . 0.58 ' HB2' ' HB ' ' A' ' 97' ' ' ILE . 33.7 m -68.16 105.23 2.02 Favored 'General case' 0 CA--C 1.539 0.544 0 C-N-CA 123.305 0.642 . . . . 61.01 109.601 -179.632 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 116' ' ' THR . . . . . 0.477 HG22 HG12 ' A' ' 139' ' ' VAL . 41.3 p -70.32 -30.4 67.37 Favored 'General case' 0 N--CA 1.475 0.797 0 C-N-CA 124.009 0.924 . . . . 51.34 110.822 -175.876 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -112.32 159.64 18.46 Favored 'General case' 0 C--O 1.243 0.725 0 N-CA-C 108.115 -1.069 . . . . 71.1 108.115 169.231 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -68.73 98.84 0.94 Allowed 'General case' 0 CA--C 1.542 0.661 0 CA-C-O 121.383 0.611 . . . . 73.22 109.491 176.669 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 119' ' ' THR . . . . . . . . . . . . . 33.9 p -81.66 85.35 6.58 Favored 'General case' 0 C--O 1.239 0.502 0 CA-C-O 121.778 0.799 . . . . 75.54 109.471 -179.183 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 12.1 pt-20 -72.25 -22.51 61.22 Favored 'General case' 0 N--CA 1.473 0.68 0 CA-C-N 114.805 -1.089 . . . . 74.5 112.001 -170.862 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 121' ' ' TRP . . . . . 0.441 ' HE1' ' HE1' ' A' ' 60' ' ' PHE . 26.8 p90 -69.79 -10.28 57.8 Favored 'General case' 0 N--CA 1.477 0.91 0 C-N-CA 123.261 0.624 . . . . 72.04 111.863 175.572 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 122' ' ' LEU . . . . . 0.547 ' HA ' ' HE2' ' A' ' 125' ' ' LYS . 79.3 mt -94.71 7.6 45.27 Favored 'General case' 0 N--CA 1.475 0.825 0 C-N-CA 122.952 0.501 . . . . 75.51 111.716 176.375 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 74.3 m-20 -80.59 148.38 30.33 Favored 'General case' 0 N--CA 1.478 0.945 0 N-CA-C 109.757 -0.46 . . . . 41.13 109.757 172.247 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 77.29 22.38 70.82 Favored Glycine 0 C--N 1.344 1.01 0 N-CA-C 111.992 -0.443 . . . . 42.44 111.992 -170.02 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 125' ' ' LYS . . . . . 0.547 ' HE2' ' HA ' ' A' ' 122' ' ' LEU . 27.1 mtmm -142.4 -167.47 2.5 Favored 'General case' 0 CA--C 1.545 0.759 0 C-N-CA 124.647 1.179 . . . . 72.55 110.356 -175.091 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 126' ' ' HIS . . . . . . . . . . . . . 14.7 p-80 -64.72 157.67 26.81 Favored 'General case' 0 N--CA 1.475 0.785 0 C-N-CA 124.502 1.121 . . . . 62.12 113.955 -160.425 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 46.7 t -63.85 127.42 24.32 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.719 0 CA-C-N 113.337 -1.756 . . . . 72.03 113.627 -164.142 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 86.9 t -84.26 146.66 6.46 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.481 0 N-CA-C 108.034 -1.099 . . . . 73.2 108.034 164.196 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 129' ' ' PHE . . . . . 0.443 ' HA ' HG21 ' A' ' 29' ' ' VAL . 50.6 p90 -134.85 -6.38 2.42 Favored 'General case' 0 N--CA 1.478 0.965 0 CA-C-N 118.287 0.494 . . . . 73.55 111.721 -179.375 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . -150.02 168.44 30.07 Favored Glycine 0 C--N 1.342 0.869 0 C-N-CA 121.479 -0.391 . . . . 41.4 113.276 -175.402 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 32.2 ttpt -156.0 139.42 15.81 Favored 'General case' 0 N--CA 1.467 0.385 0 N-CA-C 107.861 -1.162 . . . . 74.55 107.861 175.04 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 132' ' ' VAL . . . . . 0.462 HG11 ' HA ' ' A' ' 136' ' ' MET . 21.8 t -64.0 114.48 2.11 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.717 0 CA-C-N 118.303 0.501 . . . . 74.21 109.871 179.733 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 133' ' ' LYS . . . . . 0.608 ' HD3' HG23 ' A' ' 5' ' ' THR . 21.6 ptmt -92.79 -30.62 15.39 Favored 'General case' 0 N--CA 1.478 0.944 0 C-N-CA 122.737 0.415 . . . . 70.23 109.884 178.861 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 134' ' ' GLU . . . . . 0.551 ' HB2' ' HB2' ' A' ' 21' ' ' SER . 41.4 mt-10 -142.49 135.8 28.74 Favored 'General case' 0 N--CA 1.473 0.725 0 C-N-CA 124.313 1.045 . . . . 63.31 109.657 -173.121 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 77.84 32.92 43.54 Favored Glycine 0 CA--C 1.531 1.076 0 O-C-N 123.327 0.392 . . . . 70.35 113.406 178.505 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 136' ' ' MET . . . . . 0.462 ' HA ' HG11 ' A' ' 132' ' ' VAL . 14.2 tpt -65.08 -35.31 80.75 Favored 'General case' 0 N--CA 1.482 1.148 0 C-N-CA 123.133 0.573 . . . . 63.32 111.643 -179.553 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 137' ' ' ASN . . . . . . . . . . . . . 18.2 m120 -67.1 -23.72 65.86 Favored 'General case' 0 N--CA 1.481 1.087 0 C-N-CA 123.294 0.638 . . . . 70.24 111.543 179.968 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 138' ' ' ILE . . . . . . . . . . . . . 36.7 mm -75.67 -37.96 37.09 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.063 0 C-N-CA 123.252 0.621 . . . . 72.41 109.61 175.913 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 139' ' ' VAL . . . . . 0.477 HG12 HG22 ' A' ' 116' ' ' THR . 95.9 t -63.5 -39.73 86.43 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.022 0 C-N-CA 123.592 0.757 . . . . 73.31 110.205 173.494 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 47.2 mt-10 -76.4 -20.68 56.88 Favored 'General case' 0 N--CA 1.474 0.774 0 CA-C-N 115.374 -0.83 . . . . 72.54 111.674 177.973 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -74.92 -50.66 16.07 Favored 'General case' 0 N--CA 1.471 0.594 0 C-N-CA 122.642 0.377 . . . . 55.34 110.387 173.939 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 142' ' ' MET . . . . . 0.652 ' HB2' HD13 ' A' ' 156' ' ' ILE . 18.3 ptt? -66.59 -28.15 68.28 Favored 'General case' 0 N--CA 1.483 1.182 0 C-N-CA 122.923 0.489 . . . . 71.24 111.63 -179.221 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 24.5 tt0 -47.46 -47.36 27.19 Favored 'General case' 0 N--CA 1.482 1.173 0 C-N-CA 125.28 1.432 . . . . 70.25 111.224 170.484 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 144' ' ' ARG . . . . . . . . . . . . . 88.6 mtt180 -85.78 -6.82 59.06 Favored 'General case' 0 CA--C 1.541 0.607 0 CA-C-N 114.123 -1.399 . . . . 74.32 111.678 -173.075 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 145' ' ' PHE . . . . . 0.51 ' HD2' ' HA ' ' A' ' 142' ' ' MET . 49.6 m-85 -89.48 2.5 54.47 Favored 'General case' 0 N--CA 1.479 1.005 0 C-N-CA 122.871 0.468 . . . . 64.11 110.448 168.149 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . -96.58 -170.55 34.42 Favored Glycine 0 C--N 1.349 1.267 0 CA-C-N 115.877 -0.602 . . . . 62.34 111.992 168.364 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 44.2 t -134.68 155.12 51.08 Favored 'General case' 0 N--CA 1.473 0.702 0 C-N-CA 124.191 0.996 . . . . 61.15 109.681 -177.833 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 148' ' ' ARG . . . . . . . . . . . . . 20.2 mmm-85 -62.24 -31.86 72.47 Favored 'General case' 0 N--CA 1.478 0.969 0 C-N-CA 123.916 0.886 . . . . 71.3 112.484 -173.055 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 149' ' ' ASN . . . . . . . . . . . . . 25.6 p-10 -76.97 -19.5 57.25 Favored 'General case' 0 N--CA 1.484 1.247 0 C-N-CA 123.021 0.528 . . . . 61.43 111.764 -179.464 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 150' ' ' GLY . . . . . 0.527 ' O ' ' HA ' ' A' ' 55' ' ' ARG . . . 119.64 -6.05 12.68 Favored Glycine 0 C--N 1.349 1.253 0 CA-C-O 119.702 -0.499 . . . . 74.4 113.367 -177.826 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 38.2 ttmt -66.62 141.15 57.91 Favored 'General case' 0 N--CA 1.474 0.747 0 CA-C-N 117.657 0.729 . . . . 65.24 110.553 177.041 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 152' ' ' THR . . . . . . . . . . . . . 18.1 p -92.46 115.26 27.93 Favored 'General case' 0 CA--C 1.538 0.488 0 N-CA-C 108.771 -0.825 . . . . 70.12 108.771 166.373 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 153' ' ' SER . . . . . . . . . . . . . 10.3 m -74.2 -21.03 59.99 Favored 'General case' 0 CA--C 1.545 0.758 0 CA-C-O 121.355 0.598 . . . . 60.41 110.295 179.624 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 71.7 mmtt -124.8 150.33 46.45 Favored 'General case' 0 N--CA 1.467 0.423 0 C-N-CA 124.537 1.135 . . . . 73.14 110.267 176.325 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 3.9 tppp? -79.92 94.96 5.96 Favored 'General case' 0 C--O 1.242 0.69 0 N-CA-C 108.927 -0.768 . . . . 74.33 108.927 173.478 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 156' ' ' ILE . . . . . 0.652 HD13 ' HB2' ' A' ' 142' ' ' MET . 60.8 mt -101.45 124.13 55.0 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.155 0 CA-C-N 114.972 -1.013 . . . . 70.15 108.621 -178.575 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 157' ' ' THR . . . . . . . . . . . . . 31.6 p -138.78 157.78 45.44 Favored 'General case' 0 N--CA 1.47 0.56 0 C-N-CA 124.567 1.147 . . . . 73.25 109.256 -173.686 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 158' ' ' ILE . . . . . 0.44 HG23 ' HB3' ' A' ' 8' ' ' PHE . 59.3 mt -80.24 94.28 2.12 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.72 0 N-CA-C 108.5 -0.926 . . . . 52.14 108.5 169.773 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 159' ' ' ALA . . . . . 0.688 ' HB2' ' HB2' ' A' ' 11' ' ' ALA . . . -52.76 -53.69 44.47 Favored 'General case' 0 N--CA 1.481 1.105 0 C-N-CA 124.114 0.966 . . . . 64.13 112.357 -177.852 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 160' ' ' ASP . . . . . . . . . . . . . 26.9 t0 -148.54 157.66 43.61 Favored 'General case' 0 N--CA 1.471 0.618 0 CA-C-N 115.808 -0.633 . . . . 75.44 110.091 -173.557 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 161' ' ' CYS . . . . . . . . . . . . . 28.0 p -129.23 -170.62 2.31 Favored 'General case' 0 CA--C 1.539 0.543 0 C-N-CA 124.922 1.289 . . . . 71.12 108.513 176.888 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 162' ' ' GLY . . . . . . . . . . . . . . . 132.35 53.07 0.08 OUTLIER Glycine 0 C--N 1.342 0.906 0 N-CA-C 110.708 -0.957 . . . . 44.3 110.708 -168.442 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 163' ' ' GLN . . . . . 0.556 ' HB2' ' HA ' ' A' ' 6' ' ' VAL . 13.2 pt20 -55.99 143.73 31.22 Favored 'General case' 0 CA--C 1.544 0.749 0 C-N-CA 124.487 1.115 . . . . 72.43 113.097 -174.293 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 164' ' ' LEU . . . . . . . . . . . . . 77.5 mt -82.1 105.64 13.36 Favored 'General case' 0 CA--C 1.539 0.524 0 CA-C-N 115.404 -0.816 . . . . 74.14 110.277 -176.724 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 165' ' ' GLU . . . . . . . . . . . . . 7.5 pt-20 . . . . . 0 CA--C 1.558 1.258 0 C-N-CA 123.836 0.855 . . . . 62.43 109.426 169.363 . . . . . . . . 0 0 . 1 . 013 nuclear build full ' B' B ' 216' ' ' PRO . . . . . . . . . . . . . 18.1 Cg_exo . . . . . 0 N--CA 1.485 1.0 0 N-CA-C 109.821 -0.876 . . . . 70.53 109.821 . . . . . . . . . 0 0 . 1 . 013 nuclear build full ' B' B ' 217' ' ' GLU . . . . . . . . . . . . . 28.9 tt0 -145.44 140.69 16.16 Favored Pre-proline 0 C--O 1.245 0.817 0 C-N-CA 124.185 0.994 . . . . 62.5 108.454 179.773 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 218' ' ' PRO . . . . . . . . . . . . . 37.3 Cg_exo -62.74 101.08 0.25 Allowed 'Trans proline' 0 C--N 1.37 1.665 0 C-N-CA 122.04 1.827 . . . . 70.53 110.494 161.485 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 219' ' ' GLY . . . . . . . . . . . . . . . 171.1 171.49 36.39 Favored Glycine 0 CA--C 1.527 0.786 0 CA-C-N 116.283 -0.417 . . . . 24.42 112.776 -179.59 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 220' ' ' PRO . . . . . . . . . . . . . 97.6 Cg_endo -85.02 -169.17 0.59 Allowed 'Trans proline' 0 C--N 1.371 1.739 0 C-N-CA 123.429 2.752 . . . . 62.51 113.496 -178.785 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 221' ' ' TYR . . . . . . . . . . . . . 96.8 m-85 -117.92 125.47 50.52 Favored 'General case' 0 N--CA 1.483 1.177 0 C-N-CA 123.781 0.833 . . . . 61.2 109.742 179.111 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 222' ' ' ALA . . . . . 0.488 ' HB2' HD13 ' A' ' 57' ' ' ILE . . . -68.94 105.04 2.24 Favored 'General case' 0 N--CA 1.475 0.809 0 C-N-CA 124.219 1.008 . . . . 73.11 111.671 -175.724 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 223' ' ' GLN . . . . . . . . . . . . . 23.0 mp0 38.81 73.54 0.78 Allowed Pre-proline 0 CA--C 1.56 1.361 0 O-C-N 125.093 1.495 . . . . 74.2 112.383 178.976 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 224' ' ' PRO . . . . . . . . . . . . . 50.2 Cg_exo . . . . . 0 C--N 1.373 1.829 0 C-N-CA 123.611 2.874 . . . . 63.31 112.811 -176.482 . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 74.5 mtp . . . . . 0 N--CA 1.48 1.059 0 N-CA-C 109.288 -0.634 . . . . 63.22 109.288 . . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 15.4 m -77.11 78.72 0.68 Allowed 'Isoleucine or valine' 0 N--CA 1.478 0.966 0 CA-C-O 122.521 1.153 . . . . 71.2 110.294 178.263 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 3' ' ' ASN . . . . . 0.503 ' ND2' ' HA ' ' A' ' 25' ' ' PHE . 11.8 m120 -98.04 107.71 42.46 Favored Pre-proline 0 CA--C 1.545 0.757 0 CA-C-N 114.413 -1.267 . . . . 72.34 110.043 -179.813 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 6.7 Cg_endo -80.73 152.68 19.7 Favored 'Trans proline' 0 C--N 1.371 1.755 0 C-N-CA 122.429 2.086 . . . . 65.01 110.963 173.872 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 5' ' ' THR . . . . . 0.46 ' HB ' ' O ' ' A' ' 164' ' ' LEU . 93.2 m -96.15 142.72 28.0 Favored 'General case' 0 CA--C 1.549 0.912 0 C-N-CA 123.096 0.558 . . . . 74.01 109.638 178.643 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 6' ' ' VAL . . . . . 0.665 ' HA ' ' HG3' ' A' ' 163' ' ' GLN . 29.1 t -110.37 147.12 14.8 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.436 0 N-CA-C 107.222 -1.399 . . . . 74.33 107.222 177.333 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 7' ' ' PHE . . . . . 0.536 ' H ' ' HA ' ' A' ' 163' ' ' GLN . 65.0 t80 -125.59 126.29 44.54 Favored 'General case' 0 C--O 1.238 0.468 0 N-CA-C 108.916 -0.772 . . . . 74.31 108.916 178.905 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 8' ' ' PHE . . . . . 0.541 ' HD2' ' HE2' ' A' ' 22' ' ' PHE . 33.9 m-85 -134.56 165.28 25.57 Favored 'General case' 0 N--CA 1.47 0.557 0 C-N-CA 124.074 0.95 . . . . 73.54 109.701 169.25 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 23.7 m-20 -118.27 117.33 28.83 Favored 'General case' 0 C--N 1.327 -0.406 0 N-CA-C 107.311 -1.366 . . . . 75.12 107.311 171.152 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 42.4 mm -90.05 136.12 24.61 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.823 0 N-CA-C 108.672 -0.862 . . . . 71.31 108.672 178.506 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 11' ' ' ALA . . . . . 0.662 ' HB2' ' HB2' ' A' ' 159' ' ' ALA . . . -135.47 122.27 21.07 Favored 'General case' 0 N--CA 1.478 0.951 0 C-N-CA 123.44 0.696 . . . . 65.24 111.666 -170.513 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 12' ' ' VAL . . . . . 0.442 HG22 HG12 ' A' ' 156' ' ' ILE . 62.4 t -95.94 122.99 47.95 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.709 0 C-N-CA 124.186 0.994 . . . . 71.02 108.962 176.846 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 42.3 m-20 64.1 23.09 13.11 Favored 'General case' 0 N--CA 1.491 1.616 0 C-N-CA 125.331 1.452 . . . . 74.12 110.836 -172.932 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 83.38 -13.21 47.41 Favored Glycine 0 C--N 1.351 1.384 0 CA-C-O 119.571 -0.572 . . . . 73.21 113.067 -173.079 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 37.8 mm-40 -83.49 117.23 68.04 Favored Pre-proline 0 C--N 1.353 0.759 0 C-N-CA 123.553 0.741 . . . . 63.13 109.981 177.863 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 93.1 Cg_exo -46.7 106.36 0.1 OUTLIER 'Trans proline' 0 C--N 1.379 2.134 0 C-N-CA 124.072 3.182 . . . . 61.03 113.891 -179.411 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 43.3 tp -76.08 -40.96 51.92 Favored 'General case' 0 N--CA 1.48 1.055 0 C-N-CA 123.705 0.802 . . . . 71.11 109.66 179.319 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -179.77 172.22 43.88 Favored Glycine 0 C--N 1.345 1.047 0 O-C-N 123.367 0.417 . . . . 24.11 112.957 178.386 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 13.2 ptm180 -105.82 124.47 49.61 Favored 'General case' 0 N--CA 1.473 0.71 0 N-CA-C 108.255 -1.017 . . . . 74.04 108.255 -177.988 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 51.8 t -120.89 137.91 53.08 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.407 0 C-N-CA 123.692 0.797 . . . . 74.25 109.382 -175.14 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 21' ' ' SER . . . . . 0.497 ' HB2' ' HB2' ' A' ' 134' ' ' GLU . 51.7 m -121.18 125.25 46.68 Favored 'General case' 0 C--O 1.248 1.004 0 C-N-CA 123.706 0.802 . . . . 73.42 109.519 176.677 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 22' ' ' PHE . . . . . 0.541 ' HE2' ' HD2' ' A' ' 8' ' ' PHE . 57.4 m-85 -100.81 169.95 8.65 Favored 'General case' 0 N--CA 1.474 0.735 0 C-N-CA 123.833 0.853 . . . . 72.21 109.358 178.47 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 23' ' ' GLU . . . . . 0.545 ' HB2' ' HD2' ' A' ' 133' ' ' LYS . 37.7 tt0 -138.32 112.31 8.48 Favored 'General case' 0 CA--C 1.543 0.684 0 C-N-CA 123.156 0.582 . . . . 74.02 109.632 -179.513 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 24' ' ' LEU . . . . . 0.414 HD22 ' HD1' ' A' ' 129' ' ' PHE . 62.1 mt -84.12 136.48 33.98 Favored 'General case' 0 N--CA 1.478 0.951 0 C-N-CA 123.692 0.797 . . . . 65.1 110.804 -176.784 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 25' ' ' PHE . . . . . 0.503 ' HA ' ' ND2' ' A' ' 3' ' ' ASN . 32.7 m-85 -85.65 64.29 8.54 Favored 'General case' 0 CA--C 1.546 0.805 0 CA-C-O 121.186 0.517 . . . . 73.35 109.642 175.886 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -72.91 1.03 9.52 Favored 'General case' 0 N--CA 1.486 1.364 0 N-CA-C 113.125 0.787 . . . . 55.4 113.125 -175.407 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 11.7 p-10 -87.33 -24.3 24.34 Favored 'General case' 0 CA--C 1.548 0.896 0 C-N-CA 123.555 0.742 . . . . 64.13 111.096 174.433 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 97.7 mttt -114.02 -35.02 5.21 Favored 'General case' 0 N--CA 1.489 1.489 0 C-N-CA 123.692 0.797 . . . . 70.21 111.12 -176.339 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 29' ' ' VAL . . . . . 0.505 HG21 ' HA ' ' A' ' 129' ' ' PHE . 6.7 m -128.85 71.15 81.46 Favored Pre-proline 0 CA--C 1.553 1.074 0 C-N-CA 123.927 0.891 . . . . 73.0 110.209 175.333 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 15.3 Cg_exo -66.03 -33.96 39.64 Favored 'Trans proline' 0 C--N 1.381 2.244 0 C-N-CA 122.567 2.178 . . . . 73.54 111.104 -179.13 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 87.7 tttt -63.51 -57.19 10.97 Favored 'General case' 0 CA--C 1.54 0.575 0 C-N-CA 124.796 1.238 . . . . 75.01 111.083 -179.17 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 6.5 m -68.98 -30.46 68.87 Favored 'General case' 0 CA--C 1.554 1.098 0 C-N-CA 123.613 0.765 . . . . 61.33 111.292 -174.964 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -71.81 -40.03 69.42 Favored 'General case' 0 CA--C 1.548 0.904 0 C-N-CA 123.403 0.681 . . . . 45.03 111.347 175.894 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 9.3 tp10 -71.81 -34.26 69.2 Favored 'General case' 0 N--CA 1.482 1.136 0 C-N-CA 123.436 0.695 . . . . 75.14 110.154 -178.458 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 35' ' ' ASN . . . . . 0.419 ' O ' ' HG ' ' A' ' 39' ' ' LEU . 40.1 t30 -57.98 -54.82 42.66 Favored 'General case' 0 N--CA 1.474 0.738 0 CA-C-N 114.527 -1.215 . . . . 64.22 109.766 173.526 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 74.2 t80 -58.91 -42.01 88.62 Favored 'General case' 0 CA--C 1.543 0.701 0 O-C-N 124.742 1.276 . . . . 73.1 111.096 -177.874 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 36.3 ttm180 -55.58 -57.14 13.18 Favored 'General case' 0 C--N 1.358 0.958 0 O-C-N 123.766 0.666 . . . . 63.14 110.394 175.629 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 38' ' ' ALA . . . . . 0.515 ' HB1' ' HG2' ' A' ' 44' ' ' LYS . . . -63.62 -32.96 74.6 Favored 'General case' 0 C--O 1.243 0.732 0 O-C-N 124.041 0.838 . . . . 60.02 112.129 -173.078 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 39' ' ' LEU . . . . . 0.566 HD22 ' HE2' ' A' ' 48' ' ' TYR . 74.2 mt -65.56 -45.0 85.02 Favored 'General case' 0 N--CA 1.475 0.792 0 O-C-N 124.147 0.904 . . . . 70.53 111.02 176.517 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 41.2 m -76.42 -49.45 16.67 Favored 'General case' 0 N--CA 1.475 0.814 0 C-N-CA 123.408 0.683 . . . . 41.24 112.01 -174.31 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 41' ' ' THR . . . . . 0.426 ' OG1' ' HG2' ' A' ' 43' ' ' GLU . 67.6 p -76.53 -31.48 57.67 Favored 'General case' 0 N--CA 1.471 0.609 0 C-N-CA 124.204 1.002 . . . . 71.12 111.647 -174.138 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 92.57 26.44 17.62 Favored Glycine 0 C--N 1.349 1.25 0 CA-C-O 119.683 -0.509 . . . . 74.35 113.071 -179.677 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 43' ' ' GLU . . . . . 0.426 ' HG2' ' OG1' ' A' ' 41' ' ' THR . 19.9 mm-40 -63.39 -22.97 67.2 Favored 'General case' 0 N--CA 1.483 1.213 0 C-N-CA 123.086 0.555 . . . . 63.32 111.69 174.31 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 44' ' ' LYS . . . . . 0.515 ' HG2' ' HB1' ' A' ' 38' ' ' ALA . 75.8 mmtt -114.38 16.43 17.81 Favored 'General case' 0 N--CA 1.482 1.149 0 C-N-CA 123.63 0.772 . . . . 73.53 111.022 177.242 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 93.41 -25.06 22.57 Favored Glycine 0 C--N 1.355 1.627 0 N-CA-C 114.794 0.677 . . . . 75.23 114.794 174.893 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 46' ' ' PHE . . . . . 0.424 ' HE2' ' HA ' ' A' ' 78' ' ' ILE . 21.8 m-85 -68.77 -48.22 64.22 Favored 'General case' 0 N--CA 1.479 0.992 0 C-N-CA 122.953 0.501 . . . . 75.12 111.846 -167.407 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 40.97 62.05 1.82 Allowed Glycine 0 C--N 1.358 1.786 0 O-C-N 124.975 1.422 . . . . 75.42 115.321 169.92 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 48' ' ' TYR . . . . . 0.566 ' HE2' HD22 ' A' ' 39' ' ' LEU . 97.3 m-85 -62.88 90.76 0.04 OUTLIER 'General case' 0 N--CA 1.476 0.859 0 CA-C-O 121.478 0.656 . . . . 74.41 111.52 -176.678 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 3.7 tppp? -105.24 125.81 51.4 Favored 'General case' 0 C--O 1.232 0.148 0 N-CA-C 108.328 -0.989 . . . . 72.3 108.328 175.05 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 80.96 20.23 65.72 Favored Glycine 0 CA--C 1.524 0.636 0 CA-C-O 119.681 -0.511 . . . . 51.14 112.742 -175.427 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 51' ' ' SER . . . . . 0.414 ' HB2' ' HB3' ' A' ' 48' ' ' TYR . 36.0 t -62.38 118.41 7.45 Favored 'General case' 0 C--N 1.354 0.786 0 N-CA-C 109.032 -0.729 . . . . 70.42 109.032 176.9 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 52' ' ' CYS . . . . . . . . . . . . . 25.6 p -86.75 129.48 34.86 Favored 'General case' 0 CA--C 1.536 0.425 0 C-N-CA 123.54 0.736 . . . . 64.01 111.645 -170.577 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 53' ' ' PHE . . . . . 0.65 ' HA ' ' HA2' ' A' ' 64' ' ' GLY . 46.5 m-85 -76.79 74.4 3.43 Favored 'General case' 0 CA--C 1.538 0.516 0 N-CA-C 108.353 -0.98 . . . . 73.25 108.353 168.415 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 27.1 p-80 -75.0 -22.84 58.27 Favored 'General case' 0 N--CA 1.476 0.868 0 CA-C-N 115.146 -0.934 . . . . 74.45 111.522 -174.674 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 55' ' ' ARG . . . . . 0.41 ' HA ' ' O ' ' A' ' 150' ' ' GLY . 38.4 ttt180 -112.96 99.41 7.84 Favored 'General case' 0 C--O 1.218 -0.601 0 N-CA-C 109.108 -0.701 . . . . 72.03 109.108 178.238 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 42.7 mt -127.63 137.86 56.44 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.643 0 N-CA-C 108.47 -0.937 . . . . 75.41 108.47 171.747 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 57' ' ' ILE . . . . . 0.687 HG23 ' HA ' ' A' ' 148' ' ' ARG . 70.2 mt -134.56 125.3 17.52 Favored Pre-proline 0 CA--C 1.553 1.08 0 C-N-CA 124.811 1.244 . . . . 72.43 108.621 -176.267 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 58' ' ' PRO . . . . . 0.411 ' HA ' ' HG2' ' A' ' 143' ' ' GLU . 84.3 Cg_endo -76.82 145.41 25.42 Favored 'Trans proline' 0 C--N 1.375 1.943 0 C-N-CA 122.687 2.258 . . . . 73.43 112.15 -177.606 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 70.04 25.48 75.55 Favored Glycine 0 C--N 1.342 0.868 0 CA-C-N 115.398 -0.819 . . . . 53.54 112.653 -175.486 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 60' ' ' PHE . . . . . 0.4 ' HD2' ' HB ' ' A' ' 57' ' ' ILE . 36.5 t80 -151.57 -73.58 0.15 Allowed 'General case' 0 C--O 1.247 0.95 0 C-N-CA 122.835 0.454 . . . . 74.12 111.172 -171.646 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 61' ' ' MET . . . . . 0.543 ' SD ' ' HB2' ' A' ' 113' ' ' PHE . 38.8 ttm -176.79 143.9 0.46 Allowed 'General case' 0 N--CA 1.482 1.166 0 N-CA-C 112.445 0.535 . . . . 63.02 112.445 -159.06 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 62' ' ' CYS . . . . . 0.472 ' SG ' HG13 ' A' ' 139' ' ' VAL . 25.1 p -112.72 112.45 23.96 Favored 'General case' 0 CA--C 1.55 0.962 0 N-CA-C 109.018 -0.734 . . . . 75.3 109.018 169.344 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 63' ' ' GLN . . . . . 0.528 ' HA ' ' HA ' ' A' ' 113' ' ' PHE . 51.4 tt0 -105.43 120.68 42.21 Favored 'General case' 0 N--CA 1.485 1.284 0 C-N-CA 124.248 1.019 . . . . 74.33 111.503 -175.185 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 64' ' ' GLY . . . . . 0.65 ' HA2' ' HA ' ' A' ' 53' ' ' PHE . . . -91.84 148.75 19.38 Favored Glycine 0 C--N 1.347 1.16 0 CA-C-N 115.206 -0.906 . . . . 75.11 112.34 176.403 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 65' ' ' GLY . . . . . 0.517 ' HA3' ' HG2' ' A' ' 111' ' ' GLN . . . -176.84 131.25 1.8 Allowed Glycine 0 C--N 1.338 0.656 0 N-CA-C 111.984 -0.447 . . . . 73.2 111.984 179.511 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 33.2 t70 -75.99 165.35 25.09 Favored 'General case' 0 CA--C 1.547 0.846 0 C-N-CA 123.046 0.538 . . . . 72.45 111.31 -175.613 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 90.2 t80 -64.92 -32.88 74.81 Favored 'General case' 0 C--O 1.245 0.853 0 C-N-CA 123.665 0.786 . . . . 72.34 111.365 178.176 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 33.9 m -60.81 112.67 2.13 Favored 'General case' 0 C--N 1.354 0.772 0 C-N-CA 122.985 0.514 . . . . 73.34 111.254 -177.057 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 69' ' ' ARG . . . . . 0.43 ' HD3' ' HG3' ' A' ' 81' ' ' GLU . 81.1 mtt85 65.33 28.01 11.9 Favored 'General case' 0 CA--C 1.547 0.843 0 O-C-N 124.618 1.199 . . . . 74.44 112.02 178.381 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 15.4 p80 -55.18 -25.41 32.44 Favored 'General case' 0 N--CA 1.498 1.969 0 C-N-CA 123.529 0.732 . . . . 70.01 112.759 -174.571 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 11.2 m120 -77.5 87.84 3.84 Favored 'General case' 0 CA--C 1.544 0.747 0 C-N-CA 123.849 0.86 . . . . 64.31 109.373 174.353 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 91.25 -1.2 76.46 Favored Glycine 0 N--CA 1.474 1.213 0 CA-C-O 119.4 -0.667 . . . . 63.45 114.61 175.381 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 73' ' ' THR . . . . . 0.461 ' HA ' ' HB2' ' A' ' 110' ' ' SER . 96.2 m -140.31 -92.16 0.16 Allowed 'General case' 0 CA--C 1.558 1.277 0 CA-C-N 117.738 0.769 . . . . 71.23 110.046 172.951 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 81.67 43.66 8.27 Favored Glycine 0 C--N 1.359 1.84 0 CA-C-N 118.279 0.491 . . . . 73.51 113.985 176.684 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 140.79 53.46 0.04 OUTLIER Glycine 0 C--N 1.346 1.095 0 CA-C-N 117.552 0.676 . . . . 74.32 111.495 -176.482 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 76' ' ' LYS . . . . . 0.503 ' HB2' ' HA ' ' A' ' 81' ' ' GLU . 13.9 ptmm? -56.09 162.86 1.76 Allowed 'General case' 0 N--CA 1.483 1.182 0 C-N-CA 124.026 0.93 . . . . 73.22 112.749 -174.541 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 87.3 p -94.49 -177.77 4.35 Favored 'General case' 0 C--O 1.243 0.734 0 C-N-CA 122.995 0.518 . . . . 63.03 111.345 -170.775 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 78' ' ' ILE . . . . . 0.51 HG21 ' HB3' ' A' ' 38' ' ' ALA . 20.9 pt -88.59 -12.38 10.21 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.889 0 CA-C-N 115.56 -0.746 . . . . 65.42 110.668 173.985 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 42.9 m-85 -88.17 -24.62 23.27 Favored 'General case' 0 N--CA 1.472 0.646 0 C-N-CA 123.935 0.894 . . . . 73.3 109.662 178.476 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 167.86 -145.29 9.58 Favored Glycine 0 C--N 1.346 1.084 0 CA-C-N 115.365 -0.834 . . . . 72.05 111.095 176.827 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 81' ' ' GLU . . . . . 0.503 ' HA ' ' HB2' ' A' ' 76' ' ' LYS . 36.3 tt0 -69.16 -34.93 75.74 Favored 'General case' 0 CA--C 1.543 0.709 0 C-N-CA 123.293 0.637 . . . . 71.54 110.06 174.475 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 82' ' ' LYS . . . . . 0.706 ' HD2' ' HA ' ' A' ' 107' ' ' THR . 20.6 pttp -169.99 177.2 4.41 Favored 'General case' 0 N--CA 1.476 0.842 0 C-N-CA 124.733 1.213 . . . . 71.33 109.047 178.397 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 46.5 p90 -146.78 173.49 12.33 Favored 'General case' 0 N--CA 1.474 0.767 0 C-N-CA 123.651 0.78 . . . . 71.13 110.563 -179.208 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 13.5 pt-20 -88.34 158.99 18.26 Favored 'General case' 0 N--CA 1.475 0.821 0 C-N-CA 123.055 0.542 . . . . 73.21 110.208 177.917 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 27.0 m-20 -60.81 118.64 6.91 Favored 'General case' 0 N--CA 1.477 0.924 0 C-N-CA 124.376 1.071 . . . . 74.25 109.967 -179.337 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 20.6 tp10 -66.79 -59.01 3.92 Favored 'General case' 0 N--CA 1.479 0.983 0 C-N-CA 123.133 0.573 . . . . 63.31 111.198 -175.158 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 26.4 p30 -143.01 -174.46 4.19 Favored 'General case' 0 N--CA 1.47 0.543 0 C-N-CA 123.757 0.823 . . . . 74.32 109.593 179.966 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 79.8 m-85 -136.27 39.54 2.69 Favored 'General case' 0 N--CA 1.481 1.082 0 C-N-CA 123.591 0.756 . . . . 75.25 109.754 -179.325 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 60.5 mt -69.01 -62.07 1.42 Allowed 'Isoleucine or valine' 0 N--CA 1.477 0.9 0 CA-C-N 115.431 -0.804 . . . . 74.42 110.966 -178.806 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 90' ' ' LEU . . . . . 0.696 ' H ' HG23 ' A' ' 127' ' ' VAL . 66.1 mt -87.55 140.96 28.99 Favored 'General case' 0 C--O 1.238 0.492 0 CA-C-N 115.539 -0.755 . . . . 65.25 110.678 -171.748 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 55.3 mtpt -125.5 168.83 13.09 Favored 'General case' 0 N--CA 1.47 0.526 0 C-N-CA 124.152 0.981 . . . . 53.12 110.174 -174.285 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 92' ' ' HIS . . . . . 0.415 ' HA ' HG21 ' A' ' 97' ' ' ILE . 43.5 m80 -92.88 51.28 1.67 Allowed 'General case' 0 N--CA 1.48 1.026 0 C-N-CA 124.235 1.014 . . . . 62.24 109.503 -174.486 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 41.3 p -84.3 -7.12 59.42 Favored 'General case' 0 N--CA 1.472 0.632 0 CA-C-N 114.476 -1.238 . . . . 73.33 112.799 -171.371 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -143.5 -179.57 20.2 Favored Glycine 0 C--N 1.347 1.164 0 CA-C-O 120.117 -0.268 . . . . 41.44 113.057 -177.12 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 82.1 Cg_endo -82.4 158.21 17.06 Favored 'Trans proline' 0 C--N 1.367 1.523 0 C-N-CA 123.412 2.741 . . . . 73.31 112.561 175.241 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 73.83 18.83 79.69 Favored Glycine 0 CA--C 1.531 1.059 0 CA-C-N 115.524 -0.762 . . . . 71.21 114.467 178.867 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 97' ' ' ILE . . . . . 0.415 HG21 ' HA ' ' A' ' 92' ' ' HIS . 17.0 mm -78.93 108.28 12.33 Favored 'Isoleucine or valine' 0 CA--C 1.562 1.428 0 CA-C-N 117.533 0.666 . . . . 71.1 112.466 -171.824 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 98' ' ' LEU . . . . . 0.636 ' HG ' HG12 ' A' ' 114' ' ' ILE . 7.6 mp -87.21 117.93 26.29 Favored 'General case' 0 N--CA 1.488 1.468 0 C-N-CA 123.535 0.734 . . . . 74.2 111.033 175.923 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 99' ' ' SER . . . . . 0.644 ' HB3' ' HA ' ' A' ' 128' ' ' VAL . 2.7 p -139.78 143.5 36.93 Favored 'General case' 0 N--CA 1.476 0.874 0 N-CA-C 108.306 -0.998 . . . . 74.4 108.306 173.707 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 100' ' ' MET . . . . . 0.473 ' HA ' ' HA ' ' A' ' 112' ' ' PHE . 49.7 mtp -76.23 138.9 40.91 Favored 'General case' 0 N--CA 1.485 1.31 0 N-CA-C 109.689 -0.486 . . . . 75.14 109.689 -171.491 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 101' ' ' ALA . . . . . 0.549 ' HB3' ' HB2' ' A' ' 111' ' ' GLN . . . -75.69 158.25 32.57 Favored 'General case' 0 N--CA 1.481 1.082 0 CA-C-O 121.216 0.531 . . . . 75.13 111.635 -170.48 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 30.4 p-10 -162.67 163.13 27.13 Favored 'General case' 0 CA--C 1.537 0.453 0 CA-C-N 114.95 -1.023 . . . . 74.43 110.131 -179.361 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -103.91 1.67 31.61 Favored 'General case' 0 N--CA 1.473 0.707 0 C-N-CA 124.203 1.001 . . . . 75.54 110.196 169.686 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 149.45 -164.41 29.39 Favored Glycine 0 C--N 1.345 1.031 0 CA-C-O 119.273 -0.737 . . . . 61.14 111.466 -178.269 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 53.2 Cg_exo -56.89 141.73 93.14 Favored 'Trans proline' 0 C--N 1.368 1.6 0 C-N-CA 123.286 2.657 . . . . 75.14 112.795 175.978 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 63.9 t30 68.46 10.18 7.71 Favored 'General case' 0 N--CA 1.495 1.788 0 C-N-CA 125.102 1.361 . . . . 73.24 112.332 179.526 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 107' ' ' THR . . . . . 0.706 ' HA ' ' HD2' ' A' ' 82' ' ' LYS . 2.4 m -113.1 0.23 14.9 Favored 'General case' 0 CA--C 1.551 0.997 0 O-C-N 121.511 -0.743 . . . . 74.35 110.775 178.307 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 57.5 t30 -70.76 155.57 40.6 Favored 'General case' 0 N--CA 1.481 1.108 0 C-N-CA 123.784 0.834 . . . . 74.25 110.738 -178.034 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 89.76 0.73 78.13 Favored Glycine 0 N--CA 1.468 0.773 0 CA-C-N 116.713 -0.221 . . . . 52.34 113.55 179.026 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 110' ' ' SER . . . . . 0.461 ' HB2' ' HA ' ' A' ' 73' ' ' THR . 79.6 p -100.25 120.64 40.22 Favored 'General case' 0 CA--C 1.531 0.22 0 N-CA-C 108.012 -1.107 . . . . 65.23 108.012 173.731 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 111' ' ' GLN . . . . . 0.549 ' HB2' ' HB3' ' A' ' 101' ' ' ALA . 49.4 mt-30 62.53 176.57 0.14 Allowed 'General case' 0 N--CA 1.492 1.66 0 C-N-CA 123.609 0.764 . . . . 75.53 111.769 -174.839 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 112' ' ' PHE . . . . . 0.473 ' HA ' ' HA ' ' A' ' 100' ' ' MET . 29.1 p90 -147.13 133.71 19.85 Favored 'General case' 0 N--CA 1.471 0.622 0 N-CA-C 108.021 -1.103 . . . . 72.41 108.021 172.932 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 113' ' ' PHE . . . . . 0.543 ' HB2' ' SD ' ' A' ' 61' ' ' MET . 46.4 p90 -113.49 134.3 54.75 Favored 'General case' 0 C--O 1.239 0.539 0 CA-C-O 121.235 0.54 . . . . 71.34 110.751 178.349 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 114' ' ' ILE . . . . . 0.636 HG12 ' HG ' ' A' ' 98' ' ' LEU . 22.1 mt -99.96 101.04 11.56 Favored 'Isoleucine or valine' 0 C--O 1.239 0.532 0 N-CA-C 108.047 -1.094 . . . . 70.42 108.047 176.612 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 115' ' ' CYS . . . . . 0.414 ' SG ' ' HD2' ' A' ' 92' ' ' HIS . 32.4 m -65.92 103.78 0.99 Allowed 'General case' 0 N--CA 1.467 0.388 0 N-CA-C 108.611 -0.885 . . . . 73.33 108.611 174.485 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 116' ' ' THR . . . . . 0.521 HG22 HG12 ' A' ' 139' ' ' VAL . 35.6 p -70.04 -28.86 65.81 Favored 'General case' 0 N--CA 1.48 1.05 0 C-N-CA 123.707 0.803 . . . . 61.42 110.675 -177.206 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -119.49 168.25 11.16 Favored 'General case' 0 C--O 1.243 0.72 0 C-N-CA 124.051 0.941 . . . . 63.21 109.279 171.159 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 13.3 ptmm? -72.55 89.3 1.28 Allowed 'General case' 0 C--O 1.246 0.89 0 CA-C-O 121.657 0.742 . . . . 74.34 110.3 178.1 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 119' ' ' THR . . . . . 0.506 ' HB ' HD13 ' A' ' 122' ' ' LEU . 37.6 p -71.22 89.2 0.85 Allowed 'General case' 0 CA--C 1.542 0.651 0 CA-C-O 122.0 0.905 . . . . 54.33 108.971 176.829 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 9.5 pt-20 -75.98 -21.44 56.95 Favored 'General case' 0 N--CA 1.475 0.788 0 CA-C-N 114.578 -1.192 . . . . 63.04 111.773 -171.486 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 121' ' ' TRP . . . . . . . . . . . . . 33.1 p90 -77.18 -0.84 26.58 Favored 'General case' 0 CA--C 1.549 0.937 0 C-N-CA 123.581 0.752 . . . . 64.11 110.829 172.35 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 122' ' ' LEU . . . . . 0.564 ' HA ' ' HE2' ' A' ' 125' ' ' LYS . 10.9 mp -101.97 7.04 41.5 Favored 'General case' 0 N--CA 1.474 0.727 0 C-N-CA 123.682 0.793 . . . . 74.05 110.879 170.832 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 93.8 m-20 -84.82 128.09 34.45 Favored 'General case' 0 N--CA 1.475 0.776 0 N-CA-C 109.588 -0.523 . . . . 53.51 109.588 173.558 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 94.42 7.41 60.55 Favored Glycine 0 C--N 1.345 1.043 0 N-CA-C 111.69 -0.564 . . . . 62.22 111.69 -168.454 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 125' ' ' LYS . . . . . 0.564 ' HE2' ' HA ' ' A' ' 122' ' ' LEU . 19.4 ttmm -104.26 -167.39 1.35 Allowed 'General case' 0 CA--C 1.552 1.049 0 C-N-CA 124.918 1.287 . . . . 73.35 108.375 179.021 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 126' ' ' HIS . . . . . 0.508 ' H ' ' HG2' ' A' ' 125' ' ' LYS . 42.5 p-80 -67.75 155.61 38.89 Favored 'General case' 0 C--O 1.244 0.769 0 CA-C-O 121.245 0.545 . . . . 74.35 111.672 -175.575 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 127' ' ' VAL . . . . . 0.696 HG23 ' H ' ' A' ' 90' ' ' LEU . 11.0 p -64.0 148.37 11.67 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.938 0 CA-C-N 113.988 -1.46 . . . . 53.42 112.99 -174.537 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 128' ' ' VAL . . . . . 0.644 ' HA ' ' HB3' ' A' ' 99' ' ' SER . 94.7 t -81.39 155.57 4.17 Favored 'Isoleucine or valine' 0 CA--C 1.551 1.0 0 C-N-CA 125.421 1.488 . . . . 71.25 109.23 172.055 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 129' ' ' PHE . . . . . 0.505 ' HA ' HG21 ' A' ' 29' ' ' VAL . 48.7 p90 -119.35 -24.33 6.41 Favored 'General case' 0 N--CA 1.487 1.383 0 CA-C-N 118.549 0.613 . . . . 71.01 111.603 177.416 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . -158.88 177.1 35.61 Favored Glycine 0 C--N 1.344 1.01 0 O-C-N 123.183 0.302 . . . . 45.2 112.468 -174.92 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 34.4 ttpt -153.33 147.41 25.58 Favored 'General case' 0 N--CA 1.472 0.671 0 C-N-CA 123.484 0.714 . . . . 74.45 109.3 -179.877 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 132' ' ' VAL . . . . . 0.442 HG22 ' HE1' ' A' ' 22' ' ' PHE . 16.9 t -68.29 120.33 15.55 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.552 0 N-CA-C 109.253 -0.647 . . . . 74.23 109.253 176.203 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 133' ' ' LYS . . . . . 0.545 ' HD2' ' HB2' ' A' ' 23' ' ' GLU . 20.6 ptmt -100.2 -33.54 10.39 Favored 'General case' 0 N--CA 1.477 0.895 0 N-CA-C 109.584 -0.524 . . . . 61.23 109.584 176.49 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 134' ' ' GLU . . . . . 0.497 ' HB2' ' HB2' ' A' ' 21' ' ' SER . 31.5 mt-10 -144.29 149.63 36.57 Favored 'General case' 0 N--CA 1.478 0.97 0 C-N-CA 125.166 1.387 . . . . 71.53 108.654 -178.516 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 83.43 17.44 66.47 Favored Glycine 0 C--N 1.339 0.742 0 N-CA-C 112.182 -0.367 . . . . 61.12 112.182 -177.701 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 136' ' ' MET . . . . . . . . . . . . . 15.7 tpt -64.01 -34.78 78.79 Favored 'General case' 0 C--N 1.354 0.796 0 C-N-CA 123.863 0.865 . . . . 73.11 110.913 -179.527 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 137' ' ' ASN . . . . . . . . . . . . . 27.3 t-20 -58.75 -42.31 88.57 Favored 'General case' 0 CA--C 1.542 0.644 0 C-N-CA 123.588 0.755 . . . . 73.21 110.568 174.049 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 138' ' ' ILE . . . . . . . . . . . . . 48.9 mm -67.67 -35.64 73.44 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.956 0 C-N-CA 123.331 0.652 . . . . 74.25 110.657 178.925 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 139' ' ' VAL . . . . . 0.521 HG12 HG22 ' A' ' 116' ' ' THR . 94.3 t -65.8 -37.98 81.15 Favored 'Isoleucine or valine' 0 CA--C 1.559 1.32 0 C-N-CA 123.941 0.896 . . . . 51.24 110.93 176.772 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 39.0 mt-10 -77.02 -27.55 54.63 Favored 'General case' 0 N--CA 1.48 1.04 0 C-N-CA 123.537 0.735 . . . . 74.42 111.186 177.625 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -72.65 -46.98 51.27 Favored 'General case' 0 N--CA 1.48 1.069 0 C-N-CA 123.338 0.655 . . . . 51.44 110.305 178.717 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 142' ' ' MET . . . . . 0.538 ' HA ' ' HD2' ' A' ' 145' ' ' PHE . 27.3 ptm -68.48 -30.34 69.16 Favored 'General case' 0 N--CA 1.475 0.81 0 CA-C-N 115.475 -0.784 . . . . 73.43 110.962 178.106 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 143' ' ' GLU . . . . . 0.411 ' HG2' ' HA ' ' A' ' 58' ' ' PRO . 35.8 tt0 -55.11 -42.26 72.69 Favored 'General case' 0 C--N 1.364 1.203 0 O-C-N 123.807 0.692 . . . . 74.43 111.361 174.71 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 144' ' ' ARG . . . . . . . . . . . . . 51.5 mtp180 -64.79 -22.91 67.09 Favored 'General case' 0 N--CA 1.473 0.715 0 CA-C-N 115.376 -0.829 . . . . 74.04 112.189 -178.233 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 145' ' ' PHE . . . . . 0.538 ' HD2' ' HA ' ' A' ' 142' ' ' MET . 47.7 m-85 -83.53 -1.02 52.79 Favored 'General case' 0 N--CA 1.479 0.987 0 C-N-CA 122.768 0.427 . . . . 54.42 111.876 179.426 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 146' ' ' GLY . . . . . 0.522 ' HA2' ' HA ' ' A' ' 152' ' ' THR . . . -96.71 172.06 28.17 Favored Glycine 0 C--N 1.342 0.867 0 N-CA-C 112.687 -0.165 . . . . 61.21 112.687 177.597 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 16.2 m -128.1 156.48 42.75 Favored 'General case' 0 N--CA 1.481 1.112 0 C-N-CA 123.845 0.858 . . . . 74.23 109.801 -178.332 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 148' ' ' ARG . . . . . 0.687 ' HA ' HG23 ' A' ' 57' ' ' ILE . 26.2 mmm-85 -58.53 -31.66 68.13 Favored 'General case' 0 N--CA 1.48 1.048 0 C-N-CA 124.595 1.158 . . . . 72.15 113.279 -174.359 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 149' ' ' ASN . . . . . . . . . . . . . 29.9 p-10 -77.7 -12.27 59.96 Favored 'General case' 0 N--CA 1.476 0.844 0 C-N-CA 123.364 0.666 . . . . 74.1 111.983 -178.279 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 150' ' ' GLY . . . . . 0.41 ' O ' ' HA ' ' A' ' 55' ' ' ARG . . . 106.45 6.05 36.27 Favored Glycine 0 C--N 1.348 1.2 0 CA-C-O 120.046 -0.308 . . . . 71.11 113.165 179.487 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 86.9 tttt -90.07 122.99 33.55 Favored 'General case' 0 N--CA 1.471 0.619 0 C-N-CA 123.08 0.552 . . . . 70.23 109.866 178.587 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 152' ' ' THR . . . . . 0.522 ' HA ' ' HA2' ' A' ' 146' ' ' GLY . 21.1 m -90.67 113.56 25.65 Favored 'General case' 0 CA--C 1.536 0.425 0 N-CA-C 108.82 -0.807 . . . . 63.14 108.82 174.978 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 153' ' ' SER . . . . . . . . . . . . . 9.1 m -52.8 -32.84 46.15 Favored 'General case' 0 N--CA 1.48 1.07 0 C-N-CA 124.646 1.178 . . . . 72.11 112.367 -178.394 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 70.7 mmtt -109.24 150.02 28.55 Favored 'General case' 0 N--CA 1.469 0.509 0 C-N-CA 124.358 1.063 . . . . 64.22 110.631 -175.731 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 75.0 mmtt -83.01 90.32 7.0 Favored 'General case' 0 N--CA 1.468 0.456 0 N-CA-C 108.527 -0.916 . . . . 71.42 108.527 172.542 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 156' ' ' ILE . . . . . 0.484 ' HA ' ' O ' ' A' ' 11' ' ' ALA . 54.0 mt -100.35 108.49 23.08 Favored 'Isoleucine or valine' 0 C--O 1.221 -0.43 0 CA-C-N 114.981 -1.009 . . . . 74.51 109.04 -175.693 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 157' ' ' THR . . . . . . . . . . . . . 56.9 p -118.47 159.71 23.01 Favored 'General case' 0 N--CA 1.473 0.713 0 C-N-CA 124.07 0.948 . . . . 72.32 110.53 -175.342 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 158' ' ' ILE . . . . . . . . . . . . . 62.5 mt -77.22 94.09 1.28 Allowed 'Isoleucine or valine' 0 CA--C 1.548 0.892 0 N-CA-C 108.988 -0.745 . . . . 55.31 108.988 170.398 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 159' ' ' ALA . . . . . 0.662 ' HB2' ' HB2' ' A' ' 11' ' ' ALA . . . -51.82 -49.56 62.55 Favored 'General case' 0 N--CA 1.483 1.21 0 C-N-CA 124.446 1.098 . . . . 64.21 112.411 -178.764 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 160' ' ' ASP . . . . . . . . . . . . . 19.7 t70 -152.92 169.94 21.6 Favored 'General case' 0 CA--C 1.546 0.805 0 CA-C-N 116.257 -0.428 . . . . 64.3 111.208 -179.351 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 161' ' ' CYS . . . . . . . . . . . . . 46.4 m -136.48 -168.93 2.34 Favored 'General case' 0 N--CA 1.47 0.56 0 C-N-CA 125.138 1.375 . . . . 73.31 108.623 -177.148 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 162' ' ' GLY . . . . . . . . . . . . . . . 132.44 53.52 0.08 OUTLIER Glycine 0 C--N 1.344 0.986 0 N-CA-C 111.025 -0.83 . . . . 72.32 111.025 -172.929 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 163' ' ' GLN . . . . . 0.665 ' HG3' ' HA ' ' A' ' 6' ' ' VAL . 46.8 tt0 -46.69 104.12 0.05 OUTLIER 'General case' 0 N--CA 1.481 1.086 0 C-N-CA 125.281 1.432 . . . . 71.2 112.312 -176.756 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 164' ' ' LEU . . . . . 0.46 ' O ' ' HB ' ' A' ' 5' ' ' THR . 64.9 mt -91.17 97.22 11.01 Favored 'General case' 0 N--CA 1.468 0.432 0 N-CA-C 107.272 -1.381 . . . . 73.23 107.272 -179.542 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 165' ' ' GLU . . . . . . . . . . . . . 7.2 pt-20 . . . . . 0 C--O 1.253 1.248 0 CA-C-O 119.387 -0.339 . . . . 72.1 111.097 -172.533 . . . . . . . . 0 0 . 1 . 014 nuclear build full ' B' B ' 216' ' ' PRO . . . . . . . . . . . . . 35.0 Cg_endo . . . . . 0 CA--C 1.547 1.138 0 N-CA-C 110.081 -0.777 . . . . 64.34 110.081 . . . . . . . . . 0 0 . 1 . 014 nuclear build full ' B' B ' 217' ' ' GLU . . . . . . . . . . . . . 40.8 tt0 -122.53 102.95 38.55 Favored Pre-proline 0 CA--C 1.549 0.94 0 C-N-CA 124.13 0.972 . . . . 52.34 109.531 -177.272 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 218' ' ' PRO . . . . . . . . . . . . . 15.4 Cg_exo -69.58 151.02 70.03 Favored 'Trans proline' 0 C--N 1.377 2.036 0 C-N-CA 122.615 2.21 . . . . 53.52 111.234 168.001 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 219' ' ' GLY . . . . . . . . . . . . . . . 130.63 163.97 11.15 Favored Glycine 0 CA--C 1.531 1.065 0 CA-C-O 119.605 -0.553 . . . . 63.01 112.372 177.67 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 220' ' ' PRO . . . . . 0.461 ' HG3' HD21 ' A' ' 122' ' ' LEU . 96.3 Cg_endo -78.39 160.03 29.13 Favored 'Trans proline' 0 C--N 1.368 1.56 0 C-N-CA 123.669 2.912 . . . . 72.53 113.025 -175.394 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 221' ' ' TYR . . . . . . . . . . . . . 49.1 m-85 -85.69 139.11 31.64 Favored 'General case' 0 N--CA 1.475 0.783 0 C-N-CA 123.493 0.717 . . . . 72.25 111.651 -173.123 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 222' ' ' ALA . . . . . 0.534 ' HB2' HD13 ' A' ' 57' ' ' ILE . . . -82.13 102.26 10.95 Favored 'General case' 0 C--N 1.348 0.504 0 CA-C-N 115.198 -0.91 . . . . 71.14 112.451 -171.87 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 223' ' ' GLN . . . . . . . . . . . . . 17.1 mt-30 58.42 90.45 0.09 OUTLIER Pre-proline 0 CA--C 1.562 1.419 0 O-C-N 124.713 1.258 . . . . 75.45 111.345 169.507 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 224' ' ' PRO . . . . . . . . . . . . . 11.4 Cg_exo . . . . . 0 C--N 1.373 1.853 0 C-N-CA 123.036 2.491 . . . . 72.21 111.954 -178.896 . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 17.7 ptp . . . . . 0 N--CA 1.473 0.711 0 CA-C-O 120.805 0.336 . . . . 71.33 110.27 . . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 5.3 p -77.93 94.96 1.54 Allowed 'Isoleucine or valine' 0 CA--C 1.55 0.946 0 CA-C-O 122.073 0.94 . . . . 71.41 110.744 -179.234 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 18.2 m-80 -94.88 106.08 22.83 Favored Pre-proline 0 C--O 1.241 0.655 0 N-CA-C 107.498 -1.297 . . . . 74.23 107.498 169.291 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 4' ' ' PRO . . . . . 0.687 ' HB3' HH11 ' A' ' 37' ' ' ARG . 48.8 Cg_endo -69.18 119.76 6.7 Favored 'Trans proline' 0 C--N 1.371 1.745 0 C-N-CA 122.107 1.871 . . . . 72.53 110.917 177.35 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 86.6 m -96.84 117.85 31.98 Favored 'General case' 0 C--O 1.217 -0.61 0 N-CA-C 106.906 -1.516 . . . . 72.31 106.906 173.234 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 5.3 m -98.22 122.12 49.52 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.421 0 CA-C-O 121.782 0.801 . . . . 75.41 109.485 -176.537 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 7' ' ' PHE . . . . . 0.57 ' H ' ' HA ' ' A' ' 163' ' ' GLN . 73.2 t80 -100.75 131.79 46.47 Favored 'General case' 0 C--O 1.236 0.365 0 CA-C-N 114.485 -1.234 . . . . 73.15 108.893 -175.031 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 8' ' ' PHE . . . . . 0.461 ' HB3' HG23 ' A' ' 158' ' ' ILE . 44.2 m-85 -132.04 165.01 24.95 Favored 'General case' 0 C--O 1.24 0.566 0 C-N-CA 124.489 1.116 . . . . 70.43 109.125 170.566 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 49.5 m-20 -112.94 111.07 21.55 Favored 'General case' 0 C--N 1.326 -0.442 0 N-CA-C 107.564 -1.272 . . . . 72.15 107.564 169.281 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 10' ' ' ILE . . . . . 0.475 HG21 ' SD ' ' A' ' 142' ' ' MET . 41.3 mm -80.04 115.26 22.17 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.412 0 N-CA-C 108.518 -0.919 . . . . 73.25 108.518 179.154 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 11' ' ' ALA . . . . . 0.566 ' HB2' ' HB2' ' A' ' 159' ' ' ALA . . . -116.79 128.62 55.46 Favored 'General case' 0 N--CA 1.47 0.56 0 C-N-CA 123.793 0.837 . . . . 64.42 111.21 -173.761 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 73.2 t -95.8 113.64 30.66 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.616 0 N-CA-C 108.097 -1.075 . . . . 75.34 108.097 173.585 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 48.0 m-20 63.91 23.93 13.51 Favored 'General case' 0 N--CA 1.489 1.502 0 C-N-CA 125.567 1.547 . . . . 64.21 111.731 -178.676 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 96.85 -20.45 50.65 Favored Glycine 0 C--N 1.341 0.841 0 CA-C-O 119.569 -0.573 . . . . 63.21 112.838 -177.326 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 50.6 mm-40 -84.22 114.32 53.84 Favored Pre-proline 0 N--CA 1.476 0.841 0 CA-C-N 117.299 0.55 . . . . 73.23 110.215 178.353 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 76.5 Cg_exo -50.48 109.35 0.29 Allowed 'Trans proline' 0 C--N 1.382 2.309 0 C-N-CA 123.684 2.923 . . . . 74.02 112.802 177.875 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 44.3 tp -77.06 -45.01 28.54 Favored 'General case' 0 N--CA 1.473 0.701 0 N-CA-C 109.114 -0.698 . . . . 74.52 109.114 177.653 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -168.35 170.8 42.32 Favored Glycine 0 C--N 1.342 0.891 0 CA-C-N 115.873 -0.603 . . . . 74.25 112.543 179.694 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 69.3 mtt-85 -107.04 125.98 51.74 Favored 'General case' 0 N--CA 1.474 0.759 0 C-N-CA 123.718 0.807 . . . . 72.13 108.955 -176.466 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 93.1 t -121.76 144.92 29.36 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.769 0 C-N-CA 123.512 0.725 . . . . 71.12 110.11 -176.77 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 21' ' ' SER . . . . . 0.473 ' HB2' ' HB2' ' A' ' 134' ' ' GLU . 60.0 m -141.21 128.21 20.67 Favored 'General case' 0 CA--C 1.541 0.602 0 C-N-CA 124.733 1.213 . . . . 72.34 108.925 178.447 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 57.9 m-85 -109.59 121.35 45.01 Favored 'General case' 0 N--CA 1.476 0.83 0 C-N-CA 123.248 0.619 . . . . 73.01 110.02 -178.242 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 38.0 tt0 -74.53 104.23 5.16 Favored 'General case' 0 CA--C 1.547 0.854 0 C-N-CA 123.533 0.733 . . . . 74.52 109.192 171.36 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 24' ' ' LEU . . . . . 0.522 ' HB2' ' HG2' ' A' ' 4' ' ' PRO . 38.4 mt -85.6 123.83 31.46 Favored 'General case' 0 C--O 1.241 0.627 0 N-CA-C 109.114 -0.699 . . . . 61.41 109.114 175.971 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 58.0 m-85 -83.16 76.44 9.86 Favored 'General case' 0 CA--C 1.543 0.674 0 C-N-CA 123.498 0.719 . . . . 74.53 110.52 -177.043 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -71.14 -6.63 40.81 Favored 'General case' 0 N--CA 1.489 1.482 0 C-N-CA 122.913 0.485 . . . . 63.45 112.004 178.363 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 10.1 p-10 -89.07 -17.38 29.42 Favored 'General case' 0 CA--C 1.554 1.104 0 C-N-CA 123.746 0.819 . . . . 64.54 111.343 176.344 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 57.2 mttp -112.59 -44.78 3.3 Favored 'General case' 0 N--CA 1.494 1.758 0 C-N-CA 123.441 0.697 . . . . 73.22 111.033 -176.185 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 29' ' ' VAL . . . . . 0.503 HG21 ' HA ' ' A' ' 129' ' ' PHE . 12.0 m -127.91 62.97 59.49 Favored Pre-proline 0 CA--C 1.566 1.59 0 C-N-CA 124.448 1.099 . . . . 75.23 110.267 177.382 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 2.8 Cg_endo -49.83 -41.34 47.15 Favored 'Trans proline' 0 C--N 1.391 2.78 0 C-N-CA 123.41 2.74 . . . . 75.43 114.717 -172.994 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 39.3 ttpt -64.46 -49.96 69.4 Favored 'General case' 0 N--CA 1.476 0.837 0 C-N-CA 123.449 0.699 . . . . 74.3 111.132 -177.496 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 7.1 m -76.01 -31.64 59.02 Favored 'General case' 0 CA--C 1.55 0.974 0 CA-C-N 115.115 -0.948 . . . . 71.35 111.504 -171.034 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -74.29 -46.93 38.08 Favored 'General case' 0 CA--C 1.543 0.704 0 C-N-CA 123.695 0.798 . . . . 43.55 110.336 177.976 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 11.6 tp10 -66.34 -29.66 69.89 Favored 'General case' 0 N--CA 1.482 1.134 0 C-N-CA 123.764 0.825 . . . . 71.32 110.979 178.852 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 35' ' ' ASN . . . . . 0.479 ' O ' ' HG ' ' A' ' 39' ' ' LEU . 25.8 t30 -54.06 -60.6 3.11 Favored 'General case' 0 N--CA 1.476 0.869 0 C-N-CA 123.826 0.85 . . . . 74.3 110.034 173.239 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 52.7 t80 -66.51 -34.84 78.83 Favored 'General case' 0 CA--C 1.541 0.598 0 O-C-N 124.224 0.953 . . . . 65.01 111.095 -175.094 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 37' ' ' ARG . . . . . 0.687 HH11 ' HB3' ' A' ' 4' ' ' PRO . 24.7 ttt180 -59.36 -45.56 91.05 Favored 'General case' 0 C--N 1.35 0.628 0 C-N-CA 123.541 0.736 . . . . 63.34 110.659 175.357 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 38' ' ' ALA . . . . . 0.592 ' HB1' ' HG2' ' A' ' 44' ' ' LYS . . . -73.3 -27.41 61.53 Favored 'General case' 0 CA--C 1.543 0.68 0 C-N-CA 123.434 0.694 . . . . 74.35 111.515 -177.956 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 39' ' ' LEU . . . . . 0.621 HD22 ' HE2' ' A' ' 48' ' ' TYR . 86.6 mt -72.97 -30.14 63.61 Favored 'General case' 0 N--CA 1.48 1.053 0 C-N-CA 123.462 0.705 . . . . 75.24 110.513 174.17 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 33.3 t -76.6 -53.95 7.35 Favored 'General case' 0 N--CA 1.478 0.946 0 C-N-CA 124.356 1.062 . . . . 73.43 110.898 179.452 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 41' ' ' THR . . . . . 0.4 ' OG1' ' HG2' ' A' ' 43' ' ' GLU . 44.0 p -76.83 -30.31 56.31 Favored 'General case' 0 N--CA 1.471 0.588 0 C-N-CA 124.401 1.08 . . . . 53.31 111.847 -174.523 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 79.86 30.89 41.6 Favored Glycine 0 C--N 1.341 0.851 0 CA-C-N 115.706 -0.679 . . . . 41.45 112.914 -179.076 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 43' ' ' GLU . . . . . 0.4 ' HG2' ' OG1' ' A' ' 41' ' ' THR . 55.7 mm-40 -58.33 -40.6 82.57 Favored 'General case' 0 N--CA 1.476 0.854 0 C-N-CA 123.079 0.551 . . . . 74.13 110.027 172.461 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 44' ' ' LYS . . . . . 0.592 ' HG2' ' HB1' ' A' ' 38' ' ' ALA . 28.4 mmmt -92.99 18.32 9.34 Favored 'General case' 0 CA--C 1.551 0.993 0 CA-C-N 115.315 -0.857 . . . . 72.41 111.379 -179.849 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 82.71 -8.87 61.02 Favored Glycine 0 C--N 1.35 1.335 0 N-CA-C 115.225 0.85 . . . . 72.54 115.225 172.872 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 46' ' ' PHE . . . . . 0.465 ' HE2' ' HA ' ' A' ' 78' ' ' ILE . 22.4 m-85 -82.09 -48.66 11.1 Favored 'General case' 0 N--CA 1.479 1.023 0 CA-C-N 117.713 0.756 . . . . 71.21 111.393 -170.224 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 38.04 62.6 1.02 Allowed Glycine 0 C--N 1.357 1.746 0 O-C-N 125.016 1.447 . . . . 42.31 116.186 168.278 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 48' ' ' TYR . . . . . 0.621 ' HE2' HD22 ' A' ' 39' ' ' LEU . 97.4 m-85 -62.18 92.85 0.04 OUTLIER 'General case' 0 N--CA 1.479 1.013 0 CA-C-O 121.908 0.861 . . . . 73.32 112.37 -170.736 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 49' ' ' LYS . . . . . 0.441 ' HE2' ' HA ' ' A' ' 160' ' ' ASP . 28.3 tptp -100.55 129.2 46.46 Favored 'General case' 0 C--O 1.237 0.436 0 C-N-CA 125.067 1.347 . . . . 74.04 107.954 179.593 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 73.63 20.5 79.82 Favored Glycine 0 C--N 1.345 1.045 0 O-C-N 123.33 0.394 . . . . 65.22 112.681 -176.007 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 51' ' ' SER . . . . . 0.464 ' HB2' ' HB3' ' A' ' 48' ' ' TYR . 22.7 t -64.92 119.83 11.43 Favored 'General case' 0 CA--C 1.546 0.819 0 C-N-CA 123.651 0.78 . . . . 72.54 109.901 -178.191 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 52' ' ' CYS . . . . . 0.417 ' H ' ' HB2' ' A' ' 67' ' ' PHE . 37.6 t -93.36 153.79 18.33 Favored 'General case' 0 N--CA 1.472 0.642 0 C-N-CA 123.275 0.63 . . . . 70.03 111.959 -166.934 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 53' ' ' PHE . . . . . 0.487 ' HA ' ' HA2' ' A' ' 64' ' ' GLY . 45.9 m-85 -97.89 120.9 39.1 Favored 'General case' 0 C--O 1.237 0.412 0 C-N-CA 124.787 1.235 . . . . 71.51 108.04 172.724 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 19.5 p-80 -108.68 -36.71 6.09 Favored 'General case' 0 N--CA 1.479 0.996 0 C-N-CA 123.822 0.849 . . . . 71.43 110.146 -173.269 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 50.2 ttt180 -122.61 97.34 5.41 Favored 'General case' 0 C--O 1.217 -0.643 0 N-CA-C 108.703 -0.851 . . . . 73.24 108.703 -175.057 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 56' ' ' ILE . . . . . 0.511 HG21 ' HA ' ' A' ' 143' ' ' GLU . 44.9 mt -119.85 128.35 75.91 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.586 0 N-CA-C 108.192 -1.04 . . . . 63.52 108.192 172.931 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 57' ' ' ILE . . . . . 0.574 HG23 ' HA ' ' A' ' 148' ' ' ARG . 60.5 mt -120.68 124.86 27.37 Favored Pre-proline 0 CA--C 1.547 0.831 0 N-CA-C 108.34 -0.985 . . . . 61.2 108.34 175.436 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 58' ' ' PRO . . . . . 0.526 ' HA ' ' HG2' ' A' ' 143' ' ' GLU . 37.8 Cg_endo -63.1 141.69 84.22 Favored 'Trans proline' 0 C--N 1.383 2.352 0 C-N-CA 123.31 2.673 . . . . 71.43 112.505 -178.364 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 65.29 21.6 68.5 Favored Glycine 0 C--N 1.343 0.967 0 CA-C-N 115.326 -0.852 . . . . 73.51 113.717 -177.738 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 60' ' ' PHE . . . . . 0.725 ' HB2' ' HG3' ' B' ' 223' ' ' GLN . 27.8 t80 -138.01 -74.78 0.4 Allowed 'General case' 0 N--CA 1.468 0.447 0 N-CA-C 109.245 -0.65 . . . . 74.51 109.245 -172.42 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 11.9 ptp -175.31 154.1 1.66 Allowed 'General case' 0 N--CA 1.483 1.215 0 O-C-N 123.677 0.611 . . . . 62.41 112.501 -178.472 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 62' ' ' CYS . . . . . . . . . . . . . 56.7 m -102.94 109.74 21.4 Favored 'General case' 0 CA--C 1.539 0.539 0 CA-C-N 115.076 -0.965 . . . . 73.4 108.973 170.369 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 63' ' ' GLN . . . . . 0.46 ' HA ' ' HA ' ' A' ' 113' ' ' PHE . 53.1 tt0 -100.08 105.33 16.96 Favored 'General case' 0 C--O 1.248 0.977 0 CA-C-O 121.336 0.589 . . . . 71.54 109.901 -178.05 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 64' ' ' GLY . . . . . 0.487 ' HA2' ' HA ' ' A' ' 53' ' ' PHE . . . -110.79 -153.38 13.2 Favored Glycine 0 C--N 1.344 1.006 0 CA-C-N 114.466 -1.243 . . . . 72.11 111.31 174.931 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 86.05 -35.6 3.25 Favored Glycine 0 C--N 1.344 1.025 0 N-CA-C 111.856 -0.498 . . . . 62.54 111.856 -173.494 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 66' ' ' ASP . . . . . 0.554 ' HB2' ' HG2' ' A' ' 111' ' ' GLN . 35.5 t70 -66.54 103.1 0.99 Allowed 'General case' 0 N--CA 1.445 -0.688 0 C-N-CA 124.836 1.254 . . . . 74.32 110.686 -177.855 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 67' ' ' PHE . . . . . 0.417 ' HB2' ' H ' ' A' ' 52' ' ' CYS . 71.5 t80 -156.92 -68.83 0.1 Allowed 'General case' 0 C--O 1.239 0.521 0 N-CA-C 108.361 -0.978 . . . . 74.53 108.361 177.919 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 27.5 m -79.25 122.06 25.85 Favored 'General case' 0 C--O 1.24 0.57 0 CA-C-N 115.49 -0.777 . . . . 54.54 108.943 178.693 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 49.5 mtt85 65.94 36.06 6.16 Favored 'General case' 0 N--CA 1.482 1.159 0 C-N-CA 124.302 1.041 . . . . 64.31 111.538 177.787 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 1.2 t60 -41.1 -52.73 3.2 Favored 'General case' 0 N--CA 1.494 1.741 0 C-N-CA 125.804 1.642 . . . . 74.22 113.88 -175.273 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 93.2 m-20 -65.58 99.77 0.46 Allowed 'General case' 0 N--CA 1.477 0.887 0 C-N-CA 123.118 0.567 . . . . 53.53 110.777 -175.847 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 72' ' ' GLY . . . . . 0.63 ' HA2' ' HG2' ' B' ' 216' ' ' PRO . . . 88.29 -7.05 82.73 Favored Glycine 0 C--N 1.345 1.044 0 CA-C-N 115.677 -0.692 . . . . 74.22 114.688 174.689 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 73' ' ' THR . . . . . 0.439 ' O ' ' HB3' ' A' ' 110' ' ' SER . 26.1 m -137.09 -83.02 0.35 Allowed 'General case' 0 N--CA 1.48 1.072 0 CA-C-N 118.076 0.938 . . . . 65.55 110.526 -178.049 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 74' ' ' GLY . . . . . 0.448 ' O ' ' HG3' ' A' ' 111' ' ' GLN . . . 71.95 64.12 2.78 Favored Glycine 0 C--N 1.354 1.535 0 N-CA-C 114.371 0.508 . . . . 70.01 114.371 173.171 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 97.43 54.53 1.24 Allowed Glycine 0 N--CA 1.472 1.052 0 C-N-CA 120.309 -0.948 . . . . 64.33 112.305 176.016 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 64.3 pttt -61.05 172.15 1.08 Allowed 'General case' 0 CA--C 1.551 1.001 0 C-N-CA 123.959 0.904 . . . . 71.33 113.283 -175.4 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 88.1 p -90.57 179.42 5.84 Favored 'General case' 0 C--O 1.242 0.684 0 CA-C-N 115.212 -0.904 . . . . 70.21 111.187 -176.146 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 78' ' ' ILE . . . . . 0.465 ' HA ' ' HE2' ' A' ' 46' ' ' PHE . 35.0 pt -74.56 -15.54 16.25 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.663 0 CA-C-N 115.72 -0.673 . . . . 71.21 111.359 177.608 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 82.1 m-85 -95.0 11.27 32.57 Favored 'General case' 0 N--CA 1.475 0.821 0 C-N-CA 123.735 0.814 . . . . 74.22 111.35 177.287 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 105.88 -146.08 16.02 Favored Glycine 0 C--N 1.345 1.053 0 N-CA-C 111.244 -0.742 . . . . 71.12 111.244 -179.253 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 36.1 tt0 -57.81 -38.5 75.66 Favored 'General case' 0 N--CA 1.477 0.877 0 C-N-CA 124.08 0.952 . . . . 74.24 111.423 -178.227 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 3.8 ptpp? -160.15 172.48 17.36 Favored 'General case' 0 N--CA 1.474 0.743 0 C-N-CA 123.417 0.687 . . . . 74.0 111.805 -177.451 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 4.1 p90 -159.07 171.89 19.16 Favored 'General case' 0 CA--C 1.544 0.726 0 C-N-CA 125.012 1.325 . . . . 73.14 109.514 177.657 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 84' ' ' GLU . . . . . 0.486 ' HA ' ' HA ' ' A' ' 106' ' ' ASN . 12.6 pt-20 -81.67 158.4 24.29 Favored 'General case' 0 N--CA 1.475 0.776 0 C-N-CA 123.574 0.75 . . . . 74.32 111.758 -177.319 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 52.7 m-20 -81.85 143.74 31.51 Favored 'General case' 0 N--CA 1.476 0.875 0 C-N-CA 123.761 0.824 . . . . 75.33 109.269 173.294 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 12.5 tp10 -83.21 -59.38 2.48 Favored 'General case' 0 N--CA 1.477 0.883 0 CA-C-O 121.278 0.561 . . . . 63.31 111.051 -174.551 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 32.0 p30 -153.68 -167.5 2.7 Favored 'General case' 0 N--CA 1.472 0.673 0 C-N-CA 123.747 0.819 . . . . 63.51 109.157 -174.167 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 81.4 m-85 -138.58 39.49 2.22 Favored 'General case' 0 N--CA 1.482 1.166 0 C-N-CA 123.717 0.807 . . . . 73.54 110.451 178.046 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 67.8 mt -62.31 -38.18 80.49 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.324 0 CA-C-O 121.531 0.681 . . . . 71.44 109.904 174.612 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 90' ' ' LEU . . . . . 0.67 ' HB3' ' HB ' ' A' ' 128' ' ' VAL . 95.4 mt -98.9 150.62 21.73 Favored 'General case' 0 CA--C 1.543 0.705 0 C-N-CA 124.088 0.955 . . . . 74.45 110.893 179.379 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 47.2 pttt -158.77 163.87 36.35 Favored 'General case' 0 N--CA 1.482 1.172 0 C-N-CA 124.165 0.986 . . . . 75.21 110.294 -170.946 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 92' ' ' HIS . . . . . 0.402 ' HA ' HG13 ' A' ' 97' ' ' ILE . 13.3 m-70 -88.89 63.38 6.76 Favored 'General case' 0 N--CA 1.488 1.439 0 C-N-CA 123.63 0.772 . . . . 74.31 109.93 -175.196 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 15.3 p -90.8 2.57 55.97 Favored 'General case' 0 N--CA 1.48 1.064 0 C-N-CA 123.849 0.86 . . . . 74.12 111.811 178.508 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -157.27 173.36 34.79 Favored Glycine 0 C--N 1.343 0.926 0 CA-C-N 116.653 -0.248 . . . . 61.31 112.918 -178.644 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 86.2 Cg_endo -78.16 157.1 30.05 Favored 'Trans proline' 0 C--N 1.362 1.249 0 C-N-CA 123.276 2.651 . . . . 74.0 112.64 175.895 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 79.63 18.77 72.51 Favored Glycine 0 C--N 1.342 0.871 0 CA-C-N 115.694 -0.685 . . . . 54.32 114.476 175.396 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 97' ' ' ILE . . . . . 0.67 ' HB ' ' SG ' ' A' ' 115' ' ' CYS . 19.0 mm -73.03 128.54 35.85 Favored 'Isoleucine or valine' 0 CA--C 1.554 1.119 0 C-N-CA 123.967 0.907 . . . . 62.52 110.592 178.932 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 98' ' ' LEU . . . . . 0.501 HD13 HG12 ' A' ' 114' ' ' ILE . 67.7 tp -103.88 122.71 45.72 Favored 'General case' 0 C--O 1.252 1.207 0 C-N-CA 123.637 0.775 . . . . 72.25 110.13 176.139 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 99' ' ' SER . . . . . 0.422 ' HB3' ' HD2' ' A' ' 126' ' ' HIS . 50.7 m -145.34 139.68 27.18 Favored 'General case' 0 CA--C 1.555 1.155 0 C-N-CA 124.735 1.214 . . . . 72.12 109.418 179.744 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 100' ' ' MET . . . . . 0.675 ' HA ' ' HA ' ' A' ' 112' ' ' PHE . 85.9 mtp -76.57 147.54 37.61 Favored 'General case' 0 N--CA 1.491 1.605 0 C-N-CA 123.877 0.871 . . . . 74.31 111.647 178.48 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 101' ' ' ALA . . . . . 0.4 ' HB3' ' HB2' ' A' ' 111' ' ' GLN . . . -75.25 145.77 41.66 Favored 'General case' 0 N--CA 1.479 0.995 0 C-N-CA 123.654 0.782 . . . . 54.14 111.843 -175.261 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 26.9 p-10 -168.54 173.04 7.72 Favored 'General case' 0 N--CA 1.477 0.908 0 C-N-CA 123.958 0.903 . . . . 71.2 110.675 -178.902 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -91.45 -47.81 7.23 Favored 'General case' 0 N--CA 1.471 0.578 0 CA-C-N 115.7 -0.682 . . . . 42.15 109.551 168.636 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -163.1 -161.2 12.09 Favored Glycine 0 C--N 1.345 1.074 0 CA-C-N 115.512 -0.767 . . . . 42.11 111.973 178.111 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 51.9 Cg_exo -55.8 135.68 70.73 Favored 'Trans proline' 0 C--N 1.375 1.965 0 C-N-CA 123.417 2.745 . . . . 70.23 112.608 179.133 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 106' ' ' ASN . . . . . 0.486 ' HA ' ' HA ' ' A' ' 84' ' ' GLU . 64.9 t30 69.45 11.22 7.99 Favored 'General case' 0 N--CA 1.484 1.261 0 C-N-CA 124.982 1.313 . . . . 64.43 112.247 179.269 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 8.8 m -105.08 -12.98 15.89 Favored 'General case' 0 CA--C 1.552 1.057 0 C-N-CA 123.452 0.701 . . . . 61.03 109.576 171.549 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 15.1 t30 -57.88 146.6 31.44 Favored 'General case' 0 N--CA 1.481 1.081 0 C-N-CA 125.609 1.563 . . . . 72.53 111.451 175.306 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 113.13 21.15 6.02 Favored Glycine 0 N--CA 1.471 1.02 0 N-CA-C 113.996 0.359 . . . . 23.54 113.996 175.944 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 110' ' ' SER . . . . . 0.439 ' HB3' ' O ' ' A' ' 73' ' ' THR . 69.0 m -138.36 122.62 18.16 Favored 'General case' 0 N--CA 1.474 0.765 0 N-CA-C 108.744 -0.836 . . . . 73.01 108.744 171.546 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 111' ' ' GLN . . . . . 0.554 ' HG2' ' HB2' ' A' ' 66' ' ' ASP . 18.1 mt-30 65.72 170.92 0.22 Allowed 'General case' 0 N--CA 1.498 1.953 0 C-N-CA 124.302 1.041 . . . . 74.41 111.802 -178.255 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 112' ' ' PHE . . . . . 0.675 ' HA ' ' HA ' ' A' ' 100' ' ' MET . 53.2 p90 -150.07 138.81 20.82 Favored 'General case' 0 N--CA 1.479 0.978 0 C-N-CA 123.118 0.567 . . . . 73.43 110.102 174.975 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 113' ' ' PHE . . . . . 0.46 ' HA ' ' HA ' ' A' ' 63' ' ' GLN . 42.9 p90 -111.84 144.99 40.24 Favored 'General case' 0 C--O 1.24 0.588 0 C-N-CA 123.753 0.821 . . . . 74.32 110.668 174.435 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 114' ' ' ILE . . . . . 0.501 HG12 HD13 ' A' ' 98' ' ' LEU . 8.2 mt -116.46 99.67 8.81 Favored 'Isoleucine or valine' 0 C--O 1.24 0.577 0 N-CA-C 106.919 -1.511 . . . . 74.11 106.919 178.232 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 115' ' ' CYS . . . . . 0.67 ' SG ' ' HB ' ' A' ' 97' ' ' ILE . 19.3 p -84.45 118.05 24.04 Favored 'General case' 0 N--CA 1.472 0.644 0 C-N-CA 122.404 0.282 . . . . 72.43 110.758 -175.768 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 59.5 p -78.65 1.17 23.69 Favored 'General case' 0 N--CA 1.481 1.075 0 C-N-CA 124.052 0.941 . . . . 74.42 111.902 -179.024 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -133.22 162.22 32.35 Favored 'General case' 0 C--O 1.244 0.787 0 C-N-CA 123.704 0.802 . . . . 71.01 109.966 -179.827 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 8.8 ptmt -71.82 81.51 0.89 Allowed 'General case' 0 CA--C 1.549 0.937 0 CA-C-O 121.846 0.831 . . . . 74.54 109.415 171.944 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 119' ' ' THR . . . . . 0.491 ' HB ' HD23 ' A' ' 122' ' ' LEU . 32.2 p -82.56 85.31 7.0 Favored 'General case' 0 CA--C 1.55 0.971 0 CA-C-O 122.147 0.975 . . . . 71.32 109.309 -177.331 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 12.8 pt-20 -74.57 -27.64 60.58 Favored 'General case' 0 N--CA 1.48 1.06 0 CA-C-N 114.67 -1.15 . . . . 61.05 112.318 -167.724 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 121' ' ' TRP . . . . . . . . . . . . . 46.5 p90 -67.49 -1.75 5.39 Favored 'General case' 0 N--CA 1.483 1.2 0 C-N-CA 123.747 0.819 . . . . 73.03 112.238 178.352 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 122' ' ' LEU . . . . . 0.491 HD23 ' HB ' ' A' ' 119' ' ' THR . 3.2 mm? -78.06 -3.91 44.58 Favored 'General case' 0 CA--C 1.548 0.895 0 C-N-CA 124.454 1.102 . . . . 73.45 112.48 174.064 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 40.6 m-20 -65.22 128.38 35.58 Favored 'General case' 0 N--CA 1.487 1.384 0 CA-C-N 118.247 0.476 . . . . 63.1 111.164 176.592 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 104.23 -25.79 25.0 Favored Glycine 0 N--CA 1.477 1.378 0 N-CA-C 111.867 -0.493 . . . . 60.12 111.867 -174.665 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 12.5 ttmm -85.59 -164.46 1.02 Allowed 'General case' 0 CA--C 1.552 1.033 0 C-N-CA 124.329 1.052 . . . . 60.11 108.449 177.443 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 126' ' ' HIS . . . . . 0.422 ' HD2' ' HB3' ' A' ' 99' ' ' SER . 34.6 t60 -66.91 131.7 46.44 Favored 'General case' 0 CA--C 1.546 0.825 0 CA-C-O 121.183 0.516 . . . . 71.04 111.063 -175.343 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 7.4 p -62.42 147.4 11.62 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.808 0 CA-C-N 114.038 -1.437 . . . . 75.4 112.074 178.126 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 128' ' ' VAL . . . . . 0.67 ' HB ' ' HB3' ' A' ' 90' ' ' LEU . 46.3 t -64.43 149.98 10.61 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.721 0 C-N-CA 123.374 0.67 . . . . 72.12 110.3 174.699 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 129' ' ' PHE . . . . . 0.503 ' HA ' HG21 ' A' ' 29' ' ' VAL . 49.3 p90 -136.51 -27.95 1.03 Allowed 'General case' 0 N--CA 1.479 0.977 0 C-N-CA 122.378 0.271 . . . . 74.3 111.127 174.567 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . -123.54 167.13 15.84 Favored Glycine 0 C--N 1.343 0.942 0 O-C-N 123.424 0.452 . . . . 61.01 112.323 -177.719 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 30.2 ttpt -154.65 122.84 5.97 Favored 'General case' 0 N--CA 1.468 0.454 0 N-CA-C 107.997 -1.112 . . . . 74.11 107.997 179.092 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 12.7 p -67.0 122.39 17.94 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.959 0 CA-C-O 121.515 0.674 . . . . 52.45 109.98 177.468 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 21.2 ptmt -108.66 -22.98 12.01 Favored 'General case' 0 N--CA 1.476 0.844 0 C-N-CA 124.054 0.941 . . . . 63.12 110.251 179.009 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 134' ' ' GLU . . . . . 0.473 ' HB2' ' HB2' ' A' ' 21' ' ' SER . 34.6 mt-10 -136.71 134.03 36.74 Favored 'General case' 0 N--CA 1.475 0.817 0 C-N-CA 124.798 1.239 . . . . 75.44 108.17 179.863 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 135' ' ' GLY . . . . . 0.411 ' O ' HG23 ' A' ' 139' ' ' VAL . . . 80.1 26.66 54.94 Favored Glycine 0 CA--C 1.528 0.862 0 CA-C-O 119.837 -0.424 . . . . 41.41 113.235 -177.624 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 136' ' ' MET . . . . . . . . . . . . . 5.8 tpt -59.79 -53.17 61.1 Favored 'General case' 0 N--CA 1.485 1.288 0 C-N-CA 123.664 0.786 . . . . 70.32 110.471 175.103 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 137' ' ' ASN . . . . . . . . . . . . . 20.5 m120 -64.65 -25.79 68.11 Favored 'General case' 0 N--CA 1.477 0.884 0 CA-C-N 115.902 -0.59 . . . . 74.44 110.997 -179.537 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 138' ' ' ILE . . . . . . . . . . . . . 50.9 mm -69.52 -40.4 79.65 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.728 0 C-N-CA 123.393 0.677 . . . . 73.54 110.433 175.853 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 139' ' ' VAL . . . . . 0.411 HG23 ' O ' ' A' ' 135' ' ' GLY . 91.2 t -63.18 -40.33 88.62 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.131 0 C-N-CA 123.033 0.533 . . . . 74.41 109.888 174.987 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 40.3 mt-10 -65.46 -33.23 75.44 Favored 'General case' 0 CA--C 1.551 0.985 0 CA-C-N 115.541 -0.754 . . . . 75.31 111.329 175.808 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -75.2 -45.11 42.57 Favored 'General case' 0 N--CA 1.481 1.08 0 C-N-CA 123.753 0.821 . . . . 71.31 111.739 -177.667 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 142' ' ' MET . . . . . 0.551 ' HB2' HD13 ' A' ' 156' ' ' ILE . 25.4 ptm -69.48 -29.38 67.03 Favored 'General case' 0 N--CA 1.476 0.852 0 CA-C-N 115.823 -0.626 . . . . 74.1 110.66 179.031 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 143' ' ' GLU . . . . . 0.526 ' HG2' ' HA ' ' A' ' 58' ' ' PRO . 30.9 tt0 -64.88 -29.01 69.94 Favored 'General case' 0 C--N 1.353 0.731 0 C-N-CA 123.243 0.617 . . . . 70.02 111.531 -179.927 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 144' ' ' ARG . . . . . . . . . . . . . 24.3 mtp180 -63.15 -23.61 67.51 Favored 'General case' 0 N--CA 1.474 0.761 0 C-N-CA 123.572 0.749 . . . . 73.34 111.843 177.475 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 145' ' ' PHE . . . . . . . . . . . . . 65.7 m-85 -80.14 -13.82 58.97 Favored 'General case' 0 N--CA 1.481 1.111 0 C-N-CA 122.42 0.288 . . . . 73.4 111.506 179.68 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 146' ' ' GLY . . . . . 0.411 ' HA2' ' HA ' ' A' ' 152' ' ' THR . . . -84.4 171.09 47.41 Favored Glycine 0 C--N 1.343 0.949 0 O-C-N 122.979 0.174 . . . . 64.31 112.675 177.192 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 34.1 t -132.96 167.29 20.54 Favored 'General case' 0 N--CA 1.48 1.05 0 C-N-CA 123.966 0.906 . . . . 74.24 109.716 -176.229 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 148' ' ' ARG . . . . . 0.574 ' HA ' HG23 ' A' ' 57' ' ' ILE . 23.7 mmt85 -67.6 -23.39 65.38 Favored 'General case' 0 N--CA 1.488 1.46 0 C-N-CA 123.925 0.89 . . . . 75.55 112.591 -175.481 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 149' ' ' ASN . . . . . . . . . . . . . 27.8 p-10 -86.97 1.09 53.89 Favored 'General case' 0 N--CA 1.487 1.38 0 C-N-CA 123.363 0.665 . . . . 60.52 111.106 174.818 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . 95.32 -26.5 19.21 Favored Glycine 0 C--N 1.341 0.809 0 CA-C-O 119.692 -0.504 . . . . 73.13 113.169 179.282 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 65.0 tttp -63.69 118.14 7.84 Favored 'General case' 0 N--CA 1.476 0.827 0 CA-C-N 117.507 0.654 . . . . 70.44 110.921 -174.542 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 152' ' ' THR . . . . . 0.411 ' HA ' ' HA2' ' A' ' 146' ' ' GLY . 9.6 m -93.39 124.7 37.56 Favored 'General case' 0 CA--C 1.542 0.644 0 CA-C-N 114.763 -1.108 . . . . 74.4 109.062 179.269 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 153' ' ' SER . . . . . . . . . . . . . 66.2 p -63.77 -26.81 68.81 Favored 'General case' 0 N--CA 1.48 1.066 0 C-N-CA 124.13 0.972 . . . . 35.31 112.056 -178.655 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 72.1 mmtt -111.89 141.3 45.7 Favored 'General case' 0 C--O 1.238 0.472 0 C-N-CA 124.009 0.924 . . . . 60.44 111.252 -176.38 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 72.9 mmtt -83.16 91.23 7.2 Favored 'General case' 0 C--O 1.238 0.487 0 N-CA-C 108.369 -0.975 . . . . 60.54 108.369 172.798 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 156' ' ' ILE . . . . . 0.551 HD13 ' HB2' ' A' ' 142' ' ' MET . 62.6 mt -94.13 110.97 24.38 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.473 0 CA-C-N 114.84 -1.073 . . . . 52.13 108.955 -177.94 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 157' ' ' THR . . . . . . . . . . . . . 49.3 p -115.59 155.07 28.29 Favored 'General case' 0 C--O 1.243 0.743 0 C-N-CA 123.847 0.859 . . . . 74.22 110.454 -176.979 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 158' ' ' ILE . . . . . 0.461 HG23 ' HB3' ' A' ' 8' ' ' PHE . 62.6 mt -75.5 93.71 0.92 Allowed 'Isoleucine or valine' 0 CA--C 1.542 0.644 0 N-CA-C 108.205 -1.035 . . . . 73.03 108.205 171.199 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 159' ' ' ALA . . . . . 0.566 ' HB2' ' HB2' ' A' ' 11' ' ' ALA . . . -58.31 -35.62 72.13 Favored 'General case' 0 N--CA 1.474 0.744 0 C-N-CA 124.485 1.114 . . . . 71.1 112.834 -177.028 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 160' ' ' ASP . . . . . 0.441 ' HA ' ' HE2' ' A' ' 49' ' ' LYS . 23.7 t0 -161.16 157.39 25.8 Favored 'General case' 0 N--CA 1.477 0.906 0 O-C-N 123.358 0.411 . . . . 70.14 110.648 -174.986 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 161' ' ' CYS . . . . . . . . . . . . . 58.7 m -123.49 -172.59 2.55 Favored 'General case' 0 N--CA 1.485 1.299 0 C-N-CA 125.048 1.339 . . . . 71.2 108.473 177.281 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 162' ' ' GLY . . . . . . . . . . . . . . . 132.25 57.09 0.08 OUTLIER Glycine 0 C--N 1.354 1.572 0 CA-C-N 118.716 0.689 . . . . 61.15 112.977 -172.957 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 163' ' ' GLN . . . . . 0.57 ' HA ' ' H ' ' A' ' 7' ' ' PHE . 2.0 pt20 -47.84 137.46 9.77 Favored 'General case' 0 N--CA 1.485 1.288 0 C-N-CA 124.356 1.062 . . . . 72.3 113.708 -173.242 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 164' ' ' LEU . . . . . 0.473 ' HG ' ' HB2' ' A' ' 7' ' ' PHE . 41.2 mt -84.08 125.1 31.8 Favored 'General case' 0 CA--C 1.543 0.698 0 C-N-CA 124.005 0.922 . . . . 74.23 110.151 179.914 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 165' ' ' GLU . . . . . . . . . . . . . 29.0 tt0 . . . . . 0 C--O 1.253 1.245 0 C-N-CA 123.39 0.676 . . . . 74.13 109.602 176.971 . . . . . . . . 0 0 . 1 . 015 nuclear build full ' B' B ' 216' ' ' PRO . . . . . 0.63 ' HG2' ' HA2' ' A' ' 72' ' ' GLY . 24.2 Cg_exo . . . . . 0 N--CA 1.492 1.415 0 N-CA-C 111.527 -0.22 . . . . 72.41 111.527 . . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 217' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER 55.74 64.39 5.38 Favored Pre-proline 0 CA--C 1.558 1.261 0 C-N-CA 124.775 1.23 . . . . 61.34 110.68 -176.331 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 218' ' ' PRO . . . . . . . . . . . . . 93.4 Cg_endo -78.7 146.97 21.57 Favored 'Trans proline' 0 C--N 1.378 2.128 0 C-N-CA 122.28 1.986 . . . . 70.03 112.044 -178.634 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 219' ' ' GLY . . . . . . . . . . . . . . . 112.38 177.55 19.88 Favored Glycine 0 CA--C 1.527 0.834 0 CA-C-N 115.186 -0.916 . . . . 75.52 111.909 -175.981 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 220' ' ' PRO . . . . . 0.436 ' HG3' HD11 ' A' ' 122' ' ' LEU . 91.7 Cg_endo -75.65 178.48 7.33 Favored 'Trans proline' 0 N--CA 1.489 1.254 0 C-N-CA 123.41 2.74 . . . . 63.54 113.419 -177.067 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 221' ' ' TYR . . . . . . . . . . . . . 99.7 m-85 -129.62 -166.13 1.62 Allowed 'General case' 0 N--CA 1.476 0.87 0 C-N-CA 124.464 1.105 . . . . 73.3 109.558 179.381 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 222' ' ' ALA . . . . . . . . . . . . . . . 86.31 179.65 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.533 0 C-N-CA 126.513 1.925 . . . . 43.14 110.03 -167.908 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 223' ' ' GLN . . . . . 0.725 ' HG3' ' HB2' ' A' ' 60' ' ' PHE . 18.2 mm-40 64.84 68.18 0.77 Allowed Pre-proline 0 N--CA 1.481 1.091 0 C-N-CA 124.794 1.238 . . . . 74.1 110.787 -171.954 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 224' ' ' PRO . . . . . . . . . . . . . 17.3 Cg_endo . . . . . 0 C--N 1.379 2.182 0 C-N-CA 123.023 2.482 . . . . 63.15 111.006 -177.65 . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 26.3 mmt . . . . . 0 N--CA 1.475 0.813 0 CA-C-O 121.285 0.565 . . . . 74.13 110.112 . . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 9.4 p -99.67 9.83 7.51 Favored 'Isoleucine or valine' 0 CA--C 1.561 1.388 0 C-N-CA 124.123 0.969 . . . . 71.52 109.492 173.055 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 55.5 m-80 -57.93 120.77 45.17 Favored Pre-proline 0 C--N 1.362 1.114 0 C-N-CA 123.908 0.883 . . . . 73.15 111.723 -176.836 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 4' ' ' PRO . . . . . 0.497 ' HG2' ' HB2' ' A' ' 24' ' ' LEU . 42.5 Cg_endo -65.42 135.34 42.26 Favored 'Trans proline' 0 C--N 1.378 2.1 0 C-N-CA 122.525 2.15 . . . . 73.31 110.816 178.522 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 5' ' ' THR . . . . . 0.408 ' HB ' ' O ' ' A' ' 164' ' ' LEU . 55.9 m -122.3 123.26 41.01 Favored 'General case' 0 CA--C 1.54 0.568 0 N-CA-C 109.278 -0.638 . . . . 71.22 109.278 -172.882 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 6' ' ' VAL . . . . . 0.552 ' HA ' ' HB2' ' A' ' 163' ' ' GLN . 14.4 m -101.33 136.39 33.35 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.659 0 C-N-CA 123.965 0.906 . . . . 74.23 109.256 -175.915 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 7' ' ' PHE . . . . . 0.438 ' HB3' ' HA ' ' A' ' 163' ' ' GLN . 86.4 t80 -125.6 136.98 53.85 Favored 'General case' 0 C--O 1.238 0.47 0 C-N-CA 123.469 0.707 . . . . 73.1 109.683 -175.627 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 8' ' ' PHE . . . . . 0.427 ' HB3' HG23 ' A' ' 158' ' ' ILE . 53.3 m-85 -138.76 165.84 25.96 Favored 'General case' 0 CA--C 1.534 0.349 0 C-N-CA 124.809 1.243 . . . . 70.21 109.493 177.254 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 13.9 m-20 -111.67 118.23 35.07 Favored 'General case' 0 C--N 1.323 -0.565 0 N-CA-C 106.386 -1.709 . . . . 73.54 106.386 168.868 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 10' ' ' ILE . . . . . 0.459 HG21 ' SD ' ' A' ' 142' ' ' MET . 46.3 mm -84.98 129.53 37.58 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.56 0 N-CA-C 109.159 -0.682 . . . . 52.53 109.159 178.722 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 11' ' ' ALA . . . . . 0.792 ' HB2' ' HB2' ' A' ' 159' ' ' ALA . . . -124.59 126.98 46.69 Favored 'General case' 0 C--O 1.217 -0.642 0 C-N-CA 123.691 0.796 . . . . 65.0 110.496 -176.89 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 12' ' ' VAL . . . . . 0.497 HG23 ' HB2' ' A' ' 17' ' ' LEU . 89.1 t -96.14 116.38 37.85 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.759 0 N-CA-C 107.976 -1.12 . . . . 41.14 107.976 173.418 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 30.2 m-20 62.99 24.14 14.39 Favored 'General case' 0 N--CA 1.488 1.446 0 C-N-CA 125.59 1.556 . . . . 74.13 112.048 -177.288 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 97.24 -17.77 58.57 Favored Glycine 0 C--N 1.347 1.151 0 CA-C-O 119.951 -0.361 . . . . 75.12 113.037 -179.201 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 40.9 mm-40 -94.32 124.66 54.95 Favored Pre-proline 0 CA--C 1.545 0.755 0 CA-C-O 118.551 -0.738 . . . . 51.41 109.767 179.66 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 19.7 Cg_endo -56.06 118.07 4.81 Favored 'Trans proline' 0 C--N 1.381 2.274 0 C-N-CA 123.222 2.615 . . . . 74.21 113.111 -176.308 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 17' ' ' LEU . . . . . 0.497 ' HB2' HG23 ' A' ' 12' ' ' VAL . 49.3 tp -78.12 -38.55 43.63 Favored 'General case' 0 N--CA 1.476 0.871 0 C-N-CA 124.244 1.018 . . . . 73.41 109.407 171.371 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 177.39 -160.3 27.0 Favored Glycine 0 N--CA 1.449 -0.481 0 CA-C-N 114.317 -1.311 . . . . 63.11 110.707 -175.521 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 6.3 ptp180 -140.08 147.22 39.97 Favored 'General case' 0 N--CA 1.468 0.456 0 C-N-CA 123.934 0.893 . . . . 72.14 109.693 179.799 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 87.4 t -137.18 132.5 46.53 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.7 0 C-N-CA 124.092 0.957 . . . . 64.21 109.593 -175.24 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 7.9 t -120.1 122.62 41.45 Favored 'General case' 0 CA--C 1.547 0.855 0 N-CA-C 108.999 -0.741 . . . . 71.3 108.999 172.601 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 22' ' ' PHE . . . . . 0.549 ' HA ' ' HA ' ' A' ' 132' ' ' VAL . 11.1 m-85 -100.15 152.22 20.51 Favored 'General case' 0 N--CA 1.476 0.857 0 C-N-CA 124.027 0.931 . . . . 71.42 108.819 176.556 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 23' ' ' GLU . . . . . 0.649 ' HB2' ' HD2' ' A' ' 133' ' ' LYS . 39.7 tt0 -110.76 119.01 37.7 Favored 'General case' 0 CA--C 1.54 0.58 0 C-N-CA 123.318 0.647 . . . . 70.21 109.538 175.517 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 24' ' ' LEU . . . . . 0.497 ' HB2' ' HG2' ' A' ' 4' ' ' PRO . 18.5 mt -90.8 127.86 36.5 Favored 'General case' 0 N--CA 1.472 0.654 0 C-N-CA 124.462 1.105 . . . . 73.05 110.028 -178.301 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 25' ' ' PHE . . . . . 0.536 ' HB2' HD11 ' A' ' 90' ' ' LEU . 85.4 m-85 -88.92 71.9 8.52 Favored 'General case' 0 CA--C 1.536 0.427 0 C-N-CA 123.776 0.83 . . . . 64.35 110.34 -178.534 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -67.12 -15.59 63.81 Favored 'General case' 0 N--CA 1.481 1.122 0 CA-C-N 115.403 -0.817 . . . . 63.35 112.223 177.58 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 9.2 p-10 -76.3 -18.71 58.82 Favored 'General case' 0 CA--C 1.555 1.156 0 C-N-CA 123.409 0.683 . . . . 64.34 111.088 176.885 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 52.2 mttp -106.67 -45.65 4.17 Favored 'General case' 0 N--CA 1.483 1.201 0 C-N-CA 123.902 0.881 . . . . 75.34 110.37 -178.536 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 29' ' ' VAL . . . . . 0.586 HG21 ' HA ' ' A' ' 129' ' ' PHE . 4.6 m -134.68 69.98 71.8 Favored Pre-proline 0 CA--C 1.562 1.437 0 C-N-CA 124.36 1.064 . . . . 62.5 109.913 -175.748 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 18.8 Cg_endo -58.57 -29.54 89.26 Favored 'Trans proline' 0 C--N 1.382 2.324 0 C-N-CA 123.062 2.508 . . . . 64.51 113.985 -175.004 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 34.8 ttmt -72.63 -56.95 4.54 Favored 'General case' 0 N--CA 1.479 1.01 0 C-N-CA 123.668 0.787 . . . . 74.52 111.217 -179.648 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 6.6 m -69.31 -25.54 64.27 Favored 'General case' 0 CA--C 1.559 1.298 0 CA-C-N 115.081 -0.963 . . . . 52.5 111.074 -173.373 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -82.89 -42.4 17.77 Favored 'General case' 0 CA--C 1.548 0.898 0 C-N-CA 123.717 0.807 . . . . 63.42 111.085 177.254 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 38.8 tt0 -56.13 -39.44 72.25 Favored 'General case' 0 N--CA 1.493 1.675 0 C-N-CA 123.681 0.792 . . . . 52.42 110.57 177.192 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 35' ' ' ASN . . . . . 0.591 ' ND2' ' SD ' ' A' ' 100' ' ' MET . 41.4 t30 -50.95 -67.08 0.28 Allowed 'General case' 0 CA--C 1.538 0.488 0 O-C-N 125.149 1.531 . . . . 74.22 111.256 179.848 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 60.6 t80 -64.46 -36.02 82.82 Favored 'General case' 0 CA--C 1.543 0.707 0 O-C-N 124.016 0.822 . . . . 75.44 111.267 -173.62 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 62.2 ttt180 -60.63 -47.01 88.13 Favored 'General case' 0 N--CA 1.478 0.936 0 O-C-N 124.068 0.855 . . . . 75.43 111.042 178.906 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 38' ' ' ALA . . . . . 0.486 ' HB3' HG21 ' A' ' 78' ' ' ILE . . . -78.06 -19.92 53.35 Favored 'General case' 0 N--CA 1.475 0.811 0 CA-C-N 115.153 -0.93 . . . . 73.12 111.671 -177.416 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 39' ' ' LEU . . . . . 0.422 ' HG ' ' O ' ' A' ' 35' ' ' ASN . 94.0 mt -73.94 -37.56 64.51 Favored 'General case' 0 N--CA 1.481 1.104 0 C-N-CA 123.162 0.585 . . . . 74.32 109.89 170.93 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 50.4 m -67.74 -49.4 62.74 Favored 'General case' 0 N--CA 1.48 1.041 0 C-N-CA 123.765 0.826 . . . . 75.5 110.831 -178.585 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 41' ' ' THR . . . . . 0.461 ' OG1' ' HG2' ' A' ' 43' ' ' GLU . 7.6 p -76.3 -33.78 59.07 Favored 'General case' 0 N--CA 1.477 0.895 0 C-N-CA 123.527 0.731 . . . . 72.13 111.619 178.344 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 76.99 37.9 31.78 Favored Glycine 0 C--N 1.34 0.756 0 CA-C-N 116.257 -0.429 . . . . 74.34 112.411 -172.525 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 43' ' ' GLU . . . . . 0.461 ' HG2' ' OG1' ' A' ' 41' ' ' THR . 22.7 mm-40 -64.67 -20.9 66.57 Favored 'General case' 0 N--CA 1.486 1.339 0 C-N-CA 123.159 0.584 . . . . 74.33 111.599 174.231 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 44' ' ' LYS . . . . . 0.514 ' HG3' ' HB ' ' A' ' 78' ' ' ILE . 71.1 mmtt -106.63 15.13 26.13 Favored 'General case' 0 CA--C 1.55 0.974 0 C-N-CA 124.296 1.038 . . . . 74.11 110.478 179.568 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 68.57 38.15 85.98 Favored Glycine 0 C--N 1.352 1.456 0 CA-C-N 116.103 -0.499 . . . . 73.03 114.227 177.466 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 46' ' ' PHE . . . . . 0.474 ' HE2' ' HA ' ' A' ' 78' ' ' ILE . 23.0 m-85 -117.49 -48.55 2.59 Favored 'General case' 0 N--CA 1.489 1.476 0 CA-C-N 117.432 0.616 . . . . 63.34 110.654 -179.246 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 48.14 61.51 4.88 Favored Glycine 0 C--N 1.356 1.672 0 O-C-N 124.415 1.072 . . . . 65.32 114.51 167.823 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 48' ' ' TYR . . . . . 0.418 ' HE2' HD22 ' A' ' 39' ' ' LEU . 64.0 m-85 -65.47 92.94 0.14 Allowed 'General case' 0 N--CA 1.477 0.903 0 CA-C-O 121.693 0.759 . . . . 75.15 112.339 -174.417 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 49' ' ' LYS . . . . . 0.558 ' HZ3' ' HB2' ' A' ' 49' ' ' LYS . 0.0 OUTLIER -105.77 135.78 46.59 Favored 'General case' 0 C--O 1.236 0.37 0 CA-C-N 114.006 -1.452 . . . . 63.01 108.658 175.238 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 78.34 21.59 69.65 Favored Glycine 0 C--N 1.341 0.853 0 CA-C-O 119.838 -0.423 . . . . 55.32 113.417 177.445 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 16.2 m -57.37 115.34 2.65 Favored 'General case' 0 N--CA 1.474 0.733 0 C-N-CA 123.586 0.754 . . . . 53.24 110.358 179.051 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 52' ' ' CYS . . . . . . . . . . . . . 23.8 p -81.36 114.55 20.2 Favored 'General case' 0 CA--C 1.538 0.5 0 C-N-CA 124.513 1.125 . . . . 71.34 111.459 -172.992 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 53' ' ' PHE . . . . . 0.718 ' HA ' ' HA2' ' A' ' 64' ' ' GLY . 38.6 m-85 -66.07 93.23 0.19 Allowed 'General case' 0 CA--C 1.539 0.539 0 C-N-CA 123.896 0.878 . . . . 74.41 108.784 164.715 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 17.0 p-80 -108.5 -0.34 20.49 Favored 'General case' 0 N--CA 1.479 0.977 0 CA-C-N 115.383 -0.826 . . . . 73.14 111.536 -176.498 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 55' ' ' ARG . . . . . 0.464 ' O ' ' HB3' ' A' ' 63' ' ' GLN . 53.2 ttt-85 -138.16 99.66 3.93 Favored 'General case' 0 C--O 1.21 -0.986 0 N-CA-C 109.228 -0.656 . . . . 50.11 109.228 173.796 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 56' ' ' ILE . . . . . 0.442 HG21 ' HA ' ' A' ' 143' ' ' GLU . 51.1 mt -131.33 134.35 61.11 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.935 0 N-CA-C 109.6 -0.519 . . . . 53.43 109.6 175.911 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 57' ' ' ILE . . . . . 0.415 HG23 ' HA ' ' A' ' 148' ' ' ARG . 63.0 mt -128.82 113.38 18.96 Favored Pre-proline 0 CA--C 1.553 1.08 0 C-N-CA 124.694 1.197 . . . . 61.41 108.726 177.975 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 58' ' ' PRO . . . . . 0.556 ' HA ' ' HG2' ' A' ' 143' ' ' GLU . 41.4 Cg_endo -64.77 143.64 81.02 Favored 'Trans proline' 0 C--N 1.386 2.523 0 C-N-CA 123.415 2.743 . . . . 73.02 112.158 -177.322 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 72.36 27.47 69.73 Favored Glycine 0 C--N 1.344 1.013 0 CA-C-N 115.713 -0.676 . . . . 50.1 112.304 -176.888 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 20.5 t80 -153.59 -77.38 0.11 Allowed 'General case' 0 CA--C 1.543 0.685 0 C-N-CA 123.579 0.752 . . . . 75.03 109.644 -178.472 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 61' ' ' MET . . . . . 0.761 ' SD ' ' HB2' ' A' ' 113' ' ' PHE . 13.3 tmm? -167.86 137.75 2.67 Favored 'General case' 0 CA--C 1.548 0.88 0 C-N-CA 122.807 0.443 . . . . 72.12 111.585 -164.018 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 62' ' ' CYS . . . . . . . . . . . . . 4.3 p -106.94 113.56 27.12 Favored 'General case' 0 CA--C 1.552 1.057 0 C-N-CA 124.78 1.232 . . . . 63.41 109.923 172.343 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 63' ' ' GLN . . . . . 0.586 ' HB2' ' SD ' ' A' ' 61' ' ' MET . 49.2 tt0 -107.99 121.66 45.24 Favored 'General case' 0 N--CA 1.487 1.382 0 C-N-CA 124.155 0.982 . . . . 74.1 111.138 -174.65 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 64' ' ' GLY . . . . . 0.718 ' HA2' ' HA ' ' A' ' 53' ' ' PHE . . . -97.55 170.88 25.91 Favored Glycine 0 C--N 1.34 0.796 0 CA-C-N 114.721 -1.127 . . . . 73.31 112.0 172.755 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 176.7 179.43 47.11 Favored Glycine 0 C--O 1.224 -0.524 0 N-CA-C 111.77 -0.532 . . . . 74.22 111.77 178.704 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 6.9 t0 -102.73 151.75 22.03 Favored 'General case' 0 CA--C 1.546 0.803 0 C-N-CA 124.385 1.074 . . . . 72.5 110.434 -173.901 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 68.6 t80 -82.25 -30.28 30.81 Favored 'General case' 0 N--CA 1.478 0.929 0 C-N-CA 124.727 1.211 . . . . 72.34 110.46 -178.404 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 68' ' ' THR . . . . . 0.684 HG22 ' HG3' ' A' ' 69' ' ' ARG . 6.9 m -74.89 143.06 43.97 Favored 'General case' 0 CA--C 1.549 0.929 0 C-N-CA 123.661 0.784 . . . . 61.43 109.49 177.118 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 69' ' ' ARG . . . . . 0.684 ' HG3' HG22 ' A' ' 68' ' ' THR . 50.7 mtt180 60.68 26.09 15.85 Favored 'General case' 0 N--CA 1.491 1.611 0 C-N-CA 124.565 1.146 . . . . 73.15 111.798 175.627 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 20.3 t-80 -58.83 -40.59 84.63 Favored 'General case' 0 N--CA 1.474 0.742 0 C-N-CA 124.624 1.17 . . . . 54.31 113.241 -165.777 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 43.3 m-80 -67.35 103.81 1.36 Allowed 'General case' 0 N--CA 1.474 0.76 0 C-N-CA 122.785 0.434 . . . . 75.22 110.004 177.747 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 89.28 -7.93 80.97 Favored Glycine 0 CA--C 1.531 1.09 0 CA-C-N 115.643 -0.708 . . . . 31.11 114.602 173.869 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 18.3 m -144.48 -88.66 0.11 Allowed 'General case' 0 CA--C 1.556 1.211 0 CA-C-N 117.891 0.845 . . . . 74.5 110.297 -178.83 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 65.66 61.64 5.44 Favored Glycine 0 C--N 1.362 1.973 0 CA-C-O 119.593 -0.559 . . . . 65.14 113.718 176.999 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 121.22 51.96 0.24 Allowed Glycine 0 N--CA 1.479 1.508 0 CA-C-N 117.841 0.82 . . . . 43.33 111.736 -174.0 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 76' ' ' LYS . . . . . 0.432 ' HB2' ' O ' ' A' ' 80' ' ' GLY . 64.0 pttt -60.91 168.93 2.13 Favored 'General case' 0 CA--C 1.548 0.867 0 C-N-CA 123.799 0.84 . . . . 73.14 112.498 -175.518 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 80.9 p -91.23 176.16 6.68 Favored 'General case' 0 CA--C 1.542 0.639 0 CA-C-N 115.033 -0.985 . . . . 62.1 110.605 -177.671 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 78' ' ' ILE . . . . . 0.514 ' HB ' ' HG3' ' A' ' 44' ' ' LYS . 26.0 pt -74.5 -18.61 16.78 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.547 0 CA-C-N 115.939 -0.573 . . . . 75.45 110.026 172.145 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 55.0 m-85 -89.4 11.39 19.34 Favored 'General case' 0 CA--C 1.544 0.724 0 C-N-CA 124.764 1.225 . . . . 71.32 110.855 179.058 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 80' ' ' GLY . . . . . 0.432 ' O ' ' HB2' ' A' ' 76' ' ' LYS . . . 109.63 -133.8 11.84 Favored Glycine 0 C--N 1.351 1.396 0 N-CA-C 110.831 -0.908 . . . . 72.41 110.831 -179.82 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 35.9 tt0 -65.13 -41.11 95.13 Favored 'General case' 0 N--CA 1.478 0.934 0 C-N-CA 123.88 0.872 . . . . 65.03 111.114 -179.326 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 82' ' ' LYS . . . . . 0.727 ' HD2' ' HA ' ' A' ' 107' ' ' THR . 21.0 pttp -169.49 178.36 4.25 Favored 'General case' 0 CA--C 1.545 0.776 0 CA-C-N 115.065 -0.97 . . . . 75.25 109.836 -165.777 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 26.2 p90 -158.16 171.73 19.69 Favored 'General case' 0 N--CA 1.475 0.809 0 C-N-CA 123.479 0.712 . . . . 74.11 110.191 174.339 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 12.2 pt-20 -94.18 162.66 13.77 Favored 'General case' 0 N--CA 1.476 0.86 0 C-N-CA 123.204 0.602 . . . . 74.53 109.834 175.796 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 65.1 m-20 -68.45 148.23 50.92 Favored 'General case' 0 N--CA 1.475 0.815 0 C-N-CA 123.871 0.868 . . . . 74.54 112.562 -172.345 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 86' ' ' GLU . . . . . 0.561 ' HG2' ' HA ' ' A' ' 29' ' ' VAL . 5.2 tp10 -73.96 -62.99 1.31 Allowed 'General case' 0 CA--C 1.544 0.728 0 CA-C-N 115.447 -0.797 . . . . 74.11 110.097 179.083 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 25.5 p30 -175.05 150.54 1.21 Allowed 'General case' 0 N--CA 1.483 1.185 0 C-N-CA 124.338 1.055 . . . . 60.43 109.801 -177.518 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 91.5 m-85 -90.06 57.51 3.81 Favored 'General case' 0 N--CA 1.483 1.205 0 C-N-CA 123.783 0.833 . . . . 63.22 111.182 -171.248 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 72.8 mt -82.24 -53.8 11.06 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.76 0 CA-C-N 115.684 -0.689 . . . . 54.4 109.393 175.394 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 90' ' ' LEU . . . . . 0.536 HD11 ' HB2' ' A' ' 25' ' ' PHE . 87.0 mt -84.11 109.92 18.08 Favored 'General case' 0 CA--C 1.541 0.613 0 CA-C-N 115.197 -0.91 . . . . 72.41 110.84 -178.384 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 18.3 ptpt -102.27 171.29 7.56 Favored 'General case' 0 N--CA 1.473 0.685 0 C-N-CA 124.385 1.074 . . . . 64.54 109.884 175.566 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 92' ' ' HIS . . . . . . . . . . . . . 39.2 m80 -89.75 48.33 1.58 Allowed 'General case' 0 CA--C 1.551 1.009 0 C-N-CA 124.269 1.028 . . . . 75.44 110.266 -175.06 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 12.0 t -91.95 -16.3 26.79 Favored 'General case' 0 N--CA 1.481 1.102 0 C-N-CA 123.46 0.704 . . . . 71.23 111.108 -179.331 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -104.97 157.32 16.59 Favored Glycine 0 C--N 1.343 0.959 0 CA-C-O 119.603 -0.554 . . . . 64.32 112.245 178.51 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 71.9 Cg_endo -80.87 150.74 18.51 Favored 'Trans proline' 0 C--N 1.363 1.303 0 C-N-CA 122.505 2.137 . . . . 64.01 111.421 169.359 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 96' ' ' GLY . . . . . 0.431 ' HA3' HG12 ' A' ' 132' ' ' VAL . . . 84.22 22.89 53.49 Favored Glycine 0 C--N 1.344 0.992 0 N-CA-C 114.114 0.406 . . . . 63.34 114.114 176.993 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 97' ' ' ILE . . . . . . . . . . . . . 14.7 mm -63.0 115.71 2.37 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.897 0 C-N-CA 124.603 1.161 . . . . 75.22 112.093 -174.746 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 59.1 tp -97.8 114.22 26.2 Favored 'General case' 0 C--O 1.249 1.062 0 CA-C-O 121.77 0.795 . . . . 71.14 109.829 175.641 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 32.8 t -142.9 143.22 31.95 Favored 'General case' 0 CA--C 1.545 0.767 0 C-N-CA 124.771 1.229 . . . . 70.51 107.955 179.058 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 100' ' ' MET . . . . . 0.72 ' HA ' ' HA ' ' A' ' 112' ' ' PHE . 81.1 mtp -84.55 142.01 30.31 Favored 'General case' 0 N--CA 1.492 1.643 0 CA-C-N 118.496 0.589 . . . . 73.35 111.063 -176.329 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 101' ' ' ALA . . . . . 0.582 ' HB3' ' HB2' ' A' ' 111' ' ' GLN . . . -73.4 171.38 13.2 Favored 'General case' 0 N--CA 1.484 1.254 0 CA-C-O 121.102 0.477 . . . . 64.43 111.874 -171.504 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 102' ' ' ASN . . . . . 0.466 ' HB3' ' HA ' ' A' ' 108' ' ' ASN . 30.1 p-10 -168.39 167.25 12.01 Favored 'General case' 0 N--CA 1.472 0.67 0 CA-C-N 115.536 -0.757 . . . . 72.35 111.234 -173.499 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -105.89 6.21 31.3 Favored 'General case' 0 N--CA 1.477 0.908 0 C-N-CA 124.147 0.979 . . . . 62.32 110.544 169.182 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 152.91 -174.87 31.62 Favored Glycine 0 C--N 1.354 1.528 0 CA-C-O 119.244 -0.753 . . . . 50.33 112.167 179.665 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 44.0 Cg_exo -59.14 148.02 87.7 Favored 'Trans proline' 0 C--N 1.373 1.816 0 C-N-CA 123.041 2.494 . . . . 70.21 111.932 173.064 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 66.3 t30 68.01 9.55 7.23 Favored 'General case' 0 N--CA 1.483 1.212 0 C-N-CA 124.943 1.297 . . . . 64.52 111.128 -177.129 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 107' ' ' THR . . . . . 0.727 ' HA ' ' HD2' ' A' ' 82' ' ' LYS . 5.0 m -121.65 1.61 10.03 Favored 'General case' 0 CA--C 1.55 0.974 0 C-N-CA 123.857 0.863 . . . . 64.31 110.545 -178.907 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 108' ' ' ASN . . . . . 0.466 ' HA ' ' HB3' ' A' ' 102' ' ' ASN . 43.7 t30 -69.29 132.84 47.09 Favored 'General case' 0 N--CA 1.478 0.951 0 C-N-CA 123.72 0.808 . . . . 72.0 109.673 179.976 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 112.57 15.12 9.76 Favored Glycine 0 N--CA 1.472 1.076 0 N-CA-C 114.045 0.378 . . . . 43.44 114.045 -179.371 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 32.1 p -112.63 119.44 38.12 Favored 'General case' 0 CA--C 1.543 0.687 0 N-CA-C 107.626 -1.25 . . . . 73.33 107.626 167.78 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 111' ' ' GLN . . . . . 0.582 ' HB2' ' HB3' ' A' ' 101' ' ' ALA . 40.0 mt-30 66.18 178.18 0.21 Allowed 'General case' 0 N--CA 1.497 1.898 0 C-N-CA 124.458 1.103 . . . . 74.15 111.112 -169.741 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 112' ' ' PHE . . . . . 0.72 ' HA ' ' HA ' ' A' ' 100' ' ' MET . 45.1 p90 -145.54 154.2 41.92 Favored 'General case' 0 N--CA 1.48 1.057 0 C-N-CA 123.675 0.79 . . . . 72.02 108.951 177.959 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 113' ' ' PHE . . . . . 0.761 ' HB2' ' SD ' ' A' ' 61' ' ' MET . 51.4 p90 -144.65 154.61 42.97 Favored 'General case' 0 C--O 1.238 0.471 0 CA-C-O 120.823 0.344 . . . . 63.13 111.626 179.306 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 114' ' ' ILE . . . . . . . . . . . . . 5.7 mt -130.3 101.59 6.03 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.724 0 C-N-CA 124.077 0.951 . . . . 65.41 108.769 -174.236 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 115' ' ' CYS . . . . . . . . . . . . . 63.2 m -80.4 104.96 11.3 Favored 'General case' 0 N--CA 1.47 0.549 0 C-N-CA 123.507 0.723 . . . . 72.12 109.709 178.101 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 81.7 p -69.08 -27.62 65.78 Favored 'General case' 0 N--CA 1.488 1.434 0 CA-C-O 121.161 0.505 . . . . 64.24 111.257 -178.63 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -97.75 151.23 20.38 Favored 'General case' 0 C--O 1.24 0.591 0 CA-C-N 115.212 -0.903 . . . . 61.03 108.678 172.997 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 11.5 ptmm? -71.82 86.85 0.97 Allowed 'General case' 0 CA--C 1.552 1.029 0 CA-C-O 121.645 0.736 . . . . 72.44 109.396 174.325 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 119' ' ' THR . . . . . . . . . . . . . 40.6 p -76.21 86.7 3.04 Favored 'General case' 0 CA--C 1.543 0.678 0 CA-C-N 115.028 -0.987 . . . . 73.1 110.872 -172.607 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 12.4 pt-20 -65.24 -31.39 72.52 Favored 'General case' 0 CA--C 1.542 0.668 0 CA-C-N 114.545 -1.207 . . . . 74.54 111.866 -172.108 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 121' ' ' TRP . . . . . . . . . . . . . 42.6 p90 -70.83 -14.51 62.44 Favored 'General case' 0 N--CA 1.475 0.791 0 C-N-CA 123.543 0.737 . . . . 71.3 111.793 -178.794 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 42.7 mt -87.9 5.46 40.37 Favored 'General case' 0 N--CA 1.481 1.103 0 C-N-CA 122.828 0.451 . . . . 74.52 111.873 176.405 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 69.1 m-20 -80.39 140.33 36.09 Favored 'General case' 0 N--CA 1.482 1.144 0 C-N-CA 122.642 0.377 . . . . 61.01 110.451 172.275 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 94.35 -10.9 71.01 Favored Glycine 0 C--N 1.347 1.175 0 CA-C-N 115.602 -0.727 . . . . 71.11 112.183 -169.281 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 1.7 mppt? -94.6 -168.26 1.8 Allowed 'General case' 0 N--CA 1.472 0.662 0 C-N-CA 124.476 1.11 . . . . 71.01 109.535 173.722 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 126' ' ' HIS . . . . . . . . . . . . . 53.9 p-80 -66.58 154.53 40.21 Favored 'General case' 0 CA--C 1.551 0.981 0 C-N-CA 124.179 0.991 . . . . 64.31 111.237 -172.146 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 17.6 m -78.81 147.54 6.76 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.813 0 CA-C-N 115.176 -0.92 . . . . 72.03 113.018 -163.262 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 128' ' ' VAL . . . . . 0.469 ' HB ' ' HB3' ' A' ' 90' ' ' LEU . 48.2 t -80.41 152.89 4.44 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.634 0 CA-C-N 114.159 -1.382 . . . . 52.33 108.537 172.576 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 129' ' ' PHE . . . . . 0.586 ' HA ' HG21 ' A' ' 29' ' ' VAL . 50.4 p90 -130.74 -15.81 3.42 Favored 'General case' 0 N--CA 1.482 1.173 0 N-CA-C 112.184 0.439 . . . . 73.41 112.184 179.187 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . -155.85 175.65 33.59 Favored Glycine 0 C--N 1.334 0.445 0 N-CA-C 112.109 -0.396 . . . . 53.13 112.109 -177.548 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 33.2 ttpt -156.23 140.51 16.6 Favored 'General case' 0 C--N 1.324 -0.519 0 N-CA-C 108.246 -1.02 . . . . 73.41 108.246 177.265 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 132' ' ' VAL . . . . . 0.549 ' HA ' ' HA ' ' A' ' 22' ' ' PHE . 6.7 p -61.1 134.23 26.57 Favored 'Isoleucine or valine' 0 CA--C 1.552 1.042 0 O-C-N 123.423 0.452 . . . . 73.04 111.279 177.336 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 133' ' ' LYS . . . . . 0.649 ' HD2' ' HB2' ' A' ' 23' ' ' GLU . 19.1 ptmt -111.52 -37.21 5.29 Favored 'General case' 0 N--CA 1.475 0.802 0 C-N-CA 123.472 0.709 . . . . 75.42 109.803 173.702 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 134' ' ' GLU . . . . . 0.546 ' HG2' ' HG3' ' A' ' 133' ' ' LYS . 40.9 mm-40 -119.91 133.94 55.4 Favored 'General case' 0 N--CA 1.48 1.06 0 C-N-CA 123.93 0.892 . . . . 53.11 109.728 -179.723 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 81.54 29.54 39.45 Favored Glycine 0 C--N 1.341 0.856 0 O-C-N 123.307 0.379 . . . . 61.34 113.421 176.965 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 136' ' ' MET . . . . . . . . . . . . . 15.8 tpt -59.43 -43.79 93.04 Favored 'General case' 0 N--CA 1.476 0.855 0 C-N-CA 123.487 0.715 . . . . 70.23 110.696 176.449 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 137' ' ' ASN . . . . . . . . . . . . . 17.0 m120 -63.55 -28.93 70.28 Favored 'General case' 0 N--CA 1.475 0.804 0 C-N-CA 123.607 0.763 . . . . 73.3 111.457 179.099 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 138' ' ' ILE . . . . . . . . . . . . . 43.4 mm -71.26 -39.03 72.28 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.119 0 C-N-CA 123.292 0.637 . . . . 62.12 110.255 176.316 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 50.8 t -64.12 -44.61 97.66 Favored 'Isoleucine or valine' 0 CA--C 1.552 1.054 0 C-N-CA 123.406 0.682 . . . . 74.43 110.189 177.982 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 43.5 mt-10 -67.99 -35.76 78.87 Favored 'General case' 0 N--CA 1.477 0.916 0 CA-C-N 115.149 -0.932 . . . . 74.45 110.908 178.956 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -68.4 -43.13 77.92 Favored 'General case' 0 N--CA 1.477 0.9 0 C-N-CA 123.479 0.712 . . . . 71.41 111.141 179.248 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 142' ' ' MET . . . . . 0.603 ' HB2' HD13 ' A' ' 156' ' ' ILE . 23.0 ptt? -73.68 -28.77 61.92 Favored 'General case' 0 N--CA 1.475 0.818 0 O-C-N 123.637 0.585 . . . . 75.41 110.793 -177.537 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 143' ' ' GLU . . . . . 0.556 ' HG2' ' HA ' ' A' ' 58' ' ' PRO . 33.0 tt0 -64.14 -28.93 70.1 Favored 'General case' 0 CA--C 1.553 1.083 0 CA-C-O 121.159 0.504 . . . . 62.24 111.555 -179.83 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 144' ' ' ARG . . . . . . . . . . . . . 48.1 mtm180 -70.67 -15.47 62.72 Favored 'General case' 0 N--CA 1.476 0.861 0 C-N-CA 123.191 0.596 . . . . 74.21 112.118 -179.957 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 145' ' ' PHE . . . . . 0.513 ' HB2' HD11 ' A' ' 156' ' ' ILE . 75.9 m-85 -82.87 -2.77 55.71 Favored 'General case' 0 N--CA 1.482 1.169 0 C-N-CA 122.592 0.357 . . . . 74.55 111.852 176.373 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . -95.42 -179.73 36.51 Favored Glycine 0 C--N 1.353 1.501 0 N-CA-C 112.331 -0.307 . . . . 45.13 112.331 176.193 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 16.5 m -132.58 169.44 16.6 Favored 'General case' 0 N--CA 1.487 1.376 0 C-N-CA 123.663 0.785 . . . . 74.52 110.842 -176.512 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 148' ' ' ARG . . . . . 0.415 ' HA ' HG23 ' A' ' 57' ' ' ILE . 10.6 mmt180 -65.65 -28.26 68.97 Favored 'General case' 0 N--CA 1.485 1.323 0 C-N-CA 123.926 0.891 . . . . 74.52 112.641 -174.255 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 149' ' ' ASN . . . . . . . . . . . . . 29.5 p-10 -81.88 -17.0 48.81 Favored 'General case' 0 N--CA 1.486 1.326 0 C-N-CA 123.444 0.698 . . . . 73.42 111.542 178.202 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 150' ' ' GLY . . . . . 0.441 ' O ' ' HA ' ' A' ' 55' ' ' ARG . . . 112.63 -17.01 23.55 Favored Glycine 0 C--N 1.348 1.205 0 CA-C-N 116.383 -0.371 . . . . 71.41 112.887 -178.831 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 62.7 tttp -67.21 133.98 50.8 Favored 'General case' 0 N--CA 1.473 0.695 0 CA-C-N 117.312 0.556 . . . . 70.31 110.603 -178.068 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 152' ' ' THR . . . . . . . . . . . . . 39.9 p -92.26 123.39 35.56 Favored 'General case' 0 CA--C 1.539 0.541 0 C-N-CA 123.301 0.64 . . . . 73.22 109.823 177.103 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 153' ' ' SER . . . . . . . . . . . . . 43.7 t -63.98 -36.22 83.28 Favored 'General case' 0 N--CA 1.475 0.813 0 C-N-CA 123.586 0.754 . . . . 74.11 110.176 174.148 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 45.4 mmtm -120.66 136.81 54.73 Favored 'General case' 0 N--CA 1.47 0.547 0 C-N-CA 124.205 1.002 . . . . 75.23 108.937 -179.046 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 33.4 mmtp -83.1 91.39 7.2 Favored 'General case' 0 N--CA 1.477 0.903 0 CA-C-O 121.513 0.673 . . . . 74.31 110.223 -174.568 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 156' ' ' ILE . . . . . 0.603 HD13 ' HB2' ' A' ' 142' ' ' MET . 68.2 mt -85.49 130.41 36.33 Favored 'Isoleucine or valine' 0 C--O 1.221 -0.397 0 CA-C-N 114.84 -1.073 . . . . 63.25 108.487 -178.349 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 157' ' ' THR . . . . . . . . . . . . . 35.9 p -138.68 156.4 47.44 Favored 'General case' 0 C--O 1.24 0.563 0 C-N-CA 124.444 1.098 . . . . 73.23 109.282 -175.536 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 158' ' ' ILE . . . . . 0.427 HG23 ' HB3' ' A' ' 8' ' ' PHE . 42.6 mt -74.43 95.26 0.86 Allowed 'Isoleucine or valine' 0 N--CA 1.475 0.822 0 N-CA-C 109.0 -0.741 . . . . 73.51 109.0 171.939 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 159' ' ' ALA . . . . . 0.792 ' HB2' ' HB2' ' A' ' 11' ' ' ALA . . . -51.7 -48.25 63.6 Favored 'General case' 0 N--CA 1.483 1.216 0 C-N-CA 124.585 1.154 . . . . 43.13 112.267 179.71 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 160' ' ' ASP . . . . . . . . . . . . . 35.6 t0 -154.23 162.11 41.39 Favored 'General case' 0 CA--C 1.54 0.567 0 CA-C-N 115.83 -0.623 . . . . 73.5 110.284 -175.639 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 161' ' ' CYS . . . . . . . . . . . . . 27.6 p -136.53 -173.79 3.52 Favored 'General case' 0 N--CA 1.476 0.86 0 C-N-CA 124.274 1.03 . . . . 73.22 108.538 175.763 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 162' ' ' GLY . . . . . . . . . . . . . . . 131.08 55.24 0.09 OUTLIER Glycine 0 C--N 1.346 1.131 0 N-CA-C 111.007 -0.837 . . . . 52.45 111.007 -166.999 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 163' ' ' GLN . . . . . 0.552 ' HB2' ' HA ' ' A' ' 6' ' ' VAL . 13.8 pt20 -47.25 142.92 3.58 Favored 'General case' 0 CA--C 1.554 1.117 0 C-N-CA 125.056 1.342 . . . . 64.02 114.13 -170.956 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 164' ' ' LEU . . . . . 0.408 ' O ' ' HB ' ' A' ' 5' ' ' THR . 95.9 mt -98.81 106.14 18.37 Favored 'General case' 0 N--CA 1.477 0.876 0 C-N-CA 123.729 0.811 . . . . 74.43 111.034 -172.237 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 165' ' ' GLU . . . . . . . . . . . . . 48.7 mt-10 . . . . . 0 C--O 1.252 1.203 0 N-CA-C 108.341 -0.985 . . . . 71.54 108.341 173.88 . . . . . . . . 0 0 . 1 . 016 nuclear build full ' B' B ' 216' ' ' PRO . . . . . . . . . . . . . 6.2 Cg_exo . . . . . 0 CA--C 1.545 1.061 0 N-CA-C 109.989 -0.812 . . . . 71.52 109.989 . . . . . . . . . 0 0 . 1 . 016 nuclear build full ' B' B ' 217' ' ' GLU . . . . . . . . . . . . . 44.7 tt0 -167.33 110.12 0.62 Allowed Pre-proline 0 CA--C 1.549 0.929 0 C-N-CA 124.281 1.033 . . . . 75.14 108.695 -179.688 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 218' ' ' PRO . . . . . 0.428 ' HB2' ' NE2' ' A' ' 111' ' ' GLN . 3.9 Cg_exo -79.42 77.62 4.02 Favored 'Trans proline' 0 C--N 1.376 2.003 0 C-N-CA 122.7 2.267 . . . . 62.34 110.678 176.333 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 219' ' ' GLY . . . . . . . . . . . . . . . -178.88 164.87 33.51 Favored Glycine 0 CA--C 1.53 1.031 0 CA-C-N 114.765 -1.107 . . . . 70.41 111.435 -178.736 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 220' ' ' PRO . . . . . . . . . . . . . 62.0 Cg_endo -80.57 160.81 22.19 Favored 'Trans proline' 0 C--N 1.371 1.738 0 C-N-CA 123.09 2.527 . . . . 71.01 113.416 -178.043 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 221' ' ' TYR . . . . . . . . . . . . . 56.6 m-85 -68.0 135.39 52.25 Favored 'General case' 0 N--CA 1.486 1.348 0 C-N-CA 123.991 0.917 . . . . 73.43 111.106 -179.71 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 222' ' ' ALA . . . . . . . . . . . . . . . -88.2 -85.59 0.18 Allowed 'General case' 0 N--CA 1.468 0.436 0 C-N-CA 123.987 0.915 . . . . 25.14 112.921 -172.185 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 223' ' ' GLN . . . . . 0.471 ' HB2' ' HD3' ' B' ' 224' ' ' PRO . 72.6 mt-30 -142.0 -45.12 0.02 OUTLIER Pre-proline 0 CA--C 1.562 1.416 0 C-N-CA 125.029 1.332 . . . . 73.42 109.179 -167.733 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 224' ' ' PRO . . . . . 0.471 ' HD3' ' HB2' ' B' ' 223' ' ' GLN . 31.9 Cg_exo . . . . . 0 C--N 1.403 3.432 0 C-N-CA 122.26 1.973 . . . . 63.11 111.739 165.044 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 1' ' ' MET . . . . . 0.448 ' SD ' ' NZ ' ' A' ' 133' ' ' LYS . 61.0 mtt . . . . . 0 N--CA 1.481 1.109 0 N-CA-C 109.828 -0.434 . . . . 71.11 109.828 . . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 11.9 p -78.46 -13.43 13.75 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.093 0 C-N-CA 123.994 0.918 . . . . 73.42 110.499 175.298 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 3' ' ' ASN . . . . . 0.437 ' OD1' ' HA ' ' A' ' 25' ' ' PHE . 68.7 m-80 -75.99 130.13 79.06 Favored Pre-proline 0 CA--C 1.545 0.786 0 C-N-CA 123.64 0.776 . . . . 75.25 111.088 -178.507 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 4' ' ' PRO . . . . . 0.498 ' HG2' ' HB2' ' A' ' 24' ' ' LEU . 33.2 Cg_endo -63.63 119.53 6.62 Favored 'Trans proline' 0 C--N 1.38 2.219 0 C-N-CA 122.63 2.22 . . . . 61.22 112.043 176.368 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 5' ' ' THR . . . . . 0.601 HG23 ' HD3' ' A' ' 133' ' ' LYS . 61.1 m -97.42 110.71 23.22 Favored 'General case' 0 CA--C 1.539 0.556 0 C-N-CA 123.748 0.819 . . . . 65.24 108.807 178.703 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 10.0 m -97.83 123.31 50.21 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.155 0 N-CA-C 109.252 -0.647 . . . . 64.31 109.252 -175.588 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 7' ' ' PHE . . . . . 0.45 ' H ' ' HA ' ' A' ' 163' ' ' GLN . 82.3 t80 -103.82 142.39 34.46 Favored 'General case' 0 C--O 1.236 0.368 0 CA-C-N 115.706 -0.679 . . . . 63.12 109.946 -171.44 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 8' ' ' PHE . . . . . 0.429 ' HB3' HG23 ' A' ' 158' ' ' ILE . 72.5 m-85 -140.85 164.46 30.17 Favored 'General case' 0 C--O 1.239 0.508 0 C-N-CA 124.235 1.014 . . . . 75.41 109.494 174.535 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 24.5 m-20 -118.52 113.21 20.96 Favored 'General case' 0 N--CA 1.469 0.488 0 N-CA-C 107.134 -1.432 . . . . 54.14 107.134 168.551 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 37.8 mm -91.19 143.87 10.34 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.678 0 C-N-CA 123.137 0.575 . . . . 65.3 109.639 -175.965 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 11' ' ' ALA . . . . . 0.407 ' HB2' ' HB2' ' A' ' 159' ' ' ALA . . . -132.73 143.57 49.69 Favored 'General case' 0 CA--C 1.537 0.461 0 C-N-CA 123.831 0.852 . . . . 74.44 111.634 -167.624 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 12' ' ' VAL . . . . . 0.54 HG23 ' HB2' ' A' ' 17' ' ' LEU . 24.3 t -98.51 107.17 19.9 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.642 0 N-CA-C 108.256 -1.016 . . . . 73.23 108.256 172.439 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 27.5 m-20 62.03 32.01 17.77 Favored 'General case' 0 N--CA 1.488 1.461 0 C-N-CA 124.508 1.123 . . . . 74.31 111.78 179.338 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 99.27 -26.71 23.25 Favored Glycine 0 C--N 1.346 1.127 0 CA-C-N 115.424 -0.807 . . . . 63.23 112.87 -178.653 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 17.7 mm-40 -82.29 114.09 48.72 Favored Pre-proline 0 CA--C 1.547 0.853 0 CA-C-O 118.657 -0.687 . . . . 72.33 110.249 -174.349 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 21.7 Cg_endo -57.8 112.03 1.02 Allowed 'Trans proline' 0 C--N 1.382 2.304 0 C-N-CA 123.468 2.779 . . . . 72.22 112.52 -173.748 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 17' ' ' LEU . . . . . 0.54 ' HB2' HG23 ' A' ' 12' ' ' VAL . 61.6 tp -80.17 -46.49 16.28 Favored 'General case' 0 N--CA 1.472 0.642 0 C-N-CA 123.652 0.781 . . . . 62.05 110.551 -179.819 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -175.26 -163.88 28.96 Favored Glycine 0 C--N 1.34 0.761 0 CA-C-N 115.543 -0.753 . . . . 65.4 112.147 -177.768 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 8.9 ptp180 -107.13 150.59 26.42 Favored 'General case' 0 N--CA 1.479 1.004 0 C-N-CA 123.354 0.662 . . . . 71.13 109.927 -178.677 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 54.9 t -143.67 123.46 8.66 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.844 0 N-CA-C 108.275 -1.009 . . . . 74.43 108.275 169.04 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 11.1 t -126.9 138.41 53.3 Favored 'General case' 0 CA--C 1.546 0.821 0 C-N-CA 123.57 0.748 . . . . 41.25 109.618 178.128 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 22' ' ' PHE . . . . . 0.426 ' CG ' HD22 ' A' ' 98' ' ' LEU . 72.8 m-85 -109.69 150.18 28.65 Favored 'General case' 0 N--CA 1.476 0.826 0 C-N-CA 123.7 0.8 . . . . 63.52 111.012 -175.078 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 23' ' ' GLU . . . . . 0.544 ' HB2' ' HD2' ' A' ' 133' ' ' LYS . 5.2 tp10 -98.06 102.65 14.46 Favored 'General case' 0 N--CA 1.473 0.692 0 C-N-CA 124.462 1.105 . . . . 62.25 108.396 173.383 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 24' ' ' LEU . . . . . 0.512 ' HB3' ' HB1' ' A' ' 33' ' ' ALA . 26.5 mt -87.68 117.56 26.59 Favored 'General case' 0 N--CA 1.476 0.837 0 N-CA-C 109.598 -0.519 . . . . 64.41 109.598 179.972 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 25' ' ' PHE . . . . . 0.57 ' HB2' HD11 ' A' ' 90' ' ' LEU . 77.1 m-85 -86.45 65.35 9.01 Favored 'General case' 0 CA--C 1.539 0.533 0 CA-C-O 121.371 0.605 . . . . 74.45 110.701 -175.383 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -72.81 -4.99 35.02 Favored 'General case' 0 N--CA 1.481 1.11 0 C-N-CA 123.946 0.898 . . . . 75.0 112.961 -175.502 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 12.4 p-10 -78.58 -29.92 46.42 Favored 'General case' 0 N--CA 1.478 0.952 0 C-N-CA 123.049 0.54 . . . . 73.33 110.061 172.926 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 93.3 mttt -96.42 -42.26 8.2 Favored 'General case' 0 N--CA 1.474 0.752 0 C-N-CA 124.099 0.959 . . . . 53.42 110.34 -179.015 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 29' ' ' VAL . . . . . 0.549 HG21 ' HA ' ' A' ' 129' ' ' PHE . 4.1 m -126.85 76.19 75.45 Favored Pre-proline 0 CA--C 1.558 1.271 0 C-N-CA 123.887 0.875 . . . . 75.51 110.663 178.302 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 81.7 Cg_exo -49.09 -52.57 8.49 Favored 'Trans proline' 0 C--N 1.381 2.244 0 C-N-CA 123.388 2.725 . . . . 51.42 113.967 176.103 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 85.0 tttt -67.62 -54.48 19.4 Favored 'General case' 0 N--CA 1.478 0.929 0 C-N-CA 123.588 0.755 . . . . 74.42 111.66 -174.194 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 7.0 m -69.08 -33.12 73.04 Favored 'General case' 0 CA--C 1.551 0.983 0 C-N-CA 123.022 0.529 . . . . 41.11 111.642 -170.499 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 33' ' ' ALA . . . . . 0.512 ' HB1' ' HB3' ' A' ' 24' ' ' LEU . . . -79.58 -40.24 29.86 Favored 'General case' 0 CA--C 1.547 0.836 0 C-N-CA 122.619 0.367 . . . . 64.53 111.19 178.303 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 39.0 tt0 -59.86 -35.46 74.84 Favored 'General case' 0 N--CA 1.486 1.369 0 C-N-CA 123.324 0.65 . . . . 75.13 111.052 178.128 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 35' ' ' ASN . . . . . 0.516 ' ND2' ' SD ' ' A' ' 100' ' ' MET . 43.9 t30 -53.16 -65.87 0.49 Allowed 'General case' 0 C--N 1.35 0.618 0 O-C-N 124.552 1.157 . . . . 73.33 110.989 179.74 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 85.8 t80 -62.37 -34.03 75.89 Favored 'General case' 0 CA--C 1.542 0.649 0 O-C-N 124.332 1.02 . . . . 65.13 111.106 -177.008 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 37' ' ' ARG . . . . . 0.423 ' HG3' ' OE1' ' A' ' 163' ' ' GLN . 48.9 ttp180 -59.94 -45.88 91.19 Favored 'General case' 0 N--CA 1.473 0.676 0 O-C-N 123.926 0.766 . . . . 73.31 111.374 175.277 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 38' ' ' ALA . . . . . 0.411 ' HB1' ' HG2' ' A' ' 44' ' ' LYS . . . -81.77 -18.84 42.75 Favored 'General case' 0 CA--C 1.537 0.477 0 CA-C-N 115.668 -0.696 . . . . 74.42 111.425 -174.374 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 39' ' ' LEU . . . . . 0.481 HD22 ' HE1' ' A' ' 48' ' ' TYR . 98.5 mt -74.26 -39.88 62.72 Favored 'General case' 0 CA--C 1.547 0.844 0 C-N-CA 123.312 0.645 . . . . 65.25 109.31 170.469 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 35.1 t -64.92 -55.03 21.71 Favored 'General case' 0 N--CA 1.477 0.877 0 C-N-CA 124.596 1.159 . . . . 54.5 111.155 -179.938 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 34.8 p -76.58 -31.37 57.46 Favored 'General case' 0 CA--C 1.541 0.607 0 CA-C-N 115.382 -0.826 . . . . 51.13 111.224 -178.289 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 79.23 22.1 66.05 Favored Glycine 0 C--N 1.346 1.139 0 CA-C-O 119.614 -0.548 . . . . 64.24 113.951 176.679 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 8.7 mm-40 -63.64 -22.41 66.88 Favored 'General case' 0 N--CA 1.483 1.221 0 C-N-CA 123.368 0.667 . . . . 72.01 111.728 179.857 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 44' ' ' LYS . . . . . 0.411 ' HG2' ' HB1' ' A' ' 38' ' ' ALA . 30.6 mmmt -94.6 15.33 18.32 Favored 'General case' 0 CA--C 1.55 0.947 0 C-N-CA 124.035 0.934 . . . . 74.34 111.558 -179.962 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 76.98 36.71 35.1 Favored Glycine 0 C--N 1.35 1.335 0 N-CA-C 114.417 0.527 . . . . 75.45 114.417 174.843 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 46' ' ' PHE . . . . . 0.435 ' HE2' ' HA ' ' A' ' 78' ' ' ILE . 25.2 m-85 -122.6 -48.35 2.05 Favored 'General case' 0 N--CA 1.491 1.575 0 CA-C-N 117.758 0.779 . . . . 75.02 111.514 -177.457 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 54.18 63.83 4.82 Favored Glycine 0 C--N 1.35 1.312 0 O-C-N 124.077 0.86 . . . . 54.51 115.018 170.218 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 48' ' ' TYR . . . . . 0.688 ' HE2' ' HB2' ' A' ' 66' ' ' ASP . 54.6 m-85 -65.27 89.79 0.09 Allowed 'General case' 0 N--CA 1.481 1.118 0 CA-C-O 121.745 0.783 . . . . 75.34 111.731 179.885 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 27.6 tptp -111.23 107.0 16.16 Favored 'General case' 0 CA--C 1.535 0.377 0 CA-C-N 114.576 -1.193 . . . . 62.14 108.476 178.247 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 99.08 13.8 38.33 Favored Glycine 0 N--CA 1.471 0.999 0 CA-C-O 118.992 -0.893 . . . . 54.41 113.763 178.754 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 20.3 p -57.67 122.89 13.86 Favored 'General case' 0 N--CA 1.48 1.035 0 C-N-CA 123.414 0.686 . . . . 60.21 110.818 -178.482 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 52' ' ' CYS . . . . . . . . . . . . . 7.0 p -100.98 132.37 46.42 Favored 'General case' 0 CA--C 1.539 0.533 0 C-N-CA 123.721 0.808 . . . . 55.13 112.729 -164.058 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 53' ' ' PHE . . . . . 0.604 ' HA ' ' HA3' ' A' ' 64' ' ' GLY . 45.5 m-85 -72.04 140.22 48.9 Favored 'General case' 0 CA--C 1.54 0.559 0 C-N-CA 124.381 1.072 . . . . 73.24 110.151 168.899 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 15.8 p-80 -153.4 13.55 0.49 Allowed 'General case' 0 N--CA 1.478 0.959 0 CA-C-N 116.087 -0.506 . . . . 62.15 112.213 -173.82 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 55' ' ' ARG . . . . . 0.451 ' HA ' ' O ' ' A' ' 150' ' ' GLY . 33.4 ttt180 -155.8 98.29 1.9 Allowed 'General case' 0 N--CA 1.474 0.728 0 N-CA-C 109.732 -0.47 . . . . 74.14 109.732 174.342 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 29.3 mt -130.23 135.88 59.86 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.105 0 C-N-CA 123.053 0.541 . . . . 75.1 109.799 -178.449 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 61.7 mt -134.58 124.55 17.03 Favored Pre-proline 0 CA--C 1.553 1.072 0 C-N-CA 124.976 1.31 . . . . 74.42 109.497 -173.454 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 31.0 Cg_endo -61.31 139.74 84.59 Favored 'Trans proline' 0 C--N 1.384 2.411 0 C-N-CA 123.609 2.873 . . . . 73.44 113.573 -179.452 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 60.22 24.55 61.24 Favored Glycine 0 C--N 1.353 1.504 0 CA-C-N 115.006 -0.997 . . . . 41.11 113.872 -179.813 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 40.5 t80 -139.76 -69.55 0.41 Allowed 'General case' 0 C--O 1.241 0.651 0 CA-C-N 116.973 0.386 . . . . 72.53 110.495 -174.583 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 53.3 ttp -171.44 148.34 2.53 Favored 'General case' 0 N--CA 1.482 1.151 0 N-CA-C 111.905 0.335 . . . . 65.45 111.905 -165.464 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 62' ' ' CYS . . . . . 0.611 ' SG ' ' HB ' ' A' ' 114' ' ' ILE . 21.9 p -119.81 117.58 28.57 Favored 'General case' 0 N--CA 1.477 0.89 0 C-N-CA 123.894 0.878 . . . . 65.23 108.974 169.591 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 63' ' ' GLN . . . . . 0.442 ' OE1' ' HD3' ' A' ' 55' ' ' ARG . 35.9 tt0 -123.24 143.92 49.73 Favored 'General case' 0 N--CA 1.487 1.42 0 C-N-CA 124.166 0.986 . . . . 73.03 111.781 -170.439 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 64' ' ' GLY . . . . . 0.604 ' HA3' ' HA ' ' A' ' 53' ' ' PHE . . . -161.78 -169.58 25.3 Favored Glycine 0 C--N 1.348 1.203 0 CA-C-N 115.039 -0.982 . . . . 52.33 113.011 176.403 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 166.4 -149.84 16.25 Favored Glycine 0 C--N 1.341 0.825 0 N-CA-C 112.242 -0.343 . . . . 44.21 112.242 -179.056 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 66' ' ' ASP . . . . . 0.688 ' HB2' ' HE2' ' A' ' 48' ' ' TYR . 41.2 t0 -74.94 146.4 41.8 Favored 'General case' 0 N--CA 1.477 0.919 0 C-N-CA 124.318 1.047 . . . . 64.22 110.601 -178.825 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 51.7 t80 -79.88 -33.69 39.8 Favored 'General case' 0 CA--C 1.542 0.673 0 C-N-CA 123.663 0.785 . . . . 61.21 109.46 178.043 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 68' ' ' THR . . . . . 0.637 HG22 ' HG3' ' A' ' 69' ' ' ARG . 14.1 m -72.56 150.59 43.01 Favored 'General case' 0 CA--C 1.544 0.748 0 CA-C-N 114.961 -1.018 . . . . 63.32 109.206 173.019 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 69' ' ' ARG . . . . . 0.637 ' HG3' HG22 ' A' ' 68' ' ' THR . 65.9 mtt85 66.71 13.68 9.46 Favored 'General case' 0 N--CA 1.488 1.438 0 C-N-CA 124.033 0.933 . . . . 73.32 112.296 174.921 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 15.9 t-80 -52.59 -29.1 24.06 Favored 'General case' 0 N--CA 1.484 1.253 0 C-N-CA 125.012 1.325 . . . . 74.44 112.007 -173.724 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 5.3 m-20 -69.28 88.2 0.44 Allowed 'General case' 0 CA--C 1.548 0.887 0 C-N-CA 123.987 0.915 . . . . 62.35 110.377 172.391 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 85.46 -1.2 88.47 Favored Glycine 0 CA--C 1.533 1.16 0 N-CA-C 115.195 0.838 . . . . 13.14 115.195 172.774 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 28.5 m -139.74 -90.74 0.18 Allowed 'General case' 0 N--CA 1.478 0.943 0 CA-C-N 118.06 0.93 . . . . 53.4 110.019 176.02 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 74' ' ' GLY . . . . . 0.464 ' HA2' ' O ' ' A' ' 68' ' ' THR . . . 61.32 60.65 7.93 Favored Glycine 0 C--N 1.356 1.668 0 O-C-N 123.577 0.548 . . . . 24.24 113.277 -176.905 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 141.36 52.19 0.04 OUTLIER Glycine 0 C--N 1.353 1.518 0 C-N-CA 121.101 -0.571 . . . . 73.22 113.055 -176.502 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 63.6 pttt -56.8 158.9 4.34 Favored 'General case' 0 N--CA 1.487 1.377 0 C-N-CA 123.406 0.682 . . . . 72.1 111.896 -179.881 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 71.8 p -98.29 -179.21 4.29 Favored 'General case' 0 CA--C 1.544 0.729 0 C-N-CA 123.338 0.655 . . . . 74.52 110.92 -176.214 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 78' ' ' ILE . . . . . 0.435 ' HA ' ' HE2' ' A' ' 46' ' ' PHE . 25.4 pt -84.96 -8.18 11.12 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.802 0 C-N-CA 122.936 0.494 . . . . 72.24 110.569 173.483 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 53.3 m-85 -103.87 12.42 34.44 Favored 'General case' 0 N--CA 1.472 0.669 0 C-N-CA 124.338 1.055 . . . . 64.43 110.361 -179.992 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 126.42 -134.62 8.62 Favored Glycine 0 C--N 1.348 1.211 0 N-CA-C 110.623 -0.991 . . . . 62.35 110.623 -179.113 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 36.7 tt0 -81.81 -45.66 15.26 Favored 'General case' 0 N--CA 1.47 0.53 0 N-CA-C 109.042 -0.725 . . . . 72.34 109.042 173.701 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 82' ' ' LYS . . . . . 0.799 ' HD2' ' HA ' ' A' ' 107' ' ' THR . 22.6 pttm -156.07 165.32 36.78 Favored 'General case' 0 CA--C 1.54 0.561 0 CA-C-N 114.217 -1.356 . . . . 74.4 110.096 -171.284 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 45.7 p90 -145.76 172.77 12.82 Favored 'General case' 0 N--CA 1.474 0.742 0 C-N-CA 124.177 0.991 . . . . 75.34 109.821 -178.663 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 12.2 pt-20 -91.9 159.73 15.62 Favored 'General case' 0 N--CA 1.472 0.666 0 C-N-CA 122.668 0.387 . . . . 62.45 110.614 178.722 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 62.5 m-20 -63.25 124.78 22.11 Favored 'General case' 0 N--CA 1.472 0.668 0 C-N-CA 123.621 0.768 . . . . 71.52 110.669 -179.767 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 62.1 tt0 -62.72 -48.28 79.91 Favored 'General case' 0 CA--C 1.54 0.566 0 CA-C-N 115.025 -0.989 . . . . 74.41 111.338 -178.95 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 31.9 p30 -161.65 -162.21 0.85 Allowed 'General case' 0 N--CA 1.474 0.759 0 C-N-CA 124.059 0.944 . . . . 75.24 108.517 -179.068 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 87.1 m-85 -142.16 46.14 1.64 Allowed 'General case' 0 N--CA 1.492 1.654 0 C-N-CA 123.043 0.537 . . . . 71.4 110.357 175.494 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 78.3 mt -69.59 -56.67 10.77 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.008 0 CA-C-N 115.764 -0.653 . . . . 42.14 109.882 176.111 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 90' ' ' LEU . . . . . 0.57 HD11 ' HB2' ' A' ' 25' ' ' PHE . 72.0 mt -87.42 126.69 35.03 Favored 'General case' 0 C--O 1.237 0.434 0 CA-C-N 115.045 -0.979 . . . . 54.12 109.751 -176.899 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 9.6 mtpm? -119.72 165.58 14.33 Favored 'General case' 0 CA--C 1.542 0.638 0 C-N-CA 124.194 0.998 . . . . 64.13 110.768 -175.291 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 92' ' ' HIS . . . . . . . . . . . . . 52.1 m-70 -83.73 51.31 1.99 Allowed 'General case' 0 N--CA 1.485 1.297 0 C-N-CA 124.478 1.111 . . . . 74.03 110.463 -177.326 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 11.6 t -95.94 13.39 27.06 Favored 'General case' 0 N--CA 1.48 1.036 0 C-N-CA 123.706 0.802 . . . . 73.35 112.242 -170.557 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -161.34 173.18 37.72 Favored Glycine 0 C--N 1.342 0.893 0 CA-C-O 120.027 -0.318 . . . . 64.43 112.524 179.618 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 98.6 Cg_endo -78.87 157.64 27.46 Favored 'Trans proline' 0 C--N 1.363 1.31 0 C-N-CA 122.68 2.253 . . . . 70.1 111.737 170.651 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 81.42 10.52 84.45 Favored Glycine 0 CA--C 1.533 1.171 0 CA-C-N 116.143 -0.481 . . . . 72.14 114.284 179.746 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 97' ' ' ILE . . . . . 0.579 ' HB ' ' HB2' ' A' ' 115' ' ' CYS . 9.8 mm -66.85 111.03 1.69 Allowed 'Isoleucine or valine' 0 CA--C 1.553 1.065 0 C-N-CA 124.36 1.064 . . . . 73.2 111.775 -176.56 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 98' ' ' LEU . . . . . 0.426 HD22 ' CG ' ' A' ' 22' ' ' PHE . 36.6 tp -92.09 113.98 26.39 Favored 'General case' 0 C--O 1.246 0.897 0 CA-C-O 121.257 0.551 . . . . 70.14 110.596 178.577 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 36.2 t -137.25 144.2 42.63 Favored 'General case' 0 CA--C 1.545 0.76 0 C-N-CA 124.395 1.078 . . . . 63.13 108.263 175.167 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 100' ' ' MET . . . . . 0.656 ' HA ' ' HA ' ' A' ' 112' ' ' PHE . 74.1 mtp -78.7 147.03 33.63 Favored 'General case' 0 N--CA 1.483 1.217 0 N-CA-C 109.168 -0.678 . . . . 53.21 109.168 175.316 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 101' ' ' ALA . . . . . 0.548 ' HB3' ' HB2' ' A' ' 111' ' ' GLN . . . -79.53 164.64 23.72 Favored 'General case' 0 N--CA 1.479 0.985 0 CA-C-O 121.399 0.619 . . . . 54.45 112.59 -169.875 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 24.2 p-10 -153.98 167.58 29.28 Favored 'General case' 0 N--CA 1.471 0.612 0 CA-C-N 114.82 -1.082 . . . . 71.35 110.071 -178.591 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -113.63 -7.12 13.35 Favored 'General case' 0 CA--C 1.544 0.747 0 C-N-CA 123.765 0.826 . . . . 72.41 110.02 167.56 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 171.5 -164.76 37.64 Favored Glycine 0 C--N 1.351 1.374 0 CA-C-O 119.399 -0.667 . . . . 44.33 111.555 -178.572 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 14.1 Cg_exo -70.69 143.06 45.35 Favored 'Trans proline' 0 C--N 1.37 1.658 0 C-N-CA 123.322 2.682 . . . . 73.2 111.856 177.952 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 64.4 t30 64.57 16.31 10.21 Favored 'General case' 0 N--CA 1.485 1.29 0 C-N-CA 125.131 1.372 . . . . 73.35 110.997 -177.174 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 107' ' ' THR . . . . . 0.799 ' HA ' ' HD2' ' A' ' 82' ' ' LYS . 4.6 m -117.26 5.48 12.66 Favored 'General case' 0 CA--C 1.547 0.828 0 C-N-CA 124.162 0.985 . . . . 70.23 110.042 -178.828 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 53.1 t30 -84.09 133.53 34.63 Favored 'General case' 0 N--CA 1.474 0.753 0 C-N-CA 123.867 0.867 . . . . 71.52 109.937 -176.842 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 113.12 10.39 15.84 Favored Glycine 0 N--CA 1.472 1.074 0 CA-C-O 120.203 -0.22 . . . . 72.23 113.181 -176.191 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 46.4 p -104.11 120.91 42.11 Favored 'General case' 0 CA--C 1.542 0.652 0 N-CA-C 107.48 -1.304 . . . . 72.3 107.48 166.383 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 111' ' ' GLN . . . . . 0.548 ' HB2' ' HB3' ' A' ' 101' ' ' ALA . 46.5 mt-30 66.9 178.01 0.23 Allowed 'General case' 0 N--CA 1.498 1.943 0 C-N-CA 124.567 1.147 . . . . 64.32 111.533 -172.929 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 112' ' ' PHE . . . . . 0.656 ' HA ' ' HA ' ' A' ' 100' ' ' MET . 45.2 p90 -143.74 161.45 38.56 Favored 'General case' 0 N--CA 1.473 0.708 0 C-N-CA 124.409 1.084 . . . . 64.04 108.874 173.273 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 113' ' ' PHE . . . . . 0.462 ' HE1' ' SG ' ' A' ' 115' ' ' CYS . 48.0 p90 -153.91 161.71 41.79 Favored 'General case' 0 N--CA 1.464 0.266 0 CA-C-O 121.354 0.597 . . . . 75.42 111.673 176.423 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 114' ' ' ILE . . . . . 0.611 ' HB ' ' SG ' ' A' ' 62' ' ' CYS . 15.6 mt -119.24 100.7 10.25 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.744 0 CA-C-N 114.31 -1.314 . . . . 64.41 107.577 175.184 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 115' ' ' CYS . . . . . 0.579 ' HB2' ' HB ' ' A' ' 97' ' ' ILE . 87.0 m -62.23 104.4 0.48 Allowed 'General case' 0 N--CA 1.474 0.769 0 N-CA-C 109.245 -0.65 . . . . 51.33 109.245 171.612 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 28.0 p -82.05 -0.19 43.33 Favored 'General case' 0 CA--C 1.547 0.853 0 C-N-CA 124.316 1.047 . . . . 73.11 111.609 -177.059 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -129.8 160.94 31.91 Favored 'General case' 0 C--O 1.245 0.834 0 C-N-CA 123.93 0.892 . . . . 41.34 109.608 169.471 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 10.3 ptmt -70.66 79.76 0.6 Allowed 'General case' 0 CA--C 1.546 0.82 0 CA-C-O 121.613 0.72 . . . . 50.23 109.418 171.123 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 119' ' ' THR . . . . . . . . . . . . . 36.6 p -72.35 87.05 1.13 Allowed 'General case' 0 CA--C 1.549 0.931 0 CA-C-O 122.013 0.911 . . . . 72.44 110.132 -176.161 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 9.5 pt-20 -72.8 -30.8 64.36 Favored 'General case' 0 N--CA 1.477 0.907 0 CA-C-N 114.611 -1.177 . . . . 73.05 112.307 -169.879 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 121' ' ' TRP . . . . . . . . . . . . . 41.4 p90 -68.39 -21.49 64.69 Favored 'General case' 0 CA--C 1.544 0.746 0 C-N-CA 122.965 0.506 . . . . 75.31 110.936 176.557 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 52.7 mt -83.41 0.36 46.45 Favored 'General case' 0 N--CA 1.482 1.139 0 C-N-CA 122.882 0.473 . . . . 42.23 112.254 177.768 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 62.7 m-20 -78.32 119.79 22.17 Favored 'General case' 0 CA--C 1.542 0.656 0 N-CA-C 109.082 -0.71 . . . . 74.35 109.082 172.728 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 111.02 -25.15 14.7 Favored Glycine 0 C--N 1.346 1.123 0 CA-C-N 115.589 -0.732 . . . . 74.43 111.279 -168.189 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 125' ' ' LYS . . . . . 0.655 ' HG3' ' H ' ' A' ' 126' ' ' HIS . 0.5 OUTLIER -77.32 -167.13 0.85 Allowed 'General case' 0 CA--C 1.568 1.641 0 C-N-CA 124.512 1.125 . . . . 61.14 107.984 170.997 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 126' ' ' HIS . . . . . 0.655 ' H ' ' HG3' ' A' ' 125' ' ' LYS . 0.0 OUTLIER -64.57 150.03 47.65 Favored 'General case' 0 C--O 1.248 0.996 0 C-N-CA 123.944 0.898 . . . . 74.24 112.93 -170.777 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 13.9 p -73.01 145.55 11.7 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.585 0 CA-C-N 114.354 -1.293 . . . . 64.54 111.906 -169.669 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 46.5 t -81.96 149.43 4.8 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.533 0 CA-C-N 114.379 -1.282 . . . . 74.12 108.616 172.41 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 129' ' ' PHE . . . . . 0.549 ' HA ' HG21 ' A' ' 29' ' ' VAL . 46.0 p90 -129.33 -9.1 4.7 Favored 'General case' 0 N--CA 1.481 1.086 0 CA-C-N 118.158 0.435 . . . . 72.41 111.753 179.611 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . -160.92 176.58 37.51 Favored Glycine 0 C--N 1.337 0.59 0 O-C-N 123.371 0.419 . . . . 73.23 112.67 -177.578 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 34.2 ttpt -151.47 135.86 16.89 Favored 'General case' 0 N--CA 1.467 0.415 0 N-CA-C 108.307 -0.997 . . . . 63.0 108.307 173.977 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 6.4 p -60.8 117.31 2.46 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.921 0 O-C-N 123.557 0.535 . . . . 74.44 110.661 178.568 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 133' ' ' LYS . . . . . 0.601 ' HD3' HG23 ' A' ' 5' ' ' THR . 22.3 ptmt -102.12 -14.93 16.87 Favored 'General case' 0 N--CA 1.481 1.124 0 C-N-CA 123.835 0.854 . . . . 75.31 110.609 -178.22 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 3.7 mm-40 -145.36 141.7 28.72 Favored 'General case' 0 N--CA 1.47 0.568 0 C-N-CA 123.11 0.564 . . . . 73.51 110.263 -177.808 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 135' ' ' GLY . . . . . 0.405 ' O ' HG23 ' A' ' 139' ' ' VAL . . . 71.75 26.47 72.78 Favored Glycine 0 C--N 1.338 0.645 0 O-C-N 123.797 0.686 . . . . 54.1 112.76 -174.384 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 136' ' ' MET . . . . . . . . . . . . . 7.0 tpt -60.58 -41.96 95.73 Favored 'General case' 0 N--CA 1.481 1.076 0 C-N-CA 123.379 0.672 . . . . 74.11 109.996 177.223 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 137' ' ' ASN . . . . . . . . . . . . . 12.4 m120 -62.95 -37.08 85.66 Favored 'General case' 0 N--CA 1.477 0.894 0 C-N-CA 123.68 0.792 . . . . 74.4 110.759 178.733 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 138' ' ' ILE . . . . . 0.53 ' O ' ' HG3' ' A' ' 142' ' ' MET . 49.6 mm -61.0 -51.16 76.43 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.809 0 C-N-CA 123.29 0.636 . . . . 74.51 109.663 175.922 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 139' ' ' VAL . . . . . 0.463 HG13 ' SG ' ' A' ' 62' ' ' CYS . 94.6 t -54.36 -47.0 70.06 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.138 0 C-N-CA 124.293 1.037 . . . . 74.42 111.454 179.859 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 38.2 mt-10 -67.24 -29.98 69.77 Favored 'General case' 0 N--CA 1.481 1.079 0 C-N-CA 123.689 0.796 . . . . 73.02 111.569 -179.222 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -77.59 -35.66 52.71 Favored 'General case' 0 N--CA 1.475 0.786 0 C-N-CA 122.938 0.495 . . . . 42.0 111.513 178.833 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 142' ' ' MET . . . . . 0.53 ' HG3' ' O ' ' A' ' 138' ' ' ILE . 45.3 mtp -80.52 -19.58 45.49 Favored 'General case' 0 N--CA 1.483 1.193 0 C-N-CA 122.693 0.397 . . . . 75.15 111.106 -178.935 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 24.8 tt0 -54.15 -35.15 61.94 Favored 'General case' 0 CA--C 1.55 0.974 0 C-N-CA 124.445 1.098 . . . . 52.14 110.847 168.452 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 144' ' ' ARG . . . . . . . . . . . . . 71.9 mtp180 -74.42 -11.91 60.36 Favored 'General case' 0 CA--C 1.542 0.636 0 C-N-CA 124.69 1.196 . . . . 63.44 112.067 -175.833 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 145' ' ' PHE . . . . . 0.46 ' HD2' ' HA ' ' A' ' 142' ' ' MET . 67.2 m-85 -90.94 -4.89 56.14 Favored 'General case' 0 N--CA 1.479 0.986 0 C-N-CA 122.816 0.446 . . . . 64.04 110.962 173.541 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . -91.76 173.92 37.18 Favored Glycine 0 C--N 1.343 0.939 0 CA-C-N 116.827 -0.17 . . . . 75.41 112.714 176.614 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 20.0 m -132.0 167.92 18.84 Favored 'General case' 0 N--CA 1.484 1.259 0 C-N-CA 124.054 0.942 . . . . 73.43 110.434 -177.491 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 148' ' ' ARG . . . . . . . . . . . . . 19.7 mmm180 -61.77 -32.22 72.47 Favored 'General case' 0 N--CA 1.484 1.235 0 C-N-CA 123.852 0.861 . . . . 52.32 112.246 -173.071 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 149' ' ' ASN . . . . . . . . . . . . . 30.6 p-10 -88.61 -7.2 56.81 Favored 'General case' 0 N--CA 1.483 1.191 0 C-N-CA 123.716 0.806 . . . . 62.13 111.83 -179.457 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 150' ' ' GLY . . . . . 0.451 ' O ' ' HA ' ' A' ' 55' ' ' ARG . . . 105.29 -3.04 40.21 Favored Glycine 0 C--N 1.34 0.797 0 CA-C-O 119.85 -0.417 . . . . 74.13 113.421 -178.331 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 84.8 tttt -63.84 112.56 2.95 Favored 'General case' 0 N--CA 1.472 0.626 0 CA-C-O 121.229 0.537 . . . . 73.24 109.796 -179.212 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 152' ' ' THR . . . . . . . . . . . . . 9.1 m -94.21 109.51 21.31 Favored 'General case' 0 CA--C 1.541 0.604 0 N-CA-C 108.17 -1.048 . . . . 74.22 108.17 179.542 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 153' ' ' SER . . . . . . . . . . . . . 16.0 m -59.32 -35.5 73.93 Favored 'General case' 0 N--CA 1.478 0.941 0 C-N-CA 124.914 1.285 . . . . 71.43 112.164 -174.965 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 74.9 mmtt -109.98 137.04 48.31 Favored 'General case' 0 N--CA 1.467 0.379 0 C-N-CA 123.895 0.878 . . . . 74.3 109.236 -177.475 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 16.7 tppt? -77.52 91.03 3.9 Favored 'General case' 0 CA--C 1.534 0.341 0 N-CA-C 108.418 -0.956 . . . . 73.35 108.418 176.215 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 156' ' ' ILE . . . . . 0.539 ' HB ' ' HB2' ' A' ' 53' ' ' PHE . 85.6 mt -84.93 130.25 36.38 Favored 'Isoleucine or valine' 0 C--O 1.221 -0.446 0 CA-C-N 115.126 -0.943 . . . . 71.55 108.726 -175.383 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 157' ' ' THR . . . . . . . . . . . . . 32.3 p -130.55 155.39 46.59 Favored 'General case' 0 N--CA 1.476 0.867 0 C-N-CA 123.922 0.889 . . . . 52.44 109.934 -176.03 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 158' ' ' ILE . . . . . 0.429 HG23 ' HB3' ' A' ' 8' ' ' PHE . 23.3 mt -88.76 95.3 5.25 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.641 0 N-CA-C 108.598 -0.89 . . . . 72.43 108.598 171.643 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 159' ' ' ALA . . . . . 0.407 ' HB2' ' HB2' ' A' ' 11' ' ' ALA . . . -59.72 -33.37 71.55 Favored 'General case' 0 N--CA 1.474 0.729 0 C-N-CA 124.102 0.961 . . . . 75.32 113.023 -175.267 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 160' ' ' ASP . . . . . . . . . . . . . 1.7 t70 -159.34 170.83 20.97 Favored 'General case' 0 N--CA 1.483 1.206 0 CA-C-O 120.765 0.316 . . . . 75.41 111.496 -175.285 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 161' ' ' CYS . . . . . . . . . . . . . 19.9 p -139.02 -168.83 2.51 Favored 'General case' 0 N--CA 1.481 1.118 0 C-N-CA 125.305 1.442 . . . . 72.25 108.553 -179.463 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 162' ' ' GLY . . . . . . . . . . . . . . . 135.56 56.45 0.06 OUTLIER Glycine 0 N--CA 1.48 1.591 0 CA-C-N 119.294 0.952 . . . . 72.45 113.562 -170.735 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 163' ' ' GLN . . . . . 0.45 ' HA ' ' H ' ' A' ' 7' ' ' PHE . 49.3 tt0 -44.42 119.87 2.01 Favored 'General case' 0 N--CA 1.484 1.23 0 C-N-CA 125.336 1.454 . . . . 53.31 113.069 -178.44 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 164' ' ' LEU . . . . . 0.489 ' O ' ' HB ' ' A' ' 5' ' ' THR . 97.8 mt -91.24 107.96 19.56 Favored 'General case' 0 CA--C 1.536 0.43 0 CA-C-N 115.123 -0.944 . . . . 75.15 110.306 -176.591 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 165' ' ' GLU . . . . . . . . . . . . . 4.4 pt-20 . . . . . 0 CA--C 1.552 1.049 0 N-CA-C 109.196 -0.668 . . . . 73.44 109.196 175.63 . . . . . . . . 0 0 . 1 . 017 nuclear build full ' B' B ' 216' ' ' PRO . . . . . . . . . . . . . 16.6 Cg_exo . . . . . 0 N--CA 1.489 1.249 0 N-CA-C 110.784 -0.506 . . . . 60.12 110.784 . . . . . . . . . 0 0 . 1 . 017 nuclear build full ' B' B ' 217' ' ' GLU . . . . . . . . . . . . . 39.3 tt0 -142.25 105.88 5.61 Favored Pre-proline 0 CA--C 1.546 0.798 0 N-CA-C 108.272 -1.01 . . . . 51.43 108.272 -175.291 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 218' ' ' PRO . . . . . . . . . . . . . 26.3 Cg_exo -63.2 105.37 0.47 Allowed 'Trans proline' 0 C--N 1.381 2.278 0 C-N-CA 122.73 2.287 . . . . 65.22 111.732 -179.906 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 219' ' ' GLY . . . . . . . . . . . . . . . 177.95 163.97 30.47 Favored Glycine 0 CA--C 1.525 0.674 0 CA-C-N 115.612 -0.722 . . . . 75.54 112.407 -179.844 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 220' ' ' PRO . . . . . . . . . . . . . 24.5 Cg_exo -68.09 157.65 60.87 Favored 'Trans proline' 0 N--CA 1.489 1.254 0 C-N-CA 123.5 2.8 . . . . 75.1 113.264 175.612 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 221' ' ' TYR . . . . . . . . . . . . . 78.4 m-85 -86.59 139.2 31.05 Favored 'General case' 0 N--CA 1.476 0.844 0 C-N-CA 123.365 0.666 . . . . 72.04 110.04 179.988 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 222' ' ' ALA . . . . . . . . . . . . . . . -103.83 -173.31 2.28 Favored 'General case' 0 N--CA 1.473 0.717 0 C-N-CA 123.934 0.894 . . . . 63.45 113.15 -167.734 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 223' ' ' GLN . . . . . . . . . . . . . 24.2 pt20 -95.71 108.38 39.76 Favored Pre-proline 0 CA--C 1.56 1.36 0 CA-C-N 114.121 -1.4 . . . . 75.2 108.974 170.14 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 224' ' ' PRO . . . . . . . . . . . . . 24.0 Cg_exo . . . . . 0 C--N 1.373 1.849 0 C-N-CA 122.863 2.376 . . . . 74.54 112.131 177.524 . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 N--CA 1.476 0.863 0 N-CA-C 109.165 -0.68 . . . . 73.41 109.165 . . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 9.9 p -79.46 -25.58 12.54 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.948 0 C-N-CA 123.752 0.821 . . . . 72.41 111.759 -170.9 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 79.2 m-20 -95.79 109.28 45.41 Favored Pre-proline 0 CA--C 1.548 0.884 0 C-N-CA 123.544 0.738 . . . . 74.23 110.895 -175.123 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 4' ' ' PRO . . . . . 0.49 ' HG2' ' HB2' ' A' ' 24' ' ' LEU . 16.1 Cg_endo -56.39 147.12 69.78 Favored 'Trans proline' 0 C--N 1.386 2.504 0 C-N-CA 123.51 2.807 . . . . 64.41 114.276 179.111 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 5' ' ' THR . . . . . 0.521 HG23 ' HD3' ' A' ' 133' ' ' LYS . 86.6 m -98.52 116.82 31.58 Favored 'General case' 0 CA--C 1.542 0.637 0 C-N-CA 124.903 1.281 . . . . 73.42 108.56 178.271 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 6' ' ' VAL . . . . . 0.454 ' HA ' ' HG3' ' A' ' 163' ' ' GLN . 28.6 t -99.42 119.93 48.11 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.737 0 N-CA-C 108.358 -0.978 . . . . 60.41 108.358 178.784 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 7' ' ' PHE . . . . . 0.573 ' H ' ' HA ' ' A' ' 163' ' ' GLN . 75.7 t80 -100.76 131.17 46.78 Favored 'General case' 0 C--N 1.324 -0.539 0 N-CA-C 109.439 -0.578 . . . . 75.4 109.439 -176.712 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 8' ' ' PHE . . . . . 0.48 ' HD2' ' HE2' ' A' ' 22' ' ' PHE . 46.7 m-85 -133.74 165.07 25.81 Favored 'General case' 0 C--O 1.241 0.65 0 C-N-CA 124.584 1.153 . . . . 74.02 108.949 167.095 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 9' ' ' ASP . . . . . 0.47 ' HB2' ' HB3' ' A' ' 159' ' ' ALA . 27.9 m-20 -112.94 112.62 24.21 Favored 'General case' 0 C--N 1.318 -0.79 0 N-CA-C 106.337 -1.727 . . . . 70.34 106.337 170.422 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 10' ' ' ILE . . . . . 0.425 HG21 ' SD ' ' A' ' 142' ' ' MET . 43.5 mm -81.51 125.12 39.55 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.213 0 N-CA-C 108.695 -0.854 . . . . 71.42 108.695 -179.995 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 11' ' ' ALA . . . . . 0.641 ' HB2' ' HB2' ' A' ' 159' ' ' ALA . . . -121.76 123.54 42.07 Favored 'General case' 0 C--O 1.213 -0.847 0 C-N-CA 124.403 1.081 . . . . 73.43 110.247 -171.405 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 12' ' ' VAL . . . . . 0.42 HG22 HG12 ' A' ' 156' ' ' ILE . 67.9 t -99.24 131.36 46.68 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.653 0 N-CA-C 107.844 -1.169 . . . . 65.11 107.844 173.515 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 23.1 m-20 67.87 17.58 9.67 Favored 'General case' 0 N--CA 1.491 1.621 0 C-N-CA 124.418 1.087 . . . . 71.11 110.582 -173.577 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 82.75 -9.3 59.85 Favored Glycine 0 C--N 1.351 1.364 0 CA-C-O 119.907 -0.385 . . . . 72.23 113.131 -171.27 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 37.6 mm-40 -97.35 127.48 38.04 Favored Pre-proline 0 CA--C 1.548 0.888 0 C-N-CA 124.329 1.052 . . . . 73.43 110.209 -178.127 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 18.6 Cg_endo -55.28 112.5 1.06 Allowed 'Trans proline' 0 C--N 1.381 2.282 0 C-N-CA 123.75 2.967 . . . . 70.23 113.483 -172.995 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 17' ' ' LEU . . . . . 0.506 HD23 HG23 ' A' ' 138' ' ' ILE . 40.0 tp -79.33 -40.55 30.03 Favored 'General case' 0 N--CA 1.476 0.87 0 C-N-CA 123.469 0.708 . . . . 64.15 110.087 174.704 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -176.04 -179.36 46.48 Favored Glycine 0 C--N 1.348 1.206 0 CA-C-N 116.212 -0.449 . . . . 52.11 113.286 -179.813 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 30.5 mtp85 -107.69 125.48 51.42 Favored 'General case' 0 N--CA 1.475 0.792 0 C-N-CA 124.46 1.104 . . . . 74.13 109.142 -176.967 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 71.9 t -126.0 142.61 42.17 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.804 0 C-N-CA 124.13 0.972 . . . . 71.05 109.684 -177.903 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 21' ' ' SER . . . . . 0.48 ' HB2' ' HB2' ' A' ' 134' ' ' GLU . 49.4 m -130.64 134.69 47.17 Favored 'General case' 0 CA--C 1.539 0.539 0 C-N-CA 123.579 0.752 . . . . 55.02 109.556 173.447 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 22' ' ' PHE . . . . . 0.48 ' HE2' ' HD2' ' A' ' 8' ' ' PHE . 73.3 m-85 -100.49 170.28 8.5 Favored 'General case' 0 N--CA 1.467 0.389 0 C-N-CA 125.039 1.336 . . . . 72.22 108.945 175.32 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 23' ' ' GLU . . . . . 0.531 ' HB2' ' HD2' ' A' ' 133' ' ' LYS . 35.5 tt0 -137.07 107.15 6.33 Favored 'General case' 0 CA--C 1.539 0.523 0 C-N-CA 122.98 0.512 . . . . 71.14 109.674 -178.608 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 24' ' ' LEU . . . . . 0.49 ' HB2' ' HG2' ' A' ' 4' ' ' PRO . 25.5 mt -87.23 126.83 35.06 Favored 'General case' 0 N--CA 1.476 0.83 0 C-N-CA 123.347 0.659 . . . . 64.41 110.531 -175.734 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 50.9 m-85 -86.21 67.17 9.87 Favored 'General case' 0 CA--C 1.54 0.594 0 C-N-CA 123.905 0.882 . . . . 75.32 109.267 178.51 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -66.83 -18.32 65.32 Favored 'General case' 0 N--CA 1.48 1.059 0 C-N-CA 124.323 1.049 . . . . 75.01 112.923 -173.271 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 12.9 p-10 -79.01 -32.01 44.92 Favored 'General case' 0 CA--C 1.546 0.804 0 C-N-CA 123.441 0.696 . . . . 74.32 110.672 176.258 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 97.9 mttt -89.94 -41.93 11.48 Favored 'General case' 0 N--CA 1.478 0.933 0 C-N-CA 123.69 0.796 . . . . 65.23 111.066 -175.703 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 29' ' ' VAL . . . . . 0.499 HG21 ' HA ' ' A' ' 129' ' ' PHE . 17.0 m -137.81 70.24 50.9 Favored Pre-proline 0 CA--C 1.561 1.374 0 C-N-CA 123.879 0.872 . . . . 52.43 110.096 -172.939 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 27.6 Cg_exo -60.93 -35.66 86.96 Favored 'Trans proline' 0 C--N 1.38 2.197 0 C-N-CA 123.169 2.58 . . . . 72.44 113.599 -170.727 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 22.9 ttmm -59.83 -61.11 2.85 Favored 'General case' 0 N--CA 1.475 0.782 0 C-N-CA 123.617 0.767 . . . . 65.43 111.725 -178.398 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 3.6 m -74.37 -27.53 60.7 Favored 'General case' 0 CA--C 1.553 1.077 0 CA-C-N 115.235 -0.893 . . . . 73.13 111.242 -171.059 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -74.2 -52.44 12.43 Favored 'General case' 0 CA--C 1.549 0.933 0 C-N-CA 122.774 0.43 . . . . 73.23 111.109 177.061 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 27.5 tt0 -61.14 -31.29 71.01 Favored 'General case' 0 N--CA 1.491 1.612 0 C-N-CA 123.305 0.642 . . . . 73.3 110.763 179.1 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 35' ' ' ASN . . . . . 0.519 ' O ' ' HG ' ' A' ' 39' ' ' LEU . 45.1 t30 -54.1 -66.55 0.38 Allowed 'General case' 0 C--N 1.354 0.797 0 O-C-N 123.97 0.794 . . . . 54.24 109.47 175.395 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 74.1 t80 -56.95 -38.2 72.62 Favored 'General case' 0 N--CA 1.479 1.011 0 C-N-CA 124.716 1.206 . . . . 70.4 111.51 -175.941 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 14.0 ttm180 -55.24 -58.33 8.14 Favored 'General case' 0 C--N 1.353 0.759 0 CA-C-N 115.372 -0.831 . . . . 74.34 110.331 173.957 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 38' ' ' ALA . . . . . 0.435 ' HB1' ' HG2' ' A' ' 44' ' ' LYS . . . -74.11 -18.92 60.74 Favored 'General case' 0 N--CA 1.468 0.452 0 C-N-CA 123.785 0.834 . . . . 74.51 111.899 -171.782 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 39' ' ' LEU . . . . . 0.639 HD22 ' HE2' ' A' ' 48' ' ' TYR . 43.3 mt -71.58 -46.64 58.75 Favored 'General case' 0 CA--C 1.538 0.517 0 N-CA-C 109.371 -0.603 . . . . 72.02 109.371 173.229 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 33.7 t -68.5 -56.8 7.13 Favored 'General case' 0 CA--C 1.547 0.861 0 C-N-CA 123.797 0.839 . . . . 74.31 111.411 -179.433 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 41' ' ' THR . . . . . 0.406 ' OG1' ' HG2' ' A' ' 43' ' ' GLU . 71.6 p -76.62 -31.03 57.16 Favored 'General case' 0 N--CA 1.471 0.619 0 C-N-CA 124.075 0.95 . . . . 73.02 111.442 -174.012 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 85.74 31.92 19.85 Favored Glycine 0 C--N 1.349 1.261 0 CA-C-O 119.908 -0.384 . . . . 50.31 113.101 -179.022 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 43' ' ' GLU . . . . . 0.406 ' HG2' ' OG1' ' A' ' 41' ' ' THR . 24.5 mm-40 -66.12 -27.87 68.38 Favored 'General case' 0 N--CA 1.483 1.187 0 C-N-CA 122.706 0.402 . . . . 64.33 111.665 176.709 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 44' ' ' LYS . . . . . 0.435 ' HG2' ' HB1' ' A' ' 38' ' ' ALA . 33.3 mmtp -105.95 18.6 21.85 Favored 'General case' 0 N--CA 1.484 1.269 0 C-N-CA 122.992 0.517 . . . . 72.35 110.645 175.405 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 79.23 48.39 6.91 Favored Glycine 0 C--N 1.352 1.43 0 N-CA-C 114.803 0.681 . . . . 75.02 114.803 169.279 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 46' ' ' PHE . . . . . 0.493 ' HE2' ' HA ' ' A' ' 78' ' ' ILE . 25.1 m-85 -130.08 -50.79 1.12 Allowed 'General case' 0 N--CA 1.49 1.545 0 CA-C-N 118.021 0.911 . . . . 75.1 111.399 -178.557 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 47.87 53.97 12.76 Favored Glycine 0 C--N 1.354 1.547 0 O-C-N 124.593 1.183 . . . . 75.14 114.687 176.17 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 48' ' ' TYR . . . . . 0.639 ' HE2' HD22 ' A' ' 39' ' ' LEU . 33.5 m-85 -61.55 95.47 0.05 Allowed 'General case' 0 N--CA 1.479 1.001 0 C-N-CA 123.28 0.632 . . . . 65.31 111.487 -177.803 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 46.9 tptt -98.48 102.42 14.15 Favored 'General case' 0 CA--C 1.537 0.447 0 CA-C-N 114.866 -1.061 . . . . 55.11 108.925 -175.65 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 50' ' ' GLY . . . . . 0.43 ' HA2' ' O ' ' A' ' 158' ' ' ILE . . . 110.62 22.66 6.27 Favored Glycine 0 C--N 1.346 1.117 0 CA-C-O 119.362 -0.688 . . . . 74.32 114.651 173.647 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 51' ' ' SER . . . . . 0.42 ' HB2' HD12 ' A' ' 158' ' ' ILE . 19.3 m -53.43 128.35 28.35 Favored 'General case' 0 N--CA 1.484 1.268 0 C-N-CA 123.732 0.813 . . . . 72.12 111.175 178.005 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 52' ' ' CYS . . . . . 0.53 ' HA ' ' HA ' ' A' ' 157' ' ' THR . 19.4 p -103.25 133.83 47.67 Favored 'General case' 0 N--CA 1.478 0.937 0 N-CA-C 112.59 0.589 . . . . 63.23 112.59 -168.282 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 53' ' ' PHE . . . . . 0.684 ' HA ' ' HA2' ' A' ' 64' ' ' GLY . 79.4 m-85 -74.05 102.62 4.25 Favored 'General case' 0 N--CA 1.472 0.661 0 C-N-CA 124.069 0.948 . . . . 74.4 108.665 166.206 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 16.5 p-80 -114.82 -12.93 12.04 Favored 'General case' 0 N--CA 1.481 1.094 0 C-N-CA 123.603 0.761 . . . . 61.23 112.006 -173.316 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 36.1 ttt180 -128.39 100.82 5.95 Favored 'General case' 0 C--O 1.217 -0.618 0 C-N-CA 122.884 0.474 . . . . 65.21 109.75 179.13 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 57.9 mt -128.96 125.4 62.82 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.96 0 C-N-CA 122.905 0.482 . . . . 65.53 110.126 178.375 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 54.7 mt -116.48 114.25 40.38 Favored Pre-proline 0 CA--C 1.557 1.217 0 C-N-CA 124.367 1.067 . . . . 52.1 109.162 178.228 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 31.8 Cg_exo -60.32 129.88 31.66 Favored 'Trans proline' 0 C--N 1.387 2.582 0 C-N-CA 123.704 2.936 . . . . 71.24 112.61 178.103 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 81.26 26.17 52.82 Favored Glycine 0 C--N 1.341 0.807 0 O-C-N 123.778 0.674 . . . . 52.44 112.661 -176.113 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 60' ' ' PHE . . . . . 0.508 ' HB2' HE21 ' B' ' 223' ' ' GLN . 23.1 t80 -151.88 -75.99 0.13 Allowed 'General case' 0 C--O 1.247 0.933 0 C-N-CA 123.016 0.526 . . . . 74.42 110.685 179.712 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 61' ' ' MET . . . . . 0.481 ' HA ' ' H ' ' A' ' 116' ' ' THR . 22.9 ptt? -165.35 163.62 19.87 Favored 'General case' 0 N--CA 1.485 1.305 0 N-CA-C 112.813 0.672 . . . . 70.31 112.813 -174.528 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 62' ' ' CYS . . . . . 0.464 ' SG ' ' HB ' ' A' ' 114' ' ' ILE . 20.5 p -115.59 111.68 21.03 Favored 'General case' 0 CA--C 1.545 0.766 0 C-N-CA 124.253 1.021 . . . . 65.44 108.933 168.572 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 63' ' ' GLN . . . . . 0.561 ' HA ' ' HA ' ' A' ' 113' ' ' PHE . 52.1 tt0 -102.74 116.73 33.16 Favored 'General case' 0 N--CA 1.479 1.014 0 C-N-CA 124.019 0.928 . . . . 74.11 110.877 -174.955 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 64' ' ' GLY . . . . . 0.684 ' HA2' ' HA ' ' A' ' 53' ' ' PHE . . . -92.36 173.19 35.48 Favored Glycine 0 C--N 1.342 0.896 0 CA-C-N 115.221 -0.899 . . . . 72.13 112.284 171.362 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 174.29 150.46 7.69 Favored Glycine 0 C--O 1.238 0.344 0 N-CA-C 110.504 -1.038 . . . . 71.41 110.504 179.379 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 38.8 t70 -79.75 162.0 25.41 Favored 'General case' 0 CA--C 1.547 0.865 0 CA-C-O 121.608 0.718 . . . . 63.02 112.658 -169.804 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 55.0 t80 -79.95 -40.59 27.73 Favored 'General case' 0 CA--C 1.548 0.871 0 C-N-CA 124.701 1.2 . . . . 73.3 111.678 -177.281 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 25.3 m -61.16 112.68 2.21 Favored 'General case' 0 N--CA 1.479 0.979 0 C-N-CA 123.757 0.823 . . . . 71.44 111.681 -172.673 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 36.3 ttm180 55.83 77.03 0.25 Allowed 'General case' 0 N--CA 1.48 1.035 0 C-N-CA 124.852 1.261 . . . . 74.43 111.19 -178.877 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 12.2 t60 -79.16 -14.55 59.02 Favored 'General case' 0 CA--C 1.546 0.79 0 CA-C-N 115.261 -0.881 . . . . 71.23 110.806 -179.559 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 16.8 m120 -55.97 93.36 0.01 OUTLIER 'General case' 0 N--CA 1.485 1.279 0 C-N-CA 124.211 1.004 . . . . 74.44 110.723 178.18 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 70.18 11.25 67.05 Favored Glycine 0 C--N 1.351 1.4 0 CA-C-N 115.45 -0.795 . . . . 73.53 114.904 176.071 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 21.0 m -143.25 -83.62 0.16 Allowed 'General case' 0 CA--C 1.553 1.075 0 CA-C-N 117.663 0.731 . . . . 63.34 110.634 -178.578 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 64.4 59.22 8.6 Favored Glycine 0 C--N 1.357 1.731 0 O-C-N 123.301 0.376 . . . . 63.35 113.117 -177.008 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 134.6 49.07 0.08 OUTLIER Glycine 0 C--N 1.35 1.359 0 CA-C-N 117.05 0.425 . . . . 43.2 112.475 -176.135 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 14.0 ptmm? -65.59 159.91 23.66 Favored 'General case' 0 N--CA 1.484 1.243 0 C-N-CA 123.64 0.776 . . . . 75.04 111.454 -178.683 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 79.6 p -105.86 -175.65 2.85 Favored 'General case' 0 N--CA 1.481 1.095 0 N-CA-C 112.666 0.617 . . . . 65.44 112.666 -162.897 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 78' ' ' ILE . . . . . 0.493 ' HA ' ' HE2' ' A' ' 46' ' ' PHE . 44.3 pt -70.79 -21.08 22.38 Favored 'Isoleucine or valine' 0 C--N 1.358 0.971 0 CA-C-N 115.595 -0.73 . . . . 65.34 111.254 176.447 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 98.9 m-85 -88.66 33.83 0.77 Allowed 'General case' 0 N--CA 1.475 0.778 0 C-N-CA 123.83 0.852 . . . . 52.34 109.736 173.564 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 70.23 -99.16 0.69 Allowed Glycine 0 C--N 1.351 1.399 0 CA-C-N 115.403 -0.817 . . . . 74.03 111.604 -176.744 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 42.8 tt0 -73.03 -60.22 2.34 Favored 'General case' 0 CA--C 1.544 0.744 0 C-N-CA 123.956 0.902 . . . . 63.44 110.652 -176.498 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 82' ' ' LYS . . . . . 0.75 ' HD2' ' HA ' ' A' ' 107' ' ' THR . 18.8 pttp -169.2 177.37 4.83 Favored 'General case' 0 N--CA 1.482 1.148 0 C-N-CA 123.11 0.564 . . . . 64.14 111.162 -169.721 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 51.6 p90 -156.19 174.93 14.65 Favored 'General case' 0 N--CA 1.478 0.959 0 C-N-CA 124.204 1.002 . . . . 72.11 110.852 -177.574 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 13.5 pt-20 -102.76 162.96 12.5 Favored 'General case' 0 N--CA 1.481 1.117 0 C-N-CA 123.223 0.609 . . . . 71.35 110.872 177.233 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 85' ' ' ASP . . . . . 0.469 ' HB3' HG23 ' A' ' 127' ' ' VAL . 48.0 m-20 -64.71 130.63 44.29 Favored 'General case' 0 N--CA 1.478 0.926 0 CA-C-N 115.687 -0.688 . . . . 74.31 111.276 -179.993 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 9.3 tp10 -69.12 -61.36 1.82 Allowed 'General case' 0 N--CA 1.474 0.747 0 O-C-N 123.57 0.544 . . . . 72.13 111.102 -178.836 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 24.3 p-10 -161.2 127.89 3.98 Favored 'General case' 0 N--CA 1.477 0.887 0 C-N-CA 123.054 0.541 . . . . 75.12 110.325 -171.891 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 86.4 m-85 -88.58 74.11 8.52 Favored 'General case' 0 N--CA 1.476 0.85 0 CA-C-O 121.533 0.682 . . . . 74.15 110.18 -171.727 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 65.1 mt -88.87 -60.27 2.38 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.637 0 CA-C-N 115.221 -0.9 . . . . 70.12 108.998 173.453 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 67.4 mt -85.36 131.13 34.45 Favored 'General case' 0 C--O 1.241 0.626 0 CA-C-N 114.372 -1.286 . . . . 60.54 110.392 -173.05 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 32.2 mtmm -122.46 169.11 11.32 Favored 'General case' 0 N--CA 1.47 0.55 0 C-N-CA 124.933 1.293 . . . . 75.23 109.479 -174.485 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 92' ' ' HIS . . . . . . . . . . . . . 20.7 m-70 -91.95 36.83 0.97 Allowed 'General case' 0 N--CA 1.481 1.105 0 C-N-CA 123.992 0.917 . . . . 72.11 110.852 -170.79 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 80.7 p -67.92 -26.08 65.8 Favored 'General case' 0 N--CA 1.474 0.725 0 C-N-CA 124.387 1.075 . . . . 75.51 112.226 -170.935 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -124.88 175.6 17.17 Favored Glycine 0 C--N 1.344 1.007 0 O-C-N 123.232 0.332 . . . . 72.31 113.221 -177.067 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 93.0 Cg_endo -80.89 157.49 20.89 Favored 'Trans proline' 0 C--N 1.367 1.546 0 C-N-CA 123.046 2.498 . . . . 53.41 111.395 169.484 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 89.36 -0.71 81.34 Favored Glycine 0 N--CA 1.472 1.039 0 CA-C-N 116.27 -0.423 . . . . 34.4 112.971 -177.206 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 97' ' ' ILE . . . . . 0.44 ' HB ' ' HB2' ' A' ' 115' ' ' CYS . 13.9 mm -66.94 114.07 3.5 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.949 0 C-N-CA 124.041 0.936 . . . . 60.32 111.466 -176.591 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 98' ' ' LEU . . . . . 0.489 HD13 HG12 ' A' ' 114' ' ' ILE . 67.2 tp -102.28 113.11 26.13 Favored 'General case' 0 CA--C 1.551 0.999 0 C-N-CA 123.489 0.716 . . . . 74.51 109.761 177.827 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 42.6 t -131.44 168.77 17.04 Favored 'General case' 0 N--CA 1.479 0.978 0 C-N-CA 124.95 1.3 . . . . 71.14 108.296 176.533 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 100' ' ' MET . . . . . 0.505 ' HA ' ' HA ' ' A' ' 112' ' ' PHE . 44.4 mtp -101.62 146.59 27.49 Favored 'General case' 0 N--CA 1.491 1.604 0 CA-C-N 118.596 0.635 . . . . 62.12 110.482 -176.639 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 101' ' ' ALA . . . . . 0.553 ' HB3' ' HB2' ' A' ' 111' ' ' GLN . . . -85.49 167.58 15.32 Favored 'General case' 0 N--CA 1.482 1.151 0 C-N-CA 123.202 0.601 . . . . 64.33 111.174 -175.649 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 102' ' ' ASN . . . . . 0.593 ' HB3' ' HA ' ' A' ' 108' ' ' ASN . 29.4 p-10 -169.9 170.93 7.46 Favored 'General case' 0 N--CA 1.478 0.961 0 C-N-CA 122.829 0.451 . . . . 63.23 111.996 -177.111 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 103' ' ' ALA . . . . . 0.476 ' HB3' HG21 ' A' ' 107' ' ' THR . . . -99.59 -22.1 15.59 Favored 'General case' 0 CA--C 1.547 0.865 0 CA-C-N 115.377 -0.829 . . . . 44.03 111.142 171.55 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -178.15 -177.0 46.56 Favored Glycine 0 C--N 1.357 1.696 0 CA-C-O 119.467 -0.629 . . . . 53.55 113.053 -178.134 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 32.4 Cg_exo -58.62 136.52 74.55 Favored 'Trans proline' 0 C--N 1.375 1.948 0 C-N-CA 122.791 2.327 . . . . 75.42 112.908 175.002 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 66.6 t30 69.72 9.94 7.38 Favored 'General case' 0 N--CA 1.486 1.354 0 C-N-CA 124.805 1.242 . . . . 75.13 111.639 -176.459 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 107' ' ' THR . . . . . 0.75 ' HA ' ' HD2' ' A' ' 82' ' ' LYS . 3.9 m -109.96 5.16 22.11 Favored 'General case' 0 CA--C 1.553 1.087 0 C-N-CA 124.093 0.957 . . . . 71.34 110.305 178.301 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 108' ' ' ASN . . . . . 0.593 ' HA ' ' HB3' ' A' ' 102' ' ' ASN . 66.4 t30 -80.93 154.36 27.04 Favored 'General case' 0 N--CA 1.478 0.97 0 C-N-CA 123.467 0.707 . . . . 71.53 111.3 -173.772 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 106.36 -3.47 37.4 Favored Glycine 0 N--CA 1.467 0.725 0 CA-C-O 119.966 -0.352 . . . . 54.14 112.7 -178.394 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 41.1 p -91.29 119.23 31.16 Favored 'General case' 0 CA--C 1.54 0.563 0 N-CA-C 108.11 -1.07 . . . . 70.02 108.11 170.329 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 111' ' ' GLN . . . . . 0.572 HE22 ' HG2' ' B' ' 218' ' ' PRO . 35.7 mt-30 66.75 173.19 0.25 Allowed 'General case' 0 N--CA 1.496 1.857 0 C-N-CA 124.208 1.003 . . . . 73.53 112.093 -177.919 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 112' ' ' PHE . . . . . 0.505 ' HA ' ' HA ' ' A' ' 100' ' ' MET . 32.6 p90 -143.69 133.72 24.18 Favored 'General case' 0 N--CA 1.474 0.737 0 C-N-CA 123.879 0.871 . . . . 72.15 108.963 177.983 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 113' ' ' PHE . . . . . 0.561 ' HA ' ' HA ' ' A' ' 63' ' ' GLN . 52.2 p90 -116.52 142.06 47.37 Favored 'General case' 0 C--O 1.24 0.603 0 C-N-CA 123.342 0.657 . . . . 74.33 110.595 176.497 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 114' ' ' ILE . . . . . 0.489 HG12 HD13 ' A' ' 98' ' ' LEU . 15.3 mt -109.01 106.5 20.83 Favored 'Isoleucine or valine' 0 C--O 1.238 0.454 0 N-CA-C 108.066 -1.087 . . . . 74.34 108.066 175.39 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 115' ' ' CYS . . . . . 0.44 ' HB2' ' HB ' ' A' ' 97' ' ' ILE . 59.7 m -61.69 103.27 0.32 Allowed 'General case' 0 CA--C 1.546 0.823 0 C-N-CA 123.156 0.582 . . . . 64.44 109.607 173.554 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 116' ' ' THR . . . . . 0.567 HG22 HG12 ' A' ' 139' ' ' VAL . 35.2 p -74.56 -32.71 62.51 Favored 'General case' 0 N--CA 1.474 0.76 0 C-N-CA 124.29 1.036 . . . . 50.12 109.703 178.87 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -100.0 159.04 15.4 Favored 'General case' 0 C--O 1.243 0.761 0 C-N-CA 124.46 1.104 . . . . 31.34 108.561 171.051 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -71.88 111.98 7.59 Favored 'General case' 0 CA--C 1.543 0.693 0 N-CA-C 107.586 -1.264 . . . . 72.31 107.586 169.839 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 119' ' ' THR . . . . . . . . . . . . . 52.2 p -101.86 84.57 2.56 Favored 'General case' 0 CA--C 1.539 0.558 0 CA-C-O 122.319 1.057 . . . . 73.13 109.168 -175.974 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 11.1 pt-20 -77.0 -25.52 52.78 Favored 'General case' 0 N--CA 1.48 1.055 0 CA-C-N 114.543 -1.208 . . . . 71.22 110.903 -174.314 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 121' ' ' TRP . . . . . . . . . . . . . 43.8 p90 -70.19 -6.82 37.08 Favored 'General case' 0 CA--C 1.55 0.962 0 C-N-CA 123.914 0.886 . . . . 62.11 111.258 174.517 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 122' ' ' LEU . . . . . 0.422 HD22 ' HG2' ' A' ' 125' ' ' LYS . 42.7 mt -96.86 24.2 6.38 Favored 'General case' 0 CA--C 1.55 0.965 0 C-N-CA 123.32 0.648 . . . . 63.1 111.45 172.426 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 24.2 m-20 -71.79 133.9 45.83 Favored 'General case' 0 N--CA 1.484 1.247 0 N-CA-C 109.32 -0.622 . . . . 63.44 109.32 163.107 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 89.08 -13.84 62.22 Favored Glycine 0 C--N 1.345 1.056 0 CA-C-N 115.792 -0.64 . . . . 74.41 112.528 -173.26 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 125' ' ' LYS . . . . . 0.422 ' HG2' HD22 ' A' ' 122' ' ' LEU . 0.4 OUTLIER -81.63 -169.45 2.33 Favored 'General case' 0 N--CA 1.477 0.877 0 C-N-CA 123.657 0.783 . . . . 64.43 111.012 -179.02 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 126' ' ' HIS . . . . . . . . . . . . . 24.0 m80 -71.74 146.68 47.98 Favored 'General case' 0 N--CA 1.477 0.924 0 C-N-CA 124.481 1.112 . . . . 63.34 111.257 -163.059 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 127' ' ' VAL . . . . . 0.469 HG23 ' HB3' ' A' ' 85' ' ' ASP . 62.1 t -63.32 128.14 24.86 Favored 'Isoleucine or valine' 0 C--O 1.242 0.664 0 O-C-N 124.534 1.146 . . . . 75.21 112.108 -168.724 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 128' ' ' VAL . . . . . 0.408 HG11 HD12 ' A' ' 97' ' ' ILE . 47.6 t -75.5 140.39 17.46 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.356 0 CA-C-N 114.859 -1.064 . . . . 31.52 108.429 170.787 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 129' ' ' PHE . . . . . 0.499 ' HA ' HG21 ' A' ' 29' ' ' VAL . 41.1 p90 -128.13 -20.87 3.7 Favored 'General case' 0 N--CA 1.474 0.756 0 C-N-CA 122.623 0.369 . . . . 74.24 110.867 -177.475 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . -134.65 168.84 23.4 Favored Glycine 0 C--N 1.34 0.793 0 O-C-N 123.34 0.4 . . . . 62.12 112.188 -176.488 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 33.2 ttpt -152.26 137.11 17.12 Favored 'General case' 0 N--CA 1.47 0.569 0 C-N-CA 123.838 0.855 . . . . 63.51 109.091 176.568 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 17.1 t -70.95 111.71 5.03 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.528 0 N-CA-C 109.439 -0.578 . . . . 74.13 109.439 178.311 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 133' ' ' LYS . . . . . 0.531 ' HD2' ' HB2' ' A' ' 23' ' ' GLU . 20.2 ptmt -94.94 -37.63 11.07 Favored 'General case' 0 CA--C 1.541 0.605 0 C-N-CA 123.242 0.617 . . . . 75.32 110.19 178.193 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 134' ' ' GLU . . . . . 0.48 ' HB2' ' HB2' ' A' ' 21' ' ' SER . 17.9 mm-40 -124.4 136.4 54.03 Favored 'General case' 0 N--CA 1.474 0.757 0 C-N-CA 123.984 0.913 . . . . 65.24 109.274 -178.337 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 76.27 28.34 60.21 Favored Glycine 0 C--N 1.342 0.907 0 O-C-N 123.562 0.539 . . . . 42.3 113.913 175.245 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 136' ' ' MET . . . . . . . . . . . . . 15.3 tpt -63.91 -26.98 68.84 Favored 'General case' 0 N--CA 1.487 1.403 0 CA-C-N 117.418 0.609 . . . . 75.13 110.303 173.418 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 137' ' ' ASN . . . . . . . . . . . . . 1.7 m-20 -55.77 -46.69 77.84 Favored 'General case' 0 CA--C 1.549 0.927 0 C-N-CA 124.4 1.08 . . . . 74.14 110.291 171.502 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 138' ' ' ILE . . . . . 0.506 HG23 HD23 ' A' ' 17' ' ' LEU . 48.5 mm -68.17 -33.23 59.59 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.084 0 C-N-CA 123.876 0.871 . . . . 64.4 111.116 179.622 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 139' ' ' VAL . . . . . 0.567 HG12 HG22 ' A' ' 116' ' ' THR . 78.9 t -65.85 -44.5 92.78 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.072 0 C-N-CA 123.595 0.758 . . . . 71.35 111.12 178.839 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 45.1 mt-10 -74.34 -20.2 60.18 Favored 'General case' 0 N--CA 1.48 1.041 0 CA-C-N 115.747 -0.661 . . . . 74.01 110.99 176.919 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -72.16 -40.18 68.18 Favored 'General case' 0 CA--C 1.542 0.654 0 C-N-CA 122.895 0.478 . . . . 63.43 109.732 170.713 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 142' ' ' MET . . . . . 0.425 ' SD ' HG21 ' A' ' 10' ' ' ILE . 72.6 mtm -61.18 -38.81 87.82 Favored 'General case' 0 N--CA 1.484 1.26 0 C-N-CA 123.303 0.641 . . . . 72.14 110.289 176.744 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 143' ' ' GLU . . . . . 0.408 ' HB2' HG21 ' A' ' 116' ' ' THR . 42.7 tt0 -51.38 -40.31 58.95 Favored 'General case' 0 CA--C 1.552 1.041 0 O-C-N 124.402 1.064 . . . . 72.21 111.869 176.607 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 144' ' ' ARG . . . . . . . . . . . . . 53.6 mtp180 -71.81 -25.72 62.11 Favored 'General case' 0 CA--C 1.545 0.762 0 C-N-CA 123.47 0.708 . . . . 72.03 112.034 -178.279 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 145' ' ' PHE . . . . . . . . . . . . . 93.5 m-85 -82.77 2.4 34.09 Favored 'General case' 0 N--CA 1.481 1.118 0 C-N-CA 122.725 0.41 . . . . 74.12 111.223 175.749 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . -93.43 173.71 34.35 Favored Glycine 0 C--N 1.349 1.301 0 CA-C-N 117.741 0.246 . . . . 63.45 112.888 176.075 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 35.2 t -135.23 167.39 21.09 Favored 'General case' 0 N--CA 1.477 0.923 0 C-N-CA 123.911 0.884 . . . . 32.51 110.084 178.797 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 148' ' ' ARG . . . . . . . . . . . . . 23.2 mmt180 -73.6 -26.34 60.75 Favored 'General case' 0 N--CA 1.479 0.988 0 C-N-CA 123.725 0.81 . . . . 65.53 112.176 -173.352 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 149' ' ' ASN . . . . . . . . . . . . . 29.3 p-10 -77.06 -5.03 47.25 Favored 'General case' 0 N--CA 1.481 1.089 0 C-N-CA 123.17 0.588 . . . . 54.25 111.001 174.745 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . 101.54 -20.01 48.26 Favored Glycine 0 C--N 1.348 1.226 0 CA-C-O 119.959 -0.356 . . . . 63.41 112.474 177.936 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 34.9 ttpt -71.36 153.39 42.36 Favored 'General case' 0 N--CA 1.48 1.034 0 C-N-CA 122.802 0.441 . . . . 71.44 110.584 -176.894 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 152' ' ' THR . . . . . . . . . . . . . 72.2 p -94.82 134.05 37.86 Favored 'General case' 0 CA--C 1.543 0.696 0 C-N-CA 123.202 0.601 . . . . 71.15 109.452 172.484 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 153' ' ' SER . . . . . . . . . . . . . 36.5 m -65.84 -36.07 82.42 Favored 'General case' 0 CA--C 1.544 0.734 0 C-N-CA 123.641 0.776 . . . . 42.0 110.542 171.729 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 26.3 mmtp -122.87 139.47 54.0 Favored 'General case' 0 N--CA 1.479 0.985 0 C-N-CA 123.899 0.879 . . . . 72.11 109.505 175.222 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 11.7 tppt? -78.79 99.46 6.71 Favored 'General case' 0 CA--C 1.538 0.5 0 C-N-CA 123.101 0.56 . . . . 71.54 109.774 -178.127 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 156' ' ' ILE . . . . . 0.476 ' HB ' ' HB2' ' A' ' 53' ' ' PHE . 55.7 mt -89.24 126.08 42.24 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.482 0 CA-C-N 115.444 -0.798 . . . . 75.12 108.863 179.581 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 157' ' ' THR . . . . . 0.53 ' HA ' ' HA ' ' A' ' 52' ' ' CYS . 69.0 p -122.81 170.78 9.73 Favored 'General case' 0 CA--C 1.541 0.614 0 C-N-CA 125.276 1.43 . . . . 72.11 109.725 179.958 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 158' ' ' ILE . . . . . 0.43 ' O ' ' HA2' ' A' ' 50' ' ' GLY . 75.4 mt -90.83 113.51 26.74 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.685 0 N-CA-C 108.086 -1.079 . . . . 71.32 108.086 166.274 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 159' ' ' ALA . . . . . 0.641 ' HB2' ' HB2' ' A' ' 11' ' ' ALA . . . -63.84 -52.08 61.75 Favored 'General case' 0 N--CA 1.476 0.871 0 C-N-CA 123.9 0.88 . . . . 32.3 111.662 177.959 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 160' ' ' ASP . . . . . . . . . . . . . 14.7 t70 -157.36 173.27 17.17 Favored 'General case' 0 N--CA 1.48 1.043 0 C-N-CA 122.881 0.472 . . . . 73.51 109.823 -174.025 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 161' ' ' CYS . . . . . . . . . . . . . 19.4 p -134.55 -166.99 1.9 Allowed 'General case' 0 N--CA 1.475 0.817 0 C-N-CA 125.309 1.444 . . . . 45.54 109.101 -173.542 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 162' ' ' GLY . . . . . . . . . . . . . . . 134.92 53.17 0.07 OUTLIER Glycine 0 C--N 1.344 1.005 0 O-C-N 122.173 -0.33 . . . . 71.01 112.358 -173.163 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 163' ' ' GLN . . . . . 0.573 ' HA ' ' H ' ' A' ' 7' ' ' PHE . 46.4 tt0 -47.33 103.6 0.04 OUTLIER 'General case' 0 N--CA 1.48 1.035 0 C-N-CA 125.101 1.36 . . . . 64.35 111.614 -179.878 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 164' ' ' LEU . . . . . . . . . . . . . 85.2 mt -71.27 121.85 19.19 Favored 'General case' 0 CA--C 1.538 0.483 0 CA-C-N 114.765 -1.107 . . . . 42.25 110.882 -174.054 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 165' ' ' GLU . . . . . . . . . . . . . 19.0 pt-20 . . . . . 0 C--O 1.249 1.04 0 C-N-CA 124.114 0.965 . . . . 74.43 109.756 171.89 . . . . . . . . 0 0 . 1 . 018 nuclear build full ' B' B ' 216' ' ' PRO . . . . . . . . . . . . . 10.9 Cg_endo . . . . . 0 N--CA 1.486 1.048 0 N-CA-C 110.449 -0.635 . . . . 63.15 110.449 . . . . . . . . . 0 0 . 1 . 018 nuclear build full ' B' B ' 217' ' ' GLU . . . . . . . . . . . . . 40.6 mt-10 -131.79 142.08 43.91 Favored Pre-proline 0 N--CA 1.483 1.183 0 C-N-CA 123.507 0.723 . . . . 75.14 110.379 -172.994 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 218' ' ' PRO . . . . . 0.572 ' HG2' HE22 ' A' ' 111' ' ' GLN . 23.8 Cg_endo -62.37 102.69 0.28 Allowed 'Trans proline' 0 C--N 1.381 2.242 0 C-N-CA 122.386 2.058 . . . . 65.3 111.216 175.845 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 219' ' ' GLY . . . . . . . . . . . . . . . 162.61 160.47 11.18 Favored Glycine 0 CA--C 1.533 1.162 0 CA-C-N 115.032 -0.985 . . . . 74.11 111.51 -178.197 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 220' ' ' PRO . . . . . . . . . . . . . 27.5 Cg_exo -64.63 169.96 10.58 Favored 'Trans proline' 0 C--N 1.375 1.955 0 C-N-CA 123.492 2.794 . . . . 73.11 114.308 179.995 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 221' ' ' TYR . . . . . . . . . . . . . 73.1 m-85 -132.66 173.94 10.82 Favored 'General case' 0 N--CA 1.484 1.273 0 C-N-CA 123.949 0.9 . . . . 71.24 110.987 -174.938 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 222' ' ' ALA . . . . . . . . . . . . . . . -172.29 -175.37 1.39 Allowed 'General case' 0 N--CA 1.477 0.894 0 C-N-CA 124.23 1.012 . . . . 60.51 111.055 -178.93 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 223' ' ' GLN . . . . . 0.508 HE21 ' HB2' ' A' ' 60' ' ' PHE . 75.3 mt-30 61.71 91.73 0.07 OUTLIER Pre-proline 0 N--CA 1.479 0.997 0 C-N-CA 125.08 1.352 . . . . 61.51 112.546 168.06 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 224' ' ' PRO . . . . . . . . . . . . . 33.0 Cg_exo . . . . . 0 C--N 1.376 2.021 0 C-N-CA 123.219 2.612 . . . . 52.5 111.936 175.607 . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 96.0 mmm . . . . . 0 N--CA 1.472 0.672 0 N-CA-C 110.119 -0.326 . . . . 73.52 110.119 . . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 9.1 p -68.03 -21.99 27.39 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.169 0 C-N-CA 123.744 0.818 . . . . 75.21 110.086 174.064 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 33.1 m-80 -59.23 119.31 37.73 Favored Pre-proline 0 CA--C 1.549 0.935 0 C-N-CA 124.914 1.286 . . . . 31.55 110.622 174.402 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 4' ' ' PRO . . . . . 0.62 ' HG2' ' HB2' ' A' ' 24' ' ' LEU . 32.7 Cg_endo -65.2 129.17 22.17 Favored 'Trans proline' 0 C--N 1.38 2.236 0 C-N-CA 122.696 2.264 . . . . 74.24 111.379 175.102 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 5' ' ' THR . . . . . 0.467 HG23 ' HD3' ' A' ' 133' ' ' LYS . 65.9 m -95.93 122.74 39.07 Favored 'General case' 0 N--CA 1.464 0.257 0 N-CA-C 108.112 -1.07 . . . . 63.24 108.112 177.44 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 34.7 m -107.15 128.6 61.95 Favored 'Isoleucine or valine' 0 C--O 1.22 -0.478 0 CA-C-O 121.432 0.634 . . . . 75.42 110.557 -179.018 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 7' ' ' PHE . . . . . 0.664 ' H ' ' HA ' ' A' ' 163' ' ' GLN . 74.6 t80 -116.03 138.79 50.9 Favored 'General case' 0 C--O 1.239 0.532 0 C-N-CA 124.792 1.237 . . . . 52.22 109.292 -171.579 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 8' ' ' PHE . . . . . 0.483 ' HB3' HG23 ' A' ' 158' ' ' ILE . 63.2 m-85 -141.02 162.68 34.92 Favored 'General case' 0 N--CA 1.47 0.568 0 O-C-N 124.375 1.047 . . . . 74.43 110.11 172.17 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 11.9 m-20 -108.67 106.8 17.01 Favored 'General case' 0 C--N 1.328 -0.341 0 C-N-CA 125.124 1.369 . . . . 62.21 107.359 171.523 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 49.5 mm -81.2 130.88 35.11 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.65 0 N-CA-C 108.664 -0.865 . . . . 73.34 108.664 177.863 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 11' ' ' ALA . . . . . 0.451 ' HB2' ' HB2' ' A' ' 159' ' ' ALA . . . -132.97 139.68 47.41 Favored 'General case' 0 N--CA 1.473 0.696 0 C-N-CA 123.754 0.822 . . . . 73.44 110.69 -174.256 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 12' ' ' VAL . . . . . 0.538 HG23 ' HB2' ' A' ' 17' ' ' LEU . 72.0 t -94.67 98.31 7.91 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.596 0 C-N-CA 124.899 1.28 . . . . 70.33 108.388 175.697 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 22.6 m-20 61.23 31.18 19.51 Favored 'General case' 0 N--CA 1.483 1.182 0 C-N-CA 124.702 1.201 . . . . 73.13 111.968 -177.993 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 96.14 -8.85 67.57 Favored Glycine 0 C--N 1.348 1.224 0 CA-C-O 119.749 -0.473 . . . . 63.31 113.302 179.215 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 39.1 mm-40 -85.56 113.38 50.65 Favored Pre-proline 0 N--CA 1.473 0.721 0 CA-C-O 118.418 -0.801 . . . . 73.04 109.223 173.321 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 19.2 Cg_endo -55.47 106.06 0.18 Allowed 'Trans proline' 0 C--N 1.385 2.491 0 C-N-CA 123.042 2.495 . . . . 50.22 112.249 -176.381 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 17' ' ' LEU . . . . . 0.538 ' HB2' HG23 ' A' ' 12' ' ' VAL . 68.9 tp -76.31 -41.37 48.81 Favored 'General case' 0 N--CA 1.476 0.858 0 C-N-CA 123.793 0.837 . . . . 51.05 109.115 -179.313 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 169.97 -172.98 44.03 Favored Glycine 0 C--N 1.341 0.836 0 CA-C-N 115.376 -0.829 . . . . 55.33 112.428 176.513 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 56.0 mtm180 -111.84 136.47 51.09 Favored 'General case' 0 C--O 1.239 0.529 0 C-N-CA 124.111 0.965 . . . . 72.01 109.766 -175.8 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 20' ' ' VAL . . . . . 0.413 ' HA ' ' HA3' ' A' ' 135' ' ' GLY . 61.1 t -129.57 131.98 66.6 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.998 0 C-N-CA 123.644 0.778 . . . . 34.14 109.522 177.494 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 45.7 m -119.62 123.8 44.75 Favored 'General case' 0 CA--C 1.543 0.673 0 C-N-CA 124.139 0.975 . . . . 74.32 108.831 174.365 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 14.7 m-85 -99.85 169.09 9.47 Favored 'General case' 0 CA--C 1.541 0.618 0 C-N-CA 123.999 0.92 . . . . 75.43 109.007 174.886 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 23' ' ' GLU . . . . . 0.527 ' HB2' ' HD2' ' A' ' 133' ' ' LYS . 34.2 tt0 -125.86 108.58 11.59 Favored 'General case' 0 C--O 1.239 0.532 0 N-CA-C 107.697 -1.223 . . . . 73.24 107.697 179.404 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 24' ' ' LEU . . . . . 0.62 ' HB2' ' HG2' ' A' ' 4' ' ' PRO . 15.8 mt -84.89 124.5 31.7 Favored 'General case' 0 C--O 1.238 0.499 0 CA-C-O 120.935 0.398 . . . . 72.31 110.028 -179.884 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 25' ' ' PHE . . . . . 0.635 ' HB2' HD11 ' A' ' 90' ' ' LEU . 86.1 m-85 -86.04 64.86 8.82 Favored 'General case' 0 CA--C 1.535 0.375 0 CA-C-N 115.66 -0.7 . . . . 61.23 109.586 174.899 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -72.42 -16.06 61.83 Favored 'General case' 0 N--CA 1.479 0.989 0 CA-C-N 115.383 -0.826 . . . . 72.1 111.445 -179.11 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 9.8 p-10 -74.15 -23.0 59.21 Favored 'General case' 0 CA--C 1.553 1.068 0 C-N-CA 123.96 0.904 . . . . 51.53 110.782 173.851 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 58.2 mttp -101.52 -52.33 3.25 Favored 'General case' 0 N--CA 1.478 0.973 0 C-N-CA 123.874 0.87 . . . . 71.21 110.771 -177.618 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 30.0 m -122.85 74.37 46.57 Favored Pre-proline 0 CA--C 1.559 1.296 0 C-N-CA 124.308 1.043 . . . . 72.3 109.761 -173.884 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 24.8 Cg_exo -62.29 -43.36 23.62 Favored 'Trans proline' 0 C--N 1.38 2.206 0 C-N-CA 122.726 2.284 . . . . 74.05 113.136 -169.717 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 31' ' ' LYS . . . . . 0.416 ' HD2' ' HB2' ' A' ' 86' ' ' GLU . 1.5 ttmp? -57.05 -54.73 43.42 Favored 'General case' 0 N--CA 1.484 1.232 0 C-N-CA 123.472 0.709 . . . . 64.13 111.495 177.476 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 6.4 m -71.21 -36.3 71.84 Favored 'General case' 0 CA--C 1.551 0.993 0 C-N-CA 123.773 0.829 . . . . 71.52 111.776 -168.932 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 33' ' ' ALA . . . . . 0.414 ' HB1' ' HB3' ' A' ' 24' ' ' LEU . . . -79.85 -48.54 13.35 Favored 'General case' 0 N--CA 1.474 0.77 0 C-N-CA 123.447 0.699 . . . . 41.35 111.103 -177.792 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 12.6 tp10 -63.47 -28.48 69.99 Favored 'General case' 0 N--CA 1.482 1.141 0 C-N-CA 123.59 0.756 . . . . 63.21 111.099 -179.491 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 35' ' ' ASN . . . . . 0.543 ' ND2' ' SD ' ' A' ' 100' ' ' MET . 32.6 t30 -52.79 -69.37 0.12 Allowed 'General case' 0 C--N 1.353 0.721 0 O-C-N 123.948 0.78 . . . . 75.24 110.316 174.239 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 85.5 t80 -66.69 -32.41 73.71 Favored 'General case' 0 N--CA 1.476 0.875 0 C-N-CA 123.501 0.721 . . . . 71.15 111.296 -173.869 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 56.2 ttt-85 -55.4 -54.33 45.08 Favored 'General case' 0 N--CA 1.474 0.767 0 C-N-CA 124.192 0.997 . . . . 64.15 110.268 175.803 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 38' ' ' ALA . . . . . 0.426 ' HB1' ' HG2' ' A' ' 44' ' ' LYS . . . -76.2 -24.15 54.67 Favored 'General case' 0 CA--C 1.541 0.623 0 CA-C-N 115.147 -0.933 . . . . 35.41 112.218 -174.941 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 39' ' ' LEU . . . . . 0.525 HD22 ' HE2' ' A' ' 48' ' ' TYR . 81.7 mt -66.03 -43.16 88.41 Favored 'General case' 0 N--CA 1.482 1.145 0 C-N-CA 123.329 0.651 . . . . 64.55 110.144 173.794 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 47.4 m -82.55 -37.37 25.25 Favored 'General case' 0 CA--C 1.547 0.838 0 CA-C-N 115.143 -0.935 . . . . 64.44 112.317 -172.718 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 41' ' ' THR . . . . . 0.421 ' OG1' ' HG2' ' A' ' 43' ' ' GLU . 3.7 p -72.79 -32.06 65.31 Favored 'General case' 0 N--CA 1.485 1.323 0 C-N-CA 122.519 0.328 . . . . 73.24 110.309 172.664 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 84.85 29.5 28.8 Favored Glycine 0 C--N 1.345 1.059 0 CA-C-N 116.025 -0.534 . . . . 70.05 112.558 -178.789 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 43' ' ' GLU . . . . . 0.421 ' HG2' ' OG1' ' A' ' 41' ' ' THR . 17.6 mm-40 -63.85 -31.41 72.59 Favored 'General case' 0 N--CA 1.48 1.058 0 C-N-CA 123.266 0.626 . . . . 64.21 110.793 176.606 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 44' ' ' LYS . . . . . 0.426 ' HG2' ' HB1' ' A' ' 38' ' ' ALA . 71.6 mmtt -95.42 19.25 11.15 Favored 'General case' 0 N--CA 1.48 1.028 0 C-N-CA 123.719 0.807 . . . . 64.44 110.533 179.012 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 83.72 -15.97 33.77 Favored Glycine 0 C--N 1.353 1.482 0 CA-C-O 119.472 -0.627 . . . . 62.1 114.486 175.814 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 46' ' ' PHE . . . . . 0.421 ' HE2' ' HA ' ' A' ' 78' ' ' ILE . 23.6 m-85 -76.77 -51.24 11.75 Favored 'General case' 0 N--CA 1.476 0.853 0 CA-C-N 117.508 0.654 . . . . 61.34 112.686 -166.77 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 48.82 63.3 3.95 Favored Glycine 0 C--N 1.355 1.628 0 O-C-N 123.978 0.799 . . . . 54.33 114.653 176.302 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 48' ' ' TYR . . . . . 0.525 ' HE2' HD22 ' A' ' 39' ' ' LEU . 30.2 m-85 -70.04 100.2 1.58 Allowed 'General case' 0 N--CA 1.484 1.25 0 CA-C-N 117.763 0.782 . . . . 74.1 111.332 -175.511 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 49' ' ' LYS . . . . . 0.582 ' HE3' ' HA ' ' A' ' 160' ' ' ASP . 23.5 tptm -107.47 132.32 53.35 Favored 'General case' 0 CA--C 1.534 0.332 0 C-N-CA 124.951 1.301 . . . . 71.43 109.063 -176.004 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 83.2 21.38 58.93 Favored Glycine 0 C--N 1.348 1.196 0 CA-C-O 119.722 -0.488 . . . . 72.1 112.958 179.408 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 51' ' ' SER . . . . . 0.73 ' HA ' ' HB2' ' A' ' 67' ' ' PHE . 22.4 t -61.91 114.26 3.26 Favored 'General case' 0 C--N 1.358 0.959 0 C-N-CA 122.937 0.495 . . . . 74.52 110.601 -179.761 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 52' ' ' CYS . . . . . 0.609 ' HB3' ' HB3' ' A' ' 66' ' ' ASP . 53.5 t -89.89 157.95 17.65 Favored 'General case' 0 C--O 1.24 0.58 0 C-N-CA 123.352 0.661 . . . . 52.52 111.412 -173.349 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 53' ' ' PHE . . . . . 0.7 ' HA ' ' HA2' ' A' ' 64' ' ' GLY . 14.5 m-85 -105.85 98.0 7.75 Favored 'General case' 0 CA--C 1.535 0.402 0 C-N-CA 124.973 1.309 . . . . 70.24 107.64 176.263 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 40.8 p-80 -88.22 -27.26 21.91 Favored 'General case' 0 N--CA 1.483 1.206 0 C-N-CA 122.464 0.306 . . . . 74.45 111.519 -178.068 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 55' ' ' ARG . . . . . 0.501 ' HA ' ' O ' ' A' ' 150' ' ' GLY . 42.4 ttt180 -116.1 104.86 11.97 Favored 'General case' 0 C--O 1.212 -0.917 0 N-CA-C 109.762 -0.458 . . . . 71.33 109.762 -175.583 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 63.5 mt -132.46 133.39 59.89 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.044 0 N-CA-C 108.963 -0.754 . . . . 74.55 108.963 174.066 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 57' ' ' ILE . . . . . 0.409 ' HB ' ' HD2' ' A' ' 60' ' ' PHE . 62.0 mt -123.15 123.18 26.73 Favored Pre-proline 0 CA--C 1.558 1.265 0 C-N-CA 124.41 1.084 . . . . 71.0 109.044 176.475 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 55.9 Cg_endo -67.31 144.7 69.22 Favored 'Trans proline' 0 C--N 1.383 2.392 0 C-N-CA 122.983 2.455 . . . . 75.54 111.798 178.706 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 73.56 13.48 80.15 Favored Glycine 0 CA--C 1.527 0.838 0 CA-C-N 115.46 -0.791 . . . . 71.1 114.027 -176.409 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 60' ' ' PHE . . . . . 0.409 ' HD2' ' HB ' ' A' ' 57' ' ' ILE . 17.6 t80 -139.73 -75.06 0.35 Allowed 'General case' 0 C--O 1.245 0.859 0 C-N-CA 123.091 0.556 . . . . 65.21 110.495 -173.964 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 61' ' ' MET . . . . . 0.68 ' SD ' ' HB2' ' A' ' 113' ' ' PHE . 13.9 tmm? -174.62 147.26 1.06 Allowed 'General case' 0 CA--C 1.55 0.957 0 N-CA-C 112.064 0.394 . . . . 71.43 112.064 -164.827 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 62' ' ' CYS . . . . . 0.527 ' SG ' ' HB ' ' A' ' 114' ' ' ILE . 21.8 p -108.11 112.48 25.04 Favored 'General case' 0 CA--C 1.552 1.053 0 C-N-CA 124.182 0.993 . . . . 51.4 109.873 172.984 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 63' ' ' GLN . . . . . 0.607 ' HB2' ' SD ' ' A' ' 61' ' ' MET . 49.2 tt0 -104.87 111.33 24.05 Favored 'General case' 0 N--CA 1.487 1.404 0 C-N-CA 124.064 0.946 . . . . 71.15 111.465 -173.637 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 64' ' ' GLY . . . . . 0.7 ' HA2' ' HA ' ' A' ' 53' ' ' PHE . . . -89.51 -179.6 45.01 Favored Glycine 0 C--N 1.342 0.865 0 CA-C-N 114.952 -1.022 . . . . 55.2 112.583 173.483 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 99.42 72.22 1.02 Allowed Glycine 0 N--CA 1.444 -0.809 0 N-CA-C 110.491 -1.044 . . . . 45.31 110.491 -174.334 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 66' ' ' ASP . . . . . 0.609 ' HB3' ' HB3' ' A' ' 52' ' ' CYS . 38.2 t70 -123.88 -4.64 8.06 Favored 'General case' 0 N--CA 1.484 1.256 0 C-N-CA 123.735 0.814 . . . . 72.35 110.756 175.915 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 67' ' ' PHE . . . . . 0.73 ' HB2' ' HA ' ' A' ' 51' ' ' SER . 56.0 t80 -79.25 -70.58 0.5 Allowed 'General case' 0 CA--C 1.544 0.718 0 CA-C-N 116.082 -0.508 . . . . 74.1 111.315 -171.402 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 30.9 m -86.28 102.17 13.73 Favored 'General case' 0 N--CA 1.471 0.602 0 C-N-CA 122.484 0.313 . . . . 72.54 110.954 -171.136 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 81.5 mtp180 52.69 81.94 0.08 Allowed 'General case' 0 N--CA 1.476 0.844 0 C-N-CA 124.518 1.127 . . . . 74.52 111.335 -178.266 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 27.5 p80 -74.68 26.11 0.09 Allowed 'General case' 0 N--CA 1.495 1.78 0 N-CA-C 113.74 1.015 . . . . 74.4 113.74 -170.843 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 1.9 m-20 -86.65 45.06 1.21 Allowed 'General case' 0 CA--C 1.555 1.155 0 C-N-CA 124.344 1.058 . . . . 73.22 109.62 175.436 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 86.79 -7.9 77.99 Favored Glycine 0 C--N 1.353 1.515 0 CA-C-N 116.081 -0.509 . . . . 63.14 113.459 -176.811 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 73' ' ' THR . . . . . 0.507 ' HA ' ' HB2' ' A' ' 110' ' ' SER . 3.7 m -90.45 -61.57 1.65 Allowed 'General case' 0 N--CA 1.475 0.786 0 CA-C-N 117.499 0.65 . . . . 64.1 109.35 179.62 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 62.76 10.12 29.91 Favored Glycine 0 CA--C 1.538 1.525 0 N-CA-C 116.585 1.394 . . . . 62.32 116.585 164.772 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 145.44 55.4 0.02 OUTLIER Glycine 0 N--CA 1.471 1.012 0 CA-C-N 118.179 0.99 . . . . 72.23 111.451 -164.512 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 23.3 pttm -51.13 165.54 0.12 Allowed 'General case' 0 N--CA 1.488 1.428 0 C-N-CA 124.881 1.272 . . . . 75.24 112.658 179.8 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 77' ' ' SER . . . . . 0.428 ' HA ' HD11 ' A' ' 39' ' ' LEU . 77.0 p -90.65 178.59 6.03 Favored 'General case' 0 CA--C 1.545 0.767 0 C-N-CA 123.386 0.674 . . . . 71.1 112.446 -169.697 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 78' ' ' ILE . . . . . 0.421 ' HA ' ' HE2' ' A' ' 46' ' ' PHE . 34.7 pt -72.14 -14.57 17.43 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.074 0 C-N-CA 123.935 0.894 . . . . 73.43 110.663 175.207 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 89.6 m-85 -94.54 16.06 16.37 Favored 'General case' 0 CA--C 1.548 0.872 0 C-N-CA 124.458 1.103 . . . . 73.23 110.541 175.674 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 89.79 -121.76 6.26 Favored Glycine 0 C--N 1.355 1.587 0 N-CA-C 111.005 -0.838 . . . . 74.13 111.005 -179.35 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 42.3 tt0 -55.56 -56.4 20.74 Favored 'General case' 0 N--CA 1.48 1.059 0 C-N-CA 125.02 1.328 . . . . 73.11 111.321 -177.384 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 82' ' ' LYS . . . . . 0.842 ' HD2' ' HA ' ' A' ' 107' ' ' THR . 21.0 pttp -169.79 179.2 3.76 Favored 'General case' 0 N--CA 1.48 1.04 0 C-N-CA 124.322 1.049 . . . . 75.41 109.895 -174.999 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 53.5 p90 -148.79 173.66 13.03 Favored 'General case' 0 N--CA 1.475 0.817 0 C-N-CA 123.908 0.883 . . . . 75.25 111.269 -177.422 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 13.9 pt-20 -94.8 151.43 19.25 Favored 'General case' 0 CA--C 1.541 0.603 0 CA-C-N 115.009 -0.996 . . . . 74.3 110.908 178.532 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 85' ' ' ASP . . . . . 0.424 ' HB3' HG23 ' A' ' 127' ' ' VAL . 44.7 m-20 -65.91 136.69 56.46 Favored 'General case' 0 N--CA 1.475 0.813 0 C-N-CA 124.375 1.07 . . . . 75.41 111.811 -176.93 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 86' ' ' GLU . . . . . 0.416 ' HB2' ' HD2' ' A' ' 31' ' ' LYS . 11.8 tp10 -86.06 -63.54 1.3 Allowed 'General case' 0 CA--C 1.548 0.895 0 CA-C-N 116.106 -0.497 . . . . 63.23 111.399 -173.144 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 26.0 p-10 -166.71 135.59 2.87 Favored 'General case' 0 N--CA 1.482 1.164 0 C-N-CA 122.936 0.494 . . . . 74.55 110.194 -173.944 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 25.9 m-85 -95.34 59.83 2.22 Favored 'General case' 0 N--CA 1.478 0.928 0 C-N-CA 123.841 0.856 . . . . 74.1 110.71 -170.797 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 34.0 mt -75.22 -35.32 33.61 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.17 0 CA-C-N 115.795 -0.639 . . . . 73.05 110.169 176.004 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 90' ' ' LEU . . . . . 0.635 HD11 ' HB2' ' A' ' 25' ' ' PHE . 78.8 mt -100.1 161.53 13.55 Favored 'General case' 0 N--CA 1.471 0.623 0 C-N-CA 123.798 0.839 . . . . 73.32 110.61 -179.125 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 91' ' ' LYS . . . . . 0.659 ' HG3' HG22 ' A' ' 93' ' ' THR . 49.3 pttt -159.17 160.37 35.42 Favored 'General case' 0 CA--C 1.547 0.864 0 CA-C-O 121.646 0.736 . . . . 43.04 111.931 -174.293 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 92' ' ' HIS . . . . . . . . . . . . . 22.9 m-70 -88.93 32.88 0.79 Allowed 'General case' 0 N--CA 1.483 1.195 0 C-N-CA 124.401 1.08 . . . . 73.13 112.434 -167.877 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 93' ' ' THR . . . . . 0.659 HG22 ' HG3' ' A' ' 91' ' ' LYS . 6.1 t -89.44 68.72 7.92 Favored 'General case' 0 N--CA 1.479 1.003 0 CA-C-O 122.52 1.152 . . . . 74.13 110.007 -179.217 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 153.12 164.51 12.59 Favored Glycine 0 C--N 1.338 0.64 0 CA-C-N 114.572 -1.195 . . . . 63.13 111.745 179.245 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 63.6 Cg_endo -76.82 157.37 35.16 Favored 'Trans proline' 0 CA--C 1.554 1.485 0 C-N-CA 122.308 2.006 . . . . 73.4 112.167 172.965 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 84.16 18.61 62.45 Favored Glycine 0 CA--C 1.532 1.145 0 N-CA-C 114.543 0.577 . . . . 60.33 114.543 177.506 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 97' ' ' ILE . . . . . . . . . . . . . 37.6 mm -86.48 106.93 16.19 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.311 0 CA-C-N 117.765 0.783 . . . . 71.22 111.689 -175.07 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 98' ' ' LEU . . . . . 0.449 HD13 HG12 ' A' ' 114' ' ' ILE . 67.2 tp -92.89 119.25 32.0 Favored 'General case' 0 CA--C 1.552 1.055 0 C-N-CA 123.582 0.753 . . . . 73.23 110.746 -178.614 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 13.5 m -138.0 143.28 40.56 Favored 'General case' 0 N--CA 1.482 1.134 0 C-N-CA 124.744 1.218 . . . . 62.51 108.774 177.492 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 100' ' ' MET . . . . . 0.649 ' HA ' ' HA ' ' A' ' 112' ' ' PHE . 73.3 mtp -77.95 138.95 39.13 Favored 'General case' 0 N--CA 1.488 1.433 0 CA-C-N 118.616 0.644 . . . . 73.44 109.335 176.144 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 101' ' ' ALA . . . . . 0.53 ' HB3' ' HB2' ' A' ' 111' ' ' GLN . . . -74.68 160.82 30.3 Favored 'General case' 0 N--CA 1.483 1.178 0 C-N-CA 123.106 0.562 . . . . 74.34 112.21 -168.281 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 102' ' ' ASN . . . . . 0.439 ' HB3' ' HA ' ' A' ' 108' ' ' ASN . 27.5 p-10 -165.28 164.3 19.94 Favored 'General case' 0 N--CA 1.476 0.839 0 CA-C-N 115.515 -0.766 . . . . 70.3 110.974 -176.383 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -107.85 10.34 28.63 Favored 'General case' 0 CA--C 1.549 0.91 0 C-N-CA 123.903 0.881 . . . . 64.23 110.615 171.676 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 148.65 -175.57 27.86 Favored Glycine 0 C--N 1.356 1.669 0 CA-C-O 119.543 -0.587 . . . . 40.52 112.373 179.666 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 40.4 Cg_exo -59.0 143.94 99.58 Favored 'Trans proline' 0 C--N 1.375 1.955 0 C-N-CA 123.358 2.705 . . . . 64.15 112.326 174.311 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 65.1 t30 70.56 9.57 6.94 Favored 'General case' 0 N--CA 1.49 1.573 0 C-N-CA 125.27 1.428 . . . . 73.41 111.245 -177.914 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 107' ' ' THR . . . . . 0.842 ' HA ' ' HD2' ' A' ' 82' ' ' LYS . 4.0 m -121.88 4.65 9.95 Favored 'General case' 0 CA--C 1.556 1.18 0 C-N-CA 123.476 0.711 . . . . 73.43 110.945 -175.895 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 108' ' ' ASN . . . . . 0.439 ' HA ' ' HB3' ' A' ' 102' ' ' ASN . 48.5 t30 -84.7 140.74 31.08 Favored 'General case' 0 N--CA 1.485 1.324 0 C-N-CA 123.71 0.804 . . . . 72.21 110.68 -176.682 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 111.98 23.34 5.6 Favored Glycine 0 N--CA 1.474 1.206 0 C-N-CA 122.556 0.122 . . . . 55.03 113.354 -177.946 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 110' ' ' SER . . . . . 0.507 ' HB2' ' HA ' ' A' ' 73' ' ' THR . 12.2 p -127.77 120.33 27.66 Favored 'General case' 0 CA--C 1.536 0.433 0 N-CA-C 107.334 -1.358 . . . . 62.51 107.334 171.866 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 111' ' ' GLN . . . . . 0.53 ' HB2' ' HB3' ' A' ' 101' ' ' ALA . 49.4 mt-30 67.65 175.22 0.26 Allowed 'General case' 0 N--CA 1.488 1.436 0 C-N-CA 124.942 1.297 . . . . 74.33 111.051 -172.82 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 112' ' ' PHE . . . . . 0.649 ' HA ' ' HA ' ' A' ' 100' ' ' MET . 23.7 p90 -149.86 142.18 24.22 Favored 'General case' 0 N--CA 1.477 0.885 0 N-CA-C 108.12 -1.067 . . . . 74.34 108.12 176.209 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 113' ' ' PHE . . . . . 0.68 ' HB2' ' SD ' ' A' ' 61' ' ' MET . 54.3 p90 -135.27 139.02 44.07 Favored 'General case' 0 C--O 1.239 0.509 0 CA-C-O 121.198 0.523 . . . . 72.53 111.227 -177.649 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 114' ' ' ILE . . . . . 0.527 ' HB ' ' SG ' ' A' ' 62' ' ' CYS . 11.8 mt -103.17 108.36 24.19 Favored 'Isoleucine or valine' 0 C--O 1.241 0.629 0 N-CA-C 107.475 -1.306 . . . . 73.42 107.475 176.805 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 115' ' ' CYS . . . . . . . . . . . . . 58.6 m -67.87 103.72 1.52 Allowed 'General case' 0 N--CA 1.467 0.395 0 N-CA-C 109.059 -0.719 . . . . 71.42 109.059 177.01 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 116' ' ' THR . . . . . 0.609 HG22 HG12 ' A' ' 139' ' ' VAL . 36.6 p -70.9 -32.39 69.33 Favored 'General case' 0 CA--C 1.54 0.584 0 C-N-CA 124.361 1.065 . . . . 64.1 110.317 179.737 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -110.25 167.91 9.84 Favored 'General case' 0 CA--C 1.543 0.686 0 C-N-CA 124.339 1.056 . . . . 72.33 109.853 173.92 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 18.2 ptmt -76.83 85.08 3.41 Favored 'General case' 0 N--CA 1.479 0.98 0 C-N-CA 123.427 0.691 . . . . 70.44 110.568 179.309 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 119' ' ' THR . . . . . 0.656 ' HB ' HD23 ' A' ' 122' ' ' LEU . 73.5 p -77.44 85.33 3.84 Favored 'General case' 0 CA--C 1.552 1.034 0 CA-C-O 122.068 0.937 . . . . 75.14 110.168 -175.559 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 9.8 pt-20 -81.52 -20.88 39.12 Favored 'General case' 0 N--CA 1.486 1.34 0 C-N-CA 123.691 0.796 . . . . 73.41 112.247 -167.862 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 121' ' ' TRP . . . . . . . . . . . . . 28.5 p90 -73.06 -8.16 54.49 Favored 'General case' 0 N--CA 1.484 1.23 0 C-N-CA 123.525 0.73 . . . . 74.31 110.794 174.748 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 122' ' ' LEU . . . . . 0.656 HD23 ' HB ' ' A' ' 119' ' ' THR . 4.2 mm? -84.23 11.48 8.18 Favored 'General case' 0 CA--C 1.554 1.105 0 C-N-CA 124.16 0.984 . . . . 64.13 111.239 170.932 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 34.5 m-20 -75.92 150.84 37.46 Favored 'General case' 0 N--CA 1.491 1.602 0 CA-C-N 118.804 0.729 . . . . 72.12 110.744 171.228 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 64.45 13.45 54.88 Favored Glycine 0 C--N 1.352 1.43 0 O-C-N 123.877 0.735 . . . . 55.14 112.829 -173.827 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -106.76 -166.21 1.15 Allowed 'General case' 0 CA--C 1.547 0.86 0 C-N-CA 124.941 1.296 . . . . 73.31 108.05 -173.108 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 126' ' ' HIS . . . . . . . . . . . . . 14.0 p-80 -66.84 156.79 34.68 Favored 'General case' 0 N--CA 1.476 0.865 0 C-N-CA 124.48 1.112 . . . . 75.32 113.039 -173.68 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 127' ' ' VAL . . . . . 0.424 HG23 ' HB3' ' A' ' 85' ' ' ASP . 45.9 t -65.74 133.3 30.97 Favored 'Isoleucine or valine' 0 CA--C 1.553 1.084 0 C-N-CA 125.476 1.51 . . . . 73.44 112.955 -168.894 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 128' ' ' VAL . . . . . 0.509 ' HB ' ' HB2' ' A' ' 90' ' ' LEU . 47.3 t -85.19 158.57 3.41 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.148 0 C-N-CA 124.759 1.224 . . . . 71.13 108.701 168.813 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 129' ' ' PHE . . . . . 0.417 ' HD2' HD22 ' A' ' 24' ' ' LEU . 36.8 p90 -139.87 -32.53 0.62 Allowed 'General case' 0 N--CA 1.481 1.092 0 CA-C-N 118.422 0.556 . . . . 74.43 111.936 176.578 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . -117.84 162.41 13.07 Favored Glycine 0 C--N 1.341 0.855 0 CA-C-O 121.071 0.262 . . . . 62.01 113.427 -173.112 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 131' ' ' LYS . . . . . 0.404 ' HB3' ' HE2' ' A' ' 131' ' ' LYS . 29.6 ttpt -149.51 120.06 7.46 Favored 'General case' 0 N--CA 1.469 0.489 0 C-N-CA 124.717 1.207 . . . . 71.04 108.796 -179.608 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 34.8 t -61.17 100.78 0.13 Allowed 'Isoleucine or valine' 0 N--CA 1.473 0.7 0 N-CA-C 109.567 -0.531 . . . . 74.12 109.567 177.266 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 133' ' ' LYS . . . . . 0.527 ' HD2' ' HB2' ' A' ' 23' ' ' GLU . 0.1 OUTLIER -86.25 -28.76 23.61 Favored 'General case' 0 N--CA 1.473 0.68 0 N-CA-C 109.454 -0.573 . . . . 73.31 109.454 -179.901 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 42.4 mt-10 -144.27 149.83 36.91 Favored 'General case' 0 N--CA 1.478 0.968 0 C-N-CA 124.937 1.295 . . . . 71.5 109.945 176.748 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 135' ' ' GLY . . . . . 0.413 ' HA3' ' HA ' ' A' ' 20' ' ' VAL . . . 85.73 20.21 56.52 Favored Glycine 0 C--N 1.347 1.157 0 CA-C-O 119.822 -0.432 . . . . 51.3 113.687 176.749 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 136' ' ' MET . . . . . . . . . . . . . 14.4 tpt -67.24 -26.54 66.63 Favored 'General case' 0 N--CA 1.48 1.056 0 C-N-CA 123.156 0.582 . . . . 74.32 110.867 179.153 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 137' ' ' ASN . . . . . . . . . . . . . 52.9 t-20 -56.88 -44.39 82.22 Favored 'General case' 0 N--CA 1.48 1.07 0 C-N-CA 124.259 1.023 . . . . 65.15 109.812 172.164 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 138' ' ' ILE . . . . . . . . . . . . . 49.4 mm -71.47 -32.77 47.42 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.748 0 C-N-CA 123.861 0.864 . . . . 71.12 110.742 -179.08 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 139' ' ' VAL . . . . . 0.609 HG12 HG22 ' A' ' 116' ' ' THR . 93.5 t -67.09 -42.13 87.97 Favored 'Isoleucine or valine' 0 CA--C 1.559 1.317 0 C-N-CA 123.534 0.734 . . . . 54.12 110.837 177.904 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 39.3 mt-10 -73.92 -28.14 61.38 Favored 'General case' 0 N--CA 1.478 0.949 0 CA-C-N 115.563 -0.744 . . . . 62.51 110.804 176.747 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -70.43 -44.27 68.2 Favored 'General case' 0 N--CA 1.476 0.847 0 C-N-CA 123.688 0.795 . . . . 63.3 110.848 178.031 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 142' ' ' MET . . . . . 0.522 ' HB2' HD13 ' A' ' 156' ' ' ILE . 27.7 ptm -73.91 -29.36 62.01 Favored 'General case' 0 N--CA 1.473 0.679 0 CA-C-N 115.567 -0.742 . . . . 74.43 111.133 -177.975 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 143' ' ' GLU . . . . . 0.447 ' HB2' HG21 ' A' ' 116' ' ' THR . 41.2 tt0 -51.29 -38.44 52.87 Favored 'General case' 0 N--CA 1.478 0.97 0 C-N-CA 124.105 0.962 . . . . 71.54 111.707 174.189 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 144' ' ' ARG . . . . . . . . . . . . . 39.1 mtp85 -66.92 -22.1 65.97 Favored 'General case' 0 CA--C 1.542 0.667 0 CA-C-N 115.243 -0.889 . . . . 55.13 112.216 -173.432 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 145' ' ' PHE . . . . . . . . . . . . . 58.4 m-85 -82.35 -5.84 58.87 Favored 'General case' 0 N--CA 1.481 1.106 0 N-CA-C 112.088 0.403 . . . . 74.31 112.088 -178.181 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . -97.51 173.09 28.16 Favored Glycine 0 C--N 1.35 1.347 0 N-CA-C 112.52 -0.232 . . . . 73.04 112.52 177.655 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 46.1 m -134.25 172.37 12.96 Favored 'General case' 0 N--CA 1.486 1.328 0 C-N-CA 124.146 0.978 . . . . 72.44 111.106 -176.164 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 148' ' ' ARG . . . . . 0.422 ' NH1' ' HB3' ' B' ' 223' ' ' GLN . 11.0 mmt180 -57.14 -46.57 82.58 Favored 'General case' 0 N--CA 1.49 1.557 0 C-N-CA 124.697 1.199 . . . . 64.43 112.567 -178.553 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 149' ' ' ASN . . . . . . . . . . . . . 29.9 p-10 -67.34 -14.16 62.67 Favored 'General case' 0 N--CA 1.479 1.02 0 C-N-CA 123.801 0.841 . . . . 70.23 111.884 179.136 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 150' ' ' GLY . . . . . 0.501 ' O ' ' HA ' ' A' ' 55' ' ' ARG . . . 102.68 -4.34 50.2 Favored Glycine 0 C--N 1.351 1.372 0 CA-C-O 119.808 -0.44 . . . . 25.34 112.711 -179.732 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 62.3 tttp -69.93 133.56 47.44 Favored 'General case' 0 N--CA 1.475 0.778 0 CA-C-N 117.15 0.475 . . . . 72.01 110.408 -177.66 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 152' ' ' THR . . . . . . . . . . . . . 24.8 p -102.06 124.68 48.08 Favored 'General case' 0 C--O 1.236 0.38 0 C-N-CA 123.601 0.761 . . . . 73.43 109.468 174.165 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 153' ' ' SER . . . . . . . . . . . . . 47.7 t -75.15 -8.62 57.08 Favored 'General case' 0 CA--C 1.55 0.952 0 C-N-CA 123.419 0.688 . . . . 71.42 111.059 174.866 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 74.7 mmtt -133.96 132.42 40.16 Favored 'General case' 0 N--CA 1.475 0.777 0 C-N-CA 124.54 1.136 . . . . 71.3 109.424 178.489 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 46.1 mtmt -82.31 93.29 7.12 Favored 'General case' 0 N--CA 1.474 0.767 0 N-CA-C 108.085 -1.08 . . . . 73.4 108.085 173.757 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 156' ' ' ILE . . . . . 0.522 HD13 ' HB2' ' A' ' 142' ' ' MET . 62.6 mt -85.23 104.67 13.45 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.557 0 CA-C-N 115.707 -0.679 . . . . 74.21 109.886 -175.223 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 157' ' ' THR . . . . . . . . . . . . . 50.1 p -103.93 148.17 26.48 Favored 'General case' 0 N--CA 1.476 0.83 0 C-N-CA 124.44 1.096 . . . . 73.52 110.712 -173.393 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 158' ' ' ILE . . . . . 0.483 HG23 ' HB3' ' A' ' 8' ' ' PHE . 60.3 mt -74.93 93.43 0.8 Allowed 'Isoleucine or valine' 0 CA--C 1.543 0.706 0 N-CA-C 108.136 -1.061 . . . . 74.34 108.136 169.264 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 159' ' ' ALA . . . . . 0.451 ' HB2' ' HB2' ' A' ' 11' ' ' ALA . . . -57.29 -40.08 77.07 Favored 'General case' 0 N--CA 1.476 0.838 0 C-N-CA 124.585 1.154 . . . . 73.14 112.784 -177.335 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 160' ' ' ASP . . . . . 0.582 ' HA ' ' HE3' ' A' ' 49' ' ' LYS . 29.4 t70 -156.15 163.87 39.08 Favored 'General case' 0 N--CA 1.474 0.738 0 O-C-N 123.394 0.434 . . . . 61.32 111.06 -175.862 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 161' ' ' CYS . . . . . . . . . . . . . 18.6 p -131.39 -169.94 2.28 Favored 'General case' 0 CA--C 1.542 0.661 0 C-N-CA 124.976 1.311 . . . . 72.3 108.729 177.844 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 162' ' ' GLY . . . . . . . . . . . . . . . 131.22 51.69 0.1 OUTLIER Glycine 0 N--CA 1.471 1.008 0 N-CA-C 109.915 -1.274 . . . . 73.35 109.915 -170.225 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 163' ' ' GLN . . . . . 0.664 ' HA ' ' H ' ' A' ' 7' ' ' PHE . 36.7 mt-30 -54.33 122.19 9.87 Favored 'General case' 0 CA--C 1.546 0.821 0 CA-C-N 112.429 -1.885 . . . . 74.52 111.927 -175.836 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 164' ' ' LEU . . . . . . . . . . . . . 82.5 mt -71.62 98.8 1.96 Allowed 'General case' 0 N--CA 1.475 0.806 0 C-N-CA 123.377 0.671 . . . . 70.31 111.377 -168.046 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 165' ' ' GLU . . . . . . . . . . . . . 42.5 mt-10 . . . . . 0 C--O 1.252 1.189 0 N-CA-C 107.742 -1.207 . . . . 73.23 107.742 173.77 . . . . . . . . 0 0 . 1 . 019 nuclear build full ' B' B ' 216' ' ' PRO . . . . . 0.575 ' N ' ' HH ' ' B' ' 221' ' ' TYR . 24.0 Cg_exo . . . . . 0 N--CA 1.486 1.068 0 N-CA-C 110.361 -0.669 . . . . 64.24 110.361 . . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 217' ' ' GLU . . . . . . . . . . . . . 11.2 pt-20 -59.89 145.08 85.03 Favored Pre-proline 0 CA--C 1.554 1.097 0 CA-C-N 114.543 -1.208 . . . . 72.11 112.259 -178.503 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 218' ' ' PRO . . . . . . . . . . . . . 32.4 Cg_exo -61.89 98.17 0.16 Allowed 'Trans proline' 0 C--N 1.374 1.9 0 C-N-CA 122.63 2.22 . . . . 63.2 111.787 167.861 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 219' ' ' GLY . . . . . . . . . . . . . . . 171.14 152.48 8.27 Favored Glycine 0 C--N 1.339 0.748 0 CA-C-N 115.827 -0.624 . . . . 72.42 111.865 178.4 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 220' ' ' PRO . . . . . 0.623 ' HB3' HD11 ' A' ' 122' ' ' LEU . 84.5 Cg_endo -77.72 155.52 31.13 Favored 'Trans proline' 0 C--N 1.373 1.852 0 C-N-CA 122.691 2.26 . . . . 61.21 112.395 179.888 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 221' ' ' TYR . . . . . 0.575 ' HH ' ' N ' ' B' ' 216' ' ' PRO . 54.4 m-85 -114.08 142.88 45.64 Favored 'General case' 0 C--O 1.244 0.777 0 C-N-CA 123.306 0.642 . . . . 74.14 109.469 -174.799 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 222' ' ' ALA . . . . . . . . . . . . . . . -171.08 161.13 6.71 Favored 'General case' 0 C--O 1.243 0.742 0 C-N-CA 124.457 1.103 . . . . 75.04 110.198 175.086 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 223' ' ' GLN . . . . . 0.422 ' HB3' ' NH1' ' A' ' 148' ' ' ARG . 76.4 mt-30 60.19 64.31 2.7 Favored Pre-proline 0 CA--C 1.553 1.085 0 C-N-CA 124.725 1.21 . . . . 73.44 111.572 174.748 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 224' ' ' PRO . . . . . . . . . . . . . 22.1 Cg_exo . . . . . 0 C--N 1.379 2.178 0 C-N-CA 123.411 2.741 . . . . 53.24 112.399 -176.535 . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 60.7 mtt . . . . . 0 N--CA 1.482 1.157 0 N-CA-C 109.075 -0.713 . . . . 65.11 109.075 . . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 24.0 t -77.54 72.24 0.5 Allowed 'Isoleucine or valine' 0 N--CA 1.483 1.21 0 CA-C-O 121.915 0.864 . . . . 70.42 109.099 179.185 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 88.1 m-20 -101.92 105.5 42.14 Favored Pre-proline 0 C--O 1.24 0.588 0 CA-C-N 114.267 -1.333 . . . . 73.35 110.024 177.179 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 4' ' ' PRO . . . . . 0.451 ' HG2' ' HB2' ' A' ' 24' ' ' LEU . 60.7 Cg_endo -80.04 141.02 14.54 Favored 'Trans proline' 0 C--N 1.362 1.283 0 C-N-CA 122.116 1.877 . . . . 75.34 111.003 164.518 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 5' ' ' THR . . . . . 0.402 ' HB ' ' O ' ' A' ' 164' ' ' LEU . 50.6 m -96.54 134.0 40.31 Favored 'General case' 0 CA--C 1.533 0.302 0 N-CA-C 108.744 -0.835 . . . . 72.53 108.744 175.673 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 6' ' ' VAL . . . . . 0.6 ' HA ' ' HB2' ' A' ' 163' ' ' GLN . 58.2 t -100.47 145.84 10.27 Favored 'Isoleucine or valine' 0 C--O 1.217 -0.645 0 N-CA-C 107.869 -1.16 . . . . 63.21 107.869 174.593 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 7' ' ' PHE . . . . . 0.443 ' HB2' ' HG ' ' A' ' 164' ' ' LEU . 87.7 t80 -129.26 126.46 39.12 Favored 'General case' 0 C--O 1.239 0.552 0 N-CA-C 109.132 -0.692 . . . . 75.52 109.132 178.663 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 8' ' ' PHE . . . . . 0.441 ' HE2' ' HZ ' ' A' ' 36' ' ' PHE . 31.0 m-85 -128.16 166.0 19.35 Favored 'General case' 0 C--O 1.238 0.477 0 C-N-CA 124.253 1.021 . . . . 73.41 109.409 168.8 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 29.1 m-20 -115.16 111.96 21.8 Favored 'General case' 0 C--N 1.326 -0.419 0 N-CA-C 107.291 -1.374 . . . . 75.14 107.291 170.835 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 10' ' ' ILE . . . . . 0.482 HG21 ' SD ' ' A' ' 142' ' ' MET . 46.8 mm -80.89 125.76 39.5 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.473 0 N-CA-C 108.896 -0.779 . . . . 60.1 108.896 -179.461 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 11' ' ' ALA . . . . . 0.821 ' HB2' ' HB2' ' A' ' 159' ' ' ALA . . . -114.6 142.82 45.94 Favored 'General case' 0 C--O 1.217 -0.634 0 C-N-CA 124.556 1.142 . . . . 52.21 110.199 -173.839 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 12' ' ' VAL . . . . . 0.46 HG22 HG12 ' A' ' 156' ' ' ILE . 60.9 t -123.99 135.12 64.61 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.907 0 N-CA-C 107.237 -1.394 . . . . 64.21 107.237 172.097 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 25.4 m-20 65.49 20.32 11.68 Favored 'General case' 0 N--CA 1.494 1.73 0 C-N-CA 124.304 1.041 . . . . 75.21 110.424 -168.841 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 80.36 -5.7 62.93 Favored Glycine 0 C--N 1.358 1.753 0 CA-C-N 116.065 -0.516 . . . . 60.11 113.757 -173.849 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 30.8 mm-40 -104.77 126.94 29.9 Favored Pre-proline 0 N--CA 1.475 0.823 0 C-N-CA 123.882 0.873 . . . . 75.33 110.45 -175.52 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 14.8 Cg_endo -51.87 112.94 0.96 Allowed 'Trans proline' 0 C--N 1.385 2.494 0 C-N-CA 123.538 2.826 . . . . 63.52 112.647 -174.397 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 50.7 tp -76.42 -46.35 27.52 Favored 'General case' 0 N--CA 1.468 0.472 0 CA-C-N 115.007 -0.997 . . . . 52.41 108.859 175.535 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -169.57 -176.21 39.25 Favored Glycine 0 C--N 1.34 0.781 0 CA-C-N 115.169 -0.923 . . . . 72.34 112.258 179.777 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 13.5 ptp180 -109.79 144.44 38.21 Favored 'General case' 0 N--CA 1.475 0.786 0 C-N-CA 123.833 0.853 . . . . 54.34 110.256 -179.536 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 99.3 t -135.55 131.97 51.38 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.733 0 C-N-CA 124.058 0.943 . . . . 74.25 108.918 177.117 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 21' ' ' SER . . . . . 0.473 ' OG ' ' HB2' ' A' ' 134' ' ' GLU . 78.0 p -116.13 130.9 57.02 Favored 'General case' 0 CA--C 1.552 1.021 0 C-N-CA 123.388 0.675 . . . . 75.24 109.561 173.914 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 22' ' ' PHE . . . . . 0.452 ' CD1' HD22 ' A' ' 98' ' ' LEU . 44.9 m-85 -102.61 169.94 8.34 Favored 'General case' 0 N--CA 1.471 0.575 0 C-N-CA 124.785 1.234 . . . . 64.2 110.015 178.928 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 6.4 tp10 -130.95 106.31 8.33 Favored 'General case' 0 C--O 1.24 0.57 0 N-CA-C 108.593 -0.891 . . . . 54.44 108.593 -179.691 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 24' ' ' LEU . . . . . 0.451 ' HB2' ' HG2' ' A' ' 4' ' ' PRO . 52.1 mt -78.71 124.75 28.52 Favored 'General case' 0 N--CA 1.468 0.448 0 N-CA-C 109.962 -0.384 . . . . 75.15 109.962 178.383 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 25' ' ' PHE . . . . . 0.483 ' HB2' HD11 ' A' ' 90' ' ' LEU . 36.4 m-85 -85.34 60.0 5.98 Favored 'General case' 0 CA--C 1.545 0.771 0 N-CA-C 108.777 -0.823 . . . . 73.24 108.777 173.132 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -61.34 -33.41 73.57 Favored 'General case' 0 N--CA 1.483 1.21 0 C-N-CA 123.613 0.765 . . . . 75.42 111.666 -175.344 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 12.2 p-10 -59.98 -29.59 68.55 Favored 'General case' 0 CA--C 1.549 0.907 0 C-N-CA 124.372 1.069 . . . . 70.04 111.92 176.765 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 28' ' ' LYS . . . . . 0.579 ' HD2' HD21 ' A' ' 90' ' ' LEU . 40.0 mttm -94.72 -42.29 8.83 Favored 'General case' 0 N--CA 1.482 1.14 0 C-N-CA 123.548 0.739 . . . . 74.24 110.637 -178.114 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 29' ' ' VAL . . . . . 0.532 HG21 ' HA ' ' A' ' 129' ' ' PHE . 18.9 m -124.58 82.17 59.47 Favored Pre-proline 0 CA--C 1.563 1.473 0 C-N-CA 123.843 0.857 . . . . 74.33 110.867 -176.369 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 60.7 Cg_exo -53.77 -52.6 8.12 Favored 'Trans proline' 0 C--N 1.386 2.533 0 C-N-CA 123.183 2.589 . . . . 75.03 113.504 -177.83 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 4.0 ttmp? -66.47 -52.77 42.72 Favored 'General case' 0 N--CA 1.481 1.096 0 C-N-CA 124.252 1.021 . . . . 75.02 111.975 -177.301 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 32' ' ' THR . . . . . 0.66 HG22 ' HD2' ' A' ' 129' ' ' PHE . 1.4 m -64.55 -38.04 89.63 Favored 'General case' 0 CA--C 1.549 0.925 0 CA-C-N 115.23 -0.895 . . . . 73.03 110.94 -169.586 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -83.6 -36.44 23.92 Favored 'General case' 0 CA--C 1.548 0.885 0 C-N-CA 122.825 0.45 . . . . 75.44 112.2 -178.826 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 29.9 tt0 -57.03 -47.42 80.95 Favored 'General case' 0 N--CA 1.492 1.64 0 C-N-CA 123.371 0.668 . . . . 53.11 110.535 175.439 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 35' ' ' ASN . . . . . 0.499 ' O ' ' HG ' ' A' ' 39' ' ' LEU . 39.8 t30 -49.63 -57.38 7.27 Favored 'General case' 0 C--N 1.349 0.577 0 O-C-N 125.406 1.691 . . . . 73.5 110.474 179.209 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 36' ' ' PHE . . . . . 0.441 ' HZ ' ' HE2' ' A' ' 8' ' ' PHE . 72.3 t80 -62.24 -45.2 94.38 Favored 'General case' 0 CA--C 1.543 0.675 0 O-C-N 124.169 0.918 . . . . 73.13 112.051 -175.939 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 11.6 ttm180 -54.14 -47.72 71.59 Favored 'General case' 0 N--CA 1.482 1.143 0 O-C-N 123.843 0.714 . . . . 75.44 111.507 176.123 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 38' ' ' ALA . . . . . 0.522 ' HB1' ' HG2' ' A' ' 44' ' ' LYS . . . -70.44 -30.37 67.19 Favored 'General case' 0 CA--C 1.544 0.724 0 CA-C-N 115.578 -0.737 . . . . 74.03 111.809 -175.605 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 39' ' ' LEU . . . . . 0.552 HD22 ' HE2' ' A' ' 48' ' ' TYR . 99.7 mt -71.31 -43.64 66.7 Favored 'General case' 0 N--CA 1.477 0.883 0 C-N-CA 123.603 0.761 . . . . 71.13 110.593 175.161 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 34.9 t -64.56 -52.32 58.29 Favored 'General case' 0 N--CA 1.477 0.924 0 C-N-CA 124.979 1.312 . . . . 70.2 111.562 -174.843 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 41' ' ' THR . . . . . 0.446 ' OG1' ' HG2' ' A' ' 43' ' ' GLU . 67.4 p -85.18 -31.25 23.33 Favored 'General case' 0 C--O 1.24 0.587 0 CA-C-N 115.096 -0.956 . . . . 74.11 111.388 -176.054 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 85.99 35.72 10.92 Favored Glycine 0 C--N 1.347 1.16 0 CA-C-N 116.154 -0.476 . . . . 53.24 112.736 -177.803 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 43' ' ' GLU . . . . . 0.446 ' HG2' ' OG1' ' A' ' 41' ' ' THR . 26.7 mm-40 -62.89 -30.86 71.85 Favored 'General case' 0 N--CA 1.483 1.218 0 C-N-CA 122.92 0.488 . . . . 55.41 110.606 172.682 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 44' ' ' LYS . . . . . 0.522 ' HG2' ' HB1' ' A' ' 38' ' ' ALA . 31.5 mmmt -100.57 20.19 15.51 Favored 'General case' 0 CA--C 1.548 0.899 0 C-N-CA 123.707 0.803 . . . . 74.53 111.465 177.353 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 71.17 41.91 59.15 Favored Glycine 0 C--N 1.35 1.334 0 CA-C-O 119.528 -0.595 . . . . 71.23 114.562 171.896 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 24.1 m-85 -123.19 -48.33 1.98 Allowed 'General case' 0 N--CA 1.486 1.372 0 CA-C-N 117.596 0.698 . . . . 71.42 111.071 -176.876 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 48.58 62.64 4.3 Favored Glycine 0 C--N 1.356 1.685 0 O-C-N 124.169 0.918 . . . . 15.11 114.288 171.669 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 48' ' ' TYR . . . . . 0.589 ' CE1' ' HA2' ' A' ' 75' ' ' GLY . 66.1 m-85 -60.78 95.37 0.04 OUTLIER 'General case' 0 N--CA 1.48 1.065 0 CA-C-O 122.108 0.956 . . . . 72.1 112.751 -174.617 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 28.6 tptp -109.41 131.45 55.05 Favored 'General case' 0 CA--C 1.537 0.457 0 CA-C-N 113.337 -1.756 . . . . 51.53 109.149 -176.798 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 72.71 20.34 79.64 Favored Glycine 0 C--N 1.346 1.098 0 CA-C-O 119.665 -0.519 . . . . 70.04 113.793 177.412 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 51' ' ' SER . . . . . 0.485 ' HB3' ' HA2' ' A' ' 65' ' ' GLY . 49.0 m -61.14 114.56 3.2 Favored 'General case' 0 N--CA 1.476 0.858 0 C-N-CA 123.249 0.62 . . . . 63.04 110.368 -178.29 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 52' ' ' CYS . . . . . . . . . . . . . 53.5 t -92.14 121.44 33.69 Favored 'General case' 0 N--CA 1.474 0.727 0 N-CA-C 113.031 0.752 . . . . 75.21 113.031 -165.945 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 53' ' ' PHE . . . . . 0.584 ' HB2' ' HB ' ' A' ' 156' ' ' ILE . 76.4 m-85 -69.4 114.57 7.77 Favored 'General case' 0 C--O 1.239 0.517 0 C-N-CA 124.867 1.267 . . . . 75.5 109.816 167.803 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 17.4 p-80 -128.04 -4.5 5.66 Favored 'General case' 0 N--CA 1.481 1.079 0 C-N-CA 123.565 0.746 . . . . 75.4 112.031 -173.819 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 36.0 ttt180 -135.19 107.37 7.19 Favored 'General case' 0 C--N 1.357 0.928 0 N-CA-C 108.975 -0.75 . . . . 74.23 108.975 170.756 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 56' ' ' ILE . . . . . 0.494 HG23 ' SG ' ' A' ' 62' ' ' CYS . 71.8 mt -130.62 129.25 64.17 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.694 0 C-N-CA 123.721 0.808 . . . . 64.35 109.242 177.365 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 57' ' ' ILE . . . . . 0.468 HG12 ' HA2' ' A' ' 150' ' ' GLY . 52.2 mt -117.07 121.54 32.38 Favored Pre-proline 0 CA--C 1.556 1.186 0 C-N-CA 124.584 1.154 . . . . 61.04 108.725 176.903 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 58' ' ' PRO . . . . . 0.503 ' HA ' ' HG3' ' A' ' 143' ' ' GLU . 24.3 Cg_exo -64.01 146.85 91.67 Favored 'Trans proline' 0 C--N 1.375 1.954 0 C-N-CA 122.792 2.328 . . . . 65.2 112.63 173.388 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 63.99 31.22 80.08 Favored Glycine 0 C--N 1.345 1.033 0 CA-C-N 115.117 -0.947 . . . . 63.05 113.284 -176.306 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 40.0 t80 -158.46 -77.77 0.07 Allowed 'General case' 0 CA--C 1.549 0.923 0 CA-C-N 116.814 0.307 . . . . 74.41 111.653 -174.18 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 48.3 ttm -165.6 157.12 14.32 Favored 'General case' 0 N--CA 1.489 1.49 0 N-CA-C 112.01 0.374 . . . . 70.54 112.01 -163.433 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 62' ' ' CYS . . . . . 0.494 ' SG ' HG23 ' A' ' 56' ' ' ILE . 61.2 m -131.86 113.37 13.4 Favored 'General case' 0 N--CA 1.471 0.623 0 C-N-CA 124.299 1.04 . . . . 54.22 109.11 175.772 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 13.4 pt20 -117.6 149.55 40.48 Favored 'General case' 0 N--CA 1.488 1.448 0 CA-C-O 121.396 0.617 . . . . 75.24 111.556 -177.343 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 64' ' ' GLY . . . . . 0.459 ' CA ' ' HA ' ' A' ' 53' ' ' PHE . . . -162.1 179.4 37.46 Favored Glycine 0 C--N 1.343 0.951 0 CA-C-N 114.536 -1.211 . . . . 60.11 113.94 -176.492 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 65' ' ' GLY . . . . . 0.485 ' HA2' ' HB3' ' A' ' 51' ' ' SER . . . 110.04 98.31 2.5 Favored Glycine 0 N--CA 1.447 -0.581 0 N-CA-C 108.91 -1.676 . . . . 74.45 108.91 -167.277 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 23.7 t70 -124.69 19.95 8.6 Favored 'General case' 0 N--CA 1.483 1.21 0 CA-C-O 121.765 0.793 . . . . 53.41 109.132 179.353 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 49.1 t80 -81.54 -77.83 0.2 Allowed 'General case' 0 CA--C 1.551 1.004 0 CA-C-N 115.301 -0.863 . . . . 61.42 111.746 -169.55 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 89.6 m -85.54 107.74 17.61 Favored 'General case' 0 N--CA 1.48 1.068 0 C-N-CA 122.406 0.282 . . . . 73.31 110.442 -175.348 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 77.9 mtp180 66.44 80.86 0.21 Allowed 'General case' 0 N--CA 1.472 0.672 0 C-N-CA 125.177 1.391 . . . . 74.5 110.468 -179.85 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 7.8 p80 -70.98 73.87 0.61 Allowed 'General case' 0 CA--C 1.558 1.265 0 CA-C-O 122.343 1.068 . . . . 70.31 110.652 179.709 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 7.4 t30 -153.81 30.39 0.46 Allowed 'General case' 0 CA--C 1.553 1.073 0 C-N-CA 125.066 1.347 . . . . 65.44 107.587 -172.821 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 92.17 -8.67 77.48 Favored Glycine 0 C--N 1.353 1.507 0 CA-C-N 114.874 -1.057 . . . . 53.41 113.431 -177.235 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 73' ' ' THR . . . . . 0.608 ' HA ' ' HB2' ' A' ' 110' ' ' SER . 28.7 m -85.09 -67.12 0.82 Allowed 'General case' 0 CA--C 1.546 0.815 0 N-CA-C 108.525 -0.917 . . . . 63.32 108.525 174.458 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 54.92 18.58 11.87 Favored Glycine 0 C--N 1.348 1.242 0 N-CA-C 115.807 1.083 . . . . 71.34 115.807 167.248 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 75' ' ' GLY . . . . . 0.589 ' HA2' ' CE1' ' A' ' 48' ' ' TYR . . . 147.84 54.14 0.02 OUTLIER Glycine 0 CA--C 1.494 -1.233 0 O-C-N 121.537 -0.978 . . . . 53.0 111.826 -160.287 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 64.2 pttt -60.18 167.74 2.26 Favored 'General case' 0 CA--C 1.546 0.823 0 O-C-N 124.524 0.779 . . . . 44.14 111.173 173.782 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 87.1 p -88.78 174.16 8.15 Favored 'General case' 0 C--O 1.241 0.647 0 CA-C-N 115.68 -0.691 . . . . 51.21 110.607 -177.746 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 29.6 pt -69.77 -21.69 24.44 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.787 0 CA-C-N 115.846 -0.616 . . . . 74.04 110.557 173.244 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 56.4 m-85 -87.14 0.4 55.36 Favored 'General case' 0 N--CA 1.479 0.989 0 C-N-CA 124.134 0.974 . . . . 63.43 111.636 -178.166 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 125.6 -150.71 17.47 Favored Glycine 0 C--N 1.347 1.172 0 N-CA-C 111.135 -0.786 . . . . 73.13 111.135 -179.933 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 45.9 tt0 -63.02 -40.73 98.62 Favored 'General case' 0 N--CA 1.476 0.873 0 C-N-CA 123.392 0.677 . . . . 72.25 110.612 175.997 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 82' ' ' LYS . . . . . 0.476 ' HD3' ' HA ' ' A' ' 107' ' ' THR . 11.2 ptpp? -150.66 168.38 24.5 Favored 'General case' 0 CA--C 1.548 0.887 0 CA-C-N 115.637 -0.71 . . . . 73.23 110.963 -171.727 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 35.5 p90 -159.77 164.33 33.88 Favored 'General case' 0 N--CA 1.477 0.916 0 C-N-CA 124.797 1.239 . . . . 72.23 109.512 176.065 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 11.6 pt-20 -94.25 159.16 15.26 Favored 'General case' 0 N--CA 1.478 0.931 0 C-N-CA 123.158 0.583 . . . . 74.13 109.834 173.934 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 63.9 m-20 -67.08 151.36 47.75 Favored 'General case' 0 N--CA 1.475 0.809 0 C-N-CA 124.371 1.069 . . . . 74.13 113.814 -170.74 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 6.3 tp10 -69.59 -59.33 3.03 Favored 'General case' 0 CA--C 1.55 0.958 0 CA-C-N 114.953 -1.022 . . . . 75.21 111.12 177.567 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 87' ' ' ASN . . . . . 0.417 ' OD1' HG12 ' A' ' 29' ' ' VAL . 25.8 p-10 -174.2 137.51 0.54 Allowed 'General case' 0 N--CA 1.489 1.508 0 C-N-CA 123.88 0.872 . . . . 75.52 109.912 -171.639 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 91.9 m-85 -89.12 54.82 3.1 Favored 'General case' 0 N--CA 1.489 1.508 0 CA-C-O 121.468 0.652 . . . . 74.4 111.685 -171.492 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 49.3 mt -82.47 -46.72 19.26 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.812 0 CA-C-N 115.632 -0.713 . . . . 75.41 109.16 170.591 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 90' ' ' LEU . . . . . 0.579 HD21 ' HD2' ' A' ' 28' ' ' LYS . 90.2 mt -95.33 110.73 22.7 Favored 'General case' 0 C--O 1.241 0.641 0 CA-C-N 115.445 -0.798 . . . . 53.11 110.876 -174.728 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 23.5 pttm -107.84 169.52 8.55 Favored 'General case' 0 N--CA 1.474 0.769 0 C-N-CA 124.176 0.99 . . . . 74.41 109.409 173.503 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 92' ' ' HIS . . . . . 0.463 ' HA ' HG21 ' A' ' 97' ' ' ILE . 17.1 m-70 -87.68 47.07 1.45 Allowed 'General case' 0 N--CA 1.481 1.088 0 C-N-CA 124.045 0.938 . . . . 55.2 110.371 -173.688 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 9.5 t -83.71 5.32 25.11 Favored 'General case' 0 CA--C 1.552 1.028 0 C-N-CA 124.315 1.046 . . . . 75.45 111.971 -174.059 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -133.53 153.42 20.82 Favored Glycine 0 C--N 1.347 1.155 0 CA-C-O 119.713 -0.493 . . . . 74.11 112.067 179.091 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 73.5 Cg_endo -75.89 142.38 25.2 Favored 'Trans proline' 0 C--N 1.367 1.531 0 C-N-CA 122.538 2.158 . . . . 73.02 110.064 167.258 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 89.13 6.69 71.17 Favored Glycine 0 N--CA 1.467 0.75 0 CA-C-O 120.145 -0.253 . . . . 62.42 113.121 -175.931 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 97' ' ' ILE . . . . . 0.717 ' HB ' ' SG ' ' A' ' 115' ' ' CYS . 5.9 mm -68.63 120.18 15.67 Favored 'Isoleucine or valine' 0 CA--C 1.552 1.057 0 C-N-CA 123.181 0.593 . . . . 75.34 110.782 179.191 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 98' ' ' LEU . . . . . 0.452 HD22 ' CD1' ' A' ' 22' ' ' PHE . 56.8 tp -103.4 123.05 46.11 Favored 'General case' 0 CA--C 1.554 1.122 0 C-N-CA 124.4 1.08 . . . . 54.34 111.038 -177.657 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 99' ' ' SER . . . . . 0.712 ' HB3' ' HA ' ' A' ' 128' ' ' VAL . 11.3 p -152.88 158.39 42.08 Favored 'General case' 0 N--CA 1.473 0.687 0 C-N-CA 124.369 1.067 . . . . 71.41 109.514 176.212 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 100' ' ' MET . . . . . 0.661 ' HG3' ' HE2' ' A' ' 129' ' ' PHE . 79.7 mtp -77.25 145.83 37.28 Favored 'General case' 0 N--CA 1.487 1.398 0 N-CA-C 109.944 -0.391 . . . . 75.22 109.944 -179.898 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 101' ' ' ALA . . . . . 0.518 ' HB3' ' HB2' ' A' ' 111' ' ' GLN . . . -76.07 165.85 24.34 Favored 'General case' 0 C--O 1.247 0.943 0 CA-C-O 121.015 0.436 . . . . 65.44 111.236 -177.681 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 102' ' ' ASN . . . . . 0.475 ' HB3' ' HA ' ' A' ' 108' ' ' ASN . 27.1 p-10 -160.38 156.79 26.74 Favored 'General case' 0 N--CA 1.472 0.631 0 CA-C-N 115.809 -0.632 . . . . 72.41 111.007 -176.766 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -93.33 -17.23 23.82 Favored 'General case' 0 CA--C 1.545 0.773 0 CA-C-N 115.358 -0.837 . . . . 54.31 110.674 169.587 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 177.94 -178.75 48.51 Favored Glycine 0 C--N 1.352 1.437 0 CA-C-O 119.445 -0.642 . . . . 64.51 112.957 178.839 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 50.2 Cg_exo -58.85 141.22 97.82 Favored 'Trans proline' 0 C--N 1.374 1.917 0 C-N-CA 123.22 2.614 . . . . 75.03 112.439 171.554 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 64.4 t30 66.54 10.55 7.45 Favored 'General case' 0 N--CA 1.485 1.302 0 C-N-CA 125.48 1.512 . . . . 73.23 111.243 -176.301 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 107' ' ' THR . . . . . 0.476 ' HA ' ' HD3' ' A' ' 82' ' ' LYS . 16.7 m -126.57 18.76 7.42 Favored 'General case' 0 CA--C 1.558 1.273 0 C-N-CA 124.767 1.227 . . . . 60.12 108.769 -178.828 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 108' ' ' ASN . . . . . 0.475 ' HA ' ' HB3' ' A' ' 102' ' ' ASN . 48.1 t30 -86.13 143.74 27.87 Favored 'General case' 0 N--CA 1.48 1.026 0 C-N-CA 123.827 0.851 . . . . 61.45 109.206 177.33 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 112.69 26.29 4.24 Favored Glycine 0 N--CA 1.469 0.86 0 C-N-CA 121.18 -0.533 . . . . 40.02 113.481 -177.566 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 110' ' ' SER . . . . . 0.608 ' HB2' ' HA ' ' A' ' 73' ' ' THR . 31.6 p -129.17 121.06 26.91 Favored 'General case' 0 CA--C 1.539 0.551 0 N-CA-C 107.859 -1.163 . . . . 65.24 107.859 171.697 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 111' ' ' GLN . . . . . 0.518 ' HB2' ' HB3' ' A' ' 101' ' ' ALA . 48.8 mt-30 66.49 177.21 0.23 Allowed 'General case' 0 N--CA 1.491 1.583 0 C-N-CA 124.536 1.135 . . . . 70.13 111.271 -171.574 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 112' ' ' PHE . . . . . 0.638 ' HA ' ' HA ' ' A' ' 100' ' ' MET . 3.1 m-85 -131.75 166.92 20.45 Favored 'General case' 0 N--CA 1.477 0.882 0 N-CA-C 107.396 -1.335 . . . . 72.44 107.396 175.336 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 113' ' ' PHE . . . . . 0.424 ' O ' HD12 ' A' ' 98' ' ' LEU . 48.2 p90 -157.13 160.47 38.85 Favored 'General case' 0 N--CA 1.477 0.916 0 CA-C-O 121.393 0.616 . . . . 73.43 112.138 170.902 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 114' ' ' ILE . . . . . 0.483 HG21 HG11 ' A' ' 139' ' ' VAL . 20.2 mt -124.51 109.71 23.29 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.821 0 CA-C-N 114.024 -1.444 . . . . 71.32 107.443 171.845 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 115' ' ' CYS . . . . . 0.717 ' SG ' ' HB ' ' A' ' 97' ' ' ILE . 29.8 p -74.5 105.5 5.66 Favored 'General case' 0 N--CA 1.474 0.769 0 N-CA-C 108.836 -0.802 . . . . 74.04 108.836 177.464 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 116' ' ' THR . . . . . 0.421 HG22 HG12 ' A' ' 139' ' ' VAL . 24.2 p -71.27 -23.06 61.9 Favored 'General case' 0 N--CA 1.476 0.853 0 C-N-CA 124.396 1.078 . . . . 62.14 111.601 -174.015 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -107.39 152.89 23.57 Favored 'General case' 0 C--O 1.245 0.839 0 N-CA-C 108.794 -0.817 . . . . 71.3 108.794 166.775 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 20.3 ptmt -70.69 99.0 1.61 Allowed 'General case' 0 CA--C 1.543 0.676 0 CA-C-O 121.762 0.792 . . . . 75.51 109.033 172.851 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 119' ' ' THR . . . . . . . . . . . . . 82.2 p -81.7 86.32 6.44 Favored 'General case' 0 CA--C 1.547 0.858 0 CA-C-O 121.963 0.887 . . . . 63.23 109.656 -175.721 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 12.1 pt-20 -74.28 -29.99 61.9 Favored 'General case' 0 N--CA 1.48 1.057 0 CA-C-N 114.662 -1.153 . . . . 73.14 111.132 -175.092 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 121' ' ' TRP . . . . . . . . . . . . . 34.5 p90 -64.91 -13.4 56.76 Favored 'General case' 0 N--CA 1.48 1.03 0 C-N-CA 123.987 0.915 . . . . 75.35 111.57 175.347 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 64.7 mt -99.42 29.08 4.17 Favored 'General case' 0 CA--C 1.551 0.987 0 C-N-CA 123.75 0.82 . . . . 45.12 111.51 176.125 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 83.4 m-20 -69.45 134.95 49.56 Favored 'General case' 0 N--CA 1.484 1.254 0 N-CA-C 109.651 -0.5 . . . . 63.44 109.651 166.615 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 81.9 0.86 89.97 Favored Glycine 0 C--N 1.341 0.844 0 CA-C-N 116.223 -0.444 . . . . 34.42 113.056 -176.209 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 125' ' ' LYS . . . . . 0.46 ' HG3' ' H ' ' A' ' 126' ' ' HIS . 8.5 tppt? -78.43 -170.93 2.23 Favored 'General case' 0 N--CA 1.477 0.915 0 N-CA-C 108.641 -0.874 . . . . 63.44 108.641 176.96 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 126' ' ' HIS . . . . . 0.46 ' H ' ' HG3' ' A' ' 125' ' ' LYS . 44.7 p-80 -68.57 152.84 44.81 Favored 'General case' 0 CA--C 1.545 0.781 0 O-C-N 122.051 -0.406 . . . . 65.13 110.022 -175.826 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 48.5 t -79.37 147.42 6.7 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.697 0 C-N-CA 123.631 0.772 . . . . 75.34 112.452 -164.771 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 128' ' ' VAL . . . . . 0.712 ' HA ' ' HB3' ' A' ' 99' ' ' SER . 61.7 t -83.19 158.81 3.73 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.759 0 C-N-CA 125.103 1.361 . . . . 54.35 109.933 176.375 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 129' ' ' PHE . . . . . 0.661 ' HE2' ' HG3' ' A' ' 100' ' ' MET . 7.3 p90 -130.62 -24.13 2.51 Favored 'General case' 0 N--CA 1.479 1.023 0 N-CA-C 111.918 0.34 . . . . 72.2 111.918 173.509 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . -143.23 175.53 23.25 Favored Glycine 0 C--N 1.34 0.765 0 O-C-N 123.31 0.381 . . . . 63.31 112.588 -172.997 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 34.6 ttpt -161.08 137.9 8.71 Favored 'General case' 0 N--CA 1.466 0.365 0 N-CA-C 108.52 -0.919 . . . . 74.22 108.52 179.612 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 132' ' ' VAL . . . . . 0.467 HG11 ' HA ' ' A' ' 136' ' ' MET . 40.7 t -61.35 108.45 0.47 Allowed 'Isoleucine or valine' 0 CA--C 1.544 0.72 0 C-N-CA 123.418 0.687 . . . . 64.53 109.976 177.043 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 21.4 ptmt -85.74 -39.19 17.43 Favored 'General case' 0 CA--C 1.542 0.663 0 N-CA-C 109.689 -0.485 . . . . 53.24 109.689 177.006 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 134' ' ' GLU . . . . . 0.473 ' HB2' ' OG ' ' A' ' 21' ' ' SER . 53.4 mm-40 -137.81 149.61 46.5 Favored 'General case' 0 N--CA 1.483 1.195 0 C-N-CA 124.302 1.041 . . . . 64.34 109.253 177.573 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 85.03 20.38 57.67 Favored Glycine 0 N--CA 1.473 1.161 0 O-C-N 123.414 0.446 . . . . 75.34 112.649 -179.295 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 136' ' ' MET . . . . . 0.467 ' HA ' HG11 ' A' ' 132' ' ' VAL . 15.1 tpt -61.07 -33.89 74.04 Favored 'General case' 0 N--CA 1.483 1.211 0 C-N-CA 123.763 0.825 . . . . 73.21 110.943 179.662 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 137' ' ' ASN . . . . . . . . . . . . . 11.4 m120 -64.91 -32.67 74.49 Favored 'General case' 0 CA--C 1.546 0.797 0 C-N-CA 123.849 0.86 . . . . 72.4 111.82 -179.271 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 138' ' ' ILE . . . . . 0.408 ' O ' ' HG3' ' A' ' 142' ' ' MET . 46.8 mm -70.56 -37.8 71.16 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.966 0 C-N-CA 123.143 0.577 . . . . 64.32 109.868 177.355 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 139' ' ' VAL . . . . . 0.483 HG11 HG21 ' A' ' 114' ' ' ILE . 59.3 t -67.17 -37.39 79.1 Favored 'Isoleucine or valine' 0 CA--C 1.555 1.139 0 C-N-CA 123.829 0.852 . . . . 62.3 110.963 177.338 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 38.7 mt-10 -70.86 -28.4 64.54 Favored 'General case' 0 N--CA 1.478 0.934 0 CA-C-N 115.792 -0.64 . . . . 54.05 110.706 176.328 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -68.8 -39.52 80.07 Favored 'General case' 0 N--CA 1.475 0.814 0 C-N-CA 122.876 0.47 . . . . 73.45 110.278 172.38 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 142' ' ' MET . . . . . 0.482 ' SD ' HG21 ' A' ' 10' ' ' ILE . 76.6 mtp -58.25 -41.65 84.69 Favored 'General case' 0 N--CA 1.485 1.282 0 C-N-CA 123.983 0.913 . . . . 70.45 111.157 175.654 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 143' ' ' GLU . . . . . 0.503 ' HG3' ' HA ' ' A' ' 58' ' ' PRO . 37.8 tt0 -53.69 -43.3 68.81 Favored 'General case' 0 CA--C 1.546 0.79 0 CA-C-N 114.92 -1.036 . . . . 60.42 111.69 176.767 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 144' ' ' ARG . . . . . . . . . . . . . 56.2 mtt180 -72.53 -18.58 61.63 Favored 'General case' 0 N--CA 1.475 0.812 0 C-N-CA 124.155 0.982 . . . . 53.01 111.646 -177.263 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 145' ' ' PHE . . . . . 0.494 ' HB3' ' HB2' ' A' ' 154' ' ' LYS . 24.9 m-85 -86.56 -4.27 59.15 Favored 'General case' 0 N--CA 1.479 0.981 0 C-N-CA 123.398 0.679 . . . . 61.12 111.359 176.603 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . -97.24 -179.22 34.17 Favored Glycine 0 C--N 1.347 1.192 0 C-N-CA 123.053 0.358 . . . . 74.13 112.599 175.569 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 21.4 m -134.03 163.13 30.24 Favored 'General case' 0 N--CA 1.482 1.135 0 C-N-CA 124.114 0.966 . . . . 73.31 110.512 -176.121 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 148' ' ' ARG . . . . . . . . . . . . . 26.6 mmt180 -67.91 -28.18 67.28 Favored 'General case' 0 N--CA 1.486 1.364 0 C-N-CA 123.432 0.693 . . . . 72.21 112.037 -175.733 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 149' ' ' ASN . . . . . . . . . . . . . 30.8 p-10 -82.39 2.45 32.37 Favored 'General case' 0 N--CA 1.483 1.177 0 C-N-CA 123.644 0.778 . . . . 74.31 111.358 175.816 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 150' ' ' GLY . . . . . 0.468 ' HA2' HG12 ' A' ' 57' ' ' ILE . . . 93.06 -6.29 76.09 Favored Glycine 0 C--N 1.35 1.34 0 CA-C-O 119.722 -0.488 . . . . 41.12 113.674 177.02 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 40.7 ttmt -71.04 141.13 50.92 Favored 'General case' 0 N--CA 1.475 0.804 0 CA-C-N 117.315 0.557 . . . . 70.24 110.651 -177.719 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 152' ' ' THR . . . . . . . . . . . . . 12.5 p -90.35 117.08 28.8 Favored 'General case' 0 C--O 1.237 0.443 0 N-CA-C 108.824 -0.806 . . . . 75.35 108.824 169.062 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 153' ' ' SER . . . . . . . . . . . . . 22.8 m -66.46 -31.35 72.03 Favored 'General case' 0 CA--C 1.544 0.742 0 CA-C-N 115.679 -0.691 . . . . 73.23 110.036 171.92 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 154' ' ' LYS . . . . . 0.494 ' HB2' ' HB3' ' A' ' 145' ' ' PHE . 32.2 mmmt -121.13 129.97 53.52 Favored 'General case' 0 N--CA 1.472 0.627 0 CA-C-N 115.469 -0.787 . . . . 74.2 110.399 -178.96 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 83.3 tttt -67.76 106.36 2.22 Favored 'General case' 0 C--N 1.352 0.691 0 C-N-CA 123.737 0.815 . . . . 73.14 109.396 171.759 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 156' ' ' ILE . . . . . 0.584 ' HB ' ' HB2' ' A' ' 53' ' ' PHE . 62.0 mt -102.97 131.73 50.63 Favored 'Isoleucine or valine' 0 C--O 1.221 -0.422 0 N-CA-C 108.102 -1.073 . . . . 75.22 108.102 176.509 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 157' ' ' THR . . . . . . . . . . . . . 33.1 p -127.96 160.83 30.66 Favored 'General case' 0 N--CA 1.481 1.098 0 C-N-CA 123.935 0.894 . . . . 62.23 109.732 -179.75 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 158' ' ' ILE . . . . . . . . . . . . . 57.1 mt -82.98 97.08 4.17 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.838 0 N-CA-C 108.52 -0.918 . . . . 74.14 108.52 167.477 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 159' ' ' ALA . . . . . 0.821 ' HB2' ' HB2' ' A' ' 11' ' ' ALA . . . -55.99 -41.72 75.26 Favored 'General case' 0 N--CA 1.481 1.106 0 C-N-CA 124.067 0.947 . . . . 53.02 112.626 -177.262 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 160' ' ' ASP . . . . . . . . . . . . . 2.7 t70 -165.35 174.56 9.99 Favored 'General case' 0 CA--C 1.549 0.93 0 O-C-N 123.496 0.498 . . . . 62.4 110.527 -176.68 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 161' ' ' CYS . . . . . . . . . . . . . 24.5 p -130.96 -167.85 1.9 Allowed 'General case' 0 N--CA 1.478 0.959 0 C-N-CA 125.366 1.467 . . . . 65.35 109.41 -178.55 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 162' ' ' GLY . . . . . . . . . . . . . . . 132.62 53.32 0.08 OUTLIER Glycine 0 C--N 1.351 1.369 0 N-CA-C 112.137 -0.385 . . . . 74.11 112.137 -175.327 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 163' ' ' GLN . . . . . 0.6 ' HB2' ' HA ' ' A' ' 6' ' ' VAL . 21.2 pt20 -49.44 143.4 6.67 Favored 'General case' 0 N--CA 1.482 1.131 0 C-N-CA 124.421 1.088 . . . . 73.41 113.1 -174.379 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 164' ' ' LEU . . . . . 0.443 ' HG ' ' HB2' ' A' ' 7' ' ' PHE . 86.0 mt -95.42 116.93 29.48 Favored 'General case' 0 CA--C 1.547 0.843 0 C-N-CA 123.514 0.726 . . . . 74.2 110.14 -173.365 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 165' ' ' GLU . . . . . . . . . . . . . 14.0 pt-20 . . . . . 0 C--O 1.252 1.226 0 C-N-CA 123.646 0.778 . . . . 72.14 108.938 179.406 . . . . . . . . 0 0 . 1 . 020 nuclear build full ' B' B ' 216' ' ' PRO . . . . . . . . . . . . . 32.8 Cg_endo . . . . . 0 CA--C 1.546 1.09 0 N-CA-C 110.014 -0.802 . . . . 64.52 110.014 . . . . . . . . . 0 0 . 1 . 020 nuclear build full ' B' B ' 217' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -145.93 94.11 5.06 Favored Pre-proline 0 CA--C 1.554 1.101 0 N-CA-C 106.781 -1.563 . . . . 72.02 106.781 177.217 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 218' ' ' PRO . . . . . . . . . . . . . 11.7 Cg_endo -91.23 77.87 0.55 Allowed 'Trans proline' 0 C--N 1.378 2.082 0 C-N-CA 123.424 2.75 . . . . 74.23 111.632 -178.098 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 219' ' ' GLY . . . . . . . . . . . . . . . 176.08 156.04 14.32 Favored Glycine 0 CA--C 1.525 0.71 0 CA-C-N 114.593 -1.185 . . . . 74.43 111.542 177.711 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 220' ' ' PRO . . . . . . . . . . . . . 60.5 Cg_endo -85.38 -178.97 3.27 Favored 'Trans proline' 0 CA--C 1.553 1.472 0 C-N-CA 122.961 2.441 . . . . 65.14 112.209 175.459 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 221' ' ' TYR . . . . . . . . . . . . . 43.1 p90 -147.05 178.52 8.3 Favored 'General case' 0 N--CA 1.484 1.242 0 C-N-CA 123.632 0.773 . . . . 75.3 110.986 179.802 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 222' ' ' ALA . . . . . . . . . . . . . . . 170.21 91.02 0.0 OUTLIER 'General case' 0 N--CA 1.486 1.369 0 C-N-CA 125.683 1.593 . . . . 72.23 109.976 166.072 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 223' ' ' GLN . . . . . 0.612 ' H ' ' HD2' ' B' ' 224' ' ' PRO . 35.1 mm-40 -120.66 -50.61 0.04 OUTLIER Pre-proline 0 CA--C 1.563 1.446 0 C-N-CA 124.137 0.975 . . . . 74.54 109.948 168.624 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 224' ' ' PRO . . . . . 0.612 ' HD2' ' H ' ' B' ' 223' ' ' GLN . 52.7 Cg_endo . . . . . 0 C--N 1.394 2.971 0 C-N-CA 121.6 1.533 . . . . 70.01 111.133 170.181 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 3' ' ' ASN . . . . . 0.485 ' ND2' ' HA ' ' A' ' 25' ' ' PHE . 20.1 m120 . . . . . 0 CA--C 1.549 0.917 0 N-CA-C 109.701 -0.481 . . . . 64.310000000000002 109.701 . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 4' ' ' PRO . . . . . 0.493 ' HG2' ' HB2' ' A' ' 24' ' ' LEU . 52.8 Cg_endo -75.85 133.87 15.81 Favored 'Trans proline' 0 C--N 1.372 1.779 0 C-N-CA 122.078 1.852 . . . . 73.329999999999998 111.509 170.082 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 5' ' ' THR . . . . . 0.405 ' HB ' ' O ' ' A' ' 164' ' ' LEU . 80.7 m -97.62 124.74 42.03 Favored 'General case' 0 CA--C 1.536 0.437 0 N-CA-C 108.524 -0.917 . . . . 73.140000000000001 108.524 172.631 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 7.4 m -100.87 123.47 53.89 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.81 0 N-CA-C 109.143 -0.688 . . . . 75.430000000000007 109.143 173.607 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 7' ' ' PHE . . . . . 0.621 ' H ' ' HA ' ' A' ' 163' ' ' GLN . 85.5 t80 -108.08 137.44 46.06 Favored 'General case' 0 C--O 1.241 0.608 0 C-N-CA 124.056 0.942 . . . . 73.0 109.236 -174.351 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 8' ' ' PHE . . . . . 0.497 ' HB3' HG23 ' A' ' 158' ' ' ILE . 62.8 m-85 -138.66 162.59 34.27 Favored 'General case' 0 N--CA 1.469 0.501 0 C-N-CA 123.889 0.875 . . . . 74.200000000000003 110.433 175.943 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 16.0 m-20 -110.35 117.88 34.82 Favored 'General case' 0 N--CA 1.467 0.394 0 N-CA-C 107.354 -1.35 . . . . 72.319999999999993 107.354 170.26 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 49.6 mm -89.4 124.94 42.38 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.559 0 N-CA-C 109.176 -0.676 . . . . 73.530000000000001 109.176 -179.809 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 11' ' ' ALA . . . . . 0.553 ' HB2' ' HB2' ' A' ' 159' ' ' ALA . . . -128.68 126.28 39.79 Favored 'General case' 0 N--CA 1.471 0.581 0 C-N-CA 123.34 0.656 . . . . 51.329999999999998 111.062 -173.177 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 12' ' ' VAL . . . . . 0.438 HG13 ' HB3' ' A' ' 154' ' ' LYS . 96.3 t -95.53 120.36 44.82 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.43 0 N-CA-C 108.077 -1.083 . . . . 74.420000000000002 108.077 174.801 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 31.4 m-20 60.37 24.48 13.99 Favored 'General case' 0 N--CA 1.482 1.126 0 C-N-CA 125.499 1.519 . . . . 73.530000000000001 111.767 -175.791 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 91.69 -18.61 52.26 Favored Glycine 0 C--N 1.354 1.559 0 CA-C-N 116.587 -0.279 . . . . 64.230000000000004 112.903 -175.554 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 15.8 mm-40 -82.15 114.2 49.21 Favored Pre-proline 0 CA--C 1.548 0.887 0 C-N-CA 124.213 1.005 . . . . 72.430000000000007 110.123 178.863 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 18.6 Cg_endo -56.18 108.79 0.36 Allowed 'Trans proline' 0 C--N 1.384 2.41 0 C-N-CA 123.262 2.642 . . . . 73.439999999999998 112.383 -178.077 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 48.4 tp -76.8 -29.52 56.04 Favored 'General case' 0 N--CA 1.475 0.776 0 CA-C-N 114.828 -1.078 . . . . 62.25 109.522 176.375 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 170.11 -159.65 32.24 Favored Glycine 0 N--CA 1.449 -0.5 0 CA-C-N 115.039 -0.982 . . . . 72.319999999999993 111.046 -176.109 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 2.0 ptp180 -149.08 142.93 25.68 Favored 'General case' 0 C--O 1.24 0.595 0 C-N-CA 123.282 0.633 . . . . 73.530000000000001 109.898 -177.408 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 50.7 t -132.09 129.07 59.98 Favored 'Isoleucine or valine' 0 C--O 1.24 0.582 0 C-N-CA 123.659 0.784 . . . . 74.540000000000006 109.453 -176.908 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 66.7 p -109.6 140.77 43.03 Favored 'General case' 0 C--O 1.252 1.189 0 N-CA-C 108.655 -0.869 . . . . 74.439999999999998 108.655 170.453 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 22' ' ' PHE . . . . . 0.438 ' HE1' ' HD2' ' A' ' 8' ' ' PHE . 45.2 m-85 -118.42 134.36 55.12 Favored 'General case' 0 N--CA 1.467 0.394 0 C-N-CA 123.908 0.883 . . . . 71.5 108.978 -178.113 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 7.7 tp10 -87.36 110.59 20.36 Favored 'General case' 0 CA--C 1.535 0.397 0 N-CA-C 109.35 -0.611 . . . . 75.530000000000001 109.35 174.026 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . 0.493 ' HB2' ' HG2' ' A' ' 4' ' ' PRO . 33.8 mt -83.92 121.28 27.15 Favored 'General case' 0 N--CA 1.469 0.482 0 N-CA-C 109.132 -0.692 . . . . 64.340000000000003 109.132 176.826 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 25' ' ' PHE . . . . . 0.485 ' HA ' ' ND2' ' A' ' 3' ' ' ASN . 65.6 m-85 -84.82 69.69 10.75 Favored 'General case' 0 CA--C 1.54 0.579 0 C-N-CA 123.746 0.818 . . . . 73.129999999999995 109.912 179.279 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -70.09 -20.14 63.22 Favored 'General case' 0 N--CA 1.478 0.975 0 CA-C-N 115.076 -0.966 . . . . 75.25 111.52 -179.579 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 11.5 p-10 -72.19 -19.16 61.79 Favored 'General case' 0 CA--C 1.55 0.98 0 C-N-CA 123.71 0.804 . . . . 71.310000000000002 111.188 175.579 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 28' ' ' LYS . . . . . 0.422 ' HD2' HD21 ' A' ' 90' ' ' LEU . 47.0 mttm -108.57 -51.45 2.89 Favored 'General case' 0 N--CA 1.48 1.061 0 C-N-CA 123.46 0.704 . . . . 73.510000000000005 110.765 -176.698 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 29' ' ' VAL . . . . . 0.499 HG21 ' HA ' ' A' ' 129' ' ' PHE . 5.5 m -129.82 74.92 80.27 Favored Pre-proline 0 CA--C 1.56 1.334 0 C-N-CA 124.409 1.083 . . . . 45.119999999999997 109.741 -175.8 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 58.2 Cg_endo -65.8 -34.37 40.25 Favored 'Trans proline' 0 C--N 1.378 2.094 0 C-N-CA 122.98 2.453 . . . . 72.430000000000007 112.726 -168.468 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 31' ' ' LYS . . . . . 0.469 ' HB3' ' HB2' ' A' ' 86' ' ' GLU . 27.4 ttmt -64.55 -58.73 5.57 Favored 'General case' 0 CA--C 1.533 0.311 0 C-N-CA 124.226 1.01 . . . . 70.510000000000005 111.253 -177.561 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 3.8 m -72.39 -26.3 61.83 Favored 'General case' 0 CA--C 1.559 1.308 0 O-C-N 123.63 0.581 . . . . 73.430000000000007 111.191 -173.674 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 33' ' ' ALA . . . . . 0.448 ' HB1' ' HB3' ' A' ' 24' ' ' LEU . . . -73.47 -58.27 3.42 Favored 'General case' 0 N--CA 1.482 1.143 0 C-N-CA 123.025 0.53 . . . . 71.299999999999997 111.888 177.454 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . 0.499 ' HG3' HH21 ' A' ' 37' ' ' ARG . 43.0 tt0 -62.84 -29.49 70.78 Favored 'General case' 0 N--CA 1.488 1.447 0 C-N-CA 123.383 0.673 . . . . 75.310000000000002 111.192 -178.597 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 35' ' ' ASN . . . . . 0.456 ' O ' ' HG ' ' A' ' 39' ' ' LEU . 32.1 t30 -50.93 -60.02 3.53 Favored 'General case' 0 N--CA 1.476 0.83 0 C-N-CA 124.061 0.944 . . . . 70.230000000000004 110.527 174.506 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 84.1 t80 -66.48 -33.08 74.88 Favored 'General case' 0 CA--C 1.544 0.729 0 O-C-N 124.06 0.85 . . . . 63.43 111.237 -178.573 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 37' ' ' ARG . . . . . 0.499 HH21 ' HG3' ' A' ' 34' ' ' GLU . 17.4 ttp180 -62.48 -40.98 98.41 Favored 'General case' 0 N--CA 1.478 0.943 0 C-N-CA 123.204 0.602 . . . . 72.519999999999996 110.737 177.599 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -80.47 -21.54 41.93 Favored 'General case' 0 N--CA 1.472 0.654 0 CA-C-N 115.386 -0.825 . . . . 64.049999999999997 111.321 -178.105 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 39' ' ' LEU . . . . . 0.456 ' HG ' ' O ' ' A' ' 35' ' ' ASN . 95.8 mt -72.15 -44.46 63.06 Favored 'General case' 0 N--CA 1.478 0.952 0 C-N-CA 123.203 0.601 . . . . 55.310000000000002 110.379 172.067 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 65.9 p -72.56 -40.2 66.86 Favored 'General case' 0 N--CA 1.475 0.823 0 C-N-CA 123.737 0.815 . . . . 42.420000000000002 111.484 -173.937 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 61.2 p -76.81 -31.55 57.01 Favored 'General case' 0 N--CA 1.474 0.726 0 O-C-N 123.343 0.402 . . . . 62.140000000000001 110.226 172.614 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 71.59 24.92 76.17 Favored Glycine 0 C--N 1.35 1.338 0 CA-C-N 115.659 -0.701 . . . . 72.209999999999994 114.312 175.226 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 20.9 mm-40 -68.24 -17.92 64.43 Favored 'General case' 0 N--CA 1.476 0.863 0 C-N-CA 123.203 0.601 . . . . 64.349999999999994 111.582 179.243 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 31.1 mmmt -92.18 13.5 18.87 Favored 'General case' 0 CA--C 1.552 1.024 0 C-N-CA 123.708 0.803 . . . . 72.230000000000004 111.384 177.169 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 84.76 37.84 10.04 Favored Glycine 0 C--N 1.353 1.511 0 N-CA-C 113.87 0.308 . . . . 71.439999999999998 113.87 171.229 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 23.0 m-85 -125.15 -46.84 1.79 Allowed 'General case' 0 N--CA 1.484 1.245 0 CA-C-N 117.058 0.429 . . . . 74.219999999999999 110.89 -174.257 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 53.89 58.5 12.36 Favored Glycine 0 C--N 1.349 1.297 0 O-C-N 124.161 0.913 . . . . 72.040000000000006 114.148 174.848 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 48' ' ' TYR . . . . . 0.413 ' HE2' ' HA2' ' A' ' 75' ' ' GLY . 52.1 m-85 -63.86 89.84 0.05 Allowed 'General case' 0 N--CA 1.483 1.213 0 CA-C-O 121.851 0.834 . . . . 73.219999999999999 111.885 -179.153 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 38.7 tptt -112.96 142.77 45.26 Favored 'General case' 0 CA--C 1.538 0.49 0 CA-C-N 114.058 -1.428 . . . . 65.420000000000002 108.37 179.153 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 70.74 22.02 78.04 Favored Glycine 0 C--N 1.345 1.03 0 CA-C-O 119.568 -0.573 . . . . 50.509999999999998 113.923 175.438 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 24.3 t -58.87 114.51 2.58 Favored 'General case' 0 CA--C 1.549 0.92 0 C-N-CA 123.53 0.732 . . . . 74.239999999999995 111.05 -173.817 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 52' ' ' CYS . . . . . . . . . . . . . 15.5 p -87.25 118.1 26.44 Favored 'General case' 0 CA--C 1.54 0.564 0 C-N-CA 123.905 0.882 . . . . 74.129999999999995 111.873 -169.791 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 53' ' ' PHE . . . . . 0.677 ' HA ' ' HA2' ' A' ' 64' ' ' GLY . 88.4 m-85 -69.02 78.77 0.32 Allowed 'General case' 0 CA--C 1.539 0.541 0 C-N-CA 124.454 1.102 . . . . 71.120000000000005 109.671 165.405 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 15.2 p-80 -95.45 -8.4 35.52 Favored 'General case' 0 N--CA 1.479 0.999 0 CA-C-N 115.219 -0.9 . . . . 73.099999999999994 112.461 -173.652 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 59.0 ttt-85 -130.8 100.1 5.16 Favored 'General case' 0 N--CA 1.476 0.834 0 N-CA-C 109.133 -0.691 . . . . 71.140000000000001 109.133 179.364 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 56' ' ' ILE . . . . . 0.527 HD11 ' HB3' ' A' ' 53' ' ' PHE . 65.8 mt -134.39 133.21 55.2 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.117 0 C-N-CA 123.241 0.616 . . . . 60.039999999999999 109.97 -177.725 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 57' ' ' ILE . . . . . 0.518 HG23 ' HA ' ' A' ' 148' ' ' ARG . 66.6 mt -121.34 120.63 28.9 Favored Pre-proline 0 CA--C 1.558 1.25 0 C-N-CA 124.7 1.2 . . . . 73.319999999999993 109.229 175.871 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 35.6 Cg_endo -64.64 139.23 62.66 Favored 'Trans proline' 0 C--N 1.388 2.638 0 C-N-CA 123.078 2.519 . . . . 71.030000000000001 112.362 176.323 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 76.67 21.71 74.06 Favored Glycine 0 C--N 1.346 1.12 0 CA-C-N 115.009 -0.996 . . . . 51.140000000000001 113.134 -175.686 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 60' ' ' PHE . . . . . 0.406 ' HD2' ' HB ' ' A' ' 57' ' ' ILE . 19.9 t80 -149.57 -76.91 0.15 Allowed 'General case' 0 N--CA 1.478 0.936 0 CA-C-N 117.318 0.559 . . . . 74.140000000000001 111.349 -175.738 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 61' ' ' MET . . . . . 0.586 ' SD ' ' HB2' ' A' ' 113' ' ' PHE . 15.7 tmm? -168.07 142.94 3.59 Favored 'General case' 0 N--CA 1.481 1.077 0 N-CA-C 112.115 0.413 . . . . 63.409999999999997 112.115 -163.305 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 62' ' ' CYS . . . . . . . . . . . . . 22.7 p -111.53 113.21 25.47 Favored 'General case' 0 CA--C 1.551 0.985 0 C-N-CA 124.196 0.999 . . . . 63.009999999999998 109.908 173.18 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 63' ' ' GLN . . . . . 0.498 ' HA ' ' HA ' ' A' ' 113' ' ' PHE . 17.1 tt0 -108.53 127.05 53.59 Favored 'General case' 0 N--CA 1.487 1.384 0 C-N-CA 124.019 0.927 . . . . 61.420000000000002 111.745 -173.699 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 64' ' ' GLY . . . . . 0.677 ' HA2' ' HA ' ' A' ' 53' ' ' PHE . . . -102.35 167.34 17.85 Favored Glycine 0 C--N 1.351 1.385 0 CA-C-N 114.834 -1.076 . . . . 71.200000000000003 112.423 175.993 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -178.57 -174.97 45.27 Favored Glycine 0 C--N 1.339 0.701 0 N-CA-C 112.236 -0.346 . . . . 61.140000000000001 112.236 -179.432 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 28.2 t70 -126.1 168.04 14.55 Favored 'General case' 0 C--O 1.247 0.931 0 C-N-CA 124.185 0.994 . . . . 72.109999999999999 110.337 -170.608 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 51.9 t80 -88.04 -21.45 24.76 Favored 'General case' 0 CA--C 1.548 0.873 0 C-N-CA 123.799 0.84 . . . . 74.109999999999999 111.78 -176.959 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 67.5 m -63.48 108.57 1.39 Allowed 'General case' 0 N--CA 1.484 1.233 0 N-CA-C 109.792 -0.447 . . . . 70.329999999999998 109.792 179.9 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 70.0 ttt180 56.04 54.95 7.34 Favored 'General case' 0 CA--C 1.555 1.15 0 O-C-N 124.701 1.25 . . . . 73.430000000000007 110.473 -178.02 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 44.8 t-80 -57.13 -36.14 70.33 Favored 'General case' 0 N--CA 1.482 1.17 0 CA-C-N 115.462 -0.79 . . . . 71.439999999999998 111.988 -175.793 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 37.2 t30 -64.71 114.41 4.42 Favored 'General case' 0 N--CA 1.476 0.855 0 C-N-CA 123.398 0.679 . . . . 60.399999999999999 109.856 174.663 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 76.85 -6.77 38.52 Favored Glycine 0 CA--C 1.53 0.986 0 N-CA-C 116.019 1.168 . . . . 72.409999999999997 116.019 169.376 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 23.8 m -143.77 -82.36 0.17 Allowed 'General case' 0 CA--C 1.554 1.117 0 CA-C-N 117.922 0.861 . . . . 74.439999999999998 109.528 179.192 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 63.08 50.2 65.31 Favored Glycine 0 C--N 1.353 1.477 0 C-N-CA 123.559 0.599 . . . . 43.420000000000002 114.054 174.469 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 75' ' ' GLY . . . . . 0.413 ' HA2' ' HE2' ' A' ' 48' ' ' TYR . . . 139.14 49.94 0.06 OUTLIER Glycine 0 C--N 1.345 1.053 0 CA-C-N 117.387 0.594 . . . . 72.409999999999997 111.682 -179.049 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 21.3 pttp -67.22 161.0 25.78 Favored 'General case' 0 CA--C 1.553 1.076 0 C-N-CA 123.341 0.656 . . . . 52.140000000000001 112.423 -174.122 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 80.6 p -90.11 -179.38 5.66 Favored 'General case' 0 CA--C 1.545 0.77 0 C-N-CA 124.259 1.023 . . . . 74.310000000000002 112.297 -171.106 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 24.5 pt -73.47 -13.17 15.96 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.082 0 C-N-CA 123.197 0.599 . . . . 73.230000000000004 110.677 172.052 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 98.5 m-85 -91.53 7.46 41.25 Favored 'General case' 0 CA--C 1.545 0.782 0 C-N-CA 124.389 1.076 . . . . 73.120000000000005 110.626 171.213 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 91.61 -141.33 15.6 Favored Glycine 0 C--N 1.347 1.168 0 CA-C-O 119.532 -0.593 . . . . 62.520000000000003 112.422 176.829 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 31.3 tt0 -50.04 -56.81 9.27 Favored 'General case' 0 N--CA 1.481 1.11 0 C-N-CA 125.039 1.335 . . . . 64.510000000000005 111.829 -176.852 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 82' ' ' LYS . . . . . 0.529 ' HD2' ' HA ' ' A' ' 107' ' ' THR . 19.0 pttp -161.17 157.54 26.0 Favored 'General case' 0 C--O 1.239 0.514 0 O-C-N 123.873 0.733 . . . . 62.450000000000003 110.97 -179.447 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 24.5 p90 -144.42 172.33 13.1 Favored 'General case' 0 C--O 1.24 0.577 0 C-N-CA 124.915 1.286 . . . . 74.530000000000001 109.328 -179.514 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 12.0 pt-20 -99.79 150.27 22.51 Favored 'General case' 0 N--CA 1.473 0.676 0 C-N-CA 123.801 0.84 . . . . 74.340000000000003 109.675 176.972 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 26.8 m-20 -66.84 149.59 50.37 Favored 'General case' 0 N--CA 1.48 1.049 0 C-N-CA 123.664 0.786 . . . . 75.349999999999994 112.7 -176.203 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 86' ' ' GLU . . . . . 0.469 ' HB2' ' HB3' ' A' ' 31' ' ' LYS . 6.9 tp10 -69.13 -56.11 8.67 Favored 'General case' 0 CA--C 1.544 0.742 0 CA-C-N 115.035 -0.984 . . . . 70.200000000000003 110.475 178.782 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 16.8 p-10 -168.97 138.08 2.13 Favored 'General case' 0 N--CA 1.471 0.617 0 C-N-CA 123.771 0.828 . . . . 64.230000000000004 109.703 -172.953 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 88' ' ' PHE . . . . . 0.464 ' HD1' ' HB ' ' A' ' 127' ' ' VAL . 40.4 m-85 -90.98 68.23 6.15 Favored 'General case' 0 N--CA 1.479 0.995 0 C-N-CA 123.044 0.538 . . . . 73.540000000000006 110.902 -176.035 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 40.1 mt -80.24 -61.84 1.6 Allowed 'Isoleucine or valine' 0 N--CA 1.484 1.273 0 CA-C-O 120.933 0.397 . . . . 62.140000000000001 110.008 174.359 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 90' ' ' LEU . . . . . 0.443 ' HB3' ' HB ' ' A' ' 128' ' ' VAL . 96.0 mt -75.05 104.74 5.75 Favored 'General case' 0 CA--C 1.544 0.731 0 CA-C-N 115.49 -0.777 . . . . 61.43 110.878 -173.798 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 91' ' ' LYS . . . . . 0.668 ' HE3' ' HB ' ' A' ' 93' ' ' THR . 0.1 OUTLIER -83.96 158.49 21.52 Favored 'General case' 0 CA--C 1.545 0.786 0 CA-C-N 115.099 -0.955 . . . . 71.319999999999993 110.073 173.908 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 92' ' ' HIS . . . . . . . . . . . . . 25.2 m-70 -87.46 65.96 8.85 Favored 'General case' 0 N--CA 1.479 1.016 0 CA-C-O 121.493 0.663 . . . . 75.310000000000002 109.696 -177.293 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 93' ' ' THR . . . . . 0.668 ' HB ' ' HE3' ' A' ' 91' ' ' LYS . 15.3 t -105.04 15.21 28.04 Favored 'General case' 0 N--CA 1.483 1.176 0 CA-C-N 115.599 -0.728 . . . . 61.229999999999997 111.461 -174.088 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -155.35 174.84 33.44 Favored Glycine 0 C--N 1.345 1.044 0 C-N-CA 121.553 -0.356 . . . . 62.140000000000001 113.543 -176.225 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -90.19 158.62 4.72 Favored 'Trans proline' 0 CA--C 1.553 1.459 0 C-N-CA 123.753 2.968 . . . . 65.510000000000005 111.919 175.656 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 77.23 17.95 78.87 Favored Glycine 0 C--N 1.344 0.999 0 CA-C-N 116.071 -0.513 . . . . 61.109999999999999 113.533 -179.117 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 97' ' ' ILE . . . . . 0.671 ' HB ' ' HB2' ' A' ' 115' ' ' CYS . 14.9 mm -66.5 103.09 0.52 Allowed 'Isoleucine or valine' 0 CA--C 1.555 1.169 0 C-N-CA 123.685 0.794 . . . . 62.329999999999998 111.009 -176.455 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 98' ' ' LEU . . . . . 0.417 HD22 ' CG ' ' A' ' 22' ' ' PHE . 54.9 tp -88.71 118.1 28.15 Favored 'General case' 0 C--O 1.247 0.922 0 CA-C-O 121.893 0.854 . . . . 74.430000000000007 109.471 175.577 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 23.7 t -152.08 141.67 21.76 Favored 'General case' 0 CA--C 1.547 0.854 0 N-CA-C 107.893 -1.151 . . . . 60.310000000000002 107.893 -174.664 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 100' ' ' MET . . . . . 0.527 ' HA ' ' HA ' ' A' ' 112' ' ' PHE . 70.7 mtp -76.71 138.19 39.82 Favored 'General case' 0 N--CA 1.495 1.791 0 CA-C-N 119.622 1.101 . . . . 72.200000000000003 110.319 -175.294 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 101' ' ' ALA . . . . . 0.437 ' HB3' ' HB2' ' A' ' 111' ' ' GLN . . . -70.42 156.45 39.32 Favored 'General case' 0 C--O 1.247 0.932 0 CA-C-O 121.315 0.579 . . . . 62.329999999999998 111.235 -173.263 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 102' ' ' ASN . . . . . 0.423 ' HB3' ' HA ' ' A' ' 108' ' ' ASN . 25.6 p-10 -161.69 164.05 29.37 Favored 'General case' 0 C--O 1.238 0.454 0 CA-C-N 115.055 -0.975 . . . . 72.329999999999998 110.646 -173.328 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 103' ' ' ALA . . . . . 0.503 ' HB3' HG21 ' A' ' 107' ' ' THR . . . -97.21 -14.89 21.14 Favored 'General case' 0 CA--C 1.542 0.654 0 CA-C-N 115.521 -0.763 . . . . 73.140000000000001 110.361 169.546 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 166.35 -168.18 39.82 Favored Glycine 0 C--N 1.352 1.426 0 CA-C-O 119.406 -0.663 . . . . 75.540000000000006 112.517 178.602 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 46.7 Cg_exo -58.72 139.75 92.06 Favored 'Trans proline' 0 C--N 1.374 1.876 0 C-N-CA 123.155 2.57 . . . . 73.219999999999999 112.112 173.553 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 66.0 t30 65.53 11.4 7.4 Favored 'General case' 0 N--CA 1.487 1.4 0 C-N-CA 124.967 1.307 . . . . 63.420000000000002 111.877 -177.804 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 107' ' ' THR . . . . . 0.529 ' HA ' ' HD2' ' A' ' 82' ' ' LYS . 5.0 m -124.1 17.12 9.22 Favored 'General case' 0 CA--C 1.552 1.028 0 C-N-CA 124.0 0.92 . . . . 72.209999999999994 109.705 178.158 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 108' ' ' ASN . . . . . 0.423 ' HA ' ' HB3' ' A' ' 102' ' ' ASN . 32.8 t30 -80.85 150.89 28.94 Favored 'General case' 0 N--CA 1.477 0.9 0 C-N-CA 124.34 1.056 . . . . 73.120000000000005 110.112 176.759 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 106.82 25.52 6.18 Favored Glycine 0 N--CA 1.47 0.912 0 C-N-CA 121.488 -0.387 . . . . 74.299999999999997 113.297 176.171 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 12.9 p -131.78 118.19 19.59 Favored 'General case' 0 CA--C 1.537 0.447 0 N-CA-C 108.183 -1.043 . . . . 75.510000000000005 108.183 175.107 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 111' ' ' GLN . . . . . 0.507 HE21 ' HG2' ' B' ' 218' ' ' PRO . 48.9 mt-30 61.16 -173.68 0.13 Allowed 'General case' 0 N--CA 1.493 1.683 0 C-N-CA 124.097 0.959 . . . . 75.340000000000003 111.895 -172.536 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 112' ' ' PHE . . . . . 0.527 ' HA ' ' HA ' ' A' ' 100' ' ' MET . 42.0 p90 -146.31 159.37 43.44 Favored 'General case' 0 N--CA 1.476 0.856 0 C-N-CA 123.817 0.847 . . . . 62.25 109.153 171.968 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 113' ' ' PHE . . . . . 0.586 ' HB2' ' SD ' ' A' ' 61' ' ' MET . 50.6 p90 -138.1 146.78 43.3 Favored 'General case' 0 C--O 1.238 0.458 0 C-N-CA 123.631 0.772 . . . . 75.120000000000005 109.6 -179.47 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 114' ' ' ILE . . . . . . . . . . . . . 17.2 mt -120.9 101.97 11.51 Favored 'Isoleucine or valine' 0 C--O 1.243 0.721 0 N-CA-C 107.517 -1.29 . . . . 63.25 107.517 176.419 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 115' ' ' CYS . . . . . 0.671 ' HB2' ' HB ' ' A' ' 97' ' ' ILE . 62.8 m -63.31 104.75 0.64 Allowed 'General case' 0 N--CA 1.469 0.511 0 N-CA-C 109.311 -0.626 . . . . 73.239999999999995 109.311 177.477 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 116' ' ' THR . . . . . 0.576 HG22 HG12 ' A' ' 139' ' ' VAL . 32.8 p -70.18 -32.8 70.9 Favored 'General case' 0 N--CA 1.472 0.656 0 C-N-CA 123.593 0.757 . . . . 72.0 109.859 -179.343 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -104.86 161.19 14.4 Favored 'General case' 0 C--O 1.241 0.62 0 C-N-CA 124.174 0.989 . . . . 75.319999999999993 109.505 172.27 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 9.4 ptmt -72.71 94.02 1.71 Allowed 'General case' 0 CA--C 1.546 0.826 0 CA-C-O 121.87 0.843 . . . . 75.209999999999994 109.874 174.828 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 119' ' ' THR . . . . . . . . . . . . . 75.0 p -87.22 83.99 7.31 Favored 'General case' 0 CA--C 1.545 0.771 0 CA-C-N 115.551 -0.75 . . . . 74.150000000000006 110.368 -175.354 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 8.3 pt-20 -80.36 -16.91 53.44 Favored 'General case' 0 N--CA 1.483 1.212 0 CA-C-O 121.137 0.494 . . . . 64.310000000000002 111.902 -172.426 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 121' ' ' TRP . . . . . . . . . . . . . 43.6 p90 -70.16 -9.86 56.99 Favored 'General case' 0 CA--C 1.546 0.813 0 C-N-CA 122.792 0.437 . . . . 71.319999999999993 111.58 173.971 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 122' ' ' LEU . . . . . 0.479 ' HA ' ' HE2' ' A' ' 125' ' ' LYS . 65.5 mt -89.17 4.91 47.0 Favored 'General case' 0 N--CA 1.477 0.882 0 C-N-CA 123.281 0.632 . . . . 63.329999999999998 111.936 174.723 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 78.5 m-20 -74.24 152.09 39.78 Favored 'General case' 0 N--CA 1.487 1.407 0 C-N-CA 122.482 0.313 . . . . 71.209999999999994 110.295 173.487 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 75.79 14.77 81.82 Favored Glycine 0 C--N 1.353 1.519 0 O-C-N 123.422 0.451 . . . . 41.020000000000003 112.802 -173.451 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 125' ' ' LYS . . . . . 0.479 ' HE2' ' HA ' ' A' ' 122' ' ' LEU . 30.0 mtmm -138.72 -162.09 1.27 Allowed 'General case' 0 N--CA 1.472 0.645 0 C-N-CA 125.683 1.593 . . . . 75.340000000000003 108.719 -174.95 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 126' ' ' HIS . . . . . . . . . . . . . 2.5 t60 -62.01 135.47 57.55 Favored 'General case' 0 CA--C 1.549 0.927 0 C-N-CA 123.938 0.895 . . . . 64.140000000000001 111.598 -165.715 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 127' ' ' VAL . . . . . 0.464 ' HB ' ' HD1' ' A' ' 88' ' ' PHE . 13.9 p -76.95 148.04 7.06 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.807 0 CA-C-N 114.526 -1.216 . . . . 62.109999999999999 112.317 -169.013 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 128' ' ' VAL . . . . . 0.443 ' HB ' ' HB3' ' A' ' 90' ' ' LEU . 18.9 t -72.56 156.07 6.96 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.818 0 C-N-CA 124.073 0.949 . . . . 74.340000000000003 108.884 171.619 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 129' ' ' PHE . . . . . 0.499 ' HA ' HG21 ' A' ' 29' ' ' VAL . 43.1 p90 -128.7 -23.84 3.08 Favored 'General case' 0 N--CA 1.485 1.324 0 CA-C-N 118.739 0.699 . . . . 64.420000000000002 111.661 175.4 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . -145.59 170.63 26.83 Favored Glycine 0 C--N 1.337 0.61 0 N-CA-C 111.454 -0.658 . . . . 70.230000000000004 111.454 -178.38 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 32.8 ttpt -150.07 147.27 27.6 Favored 'General case' 0 N--CA 1.472 0.646 0 N-CA-C 109.002 -0.74 . . . . 74.140000000000001 109.002 178.365 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 132' ' ' VAL . . . . . 0.573 HG21 HG21 ' A' ' 139' ' ' VAL . 58.1 t -62.43 112.32 0.97 Allowed 'Isoleucine or valine' 0 CA--C 1.538 0.49 0 C-N-CA 123.327 0.651 . . . . 74.239999999999995 109.771 174.838 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 21.9 ptmt -91.99 -33.98 14.62 Favored 'General case' 0 N--CA 1.471 0.606 0 N-CA-C 109.264 -0.643 . . . . 61.130000000000003 109.264 175.923 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 35.5 mt-10 -141.58 135.61 30.24 Favored 'General case' 0 N--CA 1.479 1.013 0 C-N-CA 124.513 1.125 . . . . 64.319999999999993 109.206 -179.072 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 95.63 24.72 15.04 Favored Glycine 0 C--N 1.349 1.301 0 O-C-N 123.381 0.426 . . . . 62.340000000000003 113.825 176.03 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 136' ' ' MET . . . . . . . . . . . . . 14.5 tpt -65.51 -32.09 73.5 Favored 'General case' 0 N--CA 1.485 1.293 0 CA-C-N 117.289 0.545 . . . . 72.239999999999995 111.119 179.787 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 137' ' ' ASN . . . . . . . . . . . . . 4.3 p-10 -61.26 -35.32 76.96 Favored 'General case' 0 CA--C 1.551 0.999 0 C-N-CA 123.941 0.897 . . . . 64.140000000000001 111.458 173.515 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 138' ' ' ILE . . . . . . . . . . . . . 50.6 mm -74.58 -32.93 30.81 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.001 0 C-N-CA 123.414 0.686 . . . . 73.439999999999998 110.532 177.51 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 139' ' ' VAL . . . . . 0.576 HG12 HG22 ' A' ' 116' ' ' THR . 87.7 t -66.52 -44.02 90.45 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.947 0 C-N-CA 123.733 0.813 . . . . 41.340000000000003 110.889 178.513 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 140' ' ' GLU . . . . . 0.419 ' O ' ' HG3' ' A' ' 144' ' ' ARG . 52.2 mt-10 -77.0 -19.41 57.31 Favored 'General case' 0 N--CA 1.475 0.795 0 CA-C-N 115.618 -0.719 . . . . 72.230000000000004 110.805 177.037 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -70.82 -37.55 73.23 Favored 'General case' 0 CA--C 1.543 0.687 0 C-N-CA 122.387 0.275 . . . . 42.539999999999999 110.295 169.068 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 142' ' ' MET . . . . . . . . . . . . . 70.6 mtm -63.24 -39.35 94.36 Favored 'General case' 0 N--CA 1.485 1.304 0 C-N-CA 123.065 0.546 . . . . 74.439999999999998 110.376 174.607 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 143' ' ' GLU . . . . . 0.412 ' HB2' HG21 ' A' ' 116' ' ' THR . 25.6 tt0 -55.61 -36.65 67.17 Favored 'General case' 0 CA--C 1.55 0.98 0 CA-C-N 114.539 -1.209 . . . . 61.240000000000002 111.784 178.252 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 144' ' ' ARG . . . . . 0.419 ' HG3' ' O ' ' A' ' 140' ' ' GLU . 29.2 mtm180 -73.82 -8.79 57.4 Favored 'General case' 0 N--CA 1.478 0.952 0 C-N-CA 123.837 0.855 . . . . 71.319999999999993 112.75 -176.952 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 145' ' ' PHE . . . . . 0.503 ' HB2' HD11 ' A' ' 156' ' ' ILE . 62.8 m-85 -97.63 -4.87 36.65 Favored 'General case' 0 N--CA 1.479 1.001 0 C-N-CA 122.674 0.389 . . . . 74.510000000000005 111.007 174.137 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . -92.92 171.36 32.8 Favored Glycine 0 C--N 1.347 1.158 0 CA-C-N 116.361 -0.381 . . . . 73.219999999999999 113.192 -179.632 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 147' ' ' SER . . . . . 0.471 ' HB2' ' HB3' ' A' ' 151' ' ' LYS . 18.3 m -133.6 156.99 46.85 Favored 'General case' 0 N--CA 1.475 0.8 0 C-N-CA 124.539 1.135 . . . . 73.109999999999999 109.566 -177.426 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 148' ' ' ARG . . . . . 0.518 ' HA ' HG23 ' A' ' 57' ' ' ILE . 18.9 mmt180 -59.12 -37.88 78.28 Favored 'General case' 0 N--CA 1.484 1.24 0 C-N-CA 123.858 0.863 . . . . 74.400000000000006 112.592 -172.219 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 149' ' ' ASN . . . . . . . . . . . . . 28.0 p-10 -72.0 -14.68 61.95 Favored 'General case' 0 N--CA 1.486 1.354 0 C-N-CA 123.518 0.727 . . . . 72.0 111.922 179.804 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . 112.89 -3.02 25.8 Favored Glycine 0 C--N 1.347 1.17 0 C-N-CA 123.428 0.537 . . . . 64.200000000000003 112.544 -178.644 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 151' ' ' LYS . . . . . 0.471 ' HB3' ' HB2' ' A' ' 147' ' ' SER . 87.9 tttt -67.82 146.47 53.66 Favored 'General case' 0 N--CA 1.478 0.938 0 C-N-CA 123.67 0.788 . . . . 73.340000000000003 111.092 -178.94 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 152' ' ' THR . . . . . . . . . . . . . 18.5 p -120.05 114.5 22.08 Favored 'General case' 0 N--CA 1.469 0.476 0 N-CA-C 109.204 -0.665 . . . . 70.420000000000002 109.204 173.062 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 153' ' ' SER . . . . . . . . . . . . . 37.8 t -67.34 -24.89 65.77 Favored 'General case' 0 CA--C 1.546 0.822 0 C-N-CA 124.242 1.017 . . . . 74.109999999999999 111.109 179.181 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 154' ' ' LYS . . . . . 0.438 ' HB3' HG13 ' A' ' 12' ' ' VAL . 69.7 mmtt -121.69 150.68 41.43 Favored 'General case' 0 N--CA 1.473 0.697 0 C-N-CA 123.951 0.901 . . . . 71.540000000000006 111.155 179.925 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 2.2 tppp? -93.37 91.16 7.05 Favored 'General case' 0 N--CA 1.474 0.773 0 CA-C-O 121.366 0.603 . . . . 74.120000000000005 110.251 -178.065 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 156' ' ' ILE . . . . . 0.527 ' HB ' ' HB2' ' A' ' 53' ' ' PHE . 48.4 mt -89.6 102.1 12.79 Favored 'Isoleucine or valine' 0 C--O 1.21 -1.009 0 N-CA-C 109.254 -0.647 . . . . 75.340000000000003 109.254 -177.05 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 157' ' ' THR . . . . . . . . . . . . . 42.3 p -108.54 145.19 35.17 Favored 'General case' 0 N--CA 1.472 0.652 0 C-N-CA 123.642 0.777 . . . . 73.310000000000002 110.151 178.841 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 158' ' ' ILE . . . . . 0.497 HG23 ' HB3' ' A' ' 8' ' ' PHE . 49.4 mt -70.47 95.86 0.47 Allowed 'Isoleucine or valine' 0 CA--C 1.547 0.839 0 N-CA-C 108.672 -0.862 . . . . 72.209999999999994 108.672 170.423 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 159' ' ' ALA . . . . . 0.553 ' HB2' ' HB2' ' A' ' 11' ' ' ALA . . . -51.72 -53.94 33.79 Favored 'General case' 0 N--CA 1.477 0.896 0 C-N-CA 124.402 1.081 . . . . 50.299999999999997 112.036 -177.599 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 160' ' ' ASP . . . . . . . . . . . . . 5.4 t70 -145.62 169.52 18.26 Favored 'General case' 0 CA--C 1.544 0.72 0 CA-C-N 116.195 -0.457 . . . . 73.120000000000005 110.583 -174.743 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 161' ' ' CYS . . . . . . . . . . . . . 12.7 p -135.16 -169.62 2.41 Favored 'General case' 0 N--CA 1.476 0.854 0 C-N-CA 125.048 1.339 . . . . 75.129999999999995 108.393 -177.822 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 162' ' ' GLY . . . . . . . . . . . . . . . 131.87 56.74 0.09 OUTLIER Glycine 0 N--CA 1.475 1.247 0 C-N-CA 120.635 -0.793 . . . . 74.239999999999995 111.922 -172.965 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 163' ' ' GLN . . . . . 0.621 ' HA ' ' H ' ' A' ' 7' ' ' PHE . 2.1 pt20 -46.93 135.54 9.21 Favored 'General case' 0 CA--C 1.552 1.022 0 C-N-CA 124.099 0.96 . . . . 72.140000000000001 113.478 -174.156 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 164' ' ' LEU . . . . . 0.405 ' O ' ' HB ' ' A' ' 5' ' ' THR . 86.6 mt . . . . . 0 CA--C 1.54 0.589 0 N-CA-C 108.751 -0.833 . . . . 44.119999999999997 108.751 178.249 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 218' ' ' PRO . . . . . 0.507 ' HG2' HE21 ' A' ' 111' ' ' GLN . 42.1 Cg_endo . . . . . 0 CA--C 1.55 1.292 0 CA-C-O 121.143 0.393 . . . . 71.329999999999998 111.113 . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 219' ' ' GLY . . . . . . . . . . . . . . . -179.86 147.84 7.69 Favored Glycine 0 CA--C 1.536 1.371 0 CA-C-N 115.534 -0.757 . . . . 74.209999999999994 111.927 -178.755 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 220' ' ' PRO . . . . . . . . . . . . . 21.5 Cg_exo -68.26 164.52 32.07 Favored 'Trans proline' 0 C--N 1.377 2.036 0 C-N-CA 123.796 2.997 . . . . 71.540000000000006 113.565 -178.07 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 221' ' ' TYR . . . . . . . . . . . . . 62.2 m-85 . . . . . 0 N--CA 1.481 1.123 0 C-N-CA 123.731 0.812 . . . . 70.099999999999994 111.157 -176.328 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 3' ' ' ASN . . . . . 0.431 ' ND2' ' HA ' ' A' ' 25' ' ' PHE . 21.5 m120 . . . . . 0 CA--C 1.543 0.696 0 N-CA-C 109.538 -0.542 . . . . 62.520000000000003 109.538 . . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 4' ' ' PRO . . . . . 0.485 ' HG2' ' HB2' ' A' ' 24' ' ' LEU . 57.6 Cg_endo -73.66 144.37 35.41 Favored 'Trans proline' 0 C--N 1.374 1.911 0 C-N-CA 122.414 2.076 . . . . 62.530000000000001 112.123 175.12 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 5' ' ' THR . . . . . 0.569 HG23 ' HD3' ' A' ' 133' ' ' LYS . 97.9 m -97.1 114.13 25.77 Favored 'General case' 0 C--O 1.223 -0.318 0 N-CA-C 108.325 -0.991 . . . . 53.210000000000001 108.325 177.475 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 43.1 t -99.7 119.17 47.38 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.852 0 N-CA-C 108.33 -0.989 . . . . 74.120000000000005 108.33 -178.721 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 75.1 t80 -99.58 132.81 44.66 Favored 'General case' 0 C--N 1.323 -0.572 0 N-CA-C 109.235 -0.654 . . . . 74.0 109.235 -173.125 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 8' ' ' PHE . . . . . 0.475 ' HD2' ' HE2' ' A' ' 22' ' ' PHE . 33.1 m-85 -136.57 161.16 36.65 Favored 'General case' 0 C--O 1.238 0.499 0 O-C-N 124.027 0.829 . . . . 74.310000000000002 110.975 170.295 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 6.4 m-20 -108.37 114.76 28.86 Favored 'General case' 0 N--CA 1.465 0.277 0 CA-C-N 113.749 -1.569 . . . . 73.349999999999994 107.652 168.389 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 10' ' ' ILE . . . . . 0.542 HG21 ' SD ' ' A' ' 142' ' ' MET . 44.5 mm -85.48 118.82 32.96 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.369 0 N-CA-C 108.707 -0.849 . . . . 74.319999999999993 108.707 174.502 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 11' ' ' ALA . . . . . 0.554 ' HB2' ' HB2' ' A' ' 159' ' ' ALA . . . -118.11 131.36 56.43 Favored 'General case' 0 N--CA 1.469 0.476 0 C-N-CA 123.37 0.668 . . . . 63.219999999999999 111.143 -176.657 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 71.1 t -96.65 112.85 29.6 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.454 0 N-CA-C 107.934 -1.136 . . . . 64.310000000000002 107.934 170.765 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 18.5 m-20 62.93 24.25 14.44 Favored 'General case' 0 N--CA 1.481 1.104 0 C-N-CA 125.12 1.368 . . . . 64.049999999999997 111.931 179.965 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 99.1 -21.24 46.75 Favored Glycine 0 C--N 1.348 1.227 0 CA-C-N 116.43 -0.35 . . . . 62.32 113.031 -177.805 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 36.7 mm-40 -83.27 114.73 55.02 Favored Pre-proline 0 CA--C 1.543 0.706 0 C-N-CA 123.529 0.731 . . . . 73.140000000000001 110.048 179.667 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 34.3 Cg_endo -60.72 109.27 0.64 Allowed 'Trans proline' 0 C--N 1.378 2.098 0 C-N-CA 122.844 2.363 . . . . 71.120000000000005 111.863 -177.265 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 66.0 tp -76.31 -35.46 58.81 Favored 'General case' 0 N--CA 1.471 0.621 0 CA-C-N 115.104 -0.953 . . . . 55.210000000000001 109.922 179.334 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -175.96 177.96 47.52 Favored Glycine 0 C--N 1.341 0.832 0 CA-C-N 115.57 -0.741 . . . . 73.099999999999994 112.882 177.338 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 80.7 mtt180 -115.16 116.91 29.14 Favored 'General case' 0 C--O 1.237 0.406 0 C-N-CA 124.219 1.008 . . . . 73.209999999999994 108.86 -179.299 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 20' ' ' VAL . . . . . 0.414 HG13 HG13 ' A' ' 132' ' ' VAL . 67.5 t -114.65 118.33 58.33 Favored 'Isoleucine or valine' 0 C--O 1.238 0.498 0 C-N-CA 123.566 0.746 . . . . 64.209999999999994 109.417 -178.182 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 21' ' ' SER . . . . . 0.413 ' OG ' ' HB2' ' A' ' 134' ' ' GLU . 71.3 p -106.47 139.37 41.05 Favored 'General case' 0 C--O 1.246 0.878 0 N-CA-C 108.982 -0.748 . . . . 65.010000000000005 108.982 173.634 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 22' ' ' PHE . . . . . 0.475 ' HE2' ' HD2' ' A' ' 8' ' ' PHE . 85.2 m-85 -108.14 168.24 9.43 Favored 'General case' 0 C--N 1.331 -0.236 0 C-N-CA 124.544 1.138 . . . . 73.409999999999997 109.516 -179.886 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 23' ' ' GLU . . . . . 0.461 ' HB2' ' HD2' ' A' ' 133' ' ' LYS . 41.3 tt0 -129.95 106.9 8.96 Favored 'General case' 0 C--O 1.24 0.578 0 N-CA-C 107.979 -1.119 . . . . 53.530000000000001 107.979 179.007 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . 0.485 ' HB2' ' HG2' ' A' ' 4' ' ' PRO . 38.7 mt -82.44 124.72 30.31 Favored 'General case' 0 N--CA 1.467 0.414 0 N-CA-C 109.67 -0.493 . . . . 72.310000000000002 109.67 -179.456 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 25' ' ' PHE . . . . . 0.431 ' HA ' ' ND2' ' A' ' 3' ' ' ASN . 44.6 m-85 -86.48 66.57 9.57 Favored 'General case' 0 CA--C 1.535 0.403 0 C-N-CA 123.338 0.655 . . . . 74.319999999999993 109.236 177.632 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -62.35 -24.89 67.6 Favored 'General case' 0 N--CA 1.477 0.883 0 CA-C-N 115.282 -0.872 . . . . 43.299999999999997 111.703 -178.476 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 9.7 p-10 -71.42 -19.53 62.23 Favored 'General case' 0 N--CA 1.477 0.875 0 C-N-CA 124.097 0.959 . . . . 71.510000000000005 112.524 -179.905 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 61.2 mttp -110.58 -41.05 4.42 Favored 'General case' 0 N--CA 1.486 1.355 0 C-N-CA 123.729 0.812 . . . . 63.130000000000003 110.992 -178.76 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 29' ' ' VAL . . . . . 0.523 HG21 ' HA ' ' A' ' 129' ' ' PHE . 8.4 m -129.48 74.06 81.15 Favored Pre-proline 0 N--CA 1.478 0.966 0 C-N-CA 123.803 0.841 . . . . 72.409999999999997 109.947 -179.452 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 25.5 Cg_endo -60.09 -37.32 84.95 Favored 'Trans proline' 0 C--N 1.378 2.097 0 C-N-CA 122.797 2.331 . . . . 71.010000000000005 112.896 -175.982 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 31' ' ' LYS . . . . . 0.408 ' HE3' ' HB2' ' A' ' 31' ' ' LYS . 36.6 ttmt -66.75 -52.0 49.33 Favored 'General case' 0 N--CA 1.482 1.136 0 C-N-CA 123.534 0.734 . . . . 75.019999999999996 112.043 -176.637 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 18.3 m -77.43 -31.25 53.83 Favored 'General case' 0 CA--C 1.55 0.978 0 CA-C-N 115.277 -0.874 . . . . 51.420000000000002 111.136 -170.617 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 33' ' ' ALA . . . . . 0.447 ' HB1' ' HB3' ' A' ' 24' ' ' LEU . . . -71.93 -47.18 54.31 Favored 'General case' 0 N--CA 1.473 0.718 0 C-N-CA 122.828 0.451 . . . . 75.129999999999995 110.057 174.327 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 11.4 tp10 -59.98 -35.63 75.41 Favored 'General case' 0 N--CA 1.485 1.308 0 C-N-CA 123.477 0.711 . . . . 73.519999999999996 111.141 178.684 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 35' ' ' ASN . . . . . 0.551 ' ND2' ' SD ' ' A' ' 100' ' ' MET . 32.7 t30 -56.12 -64.42 0.87 Allowed 'General case' 0 CA--C 1.539 0.523 0 CA-C-N 114.981 -1.009 . . . . 64.219999999999999 110.812 178.075 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 74.5 t80 -61.94 -35.38 78.25 Favored 'General case' 0 N--CA 1.474 0.74 0 C-N-CA 123.774 0.83 . . . . 72.540000000000006 111.41 -177.043 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 37' ' ' ARG . . . . . 0.417 ' HG3' HE22 ' A' ' 163' ' ' GLN . 20.7 ttt180 -58.82 -50.29 74.51 Favored 'General case' 0 N--CA 1.472 0.674 0 C-N-CA 124.046 0.938 . . . . 70.349999999999994 110.937 175.901 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 38' ' ' ALA . . . . . 0.543 ' HB3' HG21 ' A' ' 78' ' ' ILE . . . -75.69 -22.26 56.82 Favored 'General case' 0 CA--C 1.54 0.582 0 CA-C-N 115.587 -0.733 . . . . 53.409999999999997 111.727 -176.29 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 39' ' ' LEU . . . . . 0.515 HD22 ' CE1' ' A' ' 48' ' ' TYR . 96.6 mt -72.41 -42.27 65.3 Favored 'General case' 0 N--CA 1.479 1.008 0 C-N-CA 123.127 0.571 . . . . 73.420000000000002 109.86 172.214 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 48.0 t -68.63 -55.88 10.07 Favored 'General case' 0 N--CA 1.476 0.834 0 C-N-CA 124.238 1.015 . . . . 54.210000000000001 110.959 -176.139 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 71.3 p -73.41 -30.07 63.0 Favored 'General case' 0 CA--C 1.541 0.634 0 C-N-CA 123.659 0.783 . . . . 74.409999999999997 110.819 179.452 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 87.02 32.71 13.62 Favored Glycine 0 C--N 1.352 1.453 0 CA-C-O 119.909 -0.384 . . . . 63.520000000000003 113.021 176.129 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 50.9 mm-40 -54.89 -42.37 72.03 Favored 'General case' 0 N--CA 1.48 1.062 0 C-N-CA 123.551 0.741 . . . . 65.409999999999997 110.991 177.034 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 44' ' ' LYS . . . . . 0.547 ' HG3' ' HB ' ' A' ' 78' ' ' ILE . 29.6 mmmt -93.51 18.19 10.31 Favored 'General case' 0 CA--C 1.547 0.828 0 CA-C-N 115.044 -0.98 . . . . 74.230000000000004 111.683 -173.332 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 73.05 36.3 56.99 Favored Glycine 0 C--N 1.354 1.557 0 CA-C-N 116.301 -0.409 . . . . 63.409999999999997 114.068 171.722 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 46' ' ' PHE . . . . . 0.461 ' HE2' ' HA ' ' A' ' 78' ' ' ILE . 22.0 m-85 -120.25 -47.63 2.35 Favored 'General case' 0 N--CA 1.483 1.183 0 C-N-CA 122.811 0.444 . . . . 62.119999999999997 110.788 -177.391 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 53.27 62.12 6.3 Favored Glycine 0 C--N 1.356 1.644 0 O-C-N 123.92 0.763 . . . . 64.239999999999995 114.896 170.653 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 48' ' ' TYR . . . . . 0.515 ' CE1' HD22 ' A' ' 39' ' ' LEU . 66.8 m-85 -64.73 91.23 0.08 Allowed 'General case' 0 N--CA 1.48 1.042 0 CA-C-O 121.936 0.874 . . . . 65.329999999999998 111.67 -176.721 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 49' ' ' LYS . . . . . 0.548 ' HE2' ' HA ' ' A' ' 160' ' ' ASP . 28.0 tptp -109.7 130.88 55.47 Favored 'General case' 0 C--O 1.239 0.529 0 CA-C-N 113.913 -1.494 . . . . 71.230000000000004 108.726 178.985 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 80.83 21.24 63.92 Favored Glycine 0 C--N 1.348 1.248 0 CA-C-O 119.645 -0.531 . . . . 73.430000000000007 113.235 179.715 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 51' ' ' SER . . . . . 0.43 ' HB2' HD12 ' A' ' 158' ' ' ILE . 23.0 m -56.28 115.07 2.26 Favored 'General case' 0 C--N 1.355 0.806 0 C-N-CA 123.799 0.84 . . . . 73.299999999999997 110.885 -179.004 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 52' ' ' CYS . . . . . 0.69 ' SG ' ' HB3' ' A' ' 66' ' ' ASP . 6.3 p -96.76 130.11 44.06 Favored 'General case' 0 CA--C 1.548 0.888 0 C-N-CA 123.918 0.887 . . . . 73.219999999999999 112.261 -168.823 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 53' ' ' PHE . . . . . 0.722 ' HA ' ' HA2' ' A' ' 64' ' ' GLY . 11.8 m-85 -79.82 108.95 13.79 Favored 'General case' 0 CA--C 1.538 0.481 0 C-N-CA 125.155 1.382 . . . . 53.530000000000001 109.569 175.173 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 53.1 p-80 -100.52 -30.58 11.72 Favored 'General case' 0 N--CA 1.487 1.416 0 C-N-CA 122.769 0.428 . . . . 62.149999999999999 111.018 178.964 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 27.9 ttt180 -112.38 99.98 8.43 Favored 'General case' 0 C--O 1.221 -0.445 0 N-CA-C 109.048 -0.723 . . . . 64.319999999999993 109.048 -173.278 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 56' ' ' ILE . . . . . 0.497 HG21 ' HA ' ' A' ' 143' ' ' GLU . 52.5 mt -134.63 134.68 54.12 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.801 0 N-CA-C 108.929 -0.767 . . . . 72.040000000000006 108.929 176.169 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 57' ' ' ILE . . . . . 0.641 HG23 ' HA ' ' A' ' 148' ' ' ARG . 58.1 mt -131.0 121.56 18.88 Favored Pre-proline 0 CA--C 1.554 1.12 0 C-N-CA 124.501 1.12 . . . . 74.409999999999997 108.037 179.357 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 58' ' ' PRO . . . . . 0.481 ' HA ' ' HG2' ' A' ' 143' ' ' GLU . 74.4 Cg_endo -70.89 139.58 36.63 Favored 'Trans proline' 0 C--N 1.378 2.084 0 C-N-CA 123.033 2.489 . . . . 61.399999999999999 112.577 -172.846 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 74.32 26.83 67.18 Favored Glycine 0 C--N 1.343 0.937 0 CA-C-N 115.552 -0.749 . . . . 63.210000000000001 112.569 -176.048 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 60' ' ' PHE . . . . . 0.412 ' HD2' ' HB ' ' A' ' 57' ' ' ILE . 28.3 t80 -148.47 -73.24 0.19 Allowed 'General case' 0 C--O 1.243 0.732 0 C-N-CA 123.659 0.784 . . . . 73.329999999999998 109.767 -175.188 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 61' ' ' MET . . . . . 0.475 ' SD ' ' HB2' ' A' ' 113' ' ' PHE . 44.7 ttm -171.69 140.46 1.33 Allowed 'General case' 0 C--N 1.353 0.722 0 CA-C-N 116.285 -0.416 . . . . 63.340000000000003 112.058 -163.215 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 62' ' ' CYS . . . . . 0.546 ' SG ' ' HB ' ' A' ' 114' ' ' ILE . 16.6 p -109.14 113.51 26.43 Favored 'General case' 0 CA--C 1.549 0.926 0 C-N-CA 124.031 0.932 . . . . 70.230000000000004 108.966 169.346 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 63' ' ' GLN . . . . . 0.475 ' HA ' ' HA ' ' A' ' 113' ' ' PHE . 50.7 tt0 -113.91 118.54 34.46 Favored 'General case' 0 N--CA 1.48 1.032 0 C-N-CA 123.574 0.75 . . . . 75.439999999999998 110.31 -170.875 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 64' ' ' GLY . . . . . 0.722 ' HA2' ' HA ' ' A' ' 53' ' ' PHE . . . -115.81 164.94 12.16 Favored Glycine 0 C--N 1.353 1.505 0 CA-C-N 115.736 -0.666 . . . . 71.200000000000003 113.622 -173.784 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 101.59 93.56 2.2 Favored Glycine 0 C--N 1.343 0.92 0 N-CA-C 110.096 -1.202 . . . . 61.450000000000003 110.096 -173.992 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 66' ' ' ASP . . . . . 0.69 ' HB3' ' SG ' ' A' ' 52' ' ' CYS . 38.9 t70 -122.6 -73.38 0.65 Allowed 'General case' 0 N--CA 1.476 0.838 0 C-N-CA 122.899 0.479 . . . . 51.130000000000003 110.588 -179.641 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 76.0 t80 -40.72 -49.84 3.09 Favored 'General case' 0 N--CA 1.483 1.206 0 C-N-CA 125.779 1.631 . . . . 74.430000000000007 114.048 -161.917 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 15.7 m -71.46 105.62 3.64 Favored 'General case' 0 CA--C 1.545 0.755 0 O-C-N 123.571 0.544 . . . . 74.140000000000001 110.551 -176.274 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 31.2 ttm180 51.82 47.66 24.33 Favored 'General case' 0 CA--C 1.553 1.095 0 C-N-CA 125.179 1.391 . . . . 72.310000000000002 111.379 -178.234 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 27.4 p80 -55.73 -28.15 54.3 Favored 'General case' 0 N--CA 1.492 1.654 0 C-N-CA 123.345 0.658 . . . . 72.409999999999997 111.773 179.302 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 6.3 t30 -80.98 103.53 10.87 Favored 'General case' 0 CA--C 1.544 0.72 0 C-N-CA 123.755 0.822 . . . . 74.25 109.217 170.008 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 97.22 -8.19 64.65 Favored Glycine 0 C--N 1.341 0.823 0 CA-C-O 119.132 -0.815 . . . . 43.43 115.09 168.597 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 73' ' ' THR . . . . . 0.517 HG21 ' HB3' ' A' ' 76' ' ' LYS . 25.6 m -149.51 -74.91 0.17 Allowed 'General case' 0 N--CA 1.484 1.271 0 CA-C-N 118.495 1.147 . . . . 75.409999999999997 110.491 178.894 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 81.75 60.19 2.23 Favored Glycine 0 C--N 1.35 1.334 0 CA-C-O 119.958 -0.356 . . . . 23.440000000000001 112.964 177.926 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 111.06 51.27 0.6 Allowed Glycine 0 N--CA 1.479 1.524 0 CA-C-N 117.329 0.564 . . . . 74.200000000000003 112.952 178.714 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 76' ' ' LYS . . . . . 0.517 ' HB3' HG21 ' A' ' 73' ' ' THR . 20.2 pttp -56.54 161.5 2.66 Favored 'General case' 0 N--CA 1.491 1.579 0 C-N-CA 124.55 1.14 . . . . 72.109999999999999 113.38 -178.997 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 46.1 p -101.59 179.7 4.27 Favored 'General case' 0 N--CA 1.484 1.247 0 C-N-CA 124.181 0.992 . . . . 70.25 112.698 -167.395 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 78' ' ' ILE . . . . . 0.547 ' HB ' ' HG3' ' A' ' 44' ' ' LYS . 29.1 pt -69.9 -16.82 20.63 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.907 0 C-N-CA 122.819 0.448 . . . . 71.120000000000005 111.441 177.553 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 86.0 m-85 -95.04 27.04 3.35 Favored 'General case' 0 CA--C 1.545 0.754 0 C-N-CA 124.112 0.965 . . . . 74.409999999999997 110.244 176.748 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 92.11 -128.62 9.46 Favored Glycine 0 C--N 1.351 1.381 0 N-CA-C 111.497 -0.641 . . . . 74.430000000000007 111.497 178.026 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 39.5 tt0 -66.05 -49.42 67.72 Favored 'General case' 0 N--CA 1.472 0.664 0 C-N-CA 123.548 0.739 . . . . 72.299999999999997 110.531 179.168 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 82' ' ' LYS . . . . . 0.713 ' HD2' ' HA ' ' A' ' 107' ' ' THR . 21.8 pttm -167.71 155.95 9.14 Favored 'General case' 0 CA--C 1.55 0.969 0 CA-C-N 115.501 -0.772 . . . . 63.420000000000002 111.054 -171.668 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 15.0 p90 -131.04 174.32 10.13 Favored 'General case' 0 N--CA 1.481 1.089 0 C-N-CA 125.176 1.39 . . . . 71.230000000000004 110.594 176.236 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 9.8 pt-20 -84.37 157.26 21.51 Favored 'General case' 0 N--CA 1.483 1.22 0 C-N-CA 123.497 0.719 . . . . 73.129999999999995 111.278 177.203 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 40.6 m-20 -64.22 134.34 54.58 Favored 'General case' 0 N--CA 1.489 1.479 0 C-N-CA 124.047 0.939 . . . . 61.240000000000002 110.837 -176.278 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 6.2 tp10 -60.05 -58.88 6.62 Favored 'General case' 0 N--CA 1.486 1.358 0 C-N-CA 123.236 0.614 . . . . 74.519999999999996 111.091 -178.627 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 31.9 p30 -163.22 -157.18 0.41 Allowed 'General case' 0 N--CA 1.467 0.41 0 N-CA-C 107.521 -1.288 . . . . 64.439999999999998 107.521 -179.211 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 89.7 m-85 -142.43 34.1 1.47 Allowed 'General case' 0 N--CA 1.485 1.293 0 C-N-CA 123.311 0.644 . . . . 75.430000000000007 110.52 177.005 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 65.4 mt -61.94 -61.04 1.79 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.649 0 CA-C-O 121.506 0.669 . . . . 74.150000000000006 110.266 178.39 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 90' ' ' LEU . . . . . 0.451 ' HB3' ' HB ' ' A' ' 128' ' ' VAL . 59.3 mt -78.8 102.36 8.11 Favored 'General case' 0 C--O 1.242 0.665 0 CA-C-N 114.88 -1.054 . . . . 64.109999999999999 110.075 -177.305 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 91' ' ' LYS . . . . . 0.691 ' HE3' ' HB ' ' A' ' 93' ' ' THR . 0.1 OUTLIER -84.63 163.64 19.15 Favored 'General case' 0 C--O 1.24 0.586 0 CA-C-N 115.493 -0.776 . . . . 70.140000000000001 110.334 174.747 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 92' ' ' HIS . . . . . . . . . . . . . 19.0 m-70 -91.19 56.1 3.04 Favored 'General case' 0 N--CA 1.476 0.858 0 CA-C-O 122.033 0.921 . . . . 74.400000000000006 109.371 -176.699 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 93' ' ' THR . . . . . 0.691 ' HB ' ' HE3' ' A' ' 91' ' ' LYS . 12.6 t -91.33 -7.15 51.79 Favored 'General case' 0 N--CA 1.47 0.572 0 CA-C-N 114.61 -1.177 . . . . 71.299999999999997 111.385 -176.383 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -124.94 167.78 17.21 Favored Glycine 0 C--N 1.34 0.785 0 O-C-N 123.062 0.226 . . . . 62.0 113.241 -175.206 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 95' ' ' PRO . . . . . 0.445 ' HB3' ' O ' ' A' ' 116' ' ' THR . 1.1 Cg_endo -84.67 157.07 12.08 Favored 'Trans proline' 0 C--N 1.363 1.316 0 C-N-CA 123.519 2.812 . . . . 60.399999999999999 111.636 168.553 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 78.28 16.94 78.86 Favored Glycine 0 C--N 1.346 1.104 0 CA-C-N 116.203 -0.453 . . . . 74.510000000000005 113.206 179.948 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 97' ' ' ILE . . . . . 0.813 ' HB ' ' SG ' ' A' ' 115' ' ' CYS . 15.6 mm -73.14 109.42 5.33 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.921 0 C-N-CA 123.797 0.839 . . . . 70.349999999999994 111.201 -176.399 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 63.8 tp -94.21 111.86 23.62 Favored 'General case' 0 CA--C 1.552 1.037 0 C-N-CA 123.773 0.829 . . . . 74.25 109.95 174.35 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 99' ' ' SER . . . . . 0.462 ' HB2' ' HA ' ' A' ' 128' ' ' VAL . 29.8 t -137.14 147.89 46.27 Favored 'General case' 0 N--CA 1.474 0.766 0 C-N-CA 124.371 1.068 . . . . 61.210000000000001 108.743 177.059 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 100' ' ' MET . . . . . 0.565 ' HA ' ' HA ' ' A' ' 112' ' ' PHE . 67.5 mtp -77.47 146.39 36.49 Favored 'General case' 0 N--CA 1.483 1.216 0 CA-C-O 120.671 0.272 . . . . 63.509999999999998 110.657 179.918 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 101' ' ' ALA . . . . . 0.55 ' HB3' ' HB3' ' A' ' 111' ' ' GLN . . . -76.89 162.5 27.56 Favored 'General case' 0 C--O 1.245 0.844 0 CA-C-N 115.818 -0.628 . . . . 64.329999999999998 111.254 -176.469 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 102' ' ' ASN . . . . . 0.498 ' HB3' ' HA ' ' A' ' 108' ' ' ASN . 30.5 p-10 -168.47 171.1 9.26 Favored 'General case' 0 C--O 1.238 0.472 0 CA-C-N 114.823 -1.081 . . . . 54.149999999999999 109.522 179.503 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 103' ' ' ALA . . . . . 0.426 ' HB3' HG21 ' A' ' 107' ' ' THR . . . -119.59 13.41 12.52 Favored 'General case' 0 CA--C 1.543 0.695 0 CA-C-N 115.263 -0.88 . . . . 75.530000000000001 109.94 172.617 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 146.95 -166.86 28.36 Favored Glycine 0 C--N 1.352 1.438 0 CA-C-O 119.595 -0.559 . . . . 71.140000000000001 112.521 179.981 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 14.6 Cg_exo -67.34 140.79 54.15 Favored 'Trans proline' 0 C--N 1.372 1.808 0 C-N-CA 123.172 2.581 . . . . 72.430000000000007 111.433 178.957 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 66.7 t30 66.4 9.72 6.69 Favored 'General case' 0 N--CA 1.491 1.606 0 C-N-CA 124.822 1.249 . . . . 73.310000000000002 111.979 -178.89 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 107' ' ' THR . . . . . 0.713 ' HA ' ' HD2' ' A' ' 82' ' ' LYS . 3.9 m -109.6 -6.47 15.35 Favored 'General case' 0 CA--C 1.552 1.049 0 C-N-CA 124.266 1.026 . . . . 73.200000000000003 109.669 177.025 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 108' ' ' ASN . . . . . 0.498 ' HA ' ' HB3' ' A' ' 102' ' ' ASN . 24.3 t30 -60.92 151.53 30.0 Favored 'General case' 0 N--CA 1.48 1.066 0 C-N-CA 125.046 1.339 . . . . 62.520000000000003 110.657 173.564 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 93.95 18.59 36.69 Favored Glycine 0 N--CA 1.465 0.628 0 C-N-CA 121.695 -0.288 . . . . 73.510000000000005 112.962 178.881 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 15.2 p -117.36 120.55 38.53 Favored 'General case' 0 C--N 1.328 -0.335 0 N-CA-C 106.938 -1.504 . . . . 73.329999999999998 106.938 167.093 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 111' ' ' GLN . . . . . 0.55 ' HB3' ' HB3' ' A' ' 101' ' ' ALA . 5.8 tt0 69.08 171.73 0.3 Allowed 'General case' 0 CA--C 1.557 1.23 0 C-N-CA 123.43 0.692 . . . . 64.030000000000001 111.341 171.609 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 112' ' ' PHE . . . . . 0.565 ' HA ' ' HA ' ' A' ' 100' ' ' MET . 52.5 p90 -143.8 155.0 43.99 Favored 'General case' 0 N--CA 1.48 1.026 0 O-C-N 121.748 -0.595 . . . . 74.219999999999999 109.695 176.364 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 113' ' ' PHE . . . . . 0.475 ' HB2' ' SD ' ' A' ' 61' ' ' MET . 40.5 p90 -140.57 151.3 44.6 Favored 'General case' 0 N--CA 1.47 0.536 0 C-N-CA 123.329 0.652 . . . . 73.209999999999994 111.277 -179.356 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 114' ' ' ILE . . . . . 0.546 ' HB ' ' SG ' ' A' ' 62' ' ' CYS . 19.3 mt -124.55 104.88 14.41 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.613 0 N-CA-C 108.067 -1.086 . . . . 75.430000000000007 108.067 177.029 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 115' ' ' CYS . . . . . 0.813 ' SG ' ' HB ' ' A' ' 97' ' ' ILE . 27.8 p -85.69 114.53 22.74 Favored 'General case' 0 C--O 1.241 0.643 0 CA-C-N 118.284 0.493 . . . . 73.019999999999996 109.728 178.968 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 116' ' ' THR . . . . . 0.445 ' O ' ' HB3' ' A' ' 95' ' ' PRO . 70.6 p -73.21 -20.88 60.77 Favored 'General case' 0 CA--C 1.54 0.579 0 C-N-CA 123.796 0.838 . . . . 72.239999999999995 110.603 176.863 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -101.94 155.89 17.88 Favored 'General case' 0 C--O 1.241 0.627 0 CA-C-N 115.383 -0.826 . . . . 74.140000000000001 109.76 171.893 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 19.2 ptmt -75.19 83.61 2.37 Favored 'General case' 0 CA--C 1.542 0.668 0 CA-C-O 121.765 0.793 . . . . 70.140000000000001 109.434 173.938 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 119' ' ' THR . . . . . 0.582 ' HB ' HD13 ' A' ' 122' ' ' LEU . 44.5 p -76.45 86.14 3.19 Favored 'General case' 0 CA--C 1.545 0.785 0 CA-C-O 121.948 0.88 . . . . 74.409999999999997 110.004 -175.984 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 11.1 pt-20 -78.51 -16.93 56.95 Favored 'General case' 0 N--CA 1.476 0.86 0 CA-C-N 114.825 -1.079 . . . . 74.530000000000001 112.127 -171.377 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 121' ' ' TRP . . . . . . . . . . . . . 35.7 p90 -74.18 -0.57 17.17 Favored 'General case' 0 CA--C 1.55 0.965 0 C-N-CA 123.027 0.531 . . . . 75.319999999999993 111.068 173.385 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 122' ' ' LEU . . . . . 0.582 HD13 ' HB ' ' A' ' 119' ' ' THR . 9.6 mp -97.42 -1.02 45.22 Favored 'General case' 0 N--CA 1.483 1.214 0 C-N-CA 124.275 1.03 . . . . 63.340000000000003 111.799 172.946 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 56.5 m-20 -71.06 129.51 39.14 Favored 'General case' 0 N--CA 1.477 0.898 0 N-CA-C 108.293 -1.003 . . . . 75.430000000000007 108.293 173.616 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 95.95 -25.08 26.98 Favored Glycine 0 N--CA 1.471 0.977 0 N-CA-C 111.573 -0.611 . . . . 55.200000000000003 111.573 -172.012 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 125' ' ' LYS . . . . . 0.578 ' HE2' ' HB3' ' B' ' 220' ' ' PRO . 16.3 ttpp -83.28 -168.46 2.1 Favored 'General case' 0 CA--C 1.555 1.144 0 N-CA-C 107.382 -1.34 . . . . 74.129999999999995 107.382 166.578 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 126' ' ' HIS . . . . . 0.498 ' H ' ' HG2' ' A' ' 125' ' ' LYS . 16.6 t-80 -65.0 131.65 47.15 Favored 'General case' 0 CA--C 1.548 0.887 0 CA-C-N 118.713 0.688 . . . . 74.109999999999999 112.082 -166.653 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 11.4 p -58.43 147.95 6.61 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.743 0 C-N-CA 125.906 1.682 . . . . 62.439999999999998 112.047 179.33 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 128' ' ' VAL . . . . . 0.462 ' HA ' ' HB2' ' A' ' 99' ' ' SER . 17.3 t -67.67 155.65 7.38 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.819 0 C-N-CA 123.927 0.891 . . . . 74.129999999999995 109.638 175.335 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 129' ' ' PHE . . . . . 0.523 ' HA ' HG21 ' A' ' 29' ' ' VAL . 50.5 p90 -133.5 -25.07 1.74 Allowed 'General case' 0 N--CA 1.477 0.908 0 O-C-N 122.269 -0.269 . . . . 65.510000000000005 111.363 173.843 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . -136.99 161.82 25.19 Favored Glycine 0 C--N 1.341 0.833 0 N-CA-C 111.588 -0.605 . . . . 70.439999999999998 111.588 -177.562 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 35.8 ttpt -144.29 138.61 28.05 Favored 'General case' 0 N--CA 1.468 0.461 0 N-CA-C 108.852 -0.795 . . . . 64.540000000000006 108.852 177.217 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 132' ' ' VAL . . . . . 0.414 HG13 HG13 ' A' ' 20' ' ' VAL . 47.3 t -64.03 103.44 0.38 Allowed 'Isoleucine or valine' 0 C--O 1.24 0.562 0 N-CA-C 108.83 -0.804 . . . . 71.420000000000002 108.83 174.751 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 133' ' ' LYS . . . . . 0.569 ' HD3' HG23 ' A' ' 5' ' ' THR . 21.5 ptmt -85.67 -31.91 22.25 Favored 'General case' 0 CA--C 1.537 0.476 0 N-CA-C 109.371 -0.603 . . . . 73.120000000000005 109.371 179.941 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 134' ' ' GLU . . . . . 0.413 ' HB2' ' OG ' ' A' ' 21' ' ' SER . 17.0 mt-10 -143.87 149.05 36.35 Favored 'General case' 0 N--CA 1.479 1.023 0 C-N-CA 124.818 1.247 . . . . 75.129999999999995 109.222 179.02 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 84.31 22.55 54.06 Favored Glycine 0 C--N 1.345 1.048 0 O-C-N 123.379 0.424 . . . . 54.43 113.164 -179.716 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 136' ' ' MET . . . . . 0.403 ' HA ' HG11 ' A' ' 132' ' ' VAL . 16.5 tpt -62.76 -40.17 96.45 Favored 'General case' 0 N--CA 1.477 0.923 0 C-N-CA 123.239 0.616 . . . . 70.099999999999994 111.38 -179.913 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 137' ' ' ASN . . . . . . . . . . . . . 12.4 m120 -64.75 -26.61 68.43 Favored 'General case' 0 N--CA 1.478 0.973 0 C-N-CA 123.146 0.578 . . . . 70.530000000000001 111.271 179.255 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 138' ' ' ILE . . . . . . . . . . . . . 48.1 mm -76.48 -37.75 30.8 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.843 0 C-N-CA 123.444 0.698 . . . . 55.100000000000001 110.153 177.192 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 139' ' ' VAL . . . . . 0.475 HG13 ' SG ' ' A' ' 62' ' ' CYS . 95.4 t -62.26 -43.61 98.19 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.96 0 C-N-CA 123.471 0.708 . . . . 63.509999999999998 110.258 175.43 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 39.0 mt-10 -65.5 -42.37 92.17 Favored 'General case' 0 CA--C 1.544 0.734 0 CA-C-N 114.949 -1.023 . . . . 73.299999999999997 110.851 176.889 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -67.85 -39.21 83.82 Favored 'General case' 0 N--CA 1.48 1.034 0 C-N-CA 123.603 0.761 . . . . 63.039999999999999 111.884 -178.189 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 142' ' ' MET . . . . . 0.594 ' HB2' HD13 ' A' ' 156' ' ' ILE . 19.5 ptt? -75.95 -29.28 58.24 Favored 'General case' 0 N--CA 1.478 0.952 0 C-N-CA 122.644 0.378 . . . . 64.25 110.504 -178.912 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 143' ' ' GLU . . . . . 0.497 ' HA ' HG21 ' A' ' 56' ' ' ILE . 28.1 tt0 -65.61 -28.01 68.82 Favored 'General case' 0 CA--C 1.545 0.77 0 CA-C-N 115.711 -0.677 . . . . 74.030000000000001 111.68 178.677 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 144' ' ' ARG . . . . . . . . . . . . . 75.9 mtt180 -66.87 -13.22 61.4 Favored 'General case' 0 N--CA 1.479 0.992 0 C-N-CA 123.555 0.742 . . . . 72.310000000000002 111.921 177.699 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 145' ' ' PHE . . . . . . . . . . . . . 38.3 m-85 -88.68 -8.58 54.33 Favored 'General case' 0 N--CA 1.475 0.807 0 C-N-CA 123.379 0.672 . . . . 73.540000000000006 111.641 175.944 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . -87.3 171.53 42.23 Favored Glycine 0 C--N 1.346 1.095 0 CA-C-O 120.007 -0.33 . . . . 42.039999999999999 112.547 175.166 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 9.0 m -133.03 160.15 37.98 Favored 'General case' 0 N--CA 1.479 1.01 0 C-N-CA 123.565 0.746 . . . . 72.25 110.31 -175.525 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 148' ' ' ARG . . . . . 0.641 ' HA ' HG23 ' A' ' 57' ' ' ILE . 14.3 mmm180 -61.29 -31.64 71.47 Favored 'General case' 0 N--CA 1.483 1.22 0 C-N-CA 124.5 1.12 . . . . 74.430000000000007 113.407 -176.382 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 149' ' ' ASN . . . . . . . . . . . . . 31.2 p-10 -75.74 -13.1 60.3 Favored 'General case' 0 N--CA 1.483 1.2 0 C-N-CA 123.222 0.609 . . . . 63.329999999999998 111.467 178.573 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . 111.64 -17.15 25.85 Favored Glycine 0 C--N 1.348 1.208 0 CA-C-O 119.821 -0.433 . . . . 72.540000000000006 112.664 179.066 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 87.3 tttt -69.09 137.1 53.21 Favored 'General case' 0 CA--C 1.546 0.812 0 C-N-CA 122.853 0.461 . . . . 63.539999999999999 111.303 -175.214 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 152' ' ' THR . . . . . . . . . . . . . 6.8 p -92.18 121.44 33.72 Favored 'General case' 0 C--O 1.241 0.63 0 C-N-CA 123.826 0.85 . . . . 75.510000000000005 109.124 170.41 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 153' ' ' SER . . . . . . . . . . . . . 29.9 t -67.32 -36.21 81.01 Favored 'General case' 0 N--CA 1.472 0.665 0 C-N-CA 123.499 0.72 . . . . 42.329999999999998 109.995 174.042 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 69.5 mmtt -110.39 149.42 30.28 Favored 'General case' 0 N--CA 1.471 0.622 0 C-N-CA 124.256 1.023 . . . . 74.319999999999993 110.767 -178.28 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 16.2 tppt? -89.27 91.67 8.86 Favored 'General case' 0 C--N 1.345 0.376 0 N-CA-C 108.873 -0.788 . . . . 71.439999999999998 108.873 178.386 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 156' ' ' ILE . . . . . 0.594 HD13 ' HB2' ' A' ' 142' ' ' MET . 69.1 mt -91.75 126.05 44.39 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.416 0 N-CA-C 108.833 -0.802 . . . . 72.349999999999994 108.833 -179.054 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 157' ' ' THR . . . . . 0.473 HG22 ' HB3' ' A' ' 52' ' ' CYS . 21.1 p -134.11 157.47 46.09 Favored 'General case' 0 N--CA 1.477 0.915 0 C-N-CA 124.115 0.966 . . . . 60.299999999999997 109.708 -175.371 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 158' ' ' ILE . . . . . 0.43 HD12 ' HB2' ' A' ' 51' ' ' SER . 46.4 mt -80.21 93.68 2.0 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.819 0 N-CA-C 109.261 -0.644 . . . . 71.409999999999997 109.261 170.601 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 159' ' ' ALA . . . . . 0.554 ' HB2' ' HB2' ' A' ' 11' ' ' ALA . . . -61.35 -34.16 74.84 Favored 'General case' 0 N--CA 1.472 0.626 0 C-N-CA 124.614 1.166 . . . . 73.109999999999999 113.404 -176.703 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 160' ' ' ASP . . . . . 0.548 ' HA ' ' HE2' ' A' ' 49' ' ' LYS . 26.3 t0 -159.98 162.76 34.4 Favored 'General case' 0 N--CA 1.475 0.814 0 C-N-CA 122.588 0.355 . . . . 70.439999999999998 110.375 -179.469 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 161' ' ' CYS . . . . . . . . . . . . . 28.0 p -127.74 -166.55 1.63 Allowed 'General case' 0 N--CA 1.474 0.731 0 C-N-CA 125.362 1.465 . . . . 73.439999999999998 108.812 -177.977 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 162' ' ' GLY . . . . . . . . . . . . . . . 134.17 54.51 0.07 OUTLIER Glycine 0 C--N 1.351 1.403 0 C-N-CA 121.406 -0.426 . . . . 75.299999999999997 112.885 -177.196 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 163' ' ' GLN . . . . . 0.417 HE22 ' HG3' ' A' ' 37' ' ' ARG . 8.1 tt0 -46.4 106.6 0.08 Allowed 'General case' 0 N--CA 1.483 1.18 0 C-N-CA 124.547 1.139 . . . . 52.100000000000001 111.629 178.515 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 164' ' ' LEU . . . . . . . . . . . . . 86.4 mt . . . . . 0 CA--C 1.542 0.671 0 CA-C-N 114.64 -1.164 . . . . 72.530000000000001 110.886 -177.402 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' B' B ' 218' ' ' PRO . . . . . . . . . . . . . 68.1 Cg_exo . . . . . 0 N--CA 1.491 1.348 0 CA-C-O 121.214 0.423 . . . . 73.549999999999997 111.9 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' B' B ' 219' ' ' GLY . . . . . . . . . . . . . . . 153.43 172.13 21.32 Favored Glycine 0 CA--C 1.529 0.928 0 CA-C-N 114.962 -1.017 . . . . 60.140000000000001 112.021 -174.213 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 220' ' ' PRO . . . . . 0.578 ' HB3' ' HE2' ' A' ' 125' ' ' LYS . 51.9 Cg_endo -86.48 165.49 9.32 Favored 'Trans proline' 0 C--N 1.364 1.355 0 C-N-CA 123.214 2.609 . . . . 74.450000000000003 114.22 179.689 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 221' ' ' TYR . . . . . . . . . . . . . 54.9 t80 . . . . . 0 N--CA 1.475 0.79 0 C-N-CA 123.002 0.521 . . . . 44.140000000000001 110.609 175.193 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 5.6 m120 . . . . . 0 CA--C 1.55 0.96 0 CA-C-O 119.087 -0.482 . . . . 71.549999999999997 110.043 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 31.5 Cg_endo -61.62 121.73 10.0 Favored 'Trans proline' 0 C--N 1.378 2.098 0 C-N-CA 122.957 2.438 . . . . 62.310000000000002 111.591 179.847 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 5' ' ' THR . . . . . 0.401 ' HB ' ' HB2' ' A' ' 164' ' ' LEU . 93.1 m -98.14 132.11 43.94 Favored 'General case' 0 CA--C 1.536 0.435 0 C-N-CA 122.756 0.422 . . . . 71.420000000000002 110.097 -177.972 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 6' ' ' VAL . . . . . 0.521 ' HA ' ' HB2' ' A' ' 163' ' ' GLN . 12.6 m -101.16 129.49 52.08 Favored 'Isoleucine or valine' 0 C--N 1.35 0.593 0 C-N-CA 123.53 0.732 . . . . 72.239999999999995 110.008 175.591 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 7' ' ' PHE . . . . . 0.621 ' HB2' ' HG ' ' A' ' 164' ' ' LEU . 37.7 t80 -119.61 134.23 55.31 Favored 'General case' 0 C--O 1.238 0.464 0 C-N-CA 123.886 0.875 . . . . 72.040000000000006 109.7 -170.684 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 8' ' ' PHE . . . . . 0.437 ' HB3' HG23 ' A' ' 158' ' ' ILE . 64.6 m-85 -139.89 161.37 37.75 Favored 'General case' 0 N--CA 1.47 0.536 0 O-C-N 123.801 0.688 . . . . 71.349999999999994 111.467 -174.705 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 7.6 m-20 -102.36 108.05 19.27 Favored 'General case' 0 N--CA 1.47 0.536 0 CA-C-N 114.005 -1.452 . . . . 65.450000000000003 107.58 166.017 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 10' ' ' ILE . . . . . 0.475 HG21 ' SD ' ' A' ' 142' ' ' MET . 49.2 mm -82.1 120.3 33.33 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.476 0 N-CA-C 108.852 -0.795 . . . . 73.209999999999994 108.852 175.323 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 11' ' ' ALA . . . . . 0.537 ' HB2' ' HB2' ' A' ' 159' ' ' ALA . . . -117.29 121.92 42.49 Favored 'General case' 0 N--CA 1.463 0.218 0 C-N-CA 123.529 0.732 . . . . 65.549999999999997 110.915 -173.638 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 12' ' ' VAL . . . . . 0.488 HG21 HD22 ' A' ' 17' ' ' LEU . 76.6 t -98.06 118.08 43.98 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.651 0 N-CA-C 108.334 -0.988 . . . . 72.340000000000003 108.334 173.454 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 35.8 m-20 61.9 31.2 18.25 Favored 'General case' 0 N--CA 1.486 1.364 0 C-N-CA 125.566 1.546 . . . . 72.25 111.249 -174.707 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 87.32 -15.78 52.24 Favored Glycine 0 C--N 1.352 1.428 0 CA-C-N 115.488 -0.778 . . . . 43.329999999999998 113.191 -177.499 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 21.8 mm-40 -90.81 115.72 64.86 Favored Pre-proline 0 N--CA 1.474 0.766 0 CA-C-O 118.606 -0.711 . . . . 73.150000000000006 110.514 -177.165 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 14.0 Cg_endo -53.52 104.88 0.11 Allowed 'Trans proline' 0 C--N 1.387 2.564 0 C-N-CA 123.228 2.619 . . . . 72.430000000000007 111.909 178.493 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 17' ' ' LEU . . . . . 0.488 HD22 HG21 ' A' ' 12' ' ' VAL . 21.3 tp -77.12 -24.93 51.65 Favored 'General case' 0 CA--C 1.541 0.632 0 CA-C-N 114.696 -1.138 . . . . 71.099999999999994 109.777 179.3 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 170.03 -178.62 42.78 Favored Glycine 0 C--N 1.342 0.894 0 CA-C-N 115.354 -0.839 . . . . 51.140000000000001 112.337 176.373 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 94.3 mtt180 -116.44 142.27 47.08 Favored 'General case' 0 N--CA 1.473 0.687 0 C-N-CA 123.771 0.828 . . . . 72.439999999999998 110.228 -178.49 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 45.0 t -131.35 141.11 46.76 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.69 0 C-N-CA 123.179 0.592 . . . . 73.219999999999999 110.247 -178.474 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 40.6 p -120.92 116.77 25.77 Favored 'General case' 0 CA--C 1.548 0.901 0 C-N-CA 124.596 1.158 . . . . 72.109999999999999 109.109 177.1 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 63.1 m-85 -103.36 113.47 26.99 Favored 'General case' 0 N--CA 1.472 0.647 0 C-N-CA 123.927 0.891 . . . . 62.420000000000002 109.377 177.158 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 23' ' ' GLU . . . . . 0.537 ' HB2' ' HD2' ' A' ' 133' ' ' LYS . 42.4 tt0 -74.88 103.56 5.16 Favored 'General case' 0 CA--C 1.553 1.083 0 C-N-CA 123.827 0.851 . . . . 71.230000000000004 109.934 175.759 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 21.0 mt -83.94 120.07 25.66 Favored 'General case' 0 N--CA 1.477 0.904 0 N-CA-C 109.352 -0.61 . . . . 73.140000000000001 109.352 178.454 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 25' ' ' PHE . . . . . 0.585 ' HB2' HD11 ' A' ' 90' ' ' LEU . 57.8 m-85 -84.46 70.44 10.68 Favored 'General case' 0 CA--C 1.544 0.716 0 C-N-CA 123.19 0.596 . . . . 73.319999999999993 110.117 177.809 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -60.97 -30.45 70.27 Favored 'General case' 0 N--CA 1.482 1.13 0 C-N-CA 123.247 0.619 . . . . 73.319999999999993 111.789 179.901 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 10.8 p-10 -62.03 -26.59 68.34 Favored 'General case' 0 CA--C 1.548 0.866 0 C-N-CA 124.169 0.988 . . . . 75.230000000000004 112.223 178.902 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 28' ' ' LYS . . . . . 0.406 ' HD2' HD21 ' A' ' 90' ' ' LEU . 41.0 mttm -98.05 -49.69 4.66 Favored 'General case' 0 N--CA 1.479 0.991 0 C-N-CA 123.557 0.743 . . . . 52.009999999999998 110.476 -178.629 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 29' ' ' VAL . . . . . 0.569 HG21 ' HA ' ' A' ' 129' ' ' PHE . 26.7 m -120.05 83.67 31.52 Favored Pre-proline 0 CA--C 1.567 1.605 0 C-N-CA 123.844 0.858 . . . . 63.520000000000003 110.119 -174.285 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 32.7 Cg_endo -61.43 -49.84 6.79 Favored 'Trans proline' 0 C--N 1.382 2.33 0 C-N-CA 122.81 2.34 . . . . 73.109999999999999 112.337 -172.045 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 23.8 ttmm -60.5 -53.51 56.65 Favored 'General case' 0 N--CA 1.47 0.563 0 C-N-CA 124.049 0.94 . . . . 71.230000000000004 111.805 -175.247 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 7.3 m -75.85 -37.41 58.99 Favored 'General case' 0 CA--C 1.553 1.076 0 CA-C-N 115.339 -0.846 . . . . 74.219999999999999 111.912 -168.508 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -76.4 -43.37 40.76 Favored 'General case' 0 N--CA 1.479 0.998 0 C-N-CA 122.367 0.267 . . . . 61.030000000000001 111.327 -179.103 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 9.0 tp10 -62.75 -39.27 93.63 Favored 'General case' 0 N--CA 1.482 1.144 0 O-C-N 123.445 0.465 . . . . 54.020000000000003 110.878 178.134 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 35' ' ' ASN . . . . . 0.492 ' O ' ' HG ' ' A' ' 39' ' ' LEU . 35.6 t30 -50.2 -62.6 1.48 Allowed 'General case' 0 C--N 1.356 0.889 0 O-C-N 124.333 1.02 . . . . 74.129999999999995 110.885 176.865 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 36' ' ' PHE . . . . . 0.46 ' HE2' HG21 ' A' ' 6' ' ' VAL . 84.2 t80 -64.26 -34.03 77.19 Favored 'General case' 0 N--CA 1.471 0.613 0 O-C-N 124.172 0.92 . . . . 74.129999999999995 111.843 -175.544 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 41.9 ttp180 -64.71 -40.53 95.52 Favored 'General case' 0 CA--C 1.541 0.618 0 O-C-N 123.429 0.456 . . . . 65.049999999999997 110.682 178.969 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -75.88 -25.87 56.52 Favored 'General case' 0 N--CA 1.476 0.843 0 CA-C-N 115.881 -0.6 . . . . 42.450000000000003 111.432 179.226 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 39' ' ' LEU . . . . . 0.492 ' HG ' ' O ' ' A' ' 35' ' ' ASN . 85.5 mt -68.99 -40.1 78.96 Favored 'General case' 0 N--CA 1.48 1.037 0 C-N-CA 123.605 0.762 . . . . 73.040000000000006 109.868 172.544 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 37.1 t -68.38 -56.67 7.7 Favored 'General case' 0 N--CA 1.475 0.814 0 C-N-CA 124.584 1.154 . . . . 73.310000000000002 111.359 -177.151 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 18.1 p -71.87 -30.01 64.97 Favored 'General case' 0 N--CA 1.473 0.697 0 CA-C-N 115.625 -0.716 . . . . 63.119999999999997 111.587 -179.26 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 83.26 26.58 43.32 Favored Glycine 0 C--N 1.347 1.169 0 CA-C-N 116.093 -0.503 . . . . 74.340000000000003 112.805 -179.436 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 40.7 mm-40 -67.0 -21.01 65.97 Favored 'General case' 0 N--CA 1.476 0.874 0 C-N-CA 122.979 0.512 . . . . 75.120000000000005 111.873 177.887 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 3.3 mmpm? -100.61 18.31 19.55 Favored 'General case' 0 CA--C 1.548 0.866 0 C-N-CA 124.052 0.941 . . . . 73.150000000000006 111.159 175.443 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 87.43 -25.06 8.54 Favored Glycine 0 C--N 1.349 1.299 0 CA-C-O 119.437 -0.646 . . . . 73.099999999999994 114.304 175.034 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 17.4 m-85 -69.2 -48.78 61.11 Favored 'General case' 0 N--CA 1.478 0.928 0 CA-C-N 117.237 0.519 . . . . 72.140000000000001 111.655 -167.145 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 53.29 64.74 3.92 Favored Glycine 0 C--N 1.353 1.505 0 O-C-N 123.942 0.776 . . . . 75.120000000000005 114.212 170.692 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 48' ' ' TYR . . . . . 0.453 ' HB3' ' HB2' ' A' ' 51' ' ' SER . 59.3 m-85 -60.95 86.95 0.02 OUTLIER 'General case' 0 CA--C 1.551 1.006 0 CA-C-O 121.69 0.757 . . . . 73.450000000000003 111.044 178.209 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 27.7 tptp -112.68 125.28 54.13 Favored 'General case' 0 C--O 1.238 0.455 0 N-CA-C 107.306 -1.368 . . . . 73.150000000000006 107.306 177.086 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 73.92 21.62 78.99 Favored Glycine 0 CA--C 1.53 0.989 0 O-C-N 123.364 0.415 . . . . 50.210000000000001 112.097 -172.117 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 51' ' ' SER . . . . . 0.653 ' HA ' ' HB2' ' A' ' 67' ' ' PHE . 31.8 t -61.81 112.05 2.13 Favored 'General case' 0 C--N 1.358 0.944 0 C-N-CA 123.65 0.78 . . . . 73.120000000000005 111.042 -173.486 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 52' ' ' CYS . . . . . 0.605 ' SG ' ' HB3' ' A' ' 66' ' ' ASP . 5.1 p -82.06 161.76 22.8 Favored 'General case' 0 CA--C 1.537 0.446 0 CA-C-O 121.769 0.795 . . . . 62.130000000000003 111.914 -172.864 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 30.2 m-85 -113.72 133.36 55.39 Favored 'General case' 0 C--O 1.235 0.337 0 CA-C-N 114.613 -1.176 . . . . 72.109999999999999 108.136 177.164 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 55.6 p-80 -115.9 -19.98 10.18 Favored 'General case' 0 N--CA 1.485 1.319 0 C-N-CA 122.871 0.468 . . . . 63.32 110.883 -179.351 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 55' ' ' ARG . . . . . 0.472 ' HA ' ' O ' ' A' ' 150' ' ' GLY . 27.9 ttt-85 -130.22 97.02 4.31 Favored 'General case' 0 C--O 1.215 -0.728 0 C-N-CA 123.116 0.566 . . . . 74.349999999999994 109.553 -172.158 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 33.2 mt -136.05 129.46 47.37 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.716 0 C-N-CA 123.488 0.715 . . . . 75.019999999999996 109.138 178.816 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 57' ' ' ILE . . . . . 0.45 HG23 ' HA ' ' A' ' 148' ' ' ARG . 56.8 mt -128.83 118.04 19.6 Favored Pre-proline 0 CA--C 1.552 1.02 0 C-N-CA 124.591 1.157 . . . . 75.219999999999999 109.153 -178.168 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 58' ' ' PRO . . . . . 0.709 ' HB3' ' HA ' ' A' ' 144' ' ' ARG . 38.7 Cg_endo -63.96 140.27 71.92 Favored 'Trans proline' 0 C--N 1.377 2.058 0 C-N-CA 123.563 2.842 . . . . 74.530000000000001 113.325 -175.966 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 73.4 20.45 79.88 Favored Glycine 0 C--N 1.346 1.115 0 CA-C-N 115.094 -0.957 . . . . 72.450000000000003 113.057 178.839 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 60' ' ' PHE . . . . . 0.427 ' CD2' ' HB3' ' A' ' 61' ' ' MET . 47.2 t80 -145.24 -73.68 0.24 Allowed 'General case' 0 C--O 1.244 0.782 0 C-N-CA 123.662 0.785 . . . . 73.209999999999994 109.717 -174.366 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 61' ' ' MET . . . . . 0.704 ' SD ' ' HB2' ' A' ' 63' ' ' GLN . 12.3 tmm? -169.15 137.03 1.9 Allowed 'General case' 0 N--CA 1.479 1.001 0 O-C-N 123.272 0.358 . . . . 71.140000000000001 111.686 -164.883 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 62' ' ' CYS . . . . . 0.486 ' SG ' ' HB ' ' A' ' 114' ' ' ILE . 3.9 p -112.89 121.32 44.32 Favored 'General case' 0 N--CA 1.484 1.228 0 C-N-CA 124.673 1.189 . . . . 74.120000000000005 110.585 174.334 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 63' ' ' GLN . . . . . 0.704 ' HB2' ' SD ' ' A' ' 61' ' ' MET . 53.7 tt0 -126.95 137.6 53.15 Favored 'General case' 0 N--CA 1.49 1.562 0 C-N-CA 124.163 0.985 . . . . 61.439999999999998 111.489 -168.596 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -154.86 -157.81 8.4 Favored Glycine 0 C--N 1.348 1.217 0 CA-C-N 115.975 -0.557 . . . . 51.009999999999998 113.311 -178.314 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 108.46 14.04 17.27 Favored Glycine 0 N--CA 1.476 1.344 0 N-CA-C 111.477 -0.649 . . . . 53.299999999999997 111.477 -169.789 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 66' ' ' ASP . . . . . 0.605 ' HB3' ' SG ' ' A' ' 52' ' ' CYS . 28.2 t70 -72.09 1.19 7.83 Favored 'General case' 0 CA--C 1.558 1.283 0 C-N-CA 125.242 1.417 . . . . 53.020000000000003 112.876 -167.409 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 67' ' ' PHE . . . . . 0.653 ' HB2' ' HA ' ' A' ' 51' ' ' SER . 56.6 t80 -73.36 -70.96 0.34 Allowed 'General case' 0 CA--C 1.549 0.932 0 C-N-CA 124.022 0.929 . . . . 73.310000000000002 111.41 -176.509 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 68' ' ' THR . . . . . 0.511 HG22 ' HD3' ' A' ' 76' ' ' LYS . 4.3 m -86.9 108.5 18.81 Favored 'General case' 0 N--CA 1.475 0.8 0 C-N-CA 122.949 0.5 . . . . 35.299999999999997 110.115 -171.999 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 34.8 ttt85 52.99 93.64 0.02 OUTLIER 'General case' 0 N--CA 1.481 1.116 0 C-N-CA 125.501 1.52 . . . . 65.409999999999997 111.618 -179.278 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 0.4 OUTLIER -110.69 11.73 22.67 Favored 'General case' 0 N--CA 1.481 1.088 0 N-CA-C 112.866 0.691 . . . . 73.329999999999998 112.866 -177.122 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 18.7 m120 -86.21 88.14 7.55 Favored 'General case' 0 N--CA 1.477 0.896 0 N-CA-C 108.928 -0.767 . . . . 64.109999999999999 108.928 171.467 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 69.96 29.39 70.82 Favored Glycine 0 C--N 1.35 1.334 0 CA-C-N 115.478 -0.783 . . . . 74.120000000000005 113.751 176.549 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 47.9 m -143.7 -64.55 0.38 Allowed 'General case' 0 CA--C 1.547 0.832 0 C-N-CA 124.015 0.926 . . . . 65.239999999999995 108.698 178.188 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 56.14 41.11 85.29 Favored Glycine 0 C--N 1.356 1.688 0 N-CA-C 115.234 0.853 . . . . 73.510000000000005 115.234 172.063 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 141.18 51.1 0.05 OUTLIER Glycine 0 C--N 1.346 1.12 0 CA-C-N 117.241 0.521 . . . . 24.300000000000001 111.872 -175.219 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 76' ' ' LYS . . . . . 0.511 ' HD3' HG22 ' A' ' 68' ' ' THR . 0.0 OUTLIER -58.87 147.81 32.44 Favored 'General case' 0 N--CA 1.475 0.82 0 C-N-CA 123.329 0.652 . . . . 74.329999999999998 112.151 -179.129 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 85.8 p -98.52 -178.37 3.98 Favored 'General case' 0 C--O 1.238 0.454 0 CA-C-N 115.325 -0.852 . . . . 72.439999999999998 111.953 -170.874 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 26.8 pt -75.58 -12.89 14.9 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.85 0 CA-C-N 114.999 -1.0 . . . . 75.450000000000003 111.003 175.426 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 99.2 m-85 -97.78 22.08 9.63 Favored 'General case' 0 N--CA 1.479 1.018 0 C-N-CA 124.133 0.973 . . . . 70.420000000000002 110.069 175.714 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 96.52 -111.71 4.29 Favored Glycine 0 C--N 1.346 1.128 0 N-CA-C 110.895 -0.882 . . . . 71.140000000000001 110.895 -177.694 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 41.5 tt0 -78.37 -59.63 2.7 Favored 'General case' 0 N--CA 1.472 0.628 0 C-N-CA 122.978 0.511 . . . . 72.310000000000002 110.378 -179.975 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 82' ' ' LYS . . . . . 0.759 ' HD2' ' HA ' ' A' ' 107' ' ' THR . 21.3 pttp -161.47 178.5 9.07 Favored 'General case' 0 N--CA 1.477 0.902 0 C-N-CA 123.88 0.872 . . . . 74.409999999999997 109.839 -171.055 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 35.7 p90 -152.07 174.36 13.78 Favored 'General case' 0 N--CA 1.474 0.765 0 C-N-CA 124.43 1.092 . . . . 72.129999999999995 111.459 -175.81 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 84' ' ' GLU . . . . . 0.46 ' HA ' ' HA ' ' A' ' 106' ' ' ASN . 13.7 pt-20 -82.92 160.28 22.13 Favored 'General case' 0 N--CA 1.474 0.734 0 CA-C-N 115.249 -0.887 . . . . 74.200000000000003 110.795 176.263 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 85' ' ' ASP . . . . . 0.404 ' OD1' ' HA ' ' A' ' 126' ' ' HIS . 49.7 m-20 -63.04 133.98 55.39 Favored 'General case' 0 N--CA 1.47 0.56 0 C-N-CA 123.741 0.816 . . . . 72.230000000000004 110.832 179.232 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 9.9 tp10 -76.18 -61.79 1.82 Allowed 'General case' 0 CA--C 1.543 0.676 0 CA-C-N 116.074 -0.512 . . . . 73.409999999999997 109.846 179.261 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 87' ' ' ASN . . . . . 0.433 ' OD1' HG12 ' A' ' 29' ' ' VAL . 27.6 p-10 -169.36 155.39 6.27 Favored 'General case' 0 N--CA 1.477 0.899 0 C-N-CA 123.49 0.716 . . . . 60.210000000000001 110.265 -173.303 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 76.5 m-85 -109.11 33.26 4.37 Favored 'General case' 0 N--CA 1.479 1.0 0 C-N-CA 123.826 0.85 . . . . 75.540000000000006 111.442 -169.648 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 55.9 mt -60.25 -46.98 94.03 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.164 0 C-N-CA 123.311 0.644 . . . . 65.099999999999994 109.561 174.283 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 90' ' ' LEU . . . . . 0.585 HD11 ' HB2' ' A' ' 25' ' ' PHE . 95.9 mt -95.87 128.39 42.71 Favored 'General case' 0 CA--C 1.537 0.476 0 CA-C-N 115.047 -0.978 . . . . 73.129999999999995 109.803 179.067 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 17.8 ptpt -133.74 171.94 13.45 Favored 'General case' 0 N--CA 1.472 0.646 0 C-N-CA 124.305 1.042 . . . . 75.239999999999995 110.133 -179.444 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 92' ' ' HIS . . . . . . . . . . . . . 23.8 m-70 -85.49 50.28 1.93 Allowed 'General case' 0 N--CA 1.477 0.895 0 C-N-CA 124.277 1.031 . . . . 64.349999999999994 110.107 -175.909 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 8.8 t -89.28 4.92 47.19 Favored 'General case' 0 CA--C 1.549 0.929 0 C-N-CA 124.006 0.923 . . . . 54.149999999999999 111.576 -176.773 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -148.72 172.9 28.82 Favored Glycine 0 C--N 1.345 1.073 0 N-CA-C 111.93 -0.468 . . . . 62.340000000000003 111.93 178.779 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 89.9 Cg_endo -84.08 156.88 13.2 Favored 'Trans proline' 0 CA--C 1.551 1.367 0 C-N-CA 123.026 2.484 . . . . 73.340000000000003 111.921 172.363 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 78.61 19.95 72.48 Favored Glycine 0 N--CA 1.471 1.03 0 CA-C-N 116.418 -0.355 . . . . 73.140000000000001 113.86 -179.438 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 97' ' ' ILE . . . . . . . . . . . . . 22.1 mm -78.91 109.77 13.95 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.777 0 C-N-CA 123.954 0.902 . . . . 63.219999999999999 111.41 -175.483 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 98' ' ' LEU . . . . . 0.492 HD13 HG12 ' A' ' 114' ' ' ILE . 65.6 tp -90.09 118.46 29.65 Favored 'General case' 0 CA--C 1.551 1.004 0 C-N-CA 123.299 0.64 . . . . 72.400000000000006 109.661 176.35 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 99' ' ' SER . . . . . 0.486 ' HB2' HG22 ' A' ' 128' ' ' VAL . 33.5 t -137.39 155.85 48.89 Favored 'General case' 0 N--CA 1.476 0.875 0 C-N-CA 124.979 1.312 . . . . 75.349999999999994 108.911 -177.495 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 100' ' ' MET . . . . . 0.41 ' HA ' ' HA ' ' A' ' 112' ' ' PHE . 41.2 mtp -90.41 147.31 23.52 Favored 'General case' 0 N--CA 1.486 1.348 0 N-CA-C 110.069 -0.345 . . . . 72.340000000000003 110.069 178.123 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 101' ' ' ALA . . . . . 0.475 ' HB3' ' HB2' ' A' ' 111' ' ' GLN . . . -84.46 162.52 19.9 Favored 'General case' 0 N--CA 1.475 0.8 0 C-N-CA 123.443 0.697 . . . . 44.530000000000001 112.622 -169.873 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 26.1 p-10 -165.1 168.05 17.65 Favored 'General case' 0 C--N 1.352 0.714 0 CA-C-N 115.142 -0.936 . . . . 73.450000000000003 110.358 178.757 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -113.72 9.02 17.67 Favored 'General case' 0 CA--C 1.543 0.701 0 C-N-CA 123.606 0.762 . . . . 75.200000000000003 109.75 168.174 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 154.08 -173.73 32.64 Favored Glycine 0 C--N 1.354 1.548 0 CA-C-O 119.706 -0.497 . . . . 52.130000000000003 112.552 -178.887 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 48.9 Cg_exo -58.59 143.75 98.04 Favored 'Trans proline' 0 C--N 1.373 1.842 0 C-N-CA 123.43 2.753 . . . . 75.510000000000005 112.898 176.876 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 106' ' ' ASN . . . . . 0.46 ' HA ' ' HA ' ' A' ' 84' ' ' GLU . 61.6 t30 63.96 14.65 8.58 Favored 'General case' 0 N--CA 1.485 1.284 0 C-N-CA 125.267 1.427 . . . . 72.329999999999998 111.837 -178.034 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 107' ' ' THR . . . . . 0.759 ' HA ' ' HD2' ' A' ' 82' ' ' LYS . 2.8 m -115.55 -0.48 13.03 Favored 'General case' 0 CA--C 1.551 0.995 0 C-N-CA 123.766 0.827 . . . . 61.350000000000001 109.93 179.263 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 54.7 t30 -78.09 155.01 30.81 Favored 'General case' 0 N--CA 1.479 0.983 0 C-N-CA 123.363 0.665 . . . . 64.510000000000005 110.246 -178.016 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 96.37 -10.26 67.2 Favored Glycine 0 N--CA 1.468 0.801 0 CA-C-O 120.076 -0.291 . . . . 33.229999999999997 113.11 177.533 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 16.2 p -91.19 123.13 34.4 Favored 'General case' 0 CA--C 1.538 0.513 0 N-CA-C 107.539 -1.282 . . . . 62.350000000000001 107.539 167.322 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 111' ' ' GLN . . . . . 0.475 ' HB2' ' HB3' ' A' ' 101' ' ' ALA . 3.0 mt-30 69.76 165.23 0.27 Allowed 'General case' 0 N--CA 1.493 1.703 0 C-N-CA 125.852 1.661 . . . . 73.340000000000003 111.19 -178.594 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 112' ' ' PHE . . . . . 0.41 ' HA ' ' HA ' ' A' ' 100' ' ' MET . 54.3 p90 -139.43 155.6 47.5 Favored 'General case' 0 N--CA 1.482 1.134 0 N-CA-C 108.985 -0.746 . . . . 74.109999999999999 108.985 175.793 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 113' ' ' PHE . . . . . 0.557 ' HB2' ' SD ' ' A' ' 61' ' ' MET . 53.7 p90 -152.61 152.83 32.27 Favored 'General case' 0 N--CA 1.471 0.605 0 C-N-CA 122.963 0.505 . . . . 60.549999999999997 111.65 -176.337 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 114' ' ' ILE . . . . . 0.492 HG12 HD13 ' A' ' 98' ' ' LEU . 6.4 mt -119.93 108.05 22.46 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.761 0 N-CA-C 108.121 -1.066 . . . . 63.210000000000001 108.121 -176.724 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 115' ' ' CYS . . . . . . . . . . . . . 60.1 m -80.62 105.83 12.17 Favored 'General case' 0 N--CA 1.47 0.53 0 C-N-CA 123.129 0.572 . . . . 74.230000000000004 109.769 176.656 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 40.5 p -71.85 -24.98 61.78 Favored 'General case' 0 N--CA 1.482 1.152 0 C-N-CA 122.612 0.365 . . . . 71.5 110.596 173.971 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -98.48 147.07 25.12 Favored 'General case' 0 C--O 1.239 0.545 0 CA-C-N 115.828 -0.624 . . . . 64.329999999999998 109.756 171.717 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 9.0 ptmm? -70.16 84.19 0.54 Allowed 'General case' 0 N--CA 1.477 0.899 0 CA-C-O 121.848 0.832 . . . . 70.239999999999995 110.021 171.847 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 119' ' ' THR . . . . . . . . . . . . . 35.8 p -79.92 85.31 5.56 Favored 'General case' 0 CA--C 1.548 0.866 0 CA-C-N 114.947 -1.024 . . . . 71.420000000000002 110.133 -175.546 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 9.3 pt-20 -68.39 -26.25 65.47 Favored 'General case' 0 N--CA 1.48 1.071 0 CA-C-N 114.737 -1.12 . . . . 71.420000000000002 112.125 -172.444 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 121' ' ' TRP . . . . . . . . . . . . . 47.0 p90 -72.57 1.08 8.83 Favored 'General case' 0 N--CA 1.473 0.715 0 C-N-CA 123.584 0.754 . . . . 74.310000000000002 112.265 178.546 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 122' ' ' LEU . . . . . 0.523 ' HB3' ' HE1' ' A' ' 126' ' ' HIS . 40.3 mt -104.12 5.3 35.01 Favored 'General case' 0 N--CA 1.475 0.815 0 C-N-CA 123.252 0.621 . . . . 74.200000000000003 111.897 176.355 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 40.4 m-20 -80.55 153.92 27.81 Favored 'General case' 0 N--CA 1.487 1.391 0 C-N-CA 122.812 0.445 . . . . 74.340000000000003 110.963 177.425 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 71.49 19.98 78.07 Favored Glycine 0 C--N 1.359 1.823 0 O-C-N 123.442 0.463 . . . . 54.450000000000003 112.304 -173.02 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 43.4 mtmt -145.22 -158.4 0.89 Allowed 'General case' 0 N--CA 1.47 0.533 0 C-N-CA 126.805 2.042 . . . . 72.420000000000002 107.884 -171.427 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 126' ' ' HIS . . . . . 0.523 ' HE1' ' HB3' ' A' ' 122' ' ' LEU . 0.0 OUTLIER -56.3 130.62 45.31 Favored 'General case' 0 N--CA 1.478 0.973 0 C-N-CA 123.8 0.84 . . . . 74.329999999999998 113.034 -159.119 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 99.3 t -61.45 130.14 25.22 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.615 0 CA-C-N 113.058 -1.883 . . . . 65.5 113.003 -166.517 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 128' ' ' VAL . . . . . 0.486 HG22 ' HB2' ' A' ' 99' ' ' SER . 92.8 t -81.05 145.26 9.18 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.313 0 CA-C-N 114.811 -1.086 . . . . 61.200000000000003 108.754 170.45 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 129' ' ' PHE . . . . . 0.569 ' HA ' HG21 ' A' ' 29' ' ' VAL . 21.6 p90 -138.27 -33.32 0.69 Allowed 'General case' 0 N--CA 1.469 0.503 0 C-N-CA 122.411 0.284 . . . . 54.520000000000003 110.984 -177.551 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . -115.66 165.14 12.15 Favored Glycine 0 C--N 1.337 0.588 0 O-C-N 123.709 0.631 . . . . 74.219999999999999 113.122 -175.591 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 30.2 ttpt -153.1 122.19 6.57 Favored 'General case' 0 C--N 1.324 -0.516 0 N-CA-C 107.207 -1.405 . . . . 71.140000000000001 107.207 177.867 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 3.9 p -65.92 105.36 0.62 Allowed 'Isoleucine or valine' 0 CA--C 1.553 1.078 0 CA-C-O 121.716 0.77 . . . . 61.329999999999998 109.651 175.56 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 133' ' ' LYS . . . . . 0.537 ' HD2' ' HB2' ' A' ' 23' ' ' GLU . 0.1 OUTLIER -78.5 -38.79 39.96 Favored 'General case' 0 N--CA 1.474 0.766 0 CA-C-N 114.901 -1.045 . . . . 74.349999999999994 109.903 -179.295 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 49.9 mt-10 -145.62 144.5 30.49 Favored 'General case' 0 N--CA 1.481 1.114 0 C-N-CA 124.599 1.16 . . . . 65.450000000000003 108.879 177.636 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 94.84 17.24 38.85 Favored Glycine 0 N--CA 1.472 1.059 0 N-CA-C 112.417 -0.273 . . . . 74.319999999999993 112.417 -176.409 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 136' ' ' MET . . . . . . . . . . . . . 14.5 tpt -61.81 -35.19 77.48 Favored 'General case' 0 N--CA 1.482 1.167 0 C-N-CA 124.113 0.965 . . . . 74.209999999999994 111.683 179.374 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 137' ' ' ASN . . . . . . . . . . . . . 1.8 m-20 -61.68 -34.71 76.22 Favored 'General case' 0 CA--C 1.548 0.875 0 C-N-CA 123.589 0.756 . . . . 74.140000000000001 110.774 177.796 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 138' ' ' ILE . . . . . . . . . . . . . 43.9 mm -72.05 -35.76 54.78 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.854 0 C-N-CA 123.076 0.55 . . . . 64.230000000000004 110.389 179.477 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 98.7 t -63.12 -45.88 97.47 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.872 0 C-N-CA 123.18 0.592 . . . . 71.310000000000002 110.374 175.879 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 40.9 mt-10 -68.26 -26.76 65.83 Favored 'General case' 0 N--CA 1.476 0.837 0 CA-C-N 115.498 -0.774 . . . . 74.140000000000001 111.186 178.352 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -71.99 -56.69 5.21 Favored 'General case' 0 N--CA 1.475 0.782 0 C-N-CA 123.332 0.653 . . . . 71.120000000000005 111.185 176.69 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 142' ' ' MET . . . . . 0.499 ' HA ' ' HD2' ' A' ' 145' ' ' PHE . 26.8 ptm -61.12 -35.7 77.73 Favored 'General case' 0 N--CA 1.48 1.059 0 C-N-CA 123.718 0.807 . . . . 65.299999999999997 111.829 -177.753 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 33.4 tt0 -66.05 -32.14 73.44 Favored 'General case' 0 CA--C 1.543 0.709 0 CA-C-O 121.462 0.648 . . . . 65.5 112.219 -173.91 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 144' ' ' ARG . . . . . 0.709 ' HA ' ' HB3' ' A' ' 58' ' ' PRO . 96.4 mtt180 -80.54 -6.58 58.43 Favored 'General case' 0 N--CA 1.47 0.544 0 CA-C-N 115.855 -0.611 . . . . 63.210000000000001 111.866 -178.65 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 145' ' ' PHE . . . . . 0.499 ' HD2' ' HA ' ' A' ' 142' ' ' MET . 50.9 m-85 -85.12 5.47 29.68 Favored 'General case' 0 CA--C 1.552 1.025 0 C-N-CA 123.309 0.644 . . . . 72.150000000000006 111.131 167.647 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . -93.72 -170.97 38.93 Favored Glycine 0 C--N 1.35 1.359 0 N-CA-C 112.381 -0.287 . . . . 70.310000000000002 112.381 172.987 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 12.9 m -132.74 162.53 31.2 Favored 'General case' 0 N--CA 1.48 1.049 0 C-N-CA 123.545 0.738 . . . . 71.019999999999996 109.513 -179.322 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 148' ' ' ARG . . . . . 0.45 ' HA ' HG23 ' A' ' 57' ' ' ILE . 17.4 mmm180 -71.5 -18.89 62.26 Favored 'General case' 0 N--CA 1.483 1.18 0 C-N-CA 123.823 0.849 . . . . 72.510000000000005 112.946 -172.902 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 149' ' ' ASN . . . . . . . . . . . . . 30.6 p-10 -85.89 -21.47 27.98 Favored 'General case' 0 N--CA 1.481 1.085 0 C-N-CA 123.619 0.768 . . . . 72.129999999999995 110.8 174.198 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 150' ' ' GLY . . . . . 0.472 ' O ' ' HA ' ' A' ' 55' ' ' ARG . . . 119.45 -11.23 11.37 Favored Glycine 0 C--N 1.347 1.189 0 CA-C-N 115.915 -0.584 . . . . 32.329999999999998 113.187 -178.747 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 37.5 ttpt -64.56 137.55 57.91 Favored 'General case' 0 N--CA 1.476 0.844 0 CA-C-N 117.921 0.86 . . . . 73.099999999999994 110.799 -177.698 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 152' ' ' THR . . . . . . . . . . . . . 18.1 p -91.13 113.28 25.51 Favored 'General case' 0 CA--C 1.539 0.528 0 N-CA-C 109.117 -0.698 . . . . 70.129999999999995 109.117 176.079 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 153' ' ' SER . . . . . . . . . . . . . 32.1 t -67.39 -35.41 79.27 Favored 'General case' 0 N--CA 1.475 0.803 0 C-N-CA 123.208 0.603 . . . . 72.099999999999994 110.419 -179.318 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 75.6 mmtt -110.09 152.16 26.32 Favored 'General case' 0 C--O 1.243 0.714 0 CA-C-N 114.959 -1.019 . . . . 73.530000000000001 109.381 178.971 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 17.3 tppt? -79.23 88.88 4.89 Favored 'General case' 0 C--N 1.349 0.552 0 N-CA-C 108.558 -0.904 . . . . 71.129999999999995 108.558 177.338 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 156' ' ' ILE . . . . . 0.486 HD11 ' HB2' ' A' ' 145' ' ' PHE . 58.0 mt -93.01 119.29 40.47 Favored 'Isoleucine or valine' 0 C--O 1.234 0.248 0 N-CA-C 108.821 -0.807 . . . . 62.509999999999998 108.821 -177.94 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 157' ' ' THR . . . . . . . . . . . . . 37.1 p -132.9 144.28 50.06 Favored 'General case' 0 C--O 1.238 0.481 0 C-N-CA 124.861 1.264 . . . . 74.420000000000002 109.099 -177.576 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 158' ' ' ILE . . . . . 0.437 HG23 ' HB3' ' A' ' 8' ' ' PHE . 62.2 mt -73.22 92.85 0.59 Allowed 'Isoleucine or valine' 0 CA--C 1.54 0.595 0 N-CA-C 107.526 -1.287 . . . . 62.229999999999997 107.526 166.874 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 159' ' ' ALA . . . . . 0.537 ' HB2' ' HB2' ' A' ' 11' ' ' ALA . . . -55.06 -57.32 12.18 Favored 'General case' 0 N--CA 1.47 0.549 0 C-N-CA 123.839 0.856 . . . . 72.329999999999998 110.892 -176.689 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 160' ' ' ASP . . . . . . . . . . . . . 13.2 m-20 -135.62 177.18 8.03 Favored 'General case' 0 N--CA 1.469 0.511 0 CA-C-O 121.698 0.761 . . . . 75.010000000000005 111.664 -175.18 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 161' ' ' CYS . . . . . . . . . . . . . 21.8 p -144.89 -169.35 3.16 Favored 'General case' 0 CA--C 1.542 0.644 0 C-N-CA 125.919 1.688 . . . . 74.319999999999993 107.768 -177.621 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 162' ' ' GLY . . . . . . . . . . . . . . . 130.27 53.06 0.1 Allowed Glycine 0 C--N 1.341 0.825 0 N-CA-C 109.92 -1.272 . . . . 65.129999999999995 109.92 -172.724 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 163' ' ' GLN . . . . . 0.521 ' HB2' ' HA ' ' A' ' 6' ' ' VAL . 15.6 pt20 -54.23 152.81 5.8 Favored 'General case' 0 CA--C 1.548 0.87 0 N-CA-C 114.512 1.301 . . . . 73.450000000000003 114.512 -170.927 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 164' ' ' LEU . . . . . 0.621 ' HG ' ' HB2' ' A' ' 7' ' ' PHE . 82.4 mt . . . . . 0 C--O 1.241 0.628 0 C-N-CA 124.462 1.105 . . . . 75.439999999999998 110.957 -169.874 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 218' ' ' PRO . . . . . . . . . . . . . 21.9 Cg_exo . . . . . 0 CA--C 1.545 1.052 0 N-CA-C 110.482 -0.622 . . . . 73.319999999999993 110.482 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' B' B ' 219' ' ' GLY . . . . . 0.443 ' HA2' ' HB1' ' A' ' 101' ' ' ALA . . . -173.14 147.81 9.92 Favored Glycine 0 C--N 1.347 1.184 0 CA-C-O 119.722 -0.488 . . . . 71.430000000000007 113.292 -178.943 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 220' ' ' PRO . . . . . . . . . . . . . 56.6 Cg_endo -67.55 153.46 76.32 Favored 'Trans proline' 0 C--N 1.377 2.075 0 C-N-CA 123.553 2.835 . . . . 62.109999999999999 112.748 177.923 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 221' ' ' TYR . . . . . . . . . . . . . 83.2 m-85 . . . . . 0 N--CA 1.477 0.908 0 C-N-CA 122.781 0.433 . . . . 74.299999999999997 110.709 -178.571 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 3' ' ' ASN . . . . . 0.583 HD22 ' HA ' ' A' ' 25' ' ' PHE . 13.4 m120 . . . . . 0 CA--C 1.545 0.775 0 CA-C-O 118.942 -0.551 . . . . 53.200000000000003 111.849 . . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 36.4 Cg_endo -64.58 122.1 9.88 Favored 'Trans proline' 0 C--N 1.382 2.306 0 C-N-CA 122.872 2.381 . . . . 61.119999999999997 111.076 173.973 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 50.6 m -97.88 129.52 44.82 Favored 'General case' 0 CA--C 1.534 0.352 0 C-N-CA 123.585 0.754 . . . . 75.030000000000001 109.441 -178.068 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 6' ' ' VAL . . . . . 0.56 ' HA ' ' HG3' ' A' ' 163' ' ' GLN . 27.2 m -99.26 126.1 52.63 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.364 0 N-CA-C 108.209 -1.034 . . . . 54.039999999999999 108.209 175.471 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 7' ' ' PHE . . . . . 0.556 ' H ' ' HA ' ' A' ' 163' ' ' GLN . 57.7 t80 -108.85 135.52 49.92 Favored 'General case' 0 C--O 1.237 0.404 0 N-CA-C 109.037 -0.727 . . . . 70.310000000000002 109.037 -175.932 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 72.6 m-85 -139.62 166.21 25.2 Favored 'General case' 0 C--O 1.24 0.604 0 C-N-CA 124.654 1.182 . . . . 72.310000000000002 109.8 178.471 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 43.4 m-20 -118.01 116.25 26.53 Favored 'General case' 0 C--N 1.328 -0.365 0 N-CA-C 106.389 -1.708 . . . . 75.5 106.389 166.163 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 33.8 mm -98.93 143.68 12.92 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.711 0 N-CA-C 108.916 -0.772 . . . . 65.120000000000005 108.916 -177.465 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 11' ' ' ALA . . . . . 0.495 ' HB2' ' HB2' ' A' ' 159' ' ' ALA . . . -136.99 140.36 42.1 Favored 'General case' 0 N--CA 1.467 0.417 0 C-N-CA 123.304 0.642 . . . . 60.119999999999997 111.818 -164.432 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 12' ' ' VAL . . . . . 0.404 HG23 ' HB2' ' A' ' 17' ' ' LEU . 21.4 t -98.36 109.93 24.85 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.795 0 N-CA-C 107.796 -1.187 . . . . 71.409999999999997 107.796 171.418 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 45.4 m-20 68.25 20.63 8.73 Favored 'General case' 0 N--CA 1.497 1.904 0 C-N-CA 124.384 1.073 . . . . 73.349999999999994 111.766 -177.656 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 87.3 -3.19 86.75 Favored Glycine 0 C--N 1.349 1.278 0 CA-C-O 119.964 -0.353 . . . . 70.310000000000002 113.067 -174.666 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 40.0 mm-40 -84.18 113.71 49.96 Favored Pre-proline 0 CA--C 1.543 0.689 0 N-CA-C 108.902 -0.777 . . . . 71.349999999999994 108.902 175.235 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 21.1 Cg_endo -56.84 107.97 0.31 Allowed 'Trans proline' 0 C--N 1.383 2.354 0 C-N-CA 123.0 2.467 . . . . 75.239999999999995 111.749 -176.524 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 17' ' ' LEU . . . . . 0.404 ' HB2' HG23 ' A' ' 12' ' ' VAL . 46.3 tp -78.92 -45.45 20.5 Favored 'General case' 0 N--CA 1.47 0.539 0 CA-C-N 115.538 -0.756 . . . . 73.239999999999995 109.36 178.535 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -176.1 -171.46 39.92 Favored Glycine 0 C--N 1.337 0.596 0 CA-C-N 115.742 -0.663 . . . . 72.409999999999997 112.688 179.944 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 40.3 ptt85 -106.21 144.78 32.43 Favored 'General case' 0 C--O 1.239 0.537 0 C-N-CA 123.875 0.87 . . . . 74.099999999999994 108.674 178.691 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 94.6 t -134.17 139.27 48.56 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.588 0 N-CA-C 108.683 -0.858 . . . . 70.219999999999999 108.683 176.887 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 24.8 m -133.12 118.38 18.64 Favored 'General case' 0 CA--C 1.545 0.777 0 C-N-CA 124.867 1.267 . . . . 54.530000000000001 108.414 -175.872 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 22' ' ' PHE . . . . . 0.451 ' HA ' ' HA ' ' A' ' 132' ' ' VAL . 41.0 m-85 -102.87 129.63 49.63 Favored 'General case' 0 N--CA 1.479 1.002 0 N-CA-C 109.435 -0.58 . . . . 62.310000000000002 109.435 177.512 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 35.7 tt0 -90.33 108.18 19.61 Favored 'General case' 0 CA--C 1.548 0.873 0 C-N-CA 124.183 0.993 . . . . 71.340000000000003 109.426 177.447 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . 0.513 ' HB3' ' HB1' ' A' ' 33' ' ' ALA . 40.6 mt -87.25 122.09 30.56 Favored 'General case' 0 N--CA 1.48 1.063 0 C-N-CA 123.031 0.532 . . . . 65.319999999999993 110.605 -177.008 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 25' ' ' PHE . . . . . 0.583 ' HA ' HD22 ' A' ' 3' ' ' ASN . 48.8 m-85 -84.91 65.26 9.1 Favored 'General case' 0 CA--C 1.548 0.879 0 C-N-CA 123.916 0.886 . . . . 74.219999999999999 110.805 -179.951 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -65.86 -25.88 67.39 Favored 'General case' 0 N--CA 1.482 1.131 0 CA-C-N 115.127 -0.942 . . . . 41.299999999999997 111.912 -177.766 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 9.2 p-10 -72.81 -6.64 46.24 Favored 'General case' 0 N--CA 1.48 1.041 0 C-N-CA 123.489 0.716 . . . . 75.519999999999996 111.341 -179.544 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 91.7 mttt -114.6 -48.94 2.84 Favored 'General case' 0 N--CA 1.476 0.857 0 C-N-CA 123.771 0.828 . . . . 75.439999999999998 109.872 177.242 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 29' ' ' VAL . . . . . 0.451 HG21 ' HA ' ' A' ' 129' ' ' PHE . 14.6 m -121.94 79.02 41.49 Favored Pre-proline 0 CA--C 1.566 1.56 0 C-N-CA 124.329 1.052 . . . . 73.209999999999994 109.293 -178.684 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 35.6 Cg_exo -60.03 -57.3 0.82 Allowed 'Trans proline' 0 C--N 1.391 2.766 0 C-N-CA 123.204 2.603 . . . . 75.299999999999997 112.953 -169.671 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 29.2 ttmt -58.43 -45.09 89.17 Favored 'General case' 0 N--CA 1.479 0.999 0 C-N-CA 124.564 1.146 . . . . 72.239999999999995 112.085 179.385 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 6.9 m -67.0 -40.1 87.28 Favored 'General case' 0 CA--C 1.548 0.894 0 CA-C-N 114.58 -1.191 . . . . 60.020000000000003 111.671 -170.459 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 33' ' ' ALA . . . . . 0.513 ' HB1' ' HB3' ' A' ' 24' ' ' LEU . . . -80.71 -36.18 32.55 Favored 'General case' 0 N--CA 1.475 0.798 0 C-N-CA 123.586 0.755 . . . . 71.239999999999995 110.702 178.381 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 14.7 tp10 -62.41 -32.04 72.81 Favored 'General case' 0 N--CA 1.486 1.37 0 C-N-CA 124.042 0.937 . . . . 73.099999999999994 111.144 -179.526 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 35' ' ' ASN . . . . . 0.555 ' ND2' ' SD ' ' A' ' 100' ' ' MET . 44.9 t30 -55.97 -64.35 0.88 Allowed 'General case' 0 CA--C 1.544 0.741 0 C-N-CA 123.823 0.849 . . . . 63.340000000000003 110.801 176.115 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 36' ' ' PHE . . . . . 0.524 ' HE2' HG21 ' A' ' 6' ' ' VAL . 65.7 t80 -65.5 -30.14 70.87 Favored 'General case' 0 N--CA 1.476 0.856 0 C-N-CA 123.603 0.761 . . . . 55.100000000000001 111.065 -176.264 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 44.8 ttp85 -64.76 -51.43 62.31 Favored 'General case' 0 CA--C 1.551 0.985 0 C-N-CA 124.015 0.926 . . . . 64.239999999999995 109.593 -179.415 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -78.44 -15.09 59.02 Favored 'General case' 0 CA--C 1.544 0.729 0 CA-C-N 115.037 -0.983 . . . . 75.430000000000007 112.26 -176.567 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 39' ' ' LEU . . . . . 0.403 HD22 ' CE2' ' A' ' 48' ' ' TYR . 92.8 mt -79.59 -35.55 39.44 Favored 'General case' 0 N--CA 1.487 1.391 0 C-N-CA 122.96 0.504 . . . . 65.409999999999997 110.418 170.511 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 42.6 t -66.06 -54.39 26.48 Favored 'General case' 0 N--CA 1.477 0.897 0 C-N-CA 124.285 1.034 . . . . 65.530000000000001 110.592 179.892 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 10.9 p -75.67 -32.0 59.98 Favored 'General case' 0 N--CA 1.475 0.806 0 CA-C-N 115.878 -0.601 . . . . 65.340000000000003 111.52 175.87 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 81.5 34.96 24.2 Favored Glycine 0 C--N 1.348 1.221 0 CA-C-N 116.481 -0.327 . . . . 64.409999999999997 113.402 177.879 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 41.2 mm-40 -66.41 -20.47 66.07 Favored 'General case' 0 N--CA 1.476 0.867 0 C-N-CA 123.693 0.797 . . . . 74.209999999999994 111.991 -178.632 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 9.8 mmpt? -93.67 8.17 41.93 Favored 'General case' 0 CA--C 1.552 1.029 0 C-N-CA 124.193 0.997 . . . . 65.409999999999997 110.842 179.265 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 76.33 33.79 47.65 Favored Glycine 0 C--N 1.351 1.365 0 CA-C-O 119.774 -0.459 . . . . 71.140000000000001 113.384 179.995 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 23.4 m-85 -116.21 -49.35 2.69 Favored 'General case' 0 N--CA 1.484 1.266 0 CA-C-N 117.214 0.507 . . . . 74.230000000000004 110.797 -178.317 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 47.12 63.32 3.34 Favored Glycine 0 C--N 1.354 1.554 0 O-C-N 124.482 1.114 . . . . 73.329999999999998 115.371 169.609 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 48' ' ' TYR . . . . . 0.403 ' CE2' HD22 ' A' ' 39' ' ' LEU . 32.0 m-85 -66.36 92.63 0.2 Allowed 'General case' 0 C--N 1.353 0.752 0 CA-C-O 121.869 0.842 . . . . 75.420000000000002 111.435 -173.71 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 27.9 tptp -109.33 94.8 5.23 Favored 'General case' 0 C--O 1.239 0.522 0 CA-C-N 113.991 -1.458 . . . . 53.240000000000002 108.591 -175.059 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 118.95 21.37 3.85 Favored Glycine 0 C--N 1.348 1.202 0 CA-C-O 119.781 -0.455 . . . . 44.020000000000003 113.395 -179.547 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 51' ' ' SER . . . . . 0.514 ' HB2' HD12 ' A' ' 158' ' ' ILE . 19.7 m -60.5 119.15 7.49 Favored 'General case' 0 N--CA 1.476 0.854 0 C-N-CA 123.577 0.751 . . . . 62.32 110.716 179.463 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 52' ' ' CYS . . . . . . . . . . . . . 10.6 p -104.91 129.21 53.32 Favored 'General case' 0 N--CA 1.474 0.743 0 CA-C-O 121.637 0.732 . . . . 63.020000000000003 112.525 -170.415 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 53' ' ' PHE . . . . . 0.776 ' HA ' ' HA2' ' A' ' 64' ' ' GLY . 55.9 m-85 -70.52 109.71 4.99 Favored 'General case' 0 C--N 1.347 0.494 0 C-N-CA 124.842 1.257 . . . . 73.450000000000003 109.646 174.148 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 49.7 p-80 -120.28 -5.48 9.91 Favored 'General case' 0 N--CA 1.481 1.086 0 C-N-CA 123.815 0.846 . . . . 73.239999999999995 111.235 -176.454 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 55' ' ' ARG . . . . . 0.454 ' O ' ' HB3' ' A' ' 63' ' ' GLN . 53.2 ttt-85 -129.57 97.6 4.59 Favored 'General case' 0 N--CA 1.473 0.719 0 N-CA-C 108.891 -0.781 . . . . 51.439999999999998 108.891 175.604 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 56' ' ' ILE . . . . . 0.456 HG21 ' HA ' ' A' ' 143' ' ' GLU . 64.3 mt -130.55 127.18 61.9 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.943 0 N-CA-C 108.389 -0.967 . . . . 61.310000000000002 108.389 177.291 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 74.9 mt -124.85 118.16 25.84 Favored Pre-proline 0 CA--C 1.555 1.144 0 C-N-CA 123.974 0.909 . . . . 60.329999999999998 108.904 -177.884 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 52.7 Cg_exo -57.63 145.65 88.37 Favored 'Trans proline' 0 C--N 1.383 2.365 0 C-N-CA 124.229 3.286 . . . . 73.150000000000006 114.205 -179.237 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 66.1 24.19 71.69 Favored Glycine 0 C--N 1.352 1.451 0 O-C-N 124.291 0.994 . . . . 74.430000000000007 112.954 -179.272 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 60' ' ' PHE . . . . . 0.403 ' CD2' ' HB3' ' A' ' 61' ' ' MET . 36.3 t80 -145.09 -76.38 0.21 Allowed 'General case' 0 C--O 1.244 0.764 0 C-N-CA 123.886 0.875 . . . . 72.409999999999997 110.221 -173.744 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 61' ' ' MET . . . . . 0.708 ' SD ' ' HB2' ' A' ' 113' ' ' PHE . 12.1 tmm? -173.27 150.74 1.93 Allowed 'General case' 0 N--CA 1.484 1.272 0 CA-C-O 121.075 0.464 . . . . 75.140000000000001 112.19 -161.2 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 62' ' ' CYS . . . . . . . . . . . . . 36.7 t -114.45 111.92 22.19 Favored 'General case' 0 CA--C 1.558 1.287 0 C-N-CA 124.873 1.269 . . . . 72.540000000000006 109.752 175.687 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 63' ' ' GLN . . . . . 0.644 ' HB2' ' SD ' ' A' ' 61' ' ' MET . 49.6 tt0 -115.5 133.53 55.94 Favored 'General case' 0 N--CA 1.498 1.935 0 C-N-CA 124.017 0.927 . . . . 72.450000000000003 110.949 -172.209 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 64' ' ' GLY . . . . . 0.776 ' HA2' ' HA ' ' A' ' 53' ' ' PHE . . . -123.04 170.28 15.45 Favored Glycine 0 C--N 1.339 0.726 0 CA-C-N 115.259 -0.882 . . . . 63.149999999999999 112.83 179.032 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -164.54 156.99 29.21 Favored Glycine 0 C--N 1.33 0.241 0 N-CA-C 110.532 -1.027 . . . . 64.140000000000001 110.532 176.658 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 21.2 t70 -91.35 167.2 12.47 Favored 'General case' 0 C--O 1.244 0.798 0 CA-C-O 121.185 0.517 . . . . 62.409999999999997 110.34 -178.269 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 63.8 t80 -77.25 -29.08 53.81 Favored 'General case' 0 CA--C 1.552 1.035 0 C-N-CA 124.07 0.948 . . . . 73.510000000000005 111.18 -179.676 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 91.5 m -61.23 109.42 1.12 Allowed 'General case' 0 C--N 1.363 1.156 0 C-N-CA 123.922 0.889 . . . . 61.030000000000001 110.361 179.659 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 36.6 ttt180 52.98 82.89 0.07 Allowed 'General case' 0 CA--C 1.541 0.618 0 O-C-N 124.836 1.335 . . . . 75.230000000000004 110.461 -173.398 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 52.3 t60 -89.26 -19.94 24.74 Favored 'General case' 0 CA--C 1.549 0.911 0 CA-C-N 116.099 -0.501 . . . . 71.420000000000002 111.457 -174.601 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 3.5 m-20 -64.76 91.41 0.09 Allowed 'General case' 0 N--CA 1.489 1.516 0 C-N-CA 123.686 0.794 . . . . 71.310000000000002 111.214 -176.813 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 75.3 -6.19 30.88 Favored Glycine 0 C--N 1.349 1.27 0 CA-C-N 115.561 -0.745 . . . . 74.209999999999994 114.682 175.249 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -114.16 -67.03 1.03 Allowed 'General case' 0 CA--C 1.551 0.995 0 N-CA-C 109.187 -0.672 . . . . 75.129999999999995 109.187 -175.2 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 61.32 61.58 6.74 Favored Glycine 0 CA--C 1.534 1.24 0 CA-C-N 116.21 -0.45 . . . . 72.400000000000006 113.994 175.77 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 107.54 52.25 0.72 Allowed Glycine 0 N--CA 1.48 1.593 0 CA-C-N 117.674 0.737 . . . . 63.200000000000003 112.166 -177.5 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 76' ' ' LYS . . . . . 0.437 ' HA ' ' O ' ' A' ' 109' ' ' GLY . 21.5 pttp -53.77 170.58 0.11 Allowed 'General case' 0 CA--C 1.562 1.409 0 C-N-CA 125.076 1.35 . . . . 71.450000000000003 113.815 179.902 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 89.9 p -90.69 176.02 6.81 Favored 'General case' 0 N--CA 1.486 1.33 0 C-N-CA 123.689 0.796 . . . . 75.209999999999994 112.856 -165.885 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 25.5 pt -71.34 -17.95 20.05 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.225 0 C-N-CA 122.934 0.493 . . . . 74.349999999999994 110.784 174.327 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 69.7 m-85 -92.85 27.82 2.27 Favored 'General case' 0 CA--C 1.546 0.797 0 C-N-CA 124.058 0.943 . . . . 73.439999999999998 109.728 174.523 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 83.51 -119.38 4.89 Favored Glycine 0 C--N 1.354 1.551 0 CA-C-N 115.088 -0.96 . . . . 74.219999999999999 111.753 177.74 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 34.8 tt0 -61.74 -59.43 5.18 Favored 'General case' 0 C--O 1.241 0.625 0 C-N-CA 124.024 0.93 . . . . 61.200000000000003 110.723 -178.373 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 82' ' ' LYS . . . . . 0.749 ' HD2' ' HA ' ' A' ' 107' ' ' THR . 23.9 pttm -165.11 175.28 9.51 Favored 'General case' 0 CA--C 1.552 1.057 0 O-C-N 123.595 0.56 . . . . 74.200000000000003 111.742 -174.967 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 2.0 p90 -157.03 176.24 13.02 Favored 'General case' 0 N--CA 1.482 1.158 0 C-N-CA 125.83 1.652 . . . . 75.120000000000005 109.036 -179.884 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 12.5 pt-20 -93.02 -172.48 3.0 Favored 'General case' 0 N--CA 1.485 1.281 0 CA-C-O 121.255 0.55 . . . . 74.109999999999999 111.74 179.517 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 51.8 m-20 -80.42 136.74 36.41 Favored 'General case' 0 N--CA 1.471 0.614 0 C-N-CA 124.271 1.028 . . . . 70.209999999999994 109.148 173.22 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 12.6 tp10 -73.24 -52.53 13.68 Favored 'General case' 0 CA--C 1.544 0.728 0 O-C-N 123.472 0.482 . . . . 63.439999999999998 109.929 176.165 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 87' ' ' ASN . . . . . 0.402 ' OD1' HG12 ' A' ' 29' ' ' VAL . 16.5 p-10 -170.14 134.79 1.27 Allowed 'General case' 0 N--CA 1.479 0.983 0 C-N-CA 123.595 0.758 . . . . 74.319999999999993 110.193 -174.58 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 73.7 m-85 -88.58 69.52 8.85 Favored 'General case' 0 N--CA 1.483 1.189 0 CA-C-O 121.096 0.474 . . . . 72.430000000000007 110.538 -178.053 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 37.0 mt -82.03 -58.25 3.87 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.77 0 N-CA-C 108.724 -0.843 . . . . 72.030000000000001 108.724 169.44 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 53.1 mt -92.78 119.52 32.22 Favored 'General case' 0 CA--C 1.541 0.598 0 CA-C-N 114.923 -1.035 . . . . 74.109999999999999 110.596 -171.006 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 9.8 mtmp? -121.98 171.48 8.91 Favored 'General case' 0 CA--C 1.543 0.708 0 C-N-CA 124.764 1.226 . . . . 71.209999999999994 109.814 175.086 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 92' ' ' HIS . . . . . . . . . . . . . 23.0 m-70 -78.09 80.62 4.51 Favored 'General case' 0 N--CA 1.477 0.886 0 C-N-CA 123.879 0.872 . . . . 74.340000000000003 110.16 -170.232 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 19.1 p -82.85 -57.31 3.36 Favored 'General case' 0 N--CA 1.473 0.714 0 C-N-CA 123.898 0.879 . . . . 74.450000000000003 111.212 -177.006 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -121.45 -176.64 15.34 Favored Glycine 0 C--N 1.346 1.129 0 O-C-N 123.466 0.479 . . . . 23.329999999999998 112.788 -176.374 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 8.4 Cg_exo -73.6 148.22 41.81 Favored 'Trans proline' 0 C--N 1.368 1.556 0 C-N-CA 122.987 2.458 . . . . 64.150000000000006 111.564 170.354 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 105.67 -2.6 39.17 Favored Glycine 0 N--CA 1.473 1.121 0 CA-C-N 116.391 -0.368 . . . . 65.329999999999998 113.213 -179.703 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 97' ' ' ILE . . . . . 0.453 ' HB ' ' HB2' ' A' ' 115' ' ' CYS . 18.1 mm -66.34 116.18 5.28 Favored 'Isoleucine or valine' 0 CA--C 1.555 1.167 0 C-N-CA 124.366 1.066 . . . . 70.329999999999998 111.862 -174.583 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 55.3 tp -100.29 122.43 43.07 Favored 'General case' 0 N--CA 1.479 0.994 0 C-N-CA 123.312 0.645 . . . . 70.120000000000005 110.063 173.624 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 44.9 t -142.89 144.36 32.42 Favored 'General case' 0 CA--C 1.539 0.525 0 C-N-CA 124.263 1.025 . . . . 73.209999999999994 108.254 176.944 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 100' ' ' MET . . . . . 0.555 ' SD ' ' ND2' ' A' ' 35' ' ' ASN . 13.4 ttt -79.45 141.97 36.31 Favored 'General case' 0 N--CA 1.483 1.18 0 C-N-CA 124.138 0.975 . . . . 73.120000000000005 109.073 -178.729 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 101' ' ' ALA . . . . . 0.437 ' HB3' ' HB2' ' A' ' 111' ' ' GLN . . . -77.24 160.9 28.55 Favored 'General case' 0 N--CA 1.479 1.019 0 CA-C-O 121.387 0.613 . . . . 72.230000000000004 111.616 -173.02 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 102' ' ' ASN . . . . . 0.51 ' HB3' ' HA ' ' A' ' 108' ' ' ASN . 25.7 p-10 -165.79 168.84 15.65 Favored 'General case' 0 N--CA 1.472 0.669 0 CA-C-N 114.581 -1.191 . . . . 53.439999999999998 109.711 -177.468 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -90.5 -47.28 7.8 Favored 'General case' 0 N--CA 1.469 0.503 0 N-CA-C 108.917 -0.771 . . . . 73.129999999999995 108.917 167.137 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -168.0 -152.71 7.72 Favored Glycine 0 CA--C 1.533 1.172 0 CA-C-O 119.096 -0.836 . . . . 72.409999999999997 112.561 179.485 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 37.5 Cg_exo -61.79 135.39 55.78 Favored 'Trans proline' 0 C--N 1.379 2.167 0 C-N-CA 123.116 2.544 . . . . 63.450000000000003 112.898 -178.275 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 67.1 t30 66.06 9.75 6.47 Favored 'General case' 0 N--CA 1.49 1.535 0 C-N-CA 125.211 1.404 . . . . 73.540000000000006 111.852 -179.736 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 107' ' ' THR . . . . . 0.749 ' HA ' ' HD2' ' A' ' 82' ' ' LYS . 2.2 m -111.35 8.68 21.43 Favored 'General case' 0 CA--C 1.555 1.167 0 C-N-CA 124.174 0.989 . . . . 50.240000000000002 109.857 179.415 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 108' ' ' ASN . . . . . 0.51 ' HA ' ' HB3' ' A' ' 102' ' ' ASN . 8.8 t30 -70.66 145.18 50.78 Favored 'General case' 0 N--CA 1.475 0.795 0 C-N-CA 124.599 1.16 . . . . 74.420000000000002 110.268 175.135 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 109' ' ' GLY . . . . . 0.437 ' O ' ' HA ' ' A' ' 76' ' ' LYS . . . 109.99 25.12 5.49 Favored Glycine 0 N--CA 1.468 0.778 0 C-N-CA 121.568 -0.349 . . . . 50.240000000000002 112.565 178.897 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 28.4 p -131.46 118.5 20.29 Favored 'General case' 0 CA--C 1.54 0.562 0 N-CA-C 108.735 -0.839 . . . . 75.200000000000003 108.735 177.46 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 111' ' ' GLN . . . . . 0.437 ' HB2' ' HB3' ' A' ' 101' ' ' ALA . 49.7 mt-30 59.15 -175.74 0.09 Allowed 'General case' 0 N--CA 1.497 1.898 0 C-N-CA 123.724 0.81 . . . . 53.020000000000003 112.14 -173.897 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 112' ' ' PHE . . . . . 0.475 ' HA ' ' HA ' ' A' ' 100' ' ' MET . 42.6 p90 -151.64 151.7 31.85 Favored 'General case' 0 N--CA 1.484 1.241 0 N-CA-C 108.284 -1.006 . . . . 73.219999999999999 108.284 176.748 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 113' ' ' PHE . . . . . 0.708 ' HB2' ' SD ' ' A' ' 61' ' ' MET . 51.0 p90 -140.16 137.77 34.66 Favored 'General case' 0 N--CA 1.478 0.946 0 CA-C-O 121.27 0.557 . . . . 71.519999999999996 111.803 -176.568 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 114' ' ' ILE . . . . . . . . . . . . . 11.0 mt -110.09 102.52 14.1 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.663 0 C-N-CA 124.904 1.282 . . . . 72.549999999999997 108.093 -178.358 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 115' ' ' CYS . . . . . 0.453 ' HB2' ' HB ' ' A' ' 97' ' ' ILE . 56.9 m -64.83 105.26 0.97 Allowed 'General case' 0 CA--C 1.548 0.894 0 C-N-CA 123.208 0.603 . . . . 72.120000000000005 109.765 177.125 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 60.2 p -70.78 -32.01 68.99 Favored 'General case' 0 N--CA 1.476 0.844 0 C-N-CA 124.367 1.067 . . . . 65.430000000000007 110.803 -177.584 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -119.89 168.87 10.69 Favored 'General case' 0 C--O 1.247 0.946 0 C-N-CA 124.26 1.024 . . . . 30.420000000000002 108.824 169.499 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 17.5 ptmt -66.84 128.43 36.27 Favored 'General case' 0 N--CA 1.473 0.683 0 N-CA-C 109.268 -0.642 . . . . 74.530000000000001 109.268 173.462 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 119' ' ' THR . . . . . . . . . . . . . 27.0 p -131.9 84.17 2.14 Favored 'General case' 0 CA--C 1.541 0.606 0 CA-C-O 121.562 0.696 . . . . 72.049999999999997 109.15 -177.533 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 12.6 pt-20 -77.52 -15.45 59.27 Favored 'General case' 0 N--CA 1.481 1.115 0 CA-C-N 115.791 -0.64 . . . . 65.25 111.799 -172.275 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 121' ' ' TRP . . . . . . . . . . . . . 48.9 p90 -74.93 -5.05 41.71 Favored 'General case' 0 N--CA 1.478 0.928 0 C-N-CA 122.333 0.253 . . . . 73.109999999999999 111.146 174.709 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 122' ' ' LEU . . . . . 0.413 HD22 ' HB2' ' B' ' 220' ' ' PRO . 23.0 mt -94.66 8.01 43.82 Favored 'General case' 0 N--CA 1.472 0.671 0 C-N-CA 123.169 0.588 . . . . 73.510000000000005 110.89 172.949 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 53.0 m-20 -77.25 122.75 25.5 Favored 'General case' 0 CA--C 1.537 0.471 0 N-CA-C 107.475 -1.305 . . . . 64.340000000000003 107.475 168.935 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 112.88 -25.26 11.85 Favored Glycine 0 C--N 1.343 0.917 0 N-CA-C 111.185 -0.766 . . . . 74.400000000000006 111.185 -165.703 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 32.4 mmmt -72.84 -164.24 0.16 Allowed 'General case' 0 N--CA 1.489 1.499 0 C-N-CA 123.848 0.859 . . . . 65.129999999999995 109.741 167.734 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 126' ' ' HIS . . . . . . . . . . . . . 50.8 t60 -66.77 144.67 56.19 Favored 'General case' 0 CA--C 1.551 1.014 0 CA-C-O 121.082 0.468 . . . . 73.310000000000002 110.817 178.543 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 26.1 t -62.72 139.06 21.73 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.838 0 CA-C-N 114.605 -1.18 . . . . 72.430000000000007 111.194 179.595 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 49.4 t -68.18 143.38 15.31 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.739 0 N-CA-C 109.17 -0.678 . . . . 64.209999999999994 109.17 172.687 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 129' ' ' PHE . . . . . 0.451 ' HA ' HG21 ' A' ' 29' ' ' VAL . 35.9 p90 -132.81 -8.3 3.14 Favored 'General case' 0 N--CA 1.478 0.963 0 O-C-N 121.987 -0.446 . . . . 75.510000000000005 111.43 179.46 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . -151.02 171.98 30.68 Favored Glycine 0 C--N 1.34 0.772 0 O-C-N 123.473 0.483 . . . . 65.439999999999998 112.557 -175.883 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 32.2 ttpt -154.88 122.41 5.69 Favored 'General case' 0 C--O 1.236 0.384 0 N-CA-C 108.161 -1.052 . . . . 74.409999999999997 108.161 177.423 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 132' ' ' VAL . . . . . 0.451 ' HA ' ' HA ' ' A' ' 22' ' ' PHE . 3.0 p -61.44 107.73 0.44 Allowed 'Isoleucine or valine' 0 CA--C 1.551 1.01 0 CA-C-O 121.885 0.85 . . . . 74.109999999999999 110.404 178.505 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -80.9 -36.48 31.11 Favored 'General case' 0 CA--C 1.547 0.832 0 CA-C-N 114.821 -1.081 . . . . 72.310000000000002 110.385 -177.595 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 50.8 mt-10 -137.66 147.04 44.57 Favored 'General case' 0 N--CA 1.483 1.218 0 C-N-CA 124.766 1.226 . . . . 74.319999999999993 108.794 -178.734 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 80.15 14.92 79.78 Favored Glycine 0 C--N 1.344 0.982 0 O-C-N 123.208 0.318 . . . . 52.409999999999997 113.038 -177.602 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 136' ' ' MET . . . . . . . . . . . . . 12.9 tpt -65.23 -40.83 94.6 Favored 'General case' 0 N--CA 1.473 0.683 0 C-N-CA 123.482 0.713 . . . . 71.409999999999997 110.198 174.339 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 137' ' ' ASN . . . . . . . . . . . . . 17.7 m120 -59.35 -35.34 73.69 Favored 'General case' 0 N--CA 1.481 1.081 0 C-N-CA 123.384 0.673 . . . . 74.200000000000003 111.427 176.246 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 138' ' ' ILE . . . . . 0.554 ' O ' ' HG3' ' A' ' 142' ' ' MET . 36.4 mm -60.25 -56.27 18.68 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.834 0 N-CA-C 109.277 -0.638 . . . . 74.239999999999995 109.277 172.998 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 91.3 t -54.81 -42.72 63.93 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.445 0 C-N-CA 124.21 1.004 . . . . 73.010000000000005 111.727 -175.857 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 46.1 mt-10 -67.38 -36.48 81.42 Favored 'General case' 0 N--CA 1.483 1.187 0 C-N-CA 123.824 0.849 . . . . 73.319999999999993 111.101 179.676 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -71.63 -25.05 61.99 Favored 'General case' 0 N--CA 1.478 0.973 0 CA-C-N 115.932 -0.577 . . . . 65.319999999999993 111.756 175.231 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 142' ' ' MET . . . . . 0.554 ' HG3' ' O ' ' A' ' 138' ' ' ILE . 35.4 mtp -83.52 -22.9 32.31 Favored 'General case' 0 N--CA 1.485 1.282 0 C-N-CA 122.701 0.4 . . . . 63.32 111.172 178.351 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 143' ' ' GLU . . . . . 0.456 ' HA ' HG21 ' A' ' 56' ' ' ILE . 37.5 tt0 -63.44 -25.46 68.28 Favored 'General case' 0 CA--C 1.547 0.852 0 O-C-N 123.786 0.679 . . . . 75.230000000000004 110.935 174.025 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 144' ' ' ARG . . . . . . . . . . . . . 51.2 mtp85 -67.82 -18.82 64.96 Favored 'General case' 0 CA--C 1.547 0.847 0 C-N-CA 123.944 0.898 . . . . 73.340000000000003 111.916 178.384 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 145' ' ' PHE . . . . . . . . . . . . . 89.9 m-85 -85.47 -21.22 28.8 Favored 'General case' 0 N--CA 1.48 1.037 0 C-N-CA 123.135 0.574 . . . . 71.319999999999993 110.793 175.003 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . -73.33 169.83 52.84 Favored Glycine 0 C--N 1.35 1.308 0 N-CA-C 114.135 0.414 . . . . 70.299999999999997 114.135 -177.439 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 15.2 m -131.68 165.32 23.97 Favored 'General case' 0 N--CA 1.484 1.242 0 C-N-CA 124.356 1.063 . . . . 75.319999999999993 110.418 -176.444 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 148' ' ' ARG . . . . . . . . . . . . . 15.2 mmm180 -60.6 -38.57 85.13 Favored 'General case' 0 N--CA 1.485 1.305 0 C-N-CA 124.135 0.974 . . . . 75.010000000000005 111.901 -177.435 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 149' ' ' ASN . . . . . . . . . . . . . 26.6 p-10 -80.08 -7.34 58.83 Favored 'General case' 0 N--CA 1.481 1.099 0 C-N-CA 123.629 0.772 . . . . 73.310000000000002 111.857 179.784 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 150' ' ' GLY . . . . . 0.414 ' O ' ' HA ' ' A' ' 55' ' ' ARG . . . 102.41 -4.06 50.92 Favored Glycine 0 C--N 1.348 1.202 0 CA-C-O 119.648 -0.529 . . . . 75.219999999999999 113.381 -179.434 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 87.0 tttt -64.54 134.62 54.77 Favored 'General case' 0 N--CA 1.476 0.87 0 CA-C-N 117.573 0.686 . . . . 73.219999999999999 110.607 -179.733 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 152' ' ' THR . . . . . . . . . . . . . 67.4 p -95.2 126.2 40.37 Favored 'General case' 0 C--O 1.242 0.669 0 N-CA-C 108.57 -0.9 . . . . 64.150000000000006 108.57 170.168 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 153' ' ' SER . . . . . . . . . . . . . 38.8 t -60.02 -42.34 94.13 Favored 'General case' 0 N--CA 1.477 0.893 0 C-N-CA 123.568 0.747 . . . . 74.409999999999997 109.766 178.152 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 28.6 mmtp -114.69 154.54 28.27 Favored 'General case' 0 C--O 1.242 0.687 0 CA-C-N 114.928 -1.033 . . . . 53.409999999999997 109.96 179.784 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 57.1 tptt -78.15 89.59 4.25 Favored 'General case' 0 CA--C 1.54 0.59 0 N-CA-C 109.04 -0.726 . . . . 75.329999999999998 109.04 179.879 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 156' ' ' ILE . . . . . 0.423 HG23 ' HE1' ' A' ' 142' ' ' MET . 64.1 mt -84.37 116.12 27.56 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.488 0 N-CA-C 108.974 -0.75 . . . . 63.450000000000003 108.974 -176.034 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 157' ' ' THR . . . . . . . . . . . . . 50.5 p -120.41 159.97 24.03 Favored 'General case' 0 N--CA 1.479 1.018 0 C-N-CA 124.242 1.017 . . . . 64.120000000000005 110.288 -176.063 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 158' ' ' ILE . . . . . 0.514 HD12 ' HB2' ' A' ' 51' ' ' SER . 60.3 mt -87.82 100.05 9.64 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.647 0 N-CA-C 107.337 -1.357 . . . . 75.230000000000004 107.337 164.768 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 159' ' ' ALA . . . . . 0.495 ' HB2' ' HB2' ' A' ' 11' ' ' ALA . . . -57.56 -50.81 71.87 Favored 'General case' 0 N--CA 1.474 0.756 0 C-N-CA 124.193 0.997 . . . . 71.109999999999999 111.814 -177.686 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 160' ' ' ASP . . . . . . . . . . . . . 1.8 t70 -148.75 -179.15 6.77 Favored 'General case' 0 N--CA 1.48 1.049 0 CA-C-N 116.712 -0.222 . . . . 65.420000000000002 111.46 -174.049 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 161' ' ' CYS . . . . . . . . . . . . . 26.8 p -154.11 -169.07 3.14 Favored 'General case' 0 N--CA 1.475 0.816 0 C-N-CA 124.659 1.183 . . . . 62.409999999999997 108.992 -176.208 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 162' ' ' GLY . . . . . . . . . . . . . . . 136.46 53.11 0.06 OUTLIER Glycine 0 N--CA 1.475 1.287 0 N-CA-C 111.53 -0.628 . . . . 55.200000000000003 111.53 -166.056 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 163' ' ' GLN . . . . . 0.56 ' HG3' ' HA ' ' A' ' 6' ' ' VAL . 30.3 tt0 -45.8 117.43 1.48 Allowed 'General case' 0 N--CA 1.476 0.83 0 C-N-CA 126.588 1.955 . . . . 74.109999999999999 112.434 -179.869 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 164' ' ' LEU . . . . . . . . . . . . . 78.1 mt . . . . . 0 N--CA 1.466 0.343 0 N-CA-C 107.974 -1.121 . . . . 72.420000000000002 107.974 179.935 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' B' B ' 218' ' ' PRO . . . . . . . . . . . . . 86.3 Cg_endo . . . . . 0 CA--C 1.55 1.296 0 CA-C-O 121.626 0.594 . . . . 71.120000000000005 111.611 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' B' B ' 219' ' ' GLY . . . . . . . . . . . . . . . 171.73 -169.7 42.74 Favored Glycine 0 CA--C 1.531 1.093 0 CA-C-N 115.586 -0.734 . . . . 61.43 113.196 179.75 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 220' ' ' PRO . . . . . 0.413 ' HB2' HD22 ' A' ' 122' ' ' LEU . 87.4 Cg_endo -76.37 159.16 36.56 Favored 'Trans proline' 0 C--N 1.368 1.604 0 C-N-CA 123.999 3.133 . . . . 73.209999999999994 114.128 177.067 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 221' ' ' TYR . . . . . . . . . . . . . 66.3 m-85 . . . . . 0 N--CA 1.491 1.601 0 C-N-CA 123.49 0.716 . . . . 62.450000000000003 111.876 -176.907 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 15.2 m120 . . . . . 0 CA--C 1.549 0.928 0 N-CA-C 111.731 0.271 . . . . 62.32 111.731 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 4' ' ' PRO . . . . . 0.474 ' HG2' ' HB2' ' A' ' 24' ' ' LEU . 59.9 Cg_endo -73.69 146.41 38.49 Favored 'Trans proline' 0 C--N 1.374 1.871 0 C-N-CA 122.376 2.051 . . . . 62.109999999999999 111.403 166.232 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 5' ' ' THR . . . . . 0.486 ' HB ' ' O ' ' A' ' 164' ' ' LEU . 84.2 m -96.7 135.92 37.95 Favored 'General case' 0 CA--C 1.536 0.423 0 C-N-CA 123.344 0.658 . . . . 73.140000000000001 109.29 177.736 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 6' ' ' VAL . . . . . 0.475 ' HB ' ' HB2' ' A' ' 22' ' ' PHE . 23.3 t -100.19 147.08 7.96 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.485 0 N-CA-C 107.831 -1.174 . . . . 75.120000000000005 107.831 176.25 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 7' ' ' PHE . . . . . 0.439 ' H ' ' HA ' ' A' ' 163' ' ' GLN . 45.7 t80 -126.73 120.73 30.1 Favored 'General case' 0 C--O 1.237 0.412 0 N-CA-C 109.093 -0.706 . . . . 71.310000000000002 109.093 175.951 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 8' ' ' PHE . . . . . 0.402 ' HD2' ' HE2' ' A' ' 22' ' ' PHE . 30.6 m-85 -129.86 166.2 20.46 Favored 'General case' 0 N--CA 1.47 0.556 0 C-N-CA 123.864 0.865 . . . . 63.530000000000001 109.008 165.925 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 24.8 m-20 -117.82 122.9 44.6 Favored 'General case' 0 N--CA 1.466 0.349 0 N-CA-C 107.641 -1.244 . . . . 74.510000000000005 107.641 169.903 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 46.5 mm -87.2 124.41 40.63 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.509 0 N-CA-C 108.914 -0.772 . . . . 50.43 108.914 178.955 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 11' ' ' ALA . . . . . 0.851 ' HB2' ' HB2' ' A' ' 159' ' ' ALA . . . -118.82 128.13 54.17 Favored 'General case' 0 N--CA 1.469 0.483 0 C-N-CA 123.599 0.759 . . . . 63.140000000000001 110.695 -174.882 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 12' ' ' VAL . . . . . 0.467 HG13 ' HB3' ' A' ' 154' ' ' LYS . 96.0 t -95.81 107.91 20.33 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.48 0 N-CA-C 107.819 -1.178 . . . . 71.299999999999997 107.819 173.696 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 29.0 m-20 64.72 25.24 12.98 Favored 'General case' 0 N--CA 1.485 1.301 0 C-N-CA 125.284 1.434 . . . . 63.030000000000001 111.97 -175.926 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 87.24 1.36 84.22 Favored Glycine 0 C--N 1.348 1.249 0 CA-C-N 116.377 -0.374 . . . . 64.129999999999995 113.186 -177.061 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 17.5 mm-40 -94.46 113.49 61.07 Favored Pre-proline 0 CA--C 1.543 0.679 0 N-CA-C 108.584 -0.895 . . . . 54.420000000000002 108.584 175.125 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 26.4 Cg_endo -59.89 106.31 0.32 Allowed 'Trans proline' 0 C--N 1.38 2.197 0 C-N-CA 122.627 2.218 . . . . 73.310000000000002 112.181 -175.879 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 47.2 tp -75.49 -34.43 60.86 Favored 'General case' 0 N--CA 1.476 0.834 0 C-N-CA 124.178 0.991 . . . . 60.030000000000001 109.42 -179.348 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 178.47 177.44 47.15 Favored Glycine 0 C--N 1.343 0.919 0 CA-C-N 115.574 -0.739 . . . . 62.43 113.29 175.748 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 37.4 ptt85 -107.26 136.1 47.65 Favored 'General case' 0 C--O 1.24 0.584 0 C-N-CA 124.3 1.04 . . . . 75.200000000000003 108.998 177.05 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 20' ' ' VAL . . . . . 0.467 ' HA ' ' HA3' ' A' ' 135' ' ' GLY . 33.2 t -127.2 134.35 66.14 Favored 'Isoleucine or valine' 0 C--O 1.243 0.721 0 C-N-CA 123.122 0.569 . . . . 54.409999999999997 109.96 -178.856 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 21' ' ' SER . . . . . 0.453 ' HA ' ' O ' ' A' ' 6' ' ' VAL . 50.8 p -114.23 124.28 51.65 Favored 'General case' 0 CA--C 1.55 0.976 0 C-N-CA 123.83 0.852 . . . . 75.310000000000002 109.769 175.75 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 22' ' ' PHE . . . . . 0.475 ' HB2' ' HB ' ' A' ' 6' ' ' VAL . 60.7 m-85 -101.83 170.14 8.34 Favored 'General case' 0 N--CA 1.477 0.883 0 C-N-CA 123.903 0.881 . . . . 74.219999999999999 110.496 -179.962 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 35.0 tt0 -134.91 102.88 5.38 Favored 'General case' 0 N--CA 1.476 0.875 0 C-N-CA 123.649 0.78 . . . . 71.209999999999994 109.817 -175.225 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . 0.474 ' HB2' ' HG2' ' A' ' 4' ' ' PRO . 48.1 mt -82.02 131.78 35.25 Favored 'General case' 0 N--CA 1.478 0.97 0 C-N-CA 122.966 0.506 . . . . 73.319999999999993 110.423 -179.807 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 52.7 m-85 -86.93 69.06 10.24 Favored 'General case' 0 N--CA 1.469 0.506 0 N-CA-C 108.856 -0.794 . . . . 65.439999999999998 108.856 175.188 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -66.52 -12.89 59.8 Favored 'General case' 0 N--CA 1.483 1.184 0 CA-C-N 115.418 -0.81 . . . . 64.25 112.497 -175.114 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 11.1 p-10 -85.33 -34.85 21.75 Favored 'General case' 0 CA--C 1.545 0.756 0 C-N-CA 123.694 0.798 . . . . 74.109999999999999 111.482 175.323 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 96.7 mttt -93.83 -33.48 13.53 Favored 'General case' 0 N--CA 1.489 1.496 0 C-N-CA 123.099 0.56 . . . . 72.349999999999994 111.903 -172.709 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 29' ' ' VAL . . . . . 0.566 HG21 ' HA ' ' A' ' 129' ' ' PHE . 4.4 m -135.92 69.36 64.65 Favored Pre-proline 0 N--CA 1.481 1.103 0 C-N-CA 123.873 0.869 . . . . 71.409999999999997 109.07 177.45 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 37.1 Cg_exo -58.11 -35.28 98.87 Favored 'Trans proline' 0 C--N 1.381 2.26 0 C-N-CA 122.79 2.327 . . . . 73.200000000000003 113.42 -173.04 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 87.8 tttt -69.85 -50.27 44.27 Favored 'General case' 0 N--CA 1.472 0.664 0 C-N-CA 123.67 0.788 . . . . 52.210000000000001 111.776 -178.341 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 7.4 m -73.61 -29.6 62.48 Favored 'General case' 0 CA--C 1.556 1.211 0 C-N-CA 122.975 0.51 . . . . 73.409999999999997 111.113 -172.637 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -77.26 -36.01 54.8 Favored 'General case' 0 CA--C 1.547 0.855 0 C-N-CA 123.379 0.672 . . . . 74.140000000000001 110.875 175.46 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 12.2 tp10 -60.62 -42.87 97.71 Favored 'General case' 0 N--CA 1.488 1.46 0 C-N-CA 124.041 0.937 . . . . 63.43 109.942 175.102 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 35' ' ' ASN . . . . . 0.461 ' O ' ' HG ' ' A' ' 39' ' ' LEU . 43.3 t30 -55.58 -60.33 3.59 Favored 'General case' 0 C--N 1.347 0.498 0 CA-C-N 113.75 -1.568 . . . . 73.25 110.892 177.997 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 70.0 t80 -62.19 -34.12 75.83 Favored 'General case' 0 N--CA 1.471 0.618 0 O-C-N 124.361 1.038 . . . . 61.509999999999998 111.574 -174.838 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 42.1 ttp180 -64.99 -44.19 90.1 Favored 'General case' 0 C--N 1.348 0.512 0 O-C-N 123.605 0.566 . . . . 70.349999999999994 110.841 177.278 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 38' ' ' ALA . . . . . 0.541 ' HB3' HG21 ' A' ' 78' ' ' ILE . . . -73.65 -26.02 60.56 Favored 'General case' 0 N--CA 1.475 0.785 0 C-N-CA 122.896 0.479 . . . . 51.549999999999997 111.568 -178.875 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 39' ' ' LEU . . . . . 0.577 HD22 ' HE1' ' A' ' 48' ' ' TYR . 90.3 mt -68.78 -40.16 79.8 Favored 'General case' 0 CA--C 1.549 0.912 0 C-N-CA 123.705 0.802 . . . . 73.219999999999999 109.911 172.693 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 47.2 t -71.7 -51.29 23.73 Favored 'General case' 0 N--CA 1.476 0.856 0 C-N-CA 124.311 1.044 . . . . 73.129999999999995 111.329 -178.334 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 53.1 p -72.42 -31.4 65.46 Favored 'General case' 0 N--CA 1.471 0.612 0 C-N-CA 123.703 0.801 . . . . 44.039999999999999 111.652 -175.917 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 79.03 21.93 66.9 Favored Glycine 0 C--N 1.346 1.124 0 CA-C-N 115.895 -0.593 . . . . 63.140000000000001 113.794 178.151 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 30.9 mm-40 -62.08 -31.33 71.75 Favored 'General case' 0 N--CA 1.477 0.897 0 C-N-CA 123.302 0.641 . . . . 73.209999999999994 110.707 174.213 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 44' ' ' LYS . . . . . 0.444 ' HG2' ' HB1' ' A' ' 38' ' ' ALA . 30.5 mmmt -95.74 19.4 11.33 Favored 'General case' 0 CA--C 1.544 0.717 0 C-N-CA 123.896 0.878 . . . . 72.040000000000006 111.853 179.957 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 85.83 -9.65 68.01 Favored Glycine 0 C--N 1.353 1.508 0 N-CA-C 114.994 0.757 . . . . 73.349999999999994 114.994 170.802 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 46' ' ' PHE . . . . . 0.411 ' HE2' ' HA ' ' A' ' 78' ' ' ILE . 22.3 m-85 -86.45 -50.23 7.03 Favored 'General case' 0 N--CA 1.478 0.956 0 CA-C-N 118.064 0.932 . . . . 74.420000000000002 111.473 -170.453 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 44.98 65.12 1.93 Allowed Glycine 0 C--N 1.361 1.946 0 O-C-N 124.634 1.209 . . . . 64.129999999999995 115.172 169.824 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 48' ' ' TYR . . . . . 0.577 ' HE1' HD22 ' A' ' 39' ' ' LEU . 79.3 m-85 -60.07 86.09 0.01 OUTLIER 'General case' 0 N--CA 1.487 1.383 0 CA-C-O 122.241 1.019 . . . . 72.340000000000003 111.903 -173.731 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 27.6 tptp -114.72 128.49 56.34 Favored 'General case' 0 C--O 1.239 0.527 0 CA-C-N 113.376 -1.738 . . . . 74.129999999999995 108.515 -178.865 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 63.35 20.55 63.37 Favored Glycine 0 N--CA 1.476 1.317 0 O-C-N 123.255 0.347 . . . . 63.020000000000003 112.708 -173.321 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 27.0 t -76.12 123.73 26.28 Favored 'General case' 0 C--N 1.346 0.456 0 C-N-CA 123.119 0.567 . . . . 75.200000000000003 110.575 -171.137 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 52' ' ' CYS . . . . . 0.457 ' SG ' ' HD3' ' A' ' 155' ' ' LYS . 51.5 t -81.45 161.86 23.52 Favored 'General case' 0 CA--C 1.539 0.53 0 O-C-N 123.967 0.792 . . . . 70.5 112.537 -171.631 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 12.7 m-85 -111.67 131.47 55.27 Favored 'General case' 0 CA--C 1.537 0.465 0 N-CA-C 107.068 -1.456 . . . . 74.439999999999998 107.068 169.544 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 47.9 p-80 -114.18 -29.35 6.98 Favored 'General case' 0 N--CA 1.496 1.866 0 CA-C-N 118.695 0.68 . . . . 74.209999999999994 112.348 -174.016 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 55' ' ' ARG . . . . . 0.413 ' HB3' ' HG2' ' A' ' 63' ' ' GLN . 42.6 ttt-85 -119.62 98.29 6.05 Favored 'General case' 0 N--CA 1.473 0.724 0 N-CA-C 108.544 -0.91 . . . . 74.540000000000006 108.544 -176.603 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 59.5 mt -130.27 127.96 63.57 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.614 0 C-N-CA 123.807 0.843 . . . . 63.329999999999998 108.974 179.825 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 61.4 mt -127.83 118.88 21.12 Favored Pre-proline 0 CA--C 1.553 1.078 0 N-CA-C 108.189 -1.041 . . . . 72.140000000000001 108.189 176.848 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 58' ' ' PRO . . . . . 0.482 ' HB3' ' HA ' ' A' ' 144' ' ' ARG . 64.0 Cg_endo -70.35 139.02 37.24 Favored 'Trans proline' 0 C--N 1.379 2.154 0 C-N-CA 123.163 2.576 . . . . 73.239999999999995 111.98 -174.028 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 79.0 24.41 61.83 Favored Glycine 0 C--N 1.338 0.645 0 CA-C-N 115.204 -0.907 . . . . 31.140000000000001 112.325 -175.728 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 27.9 t80 -150.34 -76.87 0.14 Allowed 'General case' 0 CA--C 1.544 0.724 0 C-N-CA 123.778 0.831 . . . . 72.400000000000006 109.884 179.356 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 38.7 ttp -166.98 150.46 6.65 Favored 'General case' 0 N--CA 1.485 1.306 0 CA-C-O 120.912 0.386 . . . . 65.420000000000002 111.781 -164.412 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 62' ' ' CYS . . . . . . . . . . . . . 4.9 p -127.83 120.86 28.71 Favored 'General case' 0 N--CA 1.478 0.932 0 C-N-CA 124.829 1.251 . . . . 64.549999999999997 109.57 176.552 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 63' ' ' GLN . . . . . 0.413 ' HG2' ' HB3' ' A' ' 55' ' ' ARG . 14.2 pt20 -128.26 144.97 51.18 Favored 'General case' 0 N--CA 1.491 1.62 0 CA-C-O 121.428 0.632 . . . . 73.010000000000005 112.375 -176.156 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -163.61 -147.27 5.01 Favored Glycine 0 C--N 1.348 1.227 0 CA-C-N 114.406 -1.27 . . . . 52.140000000000001 113.556 -174.609 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 90.66 12.32 61.01 Favored Glycine 0 C--N 1.345 1.062 0 N-CA-C 110.588 -1.005 . . . . 52.140000000000001 110.588 -161.878 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 38.9 t70 -61.69 -43.64 98.47 Favored 'General case' 0 N--CA 1.472 0.66 0 C-N-CA 125.313 1.445 . . . . 74.530000000000001 112.543 -162.085 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 50.2 t80 -49.37 -36.77 22.61 Favored 'General case' 0 CA--C 1.552 1.042 0 O-C-N 124.598 1.186 . . . . 72.25 112.695 -170.236 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 54.3 m -88.11 108.23 19.15 Favored 'General case' 0 CA--C 1.545 0.782 0 C-N-CA 122.957 0.503 . . . . 71.310000000000002 110.522 176.147 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 31.8 mtp180 58.73 53.87 5.64 Favored 'General case' 0 N--CA 1.479 0.993 0 C-N-CA 124.963 1.305 . . . . 73.319999999999993 111.657 172.797 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 10.0 p80 -63.34 -13.17 36.16 Favored 'General case' 0 N--CA 1.482 1.172 0 N-CA-C 114.233 1.197 . . . . 74.349999999999994 114.233 -173.874 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 6.6 t30 -68.61 84.84 0.29 Allowed 'General case' 0 CA--C 1.552 1.049 0 C-N-CA 123.253 0.621 . . . . 65.140000000000001 110.159 179.163 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 64.47 13.95 56.19 Favored Glycine 0 C--N 1.353 1.506 0 N-CA-C 115.62 1.008 . . . . 54.310000000000002 115.62 176.397 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 73' ' ' THR . . . . . 0.406 ' O ' ' HG3' ' A' ' 111' ' ' GLN . 6.9 m -125.0 -68.01 0.87 Allowed 'General case' 0 N--CA 1.476 0.851 0 N-CA-C 109.188 -0.671 . . . . 72.239999999999995 109.188 -178.228 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 57.3 50.45 64.59 Favored Glycine 0 C--N 1.353 1.515 0 O-C-N 124.559 1.162 . . . . 74.310000000000002 115.141 171.66 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 128.83 50.81 0.13 Allowed Glycine 0 C--N 1.35 1.335 0 CA-C-N 117.833 0.817 . . . . 54.439999999999998 113.281 178.837 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 14.1 ptmm? -64.27 165.6 9.26 Favored 'General case' 0 N--CA 1.482 1.15 0 C-N-CA 123.133 0.573 . . . . 73.430000000000007 112.338 -179.042 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 84.0 p -92.77 173.8 7.58 Favored 'General case' 0 N--CA 1.472 0.655 0 CA-C-N 115.893 -0.594 . . . . 72.439999999999998 111.392 -172.811 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 78' ' ' ILE . . . . . 0.541 HG21 ' HB3' ' A' ' 38' ' ' ALA . 23.1 pt -81.0 -20.99 11.13 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.609 0 CA-C-N 115.856 -0.611 . . . . 74.540000000000006 109.877 172.638 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 79' ' ' TYR . . . . . 0.427 ' HE2' ' HB2' ' A' ' 35' ' ' ASN . 64.0 m-85 -86.62 12.53 10.37 Favored 'General case' 0 CA--C 1.546 0.821 0 C-N-CA 123.767 0.827 . . . . 71.219999999999999 110.134 175.683 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 121.17 -152.5 16.79 Favored Glycine 0 C--N 1.354 1.549 0 C-N-CA 123.126 0.393 . . . . 62.020000000000003 112.784 171.203 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 34.3 tt0 -52.13 -53.24 45.21 Favored 'General case' 0 N--CA 1.471 0.597 0 C-N-CA 124.816 1.246 . . . . 72.450000000000003 109.396 171.993 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 82' ' ' LYS . . . . . 0.676 ' HD2' ' HA ' ' A' ' 107' ' ' THR . 20.7 pttp -169.52 156.06 6.46 Favored 'General case' 0 CA--C 1.548 0.888 0 CA-C-N 114.549 -1.205 . . . . 62.130000000000003 109.697 -178.319 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 9.7 p90 -131.68 174.78 9.77 Favored 'General case' 0 N--CA 1.48 1.029 0 C-N-CA 124.341 1.056 . . . . 65.209999999999994 110.57 -179.943 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 84' ' ' GLU . . . . . 0.542 ' HA ' ' HA ' ' A' ' 106' ' ' ASN . 0.0 OUTLIER -70.98 168.68 16.51 Favored 'General case' 0 N--CA 1.479 0.992 0 CA-C-N 115.759 -0.655 . . . . 73.140000000000001 111.582 -179.483 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 56.6 m-20 -80.58 111.39 16.95 Favored 'General case' 0 N--CA 1.47 0.571 0 N-CA-C 108.289 -1.004 . . . . 74.150000000000006 108.289 173.839 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 3.9 tp10 -46.98 -53.27 12.73 Favored 'General case' 0 N--CA 1.481 1.097 0 C-N-CA 124.895 1.278 . . . . 73.450000000000003 112.636 -175.0 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 87' ' ' ASN . . . . . 0.409 ' OD1' HG21 ' A' ' 127' ' ' VAL . 32.3 p30 -159.6 -165.62 1.58 Allowed 'General case' 0 N--CA 1.473 0.683 0 C-N-CA 123.62 0.768 . . . . 73.129999999999995 109.589 -176.17 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 93.7 m-85 -137.27 29.8 2.72 Favored 'General case' 0 N--CA 1.485 1.284 0 C-N-CA 123.868 0.867 . . . . 52.530000000000001 110.274 176.004 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 65.9 mt -60.07 -49.77 82.77 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.247 0 CA-C-O 121.866 0.841 . . . . 75.310000000000002 109.791 176.482 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 90' ' ' LEU . . . . . 0.622 ' HB3' ' HB ' ' A' ' 128' ' ' VAL . 92.3 mt -96.23 99.63 11.33 Favored 'General case' 0 C--O 1.237 0.436 0 CA-C-N 114.565 -1.198 . . . . 63.450000000000003 110.102 -175.969 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 8.7 mtpm? -76.31 149.7 37.02 Favored 'General case' 0 CA--C 1.543 0.69 0 C-N-CA 123.567 0.747 . . . . 75.099999999999994 110.204 176.771 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 92' ' ' HIS . . . . . . . . . . . . . 18.2 t-80 -87.43 28.45 0.97 Allowed 'General case' 0 N--CA 1.482 1.126 0 C-N-CA 124.21 1.004 . . . . 70.530000000000001 111.368 -169.412 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 14.5 t -99.87 16.46 23.69 Favored 'General case' 0 CA--C 1.552 1.051 0 C-N-CA 123.819 0.848 . . . . 60.210000000000001 111.628 -166.996 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -113.17 161.12 12.79 Favored Glycine 0 CA--C 1.534 1.255 0 CA-C-O 119.443 -0.643 . . . . 72.519999999999996 112.1 176.937 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 86.7 Cg_endo -83.4 154.2 14.04 Favored 'Trans proline' 0 C--N 1.367 1.544 0 C-N-CA 122.816 2.344 . . . . 74.540000000000006 111.957 171.408 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 71.12 19.76 77.49 Favored Glycine 0 C--N 1.35 1.312 0 N-CA-C 113.8 0.28 . . . . 50.329999999999998 113.8 -179.944 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 97' ' ' ILE . . . . . 0.429 HG23 HG13 ' A' ' 128' ' ' VAL . 24.6 mm -77.27 125.15 36.81 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.808 0 C-N-CA 123.231 0.612 . . . . 75.209999999999994 112.042 -175.65 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 98' ' ' LEU . . . . . 0.68 ' HG ' HG12 ' A' ' 114' ' ' ILE . 7.3 mp -93.11 123.2 36.21 Favored 'General case' 0 C--O 1.241 0.612 0 C-N-CA 123.709 0.804 . . . . 72.439999999999998 109.735 168.038 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 25.9 m -139.96 144.14 36.9 Favored 'General case' 0 N--CA 1.474 0.747 0 N-CA-C 107.737 -1.209 . . . . 61.329999999999998 107.737 168.876 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 100' ' ' MET . . . . . 0.549 ' HA ' ' HA ' ' A' ' 112' ' ' PHE . 72.1 mtp -75.44 142.28 43.02 Favored 'General case' 0 N--CA 1.482 1.157 0 N-CA-C 108.842 -0.799 . . . . 74.120000000000005 108.842 177.668 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 101' ' ' ALA . . . . . 0.631 ' HB3' ' HB2' ' A' ' 111' ' ' GLN . . . -73.97 140.32 45.45 Favored 'General case' 0 C--O 1.24 0.58 0 CA-C-O 121.362 0.601 . . . . 63.109999999999999 112.343 -166.805 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 28.6 p-10 -151.8 154.7 36.73 Favored 'General case' 0 C--O 1.237 0.398 0 CA-C-N 114.734 -1.121 . . . . 65.140000000000001 109.416 179.444 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -105.27 5.45 32.02 Favored 'General case' 0 CA--C 1.537 0.46 0 CA-C-N 115.538 -0.755 . . . . 75.150000000000006 110.261 170.589 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 162.07 -174.3 38.51 Favored Glycine 0 C--N 1.35 1.317 0 CA-C-O 119.661 -0.521 . . . . 53.439999999999998 112.387 179.577 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 77.5 Cg_exo -55.39 138.92 81.26 Favored 'Trans proline' 0 C--N 1.374 1.883 0 C-N-CA 123.663 2.909 . . . . 72.030000000000001 113.218 175.219 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 106' ' ' ASN . . . . . 0.542 ' HA ' ' HA ' ' A' ' 84' ' ' GLU . 63.9 t30 68.29 10.87 8.11 Favored 'General case' 0 N--CA 1.487 1.399 0 C-N-CA 125.277 1.431 . . . . 64.519999999999996 111.64 177.826 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 107' ' ' THR . . . . . 0.676 ' HA ' ' HD2' ' A' ' 82' ' ' LYS . 3.1 m -104.65 -11.64 16.8 Favored 'General case' 0 CA--C 1.552 1.051 0 C-N-CA 123.728 0.811 . . . . 71.420000000000002 110.129 176.99 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 10.5 t30 -56.15 139.77 46.36 Favored 'General case' 0 N--CA 1.48 1.043 0 C-N-CA 124.988 1.315 . . . . 65.030000000000001 111.651 172.428 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 112.52 3.05 25.74 Favored Glycine 0 N--CA 1.471 1.026 0 CA-C-O 119.924 -0.376 . . . . 60.32 113.137 176.197 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 15.3 p -114.19 122.35 46.54 Favored 'General case' 0 CA--C 1.542 0.648 0 N-CA-C 108.395 -0.965 . . . . 73.510000000000005 108.395 172.272 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 111' ' ' GLN . . . . . 0.631 ' HB2' ' HB3' ' A' ' 101' ' ' ALA . 41.0 mt-30 66.03 168.86 0.22 Allowed 'General case' 0 N--CA 1.496 1.846 0 C-N-CA 124.746 1.218 . . . . 73.329999999999998 112.416 -175.728 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 112' ' ' PHE . . . . . 0.549 ' HA ' ' HA ' ' A' ' 100' ' ' MET . 51.4 p90 -137.02 140.47 42.12 Favored 'General case' 0 N--CA 1.476 0.827 0 N-CA-C 108.153 -1.054 . . . . 74.420000000000002 108.153 168.341 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 113' ' ' PHE . . . . . 0.409 ' HE2' ' HA ' ' A' ' 101' ' ' ALA . 54.4 p90 -128.1 150.02 50.15 Favored 'General case' 0 N--CA 1.471 0.624 0 C-N-CA 122.899 0.48 . . . . 70.349999999999994 111.832 179.881 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 114' ' ' ILE . . . . . 0.68 HG12 ' HG ' ' A' ' 98' ' ' LEU . 14.0 mt -120.95 117.9 54.52 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.654 0 CA-C-N 115.12 -0.945 . . . . 72.420000000000002 108.666 173.943 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 115' ' ' CYS . . . . . . . . . . . . . 58.8 m -94.77 110.41 22.27 Favored 'General case' 0 C--O 1.24 0.596 0 N-CA-C 108.311 -0.996 . . . . 73.409999999999997 108.311 173.891 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 116' ' ' THR . . . . . 0.459 HG21 ' HA ' ' A' ' 140' ' ' GLU . 72.5 p -71.03 -31.52 68.02 Favored 'General case' 0 N--CA 1.479 0.989 0 C-N-CA 122.51 0.324 . . . . 74.25 111.719 -175.28 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -97.25 163.67 12.81 Favored 'General case' 0 N--CA 1.479 1.004 0 N-CA-C 109.164 -0.68 . . . . 70.420000000000002 109.164 168.155 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 118' ' ' LYS . . . . . 0.47 ' HE2' ' HB3' ' A' ' 120' ' ' GLU . 0.0 OUTLIER -70.84 124.71 24.96 Favored 'General case' 0 C--N 1.347 0.466 0 N-CA-C 109.233 -0.654 . . . . 72.430000000000007 109.233 175.914 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 119' ' ' THR . . . . . 0.6 ' HB ' HD13 ' A' ' 122' ' ' LEU . 23.0 p -113.02 88.11 2.75 Favored 'General case' 0 C--O 1.238 0.462 0 CA-C-O 121.864 0.84 . . . . 73.239999999999995 109.055 179.138 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 120' ' ' GLU . . . . . 0.47 ' HB3' ' HE2' ' A' ' 118' ' ' LYS . 10.5 pt-20 -67.87 -27.16 66.44 Favored 'General case' 0 N--CA 1.478 0.965 0 CA-C-N 114.254 -1.339 . . . . 72.439999999999998 112.485 -178.009 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 121' ' ' TRP . . . . . . . . . . . . . 32.5 p90 -78.12 -1.02 30.49 Favored 'General case' 0 N--CA 1.479 1.014 0 C-N-CA 122.768 0.427 . . . . 74.319999999999993 111.113 178.49 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 122' ' ' LEU . . . . . 0.6 HD13 ' HB ' ' A' ' 119' ' ' THR . 9.3 mp -96.63 5.7 50.18 Favored 'General case' 0 N--CA 1.48 1.049 0 C-N-CA 123.904 0.882 . . . . 64.129999999999995 111.168 171.639 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 25.0 m-20 -72.62 141.12 48.33 Favored 'General case' 0 N--CA 1.481 1.09 0 N-CA-C 109.462 -0.57 . . . . 61.509999999999998 109.462 168.879 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 92.98 -28.31 9.68 Favored Glycine 0 N--CA 1.478 1.451 0 N-CA-C 111.759 -0.536 . . . . 71.299999999999997 111.759 -173.019 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 1.5 mppt? -73.65 -164.32 0.21 Allowed 'General case' 0 N--CA 1.481 1.084 0 C-N-CA 124.584 1.154 . . . . 65.25 109.538 168.585 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 126' ' ' HIS . . . . . . . . . . . . . 36.2 t60 -66.08 132.94 49.69 Favored 'General case' 0 CA--C 1.542 0.669 0 CA-C-O 121.638 0.733 . . . . 63.310000000000002 112.207 -170.853 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 127' ' ' VAL . . . . . 0.409 HG21 ' OD1' ' A' ' 87' ' ' ASN . 7.1 p -59.42 146.64 9.36 Favored 'Isoleucine or valine' 0 CA--C 1.554 1.103 0 CA-C-N 113.797 -1.547 . . . . 73.439999999999998 111.155 177.185 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 128' ' ' VAL . . . . . 0.622 ' HB ' ' HB3' ' A' ' 90' ' ' LEU . 42.1 t -62.44 147.05 11.97 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.795 0 C-N-CA 123.686 0.794 . . . . 45.340000000000003 110.333 179.625 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 129' ' ' PHE . . . . . 0.566 ' HA ' HG21 ' A' ' 29' ' ' VAL . 36.7 p90 -120.16 -28.83 5.01 Favored 'General case' 0 N--CA 1.476 0.87 0 C-N-CA 122.565 0.346 . . . . 74.049999999999997 110.277 170.575 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . -146.09 168.73 27.59 Favored Glycine 0 C--N 1.346 1.112 0 O-C-N 123.525 0.516 . . . . 74.450000000000003 112.798 -172.371 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 29.0 ttpt -152.76 134.6 14.69 Favored 'General case' 0 N--CA 1.47 0.541 0 N-CA-C 108.167 -1.049 . . . . 62.340000000000003 108.167 -177.611 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 132' ' ' VAL . . . . . 0.486 HG11 ' HA ' ' A' ' 136' ' ' MET . 7.3 t -66.62 109.95 1.36 Allowed 'Isoleucine or valine' 0 CA--C 1.542 0.671 0 N-CA-C 109.433 -0.58 . . . . 65.219999999999999 109.433 176.799 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 14.4 ptmm? -87.02 -39.52 15.57 Favored 'General case' 0 N--CA 1.481 1.104 0 N-CA-C 110.134 -0.321 . . . . 73.329999999999998 110.134 -178.269 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 134' ' ' GLU . . . . . 0.403 ' HB2' ' OG ' ' A' ' 21' ' ' SER . 20.6 mm-40 -144.53 162.13 37.35 Favored 'General case' 0 N--CA 1.488 1.471 0 C-N-CA 124.711 1.204 . . . . 61.32 108.693 173.316 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 135' ' ' GLY . . . . . 0.467 ' HA3' ' HA ' ' A' ' 20' ' ' VAL . . . 78.7 15.14 81.24 Favored Glycine 0 C--N 1.346 1.125 0 O-C-N 123.349 0.406 . . . . 71.319999999999993 112.177 -173.715 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 136' ' ' MET . . . . . 0.486 ' HA ' HG11 ' A' ' 132' ' ' VAL . 15.2 tpt -62.92 -34.38 77.32 Favored 'General case' 0 N--CA 1.472 0.626 0 C-N-CA 124.462 1.105 . . . . 72.120000000000005 111.808 -177.047 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 137' ' ' ASN . . . . . . . . . . . . . 27.3 t-20 -61.78 -35.84 79.34 Favored 'General case' 0 N--CA 1.48 1.069 0 C-N-CA 123.455 0.702 . . . . 73.219999999999999 111.164 177.571 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 138' ' ' ILE . . . . . . . . . . . . . 43.4 mm -71.12 -33.22 50.43 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.088 0 C-N-CA 123.402 0.681 . . . . 62.140000000000001 110.679 179.642 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 139' ' ' VAL . . . . . 0.422 HG11 HG21 ' A' ' 114' ' ' ILE . 62.0 t -69.76 -44.87 78.79 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.999 0 C-N-CA 123.407 0.683 . . . . 72.120000000000005 110.518 176.306 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 140' ' ' GLU . . . . . 0.459 ' HA ' HG21 ' A' ' 116' ' ' THR . 40.0 mt-10 -63.82 -33.58 75.99 Favored 'General case' 0 N--CA 1.476 0.855 0 CA-C-N 115.476 -0.784 . . . . 73.310000000000002 110.534 176.882 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -70.37 -43.84 69.3 Favored 'General case' 0 C--O 1.24 0.594 0 C-N-CA 123.662 0.785 . . . . 75.310000000000002 111.307 178.124 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 142' ' ' MET . . . . . 0.515 ' HB2' HD13 ' A' ' 156' ' ' ILE . 22.4 ptt? -69.52 -34.09 73.75 Favored 'General case' 0 C--N 1.355 0.843 0 CA-C-N 116.84 -0.164 . . . . 65.299999999999997 110.929 -175.691 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 143' ' ' GLU . . . . . 0.413 ' HG2' ' HA ' ' A' ' 58' ' ' PRO . 30.9 tt0 -62.87 -28.99 70.42 Favored 'General case' 0 CA--C 1.559 1.294 0 C-N-CA 122.722 0.409 . . . . 72.450000000000003 111.462 -178.968 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 144' ' ' ARG . . . . . 0.482 ' HA ' ' HB3' ' A' ' 58' ' ' PRO . 58.6 mtp85 -68.72 -19.47 64.36 Favored 'General case' 0 N--CA 1.485 1.295 0 C-N-CA 123.589 0.756 . . . . 61.130000000000003 112.242 -179.091 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 145' ' ' PHE . . . . . 0.529 ' HB2' HD11 ' A' ' 156' ' ' ILE . 56.6 m-85 -79.95 -8.15 59.18 Favored 'General case' 0 N--CA 1.477 0.897 0 C-N-CA 122.807 0.443 . . . . 71.430000000000007 111.321 179.328 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . -78.14 179.59 51.47 Favored Glycine 0 C--N 1.345 1.029 0 O-C-N 123.348 0.405 . . . . 53.439999999999998 112.751 172.585 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 46.0 t -133.7 168.4 18.77 Favored 'General case' 0 N--CA 1.476 0.834 0 C-N-CA 123.773 0.829 . . . . 60.450000000000003 110.148 -176.893 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 148' ' ' ARG . . . . . . . . . . . . . 18.4 mmm180 -58.55 -37.01 74.82 Favored 'General case' 0 N--CA 1.481 1.107 0 C-N-CA 123.81 0.844 . . . . 73.230000000000004 111.863 178.527 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 149' ' ' ASN . . . . . . . . . . . . . 30.2 p-10 -89.78 11.69 19.36 Favored 'General case' 0 N--CA 1.483 1.203 0 C-N-CA 123.217 0.607 . . . . 74.319999999999993 112.201 -178.614 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . 86.08 -2.8 87.61 Favored Glycine 0 C--N 1.349 1.277 0 CA-C-O 119.732 -0.482 . . . . 45.039999999999999 114.031 177.421 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 35.7 ttmt -63.73 130.79 45.65 Favored 'General case' 0 N--CA 1.474 0.756 0 C-N-CA 123.792 0.837 . . . . 70.140000000000001 110.736 179.988 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 152' ' ' THR . . . . . . . . . . . . . 82.2 p -91.91 108.84 20.21 Favored 'General case' 0 C--O 1.239 0.504 0 N-CA-C 108.069 -1.085 . . . . 72.200000000000003 108.069 170.388 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 153' ' ' SER . . . . . . . . . . . . . 49.4 m -68.32 -28.92 67.58 Favored 'General case' 0 N--CA 1.473 0.712 0 C-N-CA 123.073 0.549 . . . . 75.219999999999999 110.532 177.789 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 154' ' ' LYS . . . . . 0.467 ' HB3' HG13 ' A' ' 12' ' ' VAL . 74.4 mmtt -117.11 139.83 50.26 Favored 'General case' 0 C--O 1.241 0.621 0 C-N-CA 124.155 0.982 . . . . 71.200000000000003 109.717 177.277 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 155' ' ' LYS . . . . . 0.457 ' HD3' ' SG ' ' A' ' 52' ' ' CYS . 17.4 tppt? -78.56 89.58 4.5 Favored 'General case' 0 CA--C 1.541 0.603 0 N-CA-C 109.016 -0.735 . . . . 71.420000000000002 109.016 179.926 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 156' ' ' ILE . . . . . 0.529 HD11 ' HB2' ' A' ' 145' ' ' PHE . 72.5 mt -86.58 117.53 31.16 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.321 0 CA-C-N 115.503 -0.771 . . . . 75.109999999999999 109.051 -177.422 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 157' ' ' THR . . . . . . . . . . . . . 25.1 p -130.88 153.62 48.94 Favored 'General case' 0 C--O 1.238 0.478 0 C-N-CA 124.8 1.24 . . . . 61.229999999999997 109.484 -171.898 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 158' ' ' ILE . . . . . 0.46 HD11 ' HZ ' ' A' ' 112' ' ' PHE . 67.7 mt -76.19 93.78 1.05 Allowed 'Isoleucine or valine' 0 CA--C 1.547 0.848 0 N-CA-C 108.633 -0.877 . . . . 64.349999999999994 108.633 172.094 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 159' ' ' ALA . . . . . 0.851 ' HB2' ' HB2' ' A' ' 11' ' ' ALA . . . -51.31 -53.03 39.95 Favored 'General case' 0 N--CA 1.483 1.185 0 C-N-CA 123.729 0.812 . . . . 34.43 111.707 -178.899 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 160' ' ' ASP . . . . . . . . . . . . . 1.5 t70 -151.18 176.61 11.02 Favored 'General case' 0 CA--C 1.548 0.897 0 CA-C-N 115.827 -0.624 . . . . 65.439999999999998 109.818 -178.557 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 161' ' ' CYS . . . . . . . . . . . . . 9.8 p -148.51 -171.69 3.91 Favored 'General case' 0 N--CA 1.477 0.905 0 C-N-CA 124.459 1.104 . . . . 74.230000000000004 109.9 -172.399 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 162' ' ' GLY . . . . . . . . . . . . . . . 131.23 53.39 0.09 OUTLIER Glycine 0 C--N 1.353 1.519 0 N-CA-C 112.238 -0.345 . . . . 52.25 112.238 -172.782 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 163' ' ' GLN . . . . . 0.439 ' HA ' ' H ' ' A' ' 7' ' ' PHE . 27.5 tt0 -46.74 107.08 0.1 Allowed 'General case' 0 CA--C 1.559 1.289 0 C-N-CA 125.234 1.414 . . . . 71.439999999999998 112.888 179.953 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 164' ' ' LEU . . . . . 0.486 ' O ' ' HB ' ' A' ' 5' ' ' THR . 84.5 mt . . . . . 0 N--CA 1.475 0.795 0 C-N-CA 123.898 0.879 . . . . 72.439999999999998 109.85 -175.246 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 218' ' ' PRO . . . . . . . . . . . . . 14.7 Cg_exo . . . . . 0 CA--C 1.539 0.763 0 N-CA-C 108.847 -1.251 . . . . 71.140000000000001 108.847 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' B' B ' 219' ' ' GLY . . . . . . . . . . . . . . . 160.18 156.91 8.37 Favored Glycine 0 CA--C 1.533 1.165 0 CA-C-N 115.753 -0.658 . . . . 74.209999999999994 112.057 -175.59 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 220' ' ' PRO . . . . . . . . . . . . . 36.3 Cg_endo -86.23 -179.22 3.07 Favored 'Trans proline' 0 C--N 1.365 1.433 0 C-N-CA 123.753 2.968 . . . . 74.140000000000001 113.86 -176.288 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 221' ' ' TYR . . . . . . . . . . . . . 97.0 m-85 . . . . . 0 N--CA 1.48 1.053 0 C-N-CA 123.333 0.653 . . . . 75.340000000000003 111.868 -175.14 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 3' ' ' ASN . . . . . 0.596 ' ND2' ' HA ' ' A' ' 25' ' ' PHE . 14.9 m120 . . . . . 0 CA--C 1.545 0.785 0 N-CA-C 110.066 -0.346 . . . . 74.340000000000003 110.066 . . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 4' ' ' PRO . . . . . 0.51 ' HG2' ' HB2' ' A' ' 24' ' ' LEU . 73.3 Cg_endo -77.48 150.35 28.19 Favored 'Trans proline' 0 C--N 1.374 1.907 0 C-N-CA 122.392 2.061 . . . . 75.109999999999999 111.575 170.559 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 5' ' ' THR . . . . . 0.445 ' HB ' ' O ' ' A' ' 164' ' ' LEU . 52.5 m -98.04 142.54 29.63 Favored 'General case' 0 CA--C 1.54 0.566 0 N-CA-C 108.932 -0.766 . . . . 71.540000000000006 108.932 175.168 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 6' ' ' VAL . . . . . 0.706 ' HA ' ' HG3' ' A' ' 163' ' ' GLN . 44.1 t -101.76 150.44 6.1 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.967 0 N-CA-C 107.689 -1.226 . . . . 74.310000000000002 107.689 171.125 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 7' ' ' PHE . . . . . 0.433 ' H ' ' HA ' ' A' ' 163' ' ' GLN . 74.2 t80 -133.55 130.77 38.9 Favored 'General case' 0 C--O 1.236 0.37 0 N-CA-C 109.531 -0.544 . . . . 74.510000000000005 109.531 175.962 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 8' ' ' PHE . . . . . 0.401 ' HD2' ' HE2' ' A' ' 22' ' ' PHE . 32.3 m-85 -138.2 166.49 24.03 Favored 'General case' 0 C--O 1.237 0.418 0 C-N-CA 124.808 1.243 . . . . 73.310000000000002 109.362 170.248 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 9' ' ' ASP . . . . . 0.401 ' HB2' ' H ' ' A' ' 160' ' ' ASP . 8.7 m-20 -117.27 112.19 20.43 Favored 'General case' 0 N--CA 1.468 0.463 0 CA-C-N 114.847 -1.069 . . . . 64.439999999999998 108.126 171.555 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 10' ' ' ILE . . . . . 0.447 HG21 ' SD ' ' A' ' 142' ' ' MET . 45.8 mm -83.33 128.57 38.64 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.453 0 N-CA-C 108.673 -0.862 . . . . 74.420000000000002 108.673 178.91 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 11' ' ' ALA . . . . . 0.655 ' HB2' ' HB2' ' A' ' 159' ' ' ALA . . . -129.97 141.1 50.81 Favored 'General case' 0 N--CA 1.471 0.614 0 C-N-CA 123.749 0.82 . . . . 50.32 110.58 -173.1 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 12' ' ' VAL . . . . . 0.541 HG13 ' HB3' ' A' ' 154' ' ' LYS . 86.2 t -97.17 110.89 25.93 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.435 0 C-N-CA 124.173 0.989 . . . . 63.340000000000003 108.848 173.533 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 9.9 m-20 58.98 24.29 12.47 Favored 'General case' 0 N--CA 1.485 1.31 0 C-N-CA 124.8 1.24 . . . . 75.400000000000006 112.651 179.919 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 106.13 -24.2 27.03 Favored Glycine 0 C--N 1.349 1.304 0 CA-C-O 119.681 -0.511 . . . . 64.219999999999999 113.006 179.658 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 24.7 mm-40 -81.78 120.28 77.35 Favored Pre-proline 0 N--CA 1.479 0.991 0 CA-C-O 118.449 -0.786 . . . . 74.439999999999998 109.327 179.994 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 19.1 Cg_endo -57.72 114.65 2.05 Favored 'Trans proline' 0 C--N 1.379 2.158 0 C-N-CA 123.107 2.538 . . . . 73.439999999999998 112.498 -177.114 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 17' ' ' LEU . . . . . 0.5 ' HB2' HG23 ' A' ' 12' ' ' VAL . 52.0 tp -79.43 -41.8 26.81 Favored 'General case' 0 N--CA 1.478 0.963 0 C-N-CA 123.735 0.814 . . . . 72.209999999999994 110.058 175.765 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -177.69 174.49 46.93 Favored Glycine 0 C--N 1.344 1.024 0 CA-C-N 115.711 -0.677 . . . . 63.5 113.395 179.955 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 19.9 mtp180 -111.2 117.5 33.39 Favored 'General case' 0 N--CA 1.471 0.611 0 N-CA-C 108.456 -0.942 . . . . 75.129999999999995 108.456 -175.925 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 86.2 t -113.37 138.48 42.82 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.733 0 C-N-CA 123.78 0.832 . . . . 73.450000000000003 110.12 -175.263 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 16.4 m -124.94 135.22 52.62 Favored 'General case' 0 C--O 1.242 0.67 0 C-N-CA 123.661 0.785 . . . . 75.450000000000003 110.114 174.901 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 22' ' ' PHE . . . . . 0.431 ' HB2' ' HB ' ' A' ' 6' ' ' VAL . 60.5 m-85 -105.78 170.0 8.15 Favored 'General case' 0 N--CA 1.474 0.765 0 C-N-CA 124.145 0.978 . . . . 64.230000000000004 109.912 179.079 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 23' ' ' GLU . . . . . 0.631 ' HB2' ' HD2' ' A' ' 133' ' ' LYS . 33.0 tt0 -130.76 108.89 10.2 Favored 'General case' 0 N--CA 1.473 0.692 0 C-N-CA 123.689 0.796 . . . . 74.349999999999994 109.233 177.948 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . 0.51 ' HB2' ' HG2' ' A' ' 4' ' ' PRO . 88.5 mt -78.54 121.0 24.04 Favored 'General case' 0 N--CA 1.469 0.481 0 C-N-CA 123.377 0.671 . . . . 75.340000000000003 109.961 179.149 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 25' ' ' PHE . . . . . 0.596 ' HA ' ' ND2' ' A' ' 3' ' ' ASN . 77.7 m-85 -83.85 68.25 9.88 Favored 'General case' 0 C--O 1.233 0.206 0 CA-C-O 121.65 0.738 . . . . 62.109999999999999 109.465 171.904 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -66.21 -21.92 66.32 Favored 'General case' 0 N--CA 1.473 0.704 0 CA-C-N 114.708 -1.133 . . . . 44.149999999999999 111.128 179.032 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 10.7 p-10 -72.71 -23.61 60.88 Favored 'General case' 0 CA--C 1.543 0.701 0 C-N-CA 124.029 0.932 . . . . 63.329999999999998 111.478 178.292 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 59.5 mttp -104.6 -51.29 3.11 Favored 'General case' 0 N--CA 1.482 1.169 0 C-N-CA 123.613 0.765 . . . . 64.329999999999998 110.965 -176.536 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 29' ' ' VAL . . . . . 0.564 ' HA ' ' HG2' ' A' ' 86' ' ' GLU . 5.4 m -124.33 72.92 58.55 Favored Pre-proline 0 CA--C 1.55 0.95 0 C-N-CA 124.099 0.96 . . . . 72.329999999999998 110.185 -178.195 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 20.7 Cg_endo -60.7 -29.64 88.76 Favored 'Trans proline' 0 C--N 1.38 2.222 0 C-N-CA 122.671 2.247 . . . . 52.509999999999998 113.107 -177.072 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 21.9 ttmm -65.33 -54.12 33.73 Favored 'General case' 0 N--CA 1.481 1.111 0 CA-C-O 121.715 0.769 . . . . 62.439999999999998 111.556 -179.428 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 20.5 m -80.16 -32.17 38.87 Favored 'General case' 0 CA--C 1.547 0.842 0 CA-C-N 114.723 -1.126 . . . . 75.420000000000002 111.138 -170.244 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 33' ' ' ALA . . . . . 0.472 ' HB1' ' HB3' ' A' ' 24' ' ' LEU . . . -70.1 -40.82 74.7 Favored 'General case' 0 N--CA 1.473 0.692 0 C-N-CA 122.787 0.435 . . . . 73.299999999999997 110.222 174.609 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 9.3 tp10 -62.77 -40.75 98.24 Favored 'General case' 0 N--CA 1.488 1.467 0 O-C-N 123.668 0.605 . . . . 61.240000000000002 110.752 176.54 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 35' ' ' ASN . . . . . 0.484 ' O ' ' HG ' ' A' ' 39' ' ' LEU . 40.0 t30 -53.57 -62.91 1.35 Allowed 'General case' 0 C--N 1.349 0.577 0 O-C-N 124.293 0.996 . . . . 75.400000000000006 110.433 178.643 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 65.6 t80 -65.53 -33.96 77.13 Favored 'General case' 0 N--CA 1.474 0.743 0 CA-C-N 115.338 -0.846 . . . . 72.519999999999996 111.805 -176.167 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 37' ' ' ARG . . . . . 0.556 ' HG3' HE22 ' A' ' 163' ' ' GLN . 32.7 ttt180 -55.21 -49.67 71.34 Favored 'General case' 0 N--CA 1.485 1.293 0 C-N-CA 124.262 1.025 . . . . 62.43 110.728 173.655 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 38' ' ' ALA . . . . . 0.457 ' HB3' HG21 ' A' ' 78' ' ' ILE . . . -76.92 -25.94 53.52 Favored 'General case' 0 CA--C 1.544 0.741 0 CA-C-N 114.314 -1.312 . . . . 61.140000000000001 112.07 -174.921 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 39' ' ' LEU . . . . . 0.484 ' HG ' ' O ' ' A' ' 35' ' ' ASN . 95.4 mt -73.39 -40.26 64.45 Favored 'General case' 0 N--CA 1.479 1.022 0 C-N-CA 123.536 0.734 . . . . 65.400000000000006 110.2 173.297 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 40.3 t -65.42 -54.74 24.29 Favored 'General case' 0 N--CA 1.479 0.984 0 CA-C-N 114.42 -1.264 . . . . 71.209999999999994 110.592 -176.144 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 82.6 p -73.3 -32.09 64.42 Favored 'General case' 0 N--CA 1.472 0.637 0 CA-C-O 121.29 0.567 . . . . 70.099999999999994 109.737 177.253 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . 0.446 ' HA3' ' HA2' ' A' ' 47' ' ' GLY . . . 75.39 8.22 83.5 Favored Glycine 0 C--N 1.347 1.186 0 CA-C-N 115.221 -0.899 . . . . 64.209999999999994 114.886 171.832 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 47.8 mm-40 -69.07 -4.59 17.69 Favored 'General case' 0 N--CA 1.482 1.146 0 C-N-CA 123.804 0.842 . . . . 64.129999999999995 113.046 -178.018 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 44' ' ' LYS . . . . . 0.451 ' HG3' ' HB1' ' A' ' 38' ' ' ALA . 32.3 mmmt -94.0 13.44 22.89 Favored 'General case' 0 CA--C 1.55 0.976 0 C-N-CA 123.565 0.746 . . . . 72.140000000000001 111.462 172.356 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 92.52 22.99 27.5 Favored Glycine 0 C--N 1.357 1.709 0 N-CA-C 114.559 0.584 . . . . 32.5 114.559 173.231 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 25.9 m-85 -114.88 -46.71 2.91 Favored 'General case' 0 N--CA 1.487 1.42 0 CA-C-N 117.507 0.654 . . . . 70.420000000000002 111.279 -172.069 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . 0.446 ' HA2' ' HA3' ' A' ' 42' ' ' GLY . . . 53.84 63.68 4.91 Favored Glycine 0 C--N 1.346 1.109 0 O-C-N 124.096 0.873 . . . . 14.42 114.64 173.084 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 50.7 m-85 -71.71 84.81 0.9 Allowed 'General case' 0 N--CA 1.485 1.282 0 CA-C-O 122.119 0.962 . . . . 74.319999999999993 111.167 177.387 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 49' ' ' LYS . . . . . 0.558 ' HE3' ' HA ' ' A' ' 160' ' ' ASP . 22.2 tptm -116.3 138.56 51.22 Favored 'General case' 0 CA--C 1.538 0.51 0 CA-C-N 113.601 -1.636 . . . . 62.140000000000001 107.603 171.851 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 69.45 19.99 74.99 Favored Glycine 0 N--CA 1.478 1.477 0 CA-C-N 118.069 0.395 . . . . 70.040000000000006 114.001 177.161 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 25.1 m -70.21 119.34 14.26 Favored 'General case' 0 N--CA 1.471 0.603 0 C-N-CA 123.614 0.765 . . . . 62.420000000000002 110.137 -176.436 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 52' ' ' CYS . . . . . . . . . . . . . 21.2 p -90.93 157.54 17.25 Favored 'General case' 0 N--CA 1.474 0.767 0 CA-C-O 121.714 0.769 . . . . 61.149999999999999 111.876 -171.518 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 29.1 m-85 -96.25 164.94 12.45 Favored 'General case' 0 C--O 1.24 0.605 0 C-N-CA 124.998 1.319 . . . . 73.450000000000003 108.741 175.515 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 19.5 p-80 -149.36 -43.09 0.14 Allowed 'General case' 0 N--CA 1.477 0.897 0 N-CA-C 110.451 -0.203 . . . . 74.439999999999998 110.451 -171.222 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 55' ' ' ARG . . . . . 0.464 ' HA ' ' O ' ' A' ' 150' ' ' GLY . 42.2 ttt-85 -121.06 98.81 6.16 Favored 'General case' 0 C--N 1.347 0.49 0 N-CA-C 109.089 -0.708 . . . . 74.230000000000004 109.089 -174.578 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 57.0 mt -127.39 127.19 68.75 Favored 'Isoleucine or valine' 0 C--O 1.239 0.527 0 N-CA-C 107.778 -1.193 . . . . 74.25 107.778 176.966 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 68.4 mt -122.44 116.41 29.52 Favored Pre-proline 0 CA--C 1.55 0.967 0 N-CA-C 108.278 -1.008 . . . . 64.129999999999995 108.278 -177.386 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 31.0 Cg_exo -62.46 136.23 57.91 Favored 'Trans proline' 0 C--N 1.379 2.145 0 C-N-CA 123.313 2.675 . . . . 73.25 112.351 -179.346 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 78.86 22.72 65.66 Favored Glycine 0 C--N 1.344 1.019 0 O-C-N 123.78 0.675 . . . . 65.109999999999999 112.767 -176.202 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 60' ' ' PHE . . . . . 0.404 ' CD2' ' HB3' ' A' ' 61' ' ' MET . 55.3 t80 -148.01 -69.26 0.23 Allowed 'General case' 0 CA--C 1.55 0.958 0 C-N-CA 123.476 0.71 . . . . 43.439999999999998 111.054 -175.058 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 61' ' ' MET . . . . . 0.433 ' SD ' ' HB2' ' A' ' 113' ' ' PHE . 40.5 ttm -175.97 158.16 1.99 Allowed 'General case' 0 N--CA 1.49 1.542 0 N-CA-C 113.245 0.832 . . . . 72.049999999999997 113.245 -159.582 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 62' ' ' CYS . . . . . 0.458 ' SG ' ' HB ' ' A' ' 114' ' ' ILE . 24.9 p -122.94 113.75 19.51 Favored 'General case' 0 CA--C 1.549 0.94 0 C-N-CA 124.197 0.999 . . . . 72.140000000000001 109.647 168.579 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 57.8 tt0 -112.72 127.48 56.15 Favored 'General case' 0 N--CA 1.489 1.485 0 C-N-CA 124.125 0.97 . . . . 75.140000000000001 110.37 -176.145 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -151.47 -157.47 7.9 Favored Glycine 0 C--N 1.348 1.214 0 CA-C-N 115.698 -0.683 . . . . 43.109999999999999 113.715 -177.476 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 86.27 -8.13 75.48 Favored Glycine 0 C--N 1.35 1.35 0 N-CA-C 112.04 -0.424 . . . . 53.219999999999999 112.04 -167.722 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 38.9 t70 -75.66 86.98 2.72 Favored 'General case' 0 C--N 1.354 0.775 0 C-N-CA 124.638 1.175 . . . . 52.229999999999997 109.925 -174.221 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 91.2 t80 -144.42 -55.09 0.34 Allowed 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 114.547 -1.206 . . . . 72.450000000000003 108.697 -176.667 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 5.7 t -84.81 122.75 29.59 Favored 'General case' 0 C--O 1.246 0.873 0 C-N-CA 123.146 0.578 . . . . 72.239999999999995 109.998 178.804 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 86.0 mtt180 53.85 51.75 14.26 Favored 'General case' 0 N--CA 1.48 1.041 0 C-N-CA 124.369 1.068 . . . . 73.010000000000005 109.851 -179.251 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 20.8 p80 -78.4 66.75 4.03 Favored 'General case' 0 CA--C 1.555 1.164 0 CA-C-O 122.32 1.057 . . . . 65.120000000000005 112.046 -168.841 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 8.3 t30 -155.08 79.46 1.05 Allowed 'General case' 0 C--O 1.24 0.596 0 N-CA-C 107.289 -1.375 . . . . 72.239999999999995 107.289 -177.213 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 72' ' ' GLY . . . . . 0.568 ' HA2' ' HG3' ' B' ' 218' ' ' PRO . . . 79.65 -6.96 56.75 Favored Glycine 0 CA--C 1.533 1.163 0 CA-C-N 115.039 -0.982 . . . . 45.219999999999999 113.838 -179.006 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 7.3 m -115.51 -78.77 0.58 Allowed 'General case' 0 CA--C 1.546 0.804 0 N-CA-C 108.132 -1.062 . . . . 71.219999999999999 108.132 -179.822 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 54.67 60.61 8.37 Favored Glycine 0 C--N 1.359 1.851 0 N-CA-C 114.59 0.596 . . . . 51.340000000000003 114.59 172.199 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 119.95 52.5 0.27 Allowed Glycine 0 N--CA 1.476 1.307 0 CA-C-N 117.716 0.758 . . . . 54.119999999999997 111.289 -175.452 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 17.4 pttp -63.08 169.61 3.3 Favored 'General case' 0 CA--C 1.547 0.828 0 C-N-CA 124.186 0.995 . . . . 73.129999999999995 112.393 -174.768 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 76.1 p -93.16 179.23 5.49 Favored 'General case' 0 C--O 1.246 0.887 0 CA-C-O 121.525 0.679 . . . . 74.209999999999994 112.254 -171.134 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 78' ' ' ILE . . . . . 0.457 HG21 ' HB3' ' A' ' 38' ' ' ALA . 34.1 pt -75.23 -20.1 16.21 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.784 0 CA-C-N 115.294 -0.867 . . . . 74.310000000000002 110.187 168.735 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 82.7 m-85 -87.93 18.49 4.14 Favored 'General case' 0 CA--C 1.547 0.832 0 C-N-CA 124.57 1.148 . . . . 64.25 110.433 177.006 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 99.02 -120.79 6.98 Favored Glycine 0 C--N 1.354 1.565 0 N-CA-C 111.071 -0.812 . . . . 74.209999999999994 111.071 -179.842 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 36.8 tt0 -71.98 -59.42 2.75 Favored 'General case' 0 N--CA 1.47 0.544 0 C-N-CA 123.265 0.626 . . . . 72.409999999999997 110.057 178.057 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 82' ' ' LYS . . . . . 0.825 ' HD2' ' HA ' ' A' ' 107' ' ' THR . 21.4 pttp -155.62 175.98 13.2 Favored 'General case' 0 CA--C 1.544 0.741 0 CA-C-N 115.372 -0.831 . . . . 73.200000000000003 110.821 -172.41 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 12.1 p90 -159.15 173.72 15.97 Favored 'General case' 0 CA--C 1.538 0.507 0 C-N-CA 124.918 1.287 . . . . 74.400000000000006 110.035 -175.063 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 84' ' ' GLU . . . . . 0.511 ' HA ' ' HA ' ' A' ' 106' ' ' ASN . 7.4 pt-20 -83.84 169.85 14.71 Favored 'General case' 0 N--CA 1.475 0.803 0 C-N-CA 123.527 0.731 . . . . 72.049999999999997 111.753 -179.864 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 41.1 m-20 -74.9 143.55 43.74 Favored 'General case' 0 N--CA 1.472 0.641 0 C-N-CA 123.739 0.816 . . . . 54.43 109.677 -179.845 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 86' ' ' GLU . . . . . 0.564 ' HG2' ' HA ' ' A' ' 29' ' ' VAL . 7.9 tp10 -66.13 -59.53 3.68 Favored 'General case' 0 N--CA 1.472 0.654 0 CA-C-O 121.769 0.795 . . . . 60.509999999999998 110.107 176.202 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 32.4 p30 -163.32 -159.83 0.56 Allowed 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 113.974 -1.466 . . . . 62.25 107.909 -179.935 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 96.2 m-85 -138.35 42.74 2.19 Favored 'General case' 0 N--CA 1.482 1.158 0 C-N-CA 122.981 0.512 . . . . 70.430000000000007 110.307 179.45 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 61.9 mt -67.59 -48.43 76.69 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.488 0 CA-C-O 121.214 0.53 . . . . 75.409999999999997 110.062 175.998 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 90' ' ' LEU . . . . . 0.561 ' HB3' ' HB ' ' A' ' 128' ' ' VAL . 82.6 mt -88.99 153.08 21.31 Favored 'General case' 0 C--O 1.241 0.632 0 CA-C-N 115.556 -0.747 . . . . 63.350000000000001 110.653 179.035 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 21.1 ptmt -150.43 168.49 24.0 Favored 'General case' 0 N--CA 1.472 0.637 0 CA-C-N 115.529 -0.76 . . . . 73.310000000000002 110.62 -179.59 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 92' ' ' HIS . . . . . . . . . . . . . 27.2 m80 -87.31 68.36 9.78 Favored 'General case' 0 CA--C 1.546 0.802 0 C-N-CA 124.035 0.934 . . . . 75.540000000000006 109.454 -172.855 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 8.8 t -114.34 7.13 16.31 Favored 'General case' 0 N--CA 1.477 0.918 0 CA-C-N 114.972 -1.013 . . . . 73.450000000000003 111.338 -172.611 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -150.2 173.75 29.79 Favored Glycine 0 C--N 1.347 1.153 0 CA-C-O 119.993 -0.337 . . . . 52.130000000000003 113.137 -176.2 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 98.2 Cg_endo -85.15 155.96 11.14 Favored 'Trans proline' 0 C--N 1.368 1.579 0 C-N-CA 123.103 2.535 . . . . 63.140000000000001 112.379 174.066 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 76.18 19.09 78.87 Favored Glycine 0 N--CA 1.476 1.301 0 CA-C-N 116.481 -0.327 . . . . 63.229999999999997 113.581 178.613 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 97' ' ' ILE . . . . . 0.555 ' HB ' ' HB2' ' A' ' 115' ' ' CYS . 13.3 mm -76.34 105.45 5.26 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.907 0 C-N-CA 123.833 0.853 . . . . 74.310000000000002 111.42 -174.872 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 60.8 tp -90.62 119.42 30.85 Favored 'General case' 0 CA--C 1.549 0.941 0 C-N-CA 123.084 0.554 . . . . 74.430000000000007 110.002 176.694 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 47.2 t -143.91 148.9 36.05 Favored 'General case' 0 CA--C 1.545 0.778 0 C-N-CA 124.388 1.075 . . . . 74.219999999999999 108.576 179.126 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 100' ' ' MET . . . . . 0.451 ' HA ' ' HA ' ' A' ' 112' ' ' PHE . 57.0 mtp -82.84 147.24 28.45 Favored 'General case' 0 N--CA 1.488 1.432 0 CA-C-N 118.201 0.455 . . . . 72.310000000000002 110.535 179.819 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -76.41 145.55 39.28 Favored 'General case' 0 C--O 1.243 0.743 0 C-N-CA 122.888 0.475 . . . . 75.129999999999995 112.169 -172.248 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 20.4 p-10 -153.89 149.22 27.1 Favored 'General case' 0 C--O 1.241 0.616 0 C-N-CA 124.292 1.037 . . . . 71.409999999999997 108.7 177.894 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -87.37 -34.41 18.81 Favored 'General case' 0 N--CA 1.474 0.732 0 N-CA-C 109.477 -0.564 . . . . 74.340000000000003 109.477 169.895 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -158.71 -166.72 18.34 Favored Glycine 0 C--N 1.342 0.909 0 CA-C-N 115.387 -0.824 . . . . 24.239999999999998 111.292 174.236 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 33.7 Cg_exo -60.78 151.28 78.05 Favored 'Trans proline' 0 C--N 1.369 1.637 0 C-N-CA 122.797 2.331 . . . . 62.399999999999999 111.847 178.357 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 106' ' ' ASN . . . . . 0.511 ' HA ' ' HA ' ' A' ' 84' ' ' GLU . 65.0 t30 65.83 16.96 10.7 Favored 'General case' 0 CA--C 1.561 1.38 0 C-N-CA 124.758 1.223 . . . . 72.200000000000003 111.343 178.78 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 107' ' ' THR . . . . . 0.825 ' HA ' ' HD2' ' A' ' 82' ' ' LYS . 5.1 m -118.89 7.19 11.46 Favored 'General case' 0 N--CA 1.485 1.286 0 C-N-CA 123.968 0.907 . . . . 70.540000000000006 110.387 179.839 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 11.1 t30 -70.71 145.77 50.31 Favored 'General case' 0 C--O 1.213 -0.851 0 C-N-CA 124.696 1.198 . . . . 70.310000000000002 110.232 177.615 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 101.29 23.36 9.68 Favored Glycine 0 N--CA 1.472 1.089 0 C-N-CA 121.66 -0.305 . . . . 72.099999999999994 113.805 177.295 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 22.8 p -132.67 120.4 21.67 Favored 'General case' 0 N--CA 1.468 0.454 0 N-CA-C 107.881 -1.155 . . . . 34.109999999999999 107.881 174.249 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 111' ' ' GLN . . . . . 0.49 HE22 ' HG2' ' B' ' 218' ' ' PRO . 16.0 mt-30 62.71 161.77 0.09 Allowed 'General case' 0 N--CA 1.492 1.632 0 C-N-CA 124.114 0.966 . . . . 74.219999999999999 111.74 -171.778 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 112' ' ' PHE . . . . . 0.451 ' HA ' ' HA ' ' A' ' 100' ' ' MET . 49.1 p90 -133.72 143.14 48.31 Favored 'General case' 0 N--CA 1.472 0.645 0 N-CA-C 108.201 -1.037 . . . . 75.109999999999999 108.201 169.054 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 113' ' ' PHE . . . . . 0.433 ' HB2' ' SD ' ' A' ' 61' ' ' MET . 50.5 p90 -129.58 148.13 51.45 Favored 'General case' 0 C--O 1.236 0.391 0 C-N-CA 123.515 0.726 . . . . 64.530000000000001 110.091 179.574 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 114' ' ' ILE . . . . . 0.458 ' HB ' ' SG ' ' A' ' 62' ' ' CYS . 21.5 mt -112.63 104.61 17.31 Favored 'Isoleucine or valine' 0 C--O 1.241 0.61 0 N-CA-C 108.486 -0.931 . . . . 55.409999999999997 108.486 175.239 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 115' ' ' CYS . . . . . 0.555 ' HB2' ' HB ' ' A' ' 97' ' ' ILE . 28.9 m -64.69 104.52 0.83 Allowed 'General case' 0 CA--C 1.542 0.656 0 N-CA-C 108.406 -0.961 . . . . 74.230000000000004 108.406 170.256 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 116' ' ' THR . . . . . 0.523 HG22 HG12 ' A' ' 139' ' ' VAL . 62.5 p -70.16 -31.78 69.43 Favored 'General case' 0 N--CA 1.472 0.632 0 C-N-CA 123.216 0.606 . . . . 71.010000000000005 110.296 -179.522 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -115.62 170.99 8.02 Favored 'General case' 0 C--O 1.243 0.745 0 C-N-CA 124.012 0.925 . . . . 74.230000000000004 109.72 175.292 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 19.3 ptmt -72.01 92.09 1.27 Allowed 'General case' 0 CA--C 1.554 1.11 0 CA-C-O 121.804 0.811 . . . . 65.129999999999995 110.019 175.253 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 119' ' ' THR . . . . . 0.574 ' HB ' HD13 ' A' ' 122' ' ' LEU . 46.7 p -85.64 83.63 7.83 Favored 'General case' 0 CA--C 1.546 0.817 0 CA-C-O 121.813 0.816 . . . . 73.450000000000003 109.182 179.766 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 10.2 pt-20 -75.91 -30.13 58.65 Favored 'General case' 0 N--CA 1.482 1.148 0 CA-C-N 115.524 -0.762 . . . . 75.219999999999999 112.38 -167.086 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 121' ' ' TRP . . . . . . . . . . . . . 39.0 p90 -69.19 -4.78 18.96 Favored 'General case' 0 CA--C 1.553 1.07 0 C-N-CA 123.713 0.805 . . . . 74.510000000000005 111.624 178.03 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 122' ' ' LEU . . . . . 0.574 HD13 ' HB ' ' A' ' 119' ' ' THR . 10.8 mp -87.27 2.39 50.29 Favored 'General case' 0 N--CA 1.482 1.169 0 C-N-CA 124.055 0.942 . . . . 43.450000000000003 112.485 174.695 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 78.4 m-20 -78.01 124.54 28.15 Favored 'General case' 0 N--CA 1.477 0.907 0 CA-C-N 118.427 0.558 . . . . 72.010000000000005 109.668 177.716 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 112.09 -11.11 26.93 Favored Glycine 0 C--N 1.351 1.369 0 CA-C-N 115.497 -0.774 . . . . 63.340000000000003 111.621 -165.027 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 28.7 mtpp -90.83 -165.09 1.28 Allowed 'General case' 0 N--CA 1.486 1.341 0 C-N-CA 124.19 0.996 . . . . 74.430000000000007 109.665 169.728 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 126' ' ' HIS . . . . . . . . . . . . . 22.8 t60 -66.34 136.22 55.48 Favored 'General case' 0 CA--C 1.549 0.912 0 CA-C-O 121.35 0.595 . . . . 62.409999999999997 111.1 -178.815 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 7.1 p -59.15 147.97 7.43 Favored 'Isoleucine or valine' 0 CA--C 1.551 1.011 0 CA-C-N 113.976 -1.465 . . . . 54.049999999999997 111.726 178.03 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 128' ' ' VAL . . . . . 0.561 ' HB ' ' HB3' ' A' ' 90' ' ' LEU . 24.9 t -68.28 157.78 6.16 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.967 0 C-N-CA 123.482 0.713 . . . . 42.109999999999999 109.664 175.841 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 129' ' ' PHE . . . . . . . . . . . . . 49.1 p90 -138.9 -24.17 0.91 Allowed 'General case' 0 N--CA 1.478 0.971 0 C-N-CA 122.039 0.136 . . . . 74.219999999999999 111.127 174.189 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . -130.11 161.78 23.07 Favored Glycine 0 C--N 1.346 1.095 0 N-CA-C 112.242 -0.343 . . . . 31.100000000000001 112.242 -174.563 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 131' ' ' LYS . . . . . 0.432 ' HE2' ' HB3' ' A' ' 131' ' ' LYS . 31.2 ttpt -146.6 128.49 15.41 Favored 'General case' 0 N--CA 1.466 0.356 0 C-N-CA 123.689 0.796 . . . . 74.530000000000001 108.991 179.758 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 34.0 t -70.55 101.12 0.78 Allowed 'Isoleucine or valine' 0 CA--C 1.542 0.653 0 N-CA-C 109.282 -0.636 . . . . 63.039999999999999 109.282 177.807 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 133' ' ' LYS . . . . . 0.631 ' HD2' ' HB2' ' A' ' 23' ' ' GLU . 18.6 ptmt -87.81 -36.77 17.07 Favored 'General case' 0 N--CA 1.474 0.725 0 CA-C-N 115.615 -0.72 . . . . 74.230000000000004 109.781 -179.669 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 134' ' ' GLU . . . . . 0.524 ' HG2' ' HG3' ' A' ' 133' ' ' LYS . 30.8 mm-40 -124.23 144.93 49.67 Favored 'General case' 0 N--CA 1.472 0.648 0 C-N-CA 124.226 1.011 . . . . 75.230000000000004 108.8 176.706 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 78.47 21.45 69.58 Favored Glycine 0 N--CA 1.467 0.722 0 CA-C-O 119.582 -0.566 . . . . 53.340000000000003 113.375 175.037 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 136' ' ' MET . . . . . . . . . . . . . 16.3 tpt -62.34 -38.1 88.18 Favored 'General case' 0 N--CA 1.481 1.102 0 C-N-CA 123.042 0.537 . . . . 75.540000000000006 111.081 174.887 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 137' ' ' ASN . . . . . . . . . . . . . 16.3 m120 -64.29 -29.8 70.88 Favored 'General case' 0 CA--C 1.545 0.786 0 C-N-CA 122.937 0.495 . . . . 70.319999999999993 110.897 176.229 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 138' ' ' ILE . . . . . . . . . . . . . 46.8 mm -73.86 -36.1 44.73 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.039 0 C-N-CA 123.156 0.583 . . . . 73.209999999999994 110.153 175.797 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 139' ' ' VAL . . . . . 0.523 HG12 HG22 ' A' ' 116' ' ' THR . 91.8 t -65.91 -40.31 87.1 Favored 'Isoleucine or valine' 0 CA--C 1.555 1.149 0 C-N-CA 123.361 0.665 . . . . 73.129999999999995 110.674 178.112 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 44.1 mt-10 -74.03 -29.08 61.74 Favored 'General case' 0 N--CA 1.477 0.917 0 CA-C-N 115.64 -0.709 . . . . 75.150000000000006 110.622 177.209 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -70.86 -43.36 68.63 Favored 'General case' 0 N--CA 1.478 0.938 0 C-N-CA 122.902 0.481 . . . . 64.230000000000004 111.15 176.064 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 142' ' ' MET . . . . . 0.581 ' HB2' HD13 ' A' ' 156' ' ' ILE . 25.2 ptm -72.92 -28.05 62.22 Favored 'General case' 0 N--CA 1.477 0.878 0 C-N-CA 123.074 0.55 . . . . 72.510000000000005 111.315 -178.132 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 34.0 tt0 -59.98 -32.55 70.94 Favored 'General case' 0 C--N 1.357 0.897 0 O-C-N 123.597 0.561 . . . . 72.420000000000002 111.937 178.352 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 144' ' ' ARG . . . . . . . . . . . . . 38.6 mtm-85 -67.45 -18.79 65.22 Favored 'General case' 0 N--CA 1.477 0.882 0 C-N-CA 123.038 0.535 . . . . 73.230000000000004 111.986 -178.363 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 145' ' ' PHE . . . . . 0.522 ' HB2' HD11 ' A' ' 156' ' ' ILE . 45.2 m-85 -83.01 -5.57 59.15 Favored 'General case' 0 N--CA 1.477 0.896 0 C-N-CA 122.871 0.469 . . . . 74.340000000000003 111.412 177.185 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . -87.23 175.15 46.04 Favored Glycine 0 C--N 1.347 1.188 0 O-C-N 123.444 0.465 . . . . 61.219999999999999 112.12 172.436 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 29.7 m -134.75 169.49 17.27 Favored 'General case' 0 N--CA 1.483 1.209 0 C-N-CA 123.392 0.677 . . . . 73.200000000000003 111.59 -174.445 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 148' ' ' ARG . . . . . . . . . . . . . 8.7 mmm180 -57.59 -41.26 80.82 Favored 'General case' 0 N--CA 1.487 1.383 0 C-N-CA 124.81 1.244 . . . . 73.010000000000005 113.065 179.927 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 149' ' ' ASN . . . . . . . . . . . . . 30.5 p-10 -75.24 -17.69 60.27 Favored 'General case' 0 N--CA 1.478 0.945 0 C-N-CA 122.958 0.503 . . . . 73.030000000000001 111.238 178.191 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 150' ' ' GLY . . . . . 0.464 ' O ' ' HA ' ' A' ' 55' ' ' ARG . . . 111.65 -10.2 28.0 Favored Glycine 0 C--N 1.348 1.222 0 O-C-N 123.706 0.629 . . . . 64.450000000000003 112.378 -179.554 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 25.1 ttmm -65.55 137.64 57.52 Favored 'General case' 0 N--CA 1.471 0.624 0 C-N-CA 122.875 0.47 . . . . 74.409999999999997 111.177 -175.765 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 152' ' ' THR . . . . . . . . . . . . . 41.1 p -90.42 109.76 20.88 Favored 'General case' 0 C--O 1.239 0.516 0 N-CA-C 108.198 -1.038 . . . . 63.450000000000003 108.198 174.493 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 153' ' ' SER . . . . . . . . . . . . . 19.3 m -62.56 -29.36 70.52 Favored 'General case' 0 CA--C 1.544 0.75 0 C-N-CA 124.039 0.936 . . . . 71.329999999999998 110.804 176.172 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 154' ' ' LYS . . . . . 0.541 ' HB3' HG13 ' A' ' 12' ' ' VAL . 48.1 mmtm -118.63 133.92 55.5 Favored 'General case' 0 CA--C 1.54 0.561 0 CA-C-N 114.609 -1.178 . . . . 64.329999999999998 108.832 175.281 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 16.9 tppt? -78.99 91.68 4.87 Favored 'General case' 0 N--CA 1.473 0.689 0 N-CA-C 109.627 -0.509 . . . . 71.129999999999995 109.627 -178.272 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 156' ' ' ILE . . . . . 0.581 HD13 ' HB2' ' A' ' 142' ' ' MET . 70.5 mt -84.92 117.14 29.66 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.357 0 N-CA-C 109.835 -0.431 . . . . 74.329999999999998 109.835 -175.242 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 157' ' ' THR . . . . . . . . . . . . . 54.8 p -115.91 156.34 26.36 Favored 'General case' 0 N--CA 1.473 0.707 0 C-N-CA 124.232 1.013 . . . . 55.350000000000001 110.015 -179.126 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 158' ' ' ILE . . . . . . . . . . . . . 63.7 mt -80.6 96.0 2.68 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.819 0 N-CA-C 108.283 -1.006 . . . . 73.420000000000002 108.283 169.786 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 159' ' ' ALA . . . . . 0.655 ' HB2' ' HB2' ' A' ' 11' ' ' ALA . . . -55.55 -53.14 60.09 Favored 'General case' 0 N--CA 1.478 0.939 0 C-N-CA 124.331 1.053 . . . . 62.420000000000002 111.784 -178.177 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 160' ' ' ASP . . . . . 0.558 ' HA ' ' HE3' ' A' ' 49' ' ' LYS . 0.9 OUTLIER -140.17 175.21 9.78 Favored 'General case' 0 N--CA 1.473 0.724 0 CA-C-N 115.798 -0.637 . . . . 71.510000000000005 110.405 -176.509 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 161' ' ' CYS . . . . . . . . . . . . . 63.2 m -146.23 -169.82 3.35 Favored 'General case' 0 CA--C 1.547 0.852 0 C-N-CA 125.147 1.379 . . . . 55.100000000000001 108.4 -172.674 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 162' ' ' GLY . . . . . . . . . . . . . . . 131.71 53.26 0.09 OUTLIER Glycine 0 C--N 1.348 1.216 0 N-CA-C 112.151 -0.38 . . . . 64.430000000000007 112.151 -177.836 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 163' ' ' GLN . . . . . 0.706 ' HG3' ' HA ' ' A' ' 6' ' ' VAL . 43.4 tt0 -46.21 110.53 0.28 Allowed 'General case' 0 N--CA 1.48 1.032 0 C-N-CA 125.035 1.334 . . . . 75.319999999999993 112.392 -177.349 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 164' ' ' LEU . . . . . 0.445 ' O ' ' HB ' ' A' ' 5' ' ' THR . 45.3 mt . . . . . 0 CA--C 1.543 0.704 0 N-CA-C 108.63 -0.878 . . . . 71.25 108.63 -179.357 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 218' ' ' PRO . . . . . 0.568 ' HG3' ' HA2' ' A' ' 72' ' ' GLY . 45.7 Cg_endo . . . . . 0 CA--C 1.544 0.977 0 N-CA-C 109.973 -0.818 . . . . 72.409999999999997 109.973 . . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 219' ' ' GLY . . . . . . . . . . . . . . . 147.16 -161.42 28.47 Favored Glycine 0 CA--C 1.527 0.791 0 CA-C-N 114.71 -1.132 . . . . 71.030000000000001 111.492 -171.489 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 220' ' ' PRO . . . . . . . . . . . . . 64.0 Cg_endo -91.03 168.87 3.56 Favored 'Trans proline' 0 C--N 1.363 1.298 0 C-N-CA 123.412 2.742 . . . . 63.399999999999999 114.677 -176.644 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 221' ' ' TYR . . . . . . . . . . . . . 88.0 t80 . . . . . 0 N--CA 1.484 1.248 0 C-N-CA 123.538 0.735 . . . . 74.409999999999997 109.184 169.921 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 15.3 m120 . . . . . 0 CA--C 1.549 0.911 0 CA-C-O 119.181 -0.438 . . . . 73.540000000000006 111.429 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 4' ' ' PRO . . . . . 0.589 ' HG2' ' HB2' ' A' ' 24' ' ' LEU . 29.7 Cg_endo -65.06 123.42 11.55 Favored 'Trans proline' 0 C--N 1.379 2.18 0 C-N-CA 122.356 2.037 . . . . 65.510000000000005 110.298 170.694 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 5' ' ' THR . . . . . 0.62 HG23 ' HD3' ' A' ' 133' ' ' LYS . 99.3 m -96.48 119.39 34.89 Favored 'General case' 0 C--N 1.328 -0.351 0 N-CA-C 108.743 -0.836 . . . . 70.310000000000002 108.743 -174.811 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 32.1 m -102.77 123.66 56.28 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.646 0 N-CA-C 109.772 -0.455 . . . . 73.310000000000002 109.772 -177.694 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 7' ' ' PHE . . . . . 0.589 ' H ' ' HA ' ' A' ' 163' ' ' GLN . 76.7 t80 -109.89 130.16 55.56 Favored 'General case' 0 N--CA 1.47 0.543 0 C-N-CA 123.307 0.643 . . . . 73.129999999999995 109.849 -174.398 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 8' ' ' PHE . . . . . 0.456 ' HB3' HG23 ' A' ' 158' ' ' ILE . 36.9 m-85 -135.31 165.64 24.98 Favored 'General case' 0 N--CA 1.472 0.649 0 C-N-CA 124.604 1.162 . . . . 71.209999999999994 109.449 173.485 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 18.5 m-20 -120.15 115.08 22.94 Favored 'General case' 0 N--CA 1.467 0.423 0 C-N-CA 124.456 1.102 . . . . 71.0 108.544 171.532 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 10' ' ' ILE . . . . . 0.531 HG21 ' SD ' ' A' ' 142' ' ' MET . 44.3 mm -83.85 132.45 31.47 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.562 0 C-N-CA 123.611 0.764 . . . . 64.109999999999999 108.98 178.98 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 11' ' ' ALA . . . . . 0.408 ' O ' ' HA ' ' A' ' 156' ' ' ILE . . . -139.72 135.49 33.2 Favored 'General case' 0 N--CA 1.465 0.299 0 C-N-CA 122.561 0.345 . . . . 73.219999999999999 111.799 -171.984 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 14.6 m -96.03 113.77 31.2 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.682 0 C-N-CA 124.703 1.201 . . . . 61.229999999999997 109.487 179.752 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 54.8 m-20 63.35 20.43 12.26 Favored 'General case' 0 N--CA 1.489 1.521 0 C-N-CA 125.039 1.336 . . . . 71.349999999999994 110.987 -170.262 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 89.44 -6.4 83.29 Favored Glycine 0 C--N 1.348 1.244 0 CA-C-N 116.225 -0.443 . . . . 61.210000000000001 113.258 -174.774 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 27.2 mm-40 -86.51 125.99 65.7 Favored Pre-proline 0 CA--C 1.548 0.871 0 C-N-CA 123.39 0.676 . . . . 74.140000000000001 110.305 179.356 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 18.0 Cg_endo -52.64 101.85 0.06 OUTLIER 'Trans proline' 0 C--N 1.386 2.536 0 C-N-CA 124.168 3.245 . . . . 74.109999999999999 113.996 -170.475 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 53.1 tp -79.19 -35.87 41.14 Favored 'General case' 0 N--CA 1.479 1.003 0 N-CA-C 109.261 -0.644 . . . . 52.399999999999999 109.261 175.454 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 166.21 -173.82 41.73 Favored Glycine 0 C--N 1.337 0.614 0 CA-C-N 115.153 -0.93 . . . . 61.43 111.563 176.817 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 47.7 ptt85 -110.59 141.75 43.36 Favored 'General case' 0 C--O 1.239 0.51 0 C-N-CA 123.983 0.913 . . . . 75.540000000000006 109.255 177.51 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 93.7 t -134.88 121.2 33.32 Favored 'Isoleucine or valine' 0 C--O 1.239 0.504 0 C-N-CA 123.633 0.773 . . . . 52.219999999999999 109.253 175.202 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 21' ' ' SER . . . . . 0.478 ' HB3' ' HB2' ' A' ' 134' ' ' GLU . 22.8 t -115.1 136.99 52.52 Favored 'General case' 0 CA--C 1.539 0.548 0 N-CA-C 108.48 -0.933 . . . . 72.450000000000003 108.48 174.516 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 41.8 m-85 -109.69 169.14 8.9 Favored 'General case' 0 N--CA 1.472 0.668 0 C-N-CA 123.675 0.79 . . . . 61.219999999999999 110.235 177.684 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 23' ' ' GLU . . . . . 0.624 ' HB2' ' HD2' ' A' ' 133' ' ' LYS . 37.4 tt0 -122.22 103.7 8.95 Favored 'General case' 0 CA--C 1.538 0.503 0 C-N-CA 125.581 1.552 . . . . 75.010000000000005 107.938 -176.953 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . 0.589 ' HB2' ' HG2' ' A' ' 4' ' ' PRO . 18.4 mt -82.99 124.51 30.47 Favored 'General case' 0 N--CA 1.474 0.761 0 N-CA-C 109.454 -0.572 . . . . 61.32 109.454 -179.279 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 68.2 m-85 -86.6 69.37 10.35 Favored 'General case' 0 CA--C 1.534 0.357 0 C-N-CA 123.324 0.65 . . . . 74.0 109.38 179.292 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -64.65 -20.09 66.09 Favored 'General case' 0 N--CA 1.484 1.225 0 C-N-CA 123.553 0.741 . . . . 53.340000000000003 111.727 179.763 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 12.0 p-10 -74.67 -23.18 58.6 Favored 'General case' 0 CA--C 1.545 0.754 0 C-N-CA 124.308 1.043 . . . . 72.310000000000002 112.163 177.708 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 58.7 mttp -105.91 -41.54 5.38 Favored 'General case' 0 N--CA 1.486 1.328 0 C-N-CA 123.757 0.823 . . . . 62.149999999999999 111.245 -179.056 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 29' ' ' VAL . . . . . 0.585 HG12 ' HG2' ' A' ' 86' ' ' GLU . 10.7 m -138.26 74.25 42.3 Favored Pre-proline 0 CA--C 1.56 1.33 0 C-N-CA 124.445 1.098 . . . . 74.019999999999996 109.873 -172.552 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 59.2 Cg_endo -67.51 -37.97 15.76 Favored 'Trans proline' 0 C--N 1.377 2.067 0 C-N-CA 122.961 2.441 . . . . 73.040000000000006 113.383 -171.47 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 48.1 tttp -73.86 -42.09 61.3 Favored 'General case' 0 N--CA 1.478 0.95 0 C-N-CA 123.669 0.788 . . . . 73.219999999999999 110.907 -173.507 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 11.3 m -73.21 -36.98 66.59 Favored 'General case' 0 CA--C 1.547 0.832 0 CA-C-N 115.728 -0.669 . . . . 65.349999999999994 110.406 -177.707 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -67.11 -41.68 85.82 Favored 'General case' 0 CA--C 1.55 0.948 0 C-N-CA 123.053 0.541 . . . . 75.109999999999999 110.684 173.71 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 38.5 tt0 -59.92 -42.19 93.37 Favored 'General case' 0 N--CA 1.483 1.22 0 C-N-CA 124.655 1.182 . . . . 72.430000000000007 111.462 -179.428 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 35' ' ' ASN . . . . . 0.469 ' O ' ' HG ' ' A' ' 39' ' ' LEU . 47.7 t30 -56.92 -68.02 0.26 Allowed 'General case' 0 C--N 1.358 0.961 0 O-C-N 124.322 1.014 . . . . 64.239999999999995 110.266 -177.196 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 90.6 t80 -57.62 -40.7 79.74 Favored 'General case' 0 N--CA 1.474 0.734 0 O-C-N 124.315 1.009 . . . . 73.340000000000003 111.683 -175.683 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 71.5 ttt180 -58.3 -54.88 42.0 Favored 'General case' 0 C--N 1.354 0.802 0 O-C-N 123.719 0.637 . . . . 70.239999999999995 110.456 178.564 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 38' ' ' ALA . . . . . 0.448 ' HB3' HG21 ' A' ' 78' ' ' ILE . . . -64.76 -30.09 71.09 Favored 'General case' 0 N--CA 1.475 0.815 0 C-N-CA 123.616 0.766 . . . . 34.439999999999998 111.656 -175.099 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 39' ' ' LEU . . . . . 0.588 ' HB3' ' HD2' ' A' ' 48' ' ' TYR . 89.8 mt -63.11 -46.0 89.37 Favored 'General case' 0 N--CA 1.471 0.613 0 C-N-CA 123.545 0.738 . . . . 74.140000000000001 110.29 173.604 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 50.7 m -74.35 -39.1 63.01 Favored 'General case' 0 CA--C 1.547 0.843 0 C-N-CA 123.494 0.717 . . . . 72.140000000000001 112.018 -173.275 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -75.8 -30.81 59.2 Favored 'General case' 0 N--CA 1.482 1.15 0 C-N-CA 122.582 0.353 . . . . 62.210000000000001 110.581 178.195 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 84.87 32.45 21.19 Favored Glycine 0 C--N 1.347 1.152 0 CA-C-N 115.98 -0.555 . . . . 70.340000000000003 111.795 -174.432 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 5.2 mm-40 -63.65 -25.34 68.17 Favored 'General case' 0 N--CA 1.481 1.108 0 C-N-CA 123.565 0.746 . . . . 72.140000000000001 110.519 175.042 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 44' ' ' LYS . . . . . 0.458 ' HG3' ' HB ' ' A' ' 78' ' ' ILE . 29.2 mmmt -110.75 19.08 18.97 Favored 'General case' 0 CA--C 1.547 0.842 0 C-N-CA 124.2 1.0 . . . . 53.520000000000003 110.922 -178.999 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 78.88 -0.23 78.94 Favored Glycine 0 C--N 1.355 1.6 0 N-CA-C 115.05 0.78 . . . . 61.240000000000002 115.05 174.616 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 20.2 m-85 -85.62 -47.84 9.46 Favored 'General case' 0 N--CA 1.48 1.041 0 CA-C-N 117.785 0.793 . . . . 53.240000000000002 111.074 -174.181 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 49.66 62.64 4.7 Favored Glycine 0 C--N 1.355 1.619 0 O-C-N 124.358 1.036 . . . . 74.120000000000005 113.83 174.937 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 48' ' ' TYR . . . . . 0.588 ' HD2' ' HB3' ' A' ' 39' ' ' LEU . 35.5 m-85 -65.56 90.42 0.11 Allowed 'General case' 0 N--CA 1.474 0.759 0 CA-C-O 122.109 0.957 . . . . 73.409999999999997 111.773 -176.309 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 49' ' ' LYS . . . . . 0.595 ' HE3' ' HA ' ' A' ' 160' ' ' ASP . 24.1 tptm -109.88 131.25 55.23 Favored 'General case' 0 C--O 1.238 0.486 0 CA-C-N 113.686 -1.597 . . . . 64.209999999999994 108.53 179.939 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 79.95 20.36 68.05 Favored Glycine 0 C--N 1.346 1.137 0 CA-C-O 119.85 -0.417 . . . . 60.109999999999999 113.203 -179.464 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 39.0 t -60.69 126.75 28.57 Favored 'General case' 0 N--CA 1.479 1.021 0 C-N-CA 123.907 0.883 . . . . 72.140000000000001 110.243 179.39 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 52' ' ' CYS . . . . . . . . . . . . . 26.8 p -97.92 120.52 38.45 Favored 'General case' 0 N--CA 1.475 0.783 0 O-C-N 123.618 0.574 . . . . 74.439999999999998 111.933 -168.517 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 53' ' ' PHE . . . . . 0.749 ' HA ' ' HA2' ' A' ' 64' ' ' GLY . 82.3 m-85 -67.55 92.72 0.32 Allowed 'General case' 0 CA--C 1.536 0.442 0 C-N-CA 123.759 0.824 . . . . 61.100000000000001 108.884 166.894 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 26.2 p-80 -101.09 -9.81 21.04 Favored 'General case' 0 N--CA 1.475 0.795 0 CA-C-N 114.922 -1.035 . . . . 63.049999999999997 111.881 -172.215 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 37.8 ttt180 -132.28 98.99 4.55 Favored 'General case' 0 N--CA 1.472 0.628 0 N-CA-C 108.952 -0.759 . . . . 71.030000000000001 108.952 177.712 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 53.7 mt -128.12 130.95 69.75 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.82 0 N-CA-C 109.367 -0.605 . . . . 73.340000000000003 109.367 176.167 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 59.5 mt -125.12 124.85 25.33 Favored Pre-proline 0 CA--C 1.558 1.268 0 C-N-CA 124.172 0.989 . . . . 71.310000000000002 108.851 175.132 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 24.3 Cg_endo -60.37 151.13 76.55 Favored 'Trans proline' 0 C--N 1.385 2.499 0 C-N-CA 123.6 2.867 . . . . 73.329999999999998 113.795 -177.541 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 61.44 16.03 48.31 Favored Glycine 0 C--N 1.348 1.24 0 CA-C-N 114.963 -1.017 . . . . 62.439999999999998 114.086 179.715 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 36.3 t80 -137.28 -73.6 0.42 Allowed 'General case' 0 C--O 1.239 0.55 0 C-N-CA 123.274 0.63 . . . . 71.400000000000006 110.297 -171.735 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 51.4 ttp -171.05 138.43 1.28 Allowed 'General case' 0 N--CA 1.475 0.822 0 O-C-N 123.095 0.247 . . . . 54.229999999999997 111.567 -164.018 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 62' ' ' CYS . . . . . 0.563 ' SG ' ' HB ' ' A' ' 114' ' ' ILE . 21.9 p -108.03 110.85 22.65 Favored 'General case' 0 CA--C 1.548 0.881 0 C-N-CA 123.577 0.751 . . . . 71.450000000000003 109.266 168.017 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 63' ' ' GLN . . . . . 0.464 ' HA ' ' HA ' ' A' ' 113' ' ' PHE . 52.0 tt0 -102.71 118.59 37.16 Favored 'General case' 0 N--CA 1.48 1.067 0 C-N-CA 124.353 1.061 . . . . 64.319999999999993 110.464 -175.172 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 64' ' ' GLY . . . . . 0.749 ' HA2' ' HA ' ' A' ' 53' ' ' PHE . . . -95.81 165.49 24.49 Favored Glycine 0 C--N 1.342 0.884 0 CA-C-N 115.262 -0.881 . . . . 43.25 112.842 177.292 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 65' ' ' GLY . . . . . 0.419 ' HA3' ' HG2' ' A' ' 111' ' ' GLN . . . 177.19 133.04 1.76 Allowed Glycine 0 C--N 1.337 0.591 0 N-CA-C 111.922 -0.471 . . . . 44.329999999999998 111.922 179.286 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 22.6 t70 -75.78 170.3 16.47 Favored 'General case' 0 CA--C 1.551 0.993 0 C-N-CA 123.437 0.695 . . . . 74.109999999999999 110.867 -176.137 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 74.2 t80 -69.8 -25.78 63.95 Favored 'General case' 0 CA--C 1.553 1.071 0 C-N-CA 123.435 0.694 . . . . 71.310000000000002 111.285 176.547 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 63.4 m -63.37 109.48 1.61 Allowed 'General case' 0 N--CA 1.478 0.947 0 C-N-CA 123.415 0.686 . . . . 74.310000000000002 110.782 179.519 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 58.4 mtt180 59.63 34.52 22.27 Favored 'General case' 0 N--CA 1.479 0.997 0 C-N-CA 125.068 1.347 . . . . 73.140000000000001 111.435 -176.597 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 36.8 p-80 -55.42 -20.31 11.85 Favored 'General case' 0 N--CA 1.497 1.918 0 C-N-CA 123.558 0.743 . . . . 72.340000000000003 112.886 -172.43 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 5.1 t30 -66.08 87.28 0.1 Allowed 'General case' 0 CA--C 1.554 1.109 0 C-N-CA 124.257 1.023 . . . . 75.340000000000003 109.827 167.956 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 76.41 -7.2 32.8 Favored Glycine 0 CA--C 1.535 1.321 0 N-CA-C 115.805 1.082 . . . . 34.25 115.805 172.097 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 73' ' ' THR . . . . . 0.6 ' HA ' ' HB2' ' A' ' 110' ' ' SER . 79.2 m -118.09 -65.84 1.14 Allowed 'General case' 0 N--CA 1.479 0.997 0 CA-C-N 118.598 1.199 . . . . 73.439999999999998 110.843 -178.861 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 49.76 54.42 17.78 Favored Glycine 0 C--N 1.356 1.655 0 O-C-N 123.838 0.711 . . . . 31.43 114.379 172.967 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 127.07 55.37 0.14 Allowed Glycine 0 N--CA 1.469 0.895 0 C-N-CA 120.964 -0.636 . . . . 71.409999999999997 111.778 -172.449 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 76' ' ' LYS . . . . . 0.557 ' HG2' ' OH ' ' A' ' 48' ' ' TYR . 14.8 ptmm? -52.4 164.38 0.33 Allowed 'General case' 0 N--CA 1.49 1.54 0 C-N-CA 124.117 0.967 . . . . 74.430000000000007 111.915 178.584 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 94.9 p -88.95 175.38 7.45 Favored 'General case' 0 C--O 1.247 0.938 0 CA-C-O 121.214 0.53 . . . . 53.009999999999998 110.441 -171.981 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 78' ' ' ILE . . . . . 0.458 ' HB ' ' HG3' ' A' ' 44' ' ' LYS . 38.6 pt -74.64 -24.82 18.65 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.654 0 CA-C-N 115.344 -0.843 . . . . 60.420000000000002 110.757 179.726 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 51.0 m-85 -86.93 -43.34 12.47 Favored 'General case' 0 N--CA 1.476 0.865 0 C-N-CA 123.713 0.805 . . . . 71.439999999999998 110.337 -178.866 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -165.69 -134.79 1.73 Allowed Glycine 0 C--N 1.339 0.745 0 N-CA-C 110.539 -1.024 . . . . 74.150000000000006 110.539 -179.098 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 81' ' ' GLU . . . . . 0.529 ' HA ' ' HB2' ' A' ' 76' ' ' LYS . 36.6 tt0 -75.38 -36.8 60.86 Favored 'General case' 0 N--CA 1.477 0.879 0 CA-C-N 117.498 0.649 . . . . 64.329999999999998 109.734 175.293 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 82' ' ' LYS . . . . . 0.749 ' HD2' ' HA ' ' A' ' 107' ' ' THR . 19.7 pttp -159.62 166.58 30.37 Favored 'General case' 0 CA--C 1.544 0.732 0 C-N-CA 124.343 1.057 . . . . 62.119999999999997 109.309 -170.189 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 11.8 p90 -143.92 174.31 10.95 Favored 'General case' 0 N--CA 1.473 0.723 0 C-N-CA 124.064 0.945 . . . . 73.540000000000006 109.111 179.112 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 84' ' ' GLU . . . . . 0.414 ' HA ' ' HA ' ' A' ' 106' ' ' ASN . 11.7 pt-20 -79.19 -175.71 4.77 Favored 'General case' 0 CA--C 1.545 0.775 0 C-N-CA 123.519 0.728 . . . . 74.329999999999998 112.083 -178.521 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 30.5 m-20 -85.35 149.51 25.39 Favored 'General case' 0 N--CA 1.475 0.809 0 C-N-CA 123.428 0.691 . . . . 62.130000000000003 109.93 -176.672 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 86' ' ' GLU . . . . . 0.585 ' HG2' HG12 ' A' ' 29' ' ' VAL . 3.2 tp10 -77.53 -61.74 1.89 Allowed 'General case' 0 N--CA 1.478 0.957 0 C-N-CA 123.263 0.625 . . . . 54.439999999999998 110.54 175.594 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 29.9 p30 -173.57 -156.82 0.08 Allowed 'General case' 0 N--CA 1.475 0.806 0 C-N-CA 125.192 1.397 . . . . 74.219999999999999 107.413 -172.826 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 82.2 m-85 -142.04 39.18 1.62 Allowed 'General case' 0 N--CA 1.494 1.729 0 C-N-CA 123.245 0.618 . . . . 65.530000000000001 110.824 176.952 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 70.5 mt -65.01 -62.94 1.0 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.483 0 CA-C-O 121.312 0.577 . . . . 64.030000000000001 110.423 178.602 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 90' ' ' LEU . . . . . 0.409 ' H ' HG23 ' A' ' 127' ' ' VAL . 87.4 mt -86.9 135.82 33.18 Favored 'General case' 0 N--CA 1.47 0.547 0 C-N-CA 124.304 1.042 . . . . 74.400000000000006 110.643 -176.402 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 54.3 mtmt -118.89 160.02 22.71 Favored 'General case' 0 N--CA 1.473 0.723 0 C-N-CA 123.88 0.872 . . . . 71.140000000000001 111.072 -177.871 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 92' ' ' HIS . . . . . 0.534 ' HA ' HG21 ' A' ' 97' ' ' ILE . 13.6 m80 -83.25 21.14 1.16 Allowed 'General case' 0 N--CA 1.481 1.099 0 C-N-CA 124.777 1.231 . . . . 70.219999999999999 111.664 -174.436 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 11.4 t -86.74 31.32 0.69 Allowed 'General case' 0 CA--C 1.56 1.345 0 C-N-CA 124.259 1.024 . . . . 64.430000000000007 111.237 -170.562 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -151.14 162.38 29.44 Favored Glycine 0 C--N 1.348 1.208 0 N-CA-C 111.705 -0.558 . . . . 33.109999999999999 111.705 176.404 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 73.3 Cg_endo -75.96 145.53 28.37 Favored 'Trans proline' 0 C--N 1.369 1.615 0 C-N-CA 122.689 2.259 . . . . 71.329999999999998 112.292 173.757 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 96' ' ' GLY . . . . . 0.523 ' HA3' HG12 ' A' ' 132' ' ' VAL . . . 79.76 17.85 74.26 Favored Glycine 0 C--N 1.345 1.058 0 CA-C-N 116.078 -0.51 . . . . 53.310000000000002 114.334 177.475 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 97' ' ' ILE . . . . . 0.534 HG21 ' HA ' ' A' ' 92' ' ' HIS . 8.3 mm -71.41 124.25 27.43 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.893 0 C-N-CA 124.236 1.014 . . . . 63.210000000000001 110.757 178.963 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 63.2 tp -108.56 115.34 29.92 Favored 'General case' 0 N--CA 1.484 1.273 0 C-N-CA 123.53 0.732 . . . . 62.420000000000002 110.355 179.059 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 18.5 m -133.78 144.5 49.08 Favored 'General case' 0 N--CA 1.48 1.06 0 C-N-CA 124.632 1.173 . . . . 73.129999999999995 108.641 174.123 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 100' ' ' MET . . . . . 0.647 ' HA ' ' HA ' ' A' ' 112' ' ' PHE . 72.6 mtp -78.7 137.22 37.69 Favored 'General case' 0 N--CA 1.488 1.471 0 CA-C-N 118.412 0.551 . . . . 73.219999999999999 110.008 178.786 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 101' ' ' ALA . . . . . 0.477 ' HB3' ' HB2' ' A' ' 111' ' ' GLN . . . -72.32 168.78 17.64 Favored 'General case' 0 N--CA 1.481 1.088 0 C-N-CA 123.109 0.564 . . . . 55.149999999999999 111.981 -170.803 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 102' ' ' ASN . . . . . 0.57 ' HB3' ' HA ' ' A' ' 108' ' ' ASN . 29.4 p-10 -168.04 179.16 4.74 Favored 'General case' 0 CA--C 1.542 0.655 0 CA-C-N 115.646 -0.707 . . . . 62.229999999999997 111.278 -177.597 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -117.08 -5.41 11.4 Favored 'General case' 0 N--CA 1.479 0.999 0 C-N-CA 124.188 0.995 . . . . 70.439999999999998 110.726 169.165 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 163.7 -171.36 39.32 Favored Glycine 0 C--N 1.358 1.782 0 CA-C-O 119.507 -0.607 . . . . 75.340000000000003 112.901 179.695 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 52.7 Cg_exo -57.9 143.25 96.23 Favored 'Trans proline' 0 C--N 1.378 2.12 0 C-N-CA 123.419 2.746 . . . . 73.310000000000002 112.041 172.791 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 106' ' ' ASN . . . . . 0.414 ' HA ' ' HA ' ' A' ' 84' ' ' GLU . 65.6 t30 66.07 12.82 8.75 Favored 'General case' 0 N--CA 1.488 1.467 0 C-N-CA 124.135 0.974 . . . . 73.329999999999998 111.243 -178.617 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 107' ' ' THR . . . . . 0.749 ' HA ' ' HD2' ' A' ' 82' ' ' LYS . 6.4 m -123.72 1.48 8.8 Favored 'General case' 0 CA--C 1.556 1.188 0 C-N-CA 124.128 0.971 . . . . 63.409999999999997 110.017 179.665 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 108' ' ' ASN . . . . . 0.57 ' HA ' ' HB3' ' A' ' 102' ' ' ASN . 40.0 t30 -70.88 143.77 50.9 Favored 'General case' 0 N--CA 1.479 1.024 0 C-N-CA 124.26 1.024 . . . . 73.219999999999999 110.604 -178.626 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 94.93 20.66 27.79 Favored Glycine 0 N--CA 1.47 0.957 0 N-CA-C 113.847 0.299 . . . . 64.030000000000001 113.847 177.983 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 110' ' ' SER . . . . . 0.6 ' HB2' ' HA ' ' A' ' 73' ' ' THR . 27.5 p -112.42 118.37 34.99 Favored 'General case' 0 CA--C 1.54 0.591 0 N-CA-C 107.525 -1.287 . . . . 41.049999999999997 107.525 169.758 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 111' ' ' GLN . . . . . 0.524 ' HG3' ' O ' ' A' ' 73' ' ' THR . 38.3 mt-30 65.35 -177.94 0.18 Allowed 'General case' 0 N--CA 1.495 1.812 0 C-N-CA 124.183 0.993 . . . . 62.340000000000003 110.672 -168.284 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 112' ' ' PHE . . . . . 0.647 ' HA ' ' HA ' ' A' ' 100' ' ' MET . 30.0 p90 -147.99 158.58 44.13 Favored 'General case' 0 N--CA 1.472 0.667 0 C-N-CA 124.105 0.962 . . . . 73.310000000000002 108.805 175.685 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 113' ' ' PHE . . . . . 0.464 ' HA ' ' HA ' ' A' ' 63' ' ' GLN . 53.1 p90 -146.82 145.22 29.82 Favored 'General case' 0 C--O 1.235 0.326 0 CA-C-O 121.057 0.456 . . . . 74.25 110.701 -179.581 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 114' ' ' ILE . . . . . 0.563 ' HB ' ' SG ' ' A' ' 62' ' ' CYS . 10.7 mt -115.51 102.26 13.49 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.456 0 N-CA-C 107.066 -1.457 . . . . 73.239999999999995 107.066 177.512 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 115' ' ' CYS . . . . . 0.493 ' HB2' ' HB ' ' A' ' 97' ' ' ILE . 50.5 m -60.85 103.38 0.26 Allowed 'General case' 0 C--N 1.348 0.518 0 N-CA-C 108.432 -0.951 . . . . 62.219999999999999 108.432 172.044 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 116' ' ' THR . . . . . 0.545 HG22 HG12 ' A' ' 139' ' ' VAL . 34.6 p -71.51 -32.7 68.5 Favored 'General case' 0 N--CA 1.47 0.568 0 C-N-CA 123.833 0.853 . . . . 74.299999999999997 110.183 -175.195 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -115.35 169.16 9.35 Favored 'General case' 0 N--CA 1.472 0.663 0 C-N-CA 123.99 0.916 . . . . 74.239999999999995 109.857 172.39 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 15.0 ptmt -66.76 115.85 7.01 Favored 'General case' 0 CA--C 1.549 0.926 0 CA-C-O 121.269 0.557 . . . . 72.200000000000003 110.074 176.029 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 119' ' ' THR . . . . . 0.559 ' HB ' HD13 ' A' ' 122' ' ' LEU . 43.7 p -115.76 87.86 2.76 Favored 'General case' 0 CA--C 1.546 0.798 0 CA-C-O 121.712 0.767 . . . . 74.219999999999999 110.363 -178.76 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 11.9 pt-20 -80.22 -19.99 45.67 Favored 'General case' 0 N--CA 1.481 1.082 0 CA-C-N 115.744 -0.662 . . . . 73.129999999999995 111.278 -176.462 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 121' ' ' TRP . . . . . . . . . . . . . 33.5 p90 -77.64 -7.34 56.28 Favored 'General case' 0 N--CA 1.477 0.919 0 C-N-CA 122.999 0.52 . . . . 71.519999999999996 110.569 173.479 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 122' ' ' LEU . . . . . 0.559 HD13 ' HB ' ' A' ' 119' ' ' THR . 9.9 mp -88.86 -7.88 55.31 Favored 'General case' 0 N--CA 1.481 1.076 0 C-N-CA 123.638 0.775 . . . . 72.5 110.698 169.708 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 44.3 m-20 -79.06 150.77 31.77 Favored 'General case' 0 N--CA 1.478 0.969 0 N-CA-C 108.751 -0.833 . . . . 54.43 108.751 173.128 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 97.03 -28.31 14.43 Favored Glycine 0 CA--C 1.526 0.722 0 N-CA-C 110.48 -1.048 . . . . 65.430000000000007 110.48 -165.045 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 2.3 mppt? -85.37 -174.07 5.01 Favored 'General case' 0 N--CA 1.478 0.938 0 C-N-CA 124.139 0.976 . . . . 75.129999999999995 109.453 170.711 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 126' ' ' HIS . . . . . . . . . . . . . 49.9 p-80 -68.92 154.12 42.6 Favored 'General case' 0 N--CA 1.475 0.824 0 C-N-CA 123.756 0.822 . . . . 73.420000000000002 111.374 -166.204 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 127' ' ' VAL . . . . . 0.409 HG23 ' H ' ' A' ' 90' ' ' LEU . 13.6 p -60.56 149.44 7.6 Favored 'Isoleucine or valine' 0 CA--C 1.552 1.035 0 C-N-CA 125.363 1.465 . . . . 71.239999999999995 113.569 -176.915 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 128' ' ' VAL . . . . . 0.41 HG11 HD12 ' A' ' 97' ' ' ILE . 46.5 t -76.94 153.64 5.62 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.82 0 C-N-CA 124.805 1.242 . . . . 74.150000000000006 109.688 171.661 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 129' ' ' PHE . . . . . 0.544 ' HA ' HG21 ' A' ' 29' ' ' VAL . 26.4 p90 -129.66 -19.73 3.32 Favored 'General case' 0 N--CA 1.482 1.173 0 CA-C-N 117.914 0.325 . . . . 75.219999999999999 111.572 178.256 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . -134.12 162.73 24.55 Favored Glycine 0 C--N 1.339 0.747 0 N-CA-C 112.297 -0.321 . . . . 73.450000000000003 112.297 -176.234 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 131' ' ' LYS . . . . . 0.42 ' HE2' ' HB3' ' A' ' 131' ' ' LYS . 29.4 ttpt -150.14 134.34 17.13 Favored 'General case' 0 N--CA 1.472 0.626 0 N-CA-C 107.757 -1.201 . . . . 62.210000000000001 107.757 177.123 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 132' ' ' VAL . . . . . 0.523 HG12 ' HA3' ' A' ' 96' ' ' GLY . 12.1 p -64.7 131.23 30.44 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.876 0 CA-C-O 121.117 0.484 . . . . 72.299999999999997 109.81 178.105 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 133' ' ' LYS . . . . . 0.624 ' HD2' ' HB2' ' A' ' 23' ' ' GLU . 0.1 OUTLIER -118.52 -24.19 6.88 Favored 'General case' 0 N--CA 1.473 0.725 0 C-N-CA 123.736 0.814 . . . . 74.140000000000001 110.046 179.185 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 134' ' ' GLU . . . . . 0.478 ' HB2' ' HB3' ' A' ' 21' ' ' SER . 20.8 mm-40 -133.79 129.42 36.56 Favored 'General case' 0 N--CA 1.472 0.673 0 C-N-CA 124.224 1.01 . . . . 72.310000000000002 109.224 177.677 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 79.51 36.2 27.11 Favored Glycine 0 C--N 1.345 1.06 0 O-C-N 123.634 0.584 . . . . 43.039999999999999 113.945 174.676 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 136' ' ' MET . . . . . . . . . . . . . 5.3 tpt -57.23 -43.6 83.04 Favored 'General case' 0 N--CA 1.491 1.607 0 C-N-CA 123.669 0.787 . . . . 61.439999999999998 110.085 172.164 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 137' ' ' ASN . . . . . . . . . . . . . 2.8 t-20 -61.4 -35.08 76.52 Favored 'General case' 0 CA--C 1.548 0.886 0 C-N-CA 124.058 0.943 . . . . 73.099999999999994 111.476 177.427 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 138' ' ' ILE . . . . . . . . . . . . . 45.5 mm -69.48 -37.61 75.28 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.999 0 C-N-CA 122.835 0.454 . . . . 72.209999999999994 110.349 177.839 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 139' ' ' VAL . . . . . 0.545 HG12 HG22 ' A' ' 116' ' ' THR . 85.8 t -64.3 -37.01 78.82 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.3 0 C-N-CA 123.475 0.71 . . . . 75.5 110.471 174.738 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 44.9 mt-10 -78.6 -19.01 53.7 Favored 'General case' 0 CA--C 1.543 0.683 0 CA-C-N 115.595 -0.73 . . . . 62.200000000000003 111.345 178.016 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -78.86 -48.57 14.44 Favored 'General case' 0 N--CA 1.475 0.784 0 C-N-CA 122.987 0.515 . . . . 52.240000000000002 110.17 177.069 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 142' ' ' MET . . . . . 0.558 ' HA ' ' HD2' ' A' ' 145' ' ' PHE . 25.5 ptm -65.5 -31.43 72.49 Favored 'General case' 0 N--CA 1.479 0.977 0 C-N-CA 123.502 0.721 . . . . 71.200000000000003 110.841 177.429 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 23.6 tt0 -48.41 -45.41 36.09 Favored 'General case' 0 N--CA 1.481 1.089 0 C-N-CA 124.997 1.319 . . . . 64.409999999999997 111.426 171.309 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 144' ' ' ARG . . . . . . . . . . . . . 90.7 mtt180 -73.11 -18.78 61.26 Favored 'General case' 0 N--CA 1.474 0.739 0 CA-C-N 114.542 -1.208 . . . . 74.519999999999996 111.845 -174.701 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 145' ' ' PHE . . . . . 0.558 ' HD2' ' HA ' ' A' ' 142' ' ' MET . 54.1 m-85 -80.62 -19.65 44.97 Favored 'General case' 0 N--CA 1.475 0.812 0 N-CA-C 109.929 -0.396 . . . . 72.340000000000003 109.929 174.13 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . -77.01 165.04 53.29 Favored Glycine 0 C--N 1.344 1.016 0 N-CA-C 111.881 -0.488 . . . . 64.439999999999998 111.881 172.586 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 10.1 m -133.08 170.47 15.35 Favored 'General case' 0 N--CA 1.479 1.006 0 C-N-CA 123.255 0.622 . . . . 73.200000000000003 110.384 -173.929 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 148' ' ' ARG . . . . . . . . . . . . . 34.7 mmt180 -64.48 -32.57 74.25 Favored 'General case' 0 N--CA 1.487 1.404 0 C-N-CA 123.612 0.765 . . . . 74.310000000000002 111.809 -179.417 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 149' ' ' ASN . . . . . . . . . . . . . 25.5 p-10 -75.85 -5.09 44.32 Favored 'General case' 0 N--CA 1.481 1.11 0 C-N-CA 123.09 0.556 . . . . 74.319999999999993 111.476 177.781 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . 97.13 -19.52 54.44 Favored Glycine 0 C--N 1.35 1.348 0 C-N-CA 123.115 0.388 . . . . 74.329999999999998 113.28 176.507 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 61.0 tttm -78.1 146.93 34.9 Favored 'General case' 0 N--CA 1.474 0.749 0 CA-C-N 117.169 0.485 . . . . 63.109999999999999 110.476 -176.481 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 152' ' ' THR . . . . . . . . . . . . . 77.7 p -92.91 162.99 13.86 Favored 'General case' 0 CA--C 1.549 0.907 0 C-N-CA 123.972 0.909 . . . . 52.43 110.447 177.734 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 153' ' ' SER . . . . . . . . . . . . . 37.8 m -96.64 -27.34 14.85 Favored 'General case' 0 N--CA 1.477 0.907 0 C-N-CA 124.231 1.012 . . . . 74.439999999999998 109.675 178.149 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 74.9 mmtt -115.12 148.05 39.45 Favored 'General case' 0 C--O 1.239 0.541 0 C-N-CA 124.592 1.157 . . . . 71.219999999999999 108.974 176.276 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 44.7 mtmt -78.13 88.79 4.23 Favored 'General case' 0 N--CA 1.472 0.658 0 N-CA-C 107.828 -1.175 . . . . 73.420000000000002 107.828 171.673 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 156' ' ' ILE . . . . . 0.503 HD13 ' HB2' ' A' ' 142' ' ' MET . 65.8 mt -86.97 107.82 17.38 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.32 0 CA-C-N 115.805 -0.634 . . . . 71.25 109.459 -171.412 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 157' ' ' THR . . . . . . . . . . . . . 34.9 p -121.59 156.87 31.99 Favored 'General case' 0 C--O 1.243 0.722 0 C-N-CA 124.514 1.126 . . . . 72.040000000000006 110.587 -174.55 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 158' ' ' ILE . . . . . 0.456 HG23 ' HB3' ' A' ' 8' ' ' PHE . 58.6 mt -78.72 93.37 1.54 Allowed 'Isoleucine or valine' 0 CA--C 1.547 0.858 0 N-CA-C 108.766 -0.827 . . . . 54.100000000000001 108.766 171.779 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 159' ' ' ALA . . . . . . . . . . . . . . . -61.46 -39.83 92.31 Favored 'General case' 0 N--CA 1.479 1.009 0 C-N-CA 124.567 1.147 . . . . 71.010000000000005 113.066 -176.289 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 160' ' ' ASP . . . . . 0.595 ' HA ' ' HE3' ' A' ' 49' ' ' LYS . 16.2 t70 -150.67 168.59 23.88 Favored 'General case' 0 CA--C 1.551 0.99 0 O-C-N 123.528 0.517 . . . . 73.109999999999999 110.033 -174.595 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 161' ' ' CYS . . . . . . . . . . . . . 21.8 p -147.04 -170.46 3.55 Favored 'General case' 0 N--CA 1.478 0.953 0 C-N-CA 124.725 1.21 . . . . 60.240000000000002 109.234 -172.067 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 162' ' ' GLY . . . . . . . . . . . . . . . 132.12 52.72 0.09 OUTLIER Glycine 0 N--CA 1.476 1.344 0 O-C-N 122.016 -0.427 . . . . 55.109999999999999 112.097 -174.244 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 163' ' ' GLN . . . . . 0.589 ' HA ' ' H ' ' A' ' 7' ' ' PHE . 44.9 mt-30 -47.63 106.39 0.09 Allowed 'General case' 0 N--CA 1.48 1.039 0 C-N-CA 125.44 1.496 . . . . 70.010000000000005 111.887 -179.737 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 164' ' ' LEU . . . . . . . . . . . . . 74.1 mt . . . . . 0 CA--C 1.545 0.752 0 C-N-CA 125.005 1.322 . . . . 72.420000000000002 112.141 -171.393 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' B' B ' 218' ' ' PRO . . . . . . . . . . . . . 57.9 Cg_endo . . . . . 0 CA--C 1.544 0.982 0 N-CA-C 111.248 -0.328 . . . . 52.399999999999999 111.248 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' B' B ' 219' ' ' GLY . . . . . . . . . . . . . . . 112.99 166.82 16.77 Favored Glycine 0 CA--C 1.526 0.732 0 CA-C-N 116.051 -0.522 . . . . 73.310000000000002 112.493 -178.79 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 220' ' ' PRO . . . . . . . . . . . . . 8.3 Cg_exo -74.76 154.82 43.98 Favored 'Trans proline' 0 CA--C 1.554 1.517 0 C-N-CA 123.76 2.974 . . . . 22.329999999999998 114.064 -172.605 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 221' ' ' TYR . . . . . . . . . . . . . 95.9 m-85 . . . . . 0 N--CA 1.483 1.204 0 C-N-CA 124.216 1.007 . . . . 60.25 111.277 -178.395 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 3' ' ' ASN . . . . . 0.457 ' ND2' ' HA ' ' A' ' 25' ' ' PHE . 15.9 m120 . . . . . 0 CA--C 1.556 1.176 0 CA-C-O 119.571 -0.252 . . . . 73.219999999999999 111.346 . . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 56.0 Cg_endo -70.8 123.31 9.64 Favored 'Trans proline' 0 C--N 1.379 2.178 0 C-N-CA 122.576 2.184 . . . . 70.310000000000002 110.652 175.159 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 5' ' ' THR . . . . . 0.476 ' HB ' ' O ' ' A' ' 164' ' ' LEU . 83.0 m -104.15 125.59 50.58 Favored 'General case' 0 CA--C 1.535 0.369 0 N-CA-C 109.703 -0.48 . . . . 55.149999999999999 109.703 -179.807 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 6' ' ' VAL . . . . . 0.616 ' HA ' ' HB2' ' A' ' 163' ' ' GLN . 6.7 m -100.51 122.94 53.09 Favored 'Isoleucine or valine' 0 C--N 1.347 0.457 0 CA-C-O 122.156 0.979 . . . . 73.310000000000002 109.732 -178.618 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 7' ' ' PHE . . . . . 0.708 ' H ' ' HA ' ' A' ' 163' ' ' GLN . 76.1 t80 -103.43 133.74 47.98 Favored 'General case' 0 C--O 1.243 0.734 0 CA-C-N 114.224 -1.353 . . . . 72.340000000000003 108.99 -174.877 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 8' ' ' PHE . . . . . 0.428 ' HD2' ' HE2' ' A' ' 22' ' ' PHE . 61.4 m-85 -135.23 162.08 33.56 Favored 'General case' 0 C--O 1.238 0.468 0 O-C-N 124.161 0.913 . . . . 74.200000000000003 109.702 172.258 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 24.9 m-20 -108.74 115.99 31.14 Favored 'General case' 0 C--N 1.322 -0.604 0 N-CA-C 106.975 -1.491 . . . . 74.540000000000006 106.975 170.235 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 51.3 mm -85.42 113.16 23.31 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.546 0 N-CA-C 108.707 -0.849 . . . . 63.210000000000001 108.707 178.068 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 11' ' ' ALA . . . . . 0.502 ' HB2' ' HB2' ' A' ' 159' ' ' ALA . . . -116.26 125.24 51.92 Favored 'General case' 0 N--CA 1.477 0.91 0 C-N-CA 122.974 0.51 . . . . 72.450000000000003 110.397 178.858 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 48.7 t -95.34 107.18 19.19 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.626 0 N-CA-C 108.088 -1.079 . . . . 53.329999999999998 108.088 177.449 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 20.3 m-20 61.58 31.19 18.85 Favored 'General case' 0 N--CA 1.489 1.485 0 C-N-CA 124.662 1.185 . . . . 72.310000000000002 112.023 179.409 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 96.79 -19.55 54.28 Favored Glycine 0 C--N 1.344 0.977 0 CA-C-N 115.62 -0.718 . . . . 71.409999999999997 112.905 179.035 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 26.3 mm-40 -83.58 114.57 54.4 Favored Pre-proline 0 CA--C 1.542 0.653 0 N-CA-C 109.227 -0.657 . . . . 75.510000000000005 109.227 -179.928 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 47.2 Cg_endo -65.36 107.77 1.06 Allowed 'Trans proline' 0 C--N 1.376 2.018 0 C-N-CA 122.248 1.965 . . . . 73.129999999999995 111.285 -178.201 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 58.0 tp -75.89 -38.54 57.72 Favored 'General case' 0 C--O 1.241 0.635 0 CA-C-N 115.084 -0.962 . . . . 63.539999999999999 109.774 -177.827 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 173.0 -171.7 44.62 Favored Glycine 0 C--N 1.343 0.92 0 CA-C-N 116.159 -0.473 . . . . 63.399999999999999 113.875 176.52 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 19' ' ' ARG . . . . . 0.458 ' HB3' ' HE1' ' A' ' 7' ' ' PHE . 67.8 mtt85 -115.99 129.27 56.3 Favored 'General case' 0 N--CA 1.472 0.667 0 C-N-CA 124.312 1.045 . . . . 74.400000000000006 109.462 -173.843 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 20' ' ' VAL . . . . . 0.44 HG13 HG13 ' A' ' 132' ' ' VAL . 61.9 t -125.74 133.16 69.75 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.883 0 C-N-CA 123.106 0.563 . . . . 72.030000000000001 109.999 178.696 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 37.9 m -119.93 119.16 32.68 Favored 'General case' 0 CA--C 1.558 1.273 0 C-N-CA 124.389 1.075 . . . . 65.329999999999998 108.973 177.389 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 22' ' ' PHE . . . . . 0.428 ' HE2' ' HD2' ' A' ' 8' ' ' PHE . 52.7 m-85 -101.13 114.95 29.38 Favored 'General case' 0 N--CA 1.477 0.876 0 C-N-CA 124.22 1.008 . . . . 52.420000000000002 110.233 -179.255 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 23' ' ' GLU . . . . . 0.662 ' HB2' ' HD2' ' A' ' 133' ' ' LYS . 43.2 tt0 -76.06 105.06 6.89 Favored 'General case' 0 CA--C 1.549 0.933 0 C-N-CA 123.859 0.864 . . . . 61.340000000000003 109.799 176.601 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . 0.521 ' HB3' ' HB1' ' A' ' 33' ' ' ALA . 55.5 mt -82.99 128.06 34.12 Favored 'General case' 0 N--CA 1.478 0.954 0 C-N-CA 122.992 0.517 . . . . 72.329999999999998 110.66 -179.697 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 25' ' ' PHE . . . . . 0.457 ' HA ' ' ND2' ' A' ' 3' ' ' ASN . 54.1 m-85 -90.99 61.13 4.54 Favored 'General case' 0 CA--C 1.532 0.265 0 C-N-CA 123.787 0.835 . . . . 73.329999999999998 109.883 -179.295 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -67.9 -13.31 62.05 Favored 'General case' 0 N--CA 1.48 1.04 0 CA-C-N 115.849 -0.614 . . . . 51.450000000000003 112.042 179.371 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 11.2 p-10 -71.85 -31.83 66.88 Favored 'General case' 0 CA--C 1.55 0.944 0 C-N-CA 123.481 0.712 . . . . 74.209999999999994 110.829 173.848 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 58.0 mttp -96.88 -49.54 5.01 Favored 'General case' 0 N--CA 1.485 1.288 0 C-N-CA 123.948 0.899 . . . . 73.450000000000003 111.285 -178.317 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 29' ' ' VAL . . . . . 0.642 ' HB ' ' HB ' ' A' ' 32' ' ' THR . 11.8 m -117.77 76.14 10.53 Favored Pre-proline 0 CA--C 1.562 1.432 0 C-N-CA 124.165 0.986 . . . . 52.350000000000001 110.054 179.117 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 30' ' ' PRO . . . . . 0.449 ' HD2' ' HG2' ' A' ' 86' ' ' GLU . 7.2 Cg_endo -51.24 -59.59 1.1 Allowed 'Trans proline' 0 C--N 1.394 2.968 0 C-N-CA 123.381 2.721 . . . . 70.310000000000002 113.207 179.699 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 5.8 ttpm? -57.75 -50.2 74.03 Favored 'General case' 0 N--CA 1.482 1.172 0 C-N-CA 123.398 0.679 . . . . 72.340000000000003 112.098 -179.562 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 32' ' ' THR . . . . . 0.642 ' HB ' ' HB ' ' A' ' 29' ' ' VAL . 88.9 m -67.78 -35.6 78.97 Favored 'General case' 0 CA--C 1.56 1.357 0 C-N-CA 123.998 0.919 . . . . 71.319999999999993 112.593 -170.632 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 33' ' ' ALA . . . . . 0.521 ' HB1' ' HB3' ' A' ' 24' ' ' LEU . . . -90.47 -43.7 10.09 Favored 'General case' 0 N--CA 1.485 1.294 0 C-N-CA 123.019 0.528 . . . . 54.240000000000002 112.173 -176.985 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 39.3 tt0 -63.63 -31.73 72.99 Favored 'General case' 0 N--CA 1.484 1.255 0 C-N-CA 123.372 0.669 . . . . 73.150000000000006 110.733 179.754 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 35' ' ' ASN . . . . . 0.421 ' O ' ' HG ' ' A' ' 39' ' ' LEU . 35.8 t30 -49.01 -59.51 3.56 Favored 'General case' 0 C--N 1.36 1.029 0 O-C-N 124.566 1.166 . . . . 75.030000000000001 110.314 171.457 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 76.3 t80 -65.17 -40.55 94.44 Favored 'General case' 0 C--N 1.348 0.526 0 O-C-N 124.045 0.84 . . . . 70.209999999999994 111.249 -175.035 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 56.1 ttp180 -58.26 -44.98 88.62 Favored 'General case' 0 N--CA 1.48 1.044 0 O-C-N 123.723 0.639 . . . . 72.209999999999994 110.919 179.057 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 38' ' ' ALA . . . . . 0.547 ' HB3' HG21 ' A' ' 78' ' ' ILE . . . -69.38 -32.24 71.15 Favored 'General case' 0 N--CA 1.473 0.694 0 CA-C-N 115.274 -0.875 . . . . 74.239999999999995 111.487 -179.726 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 39' ' ' LEU . . . . . 0.421 ' HG ' ' O ' ' A' ' 35' ' ' ASN . 94.3 mt -69.74 -35.96 75.42 Favored 'General case' 0 N--CA 1.477 0.915 0 C-N-CA 123.87 0.868 . . . . 75.340000000000003 111.06 175.326 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 50.0 m -73.52 -54.81 7.34 Favored 'General case' 0 N--CA 1.474 0.75 0 C-N-CA 124.015 0.926 . . . . 75.549999999999997 111.284 -175.567 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 56.4 p -78.77 -31.51 46.16 Favored 'General case' 0 CA--C 1.538 0.519 0 CA-C-N 115.128 -0.942 . . . . 32.409999999999997 111.376 -175.188 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 92.09 37.68 5.92 Favored Glycine 0 C--N 1.347 1.168 0 CA-C-O 119.647 -0.529 . . . . 60.329999999999998 112.682 -178.204 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 68.1 mm-40 -61.1 -29.24 69.64 Favored 'General case' 0 N--CA 1.482 1.152 0 C-N-CA 123.089 0.555 . . . . 64.439999999999998 110.432 172.08 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 44' ' ' LYS . . . . . 0.547 ' HG3' ' HB ' ' A' ' 78' ' ' ILE . 32.0 mmmt -108.43 17.75 21.74 Favored 'General case' 0 CA--C 1.541 0.614 0 C-N-CA 124.696 1.199 . . . . 75.200000000000003 111.366 -178.965 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 80.23 -1.77 79.36 Favored Glycine 0 C--N 1.355 1.604 0 CA-C-O 119.118 -0.823 . . . . 73.349999999999994 114.923 173.353 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 19.7 m-85 -85.17 -48.15 9.43 Favored 'General case' 0 N--CA 1.477 0.924 0 CA-C-N 117.96 0.88 . . . . 64.129999999999995 111.05 -174.2 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 41.6 62.23 1.97 Allowed Glycine 0 N--CA 1.485 1.964 0 O-C-N 124.508 1.13 . . . . 61.140000000000001 114.816 171.517 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 48' ' ' TYR . . . . . 0.471 ' HB3' ' OG ' ' A' ' 51' ' ' SER . 34.5 m-85 -59.68 98.89 0.05 Allowed 'General case' 0 CA--C 1.548 0.898 0 CA-C-O 121.843 0.83 . . . . 72.299999999999997 112.191 -170.095 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 23.2 tptm -108.39 113.53 26.66 Favored 'General case' 0 CA--C 1.539 0.544 0 CA-C-N 113.941 -1.481 . . . . 72.019999999999996 108.841 -175.771 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 93.61 18.59 37.68 Favored Glycine 0 C--N 1.346 1.13 0 CA-C-O 119.267 -0.741 . . . . 63.409999999999997 113.078 179.823 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 51' ' ' SER . . . . . 0.471 ' OG ' ' HB3' ' A' ' 48' ' ' TYR . 19.6 m -59.95 118.62 6.47 Favored 'General case' 0 N--CA 1.476 0.853 0 C-N-CA 123.317 0.647 . . . . 73.219999999999999 111.177 -176.849 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 52' ' ' CYS . . . . . 0.642 ' SG ' ' HD2' ' A' ' 155' ' ' LYS . 36.0 t -86.28 125.15 33.39 Favored 'General case' 0 CA--C 1.533 0.306 0 CA-C-N 115.447 -0.797 . . . . 73.409999999999997 112.302 -167.539 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 53' ' ' PHE . . . . . 0.667 ' HA ' ' HA2' ' A' ' 64' ' ' GLY . 95.4 m-85 -73.08 109.33 6.54 Favored 'General case' 0 C--O 1.238 0.479 0 N-CA-C 108.756 -0.831 . . . . 72.540000000000006 108.756 166.27 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 19.2 p-80 -128.43 8.41 5.95 Favored 'General case' 0 N--CA 1.482 1.135 0 CA-C-N 115.611 -0.722 . . . . 74.430000000000007 111.856 -169.267 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 80.0 ttt-85 -152.25 99.31 2.5 Favored 'General case' 0 N--CA 1.472 0.67 0 N-CA-C 108.794 -0.817 . . . . 75.209999999999994 108.794 177.768 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 56' ' ' ILE . . . . . 0.463 HD11 ' HB3' ' A' ' 53' ' ' PHE . 58.3 mt -137.31 134.01 46.89 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.8 0 C-N-CA 123.181 0.592 . . . . 71.129999999999995 109.908 -174.688 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 41.8 mt -117.58 118.32 35.31 Favored Pre-proline 0 CA--C 1.554 1.109 0 C-N-CA 124.164 0.986 . . . . 51.100000000000001 108.549 174.229 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 58' ' ' PRO . . . . . 0.574 ' HA ' ' HG2' ' A' ' 143' ' ' GLU . 53.8 Cg_endo -67.3 135.95 38.57 Favored 'Trans proline' 0 C--N 1.38 2.206 0 C-N-CA 123.021 2.481 . . . . 74.450000000000003 111.508 179.847 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 77.35 30.01 54.97 Favored Glycine 0 CA--C 1.526 0.765 0 CA-C-N 115.345 -0.843 . . . . 71.129999999999995 113.091 -176.168 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 29.0 t80 -156.57 -67.04 0.11 Allowed 'General case' 0 C--O 1.247 0.96 0 C-N-CA 123.027 0.531 . . . . 73.319999999999993 110.715 -176.921 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 61' ' ' MET . . . . . 0.4 ' HE2' ' HB2' ' A' ' 61' ' ' MET . 45.6 ttm -167.16 146.96 5.35 Favored 'General case' 0 N--CA 1.48 1.073 0 N-CA-C 112.188 0.44 . . . . 74.239999999999995 112.188 -165.654 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 62' ' ' CYS . . . . . 0.456 ' SG ' HG13 ' A' ' 139' ' ' VAL . 23.5 p -116.55 114.25 23.88 Favored 'General case' 0 CA--C 1.545 0.781 0 C-N-CA 123.726 0.81 . . . . 72.450000000000003 109.111 169.322 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 28.4 tt0 -112.63 140.96 46.96 Favored 'General case' 0 N--CA 1.479 0.995 0 C-N-CA 123.627 0.771 . . . . 74.25 110.66 -179.506 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 64' ' ' GLY . . . . . 0.667 ' HA2' ' HA ' ' A' ' 53' ' ' PHE . . . -130.81 -176.55 14.46 Favored Glycine 0 C--N 1.344 0.976 0 CA-C-N 115.306 -0.861 . . . . 72.239999999999995 112.754 176.669 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 176.22 155.07 12.41 Favored Glycine 0 C--N 1.335 0.486 0 N-CA-C 111.721 -0.552 . . . . 74.540000000000006 111.721 -179.262 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 21.2 t70 -83.06 179.79 7.65 Favored 'General case' 0 CA--C 1.552 1.031 0 C-N-CA 124.017 0.927 . . . . 74.420000000000002 110.593 -176.979 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 53.2 t80 -88.51 -15.68 34.65 Favored 'General case' 0 CA--C 1.548 0.89 0 C-N-CA 123.188 0.595 . . . . 52.350000000000001 111.538 177.635 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 42.5 m -65.01 107.79 1.61 Allowed 'General case' 0 C--N 1.357 0.93 0 N-CA-C 109.724 -0.472 . . . . 74.430000000000007 109.724 178.057 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 85.1 mtt85 58.64 47.66 12.8 Favored 'General case' 0 N--CA 1.479 1.002 0 C-N-CA 124.821 1.248 . . . . 73.049999999999997 110.633 -170.805 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 48.6 t-80 -49.82 -37.66 31.42 Favored 'General case' 0 N--CA 1.482 1.164 0 C-N-CA 124.754 1.222 . . . . 74.400000000000006 112.69 -172.297 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 53.1 t30 -68.26 96.47 0.65 Allowed 'General case' 0 CA--C 1.542 0.65 0 O-C-N 123.499 0.499 . . . . 50.109999999999999 109.991 175.233 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 67.56 16.15 67.2 Favored Glycine 0 C--N 1.345 1.06 0 N-CA-C 116.022 1.169 . . . . 73.239999999999995 116.022 168.805 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 73' ' ' THR . . . . . 0.58 ' HA ' ' HB2' ' A' ' 110' ' ' SER . 88.3 m -132.65 -75.93 0.5 Allowed 'General case' 0 N--CA 1.472 0.638 0 N-CA-C 108.426 -0.953 . . . . 72.120000000000005 108.426 168.871 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 53.95 60.26 8.67 Favored Glycine 0 C--N 1.355 1.59 0 O-C-N 123.781 0.675 . . . . 70.349999999999994 113.725 170.137 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 130.96 51.4 0.1 OUTLIER Glycine 0 C--N 1.344 1.026 0 N-CA-C 111.855 -0.498 . . . . 74.109999999999999 111.855 -176.716 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -52.36 166.09 0.2 Allowed 'General case' 0 N--CA 1.491 1.606 0 C-N-CA 124.369 1.068 . . . . 62.439999999999998 112.583 174.688 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 80.9 p -90.65 177.67 6.28 Favored 'General case' 0 N--CA 1.478 0.965 0 C-N-CA 122.994 0.518 . . . . 72.349999999999994 111.043 -175.699 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 78' ' ' ILE . . . . . 0.547 HG21 ' HB3' ' A' ' 38' ' ' ALA . 31.9 pt -79.02 -22.83 12.7 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.022 0 C-N-CA 123.275 0.63 . . . . 54.350000000000001 110.773 176.505 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 71.0 m-85 -79.42 -40.32 30.28 Favored 'General case' 0 N--CA 1.47 0.548 0 C-N-CA 124.19 0.996 . . . . 73.349999999999994 109.704 -179.724 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 177.45 -138.69 3.98 Favored Glycine 0 C--N 1.339 0.746 0 CA-C-N 115.152 -0.931 . . . . 63.030000000000001 111.528 177.734 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 36.0 tt0 -65.64 -44.44 86.39 Favored 'General case' 0 N--CA 1.471 0.604 0 C-N-CA 123.917 0.887 . . . . 51.439999999999998 109.855 177.025 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 82' ' ' LYS . . . . . 0.447 ' HD2' ' HA ' ' A' ' 107' ' ' THR . 20.8 pttp -154.07 175.31 13.58 Favored 'General case' 0 CA--C 1.55 0.977 0 CA-C-N 114.943 -1.026 . . . . 72.530000000000001 110.383 -175.219 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 2.2 p90 -159.42 170.48 21.67 Favored 'General case' 0 CA--C 1.554 1.104 0 C-N-CA 124.132 0.973 . . . . 53.210000000000001 110.311 -173.765 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 13.0 pt-20 -96.4 157.37 15.93 Favored 'General case' 0 N--CA 1.486 1.343 0 C-N-CA 123.664 0.785 . . . . 74.400000000000006 109.014 173.219 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 28.4 m-20 -77.53 150.85 34.77 Favored 'General case' 0 N--CA 1.483 1.206 0 N-CA-C 113.099 0.777 . . . . 74.120000000000005 113.099 178.1 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 86' ' ' GLU . . . . . 0.449 ' HG2' ' HD2' ' A' ' 30' ' ' PRO . 13.8 tp10 -61.95 -60.6 3.39 Favored 'General case' 0 CA--C 1.541 0.614 0 CA-C-N 114.044 -1.435 . . . . 73.409999999999997 111.158 -179.763 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 26.2 p30 -165.73 152.85 10.18 Favored 'General case' 0 N--CA 1.475 0.789 0 C-N-CA 123.556 0.743 . . . . 74.340000000000003 109.723 -176.973 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 89.9 m-85 -90.58 47.26 1.41 Allowed 'General case' 0 N--CA 1.48 1.055 0 C-N-CA 123.624 0.769 . . . . 74.310000000000002 111.267 -176.362 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 71.3 mt -69.87 -59.5 3.45 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.925 0 N-CA-C 108.926 -0.768 . . . . 71.340000000000003 108.926 173.209 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 90' ' ' LEU . . . . . 0.59 ' HB3' ' HB ' ' A' ' 128' ' ' VAL . 80.3 mt -86.69 104.92 16.54 Favored 'General case' 0 CA--C 1.539 0.542 0 CA-C-N 114.878 -1.055 . . . . 61.210000000000001 110.596 -172.057 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 20.4 ptmt -103.97 167.77 9.55 Favored 'General case' 0 N--CA 1.475 0.797 0 C-N-CA 123.278 0.631 . . . . 60.450000000000003 110.492 -179.617 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 92' ' ' HIS . . . . . . . . . . . . . 57.7 m-70 -83.53 69.38 10.07 Favored 'General case' 0 N--CA 1.48 1.028 0 C-N-CA 123.4 0.68 . . . . 71.400000000000006 110.799 -173.666 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 14.5 t -122.26 20.32 10.55 Favored 'General case' 0 N--CA 1.474 0.761 0 C-N-CA 123.338 0.655 . . . . 64.310000000000002 110.084 -176.546 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -143.99 172.27 25.22 Favored Glycine 0 C--N 1.348 1.197 0 CA-C-N 116.287 -0.415 . . . . 71.200000000000003 113.445 -176.336 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 58.4 Cg_endo -94.02 153.53 2.19 Favored 'Trans proline' 0 C--N 1.368 1.578 0 C-N-CA 123.676 2.918 . . . . 74.209999999999994 112.732 175.238 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 72.82 19.85 79.55 Favored Glycine 0 C--N 1.353 1.507 0 CA-C-N 116.244 -0.435 . . . . 42.25 112.827 177.008 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 97' ' ' ILE . . . . . 0.737 ' HB ' ' SG ' ' A' ' 115' ' ' CYS . 20.1 mm -68.84 108.36 1.6 Allowed 'Isoleucine or valine' 0 CA--C 1.541 0.625 0 C-N-CA 124.238 1.015 . . . . 70.120000000000005 111.257 -174.213 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 62.1 tp -90.06 120.55 31.35 Favored 'General case' 0 C--O 1.247 0.94 0 CA-C-N 115.581 -0.736 . . . . 75.120000000000005 109.95 172.575 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 99' ' ' SER . . . . . 0.467 ' HB3' ' HA ' ' A' ' 128' ' ' VAL . 7.9 p -149.62 147.67 28.4 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 114.483 -1.235 . . . . 72.349999999999994 107.902 171.81 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 100' ' ' MET . . . . . 0.734 ' HA ' ' HA ' ' A' ' 112' ' ' PHE . 96.9 mtp -77.29 149.14 35.39 Favored 'General case' 0 N--CA 1.493 1.68 0 C-N-CA 122.627 0.371 . . . . 63.130000000000003 110.276 -175.569 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 101' ' ' ALA . . . . . 0.533 ' HB3' ' HB2' ' A' ' 111' ' ' GLN . . . -73.57 162.71 28.93 Favored 'General case' 0 C--O 1.247 0.944 0 CA-C-O 121.535 0.683 . . . . 63.229999999999997 111.347 -176.851 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 102' ' ' ASN . . . . . 0.47 ' HB3' ' HA ' ' A' ' 108' ' ' ASN . 24.3 p-10 -167.24 168.4 13.41 Favored 'General case' 0 C--O 1.242 0.706 0 CA-C-N 114.583 -1.19 . . . . 52.43 109.903 -178.14 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -114.96 6.74 15.41 Favored 'General case' 0 CA--C 1.543 0.695 0 C-N-CA 123.802 0.841 . . . . 54.140000000000001 110.304 171.183 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 158.54 179.75 33.63 Favored Glycine 0 C--N 1.354 1.582 0 CA-C-O 119.468 -0.629 . . . . 73.340000000000003 112.408 178.094 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 26.0 Cg_exo -64.47 137.54 55.67 Favored 'Trans proline' 0 C--N 1.375 1.926 0 C-N-CA 122.933 2.422 . . . . 71.450000000000003 110.509 171.514 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 63.0 t30 68.8 8.79 7.0 Favored 'General case' 0 N--CA 1.49 1.528 0 C-N-CA 124.988 1.315 . . . . 72.530000000000001 111.116 -174.851 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 107' ' ' THR . . . . . 0.447 ' HA ' ' HD2' ' A' ' 82' ' ' LYS . 1.7 m -116.93 15.82 15.17 Favored 'General case' 0 CA--C 1.551 0.998 0 N-CA-C 108.359 -0.978 . . . . 65.329999999999998 108.359 171.6 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 108' ' ' ASN . . . . . 0.47 ' HA ' ' HB3' ' A' ' 102' ' ' ASN . 20.9 t30 -92.05 145.31 24.62 Favored 'General case' 0 C--O 1.202 -1.426 0 C-N-CA 124.832 1.253 . . . . 70.109999999999999 110.498 -176.317 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 113.3 26.99 3.8 Favored Glycine 0 N--CA 1.478 1.48 0 CA-C-N 118.303 0.501 . . . . 75.319999999999993 112.436 -178.787 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 110' ' ' SER . . . . . 0.58 ' HB2' ' HA ' ' A' ' 73' ' ' THR . 22.5 p -137.04 121.13 17.8 Favored 'General case' 0 CA--C 1.535 0.401 0 N-CA-C 108.675 -0.861 . . . . 62.439999999999998 108.675 -177.926 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 111' ' ' GLN . . . . . 0.533 ' HB2' ' HB3' ' A' ' 101' ' ' ALA . 47.4 mt-30 61.47 -177.25 0.12 Allowed 'General case' 0 N--CA 1.493 1.677 0 C-N-CA 123.898 0.879 . . . . 73.400000000000006 111.62 -174.551 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 112' ' ' PHE . . . . . 0.734 ' HA ' ' HA ' ' A' ' 100' ' ' MET . 35.5 p90 -151.75 152.92 33.34 Favored 'General case' 0 N--CA 1.475 0.804 0 C-N-CA 123.672 0.789 . . . . 65.540000000000006 109.348 176.698 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 113' ' ' PHE . . . . . . . . . . . . . 55.0 p90 -140.59 151.43 44.67 Favored 'General case' 0 N--CA 1.472 0.667 0 C-N-CA 122.963 0.505 . . . . 75.439999999999998 110.934 -178.803 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 114' ' ' ILE . . . . . . . . . . . . . 10.9 mt -125.92 107.77 18.22 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.705 0 N-CA-C 107.849 -1.167 . . . . 74.310000000000002 107.849 178.765 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 115' ' ' CYS . . . . . 0.737 ' SG ' ' HB ' ' A' ' 97' ' ' ILE . 28.5 p -89.3 113.68 24.97 Favored 'General case' 0 C--O 1.243 0.745 0 N-CA-C 108.964 -0.754 . . . . 71.120000000000005 108.964 175.601 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 71.6 p -70.84 -27.02 63.55 Favored 'General case' 0 N--CA 1.474 0.772 0 CA-C-N 115.253 -0.885 . . . . 63.299999999999997 111.291 -177.534 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -104.34 162.34 13.3 Favored 'General case' 0 C--O 1.248 0.977 0 C-N-CA 123.815 0.846 . . . . 75.409999999999997 110.058 174.826 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 18.1 ptmt -74.04 85.19 1.8 Allowed 'General case' 0 CA--C 1.546 0.825 0 CA-C-O 122.302 1.048 . . . . 74.420000000000002 110.248 175.329 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 119' ' ' THR . . . . . . . . . . . . . 50.8 p -82.04 84.39 7.0 Favored 'General case' 0 CA--C 1.546 0.793 0 CA-C-N 115.01 -0.996 . . . . 60.350000000000001 109.307 179.359 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 11.4 pt-20 -75.44 -23.36 56.9 Favored 'General case' 0 N--CA 1.484 1.257 0 CA-C-N 115.019 -0.991 . . . . 74.519999999999996 112.727 -167.628 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 121' ' ' TRP . . . . . . . . . . . . . 38.7 p90 -67.05 -8.72 32.41 Favored 'General case' 0 CA--C 1.551 1.0 0 C-N-CA 123.452 0.701 . . . . 74.230000000000004 112.201 176.79 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 31.9 mt -88.23 10.33 19.94 Favored 'General case' 0 CA--C 1.547 0.833 0 C-N-CA 122.947 0.499 . . . . 64.540000000000006 111.954 176.764 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 69.7 m-20 -72.4 121.18 19.11 Favored 'General case' 0 N--CA 1.483 1.207 0 N-CA-C 108.9 -0.778 . . . . 74.420000000000002 108.9 170.721 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 110.0 -17.94 29.21 Favored Glycine 0 N--CA 1.475 1.269 0 N-CA-C 111.04 -0.824 . . . . 53.030000000000001 111.04 -170.113 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 125' ' ' LYS . . . . . 0.602 ' HG2' ' H ' ' A' ' 126' ' ' HIS . 21.0 ttmm -86.72 -165.58 1.32 Allowed 'General case' 0 CA--C 1.559 1.3 0 N-CA-C 108.045 -1.094 . . . . 63.530000000000001 108.045 169.707 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 126' ' ' HIS . . . . . 0.602 ' H ' ' HG2' ' A' ' 125' ' ' LYS . 9.4 t-160 -65.59 130.08 42.02 Favored 'General case' 0 C--N 1.353 0.758 0 CA-C-N 118.583 0.628 . . . . 73.049999999999997 109.826 -173.71 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 127' ' ' VAL . . . . . 0.4 ' N ' ' HD2' ' A' ' 126' ' ' HIS . 57.6 t -58.68 143.7 12.69 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.835 0 CA-C-N 113.75 -1.568 . . . . 75.519999999999996 110.966 175.829 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 128' ' ' VAL . . . . . 0.59 ' HB ' ' HB3' ' A' ' 90' ' ' LEU . 21.8 t -66.94 149.01 11.83 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.583 0 N-CA-C 109.578 -0.527 . . . . 61.409999999999997 109.578 177.098 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 129' ' ' PHE . . . . . 0.545 ' HB3' HG22 ' A' ' 32' ' ' THR . 32.1 p90 -136.32 -23.89 1.26 Allowed 'General case' 0 N--CA 1.474 0.754 0 C-N-CA 122.243 0.217 . . . . 73.530000000000001 111.117 171.409 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . -127.09 157.75 20.78 Favored Glycine 0 C--N 1.338 0.689 0 N-CA-C 111.493 -0.643 . . . . 72.200000000000003 111.493 -177.552 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 131' ' ' LYS . . . . . 0.407 ' HE2' ' HB3' ' A' ' 131' ' ' LYS . 31.3 ttpt -144.74 127.41 16.17 Favored 'General case' 0 C--N 1.324 -0.543 0 N-CA-C 108.616 -0.883 . . . . 63.149999999999999 108.616 179.967 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 132' ' ' VAL . . . . . 0.478 HG21 HG21 ' A' ' 139' ' ' VAL . 59.4 t -63.67 100.19 0.22 Allowed 'Isoleucine or valine' 0 CA--C 1.539 0.525 0 N-CA-C 108.589 -0.893 . . . . 71.329999999999998 108.589 171.902 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 133' ' ' LYS . . . . . 0.662 ' HD2' ' HB2' ' A' ' 23' ' ' GLU . 19.5 ptmt -87.65 -32.03 19.46 Favored 'General case' 0 N--CA 1.473 0.682 0 N-CA-C 109.581 -0.526 . . . . 71.430000000000007 109.581 178.315 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 44.8 mt-10 -139.41 146.29 39.95 Favored 'General case' 0 N--CA 1.473 0.7 0 C-N-CA 124.999 1.32 . . . . 61.030000000000001 108.936 176.728 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 87.83 21.76 45.43 Favored Glycine 0 C--N 1.342 0.868 0 O-C-N 123.541 0.526 . . . . 51.43 112.536 -175.89 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 136' ' ' MET . . . . . 0.428 ' HA ' HG11 ' A' ' 132' ' ' VAL . 7.1 tpt -58.88 -46.84 86.85 Favored 'General case' 0 C--N 1.359 1.004 0 C-N-CA 123.92 0.888 . . . . 71.430000000000007 111.337 -179.772 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 137' ' ' ASN . . . . . . . . . . . . . 20.1 m120 -65.03 -28.86 69.78 Favored 'General case' 0 N--CA 1.477 0.886 0 C-N-CA 123.228 0.611 . . . . 74.430000000000007 111.619 -179.394 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 138' ' ' ILE . . . . . . . . . . . . . 43.2 mm -70.41 -38.84 75.36 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.657 0 C-N-CA 123.329 0.652 . . . . 74.450000000000003 109.895 178.839 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 139' ' ' VAL . . . . . 0.478 HG21 HG21 ' A' ' 132' ' ' VAL . 69.6 t -68.64 -39.78 80.84 Favored 'Isoleucine or valine' 0 CA--C 1.553 1.063 0 C-N-CA 123.481 0.713 . . . . 74.439999999999998 110.492 176.186 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 48.8 mt-10 -69.2 -27.53 65.58 Favored 'General case' 0 N--CA 1.476 0.872 0 C-N-CA 123.623 0.769 . . . . 71.549999999999997 111.224 177.92 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -80.35 -45.6 17.51 Favored 'General case' 0 N--CA 1.477 0.91 0 C-N-CA 123.639 0.776 . . . . 63.140000000000001 111.196 178.914 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 142' ' ' MET . . . . . 0.544 ' HA ' ' HD2' ' A' ' 145' ' ' PHE . 27.9 ptm -65.68 -31.71 72.87 Favored 'General case' 0 N--CA 1.478 0.969 0 C-N-CA 123.095 0.558 . . . . 64.310000000000002 111.22 -178.35 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 143' ' ' GLU . . . . . 0.574 ' HG2' ' HA ' ' A' ' 58' ' ' PRO . 39.1 tt0 -57.94 -32.22 67.58 Favored 'General case' 0 CA--C 1.552 1.037 0 C-N-CA 123.71 0.804 . . . . 75.209999999999994 111.969 177.957 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 144' ' ' ARG . . . . . . . . . . . . . 46.3 mtp85 -75.62 -16.98 60.15 Favored 'General case' 0 N--CA 1.473 0.705 0 CA-C-N 116.261 -0.427 . . . . 74.129999999999995 111.814 -175.782 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 145' ' ' PHE . . . . . 0.596 ' HB2' HD11 ' A' ' 156' ' ' ILE . 95.2 m-85 -79.88 2.09 24.62 Favored 'General case' 0 N--CA 1.479 0.994 0 C-N-CA 122.728 0.411 . . . . 71.030000000000001 110.844 175.38 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . -89.58 -174.75 45.92 Favored Glycine 0 C--N 1.352 1.426 0 O-C-N 123.199 0.312 . . . . 73.409999999999997 112.635 171.787 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 19.8 t -135.6 167.99 20.08 Favored 'General case' 0 N--CA 1.475 0.803 0 C-N-CA 123.796 0.838 . . . . 62.450000000000003 110.369 -177.869 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 148' ' ' ARG . . . . . . . . . . . . . 12.1 mmm180 -71.04 -29.84 65.87 Favored 'General case' 0 N--CA 1.477 0.907 0 C-N-CA 123.534 0.734 . . . . 74.109999999999999 112.09 -173.601 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 149' ' ' ASN . . . . . . . . . . . . . 28.7 p-10 -79.72 -3.05 45.75 Favored 'General case' 0 N--CA 1.484 1.237 0 C-N-CA 123.51 0.724 . . . . 73.140000000000001 111.451 176.141 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . 90.68 11.02 62.6 Favored Glycine 0 C--N 1.35 1.336 0 C-N-CA 123.052 0.358 . . . . 55.229999999999997 113.098 -179.522 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 56.1 tttm -84.77 158.67 20.65 Favored 'General case' 0 N--CA 1.474 0.761 0 C-N-CA 123.378 0.671 . . . . 72.430000000000007 109.458 177.384 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 152' ' ' THR . . . . . . . . . . . . . 24.8 p -101.58 128.72 47.71 Favored 'General case' 0 N--CA 1.475 0.821 0 C-N-CA 122.82 0.448 . . . . 53.109999999999999 109.905 171.86 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 153' ' ' SER . . . . . . . . . . . . . 42.4 t -70.25 -42.97 71.49 Favored 'General case' 0 N--CA 1.474 0.742 0 N-CA-C 109.245 -0.65 . . . . 63.039999999999999 109.245 168.851 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 154' ' ' LYS . . . . . 0.4 ' HB2' ' HB3' ' A' ' 145' ' ' PHE . 34.1 mmtp -118.4 140.68 49.48 Favored 'General case' 0 C--O 1.239 0.506 0 C-N-CA 123.614 0.766 . . . . 75.310000000000002 110.654 -179.338 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 155' ' ' LYS . . . . . 0.642 ' HD2' ' SG ' ' A' ' 52' ' ' CYS . 0.0 OUTLIER -87.03 93.24 9.3 Favored 'General case' 0 CA--C 1.535 0.374 0 O-C-N 123.944 0.778 . . . . 70.040000000000006 109.369 -172.271 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 156' ' ' ILE . . . . . 0.624 ' HB ' ' HB2' ' A' ' 53' ' ' PHE . 27.1 mt -87.63 149.27 4.13 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.591 0 CA-C-N 115.488 -0.778 . . . . 61.43 109.231 -177.685 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 157' ' ' THR . . . . . . . . . . . . . 71.9 p -146.25 170.41 16.82 Favored 'General case' 0 N--CA 1.482 1.153 0 C-N-CA 124.091 0.956 . . . . 72.310000000000002 109.951 -176.661 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 158' ' ' ILE . . . . . 0.4 HG23 ' HB3' ' A' ' 8' ' ' PHE . 67.8 mt -88.87 102.2 12.7 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.705 0 N-CA-C 107.954 -1.128 . . . . 72.409999999999997 107.954 165.05 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 159' ' ' ALA . . . . . 0.502 ' HB2' ' HB2' ' A' ' 11' ' ' ALA . . . -56.03 -49.66 73.08 Favored 'General case' 0 N--CA 1.476 0.835 0 C-N-CA 124.186 0.995 . . . . 71.519999999999996 112.115 179.048 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 160' ' ' ASP . . . . . . . . . . . . . 27.5 t70 -160.45 156.96 26.84 Favored 'General case' 0 N--CA 1.471 0.584 0 O-C-N 123.904 0.752 . . . . 62.039999999999999 110.685 -174.077 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 161' ' ' CYS . . . . . . . . . . . . . 14.9 p -110.8 -168.71 1.34 Allowed 'General case' 0 N--CA 1.475 0.811 0 C-N-CA 125.122 1.369 . . . . 62.329999999999998 108.839 175.851 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 162' ' ' GLY . . . . . . . . . . . . . . . 132.45 53.39 0.08 OUTLIER Glycine 0 C--N 1.346 1.1 0 N-CA-C 111.006 -0.838 . . . . 60.229999999999997 111.006 -171.274 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 163' ' ' GLN . . . . . 0.708 ' HA ' ' H ' ' A' ' 7' ' ' PHE . 16.2 pt20 -50.34 132.46 24.52 Favored 'General case' 0 C--N 1.357 0.915 0 C-N-CA 123.908 0.883 . . . . 71.430000000000007 113.034 -172.499 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 164' ' ' LEU . . . . . 0.476 ' O ' ' HB ' ' A' ' 5' ' ' THR . 96.7 mt . . . . . 0 CA--C 1.534 0.362 0 N-CA-C 107.92 -1.141 . . . . 73.400000000000006 107.92 177.44 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 218' ' ' PRO . . . . . . . . . . . . . 13.5 Cg_exo . . . . . 0 CA--C 1.544 0.987 0 CA-C-O 121.055 0.356 . . . . 71.120000000000005 111.223 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' B' B ' 219' ' ' GLY . . . . . 0.429 ' HA2' ' HD3' ' B' ' 220' ' ' PRO . . . 155.55 140.91 3.09 Favored Glycine 0 CA--C 1.53 1.006 0 CA-C-N 115.435 -0.802 . . . . 51.130000000000003 111.313 -176.5 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 220' ' ' PRO . . . . . 0.429 ' HD3' ' HA2' ' B' ' 219' ' ' GLY . 6.1 Cg_exo -77.13 173.25 14.7 Favored 'Trans proline' 0 C--N 1.369 1.634 0 C-N-CA 123.422 2.748 . . . . 71.219999999999999 114.108 -173.866 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 221' ' ' TYR . . . . . . . . . . . . . 43.0 p90 . . . . . 0 C--O 1.25 1.108 0 CA-C-N 114.697 -1.138 . . . . 74.420000000000002 109.776 -175.601 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 3' ' ' ASN . . . . . 0.553 HD22 ' HA ' ' A' ' 25' ' ' PHE . 19.6 m120 . . . . . 0 C--O 1.245 0.833 0 CA-C-O 119.052 -0.499 . . . . 63.299999999999997 110.911 . . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 26.5 Cg_endo -60.79 118.53 5.4 Favored 'Trans proline' 0 C--N 1.382 2.29 0 C-N-CA 122.422 2.081 . . . . 74.409999999999997 110.227 177.731 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 5' ' ' THR . . . . . 0.459 ' HB ' ' O ' ' A' ' 164' ' ' LEU . 40.1 m -95.56 130.2 42.49 Favored 'General case' 0 C--O 1.239 0.501 0 N-CA-C 108.95 -0.759 . . . . 75.230000000000004 108.95 -173.116 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 6' ' ' VAL . . . . . 0.837 ' HA ' ' HB2' ' A' ' 163' ' ' GLN . 48.5 t -99.6 152.53 4.57 Favored 'Isoleucine or valine' 0 C--O 1.215 -0.748 0 N-CA-C 108.513 -0.921 . . . . 55.32 108.513 -179.426 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 7' ' ' PHE . . . . . 0.466 ' HB3' ' HA ' ' A' ' 163' ' ' GLN . 56.2 t80 -139.6 133.62 30.96 Favored 'General case' 0 C--O 1.242 0.682 0 C-N-CA 123.336 0.654 . . . . 72.129999999999995 109.832 179.877 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 40.2 m-85 -135.62 164.39 27.95 Favored 'General case' 0 C--O 1.241 0.642 0 O-C-N 124.663 1.227 . . . . 72.25 109.0 171.808 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 9' ' ' ASP . . . . . 0.522 ' HB2' ' HB3' ' A' ' 159' ' ' ALA . 40.8 m-20 -108.02 114.2 27.93 Favored 'General case' 0 N--CA 1.468 0.434 0 N-CA-C 107.605 -1.257 . . . . 71.209999999999994 107.605 171.134 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 10' ' ' ILE . . . . . 0.514 HG21 ' SD ' ' A' ' 142' ' ' MET . 46.1 mm -81.42 129.88 36.76 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.593 0 N-CA-C 109.089 -0.708 . . . . 64.319999999999993 109.089 177.799 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 11' ' ' ALA . . . . . 0.568 ' HB2' ' HB2' ' A' ' 159' ' ' ALA . . . -132.3 133.51 44.14 Favored 'General case' 0 N--CA 1.468 0.454 0 C-N-CA 123.379 0.672 . . . . 71.129999999999995 111.613 -168.131 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 12' ' ' VAL . . . . . 0.404 HG13 ' HB3' ' A' ' 154' ' ' LYS . 50.9 t -94.6 109.52 22.33 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.848 0 C-N-CA 124.607 1.163 . . . . 64.109999999999999 108.847 174.978 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 33.5 m-20 57.97 25.57 12.38 Favored 'General case' 0 N--CA 1.488 1.457 0 C-N-CA 125.449 1.5 . . . . 70.420000000000002 112.222 -172.96 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 100.45 -14.64 59.3 Favored Glycine 0 C--N 1.346 1.098 0 CA-C-O 119.475 -0.625 . . . . 73.450000000000003 113.326 179.129 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 17.6 mm-40 -87.72 114.25 58.14 Favored Pre-proline 0 N--CA 1.48 1.074 0 CA-C-N 117.559 0.679 . . . . 72.299999999999997 109.556 176.875 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 52.8 Cg_exo -50.26 108.64 0.23 Allowed 'Trans proline' 0 C--N 1.378 2.118 0 C-N-CA 123.649 2.9 . . . . 74.400000000000006 113.438 -178.795 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 59.4 tp -77.46 -40.49 42.99 Favored 'General case' 0 N--CA 1.472 0.648 0 C-N-CA 124.004 0.922 . . . . 25.140000000000001 109.546 175.459 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -167.43 170.38 41.6 Favored Glycine 0 C--N 1.342 0.904 0 CA-C-N 115.534 -0.757 . . . . 33.340000000000003 112.753 -178.823 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 19' ' ' ARG . . . . . 0.415 ' HB3' ' HE1' ' A' ' 7' ' ' PHE . 81.1 mtm180 -110.46 127.81 55.31 Favored 'General case' 0 N--CA 1.471 0.577 0 C-N-CA 124.299 1.04 . . . . 71.319999999999993 108.858 -178.587 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 76.5 t -129.17 122.16 55.54 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.723 0 C-N-CA 123.426 0.691 . . . . 71.530000000000001 110.67 -173.926 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 21' ' ' SER . . . . . 0.456 ' HB2' ' HB2' ' A' ' 134' ' ' GLU . 16.0 m -106.1 129.91 54.1 Favored 'General case' 0 CA--C 1.545 0.788 0 C-N-CA 123.58 0.752 . . . . 53.210000000000001 109.92 173.522 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 85.9 m-85 -100.64 170.23 8.5 Favored 'General case' 0 N--CA 1.474 0.768 0 C-N-CA 124.545 1.138 . . . . 65.450000000000003 110.038 175.022 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 23' ' ' GLU . . . . . 0.802 ' HB2' ' HD2' ' A' ' 133' ' ' LYS . 41.4 tt0 -135.35 118.75 16.79 Favored 'General case' 0 N--CA 1.472 0.648 0 C-N-CA 123.677 0.791 . . . . 72.400000000000006 109.261 -177.763 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . 0.471 ' HB3' ' HB1' ' A' ' 33' ' ' ALA . 36.3 mt -96.84 127.29 42.66 Favored 'General case' 0 N--CA 1.474 0.77 0 C-N-CA 122.747 0.419 . . . . 75.420000000000002 110.881 -177.062 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 25' ' ' PHE . . . . . 0.553 ' HA ' HD22 ' A' ' 3' ' ' ASN . 33.7 m-85 -86.15 65.85 9.28 Favored 'General case' 0 CA--C 1.537 0.466 0 C-N-CA 123.561 0.744 . . . . 75.420000000000002 109.188 175.851 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -65.47 -20.86 66.53 Favored 'General case' 0 N--CA 1.482 1.157 0 C-N-CA 124.193 0.997 . . . . 62.439999999999998 111.938 180.0 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 12.1 p-10 -77.15 -21.94 53.31 Favored 'General case' 0 CA--C 1.549 0.917 0 CA-C-N 114.924 -1.035 . . . . 72.049999999999997 111.589 178.668 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 60.2 mttp -106.11 -48.75 3.52 Favored 'General case' 0 N--CA 1.481 1.121 0 C-N-CA 123.392 0.677 . . . . 72.120000000000005 111.066 -176.207 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 29' ' ' VAL . . . . . 0.461 HG21 ' HA ' ' A' ' 129' ' ' PHE . 15.1 m -121.69 76.5 37.07 Favored Pre-proline 0 CA--C 1.552 1.054 0 C-N-CA 124.221 1.008 . . . . 74.120000000000005 109.613 -179.478 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 26.5 Cg_endo -61.45 -38.72 61.5 Favored 'Trans proline' 0 C--N 1.381 2.267 0 C-N-CA 122.492 2.128 . . . . 73.420000000000002 112.811 -173.194 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 4.7 ttmp? -65.21 -58.08 6.89 Favored 'General case' 0 N--CA 1.473 0.706 0 C-N-CA 122.971 0.509 . . . . 64.530000000000001 111.711 179.749 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 6.6 m -71.78 -28.46 63.64 Favored 'General case' 0 CA--C 1.555 1.168 0 CA-C-N 115.365 -0.834 . . . . 74.439999999999998 111.888 -168.79 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 33' ' ' ALA . . . . . 0.471 ' HB1' ' HB3' ' A' ' 24' ' ' LEU . . . -85.05 -45.79 11.78 Favored 'General case' 0 N--CA 1.478 0.942 0 C-N-CA 123.12 0.568 . . . . 55.539999999999999 111.275 179.793 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 8.5 tp10 -60.3 -34.73 74.19 Favored 'General case' 0 N--CA 1.487 1.386 0 C-N-CA 122.71 0.404 . . . . 43.520000000000003 110.988 178.96 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 35' ' ' ASN . . . . . 0.485 ' O ' ' HG ' ' A' ' 39' ' ' LEU . 36.2 t30 -49.44 -60.61 2.69 Favored 'General case' 0 C--N 1.351 0.651 0 O-C-N 124.514 1.134 . . . . 62.409999999999997 110.7 172.626 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 87.8 t80 -62.08 -40.91 97.42 Favored 'General case' 0 N--CA 1.466 0.371 0 CA-C-N 115.183 -0.917 . . . . 72.230000000000004 111.68 -176.307 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 37' ' ' ARG . . . . . 0.491 ' HG3' HE22 ' A' ' 163' ' ' GLN . 23.1 ttp180 -62.57 -42.99 99.89 Favored 'General case' 0 N--CA 1.477 0.9 0 C-N-CA 122.977 0.511 . . . . 73.430000000000007 110.909 -177.822 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 38' ' ' ALA . . . . . 0.547 ' HB1' ' HG2' ' A' ' 44' ' ' LYS . . . -69.1 -30.8 69.17 Favored 'General case' 0 CA--C 1.545 0.77 0 CA-C-N 115.341 -0.845 . . . . 62.109999999999999 111.508 179.754 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 39' ' ' LEU . . . . . 0.505 HD22 ' HE1' ' A' ' 48' ' ' TYR . 99.2 mt -72.48 -37.12 68.54 Favored 'General case' 0 CA--C 1.55 0.965 0 C-N-CA 123.582 0.753 . . . . 74.230000000000004 110.955 175.005 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 49.3 m -69.31 -46.2 67.69 Favored 'General case' 0 N--CA 1.479 1.006 0 C-N-CA 124.186 0.994 . . . . 74.430000000000007 111.284 -176.302 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 25.2 p -79.7 -30.01 40.9 Favored 'General case' 0 N--CA 1.472 0.668 0 C-N-CA 123.878 0.871 . . . . 40.299999999999997 111.288 178.587 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 83.03 28.82 36.09 Favored Glycine 0 C--N 1.346 1.119 0 CA-C-N 115.825 -0.625 . . . . 65.519999999999996 113.033 179.487 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 47.9 mm-40 -63.98 -23.06 67.19 Favored 'General case' 0 N--CA 1.477 0.887 0 C-N-CA 123.138 0.575 . . . . 73.430000000000007 111.604 177.024 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 44' ' ' LYS . . . . . 0.547 ' HG2' ' HB1' ' A' ' 38' ' ' ALA . 30.6 mmmt -99.77 19.83 15.27 Favored 'General case' 0 CA--C 1.541 0.631 0 C-N-CA 123.544 0.738 . . . . 73.530000000000001 111.985 -179.6 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 80.81 -21.99 5.19 Favored Glycine 0 C--N 1.355 1.607 0 N-CA-C 114.765 0.666 . . . . 63.119999999999997 114.765 173.224 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 46' ' ' PHE . . . . . 0.43 ' HE2' ' HA ' ' A' ' 78' ' ' ILE . 19.0 m-85 -69.84 -45.39 67.91 Favored 'General case' 0 C--N 1.348 0.534 0 C-N-CA 123.328 0.651 . . . . 63.509999999999998 110.684 -174.042 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 57.71 66.32 2.91 Favored Glycine 0 C--N 1.357 1.748 0 CA-C-O 119.008 -0.885 . . . . 74.340000000000003 113.927 168.544 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 48' ' ' TYR . . . . . 0.505 ' HE1' HD22 ' A' ' 39' ' ' LEU . 60.3 m-85 -66.21 85.59 0.1 Allowed 'General case' 0 N--CA 1.476 0.837 0 CA-C-O 122.71 1.243 . . . . 65.340000000000003 111.501 -176.494 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 29.0 tptp -113.32 109.21 18.35 Favored 'General case' 0 N--CA 1.451 -0.39 0 CA-C-N 112.662 -2.063 . . . . 73.140000000000001 107.975 179.439 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 89.8 19.89 45.9 Favored Glycine 0 N--CA 1.468 0.829 0 CA-C-O 119.657 -0.524 . . . . 73.329999999999998 113.695 -179.642 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 23.2 m -61.51 116.73 4.94 Favored 'General case' 0 C--O 1.243 0.745 0 C-N-CA 123.139 0.575 . . . . 70.140000000000001 109.572 174.228 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 52' ' ' CYS . . . . . 0.406 ' HA ' ' HA ' ' A' ' 157' ' ' THR . 20.1 p -102.03 128.96 48.24 Favored 'General case' 0 CA--C 1.538 0.487 0 CA-C-O 121.528 0.68 . . . . 71.310000000000002 112.19 -165.84 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 53' ' ' PHE . . . . . 0.585 ' HA ' ' HA2' ' A' ' 64' ' ' GLY . 77.7 m-85 -61.45 109.87 1.29 Allowed 'General case' 0 C--O 1.24 0.555 0 C-N-CA 124.804 1.241 . . . . 74.439999999999998 109.833 169.459 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 28.3 p-80 -124.15 2.42 8.57 Favored 'General case' 0 N--CA 1.475 0.791 0 CA-C-N 115.076 -0.965 . . . . 72.129999999999995 110.962 -175.532 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 55' ' ' ARG . . . . . 0.445 ' O ' ' HB3' ' A' ' 63' ' ' GLN . 53.4 ttt-85 -144.45 95.25 2.68 Favored 'General case' 0 C--O 1.218 -0.563 0 N-CA-C 108.396 -0.964 . . . . 73.109999999999999 108.396 177.046 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 56' ' ' ILE . . . . . 0.43 HG21 ' HA ' ' A' ' 143' ' ' GLU . 52.6 mt -130.4 133.68 63.49 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.088 0 N-CA-C 108.661 -0.866 . . . . 71.299999999999997 108.661 178.552 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 67.2 mt -126.65 118.61 22.75 Favored Pre-proline 0 CA--C 1.556 1.193 0 C-N-CA 123.606 0.762 . . . . 64.540000000000006 109.024 178.098 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 51.6 Cg_exo -57.62 141.79 95.49 Favored 'Trans proline' 0 C--N 1.387 2.559 0 C-N-CA 124.067 3.178 . . . . 74.329999999999998 113.784 -178.363 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 67.98 31.43 75.27 Favored Glycine 0 C--N 1.348 1.215 0 O-C-N 124.03 0.831 . . . . 50.299999999999997 112.807 -179.273 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 49.1 t80 -152.73 -71.23 0.15 Allowed 'General case' 0 CA--C 1.546 0.808 0 C-N-CA 123.75 0.82 . . . . 65.299999999999997 110.364 -177.703 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 37.0 ttp -170.25 150.1 3.57 Favored 'General case' 0 N--CA 1.485 1.296 0 N-CA-C 112.432 0.531 . . . . 75.140000000000001 112.432 -163.532 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 62' ' ' CYS . . . . . 0.497 ' SG ' ' HB2' ' A' ' 143' ' ' GLU . 35.4 m -108.77 112.41 24.69 Favored 'General case' 0 N--CA 1.474 0.774 0 C-N-CA 123.806 0.842 . . . . 73.019999999999996 109.5 168.4 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 63' ' ' GLN . . . . . 0.445 ' HB3' ' O ' ' A' ' 55' ' ' ARG . 52.1 tt0 -112.57 134.74 53.94 Favored 'General case' 0 N--CA 1.486 1.365 0 CA-C-O 121.644 0.735 . . . . 63.340000000000003 110.115 179.975 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 64' ' ' GLY . . . . . 0.585 ' HA2' ' HA ' ' A' ' 53' ' ' PHE . . . -134.45 175.56 20.39 Favored Glycine 0 CA--C 1.499 -0.947 0 CA-C-N 115.238 -0.892 . . . . 52.32 112.478 178.697 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 178.6 170.99 41.39 Favored Glycine 0 N--CA 1.444 -0.833 0 N-CA-C 110.726 -0.95 . . . . 64.310000000000002 110.726 179.383 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 14.8 t70 -94.18 166.31 12.18 Favored 'General case' 0 C--O 1.241 0.654 0 N-CA-C 109.862 -0.421 . . . . 54.130000000000003 109.862 -172.366 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 37.7 t80 -70.83 -22.93 62.27 Favored 'General case' 0 CA--C 1.548 0.9 0 C-N-CA 122.742 0.417 . . . . 64.439999999999998 110.356 175.142 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 52.7 m -61.64 113.65 2.84 Favored 'General case' 0 C--O 1.247 0.922 0 C-N-CA 123.823 0.849 . . . . 72.5 110.994 176.417 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 69' ' ' ARG . . . . . 0.415 ' HB3' ' HB ' ' A' ' 73' ' ' THR . 53.5 mtt180 58.99 29.78 19.41 Favored 'General case' 0 C--N 1.361 1.103 0 C-N-CA 124.577 1.151 . . . . 65.109999999999999 112.353 -176.114 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 32.4 p80 -51.72 -33.79 36.08 Favored 'General case' 0 N--CA 1.495 1.811 0 C-N-CA 123.252 0.621 . . . . 75.319999999999993 111.381 -179.427 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 6.8 t30 -75.49 89.96 2.71 Favored 'General case' 0 CA--C 1.551 0.992 0 C-N-CA 124.104 0.962 . . . . 62.350000000000001 109.164 171.622 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 100.59 -7.24 57.76 Favored Glycine 0 C--N 1.347 1.176 0 N-CA-C 115.93 1.132 . . . . 44.32 115.93 171.089 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 73' ' ' THR . . . . . 0.415 ' HB ' ' HB3' ' A' ' 69' ' ' ARG . 15.0 m -142.92 -75.23 0.27 Allowed 'General case' 0 N--CA 1.483 1.198 0 CA-C-N 118.687 1.243 . . . . 62.119999999999997 109.792 179.763 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 72.07 40.29 56.87 Favored Glycine 0 C--N 1.354 1.546 0 C-N-CA 123.234 0.445 . . . . 35.109999999999999 113.634 173.975 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 142.45 52.79 0.04 OUTLIER Glycine 0 C--N 1.344 0.995 0 CA-C-N 117.402 0.601 . . . . 75.109999999999999 111.741 -173.236 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 76' ' ' LYS . . . . . 0.407 ' HG2' ' OH ' ' A' ' 48' ' ' TYR . 16.5 ptpt -56.55 162.78 2.05 Favored 'General case' 0 N--CA 1.477 0.913 0 C-N-CA 124.183 0.993 . . . . 71.439999999999998 112.165 -176.237 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 77.9 p -91.33 173.63 7.81 Favored 'General case' 0 C--O 1.241 0.634 0 CA-C-N 115.343 -0.844 . . . . 63.43 110.42 -179.991 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 78' ' ' ILE . . . . . 0.441 HG21 ' HB3' ' A' ' 38' ' ' ALA . 21.4 pt -74.7 -17.5 16.47 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.608 0 CA-C-N 116.067 -0.515 . . . . 64.400000000000006 109.96 173.133 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 49.5 m-85 -87.67 -13.23 43.15 Favored 'General case' 0 CA--C 1.541 0.619 0 C-N-CA 124.615 1.166 . . . . 75.049999999999997 110.795 -178.445 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 142.37 -133.02 5.41 Favored Glycine 0 C--N 1.348 1.228 0 N-CA-C 110.858 -0.897 . . . . 44.409999999999997 110.858 178.689 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 36.4 tt0 -65.51 -54.34 29.61 Favored 'General case' 0 CA--C 1.54 0.596 0 C-N-CA 123.365 0.666 . . . . 74.010000000000005 109.86 175.215 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 82' ' ' LYS . . . . . 0.805 ' HD2' ' HA ' ' A' ' 107' ' ' THR . 24.1 pttm -158.81 174.15 15.45 Favored 'General case' 0 C--O 1.243 0.73 0 CA-C-N 114.52 -1.218 . . . . 62.350000000000001 109.17 -172.787 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 12.5 p90 -155.39 172.56 18.01 Favored 'General case' 0 N--CA 1.478 0.939 0 C-N-CA 123.59 0.756 . . . . 64.409999999999997 110.245 -175.518 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 14.1 pt-20 -87.25 168.34 13.29 Favored 'General case' 0 CA--C 1.548 0.885 0 CA-C-N 115.897 -0.592 . . . . 73.450000000000003 110.614 179.23 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 85' ' ' ASP . . . . . 0.432 ' HB3' HG23 ' A' ' 127' ' ' VAL . 35.7 m-20 -80.31 150.36 29.98 Favored 'General case' 0 N--CA 1.478 0.971 0 C-N-CA 123.898 0.879 . . . . 65.319999999999993 112.199 -174.597 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 6.9 tp10 -78.26 -62.55 1.64 Allowed 'General case' 0 C--N 1.352 0.687 0 CA-C-N 115.425 -0.807 . . . . 73.150000000000006 111.403 -178.02 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 23.0 p30 -176.75 143.46 0.45 Allowed 'General case' 0 N--CA 1.48 1.056 0 C-N-CA 124.419 1.087 . . . . 63.240000000000002 109.159 -175.825 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 98.8 m-85 -89.3 50.11 1.87 Allowed 'General case' 0 N--CA 1.491 1.585 0 CA-C-O 121.607 0.718 . . . . 63.549999999999997 111.448 -168.073 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 70.9 mt -67.86 -48.16 76.46 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.695 0 C-N-CA 124.145 0.978 . . . . 62.25 109.885 174.202 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 90' ' ' LEU . . . . . 0.532 HD11 ' HB2' ' A' ' 25' ' ' PHE . 74.5 mt -99.89 122.69 43.2 Favored 'General case' 0 C--O 1.241 0.63 0 CA-C-N 115.462 -0.79 . . . . 64.409999999999997 110.585 -174.665 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 44.0 mtmt -119.89 171.71 8.23 Favored 'General case' 0 N--CA 1.475 0.807 0 C-N-CA 124.073 0.949 . . . . 70.040000000000006 110.4 177.098 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 92' ' ' HIS . . . . . 0.559 ' HA ' HG13 ' A' ' 97' ' ' ILE . 13.0 m-70 -87.59 41.65 1.0 Allowed 'General case' 0 N--CA 1.482 1.15 0 C-N-CA 124.223 1.009 . . . . 64.530000000000001 110.297 -176.115 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 13.0 t -84.92 1.49 47.05 Favored 'General case' 0 CA--C 1.555 1.16 0 C-N-CA 123.986 0.914 . . . . 72.439999999999998 111.679 -174.777 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -140.53 161.22 26.58 Favored Glycine 0 C--N 1.344 1.002 0 CA-C-O 119.552 -0.582 . . . . 72.319999999999993 111.709 179.601 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 7.3 Cg_exo -75.27 149.74 36.03 Favored 'Trans proline' 0 C--N 1.37 1.692 0 C-N-CA 123.135 2.557 . . . . 72.120000000000005 112.146 175.295 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 96' ' ' GLY . . . . . 0.43 ' HA3' HG12 ' A' ' 132' ' ' VAL . . . 84.61 19.45 59.99 Favored Glycine 0 C--N 1.343 0.957 0 N-CA-C 114.586 0.594 . . . . 73.510000000000005 114.586 177.357 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 97' ' ' ILE . . . . . 0.559 HG13 ' HA ' ' A' ' 92' ' ' HIS . 7.8 mm -70.54 122.49 22.48 Favored 'Isoleucine or valine' 0 CA--C 1.553 1.088 0 C-N-CA 124.061 0.944 . . . . 64.340000000000003 111.99 -177.199 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 56.8 tp -104.91 124.08 48.87 Favored 'General case' 0 N--CA 1.482 1.133 0 C-N-CA 123.266 0.626 . . . . 64.409999999999997 110.548 179.813 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 32.2 t -151.22 154.42 36.8 Favored 'General case' 0 CA--C 1.548 0.882 0 C-N-CA 123.627 0.771 . . . . 71.329999999999998 109.822 179.685 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 100' ' ' MET . . . . . 0.632 ' HA ' ' HA ' ' A' ' 112' ' ' PHE . 85.3 mtp -86.25 141.34 29.36 Favored 'General case' 0 N--CA 1.492 1.655 0 CA-C-N 118.272 0.487 . . . . 62.409999999999997 109.79 179.324 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 101' ' ' ALA . . . . . 0.432 ' HB3' ' HB2' ' A' ' 111' ' ' GLN . . . -73.07 162.41 29.49 Favored 'General case' 0 N--CA 1.487 1.401 0 N-CA-C 112.432 0.531 . . . . 41.219999999999999 112.432 -169.75 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 21.3 p-10 -161.71 170.16 20.17 Favored 'General case' 0 N--CA 1.474 0.753 0 CA-C-N 115.736 -0.665 . . . . 64.439999999999998 111.295 -174.28 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -103.73 -20.05 14.1 Favored 'General case' 0 N--CA 1.477 0.899 0 C-N-CA 124.124 0.97 . . . . 62.340000000000003 110.575 169.412 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 167.41 -151.38 18.96 Favored Glycine 0 CA--C 1.536 1.403 0 CA-C-O 119.269 -0.739 . . . . 52.130000000000003 111.439 -173.473 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 31.4 Cg_exo -62.46 144.07 94.21 Favored 'Trans proline' 0 C--N 1.37 1.709 0 C-N-CA 122.751 2.301 . . . . 73.140000000000001 112.671 175.108 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 64.4 t30 66.93 9.89 7.21 Favored 'General case' 0 N--CA 1.493 1.695 0 C-N-CA 124.745 1.218 . . . . 73.430000000000007 112.578 175.03 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 107' ' ' THR . . . . . 0.805 ' HA ' ' HD2' ' A' ' 82' ' ' LYS . 46.8 p -114.45 2.74 14.74 Favored 'General case' 0 N--CA 1.474 0.765 0 O-C-N 121.688 -0.632 . . . . 71.420000000000002 112.04 177.945 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 39.8 t30 -71.96 131.87 43.54 Favored 'General case' 0 N--CA 1.475 0.787 0 N-CA-C 108.925 -0.769 . . . . 74.219999999999999 108.925 174.924 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 112.43 22.15 5.91 Favored Glycine 0 N--CA 1.468 0.793 0 CA-C-O 120.239 -0.201 . . . . 44.130000000000003 113.08 -176.058 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 27.7 p -125.11 120.1 30.45 Favored 'General case' 0 N--CA 1.47 0.539 0 N-CA-C 107.745 -1.205 . . . . 74.019999999999996 107.745 169.21 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 111' ' ' GLN . . . . . 0.432 ' HB2' ' HB3' ' A' ' 101' ' ' ALA . 49.4 mt-30 63.41 176.95 0.16 Allowed 'General case' 0 N--CA 1.492 1.637 0 C-N-CA 124.133 0.973 . . . . 74.450000000000003 111.769 -171.897 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 112' ' ' PHE . . . . . 0.632 ' HA ' ' HA ' ' A' ' 100' ' ' MET . 44.9 p90 -139.88 159.46 42.13 Favored 'General case' 0 N--CA 1.476 0.87 0 C-N-CA 124.249 1.02 . . . . 74.239999999999995 108.461 175.478 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 113' ' ' PHE . . . . . . . . . . . . . 54.0 p90 -152.59 153.83 34.17 Favored 'General case' 0 N--CA 1.471 0.606 0 CA-C-O 121.004 0.431 . . . . 70.239999999999995 111.191 178.901 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 114' ' ' ILE . . . . . . . . . . . . . 9.3 mt -119.73 101.96 12.02 Favored 'Isoleucine or valine' 0 C--O 1.245 0.831 0 N-CA-C 107.663 -1.236 . . . . 44.210000000000001 107.663 176.468 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 115' ' ' CYS . . . . . 0.407 ' HB2' ' HB ' ' A' ' 97' ' ' ILE . 69.9 m -62.31 104.77 0.53 Allowed 'General case' 0 CA--C 1.537 0.46 0 N-CA-C 108.602 -0.888 . . . . 63.530000000000001 108.602 169.502 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 116' ' ' THR . . . . . 0.604 HG22 HG12 ' A' ' 139' ' ' VAL . 64.3 p -69.45 -35.15 75.37 Favored 'General case' 0 N--CA 1.473 0.725 0 C-N-CA 123.461 0.705 . . . . 73.310000000000002 110.334 -175.708 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -107.87 167.17 10.17 Favored 'General case' 0 C--O 1.246 0.887 0 CA-C-N 114.716 -1.129 . . . . 44.310000000000002 109.289 174.465 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 20.7 ptmt -73.73 91.23 1.89 Allowed 'General case' 0 CA--C 1.545 0.769 0 CA-C-O 122.013 0.911 . . . . 75.209999999999994 109.954 174.757 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 119' ' ' THR . . . . . . . . . . . . . 58.4 p -86.97 83.28 7.54 Favored 'General case' 0 CA--C 1.542 0.663 0 CA-C-O 121.997 0.904 . . . . 62.539999999999999 109.022 -179.242 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 15.9 pt-20 -79.72 -15.23 57.91 Favored 'General case' 0 N--CA 1.48 1.056 0 CA-C-N 115.129 -0.941 . . . . 44.240000000000002 112.406 -167.953 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 121' ' ' TRP . . . . . . . . . . . . . 44.2 p90 -71.97 -14.62 61.95 Favored 'General case' 0 N--CA 1.481 1.1 0 C-N-CA 122.977 0.511 . . . . 64.319999999999993 110.832 172.928 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 54.2 mt -88.37 6.47 37.2 Favored 'General case' 0 N--CA 1.474 0.729 0 C-N-CA 123.121 0.568 . . . . 71.140000000000001 111.092 174.238 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 30.7 m-20 -79.29 136.84 37.15 Favored 'General case' 0 N--CA 1.474 0.759 0 N-CA-C 107.905 -1.146 . . . . 52.240000000000002 107.905 167.546 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 95.42 -24.3 29.79 Favored Glycine 0 N--CA 1.472 1.067 0 N-CA-C 111.17 -0.772 . . . . 64.019999999999996 111.17 -168.408 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 125' ' ' LYS . . . . . 0.631 ' HG3' ' H ' ' A' ' 126' ' ' HIS . 12.2 tppt? -75.27 -169.45 0.97 Allowed 'General case' 0 CA--C 1.563 1.48 0 N-CA-C 107.913 -1.143 . . . . 73.530000000000001 107.913 169.274 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 126' ' ' HIS . . . . . 0.631 ' H ' ' HG3' ' A' ' 125' ' ' LYS . 43.2 p-80 -67.56 157.59 34.02 Favored 'General case' 0 CA--C 1.549 0.941 0 C-N-CA 123.919 0.887 . . . . 75.140000000000001 111.685 -173.347 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 127' ' ' VAL . . . . . 0.491 HG12 ' O ' ' A' ' 128' ' ' VAL . 43.1 t -67.86 140.45 19.16 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.85 0 CA-C-N 114.292 -1.322 . . . . 73.349999999999994 112.466 -173.033 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 128' ' ' VAL . . . . . 0.501 HG11 HD12 ' A' ' 97' ' ' ILE . 97.2 t -80.98 154.28 4.26 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.832 0 C-N-CA 124.803 1.241 . . . . 62.130000000000003 109.276 170.429 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 129' ' ' PHE . . . . . 0.523 ' CE2' ' HG3' ' A' ' 100' ' ' MET . 37.6 p90 -131.57 -17.41 2.91 Favored 'General case' 0 N--CA 1.484 1.239 0 O-C-N 121.626 -0.671 . . . . 63.520000000000003 111.663 177.938 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . -138.4 175.01 21.69 Favored Glycine 0 C--N 1.342 0.904 0 CA-C-O 121.431 0.462 . . . . 73.129999999999995 113.314 -169.283 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 31.3 ttpt -160.81 136.07 7.82 Favored 'General case' 0 CA--C 1.536 0.431 0 N-CA-C 108.205 -1.035 . . . . 71.409999999999997 108.205 -178.565 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 132' ' ' VAL . . . . . 0.43 HG12 ' HA3' ' A' ' 96' ' ' GLY . 13.3 p -72.25 130.97 35.31 Favored 'Isoleucine or valine' 0 CA--C 1.553 1.063 0 N-CA-C 109.251 -0.648 . . . . 62.140000000000001 109.251 173.239 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 133' ' ' LYS . . . . . 0.802 ' HD2' ' HB2' ' A' ' 23' ' ' GLU . 19.9 ptmt -116.15 -26.96 7.04 Favored 'General case' 0 N--CA 1.48 1.042 0 C-N-CA 123.582 0.753 . . . . 73.25 110.257 -179.721 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 134' ' ' GLU . . . . . 0.456 ' HB2' ' HB2' ' A' ' 21' ' ' SER . 71.3 mm-40 -131.24 130.22 42.62 Favored 'General case' 0 N--CA 1.471 0.617 0 C-N-CA 124.656 1.183 . . . . 54.149999999999999 108.558 175.308 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 135' ' ' GLY . . . . . 0.414 ' O ' HG23 ' A' ' 139' ' ' VAL . . . 90.89 27.71 18.19 Favored Glycine 0 N--CA 1.468 0.829 0 CA-C-O 119.569 -0.573 . . . . 62.049999999999997 113.688 175.444 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 136' ' ' MET . . . . . . . . . . . . . 6.4 tpt -58.76 -43.7 90.39 Favored 'General case' 0 N--CA 1.486 1.333 0 C-N-CA 123.561 0.745 . . . . 74.540000000000006 110.52 174.964 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 137' ' ' ASN . . . . . . . . . . . . . 18.7 m120 -60.61 -37.23 80.73 Favored 'General case' 0 N--CA 1.479 1.016 0 CA-C-N 115.625 -0.716 . . . . 73.540000000000006 111.283 178.29 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 138' ' ' ILE . . . . . . . . . . . . . 43.4 mm -67.78 -41.32 85.07 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.035 0 C-N-CA 123.555 0.742 . . . . 75.129999999999995 110.617 -179.566 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 139' ' ' VAL . . . . . 0.604 HG12 HG22 ' A' ' 116' ' ' THR . 96.1 t -61.5 -44.1 98.01 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.979 0 C-N-CA 123.503 0.721 . . . . 73.340000000000003 110.699 177.664 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 41.7 mt-10 -69.11 -34.24 74.76 Favored 'General case' 0 N--CA 1.477 0.914 0 CA-C-N 115.455 -0.793 . . . . 75.530000000000001 111.02 178.121 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -73.11 -33.8 65.78 Favored 'General case' 0 N--CA 1.475 0.822 0 C-N-CA 123.367 0.667 . . . . 72.329999999999998 111.669 -178.863 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 142' ' ' MET . . . . . 0.561 ' HB2' HD13 ' A' ' 156' ' ' ILE . 21.8 ptt? -79.38 -27.14 41.91 Favored 'General case' 0 N--CA 1.473 0.7 0 C-N-CA 122.423 0.289 . . . . 72.010000000000005 110.414 177.985 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 143' ' ' GLU . . . . . 0.497 ' HB2' ' SG ' ' A' ' 62' ' ' CYS . 33.4 tt0 -59.36 -29.3 67.58 Favored 'General case' 0 N--CA 1.482 1.144 0 C-N-CA 123.041 0.536 . . . . 73.049999999999997 111.609 176.134 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 144' ' ' ARG . . . . . . . . . . . . . 80.1 mtp180 -64.94 -21.45 66.83 Favored 'General case' 0 CA--C 1.543 0.707 0 C-N-CA 123.704 0.802 . . . . 72.439999999999998 112.365 -178.554 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 145' ' ' PHE . . . . . 0.499 ' HB2' HD11 ' A' ' 156' ' ' ILE . 77.6 m-85 -81.47 -12.7 58.79 Favored 'General case' 0 N--CA 1.478 0.933 0 C-N-CA 122.502 0.321 . . . . 71.120000000000005 111.337 175.554 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . -70.75 166.6 51.6 Favored Glycine 0 CA--C 1.531 1.034 0 N-CA-C 113.898 0.319 . . . . 55.409999999999997 113.898 179.347 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 14.7 m -134.86 161.27 35.7 Favored 'General case' 0 N--CA 1.479 0.994 0 C-N-CA 124.376 1.07 . . . . 74.299999999999997 109.749 -179.792 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 148' ' ' ARG . . . . . . . . . . . . . 22.8 mmt85 -68.3 -26.51 65.68 Favored 'General case' 0 N--CA 1.484 1.261 0 C-N-CA 123.557 0.743 . . . . 70.540000000000006 112.464 -176.714 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 149' ' ' ASN . . . . . . . . . . . . . 30.1 p-10 -84.33 0.47 49.09 Favored 'General case' 0 N--CA 1.486 1.33 0 C-N-CA 122.996 0.518 . . . . 70.239999999999995 111.452 175.682 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . 95.29 -6.16 68.4 Favored Glycine 0 C--N 1.349 1.26 0 CA-C-O 119.683 -0.509 . . . . 55.009999999999998 112.982 179.445 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 53.8 tttp -62.94 141.31 58.77 Favored 'General case' 0 N--CA 1.475 0.823 0 C-N-CA 123.035 0.534 . . . . 64.310000000000002 111.072 179.987 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 152' ' ' THR . . . . . . . . . . . . . 26.4 p -102.74 131.8 49.33 Favored 'General case' 0 C--O 1.244 0.811 0 N-CA-C 108.776 -0.824 . . . . 71.420000000000002 108.776 166.686 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 153' ' ' SER . . . . . . . . . . . . . 16.4 m -72.49 -23.38 61.02 Favored 'General case' 0 N--CA 1.473 0.696 0 C-N-CA 123.834 0.854 . . . . 45.020000000000003 110.598 178.131 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 154' ' ' LYS . . . . . 0.404 ' HB3' HG13 ' A' ' 12' ' ' VAL . 73.6 mmtt -134.88 143.38 46.94 Favored 'General case' 0 C--O 1.241 0.625 0 C-N-CA 125.338 1.455 . . . . 73.439999999999998 108.289 -178.678 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 3.8 tppp? -74.63 89.55 2.24 Favored 'General case' 0 C--N 1.345 0.373 0 N-CA-C 108.903 -0.777 . . . . 71.319999999999993 108.903 177.761 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 156' ' ' ILE . . . . . 0.561 HD13 ' HB2' ' A' ' 142' ' ' MET . 66.5 mt -84.02 130.17 36.36 Favored 'Isoleucine or valine' 0 C--O 1.222 -0.367 0 N-CA-C 106.967 -1.494 . . . . 72.239999999999995 106.967 179.989 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 157' ' ' THR . . . . . 0.406 ' HA ' ' HA ' ' A' ' 52' ' ' CYS . 4.8 t -154.44 156.54 36.95 Favored 'General case' 0 C--O 1.237 0.424 0 C-N-CA 122.74 0.416 . . . . 72.209999999999994 110.651 -167.166 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 158' ' ' ILE . . . . . . . . . . . . . 74.1 mt -75.2 98.33 1.39 Allowed 'Isoleucine or valine' 0 CA--C 1.539 0.553 0 N-CA-C 109.015 -0.735 . . . . 74.019999999999996 109.015 172.963 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 159' ' ' ALA . . . . . 0.568 ' HB2' ' HB2' ' A' ' 11' ' ' ALA . . . -53.6 -53.65 48.75 Favored 'General case' 0 N--CA 1.472 0.667 0 C-N-CA 123.629 0.772 . . . . 75.010000000000005 111.289 177.155 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 160' ' ' ASP . . . . . . . . . . . . . 25.9 t70 -156.33 152.87 28.16 Favored 'General case' 0 N--CA 1.476 0.834 0 CA-C-N 116.321 -0.399 . . . . 74.019999999999996 111.03 -177.77 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 161' ' ' CYS . . . . . . . . . . . . . 23.7 p -102.8 -171.45 1.95 Allowed 'General case' 0 N--CA 1.475 0.805 0 C-N-CA 124.888 1.275 . . . . 42.229999999999997 109.76 175.501 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 162' ' ' GLY . . . . . . . . . . . . . . . 130.49 52.25 0.1 Allowed Glycine 0 C--N 1.346 1.086 0 N-CA-C 111.176 -0.77 . . . . 71.230000000000004 111.176 -171.314 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 163' ' ' GLN . . . . . 0.837 ' HB2' ' HA ' ' A' ' 6' ' ' VAL . 3.6 pt20 -52.48 126.6 19.93 Favored 'General case' 0 CA--C 1.552 1.02 0 C-N-CA 124.527 1.131 . . . . 54.200000000000003 113.57 -169.82 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 164' ' ' LEU . . . . . 0.459 ' O ' ' HB ' ' A' ' 5' ' ' THR . 88.1 mt . . . . . 0 C--O 1.216 -0.706 0 CA-C-N 115.586 -0.734 . . . . 63.240000000000002 109.312 -175.114 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 218' ' ' PRO . . . . . . . . . . . . . 75.0 Cg_exo . . . . . 0 CA--C 1.547 1.139 0 CA-C-O 120.909 0.295 . . . . 73.049999999999997 111.516 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' B' B ' 219' ' ' GLY . . . . . . . . . . . . . . . 170.0 148.51 5.93 Favored Glycine 0 CA--C 1.534 1.264 0 CA-C-N 115.617 -0.719 . . . . 63.310000000000002 111.87 -178.006 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 220' ' ' PRO . . . . . . . . . . . . . 88.0 Cg_endo -76.85 169.75 21.11 Favored 'Trans proline' 0 C--N 1.37 1.688 0 C-N-CA 123.34 2.693 . . . . 73.349999999999994 114.823 -175.334 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 221' ' ' TYR . . . . . . . . . . . . . 91.4 m-85 . . . . . 0 N--CA 1.487 1.404 0 C-N-CA 124.175 0.99 . . . . 75.219999999999999 111.42 -176.44 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 3' ' ' ASN . . . . . 0.571 HD22 ' HA ' ' A' ' 25' ' ' PHE . 17.1 m120 . . . . . 0 CA--C 1.542 0.651 0 CA-C-O 119.236 -0.411 . . . . 73.109999999999999 111.234 . . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 4' ' ' PRO . . . . . 0.449 ' HG2' ' HB2' ' A' ' 24' ' ' LEU . 56.0 Cg_endo -68.28 153.19 74.93 Favored 'Trans proline' 0 C--N 1.369 1.634 0 C-N-CA 122.366 2.044 . . . . 74.409999999999997 110.517 170.216 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 5' ' ' THR . . . . . 0.515 ' HB ' ' O ' ' A' ' 164' ' ' LEU . 76.3 m -123.55 136.6 54.63 Favored 'General case' 0 C--O 1.236 0.374 0 N-CA-C 109.672 -0.492 . . . . 75.239999999999995 109.672 177.427 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 6' ' ' VAL . . . . . 0.49 ' HA ' ' HB2' ' A' ' 163' ' ' GLN . 17.3 m -102.67 145.99 11.3 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.36 0 C-N-CA 123.754 0.822 . . . . 72.510000000000005 109.653 174.813 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 7' ' ' PHE . . . . . 0.497 ' H ' ' HA ' ' A' ' 163' ' ' GLN . 84.3 t80 -121.47 133.53 55.05 Favored 'General case' 0 C--O 1.237 0.415 0 C-N-CA 123.896 0.879 . . . . 72.010000000000005 109.169 -176.342 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 8' ' ' PHE . . . . . 0.431 ' HD2' ' HE1' ' A' ' 22' ' ' PHE . 36.5 m-85 -133.43 164.87 26.17 Favored 'General case' 0 C--O 1.24 0.556 0 C-N-CA 124.11 0.964 . . . . 71.230000000000004 109.873 172.209 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 19.3 m-20 -118.2 112.89 20.72 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 114.209 -1.36 . . . . 73.209999999999994 107.819 173.039 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 10' ' ' ILE . . . . . 0.464 HG21 ' SD ' ' A' ' 142' ' ' MET . 40.3 mm -81.98 134.0 27.98 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.566 0 N-CA-C 108.853 -0.795 . . . . 75.409999999999997 108.853 177.906 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 11' ' ' ALA . . . . . 0.551 ' HB2' ' HB2' ' A' ' 159' ' ' ALA . . . -135.08 111.29 9.63 Favored 'General case' 0 N--CA 1.468 0.448 0 C-N-CA 123.482 0.713 . . . . 70.120000000000005 110.905 -173.064 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 12' ' ' VAL . . . . . 0.503 HG22 HG12 ' A' ' 156' ' ' ILE . 85.5 t -94.82 129.15 45.39 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.832 0 N-CA-C 108.14 -1.059 . . . . 74.140000000000001 108.14 178.708 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 22.9 m-20 68.92 13.96 8.85 Favored 'General case' 0 N--CA 1.493 1.684 0 C-N-CA 124.691 1.196 . . . . 74.420000000000002 110.481 -170.507 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 80.3 -2.62 76.14 Favored Glycine 0 C--N 1.354 1.55 0 CA-C-O 120.186 -0.23 . . . . 71.439999999999998 112.792 -168.972 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 18.3 mm-40 -93.17 117.73 67.55 Favored Pre-proline 0 C--O 1.243 0.751 0 C-N-CA 124.025 0.93 . . . . 74.5 109.454 178.722 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 92.5 Cg_exo -45.51 105.19 0.07 OUTLIER 'Trans proline' 0 C--N 1.378 2.13 0 C-N-CA 123.912 3.075 . . . . 70.310000000000002 113.681 179.302 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 31.9 tp -76.36 -35.54 58.65 Favored 'General case' 0 N--CA 1.477 0.915 0 C-N-CA 123.574 0.75 . . . . 74.409999999999997 109.411 179.219 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 166.52 -176.47 41.68 Favored Glycine 0 C--N 1.337 0.635 0 CA-C-N 115.617 -0.72 . . . . 72.219999999999999 111.662 178.244 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 19.9 ptt85 -106.58 148.13 28.64 Favored 'General case' 0 N--CA 1.472 0.644 0 C-N-CA 122.739 0.416 . . . . 74.030000000000001 110.088 -175.641 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 20' ' ' VAL . . . . . 0.401 HG13 HG13 ' A' ' 132' ' ' VAL . 81.9 t -136.7 142.08 39.06 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.517 0 N-CA-C 108.635 -0.876 . . . . 72.040000000000006 108.635 176.788 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 15.7 m -130.21 132.79 46.16 Favored 'General case' 0 CA--C 1.542 0.662 0 N-CA-C 108.664 -0.865 . . . . 50.439999999999998 108.664 173.688 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 22' ' ' PHE . . . . . 0.431 ' HE1' ' HD2' ' A' ' 8' ' ' PHE . 40.8 m-85 -111.28 125.84 54.26 Favored 'General case' 0 N--CA 1.475 0.796 0 C-N-CA 123.516 0.726 . . . . 73.519999999999996 109.697 -179.524 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 37.0 tt0 -76.91 111.39 12.4 Favored 'General case' 0 CA--C 1.546 0.815 0 C-N-CA 123.252 0.621 . . . . 72.319999999999993 109.894 172.494 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . 0.449 ' HB2' ' HG2' ' A' ' 4' ' ' PRO . 76.1 mt -77.9 125.89 30.03 Favored 'General case' 0 N--CA 1.471 0.606 0 C-N-CA 123.325 0.65 . . . . 72.129999999999995 110.163 175.305 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 25' ' ' PHE . . . . . 0.571 ' HA ' HD22 ' A' ' 3' ' ' ASN . 90.8 m-85 -85.53 62.49 7.5 Favored 'General case' 0 CA--C 1.538 0.499 0 C-N-CA 123.777 0.831 . . . . 72.209999999999994 110.702 178.961 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -69.65 -8.56 48.68 Favored 'General case' 0 CA--C 1.547 0.845 0 CA-C-N 115.387 -0.824 . . . . 73.239999999999995 111.627 179.008 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 13.2 p-10 -76.23 -31.68 58.5 Favored 'General case' 0 CA--C 1.549 0.939 0 C-N-CA 123.427 0.691 . . . . 73.230000000000004 110.956 175.432 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 28' ' ' LYS . . . . . 0.513 ' HD2' HD21 ' A' ' 90' ' ' LEU . 62.0 mttp -106.18 -47.69 3.76 Favored 'General case' 0 N--CA 1.487 1.404 0 C-N-CA 123.261 0.624 . . . . 65.099999999999994 111.137 -176.211 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 21.1 m -122.6 67.58 29.55 Favored Pre-proline 0 CA--C 1.563 1.475 0 C-N-CA 123.803 0.841 . . . . 73.549999999999997 110.144 -179.914 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 38.4 Cg_endo -62.17 -30.74 82.45 Favored 'Trans proline' 0 C--N 1.384 2.399 0 C-N-CA 122.704 2.269 . . . . 71.099999999999994 112.264 -175.924 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 64.4 tttm -69.22 -51.14 40.72 Favored 'General case' 0 CA--C 1.543 0.7 0 C-N-CA 124.559 1.143 . . . . 74.040000000000006 111.223 -177.451 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 16.5 m -75.03 -30.15 61.01 Favored 'General case' 0 CA--C 1.551 1.009 0 CA-C-N 115.271 -0.877 . . . . 71.400000000000006 111.041 -175.264 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -72.81 -41.71 64.63 Favored 'General case' 0 CA--C 1.544 0.74 0 C-N-CA 123.18 0.592 . . . . 73.310000000000002 110.532 176.508 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 41.9 tt0 -61.16 -39.91 91.89 Favored 'General case' 0 N--CA 1.486 1.358 0 C-N-CA 124.002 0.921 . . . . 53.020000000000003 110.732 177.359 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 35' ' ' ASN . . . . . 0.426 ' O ' ' HG ' ' A' ' 39' ' ' LEU . 35.5 t30 -51.55 -67.28 0.26 Allowed 'General case' 0 CA--C 1.548 0.869 0 O-C-N 124.734 1.271 . . . . 54.420000000000002 111.034 178.083 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 85.0 t80 -62.23 -37.83 86.87 Favored 'General case' 0 N--CA 1.474 0.741 0 C-N-CA 123.156 0.582 . . . . 54.520000000000003 111.677 -176.161 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 73.8 ttt180 -59.03 -45.53 90.51 Favored 'General case' 0 CA--C 1.542 0.673 0 C-N-CA 123.419 0.687 . . . . 64.010000000000005 110.877 -179.936 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 38' ' ' ALA . . . . . 0.416 ' HB1' ' HG2' ' A' ' 44' ' ' LYS . . . -69.95 -30.09 67.39 Favored 'General case' 0 N--CA 1.472 0.674 0 C-N-CA 123.453 0.701 . . . . 75.129999999999995 111.748 -179.869 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 39' ' ' LEU . . . . . 0.426 ' HG ' ' O ' ' A' ' 35' ' ' ASN . 90.2 mt -67.22 -37.46 83.62 Favored 'General case' 0 N--CA 1.477 0.903 0 C-N-CA 123.241 0.616 . . . . 44.030000000000001 110.684 173.667 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 36.9 m -77.77 -41.02 38.93 Favored 'General case' 0 N--CA 1.476 0.857 0 C-N-CA 123.641 0.776 . . . . 63.039999999999999 111.691 -175.493 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 41.1 p -82.21 -33.18 29.46 Favored 'General case' 0 N--CA 1.473 0.702 0 C-N-CA 123.54 0.736 . . . . 61.43 111.413 -176.344 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 92.77 24.59 22.81 Favored Glycine 0 C--N 1.342 0.909 0 CA-C-N 115.812 -0.631 . . . . 64.129999999999995 113.407 -176.86 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 45.6 mm-40 -60.99 -28.18 68.84 Favored 'General case' 0 N--CA 1.484 1.239 0 C-N-CA 122.865 0.466 . . . . 65.239999999999995 111.522 173.481 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 44' ' ' LYS . . . . . 0.416 ' HG2' ' HB1' ' A' ' 38' ' ' ALA . 30.8 mmmt -106.49 15.67 25.62 Favored 'General case' 0 N--CA 1.47 0.531 0 C-N-CA 123.806 0.843 . . . . 73.209999999999994 111.298 -178.985 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 88.01 -34.53 3.73 Favored Glycine 0 C--N 1.35 1.311 0 CA-C-O 119.807 -0.44 . . . . 63.299999999999997 113.966 175.745 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 14.3 m-85 -62.42 -47.16 85.33 Favored 'General case' 0 N--CA 1.479 1.011 0 C-N-CA 123.44 0.696 . . . . 75.310000000000002 111.624 -169.463 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 47.2 56.85 7.57 Favored Glycine 0 C--N 1.356 1.665 0 O-C-N 124.521 1.138 . . . . 75.409999999999997 115.367 168.479 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 48' ' ' TYR . . . . . 0.511 ' OH ' ' HG2' ' A' ' 76' ' ' LYS . 56.7 m-85 -55.89 91.25 0.01 OUTLIER 'General case' 0 N--CA 1.479 1.006 0 C-N-CA 124.106 0.962 . . . . 74.319999999999993 112.933 -174.68 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 49' ' ' LYS . . . . . 0.507 ' HE2' ' HA ' ' A' ' 160' ' ' ASP . 29.5 tptp -110.09 120.79 43.56 Favored 'General case' 0 C--O 1.236 0.369 0 CA-C-N 113.99 -1.459 . . . . 61.549999999999997 108.582 -179.905 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 86.13 21.08 53.67 Favored Glycine 0 C--N 1.346 1.107 0 O-C-N 123.236 0.335 . . . . 50.439999999999998 112.79 -176.279 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 23.4 t -62.39 117.15 5.75 Favored 'General case' 0 CA--C 1.549 0.931 0 C-N-CA 124.075 0.95 . . . . 72.310000000000002 110.246 -178.357 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 52' ' ' CYS . . . . . . . . . . . . . 23.2 p -92.94 125.8 37.72 Favored 'General case' 0 C--O 1.24 0.566 0 C-N-CA 123.593 0.757 . . . . 74.329999999999998 112.573 -169.773 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 53' ' ' PHE . . . . . 0.745 ' HA ' ' HA2' ' A' ' 64' ' ' GLY . 64.1 m-85 -65.21 111.91 3.18 Favored 'General case' 0 CA--C 1.539 0.554 0 CA-C-N 115.035 -0.984 . . . . 73.239999999999995 108.956 164.404 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 21.8 p-80 -125.36 4.82 7.71 Favored 'General case' 0 N--CA 1.483 1.177 0 C-N-CA 123.447 0.699 . . . . 73.219999999999999 111.599 -175.983 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 65.5 ttt-85 -148.87 101.61 3.2 Favored 'General case' 0 N--CA 1.473 0.716 0 N-CA-C 109.431 -0.581 . . . . 75.239999999999995 109.431 176.648 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 56' ' ' ILE . . . . . 0.467 HG21 ' HA ' ' A' ' 143' ' ' GLU . 64.3 mt -133.7 134.12 56.55 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.098 0 C-N-CA 122.73 0.412 . . . . 71.040000000000006 110.007 -179.964 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 57' ' ' ILE . . . . . 0.414 ' HB ' ' HD2' ' A' ' 60' ' ' PHE . 71.7 mt -117.91 120.06 33.07 Favored Pre-proline 0 CA--C 1.55 0.964 0 N-CA-C 107.882 -1.155 . . . . 72.150000000000006 107.882 171.177 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 58' ' ' PRO . . . . . 0.525 ' HA ' ' HG2' ' A' ' 143' ' ' GLU . 28.0 Cg_endo -60.01 146.32 96.29 Favored 'Trans proline' 0 C--N 1.381 2.246 0 C-N-CA 123.043 2.495 . . . . 63.43 112.82 178.956 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 67.28 24.97 73.62 Favored Glycine 0 C--N 1.345 1.082 0 CA-C-N 115.74 -0.664 . . . . 74.150000000000006 113.935 179.446 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 60' ' ' PHE . . . . . 0.414 ' HD2' ' HB ' ' A' ' 57' ' ' ILE . 10.7 t80 -151.51 -72.4 0.16 Allowed 'General case' 0 N--CA 1.474 0.757 0 C-N-CA 122.978 0.511 . . . . 54.409999999999997 110.361 -175.173 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 47.1 ttp -160.04 135.05 7.91 Favored 'General case' 0 N--CA 1.474 0.728 0 CA-C-N 116.536 -0.302 . . . . 52.509999999999998 111.609 -167.112 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 62' ' ' CYS . . . . . 0.555 ' SG ' ' HB ' ' A' ' 114' ' ' ILE . 10.0 p -105.97 111.75 24.51 Favored 'General case' 0 CA--C 1.543 0.689 0 N-CA-C 108.764 -0.828 . . . . 73.109999999999999 108.764 167.898 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 63' ' ' GLN . . . . . 0.463 ' HA ' ' HA ' ' A' ' 113' ' ' PHE . 21.0 tt0 -109.13 133.76 52.59 Favored 'General case' 0 N--CA 1.48 1.062 0 C-N-CA 123.67 0.788 . . . . 54.399999999999999 110.933 -176.397 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 64' ' ' GLY . . . . . 0.745 ' HA2' ' HA ' ' A' ' 53' ' ' PHE . . . -122.52 175.24 16.42 Favored Glycine 0 C--N 1.345 1.078 0 CA-C-N 114.994 -1.003 . . . . 70.040000000000006 112.368 179.536 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 172.89 -166.26 38.81 Favored Glycine 0 C--N 1.331 0.291 0 N-CA-C 111.043 -0.823 . . . . 72.150000000000006 111.043 -179.792 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 38.8 t70 -126.32 160.8 29.38 Favored 'General case' 0 N--CA 1.476 0.863 0 C-N-CA 123.026 0.531 . . . . 74.510000000000005 110.55 -175.463 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 71.7 t80 -73.67 -32.43 63.96 Favored 'General case' 0 N--CA 1.472 0.669 0 C-N-CA 123.459 0.704 . . . . 74.430000000000007 111.211 -178.731 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 28.2 m -65.24 110.88 2.73 Favored 'General case' 0 N--CA 1.473 0.692 0 N-CA-C 109.925 -0.398 . . . . 74.25 109.925 -179.203 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 57.7 mtt85 66.99 30.52 7.49 Favored 'General case' 0 C--N 1.354 0.787 0 C-N-CA 125.052 1.341 . . . . 74.129999999999995 111.133 177.852 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 70' ' ' HIS . . . . . 0.413 ' HA ' ' HA3' ' A' ' 74' ' ' GLY . 27.5 p-80 -57.8 -23.69 53.69 Favored 'General case' 0 N--CA 1.49 1.537 0 C-N-CA 123.62 0.768 . . . . 71.230000000000004 111.774 -178.793 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 6.0 t30 -63.62 95.16 0.1 Allowed 'General case' 0 CA--C 1.543 0.694 0 C-N-CA 124.584 1.154 . . . . 73.340000000000003 109.339 168.376 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 79.05 -8.44 45.07 Favored Glycine 0 CA--C 1.529 0.92 0 N-CA-C 114.91 0.724 . . . . 72.129999999999995 114.91 174.258 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 18.0 m -135.47 -95.45 0.25 Allowed 'General case' 0 CA--C 1.558 1.279 0 CA-C-N 117.915 0.858 . . . . 71.239999999999995 110.179 -177.963 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 74' ' ' GLY . . . . . 0.413 ' HA3' ' HA ' ' A' ' 70' ' ' HIS . . . 59.51 56.15 26.61 Favored Glycine 0 C--N 1.359 1.855 0 CA-C-N 118.459 0.572 . . . . 65.049999999999997 113.626 177.776 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 134.76 49.41 0.08 OUTLIER Glycine 0 C--N 1.333 0.37 0 N-CA-C 109.443 -1.463 . . . . 70.549999999999997 109.443 -170.945 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 76' ' ' LYS . . . . . 0.511 ' HG2' ' OH ' ' A' ' 48' ' ' TYR . 22.7 ptmt -60.27 160.55 8.31 Favored 'General case' 0 N--CA 1.475 0.802 0 C-N-CA 124.113 0.965 . . . . 51.219999999999999 111.588 -177.548 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 79.1 p -90.27 174.22 7.71 Favored 'General case' 0 CA--C 1.54 0.58 0 CA-C-N 115.492 -0.776 . . . . 44.340000000000003 110.746 -178.486 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 24.8 pt -69.73 -17.54 21.38 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.818 0 C-N-CA 123.252 0.621 . . . . 74.319999999999993 110.806 176.611 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 36.5 m-85 -87.0 -16.2 36.45 Favored 'General case' 0 N--CA 1.47 0.563 0 C-N-CA 124.775 1.23 . . . . 72.310000000000002 110.643 -178.086 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 132.8 -134.04 7.35 Favored Glycine 0 C--N 1.345 1.064 0 N-CA-C 110.537 -1.025 . . . . 74.239999999999995 110.537 -177.179 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 37.1 tt0 -56.83 -54.6 44.52 Favored 'General case' 0 N--CA 1.473 0.707 0 C-N-CA 124.223 1.009 . . . . 74.409999999999997 111.427 179.453 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 82' ' ' LYS . . . . . 0.645 ' HD2' ' HA ' ' A' ' 107' ' ' THR . 21.6 pttp -168.19 177.35 5.52 Favored 'General case' 0 N--CA 1.474 0.742 0 C-N-CA 123.604 0.762 . . . . 74.319999999999993 110.69 -174.157 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 3.2 p90 -159.2 172.37 18.18 Favored 'General case' 0 CA--C 1.544 0.719 0 C-N-CA 124.73 1.212 . . . . 74.120000000000005 110.006 -174.68 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 84' ' ' GLU . . . . . 0.499 ' HA ' ' HA ' ' A' ' 106' ' ' ASN . 13.6 pt-20 -88.86 171.42 9.93 Favored 'General case' 0 N--CA 1.481 1.08 0 C-N-CA 123.094 0.558 . . . . 71.030000000000001 110.73 178.136 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 48.8 m-20 -80.63 148.71 30.14 Favored 'General case' 0 N--CA 1.478 0.928 0 N-CA-C 109.542 -0.54 . . . . 74.200000000000003 109.542 178.492 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 10.5 tp10 -86.98 -59.57 2.22 Favored 'General case' 0 N--CA 1.476 0.833 0 CA-C-O 120.606 0.241 . . . . 74.340000000000003 111.15 -179.659 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 13.0 p-10 -156.48 124.2 5.51 Favored 'General case' 0 N--CA 1.474 0.77 0 C-N-CA 123.015 0.526 . . . . 71.329999999999998 109.975 -169.603 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 79.1 m-85 -88.52 66.72 8.32 Favored 'General case' 0 N--CA 1.478 0.954 0 CA-C-O 121.683 0.754 . . . . 74.340000000000003 109.766 -174.53 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 55.0 mt -86.98 -51.6 12.74 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.587 0 CA-C-N 115.092 -0.958 . . . . 74.420000000000002 108.739 174.976 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 90' ' ' LEU . . . . . 0.543 ' HB3' ' HB ' ' A' ' 128' ' ' VAL . 94.6 mt -88.72 106.34 18.28 Favored 'General case' 0 C--O 1.24 0.57 0 CA-C-N 114.991 -1.004 . . . . 75.329999999999998 110.571 -175.789 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 50.0 mtmt -91.62 169.63 10.58 Favored 'General case' 0 C--O 1.24 0.593 0 CA-C-N 115.039 -0.982 . . . . 64.400000000000006 109.764 173.755 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 92' ' ' HIS . . . . . . . . . . . . . 20.8 m-70 -87.74 55.29 3.43 Favored 'General case' 0 N--CA 1.478 0.936 0 N-CA-C 108.826 -0.805 . . . . 72.530000000000001 108.826 -178.995 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 14.8 t -96.94 -2.67 43.2 Favored 'General case' 0 N--CA 1.475 0.776 0 CA-C-N 115.211 -0.904 . . . . 44.310000000000002 112.331 -169.707 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -131.77 178.65 17.74 Favored Glycine 0 C--N 1.342 0.912 0 CA-C-O 119.989 -0.34 . . . . 74.25 112.379 -179.564 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 76.9 Cg_endo -85.72 152.84 10.13 Favored 'Trans proline' 0 CA--C 1.551 1.373 0 C-N-CA 123.105 2.537 . . . . 73.340000000000003 112.37 172.16 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 80.66 19.96 67.1 Favored Glycine 0 C--N 1.343 0.954 0 CA-C-N 116.135 -0.484 . . . . 41.299999999999997 113.844 175.663 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 97' ' ' ILE . . . . . 0.668 ' HB ' ' HB2' ' A' ' 115' ' ' CYS . 25.8 mm -65.79 103.27 0.48 Allowed 'Isoleucine or valine' 0 CA--C 1.551 1.013 0 C-N-CA 124.138 0.975 . . . . 74.540000000000006 111.784 -175.606 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 58.5 tp -89.4 119.98 30.33 Favored 'General case' 0 C--O 1.247 0.972 0 CA-C-O 121.485 0.659 . . . . 61.399999999999999 109.819 174.264 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 46.0 t -149.55 146.38 27.32 Favored 'General case' 0 CA--C 1.549 0.929 0 C-N-CA 124.554 1.141 . . . . 63.240000000000002 108.119 -179.096 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 100' ' ' MET . . . . . 0.596 ' HA ' ' HA ' ' A' ' 112' ' ' PHE . 85.4 mtp -77.42 142.89 39.0 Favored 'General case' 0 N--CA 1.487 1.419 0 CA-C-N 118.216 0.462 . . . . 70.430000000000007 109.919 179.311 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 101' ' ' ALA . . . . . 0.538 ' HB3' ' HB2' ' A' ' 111' ' ' GLN . . . -75.04 155.52 37.17 Favored 'General case' 0 N--CA 1.474 0.731 0 CA-C-O 121.497 0.665 . . . . 72.310000000000002 112.083 -169.823 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 102' ' ' ASN . . . . . 0.423 ' HB2' ' HB ' ' A' ' 107' ' ' THR . 26.9 p-10 -167.49 166.32 14.34 Favored 'General case' 0 C--O 1.24 0.553 0 CA-C-N 114.421 -1.263 . . . . 73.030000000000001 109.744 -177.614 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -89.77 -50.98 5.74 Favored 'General case' 0 CA--C 1.537 0.452 0 N-CA-C 108.413 -0.958 . . . . 52.329999999999998 108.413 167.271 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -156.85 -156.11 7.74 Favored Glycine 0 C--N 1.347 1.193 0 CA-C-N 115.427 -0.806 . . . . 74.230000000000004 112.803 179.248 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 51.6 Cg_exo -55.7 139.62 83.49 Favored 'Trans proline' 0 C--N 1.375 1.932 0 C-N-CA 123.55 2.833 . . . . 50.109999999999999 113.165 178.134 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 106' ' ' ASN . . . . . 0.499 ' HA ' ' HA ' ' A' ' 84' ' ' GLU . 65.0 t30 66.24 8.51 5.64 Favored 'General case' 0 N--CA 1.483 1.217 0 C-N-CA 125.118 1.367 . . . . 62.420000000000002 112.487 177.215 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 107' ' ' THR . . . . . 0.645 ' HA ' ' HD2' ' A' ' 82' ' ' LYS . 3.8 m -100.72 -15.33 17.74 Favored 'General case' 0 CA--C 1.55 0.975 0 C-N-CA 123.749 0.82 . . . . 71.319999999999993 109.81 177.225 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 13.1 t30 -55.84 139.84 44.33 Favored 'General case' 0 C--O 1.208 -1.127 0 C-N-CA 125.658 1.583 . . . . 73.120000000000005 111.442 176.938 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 111.3 23.93 5.57 Favored Glycine 0 N--CA 1.469 0.886 0 N-CA-C 112.285 -0.326 . . . . 50.130000000000003 112.285 -178.872 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 13.6 p -136.98 120.8 17.46 Favored 'General case' 0 C--O 1.223 -0.311 0 C-N-CA 123.881 0.873 . . . . 72.400000000000006 108.645 178.126 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 111' ' ' GLN . . . . . 0.538 ' HB2' ' HB3' ' A' ' 101' ' ' ALA . 46.1 mt-30 59.51 -174.79 0.1 Allowed 'General case' 0 N--CA 1.489 1.489 0 C-N-CA 123.68 0.792 . . . . 74.329999999999998 111.563 -174.86 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 112' ' ' PHE . . . . . 0.596 ' HA ' ' HA ' ' A' ' 100' ' ' MET . 49.3 p90 -144.5 166.21 25.78 Favored 'General case' 0 N--CA 1.473 0.692 0 C-N-CA 123.953 0.901 . . . . 71.540000000000006 108.78 172.701 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 113' ' ' PHE . . . . . 0.463 ' HA ' ' HA ' ' A' ' 63' ' ' GLN . 51.8 p90 -152.64 154.94 36.35 Favored 'General case' 0 C--O 1.236 0.377 0 C-N-CA 122.969 0.508 . . . . 74.299999999999997 110.387 179.663 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 114' ' ' ILE . . . . . 0.555 ' HB ' ' SG ' ' A' ' 62' ' ' CYS . 16.2 mt -126.65 104.48 12.82 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.569 0 N-CA-C 108.698 -0.852 . . . . 45.5 108.698 178.492 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 115' ' ' CYS . . . . . 0.668 ' HB2' ' HB ' ' A' ' 97' ' ' ILE . 61.4 m -73.42 106.91 5.42 Favored 'General case' 0 CA--C 1.539 0.541 0 N-CA-C 109.016 -0.735 . . . . 52.450000000000003 109.016 172.772 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 116' ' ' THR . . . . . 0.426 HG22 HG12 ' A' ' 139' ' ' VAL . 75.1 p -71.39 -18.87 62.33 Favored 'General case' 0 N--CA 1.479 0.997 0 C-N-CA 123.261 0.624 . . . . 73.340000000000003 111.529 -177.273 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -124.72 169.52 11.9 Favored 'General case' 0 C--O 1.243 0.752 0 C-N-CA 123.682 0.793 . . . . 73.109999999999999 110.07 177.435 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 11.9 ptmm? -71.85 87.86 1.01 Allowed 'General case' 0 CA--C 1.55 0.95 0 CA-C-O 121.961 0.886 . . . . 73.329999999999998 110.92 176.173 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 119' ' ' THR . . . . . . . . . . . . . 52.9 p -85.34 87.89 7.44 Favored 'General case' 0 CA--C 1.544 0.734 0 CA-C-N 114.946 -1.025 . . . . 74.430000000000007 109.937 -176.894 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 120' ' ' GLU . . . . . 0.4 ' H ' ' HG2' ' A' ' 120' ' ' GLU . 7.9 pt-20 -73.07 -26.22 61.19 Favored 'General case' 0 N--CA 1.48 1.026 0 CA-C-N 114.535 -1.211 . . . . 75.209999999999994 112.934 -169.229 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 121' ' ' TRP . . . . . . . . . . . . . 39.5 p90 -70.72 -10.55 59.68 Favored 'General case' 0 N--CA 1.479 0.976 0 C-N-CA 123.732 0.813 . . . . 75.140000000000001 111.797 177.062 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 51.1 mt -95.05 0.07 54.13 Favored 'General case' 0 N--CA 1.477 0.904 0 C-N-CA 123.236 0.615 . . . . 74.450000000000003 111.673 177.514 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 32.9 m-20 -71.66 126.12 28.88 Favored 'General case' 0 N--CA 1.478 0.962 0 N-CA-C 108.801 -0.815 . . . . 73.510000000000005 108.801 172.762 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 106.82 -26.9 18.02 Favored Glycine 0 N--CA 1.471 1.02 0 N-CA-C 111.43 -0.668 . . . . 63.030000000000001 111.43 -171.933 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 125' ' ' LYS . . . . . 0.62 ' HG2' ' H ' ' A' ' 126' ' ' HIS . 20.9 ttmm -80.09 -164.96 0.75 Allowed 'General case' 0 CA--C 1.559 1.301 0 N-CA-C 107.979 -1.119 . . . . 73.019999999999996 107.979 170.907 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 126' ' ' HIS . . . . . 0.62 ' H ' ' HG2' ' A' ' 125' ' ' LYS . 8.9 t-80 -64.81 134.77 54.8 Favored 'General case' 0 C--N 1.353 0.76 0 CA-C-N 119.204 0.911 . . . . 64.099999999999994 111.132 -168.642 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 6.6 t -59.78 146.08 10.61 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.611 0 CA-C-N 112.787 -2.006 . . . . 74.329999999999998 111.091 -179.241 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 128' ' ' VAL . . . . . 0.543 ' HB ' ' HB3' ' A' ' 90' ' ' LEU . 18.9 t -74.8 156.1 6.28 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.789 0 N-CA-C 108.998 -0.742 . . . . 74.5 108.998 175.153 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 129' ' ' PHE . . . . . 0.441 ' CE2' ' HG3' ' A' ' 100' ' ' MET . 26.7 p90 -137.76 -11.72 1.54 Allowed 'General case' 0 N--CA 1.485 1.288 0 C-N-CA 122.189 0.195 . . . . 75.010000000000005 111.453 174.047 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . -148.14 159.11 27.92 Favored Glycine 0 C--N 1.341 0.84 0 N-CA-C 111.518 -0.633 . . . . 45.340000000000003 111.518 -177.056 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 35.1 ttpt -147.31 137.46 23.19 Favored 'General case' 0 N--CA 1.474 0.741 0 N-CA-C 109.39 -0.596 . . . . 75.239999999999995 109.39 178.728 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 132' ' ' VAL . . . . . 0.513 HG11 ' HA ' ' A' ' 136' ' ' MET . 37.5 t -63.91 111.89 1.18 Allowed 'Isoleucine or valine' 0 CA--C 1.543 0.705 0 O-C-N 123.658 0.599 . . . . 74.140000000000001 110.227 178.054 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 133' ' ' LYS . . . . . 0.593 ' HG3' ' HG2' ' A' ' 134' ' ' GLU . 0.0 OUTLIER -95.7 -42.42 8.39 Favored 'General case' 0 N--CA 1.474 0.751 0 C-N-CA 123.068 0.547 . . . . 60.420000000000002 109.569 172.457 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 134' ' ' GLU . . . . . 0.593 ' HG2' ' HG3' ' A' ' 133' ' ' LYS . 18.7 mm-40 -116.4 139.11 50.78 Favored 'General case' 0 N--CA 1.474 0.745 0 N-CA-C 108.674 -0.862 . . . . 74.209999999999994 108.674 -178.088 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 76.68 29.08 58.19 Favored Glycine 0 C--N 1.342 0.862 0 N-CA-C 114.156 0.422 . . . . 60.310000000000002 114.156 175.455 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 136' ' ' MET . . . . . 0.513 ' HA ' HG11 ' A' ' 132' ' ' VAL . 14.9 tpt -60.11 -38.08 81.93 Favored 'General case' 0 N--CA 1.477 0.908 0 C-N-CA 122.992 0.517 . . . . 74.299999999999997 111.216 177.647 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 137' ' ' ASN . . . . . . . . . . . . . 6.0 t30 -61.81 -39.23 91.01 Favored 'General case' 0 CA--C 1.543 0.679 0 CA-C-N 115.448 -0.796 . . . . 74.140000000000001 110.88 176.238 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 138' ' ' ILE . . . . . . . . . . . . . 49.2 mm -67.56 -35.57 73.51 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.089 0 C-N-CA 123.523 0.729 . . . . 62.329999999999998 110.868 -179.822 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 139' ' ' VAL . . . . . 0.446 HG21 HG21 ' A' ' 132' ' ' VAL . 92.1 t -65.61 -47.26 86.93 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.939 0 C-N-CA 123.561 0.744 . . . . 55.200000000000003 110.648 177.203 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 41.6 mt-10 -66.83 -34.81 78.63 Favored 'General case' 0 CA--C 1.548 0.867 0 CA-C-N 115.396 -0.82 . . . . 71.439999999999998 110.964 177.739 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -69.01 -44.06 73.55 Favored 'General case' 0 N--CA 1.475 0.815 0 C-N-CA 123.309 0.644 . . . . 51.450000000000003 110.881 -178.984 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 142' ' ' MET . . . . . 0.567 ' HB2' HD13 ' A' ' 156' ' ' ILE . 19.7 ptt? -69.29 -31.16 69.47 Favored 'General case' 0 N--CA 1.477 0.88 0 O-C-N 123.429 0.456 . . . . 73.519999999999996 110.394 179.172 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 143' ' ' GLU . . . . . 0.525 ' HG2' ' HA ' ' A' ' 58' ' ' PRO . 36.9 tt0 -62.32 -31.76 72.43 Favored 'General case' 0 CA--C 1.549 0.907 0 C-N-CA 122.784 0.434 . . . . 70.120000000000005 112.009 178.868 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 144' ' ' ARG . . . . . . . . . . . . . 33.1 mtp85 -65.27 -20.57 66.48 Favored 'General case' 0 N--CA 1.48 1.035 0 C-N-CA 122.706 0.402 . . . . 72.409999999999997 111.863 178.607 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 145' ' ' PHE . . . . . 0.534 ' HB2' HD11 ' A' ' 156' ' ' ILE . 66.3 m-85 -85.75 13.22 7.51 Favored 'General case' 0 N--CA 1.479 0.983 0 C-N-CA 123.388 0.675 . . . . 74.5 111.625 176.403 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . -98.45 -179.24 32.48 Favored Glycine 0 C--N 1.345 1.08 0 N-CA-C 111.743 -0.543 . . . . 63.119999999999997 111.743 169.838 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 10.8 m -133.45 163.09 30.14 Favored 'General case' 0 N--CA 1.478 0.944 0 C-N-CA 123.149 0.58 . . . . 73.329999999999998 111.203 -175.542 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 148' ' ' ARG . . . . . . . . . . . . . 7.3 mmm180 -67.82 -28.77 67.85 Favored 'General case' 0 N--CA 1.473 0.691 0 C-N-CA 124.383 1.073 . . . . 75.409999999999997 112.533 -177.511 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 149' ' ' ASN . . . . . . . . . . . . . 27.3 p-10 -84.58 -3.37 58.42 Favored 'General case' 0 N--CA 1.483 1.217 0 C-N-CA 123.349 0.659 . . . . 72.430000000000007 111.607 177.603 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . 100.25 -8.9 59.16 Favored Glycine 0 C--N 1.354 1.561 0 CA-C-O 119.975 -0.347 . . . . 55.409999999999997 113.188 179.028 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 59.6 tttp -65.44 143.08 57.93 Favored 'General case' 0 N--CA 1.478 0.956 0 C-N-CA 123.847 0.859 . . . . 74.25 110.408 178.336 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 152' ' ' THR . . . . . . . . . . . . . 16.5 p -92.92 114.21 26.71 Favored 'General case' 0 N--CA 1.467 0.398 0 N-CA-C 109.025 -0.732 . . . . 73.219999999999999 109.025 168.553 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 153' ' ' SER . . . . . . . . . . . . . 33.1 t -62.76 -29.02 70.38 Favored 'General case' 0 N--CA 1.475 0.784 0 C-N-CA 123.759 0.823 . . . . 72.230000000000004 110.719 177.063 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 154' ' ' LYS . . . . . 0.407 ' HB2' ' HB3' ' A' ' 145' ' ' PHE . 69.9 mmtt -124.93 145.06 50.03 Favored 'General case' 0 C--O 1.239 0.517 0 C-N-CA 123.942 0.897 . . . . 71.319999999999993 110.518 179.84 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 3.4 tppp? -79.23 99.41 7.03 Favored 'General case' 0 C--O 1.24 0.565 0 N-CA-C 109.031 -0.729 . . . . 75.319999999999993 109.031 172.651 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 156' ' ' ILE . . . . . 0.567 HD13 ' HB2' ' A' ' 142' ' ' MET . 52.3 mt -99.43 123.3 52.06 Favored 'Isoleucine or valine' 0 C--O 1.221 -0.406 0 CA-C-N 114.744 -1.116 . . . . 72.200000000000003 108.123 178.395 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 157' ' ' THR . . . . . . . . . . . . . 33.2 p -124.81 156.89 37.07 Favored 'General case' 0 N--CA 1.472 0.631 0 C-N-CA 124.13 0.972 . . . . 75.209999999999994 109.816 -177.521 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 158' ' ' ILE . . . . . . . . . . . . . 56.4 mt -82.25 93.73 2.7 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.719 0 N-CA-C 108.106 -1.072 . . . . 72.0 108.106 169.095 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 159' ' ' ALA . . . . . 0.551 ' HB2' ' HB2' ' A' ' 11' ' ' ALA . . . -54.54 -37.08 64.99 Favored 'General case' 0 N--CA 1.478 0.948 0 C-N-CA 124.759 1.224 . . . . 71.430000000000007 112.914 -177.736 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 160' ' ' ASP . . . . . 0.507 ' HA ' ' HE2' ' A' ' 49' ' ' LYS . 26.8 t0 -162.64 156.17 20.33 Favored 'General case' 0 N--CA 1.477 0.88 0 O-C-N 123.61 0.569 . . . . 74.150000000000006 111.214 -179.983 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 161' ' ' CYS . . . . . . . . . . . . . 6.9 p -123.15 -171.68 2.35 Favored 'General case' 0 N--CA 1.475 0.816 0 C-N-CA 125.255 1.422 . . . . 75.019999999999996 108.24 172.917 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 162' ' ' GLY . . . . . . . . . . . . . . . 131.42 57.93 0.09 OUTLIER Glycine 0 N--CA 1.475 1.266 0 O-C-N 121.473 -0.767 . . . . 14.220000000000001 111.507 -169.214 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 163' ' ' GLN . . . . . 0.497 ' HA ' ' H ' ' A' ' 7' ' ' PHE . 11.5 pt20 -45.36 132.71 7.65 Favored 'General case' 0 CA--C 1.547 0.838 0 C-N-CA 125.19 1.396 . . . . 74.209999999999994 114.031 -169.683 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 164' ' ' LEU . . . . . 0.515 ' O ' ' HB ' ' A' ' 5' ' ' THR . 85.1 mt . . . . . 0 N--CA 1.472 0.645 0 C-N-CA 123.976 0.911 . . . . 72.209999999999994 110.959 -179.731 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 218' ' ' PRO . . . . . . . . . . . . . 7.9 Cg_exo . . . . . 0 CA--C 1.545 1.052 0 N-CA-C 110.804 -0.499 . . . . 70.040000000000006 110.804 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' B' B ' 219' ' ' GLY . . . . . . . . . . . . . . . 166.37 141.91 3.28 Favored Glycine 0 CA--C 1.531 1.071 0 CA-C-O 119.471 -0.627 . . . . 72.299999999999997 112.277 -179.961 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 220' ' ' PRO . . . . . . . . . . . . . 52.4 Cg_exo -60.84 159.95 27.13 Favored 'Trans proline' 0 N--CA 1.498 1.788 0 C-N-CA 123.957 3.105 . . . . 72.340000000000003 114.698 178.308 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 221' ' ' TYR . . . . . . . . . . . . . 48.1 m-85 . . . . . 0 N--CA 1.484 1.247 0 C-N-CA 123.655 0.782 . . . . 70.239999999999995 110.704 -175.131 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 13.3 m120 . . . . . 0 N--CA 1.478 0.956 0 CA-C-O 119.247 -0.406 . . . . 65.430000000000007 110.909 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 19.9 Cg_endo -57.12 118.43 5.3 Favored 'Trans proline' 0 C--N 1.379 2.184 0 C-N-CA 122.889 2.392 . . . . 74.030000000000001 111.448 -174.337 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 5' ' ' THR . . . . . 0.421 ' HB ' ' O ' ' A' ' 164' ' ' LEU . 19.7 m -95.56 127.3 41.48 Favored 'General case' 0 N--CA 1.443 -0.794 0 N-CA-C 108.407 -0.96 . . . . 70.239999999999995 108.407 -176.757 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 6' ' ' VAL . . . . . 0.472 HG22 ' HB2' ' A' ' 22' ' ' PHE . 15.6 m -106.92 150.5 9.41 Favored 'Isoleucine or valine' 0 CA--C 1.522 -0.106 0 CA-C-N 115.536 -0.756 . . . . 71.319999999999993 109.096 -174.918 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 79.7 t80 -138.96 135.63 34.56 Favored 'General case' 0 C--O 1.239 0.531 0 C-N-CA 122.824 0.45 . . . . 73.310000000000002 110.389 -173.765 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 8' ' ' PHE . . . . . 0.448 ' HE1' ' HG ' ' A' ' 40' ' ' SER . 61.2 m-85 -141.87 165.58 27.09 Favored 'General case' 0 N--CA 1.469 0.513 0 C-N-CA 123.998 0.919 . . . . 61.210000000000001 110.504 178.946 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 11.3 m-20 -106.74 119.01 38.18 Favored 'General case' 0 N--CA 1.468 0.454 0 N-CA-C 108.012 -1.107 . . . . 61.020000000000003 108.012 165.168 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 10' ' ' ILE . . . . . 0.539 HG21 ' SD ' ' A' ' 142' ' ' MET . 48.6 mm -86.49 118.5 32.91 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.559 0 N-CA-C 109.021 -0.733 . . . . 73.420000000000002 109.021 176.532 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 11' ' ' ALA . . . . . 0.757 ' HB2' ' HB2' ' A' ' 159' ' ' ALA . . . -109.32 133.09 53.48 Favored 'General case' 0 C--O 1.219 -0.538 0 C-N-CA 123.975 0.91 . . . . 60.539999999999999 111.383 -174.689 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 43.0 t -97.64 123.54 50.12 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.533 0 N-CA-C 108.437 -0.949 . . . . 74.219999999999999 108.437 170.532 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 13' ' ' ASP . . . . . 0.454 ' HA ' ' HB2' ' A' ' 155' ' ' LYS . 66.7 m-20 61.22 15.02 6.02 Favored 'General case' 0 N--CA 1.483 1.206 0 C-N-CA 125.55 1.54 . . . . 74.439999999999998 112.928 -178.036 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 108.42 -27.32 14.05 Favored Glycine 0 C--N 1.346 1.103 0 CA-C-O 119.679 -0.512 . . . . 74.239999999999995 112.825 -176.502 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 30.8 mm-40 -89.17 122.69 68.49 Favored Pre-proline 0 N--CA 1.487 1.379 0 CA-C-N 117.666 0.733 . . . . 64.150000000000006 110.427 -179.1 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 16' ' ' PRO . . . . . 0.477 ' HA ' ' HA ' ' A' ' 11' ' ' ALA . 19.2 Cg_endo -54.36 113.22 1.26 Allowed 'Trans proline' 0 C--N 1.386 2.55 0 C-N-CA 123.344 2.696 . . . . 65.0 112.974 -177.428 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 37.2 tp -77.03 -36.72 55.92 Favored 'General case' 0 N--CA 1.479 0.991 0 C-N-CA 124.041 0.936 . . . . 72.019999999999996 109.552 175.883 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -173.4 -161.78 24.23 Favored Glycine 0 C--N 1.335 0.479 0 CA-C-N 114.671 -1.149 . . . . 32.439999999999998 111.291 -178.741 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 3.5 ptp180 -144.31 140.82 29.38 Favored 'General case' 0 N--CA 1.469 0.516 0 C-N-CA 123.374 0.67 . . . . 62.340000000000003 109.858 -176.762 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 20' ' ' VAL . . . . . 0.436 ' HA ' ' HA3' ' A' ' 135' ' ' GLY . 60.8 t -128.54 135.89 61.32 Favored 'Isoleucine or valine' 0 C--O 1.24 0.599 0 C-N-CA 124.029 0.931 . . . . 43.520000000000003 109.464 -176.213 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 31.5 t -113.39 121.03 43.13 Favored 'General case' 0 CA--C 1.547 0.841 0 C-N-CA 123.864 0.865 . . . . 54.509999999999998 108.852 172.951 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 22' ' ' PHE . . . . . 0.472 ' HB2' HG22 ' A' ' 6' ' ' VAL . 12.2 m-85 -101.0 170.87 7.99 Favored 'General case' 0 CA--C 1.543 0.706 0 N-CA-C 108.731 -0.841 . . . . 73.349999999999994 108.731 175.458 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 23' ' ' GLU . . . . . 0.66 ' HB2' ' HD2' ' A' ' 133' ' ' LYS . 38.9 tt0 -134.08 108.5 8.36 Favored 'General case' 0 N--CA 1.472 0.663 0 C-N-CA 123.977 0.911 . . . . 61.439999999999998 109.094 -178.557 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 13.6 mt -91.48 121.09 32.87 Favored 'General case' 0 CA--C 1.542 0.663 0 C-N-CA 122.949 0.5 . . . . 72.329999999999998 110.09 -176.726 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 25' ' ' PHE . . . . . 0.52 ' HB2' HD11 ' A' ' 90' ' ' LEU . 31.4 m-85 -86.98 69.98 10.28 Favored 'General case' 0 N--CA 1.472 0.658 0 C-N-CA 123.631 0.772 . . . . 74.319999999999993 109.777 -177.766 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -64.53 -16.07 61.97 Favored 'General case' 0 N--CA 1.48 1.034 0 N-CA-C 112.929 0.714 . . . . 60.409999999999997 112.929 -178.085 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 10.3 p-10 -72.67 -29.72 63.65 Favored 'General case' 0 CA--C 1.553 1.073 0 C-N-CA 123.279 0.632 . . . . 72.430000000000007 111.431 177.281 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 54.5 mttp -98.54 -41.65 7.66 Favored 'General case' 0 N--CA 1.485 1.319 0 C-N-CA 123.833 0.853 . . . . 75.430000000000007 110.891 -176.407 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 29' ' ' VAL . . . . . 0.517 HG21 ' HA ' ' A' ' 129' ' ' PHE . 9.7 m -129.97 70.62 82.16 Favored Pre-proline 0 CA--C 1.561 1.39 0 C-N-CA 123.992 0.917 . . . . 54.409999999999997 109.815 -178.071 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 18.5 Cg_endo -57.73 -40.07 82.35 Favored 'Trans proline' 0 C--N 1.387 2.56 0 C-N-CA 123.221 2.614 . . . . 70.150000000000006 113.39 -175.28 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 37.9 ttpt -66.87 -55.49 14.49 Favored 'General case' 0 N--CA 1.476 0.872 0 C-N-CA 123.539 0.735 . . . . 72.209999999999994 111.935 -179.587 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 5.8 m -68.74 -32.29 71.95 Favored 'General case' 0 CA--C 1.554 1.114 0 CA-C-N 115.591 -0.731 . . . . 70.400000000000006 111.455 -172.039 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -79.26 -45.5 19.63 Favored 'General case' 0 N--CA 1.477 0.878 0 C-N-CA 123.531 0.733 . . . . 64.319999999999993 111.115 179.745 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 32.3 tt0 -58.76 -35.07 72.15 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 123.604 0.565 . . . . 74.530000000000001 110.698 178.111 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 35' ' ' ASN . . . . . 0.527 ' O ' ' HG ' ' A' ' 39' ' ' LEU . 51.5 t30 -53.61 -69.25 0.12 Allowed 'General case' 0 C--N 1.353 0.751 0 O-C-N 124.267 0.98 . . . . 62.240000000000002 110.822 -179.175 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 91.4 t80 -62.83 -35.01 78.53 Favored 'General case' 0 N--CA 1.48 1.064 0 C-N-CA 123.493 0.717 . . . . 75.340000000000003 111.962 -176.128 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 56.2 ttt180 -61.74 -48.81 79.05 Favored 'General case' 0 N--CA 1.479 0.977 0 C-N-CA 123.535 0.734 . . . . 72.409999999999997 111.141 179.668 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -84.16 -19.45 34.1 Favored 'General case' 0 N--CA 1.475 0.808 0 CA-C-N 115.515 -0.766 . . . . 62.229999999999997 111.994 -174.832 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 39' ' ' LEU . . . . . 0.527 ' HG ' ' O ' ' A' ' 35' ' ' ASN . 66.4 mt -64.78 -46.1 83.52 Favored 'General case' 0 N--CA 1.474 0.752 0 N-CA-C 108.538 -0.912 . . . . 63.450000000000003 108.538 167.636 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 40' ' ' SER . . . . . 0.448 ' HG ' ' HE1' ' A' ' 8' ' ' PHE . 27.0 t -64.54 -56.21 15.54 Favored 'General case' 0 CA--C 1.543 0.683 0 C-N-CA 124.463 1.105 . . . . 71.099999999999994 112.047 -178.162 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 41' ' ' THR . . . . . 0.553 HG23 ' NE2' ' A' ' 163' ' ' GLN . 2.9 p -67.79 -30.71 70.21 Favored 'General case' 0 N--CA 1.477 0.901 0 C-N-CA 122.761 0.424 . . . . 75.439999999999998 111.541 179.652 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . 0.421 ' HA2' ' H ' ' A' ' 47' ' ' GLY . . . 84.09 29.01 32.31 Favored Glycine 0 C--N 1.345 1.069 0 CA-C-N 116.236 -0.438 . . . . 74.310000000000002 112.486 -179.06 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 21.2 mm-40 -64.49 -24.95 67.79 Favored 'General case' 0 N--CA 1.478 0.943 0 C-N-CA 123.437 0.695 . . . . 63.109999999999999 111.504 175.781 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 44' ' ' LYS . . . . . 0.548 ' HG3' HG22 ' A' ' 78' ' ' ILE . 70.8 mmtt -98.35 5.69 47.98 Favored 'General case' 0 CA--C 1.548 0.897 0 C-N-CA 124.088 0.955 . . . . 71.329999999999998 111.117 -179.936 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 79.08 39.21 20.44 Favored Glycine 0 C--N 1.348 1.218 0 CA-C-O 119.973 -0.348 . . . . 65.530000000000001 113.612 179.026 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 22.9 m-85 -123.98 -48.54 1.87 Allowed 'General case' 0 N--CA 1.485 1.3 0 CA-C-N 117.207 0.503 . . . . 64.409999999999997 111.309 -176.758 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . 0.421 ' H ' ' HA2' ' A' ' 42' ' ' GLY . . . 53.1 61.83 6.54 Favored Glycine 0 C--N 1.352 1.462 0 O-C-N 124.127 0.892 . . . . 73.140000000000001 114.461 171.009 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 48' ' ' TYR . . . . . 0.46 ' CE1' ' HA2' ' A' ' 75' ' ' GLY . 61.7 m-85 -67.51 97.94 0.63 Allowed 'General case' 0 N--CA 1.473 0.679 0 C-N-CA 123.499 0.72 . . . . 65.010000000000005 112.44 -176.289 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 3.0 tppp? -109.86 145.7 36.34 Favored 'General case' 0 CA--C 1.537 0.46 0 CA-C-N 114.532 -1.213 . . . . 62.520000000000003 108.938 172.26 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 71.01 20.63 77.99 Favored Glycine 0 C--N 1.343 0.953 0 CA-C-O 119.515 -0.603 . . . . 53.240000000000002 113.444 179.318 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 20.3 m -55.83 113.83 1.65 Allowed 'General case' 0 C--N 1.354 0.787 0 C-N-CA 123.595 0.758 . . . . 70.120000000000005 109.842 -179.324 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 52' ' ' CYS . . . . . 0.569 ' SG ' ' HB3' ' A' ' 66' ' ' ASP . 7.7 p -100.28 123.03 44.01 Favored 'General case' 0 CA--C 1.545 0.77 0 CA-C-N 115.277 -0.874 . . . . 73.540000000000006 112.505 -163.441 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 53' ' ' PHE . . . . . 0.734 ' HA ' ' HA2' ' A' ' 64' ' ' GLY . 33.3 m-85 -71.07 118.32 13.7 Favored 'General case' 0 C--O 1.239 0.504 0 C-N-CA 125.461 1.504 . . . . 73.019999999999996 109.79 171.874 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 54' ' ' HIS . . . . . 0.477 ' ND1' ' HB2' ' A' ' 66' ' ' ASP . 45.5 p-80 -115.96 -22.97 8.76 Favored 'General case' 0 N--CA 1.475 0.792 0 C-N-CA 123.772 0.829 . . . . 74.030000000000001 110.858 -176.675 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 47.9 ttt-85 -128.95 106.21 8.73 Favored 'General case' 0 C--N 1.359 1.005 0 N-CA-C 109.572 -0.529 . . . . 73.340000000000003 109.572 178.704 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 56' ' ' ILE . . . . . 0.55 HG21 ' HA ' ' A' ' 143' ' ' GLU . 56.5 mt -130.58 128.23 63.16 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.749 0 C-N-CA 123.72 0.808 . . . . 73.140000000000001 108.973 174.695 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 57' ' ' ILE . . . . . 0.409 ' HB ' ' HD2' ' A' ' 60' ' ' PHE . 76.3 mt -108.02 117.66 54.57 Favored Pre-proline 0 CA--C 1.557 1.219 0 C-N-CA 124.281 1.032 . . . . 74.329999999999998 108.256 173.254 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 58' ' ' PRO . . . . . 0.565 ' HA ' ' HG2' ' A' ' 143' ' ' GLU . 32.0 Cg_exo -58.84 131.52 42.42 Favored 'Trans proline' 0 C--N 1.382 2.313 0 C-N-CA 123.64 2.893 . . . . 64.040000000000006 112.83 179.62 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 79.2 21.09 68.31 Favored Glycine 0 CA--C 1.529 0.928 0 O-C-N 124.018 0.824 . . . . 53.329999999999998 113.597 179.885 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 60' ' ' PHE . . . . . 0.409 ' HD2' ' HB ' ' A' ' 57' ' ' ILE . 17.3 t80 -148.04 -73.42 0.2 Allowed 'General case' 0 N--CA 1.48 1.032 0 CA-C-N 117.659 0.73 . . . . 74.439999999999998 111.121 -173.888 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 61' ' ' MET . . . . . 0.411 ' SD ' ' CD1' ' A' ' 113' ' ' PHE . 58.5 ttp -159.75 142.56 13.83 Favored 'General case' 0 N--CA 1.483 1.221 0 N-CA-C 112.578 0.585 . . . . 72.150000000000006 112.578 -165.412 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 62' ' ' CYS . . . . . 0.501 ' SG ' ' HB2' ' A' ' 143' ' ' GLU . 52.2 m -117.18 116.92 28.23 Favored 'General case' 0 N--CA 1.474 0.74 0 C-N-CA 124.511 1.125 . . . . 73.409999999999997 110.179 175.145 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 15.0 pt20 -121.0 130.31 53.75 Favored 'General case' 0 N--CA 1.484 1.259 0 CA-C-O 122.103 0.954 . . . . 72.409999999999997 112.11 179.499 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 64' ' ' GLY . . . . . 0.734 ' HA2' ' HA ' ' A' ' 53' ' ' PHE . . . -113.49 -177.21 19.42 Favored Glycine 0 C--N 1.343 0.94 0 CA-C-N 113.79 -1.55 . . . . 43.109999999999999 112.758 178.27 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 98.83 73.66 1.11 Allowed Glycine 0 C--N 1.337 0.614 0 N-CA-C 110.871 -0.892 . . . . 52.039999999999999 110.871 -178.959 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 66' ' ' ASP . . . . . 0.569 ' HB3' ' SG ' ' A' ' 52' ' ' CYS . 32.6 t70 -127.56 30.29 5.36 Favored 'General case' 0 N--CA 1.482 1.141 0 C-N-CA 123.099 0.56 . . . . 70.030000000000001 109.916 172.124 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 57.0 t80 -93.8 -83.83 0.32 Allowed 'General case' 0 CA--C 1.555 1.148 0 O-C-N 122.055 -0.403 . . . . 71.299999999999997 111.044 -177.12 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 69.9 m -81.15 113.11 19.09 Favored 'General case' 0 N--CA 1.482 1.148 0 C-N-CA 123.407 0.683 . . . . 43.109999999999999 111.346 -171.307 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 60.7 ttt85 62.76 66.51 0.75 Allowed 'General case' 0 N--CA 1.476 0.856 0 C-N-CA 124.349 1.06 . . . . 52.43 109.522 -174.471 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 2.5 p-80 -74.63 74.85 2.02 Favored 'General case' 0 N--CA 1.482 1.161 0 CA-C-N 114.819 -1.082 . . . . 74.299999999999997 112.083 -175.272 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 64.5 t30 -154.72 77.98 1.05 Allowed 'General case' 0 N--CA 1.473 0.719 0 N-CA-C 108.085 -1.08 . . . . 71.239999999999995 108.085 177.163 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 63.98 22.81 67.08 Favored Glycine 0 CA--C 1.534 1.26 0 CA-C-N 115.67 -0.696 . . . . 75.329999999999998 114.044 -176.32 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 73' ' ' THR . . . . . 0.551 ' HA ' ' HB2' ' A' ' 110' ' ' SER . 46.9 m -142.53 -65.37 0.4 Allowed 'General case' 0 N--CA 1.476 0.854 0 C-N-CA 123.855 0.862 . . . . 72.519999999999996 109.492 -174.582 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 44.04 38.53 4.75 Favored Glycine 0 C--N 1.355 1.599 0 C-N-CA 124.517 1.056 . . . . 44.140000000000001 115.655 174.922 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 75' ' ' GLY . . . . . 0.46 ' HA2' ' CE1' ' A' ' 48' ' ' TYR . . . 149.78 54.05 0.01 OUTLIER Glycine 0 C--N 1.337 0.584 0 O-C-N 122.122 -0.634 . . . . 75.129999999999995 112.256 -161.281 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -48.22 149.62 1.45 Allowed 'General case' 0 N--CA 1.481 1.108 0 C-N-CA 124.685 1.194 . . . . 71.109999999999999 111.621 169.909 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 94.3 p -90.03 -178.4 5.43 Favored 'General case' 0 C--O 1.24 0.59 0 CA-C-O 121.781 0.8 . . . . 64.239999999999995 112.244 -169.504 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 78' ' ' ILE . . . . . 0.548 HG22 ' HG3' ' A' ' 44' ' ' LYS . 27.7 pt -72.62 -19.48 19.11 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.941 0 CA-C-N 114.909 -1.041 . . . . 65.120000000000005 110.751 175.787 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 92.8 m-85 -92.08 25.78 2.73 Favored 'General case' 0 N--CA 1.481 1.115 0 C-N-CA 123.701 0.8 . . . . 73.109999999999999 110.381 173.062 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 83.92 -105.15 2.74 Favored Glycine 0 C--N 1.343 0.939 0 N-CA-C 111.015 -0.834 . . . . 62.350000000000001 111.015 -178.243 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 43.0 tt0 -74.34 -61.26 1.92 Allowed 'General case' 0 C--O 1.242 0.7 0 C-N-CA 122.872 0.469 . . . . 75.099999999999994 110.493 -177.237 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 82' ' ' LYS . . . . . 0.729 ' HD2' ' HA ' ' A' ' 107' ' ' THR . 20.4 pttp -168.78 177.15 5.2 Favored 'General case' 0 CA--C 1.542 0.635 0 CA-C-N 115.465 -0.788 . . . . 74.439999999999998 110.475 -173.128 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 28.9 p90 -159.35 177.45 10.99 Favored 'General case' 0 CA--C 1.546 0.791 0 C-N-CA 125.467 1.507 . . . . 75.319999999999993 108.251 -174.714 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 11.5 pt-20 -94.97 167.6 11.3 Favored 'General case' 0 N--CA 1.485 1.283 0 O-C-N 121.926 -0.484 . . . . 74.400000000000006 111.552 179.224 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 25.9 m-20 -61.41 150.13 36.31 Favored 'General case' 0 N--CA 1.479 1.021 0 C-N-CA 123.82 0.848 . . . . 54.030000000000001 111.302 174.489 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 86' ' ' GLU . . . . . 0.505 ' HG2' ' HA ' ' A' ' 29' ' ' VAL . 6.3 tp10 -74.63 -61.82 1.74 Allowed 'General case' 0 N--CA 1.474 0.747 0 CA-C-N 116.55 -0.296 . . . . 73.019999999999996 111.329 -176.664 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 87' ' ' ASN . . . . . 0.425 ' O ' HG11 ' A' ' 127' ' ' VAL . 31.2 p-10 -174.32 143.97 0.9 Allowed 'General case' 0 N--CA 1.479 1.009 0 C-N-CA 123.85 0.86 . . . . 64.019999999999996 109.134 -174.643 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 92.7 m-85 -88.25 53.24 2.67 Favored 'General case' 0 N--CA 1.483 1.218 0 C-N-CA 123.819 0.848 . . . . 74.420000000000002 112.115 -166.565 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 63.3 mt -77.38 -57.5 5.67 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.855 0 C-N-CA 123.654 0.782 . . . . 52.25 108.946 173.298 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 90' ' ' LEU . . . . . 0.575 ' HB3' ' HB ' ' A' ' 128' ' ' VAL . 86.7 mt -85.03 121.58 28.01 Favored 'General case' 0 C--O 1.238 0.467 0 CA-C-N 114.672 -1.149 . . . . 73.430000000000007 110.619 -175.145 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 46.5 mtmt -117.5 169.39 9.57 Favored 'General case' 0 N--CA 1.474 0.756 0 C-N-CA 124.141 0.976 . . . . 73.239999999999995 110.193 -175.831 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 92' ' ' HIS . . . . . 0.404 ' HA ' HG13 ' A' ' 97' ' ' ILE . 28.1 m-70 -86.38 50.15 1.94 Allowed 'General case' 0 N--CA 1.48 1.068 0 C-N-CA 124.062 0.945 . . . . 72.239999999999995 109.942 -178.988 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 10.5 t -95.0 -2.45 50.32 Favored 'General case' 0 CA--C 1.547 0.84 0 CA-C-N 115.112 -0.949 . . . . 75.540000000000006 110.965 -175.281 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -131.66 170.33 21.62 Favored Glycine 0 CA--C 1.533 1.189 0 CA-C-O 119.735 -0.48 . . . . 60.009999999999998 112.272 179.07 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 83.8 Cg_endo -81.99 157.36 17.95 Favored 'Trans proline' 0 CA--C 1.554 1.519 0 C-N-CA 122.799 2.333 . . . . 71.310000000000002 112.209 170.83 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 79.3 21.17 67.87 Favored Glycine 0 C--N 1.35 1.306 0 CA-C-N 116.601 -0.272 . . . . 54.130000000000003 113.624 176.544 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 97' ' ' ILE . . . . . 0.623 ' HB ' ' HB2' ' A' ' 115' ' ' CYS . 24.9 mm -65.63 103.72 0.5 Allowed 'Isoleucine or valine' 0 CA--C 1.547 0.836 0 C-N-CA 123.603 0.761 . . . . 74.430000000000007 111.816 -175.559 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 63.0 tp -89.02 114.38 25.57 Favored 'General case' 0 CA--C 1.547 0.84 0 CA-C-O 121.586 0.708 . . . . 72.129999999999995 109.368 173.708 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 99' ' ' SER . . . . . 0.692 ' HB3' ' HA ' ' A' ' 128' ' ' VAL . 4.9 p -148.05 139.75 23.82 Favored 'General case' 0 CA--C 1.537 0.473 0 C-N-CA 124.801 1.24 . . . . 61.299999999999997 108.033 178.354 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 100' ' ' MET . . . . . 0.736 ' HA ' ' HA ' ' A' ' 112' ' ' PHE . 67.3 mtp -75.55 148.05 39.21 Favored 'General case' 0 N--CA 1.489 1.522 0 C-N-CA 122.625 0.37 . . . . 63.229999999999997 110.775 -173.187 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 101' ' ' ALA . . . . . 0.71 ' HB3' ' HB2' ' A' ' 111' ' ' GLN . . . -72.34 152.28 42.18 Favored 'General case' 0 N--CA 1.479 0.984 0 CA-C-O 121.196 0.522 . . . . 73.319999999999993 112.301 -171.928 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 102' ' ' ASN . . . . . 0.459 ' HB2' ' HB ' ' A' ' 107' ' ' THR . 30.1 p-10 -165.83 159.42 15.99 Favored 'General case' 0 CA--C 1.536 0.438 0 CA-C-N 114.821 -1.081 . . . . 75.340000000000003 109.774 -177.022 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -110.14 25.08 12.18 Favored 'General case' 0 N--CA 1.472 0.654 0 C-N-CA 123.356 0.662 . . . . 63.229999999999997 109.379 169.821 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 136.9 -174.1 21.81 Favored Glycine 0 CA--C 1.535 1.292 0 CA-C-N 115.484 -0.78 . . . . 54.100000000000001 112.029 -179.422 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 51.7 Cg_exo -57.22 152.24 46.7 Favored 'Trans proline' 0 C--N 1.37 1.671 0 C-N-CA 123.439 2.759 . . . . 62.210000000000001 112.595 175.316 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 65.1 t30 66.74 12.67 8.98 Favored 'General case' 0 N--CA 1.489 1.491 0 C-N-CA 124.347 1.059 . . . . 75.400000000000006 111.965 179.638 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 107' ' ' THR . . . . . 0.729 ' HA ' ' HD2' ' A' ' 82' ' ' LYS . 2.7 m -120.77 7.23 10.45 Favored 'General case' 0 N--CA 1.489 1.506 0 C-N-CA 123.451 0.701 . . . . 72.239999999999995 110.579 -179.504 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 12.4 t30 -76.89 139.93 40.4 Favored 'General case' 0 N--CA 1.478 0.965 0 C-N-CA 124.643 1.177 . . . . 73.519999999999996 110.26 179.181 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 112.59 -11.35 25.73 Favored Glycine 0 N--CA 1.471 1.003 0 CA-C-O 119.843 -0.42 . . . . 64.219999999999999 113.269 178.518 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 110' ' ' SER . . . . . 0.551 ' HB2' ' HA ' ' A' ' 73' ' ' THR . 33.9 p -99.87 121.61 41.57 Favored 'General case' 0 N--CA 1.474 0.773 0 N-CA-C 109.047 -0.723 . . . . 74.409999999999997 109.047 173.009 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 111' ' ' GLN . . . . . 0.71 ' HB2' ' HB3' ' A' ' 101' ' ' ALA . 38.5 mt-30 63.67 175.74 0.17 Allowed 'General case' 0 N--CA 1.498 1.969 0 C-N-CA 124.294 1.037 . . . . 70.010000000000005 111.848 -177.705 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 112' ' ' PHE . . . . . 0.736 ' HA ' ' HA ' ' A' ' 100' ' ' MET . 36.6 p90 -148.93 133.36 17.57 Favored 'General case' 0 N--CA 1.482 1.147 0 N-CA-C 109.427 -0.583 . . . . 62.399999999999999 109.427 177.133 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 113' ' ' PHE . . . . . 0.411 ' CD1' ' SD ' ' A' ' 61' ' ' MET . 51.7 p90 -118.98 149.83 40.96 Favored 'General case' 0 N--CA 1.478 0.935 0 C-N-CA 123.151 0.58 . . . . 64.120000000000005 111.592 179.627 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 114' ' ' ILE . . . . . . . . . . . . . 22.5 mt -123.0 103.8 13.59 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.611 0 C-N-CA 124.279 1.032 . . . . 52.039999999999999 108.698 -179.753 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 115' ' ' CYS . . . . . 0.623 ' HB2' ' HB ' ' A' ' 97' ' ' ILE . 62.2 m -75.71 106.22 7.16 Favored 'General case' 0 CA--C 1.541 0.623 0 N-CA-C 109.336 -0.616 . . . . 52.219999999999999 109.336 175.584 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 39.5 p -70.63 -31.5 68.47 Favored 'General case' 0 N--CA 1.471 0.584 0 C-N-CA 123.534 0.734 . . . . 72.510000000000005 111.3 -179.104 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -99.06 159.04 15.25 Favored 'General case' 0 C--O 1.247 0.936 0 CA-C-N 115.462 -0.79 . . . . 44.049999999999997 109.478 171.69 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -72.36 88.89 1.2 Allowed 'General case' 0 CA--C 1.539 0.543 0 CA-C-O 121.765 0.793 . . . . 61.329999999999998 109.182 173.471 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 119' ' ' THR . . . . . . . . . . . . . 34.6 p -76.06 85.7 2.94 Favored 'General case' 0 CA--C 1.546 0.804 0 CA-C-O 122.276 1.036 . . . . 75.5 110.36 -174.381 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 11.5 pt-20 -71.29 -29.76 65.44 Favored 'General case' 0 N--CA 1.474 0.748 0 CA-C-N 114.158 -1.383 . . . . 75.409999999999997 111.38 -171.278 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 121' ' ' TRP . . . . . . . . . . . . . 43.6 p90 -67.94 -3.17 9.04 Favored 'General case' 0 N--CA 1.479 1.003 0 C-N-CA 123.367 0.667 . . . . 63.140000000000001 112.218 179.251 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 45.7 mt -96.24 26.32 4.35 Favored 'General case' 0 CA--C 1.555 1.141 0 C-N-CA 123.523 0.729 . . . . 62.409999999999997 111.535 174.037 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 56.7 m-20 -59.55 123.08 15.7 Favored 'General case' 0 N--CA 1.49 1.545 0 C-N-CA 122.758 0.423 . . . . 62.32 110.376 165.054 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 85.56 -9.1 69.03 Favored Glycine 0 N--CA 1.475 1.278 0 O-C-N 123.209 0.318 . . . . 61.439999999999998 113.27 -179.271 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 125' ' ' LYS . . . . . 0.641 ' HG3' ' H ' ' A' ' 126' ' ' HIS . 0.1 OUTLIER -82.74 -163.97 0.79 Allowed 'General case' 0 CA--C 1.561 1.371 0 C-N-CA 124.628 1.171 . . . . 73.430000000000007 108.412 177.511 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 126' ' ' HIS . . . . . 0.641 ' H ' ' HG3' ' A' ' 125' ' ' LYS . 57.3 t-80 -64.35 136.43 57.13 Favored 'General case' 0 N--CA 1.473 0.709 0 C-N-CA 124.119 0.968 . . . . 75.040000000000006 111.218 -166.38 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 127' ' ' VAL . . . . . 0.425 HG11 ' O ' ' A' ' 87' ' ' ASN . 45.1 t -71.76 140.33 18.32 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.536 0 CA-C-N 115.634 -0.712 . . . . 61.399999999999999 110.676 -176.466 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 128' ' ' VAL . . . . . 0.692 ' HA ' ' HB3' ' A' ' 99' ' ' SER . 25.1 t -73.37 148.0 9.14 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.558 0 N-CA-C 109.166 -0.679 . . . . 71.439999999999998 109.166 175.767 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 129' ' ' PHE . . . . . 0.517 ' HA ' HG21 ' A' ' 29' ' ' VAL . 39.5 p90 -129.2 -20.02 3.44 Favored 'General case' 0 N--CA 1.479 0.996 0 O-C-N 122.105 -0.372 . . . . 73.349999999999994 110.694 174.827 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . -140.23 164.18 26.25 Favored Glycine 0 C--N 1.34 0.761 0 O-C-N 123.717 0.636 . . . . 75.310000000000002 112.017 -175.87 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 34.6 ttpt -148.86 130.28 14.77 Favored 'General case' 0 N--CA 1.468 0.462 0 N-CA-C 109.271 -0.641 . . . . 74.209999999999994 109.271 -178.148 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 49.0 t -63.76 104.45 0.41 Allowed 'Isoleucine or valine' 0 C--O 1.238 0.496 0 N-CA-C 108.847 -0.797 . . . . 65.219999999999999 108.847 174.759 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 133' ' ' LYS . . . . . 0.66 ' HD2' ' HB2' ' A' ' 23' ' ' GLU . 19.4 ptmt -85.63 -33.4 21.63 Favored 'General case' 0 N--CA 1.471 0.618 0 N-CA-C 109.335 -0.617 . . . . 71.340000000000003 109.335 179.545 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 32.8 mt-10 -145.39 152.27 39.58 Favored 'General case' 0 N--CA 1.473 0.707 0 C-N-CA 125.033 1.333 . . . . 74.439999999999998 109.166 -178.135 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 135' ' ' GLY . . . . . 0.436 ' HA3' ' HA ' ' A' ' 20' ' ' VAL . . . 81.85 16.62 72.21 Favored Glycine 0 C--N 1.345 1.041 0 CA-C-N 116.534 -0.303 . . . . 74.019999999999996 112.729 -178.848 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 136' ' ' MET . . . . . . . . . . . . . 14.5 tpt -62.6 -31.11 71.88 Favored 'General case' 0 N--CA 1.479 0.998 0 C-N-CA 124.232 1.013 . . . . 73.0 110.857 177.72 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 137' ' ' ASN . . . . . . . . . . . . . 45.3 t30 -56.53 -44.66 81.04 Favored 'General case' 0 N--CA 1.477 0.883 0 CA-C-N 114.51 -1.223 . . . . 75.439999999999998 110.779 171.824 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 138' ' ' ILE . . . . . . . . . . . . . 46.4 mm -73.72 -33.13 37.21 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.009 0 C-N-CA 123.682 0.793 . . . . 64.420000000000002 111.135 -178.199 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 70.2 t -63.27 -47.72 90.83 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.114 0 CA-C-O 121.32 0.581 . . . . 73.430000000000007 110.511 177.146 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 49.0 mt-10 -73.13 -29.29 62.78 Favored 'General case' 0 CA--C 1.548 0.884 0 CA-C-N 115.827 -0.624 . . . . 75.209999999999994 111.385 179.092 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -70.22 -40.17 74.67 Favored 'General case' 0 N--CA 1.479 0.991 0 C-N-CA 123.089 0.555 . . . . 75.540000000000006 111.269 177.503 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 142' ' ' MET . . . . . 0.539 ' SD ' HG21 ' A' ' 10' ' ' ILE . 22.9 ptt? -74.51 -27.03 60.37 Favored 'General case' 0 N--CA 1.484 1.271 0 C-N-CA 122.622 0.369 . . . . 53.039999999999999 110.107 178.501 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 143' ' ' GLU . . . . . 0.565 ' HG2' ' HA ' ' A' ' 58' ' ' PRO . 33.8 tt0 -65.41 -27.51 68.59 Favored 'General case' 0 CA--C 1.545 0.756 0 C-N-CA 123.202 0.601 . . . . 73.310000000000002 112.417 177.686 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 144' ' ' ARG . . . . . . . . . . . . . 74.3 mtp180 -65.7 -20.23 66.2 Favored 'General case' 0 CA--C 1.55 0.949 0 C-N-CA 123.48 0.712 . . . . 75.150000000000006 111.458 176.114 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 145' ' ' PHE . . . . . 0.407 ' HB2' HD11 ' A' ' 156' ' ' ILE . 43.6 m-85 -89.52 3.97 50.73 Favored 'General case' 0 CA--C 1.548 0.874 0 C-N-CA 123.607 0.763 . . . . 74.129999999999995 111.706 177.406 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . -85.52 177.26 50.07 Favored Glycine 0 C--N 1.347 1.167 0 N-CA-C 111.66 -0.576 . . . . 74.439999999999998 111.66 171.01 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 16.4 m -133.71 163.15 30.09 Favored 'General case' 0 N--CA 1.48 1.053 0 CA-C-N 117.587 0.694 . . . . 51.43 111.741 -175.895 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 148' ' ' ARG . . . . . . . . . . . . . 9.3 mmm180 -75.99 -15.31 60.17 Favored 'General case' 0 N--CA 1.475 0.798 0 C-N-CA 124.897 1.279 . . . . 52.119999999999997 112.879 -177.747 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 149' ' ' ASN . . . . . . . . . . . . . 34.3 p-10 -90.72 -3.51 57.41 Favored 'General case' 0 N--CA 1.481 1.117 0 C-N-CA 122.884 0.474 . . . . 73.310000000000002 110.333 171.982 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . 105.36 -27.33 18.69 Favored Glycine 0 C--N 1.351 1.393 0 CA-C-N 116.0 -0.546 . . . . 41.149999999999999 112.917 177.003 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 56.9 tttm -69.43 156.32 39.04 Favored 'General case' 0 N--CA 1.484 1.27 0 C-N-CA 123.217 0.607 . . . . 74.329999999999998 111.78 -173.358 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 152' ' ' THR . . . . . . . . . . . . . 69.2 p -94.39 130.63 40.65 Favored 'General case' 0 N--CA 1.474 0.765 0 CA-C-O 120.941 0.4 . . . . 75.420000000000002 110.428 172.304 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 153' ' ' SER . . . . . . . . . . . . . 15.0 m -69.47 -31.44 69.73 Favored 'General case' 0 N--CA 1.474 0.731 0 C-N-CA 123.928 0.891 . . . . 72.299999999999997 111.148 174.723 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 75.3 mmtt -115.13 153.63 30.42 Favored 'General case' 0 N--CA 1.473 0.723 0 C-N-CA 124.052 0.941 . . . . 70.200000000000003 109.972 -177.277 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 155' ' ' LYS . . . . . 0.454 ' HB2' ' HA ' ' A' ' 13' ' ' ASP . 30.3 mmmt -86.32 89.11 7.76 Favored 'General case' 0 N--CA 1.468 0.466 0 N-CA-C 109.244 -0.651 . . . . 75.519999999999996 109.244 175.626 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 156' ' ' ILE . . . . . 0.526 HD13 ' HB2' ' A' ' 142' ' ' MET . 59.2 mt -90.23 103.02 13.85 Favored 'Isoleucine or valine' 0 C--O 1.213 -0.837 0 N-CA-C 109.28 -0.637 . . . . 75.099999999999994 109.28 -174.706 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 157' ' ' THR . . . . . . . . . . . . . 44.7 p -114.45 147.99 38.47 Favored 'General case' 0 N--CA 1.476 0.868 0 C-N-CA 123.976 0.91 . . . . 73.109999999999999 109.972 -175.222 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 158' ' ' ILE . . . . . 0.408 HG23 ' HB3' ' A' ' 8' ' ' PHE . 47.2 mt -71.91 97.43 0.67 Allowed 'Isoleucine or valine' 0 CA--C 1.555 1.156 0 N-CA-C 109.546 -0.539 . . . . 74.120000000000005 109.546 170.638 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 159' ' ' ALA . . . . . 0.757 ' HB2' ' HB2' ' A' ' 11' ' ' ALA . . . -58.7 -48.57 80.67 Favored 'General case' 0 N--CA 1.482 1.136 0 C-N-CA 124.581 1.152 . . . . 45.43 112.757 -175.894 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 160' ' ' ASP . . . . . . . . . . . . . 25.4 t0 -148.86 166.16 29.36 Favored 'General case' 0 N--CA 1.478 0.974 0 CA-C-N 115.926 -0.579 . . . . 73.319999999999993 110.307 -175.734 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 161' ' ' CYS . . . . . . . . . . . . . 19.4 p -132.56 -170.91 2.53 Favored 'General case' 0 CA--C 1.548 0.888 0 C-N-CA 125.315 1.446 . . . . 52.210000000000001 109.056 179.85 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 162' ' ' GLY . . . . . . . . . . . . . . . 132.02 53.88 0.09 OUTLIER Glycine 0 N--CA 1.473 1.134 0 N-CA-C 111.265 -0.734 . . . . 73.409999999999997 111.265 -170.83 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 163' ' ' GLN . . . . . 0.553 ' NE2' HG23 ' A' ' 41' ' ' THR . 69.7 mt-30 -46.74 112.56 0.52 Allowed 'General case' 0 CA--C 1.55 0.952 0 C-N-CA 125.586 1.555 . . . . 60.219999999999999 112.762 -177.337 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 164' ' ' LEU . . . . . 0.421 ' O ' ' HB ' ' A' ' 5' ' ' THR . 88.0 mt . . . . . 0 N--CA 1.474 0.751 0 C-N-CA 124.045 0.938 . . . . 73.400000000000006 110.186 -175.646 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 218' ' ' PRO . . . . . . . . . . . . . 10.8 Cg_endo . . . . . 0 CA--C 1.549 1.267 0 CA-C-O 121.216 0.423 . . . . 73.040000000000006 111.37 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' B' B ' 219' ' ' GLY . . . . . . . . . . . . . . . 137.0 126.95 2.57 Favored Glycine 0 CA--C 1.541 1.679 0 CA-C-N 114.931 -1.031 . . . . 72.340000000000003 110.585 -174.482 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 220' ' ' PRO . . . . . . . . . . . . . 57.5 Cg_endo -67.18 170.5 13.09 Favored 'Trans proline' 0 C--N 1.377 2.055 0 C-N-CA 123.178 2.585 . . . . 53.009999999999998 113.485 -177.163 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 221' ' ' TYR . . . . . . . . . . . . . 13.7 p90 . . . . . 0 C--O 1.252 1.192 0 CA-C-O 121.321 0.581 . . . . 72.319999999999993 111.265 -175.054 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 3' ' ' ASN . . . . . 0.502 ' HB3' ' O ' ' A' ' 24' ' ' LEU . 13.2 m120 . . . . . 0 CA--C 1.552 1.046 0 CA-C-O 119.328 -0.367 . . . . 72.340000000000003 111.936 . . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 42.9 Cg_endo -66.71 119.36 6.38 Favored 'Trans proline' 0 C--N 1.384 2.443 0 C-N-CA 122.973 2.449 . . . . 65.319999999999993 111.049 175.572 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 5' ' ' THR . . . . . 0.428 ' O ' ' HB2' ' A' ' 163' ' ' GLN . 97.5 m -98.6 127.82 44.68 Favored 'General case' 0 CA--C 1.537 0.444 0 N-CA-C 109.239 -0.652 . . . . 74.129999999999995 109.239 -178.934 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 6' ' ' VAL . . . . . 0.501 ' HA ' ' HB2' ' A' ' 163' ' ' GLN . 14.1 m -102.13 123.13 55.17 Favored 'Isoleucine or valine' 0 C--N 1.351 0.652 0 C-N-CA 123.972 0.909 . . . . 73.040000000000006 109.563 178.252 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 7' ' ' PHE . . . . . 0.635 ' H ' ' HA ' ' A' ' 163' ' ' GLN . 57.5 t80 -102.79 137.27 41.22 Favored 'General case' 0 C--O 1.24 0.597 0 CA-C-N 115.058 -0.974 . . . . 72.239999999999995 108.905 -178.49 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 51.2 m-85 -136.59 164.78 27.4 Favored 'General case' 0 C--O 1.24 0.563 0 O-C-N 124.534 1.146 . . . . 74.310000000000002 109.971 174.32 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 24.6 m-20 -112.96 109.06 18.23 Favored 'General case' 0 C--N 1.324 -0.511 0 N-CA-C 106.263 -1.754 . . . . 72.109999999999999 106.263 169.976 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 10' ' ' ILE . . . . . 0.453 HG21 ' SD ' ' A' ' 142' ' ' MET . 46.7 mm -78.95 129.43 37.58 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.479 0 N-CA-C 108.013 -1.106 . . . . 44.119999999999997 108.013 177.555 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 11' ' ' ALA . . . . . 0.75 ' HB2' ' HB2' ' A' ' 159' ' ' ALA . . . -124.53 133.54 53.28 Favored 'General case' 0 C--O 1.217 -0.654 0 C-N-CA 123.849 0.86 . . . . 53.530000000000001 110.785 -171.782 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 12' ' ' VAL . . . . . 0.453 HG13 ' HB3' ' A' ' 154' ' ' LYS . 53.4 t -97.53 117.59 42.51 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.64 0 C-N-CA 124.236 1.014 . . . . 63.140000000000001 108.983 172.128 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 13' ' ' ASP . . . . . 0.47 ' HA ' ' HB3' ' A' ' 155' ' ' LYS . 31.6 m-20 54.97 38.93 31.29 Favored 'General case' 0 N--CA 1.484 1.257 0 C-N-CA 125.288 1.435 . . . . 64.140000000000001 111.211 -174.372 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 84.07 -14.51 43.6 Favored Glycine 0 C--N 1.353 1.508 0 CA-C-N 115.292 -0.867 . . . . 53.049999999999997 113.964 179.479 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 18.4 mm-40 -89.89 122.15 68.18 Favored Pre-proline 0 N--CA 1.474 0.756 0 CA-C-O 118.347 -0.835 . . . . 53.310000000000002 109.865 -178.896 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_exo -50.42 109.55 0.3 Allowed 'Trans proline' 0 C--N 1.378 2.119 0 C-N-CA 123.786 2.99 . . . . 53.200000000000003 113.397 -178.056 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 42.6 tp -77.11 -45.08 28.13 Favored 'General case' 0 N--CA 1.477 0.924 0 C-N-CA 123.647 0.779 . . . . 73.409999999999997 109.503 175.99 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -177.3 -172.45 41.86 Favored Glycine 0 C--N 1.343 0.961 0 CA-C-N 115.519 -0.764 . . . . 43.340000000000003 112.227 -179.933 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 19' ' ' ARG . . . . . 0.497 ' HB3' ' HE1' ' A' ' 7' ' ' PHE . 54.3 mtt180 -118.71 138.39 52.67 Favored 'General case' 0 N--CA 1.473 0.69 0 C-N-CA 124.185 0.994 . . . . 75.040000000000006 110.423 -174.02 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 36.7 t -135.29 144.23 34.77 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.819 0 C-N-CA 124.065 0.946 . . . . 71.430000000000007 109.09 178.328 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 75.1 m -128.94 126.41 39.58 Favored 'General case' 0 CA--C 1.549 0.933 0 C-N-CA 123.688 0.795 . . . . 62.210000000000001 108.931 172.185 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 70.4 m-85 -106.66 121.94 45.36 Favored 'General case' 0 N--CA 1.475 0.792 0 C-N-CA 123.909 0.884 . . . . 71.340000000000003 110.106 178.969 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 23' ' ' GLU . . . . . 0.477 ' HG3' ' HB2' ' A' ' 3' ' ' ASN . 39.7 tt0 -75.92 113.4 13.37 Favored 'General case' 0 CA--C 1.552 1.055 0 C-N-CA 123.764 0.825 . . . . 75.430000000000007 109.487 171.456 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . 0.502 ' O ' ' HB3' ' A' ' 3' ' ' ASN . 37.4 mt -91.39 123.5 34.86 Favored 'General case' 0 N--CA 1.482 1.127 0 C-N-CA 123.538 0.735 . . . . 62.130000000000003 110.305 179.452 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 25' ' ' PHE . . . . . 0.412 ' HA ' HD22 ' A' ' 3' ' ' ASN . 79.3 m-85 -79.72 70.98 6.34 Favored 'General case' 0 N--CA 1.476 0.863 0 C-N-CA 123.688 0.795 . . . . 73.530000000000001 111.15 -178.506 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -74.99 1.44 12.92 Favored 'General case' 0 N--CA 1.483 1.196 0 C-N-CA 123.55 0.74 . . . . 74.430000000000007 112.172 -179.666 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 11.3 p-10 -89.55 -27.81 20.02 Favored 'General case' 0 CA--C 1.551 1.007 0 C-N-CA 123.537 0.735 . . . . 73.319999999999993 110.568 172.791 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 57.4 mttp -100.72 -39.33 7.9 Favored 'General case' 0 N--CA 1.485 1.3 0 C-N-CA 123.362 0.665 . . . . 74.200000000000003 110.845 -176.546 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 29' ' ' VAL . . . . . 0.519 HG21 ' HA ' ' A' ' 129' ' ' PHE . 12.0 m -137.44 61.82 33.65 Favored Pre-proline 0 CA--C 1.56 1.341 0 C-N-CA 124.341 1.056 . . . . 75.109999999999999 110.355 -176.367 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 20.7 Cg_endo -58.9 -23.81 69.54 Favored 'Trans proline' 0 C--N 1.387 2.561 0 C-N-CA 122.559 2.173 . . . . 71.230000000000004 113.733 -178.076 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 86.4 tttt -68.66 -56.47 8.07 Favored 'General case' 0 N--CA 1.477 0.912 0 C-N-CA 122.79 0.436 . . . . 71.239999999999995 110.688 179.662 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 5.7 m -74.06 -33.2 63.61 Favored 'General case' 0 CA--C 1.552 1.05 0 CA-C-N 115.418 -0.81 . . . . 74.310000000000002 111.177 -173.784 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -72.04 -46.62 56.35 Favored 'General case' 0 CA--C 1.546 0.816 0 C-N-CA 123.651 0.78 . . . . 75.349999999999994 111.056 179.948 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 34.4 tt0 -64.38 -37.31 87.06 Favored 'General case' 0 N--CA 1.487 1.419 0 C-N-CA 123.187 0.595 . . . . 74.140000000000001 110.652 178.497 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 35' ' ' ASN . . . . . 0.477 ' O ' ' HG ' ' A' ' 39' ' ' LEU . 38.8 t30 -51.61 -64.44 0.81 Allowed 'General case' 0 C--N 1.36 1.022 0 O-C-N 124.559 1.162 . . . . 72.099999999999994 110.14 177.232 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 86.9 t80 -61.09 -35.99 78.48 Favored 'General case' 0 CA--C 1.544 0.712 0 C-N-CA 123.92 0.888 . . . . 74.120000000000005 111.88 -177.808 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 77.3 ttt180 -64.93 -43.69 91.93 Favored 'General case' 0 N--CA 1.474 0.751 0 C-N-CA 123.715 0.806 . . . . 65.519999999999996 111.436 -177.922 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 38' ' ' ALA . . . . . 0.513 ' HB1' ' HG2' ' A' ' 44' ' ' LYS . . . -78.21 -27.84 47.86 Favored 'General case' 0 N--CA 1.474 0.755 0 C-N-CA 123.32 0.648 . . . . 73.430000000000007 111.209 -177.525 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 39' ' ' LEU . . . . . 0.477 ' HG ' ' O ' ' A' ' 35' ' ' ASN . 88.5 mt -66.02 -43.29 88.05 Favored 'General case' 0 CA--C 1.549 0.908 0 C-N-CA 123.437 0.695 . . . . 62.240000000000002 109.973 169.877 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 16.3 t -62.7 -51.88 65.47 Favored 'General case' 0 N--CA 1.476 0.855 0 C-N-CA 125.22 1.408 . . . . 74.120000000000005 111.336 -178.095 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 25.4 p -77.17 -32.95 56.5 Favored 'General case' 0 CA--C 1.536 0.424 0 CA-C-N 115.559 -0.746 . . . . 73.040000000000006 111.667 -176.167 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 88.42 26.97 26.39 Favored Glycine 0 C--N 1.346 1.116 0 O-C-N 123.406 0.441 . . . . 52.229999999999997 112.558 -175.33 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 22.8 mm-40 -63.59 -22.65 67.01 Favored 'General case' 0 N--CA 1.482 1.165 0 C-N-CA 123.471 0.708 . . . . 72.319999999999993 111.495 173.506 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 44' ' ' LYS . . . . . 0.513 ' HG2' ' HB1' ' A' ' 38' ' ' ALA . 31.0 mmmt -105.69 17.09 24.32 Favored 'General case' 0 CA--C 1.545 0.756 0 C-N-CA 123.998 0.919 . . . . 72.430000000000007 110.905 179.241 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 81.55 -25.86 3.74 Favored Glycine 0 C--N 1.355 1.593 0 N-CA-C 114.641 0.617 . . . . 72.319999999999993 114.641 175.661 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 16.4 m-85 -64.94 -44.03 90.79 Favored 'General case' 0 N--CA 1.48 1.055 0 C-N-CA 123.406 0.682 . . . . 51.240000000000002 111.186 -171.354 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 56.87 64.66 4.2 Favored Glycine 0 C--N 1.356 1.673 0 O-C-N 123.958 0.786 . . . . 62.219999999999999 114.34 166.049 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 48' ' ' TYR . . . . . 0.401 ' HE1' HD22 ' A' ' 39' ' ' LEU . 51.4 m-85 -62.44 87.59 0.02 OUTLIER 'General case' 0 N--CA 1.48 1.075 0 CA-C-O 122.33 1.062 . . . . 75.540000000000006 111.426 -178.721 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 28.5 tptp -111.4 117.15 32.29 Favored 'General case' 0 C--O 1.235 0.33 0 CA-C-N 113.452 -1.703 . . . . 71.209999999999994 107.775 178.762 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 79.46 20.75 68.4 Favored Glycine 0 C--N 1.339 0.742 0 CA-C-O 119.698 -0.501 . . . . 50.350000000000001 112.877 -177.088 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 34.5 t -55.83 115.4 2.36 Favored 'General case' 0 C--N 1.357 0.921 0 C-N-CA 123.365 0.666 . . . . 73.129999999999995 109.387 178.078 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 52' ' ' CYS . . . . . 0.742 ' SG ' ' HB3' ' A' ' 66' ' ' ASP . 2.3 p -86.54 138.6 31.59 Favored 'General case' 0 C--O 1.242 0.685 0 O-C-N 124.255 0.972 . . . . 73.230000000000004 111.491 -172.495 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 53' ' ' PHE . . . . . 0.667 ' HA ' ' HA2' ' A' ' 64' ' ' GLY . 36.6 m-85 -89.29 99.09 12.15 Favored 'General case' 0 N--CA 1.451 -0.415 0 C-N-CA 125.338 1.455 . . . . 74.420000000000002 107.988 175.544 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 43.8 p-80 -82.49 -31.11 29.49 Favored 'General case' 0 N--CA 1.476 0.841 0 C-N-CA 123.608 0.763 . . . . 71.310000000000002 111.342 -177.098 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 55' ' ' ARG . . . . . 0.403 ' HA ' ' O ' ' A' ' 150' ' ' GLY . 52.5 ttt180 -122.92 98.43 5.9 Favored 'General case' 0 C--O 1.21 -0.979 0 C-N-CA 122.885 0.474 . . . . 65.340000000000003 109.85 -173.97 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 56' ' ' ILE . . . . . 0.484 HG21 ' HA ' ' A' ' 143' ' ' GLU . 38.8 mt -127.87 138.95 53.24 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.717 0 N-CA-C 109.296 -0.631 . . . . 74.120000000000005 109.296 173.139 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 57' ' ' ILE . . . . . 0.565 HG23 ' HA ' ' A' ' 148' ' ' ARG . 64.1 mt -134.08 113.71 12.57 Favored Pre-proline 0 CA--C 1.557 1.24 0 C-N-CA 125.133 1.373 . . . . 70.209999999999994 108.781 -174.694 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 58' ' ' PRO . . . . . 0.578 ' HA ' ' HG2' ' A' ' 143' ' ' GLU . 56.0 Cg_endo -66.17 131.46 26.9 Favored 'Trans proline' 0 C--N 1.386 2.516 0 C-N-CA 123.641 2.894 . . . . 43.229999999999997 113.357 -173.104 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 78.03 31.31 48.54 Favored Glycine 0 C--N 1.345 1.08 0 CA-C-N 115.387 -0.824 . . . . 72.549999999999997 112.696 -178.58 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 20.2 t80 -157.71 -73.73 0.09 Allowed 'General case' 0 CA--C 1.545 0.772 0 CA-C-N 116.781 0.291 . . . . 72.540000000000006 111.393 -174.533 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 43.6 ttp -159.59 138.8 11.13 Favored 'General case' 0 N--CA 1.481 1.09 0 C-N-CA 122.679 0.392 . . . . 55.009999999999998 111.299 -166.057 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 62' ' ' CYS . . . . . 0.648 ' SG ' ' HB ' ' A' ' 114' ' ' ILE . 5.4 p -116.31 111.65 20.42 Favored 'General case' 0 CA--C 1.554 1.099 0 C-N-CA 123.494 0.718 . . . . 53.210000000000001 109.429 169.572 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 63' ' ' GLN . . . . . 0.4 ' HA ' ' HA ' ' A' ' 113' ' ' PHE . 54.2 tt0 -109.34 117.71 34.77 Favored 'General case' 0 N--CA 1.487 1.379 0 C-N-CA 124.438 1.095 . . . . 63.039999999999999 110.897 -173.342 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 64' ' ' GLY . . . . . 0.667 ' HA2' ' HA ' ' A' ' 53' ' ' PHE . . . -106.73 -176.3 23.08 Favored Glycine 0 C--N 1.345 1.073 0 CA-C-N 115.713 -0.676 . . . . 62.109999999999999 113.34 179.621 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 84.4 91.5 0.76 Allowed Glycine 0 C--N 1.341 0.859 0 N-CA-C 110.446 -1.062 . . . . 32.450000000000003 110.446 -174.566 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 66' ' ' ASP . . . . . 0.742 ' HB3' ' SG ' ' A' ' 52' ' ' CYS . 32.9 t70 -128.56 -56.89 1.21 Allowed 'General case' 0 N--CA 1.473 0.718 0 C-N-CA 122.938 0.495 . . . . 65.439999999999998 110.532 176.019 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 65.7 t80 -40.25 -57.32 1.75 Allowed 'General case' 0 N--CA 1.485 1.307 0 C-N-CA 125.344 1.458 . . . . 75.340000000000003 114.196 -170.756 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 26.4 m -79.93 107.2 12.52 Favored 'General case' 0 C--O 1.243 0.738 0 CA-C-O 120.862 0.363 . . . . 72.120000000000005 110.992 -174.782 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 62.6 mtt-85 54.29 71.67 0.51 Allowed 'General case' 0 N--CA 1.472 0.669 0 C-N-CA 125.929 1.692 . . . . 61.240000000000002 112.147 173.245 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 70' ' ' HIS . . . . . 0.439 ' HB3' ' O ' ' A' ' 66' ' ' ASP . 15.9 p-80 -85.34 17.5 3.09 Favored 'General case' 0 N--CA 1.481 1.118 0 N-CA-C 113.198 0.814 . . . . 73.150000000000006 113.198 -172.438 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 44.4 t30 -77.0 73.18 3.58 Favored 'General case' 0 N--CA 1.481 1.099 0 CA-C-O 121.561 0.696 . . . . 72.340000000000003 109.561 173.435 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 72' ' ' GLY . . . . . 0.563 ' HA2' ' HG2' ' B' ' 218' ' ' PRO . . . 63.68 20.79 64.36 Favored Glycine 0 C--N 1.346 1.092 0 CA-C-N 115.208 -0.905 . . . . 64.329999999999998 114.505 -179.071 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 37.1 m -125.03 -66.25 0.97 Allowed 'General case' 0 CA--C 1.542 0.669 0 C-N-CA 123.16 0.584 . . . . 63.420000000000002 109.459 -177.357 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 51.64 60.42 7.42 Favored Glycine 0 C--N 1.355 1.636 0 O-C-N 124.275 0.984 . . . . 35.310000000000002 113.543 177.589 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 132.21 53.03 0.08 OUTLIER Glycine 0 N--CA 1.469 0.899 0 CA-C-N 118.049 0.924 . . . . 64.400000000000006 112.35 -176.387 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -51.57 149.47 4.4 Favored 'General case' 0 N--CA 1.481 1.125 0 C-N-CA 123.75 0.82 . . . . 74.420000000000002 111.49 177.242 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 92.0 p -91.45 176.01 6.71 Favored 'General case' 0 CA--C 1.538 0.509 0 CA-C-O 121.361 0.6 . . . . 73.510000000000005 111.163 -168.542 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 78' ' ' ILE . . . . . 0.407 HG21 ' HB3' ' A' ' 38' ' ' ALA . 25.5 pt -75.93 -18.05 15.44 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.615 0 CA-C-N 115.45 -0.795 . . . . 61.329999999999998 110.218 174.329 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 85.1 m-85 -87.76 -14.82 38.69 Favored 'General case' 0 N--CA 1.472 0.642 0 C-N-CA 124.291 1.036 . . . . 74.209999999999994 110.607 177.601 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 147.36 -112.39 0.59 Allowed Glycine 0 C--N 1.348 1.199 0 N-CA-C 110.612 -0.995 . . . . 72.519999999999996 110.612 178.817 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 32.1 tt0 -89.1 -50.72 5.99 Favored 'General case' 0 CA--C 1.539 0.533 0 CA-C-O 121.657 0.741 . . . . 75.099999999999994 109.358 176.017 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 82' ' ' LYS . . . . . 0.438 ' HD2' ' HA ' ' A' ' 107' ' ' THR . 23.7 pttm -151.88 177.46 10.41 Favored 'General case' 0 N--CA 1.47 0.541 0 CA-C-N 114.336 -1.302 . . . . 73.120000000000005 109.791 -169.335 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 45.7 p90 -158.43 170.7 21.62 Favored 'General case' 0 N--CA 1.476 0.836 0 C-N-CA 123.492 0.717 . . . . 71.239999999999995 110.362 176.468 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 84' ' ' GLU . . . . . 0.534 ' HA ' ' HA ' ' A' ' 106' ' ' ASN . 9.7 pt-20 -82.73 160.46 22.34 Favored 'General case' 0 N--CA 1.474 0.747 0 C-N-CA 122.899 0.48 . . . . 74.310000000000002 111.036 178.226 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 52.3 m-20 -65.23 131.73 47.25 Favored 'General case' 0 C--O 1.239 0.511 0 CA-C-N 114.802 -1.09 . . . . 73.239999999999995 110.298 177.509 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 10.9 tp10 -72.33 -58.13 3.65 Favored 'General case' 0 C--O 1.239 0.503 0 O-C-N 124.166 0.916 . . . . 63.399999999999999 109.323 175.224 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 32.3 p30 -159.02 -173.77 4.41 Favored 'General case' 0 C--O 1.237 0.405 0 CA-C-N 114.437 -1.256 . . . . 75.150000000000006 108.966 -175.97 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 89.0 m-85 -137.56 61.26 1.61 Allowed 'General case' 0 N--CA 1.477 0.886 0 C-N-CA 123.602 0.761 . . . . 74.129999999999995 108.982 173.193 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 62.5 mt -78.77 -54.32 12.09 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.151 0 CA-C-O 121.383 0.611 . . . . 73.420000000000002 109.909 177.495 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 90' ' ' LEU . . . . . 0.499 ' HB3' ' HB ' ' A' ' 128' ' ' VAL . 94.3 mt -89.05 140.88 28.99 Favored 'General case' 0 C--O 1.236 0.37 0 CA-C-N 115.067 -0.97 . . . . 61.25 111.389 -172.672 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 16.8 ptpt -139.63 170.56 15.68 Favored 'General case' 0 CA--C 1.541 0.612 0 C-N-CA 124.113 0.965 . . . . 63.450000000000003 110.83 -173.571 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 92' ' ' HIS . . . . . 0.574 ' HA ' HG21 ' A' ' 97' ' ' ILE . 13.2 m80 -92.12 53.72 2.22 Favored 'General case' 0 N--CA 1.48 1.041 0 C-N-CA 124.791 1.236 . . . . 72.239999999999995 110.78 -167.528 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 3.8 p -94.52 20.32 8.58 Favored 'General case' 0 N--CA 1.481 1.103 0 C-N-CA 124.196 0.998 . . . . 32.549999999999997 113.286 -174.125 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -163.93 178.92 39.17 Favored Glycine 0 C--N 1.344 0.974 0 C-N-CA 121.018 -0.611 . . . . 43.329999999999998 113.652 -178.214 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 85.0 Cg_endo -81.64 138.5 10.73 Favored 'Trans proline' 0 C--N 1.369 1.657 0 C-N-CA 123.046 2.497 . . . . 74.439999999999998 112.805 175.935 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 96' ' ' GLY . . . . . 0.551 ' HA3' HG12 ' A' ' 132' ' ' VAL . . . 80.28 20.12 67.75 Favored Glycine 0 C--N 1.35 1.316 0 CA-C-N 116.04 -0.527 . . . . 75.430000000000007 113.692 174.1 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 97' ' ' ILE . . . . . 0.574 HG21 ' HA ' ' A' ' 92' ' ' HIS . 21.7 mm -66.87 105.62 0.73 Allowed 'Isoleucine or valine' 0 CA--C 1.549 0.914 0 C-N-CA 124.518 1.127 . . . . 61.530000000000001 110.613 178.077 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 98' ' ' LEU . . . . . 0.451 HD13 HG12 ' A' ' 114' ' ' ILE . 59.2 tp -87.17 101.47 13.53 Favored 'General case' 0 CA--C 1.55 0.973 0 CA-C-O 121.894 0.855 . . . . 71.140000000000001 109.532 177.089 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 99' ' ' SER . . . . . 0.522 ' HB2' HG22 ' A' ' 128' ' ' VAL . 33.0 t -106.07 170.39 7.94 Favored 'General case' 0 N--CA 1.472 0.664 0 C-N-CA 124.965 1.306 . . . . 44.329999999999998 108.67 176.141 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 100' ' ' MET . . . . . 0.5 ' SD ' ' HA2' ' A' ' 109' ' ' GLY . 4.4 ttt -113.53 135.68 53.63 Favored 'General case' 0 N--CA 1.482 1.125 0 CA-C-N 118.356 0.525 . . . . 64.099999999999994 110.048 -178.175 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 101' ' ' ALA . . . . . 0.441 ' HB3' ' HB2' ' A' ' 111' ' ' GLN . . . -84.35 -178.95 7.07 Favored 'General case' 0 C--O 1.244 0.811 0 C-N-CA 123.764 0.826 . . . . 43.399999999999999 111.105 -173.79 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 25.8 p-10 -168.84 -178.83 3.49 Favored 'General case' 0 CA--C 1.539 0.552 0 CA-C-N 115.166 -0.925 . . . . 72.239999999999995 111.369 -168.322 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 103' ' ' ALA . . . . . 0.495 ' HB3' HG21 ' A' ' 107' ' ' THR . . . -124.46 13.2 8.78 Favored 'General case' 0 N--CA 1.479 1.002 0 C-N-CA 124.249 1.02 . . . . 71.219999999999999 109.496 161.94 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 145.39 178.07 20.64 Favored Glycine 0 C--N 1.352 1.424 0 CA-C-O 119.065 -0.853 . . . . 74.140000000000001 111.539 -179.556 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 32.5 Cg_exo -61.19 149.91 87.05 Favored 'Trans proline' 0 C--N 1.375 1.962 0 C-N-CA 123.198 2.599 . . . . 75.129999999999995 111.731 169.496 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 106' ' ' ASN . . . . . 0.534 ' HA ' ' HA ' ' A' ' 84' ' ' GLU . 65.6 t30 62.87 21.87 13.09 Favored 'General case' 0 CA--C 1.557 1.249 0 O-C-N 124.168 0.917 . . . . 62.109999999999999 110.325 -174.031 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 107' ' ' THR . . . . . 0.495 HG21 ' HB3' ' A' ' 103' ' ' ALA . 12.2 m -142.15 24.11 1.99 Allowed 'General case' 0 CA--C 1.555 1.137 0 C-N-CA 125.066 1.346 . . . . 73.329999999999998 109.094 178.154 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 61.1 t30 -80.27 147.95 30.97 Favored 'General case' 0 N--CA 1.476 0.851 0 C-N-CA 123.739 0.816 . . . . 73.439999999999998 109.46 176.534 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 109' ' ' GLY . . . . . 0.5 ' HA2' ' SD ' ' A' ' 100' ' ' MET . . . 106.49 -14.24 42.83 Favored Glycine 0 N--CA 1.472 1.04 0 CA-C-O 119.946 -0.363 . . . . 54.020000000000003 113.805 177.608 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 38.6 p -94.81 120.18 34.61 Favored 'General case' 0 CA--C 1.543 0.699 0 C-N-CA 123.382 0.673 . . . . 71.230000000000004 109.361 177.861 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 111' ' ' GLN . . . . . 0.693 HE22 ' HB2' ' B' ' 218' ' ' PRO . 27.8 mt-30 66.95 162.95 0.18 Allowed 'General case' 0 N--CA 1.497 1.906 0 C-N-CA 125.044 1.338 . . . . 75.310000000000002 111.408 -170.491 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 44.9 p90 -144.5 150.29 37.34 Favored 'General case' 0 N--CA 1.484 1.233 0 N-CA-C 108.362 -0.977 . . . . 64.129999999999995 108.362 178.19 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 113' ' ' PHE . . . . . 0.4 ' HA ' ' HA ' ' A' ' 63' ' ' GLN . 51.3 p90 -140.98 142.37 34.29 Favored 'General case' 0 N--CA 1.472 0.644 0 N-CA-C 111.969 0.359 . . . . 63.340000000000003 111.969 -175.895 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 114' ' ' ILE . . . . . 0.648 ' HB ' ' SG ' ' A' ' 62' ' ' CYS . 12.1 mt -111.98 105.02 17.98 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.733 0 C-N-CA 124.168 0.987 . . . . 65.109999999999999 109.127 -178.391 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 115' ' ' CYS . . . . . . . . . . . . . 69.5 m -75.71 107.89 8.19 Favored 'General case' 0 CA--C 1.541 0.597 0 N-CA-C 109.171 -0.677 . . . . 75.140000000000001 109.171 173.335 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 116' ' ' THR . . . . . 0.468 ' HA ' ' H ' ' A' ' 96' ' ' GLY . 72.3 p -78.6 -10.71 59.84 Favored 'General case' 0 N--CA 1.481 1.078 0 C-N-CA 123.379 0.672 . . . . 52.340000000000003 111.681 -179.559 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -125.46 166.92 15.76 Favored 'General case' 0 C--O 1.243 0.746 0 C-N-CA 123.358 0.663 . . . . 45.439999999999998 109.741 176.37 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 11.3 ptmt -71.72 74.49 0.83 Allowed 'General case' 0 CA--C 1.548 0.893 0 C-N-CA 124.003 0.921 . . . . 64.299999999999997 110.097 174.829 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 119' ' ' THR . . . . . 0.547 ' HB ' HD23 ' A' ' 122' ' ' LEU . 41.1 p -76.53 90.66 3.32 Favored 'General case' 0 CA--C 1.546 0.821 0 CA-C-O 121.928 0.871 . . . . 71.200000000000003 109.588 -177.514 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 9.6 pt-20 -71.82 -32.11 67.23 Favored 'General case' 0 N--CA 1.472 0.648 0 CA-C-N 115.057 -0.974 . . . . 62.119999999999997 112.19 -173.987 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 121' ' ' TRP . . . . . . . . . . . . . 27.4 p90 -74.09 -4.82 37.94 Favored 'General case' 0 N--CA 1.479 0.99 0 C-N-CA 122.757 0.423 . . . . 73.439999999999998 111.058 176.793 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 122' ' ' LEU . . . . . 0.547 HD23 ' HB ' ' A' ' 119' ' ' THR . 3.8 mm? -86.88 -15.67 38.35 Favored 'General case' 0 N--CA 1.477 0.878 0 C-N-CA 123.761 0.824 . . . . 70.0 111.394 173.347 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 41.4 m-20 -72.41 149.39 44.32 Favored 'General case' 0 N--CA 1.482 1.134 0 N-CA-C 109.767 -0.457 . . . . 65.040000000000006 109.767 176.105 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 93.93 -26.9 14.4 Favored Glycine 0 N--CA 1.47 0.912 0 N-CA-C 111.628 -0.589 . . . . 51.130000000000003 111.628 -171.274 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 125' ' ' LYS . . . . . 0.504 ' HD2' ' HE2' ' B' ' 221' ' ' TYR . 1.8 mppt? -80.1 -169.89 2.24 Favored 'General case' 0 N--CA 1.478 0.951 0 C-N-CA 123.902 0.881 . . . . 74.549999999999997 109.709 172.387 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 126' ' ' HIS . . . . . . . . . . . . . 0.6 OUTLIER -69.34 145.68 52.77 Favored 'General case' 0 C--O 1.242 0.673 0 C-N-CA 123.372 0.669 . . . . 75.230000000000004 111.79 -167.51 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 11.1 p -65.32 145.19 14.12 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.726 0 CA-C-N 113.656 -1.611 . . . . 63.119999999999997 112.361 -165.521 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 128' ' ' VAL . . . . . 0.522 HG22 ' HB2' ' A' ' 99' ' ' SER . 60.2 t -74.25 150.22 7.43 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.53 0 CA-C-N 114.569 -1.196 . . . . 73.0 108.932 172.791 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 129' ' ' PHE . . . . . 0.519 ' HA ' HG21 ' A' ' 29' ' ' VAL . 45.5 p90 -133.59 -10.76 2.78 Favored 'General case' 0 N--CA 1.476 0.831 0 C-N-CA 122.202 0.201 . . . . 74.420000000000002 111.424 -179.396 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . -146.3 170.93 27.3 Favored Glycine 0 C--N 1.343 0.941 0 O-C-N 123.559 0.537 . . . . 75.329999999999998 112.751 -173.357 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 29.4 ttpt -161.19 134.21 6.34 Favored 'General case' 0 C--N 1.325 -0.46 0 C-N-CA 124.346 1.058 . . . . 63.210000000000001 108.235 -175.959 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 132' ' ' VAL . . . . . 0.551 HG12 ' HA3' ' A' ' 96' ' ' GLY . 13.7 p -68.41 131.02 33.82 Favored 'Isoleucine or valine' 0 CA--C 1.554 1.124 0 CA-C-N 118.329 0.513 . . . . 71.209999999999994 109.959 175.107 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -91.62 -48.82 6.63 Favored 'General case' 0 N--CA 1.48 1.061 0 N-CA-C 108.975 -0.75 . . . . 61.409999999999997 108.975 173.306 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 3.2 mp0 -146.63 155.85 42.76 Favored 'General case' 0 C--O 1.243 0.747 0 C-N-CA 124.983 1.313 . . . . 71.439999999999998 108.544 177.052 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 94.24 12.22 56.47 Favored Glycine 0 C--N 1.342 0.877 0 CA-C-N 115.926 -0.579 . . . . 51.420000000000002 112.376 -174.546 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 136' ' ' MET . . . . . 0.423 ' SD ' HG11 ' A' ' 132' ' ' VAL . 15.0 tpt -62.5 -31.1 71.8 Favored 'General case' 0 N--CA 1.48 1.031 0 C-N-CA 123.847 0.859 . . . . 60.329999999999998 111.192 178.522 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 137' ' ' ASN . . . . . . . . . . . . . 26.6 t-20 -55.51 -42.22 74.18 Favored 'General case' 0 N--CA 1.479 0.994 0 C-N-CA 123.964 0.906 . . . . 74.230000000000004 110.506 174.238 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 138' ' ' ILE . . . . . . . . . . . . . 44.9 mm -74.19 -32.85 33.24 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.73 0 CA-C-N 115.232 -0.895 . . . . 72.329999999999998 110.691 -178.95 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 69.3 t -64.55 -41.43 92.25 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.366 0 C-N-CA 123.471 0.709 . . . . 62.009999999999998 110.495 176.347 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 38.3 mt-10 -69.92 -39.22 76.29 Favored 'General case' 0 N--CA 1.473 0.722 0 CA-C-N 115.311 -0.859 . . . . 62.5 110.747 177.681 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -65.06 -52.45 55.67 Favored 'General case' 0 N--CA 1.475 0.784 0 O-C-N 123.681 0.613 . . . . 74.099999999999994 110.632 -179.568 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 142' ' ' MET . . . . . 0.459 ' HB2' HD13 ' A' ' 156' ' ' ILE . 27.6 ptm -59.73 -37.66 79.57 Favored 'General case' 0 N--CA 1.477 0.888 0 C-N-CA 123.055 0.542 . . . . 71.310000000000002 110.538 179.144 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 143' ' ' GLU . . . . . 0.578 ' HG2' ' HA ' ' A' ' 58' ' ' PRO . 39.4 tt0 -62.74 -35.76 80.8 Favored 'General case' 0 CA--C 1.546 0.822 0 CA-C-O 121.253 0.549 . . . . 74.019999999999996 112.144 -176.966 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 144' ' ' ARG . . . . . 0.557 ' HA ' ' HB3' ' A' ' 58' ' ' PRO . 62.3 mtt180 -73.58 -7.31 51.38 Favored 'General case' 0 CA--C 1.547 0.828 0 CA-C-N 115.769 -0.65 . . . . 73.150000000000006 112.711 -178.236 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 145' ' ' PHE . . . . . 0.546 ' HB2' HD11 ' A' ' 156' ' ' ILE . 55.0 m-85 -89.2 6.74 38.74 Favored 'General case' 0 CA--C 1.558 1.251 0 C-N-CA 123.07 0.548 . . . . 74.530000000000001 111.933 172.416 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . -102.5 -175.23 27.25 Favored Glycine 0 C--N 1.355 1.608 0 CA-C-N 117.646 0.203 . . . . 21.239999999999998 112.708 177.842 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 31.0 m -132.91 168.99 17.44 Favored 'General case' 0 N--CA 1.489 1.496 0 C-N-CA 124.202 1.001 . . . . 71.430000000000007 110.3 179.84 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 148' ' ' ARG . . . . . 0.565 ' HA ' HG23 ' A' ' 57' ' ' ILE . 21.9 mmt85 -65.98 -33.97 77.04 Favored 'General case' 0 N--CA 1.487 1.4 0 C-N-CA 123.845 0.858 . . . . 64.519999999999996 112.758 -175.143 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 149' ' ' ASN . . . . . . . . . . . . . 30.9 p-10 -74.7 -15.75 60.78 Favored 'General case' 0 N--CA 1.484 1.272 0 C-N-CA 123.411 0.684 . . . . 70.120000000000005 111.325 175.148 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 150' ' ' GLY . . . . . 0.403 ' O ' ' HA ' ' A' ' 55' ' ' ARG . . . 109.67 -17.06 30.86 Favored Glycine 0 C--N 1.344 1.004 0 CA-C-N 115.671 -0.695 . . . . 64.049999999999997 112.462 -179.962 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 66.2 tttp -60.3 124.01 19.0 Favored 'General case' 0 N--CA 1.474 0.769 0 CA-C-N 117.417 0.609 . . . . 71.010000000000005 110.918 -177.955 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 152' ' ' THR . . . . . 0.432 HG22 ' HB ' ' A' ' 56' ' ' ILE . 14.0 p -89.56 118.02 28.89 Favored 'General case' 0 CA--C 1.538 0.482 0 C-N-CA 123.235 0.614 . . . . 70.439999999999998 109.567 -177.897 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 153' ' ' SER . . . . . . . . . . . . . 19.8 m -66.89 -19.07 65.66 Favored 'General case' 0 CA--C 1.549 0.921 0 C-N-CA 124.153 0.981 . . . . 74.439999999999998 111.724 178.77 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 154' ' ' LYS . . . . . 0.453 ' HB3' HG13 ' A' ' 12' ' ' VAL . 74.6 mmtt -128.58 144.14 51.09 Favored 'General case' 0 N--CA 1.48 1.067 0 C-N-CA 124.478 1.111 . . . . 75.549999999999997 108.666 176.498 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 155' ' ' LYS . . . . . 0.47 ' HB3' ' HA ' ' A' ' 13' ' ' ASP . 0.0 OUTLIER -81.47 90.13 6.2 Favored 'General case' 0 N--CA 1.477 0.882 0 CA-C-O 121.54 0.686 . . . . 71.299999999999997 109.743 -177.269 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 156' ' ' ILE . . . . . 0.546 HD11 ' HB2' ' A' ' 145' ' ' PHE . 66.3 mt -88.74 118.48 34.22 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.432 0 CA-C-N 115.855 -0.611 . . . . 72.349999999999994 109.449 -176.206 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 157' ' ' THR . . . . . . . . . . . . . 30.7 p -131.15 156.09 45.88 Favored 'General case' 0 C--O 1.239 0.534 0 C-N-CA 124.469 1.108 . . . . 74.040000000000006 109.382 -174.931 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 158' ' ' ILE . . . . . . . . . . . . . 60.1 mt -77.96 94.15 1.46 Allowed 'Isoleucine or valine' 0 CA--C 1.55 0.946 0 N-CA-C 108.926 -0.768 . . . . 64.019999999999996 108.926 172.572 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 159' ' ' ALA . . . . . 0.75 ' HB2' ' HB2' ' A' ' 11' ' ' ALA . . . -51.9 -40.88 61.43 Favored 'General case' 0 N--CA 1.488 1.439 0 C-N-CA 124.551 1.14 . . . . 61.340000000000003 113.03 -177.932 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 160' ' ' ASP . . . . . . . . . . . . . 25.3 t0 -164.36 157.74 17.87 Favored 'General case' 0 N--CA 1.478 0.958 0 C-N-CA 122.946 0.498 . . . . 73.120000000000005 110.311 178.718 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 161' ' ' CYS . . . . . . . . . . . . . 29.2 p -119.82 -169.97 1.87 Allowed 'General case' 0 N--CA 1.475 0.779 0 C-N-CA 124.774 1.229 . . . . 75.420000000000002 108.36 175.398 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 162' ' ' GLY . . . . . . . . . . . . . . . 132.49 55.02 0.08 OUTLIER Glycine 0 C--N 1.347 1.156 0 N-CA-C 111.095 -0.802 . . . . 54.329999999999998 111.095 -170.393 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 163' ' ' GLN . . . . . 0.635 ' HA ' ' H ' ' A' ' 7' ' ' PHE . 3.0 pt20 -49.63 137.49 15.54 Favored 'General case' 0 CA--C 1.55 0.961 0 N-CA-C 114.357 1.243 . . . . 63.539999999999999 114.357 -169.296 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 164' ' ' LEU . . . . . 0.415 ' O ' ' HB ' ' A' ' 5' ' ' THR . 85.2 mt . . . . . 0 N--CA 1.472 0.644 0 CA-C-N 115.859 -0.61 . . . . 62.340000000000003 110.114 -176.502 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 218' ' ' PRO . . . . . 0.693 ' HB2' HE22 ' A' ' 111' ' ' GLN . 50.2 Cg_exo . . . . . 0 CA--C 1.543 0.94 0 CA-C-O 121.209 0.42 . . . . 61.520000000000003 112.484 . . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 219' ' ' GLY . . . . . . . . . . . . . . . 169.37 -176.47 43.36 Favored Glycine 0 CA--C 1.524 0.607 0 N-CA-C 110.164 -1.174 . . . . 43.520000000000003 110.164 -178.489 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 220' ' ' PRO . . . . . . . . . . . . . 82.4 Cg_endo -79.56 -177.59 3.97 Favored 'Trans proline' 0 CA--C 1.553 1.425 0 C-N-CA 122.519 2.146 . . . . 75.25 113.88 175.211 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 221' ' ' TYR . . . . . 0.504 ' HE2' ' HD2' ' A' ' 125' ' ' LYS . 64.4 m-85 . . . . . 0 N--CA 1.476 0.872 0 C-N-CA 123.852 0.861 . . . . 71.400000000000006 110.237 -178.051 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 3' ' ' ASN . . . . . 0.628 ' ND2' ' HA ' ' A' ' 25' ' ' PHE . 9.7 m120 . . . . . 0 N--CA 1.478 0.954 0 CA-C-O 118.888 -0.577 . . . . 75.099999999999994 110.838 . . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 4' ' ' PRO . . . . . 0.645 ' HG2' ' HB2' ' A' ' 24' ' ' LEU . 67.2 Cg_endo -72.66 136.74 26.24 Favored 'Trans proline' 0 C--N 1.374 1.872 0 C-N-CA 122.144 1.896 . . . . 64.209999999999994 111.653 176.37 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 5' ' ' THR . . . . . 0.608 HG23 ' HD3' ' A' ' 133' ' ' LYS . 85.5 m -95.99 113.56 25.19 Favored 'General case' 0 C--O 1.236 0.368 0 N-CA-C 107.893 -1.151 . . . . 73.129999999999995 107.893 176.002 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 6' ' ' VAL . . . . . 0.556 ' HA ' ' HB2' ' A' ' 163' ' ' GLN . 13.7 m -98.62 121.1 48.8 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.51 0 CA-C-O 121.956 0.884 . . . . 75.230000000000004 109.328 -178.22 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 7' ' ' PHE . . . . . 0.436 ' H ' ' HA ' ' A' ' 163' ' ' GLN . 77.3 t80 -105.08 135.09 47.08 Favored 'General case' 0 C--O 1.239 0.52 0 CA-C-N 114.423 -1.262 . . . . 70.209999999999994 109.237 -173.328 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 8' ' ' PHE . . . . . 0.44 ' HB3' HG23 ' A' ' 158' ' ' ILE . 64.4 m-85 -142.27 165.25 27.94 Favored 'General case' 0 C--O 1.24 0.578 0 O-C-N 124.398 1.061 . . . . 64.239999999999995 109.757 176.11 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 17.4 m-20 -113.91 108.51 17.15 Favored 'General case' 0 N--CA 1.465 0.314 0 N-CA-C 107.625 -1.25 . . . . 71.109999999999999 107.625 171.637 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 10' ' ' ILE . . . . . 0.441 HG21 ' SD ' ' A' ' 142' ' ' MET . 47.3 mm -80.7 116.82 25.61 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.351 0 N-CA-C 108.313 -0.995 . . . . 52.009999999999998 108.313 -179.545 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 11' ' ' ALA . . . . . 0.688 ' HB2' ' HB2' ' A' ' 159' ' ' ALA . . . -116.04 109.92 18.2 Favored 'General case' 0 N--CA 1.469 0.493 0 C-N-CA 123.684 0.794 . . . . 70.420000000000002 111.941 -168.586 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 12' ' ' VAL . . . . . 0.502 HG21 HD22 ' A' ' 17' ' ' LEU . 89.6 t -96.04 128.91 46.81 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.467 0 N-CA-C 108.057 -1.09 . . . . 75.010000000000005 108.057 176.684 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 25.0 m-20 70.24 15.94 7.4 Favored 'General case' 0 N--CA 1.493 1.688 0 C-N-CA 124.218 1.007 . . . . 74.549999999999997 110.484 -172.325 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 81.29 -5.89 65.92 Favored Glycine 0 C--N 1.353 1.507 0 CA-C-N 116.005 -0.543 . . . . 65.420000000000002 112.754 -170.505 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 25.7 mm-40 -98.32 120.81 58.68 Favored Pre-proline 0 N--CA 1.471 0.599 0 C-N-CA 123.823 0.849 . . . . 64.239999999999995 109.437 -178.213 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 52.3 Cg_exo -51.21 105.19 0.1 OUTLIER 'Trans proline' 0 C--N 1.375 1.963 0 C-N-CA 123.257 2.638 . . . . 60.140000000000001 112.344 178.536 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 17' ' ' LEU . . . . . 0.502 HD22 HG21 ' A' ' 12' ' ' VAL . 26.9 tp -75.08 -31.69 61.27 Favored 'General case' 0 N--CA 1.472 0.67 0 C-N-CA 124.126 0.97 . . . . 61.210000000000001 109.573 -179.892 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -175.66 173.15 46.07 Favored Glycine 0 C--N 1.341 0.814 0 CA-C-N 115.071 -0.968 . . . . 64.519999999999996 112.054 175.925 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 19' ' ' ARG . . . . . 0.428 ' HD2' ' HZ ' ' A' ' 7' ' ' PHE . 47.6 mtm180 -107.2 124.39 49.66 Favored 'General case' 0 N--CA 1.471 0.595 0 N-CA-C 108.541 -0.911 . . . . 74.209999999999994 108.541 -179.095 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 71.3 t -120.74 141.45 41.11 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.881 0 C-N-CA 123.1 0.56 . . . . 71.519999999999996 109.9 -176.945 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 21' ' ' SER . . . . . 0.551 ' HB2' ' HB2' ' A' ' 134' ' ' GLU . 60.6 m -127.39 132.14 50.2 Favored 'General case' 0 C--O 1.245 0.828 0 C-N-CA 123.878 0.871 . . . . 64.349999999999994 109.39 173.533 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 17.3 m-85 -107.42 153.67 22.45 Favored 'General case' 0 N--CA 1.469 0.513 0 N-CA-C 108.338 -0.986 . . . . 72.230000000000004 108.338 177.729 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 5.8 tp10 -104.75 109.64 21.67 Favored 'General case' 0 C--O 1.239 0.543 0 N-CA-C 108.598 -0.889 . . . . 73.450000000000003 108.598 176.954 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . 0.645 ' HB2' ' HG2' ' A' ' 4' ' ' PRO . 29.6 mt -81.11 122.77 27.77 Favored 'General case' 0 N--CA 1.465 0.285 0 N-CA-C 108.784 -0.821 . . . . 53.049999999999997 108.784 175.309 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 25' ' ' PHE . . . . . 0.628 ' HA ' ' ND2' ' A' ' 3' ' ' ASN . 86.9 m-85 -84.91 65.46 9.2 Favored 'General case' 0 N--CA 1.467 0.377 0 C-N-CA 123.166 0.586 . . . . 75.209999999999994 110.468 179.888 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -64.17 -24.16 67.58 Favored 'General case' 0 N--CA 1.477 0.877 0 C-N-CA 123.418 0.687 . . . . 65.150000000000006 111.876 -179.799 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 10.9 p-10 -66.09 -25.73 67.15 Favored 'General case' 0 N--CA 1.476 0.853 0 C-N-CA 123.535 0.734 . . . . 73.329999999999998 111.33 177.467 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 52.4 mttm -102.32 -43.93 5.55 Favored 'General case' 0 N--CA 1.478 0.962 0 C-N-CA 124.163 0.985 . . . . 63.140000000000001 110.238 -179.433 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 29' ' ' VAL . . . . . 0.443 HG21 ' HA ' ' A' ' 129' ' ' PHE . 16.0 m -127.31 78.85 74.03 Favored Pre-proline 0 CA--C 1.556 1.194 0 C-N-CA 124.128 0.971 . . . . 43.229999999999997 109.942 -177.11 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 11.3 Cg_endo -55.21 -48.02 23.09 Favored 'Trans proline' 0 C--N 1.383 2.373 0 C-N-CA 123.038 2.492 . . . . 74.439999999999998 112.89 -177.792 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 31' ' ' LYS . . . . . 0.446 ' HG3' ' OH ' ' A' ' 79' ' ' TYR . 23.4 ttmm -76.86 -43.48 35.96 Favored 'General case' 0 N--CA 1.474 0.771 0 C-N-CA 123.967 0.907 . . . . 74.349999999999994 112.344 -172.631 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 9.1 m -69.14 -33.36 73.33 Favored 'General case' 0 CA--C 1.549 0.94 0 CA-C-O 120.867 0.365 . . . . 51.530000000000001 110.273 -176.062 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -78.43 -34.52 47.81 Favored 'General case' 0 CA--C 1.55 0.976 0 CA-C-N 116.112 -0.494 . . . . 64.319999999999993 111.533 174.03 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 29.7 tt0 -60.32 -41.58 93.8 Favored 'General case' 0 N--CA 1.49 1.555 0 C-N-CA 124.421 1.088 . . . . 64.040000000000006 111.077 178.536 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 35' ' ' ASN . . . . . 0.478 ' O ' ' HG ' ' A' ' 39' ' ' LEU . 40.9 t30 -54.15 -60.16 3.7 Favored 'General case' 0 CA--C 1.537 0.448 0 CA-C-N 114.297 -1.32 . . . . 75.319999999999993 110.191 178.635 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 63.1 t80 -65.48 -32.51 74.16 Favored 'General case' 0 CA--C 1.545 0.76 0 CA-C-N 115.225 -0.898 . . . . 71.519999999999996 111.613 -176.695 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 37.0 ttm-85 -57.02 -50.98 71.06 Favored 'General case' 0 N--CA 1.482 1.139 0 C-N-CA 124.028 0.931 . . . . 75.400000000000006 110.346 177.195 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 38' ' ' ALA . . . . . 0.538 ' HB3' HG21 ' A' ' 78' ' ' ILE . . . -79.26 -23.33 43.73 Favored 'General case' 0 CA--C 1.545 0.766 0 CA-C-N 115.029 -0.987 . . . . 73.340000000000003 112.22 -175.24 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 39' ' ' LEU . . . . . 0.478 ' HG ' ' O ' ' A' ' 35' ' ' ASN . 85.7 mt -71.78 -40.19 69.42 Favored 'General case' 0 N--CA 1.483 1.221 0 C-N-CA 123.004 0.522 . . . . 52.210000000000001 110.158 172.899 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 28.8 t -65.48 -55.05 20.03 Favored 'General case' 0 N--CA 1.475 0.805 0 C-N-CA 124.513 1.125 . . . . 54.439999999999998 110.682 -179.368 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 20.8 p -67.73 -32.07 72.43 Favored 'General case' 0 N--CA 1.477 0.894 0 CA-C-N 116.08 -0.509 . . . . 73.540000000000006 111.411 177.284 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 71.21 28.18 70.52 Favored Glycine 0 C--N 1.343 0.972 0 CA-C-N 115.686 -0.688 . . . . 53.32 112.838 -176.662 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 19.4 mm-40 -62.85 -31.07 72.01 Favored 'General case' 0 N--CA 1.479 0.992 0 C-N-CA 123.268 0.627 . . . . 75.329999999999998 111.461 177.62 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 44' ' ' LYS . . . . . 0.403 ' HG2' ' HB1' ' A' ' 38' ' ' ALA . 75.7 mmtt -83.98 9.44 12.33 Favored 'General case' 0 CA--C 1.556 1.197 0 CA-C-N 115.706 -0.679 . . . . 74.420000000000002 111.592 178.062 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 76.1 32.51 52.39 Favored Glycine 0 C--N 1.352 1.455 0 C-N-CA 123.146 0.403 . . . . 64.310000000000002 113.706 175.711 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 17.9 m-85 -110.28 -47.23 3.32 Favored 'General case' 0 N--CA 1.483 1.182 0 N-CA-C 109.654 -0.498 . . . . 75.329999999999998 109.654 179.453 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 56.66 65.58 3.47 Favored Glycine 0 C--N 1.354 1.548 0 O-C-N 124.107 0.879 . . . . 53.030000000000001 114.21 168.627 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 48' ' ' TYR . . . . . 0.472 ' HE1' HD22 ' A' ' 39' ' ' LEU . 51.3 m-85 -65.25 87.33 0.07 Allowed 'General case' 0 N--CA 1.476 0.848 0 CA-C-O 122.644 1.212 . . . . 74.099999999999994 111.237 -179.378 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 50.6 tptt -111.13 134.83 52.42 Favored 'General case' 0 C--O 1.244 0.812 0 CA-C-N 112.698 -2.046 . . . . 73.349999999999994 107.655 -179.486 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 65.22 21.86 68.6 Favored Glycine 0 N--CA 1.468 0.823 0 CA-C-O 119.57 -0.572 . . . . 75.209999999999994 113.032 -179.321 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 28.1 t -57.98 114.24 2.25 Favored 'General case' 0 C--N 1.362 1.11 0 C-N-CA 123.688 0.795 . . . . 64.120000000000005 109.946 -176.379 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 52' ' ' CYS . . . . . . . . . . . . . 45.2 t -83.31 137.37 34.0 Favored 'General case' 0 C--O 1.241 0.619 0 CA-C-N 115.437 -0.802 . . . . 60.130000000000003 111.757 -166.872 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 53' ' ' PHE . . . . . 0.747 ' HA ' ' HA2' ' A' ' 64' ' ' GLY . 38.6 m-85 -87.2 115.65 24.75 Favored 'General case' 0 C--O 1.238 0.474 0 N-CA-C 107.886 -1.153 . . . . 75.25 107.886 169.647 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 47.3 p-80 -99.5 -29.71 12.58 Favored 'General case' 0 N--CA 1.48 1.072 0 C-N-CA 123.278 0.631 . . . . 74.099999999999994 111.153 -175.748 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 55' ' ' ARG . . . . . 0.527 ' HA ' ' O ' ' A' ' 150' ' ' GLY . 59.5 ttt180 -132.92 98.96 4.44 Favored 'General case' 0 C--O 1.218 -0.588 0 CA-C-N 115.78 -0.646 . . . . 73.430000000000007 109.412 -168.805 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 56' ' ' ILE . . . . . 0.504 HD12 HD12 ' A' ' 156' ' ' ILE . 47.5 mt -123.67 124.36 69.23 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.813 0 N-CA-C 109.162 -0.681 . . . . 73.140000000000001 109.162 178.564 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 57' ' ' ILE . . . . . 0.414 HG12 ' HA2' ' A' ' 150' ' ' GLY . 45.4 mt -126.61 112.16 22.83 Favored Pre-proline 0 CA--C 1.561 1.372 0 C-N-CA 124.87 1.268 . . . . 63.43 109.242 -170.985 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 71.0 Cg_exo -54.32 145.11 57.57 Favored 'Trans proline' 0 C--N 1.374 1.879 0 C-N-CA 123.924 3.083 . . . . 74.439999999999998 115.024 176.848 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 64.72 21.06 66.89 Favored Glycine 0 C--N 1.351 1.414 0 CA-C-N 114.643 -1.162 . . . . 54.219999999999999 113.71 -179.772 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 60' ' ' PHE . . . . . 0.441 ' HE1' ' HE1' ' A' ' 121' ' ' TRP . 33.1 t80 -144.42 -76.61 0.22 Allowed 'General case' 0 C--O 1.242 0.667 0 C-N-CA 123.099 0.559 . . . . 63.329999999999998 110.639 -171.09 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 61' ' ' MET . . . . . 0.664 ' SD ' ' HB2' ' A' ' 113' ' ' PHE . 12.3 tmm? -174.89 144.85 0.81 Allowed 'General case' 0 CA--C 1.543 0.711 0 O-C-N 123.457 0.473 . . . . 73.099999999999994 111.341 -162.187 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 62' ' ' CYS . . . . . 0.513 ' SG ' ' HB ' ' A' ' 114' ' ' ILE . 8.1 p -113.78 112.66 23.78 Favored 'General case' 0 CA--C 1.552 1.054 0 C-N-CA 124.25 1.02 . . . . 65.109999999999999 109.653 172.827 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 63' ' ' GLN . . . . . 0.63 ' HB2' ' SD ' ' A' ' 61' ' ' MET . 49.6 tt0 -103.05 114.49 28.83 Favored 'General case' 0 N--CA 1.485 1.32 0 C-N-CA 124.248 1.019 . . . . 75.019999999999996 111.129 -171.145 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 64' ' ' GLY . . . . . 0.747 ' HA2' ' HA ' ' A' ' 53' ' ' PHE . . . -98.95 -169.62 30.93 Favored Glycine 0 C--O 1.244 0.72 0 CA-C-N 114.863 -1.062 . . . . 71.519999999999996 112.111 175.597 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 72.92 87.14 0.19 Allowed Glycine 0 C--N 1.337 0.632 0 N-CA-C 111.062 -0.815 . . . . 64.209999999999994 111.062 -178.178 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 38.8 t70 -128.04 -38.46 1.82 Allowed 'General case' 0 N--CA 1.469 0.525 0 C-N-CA 122.825 0.45 . . . . 74.230000000000004 111.474 -179.518 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 77.0 t80 -70.83 -68.56 0.42 Allowed 'General case' 0 CA--C 1.552 1.043 0 N-CA-C 113.505 0.928 . . . . 61.450000000000003 113.505 -164.812 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 48.9 m -60.04 109.37 0.94 Allowed 'General case' 0 N--CA 1.482 1.141 0 C-N-CA 123.62 0.768 . . . . 65.120000000000005 112.038 -168.797 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 69' ' ' ARG . . . . . 0.557 ' HD3' ' HD3' ' A' ' 76' ' ' LYS . 73.3 mtp180 57.93 69.18 0.76 Allowed 'General case' 0 C--N 1.352 0.686 0 C-N-CA 124.763 1.225 . . . . 72.430000000000007 110.637 -170.856 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 24.5 p-80 -79.89 66.71 5.45 Favored 'General case' 0 N--CA 1.476 0.854 0 CA-C-O 122.128 0.966 . . . . 72.030000000000001 111.939 -176.921 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 15.5 m120 -119.68 20.74 12.26 Favored 'General case' 0 N--CA 1.476 0.832 0 C-N-CA 124.51 1.124 . . . . 74.430000000000007 108.628 173.898 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 100.67 -8.1 58.05 Favored Glycine 0 C--N 1.349 1.26 0 CA-C-N 115.302 -0.863 . . . . 72.319999999999993 112.519 -170.747 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 10.2 m -81.59 -61.8 1.83 Allowed 'General case' 0 N--CA 1.475 0.78 0 CA-C-N 117.589 0.694 . . . . 73.530000000000001 109.286 179.376 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 48.37 47.61 28.18 Favored Glycine 0 C--N 1.351 1.368 0 O-C-N 124.146 0.904 . . . . 43.5 115.309 170.236 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 138.11 51.37 0.06 OUTLIER Glycine 0 N--CA 1.474 1.218 0 CA-C-N 118.532 1.166 . . . . 53.520000000000003 113.382 -178.388 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 76' ' ' LYS . . . . . 0.557 ' HD3' ' HD3' ' A' ' 69' ' ' ARG . 22.8 pttp -61.35 160.26 11.07 Favored 'General case' 0 CA--C 1.556 1.177 0 C-N-CA 123.71 0.804 . . . . 74.299999999999997 111.95 179.85 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 87.1 p -91.3 164.5 13.84 Favored 'General case' 0 N--CA 1.483 1.206 0 C-N-CA 123.693 0.797 . . . . 75.120000000000005 111.685 -171.266 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 78' ' ' ILE . . . . . 0.538 HG21 ' HB3' ' A' ' 38' ' ' ALA . 45.6 pt -65.18 -15.89 19.16 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.397 0 N-CA-C 112.396 0.517 . . . . 72.030000000000001 112.396 179.89 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 79' ' ' TYR . . . . . 0.446 ' OH ' ' HG3' ' A' ' 31' ' ' LYS . 32.3 m-85 -89.79 -32.4 16.96 Favored 'General case' 0 N--CA 1.472 0.629 0 C-N-CA 123.647 0.779 . . . . 73.019999999999996 110.833 179.216 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 171.79 -137.53 4.36 Favored Glycine 0 C--N 1.339 0.726 0 CA-C-N 116.046 -0.524 . . . . 61.329999999999998 112.141 179.43 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 35.3 tt0 -65.31 -40.39 93.7 Favored 'General case' 0 CA--C 1.544 0.715 0 C-N-CA 123.375 0.67 . . . . 73.219999999999999 110.617 176.249 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 82' ' ' LYS . . . . . 0.652 ' HD2' ' HA ' ' A' ' 107' ' ' THR . 23.3 pttm -170.97 178.68 3.34 Favored 'General case' 0 CA--C 1.549 0.932 0 C-N-CA 124.129 0.971 . . . . 74.430000000000007 110.125 -173.79 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 18.9 p90 -154.11 173.18 16.4 Favored 'General case' 0 N--CA 1.477 0.907 0 C-N-CA 124.682 1.193 . . . . 71.230000000000004 110.067 -177.026 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 84' ' ' GLU . . . . . 0.512 ' HA ' ' HA ' ' A' ' 106' ' ' ASN . 14.2 pt-20 -90.79 154.23 19.67 Favored 'General case' 0 C--O 1.24 0.575 0 CA-C-O 121.023 0.439 . . . . 74.010000000000005 110.875 -179.9 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 35.2 m-20 -64.83 130.61 44.1 Favored 'General case' 0 CA--C 1.536 0.436 0 CA-C-N 114.799 -1.091 . . . . 75.420000000000002 111.446 -175.185 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 28.3 tt0 -72.54 -60.83 2.04 Favored 'General case' 0 CA--C 1.54 0.592 0 C-N-CA 123.302 0.641 . . . . 64.030000000000001 111.972 -173.276 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 31.0 p30 -164.74 158.28 17.48 Favored 'General case' 0 N--CA 1.475 0.809 0 C-N-CA 122.679 0.392 . . . . 43.299999999999997 111.124 -179.069 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 93.1 m-85 -103.35 38.32 1.8 Allowed 'General case' 0 N--CA 1.479 0.975 0 C-N-CA 123.765 0.826 . . . . 62.109999999999999 111.217 -172.413 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 64.9 mt -66.02 -52.41 49.05 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.075 0 C-N-CA 123.039 0.535 . . . . 74.450000000000003 110.42 177.317 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 90' ' ' LEU . . . . . 0.508 HD11 ' HB2' ' A' ' 25' ' ' PHE . 62.0 mt -83.17 139.82 32.94 Favored 'General case' 0 N--CA 1.473 0.691 0 CA-C-N 115.894 -0.594 . . . . 64.319999999999993 111.846 -177.009 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 91' ' ' LYS . . . . . 0.479 ' HZ3' ' HB3' ' A' ' 91' ' ' LYS . 9.2 mtpm? -124.27 167.6 14.1 Favored 'General case' 0 N--CA 1.471 0.59 0 C-N-CA 124.377 1.071 . . . . 75.120000000000005 109.604 177.751 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 92' ' ' HIS . . . . . . . . . . . . . 24.9 m-70 -86.52 62.16 7.25 Favored 'General case' 0 CA--C 1.544 0.736 0 C-N-CA 124.173 0.989 . . . . 71.010000000000005 108.861 176.3 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 93' ' ' THR . . . . . 0.435 HG23 ' HB2' ' A' ' 91' ' ' LYS . 21.9 p -83.92 -33.97 24.61 Favored 'General case' 0 N--CA 1.473 0.709 0 CA-C-N 115.132 -0.94 . . . . 75.430000000000007 111.563 -175.112 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -121.11 -177.42 15.63 Favored Glycine 0 C--N 1.342 0.888 0 CA-C-N 116.07 -0.514 . . . . 65.420000000000002 112.876 -177.201 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 79.2 Cg_endo -85.26 158.1 11.15 Favored 'Trans proline' 0 CA--C 1.553 1.449 0 C-N-CA 123.281 2.654 . . . . 64.0 112.099 173.024 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 83.07 17.67 66.72 Favored Glycine 0 N--CA 1.47 0.911 0 CA-C-N 116.054 -0.521 . . . . 74.430000000000007 114.126 179.043 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 97' ' ' ILE . . . . . 0.58 ' HB ' ' HB2' ' A' ' 115' ' ' CYS . 31.6 mm -66.47 102.99 0.51 Allowed 'Isoleucine or valine' 0 CA--C 1.549 0.934 0 C-N-CA 123.64 0.776 . . . . 73.010000000000005 111.774 -174.6 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 98' ' ' LEU . . . . . 0.467 HD13 HG12 ' A' ' 114' ' ' ILE . 58.1 tp -85.74 105.73 16.48 Favored 'General case' 0 CA--C 1.551 0.991 0 C-N-CA 123.44 0.696 . . . . 74.540000000000006 109.68 177.598 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 47.8 t -126.66 135.39 51.11 Favored 'General case' 0 N--CA 1.468 0.467 0 C-N-CA 124.69 1.196 . . . . 74.140000000000001 108.78 178.308 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 100' ' ' MET . . . . . 0.502 ' SD ' ' HA2' ' A' ' 109' ' ' GLY . 14.3 ttt -78.8 135.77 37.17 Favored 'General case' 0 N--CA 1.474 0.761 0 N-CA-C 108.343 -0.984 . . . . 72.239999999999995 108.343 -179.357 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -74.5 158.16 34.27 Favored 'General case' 0 CA--C 1.545 0.783 0 N-CA-C 112.916 0.71 . . . . 61.399999999999999 112.916 -167.462 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 22.2 p-10 -158.09 169.07 25.36 Favored 'General case' 0 N--CA 1.476 0.868 0 CA-C-N 115.542 -0.754 . . . . 75.319999999999993 110.759 -179.692 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 103' ' ' ALA . . . . . 0.453 ' HB3' HG21 ' A' ' 107' ' ' THR . . . -113.96 -1.14 13.88 Favored 'General case' 0 N--CA 1.476 0.839 0 CA-C-N 115.492 -0.777 . . . . 74.329999999999998 110.758 171.721 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 160.22 -165.59 34.89 Favored Glycine 0 C--N 1.354 1.536 0 CA-C-O 119.668 -0.518 . . . . 71.239999999999995 113.056 178.891 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 26.6 Cg_exo -64.03 134.74 44.29 Favored 'Trans proline' 0 C--N 1.376 1.997 0 C-N-CA 123.529 2.819 . . . . 71.439999999999998 112.266 178.355 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 106' ' ' ASN . . . . . 0.512 ' HA ' ' HA ' ' A' ' 84' ' ' GLU . 65.0 t30 66.82 14.24 9.73 Favored 'General case' 0 N--CA 1.485 1.32 0 C-N-CA 124.534 1.134 . . . . 41.43 111.212 -179.102 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 107' ' ' THR . . . . . 0.652 ' HA ' ' HD2' ' A' ' 82' ' ' LYS . 2.3 m -115.11 7.26 15.36 Favored 'General case' 0 CA--C 1.549 0.923 0 C-N-CA 124.208 1.003 . . . . 73.200000000000003 109.918 -178.874 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 55.1 t30 -88.67 139.51 30.4 Favored 'General case' 0 N--CA 1.476 0.865 0 C-N-CA 123.248 0.619 . . . . 73.230000000000004 110.097 -177.397 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 109' ' ' GLY . . . . . 0.502 ' HA2' ' SD ' ' A' ' 100' ' ' MET . . . 113.07 25.35 4.49 Favored Glycine 0 N--CA 1.464 0.534 0 CA-C-O 120.204 -0.22 . . . . 64.439999999999998 112.772 -175.553 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 5.1 m -132.72 126.2 31.96 Favored 'General case' 0 CA--C 1.541 0.623 0 N-CA-C 108.013 -1.106 . . . . 65.239999999999995 108.013 170.206 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 10.5 mt-30 64.52 175.81 0.19 Allowed 'General case' 0 N--CA 1.504 2.23 0 C-N-CA 125.25 1.42 . . . . 65.219999999999999 110.82 -174.615 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 54.9 p90 -148.41 159.21 44.25 Favored 'General case' 0 N--CA 1.486 1.366 0 O-C-N 121.603 -0.686 . . . . 71.450000000000003 109.865 174.681 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 113' ' ' PHE . . . . . 0.664 ' HB2' ' SD ' ' A' ' 61' ' ' MET . 55.1 p90 -146.26 147.07 31.03 Favored 'General case' 0 N--CA 1.469 0.502 0 CA-C-O 121.109 0.481 . . . . 71.109999999999999 111.452 177.625 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 114' ' ' ILE . . . . . 0.513 ' HB ' ' SG ' ' A' ' 62' ' ' CYS . 13.9 mt -117.5 102.67 13.75 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.536 0 N-CA-C 108.071 -1.085 . . . . 72.400000000000006 108.071 -179.044 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 115' ' ' CYS . . . . . 0.58 ' HB2' ' HB ' ' A' ' 97' ' ' ILE . 33.7 m -68.16 105.23 2.02 Favored 'General case' 0 CA--C 1.539 0.544 0 C-N-CA 123.305 0.642 . . . . 61.009999999999998 109.601 -179.632 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 116' ' ' THR . . . . . 0.477 HG22 HG12 ' A' ' 139' ' ' VAL . 41.3 p -70.32 -30.4 67.37 Favored 'General case' 0 N--CA 1.475 0.797 0 C-N-CA 124.009 0.924 . . . . 51.340000000000003 110.822 -175.876 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -112.32 159.64 18.46 Favored 'General case' 0 C--O 1.243 0.725 0 N-CA-C 108.115 -1.069 . . . . 71.099999999999994 108.115 169.231 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -68.73 98.84 0.94 Allowed 'General case' 0 CA--C 1.542 0.661 0 CA-C-O 121.383 0.611 . . . . 73.219999999999999 109.491 176.669 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 119' ' ' THR . . . . . . . . . . . . . 33.9 p -81.66 85.35 6.58 Favored 'General case' 0 C--O 1.239 0.502 0 CA-C-O 121.778 0.799 . . . . 75.540000000000006 109.471 -179.183 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 12.1 pt-20 -72.25 -22.51 61.22 Favored 'General case' 0 N--CA 1.473 0.68 0 CA-C-N 114.805 -1.089 . . . . 74.5 112.001 -170.862 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 121' ' ' TRP . . . . . 0.441 ' HE1' ' HE1' ' A' ' 60' ' ' PHE . 26.8 p90 -69.79 -10.28 57.8 Favored 'General case' 0 N--CA 1.477 0.91 0 C-N-CA 123.261 0.624 . . . . 72.040000000000006 111.863 175.572 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 122' ' ' LEU . . . . . 0.547 ' HA ' ' HE2' ' A' ' 125' ' ' LYS . 79.3 mt -94.71 7.6 45.27 Favored 'General case' 0 N--CA 1.475 0.825 0 C-N-CA 122.952 0.501 . . . . 75.510000000000005 111.716 176.375 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 74.3 m-20 -80.59 148.38 30.33 Favored 'General case' 0 N--CA 1.478 0.945 0 N-CA-C 109.757 -0.46 . . . . 41.130000000000003 109.757 172.247 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 77.29 22.38 70.82 Favored Glycine 0 C--N 1.344 1.01 0 N-CA-C 111.992 -0.443 . . . . 42.439999999999998 111.992 -170.02 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 125' ' ' LYS . . . . . 0.547 ' HE2' ' HA ' ' A' ' 122' ' ' LEU . 27.1 mtmm -142.4 -167.47 2.5 Favored 'General case' 0 CA--C 1.545 0.759 0 C-N-CA 124.647 1.179 . . . . 72.549999999999997 110.356 -175.091 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 126' ' ' HIS . . . . . . . . . . . . . 2.3 p80 -64.72 157.67 26.81 Favored 'General case' 0 N--CA 1.475 0.785 0 C-N-CA 124.502 1.121 . . . . 62.119999999999997 113.955 -160.425 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 46.7 t -63.85 127.42 24.32 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.719 0 CA-C-N 113.337 -1.756 . . . . 72.030000000000001 113.627 -164.142 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 86.9 t -84.26 146.66 6.46 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.481 0 N-CA-C 108.034 -1.099 . . . . 73.200000000000003 108.034 164.196 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 129' ' ' PHE . . . . . 0.443 ' HA ' HG21 ' A' ' 29' ' ' VAL . 50.6 p90 -134.85 -6.38 2.42 Favored 'General case' 0 N--CA 1.478 0.965 0 CA-C-N 118.287 0.494 . . . . 73.549999999999997 111.721 -179.375 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . -150.02 168.44 30.07 Favored Glycine 0 C--N 1.342 0.869 0 C-N-CA 121.479 -0.391 . . . . 41.399999999999999 113.276 -175.402 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 32.2 ttpt -156.0 139.42 15.81 Favored 'General case' 0 N--CA 1.467 0.385 0 N-CA-C 107.861 -1.162 . . . . 74.549999999999997 107.861 175.04 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 132' ' ' VAL . . . . . 0.462 HG11 ' HA ' ' A' ' 136' ' ' MET . 21.8 t -64.0 114.48 2.11 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.717 0 CA-C-N 118.303 0.501 . . . . 74.209999999999994 109.871 179.733 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 133' ' ' LYS . . . . . 0.608 ' HD3' HG23 ' A' ' 5' ' ' THR . 21.6 ptmt -92.79 -30.62 15.39 Favored 'General case' 0 N--CA 1.478 0.944 0 C-N-CA 122.737 0.415 . . . . 70.230000000000004 109.884 178.861 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 134' ' ' GLU . . . . . 0.551 ' HB2' ' HB2' ' A' ' 21' ' ' SER . 41.4 mt-10 -142.49 135.8 28.74 Favored 'General case' 0 N--CA 1.473 0.725 0 C-N-CA 124.313 1.045 . . . . 63.310000000000002 109.657 -173.121 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 77.84 32.92 43.54 Favored Glycine 0 CA--C 1.531 1.076 0 O-C-N 123.327 0.392 . . . . 70.349999999999994 113.406 178.505 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 136' ' ' MET . . . . . 0.462 ' HA ' HG11 ' A' ' 132' ' ' VAL . 14.2 tpt -65.08 -35.31 80.75 Favored 'General case' 0 N--CA 1.482 1.148 0 C-N-CA 123.133 0.573 . . . . 63.32 111.643 -179.553 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 137' ' ' ASN . . . . . . . . . . . . . 18.2 m120 -67.1 -23.72 65.86 Favored 'General case' 0 N--CA 1.481 1.087 0 C-N-CA 123.294 0.638 . . . . 70.239999999999995 111.543 179.968 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 138' ' ' ILE . . . . . . . . . . . . . 36.7 mm -75.67 -37.96 37.09 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.063 0 C-N-CA 123.252 0.621 . . . . 72.409999999999997 109.61 175.913 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 139' ' ' VAL . . . . . 0.477 HG12 HG22 ' A' ' 116' ' ' THR . 95.9 t -63.5 -39.73 86.43 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.022 0 C-N-CA 123.592 0.757 . . . . 73.310000000000002 110.205 173.494 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 47.2 mt-10 -76.4 -20.68 56.88 Favored 'General case' 0 N--CA 1.474 0.774 0 CA-C-N 115.374 -0.83 . . . . 72.540000000000006 111.674 177.973 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -74.92 -50.66 16.07 Favored 'General case' 0 N--CA 1.471 0.594 0 C-N-CA 122.642 0.377 . . . . 55.340000000000003 110.387 173.939 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 142' ' ' MET . . . . . 0.652 ' HB2' HD13 ' A' ' 156' ' ' ILE . 18.3 ptt? -66.59 -28.15 68.28 Favored 'General case' 0 N--CA 1.483 1.182 0 C-N-CA 122.923 0.489 . . . . 71.239999999999995 111.63 -179.221 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 24.5 tt0 -47.46 -47.36 27.19 Favored 'General case' 0 N--CA 1.482 1.173 0 C-N-CA 125.28 1.432 . . . . 70.25 111.224 170.484 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 144' ' ' ARG . . . . . . . . . . . . . 88.6 mtt180 -85.78 -6.82 59.06 Favored 'General case' 0 CA--C 1.541 0.607 0 CA-C-N 114.123 -1.399 . . . . 74.319999999999993 111.678 -173.075 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 145' ' ' PHE . . . . . 0.51 ' HD2' ' HA ' ' A' ' 142' ' ' MET . 49.6 m-85 -89.48 2.5 54.47 Favored 'General case' 0 N--CA 1.479 1.005 0 C-N-CA 122.871 0.468 . . . . 64.109999999999999 110.448 168.149 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . -96.58 -170.55 34.42 Favored Glycine 0 C--N 1.349 1.267 0 CA-C-N 115.877 -0.602 . . . . 62.340000000000003 111.992 168.364 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 44.2 t -134.68 155.12 51.08 Favored 'General case' 0 N--CA 1.473 0.702 0 C-N-CA 124.191 0.996 . . . . 61.149999999999999 109.681 -177.833 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 148' ' ' ARG . . . . . . . . . . . . . 20.2 mmm-85 -62.24 -31.86 72.47 Favored 'General case' 0 N--CA 1.478 0.969 0 C-N-CA 123.916 0.886 . . . . 71.299999999999997 112.484 -173.055 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 149' ' ' ASN . . . . . . . . . . . . . 25.6 p-10 -76.97 -19.5 57.25 Favored 'General case' 0 N--CA 1.484 1.247 0 C-N-CA 123.021 0.528 . . . . 61.43 111.764 -179.464 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 150' ' ' GLY . . . . . 0.527 ' O ' ' HA ' ' A' ' 55' ' ' ARG . . . 119.64 -6.05 12.68 Favored Glycine 0 C--N 1.349 1.253 0 CA-C-O 119.702 -0.499 . . . . 74.400000000000006 113.367 -177.826 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 38.2 ttmt -66.62 141.15 57.91 Favored 'General case' 0 N--CA 1.474 0.747 0 CA-C-N 117.657 0.729 . . . . 65.239999999999995 110.553 177.041 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 152' ' ' THR . . . . . . . . . . . . . 18.1 p -92.46 115.26 27.93 Favored 'General case' 0 CA--C 1.538 0.488 0 N-CA-C 108.771 -0.825 . . . . 70.120000000000005 108.771 166.373 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 153' ' ' SER . . . . . . . . . . . . . 10.3 m -74.2 -21.03 59.99 Favored 'General case' 0 CA--C 1.545 0.758 0 CA-C-O 121.355 0.598 . . . . 60.409999999999997 110.295 179.624 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 71.7 mmtt -124.8 150.33 46.45 Favored 'General case' 0 N--CA 1.467 0.423 0 C-N-CA 124.537 1.135 . . . . 73.140000000000001 110.267 176.325 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 3.9 tppp? -79.92 94.96 5.96 Favored 'General case' 0 C--O 1.242 0.69 0 N-CA-C 108.927 -0.768 . . . . 74.329999999999998 108.927 173.478 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 156' ' ' ILE . . . . . 0.652 HD13 ' HB2' ' A' ' 142' ' ' MET . 60.8 mt -101.45 124.13 55.0 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.155 0 CA-C-N 114.972 -1.013 . . . . 70.150000000000006 108.621 -178.575 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 157' ' ' THR . . . . . . . . . . . . . 31.6 p -138.78 157.78 45.44 Favored 'General case' 0 N--CA 1.47 0.56 0 C-N-CA 124.567 1.147 . . . . 73.25 109.256 -173.686 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 158' ' ' ILE . . . . . 0.44 HG23 ' HB3' ' A' ' 8' ' ' PHE . 59.3 mt -80.24 94.28 2.12 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.72 0 N-CA-C 108.5 -0.926 . . . . 52.140000000000001 108.5 169.773 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 159' ' ' ALA . . . . . 0.688 ' HB2' ' HB2' ' A' ' 11' ' ' ALA . . . -52.76 -53.69 44.47 Favored 'General case' 0 N--CA 1.481 1.105 0 C-N-CA 124.114 0.966 . . . . 64.129999999999995 112.357 -177.852 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 160' ' ' ASP . . . . . . . . . . . . . 26.9 t0 -148.54 157.66 43.61 Favored 'General case' 0 N--CA 1.471 0.618 0 CA-C-N 115.808 -0.633 . . . . 75.439999999999998 110.091 -173.557 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 161' ' ' CYS . . . . . . . . . . . . . 28.0 p -129.23 -170.62 2.31 Favored 'General case' 0 CA--C 1.539 0.543 0 C-N-CA 124.922 1.289 . . . . 71.120000000000005 108.513 176.888 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 162' ' ' GLY . . . . . . . . . . . . . . . 132.35 53.07 0.08 OUTLIER Glycine 0 C--N 1.342 0.906 0 N-CA-C 110.708 -0.957 . . . . 44.299999999999997 110.708 -168.442 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 163' ' ' GLN . . . . . 0.556 ' HB2' ' HA ' ' A' ' 6' ' ' VAL . 13.2 pt20 -55.99 143.73 31.22 Favored 'General case' 0 CA--C 1.544 0.749 0 C-N-CA 124.487 1.115 . . . . 72.430000000000007 113.097 -174.293 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 164' ' ' LEU . . . . . . . . . . . . . 77.5 mt . . . . . 0 CA--C 1.539 0.524 0 CA-C-N 115.404 -0.816 . . . . 74.140000000000001 110.277 -176.724 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' B' B ' 218' ' ' PRO . . . . . . . . . . . . . 37.3 Cg_exo . . . . . 0 CA--C 1.542 0.924 0 N-CA-C 110.494 -0.618 . . . . 70.530000000000001 110.494 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' B' B ' 219' ' ' GLY . . . . . . . . . . . . . . . 171.1 171.49 36.39 Favored Glycine 0 CA--C 1.527 0.786 0 CA-C-N 116.283 -0.417 . . . . 24.420000000000002 112.776 -179.59 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 220' ' ' PRO . . . . . . . . . . . . . 97.6 Cg_endo -85.02 -169.17 0.59 Allowed 'Trans proline' 0 C--N 1.371 1.739 0 C-N-CA 123.429 2.752 . . . . 62.509999999999998 113.496 -178.785 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 221' ' ' TYR . . . . . . . . . . . . . 96.8 m-85 . . . . . 0 N--CA 1.483 1.177 0 C-N-CA 123.781 0.833 . . . . 61.200000000000003 109.742 179.111 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 3' ' ' ASN . . . . . 0.503 ' ND2' ' HA ' ' A' ' 25' ' ' PHE . 11.8 m120 . . . . . 0 CA--C 1.545 0.757 0 CA-C-O 119.248 -0.406 . . . . 72.340000000000003 110.043 . . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 6.7 Cg_endo -80.73 152.68 19.7 Favored 'Trans proline' 0 C--N 1.371 1.755 0 C-N-CA 122.429 2.086 . . . . 65.010000000000005 110.963 173.872 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 5' ' ' THR . . . . . 0.46 ' HB ' ' O ' ' A' ' 164' ' ' LEU . 93.2 m -96.15 142.72 28.0 Favored 'General case' 0 CA--C 1.549 0.912 0 C-N-CA 123.096 0.558 . . . . 74.010000000000005 109.638 178.643 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 6' ' ' VAL . . . . . 0.665 ' HA ' ' HG3' ' A' ' 163' ' ' GLN . 29.1 t -110.37 147.12 14.8 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.436 0 N-CA-C 107.222 -1.399 . . . . 74.329999999999998 107.222 177.333 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 7' ' ' PHE . . . . . 0.536 ' H ' ' HA ' ' A' ' 163' ' ' GLN . 65.0 t80 -125.59 126.29 44.54 Favored 'General case' 0 C--O 1.238 0.468 0 N-CA-C 108.916 -0.772 . . . . 74.310000000000002 108.916 178.905 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 8' ' ' PHE . . . . . 0.541 ' HD2' ' HE2' ' A' ' 22' ' ' PHE . 33.9 m-85 -134.56 165.28 25.57 Favored 'General case' 0 N--CA 1.47 0.557 0 C-N-CA 124.074 0.95 . . . . 73.540000000000006 109.701 169.25 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 23.7 m-20 -118.27 117.33 28.83 Favored 'General case' 0 C--N 1.327 -0.406 0 N-CA-C 107.311 -1.366 . . . . 75.120000000000005 107.311 171.152 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 42.4 mm -90.05 136.12 24.61 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.823 0 N-CA-C 108.672 -0.862 . . . . 71.310000000000002 108.672 178.506 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 11' ' ' ALA . . . . . 0.662 ' HB2' ' HB2' ' A' ' 159' ' ' ALA . . . -135.47 122.27 21.07 Favored 'General case' 0 N--CA 1.478 0.951 0 C-N-CA 123.44 0.696 . . . . 65.239999999999995 111.666 -170.513 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 12' ' ' VAL . . . . . 0.442 HG22 HG12 ' A' ' 156' ' ' ILE . 62.4 t -95.94 122.99 47.95 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.709 0 C-N-CA 124.186 0.994 . . . . 71.019999999999996 108.962 176.846 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 42.3 m-20 64.1 23.09 13.11 Favored 'General case' 0 N--CA 1.491 1.616 0 C-N-CA 125.331 1.452 . . . . 74.120000000000005 110.836 -172.932 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 83.38 -13.21 47.41 Favored Glycine 0 C--N 1.351 1.384 0 CA-C-O 119.571 -0.572 . . . . 73.209999999999994 113.067 -173.079 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 37.8 mm-40 -83.49 117.23 68.04 Favored Pre-proline 0 C--N 1.353 0.759 0 C-N-CA 123.553 0.741 . . . . 63.130000000000003 109.981 177.863 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 93.1 Cg_exo -46.7 106.36 0.1 OUTLIER 'Trans proline' 0 C--N 1.379 2.134 0 C-N-CA 124.072 3.182 . . . . 61.030000000000001 113.891 -179.411 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 43.3 tp -76.08 -40.96 51.92 Favored 'General case' 0 N--CA 1.48 1.055 0 C-N-CA 123.705 0.802 . . . . 71.109999999999999 109.66 179.319 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -179.77 172.22 43.88 Favored Glycine 0 C--N 1.345 1.047 0 O-C-N 123.367 0.417 . . . . 24.109999999999999 112.957 178.386 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 13.2 ptm180 -105.82 124.47 49.61 Favored 'General case' 0 N--CA 1.473 0.71 0 N-CA-C 108.255 -1.017 . . . . 74.040000000000006 108.255 -177.988 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 51.8 t -120.89 137.91 53.08 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.407 0 C-N-CA 123.692 0.797 . . . . 74.25 109.382 -175.14 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 21' ' ' SER . . . . . 0.497 ' HB2' ' HB2' ' A' ' 134' ' ' GLU . 51.7 m -121.18 125.25 46.68 Favored 'General case' 0 C--O 1.248 1.004 0 C-N-CA 123.706 0.802 . . . . 73.420000000000002 109.519 176.677 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 22' ' ' PHE . . . . . 0.541 ' HE2' ' HD2' ' A' ' 8' ' ' PHE . 57.4 m-85 -100.81 169.95 8.65 Favored 'General case' 0 N--CA 1.474 0.735 0 C-N-CA 123.833 0.853 . . . . 72.209999999999994 109.358 178.47 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 23' ' ' GLU . . . . . 0.545 ' HB2' ' HD2' ' A' ' 133' ' ' LYS . 37.7 tt0 -138.32 112.31 8.48 Favored 'General case' 0 CA--C 1.543 0.684 0 C-N-CA 123.156 0.582 . . . . 74.019999999999996 109.632 -179.513 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . 0.414 HD22 ' HD1' ' A' ' 129' ' ' PHE . 62.1 mt -84.12 136.48 33.98 Favored 'General case' 0 N--CA 1.478 0.951 0 C-N-CA 123.692 0.797 . . . . 65.099999999999994 110.804 -176.784 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 25' ' ' PHE . . . . . 0.503 ' HA ' ' ND2' ' A' ' 3' ' ' ASN . 32.7 m-85 -85.65 64.29 8.54 Favored 'General case' 0 CA--C 1.546 0.805 0 CA-C-O 121.186 0.517 . . . . 73.349999999999994 109.642 175.886 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -72.91 1.03 9.52 Favored 'General case' 0 N--CA 1.486 1.364 0 N-CA-C 113.125 0.787 . . . . 55.399999999999999 113.125 -175.407 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 11.7 p-10 -87.33 -24.3 24.34 Favored 'General case' 0 CA--C 1.548 0.896 0 C-N-CA 123.555 0.742 . . . . 64.129999999999995 111.096 174.433 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 97.7 mttt -114.02 -35.02 5.21 Favored 'General case' 0 N--CA 1.489 1.489 0 C-N-CA 123.692 0.797 . . . . 70.209999999999994 111.12 -176.339 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 29' ' ' VAL . . . . . 0.505 HG21 ' HA ' ' A' ' 129' ' ' PHE . 6.7 m -128.85 71.15 81.46 Favored Pre-proline 0 CA--C 1.553 1.074 0 C-N-CA 123.927 0.891 . . . . 73.0 110.209 175.333 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 15.3 Cg_exo -66.03 -33.96 39.64 Favored 'Trans proline' 0 C--N 1.381 2.244 0 C-N-CA 122.567 2.178 . . . . 73.540000000000006 111.104 -179.13 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 87.7 tttt -63.51 -57.19 10.97 Favored 'General case' 0 CA--C 1.54 0.575 0 C-N-CA 124.796 1.238 . . . . 75.010000000000005 111.083 -179.17 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 6.5 m -68.98 -30.46 68.87 Favored 'General case' 0 CA--C 1.554 1.098 0 C-N-CA 123.613 0.765 . . . . 61.329999999999998 111.292 -174.964 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -71.81 -40.03 69.42 Favored 'General case' 0 CA--C 1.548 0.904 0 C-N-CA 123.403 0.681 . . . . 45.030000000000001 111.347 175.894 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 9.3 tp10 -71.81 -34.26 69.2 Favored 'General case' 0 N--CA 1.482 1.136 0 C-N-CA 123.436 0.695 . . . . 75.140000000000001 110.154 -178.458 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 35' ' ' ASN . . . . . 0.419 ' O ' ' HG ' ' A' ' 39' ' ' LEU . 40.1 t30 -57.98 -54.82 42.66 Favored 'General case' 0 N--CA 1.474 0.738 0 CA-C-N 114.527 -1.215 . . . . 64.219999999999999 109.766 173.526 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 74.2 t80 -58.91 -42.01 88.62 Favored 'General case' 0 CA--C 1.543 0.701 0 O-C-N 124.742 1.276 . . . . 73.099999999999994 111.096 -177.874 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 36.3 ttm180 -55.58 -57.14 13.18 Favored 'General case' 0 C--N 1.358 0.958 0 O-C-N 123.766 0.666 . . . . 63.140000000000001 110.394 175.629 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 38' ' ' ALA . . . . . 0.515 ' HB1' ' HG2' ' A' ' 44' ' ' LYS . . . -63.62 -32.96 74.6 Favored 'General case' 0 C--O 1.243 0.732 0 O-C-N 124.041 0.838 . . . . 60.020000000000003 112.129 -173.078 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 39' ' ' LEU . . . . . 0.566 HD22 ' HE2' ' A' ' 48' ' ' TYR . 74.2 mt -65.56 -45.0 85.02 Favored 'General case' 0 N--CA 1.475 0.792 0 O-C-N 124.147 0.904 . . . . 70.530000000000001 111.02 176.517 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 41.2 m -76.42 -49.45 16.67 Favored 'General case' 0 N--CA 1.475 0.814 0 C-N-CA 123.408 0.683 . . . . 41.240000000000002 112.01 -174.31 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 41' ' ' THR . . . . . 0.426 ' OG1' ' HG2' ' A' ' 43' ' ' GLU . 67.6 p -76.53 -31.48 57.67 Favored 'General case' 0 N--CA 1.471 0.609 0 C-N-CA 124.204 1.002 . . . . 71.120000000000005 111.647 -174.138 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 92.57 26.44 17.62 Favored Glycine 0 C--N 1.349 1.25 0 CA-C-O 119.683 -0.509 . . . . 74.349999999999994 113.071 -179.677 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 43' ' ' GLU . . . . . 0.426 ' HG2' ' OG1' ' A' ' 41' ' ' THR . 19.9 mm-40 -63.39 -22.97 67.2 Favored 'General case' 0 N--CA 1.483 1.213 0 C-N-CA 123.086 0.555 . . . . 63.32 111.69 174.31 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 44' ' ' LYS . . . . . 0.515 ' HG2' ' HB1' ' A' ' 38' ' ' ALA . 75.8 mmtt -114.38 16.43 17.81 Favored 'General case' 0 N--CA 1.482 1.149 0 C-N-CA 123.63 0.772 . . . . 73.530000000000001 111.022 177.242 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 93.41 -25.06 22.57 Favored Glycine 0 C--N 1.355 1.627 0 N-CA-C 114.794 0.677 . . . . 75.230000000000004 114.794 174.893 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 46' ' ' PHE . . . . . 0.424 ' HE2' ' HA ' ' A' ' 78' ' ' ILE . 21.8 m-85 -68.77 -48.22 64.22 Favored 'General case' 0 N--CA 1.479 0.992 0 C-N-CA 122.953 0.501 . . . . 75.120000000000005 111.846 -167.407 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 40.97 62.05 1.82 Allowed Glycine 0 C--N 1.358 1.786 0 O-C-N 124.975 1.422 . . . . 75.420000000000002 115.321 169.92 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 48' ' ' TYR . . . . . 0.566 ' HE2' HD22 ' A' ' 39' ' ' LEU . 97.3 m-85 -62.88 90.76 0.04 OUTLIER 'General case' 0 N--CA 1.476 0.859 0 CA-C-O 121.478 0.656 . . . . 74.409999999999997 111.52 -176.678 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 3.7 tppp? -105.24 125.81 51.4 Favored 'General case' 0 C--O 1.232 0.148 0 N-CA-C 108.328 -0.989 . . . . 72.299999999999997 108.328 175.05 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 80.96 20.23 65.72 Favored Glycine 0 CA--C 1.524 0.636 0 CA-C-O 119.681 -0.511 . . . . 51.140000000000001 112.742 -175.427 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 51' ' ' SER . . . . . 0.414 ' HB2' ' HB3' ' A' ' 48' ' ' TYR . 36.0 t -62.38 118.41 7.45 Favored 'General case' 0 C--N 1.354 0.786 0 N-CA-C 109.032 -0.729 . . . . 70.420000000000002 109.032 176.9 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 52' ' ' CYS . . . . . . . . . . . . . 25.6 p -86.75 129.48 34.86 Favored 'General case' 0 CA--C 1.536 0.425 0 C-N-CA 123.54 0.736 . . . . 64.010000000000005 111.645 -170.577 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 53' ' ' PHE . . . . . 0.65 ' HA ' ' HA2' ' A' ' 64' ' ' GLY . 46.5 m-85 -76.79 74.4 3.43 Favored 'General case' 0 CA--C 1.538 0.516 0 N-CA-C 108.353 -0.98 . . . . 73.25 108.353 168.415 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 27.1 p-80 -75.0 -22.84 58.27 Favored 'General case' 0 N--CA 1.476 0.868 0 CA-C-N 115.146 -0.934 . . . . 74.450000000000003 111.522 -174.674 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 55' ' ' ARG . . . . . 0.41 ' HA ' ' O ' ' A' ' 150' ' ' GLY . 38.4 ttt180 -112.96 99.41 7.84 Favored 'General case' 0 C--O 1.218 -0.601 0 N-CA-C 109.108 -0.701 . . . . 72.030000000000001 109.108 178.238 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 42.7 mt -127.63 137.86 56.44 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.643 0 N-CA-C 108.47 -0.937 . . . . 75.409999999999997 108.47 171.747 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 57' ' ' ILE . . . . . 0.687 HG23 ' HA ' ' A' ' 148' ' ' ARG . 70.2 mt -134.56 125.3 17.52 Favored Pre-proline 0 CA--C 1.553 1.08 0 C-N-CA 124.811 1.244 . . . . 72.430000000000007 108.621 -176.267 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 58' ' ' PRO . . . . . 0.411 ' HA ' ' HG2' ' A' ' 143' ' ' GLU . 84.3 Cg_endo -76.82 145.41 25.42 Favored 'Trans proline' 0 C--N 1.375 1.943 0 C-N-CA 122.687 2.258 . . . . 73.430000000000007 112.15 -177.606 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 70.04 25.48 75.55 Favored Glycine 0 C--N 1.342 0.868 0 CA-C-N 115.398 -0.819 . . . . 53.539999999999999 112.653 -175.486 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 60' ' ' PHE . . . . . 0.4 ' HD2' ' HB ' ' A' ' 57' ' ' ILE . 36.5 t80 -151.57 -73.58 0.15 Allowed 'General case' 0 C--O 1.247 0.95 0 C-N-CA 122.835 0.454 . . . . 74.120000000000005 111.172 -171.646 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 61' ' ' MET . . . . . 0.543 ' SD ' ' HB2' ' A' ' 113' ' ' PHE . 38.8 ttm -176.79 143.9 0.46 Allowed 'General case' 0 N--CA 1.482 1.166 0 N-CA-C 112.445 0.535 . . . . 63.020000000000003 112.445 -159.06 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 62' ' ' CYS . . . . . 0.472 ' SG ' HG13 ' A' ' 139' ' ' VAL . 25.1 p -112.72 112.45 23.96 Favored 'General case' 0 CA--C 1.55 0.962 0 N-CA-C 109.018 -0.734 . . . . 75.299999999999997 109.018 169.344 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 63' ' ' GLN . . . . . 0.528 ' HA ' ' HA ' ' A' ' 113' ' ' PHE . 51.4 tt0 -105.43 120.68 42.21 Favored 'General case' 0 N--CA 1.485 1.284 0 C-N-CA 124.248 1.019 . . . . 74.329999999999998 111.503 -175.185 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 64' ' ' GLY . . . . . 0.65 ' HA2' ' HA ' ' A' ' 53' ' ' PHE . . . -91.84 148.75 19.38 Favored Glycine 0 C--N 1.347 1.16 0 CA-C-N 115.206 -0.906 . . . . 75.109999999999999 112.34 176.403 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 65' ' ' GLY . . . . . 0.517 ' HA3' ' HG2' ' A' ' 111' ' ' GLN . . . -176.84 131.25 1.8 Allowed Glycine 0 C--N 1.338 0.656 0 N-CA-C 111.984 -0.447 . . . . 73.200000000000003 111.984 179.511 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 33.2 t70 -75.99 165.35 25.09 Favored 'General case' 0 CA--C 1.547 0.846 0 C-N-CA 123.046 0.538 . . . . 72.450000000000003 111.31 -175.613 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 90.2 t80 -64.92 -32.88 74.81 Favored 'General case' 0 C--O 1.245 0.853 0 C-N-CA 123.665 0.786 . . . . 72.340000000000003 111.365 178.176 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 33.9 m -60.81 112.67 2.13 Favored 'General case' 0 C--N 1.354 0.772 0 C-N-CA 122.985 0.514 . . . . 73.340000000000003 111.254 -177.057 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 69' ' ' ARG . . . . . 0.43 ' HD3' ' HG3' ' A' ' 81' ' ' GLU . 81.1 mtt85 65.33 28.01 11.9 Favored 'General case' 0 CA--C 1.547 0.843 0 O-C-N 124.618 1.199 . . . . 74.439999999999998 112.02 178.381 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 15.4 p80 -55.18 -25.41 32.44 Favored 'General case' 0 N--CA 1.498 1.969 0 C-N-CA 123.529 0.732 . . . . 70.010000000000005 112.759 -174.571 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 11.2 m120 -77.5 87.84 3.84 Favored 'General case' 0 CA--C 1.544 0.747 0 C-N-CA 123.849 0.86 . . . . 64.310000000000002 109.373 174.353 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 91.25 -1.2 76.46 Favored Glycine 0 N--CA 1.474 1.213 0 CA-C-O 119.4 -0.667 . . . . 63.450000000000003 114.61 175.381 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 73' ' ' THR . . . . . 0.461 ' HA ' ' HB2' ' A' ' 110' ' ' SER . 96.2 m -140.31 -92.16 0.16 Allowed 'General case' 0 CA--C 1.558 1.277 0 CA-C-N 117.738 0.769 . . . . 71.230000000000004 110.046 172.951 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 81.67 43.66 8.27 Favored Glycine 0 C--N 1.359 1.84 0 CA-C-N 118.279 0.491 . . . . 73.510000000000005 113.985 176.684 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 140.79 53.46 0.04 OUTLIER Glycine 0 C--N 1.346 1.095 0 CA-C-N 117.552 0.676 . . . . 74.319999999999993 111.495 -176.482 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 76' ' ' LYS . . . . . 0.503 ' HB2' ' HA ' ' A' ' 81' ' ' GLU . 13.9 ptmm? -56.09 162.86 1.76 Allowed 'General case' 0 N--CA 1.483 1.182 0 C-N-CA 124.026 0.93 . . . . 73.219999999999999 112.749 -174.541 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 87.3 p -94.49 -177.77 4.35 Favored 'General case' 0 C--O 1.243 0.734 0 C-N-CA 122.995 0.518 . . . . 63.030000000000001 111.345 -170.775 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 78' ' ' ILE . . . . . 0.51 HG21 ' HB3' ' A' ' 38' ' ' ALA . 20.9 pt -88.59 -12.38 10.21 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.889 0 CA-C-N 115.56 -0.746 . . . . 65.420000000000002 110.668 173.985 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 42.9 m-85 -88.17 -24.62 23.27 Favored 'General case' 0 N--CA 1.472 0.646 0 C-N-CA 123.935 0.894 . . . . 73.299999999999997 109.662 178.476 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 167.86 -145.29 9.58 Favored Glycine 0 C--N 1.346 1.084 0 CA-C-N 115.365 -0.834 . . . . 72.049999999999997 111.095 176.827 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 81' ' ' GLU . . . . . 0.503 ' HA ' ' HB2' ' A' ' 76' ' ' LYS . 36.3 tt0 -69.16 -34.93 75.74 Favored 'General case' 0 CA--C 1.543 0.709 0 C-N-CA 123.293 0.637 . . . . 71.540000000000006 110.06 174.475 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 82' ' ' LYS . . . . . 0.706 ' HD2' ' HA ' ' A' ' 107' ' ' THR . 20.6 pttp -169.99 177.2 4.41 Favored 'General case' 0 N--CA 1.476 0.842 0 C-N-CA 124.733 1.213 . . . . 71.329999999999998 109.047 178.397 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 46.5 p90 -146.78 173.49 12.33 Favored 'General case' 0 N--CA 1.474 0.767 0 C-N-CA 123.651 0.78 . . . . 71.129999999999995 110.563 -179.208 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 13.5 pt-20 -88.34 158.99 18.26 Favored 'General case' 0 N--CA 1.475 0.821 0 C-N-CA 123.055 0.542 . . . . 73.209999999999994 110.208 177.917 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 27.0 m-20 -60.81 118.64 6.91 Favored 'General case' 0 N--CA 1.477 0.924 0 C-N-CA 124.376 1.071 . . . . 74.25 109.967 -179.337 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 20.6 tp10 -66.79 -59.01 3.92 Favored 'General case' 0 N--CA 1.479 0.983 0 C-N-CA 123.133 0.573 . . . . 63.310000000000002 111.198 -175.158 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 26.4 p30 -143.01 -174.46 4.19 Favored 'General case' 0 N--CA 1.47 0.543 0 C-N-CA 123.757 0.823 . . . . 74.319999999999993 109.593 179.966 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 79.8 m-85 -136.27 39.54 2.69 Favored 'General case' 0 N--CA 1.481 1.082 0 C-N-CA 123.591 0.756 . . . . 75.25 109.754 -179.325 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 60.5 mt -69.01 -62.07 1.42 Allowed 'Isoleucine or valine' 0 N--CA 1.477 0.9 0 CA-C-N 115.431 -0.804 . . . . 74.420000000000002 110.966 -178.806 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 90' ' ' LEU . . . . . 0.696 ' H ' HG23 ' A' ' 127' ' ' VAL . 66.1 mt -87.55 140.96 28.99 Favored 'General case' 0 C--O 1.238 0.492 0 CA-C-N 115.539 -0.755 . . . . 65.25 110.678 -171.748 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 55.3 mtpt -125.5 168.83 13.09 Favored 'General case' 0 N--CA 1.47 0.526 0 C-N-CA 124.152 0.981 . . . . 53.119999999999997 110.174 -174.285 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 92' ' ' HIS . . . . . 0.415 ' HA ' HG21 ' A' ' 97' ' ' ILE . 43.5 m80 -92.88 51.28 1.67 Allowed 'General case' 0 N--CA 1.48 1.026 0 C-N-CA 124.235 1.014 . . . . 62.240000000000002 109.503 -174.486 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 41.3 p -84.3 -7.12 59.42 Favored 'General case' 0 N--CA 1.472 0.632 0 CA-C-N 114.476 -1.238 . . . . 73.329999999999998 112.799 -171.371 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -143.5 -179.57 20.2 Favored Glycine 0 C--N 1.347 1.164 0 CA-C-O 120.117 -0.268 . . . . 41.439999999999998 113.057 -177.12 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 82.1 Cg_endo -82.4 158.21 17.06 Favored 'Trans proline' 0 C--N 1.367 1.523 0 C-N-CA 123.412 2.741 . . . . 73.310000000000002 112.561 175.241 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 73.83 18.83 79.69 Favored Glycine 0 CA--C 1.531 1.059 0 CA-C-N 115.524 -0.762 . . . . 71.209999999999994 114.467 178.867 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 97' ' ' ILE . . . . . 0.415 HG21 ' HA ' ' A' ' 92' ' ' HIS . 17.0 mm -78.93 108.28 12.33 Favored 'Isoleucine or valine' 0 CA--C 1.562 1.428 0 CA-C-N 117.533 0.666 . . . . 71.099999999999994 112.466 -171.824 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 98' ' ' LEU . . . . . 0.636 ' HG ' HG12 ' A' ' 114' ' ' ILE . 7.6 mp -87.21 117.93 26.29 Favored 'General case' 0 N--CA 1.488 1.468 0 C-N-CA 123.535 0.734 . . . . 74.200000000000003 111.033 175.923 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 99' ' ' SER . . . . . 0.644 ' HB3' ' HA ' ' A' ' 128' ' ' VAL . 2.7 p -139.78 143.5 36.93 Favored 'General case' 0 N--CA 1.476 0.874 0 N-CA-C 108.306 -0.998 . . . . 74.400000000000006 108.306 173.707 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 100' ' ' MET . . . . . 0.473 ' HA ' ' HA ' ' A' ' 112' ' ' PHE . 49.7 mtp -76.23 138.9 40.91 Favored 'General case' 0 N--CA 1.485 1.31 0 N-CA-C 109.689 -0.486 . . . . 75.140000000000001 109.689 -171.491 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 101' ' ' ALA . . . . . 0.549 ' HB3' ' HB2' ' A' ' 111' ' ' GLN . . . -75.69 158.25 32.57 Favored 'General case' 0 N--CA 1.481 1.082 0 CA-C-O 121.216 0.531 . . . . 75.129999999999995 111.635 -170.48 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 30.4 p-10 -162.67 163.13 27.13 Favored 'General case' 0 CA--C 1.537 0.453 0 CA-C-N 114.95 -1.023 . . . . 74.430000000000007 110.131 -179.361 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -103.91 1.67 31.61 Favored 'General case' 0 N--CA 1.473 0.707 0 C-N-CA 124.203 1.001 . . . . 75.540000000000006 110.196 169.686 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 149.45 -164.41 29.39 Favored Glycine 0 C--N 1.345 1.031 0 CA-C-O 119.273 -0.737 . . . . 61.140000000000001 111.466 -178.269 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 53.2 Cg_exo -56.89 141.73 93.14 Favored 'Trans proline' 0 C--N 1.368 1.6 0 C-N-CA 123.286 2.657 . . . . 75.140000000000001 112.795 175.978 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 63.9 t30 68.46 10.18 7.71 Favored 'General case' 0 N--CA 1.495 1.788 0 C-N-CA 125.102 1.361 . . . . 73.239999999999995 112.332 179.526 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 107' ' ' THR . . . . . 0.706 ' HA ' ' HD2' ' A' ' 82' ' ' LYS . 2.4 m -113.1 0.23 14.9 Favored 'General case' 0 CA--C 1.551 0.997 0 O-C-N 121.511 -0.743 . . . . 74.349999999999994 110.775 178.307 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 57.5 t30 -70.76 155.57 40.6 Favored 'General case' 0 N--CA 1.481 1.108 0 C-N-CA 123.784 0.834 . . . . 74.25 110.738 -178.034 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 89.76 0.73 78.13 Favored Glycine 0 N--CA 1.468 0.773 0 CA-C-N 116.713 -0.221 . . . . 52.340000000000003 113.55 179.026 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 110' ' ' SER . . . . . 0.461 ' HB2' ' HA ' ' A' ' 73' ' ' THR . 79.6 p -100.25 120.64 40.22 Favored 'General case' 0 CA--C 1.531 0.22 0 N-CA-C 108.012 -1.107 . . . . 65.230000000000004 108.012 173.731 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 111' ' ' GLN . . . . . 0.549 ' HB2' ' HB3' ' A' ' 101' ' ' ALA . 49.4 mt-30 62.53 176.57 0.14 Allowed 'General case' 0 N--CA 1.492 1.66 0 C-N-CA 123.609 0.764 . . . . 75.530000000000001 111.769 -174.839 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 112' ' ' PHE . . . . . 0.473 ' HA ' ' HA ' ' A' ' 100' ' ' MET . 29.1 p90 -147.13 133.71 19.85 Favored 'General case' 0 N--CA 1.471 0.622 0 N-CA-C 108.021 -1.103 . . . . 72.409999999999997 108.021 172.932 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 113' ' ' PHE . . . . . 0.543 ' HB2' ' SD ' ' A' ' 61' ' ' MET . 46.4 p90 -113.49 134.3 54.75 Favored 'General case' 0 C--O 1.239 0.539 0 CA-C-O 121.235 0.54 . . . . 71.340000000000003 110.751 178.349 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 114' ' ' ILE . . . . . 0.636 HG12 ' HG ' ' A' ' 98' ' ' LEU . 22.1 mt -99.96 101.04 11.56 Favored 'Isoleucine or valine' 0 C--O 1.239 0.532 0 N-CA-C 108.047 -1.094 . . . . 70.420000000000002 108.047 176.612 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 115' ' ' CYS . . . . . 0.414 ' SG ' ' HD2' ' A' ' 92' ' ' HIS . 32.4 m -65.92 103.78 0.99 Allowed 'General case' 0 N--CA 1.467 0.388 0 N-CA-C 108.611 -0.885 . . . . 73.329999999999998 108.611 174.485 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 116' ' ' THR . . . . . 0.521 HG22 HG12 ' A' ' 139' ' ' VAL . 35.6 p -70.04 -28.86 65.81 Favored 'General case' 0 N--CA 1.48 1.05 0 C-N-CA 123.707 0.803 . . . . 61.420000000000002 110.675 -177.206 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -119.49 168.25 11.16 Favored 'General case' 0 C--O 1.243 0.72 0 C-N-CA 124.051 0.941 . . . . 63.210000000000001 109.279 171.159 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 13.3 ptmm? -72.55 89.3 1.28 Allowed 'General case' 0 C--O 1.246 0.89 0 CA-C-O 121.657 0.742 . . . . 74.340000000000003 110.3 178.1 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 119' ' ' THR . . . . . 0.506 ' HB ' HD13 ' A' ' 122' ' ' LEU . 37.6 p -71.22 89.2 0.85 Allowed 'General case' 0 CA--C 1.542 0.651 0 CA-C-O 122.0 0.905 . . . . 54.329999999999998 108.971 176.829 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 9.5 pt-20 -75.98 -21.44 56.95 Favored 'General case' 0 N--CA 1.475 0.788 0 CA-C-N 114.578 -1.192 . . . . 63.039999999999999 111.773 -171.486 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 121' ' ' TRP . . . . . . . . . . . . . 33.1 p90 -77.18 -0.84 26.58 Favored 'General case' 0 CA--C 1.549 0.937 0 C-N-CA 123.581 0.752 . . . . 64.109999999999999 110.829 172.35 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 122' ' ' LEU . . . . . 0.564 ' HA ' ' HE2' ' A' ' 125' ' ' LYS . 10.9 mp -101.97 7.04 41.5 Favored 'General case' 0 N--CA 1.474 0.727 0 C-N-CA 123.682 0.793 . . . . 74.049999999999997 110.879 170.832 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 93.8 m-20 -84.82 128.09 34.45 Favored 'General case' 0 N--CA 1.475 0.776 0 N-CA-C 109.588 -0.523 . . . . 53.509999999999998 109.588 173.558 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 94.42 7.41 60.55 Favored Glycine 0 C--N 1.345 1.043 0 N-CA-C 111.69 -0.564 . . . . 62.219999999999999 111.69 -168.454 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 125' ' ' LYS . . . . . 0.564 ' HE2' ' HA ' ' A' ' 122' ' ' LEU . 19.4 ttmm -104.26 -167.39 1.35 Allowed 'General case' 0 CA--C 1.552 1.049 0 C-N-CA 124.918 1.287 . . . . 73.349999999999994 108.375 179.021 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 126' ' ' HIS . . . . . 0.508 ' H ' ' HG2' ' A' ' 125' ' ' LYS . 42.5 p-80 -67.75 155.61 38.89 Favored 'General case' 0 C--O 1.244 0.769 0 CA-C-O 121.245 0.545 . . . . 74.349999999999994 111.672 -175.575 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 127' ' ' VAL . . . . . 0.696 HG23 ' H ' ' A' ' 90' ' ' LEU . 11.0 p -64.0 148.37 11.67 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.938 0 CA-C-N 113.988 -1.46 . . . . 53.420000000000002 112.99 -174.537 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 128' ' ' VAL . . . . . 0.644 ' HA ' ' HB3' ' A' ' 99' ' ' SER . 94.7 t -81.39 155.57 4.17 Favored 'Isoleucine or valine' 0 CA--C 1.551 1.0 0 C-N-CA 125.421 1.488 . . . . 71.25 109.23 172.055 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 129' ' ' PHE . . . . . 0.505 ' HA ' HG21 ' A' ' 29' ' ' VAL . 48.7 p90 -119.35 -24.33 6.41 Favored 'General case' 0 N--CA 1.487 1.383 0 CA-C-N 118.549 0.613 . . . . 71.010000000000005 111.603 177.416 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . -158.88 177.1 35.61 Favored Glycine 0 C--N 1.344 1.01 0 O-C-N 123.183 0.302 . . . . 45.200000000000003 112.468 -174.92 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 34.4 ttpt -153.33 147.41 25.58 Favored 'General case' 0 N--CA 1.472 0.671 0 C-N-CA 123.484 0.714 . . . . 74.450000000000003 109.3 -179.877 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 132' ' ' VAL . . . . . 0.442 HG22 ' HE1' ' A' ' 22' ' ' PHE . 16.9 t -68.29 120.33 15.55 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.552 0 N-CA-C 109.253 -0.647 . . . . 74.230000000000004 109.253 176.203 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 133' ' ' LYS . . . . . 0.545 ' HD2' ' HB2' ' A' ' 23' ' ' GLU . 20.6 ptmt -100.2 -33.54 10.39 Favored 'General case' 0 N--CA 1.477 0.895 0 N-CA-C 109.584 -0.524 . . . . 61.229999999999997 109.584 176.49 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 134' ' ' GLU . . . . . 0.497 ' HB2' ' HB2' ' A' ' 21' ' ' SER . 31.5 mt-10 -144.29 149.63 36.57 Favored 'General case' 0 N--CA 1.478 0.97 0 C-N-CA 125.166 1.387 . . . . 71.530000000000001 108.654 -178.516 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 83.43 17.44 66.47 Favored Glycine 0 C--N 1.339 0.742 0 N-CA-C 112.182 -0.367 . . . . 61.119999999999997 112.182 -177.701 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 136' ' ' MET . . . . . . . . . . . . . 15.7 tpt -64.01 -34.78 78.79 Favored 'General case' 0 C--N 1.354 0.796 0 C-N-CA 123.863 0.865 . . . . 73.109999999999999 110.913 -179.527 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 137' ' ' ASN . . . . . . . . . . . . . 27.3 t-20 -58.75 -42.31 88.57 Favored 'General case' 0 CA--C 1.542 0.644 0 C-N-CA 123.588 0.755 . . . . 73.209999999999994 110.568 174.049 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 138' ' ' ILE . . . . . . . . . . . . . 48.9 mm -67.67 -35.64 73.44 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.956 0 C-N-CA 123.331 0.652 . . . . 74.25 110.657 178.925 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 139' ' ' VAL . . . . . 0.521 HG12 HG22 ' A' ' 116' ' ' THR . 94.3 t -65.8 -37.98 81.15 Favored 'Isoleucine or valine' 0 CA--C 1.559 1.32 0 C-N-CA 123.941 0.896 . . . . 51.240000000000002 110.93 176.772 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 39.0 mt-10 -77.02 -27.55 54.63 Favored 'General case' 0 N--CA 1.48 1.04 0 C-N-CA 123.537 0.735 . . . . 74.420000000000002 111.186 177.625 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -72.65 -46.98 51.27 Favored 'General case' 0 N--CA 1.48 1.069 0 C-N-CA 123.338 0.655 . . . . 51.439999999999998 110.305 178.717 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 142' ' ' MET . . . . . 0.538 ' HA ' ' HD2' ' A' ' 145' ' ' PHE . 27.3 ptm -68.48 -30.34 69.16 Favored 'General case' 0 N--CA 1.475 0.81 0 CA-C-N 115.475 -0.784 . . . . 73.430000000000007 110.962 178.106 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 143' ' ' GLU . . . . . 0.411 ' HG2' ' HA ' ' A' ' 58' ' ' PRO . 35.8 tt0 -55.11 -42.26 72.69 Favored 'General case' 0 C--N 1.364 1.203 0 O-C-N 123.807 0.692 . . . . 74.430000000000007 111.361 174.71 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 144' ' ' ARG . . . . . . . . . . . . . 51.5 mtp180 -64.79 -22.91 67.09 Favored 'General case' 0 N--CA 1.473 0.715 0 CA-C-N 115.376 -0.829 . . . . 74.040000000000006 112.189 -178.233 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 145' ' ' PHE . . . . . 0.538 ' HD2' ' HA ' ' A' ' 142' ' ' MET . 47.7 m-85 -83.53 -1.02 52.79 Favored 'General case' 0 N--CA 1.479 0.987 0 C-N-CA 122.768 0.427 . . . . 54.420000000000002 111.876 179.426 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 146' ' ' GLY . . . . . 0.522 ' HA2' ' HA ' ' A' ' 152' ' ' THR . . . -96.71 172.06 28.17 Favored Glycine 0 C--N 1.342 0.867 0 N-CA-C 112.687 -0.165 . . . . 61.210000000000001 112.687 177.597 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 16.2 m -128.1 156.48 42.75 Favored 'General case' 0 N--CA 1.481 1.112 0 C-N-CA 123.845 0.858 . . . . 74.230000000000004 109.801 -178.332 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 148' ' ' ARG . . . . . 0.687 ' HA ' HG23 ' A' ' 57' ' ' ILE . 26.2 mmm-85 -58.53 -31.66 68.13 Favored 'General case' 0 N--CA 1.48 1.048 0 C-N-CA 124.595 1.158 . . . . 72.150000000000006 113.279 -174.359 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 149' ' ' ASN . . . . . . . . . . . . . 29.9 p-10 -77.7 -12.27 59.96 Favored 'General case' 0 N--CA 1.476 0.844 0 C-N-CA 123.364 0.666 . . . . 74.099999999999994 111.983 -178.279 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 150' ' ' GLY . . . . . 0.41 ' O ' ' HA ' ' A' ' 55' ' ' ARG . . . 106.45 6.05 36.27 Favored Glycine 0 C--N 1.348 1.2 0 CA-C-O 120.046 -0.308 . . . . 71.109999999999999 113.165 179.487 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 86.9 tttt -90.07 122.99 33.55 Favored 'General case' 0 N--CA 1.471 0.619 0 C-N-CA 123.08 0.552 . . . . 70.230000000000004 109.866 178.587 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 152' ' ' THR . . . . . 0.522 ' HA ' ' HA2' ' A' ' 146' ' ' GLY . 21.1 m -90.67 113.56 25.65 Favored 'General case' 0 CA--C 1.536 0.425 0 N-CA-C 108.82 -0.807 . . . . 63.140000000000001 108.82 174.978 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 153' ' ' SER . . . . . . . . . . . . . 9.1 m -52.8 -32.84 46.15 Favored 'General case' 0 N--CA 1.48 1.07 0 C-N-CA 124.646 1.178 . . . . 72.109999999999999 112.367 -178.394 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 70.7 mmtt -109.24 150.02 28.55 Favored 'General case' 0 N--CA 1.469 0.509 0 C-N-CA 124.358 1.063 . . . . 64.219999999999999 110.631 -175.731 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 75.0 mmtt -83.01 90.32 7.0 Favored 'General case' 0 N--CA 1.468 0.456 0 N-CA-C 108.527 -0.916 . . . . 71.420000000000002 108.527 172.542 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 156' ' ' ILE . . . . . 0.484 ' HA ' ' O ' ' A' ' 11' ' ' ALA . 54.0 mt -100.35 108.49 23.08 Favored 'Isoleucine or valine' 0 C--O 1.221 -0.43 0 CA-C-N 114.981 -1.009 . . . . 74.510000000000005 109.04 -175.693 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 157' ' ' THR . . . . . . . . . . . . . 56.9 p -118.47 159.71 23.01 Favored 'General case' 0 N--CA 1.473 0.713 0 C-N-CA 124.07 0.948 . . . . 72.319999999999993 110.53 -175.342 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 158' ' ' ILE . . . . . . . . . . . . . 62.5 mt -77.22 94.09 1.28 Allowed 'Isoleucine or valine' 0 CA--C 1.548 0.892 0 N-CA-C 108.988 -0.745 . . . . 55.310000000000002 108.988 170.398 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 159' ' ' ALA . . . . . 0.662 ' HB2' ' HB2' ' A' ' 11' ' ' ALA . . . -51.82 -49.56 62.55 Favored 'General case' 0 N--CA 1.483 1.21 0 C-N-CA 124.446 1.098 . . . . 64.209999999999994 112.411 -178.764 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 160' ' ' ASP . . . . . . . . . . . . . 19.7 t70 -152.92 169.94 21.6 Favored 'General case' 0 CA--C 1.546 0.805 0 CA-C-N 116.257 -0.428 . . . . 64.299999999999997 111.208 -179.351 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 161' ' ' CYS . . . . . . . . . . . . . 46.4 m -136.48 -168.93 2.34 Favored 'General case' 0 N--CA 1.47 0.56 0 C-N-CA 125.138 1.375 . . . . 73.310000000000002 108.623 -177.148 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 162' ' ' GLY . . . . . . . . . . . . . . . 132.44 53.52 0.08 OUTLIER Glycine 0 C--N 1.344 0.986 0 N-CA-C 111.025 -0.83 . . . . 72.319999999999993 111.025 -172.929 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 163' ' ' GLN . . . . . 0.665 ' HG3' ' HA ' ' A' ' 6' ' ' VAL . 46.8 tt0 -46.69 104.12 0.05 OUTLIER 'General case' 0 N--CA 1.481 1.086 0 C-N-CA 125.281 1.432 . . . . 71.200000000000003 112.312 -176.756 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 164' ' ' LEU . . . . . 0.46 ' O ' ' HB ' ' A' ' 5' ' ' THR . 64.9 mt . . . . . 0 N--CA 1.468 0.432 0 N-CA-C 107.272 -1.381 . . . . 73.230000000000004 107.272 -179.542 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 218' ' ' PRO . . . . . . . . . . . . . 15.4 Cg_exo . . . . . 0 CA--C 1.546 1.079 0 N-CA-C 111.234 -0.333 . . . . 53.520000000000003 111.234 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' B' B ' 219' ' ' GLY . . . . . . . . . . . . . . . 130.63 163.97 11.15 Favored Glycine 0 CA--C 1.531 1.065 0 CA-C-O 119.605 -0.553 . . . . 63.009999999999998 112.372 177.67 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 220' ' ' PRO . . . . . 0.461 ' HG3' HD21 ' A' ' 122' ' ' LEU . 96.3 Cg_endo -78.39 160.03 29.13 Favored 'Trans proline' 0 C--N 1.368 1.56 0 C-N-CA 123.669 2.912 . . . . 72.530000000000001 113.025 -175.394 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 221' ' ' TYR . . . . . . . . . . . . . 49.1 m-85 . . . . . 0 N--CA 1.475 0.783 0 C-N-CA 123.493 0.717 . . . . 72.25 111.651 -173.123 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 3' ' ' ASN . . . . . 0.447 HD22 ' HA ' ' A' ' 25' ' ' PHE . 13.7 m120 . . . . . 0 C--O 1.241 0.655 0 N-CA-C 107.498 -1.297 . . . . 74.230000000000004 107.498 . . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 4' ' ' PRO . . . . . 0.687 ' HB3' HH11 ' A' ' 37' ' ' ARG . 48.8 Cg_endo -69.18 119.76 6.7 Favored 'Trans proline' 0 C--N 1.371 1.745 0 C-N-CA 122.107 1.871 . . . . 72.530000000000001 110.917 177.35 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 86.6 m -96.84 117.85 31.98 Favored 'General case' 0 C--O 1.217 -0.61 0 N-CA-C 106.906 -1.516 . . . . 72.310000000000002 106.906 173.234 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 5.3 m -98.22 122.12 49.52 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.421 0 CA-C-O 121.782 0.801 . . . . 75.409999999999997 109.485 -176.537 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 7' ' ' PHE . . . . . 0.57 ' H ' ' HA ' ' A' ' 163' ' ' GLN . 73.2 t80 -100.75 131.79 46.47 Favored 'General case' 0 C--O 1.236 0.365 0 CA-C-N 114.485 -1.234 . . . . 73.150000000000006 108.893 -175.031 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 8' ' ' PHE . . . . . 0.461 ' HB3' HG23 ' A' ' 158' ' ' ILE . 44.2 m-85 -132.04 165.01 24.95 Favored 'General case' 0 C--O 1.24 0.566 0 C-N-CA 124.489 1.116 . . . . 70.430000000000007 109.125 170.566 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 49.5 m-20 -112.94 111.07 21.55 Favored 'General case' 0 C--N 1.326 -0.442 0 N-CA-C 107.564 -1.272 . . . . 72.150000000000006 107.564 169.281 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 10' ' ' ILE . . . . . 0.475 HG21 ' SD ' ' A' ' 142' ' ' MET . 41.3 mm -80.04 115.26 22.17 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.412 0 N-CA-C 108.518 -0.919 . . . . 73.25 108.518 179.154 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 11' ' ' ALA . . . . . 0.566 ' HB2' ' HB2' ' A' ' 159' ' ' ALA . . . -116.79 128.62 55.46 Favored 'General case' 0 N--CA 1.47 0.56 0 C-N-CA 123.793 0.837 . . . . 64.420000000000002 111.21 -173.761 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 73.2 t -95.8 113.64 30.66 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.616 0 N-CA-C 108.097 -1.075 . . . . 75.340000000000003 108.097 173.585 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 48.0 m-20 63.91 23.93 13.51 Favored 'General case' 0 N--CA 1.489 1.502 0 C-N-CA 125.567 1.547 . . . . 64.209999999999994 111.731 -178.676 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 96.85 -20.45 50.65 Favored Glycine 0 C--N 1.341 0.841 0 CA-C-O 119.569 -0.573 . . . . 63.210000000000001 112.838 -177.326 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 50.6 mm-40 -84.22 114.32 53.84 Favored Pre-proline 0 N--CA 1.476 0.841 0 CA-C-N 117.299 0.55 . . . . 73.230000000000004 110.215 178.353 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 76.5 Cg_exo -50.48 109.35 0.29 Allowed 'Trans proline' 0 C--N 1.382 2.309 0 C-N-CA 123.684 2.923 . . . . 74.019999999999996 112.802 177.875 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 44.3 tp -77.06 -45.01 28.54 Favored 'General case' 0 N--CA 1.473 0.701 0 N-CA-C 109.114 -0.698 . . . . 74.519999999999996 109.114 177.653 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -168.35 170.8 42.32 Favored Glycine 0 C--N 1.342 0.891 0 CA-C-N 115.873 -0.603 . . . . 74.25 112.543 179.694 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 69.3 mtt-85 -107.04 125.98 51.74 Favored 'General case' 0 N--CA 1.474 0.759 0 C-N-CA 123.718 0.807 . . . . 72.129999999999995 108.955 -176.466 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 93.1 t -121.76 144.92 29.36 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.769 0 C-N-CA 123.512 0.725 . . . . 71.120000000000005 110.11 -176.77 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 21' ' ' SER . . . . . 0.473 ' HB2' ' HB2' ' A' ' 134' ' ' GLU . 60.0 m -141.21 128.21 20.67 Favored 'General case' 0 CA--C 1.541 0.602 0 C-N-CA 124.733 1.213 . . . . 72.340000000000003 108.925 178.447 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 57.9 m-85 -109.59 121.35 45.01 Favored 'General case' 0 N--CA 1.476 0.83 0 C-N-CA 123.248 0.619 . . . . 73.010000000000005 110.02 -178.242 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 38.0 tt0 -74.53 104.23 5.16 Favored 'General case' 0 CA--C 1.547 0.854 0 C-N-CA 123.533 0.733 . . . . 74.519999999999996 109.192 171.36 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . 0.522 ' HB2' ' HG2' ' A' ' 4' ' ' PRO . 38.4 mt -85.6 123.83 31.46 Favored 'General case' 0 C--O 1.241 0.627 0 N-CA-C 109.114 -0.699 . . . . 61.409999999999997 109.114 175.971 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 25' ' ' PHE . . . . . 0.447 ' HA ' HD22 ' A' ' 3' ' ' ASN . 58.0 m-85 -83.16 76.44 9.86 Favored 'General case' 0 CA--C 1.543 0.674 0 C-N-CA 123.498 0.719 . . . . 74.530000000000001 110.52 -177.043 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -71.14 -6.63 40.81 Favored 'General case' 0 N--CA 1.489 1.482 0 C-N-CA 122.913 0.485 . . . . 63.450000000000003 112.004 178.363 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 10.1 p-10 -89.07 -17.38 29.42 Favored 'General case' 0 CA--C 1.554 1.104 0 C-N-CA 123.746 0.819 . . . . 64.540000000000006 111.343 176.344 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 57.2 mttp -112.59 -44.78 3.3 Favored 'General case' 0 N--CA 1.494 1.758 0 C-N-CA 123.441 0.697 . . . . 73.219999999999999 111.033 -176.185 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 29' ' ' VAL . . . . . 0.503 HG21 ' HA ' ' A' ' 129' ' ' PHE . 12.0 m -127.91 62.97 59.49 Favored Pre-proline 0 CA--C 1.566 1.59 0 C-N-CA 124.448 1.099 . . . . 75.230000000000004 110.267 177.382 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 2.8 Cg_endo -49.83 -41.34 47.15 Favored 'Trans proline' 0 C--N 1.391 2.78 0 C-N-CA 123.41 2.74 . . . . 75.430000000000007 114.717 -172.994 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 39.3 ttpt -64.46 -49.96 69.4 Favored 'General case' 0 N--CA 1.476 0.837 0 C-N-CA 123.449 0.699 . . . . 74.299999999999997 111.132 -177.496 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 7.1 m -76.01 -31.64 59.02 Favored 'General case' 0 CA--C 1.55 0.974 0 CA-C-N 115.115 -0.948 . . . . 71.349999999999994 111.504 -171.034 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -74.29 -46.93 38.08 Favored 'General case' 0 CA--C 1.543 0.704 0 C-N-CA 123.695 0.798 . . . . 43.549999999999997 110.336 177.976 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 11.6 tp10 -66.34 -29.66 69.89 Favored 'General case' 0 N--CA 1.482 1.134 0 C-N-CA 123.764 0.825 . . . . 71.319999999999993 110.979 178.852 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 35' ' ' ASN . . . . . 0.479 ' O ' ' HG ' ' A' ' 39' ' ' LEU . 25.8 t30 -54.06 -60.6 3.11 Favored 'General case' 0 N--CA 1.476 0.869 0 C-N-CA 123.826 0.85 . . . . 74.299999999999997 110.034 173.239 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 52.7 t80 -66.51 -34.84 78.83 Favored 'General case' 0 CA--C 1.541 0.598 0 O-C-N 124.224 0.953 . . . . 65.010000000000005 111.095 -175.094 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 37' ' ' ARG . . . . . 0.687 HH11 ' HB3' ' A' ' 4' ' ' PRO . 24.7 ttt180 -59.36 -45.56 91.05 Favored 'General case' 0 C--N 1.35 0.628 0 C-N-CA 123.541 0.736 . . . . 63.340000000000003 110.659 175.357 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 38' ' ' ALA . . . . . 0.592 ' HB1' ' HG2' ' A' ' 44' ' ' LYS . . . -73.3 -27.41 61.53 Favored 'General case' 0 CA--C 1.543 0.68 0 C-N-CA 123.434 0.694 . . . . 74.349999999999994 111.515 -177.956 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 39' ' ' LEU . . . . . 0.621 HD22 ' HE2' ' A' ' 48' ' ' TYR . 86.6 mt -72.97 -30.14 63.61 Favored 'General case' 0 N--CA 1.48 1.053 0 C-N-CA 123.462 0.705 . . . . 75.239999999999995 110.513 174.17 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 33.3 t -76.6 -53.95 7.35 Favored 'General case' 0 N--CA 1.478 0.946 0 C-N-CA 124.356 1.062 . . . . 73.430000000000007 110.898 179.452 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 41' ' ' THR . . . . . 0.4 ' OG1' ' HG2' ' A' ' 43' ' ' GLU . 44.0 p -76.83 -30.31 56.31 Favored 'General case' 0 N--CA 1.471 0.588 0 C-N-CA 124.401 1.08 . . . . 53.310000000000002 111.847 -174.523 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 79.86 30.89 41.6 Favored Glycine 0 C--N 1.341 0.851 0 CA-C-N 115.706 -0.679 . . . . 41.450000000000003 112.914 -179.076 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 43' ' ' GLU . . . . . 0.4 ' HG2' ' OG1' ' A' ' 41' ' ' THR . 55.7 mm-40 -58.33 -40.6 82.57 Favored 'General case' 0 N--CA 1.476 0.854 0 C-N-CA 123.079 0.551 . . . . 74.129999999999995 110.027 172.461 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 44' ' ' LYS . . . . . 0.592 ' HG2' ' HB1' ' A' ' 38' ' ' ALA . 28.4 mmmt -92.99 18.32 9.34 Favored 'General case' 0 CA--C 1.551 0.993 0 CA-C-N 115.315 -0.857 . . . . 72.409999999999997 111.379 -179.849 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 82.71 -8.87 61.02 Favored Glycine 0 C--N 1.35 1.335 0 N-CA-C 115.225 0.85 . . . . 72.540000000000006 115.225 172.872 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 46' ' ' PHE . . . . . 0.465 ' HE2' ' HA ' ' A' ' 78' ' ' ILE . 22.4 m-85 -82.09 -48.66 11.1 Favored 'General case' 0 N--CA 1.479 1.023 0 CA-C-N 117.713 0.756 . . . . 71.209999999999994 111.393 -170.224 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 38.04 62.6 1.02 Allowed Glycine 0 C--N 1.357 1.746 0 O-C-N 125.016 1.447 . . . . 42.310000000000002 116.186 168.278 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 48' ' ' TYR . . . . . 0.621 ' HE2' HD22 ' A' ' 39' ' ' LEU . 97.4 m-85 -62.18 92.85 0.04 OUTLIER 'General case' 0 N--CA 1.479 1.013 0 CA-C-O 121.908 0.861 . . . . 73.319999999999993 112.37 -170.736 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 49' ' ' LYS . . . . . 0.441 ' HE2' ' HA ' ' A' ' 160' ' ' ASP . 28.3 tptp -100.55 129.2 46.46 Favored 'General case' 0 C--O 1.237 0.436 0 C-N-CA 125.067 1.347 . . . . 74.040000000000006 107.954 179.593 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 73.63 20.5 79.82 Favored Glycine 0 C--N 1.345 1.045 0 O-C-N 123.33 0.394 . . . . 65.219999999999999 112.681 -176.007 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 51' ' ' SER . . . . . 0.464 ' HB2' ' HB3' ' A' ' 48' ' ' TYR . 22.7 t -64.92 119.83 11.43 Favored 'General case' 0 CA--C 1.546 0.819 0 C-N-CA 123.651 0.78 . . . . 72.540000000000006 109.901 -178.191 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 52' ' ' CYS . . . . . 0.417 ' H ' ' HB2' ' A' ' 67' ' ' PHE . 37.6 t -93.36 153.79 18.33 Favored 'General case' 0 N--CA 1.472 0.642 0 C-N-CA 123.275 0.63 . . . . 70.030000000000001 111.959 -166.934 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 53' ' ' PHE . . . . . 0.487 ' HA ' ' HA2' ' A' ' 64' ' ' GLY . 45.9 m-85 -97.89 120.9 39.1 Favored 'General case' 0 C--O 1.237 0.412 0 C-N-CA 124.787 1.235 . . . . 71.510000000000005 108.04 172.724 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 19.5 p-80 -108.68 -36.71 6.09 Favored 'General case' 0 N--CA 1.479 0.996 0 C-N-CA 123.822 0.849 . . . . 71.430000000000007 110.146 -173.269 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 50.2 ttt180 -122.61 97.34 5.41 Favored 'General case' 0 C--O 1.217 -0.643 0 N-CA-C 108.703 -0.851 . . . . 73.239999999999995 108.703 -175.057 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 56' ' ' ILE . . . . . 0.511 HG21 ' HA ' ' A' ' 143' ' ' GLU . 44.9 mt -119.85 128.35 75.91 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.586 0 N-CA-C 108.192 -1.04 . . . . 63.520000000000003 108.192 172.931 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 57' ' ' ILE . . . . . 0.574 HG23 ' HA ' ' A' ' 148' ' ' ARG . 60.5 mt -120.68 124.86 27.37 Favored Pre-proline 0 CA--C 1.547 0.831 0 N-CA-C 108.34 -0.985 . . . . 61.200000000000003 108.34 175.436 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 58' ' ' PRO . . . . . 0.526 ' HA ' ' HG2' ' A' ' 143' ' ' GLU . 37.8 Cg_endo -63.1 141.69 84.22 Favored 'Trans proline' 0 C--N 1.383 2.352 0 C-N-CA 123.31 2.673 . . . . 71.430000000000007 112.505 -178.364 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 65.29 21.6 68.5 Favored Glycine 0 C--N 1.343 0.967 0 CA-C-N 115.326 -0.852 . . . . 73.510000000000005 113.717 -177.738 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 60' ' ' PHE . . . . . 0.453 ' HD2' ' HB ' ' A' ' 57' ' ' ILE . 27.8 t80 -138.01 -74.78 0.4 Allowed 'General case' 0 N--CA 1.468 0.447 0 N-CA-C 109.245 -0.65 . . . . 74.510000000000005 109.245 -172.42 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 11.9 ptp -175.31 154.1 1.66 Allowed 'General case' 0 N--CA 1.483 1.215 0 O-C-N 123.677 0.611 . . . . 62.409999999999997 112.501 -178.472 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 62' ' ' CYS . . . . . . . . . . . . . 56.7 m -102.94 109.74 21.4 Favored 'General case' 0 CA--C 1.539 0.539 0 CA-C-N 115.076 -0.965 . . . . 73.400000000000006 108.973 170.369 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 63' ' ' GLN . . . . . 0.46 ' HA ' ' HA ' ' A' ' 113' ' ' PHE . 53.1 tt0 -100.08 105.33 16.96 Favored 'General case' 0 C--O 1.248 0.977 0 CA-C-O 121.336 0.589 . . . . 71.540000000000006 109.901 -178.05 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 64' ' ' GLY . . . . . 0.487 ' HA2' ' HA ' ' A' ' 53' ' ' PHE . . . -110.79 -153.38 13.2 Favored Glycine 0 C--N 1.344 1.006 0 CA-C-N 114.466 -1.243 . . . . 72.109999999999999 111.31 174.931 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 86.05 -35.6 3.25 Favored Glycine 0 C--N 1.344 1.025 0 N-CA-C 111.856 -0.498 . . . . 62.539999999999999 111.856 -173.494 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 66' ' ' ASP . . . . . 0.554 ' HB2' ' HG2' ' A' ' 111' ' ' GLN . 35.5 t70 -66.54 103.1 0.99 Allowed 'General case' 0 N--CA 1.445 -0.688 0 C-N-CA 124.836 1.254 . . . . 74.319999999999993 110.686 -177.855 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 67' ' ' PHE . . . . . 0.417 ' HB2' ' H ' ' A' ' 52' ' ' CYS . 71.5 t80 -156.92 -68.83 0.1 Allowed 'General case' 0 C--O 1.239 0.521 0 N-CA-C 108.361 -0.978 . . . . 74.530000000000001 108.361 177.919 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 27.5 m -79.25 122.06 25.85 Favored 'General case' 0 C--O 1.24 0.57 0 CA-C-N 115.49 -0.777 . . . . 54.539999999999999 108.943 178.693 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 49.5 mtt85 65.94 36.06 6.16 Favored 'General case' 0 N--CA 1.482 1.159 0 C-N-CA 124.302 1.041 . . . . 64.310000000000002 111.538 177.787 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 1.2 t60 -41.1 -52.73 3.2 Favored 'General case' 0 N--CA 1.494 1.741 0 C-N-CA 125.804 1.642 . . . . 74.219999999999999 113.88 -175.273 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 93.2 m-20 -65.58 99.77 0.46 Allowed 'General case' 0 N--CA 1.477 0.887 0 C-N-CA 123.118 0.567 . . . . 53.530000000000001 110.777 -175.847 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 88.29 -7.05 82.73 Favored Glycine 0 C--N 1.345 1.044 0 CA-C-N 115.677 -0.692 . . . . 74.219999999999999 114.688 174.689 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 73' ' ' THR . . . . . 0.439 ' O ' ' HB3' ' A' ' 110' ' ' SER . 26.1 m -137.09 -83.02 0.35 Allowed 'General case' 0 N--CA 1.48 1.072 0 CA-C-N 118.076 0.938 . . . . 65.549999999999997 110.526 -178.049 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 74' ' ' GLY . . . . . 0.448 ' O ' ' HG3' ' A' ' 111' ' ' GLN . . . 71.95 64.12 2.78 Favored Glycine 0 C--N 1.354 1.535 0 N-CA-C 114.371 0.508 . . . . 70.010000000000005 114.371 173.171 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 97.43 54.53 1.24 Allowed Glycine 0 N--CA 1.472 1.052 0 C-N-CA 120.309 -0.948 . . . . 64.329999999999998 112.305 176.016 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 64.3 pttt -61.05 172.15 1.08 Allowed 'General case' 0 CA--C 1.551 1.001 0 C-N-CA 123.959 0.904 . . . . 71.329999999999998 113.283 -175.4 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 88.1 p -90.57 179.42 5.84 Favored 'General case' 0 C--O 1.242 0.684 0 CA-C-N 115.212 -0.904 . . . . 70.209999999999994 111.187 -176.146 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 78' ' ' ILE . . . . . 0.465 ' HA ' ' HE2' ' A' ' 46' ' ' PHE . 35.0 pt -74.56 -15.54 16.25 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.663 0 CA-C-N 115.72 -0.673 . . . . 71.209999999999994 111.359 177.608 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 82.1 m-85 -95.0 11.27 32.57 Favored 'General case' 0 N--CA 1.475 0.821 0 C-N-CA 123.735 0.814 . . . . 74.219999999999999 111.35 177.287 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 105.88 -146.08 16.02 Favored Glycine 0 C--N 1.345 1.053 0 N-CA-C 111.244 -0.742 . . . . 71.120000000000005 111.244 -179.253 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 36.1 tt0 -57.81 -38.5 75.66 Favored 'General case' 0 N--CA 1.477 0.877 0 C-N-CA 124.08 0.952 . . . . 74.239999999999995 111.423 -178.227 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 3.8 ptpp? -160.15 172.48 17.36 Favored 'General case' 0 N--CA 1.474 0.743 0 C-N-CA 123.417 0.687 . . . . 74.0 111.805 -177.451 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 4.1 p90 -159.07 171.89 19.16 Favored 'General case' 0 CA--C 1.544 0.726 0 C-N-CA 125.012 1.325 . . . . 73.140000000000001 109.514 177.657 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 84' ' ' GLU . . . . . 0.486 ' HA ' ' HA ' ' A' ' 106' ' ' ASN . 12.6 pt-20 -81.67 158.4 24.29 Favored 'General case' 0 N--CA 1.475 0.776 0 C-N-CA 123.574 0.75 . . . . 74.319999999999993 111.758 -177.319 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 52.7 m-20 -81.85 143.74 31.51 Favored 'General case' 0 N--CA 1.476 0.875 0 C-N-CA 123.761 0.824 . . . . 75.329999999999998 109.269 173.294 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 12.5 tp10 -83.21 -59.38 2.48 Favored 'General case' 0 N--CA 1.477 0.883 0 CA-C-O 121.278 0.561 . . . . 63.310000000000002 111.051 -174.551 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 32.0 p30 -153.68 -167.5 2.7 Favored 'General case' 0 N--CA 1.472 0.673 0 C-N-CA 123.747 0.819 . . . . 63.509999999999998 109.157 -174.167 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 81.4 m-85 -138.58 39.49 2.22 Favored 'General case' 0 N--CA 1.482 1.166 0 C-N-CA 123.717 0.807 . . . . 73.540000000000006 110.451 178.046 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 67.8 mt -62.31 -38.18 80.49 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.324 0 CA-C-O 121.531 0.681 . . . . 71.439999999999998 109.904 174.612 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 90' ' ' LEU . . . . . 0.67 ' HB3' ' HB ' ' A' ' 128' ' ' VAL . 95.4 mt -98.9 150.62 21.73 Favored 'General case' 0 CA--C 1.543 0.705 0 C-N-CA 124.088 0.955 . . . . 74.450000000000003 110.893 179.379 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 47.2 pttt -158.77 163.87 36.35 Favored 'General case' 0 N--CA 1.482 1.172 0 C-N-CA 124.165 0.986 . . . . 75.209999999999994 110.294 -170.946 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 92' ' ' HIS . . . . . 0.402 ' HA ' HG13 ' A' ' 97' ' ' ILE . 13.3 m-70 -88.89 63.38 6.76 Favored 'General case' 0 N--CA 1.488 1.439 0 C-N-CA 123.63 0.772 . . . . 74.310000000000002 109.93 -175.196 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 15.3 p -90.8 2.57 55.97 Favored 'General case' 0 N--CA 1.48 1.064 0 C-N-CA 123.849 0.86 . . . . 74.120000000000005 111.811 178.508 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -157.27 173.36 34.79 Favored Glycine 0 C--N 1.343 0.926 0 CA-C-N 116.653 -0.248 . . . . 61.310000000000002 112.918 -178.644 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 86.2 Cg_endo -78.16 157.1 30.05 Favored 'Trans proline' 0 C--N 1.362 1.249 0 C-N-CA 123.276 2.651 . . . . 74.0 112.64 175.895 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 79.63 18.77 72.51 Favored Glycine 0 C--N 1.342 0.871 0 CA-C-N 115.694 -0.685 . . . . 54.32 114.476 175.396 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 97' ' ' ILE . . . . . 0.67 ' HB ' ' SG ' ' A' ' 115' ' ' CYS . 19.0 mm -73.03 128.54 35.85 Favored 'Isoleucine or valine' 0 CA--C 1.554 1.119 0 C-N-CA 123.967 0.907 . . . . 62.520000000000003 110.592 178.932 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 98' ' ' LEU . . . . . 0.501 HD13 HG12 ' A' ' 114' ' ' ILE . 67.7 tp -103.88 122.71 45.72 Favored 'General case' 0 C--O 1.252 1.207 0 C-N-CA 123.637 0.775 . . . . 72.25 110.13 176.139 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 99' ' ' SER . . . . . 0.422 ' HB3' ' HD2' ' A' ' 126' ' ' HIS . 50.7 m -145.34 139.68 27.18 Favored 'General case' 0 CA--C 1.555 1.155 0 C-N-CA 124.735 1.214 . . . . 72.120000000000005 109.418 179.744 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 100' ' ' MET . . . . . 0.675 ' HA ' ' HA ' ' A' ' 112' ' ' PHE . 85.9 mtp -76.57 147.54 37.61 Favored 'General case' 0 N--CA 1.491 1.605 0 C-N-CA 123.877 0.871 . . . . 74.310000000000002 111.647 178.48 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 101' ' ' ALA . . . . . 0.4 ' HB3' ' HB2' ' A' ' 111' ' ' GLN . . . -75.25 145.77 41.66 Favored 'General case' 0 N--CA 1.479 0.995 0 C-N-CA 123.654 0.782 . . . . 54.140000000000001 111.843 -175.261 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 26.9 p-10 -168.54 173.04 7.72 Favored 'General case' 0 N--CA 1.477 0.908 0 C-N-CA 123.958 0.903 . . . . 71.200000000000003 110.675 -178.902 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -91.45 -47.81 7.23 Favored 'General case' 0 N--CA 1.471 0.578 0 CA-C-N 115.7 -0.682 . . . . 42.149999999999999 109.551 168.636 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -163.1 -161.2 12.09 Favored Glycine 0 C--N 1.345 1.074 0 CA-C-N 115.512 -0.767 . . . . 42.109999999999999 111.973 178.111 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 51.9 Cg_exo -55.8 135.68 70.73 Favored 'Trans proline' 0 C--N 1.375 1.965 0 C-N-CA 123.417 2.745 . . . . 70.230000000000004 112.608 179.133 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 106' ' ' ASN . . . . . 0.486 ' HA ' ' HA ' ' A' ' 84' ' ' GLU . 64.9 t30 69.45 11.22 7.99 Favored 'General case' 0 N--CA 1.484 1.261 0 C-N-CA 124.982 1.313 . . . . 64.430000000000007 112.247 179.269 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 8.8 m -105.08 -12.98 15.89 Favored 'General case' 0 CA--C 1.552 1.057 0 C-N-CA 123.452 0.701 . . . . 61.030000000000001 109.576 171.549 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 15.1 t30 -57.88 146.6 31.44 Favored 'General case' 0 N--CA 1.481 1.081 0 C-N-CA 125.609 1.563 . . . . 72.530000000000001 111.451 175.306 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 113.13 21.15 6.02 Favored Glycine 0 N--CA 1.471 1.02 0 N-CA-C 113.996 0.359 . . . . 23.539999999999999 113.996 175.944 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 110' ' ' SER . . . . . 0.439 ' HB3' ' O ' ' A' ' 73' ' ' THR . 69.0 m -138.36 122.62 18.16 Favored 'General case' 0 N--CA 1.474 0.765 0 N-CA-C 108.744 -0.836 . . . . 73.010000000000005 108.744 171.546 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 111' ' ' GLN . . . . . 0.554 ' HG2' ' HB2' ' A' ' 66' ' ' ASP . 18.1 mt-30 65.72 170.92 0.22 Allowed 'General case' 0 N--CA 1.498 1.953 0 C-N-CA 124.302 1.041 . . . . 74.409999999999997 111.802 -178.255 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 112' ' ' PHE . . . . . 0.675 ' HA ' ' HA ' ' A' ' 100' ' ' MET . 53.2 p90 -150.07 138.81 20.82 Favored 'General case' 0 N--CA 1.479 0.978 0 C-N-CA 123.118 0.567 . . . . 73.430000000000007 110.102 174.975 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 113' ' ' PHE . . . . . 0.46 ' HA ' ' HA ' ' A' ' 63' ' ' GLN . 42.9 p90 -111.84 144.99 40.24 Favored 'General case' 0 C--O 1.24 0.588 0 C-N-CA 123.753 0.821 . . . . 74.319999999999993 110.668 174.435 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 114' ' ' ILE . . . . . 0.501 HG12 HD13 ' A' ' 98' ' ' LEU . 8.2 mt -116.46 99.67 8.81 Favored 'Isoleucine or valine' 0 C--O 1.24 0.577 0 N-CA-C 106.919 -1.511 . . . . 74.109999999999999 106.919 178.232 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 115' ' ' CYS . . . . . 0.67 ' SG ' ' HB ' ' A' ' 97' ' ' ILE . 19.3 p -84.45 118.05 24.04 Favored 'General case' 0 N--CA 1.472 0.644 0 C-N-CA 122.404 0.282 . . . . 72.430000000000007 110.758 -175.768 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 59.5 p -78.65 1.17 23.69 Favored 'General case' 0 N--CA 1.481 1.075 0 C-N-CA 124.052 0.941 . . . . 74.420000000000002 111.902 -179.024 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -133.22 162.22 32.35 Favored 'General case' 0 C--O 1.244 0.787 0 C-N-CA 123.704 0.802 . . . . 71.010000000000005 109.966 -179.827 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 8.8 ptmt -71.82 81.51 0.89 Allowed 'General case' 0 CA--C 1.549 0.937 0 CA-C-O 121.846 0.831 . . . . 74.540000000000006 109.415 171.944 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 119' ' ' THR . . . . . 0.491 ' HB ' HD23 ' A' ' 122' ' ' LEU . 32.2 p -82.56 85.31 7.0 Favored 'General case' 0 CA--C 1.55 0.971 0 CA-C-O 122.147 0.975 . . . . 71.319999999999993 109.309 -177.331 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 12.8 pt-20 -74.57 -27.64 60.58 Favored 'General case' 0 N--CA 1.48 1.06 0 CA-C-N 114.67 -1.15 . . . . 61.049999999999997 112.318 -167.724 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 121' ' ' TRP . . . . . . . . . . . . . 46.5 p90 -67.49 -1.75 5.39 Favored 'General case' 0 N--CA 1.483 1.2 0 C-N-CA 123.747 0.819 . . . . 73.030000000000001 112.238 178.352 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 122' ' ' LEU . . . . . 0.491 HD23 ' HB ' ' A' ' 119' ' ' THR . 3.2 mm? -78.06 -3.91 44.58 Favored 'General case' 0 CA--C 1.548 0.895 0 C-N-CA 124.454 1.102 . . . . 73.450000000000003 112.48 174.064 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 40.6 m-20 -65.22 128.38 35.58 Favored 'General case' 0 N--CA 1.487 1.384 0 CA-C-N 118.247 0.476 . . . . 63.100000000000001 111.164 176.592 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 104.23 -25.79 25.0 Favored Glycine 0 N--CA 1.477 1.378 0 N-CA-C 111.867 -0.493 . . . . 60.119999999999997 111.867 -174.665 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 12.5 ttmm -85.59 -164.46 1.02 Allowed 'General case' 0 CA--C 1.552 1.033 0 C-N-CA 124.329 1.052 . . . . 60.109999999999999 108.449 177.443 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 126' ' ' HIS . . . . . 0.422 ' HD2' ' HB3' ' A' ' 99' ' ' SER . 34.6 t60 -66.91 131.7 46.44 Favored 'General case' 0 CA--C 1.546 0.825 0 CA-C-O 121.183 0.516 . . . . 71.040000000000006 111.063 -175.343 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 7.4 p -62.42 147.4 11.62 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.808 0 CA-C-N 114.038 -1.437 . . . . 75.400000000000006 112.074 178.126 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 128' ' ' VAL . . . . . 0.67 ' HB ' ' HB3' ' A' ' 90' ' ' LEU . 46.3 t -64.43 149.98 10.61 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.721 0 C-N-CA 123.374 0.67 . . . . 72.120000000000005 110.3 174.699 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 129' ' ' PHE . . . . . 0.503 ' HA ' HG21 ' A' ' 29' ' ' VAL . 49.3 p90 -136.51 -27.95 1.03 Allowed 'General case' 0 N--CA 1.479 0.977 0 C-N-CA 122.378 0.271 . . . . 74.299999999999997 111.127 174.567 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . -123.54 167.13 15.84 Favored Glycine 0 C--N 1.343 0.942 0 O-C-N 123.424 0.452 . . . . 61.009999999999998 112.323 -177.719 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 30.2 ttpt -154.65 122.84 5.97 Favored 'General case' 0 N--CA 1.468 0.454 0 N-CA-C 107.997 -1.112 . . . . 74.109999999999999 107.997 179.092 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 12.7 p -67.0 122.39 17.94 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.959 0 CA-C-O 121.515 0.674 . . . . 52.450000000000003 109.98 177.468 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 21.2 ptmt -108.66 -22.98 12.01 Favored 'General case' 0 N--CA 1.476 0.844 0 C-N-CA 124.054 0.941 . . . . 63.119999999999997 110.251 179.009 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 134' ' ' GLU . . . . . 0.473 ' HB2' ' HB2' ' A' ' 21' ' ' SER . 34.6 mt-10 -136.71 134.03 36.74 Favored 'General case' 0 N--CA 1.475 0.817 0 C-N-CA 124.798 1.239 . . . . 75.439999999999998 108.17 179.863 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 135' ' ' GLY . . . . . 0.411 ' O ' HG23 ' A' ' 139' ' ' VAL . . . 80.1 26.66 54.94 Favored Glycine 0 CA--C 1.528 0.862 0 CA-C-O 119.837 -0.424 . . . . 41.409999999999997 113.235 -177.624 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 136' ' ' MET . . . . . . . . . . . . . 5.8 tpt -59.79 -53.17 61.1 Favored 'General case' 0 N--CA 1.485 1.288 0 C-N-CA 123.664 0.786 . . . . 70.319999999999993 110.471 175.103 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 137' ' ' ASN . . . . . . . . . . . . . 20.5 m120 -64.65 -25.79 68.11 Favored 'General case' 0 N--CA 1.477 0.884 0 CA-C-N 115.902 -0.59 . . . . 74.439999999999998 110.997 -179.537 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 138' ' ' ILE . . . . . . . . . . . . . 50.9 mm -69.52 -40.4 79.65 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.728 0 C-N-CA 123.393 0.677 . . . . 73.540000000000006 110.433 175.853 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 139' ' ' VAL . . . . . 0.411 HG23 ' O ' ' A' ' 135' ' ' GLY . 91.2 t -63.18 -40.33 88.62 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.131 0 C-N-CA 123.033 0.533 . . . . 74.409999999999997 109.888 174.987 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 40.3 mt-10 -65.46 -33.23 75.44 Favored 'General case' 0 CA--C 1.551 0.985 0 CA-C-N 115.541 -0.754 . . . . 75.310000000000002 111.329 175.808 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -75.2 -45.11 42.57 Favored 'General case' 0 N--CA 1.481 1.08 0 C-N-CA 123.753 0.821 . . . . 71.310000000000002 111.739 -177.667 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 142' ' ' MET . . . . . 0.551 ' HB2' HD13 ' A' ' 156' ' ' ILE . 25.4 ptm -69.48 -29.38 67.03 Favored 'General case' 0 N--CA 1.476 0.852 0 CA-C-N 115.823 -0.626 . . . . 74.099999999999994 110.66 179.031 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 143' ' ' GLU . . . . . 0.526 ' HG2' ' HA ' ' A' ' 58' ' ' PRO . 30.9 tt0 -64.88 -29.01 69.94 Favored 'General case' 0 C--N 1.353 0.731 0 C-N-CA 123.243 0.617 . . . . 70.019999999999996 111.531 -179.927 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 144' ' ' ARG . . . . . . . . . . . . . 24.3 mtp180 -63.15 -23.61 67.51 Favored 'General case' 0 N--CA 1.474 0.761 0 C-N-CA 123.572 0.749 . . . . 73.340000000000003 111.843 177.475 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 145' ' ' PHE . . . . . . . . . . . . . 65.7 m-85 -80.14 -13.82 58.97 Favored 'General case' 0 N--CA 1.481 1.111 0 C-N-CA 122.42 0.288 . . . . 73.400000000000006 111.506 179.68 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 146' ' ' GLY . . . . . 0.411 ' HA2' ' HA ' ' A' ' 152' ' ' THR . . . -84.4 171.09 47.41 Favored Glycine 0 C--N 1.343 0.949 0 O-C-N 122.979 0.174 . . . . 64.310000000000002 112.675 177.192 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 34.1 t -132.96 167.29 20.54 Favored 'General case' 0 N--CA 1.48 1.05 0 C-N-CA 123.966 0.906 . . . . 74.239999999999995 109.716 -176.229 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 148' ' ' ARG . . . . . 0.574 ' HA ' HG23 ' A' ' 57' ' ' ILE . 23.7 mmt85 -67.6 -23.39 65.38 Favored 'General case' 0 N--CA 1.488 1.46 0 C-N-CA 123.925 0.89 . . . . 75.549999999999997 112.591 -175.481 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 149' ' ' ASN . . . . . . . . . . . . . 27.8 p-10 -86.97 1.09 53.89 Favored 'General case' 0 N--CA 1.487 1.38 0 C-N-CA 123.363 0.665 . . . . 60.520000000000003 111.106 174.818 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . 95.32 -26.5 19.21 Favored Glycine 0 C--N 1.341 0.809 0 CA-C-O 119.692 -0.504 . . . . 73.129999999999995 113.169 179.282 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 65.0 tttp -63.69 118.14 7.84 Favored 'General case' 0 N--CA 1.476 0.827 0 CA-C-N 117.507 0.654 . . . . 70.439999999999998 110.921 -174.542 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 152' ' ' THR . . . . . 0.411 ' HA ' ' HA2' ' A' ' 146' ' ' GLY . 9.6 m -93.39 124.7 37.56 Favored 'General case' 0 CA--C 1.542 0.644 0 CA-C-N 114.763 -1.108 . . . . 74.400000000000006 109.062 179.269 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 153' ' ' SER . . . . . . . . . . . . . 66.2 p -63.77 -26.81 68.81 Favored 'General case' 0 N--CA 1.48 1.066 0 C-N-CA 124.13 0.972 . . . . 35.310000000000002 112.056 -178.655 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 72.1 mmtt -111.89 141.3 45.7 Favored 'General case' 0 C--O 1.238 0.472 0 C-N-CA 124.009 0.924 . . . . 60.439999999999998 111.252 -176.38 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 72.9 mmtt -83.16 91.23 7.2 Favored 'General case' 0 C--O 1.238 0.487 0 N-CA-C 108.369 -0.975 . . . . 60.539999999999999 108.369 172.798 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 156' ' ' ILE . . . . . 0.551 HD13 ' HB2' ' A' ' 142' ' ' MET . 62.6 mt -94.13 110.97 24.38 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.473 0 CA-C-N 114.84 -1.073 . . . . 52.130000000000003 108.955 -177.94 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 157' ' ' THR . . . . . . . . . . . . . 49.3 p -115.59 155.07 28.29 Favored 'General case' 0 C--O 1.243 0.743 0 C-N-CA 123.847 0.859 . . . . 74.219999999999999 110.454 -176.979 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 158' ' ' ILE . . . . . 0.461 HG23 ' HB3' ' A' ' 8' ' ' PHE . 62.6 mt -75.5 93.71 0.92 Allowed 'Isoleucine or valine' 0 CA--C 1.542 0.644 0 N-CA-C 108.205 -1.035 . . . . 73.030000000000001 108.205 171.199 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 159' ' ' ALA . . . . . 0.566 ' HB2' ' HB2' ' A' ' 11' ' ' ALA . . . -58.31 -35.62 72.13 Favored 'General case' 0 N--CA 1.474 0.744 0 C-N-CA 124.485 1.114 . . . . 71.099999999999994 112.834 -177.028 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 160' ' ' ASP . . . . . 0.441 ' HA ' ' HE2' ' A' ' 49' ' ' LYS . 23.7 t0 -161.16 157.39 25.8 Favored 'General case' 0 N--CA 1.477 0.906 0 O-C-N 123.358 0.411 . . . . 70.140000000000001 110.648 -174.986 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 161' ' ' CYS . . . . . . . . . . . . . 58.7 m -123.49 -172.59 2.55 Favored 'General case' 0 N--CA 1.485 1.299 0 C-N-CA 125.048 1.339 . . . . 71.200000000000003 108.473 177.281 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 162' ' ' GLY . . . . . . . . . . . . . . . 132.25 57.09 0.08 OUTLIER Glycine 0 C--N 1.354 1.572 0 CA-C-N 118.716 0.689 . . . . 61.149999999999999 112.977 -172.957 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 163' ' ' GLN . . . . . 0.57 ' HA ' ' H ' ' A' ' 7' ' ' PHE . 21.8 pt20 -47.84 137.46 9.77 Favored 'General case' 0 N--CA 1.485 1.288 0 C-N-CA 124.356 1.062 . . . . 72.299999999999997 113.708 -173.242 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 164' ' ' LEU . . . . . 0.473 ' HG ' ' HB2' ' A' ' 7' ' ' PHE . 41.2 mt . . . . . 0 CA--C 1.543 0.698 0 C-N-CA 124.005 0.922 . . . . 74.230000000000004 110.151 179.914 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 218' ' ' PRO . . . . . . . . . . . . . 93.4 Cg_endo . . . . . 0 CA--C 1.54 0.796 0 CA-C-O 121.215 0.423 . . . . 70.030000000000001 112.044 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' B' B ' 219' ' ' GLY . . . . . . . . . . . . . . . 112.38 177.55 19.88 Favored Glycine 0 CA--C 1.527 0.834 0 CA-C-N 115.186 -0.916 . . . . 75.519999999999996 111.909 -175.981 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 220' ' ' PRO . . . . . 0.436 ' HG3' HD11 ' A' ' 122' ' ' LEU . 91.7 Cg_endo -75.65 178.48 7.33 Favored 'Trans proline' 0 N--CA 1.489 1.254 0 C-N-CA 123.41 2.74 . . . . 63.539999999999999 113.419 -177.067 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 221' ' ' TYR . . . . . . . . . . . . . 99.7 m-85 . . . . . 0 N--CA 1.476 0.87 0 C-N-CA 124.464 1.105 . . . . 73.299999999999997 109.558 179.381 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 3' ' ' ASN . . . . . 0.529 HD22 ' HA ' ' A' ' 25' ' ' PHE . 20.8 m120 . . . . . 0 N--CA 1.48 1.052 0 CA-C-O 119.288 -0.387 . . . . 73.150000000000006 111.723 . . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 4' ' ' PRO . . . . . 0.497 ' HG2' ' HB2' ' A' ' 24' ' ' LEU . 42.5 Cg_endo -65.42 135.34 42.26 Favored 'Trans proline' 0 C--N 1.378 2.1 0 C-N-CA 122.525 2.15 . . . . 73.310000000000002 110.816 178.522 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 5' ' ' THR . . . . . 0.408 ' HB ' ' O ' ' A' ' 164' ' ' LEU . 55.9 m -122.3 123.26 41.01 Favored 'General case' 0 CA--C 1.54 0.568 0 N-CA-C 109.278 -0.638 . . . . 71.219999999999999 109.278 -172.882 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 6' ' ' VAL . . . . . 0.552 ' HA ' ' HB2' ' A' ' 163' ' ' GLN . 14.4 m -101.33 136.39 33.35 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.659 0 C-N-CA 123.965 0.906 . . . . 74.230000000000004 109.256 -175.915 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 7' ' ' PHE . . . . . 0.438 ' HB3' ' HA ' ' A' ' 163' ' ' GLN . 86.4 t80 -125.6 136.98 53.85 Favored 'General case' 0 C--O 1.238 0.47 0 C-N-CA 123.469 0.707 . . . . 73.099999999999994 109.683 -175.627 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 8' ' ' PHE . . . . . 0.427 ' HB3' HG23 ' A' ' 158' ' ' ILE . 53.3 m-85 -138.76 165.84 25.96 Favored 'General case' 0 CA--C 1.534 0.349 0 C-N-CA 124.809 1.243 . . . . 70.209999999999994 109.493 177.254 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 13.9 m-20 -111.67 118.23 35.07 Favored 'General case' 0 C--N 1.323 -0.565 0 N-CA-C 106.386 -1.709 . . . . 73.540000000000006 106.386 168.868 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 10' ' ' ILE . . . . . 0.459 HG21 ' SD ' ' A' ' 142' ' ' MET . 46.3 mm -84.98 129.53 37.58 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.56 0 N-CA-C 109.159 -0.682 . . . . 52.530000000000001 109.159 178.722 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 11' ' ' ALA . . . . . 0.792 ' HB2' ' HB2' ' A' ' 159' ' ' ALA . . . -124.59 126.98 46.69 Favored 'General case' 0 C--O 1.217 -0.642 0 C-N-CA 123.691 0.796 . . . . 65.0 110.496 -176.89 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 12' ' ' VAL . . . . . 0.497 HG23 ' HB2' ' A' ' 17' ' ' LEU . 89.1 t -96.14 116.38 37.85 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.759 0 N-CA-C 107.976 -1.12 . . . . 41.140000000000001 107.976 173.418 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 30.2 m-20 62.99 24.14 14.39 Favored 'General case' 0 N--CA 1.488 1.446 0 C-N-CA 125.59 1.556 . . . . 74.129999999999995 112.048 -177.288 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 97.24 -17.77 58.57 Favored Glycine 0 C--N 1.347 1.151 0 CA-C-O 119.951 -0.361 . . . . 75.120000000000005 113.037 -179.201 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 40.9 mm-40 -94.32 124.66 54.95 Favored Pre-proline 0 CA--C 1.545 0.755 0 CA-C-O 118.551 -0.738 . . . . 51.409999999999997 109.767 179.66 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 19.7 Cg_endo -56.06 118.07 4.81 Favored 'Trans proline' 0 C--N 1.381 2.274 0 C-N-CA 123.222 2.615 . . . . 74.209999999999994 113.111 -176.308 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 17' ' ' LEU . . . . . 0.497 ' HB2' HG23 ' A' ' 12' ' ' VAL . 49.3 tp -78.12 -38.55 43.63 Favored 'General case' 0 N--CA 1.476 0.871 0 C-N-CA 124.244 1.018 . . . . 73.409999999999997 109.407 171.371 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 177.39 -160.3 27.0 Favored Glycine 0 N--CA 1.449 -0.481 0 CA-C-N 114.317 -1.311 . . . . 63.109999999999999 110.707 -175.521 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 6.3 ptp180 -140.08 147.22 39.97 Favored 'General case' 0 N--CA 1.468 0.456 0 C-N-CA 123.934 0.893 . . . . 72.140000000000001 109.693 179.799 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 87.4 t -137.18 132.5 46.53 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.7 0 C-N-CA 124.092 0.957 . . . . 64.209999999999994 109.593 -175.24 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 7.9 t -120.1 122.62 41.45 Favored 'General case' 0 CA--C 1.547 0.855 0 N-CA-C 108.999 -0.741 . . . . 71.299999999999997 108.999 172.601 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 22' ' ' PHE . . . . . 0.549 ' HA ' ' HA ' ' A' ' 132' ' ' VAL . 11.1 m-85 -100.15 152.22 20.51 Favored 'General case' 0 N--CA 1.476 0.857 0 C-N-CA 124.027 0.931 . . . . 71.420000000000002 108.819 176.556 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 23' ' ' GLU . . . . . 0.649 ' HB2' ' HD2' ' A' ' 133' ' ' LYS . 39.7 tt0 -110.76 119.01 37.7 Favored 'General case' 0 CA--C 1.54 0.58 0 C-N-CA 123.318 0.647 . . . . 70.209999999999994 109.538 175.517 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . 0.497 ' HB2' ' HG2' ' A' ' 4' ' ' PRO . 18.5 mt -90.8 127.86 36.5 Favored 'General case' 0 N--CA 1.472 0.654 0 C-N-CA 124.462 1.105 . . . . 73.049999999999997 110.028 -178.301 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 25' ' ' PHE . . . . . 0.536 ' HB2' HD11 ' A' ' 90' ' ' LEU . 85.4 m-85 -88.92 71.9 8.52 Favored 'General case' 0 CA--C 1.536 0.427 0 C-N-CA 123.776 0.83 . . . . 64.349999999999994 110.34 -178.534 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -67.12 -15.59 63.81 Favored 'General case' 0 N--CA 1.481 1.122 0 CA-C-N 115.403 -0.817 . . . . 63.350000000000001 112.223 177.58 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 9.2 p-10 -76.3 -18.71 58.82 Favored 'General case' 0 CA--C 1.555 1.156 0 C-N-CA 123.409 0.683 . . . . 64.340000000000003 111.088 176.885 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 52.2 mttp -106.67 -45.65 4.17 Favored 'General case' 0 N--CA 1.483 1.201 0 C-N-CA 123.902 0.881 . . . . 75.340000000000003 110.37 -178.536 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 29' ' ' VAL . . . . . 0.586 HG21 ' HA ' ' A' ' 129' ' ' PHE . 4.6 m -134.68 69.98 71.8 Favored Pre-proline 0 CA--C 1.562 1.437 0 C-N-CA 124.36 1.064 . . . . 62.5 109.913 -175.748 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 18.8 Cg_endo -58.57 -29.54 89.26 Favored 'Trans proline' 0 C--N 1.382 2.324 0 C-N-CA 123.062 2.508 . . . . 64.510000000000005 113.985 -175.004 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 34.8 ttmt -72.63 -56.95 4.54 Favored 'General case' 0 N--CA 1.479 1.01 0 C-N-CA 123.668 0.787 . . . . 74.519999999999996 111.217 -179.648 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 6.6 m -69.31 -25.54 64.27 Favored 'General case' 0 CA--C 1.559 1.298 0 CA-C-N 115.081 -0.963 . . . . 52.5 111.074 -173.373 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -82.89 -42.4 17.77 Favored 'General case' 0 CA--C 1.548 0.898 0 C-N-CA 123.717 0.807 . . . . 63.420000000000002 111.085 177.254 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 38.8 tt0 -56.13 -39.44 72.25 Favored 'General case' 0 N--CA 1.493 1.675 0 C-N-CA 123.681 0.792 . . . . 52.420000000000002 110.57 177.192 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 35' ' ' ASN . . . . . 0.591 ' ND2' ' SD ' ' A' ' 100' ' ' MET . 41.4 t30 -50.95 -67.08 0.28 Allowed 'General case' 0 CA--C 1.538 0.488 0 O-C-N 125.149 1.531 . . . . 74.219999999999999 111.256 179.848 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 60.6 t80 -64.46 -36.02 82.82 Favored 'General case' 0 CA--C 1.543 0.707 0 O-C-N 124.016 0.822 . . . . 75.439999999999998 111.267 -173.62 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 62.2 ttt180 -60.63 -47.01 88.13 Favored 'General case' 0 N--CA 1.478 0.936 0 O-C-N 124.068 0.855 . . . . 75.430000000000007 111.042 178.906 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 38' ' ' ALA . . . . . 0.486 ' HB3' HG21 ' A' ' 78' ' ' ILE . . . -78.06 -19.92 53.35 Favored 'General case' 0 N--CA 1.475 0.811 0 CA-C-N 115.153 -0.93 . . . . 73.120000000000005 111.671 -177.416 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 39' ' ' LEU . . . . . 0.422 ' HG ' ' O ' ' A' ' 35' ' ' ASN . 94.0 mt -73.94 -37.56 64.51 Favored 'General case' 0 N--CA 1.481 1.104 0 C-N-CA 123.162 0.585 . . . . 74.319999999999993 109.89 170.93 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 50.4 m -67.74 -49.4 62.74 Favored 'General case' 0 N--CA 1.48 1.041 0 C-N-CA 123.765 0.826 . . . . 75.5 110.831 -178.585 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 41' ' ' THR . . . . . 0.461 ' OG1' ' HG2' ' A' ' 43' ' ' GLU . 7.6 p -76.3 -33.78 59.07 Favored 'General case' 0 N--CA 1.477 0.895 0 C-N-CA 123.527 0.731 . . . . 72.129999999999995 111.619 178.344 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 76.99 37.9 31.78 Favored Glycine 0 C--N 1.34 0.756 0 CA-C-N 116.257 -0.429 . . . . 74.340000000000003 112.411 -172.525 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 43' ' ' GLU . . . . . 0.461 ' HG2' ' OG1' ' A' ' 41' ' ' THR . 22.7 mm-40 -64.67 -20.9 66.57 Favored 'General case' 0 N--CA 1.486 1.339 0 C-N-CA 123.159 0.584 . . . . 74.329999999999998 111.599 174.231 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 44' ' ' LYS . . . . . 0.514 ' HG3' ' HB ' ' A' ' 78' ' ' ILE . 71.1 mmtt -106.63 15.13 26.13 Favored 'General case' 0 CA--C 1.55 0.974 0 C-N-CA 124.296 1.038 . . . . 74.109999999999999 110.478 179.568 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 68.57 38.15 85.98 Favored Glycine 0 C--N 1.352 1.456 0 CA-C-N 116.103 -0.499 . . . . 73.030000000000001 114.227 177.466 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 46' ' ' PHE . . . . . 0.474 ' HE2' ' HA ' ' A' ' 78' ' ' ILE . 23.0 m-85 -117.49 -48.55 2.59 Favored 'General case' 0 N--CA 1.489 1.476 0 CA-C-N 117.432 0.616 . . . . 63.340000000000003 110.654 -179.246 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 48.14 61.51 4.88 Favored Glycine 0 C--N 1.356 1.672 0 O-C-N 124.415 1.072 . . . . 65.319999999999993 114.51 167.823 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 48' ' ' TYR . . . . . 0.418 ' HE2' HD22 ' A' ' 39' ' ' LEU . 64.0 m-85 -65.47 92.94 0.14 Allowed 'General case' 0 N--CA 1.477 0.903 0 CA-C-O 121.693 0.759 . . . . 75.150000000000006 112.339 -174.417 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 49' ' ' LYS . . . . . 0.558 ' HZ3' ' HB2' ' A' ' 49' ' ' LYS . 0.0 OUTLIER -105.77 135.78 46.59 Favored 'General case' 0 C--O 1.236 0.37 0 CA-C-N 114.006 -1.452 . . . . 63.009999999999998 108.658 175.238 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 78.34 21.59 69.65 Favored Glycine 0 C--N 1.341 0.853 0 CA-C-O 119.838 -0.423 . . . . 55.32 113.417 177.445 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 16.2 m -57.37 115.34 2.65 Favored 'General case' 0 N--CA 1.474 0.733 0 C-N-CA 123.586 0.754 . . . . 53.240000000000002 110.358 179.051 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 52' ' ' CYS . . . . . . . . . . . . . 23.8 p -81.36 114.55 20.2 Favored 'General case' 0 CA--C 1.538 0.5 0 C-N-CA 124.513 1.125 . . . . 71.340000000000003 111.459 -172.992 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 53' ' ' PHE . . . . . 0.718 ' HA ' ' HA2' ' A' ' 64' ' ' GLY . 38.6 m-85 -66.07 93.23 0.19 Allowed 'General case' 0 CA--C 1.539 0.539 0 C-N-CA 123.896 0.878 . . . . 74.409999999999997 108.784 164.715 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 17.0 p-80 -108.5 -0.34 20.49 Favored 'General case' 0 N--CA 1.479 0.977 0 CA-C-N 115.383 -0.826 . . . . 73.140000000000001 111.536 -176.498 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 55' ' ' ARG . . . . . 0.464 ' O ' ' HB3' ' A' ' 63' ' ' GLN . 53.2 ttt-85 -138.16 99.66 3.93 Favored 'General case' 0 C--O 1.21 -0.986 0 N-CA-C 109.228 -0.656 . . . . 50.109999999999999 109.228 173.796 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 56' ' ' ILE . . . . . 0.442 HG21 ' HA ' ' A' ' 143' ' ' GLU . 51.1 mt -131.33 134.35 61.11 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.935 0 N-CA-C 109.6 -0.519 . . . . 53.43 109.6 175.911 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 57' ' ' ILE . . . . . 0.415 HG23 ' HA ' ' A' ' 148' ' ' ARG . 63.0 mt -128.82 113.38 18.96 Favored Pre-proline 0 CA--C 1.553 1.08 0 C-N-CA 124.694 1.197 . . . . 61.409999999999997 108.726 177.975 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 58' ' ' PRO . . . . . 0.556 ' HA ' ' HG2' ' A' ' 143' ' ' GLU . 41.4 Cg_endo -64.77 143.64 81.02 Favored 'Trans proline' 0 C--N 1.386 2.523 0 C-N-CA 123.415 2.743 . . . . 73.019999999999996 112.158 -177.322 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 72.36 27.47 69.73 Favored Glycine 0 C--N 1.344 1.013 0 CA-C-N 115.713 -0.676 . . . . 50.100000000000001 112.304 -176.888 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 20.5 t80 -153.59 -77.38 0.11 Allowed 'General case' 0 CA--C 1.543 0.685 0 C-N-CA 123.579 0.752 . . . . 75.030000000000001 109.644 -178.472 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 61' ' ' MET . . . . . 0.761 ' SD ' ' HB2' ' A' ' 113' ' ' PHE . 13.3 tmm? -167.86 137.75 2.67 Favored 'General case' 0 CA--C 1.548 0.88 0 C-N-CA 122.807 0.443 . . . . 72.120000000000005 111.585 -164.018 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 62' ' ' CYS . . . . . . . . . . . . . 4.3 p -106.94 113.56 27.12 Favored 'General case' 0 CA--C 1.552 1.057 0 C-N-CA 124.78 1.232 . . . . 63.409999999999997 109.923 172.343 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 63' ' ' GLN . . . . . 0.586 ' HB2' ' SD ' ' A' ' 61' ' ' MET . 49.2 tt0 -107.99 121.66 45.24 Favored 'General case' 0 N--CA 1.487 1.382 0 C-N-CA 124.155 0.982 . . . . 74.099999999999994 111.138 -174.65 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 64' ' ' GLY . . . . . 0.718 ' HA2' ' HA ' ' A' ' 53' ' ' PHE . . . -97.55 170.88 25.91 Favored Glycine 0 C--N 1.34 0.796 0 CA-C-N 114.721 -1.127 . . . . 73.310000000000002 112.0 172.755 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 176.7 179.43 47.11 Favored Glycine 0 C--O 1.224 -0.524 0 N-CA-C 111.77 -0.532 . . . . 74.219999999999999 111.77 178.704 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 6.9 t0 -102.73 151.75 22.03 Favored 'General case' 0 CA--C 1.546 0.803 0 C-N-CA 124.385 1.074 . . . . 72.5 110.434 -173.901 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 68.6 t80 -82.25 -30.28 30.81 Favored 'General case' 0 N--CA 1.478 0.929 0 C-N-CA 124.727 1.211 . . . . 72.340000000000003 110.46 -178.404 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 68' ' ' THR . . . . . 0.684 HG22 ' HG3' ' A' ' 69' ' ' ARG . 6.9 m -74.89 143.06 43.97 Favored 'General case' 0 CA--C 1.549 0.929 0 C-N-CA 123.661 0.784 . . . . 61.43 109.49 177.118 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 69' ' ' ARG . . . . . 0.684 ' HG3' HG22 ' A' ' 68' ' ' THR . 50.7 mtt180 60.68 26.09 15.85 Favored 'General case' 0 N--CA 1.491 1.611 0 C-N-CA 124.565 1.146 . . . . 73.150000000000006 111.798 175.627 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 20.3 t-80 -58.83 -40.59 84.63 Favored 'General case' 0 N--CA 1.474 0.742 0 C-N-CA 124.624 1.17 . . . . 54.310000000000002 113.241 -165.777 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 43.3 m-80 -67.35 103.81 1.36 Allowed 'General case' 0 N--CA 1.474 0.76 0 C-N-CA 122.785 0.434 . . . . 75.219999999999999 110.004 177.747 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 89.28 -7.93 80.97 Favored Glycine 0 CA--C 1.531 1.09 0 CA-C-N 115.643 -0.708 . . . . 31.109999999999999 114.602 173.869 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 18.3 m -144.48 -88.66 0.11 Allowed 'General case' 0 CA--C 1.556 1.211 0 CA-C-N 117.891 0.845 . . . . 74.5 110.297 -178.83 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 65.66 61.64 5.44 Favored Glycine 0 C--N 1.362 1.973 0 CA-C-O 119.593 -0.559 . . . . 65.140000000000001 113.718 176.999 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 121.22 51.96 0.24 Allowed Glycine 0 N--CA 1.479 1.508 0 CA-C-N 117.841 0.82 . . . . 43.329999999999998 111.736 -174.0 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 76' ' ' LYS . . . . . 0.432 ' HB2' ' O ' ' A' ' 80' ' ' GLY . 64.0 pttt -60.91 168.93 2.13 Favored 'General case' 0 CA--C 1.548 0.867 0 C-N-CA 123.799 0.84 . . . . 73.140000000000001 112.498 -175.518 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 80.9 p -91.23 176.16 6.68 Favored 'General case' 0 CA--C 1.542 0.639 0 CA-C-N 115.033 -0.985 . . . . 62.100000000000001 110.605 -177.671 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 78' ' ' ILE . . . . . 0.514 ' HB ' ' HG3' ' A' ' 44' ' ' LYS . 26.0 pt -74.5 -18.61 16.78 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.547 0 CA-C-N 115.939 -0.573 . . . . 75.450000000000003 110.026 172.145 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 55.0 m-85 -89.4 11.39 19.34 Favored 'General case' 0 CA--C 1.544 0.724 0 C-N-CA 124.764 1.225 . . . . 71.319999999999993 110.855 179.058 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 80' ' ' GLY . . . . . 0.432 ' O ' ' HB2' ' A' ' 76' ' ' LYS . . . 109.63 -133.8 11.84 Favored Glycine 0 C--N 1.351 1.396 0 N-CA-C 110.831 -0.908 . . . . 72.409999999999997 110.831 -179.82 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 35.9 tt0 -65.13 -41.11 95.13 Favored 'General case' 0 N--CA 1.478 0.934 0 C-N-CA 123.88 0.872 . . . . 65.030000000000001 111.114 -179.326 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 82' ' ' LYS . . . . . 0.727 ' HD2' ' HA ' ' A' ' 107' ' ' THR . 21.0 pttp -169.49 178.36 4.25 Favored 'General case' 0 CA--C 1.545 0.776 0 CA-C-N 115.065 -0.97 . . . . 75.25 109.836 -165.777 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 26.2 p90 -158.16 171.73 19.69 Favored 'General case' 0 N--CA 1.475 0.809 0 C-N-CA 123.479 0.712 . . . . 74.109999999999999 110.191 174.339 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 12.2 pt-20 -94.18 162.66 13.77 Favored 'General case' 0 N--CA 1.476 0.86 0 C-N-CA 123.204 0.602 . . . . 74.530000000000001 109.834 175.796 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 65.1 m-20 -68.45 148.23 50.92 Favored 'General case' 0 N--CA 1.475 0.815 0 C-N-CA 123.871 0.868 . . . . 74.540000000000006 112.562 -172.345 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 86' ' ' GLU . . . . . 0.561 ' HG2' ' HA ' ' A' ' 29' ' ' VAL . 5.2 tp10 -73.96 -62.99 1.31 Allowed 'General case' 0 CA--C 1.544 0.728 0 CA-C-N 115.447 -0.797 . . . . 74.109999999999999 110.097 179.083 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 25.5 p30 -175.05 150.54 1.21 Allowed 'General case' 0 N--CA 1.483 1.185 0 C-N-CA 124.338 1.055 . . . . 60.43 109.801 -177.518 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 91.5 m-85 -90.06 57.51 3.81 Favored 'General case' 0 N--CA 1.483 1.205 0 C-N-CA 123.783 0.833 . . . . 63.219999999999999 111.182 -171.248 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 72.8 mt -82.24 -53.8 11.06 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.76 0 CA-C-N 115.684 -0.689 . . . . 54.399999999999999 109.393 175.394 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 90' ' ' LEU . . . . . 0.536 HD11 ' HB2' ' A' ' 25' ' ' PHE . 87.0 mt -84.11 109.92 18.08 Favored 'General case' 0 CA--C 1.541 0.613 0 CA-C-N 115.197 -0.91 . . . . 72.409999999999997 110.84 -178.384 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 18.3 ptpt -102.27 171.29 7.56 Favored 'General case' 0 N--CA 1.473 0.685 0 C-N-CA 124.385 1.074 . . . . 64.540000000000006 109.884 175.566 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 92' ' ' HIS . . . . . . . . . . . . . 39.2 m80 -89.75 48.33 1.58 Allowed 'General case' 0 CA--C 1.551 1.009 0 C-N-CA 124.269 1.028 . . . . 75.439999999999998 110.266 -175.06 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 12.0 t -91.95 -16.3 26.79 Favored 'General case' 0 N--CA 1.481 1.102 0 C-N-CA 123.46 0.704 . . . . 71.230000000000004 111.108 -179.331 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -104.97 157.32 16.59 Favored Glycine 0 C--N 1.343 0.959 0 CA-C-O 119.603 -0.554 . . . . 64.319999999999993 112.245 178.51 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 71.9 Cg_endo -80.87 150.74 18.51 Favored 'Trans proline' 0 C--N 1.363 1.303 0 C-N-CA 122.505 2.137 . . . . 64.010000000000005 111.421 169.359 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 96' ' ' GLY . . . . . 0.431 ' HA3' HG12 ' A' ' 132' ' ' VAL . . . 84.22 22.89 53.49 Favored Glycine 0 C--N 1.344 0.992 0 N-CA-C 114.114 0.406 . . . . 63.340000000000003 114.114 176.993 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 97' ' ' ILE . . . . . . . . . . . . . 14.7 mm -63.0 115.71 2.37 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.897 0 C-N-CA 124.603 1.161 . . . . 75.219999999999999 112.093 -174.746 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 59.1 tp -97.8 114.22 26.2 Favored 'General case' 0 C--O 1.249 1.062 0 CA-C-O 121.77 0.795 . . . . 71.140000000000001 109.829 175.641 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 32.8 t -142.9 143.22 31.95 Favored 'General case' 0 CA--C 1.545 0.767 0 C-N-CA 124.771 1.229 . . . . 70.510000000000005 107.955 179.058 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 100' ' ' MET . . . . . 0.72 ' HA ' ' HA ' ' A' ' 112' ' ' PHE . 81.1 mtp -84.55 142.01 30.31 Favored 'General case' 0 N--CA 1.492 1.643 0 CA-C-N 118.496 0.589 . . . . 73.349999999999994 111.063 -176.329 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 101' ' ' ALA . . . . . 0.582 ' HB3' ' HB2' ' A' ' 111' ' ' GLN . . . -73.4 171.38 13.2 Favored 'General case' 0 N--CA 1.484 1.254 0 CA-C-O 121.102 0.477 . . . . 64.430000000000007 111.874 -171.504 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 102' ' ' ASN . . . . . 0.466 ' HB3' ' HA ' ' A' ' 108' ' ' ASN . 30.1 p-10 -168.39 167.25 12.01 Favored 'General case' 0 N--CA 1.472 0.67 0 CA-C-N 115.536 -0.757 . . . . 72.349999999999994 111.234 -173.499 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -105.89 6.21 31.3 Favored 'General case' 0 N--CA 1.477 0.908 0 C-N-CA 124.147 0.979 . . . . 62.32 110.544 169.182 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 152.91 -174.87 31.62 Favored Glycine 0 C--N 1.354 1.528 0 CA-C-O 119.244 -0.753 . . . . 50.329999999999998 112.167 179.665 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 44.0 Cg_exo -59.14 148.02 87.7 Favored 'Trans proline' 0 C--N 1.373 1.816 0 C-N-CA 123.041 2.494 . . . . 70.209999999999994 111.932 173.064 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 66.3 t30 68.01 9.55 7.23 Favored 'General case' 0 N--CA 1.483 1.212 0 C-N-CA 124.943 1.297 . . . . 64.519999999999996 111.128 -177.129 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 107' ' ' THR . . . . . 0.727 ' HA ' ' HD2' ' A' ' 82' ' ' LYS . 5.0 m -121.65 1.61 10.03 Favored 'General case' 0 CA--C 1.55 0.974 0 C-N-CA 123.857 0.863 . . . . 64.310000000000002 110.545 -178.907 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 108' ' ' ASN . . . . . 0.466 ' HA ' ' HB3' ' A' ' 102' ' ' ASN . 43.7 t30 -69.29 132.84 47.09 Favored 'General case' 0 N--CA 1.478 0.951 0 C-N-CA 123.72 0.808 . . . . 72.0 109.673 179.976 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 112.57 15.12 9.76 Favored Glycine 0 N--CA 1.472 1.076 0 N-CA-C 114.045 0.378 . . . . 43.439999999999998 114.045 -179.371 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 32.1 p -112.63 119.44 38.12 Favored 'General case' 0 CA--C 1.543 0.687 0 N-CA-C 107.626 -1.25 . . . . 73.329999999999998 107.626 167.78 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 111' ' ' GLN . . . . . 0.582 ' HB2' ' HB3' ' A' ' 101' ' ' ALA . 40.0 mt-30 66.18 178.18 0.21 Allowed 'General case' 0 N--CA 1.497 1.898 0 C-N-CA 124.458 1.103 . . . . 74.150000000000006 111.112 -169.741 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 112' ' ' PHE . . . . . 0.72 ' HA ' ' HA ' ' A' ' 100' ' ' MET . 45.1 p90 -145.54 154.2 41.92 Favored 'General case' 0 N--CA 1.48 1.057 0 C-N-CA 123.675 0.79 . . . . 72.019999999999996 108.951 177.959 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 113' ' ' PHE . . . . . 0.761 ' HB2' ' SD ' ' A' ' 61' ' ' MET . 51.4 p90 -144.65 154.61 42.97 Favored 'General case' 0 C--O 1.238 0.471 0 CA-C-O 120.823 0.344 . . . . 63.130000000000003 111.626 179.306 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 114' ' ' ILE . . . . . . . . . . . . . 5.7 mt -130.3 101.59 6.03 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.724 0 C-N-CA 124.077 0.951 . . . . 65.409999999999997 108.769 -174.236 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 115' ' ' CYS . . . . . . . . . . . . . 63.2 m -80.4 104.96 11.3 Favored 'General case' 0 N--CA 1.47 0.549 0 C-N-CA 123.507 0.723 . . . . 72.120000000000005 109.709 178.101 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 81.7 p -69.08 -27.62 65.78 Favored 'General case' 0 N--CA 1.488 1.434 0 CA-C-O 121.161 0.505 . . . . 64.239999999999995 111.257 -178.63 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -97.75 151.23 20.38 Favored 'General case' 0 C--O 1.24 0.591 0 CA-C-N 115.212 -0.903 . . . . 61.030000000000001 108.678 172.997 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 11.5 ptmm? -71.82 86.85 0.97 Allowed 'General case' 0 CA--C 1.552 1.029 0 CA-C-O 121.645 0.736 . . . . 72.439999999999998 109.396 174.325 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 119' ' ' THR . . . . . . . . . . . . . 40.6 p -76.21 86.7 3.04 Favored 'General case' 0 CA--C 1.543 0.678 0 CA-C-N 115.028 -0.987 . . . . 73.099999999999994 110.872 -172.607 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 12.4 pt-20 -65.24 -31.39 72.52 Favored 'General case' 0 CA--C 1.542 0.668 0 CA-C-N 114.545 -1.207 . . . . 74.540000000000006 111.866 -172.108 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 121' ' ' TRP . . . . . . . . . . . . . 42.6 p90 -70.83 -14.51 62.44 Favored 'General case' 0 N--CA 1.475 0.791 0 C-N-CA 123.543 0.737 . . . . 71.299999999999997 111.793 -178.794 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 42.7 mt -87.9 5.46 40.37 Favored 'General case' 0 N--CA 1.481 1.103 0 C-N-CA 122.828 0.451 . . . . 74.519999999999996 111.873 176.405 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 69.1 m-20 -80.39 140.33 36.09 Favored 'General case' 0 N--CA 1.482 1.144 0 C-N-CA 122.642 0.377 . . . . 61.009999999999998 110.451 172.275 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 94.35 -10.9 71.01 Favored Glycine 0 C--N 1.347 1.175 0 CA-C-N 115.602 -0.727 . . . . 71.109999999999999 112.183 -169.281 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 1.7 mppt? -94.6 -168.26 1.8 Allowed 'General case' 0 N--CA 1.472 0.662 0 C-N-CA 124.476 1.11 . . . . 71.010000000000005 109.535 173.722 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 126' ' ' HIS . . . . . . . . . . . . . 17.6 p80 -66.58 154.53 40.21 Favored 'General case' 0 CA--C 1.551 0.981 0 C-N-CA 124.179 0.991 . . . . 64.310000000000002 111.237 -172.146 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 17.6 m -78.81 147.54 6.76 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.813 0 CA-C-N 115.176 -0.92 . . . . 72.030000000000001 113.018 -163.262 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 128' ' ' VAL . . . . . 0.469 ' HB ' ' HB3' ' A' ' 90' ' ' LEU . 48.2 t -80.41 152.89 4.44 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.634 0 CA-C-N 114.159 -1.382 . . . . 52.329999999999998 108.537 172.576 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 129' ' ' PHE . . . . . 0.586 ' HA ' HG21 ' A' ' 29' ' ' VAL . 50.4 p90 -130.74 -15.81 3.42 Favored 'General case' 0 N--CA 1.482 1.173 0 N-CA-C 112.184 0.439 . . . . 73.409999999999997 112.184 179.187 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . -155.85 175.65 33.59 Favored Glycine 0 C--N 1.334 0.445 0 N-CA-C 112.109 -0.396 . . . . 53.130000000000003 112.109 -177.548 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 33.2 ttpt -156.23 140.51 16.6 Favored 'General case' 0 C--N 1.324 -0.519 0 N-CA-C 108.246 -1.02 . . . . 73.409999999999997 108.246 177.265 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 132' ' ' VAL . . . . . 0.549 ' HA ' ' HA ' ' A' ' 22' ' ' PHE . 6.7 p -61.1 134.23 26.57 Favored 'Isoleucine or valine' 0 CA--C 1.552 1.042 0 O-C-N 123.423 0.452 . . . . 73.040000000000006 111.279 177.336 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 133' ' ' LYS . . . . . 0.649 ' HD2' ' HB2' ' A' ' 23' ' ' GLU . 19.1 ptmt -111.52 -37.21 5.29 Favored 'General case' 0 N--CA 1.475 0.802 0 C-N-CA 123.472 0.709 . . . . 75.420000000000002 109.803 173.702 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 134' ' ' GLU . . . . . 0.546 ' HG2' ' HG3' ' A' ' 133' ' ' LYS . 40.9 mm-40 -119.91 133.94 55.4 Favored 'General case' 0 N--CA 1.48 1.06 0 C-N-CA 123.93 0.892 . . . . 53.109999999999999 109.728 -179.723 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 81.54 29.54 39.45 Favored Glycine 0 C--N 1.341 0.856 0 O-C-N 123.307 0.379 . . . . 61.340000000000003 113.421 176.965 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 136' ' ' MET . . . . . . . . . . . . . 15.8 tpt -59.43 -43.79 93.04 Favored 'General case' 0 N--CA 1.476 0.855 0 C-N-CA 123.487 0.715 . . . . 70.230000000000004 110.696 176.449 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 137' ' ' ASN . . . . . . . . . . . . . 17.0 m120 -63.55 -28.93 70.28 Favored 'General case' 0 N--CA 1.475 0.804 0 C-N-CA 123.607 0.763 . . . . 73.299999999999997 111.457 179.099 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 138' ' ' ILE . . . . . . . . . . . . . 43.4 mm -71.26 -39.03 72.28 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.119 0 C-N-CA 123.292 0.637 . . . . 62.119999999999997 110.255 176.316 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 50.8 t -64.12 -44.61 97.66 Favored 'Isoleucine or valine' 0 CA--C 1.552 1.054 0 C-N-CA 123.406 0.682 . . . . 74.430000000000007 110.189 177.982 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 43.5 mt-10 -67.99 -35.76 78.87 Favored 'General case' 0 N--CA 1.477 0.916 0 CA-C-N 115.149 -0.932 . . . . 74.450000000000003 110.908 178.956 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -68.4 -43.13 77.92 Favored 'General case' 0 N--CA 1.477 0.9 0 C-N-CA 123.479 0.712 . . . . 71.409999999999997 111.141 179.248 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 142' ' ' MET . . . . . 0.603 ' HB2' HD13 ' A' ' 156' ' ' ILE . 23.0 ptt? -73.68 -28.77 61.92 Favored 'General case' 0 N--CA 1.475 0.818 0 O-C-N 123.637 0.585 . . . . 75.409999999999997 110.793 -177.537 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 143' ' ' GLU . . . . . 0.556 ' HG2' ' HA ' ' A' ' 58' ' ' PRO . 33.0 tt0 -64.14 -28.93 70.1 Favored 'General case' 0 CA--C 1.553 1.083 0 CA-C-O 121.159 0.504 . . . . 62.240000000000002 111.555 -179.83 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 144' ' ' ARG . . . . . . . . . . . . . 48.1 mtm180 -70.67 -15.47 62.72 Favored 'General case' 0 N--CA 1.476 0.861 0 C-N-CA 123.191 0.596 . . . . 74.209999999999994 112.118 -179.957 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 145' ' ' PHE . . . . . 0.513 ' HB2' HD11 ' A' ' 156' ' ' ILE . 75.9 m-85 -82.87 -2.77 55.71 Favored 'General case' 0 N--CA 1.482 1.169 0 C-N-CA 122.592 0.357 . . . . 74.549999999999997 111.852 176.373 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . -95.42 -179.73 36.51 Favored Glycine 0 C--N 1.353 1.501 0 N-CA-C 112.331 -0.307 . . . . 45.130000000000003 112.331 176.193 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 16.5 m -132.58 169.44 16.6 Favored 'General case' 0 N--CA 1.487 1.376 0 C-N-CA 123.663 0.785 . . . . 74.519999999999996 110.842 -176.512 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 148' ' ' ARG . . . . . 0.415 ' HA ' HG23 ' A' ' 57' ' ' ILE . 10.6 mmt180 -65.65 -28.26 68.97 Favored 'General case' 0 N--CA 1.485 1.323 0 C-N-CA 123.926 0.891 . . . . 74.519999999999996 112.641 -174.255 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 149' ' ' ASN . . . . . . . . . . . . . 29.5 p-10 -81.88 -17.0 48.81 Favored 'General case' 0 N--CA 1.486 1.326 0 C-N-CA 123.444 0.698 . . . . 73.420000000000002 111.542 178.202 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 150' ' ' GLY . . . . . 0.441 ' O ' ' HA ' ' A' ' 55' ' ' ARG . . . 112.63 -17.01 23.55 Favored Glycine 0 C--N 1.348 1.205 0 CA-C-N 116.383 -0.371 . . . . 71.409999999999997 112.887 -178.831 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 62.7 tttp -67.21 133.98 50.8 Favored 'General case' 0 N--CA 1.473 0.695 0 CA-C-N 117.312 0.556 . . . . 70.310000000000002 110.603 -178.068 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 152' ' ' THR . . . . . . . . . . . . . 39.9 p -92.26 123.39 35.56 Favored 'General case' 0 CA--C 1.539 0.541 0 C-N-CA 123.301 0.64 . . . . 73.219999999999999 109.823 177.103 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 153' ' ' SER . . . . . . . . . . . . . 43.7 t -63.98 -36.22 83.28 Favored 'General case' 0 N--CA 1.475 0.813 0 C-N-CA 123.586 0.754 . . . . 74.109999999999999 110.176 174.148 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 45.4 mmtm -120.66 136.81 54.73 Favored 'General case' 0 N--CA 1.47 0.547 0 C-N-CA 124.205 1.002 . . . . 75.230000000000004 108.937 -179.046 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 33.4 mmtp -83.1 91.39 7.2 Favored 'General case' 0 N--CA 1.477 0.903 0 CA-C-O 121.513 0.673 . . . . 74.310000000000002 110.223 -174.568 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 156' ' ' ILE . . . . . 0.603 HD13 ' HB2' ' A' ' 142' ' ' MET . 68.2 mt -85.49 130.41 36.33 Favored 'Isoleucine or valine' 0 C--O 1.221 -0.397 0 CA-C-N 114.84 -1.073 . . . . 63.25 108.487 -178.349 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 157' ' ' THR . . . . . . . . . . . . . 35.9 p -138.68 156.4 47.44 Favored 'General case' 0 C--O 1.24 0.563 0 C-N-CA 124.444 1.098 . . . . 73.230000000000004 109.282 -175.536 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 158' ' ' ILE . . . . . 0.427 HG23 ' HB3' ' A' ' 8' ' ' PHE . 42.6 mt -74.43 95.26 0.86 Allowed 'Isoleucine or valine' 0 N--CA 1.475 0.822 0 N-CA-C 109.0 -0.741 . . . . 73.510000000000005 109.0 171.939 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 159' ' ' ALA . . . . . 0.792 ' HB2' ' HB2' ' A' ' 11' ' ' ALA . . . -51.7 -48.25 63.6 Favored 'General case' 0 N--CA 1.483 1.216 0 C-N-CA 124.585 1.154 . . . . 43.130000000000003 112.267 179.71 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 160' ' ' ASP . . . . . . . . . . . . . 35.6 t0 -154.23 162.11 41.39 Favored 'General case' 0 CA--C 1.54 0.567 0 CA-C-N 115.83 -0.623 . . . . 73.5 110.284 -175.639 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 161' ' ' CYS . . . . . . . . . . . . . 27.6 p -136.53 -173.79 3.52 Favored 'General case' 0 N--CA 1.476 0.86 0 C-N-CA 124.274 1.03 . . . . 73.219999999999999 108.538 175.763 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 162' ' ' GLY . . . . . . . . . . . . . . . 131.08 55.24 0.09 OUTLIER Glycine 0 C--N 1.346 1.131 0 N-CA-C 111.007 -0.837 . . . . 52.450000000000003 111.007 -166.999 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 163' ' ' GLN . . . . . 0.552 ' HB2' ' HA ' ' A' ' 6' ' ' VAL . 13.8 pt20 -47.25 142.92 3.58 Favored 'General case' 0 CA--C 1.554 1.117 0 C-N-CA 125.056 1.342 . . . . 64.019999999999996 114.13 -170.956 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 164' ' ' LEU . . . . . 0.408 ' O ' ' HB ' ' A' ' 5' ' ' THR . 95.9 mt . . . . . 0 N--CA 1.477 0.876 0 C-N-CA 123.729 0.811 . . . . 74.430000000000007 111.034 -172.237 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 218' ' ' PRO . . . . . 0.428 ' HB2' ' NE2' ' A' ' 111' ' ' GLN . 3.9 Cg_exo . . . . . 0 CA--C 1.547 1.16 0 N-CA-C 110.678 -0.547 . . . . 62.340000000000003 110.678 . . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 219' ' ' GLY . . . . . . . . . . . . . . . -178.88 164.87 33.51 Favored Glycine 0 CA--C 1.53 1.031 0 CA-C-N 114.765 -1.107 . . . . 70.409999999999997 111.435 -178.736 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 220' ' ' PRO . . . . . . . . . . . . . 62.0 Cg_endo -80.57 160.81 22.19 Favored 'Trans proline' 0 C--N 1.371 1.738 0 C-N-CA 123.09 2.527 . . . . 71.010000000000005 113.416 -178.043 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 221' ' ' TYR . . . . . . . . . . . . . 56.6 m-85 . . . . . 0 N--CA 1.486 1.348 0 C-N-CA 123.991 0.917 . . . . 73.430000000000007 111.106 -179.71 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 3' ' ' ASN . . . . . 0.587 ' ND2' ' HA ' ' A' ' 25' ' ' PHE . 31.0 m120 . . . . . 0 CA--C 1.545 0.786 0 CA-C-O 119.565 -0.255 . . . . 75.25 111.088 . . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 4' ' ' PRO . . . . . 0.498 ' HG2' ' HB2' ' A' ' 24' ' ' LEU . 33.2 Cg_endo -63.63 119.53 6.62 Favored 'Trans proline' 0 C--N 1.38 2.219 0 C-N-CA 122.63 2.22 . . . . 61.219999999999999 112.043 176.368 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 5' ' ' THR . . . . . 0.601 HG23 ' HD3' ' A' ' 133' ' ' LYS . 61.1 m -97.42 110.71 23.22 Favored 'General case' 0 CA--C 1.539 0.556 0 C-N-CA 123.748 0.819 . . . . 65.239999999999995 108.807 178.703 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 10.0 m -97.83 123.31 50.21 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.155 0 N-CA-C 109.252 -0.647 . . . . 64.310000000000002 109.252 -175.588 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 7' ' ' PHE . . . . . 0.45 ' H ' ' HA ' ' A' ' 163' ' ' GLN . 82.3 t80 -103.82 142.39 34.46 Favored 'General case' 0 C--O 1.236 0.368 0 CA-C-N 115.706 -0.679 . . . . 63.119999999999997 109.946 -171.44 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 8' ' ' PHE . . . . . 0.429 ' HB3' HG23 ' A' ' 158' ' ' ILE . 72.5 m-85 -140.85 164.46 30.17 Favored 'General case' 0 C--O 1.239 0.508 0 C-N-CA 124.235 1.014 . . . . 75.409999999999997 109.494 174.535 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 24.5 m-20 -118.52 113.21 20.96 Favored 'General case' 0 N--CA 1.469 0.488 0 N-CA-C 107.134 -1.432 . . . . 54.140000000000001 107.134 168.551 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 37.8 mm -91.19 143.87 10.34 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.678 0 C-N-CA 123.137 0.575 . . . . 65.299999999999997 109.639 -175.965 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 11' ' ' ALA . . . . . 0.407 ' HB2' ' HB2' ' A' ' 159' ' ' ALA . . . -132.73 143.57 49.69 Favored 'General case' 0 CA--C 1.537 0.461 0 C-N-CA 123.831 0.852 . . . . 74.439999999999998 111.634 -167.624 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 12' ' ' VAL . . . . . 0.54 HG23 ' HB2' ' A' ' 17' ' ' LEU . 24.3 t -98.51 107.17 19.9 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.642 0 N-CA-C 108.256 -1.016 . . . . 73.230000000000004 108.256 172.439 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 27.5 m-20 62.03 32.01 17.77 Favored 'General case' 0 N--CA 1.488 1.461 0 C-N-CA 124.508 1.123 . . . . 74.310000000000002 111.78 179.338 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 99.27 -26.71 23.25 Favored Glycine 0 C--N 1.346 1.127 0 CA-C-N 115.424 -0.807 . . . . 63.229999999999997 112.87 -178.653 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 17.7 mm-40 -82.29 114.09 48.72 Favored Pre-proline 0 CA--C 1.547 0.853 0 CA-C-O 118.657 -0.687 . . . . 72.329999999999998 110.249 -174.349 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 21.7 Cg_endo -57.8 112.03 1.02 Allowed 'Trans proline' 0 C--N 1.382 2.304 0 C-N-CA 123.468 2.779 . . . . 72.219999999999999 112.52 -173.748 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 17' ' ' LEU . . . . . 0.54 ' HB2' HG23 ' A' ' 12' ' ' VAL . 61.6 tp -80.17 -46.49 16.28 Favored 'General case' 0 N--CA 1.472 0.642 0 C-N-CA 123.652 0.781 . . . . 62.049999999999997 110.551 -179.819 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -175.26 -163.88 28.96 Favored Glycine 0 C--N 1.34 0.761 0 CA-C-N 115.543 -0.753 . . . . 65.400000000000006 112.147 -177.768 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 8.9 ptp180 -107.13 150.59 26.42 Favored 'General case' 0 N--CA 1.479 1.004 0 C-N-CA 123.354 0.662 . . . . 71.129999999999995 109.927 -178.677 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 54.9 t -143.67 123.46 8.66 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.844 0 N-CA-C 108.275 -1.009 . . . . 74.430000000000007 108.275 169.04 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 11.1 t -126.9 138.41 53.3 Favored 'General case' 0 CA--C 1.546 0.821 0 C-N-CA 123.57 0.748 . . . . 41.25 109.618 178.128 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 22' ' ' PHE . . . . . 0.426 ' CG ' HD22 ' A' ' 98' ' ' LEU . 72.8 m-85 -109.69 150.18 28.65 Favored 'General case' 0 N--CA 1.476 0.826 0 C-N-CA 123.7 0.8 . . . . 63.520000000000003 111.012 -175.078 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 23' ' ' GLU . . . . . 0.544 ' HB2' ' HD2' ' A' ' 133' ' ' LYS . 5.2 tp10 -98.06 102.65 14.46 Favored 'General case' 0 N--CA 1.473 0.692 0 C-N-CA 124.462 1.105 . . . . 62.25 108.396 173.383 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . 0.512 ' HB3' ' HB1' ' A' ' 33' ' ' ALA . 26.5 mt -87.68 117.56 26.59 Favored 'General case' 0 N--CA 1.476 0.837 0 N-CA-C 109.598 -0.519 . . . . 64.409999999999997 109.598 179.972 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 25' ' ' PHE . . . . . 0.587 ' HA ' ' ND2' ' A' ' 3' ' ' ASN . 77.1 m-85 -86.45 65.35 9.01 Favored 'General case' 0 CA--C 1.539 0.533 0 CA-C-O 121.371 0.605 . . . . 74.450000000000003 110.701 -175.383 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -72.81 -4.99 35.02 Favored 'General case' 0 N--CA 1.481 1.11 0 C-N-CA 123.946 0.898 . . . . 75.0 112.961 -175.502 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 12.4 p-10 -78.58 -29.92 46.42 Favored 'General case' 0 N--CA 1.478 0.952 0 C-N-CA 123.049 0.54 . . . . 73.329999999999998 110.061 172.926 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 93.3 mttt -96.42 -42.26 8.2 Favored 'General case' 0 N--CA 1.474 0.752 0 C-N-CA 124.099 0.959 . . . . 53.420000000000002 110.34 -179.015 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 29' ' ' VAL . . . . . 0.549 HG21 ' HA ' ' A' ' 129' ' ' PHE . 4.1 m -126.85 76.19 75.45 Favored Pre-proline 0 CA--C 1.558 1.271 0 C-N-CA 123.887 0.875 . . . . 75.510000000000005 110.663 178.302 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 81.7 Cg_exo -49.09 -52.57 8.49 Favored 'Trans proline' 0 C--N 1.381 2.244 0 C-N-CA 123.388 2.725 . . . . 51.420000000000002 113.967 176.103 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 85.0 tttt -67.62 -54.48 19.4 Favored 'General case' 0 N--CA 1.478 0.929 0 C-N-CA 123.588 0.755 . . . . 74.420000000000002 111.66 -174.194 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 7.0 m -69.08 -33.12 73.04 Favored 'General case' 0 CA--C 1.551 0.983 0 C-N-CA 123.022 0.529 . . . . 41.109999999999999 111.642 -170.499 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 33' ' ' ALA . . . . . 0.512 ' HB1' ' HB3' ' A' ' 24' ' ' LEU . . . -79.58 -40.24 29.86 Favored 'General case' 0 CA--C 1.547 0.836 0 C-N-CA 122.619 0.367 . . . . 64.530000000000001 111.19 178.303 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 39.0 tt0 -59.86 -35.46 74.84 Favored 'General case' 0 N--CA 1.486 1.369 0 C-N-CA 123.324 0.65 . . . . 75.129999999999995 111.052 178.128 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 35' ' ' ASN . . . . . 0.516 ' ND2' ' SD ' ' A' ' 100' ' ' MET . 43.9 t30 -53.16 -65.87 0.49 Allowed 'General case' 0 C--N 1.35 0.618 0 O-C-N 124.552 1.157 . . . . 73.329999999999998 110.989 179.74 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 85.8 t80 -62.37 -34.03 75.89 Favored 'General case' 0 CA--C 1.542 0.649 0 O-C-N 124.332 1.02 . . . . 65.129999999999995 111.106 -177.008 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 37' ' ' ARG . . . . . 0.423 ' HG3' ' OE1' ' A' ' 163' ' ' GLN . 48.9 ttp180 -59.94 -45.88 91.19 Favored 'General case' 0 N--CA 1.473 0.676 0 O-C-N 123.926 0.766 . . . . 73.310000000000002 111.374 175.277 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 38' ' ' ALA . . . . . 0.411 ' HB1' ' HG2' ' A' ' 44' ' ' LYS . . . -81.77 -18.84 42.75 Favored 'General case' 0 CA--C 1.537 0.477 0 CA-C-N 115.668 -0.696 . . . . 74.420000000000002 111.425 -174.374 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 39' ' ' LEU . . . . . 0.481 HD22 ' HE1' ' A' ' 48' ' ' TYR . 98.5 mt -74.26 -39.88 62.72 Favored 'General case' 0 CA--C 1.547 0.844 0 C-N-CA 123.312 0.645 . . . . 65.25 109.31 170.469 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 35.1 t -64.92 -55.03 21.71 Favored 'General case' 0 N--CA 1.477 0.877 0 C-N-CA 124.596 1.159 . . . . 54.5 111.155 -179.938 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 34.8 p -76.58 -31.37 57.46 Favored 'General case' 0 CA--C 1.541 0.607 0 CA-C-N 115.382 -0.826 . . . . 51.130000000000003 111.224 -178.289 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 79.23 22.1 66.05 Favored Glycine 0 C--N 1.346 1.139 0 CA-C-O 119.614 -0.548 . . . . 64.239999999999995 113.951 176.679 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 8.7 mm-40 -63.64 -22.41 66.88 Favored 'General case' 0 N--CA 1.483 1.221 0 C-N-CA 123.368 0.667 . . . . 72.010000000000005 111.728 179.857 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 44' ' ' LYS . . . . . 0.411 ' HG2' ' HB1' ' A' ' 38' ' ' ALA . 30.6 mmmt -94.6 15.33 18.32 Favored 'General case' 0 CA--C 1.55 0.947 0 C-N-CA 124.035 0.934 . . . . 74.340000000000003 111.558 -179.962 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 76.98 36.71 35.1 Favored Glycine 0 C--N 1.35 1.335 0 N-CA-C 114.417 0.527 . . . . 75.450000000000003 114.417 174.843 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 46' ' ' PHE . . . . . 0.435 ' HE2' ' HA ' ' A' ' 78' ' ' ILE . 25.2 m-85 -122.6 -48.35 2.05 Favored 'General case' 0 N--CA 1.491 1.575 0 CA-C-N 117.758 0.779 . . . . 75.019999999999996 111.514 -177.457 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 54.18 63.83 4.82 Favored Glycine 0 C--N 1.35 1.312 0 O-C-N 124.077 0.86 . . . . 54.509999999999998 115.018 170.218 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 48' ' ' TYR . . . . . 0.688 ' HE2' ' HB2' ' A' ' 66' ' ' ASP . 54.6 m-85 -65.27 89.79 0.09 Allowed 'General case' 0 N--CA 1.481 1.118 0 CA-C-O 121.745 0.783 . . . . 75.340000000000003 111.731 179.885 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 27.6 tptp -111.23 107.0 16.16 Favored 'General case' 0 CA--C 1.535 0.377 0 CA-C-N 114.576 -1.193 . . . . 62.140000000000001 108.476 178.247 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 99.08 13.8 38.33 Favored Glycine 0 N--CA 1.471 0.999 0 CA-C-O 118.992 -0.893 . . . . 54.409999999999997 113.763 178.754 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 20.3 p -57.67 122.89 13.86 Favored 'General case' 0 N--CA 1.48 1.035 0 C-N-CA 123.414 0.686 . . . . 60.210000000000001 110.818 -178.482 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 52' ' ' CYS . . . . . . . . . . . . . 7.0 p -100.98 132.37 46.42 Favored 'General case' 0 CA--C 1.539 0.533 0 C-N-CA 123.721 0.808 . . . . 55.130000000000003 112.729 -164.058 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 53' ' ' PHE . . . . . 0.604 ' HA ' ' HA3' ' A' ' 64' ' ' GLY . 45.5 m-85 -72.04 140.22 48.9 Favored 'General case' 0 CA--C 1.54 0.559 0 C-N-CA 124.381 1.072 . . . . 73.239999999999995 110.151 168.899 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 15.8 p-80 -153.4 13.55 0.49 Allowed 'General case' 0 N--CA 1.478 0.959 0 CA-C-N 116.087 -0.506 . . . . 62.149999999999999 112.213 -173.82 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 55' ' ' ARG . . . . . 0.451 ' HA ' ' O ' ' A' ' 150' ' ' GLY . 33.4 ttt180 -155.8 98.29 1.9 Allowed 'General case' 0 N--CA 1.474 0.728 0 N-CA-C 109.732 -0.47 . . . . 74.140000000000001 109.732 174.342 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 29.3 mt -130.23 135.88 59.86 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.105 0 C-N-CA 123.053 0.541 . . . . 75.099999999999994 109.799 -178.449 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 61.7 mt -134.58 124.55 17.03 Favored Pre-proline 0 CA--C 1.553 1.072 0 C-N-CA 124.976 1.31 . . . . 74.420000000000002 109.497 -173.454 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 31.0 Cg_endo -61.31 139.74 84.59 Favored 'Trans proline' 0 C--N 1.384 2.411 0 C-N-CA 123.609 2.873 . . . . 73.439999999999998 113.573 -179.452 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 60.22 24.55 61.24 Favored Glycine 0 C--N 1.353 1.504 0 CA-C-N 115.006 -0.997 . . . . 41.109999999999999 113.872 -179.813 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 40.5 t80 -139.76 -69.55 0.41 Allowed 'General case' 0 C--O 1.241 0.651 0 CA-C-N 116.973 0.386 . . . . 72.530000000000001 110.495 -174.583 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 53.3 ttp -171.44 148.34 2.53 Favored 'General case' 0 N--CA 1.482 1.151 0 N-CA-C 111.905 0.335 . . . . 65.450000000000003 111.905 -165.464 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 62' ' ' CYS . . . . . 0.611 ' SG ' ' HB ' ' A' ' 114' ' ' ILE . 21.9 p -119.81 117.58 28.57 Favored 'General case' 0 N--CA 1.477 0.89 0 C-N-CA 123.894 0.878 . . . . 65.230000000000004 108.974 169.591 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 63' ' ' GLN . . . . . 0.442 ' OE1' ' HD3' ' A' ' 55' ' ' ARG . 35.9 tt0 -123.24 143.92 49.73 Favored 'General case' 0 N--CA 1.487 1.42 0 C-N-CA 124.166 0.986 . . . . 73.030000000000001 111.781 -170.439 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 64' ' ' GLY . . . . . 0.604 ' HA3' ' HA ' ' A' ' 53' ' ' PHE . . . -161.78 -169.58 25.3 Favored Glycine 0 C--N 1.348 1.203 0 CA-C-N 115.039 -0.982 . . . . 52.329999999999998 113.011 176.403 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 166.4 -149.84 16.25 Favored Glycine 0 C--N 1.341 0.825 0 N-CA-C 112.242 -0.343 . . . . 44.210000000000001 112.242 -179.056 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 66' ' ' ASP . . . . . 0.688 ' HB2' ' HE2' ' A' ' 48' ' ' TYR . 41.2 t0 -74.94 146.4 41.8 Favored 'General case' 0 N--CA 1.477 0.919 0 C-N-CA 124.318 1.047 . . . . 64.219999999999999 110.601 -178.825 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 51.7 t80 -79.88 -33.69 39.8 Favored 'General case' 0 CA--C 1.542 0.673 0 C-N-CA 123.663 0.785 . . . . 61.210000000000001 109.46 178.043 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 68' ' ' THR . . . . . 0.637 HG22 ' HG3' ' A' ' 69' ' ' ARG . 14.1 m -72.56 150.59 43.01 Favored 'General case' 0 CA--C 1.544 0.748 0 CA-C-N 114.961 -1.018 . . . . 63.32 109.206 173.019 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 69' ' ' ARG . . . . . 0.637 ' HG3' HG22 ' A' ' 68' ' ' THR . 65.9 mtt85 66.71 13.68 9.46 Favored 'General case' 0 N--CA 1.488 1.438 0 C-N-CA 124.033 0.933 . . . . 73.319999999999993 112.296 174.921 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 15.9 t-80 -52.59 -29.1 24.06 Favored 'General case' 0 N--CA 1.484 1.253 0 C-N-CA 125.012 1.325 . . . . 74.439999999999998 112.007 -173.724 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 5.3 m-20 -69.28 88.2 0.44 Allowed 'General case' 0 CA--C 1.548 0.887 0 C-N-CA 123.987 0.915 . . . . 62.350000000000001 110.377 172.391 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 85.46 -1.2 88.47 Favored Glycine 0 CA--C 1.533 1.16 0 N-CA-C 115.195 0.838 . . . . 13.140000000000001 115.195 172.774 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 28.5 m -139.74 -90.74 0.18 Allowed 'General case' 0 N--CA 1.478 0.943 0 CA-C-N 118.06 0.93 . . . . 53.399999999999999 110.019 176.02 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 74' ' ' GLY . . . . . 0.464 ' HA2' ' O ' ' A' ' 68' ' ' THR . . . 61.32 60.65 7.93 Favored Glycine 0 C--N 1.356 1.668 0 O-C-N 123.577 0.548 . . . . 24.239999999999998 113.277 -176.905 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 141.36 52.19 0.04 OUTLIER Glycine 0 C--N 1.353 1.518 0 C-N-CA 121.101 -0.571 . . . . 73.219999999999999 113.055 -176.502 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 63.6 pttt -56.8 158.9 4.34 Favored 'General case' 0 N--CA 1.487 1.377 0 C-N-CA 123.406 0.682 . . . . 72.099999999999994 111.896 -179.881 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 71.8 p -98.29 -179.21 4.29 Favored 'General case' 0 CA--C 1.544 0.729 0 C-N-CA 123.338 0.655 . . . . 74.519999999999996 110.92 -176.214 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 78' ' ' ILE . . . . . 0.435 ' HA ' ' HE2' ' A' ' 46' ' ' PHE . 25.4 pt -84.96 -8.18 11.12 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.802 0 C-N-CA 122.936 0.494 . . . . 72.239999999999995 110.569 173.483 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 53.3 m-85 -103.87 12.42 34.44 Favored 'General case' 0 N--CA 1.472 0.669 0 C-N-CA 124.338 1.055 . . . . 64.430000000000007 110.361 -179.992 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 126.42 -134.62 8.62 Favored Glycine 0 C--N 1.348 1.211 0 N-CA-C 110.623 -0.991 . . . . 62.350000000000001 110.623 -179.113 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 36.7 tt0 -81.81 -45.66 15.26 Favored 'General case' 0 N--CA 1.47 0.53 0 N-CA-C 109.042 -0.725 . . . . 72.340000000000003 109.042 173.701 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 82' ' ' LYS . . . . . 0.799 ' HD2' ' HA ' ' A' ' 107' ' ' THR . 22.6 pttm -156.07 165.32 36.78 Favored 'General case' 0 CA--C 1.54 0.561 0 CA-C-N 114.217 -1.356 . . . . 74.400000000000006 110.096 -171.284 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 45.7 p90 -145.76 172.77 12.82 Favored 'General case' 0 N--CA 1.474 0.742 0 C-N-CA 124.177 0.991 . . . . 75.340000000000003 109.821 -178.663 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 12.2 pt-20 -91.9 159.73 15.62 Favored 'General case' 0 N--CA 1.472 0.666 0 C-N-CA 122.668 0.387 . . . . 62.450000000000003 110.614 178.722 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 62.5 m-20 -63.25 124.78 22.11 Favored 'General case' 0 N--CA 1.472 0.668 0 C-N-CA 123.621 0.768 . . . . 71.519999999999996 110.669 -179.767 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 62.1 tt0 -62.72 -48.28 79.91 Favored 'General case' 0 CA--C 1.54 0.566 0 CA-C-N 115.025 -0.989 . . . . 74.409999999999997 111.338 -178.95 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 31.9 p30 -161.65 -162.21 0.85 Allowed 'General case' 0 N--CA 1.474 0.759 0 C-N-CA 124.059 0.944 . . . . 75.239999999999995 108.517 -179.068 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 87.1 m-85 -142.16 46.14 1.64 Allowed 'General case' 0 N--CA 1.492 1.654 0 C-N-CA 123.043 0.537 . . . . 71.400000000000006 110.357 175.494 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 78.3 mt -69.59 -56.67 10.77 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.008 0 CA-C-N 115.764 -0.653 . . . . 42.140000000000001 109.882 176.111 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 90' ' ' LEU . . . . . 0.57 HD11 ' HB2' ' A' ' 25' ' ' PHE . 72.0 mt -87.42 126.69 35.03 Favored 'General case' 0 C--O 1.237 0.434 0 CA-C-N 115.045 -0.979 . . . . 54.119999999999997 109.751 -176.899 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 9.6 mtpm? -119.72 165.58 14.33 Favored 'General case' 0 CA--C 1.542 0.638 0 C-N-CA 124.194 0.998 . . . . 64.129999999999995 110.768 -175.291 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 92' ' ' HIS . . . . . . . . . . . . . 52.1 m-70 -83.73 51.31 1.99 Allowed 'General case' 0 N--CA 1.485 1.297 0 C-N-CA 124.478 1.111 . . . . 74.030000000000001 110.463 -177.326 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 11.6 t -95.94 13.39 27.06 Favored 'General case' 0 N--CA 1.48 1.036 0 C-N-CA 123.706 0.802 . . . . 73.349999999999994 112.242 -170.557 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -161.34 173.18 37.72 Favored Glycine 0 C--N 1.342 0.893 0 CA-C-O 120.027 -0.318 . . . . 64.430000000000007 112.524 179.618 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 98.6 Cg_endo -78.87 157.64 27.46 Favored 'Trans proline' 0 C--N 1.363 1.31 0 C-N-CA 122.68 2.253 . . . . 70.099999999999994 111.737 170.651 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 81.42 10.52 84.45 Favored Glycine 0 CA--C 1.533 1.171 0 CA-C-N 116.143 -0.481 . . . . 72.140000000000001 114.284 179.746 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 97' ' ' ILE . . . . . 0.579 ' HB ' ' HB2' ' A' ' 115' ' ' CYS . 9.8 mm -66.85 111.03 1.69 Allowed 'Isoleucine or valine' 0 CA--C 1.553 1.065 0 C-N-CA 124.36 1.064 . . . . 73.200000000000003 111.775 -176.56 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 98' ' ' LEU . . . . . 0.426 HD22 ' CG ' ' A' ' 22' ' ' PHE . 36.6 tp -92.09 113.98 26.39 Favored 'General case' 0 C--O 1.246 0.897 0 CA-C-O 121.257 0.551 . . . . 70.140000000000001 110.596 178.577 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 36.2 t -137.25 144.2 42.63 Favored 'General case' 0 CA--C 1.545 0.76 0 C-N-CA 124.395 1.078 . . . . 63.130000000000003 108.263 175.167 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 100' ' ' MET . . . . . 0.656 ' HA ' ' HA ' ' A' ' 112' ' ' PHE . 74.1 mtp -78.7 147.03 33.63 Favored 'General case' 0 N--CA 1.483 1.217 0 N-CA-C 109.168 -0.678 . . . . 53.210000000000001 109.168 175.316 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 101' ' ' ALA . . . . . 0.548 ' HB3' ' HB2' ' A' ' 111' ' ' GLN . . . -79.53 164.64 23.72 Favored 'General case' 0 N--CA 1.479 0.985 0 CA-C-O 121.399 0.619 . . . . 54.450000000000003 112.59 -169.875 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 24.2 p-10 -153.98 167.58 29.28 Favored 'General case' 0 N--CA 1.471 0.612 0 CA-C-N 114.82 -1.082 . . . . 71.349999999999994 110.071 -178.591 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -113.63 -7.12 13.35 Favored 'General case' 0 CA--C 1.544 0.747 0 C-N-CA 123.765 0.826 . . . . 72.409999999999997 110.02 167.56 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 171.5 -164.76 37.64 Favored Glycine 0 C--N 1.351 1.374 0 CA-C-O 119.399 -0.667 . . . . 44.329999999999998 111.555 -178.572 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 14.1 Cg_exo -70.69 143.06 45.35 Favored 'Trans proline' 0 C--N 1.37 1.658 0 C-N-CA 123.322 2.682 . . . . 73.200000000000003 111.856 177.952 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 64.4 t30 64.57 16.31 10.21 Favored 'General case' 0 N--CA 1.485 1.29 0 C-N-CA 125.131 1.372 . . . . 73.349999999999994 110.997 -177.174 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 107' ' ' THR . . . . . 0.799 ' HA ' ' HD2' ' A' ' 82' ' ' LYS . 4.6 m -117.26 5.48 12.66 Favored 'General case' 0 CA--C 1.547 0.828 0 C-N-CA 124.162 0.985 . . . . 70.230000000000004 110.042 -178.828 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 53.1 t30 -84.09 133.53 34.63 Favored 'General case' 0 N--CA 1.474 0.753 0 C-N-CA 123.867 0.867 . . . . 71.519999999999996 109.937 -176.842 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 113.12 10.39 15.84 Favored Glycine 0 N--CA 1.472 1.074 0 CA-C-O 120.203 -0.22 . . . . 72.230000000000004 113.181 -176.191 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 46.4 p -104.11 120.91 42.11 Favored 'General case' 0 CA--C 1.542 0.652 0 N-CA-C 107.48 -1.304 . . . . 72.299999999999997 107.48 166.383 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 111' ' ' GLN . . . . . 0.548 ' HB2' ' HB3' ' A' ' 101' ' ' ALA . 46.5 mt-30 66.9 178.01 0.23 Allowed 'General case' 0 N--CA 1.498 1.943 0 C-N-CA 124.567 1.147 . . . . 64.319999999999993 111.533 -172.929 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 112' ' ' PHE . . . . . 0.656 ' HA ' ' HA ' ' A' ' 100' ' ' MET . 45.2 p90 -143.74 161.45 38.56 Favored 'General case' 0 N--CA 1.473 0.708 0 C-N-CA 124.409 1.084 . . . . 64.040000000000006 108.874 173.273 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 113' ' ' PHE . . . . . 0.462 ' HE1' ' SG ' ' A' ' 115' ' ' CYS . 48.0 p90 -153.91 161.71 41.79 Favored 'General case' 0 N--CA 1.464 0.266 0 CA-C-O 121.354 0.597 . . . . 75.420000000000002 111.673 176.423 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 114' ' ' ILE . . . . . 0.611 ' HB ' ' SG ' ' A' ' 62' ' ' CYS . 15.6 mt -119.24 100.7 10.25 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.744 0 CA-C-N 114.31 -1.314 . . . . 64.409999999999997 107.577 175.184 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 115' ' ' CYS . . . . . 0.579 ' HB2' ' HB ' ' A' ' 97' ' ' ILE . 87.0 m -62.23 104.4 0.48 Allowed 'General case' 0 N--CA 1.474 0.769 0 N-CA-C 109.245 -0.65 . . . . 51.329999999999998 109.245 171.612 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 28.0 p -82.05 -0.19 43.33 Favored 'General case' 0 CA--C 1.547 0.853 0 C-N-CA 124.316 1.047 . . . . 73.109999999999999 111.609 -177.059 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -129.8 160.94 31.91 Favored 'General case' 0 C--O 1.245 0.834 0 C-N-CA 123.93 0.892 . . . . 41.340000000000003 109.608 169.471 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 10.3 ptmt -70.66 79.76 0.6 Allowed 'General case' 0 CA--C 1.546 0.82 0 CA-C-O 121.613 0.72 . . . . 50.229999999999997 109.418 171.123 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 119' ' ' THR . . . . . . . . . . . . . 36.6 p -72.35 87.05 1.13 Allowed 'General case' 0 CA--C 1.549 0.931 0 CA-C-O 122.013 0.911 . . . . 72.439999999999998 110.132 -176.161 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 9.5 pt-20 -72.8 -30.8 64.36 Favored 'General case' 0 N--CA 1.477 0.907 0 CA-C-N 114.611 -1.177 . . . . 73.049999999999997 112.307 -169.879 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 121' ' ' TRP . . . . . . . . . . . . . 41.4 p90 -68.39 -21.49 64.69 Favored 'General case' 0 CA--C 1.544 0.746 0 C-N-CA 122.965 0.506 . . . . 75.310000000000002 110.936 176.557 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 52.7 mt -83.41 0.36 46.45 Favored 'General case' 0 N--CA 1.482 1.139 0 C-N-CA 122.882 0.473 . . . . 42.229999999999997 112.254 177.768 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 62.7 m-20 -78.32 119.79 22.17 Favored 'General case' 0 CA--C 1.542 0.656 0 N-CA-C 109.082 -0.71 . . . . 74.349999999999994 109.082 172.728 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 111.02 -25.15 14.7 Favored Glycine 0 C--N 1.346 1.123 0 CA-C-N 115.589 -0.732 . . . . 74.430000000000007 111.279 -168.189 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 125' ' ' LYS . . . . . 0.655 ' HG3' ' H ' ' A' ' 126' ' ' HIS . 0.5 OUTLIER -77.32 -167.13 0.85 Allowed 'General case' 0 CA--C 1.568 1.641 0 C-N-CA 124.512 1.125 . . . . 61.140000000000001 107.984 170.997 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 126' ' ' HIS . . . . . 0.655 ' H ' ' HG3' ' A' ' 125' ' ' LYS . 0.4 OUTLIER -64.57 150.03 47.65 Favored 'General case' 0 C--O 1.248 0.996 0 C-N-CA 123.944 0.898 . . . . 74.239999999999995 112.93 -170.777 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 13.9 p -73.01 145.55 11.7 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.585 0 CA-C-N 114.354 -1.293 . . . . 64.540000000000006 111.906 -169.669 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 46.5 t -81.96 149.43 4.8 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.533 0 CA-C-N 114.379 -1.282 . . . . 74.120000000000005 108.616 172.41 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 129' ' ' PHE . . . . . 0.549 ' HA ' HG21 ' A' ' 29' ' ' VAL . 46.0 p90 -129.33 -9.1 4.7 Favored 'General case' 0 N--CA 1.481 1.086 0 CA-C-N 118.158 0.435 . . . . 72.409999999999997 111.753 179.611 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . -160.92 176.58 37.51 Favored Glycine 0 C--N 1.337 0.59 0 O-C-N 123.371 0.419 . . . . 73.230000000000004 112.67 -177.578 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 34.2 ttpt -151.47 135.86 16.89 Favored 'General case' 0 N--CA 1.467 0.415 0 N-CA-C 108.307 -0.997 . . . . 63.0 108.307 173.977 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 6.4 p -60.8 117.31 2.46 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.921 0 O-C-N 123.557 0.535 . . . . 74.439999999999998 110.661 178.568 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 133' ' ' LYS . . . . . 0.601 ' HD3' HG23 ' A' ' 5' ' ' THR . 22.3 ptmt -102.12 -14.93 16.87 Favored 'General case' 0 N--CA 1.481 1.124 0 C-N-CA 123.835 0.854 . . . . 75.310000000000002 110.609 -178.22 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 3.7 mm-40 -145.36 141.7 28.72 Favored 'General case' 0 N--CA 1.47 0.568 0 C-N-CA 123.11 0.564 . . . . 73.510000000000005 110.263 -177.808 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 135' ' ' GLY . . . . . 0.405 ' O ' HG23 ' A' ' 139' ' ' VAL . . . 71.75 26.47 72.78 Favored Glycine 0 C--N 1.338 0.645 0 O-C-N 123.797 0.686 . . . . 54.100000000000001 112.76 -174.384 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 136' ' ' MET . . . . . . . . . . . . . 7.0 tpt -60.58 -41.96 95.73 Favored 'General case' 0 N--CA 1.481 1.076 0 C-N-CA 123.379 0.672 . . . . 74.109999999999999 109.996 177.223 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 137' ' ' ASN . . . . . . . . . . . . . 12.4 m120 -62.95 -37.08 85.66 Favored 'General case' 0 N--CA 1.477 0.894 0 C-N-CA 123.68 0.792 . . . . 74.400000000000006 110.759 178.733 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 138' ' ' ILE . . . . . 0.53 ' O ' ' HG3' ' A' ' 142' ' ' MET . 49.6 mm -61.0 -51.16 76.43 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.809 0 C-N-CA 123.29 0.636 . . . . 74.510000000000005 109.663 175.922 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 139' ' ' VAL . . . . . 0.463 HG13 ' SG ' ' A' ' 62' ' ' CYS . 94.6 t -54.36 -47.0 70.06 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.138 0 C-N-CA 124.293 1.037 . . . . 74.420000000000002 111.454 179.859 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 38.2 mt-10 -67.24 -29.98 69.77 Favored 'General case' 0 N--CA 1.481 1.079 0 C-N-CA 123.689 0.796 . . . . 73.019999999999996 111.569 -179.222 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -77.59 -35.66 52.71 Favored 'General case' 0 N--CA 1.475 0.786 0 C-N-CA 122.938 0.495 . . . . 42.0 111.513 178.833 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 142' ' ' MET . . . . . 0.53 ' HG3' ' O ' ' A' ' 138' ' ' ILE . 45.3 mtp -80.52 -19.58 45.49 Favored 'General case' 0 N--CA 1.483 1.193 0 C-N-CA 122.693 0.397 . . . . 75.150000000000006 111.106 -178.935 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 24.8 tt0 -54.15 -35.15 61.94 Favored 'General case' 0 CA--C 1.55 0.974 0 C-N-CA 124.445 1.098 . . . . 52.140000000000001 110.847 168.452 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 144' ' ' ARG . . . . . . . . . . . . . 71.9 mtp180 -74.42 -11.91 60.36 Favored 'General case' 0 CA--C 1.542 0.636 0 C-N-CA 124.69 1.196 . . . . 63.439999999999998 112.067 -175.833 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 145' ' ' PHE . . . . . 0.46 ' HD2' ' HA ' ' A' ' 142' ' ' MET . 67.2 m-85 -90.94 -4.89 56.14 Favored 'General case' 0 N--CA 1.479 0.986 0 C-N-CA 122.816 0.446 . . . . 64.040000000000006 110.962 173.541 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . -91.76 173.92 37.18 Favored Glycine 0 C--N 1.343 0.939 0 CA-C-N 116.827 -0.17 . . . . 75.409999999999997 112.714 176.614 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 20.0 m -132.0 167.92 18.84 Favored 'General case' 0 N--CA 1.484 1.259 0 C-N-CA 124.054 0.942 . . . . 73.430000000000007 110.434 -177.491 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 148' ' ' ARG . . . . . . . . . . . . . 19.7 mmm180 -61.77 -32.22 72.47 Favored 'General case' 0 N--CA 1.484 1.235 0 C-N-CA 123.852 0.861 . . . . 52.32 112.246 -173.071 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 149' ' ' ASN . . . . . . . . . . . . . 30.6 p-10 -88.61 -7.2 56.81 Favored 'General case' 0 N--CA 1.483 1.191 0 C-N-CA 123.716 0.806 . . . . 62.130000000000003 111.83 -179.457 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 150' ' ' GLY . . . . . 0.451 ' O ' ' HA ' ' A' ' 55' ' ' ARG . . . 105.29 -3.04 40.21 Favored Glycine 0 C--N 1.34 0.797 0 CA-C-O 119.85 -0.417 . . . . 74.129999999999995 113.421 -178.331 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 84.8 tttt -63.84 112.56 2.95 Favored 'General case' 0 N--CA 1.472 0.626 0 CA-C-O 121.229 0.537 . . . . 73.239999999999995 109.796 -179.212 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 152' ' ' THR . . . . . . . . . . . . . 9.1 m -94.21 109.51 21.31 Favored 'General case' 0 CA--C 1.541 0.604 0 N-CA-C 108.17 -1.048 . . . . 74.219999999999999 108.17 179.542 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 153' ' ' SER . . . . . . . . . . . . . 16.0 m -59.32 -35.5 73.93 Favored 'General case' 0 N--CA 1.478 0.941 0 C-N-CA 124.914 1.285 . . . . 71.430000000000007 112.164 -174.965 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 74.9 mmtt -109.98 137.04 48.31 Favored 'General case' 0 N--CA 1.467 0.379 0 C-N-CA 123.895 0.878 . . . . 74.299999999999997 109.236 -177.475 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 16.7 tppt? -77.52 91.03 3.9 Favored 'General case' 0 CA--C 1.534 0.341 0 N-CA-C 108.418 -0.956 . . . . 73.349999999999994 108.418 176.215 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 156' ' ' ILE . . . . . 0.539 ' HB ' ' HB2' ' A' ' 53' ' ' PHE . 85.6 mt -84.93 130.25 36.38 Favored 'Isoleucine or valine' 0 C--O 1.221 -0.446 0 CA-C-N 115.126 -0.943 . . . . 71.549999999999997 108.726 -175.383 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 157' ' ' THR . . . . . . . . . . . . . 32.3 p -130.55 155.39 46.59 Favored 'General case' 0 N--CA 1.476 0.867 0 C-N-CA 123.922 0.889 . . . . 52.439999999999998 109.934 -176.03 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 158' ' ' ILE . . . . . 0.429 HG23 ' HB3' ' A' ' 8' ' ' PHE . 23.3 mt -88.76 95.3 5.25 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.641 0 N-CA-C 108.598 -0.89 . . . . 72.430000000000007 108.598 171.643 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 159' ' ' ALA . . . . . 0.407 ' HB2' ' HB2' ' A' ' 11' ' ' ALA . . . -59.72 -33.37 71.55 Favored 'General case' 0 N--CA 1.474 0.729 0 C-N-CA 124.102 0.961 . . . . 75.319999999999993 113.023 -175.267 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 160' ' ' ASP . . . . . . . . . . . . . 1.7 t70 -159.34 170.83 20.97 Favored 'General case' 0 N--CA 1.483 1.206 0 CA-C-O 120.765 0.316 . . . . 75.409999999999997 111.496 -175.285 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 161' ' ' CYS . . . . . . . . . . . . . 19.9 p -139.02 -168.83 2.51 Favored 'General case' 0 N--CA 1.481 1.118 0 C-N-CA 125.305 1.442 . . . . 72.25 108.553 -179.463 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 162' ' ' GLY . . . . . . . . . . . . . . . 135.56 56.45 0.06 OUTLIER Glycine 0 N--CA 1.48 1.591 0 CA-C-N 119.294 0.952 . . . . 72.450000000000003 113.562 -170.735 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 163' ' ' GLN . . . . . 0.45 ' HA ' ' H ' ' A' ' 7' ' ' PHE . 49.3 tt0 -44.42 119.87 2.01 Favored 'General case' 0 N--CA 1.484 1.23 0 C-N-CA 125.336 1.454 . . . . 53.310000000000002 113.069 -178.44 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 164' ' ' LEU . . . . . 0.489 ' O ' ' HB ' ' A' ' 5' ' ' THR . 97.8 mt . . . . . 0 CA--C 1.536 0.43 0 CA-C-N 115.123 -0.944 . . . . 75.150000000000006 110.306 -176.591 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 218' ' ' PRO . . . . . . . . . . . . . 26.3 Cg_exo . . . . . 0 N--CA 1.485 0.989 0 CA-C-O 120.736 0.223 . . . . 65.219999999999999 111.732 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' B' B ' 219' ' ' GLY . . . . . . . . . . . . . . . 177.95 163.97 30.47 Favored Glycine 0 CA--C 1.525 0.674 0 CA-C-N 115.612 -0.722 . . . . 75.540000000000006 112.407 -179.844 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 220' ' ' PRO . . . . . . . . . . . . . 24.5 Cg_exo -68.09 157.65 60.87 Favored 'Trans proline' 0 N--CA 1.489 1.254 0 C-N-CA 123.5 2.8 . . . . 75.099999999999994 113.264 175.612 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 221' ' ' TYR . . . . . . . . . . . . . 78.4 m-85 . . . . . 0 N--CA 1.476 0.844 0 C-N-CA 123.365 0.666 . . . . 72.040000000000006 110.04 179.988 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 3' ' ' ASN . . . . . 0.496 ' ND2' ' HA ' ' A' ' 25' ' ' PHE . 14.1 m120 . . . . . 0 CA--C 1.548 0.884 0 CA-C-O 118.727 -0.654 . . . . 74.230000000000004 110.895 . . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 4' ' ' PRO . . . . . 0.49 ' HG2' ' HB2' ' A' ' 24' ' ' LEU . 16.1 Cg_endo -56.39 147.12 69.78 Favored 'Trans proline' 0 C--N 1.386 2.504 0 C-N-CA 123.51 2.807 . . . . 64.409999999999997 114.276 179.111 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 5' ' ' THR . . . . . 0.521 HG23 ' HD3' ' A' ' 133' ' ' LYS . 86.6 m -98.52 116.82 31.58 Favored 'General case' 0 CA--C 1.542 0.637 0 C-N-CA 124.903 1.281 . . . . 73.420000000000002 108.56 178.271 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 6' ' ' VAL . . . . . 0.454 ' HA ' ' HG3' ' A' ' 163' ' ' GLN . 28.6 t -99.42 119.93 48.11 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.737 0 N-CA-C 108.358 -0.978 . . . . 60.409999999999997 108.358 178.784 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 7' ' ' PHE . . . . . 0.573 ' H ' ' HA ' ' A' ' 163' ' ' GLN . 75.7 t80 -100.76 131.17 46.78 Favored 'General case' 0 C--N 1.324 -0.539 0 N-CA-C 109.439 -0.578 . . . . 75.400000000000006 109.439 -176.712 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 8' ' ' PHE . . . . . 0.48 ' HD2' ' HE2' ' A' ' 22' ' ' PHE . 46.7 m-85 -133.74 165.07 25.81 Favored 'General case' 0 C--O 1.241 0.65 0 C-N-CA 124.584 1.153 . . . . 74.019999999999996 108.949 167.095 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 9' ' ' ASP . . . . . 0.47 ' HB2' ' HB3' ' A' ' 159' ' ' ALA . 27.9 m-20 -112.94 112.62 24.21 Favored 'General case' 0 C--N 1.318 -0.79 0 N-CA-C 106.337 -1.727 . . . . 70.340000000000003 106.337 170.422 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 10' ' ' ILE . . . . . 0.425 HG21 ' SD ' ' A' ' 142' ' ' MET . 43.5 mm -81.51 125.12 39.55 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.213 0 N-CA-C 108.695 -0.854 . . . . 71.420000000000002 108.695 -179.995 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 11' ' ' ALA . . . . . 0.641 ' HB2' ' HB2' ' A' ' 159' ' ' ALA . . . -121.76 123.54 42.07 Favored 'General case' 0 C--O 1.213 -0.847 0 C-N-CA 124.403 1.081 . . . . 73.430000000000007 110.247 -171.405 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 12' ' ' VAL . . . . . 0.42 HG22 HG12 ' A' ' 156' ' ' ILE . 67.9 t -99.24 131.36 46.68 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.653 0 N-CA-C 107.844 -1.169 . . . . 65.109999999999999 107.844 173.515 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 23.1 m-20 67.87 17.58 9.67 Favored 'General case' 0 N--CA 1.491 1.621 0 C-N-CA 124.418 1.087 . . . . 71.109999999999999 110.582 -173.577 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 82.75 -9.3 59.85 Favored Glycine 0 C--N 1.351 1.364 0 CA-C-O 119.907 -0.385 . . . . 72.230000000000004 113.131 -171.27 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 37.6 mm-40 -97.35 127.48 38.04 Favored Pre-proline 0 CA--C 1.548 0.888 0 C-N-CA 124.329 1.052 . . . . 73.430000000000007 110.209 -178.127 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 18.6 Cg_endo -55.28 112.5 1.06 Allowed 'Trans proline' 0 C--N 1.381 2.282 0 C-N-CA 123.75 2.967 . . . . 70.230000000000004 113.483 -172.995 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 17' ' ' LEU . . . . . 0.506 HD23 HG23 ' A' ' 138' ' ' ILE . 40.0 tp -79.33 -40.55 30.03 Favored 'General case' 0 N--CA 1.476 0.87 0 C-N-CA 123.469 0.708 . . . . 64.150000000000006 110.087 174.704 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -176.04 -179.36 46.48 Favored Glycine 0 C--N 1.348 1.206 0 CA-C-N 116.212 -0.449 . . . . 52.109999999999999 113.286 -179.813 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 30.5 mtp85 -107.69 125.48 51.42 Favored 'General case' 0 N--CA 1.475 0.792 0 C-N-CA 124.46 1.104 . . . . 74.129999999999995 109.142 -176.967 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 71.9 t -126.0 142.61 42.17 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.804 0 C-N-CA 124.13 0.972 . . . . 71.049999999999997 109.684 -177.903 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 21' ' ' SER . . . . . 0.48 ' HB2' ' HB2' ' A' ' 134' ' ' GLU . 49.4 m -130.64 134.69 47.17 Favored 'General case' 0 CA--C 1.539 0.539 0 C-N-CA 123.579 0.752 . . . . 55.020000000000003 109.556 173.447 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 22' ' ' PHE . . . . . 0.48 ' HE2' ' HD2' ' A' ' 8' ' ' PHE . 73.3 m-85 -100.49 170.28 8.5 Favored 'General case' 0 N--CA 1.467 0.389 0 C-N-CA 125.039 1.336 . . . . 72.219999999999999 108.945 175.32 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 23' ' ' GLU . . . . . 0.531 ' HB2' ' HD2' ' A' ' 133' ' ' LYS . 35.5 tt0 -137.07 107.15 6.33 Favored 'General case' 0 CA--C 1.539 0.523 0 C-N-CA 122.98 0.512 . . . . 71.140000000000001 109.674 -178.608 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . 0.49 ' HB2' ' HG2' ' A' ' 4' ' ' PRO . 25.5 mt -87.23 126.83 35.06 Favored 'General case' 0 N--CA 1.476 0.83 0 C-N-CA 123.347 0.659 . . . . 64.409999999999997 110.531 -175.734 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 25' ' ' PHE . . . . . 0.496 ' HA ' ' ND2' ' A' ' 3' ' ' ASN . 50.9 m-85 -86.21 67.17 9.87 Favored 'General case' 0 CA--C 1.54 0.594 0 C-N-CA 123.905 0.882 . . . . 75.319999999999993 109.267 178.51 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -66.83 -18.32 65.32 Favored 'General case' 0 N--CA 1.48 1.059 0 C-N-CA 124.323 1.049 . . . . 75.010000000000005 112.923 -173.271 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 12.9 p-10 -79.01 -32.01 44.92 Favored 'General case' 0 CA--C 1.546 0.804 0 C-N-CA 123.441 0.696 . . . . 74.319999999999993 110.672 176.258 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 97.9 mttt -89.94 -41.93 11.48 Favored 'General case' 0 N--CA 1.478 0.933 0 C-N-CA 123.69 0.796 . . . . 65.230000000000004 111.066 -175.703 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 29' ' ' VAL . . . . . 0.499 HG21 ' HA ' ' A' ' 129' ' ' PHE . 17.0 m -137.81 70.24 50.9 Favored Pre-proline 0 CA--C 1.561 1.374 0 C-N-CA 123.879 0.872 . . . . 52.43 110.096 -172.939 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 27.6 Cg_exo -60.93 -35.66 86.96 Favored 'Trans proline' 0 C--N 1.38 2.197 0 C-N-CA 123.169 2.58 . . . . 72.439999999999998 113.599 -170.727 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 22.9 ttmm -59.83 -61.11 2.85 Favored 'General case' 0 N--CA 1.475 0.782 0 C-N-CA 123.617 0.767 . . . . 65.430000000000007 111.725 -178.398 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 3.6 m -74.37 -27.53 60.7 Favored 'General case' 0 CA--C 1.553 1.077 0 CA-C-N 115.235 -0.893 . . . . 73.129999999999995 111.242 -171.059 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -74.2 -52.44 12.43 Favored 'General case' 0 CA--C 1.549 0.933 0 C-N-CA 122.774 0.43 . . . . 73.230000000000004 111.109 177.061 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 27.5 tt0 -61.14 -31.29 71.01 Favored 'General case' 0 N--CA 1.491 1.612 0 C-N-CA 123.305 0.642 . . . . 73.299999999999997 110.763 179.1 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 35' ' ' ASN . . . . . 0.519 ' O ' ' HG ' ' A' ' 39' ' ' LEU . 45.1 t30 -54.1 -66.55 0.38 Allowed 'General case' 0 C--N 1.354 0.797 0 O-C-N 123.97 0.794 . . . . 54.240000000000002 109.47 175.395 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 74.1 t80 -56.95 -38.2 72.62 Favored 'General case' 0 N--CA 1.479 1.011 0 C-N-CA 124.716 1.206 . . . . 70.400000000000006 111.51 -175.941 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 37' ' ' ARG . . . . . 0.566 ' HA ' HE22 ' A' ' 163' ' ' GLN . 14.0 ttm180 -55.24 -58.33 8.14 Favored 'General case' 0 C--N 1.353 0.759 0 CA-C-N 115.372 -0.831 . . . . 74.340000000000003 110.331 173.957 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 38' ' ' ALA . . . . . 0.435 ' HB1' ' HG2' ' A' ' 44' ' ' LYS . . . -74.11 -18.92 60.74 Favored 'General case' 0 N--CA 1.468 0.452 0 C-N-CA 123.785 0.834 . . . . 74.510000000000005 111.899 -171.782 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 39' ' ' LEU . . . . . 0.639 HD22 ' HE2' ' A' ' 48' ' ' TYR . 43.3 mt -71.58 -46.64 58.75 Favored 'General case' 0 CA--C 1.538 0.517 0 N-CA-C 109.371 -0.603 . . . . 72.019999999999996 109.371 173.229 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 33.7 t -68.5 -56.8 7.13 Favored 'General case' 0 CA--C 1.547 0.861 0 C-N-CA 123.797 0.839 . . . . 74.310000000000002 111.411 -179.433 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 41' ' ' THR . . . . . 0.406 ' OG1' ' HG2' ' A' ' 43' ' ' GLU . 71.6 p -76.62 -31.03 57.16 Favored 'General case' 0 N--CA 1.471 0.619 0 C-N-CA 124.075 0.95 . . . . 73.019999999999996 111.442 -174.012 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 85.74 31.92 19.85 Favored Glycine 0 C--N 1.349 1.261 0 CA-C-O 119.908 -0.384 . . . . 50.310000000000002 113.101 -179.022 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 43' ' ' GLU . . . . . 0.406 ' HG2' ' OG1' ' A' ' 41' ' ' THR . 24.5 mm-40 -66.12 -27.87 68.38 Favored 'General case' 0 N--CA 1.483 1.187 0 C-N-CA 122.706 0.402 . . . . 64.329999999999998 111.665 176.709 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 44' ' ' LYS . . . . . 0.435 ' HG2' ' HB1' ' A' ' 38' ' ' ALA . 33.3 mmtp -105.95 18.6 21.85 Favored 'General case' 0 N--CA 1.484 1.269 0 C-N-CA 122.992 0.517 . . . . 72.349999999999994 110.645 175.405 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 79.23 48.39 6.91 Favored Glycine 0 C--N 1.352 1.43 0 N-CA-C 114.803 0.681 . . . . 75.019999999999996 114.803 169.279 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 46' ' ' PHE . . . . . 0.493 ' HE2' ' HA ' ' A' ' 78' ' ' ILE . 25.1 m-85 -130.08 -50.79 1.12 Allowed 'General case' 0 N--CA 1.49 1.545 0 CA-C-N 118.021 0.911 . . . . 75.099999999999994 111.399 -178.557 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 47.87 53.97 12.76 Favored Glycine 0 C--N 1.354 1.547 0 O-C-N 124.593 1.183 . . . . 75.140000000000001 114.687 176.17 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 48' ' ' TYR . . . . . 0.639 ' HE2' HD22 ' A' ' 39' ' ' LEU . 33.5 m-85 -61.55 95.47 0.05 Allowed 'General case' 0 N--CA 1.479 1.001 0 C-N-CA 123.28 0.632 . . . . 65.310000000000002 111.487 -177.803 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 46.9 tptt -98.48 102.42 14.15 Favored 'General case' 0 CA--C 1.537 0.447 0 CA-C-N 114.866 -1.061 . . . . 55.109999999999999 108.925 -175.65 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 50' ' ' GLY . . . . . 0.43 ' HA2' ' O ' ' A' ' 158' ' ' ILE . . . 110.62 22.66 6.27 Favored Glycine 0 C--N 1.346 1.117 0 CA-C-O 119.362 -0.688 . . . . 74.319999999999993 114.651 173.647 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 51' ' ' SER . . . . . 0.42 ' HB2' HD12 ' A' ' 158' ' ' ILE . 19.3 m -53.43 128.35 28.35 Favored 'General case' 0 N--CA 1.484 1.268 0 C-N-CA 123.732 0.813 . . . . 72.120000000000005 111.175 178.005 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 52' ' ' CYS . . . . . 0.53 ' HA ' ' HA ' ' A' ' 157' ' ' THR . 19.4 p -103.25 133.83 47.67 Favored 'General case' 0 N--CA 1.478 0.937 0 N-CA-C 112.59 0.589 . . . . 63.229999999999997 112.59 -168.282 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 53' ' ' PHE . . . . . 0.684 ' HA ' ' HA2' ' A' ' 64' ' ' GLY . 79.4 m-85 -74.05 102.62 4.25 Favored 'General case' 0 N--CA 1.472 0.661 0 C-N-CA 124.069 0.948 . . . . 74.400000000000006 108.665 166.206 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 16.5 p-80 -114.82 -12.93 12.04 Favored 'General case' 0 N--CA 1.481 1.094 0 C-N-CA 123.603 0.761 . . . . 61.229999999999997 112.006 -173.316 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 36.1 ttt180 -128.39 100.82 5.95 Favored 'General case' 0 C--O 1.217 -0.618 0 C-N-CA 122.884 0.474 . . . . 65.209999999999994 109.75 179.13 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 57.9 mt -128.96 125.4 62.82 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.96 0 C-N-CA 122.905 0.482 . . . . 65.530000000000001 110.126 178.375 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 54.7 mt -116.48 114.25 40.38 Favored Pre-proline 0 CA--C 1.557 1.217 0 C-N-CA 124.367 1.067 . . . . 52.100000000000001 109.162 178.228 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 31.8 Cg_exo -60.32 129.88 31.66 Favored 'Trans proline' 0 C--N 1.387 2.582 0 C-N-CA 123.704 2.936 . . . . 71.239999999999995 112.61 178.103 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 81.26 26.17 52.82 Favored Glycine 0 C--N 1.341 0.807 0 O-C-N 123.778 0.674 . . . . 52.439999999999998 112.661 -176.113 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 23.1 t80 -151.88 -75.99 0.13 Allowed 'General case' 0 C--O 1.247 0.933 0 C-N-CA 123.016 0.526 . . . . 74.420000000000002 110.685 179.712 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 61' ' ' MET . . . . . 0.481 ' HA ' ' H ' ' A' ' 116' ' ' THR . 22.9 ptt? -165.35 163.62 19.87 Favored 'General case' 0 N--CA 1.485 1.305 0 N-CA-C 112.813 0.672 . . . . 70.310000000000002 112.813 -174.528 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 62' ' ' CYS . . . . . 0.464 ' SG ' ' HB ' ' A' ' 114' ' ' ILE . 20.5 p -115.59 111.68 21.03 Favored 'General case' 0 CA--C 1.545 0.766 0 C-N-CA 124.253 1.021 . . . . 65.439999999999998 108.933 168.572 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 63' ' ' GLN . . . . . 0.561 ' HA ' ' HA ' ' A' ' 113' ' ' PHE . 52.1 tt0 -102.74 116.73 33.16 Favored 'General case' 0 N--CA 1.479 1.014 0 C-N-CA 124.019 0.928 . . . . 74.109999999999999 110.877 -174.955 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 64' ' ' GLY . . . . . 0.684 ' HA2' ' HA ' ' A' ' 53' ' ' PHE . . . -92.36 173.19 35.48 Favored Glycine 0 C--N 1.342 0.896 0 CA-C-N 115.221 -0.899 . . . . 72.129999999999995 112.284 171.362 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 174.29 150.46 7.69 Favored Glycine 0 C--O 1.238 0.344 0 N-CA-C 110.504 -1.038 . . . . 71.409999999999997 110.504 179.379 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 38.8 t70 -79.75 162.0 25.41 Favored 'General case' 0 CA--C 1.547 0.865 0 CA-C-O 121.608 0.718 . . . . 63.020000000000003 112.658 -169.804 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 55.0 t80 -79.95 -40.59 27.73 Favored 'General case' 0 CA--C 1.548 0.871 0 C-N-CA 124.701 1.2 . . . . 73.299999999999997 111.678 -177.281 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 25.3 m -61.16 112.68 2.21 Favored 'General case' 0 N--CA 1.479 0.979 0 C-N-CA 123.757 0.823 . . . . 71.439999999999998 111.681 -172.673 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 36.3 ttm180 55.83 77.03 0.25 Allowed 'General case' 0 N--CA 1.48 1.035 0 C-N-CA 124.852 1.261 . . . . 74.430000000000007 111.19 -178.877 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 12.2 t60 -79.16 -14.55 59.02 Favored 'General case' 0 CA--C 1.546 0.79 0 CA-C-N 115.261 -0.881 . . . . 71.230000000000004 110.806 -179.559 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 16.8 m120 -55.97 93.36 0.01 OUTLIER 'General case' 0 N--CA 1.485 1.279 0 C-N-CA 124.211 1.004 . . . . 74.439999999999998 110.723 178.18 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 70.18 11.25 67.05 Favored Glycine 0 C--N 1.351 1.4 0 CA-C-N 115.45 -0.795 . . . . 73.530000000000001 114.904 176.071 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 21.0 m -143.25 -83.62 0.16 Allowed 'General case' 0 CA--C 1.553 1.075 0 CA-C-N 117.663 0.731 . . . . 63.340000000000003 110.634 -178.578 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 64.4 59.22 8.6 Favored Glycine 0 C--N 1.357 1.731 0 O-C-N 123.301 0.376 . . . . 63.350000000000001 113.117 -177.008 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 134.6 49.07 0.08 OUTLIER Glycine 0 C--N 1.35 1.359 0 CA-C-N 117.05 0.425 . . . . 43.200000000000003 112.475 -176.135 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 14.0 ptmm? -65.59 159.91 23.66 Favored 'General case' 0 N--CA 1.484 1.243 0 C-N-CA 123.64 0.776 . . . . 75.040000000000006 111.454 -178.683 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 79.6 p -105.86 -175.65 2.85 Favored 'General case' 0 N--CA 1.481 1.095 0 N-CA-C 112.666 0.617 . . . . 65.439999999999998 112.666 -162.897 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 78' ' ' ILE . . . . . 0.493 ' HA ' ' HE2' ' A' ' 46' ' ' PHE . 44.3 pt -70.79 -21.08 22.38 Favored 'Isoleucine or valine' 0 C--N 1.358 0.971 0 CA-C-N 115.595 -0.73 . . . . 65.340000000000003 111.254 176.447 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 98.9 m-85 -88.66 33.83 0.77 Allowed 'General case' 0 N--CA 1.475 0.778 0 C-N-CA 123.83 0.852 . . . . 52.340000000000003 109.736 173.564 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 70.23 -99.16 0.69 Allowed Glycine 0 C--N 1.351 1.399 0 CA-C-N 115.403 -0.817 . . . . 74.030000000000001 111.604 -176.744 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 42.8 tt0 -73.03 -60.22 2.34 Favored 'General case' 0 CA--C 1.544 0.744 0 C-N-CA 123.956 0.902 . . . . 63.439999999999998 110.652 -176.498 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 82' ' ' LYS . . . . . 0.75 ' HD2' ' HA ' ' A' ' 107' ' ' THR . 18.8 pttp -169.2 177.37 4.83 Favored 'General case' 0 N--CA 1.482 1.148 0 C-N-CA 123.11 0.564 . . . . 64.140000000000001 111.162 -169.721 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 51.6 p90 -156.19 174.93 14.65 Favored 'General case' 0 N--CA 1.478 0.959 0 C-N-CA 124.204 1.002 . . . . 72.109999999999999 110.852 -177.574 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 13.5 pt-20 -102.76 162.96 12.5 Favored 'General case' 0 N--CA 1.481 1.117 0 C-N-CA 123.223 0.609 . . . . 71.349999999999994 110.872 177.233 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 85' ' ' ASP . . . . . 0.469 ' HB3' HG23 ' A' ' 127' ' ' VAL . 48.0 m-20 -64.71 130.63 44.29 Favored 'General case' 0 N--CA 1.478 0.926 0 CA-C-N 115.687 -0.688 . . . . 74.310000000000002 111.276 -179.993 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 9.3 tp10 -69.12 -61.36 1.82 Allowed 'General case' 0 N--CA 1.474 0.747 0 O-C-N 123.57 0.544 . . . . 72.129999999999995 111.102 -178.836 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 24.3 p-10 -161.2 127.89 3.98 Favored 'General case' 0 N--CA 1.477 0.887 0 C-N-CA 123.054 0.541 . . . . 75.120000000000005 110.325 -171.891 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 86.4 m-85 -88.58 74.11 8.52 Favored 'General case' 0 N--CA 1.476 0.85 0 CA-C-O 121.533 0.682 . . . . 74.150000000000006 110.18 -171.727 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 65.1 mt -88.87 -60.27 2.38 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.637 0 CA-C-N 115.221 -0.9 . . . . 70.120000000000005 108.998 173.453 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 67.4 mt -85.36 131.13 34.45 Favored 'General case' 0 C--O 1.241 0.626 0 CA-C-N 114.372 -1.286 . . . . 60.539999999999999 110.392 -173.05 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 32.2 mtmm -122.46 169.11 11.32 Favored 'General case' 0 N--CA 1.47 0.55 0 C-N-CA 124.933 1.293 . . . . 75.230000000000004 109.479 -174.485 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 92' ' ' HIS . . . . . . . . . . . . . 20.7 m-70 -91.95 36.83 0.97 Allowed 'General case' 0 N--CA 1.481 1.105 0 C-N-CA 123.992 0.917 . . . . 72.109999999999999 110.852 -170.79 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 80.7 p -67.92 -26.08 65.8 Favored 'General case' 0 N--CA 1.474 0.725 0 C-N-CA 124.387 1.075 . . . . 75.510000000000005 112.226 -170.935 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -124.88 175.6 17.17 Favored Glycine 0 C--N 1.344 1.007 0 O-C-N 123.232 0.332 . . . . 72.310000000000002 113.221 -177.067 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 93.0 Cg_endo -80.89 157.49 20.89 Favored 'Trans proline' 0 C--N 1.367 1.546 0 C-N-CA 123.046 2.498 . . . . 53.409999999999997 111.395 169.484 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 89.36 -0.71 81.34 Favored Glycine 0 N--CA 1.472 1.039 0 CA-C-N 116.27 -0.423 . . . . 34.399999999999999 112.971 -177.206 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 97' ' ' ILE . . . . . 0.44 ' HB ' ' HB2' ' A' ' 115' ' ' CYS . 13.9 mm -66.94 114.07 3.5 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.949 0 C-N-CA 124.041 0.936 . . . . 60.32 111.466 -176.591 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 98' ' ' LEU . . . . . 0.489 HD13 HG12 ' A' ' 114' ' ' ILE . 67.2 tp -102.28 113.11 26.13 Favored 'General case' 0 CA--C 1.551 0.999 0 C-N-CA 123.489 0.716 . . . . 74.510000000000005 109.761 177.827 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 42.6 t -131.44 168.77 17.04 Favored 'General case' 0 N--CA 1.479 0.978 0 C-N-CA 124.95 1.3 . . . . 71.140000000000001 108.296 176.533 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 100' ' ' MET . . . . . 0.505 ' HA ' ' HA ' ' A' ' 112' ' ' PHE . 44.4 mtp -101.62 146.59 27.49 Favored 'General case' 0 N--CA 1.491 1.604 0 CA-C-N 118.596 0.635 . . . . 62.119999999999997 110.482 -176.639 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 101' ' ' ALA . . . . . 0.553 ' HB3' ' HB2' ' A' ' 111' ' ' GLN . . . -85.49 167.58 15.32 Favored 'General case' 0 N--CA 1.482 1.151 0 C-N-CA 123.202 0.601 . . . . 64.329999999999998 111.174 -175.649 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 102' ' ' ASN . . . . . 0.593 ' HB3' ' HA ' ' A' ' 108' ' ' ASN . 29.4 p-10 -169.9 170.93 7.46 Favored 'General case' 0 N--CA 1.478 0.961 0 C-N-CA 122.829 0.451 . . . . 63.229999999999997 111.996 -177.111 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 103' ' ' ALA . . . . . 0.476 ' HB3' HG21 ' A' ' 107' ' ' THR . . . -99.59 -22.1 15.59 Favored 'General case' 0 CA--C 1.547 0.865 0 CA-C-N 115.377 -0.829 . . . . 44.030000000000001 111.142 171.55 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -178.15 -177.0 46.56 Favored Glycine 0 C--N 1.357 1.696 0 CA-C-O 119.467 -0.629 . . . . 53.549999999999997 113.053 -178.134 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 32.4 Cg_exo -58.62 136.52 74.55 Favored 'Trans proline' 0 C--N 1.375 1.948 0 C-N-CA 122.791 2.327 . . . . 75.420000000000002 112.908 175.002 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 66.6 t30 69.72 9.94 7.38 Favored 'General case' 0 N--CA 1.486 1.354 0 C-N-CA 124.805 1.242 . . . . 75.129999999999995 111.639 -176.459 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 107' ' ' THR . . . . . 0.75 ' HA ' ' HD2' ' A' ' 82' ' ' LYS . 3.9 m -109.96 5.16 22.11 Favored 'General case' 0 CA--C 1.553 1.087 0 C-N-CA 124.093 0.957 . . . . 71.340000000000003 110.305 178.301 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 108' ' ' ASN . . . . . 0.593 ' HA ' ' HB3' ' A' ' 102' ' ' ASN . 66.4 t30 -80.93 154.36 27.04 Favored 'General case' 0 N--CA 1.478 0.97 0 C-N-CA 123.467 0.707 . . . . 71.530000000000001 111.3 -173.772 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 106.36 -3.47 37.4 Favored Glycine 0 N--CA 1.467 0.725 0 CA-C-O 119.966 -0.352 . . . . 54.140000000000001 112.7 -178.394 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 41.1 p -91.29 119.23 31.16 Favored 'General case' 0 CA--C 1.54 0.563 0 N-CA-C 108.11 -1.07 . . . . 70.019999999999996 108.11 170.329 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 111' ' ' GLN . . . . . 0.572 HE22 ' HG2' ' B' ' 218' ' ' PRO . 35.7 mt-30 66.75 173.19 0.25 Allowed 'General case' 0 N--CA 1.496 1.857 0 C-N-CA 124.208 1.003 . . . . 73.530000000000001 112.093 -177.919 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 112' ' ' PHE . . . . . 0.505 ' HA ' ' HA ' ' A' ' 100' ' ' MET . 32.6 p90 -143.69 133.72 24.18 Favored 'General case' 0 N--CA 1.474 0.737 0 C-N-CA 123.879 0.871 . . . . 72.150000000000006 108.963 177.983 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 113' ' ' PHE . . . . . 0.561 ' HA ' ' HA ' ' A' ' 63' ' ' GLN . 52.2 p90 -116.52 142.06 47.37 Favored 'General case' 0 C--O 1.24 0.603 0 C-N-CA 123.342 0.657 . . . . 74.329999999999998 110.595 176.497 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 114' ' ' ILE . . . . . 0.489 HG12 HD13 ' A' ' 98' ' ' LEU . 15.3 mt -109.01 106.5 20.83 Favored 'Isoleucine or valine' 0 C--O 1.238 0.454 0 N-CA-C 108.066 -1.087 . . . . 74.340000000000003 108.066 175.39 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 115' ' ' CYS . . . . . 0.44 ' HB2' ' HB ' ' A' ' 97' ' ' ILE . 59.7 m -61.69 103.27 0.32 Allowed 'General case' 0 CA--C 1.546 0.823 0 C-N-CA 123.156 0.582 . . . . 64.439999999999998 109.607 173.554 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 116' ' ' THR . . . . . 0.567 HG22 HG12 ' A' ' 139' ' ' VAL . 35.2 p -74.56 -32.71 62.51 Favored 'General case' 0 N--CA 1.474 0.76 0 C-N-CA 124.29 1.036 . . . . 50.119999999999997 109.703 178.87 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -100.0 159.04 15.4 Favored 'General case' 0 C--O 1.243 0.761 0 C-N-CA 124.46 1.104 . . . . 31.34 108.561 171.051 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -71.88 111.98 7.59 Favored 'General case' 0 CA--C 1.543 0.693 0 N-CA-C 107.586 -1.264 . . . . 72.310000000000002 107.586 169.839 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 119' ' ' THR . . . . . . . . . . . . . 52.2 p -101.86 84.57 2.56 Favored 'General case' 0 CA--C 1.539 0.558 0 CA-C-O 122.319 1.057 . . . . 73.129999999999995 109.168 -175.974 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 11.1 pt-20 -77.0 -25.52 52.78 Favored 'General case' 0 N--CA 1.48 1.055 0 CA-C-N 114.543 -1.208 . . . . 71.219999999999999 110.903 -174.314 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 121' ' ' TRP . . . . . . . . . . . . . 43.8 p90 -70.19 -6.82 37.08 Favored 'General case' 0 CA--C 1.55 0.962 0 C-N-CA 123.914 0.886 . . . . 62.109999999999999 111.258 174.517 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 122' ' ' LEU . . . . . 0.422 HD22 ' HG2' ' A' ' 125' ' ' LYS . 42.7 mt -96.86 24.2 6.38 Favored 'General case' 0 CA--C 1.55 0.965 0 C-N-CA 123.32 0.648 . . . . 63.100000000000001 111.45 172.426 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 24.2 m-20 -71.79 133.9 45.83 Favored 'General case' 0 N--CA 1.484 1.247 0 N-CA-C 109.32 -0.622 . . . . 63.439999999999998 109.32 163.107 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 89.08 -13.84 62.22 Favored Glycine 0 C--N 1.345 1.056 0 CA-C-N 115.792 -0.64 . . . . 74.409999999999997 112.528 -173.26 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 125' ' ' LYS . . . . . 0.422 ' HG2' HD22 ' A' ' 122' ' ' LEU . 0.4 OUTLIER -81.63 -169.45 2.33 Favored 'General case' 0 N--CA 1.477 0.877 0 C-N-CA 123.657 0.783 . . . . 64.430000000000007 111.012 -179.02 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 126' ' ' HIS . . . . . . . . . . . . . 24.0 m80 -71.74 146.68 47.98 Favored 'General case' 0 N--CA 1.477 0.924 0 C-N-CA 124.481 1.112 . . . . 63.340000000000003 111.257 -163.059 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 127' ' ' VAL . . . . . 0.469 HG23 ' HB3' ' A' ' 85' ' ' ASP . 62.1 t -63.32 128.14 24.86 Favored 'Isoleucine or valine' 0 C--O 1.242 0.664 0 O-C-N 124.534 1.146 . . . . 75.209999999999994 112.108 -168.724 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 128' ' ' VAL . . . . . 0.408 HG11 HD12 ' A' ' 97' ' ' ILE . 47.6 t -75.5 140.39 17.46 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.356 0 CA-C-N 114.859 -1.064 . . . . 31.52 108.429 170.787 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 129' ' ' PHE . . . . . 0.499 ' HA ' HG21 ' A' ' 29' ' ' VAL . 41.1 p90 -128.13 -20.87 3.7 Favored 'General case' 0 N--CA 1.474 0.756 0 C-N-CA 122.623 0.369 . . . . 74.239999999999995 110.867 -177.475 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . -134.65 168.84 23.4 Favored Glycine 0 C--N 1.34 0.793 0 O-C-N 123.34 0.4 . . . . 62.119999999999997 112.188 -176.488 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 33.2 ttpt -152.26 137.11 17.12 Favored 'General case' 0 N--CA 1.47 0.569 0 C-N-CA 123.838 0.855 . . . . 63.509999999999998 109.091 176.568 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 17.1 t -70.95 111.71 5.03 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.528 0 N-CA-C 109.439 -0.578 . . . . 74.129999999999995 109.439 178.311 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 133' ' ' LYS . . . . . 0.531 ' HD2' ' HB2' ' A' ' 23' ' ' GLU . 20.2 ptmt -94.94 -37.63 11.07 Favored 'General case' 0 CA--C 1.541 0.605 0 C-N-CA 123.242 0.617 . . . . 75.319999999999993 110.19 178.193 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 134' ' ' GLU . . . . . 0.48 ' HB2' ' HB2' ' A' ' 21' ' ' SER . 17.9 mm-40 -124.4 136.4 54.03 Favored 'General case' 0 N--CA 1.474 0.757 0 C-N-CA 123.984 0.913 . . . . 65.239999999999995 109.274 -178.337 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 76.27 28.34 60.21 Favored Glycine 0 C--N 1.342 0.907 0 O-C-N 123.562 0.539 . . . . 42.299999999999997 113.913 175.245 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 136' ' ' MET . . . . . . . . . . . . . 15.3 tpt -63.91 -26.98 68.84 Favored 'General case' 0 N--CA 1.487 1.403 0 CA-C-N 117.418 0.609 . . . . 75.129999999999995 110.303 173.418 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 137' ' ' ASN . . . . . . . . . . . . . 1.7 m-20 -55.77 -46.69 77.84 Favored 'General case' 0 CA--C 1.549 0.927 0 C-N-CA 124.4 1.08 . . . . 74.140000000000001 110.291 171.502 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 138' ' ' ILE . . . . . 0.506 HG23 HD23 ' A' ' 17' ' ' LEU . 48.5 mm -68.17 -33.23 59.59 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.084 0 C-N-CA 123.876 0.871 . . . . 64.400000000000006 111.116 179.622 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 139' ' ' VAL . . . . . 0.567 HG12 HG22 ' A' ' 116' ' ' THR . 78.9 t -65.85 -44.5 92.78 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.072 0 C-N-CA 123.595 0.758 . . . . 71.349999999999994 111.12 178.839 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 45.1 mt-10 -74.34 -20.2 60.18 Favored 'General case' 0 N--CA 1.48 1.041 0 CA-C-N 115.747 -0.661 . . . . 74.010000000000005 110.99 176.919 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -72.16 -40.18 68.18 Favored 'General case' 0 CA--C 1.542 0.654 0 C-N-CA 122.895 0.478 . . . . 63.43 109.732 170.713 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 142' ' ' MET . . . . . 0.425 ' SD ' HG21 ' A' ' 10' ' ' ILE . 72.6 mtm -61.18 -38.81 87.82 Favored 'General case' 0 N--CA 1.484 1.26 0 C-N-CA 123.303 0.641 . . . . 72.140000000000001 110.289 176.744 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 143' ' ' GLU . . . . . 0.408 ' HB2' HG21 ' A' ' 116' ' ' THR . 42.7 tt0 -51.38 -40.31 58.95 Favored 'General case' 0 CA--C 1.552 1.041 0 O-C-N 124.402 1.064 . . . . 72.209999999999994 111.869 176.607 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 144' ' ' ARG . . . . . . . . . . . . . 53.6 mtp180 -71.81 -25.72 62.11 Favored 'General case' 0 CA--C 1.545 0.762 0 C-N-CA 123.47 0.708 . . . . 72.030000000000001 112.034 -178.279 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 145' ' ' PHE . . . . . . . . . . . . . 93.5 m-85 -82.77 2.4 34.09 Favored 'General case' 0 N--CA 1.481 1.118 0 C-N-CA 122.725 0.41 . . . . 74.120000000000005 111.223 175.749 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . -93.43 173.71 34.35 Favored Glycine 0 C--N 1.349 1.301 0 CA-C-N 117.741 0.246 . . . . 63.450000000000003 112.888 176.075 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 35.2 t -135.23 167.39 21.09 Favored 'General case' 0 N--CA 1.477 0.923 0 C-N-CA 123.911 0.884 . . . . 32.509999999999998 110.084 178.797 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 148' ' ' ARG . . . . . . . . . . . . . 23.2 mmt180 -73.6 -26.34 60.75 Favored 'General case' 0 N--CA 1.479 0.988 0 C-N-CA 123.725 0.81 . . . . 65.530000000000001 112.176 -173.352 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 149' ' ' ASN . . . . . . . . . . . . . 29.3 p-10 -77.06 -5.03 47.25 Favored 'General case' 0 N--CA 1.481 1.089 0 C-N-CA 123.17 0.588 . . . . 54.25 111.001 174.745 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . 101.54 -20.01 48.26 Favored Glycine 0 C--N 1.348 1.226 0 CA-C-O 119.959 -0.356 . . . . 63.409999999999997 112.474 177.936 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 34.9 ttpt -71.36 153.39 42.36 Favored 'General case' 0 N--CA 1.48 1.034 0 C-N-CA 122.802 0.441 . . . . 71.439999999999998 110.584 -176.894 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 152' ' ' THR . . . . . . . . . . . . . 72.2 p -94.82 134.05 37.86 Favored 'General case' 0 CA--C 1.543 0.696 0 C-N-CA 123.202 0.601 . . . . 71.150000000000006 109.452 172.484 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 153' ' ' SER . . . . . . . . . . . . . 36.5 m -65.84 -36.07 82.42 Favored 'General case' 0 CA--C 1.544 0.734 0 C-N-CA 123.641 0.776 . . . . 42.0 110.542 171.729 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 26.3 mmtp -122.87 139.47 54.0 Favored 'General case' 0 N--CA 1.479 0.985 0 C-N-CA 123.899 0.879 . . . . 72.109999999999999 109.505 175.222 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 11.7 tppt? -78.79 99.46 6.71 Favored 'General case' 0 CA--C 1.538 0.5 0 C-N-CA 123.101 0.56 . . . . 71.540000000000006 109.774 -178.127 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 156' ' ' ILE . . . . . 0.476 ' HB ' ' HB2' ' A' ' 53' ' ' PHE . 55.7 mt -89.24 126.08 42.24 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.482 0 CA-C-N 115.444 -0.798 . . . . 75.120000000000005 108.863 179.581 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 157' ' ' THR . . . . . 0.53 ' HA ' ' HA ' ' A' ' 52' ' ' CYS . 69.0 p -122.81 170.78 9.73 Favored 'General case' 0 CA--C 1.541 0.614 0 C-N-CA 125.276 1.43 . . . . 72.109999999999999 109.725 179.958 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 158' ' ' ILE . . . . . 0.43 ' O ' ' HA2' ' A' ' 50' ' ' GLY . 75.4 mt -90.83 113.51 26.74 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.685 0 N-CA-C 108.086 -1.079 . . . . 71.319999999999993 108.086 166.274 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 159' ' ' ALA . . . . . 0.641 ' HB2' ' HB2' ' A' ' 11' ' ' ALA . . . -63.84 -52.08 61.75 Favored 'General case' 0 N--CA 1.476 0.871 0 C-N-CA 123.9 0.88 . . . . 32.299999999999997 111.662 177.959 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 160' ' ' ASP . . . . . . . . . . . . . 14.7 t70 -157.36 173.27 17.17 Favored 'General case' 0 N--CA 1.48 1.043 0 C-N-CA 122.881 0.472 . . . . 73.510000000000005 109.823 -174.025 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 161' ' ' CYS . . . . . . . . . . . . . 19.4 p -134.55 -166.99 1.9 Allowed 'General case' 0 N--CA 1.475 0.817 0 C-N-CA 125.309 1.444 . . . . 45.539999999999999 109.101 -173.542 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 162' ' ' GLY . . . . . . . . . . . . . . . 134.92 53.17 0.07 OUTLIER Glycine 0 C--N 1.344 1.005 0 O-C-N 122.173 -0.33 . . . . 71.010000000000005 112.358 -173.163 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 163' ' ' GLN . . . . . 0.573 ' HA ' ' H ' ' A' ' 7' ' ' PHE . 6.6 tt0 -47.33 103.6 0.04 OUTLIER 'General case' 0 N--CA 1.48 1.035 0 C-N-CA 125.101 1.36 . . . . 64.349999999999994 111.614 -179.878 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 164' ' ' LEU . . . . . . . . . . . . . 85.2 mt . . . . . 0 CA--C 1.538 0.483 0 CA-C-N 114.765 -1.107 . . . . 42.25 110.882 -174.054 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' B' B ' 218' ' ' PRO . . . . . 0.572 ' HG2' HE22 ' A' ' 111' ' ' GLN . 23.8 Cg_endo . . . . . 0 CA--C 1.554 1.503 0 CA-C-O 121.096 0.373 . . . . 65.299999999999997 111.216 . . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 219' ' ' GLY . . . . . . . . . . . . . . . 162.61 160.47 11.18 Favored Glycine 0 CA--C 1.533 1.162 0 CA-C-N 115.032 -0.985 . . . . 74.109999999999999 111.51 -178.197 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 220' ' ' PRO . . . . . . . . . . . . . 27.5 Cg_exo -64.63 169.96 10.58 Favored 'Trans proline' 0 C--N 1.375 1.955 0 C-N-CA 123.492 2.794 . . . . 73.109999999999999 114.308 179.995 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 221' ' ' TYR . . . . . . . . . . . . . 73.1 m-85 . . . . . 0 N--CA 1.484 1.273 0 C-N-CA 123.949 0.9 . . . . 71.239999999999995 110.987 -174.938 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 3' ' ' ASN . . . . . 0.541 HD22 ' HA ' ' A' ' 25' ' ' PHE . 16.3 m120 . . . . . 0 CA--C 1.549 0.935 0 CA-C-O 118.971 -0.538 . . . . 31.550000000000001 110.622 . . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 4' ' ' PRO . . . . . 0.62 ' HG2' ' HB2' ' A' ' 24' ' ' LEU . 32.7 Cg_endo -65.2 129.17 22.17 Favored 'Trans proline' 0 C--N 1.38 2.236 0 C-N-CA 122.696 2.264 . . . . 74.239999999999995 111.379 175.102 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 5' ' ' THR . . . . . 0.467 HG23 ' HD3' ' A' ' 133' ' ' LYS . 65.9 m -95.93 122.74 39.07 Favored 'General case' 0 N--CA 1.464 0.257 0 N-CA-C 108.112 -1.07 . . . . 63.240000000000002 108.112 177.44 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 34.7 m -107.15 128.6 61.95 Favored 'Isoleucine or valine' 0 C--O 1.22 -0.478 0 CA-C-O 121.432 0.634 . . . . 75.420000000000002 110.557 -179.018 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 7' ' ' PHE . . . . . 0.664 ' H ' ' HA ' ' A' ' 163' ' ' GLN . 74.6 t80 -116.03 138.79 50.9 Favored 'General case' 0 C--O 1.239 0.532 0 C-N-CA 124.792 1.237 . . . . 52.219999999999999 109.292 -171.579 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 8' ' ' PHE . . . . . 0.483 ' HB3' HG23 ' A' ' 158' ' ' ILE . 63.2 m-85 -141.02 162.68 34.92 Favored 'General case' 0 N--CA 1.47 0.568 0 O-C-N 124.375 1.047 . . . . 74.430000000000007 110.11 172.17 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 11.9 m-20 -108.67 106.8 17.01 Favored 'General case' 0 C--N 1.328 -0.341 0 C-N-CA 125.124 1.369 . . . . 62.210000000000001 107.359 171.523 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 49.5 mm -81.2 130.88 35.11 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.65 0 N-CA-C 108.664 -0.865 . . . . 73.340000000000003 108.664 177.863 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 11' ' ' ALA . . . . . 0.451 ' HB2' ' HB2' ' A' ' 159' ' ' ALA . . . -132.97 139.68 47.41 Favored 'General case' 0 N--CA 1.473 0.696 0 C-N-CA 123.754 0.822 . . . . 73.439999999999998 110.69 -174.256 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 12' ' ' VAL . . . . . 0.538 HG23 ' HB2' ' A' ' 17' ' ' LEU . 72.0 t -94.67 98.31 7.91 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.596 0 C-N-CA 124.899 1.28 . . . . 70.329999999999998 108.388 175.697 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 22.6 m-20 61.23 31.18 19.51 Favored 'General case' 0 N--CA 1.483 1.182 0 C-N-CA 124.702 1.201 . . . . 73.129999999999995 111.968 -177.993 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 96.14 -8.85 67.57 Favored Glycine 0 C--N 1.348 1.224 0 CA-C-O 119.749 -0.473 . . . . 63.310000000000002 113.302 179.215 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 39.1 mm-40 -85.56 113.38 50.65 Favored Pre-proline 0 N--CA 1.473 0.721 0 CA-C-O 118.418 -0.801 . . . . 73.040000000000006 109.223 173.321 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 19.2 Cg_endo -55.47 106.06 0.18 Allowed 'Trans proline' 0 C--N 1.385 2.491 0 C-N-CA 123.042 2.495 . . . . 50.219999999999999 112.249 -176.381 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 17' ' ' LEU . . . . . 0.538 ' HB2' HG23 ' A' ' 12' ' ' VAL . 68.9 tp -76.31 -41.37 48.81 Favored 'General case' 0 N--CA 1.476 0.858 0 C-N-CA 123.793 0.837 . . . . 51.049999999999997 109.115 -179.313 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 169.97 -172.98 44.03 Favored Glycine 0 C--N 1.341 0.836 0 CA-C-N 115.376 -0.829 . . . . 55.329999999999998 112.428 176.513 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 56.0 mtm180 -111.84 136.47 51.09 Favored 'General case' 0 C--O 1.239 0.529 0 C-N-CA 124.111 0.965 . . . . 72.010000000000005 109.766 -175.8 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 20' ' ' VAL . . . . . 0.413 ' HA ' ' HA3' ' A' ' 135' ' ' GLY . 61.1 t -129.57 131.98 66.6 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.998 0 C-N-CA 123.644 0.778 . . . . 34.140000000000001 109.522 177.494 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 45.7 m -119.62 123.8 44.75 Favored 'General case' 0 CA--C 1.543 0.673 0 C-N-CA 124.139 0.975 . . . . 74.319999999999993 108.831 174.365 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 14.7 m-85 -99.85 169.09 9.47 Favored 'General case' 0 CA--C 1.541 0.618 0 C-N-CA 123.999 0.92 . . . . 75.430000000000007 109.007 174.886 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 23' ' ' GLU . . . . . 0.527 ' HB2' ' HD2' ' A' ' 133' ' ' LYS . 34.2 tt0 -125.86 108.58 11.59 Favored 'General case' 0 C--O 1.239 0.532 0 N-CA-C 107.697 -1.223 . . . . 73.239999999999995 107.697 179.404 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . 0.62 ' HB2' ' HG2' ' A' ' 4' ' ' PRO . 15.8 mt -84.89 124.5 31.7 Favored 'General case' 0 C--O 1.238 0.499 0 CA-C-O 120.935 0.398 . . . . 72.310000000000002 110.028 -179.884 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 25' ' ' PHE . . . . . 0.635 ' HB2' HD11 ' A' ' 90' ' ' LEU . 86.1 m-85 -86.04 64.86 8.82 Favored 'General case' 0 CA--C 1.535 0.375 0 CA-C-N 115.66 -0.7 . . . . 61.229999999999997 109.586 174.899 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -72.42 -16.06 61.83 Favored 'General case' 0 N--CA 1.479 0.989 0 CA-C-N 115.383 -0.826 . . . . 72.099999999999994 111.445 -179.11 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 9.8 p-10 -74.15 -23.0 59.21 Favored 'General case' 0 CA--C 1.553 1.068 0 C-N-CA 123.96 0.904 . . . . 51.530000000000001 110.782 173.851 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 58.2 mttp -101.52 -52.33 3.25 Favored 'General case' 0 N--CA 1.478 0.973 0 C-N-CA 123.874 0.87 . . . . 71.209999999999994 110.771 -177.618 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 30.0 m -122.85 74.37 46.57 Favored Pre-proline 0 CA--C 1.559 1.296 0 C-N-CA 124.308 1.043 . . . . 72.299999999999997 109.761 -173.884 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 24.8 Cg_exo -62.29 -43.36 23.62 Favored 'Trans proline' 0 C--N 1.38 2.206 0 C-N-CA 122.726 2.284 . . . . 74.049999999999997 113.136 -169.717 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 31' ' ' LYS . . . . . 0.416 ' HD2' ' HB2' ' A' ' 86' ' ' GLU . 1.5 ttmp? -57.05 -54.73 43.42 Favored 'General case' 0 N--CA 1.484 1.232 0 C-N-CA 123.472 0.709 . . . . 64.129999999999995 111.495 177.476 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 6.4 m -71.21 -36.3 71.84 Favored 'General case' 0 CA--C 1.551 0.993 0 C-N-CA 123.773 0.829 . . . . 71.519999999999996 111.776 -168.932 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 33' ' ' ALA . . . . . 0.414 ' HB1' ' HB3' ' A' ' 24' ' ' LEU . . . -79.85 -48.54 13.35 Favored 'General case' 0 N--CA 1.474 0.77 0 C-N-CA 123.447 0.699 . . . . 41.350000000000001 111.103 -177.792 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 12.6 tp10 -63.47 -28.48 69.99 Favored 'General case' 0 N--CA 1.482 1.141 0 C-N-CA 123.59 0.756 . . . . 63.210000000000001 111.099 -179.491 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 35' ' ' ASN . . . . . 0.543 ' ND2' ' SD ' ' A' ' 100' ' ' MET . 32.6 t30 -52.79 -69.37 0.12 Allowed 'General case' 0 C--N 1.353 0.721 0 O-C-N 123.948 0.78 . . . . 75.239999999999995 110.316 174.239 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 85.5 t80 -66.69 -32.41 73.71 Favored 'General case' 0 N--CA 1.476 0.875 0 C-N-CA 123.501 0.721 . . . . 71.150000000000006 111.296 -173.869 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 56.2 ttt-85 -55.4 -54.33 45.08 Favored 'General case' 0 N--CA 1.474 0.767 0 C-N-CA 124.192 0.997 . . . . 64.150000000000006 110.268 175.803 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 38' ' ' ALA . . . . . 0.426 ' HB1' ' HG2' ' A' ' 44' ' ' LYS . . . -76.2 -24.15 54.67 Favored 'General case' 0 CA--C 1.541 0.623 0 CA-C-N 115.147 -0.933 . . . . 35.409999999999997 112.218 -174.941 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 39' ' ' LEU . . . . . 0.525 HD22 ' HE2' ' A' ' 48' ' ' TYR . 81.7 mt -66.03 -43.16 88.41 Favored 'General case' 0 N--CA 1.482 1.145 0 C-N-CA 123.329 0.651 . . . . 64.549999999999997 110.144 173.794 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 47.4 m -82.55 -37.37 25.25 Favored 'General case' 0 CA--C 1.547 0.838 0 CA-C-N 115.143 -0.935 . . . . 64.439999999999998 112.317 -172.718 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 41' ' ' THR . . . . . 0.421 ' OG1' ' HG2' ' A' ' 43' ' ' GLU . 3.7 p -72.79 -32.06 65.31 Favored 'General case' 0 N--CA 1.485 1.323 0 C-N-CA 122.519 0.328 . . . . 73.239999999999995 110.309 172.664 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 84.85 29.5 28.8 Favored Glycine 0 C--N 1.345 1.059 0 CA-C-N 116.025 -0.534 . . . . 70.049999999999997 112.558 -178.789 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 43' ' ' GLU . . . . . 0.421 ' HG2' ' OG1' ' A' ' 41' ' ' THR . 17.6 mm-40 -63.85 -31.41 72.59 Favored 'General case' 0 N--CA 1.48 1.058 0 C-N-CA 123.266 0.626 . . . . 64.209999999999994 110.793 176.606 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 44' ' ' LYS . . . . . 0.426 ' HG2' ' HB1' ' A' ' 38' ' ' ALA . 71.6 mmtt -95.42 19.25 11.15 Favored 'General case' 0 N--CA 1.48 1.028 0 C-N-CA 123.719 0.807 . . . . 64.439999999999998 110.533 179.012 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 83.72 -15.97 33.77 Favored Glycine 0 C--N 1.353 1.482 0 CA-C-O 119.472 -0.627 . . . . 62.100000000000001 114.486 175.814 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 46' ' ' PHE . . . . . 0.421 ' HE2' ' HA ' ' A' ' 78' ' ' ILE . 23.6 m-85 -76.77 -51.24 11.75 Favored 'General case' 0 N--CA 1.476 0.853 0 CA-C-N 117.508 0.654 . . . . 61.340000000000003 112.686 -166.77 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 48.82 63.3 3.95 Favored Glycine 0 C--N 1.355 1.628 0 O-C-N 123.978 0.799 . . . . 54.329999999999998 114.653 176.302 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 48' ' ' TYR . . . . . 0.525 ' HE2' HD22 ' A' ' 39' ' ' LEU . 30.2 m-85 -70.04 100.2 1.58 Allowed 'General case' 0 N--CA 1.484 1.25 0 CA-C-N 117.763 0.782 . . . . 74.099999999999994 111.332 -175.511 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 49' ' ' LYS . . . . . 0.582 ' HE3' ' HA ' ' A' ' 160' ' ' ASP . 23.5 tptm -107.47 132.32 53.35 Favored 'General case' 0 CA--C 1.534 0.332 0 C-N-CA 124.951 1.301 . . . . 71.430000000000007 109.063 -176.004 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 83.2 21.38 58.93 Favored Glycine 0 C--N 1.348 1.196 0 CA-C-O 119.722 -0.488 . . . . 72.099999999999994 112.958 179.408 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 51' ' ' SER . . . . . 0.73 ' HA ' ' HB2' ' A' ' 67' ' ' PHE . 22.4 t -61.91 114.26 3.26 Favored 'General case' 0 C--N 1.358 0.959 0 C-N-CA 122.937 0.495 . . . . 74.519999999999996 110.601 -179.761 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 52' ' ' CYS . . . . . 0.609 ' HB3' ' HB3' ' A' ' 66' ' ' ASP . 53.5 t -89.89 157.95 17.65 Favored 'General case' 0 C--O 1.24 0.58 0 C-N-CA 123.352 0.661 . . . . 52.520000000000003 111.412 -173.349 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 53' ' ' PHE . . . . . 0.7 ' HA ' ' HA2' ' A' ' 64' ' ' GLY . 14.5 m-85 -105.85 98.0 7.75 Favored 'General case' 0 CA--C 1.535 0.402 0 C-N-CA 124.973 1.309 . . . . 70.239999999999995 107.64 176.263 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 40.8 p-80 -88.22 -27.26 21.91 Favored 'General case' 0 N--CA 1.483 1.206 0 C-N-CA 122.464 0.306 . . . . 74.450000000000003 111.519 -178.068 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 55' ' ' ARG . . . . . 0.501 ' HA ' ' O ' ' A' ' 150' ' ' GLY . 42.4 ttt180 -116.1 104.86 11.97 Favored 'General case' 0 C--O 1.212 -0.917 0 N-CA-C 109.762 -0.458 . . . . 71.329999999999998 109.762 -175.583 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 63.5 mt -132.46 133.39 59.89 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.044 0 N-CA-C 108.963 -0.754 . . . . 74.549999999999997 108.963 174.066 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 57' ' ' ILE . . . . . 0.409 ' HB ' ' HD2' ' A' ' 60' ' ' PHE . 62.0 mt -123.15 123.18 26.73 Favored Pre-proline 0 CA--C 1.558 1.265 0 C-N-CA 124.41 1.084 . . . . 71.0 109.044 176.475 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 55.9 Cg_endo -67.31 144.7 69.22 Favored 'Trans proline' 0 C--N 1.383 2.392 0 C-N-CA 122.983 2.455 . . . . 75.540000000000006 111.798 178.706 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 73.56 13.48 80.15 Favored Glycine 0 CA--C 1.527 0.838 0 CA-C-N 115.46 -0.791 . . . . 71.099999999999994 114.027 -176.409 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 60' ' ' PHE . . . . . 0.409 ' HD2' ' HB ' ' A' ' 57' ' ' ILE . 17.6 t80 -139.73 -75.06 0.35 Allowed 'General case' 0 C--O 1.245 0.859 0 C-N-CA 123.091 0.556 . . . . 65.209999999999994 110.495 -173.964 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 61' ' ' MET . . . . . 0.68 ' SD ' ' HB2' ' A' ' 113' ' ' PHE . 13.9 tmm? -174.62 147.26 1.06 Allowed 'General case' 0 CA--C 1.55 0.957 0 N-CA-C 112.064 0.394 . . . . 71.430000000000007 112.064 -164.827 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 62' ' ' CYS . . . . . 0.527 ' SG ' ' HB ' ' A' ' 114' ' ' ILE . 21.8 p -108.11 112.48 25.04 Favored 'General case' 0 CA--C 1.552 1.053 0 C-N-CA 124.182 0.993 . . . . 51.399999999999999 109.873 172.984 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 63' ' ' GLN . . . . . 0.607 ' HB2' ' SD ' ' A' ' 61' ' ' MET . 49.2 tt0 -104.87 111.33 24.05 Favored 'General case' 0 N--CA 1.487 1.404 0 C-N-CA 124.064 0.946 . . . . 71.150000000000006 111.465 -173.637 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 64' ' ' GLY . . . . . 0.7 ' HA2' ' HA ' ' A' ' 53' ' ' PHE . . . -89.51 -179.6 45.01 Favored Glycine 0 C--N 1.342 0.865 0 CA-C-N 114.952 -1.022 . . . . 55.200000000000003 112.583 173.483 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 99.42 72.22 1.02 Allowed Glycine 0 N--CA 1.444 -0.809 0 N-CA-C 110.491 -1.044 . . . . 45.310000000000002 110.491 -174.334 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 66' ' ' ASP . . . . . 0.609 ' HB3' ' HB3' ' A' ' 52' ' ' CYS . 38.2 t70 -123.88 -4.64 8.06 Favored 'General case' 0 N--CA 1.484 1.256 0 C-N-CA 123.735 0.814 . . . . 72.349999999999994 110.756 175.915 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 67' ' ' PHE . . . . . 0.73 ' HB2' ' HA ' ' A' ' 51' ' ' SER . 56.0 t80 -79.25 -70.58 0.5 Allowed 'General case' 0 CA--C 1.544 0.718 0 CA-C-N 116.082 -0.508 . . . . 74.099999999999994 111.315 -171.402 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 30.9 m -86.28 102.17 13.73 Favored 'General case' 0 N--CA 1.471 0.602 0 C-N-CA 122.484 0.313 . . . . 72.540000000000006 110.954 -171.136 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 81.5 mtp180 52.69 81.94 0.08 Allowed 'General case' 0 N--CA 1.476 0.844 0 C-N-CA 124.518 1.127 . . . . 74.519999999999996 111.335 -178.266 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 27.5 p80 -74.68 26.11 0.09 Allowed 'General case' 0 N--CA 1.495 1.78 0 N-CA-C 113.74 1.015 . . . . 74.400000000000006 113.74 -170.843 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 1.9 m-20 -86.65 45.06 1.21 Allowed 'General case' 0 CA--C 1.555 1.155 0 C-N-CA 124.344 1.058 . . . . 73.219999999999999 109.62 175.436 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 86.79 -7.9 77.99 Favored Glycine 0 C--N 1.353 1.515 0 CA-C-N 116.081 -0.509 . . . . 63.140000000000001 113.459 -176.811 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 73' ' ' THR . . . . . 0.507 ' HA ' ' HB2' ' A' ' 110' ' ' SER . 3.7 m -90.45 -61.57 1.65 Allowed 'General case' 0 N--CA 1.475 0.786 0 CA-C-N 117.499 0.65 . . . . 64.099999999999994 109.35 179.62 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 62.76 10.12 29.91 Favored Glycine 0 CA--C 1.538 1.525 0 N-CA-C 116.585 1.394 . . . . 62.32 116.585 164.772 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 145.44 55.4 0.02 OUTLIER Glycine 0 N--CA 1.471 1.012 0 CA-C-N 118.179 0.99 . . . . 72.230000000000004 111.451 -164.512 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 23.3 pttm -51.13 165.54 0.12 Allowed 'General case' 0 N--CA 1.488 1.428 0 C-N-CA 124.881 1.272 . . . . 75.239999999999995 112.658 179.8 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 77' ' ' SER . . . . . 0.428 ' HA ' HD11 ' A' ' 39' ' ' LEU . 77.0 p -90.65 178.59 6.03 Favored 'General case' 0 CA--C 1.545 0.767 0 C-N-CA 123.386 0.674 . . . . 71.099999999999994 112.446 -169.697 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 78' ' ' ILE . . . . . 0.421 ' HA ' ' HE2' ' A' ' 46' ' ' PHE . 34.7 pt -72.14 -14.57 17.43 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.074 0 C-N-CA 123.935 0.894 . . . . 73.430000000000007 110.663 175.207 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 89.6 m-85 -94.54 16.06 16.37 Favored 'General case' 0 CA--C 1.548 0.872 0 C-N-CA 124.458 1.103 . . . . 73.230000000000004 110.541 175.674 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 89.79 -121.76 6.26 Favored Glycine 0 C--N 1.355 1.587 0 N-CA-C 111.005 -0.838 . . . . 74.129999999999995 111.005 -179.35 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 42.3 tt0 -55.56 -56.4 20.74 Favored 'General case' 0 N--CA 1.48 1.059 0 C-N-CA 125.02 1.328 . . . . 73.109999999999999 111.321 -177.384 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 82' ' ' LYS . . . . . 0.842 ' HD2' ' HA ' ' A' ' 107' ' ' THR . 21.0 pttp -169.79 179.2 3.76 Favored 'General case' 0 N--CA 1.48 1.04 0 C-N-CA 124.322 1.049 . . . . 75.409999999999997 109.895 -174.999 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 53.5 p90 -148.79 173.66 13.03 Favored 'General case' 0 N--CA 1.475 0.817 0 C-N-CA 123.908 0.883 . . . . 75.25 111.269 -177.422 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 13.9 pt-20 -94.8 151.43 19.25 Favored 'General case' 0 CA--C 1.541 0.603 0 CA-C-N 115.009 -0.996 . . . . 74.299999999999997 110.908 178.532 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 85' ' ' ASP . . . . . 0.424 ' HB3' HG23 ' A' ' 127' ' ' VAL . 44.7 m-20 -65.91 136.69 56.46 Favored 'General case' 0 N--CA 1.475 0.813 0 C-N-CA 124.375 1.07 . . . . 75.409999999999997 111.811 -176.93 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 86' ' ' GLU . . . . . 0.416 ' HB2' ' HD2' ' A' ' 31' ' ' LYS . 11.8 tp10 -86.06 -63.54 1.3 Allowed 'General case' 0 CA--C 1.548 0.895 0 CA-C-N 116.106 -0.497 . . . . 63.229999999999997 111.399 -173.144 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 26.0 p-10 -166.71 135.59 2.87 Favored 'General case' 0 N--CA 1.482 1.164 0 C-N-CA 122.936 0.494 . . . . 74.549999999999997 110.194 -173.944 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 25.9 m-85 -95.34 59.83 2.22 Favored 'General case' 0 N--CA 1.478 0.928 0 C-N-CA 123.841 0.856 . . . . 74.099999999999994 110.71 -170.797 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 34.0 mt -75.22 -35.32 33.61 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.17 0 CA-C-N 115.795 -0.639 . . . . 73.049999999999997 110.169 176.004 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 90' ' ' LEU . . . . . 0.635 HD11 ' HB2' ' A' ' 25' ' ' PHE . 78.8 mt -100.1 161.53 13.55 Favored 'General case' 0 N--CA 1.471 0.623 0 C-N-CA 123.798 0.839 . . . . 73.319999999999993 110.61 -179.125 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 91' ' ' LYS . . . . . 0.659 ' HG3' HG22 ' A' ' 93' ' ' THR . 49.3 pttt -159.17 160.37 35.42 Favored 'General case' 0 CA--C 1.547 0.864 0 CA-C-O 121.646 0.736 . . . . 43.039999999999999 111.931 -174.293 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 92' ' ' HIS . . . . . . . . . . . . . 22.9 m-70 -88.93 32.88 0.79 Allowed 'General case' 0 N--CA 1.483 1.195 0 C-N-CA 124.401 1.08 . . . . 73.129999999999995 112.434 -167.877 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 93' ' ' THR . . . . . 0.659 HG22 ' HG3' ' A' ' 91' ' ' LYS . 6.1 t -89.44 68.72 7.92 Favored 'General case' 0 N--CA 1.479 1.003 0 CA-C-O 122.52 1.152 . . . . 74.129999999999995 110.007 -179.217 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 153.12 164.51 12.59 Favored Glycine 0 C--N 1.338 0.64 0 CA-C-N 114.572 -1.195 . . . . 63.130000000000003 111.745 179.245 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 63.6 Cg_endo -76.82 157.37 35.16 Favored 'Trans proline' 0 CA--C 1.554 1.485 0 C-N-CA 122.308 2.006 . . . . 73.400000000000006 112.167 172.965 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 84.16 18.61 62.45 Favored Glycine 0 CA--C 1.532 1.145 0 N-CA-C 114.543 0.577 . . . . 60.329999999999998 114.543 177.506 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 97' ' ' ILE . . . . . . . . . . . . . 37.6 mm -86.48 106.93 16.19 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.311 0 CA-C-N 117.765 0.783 . . . . 71.219999999999999 111.689 -175.07 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 98' ' ' LEU . . . . . 0.449 HD13 HG12 ' A' ' 114' ' ' ILE . 67.2 tp -92.89 119.25 32.0 Favored 'General case' 0 CA--C 1.552 1.055 0 C-N-CA 123.582 0.753 . . . . 73.230000000000004 110.746 -178.614 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 13.5 m -138.0 143.28 40.56 Favored 'General case' 0 N--CA 1.482 1.134 0 C-N-CA 124.744 1.218 . . . . 62.509999999999998 108.774 177.492 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 100' ' ' MET . . . . . 0.649 ' HA ' ' HA ' ' A' ' 112' ' ' PHE . 73.3 mtp -77.95 138.95 39.13 Favored 'General case' 0 N--CA 1.488 1.433 0 CA-C-N 118.616 0.644 . . . . 73.439999999999998 109.335 176.144 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 101' ' ' ALA . . . . . 0.53 ' HB3' ' HB2' ' A' ' 111' ' ' GLN . . . -74.68 160.82 30.3 Favored 'General case' 0 N--CA 1.483 1.178 0 C-N-CA 123.106 0.562 . . . . 74.340000000000003 112.21 -168.281 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 102' ' ' ASN . . . . . 0.439 ' HB3' ' HA ' ' A' ' 108' ' ' ASN . 27.5 p-10 -165.28 164.3 19.94 Favored 'General case' 0 N--CA 1.476 0.839 0 CA-C-N 115.515 -0.766 . . . . 70.299999999999997 110.974 -176.383 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -107.85 10.34 28.63 Favored 'General case' 0 CA--C 1.549 0.91 0 C-N-CA 123.903 0.881 . . . . 64.230000000000004 110.615 171.676 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 148.65 -175.57 27.86 Favored Glycine 0 C--N 1.356 1.669 0 CA-C-O 119.543 -0.587 . . . . 40.520000000000003 112.373 179.666 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 40.4 Cg_exo -59.0 143.94 99.58 Favored 'Trans proline' 0 C--N 1.375 1.955 0 C-N-CA 123.358 2.705 . . . . 64.150000000000006 112.326 174.311 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 65.1 t30 70.56 9.57 6.94 Favored 'General case' 0 N--CA 1.49 1.573 0 C-N-CA 125.27 1.428 . . . . 73.409999999999997 111.245 -177.914 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 107' ' ' THR . . . . . 0.842 ' HA ' ' HD2' ' A' ' 82' ' ' LYS . 4.0 m -121.88 4.65 9.95 Favored 'General case' 0 CA--C 1.556 1.18 0 C-N-CA 123.476 0.711 . . . . 73.430000000000007 110.945 -175.895 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 108' ' ' ASN . . . . . 0.439 ' HA ' ' HB3' ' A' ' 102' ' ' ASN . 48.5 t30 -84.7 140.74 31.08 Favored 'General case' 0 N--CA 1.485 1.324 0 C-N-CA 123.71 0.804 . . . . 72.209999999999994 110.68 -176.682 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 111.98 23.34 5.6 Favored Glycine 0 N--CA 1.474 1.206 0 C-N-CA 122.556 0.122 . . . . 55.030000000000001 113.354 -177.946 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 110' ' ' SER . . . . . 0.507 ' HB2' ' HA ' ' A' ' 73' ' ' THR . 12.2 p -127.77 120.33 27.66 Favored 'General case' 0 CA--C 1.536 0.433 0 N-CA-C 107.334 -1.358 . . . . 62.509999999999998 107.334 171.866 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 111' ' ' GLN . . . . . 0.53 ' HB2' ' HB3' ' A' ' 101' ' ' ALA . 49.4 mt-30 67.65 175.22 0.26 Allowed 'General case' 0 N--CA 1.488 1.436 0 C-N-CA 124.942 1.297 . . . . 74.329999999999998 111.051 -172.82 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 112' ' ' PHE . . . . . 0.649 ' HA ' ' HA ' ' A' ' 100' ' ' MET . 23.7 p90 -149.86 142.18 24.22 Favored 'General case' 0 N--CA 1.477 0.885 0 N-CA-C 108.12 -1.067 . . . . 74.340000000000003 108.12 176.209 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 113' ' ' PHE . . . . . 0.68 ' HB2' ' SD ' ' A' ' 61' ' ' MET . 54.3 p90 -135.27 139.02 44.07 Favored 'General case' 0 C--O 1.239 0.509 0 CA-C-O 121.198 0.523 . . . . 72.530000000000001 111.227 -177.649 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 114' ' ' ILE . . . . . 0.527 ' HB ' ' SG ' ' A' ' 62' ' ' CYS . 11.8 mt -103.17 108.36 24.19 Favored 'Isoleucine or valine' 0 C--O 1.241 0.629 0 N-CA-C 107.475 -1.306 . . . . 73.420000000000002 107.475 176.805 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 115' ' ' CYS . . . . . . . . . . . . . 58.6 m -67.87 103.72 1.52 Allowed 'General case' 0 N--CA 1.467 0.395 0 N-CA-C 109.059 -0.719 . . . . 71.420000000000002 109.059 177.01 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 116' ' ' THR . . . . . 0.609 HG22 HG12 ' A' ' 139' ' ' VAL . 36.6 p -70.9 -32.39 69.33 Favored 'General case' 0 CA--C 1.54 0.584 0 C-N-CA 124.361 1.065 . . . . 64.099999999999994 110.317 179.737 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -110.25 167.91 9.84 Favored 'General case' 0 CA--C 1.543 0.686 0 C-N-CA 124.339 1.056 . . . . 72.329999999999998 109.853 173.92 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 18.2 ptmt -76.83 85.08 3.41 Favored 'General case' 0 N--CA 1.479 0.98 0 C-N-CA 123.427 0.691 . . . . 70.439999999999998 110.568 179.309 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 119' ' ' THR . . . . . 0.656 ' HB ' HD23 ' A' ' 122' ' ' LEU . 73.5 p -77.44 85.33 3.84 Favored 'General case' 0 CA--C 1.552 1.034 0 CA-C-O 122.068 0.937 . . . . 75.140000000000001 110.168 -175.559 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 9.8 pt-20 -81.52 -20.88 39.12 Favored 'General case' 0 N--CA 1.486 1.34 0 C-N-CA 123.691 0.796 . . . . 73.409999999999997 112.247 -167.862 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 121' ' ' TRP . . . . . . . . . . . . . 28.5 p90 -73.06 -8.16 54.49 Favored 'General case' 0 N--CA 1.484 1.23 0 C-N-CA 123.525 0.73 . . . . 74.310000000000002 110.794 174.748 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 122' ' ' LEU . . . . . 0.656 HD23 ' HB ' ' A' ' 119' ' ' THR . 4.2 mm? -84.23 11.48 8.18 Favored 'General case' 0 CA--C 1.554 1.105 0 C-N-CA 124.16 0.984 . . . . 64.129999999999995 111.239 170.932 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 34.5 m-20 -75.92 150.84 37.46 Favored 'General case' 0 N--CA 1.491 1.602 0 CA-C-N 118.804 0.729 . . . . 72.120000000000005 110.744 171.228 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 64.45 13.45 54.88 Favored Glycine 0 C--N 1.352 1.43 0 O-C-N 123.877 0.735 . . . . 55.140000000000001 112.829 -173.827 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -106.76 -166.21 1.15 Allowed 'General case' 0 CA--C 1.547 0.86 0 C-N-CA 124.941 1.296 . . . . 73.310000000000002 108.05 -173.108 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 126' ' ' HIS . . . . . . . . . . . . . 2.1 p80 -66.84 156.79 34.68 Favored 'General case' 0 N--CA 1.476 0.865 0 C-N-CA 124.48 1.112 . . . . 75.319999999999993 113.039 -173.68 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 127' ' ' VAL . . . . . 0.424 HG23 ' HB3' ' A' ' 85' ' ' ASP . 45.9 t -65.74 133.3 30.97 Favored 'Isoleucine or valine' 0 CA--C 1.553 1.084 0 C-N-CA 125.476 1.51 . . . . 73.439999999999998 112.955 -168.894 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 128' ' ' VAL . . . . . 0.509 ' HB ' ' HB2' ' A' ' 90' ' ' LEU . 47.3 t -85.19 158.57 3.41 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.148 0 C-N-CA 124.759 1.224 . . . . 71.129999999999995 108.701 168.813 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 129' ' ' PHE . . . . . 0.417 ' HD2' HD22 ' A' ' 24' ' ' LEU . 36.8 p90 -139.87 -32.53 0.62 Allowed 'General case' 0 N--CA 1.481 1.092 0 CA-C-N 118.422 0.556 . . . . 74.430000000000007 111.936 176.578 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . -117.84 162.41 13.07 Favored Glycine 0 C--N 1.341 0.855 0 CA-C-O 121.071 0.262 . . . . 62.009999999999998 113.427 -173.112 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 131' ' ' LYS . . . . . 0.404 ' HB3' ' HE2' ' A' ' 131' ' ' LYS . 29.6 ttpt -149.51 120.06 7.46 Favored 'General case' 0 N--CA 1.469 0.489 0 C-N-CA 124.717 1.207 . . . . 71.040000000000006 108.796 -179.608 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 34.8 t -61.17 100.78 0.13 Allowed 'Isoleucine or valine' 0 N--CA 1.473 0.7 0 N-CA-C 109.567 -0.531 . . . . 74.120000000000005 109.567 177.266 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 133' ' ' LYS . . . . . 0.527 ' HD2' ' HB2' ' A' ' 23' ' ' GLU . 0.1 OUTLIER -86.25 -28.76 23.61 Favored 'General case' 0 N--CA 1.473 0.68 0 N-CA-C 109.454 -0.573 . . . . 73.310000000000002 109.454 -179.901 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 42.4 mt-10 -144.27 149.83 36.91 Favored 'General case' 0 N--CA 1.478 0.968 0 C-N-CA 124.937 1.295 . . . . 71.5 109.945 176.748 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 135' ' ' GLY . . . . . 0.413 ' HA3' ' HA ' ' A' ' 20' ' ' VAL . . . 85.73 20.21 56.52 Favored Glycine 0 C--N 1.347 1.157 0 CA-C-O 119.822 -0.432 . . . . 51.299999999999997 113.687 176.749 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 136' ' ' MET . . . . . . . . . . . . . 14.4 tpt -67.24 -26.54 66.63 Favored 'General case' 0 N--CA 1.48 1.056 0 C-N-CA 123.156 0.582 . . . . 74.319999999999993 110.867 179.153 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 137' ' ' ASN . . . . . . . . . . . . . 52.9 t-20 -56.88 -44.39 82.22 Favored 'General case' 0 N--CA 1.48 1.07 0 C-N-CA 124.259 1.023 . . . . 65.150000000000006 109.812 172.164 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 138' ' ' ILE . . . . . . . . . . . . . 49.4 mm -71.47 -32.77 47.42 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.748 0 C-N-CA 123.861 0.864 . . . . 71.120000000000005 110.742 -179.08 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 139' ' ' VAL . . . . . 0.609 HG12 HG22 ' A' ' 116' ' ' THR . 93.5 t -67.09 -42.13 87.97 Favored 'Isoleucine or valine' 0 CA--C 1.559 1.317 0 C-N-CA 123.534 0.734 . . . . 54.119999999999997 110.837 177.904 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 39.3 mt-10 -73.92 -28.14 61.38 Favored 'General case' 0 N--CA 1.478 0.949 0 CA-C-N 115.563 -0.744 . . . . 62.509999999999998 110.804 176.747 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -70.43 -44.27 68.2 Favored 'General case' 0 N--CA 1.476 0.847 0 C-N-CA 123.688 0.795 . . . . 63.299999999999997 110.848 178.031 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 142' ' ' MET . . . . . 0.522 ' HB2' HD13 ' A' ' 156' ' ' ILE . 27.7 ptm -73.91 -29.36 62.01 Favored 'General case' 0 N--CA 1.473 0.679 0 CA-C-N 115.567 -0.742 . . . . 74.430000000000007 111.133 -177.975 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 143' ' ' GLU . . . . . 0.447 ' HB2' HG21 ' A' ' 116' ' ' THR . 41.2 tt0 -51.29 -38.44 52.87 Favored 'General case' 0 N--CA 1.478 0.97 0 C-N-CA 124.105 0.962 . . . . 71.540000000000006 111.707 174.189 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 144' ' ' ARG . . . . . . . . . . . . . 39.1 mtp85 -66.92 -22.1 65.97 Favored 'General case' 0 CA--C 1.542 0.667 0 CA-C-N 115.243 -0.889 . . . . 55.130000000000003 112.216 -173.432 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 145' ' ' PHE . . . . . . . . . . . . . 58.4 m-85 -82.35 -5.84 58.87 Favored 'General case' 0 N--CA 1.481 1.106 0 N-CA-C 112.088 0.403 . . . . 74.310000000000002 112.088 -178.181 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . -97.51 173.09 28.16 Favored Glycine 0 C--N 1.35 1.347 0 N-CA-C 112.52 -0.232 . . . . 73.040000000000006 112.52 177.655 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 46.1 m -134.25 172.37 12.96 Favored 'General case' 0 N--CA 1.486 1.328 0 C-N-CA 124.146 0.978 . . . . 72.439999999999998 111.106 -176.164 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 148' ' ' ARG . . . . . . . . . . . . . 11.0 mmt180 -57.14 -46.57 82.58 Favored 'General case' 0 N--CA 1.49 1.557 0 C-N-CA 124.697 1.199 . . . . 64.430000000000007 112.567 -178.553 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 149' ' ' ASN . . . . . . . . . . . . . 29.9 p-10 -67.34 -14.16 62.67 Favored 'General case' 0 N--CA 1.479 1.02 0 C-N-CA 123.801 0.841 . . . . 70.230000000000004 111.884 179.136 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 150' ' ' GLY . . . . . 0.501 ' O ' ' HA ' ' A' ' 55' ' ' ARG . . . 102.68 -4.34 50.2 Favored Glycine 0 C--N 1.351 1.372 0 CA-C-O 119.808 -0.44 . . . . 25.34 112.711 -179.732 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 62.3 tttp -69.93 133.56 47.44 Favored 'General case' 0 N--CA 1.475 0.778 0 CA-C-N 117.15 0.475 . . . . 72.010000000000005 110.408 -177.66 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 152' ' ' THR . . . . . . . . . . . . . 24.8 p -102.06 124.68 48.08 Favored 'General case' 0 C--O 1.236 0.38 0 C-N-CA 123.601 0.761 . . . . 73.430000000000007 109.468 174.165 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 153' ' ' SER . . . . . . . . . . . . . 47.7 t -75.15 -8.62 57.08 Favored 'General case' 0 CA--C 1.55 0.952 0 C-N-CA 123.419 0.688 . . . . 71.420000000000002 111.059 174.866 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 74.7 mmtt -133.96 132.42 40.16 Favored 'General case' 0 N--CA 1.475 0.777 0 C-N-CA 124.54 1.136 . . . . 71.299999999999997 109.424 178.489 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 46.1 mtmt -82.31 93.29 7.12 Favored 'General case' 0 N--CA 1.474 0.767 0 N-CA-C 108.085 -1.08 . . . . 73.400000000000006 108.085 173.757 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 156' ' ' ILE . . . . . 0.522 HD13 ' HB2' ' A' ' 142' ' ' MET . 62.6 mt -85.23 104.67 13.45 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.557 0 CA-C-N 115.707 -0.679 . . . . 74.209999999999994 109.886 -175.223 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 157' ' ' THR . . . . . . . . . . . . . 50.1 p -103.93 148.17 26.48 Favored 'General case' 0 N--CA 1.476 0.83 0 C-N-CA 124.44 1.096 . . . . 73.519999999999996 110.712 -173.393 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 158' ' ' ILE . . . . . 0.483 HG23 ' HB3' ' A' ' 8' ' ' PHE . 60.3 mt -74.93 93.43 0.8 Allowed 'Isoleucine or valine' 0 CA--C 1.543 0.706 0 N-CA-C 108.136 -1.061 . . . . 74.340000000000003 108.136 169.264 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 159' ' ' ALA . . . . . 0.451 ' HB2' ' HB2' ' A' ' 11' ' ' ALA . . . -57.29 -40.08 77.07 Favored 'General case' 0 N--CA 1.476 0.838 0 C-N-CA 124.585 1.154 . . . . 73.140000000000001 112.784 -177.335 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 160' ' ' ASP . . . . . 0.582 ' HA ' ' HE3' ' A' ' 49' ' ' LYS . 29.4 t70 -156.15 163.87 39.08 Favored 'General case' 0 N--CA 1.474 0.738 0 O-C-N 123.394 0.434 . . . . 61.32 111.06 -175.862 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 161' ' ' CYS . . . . . . . . . . . . . 18.6 p -131.39 -169.94 2.28 Favored 'General case' 0 CA--C 1.542 0.661 0 C-N-CA 124.976 1.311 . . . . 72.299999999999997 108.729 177.844 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 162' ' ' GLY . . . . . . . . . . . . . . . 131.22 51.69 0.1 OUTLIER Glycine 0 N--CA 1.471 1.008 0 N-CA-C 109.915 -1.274 . . . . 73.349999999999994 109.915 -170.225 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 163' ' ' GLN . . . . . 0.664 ' HA ' ' H ' ' A' ' 7' ' ' PHE . 36.7 mt-30 -54.33 122.19 9.87 Favored 'General case' 0 CA--C 1.546 0.821 0 CA-C-N 112.429 -1.885 . . . . 74.519999999999996 111.927 -175.836 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 164' ' ' LEU . . . . . . . . . . . . . 82.5 mt . . . . . 0 N--CA 1.475 0.806 0 C-N-CA 123.377 0.671 . . . . 70.310000000000002 111.377 -168.046 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' B' B ' 218' ' ' PRO . . . . . . . . . . . . . 32.4 Cg_exo . . . . . 0 CA--C 1.547 1.168 0 CA-C-O 120.927 0.303 . . . . 63.200000000000003 111.787 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' B' B ' 219' ' ' GLY . . . . . . . . . . . . . . . 171.14 152.48 8.27 Favored Glycine 0 C--N 1.339 0.748 0 CA-C-N 115.827 -0.624 . . . . 72.420000000000002 111.865 178.4 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 220' ' ' PRO . . . . . 0.623 ' HB3' HD11 ' A' ' 122' ' ' LEU . 84.5 Cg_endo -77.72 155.52 31.13 Favored 'Trans proline' 0 C--N 1.373 1.852 0 C-N-CA 122.691 2.26 . . . . 61.210000000000001 112.395 179.888 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 221' ' ' TYR . . . . . . . . . . . . . 54.4 m-85 . . . . . 0 C--O 1.244 0.777 0 C-N-CA 123.306 0.642 . . . . 74.140000000000001 109.469 -174.799 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 3' ' ' ASN . . . . . 0.4 ' ND2' ' HA ' ' A' ' 25' ' ' PHE . 16.6 m120 . . . . . 0 C--O 1.24 0.588 0 N-CA-C 110.024 -0.362 . . . . 73.349999999999994 110.024 . . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 4' ' ' PRO . . . . . 0.451 ' HG2' ' HB2' ' A' ' 24' ' ' LEU . 60.7 Cg_endo -80.04 141.02 14.54 Favored 'Trans proline' 0 C--N 1.362 1.283 0 C-N-CA 122.116 1.877 . . . . 75.340000000000003 111.003 164.518 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 5' ' ' THR . . . . . 0.402 ' HB ' ' O ' ' A' ' 164' ' ' LEU . 50.6 m -96.54 134.0 40.31 Favored 'General case' 0 CA--C 1.533 0.302 0 N-CA-C 108.744 -0.835 . . . . 72.530000000000001 108.744 175.673 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 6' ' ' VAL . . . . . 0.6 ' HA ' ' HB2' ' A' ' 163' ' ' GLN . 58.2 t -100.47 145.84 10.27 Favored 'Isoleucine or valine' 0 C--O 1.217 -0.645 0 N-CA-C 107.869 -1.16 . . . . 63.210000000000001 107.869 174.593 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 7' ' ' PHE . . . . . 0.443 ' HB2' ' HG ' ' A' ' 164' ' ' LEU . 87.7 t80 -129.26 126.46 39.12 Favored 'General case' 0 C--O 1.239 0.552 0 N-CA-C 109.132 -0.692 . . . . 75.519999999999996 109.132 178.663 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 8' ' ' PHE . . . . . 0.441 ' HE2' ' HZ ' ' A' ' 36' ' ' PHE . 31.0 m-85 -128.16 166.0 19.35 Favored 'General case' 0 C--O 1.238 0.477 0 C-N-CA 124.253 1.021 . . . . 73.409999999999997 109.409 168.8 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 29.1 m-20 -115.16 111.96 21.8 Favored 'General case' 0 C--N 1.326 -0.419 0 N-CA-C 107.291 -1.374 . . . . 75.140000000000001 107.291 170.835 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 10' ' ' ILE . . . . . 0.482 HG21 ' SD ' ' A' ' 142' ' ' MET . 46.8 mm -80.89 125.76 39.5 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.473 0 N-CA-C 108.896 -0.779 . . . . 60.100000000000001 108.896 -179.461 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 11' ' ' ALA . . . . . 0.821 ' HB2' ' HB2' ' A' ' 159' ' ' ALA . . . -114.6 142.82 45.94 Favored 'General case' 0 C--O 1.217 -0.634 0 C-N-CA 124.556 1.142 . . . . 52.210000000000001 110.199 -173.839 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 12' ' ' VAL . . . . . 0.46 HG22 HG12 ' A' ' 156' ' ' ILE . 60.9 t -123.99 135.12 64.61 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.907 0 N-CA-C 107.237 -1.394 . . . . 64.209999999999994 107.237 172.097 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 25.4 m-20 65.49 20.32 11.68 Favored 'General case' 0 N--CA 1.494 1.73 0 C-N-CA 124.304 1.041 . . . . 75.209999999999994 110.424 -168.841 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 80.36 -5.7 62.93 Favored Glycine 0 C--N 1.358 1.753 0 CA-C-N 116.065 -0.516 . . . . 60.109999999999999 113.757 -173.849 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 30.8 mm-40 -104.77 126.94 29.9 Favored Pre-proline 0 N--CA 1.475 0.823 0 C-N-CA 123.882 0.873 . . . . 75.329999999999998 110.45 -175.52 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 14.8 Cg_endo -51.87 112.94 0.96 Allowed 'Trans proline' 0 C--N 1.385 2.494 0 C-N-CA 123.538 2.826 . . . . 63.520000000000003 112.647 -174.397 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 50.7 tp -76.42 -46.35 27.52 Favored 'General case' 0 N--CA 1.468 0.472 0 CA-C-N 115.007 -0.997 . . . . 52.409999999999997 108.859 175.535 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -169.57 -176.21 39.25 Favored Glycine 0 C--N 1.34 0.781 0 CA-C-N 115.169 -0.923 . . . . 72.340000000000003 112.258 179.777 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 13.5 ptp180 -109.79 144.44 38.21 Favored 'General case' 0 N--CA 1.475 0.786 0 C-N-CA 123.833 0.853 . . . . 54.340000000000003 110.256 -179.536 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 99.3 t -135.55 131.97 51.38 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.733 0 C-N-CA 124.058 0.943 . . . . 74.25 108.918 177.117 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 21' ' ' SER . . . . . 0.473 ' OG ' ' HB2' ' A' ' 134' ' ' GLU . 78.0 p -116.13 130.9 57.02 Favored 'General case' 0 CA--C 1.552 1.021 0 C-N-CA 123.388 0.675 . . . . 75.239999999999995 109.561 173.914 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 22' ' ' PHE . . . . . 0.452 ' CD1' HD22 ' A' ' 98' ' ' LEU . 44.9 m-85 -102.61 169.94 8.34 Favored 'General case' 0 N--CA 1.471 0.575 0 C-N-CA 124.785 1.234 . . . . 64.200000000000003 110.015 178.928 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 6.4 tp10 -130.95 106.31 8.33 Favored 'General case' 0 C--O 1.24 0.57 0 N-CA-C 108.593 -0.891 . . . . 54.439999999999998 108.593 -179.691 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . 0.451 ' HB2' ' HG2' ' A' ' 4' ' ' PRO . 52.1 mt -78.71 124.75 28.52 Favored 'General case' 0 N--CA 1.468 0.448 0 N-CA-C 109.962 -0.384 . . . . 75.150000000000006 109.962 178.383 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 25' ' ' PHE . . . . . 0.483 ' HB2' HD11 ' A' ' 90' ' ' LEU . 36.4 m-85 -85.34 60.0 5.98 Favored 'General case' 0 CA--C 1.545 0.771 0 N-CA-C 108.777 -0.823 . . . . 73.239999999999995 108.777 173.132 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -61.34 -33.41 73.57 Favored 'General case' 0 N--CA 1.483 1.21 0 C-N-CA 123.613 0.765 . . . . 75.420000000000002 111.666 -175.344 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 12.2 p-10 -59.98 -29.59 68.55 Favored 'General case' 0 CA--C 1.549 0.907 0 C-N-CA 124.372 1.069 . . . . 70.040000000000006 111.92 176.765 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 28' ' ' LYS . . . . . 0.579 ' HD2' HD21 ' A' ' 90' ' ' LEU . 40.0 mttm -94.72 -42.29 8.83 Favored 'General case' 0 N--CA 1.482 1.14 0 C-N-CA 123.548 0.739 . . . . 74.239999999999995 110.637 -178.114 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 29' ' ' VAL . . . . . 0.532 HG21 ' HA ' ' A' ' 129' ' ' PHE . 18.9 m -124.58 82.17 59.47 Favored Pre-proline 0 CA--C 1.563 1.473 0 C-N-CA 123.843 0.857 . . . . 74.329999999999998 110.867 -176.369 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 60.7 Cg_exo -53.77 -52.6 8.12 Favored 'Trans proline' 0 C--N 1.386 2.533 0 C-N-CA 123.183 2.589 . . . . 75.030000000000001 113.504 -177.83 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 4.0 ttmp? -66.47 -52.77 42.72 Favored 'General case' 0 N--CA 1.481 1.096 0 C-N-CA 124.252 1.021 . . . . 75.019999999999996 111.975 -177.301 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 32' ' ' THR . . . . . 0.66 HG22 ' HD2' ' A' ' 129' ' ' PHE . 1.4 m -64.55 -38.04 89.63 Favored 'General case' 0 CA--C 1.549 0.925 0 CA-C-N 115.23 -0.895 . . . . 73.030000000000001 110.94 -169.586 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -83.6 -36.44 23.92 Favored 'General case' 0 CA--C 1.548 0.885 0 C-N-CA 122.825 0.45 . . . . 75.439999999999998 112.2 -178.826 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 29.9 tt0 -57.03 -47.42 80.95 Favored 'General case' 0 N--CA 1.492 1.64 0 C-N-CA 123.371 0.668 . . . . 53.109999999999999 110.535 175.439 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 35' ' ' ASN . . . . . 0.499 ' O ' ' HG ' ' A' ' 39' ' ' LEU . 39.8 t30 -49.63 -57.38 7.27 Favored 'General case' 0 C--N 1.349 0.577 0 O-C-N 125.406 1.691 . . . . 73.5 110.474 179.209 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 36' ' ' PHE . . . . . 0.441 ' HZ ' ' HE2' ' A' ' 8' ' ' PHE . 72.3 t80 -62.24 -45.2 94.38 Favored 'General case' 0 CA--C 1.543 0.675 0 O-C-N 124.169 0.918 . . . . 73.129999999999995 112.051 -175.939 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 11.6 ttm180 -54.14 -47.72 71.59 Favored 'General case' 0 N--CA 1.482 1.143 0 O-C-N 123.843 0.714 . . . . 75.439999999999998 111.507 176.123 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 38' ' ' ALA . . . . . 0.522 ' HB1' ' HG2' ' A' ' 44' ' ' LYS . . . -70.44 -30.37 67.19 Favored 'General case' 0 CA--C 1.544 0.724 0 CA-C-N 115.578 -0.737 . . . . 74.030000000000001 111.809 -175.605 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 39' ' ' LEU . . . . . 0.552 HD22 ' HE2' ' A' ' 48' ' ' TYR . 99.7 mt -71.31 -43.64 66.7 Favored 'General case' 0 N--CA 1.477 0.883 0 C-N-CA 123.603 0.761 . . . . 71.129999999999995 110.593 175.161 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 34.9 t -64.56 -52.32 58.29 Favored 'General case' 0 N--CA 1.477 0.924 0 C-N-CA 124.979 1.312 . . . . 70.200000000000003 111.562 -174.843 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 41' ' ' THR . . . . . 0.446 ' OG1' ' HG2' ' A' ' 43' ' ' GLU . 67.4 p -85.18 -31.25 23.33 Favored 'General case' 0 C--O 1.24 0.587 0 CA-C-N 115.096 -0.956 . . . . 74.109999999999999 111.388 -176.054 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 85.99 35.72 10.92 Favored Glycine 0 C--N 1.347 1.16 0 CA-C-N 116.154 -0.476 . . . . 53.240000000000002 112.736 -177.803 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 43' ' ' GLU . . . . . 0.446 ' HG2' ' OG1' ' A' ' 41' ' ' THR . 26.7 mm-40 -62.89 -30.86 71.85 Favored 'General case' 0 N--CA 1.483 1.218 0 C-N-CA 122.92 0.488 . . . . 55.409999999999997 110.606 172.682 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 44' ' ' LYS . . . . . 0.522 ' HG2' ' HB1' ' A' ' 38' ' ' ALA . 31.5 mmmt -100.57 20.19 15.51 Favored 'General case' 0 CA--C 1.548 0.899 0 C-N-CA 123.707 0.803 . . . . 74.530000000000001 111.465 177.353 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 71.17 41.91 59.15 Favored Glycine 0 C--N 1.35 1.334 0 CA-C-O 119.528 -0.595 . . . . 71.230000000000004 114.562 171.896 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 24.1 m-85 -123.19 -48.33 1.98 Allowed 'General case' 0 N--CA 1.486 1.372 0 CA-C-N 117.596 0.698 . . . . 71.420000000000002 111.071 -176.876 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 48.58 62.64 4.3 Favored Glycine 0 C--N 1.356 1.685 0 O-C-N 124.169 0.918 . . . . 15.109999999999999 114.288 171.669 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 48' ' ' TYR . . . . . 0.589 ' CE1' ' HA2' ' A' ' 75' ' ' GLY . 66.1 m-85 -60.78 95.37 0.04 OUTLIER 'General case' 0 N--CA 1.48 1.065 0 CA-C-O 122.108 0.956 . . . . 72.099999999999994 112.751 -174.617 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 28.6 tptp -109.41 131.45 55.05 Favored 'General case' 0 CA--C 1.537 0.457 0 CA-C-N 113.337 -1.756 . . . . 51.530000000000001 109.149 -176.798 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 72.71 20.34 79.64 Favored Glycine 0 C--N 1.346 1.098 0 CA-C-O 119.665 -0.519 . . . . 70.040000000000006 113.793 177.412 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 51' ' ' SER . . . . . 0.485 ' HB3' ' HA2' ' A' ' 65' ' ' GLY . 49.0 m -61.14 114.56 3.2 Favored 'General case' 0 N--CA 1.476 0.858 0 C-N-CA 123.249 0.62 . . . . 63.039999999999999 110.368 -178.29 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 52' ' ' CYS . . . . . . . . . . . . . 53.5 t -92.14 121.44 33.69 Favored 'General case' 0 N--CA 1.474 0.727 0 N-CA-C 113.031 0.752 . . . . 75.209999999999994 113.031 -165.945 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 53' ' ' PHE . . . . . 0.584 ' HB2' ' HB ' ' A' ' 156' ' ' ILE . 76.4 m-85 -69.4 114.57 7.77 Favored 'General case' 0 C--O 1.239 0.517 0 C-N-CA 124.867 1.267 . . . . 75.5 109.816 167.803 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 17.4 p-80 -128.04 -4.5 5.66 Favored 'General case' 0 N--CA 1.481 1.079 0 C-N-CA 123.565 0.746 . . . . 75.400000000000006 112.031 -173.819 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 36.0 ttt180 -135.19 107.37 7.19 Favored 'General case' 0 C--N 1.357 0.928 0 N-CA-C 108.975 -0.75 . . . . 74.230000000000004 108.975 170.756 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 56' ' ' ILE . . . . . 0.494 HG23 ' SG ' ' A' ' 62' ' ' CYS . 71.8 mt -130.62 129.25 64.17 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.694 0 C-N-CA 123.721 0.808 . . . . 64.349999999999994 109.242 177.365 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 57' ' ' ILE . . . . . 0.468 HG12 ' HA2' ' A' ' 150' ' ' GLY . 52.2 mt -117.07 121.54 32.38 Favored Pre-proline 0 CA--C 1.556 1.186 0 C-N-CA 124.584 1.154 . . . . 61.039999999999999 108.725 176.903 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 58' ' ' PRO . . . . . 0.503 ' HA ' ' HG3' ' A' ' 143' ' ' GLU . 24.3 Cg_exo -64.01 146.85 91.67 Favored 'Trans proline' 0 C--N 1.375 1.954 0 C-N-CA 122.792 2.328 . . . . 65.200000000000003 112.63 173.388 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 63.99 31.22 80.08 Favored Glycine 0 C--N 1.345 1.033 0 CA-C-N 115.117 -0.947 . . . . 63.049999999999997 113.284 -176.306 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 40.0 t80 -158.46 -77.77 0.07 Allowed 'General case' 0 CA--C 1.549 0.923 0 CA-C-N 116.814 0.307 . . . . 74.409999999999997 111.653 -174.18 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 48.3 ttm -165.6 157.12 14.32 Favored 'General case' 0 N--CA 1.489 1.49 0 N-CA-C 112.01 0.374 . . . . 70.540000000000006 112.01 -163.433 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 62' ' ' CYS . . . . . 0.494 ' SG ' HG23 ' A' ' 56' ' ' ILE . 61.2 m -131.86 113.37 13.4 Favored 'General case' 0 N--CA 1.471 0.623 0 C-N-CA 124.299 1.04 . . . . 54.219999999999999 109.11 175.772 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 13.4 pt20 -117.6 149.55 40.48 Favored 'General case' 0 N--CA 1.488 1.448 0 CA-C-O 121.396 0.617 . . . . 75.239999999999995 111.556 -177.343 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 64' ' ' GLY . . . . . 0.459 ' CA ' ' HA ' ' A' ' 53' ' ' PHE . . . -162.1 179.4 37.46 Favored Glycine 0 C--N 1.343 0.951 0 CA-C-N 114.536 -1.211 . . . . 60.109999999999999 113.94 -176.492 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 65' ' ' GLY . . . . . 0.485 ' HA2' ' HB3' ' A' ' 51' ' ' SER . . . 110.04 98.31 2.5 Favored Glycine 0 N--CA 1.447 -0.581 0 N-CA-C 108.91 -1.676 . . . . 74.450000000000003 108.91 -167.277 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 23.7 t70 -124.69 19.95 8.6 Favored 'General case' 0 N--CA 1.483 1.21 0 CA-C-O 121.765 0.793 . . . . 53.409999999999997 109.132 179.353 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 49.1 t80 -81.54 -77.83 0.2 Allowed 'General case' 0 CA--C 1.551 1.004 0 CA-C-N 115.301 -0.863 . . . . 61.420000000000002 111.746 -169.55 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 89.6 m -85.54 107.74 17.61 Favored 'General case' 0 N--CA 1.48 1.068 0 C-N-CA 122.406 0.282 . . . . 73.310000000000002 110.442 -175.348 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 77.9 mtp180 66.44 80.86 0.21 Allowed 'General case' 0 N--CA 1.472 0.672 0 C-N-CA 125.177 1.391 . . . . 74.5 110.468 -179.85 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 7.8 p80 -70.98 73.87 0.61 Allowed 'General case' 0 CA--C 1.558 1.265 0 CA-C-O 122.343 1.068 . . . . 70.310000000000002 110.652 179.709 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 7.4 t30 -153.81 30.39 0.46 Allowed 'General case' 0 CA--C 1.553 1.073 0 C-N-CA 125.066 1.347 . . . . 65.439999999999998 107.587 -172.821 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 92.17 -8.67 77.48 Favored Glycine 0 C--N 1.353 1.507 0 CA-C-N 114.874 -1.057 . . . . 53.409999999999997 113.431 -177.235 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 73' ' ' THR . . . . . 0.608 ' HA ' ' HB2' ' A' ' 110' ' ' SER . 28.7 m -85.09 -67.12 0.82 Allowed 'General case' 0 CA--C 1.546 0.815 0 N-CA-C 108.525 -0.917 . . . . 63.32 108.525 174.458 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 54.92 18.58 11.87 Favored Glycine 0 C--N 1.348 1.242 0 N-CA-C 115.807 1.083 . . . . 71.340000000000003 115.807 167.248 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 75' ' ' GLY . . . . . 0.589 ' HA2' ' CE1' ' A' ' 48' ' ' TYR . . . 147.84 54.14 0.02 OUTLIER Glycine 0 CA--C 1.494 -1.233 0 O-C-N 121.537 -0.978 . . . . 53.0 111.826 -160.287 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 64.2 pttt -60.18 167.74 2.26 Favored 'General case' 0 CA--C 1.546 0.823 0 O-C-N 124.524 0.779 . . . . 44.140000000000001 111.173 173.782 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 87.1 p -88.78 174.16 8.15 Favored 'General case' 0 C--O 1.241 0.647 0 CA-C-N 115.68 -0.691 . . . . 51.210000000000001 110.607 -177.746 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 29.6 pt -69.77 -21.69 24.44 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.787 0 CA-C-N 115.846 -0.616 . . . . 74.040000000000006 110.557 173.244 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 56.4 m-85 -87.14 0.4 55.36 Favored 'General case' 0 N--CA 1.479 0.989 0 C-N-CA 124.134 0.974 . . . . 63.43 111.636 -178.166 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 125.6 -150.71 17.47 Favored Glycine 0 C--N 1.347 1.172 0 N-CA-C 111.135 -0.786 . . . . 73.129999999999995 111.135 -179.933 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 45.9 tt0 -63.02 -40.73 98.62 Favored 'General case' 0 N--CA 1.476 0.873 0 C-N-CA 123.392 0.677 . . . . 72.25 110.612 175.997 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 82' ' ' LYS . . . . . 0.476 ' HD3' ' HA ' ' A' ' 107' ' ' THR . 11.2 ptpp? -150.66 168.38 24.5 Favored 'General case' 0 CA--C 1.548 0.887 0 CA-C-N 115.637 -0.71 . . . . 73.230000000000004 110.963 -171.727 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 35.5 p90 -159.77 164.33 33.88 Favored 'General case' 0 N--CA 1.477 0.916 0 C-N-CA 124.797 1.239 . . . . 72.230000000000004 109.512 176.065 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 11.6 pt-20 -94.25 159.16 15.26 Favored 'General case' 0 N--CA 1.478 0.931 0 C-N-CA 123.158 0.583 . . . . 74.129999999999995 109.834 173.934 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 63.9 m-20 -67.08 151.36 47.75 Favored 'General case' 0 N--CA 1.475 0.809 0 C-N-CA 124.371 1.069 . . . . 74.129999999999995 113.814 -170.74 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 6.3 tp10 -69.59 -59.33 3.03 Favored 'General case' 0 CA--C 1.55 0.958 0 CA-C-N 114.953 -1.022 . . . . 75.209999999999994 111.12 177.567 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 87' ' ' ASN . . . . . 0.417 ' OD1' HG12 ' A' ' 29' ' ' VAL . 25.8 p-10 -174.2 137.51 0.54 Allowed 'General case' 0 N--CA 1.489 1.508 0 C-N-CA 123.88 0.872 . . . . 75.519999999999996 109.912 -171.639 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 91.9 m-85 -89.12 54.82 3.1 Favored 'General case' 0 N--CA 1.489 1.508 0 CA-C-O 121.468 0.652 . . . . 74.400000000000006 111.685 -171.492 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 49.3 mt -82.47 -46.72 19.26 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.812 0 CA-C-N 115.632 -0.713 . . . . 75.409999999999997 109.16 170.591 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 90' ' ' LEU . . . . . 0.579 HD21 ' HD2' ' A' ' 28' ' ' LYS . 90.2 mt -95.33 110.73 22.7 Favored 'General case' 0 C--O 1.241 0.641 0 CA-C-N 115.445 -0.798 . . . . 53.109999999999999 110.876 -174.728 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 23.5 pttm -107.84 169.52 8.55 Favored 'General case' 0 N--CA 1.474 0.769 0 C-N-CA 124.176 0.99 . . . . 74.409999999999997 109.409 173.503 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 92' ' ' HIS . . . . . 0.463 ' HA ' HG21 ' A' ' 97' ' ' ILE . 17.1 m-70 -87.68 47.07 1.45 Allowed 'General case' 0 N--CA 1.481 1.088 0 C-N-CA 124.045 0.938 . . . . 55.200000000000003 110.371 -173.688 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 9.5 t -83.71 5.32 25.11 Favored 'General case' 0 CA--C 1.552 1.028 0 C-N-CA 124.315 1.046 . . . . 75.450000000000003 111.971 -174.059 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -133.53 153.42 20.82 Favored Glycine 0 C--N 1.347 1.155 0 CA-C-O 119.713 -0.493 . . . . 74.109999999999999 112.067 179.091 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 73.5 Cg_endo -75.89 142.38 25.2 Favored 'Trans proline' 0 C--N 1.367 1.531 0 C-N-CA 122.538 2.158 . . . . 73.019999999999996 110.064 167.258 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 89.13 6.69 71.17 Favored Glycine 0 N--CA 1.467 0.75 0 CA-C-O 120.145 -0.253 . . . . 62.420000000000002 113.121 -175.931 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 97' ' ' ILE . . . . . 0.717 ' HB ' ' SG ' ' A' ' 115' ' ' CYS . 5.9 mm -68.63 120.18 15.67 Favored 'Isoleucine or valine' 0 CA--C 1.552 1.057 0 C-N-CA 123.181 0.593 . . . . 75.340000000000003 110.782 179.191 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 98' ' ' LEU . . . . . 0.452 HD22 ' CD1' ' A' ' 22' ' ' PHE . 56.8 tp -103.4 123.05 46.11 Favored 'General case' 0 CA--C 1.554 1.122 0 C-N-CA 124.4 1.08 . . . . 54.340000000000003 111.038 -177.657 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 99' ' ' SER . . . . . 0.712 ' HB3' ' HA ' ' A' ' 128' ' ' VAL . 11.3 p -152.88 158.39 42.08 Favored 'General case' 0 N--CA 1.473 0.687 0 C-N-CA 124.369 1.067 . . . . 71.409999999999997 109.514 176.212 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 100' ' ' MET . . . . . 0.661 ' HG3' ' HE2' ' A' ' 129' ' ' PHE . 79.7 mtp -77.25 145.83 37.28 Favored 'General case' 0 N--CA 1.487 1.398 0 N-CA-C 109.944 -0.391 . . . . 75.219999999999999 109.944 -179.898 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 101' ' ' ALA . . . . . 0.518 ' HB3' ' HB2' ' A' ' 111' ' ' GLN . . . -76.07 165.85 24.34 Favored 'General case' 0 C--O 1.247 0.943 0 CA-C-O 121.015 0.436 . . . . 65.439999999999998 111.236 -177.681 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 102' ' ' ASN . . . . . 0.475 ' HB3' ' HA ' ' A' ' 108' ' ' ASN . 27.1 p-10 -160.38 156.79 26.74 Favored 'General case' 0 N--CA 1.472 0.631 0 CA-C-N 115.809 -0.632 . . . . 72.409999999999997 111.007 -176.766 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -93.33 -17.23 23.82 Favored 'General case' 0 CA--C 1.545 0.773 0 CA-C-N 115.358 -0.837 . . . . 54.310000000000002 110.674 169.587 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 177.94 -178.75 48.51 Favored Glycine 0 C--N 1.352 1.437 0 CA-C-O 119.445 -0.642 . . . . 64.510000000000005 112.957 178.839 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 50.2 Cg_exo -58.85 141.22 97.82 Favored 'Trans proline' 0 C--N 1.374 1.917 0 C-N-CA 123.22 2.614 . . . . 75.030000000000001 112.439 171.554 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 64.4 t30 66.54 10.55 7.45 Favored 'General case' 0 N--CA 1.485 1.302 0 C-N-CA 125.48 1.512 . . . . 73.230000000000004 111.243 -176.301 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 107' ' ' THR . . . . . 0.476 ' HA ' ' HD3' ' A' ' 82' ' ' LYS . 16.7 m -126.57 18.76 7.42 Favored 'General case' 0 CA--C 1.558 1.273 0 C-N-CA 124.767 1.227 . . . . 60.119999999999997 108.769 -178.828 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 108' ' ' ASN . . . . . 0.475 ' HA ' ' HB3' ' A' ' 102' ' ' ASN . 48.1 t30 -86.13 143.74 27.87 Favored 'General case' 0 N--CA 1.48 1.026 0 C-N-CA 123.827 0.851 . . . . 61.450000000000003 109.206 177.33 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 112.69 26.29 4.24 Favored Glycine 0 N--CA 1.469 0.86 0 C-N-CA 121.18 -0.533 . . . . 40.020000000000003 113.481 -177.566 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 110' ' ' SER . . . . . 0.608 ' HB2' ' HA ' ' A' ' 73' ' ' THR . 31.6 p -129.17 121.06 26.91 Favored 'General case' 0 CA--C 1.539 0.551 0 N-CA-C 107.859 -1.163 . . . . 65.239999999999995 107.859 171.697 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 111' ' ' GLN . . . . . 0.518 ' HB2' ' HB3' ' A' ' 101' ' ' ALA . 48.8 mt-30 66.49 177.21 0.23 Allowed 'General case' 0 N--CA 1.491 1.583 0 C-N-CA 124.536 1.135 . . . . 70.129999999999995 111.271 -171.574 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 112' ' ' PHE . . . . . 0.638 ' HA ' ' HA ' ' A' ' 100' ' ' MET . 3.1 m-85 -131.75 166.92 20.45 Favored 'General case' 0 N--CA 1.477 0.882 0 N-CA-C 107.396 -1.335 . . . . 72.439999999999998 107.396 175.336 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 113' ' ' PHE . . . . . 0.424 ' O ' HD12 ' A' ' 98' ' ' LEU . 48.2 p90 -157.13 160.47 38.85 Favored 'General case' 0 N--CA 1.477 0.916 0 CA-C-O 121.393 0.616 . . . . 73.430000000000007 112.138 170.902 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 114' ' ' ILE . . . . . 0.483 HG21 HG11 ' A' ' 139' ' ' VAL . 20.2 mt -124.51 109.71 23.29 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.821 0 CA-C-N 114.024 -1.444 . . . . 71.319999999999993 107.443 171.845 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 115' ' ' CYS . . . . . 0.717 ' SG ' ' HB ' ' A' ' 97' ' ' ILE . 29.8 p -74.5 105.5 5.66 Favored 'General case' 0 N--CA 1.474 0.769 0 N-CA-C 108.836 -0.802 . . . . 74.040000000000006 108.836 177.464 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 116' ' ' THR . . . . . 0.421 HG22 HG12 ' A' ' 139' ' ' VAL . 24.2 p -71.27 -23.06 61.9 Favored 'General case' 0 N--CA 1.476 0.853 0 C-N-CA 124.396 1.078 . . . . 62.140000000000001 111.601 -174.015 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -107.39 152.89 23.57 Favored 'General case' 0 C--O 1.245 0.839 0 N-CA-C 108.794 -0.817 . . . . 71.299999999999997 108.794 166.775 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 20.3 ptmt -70.69 99.0 1.61 Allowed 'General case' 0 CA--C 1.543 0.676 0 CA-C-O 121.762 0.792 . . . . 75.510000000000005 109.033 172.851 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 119' ' ' THR . . . . . . . . . . . . . 82.2 p -81.7 86.32 6.44 Favored 'General case' 0 CA--C 1.547 0.858 0 CA-C-O 121.963 0.887 . . . . 63.229999999999997 109.656 -175.721 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 12.1 pt-20 -74.28 -29.99 61.9 Favored 'General case' 0 N--CA 1.48 1.057 0 CA-C-N 114.662 -1.153 . . . . 73.140000000000001 111.132 -175.092 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 121' ' ' TRP . . . . . . . . . . . . . 34.5 p90 -64.91 -13.4 56.76 Favored 'General case' 0 N--CA 1.48 1.03 0 C-N-CA 123.987 0.915 . . . . 75.349999999999994 111.57 175.347 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 64.7 mt -99.42 29.08 4.17 Favored 'General case' 0 CA--C 1.551 0.987 0 C-N-CA 123.75 0.82 . . . . 45.119999999999997 111.51 176.125 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 83.4 m-20 -69.45 134.95 49.56 Favored 'General case' 0 N--CA 1.484 1.254 0 N-CA-C 109.651 -0.5 . . . . 63.439999999999998 109.651 166.615 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 81.9 0.86 89.97 Favored Glycine 0 C--N 1.341 0.844 0 CA-C-N 116.223 -0.444 . . . . 34.420000000000002 113.056 -176.209 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 125' ' ' LYS . . . . . 0.46 ' HG3' ' H ' ' A' ' 126' ' ' HIS . 8.5 tppt? -78.43 -170.93 2.23 Favored 'General case' 0 N--CA 1.477 0.915 0 N-CA-C 108.641 -0.874 . . . . 63.439999999999998 108.641 176.96 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 126' ' ' HIS . . . . . 0.46 ' H ' ' HG3' ' A' ' 125' ' ' LYS . 44.7 p-80 -68.57 152.84 44.81 Favored 'General case' 0 CA--C 1.545 0.781 0 O-C-N 122.051 -0.406 . . . . 65.129999999999995 110.022 -175.826 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 48.5 t -79.37 147.42 6.7 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.697 0 C-N-CA 123.631 0.772 . . . . 75.340000000000003 112.452 -164.771 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 128' ' ' VAL . . . . . 0.712 ' HA ' ' HB3' ' A' ' 99' ' ' SER . 61.7 t -83.19 158.81 3.73 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.759 0 C-N-CA 125.103 1.361 . . . . 54.350000000000001 109.933 176.375 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 129' ' ' PHE . . . . . 0.661 ' HE2' ' HG3' ' A' ' 100' ' ' MET . 7.3 p90 -130.62 -24.13 2.51 Favored 'General case' 0 N--CA 1.479 1.023 0 N-CA-C 111.918 0.34 . . . . 72.200000000000003 111.918 173.509 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . -143.23 175.53 23.25 Favored Glycine 0 C--N 1.34 0.765 0 O-C-N 123.31 0.381 . . . . 63.310000000000002 112.588 -172.997 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 34.6 ttpt -161.08 137.9 8.71 Favored 'General case' 0 N--CA 1.466 0.365 0 N-CA-C 108.52 -0.919 . . . . 74.219999999999999 108.52 179.612 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 132' ' ' VAL . . . . . 0.467 HG11 ' HA ' ' A' ' 136' ' ' MET . 40.7 t -61.35 108.45 0.47 Allowed 'Isoleucine or valine' 0 CA--C 1.544 0.72 0 C-N-CA 123.418 0.687 . . . . 64.530000000000001 109.976 177.043 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 21.4 ptmt -85.74 -39.19 17.43 Favored 'General case' 0 CA--C 1.542 0.663 0 N-CA-C 109.689 -0.485 . . . . 53.240000000000002 109.689 177.006 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 134' ' ' GLU . . . . . 0.473 ' HB2' ' OG ' ' A' ' 21' ' ' SER . 53.4 mm-40 -137.81 149.61 46.5 Favored 'General case' 0 N--CA 1.483 1.195 0 C-N-CA 124.302 1.041 . . . . 64.340000000000003 109.253 177.573 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 85.03 20.38 57.67 Favored Glycine 0 N--CA 1.473 1.161 0 O-C-N 123.414 0.446 . . . . 75.340000000000003 112.649 -179.295 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 136' ' ' MET . . . . . 0.467 ' HA ' HG11 ' A' ' 132' ' ' VAL . 15.1 tpt -61.07 -33.89 74.04 Favored 'General case' 0 N--CA 1.483 1.211 0 C-N-CA 123.763 0.825 . . . . 73.209999999999994 110.943 179.662 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 137' ' ' ASN . . . . . . . . . . . . . 11.4 m120 -64.91 -32.67 74.49 Favored 'General case' 0 CA--C 1.546 0.797 0 C-N-CA 123.849 0.86 . . . . 72.400000000000006 111.82 -179.271 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 138' ' ' ILE . . . . . 0.408 ' O ' ' HG3' ' A' ' 142' ' ' MET . 46.8 mm -70.56 -37.8 71.16 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.966 0 C-N-CA 123.143 0.577 . . . . 64.319999999999993 109.868 177.355 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 139' ' ' VAL . . . . . 0.483 HG11 HG21 ' A' ' 114' ' ' ILE . 59.3 t -67.17 -37.39 79.1 Favored 'Isoleucine or valine' 0 CA--C 1.555 1.139 0 C-N-CA 123.829 0.852 . . . . 62.299999999999997 110.963 177.338 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 38.7 mt-10 -70.86 -28.4 64.54 Favored 'General case' 0 N--CA 1.478 0.934 0 CA-C-N 115.792 -0.64 . . . . 54.049999999999997 110.706 176.328 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -68.8 -39.52 80.07 Favored 'General case' 0 N--CA 1.475 0.814 0 C-N-CA 122.876 0.47 . . . . 73.450000000000003 110.278 172.38 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 142' ' ' MET . . . . . 0.482 ' SD ' HG21 ' A' ' 10' ' ' ILE . 76.6 mtp -58.25 -41.65 84.69 Favored 'General case' 0 N--CA 1.485 1.282 0 C-N-CA 123.983 0.913 . . . . 70.450000000000003 111.157 175.654 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 143' ' ' GLU . . . . . 0.503 ' HG3' ' HA ' ' A' ' 58' ' ' PRO . 37.8 tt0 -53.69 -43.3 68.81 Favored 'General case' 0 CA--C 1.546 0.79 0 CA-C-N 114.92 -1.036 . . . . 60.420000000000002 111.69 176.767 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 144' ' ' ARG . . . . . . . . . . . . . 56.2 mtt180 -72.53 -18.58 61.63 Favored 'General case' 0 N--CA 1.475 0.812 0 C-N-CA 124.155 0.982 . . . . 53.009999999999998 111.646 -177.263 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 145' ' ' PHE . . . . . 0.494 ' HB3' ' HB2' ' A' ' 154' ' ' LYS . 24.9 m-85 -86.56 -4.27 59.15 Favored 'General case' 0 N--CA 1.479 0.981 0 C-N-CA 123.398 0.679 . . . . 61.119999999999997 111.359 176.603 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . -97.24 -179.22 34.17 Favored Glycine 0 C--N 1.347 1.192 0 C-N-CA 123.053 0.358 . . . . 74.129999999999995 112.599 175.569 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 21.4 m -134.03 163.13 30.24 Favored 'General case' 0 N--CA 1.482 1.135 0 C-N-CA 124.114 0.966 . . . . 73.310000000000002 110.512 -176.121 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 148' ' ' ARG . . . . . . . . . . . . . 26.6 mmt180 -67.91 -28.18 67.28 Favored 'General case' 0 N--CA 1.486 1.364 0 C-N-CA 123.432 0.693 . . . . 72.209999999999994 112.037 -175.733 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 149' ' ' ASN . . . . . . . . . . . . . 30.8 p-10 -82.39 2.45 32.37 Favored 'General case' 0 N--CA 1.483 1.177 0 C-N-CA 123.644 0.778 . . . . 74.310000000000002 111.358 175.816 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 150' ' ' GLY . . . . . 0.468 ' HA2' HG12 ' A' ' 57' ' ' ILE . . . 93.06 -6.29 76.09 Favored Glycine 0 C--N 1.35 1.34 0 CA-C-O 119.722 -0.488 . . . . 41.119999999999997 113.674 177.02 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 40.7 ttmt -71.04 141.13 50.92 Favored 'General case' 0 N--CA 1.475 0.804 0 CA-C-N 117.315 0.557 . . . . 70.239999999999995 110.651 -177.719 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 152' ' ' THR . . . . . . . . . . . . . 12.5 p -90.35 117.08 28.8 Favored 'General case' 0 C--O 1.237 0.443 0 N-CA-C 108.824 -0.806 . . . . 75.349999999999994 108.824 169.062 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 153' ' ' SER . . . . . . . . . . . . . 22.8 m -66.46 -31.35 72.03 Favored 'General case' 0 CA--C 1.544 0.742 0 CA-C-N 115.679 -0.691 . . . . 73.230000000000004 110.036 171.92 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 154' ' ' LYS . . . . . 0.494 ' HB2' ' HB3' ' A' ' 145' ' ' PHE . 32.2 mmmt -121.13 129.97 53.52 Favored 'General case' 0 N--CA 1.472 0.627 0 CA-C-N 115.469 -0.787 . . . . 74.200000000000003 110.399 -178.96 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 83.3 tttt -67.76 106.36 2.22 Favored 'General case' 0 C--N 1.352 0.691 0 C-N-CA 123.737 0.815 . . . . 73.140000000000001 109.396 171.759 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 156' ' ' ILE . . . . . 0.584 ' HB ' ' HB2' ' A' ' 53' ' ' PHE . 62.0 mt -102.97 131.73 50.63 Favored 'Isoleucine or valine' 0 C--O 1.221 -0.422 0 N-CA-C 108.102 -1.073 . . . . 75.219999999999999 108.102 176.509 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 157' ' ' THR . . . . . . . . . . . . . 33.1 p -127.96 160.83 30.66 Favored 'General case' 0 N--CA 1.481 1.098 0 C-N-CA 123.935 0.894 . . . . 62.229999999999997 109.732 -179.75 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 158' ' ' ILE . . . . . . . . . . . . . 57.1 mt -82.98 97.08 4.17 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.838 0 N-CA-C 108.52 -0.918 . . . . 74.140000000000001 108.52 167.477 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 159' ' ' ALA . . . . . 0.821 ' HB2' ' HB2' ' A' ' 11' ' ' ALA . . . -55.99 -41.72 75.26 Favored 'General case' 0 N--CA 1.481 1.106 0 C-N-CA 124.067 0.947 . . . . 53.020000000000003 112.626 -177.262 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 160' ' ' ASP . . . . . . . . . . . . . 2.7 t70 -165.35 174.56 9.99 Favored 'General case' 0 CA--C 1.549 0.93 0 O-C-N 123.496 0.498 . . . . 62.399999999999999 110.527 -176.68 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 161' ' ' CYS . . . . . . . . . . . . . 24.5 p -130.96 -167.85 1.9 Allowed 'General case' 0 N--CA 1.478 0.959 0 C-N-CA 125.366 1.467 . . . . 65.349999999999994 109.41 -178.55 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 162' ' ' GLY . . . . . . . . . . . . . . . 132.62 53.32 0.08 OUTLIER Glycine 0 C--N 1.351 1.369 0 N-CA-C 112.137 -0.385 . . . . 74.109999999999999 112.137 -175.327 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 163' ' ' GLN . . . . . 0.6 ' HB2' ' HA ' ' A' ' 6' ' ' VAL . 21.2 pt20 -49.44 143.4 6.67 Favored 'General case' 0 N--CA 1.482 1.131 0 C-N-CA 124.421 1.088 . . . . 73.409999999999997 113.1 -174.379 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 164' ' ' LEU . . . . . 0.443 ' HG ' ' HB2' ' A' ' 7' ' ' PHE . 86.0 mt . . . . . 0 CA--C 1.547 0.843 0 C-N-CA 123.514 0.726 . . . . 74.200000000000003 110.14 -173.365 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 218' ' ' PRO . . . . . . . . . . . . . 11.7 Cg_endo . . . . . 0 CA--C 1.544 0.992 0 CA-C-O 121.651 0.605 . . . . 74.230000000000004 111.632 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' B' B ' 219' ' ' GLY . . . . . . . . . . . . . . . 176.08 156.04 14.32 Favored Glycine 0 CA--C 1.525 0.71 0 CA-C-N 114.593 -1.185 . . . . 74.430000000000007 111.542 177.711 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 220' ' ' PRO . . . . . . . . . . . . . 60.5 Cg_endo -85.38 -178.97 3.27 Favored 'Trans proline' 0 CA--C 1.553 1.472 0 C-N-CA 122.961 2.441 . . . . 65.140000000000001 112.209 175.459 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 221' ' ' TYR . . . . . . . . . . . . . 43.1 p90 . . . . . 0 N--CA 1.484 1.242 0 C-N-CA 123.632 0.773 . . . . 75.299999999999997 110.986 179.802 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 56.3 mtt . . . . . 0 N--CA 1.477 0.912 0 N-CA-C 108.184 -1.043 . . . . 65.319999999999993 108.184 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 12.8 m 48.71 35.08 0.24 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.855 0 C-N-CA 126.418 1.887 . . . . 73.310000000000002 112.848 -174.273 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 3' ' ' ASN . . . . . 0.485 ' ND2' ' HA ' ' A' ' 25' ' ' PHE . 20.1 m120 -88.26 113.81 56.76 Favored Pre-proline 0 CA--C 1.549 0.917 0 CA-C-N 115.012 -0.995 . . . . 64.310000000000002 109.701 177.703 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 4' ' ' PRO . . . . . 0.493 ' HG2' ' HB2' ' A' ' 24' ' ' LEU . 52.8 Cg_endo -75.85 133.87 15.81 Favored 'Trans proline' 0 C--N 1.372 1.779 0 C-N-CA 122.078 1.852 . . . . 73.329999999999998 111.509 170.082 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 5' ' ' THR . . . . . 0.405 ' HB ' ' O ' ' A' ' 164' ' ' LEU . 80.7 m -97.62 124.74 42.03 Favored 'General case' 0 CA--C 1.536 0.437 0 N-CA-C 108.524 -0.917 . . . . 73.140000000000001 108.524 172.631 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 7.4 m -100.87 123.47 53.89 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.81 0 N-CA-C 109.143 -0.688 . . . . 75.430000000000007 109.143 173.607 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 7' ' ' PHE . . . . . 0.621 ' H ' ' HA ' ' A' ' 163' ' ' GLN . 85.5 t80 -108.08 137.44 46.06 Favored 'General case' 0 C--O 1.241 0.608 0 C-N-CA 124.056 0.942 . . . . 73.0 109.236 -174.351 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 8' ' ' PHE . . . . . 0.497 ' HB3' HG23 ' A' ' 158' ' ' ILE . 62.8 m-85 -138.66 162.59 34.27 Favored 'General case' 0 N--CA 1.469 0.501 0 C-N-CA 123.889 0.875 . . . . 74.200000000000003 110.433 175.943 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 16.0 m-20 -110.35 117.88 34.82 Favored 'General case' 0 N--CA 1.467 0.394 0 N-CA-C 107.354 -1.35 . . . . 72.319999999999993 107.354 170.26 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 49.6 mm -89.4 124.94 42.38 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.559 0 N-CA-C 109.176 -0.676 . . . . 73.530000000000001 109.176 -179.809 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 11' ' ' ALA . . . . . 0.553 ' HB2' ' HB2' ' A' ' 159' ' ' ALA . . . -128.68 126.28 39.79 Favored 'General case' 0 N--CA 1.471 0.581 0 C-N-CA 123.34 0.656 . . . . 51.329999999999998 111.062 -173.177 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . 0.438 HG13 ' HB3' ' A' ' 154' ' ' LYS . 96.3 t -95.53 120.36 44.82 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.43 0 N-CA-C 108.077 -1.083 . . . . 74.420000000000002 108.077 174.801 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 31.4 m-20 60.37 24.48 13.99 Favored 'General case' 0 N--CA 1.482 1.126 0 C-N-CA 125.499 1.519 . . . . 73.530000000000001 111.767 -175.791 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 91.69 -18.61 52.26 Favored Glycine 0 C--N 1.354 1.559 0 CA-C-N 116.587 -0.279 . . . . 64.230000000000004 112.903 -175.554 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 15.8 mm-40 -82.15 114.2 49.21 Favored Pre-proline 0 CA--C 1.548 0.887 0 C-N-CA 124.213 1.005 . . . . 72.430000000000007 110.123 178.863 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 18.6 Cg_endo -56.18 108.79 0.36 Allowed 'Trans proline' 0 C--N 1.384 2.41 0 C-N-CA 123.262 2.642 . . . . 73.439999999999998 112.383 -178.077 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 48.4 tp -76.8 -29.52 56.04 Favored 'General case' 0 N--CA 1.475 0.776 0 CA-C-N 114.828 -1.078 . . . . 62.25 109.522 176.375 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 170.11 -159.65 32.24 Favored Glycine 0 N--CA 1.449 -0.5 0 CA-C-N 115.039 -0.982 . . . . 72.319999999999993 111.046 -176.109 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 2.0 ptp180 -149.08 142.93 25.68 Favored 'General case' 0 C--O 1.24 0.595 0 C-N-CA 123.282 0.633 . . . . 73.530000000000001 109.898 -177.408 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 50.7 t -132.09 129.07 59.98 Favored 'Isoleucine or valine' 0 C--O 1.24 0.582 0 C-N-CA 123.659 0.784 . . . . 74.540000000000006 109.453 -176.908 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 66.7 p -109.6 140.77 43.03 Favored 'General case' 0 C--O 1.252 1.189 0 N-CA-C 108.655 -0.869 . . . . 74.439999999999998 108.655 170.453 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 22' ' ' PHE . . . . . 0.438 ' HE1' ' HD2' ' A' ' 8' ' ' PHE . 45.2 m-85 -118.42 134.36 55.12 Favored 'General case' 0 N--CA 1.467 0.394 0 C-N-CA 123.908 0.883 . . . . 71.5 108.978 -178.113 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 7.7 tp10 -87.36 110.59 20.36 Favored 'General case' 0 CA--C 1.535 0.397 0 N-CA-C 109.35 -0.611 . . . . 75.530000000000001 109.35 174.026 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . 0.493 ' HB2' ' HG2' ' A' ' 4' ' ' PRO . 33.8 mt -83.92 121.28 27.15 Favored 'General case' 0 N--CA 1.469 0.482 0 N-CA-C 109.132 -0.692 . . . . 64.340000000000003 109.132 176.826 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 25' ' ' PHE . . . . . 0.485 ' HA ' ' ND2' ' A' ' 3' ' ' ASN . 65.6 m-85 -84.82 69.69 10.75 Favored 'General case' 0 CA--C 1.54 0.579 0 C-N-CA 123.746 0.818 . . . . 73.129999999999995 109.912 179.279 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -70.09 -20.14 63.22 Favored 'General case' 0 N--CA 1.478 0.975 0 CA-C-N 115.076 -0.966 . . . . 75.25 111.52 -179.579 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 11.5 p-10 -72.19 -19.16 61.79 Favored 'General case' 0 CA--C 1.55 0.98 0 C-N-CA 123.71 0.804 . . . . 71.310000000000002 111.188 175.579 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 28' ' ' LYS . . . . . 0.422 ' HD2' HD21 ' A' ' 90' ' ' LEU . 47.0 mttm -108.57 -51.45 2.89 Favored 'General case' 0 N--CA 1.48 1.061 0 C-N-CA 123.46 0.704 . . . . 73.510000000000005 110.765 -176.698 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 29' ' ' VAL . . . . . 0.499 HG21 ' HA ' ' A' ' 129' ' ' PHE . 5.5 m -129.82 74.92 80.27 Favored Pre-proline 0 CA--C 1.56 1.334 0 C-N-CA 124.409 1.083 . . . . 45.119999999999997 109.741 -175.8 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 58.2 Cg_endo -65.8 -34.37 40.25 Favored 'Trans proline' 0 C--N 1.378 2.094 0 C-N-CA 122.98 2.453 . . . . 72.430000000000007 112.726 -168.468 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 31' ' ' LYS . . . . . 0.469 ' HB3' ' HB2' ' A' ' 86' ' ' GLU . 27.4 ttmt -64.55 -58.73 5.57 Favored 'General case' 0 CA--C 1.533 0.311 0 C-N-CA 124.226 1.01 . . . . 70.510000000000005 111.253 -177.561 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 3.8 m -72.39 -26.3 61.83 Favored 'General case' 0 CA--C 1.559 1.308 0 O-C-N 123.63 0.581 . . . . 73.430000000000007 111.191 -173.674 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 33' ' ' ALA . . . . . 0.448 ' HB1' ' HB3' ' A' ' 24' ' ' LEU . . . -73.47 -58.27 3.42 Favored 'General case' 0 N--CA 1.482 1.143 0 C-N-CA 123.025 0.53 . . . . 71.299999999999997 111.888 177.454 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . 0.499 ' HG3' HH21 ' A' ' 37' ' ' ARG . 43.0 tt0 -62.84 -29.49 70.78 Favored 'General case' 0 N--CA 1.488 1.447 0 C-N-CA 123.383 0.673 . . . . 75.310000000000002 111.192 -178.597 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 35' ' ' ASN . . . . . 0.456 ' O ' ' HG ' ' A' ' 39' ' ' LEU . 32.1 t30 -50.93 -60.02 3.53 Favored 'General case' 0 N--CA 1.476 0.83 0 C-N-CA 124.061 0.944 . . . . 70.230000000000004 110.527 174.506 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 84.1 t80 -66.48 -33.08 74.88 Favored 'General case' 0 CA--C 1.544 0.729 0 O-C-N 124.06 0.85 . . . . 63.43 111.237 -178.573 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 37' ' ' ARG . . . . . 0.499 HH21 ' HG3' ' A' ' 34' ' ' GLU . 17.4 ttp180 -62.48 -40.98 98.41 Favored 'General case' 0 N--CA 1.478 0.943 0 C-N-CA 123.204 0.602 . . . . 72.519999999999996 110.737 177.599 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -80.47 -21.54 41.93 Favored 'General case' 0 N--CA 1.472 0.654 0 CA-C-N 115.386 -0.825 . . . . 64.049999999999997 111.321 -178.105 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 39' ' ' LEU . . . . . 0.456 ' HG ' ' O ' ' A' ' 35' ' ' ASN . 95.8 mt -72.15 -44.46 63.06 Favored 'General case' 0 N--CA 1.478 0.952 0 C-N-CA 123.203 0.601 . . . . 55.310000000000002 110.379 172.067 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 65.9 p -72.56 -40.2 66.86 Favored 'General case' 0 N--CA 1.475 0.823 0 C-N-CA 123.737 0.815 . . . . 42.420000000000002 111.484 -173.937 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 61.2 p -76.81 -31.55 57.01 Favored 'General case' 0 N--CA 1.474 0.726 0 O-C-N 123.343 0.402 . . . . 62.140000000000001 110.226 172.614 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 71.59 24.92 76.17 Favored Glycine 0 C--N 1.35 1.338 0 CA-C-N 115.659 -0.701 . . . . 72.209999999999994 114.312 175.226 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 20.9 mm-40 -68.24 -17.92 64.43 Favored 'General case' 0 N--CA 1.476 0.863 0 C-N-CA 123.203 0.601 . . . . 64.349999999999994 111.582 179.243 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 31.1 mmmt -92.18 13.5 18.87 Favored 'General case' 0 CA--C 1.552 1.024 0 C-N-CA 123.708 0.803 . . . . 72.230000000000004 111.384 177.169 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 84.76 37.84 10.04 Favored Glycine 0 C--N 1.353 1.511 0 N-CA-C 113.87 0.308 . . . . 71.439999999999998 113.87 171.229 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 23.0 m-85 -125.15 -46.84 1.79 Allowed 'General case' 0 N--CA 1.484 1.245 0 CA-C-N 117.058 0.429 . . . . 74.219999999999999 110.89 -174.257 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 53.89 58.5 12.36 Favored Glycine 0 C--N 1.349 1.297 0 O-C-N 124.161 0.913 . . . . 72.040000000000006 114.148 174.848 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 48' ' ' TYR . . . . . 0.413 ' HE2' ' HA2' ' A' ' 75' ' ' GLY . 52.1 m-85 -63.86 89.84 0.05 Allowed 'General case' 0 N--CA 1.483 1.213 0 CA-C-O 121.851 0.834 . . . . 73.219999999999999 111.885 -179.153 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 38.7 tptt -112.96 142.77 45.26 Favored 'General case' 0 CA--C 1.538 0.49 0 CA-C-N 114.058 -1.428 . . . . 65.420000000000002 108.37 179.153 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 70.74 22.02 78.04 Favored Glycine 0 C--N 1.345 1.03 0 CA-C-O 119.568 -0.573 . . . . 50.509999999999998 113.923 175.438 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 24.3 t -58.87 114.51 2.58 Favored 'General case' 0 CA--C 1.549 0.92 0 C-N-CA 123.53 0.732 . . . . 74.239999999999995 111.05 -173.817 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 52' ' ' CYS . . . . . . . . . . . . . 15.5 p -87.25 118.1 26.44 Favored 'General case' 0 CA--C 1.54 0.564 0 C-N-CA 123.905 0.882 . . . . 74.129999999999995 111.873 -169.791 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 53' ' ' PHE . . . . . 0.677 ' HA ' ' HA2' ' A' ' 64' ' ' GLY . 88.4 m-85 -69.02 78.77 0.32 Allowed 'General case' 0 CA--C 1.539 0.541 0 C-N-CA 124.454 1.102 . . . . 71.120000000000005 109.671 165.405 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 15.2 p-80 -95.45 -8.4 35.52 Favored 'General case' 0 N--CA 1.479 0.999 0 CA-C-N 115.219 -0.9 . . . . 73.099999999999994 112.461 -173.652 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 59.0 ttt-85 -130.8 100.1 5.16 Favored 'General case' 0 N--CA 1.476 0.834 0 N-CA-C 109.133 -0.691 . . . . 71.140000000000001 109.133 179.364 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 56' ' ' ILE . . . . . 0.527 HD11 ' HB3' ' A' ' 53' ' ' PHE . 65.8 mt -134.39 133.21 55.2 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.117 0 C-N-CA 123.241 0.616 . . . . 60.039999999999999 109.97 -177.725 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 57' ' ' ILE . . . . . 0.518 HG23 ' HA ' ' A' ' 148' ' ' ARG . 66.6 mt -121.34 120.63 28.9 Favored Pre-proline 0 CA--C 1.558 1.25 0 C-N-CA 124.7 1.2 . . . . 73.319999999999993 109.229 175.871 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 35.6 Cg_endo -64.64 139.23 62.66 Favored 'Trans proline' 0 C--N 1.388 2.638 0 C-N-CA 123.078 2.519 . . . . 71.030000000000001 112.362 176.323 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 76.67 21.71 74.06 Favored Glycine 0 C--N 1.346 1.12 0 CA-C-N 115.009 -0.996 . . . . 51.140000000000001 113.134 -175.686 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 60' ' ' PHE . . . . . 0.406 ' HD2' ' HB ' ' A' ' 57' ' ' ILE . 19.9 t80 -149.57 -76.91 0.15 Allowed 'General case' 0 N--CA 1.478 0.936 0 CA-C-N 117.318 0.559 . . . . 74.140000000000001 111.349 -175.738 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 61' ' ' MET . . . . . 0.586 ' SD ' ' HB2' ' A' ' 113' ' ' PHE . 15.7 tmm? -168.07 142.94 3.59 Favored 'General case' 0 N--CA 1.481 1.077 0 N-CA-C 112.115 0.413 . . . . 63.409999999999997 112.115 -163.305 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 62' ' ' CYS . . . . . . . . . . . . . 22.7 p -111.53 113.21 25.47 Favored 'General case' 0 CA--C 1.551 0.985 0 C-N-CA 124.196 0.999 . . . . 63.009999999999998 109.908 173.18 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 63' ' ' GLN . . . . . 0.498 ' HA ' ' HA ' ' A' ' 113' ' ' PHE . 17.1 tt0 -108.53 127.05 53.59 Favored 'General case' 0 N--CA 1.487 1.384 0 C-N-CA 124.019 0.927 . . . . 61.420000000000002 111.745 -173.699 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 64' ' ' GLY . . . . . 0.677 ' HA2' ' HA ' ' A' ' 53' ' ' PHE . . . -102.35 167.34 17.85 Favored Glycine 0 C--N 1.351 1.385 0 CA-C-N 114.834 -1.076 . . . . 71.200000000000003 112.423 175.993 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -178.57 -174.97 45.27 Favored Glycine 0 C--N 1.339 0.701 0 N-CA-C 112.236 -0.346 . . . . 61.140000000000001 112.236 -179.432 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 28.2 t70 -126.1 168.04 14.55 Favored 'General case' 0 C--O 1.247 0.931 0 C-N-CA 124.185 0.994 . . . . 72.109999999999999 110.337 -170.608 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 51.9 t80 -88.04 -21.45 24.76 Favored 'General case' 0 CA--C 1.548 0.873 0 C-N-CA 123.799 0.84 . . . . 74.109999999999999 111.78 -176.959 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 67.5 m -63.48 108.57 1.39 Allowed 'General case' 0 N--CA 1.484 1.233 0 N-CA-C 109.792 -0.447 . . . . 70.329999999999998 109.792 179.9 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 70.0 ttt180 56.04 54.95 7.34 Favored 'General case' 0 CA--C 1.555 1.15 0 O-C-N 124.701 1.25 . . . . 73.430000000000007 110.473 -178.02 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 44.8 t-80 -57.13 -36.14 70.33 Favored 'General case' 0 N--CA 1.482 1.17 0 CA-C-N 115.462 -0.79 . . . . 71.439999999999998 111.988 -175.793 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 37.2 t30 -64.71 114.41 4.42 Favored 'General case' 0 N--CA 1.476 0.855 0 C-N-CA 123.398 0.679 . . . . 60.399999999999999 109.856 174.663 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 76.85 -6.77 38.52 Favored Glycine 0 CA--C 1.53 0.986 0 N-CA-C 116.019 1.168 . . . . 72.409999999999997 116.019 169.376 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 23.8 m -143.77 -82.36 0.17 Allowed 'General case' 0 CA--C 1.554 1.117 0 CA-C-N 117.922 0.861 . . . . 74.439999999999998 109.528 179.192 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 63.08 50.2 65.31 Favored Glycine 0 C--N 1.353 1.477 0 C-N-CA 123.559 0.599 . . . . 43.420000000000002 114.054 174.469 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . 0.413 ' HA2' ' HE2' ' A' ' 48' ' ' TYR . . . 139.14 49.94 0.06 OUTLIER Glycine 0 C--N 1.345 1.053 0 CA-C-N 117.387 0.594 . . . . 72.409999999999997 111.682 -179.049 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 21.3 pttp -67.22 161.0 25.78 Favored 'General case' 0 CA--C 1.553 1.076 0 C-N-CA 123.341 0.656 . . . . 52.140000000000001 112.423 -174.122 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 80.6 p -90.11 -179.38 5.66 Favored 'General case' 0 CA--C 1.545 0.77 0 C-N-CA 124.259 1.023 . . . . 74.310000000000002 112.297 -171.106 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 24.5 pt -73.47 -13.17 15.96 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.082 0 C-N-CA 123.197 0.599 . . . . 73.230000000000004 110.677 172.052 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 98.5 m-85 -91.53 7.46 41.25 Favored 'General case' 0 CA--C 1.545 0.782 0 C-N-CA 124.389 1.076 . . . . 73.120000000000005 110.626 171.213 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 91.61 -141.33 15.6 Favored Glycine 0 C--N 1.347 1.168 0 CA-C-O 119.532 -0.593 . . . . 62.520000000000003 112.422 176.829 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 31.3 tt0 -50.04 -56.81 9.27 Favored 'General case' 0 N--CA 1.481 1.11 0 C-N-CA 125.039 1.335 . . . . 64.510000000000005 111.829 -176.852 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 82' ' ' LYS . . . . . 0.529 ' HD2' ' HA ' ' A' ' 107' ' ' THR . 19.0 pttp -161.17 157.54 26.0 Favored 'General case' 0 C--O 1.239 0.514 0 O-C-N 123.873 0.733 . . . . 62.450000000000003 110.97 -179.447 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 24.5 p90 -144.42 172.33 13.1 Favored 'General case' 0 C--O 1.24 0.577 0 C-N-CA 124.915 1.286 . . . . 74.530000000000001 109.328 -179.514 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 12.0 pt-20 -99.79 150.27 22.51 Favored 'General case' 0 N--CA 1.473 0.676 0 C-N-CA 123.801 0.84 . . . . 74.340000000000003 109.675 176.972 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 26.8 m-20 -66.84 149.59 50.37 Favored 'General case' 0 N--CA 1.48 1.049 0 C-N-CA 123.664 0.786 . . . . 75.349999999999994 112.7 -176.203 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 86' ' ' GLU . . . . . 0.469 ' HB2' ' HB3' ' A' ' 31' ' ' LYS . 6.9 tp10 -69.13 -56.11 8.67 Favored 'General case' 0 CA--C 1.544 0.742 0 CA-C-N 115.035 -0.984 . . . . 70.200000000000003 110.475 178.782 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 16.8 p-10 -168.97 138.08 2.13 Favored 'General case' 0 N--CA 1.471 0.617 0 C-N-CA 123.771 0.828 . . . . 64.230000000000004 109.703 -172.953 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 88' ' ' PHE . . . . . 0.464 ' HD1' ' HB ' ' A' ' 127' ' ' VAL . 40.4 m-85 -90.98 68.23 6.15 Favored 'General case' 0 N--CA 1.479 0.995 0 C-N-CA 123.044 0.538 . . . . 73.540000000000006 110.902 -176.035 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 40.1 mt -80.24 -61.84 1.6 Allowed 'Isoleucine or valine' 0 N--CA 1.484 1.273 0 CA-C-O 120.933 0.397 . . . . 62.140000000000001 110.008 174.359 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 90' ' ' LEU . . . . . 0.443 ' HB3' ' HB ' ' A' ' 128' ' ' VAL . 96.0 mt -75.05 104.74 5.75 Favored 'General case' 0 CA--C 1.544 0.731 0 CA-C-N 115.49 -0.777 . . . . 61.43 110.878 -173.798 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 91' ' ' LYS . . . . . 0.668 ' HE3' ' HB ' ' A' ' 93' ' ' THR . 0.1 OUTLIER -83.96 158.49 21.52 Favored 'General case' 0 CA--C 1.545 0.786 0 CA-C-N 115.099 -0.955 . . . . 71.319999999999993 110.073 173.908 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 92' ' ' HIS . . . . . . . . . . . . . 25.2 m-70 -87.46 65.96 8.85 Favored 'General case' 0 N--CA 1.479 1.016 0 CA-C-O 121.493 0.663 . . . . 75.310000000000002 109.696 -177.293 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 93' ' ' THR . . . . . 0.668 ' HB ' ' HE3' ' A' ' 91' ' ' LYS . 15.3 t -105.04 15.21 28.04 Favored 'General case' 0 N--CA 1.483 1.176 0 CA-C-N 115.599 -0.728 . . . . 61.229999999999997 111.461 -174.088 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -155.35 174.84 33.44 Favored Glycine 0 C--N 1.345 1.044 0 C-N-CA 121.553 -0.356 . . . . 62.140000000000001 113.543 -176.225 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -90.19 158.62 4.72 Favored 'Trans proline' 0 CA--C 1.553 1.459 0 C-N-CA 123.753 2.968 . . . . 65.510000000000005 111.919 175.656 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 77.23 17.95 78.87 Favored Glycine 0 C--N 1.344 0.999 0 CA-C-N 116.071 -0.513 . . . . 61.109999999999999 113.533 -179.117 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 97' ' ' ILE . . . . . 0.671 ' HB ' ' HB2' ' A' ' 115' ' ' CYS . 14.9 mm -66.5 103.09 0.52 Allowed 'Isoleucine or valine' 0 CA--C 1.555 1.169 0 C-N-CA 123.685 0.794 . . . . 62.329999999999998 111.009 -176.455 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 98' ' ' LEU . . . . . 0.417 HD22 ' CG ' ' A' ' 22' ' ' PHE . 54.9 tp -88.71 118.1 28.15 Favored 'General case' 0 C--O 1.247 0.922 0 CA-C-O 121.893 0.854 . . . . 74.430000000000007 109.471 175.577 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 23.7 t -152.08 141.67 21.76 Favored 'General case' 0 CA--C 1.547 0.854 0 N-CA-C 107.893 -1.151 . . . . 60.310000000000002 107.893 -174.664 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 100' ' ' MET . . . . . 0.527 ' HA ' ' HA ' ' A' ' 112' ' ' PHE . 70.7 mtp -76.71 138.19 39.82 Favored 'General case' 0 N--CA 1.495 1.791 0 CA-C-N 119.622 1.101 . . . . 72.200000000000003 110.319 -175.294 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 101' ' ' ALA . . . . . 0.437 ' HB3' ' HB2' ' A' ' 111' ' ' GLN . . . -70.42 156.45 39.32 Favored 'General case' 0 C--O 1.247 0.932 0 CA-C-O 121.315 0.579 . . . . 62.329999999999998 111.235 -173.263 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 102' ' ' ASN . . . . . 0.423 ' HB3' ' HA ' ' A' ' 108' ' ' ASN . 25.6 p-10 -161.69 164.05 29.37 Favored 'General case' 0 C--O 1.238 0.454 0 CA-C-N 115.055 -0.975 . . . . 72.329999999999998 110.646 -173.328 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 103' ' ' ALA . . . . . 0.503 ' HB3' HG21 ' A' ' 107' ' ' THR . . . -97.21 -14.89 21.14 Favored 'General case' 0 CA--C 1.542 0.654 0 CA-C-N 115.521 -0.763 . . . . 73.140000000000001 110.361 169.546 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 166.35 -168.18 39.82 Favored Glycine 0 C--N 1.352 1.426 0 CA-C-O 119.406 -0.663 . . . . 75.540000000000006 112.517 178.602 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 46.7 Cg_exo -58.72 139.75 92.06 Favored 'Trans proline' 0 C--N 1.374 1.876 0 C-N-CA 123.155 2.57 . . . . 73.219999999999999 112.112 173.553 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 66.0 t30 65.53 11.4 7.4 Favored 'General case' 0 N--CA 1.487 1.4 0 C-N-CA 124.967 1.307 . . . . 63.420000000000002 111.877 -177.804 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 107' ' ' THR . . . . . 0.529 ' HA ' ' HD2' ' A' ' 82' ' ' LYS . 5.0 m -124.1 17.12 9.22 Favored 'General case' 0 CA--C 1.552 1.028 0 C-N-CA 124.0 0.92 . . . . 72.209999999999994 109.705 178.158 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 108' ' ' ASN . . . . . 0.423 ' HA ' ' HB3' ' A' ' 102' ' ' ASN . 32.8 t30 -80.85 150.89 28.94 Favored 'General case' 0 N--CA 1.477 0.9 0 C-N-CA 124.34 1.056 . . . . 73.120000000000005 110.112 176.759 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 106.82 25.52 6.18 Favored Glycine 0 N--CA 1.47 0.912 0 C-N-CA 121.488 -0.387 . . . . 74.299999999999997 113.297 176.171 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 12.9 p -131.78 118.19 19.59 Favored 'General case' 0 CA--C 1.537 0.447 0 N-CA-C 108.183 -1.043 . . . . 75.510000000000005 108.183 175.107 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 111' ' ' GLN . . . . . 0.507 HE21 ' HG2' ' B' ' 218' ' ' PRO . 48.9 mt-30 61.16 -173.68 0.13 Allowed 'General case' 0 N--CA 1.493 1.683 0 C-N-CA 124.097 0.959 . . . . 75.340000000000003 111.895 -172.536 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 112' ' ' PHE . . . . . 0.527 ' HA ' ' HA ' ' A' ' 100' ' ' MET . 42.0 p90 -146.31 159.37 43.44 Favored 'General case' 0 N--CA 1.476 0.856 0 C-N-CA 123.817 0.847 . . . . 62.25 109.153 171.968 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 113' ' ' PHE . . . . . 0.586 ' HB2' ' SD ' ' A' ' 61' ' ' MET . 50.6 p90 -138.1 146.78 43.3 Favored 'General case' 0 C--O 1.238 0.458 0 C-N-CA 123.631 0.772 . . . . 75.120000000000005 109.6 -179.47 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 114' ' ' ILE . . . . . . . . . . . . . 17.2 mt -120.9 101.97 11.51 Favored 'Isoleucine or valine' 0 C--O 1.243 0.721 0 N-CA-C 107.517 -1.29 . . . . 63.25 107.517 176.419 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 115' ' ' CYS . . . . . 0.671 ' HB2' ' HB ' ' A' ' 97' ' ' ILE . 62.8 m -63.31 104.75 0.64 Allowed 'General case' 0 N--CA 1.469 0.511 0 N-CA-C 109.311 -0.626 . . . . 73.239999999999995 109.311 177.477 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 116' ' ' THR . . . . . 0.576 HG22 HG12 ' A' ' 139' ' ' VAL . 32.8 p -70.18 -32.8 70.9 Favored 'General case' 0 N--CA 1.472 0.656 0 C-N-CA 123.593 0.757 . . . . 72.0 109.859 -179.343 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -104.86 161.19 14.4 Favored 'General case' 0 C--O 1.241 0.62 0 C-N-CA 124.174 0.989 . . . . 75.319999999999993 109.505 172.27 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 9.4 ptmt -72.71 94.02 1.71 Allowed 'General case' 0 CA--C 1.546 0.826 0 CA-C-O 121.87 0.843 . . . . 75.209999999999994 109.874 174.828 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 119' ' ' THR . . . . . . . . . . . . . 75.0 p -87.22 83.99 7.31 Favored 'General case' 0 CA--C 1.545 0.771 0 CA-C-N 115.551 -0.75 . . . . 74.150000000000006 110.368 -175.354 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 8.3 pt-20 -80.36 -16.91 53.44 Favored 'General case' 0 N--CA 1.483 1.212 0 CA-C-O 121.137 0.494 . . . . 64.310000000000002 111.902 -172.426 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 121' ' ' TRP . . . . . . . . . . . . . 43.6 p90 -70.16 -9.86 56.99 Favored 'General case' 0 CA--C 1.546 0.813 0 C-N-CA 122.792 0.437 . . . . 71.319999999999993 111.58 173.971 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 122' ' ' LEU . . . . . 0.479 ' HA ' ' HE2' ' A' ' 125' ' ' LYS . 65.5 mt -89.17 4.91 47.0 Favored 'General case' 0 N--CA 1.477 0.882 0 C-N-CA 123.281 0.632 . . . . 63.329999999999998 111.936 174.723 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 78.5 m-20 -74.24 152.09 39.78 Favored 'General case' 0 N--CA 1.487 1.407 0 C-N-CA 122.482 0.313 . . . . 71.209999999999994 110.295 173.487 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 75.79 14.77 81.82 Favored Glycine 0 C--N 1.353 1.519 0 O-C-N 123.422 0.451 . . . . 41.020000000000003 112.802 -173.451 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 125' ' ' LYS . . . . . 0.479 ' HE2' ' HA ' ' A' ' 122' ' ' LEU . 30.0 mtmm -138.72 -162.09 1.27 Allowed 'General case' 0 N--CA 1.472 0.645 0 C-N-CA 125.683 1.593 . . . . 75.340000000000003 108.719 -174.95 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 126' ' ' HIS . . . . . . . . . . . . . 2.5 t60 -62.01 135.47 57.55 Favored 'General case' 0 CA--C 1.549 0.927 0 C-N-CA 123.938 0.895 . . . . 64.140000000000001 111.598 -165.715 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 127' ' ' VAL . . . . . 0.464 ' HB ' ' HD1' ' A' ' 88' ' ' PHE . 13.9 p -76.95 148.04 7.06 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.807 0 CA-C-N 114.526 -1.216 . . . . 62.109999999999999 112.317 -169.013 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 128' ' ' VAL . . . . . 0.443 ' HB ' ' HB3' ' A' ' 90' ' ' LEU . 18.9 t -72.56 156.07 6.96 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.818 0 C-N-CA 124.073 0.949 . . . . 74.340000000000003 108.884 171.619 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 129' ' ' PHE . . . . . 0.499 ' HA ' HG21 ' A' ' 29' ' ' VAL . 43.1 p90 -128.7 -23.84 3.08 Favored 'General case' 0 N--CA 1.485 1.324 0 CA-C-N 118.739 0.699 . . . . 64.420000000000002 111.661 175.4 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . -145.59 170.63 26.83 Favored Glycine 0 C--N 1.337 0.61 0 N-CA-C 111.454 -0.658 . . . . 70.230000000000004 111.454 -178.38 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 32.8 ttpt -150.07 147.27 27.6 Favored 'General case' 0 N--CA 1.472 0.646 0 N-CA-C 109.002 -0.74 . . . . 74.140000000000001 109.002 178.365 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 132' ' ' VAL . . . . . 0.573 HG21 HG21 ' A' ' 139' ' ' VAL . 58.1 t -62.43 112.32 0.97 Allowed 'Isoleucine or valine' 0 CA--C 1.538 0.49 0 C-N-CA 123.327 0.651 . . . . 74.239999999999995 109.771 174.838 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 21.9 ptmt -91.99 -33.98 14.62 Favored 'General case' 0 N--CA 1.471 0.606 0 N-CA-C 109.264 -0.643 . . . . 61.130000000000003 109.264 175.923 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 35.5 mt-10 -141.58 135.61 30.24 Favored 'General case' 0 N--CA 1.479 1.013 0 C-N-CA 124.513 1.125 . . . . 64.319999999999993 109.206 -179.072 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 95.63 24.72 15.04 Favored Glycine 0 C--N 1.349 1.301 0 O-C-N 123.381 0.426 . . . . 62.340000000000003 113.825 176.03 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 136' ' ' MET . . . . . . . . . . . . . 14.5 tpt -65.51 -32.09 73.5 Favored 'General case' 0 N--CA 1.485 1.293 0 CA-C-N 117.289 0.545 . . . . 72.239999999999995 111.119 179.787 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 137' ' ' ASN . . . . . . . . . . . . . 4.3 p-10 -61.26 -35.32 76.96 Favored 'General case' 0 CA--C 1.551 0.999 0 C-N-CA 123.941 0.897 . . . . 64.140000000000001 111.458 173.515 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 138' ' ' ILE . . . . . . . . . . . . . 50.6 mm -74.58 -32.93 30.81 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.001 0 C-N-CA 123.414 0.686 . . . . 73.439999999999998 110.532 177.51 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 139' ' ' VAL . . . . . 0.576 HG12 HG22 ' A' ' 116' ' ' THR . 87.7 t -66.52 -44.02 90.45 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.947 0 C-N-CA 123.733 0.813 . . . . 41.340000000000003 110.889 178.513 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 140' ' ' GLU . . . . . 0.419 ' O ' ' HG3' ' A' ' 144' ' ' ARG . 52.2 mt-10 -77.0 -19.41 57.31 Favored 'General case' 0 N--CA 1.475 0.795 0 CA-C-N 115.618 -0.719 . . . . 72.230000000000004 110.805 177.037 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -70.82 -37.55 73.23 Favored 'General case' 0 CA--C 1.543 0.687 0 C-N-CA 122.387 0.275 . . . . 42.539999999999999 110.295 169.068 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 142' ' ' MET . . . . . . . . . . . . . 70.6 mtm -63.24 -39.35 94.36 Favored 'General case' 0 N--CA 1.485 1.304 0 C-N-CA 123.065 0.546 . . . . 74.439999999999998 110.376 174.607 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 143' ' ' GLU . . . . . 0.412 ' HB2' HG21 ' A' ' 116' ' ' THR . 25.6 tt0 -55.61 -36.65 67.17 Favored 'General case' 0 CA--C 1.55 0.98 0 CA-C-N 114.539 -1.209 . . . . 61.240000000000002 111.784 178.252 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 144' ' ' ARG . . . . . 0.419 ' HG3' ' O ' ' A' ' 140' ' ' GLU . 29.2 mtm180 -73.82 -8.79 57.4 Favored 'General case' 0 N--CA 1.478 0.952 0 C-N-CA 123.837 0.855 . . . . 71.319999999999993 112.75 -176.952 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 145' ' ' PHE . . . . . 0.503 ' HB2' HD11 ' A' ' 156' ' ' ILE . 62.8 m-85 -97.63 -4.87 36.65 Favored 'General case' 0 N--CA 1.479 1.001 0 C-N-CA 122.674 0.389 . . . . 74.510000000000005 111.007 174.137 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . -92.92 171.36 32.8 Favored Glycine 0 C--N 1.347 1.158 0 CA-C-N 116.361 -0.381 . . . . 73.219999999999999 113.192 -179.632 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 147' ' ' SER . . . . . 0.471 ' HB2' ' HB3' ' A' ' 151' ' ' LYS . 18.3 m -133.6 156.99 46.85 Favored 'General case' 0 N--CA 1.475 0.8 0 C-N-CA 124.539 1.135 . . . . 73.109999999999999 109.566 -177.426 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 148' ' ' ARG . . . . . 0.518 ' HA ' HG23 ' A' ' 57' ' ' ILE . 18.9 mmt180 -59.12 -37.88 78.28 Favored 'General case' 0 N--CA 1.484 1.24 0 C-N-CA 123.858 0.863 . . . . 74.400000000000006 112.592 -172.219 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 149' ' ' ASN . . . . . . . . . . . . . 28.0 p-10 -72.0 -14.68 61.95 Favored 'General case' 0 N--CA 1.486 1.354 0 C-N-CA 123.518 0.727 . . . . 72.0 111.922 179.804 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . 112.89 -3.02 25.8 Favored Glycine 0 C--N 1.347 1.17 0 C-N-CA 123.428 0.537 . . . . 64.200000000000003 112.544 -178.644 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 151' ' ' LYS . . . . . 0.471 ' HB3' ' HB2' ' A' ' 147' ' ' SER . 87.9 tttt -67.82 146.47 53.66 Favored 'General case' 0 N--CA 1.478 0.938 0 C-N-CA 123.67 0.788 . . . . 73.340000000000003 111.092 -178.94 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 152' ' ' THR . . . . . . . . . . . . . 18.5 p -120.05 114.5 22.08 Favored 'General case' 0 N--CA 1.469 0.476 0 N-CA-C 109.204 -0.665 . . . . 70.420000000000002 109.204 173.062 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 153' ' ' SER . . . . . . . . . . . . . 37.8 t -67.34 -24.89 65.77 Favored 'General case' 0 CA--C 1.546 0.822 0 C-N-CA 124.242 1.017 . . . . 74.109999999999999 111.109 179.181 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 154' ' ' LYS . . . . . 0.438 ' HB3' HG13 ' A' ' 12' ' ' VAL . 69.7 mmtt -121.69 150.68 41.43 Favored 'General case' 0 N--CA 1.473 0.697 0 C-N-CA 123.951 0.901 . . . . 71.540000000000006 111.155 179.925 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 2.2 tppp? -93.37 91.16 7.05 Favored 'General case' 0 N--CA 1.474 0.773 0 CA-C-O 121.366 0.603 . . . . 74.120000000000005 110.251 -178.065 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 156' ' ' ILE . . . . . 0.527 ' HB ' ' HB2' ' A' ' 53' ' ' PHE . 48.4 mt -89.6 102.1 12.79 Favored 'Isoleucine or valine' 0 C--O 1.21 -1.009 0 N-CA-C 109.254 -0.647 . . . . 75.340000000000003 109.254 -177.05 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 157' ' ' THR . . . . . . . . . . . . . 42.3 p -108.54 145.19 35.17 Favored 'General case' 0 N--CA 1.472 0.652 0 C-N-CA 123.642 0.777 . . . . 73.310000000000002 110.151 178.841 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 158' ' ' ILE . . . . . 0.497 HG23 ' HB3' ' A' ' 8' ' ' PHE . 49.4 mt -70.47 95.86 0.47 Allowed 'Isoleucine or valine' 0 CA--C 1.547 0.839 0 N-CA-C 108.672 -0.862 . . . . 72.209999999999994 108.672 170.423 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 159' ' ' ALA . . . . . 0.553 ' HB2' ' HB2' ' A' ' 11' ' ' ALA . . . -51.72 -53.94 33.79 Favored 'General case' 0 N--CA 1.477 0.896 0 C-N-CA 124.402 1.081 . . . . 50.299999999999997 112.036 -177.599 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 160' ' ' ASP . . . . . . . . . . . . . 5.4 t70 -145.62 169.52 18.26 Favored 'General case' 0 CA--C 1.544 0.72 0 CA-C-N 116.195 -0.457 . . . . 73.120000000000005 110.583 -174.743 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 161' ' ' CYS . . . . . . . . . . . . . 12.7 p -135.16 -169.62 2.41 Favored 'General case' 0 N--CA 1.476 0.854 0 C-N-CA 125.048 1.339 . . . . 75.129999999999995 108.393 -177.822 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 162' ' ' GLY . . . . . . . . . . . . . . . 131.87 56.74 0.09 OUTLIER Glycine 0 N--CA 1.475 1.247 0 C-N-CA 120.635 -0.793 . . . . 74.239999999999995 111.922 -172.965 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 163' ' ' GLN . . . . . 0.621 ' HA ' ' H ' ' A' ' 7' ' ' PHE . 2.1 pt20 -46.93 135.54 9.21 Favored 'General case' 0 CA--C 1.552 1.022 0 C-N-CA 124.099 0.96 . . . . 72.140000000000001 113.478 -174.156 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 164' ' ' LEU . . . . . 0.405 ' O ' ' HB ' ' A' ' 5' ' ' THR . 86.6 mt -82.17 99.76 9.44 Favored 'General case' 0 CA--C 1.54 0.589 0 N-CA-C 108.751 -0.833 . . . . 44.119999999999997 108.751 178.249 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 165' ' ' GLU . . . . . . . . . . . . . 28.4 tt0 . . . . . 0 CA--C 1.554 1.132 0 N-CA-C 107.56 -1.274 . . . . 64.019999999999996 107.56 -175.307 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' B' B ' 216' ' ' PRO . . . . . 0.612 ' N ' ' HH ' ' B' ' 221' ' ' TYR . 25.0 Cg_exo . . . . . 0 N--CA 1.493 1.458 0 N-CA-C 110.465 -0.629 . . . . 73.439999999999998 110.465 . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 217' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -163.07 163.3 17.36 Favored Pre-proline 0 CA--C 1.551 0.993 0 C-N-CA 124.469 1.107 . . . . 74.439999999999998 108.207 -176.395 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 218' ' ' PRO . . . . . 0.507 ' HG2' HE21 ' A' ' 111' ' ' GLN . 42.1 Cg_endo -67.33 94.18 0.36 Allowed 'Trans proline' 0 C--N 1.367 1.519 0 C-N-CA 121.746 1.63 . . . . 71.329999999999998 111.113 170.719 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 219' ' ' GLY . . . . . . . . . . . . . . . -179.86 147.84 7.69 Favored Glycine 0 CA--C 1.536 1.371 0 CA-C-N 115.534 -0.757 . . . . 74.209999999999994 111.927 -178.755 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 220' ' ' PRO . . . . . . . . . . . . . 21.5 Cg_exo -68.26 164.52 32.07 Favored 'Trans proline' 0 C--N 1.377 2.036 0 C-N-CA 123.796 2.997 . . . . 71.540000000000006 113.565 -178.07 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 221' ' ' TYR . . . . . 0.612 ' HH ' ' N ' ' B' ' 216' ' ' PRO . 62.2 m-85 -129.05 157.14 42.55 Favored 'General case' 0 N--CA 1.481 1.123 0 C-N-CA 123.731 0.812 . . . . 70.099999999999994 111.157 -176.328 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 222' ' ' ALA . . . . . . . . . . . . . . . -171.96 173.53 4.4 Favored 'General case' 0 C--O 1.242 0.68 0 O-C-N 124.818 1.323 . . . . 72.319999999999993 109.672 174.753 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 223' ' ' GLN . . . . . . . . . . . . . 75.1 mt-30 63.62 86.95 0.13 Allowed Pre-proline 0 CA--C 1.551 0.994 0 O-C-N 124.365 1.04 . . . . 73.340000000000003 111.29 171.984 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 224' ' ' PRO . . . . . . . . . . . . . 31.4 Cg_exo . . . . . 0 C--N 1.378 2.083 0 C-N-CA 123.513 2.808 . . . . 72.530000000000001 113.079 -177.459 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 76.6 mtp . . . . . 0 N--CA 1.479 1.004 0 N-CA-C 110.189 -0.3 . . . . 62.210000000000001 110.189 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 47.1 t -77.09 88.7 0.91 Allowed 'Isoleucine or valine' 0 N--CA 1.476 0.864 0 N-CA-C 108.293 -1.002 . . . . 74.049999999999997 108.293 174.876 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 3' ' ' ASN . . . . . 0.431 ' ND2' ' HA ' ' A' ' 25' ' ' PHE . 21.5 m120 -97.87 103.92 19.35 Favored Pre-proline 0 CA--C 1.543 0.696 0 CA-C-N 115.336 -0.847 . . . . 62.520000000000003 109.538 177.587 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 4' ' ' PRO . . . . . 0.485 ' HG2' ' HB2' ' A' ' 24' ' ' LEU . 57.6 Cg_endo -73.66 144.37 35.41 Favored 'Trans proline' 0 C--N 1.374 1.911 0 C-N-CA 122.414 2.076 . . . . 62.530000000000001 112.123 175.12 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 5' ' ' THR . . . . . 0.569 HG23 ' HD3' ' A' ' 133' ' ' LYS . 97.9 m -97.1 114.13 25.77 Favored 'General case' 0 C--O 1.223 -0.318 0 N-CA-C 108.325 -0.991 . . . . 53.210000000000001 108.325 177.475 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 43.1 t -99.7 119.17 47.38 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.852 0 N-CA-C 108.33 -0.989 . . . . 74.120000000000005 108.33 -178.721 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 75.1 t80 -99.58 132.81 44.66 Favored 'General case' 0 C--N 1.323 -0.572 0 N-CA-C 109.235 -0.654 . . . . 74.0 109.235 -173.125 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 8' ' ' PHE . . . . . 0.475 ' HD2' ' HE2' ' A' ' 22' ' ' PHE . 33.1 m-85 -136.57 161.16 36.65 Favored 'General case' 0 C--O 1.238 0.499 0 O-C-N 124.027 0.829 . . . . 74.310000000000002 110.975 170.295 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 6.4 m-20 -108.37 114.76 28.86 Favored 'General case' 0 N--CA 1.465 0.277 0 CA-C-N 113.749 -1.569 . . . . 73.349999999999994 107.652 168.389 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 10' ' ' ILE . . . . . 0.542 HG21 ' SD ' ' A' ' 142' ' ' MET . 44.5 mm -85.48 118.82 32.96 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.369 0 N-CA-C 108.707 -0.849 . . . . 74.319999999999993 108.707 174.502 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 11' ' ' ALA . . . . . 0.554 ' HB2' ' HB2' ' A' ' 159' ' ' ALA . . . -118.11 131.36 56.43 Favored 'General case' 0 N--CA 1.469 0.476 0 C-N-CA 123.37 0.668 . . . . 63.219999999999999 111.143 -176.657 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 71.1 t -96.65 112.85 29.6 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.454 0 N-CA-C 107.934 -1.136 . . . . 64.310000000000002 107.934 170.765 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 18.5 m-20 62.93 24.25 14.44 Favored 'General case' 0 N--CA 1.481 1.104 0 C-N-CA 125.12 1.368 . . . . 64.049999999999997 111.931 179.965 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 99.1 -21.24 46.75 Favored Glycine 0 C--N 1.348 1.227 0 CA-C-N 116.43 -0.35 . . . . 62.32 113.031 -177.805 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 36.7 mm-40 -83.27 114.73 55.02 Favored Pre-proline 0 CA--C 1.543 0.706 0 C-N-CA 123.529 0.731 . . . . 73.140000000000001 110.048 179.667 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 34.3 Cg_endo -60.72 109.27 0.64 Allowed 'Trans proline' 0 C--N 1.378 2.098 0 C-N-CA 122.844 2.363 . . . . 71.120000000000005 111.863 -177.265 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 66.0 tp -76.31 -35.46 58.81 Favored 'General case' 0 N--CA 1.471 0.621 0 CA-C-N 115.104 -0.953 . . . . 55.210000000000001 109.922 179.334 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -175.96 177.96 47.52 Favored Glycine 0 C--N 1.341 0.832 0 CA-C-N 115.57 -0.741 . . . . 73.099999999999994 112.882 177.338 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 80.7 mtt180 -115.16 116.91 29.14 Favored 'General case' 0 C--O 1.237 0.406 0 C-N-CA 124.219 1.008 . . . . 73.209999999999994 108.86 -179.299 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 20' ' ' VAL . . . . . 0.414 HG13 HG13 ' A' ' 132' ' ' VAL . 67.5 t -114.65 118.33 58.33 Favored 'Isoleucine or valine' 0 C--O 1.238 0.498 0 C-N-CA 123.566 0.746 . . . . 64.209999999999994 109.417 -178.182 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 21' ' ' SER . . . . . 0.413 ' OG ' ' HB2' ' A' ' 134' ' ' GLU . 71.3 p -106.47 139.37 41.05 Favored 'General case' 0 C--O 1.246 0.878 0 N-CA-C 108.982 -0.748 . . . . 65.010000000000005 108.982 173.634 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 22' ' ' PHE . . . . . 0.475 ' HE2' ' HD2' ' A' ' 8' ' ' PHE . 85.2 m-85 -108.14 168.24 9.43 Favored 'General case' 0 C--N 1.331 -0.236 0 C-N-CA 124.544 1.138 . . . . 73.409999999999997 109.516 -179.886 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . 0.461 ' HB2' ' HD2' ' A' ' 133' ' ' LYS . 41.3 tt0 -129.95 106.9 8.96 Favored 'General case' 0 C--O 1.24 0.578 0 N-CA-C 107.979 -1.119 . . . . 53.530000000000001 107.979 179.007 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . 0.485 ' HB2' ' HG2' ' A' ' 4' ' ' PRO . 38.7 mt -82.44 124.72 30.31 Favored 'General case' 0 N--CA 1.467 0.414 0 N-CA-C 109.67 -0.493 . . . . 72.310000000000002 109.67 -179.456 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 25' ' ' PHE . . . . . 0.431 ' HA ' ' ND2' ' A' ' 3' ' ' ASN . 44.6 m-85 -86.48 66.57 9.57 Favored 'General case' 0 CA--C 1.535 0.403 0 C-N-CA 123.338 0.655 . . . . 74.319999999999993 109.236 177.632 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -62.35 -24.89 67.6 Favored 'General case' 0 N--CA 1.477 0.883 0 CA-C-N 115.282 -0.872 . . . . 43.299999999999997 111.703 -178.476 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 9.7 p-10 -71.42 -19.53 62.23 Favored 'General case' 0 N--CA 1.477 0.875 0 C-N-CA 124.097 0.959 . . . . 71.510000000000005 112.524 -179.905 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 61.2 mttp -110.58 -41.05 4.42 Favored 'General case' 0 N--CA 1.486 1.355 0 C-N-CA 123.729 0.812 . . . . 63.130000000000003 110.992 -178.76 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 29' ' ' VAL . . . . . 0.523 HG21 ' HA ' ' A' ' 129' ' ' PHE . 8.4 m -129.48 74.06 81.15 Favored Pre-proline 0 N--CA 1.478 0.966 0 C-N-CA 123.803 0.841 . . . . 72.409999999999997 109.947 -179.452 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 25.5 Cg_endo -60.09 -37.32 84.95 Favored 'Trans proline' 0 C--N 1.378 2.097 0 C-N-CA 122.797 2.331 . . . . 71.010000000000005 112.896 -175.982 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 31' ' ' LYS . . . . . 0.408 ' HE3' ' HB2' ' A' ' 31' ' ' LYS . 36.6 ttmt -66.75 -52.0 49.33 Favored 'General case' 0 N--CA 1.482 1.136 0 C-N-CA 123.534 0.734 . . . . 75.019999999999996 112.043 -176.637 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 18.3 m -77.43 -31.25 53.83 Favored 'General case' 0 CA--C 1.55 0.978 0 CA-C-N 115.277 -0.874 . . . . 51.420000000000002 111.136 -170.617 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 33' ' ' ALA . . . . . 0.447 ' HB1' ' HB3' ' A' ' 24' ' ' LEU . . . -71.93 -47.18 54.31 Favored 'General case' 0 N--CA 1.473 0.718 0 C-N-CA 122.828 0.451 . . . . 75.129999999999995 110.057 174.327 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 11.4 tp10 -59.98 -35.63 75.41 Favored 'General case' 0 N--CA 1.485 1.308 0 C-N-CA 123.477 0.711 . . . . 73.519999999999996 111.141 178.684 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 35' ' ' ASN . . . . . 0.551 ' ND2' ' SD ' ' A' ' 100' ' ' MET . 32.7 t30 -56.12 -64.42 0.87 Allowed 'General case' 0 CA--C 1.539 0.523 0 CA-C-N 114.981 -1.009 . . . . 64.219999999999999 110.812 178.075 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 74.5 t80 -61.94 -35.38 78.25 Favored 'General case' 0 N--CA 1.474 0.74 0 C-N-CA 123.774 0.83 . . . . 72.540000000000006 111.41 -177.043 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 37' ' ' ARG . . . . . 0.417 ' HG3' HE22 ' A' ' 163' ' ' GLN . 20.7 ttt180 -58.82 -50.29 74.51 Favored 'General case' 0 N--CA 1.472 0.674 0 C-N-CA 124.046 0.938 . . . . 70.349999999999994 110.937 175.901 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 38' ' ' ALA . . . . . 0.543 ' HB3' HG21 ' A' ' 78' ' ' ILE . . . -75.69 -22.26 56.82 Favored 'General case' 0 CA--C 1.54 0.582 0 CA-C-N 115.587 -0.733 . . . . 53.409999999999997 111.727 -176.29 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 39' ' ' LEU . . . . . 0.515 HD22 ' CE1' ' A' ' 48' ' ' TYR . 96.6 mt -72.41 -42.27 65.3 Favored 'General case' 0 N--CA 1.479 1.008 0 C-N-CA 123.127 0.571 . . . . 73.420000000000002 109.86 172.214 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 48.0 t -68.63 -55.88 10.07 Favored 'General case' 0 N--CA 1.476 0.834 0 C-N-CA 124.238 1.015 . . . . 54.210000000000001 110.959 -176.139 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 71.3 p -73.41 -30.07 63.0 Favored 'General case' 0 CA--C 1.541 0.634 0 C-N-CA 123.659 0.783 . . . . 74.409999999999997 110.819 179.452 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 87.02 32.71 13.62 Favored Glycine 0 C--N 1.352 1.453 0 CA-C-O 119.909 -0.384 . . . . 63.520000000000003 113.021 176.129 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 50.9 mm-40 -54.89 -42.37 72.03 Favored 'General case' 0 N--CA 1.48 1.062 0 C-N-CA 123.551 0.741 . . . . 65.409999999999997 110.991 177.034 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 44' ' ' LYS . . . . . 0.547 ' HG3' ' HB ' ' A' ' 78' ' ' ILE . 29.6 mmmt -93.51 18.19 10.31 Favored 'General case' 0 CA--C 1.547 0.828 0 CA-C-N 115.044 -0.98 . . . . 74.230000000000004 111.683 -173.332 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 73.05 36.3 56.99 Favored Glycine 0 C--N 1.354 1.557 0 CA-C-N 116.301 -0.409 . . . . 63.409999999999997 114.068 171.722 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 46' ' ' PHE . . . . . 0.461 ' HE2' ' HA ' ' A' ' 78' ' ' ILE . 22.0 m-85 -120.25 -47.63 2.35 Favored 'General case' 0 N--CA 1.483 1.183 0 C-N-CA 122.811 0.444 . . . . 62.119999999999997 110.788 -177.391 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 53.27 62.12 6.3 Favored Glycine 0 C--N 1.356 1.644 0 O-C-N 123.92 0.763 . . . . 64.239999999999995 114.896 170.653 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 48' ' ' TYR . . . . . 0.515 ' CE1' HD22 ' A' ' 39' ' ' LEU . 66.8 m-85 -64.73 91.23 0.08 Allowed 'General case' 0 N--CA 1.48 1.042 0 CA-C-O 121.936 0.874 . . . . 65.329999999999998 111.67 -176.721 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 49' ' ' LYS . . . . . 0.548 ' HE2' ' HA ' ' A' ' 160' ' ' ASP . 28.0 tptp -109.7 130.88 55.47 Favored 'General case' 0 C--O 1.239 0.529 0 CA-C-N 113.913 -1.494 . . . . 71.230000000000004 108.726 178.985 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 80.83 21.24 63.92 Favored Glycine 0 C--N 1.348 1.248 0 CA-C-O 119.645 -0.531 . . . . 73.430000000000007 113.235 179.715 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 51' ' ' SER . . . . . 0.43 ' HB2' HD12 ' A' ' 158' ' ' ILE . 23.0 m -56.28 115.07 2.26 Favored 'General case' 0 C--N 1.355 0.806 0 C-N-CA 123.799 0.84 . . . . 73.299999999999997 110.885 -179.004 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 52' ' ' CYS . . . . . 0.69 ' SG ' ' HB3' ' A' ' 66' ' ' ASP . 6.3 p -96.76 130.11 44.06 Favored 'General case' 0 CA--C 1.548 0.888 0 C-N-CA 123.918 0.887 . . . . 73.219999999999999 112.261 -168.823 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 53' ' ' PHE . . . . . 0.722 ' HA ' ' HA2' ' A' ' 64' ' ' GLY . 11.8 m-85 -79.82 108.95 13.79 Favored 'General case' 0 CA--C 1.538 0.481 0 C-N-CA 125.155 1.382 . . . . 53.530000000000001 109.569 175.173 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 53.1 p-80 -100.52 -30.58 11.72 Favored 'General case' 0 N--CA 1.487 1.416 0 C-N-CA 122.769 0.428 . . . . 62.149999999999999 111.018 178.964 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 27.9 ttt180 -112.38 99.98 8.43 Favored 'General case' 0 C--O 1.221 -0.445 0 N-CA-C 109.048 -0.723 . . . . 64.319999999999993 109.048 -173.278 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 56' ' ' ILE . . . . . 0.497 HG21 ' HA ' ' A' ' 143' ' ' GLU . 52.5 mt -134.63 134.68 54.12 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.801 0 N-CA-C 108.929 -0.767 . . . . 72.040000000000006 108.929 176.169 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 57' ' ' ILE . . . . . 0.641 HG23 ' HA ' ' A' ' 148' ' ' ARG . 58.1 mt -131.0 121.56 18.88 Favored Pre-proline 0 CA--C 1.554 1.12 0 C-N-CA 124.501 1.12 . . . . 74.409999999999997 108.037 179.357 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 58' ' ' PRO . . . . . 0.481 ' HA ' ' HG2' ' A' ' 143' ' ' GLU . 74.4 Cg_endo -70.89 139.58 36.63 Favored 'Trans proline' 0 C--N 1.378 2.084 0 C-N-CA 123.033 2.489 . . . . 61.399999999999999 112.577 -172.846 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 74.32 26.83 67.18 Favored Glycine 0 C--N 1.343 0.937 0 CA-C-N 115.552 -0.749 . . . . 63.210000000000001 112.569 -176.048 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 60' ' ' PHE . . . . . 0.412 ' HD2' ' HB ' ' A' ' 57' ' ' ILE . 28.3 t80 -148.47 -73.24 0.19 Allowed 'General case' 0 C--O 1.243 0.732 0 C-N-CA 123.659 0.784 . . . . 73.329999999999998 109.767 -175.188 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 61' ' ' MET . . . . . 0.475 ' SD ' ' HB2' ' A' ' 113' ' ' PHE . 44.7 ttm -171.69 140.46 1.33 Allowed 'General case' 0 C--N 1.353 0.722 0 CA-C-N 116.285 -0.416 . . . . 63.340000000000003 112.058 -163.215 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 62' ' ' CYS . . . . . 0.546 ' SG ' ' HB ' ' A' ' 114' ' ' ILE . 16.6 p -109.14 113.51 26.43 Favored 'General case' 0 CA--C 1.549 0.926 0 C-N-CA 124.031 0.932 . . . . 70.230000000000004 108.966 169.346 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 63' ' ' GLN . . . . . 0.475 ' HA ' ' HA ' ' A' ' 113' ' ' PHE . 50.7 tt0 -113.91 118.54 34.46 Favored 'General case' 0 N--CA 1.48 1.032 0 C-N-CA 123.574 0.75 . . . . 75.439999999999998 110.31 -170.875 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 64' ' ' GLY . . . . . 0.722 ' HA2' ' HA ' ' A' ' 53' ' ' PHE . . . -115.81 164.94 12.16 Favored Glycine 0 C--N 1.353 1.505 0 CA-C-N 115.736 -0.666 . . . . 71.200000000000003 113.622 -173.784 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 101.59 93.56 2.2 Favored Glycine 0 C--N 1.343 0.92 0 N-CA-C 110.096 -1.202 . . . . 61.450000000000003 110.096 -173.992 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 66' ' ' ASP . . . . . 0.69 ' HB3' ' SG ' ' A' ' 52' ' ' CYS . 38.9 t70 -122.6 -73.38 0.65 Allowed 'General case' 0 N--CA 1.476 0.838 0 C-N-CA 122.899 0.479 . . . . 51.130000000000003 110.588 -179.641 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 76.0 t80 -40.72 -49.84 3.09 Favored 'General case' 0 N--CA 1.483 1.206 0 C-N-CA 125.779 1.631 . . . . 74.430000000000007 114.048 -161.917 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 15.7 m -71.46 105.62 3.64 Favored 'General case' 0 CA--C 1.545 0.755 0 O-C-N 123.571 0.544 . . . . 74.140000000000001 110.551 -176.274 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 31.2 ttm180 51.82 47.66 24.33 Favored 'General case' 0 CA--C 1.553 1.095 0 C-N-CA 125.179 1.391 . . . . 72.310000000000002 111.379 -178.234 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 27.4 p80 -55.73 -28.15 54.3 Favored 'General case' 0 N--CA 1.492 1.654 0 C-N-CA 123.345 0.658 . . . . 72.409999999999997 111.773 179.302 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 6.3 t30 -80.98 103.53 10.87 Favored 'General case' 0 CA--C 1.544 0.72 0 C-N-CA 123.755 0.822 . . . . 74.25 109.217 170.008 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 97.22 -8.19 64.65 Favored Glycine 0 C--N 1.341 0.823 0 CA-C-O 119.132 -0.815 . . . . 43.43 115.09 168.597 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 73' ' ' THR . . . . . 0.517 HG21 ' HB3' ' A' ' 76' ' ' LYS . 25.6 m -149.51 -74.91 0.17 Allowed 'General case' 0 N--CA 1.484 1.271 0 CA-C-N 118.495 1.147 . . . . 75.409999999999997 110.491 178.894 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 81.75 60.19 2.23 Favored Glycine 0 C--N 1.35 1.334 0 CA-C-O 119.958 -0.356 . . . . 23.440000000000001 112.964 177.926 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 111.06 51.27 0.6 Allowed Glycine 0 N--CA 1.479 1.524 0 CA-C-N 117.329 0.564 . . . . 74.200000000000003 112.952 178.714 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 76' ' ' LYS . . . . . 0.517 ' HB3' HG21 ' A' ' 73' ' ' THR . 20.2 pttp -56.54 161.5 2.66 Favored 'General case' 0 N--CA 1.491 1.579 0 C-N-CA 124.55 1.14 . . . . 72.109999999999999 113.38 -178.997 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 46.1 p -101.59 179.7 4.27 Favored 'General case' 0 N--CA 1.484 1.247 0 C-N-CA 124.181 0.992 . . . . 70.25 112.698 -167.395 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 78' ' ' ILE . . . . . 0.547 ' HB ' ' HG3' ' A' ' 44' ' ' LYS . 29.1 pt -69.9 -16.82 20.63 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.907 0 C-N-CA 122.819 0.448 . . . . 71.120000000000005 111.441 177.553 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 86.0 m-85 -95.04 27.04 3.35 Favored 'General case' 0 CA--C 1.545 0.754 0 C-N-CA 124.112 0.965 . . . . 74.409999999999997 110.244 176.748 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 92.11 -128.62 9.46 Favored Glycine 0 C--N 1.351 1.381 0 N-CA-C 111.497 -0.641 . . . . 74.430000000000007 111.497 178.026 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 39.5 tt0 -66.05 -49.42 67.72 Favored 'General case' 0 N--CA 1.472 0.664 0 C-N-CA 123.548 0.739 . . . . 72.299999999999997 110.531 179.168 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 82' ' ' LYS . . . . . 0.713 ' HD2' ' HA ' ' A' ' 107' ' ' THR . 21.8 pttm -167.71 155.95 9.14 Favored 'General case' 0 CA--C 1.55 0.969 0 CA-C-N 115.501 -0.772 . . . . 63.420000000000002 111.054 -171.668 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 15.0 p90 -131.04 174.32 10.13 Favored 'General case' 0 N--CA 1.481 1.089 0 C-N-CA 125.176 1.39 . . . . 71.230000000000004 110.594 176.236 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 9.8 pt-20 -84.37 157.26 21.51 Favored 'General case' 0 N--CA 1.483 1.22 0 C-N-CA 123.497 0.719 . . . . 73.129999999999995 111.278 177.203 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 40.6 m-20 -64.22 134.34 54.58 Favored 'General case' 0 N--CA 1.489 1.479 0 C-N-CA 124.047 0.939 . . . . 61.240000000000002 110.837 -176.278 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 6.2 tp10 -60.05 -58.88 6.62 Favored 'General case' 0 N--CA 1.486 1.358 0 C-N-CA 123.236 0.614 . . . . 74.519999999999996 111.091 -178.627 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 31.9 p30 -163.22 -157.18 0.41 Allowed 'General case' 0 N--CA 1.467 0.41 0 N-CA-C 107.521 -1.288 . . . . 64.439999999999998 107.521 -179.211 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 89.7 m-85 -142.43 34.1 1.47 Allowed 'General case' 0 N--CA 1.485 1.293 0 C-N-CA 123.311 0.644 . . . . 75.430000000000007 110.52 177.005 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 65.4 mt -61.94 -61.04 1.79 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.649 0 CA-C-O 121.506 0.669 . . . . 74.150000000000006 110.266 178.39 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 90' ' ' LEU . . . . . 0.451 ' HB3' ' HB ' ' A' ' 128' ' ' VAL . 59.3 mt -78.8 102.36 8.11 Favored 'General case' 0 C--O 1.242 0.665 0 CA-C-N 114.88 -1.054 . . . . 64.109999999999999 110.075 -177.305 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 91' ' ' LYS . . . . . 0.691 ' HE3' ' HB ' ' A' ' 93' ' ' THR . 0.1 OUTLIER -84.63 163.64 19.15 Favored 'General case' 0 C--O 1.24 0.586 0 CA-C-N 115.493 -0.776 . . . . 70.140000000000001 110.334 174.747 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 92' ' ' HIS . . . . . . . . . . . . . 19.0 m-70 -91.19 56.1 3.04 Favored 'General case' 0 N--CA 1.476 0.858 0 CA-C-O 122.033 0.921 . . . . 74.400000000000006 109.371 -176.699 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 93' ' ' THR . . . . . 0.691 ' HB ' ' HE3' ' A' ' 91' ' ' LYS . 12.6 t -91.33 -7.15 51.79 Favored 'General case' 0 N--CA 1.47 0.572 0 CA-C-N 114.61 -1.177 . . . . 71.299999999999997 111.385 -176.383 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -124.94 167.78 17.21 Favored Glycine 0 C--N 1.34 0.785 0 O-C-N 123.062 0.226 . . . . 62.0 113.241 -175.206 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 95' ' ' PRO . . . . . 0.445 ' HB3' ' O ' ' A' ' 116' ' ' THR . 1.1 Cg_endo -84.67 157.07 12.08 Favored 'Trans proline' 0 C--N 1.363 1.316 0 C-N-CA 123.519 2.812 . . . . 60.399999999999999 111.636 168.553 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 78.28 16.94 78.86 Favored Glycine 0 C--N 1.346 1.104 0 CA-C-N 116.203 -0.453 . . . . 74.510000000000005 113.206 179.948 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 97' ' ' ILE . . . . . 0.813 ' HB ' ' SG ' ' A' ' 115' ' ' CYS . 15.6 mm -73.14 109.42 5.33 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.921 0 C-N-CA 123.797 0.839 . . . . 70.349999999999994 111.201 -176.399 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 63.8 tp -94.21 111.86 23.62 Favored 'General case' 0 CA--C 1.552 1.037 0 C-N-CA 123.773 0.829 . . . . 74.25 109.95 174.35 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 99' ' ' SER . . . . . 0.462 ' HB2' ' HA ' ' A' ' 128' ' ' VAL . 29.8 t -137.14 147.89 46.27 Favored 'General case' 0 N--CA 1.474 0.766 0 C-N-CA 124.371 1.068 . . . . 61.210000000000001 108.743 177.059 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 100' ' ' MET . . . . . 0.565 ' HA ' ' HA ' ' A' ' 112' ' ' PHE . 67.5 mtp -77.47 146.39 36.49 Favored 'General case' 0 N--CA 1.483 1.216 0 CA-C-O 120.671 0.272 . . . . 63.509999999999998 110.657 179.918 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 101' ' ' ALA . . . . . 0.55 ' HB3' ' HB3' ' A' ' 111' ' ' GLN . . . -76.89 162.5 27.56 Favored 'General case' 0 C--O 1.245 0.844 0 CA-C-N 115.818 -0.628 . . . . 64.329999999999998 111.254 -176.469 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 102' ' ' ASN . . . . . 0.498 ' HB3' ' HA ' ' A' ' 108' ' ' ASN . 30.5 p-10 -168.47 171.1 9.26 Favored 'General case' 0 C--O 1.238 0.472 0 CA-C-N 114.823 -1.081 . . . . 54.149999999999999 109.522 179.503 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 103' ' ' ALA . . . . . 0.426 ' HB3' HG21 ' A' ' 107' ' ' THR . . . -119.59 13.41 12.52 Favored 'General case' 0 CA--C 1.543 0.695 0 CA-C-N 115.263 -0.88 . . . . 75.530000000000001 109.94 172.617 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 146.95 -166.86 28.36 Favored Glycine 0 C--N 1.352 1.438 0 CA-C-O 119.595 -0.559 . . . . 71.140000000000001 112.521 179.981 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 14.6 Cg_exo -67.34 140.79 54.15 Favored 'Trans proline' 0 C--N 1.372 1.808 0 C-N-CA 123.172 2.581 . . . . 72.430000000000007 111.433 178.957 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 66.7 t30 66.4 9.72 6.69 Favored 'General case' 0 N--CA 1.491 1.606 0 C-N-CA 124.822 1.249 . . . . 73.310000000000002 111.979 -178.89 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 107' ' ' THR . . . . . 0.713 ' HA ' ' HD2' ' A' ' 82' ' ' LYS . 3.9 m -109.6 -6.47 15.35 Favored 'General case' 0 CA--C 1.552 1.049 0 C-N-CA 124.266 1.026 . . . . 73.200000000000003 109.669 177.025 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 108' ' ' ASN . . . . . 0.498 ' HA ' ' HB3' ' A' ' 102' ' ' ASN . 24.3 t30 -60.92 151.53 30.0 Favored 'General case' 0 N--CA 1.48 1.066 0 C-N-CA 125.046 1.339 . . . . 62.520000000000003 110.657 173.564 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 93.95 18.59 36.69 Favored Glycine 0 N--CA 1.465 0.628 0 C-N-CA 121.695 -0.288 . . . . 73.510000000000005 112.962 178.881 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 15.2 p -117.36 120.55 38.53 Favored 'General case' 0 C--N 1.328 -0.335 0 N-CA-C 106.938 -1.504 . . . . 73.329999999999998 106.938 167.093 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 111' ' ' GLN . . . . . 0.55 ' HB3' ' HB3' ' A' ' 101' ' ' ALA . 5.8 tt0 69.08 171.73 0.3 Allowed 'General case' 0 CA--C 1.557 1.23 0 C-N-CA 123.43 0.692 . . . . 64.030000000000001 111.341 171.609 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 112' ' ' PHE . . . . . 0.565 ' HA ' ' HA ' ' A' ' 100' ' ' MET . 52.5 p90 -143.8 155.0 43.99 Favored 'General case' 0 N--CA 1.48 1.026 0 O-C-N 121.748 -0.595 . . . . 74.219999999999999 109.695 176.364 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 113' ' ' PHE . . . . . 0.475 ' HB2' ' SD ' ' A' ' 61' ' ' MET . 40.5 p90 -140.57 151.3 44.6 Favored 'General case' 0 N--CA 1.47 0.536 0 C-N-CA 123.329 0.652 . . . . 73.209999999999994 111.277 -179.356 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 114' ' ' ILE . . . . . 0.546 ' HB ' ' SG ' ' A' ' 62' ' ' CYS . 19.3 mt -124.55 104.88 14.41 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.613 0 N-CA-C 108.067 -1.086 . . . . 75.430000000000007 108.067 177.029 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 115' ' ' CYS . . . . . 0.813 ' SG ' ' HB ' ' A' ' 97' ' ' ILE . 27.8 p -85.69 114.53 22.74 Favored 'General case' 0 C--O 1.241 0.643 0 CA-C-N 118.284 0.493 . . . . 73.019999999999996 109.728 178.968 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 116' ' ' THR . . . . . 0.445 ' O ' ' HB3' ' A' ' 95' ' ' PRO . 70.6 p -73.21 -20.88 60.77 Favored 'General case' 0 CA--C 1.54 0.579 0 C-N-CA 123.796 0.838 . . . . 72.239999999999995 110.603 176.863 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -101.94 155.89 17.88 Favored 'General case' 0 C--O 1.241 0.627 0 CA-C-N 115.383 -0.826 . . . . 74.140000000000001 109.76 171.893 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 19.2 ptmt -75.19 83.61 2.37 Favored 'General case' 0 CA--C 1.542 0.668 0 CA-C-O 121.765 0.793 . . . . 70.140000000000001 109.434 173.938 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 119' ' ' THR . . . . . 0.582 ' HB ' HD13 ' A' ' 122' ' ' LEU . 44.5 p -76.45 86.14 3.19 Favored 'General case' 0 CA--C 1.545 0.785 0 CA-C-O 121.948 0.88 . . . . 74.409999999999997 110.004 -175.984 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 11.1 pt-20 -78.51 -16.93 56.95 Favored 'General case' 0 N--CA 1.476 0.86 0 CA-C-N 114.825 -1.079 . . . . 74.530000000000001 112.127 -171.377 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 121' ' ' TRP . . . . . . . . . . . . . 35.7 p90 -74.18 -0.57 17.17 Favored 'General case' 0 CA--C 1.55 0.965 0 C-N-CA 123.027 0.531 . . . . 75.319999999999993 111.068 173.385 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 122' ' ' LEU . . . . . 0.582 HD13 ' HB ' ' A' ' 119' ' ' THR . 9.6 mp -97.42 -1.02 45.22 Favored 'General case' 0 N--CA 1.483 1.214 0 C-N-CA 124.275 1.03 . . . . 63.340000000000003 111.799 172.946 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 56.5 m-20 -71.06 129.51 39.14 Favored 'General case' 0 N--CA 1.477 0.898 0 N-CA-C 108.293 -1.003 . . . . 75.430000000000007 108.293 173.616 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 95.95 -25.08 26.98 Favored Glycine 0 N--CA 1.471 0.977 0 N-CA-C 111.573 -0.611 . . . . 55.200000000000003 111.573 -172.012 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 125' ' ' LYS . . . . . 0.578 ' HE2' ' HB3' ' B' ' 220' ' ' PRO . 16.3 ttpp -83.28 -168.46 2.1 Favored 'General case' 0 CA--C 1.555 1.144 0 N-CA-C 107.382 -1.34 . . . . 74.129999999999995 107.382 166.578 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 126' ' ' HIS . . . . . 0.498 ' H ' ' HG2' ' A' ' 125' ' ' LYS . 16.6 t-80 -65.0 131.65 47.15 Favored 'General case' 0 CA--C 1.548 0.887 0 CA-C-N 118.713 0.688 . . . . 74.109999999999999 112.082 -166.653 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 11.4 p -58.43 147.95 6.61 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.743 0 C-N-CA 125.906 1.682 . . . . 62.439999999999998 112.047 179.33 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 128' ' ' VAL . . . . . 0.462 ' HA ' ' HB2' ' A' ' 99' ' ' SER . 17.3 t -67.67 155.65 7.38 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.819 0 C-N-CA 123.927 0.891 . . . . 74.129999999999995 109.638 175.335 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 129' ' ' PHE . . . . . 0.523 ' HA ' HG21 ' A' ' 29' ' ' VAL . 50.5 p90 -133.5 -25.07 1.74 Allowed 'General case' 0 N--CA 1.477 0.908 0 O-C-N 122.269 -0.269 . . . . 65.510000000000005 111.363 173.843 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . -136.99 161.82 25.19 Favored Glycine 0 C--N 1.341 0.833 0 N-CA-C 111.588 -0.605 . . . . 70.439999999999998 111.588 -177.562 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 35.8 ttpt -144.29 138.61 28.05 Favored 'General case' 0 N--CA 1.468 0.461 0 N-CA-C 108.852 -0.795 . . . . 64.540000000000006 108.852 177.217 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 132' ' ' VAL . . . . . 0.414 HG13 HG13 ' A' ' 20' ' ' VAL . 47.3 t -64.03 103.44 0.38 Allowed 'Isoleucine or valine' 0 C--O 1.24 0.562 0 N-CA-C 108.83 -0.804 . . . . 71.420000000000002 108.83 174.751 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 133' ' ' LYS . . . . . 0.569 ' HD3' HG23 ' A' ' 5' ' ' THR . 21.5 ptmt -85.67 -31.91 22.25 Favored 'General case' 0 CA--C 1.537 0.476 0 N-CA-C 109.371 -0.603 . . . . 73.120000000000005 109.371 179.941 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 134' ' ' GLU . . . . . 0.413 ' HB2' ' OG ' ' A' ' 21' ' ' SER . 17.0 mt-10 -143.87 149.05 36.35 Favored 'General case' 0 N--CA 1.479 1.023 0 C-N-CA 124.818 1.247 . . . . 75.129999999999995 109.222 179.02 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 84.31 22.55 54.06 Favored Glycine 0 C--N 1.345 1.048 0 O-C-N 123.379 0.424 . . . . 54.43 113.164 -179.716 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 136' ' ' MET . . . . . 0.403 ' HA ' HG11 ' A' ' 132' ' ' VAL . 16.5 tpt -62.76 -40.17 96.45 Favored 'General case' 0 N--CA 1.477 0.923 0 C-N-CA 123.239 0.616 . . . . 70.099999999999994 111.38 -179.913 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 137' ' ' ASN . . . . . . . . . . . . . 12.4 m120 -64.75 -26.61 68.43 Favored 'General case' 0 N--CA 1.478 0.973 0 C-N-CA 123.146 0.578 . . . . 70.530000000000001 111.271 179.255 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 138' ' ' ILE . . . . . . . . . . . . . 48.1 mm -76.48 -37.75 30.8 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.843 0 C-N-CA 123.444 0.698 . . . . 55.100000000000001 110.153 177.192 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 139' ' ' VAL . . . . . 0.475 HG13 ' SG ' ' A' ' 62' ' ' CYS . 95.4 t -62.26 -43.61 98.19 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.96 0 C-N-CA 123.471 0.708 . . . . 63.509999999999998 110.258 175.43 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 39.0 mt-10 -65.5 -42.37 92.17 Favored 'General case' 0 CA--C 1.544 0.734 0 CA-C-N 114.949 -1.023 . . . . 73.299999999999997 110.851 176.889 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -67.85 -39.21 83.82 Favored 'General case' 0 N--CA 1.48 1.034 0 C-N-CA 123.603 0.761 . . . . 63.039999999999999 111.884 -178.189 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 142' ' ' MET . . . . . 0.594 ' HB2' HD13 ' A' ' 156' ' ' ILE . 19.5 ptt? -75.95 -29.28 58.24 Favored 'General case' 0 N--CA 1.478 0.952 0 C-N-CA 122.644 0.378 . . . . 64.25 110.504 -178.912 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 143' ' ' GLU . . . . . 0.497 ' HA ' HG21 ' A' ' 56' ' ' ILE . 28.1 tt0 -65.61 -28.01 68.82 Favored 'General case' 0 CA--C 1.545 0.77 0 CA-C-N 115.711 -0.677 . . . . 74.030000000000001 111.68 178.677 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 144' ' ' ARG . . . . . . . . . . . . . 75.9 mtt180 -66.87 -13.22 61.4 Favored 'General case' 0 N--CA 1.479 0.992 0 C-N-CA 123.555 0.742 . . . . 72.310000000000002 111.921 177.699 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 145' ' ' PHE . . . . . . . . . . . . . 38.3 m-85 -88.68 -8.58 54.33 Favored 'General case' 0 N--CA 1.475 0.807 0 C-N-CA 123.379 0.672 . . . . 73.540000000000006 111.641 175.944 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . -87.3 171.53 42.23 Favored Glycine 0 C--N 1.346 1.095 0 CA-C-O 120.007 -0.33 . . . . 42.039999999999999 112.547 175.166 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 9.0 m -133.03 160.15 37.98 Favored 'General case' 0 N--CA 1.479 1.01 0 C-N-CA 123.565 0.746 . . . . 72.25 110.31 -175.525 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 148' ' ' ARG . . . . . 0.641 ' HA ' HG23 ' A' ' 57' ' ' ILE . 14.3 mmm180 -61.29 -31.64 71.47 Favored 'General case' 0 N--CA 1.483 1.22 0 C-N-CA 124.5 1.12 . . . . 74.430000000000007 113.407 -176.382 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 149' ' ' ASN . . . . . . . . . . . . . 31.2 p-10 -75.74 -13.1 60.3 Favored 'General case' 0 N--CA 1.483 1.2 0 C-N-CA 123.222 0.609 . . . . 63.329999999999998 111.467 178.573 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . 111.64 -17.15 25.85 Favored Glycine 0 C--N 1.348 1.208 0 CA-C-O 119.821 -0.433 . . . . 72.540000000000006 112.664 179.066 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 87.3 tttt -69.09 137.1 53.21 Favored 'General case' 0 CA--C 1.546 0.812 0 C-N-CA 122.853 0.461 . . . . 63.539999999999999 111.303 -175.214 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 152' ' ' THR . . . . . . . . . . . . . 6.8 p -92.18 121.44 33.72 Favored 'General case' 0 C--O 1.241 0.63 0 C-N-CA 123.826 0.85 . . . . 75.510000000000005 109.124 170.41 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 153' ' ' SER . . . . . . . . . . . . . 29.9 t -67.32 -36.21 81.01 Favored 'General case' 0 N--CA 1.472 0.665 0 C-N-CA 123.499 0.72 . . . . 42.329999999999998 109.995 174.042 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 69.5 mmtt -110.39 149.42 30.28 Favored 'General case' 0 N--CA 1.471 0.622 0 C-N-CA 124.256 1.023 . . . . 74.319999999999993 110.767 -178.28 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 16.2 tppt? -89.27 91.67 8.86 Favored 'General case' 0 C--N 1.345 0.376 0 N-CA-C 108.873 -0.788 . . . . 71.439999999999998 108.873 178.386 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 156' ' ' ILE . . . . . 0.594 HD13 ' HB2' ' A' ' 142' ' ' MET . 69.1 mt -91.75 126.05 44.39 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.416 0 N-CA-C 108.833 -0.802 . . . . 72.349999999999994 108.833 -179.054 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 157' ' ' THR . . . . . 0.473 HG22 ' HB3' ' A' ' 52' ' ' CYS . 21.1 p -134.11 157.47 46.09 Favored 'General case' 0 N--CA 1.477 0.915 0 C-N-CA 124.115 0.966 . . . . 60.299999999999997 109.708 -175.371 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 158' ' ' ILE . . . . . 0.43 HD12 ' HB2' ' A' ' 51' ' ' SER . 46.4 mt -80.21 93.68 2.0 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.819 0 N-CA-C 109.261 -0.644 . . . . 71.409999999999997 109.261 170.601 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 159' ' ' ALA . . . . . 0.554 ' HB2' ' HB2' ' A' ' 11' ' ' ALA . . . -61.35 -34.16 74.84 Favored 'General case' 0 N--CA 1.472 0.626 0 C-N-CA 124.614 1.166 . . . . 73.109999999999999 113.404 -176.703 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 160' ' ' ASP . . . . . 0.548 ' HA ' ' HE2' ' A' ' 49' ' ' LYS . 26.3 t0 -159.98 162.76 34.4 Favored 'General case' 0 N--CA 1.475 0.814 0 C-N-CA 122.588 0.355 . . . . 70.439999999999998 110.375 -179.469 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 161' ' ' CYS . . . . . . . . . . . . . 28.0 p -127.74 -166.55 1.63 Allowed 'General case' 0 N--CA 1.474 0.731 0 C-N-CA 125.362 1.465 . . . . 73.439999999999998 108.812 -177.977 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 162' ' ' GLY . . . . . . . . . . . . . . . 134.17 54.51 0.07 OUTLIER Glycine 0 C--N 1.351 1.403 0 C-N-CA 121.406 -0.426 . . . . 75.299999999999997 112.885 -177.196 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 163' ' ' GLN . . . . . 0.417 HE22 ' HG3' ' A' ' 37' ' ' ARG . 8.1 tt0 -46.4 106.6 0.08 Allowed 'General case' 0 N--CA 1.483 1.18 0 C-N-CA 124.547 1.139 . . . . 52.100000000000001 111.629 178.515 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 164' ' ' LEU . . . . . . . . . . . . . 86.4 mt -73.39 113.09 10.08 Favored 'General case' 0 CA--C 1.542 0.671 0 CA-C-N 114.64 -1.164 . . . . 72.530000000000001 110.886 -177.402 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 165' ' ' GLU . . . . . . . . . . . . . 36.4 tt0 . . . . . 0 C--O 1.251 1.184 0 N-CA-C 108.448 -0.945 . . . . 74.510000000000005 108.448 172.512 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' B' B ' 216' ' ' PRO . . . . . . . . . . . . . 5.3 Cg_exo . . . . . 0 N--CA 1.482 0.821 0 N-CA-C 110.247 -0.713 . . . . 74.519999999999996 110.247 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' B' B ' 217' ' ' GLU . . . . . . . . . . . . . 80.7 tt0 -63.48 133.79 95.63 Favored Pre-proline 0 CA--C 1.552 1.021 0 C-N-CA 124.328 1.051 . . . . 74.230000000000004 110.679 -179.529 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 218' ' ' PRO . . . . . . . . . . . . . 68.1 Cg_exo -52.96 95.15 0.04 OUTLIER 'Trans proline' 0 C--N 1.388 2.647 0 C-N-CA 122.848 2.365 . . . . 73.549999999999997 111.9 175.172 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 219' ' ' GLY . . . . . . . . . . . . . . . 153.43 172.13 21.32 Favored Glycine 0 CA--C 1.529 0.928 0 CA-C-N 114.962 -1.017 . . . . 60.140000000000001 112.021 -174.213 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 220' ' ' PRO . . . . . 0.578 ' HB3' ' HE2' ' A' ' 125' ' ' LYS . 51.9 Cg_endo -86.48 165.49 9.32 Favored 'Trans proline' 0 C--N 1.364 1.355 0 C-N-CA 123.214 2.609 . . . . 74.450000000000003 114.22 179.689 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 221' ' ' TYR . . . . . . . . . . . . . 54.9 t80 -78.99 141.25 37.66 Favored 'General case' 0 N--CA 1.475 0.79 0 C-N-CA 123.002 0.521 . . . . 44.140000000000001 110.609 175.193 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 222' ' ' ALA . . . . . . . . . . . . . . . -85.01 -164.61 1.01 Allowed 'General case' 0 N--CA 1.475 0.806 0 C-N-CA 124.293 1.037 . . . . 64.299999999999997 111.893 -179.155 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 223' ' ' GLN . . . . . 0.409 ' NE2' ' HB2' ' A' ' 60' ' ' PHE . 14.3 mp0 -59.1 147.59 74.06 Favored Pre-proline 0 CA--C 1.557 1.219 0 C-N-CA 123.414 0.686 . . . . 71.299999999999997 109.555 172.968 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 224' ' ' PRO . . . . . . . . . . . . . 18.7 Cg_endo . . . . . 0 C--N 1.376 2.01 0 C-N-CA 122.781 2.321 . . . . 73.310000000000002 112.288 177.597 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 34.5 mmt . . . . . 0 N--CA 1.482 1.17 0 N-CA-C 109.371 -0.603 . . . . 75.329999999999998 109.371 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 11.8 p -92.95 -2.95 10.78 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.49 0 CA-C-O 121.774 0.797 . . . . 35.350000000000001 110.801 175.08 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 5.6 m120 -83.44 118.13 70.64 Favored Pre-proline 0 CA--C 1.55 0.96 0 C-N-CA 123.794 0.838 . . . . 71.549999999999997 110.043 -168.245 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 31.5 Cg_endo -61.62 121.73 10.0 Favored 'Trans proline' 0 C--N 1.378 2.098 0 C-N-CA 122.957 2.438 . . . . 62.310000000000002 111.591 179.847 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 5' ' ' THR . . . . . 0.401 ' HB ' ' HB2' ' A' ' 164' ' ' LEU . 93.1 m -98.14 132.11 43.94 Favored 'General case' 0 CA--C 1.536 0.435 0 C-N-CA 122.756 0.422 . . . . 71.420000000000002 110.097 -177.972 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . 0.521 ' HA ' ' HB2' ' A' ' 163' ' ' GLN . 12.6 m -101.16 129.49 52.08 Favored 'Isoleucine or valine' 0 C--N 1.35 0.593 0 C-N-CA 123.53 0.732 . . . . 72.239999999999995 110.008 175.591 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 7' ' ' PHE . . . . . 0.621 ' HB2' ' HG ' ' A' ' 164' ' ' LEU . 37.7 t80 -119.61 134.23 55.31 Favored 'General case' 0 C--O 1.238 0.464 0 C-N-CA 123.886 0.875 . . . . 72.040000000000006 109.7 -170.684 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 8' ' ' PHE . . . . . 0.437 ' HB3' HG23 ' A' ' 158' ' ' ILE . 64.6 m-85 -139.89 161.37 37.75 Favored 'General case' 0 N--CA 1.47 0.536 0 O-C-N 123.801 0.688 . . . . 71.349999999999994 111.467 -174.705 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 7.6 m-20 -102.36 108.05 19.27 Favored 'General case' 0 N--CA 1.47 0.536 0 CA-C-N 114.005 -1.452 . . . . 65.450000000000003 107.58 166.017 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 10' ' ' ILE . . . . . 0.475 HG21 ' SD ' ' A' ' 142' ' ' MET . 49.2 mm -82.1 120.3 33.33 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.476 0 N-CA-C 108.852 -0.795 . . . . 73.209999999999994 108.852 175.323 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 11' ' ' ALA . . . . . 0.537 ' HB2' ' HB2' ' A' ' 159' ' ' ALA . . . -117.29 121.92 42.49 Favored 'General case' 0 N--CA 1.463 0.218 0 C-N-CA 123.529 0.732 . . . . 65.549999999999997 110.915 -173.638 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . 0.488 HG21 HD22 ' A' ' 17' ' ' LEU . 76.6 t -98.06 118.08 43.98 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.651 0 N-CA-C 108.334 -0.988 . . . . 72.340000000000003 108.334 173.454 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 35.8 m-20 61.9 31.2 18.25 Favored 'General case' 0 N--CA 1.486 1.364 0 C-N-CA 125.566 1.546 . . . . 72.25 111.249 -174.707 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 87.32 -15.78 52.24 Favored Glycine 0 C--N 1.352 1.428 0 CA-C-N 115.488 -0.778 . . . . 43.329999999999998 113.191 -177.499 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 21.8 mm-40 -90.81 115.72 64.86 Favored Pre-proline 0 N--CA 1.474 0.766 0 CA-C-O 118.606 -0.711 . . . . 73.150000000000006 110.514 -177.165 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 14.0 Cg_endo -53.52 104.88 0.11 Allowed 'Trans proline' 0 C--N 1.387 2.564 0 C-N-CA 123.228 2.619 . . . . 72.430000000000007 111.909 178.493 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . 0.488 HD22 HG21 ' A' ' 12' ' ' VAL . 21.3 tp -77.12 -24.93 51.65 Favored 'General case' 0 CA--C 1.541 0.632 0 CA-C-N 114.696 -1.138 . . . . 71.099999999999994 109.777 179.3 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 170.03 -178.62 42.78 Favored Glycine 0 C--N 1.342 0.894 0 CA-C-N 115.354 -0.839 . . . . 51.140000000000001 112.337 176.373 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 94.3 mtt180 -116.44 142.27 47.08 Favored 'General case' 0 N--CA 1.473 0.687 0 C-N-CA 123.771 0.828 . . . . 72.439999999999998 110.228 -178.49 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 45.0 t -131.35 141.11 46.76 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.69 0 C-N-CA 123.179 0.592 . . . . 73.219999999999999 110.247 -178.474 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 40.6 p -120.92 116.77 25.77 Favored 'General case' 0 CA--C 1.548 0.901 0 C-N-CA 124.596 1.158 . . . . 72.109999999999999 109.109 177.1 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 63.1 m-85 -103.36 113.47 26.99 Favored 'General case' 0 N--CA 1.472 0.647 0 C-N-CA 123.927 0.891 . . . . 62.420000000000002 109.377 177.158 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . 0.537 ' HB2' ' HD2' ' A' ' 133' ' ' LYS . 42.4 tt0 -74.88 103.56 5.16 Favored 'General case' 0 CA--C 1.553 1.083 0 C-N-CA 123.827 0.851 . . . . 71.230000000000004 109.934 175.759 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 21.0 mt -83.94 120.07 25.66 Favored 'General case' 0 N--CA 1.477 0.904 0 N-CA-C 109.352 -0.61 . . . . 73.140000000000001 109.352 178.454 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 25' ' ' PHE . . . . . 0.585 ' HB2' HD11 ' A' ' 90' ' ' LEU . 57.8 m-85 -84.46 70.44 10.68 Favored 'General case' 0 CA--C 1.544 0.716 0 C-N-CA 123.19 0.596 . . . . 73.319999999999993 110.117 177.809 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -60.97 -30.45 70.27 Favored 'General case' 0 N--CA 1.482 1.13 0 C-N-CA 123.247 0.619 . . . . 73.319999999999993 111.789 179.901 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 10.8 p-10 -62.03 -26.59 68.34 Favored 'General case' 0 CA--C 1.548 0.866 0 C-N-CA 124.169 0.988 . . . . 75.230000000000004 112.223 178.902 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 28' ' ' LYS . . . . . 0.406 ' HD2' HD21 ' A' ' 90' ' ' LEU . 41.0 mttm -98.05 -49.69 4.66 Favored 'General case' 0 N--CA 1.479 0.991 0 C-N-CA 123.557 0.743 . . . . 52.009999999999998 110.476 -178.629 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 29' ' ' VAL . . . . . 0.569 HG21 ' HA ' ' A' ' 129' ' ' PHE . 26.7 m -120.05 83.67 31.52 Favored Pre-proline 0 CA--C 1.567 1.605 0 C-N-CA 123.844 0.858 . . . . 63.520000000000003 110.119 -174.285 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 32.7 Cg_endo -61.43 -49.84 6.79 Favored 'Trans proline' 0 C--N 1.382 2.33 0 C-N-CA 122.81 2.34 . . . . 73.109999999999999 112.337 -172.045 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 23.8 ttmm -60.5 -53.51 56.65 Favored 'General case' 0 N--CA 1.47 0.563 0 C-N-CA 124.049 0.94 . . . . 71.230000000000004 111.805 -175.247 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 7.3 m -75.85 -37.41 58.99 Favored 'General case' 0 CA--C 1.553 1.076 0 CA-C-N 115.339 -0.846 . . . . 74.219999999999999 111.912 -168.508 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -76.4 -43.37 40.76 Favored 'General case' 0 N--CA 1.479 0.998 0 C-N-CA 122.367 0.267 . . . . 61.030000000000001 111.327 -179.103 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 9.0 tp10 -62.75 -39.27 93.63 Favored 'General case' 0 N--CA 1.482 1.144 0 O-C-N 123.445 0.465 . . . . 54.020000000000003 110.878 178.134 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 35' ' ' ASN . . . . . 0.492 ' O ' ' HG ' ' A' ' 39' ' ' LEU . 35.6 t30 -50.2 -62.6 1.48 Allowed 'General case' 0 C--N 1.356 0.889 0 O-C-N 124.333 1.02 . . . . 74.129999999999995 110.885 176.865 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 36' ' ' PHE . . . . . 0.46 ' HE2' HG21 ' A' ' 6' ' ' VAL . 84.2 t80 -64.26 -34.03 77.19 Favored 'General case' 0 N--CA 1.471 0.613 0 O-C-N 124.172 0.92 . . . . 74.129999999999995 111.843 -175.544 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 41.9 ttp180 -64.71 -40.53 95.52 Favored 'General case' 0 CA--C 1.541 0.618 0 O-C-N 123.429 0.456 . . . . 65.049999999999997 110.682 178.969 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -75.88 -25.87 56.52 Favored 'General case' 0 N--CA 1.476 0.843 0 CA-C-N 115.881 -0.6 . . . . 42.450000000000003 111.432 179.226 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 39' ' ' LEU . . . . . 0.492 ' HG ' ' O ' ' A' ' 35' ' ' ASN . 85.5 mt -68.99 -40.1 78.96 Favored 'General case' 0 N--CA 1.48 1.037 0 C-N-CA 123.605 0.762 . . . . 73.040000000000006 109.868 172.544 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 37.1 t -68.38 -56.67 7.7 Favored 'General case' 0 N--CA 1.475 0.814 0 C-N-CA 124.584 1.154 . . . . 73.310000000000002 111.359 -177.151 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 18.1 p -71.87 -30.01 64.97 Favored 'General case' 0 N--CA 1.473 0.697 0 CA-C-N 115.625 -0.716 . . . . 63.119999999999997 111.587 -179.26 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 83.26 26.58 43.32 Favored Glycine 0 C--N 1.347 1.169 0 CA-C-N 116.093 -0.503 . . . . 74.340000000000003 112.805 -179.436 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 40.7 mm-40 -67.0 -21.01 65.97 Favored 'General case' 0 N--CA 1.476 0.874 0 C-N-CA 122.979 0.512 . . . . 75.120000000000005 111.873 177.887 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 3.3 mmpm? -100.61 18.31 19.55 Favored 'General case' 0 CA--C 1.548 0.866 0 C-N-CA 124.052 0.941 . . . . 73.150000000000006 111.159 175.443 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 87.43 -25.06 8.54 Favored Glycine 0 C--N 1.349 1.299 0 CA-C-O 119.437 -0.646 . . . . 73.099999999999994 114.304 175.034 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 17.4 m-85 -69.2 -48.78 61.11 Favored 'General case' 0 N--CA 1.478 0.928 0 CA-C-N 117.237 0.519 . . . . 72.140000000000001 111.655 -167.145 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 53.29 64.74 3.92 Favored Glycine 0 C--N 1.353 1.505 0 O-C-N 123.942 0.776 . . . . 75.120000000000005 114.212 170.692 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 48' ' ' TYR . . . . . 0.453 ' HB3' ' HB2' ' A' ' 51' ' ' SER . 59.3 m-85 -60.95 86.95 0.02 OUTLIER 'General case' 0 CA--C 1.551 1.006 0 CA-C-O 121.69 0.757 . . . . 73.450000000000003 111.044 178.209 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 27.7 tptp -112.68 125.28 54.13 Favored 'General case' 0 C--O 1.238 0.455 0 N-CA-C 107.306 -1.368 . . . . 73.150000000000006 107.306 177.086 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 73.92 21.62 78.99 Favored Glycine 0 CA--C 1.53 0.989 0 O-C-N 123.364 0.415 . . . . 50.210000000000001 112.097 -172.117 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 51' ' ' SER . . . . . 0.653 ' HA ' ' HB2' ' A' ' 67' ' ' PHE . 31.8 t -61.81 112.05 2.13 Favored 'General case' 0 C--N 1.358 0.944 0 C-N-CA 123.65 0.78 . . . . 73.120000000000005 111.042 -173.486 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 52' ' ' CYS . . . . . 0.605 ' SG ' ' HB3' ' A' ' 66' ' ' ASP . 5.1 p -82.06 161.76 22.8 Favored 'General case' 0 CA--C 1.537 0.446 0 CA-C-O 121.769 0.795 . . . . 62.130000000000003 111.914 -172.864 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 30.2 m-85 -113.72 133.36 55.39 Favored 'General case' 0 C--O 1.235 0.337 0 CA-C-N 114.613 -1.176 . . . . 72.109999999999999 108.136 177.164 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 55.6 p-80 -115.9 -19.98 10.18 Favored 'General case' 0 N--CA 1.485 1.319 0 C-N-CA 122.871 0.468 . . . . 63.32 110.883 -179.351 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 55' ' ' ARG . . . . . 0.472 ' HA ' ' O ' ' A' ' 150' ' ' GLY . 27.9 ttt-85 -130.22 97.02 4.31 Favored 'General case' 0 C--O 1.215 -0.728 0 C-N-CA 123.116 0.566 . . . . 74.349999999999994 109.553 -172.158 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 33.2 mt -136.05 129.46 47.37 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.716 0 C-N-CA 123.488 0.715 . . . . 75.019999999999996 109.138 178.816 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 57' ' ' ILE . . . . . 0.45 HG23 ' HA ' ' A' ' 148' ' ' ARG . 56.8 mt -128.83 118.04 19.6 Favored Pre-proline 0 CA--C 1.552 1.02 0 C-N-CA 124.591 1.157 . . . . 75.219999999999999 109.153 -178.168 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 58' ' ' PRO . . . . . 0.709 ' HB3' ' HA ' ' A' ' 144' ' ' ARG . 38.7 Cg_endo -63.96 140.27 71.92 Favored 'Trans proline' 0 C--N 1.377 2.058 0 C-N-CA 123.563 2.842 . . . . 74.530000000000001 113.325 -175.966 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 73.4 20.45 79.88 Favored Glycine 0 C--N 1.346 1.115 0 CA-C-N 115.094 -0.957 . . . . 72.450000000000003 113.057 178.839 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 60' ' ' PHE . . . . . 0.47 ' HB2' HE21 ' B' ' 223' ' ' GLN . 47.2 t80 -145.24 -73.68 0.24 Allowed 'General case' 0 C--O 1.244 0.782 0 C-N-CA 123.662 0.785 . . . . 73.209999999999994 109.717 -174.366 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 61' ' ' MET . . . . . 0.704 ' SD ' ' HB2' ' A' ' 63' ' ' GLN . 12.3 tmm? -169.15 137.03 1.9 Allowed 'General case' 0 N--CA 1.479 1.001 0 O-C-N 123.272 0.358 . . . . 71.140000000000001 111.686 -164.883 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 62' ' ' CYS . . . . . 0.486 ' SG ' ' HB ' ' A' ' 114' ' ' ILE . 3.9 p -112.89 121.32 44.32 Favored 'General case' 0 N--CA 1.484 1.228 0 C-N-CA 124.673 1.189 . . . . 74.120000000000005 110.585 174.334 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 63' ' ' GLN . . . . . 0.704 ' HB2' ' SD ' ' A' ' 61' ' ' MET . 53.7 tt0 -126.95 137.6 53.15 Favored 'General case' 0 N--CA 1.49 1.562 0 C-N-CA 124.163 0.985 . . . . 61.439999999999998 111.489 -168.596 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -154.86 -157.81 8.4 Favored Glycine 0 C--N 1.348 1.217 0 CA-C-N 115.975 -0.557 . . . . 51.009999999999998 113.311 -178.314 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 108.46 14.04 17.27 Favored Glycine 0 N--CA 1.476 1.344 0 N-CA-C 111.477 -0.649 . . . . 53.299999999999997 111.477 -169.789 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 66' ' ' ASP . . . . . 0.605 ' HB3' ' SG ' ' A' ' 52' ' ' CYS . 28.2 t70 -72.09 1.19 7.83 Favored 'General case' 0 CA--C 1.558 1.283 0 C-N-CA 125.242 1.417 . . . . 53.020000000000003 112.876 -167.409 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 67' ' ' PHE . . . . . 0.653 ' HB2' ' HA ' ' A' ' 51' ' ' SER . 56.6 t80 -73.36 -70.96 0.34 Allowed 'General case' 0 CA--C 1.549 0.932 0 C-N-CA 124.022 0.929 . . . . 73.310000000000002 111.41 -176.509 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 68' ' ' THR . . . . . 0.511 HG22 ' HD3' ' A' ' 76' ' ' LYS . 4.3 m -86.9 108.5 18.81 Favored 'General case' 0 N--CA 1.475 0.8 0 C-N-CA 122.949 0.5 . . . . 35.299999999999997 110.115 -171.999 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 34.8 ttt85 52.99 93.64 0.02 OUTLIER 'General case' 0 N--CA 1.481 1.116 0 C-N-CA 125.501 1.52 . . . . 65.409999999999997 111.618 -179.278 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 0.4 OUTLIER -110.69 11.73 22.67 Favored 'General case' 0 N--CA 1.481 1.088 0 N-CA-C 112.866 0.691 . . . . 73.329999999999998 112.866 -177.122 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 18.7 m120 -86.21 88.14 7.55 Favored 'General case' 0 N--CA 1.477 0.896 0 N-CA-C 108.928 -0.767 . . . . 64.109999999999999 108.928 171.467 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 69.96 29.39 70.82 Favored Glycine 0 C--N 1.35 1.334 0 CA-C-N 115.478 -0.783 . . . . 74.120000000000005 113.751 176.549 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 47.9 m -143.7 -64.55 0.38 Allowed 'General case' 0 CA--C 1.547 0.832 0 C-N-CA 124.015 0.926 . . . . 65.239999999999995 108.698 178.188 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 56.14 41.11 85.29 Favored Glycine 0 C--N 1.356 1.688 0 N-CA-C 115.234 0.853 . . . . 73.510000000000005 115.234 172.063 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 141.18 51.1 0.05 OUTLIER Glycine 0 C--N 1.346 1.12 0 CA-C-N 117.241 0.521 . . . . 24.300000000000001 111.872 -175.219 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 76' ' ' LYS . . . . . 0.511 ' HD3' HG22 ' A' ' 68' ' ' THR . 0.0 OUTLIER -58.87 147.81 32.44 Favored 'General case' 0 N--CA 1.475 0.82 0 C-N-CA 123.329 0.652 . . . . 74.329999999999998 112.151 -179.129 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 85.8 p -98.52 -178.37 3.98 Favored 'General case' 0 C--O 1.238 0.454 0 CA-C-N 115.325 -0.852 . . . . 72.439999999999998 111.953 -170.874 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 26.8 pt -75.58 -12.89 14.9 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.85 0 CA-C-N 114.999 -1.0 . . . . 75.450000000000003 111.003 175.426 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 99.2 m-85 -97.78 22.08 9.63 Favored 'General case' 0 N--CA 1.479 1.018 0 C-N-CA 124.133 0.973 . . . . 70.420000000000002 110.069 175.714 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 96.52 -111.71 4.29 Favored Glycine 0 C--N 1.346 1.128 0 N-CA-C 110.895 -0.882 . . . . 71.140000000000001 110.895 -177.694 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 41.5 tt0 -78.37 -59.63 2.7 Favored 'General case' 0 N--CA 1.472 0.628 0 C-N-CA 122.978 0.511 . . . . 72.310000000000002 110.378 -179.975 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 82' ' ' LYS . . . . . 0.759 ' HD2' ' HA ' ' A' ' 107' ' ' THR . 21.3 pttp -161.47 178.5 9.07 Favored 'General case' 0 N--CA 1.477 0.902 0 C-N-CA 123.88 0.872 . . . . 74.409999999999997 109.839 -171.055 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 35.7 p90 -152.07 174.36 13.78 Favored 'General case' 0 N--CA 1.474 0.765 0 C-N-CA 124.43 1.092 . . . . 72.129999999999995 111.459 -175.81 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 84' ' ' GLU . . . . . 0.46 ' HA ' ' HA ' ' A' ' 106' ' ' ASN . 13.7 pt-20 -82.92 160.28 22.13 Favored 'General case' 0 N--CA 1.474 0.734 0 CA-C-N 115.249 -0.887 . . . . 74.200000000000003 110.795 176.263 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 85' ' ' ASP . . . . . 0.404 ' OD1' ' HA ' ' A' ' 126' ' ' HIS . 49.7 m-20 -63.04 133.98 55.39 Favored 'General case' 0 N--CA 1.47 0.56 0 C-N-CA 123.741 0.816 . . . . 72.230000000000004 110.832 179.232 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 9.9 tp10 -76.18 -61.79 1.82 Allowed 'General case' 0 CA--C 1.543 0.676 0 CA-C-N 116.074 -0.512 . . . . 73.409999999999997 109.846 179.261 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 87' ' ' ASN . . . . . 0.433 ' OD1' HG12 ' A' ' 29' ' ' VAL . 27.6 p-10 -169.36 155.39 6.27 Favored 'General case' 0 N--CA 1.477 0.899 0 C-N-CA 123.49 0.716 . . . . 60.210000000000001 110.265 -173.303 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 76.5 m-85 -109.11 33.26 4.37 Favored 'General case' 0 N--CA 1.479 1.0 0 C-N-CA 123.826 0.85 . . . . 75.540000000000006 111.442 -169.648 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 55.9 mt -60.25 -46.98 94.03 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.164 0 C-N-CA 123.311 0.644 . . . . 65.099999999999994 109.561 174.283 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 90' ' ' LEU . . . . . 0.585 HD11 ' HB2' ' A' ' 25' ' ' PHE . 95.9 mt -95.87 128.39 42.71 Favored 'General case' 0 CA--C 1.537 0.476 0 CA-C-N 115.047 -0.978 . . . . 73.129999999999995 109.803 179.067 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 17.8 ptpt -133.74 171.94 13.45 Favored 'General case' 0 N--CA 1.472 0.646 0 C-N-CA 124.305 1.042 . . . . 75.239999999999995 110.133 -179.444 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 92' ' ' HIS . . . . . . . . . . . . . 23.8 m-70 -85.49 50.28 1.93 Allowed 'General case' 0 N--CA 1.477 0.895 0 C-N-CA 124.277 1.031 . . . . 64.349999999999994 110.107 -175.909 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 8.8 t -89.28 4.92 47.19 Favored 'General case' 0 CA--C 1.549 0.929 0 C-N-CA 124.006 0.923 . . . . 54.149999999999999 111.576 -176.773 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -148.72 172.9 28.82 Favored Glycine 0 C--N 1.345 1.073 0 N-CA-C 111.93 -0.468 . . . . 62.340000000000003 111.93 178.779 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 89.9 Cg_endo -84.08 156.88 13.2 Favored 'Trans proline' 0 CA--C 1.551 1.367 0 C-N-CA 123.026 2.484 . . . . 73.340000000000003 111.921 172.363 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 78.61 19.95 72.48 Favored Glycine 0 N--CA 1.471 1.03 0 CA-C-N 116.418 -0.355 . . . . 73.140000000000001 113.86 -179.438 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 97' ' ' ILE . . . . . . . . . . . . . 22.1 mm -78.91 109.77 13.95 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.777 0 C-N-CA 123.954 0.902 . . . . 63.219999999999999 111.41 -175.483 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 98' ' ' LEU . . . . . 0.492 HD13 HG12 ' A' ' 114' ' ' ILE . 65.6 tp -90.09 118.46 29.65 Favored 'General case' 0 CA--C 1.551 1.004 0 C-N-CA 123.299 0.64 . . . . 72.400000000000006 109.661 176.35 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 99' ' ' SER . . . . . 0.486 ' HB2' HG22 ' A' ' 128' ' ' VAL . 33.5 t -137.39 155.85 48.89 Favored 'General case' 0 N--CA 1.476 0.875 0 C-N-CA 124.979 1.312 . . . . 75.349999999999994 108.911 -177.495 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 100' ' ' MET . . . . . 0.41 ' HA ' ' HA ' ' A' ' 112' ' ' PHE . 41.2 mtp -90.41 147.31 23.52 Favored 'General case' 0 N--CA 1.486 1.348 0 N-CA-C 110.069 -0.345 . . . . 72.340000000000003 110.069 178.123 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 101' ' ' ALA . . . . . 0.475 ' HB3' ' HB2' ' A' ' 111' ' ' GLN . . . -84.46 162.52 19.9 Favored 'General case' 0 N--CA 1.475 0.8 0 C-N-CA 123.443 0.697 . . . . 44.530000000000001 112.622 -169.873 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 26.1 p-10 -165.1 168.05 17.65 Favored 'General case' 0 C--N 1.352 0.714 0 CA-C-N 115.142 -0.936 . . . . 73.450000000000003 110.358 178.757 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -113.72 9.02 17.67 Favored 'General case' 0 CA--C 1.543 0.701 0 C-N-CA 123.606 0.762 . . . . 75.200000000000003 109.75 168.174 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 154.08 -173.73 32.64 Favored Glycine 0 C--N 1.354 1.548 0 CA-C-O 119.706 -0.497 . . . . 52.130000000000003 112.552 -178.887 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 48.9 Cg_exo -58.59 143.75 98.04 Favored 'Trans proline' 0 C--N 1.373 1.842 0 C-N-CA 123.43 2.753 . . . . 75.510000000000005 112.898 176.876 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 106' ' ' ASN . . . . . 0.46 ' HA ' ' HA ' ' A' ' 84' ' ' GLU . 61.6 t30 63.96 14.65 8.58 Favored 'General case' 0 N--CA 1.485 1.284 0 C-N-CA 125.267 1.427 . . . . 72.329999999999998 111.837 -178.034 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 107' ' ' THR . . . . . 0.759 ' HA ' ' HD2' ' A' ' 82' ' ' LYS . 2.8 m -115.55 -0.48 13.03 Favored 'General case' 0 CA--C 1.551 0.995 0 C-N-CA 123.766 0.827 . . . . 61.350000000000001 109.93 179.263 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 54.7 t30 -78.09 155.01 30.81 Favored 'General case' 0 N--CA 1.479 0.983 0 C-N-CA 123.363 0.665 . . . . 64.510000000000005 110.246 -178.016 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 96.37 -10.26 67.2 Favored Glycine 0 N--CA 1.468 0.801 0 CA-C-O 120.076 -0.291 . . . . 33.229999999999997 113.11 177.533 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 16.2 p -91.19 123.13 34.4 Favored 'General case' 0 CA--C 1.538 0.513 0 N-CA-C 107.539 -1.282 . . . . 62.350000000000001 107.539 167.322 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 111' ' ' GLN . . . . . 0.475 ' HB2' ' HB3' ' A' ' 101' ' ' ALA . 3.0 mt-30 69.76 165.23 0.27 Allowed 'General case' 0 N--CA 1.493 1.703 0 C-N-CA 125.852 1.661 . . . . 73.340000000000003 111.19 -178.594 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 112' ' ' PHE . . . . . 0.41 ' HA ' ' HA ' ' A' ' 100' ' ' MET . 54.3 p90 -139.43 155.6 47.5 Favored 'General case' 0 N--CA 1.482 1.134 0 N-CA-C 108.985 -0.746 . . . . 74.109999999999999 108.985 175.793 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 113' ' ' PHE . . . . . 0.557 ' HB2' ' SD ' ' A' ' 61' ' ' MET . 53.7 p90 -152.61 152.83 32.27 Favored 'General case' 0 N--CA 1.471 0.605 0 C-N-CA 122.963 0.505 . . . . 60.549999999999997 111.65 -176.337 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 114' ' ' ILE . . . . . 0.492 HG12 HD13 ' A' ' 98' ' ' LEU . 6.4 mt -119.93 108.05 22.46 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.761 0 N-CA-C 108.121 -1.066 . . . . 63.210000000000001 108.121 -176.724 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 115' ' ' CYS . . . . . . . . . . . . . 60.1 m -80.62 105.83 12.17 Favored 'General case' 0 N--CA 1.47 0.53 0 C-N-CA 123.129 0.572 . . . . 74.230000000000004 109.769 176.656 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 40.5 p -71.85 -24.98 61.78 Favored 'General case' 0 N--CA 1.482 1.152 0 C-N-CA 122.612 0.365 . . . . 71.5 110.596 173.971 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -98.48 147.07 25.12 Favored 'General case' 0 C--O 1.239 0.545 0 CA-C-N 115.828 -0.624 . . . . 64.329999999999998 109.756 171.717 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 9.0 ptmm? -70.16 84.19 0.54 Allowed 'General case' 0 N--CA 1.477 0.899 0 CA-C-O 121.848 0.832 . . . . 70.239999999999995 110.021 171.847 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 119' ' ' THR . . . . . . . . . . . . . 35.8 p -79.92 85.31 5.56 Favored 'General case' 0 CA--C 1.548 0.866 0 CA-C-N 114.947 -1.024 . . . . 71.420000000000002 110.133 -175.546 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 9.3 pt-20 -68.39 -26.25 65.47 Favored 'General case' 0 N--CA 1.48 1.071 0 CA-C-N 114.737 -1.12 . . . . 71.420000000000002 112.125 -172.444 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 121' ' ' TRP . . . . . . . . . . . . . 47.0 p90 -72.57 1.08 8.83 Favored 'General case' 0 N--CA 1.473 0.715 0 C-N-CA 123.584 0.754 . . . . 74.310000000000002 112.265 178.546 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 122' ' ' LEU . . . . . 0.523 ' HB3' ' HE1' ' A' ' 126' ' ' HIS . 40.3 mt -104.12 5.3 35.01 Favored 'General case' 0 N--CA 1.475 0.815 0 C-N-CA 123.252 0.621 . . . . 74.200000000000003 111.897 176.355 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 40.4 m-20 -80.55 153.92 27.81 Favored 'General case' 0 N--CA 1.487 1.391 0 C-N-CA 122.812 0.445 . . . . 74.340000000000003 110.963 177.425 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 71.49 19.98 78.07 Favored Glycine 0 C--N 1.359 1.823 0 O-C-N 123.442 0.463 . . . . 54.450000000000003 112.304 -173.02 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 43.4 mtmt -145.22 -158.4 0.89 Allowed 'General case' 0 N--CA 1.47 0.533 0 C-N-CA 126.805 2.042 . . . . 72.420000000000002 107.884 -171.427 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 126' ' ' HIS . . . . . 0.523 ' HE1' ' HB3' ' A' ' 122' ' ' LEU . 0.0 OUTLIER -56.3 130.62 45.31 Favored 'General case' 0 N--CA 1.478 0.973 0 C-N-CA 123.8 0.84 . . . . 74.329999999999998 113.034 -159.119 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 99.3 t -61.45 130.14 25.22 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.615 0 CA-C-N 113.058 -1.883 . . . . 65.5 113.003 -166.517 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 128' ' ' VAL . . . . . 0.486 HG22 ' HB2' ' A' ' 99' ' ' SER . 92.8 t -81.05 145.26 9.18 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.313 0 CA-C-N 114.811 -1.086 . . . . 61.200000000000003 108.754 170.45 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 129' ' ' PHE . . . . . 0.569 ' HA ' HG21 ' A' ' 29' ' ' VAL . 21.6 p90 -138.27 -33.32 0.69 Allowed 'General case' 0 N--CA 1.469 0.503 0 C-N-CA 122.411 0.284 . . . . 54.520000000000003 110.984 -177.551 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . -115.66 165.14 12.15 Favored Glycine 0 C--N 1.337 0.588 0 O-C-N 123.709 0.631 . . . . 74.219999999999999 113.122 -175.591 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 30.2 ttpt -153.1 122.19 6.57 Favored 'General case' 0 C--N 1.324 -0.516 0 N-CA-C 107.207 -1.405 . . . . 71.140000000000001 107.207 177.867 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 3.9 p -65.92 105.36 0.62 Allowed 'Isoleucine or valine' 0 CA--C 1.553 1.078 0 CA-C-O 121.716 0.77 . . . . 61.329999999999998 109.651 175.56 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 133' ' ' LYS . . . . . 0.537 ' HD2' ' HB2' ' A' ' 23' ' ' GLU . 0.1 OUTLIER -78.5 -38.79 39.96 Favored 'General case' 0 N--CA 1.474 0.766 0 CA-C-N 114.901 -1.045 . . . . 74.349999999999994 109.903 -179.295 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 49.9 mt-10 -145.62 144.5 30.49 Favored 'General case' 0 N--CA 1.481 1.114 0 C-N-CA 124.599 1.16 . . . . 65.450000000000003 108.879 177.636 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 94.84 17.24 38.85 Favored Glycine 0 N--CA 1.472 1.059 0 N-CA-C 112.417 -0.273 . . . . 74.319999999999993 112.417 -176.409 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 136' ' ' MET . . . . . . . . . . . . . 14.5 tpt -61.81 -35.19 77.48 Favored 'General case' 0 N--CA 1.482 1.167 0 C-N-CA 124.113 0.965 . . . . 74.209999999999994 111.683 179.374 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 137' ' ' ASN . . . . . . . . . . . . . 1.8 m-20 -61.68 -34.71 76.22 Favored 'General case' 0 CA--C 1.548 0.875 0 C-N-CA 123.589 0.756 . . . . 74.140000000000001 110.774 177.796 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 138' ' ' ILE . . . . . . . . . . . . . 43.9 mm -72.05 -35.76 54.78 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.854 0 C-N-CA 123.076 0.55 . . . . 64.230000000000004 110.389 179.477 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 98.7 t -63.12 -45.88 97.47 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.872 0 C-N-CA 123.18 0.592 . . . . 71.310000000000002 110.374 175.879 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 40.9 mt-10 -68.26 -26.76 65.83 Favored 'General case' 0 N--CA 1.476 0.837 0 CA-C-N 115.498 -0.774 . . . . 74.140000000000001 111.186 178.352 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -71.99 -56.69 5.21 Favored 'General case' 0 N--CA 1.475 0.782 0 C-N-CA 123.332 0.653 . . . . 71.120000000000005 111.185 176.69 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 142' ' ' MET . . . . . 0.499 ' HA ' ' HD2' ' A' ' 145' ' ' PHE . 26.8 ptm -61.12 -35.7 77.73 Favored 'General case' 0 N--CA 1.48 1.059 0 C-N-CA 123.718 0.807 . . . . 65.299999999999997 111.829 -177.753 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 33.4 tt0 -66.05 -32.14 73.44 Favored 'General case' 0 CA--C 1.543 0.709 0 CA-C-O 121.462 0.648 . . . . 65.5 112.219 -173.91 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 144' ' ' ARG . . . . . 0.709 ' HA ' ' HB3' ' A' ' 58' ' ' PRO . 96.4 mtt180 -80.54 -6.58 58.43 Favored 'General case' 0 N--CA 1.47 0.544 0 CA-C-N 115.855 -0.611 . . . . 63.210000000000001 111.866 -178.65 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 145' ' ' PHE . . . . . 0.499 ' HD2' ' HA ' ' A' ' 142' ' ' MET . 50.9 m-85 -85.12 5.47 29.68 Favored 'General case' 0 CA--C 1.552 1.025 0 C-N-CA 123.309 0.644 . . . . 72.150000000000006 111.131 167.647 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . -93.72 -170.97 38.93 Favored Glycine 0 C--N 1.35 1.359 0 N-CA-C 112.381 -0.287 . . . . 70.310000000000002 112.381 172.987 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 12.9 m -132.74 162.53 31.2 Favored 'General case' 0 N--CA 1.48 1.049 0 C-N-CA 123.545 0.738 . . . . 71.019999999999996 109.513 -179.322 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 148' ' ' ARG . . . . . 0.45 ' HA ' HG23 ' A' ' 57' ' ' ILE . 17.4 mmm180 -71.5 -18.89 62.26 Favored 'General case' 0 N--CA 1.483 1.18 0 C-N-CA 123.823 0.849 . . . . 72.510000000000005 112.946 -172.902 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 149' ' ' ASN . . . . . . . . . . . . . 30.6 p-10 -85.89 -21.47 27.98 Favored 'General case' 0 N--CA 1.481 1.085 0 C-N-CA 123.619 0.768 . . . . 72.129999999999995 110.8 174.198 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 150' ' ' GLY . . . . . 0.472 ' O ' ' HA ' ' A' ' 55' ' ' ARG . . . 119.45 -11.23 11.37 Favored Glycine 0 C--N 1.347 1.189 0 CA-C-N 115.915 -0.584 . . . . 32.329999999999998 113.187 -178.747 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 37.5 ttpt -64.56 137.55 57.91 Favored 'General case' 0 N--CA 1.476 0.844 0 CA-C-N 117.921 0.86 . . . . 73.099999999999994 110.799 -177.698 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 152' ' ' THR . . . . . . . . . . . . . 18.1 p -91.13 113.28 25.51 Favored 'General case' 0 CA--C 1.539 0.528 0 N-CA-C 109.117 -0.698 . . . . 70.129999999999995 109.117 176.079 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 153' ' ' SER . . . . . . . . . . . . . 32.1 t -67.39 -35.41 79.27 Favored 'General case' 0 N--CA 1.475 0.803 0 C-N-CA 123.208 0.603 . . . . 72.099999999999994 110.419 -179.318 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 75.6 mmtt -110.09 152.16 26.32 Favored 'General case' 0 C--O 1.243 0.714 0 CA-C-N 114.959 -1.019 . . . . 73.530000000000001 109.381 178.971 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 17.3 tppt? -79.23 88.88 4.89 Favored 'General case' 0 C--N 1.349 0.552 0 N-CA-C 108.558 -0.904 . . . . 71.129999999999995 108.558 177.338 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 156' ' ' ILE . . . . . 0.486 HD11 ' HB2' ' A' ' 145' ' ' PHE . 58.0 mt -93.01 119.29 40.47 Favored 'Isoleucine or valine' 0 C--O 1.234 0.248 0 N-CA-C 108.821 -0.807 . . . . 62.509999999999998 108.821 -177.94 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 157' ' ' THR . . . . . . . . . . . . . 37.1 p -132.9 144.28 50.06 Favored 'General case' 0 C--O 1.238 0.481 0 C-N-CA 124.861 1.264 . . . . 74.420000000000002 109.099 -177.576 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 158' ' ' ILE . . . . . 0.437 HG23 ' HB3' ' A' ' 8' ' ' PHE . 62.2 mt -73.22 92.85 0.59 Allowed 'Isoleucine or valine' 0 CA--C 1.54 0.595 0 N-CA-C 107.526 -1.287 . . . . 62.229999999999997 107.526 166.874 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 159' ' ' ALA . . . . . 0.537 ' HB2' ' HB2' ' A' ' 11' ' ' ALA . . . -55.06 -57.32 12.18 Favored 'General case' 0 N--CA 1.47 0.549 0 C-N-CA 123.839 0.856 . . . . 72.329999999999998 110.892 -176.689 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 160' ' ' ASP . . . . . . . . . . . . . 13.2 m-20 -135.62 177.18 8.03 Favored 'General case' 0 N--CA 1.469 0.511 0 CA-C-O 121.698 0.761 . . . . 75.010000000000005 111.664 -175.18 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 161' ' ' CYS . . . . . . . . . . . . . 21.8 p -144.89 -169.35 3.16 Favored 'General case' 0 CA--C 1.542 0.644 0 C-N-CA 125.919 1.688 . . . . 74.319999999999993 107.768 -177.621 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 162' ' ' GLY . . . . . . . . . . . . . . . 130.27 53.06 0.1 Allowed Glycine 0 C--N 1.341 0.825 0 N-CA-C 109.92 -1.272 . . . . 65.129999999999995 109.92 -172.724 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 163' ' ' GLN . . . . . 0.521 ' HB2' ' HA ' ' A' ' 6' ' ' VAL . 15.6 pt20 -54.23 152.81 5.8 Favored 'General case' 0 CA--C 1.548 0.87 0 N-CA-C 114.512 1.301 . . . . 73.450000000000003 114.512 -170.927 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 164' ' ' LEU . . . . . 0.621 ' HG ' ' HB2' ' A' ' 7' ' ' PHE . 82.4 mt -88.51 118.2 28.0 Favored 'General case' 0 C--O 1.241 0.628 0 C-N-CA 124.462 1.105 . . . . 75.439999999999998 110.957 -169.874 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 165' ' ' GLU . . . . . . . . . . . . . 8.9 pt-20 . . . . . 0 CA--C 1.556 1.201 0 C-N-CA 124.181 0.992 . . . . 71.030000000000001 109.815 179.676 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' B' B ' 216' ' ' PRO . . . . . . . . . . . . . 17.0 Cg_endo . . . . . 0 N--CA 1.487 1.111 0 N-CA-C 110.081 -0.777 . . . . 75.450000000000003 110.081 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' B' B ' 217' ' ' GLU . . . . . . . . . . . . . 16.9 pt-20 -79.17 159.34 73.11 Favored Pre-proline 0 CA--C 1.554 1.12 0 C-N-CA 123.318 0.647 . . . . 72.420000000000002 110.041 178.198 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 218' ' ' PRO . . . . . . . . . . . . . 21.9 Cg_exo -65.33 99.18 0.35 Allowed 'Trans proline' 0 C--N 1.375 1.971 0 C-N-CA 121.985 1.79 . . . . 73.319999999999993 110.482 169.994 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 219' ' ' GLY . . . . . 0.443 ' HA2' ' HB1' ' A' ' 101' ' ' ALA . . . -173.14 147.81 9.92 Favored Glycine 0 C--N 1.347 1.184 0 CA-C-O 119.722 -0.488 . . . . 71.430000000000007 113.292 -178.943 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 220' ' ' PRO . . . . . . . . . . . . . 56.6 Cg_endo -67.55 153.46 76.32 Favored 'Trans proline' 0 C--N 1.377 2.075 0 C-N-CA 123.553 2.835 . . . . 62.109999999999999 112.748 177.923 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 221' ' ' TYR . . . . . . . . . . . . . 83.2 m-85 -79.95 138.62 37.14 Favored 'General case' 0 N--CA 1.477 0.908 0 C-N-CA 122.781 0.433 . . . . 74.299999999999997 110.709 -178.571 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 222' ' ' ALA . . . . . . . . . . . . . . . -112.15 179.88 3.87 Favored 'General case' 0 N--CA 1.468 0.435 0 N-CA-C 113.791 1.034 . . . . 73.010000000000005 113.791 -162.964 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 223' ' ' GLN . . . . . 0.47 HE21 ' HB2' ' A' ' 60' ' ' PHE . 27.6 pt20 -94.84 121.81 61.91 Favored Pre-proline 0 CA--C 1.56 1.358 0 CA-C-N 114.318 -1.31 . . . . 74.340000000000003 109.604 178.1 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 224' ' ' PRO . . . . . . . . . . . . . 13.6 Cg_exo . . . . . 0 C--N 1.376 2.014 0 C-N-CA 122.834 2.356 . . . . 73.400000000000006 111.16 172.031 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 92.2 mmm . . . . . 0 N--CA 1.49 1.559 0 N-CA-C 110.023 -0.362 . . . . 74.299999999999997 110.023 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 13.5 p -80.33 -20.05 11.88 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.222 0 CA-C-O 121.685 0.755 . . . . 74.049999999999997 109.584 168.012 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 3' ' ' ASN . . . . . 0.583 HD22 ' HA ' ' A' ' 25' ' ' PHE . 13.4 m120 -77.06 124.47 87.32 Favored Pre-proline 0 CA--C 1.545 0.775 0 C-N-CA 124.442 1.097 . . . . 53.200000000000003 111.849 -171.888 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 36.4 Cg_endo -64.58 122.1 9.88 Favored 'Trans proline' 0 C--N 1.382 2.306 0 C-N-CA 122.872 2.381 . . . . 61.119999999999997 111.076 173.973 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 50.6 m -97.88 129.52 44.82 Favored 'General case' 0 CA--C 1.534 0.352 0 C-N-CA 123.585 0.754 . . . . 75.030000000000001 109.441 -178.068 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . 0.56 ' HA ' ' HG3' ' A' ' 163' ' ' GLN . 27.2 m -99.26 126.1 52.63 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.364 0 N-CA-C 108.209 -1.034 . . . . 54.039999999999999 108.209 175.471 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 7' ' ' PHE . . . . . 0.556 ' H ' ' HA ' ' A' ' 163' ' ' GLN . 57.7 t80 -108.85 135.52 49.92 Favored 'General case' 0 C--O 1.237 0.404 0 N-CA-C 109.037 -0.727 . . . . 70.310000000000002 109.037 -175.932 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 72.6 m-85 -139.62 166.21 25.2 Favored 'General case' 0 C--O 1.24 0.604 0 C-N-CA 124.654 1.182 . . . . 72.310000000000002 109.8 178.471 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 43.4 m-20 -118.01 116.25 26.53 Favored 'General case' 0 C--N 1.328 -0.365 0 N-CA-C 106.389 -1.708 . . . . 75.5 106.389 166.163 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 33.8 mm -98.93 143.68 12.92 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.711 0 N-CA-C 108.916 -0.772 . . . . 65.120000000000005 108.916 -177.465 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 11' ' ' ALA . . . . . 0.495 ' HB2' ' HB2' ' A' ' 159' ' ' ALA . . . -136.99 140.36 42.1 Favored 'General case' 0 N--CA 1.467 0.417 0 C-N-CA 123.304 0.642 . . . . 60.119999999999997 111.818 -164.432 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . 0.404 HG23 ' HB2' ' A' ' 17' ' ' LEU . 21.4 t -98.36 109.93 24.85 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.795 0 N-CA-C 107.796 -1.187 . . . . 71.409999999999997 107.796 171.418 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 45.4 m-20 68.25 20.63 8.73 Favored 'General case' 0 N--CA 1.497 1.904 0 C-N-CA 124.384 1.073 . . . . 73.349999999999994 111.766 -177.656 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 87.3 -3.19 86.75 Favored Glycine 0 C--N 1.349 1.278 0 CA-C-O 119.964 -0.353 . . . . 70.310000000000002 113.067 -174.666 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 40.0 mm-40 -84.18 113.71 49.96 Favored Pre-proline 0 CA--C 1.543 0.689 0 N-CA-C 108.902 -0.777 . . . . 71.349999999999994 108.902 175.235 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 21.1 Cg_endo -56.84 107.97 0.31 Allowed 'Trans proline' 0 C--N 1.383 2.354 0 C-N-CA 123.0 2.467 . . . . 75.239999999999995 111.749 -176.524 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . 0.404 ' HB2' HG23 ' A' ' 12' ' ' VAL . 46.3 tp -78.92 -45.45 20.5 Favored 'General case' 0 N--CA 1.47 0.539 0 CA-C-N 115.538 -0.756 . . . . 73.239999999999995 109.36 178.535 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -176.1 -171.46 39.92 Favored Glycine 0 C--N 1.337 0.596 0 CA-C-N 115.742 -0.663 . . . . 72.409999999999997 112.688 179.944 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 40.3 ptt85 -106.21 144.78 32.43 Favored 'General case' 0 C--O 1.239 0.537 0 C-N-CA 123.875 0.87 . . . . 74.099999999999994 108.674 178.691 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 94.6 t -134.17 139.27 48.56 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.588 0 N-CA-C 108.683 -0.858 . . . . 70.219999999999999 108.683 176.887 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 24.8 m -133.12 118.38 18.64 Favored 'General case' 0 CA--C 1.545 0.777 0 C-N-CA 124.867 1.267 . . . . 54.530000000000001 108.414 -175.872 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 22' ' ' PHE . . . . . 0.451 ' HA ' ' HA ' ' A' ' 132' ' ' VAL . 41.0 m-85 -102.87 129.63 49.63 Favored 'General case' 0 N--CA 1.479 1.002 0 N-CA-C 109.435 -0.58 . . . . 62.310000000000002 109.435 177.512 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 35.7 tt0 -90.33 108.18 19.61 Favored 'General case' 0 CA--C 1.548 0.873 0 C-N-CA 124.183 0.993 . . . . 71.340000000000003 109.426 177.447 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . 0.513 ' HB3' ' HB1' ' A' ' 33' ' ' ALA . 40.6 mt -87.25 122.09 30.56 Favored 'General case' 0 N--CA 1.48 1.063 0 C-N-CA 123.031 0.532 . . . . 65.319999999999993 110.605 -177.008 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 25' ' ' PHE . . . . . 0.583 ' HA ' HD22 ' A' ' 3' ' ' ASN . 48.8 m-85 -84.91 65.26 9.1 Favored 'General case' 0 CA--C 1.548 0.879 0 C-N-CA 123.916 0.886 . . . . 74.219999999999999 110.805 -179.951 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -65.86 -25.88 67.39 Favored 'General case' 0 N--CA 1.482 1.131 0 CA-C-N 115.127 -0.942 . . . . 41.299999999999997 111.912 -177.766 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 9.2 p-10 -72.81 -6.64 46.24 Favored 'General case' 0 N--CA 1.48 1.041 0 C-N-CA 123.489 0.716 . . . . 75.519999999999996 111.341 -179.544 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 91.7 mttt -114.6 -48.94 2.84 Favored 'General case' 0 N--CA 1.476 0.857 0 C-N-CA 123.771 0.828 . . . . 75.439999999999998 109.872 177.242 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 29' ' ' VAL . . . . . 0.451 HG21 ' HA ' ' A' ' 129' ' ' PHE . 14.6 m -121.94 79.02 41.49 Favored Pre-proline 0 CA--C 1.566 1.56 0 C-N-CA 124.329 1.052 . . . . 73.209999999999994 109.293 -178.684 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 35.6 Cg_exo -60.03 -57.3 0.82 Allowed 'Trans proline' 0 C--N 1.391 2.766 0 C-N-CA 123.204 2.603 . . . . 75.299999999999997 112.953 -169.671 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 29.2 ttmt -58.43 -45.09 89.17 Favored 'General case' 0 N--CA 1.479 0.999 0 C-N-CA 124.564 1.146 . . . . 72.239999999999995 112.085 179.385 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 6.9 m -67.0 -40.1 87.28 Favored 'General case' 0 CA--C 1.548 0.894 0 CA-C-N 114.58 -1.191 . . . . 60.020000000000003 111.671 -170.459 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 33' ' ' ALA . . . . . 0.513 ' HB1' ' HB3' ' A' ' 24' ' ' LEU . . . -80.71 -36.18 32.55 Favored 'General case' 0 N--CA 1.475 0.798 0 C-N-CA 123.586 0.755 . . . . 71.239999999999995 110.702 178.381 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 14.7 tp10 -62.41 -32.04 72.81 Favored 'General case' 0 N--CA 1.486 1.37 0 C-N-CA 124.042 0.937 . . . . 73.099999999999994 111.144 -179.526 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 35' ' ' ASN . . . . . 0.555 ' ND2' ' SD ' ' A' ' 100' ' ' MET . 44.9 t30 -55.97 -64.35 0.88 Allowed 'General case' 0 CA--C 1.544 0.741 0 C-N-CA 123.823 0.849 . . . . 63.340000000000003 110.801 176.115 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 36' ' ' PHE . . . . . 0.524 ' HE2' HG21 ' A' ' 6' ' ' VAL . 65.7 t80 -65.5 -30.14 70.87 Favored 'General case' 0 N--CA 1.476 0.856 0 C-N-CA 123.603 0.761 . . . . 55.100000000000001 111.065 -176.264 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 44.8 ttp85 -64.76 -51.43 62.31 Favored 'General case' 0 CA--C 1.551 0.985 0 C-N-CA 124.015 0.926 . . . . 64.239999999999995 109.593 -179.415 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -78.44 -15.09 59.02 Favored 'General case' 0 CA--C 1.544 0.729 0 CA-C-N 115.037 -0.983 . . . . 75.430000000000007 112.26 -176.567 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 39' ' ' LEU . . . . . 0.403 HD22 ' CE2' ' A' ' 48' ' ' TYR . 92.8 mt -79.59 -35.55 39.44 Favored 'General case' 0 N--CA 1.487 1.391 0 C-N-CA 122.96 0.504 . . . . 65.409999999999997 110.418 170.511 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 42.6 t -66.06 -54.39 26.48 Favored 'General case' 0 N--CA 1.477 0.897 0 C-N-CA 124.285 1.034 . . . . 65.530000000000001 110.592 179.892 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 10.9 p -75.67 -32.0 59.98 Favored 'General case' 0 N--CA 1.475 0.806 0 CA-C-N 115.878 -0.601 . . . . 65.340000000000003 111.52 175.87 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 81.5 34.96 24.2 Favored Glycine 0 C--N 1.348 1.221 0 CA-C-N 116.481 -0.327 . . . . 64.409999999999997 113.402 177.879 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 41.2 mm-40 -66.41 -20.47 66.07 Favored 'General case' 0 N--CA 1.476 0.867 0 C-N-CA 123.693 0.797 . . . . 74.209999999999994 111.991 -178.632 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 9.8 mmpt? -93.67 8.17 41.93 Favored 'General case' 0 CA--C 1.552 1.029 0 C-N-CA 124.193 0.997 . . . . 65.409999999999997 110.842 179.265 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 76.33 33.79 47.65 Favored Glycine 0 C--N 1.351 1.365 0 CA-C-O 119.774 -0.459 . . . . 71.140000000000001 113.384 179.995 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 23.4 m-85 -116.21 -49.35 2.69 Favored 'General case' 0 N--CA 1.484 1.266 0 CA-C-N 117.214 0.507 . . . . 74.230000000000004 110.797 -178.317 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 47.12 63.32 3.34 Favored Glycine 0 C--N 1.354 1.554 0 O-C-N 124.482 1.114 . . . . 73.329999999999998 115.371 169.609 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 48' ' ' TYR . . . . . 0.403 ' CE2' HD22 ' A' ' 39' ' ' LEU . 32.0 m-85 -66.36 92.63 0.2 Allowed 'General case' 0 C--N 1.353 0.752 0 CA-C-O 121.869 0.842 . . . . 75.420000000000002 111.435 -173.71 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 27.9 tptp -109.33 94.8 5.23 Favored 'General case' 0 C--O 1.239 0.522 0 CA-C-N 113.991 -1.458 . . . . 53.240000000000002 108.591 -175.059 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 118.95 21.37 3.85 Favored Glycine 0 C--N 1.348 1.202 0 CA-C-O 119.781 -0.455 . . . . 44.020000000000003 113.395 -179.547 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 51' ' ' SER . . . . . 0.514 ' HB2' HD12 ' A' ' 158' ' ' ILE . 19.7 m -60.5 119.15 7.49 Favored 'General case' 0 N--CA 1.476 0.854 0 C-N-CA 123.577 0.751 . . . . 62.32 110.716 179.463 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 52' ' ' CYS . . . . . . . . . . . . . 10.6 p -104.91 129.21 53.32 Favored 'General case' 0 N--CA 1.474 0.743 0 CA-C-O 121.637 0.732 . . . . 63.020000000000003 112.525 -170.415 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 53' ' ' PHE . . . . . 0.776 ' HA ' ' HA2' ' A' ' 64' ' ' GLY . 55.9 m-85 -70.52 109.71 4.99 Favored 'General case' 0 C--N 1.347 0.494 0 C-N-CA 124.842 1.257 . . . . 73.450000000000003 109.646 174.148 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 49.7 p-80 -120.28 -5.48 9.91 Favored 'General case' 0 N--CA 1.481 1.086 0 C-N-CA 123.815 0.846 . . . . 73.239999999999995 111.235 -176.454 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 55' ' ' ARG . . . . . 0.454 ' O ' ' HB3' ' A' ' 63' ' ' GLN . 53.2 ttt-85 -129.57 97.6 4.59 Favored 'General case' 0 N--CA 1.473 0.719 0 N-CA-C 108.891 -0.781 . . . . 51.439999999999998 108.891 175.604 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 56' ' ' ILE . . . . . 0.456 HG21 ' HA ' ' A' ' 143' ' ' GLU . 64.3 mt -130.55 127.18 61.9 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.943 0 N-CA-C 108.389 -0.967 . . . . 61.310000000000002 108.389 177.291 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 74.9 mt -124.85 118.16 25.84 Favored Pre-proline 0 CA--C 1.555 1.144 0 C-N-CA 123.974 0.909 . . . . 60.329999999999998 108.904 -177.884 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 52.7 Cg_exo -57.63 145.65 88.37 Favored 'Trans proline' 0 C--N 1.383 2.365 0 C-N-CA 124.229 3.286 . . . . 73.150000000000006 114.205 -179.237 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 66.1 24.19 71.69 Favored Glycine 0 C--N 1.352 1.451 0 O-C-N 124.291 0.994 . . . . 74.430000000000007 112.954 -179.272 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 60' ' ' PHE . . . . . 0.653 ' HB2' HE22 ' B' ' 223' ' ' GLN . 36.3 t80 -145.09 -76.38 0.21 Allowed 'General case' 0 C--O 1.244 0.764 0 C-N-CA 123.886 0.875 . . . . 72.409999999999997 110.221 -173.744 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 61' ' ' MET . . . . . 0.708 ' SD ' ' HB2' ' A' ' 113' ' ' PHE . 12.1 tmm? -173.27 150.74 1.93 Allowed 'General case' 0 N--CA 1.484 1.272 0 CA-C-O 121.075 0.464 . . . . 75.140000000000001 112.19 -161.2 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 62' ' ' CYS . . . . . . . . . . . . . 36.7 t -114.45 111.92 22.19 Favored 'General case' 0 CA--C 1.558 1.287 0 C-N-CA 124.873 1.269 . . . . 72.540000000000006 109.752 175.687 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 63' ' ' GLN . . . . . 0.644 ' HB2' ' SD ' ' A' ' 61' ' ' MET . 49.6 tt0 -115.5 133.53 55.94 Favored 'General case' 0 N--CA 1.498 1.935 0 C-N-CA 124.017 0.927 . . . . 72.450000000000003 110.949 -172.209 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 64' ' ' GLY . . . . . 0.776 ' HA2' ' HA ' ' A' ' 53' ' ' PHE . . . -123.04 170.28 15.45 Favored Glycine 0 C--N 1.339 0.726 0 CA-C-N 115.259 -0.882 . . . . 63.149999999999999 112.83 179.032 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -164.54 156.99 29.21 Favored Glycine 0 C--N 1.33 0.241 0 N-CA-C 110.532 -1.027 . . . . 64.140000000000001 110.532 176.658 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 21.2 t70 -91.35 167.2 12.47 Favored 'General case' 0 C--O 1.244 0.798 0 CA-C-O 121.185 0.517 . . . . 62.409999999999997 110.34 -178.269 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 63.8 t80 -77.25 -29.08 53.81 Favored 'General case' 0 CA--C 1.552 1.035 0 C-N-CA 124.07 0.948 . . . . 73.510000000000005 111.18 -179.676 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 91.5 m -61.23 109.42 1.12 Allowed 'General case' 0 C--N 1.363 1.156 0 C-N-CA 123.922 0.889 . . . . 61.030000000000001 110.361 179.659 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 36.6 ttt180 52.98 82.89 0.07 Allowed 'General case' 0 CA--C 1.541 0.618 0 O-C-N 124.836 1.335 . . . . 75.230000000000004 110.461 -173.398 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 52.3 t60 -89.26 -19.94 24.74 Favored 'General case' 0 CA--C 1.549 0.911 0 CA-C-N 116.099 -0.501 . . . . 71.420000000000002 111.457 -174.601 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 3.5 m-20 -64.76 91.41 0.09 Allowed 'General case' 0 N--CA 1.489 1.516 0 C-N-CA 123.686 0.794 . . . . 71.310000000000002 111.214 -176.813 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 75.3 -6.19 30.88 Favored Glycine 0 C--N 1.349 1.27 0 CA-C-N 115.561 -0.745 . . . . 74.209999999999994 114.682 175.249 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -114.16 -67.03 1.03 Allowed 'General case' 0 CA--C 1.551 0.995 0 N-CA-C 109.187 -0.672 . . . . 75.129999999999995 109.187 -175.2 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 61.32 61.58 6.74 Favored Glycine 0 CA--C 1.534 1.24 0 CA-C-N 116.21 -0.45 . . . . 72.400000000000006 113.994 175.77 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 107.54 52.25 0.72 Allowed Glycine 0 N--CA 1.48 1.593 0 CA-C-N 117.674 0.737 . . . . 63.200000000000003 112.166 -177.5 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 76' ' ' LYS . . . . . 0.437 ' HA ' ' O ' ' A' ' 109' ' ' GLY . 21.5 pttp -53.77 170.58 0.11 Allowed 'General case' 0 CA--C 1.562 1.409 0 C-N-CA 125.076 1.35 . . . . 71.450000000000003 113.815 179.902 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 89.9 p -90.69 176.02 6.81 Favored 'General case' 0 N--CA 1.486 1.33 0 C-N-CA 123.689 0.796 . . . . 75.209999999999994 112.856 -165.885 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 25.5 pt -71.34 -17.95 20.05 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.225 0 C-N-CA 122.934 0.493 . . . . 74.349999999999994 110.784 174.327 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 69.7 m-85 -92.85 27.82 2.27 Favored 'General case' 0 CA--C 1.546 0.797 0 C-N-CA 124.058 0.943 . . . . 73.439999999999998 109.728 174.523 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 83.51 -119.38 4.89 Favored Glycine 0 C--N 1.354 1.551 0 CA-C-N 115.088 -0.96 . . . . 74.219999999999999 111.753 177.74 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 34.8 tt0 -61.74 -59.43 5.18 Favored 'General case' 0 C--O 1.241 0.625 0 C-N-CA 124.024 0.93 . . . . 61.200000000000003 110.723 -178.373 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 82' ' ' LYS . . . . . 0.749 ' HD2' ' HA ' ' A' ' 107' ' ' THR . 23.9 pttm -165.11 175.28 9.51 Favored 'General case' 0 CA--C 1.552 1.057 0 O-C-N 123.595 0.56 . . . . 74.200000000000003 111.742 -174.967 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 2.0 p90 -157.03 176.24 13.02 Favored 'General case' 0 N--CA 1.482 1.158 0 C-N-CA 125.83 1.652 . . . . 75.120000000000005 109.036 -179.884 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 12.5 pt-20 -93.02 -172.48 3.0 Favored 'General case' 0 N--CA 1.485 1.281 0 CA-C-O 121.255 0.55 . . . . 74.109999999999999 111.74 179.517 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 51.8 m-20 -80.42 136.74 36.41 Favored 'General case' 0 N--CA 1.471 0.614 0 C-N-CA 124.271 1.028 . . . . 70.209999999999994 109.148 173.22 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 12.6 tp10 -73.24 -52.53 13.68 Favored 'General case' 0 CA--C 1.544 0.728 0 O-C-N 123.472 0.482 . . . . 63.439999999999998 109.929 176.165 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 87' ' ' ASN . . . . . 0.402 ' OD1' HG12 ' A' ' 29' ' ' VAL . 16.5 p-10 -170.14 134.79 1.27 Allowed 'General case' 0 N--CA 1.479 0.983 0 C-N-CA 123.595 0.758 . . . . 74.319999999999993 110.193 -174.58 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 73.7 m-85 -88.58 69.52 8.85 Favored 'General case' 0 N--CA 1.483 1.189 0 CA-C-O 121.096 0.474 . . . . 72.430000000000007 110.538 -178.053 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 37.0 mt -82.03 -58.25 3.87 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.77 0 N-CA-C 108.724 -0.843 . . . . 72.030000000000001 108.724 169.44 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 53.1 mt -92.78 119.52 32.22 Favored 'General case' 0 CA--C 1.541 0.598 0 CA-C-N 114.923 -1.035 . . . . 74.109999999999999 110.596 -171.006 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 9.8 mtmp? -121.98 171.48 8.91 Favored 'General case' 0 CA--C 1.543 0.708 0 C-N-CA 124.764 1.226 . . . . 71.209999999999994 109.814 175.086 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 92' ' ' HIS . . . . . . . . . . . . . 23.0 m-70 -78.09 80.62 4.51 Favored 'General case' 0 N--CA 1.477 0.886 0 C-N-CA 123.879 0.872 . . . . 74.340000000000003 110.16 -170.232 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 19.1 p -82.85 -57.31 3.36 Favored 'General case' 0 N--CA 1.473 0.714 0 C-N-CA 123.898 0.879 . . . . 74.450000000000003 111.212 -177.006 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -121.45 -176.64 15.34 Favored Glycine 0 C--N 1.346 1.129 0 O-C-N 123.466 0.479 . . . . 23.329999999999998 112.788 -176.374 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 8.4 Cg_exo -73.6 148.22 41.81 Favored 'Trans proline' 0 C--N 1.368 1.556 0 C-N-CA 122.987 2.458 . . . . 64.150000000000006 111.564 170.354 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 105.67 -2.6 39.17 Favored Glycine 0 N--CA 1.473 1.121 0 CA-C-N 116.391 -0.368 . . . . 65.329999999999998 113.213 -179.703 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 97' ' ' ILE . . . . . 0.453 ' HB ' ' HB2' ' A' ' 115' ' ' CYS . 18.1 mm -66.34 116.18 5.28 Favored 'Isoleucine or valine' 0 CA--C 1.555 1.167 0 C-N-CA 124.366 1.066 . . . . 70.329999999999998 111.862 -174.583 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 55.3 tp -100.29 122.43 43.07 Favored 'General case' 0 N--CA 1.479 0.994 0 C-N-CA 123.312 0.645 . . . . 70.120000000000005 110.063 173.624 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 44.9 t -142.89 144.36 32.42 Favored 'General case' 0 CA--C 1.539 0.525 0 C-N-CA 124.263 1.025 . . . . 73.209999999999994 108.254 176.944 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 100' ' ' MET . . . . . 0.555 ' SD ' ' ND2' ' A' ' 35' ' ' ASN . 13.4 ttt -79.45 141.97 36.31 Favored 'General case' 0 N--CA 1.483 1.18 0 C-N-CA 124.138 0.975 . . . . 73.120000000000005 109.073 -178.729 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 101' ' ' ALA . . . . . 0.437 ' HB3' ' HB2' ' A' ' 111' ' ' GLN . . . -77.24 160.9 28.55 Favored 'General case' 0 N--CA 1.479 1.019 0 CA-C-O 121.387 0.613 . . . . 72.230000000000004 111.616 -173.02 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 102' ' ' ASN . . . . . 0.51 ' HB3' ' HA ' ' A' ' 108' ' ' ASN . 25.7 p-10 -165.79 168.84 15.65 Favored 'General case' 0 N--CA 1.472 0.669 0 CA-C-N 114.581 -1.191 . . . . 53.439999999999998 109.711 -177.468 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -90.5 -47.28 7.8 Favored 'General case' 0 N--CA 1.469 0.503 0 N-CA-C 108.917 -0.771 . . . . 73.129999999999995 108.917 167.137 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -168.0 -152.71 7.72 Favored Glycine 0 CA--C 1.533 1.172 0 CA-C-O 119.096 -0.836 . . . . 72.409999999999997 112.561 179.485 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 37.5 Cg_exo -61.79 135.39 55.78 Favored 'Trans proline' 0 C--N 1.379 2.167 0 C-N-CA 123.116 2.544 . . . . 63.450000000000003 112.898 -178.275 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 67.1 t30 66.06 9.75 6.47 Favored 'General case' 0 N--CA 1.49 1.535 0 C-N-CA 125.211 1.404 . . . . 73.540000000000006 111.852 -179.736 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 107' ' ' THR . . . . . 0.749 ' HA ' ' HD2' ' A' ' 82' ' ' LYS . 2.2 m -111.35 8.68 21.43 Favored 'General case' 0 CA--C 1.555 1.167 0 C-N-CA 124.174 0.989 . . . . 50.240000000000002 109.857 179.415 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 108' ' ' ASN . . . . . 0.51 ' HA ' ' HB3' ' A' ' 102' ' ' ASN . 8.8 t30 -70.66 145.18 50.78 Favored 'General case' 0 N--CA 1.475 0.795 0 C-N-CA 124.599 1.16 . . . . 74.420000000000002 110.268 175.135 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 109' ' ' GLY . . . . . 0.437 ' O ' ' HA ' ' A' ' 76' ' ' LYS . . . 109.99 25.12 5.49 Favored Glycine 0 N--CA 1.468 0.778 0 C-N-CA 121.568 -0.349 . . . . 50.240000000000002 112.565 178.897 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 28.4 p -131.46 118.5 20.29 Favored 'General case' 0 CA--C 1.54 0.562 0 N-CA-C 108.735 -0.839 . . . . 75.200000000000003 108.735 177.46 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 111' ' ' GLN . . . . . 0.437 ' HB2' ' HB3' ' A' ' 101' ' ' ALA . 49.7 mt-30 59.15 -175.74 0.09 Allowed 'General case' 0 N--CA 1.497 1.898 0 C-N-CA 123.724 0.81 . . . . 53.020000000000003 112.14 -173.897 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 112' ' ' PHE . . . . . 0.475 ' HA ' ' HA ' ' A' ' 100' ' ' MET . 42.6 p90 -151.64 151.7 31.85 Favored 'General case' 0 N--CA 1.484 1.241 0 N-CA-C 108.284 -1.006 . . . . 73.219999999999999 108.284 176.748 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 113' ' ' PHE . . . . . 0.708 ' HB2' ' SD ' ' A' ' 61' ' ' MET . 51.0 p90 -140.16 137.77 34.66 Favored 'General case' 0 N--CA 1.478 0.946 0 CA-C-O 121.27 0.557 . . . . 71.519999999999996 111.803 -176.568 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 114' ' ' ILE . . . . . . . . . . . . . 11.0 mt -110.09 102.52 14.1 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.663 0 C-N-CA 124.904 1.282 . . . . 72.549999999999997 108.093 -178.358 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 115' ' ' CYS . . . . . 0.453 ' HB2' ' HB ' ' A' ' 97' ' ' ILE . 56.9 m -64.83 105.26 0.97 Allowed 'General case' 0 CA--C 1.548 0.894 0 C-N-CA 123.208 0.603 . . . . 72.120000000000005 109.765 177.125 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 60.2 p -70.78 -32.01 68.99 Favored 'General case' 0 N--CA 1.476 0.844 0 C-N-CA 124.367 1.067 . . . . 65.430000000000007 110.803 -177.584 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -119.89 168.87 10.69 Favored 'General case' 0 C--O 1.247 0.946 0 C-N-CA 124.26 1.024 . . . . 30.420000000000002 108.824 169.499 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 17.5 ptmt -66.84 128.43 36.27 Favored 'General case' 0 N--CA 1.473 0.683 0 N-CA-C 109.268 -0.642 . . . . 74.530000000000001 109.268 173.462 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 119' ' ' THR . . . . . . . . . . . . . 27.0 p -131.9 84.17 2.14 Favored 'General case' 0 CA--C 1.541 0.606 0 CA-C-O 121.562 0.696 . . . . 72.049999999999997 109.15 -177.533 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 12.6 pt-20 -77.52 -15.45 59.27 Favored 'General case' 0 N--CA 1.481 1.115 0 CA-C-N 115.791 -0.64 . . . . 65.25 111.799 -172.275 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 121' ' ' TRP . . . . . . . . . . . . . 48.9 p90 -74.93 -5.05 41.71 Favored 'General case' 0 N--CA 1.478 0.928 0 C-N-CA 122.333 0.253 . . . . 73.109999999999999 111.146 174.709 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 122' ' ' LEU . . . . . 0.413 HD22 ' HB2' ' B' ' 220' ' ' PRO . 23.0 mt -94.66 8.01 43.82 Favored 'General case' 0 N--CA 1.472 0.671 0 C-N-CA 123.169 0.588 . . . . 73.510000000000005 110.89 172.949 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 53.0 m-20 -77.25 122.75 25.5 Favored 'General case' 0 CA--C 1.537 0.471 0 N-CA-C 107.475 -1.305 . . . . 64.340000000000003 107.475 168.935 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 112.88 -25.26 11.85 Favored Glycine 0 C--N 1.343 0.917 0 N-CA-C 111.185 -0.766 . . . . 74.400000000000006 111.185 -165.703 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 32.4 mmmt -72.84 -164.24 0.16 Allowed 'General case' 0 N--CA 1.489 1.499 0 C-N-CA 123.848 0.859 . . . . 65.129999999999995 109.741 167.734 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 126' ' ' HIS . . . . . . . . . . . . . 50.8 t60 -66.77 144.67 56.19 Favored 'General case' 0 CA--C 1.551 1.014 0 CA-C-O 121.082 0.468 . . . . 73.310000000000002 110.817 178.543 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 26.1 t -62.72 139.06 21.73 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.838 0 CA-C-N 114.605 -1.18 . . . . 72.430000000000007 111.194 179.595 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 49.4 t -68.18 143.38 15.31 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.739 0 N-CA-C 109.17 -0.678 . . . . 64.209999999999994 109.17 172.687 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 129' ' ' PHE . . . . . 0.451 ' HA ' HG21 ' A' ' 29' ' ' VAL . 35.9 p90 -132.81 -8.3 3.14 Favored 'General case' 0 N--CA 1.478 0.963 0 O-C-N 121.987 -0.446 . . . . 75.510000000000005 111.43 179.46 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . -151.02 171.98 30.68 Favored Glycine 0 C--N 1.34 0.772 0 O-C-N 123.473 0.483 . . . . 65.439999999999998 112.557 -175.883 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 32.2 ttpt -154.88 122.41 5.69 Favored 'General case' 0 C--O 1.236 0.384 0 N-CA-C 108.161 -1.052 . . . . 74.409999999999997 108.161 177.423 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 132' ' ' VAL . . . . . 0.451 ' HA ' ' HA ' ' A' ' 22' ' ' PHE . 3.0 p -61.44 107.73 0.44 Allowed 'Isoleucine or valine' 0 CA--C 1.551 1.01 0 CA-C-O 121.885 0.85 . . . . 74.109999999999999 110.404 178.505 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -80.9 -36.48 31.11 Favored 'General case' 0 CA--C 1.547 0.832 0 CA-C-N 114.821 -1.081 . . . . 72.310000000000002 110.385 -177.595 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 50.8 mt-10 -137.66 147.04 44.57 Favored 'General case' 0 N--CA 1.483 1.218 0 C-N-CA 124.766 1.226 . . . . 74.319999999999993 108.794 -178.734 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 80.15 14.92 79.78 Favored Glycine 0 C--N 1.344 0.982 0 O-C-N 123.208 0.318 . . . . 52.409999999999997 113.038 -177.602 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 136' ' ' MET . . . . . . . . . . . . . 12.9 tpt -65.23 -40.83 94.6 Favored 'General case' 0 N--CA 1.473 0.683 0 C-N-CA 123.482 0.713 . . . . 71.409999999999997 110.198 174.339 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 137' ' ' ASN . . . . . . . . . . . . . 17.7 m120 -59.35 -35.34 73.69 Favored 'General case' 0 N--CA 1.481 1.081 0 C-N-CA 123.384 0.673 . . . . 74.200000000000003 111.427 176.246 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 138' ' ' ILE . . . . . 0.554 ' O ' ' HG3' ' A' ' 142' ' ' MET . 36.4 mm -60.25 -56.27 18.68 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.834 0 N-CA-C 109.277 -0.638 . . . . 74.239999999999995 109.277 172.998 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 91.3 t -54.81 -42.72 63.93 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.445 0 C-N-CA 124.21 1.004 . . . . 73.010000000000005 111.727 -175.857 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 46.1 mt-10 -67.38 -36.48 81.42 Favored 'General case' 0 N--CA 1.483 1.187 0 C-N-CA 123.824 0.849 . . . . 73.319999999999993 111.101 179.676 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -71.63 -25.05 61.99 Favored 'General case' 0 N--CA 1.478 0.973 0 CA-C-N 115.932 -0.577 . . . . 65.319999999999993 111.756 175.231 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 142' ' ' MET . . . . . 0.554 ' HG3' ' O ' ' A' ' 138' ' ' ILE . 35.4 mtp -83.52 -22.9 32.31 Favored 'General case' 0 N--CA 1.485 1.282 0 C-N-CA 122.701 0.4 . . . . 63.32 111.172 178.351 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 143' ' ' GLU . . . . . 0.456 ' HA ' HG21 ' A' ' 56' ' ' ILE . 37.5 tt0 -63.44 -25.46 68.28 Favored 'General case' 0 CA--C 1.547 0.852 0 O-C-N 123.786 0.679 . . . . 75.230000000000004 110.935 174.025 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 144' ' ' ARG . . . . . . . . . . . . . 51.2 mtp85 -67.82 -18.82 64.96 Favored 'General case' 0 CA--C 1.547 0.847 0 C-N-CA 123.944 0.898 . . . . 73.340000000000003 111.916 178.384 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 145' ' ' PHE . . . . . . . . . . . . . 89.9 m-85 -85.47 -21.22 28.8 Favored 'General case' 0 N--CA 1.48 1.037 0 C-N-CA 123.135 0.574 . . . . 71.319999999999993 110.793 175.003 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . -73.33 169.83 52.84 Favored Glycine 0 C--N 1.35 1.308 0 N-CA-C 114.135 0.414 . . . . 70.299999999999997 114.135 -177.439 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 15.2 m -131.68 165.32 23.97 Favored 'General case' 0 N--CA 1.484 1.242 0 C-N-CA 124.356 1.063 . . . . 75.319999999999993 110.418 -176.444 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 148' ' ' ARG . . . . . . . . . . . . . 15.2 mmm180 -60.6 -38.57 85.13 Favored 'General case' 0 N--CA 1.485 1.305 0 C-N-CA 124.135 0.974 . . . . 75.010000000000005 111.901 -177.435 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 149' ' ' ASN . . . . . . . . . . . . . 26.6 p-10 -80.08 -7.34 58.83 Favored 'General case' 0 N--CA 1.481 1.099 0 C-N-CA 123.629 0.772 . . . . 73.310000000000002 111.857 179.784 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 150' ' ' GLY . . . . . 0.414 ' O ' ' HA ' ' A' ' 55' ' ' ARG . . . 102.41 -4.06 50.92 Favored Glycine 0 C--N 1.348 1.202 0 CA-C-O 119.648 -0.529 . . . . 75.219999999999999 113.381 -179.434 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 87.0 tttt -64.54 134.62 54.77 Favored 'General case' 0 N--CA 1.476 0.87 0 CA-C-N 117.573 0.686 . . . . 73.219999999999999 110.607 -179.733 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 152' ' ' THR . . . . . . . . . . . . . 67.4 p -95.2 126.2 40.37 Favored 'General case' 0 C--O 1.242 0.669 0 N-CA-C 108.57 -0.9 . . . . 64.150000000000006 108.57 170.168 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 153' ' ' SER . . . . . . . . . . . . . 38.8 t -60.02 -42.34 94.13 Favored 'General case' 0 N--CA 1.477 0.893 0 C-N-CA 123.568 0.747 . . . . 74.409999999999997 109.766 178.152 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 28.6 mmtp -114.69 154.54 28.27 Favored 'General case' 0 C--O 1.242 0.687 0 CA-C-N 114.928 -1.033 . . . . 53.409999999999997 109.96 179.784 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 57.1 tptt -78.15 89.59 4.25 Favored 'General case' 0 CA--C 1.54 0.59 0 N-CA-C 109.04 -0.726 . . . . 75.329999999999998 109.04 179.879 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 156' ' ' ILE . . . . . 0.423 HG23 ' HE1' ' A' ' 142' ' ' MET . 64.1 mt -84.37 116.12 27.56 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.488 0 N-CA-C 108.974 -0.75 . . . . 63.450000000000003 108.974 -176.034 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 157' ' ' THR . . . . . . . . . . . . . 50.5 p -120.41 159.97 24.03 Favored 'General case' 0 N--CA 1.479 1.018 0 C-N-CA 124.242 1.017 . . . . 64.120000000000005 110.288 -176.063 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 158' ' ' ILE . . . . . 0.514 HD12 ' HB2' ' A' ' 51' ' ' SER . 60.3 mt -87.82 100.05 9.64 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.647 0 N-CA-C 107.337 -1.357 . . . . 75.230000000000004 107.337 164.768 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 159' ' ' ALA . . . . . 0.495 ' HB2' ' HB2' ' A' ' 11' ' ' ALA . . . -57.56 -50.81 71.87 Favored 'General case' 0 N--CA 1.474 0.756 0 C-N-CA 124.193 0.997 . . . . 71.109999999999999 111.814 -177.686 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 160' ' ' ASP . . . . . . . . . . . . . 1.8 t70 -148.75 -179.15 6.77 Favored 'General case' 0 N--CA 1.48 1.049 0 CA-C-N 116.712 -0.222 . . . . 65.420000000000002 111.46 -174.049 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 161' ' ' CYS . . . . . . . . . . . . . 26.8 p -154.11 -169.07 3.14 Favored 'General case' 0 N--CA 1.475 0.816 0 C-N-CA 124.659 1.183 . . . . 62.409999999999997 108.992 -176.208 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 162' ' ' GLY . . . . . . . . . . . . . . . 136.46 53.11 0.06 OUTLIER Glycine 0 N--CA 1.475 1.287 0 N-CA-C 111.53 -0.628 . . . . 55.200000000000003 111.53 -166.056 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 163' ' ' GLN . . . . . 0.56 ' HG3' ' HA ' ' A' ' 6' ' ' VAL . 30.3 tt0 -45.8 117.43 1.48 Allowed 'General case' 0 N--CA 1.476 0.83 0 C-N-CA 126.588 1.955 . . . . 74.109999999999999 112.434 -179.869 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 164' ' ' LEU . . . . . . . . . . . . . 78.1 mt -89.3 98.48 11.79 Favored 'General case' 0 N--CA 1.466 0.343 0 N-CA-C 107.974 -1.121 . . . . 72.420000000000002 107.974 179.935 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 165' ' ' GLU . . . . . . . . . . . . . 11.3 pt-20 . . . . . 0 C--O 1.254 1.324 0 C-N-CA 123.946 0.898 . . . . 72.530000000000001 110.096 -172.922 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' B' B ' 216' ' ' PRO . . . . . . . . . . . . . 2.6 Cg_exo . . . . . 0 N--CA 1.489 1.221 0 N-CA-C 110.264 -0.706 . . . . 62.140000000000001 110.264 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' B' B ' 217' ' ' GLU . . . . . . . . . . . . . 5.7 tp10 -102.89 101.03 18.54 Favored Pre-proline 0 CA--C 1.554 1.121 0 N-CA-C 108.968 -0.753 . . . . 74.040000000000006 108.968 176.144 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 218' ' ' PRO . . . . . . . . . . . . . 86.3 Cg_endo -90.03 79.72 0.7 Allowed 'Trans proline' 0 C--N 1.382 2.291 0 C-N-CA 122.923 2.415 . . . . 71.120000000000005 111.611 179.312 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 219' ' ' GLY . . . . . . . . . . . . . . . 171.73 -169.7 42.74 Favored Glycine 0 CA--C 1.531 1.093 0 CA-C-N 115.586 -0.734 . . . . 61.43 113.196 179.75 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 220' ' ' PRO . . . . . 0.413 ' HB2' HD22 ' A' ' 122' ' ' LEU . 87.4 Cg_endo -76.37 159.16 36.56 Favored 'Trans proline' 0 C--N 1.368 1.604 0 C-N-CA 123.999 3.133 . . . . 73.209999999999994 114.128 177.067 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 221' ' ' TYR . . . . . . . . . . . . . 66.3 m-85 -84.06 140.59 31.73 Favored 'General case' 0 N--CA 1.491 1.601 0 C-N-CA 123.49 0.716 . . . . 62.450000000000003 111.876 -176.907 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 222' ' ' ALA . . . . . . . . . . . . . . . -127.37 -176.17 3.66 Favored 'General case' 0 N--CA 1.481 1.081 0 C-N-CA 124.065 0.946 . . . . 70.099999999999994 112.711 -173.281 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 223' ' ' GLN . . . . . 0.653 HE22 ' HB2' ' A' ' 60' ' ' PHE . 0.9 OUTLIER -74.77 126.99 87.87 Favored Pre-proline 0 CA--C 1.551 0.995 0 CA-C-N 114.853 -1.067 . . . . 73.150000000000006 109.314 176.128 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' B' B ' 224' ' ' PRO . . . . . . . . . . . . . 36.5 Cg_endo . . . . . 0 C--N 1.379 2.161 0 C-N-CA 123.046 2.497 . . . . 72.319999999999993 112.821 -176.7 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . 0.574 ' SD ' ' HE3' ' A' ' 28' ' ' LYS . 93.7 mmm . . . . . 0 N--CA 1.483 1.188 0 N-CA-C 110.179 -0.304 . . . . 64.129999999999995 110.179 . . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 2' ' ' VAL . . . . . 0.487 HG12 ' HB3' ' A' ' 27' ' ' ASP . 3.4 p -143.69 87.79 0.32 Allowed 'Isoleucine or valine' 0 N--CA 1.477 0.89 0 CA-C-O 122.542 1.163 . . . . 75.420000000000002 108.405 172.844 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 15.2 m120 -99.62 108.67 52.11 Favored Pre-proline 0 CA--C 1.549 0.928 0 CA-C-N 113.915 -1.493 . . . . 62.32 111.731 -175.663 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 4' ' ' PRO . . . . . 0.474 ' HG2' ' HB2' ' A' ' 24' ' ' LEU . 59.9 Cg_endo -73.69 146.41 38.49 Favored 'Trans proline' 0 C--N 1.374 1.871 0 C-N-CA 122.376 2.051 . . . . 62.109999999999999 111.403 166.232 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 5' ' ' THR . . . . . 0.486 ' HB ' ' O ' ' A' ' 164' ' ' LEU . 84.2 m -96.7 135.92 37.95 Favored 'General case' 0 CA--C 1.536 0.423 0 C-N-CA 123.344 0.658 . . . . 73.140000000000001 109.29 177.736 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . 0.475 ' HB ' ' HB2' ' A' ' 22' ' ' PHE . 23.3 t -100.19 147.08 7.96 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.485 0 N-CA-C 107.831 -1.174 . . . . 75.120000000000005 107.831 176.25 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 7' ' ' PHE . . . . . 0.439 ' H ' ' HA ' ' A' ' 163' ' ' GLN . 45.7 t80 -126.73 120.73 30.1 Favored 'General case' 0 C--O 1.237 0.412 0 N-CA-C 109.093 -0.706 . . . . 71.310000000000002 109.093 175.951 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 8' ' ' PHE . . . . . 0.402 ' HD2' ' HE2' ' A' ' 22' ' ' PHE . 30.6 m-85 -129.86 166.2 20.46 Favored 'General case' 0 N--CA 1.47 0.556 0 C-N-CA 123.864 0.865 . . . . 63.530000000000001 109.008 165.925 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 24.8 m-20 -117.82 122.9 44.6 Favored 'General case' 0 N--CA 1.466 0.349 0 N-CA-C 107.641 -1.244 . . . . 74.510000000000005 107.641 169.903 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 46.5 mm -87.2 124.41 40.63 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.509 0 N-CA-C 108.914 -0.772 . . . . 50.43 108.914 178.955 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 11' ' ' ALA . . . . . 0.851 ' HB2' ' HB2' ' A' ' 159' ' ' ALA . . . -118.82 128.13 54.17 Favored 'General case' 0 N--CA 1.469 0.483 0 C-N-CA 123.599 0.759 . . . . 63.140000000000001 110.695 -174.882 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . 0.467 HG13 ' HB3' ' A' ' 154' ' ' LYS . 96.0 t -95.81 107.91 20.33 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.48 0 N-CA-C 107.819 -1.178 . . . . 71.299999999999997 107.819 173.696 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 29.0 m-20 64.72 25.24 12.98 Favored 'General case' 0 N--CA 1.485 1.301 0 C-N-CA 125.284 1.434 . . . . 63.030000000000001 111.97 -175.926 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 87.24 1.36 84.22 Favored Glycine 0 C--N 1.348 1.249 0 CA-C-N 116.377 -0.374 . . . . 64.129999999999995 113.186 -177.061 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 17.5 mm-40 -94.46 113.49 61.07 Favored Pre-proline 0 CA--C 1.543 0.679 0 N-CA-C 108.584 -0.895 . . . . 54.420000000000002 108.584 175.125 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 26.4 Cg_endo -59.89 106.31 0.32 Allowed 'Trans proline' 0 C--N 1.38 2.197 0 C-N-CA 122.627 2.218 . . . . 73.310000000000002 112.181 -175.879 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 47.2 tp -75.49 -34.43 60.86 Favored 'General case' 0 N--CA 1.476 0.834 0 C-N-CA 124.178 0.991 . . . . 60.030000000000001 109.42 -179.348 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 178.47 177.44 47.15 Favored Glycine 0 C--N 1.343 0.919 0 CA-C-N 115.574 -0.739 . . . . 62.43 113.29 175.748 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 37.4 ptt85 -107.26 136.1 47.65 Favored 'General case' 0 C--O 1.24 0.584 0 C-N-CA 124.3 1.04 . . . . 75.200000000000003 108.998 177.05 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 20' ' ' VAL . . . . . 0.467 ' HA ' ' HA3' ' A' ' 135' ' ' GLY . 33.2 t -127.2 134.35 66.14 Favored 'Isoleucine or valine' 0 C--O 1.243 0.721 0 C-N-CA 123.122 0.569 . . . . 54.409999999999997 109.96 -178.856 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 21' ' ' SER . . . . . 0.453 ' HA ' ' O ' ' A' ' 6' ' ' VAL . 50.8 p -114.23 124.28 51.65 Favored 'General case' 0 CA--C 1.55 0.976 0 C-N-CA 123.83 0.852 . . . . 75.310000000000002 109.769 175.75 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 22' ' ' PHE . . . . . 0.475 ' HB2' ' HB ' ' A' ' 6' ' ' VAL . 60.7 m-85 -101.83 170.14 8.34 Favored 'General case' 0 N--CA 1.477 0.883 0 C-N-CA 123.903 0.881 . . . . 74.219999999999999 110.496 -179.962 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 35.0 tt0 -134.91 102.88 5.38 Favored 'General case' 0 N--CA 1.476 0.875 0 C-N-CA 123.649 0.78 . . . . 71.209999999999994 109.817 -175.225 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . 0.474 ' HB2' ' HG2' ' A' ' 4' ' ' PRO . 48.1 mt -82.02 131.78 35.25 Favored 'General case' 0 N--CA 1.478 0.97 0 C-N-CA 122.966 0.506 . . . . 73.319999999999993 110.423 -179.807 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 52.7 m-85 -86.93 69.06 10.24 Favored 'General case' 0 N--CA 1.469 0.506 0 N-CA-C 108.856 -0.794 . . . . 65.439999999999998 108.856 175.188 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -66.52 -12.89 59.8 Favored 'General case' 0 N--CA 1.483 1.184 0 CA-C-N 115.418 -0.81 . . . . 64.25 112.497 -175.114 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 27' ' ' ASP . . . . . 0.487 ' HB3' HG12 ' A' ' 2' ' ' VAL . 11.1 p-10 -85.33 -34.85 21.75 Favored 'General case' 0 CA--C 1.545 0.756 0 C-N-CA 123.694 0.798 . . . . 74.109999999999999 111.482 175.323 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 28' ' ' LYS . . . . . 0.574 ' HE3' ' SD ' ' A' ' 1' ' ' MET . 96.7 mttt -93.83 -33.48 13.53 Favored 'General case' 0 N--CA 1.489 1.496 0 C-N-CA 123.099 0.56 . . . . 72.349999999999994 111.903 -172.709 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 29' ' ' VAL . . . . . 0.566 HG21 ' HA ' ' A' ' 129' ' ' PHE . 4.4 m -135.92 69.36 64.65 Favored Pre-proline 0 N--CA 1.481 1.103 0 C-N-CA 123.873 0.869 . . . . 71.409999999999997 109.07 177.45 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 37.1 Cg_exo -58.11 -35.28 98.87 Favored 'Trans proline' 0 C--N 1.381 2.26 0 C-N-CA 122.79 2.327 . . . . 73.200000000000003 113.42 -173.04 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 87.8 tttt -69.85 -50.27 44.27 Favored 'General case' 0 N--CA 1.472 0.664 0 C-N-CA 123.67 0.788 . . . . 52.210000000000001 111.776 -178.341 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 7.4 m -73.61 -29.6 62.48 Favored 'General case' 0 CA--C 1.556 1.211 0 C-N-CA 122.975 0.51 . . . . 73.409999999999997 111.113 -172.637 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -77.26 -36.01 54.8 Favored 'General case' 0 CA--C 1.547 0.855 0 C-N-CA 123.379 0.672 . . . . 74.140000000000001 110.875 175.46 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 12.2 tp10 -60.62 -42.87 97.71 Favored 'General case' 0 N--CA 1.488 1.46 0 C-N-CA 124.041 0.937 . . . . 63.43 109.942 175.102 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 35' ' ' ASN . . . . . 0.461 ' O ' ' HG ' ' A' ' 39' ' ' LEU . 43.3 t30 -55.58 -60.33 3.59 Favored 'General case' 0 C--N 1.347 0.498 0 CA-C-N 113.75 -1.568 . . . . 73.25 110.892 177.997 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 70.0 t80 -62.19 -34.12 75.83 Favored 'General case' 0 N--CA 1.471 0.618 0 O-C-N 124.361 1.038 . . . . 61.509999999999998 111.574 -174.838 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 42.1 ttp180 -64.99 -44.19 90.1 Favored 'General case' 0 C--N 1.348 0.512 0 O-C-N 123.605 0.566 . . . . 70.349999999999994 110.841 177.278 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 38' ' ' ALA . . . . . 0.541 ' HB3' HG21 ' A' ' 78' ' ' ILE . . . -73.65 -26.02 60.56 Favored 'General case' 0 N--CA 1.475 0.785 0 C-N-CA 122.896 0.479 . . . . 51.549999999999997 111.568 -178.875 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 39' ' ' LEU . . . . . 0.577 HD22 ' HE1' ' A' ' 48' ' ' TYR . 90.3 mt -68.78 -40.16 79.8 Favored 'General case' 0 CA--C 1.549 0.912 0 C-N-CA 123.705 0.802 . . . . 73.219999999999999 109.911 172.693 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 47.2 t -71.7 -51.29 23.73 Favored 'General case' 0 N--CA 1.476 0.856 0 C-N-CA 124.311 1.044 . . . . 73.129999999999995 111.329 -178.334 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 53.1 p -72.42 -31.4 65.46 Favored 'General case' 0 N--CA 1.471 0.612 0 C-N-CA 123.703 0.801 . . . . 44.039999999999999 111.652 -175.917 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 79.03 21.93 66.9 Favored Glycine 0 C--N 1.346 1.124 0 CA-C-N 115.895 -0.593 . . . . 63.140000000000001 113.794 178.151 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 30.9 mm-40 -62.08 -31.33 71.75 Favored 'General case' 0 N--CA 1.477 0.897 0 C-N-CA 123.302 0.641 . . . . 73.209999999999994 110.707 174.213 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 44' ' ' LYS . . . . . 0.444 ' HG2' ' HB1' ' A' ' 38' ' ' ALA . 30.5 mmmt -95.74 19.4 11.33 Favored 'General case' 0 CA--C 1.544 0.717 0 C-N-CA 123.896 0.878 . . . . 72.040000000000006 111.853 179.957 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 85.83 -9.65 68.01 Favored Glycine 0 C--N 1.353 1.508 0 N-CA-C 114.994 0.757 . . . . 73.349999999999994 114.994 170.802 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 46' ' ' PHE . . . . . 0.411 ' HE2' ' HA ' ' A' ' 78' ' ' ILE . 22.3 m-85 -86.45 -50.23 7.03 Favored 'General case' 0 N--CA 1.478 0.956 0 CA-C-N 118.064 0.932 . . . . 74.420000000000002 111.473 -170.453 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 44.98 65.12 1.93 Allowed Glycine 0 C--N 1.361 1.946 0 O-C-N 124.634 1.209 . . . . 64.129999999999995 115.172 169.824 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 48' ' ' TYR . . . . . 0.577 ' HE1' HD22 ' A' ' 39' ' ' LEU . 79.3 m-85 -60.07 86.09 0.01 OUTLIER 'General case' 0 N--CA 1.487 1.383 0 CA-C-O 122.241 1.019 . . . . 72.340000000000003 111.903 -173.731 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 27.6 tptp -114.72 128.49 56.34 Favored 'General case' 0 C--O 1.239 0.527 0 CA-C-N 113.376 -1.738 . . . . 74.129999999999995 108.515 -178.865 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 63.35 20.55 63.37 Favored Glycine 0 N--CA 1.476 1.317 0 O-C-N 123.255 0.347 . . . . 63.020000000000003 112.708 -173.321 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 27.0 t -76.12 123.73 26.28 Favored 'General case' 0 C--N 1.346 0.456 0 C-N-CA 123.119 0.567 . . . . 75.200000000000003 110.575 -171.137 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 52' ' ' CYS . . . . . 0.457 ' SG ' ' HD3' ' A' ' 155' ' ' LYS . 51.5 t -81.45 161.86 23.52 Favored 'General case' 0 CA--C 1.539 0.53 0 O-C-N 123.967 0.792 . . . . 70.5 112.537 -171.631 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 12.7 m-85 -111.67 131.47 55.27 Favored 'General case' 0 CA--C 1.537 0.465 0 N-CA-C 107.068 -1.456 . . . . 74.439999999999998 107.068 169.544 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 47.9 p-80 -114.18 -29.35 6.98 Favored 'General case' 0 N--CA 1.496 1.866 0 CA-C-N 118.695 0.68 . . . . 74.209999999999994 112.348 -174.016 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 55' ' ' ARG . . . . . 0.413 ' HB3' ' HG2' ' A' ' 63' ' ' GLN . 42.6 ttt-85 -119.62 98.29 6.05 Favored 'General case' 0 N--CA 1.473 0.724 0 N-CA-C 108.544 -0.91 . . . . 74.540000000000006 108.544 -176.603 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 59.5 mt -130.27 127.96 63.57 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.614 0 C-N-CA 123.807 0.843 . . . . 63.329999999999998 108.974 179.825 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 61.4 mt -127.83 118.88 21.12 Favored Pre-proline 0 CA--C 1.553 1.078 0 N-CA-C 108.189 -1.041 . . . . 72.140000000000001 108.189 176.848 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 58' ' ' PRO . . . . . 0.482 ' HB3' ' HA ' ' A' ' 144' ' ' ARG . 64.0 Cg_endo -70.35 139.02 37.24 Favored 'Trans proline' 0 C--N 1.379 2.154 0 C-N-CA 123.163 2.576 . . . . 73.239999999999995 111.98 -174.028 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 79.0 24.41 61.83 Favored Glycine 0 C--N 1.338 0.645 0 CA-C-N 115.204 -0.907 . . . . 31.140000000000001 112.325 -175.728 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 27.9 t80 -150.34 -76.87 0.14 Allowed 'General case' 0 CA--C 1.544 0.724 0 C-N-CA 123.778 0.831 . . . . 72.400000000000006 109.884 179.356 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 38.7 ttp -166.98 150.46 6.65 Favored 'General case' 0 N--CA 1.485 1.306 0 CA-C-O 120.912 0.386 . . . . 65.420000000000002 111.781 -164.412 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 62' ' ' CYS . . . . . . . . . . . . . 4.9 p -127.83 120.86 28.71 Favored 'General case' 0 N--CA 1.478 0.932 0 C-N-CA 124.829 1.251 . . . . 64.549999999999997 109.57 176.552 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 63' ' ' GLN . . . . . 0.413 ' HG2' ' HB3' ' A' ' 55' ' ' ARG . 14.2 pt20 -128.26 144.97 51.18 Favored 'General case' 0 N--CA 1.491 1.62 0 CA-C-O 121.428 0.632 . . . . 73.010000000000005 112.375 -176.156 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -163.61 -147.27 5.01 Favored Glycine 0 C--N 1.348 1.227 0 CA-C-N 114.406 -1.27 . . . . 52.140000000000001 113.556 -174.609 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 90.66 12.32 61.01 Favored Glycine 0 C--N 1.345 1.062 0 N-CA-C 110.588 -1.005 . . . . 52.140000000000001 110.588 -161.878 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 38.9 t70 -61.69 -43.64 98.47 Favored 'General case' 0 N--CA 1.472 0.66 0 C-N-CA 125.313 1.445 . . . . 74.530000000000001 112.543 -162.085 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 50.2 t80 -49.37 -36.77 22.61 Favored 'General case' 0 CA--C 1.552 1.042 0 O-C-N 124.598 1.186 . . . . 72.25 112.695 -170.236 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 54.3 m -88.11 108.23 19.15 Favored 'General case' 0 CA--C 1.545 0.782 0 C-N-CA 122.957 0.503 . . . . 71.310000000000002 110.522 176.147 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 31.8 mtp180 58.73 53.87 5.64 Favored 'General case' 0 N--CA 1.479 0.993 0 C-N-CA 124.963 1.305 . . . . 73.319999999999993 111.657 172.797 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 10.0 p80 -63.34 -13.17 36.16 Favored 'General case' 0 N--CA 1.482 1.172 0 N-CA-C 114.233 1.197 . . . . 74.349999999999994 114.233 -173.874 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 6.6 t30 -68.61 84.84 0.29 Allowed 'General case' 0 CA--C 1.552 1.049 0 C-N-CA 123.253 0.621 . . . . 65.140000000000001 110.159 179.163 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 64.47 13.95 56.19 Favored Glycine 0 C--N 1.353 1.506 0 N-CA-C 115.62 1.008 . . . . 54.310000000000002 115.62 176.397 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 73' ' ' THR . . . . . 0.406 ' O ' ' HG3' ' A' ' 111' ' ' GLN . 6.9 m -125.0 -68.01 0.87 Allowed 'General case' 0 N--CA 1.476 0.851 0 N-CA-C 109.188 -0.671 . . . . 72.239999999999995 109.188 -178.228 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 57.3 50.45 64.59 Favored Glycine 0 C--N 1.353 1.515 0 O-C-N 124.559 1.162 . . . . 74.310000000000002 115.141 171.66 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 128.83 50.81 0.13 Allowed Glycine 0 C--N 1.35 1.335 0 CA-C-N 117.833 0.817 . . . . 54.439999999999998 113.281 178.837 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 14.1 ptmm? -64.27 165.6 9.26 Favored 'General case' 0 N--CA 1.482 1.15 0 C-N-CA 123.133 0.573 . . . . 73.430000000000007 112.338 -179.042 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 84.0 p -92.77 173.8 7.58 Favored 'General case' 0 N--CA 1.472 0.655 0 CA-C-N 115.893 -0.594 . . . . 72.439999999999998 111.392 -172.811 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 78' ' ' ILE . . . . . 0.541 HG21 ' HB3' ' A' ' 38' ' ' ALA . 23.1 pt -81.0 -20.99 11.13 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.609 0 CA-C-N 115.856 -0.611 . . . . 74.540000000000006 109.877 172.638 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 79' ' ' TYR . . . . . 0.427 ' HE2' ' HB2' ' A' ' 35' ' ' ASN . 64.0 m-85 -86.62 12.53 10.37 Favored 'General case' 0 CA--C 1.546 0.821 0 C-N-CA 123.767 0.827 . . . . 71.219999999999999 110.134 175.683 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 121.17 -152.5 16.79 Favored Glycine 0 C--N 1.354 1.549 0 C-N-CA 123.126 0.393 . . . . 62.020000000000003 112.784 171.203 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 34.3 tt0 -52.13 -53.24 45.21 Favored 'General case' 0 N--CA 1.471 0.597 0 C-N-CA 124.816 1.246 . . . . 72.450000000000003 109.396 171.993 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 82' ' ' LYS . . . . . 0.676 ' HD2' ' HA ' ' A' ' 107' ' ' THR . 20.7 pttp -169.52 156.06 6.46 Favored 'General case' 0 CA--C 1.548 0.888 0 CA-C-N 114.549 -1.205 . . . . 62.130000000000003 109.697 -178.319 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 9.7 p90 -131.68 174.78 9.77 Favored 'General case' 0 N--CA 1.48 1.029 0 C-N-CA 124.341 1.056 . . . . 65.209999999999994 110.57 -179.943 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 84' ' ' GLU . . . . . 0.542 ' HA ' ' HA ' ' A' ' 106' ' ' ASN . 0.0 OUTLIER -70.98 168.68 16.51 Favored 'General case' 0 N--CA 1.479 0.992 0 CA-C-N 115.759 -0.655 . . . . 73.140000000000001 111.582 -179.483 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 56.6 m-20 -80.58 111.39 16.95 Favored 'General case' 0 N--CA 1.47 0.571 0 N-CA-C 108.289 -1.004 . . . . 74.150000000000006 108.289 173.839 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 3.9 tp10 -46.98 -53.27 12.73 Favored 'General case' 0 N--CA 1.481 1.097 0 C-N-CA 124.895 1.278 . . . . 73.450000000000003 112.636 -175.0 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 87' ' ' ASN . . . . . 0.409 ' OD1' HG21 ' A' ' 127' ' ' VAL . 32.3 p30 -159.6 -165.62 1.58 Allowed 'General case' 0 N--CA 1.473 0.683 0 C-N-CA 123.62 0.768 . . . . 73.129999999999995 109.589 -176.17 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 93.7 m-85 -137.27 29.8 2.72 Favored 'General case' 0 N--CA 1.485 1.284 0 C-N-CA 123.868 0.867 . . . . 52.530000000000001 110.274 176.004 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 65.9 mt -60.07 -49.77 82.77 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.247 0 CA-C-O 121.866 0.841 . . . . 75.310000000000002 109.791 176.482 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 90' ' ' LEU . . . . . 0.622 ' HB3' ' HB ' ' A' ' 128' ' ' VAL . 92.3 mt -96.23 99.63 11.33 Favored 'General case' 0 C--O 1.237 0.436 0 CA-C-N 114.565 -1.198 . . . . 63.450000000000003 110.102 -175.969 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 8.7 mtpm? -76.31 149.7 37.02 Favored 'General case' 0 CA--C 1.543 0.69 0 C-N-CA 123.567 0.747 . . . . 75.099999999999994 110.204 176.771 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 92' ' ' HIS . . . . . . . . . . . . . 18.2 t-80 -87.43 28.45 0.97 Allowed 'General case' 0 N--CA 1.482 1.126 0 C-N-CA 124.21 1.004 . . . . 70.530000000000001 111.368 -169.412 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 14.5 t -99.87 16.46 23.69 Favored 'General case' 0 CA--C 1.552 1.051 0 C-N-CA 123.819 0.848 . . . . 60.210000000000001 111.628 -166.996 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -113.17 161.12 12.79 Favored Glycine 0 CA--C 1.534 1.255 0 CA-C-O 119.443 -0.643 . . . . 72.519999999999996 112.1 176.937 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 86.7 Cg_endo -83.4 154.2 14.04 Favored 'Trans proline' 0 C--N 1.367 1.544 0 C-N-CA 122.816 2.344 . . . . 74.540000000000006 111.957 171.408 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 71.12 19.76 77.49 Favored Glycine 0 C--N 1.35 1.312 0 N-CA-C 113.8 0.28 . . . . 50.329999999999998 113.8 -179.944 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 97' ' ' ILE . . . . . 0.429 HG23 HG13 ' A' ' 128' ' ' VAL . 24.6 mm -77.27 125.15 36.81 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.808 0 C-N-CA 123.231 0.612 . . . . 75.209999999999994 112.042 -175.65 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 98' ' ' LEU . . . . . 0.68 ' HG ' HG12 ' A' ' 114' ' ' ILE . 7.3 mp -93.11 123.2 36.21 Favored 'General case' 0 C--O 1.241 0.612 0 C-N-CA 123.709 0.804 . . . . 72.439999999999998 109.735 168.038 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 25.9 m -139.96 144.14 36.9 Favored 'General case' 0 N--CA 1.474 0.747 0 N-CA-C 107.737 -1.209 . . . . 61.329999999999998 107.737 168.876 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 100' ' ' MET . . . . . 0.549 ' HA ' ' HA ' ' A' ' 112' ' ' PHE . 72.1 mtp -75.44 142.28 43.02 Favored 'General case' 0 N--CA 1.482 1.157 0 N-CA-C 108.842 -0.799 . . . . 74.120000000000005 108.842 177.668 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 101' ' ' ALA . . . . . 0.631 ' HB3' ' HB2' ' A' ' 111' ' ' GLN . . . -73.97 140.32 45.45 Favored 'General case' 0 C--O 1.24 0.58 0 CA-C-O 121.362 0.601 . . . . 63.109999999999999 112.343 -166.805 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 28.6 p-10 -151.8 154.7 36.73 Favored 'General case' 0 C--O 1.237 0.398 0 CA-C-N 114.734 -1.121 . . . . 65.140000000000001 109.416 179.444 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -105.27 5.45 32.02 Favored 'General case' 0 CA--C 1.537 0.46 0 CA-C-N 115.538 -0.755 . . . . 75.150000000000006 110.261 170.589 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 162.07 -174.3 38.51 Favored Glycine 0 C--N 1.35 1.317 0 CA-C-O 119.661 -0.521 . . . . 53.439999999999998 112.387 179.577 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 77.5 Cg_exo -55.39 138.92 81.26 Favored 'Trans proline' 0 C--N 1.374 1.883 0 C-N-CA 123.663 2.909 . . . . 72.030000000000001 113.218 175.219 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 106' ' ' ASN . . . . . 0.542 ' HA ' ' HA ' ' A' ' 84' ' ' GLU . 63.9 t30 68.29 10.87 8.11 Favored 'General case' 0 N--CA 1.487 1.399 0 C-N-CA 125.277 1.431 . . . . 64.519999999999996 111.64 177.826 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 107' ' ' THR . . . . . 0.676 ' HA ' ' HD2' ' A' ' 82' ' ' LYS . 3.1 m -104.65 -11.64 16.8 Favored 'General case' 0 CA--C 1.552 1.051 0 C-N-CA 123.728 0.811 . . . . 71.420000000000002 110.129 176.99 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 10.5 t30 -56.15 139.77 46.36 Favored 'General case' 0 N--CA 1.48 1.043 0 C-N-CA 124.988 1.315 . . . . 65.030000000000001 111.651 172.428 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 112.52 3.05 25.74 Favored Glycine 0 N--CA 1.471 1.026 0 CA-C-O 119.924 -0.376 . . . . 60.32 113.137 176.197 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 15.3 p -114.19 122.35 46.54 Favored 'General case' 0 CA--C 1.542 0.648 0 N-CA-C 108.395 -0.965 . . . . 73.510000000000005 108.395 172.272 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 111' ' ' GLN . . . . . 0.631 ' HB2' ' HB3' ' A' ' 101' ' ' ALA . 41.0 mt-30 66.03 168.86 0.22 Allowed 'General case' 0 N--CA 1.496 1.846 0 C-N-CA 124.746 1.218 . . . . 73.329999999999998 112.416 -175.728 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 112' ' ' PHE . . . . . 0.549 ' HA ' ' HA ' ' A' ' 100' ' ' MET . 51.4 p90 -137.02 140.47 42.12 Favored 'General case' 0 N--CA 1.476 0.827 0 N-CA-C 108.153 -1.054 . . . . 74.420000000000002 108.153 168.341 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 113' ' ' PHE . . . . . 0.409 ' HE2' ' HA ' ' A' ' 101' ' ' ALA . 54.4 p90 -128.1 150.02 50.15 Favored 'General case' 0 N--CA 1.471 0.624 0 C-N-CA 122.899 0.48 . . . . 70.349999999999994 111.832 179.881 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 114' ' ' ILE . . . . . 0.68 HG12 ' HG ' ' A' ' 98' ' ' LEU . 14.0 mt -120.95 117.9 54.52 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.654 0 CA-C-N 115.12 -0.945 . . . . 72.420000000000002 108.666 173.943 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 115' ' ' CYS . . . . . . . . . . . . . 58.8 m -94.77 110.41 22.27 Favored 'General case' 0 C--O 1.24 0.596 0 N-CA-C 108.311 -0.996 . . . . 73.409999999999997 108.311 173.891 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 116' ' ' THR . . . . . 0.459 HG21 ' HA ' ' A' ' 140' ' ' GLU . 72.5 p -71.03 -31.52 68.02 Favored 'General case' 0 N--CA 1.479 0.989 0 C-N-CA 122.51 0.324 . . . . 74.25 111.719 -175.28 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -97.25 163.67 12.81 Favored 'General case' 0 N--CA 1.479 1.004 0 N-CA-C 109.164 -0.68 . . . . 70.420000000000002 109.164 168.155 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 118' ' ' LYS . . . . . 0.47 ' HE2' ' HB3' ' A' ' 120' ' ' GLU . 0.0 OUTLIER -70.84 124.71 24.96 Favored 'General case' 0 C--N 1.347 0.466 0 N-CA-C 109.233 -0.654 . . . . 72.430000000000007 109.233 175.914 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 119' ' ' THR . . . . . 0.6 ' HB ' HD13 ' A' ' 122' ' ' LEU . 23.0 p -113.02 88.11 2.75 Favored 'General case' 0 C--O 1.238 0.462 0 CA-C-O 121.864 0.84 . . . . 73.239999999999995 109.055 179.138 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 120' ' ' GLU . . . . . 0.47 ' HB3' ' HE2' ' A' ' 118' ' ' LYS . 10.5 pt-20 -67.87 -27.16 66.44 Favored 'General case' 0 N--CA 1.478 0.965 0 CA-C-N 114.254 -1.339 . . . . 72.439999999999998 112.485 -178.009 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 121' ' ' TRP . . . . . . . . . . . . . 32.5 p90 -78.12 -1.02 30.49 Favored 'General case' 0 N--CA 1.479 1.014 0 C-N-CA 122.768 0.427 . . . . 74.319999999999993 111.113 178.49 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 122' ' ' LEU . . . . . 0.6 HD13 ' HB ' ' A' ' 119' ' ' THR . 9.3 mp -96.63 5.7 50.18 Favored 'General case' 0 N--CA 1.48 1.049 0 C-N-CA 123.904 0.882 . . . . 64.129999999999995 111.168 171.639 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 25.0 m-20 -72.62 141.12 48.33 Favored 'General case' 0 N--CA 1.481 1.09 0 N-CA-C 109.462 -0.57 . . . . 61.509999999999998 109.462 168.879 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 92.98 -28.31 9.68 Favored Glycine 0 N--CA 1.478 1.451 0 N-CA-C 111.759 -0.536 . . . . 71.299999999999997 111.759 -173.019 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 1.5 mppt? -73.65 -164.32 0.21 Allowed 'General case' 0 N--CA 1.481 1.084 0 C-N-CA 124.584 1.154 . . . . 65.25 109.538 168.585 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 126' ' ' HIS . . . . . . . . . . . . . 36.2 t60 -66.08 132.94 49.69 Favored 'General case' 0 CA--C 1.542 0.669 0 CA-C-O 121.638 0.733 . . . . 63.310000000000002 112.207 -170.853 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 127' ' ' VAL . . . . . 0.409 HG21 ' OD1' ' A' ' 87' ' ' ASN . 7.1 p -59.42 146.64 9.36 Favored 'Isoleucine or valine' 0 CA--C 1.554 1.103 0 CA-C-N 113.797 -1.547 . . . . 73.439999999999998 111.155 177.185 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 128' ' ' VAL . . . . . 0.622 ' HB ' ' HB3' ' A' ' 90' ' ' LEU . 42.1 t -62.44 147.05 11.97 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.795 0 C-N-CA 123.686 0.794 . . . . 45.340000000000003 110.333 179.625 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 129' ' ' PHE . . . . . 0.566 ' HA ' HG21 ' A' ' 29' ' ' VAL . 36.7 p90 -120.16 -28.83 5.01 Favored 'General case' 0 N--CA 1.476 0.87 0 C-N-CA 122.565 0.346 . . . . 74.049999999999997 110.277 170.575 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . -146.09 168.73 27.59 Favored Glycine 0 C--N 1.346 1.112 0 O-C-N 123.525 0.516 . . . . 74.450000000000003 112.798 -172.371 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 29.0 ttpt -152.76 134.6 14.69 Favored 'General case' 0 N--CA 1.47 0.541 0 N-CA-C 108.167 -1.049 . . . . 62.340000000000003 108.167 -177.611 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 132' ' ' VAL . . . . . 0.486 HG11 ' HA ' ' A' ' 136' ' ' MET . 7.3 t -66.62 109.95 1.36 Allowed 'Isoleucine or valine' 0 CA--C 1.542 0.671 0 N-CA-C 109.433 -0.58 . . . . 65.219999999999999 109.433 176.799 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 14.4 ptmm? -87.02 -39.52 15.57 Favored 'General case' 0 N--CA 1.481 1.104 0 N-CA-C 110.134 -0.321 . . . . 73.329999999999998 110.134 -178.269 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 134' ' ' GLU . . . . . 0.403 ' HB2' ' OG ' ' A' ' 21' ' ' SER . 20.6 mm-40 -144.53 162.13 37.35 Favored 'General case' 0 N--CA 1.488 1.471 0 C-N-CA 124.711 1.204 . . . . 61.32 108.693 173.316 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 135' ' ' GLY . . . . . 0.467 ' HA3' ' HA ' ' A' ' 20' ' ' VAL . . . 78.7 15.14 81.24 Favored Glycine 0 C--N 1.346 1.125 0 O-C-N 123.349 0.406 . . . . 71.319999999999993 112.177 -173.715 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 136' ' ' MET . . . . . 0.486 ' HA ' HG11 ' A' ' 132' ' ' VAL . 15.2 tpt -62.92 -34.38 77.32 Favored 'General case' 0 N--CA 1.472 0.626 0 C-N-CA 124.462 1.105 . . . . 72.120000000000005 111.808 -177.047 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 137' ' ' ASN . . . . . . . . . . . . . 27.3 t-20 -61.78 -35.84 79.34 Favored 'General case' 0 N--CA 1.48 1.069 0 C-N-CA 123.455 0.702 . . . . 73.219999999999999 111.164 177.571 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 138' ' ' ILE . . . . . . . . . . . . . 43.4 mm -71.12 -33.22 50.43 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.088 0 C-N-CA 123.402 0.681 . . . . 62.140000000000001 110.679 179.642 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 139' ' ' VAL . . . . . 0.422 HG11 HG21 ' A' ' 114' ' ' ILE . 62.0 t -69.76 -44.87 78.79 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.999 0 C-N-CA 123.407 0.683 . . . . 72.120000000000005 110.518 176.306 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 140' ' ' GLU . . . . . 0.459 ' HA ' HG21 ' A' ' 116' ' ' THR . 40.0 mt-10 -63.82 -33.58 75.99 Favored 'General case' 0 N--CA 1.476 0.855 0 CA-C-N 115.476 -0.784 . . . . 73.310000000000002 110.534 176.882 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -70.37 -43.84 69.3 Favored 'General case' 0 C--O 1.24 0.594 0 C-N-CA 123.662 0.785 . . . . 75.310000000000002 111.307 178.124 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 142' ' ' MET . . . . . 0.515 ' HB2' HD13 ' A' ' 156' ' ' ILE . 22.4 ptt? -69.52 -34.09 73.75 Favored 'General case' 0 C--N 1.355 0.843 0 CA-C-N 116.84 -0.164 . . . . 65.299999999999997 110.929 -175.691 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 143' ' ' GLU . . . . . 0.413 ' HG2' ' HA ' ' A' ' 58' ' ' PRO . 30.9 tt0 -62.87 -28.99 70.42 Favored 'General case' 0 CA--C 1.559 1.294 0 C-N-CA 122.722 0.409 . . . . 72.450000000000003 111.462 -178.968 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 144' ' ' ARG . . . . . 0.482 ' HA ' ' HB3' ' A' ' 58' ' ' PRO . 58.6 mtp85 -68.72 -19.47 64.36 Favored 'General case' 0 N--CA 1.485 1.295 0 C-N-CA 123.589 0.756 . . . . 61.130000000000003 112.242 -179.091 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 145' ' ' PHE . . . . . 0.529 ' HB2' HD11 ' A' ' 156' ' ' ILE . 56.6 m-85 -79.95 -8.15 59.18 Favored 'General case' 0 N--CA 1.477 0.897 0 C-N-CA 122.807 0.443 . . . . 71.430000000000007 111.321 179.328 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . -78.14 179.59 51.47 Favored Glycine 0 C--N 1.345 1.029 0 O-C-N 123.348 0.405 . . . . 53.439999999999998 112.751 172.585 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 46.0 t -133.7 168.4 18.77 Favored 'General case' 0 N--CA 1.476 0.834 0 C-N-CA 123.773 0.829 . . . . 60.450000000000003 110.148 -176.893 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 148' ' ' ARG . . . . . . . . . . . . . 18.4 mmm180 -58.55 -37.01 74.82 Favored 'General case' 0 N--CA 1.481 1.107 0 C-N-CA 123.81 0.844 . . . . 73.230000000000004 111.863 178.527 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 149' ' ' ASN . . . . . . . . . . . . . 30.2 p-10 -89.78 11.69 19.36 Favored 'General case' 0 N--CA 1.483 1.203 0 C-N-CA 123.217 0.607 . . . . 74.319999999999993 112.201 -178.614 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . 86.08 -2.8 87.61 Favored Glycine 0 C--N 1.349 1.277 0 CA-C-O 119.732 -0.482 . . . . 45.039999999999999 114.031 177.421 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 35.7 ttmt -63.73 130.79 45.65 Favored 'General case' 0 N--CA 1.474 0.756 0 C-N-CA 123.792 0.837 . . . . 70.140000000000001 110.736 179.988 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 152' ' ' THR . . . . . . . . . . . . . 82.2 p -91.91 108.84 20.21 Favored 'General case' 0 C--O 1.239 0.504 0 N-CA-C 108.069 -1.085 . . . . 72.200000000000003 108.069 170.388 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 153' ' ' SER . . . . . . . . . . . . . 49.4 m -68.32 -28.92 67.58 Favored 'General case' 0 N--CA 1.473 0.712 0 C-N-CA 123.073 0.549 . . . . 75.219999999999999 110.532 177.789 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 154' ' ' LYS . . . . . 0.467 ' HB3' HG13 ' A' ' 12' ' ' VAL . 74.4 mmtt -117.11 139.83 50.26 Favored 'General case' 0 C--O 1.241 0.621 0 C-N-CA 124.155 0.982 . . . . 71.200000000000003 109.717 177.277 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 155' ' ' LYS . . . . . 0.457 ' HD3' ' SG ' ' A' ' 52' ' ' CYS . 17.4 tppt? -78.56 89.58 4.5 Favored 'General case' 0 CA--C 1.541 0.603 0 N-CA-C 109.016 -0.735 . . . . 71.420000000000002 109.016 179.926 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 156' ' ' ILE . . . . . 0.529 HD11 ' HB2' ' A' ' 145' ' ' PHE . 72.5 mt -86.58 117.53 31.16 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.321 0 CA-C-N 115.503 -0.771 . . . . 75.109999999999999 109.051 -177.422 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 157' ' ' THR . . . . . . . . . . . . . 25.1 p -130.88 153.62 48.94 Favored 'General case' 0 C--O 1.238 0.478 0 C-N-CA 124.8 1.24 . . . . 61.229999999999997 109.484 -171.898 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 158' ' ' ILE . . . . . 0.46 HD11 ' HZ ' ' A' ' 112' ' ' PHE . 67.7 mt -76.19 93.78 1.05 Allowed 'Isoleucine or valine' 0 CA--C 1.547 0.848 0 N-CA-C 108.633 -0.877 . . . . 64.349999999999994 108.633 172.094 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 159' ' ' ALA . . . . . 0.851 ' HB2' ' HB2' ' A' ' 11' ' ' ALA . . . -51.31 -53.03 39.95 Favored 'General case' 0 N--CA 1.483 1.185 0 C-N-CA 123.729 0.812 . . . . 34.43 111.707 -178.899 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 160' ' ' ASP . . . . . . . . . . . . . 1.5 t70 -151.18 176.61 11.02 Favored 'General case' 0 CA--C 1.548 0.897 0 CA-C-N 115.827 -0.624 . . . . 65.439999999999998 109.818 -178.557 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 161' ' ' CYS . . . . . . . . . . . . . 9.8 p -148.51 -171.69 3.91 Favored 'General case' 0 N--CA 1.477 0.905 0 C-N-CA 124.459 1.104 . . . . 74.230000000000004 109.9 -172.399 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 162' ' ' GLY . . . . . . . . . . . . . . . 131.23 53.39 0.09 OUTLIER Glycine 0 C--N 1.353 1.519 0 N-CA-C 112.238 -0.345 . . . . 52.25 112.238 -172.782 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 163' ' ' GLN . . . . . 0.439 ' HA ' ' H ' ' A' ' 7' ' ' PHE . 27.5 tt0 -46.74 107.08 0.1 Allowed 'General case' 0 CA--C 1.559 1.289 0 C-N-CA 125.234 1.414 . . . . 71.439999999999998 112.888 179.953 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 164' ' ' LEU . . . . . 0.486 ' O ' ' HB ' ' A' ' 5' ' ' THR . 84.5 mt -87.37 100.54 12.81 Favored 'General case' 0 N--CA 1.475 0.795 0 C-N-CA 123.898 0.879 . . . . 72.439999999999998 109.85 -175.246 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 165' ' ' GLU . . . . . . . . . . . . . 11.4 pt-20 . . . . . 0 N--CA 1.486 1.34 0 CA-C-O 118.945 -0.55 . . . . 75.430000000000007 110.68 177.947 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' B' B ' 216' ' ' PRO . . . . . . . . . . . . . 2.1 Cg_endo . . . . . 0 CA--C 1.542 0.9 0 N-CA-C 110.255 -0.71 . . . . 75.019999999999996 110.255 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' B' B ' 217' ' ' GLU . . . . . . . . . . . . . 42.9 mt-10 -115.84 162.93 22.97 Favored Pre-proline 0 CA--C 1.545 0.779 0 C-N-CA 124.867 1.267 . . . . 73.540000000000006 109.196 178.647 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 218' ' ' PRO . . . . . . . . . . . . . 14.7 Cg_exo -68.54 92.03 0.41 Allowed 'Trans proline' 0 C--N 1.376 2.015 0 C-N-CA 121.818 1.679 . . . . 71.140000000000001 108.847 163.865 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 219' ' ' GLY . . . . . . . . . . . . . . . 160.18 156.91 8.37 Favored Glycine 0 CA--C 1.533 1.165 0 CA-C-N 115.753 -0.658 . . . . 74.209999999999994 112.057 -175.59 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 220' ' ' PRO . . . . . . . . . . . . . 36.3 Cg_endo -86.23 -179.22 3.07 Favored 'Trans proline' 0 C--N 1.365 1.433 0 C-N-CA 123.753 2.968 . . . . 74.140000000000001 113.86 -176.288 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 221' ' ' TYR . . . . . . . . . . . . . 97.0 m-85 -100.38 138.01 38.04 Favored 'General case' 0 N--CA 1.48 1.053 0 C-N-CA 123.333 0.653 . . . . 75.340000000000003 111.868 -175.14 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 222' ' ' ALA . . . . . . . . . . . . . . . -81.5 -169.96 2.56 Favored 'General case' 0 N--CA 1.477 0.911 0 C-N-CA 124.829 1.252 . . . . 72.109999999999999 112.44 175.791 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 223' ' ' GLN . . . . . . . . . . . . . 9.9 mp0 -53.38 116.23 9.23 Favored Pre-proline 0 CA--C 1.556 1.176 0 C-N-CA 123.934 0.894 . . . . 72.230000000000004 108.952 170.871 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 224' ' ' PRO . . . . . . . . . . . . . 5.7 Cg_exo . . . . . 0 C--N 1.38 2.187 0 C-N-CA 122.486 2.124 . . . . 73.310000000000002 112.036 -176.009 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 51.3 ttp . . . . . 0 N--CA 1.478 0.939 0 N-CA-C 109.791 -0.448 . . . . 64.409999999999997 109.791 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 27.0 m -83.75 -19.68 9.43 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.19 0 C-N-CA 123.82 0.848 . . . . 64.150000000000006 111.542 -179.113 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 3' ' ' ASN . . . . . 0.596 ' ND2' ' HA ' ' A' ' 25' ' ' PHE . 14.9 m120 -84.38 118.48 71.25 Favored Pre-proline 0 CA--C 1.545 0.785 0 C-N-CA 123.852 0.861 . . . . 74.340000000000003 110.066 -177.66 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 4' ' ' PRO . . . . . 0.51 ' HG2' ' HB2' ' A' ' 24' ' ' LEU . 73.3 Cg_endo -77.48 150.35 28.19 Favored 'Trans proline' 0 C--N 1.374 1.907 0 C-N-CA 122.392 2.061 . . . . 75.109999999999999 111.575 170.559 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 5' ' ' THR . . . . . 0.445 ' HB ' ' O ' ' A' ' 164' ' ' LEU . 52.5 m -98.04 142.54 29.63 Favored 'General case' 0 CA--C 1.54 0.566 0 N-CA-C 108.932 -0.766 . . . . 71.540000000000006 108.932 175.168 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . 0.706 ' HA ' ' HG3' ' A' ' 163' ' ' GLN . 44.1 t -101.76 150.44 6.1 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.967 0 N-CA-C 107.689 -1.226 . . . . 74.310000000000002 107.689 171.125 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 7' ' ' PHE . . . . . 0.433 ' H ' ' HA ' ' A' ' 163' ' ' GLN . 74.2 t80 -133.55 130.77 38.9 Favored 'General case' 0 C--O 1.236 0.37 0 N-CA-C 109.531 -0.544 . . . . 74.510000000000005 109.531 175.962 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 8' ' ' PHE . . . . . 0.401 ' HD2' ' HE2' ' A' ' 22' ' ' PHE . 32.3 m-85 -138.2 166.49 24.03 Favored 'General case' 0 C--O 1.237 0.418 0 C-N-CA 124.808 1.243 . . . . 73.310000000000002 109.362 170.248 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 9' ' ' ASP . . . . . 0.401 ' HB2' ' H ' ' A' ' 160' ' ' ASP . 8.7 m-20 -117.27 112.19 20.43 Favored 'General case' 0 N--CA 1.468 0.463 0 CA-C-N 114.847 -1.069 . . . . 64.439999999999998 108.126 171.555 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 10' ' ' ILE . . . . . 0.447 HG21 ' SD ' ' A' ' 142' ' ' MET . 45.8 mm -83.33 128.57 38.64 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.453 0 N-CA-C 108.673 -0.862 . . . . 74.420000000000002 108.673 178.91 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 11' ' ' ALA . . . . . 0.655 ' HB2' ' HB2' ' A' ' 159' ' ' ALA . . . -129.97 141.1 50.81 Favored 'General case' 0 N--CA 1.471 0.614 0 C-N-CA 123.749 0.82 . . . . 50.32 110.58 -173.1 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . 0.541 HG13 ' HB3' ' A' ' 154' ' ' LYS . 86.2 t -97.17 110.89 25.93 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.435 0 C-N-CA 124.173 0.989 . . . . 63.340000000000003 108.848 173.533 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 9.9 m-20 58.98 24.29 12.47 Favored 'General case' 0 N--CA 1.485 1.31 0 C-N-CA 124.8 1.24 . . . . 75.400000000000006 112.651 179.919 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 106.13 -24.2 27.03 Favored Glycine 0 C--N 1.349 1.304 0 CA-C-O 119.681 -0.511 . . . . 64.219999999999999 113.006 179.658 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 24.7 mm-40 -81.78 120.28 77.35 Favored Pre-proline 0 N--CA 1.479 0.991 0 CA-C-O 118.449 -0.786 . . . . 74.439999999999998 109.327 179.994 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 19.1 Cg_endo -57.72 114.65 2.05 Favored 'Trans proline' 0 C--N 1.379 2.158 0 C-N-CA 123.107 2.538 . . . . 73.439999999999998 112.498 -177.114 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . 0.5 ' HB2' HG23 ' A' ' 12' ' ' VAL . 52.0 tp -79.43 -41.8 26.81 Favored 'General case' 0 N--CA 1.478 0.963 0 C-N-CA 123.735 0.814 . . . . 72.209999999999994 110.058 175.765 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -177.69 174.49 46.93 Favored Glycine 0 C--N 1.344 1.024 0 CA-C-N 115.711 -0.677 . . . . 63.5 113.395 179.955 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 19.9 mtp180 -111.2 117.5 33.39 Favored 'General case' 0 N--CA 1.471 0.611 0 N-CA-C 108.456 -0.942 . . . . 75.129999999999995 108.456 -175.925 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 86.2 t -113.37 138.48 42.82 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.733 0 C-N-CA 123.78 0.832 . . . . 73.450000000000003 110.12 -175.263 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 16.4 m -124.94 135.22 52.62 Favored 'General case' 0 C--O 1.242 0.67 0 C-N-CA 123.661 0.785 . . . . 75.450000000000003 110.114 174.901 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 22' ' ' PHE . . . . . 0.431 ' HB2' ' HB ' ' A' ' 6' ' ' VAL . 60.5 m-85 -105.78 170.0 8.15 Favored 'General case' 0 N--CA 1.474 0.765 0 C-N-CA 124.145 0.978 . . . . 64.230000000000004 109.912 179.079 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . 0.631 ' HB2' ' HD2' ' A' ' 133' ' ' LYS . 33.0 tt0 -130.76 108.89 10.2 Favored 'General case' 0 N--CA 1.473 0.692 0 C-N-CA 123.689 0.796 . . . . 74.349999999999994 109.233 177.948 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . 0.51 ' HB2' ' HG2' ' A' ' 4' ' ' PRO . 88.5 mt -78.54 121.0 24.04 Favored 'General case' 0 N--CA 1.469 0.481 0 C-N-CA 123.377 0.671 . . . . 75.340000000000003 109.961 179.149 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 25' ' ' PHE . . . . . 0.596 ' HA ' ' ND2' ' A' ' 3' ' ' ASN . 77.7 m-85 -83.85 68.25 9.88 Favored 'General case' 0 C--O 1.233 0.206 0 CA-C-O 121.65 0.738 . . . . 62.109999999999999 109.465 171.904 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -66.21 -21.92 66.32 Favored 'General case' 0 N--CA 1.473 0.704 0 CA-C-N 114.708 -1.133 . . . . 44.149999999999999 111.128 179.032 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 10.7 p-10 -72.71 -23.61 60.88 Favored 'General case' 0 CA--C 1.543 0.701 0 C-N-CA 124.029 0.932 . . . . 63.329999999999998 111.478 178.292 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 59.5 mttp -104.6 -51.29 3.11 Favored 'General case' 0 N--CA 1.482 1.169 0 C-N-CA 123.613 0.765 . . . . 64.329999999999998 110.965 -176.536 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 29' ' ' VAL . . . . . 0.564 ' HA ' ' HG2' ' A' ' 86' ' ' GLU . 5.4 m -124.33 72.92 58.55 Favored Pre-proline 0 CA--C 1.55 0.95 0 C-N-CA 124.099 0.96 . . . . 72.329999999999998 110.185 -178.195 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 20.7 Cg_endo -60.7 -29.64 88.76 Favored 'Trans proline' 0 C--N 1.38 2.222 0 C-N-CA 122.671 2.247 . . . . 52.509999999999998 113.107 -177.072 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 21.9 ttmm -65.33 -54.12 33.73 Favored 'General case' 0 N--CA 1.481 1.111 0 CA-C-O 121.715 0.769 . . . . 62.439999999999998 111.556 -179.428 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 20.5 m -80.16 -32.17 38.87 Favored 'General case' 0 CA--C 1.547 0.842 0 CA-C-N 114.723 -1.126 . . . . 75.420000000000002 111.138 -170.244 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 33' ' ' ALA . . . . . 0.472 ' HB1' ' HB3' ' A' ' 24' ' ' LEU . . . -70.1 -40.82 74.7 Favored 'General case' 0 N--CA 1.473 0.692 0 C-N-CA 122.787 0.435 . . . . 73.299999999999997 110.222 174.609 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 9.3 tp10 -62.77 -40.75 98.24 Favored 'General case' 0 N--CA 1.488 1.467 0 O-C-N 123.668 0.605 . . . . 61.240000000000002 110.752 176.54 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 35' ' ' ASN . . . . . 0.484 ' O ' ' HG ' ' A' ' 39' ' ' LEU . 40.0 t30 -53.57 -62.91 1.35 Allowed 'General case' 0 C--N 1.349 0.577 0 O-C-N 124.293 0.996 . . . . 75.400000000000006 110.433 178.643 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 65.6 t80 -65.53 -33.96 77.13 Favored 'General case' 0 N--CA 1.474 0.743 0 CA-C-N 115.338 -0.846 . . . . 72.519999999999996 111.805 -176.167 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 37' ' ' ARG . . . . . 0.556 ' HG3' HE22 ' A' ' 163' ' ' GLN . 32.7 ttt180 -55.21 -49.67 71.34 Favored 'General case' 0 N--CA 1.485 1.293 0 C-N-CA 124.262 1.025 . . . . 62.43 110.728 173.655 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 38' ' ' ALA . . . . . 0.457 ' HB3' HG21 ' A' ' 78' ' ' ILE . . . -76.92 -25.94 53.52 Favored 'General case' 0 CA--C 1.544 0.741 0 CA-C-N 114.314 -1.312 . . . . 61.140000000000001 112.07 -174.921 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 39' ' ' LEU . . . . . 0.484 ' HG ' ' O ' ' A' ' 35' ' ' ASN . 95.4 mt -73.39 -40.26 64.45 Favored 'General case' 0 N--CA 1.479 1.022 0 C-N-CA 123.536 0.734 . . . . 65.400000000000006 110.2 173.297 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 40.3 t -65.42 -54.74 24.29 Favored 'General case' 0 N--CA 1.479 0.984 0 CA-C-N 114.42 -1.264 . . . . 71.209999999999994 110.592 -176.144 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 82.6 p -73.3 -32.09 64.42 Favored 'General case' 0 N--CA 1.472 0.637 0 CA-C-O 121.29 0.567 . . . . 70.099999999999994 109.737 177.253 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . 0.446 ' HA3' ' HA2' ' A' ' 47' ' ' GLY . . . 75.39 8.22 83.5 Favored Glycine 0 C--N 1.347 1.186 0 CA-C-N 115.221 -0.899 . . . . 64.209999999999994 114.886 171.832 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 47.8 mm-40 -69.07 -4.59 17.69 Favored 'General case' 0 N--CA 1.482 1.146 0 C-N-CA 123.804 0.842 . . . . 64.129999999999995 113.046 -178.018 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 44' ' ' LYS . . . . . 0.451 ' HG3' ' HB1' ' A' ' 38' ' ' ALA . 32.3 mmmt -94.0 13.44 22.89 Favored 'General case' 0 CA--C 1.55 0.976 0 C-N-CA 123.565 0.746 . . . . 72.140000000000001 111.462 172.356 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 92.52 22.99 27.5 Favored Glycine 0 C--N 1.357 1.709 0 N-CA-C 114.559 0.584 . . . . 32.5 114.559 173.231 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 25.9 m-85 -114.88 -46.71 2.91 Favored 'General case' 0 N--CA 1.487 1.42 0 CA-C-N 117.507 0.654 . . . . 70.420000000000002 111.279 -172.069 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . 0.446 ' HA2' ' HA3' ' A' ' 42' ' ' GLY . . . 53.84 63.68 4.91 Favored Glycine 0 C--N 1.346 1.109 0 O-C-N 124.096 0.873 . . . . 14.42 114.64 173.084 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 50.7 m-85 -71.71 84.81 0.9 Allowed 'General case' 0 N--CA 1.485 1.282 0 CA-C-O 122.119 0.962 . . . . 74.319999999999993 111.167 177.387 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 49' ' ' LYS . . . . . 0.558 ' HE3' ' HA ' ' A' ' 160' ' ' ASP . 22.2 tptm -116.3 138.56 51.22 Favored 'General case' 0 CA--C 1.538 0.51 0 CA-C-N 113.601 -1.636 . . . . 62.140000000000001 107.603 171.851 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 69.45 19.99 74.99 Favored Glycine 0 N--CA 1.478 1.477 0 CA-C-N 118.069 0.395 . . . . 70.040000000000006 114.001 177.161 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 25.1 m -70.21 119.34 14.26 Favored 'General case' 0 N--CA 1.471 0.603 0 C-N-CA 123.614 0.765 . . . . 62.420000000000002 110.137 -176.436 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 52' ' ' CYS . . . . . . . . . . . . . 21.2 p -90.93 157.54 17.25 Favored 'General case' 0 N--CA 1.474 0.767 0 CA-C-O 121.714 0.769 . . . . 61.149999999999999 111.876 -171.518 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 29.1 m-85 -96.25 164.94 12.45 Favored 'General case' 0 C--O 1.24 0.605 0 C-N-CA 124.998 1.319 . . . . 73.450000000000003 108.741 175.515 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 19.5 p-80 -149.36 -43.09 0.14 Allowed 'General case' 0 N--CA 1.477 0.897 0 N-CA-C 110.451 -0.203 . . . . 74.439999999999998 110.451 -171.222 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 55' ' ' ARG . . . . . 0.464 ' HA ' ' O ' ' A' ' 150' ' ' GLY . 42.2 ttt-85 -121.06 98.81 6.16 Favored 'General case' 0 C--N 1.347 0.49 0 N-CA-C 109.089 -0.708 . . . . 74.230000000000004 109.089 -174.578 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 57.0 mt -127.39 127.19 68.75 Favored 'Isoleucine or valine' 0 C--O 1.239 0.527 0 N-CA-C 107.778 -1.193 . . . . 74.25 107.778 176.966 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 68.4 mt -122.44 116.41 29.52 Favored Pre-proline 0 CA--C 1.55 0.967 0 N-CA-C 108.278 -1.008 . . . . 64.129999999999995 108.278 -177.386 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 31.0 Cg_exo -62.46 136.23 57.91 Favored 'Trans proline' 0 C--N 1.379 2.145 0 C-N-CA 123.313 2.675 . . . . 73.25 112.351 -179.346 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 78.86 22.72 65.66 Favored Glycine 0 C--N 1.344 1.019 0 O-C-N 123.78 0.675 . . . . 65.109999999999999 112.767 -176.202 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 60' ' ' PHE . . . . . 0.435 ' HB2' HE22 ' B' ' 223' ' ' GLN . 55.3 t80 -148.01 -69.26 0.23 Allowed 'General case' 0 CA--C 1.55 0.958 0 C-N-CA 123.476 0.71 . . . . 43.439999999999998 111.054 -175.058 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 61' ' ' MET . . . . . 0.433 ' SD ' ' HB2' ' A' ' 113' ' ' PHE . 40.5 ttm -175.97 158.16 1.99 Allowed 'General case' 0 N--CA 1.49 1.542 0 N-CA-C 113.245 0.832 . . . . 72.049999999999997 113.245 -159.582 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 62' ' ' CYS . . . . . 0.458 ' SG ' ' HB ' ' A' ' 114' ' ' ILE . 24.9 p -122.94 113.75 19.51 Favored 'General case' 0 CA--C 1.549 0.94 0 C-N-CA 124.197 0.999 . . . . 72.140000000000001 109.647 168.579 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 57.8 tt0 -112.72 127.48 56.15 Favored 'General case' 0 N--CA 1.489 1.485 0 C-N-CA 124.125 0.97 . . . . 75.140000000000001 110.37 -176.145 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -151.47 -157.47 7.9 Favored Glycine 0 C--N 1.348 1.214 0 CA-C-N 115.698 -0.683 . . . . 43.109999999999999 113.715 -177.476 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 86.27 -8.13 75.48 Favored Glycine 0 C--N 1.35 1.35 0 N-CA-C 112.04 -0.424 . . . . 53.219999999999999 112.04 -167.722 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 38.9 t70 -75.66 86.98 2.72 Favored 'General case' 0 C--N 1.354 0.775 0 C-N-CA 124.638 1.175 . . . . 52.229999999999997 109.925 -174.221 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 91.2 t80 -144.42 -55.09 0.34 Allowed 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 114.547 -1.206 . . . . 72.450000000000003 108.697 -176.667 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 5.7 t -84.81 122.75 29.59 Favored 'General case' 0 C--O 1.246 0.873 0 C-N-CA 123.146 0.578 . . . . 72.239999999999995 109.998 178.804 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 86.0 mtt180 53.85 51.75 14.26 Favored 'General case' 0 N--CA 1.48 1.041 0 C-N-CA 124.369 1.068 . . . . 73.010000000000005 109.851 -179.251 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 20.8 p80 -78.4 66.75 4.03 Favored 'General case' 0 CA--C 1.555 1.164 0 CA-C-O 122.32 1.057 . . . . 65.120000000000005 112.046 -168.841 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 8.3 t30 -155.08 79.46 1.05 Allowed 'General case' 0 C--O 1.24 0.596 0 N-CA-C 107.289 -1.375 . . . . 72.239999999999995 107.289 -177.213 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 72' ' ' GLY . . . . . 0.568 ' HA2' ' HG3' ' B' ' 218' ' ' PRO . . . 79.65 -6.96 56.75 Favored Glycine 0 CA--C 1.533 1.163 0 CA-C-N 115.039 -0.982 . . . . 45.219999999999999 113.838 -179.006 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 7.3 m -115.51 -78.77 0.58 Allowed 'General case' 0 CA--C 1.546 0.804 0 N-CA-C 108.132 -1.062 . . . . 71.219999999999999 108.132 -179.822 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 54.67 60.61 8.37 Favored Glycine 0 C--N 1.359 1.851 0 N-CA-C 114.59 0.596 . . . . 51.340000000000003 114.59 172.199 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 119.95 52.5 0.27 Allowed Glycine 0 N--CA 1.476 1.307 0 CA-C-N 117.716 0.758 . . . . 54.119999999999997 111.289 -175.452 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 17.4 pttp -63.08 169.61 3.3 Favored 'General case' 0 CA--C 1.547 0.828 0 C-N-CA 124.186 0.995 . . . . 73.129999999999995 112.393 -174.768 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 76.1 p -93.16 179.23 5.49 Favored 'General case' 0 C--O 1.246 0.887 0 CA-C-O 121.525 0.679 . . . . 74.209999999999994 112.254 -171.134 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 78' ' ' ILE . . . . . 0.457 HG21 ' HB3' ' A' ' 38' ' ' ALA . 34.1 pt -75.23 -20.1 16.21 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.784 0 CA-C-N 115.294 -0.867 . . . . 74.310000000000002 110.187 168.735 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 82.7 m-85 -87.93 18.49 4.14 Favored 'General case' 0 CA--C 1.547 0.832 0 C-N-CA 124.57 1.148 . . . . 64.25 110.433 177.006 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 99.02 -120.79 6.98 Favored Glycine 0 C--N 1.354 1.565 0 N-CA-C 111.071 -0.812 . . . . 74.209999999999994 111.071 -179.842 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 36.8 tt0 -71.98 -59.42 2.75 Favored 'General case' 0 N--CA 1.47 0.544 0 C-N-CA 123.265 0.626 . . . . 72.409999999999997 110.057 178.057 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 82' ' ' LYS . . . . . 0.825 ' HD2' ' HA ' ' A' ' 107' ' ' THR . 21.4 pttp -155.62 175.98 13.2 Favored 'General case' 0 CA--C 1.544 0.741 0 CA-C-N 115.372 -0.831 . . . . 73.200000000000003 110.821 -172.41 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 12.1 p90 -159.15 173.72 15.97 Favored 'General case' 0 CA--C 1.538 0.507 0 C-N-CA 124.918 1.287 . . . . 74.400000000000006 110.035 -175.063 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 84' ' ' GLU . . . . . 0.511 ' HA ' ' HA ' ' A' ' 106' ' ' ASN . 7.4 pt-20 -83.84 169.85 14.71 Favored 'General case' 0 N--CA 1.475 0.803 0 C-N-CA 123.527 0.731 . . . . 72.049999999999997 111.753 -179.864 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 41.1 m-20 -74.9 143.55 43.74 Favored 'General case' 0 N--CA 1.472 0.641 0 C-N-CA 123.739 0.816 . . . . 54.43 109.677 -179.845 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 86' ' ' GLU . . . . . 0.564 ' HG2' ' HA ' ' A' ' 29' ' ' VAL . 7.9 tp10 -66.13 -59.53 3.68 Favored 'General case' 0 N--CA 1.472 0.654 0 CA-C-O 121.769 0.795 . . . . 60.509999999999998 110.107 176.202 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 32.4 p30 -163.32 -159.83 0.56 Allowed 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 113.974 -1.466 . . . . 62.25 107.909 -179.935 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 96.2 m-85 -138.35 42.74 2.19 Favored 'General case' 0 N--CA 1.482 1.158 0 C-N-CA 122.981 0.512 . . . . 70.430000000000007 110.307 179.45 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 61.9 mt -67.59 -48.43 76.69 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.488 0 CA-C-O 121.214 0.53 . . . . 75.409999999999997 110.062 175.998 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 90' ' ' LEU . . . . . 0.561 ' HB3' ' HB ' ' A' ' 128' ' ' VAL . 82.6 mt -88.99 153.08 21.31 Favored 'General case' 0 C--O 1.241 0.632 0 CA-C-N 115.556 -0.747 . . . . 63.350000000000001 110.653 179.035 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 21.1 ptmt -150.43 168.49 24.0 Favored 'General case' 0 N--CA 1.472 0.637 0 CA-C-N 115.529 -0.76 . . . . 73.310000000000002 110.62 -179.59 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 92' ' ' HIS . . . . . . . . . . . . . 27.2 m80 -87.31 68.36 9.78 Favored 'General case' 0 CA--C 1.546 0.802 0 C-N-CA 124.035 0.934 . . . . 75.540000000000006 109.454 -172.855 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 8.8 t -114.34 7.13 16.31 Favored 'General case' 0 N--CA 1.477 0.918 0 CA-C-N 114.972 -1.013 . . . . 73.450000000000003 111.338 -172.611 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -150.2 173.75 29.79 Favored Glycine 0 C--N 1.347 1.153 0 CA-C-O 119.993 -0.337 . . . . 52.130000000000003 113.137 -176.2 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 98.2 Cg_endo -85.15 155.96 11.14 Favored 'Trans proline' 0 C--N 1.368 1.579 0 C-N-CA 123.103 2.535 . . . . 63.140000000000001 112.379 174.066 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 76.18 19.09 78.87 Favored Glycine 0 N--CA 1.476 1.301 0 CA-C-N 116.481 -0.327 . . . . 63.229999999999997 113.581 178.613 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 97' ' ' ILE . . . . . 0.555 ' HB ' ' HB2' ' A' ' 115' ' ' CYS . 13.3 mm -76.34 105.45 5.26 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.907 0 C-N-CA 123.833 0.853 . . . . 74.310000000000002 111.42 -174.872 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 60.8 tp -90.62 119.42 30.85 Favored 'General case' 0 CA--C 1.549 0.941 0 C-N-CA 123.084 0.554 . . . . 74.430000000000007 110.002 176.694 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 47.2 t -143.91 148.9 36.05 Favored 'General case' 0 CA--C 1.545 0.778 0 C-N-CA 124.388 1.075 . . . . 74.219999999999999 108.576 179.126 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 100' ' ' MET . . . . . 0.451 ' HA ' ' HA ' ' A' ' 112' ' ' PHE . 57.0 mtp -82.84 147.24 28.45 Favored 'General case' 0 N--CA 1.488 1.432 0 CA-C-N 118.201 0.455 . . . . 72.310000000000002 110.535 179.819 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -76.41 145.55 39.28 Favored 'General case' 0 C--O 1.243 0.743 0 C-N-CA 122.888 0.475 . . . . 75.129999999999995 112.169 -172.248 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 20.4 p-10 -153.89 149.22 27.1 Favored 'General case' 0 C--O 1.241 0.616 0 C-N-CA 124.292 1.037 . . . . 71.409999999999997 108.7 177.894 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -87.37 -34.41 18.81 Favored 'General case' 0 N--CA 1.474 0.732 0 N-CA-C 109.477 -0.564 . . . . 74.340000000000003 109.477 169.895 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -158.71 -166.72 18.34 Favored Glycine 0 C--N 1.342 0.909 0 CA-C-N 115.387 -0.824 . . . . 24.239999999999998 111.292 174.236 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 33.7 Cg_exo -60.78 151.28 78.05 Favored 'Trans proline' 0 C--N 1.369 1.637 0 C-N-CA 122.797 2.331 . . . . 62.399999999999999 111.847 178.357 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 106' ' ' ASN . . . . . 0.511 ' HA ' ' HA ' ' A' ' 84' ' ' GLU . 65.0 t30 65.83 16.96 10.7 Favored 'General case' 0 CA--C 1.561 1.38 0 C-N-CA 124.758 1.223 . . . . 72.200000000000003 111.343 178.78 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 107' ' ' THR . . . . . 0.825 ' HA ' ' HD2' ' A' ' 82' ' ' LYS . 5.1 m -118.89 7.19 11.46 Favored 'General case' 0 N--CA 1.485 1.286 0 C-N-CA 123.968 0.907 . . . . 70.540000000000006 110.387 179.839 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 11.1 t30 -70.71 145.77 50.31 Favored 'General case' 0 C--O 1.213 -0.851 0 C-N-CA 124.696 1.198 . . . . 70.310000000000002 110.232 177.615 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 101.29 23.36 9.68 Favored Glycine 0 N--CA 1.472 1.089 0 C-N-CA 121.66 -0.305 . . . . 72.099999999999994 113.805 177.295 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 22.8 p -132.67 120.4 21.67 Favored 'General case' 0 N--CA 1.468 0.454 0 N-CA-C 107.881 -1.155 . . . . 34.109999999999999 107.881 174.249 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 111' ' ' GLN . . . . . 0.49 HE22 ' HG2' ' B' ' 218' ' ' PRO . 16.0 mt-30 62.71 161.77 0.09 Allowed 'General case' 0 N--CA 1.492 1.632 0 C-N-CA 124.114 0.966 . . . . 74.219999999999999 111.74 -171.778 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 112' ' ' PHE . . . . . 0.451 ' HA ' ' HA ' ' A' ' 100' ' ' MET . 49.1 p90 -133.72 143.14 48.31 Favored 'General case' 0 N--CA 1.472 0.645 0 N-CA-C 108.201 -1.037 . . . . 75.109999999999999 108.201 169.054 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 113' ' ' PHE . . . . . 0.433 ' HB2' ' SD ' ' A' ' 61' ' ' MET . 50.5 p90 -129.58 148.13 51.45 Favored 'General case' 0 C--O 1.236 0.391 0 C-N-CA 123.515 0.726 . . . . 64.530000000000001 110.091 179.574 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 114' ' ' ILE . . . . . 0.458 ' HB ' ' SG ' ' A' ' 62' ' ' CYS . 21.5 mt -112.63 104.61 17.31 Favored 'Isoleucine or valine' 0 C--O 1.241 0.61 0 N-CA-C 108.486 -0.931 . . . . 55.409999999999997 108.486 175.239 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 115' ' ' CYS . . . . . 0.555 ' HB2' ' HB ' ' A' ' 97' ' ' ILE . 28.9 m -64.69 104.52 0.83 Allowed 'General case' 0 CA--C 1.542 0.656 0 N-CA-C 108.406 -0.961 . . . . 74.230000000000004 108.406 170.256 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 116' ' ' THR . . . . . 0.523 HG22 HG12 ' A' ' 139' ' ' VAL . 62.5 p -70.16 -31.78 69.43 Favored 'General case' 0 N--CA 1.472 0.632 0 C-N-CA 123.216 0.606 . . . . 71.010000000000005 110.296 -179.522 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -115.62 170.99 8.02 Favored 'General case' 0 C--O 1.243 0.745 0 C-N-CA 124.012 0.925 . . . . 74.230000000000004 109.72 175.292 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 19.3 ptmt -72.01 92.09 1.27 Allowed 'General case' 0 CA--C 1.554 1.11 0 CA-C-O 121.804 0.811 . . . . 65.129999999999995 110.019 175.253 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 119' ' ' THR . . . . . 0.574 ' HB ' HD13 ' A' ' 122' ' ' LEU . 46.7 p -85.64 83.63 7.83 Favored 'General case' 0 CA--C 1.546 0.817 0 CA-C-O 121.813 0.816 . . . . 73.450000000000003 109.182 179.766 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 10.2 pt-20 -75.91 -30.13 58.65 Favored 'General case' 0 N--CA 1.482 1.148 0 CA-C-N 115.524 -0.762 . . . . 75.219999999999999 112.38 -167.086 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 121' ' ' TRP . . . . . . . . . . . . . 39.0 p90 -69.19 -4.78 18.96 Favored 'General case' 0 CA--C 1.553 1.07 0 C-N-CA 123.713 0.805 . . . . 74.510000000000005 111.624 178.03 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 122' ' ' LEU . . . . . 0.574 HD13 ' HB ' ' A' ' 119' ' ' THR . 10.8 mp -87.27 2.39 50.29 Favored 'General case' 0 N--CA 1.482 1.169 0 C-N-CA 124.055 0.942 . . . . 43.450000000000003 112.485 174.695 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 78.4 m-20 -78.01 124.54 28.15 Favored 'General case' 0 N--CA 1.477 0.907 0 CA-C-N 118.427 0.558 . . . . 72.010000000000005 109.668 177.716 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 112.09 -11.11 26.93 Favored Glycine 0 C--N 1.351 1.369 0 CA-C-N 115.497 -0.774 . . . . 63.340000000000003 111.621 -165.027 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 28.7 mtpp -90.83 -165.09 1.28 Allowed 'General case' 0 N--CA 1.486 1.341 0 C-N-CA 124.19 0.996 . . . . 74.430000000000007 109.665 169.728 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 126' ' ' HIS . . . . . . . . . . . . . 22.8 t60 -66.34 136.22 55.48 Favored 'General case' 0 CA--C 1.549 0.912 0 CA-C-O 121.35 0.595 . . . . 62.409999999999997 111.1 -178.815 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 7.1 p -59.15 147.97 7.43 Favored 'Isoleucine or valine' 0 CA--C 1.551 1.011 0 CA-C-N 113.976 -1.465 . . . . 54.049999999999997 111.726 178.03 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 128' ' ' VAL . . . . . 0.561 ' HB ' ' HB3' ' A' ' 90' ' ' LEU . 24.9 t -68.28 157.78 6.16 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.967 0 C-N-CA 123.482 0.713 . . . . 42.109999999999999 109.664 175.841 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 129' ' ' PHE . . . . . . . . . . . . . 49.1 p90 -138.9 -24.17 0.91 Allowed 'General case' 0 N--CA 1.478 0.971 0 C-N-CA 122.039 0.136 . . . . 74.219999999999999 111.127 174.189 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . -130.11 161.78 23.07 Favored Glycine 0 C--N 1.346 1.095 0 N-CA-C 112.242 -0.343 . . . . 31.100000000000001 112.242 -174.563 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 131' ' ' LYS . . . . . 0.432 ' HE2' ' HB3' ' A' ' 131' ' ' LYS . 31.2 ttpt -146.6 128.49 15.41 Favored 'General case' 0 N--CA 1.466 0.356 0 C-N-CA 123.689 0.796 . . . . 74.530000000000001 108.991 179.758 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 34.0 t -70.55 101.12 0.78 Allowed 'Isoleucine or valine' 0 CA--C 1.542 0.653 0 N-CA-C 109.282 -0.636 . . . . 63.039999999999999 109.282 177.807 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 133' ' ' LYS . . . . . 0.631 ' HD2' ' HB2' ' A' ' 23' ' ' GLU . 18.6 ptmt -87.81 -36.77 17.07 Favored 'General case' 0 N--CA 1.474 0.725 0 CA-C-N 115.615 -0.72 . . . . 74.230000000000004 109.781 -179.669 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 134' ' ' GLU . . . . . 0.524 ' HG2' ' HG3' ' A' ' 133' ' ' LYS . 30.8 mm-40 -124.23 144.93 49.67 Favored 'General case' 0 N--CA 1.472 0.648 0 C-N-CA 124.226 1.011 . . . . 75.230000000000004 108.8 176.706 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 78.47 21.45 69.58 Favored Glycine 0 N--CA 1.467 0.722 0 CA-C-O 119.582 -0.566 . . . . 53.340000000000003 113.375 175.037 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 136' ' ' MET . . . . . . . . . . . . . 16.3 tpt -62.34 -38.1 88.18 Favored 'General case' 0 N--CA 1.481 1.102 0 C-N-CA 123.042 0.537 . . . . 75.540000000000006 111.081 174.887 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 137' ' ' ASN . . . . . . . . . . . . . 16.3 m120 -64.29 -29.8 70.88 Favored 'General case' 0 CA--C 1.545 0.786 0 C-N-CA 122.937 0.495 . . . . 70.319999999999993 110.897 176.229 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 138' ' ' ILE . . . . . . . . . . . . . 46.8 mm -73.86 -36.1 44.73 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.039 0 C-N-CA 123.156 0.583 . . . . 73.209999999999994 110.153 175.797 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 139' ' ' VAL . . . . . 0.523 HG12 HG22 ' A' ' 116' ' ' THR . 91.8 t -65.91 -40.31 87.1 Favored 'Isoleucine or valine' 0 CA--C 1.555 1.149 0 C-N-CA 123.361 0.665 . . . . 73.129999999999995 110.674 178.112 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 44.1 mt-10 -74.03 -29.08 61.74 Favored 'General case' 0 N--CA 1.477 0.917 0 CA-C-N 115.64 -0.709 . . . . 75.150000000000006 110.622 177.209 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -70.86 -43.36 68.63 Favored 'General case' 0 N--CA 1.478 0.938 0 C-N-CA 122.902 0.481 . . . . 64.230000000000004 111.15 176.064 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 142' ' ' MET . . . . . 0.581 ' HB2' HD13 ' A' ' 156' ' ' ILE . 25.2 ptm -72.92 -28.05 62.22 Favored 'General case' 0 N--CA 1.477 0.878 0 C-N-CA 123.074 0.55 . . . . 72.510000000000005 111.315 -178.132 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 34.0 tt0 -59.98 -32.55 70.94 Favored 'General case' 0 C--N 1.357 0.897 0 O-C-N 123.597 0.561 . . . . 72.420000000000002 111.937 178.352 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 144' ' ' ARG . . . . . . . . . . . . . 38.6 mtm-85 -67.45 -18.79 65.22 Favored 'General case' 0 N--CA 1.477 0.882 0 C-N-CA 123.038 0.535 . . . . 73.230000000000004 111.986 -178.363 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 145' ' ' PHE . . . . . 0.522 ' HB2' HD11 ' A' ' 156' ' ' ILE . 45.2 m-85 -83.01 -5.57 59.15 Favored 'General case' 0 N--CA 1.477 0.896 0 C-N-CA 122.871 0.469 . . . . 74.340000000000003 111.412 177.185 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . -87.23 175.15 46.04 Favored Glycine 0 C--N 1.347 1.188 0 O-C-N 123.444 0.465 . . . . 61.219999999999999 112.12 172.436 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 29.7 m -134.75 169.49 17.27 Favored 'General case' 0 N--CA 1.483 1.209 0 C-N-CA 123.392 0.677 . . . . 73.200000000000003 111.59 -174.445 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 148' ' ' ARG . . . . . . . . . . . . . 8.7 mmm180 -57.59 -41.26 80.82 Favored 'General case' 0 N--CA 1.487 1.383 0 C-N-CA 124.81 1.244 . . . . 73.010000000000005 113.065 179.927 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 149' ' ' ASN . . . . . . . . . . . . . 30.5 p-10 -75.24 -17.69 60.27 Favored 'General case' 0 N--CA 1.478 0.945 0 C-N-CA 122.958 0.503 . . . . 73.030000000000001 111.238 178.191 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 150' ' ' GLY . . . . . 0.464 ' O ' ' HA ' ' A' ' 55' ' ' ARG . . . 111.65 -10.2 28.0 Favored Glycine 0 C--N 1.348 1.222 0 O-C-N 123.706 0.629 . . . . 64.450000000000003 112.378 -179.554 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 25.1 ttmm -65.55 137.64 57.52 Favored 'General case' 0 N--CA 1.471 0.624 0 C-N-CA 122.875 0.47 . . . . 74.409999999999997 111.177 -175.765 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 152' ' ' THR . . . . . . . . . . . . . 41.1 p -90.42 109.76 20.88 Favored 'General case' 0 C--O 1.239 0.516 0 N-CA-C 108.198 -1.038 . . . . 63.450000000000003 108.198 174.493 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 153' ' ' SER . . . . . . . . . . . . . 19.3 m -62.56 -29.36 70.52 Favored 'General case' 0 CA--C 1.544 0.75 0 C-N-CA 124.039 0.936 . . . . 71.329999999999998 110.804 176.172 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 154' ' ' LYS . . . . . 0.541 ' HB3' HG13 ' A' ' 12' ' ' VAL . 48.1 mmtm -118.63 133.92 55.5 Favored 'General case' 0 CA--C 1.54 0.561 0 CA-C-N 114.609 -1.178 . . . . 64.329999999999998 108.832 175.281 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 16.9 tppt? -78.99 91.68 4.87 Favored 'General case' 0 N--CA 1.473 0.689 0 N-CA-C 109.627 -0.509 . . . . 71.129999999999995 109.627 -178.272 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 156' ' ' ILE . . . . . 0.581 HD13 ' HB2' ' A' ' 142' ' ' MET . 70.5 mt -84.92 117.14 29.66 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.357 0 N-CA-C 109.835 -0.431 . . . . 74.329999999999998 109.835 -175.242 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 157' ' ' THR . . . . . . . . . . . . . 54.8 p -115.91 156.34 26.36 Favored 'General case' 0 N--CA 1.473 0.707 0 C-N-CA 124.232 1.013 . . . . 55.350000000000001 110.015 -179.126 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 158' ' ' ILE . . . . . . . . . . . . . 63.7 mt -80.6 96.0 2.68 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.819 0 N-CA-C 108.283 -1.006 . . . . 73.420000000000002 108.283 169.786 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 159' ' ' ALA . . . . . 0.655 ' HB2' ' HB2' ' A' ' 11' ' ' ALA . . . -55.55 -53.14 60.09 Favored 'General case' 0 N--CA 1.478 0.939 0 C-N-CA 124.331 1.053 . . . . 62.420000000000002 111.784 -178.177 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 160' ' ' ASP . . . . . 0.558 ' HA ' ' HE3' ' A' ' 49' ' ' LYS . 0.9 OUTLIER -140.17 175.21 9.78 Favored 'General case' 0 N--CA 1.473 0.724 0 CA-C-N 115.798 -0.637 . . . . 71.510000000000005 110.405 -176.509 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 161' ' ' CYS . . . . . . . . . . . . . 63.2 m -146.23 -169.82 3.35 Favored 'General case' 0 CA--C 1.547 0.852 0 C-N-CA 125.147 1.379 . . . . 55.100000000000001 108.4 -172.674 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 162' ' ' GLY . . . . . . . . . . . . . . . 131.71 53.26 0.09 OUTLIER Glycine 0 C--N 1.348 1.216 0 N-CA-C 112.151 -0.38 . . . . 64.430000000000007 112.151 -177.836 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 163' ' ' GLN . . . . . 0.706 ' HG3' ' HA ' ' A' ' 6' ' ' VAL . 43.4 tt0 -46.21 110.53 0.28 Allowed 'General case' 0 N--CA 1.48 1.032 0 C-N-CA 125.035 1.334 . . . . 75.319999999999993 112.392 -177.349 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 164' ' ' LEU . . . . . 0.445 ' O ' ' HB ' ' A' ' 5' ' ' THR . 45.3 mt -79.62 94.7 5.72 Favored 'General case' 0 CA--C 1.543 0.704 0 N-CA-C 108.63 -0.878 . . . . 71.25 108.63 -179.357 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 165' ' ' GLU . . . . . . . . . . . . . 41.6 mt-10 . . . . . 0 C--O 1.25 1.096 0 CA-C-O 118.862 -0.589 . . . . 74.239999999999995 110.553 -173.114 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' B' B ' 216' ' ' PRO . . . . . . . . . . . . . 5.5 Cg_endo . . . . . 0 CA--C 1.545 1.054 0 N-CA-C 110.421 -0.646 . . . . 72.120000000000005 110.421 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' B' B ' 217' ' ' GLU . . . . . . . . . . . . . 42.9 mt-10 -90.65 162.69 32.94 Favored Pre-proline 0 N--CA 1.481 1.1 0 C-N-CA 123.853 0.861 . . . . 63.119999999999997 110.585 -177.045 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 218' ' ' PRO . . . . . 0.568 ' HG3' ' HA2' ' A' ' 72' ' ' GLY . 45.7 Cg_endo -66.23 93.58 0.29 Allowed 'Trans proline' 0 C--N 1.383 2.368 0 C-N-CA 122.448 2.099 . . . . 72.409999999999997 109.973 173.344 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 219' ' ' GLY . . . . . . . . . . . . . . . 147.16 -161.42 28.47 Favored Glycine 0 CA--C 1.527 0.791 0 CA-C-N 114.71 -1.132 . . . . 71.030000000000001 111.492 -171.489 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 220' ' ' PRO . . . . . . . . . . . . . 64.0 Cg_endo -91.03 168.87 3.56 Favored 'Trans proline' 0 C--N 1.363 1.298 0 C-N-CA 123.412 2.742 . . . . 63.399999999999999 114.677 -176.644 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 221' ' ' TYR . . . . . . . . . . . . . 88.0 t80 -99.56 155.95 17.31 Favored 'General case' 0 N--CA 1.484 1.248 0 C-N-CA 123.538 0.735 . . . . 74.409999999999997 109.184 169.921 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 222' ' ' ALA . . . . . 0.401 ' HB2' ' CE2' ' A' ' 60' ' ' PHE . . . -147.7 139.55 24.07 Favored 'General case' 0 N--CA 1.476 0.828 0 C-N-CA 123.925 0.89 . . . . 54.109999999999999 112.294 -173.519 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 223' ' ' GLN . . . . . 0.435 HE22 ' HB2' ' A' ' 60' ' ' PHE . 2.0 mp0 67.61 153.85 0.13 Allowed Pre-proline 0 CA--C 1.561 1.383 0 O-C-N 125.135 1.522 . . . . 73.549999999999997 113.393 163.087 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 224' ' ' PRO . . . . . . . . . . . . . 55.4 Cg_endo . . . . . 0 C--N 1.381 2.259 0 C-N-CA 122.165 1.91 . . . . 73.340000000000003 111.319 172.374 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 64.1 mtt . . . . . 0 N--CA 1.475 0.784 0 N-CA-C 109.179 -0.675 . . . . 74.439999999999998 109.179 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 14.8 p -116.1 -10.97 12.05 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.267 0 C-N-CA 124.517 1.127 . . . . 62.149999999999999 110.237 -179.764 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 15.3 m120 -71.52 114.93 32.31 Favored Pre-proline 0 CA--C 1.549 0.911 0 C-N-CA 124.51 1.124 . . . . 73.540000000000006 111.429 -176.022 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 4' ' ' PRO . . . . . 0.589 ' HG2' ' HB2' ' A' ' 24' ' ' LEU . 29.7 Cg_endo -65.06 123.42 11.55 Favored 'Trans proline' 0 C--N 1.379 2.18 0 C-N-CA 122.356 2.037 . . . . 65.510000000000005 110.298 170.694 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 5' ' ' THR . . . . . 0.62 HG23 ' HD3' ' A' ' 133' ' ' LYS . 99.3 m -96.48 119.39 34.89 Favored 'General case' 0 C--N 1.328 -0.351 0 N-CA-C 108.743 -0.836 . . . . 70.310000000000002 108.743 -174.811 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 32.1 m -102.77 123.66 56.28 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.646 0 N-CA-C 109.772 -0.455 . . . . 73.310000000000002 109.772 -177.694 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 7' ' ' PHE . . . . . 0.589 ' H ' ' HA ' ' A' ' 163' ' ' GLN . 76.7 t80 -109.89 130.16 55.56 Favored 'General case' 0 N--CA 1.47 0.543 0 C-N-CA 123.307 0.643 . . . . 73.129999999999995 109.849 -174.398 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 8' ' ' PHE . . . . . 0.456 ' HB3' HG23 ' A' ' 158' ' ' ILE . 36.9 m-85 -135.31 165.64 24.98 Favored 'General case' 0 N--CA 1.472 0.649 0 C-N-CA 124.604 1.162 . . . . 71.209999999999994 109.449 173.485 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 18.5 m-20 -120.15 115.08 22.94 Favored 'General case' 0 N--CA 1.467 0.423 0 C-N-CA 124.456 1.102 . . . . 71.0 108.544 171.532 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 10' ' ' ILE . . . . . 0.531 HG21 ' SD ' ' A' ' 142' ' ' MET . 44.3 mm -83.85 132.45 31.47 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.562 0 C-N-CA 123.611 0.764 . . . . 64.109999999999999 108.98 178.98 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 11' ' ' ALA . . . . . 0.408 ' O ' ' HA ' ' A' ' 156' ' ' ILE . . . -139.72 135.49 33.2 Favored 'General case' 0 N--CA 1.465 0.299 0 C-N-CA 122.561 0.345 . . . . 73.219999999999999 111.799 -171.984 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 14.6 m -96.03 113.77 31.2 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.682 0 C-N-CA 124.703 1.201 . . . . 61.229999999999997 109.487 179.752 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 54.8 m-20 63.35 20.43 12.26 Favored 'General case' 0 N--CA 1.489 1.521 0 C-N-CA 125.039 1.336 . . . . 71.349999999999994 110.987 -170.262 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 89.44 -6.4 83.29 Favored Glycine 0 C--N 1.348 1.244 0 CA-C-N 116.225 -0.443 . . . . 61.210000000000001 113.258 -174.774 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 27.2 mm-40 -86.51 125.99 65.7 Favored Pre-proline 0 CA--C 1.548 0.871 0 C-N-CA 123.39 0.676 . . . . 74.140000000000001 110.305 179.356 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 18.0 Cg_endo -52.64 101.85 0.06 OUTLIER 'Trans proline' 0 C--N 1.386 2.536 0 C-N-CA 124.168 3.245 . . . . 74.109999999999999 113.996 -170.475 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 53.1 tp -79.19 -35.87 41.14 Favored 'General case' 0 N--CA 1.479 1.003 0 N-CA-C 109.261 -0.644 . . . . 52.399999999999999 109.261 175.454 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 166.21 -173.82 41.73 Favored Glycine 0 C--N 1.337 0.614 0 CA-C-N 115.153 -0.93 . . . . 61.43 111.563 176.817 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 47.7 ptt85 -110.59 141.75 43.36 Favored 'General case' 0 C--O 1.239 0.51 0 C-N-CA 123.983 0.913 . . . . 75.540000000000006 109.255 177.51 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 93.7 t -134.88 121.2 33.32 Favored 'Isoleucine or valine' 0 C--O 1.239 0.504 0 C-N-CA 123.633 0.773 . . . . 52.219999999999999 109.253 175.202 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 21' ' ' SER . . . . . 0.478 ' HB3' ' HB2' ' A' ' 134' ' ' GLU . 22.8 t -115.1 136.99 52.52 Favored 'General case' 0 CA--C 1.539 0.548 0 N-CA-C 108.48 -0.933 . . . . 72.450000000000003 108.48 174.516 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 41.8 m-85 -109.69 169.14 8.9 Favored 'General case' 0 N--CA 1.472 0.668 0 C-N-CA 123.675 0.79 . . . . 61.219999999999999 110.235 177.684 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . 0.624 ' HB2' ' HD2' ' A' ' 133' ' ' LYS . 37.4 tt0 -122.22 103.7 8.95 Favored 'General case' 0 CA--C 1.538 0.503 0 C-N-CA 125.581 1.552 . . . . 75.010000000000005 107.938 -176.953 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . 0.589 ' HB2' ' HG2' ' A' ' 4' ' ' PRO . 18.4 mt -82.99 124.51 30.47 Favored 'General case' 0 N--CA 1.474 0.761 0 N-CA-C 109.454 -0.572 . . . . 61.32 109.454 -179.279 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 68.2 m-85 -86.6 69.37 10.35 Favored 'General case' 0 CA--C 1.534 0.357 0 C-N-CA 123.324 0.65 . . . . 74.0 109.38 179.292 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -64.65 -20.09 66.09 Favored 'General case' 0 N--CA 1.484 1.225 0 C-N-CA 123.553 0.741 . . . . 53.340000000000003 111.727 179.763 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 12.0 p-10 -74.67 -23.18 58.6 Favored 'General case' 0 CA--C 1.545 0.754 0 C-N-CA 124.308 1.043 . . . . 72.310000000000002 112.163 177.708 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 58.7 mttp -105.91 -41.54 5.38 Favored 'General case' 0 N--CA 1.486 1.328 0 C-N-CA 123.757 0.823 . . . . 62.149999999999999 111.245 -179.056 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 29' ' ' VAL . . . . . 0.585 HG12 ' HG2' ' A' ' 86' ' ' GLU . 10.7 m -138.26 74.25 42.3 Favored Pre-proline 0 CA--C 1.56 1.33 0 C-N-CA 124.445 1.098 . . . . 74.019999999999996 109.873 -172.552 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 59.2 Cg_endo -67.51 -37.97 15.76 Favored 'Trans proline' 0 C--N 1.377 2.067 0 C-N-CA 122.961 2.441 . . . . 73.040000000000006 113.383 -171.47 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 48.1 tttp -73.86 -42.09 61.3 Favored 'General case' 0 N--CA 1.478 0.95 0 C-N-CA 123.669 0.788 . . . . 73.219999999999999 110.907 -173.507 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 11.3 m -73.21 -36.98 66.59 Favored 'General case' 0 CA--C 1.547 0.832 0 CA-C-N 115.728 -0.669 . . . . 65.349999999999994 110.406 -177.707 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -67.11 -41.68 85.82 Favored 'General case' 0 CA--C 1.55 0.948 0 C-N-CA 123.053 0.541 . . . . 75.109999999999999 110.684 173.71 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 38.5 tt0 -59.92 -42.19 93.37 Favored 'General case' 0 N--CA 1.483 1.22 0 C-N-CA 124.655 1.182 . . . . 72.430000000000007 111.462 -179.428 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 35' ' ' ASN . . . . . 0.469 ' O ' ' HG ' ' A' ' 39' ' ' LEU . 47.7 t30 -56.92 -68.02 0.26 Allowed 'General case' 0 C--N 1.358 0.961 0 O-C-N 124.322 1.014 . . . . 64.239999999999995 110.266 -177.196 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 90.6 t80 -57.62 -40.7 79.74 Favored 'General case' 0 N--CA 1.474 0.734 0 O-C-N 124.315 1.009 . . . . 73.340000000000003 111.683 -175.683 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 71.5 ttt180 -58.3 -54.88 42.0 Favored 'General case' 0 C--N 1.354 0.802 0 O-C-N 123.719 0.637 . . . . 70.239999999999995 110.456 178.564 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 38' ' ' ALA . . . . . 0.448 ' HB3' HG21 ' A' ' 78' ' ' ILE . . . -64.76 -30.09 71.09 Favored 'General case' 0 N--CA 1.475 0.815 0 C-N-CA 123.616 0.766 . . . . 34.439999999999998 111.656 -175.099 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 39' ' ' LEU . . . . . 0.588 ' HB3' ' HD2' ' A' ' 48' ' ' TYR . 89.8 mt -63.11 -46.0 89.37 Favored 'General case' 0 N--CA 1.471 0.613 0 C-N-CA 123.545 0.738 . . . . 74.140000000000001 110.29 173.604 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 50.7 m -74.35 -39.1 63.01 Favored 'General case' 0 CA--C 1.547 0.843 0 C-N-CA 123.494 0.717 . . . . 72.140000000000001 112.018 -173.275 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -75.8 -30.81 59.2 Favored 'General case' 0 N--CA 1.482 1.15 0 C-N-CA 122.582 0.353 . . . . 62.210000000000001 110.581 178.195 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 84.87 32.45 21.19 Favored Glycine 0 C--N 1.347 1.152 0 CA-C-N 115.98 -0.555 . . . . 70.340000000000003 111.795 -174.432 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 5.2 mm-40 -63.65 -25.34 68.17 Favored 'General case' 0 N--CA 1.481 1.108 0 C-N-CA 123.565 0.746 . . . . 72.140000000000001 110.519 175.042 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 44' ' ' LYS . . . . . 0.458 ' HG3' ' HB ' ' A' ' 78' ' ' ILE . 29.2 mmmt -110.75 19.08 18.97 Favored 'General case' 0 CA--C 1.547 0.842 0 C-N-CA 124.2 1.0 . . . . 53.520000000000003 110.922 -178.999 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 78.88 -0.23 78.94 Favored Glycine 0 C--N 1.355 1.6 0 N-CA-C 115.05 0.78 . . . . 61.240000000000002 115.05 174.616 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 20.2 m-85 -85.62 -47.84 9.46 Favored 'General case' 0 N--CA 1.48 1.041 0 CA-C-N 117.785 0.793 . . . . 53.240000000000002 111.074 -174.181 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 49.66 62.64 4.7 Favored Glycine 0 C--N 1.355 1.619 0 O-C-N 124.358 1.036 . . . . 74.120000000000005 113.83 174.937 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 48' ' ' TYR . . . . . 0.588 ' HD2' ' HB3' ' A' ' 39' ' ' LEU . 35.5 m-85 -65.56 90.42 0.11 Allowed 'General case' 0 N--CA 1.474 0.759 0 CA-C-O 122.109 0.957 . . . . 73.409999999999997 111.773 -176.309 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 49' ' ' LYS . . . . . 0.595 ' HE3' ' HA ' ' A' ' 160' ' ' ASP . 24.1 tptm -109.88 131.25 55.23 Favored 'General case' 0 C--O 1.238 0.486 0 CA-C-N 113.686 -1.597 . . . . 64.209999999999994 108.53 179.939 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 79.95 20.36 68.05 Favored Glycine 0 C--N 1.346 1.137 0 CA-C-O 119.85 -0.417 . . . . 60.109999999999999 113.203 -179.464 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 39.0 t -60.69 126.75 28.57 Favored 'General case' 0 N--CA 1.479 1.021 0 C-N-CA 123.907 0.883 . . . . 72.140000000000001 110.243 179.39 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 52' ' ' CYS . . . . . . . . . . . . . 26.8 p -97.92 120.52 38.45 Favored 'General case' 0 N--CA 1.475 0.783 0 O-C-N 123.618 0.574 . . . . 74.439999999999998 111.933 -168.517 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 53' ' ' PHE . . . . . 0.749 ' HA ' ' HA2' ' A' ' 64' ' ' GLY . 82.3 m-85 -67.55 92.72 0.32 Allowed 'General case' 0 CA--C 1.536 0.442 0 C-N-CA 123.759 0.824 . . . . 61.100000000000001 108.884 166.894 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 26.2 p-80 -101.09 -9.81 21.04 Favored 'General case' 0 N--CA 1.475 0.795 0 CA-C-N 114.922 -1.035 . . . . 63.049999999999997 111.881 -172.215 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 37.8 ttt180 -132.28 98.99 4.55 Favored 'General case' 0 N--CA 1.472 0.628 0 N-CA-C 108.952 -0.759 . . . . 71.030000000000001 108.952 177.712 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 53.7 mt -128.12 130.95 69.75 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.82 0 N-CA-C 109.367 -0.605 . . . . 73.340000000000003 109.367 176.167 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 59.5 mt -125.12 124.85 25.33 Favored Pre-proline 0 CA--C 1.558 1.268 0 C-N-CA 124.172 0.989 . . . . 71.310000000000002 108.851 175.132 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 24.3 Cg_endo -60.37 151.13 76.55 Favored 'Trans proline' 0 C--N 1.385 2.499 0 C-N-CA 123.6 2.867 . . . . 73.329999999999998 113.795 -177.541 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 61.44 16.03 48.31 Favored Glycine 0 C--N 1.348 1.24 0 CA-C-N 114.963 -1.017 . . . . 62.439999999999998 114.086 179.715 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 36.3 t80 -137.28 -73.6 0.42 Allowed 'General case' 0 C--O 1.239 0.55 0 C-N-CA 123.274 0.63 . . . . 71.400000000000006 110.297 -171.735 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 51.4 ttp -171.05 138.43 1.28 Allowed 'General case' 0 N--CA 1.475 0.822 0 O-C-N 123.095 0.247 . . . . 54.229999999999997 111.567 -164.018 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 62' ' ' CYS . . . . . 0.563 ' SG ' ' HB ' ' A' ' 114' ' ' ILE . 21.9 p -108.03 110.85 22.65 Favored 'General case' 0 CA--C 1.548 0.881 0 C-N-CA 123.577 0.751 . . . . 71.450000000000003 109.266 168.017 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 63' ' ' GLN . . . . . 0.464 ' HA ' ' HA ' ' A' ' 113' ' ' PHE . 52.0 tt0 -102.71 118.59 37.16 Favored 'General case' 0 N--CA 1.48 1.067 0 C-N-CA 124.353 1.061 . . . . 64.319999999999993 110.464 -175.172 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 64' ' ' GLY . . . . . 0.749 ' HA2' ' HA ' ' A' ' 53' ' ' PHE . . . -95.81 165.49 24.49 Favored Glycine 0 C--N 1.342 0.884 0 CA-C-N 115.262 -0.881 . . . . 43.25 112.842 177.292 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . 0.419 ' HA3' ' HG2' ' A' ' 111' ' ' GLN . . . 177.19 133.04 1.76 Allowed Glycine 0 C--N 1.337 0.591 0 N-CA-C 111.922 -0.471 . . . . 44.329999999999998 111.922 179.286 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 22.6 t70 -75.78 170.3 16.47 Favored 'General case' 0 CA--C 1.551 0.993 0 C-N-CA 123.437 0.695 . . . . 74.109999999999999 110.867 -176.137 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 74.2 t80 -69.8 -25.78 63.95 Favored 'General case' 0 CA--C 1.553 1.071 0 C-N-CA 123.435 0.694 . . . . 71.310000000000002 111.285 176.547 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 63.4 m -63.37 109.48 1.61 Allowed 'General case' 0 N--CA 1.478 0.947 0 C-N-CA 123.415 0.686 . . . . 74.310000000000002 110.782 179.519 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 58.4 mtt180 59.63 34.52 22.27 Favored 'General case' 0 N--CA 1.479 0.997 0 C-N-CA 125.068 1.347 . . . . 73.140000000000001 111.435 -176.597 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 36.8 p-80 -55.42 -20.31 11.85 Favored 'General case' 0 N--CA 1.497 1.918 0 C-N-CA 123.558 0.743 . . . . 72.340000000000003 112.886 -172.43 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 5.1 t30 -66.08 87.28 0.1 Allowed 'General case' 0 CA--C 1.554 1.109 0 C-N-CA 124.257 1.023 . . . . 75.340000000000003 109.827 167.956 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 76.41 -7.2 32.8 Favored Glycine 0 CA--C 1.535 1.321 0 N-CA-C 115.805 1.082 . . . . 34.25 115.805 172.097 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 73' ' ' THR . . . . . 0.6 ' HA ' ' HB2' ' A' ' 110' ' ' SER . 79.2 m -118.09 -65.84 1.14 Allowed 'General case' 0 N--CA 1.479 0.997 0 CA-C-N 118.598 1.199 . . . . 73.439999999999998 110.843 -178.861 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 49.76 54.42 17.78 Favored Glycine 0 C--N 1.356 1.655 0 O-C-N 123.838 0.711 . . . . 31.43 114.379 172.967 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 127.07 55.37 0.14 Allowed Glycine 0 N--CA 1.469 0.895 0 C-N-CA 120.964 -0.636 . . . . 71.409999999999997 111.778 -172.449 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 76' ' ' LYS . . . . . 0.557 ' HG2' ' OH ' ' A' ' 48' ' ' TYR . 14.8 ptmm? -52.4 164.38 0.33 Allowed 'General case' 0 N--CA 1.49 1.54 0 C-N-CA 124.117 0.967 . . . . 74.430000000000007 111.915 178.584 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 94.9 p -88.95 175.38 7.45 Favored 'General case' 0 C--O 1.247 0.938 0 CA-C-O 121.214 0.53 . . . . 53.009999999999998 110.441 -171.981 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 78' ' ' ILE . . . . . 0.458 ' HB ' ' HG3' ' A' ' 44' ' ' LYS . 38.6 pt -74.64 -24.82 18.65 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.654 0 CA-C-N 115.344 -0.843 . . . . 60.420000000000002 110.757 179.726 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 51.0 m-85 -86.93 -43.34 12.47 Favored 'General case' 0 N--CA 1.476 0.865 0 C-N-CA 123.713 0.805 . . . . 71.439999999999998 110.337 -178.866 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -165.69 -134.79 1.73 Allowed Glycine 0 C--N 1.339 0.745 0 N-CA-C 110.539 -1.024 . . . . 74.150000000000006 110.539 -179.098 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 81' ' ' GLU . . . . . 0.529 ' HA ' ' HB2' ' A' ' 76' ' ' LYS . 36.6 tt0 -75.38 -36.8 60.86 Favored 'General case' 0 N--CA 1.477 0.879 0 CA-C-N 117.498 0.649 . . . . 64.329999999999998 109.734 175.293 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 82' ' ' LYS . . . . . 0.749 ' HD2' ' HA ' ' A' ' 107' ' ' THR . 19.7 pttp -159.62 166.58 30.37 Favored 'General case' 0 CA--C 1.544 0.732 0 C-N-CA 124.343 1.057 . . . . 62.119999999999997 109.309 -170.189 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 11.8 p90 -143.92 174.31 10.95 Favored 'General case' 0 N--CA 1.473 0.723 0 C-N-CA 124.064 0.945 . . . . 73.540000000000006 109.111 179.112 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 84' ' ' GLU . . . . . 0.414 ' HA ' ' HA ' ' A' ' 106' ' ' ASN . 11.7 pt-20 -79.19 -175.71 4.77 Favored 'General case' 0 CA--C 1.545 0.775 0 C-N-CA 123.519 0.728 . . . . 74.329999999999998 112.083 -178.521 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 30.5 m-20 -85.35 149.51 25.39 Favored 'General case' 0 N--CA 1.475 0.809 0 C-N-CA 123.428 0.691 . . . . 62.130000000000003 109.93 -176.672 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 86' ' ' GLU . . . . . 0.585 ' HG2' HG12 ' A' ' 29' ' ' VAL . 3.2 tp10 -77.53 -61.74 1.89 Allowed 'General case' 0 N--CA 1.478 0.957 0 C-N-CA 123.263 0.625 . . . . 54.439999999999998 110.54 175.594 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 29.9 p30 -173.57 -156.82 0.08 Allowed 'General case' 0 N--CA 1.475 0.806 0 C-N-CA 125.192 1.397 . . . . 74.219999999999999 107.413 -172.826 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 82.2 m-85 -142.04 39.18 1.62 Allowed 'General case' 0 N--CA 1.494 1.729 0 C-N-CA 123.245 0.618 . . . . 65.530000000000001 110.824 176.952 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 70.5 mt -65.01 -62.94 1.0 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.483 0 CA-C-O 121.312 0.577 . . . . 64.030000000000001 110.423 178.602 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 90' ' ' LEU . . . . . 0.409 ' H ' HG23 ' A' ' 127' ' ' VAL . 87.4 mt -86.9 135.82 33.18 Favored 'General case' 0 N--CA 1.47 0.547 0 C-N-CA 124.304 1.042 . . . . 74.400000000000006 110.643 -176.402 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 54.3 mtmt -118.89 160.02 22.71 Favored 'General case' 0 N--CA 1.473 0.723 0 C-N-CA 123.88 0.872 . . . . 71.140000000000001 111.072 -177.871 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 92' ' ' HIS . . . . . 0.534 ' HA ' HG21 ' A' ' 97' ' ' ILE . 13.6 m80 -83.25 21.14 1.16 Allowed 'General case' 0 N--CA 1.481 1.099 0 C-N-CA 124.777 1.231 . . . . 70.219999999999999 111.664 -174.436 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 11.4 t -86.74 31.32 0.69 Allowed 'General case' 0 CA--C 1.56 1.345 0 C-N-CA 124.259 1.024 . . . . 64.430000000000007 111.237 -170.562 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -151.14 162.38 29.44 Favored Glycine 0 C--N 1.348 1.208 0 N-CA-C 111.705 -0.558 . . . . 33.109999999999999 111.705 176.404 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 73.3 Cg_endo -75.96 145.53 28.37 Favored 'Trans proline' 0 C--N 1.369 1.615 0 C-N-CA 122.689 2.259 . . . . 71.329999999999998 112.292 173.757 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 96' ' ' GLY . . . . . 0.523 ' HA3' HG12 ' A' ' 132' ' ' VAL . . . 79.76 17.85 74.26 Favored Glycine 0 C--N 1.345 1.058 0 CA-C-N 116.078 -0.51 . . . . 53.310000000000002 114.334 177.475 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 97' ' ' ILE . . . . . 0.534 HG21 ' HA ' ' A' ' 92' ' ' HIS . 8.3 mm -71.41 124.25 27.43 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.893 0 C-N-CA 124.236 1.014 . . . . 63.210000000000001 110.757 178.963 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 63.2 tp -108.56 115.34 29.92 Favored 'General case' 0 N--CA 1.484 1.273 0 C-N-CA 123.53 0.732 . . . . 62.420000000000002 110.355 179.059 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 18.5 m -133.78 144.5 49.08 Favored 'General case' 0 N--CA 1.48 1.06 0 C-N-CA 124.632 1.173 . . . . 73.129999999999995 108.641 174.123 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 100' ' ' MET . . . . . 0.647 ' HA ' ' HA ' ' A' ' 112' ' ' PHE . 72.6 mtp -78.7 137.22 37.69 Favored 'General case' 0 N--CA 1.488 1.471 0 CA-C-N 118.412 0.551 . . . . 73.219999999999999 110.008 178.786 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 101' ' ' ALA . . . . . 0.477 ' HB3' ' HB2' ' A' ' 111' ' ' GLN . . . -72.32 168.78 17.64 Favored 'General case' 0 N--CA 1.481 1.088 0 C-N-CA 123.109 0.564 . . . . 55.149999999999999 111.981 -170.803 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 102' ' ' ASN . . . . . 0.57 ' HB3' ' HA ' ' A' ' 108' ' ' ASN . 29.4 p-10 -168.04 179.16 4.74 Favored 'General case' 0 CA--C 1.542 0.655 0 CA-C-N 115.646 -0.707 . . . . 62.229999999999997 111.278 -177.597 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -117.08 -5.41 11.4 Favored 'General case' 0 N--CA 1.479 0.999 0 C-N-CA 124.188 0.995 . . . . 70.439999999999998 110.726 169.165 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 163.7 -171.36 39.32 Favored Glycine 0 C--N 1.358 1.782 0 CA-C-O 119.507 -0.607 . . . . 75.340000000000003 112.901 179.695 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 52.7 Cg_exo -57.9 143.25 96.23 Favored 'Trans proline' 0 C--N 1.378 2.12 0 C-N-CA 123.419 2.746 . . . . 73.310000000000002 112.041 172.791 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 106' ' ' ASN . . . . . 0.414 ' HA ' ' HA ' ' A' ' 84' ' ' GLU . 65.6 t30 66.07 12.82 8.75 Favored 'General case' 0 N--CA 1.488 1.467 0 C-N-CA 124.135 0.974 . . . . 73.329999999999998 111.243 -178.617 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 107' ' ' THR . . . . . 0.749 ' HA ' ' HD2' ' A' ' 82' ' ' LYS . 6.4 m -123.72 1.48 8.8 Favored 'General case' 0 CA--C 1.556 1.188 0 C-N-CA 124.128 0.971 . . . . 63.409999999999997 110.017 179.665 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 108' ' ' ASN . . . . . 0.57 ' HA ' ' HB3' ' A' ' 102' ' ' ASN . 40.0 t30 -70.88 143.77 50.9 Favored 'General case' 0 N--CA 1.479 1.024 0 C-N-CA 124.26 1.024 . . . . 73.219999999999999 110.604 -178.626 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 94.93 20.66 27.79 Favored Glycine 0 N--CA 1.47 0.957 0 N-CA-C 113.847 0.299 . . . . 64.030000000000001 113.847 177.983 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 110' ' ' SER . . . . . 0.6 ' HB2' ' HA ' ' A' ' 73' ' ' THR . 27.5 p -112.42 118.37 34.99 Favored 'General case' 0 CA--C 1.54 0.591 0 N-CA-C 107.525 -1.287 . . . . 41.049999999999997 107.525 169.758 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 111' ' ' GLN . . . . . 0.524 ' HG3' ' O ' ' A' ' 73' ' ' THR . 38.3 mt-30 65.35 -177.94 0.18 Allowed 'General case' 0 N--CA 1.495 1.812 0 C-N-CA 124.183 0.993 . . . . 62.340000000000003 110.672 -168.284 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 112' ' ' PHE . . . . . 0.647 ' HA ' ' HA ' ' A' ' 100' ' ' MET . 30.0 p90 -147.99 158.58 44.13 Favored 'General case' 0 N--CA 1.472 0.667 0 C-N-CA 124.105 0.962 . . . . 73.310000000000002 108.805 175.685 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 113' ' ' PHE . . . . . 0.464 ' HA ' ' HA ' ' A' ' 63' ' ' GLN . 53.1 p90 -146.82 145.22 29.82 Favored 'General case' 0 C--O 1.235 0.326 0 CA-C-O 121.057 0.456 . . . . 74.25 110.701 -179.581 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 114' ' ' ILE . . . . . 0.563 ' HB ' ' SG ' ' A' ' 62' ' ' CYS . 10.7 mt -115.51 102.26 13.49 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.456 0 N-CA-C 107.066 -1.457 . . . . 73.239999999999995 107.066 177.512 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 115' ' ' CYS . . . . . 0.493 ' HB2' ' HB ' ' A' ' 97' ' ' ILE . 50.5 m -60.85 103.38 0.26 Allowed 'General case' 0 C--N 1.348 0.518 0 N-CA-C 108.432 -0.951 . . . . 62.219999999999999 108.432 172.044 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 116' ' ' THR . . . . . 0.545 HG22 HG12 ' A' ' 139' ' ' VAL . 34.6 p -71.51 -32.7 68.5 Favored 'General case' 0 N--CA 1.47 0.568 0 C-N-CA 123.833 0.853 . . . . 74.299999999999997 110.183 -175.195 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -115.35 169.16 9.35 Favored 'General case' 0 N--CA 1.472 0.663 0 C-N-CA 123.99 0.916 . . . . 74.239999999999995 109.857 172.39 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 15.0 ptmt -66.76 115.85 7.01 Favored 'General case' 0 CA--C 1.549 0.926 0 CA-C-O 121.269 0.557 . . . . 72.200000000000003 110.074 176.029 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 119' ' ' THR . . . . . 0.559 ' HB ' HD13 ' A' ' 122' ' ' LEU . 43.7 p -115.76 87.86 2.76 Favored 'General case' 0 CA--C 1.546 0.798 0 CA-C-O 121.712 0.767 . . . . 74.219999999999999 110.363 -178.76 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 11.9 pt-20 -80.22 -19.99 45.67 Favored 'General case' 0 N--CA 1.481 1.082 0 CA-C-N 115.744 -0.662 . . . . 73.129999999999995 111.278 -176.462 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 121' ' ' TRP . . . . . . . . . . . . . 33.5 p90 -77.64 -7.34 56.28 Favored 'General case' 0 N--CA 1.477 0.919 0 C-N-CA 122.999 0.52 . . . . 71.519999999999996 110.569 173.479 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 122' ' ' LEU . . . . . 0.559 HD13 ' HB ' ' A' ' 119' ' ' THR . 9.9 mp -88.86 -7.88 55.31 Favored 'General case' 0 N--CA 1.481 1.076 0 C-N-CA 123.638 0.775 . . . . 72.5 110.698 169.708 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 44.3 m-20 -79.06 150.77 31.77 Favored 'General case' 0 N--CA 1.478 0.969 0 N-CA-C 108.751 -0.833 . . . . 54.43 108.751 173.128 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 97.03 -28.31 14.43 Favored Glycine 0 CA--C 1.526 0.722 0 N-CA-C 110.48 -1.048 . . . . 65.430000000000007 110.48 -165.045 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 2.3 mppt? -85.37 -174.07 5.01 Favored 'General case' 0 N--CA 1.478 0.938 0 C-N-CA 124.139 0.976 . . . . 75.129999999999995 109.453 170.711 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 126' ' ' HIS . . . . . . . . . . . . . 49.9 p-80 -68.92 154.12 42.6 Favored 'General case' 0 N--CA 1.475 0.824 0 C-N-CA 123.756 0.822 . . . . 73.420000000000002 111.374 -166.204 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 127' ' ' VAL . . . . . 0.409 HG23 ' H ' ' A' ' 90' ' ' LEU . 13.6 p -60.56 149.44 7.6 Favored 'Isoleucine or valine' 0 CA--C 1.552 1.035 0 C-N-CA 125.363 1.465 . . . . 71.239999999999995 113.569 -176.915 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 128' ' ' VAL . . . . . 0.41 HG11 HD12 ' A' ' 97' ' ' ILE . 46.5 t -76.94 153.64 5.62 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.82 0 C-N-CA 124.805 1.242 . . . . 74.150000000000006 109.688 171.661 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 129' ' ' PHE . . . . . 0.544 ' HA ' HG21 ' A' ' 29' ' ' VAL . 26.4 p90 -129.66 -19.73 3.32 Favored 'General case' 0 N--CA 1.482 1.173 0 CA-C-N 117.914 0.325 . . . . 75.219999999999999 111.572 178.256 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . -134.12 162.73 24.55 Favored Glycine 0 C--N 1.339 0.747 0 N-CA-C 112.297 -0.321 . . . . 73.450000000000003 112.297 -176.234 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 131' ' ' LYS . . . . . 0.42 ' HE2' ' HB3' ' A' ' 131' ' ' LYS . 29.4 ttpt -150.14 134.34 17.13 Favored 'General case' 0 N--CA 1.472 0.626 0 N-CA-C 107.757 -1.201 . . . . 62.210000000000001 107.757 177.123 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 132' ' ' VAL . . . . . 0.523 HG12 ' HA3' ' A' ' 96' ' ' GLY . 12.1 p -64.7 131.23 30.44 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.876 0 CA-C-O 121.117 0.484 . . . . 72.299999999999997 109.81 178.105 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 133' ' ' LYS . . . . . 0.624 ' HD2' ' HB2' ' A' ' 23' ' ' GLU . 0.1 OUTLIER -118.52 -24.19 6.88 Favored 'General case' 0 N--CA 1.473 0.725 0 C-N-CA 123.736 0.814 . . . . 74.140000000000001 110.046 179.185 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 134' ' ' GLU . . . . . 0.478 ' HB2' ' HB3' ' A' ' 21' ' ' SER . 20.8 mm-40 -133.79 129.42 36.56 Favored 'General case' 0 N--CA 1.472 0.673 0 C-N-CA 124.224 1.01 . . . . 72.310000000000002 109.224 177.677 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 79.51 36.2 27.11 Favored Glycine 0 C--N 1.345 1.06 0 O-C-N 123.634 0.584 . . . . 43.039999999999999 113.945 174.676 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 136' ' ' MET . . . . . . . . . . . . . 5.3 tpt -57.23 -43.6 83.04 Favored 'General case' 0 N--CA 1.491 1.607 0 C-N-CA 123.669 0.787 . . . . 61.439999999999998 110.085 172.164 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 137' ' ' ASN . . . . . . . . . . . . . 2.8 t-20 -61.4 -35.08 76.52 Favored 'General case' 0 CA--C 1.548 0.886 0 C-N-CA 124.058 0.943 . . . . 73.099999999999994 111.476 177.427 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 138' ' ' ILE . . . . . . . . . . . . . 45.5 mm -69.48 -37.61 75.28 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.999 0 C-N-CA 122.835 0.454 . . . . 72.209999999999994 110.349 177.839 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 139' ' ' VAL . . . . . 0.545 HG12 HG22 ' A' ' 116' ' ' THR . 85.8 t -64.3 -37.01 78.82 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.3 0 C-N-CA 123.475 0.71 . . . . 75.5 110.471 174.738 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 44.9 mt-10 -78.6 -19.01 53.7 Favored 'General case' 0 CA--C 1.543 0.683 0 CA-C-N 115.595 -0.73 . . . . 62.200000000000003 111.345 178.016 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -78.86 -48.57 14.44 Favored 'General case' 0 N--CA 1.475 0.784 0 C-N-CA 122.987 0.515 . . . . 52.240000000000002 110.17 177.069 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 142' ' ' MET . . . . . 0.558 ' HA ' ' HD2' ' A' ' 145' ' ' PHE . 25.5 ptm -65.5 -31.43 72.49 Favored 'General case' 0 N--CA 1.479 0.977 0 C-N-CA 123.502 0.721 . . . . 71.200000000000003 110.841 177.429 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 23.6 tt0 -48.41 -45.41 36.09 Favored 'General case' 0 N--CA 1.481 1.089 0 C-N-CA 124.997 1.319 . . . . 64.409999999999997 111.426 171.309 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 144' ' ' ARG . . . . . . . . . . . . . 90.7 mtt180 -73.11 -18.78 61.26 Favored 'General case' 0 N--CA 1.474 0.739 0 CA-C-N 114.542 -1.208 . . . . 74.519999999999996 111.845 -174.701 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 145' ' ' PHE . . . . . 0.558 ' HD2' ' HA ' ' A' ' 142' ' ' MET . 54.1 m-85 -80.62 -19.65 44.97 Favored 'General case' 0 N--CA 1.475 0.812 0 N-CA-C 109.929 -0.396 . . . . 72.340000000000003 109.929 174.13 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . -77.01 165.04 53.29 Favored Glycine 0 C--N 1.344 1.016 0 N-CA-C 111.881 -0.488 . . . . 64.439999999999998 111.881 172.586 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 10.1 m -133.08 170.47 15.35 Favored 'General case' 0 N--CA 1.479 1.006 0 C-N-CA 123.255 0.622 . . . . 73.200000000000003 110.384 -173.929 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 148' ' ' ARG . . . . . . . . . . . . . 34.7 mmt180 -64.48 -32.57 74.25 Favored 'General case' 0 N--CA 1.487 1.404 0 C-N-CA 123.612 0.765 . . . . 74.310000000000002 111.809 -179.417 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 149' ' ' ASN . . . . . . . . . . . . . 25.5 p-10 -75.85 -5.09 44.32 Favored 'General case' 0 N--CA 1.481 1.11 0 C-N-CA 123.09 0.556 . . . . 74.319999999999993 111.476 177.781 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . 97.13 -19.52 54.44 Favored Glycine 0 C--N 1.35 1.348 0 C-N-CA 123.115 0.388 . . . . 74.329999999999998 113.28 176.507 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 61.0 tttm -78.1 146.93 34.9 Favored 'General case' 0 N--CA 1.474 0.749 0 CA-C-N 117.169 0.485 . . . . 63.109999999999999 110.476 -176.481 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 152' ' ' THR . . . . . . . . . . . . . 77.7 p -92.91 162.99 13.86 Favored 'General case' 0 CA--C 1.549 0.907 0 C-N-CA 123.972 0.909 . . . . 52.43 110.447 177.734 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 153' ' ' SER . . . . . . . . . . . . . 37.8 m -96.64 -27.34 14.85 Favored 'General case' 0 N--CA 1.477 0.907 0 C-N-CA 124.231 1.012 . . . . 74.439999999999998 109.675 178.149 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 74.9 mmtt -115.12 148.05 39.45 Favored 'General case' 0 C--O 1.239 0.541 0 C-N-CA 124.592 1.157 . . . . 71.219999999999999 108.974 176.276 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 44.7 mtmt -78.13 88.79 4.23 Favored 'General case' 0 N--CA 1.472 0.658 0 N-CA-C 107.828 -1.175 . . . . 73.420000000000002 107.828 171.673 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 156' ' ' ILE . . . . . 0.503 HD13 ' HB2' ' A' ' 142' ' ' MET . 65.8 mt -86.97 107.82 17.38 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.32 0 CA-C-N 115.805 -0.634 . . . . 71.25 109.459 -171.412 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 157' ' ' THR . . . . . . . . . . . . . 34.9 p -121.59 156.87 31.99 Favored 'General case' 0 C--O 1.243 0.722 0 C-N-CA 124.514 1.126 . . . . 72.040000000000006 110.587 -174.55 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 158' ' ' ILE . . . . . 0.456 HG23 ' HB3' ' A' ' 8' ' ' PHE . 58.6 mt -78.72 93.37 1.54 Allowed 'Isoleucine or valine' 0 CA--C 1.547 0.858 0 N-CA-C 108.766 -0.827 . . . . 54.100000000000001 108.766 171.779 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 159' ' ' ALA . . . . . . . . . . . . . . . -61.46 -39.83 92.31 Favored 'General case' 0 N--CA 1.479 1.009 0 C-N-CA 124.567 1.147 . . . . 71.010000000000005 113.066 -176.289 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 160' ' ' ASP . . . . . 0.595 ' HA ' ' HE3' ' A' ' 49' ' ' LYS . 16.2 t70 -150.67 168.59 23.88 Favored 'General case' 0 CA--C 1.551 0.99 0 O-C-N 123.528 0.517 . . . . 73.109999999999999 110.033 -174.595 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 161' ' ' CYS . . . . . . . . . . . . . 21.8 p -147.04 -170.46 3.55 Favored 'General case' 0 N--CA 1.478 0.953 0 C-N-CA 124.725 1.21 . . . . 60.240000000000002 109.234 -172.067 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 162' ' ' GLY . . . . . . . . . . . . . . . 132.12 52.72 0.09 OUTLIER Glycine 0 N--CA 1.476 1.344 0 O-C-N 122.016 -0.427 . . . . 55.109999999999999 112.097 -174.244 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 163' ' ' GLN . . . . . 0.589 ' HA ' ' H ' ' A' ' 7' ' ' PHE . 44.9 mt-30 -47.63 106.39 0.09 Allowed 'General case' 0 N--CA 1.48 1.039 0 C-N-CA 125.44 1.496 . . . . 70.010000000000005 111.887 -179.737 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 164' ' ' LEU . . . . . . . . . . . . . 74.1 mt -63.61 105.29 0.77 Allowed 'General case' 0 CA--C 1.545 0.752 0 C-N-CA 125.005 1.322 . . . . 72.420000000000002 112.141 -171.393 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 165' ' ' GLU . . . . . . . . . . . . . 33.2 tt0 . . . . . 0 CA--C 1.554 1.114 0 N-CA-C 108.057 -1.09 . . . . 72.5 108.057 170.373 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' B' B ' 216' ' ' PRO . . . . . . . . . . . . . 5.7 Cg_endo . . . . . 0 CA--C 1.543 0.959 0 N-CA-C 110.506 -0.613 . . . . 70.519999999999996 110.506 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' B' B ' 217' ' ' GLU . . . . . . . . . . . . . 28.7 tt0 -123.62 105.3 33.1 Favored Pre-proline 0 N--CA 1.475 0.82 0 C-N-CA 123.734 0.813 . . . . 54.420000000000002 109.714 -178.061 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 218' ' ' PRO . . . . . . . . . . . . . 57.9 Cg_endo -86.09 170.88 8.18 Favored 'Trans proline' 0 C--N 1.369 1.616 0 C-N-CA 122.462 2.108 . . . . 52.399999999999999 111.248 169.457 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 219' ' ' GLY . . . . . . . . . . . . . . . 112.99 166.82 16.77 Favored Glycine 0 CA--C 1.526 0.732 0 CA-C-N 116.051 -0.522 . . . . 73.310000000000002 112.493 -178.79 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 220' ' ' PRO . . . . . . . . . . . . . 8.3 Cg_exo -74.76 154.82 43.98 Favored 'Trans proline' 0 CA--C 1.554 1.517 0 C-N-CA 123.76 2.974 . . . . 22.329999999999998 114.064 -172.605 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 221' ' ' TYR . . . . . . . . . . . . . 95.9 m-85 -89.5 151.05 22.18 Favored 'General case' 0 N--CA 1.483 1.204 0 C-N-CA 124.216 1.007 . . . . 60.25 111.277 -178.395 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 222' ' ' ALA . . . . . . . . . . . . . . . -104.24 -168.04 1.44 Allowed 'General case' 0 N--CA 1.475 0.819 0 C-N-CA 124.417 1.087 . . . . 65.019999999999996 112.805 -169.34 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 223' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -84.29 139.6 39.03 Favored Pre-proline 0 CA--C 1.557 1.233 0 CA-C-N 114.752 -1.113 . . . . 71.530000000000001 108.669 166.919 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 224' ' ' PRO . . . . . . . . . . . . . 60.8 Cg_endo . . . . . 0 C--N 1.378 2.092 0 C-N-CA 122.692 2.261 . . . . 70.120000000000005 111.863 -179.423 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 24.8 mmt . . . . . 0 N--CA 1.478 0.946 0 N-CA-C 109.458 -0.571 . . . . 64.25 109.458 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 14.7 p -77.0 -26.18 15.82 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.942 0 C-N-CA 123.669 0.788 . . . . 61.439999999999998 110.817 179.762 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 3' ' ' ASN . . . . . 0.457 ' ND2' ' HA ' ' A' ' 25' ' ' PHE . 15.9 m120 -66.03 113.32 11.76 Favored Pre-proline 0 CA--C 1.556 1.176 0 C-N-CA 124.097 0.959 . . . . 73.219999999999999 111.346 -178.131 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 56.0 Cg_endo -70.8 123.31 9.64 Favored 'Trans proline' 0 C--N 1.379 2.178 0 C-N-CA 122.576 2.184 . . . . 70.310000000000002 110.652 175.159 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 5' ' ' THR . . . . . 0.476 ' HB ' ' O ' ' A' ' 164' ' ' LEU . 83.0 m -104.15 125.59 50.58 Favored 'General case' 0 CA--C 1.535 0.369 0 N-CA-C 109.703 -0.48 . . . . 55.149999999999999 109.703 -179.807 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . 0.616 ' HA ' ' HB2' ' A' ' 163' ' ' GLN . 6.7 m -100.51 122.94 53.09 Favored 'Isoleucine or valine' 0 C--N 1.347 0.457 0 CA-C-O 122.156 0.979 . . . . 73.310000000000002 109.732 -178.618 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 7' ' ' PHE . . . . . 0.708 ' H ' ' HA ' ' A' ' 163' ' ' GLN . 76.1 t80 -103.43 133.74 47.98 Favored 'General case' 0 C--O 1.243 0.734 0 CA-C-N 114.224 -1.353 . . . . 72.340000000000003 108.99 -174.877 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 8' ' ' PHE . . . . . 0.428 ' HD2' ' HE2' ' A' ' 22' ' ' PHE . 61.4 m-85 -135.23 162.08 33.56 Favored 'General case' 0 C--O 1.238 0.468 0 O-C-N 124.161 0.913 . . . . 74.200000000000003 109.702 172.258 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 24.9 m-20 -108.74 115.99 31.14 Favored 'General case' 0 C--N 1.322 -0.604 0 N-CA-C 106.975 -1.491 . . . . 74.540000000000006 106.975 170.235 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 51.3 mm -85.42 113.16 23.31 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.546 0 N-CA-C 108.707 -0.849 . . . . 63.210000000000001 108.707 178.068 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 11' ' ' ALA . . . . . 0.502 ' HB2' ' HB2' ' A' ' 159' ' ' ALA . . . -116.26 125.24 51.92 Favored 'General case' 0 N--CA 1.477 0.91 0 C-N-CA 122.974 0.51 . . . . 72.450000000000003 110.397 178.858 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 48.7 t -95.34 107.18 19.19 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.626 0 N-CA-C 108.088 -1.079 . . . . 53.329999999999998 108.088 177.449 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 20.3 m-20 61.58 31.19 18.85 Favored 'General case' 0 N--CA 1.489 1.485 0 C-N-CA 124.662 1.185 . . . . 72.310000000000002 112.023 179.409 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 96.79 -19.55 54.28 Favored Glycine 0 C--N 1.344 0.977 0 CA-C-N 115.62 -0.718 . . . . 71.409999999999997 112.905 179.035 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 26.3 mm-40 -83.58 114.57 54.4 Favored Pre-proline 0 CA--C 1.542 0.653 0 N-CA-C 109.227 -0.657 . . . . 75.510000000000005 109.227 -179.928 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 47.2 Cg_endo -65.36 107.77 1.06 Allowed 'Trans proline' 0 C--N 1.376 2.018 0 C-N-CA 122.248 1.965 . . . . 73.129999999999995 111.285 -178.201 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 58.0 tp -75.89 -38.54 57.72 Favored 'General case' 0 C--O 1.241 0.635 0 CA-C-N 115.084 -0.962 . . . . 63.539999999999999 109.774 -177.827 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 173.0 -171.7 44.62 Favored Glycine 0 C--N 1.343 0.92 0 CA-C-N 116.159 -0.473 . . . . 63.399999999999999 113.875 176.52 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 19' ' ' ARG . . . . . 0.458 ' HB3' ' HE1' ' A' ' 7' ' ' PHE . 67.8 mtt85 -115.99 129.27 56.3 Favored 'General case' 0 N--CA 1.472 0.667 0 C-N-CA 124.312 1.045 . . . . 74.400000000000006 109.462 -173.843 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 20' ' ' VAL . . . . . 0.44 HG13 HG13 ' A' ' 132' ' ' VAL . 61.9 t -125.74 133.16 69.75 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.883 0 C-N-CA 123.106 0.563 . . . . 72.030000000000001 109.999 178.696 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 37.9 m -119.93 119.16 32.68 Favored 'General case' 0 CA--C 1.558 1.273 0 C-N-CA 124.389 1.075 . . . . 65.329999999999998 108.973 177.389 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 22' ' ' PHE . . . . . 0.428 ' HE2' ' HD2' ' A' ' 8' ' ' PHE . 52.7 m-85 -101.13 114.95 29.38 Favored 'General case' 0 N--CA 1.477 0.876 0 C-N-CA 124.22 1.008 . . . . 52.420000000000002 110.233 -179.255 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . 0.662 ' HB2' ' HD2' ' A' ' 133' ' ' LYS . 43.2 tt0 -76.06 105.06 6.89 Favored 'General case' 0 CA--C 1.549 0.933 0 C-N-CA 123.859 0.864 . . . . 61.340000000000003 109.799 176.601 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . 0.521 ' HB3' ' HB1' ' A' ' 33' ' ' ALA . 55.5 mt -82.99 128.06 34.12 Favored 'General case' 0 N--CA 1.478 0.954 0 C-N-CA 122.992 0.517 . . . . 72.329999999999998 110.66 -179.697 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 25' ' ' PHE . . . . . 0.457 ' HA ' ' ND2' ' A' ' 3' ' ' ASN . 54.1 m-85 -90.99 61.13 4.54 Favored 'General case' 0 CA--C 1.532 0.265 0 C-N-CA 123.787 0.835 . . . . 73.329999999999998 109.883 -179.295 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -67.9 -13.31 62.05 Favored 'General case' 0 N--CA 1.48 1.04 0 CA-C-N 115.849 -0.614 . . . . 51.450000000000003 112.042 179.371 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 11.2 p-10 -71.85 -31.83 66.88 Favored 'General case' 0 CA--C 1.55 0.944 0 C-N-CA 123.481 0.712 . . . . 74.209999999999994 110.829 173.848 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 58.0 mttp -96.88 -49.54 5.01 Favored 'General case' 0 N--CA 1.485 1.288 0 C-N-CA 123.948 0.899 . . . . 73.450000000000003 111.285 -178.317 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 29' ' ' VAL . . . . . 0.642 ' HB ' ' HB ' ' A' ' 32' ' ' THR . 11.8 m -117.77 76.14 10.53 Favored Pre-proline 0 CA--C 1.562 1.432 0 C-N-CA 124.165 0.986 . . . . 52.350000000000001 110.054 179.117 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 30' ' ' PRO . . . . . 0.449 ' HD2' ' HG2' ' A' ' 86' ' ' GLU . 7.2 Cg_endo -51.24 -59.59 1.1 Allowed 'Trans proline' 0 C--N 1.394 2.968 0 C-N-CA 123.381 2.721 . . . . 70.310000000000002 113.207 179.699 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 5.8 ttpm? -57.75 -50.2 74.03 Favored 'General case' 0 N--CA 1.482 1.172 0 C-N-CA 123.398 0.679 . . . . 72.340000000000003 112.098 -179.562 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 32' ' ' THR . . . . . 0.642 ' HB ' ' HB ' ' A' ' 29' ' ' VAL . 88.9 m -67.78 -35.6 78.97 Favored 'General case' 0 CA--C 1.56 1.357 0 C-N-CA 123.998 0.919 . . . . 71.319999999999993 112.593 -170.632 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 33' ' ' ALA . . . . . 0.521 ' HB1' ' HB3' ' A' ' 24' ' ' LEU . . . -90.47 -43.7 10.09 Favored 'General case' 0 N--CA 1.485 1.294 0 C-N-CA 123.019 0.528 . . . . 54.240000000000002 112.173 -176.985 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 39.3 tt0 -63.63 -31.73 72.99 Favored 'General case' 0 N--CA 1.484 1.255 0 C-N-CA 123.372 0.669 . . . . 73.150000000000006 110.733 179.754 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 35' ' ' ASN . . . . . 0.421 ' O ' ' HG ' ' A' ' 39' ' ' LEU . 35.8 t30 -49.01 -59.51 3.56 Favored 'General case' 0 C--N 1.36 1.029 0 O-C-N 124.566 1.166 . . . . 75.030000000000001 110.314 171.457 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 76.3 t80 -65.17 -40.55 94.44 Favored 'General case' 0 C--N 1.348 0.526 0 O-C-N 124.045 0.84 . . . . 70.209999999999994 111.249 -175.035 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 56.1 ttp180 -58.26 -44.98 88.62 Favored 'General case' 0 N--CA 1.48 1.044 0 O-C-N 123.723 0.639 . . . . 72.209999999999994 110.919 179.057 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 38' ' ' ALA . . . . . 0.547 ' HB3' HG21 ' A' ' 78' ' ' ILE . . . -69.38 -32.24 71.15 Favored 'General case' 0 N--CA 1.473 0.694 0 CA-C-N 115.274 -0.875 . . . . 74.239999999999995 111.487 -179.726 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 39' ' ' LEU . . . . . 0.421 ' HG ' ' O ' ' A' ' 35' ' ' ASN . 94.3 mt -69.74 -35.96 75.42 Favored 'General case' 0 N--CA 1.477 0.915 0 C-N-CA 123.87 0.868 . . . . 75.340000000000003 111.06 175.326 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 50.0 m -73.52 -54.81 7.34 Favored 'General case' 0 N--CA 1.474 0.75 0 C-N-CA 124.015 0.926 . . . . 75.549999999999997 111.284 -175.567 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 56.4 p -78.77 -31.51 46.16 Favored 'General case' 0 CA--C 1.538 0.519 0 CA-C-N 115.128 -0.942 . . . . 32.409999999999997 111.376 -175.188 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 92.09 37.68 5.92 Favored Glycine 0 C--N 1.347 1.168 0 CA-C-O 119.647 -0.529 . . . . 60.329999999999998 112.682 -178.204 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 68.1 mm-40 -61.1 -29.24 69.64 Favored 'General case' 0 N--CA 1.482 1.152 0 C-N-CA 123.089 0.555 . . . . 64.439999999999998 110.432 172.08 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 44' ' ' LYS . . . . . 0.547 ' HG3' ' HB ' ' A' ' 78' ' ' ILE . 32.0 mmmt -108.43 17.75 21.74 Favored 'General case' 0 CA--C 1.541 0.614 0 C-N-CA 124.696 1.199 . . . . 75.200000000000003 111.366 -178.965 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 80.23 -1.77 79.36 Favored Glycine 0 C--N 1.355 1.604 0 CA-C-O 119.118 -0.823 . . . . 73.349999999999994 114.923 173.353 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 19.7 m-85 -85.17 -48.15 9.43 Favored 'General case' 0 N--CA 1.477 0.924 0 CA-C-N 117.96 0.88 . . . . 64.129999999999995 111.05 -174.2 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 41.6 62.23 1.97 Allowed Glycine 0 N--CA 1.485 1.964 0 O-C-N 124.508 1.13 . . . . 61.140000000000001 114.816 171.517 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 48' ' ' TYR . . . . . 0.471 ' HB3' ' OG ' ' A' ' 51' ' ' SER . 34.5 m-85 -59.68 98.89 0.05 Allowed 'General case' 0 CA--C 1.548 0.898 0 CA-C-O 121.843 0.83 . . . . 72.299999999999997 112.191 -170.095 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 23.2 tptm -108.39 113.53 26.66 Favored 'General case' 0 CA--C 1.539 0.544 0 CA-C-N 113.941 -1.481 . . . . 72.019999999999996 108.841 -175.771 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 93.61 18.59 37.68 Favored Glycine 0 C--N 1.346 1.13 0 CA-C-O 119.267 -0.741 . . . . 63.409999999999997 113.078 179.823 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 51' ' ' SER . . . . . 0.471 ' OG ' ' HB3' ' A' ' 48' ' ' TYR . 19.6 m -59.95 118.62 6.47 Favored 'General case' 0 N--CA 1.476 0.853 0 C-N-CA 123.317 0.647 . . . . 73.219999999999999 111.177 -176.849 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 52' ' ' CYS . . . . . 0.642 ' SG ' ' HD2' ' A' ' 155' ' ' LYS . 36.0 t -86.28 125.15 33.39 Favored 'General case' 0 CA--C 1.533 0.306 0 CA-C-N 115.447 -0.797 . . . . 73.409999999999997 112.302 -167.539 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 53' ' ' PHE . . . . . 0.667 ' HA ' ' HA2' ' A' ' 64' ' ' GLY . 95.4 m-85 -73.08 109.33 6.54 Favored 'General case' 0 C--O 1.238 0.479 0 N-CA-C 108.756 -0.831 . . . . 72.540000000000006 108.756 166.27 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 19.2 p-80 -128.43 8.41 5.95 Favored 'General case' 0 N--CA 1.482 1.135 0 CA-C-N 115.611 -0.722 . . . . 74.430000000000007 111.856 -169.267 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 80.0 ttt-85 -152.25 99.31 2.5 Favored 'General case' 0 N--CA 1.472 0.67 0 N-CA-C 108.794 -0.817 . . . . 75.209999999999994 108.794 177.768 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 56' ' ' ILE . . . . . 0.463 HD11 ' HB3' ' A' ' 53' ' ' PHE . 58.3 mt -137.31 134.01 46.89 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.8 0 C-N-CA 123.181 0.592 . . . . 71.129999999999995 109.908 -174.688 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 41.8 mt -117.58 118.32 35.31 Favored Pre-proline 0 CA--C 1.554 1.109 0 C-N-CA 124.164 0.986 . . . . 51.100000000000001 108.549 174.229 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 58' ' ' PRO . . . . . 0.574 ' HA ' ' HG2' ' A' ' 143' ' ' GLU . 53.8 Cg_endo -67.3 135.95 38.57 Favored 'Trans proline' 0 C--N 1.38 2.206 0 C-N-CA 123.021 2.481 . . . . 74.450000000000003 111.508 179.847 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 77.35 30.01 54.97 Favored Glycine 0 CA--C 1.526 0.765 0 CA-C-N 115.345 -0.843 . . . . 71.129999999999995 113.091 -176.168 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 29.0 t80 -156.57 -67.04 0.11 Allowed 'General case' 0 C--O 1.247 0.96 0 C-N-CA 123.027 0.531 . . . . 73.319999999999993 110.715 -176.921 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 61' ' ' MET . . . . . 0.4 ' HE2' ' HB2' ' A' ' 61' ' ' MET . 45.6 ttm -167.16 146.96 5.35 Favored 'General case' 0 N--CA 1.48 1.073 0 N-CA-C 112.188 0.44 . . . . 74.239999999999995 112.188 -165.654 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 62' ' ' CYS . . . . . 0.456 ' SG ' HG13 ' A' ' 139' ' ' VAL . 23.5 p -116.55 114.25 23.88 Favored 'General case' 0 CA--C 1.545 0.781 0 C-N-CA 123.726 0.81 . . . . 72.450000000000003 109.111 169.322 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 28.4 tt0 -112.63 140.96 46.96 Favored 'General case' 0 N--CA 1.479 0.995 0 C-N-CA 123.627 0.771 . . . . 74.25 110.66 -179.506 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 64' ' ' GLY . . . . . 0.667 ' HA2' ' HA ' ' A' ' 53' ' ' PHE . . . -130.81 -176.55 14.46 Favored Glycine 0 C--N 1.344 0.976 0 CA-C-N 115.306 -0.861 . . . . 72.239999999999995 112.754 176.669 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 176.22 155.07 12.41 Favored Glycine 0 C--N 1.335 0.486 0 N-CA-C 111.721 -0.552 . . . . 74.540000000000006 111.721 -179.262 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 21.2 t70 -83.06 179.79 7.65 Favored 'General case' 0 CA--C 1.552 1.031 0 C-N-CA 124.017 0.927 . . . . 74.420000000000002 110.593 -176.979 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 53.2 t80 -88.51 -15.68 34.65 Favored 'General case' 0 CA--C 1.548 0.89 0 C-N-CA 123.188 0.595 . . . . 52.350000000000001 111.538 177.635 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 42.5 m -65.01 107.79 1.61 Allowed 'General case' 0 C--N 1.357 0.93 0 N-CA-C 109.724 -0.472 . . . . 74.430000000000007 109.724 178.057 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 85.1 mtt85 58.64 47.66 12.8 Favored 'General case' 0 N--CA 1.479 1.002 0 C-N-CA 124.821 1.248 . . . . 73.049999999999997 110.633 -170.805 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 48.6 t-80 -49.82 -37.66 31.42 Favored 'General case' 0 N--CA 1.482 1.164 0 C-N-CA 124.754 1.222 . . . . 74.400000000000006 112.69 -172.297 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 53.1 t30 -68.26 96.47 0.65 Allowed 'General case' 0 CA--C 1.542 0.65 0 O-C-N 123.499 0.499 . . . . 50.109999999999999 109.991 175.233 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 67.56 16.15 67.2 Favored Glycine 0 C--N 1.345 1.06 0 N-CA-C 116.022 1.169 . . . . 73.239999999999995 116.022 168.805 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 73' ' ' THR . . . . . 0.58 ' HA ' ' HB2' ' A' ' 110' ' ' SER . 88.3 m -132.65 -75.93 0.5 Allowed 'General case' 0 N--CA 1.472 0.638 0 N-CA-C 108.426 -0.953 . . . . 72.120000000000005 108.426 168.871 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 53.95 60.26 8.67 Favored Glycine 0 C--N 1.355 1.59 0 O-C-N 123.781 0.675 . . . . 70.349999999999994 113.725 170.137 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 130.96 51.4 0.1 OUTLIER Glycine 0 C--N 1.344 1.026 0 N-CA-C 111.855 -0.498 . . . . 74.109999999999999 111.855 -176.716 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -52.36 166.09 0.2 Allowed 'General case' 0 N--CA 1.491 1.606 0 C-N-CA 124.369 1.068 . . . . 62.439999999999998 112.583 174.688 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 80.9 p -90.65 177.67 6.28 Favored 'General case' 0 N--CA 1.478 0.965 0 C-N-CA 122.994 0.518 . . . . 72.349999999999994 111.043 -175.699 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 78' ' ' ILE . . . . . 0.547 HG21 ' HB3' ' A' ' 38' ' ' ALA . 31.9 pt -79.02 -22.83 12.7 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.022 0 C-N-CA 123.275 0.63 . . . . 54.350000000000001 110.773 176.505 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 71.0 m-85 -79.42 -40.32 30.28 Favored 'General case' 0 N--CA 1.47 0.548 0 C-N-CA 124.19 0.996 . . . . 73.349999999999994 109.704 -179.724 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 177.45 -138.69 3.98 Favored Glycine 0 C--N 1.339 0.746 0 CA-C-N 115.152 -0.931 . . . . 63.030000000000001 111.528 177.734 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 36.0 tt0 -65.64 -44.44 86.39 Favored 'General case' 0 N--CA 1.471 0.604 0 C-N-CA 123.917 0.887 . . . . 51.439999999999998 109.855 177.025 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 82' ' ' LYS . . . . . 0.447 ' HD2' ' HA ' ' A' ' 107' ' ' THR . 20.8 pttp -154.07 175.31 13.58 Favored 'General case' 0 CA--C 1.55 0.977 0 CA-C-N 114.943 -1.026 . . . . 72.530000000000001 110.383 -175.219 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 2.2 p90 -159.42 170.48 21.67 Favored 'General case' 0 CA--C 1.554 1.104 0 C-N-CA 124.132 0.973 . . . . 53.210000000000001 110.311 -173.765 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 13.0 pt-20 -96.4 157.37 15.93 Favored 'General case' 0 N--CA 1.486 1.343 0 C-N-CA 123.664 0.785 . . . . 74.400000000000006 109.014 173.219 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 28.4 m-20 -77.53 150.85 34.77 Favored 'General case' 0 N--CA 1.483 1.206 0 N-CA-C 113.099 0.777 . . . . 74.120000000000005 113.099 178.1 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 86' ' ' GLU . . . . . 0.449 ' HG2' ' HD2' ' A' ' 30' ' ' PRO . 13.8 tp10 -61.95 -60.6 3.39 Favored 'General case' 0 CA--C 1.541 0.614 0 CA-C-N 114.044 -1.435 . . . . 73.409999999999997 111.158 -179.763 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 26.2 p30 -165.73 152.85 10.18 Favored 'General case' 0 N--CA 1.475 0.789 0 C-N-CA 123.556 0.743 . . . . 74.340000000000003 109.723 -176.973 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 89.9 m-85 -90.58 47.26 1.41 Allowed 'General case' 0 N--CA 1.48 1.055 0 C-N-CA 123.624 0.769 . . . . 74.310000000000002 111.267 -176.362 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 71.3 mt -69.87 -59.5 3.45 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.925 0 N-CA-C 108.926 -0.768 . . . . 71.340000000000003 108.926 173.209 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 90' ' ' LEU . . . . . 0.59 ' HB3' ' HB ' ' A' ' 128' ' ' VAL . 80.3 mt -86.69 104.92 16.54 Favored 'General case' 0 CA--C 1.539 0.542 0 CA-C-N 114.878 -1.055 . . . . 61.210000000000001 110.596 -172.057 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 20.4 ptmt -103.97 167.77 9.55 Favored 'General case' 0 N--CA 1.475 0.797 0 C-N-CA 123.278 0.631 . . . . 60.450000000000003 110.492 -179.617 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 92' ' ' HIS . . . . . . . . . . . . . 57.7 m-70 -83.53 69.38 10.07 Favored 'General case' 0 N--CA 1.48 1.028 0 C-N-CA 123.4 0.68 . . . . 71.400000000000006 110.799 -173.666 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 14.5 t -122.26 20.32 10.55 Favored 'General case' 0 N--CA 1.474 0.761 0 C-N-CA 123.338 0.655 . . . . 64.310000000000002 110.084 -176.546 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -143.99 172.27 25.22 Favored Glycine 0 C--N 1.348 1.197 0 CA-C-N 116.287 -0.415 . . . . 71.200000000000003 113.445 -176.336 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 58.4 Cg_endo -94.02 153.53 2.19 Favored 'Trans proline' 0 C--N 1.368 1.578 0 C-N-CA 123.676 2.918 . . . . 74.209999999999994 112.732 175.238 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 72.82 19.85 79.55 Favored Glycine 0 C--N 1.353 1.507 0 CA-C-N 116.244 -0.435 . . . . 42.25 112.827 177.008 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 97' ' ' ILE . . . . . 0.737 ' HB ' ' SG ' ' A' ' 115' ' ' CYS . 20.1 mm -68.84 108.36 1.6 Allowed 'Isoleucine or valine' 0 CA--C 1.541 0.625 0 C-N-CA 124.238 1.015 . . . . 70.120000000000005 111.257 -174.213 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 62.1 tp -90.06 120.55 31.35 Favored 'General case' 0 C--O 1.247 0.94 0 CA-C-N 115.581 -0.736 . . . . 75.120000000000005 109.95 172.575 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 99' ' ' SER . . . . . 0.467 ' HB3' ' HA ' ' A' ' 128' ' ' VAL . 7.9 p -149.62 147.67 28.4 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 114.483 -1.235 . . . . 72.349999999999994 107.902 171.81 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 100' ' ' MET . . . . . 0.734 ' HA ' ' HA ' ' A' ' 112' ' ' PHE . 96.9 mtp -77.29 149.14 35.39 Favored 'General case' 0 N--CA 1.493 1.68 0 C-N-CA 122.627 0.371 . . . . 63.130000000000003 110.276 -175.569 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 101' ' ' ALA . . . . . 0.533 ' HB3' ' HB2' ' A' ' 111' ' ' GLN . . . -73.57 162.71 28.93 Favored 'General case' 0 C--O 1.247 0.944 0 CA-C-O 121.535 0.683 . . . . 63.229999999999997 111.347 -176.851 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 102' ' ' ASN . . . . . 0.47 ' HB3' ' HA ' ' A' ' 108' ' ' ASN . 24.3 p-10 -167.24 168.4 13.41 Favored 'General case' 0 C--O 1.242 0.706 0 CA-C-N 114.583 -1.19 . . . . 52.43 109.903 -178.14 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 103' ' ' ALA . . . . . 0.591 ' HB1' ' HB2' ' B' ' 216' ' ' PRO . . . -114.96 6.74 15.41 Favored 'General case' 0 CA--C 1.543 0.695 0 C-N-CA 123.802 0.841 . . . . 54.140000000000001 110.304 171.183 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 158.54 179.75 33.63 Favored Glycine 0 C--N 1.354 1.582 0 CA-C-O 119.468 -0.629 . . . . 73.340000000000003 112.408 178.094 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 26.0 Cg_exo -64.47 137.54 55.67 Favored 'Trans proline' 0 C--N 1.375 1.926 0 C-N-CA 122.933 2.422 . . . . 71.450000000000003 110.509 171.514 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 63.0 t30 68.8 8.79 7.0 Favored 'General case' 0 N--CA 1.49 1.528 0 C-N-CA 124.988 1.315 . . . . 72.530000000000001 111.116 -174.851 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 107' ' ' THR . . . . . 0.447 ' HA ' ' HD2' ' A' ' 82' ' ' LYS . 1.7 m -116.93 15.82 15.17 Favored 'General case' 0 CA--C 1.551 0.998 0 N-CA-C 108.359 -0.978 . . . . 65.329999999999998 108.359 171.6 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 108' ' ' ASN . . . . . 0.47 ' HA ' ' HB3' ' A' ' 102' ' ' ASN . 20.9 t30 -92.05 145.31 24.62 Favored 'General case' 0 C--O 1.202 -1.426 0 C-N-CA 124.832 1.253 . . . . 70.109999999999999 110.498 -176.317 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 113.3 26.99 3.8 Favored Glycine 0 N--CA 1.478 1.48 0 CA-C-N 118.303 0.501 . . . . 75.319999999999993 112.436 -178.787 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 110' ' ' SER . . . . . 0.58 ' HB2' ' HA ' ' A' ' 73' ' ' THR . 22.5 p -137.04 121.13 17.8 Favored 'General case' 0 CA--C 1.535 0.401 0 N-CA-C 108.675 -0.861 . . . . 62.439999999999998 108.675 -177.926 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 111' ' ' GLN . . . . . 0.533 ' HB2' ' HB3' ' A' ' 101' ' ' ALA . 47.4 mt-30 61.47 -177.25 0.12 Allowed 'General case' 0 N--CA 1.493 1.677 0 C-N-CA 123.898 0.879 . . . . 73.400000000000006 111.62 -174.551 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 112' ' ' PHE . . . . . 0.734 ' HA ' ' HA ' ' A' ' 100' ' ' MET . 35.5 p90 -151.75 152.92 33.34 Favored 'General case' 0 N--CA 1.475 0.804 0 C-N-CA 123.672 0.789 . . . . 65.540000000000006 109.348 176.698 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 113' ' ' PHE . . . . . . . . . . . . . 55.0 p90 -140.59 151.43 44.67 Favored 'General case' 0 N--CA 1.472 0.667 0 C-N-CA 122.963 0.505 . . . . 75.439999999999998 110.934 -178.803 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 114' ' ' ILE . . . . . . . . . . . . . 10.9 mt -125.92 107.77 18.22 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.705 0 N-CA-C 107.849 -1.167 . . . . 74.310000000000002 107.849 178.765 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 115' ' ' CYS . . . . . 0.737 ' SG ' ' HB ' ' A' ' 97' ' ' ILE . 28.5 p -89.3 113.68 24.97 Favored 'General case' 0 C--O 1.243 0.745 0 N-CA-C 108.964 -0.754 . . . . 71.120000000000005 108.964 175.601 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 71.6 p -70.84 -27.02 63.55 Favored 'General case' 0 N--CA 1.474 0.772 0 CA-C-N 115.253 -0.885 . . . . 63.299999999999997 111.291 -177.534 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -104.34 162.34 13.3 Favored 'General case' 0 C--O 1.248 0.977 0 C-N-CA 123.815 0.846 . . . . 75.409999999999997 110.058 174.826 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 18.1 ptmt -74.04 85.19 1.8 Allowed 'General case' 0 CA--C 1.546 0.825 0 CA-C-O 122.302 1.048 . . . . 74.420000000000002 110.248 175.329 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 119' ' ' THR . . . . . . . . . . . . . 50.8 p -82.04 84.39 7.0 Favored 'General case' 0 CA--C 1.546 0.793 0 CA-C-N 115.01 -0.996 . . . . 60.350000000000001 109.307 179.359 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 11.4 pt-20 -75.44 -23.36 56.9 Favored 'General case' 0 N--CA 1.484 1.257 0 CA-C-N 115.019 -0.991 . . . . 74.519999999999996 112.727 -167.628 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 121' ' ' TRP . . . . . . . . . . . . . 38.7 p90 -67.05 -8.72 32.41 Favored 'General case' 0 CA--C 1.551 1.0 0 C-N-CA 123.452 0.701 . . . . 74.230000000000004 112.201 176.79 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 31.9 mt -88.23 10.33 19.94 Favored 'General case' 0 CA--C 1.547 0.833 0 C-N-CA 122.947 0.499 . . . . 64.540000000000006 111.954 176.764 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 69.7 m-20 -72.4 121.18 19.11 Favored 'General case' 0 N--CA 1.483 1.207 0 N-CA-C 108.9 -0.778 . . . . 74.420000000000002 108.9 170.721 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 110.0 -17.94 29.21 Favored Glycine 0 N--CA 1.475 1.269 0 N-CA-C 111.04 -0.824 . . . . 53.030000000000001 111.04 -170.113 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 125' ' ' LYS . . . . . 0.602 ' HG2' ' H ' ' A' ' 126' ' ' HIS . 21.0 ttmm -86.72 -165.58 1.32 Allowed 'General case' 0 CA--C 1.559 1.3 0 N-CA-C 108.045 -1.094 . . . . 63.530000000000001 108.045 169.707 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 126' ' ' HIS . . . . . 0.602 ' H ' ' HG2' ' A' ' 125' ' ' LYS . 9.4 t-160 -65.59 130.08 42.02 Favored 'General case' 0 C--N 1.353 0.758 0 CA-C-N 118.583 0.628 . . . . 73.049999999999997 109.826 -173.71 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 127' ' ' VAL . . . . . 0.4 ' N ' ' HD2' ' A' ' 126' ' ' HIS . 57.6 t -58.68 143.7 12.69 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.835 0 CA-C-N 113.75 -1.568 . . . . 75.519999999999996 110.966 175.829 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 128' ' ' VAL . . . . . 0.59 ' HB ' ' HB3' ' A' ' 90' ' ' LEU . 21.8 t -66.94 149.01 11.83 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.583 0 N-CA-C 109.578 -0.527 . . . . 61.409999999999997 109.578 177.098 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 129' ' ' PHE . . . . . 0.545 ' HB3' HG22 ' A' ' 32' ' ' THR . 32.1 p90 -136.32 -23.89 1.26 Allowed 'General case' 0 N--CA 1.474 0.754 0 C-N-CA 122.243 0.217 . . . . 73.530000000000001 111.117 171.409 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . -127.09 157.75 20.78 Favored Glycine 0 C--N 1.338 0.689 0 N-CA-C 111.493 -0.643 . . . . 72.200000000000003 111.493 -177.552 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 131' ' ' LYS . . . . . 0.407 ' HE2' ' HB3' ' A' ' 131' ' ' LYS . 31.3 ttpt -144.74 127.41 16.17 Favored 'General case' 0 C--N 1.324 -0.543 0 N-CA-C 108.616 -0.883 . . . . 63.149999999999999 108.616 179.967 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 132' ' ' VAL . . . . . 0.478 HG21 HG21 ' A' ' 139' ' ' VAL . 59.4 t -63.67 100.19 0.22 Allowed 'Isoleucine or valine' 0 CA--C 1.539 0.525 0 N-CA-C 108.589 -0.893 . . . . 71.329999999999998 108.589 171.902 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 133' ' ' LYS . . . . . 0.662 ' HD2' ' HB2' ' A' ' 23' ' ' GLU . 19.5 ptmt -87.65 -32.03 19.46 Favored 'General case' 0 N--CA 1.473 0.682 0 N-CA-C 109.581 -0.526 . . . . 71.430000000000007 109.581 178.315 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 44.8 mt-10 -139.41 146.29 39.95 Favored 'General case' 0 N--CA 1.473 0.7 0 C-N-CA 124.999 1.32 . . . . 61.030000000000001 108.936 176.728 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 87.83 21.76 45.43 Favored Glycine 0 C--N 1.342 0.868 0 O-C-N 123.541 0.526 . . . . 51.43 112.536 -175.89 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 136' ' ' MET . . . . . 0.428 ' HA ' HG11 ' A' ' 132' ' ' VAL . 7.1 tpt -58.88 -46.84 86.85 Favored 'General case' 0 C--N 1.359 1.004 0 C-N-CA 123.92 0.888 . . . . 71.430000000000007 111.337 -179.772 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 137' ' ' ASN . . . . . . . . . . . . . 20.1 m120 -65.03 -28.86 69.78 Favored 'General case' 0 N--CA 1.477 0.886 0 C-N-CA 123.228 0.611 . . . . 74.430000000000007 111.619 -179.394 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 138' ' ' ILE . . . . . . . . . . . . . 43.2 mm -70.41 -38.84 75.36 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.657 0 C-N-CA 123.329 0.652 . . . . 74.450000000000003 109.895 178.839 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 139' ' ' VAL . . . . . 0.478 HG21 HG21 ' A' ' 132' ' ' VAL . 69.6 t -68.64 -39.78 80.84 Favored 'Isoleucine or valine' 0 CA--C 1.553 1.063 0 C-N-CA 123.481 0.713 . . . . 74.439999999999998 110.492 176.186 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 48.8 mt-10 -69.2 -27.53 65.58 Favored 'General case' 0 N--CA 1.476 0.872 0 C-N-CA 123.623 0.769 . . . . 71.549999999999997 111.224 177.92 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -80.35 -45.6 17.51 Favored 'General case' 0 N--CA 1.477 0.91 0 C-N-CA 123.639 0.776 . . . . 63.140000000000001 111.196 178.914 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 142' ' ' MET . . . . . 0.544 ' HA ' ' HD2' ' A' ' 145' ' ' PHE . 27.9 ptm -65.68 -31.71 72.87 Favored 'General case' 0 N--CA 1.478 0.969 0 C-N-CA 123.095 0.558 . . . . 64.310000000000002 111.22 -178.35 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 143' ' ' GLU . . . . . 0.574 ' HG2' ' HA ' ' A' ' 58' ' ' PRO . 39.1 tt0 -57.94 -32.22 67.58 Favored 'General case' 0 CA--C 1.552 1.037 0 C-N-CA 123.71 0.804 . . . . 75.209999999999994 111.969 177.957 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 144' ' ' ARG . . . . . . . . . . . . . 46.3 mtp85 -75.62 -16.98 60.15 Favored 'General case' 0 N--CA 1.473 0.705 0 CA-C-N 116.261 -0.427 . . . . 74.129999999999995 111.814 -175.782 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 145' ' ' PHE . . . . . 0.596 ' HB2' HD11 ' A' ' 156' ' ' ILE . 95.2 m-85 -79.88 2.09 24.62 Favored 'General case' 0 N--CA 1.479 0.994 0 C-N-CA 122.728 0.411 . . . . 71.030000000000001 110.844 175.38 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . -89.58 -174.75 45.92 Favored Glycine 0 C--N 1.352 1.426 0 O-C-N 123.199 0.312 . . . . 73.409999999999997 112.635 171.787 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 19.8 t -135.6 167.99 20.08 Favored 'General case' 0 N--CA 1.475 0.803 0 C-N-CA 123.796 0.838 . . . . 62.450000000000003 110.369 -177.869 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 148' ' ' ARG . . . . . . . . . . . . . 12.1 mmm180 -71.04 -29.84 65.87 Favored 'General case' 0 N--CA 1.477 0.907 0 C-N-CA 123.534 0.734 . . . . 74.109999999999999 112.09 -173.601 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 149' ' ' ASN . . . . . . . . . . . . . 28.7 p-10 -79.72 -3.05 45.75 Favored 'General case' 0 N--CA 1.484 1.237 0 C-N-CA 123.51 0.724 . . . . 73.140000000000001 111.451 176.141 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . 90.68 11.02 62.6 Favored Glycine 0 C--N 1.35 1.336 0 C-N-CA 123.052 0.358 . . . . 55.229999999999997 113.098 -179.522 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 56.1 tttm -84.77 158.67 20.65 Favored 'General case' 0 N--CA 1.474 0.761 0 C-N-CA 123.378 0.671 . . . . 72.430000000000007 109.458 177.384 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 152' ' ' THR . . . . . . . . . . . . . 24.8 p -101.58 128.72 47.71 Favored 'General case' 0 N--CA 1.475 0.821 0 C-N-CA 122.82 0.448 . . . . 53.109999999999999 109.905 171.86 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 153' ' ' SER . . . . . . . . . . . . . 42.4 t -70.25 -42.97 71.49 Favored 'General case' 0 N--CA 1.474 0.742 0 N-CA-C 109.245 -0.65 . . . . 63.039999999999999 109.245 168.851 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 154' ' ' LYS . . . . . 0.4 ' HB2' ' HB3' ' A' ' 145' ' ' PHE . 34.1 mmtp -118.4 140.68 49.48 Favored 'General case' 0 C--O 1.239 0.506 0 C-N-CA 123.614 0.766 . . . . 75.310000000000002 110.654 -179.338 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 155' ' ' LYS . . . . . 0.642 ' HD2' ' SG ' ' A' ' 52' ' ' CYS . 0.0 OUTLIER -87.03 93.24 9.3 Favored 'General case' 0 CA--C 1.535 0.374 0 O-C-N 123.944 0.778 . . . . 70.040000000000006 109.369 -172.271 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 156' ' ' ILE . . . . . 0.624 ' HB ' ' HB2' ' A' ' 53' ' ' PHE . 27.1 mt -87.63 149.27 4.13 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.591 0 CA-C-N 115.488 -0.778 . . . . 61.43 109.231 -177.685 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 157' ' ' THR . . . . . . . . . . . . . 71.9 p -146.25 170.41 16.82 Favored 'General case' 0 N--CA 1.482 1.153 0 C-N-CA 124.091 0.956 . . . . 72.310000000000002 109.951 -176.661 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 158' ' ' ILE . . . . . 0.4 HG23 ' HB3' ' A' ' 8' ' ' PHE . 67.8 mt -88.87 102.2 12.7 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.705 0 N-CA-C 107.954 -1.128 . . . . 72.409999999999997 107.954 165.05 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 159' ' ' ALA . . . . . 0.502 ' HB2' ' HB2' ' A' ' 11' ' ' ALA . . . -56.03 -49.66 73.08 Favored 'General case' 0 N--CA 1.476 0.835 0 C-N-CA 124.186 0.995 . . . . 71.519999999999996 112.115 179.048 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 160' ' ' ASP . . . . . . . . . . . . . 27.5 t70 -160.45 156.96 26.84 Favored 'General case' 0 N--CA 1.471 0.584 0 O-C-N 123.904 0.752 . . . . 62.039999999999999 110.685 -174.077 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 161' ' ' CYS . . . . . . . . . . . . . 14.9 p -110.8 -168.71 1.34 Allowed 'General case' 0 N--CA 1.475 0.811 0 C-N-CA 125.122 1.369 . . . . 62.329999999999998 108.839 175.851 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 162' ' ' GLY . . . . . . . . . . . . . . . 132.45 53.39 0.08 OUTLIER Glycine 0 C--N 1.346 1.1 0 N-CA-C 111.006 -0.838 . . . . 60.229999999999997 111.006 -171.274 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 163' ' ' GLN . . . . . 0.708 ' HA ' ' H ' ' A' ' 7' ' ' PHE . 16.2 pt20 -50.34 132.46 24.52 Favored 'General case' 0 C--N 1.357 0.915 0 C-N-CA 123.908 0.883 . . . . 71.430000000000007 113.034 -172.499 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 164' ' ' LEU . . . . . 0.476 ' O ' ' HB ' ' A' ' 5' ' ' THR . 96.7 mt -92.87 97.3 10.66 Favored 'General case' 0 CA--C 1.534 0.362 0 N-CA-C 107.92 -1.141 . . . . 73.400000000000006 107.92 177.44 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 165' ' ' GLU . . . . . . . . . . . . . 38.0 tt0 . . . . . 0 CA--C 1.547 0.831 0 C-N-CA 123.994 0.918 . . . . 71.340000000000003 108.738 -173.966 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' B' B ' 216' ' ' PRO . . . . . 0.591 ' HB2' ' HB1' ' A' ' 103' ' ' ALA . 1.5 Cg_endo . . . . . 0 CA--C 1.541 0.83 0 N-CA-C 110.482 -0.622 . . . . 61.439999999999998 110.482 . . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 217' ' ' GLU . . . . . 0.416 ' HA ' ' HD3' ' B' ' 218' ' ' PRO . 40.9 tt0 -94.8 133.11 27.1 Favored Pre-proline 0 CA--C 1.549 0.941 0 C-N-CA 123.761 0.824 . . . . 75.109999999999999 109.612 178.44 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 218' ' ' PRO . . . . . 0.416 ' HD3' ' HA ' ' B' ' 217' ' ' GLU . 13.5 Cg_exo -70.17 86.6 0.63 Allowed 'Trans proline' 0 C--N 1.383 2.385 0 C-N-CA 122.958 2.438 . . . . 71.120000000000005 111.223 175.81 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 219' ' ' GLY . . . . . 0.429 ' HA2' ' HD3' ' B' ' 220' ' ' PRO . . . 155.55 140.91 3.09 Favored Glycine 0 CA--C 1.53 1.006 0 CA-C-N 115.435 -0.802 . . . . 51.130000000000003 111.313 -176.5 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 220' ' ' PRO . . . . . 0.429 ' HD3' ' HA2' ' B' ' 219' ' ' GLY . 6.1 Cg_exo -77.13 173.25 14.7 Favored 'Trans proline' 0 C--N 1.369 1.634 0 C-N-CA 123.422 2.748 . . . . 71.219999999999999 114.108 -173.866 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 221' ' ' TYR . . . . . . . . . . . . . 43.0 p90 -155.81 170.36 22.25 Favored 'General case' 0 C--O 1.25 1.108 0 CA-C-N 114.697 -1.138 . . . . 74.420000000000002 109.776 -175.601 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 222' ' ' ALA . . . . . . . . . . . . . . . -172.94 -70.79 0.01 OUTLIER 'General case' 0 N--CA 1.474 0.739 0 C-N-CA 123.82 0.848 . . . . 72.120000000000005 109.952 -179.951 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 223' ' ' GLN . . . . . . . . . . . . . 13.5 pt20 -100.78 143.42 26.54 Favored Pre-proline 0 CA--C 1.54 0.58 0 CA-C-N 114.142 -1.39 . . . . 74.519999999999996 108.932 -177.347 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 224' ' ' PRO . . . . . . . . . . . . . 60.0 Cg_endo . . . . . 0 C--N 1.371 1.752 0 C-N-CA 122.15 1.9 . . . . 65.409999999999997 110.261 172.528 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 26.7 ptt? . . . . . 0 N--CA 1.475 0.785 0 N-CA-C 111.555 0.205 . . . . 62.32 111.555 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 9.7 p -92.52 13.0 2.36 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.681 0 CA-C-O 122.06 0.933 . . . . 45.43 110.748 -178.441 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 3' ' ' ASN . . . . . 0.553 HD22 ' HA ' ' A' ' 25' ' ' PHE . 19.6 m120 -69.2 122.28 84.84 Favored Pre-proline 0 C--O 1.245 0.833 0 C-N-CA 124.06 0.944 . . . . 63.299999999999997 110.911 -173.414 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 26.5 Cg_endo -60.79 118.53 5.4 Favored 'Trans proline' 0 C--N 1.382 2.29 0 C-N-CA 122.422 2.081 . . . . 74.409999999999997 110.227 177.731 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 5' ' ' THR . . . . . 0.459 ' HB ' ' O ' ' A' ' 164' ' ' LEU . 40.1 m -95.56 130.2 42.49 Favored 'General case' 0 C--O 1.239 0.501 0 N-CA-C 108.95 -0.759 . . . . 75.230000000000004 108.95 -173.116 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . 0.837 ' HA ' ' HB2' ' A' ' 163' ' ' GLN . 48.5 t -99.6 152.53 4.57 Favored 'Isoleucine or valine' 0 C--O 1.215 -0.748 0 N-CA-C 108.513 -0.921 . . . . 55.32 108.513 -179.426 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 7' ' ' PHE . . . . . 0.466 ' HB3' ' HA ' ' A' ' 163' ' ' GLN . 56.2 t80 -139.6 133.62 30.96 Favored 'General case' 0 C--O 1.242 0.682 0 C-N-CA 123.336 0.654 . . . . 72.129999999999995 109.832 179.877 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 40.2 m-85 -135.62 164.39 27.95 Favored 'General case' 0 C--O 1.241 0.642 0 O-C-N 124.663 1.227 . . . . 72.25 109.0 171.808 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 9' ' ' ASP . . . . . 0.522 ' HB2' ' HB3' ' A' ' 159' ' ' ALA . 40.8 m-20 -108.02 114.2 27.93 Favored 'General case' 0 N--CA 1.468 0.434 0 N-CA-C 107.605 -1.257 . . . . 71.209999999999994 107.605 171.134 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 10' ' ' ILE . . . . . 0.514 HG21 ' SD ' ' A' ' 142' ' ' MET . 46.1 mm -81.42 129.88 36.76 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.593 0 N-CA-C 109.089 -0.708 . . . . 64.319999999999993 109.089 177.799 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 11' ' ' ALA . . . . . 0.568 ' HB2' ' HB2' ' A' ' 159' ' ' ALA . . . -132.3 133.51 44.14 Favored 'General case' 0 N--CA 1.468 0.454 0 C-N-CA 123.379 0.672 . . . . 71.129999999999995 111.613 -168.131 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . 0.404 HG13 ' HB3' ' A' ' 154' ' ' LYS . 50.9 t -94.6 109.52 22.33 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.848 0 C-N-CA 124.607 1.163 . . . . 64.109999999999999 108.847 174.978 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 33.5 m-20 57.97 25.57 12.38 Favored 'General case' 0 N--CA 1.488 1.457 0 C-N-CA 125.449 1.5 . . . . 70.420000000000002 112.222 -172.96 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 100.45 -14.64 59.3 Favored Glycine 0 C--N 1.346 1.098 0 CA-C-O 119.475 -0.625 . . . . 73.450000000000003 113.326 179.129 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 17.6 mm-40 -87.72 114.25 58.14 Favored Pre-proline 0 N--CA 1.48 1.074 0 CA-C-N 117.559 0.679 . . . . 72.299999999999997 109.556 176.875 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 52.8 Cg_exo -50.26 108.64 0.23 Allowed 'Trans proline' 0 C--N 1.378 2.118 0 C-N-CA 123.649 2.9 . . . . 74.400000000000006 113.438 -178.795 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 59.4 tp -77.46 -40.49 42.99 Favored 'General case' 0 N--CA 1.472 0.648 0 C-N-CA 124.004 0.922 . . . . 25.140000000000001 109.546 175.459 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -167.43 170.38 41.6 Favored Glycine 0 C--N 1.342 0.904 0 CA-C-N 115.534 -0.757 . . . . 33.340000000000003 112.753 -178.823 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 19' ' ' ARG . . . . . 0.415 ' HB3' ' HE1' ' A' ' 7' ' ' PHE . 81.1 mtm180 -110.46 127.81 55.31 Favored 'General case' 0 N--CA 1.471 0.577 0 C-N-CA 124.299 1.04 . . . . 71.319999999999993 108.858 -178.587 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 76.5 t -129.17 122.16 55.54 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.723 0 C-N-CA 123.426 0.691 . . . . 71.530000000000001 110.67 -173.926 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 21' ' ' SER . . . . . 0.456 ' HB2' ' HB2' ' A' ' 134' ' ' GLU . 16.0 m -106.1 129.91 54.1 Favored 'General case' 0 CA--C 1.545 0.788 0 C-N-CA 123.58 0.752 . . . . 53.210000000000001 109.92 173.522 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 85.9 m-85 -100.64 170.23 8.5 Favored 'General case' 0 N--CA 1.474 0.768 0 C-N-CA 124.545 1.138 . . . . 65.450000000000003 110.038 175.022 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . 0.802 ' HB2' ' HD2' ' A' ' 133' ' ' LYS . 41.4 tt0 -135.35 118.75 16.79 Favored 'General case' 0 N--CA 1.472 0.648 0 C-N-CA 123.677 0.791 . . . . 72.400000000000006 109.261 -177.763 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . 0.471 ' HB3' ' HB1' ' A' ' 33' ' ' ALA . 36.3 mt -96.84 127.29 42.66 Favored 'General case' 0 N--CA 1.474 0.77 0 C-N-CA 122.747 0.419 . . . . 75.420000000000002 110.881 -177.062 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 25' ' ' PHE . . . . . 0.553 ' HA ' HD22 ' A' ' 3' ' ' ASN . 33.7 m-85 -86.15 65.85 9.28 Favored 'General case' 0 CA--C 1.537 0.466 0 C-N-CA 123.561 0.744 . . . . 75.420000000000002 109.188 175.851 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -65.47 -20.86 66.53 Favored 'General case' 0 N--CA 1.482 1.157 0 C-N-CA 124.193 0.997 . . . . 62.439999999999998 111.938 180.0 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 12.1 p-10 -77.15 -21.94 53.31 Favored 'General case' 0 CA--C 1.549 0.917 0 CA-C-N 114.924 -1.035 . . . . 72.049999999999997 111.589 178.668 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 60.2 mttp -106.11 -48.75 3.52 Favored 'General case' 0 N--CA 1.481 1.121 0 C-N-CA 123.392 0.677 . . . . 72.120000000000005 111.066 -176.207 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 29' ' ' VAL . . . . . 0.461 HG21 ' HA ' ' A' ' 129' ' ' PHE . 15.1 m -121.69 76.5 37.07 Favored Pre-proline 0 CA--C 1.552 1.054 0 C-N-CA 124.221 1.008 . . . . 74.120000000000005 109.613 -179.478 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 26.5 Cg_endo -61.45 -38.72 61.5 Favored 'Trans proline' 0 C--N 1.381 2.267 0 C-N-CA 122.492 2.128 . . . . 73.420000000000002 112.811 -173.194 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 4.7 ttmp? -65.21 -58.08 6.89 Favored 'General case' 0 N--CA 1.473 0.706 0 C-N-CA 122.971 0.509 . . . . 64.530000000000001 111.711 179.749 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 6.6 m -71.78 -28.46 63.64 Favored 'General case' 0 CA--C 1.555 1.168 0 CA-C-N 115.365 -0.834 . . . . 74.439999999999998 111.888 -168.79 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 33' ' ' ALA . . . . . 0.471 ' HB1' ' HB3' ' A' ' 24' ' ' LEU . . . -85.05 -45.79 11.78 Favored 'General case' 0 N--CA 1.478 0.942 0 C-N-CA 123.12 0.568 . . . . 55.539999999999999 111.275 179.793 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 8.5 tp10 -60.3 -34.73 74.19 Favored 'General case' 0 N--CA 1.487 1.386 0 C-N-CA 122.71 0.404 . . . . 43.520000000000003 110.988 178.96 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 35' ' ' ASN . . . . . 0.485 ' O ' ' HG ' ' A' ' 39' ' ' LEU . 36.2 t30 -49.44 -60.61 2.69 Favored 'General case' 0 C--N 1.351 0.651 0 O-C-N 124.514 1.134 . . . . 62.409999999999997 110.7 172.626 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 87.8 t80 -62.08 -40.91 97.42 Favored 'General case' 0 N--CA 1.466 0.371 0 CA-C-N 115.183 -0.917 . . . . 72.230000000000004 111.68 -176.307 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 37' ' ' ARG . . . . . 0.491 ' HG3' HE22 ' A' ' 163' ' ' GLN . 23.1 ttp180 -62.57 -42.99 99.89 Favored 'General case' 0 N--CA 1.477 0.9 0 C-N-CA 122.977 0.511 . . . . 73.430000000000007 110.909 -177.822 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 38' ' ' ALA . . . . . 0.547 ' HB1' ' HG2' ' A' ' 44' ' ' LYS . . . -69.1 -30.8 69.17 Favored 'General case' 0 CA--C 1.545 0.77 0 CA-C-N 115.341 -0.845 . . . . 62.109999999999999 111.508 179.754 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 39' ' ' LEU . . . . . 0.505 HD22 ' HE1' ' A' ' 48' ' ' TYR . 99.2 mt -72.48 -37.12 68.54 Favored 'General case' 0 CA--C 1.55 0.965 0 C-N-CA 123.582 0.753 . . . . 74.230000000000004 110.955 175.005 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 49.3 m -69.31 -46.2 67.69 Favored 'General case' 0 N--CA 1.479 1.006 0 C-N-CA 124.186 0.994 . . . . 74.430000000000007 111.284 -176.302 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 25.2 p -79.7 -30.01 40.9 Favored 'General case' 0 N--CA 1.472 0.668 0 C-N-CA 123.878 0.871 . . . . 40.299999999999997 111.288 178.587 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 83.03 28.82 36.09 Favored Glycine 0 C--N 1.346 1.119 0 CA-C-N 115.825 -0.625 . . . . 65.519999999999996 113.033 179.487 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 47.9 mm-40 -63.98 -23.06 67.19 Favored 'General case' 0 N--CA 1.477 0.887 0 C-N-CA 123.138 0.575 . . . . 73.430000000000007 111.604 177.024 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 44' ' ' LYS . . . . . 0.547 ' HG2' ' HB1' ' A' ' 38' ' ' ALA . 30.6 mmmt -99.77 19.83 15.27 Favored 'General case' 0 CA--C 1.541 0.631 0 C-N-CA 123.544 0.738 . . . . 73.530000000000001 111.985 -179.6 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 80.81 -21.99 5.19 Favored Glycine 0 C--N 1.355 1.607 0 N-CA-C 114.765 0.666 . . . . 63.119999999999997 114.765 173.224 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 46' ' ' PHE . . . . . 0.43 ' HE2' ' HA ' ' A' ' 78' ' ' ILE . 19.0 m-85 -69.84 -45.39 67.91 Favored 'General case' 0 C--N 1.348 0.534 0 C-N-CA 123.328 0.651 . . . . 63.509999999999998 110.684 -174.042 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 57.71 66.32 2.91 Favored Glycine 0 C--N 1.357 1.748 0 CA-C-O 119.008 -0.885 . . . . 74.340000000000003 113.927 168.544 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 48' ' ' TYR . . . . . 0.505 ' HE1' HD22 ' A' ' 39' ' ' LEU . 60.3 m-85 -66.21 85.59 0.1 Allowed 'General case' 0 N--CA 1.476 0.837 0 CA-C-O 122.71 1.243 . . . . 65.340000000000003 111.501 -176.494 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 29.0 tptp -113.32 109.21 18.35 Favored 'General case' 0 N--CA 1.451 -0.39 0 CA-C-N 112.662 -2.063 . . . . 73.140000000000001 107.975 179.439 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 89.8 19.89 45.9 Favored Glycine 0 N--CA 1.468 0.829 0 CA-C-O 119.657 -0.524 . . . . 73.329999999999998 113.695 -179.642 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 23.2 m -61.51 116.73 4.94 Favored 'General case' 0 C--O 1.243 0.745 0 C-N-CA 123.139 0.575 . . . . 70.140000000000001 109.572 174.228 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 52' ' ' CYS . . . . . 0.406 ' HA ' ' HA ' ' A' ' 157' ' ' THR . 20.1 p -102.03 128.96 48.24 Favored 'General case' 0 CA--C 1.538 0.487 0 CA-C-O 121.528 0.68 . . . . 71.310000000000002 112.19 -165.84 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 53' ' ' PHE . . . . . 0.585 ' HA ' ' HA2' ' A' ' 64' ' ' GLY . 77.7 m-85 -61.45 109.87 1.29 Allowed 'General case' 0 C--O 1.24 0.555 0 C-N-CA 124.804 1.241 . . . . 74.439999999999998 109.833 169.459 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 28.3 p-80 -124.15 2.42 8.57 Favored 'General case' 0 N--CA 1.475 0.791 0 CA-C-N 115.076 -0.965 . . . . 72.129999999999995 110.962 -175.532 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 55' ' ' ARG . . . . . 0.445 ' O ' ' HB3' ' A' ' 63' ' ' GLN . 53.4 ttt-85 -144.45 95.25 2.68 Favored 'General case' 0 C--O 1.218 -0.563 0 N-CA-C 108.396 -0.964 . . . . 73.109999999999999 108.396 177.046 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 56' ' ' ILE . . . . . 0.43 HG21 ' HA ' ' A' ' 143' ' ' GLU . 52.6 mt -130.4 133.68 63.49 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.088 0 N-CA-C 108.661 -0.866 . . . . 71.299999999999997 108.661 178.552 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 67.2 mt -126.65 118.61 22.75 Favored Pre-proline 0 CA--C 1.556 1.193 0 C-N-CA 123.606 0.762 . . . . 64.540000000000006 109.024 178.098 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 51.6 Cg_exo -57.62 141.79 95.49 Favored 'Trans proline' 0 C--N 1.387 2.559 0 C-N-CA 124.067 3.178 . . . . 74.329999999999998 113.784 -178.363 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 67.98 31.43 75.27 Favored Glycine 0 C--N 1.348 1.215 0 O-C-N 124.03 0.831 . . . . 50.299999999999997 112.807 -179.273 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 49.1 t80 -152.73 -71.23 0.15 Allowed 'General case' 0 CA--C 1.546 0.808 0 C-N-CA 123.75 0.82 . . . . 65.299999999999997 110.364 -177.703 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 37.0 ttp -170.25 150.1 3.57 Favored 'General case' 0 N--CA 1.485 1.296 0 N-CA-C 112.432 0.531 . . . . 75.140000000000001 112.432 -163.532 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 62' ' ' CYS . . . . . 0.497 ' SG ' ' HB2' ' A' ' 143' ' ' GLU . 35.4 m -108.77 112.41 24.69 Favored 'General case' 0 N--CA 1.474 0.774 0 C-N-CA 123.806 0.842 . . . . 73.019999999999996 109.5 168.4 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 63' ' ' GLN . . . . . 0.445 ' HB3' ' O ' ' A' ' 55' ' ' ARG . 52.1 tt0 -112.57 134.74 53.94 Favored 'General case' 0 N--CA 1.486 1.365 0 CA-C-O 121.644 0.735 . . . . 63.340000000000003 110.115 179.975 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 64' ' ' GLY . . . . . 0.585 ' HA2' ' HA ' ' A' ' 53' ' ' PHE . . . -134.45 175.56 20.39 Favored Glycine 0 CA--C 1.499 -0.947 0 CA-C-N 115.238 -0.892 . . . . 52.32 112.478 178.697 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 178.6 170.99 41.39 Favored Glycine 0 N--CA 1.444 -0.833 0 N-CA-C 110.726 -0.95 . . . . 64.310000000000002 110.726 179.383 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 14.8 t70 -94.18 166.31 12.18 Favored 'General case' 0 C--O 1.241 0.654 0 N-CA-C 109.862 -0.421 . . . . 54.130000000000003 109.862 -172.366 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 37.7 t80 -70.83 -22.93 62.27 Favored 'General case' 0 CA--C 1.548 0.9 0 C-N-CA 122.742 0.417 . . . . 64.439999999999998 110.356 175.142 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 52.7 m -61.64 113.65 2.84 Favored 'General case' 0 C--O 1.247 0.922 0 C-N-CA 123.823 0.849 . . . . 72.5 110.994 176.417 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 69' ' ' ARG . . . . . 0.415 ' HB3' ' HB ' ' A' ' 73' ' ' THR . 53.5 mtt180 58.99 29.78 19.41 Favored 'General case' 0 C--N 1.361 1.103 0 C-N-CA 124.577 1.151 . . . . 65.109999999999999 112.353 -176.114 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 32.4 p80 -51.72 -33.79 36.08 Favored 'General case' 0 N--CA 1.495 1.811 0 C-N-CA 123.252 0.621 . . . . 75.319999999999993 111.381 -179.427 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 6.8 t30 -75.49 89.96 2.71 Favored 'General case' 0 CA--C 1.551 0.992 0 C-N-CA 124.104 0.962 . . . . 62.350000000000001 109.164 171.622 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 100.59 -7.24 57.76 Favored Glycine 0 C--N 1.347 1.176 0 N-CA-C 115.93 1.132 . . . . 44.32 115.93 171.089 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 73' ' ' THR . . . . . 0.415 ' HB ' ' HB3' ' A' ' 69' ' ' ARG . 15.0 m -142.92 -75.23 0.27 Allowed 'General case' 0 N--CA 1.483 1.198 0 CA-C-N 118.687 1.243 . . . . 62.119999999999997 109.792 179.763 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 72.07 40.29 56.87 Favored Glycine 0 C--N 1.354 1.546 0 C-N-CA 123.234 0.445 . . . . 35.109999999999999 113.634 173.975 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 142.45 52.79 0.04 OUTLIER Glycine 0 C--N 1.344 0.995 0 CA-C-N 117.402 0.601 . . . . 75.109999999999999 111.741 -173.236 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 76' ' ' LYS . . . . . 0.407 ' HG2' ' OH ' ' A' ' 48' ' ' TYR . 16.5 ptpt -56.55 162.78 2.05 Favored 'General case' 0 N--CA 1.477 0.913 0 C-N-CA 124.183 0.993 . . . . 71.439999999999998 112.165 -176.237 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 77.9 p -91.33 173.63 7.81 Favored 'General case' 0 C--O 1.241 0.634 0 CA-C-N 115.343 -0.844 . . . . 63.43 110.42 -179.991 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 78' ' ' ILE . . . . . 0.441 HG21 ' HB3' ' A' ' 38' ' ' ALA . 21.4 pt -74.7 -17.5 16.47 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.608 0 CA-C-N 116.067 -0.515 . . . . 64.400000000000006 109.96 173.133 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 49.5 m-85 -87.67 -13.23 43.15 Favored 'General case' 0 CA--C 1.541 0.619 0 C-N-CA 124.615 1.166 . . . . 75.049999999999997 110.795 -178.445 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 142.37 -133.02 5.41 Favored Glycine 0 C--N 1.348 1.228 0 N-CA-C 110.858 -0.897 . . . . 44.409999999999997 110.858 178.689 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 36.4 tt0 -65.51 -54.34 29.61 Favored 'General case' 0 CA--C 1.54 0.596 0 C-N-CA 123.365 0.666 . . . . 74.010000000000005 109.86 175.215 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 82' ' ' LYS . . . . . 0.805 ' HD2' ' HA ' ' A' ' 107' ' ' THR . 24.1 pttm -158.81 174.15 15.45 Favored 'General case' 0 C--O 1.243 0.73 0 CA-C-N 114.52 -1.218 . . . . 62.350000000000001 109.17 -172.787 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 12.5 p90 -155.39 172.56 18.01 Favored 'General case' 0 N--CA 1.478 0.939 0 C-N-CA 123.59 0.756 . . . . 64.409999999999997 110.245 -175.518 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 14.1 pt-20 -87.25 168.34 13.29 Favored 'General case' 0 CA--C 1.548 0.885 0 CA-C-N 115.897 -0.592 . . . . 73.450000000000003 110.614 179.23 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 85' ' ' ASP . . . . . 0.432 ' HB3' HG23 ' A' ' 127' ' ' VAL . 35.7 m-20 -80.31 150.36 29.98 Favored 'General case' 0 N--CA 1.478 0.971 0 C-N-CA 123.898 0.879 . . . . 65.319999999999993 112.199 -174.597 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 6.9 tp10 -78.26 -62.55 1.64 Allowed 'General case' 0 C--N 1.352 0.687 0 CA-C-N 115.425 -0.807 . . . . 73.150000000000006 111.403 -178.02 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 23.0 p30 -176.75 143.46 0.45 Allowed 'General case' 0 N--CA 1.48 1.056 0 C-N-CA 124.419 1.087 . . . . 63.240000000000002 109.159 -175.825 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 98.8 m-85 -89.3 50.11 1.87 Allowed 'General case' 0 N--CA 1.491 1.585 0 CA-C-O 121.607 0.718 . . . . 63.549999999999997 111.448 -168.073 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 70.9 mt -67.86 -48.16 76.46 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.695 0 C-N-CA 124.145 0.978 . . . . 62.25 109.885 174.202 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 90' ' ' LEU . . . . . 0.532 HD11 ' HB2' ' A' ' 25' ' ' PHE . 74.5 mt -99.89 122.69 43.2 Favored 'General case' 0 C--O 1.241 0.63 0 CA-C-N 115.462 -0.79 . . . . 64.409999999999997 110.585 -174.665 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 44.0 mtmt -119.89 171.71 8.23 Favored 'General case' 0 N--CA 1.475 0.807 0 C-N-CA 124.073 0.949 . . . . 70.040000000000006 110.4 177.098 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 92' ' ' HIS . . . . . 0.559 ' HA ' HG13 ' A' ' 97' ' ' ILE . 13.0 m-70 -87.59 41.65 1.0 Allowed 'General case' 0 N--CA 1.482 1.15 0 C-N-CA 124.223 1.009 . . . . 64.530000000000001 110.297 -176.115 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 13.0 t -84.92 1.49 47.05 Favored 'General case' 0 CA--C 1.555 1.16 0 C-N-CA 123.986 0.914 . . . . 72.439999999999998 111.679 -174.777 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -140.53 161.22 26.58 Favored Glycine 0 C--N 1.344 1.002 0 CA-C-O 119.552 -0.582 . . . . 72.319999999999993 111.709 179.601 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 7.3 Cg_exo -75.27 149.74 36.03 Favored 'Trans proline' 0 C--N 1.37 1.692 0 C-N-CA 123.135 2.557 . . . . 72.120000000000005 112.146 175.295 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 96' ' ' GLY . . . . . 0.43 ' HA3' HG12 ' A' ' 132' ' ' VAL . . . 84.61 19.45 59.99 Favored Glycine 0 C--N 1.343 0.957 0 N-CA-C 114.586 0.594 . . . . 73.510000000000005 114.586 177.357 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 97' ' ' ILE . . . . . 0.559 HG13 ' HA ' ' A' ' 92' ' ' HIS . 7.8 mm -70.54 122.49 22.48 Favored 'Isoleucine or valine' 0 CA--C 1.553 1.088 0 C-N-CA 124.061 0.944 . . . . 64.340000000000003 111.99 -177.199 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 56.8 tp -104.91 124.08 48.87 Favored 'General case' 0 N--CA 1.482 1.133 0 C-N-CA 123.266 0.626 . . . . 64.409999999999997 110.548 179.813 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 32.2 t -151.22 154.42 36.8 Favored 'General case' 0 CA--C 1.548 0.882 0 C-N-CA 123.627 0.771 . . . . 71.329999999999998 109.822 179.685 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 100' ' ' MET . . . . . 0.632 ' HA ' ' HA ' ' A' ' 112' ' ' PHE . 85.3 mtp -86.25 141.34 29.36 Favored 'General case' 0 N--CA 1.492 1.655 0 CA-C-N 118.272 0.487 . . . . 62.409999999999997 109.79 179.324 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 101' ' ' ALA . . . . . 0.432 ' HB3' ' HB2' ' A' ' 111' ' ' GLN . . . -73.07 162.41 29.49 Favored 'General case' 0 N--CA 1.487 1.401 0 N-CA-C 112.432 0.531 . . . . 41.219999999999999 112.432 -169.75 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 21.3 p-10 -161.71 170.16 20.17 Favored 'General case' 0 N--CA 1.474 0.753 0 CA-C-N 115.736 -0.665 . . . . 64.439999999999998 111.295 -174.28 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -103.73 -20.05 14.1 Favored 'General case' 0 N--CA 1.477 0.899 0 C-N-CA 124.124 0.97 . . . . 62.340000000000003 110.575 169.412 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 167.41 -151.38 18.96 Favored Glycine 0 CA--C 1.536 1.403 0 CA-C-O 119.269 -0.739 . . . . 52.130000000000003 111.439 -173.473 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 31.4 Cg_exo -62.46 144.07 94.21 Favored 'Trans proline' 0 C--N 1.37 1.709 0 C-N-CA 122.751 2.301 . . . . 73.140000000000001 112.671 175.108 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 64.4 t30 66.93 9.89 7.21 Favored 'General case' 0 N--CA 1.493 1.695 0 C-N-CA 124.745 1.218 . . . . 73.430000000000007 112.578 175.03 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 107' ' ' THR . . . . . 0.805 ' HA ' ' HD2' ' A' ' 82' ' ' LYS . 46.8 p -114.45 2.74 14.74 Favored 'General case' 0 N--CA 1.474 0.765 0 O-C-N 121.688 -0.632 . . . . 71.420000000000002 112.04 177.945 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 39.8 t30 -71.96 131.87 43.54 Favored 'General case' 0 N--CA 1.475 0.787 0 N-CA-C 108.925 -0.769 . . . . 74.219999999999999 108.925 174.924 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 112.43 22.15 5.91 Favored Glycine 0 N--CA 1.468 0.793 0 CA-C-O 120.239 -0.201 . . . . 44.130000000000003 113.08 -176.058 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 27.7 p -125.11 120.1 30.45 Favored 'General case' 0 N--CA 1.47 0.539 0 N-CA-C 107.745 -1.205 . . . . 74.019999999999996 107.745 169.21 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 111' ' ' GLN . . . . . 0.432 ' HB2' ' HB3' ' A' ' 101' ' ' ALA . 49.4 mt-30 63.41 176.95 0.16 Allowed 'General case' 0 N--CA 1.492 1.637 0 C-N-CA 124.133 0.973 . . . . 74.450000000000003 111.769 -171.897 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 112' ' ' PHE . . . . . 0.632 ' HA ' ' HA ' ' A' ' 100' ' ' MET . 44.9 p90 -139.88 159.46 42.13 Favored 'General case' 0 N--CA 1.476 0.87 0 C-N-CA 124.249 1.02 . . . . 74.239999999999995 108.461 175.478 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 113' ' ' PHE . . . . . . . . . . . . . 54.0 p90 -152.59 153.83 34.17 Favored 'General case' 0 N--CA 1.471 0.606 0 CA-C-O 121.004 0.431 . . . . 70.239999999999995 111.191 178.901 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 114' ' ' ILE . . . . . . . . . . . . . 9.3 mt -119.73 101.96 12.02 Favored 'Isoleucine or valine' 0 C--O 1.245 0.831 0 N-CA-C 107.663 -1.236 . . . . 44.210000000000001 107.663 176.468 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 115' ' ' CYS . . . . . 0.407 ' HB2' ' HB ' ' A' ' 97' ' ' ILE . 69.9 m -62.31 104.77 0.53 Allowed 'General case' 0 CA--C 1.537 0.46 0 N-CA-C 108.602 -0.888 . . . . 63.530000000000001 108.602 169.502 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 116' ' ' THR . . . . . 0.604 HG22 HG12 ' A' ' 139' ' ' VAL . 64.3 p -69.45 -35.15 75.37 Favored 'General case' 0 N--CA 1.473 0.725 0 C-N-CA 123.461 0.705 . . . . 73.310000000000002 110.334 -175.708 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -107.87 167.17 10.17 Favored 'General case' 0 C--O 1.246 0.887 0 CA-C-N 114.716 -1.129 . . . . 44.310000000000002 109.289 174.465 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 20.7 ptmt -73.73 91.23 1.89 Allowed 'General case' 0 CA--C 1.545 0.769 0 CA-C-O 122.013 0.911 . . . . 75.209999999999994 109.954 174.757 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 119' ' ' THR . . . . . . . . . . . . . 58.4 p -86.97 83.28 7.54 Favored 'General case' 0 CA--C 1.542 0.663 0 CA-C-O 121.997 0.904 . . . . 62.539999999999999 109.022 -179.242 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 15.9 pt-20 -79.72 -15.23 57.91 Favored 'General case' 0 N--CA 1.48 1.056 0 CA-C-N 115.129 -0.941 . . . . 44.240000000000002 112.406 -167.953 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 121' ' ' TRP . . . . . . . . . . . . . 44.2 p90 -71.97 -14.62 61.95 Favored 'General case' 0 N--CA 1.481 1.1 0 C-N-CA 122.977 0.511 . . . . 64.319999999999993 110.832 172.928 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 54.2 mt -88.37 6.47 37.2 Favored 'General case' 0 N--CA 1.474 0.729 0 C-N-CA 123.121 0.568 . . . . 71.140000000000001 111.092 174.238 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 30.7 m-20 -79.29 136.84 37.15 Favored 'General case' 0 N--CA 1.474 0.759 0 N-CA-C 107.905 -1.146 . . . . 52.240000000000002 107.905 167.546 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 95.42 -24.3 29.79 Favored Glycine 0 N--CA 1.472 1.067 0 N-CA-C 111.17 -0.772 . . . . 64.019999999999996 111.17 -168.408 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 125' ' ' LYS . . . . . 0.631 ' HG3' ' H ' ' A' ' 126' ' ' HIS . 12.2 tppt? -75.27 -169.45 0.97 Allowed 'General case' 0 CA--C 1.563 1.48 0 N-CA-C 107.913 -1.143 . . . . 73.530000000000001 107.913 169.274 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 126' ' ' HIS . . . . . 0.631 ' H ' ' HG3' ' A' ' 125' ' ' LYS . 43.2 p-80 -67.56 157.59 34.02 Favored 'General case' 0 CA--C 1.549 0.941 0 C-N-CA 123.919 0.887 . . . . 75.140000000000001 111.685 -173.347 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 127' ' ' VAL . . . . . 0.491 HG12 ' O ' ' A' ' 128' ' ' VAL . 43.1 t -67.86 140.45 19.16 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.85 0 CA-C-N 114.292 -1.322 . . . . 73.349999999999994 112.466 -173.033 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 128' ' ' VAL . . . . . 0.501 HG11 HD12 ' A' ' 97' ' ' ILE . 97.2 t -80.98 154.28 4.26 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.832 0 C-N-CA 124.803 1.241 . . . . 62.130000000000003 109.276 170.429 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 129' ' ' PHE . . . . . 0.523 ' CE2' ' HG3' ' A' ' 100' ' ' MET . 37.6 p90 -131.57 -17.41 2.91 Favored 'General case' 0 N--CA 1.484 1.239 0 O-C-N 121.626 -0.671 . . . . 63.520000000000003 111.663 177.938 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . -138.4 175.01 21.69 Favored Glycine 0 C--N 1.342 0.904 0 CA-C-O 121.431 0.462 . . . . 73.129999999999995 113.314 -169.283 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 31.3 ttpt -160.81 136.07 7.82 Favored 'General case' 0 CA--C 1.536 0.431 0 N-CA-C 108.205 -1.035 . . . . 71.409999999999997 108.205 -178.565 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 132' ' ' VAL . . . . . 0.43 HG12 ' HA3' ' A' ' 96' ' ' GLY . 13.3 p -72.25 130.97 35.31 Favored 'Isoleucine or valine' 0 CA--C 1.553 1.063 0 N-CA-C 109.251 -0.648 . . . . 62.140000000000001 109.251 173.239 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 133' ' ' LYS . . . . . 0.802 ' HD2' ' HB2' ' A' ' 23' ' ' GLU . 19.9 ptmt -116.15 -26.96 7.04 Favored 'General case' 0 N--CA 1.48 1.042 0 C-N-CA 123.582 0.753 . . . . 73.25 110.257 -179.721 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 134' ' ' GLU . . . . . 0.456 ' HB2' ' HB2' ' A' ' 21' ' ' SER . 71.3 mm-40 -131.24 130.22 42.62 Favored 'General case' 0 N--CA 1.471 0.617 0 C-N-CA 124.656 1.183 . . . . 54.149999999999999 108.558 175.308 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 135' ' ' GLY . . . . . 0.414 ' O ' HG23 ' A' ' 139' ' ' VAL . . . 90.89 27.71 18.19 Favored Glycine 0 N--CA 1.468 0.829 0 CA-C-O 119.569 -0.573 . . . . 62.049999999999997 113.688 175.444 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 136' ' ' MET . . . . . . . . . . . . . 6.4 tpt -58.76 -43.7 90.39 Favored 'General case' 0 N--CA 1.486 1.333 0 C-N-CA 123.561 0.745 . . . . 74.540000000000006 110.52 174.964 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 137' ' ' ASN . . . . . . . . . . . . . 18.7 m120 -60.61 -37.23 80.73 Favored 'General case' 0 N--CA 1.479 1.016 0 CA-C-N 115.625 -0.716 . . . . 73.540000000000006 111.283 178.29 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 138' ' ' ILE . . . . . . . . . . . . . 43.4 mm -67.78 -41.32 85.07 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.035 0 C-N-CA 123.555 0.742 . . . . 75.129999999999995 110.617 -179.566 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 139' ' ' VAL . . . . . 0.604 HG12 HG22 ' A' ' 116' ' ' THR . 96.1 t -61.5 -44.1 98.01 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.979 0 C-N-CA 123.503 0.721 . . . . 73.340000000000003 110.699 177.664 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 41.7 mt-10 -69.11 -34.24 74.76 Favored 'General case' 0 N--CA 1.477 0.914 0 CA-C-N 115.455 -0.793 . . . . 75.530000000000001 111.02 178.121 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -73.11 -33.8 65.78 Favored 'General case' 0 N--CA 1.475 0.822 0 C-N-CA 123.367 0.667 . . . . 72.329999999999998 111.669 -178.863 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 142' ' ' MET . . . . . 0.561 ' HB2' HD13 ' A' ' 156' ' ' ILE . 21.8 ptt? -79.38 -27.14 41.91 Favored 'General case' 0 N--CA 1.473 0.7 0 C-N-CA 122.423 0.289 . . . . 72.010000000000005 110.414 177.985 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 143' ' ' GLU . . . . . 0.497 ' HB2' ' SG ' ' A' ' 62' ' ' CYS . 33.4 tt0 -59.36 -29.3 67.58 Favored 'General case' 0 N--CA 1.482 1.144 0 C-N-CA 123.041 0.536 . . . . 73.049999999999997 111.609 176.134 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 144' ' ' ARG . . . . . . . . . . . . . 80.1 mtp180 -64.94 -21.45 66.83 Favored 'General case' 0 CA--C 1.543 0.707 0 C-N-CA 123.704 0.802 . . . . 72.439999999999998 112.365 -178.554 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 145' ' ' PHE . . . . . 0.499 ' HB2' HD11 ' A' ' 156' ' ' ILE . 77.6 m-85 -81.47 -12.7 58.79 Favored 'General case' 0 N--CA 1.478 0.933 0 C-N-CA 122.502 0.321 . . . . 71.120000000000005 111.337 175.554 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . -70.75 166.6 51.6 Favored Glycine 0 CA--C 1.531 1.034 0 N-CA-C 113.898 0.319 . . . . 55.409999999999997 113.898 179.347 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 14.7 m -134.86 161.27 35.7 Favored 'General case' 0 N--CA 1.479 0.994 0 C-N-CA 124.376 1.07 . . . . 74.299999999999997 109.749 -179.792 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 148' ' ' ARG . . . . . . . . . . . . . 22.8 mmt85 -68.3 -26.51 65.68 Favored 'General case' 0 N--CA 1.484 1.261 0 C-N-CA 123.557 0.743 . . . . 70.540000000000006 112.464 -176.714 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 149' ' ' ASN . . . . . . . . . . . . . 30.1 p-10 -84.33 0.47 49.09 Favored 'General case' 0 N--CA 1.486 1.33 0 C-N-CA 122.996 0.518 . . . . 70.239999999999995 111.452 175.682 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . 95.29 -6.16 68.4 Favored Glycine 0 C--N 1.349 1.26 0 CA-C-O 119.683 -0.509 . . . . 55.009999999999998 112.982 179.445 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 53.8 tttp -62.94 141.31 58.77 Favored 'General case' 0 N--CA 1.475 0.823 0 C-N-CA 123.035 0.534 . . . . 64.310000000000002 111.072 179.987 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 152' ' ' THR . . . . . . . . . . . . . 26.4 p -102.74 131.8 49.33 Favored 'General case' 0 C--O 1.244 0.811 0 N-CA-C 108.776 -0.824 . . . . 71.420000000000002 108.776 166.686 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 153' ' ' SER . . . . . . . . . . . . . 16.4 m -72.49 -23.38 61.02 Favored 'General case' 0 N--CA 1.473 0.696 0 C-N-CA 123.834 0.854 . . . . 45.020000000000003 110.598 178.131 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 154' ' ' LYS . . . . . 0.404 ' HB3' HG13 ' A' ' 12' ' ' VAL . 73.6 mmtt -134.88 143.38 46.94 Favored 'General case' 0 C--O 1.241 0.625 0 C-N-CA 125.338 1.455 . . . . 73.439999999999998 108.289 -178.678 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 3.8 tppp? -74.63 89.55 2.24 Favored 'General case' 0 C--N 1.345 0.373 0 N-CA-C 108.903 -0.777 . . . . 71.319999999999993 108.903 177.761 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 156' ' ' ILE . . . . . 0.561 HD13 ' HB2' ' A' ' 142' ' ' MET . 66.5 mt -84.02 130.17 36.36 Favored 'Isoleucine or valine' 0 C--O 1.222 -0.367 0 N-CA-C 106.967 -1.494 . . . . 72.239999999999995 106.967 179.989 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 157' ' ' THR . . . . . 0.406 ' HA ' ' HA ' ' A' ' 52' ' ' CYS . 4.8 t -154.44 156.54 36.95 Favored 'General case' 0 C--O 1.237 0.424 0 C-N-CA 122.74 0.416 . . . . 72.209999999999994 110.651 -167.166 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 158' ' ' ILE . . . . . . . . . . . . . 74.1 mt -75.2 98.33 1.39 Allowed 'Isoleucine or valine' 0 CA--C 1.539 0.553 0 N-CA-C 109.015 -0.735 . . . . 74.019999999999996 109.015 172.963 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 159' ' ' ALA . . . . . 0.568 ' HB2' ' HB2' ' A' ' 11' ' ' ALA . . . -53.6 -53.65 48.75 Favored 'General case' 0 N--CA 1.472 0.667 0 C-N-CA 123.629 0.772 . . . . 75.010000000000005 111.289 177.155 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 160' ' ' ASP . . . . . . . . . . . . . 25.9 t70 -156.33 152.87 28.16 Favored 'General case' 0 N--CA 1.476 0.834 0 CA-C-N 116.321 -0.399 . . . . 74.019999999999996 111.03 -177.77 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 161' ' ' CYS . . . . . . . . . . . . . 23.7 p -102.8 -171.45 1.95 Allowed 'General case' 0 N--CA 1.475 0.805 0 C-N-CA 124.888 1.275 . . . . 42.229999999999997 109.76 175.501 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 162' ' ' GLY . . . . . . . . . . . . . . . 130.49 52.25 0.1 Allowed Glycine 0 C--N 1.346 1.086 0 N-CA-C 111.176 -0.77 . . . . 71.230000000000004 111.176 -171.314 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 163' ' ' GLN . . . . . 0.837 ' HB2' ' HA ' ' A' ' 6' ' ' VAL . 3.6 pt20 -52.48 126.6 19.93 Favored 'General case' 0 CA--C 1.552 1.02 0 C-N-CA 124.527 1.131 . . . . 54.200000000000003 113.57 -169.82 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 164' ' ' LEU . . . . . 0.459 ' O ' ' HB ' ' A' ' 5' ' ' THR . 88.1 mt -85.57 99.77 11.48 Favored 'General case' 0 C--O 1.216 -0.706 0 CA-C-N 115.586 -0.734 . . . . 63.240000000000002 109.312 -175.114 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 165' ' ' GLU . . . . . . . . . . . . . 12.7 pt-20 . . . . . 0 C--O 1.252 1.208 0 CA-C-O 119.279 -0.391 . . . . 71.209999999999994 110.006 -178.308 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' B' B ' 216' ' ' PRO . . . . . . . . . . . . . 17.1 Cg_exo . . . . . 0 N--CA 1.49 1.311 0 N-CA-C 109.882 -0.853 . . . . 72.310000000000002 109.882 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' B' B ' 217' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -101.33 174.22 3.08 Favored Pre-proline 0 CA--C 1.554 1.133 0 C-N-CA 124.508 1.123 . . . . 63.149999999999999 109.036 176.205 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 218' ' ' PRO . . . . . . . . . . . . . 75.0 Cg_exo -54.26 95.34 0.04 OUTLIER 'Trans proline' 0 C--N 1.384 2.438 0 C-N-CA 122.114 1.876 . . . . 73.049999999999997 111.516 164.609 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 219' ' ' GLY . . . . . . . . . . . . . . . 170.0 148.51 5.93 Favored Glycine 0 CA--C 1.534 1.264 0 CA-C-N 115.617 -0.719 . . . . 63.310000000000002 111.87 -178.006 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 220' ' ' PRO . . . . . . . . . . . . . 88.0 Cg_endo -76.85 169.75 21.11 Favored 'Trans proline' 0 C--N 1.37 1.688 0 C-N-CA 123.34 2.693 . . . . 73.349999999999994 114.823 -175.334 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 221' ' ' TYR . . . . . . . . . . . . . 91.4 m-85 -89.52 137.93 31.9 Favored 'General case' 0 N--CA 1.487 1.404 0 C-N-CA 124.175 0.99 . . . . 75.219999999999999 111.42 -176.44 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 222' ' ' ALA . . . . . . . . . . . . . . . -120.58 -170.59 2.02 Favored 'General case' 0 N--CA 1.477 0.925 0 C-N-CA 124.932 1.293 . . . . 52.240000000000002 112.586 -170.045 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 223' ' ' GLN . . . . . . . . . . . . . 34.8 mt-30 -72.42 115.57 40.51 Favored Pre-proline 0 CA--C 1.549 0.938 0 N-CA-C 108.57 -0.9 . . . . 72.5 108.57 171.07 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 224' ' ' PRO . . . . . . . . . . . . . 13.8 Cg_exo . . . . . 0 C--N 1.372 1.805 0 C-N-CA 122.61 2.207 . . . . 72.310000000000002 111.043 177.779 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 3.8 mpp? . . . . . 0 N--CA 1.482 1.15 0 N-CA-C 110.196 -0.298 . . . . 72.439999999999998 110.196 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 6.9 p -60.82 -32.67 52.7 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.271 0 C-N-CA 124.346 1.059 . . . . 53.130000000000003 110.761 173.159 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 3' ' ' ASN . . . . . 0.571 HD22 ' HA ' ' A' ' 25' ' ' PHE . 17.1 m120 -68.45 122.86 86.09 Favored Pre-proline 0 CA--C 1.542 0.651 0 C-N-CA 124.795 1.238 . . . . 73.109999999999999 111.234 -175.877 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 4' ' ' PRO . . . . . 0.449 ' HG2' ' HB2' ' A' ' 24' ' ' LEU . 56.0 Cg_endo -68.28 153.19 74.93 Favored 'Trans proline' 0 C--N 1.369 1.634 0 C-N-CA 122.366 2.044 . . . . 74.409999999999997 110.517 170.216 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 5' ' ' THR . . . . . 0.515 ' HB ' ' O ' ' A' ' 164' ' ' LEU . 76.3 m -123.55 136.6 54.63 Favored 'General case' 0 C--O 1.236 0.374 0 N-CA-C 109.672 -0.492 . . . . 75.239999999999995 109.672 177.427 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . 0.49 ' HA ' ' HB2' ' A' ' 163' ' ' GLN . 17.3 m -102.67 145.99 11.3 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.36 0 C-N-CA 123.754 0.822 . . . . 72.510000000000005 109.653 174.813 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 7' ' ' PHE . . . . . 0.497 ' H ' ' HA ' ' A' ' 163' ' ' GLN . 84.3 t80 -121.47 133.53 55.05 Favored 'General case' 0 C--O 1.237 0.415 0 C-N-CA 123.896 0.879 . . . . 72.010000000000005 109.169 -176.342 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 8' ' ' PHE . . . . . 0.431 ' HD2' ' HE1' ' A' ' 22' ' ' PHE . 36.5 m-85 -133.43 164.87 26.17 Favored 'General case' 0 C--O 1.24 0.556 0 C-N-CA 124.11 0.964 . . . . 71.230000000000004 109.873 172.209 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 19.3 m-20 -118.2 112.89 20.72 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 114.209 -1.36 . . . . 73.209999999999994 107.819 173.039 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 10' ' ' ILE . . . . . 0.464 HG21 ' SD ' ' A' ' 142' ' ' MET . 40.3 mm -81.98 134.0 27.98 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.566 0 N-CA-C 108.853 -0.795 . . . . 75.409999999999997 108.853 177.906 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 11' ' ' ALA . . . . . 0.551 ' HB2' ' HB2' ' A' ' 159' ' ' ALA . . . -135.08 111.29 9.63 Favored 'General case' 0 N--CA 1.468 0.448 0 C-N-CA 123.482 0.713 . . . . 70.120000000000005 110.905 -173.064 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . 0.503 HG22 HG12 ' A' ' 156' ' ' ILE . 85.5 t -94.82 129.15 45.39 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.832 0 N-CA-C 108.14 -1.059 . . . . 74.140000000000001 108.14 178.708 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 22.9 m-20 68.92 13.96 8.85 Favored 'General case' 0 N--CA 1.493 1.684 0 C-N-CA 124.691 1.196 . . . . 74.420000000000002 110.481 -170.507 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 80.3 -2.62 76.14 Favored Glycine 0 C--N 1.354 1.55 0 CA-C-O 120.186 -0.23 . . . . 71.439999999999998 112.792 -168.972 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 18.3 mm-40 -93.17 117.73 67.55 Favored Pre-proline 0 C--O 1.243 0.751 0 C-N-CA 124.025 0.93 . . . . 74.5 109.454 178.722 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 92.5 Cg_exo -45.51 105.19 0.07 OUTLIER 'Trans proline' 0 C--N 1.378 2.13 0 C-N-CA 123.912 3.075 . . . . 70.310000000000002 113.681 179.302 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 31.9 tp -76.36 -35.54 58.65 Favored 'General case' 0 N--CA 1.477 0.915 0 C-N-CA 123.574 0.75 . . . . 74.409999999999997 109.411 179.219 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 166.52 -176.47 41.68 Favored Glycine 0 C--N 1.337 0.635 0 CA-C-N 115.617 -0.72 . . . . 72.219999999999999 111.662 178.244 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 19.9 ptt85 -106.58 148.13 28.64 Favored 'General case' 0 N--CA 1.472 0.644 0 C-N-CA 122.739 0.416 . . . . 74.030000000000001 110.088 -175.641 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 20' ' ' VAL . . . . . 0.401 HG13 HG13 ' A' ' 132' ' ' VAL . 81.9 t -136.7 142.08 39.06 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.517 0 N-CA-C 108.635 -0.876 . . . . 72.040000000000006 108.635 176.788 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 15.7 m -130.21 132.79 46.16 Favored 'General case' 0 CA--C 1.542 0.662 0 N-CA-C 108.664 -0.865 . . . . 50.439999999999998 108.664 173.688 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 22' ' ' PHE . . . . . 0.431 ' HE1' ' HD2' ' A' ' 8' ' ' PHE . 40.8 m-85 -111.28 125.84 54.26 Favored 'General case' 0 N--CA 1.475 0.796 0 C-N-CA 123.516 0.726 . . . . 73.519999999999996 109.697 -179.524 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 37.0 tt0 -76.91 111.39 12.4 Favored 'General case' 0 CA--C 1.546 0.815 0 C-N-CA 123.252 0.621 . . . . 72.319999999999993 109.894 172.494 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . 0.449 ' HB2' ' HG2' ' A' ' 4' ' ' PRO . 76.1 mt -77.9 125.89 30.03 Favored 'General case' 0 N--CA 1.471 0.606 0 C-N-CA 123.325 0.65 . . . . 72.129999999999995 110.163 175.305 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 25' ' ' PHE . . . . . 0.571 ' HA ' HD22 ' A' ' 3' ' ' ASN . 90.8 m-85 -85.53 62.49 7.5 Favored 'General case' 0 CA--C 1.538 0.499 0 C-N-CA 123.777 0.831 . . . . 72.209999999999994 110.702 178.961 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -69.65 -8.56 48.68 Favored 'General case' 0 CA--C 1.547 0.845 0 CA-C-N 115.387 -0.824 . . . . 73.239999999999995 111.627 179.008 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 13.2 p-10 -76.23 -31.68 58.5 Favored 'General case' 0 CA--C 1.549 0.939 0 C-N-CA 123.427 0.691 . . . . 73.230000000000004 110.956 175.432 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 28' ' ' LYS . . . . . 0.513 ' HD2' HD21 ' A' ' 90' ' ' LEU . 62.0 mttp -106.18 -47.69 3.76 Favored 'General case' 0 N--CA 1.487 1.404 0 C-N-CA 123.261 0.624 . . . . 65.099999999999994 111.137 -176.211 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 21.1 m -122.6 67.58 29.55 Favored Pre-proline 0 CA--C 1.563 1.475 0 C-N-CA 123.803 0.841 . . . . 73.549999999999997 110.144 -179.914 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 38.4 Cg_endo -62.17 -30.74 82.45 Favored 'Trans proline' 0 C--N 1.384 2.399 0 C-N-CA 122.704 2.269 . . . . 71.099999999999994 112.264 -175.924 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 64.4 tttm -69.22 -51.14 40.72 Favored 'General case' 0 CA--C 1.543 0.7 0 C-N-CA 124.559 1.143 . . . . 74.040000000000006 111.223 -177.451 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 16.5 m -75.03 -30.15 61.01 Favored 'General case' 0 CA--C 1.551 1.009 0 CA-C-N 115.271 -0.877 . . . . 71.400000000000006 111.041 -175.264 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -72.81 -41.71 64.63 Favored 'General case' 0 CA--C 1.544 0.74 0 C-N-CA 123.18 0.592 . . . . 73.310000000000002 110.532 176.508 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 41.9 tt0 -61.16 -39.91 91.89 Favored 'General case' 0 N--CA 1.486 1.358 0 C-N-CA 124.002 0.921 . . . . 53.020000000000003 110.732 177.359 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 35' ' ' ASN . . . . . 0.426 ' O ' ' HG ' ' A' ' 39' ' ' LEU . 35.5 t30 -51.55 -67.28 0.26 Allowed 'General case' 0 CA--C 1.548 0.869 0 O-C-N 124.734 1.271 . . . . 54.420000000000002 111.034 178.083 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 85.0 t80 -62.23 -37.83 86.87 Favored 'General case' 0 N--CA 1.474 0.741 0 C-N-CA 123.156 0.582 . . . . 54.520000000000003 111.677 -176.161 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 73.8 ttt180 -59.03 -45.53 90.51 Favored 'General case' 0 CA--C 1.542 0.673 0 C-N-CA 123.419 0.687 . . . . 64.010000000000005 110.877 -179.936 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 38' ' ' ALA . . . . . 0.416 ' HB1' ' HG2' ' A' ' 44' ' ' LYS . . . -69.95 -30.09 67.39 Favored 'General case' 0 N--CA 1.472 0.674 0 C-N-CA 123.453 0.701 . . . . 75.129999999999995 111.748 -179.869 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 39' ' ' LEU . . . . . 0.426 ' HG ' ' O ' ' A' ' 35' ' ' ASN . 90.2 mt -67.22 -37.46 83.62 Favored 'General case' 0 N--CA 1.477 0.903 0 C-N-CA 123.241 0.616 . . . . 44.030000000000001 110.684 173.667 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 36.9 m -77.77 -41.02 38.93 Favored 'General case' 0 N--CA 1.476 0.857 0 C-N-CA 123.641 0.776 . . . . 63.039999999999999 111.691 -175.493 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 41.1 p -82.21 -33.18 29.46 Favored 'General case' 0 N--CA 1.473 0.702 0 C-N-CA 123.54 0.736 . . . . 61.43 111.413 -176.344 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 92.77 24.59 22.81 Favored Glycine 0 C--N 1.342 0.909 0 CA-C-N 115.812 -0.631 . . . . 64.129999999999995 113.407 -176.86 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 45.6 mm-40 -60.99 -28.18 68.84 Favored 'General case' 0 N--CA 1.484 1.239 0 C-N-CA 122.865 0.466 . . . . 65.239999999999995 111.522 173.481 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 44' ' ' LYS . . . . . 0.416 ' HG2' ' HB1' ' A' ' 38' ' ' ALA . 30.8 mmmt -106.49 15.67 25.62 Favored 'General case' 0 N--CA 1.47 0.531 0 C-N-CA 123.806 0.843 . . . . 73.209999999999994 111.298 -178.985 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 88.01 -34.53 3.73 Favored Glycine 0 C--N 1.35 1.311 0 CA-C-O 119.807 -0.44 . . . . 63.299999999999997 113.966 175.745 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 14.3 m-85 -62.42 -47.16 85.33 Favored 'General case' 0 N--CA 1.479 1.011 0 C-N-CA 123.44 0.696 . . . . 75.310000000000002 111.624 -169.463 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 47.2 56.85 7.57 Favored Glycine 0 C--N 1.356 1.665 0 O-C-N 124.521 1.138 . . . . 75.409999999999997 115.367 168.479 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 48' ' ' TYR . . . . . 0.511 ' OH ' ' HG2' ' A' ' 76' ' ' LYS . 56.7 m-85 -55.89 91.25 0.01 OUTLIER 'General case' 0 N--CA 1.479 1.006 0 C-N-CA 124.106 0.962 . . . . 74.319999999999993 112.933 -174.68 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 49' ' ' LYS . . . . . 0.507 ' HE2' ' HA ' ' A' ' 160' ' ' ASP . 29.5 tptp -110.09 120.79 43.56 Favored 'General case' 0 C--O 1.236 0.369 0 CA-C-N 113.99 -1.459 . . . . 61.549999999999997 108.582 -179.905 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 86.13 21.08 53.67 Favored Glycine 0 C--N 1.346 1.107 0 O-C-N 123.236 0.335 . . . . 50.439999999999998 112.79 -176.279 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 23.4 t -62.39 117.15 5.75 Favored 'General case' 0 CA--C 1.549 0.931 0 C-N-CA 124.075 0.95 . . . . 72.310000000000002 110.246 -178.357 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 52' ' ' CYS . . . . . . . . . . . . . 23.2 p -92.94 125.8 37.72 Favored 'General case' 0 C--O 1.24 0.566 0 C-N-CA 123.593 0.757 . . . . 74.329999999999998 112.573 -169.773 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 53' ' ' PHE . . . . . 0.745 ' HA ' ' HA2' ' A' ' 64' ' ' GLY . 64.1 m-85 -65.21 111.91 3.18 Favored 'General case' 0 CA--C 1.539 0.554 0 CA-C-N 115.035 -0.984 . . . . 73.239999999999995 108.956 164.404 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 21.8 p-80 -125.36 4.82 7.71 Favored 'General case' 0 N--CA 1.483 1.177 0 C-N-CA 123.447 0.699 . . . . 73.219999999999999 111.599 -175.983 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 65.5 ttt-85 -148.87 101.61 3.2 Favored 'General case' 0 N--CA 1.473 0.716 0 N-CA-C 109.431 -0.581 . . . . 75.239999999999995 109.431 176.648 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 56' ' ' ILE . . . . . 0.467 HG21 ' HA ' ' A' ' 143' ' ' GLU . 64.3 mt -133.7 134.12 56.55 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.098 0 C-N-CA 122.73 0.412 . . . . 71.040000000000006 110.007 -179.964 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 57' ' ' ILE . . . . . 0.414 ' HB ' ' HD2' ' A' ' 60' ' ' PHE . 71.7 mt -117.91 120.06 33.07 Favored Pre-proline 0 CA--C 1.55 0.964 0 N-CA-C 107.882 -1.155 . . . . 72.150000000000006 107.882 171.177 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 58' ' ' PRO . . . . . 0.525 ' HA ' ' HG2' ' A' ' 143' ' ' GLU . 28.0 Cg_endo -60.01 146.32 96.29 Favored 'Trans proline' 0 C--N 1.381 2.246 0 C-N-CA 123.043 2.495 . . . . 63.43 112.82 178.956 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 67.28 24.97 73.62 Favored Glycine 0 C--N 1.345 1.082 0 CA-C-N 115.74 -0.664 . . . . 74.150000000000006 113.935 179.446 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 60' ' ' PHE . . . . . 0.414 ' HD2' ' HB ' ' A' ' 57' ' ' ILE . 10.7 t80 -151.51 -72.4 0.16 Allowed 'General case' 0 N--CA 1.474 0.757 0 C-N-CA 122.978 0.511 . . . . 54.409999999999997 110.361 -175.173 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 47.1 ttp -160.04 135.05 7.91 Favored 'General case' 0 N--CA 1.474 0.728 0 CA-C-N 116.536 -0.302 . . . . 52.509999999999998 111.609 -167.112 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 62' ' ' CYS . . . . . 0.555 ' SG ' ' HB ' ' A' ' 114' ' ' ILE . 10.0 p -105.97 111.75 24.51 Favored 'General case' 0 CA--C 1.543 0.689 0 N-CA-C 108.764 -0.828 . . . . 73.109999999999999 108.764 167.898 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 63' ' ' GLN . . . . . 0.463 ' HA ' ' HA ' ' A' ' 113' ' ' PHE . 21.0 tt0 -109.13 133.76 52.59 Favored 'General case' 0 N--CA 1.48 1.062 0 C-N-CA 123.67 0.788 . . . . 54.399999999999999 110.933 -176.397 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 64' ' ' GLY . . . . . 0.745 ' HA2' ' HA ' ' A' ' 53' ' ' PHE . . . -122.52 175.24 16.42 Favored Glycine 0 C--N 1.345 1.078 0 CA-C-N 114.994 -1.003 . . . . 70.040000000000006 112.368 179.536 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 172.89 -166.26 38.81 Favored Glycine 0 C--N 1.331 0.291 0 N-CA-C 111.043 -0.823 . . . . 72.150000000000006 111.043 -179.792 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 38.8 t70 -126.32 160.8 29.38 Favored 'General case' 0 N--CA 1.476 0.863 0 C-N-CA 123.026 0.531 . . . . 74.510000000000005 110.55 -175.463 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 71.7 t80 -73.67 -32.43 63.96 Favored 'General case' 0 N--CA 1.472 0.669 0 C-N-CA 123.459 0.704 . . . . 74.430000000000007 111.211 -178.731 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 28.2 m -65.24 110.88 2.73 Favored 'General case' 0 N--CA 1.473 0.692 0 N-CA-C 109.925 -0.398 . . . . 74.25 109.925 -179.203 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 57.7 mtt85 66.99 30.52 7.49 Favored 'General case' 0 C--N 1.354 0.787 0 C-N-CA 125.052 1.341 . . . . 74.129999999999995 111.133 177.852 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 70' ' ' HIS . . . . . 0.413 ' HA ' ' HA3' ' A' ' 74' ' ' GLY . 27.5 p-80 -57.8 -23.69 53.69 Favored 'General case' 0 N--CA 1.49 1.537 0 C-N-CA 123.62 0.768 . . . . 71.230000000000004 111.774 -178.793 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 6.0 t30 -63.62 95.16 0.1 Allowed 'General case' 0 CA--C 1.543 0.694 0 C-N-CA 124.584 1.154 . . . . 73.340000000000003 109.339 168.376 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 79.05 -8.44 45.07 Favored Glycine 0 CA--C 1.529 0.92 0 N-CA-C 114.91 0.724 . . . . 72.129999999999995 114.91 174.258 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 18.0 m -135.47 -95.45 0.25 Allowed 'General case' 0 CA--C 1.558 1.279 0 CA-C-N 117.915 0.858 . . . . 71.239999999999995 110.179 -177.963 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 74' ' ' GLY . . . . . 0.413 ' HA3' ' HA ' ' A' ' 70' ' ' HIS . . . 59.51 56.15 26.61 Favored Glycine 0 C--N 1.359 1.855 0 CA-C-N 118.459 0.572 . . . . 65.049999999999997 113.626 177.776 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 134.76 49.41 0.08 OUTLIER Glycine 0 C--N 1.333 0.37 0 N-CA-C 109.443 -1.463 . . . . 70.549999999999997 109.443 -170.945 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 76' ' ' LYS . . . . . 0.511 ' HG2' ' OH ' ' A' ' 48' ' ' TYR . 22.7 ptmt -60.27 160.55 8.31 Favored 'General case' 0 N--CA 1.475 0.802 0 C-N-CA 124.113 0.965 . . . . 51.219999999999999 111.588 -177.548 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 79.1 p -90.27 174.22 7.71 Favored 'General case' 0 CA--C 1.54 0.58 0 CA-C-N 115.492 -0.776 . . . . 44.340000000000003 110.746 -178.486 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 24.8 pt -69.73 -17.54 21.38 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.818 0 C-N-CA 123.252 0.621 . . . . 74.319999999999993 110.806 176.611 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 36.5 m-85 -87.0 -16.2 36.45 Favored 'General case' 0 N--CA 1.47 0.563 0 C-N-CA 124.775 1.23 . . . . 72.310000000000002 110.643 -178.086 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 132.8 -134.04 7.35 Favored Glycine 0 C--N 1.345 1.064 0 N-CA-C 110.537 -1.025 . . . . 74.239999999999995 110.537 -177.179 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 37.1 tt0 -56.83 -54.6 44.52 Favored 'General case' 0 N--CA 1.473 0.707 0 C-N-CA 124.223 1.009 . . . . 74.409999999999997 111.427 179.453 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 82' ' ' LYS . . . . . 0.645 ' HD2' ' HA ' ' A' ' 107' ' ' THR . 21.6 pttp -168.19 177.35 5.52 Favored 'General case' 0 N--CA 1.474 0.742 0 C-N-CA 123.604 0.762 . . . . 74.319999999999993 110.69 -174.157 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 3.2 p90 -159.2 172.37 18.18 Favored 'General case' 0 CA--C 1.544 0.719 0 C-N-CA 124.73 1.212 . . . . 74.120000000000005 110.006 -174.68 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 84' ' ' GLU . . . . . 0.499 ' HA ' ' HA ' ' A' ' 106' ' ' ASN . 13.6 pt-20 -88.86 171.42 9.93 Favored 'General case' 0 N--CA 1.481 1.08 0 C-N-CA 123.094 0.558 . . . . 71.030000000000001 110.73 178.136 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 48.8 m-20 -80.63 148.71 30.14 Favored 'General case' 0 N--CA 1.478 0.928 0 N-CA-C 109.542 -0.54 . . . . 74.200000000000003 109.542 178.492 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 10.5 tp10 -86.98 -59.57 2.22 Favored 'General case' 0 N--CA 1.476 0.833 0 CA-C-O 120.606 0.241 . . . . 74.340000000000003 111.15 -179.659 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 13.0 p-10 -156.48 124.2 5.51 Favored 'General case' 0 N--CA 1.474 0.77 0 C-N-CA 123.015 0.526 . . . . 71.329999999999998 109.975 -169.603 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 79.1 m-85 -88.52 66.72 8.32 Favored 'General case' 0 N--CA 1.478 0.954 0 CA-C-O 121.683 0.754 . . . . 74.340000000000003 109.766 -174.53 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 55.0 mt -86.98 -51.6 12.74 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.587 0 CA-C-N 115.092 -0.958 . . . . 74.420000000000002 108.739 174.976 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 90' ' ' LEU . . . . . 0.543 ' HB3' ' HB ' ' A' ' 128' ' ' VAL . 94.6 mt -88.72 106.34 18.28 Favored 'General case' 0 C--O 1.24 0.57 0 CA-C-N 114.991 -1.004 . . . . 75.329999999999998 110.571 -175.789 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 50.0 mtmt -91.62 169.63 10.58 Favored 'General case' 0 C--O 1.24 0.593 0 CA-C-N 115.039 -0.982 . . . . 64.400000000000006 109.764 173.755 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 92' ' ' HIS . . . . . . . . . . . . . 20.8 m-70 -87.74 55.29 3.43 Favored 'General case' 0 N--CA 1.478 0.936 0 N-CA-C 108.826 -0.805 . . . . 72.530000000000001 108.826 -178.995 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 14.8 t -96.94 -2.67 43.2 Favored 'General case' 0 N--CA 1.475 0.776 0 CA-C-N 115.211 -0.904 . . . . 44.310000000000002 112.331 -169.707 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -131.77 178.65 17.74 Favored Glycine 0 C--N 1.342 0.912 0 CA-C-O 119.989 -0.34 . . . . 74.25 112.379 -179.564 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 76.9 Cg_endo -85.72 152.84 10.13 Favored 'Trans proline' 0 CA--C 1.551 1.373 0 C-N-CA 123.105 2.537 . . . . 73.340000000000003 112.37 172.16 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 80.66 19.96 67.1 Favored Glycine 0 C--N 1.343 0.954 0 CA-C-N 116.135 -0.484 . . . . 41.299999999999997 113.844 175.663 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 97' ' ' ILE . . . . . 0.668 ' HB ' ' HB2' ' A' ' 115' ' ' CYS . 25.8 mm -65.79 103.27 0.48 Allowed 'Isoleucine or valine' 0 CA--C 1.551 1.013 0 C-N-CA 124.138 0.975 . . . . 74.540000000000006 111.784 -175.606 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 58.5 tp -89.4 119.98 30.33 Favored 'General case' 0 C--O 1.247 0.972 0 CA-C-O 121.485 0.659 . . . . 61.399999999999999 109.819 174.264 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 46.0 t -149.55 146.38 27.32 Favored 'General case' 0 CA--C 1.549 0.929 0 C-N-CA 124.554 1.141 . . . . 63.240000000000002 108.119 -179.096 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 100' ' ' MET . . . . . 0.596 ' HA ' ' HA ' ' A' ' 112' ' ' PHE . 85.4 mtp -77.42 142.89 39.0 Favored 'General case' 0 N--CA 1.487 1.419 0 CA-C-N 118.216 0.462 . . . . 70.430000000000007 109.919 179.311 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 101' ' ' ALA . . . . . 0.538 ' HB3' ' HB2' ' A' ' 111' ' ' GLN . . . -75.04 155.52 37.17 Favored 'General case' 0 N--CA 1.474 0.731 0 CA-C-O 121.497 0.665 . . . . 72.310000000000002 112.083 -169.823 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 102' ' ' ASN . . . . . 0.423 ' HB2' ' HB ' ' A' ' 107' ' ' THR . 26.9 p-10 -167.49 166.32 14.34 Favored 'General case' 0 C--O 1.24 0.553 0 CA-C-N 114.421 -1.263 . . . . 73.030000000000001 109.744 -177.614 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -89.77 -50.98 5.74 Favored 'General case' 0 CA--C 1.537 0.452 0 N-CA-C 108.413 -0.958 . . . . 52.329999999999998 108.413 167.271 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -156.85 -156.11 7.74 Favored Glycine 0 C--N 1.347 1.193 0 CA-C-N 115.427 -0.806 . . . . 74.230000000000004 112.803 179.248 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 51.6 Cg_exo -55.7 139.62 83.49 Favored 'Trans proline' 0 C--N 1.375 1.932 0 C-N-CA 123.55 2.833 . . . . 50.109999999999999 113.165 178.134 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 106' ' ' ASN . . . . . 0.499 ' HA ' ' HA ' ' A' ' 84' ' ' GLU . 65.0 t30 66.24 8.51 5.64 Favored 'General case' 0 N--CA 1.483 1.217 0 C-N-CA 125.118 1.367 . . . . 62.420000000000002 112.487 177.215 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 107' ' ' THR . . . . . 0.645 ' HA ' ' HD2' ' A' ' 82' ' ' LYS . 3.8 m -100.72 -15.33 17.74 Favored 'General case' 0 CA--C 1.55 0.975 0 C-N-CA 123.749 0.82 . . . . 71.319999999999993 109.81 177.225 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 13.1 t30 -55.84 139.84 44.33 Favored 'General case' 0 C--O 1.208 -1.127 0 C-N-CA 125.658 1.583 . . . . 73.120000000000005 111.442 176.938 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 111.3 23.93 5.57 Favored Glycine 0 N--CA 1.469 0.886 0 N-CA-C 112.285 -0.326 . . . . 50.130000000000003 112.285 -178.872 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 13.6 p -136.98 120.8 17.46 Favored 'General case' 0 C--O 1.223 -0.311 0 C-N-CA 123.881 0.873 . . . . 72.400000000000006 108.645 178.126 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 111' ' ' GLN . . . . . 0.538 ' HB2' ' HB3' ' A' ' 101' ' ' ALA . 46.1 mt-30 59.51 -174.79 0.1 Allowed 'General case' 0 N--CA 1.489 1.489 0 C-N-CA 123.68 0.792 . . . . 74.329999999999998 111.563 -174.86 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 112' ' ' PHE . . . . . 0.596 ' HA ' ' HA ' ' A' ' 100' ' ' MET . 49.3 p90 -144.5 166.21 25.78 Favored 'General case' 0 N--CA 1.473 0.692 0 C-N-CA 123.953 0.901 . . . . 71.540000000000006 108.78 172.701 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 113' ' ' PHE . . . . . 0.463 ' HA ' ' HA ' ' A' ' 63' ' ' GLN . 51.8 p90 -152.64 154.94 36.35 Favored 'General case' 0 C--O 1.236 0.377 0 C-N-CA 122.969 0.508 . . . . 74.299999999999997 110.387 179.663 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 114' ' ' ILE . . . . . 0.555 ' HB ' ' SG ' ' A' ' 62' ' ' CYS . 16.2 mt -126.65 104.48 12.82 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.569 0 N-CA-C 108.698 -0.852 . . . . 45.5 108.698 178.492 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 115' ' ' CYS . . . . . 0.668 ' HB2' ' HB ' ' A' ' 97' ' ' ILE . 61.4 m -73.42 106.91 5.42 Favored 'General case' 0 CA--C 1.539 0.541 0 N-CA-C 109.016 -0.735 . . . . 52.450000000000003 109.016 172.772 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 116' ' ' THR . . . . . 0.426 HG22 HG12 ' A' ' 139' ' ' VAL . 75.1 p -71.39 -18.87 62.33 Favored 'General case' 0 N--CA 1.479 0.997 0 C-N-CA 123.261 0.624 . . . . 73.340000000000003 111.529 -177.273 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -124.72 169.52 11.9 Favored 'General case' 0 C--O 1.243 0.752 0 C-N-CA 123.682 0.793 . . . . 73.109999999999999 110.07 177.435 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 11.9 ptmm? -71.85 87.86 1.01 Allowed 'General case' 0 CA--C 1.55 0.95 0 CA-C-O 121.961 0.886 . . . . 73.329999999999998 110.92 176.173 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 119' ' ' THR . . . . . . . . . . . . . 52.9 p -85.34 87.89 7.44 Favored 'General case' 0 CA--C 1.544 0.734 0 CA-C-N 114.946 -1.025 . . . . 74.430000000000007 109.937 -176.894 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 120' ' ' GLU . . . . . 0.4 ' H ' ' HG2' ' A' ' 120' ' ' GLU . 7.9 pt-20 -73.07 -26.22 61.19 Favored 'General case' 0 N--CA 1.48 1.026 0 CA-C-N 114.535 -1.211 . . . . 75.209999999999994 112.934 -169.229 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 121' ' ' TRP . . . . . . . . . . . . . 39.5 p90 -70.72 -10.55 59.68 Favored 'General case' 0 N--CA 1.479 0.976 0 C-N-CA 123.732 0.813 . . . . 75.140000000000001 111.797 177.062 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 51.1 mt -95.05 0.07 54.13 Favored 'General case' 0 N--CA 1.477 0.904 0 C-N-CA 123.236 0.615 . . . . 74.450000000000003 111.673 177.514 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 32.9 m-20 -71.66 126.12 28.88 Favored 'General case' 0 N--CA 1.478 0.962 0 N-CA-C 108.801 -0.815 . . . . 73.510000000000005 108.801 172.762 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 106.82 -26.9 18.02 Favored Glycine 0 N--CA 1.471 1.02 0 N-CA-C 111.43 -0.668 . . . . 63.030000000000001 111.43 -171.933 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 125' ' ' LYS . . . . . 0.62 ' HG2' ' H ' ' A' ' 126' ' ' HIS . 20.9 ttmm -80.09 -164.96 0.75 Allowed 'General case' 0 CA--C 1.559 1.301 0 N-CA-C 107.979 -1.119 . . . . 73.019999999999996 107.979 170.907 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 126' ' ' HIS . . . . . 0.62 ' H ' ' HG2' ' A' ' 125' ' ' LYS . 8.9 t-80 -64.81 134.77 54.8 Favored 'General case' 0 C--N 1.353 0.76 0 CA-C-N 119.204 0.911 . . . . 64.099999999999994 111.132 -168.642 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 6.6 t -59.78 146.08 10.61 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.611 0 CA-C-N 112.787 -2.006 . . . . 74.329999999999998 111.091 -179.241 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 128' ' ' VAL . . . . . 0.543 ' HB ' ' HB3' ' A' ' 90' ' ' LEU . 18.9 t -74.8 156.1 6.28 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.789 0 N-CA-C 108.998 -0.742 . . . . 74.5 108.998 175.153 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 129' ' ' PHE . . . . . 0.441 ' CE2' ' HG3' ' A' ' 100' ' ' MET . 26.7 p90 -137.76 -11.72 1.54 Allowed 'General case' 0 N--CA 1.485 1.288 0 C-N-CA 122.189 0.195 . . . . 75.010000000000005 111.453 174.047 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . -148.14 159.11 27.92 Favored Glycine 0 C--N 1.341 0.84 0 N-CA-C 111.518 -0.633 . . . . 45.340000000000003 111.518 -177.056 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 35.1 ttpt -147.31 137.46 23.19 Favored 'General case' 0 N--CA 1.474 0.741 0 N-CA-C 109.39 -0.596 . . . . 75.239999999999995 109.39 178.728 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 132' ' ' VAL . . . . . 0.513 HG11 ' HA ' ' A' ' 136' ' ' MET . 37.5 t -63.91 111.89 1.18 Allowed 'Isoleucine or valine' 0 CA--C 1.543 0.705 0 O-C-N 123.658 0.599 . . . . 74.140000000000001 110.227 178.054 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 133' ' ' LYS . . . . . 0.593 ' HG3' ' HG2' ' A' ' 134' ' ' GLU . 0.0 OUTLIER -95.7 -42.42 8.39 Favored 'General case' 0 N--CA 1.474 0.751 0 C-N-CA 123.068 0.547 . . . . 60.420000000000002 109.569 172.457 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 134' ' ' GLU . . . . . 0.593 ' HG2' ' HG3' ' A' ' 133' ' ' LYS . 18.7 mm-40 -116.4 139.11 50.78 Favored 'General case' 0 N--CA 1.474 0.745 0 N-CA-C 108.674 -0.862 . . . . 74.209999999999994 108.674 -178.088 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 76.68 29.08 58.19 Favored Glycine 0 C--N 1.342 0.862 0 N-CA-C 114.156 0.422 . . . . 60.310000000000002 114.156 175.455 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 136' ' ' MET . . . . . 0.513 ' HA ' HG11 ' A' ' 132' ' ' VAL . 14.9 tpt -60.11 -38.08 81.93 Favored 'General case' 0 N--CA 1.477 0.908 0 C-N-CA 122.992 0.517 . . . . 74.299999999999997 111.216 177.647 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 137' ' ' ASN . . . . . . . . . . . . . 6.0 t30 -61.81 -39.23 91.01 Favored 'General case' 0 CA--C 1.543 0.679 0 CA-C-N 115.448 -0.796 . . . . 74.140000000000001 110.88 176.238 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 138' ' ' ILE . . . . . . . . . . . . . 49.2 mm -67.56 -35.57 73.51 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.089 0 C-N-CA 123.523 0.729 . . . . 62.329999999999998 110.868 -179.822 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 139' ' ' VAL . . . . . 0.446 HG21 HG21 ' A' ' 132' ' ' VAL . 92.1 t -65.61 -47.26 86.93 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.939 0 C-N-CA 123.561 0.744 . . . . 55.200000000000003 110.648 177.203 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 41.6 mt-10 -66.83 -34.81 78.63 Favored 'General case' 0 CA--C 1.548 0.867 0 CA-C-N 115.396 -0.82 . . . . 71.439999999999998 110.964 177.739 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -69.01 -44.06 73.55 Favored 'General case' 0 N--CA 1.475 0.815 0 C-N-CA 123.309 0.644 . . . . 51.450000000000003 110.881 -178.984 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 142' ' ' MET . . . . . 0.567 ' HB2' HD13 ' A' ' 156' ' ' ILE . 19.7 ptt? -69.29 -31.16 69.47 Favored 'General case' 0 N--CA 1.477 0.88 0 O-C-N 123.429 0.456 . . . . 73.519999999999996 110.394 179.172 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 143' ' ' GLU . . . . . 0.525 ' HG2' ' HA ' ' A' ' 58' ' ' PRO . 36.9 tt0 -62.32 -31.76 72.43 Favored 'General case' 0 CA--C 1.549 0.907 0 C-N-CA 122.784 0.434 . . . . 70.120000000000005 112.009 178.868 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 144' ' ' ARG . . . . . . . . . . . . . 33.1 mtp85 -65.27 -20.57 66.48 Favored 'General case' 0 N--CA 1.48 1.035 0 C-N-CA 122.706 0.402 . . . . 72.409999999999997 111.863 178.607 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 145' ' ' PHE . . . . . 0.534 ' HB2' HD11 ' A' ' 156' ' ' ILE . 66.3 m-85 -85.75 13.22 7.51 Favored 'General case' 0 N--CA 1.479 0.983 0 C-N-CA 123.388 0.675 . . . . 74.5 111.625 176.403 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . -98.45 -179.24 32.48 Favored Glycine 0 C--N 1.345 1.08 0 N-CA-C 111.743 -0.543 . . . . 63.119999999999997 111.743 169.838 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 10.8 m -133.45 163.09 30.14 Favored 'General case' 0 N--CA 1.478 0.944 0 C-N-CA 123.149 0.58 . . . . 73.329999999999998 111.203 -175.542 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 148' ' ' ARG . . . . . . . . . . . . . 7.3 mmm180 -67.82 -28.77 67.85 Favored 'General case' 0 N--CA 1.473 0.691 0 C-N-CA 124.383 1.073 . . . . 75.409999999999997 112.533 -177.511 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 149' ' ' ASN . . . . . . . . . . . . . 27.3 p-10 -84.58 -3.37 58.42 Favored 'General case' 0 N--CA 1.483 1.217 0 C-N-CA 123.349 0.659 . . . . 72.430000000000007 111.607 177.603 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . 100.25 -8.9 59.16 Favored Glycine 0 C--N 1.354 1.561 0 CA-C-O 119.975 -0.347 . . . . 55.409999999999997 113.188 179.028 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 59.6 tttp -65.44 143.08 57.93 Favored 'General case' 0 N--CA 1.478 0.956 0 C-N-CA 123.847 0.859 . . . . 74.25 110.408 178.336 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 152' ' ' THR . . . . . . . . . . . . . 16.5 p -92.92 114.21 26.71 Favored 'General case' 0 N--CA 1.467 0.398 0 N-CA-C 109.025 -0.732 . . . . 73.219999999999999 109.025 168.553 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 153' ' ' SER . . . . . . . . . . . . . 33.1 t -62.76 -29.02 70.38 Favored 'General case' 0 N--CA 1.475 0.784 0 C-N-CA 123.759 0.823 . . . . 72.230000000000004 110.719 177.063 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 154' ' ' LYS . . . . . 0.407 ' HB2' ' HB3' ' A' ' 145' ' ' PHE . 69.9 mmtt -124.93 145.06 50.03 Favored 'General case' 0 C--O 1.239 0.517 0 C-N-CA 123.942 0.897 . . . . 71.319999999999993 110.518 179.84 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 3.4 tppp? -79.23 99.41 7.03 Favored 'General case' 0 C--O 1.24 0.565 0 N-CA-C 109.031 -0.729 . . . . 75.319999999999993 109.031 172.651 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 156' ' ' ILE . . . . . 0.567 HD13 ' HB2' ' A' ' 142' ' ' MET . 52.3 mt -99.43 123.3 52.06 Favored 'Isoleucine or valine' 0 C--O 1.221 -0.406 0 CA-C-N 114.744 -1.116 . . . . 72.200000000000003 108.123 178.395 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 157' ' ' THR . . . . . . . . . . . . . 33.2 p -124.81 156.89 37.07 Favored 'General case' 0 N--CA 1.472 0.631 0 C-N-CA 124.13 0.972 . . . . 75.209999999999994 109.816 -177.521 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 158' ' ' ILE . . . . . . . . . . . . . 56.4 mt -82.25 93.73 2.7 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.719 0 N-CA-C 108.106 -1.072 . . . . 72.0 108.106 169.095 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 159' ' ' ALA . . . . . 0.551 ' HB2' ' HB2' ' A' ' 11' ' ' ALA . . . -54.54 -37.08 64.99 Favored 'General case' 0 N--CA 1.478 0.948 0 C-N-CA 124.759 1.224 . . . . 71.430000000000007 112.914 -177.736 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 160' ' ' ASP . . . . . 0.507 ' HA ' ' HE2' ' A' ' 49' ' ' LYS . 26.8 t0 -162.64 156.17 20.33 Favored 'General case' 0 N--CA 1.477 0.88 0 O-C-N 123.61 0.569 . . . . 74.150000000000006 111.214 -179.983 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 161' ' ' CYS . . . . . . . . . . . . . 6.9 p -123.15 -171.68 2.35 Favored 'General case' 0 N--CA 1.475 0.816 0 C-N-CA 125.255 1.422 . . . . 75.019999999999996 108.24 172.917 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 162' ' ' GLY . . . . . . . . . . . . . . . 131.42 57.93 0.09 OUTLIER Glycine 0 N--CA 1.475 1.266 0 O-C-N 121.473 -0.767 . . . . 14.220000000000001 111.507 -169.214 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 163' ' ' GLN . . . . . 0.497 ' HA ' ' H ' ' A' ' 7' ' ' PHE . 11.5 pt20 -45.36 132.71 7.65 Favored 'General case' 0 CA--C 1.547 0.838 0 C-N-CA 125.19 1.396 . . . . 74.209999999999994 114.031 -169.683 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 164' ' ' LEU . . . . . 0.515 ' O ' ' HB ' ' A' ' 5' ' ' THR . 85.1 mt -103.4 101.48 11.38 Favored 'General case' 0 N--CA 1.472 0.645 0 C-N-CA 123.976 0.911 . . . . 72.209999999999994 110.959 -179.731 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 165' ' ' GLU . . . . . . . . . . . . . 46.9 mt-10 . . . . . 0 CA--C 1.553 1.066 0 N-CA-C 108.974 -0.75 . . . . 63.020000000000003 108.974 171.701 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' B' B ' 216' ' ' PRO . . . . . 0.635 ' N ' ' HH ' ' B' ' 221' ' ' TYR . 10.0 Cg_endo . . . . . 0 CA--C 1.554 1.5 0 CA-C-O 119.46 -0.308 . . . . 54.539999999999999 111.873 . . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 217' ' ' GLU . . . . . . . . . . . . . 16.1 pt-20 -171.73 154.8 3.74 Favored Pre-proline 0 N--CA 1.487 1.409 0 C-N-CA 123.487 0.715 . . . . 75.340000000000003 110.916 -175.861 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 218' ' ' PRO . . . . . . . . . . . . . 7.9 Cg_exo -70.77 90.8 0.62 Allowed 'Trans proline' 0 C--N 1.379 2.176 0 C-N-CA 122.618 2.212 . . . . 70.040000000000006 110.804 173.089 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 219' ' ' GLY . . . . . . . . . . . . . . . 166.37 141.91 3.28 Favored Glycine 0 CA--C 1.531 1.071 0 CA-C-O 119.471 -0.627 . . . . 72.299999999999997 112.277 -179.961 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 220' ' ' PRO . . . . . . . . . . . . . 52.4 Cg_exo -60.84 159.95 27.13 Favored 'Trans proline' 0 N--CA 1.498 1.788 0 C-N-CA 123.957 3.105 . . . . 72.340000000000003 114.698 178.308 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 221' ' ' TYR . . . . . 0.635 ' HH ' ' N ' ' B' ' 216' ' ' PRO . 48.1 m-85 -128.2 150.16 50.13 Favored 'General case' 0 N--CA 1.484 1.247 0 C-N-CA 123.655 0.782 . . . . 70.239999999999995 110.704 -175.131 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 222' ' ' ALA . . . . . . . . . . . . . . . -173.07 178.79 2.4 Favored 'General case' 0 N--CA 1.474 0.753 0 O-C-N 124.367 1.042 . . . . 61.229999999999997 110.543 174.003 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 223' ' ' GLN . . . . . . . . . . . . . 4.2 mp0 51.77 56.8 16.29 Favored Pre-proline 0 CA--C 1.565 1.532 0 C-N-CA 124.448 1.099 . . . . 74.430000000000007 110.535 -172.776 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 224' ' ' PRO . . . . . . . . . . . . . 2.0 Cg_endo . . . . . 0 C--N 1.381 2.24 0 C-N-CA 123.49 2.793 . . . . 71.540000000000006 111.529 -172.65 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 97.2 mmm . . . . . 0 N--CA 1.48 1.043 0 CA-C-O 121.291 0.567 . . . . 73.329999999999998 109.617 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 11.8 p -78.0 -17.88 13.88 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.928 0 C-N-CA 123.939 0.896 . . . . 71.219999999999999 111.108 -179.007 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 13.3 m120 -55.26 113.38 5.41 Favored Pre-proline 0 C--N 1.36 1.056 0 C-N-CA 123.572 0.749 . . . . 65.430000000000007 110.909 179.504 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 19.9 Cg_endo -57.12 118.43 5.3 Favored 'Trans proline' 0 C--N 1.379 2.184 0 C-N-CA 122.889 2.392 . . . . 74.030000000000001 111.448 -174.337 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 5' ' ' THR . . . . . 0.421 ' HB ' ' O ' ' A' ' 164' ' ' LEU . 19.7 m -95.56 127.3 41.48 Favored 'General case' 0 N--CA 1.443 -0.794 0 N-CA-C 108.407 -0.96 . . . . 70.239999999999995 108.407 -176.757 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . 0.472 HG22 ' HB2' ' A' ' 22' ' ' PHE . 15.6 m -106.92 150.5 9.41 Favored 'Isoleucine or valine' 0 CA--C 1.522 -0.106 0 CA-C-N 115.536 -0.756 . . . . 71.319999999999993 109.096 -174.918 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 79.7 t80 -138.96 135.63 34.56 Favored 'General case' 0 C--O 1.239 0.531 0 C-N-CA 122.824 0.45 . . . . 73.310000000000002 110.389 -173.765 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 8' ' ' PHE . . . . . 0.448 ' HE1' ' HG ' ' A' ' 40' ' ' SER . 61.2 m-85 -141.87 165.58 27.09 Favored 'General case' 0 N--CA 1.469 0.513 0 C-N-CA 123.998 0.919 . . . . 61.210000000000001 110.504 178.946 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 11.3 m-20 -106.74 119.01 38.18 Favored 'General case' 0 N--CA 1.468 0.454 0 N-CA-C 108.012 -1.107 . . . . 61.020000000000003 108.012 165.168 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 10' ' ' ILE . . . . . 0.539 HG21 ' SD ' ' A' ' 142' ' ' MET . 48.6 mm -86.49 118.5 32.91 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.559 0 N-CA-C 109.021 -0.733 . . . . 73.420000000000002 109.021 176.532 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 11' ' ' ALA . . . . . 0.757 ' HB2' ' HB2' ' A' ' 159' ' ' ALA . . . -109.32 133.09 53.48 Favored 'General case' 0 C--O 1.219 -0.538 0 C-N-CA 123.975 0.91 . . . . 60.539999999999999 111.383 -174.689 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 43.0 t -97.64 123.54 50.12 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.533 0 N-CA-C 108.437 -0.949 . . . . 74.219999999999999 108.437 170.532 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 13' ' ' ASP . . . . . 0.454 ' HA ' ' HB2' ' A' ' 155' ' ' LYS . 66.7 m-20 61.22 15.02 6.02 Favored 'General case' 0 N--CA 1.483 1.206 0 C-N-CA 125.55 1.54 . . . . 74.439999999999998 112.928 -178.036 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 108.42 -27.32 14.05 Favored Glycine 0 C--N 1.346 1.103 0 CA-C-O 119.679 -0.512 . . . . 74.239999999999995 112.825 -176.502 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 30.8 mm-40 -89.17 122.69 68.49 Favored Pre-proline 0 N--CA 1.487 1.379 0 CA-C-N 117.666 0.733 . . . . 64.150000000000006 110.427 -179.1 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 16' ' ' PRO . . . . . 0.477 ' HA ' ' HA ' ' A' ' 11' ' ' ALA . 19.2 Cg_endo -54.36 113.22 1.26 Allowed 'Trans proline' 0 C--N 1.386 2.55 0 C-N-CA 123.344 2.696 . . . . 65.0 112.974 -177.428 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 37.2 tp -77.03 -36.72 55.92 Favored 'General case' 0 N--CA 1.479 0.991 0 C-N-CA 124.041 0.936 . . . . 72.019999999999996 109.552 175.883 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -173.4 -161.78 24.23 Favored Glycine 0 C--N 1.335 0.479 0 CA-C-N 114.671 -1.149 . . . . 32.439999999999998 111.291 -178.741 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 3.5 ptp180 -144.31 140.82 29.38 Favored 'General case' 0 N--CA 1.469 0.516 0 C-N-CA 123.374 0.67 . . . . 62.340000000000003 109.858 -176.762 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 20' ' ' VAL . . . . . 0.436 ' HA ' ' HA3' ' A' ' 135' ' ' GLY . 60.8 t -128.54 135.89 61.32 Favored 'Isoleucine or valine' 0 C--O 1.24 0.599 0 C-N-CA 124.029 0.931 . . . . 43.520000000000003 109.464 -176.213 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 31.5 t -113.39 121.03 43.13 Favored 'General case' 0 CA--C 1.547 0.841 0 C-N-CA 123.864 0.865 . . . . 54.509999999999998 108.852 172.951 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 22' ' ' PHE . . . . . 0.472 ' HB2' HG22 ' A' ' 6' ' ' VAL . 12.2 m-85 -101.0 170.87 7.99 Favored 'General case' 0 CA--C 1.543 0.706 0 N-CA-C 108.731 -0.841 . . . . 73.349999999999994 108.731 175.458 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . 0.66 ' HB2' ' HD2' ' A' ' 133' ' ' LYS . 38.9 tt0 -134.08 108.5 8.36 Favored 'General case' 0 N--CA 1.472 0.663 0 C-N-CA 123.977 0.911 . . . . 61.439999999999998 109.094 -178.557 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 13.6 mt -91.48 121.09 32.87 Favored 'General case' 0 CA--C 1.542 0.663 0 C-N-CA 122.949 0.5 . . . . 72.329999999999998 110.09 -176.726 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 25' ' ' PHE . . . . . 0.52 ' HB2' HD11 ' A' ' 90' ' ' LEU . 31.4 m-85 -86.98 69.98 10.28 Favored 'General case' 0 N--CA 1.472 0.658 0 C-N-CA 123.631 0.772 . . . . 74.319999999999993 109.777 -177.766 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -64.53 -16.07 61.97 Favored 'General case' 0 N--CA 1.48 1.034 0 N-CA-C 112.929 0.714 . . . . 60.409999999999997 112.929 -178.085 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 10.3 p-10 -72.67 -29.72 63.65 Favored 'General case' 0 CA--C 1.553 1.073 0 C-N-CA 123.279 0.632 . . . . 72.430000000000007 111.431 177.281 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 54.5 mttp -98.54 -41.65 7.66 Favored 'General case' 0 N--CA 1.485 1.319 0 C-N-CA 123.833 0.853 . . . . 75.430000000000007 110.891 -176.407 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 29' ' ' VAL . . . . . 0.517 HG21 ' HA ' ' A' ' 129' ' ' PHE . 9.7 m -129.97 70.62 82.16 Favored Pre-proline 0 CA--C 1.561 1.39 0 C-N-CA 123.992 0.917 . . . . 54.409999999999997 109.815 -178.071 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 18.5 Cg_endo -57.73 -40.07 82.35 Favored 'Trans proline' 0 C--N 1.387 2.56 0 C-N-CA 123.221 2.614 . . . . 70.150000000000006 113.39 -175.28 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 37.9 ttpt -66.87 -55.49 14.49 Favored 'General case' 0 N--CA 1.476 0.872 0 C-N-CA 123.539 0.735 . . . . 72.209999999999994 111.935 -179.587 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 5.8 m -68.74 -32.29 71.95 Favored 'General case' 0 CA--C 1.554 1.114 0 CA-C-N 115.591 -0.731 . . . . 70.400000000000006 111.455 -172.039 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -79.26 -45.5 19.63 Favored 'General case' 0 N--CA 1.477 0.878 0 C-N-CA 123.531 0.733 . . . . 64.319999999999993 111.115 179.745 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 32.3 tt0 -58.76 -35.07 72.15 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 123.604 0.565 . . . . 74.530000000000001 110.698 178.111 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 35' ' ' ASN . . . . . 0.527 ' O ' ' HG ' ' A' ' 39' ' ' LEU . 51.5 t30 -53.61 -69.25 0.12 Allowed 'General case' 0 C--N 1.353 0.751 0 O-C-N 124.267 0.98 . . . . 62.240000000000002 110.822 -179.175 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 91.4 t80 -62.83 -35.01 78.53 Favored 'General case' 0 N--CA 1.48 1.064 0 C-N-CA 123.493 0.717 . . . . 75.340000000000003 111.962 -176.128 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 56.2 ttt180 -61.74 -48.81 79.05 Favored 'General case' 0 N--CA 1.479 0.977 0 C-N-CA 123.535 0.734 . . . . 72.409999999999997 111.141 179.668 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -84.16 -19.45 34.1 Favored 'General case' 0 N--CA 1.475 0.808 0 CA-C-N 115.515 -0.766 . . . . 62.229999999999997 111.994 -174.832 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 39' ' ' LEU . . . . . 0.527 ' HG ' ' O ' ' A' ' 35' ' ' ASN . 66.4 mt -64.78 -46.1 83.52 Favored 'General case' 0 N--CA 1.474 0.752 0 N-CA-C 108.538 -0.912 . . . . 63.450000000000003 108.538 167.636 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 40' ' ' SER . . . . . 0.448 ' HG ' ' HE1' ' A' ' 8' ' ' PHE . 27.0 t -64.54 -56.21 15.54 Favored 'General case' 0 CA--C 1.543 0.683 0 C-N-CA 124.463 1.105 . . . . 71.099999999999994 112.047 -178.162 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 41' ' ' THR . . . . . 0.553 HG23 ' NE2' ' A' ' 163' ' ' GLN . 2.9 p -67.79 -30.71 70.21 Favored 'General case' 0 N--CA 1.477 0.901 0 C-N-CA 122.761 0.424 . . . . 75.439999999999998 111.541 179.652 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . 0.421 ' HA2' ' H ' ' A' ' 47' ' ' GLY . . . 84.09 29.01 32.31 Favored Glycine 0 C--N 1.345 1.069 0 CA-C-N 116.236 -0.438 . . . . 74.310000000000002 112.486 -179.06 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 21.2 mm-40 -64.49 -24.95 67.79 Favored 'General case' 0 N--CA 1.478 0.943 0 C-N-CA 123.437 0.695 . . . . 63.109999999999999 111.504 175.781 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 44' ' ' LYS . . . . . 0.548 ' HG3' HG22 ' A' ' 78' ' ' ILE . 70.8 mmtt -98.35 5.69 47.98 Favored 'General case' 0 CA--C 1.548 0.897 0 C-N-CA 124.088 0.955 . . . . 71.329999999999998 111.117 -179.936 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 79.08 39.21 20.44 Favored Glycine 0 C--N 1.348 1.218 0 CA-C-O 119.973 -0.348 . . . . 65.530000000000001 113.612 179.026 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 22.9 m-85 -123.98 -48.54 1.87 Allowed 'General case' 0 N--CA 1.485 1.3 0 CA-C-N 117.207 0.503 . . . . 64.409999999999997 111.309 -176.758 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . 0.421 ' H ' ' HA2' ' A' ' 42' ' ' GLY . . . 53.1 61.83 6.54 Favored Glycine 0 C--N 1.352 1.462 0 O-C-N 124.127 0.892 . . . . 73.140000000000001 114.461 171.009 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 48' ' ' TYR . . . . . 0.46 ' CE1' ' HA2' ' A' ' 75' ' ' GLY . 61.7 m-85 -67.51 97.94 0.63 Allowed 'General case' 0 N--CA 1.473 0.679 0 C-N-CA 123.499 0.72 . . . . 65.010000000000005 112.44 -176.289 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 3.0 tppp? -109.86 145.7 36.34 Favored 'General case' 0 CA--C 1.537 0.46 0 CA-C-N 114.532 -1.213 . . . . 62.520000000000003 108.938 172.26 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 71.01 20.63 77.99 Favored Glycine 0 C--N 1.343 0.953 0 CA-C-O 119.515 -0.603 . . . . 53.240000000000002 113.444 179.318 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 20.3 m -55.83 113.83 1.65 Allowed 'General case' 0 C--N 1.354 0.787 0 C-N-CA 123.595 0.758 . . . . 70.120000000000005 109.842 -179.324 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 52' ' ' CYS . . . . . 0.569 ' SG ' ' HB3' ' A' ' 66' ' ' ASP . 7.7 p -100.28 123.03 44.01 Favored 'General case' 0 CA--C 1.545 0.77 0 CA-C-N 115.277 -0.874 . . . . 73.540000000000006 112.505 -163.441 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 53' ' ' PHE . . . . . 0.734 ' HA ' ' HA2' ' A' ' 64' ' ' GLY . 33.3 m-85 -71.07 118.32 13.7 Favored 'General case' 0 C--O 1.239 0.504 0 C-N-CA 125.461 1.504 . . . . 73.019999999999996 109.79 171.874 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 54' ' ' HIS . . . . . 0.477 ' ND1' ' HB2' ' A' ' 66' ' ' ASP . 45.5 p-80 -115.96 -22.97 8.76 Favored 'General case' 0 N--CA 1.475 0.792 0 C-N-CA 123.772 0.829 . . . . 74.030000000000001 110.858 -176.675 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 47.9 ttt-85 -128.95 106.21 8.73 Favored 'General case' 0 C--N 1.359 1.005 0 N-CA-C 109.572 -0.529 . . . . 73.340000000000003 109.572 178.704 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 56' ' ' ILE . . . . . 0.55 HG21 ' HA ' ' A' ' 143' ' ' GLU . 56.5 mt -130.58 128.23 63.16 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.749 0 C-N-CA 123.72 0.808 . . . . 73.140000000000001 108.973 174.695 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 57' ' ' ILE . . . . . 0.409 ' HB ' ' HD2' ' A' ' 60' ' ' PHE . 76.3 mt -108.02 117.66 54.57 Favored Pre-proline 0 CA--C 1.557 1.219 0 C-N-CA 124.281 1.032 . . . . 74.329999999999998 108.256 173.254 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 58' ' ' PRO . . . . . 0.565 ' HA ' ' HG2' ' A' ' 143' ' ' GLU . 32.0 Cg_exo -58.84 131.52 42.42 Favored 'Trans proline' 0 C--N 1.382 2.313 0 C-N-CA 123.64 2.893 . . . . 64.040000000000006 112.83 179.62 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 79.2 21.09 68.31 Favored Glycine 0 CA--C 1.529 0.928 0 O-C-N 124.018 0.824 . . . . 53.329999999999998 113.597 179.885 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 60' ' ' PHE . . . . . 0.409 ' HD2' ' HB ' ' A' ' 57' ' ' ILE . 17.3 t80 -148.04 -73.42 0.2 Allowed 'General case' 0 N--CA 1.48 1.032 0 CA-C-N 117.659 0.73 . . . . 74.439999999999998 111.121 -173.888 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 61' ' ' MET . . . . . 0.411 ' SD ' ' CD1' ' A' ' 113' ' ' PHE . 58.5 ttp -159.75 142.56 13.83 Favored 'General case' 0 N--CA 1.483 1.221 0 N-CA-C 112.578 0.585 . . . . 72.150000000000006 112.578 -165.412 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 62' ' ' CYS . . . . . 0.501 ' SG ' ' HB2' ' A' ' 143' ' ' GLU . 52.2 m -117.18 116.92 28.23 Favored 'General case' 0 N--CA 1.474 0.74 0 C-N-CA 124.511 1.125 . . . . 73.409999999999997 110.179 175.145 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 15.0 pt20 -121.0 130.31 53.75 Favored 'General case' 0 N--CA 1.484 1.259 0 CA-C-O 122.103 0.954 . . . . 72.409999999999997 112.11 179.499 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 64' ' ' GLY . . . . . 0.734 ' HA2' ' HA ' ' A' ' 53' ' ' PHE . . . -113.49 -177.21 19.42 Favored Glycine 0 C--N 1.343 0.94 0 CA-C-N 113.79 -1.55 . . . . 43.109999999999999 112.758 178.27 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 98.83 73.66 1.11 Allowed Glycine 0 C--N 1.337 0.614 0 N-CA-C 110.871 -0.892 . . . . 52.039999999999999 110.871 -178.959 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 66' ' ' ASP . . . . . 0.569 ' HB3' ' SG ' ' A' ' 52' ' ' CYS . 32.6 t70 -127.56 30.29 5.36 Favored 'General case' 0 N--CA 1.482 1.141 0 C-N-CA 123.099 0.56 . . . . 70.030000000000001 109.916 172.124 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 57.0 t80 -93.8 -83.83 0.32 Allowed 'General case' 0 CA--C 1.555 1.148 0 O-C-N 122.055 -0.403 . . . . 71.299999999999997 111.044 -177.12 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 69.9 m -81.15 113.11 19.09 Favored 'General case' 0 N--CA 1.482 1.148 0 C-N-CA 123.407 0.683 . . . . 43.109999999999999 111.346 -171.307 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 60.7 ttt85 62.76 66.51 0.75 Allowed 'General case' 0 N--CA 1.476 0.856 0 C-N-CA 124.349 1.06 . . . . 52.43 109.522 -174.471 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 2.5 p-80 -74.63 74.85 2.02 Favored 'General case' 0 N--CA 1.482 1.161 0 CA-C-N 114.819 -1.082 . . . . 74.299999999999997 112.083 -175.272 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 64.5 t30 -154.72 77.98 1.05 Allowed 'General case' 0 N--CA 1.473 0.719 0 N-CA-C 108.085 -1.08 . . . . 71.239999999999995 108.085 177.163 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 63.98 22.81 67.08 Favored Glycine 0 CA--C 1.534 1.26 0 CA-C-N 115.67 -0.696 . . . . 75.329999999999998 114.044 -176.32 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 73' ' ' THR . . . . . 0.551 ' HA ' ' HB2' ' A' ' 110' ' ' SER . 46.9 m -142.53 -65.37 0.4 Allowed 'General case' 0 N--CA 1.476 0.854 0 C-N-CA 123.855 0.862 . . . . 72.519999999999996 109.492 -174.582 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 44.04 38.53 4.75 Favored Glycine 0 C--N 1.355 1.599 0 C-N-CA 124.517 1.056 . . . . 44.140000000000001 115.655 174.922 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . 0.46 ' HA2' ' CE1' ' A' ' 48' ' ' TYR . . . 149.78 54.05 0.01 OUTLIER Glycine 0 C--N 1.337 0.584 0 O-C-N 122.122 -0.634 . . . . 75.129999999999995 112.256 -161.281 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -48.22 149.62 1.45 Allowed 'General case' 0 N--CA 1.481 1.108 0 C-N-CA 124.685 1.194 . . . . 71.109999999999999 111.621 169.909 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 94.3 p -90.03 -178.4 5.43 Favored 'General case' 0 C--O 1.24 0.59 0 CA-C-O 121.781 0.8 . . . . 64.239999999999995 112.244 -169.504 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 78' ' ' ILE . . . . . 0.548 HG22 ' HG3' ' A' ' 44' ' ' LYS . 27.7 pt -72.62 -19.48 19.11 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.941 0 CA-C-N 114.909 -1.041 . . . . 65.120000000000005 110.751 175.787 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 92.8 m-85 -92.08 25.78 2.73 Favored 'General case' 0 N--CA 1.481 1.115 0 C-N-CA 123.701 0.8 . . . . 73.109999999999999 110.381 173.062 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 83.92 -105.15 2.74 Favored Glycine 0 C--N 1.343 0.939 0 N-CA-C 111.015 -0.834 . . . . 62.350000000000001 111.015 -178.243 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 43.0 tt0 -74.34 -61.26 1.92 Allowed 'General case' 0 C--O 1.242 0.7 0 C-N-CA 122.872 0.469 . . . . 75.099999999999994 110.493 -177.237 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 82' ' ' LYS . . . . . 0.729 ' HD2' ' HA ' ' A' ' 107' ' ' THR . 20.4 pttp -168.78 177.15 5.2 Favored 'General case' 0 CA--C 1.542 0.635 0 CA-C-N 115.465 -0.788 . . . . 74.439999999999998 110.475 -173.128 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 28.9 p90 -159.35 177.45 10.99 Favored 'General case' 0 CA--C 1.546 0.791 0 C-N-CA 125.467 1.507 . . . . 75.319999999999993 108.251 -174.714 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 11.5 pt-20 -94.97 167.6 11.3 Favored 'General case' 0 N--CA 1.485 1.283 0 O-C-N 121.926 -0.484 . . . . 74.400000000000006 111.552 179.224 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 25.9 m-20 -61.41 150.13 36.31 Favored 'General case' 0 N--CA 1.479 1.021 0 C-N-CA 123.82 0.848 . . . . 54.030000000000001 111.302 174.489 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 86' ' ' GLU . . . . . 0.505 ' HG2' ' HA ' ' A' ' 29' ' ' VAL . 6.3 tp10 -74.63 -61.82 1.74 Allowed 'General case' 0 N--CA 1.474 0.747 0 CA-C-N 116.55 -0.296 . . . . 73.019999999999996 111.329 -176.664 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 87' ' ' ASN . . . . . 0.425 ' O ' HG11 ' A' ' 127' ' ' VAL . 31.2 p-10 -174.32 143.97 0.9 Allowed 'General case' 0 N--CA 1.479 1.009 0 C-N-CA 123.85 0.86 . . . . 64.019999999999996 109.134 -174.643 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 92.7 m-85 -88.25 53.24 2.67 Favored 'General case' 0 N--CA 1.483 1.218 0 C-N-CA 123.819 0.848 . . . . 74.420000000000002 112.115 -166.565 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 63.3 mt -77.38 -57.5 5.67 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.855 0 C-N-CA 123.654 0.782 . . . . 52.25 108.946 173.298 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 90' ' ' LEU . . . . . 0.575 ' HB3' ' HB ' ' A' ' 128' ' ' VAL . 86.7 mt -85.03 121.58 28.01 Favored 'General case' 0 C--O 1.238 0.467 0 CA-C-N 114.672 -1.149 . . . . 73.430000000000007 110.619 -175.145 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 46.5 mtmt -117.5 169.39 9.57 Favored 'General case' 0 N--CA 1.474 0.756 0 C-N-CA 124.141 0.976 . . . . 73.239999999999995 110.193 -175.831 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 92' ' ' HIS . . . . . 0.404 ' HA ' HG13 ' A' ' 97' ' ' ILE . 28.1 m-70 -86.38 50.15 1.94 Allowed 'General case' 0 N--CA 1.48 1.068 0 C-N-CA 124.062 0.945 . . . . 72.239999999999995 109.942 -178.988 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 10.5 t -95.0 -2.45 50.32 Favored 'General case' 0 CA--C 1.547 0.84 0 CA-C-N 115.112 -0.949 . . . . 75.540000000000006 110.965 -175.281 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -131.66 170.33 21.62 Favored Glycine 0 CA--C 1.533 1.189 0 CA-C-O 119.735 -0.48 . . . . 60.009999999999998 112.272 179.07 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 83.8 Cg_endo -81.99 157.36 17.95 Favored 'Trans proline' 0 CA--C 1.554 1.519 0 C-N-CA 122.799 2.333 . . . . 71.310000000000002 112.209 170.83 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 79.3 21.17 67.87 Favored Glycine 0 C--N 1.35 1.306 0 CA-C-N 116.601 -0.272 . . . . 54.130000000000003 113.624 176.544 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 97' ' ' ILE . . . . . 0.623 ' HB ' ' HB2' ' A' ' 115' ' ' CYS . 24.9 mm -65.63 103.72 0.5 Allowed 'Isoleucine or valine' 0 CA--C 1.547 0.836 0 C-N-CA 123.603 0.761 . . . . 74.430000000000007 111.816 -175.559 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 63.0 tp -89.02 114.38 25.57 Favored 'General case' 0 CA--C 1.547 0.84 0 CA-C-O 121.586 0.708 . . . . 72.129999999999995 109.368 173.708 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 99' ' ' SER . . . . . 0.692 ' HB3' ' HA ' ' A' ' 128' ' ' VAL . 4.9 p -148.05 139.75 23.82 Favored 'General case' 0 CA--C 1.537 0.473 0 C-N-CA 124.801 1.24 . . . . 61.299999999999997 108.033 178.354 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 100' ' ' MET . . . . . 0.736 ' HA ' ' HA ' ' A' ' 112' ' ' PHE . 67.3 mtp -75.55 148.05 39.21 Favored 'General case' 0 N--CA 1.489 1.522 0 C-N-CA 122.625 0.37 . . . . 63.229999999999997 110.775 -173.187 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 101' ' ' ALA . . . . . 0.71 ' HB3' ' HB2' ' A' ' 111' ' ' GLN . . . -72.34 152.28 42.18 Favored 'General case' 0 N--CA 1.479 0.984 0 CA-C-O 121.196 0.522 . . . . 73.319999999999993 112.301 -171.928 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 102' ' ' ASN . . . . . 0.459 ' HB2' ' HB ' ' A' ' 107' ' ' THR . 30.1 p-10 -165.83 159.42 15.99 Favored 'General case' 0 CA--C 1.536 0.438 0 CA-C-N 114.821 -1.081 . . . . 75.340000000000003 109.774 -177.022 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -110.14 25.08 12.18 Favored 'General case' 0 N--CA 1.472 0.654 0 C-N-CA 123.356 0.662 . . . . 63.229999999999997 109.379 169.821 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 136.9 -174.1 21.81 Favored Glycine 0 CA--C 1.535 1.292 0 CA-C-N 115.484 -0.78 . . . . 54.100000000000001 112.029 -179.422 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 51.7 Cg_exo -57.22 152.24 46.7 Favored 'Trans proline' 0 C--N 1.37 1.671 0 C-N-CA 123.439 2.759 . . . . 62.210000000000001 112.595 175.316 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 65.1 t30 66.74 12.67 8.98 Favored 'General case' 0 N--CA 1.489 1.491 0 C-N-CA 124.347 1.059 . . . . 75.400000000000006 111.965 179.638 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 107' ' ' THR . . . . . 0.729 ' HA ' ' HD2' ' A' ' 82' ' ' LYS . 2.7 m -120.77 7.23 10.45 Favored 'General case' 0 N--CA 1.489 1.506 0 C-N-CA 123.451 0.701 . . . . 72.239999999999995 110.579 -179.504 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 12.4 t30 -76.89 139.93 40.4 Favored 'General case' 0 N--CA 1.478 0.965 0 C-N-CA 124.643 1.177 . . . . 73.519999999999996 110.26 179.181 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 112.59 -11.35 25.73 Favored Glycine 0 N--CA 1.471 1.003 0 CA-C-O 119.843 -0.42 . . . . 64.219999999999999 113.269 178.518 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 110' ' ' SER . . . . . 0.551 ' HB2' ' HA ' ' A' ' 73' ' ' THR . 33.9 p -99.87 121.61 41.57 Favored 'General case' 0 N--CA 1.474 0.773 0 N-CA-C 109.047 -0.723 . . . . 74.409999999999997 109.047 173.009 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 111' ' ' GLN . . . . . 0.71 ' HB2' ' HB3' ' A' ' 101' ' ' ALA . 38.5 mt-30 63.67 175.74 0.17 Allowed 'General case' 0 N--CA 1.498 1.969 0 C-N-CA 124.294 1.037 . . . . 70.010000000000005 111.848 -177.705 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 112' ' ' PHE . . . . . 0.736 ' HA ' ' HA ' ' A' ' 100' ' ' MET . 36.6 p90 -148.93 133.36 17.57 Favored 'General case' 0 N--CA 1.482 1.147 0 N-CA-C 109.427 -0.583 . . . . 62.399999999999999 109.427 177.133 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 113' ' ' PHE . . . . . 0.411 ' CD1' ' SD ' ' A' ' 61' ' ' MET . 51.7 p90 -118.98 149.83 40.96 Favored 'General case' 0 N--CA 1.478 0.935 0 C-N-CA 123.151 0.58 . . . . 64.120000000000005 111.592 179.627 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 114' ' ' ILE . . . . . . . . . . . . . 22.5 mt -123.0 103.8 13.59 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.611 0 C-N-CA 124.279 1.032 . . . . 52.039999999999999 108.698 -179.753 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 115' ' ' CYS . . . . . 0.623 ' HB2' ' HB ' ' A' ' 97' ' ' ILE . 62.2 m -75.71 106.22 7.16 Favored 'General case' 0 CA--C 1.541 0.623 0 N-CA-C 109.336 -0.616 . . . . 52.219999999999999 109.336 175.584 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 39.5 p -70.63 -31.5 68.47 Favored 'General case' 0 N--CA 1.471 0.584 0 C-N-CA 123.534 0.734 . . . . 72.510000000000005 111.3 -179.104 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -99.06 159.04 15.25 Favored 'General case' 0 C--O 1.247 0.936 0 CA-C-N 115.462 -0.79 . . . . 44.049999999999997 109.478 171.69 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -72.36 88.89 1.2 Allowed 'General case' 0 CA--C 1.539 0.543 0 CA-C-O 121.765 0.793 . . . . 61.329999999999998 109.182 173.471 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 119' ' ' THR . . . . . . . . . . . . . 34.6 p -76.06 85.7 2.94 Favored 'General case' 0 CA--C 1.546 0.804 0 CA-C-O 122.276 1.036 . . . . 75.5 110.36 -174.381 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 11.5 pt-20 -71.29 -29.76 65.44 Favored 'General case' 0 N--CA 1.474 0.748 0 CA-C-N 114.158 -1.383 . . . . 75.409999999999997 111.38 -171.278 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 121' ' ' TRP . . . . . . . . . . . . . 43.6 p90 -67.94 -3.17 9.04 Favored 'General case' 0 N--CA 1.479 1.003 0 C-N-CA 123.367 0.667 . . . . 63.140000000000001 112.218 179.251 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 45.7 mt -96.24 26.32 4.35 Favored 'General case' 0 CA--C 1.555 1.141 0 C-N-CA 123.523 0.729 . . . . 62.409999999999997 111.535 174.037 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 56.7 m-20 -59.55 123.08 15.7 Favored 'General case' 0 N--CA 1.49 1.545 0 C-N-CA 122.758 0.423 . . . . 62.32 110.376 165.054 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 85.56 -9.1 69.03 Favored Glycine 0 N--CA 1.475 1.278 0 O-C-N 123.209 0.318 . . . . 61.439999999999998 113.27 -179.271 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 125' ' ' LYS . . . . . 0.641 ' HG3' ' H ' ' A' ' 126' ' ' HIS . 0.1 OUTLIER -82.74 -163.97 0.79 Allowed 'General case' 0 CA--C 1.561 1.371 0 C-N-CA 124.628 1.171 . . . . 73.430000000000007 108.412 177.511 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 126' ' ' HIS . . . . . 0.641 ' H ' ' HG3' ' A' ' 125' ' ' LYS . 57.3 t-80 -64.35 136.43 57.13 Favored 'General case' 0 N--CA 1.473 0.709 0 C-N-CA 124.119 0.968 . . . . 75.040000000000006 111.218 -166.38 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 127' ' ' VAL . . . . . 0.425 HG11 ' O ' ' A' ' 87' ' ' ASN . 45.1 t -71.76 140.33 18.32 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.536 0 CA-C-N 115.634 -0.712 . . . . 61.399999999999999 110.676 -176.466 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 128' ' ' VAL . . . . . 0.692 ' HA ' ' HB3' ' A' ' 99' ' ' SER . 25.1 t -73.37 148.0 9.14 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.558 0 N-CA-C 109.166 -0.679 . . . . 71.439999999999998 109.166 175.767 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 129' ' ' PHE . . . . . 0.517 ' HA ' HG21 ' A' ' 29' ' ' VAL . 39.5 p90 -129.2 -20.02 3.44 Favored 'General case' 0 N--CA 1.479 0.996 0 O-C-N 122.105 -0.372 . . . . 73.349999999999994 110.694 174.827 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . -140.23 164.18 26.25 Favored Glycine 0 C--N 1.34 0.761 0 O-C-N 123.717 0.636 . . . . 75.310000000000002 112.017 -175.87 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 34.6 ttpt -148.86 130.28 14.77 Favored 'General case' 0 N--CA 1.468 0.462 0 N-CA-C 109.271 -0.641 . . . . 74.209999999999994 109.271 -178.148 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 49.0 t -63.76 104.45 0.41 Allowed 'Isoleucine or valine' 0 C--O 1.238 0.496 0 N-CA-C 108.847 -0.797 . . . . 65.219999999999999 108.847 174.759 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 133' ' ' LYS . . . . . 0.66 ' HD2' ' HB2' ' A' ' 23' ' ' GLU . 19.4 ptmt -85.63 -33.4 21.63 Favored 'General case' 0 N--CA 1.471 0.618 0 N-CA-C 109.335 -0.617 . . . . 71.340000000000003 109.335 179.545 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 32.8 mt-10 -145.39 152.27 39.58 Favored 'General case' 0 N--CA 1.473 0.707 0 C-N-CA 125.033 1.333 . . . . 74.439999999999998 109.166 -178.135 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 135' ' ' GLY . . . . . 0.436 ' HA3' ' HA ' ' A' ' 20' ' ' VAL . . . 81.85 16.62 72.21 Favored Glycine 0 C--N 1.345 1.041 0 CA-C-N 116.534 -0.303 . . . . 74.019999999999996 112.729 -178.848 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 136' ' ' MET . . . . . . . . . . . . . 14.5 tpt -62.6 -31.11 71.88 Favored 'General case' 0 N--CA 1.479 0.998 0 C-N-CA 124.232 1.013 . . . . 73.0 110.857 177.72 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 137' ' ' ASN . . . . . . . . . . . . . 45.3 t30 -56.53 -44.66 81.04 Favored 'General case' 0 N--CA 1.477 0.883 0 CA-C-N 114.51 -1.223 . . . . 75.439999999999998 110.779 171.824 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 138' ' ' ILE . . . . . . . . . . . . . 46.4 mm -73.72 -33.13 37.21 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.009 0 C-N-CA 123.682 0.793 . . . . 64.420000000000002 111.135 -178.199 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 70.2 t -63.27 -47.72 90.83 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.114 0 CA-C-O 121.32 0.581 . . . . 73.430000000000007 110.511 177.146 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 49.0 mt-10 -73.13 -29.29 62.78 Favored 'General case' 0 CA--C 1.548 0.884 0 CA-C-N 115.827 -0.624 . . . . 75.209999999999994 111.385 179.092 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -70.22 -40.17 74.67 Favored 'General case' 0 N--CA 1.479 0.991 0 C-N-CA 123.089 0.555 . . . . 75.540000000000006 111.269 177.503 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 142' ' ' MET . . . . . 0.539 ' SD ' HG21 ' A' ' 10' ' ' ILE . 22.9 ptt? -74.51 -27.03 60.37 Favored 'General case' 0 N--CA 1.484 1.271 0 C-N-CA 122.622 0.369 . . . . 53.039999999999999 110.107 178.501 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 143' ' ' GLU . . . . . 0.565 ' HG2' ' HA ' ' A' ' 58' ' ' PRO . 33.8 tt0 -65.41 -27.51 68.59 Favored 'General case' 0 CA--C 1.545 0.756 0 C-N-CA 123.202 0.601 . . . . 73.310000000000002 112.417 177.686 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 144' ' ' ARG . . . . . . . . . . . . . 74.3 mtp180 -65.7 -20.23 66.2 Favored 'General case' 0 CA--C 1.55 0.949 0 C-N-CA 123.48 0.712 . . . . 75.150000000000006 111.458 176.114 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 145' ' ' PHE . . . . . 0.407 ' HB2' HD11 ' A' ' 156' ' ' ILE . 43.6 m-85 -89.52 3.97 50.73 Favored 'General case' 0 CA--C 1.548 0.874 0 C-N-CA 123.607 0.763 . . . . 74.129999999999995 111.706 177.406 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . -85.52 177.26 50.07 Favored Glycine 0 C--N 1.347 1.167 0 N-CA-C 111.66 -0.576 . . . . 74.439999999999998 111.66 171.01 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 16.4 m -133.71 163.15 30.09 Favored 'General case' 0 N--CA 1.48 1.053 0 CA-C-N 117.587 0.694 . . . . 51.43 111.741 -175.895 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 148' ' ' ARG . . . . . . . . . . . . . 9.3 mmm180 -75.99 -15.31 60.17 Favored 'General case' 0 N--CA 1.475 0.798 0 C-N-CA 124.897 1.279 . . . . 52.119999999999997 112.879 -177.747 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 149' ' ' ASN . . . . . . . . . . . . . 34.3 p-10 -90.72 -3.51 57.41 Favored 'General case' 0 N--CA 1.481 1.117 0 C-N-CA 122.884 0.474 . . . . 73.310000000000002 110.333 171.982 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . 105.36 -27.33 18.69 Favored Glycine 0 C--N 1.351 1.393 0 CA-C-N 116.0 -0.546 . . . . 41.149999999999999 112.917 177.003 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 56.9 tttm -69.43 156.32 39.04 Favored 'General case' 0 N--CA 1.484 1.27 0 C-N-CA 123.217 0.607 . . . . 74.329999999999998 111.78 -173.358 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 152' ' ' THR . . . . . . . . . . . . . 69.2 p -94.39 130.63 40.65 Favored 'General case' 0 N--CA 1.474 0.765 0 CA-C-O 120.941 0.4 . . . . 75.420000000000002 110.428 172.304 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 153' ' ' SER . . . . . . . . . . . . . 15.0 m -69.47 -31.44 69.73 Favored 'General case' 0 N--CA 1.474 0.731 0 C-N-CA 123.928 0.891 . . . . 72.299999999999997 111.148 174.723 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 75.3 mmtt -115.13 153.63 30.42 Favored 'General case' 0 N--CA 1.473 0.723 0 C-N-CA 124.052 0.941 . . . . 70.200000000000003 109.972 -177.277 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 155' ' ' LYS . . . . . 0.454 ' HB2' ' HA ' ' A' ' 13' ' ' ASP . 30.3 mmmt -86.32 89.11 7.76 Favored 'General case' 0 N--CA 1.468 0.466 0 N-CA-C 109.244 -0.651 . . . . 75.519999999999996 109.244 175.626 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 156' ' ' ILE . . . . . 0.526 HD13 ' HB2' ' A' ' 142' ' ' MET . 59.2 mt -90.23 103.02 13.85 Favored 'Isoleucine or valine' 0 C--O 1.213 -0.837 0 N-CA-C 109.28 -0.637 . . . . 75.099999999999994 109.28 -174.706 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 157' ' ' THR . . . . . . . . . . . . . 44.7 p -114.45 147.99 38.47 Favored 'General case' 0 N--CA 1.476 0.868 0 C-N-CA 123.976 0.91 . . . . 73.109999999999999 109.972 -175.222 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 158' ' ' ILE . . . . . 0.408 HG23 ' HB3' ' A' ' 8' ' ' PHE . 47.2 mt -71.91 97.43 0.67 Allowed 'Isoleucine or valine' 0 CA--C 1.555 1.156 0 N-CA-C 109.546 -0.539 . . . . 74.120000000000005 109.546 170.638 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 159' ' ' ALA . . . . . 0.757 ' HB2' ' HB2' ' A' ' 11' ' ' ALA . . . -58.7 -48.57 80.67 Favored 'General case' 0 N--CA 1.482 1.136 0 C-N-CA 124.581 1.152 . . . . 45.43 112.757 -175.894 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 160' ' ' ASP . . . . . . . . . . . . . 25.4 t0 -148.86 166.16 29.36 Favored 'General case' 0 N--CA 1.478 0.974 0 CA-C-N 115.926 -0.579 . . . . 73.319999999999993 110.307 -175.734 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 161' ' ' CYS . . . . . . . . . . . . . 19.4 p -132.56 -170.91 2.53 Favored 'General case' 0 CA--C 1.548 0.888 0 C-N-CA 125.315 1.446 . . . . 52.210000000000001 109.056 179.85 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 162' ' ' GLY . . . . . . . . . . . . . . . 132.02 53.88 0.09 OUTLIER Glycine 0 N--CA 1.473 1.134 0 N-CA-C 111.265 -0.734 . . . . 73.409999999999997 111.265 -170.83 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 163' ' ' GLN . . . . . 0.553 ' NE2' HG23 ' A' ' 41' ' ' THR . 69.7 mt-30 -46.74 112.56 0.52 Allowed 'General case' 0 CA--C 1.55 0.952 0 C-N-CA 125.586 1.555 . . . . 60.219999999999999 112.762 -177.337 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 164' ' ' LEU . . . . . 0.421 ' O ' ' HB ' ' A' ' 5' ' ' THR . 88.0 mt -80.24 102.72 9.64 Favored 'General case' 0 N--CA 1.474 0.751 0 C-N-CA 124.045 0.938 . . . . 73.400000000000006 110.186 -175.646 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 165' ' ' GLU . . . . . . . . . . . . . 5.6 pt-20 . . . . . 0 C--O 1.252 1.225 0 C-N-CA 122.697 0.399 . . . . 74.109999999999999 110.2 -174.991 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' B' B ' 216' ' ' PRO . . . . . . . . . . . . . 5.2 Cg_exo . . . . . 0 CA--C 1.547 1.147 0 N-CA-C 109.751 -0.904 . . . . 73.409999999999997 109.751 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' B' B ' 217' ' ' GLU . . . . . 0.421 ' HB2' ' HD2' ' B' ' 218' ' ' PRO . 1.0 OUTLIER -146.41 -178.84 0.84 Allowed Pre-proline 0 CA--C 1.556 1.208 0 C-N-CA 125.247 1.419 . . . . 73.219999999999999 108.59 -175.119 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' B' B ' 218' ' ' PRO . . . . . 0.421 ' HD2' ' HB2' ' B' ' 217' ' ' GLU . 10.8 Cg_endo -55.92 92.63 0.05 OUTLIER 'Trans proline' 0 C--N 1.38 2.226 0 C-N-CA 121.44 1.427 . . . . 73.040000000000006 111.37 163.55 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 219' ' ' GLY . . . . . . . . . . . . . . . 137.0 126.95 2.57 Favored Glycine 0 CA--C 1.541 1.679 0 CA-C-N 114.931 -1.031 . . . . 72.340000000000003 110.585 -174.482 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 220' ' ' PRO . . . . . . . . . . . . . 57.5 Cg_endo -67.18 170.5 13.09 Favored 'Trans proline' 0 C--N 1.377 2.055 0 C-N-CA 123.178 2.585 . . . . 53.009999999999998 113.485 -177.163 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 221' ' ' TYR . . . . . . . . . . . . . 13.7 p90 -128.97 161.87 28.9 Favored 'General case' 0 C--O 1.252 1.192 0 CA-C-O 121.321 0.581 . . . . 72.319999999999993 111.265 -175.054 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 222' ' ' ALA . . . . . . . . . . . . . . . -172.5 177.27 3.06 Favored 'General case' 0 CA--C 1.543 0.706 0 C-N-CA 125.704 1.602 . . . . 63.219999999999999 108.938 172.931 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 223' ' ' GLN . . . . . . . . . . . . . 2.7 mp0 67.78 94.84 0.05 OUTLIER Pre-proline 0 N--CA 1.484 1.235 0 C-N-CA 124.424 1.09 . . . . 74.349999999999994 110.232 -176.109 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 224' ' ' PRO . . . . . . . . . . . . . 33.4 Cg_endo . . . . . 0 C--N 1.382 2.316 0 C-N-CA 123.659 2.906 . . . . 75.340000000000003 113.382 -178.185 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 29.3 mmt . . . . . 0 N--CA 1.485 1.302 0 N-CA-C 110.165 -0.309 . . . . 71.030000000000001 110.165 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 11.2 p -64.55 -18.96 24.25 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.467 0 C-N-CA 123.825 0.85 . . . . 72.150000000000006 111.486 178.199 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 3' ' ' ASN . . . . . 0.502 ' HB3' ' O ' ' A' ' 24' ' ' LEU . 13.2 m120 -68.48 140.38 92.41 Favored Pre-proline 0 CA--C 1.552 1.046 0 C-N-CA 124.995 1.318 . . . . 72.340000000000003 111.936 -173.868 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 42.9 Cg_endo -66.71 119.36 6.38 Favored 'Trans proline' 0 C--N 1.384 2.443 0 C-N-CA 122.973 2.449 . . . . 65.319999999999993 111.049 175.572 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 5' ' ' THR . . . . . 0.428 ' O ' ' HB2' ' A' ' 163' ' ' GLN . 97.5 m -98.6 127.82 44.68 Favored 'General case' 0 CA--C 1.537 0.444 0 N-CA-C 109.239 -0.652 . . . . 74.129999999999995 109.239 -178.934 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . 0.501 ' HA ' ' HB2' ' A' ' 163' ' ' GLN . 14.1 m -102.13 123.13 55.17 Favored 'Isoleucine or valine' 0 C--N 1.351 0.652 0 C-N-CA 123.972 0.909 . . . . 73.040000000000006 109.563 178.252 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 7' ' ' PHE . . . . . 0.635 ' H ' ' HA ' ' A' ' 163' ' ' GLN . 57.5 t80 -102.79 137.27 41.22 Favored 'General case' 0 C--O 1.24 0.597 0 CA-C-N 115.058 -0.974 . . . . 72.239999999999995 108.905 -178.49 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 51.2 m-85 -136.59 164.78 27.4 Favored 'General case' 0 C--O 1.24 0.563 0 O-C-N 124.534 1.146 . . . . 74.310000000000002 109.971 174.32 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 24.6 m-20 -112.96 109.06 18.23 Favored 'General case' 0 C--N 1.324 -0.511 0 N-CA-C 106.263 -1.754 . . . . 72.109999999999999 106.263 169.976 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 10' ' ' ILE . . . . . 0.453 HG21 ' SD ' ' A' ' 142' ' ' MET . 46.7 mm -78.95 129.43 37.58 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.479 0 N-CA-C 108.013 -1.106 . . . . 44.119999999999997 108.013 177.555 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 11' ' ' ALA . . . . . 0.75 ' HB2' ' HB2' ' A' ' 159' ' ' ALA . . . -124.53 133.54 53.28 Favored 'General case' 0 C--O 1.217 -0.654 0 C-N-CA 123.849 0.86 . . . . 53.530000000000001 110.785 -171.782 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . 0.453 HG13 ' HB3' ' A' ' 154' ' ' LYS . 53.4 t -97.53 117.59 42.51 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.64 0 C-N-CA 124.236 1.014 . . . . 63.140000000000001 108.983 172.128 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 13' ' ' ASP . . . . . 0.47 ' HA ' ' HB3' ' A' ' 155' ' ' LYS . 31.6 m-20 54.97 38.93 31.29 Favored 'General case' 0 N--CA 1.484 1.257 0 C-N-CA 125.288 1.435 . . . . 64.140000000000001 111.211 -174.372 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 84.07 -14.51 43.6 Favored Glycine 0 C--N 1.353 1.508 0 CA-C-N 115.292 -0.867 . . . . 53.049999999999997 113.964 179.479 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 18.4 mm-40 -89.89 122.15 68.18 Favored Pre-proline 0 N--CA 1.474 0.756 0 CA-C-O 118.347 -0.835 . . . . 53.310000000000002 109.865 -178.896 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_exo -50.42 109.55 0.3 Allowed 'Trans proline' 0 C--N 1.378 2.119 0 C-N-CA 123.786 2.99 . . . . 53.200000000000003 113.397 -178.056 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 42.6 tp -77.11 -45.08 28.13 Favored 'General case' 0 N--CA 1.477 0.924 0 C-N-CA 123.647 0.779 . . . . 73.409999999999997 109.503 175.99 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -177.3 -172.45 41.86 Favored Glycine 0 C--N 1.343 0.961 0 CA-C-N 115.519 -0.764 . . . . 43.340000000000003 112.227 -179.933 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 19' ' ' ARG . . . . . 0.497 ' HB3' ' HE1' ' A' ' 7' ' ' PHE . 54.3 mtt180 -118.71 138.39 52.67 Favored 'General case' 0 N--CA 1.473 0.69 0 C-N-CA 124.185 0.994 . . . . 75.040000000000006 110.423 -174.02 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 36.7 t -135.29 144.23 34.77 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.819 0 C-N-CA 124.065 0.946 . . . . 71.430000000000007 109.09 178.328 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 75.1 m -128.94 126.41 39.58 Favored 'General case' 0 CA--C 1.549 0.933 0 C-N-CA 123.688 0.795 . . . . 62.210000000000001 108.931 172.185 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 70.4 m-85 -106.66 121.94 45.36 Favored 'General case' 0 N--CA 1.475 0.792 0 C-N-CA 123.909 0.884 . . . . 71.340000000000003 110.106 178.969 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . 0.477 ' HG3' ' HB2' ' A' ' 3' ' ' ASN . 39.7 tt0 -75.92 113.4 13.37 Favored 'General case' 0 CA--C 1.552 1.055 0 C-N-CA 123.764 0.825 . . . . 75.430000000000007 109.487 171.456 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . 0.502 ' O ' ' HB3' ' A' ' 3' ' ' ASN . 37.4 mt -91.39 123.5 34.86 Favored 'General case' 0 N--CA 1.482 1.127 0 C-N-CA 123.538 0.735 . . . . 62.130000000000003 110.305 179.452 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 25' ' ' PHE . . . . . 0.412 ' HA ' HD22 ' A' ' 3' ' ' ASN . 79.3 m-85 -79.72 70.98 6.34 Favored 'General case' 0 N--CA 1.476 0.863 0 C-N-CA 123.688 0.795 . . . . 73.530000000000001 111.15 -178.506 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -74.99 1.44 12.92 Favored 'General case' 0 N--CA 1.483 1.196 0 C-N-CA 123.55 0.74 . . . . 74.430000000000007 112.172 -179.666 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 11.3 p-10 -89.55 -27.81 20.02 Favored 'General case' 0 CA--C 1.551 1.007 0 C-N-CA 123.537 0.735 . . . . 73.319999999999993 110.568 172.791 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 57.4 mttp -100.72 -39.33 7.9 Favored 'General case' 0 N--CA 1.485 1.3 0 C-N-CA 123.362 0.665 . . . . 74.200000000000003 110.845 -176.546 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 29' ' ' VAL . . . . . 0.519 HG21 ' HA ' ' A' ' 129' ' ' PHE . 12.0 m -137.44 61.82 33.65 Favored Pre-proline 0 CA--C 1.56 1.341 0 C-N-CA 124.341 1.056 . . . . 75.109999999999999 110.355 -176.367 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 20.7 Cg_endo -58.9 -23.81 69.54 Favored 'Trans proline' 0 C--N 1.387 2.561 0 C-N-CA 122.559 2.173 . . . . 71.230000000000004 113.733 -178.076 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 86.4 tttt -68.66 -56.47 8.07 Favored 'General case' 0 N--CA 1.477 0.912 0 C-N-CA 122.79 0.436 . . . . 71.239999999999995 110.688 179.662 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 5.7 m -74.06 -33.2 63.61 Favored 'General case' 0 CA--C 1.552 1.05 0 CA-C-N 115.418 -0.81 . . . . 74.310000000000002 111.177 -173.784 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -72.04 -46.62 56.35 Favored 'General case' 0 CA--C 1.546 0.816 0 C-N-CA 123.651 0.78 . . . . 75.349999999999994 111.056 179.948 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 34.4 tt0 -64.38 -37.31 87.06 Favored 'General case' 0 N--CA 1.487 1.419 0 C-N-CA 123.187 0.595 . . . . 74.140000000000001 110.652 178.497 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 35' ' ' ASN . . . . . 0.477 ' O ' ' HG ' ' A' ' 39' ' ' LEU . 38.8 t30 -51.61 -64.44 0.81 Allowed 'General case' 0 C--N 1.36 1.022 0 O-C-N 124.559 1.162 . . . . 72.099999999999994 110.14 177.232 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 86.9 t80 -61.09 -35.99 78.48 Favored 'General case' 0 CA--C 1.544 0.712 0 C-N-CA 123.92 0.888 . . . . 74.120000000000005 111.88 -177.808 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 77.3 ttt180 -64.93 -43.69 91.93 Favored 'General case' 0 N--CA 1.474 0.751 0 C-N-CA 123.715 0.806 . . . . 65.519999999999996 111.436 -177.922 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 38' ' ' ALA . . . . . 0.513 ' HB1' ' HG2' ' A' ' 44' ' ' LYS . . . -78.21 -27.84 47.86 Favored 'General case' 0 N--CA 1.474 0.755 0 C-N-CA 123.32 0.648 . . . . 73.430000000000007 111.209 -177.525 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 39' ' ' LEU . . . . . 0.477 ' HG ' ' O ' ' A' ' 35' ' ' ASN . 88.5 mt -66.02 -43.29 88.05 Favored 'General case' 0 CA--C 1.549 0.908 0 C-N-CA 123.437 0.695 . . . . 62.240000000000002 109.973 169.877 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 16.3 t -62.7 -51.88 65.47 Favored 'General case' 0 N--CA 1.476 0.855 0 C-N-CA 125.22 1.408 . . . . 74.120000000000005 111.336 -178.095 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 25.4 p -77.17 -32.95 56.5 Favored 'General case' 0 CA--C 1.536 0.424 0 CA-C-N 115.559 -0.746 . . . . 73.040000000000006 111.667 -176.167 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 88.42 26.97 26.39 Favored Glycine 0 C--N 1.346 1.116 0 O-C-N 123.406 0.441 . . . . 52.229999999999997 112.558 -175.33 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 22.8 mm-40 -63.59 -22.65 67.01 Favored 'General case' 0 N--CA 1.482 1.165 0 C-N-CA 123.471 0.708 . . . . 72.319999999999993 111.495 173.506 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 44' ' ' LYS . . . . . 0.513 ' HG2' ' HB1' ' A' ' 38' ' ' ALA . 31.0 mmmt -105.69 17.09 24.32 Favored 'General case' 0 CA--C 1.545 0.756 0 C-N-CA 123.998 0.919 . . . . 72.430000000000007 110.905 179.241 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 81.55 -25.86 3.74 Favored Glycine 0 C--N 1.355 1.593 0 N-CA-C 114.641 0.617 . . . . 72.319999999999993 114.641 175.661 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 16.4 m-85 -64.94 -44.03 90.79 Favored 'General case' 0 N--CA 1.48 1.055 0 C-N-CA 123.406 0.682 . . . . 51.240000000000002 111.186 -171.354 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 56.87 64.66 4.2 Favored Glycine 0 C--N 1.356 1.673 0 O-C-N 123.958 0.786 . . . . 62.219999999999999 114.34 166.049 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 48' ' ' TYR . . . . . 0.401 ' HE1' HD22 ' A' ' 39' ' ' LEU . 51.4 m-85 -62.44 87.59 0.02 OUTLIER 'General case' 0 N--CA 1.48 1.075 0 CA-C-O 122.33 1.062 . . . . 75.540000000000006 111.426 -178.721 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 28.5 tptp -111.4 117.15 32.29 Favored 'General case' 0 C--O 1.235 0.33 0 CA-C-N 113.452 -1.703 . . . . 71.209999999999994 107.775 178.762 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 79.46 20.75 68.4 Favored Glycine 0 C--N 1.339 0.742 0 CA-C-O 119.698 -0.501 . . . . 50.350000000000001 112.877 -177.088 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 34.5 t -55.83 115.4 2.36 Favored 'General case' 0 C--N 1.357 0.921 0 C-N-CA 123.365 0.666 . . . . 73.129999999999995 109.387 178.078 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 52' ' ' CYS . . . . . 0.742 ' SG ' ' HB3' ' A' ' 66' ' ' ASP . 2.3 p -86.54 138.6 31.59 Favored 'General case' 0 C--O 1.242 0.685 0 O-C-N 124.255 0.972 . . . . 73.230000000000004 111.491 -172.495 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 53' ' ' PHE . . . . . 0.667 ' HA ' ' HA2' ' A' ' 64' ' ' GLY . 36.6 m-85 -89.29 99.09 12.15 Favored 'General case' 0 N--CA 1.451 -0.415 0 C-N-CA 125.338 1.455 . . . . 74.420000000000002 107.988 175.544 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 43.8 p-80 -82.49 -31.11 29.49 Favored 'General case' 0 N--CA 1.476 0.841 0 C-N-CA 123.608 0.763 . . . . 71.310000000000002 111.342 -177.098 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 55' ' ' ARG . . . . . 0.403 ' HA ' ' O ' ' A' ' 150' ' ' GLY . 52.5 ttt180 -122.92 98.43 5.9 Favored 'General case' 0 C--O 1.21 -0.979 0 C-N-CA 122.885 0.474 . . . . 65.340000000000003 109.85 -173.97 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 56' ' ' ILE . . . . . 0.484 HG21 ' HA ' ' A' ' 143' ' ' GLU . 38.8 mt -127.87 138.95 53.24 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.717 0 N-CA-C 109.296 -0.631 . . . . 74.120000000000005 109.296 173.139 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 57' ' ' ILE . . . . . 0.565 HG23 ' HA ' ' A' ' 148' ' ' ARG . 64.1 mt -134.08 113.71 12.57 Favored Pre-proline 0 CA--C 1.557 1.24 0 C-N-CA 125.133 1.373 . . . . 70.209999999999994 108.781 -174.694 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 58' ' ' PRO . . . . . 0.578 ' HA ' ' HG2' ' A' ' 143' ' ' GLU . 56.0 Cg_endo -66.17 131.46 26.9 Favored 'Trans proline' 0 C--N 1.386 2.516 0 C-N-CA 123.641 2.894 . . . . 43.229999999999997 113.357 -173.104 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 78.03 31.31 48.54 Favored Glycine 0 C--N 1.345 1.08 0 CA-C-N 115.387 -0.824 . . . . 72.549999999999997 112.696 -178.58 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 60' ' ' PHE . . . . . 0.43 ' CE2' ' HA ' ' B' ' 222' ' ' ALA . 20.2 t80 -157.71 -73.73 0.09 Allowed 'General case' 0 CA--C 1.545 0.772 0 CA-C-N 116.781 0.291 . . . . 72.540000000000006 111.393 -174.533 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 43.6 ttp -159.59 138.8 11.13 Favored 'General case' 0 N--CA 1.481 1.09 0 C-N-CA 122.679 0.392 . . . . 55.009999999999998 111.299 -166.057 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 62' ' ' CYS . . . . . 0.648 ' SG ' ' HB ' ' A' ' 114' ' ' ILE . 5.4 p -116.31 111.65 20.42 Favored 'General case' 0 CA--C 1.554 1.099 0 C-N-CA 123.494 0.718 . . . . 53.210000000000001 109.429 169.572 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 63' ' ' GLN . . . . . 0.4 ' HA ' ' HA ' ' A' ' 113' ' ' PHE . 54.2 tt0 -109.34 117.71 34.77 Favored 'General case' 0 N--CA 1.487 1.379 0 C-N-CA 124.438 1.095 . . . . 63.039999999999999 110.897 -173.342 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 64' ' ' GLY . . . . . 0.667 ' HA2' ' HA ' ' A' ' 53' ' ' PHE . . . -106.73 -176.3 23.08 Favored Glycine 0 C--N 1.345 1.073 0 CA-C-N 115.713 -0.676 . . . . 62.109999999999999 113.34 179.621 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 84.4 91.5 0.76 Allowed Glycine 0 C--N 1.341 0.859 0 N-CA-C 110.446 -1.062 . . . . 32.450000000000003 110.446 -174.566 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 66' ' ' ASP . . . . . 0.742 ' HB3' ' SG ' ' A' ' 52' ' ' CYS . 32.9 t70 -128.56 -56.89 1.21 Allowed 'General case' 0 N--CA 1.473 0.718 0 C-N-CA 122.938 0.495 . . . . 65.439999999999998 110.532 176.019 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 65.7 t80 -40.25 -57.32 1.75 Allowed 'General case' 0 N--CA 1.485 1.307 0 C-N-CA 125.344 1.458 . . . . 75.340000000000003 114.196 -170.756 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 26.4 m -79.93 107.2 12.52 Favored 'General case' 0 C--O 1.243 0.738 0 CA-C-O 120.862 0.363 . . . . 72.120000000000005 110.992 -174.782 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 62.6 mtt-85 54.29 71.67 0.51 Allowed 'General case' 0 N--CA 1.472 0.669 0 C-N-CA 125.929 1.692 . . . . 61.240000000000002 112.147 173.245 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 70' ' ' HIS . . . . . 0.439 ' HB3' ' O ' ' A' ' 66' ' ' ASP . 15.9 p-80 -85.34 17.5 3.09 Favored 'General case' 0 N--CA 1.481 1.118 0 N-CA-C 113.198 0.814 . . . . 73.150000000000006 113.198 -172.438 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 44.4 t30 -77.0 73.18 3.58 Favored 'General case' 0 N--CA 1.481 1.099 0 CA-C-O 121.561 0.696 . . . . 72.340000000000003 109.561 173.435 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 72' ' ' GLY . . . . . 0.563 ' HA2' ' HG2' ' B' ' 218' ' ' PRO . . . 63.68 20.79 64.36 Favored Glycine 0 C--N 1.346 1.092 0 CA-C-N 115.208 -0.905 . . . . 64.329999999999998 114.505 -179.071 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 37.1 m -125.03 -66.25 0.97 Allowed 'General case' 0 CA--C 1.542 0.669 0 C-N-CA 123.16 0.584 . . . . 63.420000000000002 109.459 -177.357 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 51.64 60.42 7.42 Favored Glycine 0 C--N 1.355 1.636 0 O-C-N 124.275 0.984 . . . . 35.310000000000002 113.543 177.589 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 132.21 53.03 0.08 OUTLIER Glycine 0 N--CA 1.469 0.899 0 CA-C-N 118.049 0.924 . . . . 64.400000000000006 112.35 -176.387 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -51.57 149.47 4.4 Favored 'General case' 0 N--CA 1.481 1.125 0 C-N-CA 123.75 0.82 . . . . 74.420000000000002 111.49 177.242 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 92.0 p -91.45 176.01 6.71 Favored 'General case' 0 CA--C 1.538 0.509 0 CA-C-O 121.361 0.6 . . . . 73.510000000000005 111.163 -168.542 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 78' ' ' ILE . . . . . 0.407 HG21 ' HB3' ' A' ' 38' ' ' ALA . 25.5 pt -75.93 -18.05 15.44 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.615 0 CA-C-N 115.45 -0.795 . . . . 61.329999999999998 110.218 174.329 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 85.1 m-85 -87.76 -14.82 38.69 Favored 'General case' 0 N--CA 1.472 0.642 0 C-N-CA 124.291 1.036 . . . . 74.209999999999994 110.607 177.601 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 147.36 -112.39 0.59 Allowed Glycine 0 C--N 1.348 1.199 0 N-CA-C 110.612 -0.995 . . . . 72.519999999999996 110.612 178.817 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 32.1 tt0 -89.1 -50.72 5.99 Favored 'General case' 0 CA--C 1.539 0.533 0 CA-C-O 121.657 0.741 . . . . 75.099999999999994 109.358 176.017 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 82' ' ' LYS . . . . . 0.438 ' HD2' ' HA ' ' A' ' 107' ' ' THR . 23.7 pttm -151.88 177.46 10.41 Favored 'General case' 0 N--CA 1.47 0.541 0 CA-C-N 114.336 -1.302 . . . . 73.120000000000005 109.791 -169.335 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 45.7 p90 -158.43 170.7 21.62 Favored 'General case' 0 N--CA 1.476 0.836 0 C-N-CA 123.492 0.717 . . . . 71.239999999999995 110.362 176.468 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 84' ' ' GLU . . . . . 0.534 ' HA ' ' HA ' ' A' ' 106' ' ' ASN . 9.7 pt-20 -82.73 160.46 22.34 Favored 'General case' 0 N--CA 1.474 0.747 0 C-N-CA 122.899 0.48 . . . . 74.310000000000002 111.036 178.226 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 52.3 m-20 -65.23 131.73 47.25 Favored 'General case' 0 C--O 1.239 0.511 0 CA-C-N 114.802 -1.09 . . . . 73.239999999999995 110.298 177.509 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 10.9 tp10 -72.33 -58.13 3.65 Favored 'General case' 0 C--O 1.239 0.503 0 O-C-N 124.166 0.916 . . . . 63.399999999999999 109.323 175.224 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 32.3 p30 -159.02 -173.77 4.41 Favored 'General case' 0 C--O 1.237 0.405 0 CA-C-N 114.437 -1.256 . . . . 75.150000000000006 108.966 -175.97 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 89.0 m-85 -137.56 61.26 1.61 Allowed 'General case' 0 N--CA 1.477 0.886 0 C-N-CA 123.602 0.761 . . . . 74.129999999999995 108.982 173.193 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 62.5 mt -78.77 -54.32 12.09 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.151 0 CA-C-O 121.383 0.611 . . . . 73.420000000000002 109.909 177.495 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 90' ' ' LEU . . . . . 0.499 ' HB3' ' HB ' ' A' ' 128' ' ' VAL . 94.3 mt -89.05 140.88 28.99 Favored 'General case' 0 C--O 1.236 0.37 0 CA-C-N 115.067 -0.97 . . . . 61.25 111.389 -172.672 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 16.8 ptpt -139.63 170.56 15.68 Favored 'General case' 0 CA--C 1.541 0.612 0 C-N-CA 124.113 0.965 . . . . 63.450000000000003 110.83 -173.571 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 92' ' ' HIS . . . . . 0.574 ' HA ' HG21 ' A' ' 97' ' ' ILE . 13.2 m80 -92.12 53.72 2.22 Favored 'General case' 0 N--CA 1.48 1.041 0 C-N-CA 124.791 1.236 . . . . 72.239999999999995 110.78 -167.528 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 3.8 p -94.52 20.32 8.58 Favored 'General case' 0 N--CA 1.481 1.103 0 C-N-CA 124.196 0.998 . . . . 32.549999999999997 113.286 -174.125 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -163.93 178.92 39.17 Favored Glycine 0 C--N 1.344 0.974 0 C-N-CA 121.018 -0.611 . . . . 43.329999999999998 113.652 -178.214 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 85.0 Cg_endo -81.64 138.5 10.73 Favored 'Trans proline' 0 C--N 1.369 1.657 0 C-N-CA 123.046 2.497 . . . . 74.439999999999998 112.805 175.935 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 96' ' ' GLY . . . . . 0.551 ' HA3' HG12 ' A' ' 132' ' ' VAL . . . 80.28 20.12 67.75 Favored Glycine 0 C--N 1.35 1.316 0 CA-C-N 116.04 -0.527 . . . . 75.430000000000007 113.692 174.1 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 97' ' ' ILE . . . . . 0.574 HG21 ' HA ' ' A' ' 92' ' ' HIS . 21.7 mm -66.87 105.62 0.73 Allowed 'Isoleucine or valine' 0 CA--C 1.549 0.914 0 C-N-CA 124.518 1.127 . . . . 61.530000000000001 110.613 178.077 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 98' ' ' LEU . . . . . 0.451 HD13 HG12 ' A' ' 114' ' ' ILE . 59.2 tp -87.17 101.47 13.53 Favored 'General case' 0 CA--C 1.55 0.973 0 CA-C-O 121.894 0.855 . . . . 71.140000000000001 109.532 177.089 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 99' ' ' SER . . . . . 0.522 ' HB2' HG22 ' A' ' 128' ' ' VAL . 33.0 t -106.07 170.39 7.94 Favored 'General case' 0 N--CA 1.472 0.664 0 C-N-CA 124.965 1.306 . . . . 44.329999999999998 108.67 176.141 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 100' ' ' MET . . . . . 0.5 ' SD ' ' HA2' ' A' ' 109' ' ' GLY . 4.4 ttt -113.53 135.68 53.63 Favored 'General case' 0 N--CA 1.482 1.125 0 CA-C-N 118.356 0.525 . . . . 64.099999999999994 110.048 -178.175 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 101' ' ' ALA . . . . . 0.441 ' HB3' ' HB2' ' A' ' 111' ' ' GLN . . . -84.35 -178.95 7.07 Favored 'General case' 0 C--O 1.244 0.811 0 C-N-CA 123.764 0.826 . . . . 43.399999999999999 111.105 -173.79 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 25.8 p-10 -168.84 -178.83 3.49 Favored 'General case' 0 CA--C 1.539 0.552 0 CA-C-N 115.166 -0.925 . . . . 72.239999999999995 111.369 -168.322 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 103' ' ' ALA . . . . . 0.495 ' HB3' HG21 ' A' ' 107' ' ' THR . . . -124.46 13.2 8.78 Favored 'General case' 0 N--CA 1.479 1.002 0 C-N-CA 124.249 1.02 . . . . 71.219999999999999 109.496 161.94 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 145.39 178.07 20.64 Favored Glycine 0 C--N 1.352 1.424 0 CA-C-O 119.065 -0.853 . . . . 74.140000000000001 111.539 -179.556 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 32.5 Cg_exo -61.19 149.91 87.05 Favored 'Trans proline' 0 C--N 1.375 1.962 0 C-N-CA 123.198 2.599 . . . . 75.129999999999995 111.731 169.496 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 106' ' ' ASN . . . . . 0.534 ' HA ' ' HA ' ' A' ' 84' ' ' GLU . 65.6 t30 62.87 21.87 13.09 Favored 'General case' 0 CA--C 1.557 1.249 0 O-C-N 124.168 0.917 . . . . 62.109999999999999 110.325 -174.031 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 107' ' ' THR . . . . . 0.495 HG21 ' HB3' ' A' ' 103' ' ' ALA . 12.2 m -142.15 24.11 1.99 Allowed 'General case' 0 CA--C 1.555 1.137 0 C-N-CA 125.066 1.346 . . . . 73.329999999999998 109.094 178.154 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 61.1 t30 -80.27 147.95 30.97 Favored 'General case' 0 N--CA 1.476 0.851 0 C-N-CA 123.739 0.816 . . . . 73.439999999999998 109.46 176.534 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 109' ' ' GLY . . . . . 0.5 ' HA2' ' SD ' ' A' ' 100' ' ' MET . . . 106.49 -14.24 42.83 Favored Glycine 0 N--CA 1.472 1.04 0 CA-C-O 119.946 -0.363 . . . . 54.020000000000003 113.805 177.608 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 38.6 p -94.81 120.18 34.61 Favored 'General case' 0 CA--C 1.543 0.699 0 C-N-CA 123.382 0.673 . . . . 71.230000000000004 109.361 177.861 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 111' ' ' GLN . . . . . 0.693 HE22 ' HB2' ' B' ' 218' ' ' PRO . 27.8 mt-30 66.95 162.95 0.18 Allowed 'General case' 0 N--CA 1.497 1.906 0 C-N-CA 125.044 1.338 . . . . 75.310000000000002 111.408 -170.491 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 44.9 p90 -144.5 150.29 37.34 Favored 'General case' 0 N--CA 1.484 1.233 0 N-CA-C 108.362 -0.977 . . . . 64.129999999999995 108.362 178.19 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 113' ' ' PHE . . . . . 0.4 ' HA ' ' HA ' ' A' ' 63' ' ' GLN . 51.3 p90 -140.98 142.37 34.29 Favored 'General case' 0 N--CA 1.472 0.644 0 N-CA-C 111.969 0.359 . . . . 63.340000000000003 111.969 -175.895 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 114' ' ' ILE . . . . . 0.648 ' HB ' ' SG ' ' A' ' 62' ' ' CYS . 12.1 mt -111.98 105.02 17.98 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.733 0 C-N-CA 124.168 0.987 . . . . 65.109999999999999 109.127 -178.391 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 115' ' ' CYS . . . . . . . . . . . . . 69.5 m -75.71 107.89 8.19 Favored 'General case' 0 CA--C 1.541 0.597 0 N-CA-C 109.171 -0.677 . . . . 75.140000000000001 109.171 173.335 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 116' ' ' THR . . . . . 0.468 ' HA ' ' H ' ' A' ' 96' ' ' GLY . 72.3 p -78.6 -10.71 59.84 Favored 'General case' 0 N--CA 1.481 1.078 0 C-N-CA 123.379 0.672 . . . . 52.340000000000003 111.681 -179.559 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -125.46 166.92 15.76 Favored 'General case' 0 C--O 1.243 0.746 0 C-N-CA 123.358 0.663 . . . . 45.439999999999998 109.741 176.37 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 11.3 ptmt -71.72 74.49 0.83 Allowed 'General case' 0 CA--C 1.548 0.893 0 C-N-CA 124.003 0.921 . . . . 64.299999999999997 110.097 174.829 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 119' ' ' THR . . . . . 0.547 ' HB ' HD23 ' A' ' 122' ' ' LEU . 41.1 p -76.53 90.66 3.32 Favored 'General case' 0 CA--C 1.546 0.821 0 CA-C-O 121.928 0.871 . . . . 71.200000000000003 109.588 -177.514 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 9.6 pt-20 -71.82 -32.11 67.23 Favored 'General case' 0 N--CA 1.472 0.648 0 CA-C-N 115.057 -0.974 . . . . 62.119999999999997 112.19 -173.987 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 121' ' ' TRP . . . . . . . . . . . . . 27.4 p90 -74.09 -4.82 37.94 Favored 'General case' 0 N--CA 1.479 0.99 0 C-N-CA 122.757 0.423 . . . . 73.439999999999998 111.058 176.793 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 122' ' ' LEU . . . . . 0.547 HD23 ' HB ' ' A' ' 119' ' ' THR . 3.8 mm? -86.88 -15.67 38.35 Favored 'General case' 0 N--CA 1.477 0.878 0 C-N-CA 123.761 0.824 . . . . 70.0 111.394 173.347 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 41.4 m-20 -72.41 149.39 44.32 Favored 'General case' 0 N--CA 1.482 1.134 0 N-CA-C 109.767 -0.457 . . . . 65.040000000000006 109.767 176.105 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 93.93 -26.9 14.4 Favored Glycine 0 N--CA 1.47 0.912 0 N-CA-C 111.628 -0.589 . . . . 51.130000000000003 111.628 -171.274 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 125' ' ' LYS . . . . . 0.504 ' HD2' ' HE2' ' B' ' 221' ' ' TYR . 1.8 mppt? -80.1 -169.89 2.24 Favored 'General case' 0 N--CA 1.478 0.951 0 C-N-CA 123.902 0.881 . . . . 74.549999999999997 109.709 172.387 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 126' ' ' HIS . . . . . . . . . . . . . 0.6 OUTLIER -69.34 145.68 52.77 Favored 'General case' 0 C--O 1.242 0.673 0 C-N-CA 123.372 0.669 . . . . 75.230000000000004 111.79 -167.51 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 11.1 p -65.32 145.19 14.12 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.726 0 CA-C-N 113.656 -1.611 . . . . 63.119999999999997 112.361 -165.521 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 128' ' ' VAL . . . . . 0.522 HG22 ' HB2' ' A' ' 99' ' ' SER . 60.2 t -74.25 150.22 7.43 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.53 0 CA-C-N 114.569 -1.196 . . . . 73.0 108.932 172.791 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 129' ' ' PHE . . . . . 0.519 ' HA ' HG21 ' A' ' 29' ' ' VAL . 45.5 p90 -133.59 -10.76 2.78 Favored 'General case' 0 N--CA 1.476 0.831 0 C-N-CA 122.202 0.201 . . . . 74.420000000000002 111.424 -179.396 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . -146.3 170.93 27.3 Favored Glycine 0 C--N 1.343 0.941 0 O-C-N 123.559 0.537 . . . . 75.329999999999998 112.751 -173.357 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 29.4 ttpt -161.19 134.21 6.34 Favored 'General case' 0 C--N 1.325 -0.46 0 C-N-CA 124.346 1.058 . . . . 63.210000000000001 108.235 -175.959 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 132' ' ' VAL . . . . . 0.551 HG12 ' HA3' ' A' ' 96' ' ' GLY . 13.7 p -68.41 131.02 33.82 Favored 'Isoleucine or valine' 0 CA--C 1.554 1.124 0 CA-C-N 118.329 0.513 . . . . 71.209999999999994 109.959 175.107 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -91.62 -48.82 6.63 Favored 'General case' 0 N--CA 1.48 1.061 0 N-CA-C 108.975 -0.75 . . . . 61.409999999999997 108.975 173.306 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 3.2 mp0 -146.63 155.85 42.76 Favored 'General case' 0 C--O 1.243 0.747 0 C-N-CA 124.983 1.313 . . . . 71.439999999999998 108.544 177.052 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 94.24 12.22 56.47 Favored Glycine 0 C--N 1.342 0.877 0 CA-C-N 115.926 -0.579 . . . . 51.420000000000002 112.376 -174.546 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 136' ' ' MET . . . . . 0.423 ' SD ' HG11 ' A' ' 132' ' ' VAL . 15.0 tpt -62.5 -31.1 71.8 Favored 'General case' 0 N--CA 1.48 1.031 0 C-N-CA 123.847 0.859 . . . . 60.329999999999998 111.192 178.522 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 137' ' ' ASN . . . . . . . . . . . . . 26.6 t-20 -55.51 -42.22 74.18 Favored 'General case' 0 N--CA 1.479 0.994 0 C-N-CA 123.964 0.906 . . . . 74.230000000000004 110.506 174.238 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 138' ' ' ILE . . . . . . . . . . . . . 44.9 mm -74.19 -32.85 33.24 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.73 0 CA-C-N 115.232 -0.895 . . . . 72.329999999999998 110.691 -178.95 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 69.3 t -64.55 -41.43 92.25 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.366 0 C-N-CA 123.471 0.709 . . . . 62.009999999999998 110.495 176.347 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 38.3 mt-10 -69.92 -39.22 76.29 Favored 'General case' 0 N--CA 1.473 0.722 0 CA-C-N 115.311 -0.859 . . . . 62.5 110.747 177.681 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -65.06 -52.45 55.67 Favored 'General case' 0 N--CA 1.475 0.784 0 O-C-N 123.681 0.613 . . . . 74.099999999999994 110.632 -179.568 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 142' ' ' MET . . . . . 0.459 ' HB2' HD13 ' A' ' 156' ' ' ILE . 27.6 ptm -59.73 -37.66 79.57 Favored 'General case' 0 N--CA 1.477 0.888 0 C-N-CA 123.055 0.542 . . . . 71.310000000000002 110.538 179.144 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 143' ' ' GLU . . . . . 0.578 ' HG2' ' HA ' ' A' ' 58' ' ' PRO . 39.4 tt0 -62.74 -35.76 80.8 Favored 'General case' 0 CA--C 1.546 0.822 0 CA-C-O 121.253 0.549 . . . . 74.019999999999996 112.144 -176.966 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 144' ' ' ARG . . . . . 0.557 ' HA ' ' HB3' ' A' ' 58' ' ' PRO . 62.3 mtt180 -73.58 -7.31 51.38 Favored 'General case' 0 CA--C 1.547 0.828 0 CA-C-N 115.769 -0.65 . . . . 73.150000000000006 112.711 -178.236 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 145' ' ' PHE . . . . . 0.546 ' HB2' HD11 ' A' ' 156' ' ' ILE . 55.0 m-85 -89.2 6.74 38.74 Favored 'General case' 0 CA--C 1.558 1.251 0 C-N-CA 123.07 0.548 . . . . 74.530000000000001 111.933 172.416 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . -102.5 -175.23 27.25 Favored Glycine 0 C--N 1.355 1.608 0 CA-C-N 117.646 0.203 . . . . 21.239999999999998 112.708 177.842 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 31.0 m -132.91 168.99 17.44 Favored 'General case' 0 N--CA 1.489 1.496 0 C-N-CA 124.202 1.001 . . . . 71.430000000000007 110.3 179.84 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 148' ' ' ARG . . . . . 0.565 ' HA ' HG23 ' A' ' 57' ' ' ILE . 21.9 mmt85 -65.98 -33.97 77.04 Favored 'General case' 0 N--CA 1.487 1.4 0 C-N-CA 123.845 0.858 . . . . 64.519999999999996 112.758 -175.143 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 149' ' ' ASN . . . . . . . . . . . . . 30.9 p-10 -74.7 -15.75 60.78 Favored 'General case' 0 N--CA 1.484 1.272 0 C-N-CA 123.411 0.684 . . . . 70.120000000000005 111.325 175.148 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 150' ' ' GLY . . . . . 0.403 ' O ' ' HA ' ' A' ' 55' ' ' ARG . . . 109.67 -17.06 30.86 Favored Glycine 0 C--N 1.344 1.004 0 CA-C-N 115.671 -0.695 . . . . 64.049999999999997 112.462 -179.962 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 66.2 tttp -60.3 124.01 19.0 Favored 'General case' 0 N--CA 1.474 0.769 0 CA-C-N 117.417 0.609 . . . . 71.010000000000005 110.918 -177.955 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 152' ' ' THR . . . . . 0.432 HG22 ' HB ' ' A' ' 56' ' ' ILE . 14.0 p -89.56 118.02 28.89 Favored 'General case' 0 CA--C 1.538 0.482 0 C-N-CA 123.235 0.614 . . . . 70.439999999999998 109.567 -177.897 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 153' ' ' SER . . . . . . . . . . . . . 19.8 m -66.89 -19.07 65.66 Favored 'General case' 0 CA--C 1.549 0.921 0 C-N-CA 124.153 0.981 . . . . 74.439999999999998 111.724 178.77 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 154' ' ' LYS . . . . . 0.453 ' HB3' HG13 ' A' ' 12' ' ' VAL . 74.6 mmtt -128.58 144.14 51.09 Favored 'General case' 0 N--CA 1.48 1.067 0 C-N-CA 124.478 1.111 . . . . 75.549999999999997 108.666 176.498 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 155' ' ' LYS . . . . . 0.47 ' HB3' ' HA ' ' A' ' 13' ' ' ASP . 0.0 OUTLIER -81.47 90.13 6.2 Favored 'General case' 0 N--CA 1.477 0.882 0 CA-C-O 121.54 0.686 . . . . 71.299999999999997 109.743 -177.269 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 156' ' ' ILE . . . . . 0.546 HD11 ' HB2' ' A' ' 145' ' ' PHE . 66.3 mt -88.74 118.48 34.22 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.432 0 CA-C-N 115.855 -0.611 . . . . 72.349999999999994 109.449 -176.206 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 157' ' ' THR . . . . . . . . . . . . . 30.7 p -131.15 156.09 45.88 Favored 'General case' 0 C--O 1.239 0.534 0 C-N-CA 124.469 1.108 . . . . 74.040000000000006 109.382 -174.931 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 158' ' ' ILE . . . . . . . . . . . . . 60.1 mt -77.96 94.15 1.46 Allowed 'Isoleucine or valine' 0 CA--C 1.55 0.946 0 N-CA-C 108.926 -0.768 . . . . 64.019999999999996 108.926 172.572 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 159' ' ' ALA . . . . . 0.75 ' HB2' ' HB2' ' A' ' 11' ' ' ALA . . . -51.9 -40.88 61.43 Favored 'General case' 0 N--CA 1.488 1.439 0 C-N-CA 124.551 1.14 . . . . 61.340000000000003 113.03 -177.932 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 160' ' ' ASP . . . . . . . . . . . . . 25.3 t0 -164.36 157.74 17.87 Favored 'General case' 0 N--CA 1.478 0.958 0 C-N-CA 122.946 0.498 . . . . 73.120000000000005 110.311 178.718 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 161' ' ' CYS . . . . . . . . . . . . . 29.2 p -119.82 -169.97 1.87 Allowed 'General case' 0 N--CA 1.475 0.779 0 C-N-CA 124.774 1.229 . . . . 75.420000000000002 108.36 175.398 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 162' ' ' GLY . . . . . . . . . . . . . . . 132.49 55.02 0.08 OUTLIER Glycine 0 C--N 1.347 1.156 0 N-CA-C 111.095 -0.802 . . . . 54.329999999999998 111.095 -170.393 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 163' ' ' GLN . . . . . 0.635 ' HA ' ' H ' ' A' ' 7' ' ' PHE . 3.0 pt20 -49.63 137.49 15.54 Favored 'General case' 0 CA--C 1.55 0.961 0 N-CA-C 114.357 1.243 . . . . 63.539999999999999 114.357 -169.296 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 164' ' ' LEU . . . . . 0.415 ' O ' ' HB ' ' A' ' 5' ' ' THR . 85.2 mt -89.96 116.67 28.19 Favored 'General case' 0 N--CA 1.472 0.644 0 CA-C-N 115.859 -0.61 . . . . 62.340000000000003 110.114 -176.502 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 165' ' ' GLU . . . . . . . . . . . . . 9.3 pt-20 . . . . . 0 C--O 1.256 1.415 0 C-N-CA 123.458 0.703 . . . . 71.310000000000002 110.322 -179.019 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' B' B ' 216' ' ' PRO . . . . . . . . . . . . . 1.2 Cg_endo . . . . . 0 N--CA 1.486 1.061 0 N-CA-C 110.601 -0.577 . . . . 65.409999999999997 110.601 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' B' B ' 217' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -89.71 151.44 45.7 Favored Pre-proline 0 N--CA 1.481 1.11 0 C-N-CA 123.069 0.548 . . . . 75.409999999999997 110.034 -179.602 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 218' ' ' PRO . . . . . 0.693 ' HB2' HE22 ' A' ' 111' ' ' GLN . 50.2 Cg_exo -56.18 113.78 1.6 Allowed 'Trans proline' 0 C--N 1.385 2.492 0 C-N-CA 123.09 2.527 . . . . 61.520000000000003 112.484 178.9 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 219' ' ' GLY . . . . . . . . . . . . . . . 169.37 -176.47 43.36 Favored Glycine 0 CA--C 1.524 0.607 0 N-CA-C 110.164 -1.174 . . . . 43.520000000000003 110.164 -178.489 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 220' ' ' PRO . . . . . . . . . . . . . 82.4 Cg_endo -79.56 -177.59 3.97 Favored 'Trans proline' 0 CA--C 1.553 1.425 0 C-N-CA 122.519 2.146 . . . . 75.25 113.88 175.211 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 221' ' ' TYR . . . . . 0.504 ' HE2' ' HD2' ' A' ' 125' ' ' LYS . 64.4 m-85 -82.12 123.54 29.06 Favored 'General case' 0 N--CA 1.476 0.872 0 C-N-CA 123.852 0.861 . . . . 71.400000000000006 110.237 -178.051 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 222' ' ' ALA . . . . . 0.43 ' HA ' ' CE2' ' A' ' 60' ' ' PHE . . . -90.24 166.44 13.35 Favored 'General case' 0 N--CA 1.476 0.834 0 N-CA-C 113.255 0.835 . . . . 53.140000000000001 113.255 -175.131 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 223' ' ' GLN . . . . . 0.47 HE21 HG22 ' A' ' 57' ' ' ILE . 28.4 pt20 -75.18 140.39 73.13 Favored Pre-proline 0 CA--C 1.556 1.176 0 CA-C-N 115.408 -0.815 . . . . 54.420000000000002 108.904 171.204 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 224' ' ' PRO . . . . . . . . . . . . . 56.2 Cg_endo . . . . . 0 CA--C 1.564 2.012 0 C-N-CA 122.72 2.28 . . . . 62.530000000000001 111.827 174.851 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . 0.405 ' SD ' ' HB2' ' A' ' 3' ' ' ASN . 23.7 ptp . . . . . 0 N--CA 1.484 1.236 0 CA-C-O 120.404 0.145 . . . . 72.430000000000007 110.693 . . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 5.9 p -83.88 -19.13 9.62 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.99 0 C-N-CA 122.996 0.518 . . . . 74.349999999999994 110.575 179.604 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 3' ' ' ASN . . . . . 0.628 ' ND2' ' HA ' ' A' ' 25' ' ' PHE . 9.7 m120 -56.21 115.69 10.54 Favored Pre-proline 0 N--CA 1.478 0.954 0 C-N-CA 124.524 1.13 . . . . 75.099999999999994 110.838 175.79 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 4' ' ' PRO . . . . . 0.645 ' HG2' ' HB2' ' A' ' 24' ' ' LEU . 67.2 Cg_endo -72.66 136.74 26.24 Favored 'Trans proline' 0 C--N 1.374 1.872 0 C-N-CA 122.144 1.896 . . . . 64.209999999999994 111.653 176.37 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 5' ' ' THR . . . . . 0.608 HG23 ' HD3' ' A' ' 133' ' ' LYS . 85.5 m -95.99 113.56 25.19 Favored 'General case' 0 C--O 1.236 0.368 0 N-CA-C 107.893 -1.151 . . . . 73.129999999999995 107.893 176.002 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . 0.556 ' HA ' ' HB2' ' A' ' 163' ' ' GLN . 13.7 m -98.62 121.1 48.8 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.51 0 CA-C-O 121.956 0.884 . . . . 75.230000000000004 109.328 -178.22 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 7' ' ' PHE . . . . . 0.436 ' H ' ' HA ' ' A' ' 163' ' ' GLN . 77.3 t80 -105.08 135.09 47.08 Favored 'General case' 0 C--O 1.239 0.52 0 CA-C-N 114.423 -1.262 . . . . 70.209999999999994 109.237 -173.328 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 8' ' ' PHE . . . . . 0.44 ' HB3' HG23 ' A' ' 158' ' ' ILE . 64.4 m-85 -142.27 165.25 27.94 Favored 'General case' 0 C--O 1.24 0.578 0 O-C-N 124.398 1.061 . . . . 64.239999999999995 109.757 176.11 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 17.4 m-20 -113.91 108.51 17.15 Favored 'General case' 0 N--CA 1.465 0.314 0 N-CA-C 107.625 -1.25 . . . . 71.109999999999999 107.625 171.637 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 10' ' ' ILE . . . . . 0.441 HG21 ' SD ' ' A' ' 142' ' ' MET . 47.3 mm -80.7 116.82 25.61 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.351 0 N-CA-C 108.313 -0.995 . . . . 52.009999999999998 108.313 -179.545 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 11' ' ' ALA . . . . . 0.688 ' HB2' ' HB2' ' A' ' 159' ' ' ALA . . . -116.04 109.92 18.2 Favored 'General case' 0 N--CA 1.469 0.493 0 C-N-CA 123.684 0.794 . . . . 70.420000000000002 111.941 -168.586 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . 0.502 HG21 HD22 ' A' ' 17' ' ' LEU . 89.6 t -96.04 128.91 46.81 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.467 0 N-CA-C 108.057 -1.09 . . . . 75.010000000000005 108.057 176.684 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 25.0 m-20 70.24 15.94 7.4 Favored 'General case' 0 N--CA 1.493 1.688 0 C-N-CA 124.218 1.007 . . . . 74.549999999999997 110.484 -172.325 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 81.29 -5.89 65.92 Favored Glycine 0 C--N 1.353 1.507 0 CA-C-N 116.005 -0.543 . . . . 65.420000000000002 112.754 -170.505 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 25.7 mm-40 -98.32 120.81 58.68 Favored Pre-proline 0 N--CA 1.471 0.599 0 C-N-CA 123.823 0.849 . . . . 64.239999999999995 109.437 -178.213 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 52.3 Cg_exo -51.21 105.19 0.1 OUTLIER 'Trans proline' 0 C--N 1.375 1.963 0 C-N-CA 123.257 2.638 . . . . 60.140000000000001 112.344 178.536 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . 0.502 HD22 HG21 ' A' ' 12' ' ' VAL . 26.9 tp -75.08 -31.69 61.27 Favored 'General case' 0 N--CA 1.472 0.67 0 C-N-CA 124.126 0.97 . . . . 61.210000000000001 109.573 -179.892 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -175.66 173.15 46.07 Favored Glycine 0 C--N 1.341 0.814 0 CA-C-N 115.071 -0.968 . . . . 64.519999999999996 112.054 175.925 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 19' ' ' ARG . . . . . 0.428 ' HD2' ' HZ ' ' A' ' 7' ' ' PHE . 47.6 mtm180 -107.2 124.39 49.66 Favored 'General case' 0 N--CA 1.471 0.595 0 N-CA-C 108.541 -0.911 . . . . 74.209999999999994 108.541 -179.095 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 71.3 t -120.74 141.45 41.11 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.881 0 C-N-CA 123.1 0.56 . . . . 71.519999999999996 109.9 -176.945 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 21' ' ' SER . . . . . 0.551 ' HB2' ' HB2' ' A' ' 134' ' ' GLU . 60.6 m -127.39 132.14 50.2 Favored 'General case' 0 C--O 1.245 0.828 0 C-N-CA 123.878 0.871 . . . . 64.349999999999994 109.39 173.533 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 17.3 m-85 -107.42 153.67 22.45 Favored 'General case' 0 N--CA 1.469 0.513 0 N-CA-C 108.338 -0.986 . . . . 72.230000000000004 108.338 177.729 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 5.8 tp10 -104.75 109.64 21.67 Favored 'General case' 0 C--O 1.239 0.543 0 N-CA-C 108.598 -0.889 . . . . 73.450000000000003 108.598 176.954 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . 0.645 ' HB2' ' HG2' ' A' ' 4' ' ' PRO . 29.6 mt -81.11 122.77 27.77 Favored 'General case' 0 N--CA 1.465 0.285 0 N-CA-C 108.784 -0.821 . . . . 53.049999999999997 108.784 175.309 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 25' ' ' PHE . . . . . 0.628 ' HA ' ' ND2' ' A' ' 3' ' ' ASN . 86.9 m-85 -84.91 65.46 9.2 Favored 'General case' 0 N--CA 1.467 0.377 0 C-N-CA 123.166 0.586 . . . . 75.209999999999994 110.468 179.888 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -64.17 -24.16 67.58 Favored 'General case' 0 N--CA 1.477 0.877 0 C-N-CA 123.418 0.687 . . . . 65.150000000000006 111.876 -179.799 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 10.9 p-10 -66.09 -25.73 67.15 Favored 'General case' 0 N--CA 1.476 0.853 0 C-N-CA 123.535 0.734 . . . . 73.329999999999998 111.33 177.467 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 52.4 mttm -102.32 -43.93 5.55 Favored 'General case' 0 N--CA 1.478 0.962 0 C-N-CA 124.163 0.985 . . . . 63.140000000000001 110.238 -179.433 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 29' ' ' VAL . . . . . 0.443 HG21 ' HA ' ' A' ' 129' ' ' PHE . 16.0 m -127.31 78.85 74.03 Favored Pre-proline 0 CA--C 1.556 1.194 0 C-N-CA 124.128 0.971 . . . . 43.229999999999997 109.942 -177.11 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 11.3 Cg_endo -55.21 -48.02 23.09 Favored 'Trans proline' 0 C--N 1.383 2.373 0 C-N-CA 123.038 2.492 . . . . 74.439999999999998 112.89 -177.792 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 31' ' ' LYS . . . . . 0.446 ' HG3' ' OH ' ' A' ' 79' ' ' TYR . 23.4 ttmm -76.86 -43.48 35.96 Favored 'General case' 0 N--CA 1.474 0.771 0 C-N-CA 123.967 0.907 . . . . 74.349999999999994 112.344 -172.631 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 9.1 m -69.14 -33.36 73.33 Favored 'General case' 0 CA--C 1.549 0.94 0 CA-C-O 120.867 0.365 . . . . 51.530000000000001 110.273 -176.062 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -78.43 -34.52 47.81 Favored 'General case' 0 CA--C 1.55 0.976 0 CA-C-N 116.112 -0.494 . . . . 64.319999999999993 111.533 174.03 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 29.7 tt0 -60.32 -41.58 93.8 Favored 'General case' 0 N--CA 1.49 1.555 0 C-N-CA 124.421 1.088 . . . . 64.040000000000006 111.077 178.536 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 35' ' ' ASN . . . . . 0.478 ' O ' ' HG ' ' A' ' 39' ' ' LEU . 40.9 t30 -54.15 -60.16 3.7 Favored 'General case' 0 CA--C 1.537 0.448 0 CA-C-N 114.297 -1.32 . . . . 75.319999999999993 110.191 178.635 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 63.1 t80 -65.48 -32.51 74.16 Favored 'General case' 0 CA--C 1.545 0.76 0 CA-C-N 115.225 -0.898 . . . . 71.519999999999996 111.613 -176.695 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 37.0 ttm-85 -57.02 -50.98 71.06 Favored 'General case' 0 N--CA 1.482 1.139 0 C-N-CA 124.028 0.931 . . . . 75.400000000000006 110.346 177.195 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 38' ' ' ALA . . . . . 0.538 ' HB3' HG21 ' A' ' 78' ' ' ILE . . . -79.26 -23.33 43.73 Favored 'General case' 0 CA--C 1.545 0.766 0 CA-C-N 115.029 -0.987 . . . . 73.340000000000003 112.22 -175.24 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 39' ' ' LEU . . . . . 0.478 ' HG ' ' O ' ' A' ' 35' ' ' ASN . 85.7 mt -71.78 -40.19 69.42 Favored 'General case' 0 N--CA 1.483 1.221 0 C-N-CA 123.004 0.522 . . . . 52.210000000000001 110.158 172.899 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 28.8 t -65.48 -55.05 20.03 Favored 'General case' 0 N--CA 1.475 0.805 0 C-N-CA 124.513 1.125 . . . . 54.439999999999998 110.682 -179.368 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 20.8 p -67.73 -32.07 72.43 Favored 'General case' 0 N--CA 1.477 0.894 0 CA-C-N 116.08 -0.509 . . . . 73.540000000000006 111.411 177.284 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 71.21 28.18 70.52 Favored Glycine 0 C--N 1.343 0.972 0 CA-C-N 115.686 -0.688 . . . . 53.32 112.838 -176.662 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 19.4 mm-40 -62.85 -31.07 72.01 Favored 'General case' 0 N--CA 1.479 0.992 0 C-N-CA 123.268 0.627 . . . . 75.329999999999998 111.461 177.62 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 44' ' ' LYS . . . . . 0.403 ' HG2' ' HB1' ' A' ' 38' ' ' ALA . 75.7 mmtt -83.98 9.44 12.33 Favored 'General case' 0 CA--C 1.556 1.197 0 CA-C-N 115.706 -0.679 . . . . 74.420000000000002 111.592 178.062 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 76.1 32.51 52.39 Favored Glycine 0 C--N 1.352 1.455 0 C-N-CA 123.146 0.403 . . . . 64.310000000000002 113.706 175.711 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 17.9 m-85 -110.28 -47.23 3.32 Favored 'General case' 0 N--CA 1.483 1.182 0 N-CA-C 109.654 -0.498 . . . . 75.329999999999998 109.654 179.453 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 56.66 65.58 3.47 Favored Glycine 0 C--N 1.354 1.548 0 O-C-N 124.107 0.879 . . . . 53.030000000000001 114.21 168.627 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 48' ' ' TYR . . . . . 0.472 ' HE1' HD22 ' A' ' 39' ' ' LEU . 51.3 m-85 -65.25 87.33 0.07 Allowed 'General case' 0 N--CA 1.476 0.848 0 CA-C-O 122.644 1.212 . . . . 74.099999999999994 111.237 -179.378 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 50.6 tptt -111.13 134.83 52.42 Favored 'General case' 0 C--O 1.244 0.812 0 CA-C-N 112.698 -2.046 . . . . 73.349999999999994 107.655 -179.486 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 65.22 21.86 68.6 Favored Glycine 0 N--CA 1.468 0.823 0 CA-C-O 119.57 -0.572 . . . . 75.209999999999994 113.032 -179.321 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 28.1 t -57.98 114.24 2.25 Favored 'General case' 0 C--N 1.362 1.11 0 C-N-CA 123.688 0.795 . . . . 64.120000000000005 109.946 -176.379 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 52' ' ' CYS . . . . . . . . . . . . . 45.2 t -83.31 137.37 34.0 Favored 'General case' 0 C--O 1.241 0.619 0 CA-C-N 115.437 -0.802 . . . . 60.130000000000003 111.757 -166.872 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 53' ' ' PHE . . . . . 0.747 ' HA ' ' HA2' ' A' ' 64' ' ' GLY . 38.6 m-85 -87.2 115.65 24.75 Favored 'General case' 0 C--O 1.238 0.474 0 N-CA-C 107.886 -1.153 . . . . 75.25 107.886 169.647 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 47.3 p-80 -99.5 -29.71 12.58 Favored 'General case' 0 N--CA 1.48 1.072 0 C-N-CA 123.278 0.631 . . . . 74.099999999999994 111.153 -175.748 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 55' ' ' ARG . . . . . 0.527 ' HA ' ' O ' ' A' ' 150' ' ' GLY . 59.5 ttt180 -132.92 98.96 4.44 Favored 'General case' 0 C--O 1.218 -0.588 0 CA-C-N 115.78 -0.646 . . . . 73.430000000000007 109.412 -168.805 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 56' ' ' ILE . . . . . 0.504 HD12 HD12 ' A' ' 156' ' ' ILE . 47.5 mt -123.67 124.36 69.23 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.813 0 N-CA-C 109.162 -0.681 . . . . 73.140000000000001 109.162 178.564 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 57' ' ' ILE . . . . . 0.488 HD13 ' HB2' ' B' ' 222' ' ' ALA . 45.4 mt -126.61 112.16 22.83 Favored Pre-proline 0 CA--C 1.561 1.372 0 C-N-CA 124.87 1.268 . . . . 63.43 109.242 -170.985 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 71.0 Cg_exo -54.32 145.11 57.57 Favored 'Trans proline' 0 C--N 1.374 1.879 0 C-N-CA 123.924 3.083 . . . . 74.439999999999998 115.024 176.848 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 64.72 21.06 66.89 Favored Glycine 0 C--N 1.351 1.414 0 CA-C-N 114.643 -1.162 . . . . 54.219999999999999 113.71 -179.772 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 60' ' ' PHE . . . . . 0.441 ' HE1' ' HE1' ' A' ' 121' ' ' TRP . 33.1 t80 -144.42 -76.61 0.22 Allowed 'General case' 0 C--O 1.242 0.667 0 C-N-CA 123.099 0.559 . . . . 63.329999999999998 110.639 -171.09 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 61' ' ' MET . . . . . 0.664 ' SD ' ' HB2' ' A' ' 113' ' ' PHE . 12.3 tmm? -174.89 144.85 0.81 Allowed 'General case' 0 CA--C 1.543 0.711 0 O-C-N 123.457 0.473 . . . . 73.099999999999994 111.341 -162.187 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 62' ' ' CYS . . . . . 0.513 ' SG ' ' HB ' ' A' ' 114' ' ' ILE . 8.1 p -113.78 112.66 23.78 Favored 'General case' 0 CA--C 1.552 1.054 0 C-N-CA 124.25 1.02 . . . . 65.109999999999999 109.653 172.827 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 63' ' ' GLN . . . . . 0.63 ' HB2' ' SD ' ' A' ' 61' ' ' MET . 49.6 tt0 -103.05 114.49 28.83 Favored 'General case' 0 N--CA 1.485 1.32 0 C-N-CA 124.248 1.019 . . . . 75.019999999999996 111.129 -171.145 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 64' ' ' GLY . . . . . 0.747 ' HA2' ' HA ' ' A' ' 53' ' ' PHE . . . -98.95 -169.62 30.93 Favored Glycine 0 C--O 1.244 0.72 0 CA-C-N 114.863 -1.062 . . . . 71.519999999999996 112.111 175.597 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 72.92 87.14 0.19 Allowed Glycine 0 C--N 1.337 0.632 0 N-CA-C 111.062 -0.815 . . . . 64.209999999999994 111.062 -178.178 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 38.8 t70 -128.04 -38.46 1.82 Allowed 'General case' 0 N--CA 1.469 0.525 0 C-N-CA 122.825 0.45 . . . . 74.230000000000004 111.474 -179.518 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 77.0 t80 -70.83 -68.56 0.42 Allowed 'General case' 0 CA--C 1.552 1.043 0 N-CA-C 113.505 0.928 . . . . 61.450000000000003 113.505 -164.812 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 48.9 m -60.04 109.37 0.94 Allowed 'General case' 0 N--CA 1.482 1.141 0 C-N-CA 123.62 0.768 . . . . 65.120000000000005 112.038 -168.797 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 69' ' ' ARG . . . . . 0.557 ' HD3' ' HD3' ' A' ' 76' ' ' LYS . 73.3 mtp180 57.93 69.18 0.76 Allowed 'General case' 0 C--N 1.352 0.686 0 C-N-CA 124.763 1.225 . . . . 72.430000000000007 110.637 -170.856 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 24.5 p-80 -79.89 66.71 5.45 Favored 'General case' 0 N--CA 1.476 0.854 0 CA-C-O 122.128 0.966 . . . . 72.030000000000001 111.939 -176.921 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 15.5 m120 -119.68 20.74 12.26 Favored 'General case' 0 N--CA 1.476 0.832 0 C-N-CA 124.51 1.124 . . . . 74.430000000000007 108.628 173.898 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 100.67 -8.1 58.05 Favored Glycine 0 C--N 1.349 1.26 0 CA-C-N 115.302 -0.863 . . . . 72.319999999999993 112.519 -170.747 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 10.2 m -81.59 -61.8 1.83 Allowed 'General case' 0 N--CA 1.475 0.78 0 CA-C-N 117.589 0.694 . . . . 73.530000000000001 109.286 179.376 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 48.37 47.61 28.18 Favored Glycine 0 C--N 1.351 1.368 0 O-C-N 124.146 0.904 . . . . 43.5 115.309 170.236 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 138.11 51.37 0.06 OUTLIER Glycine 0 N--CA 1.474 1.218 0 CA-C-N 118.532 1.166 . . . . 53.520000000000003 113.382 -178.388 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 76' ' ' LYS . . . . . 0.557 ' HD3' ' HD3' ' A' ' 69' ' ' ARG . 22.8 pttp -61.35 160.26 11.07 Favored 'General case' 0 CA--C 1.556 1.177 0 C-N-CA 123.71 0.804 . . . . 74.299999999999997 111.95 179.85 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 87.1 p -91.3 164.5 13.84 Favored 'General case' 0 N--CA 1.483 1.206 0 C-N-CA 123.693 0.797 . . . . 75.120000000000005 111.685 -171.266 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 78' ' ' ILE . . . . . 0.538 HG21 ' HB3' ' A' ' 38' ' ' ALA . 45.6 pt -65.18 -15.89 19.16 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.397 0 N-CA-C 112.396 0.517 . . . . 72.030000000000001 112.396 179.89 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 79' ' ' TYR . . . . . 0.446 ' OH ' ' HG3' ' A' ' 31' ' ' LYS . 32.3 m-85 -89.79 -32.4 16.96 Favored 'General case' 0 N--CA 1.472 0.629 0 C-N-CA 123.647 0.779 . . . . 73.019999999999996 110.833 179.216 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 171.79 -137.53 4.36 Favored Glycine 0 C--N 1.339 0.726 0 CA-C-N 116.046 -0.524 . . . . 61.329999999999998 112.141 179.43 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 35.3 tt0 -65.31 -40.39 93.7 Favored 'General case' 0 CA--C 1.544 0.715 0 C-N-CA 123.375 0.67 . . . . 73.219999999999999 110.617 176.249 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 82' ' ' LYS . . . . . 0.652 ' HD2' ' HA ' ' A' ' 107' ' ' THR . 23.3 pttm -170.97 178.68 3.34 Favored 'General case' 0 CA--C 1.549 0.932 0 C-N-CA 124.129 0.971 . . . . 74.430000000000007 110.125 -173.79 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 18.9 p90 -154.11 173.18 16.4 Favored 'General case' 0 N--CA 1.477 0.907 0 C-N-CA 124.682 1.193 . . . . 71.230000000000004 110.067 -177.026 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 84' ' ' GLU . . . . . 0.512 ' HA ' ' HA ' ' A' ' 106' ' ' ASN . 14.2 pt-20 -90.79 154.23 19.67 Favored 'General case' 0 C--O 1.24 0.575 0 CA-C-O 121.023 0.439 . . . . 74.010000000000005 110.875 -179.9 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 35.2 m-20 -64.83 130.61 44.1 Favored 'General case' 0 CA--C 1.536 0.436 0 CA-C-N 114.799 -1.091 . . . . 75.420000000000002 111.446 -175.185 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 28.3 tt0 -72.54 -60.83 2.04 Favored 'General case' 0 CA--C 1.54 0.592 0 C-N-CA 123.302 0.641 . . . . 64.030000000000001 111.972 -173.276 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 31.0 p30 -164.74 158.28 17.48 Favored 'General case' 0 N--CA 1.475 0.809 0 C-N-CA 122.679 0.392 . . . . 43.299999999999997 111.124 -179.069 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 93.1 m-85 -103.35 38.32 1.8 Allowed 'General case' 0 N--CA 1.479 0.975 0 C-N-CA 123.765 0.826 . . . . 62.109999999999999 111.217 -172.413 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 64.9 mt -66.02 -52.41 49.05 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.075 0 C-N-CA 123.039 0.535 . . . . 74.450000000000003 110.42 177.317 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 90' ' ' LEU . . . . . 0.508 HD11 ' HB2' ' A' ' 25' ' ' PHE . 62.0 mt -83.17 139.82 32.94 Favored 'General case' 0 N--CA 1.473 0.691 0 CA-C-N 115.894 -0.594 . . . . 64.319999999999993 111.846 -177.009 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 91' ' ' LYS . . . . . 0.479 ' HZ3' ' HB3' ' A' ' 91' ' ' LYS . 9.2 mtpm? -124.27 167.6 14.1 Favored 'General case' 0 N--CA 1.471 0.59 0 C-N-CA 124.377 1.071 . . . . 75.120000000000005 109.604 177.751 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 92' ' ' HIS . . . . . . . . . . . . . 24.9 m-70 -86.52 62.16 7.25 Favored 'General case' 0 CA--C 1.544 0.736 0 C-N-CA 124.173 0.989 . . . . 71.010000000000005 108.861 176.3 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 93' ' ' THR . . . . . 0.435 HG23 ' HB2' ' A' ' 91' ' ' LYS . 21.9 p -83.92 -33.97 24.61 Favored 'General case' 0 N--CA 1.473 0.709 0 CA-C-N 115.132 -0.94 . . . . 75.430000000000007 111.563 -175.112 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -121.11 -177.42 15.63 Favored Glycine 0 C--N 1.342 0.888 0 CA-C-N 116.07 -0.514 . . . . 65.420000000000002 112.876 -177.201 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 79.2 Cg_endo -85.26 158.1 11.15 Favored 'Trans proline' 0 CA--C 1.553 1.449 0 C-N-CA 123.281 2.654 . . . . 64.0 112.099 173.024 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 83.07 17.67 66.72 Favored Glycine 0 N--CA 1.47 0.911 0 CA-C-N 116.054 -0.521 . . . . 74.430000000000007 114.126 179.043 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 97' ' ' ILE . . . . . 0.58 ' HB ' ' HB2' ' A' ' 115' ' ' CYS . 31.6 mm -66.47 102.99 0.51 Allowed 'Isoleucine or valine' 0 CA--C 1.549 0.934 0 C-N-CA 123.64 0.776 . . . . 73.010000000000005 111.774 -174.6 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 98' ' ' LEU . . . . . 0.467 HD13 HG12 ' A' ' 114' ' ' ILE . 58.1 tp -85.74 105.73 16.48 Favored 'General case' 0 CA--C 1.551 0.991 0 C-N-CA 123.44 0.696 . . . . 74.540000000000006 109.68 177.598 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 47.8 t -126.66 135.39 51.11 Favored 'General case' 0 N--CA 1.468 0.467 0 C-N-CA 124.69 1.196 . . . . 74.140000000000001 108.78 178.308 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 100' ' ' MET . . . . . 0.502 ' SD ' ' HA2' ' A' ' 109' ' ' GLY . 14.3 ttt -78.8 135.77 37.17 Favored 'General case' 0 N--CA 1.474 0.761 0 N-CA-C 108.343 -0.984 . . . . 72.239999999999995 108.343 -179.357 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -74.5 158.16 34.27 Favored 'General case' 0 CA--C 1.545 0.783 0 N-CA-C 112.916 0.71 . . . . 61.399999999999999 112.916 -167.462 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 22.2 p-10 -158.09 169.07 25.36 Favored 'General case' 0 N--CA 1.476 0.868 0 CA-C-N 115.542 -0.754 . . . . 75.319999999999993 110.759 -179.692 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 103' ' ' ALA . . . . . 0.453 ' HB3' HG21 ' A' ' 107' ' ' THR . . . -113.96 -1.14 13.88 Favored 'General case' 0 N--CA 1.476 0.839 0 CA-C-N 115.492 -0.777 . . . . 74.329999999999998 110.758 171.721 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 160.22 -165.59 34.89 Favored Glycine 0 C--N 1.354 1.536 0 CA-C-O 119.668 -0.518 . . . . 71.239999999999995 113.056 178.891 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 26.6 Cg_exo -64.03 134.74 44.29 Favored 'Trans proline' 0 C--N 1.376 1.997 0 C-N-CA 123.529 2.819 . . . . 71.439999999999998 112.266 178.355 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 106' ' ' ASN . . . . . 0.512 ' HA ' ' HA ' ' A' ' 84' ' ' GLU . 65.0 t30 66.82 14.24 9.73 Favored 'General case' 0 N--CA 1.485 1.32 0 C-N-CA 124.534 1.134 . . . . 41.43 111.212 -179.102 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 107' ' ' THR . . . . . 0.652 ' HA ' ' HD2' ' A' ' 82' ' ' LYS . 2.3 m -115.11 7.26 15.36 Favored 'General case' 0 CA--C 1.549 0.923 0 C-N-CA 124.208 1.003 . . . . 73.200000000000003 109.918 -178.874 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 55.1 t30 -88.67 139.51 30.4 Favored 'General case' 0 N--CA 1.476 0.865 0 C-N-CA 123.248 0.619 . . . . 73.230000000000004 110.097 -177.397 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 109' ' ' GLY . . . . . 0.502 ' HA2' ' SD ' ' A' ' 100' ' ' MET . . . 113.07 25.35 4.49 Favored Glycine 0 N--CA 1.464 0.534 0 CA-C-O 120.204 -0.22 . . . . 64.439999999999998 112.772 -175.553 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 5.1 m -132.72 126.2 31.96 Favored 'General case' 0 CA--C 1.541 0.623 0 N-CA-C 108.013 -1.106 . . . . 65.239999999999995 108.013 170.206 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 10.5 mt-30 64.52 175.81 0.19 Allowed 'General case' 0 N--CA 1.504 2.23 0 C-N-CA 125.25 1.42 . . . . 65.219999999999999 110.82 -174.615 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 54.9 p90 -148.41 159.21 44.25 Favored 'General case' 0 N--CA 1.486 1.366 0 O-C-N 121.603 -0.686 . . . . 71.450000000000003 109.865 174.681 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 113' ' ' PHE . . . . . 0.664 ' HB2' ' SD ' ' A' ' 61' ' ' MET . 55.1 p90 -146.26 147.07 31.03 Favored 'General case' 0 N--CA 1.469 0.502 0 CA-C-O 121.109 0.481 . . . . 71.109999999999999 111.452 177.625 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 114' ' ' ILE . . . . . 0.513 ' HB ' ' SG ' ' A' ' 62' ' ' CYS . 13.9 mt -117.5 102.67 13.75 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.536 0 N-CA-C 108.071 -1.085 . . . . 72.400000000000006 108.071 -179.044 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 115' ' ' CYS . . . . . 0.58 ' HB2' ' HB ' ' A' ' 97' ' ' ILE . 33.7 m -68.16 105.23 2.02 Favored 'General case' 0 CA--C 1.539 0.544 0 C-N-CA 123.305 0.642 . . . . 61.009999999999998 109.601 -179.632 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 116' ' ' THR . . . . . 0.477 HG22 HG12 ' A' ' 139' ' ' VAL . 41.3 p -70.32 -30.4 67.37 Favored 'General case' 0 N--CA 1.475 0.797 0 C-N-CA 124.009 0.924 . . . . 51.340000000000003 110.822 -175.876 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -112.32 159.64 18.46 Favored 'General case' 0 C--O 1.243 0.725 0 N-CA-C 108.115 -1.069 . . . . 71.099999999999994 108.115 169.231 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -68.73 98.84 0.94 Allowed 'General case' 0 CA--C 1.542 0.661 0 CA-C-O 121.383 0.611 . . . . 73.219999999999999 109.491 176.669 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 119' ' ' THR . . . . . . . . . . . . . 33.9 p -81.66 85.35 6.58 Favored 'General case' 0 C--O 1.239 0.502 0 CA-C-O 121.778 0.799 . . . . 75.540000000000006 109.471 -179.183 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 12.1 pt-20 -72.25 -22.51 61.22 Favored 'General case' 0 N--CA 1.473 0.68 0 CA-C-N 114.805 -1.089 . . . . 74.5 112.001 -170.862 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 121' ' ' TRP . . . . . 0.441 ' HE1' ' HE1' ' A' ' 60' ' ' PHE . 26.8 p90 -69.79 -10.28 57.8 Favored 'General case' 0 N--CA 1.477 0.91 0 C-N-CA 123.261 0.624 . . . . 72.040000000000006 111.863 175.572 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 122' ' ' LEU . . . . . 0.547 ' HA ' ' HE2' ' A' ' 125' ' ' LYS . 79.3 mt -94.71 7.6 45.27 Favored 'General case' 0 N--CA 1.475 0.825 0 C-N-CA 122.952 0.501 . . . . 75.510000000000005 111.716 176.375 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 74.3 m-20 -80.59 148.38 30.33 Favored 'General case' 0 N--CA 1.478 0.945 0 N-CA-C 109.757 -0.46 . . . . 41.130000000000003 109.757 172.247 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 77.29 22.38 70.82 Favored Glycine 0 C--N 1.344 1.01 0 N-CA-C 111.992 -0.443 . . . . 42.439999999999998 111.992 -170.02 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 125' ' ' LYS . . . . . 0.547 ' HE2' ' HA ' ' A' ' 122' ' ' LEU . 27.1 mtmm -142.4 -167.47 2.5 Favored 'General case' 0 CA--C 1.545 0.759 0 C-N-CA 124.647 1.179 . . . . 72.549999999999997 110.356 -175.091 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 126' ' ' HIS . . . . . . . . . . . . . 2.3 p80 -64.72 157.67 26.81 Favored 'General case' 0 N--CA 1.475 0.785 0 C-N-CA 124.502 1.121 . . . . 62.119999999999997 113.955 -160.425 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 46.7 t -63.85 127.42 24.32 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.719 0 CA-C-N 113.337 -1.756 . . . . 72.030000000000001 113.627 -164.142 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 86.9 t -84.26 146.66 6.46 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.481 0 N-CA-C 108.034 -1.099 . . . . 73.200000000000003 108.034 164.196 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 129' ' ' PHE . . . . . 0.443 ' HA ' HG21 ' A' ' 29' ' ' VAL . 50.6 p90 -134.85 -6.38 2.42 Favored 'General case' 0 N--CA 1.478 0.965 0 CA-C-N 118.287 0.494 . . . . 73.549999999999997 111.721 -179.375 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . -150.02 168.44 30.07 Favored Glycine 0 C--N 1.342 0.869 0 C-N-CA 121.479 -0.391 . . . . 41.399999999999999 113.276 -175.402 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 32.2 ttpt -156.0 139.42 15.81 Favored 'General case' 0 N--CA 1.467 0.385 0 N-CA-C 107.861 -1.162 . . . . 74.549999999999997 107.861 175.04 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 132' ' ' VAL . . . . . 0.462 HG11 ' HA ' ' A' ' 136' ' ' MET . 21.8 t -64.0 114.48 2.11 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.717 0 CA-C-N 118.303 0.501 . . . . 74.209999999999994 109.871 179.733 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 133' ' ' LYS . . . . . 0.608 ' HD3' HG23 ' A' ' 5' ' ' THR . 21.6 ptmt -92.79 -30.62 15.39 Favored 'General case' 0 N--CA 1.478 0.944 0 C-N-CA 122.737 0.415 . . . . 70.230000000000004 109.884 178.861 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 134' ' ' GLU . . . . . 0.551 ' HB2' ' HB2' ' A' ' 21' ' ' SER . 41.4 mt-10 -142.49 135.8 28.74 Favored 'General case' 0 N--CA 1.473 0.725 0 C-N-CA 124.313 1.045 . . . . 63.310000000000002 109.657 -173.121 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 77.84 32.92 43.54 Favored Glycine 0 CA--C 1.531 1.076 0 O-C-N 123.327 0.392 . . . . 70.349999999999994 113.406 178.505 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 136' ' ' MET . . . . . 0.462 ' HA ' HG11 ' A' ' 132' ' ' VAL . 14.2 tpt -65.08 -35.31 80.75 Favored 'General case' 0 N--CA 1.482 1.148 0 C-N-CA 123.133 0.573 . . . . 63.32 111.643 -179.553 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 137' ' ' ASN . . . . . . . . . . . . . 18.2 m120 -67.1 -23.72 65.86 Favored 'General case' 0 N--CA 1.481 1.087 0 C-N-CA 123.294 0.638 . . . . 70.239999999999995 111.543 179.968 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 138' ' ' ILE . . . . . . . . . . . . . 36.7 mm -75.67 -37.96 37.09 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.063 0 C-N-CA 123.252 0.621 . . . . 72.409999999999997 109.61 175.913 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 139' ' ' VAL . . . . . 0.477 HG12 HG22 ' A' ' 116' ' ' THR . 95.9 t -63.5 -39.73 86.43 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.022 0 C-N-CA 123.592 0.757 . . . . 73.310000000000002 110.205 173.494 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 47.2 mt-10 -76.4 -20.68 56.88 Favored 'General case' 0 N--CA 1.474 0.774 0 CA-C-N 115.374 -0.83 . . . . 72.540000000000006 111.674 177.973 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -74.92 -50.66 16.07 Favored 'General case' 0 N--CA 1.471 0.594 0 C-N-CA 122.642 0.377 . . . . 55.340000000000003 110.387 173.939 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 142' ' ' MET . . . . . 0.652 ' HB2' HD13 ' A' ' 156' ' ' ILE . 18.3 ptt? -66.59 -28.15 68.28 Favored 'General case' 0 N--CA 1.483 1.182 0 C-N-CA 122.923 0.489 . . . . 71.239999999999995 111.63 -179.221 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 24.5 tt0 -47.46 -47.36 27.19 Favored 'General case' 0 N--CA 1.482 1.173 0 C-N-CA 125.28 1.432 . . . . 70.25 111.224 170.484 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 144' ' ' ARG . . . . . . . . . . . . . 88.6 mtt180 -85.78 -6.82 59.06 Favored 'General case' 0 CA--C 1.541 0.607 0 CA-C-N 114.123 -1.399 . . . . 74.319999999999993 111.678 -173.075 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 145' ' ' PHE . . . . . 0.51 ' HD2' ' HA ' ' A' ' 142' ' ' MET . 49.6 m-85 -89.48 2.5 54.47 Favored 'General case' 0 N--CA 1.479 1.005 0 C-N-CA 122.871 0.468 . . . . 64.109999999999999 110.448 168.149 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . -96.58 -170.55 34.42 Favored Glycine 0 C--N 1.349 1.267 0 CA-C-N 115.877 -0.602 . . . . 62.340000000000003 111.992 168.364 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 44.2 t -134.68 155.12 51.08 Favored 'General case' 0 N--CA 1.473 0.702 0 C-N-CA 124.191 0.996 . . . . 61.149999999999999 109.681 -177.833 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 148' ' ' ARG . . . . . . . . . . . . . 20.2 mmm-85 -62.24 -31.86 72.47 Favored 'General case' 0 N--CA 1.478 0.969 0 C-N-CA 123.916 0.886 . . . . 71.299999999999997 112.484 -173.055 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 149' ' ' ASN . . . . . . . . . . . . . 25.6 p-10 -76.97 -19.5 57.25 Favored 'General case' 0 N--CA 1.484 1.247 0 C-N-CA 123.021 0.528 . . . . 61.43 111.764 -179.464 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 150' ' ' GLY . . . . . 0.527 ' O ' ' HA ' ' A' ' 55' ' ' ARG . . . 119.64 -6.05 12.68 Favored Glycine 0 C--N 1.349 1.253 0 CA-C-O 119.702 -0.499 . . . . 74.400000000000006 113.367 -177.826 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 38.2 ttmt -66.62 141.15 57.91 Favored 'General case' 0 N--CA 1.474 0.747 0 CA-C-N 117.657 0.729 . . . . 65.239999999999995 110.553 177.041 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 152' ' ' THR . . . . . . . . . . . . . 18.1 p -92.46 115.26 27.93 Favored 'General case' 0 CA--C 1.538 0.488 0 N-CA-C 108.771 -0.825 . . . . 70.120000000000005 108.771 166.373 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 153' ' ' SER . . . . . . . . . . . . . 10.3 m -74.2 -21.03 59.99 Favored 'General case' 0 CA--C 1.545 0.758 0 CA-C-O 121.355 0.598 . . . . 60.409999999999997 110.295 179.624 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 71.7 mmtt -124.8 150.33 46.45 Favored 'General case' 0 N--CA 1.467 0.423 0 C-N-CA 124.537 1.135 . . . . 73.140000000000001 110.267 176.325 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 3.9 tppp? -79.92 94.96 5.96 Favored 'General case' 0 C--O 1.242 0.69 0 N-CA-C 108.927 -0.768 . . . . 74.329999999999998 108.927 173.478 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 156' ' ' ILE . . . . . 0.652 HD13 ' HB2' ' A' ' 142' ' ' MET . 60.8 mt -101.45 124.13 55.0 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.155 0 CA-C-N 114.972 -1.013 . . . . 70.150000000000006 108.621 -178.575 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 157' ' ' THR . . . . . . . . . . . . . 31.6 p -138.78 157.78 45.44 Favored 'General case' 0 N--CA 1.47 0.56 0 C-N-CA 124.567 1.147 . . . . 73.25 109.256 -173.686 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 158' ' ' ILE . . . . . 0.44 HG23 ' HB3' ' A' ' 8' ' ' PHE . 59.3 mt -80.24 94.28 2.12 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.72 0 N-CA-C 108.5 -0.926 . . . . 52.140000000000001 108.5 169.773 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 159' ' ' ALA . . . . . 0.688 ' HB2' ' HB2' ' A' ' 11' ' ' ALA . . . -52.76 -53.69 44.47 Favored 'General case' 0 N--CA 1.481 1.105 0 C-N-CA 124.114 0.966 . . . . 64.129999999999995 112.357 -177.852 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 160' ' ' ASP . . . . . . . . . . . . . 26.9 t0 -148.54 157.66 43.61 Favored 'General case' 0 N--CA 1.471 0.618 0 CA-C-N 115.808 -0.633 . . . . 75.439999999999998 110.091 -173.557 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 161' ' ' CYS . . . . . . . . . . . . . 28.0 p -129.23 -170.62 2.31 Favored 'General case' 0 CA--C 1.539 0.543 0 C-N-CA 124.922 1.289 . . . . 71.120000000000005 108.513 176.888 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 162' ' ' GLY . . . . . . . . . . . . . . . 132.35 53.07 0.08 OUTLIER Glycine 0 C--N 1.342 0.906 0 N-CA-C 110.708 -0.957 . . . . 44.299999999999997 110.708 -168.442 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 163' ' ' GLN . . . . . 0.556 ' HB2' ' HA ' ' A' ' 6' ' ' VAL . 13.2 pt20 -55.99 143.73 31.22 Favored 'General case' 0 CA--C 1.544 0.749 0 C-N-CA 124.487 1.115 . . . . 72.430000000000007 113.097 -174.293 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 164' ' ' LEU . . . . . . . . . . . . . 77.5 mt -82.1 105.64 13.36 Favored 'General case' 0 CA--C 1.539 0.524 0 CA-C-N 115.404 -0.816 . . . . 74.140000000000001 110.277 -176.724 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 165' ' ' GLU . . . . . . . . . . . . . 7.5 pt-20 . . . . . 0 CA--C 1.558 1.258 0 C-N-CA 123.836 0.855 . . . . 62.43 109.426 169.363 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' B' B ' 216' ' ' PRO . . . . . . . . . . . . . 18.1 Cg_exo . . . . . 0 N--CA 1.485 1.0 0 N-CA-C 109.821 -0.876 . . . . 70.530000000000001 109.821 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' B' B ' 217' ' ' GLU . . . . . . . . . . . . . 28.9 tt0 -145.44 140.69 16.16 Favored Pre-proline 0 C--O 1.245 0.817 0 C-N-CA 124.185 0.994 . . . . 62.5 108.454 179.773 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 218' ' ' PRO . . . . . . . . . . . . . 37.3 Cg_exo -62.74 101.08 0.25 Allowed 'Trans proline' 0 C--N 1.37 1.665 0 C-N-CA 122.04 1.827 . . . . 70.530000000000001 110.494 161.485 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 219' ' ' GLY . . . . . . . . . . . . . . . 171.1 171.49 36.39 Favored Glycine 0 CA--C 1.527 0.786 0 CA-C-N 116.283 -0.417 . . . . 24.420000000000002 112.776 -179.59 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 220' ' ' PRO . . . . . . . . . . . . . 97.6 Cg_endo -85.02 -169.17 0.59 Allowed 'Trans proline' 0 C--N 1.371 1.739 0 C-N-CA 123.429 2.752 . . . . 62.509999999999998 113.496 -178.785 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 221' ' ' TYR . . . . . . . . . . . . . 96.8 m-85 -117.92 125.47 50.52 Favored 'General case' 0 N--CA 1.483 1.177 0 C-N-CA 123.781 0.833 . . . . 61.200000000000003 109.742 179.111 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 222' ' ' ALA . . . . . 0.488 ' HB2' HD13 ' A' ' 57' ' ' ILE . . . -68.94 105.04 2.24 Favored 'General case' 0 N--CA 1.475 0.809 0 C-N-CA 124.219 1.008 . . . . 73.109999999999999 111.671 -175.724 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 223' ' ' GLN . . . . . . . . . . . . . 23.0 mp0 38.81 73.54 0.78 Allowed Pre-proline 0 CA--C 1.56 1.361 0 O-C-N 125.093 1.495 . . . . 74.200000000000003 112.383 178.976 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 224' ' ' PRO . . . . . . . . . . . . . 50.2 Cg_exo . . . . . 0 C--N 1.373 1.829 0 C-N-CA 123.611 2.874 . . . . 63.310000000000002 112.811 -176.482 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 74.5 mtp . . . . . 0 N--CA 1.48 1.059 0 N-CA-C 109.288 -0.634 . . . . 63.219999999999999 109.288 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 15.4 m -77.11 78.72 0.68 Allowed 'Isoleucine or valine' 0 N--CA 1.478 0.966 0 CA-C-O 122.521 1.153 . . . . 71.200000000000003 110.294 178.263 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 3' ' ' ASN . . . . . 0.503 ' ND2' ' HA ' ' A' ' 25' ' ' PHE . 11.8 m120 -98.04 107.71 42.46 Favored Pre-proline 0 CA--C 1.545 0.757 0 CA-C-N 114.413 -1.267 . . . . 72.340000000000003 110.043 -179.813 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 6.7 Cg_endo -80.73 152.68 19.7 Favored 'Trans proline' 0 C--N 1.371 1.755 0 C-N-CA 122.429 2.086 . . . . 65.010000000000005 110.963 173.872 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 5' ' ' THR . . . . . 0.46 ' HB ' ' O ' ' A' ' 164' ' ' LEU . 93.2 m -96.15 142.72 28.0 Favored 'General case' 0 CA--C 1.549 0.912 0 C-N-CA 123.096 0.558 . . . . 74.010000000000005 109.638 178.643 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . 0.665 ' HA ' ' HG3' ' A' ' 163' ' ' GLN . 29.1 t -110.37 147.12 14.8 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.436 0 N-CA-C 107.222 -1.399 . . . . 74.329999999999998 107.222 177.333 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 7' ' ' PHE . . . . . 0.536 ' H ' ' HA ' ' A' ' 163' ' ' GLN . 65.0 t80 -125.59 126.29 44.54 Favored 'General case' 0 C--O 1.238 0.468 0 N-CA-C 108.916 -0.772 . . . . 74.310000000000002 108.916 178.905 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 8' ' ' PHE . . . . . 0.541 ' HD2' ' HE2' ' A' ' 22' ' ' PHE . 33.9 m-85 -134.56 165.28 25.57 Favored 'General case' 0 N--CA 1.47 0.557 0 C-N-CA 124.074 0.95 . . . . 73.540000000000006 109.701 169.25 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 23.7 m-20 -118.27 117.33 28.83 Favored 'General case' 0 C--N 1.327 -0.406 0 N-CA-C 107.311 -1.366 . . . . 75.120000000000005 107.311 171.152 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 42.4 mm -90.05 136.12 24.61 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.823 0 N-CA-C 108.672 -0.862 . . . . 71.310000000000002 108.672 178.506 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 11' ' ' ALA . . . . . 0.662 ' HB2' ' HB2' ' A' ' 159' ' ' ALA . . . -135.47 122.27 21.07 Favored 'General case' 0 N--CA 1.478 0.951 0 C-N-CA 123.44 0.696 . . . . 65.239999999999995 111.666 -170.513 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . 0.442 HG22 HG12 ' A' ' 156' ' ' ILE . 62.4 t -95.94 122.99 47.95 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.709 0 C-N-CA 124.186 0.994 . . . . 71.019999999999996 108.962 176.846 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 42.3 m-20 64.1 23.09 13.11 Favored 'General case' 0 N--CA 1.491 1.616 0 C-N-CA 125.331 1.452 . . . . 74.120000000000005 110.836 -172.932 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 83.38 -13.21 47.41 Favored Glycine 0 C--N 1.351 1.384 0 CA-C-O 119.571 -0.572 . . . . 73.209999999999994 113.067 -173.079 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 37.8 mm-40 -83.49 117.23 68.04 Favored Pre-proline 0 C--N 1.353 0.759 0 C-N-CA 123.553 0.741 . . . . 63.130000000000003 109.981 177.863 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 93.1 Cg_exo -46.7 106.36 0.1 OUTLIER 'Trans proline' 0 C--N 1.379 2.134 0 C-N-CA 124.072 3.182 . . . . 61.030000000000001 113.891 -179.411 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 43.3 tp -76.08 -40.96 51.92 Favored 'General case' 0 N--CA 1.48 1.055 0 C-N-CA 123.705 0.802 . . . . 71.109999999999999 109.66 179.319 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -179.77 172.22 43.88 Favored Glycine 0 C--N 1.345 1.047 0 O-C-N 123.367 0.417 . . . . 24.109999999999999 112.957 178.386 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 13.2 ptm180 -105.82 124.47 49.61 Favored 'General case' 0 N--CA 1.473 0.71 0 N-CA-C 108.255 -1.017 . . . . 74.040000000000006 108.255 -177.988 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 51.8 t -120.89 137.91 53.08 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.407 0 C-N-CA 123.692 0.797 . . . . 74.25 109.382 -175.14 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 21' ' ' SER . . . . . 0.497 ' HB2' ' HB2' ' A' ' 134' ' ' GLU . 51.7 m -121.18 125.25 46.68 Favored 'General case' 0 C--O 1.248 1.004 0 C-N-CA 123.706 0.802 . . . . 73.420000000000002 109.519 176.677 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 22' ' ' PHE . . . . . 0.541 ' HE2' ' HD2' ' A' ' 8' ' ' PHE . 57.4 m-85 -100.81 169.95 8.65 Favored 'General case' 0 N--CA 1.474 0.735 0 C-N-CA 123.833 0.853 . . . . 72.209999999999994 109.358 178.47 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . 0.545 ' HB2' ' HD2' ' A' ' 133' ' ' LYS . 37.7 tt0 -138.32 112.31 8.48 Favored 'General case' 0 CA--C 1.543 0.684 0 C-N-CA 123.156 0.582 . . . . 74.019999999999996 109.632 -179.513 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . 0.414 HD22 ' HD1' ' A' ' 129' ' ' PHE . 62.1 mt -84.12 136.48 33.98 Favored 'General case' 0 N--CA 1.478 0.951 0 C-N-CA 123.692 0.797 . . . . 65.099999999999994 110.804 -176.784 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 25' ' ' PHE . . . . . 0.503 ' HA ' ' ND2' ' A' ' 3' ' ' ASN . 32.7 m-85 -85.65 64.29 8.54 Favored 'General case' 0 CA--C 1.546 0.805 0 CA-C-O 121.186 0.517 . . . . 73.349999999999994 109.642 175.886 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -72.91 1.03 9.52 Favored 'General case' 0 N--CA 1.486 1.364 0 N-CA-C 113.125 0.787 . . . . 55.399999999999999 113.125 -175.407 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 11.7 p-10 -87.33 -24.3 24.34 Favored 'General case' 0 CA--C 1.548 0.896 0 C-N-CA 123.555 0.742 . . . . 64.129999999999995 111.096 174.433 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 97.7 mttt -114.02 -35.02 5.21 Favored 'General case' 0 N--CA 1.489 1.489 0 C-N-CA 123.692 0.797 . . . . 70.209999999999994 111.12 -176.339 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 29' ' ' VAL . . . . . 0.505 HG21 ' HA ' ' A' ' 129' ' ' PHE . 6.7 m -128.85 71.15 81.46 Favored Pre-proline 0 CA--C 1.553 1.074 0 C-N-CA 123.927 0.891 . . . . 73.0 110.209 175.333 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 15.3 Cg_exo -66.03 -33.96 39.64 Favored 'Trans proline' 0 C--N 1.381 2.244 0 C-N-CA 122.567 2.178 . . . . 73.540000000000006 111.104 -179.13 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 87.7 tttt -63.51 -57.19 10.97 Favored 'General case' 0 CA--C 1.54 0.575 0 C-N-CA 124.796 1.238 . . . . 75.010000000000005 111.083 -179.17 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 6.5 m -68.98 -30.46 68.87 Favored 'General case' 0 CA--C 1.554 1.098 0 C-N-CA 123.613 0.765 . . . . 61.329999999999998 111.292 -174.964 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -71.81 -40.03 69.42 Favored 'General case' 0 CA--C 1.548 0.904 0 C-N-CA 123.403 0.681 . . . . 45.030000000000001 111.347 175.894 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 9.3 tp10 -71.81 -34.26 69.2 Favored 'General case' 0 N--CA 1.482 1.136 0 C-N-CA 123.436 0.695 . . . . 75.140000000000001 110.154 -178.458 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 35' ' ' ASN . . . . . 0.419 ' O ' ' HG ' ' A' ' 39' ' ' LEU . 40.1 t30 -57.98 -54.82 42.66 Favored 'General case' 0 N--CA 1.474 0.738 0 CA-C-N 114.527 -1.215 . . . . 64.219999999999999 109.766 173.526 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 74.2 t80 -58.91 -42.01 88.62 Favored 'General case' 0 CA--C 1.543 0.701 0 O-C-N 124.742 1.276 . . . . 73.099999999999994 111.096 -177.874 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 36.3 ttm180 -55.58 -57.14 13.18 Favored 'General case' 0 C--N 1.358 0.958 0 O-C-N 123.766 0.666 . . . . 63.140000000000001 110.394 175.629 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 38' ' ' ALA . . . . . 0.515 ' HB1' ' HG2' ' A' ' 44' ' ' LYS . . . -63.62 -32.96 74.6 Favored 'General case' 0 C--O 1.243 0.732 0 O-C-N 124.041 0.838 . . . . 60.020000000000003 112.129 -173.078 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 39' ' ' LEU . . . . . 0.566 HD22 ' HE2' ' A' ' 48' ' ' TYR . 74.2 mt -65.56 -45.0 85.02 Favored 'General case' 0 N--CA 1.475 0.792 0 O-C-N 124.147 0.904 . . . . 70.530000000000001 111.02 176.517 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 41.2 m -76.42 -49.45 16.67 Favored 'General case' 0 N--CA 1.475 0.814 0 C-N-CA 123.408 0.683 . . . . 41.240000000000002 112.01 -174.31 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 41' ' ' THR . . . . . 0.426 ' OG1' ' HG2' ' A' ' 43' ' ' GLU . 67.6 p -76.53 -31.48 57.67 Favored 'General case' 0 N--CA 1.471 0.609 0 C-N-CA 124.204 1.002 . . . . 71.120000000000005 111.647 -174.138 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 92.57 26.44 17.62 Favored Glycine 0 C--N 1.349 1.25 0 CA-C-O 119.683 -0.509 . . . . 74.349999999999994 113.071 -179.677 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 43' ' ' GLU . . . . . 0.426 ' HG2' ' OG1' ' A' ' 41' ' ' THR . 19.9 mm-40 -63.39 -22.97 67.2 Favored 'General case' 0 N--CA 1.483 1.213 0 C-N-CA 123.086 0.555 . . . . 63.32 111.69 174.31 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 44' ' ' LYS . . . . . 0.515 ' HG2' ' HB1' ' A' ' 38' ' ' ALA . 75.8 mmtt -114.38 16.43 17.81 Favored 'General case' 0 N--CA 1.482 1.149 0 C-N-CA 123.63 0.772 . . . . 73.530000000000001 111.022 177.242 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 93.41 -25.06 22.57 Favored Glycine 0 C--N 1.355 1.627 0 N-CA-C 114.794 0.677 . . . . 75.230000000000004 114.794 174.893 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 46' ' ' PHE . . . . . 0.424 ' HE2' ' HA ' ' A' ' 78' ' ' ILE . 21.8 m-85 -68.77 -48.22 64.22 Favored 'General case' 0 N--CA 1.479 0.992 0 C-N-CA 122.953 0.501 . . . . 75.120000000000005 111.846 -167.407 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 40.97 62.05 1.82 Allowed Glycine 0 C--N 1.358 1.786 0 O-C-N 124.975 1.422 . . . . 75.420000000000002 115.321 169.92 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 48' ' ' TYR . . . . . 0.566 ' HE2' HD22 ' A' ' 39' ' ' LEU . 97.3 m-85 -62.88 90.76 0.04 OUTLIER 'General case' 0 N--CA 1.476 0.859 0 CA-C-O 121.478 0.656 . . . . 74.409999999999997 111.52 -176.678 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 3.7 tppp? -105.24 125.81 51.4 Favored 'General case' 0 C--O 1.232 0.148 0 N-CA-C 108.328 -0.989 . . . . 72.299999999999997 108.328 175.05 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 80.96 20.23 65.72 Favored Glycine 0 CA--C 1.524 0.636 0 CA-C-O 119.681 -0.511 . . . . 51.140000000000001 112.742 -175.427 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 51' ' ' SER . . . . . 0.414 ' HB2' ' HB3' ' A' ' 48' ' ' TYR . 36.0 t -62.38 118.41 7.45 Favored 'General case' 0 C--N 1.354 0.786 0 N-CA-C 109.032 -0.729 . . . . 70.420000000000002 109.032 176.9 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 52' ' ' CYS . . . . . . . . . . . . . 25.6 p -86.75 129.48 34.86 Favored 'General case' 0 CA--C 1.536 0.425 0 C-N-CA 123.54 0.736 . . . . 64.010000000000005 111.645 -170.577 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 53' ' ' PHE . . . . . 0.65 ' HA ' ' HA2' ' A' ' 64' ' ' GLY . 46.5 m-85 -76.79 74.4 3.43 Favored 'General case' 0 CA--C 1.538 0.516 0 N-CA-C 108.353 -0.98 . . . . 73.25 108.353 168.415 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 27.1 p-80 -75.0 -22.84 58.27 Favored 'General case' 0 N--CA 1.476 0.868 0 CA-C-N 115.146 -0.934 . . . . 74.450000000000003 111.522 -174.674 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 55' ' ' ARG . . . . . 0.41 ' HA ' ' O ' ' A' ' 150' ' ' GLY . 38.4 ttt180 -112.96 99.41 7.84 Favored 'General case' 0 C--O 1.218 -0.601 0 N-CA-C 109.108 -0.701 . . . . 72.030000000000001 109.108 178.238 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 42.7 mt -127.63 137.86 56.44 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.643 0 N-CA-C 108.47 -0.937 . . . . 75.409999999999997 108.47 171.747 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 57' ' ' ILE . . . . . 0.687 HG23 ' HA ' ' A' ' 148' ' ' ARG . 70.2 mt -134.56 125.3 17.52 Favored Pre-proline 0 CA--C 1.553 1.08 0 C-N-CA 124.811 1.244 . . . . 72.430000000000007 108.621 -176.267 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 58' ' ' PRO . . . . . 0.411 ' HA ' ' HG2' ' A' ' 143' ' ' GLU . 84.3 Cg_endo -76.82 145.41 25.42 Favored 'Trans proline' 0 C--N 1.375 1.943 0 C-N-CA 122.687 2.258 . . . . 73.430000000000007 112.15 -177.606 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 70.04 25.48 75.55 Favored Glycine 0 C--N 1.342 0.868 0 CA-C-N 115.398 -0.819 . . . . 53.539999999999999 112.653 -175.486 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 60' ' ' PHE . . . . . 0.4 ' HD2' ' HB ' ' A' ' 57' ' ' ILE . 36.5 t80 -151.57 -73.58 0.15 Allowed 'General case' 0 C--O 1.247 0.95 0 C-N-CA 122.835 0.454 . . . . 74.120000000000005 111.172 -171.646 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 61' ' ' MET . . . . . 0.543 ' SD ' ' HB2' ' A' ' 113' ' ' PHE . 38.8 ttm -176.79 143.9 0.46 Allowed 'General case' 0 N--CA 1.482 1.166 0 N-CA-C 112.445 0.535 . . . . 63.020000000000003 112.445 -159.06 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 62' ' ' CYS . . . . . 0.472 ' SG ' HG13 ' A' ' 139' ' ' VAL . 25.1 p -112.72 112.45 23.96 Favored 'General case' 0 CA--C 1.55 0.962 0 N-CA-C 109.018 -0.734 . . . . 75.299999999999997 109.018 169.344 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 63' ' ' GLN . . . . . 0.528 ' HA ' ' HA ' ' A' ' 113' ' ' PHE . 51.4 tt0 -105.43 120.68 42.21 Favored 'General case' 0 N--CA 1.485 1.284 0 C-N-CA 124.248 1.019 . . . . 74.329999999999998 111.503 -175.185 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 64' ' ' GLY . . . . . 0.65 ' HA2' ' HA ' ' A' ' 53' ' ' PHE . . . -91.84 148.75 19.38 Favored Glycine 0 C--N 1.347 1.16 0 CA-C-N 115.206 -0.906 . . . . 75.109999999999999 112.34 176.403 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . 0.517 ' HA3' ' HG2' ' A' ' 111' ' ' GLN . . . -176.84 131.25 1.8 Allowed Glycine 0 C--N 1.338 0.656 0 N-CA-C 111.984 -0.447 . . . . 73.200000000000003 111.984 179.511 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 33.2 t70 -75.99 165.35 25.09 Favored 'General case' 0 CA--C 1.547 0.846 0 C-N-CA 123.046 0.538 . . . . 72.450000000000003 111.31 -175.613 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 90.2 t80 -64.92 -32.88 74.81 Favored 'General case' 0 C--O 1.245 0.853 0 C-N-CA 123.665 0.786 . . . . 72.340000000000003 111.365 178.176 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 33.9 m -60.81 112.67 2.13 Favored 'General case' 0 C--N 1.354 0.772 0 C-N-CA 122.985 0.514 . . . . 73.340000000000003 111.254 -177.057 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 69' ' ' ARG . . . . . 0.43 ' HD3' ' HG3' ' A' ' 81' ' ' GLU . 81.1 mtt85 65.33 28.01 11.9 Favored 'General case' 0 CA--C 1.547 0.843 0 O-C-N 124.618 1.199 . . . . 74.439999999999998 112.02 178.381 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 15.4 p80 -55.18 -25.41 32.44 Favored 'General case' 0 N--CA 1.498 1.969 0 C-N-CA 123.529 0.732 . . . . 70.010000000000005 112.759 -174.571 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 11.2 m120 -77.5 87.84 3.84 Favored 'General case' 0 CA--C 1.544 0.747 0 C-N-CA 123.849 0.86 . . . . 64.310000000000002 109.373 174.353 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 91.25 -1.2 76.46 Favored Glycine 0 N--CA 1.474 1.213 0 CA-C-O 119.4 -0.667 . . . . 63.450000000000003 114.61 175.381 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 73' ' ' THR . . . . . 0.461 ' HA ' ' HB2' ' A' ' 110' ' ' SER . 96.2 m -140.31 -92.16 0.16 Allowed 'General case' 0 CA--C 1.558 1.277 0 CA-C-N 117.738 0.769 . . . . 71.230000000000004 110.046 172.951 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 81.67 43.66 8.27 Favored Glycine 0 C--N 1.359 1.84 0 CA-C-N 118.279 0.491 . . . . 73.510000000000005 113.985 176.684 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 140.79 53.46 0.04 OUTLIER Glycine 0 C--N 1.346 1.095 0 CA-C-N 117.552 0.676 . . . . 74.319999999999993 111.495 -176.482 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 76' ' ' LYS . . . . . 0.503 ' HB2' ' HA ' ' A' ' 81' ' ' GLU . 13.9 ptmm? -56.09 162.86 1.76 Allowed 'General case' 0 N--CA 1.483 1.182 0 C-N-CA 124.026 0.93 . . . . 73.219999999999999 112.749 -174.541 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 87.3 p -94.49 -177.77 4.35 Favored 'General case' 0 C--O 1.243 0.734 0 C-N-CA 122.995 0.518 . . . . 63.030000000000001 111.345 -170.775 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 78' ' ' ILE . . . . . 0.51 HG21 ' HB3' ' A' ' 38' ' ' ALA . 20.9 pt -88.59 -12.38 10.21 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.889 0 CA-C-N 115.56 -0.746 . . . . 65.420000000000002 110.668 173.985 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 42.9 m-85 -88.17 -24.62 23.27 Favored 'General case' 0 N--CA 1.472 0.646 0 C-N-CA 123.935 0.894 . . . . 73.299999999999997 109.662 178.476 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 167.86 -145.29 9.58 Favored Glycine 0 C--N 1.346 1.084 0 CA-C-N 115.365 -0.834 . . . . 72.049999999999997 111.095 176.827 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 81' ' ' GLU . . . . . 0.503 ' HA ' ' HB2' ' A' ' 76' ' ' LYS . 36.3 tt0 -69.16 -34.93 75.74 Favored 'General case' 0 CA--C 1.543 0.709 0 C-N-CA 123.293 0.637 . . . . 71.540000000000006 110.06 174.475 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 82' ' ' LYS . . . . . 0.706 ' HD2' ' HA ' ' A' ' 107' ' ' THR . 20.6 pttp -169.99 177.2 4.41 Favored 'General case' 0 N--CA 1.476 0.842 0 C-N-CA 124.733 1.213 . . . . 71.329999999999998 109.047 178.397 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 46.5 p90 -146.78 173.49 12.33 Favored 'General case' 0 N--CA 1.474 0.767 0 C-N-CA 123.651 0.78 . . . . 71.129999999999995 110.563 -179.208 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 13.5 pt-20 -88.34 158.99 18.26 Favored 'General case' 0 N--CA 1.475 0.821 0 C-N-CA 123.055 0.542 . . . . 73.209999999999994 110.208 177.917 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 27.0 m-20 -60.81 118.64 6.91 Favored 'General case' 0 N--CA 1.477 0.924 0 C-N-CA 124.376 1.071 . . . . 74.25 109.967 -179.337 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 20.6 tp10 -66.79 -59.01 3.92 Favored 'General case' 0 N--CA 1.479 0.983 0 C-N-CA 123.133 0.573 . . . . 63.310000000000002 111.198 -175.158 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 26.4 p30 -143.01 -174.46 4.19 Favored 'General case' 0 N--CA 1.47 0.543 0 C-N-CA 123.757 0.823 . . . . 74.319999999999993 109.593 179.966 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 79.8 m-85 -136.27 39.54 2.69 Favored 'General case' 0 N--CA 1.481 1.082 0 C-N-CA 123.591 0.756 . . . . 75.25 109.754 -179.325 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 60.5 mt -69.01 -62.07 1.42 Allowed 'Isoleucine or valine' 0 N--CA 1.477 0.9 0 CA-C-N 115.431 -0.804 . . . . 74.420000000000002 110.966 -178.806 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 90' ' ' LEU . . . . . 0.696 ' H ' HG23 ' A' ' 127' ' ' VAL . 66.1 mt -87.55 140.96 28.99 Favored 'General case' 0 C--O 1.238 0.492 0 CA-C-N 115.539 -0.755 . . . . 65.25 110.678 -171.748 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 55.3 mtpt -125.5 168.83 13.09 Favored 'General case' 0 N--CA 1.47 0.526 0 C-N-CA 124.152 0.981 . . . . 53.119999999999997 110.174 -174.285 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 92' ' ' HIS . . . . . 0.415 ' HA ' HG21 ' A' ' 97' ' ' ILE . 43.5 m80 -92.88 51.28 1.67 Allowed 'General case' 0 N--CA 1.48 1.026 0 C-N-CA 124.235 1.014 . . . . 62.240000000000002 109.503 -174.486 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 41.3 p -84.3 -7.12 59.42 Favored 'General case' 0 N--CA 1.472 0.632 0 CA-C-N 114.476 -1.238 . . . . 73.329999999999998 112.799 -171.371 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -143.5 -179.57 20.2 Favored Glycine 0 C--N 1.347 1.164 0 CA-C-O 120.117 -0.268 . . . . 41.439999999999998 113.057 -177.12 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 82.1 Cg_endo -82.4 158.21 17.06 Favored 'Trans proline' 0 C--N 1.367 1.523 0 C-N-CA 123.412 2.741 . . . . 73.310000000000002 112.561 175.241 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 73.83 18.83 79.69 Favored Glycine 0 CA--C 1.531 1.059 0 CA-C-N 115.524 -0.762 . . . . 71.209999999999994 114.467 178.867 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 97' ' ' ILE . . . . . 0.415 HG21 ' HA ' ' A' ' 92' ' ' HIS . 17.0 mm -78.93 108.28 12.33 Favored 'Isoleucine or valine' 0 CA--C 1.562 1.428 0 CA-C-N 117.533 0.666 . . . . 71.099999999999994 112.466 -171.824 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 98' ' ' LEU . . . . . 0.636 ' HG ' HG12 ' A' ' 114' ' ' ILE . 7.6 mp -87.21 117.93 26.29 Favored 'General case' 0 N--CA 1.488 1.468 0 C-N-CA 123.535 0.734 . . . . 74.200000000000003 111.033 175.923 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 99' ' ' SER . . . . . 0.644 ' HB3' ' HA ' ' A' ' 128' ' ' VAL . 2.7 p -139.78 143.5 36.93 Favored 'General case' 0 N--CA 1.476 0.874 0 N-CA-C 108.306 -0.998 . . . . 74.400000000000006 108.306 173.707 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 100' ' ' MET . . . . . 0.473 ' HA ' ' HA ' ' A' ' 112' ' ' PHE . 49.7 mtp -76.23 138.9 40.91 Favored 'General case' 0 N--CA 1.485 1.31 0 N-CA-C 109.689 -0.486 . . . . 75.140000000000001 109.689 -171.491 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 101' ' ' ALA . . . . . 0.549 ' HB3' ' HB2' ' A' ' 111' ' ' GLN . . . -75.69 158.25 32.57 Favored 'General case' 0 N--CA 1.481 1.082 0 CA-C-O 121.216 0.531 . . . . 75.129999999999995 111.635 -170.48 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 30.4 p-10 -162.67 163.13 27.13 Favored 'General case' 0 CA--C 1.537 0.453 0 CA-C-N 114.95 -1.023 . . . . 74.430000000000007 110.131 -179.361 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -103.91 1.67 31.61 Favored 'General case' 0 N--CA 1.473 0.707 0 C-N-CA 124.203 1.001 . . . . 75.540000000000006 110.196 169.686 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 149.45 -164.41 29.39 Favored Glycine 0 C--N 1.345 1.031 0 CA-C-O 119.273 -0.737 . . . . 61.140000000000001 111.466 -178.269 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 53.2 Cg_exo -56.89 141.73 93.14 Favored 'Trans proline' 0 C--N 1.368 1.6 0 C-N-CA 123.286 2.657 . . . . 75.140000000000001 112.795 175.978 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 63.9 t30 68.46 10.18 7.71 Favored 'General case' 0 N--CA 1.495 1.788 0 C-N-CA 125.102 1.361 . . . . 73.239999999999995 112.332 179.526 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 107' ' ' THR . . . . . 0.706 ' HA ' ' HD2' ' A' ' 82' ' ' LYS . 2.4 m -113.1 0.23 14.9 Favored 'General case' 0 CA--C 1.551 0.997 0 O-C-N 121.511 -0.743 . . . . 74.349999999999994 110.775 178.307 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 57.5 t30 -70.76 155.57 40.6 Favored 'General case' 0 N--CA 1.481 1.108 0 C-N-CA 123.784 0.834 . . . . 74.25 110.738 -178.034 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 89.76 0.73 78.13 Favored Glycine 0 N--CA 1.468 0.773 0 CA-C-N 116.713 -0.221 . . . . 52.340000000000003 113.55 179.026 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 110' ' ' SER . . . . . 0.461 ' HB2' ' HA ' ' A' ' 73' ' ' THR . 79.6 p -100.25 120.64 40.22 Favored 'General case' 0 CA--C 1.531 0.22 0 N-CA-C 108.012 -1.107 . . . . 65.230000000000004 108.012 173.731 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 111' ' ' GLN . . . . . 0.549 ' HB2' ' HB3' ' A' ' 101' ' ' ALA . 49.4 mt-30 62.53 176.57 0.14 Allowed 'General case' 0 N--CA 1.492 1.66 0 C-N-CA 123.609 0.764 . . . . 75.530000000000001 111.769 -174.839 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 112' ' ' PHE . . . . . 0.473 ' HA ' ' HA ' ' A' ' 100' ' ' MET . 29.1 p90 -147.13 133.71 19.85 Favored 'General case' 0 N--CA 1.471 0.622 0 N-CA-C 108.021 -1.103 . . . . 72.409999999999997 108.021 172.932 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 113' ' ' PHE . . . . . 0.543 ' HB2' ' SD ' ' A' ' 61' ' ' MET . 46.4 p90 -113.49 134.3 54.75 Favored 'General case' 0 C--O 1.239 0.539 0 CA-C-O 121.235 0.54 . . . . 71.340000000000003 110.751 178.349 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 114' ' ' ILE . . . . . 0.636 HG12 ' HG ' ' A' ' 98' ' ' LEU . 22.1 mt -99.96 101.04 11.56 Favored 'Isoleucine or valine' 0 C--O 1.239 0.532 0 N-CA-C 108.047 -1.094 . . . . 70.420000000000002 108.047 176.612 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 115' ' ' CYS . . . . . 0.414 ' SG ' ' HD2' ' A' ' 92' ' ' HIS . 32.4 m -65.92 103.78 0.99 Allowed 'General case' 0 N--CA 1.467 0.388 0 N-CA-C 108.611 -0.885 . . . . 73.329999999999998 108.611 174.485 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 116' ' ' THR . . . . . 0.521 HG22 HG12 ' A' ' 139' ' ' VAL . 35.6 p -70.04 -28.86 65.81 Favored 'General case' 0 N--CA 1.48 1.05 0 C-N-CA 123.707 0.803 . . . . 61.420000000000002 110.675 -177.206 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -119.49 168.25 11.16 Favored 'General case' 0 C--O 1.243 0.72 0 C-N-CA 124.051 0.941 . . . . 63.210000000000001 109.279 171.159 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 13.3 ptmm? -72.55 89.3 1.28 Allowed 'General case' 0 C--O 1.246 0.89 0 CA-C-O 121.657 0.742 . . . . 74.340000000000003 110.3 178.1 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 119' ' ' THR . . . . . 0.506 ' HB ' HD13 ' A' ' 122' ' ' LEU . 37.6 p -71.22 89.2 0.85 Allowed 'General case' 0 CA--C 1.542 0.651 0 CA-C-O 122.0 0.905 . . . . 54.329999999999998 108.971 176.829 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 9.5 pt-20 -75.98 -21.44 56.95 Favored 'General case' 0 N--CA 1.475 0.788 0 CA-C-N 114.578 -1.192 . . . . 63.039999999999999 111.773 -171.486 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 121' ' ' TRP . . . . . . . . . . . . . 33.1 p90 -77.18 -0.84 26.58 Favored 'General case' 0 CA--C 1.549 0.937 0 C-N-CA 123.581 0.752 . . . . 64.109999999999999 110.829 172.35 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 122' ' ' LEU . . . . . 0.564 ' HA ' ' HE2' ' A' ' 125' ' ' LYS . 10.9 mp -101.97 7.04 41.5 Favored 'General case' 0 N--CA 1.474 0.727 0 C-N-CA 123.682 0.793 . . . . 74.049999999999997 110.879 170.832 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 93.8 m-20 -84.82 128.09 34.45 Favored 'General case' 0 N--CA 1.475 0.776 0 N-CA-C 109.588 -0.523 . . . . 53.509999999999998 109.588 173.558 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 94.42 7.41 60.55 Favored Glycine 0 C--N 1.345 1.043 0 N-CA-C 111.69 -0.564 . . . . 62.219999999999999 111.69 -168.454 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 125' ' ' LYS . . . . . 0.564 ' HE2' ' HA ' ' A' ' 122' ' ' LEU . 19.4 ttmm -104.26 -167.39 1.35 Allowed 'General case' 0 CA--C 1.552 1.049 0 C-N-CA 124.918 1.287 . . . . 73.349999999999994 108.375 179.021 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 126' ' ' HIS . . . . . 0.508 ' H ' ' HG2' ' A' ' 125' ' ' LYS . 42.5 p-80 -67.75 155.61 38.89 Favored 'General case' 0 C--O 1.244 0.769 0 CA-C-O 121.245 0.545 . . . . 74.349999999999994 111.672 -175.575 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 127' ' ' VAL . . . . . 0.696 HG23 ' H ' ' A' ' 90' ' ' LEU . 11.0 p -64.0 148.37 11.67 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.938 0 CA-C-N 113.988 -1.46 . . . . 53.420000000000002 112.99 -174.537 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 128' ' ' VAL . . . . . 0.644 ' HA ' ' HB3' ' A' ' 99' ' ' SER . 94.7 t -81.39 155.57 4.17 Favored 'Isoleucine or valine' 0 CA--C 1.551 1.0 0 C-N-CA 125.421 1.488 . . . . 71.25 109.23 172.055 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 129' ' ' PHE . . . . . 0.505 ' HA ' HG21 ' A' ' 29' ' ' VAL . 48.7 p90 -119.35 -24.33 6.41 Favored 'General case' 0 N--CA 1.487 1.383 0 CA-C-N 118.549 0.613 . . . . 71.010000000000005 111.603 177.416 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . -158.88 177.1 35.61 Favored Glycine 0 C--N 1.344 1.01 0 O-C-N 123.183 0.302 . . . . 45.200000000000003 112.468 -174.92 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 34.4 ttpt -153.33 147.41 25.58 Favored 'General case' 0 N--CA 1.472 0.671 0 C-N-CA 123.484 0.714 . . . . 74.450000000000003 109.3 -179.877 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 132' ' ' VAL . . . . . 0.442 HG22 ' HE1' ' A' ' 22' ' ' PHE . 16.9 t -68.29 120.33 15.55 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.552 0 N-CA-C 109.253 -0.647 . . . . 74.230000000000004 109.253 176.203 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 133' ' ' LYS . . . . . 0.545 ' HD2' ' HB2' ' A' ' 23' ' ' GLU . 20.6 ptmt -100.2 -33.54 10.39 Favored 'General case' 0 N--CA 1.477 0.895 0 N-CA-C 109.584 -0.524 . . . . 61.229999999999997 109.584 176.49 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 134' ' ' GLU . . . . . 0.497 ' HB2' ' HB2' ' A' ' 21' ' ' SER . 31.5 mt-10 -144.29 149.63 36.57 Favored 'General case' 0 N--CA 1.478 0.97 0 C-N-CA 125.166 1.387 . . . . 71.530000000000001 108.654 -178.516 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 83.43 17.44 66.47 Favored Glycine 0 C--N 1.339 0.742 0 N-CA-C 112.182 -0.367 . . . . 61.119999999999997 112.182 -177.701 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 136' ' ' MET . . . . . . . . . . . . . 15.7 tpt -64.01 -34.78 78.79 Favored 'General case' 0 C--N 1.354 0.796 0 C-N-CA 123.863 0.865 . . . . 73.109999999999999 110.913 -179.527 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 137' ' ' ASN . . . . . . . . . . . . . 27.3 t-20 -58.75 -42.31 88.57 Favored 'General case' 0 CA--C 1.542 0.644 0 C-N-CA 123.588 0.755 . . . . 73.209999999999994 110.568 174.049 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 138' ' ' ILE . . . . . . . . . . . . . 48.9 mm -67.67 -35.64 73.44 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.956 0 C-N-CA 123.331 0.652 . . . . 74.25 110.657 178.925 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 139' ' ' VAL . . . . . 0.521 HG12 HG22 ' A' ' 116' ' ' THR . 94.3 t -65.8 -37.98 81.15 Favored 'Isoleucine or valine' 0 CA--C 1.559 1.32 0 C-N-CA 123.941 0.896 . . . . 51.240000000000002 110.93 176.772 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 39.0 mt-10 -77.02 -27.55 54.63 Favored 'General case' 0 N--CA 1.48 1.04 0 C-N-CA 123.537 0.735 . . . . 74.420000000000002 111.186 177.625 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -72.65 -46.98 51.27 Favored 'General case' 0 N--CA 1.48 1.069 0 C-N-CA 123.338 0.655 . . . . 51.439999999999998 110.305 178.717 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 142' ' ' MET . . . . . 0.538 ' HA ' ' HD2' ' A' ' 145' ' ' PHE . 27.3 ptm -68.48 -30.34 69.16 Favored 'General case' 0 N--CA 1.475 0.81 0 CA-C-N 115.475 -0.784 . . . . 73.430000000000007 110.962 178.106 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 143' ' ' GLU . . . . . 0.411 ' HG2' ' HA ' ' A' ' 58' ' ' PRO . 35.8 tt0 -55.11 -42.26 72.69 Favored 'General case' 0 C--N 1.364 1.203 0 O-C-N 123.807 0.692 . . . . 74.430000000000007 111.361 174.71 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 144' ' ' ARG . . . . . . . . . . . . . 51.5 mtp180 -64.79 -22.91 67.09 Favored 'General case' 0 N--CA 1.473 0.715 0 CA-C-N 115.376 -0.829 . . . . 74.040000000000006 112.189 -178.233 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 145' ' ' PHE . . . . . 0.538 ' HD2' ' HA ' ' A' ' 142' ' ' MET . 47.7 m-85 -83.53 -1.02 52.79 Favored 'General case' 0 N--CA 1.479 0.987 0 C-N-CA 122.768 0.427 . . . . 54.420000000000002 111.876 179.426 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 146' ' ' GLY . . . . . 0.522 ' HA2' ' HA ' ' A' ' 152' ' ' THR . . . -96.71 172.06 28.17 Favored Glycine 0 C--N 1.342 0.867 0 N-CA-C 112.687 -0.165 . . . . 61.210000000000001 112.687 177.597 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 16.2 m -128.1 156.48 42.75 Favored 'General case' 0 N--CA 1.481 1.112 0 C-N-CA 123.845 0.858 . . . . 74.230000000000004 109.801 -178.332 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 148' ' ' ARG . . . . . 0.687 ' HA ' HG23 ' A' ' 57' ' ' ILE . 26.2 mmm-85 -58.53 -31.66 68.13 Favored 'General case' 0 N--CA 1.48 1.048 0 C-N-CA 124.595 1.158 . . . . 72.150000000000006 113.279 -174.359 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 149' ' ' ASN . . . . . . . . . . . . . 29.9 p-10 -77.7 -12.27 59.96 Favored 'General case' 0 N--CA 1.476 0.844 0 C-N-CA 123.364 0.666 . . . . 74.099999999999994 111.983 -178.279 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 150' ' ' GLY . . . . . 0.41 ' O ' ' HA ' ' A' ' 55' ' ' ARG . . . 106.45 6.05 36.27 Favored Glycine 0 C--N 1.348 1.2 0 CA-C-O 120.046 -0.308 . . . . 71.109999999999999 113.165 179.487 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 86.9 tttt -90.07 122.99 33.55 Favored 'General case' 0 N--CA 1.471 0.619 0 C-N-CA 123.08 0.552 . . . . 70.230000000000004 109.866 178.587 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 152' ' ' THR . . . . . 0.522 ' HA ' ' HA2' ' A' ' 146' ' ' GLY . 21.1 m -90.67 113.56 25.65 Favored 'General case' 0 CA--C 1.536 0.425 0 N-CA-C 108.82 -0.807 . . . . 63.140000000000001 108.82 174.978 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 153' ' ' SER . . . . . . . . . . . . . 9.1 m -52.8 -32.84 46.15 Favored 'General case' 0 N--CA 1.48 1.07 0 C-N-CA 124.646 1.178 . . . . 72.109999999999999 112.367 -178.394 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 70.7 mmtt -109.24 150.02 28.55 Favored 'General case' 0 N--CA 1.469 0.509 0 C-N-CA 124.358 1.063 . . . . 64.219999999999999 110.631 -175.731 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 75.0 mmtt -83.01 90.32 7.0 Favored 'General case' 0 N--CA 1.468 0.456 0 N-CA-C 108.527 -0.916 . . . . 71.420000000000002 108.527 172.542 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 156' ' ' ILE . . . . . 0.484 ' HA ' ' O ' ' A' ' 11' ' ' ALA . 54.0 mt -100.35 108.49 23.08 Favored 'Isoleucine or valine' 0 C--O 1.221 -0.43 0 CA-C-N 114.981 -1.009 . . . . 74.510000000000005 109.04 -175.693 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 157' ' ' THR . . . . . . . . . . . . . 56.9 p -118.47 159.71 23.01 Favored 'General case' 0 N--CA 1.473 0.713 0 C-N-CA 124.07 0.948 . . . . 72.319999999999993 110.53 -175.342 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 158' ' ' ILE . . . . . . . . . . . . . 62.5 mt -77.22 94.09 1.28 Allowed 'Isoleucine or valine' 0 CA--C 1.548 0.892 0 N-CA-C 108.988 -0.745 . . . . 55.310000000000002 108.988 170.398 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 159' ' ' ALA . . . . . 0.662 ' HB2' ' HB2' ' A' ' 11' ' ' ALA . . . -51.82 -49.56 62.55 Favored 'General case' 0 N--CA 1.483 1.21 0 C-N-CA 124.446 1.098 . . . . 64.209999999999994 112.411 -178.764 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 160' ' ' ASP . . . . . . . . . . . . . 19.7 t70 -152.92 169.94 21.6 Favored 'General case' 0 CA--C 1.546 0.805 0 CA-C-N 116.257 -0.428 . . . . 64.299999999999997 111.208 -179.351 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 161' ' ' CYS . . . . . . . . . . . . . 46.4 m -136.48 -168.93 2.34 Favored 'General case' 0 N--CA 1.47 0.56 0 C-N-CA 125.138 1.375 . . . . 73.310000000000002 108.623 -177.148 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 162' ' ' GLY . . . . . . . . . . . . . . . 132.44 53.52 0.08 OUTLIER Glycine 0 C--N 1.344 0.986 0 N-CA-C 111.025 -0.83 . . . . 72.319999999999993 111.025 -172.929 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 163' ' ' GLN . . . . . 0.665 ' HG3' ' HA ' ' A' ' 6' ' ' VAL . 46.8 tt0 -46.69 104.12 0.05 OUTLIER 'General case' 0 N--CA 1.481 1.086 0 C-N-CA 125.281 1.432 . . . . 71.200000000000003 112.312 -176.756 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 164' ' ' LEU . . . . . 0.46 ' O ' ' HB ' ' A' ' 5' ' ' THR . 64.9 mt -91.17 97.22 11.01 Favored 'General case' 0 N--CA 1.468 0.432 0 N-CA-C 107.272 -1.381 . . . . 73.230000000000004 107.272 -179.542 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 165' ' ' GLU . . . . . . . . . . . . . 7.2 pt-20 . . . . . 0 C--O 1.253 1.248 0 CA-C-O 119.387 -0.339 . . . . 72.099999999999994 111.097 -172.533 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' B' B ' 216' ' ' PRO . . . . . . . . . . . . . 35.0 Cg_endo . . . . . 0 CA--C 1.547 1.138 0 N-CA-C 110.081 -0.777 . . . . 64.340000000000003 110.081 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' B' B ' 217' ' ' GLU . . . . . . . . . . . . . 40.8 tt0 -122.53 102.95 38.55 Favored Pre-proline 0 CA--C 1.549 0.94 0 C-N-CA 124.13 0.972 . . . . 52.340000000000003 109.531 -177.272 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 218' ' ' PRO . . . . . . . . . . . . . 15.4 Cg_exo -69.58 151.02 70.03 Favored 'Trans proline' 0 C--N 1.377 2.036 0 C-N-CA 122.615 2.21 . . . . 53.520000000000003 111.234 168.001 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 219' ' ' GLY . . . . . . . . . . . . . . . 130.63 163.97 11.15 Favored Glycine 0 CA--C 1.531 1.065 0 CA-C-O 119.605 -0.553 . . . . 63.009999999999998 112.372 177.67 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 220' ' ' PRO . . . . . 0.461 ' HG3' HD21 ' A' ' 122' ' ' LEU . 96.3 Cg_endo -78.39 160.03 29.13 Favored 'Trans proline' 0 C--N 1.368 1.56 0 C-N-CA 123.669 2.912 . . . . 72.530000000000001 113.025 -175.394 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 221' ' ' TYR . . . . . . . . . . . . . 49.1 m-85 -85.69 139.11 31.64 Favored 'General case' 0 N--CA 1.475 0.783 0 C-N-CA 123.493 0.717 . . . . 72.25 111.651 -173.123 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 222' ' ' ALA . . . . . 0.534 ' HB2' HD13 ' A' ' 57' ' ' ILE . . . -82.13 102.26 10.95 Favored 'General case' 0 C--N 1.348 0.504 0 CA-C-N 115.198 -0.91 . . . . 71.140000000000001 112.451 -171.87 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 223' ' ' GLN . . . . . . . . . . . . . 55.7 mt-30 58.42 90.45 0.09 OUTLIER Pre-proline 0 CA--C 1.562 1.419 0 O-C-N 124.713 1.258 . . . . 75.450000000000003 111.345 169.507 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 224' ' ' PRO . . . . . . . . . . . . . 11.4 Cg_exo . . . . . 0 C--N 1.373 1.853 0 C-N-CA 123.036 2.491 . . . . 72.209999999999994 111.954 -178.896 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 17.7 ptp . . . . . 0 N--CA 1.473 0.711 0 CA-C-O 120.805 0.336 . . . . 71.329999999999998 110.27 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 5.3 p -77.93 94.96 1.54 Allowed 'Isoleucine or valine' 0 CA--C 1.55 0.946 0 CA-C-O 122.073 0.94 . . . . 71.409999999999997 110.744 -179.234 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 3' ' ' ASN . . . . . 0.447 HD22 ' HA ' ' A' ' 25' ' ' PHE . 13.7 m120 -94.88 106.08 22.83 Favored Pre-proline 0 C--O 1.241 0.655 0 N-CA-C 107.498 -1.297 . . . . 74.230000000000004 107.498 169.291 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 4' ' ' PRO . . . . . 0.687 ' HB3' HH11 ' A' ' 37' ' ' ARG . 48.8 Cg_endo -69.18 119.76 6.7 Favored 'Trans proline' 0 C--N 1.371 1.745 0 C-N-CA 122.107 1.871 . . . . 72.530000000000001 110.917 177.35 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 86.6 m -96.84 117.85 31.98 Favored 'General case' 0 C--O 1.217 -0.61 0 N-CA-C 106.906 -1.516 . . . . 72.310000000000002 106.906 173.234 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 5.3 m -98.22 122.12 49.52 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.421 0 CA-C-O 121.782 0.801 . . . . 75.409999999999997 109.485 -176.537 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 7' ' ' PHE . . . . . 0.57 ' H ' ' HA ' ' A' ' 163' ' ' GLN . 73.2 t80 -100.75 131.79 46.47 Favored 'General case' 0 C--O 1.236 0.365 0 CA-C-N 114.485 -1.234 . . . . 73.150000000000006 108.893 -175.031 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 8' ' ' PHE . . . . . 0.461 ' HB3' HG23 ' A' ' 158' ' ' ILE . 44.2 m-85 -132.04 165.01 24.95 Favored 'General case' 0 C--O 1.24 0.566 0 C-N-CA 124.489 1.116 . . . . 70.430000000000007 109.125 170.566 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 49.5 m-20 -112.94 111.07 21.55 Favored 'General case' 0 C--N 1.326 -0.442 0 N-CA-C 107.564 -1.272 . . . . 72.150000000000006 107.564 169.281 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 10' ' ' ILE . . . . . 0.475 HG21 ' SD ' ' A' ' 142' ' ' MET . 41.3 mm -80.04 115.26 22.17 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.412 0 N-CA-C 108.518 -0.919 . . . . 73.25 108.518 179.154 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 11' ' ' ALA . . . . . 0.566 ' HB2' ' HB2' ' A' ' 159' ' ' ALA . . . -116.79 128.62 55.46 Favored 'General case' 0 N--CA 1.47 0.56 0 C-N-CA 123.793 0.837 . . . . 64.420000000000002 111.21 -173.761 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 73.2 t -95.8 113.64 30.66 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.616 0 N-CA-C 108.097 -1.075 . . . . 75.340000000000003 108.097 173.585 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 48.0 m-20 63.91 23.93 13.51 Favored 'General case' 0 N--CA 1.489 1.502 0 C-N-CA 125.567 1.547 . . . . 64.209999999999994 111.731 -178.676 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 96.85 -20.45 50.65 Favored Glycine 0 C--N 1.341 0.841 0 CA-C-O 119.569 -0.573 . . . . 63.210000000000001 112.838 -177.326 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 50.6 mm-40 -84.22 114.32 53.84 Favored Pre-proline 0 N--CA 1.476 0.841 0 CA-C-N 117.299 0.55 . . . . 73.230000000000004 110.215 178.353 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 76.5 Cg_exo -50.48 109.35 0.29 Allowed 'Trans proline' 0 C--N 1.382 2.309 0 C-N-CA 123.684 2.923 . . . . 74.019999999999996 112.802 177.875 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 44.3 tp -77.06 -45.01 28.54 Favored 'General case' 0 N--CA 1.473 0.701 0 N-CA-C 109.114 -0.698 . . . . 74.519999999999996 109.114 177.653 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -168.35 170.8 42.32 Favored Glycine 0 C--N 1.342 0.891 0 CA-C-N 115.873 -0.603 . . . . 74.25 112.543 179.694 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 69.3 mtt-85 -107.04 125.98 51.74 Favored 'General case' 0 N--CA 1.474 0.759 0 C-N-CA 123.718 0.807 . . . . 72.129999999999995 108.955 -176.466 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 93.1 t -121.76 144.92 29.36 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.769 0 C-N-CA 123.512 0.725 . . . . 71.120000000000005 110.11 -176.77 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 21' ' ' SER . . . . . 0.473 ' HB2' ' HB2' ' A' ' 134' ' ' GLU . 60.0 m -141.21 128.21 20.67 Favored 'General case' 0 CA--C 1.541 0.602 0 C-N-CA 124.733 1.213 . . . . 72.340000000000003 108.925 178.447 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 57.9 m-85 -109.59 121.35 45.01 Favored 'General case' 0 N--CA 1.476 0.83 0 C-N-CA 123.248 0.619 . . . . 73.010000000000005 110.02 -178.242 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 38.0 tt0 -74.53 104.23 5.16 Favored 'General case' 0 CA--C 1.547 0.854 0 C-N-CA 123.533 0.733 . . . . 74.519999999999996 109.192 171.36 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . 0.522 ' HB2' ' HG2' ' A' ' 4' ' ' PRO . 38.4 mt -85.6 123.83 31.46 Favored 'General case' 0 C--O 1.241 0.627 0 N-CA-C 109.114 -0.699 . . . . 61.409999999999997 109.114 175.971 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 25' ' ' PHE . . . . . 0.447 ' HA ' HD22 ' A' ' 3' ' ' ASN . 58.0 m-85 -83.16 76.44 9.86 Favored 'General case' 0 CA--C 1.543 0.674 0 C-N-CA 123.498 0.719 . . . . 74.530000000000001 110.52 -177.043 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -71.14 -6.63 40.81 Favored 'General case' 0 N--CA 1.489 1.482 0 C-N-CA 122.913 0.485 . . . . 63.450000000000003 112.004 178.363 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 10.1 p-10 -89.07 -17.38 29.42 Favored 'General case' 0 CA--C 1.554 1.104 0 C-N-CA 123.746 0.819 . . . . 64.540000000000006 111.343 176.344 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 57.2 mttp -112.59 -44.78 3.3 Favored 'General case' 0 N--CA 1.494 1.758 0 C-N-CA 123.441 0.697 . . . . 73.219999999999999 111.033 -176.185 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 29' ' ' VAL . . . . . 0.503 HG21 ' HA ' ' A' ' 129' ' ' PHE . 12.0 m -127.91 62.97 59.49 Favored Pre-proline 0 CA--C 1.566 1.59 0 C-N-CA 124.448 1.099 . . . . 75.230000000000004 110.267 177.382 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 2.8 Cg_endo -49.83 -41.34 47.15 Favored 'Trans proline' 0 C--N 1.391 2.78 0 C-N-CA 123.41 2.74 . . . . 75.430000000000007 114.717 -172.994 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 39.3 ttpt -64.46 -49.96 69.4 Favored 'General case' 0 N--CA 1.476 0.837 0 C-N-CA 123.449 0.699 . . . . 74.299999999999997 111.132 -177.496 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 7.1 m -76.01 -31.64 59.02 Favored 'General case' 0 CA--C 1.55 0.974 0 CA-C-N 115.115 -0.948 . . . . 71.349999999999994 111.504 -171.034 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -74.29 -46.93 38.08 Favored 'General case' 0 CA--C 1.543 0.704 0 C-N-CA 123.695 0.798 . . . . 43.549999999999997 110.336 177.976 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 11.6 tp10 -66.34 -29.66 69.89 Favored 'General case' 0 N--CA 1.482 1.134 0 C-N-CA 123.764 0.825 . . . . 71.319999999999993 110.979 178.852 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 35' ' ' ASN . . . . . 0.479 ' O ' ' HG ' ' A' ' 39' ' ' LEU . 25.8 t30 -54.06 -60.6 3.11 Favored 'General case' 0 N--CA 1.476 0.869 0 C-N-CA 123.826 0.85 . . . . 74.299999999999997 110.034 173.239 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 52.7 t80 -66.51 -34.84 78.83 Favored 'General case' 0 CA--C 1.541 0.598 0 O-C-N 124.224 0.953 . . . . 65.010000000000005 111.095 -175.094 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 37' ' ' ARG . . . . . 0.687 HH11 ' HB3' ' A' ' 4' ' ' PRO . 24.7 ttt180 -59.36 -45.56 91.05 Favored 'General case' 0 C--N 1.35 0.628 0 C-N-CA 123.541 0.736 . . . . 63.340000000000003 110.659 175.357 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 38' ' ' ALA . . . . . 0.592 ' HB1' ' HG2' ' A' ' 44' ' ' LYS . . . -73.3 -27.41 61.53 Favored 'General case' 0 CA--C 1.543 0.68 0 C-N-CA 123.434 0.694 . . . . 74.349999999999994 111.515 -177.956 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 39' ' ' LEU . . . . . 0.621 HD22 ' HE2' ' A' ' 48' ' ' TYR . 86.6 mt -72.97 -30.14 63.61 Favored 'General case' 0 N--CA 1.48 1.053 0 C-N-CA 123.462 0.705 . . . . 75.239999999999995 110.513 174.17 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 33.3 t -76.6 -53.95 7.35 Favored 'General case' 0 N--CA 1.478 0.946 0 C-N-CA 124.356 1.062 . . . . 73.430000000000007 110.898 179.452 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 41' ' ' THR . . . . . 0.4 ' OG1' ' HG2' ' A' ' 43' ' ' GLU . 44.0 p -76.83 -30.31 56.31 Favored 'General case' 0 N--CA 1.471 0.588 0 C-N-CA 124.401 1.08 . . . . 53.310000000000002 111.847 -174.523 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 79.86 30.89 41.6 Favored Glycine 0 C--N 1.341 0.851 0 CA-C-N 115.706 -0.679 . . . . 41.450000000000003 112.914 -179.076 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 43' ' ' GLU . . . . . 0.4 ' HG2' ' OG1' ' A' ' 41' ' ' THR . 55.7 mm-40 -58.33 -40.6 82.57 Favored 'General case' 0 N--CA 1.476 0.854 0 C-N-CA 123.079 0.551 . . . . 74.129999999999995 110.027 172.461 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 44' ' ' LYS . . . . . 0.592 ' HG2' ' HB1' ' A' ' 38' ' ' ALA . 28.4 mmmt -92.99 18.32 9.34 Favored 'General case' 0 CA--C 1.551 0.993 0 CA-C-N 115.315 -0.857 . . . . 72.409999999999997 111.379 -179.849 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 82.71 -8.87 61.02 Favored Glycine 0 C--N 1.35 1.335 0 N-CA-C 115.225 0.85 . . . . 72.540000000000006 115.225 172.872 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 46' ' ' PHE . . . . . 0.465 ' HE2' ' HA ' ' A' ' 78' ' ' ILE . 22.4 m-85 -82.09 -48.66 11.1 Favored 'General case' 0 N--CA 1.479 1.023 0 CA-C-N 117.713 0.756 . . . . 71.209999999999994 111.393 -170.224 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 38.04 62.6 1.02 Allowed Glycine 0 C--N 1.357 1.746 0 O-C-N 125.016 1.447 . . . . 42.310000000000002 116.186 168.278 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 48' ' ' TYR . . . . . 0.621 ' HE2' HD22 ' A' ' 39' ' ' LEU . 97.4 m-85 -62.18 92.85 0.04 OUTLIER 'General case' 0 N--CA 1.479 1.013 0 CA-C-O 121.908 0.861 . . . . 73.319999999999993 112.37 -170.736 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 49' ' ' LYS . . . . . 0.441 ' HE2' ' HA ' ' A' ' 160' ' ' ASP . 28.3 tptp -100.55 129.2 46.46 Favored 'General case' 0 C--O 1.237 0.436 0 C-N-CA 125.067 1.347 . . . . 74.040000000000006 107.954 179.593 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 73.63 20.5 79.82 Favored Glycine 0 C--N 1.345 1.045 0 O-C-N 123.33 0.394 . . . . 65.219999999999999 112.681 -176.007 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 51' ' ' SER . . . . . 0.464 ' HB2' ' HB3' ' A' ' 48' ' ' TYR . 22.7 t -64.92 119.83 11.43 Favored 'General case' 0 CA--C 1.546 0.819 0 C-N-CA 123.651 0.78 . . . . 72.540000000000006 109.901 -178.191 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 52' ' ' CYS . . . . . 0.417 ' H ' ' HB2' ' A' ' 67' ' ' PHE . 37.6 t -93.36 153.79 18.33 Favored 'General case' 0 N--CA 1.472 0.642 0 C-N-CA 123.275 0.63 . . . . 70.030000000000001 111.959 -166.934 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 53' ' ' PHE . . . . . 0.487 ' HA ' ' HA2' ' A' ' 64' ' ' GLY . 45.9 m-85 -97.89 120.9 39.1 Favored 'General case' 0 C--O 1.237 0.412 0 C-N-CA 124.787 1.235 . . . . 71.510000000000005 108.04 172.724 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 19.5 p-80 -108.68 -36.71 6.09 Favored 'General case' 0 N--CA 1.479 0.996 0 C-N-CA 123.822 0.849 . . . . 71.430000000000007 110.146 -173.269 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 50.2 ttt180 -122.61 97.34 5.41 Favored 'General case' 0 C--O 1.217 -0.643 0 N-CA-C 108.703 -0.851 . . . . 73.239999999999995 108.703 -175.057 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 56' ' ' ILE . . . . . 0.511 HG21 ' HA ' ' A' ' 143' ' ' GLU . 44.9 mt -119.85 128.35 75.91 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.586 0 N-CA-C 108.192 -1.04 . . . . 63.520000000000003 108.192 172.931 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 57' ' ' ILE . . . . . 0.574 HG23 ' HA ' ' A' ' 148' ' ' ARG . 60.5 mt -120.68 124.86 27.37 Favored Pre-proline 0 CA--C 1.547 0.831 0 N-CA-C 108.34 -0.985 . . . . 61.200000000000003 108.34 175.436 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 58' ' ' PRO . . . . . 0.526 ' HA ' ' HG2' ' A' ' 143' ' ' GLU . 37.8 Cg_endo -63.1 141.69 84.22 Favored 'Trans proline' 0 C--N 1.383 2.352 0 C-N-CA 123.31 2.673 . . . . 71.430000000000007 112.505 -178.364 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 65.29 21.6 68.5 Favored Glycine 0 C--N 1.343 0.967 0 CA-C-N 115.326 -0.852 . . . . 73.510000000000005 113.717 -177.738 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 60' ' ' PHE . . . . . 0.725 ' HB2' ' HG3' ' B' ' 223' ' ' GLN . 27.8 t80 -138.01 -74.78 0.4 Allowed 'General case' 0 N--CA 1.468 0.447 0 N-CA-C 109.245 -0.65 . . . . 74.510000000000005 109.245 -172.42 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 11.9 ptp -175.31 154.1 1.66 Allowed 'General case' 0 N--CA 1.483 1.215 0 O-C-N 123.677 0.611 . . . . 62.409999999999997 112.501 -178.472 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 62' ' ' CYS . . . . . . . . . . . . . 56.7 m -102.94 109.74 21.4 Favored 'General case' 0 CA--C 1.539 0.539 0 CA-C-N 115.076 -0.965 . . . . 73.400000000000006 108.973 170.369 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 63' ' ' GLN . . . . . 0.46 ' HA ' ' HA ' ' A' ' 113' ' ' PHE . 53.1 tt0 -100.08 105.33 16.96 Favored 'General case' 0 C--O 1.248 0.977 0 CA-C-O 121.336 0.589 . . . . 71.540000000000006 109.901 -178.05 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 64' ' ' GLY . . . . . 0.487 ' HA2' ' HA ' ' A' ' 53' ' ' PHE . . . -110.79 -153.38 13.2 Favored Glycine 0 C--N 1.344 1.006 0 CA-C-N 114.466 -1.243 . . . . 72.109999999999999 111.31 174.931 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 86.05 -35.6 3.25 Favored Glycine 0 C--N 1.344 1.025 0 N-CA-C 111.856 -0.498 . . . . 62.539999999999999 111.856 -173.494 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 66' ' ' ASP . . . . . 0.554 ' HB2' ' HG2' ' A' ' 111' ' ' GLN . 35.5 t70 -66.54 103.1 0.99 Allowed 'General case' 0 N--CA 1.445 -0.688 0 C-N-CA 124.836 1.254 . . . . 74.319999999999993 110.686 -177.855 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 67' ' ' PHE . . . . . 0.417 ' HB2' ' H ' ' A' ' 52' ' ' CYS . 71.5 t80 -156.92 -68.83 0.1 Allowed 'General case' 0 C--O 1.239 0.521 0 N-CA-C 108.361 -0.978 . . . . 74.530000000000001 108.361 177.919 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 27.5 m -79.25 122.06 25.85 Favored 'General case' 0 C--O 1.24 0.57 0 CA-C-N 115.49 -0.777 . . . . 54.539999999999999 108.943 178.693 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 49.5 mtt85 65.94 36.06 6.16 Favored 'General case' 0 N--CA 1.482 1.159 0 C-N-CA 124.302 1.041 . . . . 64.310000000000002 111.538 177.787 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 1.2 t60 -41.1 -52.73 3.2 Favored 'General case' 0 N--CA 1.494 1.741 0 C-N-CA 125.804 1.642 . . . . 74.219999999999999 113.88 -175.273 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 93.2 m-20 -65.58 99.77 0.46 Allowed 'General case' 0 N--CA 1.477 0.887 0 C-N-CA 123.118 0.567 . . . . 53.530000000000001 110.777 -175.847 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 72' ' ' GLY . . . . . 0.63 ' HA2' ' HG2' ' B' ' 216' ' ' PRO . . . 88.29 -7.05 82.73 Favored Glycine 0 C--N 1.345 1.044 0 CA-C-N 115.677 -0.692 . . . . 74.219999999999999 114.688 174.689 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 73' ' ' THR . . . . . 0.439 ' O ' ' HB3' ' A' ' 110' ' ' SER . 26.1 m -137.09 -83.02 0.35 Allowed 'General case' 0 N--CA 1.48 1.072 0 CA-C-N 118.076 0.938 . . . . 65.549999999999997 110.526 -178.049 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 74' ' ' GLY . . . . . 0.448 ' O ' ' HG3' ' A' ' 111' ' ' GLN . . . 71.95 64.12 2.78 Favored Glycine 0 C--N 1.354 1.535 0 N-CA-C 114.371 0.508 . . . . 70.010000000000005 114.371 173.171 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 97.43 54.53 1.24 Allowed Glycine 0 N--CA 1.472 1.052 0 C-N-CA 120.309 -0.948 . . . . 64.329999999999998 112.305 176.016 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 64.3 pttt -61.05 172.15 1.08 Allowed 'General case' 0 CA--C 1.551 1.001 0 C-N-CA 123.959 0.904 . . . . 71.329999999999998 113.283 -175.4 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 88.1 p -90.57 179.42 5.84 Favored 'General case' 0 C--O 1.242 0.684 0 CA-C-N 115.212 -0.904 . . . . 70.209999999999994 111.187 -176.146 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 78' ' ' ILE . . . . . 0.465 ' HA ' ' HE2' ' A' ' 46' ' ' PHE . 35.0 pt -74.56 -15.54 16.25 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.663 0 CA-C-N 115.72 -0.673 . . . . 71.209999999999994 111.359 177.608 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 82.1 m-85 -95.0 11.27 32.57 Favored 'General case' 0 N--CA 1.475 0.821 0 C-N-CA 123.735 0.814 . . . . 74.219999999999999 111.35 177.287 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 105.88 -146.08 16.02 Favored Glycine 0 C--N 1.345 1.053 0 N-CA-C 111.244 -0.742 . . . . 71.120000000000005 111.244 -179.253 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 36.1 tt0 -57.81 -38.5 75.66 Favored 'General case' 0 N--CA 1.477 0.877 0 C-N-CA 124.08 0.952 . . . . 74.239999999999995 111.423 -178.227 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 3.8 ptpp? -160.15 172.48 17.36 Favored 'General case' 0 N--CA 1.474 0.743 0 C-N-CA 123.417 0.687 . . . . 74.0 111.805 -177.451 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 4.1 p90 -159.07 171.89 19.16 Favored 'General case' 0 CA--C 1.544 0.726 0 C-N-CA 125.012 1.325 . . . . 73.140000000000001 109.514 177.657 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 84' ' ' GLU . . . . . 0.486 ' HA ' ' HA ' ' A' ' 106' ' ' ASN . 12.6 pt-20 -81.67 158.4 24.29 Favored 'General case' 0 N--CA 1.475 0.776 0 C-N-CA 123.574 0.75 . . . . 74.319999999999993 111.758 -177.319 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 52.7 m-20 -81.85 143.74 31.51 Favored 'General case' 0 N--CA 1.476 0.875 0 C-N-CA 123.761 0.824 . . . . 75.329999999999998 109.269 173.294 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 12.5 tp10 -83.21 -59.38 2.48 Favored 'General case' 0 N--CA 1.477 0.883 0 CA-C-O 121.278 0.561 . . . . 63.310000000000002 111.051 -174.551 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 32.0 p30 -153.68 -167.5 2.7 Favored 'General case' 0 N--CA 1.472 0.673 0 C-N-CA 123.747 0.819 . . . . 63.509999999999998 109.157 -174.167 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 81.4 m-85 -138.58 39.49 2.22 Favored 'General case' 0 N--CA 1.482 1.166 0 C-N-CA 123.717 0.807 . . . . 73.540000000000006 110.451 178.046 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 67.8 mt -62.31 -38.18 80.49 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.324 0 CA-C-O 121.531 0.681 . . . . 71.439999999999998 109.904 174.612 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 90' ' ' LEU . . . . . 0.67 ' HB3' ' HB ' ' A' ' 128' ' ' VAL . 95.4 mt -98.9 150.62 21.73 Favored 'General case' 0 CA--C 1.543 0.705 0 C-N-CA 124.088 0.955 . . . . 74.450000000000003 110.893 179.379 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 47.2 pttt -158.77 163.87 36.35 Favored 'General case' 0 N--CA 1.482 1.172 0 C-N-CA 124.165 0.986 . . . . 75.209999999999994 110.294 -170.946 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 92' ' ' HIS . . . . . 0.402 ' HA ' HG13 ' A' ' 97' ' ' ILE . 13.3 m-70 -88.89 63.38 6.76 Favored 'General case' 0 N--CA 1.488 1.439 0 C-N-CA 123.63 0.772 . . . . 74.310000000000002 109.93 -175.196 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 15.3 p -90.8 2.57 55.97 Favored 'General case' 0 N--CA 1.48 1.064 0 C-N-CA 123.849 0.86 . . . . 74.120000000000005 111.811 178.508 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -157.27 173.36 34.79 Favored Glycine 0 C--N 1.343 0.926 0 CA-C-N 116.653 -0.248 . . . . 61.310000000000002 112.918 -178.644 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 86.2 Cg_endo -78.16 157.1 30.05 Favored 'Trans proline' 0 C--N 1.362 1.249 0 C-N-CA 123.276 2.651 . . . . 74.0 112.64 175.895 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 79.63 18.77 72.51 Favored Glycine 0 C--N 1.342 0.871 0 CA-C-N 115.694 -0.685 . . . . 54.32 114.476 175.396 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 97' ' ' ILE . . . . . 0.67 ' HB ' ' SG ' ' A' ' 115' ' ' CYS . 19.0 mm -73.03 128.54 35.85 Favored 'Isoleucine or valine' 0 CA--C 1.554 1.119 0 C-N-CA 123.967 0.907 . . . . 62.520000000000003 110.592 178.932 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 98' ' ' LEU . . . . . 0.501 HD13 HG12 ' A' ' 114' ' ' ILE . 67.7 tp -103.88 122.71 45.72 Favored 'General case' 0 C--O 1.252 1.207 0 C-N-CA 123.637 0.775 . . . . 72.25 110.13 176.139 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 99' ' ' SER . . . . . 0.422 ' HB3' ' HD2' ' A' ' 126' ' ' HIS . 50.7 m -145.34 139.68 27.18 Favored 'General case' 0 CA--C 1.555 1.155 0 C-N-CA 124.735 1.214 . . . . 72.120000000000005 109.418 179.744 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 100' ' ' MET . . . . . 0.675 ' HA ' ' HA ' ' A' ' 112' ' ' PHE . 85.9 mtp -76.57 147.54 37.61 Favored 'General case' 0 N--CA 1.491 1.605 0 C-N-CA 123.877 0.871 . . . . 74.310000000000002 111.647 178.48 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 101' ' ' ALA . . . . . 0.4 ' HB3' ' HB2' ' A' ' 111' ' ' GLN . . . -75.25 145.77 41.66 Favored 'General case' 0 N--CA 1.479 0.995 0 C-N-CA 123.654 0.782 . . . . 54.140000000000001 111.843 -175.261 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 26.9 p-10 -168.54 173.04 7.72 Favored 'General case' 0 N--CA 1.477 0.908 0 C-N-CA 123.958 0.903 . . . . 71.200000000000003 110.675 -178.902 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -91.45 -47.81 7.23 Favored 'General case' 0 N--CA 1.471 0.578 0 CA-C-N 115.7 -0.682 . . . . 42.149999999999999 109.551 168.636 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -163.1 -161.2 12.09 Favored Glycine 0 C--N 1.345 1.074 0 CA-C-N 115.512 -0.767 . . . . 42.109999999999999 111.973 178.111 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 51.9 Cg_exo -55.8 135.68 70.73 Favored 'Trans proline' 0 C--N 1.375 1.965 0 C-N-CA 123.417 2.745 . . . . 70.230000000000004 112.608 179.133 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 106' ' ' ASN . . . . . 0.486 ' HA ' ' HA ' ' A' ' 84' ' ' GLU . 64.9 t30 69.45 11.22 7.99 Favored 'General case' 0 N--CA 1.484 1.261 0 C-N-CA 124.982 1.313 . . . . 64.430000000000007 112.247 179.269 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 8.8 m -105.08 -12.98 15.89 Favored 'General case' 0 CA--C 1.552 1.057 0 C-N-CA 123.452 0.701 . . . . 61.030000000000001 109.576 171.549 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 15.1 t30 -57.88 146.6 31.44 Favored 'General case' 0 N--CA 1.481 1.081 0 C-N-CA 125.609 1.563 . . . . 72.530000000000001 111.451 175.306 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 113.13 21.15 6.02 Favored Glycine 0 N--CA 1.471 1.02 0 N-CA-C 113.996 0.359 . . . . 23.539999999999999 113.996 175.944 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 110' ' ' SER . . . . . 0.439 ' HB3' ' O ' ' A' ' 73' ' ' THR . 69.0 m -138.36 122.62 18.16 Favored 'General case' 0 N--CA 1.474 0.765 0 N-CA-C 108.744 -0.836 . . . . 73.010000000000005 108.744 171.546 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 111' ' ' GLN . . . . . 0.554 ' HG2' ' HB2' ' A' ' 66' ' ' ASP . 18.1 mt-30 65.72 170.92 0.22 Allowed 'General case' 0 N--CA 1.498 1.953 0 C-N-CA 124.302 1.041 . . . . 74.409999999999997 111.802 -178.255 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 112' ' ' PHE . . . . . 0.675 ' HA ' ' HA ' ' A' ' 100' ' ' MET . 53.2 p90 -150.07 138.81 20.82 Favored 'General case' 0 N--CA 1.479 0.978 0 C-N-CA 123.118 0.567 . . . . 73.430000000000007 110.102 174.975 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 113' ' ' PHE . . . . . 0.46 ' HA ' ' HA ' ' A' ' 63' ' ' GLN . 42.9 p90 -111.84 144.99 40.24 Favored 'General case' 0 C--O 1.24 0.588 0 C-N-CA 123.753 0.821 . . . . 74.319999999999993 110.668 174.435 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 114' ' ' ILE . . . . . 0.501 HG12 HD13 ' A' ' 98' ' ' LEU . 8.2 mt -116.46 99.67 8.81 Favored 'Isoleucine or valine' 0 C--O 1.24 0.577 0 N-CA-C 106.919 -1.511 . . . . 74.109999999999999 106.919 178.232 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 115' ' ' CYS . . . . . 0.67 ' SG ' ' HB ' ' A' ' 97' ' ' ILE . 19.3 p -84.45 118.05 24.04 Favored 'General case' 0 N--CA 1.472 0.644 0 C-N-CA 122.404 0.282 . . . . 72.430000000000007 110.758 -175.768 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 59.5 p -78.65 1.17 23.69 Favored 'General case' 0 N--CA 1.481 1.075 0 C-N-CA 124.052 0.941 . . . . 74.420000000000002 111.902 -179.024 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -133.22 162.22 32.35 Favored 'General case' 0 C--O 1.244 0.787 0 C-N-CA 123.704 0.802 . . . . 71.010000000000005 109.966 -179.827 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 8.8 ptmt -71.82 81.51 0.89 Allowed 'General case' 0 CA--C 1.549 0.937 0 CA-C-O 121.846 0.831 . . . . 74.540000000000006 109.415 171.944 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 119' ' ' THR . . . . . 0.491 ' HB ' HD23 ' A' ' 122' ' ' LEU . 32.2 p -82.56 85.31 7.0 Favored 'General case' 0 CA--C 1.55 0.971 0 CA-C-O 122.147 0.975 . . . . 71.319999999999993 109.309 -177.331 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 12.8 pt-20 -74.57 -27.64 60.58 Favored 'General case' 0 N--CA 1.48 1.06 0 CA-C-N 114.67 -1.15 . . . . 61.049999999999997 112.318 -167.724 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 121' ' ' TRP . . . . . . . . . . . . . 46.5 p90 -67.49 -1.75 5.39 Favored 'General case' 0 N--CA 1.483 1.2 0 C-N-CA 123.747 0.819 . . . . 73.030000000000001 112.238 178.352 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 122' ' ' LEU . . . . . 0.491 HD23 ' HB ' ' A' ' 119' ' ' THR . 3.2 mm? -78.06 -3.91 44.58 Favored 'General case' 0 CA--C 1.548 0.895 0 C-N-CA 124.454 1.102 . . . . 73.450000000000003 112.48 174.064 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 40.6 m-20 -65.22 128.38 35.58 Favored 'General case' 0 N--CA 1.487 1.384 0 CA-C-N 118.247 0.476 . . . . 63.100000000000001 111.164 176.592 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 104.23 -25.79 25.0 Favored Glycine 0 N--CA 1.477 1.378 0 N-CA-C 111.867 -0.493 . . . . 60.119999999999997 111.867 -174.665 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 12.5 ttmm -85.59 -164.46 1.02 Allowed 'General case' 0 CA--C 1.552 1.033 0 C-N-CA 124.329 1.052 . . . . 60.109999999999999 108.449 177.443 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 126' ' ' HIS . . . . . 0.422 ' HD2' ' HB3' ' A' ' 99' ' ' SER . 34.6 t60 -66.91 131.7 46.44 Favored 'General case' 0 CA--C 1.546 0.825 0 CA-C-O 121.183 0.516 . . . . 71.040000000000006 111.063 -175.343 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 7.4 p -62.42 147.4 11.62 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.808 0 CA-C-N 114.038 -1.437 . . . . 75.400000000000006 112.074 178.126 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 128' ' ' VAL . . . . . 0.67 ' HB ' ' HB3' ' A' ' 90' ' ' LEU . 46.3 t -64.43 149.98 10.61 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.721 0 C-N-CA 123.374 0.67 . . . . 72.120000000000005 110.3 174.699 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 129' ' ' PHE . . . . . 0.503 ' HA ' HG21 ' A' ' 29' ' ' VAL . 49.3 p90 -136.51 -27.95 1.03 Allowed 'General case' 0 N--CA 1.479 0.977 0 C-N-CA 122.378 0.271 . . . . 74.299999999999997 111.127 174.567 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . -123.54 167.13 15.84 Favored Glycine 0 C--N 1.343 0.942 0 O-C-N 123.424 0.452 . . . . 61.009999999999998 112.323 -177.719 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 30.2 ttpt -154.65 122.84 5.97 Favored 'General case' 0 N--CA 1.468 0.454 0 N-CA-C 107.997 -1.112 . . . . 74.109999999999999 107.997 179.092 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 12.7 p -67.0 122.39 17.94 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.959 0 CA-C-O 121.515 0.674 . . . . 52.450000000000003 109.98 177.468 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 21.2 ptmt -108.66 -22.98 12.01 Favored 'General case' 0 N--CA 1.476 0.844 0 C-N-CA 124.054 0.941 . . . . 63.119999999999997 110.251 179.009 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 134' ' ' GLU . . . . . 0.473 ' HB2' ' HB2' ' A' ' 21' ' ' SER . 34.6 mt-10 -136.71 134.03 36.74 Favored 'General case' 0 N--CA 1.475 0.817 0 C-N-CA 124.798 1.239 . . . . 75.439999999999998 108.17 179.863 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 135' ' ' GLY . . . . . 0.411 ' O ' HG23 ' A' ' 139' ' ' VAL . . . 80.1 26.66 54.94 Favored Glycine 0 CA--C 1.528 0.862 0 CA-C-O 119.837 -0.424 . . . . 41.409999999999997 113.235 -177.624 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 136' ' ' MET . . . . . . . . . . . . . 5.8 tpt -59.79 -53.17 61.1 Favored 'General case' 0 N--CA 1.485 1.288 0 C-N-CA 123.664 0.786 . . . . 70.319999999999993 110.471 175.103 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 137' ' ' ASN . . . . . . . . . . . . . 20.5 m120 -64.65 -25.79 68.11 Favored 'General case' 0 N--CA 1.477 0.884 0 CA-C-N 115.902 -0.59 . . . . 74.439999999999998 110.997 -179.537 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 138' ' ' ILE . . . . . . . . . . . . . 50.9 mm -69.52 -40.4 79.65 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.728 0 C-N-CA 123.393 0.677 . . . . 73.540000000000006 110.433 175.853 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 139' ' ' VAL . . . . . 0.411 HG23 ' O ' ' A' ' 135' ' ' GLY . 91.2 t -63.18 -40.33 88.62 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.131 0 C-N-CA 123.033 0.533 . . . . 74.409999999999997 109.888 174.987 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 40.3 mt-10 -65.46 -33.23 75.44 Favored 'General case' 0 CA--C 1.551 0.985 0 CA-C-N 115.541 -0.754 . . . . 75.310000000000002 111.329 175.808 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -75.2 -45.11 42.57 Favored 'General case' 0 N--CA 1.481 1.08 0 C-N-CA 123.753 0.821 . . . . 71.310000000000002 111.739 -177.667 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 142' ' ' MET . . . . . 0.551 ' HB2' HD13 ' A' ' 156' ' ' ILE . 25.4 ptm -69.48 -29.38 67.03 Favored 'General case' 0 N--CA 1.476 0.852 0 CA-C-N 115.823 -0.626 . . . . 74.099999999999994 110.66 179.031 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 143' ' ' GLU . . . . . 0.526 ' HG2' ' HA ' ' A' ' 58' ' ' PRO . 30.9 tt0 -64.88 -29.01 69.94 Favored 'General case' 0 C--N 1.353 0.731 0 C-N-CA 123.243 0.617 . . . . 70.019999999999996 111.531 -179.927 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 144' ' ' ARG . . . . . . . . . . . . . 24.3 mtp180 -63.15 -23.61 67.51 Favored 'General case' 0 N--CA 1.474 0.761 0 C-N-CA 123.572 0.749 . . . . 73.340000000000003 111.843 177.475 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 145' ' ' PHE . . . . . . . . . . . . . 65.7 m-85 -80.14 -13.82 58.97 Favored 'General case' 0 N--CA 1.481 1.111 0 C-N-CA 122.42 0.288 . . . . 73.400000000000006 111.506 179.68 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 146' ' ' GLY . . . . . 0.411 ' HA2' ' HA ' ' A' ' 152' ' ' THR . . . -84.4 171.09 47.41 Favored Glycine 0 C--N 1.343 0.949 0 O-C-N 122.979 0.174 . . . . 64.310000000000002 112.675 177.192 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 34.1 t -132.96 167.29 20.54 Favored 'General case' 0 N--CA 1.48 1.05 0 C-N-CA 123.966 0.906 . . . . 74.239999999999995 109.716 -176.229 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 148' ' ' ARG . . . . . 0.574 ' HA ' HG23 ' A' ' 57' ' ' ILE . 23.7 mmt85 -67.6 -23.39 65.38 Favored 'General case' 0 N--CA 1.488 1.46 0 C-N-CA 123.925 0.89 . . . . 75.549999999999997 112.591 -175.481 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 149' ' ' ASN . . . . . . . . . . . . . 27.8 p-10 -86.97 1.09 53.89 Favored 'General case' 0 N--CA 1.487 1.38 0 C-N-CA 123.363 0.665 . . . . 60.520000000000003 111.106 174.818 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . 95.32 -26.5 19.21 Favored Glycine 0 C--N 1.341 0.809 0 CA-C-O 119.692 -0.504 . . . . 73.129999999999995 113.169 179.282 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 65.0 tttp -63.69 118.14 7.84 Favored 'General case' 0 N--CA 1.476 0.827 0 CA-C-N 117.507 0.654 . . . . 70.439999999999998 110.921 -174.542 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 152' ' ' THR . . . . . 0.411 ' HA ' ' HA2' ' A' ' 146' ' ' GLY . 9.6 m -93.39 124.7 37.56 Favored 'General case' 0 CA--C 1.542 0.644 0 CA-C-N 114.763 -1.108 . . . . 74.400000000000006 109.062 179.269 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 153' ' ' SER . . . . . . . . . . . . . 66.2 p -63.77 -26.81 68.81 Favored 'General case' 0 N--CA 1.48 1.066 0 C-N-CA 124.13 0.972 . . . . 35.310000000000002 112.056 -178.655 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 72.1 mmtt -111.89 141.3 45.7 Favored 'General case' 0 C--O 1.238 0.472 0 C-N-CA 124.009 0.924 . . . . 60.439999999999998 111.252 -176.38 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 72.9 mmtt -83.16 91.23 7.2 Favored 'General case' 0 C--O 1.238 0.487 0 N-CA-C 108.369 -0.975 . . . . 60.539999999999999 108.369 172.798 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 156' ' ' ILE . . . . . 0.551 HD13 ' HB2' ' A' ' 142' ' ' MET . 62.6 mt -94.13 110.97 24.38 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.473 0 CA-C-N 114.84 -1.073 . . . . 52.130000000000003 108.955 -177.94 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 157' ' ' THR . . . . . . . . . . . . . 49.3 p -115.59 155.07 28.29 Favored 'General case' 0 C--O 1.243 0.743 0 C-N-CA 123.847 0.859 . . . . 74.219999999999999 110.454 -176.979 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 158' ' ' ILE . . . . . 0.461 HG23 ' HB3' ' A' ' 8' ' ' PHE . 62.6 mt -75.5 93.71 0.92 Allowed 'Isoleucine or valine' 0 CA--C 1.542 0.644 0 N-CA-C 108.205 -1.035 . . . . 73.030000000000001 108.205 171.199 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 159' ' ' ALA . . . . . 0.566 ' HB2' ' HB2' ' A' ' 11' ' ' ALA . . . -58.31 -35.62 72.13 Favored 'General case' 0 N--CA 1.474 0.744 0 C-N-CA 124.485 1.114 . . . . 71.099999999999994 112.834 -177.028 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 160' ' ' ASP . . . . . 0.441 ' HA ' ' HE2' ' A' ' 49' ' ' LYS . 23.7 t0 -161.16 157.39 25.8 Favored 'General case' 0 N--CA 1.477 0.906 0 O-C-N 123.358 0.411 . . . . 70.140000000000001 110.648 -174.986 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 161' ' ' CYS . . . . . . . . . . . . . 58.7 m -123.49 -172.59 2.55 Favored 'General case' 0 N--CA 1.485 1.299 0 C-N-CA 125.048 1.339 . . . . 71.200000000000003 108.473 177.281 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 162' ' ' GLY . . . . . . . . . . . . . . . 132.25 57.09 0.08 OUTLIER Glycine 0 C--N 1.354 1.572 0 CA-C-N 118.716 0.689 . . . . 61.149999999999999 112.977 -172.957 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 163' ' ' GLN . . . . . 0.57 ' HA ' ' H ' ' A' ' 7' ' ' PHE . 21.8 pt20 -47.84 137.46 9.77 Favored 'General case' 0 N--CA 1.485 1.288 0 C-N-CA 124.356 1.062 . . . . 72.299999999999997 113.708 -173.242 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 164' ' ' LEU . . . . . 0.473 ' HG ' ' HB2' ' A' ' 7' ' ' PHE . 41.2 mt -84.08 125.1 31.8 Favored 'General case' 0 CA--C 1.543 0.698 0 C-N-CA 124.005 0.922 . . . . 74.230000000000004 110.151 179.914 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 165' ' ' GLU . . . . . . . . . . . . . 29.0 tt0 . . . . . 0 C--O 1.253 1.245 0 C-N-CA 123.39 0.676 . . . . 74.129999999999995 109.602 176.971 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' B' B ' 216' ' ' PRO . . . . . 0.63 ' HG2' ' HA2' ' A' ' 72' ' ' GLY . 24.2 Cg_exo . . . . . 0 N--CA 1.492 1.415 0 N-CA-C 111.527 -0.22 . . . . 72.409999999999997 111.527 . . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 217' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER 55.74 64.39 5.38 Favored Pre-proline 0 CA--C 1.558 1.261 0 C-N-CA 124.775 1.23 . . . . 61.340000000000003 110.68 -176.331 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 218' ' ' PRO . . . . . . . . . . . . . 93.4 Cg_endo -78.7 146.97 21.57 Favored 'Trans proline' 0 C--N 1.378 2.128 0 C-N-CA 122.28 1.986 . . . . 70.030000000000001 112.044 -178.634 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 219' ' ' GLY . . . . . . . . . . . . . . . 112.38 177.55 19.88 Favored Glycine 0 CA--C 1.527 0.834 0 CA-C-N 115.186 -0.916 . . . . 75.519999999999996 111.909 -175.981 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 220' ' ' PRO . . . . . 0.436 ' HG3' HD11 ' A' ' 122' ' ' LEU . 91.7 Cg_endo -75.65 178.48 7.33 Favored 'Trans proline' 0 N--CA 1.489 1.254 0 C-N-CA 123.41 2.74 . . . . 63.539999999999999 113.419 -177.067 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 221' ' ' TYR . . . . . . . . . . . . . 99.7 m-85 -129.62 -166.13 1.62 Allowed 'General case' 0 N--CA 1.476 0.87 0 C-N-CA 124.464 1.105 . . . . 73.299999999999997 109.558 179.381 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 222' ' ' ALA . . . . . . . . . . . . . . . 86.31 179.65 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.533 0 C-N-CA 126.513 1.925 . . . . 43.140000000000001 110.03 -167.908 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 223' ' ' GLN . . . . . 0.725 ' HG3' ' HB2' ' A' ' 60' ' ' PHE . 18.2 mm-40 64.84 68.18 0.77 Allowed Pre-proline 0 N--CA 1.481 1.091 0 C-N-CA 124.794 1.238 . . . . 74.099999999999994 110.787 -171.954 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 224' ' ' PRO . . . . . . . . . . . . . 17.3 Cg_endo . . . . . 0 C--N 1.379 2.182 0 C-N-CA 123.023 2.482 . . . . 63.149999999999999 111.006 -177.65 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 26.3 mmt . . . . . 0 N--CA 1.475 0.813 0 CA-C-O 121.285 0.565 . . . . 74.129999999999995 110.112 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 9.4 p -99.67 9.83 7.51 Favored 'Isoleucine or valine' 0 CA--C 1.561 1.388 0 C-N-CA 124.123 0.969 . . . . 71.519999999999996 109.492 173.055 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 3' ' ' ASN . . . . . 0.529 HD22 ' HA ' ' A' ' 25' ' ' PHE . 20.8 m120 -57.93 120.77 45.17 Favored Pre-proline 0 C--N 1.362 1.114 0 C-N-CA 123.908 0.883 . . . . 73.150000000000006 111.723 -176.836 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 4' ' ' PRO . . . . . 0.497 ' HG2' ' HB2' ' A' ' 24' ' ' LEU . 42.5 Cg_endo -65.42 135.34 42.26 Favored 'Trans proline' 0 C--N 1.378 2.1 0 C-N-CA 122.525 2.15 . . . . 73.310000000000002 110.816 178.522 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 5' ' ' THR . . . . . 0.408 ' HB ' ' O ' ' A' ' 164' ' ' LEU . 55.9 m -122.3 123.26 41.01 Favored 'General case' 0 CA--C 1.54 0.568 0 N-CA-C 109.278 -0.638 . . . . 71.219999999999999 109.278 -172.882 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . 0.552 ' HA ' ' HB2' ' A' ' 163' ' ' GLN . 14.4 m -101.33 136.39 33.35 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.659 0 C-N-CA 123.965 0.906 . . . . 74.230000000000004 109.256 -175.915 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 7' ' ' PHE . . . . . 0.438 ' HB3' ' HA ' ' A' ' 163' ' ' GLN . 86.4 t80 -125.6 136.98 53.85 Favored 'General case' 0 C--O 1.238 0.47 0 C-N-CA 123.469 0.707 . . . . 73.099999999999994 109.683 -175.627 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 8' ' ' PHE . . . . . 0.427 ' HB3' HG23 ' A' ' 158' ' ' ILE . 53.3 m-85 -138.76 165.84 25.96 Favored 'General case' 0 CA--C 1.534 0.349 0 C-N-CA 124.809 1.243 . . . . 70.209999999999994 109.493 177.254 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 13.9 m-20 -111.67 118.23 35.07 Favored 'General case' 0 C--N 1.323 -0.565 0 N-CA-C 106.386 -1.709 . . . . 73.540000000000006 106.386 168.868 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 10' ' ' ILE . . . . . 0.459 HG21 ' SD ' ' A' ' 142' ' ' MET . 46.3 mm -84.98 129.53 37.58 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.56 0 N-CA-C 109.159 -0.682 . . . . 52.530000000000001 109.159 178.722 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 11' ' ' ALA . . . . . 0.792 ' HB2' ' HB2' ' A' ' 159' ' ' ALA . . . -124.59 126.98 46.69 Favored 'General case' 0 C--O 1.217 -0.642 0 C-N-CA 123.691 0.796 . . . . 65.0 110.496 -176.89 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . 0.497 HG23 ' HB2' ' A' ' 17' ' ' LEU . 89.1 t -96.14 116.38 37.85 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.759 0 N-CA-C 107.976 -1.12 . . . . 41.140000000000001 107.976 173.418 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 30.2 m-20 62.99 24.14 14.39 Favored 'General case' 0 N--CA 1.488 1.446 0 C-N-CA 125.59 1.556 . . . . 74.129999999999995 112.048 -177.288 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 97.24 -17.77 58.57 Favored Glycine 0 C--N 1.347 1.151 0 CA-C-O 119.951 -0.361 . . . . 75.120000000000005 113.037 -179.201 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 40.9 mm-40 -94.32 124.66 54.95 Favored Pre-proline 0 CA--C 1.545 0.755 0 CA-C-O 118.551 -0.738 . . . . 51.409999999999997 109.767 179.66 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 19.7 Cg_endo -56.06 118.07 4.81 Favored 'Trans proline' 0 C--N 1.381 2.274 0 C-N-CA 123.222 2.615 . . . . 74.209999999999994 113.111 -176.308 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . 0.497 ' HB2' HG23 ' A' ' 12' ' ' VAL . 49.3 tp -78.12 -38.55 43.63 Favored 'General case' 0 N--CA 1.476 0.871 0 C-N-CA 124.244 1.018 . . . . 73.409999999999997 109.407 171.371 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 177.39 -160.3 27.0 Favored Glycine 0 N--CA 1.449 -0.481 0 CA-C-N 114.317 -1.311 . . . . 63.109999999999999 110.707 -175.521 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 6.3 ptp180 -140.08 147.22 39.97 Favored 'General case' 0 N--CA 1.468 0.456 0 C-N-CA 123.934 0.893 . . . . 72.140000000000001 109.693 179.799 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 87.4 t -137.18 132.5 46.53 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.7 0 C-N-CA 124.092 0.957 . . . . 64.209999999999994 109.593 -175.24 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 7.9 t -120.1 122.62 41.45 Favored 'General case' 0 CA--C 1.547 0.855 0 N-CA-C 108.999 -0.741 . . . . 71.299999999999997 108.999 172.601 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 22' ' ' PHE . . . . . 0.549 ' HA ' ' HA ' ' A' ' 132' ' ' VAL . 11.1 m-85 -100.15 152.22 20.51 Favored 'General case' 0 N--CA 1.476 0.857 0 C-N-CA 124.027 0.931 . . . . 71.420000000000002 108.819 176.556 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . 0.649 ' HB2' ' HD2' ' A' ' 133' ' ' LYS . 39.7 tt0 -110.76 119.01 37.7 Favored 'General case' 0 CA--C 1.54 0.58 0 C-N-CA 123.318 0.647 . . . . 70.209999999999994 109.538 175.517 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . 0.497 ' HB2' ' HG2' ' A' ' 4' ' ' PRO . 18.5 mt -90.8 127.86 36.5 Favored 'General case' 0 N--CA 1.472 0.654 0 C-N-CA 124.462 1.105 . . . . 73.049999999999997 110.028 -178.301 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 25' ' ' PHE . . . . . 0.536 ' HB2' HD11 ' A' ' 90' ' ' LEU . 85.4 m-85 -88.92 71.9 8.52 Favored 'General case' 0 CA--C 1.536 0.427 0 C-N-CA 123.776 0.83 . . . . 64.349999999999994 110.34 -178.534 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -67.12 -15.59 63.81 Favored 'General case' 0 N--CA 1.481 1.122 0 CA-C-N 115.403 -0.817 . . . . 63.350000000000001 112.223 177.58 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 9.2 p-10 -76.3 -18.71 58.82 Favored 'General case' 0 CA--C 1.555 1.156 0 C-N-CA 123.409 0.683 . . . . 64.340000000000003 111.088 176.885 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 52.2 mttp -106.67 -45.65 4.17 Favored 'General case' 0 N--CA 1.483 1.201 0 C-N-CA 123.902 0.881 . . . . 75.340000000000003 110.37 -178.536 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 29' ' ' VAL . . . . . 0.586 HG21 ' HA ' ' A' ' 129' ' ' PHE . 4.6 m -134.68 69.98 71.8 Favored Pre-proline 0 CA--C 1.562 1.437 0 C-N-CA 124.36 1.064 . . . . 62.5 109.913 -175.748 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 18.8 Cg_endo -58.57 -29.54 89.26 Favored 'Trans proline' 0 C--N 1.382 2.324 0 C-N-CA 123.062 2.508 . . . . 64.510000000000005 113.985 -175.004 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 34.8 ttmt -72.63 -56.95 4.54 Favored 'General case' 0 N--CA 1.479 1.01 0 C-N-CA 123.668 0.787 . . . . 74.519999999999996 111.217 -179.648 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 6.6 m -69.31 -25.54 64.27 Favored 'General case' 0 CA--C 1.559 1.298 0 CA-C-N 115.081 -0.963 . . . . 52.5 111.074 -173.373 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -82.89 -42.4 17.77 Favored 'General case' 0 CA--C 1.548 0.898 0 C-N-CA 123.717 0.807 . . . . 63.420000000000002 111.085 177.254 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 38.8 tt0 -56.13 -39.44 72.25 Favored 'General case' 0 N--CA 1.493 1.675 0 C-N-CA 123.681 0.792 . . . . 52.420000000000002 110.57 177.192 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 35' ' ' ASN . . . . . 0.591 ' ND2' ' SD ' ' A' ' 100' ' ' MET . 41.4 t30 -50.95 -67.08 0.28 Allowed 'General case' 0 CA--C 1.538 0.488 0 O-C-N 125.149 1.531 . . . . 74.219999999999999 111.256 179.848 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 60.6 t80 -64.46 -36.02 82.82 Favored 'General case' 0 CA--C 1.543 0.707 0 O-C-N 124.016 0.822 . . . . 75.439999999999998 111.267 -173.62 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 62.2 ttt180 -60.63 -47.01 88.13 Favored 'General case' 0 N--CA 1.478 0.936 0 O-C-N 124.068 0.855 . . . . 75.430000000000007 111.042 178.906 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 38' ' ' ALA . . . . . 0.486 ' HB3' HG21 ' A' ' 78' ' ' ILE . . . -78.06 -19.92 53.35 Favored 'General case' 0 N--CA 1.475 0.811 0 CA-C-N 115.153 -0.93 . . . . 73.120000000000005 111.671 -177.416 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 39' ' ' LEU . . . . . 0.422 ' HG ' ' O ' ' A' ' 35' ' ' ASN . 94.0 mt -73.94 -37.56 64.51 Favored 'General case' 0 N--CA 1.481 1.104 0 C-N-CA 123.162 0.585 . . . . 74.319999999999993 109.89 170.93 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 50.4 m -67.74 -49.4 62.74 Favored 'General case' 0 N--CA 1.48 1.041 0 C-N-CA 123.765 0.826 . . . . 75.5 110.831 -178.585 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 41' ' ' THR . . . . . 0.461 ' OG1' ' HG2' ' A' ' 43' ' ' GLU . 7.6 p -76.3 -33.78 59.07 Favored 'General case' 0 N--CA 1.477 0.895 0 C-N-CA 123.527 0.731 . . . . 72.129999999999995 111.619 178.344 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 76.99 37.9 31.78 Favored Glycine 0 C--N 1.34 0.756 0 CA-C-N 116.257 -0.429 . . . . 74.340000000000003 112.411 -172.525 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 43' ' ' GLU . . . . . 0.461 ' HG2' ' OG1' ' A' ' 41' ' ' THR . 22.7 mm-40 -64.67 -20.9 66.57 Favored 'General case' 0 N--CA 1.486 1.339 0 C-N-CA 123.159 0.584 . . . . 74.329999999999998 111.599 174.231 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 44' ' ' LYS . . . . . 0.514 ' HG3' ' HB ' ' A' ' 78' ' ' ILE . 71.1 mmtt -106.63 15.13 26.13 Favored 'General case' 0 CA--C 1.55 0.974 0 C-N-CA 124.296 1.038 . . . . 74.109999999999999 110.478 179.568 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 68.57 38.15 85.98 Favored Glycine 0 C--N 1.352 1.456 0 CA-C-N 116.103 -0.499 . . . . 73.030000000000001 114.227 177.466 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 46' ' ' PHE . . . . . 0.474 ' HE2' ' HA ' ' A' ' 78' ' ' ILE . 23.0 m-85 -117.49 -48.55 2.59 Favored 'General case' 0 N--CA 1.489 1.476 0 CA-C-N 117.432 0.616 . . . . 63.340000000000003 110.654 -179.246 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 48.14 61.51 4.88 Favored Glycine 0 C--N 1.356 1.672 0 O-C-N 124.415 1.072 . . . . 65.319999999999993 114.51 167.823 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 48' ' ' TYR . . . . . 0.418 ' HE2' HD22 ' A' ' 39' ' ' LEU . 64.0 m-85 -65.47 92.94 0.14 Allowed 'General case' 0 N--CA 1.477 0.903 0 CA-C-O 121.693 0.759 . . . . 75.150000000000006 112.339 -174.417 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 49' ' ' LYS . . . . . 0.558 ' HZ3' ' HB2' ' A' ' 49' ' ' LYS . 0.0 OUTLIER -105.77 135.78 46.59 Favored 'General case' 0 C--O 1.236 0.37 0 CA-C-N 114.006 -1.452 . . . . 63.009999999999998 108.658 175.238 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 78.34 21.59 69.65 Favored Glycine 0 C--N 1.341 0.853 0 CA-C-O 119.838 -0.423 . . . . 55.32 113.417 177.445 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 16.2 m -57.37 115.34 2.65 Favored 'General case' 0 N--CA 1.474 0.733 0 C-N-CA 123.586 0.754 . . . . 53.240000000000002 110.358 179.051 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 52' ' ' CYS . . . . . . . . . . . . . 23.8 p -81.36 114.55 20.2 Favored 'General case' 0 CA--C 1.538 0.5 0 C-N-CA 124.513 1.125 . . . . 71.340000000000003 111.459 -172.992 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 53' ' ' PHE . . . . . 0.718 ' HA ' ' HA2' ' A' ' 64' ' ' GLY . 38.6 m-85 -66.07 93.23 0.19 Allowed 'General case' 0 CA--C 1.539 0.539 0 C-N-CA 123.896 0.878 . . . . 74.409999999999997 108.784 164.715 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 17.0 p-80 -108.5 -0.34 20.49 Favored 'General case' 0 N--CA 1.479 0.977 0 CA-C-N 115.383 -0.826 . . . . 73.140000000000001 111.536 -176.498 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 55' ' ' ARG . . . . . 0.464 ' O ' ' HB3' ' A' ' 63' ' ' GLN . 53.2 ttt-85 -138.16 99.66 3.93 Favored 'General case' 0 C--O 1.21 -0.986 0 N-CA-C 109.228 -0.656 . . . . 50.109999999999999 109.228 173.796 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 56' ' ' ILE . . . . . 0.442 HG21 ' HA ' ' A' ' 143' ' ' GLU . 51.1 mt -131.33 134.35 61.11 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.935 0 N-CA-C 109.6 -0.519 . . . . 53.43 109.6 175.911 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 57' ' ' ILE . . . . . 0.415 HG23 ' HA ' ' A' ' 148' ' ' ARG . 63.0 mt -128.82 113.38 18.96 Favored Pre-proline 0 CA--C 1.553 1.08 0 C-N-CA 124.694 1.197 . . . . 61.409999999999997 108.726 177.975 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 58' ' ' PRO . . . . . 0.556 ' HA ' ' HG2' ' A' ' 143' ' ' GLU . 41.4 Cg_endo -64.77 143.64 81.02 Favored 'Trans proline' 0 C--N 1.386 2.523 0 C-N-CA 123.415 2.743 . . . . 73.019999999999996 112.158 -177.322 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 72.36 27.47 69.73 Favored Glycine 0 C--N 1.344 1.013 0 CA-C-N 115.713 -0.676 . . . . 50.100000000000001 112.304 -176.888 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 20.5 t80 -153.59 -77.38 0.11 Allowed 'General case' 0 CA--C 1.543 0.685 0 C-N-CA 123.579 0.752 . . . . 75.030000000000001 109.644 -178.472 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 61' ' ' MET . . . . . 0.761 ' SD ' ' HB2' ' A' ' 113' ' ' PHE . 13.3 tmm? -167.86 137.75 2.67 Favored 'General case' 0 CA--C 1.548 0.88 0 C-N-CA 122.807 0.443 . . . . 72.120000000000005 111.585 -164.018 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 62' ' ' CYS . . . . . . . . . . . . . 4.3 p -106.94 113.56 27.12 Favored 'General case' 0 CA--C 1.552 1.057 0 C-N-CA 124.78 1.232 . . . . 63.409999999999997 109.923 172.343 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 63' ' ' GLN . . . . . 0.586 ' HB2' ' SD ' ' A' ' 61' ' ' MET . 49.2 tt0 -107.99 121.66 45.24 Favored 'General case' 0 N--CA 1.487 1.382 0 C-N-CA 124.155 0.982 . . . . 74.099999999999994 111.138 -174.65 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 64' ' ' GLY . . . . . 0.718 ' HA2' ' HA ' ' A' ' 53' ' ' PHE . . . -97.55 170.88 25.91 Favored Glycine 0 C--N 1.34 0.796 0 CA-C-N 114.721 -1.127 . . . . 73.310000000000002 112.0 172.755 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 176.7 179.43 47.11 Favored Glycine 0 C--O 1.224 -0.524 0 N-CA-C 111.77 -0.532 . . . . 74.219999999999999 111.77 178.704 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 6.9 t0 -102.73 151.75 22.03 Favored 'General case' 0 CA--C 1.546 0.803 0 C-N-CA 124.385 1.074 . . . . 72.5 110.434 -173.901 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 68.6 t80 -82.25 -30.28 30.81 Favored 'General case' 0 N--CA 1.478 0.929 0 C-N-CA 124.727 1.211 . . . . 72.340000000000003 110.46 -178.404 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 68' ' ' THR . . . . . 0.684 HG22 ' HG3' ' A' ' 69' ' ' ARG . 6.9 m -74.89 143.06 43.97 Favored 'General case' 0 CA--C 1.549 0.929 0 C-N-CA 123.661 0.784 . . . . 61.43 109.49 177.118 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 69' ' ' ARG . . . . . 0.684 ' HG3' HG22 ' A' ' 68' ' ' THR . 50.7 mtt180 60.68 26.09 15.85 Favored 'General case' 0 N--CA 1.491 1.611 0 C-N-CA 124.565 1.146 . . . . 73.150000000000006 111.798 175.627 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 20.3 t-80 -58.83 -40.59 84.63 Favored 'General case' 0 N--CA 1.474 0.742 0 C-N-CA 124.624 1.17 . . . . 54.310000000000002 113.241 -165.777 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 43.3 m-80 -67.35 103.81 1.36 Allowed 'General case' 0 N--CA 1.474 0.76 0 C-N-CA 122.785 0.434 . . . . 75.219999999999999 110.004 177.747 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 89.28 -7.93 80.97 Favored Glycine 0 CA--C 1.531 1.09 0 CA-C-N 115.643 -0.708 . . . . 31.109999999999999 114.602 173.869 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 18.3 m -144.48 -88.66 0.11 Allowed 'General case' 0 CA--C 1.556 1.211 0 CA-C-N 117.891 0.845 . . . . 74.5 110.297 -178.83 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 65.66 61.64 5.44 Favored Glycine 0 C--N 1.362 1.973 0 CA-C-O 119.593 -0.559 . . . . 65.140000000000001 113.718 176.999 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 121.22 51.96 0.24 Allowed Glycine 0 N--CA 1.479 1.508 0 CA-C-N 117.841 0.82 . . . . 43.329999999999998 111.736 -174.0 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 76' ' ' LYS . . . . . 0.432 ' HB2' ' O ' ' A' ' 80' ' ' GLY . 64.0 pttt -60.91 168.93 2.13 Favored 'General case' 0 CA--C 1.548 0.867 0 C-N-CA 123.799 0.84 . . . . 73.140000000000001 112.498 -175.518 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 80.9 p -91.23 176.16 6.68 Favored 'General case' 0 CA--C 1.542 0.639 0 CA-C-N 115.033 -0.985 . . . . 62.100000000000001 110.605 -177.671 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 78' ' ' ILE . . . . . 0.514 ' HB ' ' HG3' ' A' ' 44' ' ' LYS . 26.0 pt -74.5 -18.61 16.78 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.547 0 CA-C-N 115.939 -0.573 . . . . 75.450000000000003 110.026 172.145 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 55.0 m-85 -89.4 11.39 19.34 Favored 'General case' 0 CA--C 1.544 0.724 0 C-N-CA 124.764 1.225 . . . . 71.319999999999993 110.855 179.058 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 80' ' ' GLY . . . . . 0.432 ' O ' ' HB2' ' A' ' 76' ' ' LYS . . . 109.63 -133.8 11.84 Favored Glycine 0 C--N 1.351 1.396 0 N-CA-C 110.831 -0.908 . . . . 72.409999999999997 110.831 -179.82 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 35.9 tt0 -65.13 -41.11 95.13 Favored 'General case' 0 N--CA 1.478 0.934 0 C-N-CA 123.88 0.872 . . . . 65.030000000000001 111.114 -179.326 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 82' ' ' LYS . . . . . 0.727 ' HD2' ' HA ' ' A' ' 107' ' ' THR . 21.0 pttp -169.49 178.36 4.25 Favored 'General case' 0 CA--C 1.545 0.776 0 CA-C-N 115.065 -0.97 . . . . 75.25 109.836 -165.777 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 26.2 p90 -158.16 171.73 19.69 Favored 'General case' 0 N--CA 1.475 0.809 0 C-N-CA 123.479 0.712 . . . . 74.109999999999999 110.191 174.339 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 12.2 pt-20 -94.18 162.66 13.77 Favored 'General case' 0 N--CA 1.476 0.86 0 C-N-CA 123.204 0.602 . . . . 74.530000000000001 109.834 175.796 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 65.1 m-20 -68.45 148.23 50.92 Favored 'General case' 0 N--CA 1.475 0.815 0 C-N-CA 123.871 0.868 . . . . 74.540000000000006 112.562 -172.345 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 86' ' ' GLU . . . . . 0.561 ' HG2' ' HA ' ' A' ' 29' ' ' VAL . 5.2 tp10 -73.96 -62.99 1.31 Allowed 'General case' 0 CA--C 1.544 0.728 0 CA-C-N 115.447 -0.797 . . . . 74.109999999999999 110.097 179.083 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 25.5 p30 -175.05 150.54 1.21 Allowed 'General case' 0 N--CA 1.483 1.185 0 C-N-CA 124.338 1.055 . . . . 60.43 109.801 -177.518 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 91.5 m-85 -90.06 57.51 3.81 Favored 'General case' 0 N--CA 1.483 1.205 0 C-N-CA 123.783 0.833 . . . . 63.219999999999999 111.182 -171.248 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 72.8 mt -82.24 -53.8 11.06 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.76 0 CA-C-N 115.684 -0.689 . . . . 54.399999999999999 109.393 175.394 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 90' ' ' LEU . . . . . 0.536 HD11 ' HB2' ' A' ' 25' ' ' PHE . 87.0 mt -84.11 109.92 18.08 Favored 'General case' 0 CA--C 1.541 0.613 0 CA-C-N 115.197 -0.91 . . . . 72.409999999999997 110.84 -178.384 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 18.3 ptpt -102.27 171.29 7.56 Favored 'General case' 0 N--CA 1.473 0.685 0 C-N-CA 124.385 1.074 . . . . 64.540000000000006 109.884 175.566 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 92' ' ' HIS . . . . . . . . . . . . . 39.2 m80 -89.75 48.33 1.58 Allowed 'General case' 0 CA--C 1.551 1.009 0 C-N-CA 124.269 1.028 . . . . 75.439999999999998 110.266 -175.06 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 12.0 t -91.95 -16.3 26.79 Favored 'General case' 0 N--CA 1.481 1.102 0 C-N-CA 123.46 0.704 . . . . 71.230000000000004 111.108 -179.331 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -104.97 157.32 16.59 Favored Glycine 0 C--N 1.343 0.959 0 CA-C-O 119.603 -0.554 . . . . 64.319999999999993 112.245 178.51 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 71.9 Cg_endo -80.87 150.74 18.51 Favored 'Trans proline' 0 C--N 1.363 1.303 0 C-N-CA 122.505 2.137 . . . . 64.010000000000005 111.421 169.359 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 96' ' ' GLY . . . . . 0.431 ' HA3' HG12 ' A' ' 132' ' ' VAL . . . 84.22 22.89 53.49 Favored Glycine 0 C--N 1.344 0.992 0 N-CA-C 114.114 0.406 . . . . 63.340000000000003 114.114 176.993 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 97' ' ' ILE . . . . . . . . . . . . . 14.7 mm -63.0 115.71 2.37 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.897 0 C-N-CA 124.603 1.161 . . . . 75.219999999999999 112.093 -174.746 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 59.1 tp -97.8 114.22 26.2 Favored 'General case' 0 C--O 1.249 1.062 0 CA-C-O 121.77 0.795 . . . . 71.140000000000001 109.829 175.641 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 32.8 t -142.9 143.22 31.95 Favored 'General case' 0 CA--C 1.545 0.767 0 C-N-CA 124.771 1.229 . . . . 70.510000000000005 107.955 179.058 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 100' ' ' MET . . . . . 0.72 ' HA ' ' HA ' ' A' ' 112' ' ' PHE . 81.1 mtp -84.55 142.01 30.31 Favored 'General case' 0 N--CA 1.492 1.643 0 CA-C-N 118.496 0.589 . . . . 73.349999999999994 111.063 -176.329 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 101' ' ' ALA . . . . . 0.582 ' HB3' ' HB2' ' A' ' 111' ' ' GLN . . . -73.4 171.38 13.2 Favored 'General case' 0 N--CA 1.484 1.254 0 CA-C-O 121.102 0.477 . . . . 64.430000000000007 111.874 -171.504 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 102' ' ' ASN . . . . . 0.466 ' HB3' ' HA ' ' A' ' 108' ' ' ASN . 30.1 p-10 -168.39 167.25 12.01 Favored 'General case' 0 N--CA 1.472 0.67 0 CA-C-N 115.536 -0.757 . . . . 72.349999999999994 111.234 -173.499 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -105.89 6.21 31.3 Favored 'General case' 0 N--CA 1.477 0.908 0 C-N-CA 124.147 0.979 . . . . 62.32 110.544 169.182 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 152.91 -174.87 31.62 Favored Glycine 0 C--N 1.354 1.528 0 CA-C-O 119.244 -0.753 . . . . 50.329999999999998 112.167 179.665 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 44.0 Cg_exo -59.14 148.02 87.7 Favored 'Trans proline' 0 C--N 1.373 1.816 0 C-N-CA 123.041 2.494 . . . . 70.209999999999994 111.932 173.064 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 66.3 t30 68.01 9.55 7.23 Favored 'General case' 0 N--CA 1.483 1.212 0 C-N-CA 124.943 1.297 . . . . 64.519999999999996 111.128 -177.129 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 107' ' ' THR . . . . . 0.727 ' HA ' ' HD2' ' A' ' 82' ' ' LYS . 5.0 m -121.65 1.61 10.03 Favored 'General case' 0 CA--C 1.55 0.974 0 C-N-CA 123.857 0.863 . . . . 64.310000000000002 110.545 -178.907 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 108' ' ' ASN . . . . . 0.466 ' HA ' ' HB3' ' A' ' 102' ' ' ASN . 43.7 t30 -69.29 132.84 47.09 Favored 'General case' 0 N--CA 1.478 0.951 0 C-N-CA 123.72 0.808 . . . . 72.0 109.673 179.976 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 112.57 15.12 9.76 Favored Glycine 0 N--CA 1.472 1.076 0 N-CA-C 114.045 0.378 . . . . 43.439999999999998 114.045 -179.371 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 32.1 p -112.63 119.44 38.12 Favored 'General case' 0 CA--C 1.543 0.687 0 N-CA-C 107.626 -1.25 . . . . 73.329999999999998 107.626 167.78 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 111' ' ' GLN . . . . . 0.582 ' HB2' ' HB3' ' A' ' 101' ' ' ALA . 40.0 mt-30 66.18 178.18 0.21 Allowed 'General case' 0 N--CA 1.497 1.898 0 C-N-CA 124.458 1.103 . . . . 74.150000000000006 111.112 -169.741 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 112' ' ' PHE . . . . . 0.72 ' HA ' ' HA ' ' A' ' 100' ' ' MET . 45.1 p90 -145.54 154.2 41.92 Favored 'General case' 0 N--CA 1.48 1.057 0 C-N-CA 123.675 0.79 . . . . 72.019999999999996 108.951 177.959 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 113' ' ' PHE . . . . . 0.761 ' HB2' ' SD ' ' A' ' 61' ' ' MET . 51.4 p90 -144.65 154.61 42.97 Favored 'General case' 0 C--O 1.238 0.471 0 CA-C-O 120.823 0.344 . . . . 63.130000000000003 111.626 179.306 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 114' ' ' ILE . . . . . . . . . . . . . 5.7 mt -130.3 101.59 6.03 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.724 0 C-N-CA 124.077 0.951 . . . . 65.409999999999997 108.769 -174.236 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 115' ' ' CYS . . . . . . . . . . . . . 63.2 m -80.4 104.96 11.3 Favored 'General case' 0 N--CA 1.47 0.549 0 C-N-CA 123.507 0.723 . . . . 72.120000000000005 109.709 178.101 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 81.7 p -69.08 -27.62 65.78 Favored 'General case' 0 N--CA 1.488 1.434 0 CA-C-O 121.161 0.505 . . . . 64.239999999999995 111.257 -178.63 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -97.75 151.23 20.38 Favored 'General case' 0 C--O 1.24 0.591 0 CA-C-N 115.212 -0.903 . . . . 61.030000000000001 108.678 172.997 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 11.5 ptmm? -71.82 86.85 0.97 Allowed 'General case' 0 CA--C 1.552 1.029 0 CA-C-O 121.645 0.736 . . . . 72.439999999999998 109.396 174.325 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 119' ' ' THR . . . . . . . . . . . . . 40.6 p -76.21 86.7 3.04 Favored 'General case' 0 CA--C 1.543 0.678 0 CA-C-N 115.028 -0.987 . . . . 73.099999999999994 110.872 -172.607 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 12.4 pt-20 -65.24 -31.39 72.52 Favored 'General case' 0 CA--C 1.542 0.668 0 CA-C-N 114.545 -1.207 . . . . 74.540000000000006 111.866 -172.108 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 121' ' ' TRP . . . . . . . . . . . . . 42.6 p90 -70.83 -14.51 62.44 Favored 'General case' 0 N--CA 1.475 0.791 0 C-N-CA 123.543 0.737 . . . . 71.299999999999997 111.793 -178.794 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 42.7 mt -87.9 5.46 40.37 Favored 'General case' 0 N--CA 1.481 1.103 0 C-N-CA 122.828 0.451 . . . . 74.519999999999996 111.873 176.405 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 69.1 m-20 -80.39 140.33 36.09 Favored 'General case' 0 N--CA 1.482 1.144 0 C-N-CA 122.642 0.377 . . . . 61.009999999999998 110.451 172.275 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 94.35 -10.9 71.01 Favored Glycine 0 C--N 1.347 1.175 0 CA-C-N 115.602 -0.727 . . . . 71.109999999999999 112.183 -169.281 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 1.7 mppt? -94.6 -168.26 1.8 Allowed 'General case' 0 N--CA 1.472 0.662 0 C-N-CA 124.476 1.11 . . . . 71.010000000000005 109.535 173.722 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 126' ' ' HIS . . . . . . . . . . . . . 17.6 p80 -66.58 154.53 40.21 Favored 'General case' 0 CA--C 1.551 0.981 0 C-N-CA 124.179 0.991 . . . . 64.310000000000002 111.237 -172.146 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 17.6 m -78.81 147.54 6.76 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.813 0 CA-C-N 115.176 -0.92 . . . . 72.030000000000001 113.018 -163.262 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 128' ' ' VAL . . . . . 0.469 ' HB ' ' HB3' ' A' ' 90' ' ' LEU . 48.2 t -80.41 152.89 4.44 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.634 0 CA-C-N 114.159 -1.382 . . . . 52.329999999999998 108.537 172.576 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 129' ' ' PHE . . . . . 0.586 ' HA ' HG21 ' A' ' 29' ' ' VAL . 50.4 p90 -130.74 -15.81 3.42 Favored 'General case' 0 N--CA 1.482 1.173 0 N-CA-C 112.184 0.439 . . . . 73.409999999999997 112.184 179.187 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . -155.85 175.65 33.59 Favored Glycine 0 C--N 1.334 0.445 0 N-CA-C 112.109 -0.396 . . . . 53.130000000000003 112.109 -177.548 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 33.2 ttpt -156.23 140.51 16.6 Favored 'General case' 0 C--N 1.324 -0.519 0 N-CA-C 108.246 -1.02 . . . . 73.409999999999997 108.246 177.265 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 132' ' ' VAL . . . . . 0.549 ' HA ' ' HA ' ' A' ' 22' ' ' PHE . 6.7 p -61.1 134.23 26.57 Favored 'Isoleucine or valine' 0 CA--C 1.552 1.042 0 O-C-N 123.423 0.452 . . . . 73.040000000000006 111.279 177.336 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 133' ' ' LYS . . . . . 0.649 ' HD2' ' HB2' ' A' ' 23' ' ' GLU . 19.1 ptmt -111.52 -37.21 5.29 Favored 'General case' 0 N--CA 1.475 0.802 0 C-N-CA 123.472 0.709 . . . . 75.420000000000002 109.803 173.702 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 134' ' ' GLU . . . . . 0.546 ' HG2' ' HG3' ' A' ' 133' ' ' LYS . 40.9 mm-40 -119.91 133.94 55.4 Favored 'General case' 0 N--CA 1.48 1.06 0 C-N-CA 123.93 0.892 . . . . 53.109999999999999 109.728 -179.723 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 81.54 29.54 39.45 Favored Glycine 0 C--N 1.341 0.856 0 O-C-N 123.307 0.379 . . . . 61.340000000000003 113.421 176.965 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 136' ' ' MET . . . . . . . . . . . . . 15.8 tpt -59.43 -43.79 93.04 Favored 'General case' 0 N--CA 1.476 0.855 0 C-N-CA 123.487 0.715 . . . . 70.230000000000004 110.696 176.449 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 137' ' ' ASN . . . . . . . . . . . . . 17.0 m120 -63.55 -28.93 70.28 Favored 'General case' 0 N--CA 1.475 0.804 0 C-N-CA 123.607 0.763 . . . . 73.299999999999997 111.457 179.099 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 138' ' ' ILE . . . . . . . . . . . . . 43.4 mm -71.26 -39.03 72.28 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.119 0 C-N-CA 123.292 0.637 . . . . 62.119999999999997 110.255 176.316 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 50.8 t -64.12 -44.61 97.66 Favored 'Isoleucine or valine' 0 CA--C 1.552 1.054 0 C-N-CA 123.406 0.682 . . . . 74.430000000000007 110.189 177.982 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 43.5 mt-10 -67.99 -35.76 78.87 Favored 'General case' 0 N--CA 1.477 0.916 0 CA-C-N 115.149 -0.932 . . . . 74.450000000000003 110.908 178.956 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -68.4 -43.13 77.92 Favored 'General case' 0 N--CA 1.477 0.9 0 C-N-CA 123.479 0.712 . . . . 71.409999999999997 111.141 179.248 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 142' ' ' MET . . . . . 0.603 ' HB2' HD13 ' A' ' 156' ' ' ILE . 23.0 ptt? -73.68 -28.77 61.92 Favored 'General case' 0 N--CA 1.475 0.818 0 O-C-N 123.637 0.585 . . . . 75.409999999999997 110.793 -177.537 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 143' ' ' GLU . . . . . 0.556 ' HG2' ' HA ' ' A' ' 58' ' ' PRO . 33.0 tt0 -64.14 -28.93 70.1 Favored 'General case' 0 CA--C 1.553 1.083 0 CA-C-O 121.159 0.504 . . . . 62.240000000000002 111.555 -179.83 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 144' ' ' ARG . . . . . . . . . . . . . 48.1 mtm180 -70.67 -15.47 62.72 Favored 'General case' 0 N--CA 1.476 0.861 0 C-N-CA 123.191 0.596 . . . . 74.209999999999994 112.118 -179.957 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 145' ' ' PHE . . . . . 0.513 ' HB2' HD11 ' A' ' 156' ' ' ILE . 75.9 m-85 -82.87 -2.77 55.71 Favored 'General case' 0 N--CA 1.482 1.169 0 C-N-CA 122.592 0.357 . . . . 74.549999999999997 111.852 176.373 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . -95.42 -179.73 36.51 Favored Glycine 0 C--N 1.353 1.501 0 N-CA-C 112.331 -0.307 . . . . 45.130000000000003 112.331 176.193 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 16.5 m -132.58 169.44 16.6 Favored 'General case' 0 N--CA 1.487 1.376 0 C-N-CA 123.663 0.785 . . . . 74.519999999999996 110.842 -176.512 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 148' ' ' ARG . . . . . 0.415 ' HA ' HG23 ' A' ' 57' ' ' ILE . 10.6 mmt180 -65.65 -28.26 68.97 Favored 'General case' 0 N--CA 1.485 1.323 0 C-N-CA 123.926 0.891 . . . . 74.519999999999996 112.641 -174.255 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 149' ' ' ASN . . . . . . . . . . . . . 29.5 p-10 -81.88 -17.0 48.81 Favored 'General case' 0 N--CA 1.486 1.326 0 C-N-CA 123.444 0.698 . . . . 73.420000000000002 111.542 178.202 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 150' ' ' GLY . . . . . 0.441 ' O ' ' HA ' ' A' ' 55' ' ' ARG . . . 112.63 -17.01 23.55 Favored Glycine 0 C--N 1.348 1.205 0 CA-C-N 116.383 -0.371 . . . . 71.409999999999997 112.887 -178.831 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 62.7 tttp -67.21 133.98 50.8 Favored 'General case' 0 N--CA 1.473 0.695 0 CA-C-N 117.312 0.556 . . . . 70.310000000000002 110.603 -178.068 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 152' ' ' THR . . . . . . . . . . . . . 39.9 p -92.26 123.39 35.56 Favored 'General case' 0 CA--C 1.539 0.541 0 C-N-CA 123.301 0.64 . . . . 73.219999999999999 109.823 177.103 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 153' ' ' SER . . . . . . . . . . . . . 43.7 t -63.98 -36.22 83.28 Favored 'General case' 0 N--CA 1.475 0.813 0 C-N-CA 123.586 0.754 . . . . 74.109999999999999 110.176 174.148 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 45.4 mmtm -120.66 136.81 54.73 Favored 'General case' 0 N--CA 1.47 0.547 0 C-N-CA 124.205 1.002 . . . . 75.230000000000004 108.937 -179.046 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 33.4 mmtp -83.1 91.39 7.2 Favored 'General case' 0 N--CA 1.477 0.903 0 CA-C-O 121.513 0.673 . . . . 74.310000000000002 110.223 -174.568 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 156' ' ' ILE . . . . . 0.603 HD13 ' HB2' ' A' ' 142' ' ' MET . 68.2 mt -85.49 130.41 36.33 Favored 'Isoleucine or valine' 0 C--O 1.221 -0.397 0 CA-C-N 114.84 -1.073 . . . . 63.25 108.487 -178.349 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 157' ' ' THR . . . . . . . . . . . . . 35.9 p -138.68 156.4 47.44 Favored 'General case' 0 C--O 1.24 0.563 0 C-N-CA 124.444 1.098 . . . . 73.230000000000004 109.282 -175.536 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 158' ' ' ILE . . . . . 0.427 HG23 ' HB3' ' A' ' 8' ' ' PHE . 42.6 mt -74.43 95.26 0.86 Allowed 'Isoleucine or valine' 0 N--CA 1.475 0.822 0 N-CA-C 109.0 -0.741 . . . . 73.510000000000005 109.0 171.939 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 159' ' ' ALA . . . . . 0.792 ' HB2' ' HB2' ' A' ' 11' ' ' ALA . . . -51.7 -48.25 63.6 Favored 'General case' 0 N--CA 1.483 1.216 0 C-N-CA 124.585 1.154 . . . . 43.130000000000003 112.267 179.71 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 160' ' ' ASP . . . . . . . . . . . . . 35.6 t0 -154.23 162.11 41.39 Favored 'General case' 0 CA--C 1.54 0.567 0 CA-C-N 115.83 -0.623 . . . . 73.5 110.284 -175.639 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 161' ' ' CYS . . . . . . . . . . . . . 27.6 p -136.53 -173.79 3.52 Favored 'General case' 0 N--CA 1.476 0.86 0 C-N-CA 124.274 1.03 . . . . 73.219999999999999 108.538 175.763 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 162' ' ' GLY . . . . . . . . . . . . . . . 131.08 55.24 0.09 OUTLIER Glycine 0 C--N 1.346 1.131 0 N-CA-C 111.007 -0.837 . . . . 52.450000000000003 111.007 -166.999 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 163' ' ' GLN . . . . . 0.552 ' HB2' ' HA ' ' A' ' 6' ' ' VAL . 13.8 pt20 -47.25 142.92 3.58 Favored 'General case' 0 CA--C 1.554 1.117 0 C-N-CA 125.056 1.342 . . . . 64.019999999999996 114.13 -170.956 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 164' ' ' LEU . . . . . 0.408 ' O ' ' HB ' ' A' ' 5' ' ' THR . 95.9 mt -98.81 106.14 18.37 Favored 'General case' 0 N--CA 1.477 0.876 0 C-N-CA 123.729 0.811 . . . . 74.430000000000007 111.034 -172.237 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 165' ' ' GLU . . . . . . . . . . . . . 48.7 mt-10 . . . . . 0 C--O 1.252 1.203 0 N-CA-C 108.341 -0.985 . . . . 71.540000000000006 108.341 173.88 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' B' B ' 216' ' ' PRO . . . . . . . . . . . . . 6.2 Cg_exo . . . . . 0 CA--C 1.545 1.061 0 N-CA-C 109.989 -0.812 . . . . 71.519999999999996 109.989 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' B' B ' 217' ' ' GLU . . . . . . . . . . . . . 44.7 tt0 -167.33 110.12 0.62 Allowed Pre-proline 0 CA--C 1.549 0.929 0 C-N-CA 124.281 1.033 . . . . 75.140000000000001 108.695 -179.688 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 218' ' ' PRO . . . . . 0.428 ' HB2' ' NE2' ' A' ' 111' ' ' GLN . 3.9 Cg_exo -79.42 77.62 4.02 Favored 'Trans proline' 0 C--N 1.376 2.003 0 C-N-CA 122.7 2.267 . . . . 62.340000000000003 110.678 176.333 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 219' ' ' GLY . . . . . . . . . . . . . . . -178.88 164.87 33.51 Favored Glycine 0 CA--C 1.53 1.031 0 CA-C-N 114.765 -1.107 . . . . 70.409999999999997 111.435 -178.736 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 220' ' ' PRO . . . . . . . . . . . . . 62.0 Cg_endo -80.57 160.81 22.19 Favored 'Trans proline' 0 C--N 1.371 1.738 0 C-N-CA 123.09 2.527 . . . . 71.010000000000005 113.416 -178.043 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 221' ' ' TYR . . . . . . . . . . . . . 56.6 m-85 -68.0 135.39 52.25 Favored 'General case' 0 N--CA 1.486 1.348 0 C-N-CA 123.991 0.917 . . . . 73.430000000000007 111.106 -179.71 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 222' ' ' ALA . . . . . . . . . . . . . . . -88.2 -85.59 0.18 Allowed 'General case' 0 N--CA 1.468 0.436 0 C-N-CA 123.987 0.915 . . . . 25.140000000000001 112.921 -172.185 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 223' ' ' GLN . . . . . 0.471 ' HB2' ' HD3' ' B' ' 224' ' ' PRO . 72.6 mt-30 -142.0 -45.12 0.02 OUTLIER Pre-proline 0 CA--C 1.562 1.416 0 C-N-CA 125.029 1.332 . . . . 73.420000000000002 109.179 -167.733 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 224' ' ' PRO . . . . . 0.471 ' HD3' ' HB2' ' B' ' 223' ' ' GLN . 31.9 Cg_exo . . . . . 0 C--N 1.403 3.432 0 C-N-CA 122.26 1.973 . . . . 63.109999999999999 111.739 165.044 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . 0.448 ' SD ' ' NZ ' ' A' ' 133' ' ' LYS . 61.0 mtt . . . . . 0 N--CA 1.481 1.109 0 N-CA-C 109.828 -0.434 . . . . 71.109999999999999 109.828 . . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 11.9 p -78.46 -13.43 13.75 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.093 0 C-N-CA 123.994 0.918 . . . . 73.420000000000002 110.499 175.298 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 3' ' ' ASN . . . . . 0.587 ' ND2' ' HA ' ' A' ' 25' ' ' PHE . 31.0 m120 -75.99 130.13 79.06 Favored Pre-proline 0 CA--C 1.545 0.786 0 C-N-CA 123.64 0.776 . . . . 75.25 111.088 -178.507 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 4' ' ' PRO . . . . . 0.498 ' HG2' ' HB2' ' A' ' 24' ' ' LEU . 33.2 Cg_endo -63.63 119.53 6.62 Favored 'Trans proline' 0 C--N 1.38 2.219 0 C-N-CA 122.63 2.22 . . . . 61.219999999999999 112.043 176.368 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 5' ' ' THR . . . . . 0.601 HG23 ' HD3' ' A' ' 133' ' ' LYS . 61.1 m -97.42 110.71 23.22 Favored 'General case' 0 CA--C 1.539 0.556 0 C-N-CA 123.748 0.819 . . . . 65.239999999999995 108.807 178.703 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 10.0 m -97.83 123.31 50.21 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.155 0 N-CA-C 109.252 -0.647 . . . . 64.310000000000002 109.252 -175.588 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 7' ' ' PHE . . . . . 0.45 ' H ' ' HA ' ' A' ' 163' ' ' GLN . 82.3 t80 -103.82 142.39 34.46 Favored 'General case' 0 C--O 1.236 0.368 0 CA-C-N 115.706 -0.679 . . . . 63.119999999999997 109.946 -171.44 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 8' ' ' PHE . . . . . 0.429 ' HB3' HG23 ' A' ' 158' ' ' ILE . 72.5 m-85 -140.85 164.46 30.17 Favored 'General case' 0 C--O 1.239 0.508 0 C-N-CA 124.235 1.014 . . . . 75.409999999999997 109.494 174.535 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 24.5 m-20 -118.52 113.21 20.96 Favored 'General case' 0 N--CA 1.469 0.488 0 N-CA-C 107.134 -1.432 . . . . 54.140000000000001 107.134 168.551 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 37.8 mm -91.19 143.87 10.34 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.678 0 C-N-CA 123.137 0.575 . . . . 65.299999999999997 109.639 -175.965 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 11' ' ' ALA . . . . . 0.407 ' HB2' ' HB2' ' A' ' 159' ' ' ALA . . . -132.73 143.57 49.69 Favored 'General case' 0 CA--C 1.537 0.461 0 C-N-CA 123.831 0.852 . . . . 74.439999999999998 111.634 -167.624 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . 0.54 HG23 ' HB2' ' A' ' 17' ' ' LEU . 24.3 t -98.51 107.17 19.9 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.642 0 N-CA-C 108.256 -1.016 . . . . 73.230000000000004 108.256 172.439 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 27.5 m-20 62.03 32.01 17.77 Favored 'General case' 0 N--CA 1.488 1.461 0 C-N-CA 124.508 1.123 . . . . 74.310000000000002 111.78 179.338 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 99.27 -26.71 23.25 Favored Glycine 0 C--N 1.346 1.127 0 CA-C-N 115.424 -0.807 . . . . 63.229999999999997 112.87 -178.653 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 17.7 mm-40 -82.29 114.09 48.72 Favored Pre-proline 0 CA--C 1.547 0.853 0 CA-C-O 118.657 -0.687 . . . . 72.329999999999998 110.249 -174.349 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 21.7 Cg_endo -57.8 112.03 1.02 Allowed 'Trans proline' 0 C--N 1.382 2.304 0 C-N-CA 123.468 2.779 . . . . 72.219999999999999 112.52 -173.748 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . 0.54 ' HB2' HG23 ' A' ' 12' ' ' VAL . 61.6 tp -80.17 -46.49 16.28 Favored 'General case' 0 N--CA 1.472 0.642 0 C-N-CA 123.652 0.781 . . . . 62.049999999999997 110.551 -179.819 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -175.26 -163.88 28.96 Favored Glycine 0 C--N 1.34 0.761 0 CA-C-N 115.543 -0.753 . . . . 65.400000000000006 112.147 -177.768 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 8.9 ptp180 -107.13 150.59 26.42 Favored 'General case' 0 N--CA 1.479 1.004 0 C-N-CA 123.354 0.662 . . . . 71.129999999999995 109.927 -178.677 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 54.9 t -143.67 123.46 8.66 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.844 0 N-CA-C 108.275 -1.009 . . . . 74.430000000000007 108.275 169.04 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 11.1 t -126.9 138.41 53.3 Favored 'General case' 0 CA--C 1.546 0.821 0 C-N-CA 123.57 0.748 . . . . 41.25 109.618 178.128 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 22' ' ' PHE . . . . . 0.426 ' CG ' HD22 ' A' ' 98' ' ' LEU . 72.8 m-85 -109.69 150.18 28.65 Favored 'General case' 0 N--CA 1.476 0.826 0 C-N-CA 123.7 0.8 . . . . 63.520000000000003 111.012 -175.078 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . 0.544 ' HB2' ' HD2' ' A' ' 133' ' ' LYS . 5.2 tp10 -98.06 102.65 14.46 Favored 'General case' 0 N--CA 1.473 0.692 0 C-N-CA 124.462 1.105 . . . . 62.25 108.396 173.383 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . 0.512 ' HB3' ' HB1' ' A' ' 33' ' ' ALA . 26.5 mt -87.68 117.56 26.59 Favored 'General case' 0 N--CA 1.476 0.837 0 N-CA-C 109.598 -0.519 . . . . 64.409999999999997 109.598 179.972 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 25' ' ' PHE . . . . . 0.587 ' HA ' ' ND2' ' A' ' 3' ' ' ASN . 77.1 m-85 -86.45 65.35 9.01 Favored 'General case' 0 CA--C 1.539 0.533 0 CA-C-O 121.371 0.605 . . . . 74.450000000000003 110.701 -175.383 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -72.81 -4.99 35.02 Favored 'General case' 0 N--CA 1.481 1.11 0 C-N-CA 123.946 0.898 . . . . 75.0 112.961 -175.502 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 12.4 p-10 -78.58 -29.92 46.42 Favored 'General case' 0 N--CA 1.478 0.952 0 C-N-CA 123.049 0.54 . . . . 73.329999999999998 110.061 172.926 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 93.3 mttt -96.42 -42.26 8.2 Favored 'General case' 0 N--CA 1.474 0.752 0 C-N-CA 124.099 0.959 . . . . 53.420000000000002 110.34 -179.015 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 29' ' ' VAL . . . . . 0.549 HG21 ' HA ' ' A' ' 129' ' ' PHE . 4.1 m -126.85 76.19 75.45 Favored Pre-proline 0 CA--C 1.558 1.271 0 C-N-CA 123.887 0.875 . . . . 75.510000000000005 110.663 178.302 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 81.7 Cg_exo -49.09 -52.57 8.49 Favored 'Trans proline' 0 C--N 1.381 2.244 0 C-N-CA 123.388 2.725 . . . . 51.420000000000002 113.967 176.103 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 85.0 tttt -67.62 -54.48 19.4 Favored 'General case' 0 N--CA 1.478 0.929 0 C-N-CA 123.588 0.755 . . . . 74.420000000000002 111.66 -174.194 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 7.0 m -69.08 -33.12 73.04 Favored 'General case' 0 CA--C 1.551 0.983 0 C-N-CA 123.022 0.529 . . . . 41.109999999999999 111.642 -170.499 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 33' ' ' ALA . . . . . 0.512 ' HB1' ' HB3' ' A' ' 24' ' ' LEU . . . -79.58 -40.24 29.86 Favored 'General case' 0 CA--C 1.547 0.836 0 C-N-CA 122.619 0.367 . . . . 64.530000000000001 111.19 178.303 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 39.0 tt0 -59.86 -35.46 74.84 Favored 'General case' 0 N--CA 1.486 1.369 0 C-N-CA 123.324 0.65 . . . . 75.129999999999995 111.052 178.128 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 35' ' ' ASN . . . . . 0.516 ' ND2' ' SD ' ' A' ' 100' ' ' MET . 43.9 t30 -53.16 -65.87 0.49 Allowed 'General case' 0 C--N 1.35 0.618 0 O-C-N 124.552 1.157 . . . . 73.329999999999998 110.989 179.74 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 85.8 t80 -62.37 -34.03 75.89 Favored 'General case' 0 CA--C 1.542 0.649 0 O-C-N 124.332 1.02 . . . . 65.129999999999995 111.106 -177.008 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 37' ' ' ARG . . . . . 0.423 ' HG3' ' OE1' ' A' ' 163' ' ' GLN . 48.9 ttp180 -59.94 -45.88 91.19 Favored 'General case' 0 N--CA 1.473 0.676 0 O-C-N 123.926 0.766 . . . . 73.310000000000002 111.374 175.277 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 38' ' ' ALA . . . . . 0.411 ' HB1' ' HG2' ' A' ' 44' ' ' LYS . . . -81.77 -18.84 42.75 Favored 'General case' 0 CA--C 1.537 0.477 0 CA-C-N 115.668 -0.696 . . . . 74.420000000000002 111.425 -174.374 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 39' ' ' LEU . . . . . 0.481 HD22 ' HE1' ' A' ' 48' ' ' TYR . 98.5 mt -74.26 -39.88 62.72 Favored 'General case' 0 CA--C 1.547 0.844 0 C-N-CA 123.312 0.645 . . . . 65.25 109.31 170.469 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 35.1 t -64.92 -55.03 21.71 Favored 'General case' 0 N--CA 1.477 0.877 0 C-N-CA 124.596 1.159 . . . . 54.5 111.155 -179.938 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 34.8 p -76.58 -31.37 57.46 Favored 'General case' 0 CA--C 1.541 0.607 0 CA-C-N 115.382 -0.826 . . . . 51.130000000000003 111.224 -178.289 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 79.23 22.1 66.05 Favored Glycine 0 C--N 1.346 1.139 0 CA-C-O 119.614 -0.548 . . . . 64.239999999999995 113.951 176.679 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 8.7 mm-40 -63.64 -22.41 66.88 Favored 'General case' 0 N--CA 1.483 1.221 0 C-N-CA 123.368 0.667 . . . . 72.010000000000005 111.728 179.857 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 44' ' ' LYS . . . . . 0.411 ' HG2' ' HB1' ' A' ' 38' ' ' ALA . 30.6 mmmt -94.6 15.33 18.32 Favored 'General case' 0 CA--C 1.55 0.947 0 C-N-CA 124.035 0.934 . . . . 74.340000000000003 111.558 -179.962 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 76.98 36.71 35.1 Favored Glycine 0 C--N 1.35 1.335 0 N-CA-C 114.417 0.527 . . . . 75.450000000000003 114.417 174.843 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 46' ' ' PHE . . . . . 0.435 ' HE2' ' HA ' ' A' ' 78' ' ' ILE . 25.2 m-85 -122.6 -48.35 2.05 Favored 'General case' 0 N--CA 1.491 1.575 0 CA-C-N 117.758 0.779 . . . . 75.019999999999996 111.514 -177.457 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 54.18 63.83 4.82 Favored Glycine 0 C--N 1.35 1.312 0 O-C-N 124.077 0.86 . . . . 54.509999999999998 115.018 170.218 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 48' ' ' TYR . . . . . 0.688 ' HE2' ' HB2' ' A' ' 66' ' ' ASP . 54.6 m-85 -65.27 89.79 0.09 Allowed 'General case' 0 N--CA 1.481 1.118 0 CA-C-O 121.745 0.783 . . . . 75.340000000000003 111.731 179.885 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 27.6 tptp -111.23 107.0 16.16 Favored 'General case' 0 CA--C 1.535 0.377 0 CA-C-N 114.576 -1.193 . . . . 62.140000000000001 108.476 178.247 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 99.08 13.8 38.33 Favored Glycine 0 N--CA 1.471 0.999 0 CA-C-O 118.992 -0.893 . . . . 54.409999999999997 113.763 178.754 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 20.3 p -57.67 122.89 13.86 Favored 'General case' 0 N--CA 1.48 1.035 0 C-N-CA 123.414 0.686 . . . . 60.210000000000001 110.818 -178.482 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 52' ' ' CYS . . . . . . . . . . . . . 7.0 p -100.98 132.37 46.42 Favored 'General case' 0 CA--C 1.539 0.533 0 C-N-CA 123.721 0.808 . . . . 55.130000000000003 112.729 -164.058 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 53' ' ' PHE . . . . . 0.604 ' HA ' ' HA3' ' A' ' 64' ' ' GLY . 45.5 m-85 -72.04 140.22 48.9 Favored 'General case' 0 CA--C 1.54 0.559 0 C-N-CA 124.381 1.072 . . . . 73.239999999999995 110.151 168.899 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 15.8 p-80 -153.4 13.55 0.49 Allowed 'General case' 0 N--CA 1.478 0.959 0 CA-C-N 116.087 -0.506 . . . . 62.149999999999999 112.213 -173.82 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 55' ' ' ARG . . . . . 0.451 ' HA ' ' O ' ' A' ' 150' ' ' GLY . 33.4 ttt180 -155.8 98.29 1.9 Allowed 'General case' 0 N--CA 1.474 0.728 0 N-CA-C 109.732 -0.47 . . . . 74.140000000000001 109.732 174.342 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 29.3 mt -130.23 135.88 59.86 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.105 0 C-N-CA 123.053 0.541 . . . . 75.099999999999994 109.799 -178.449 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 61.7 mt -134.58 124.55 17.03 Favored Pre-proline 0 CA--C 1.553 1.072 0 C-N-CA 124.976 1.31 . . . . 74.420000000000002 109.497 -173.454 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 31.0 Cg_endo -61.31 139.74 84.59 Favored 'Trans proline' 0 C--N 1.384 2.411 0 C-N-CA 123.609 2.873 . . . . 73.439999999999998 113.573 -179.452 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 60.22 24.55 61.24 Favored Glycine 0 C--N 1.353 1.504 0 CA-C-N 115.006 -0.997 . . . . 41.109999999999999 113.872 -179.813 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 40.5 t80 -139.76 -69.55 0.41 Allowed 'General case' 0 C--O 1.241 0.651 0 CA-C-N 116.973 0.386 . . . . 72.530000000000001 110.495 -174.583 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 53.3 ttp -171.44 148.34 2.53 Favored 'General case' 0 N--CA 1.482 1.151 0 N-CA-C 111.905 0.335 . . . . 65.450000000000003 111.905 -165.464 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 62' ' ' CYS . . . . . 0.611 ' SG ' ' HB ' ' A' ' 114' ' ' ILE . 21.9 p -119.81 117.58 28.57 Favored 'General case' 0 N--CA 1.477 0.89 0 C-N-CA 123.894 0.878 . . . . 65.230000000000004 108.974 169.591 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 63' ' ' GLN . . . . . 0.442 ' OE1' ' HD3' ' A' ' 55' ' ' ARG . 35.9 tt0 -123.24 143.92 49.73 Favored 'General case' 0 N--CA 1.487 1.42 0 C-N-CA 124.166 0.986 . . . . 73.030000000000001 111.781 -170.439 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 64' ' ' GLY . . . . . 0.604 ' HA3' ' HA ' ' A' ' 53' ' ' PHE . . . -161.78 -169.58 25.3 Favored Glycine 0 C--N 1.348 1.203 0 CA-C-N 115.039 -0.982 . . . . 52.329999999999998 113.011 176.403 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 166.4 -149.84 16.25 Favored Glycine 0 C--N 1.341 0.825 0 N-CA-C 112.242 -0.343 . . . . 44.210000000000001 112.242 -179.056 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 66' ' ' ASP . . . . . 0.688 ' HB2' ' HE2' ' A' ' 48' ' ' TYR . 41.2 t0 -74.94 146.4 41.8 Favored 'General case' 0 N--CA 1.477 0.919 0 C-N-CA 124.318 1.047 . . . . 64.219999999999999 110.601 -178.825 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 51.7 t80 -79.88 -33.69 39.8 Favored 'General case' 0 CA--C 1.542 0.673 0 C-N-CA 123.663 0.785 . . . . 61.210000000000001 109.46 178.043 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 68' ' ' THR . . . . . 0.637 HG22 ' HG3' ' A' ' 69' ' ' ARG . 14.1 m -72.56 150.59 43.01 Favored 'General case' 0 CA--C 1.544 0.748 0 CA-C-N 114.961 -1.018 . . . . 63.32 109.206 173.019 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 69' ' ' ARG . . . . . 0.637 ' HG3' HG22 ' A' ' 68' ' ' THR . 65.9 mtt85 66.71 13.68 9.46 Favored 'General case' 0 N--CA 1.488 1.438 0 C-N-CA 124.033 0.933 . . . . 73.319999999999993 112.296 174.921 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 15.9 t-80 -52.59 -29.1 24.06 Favored 'General case' 0 N--CA 1.484 1.253 0 C-N-CA 125.012 1.325 . . . . 74.439999999999998 112.007 -173.724 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 5.3 m-20 -69.28 88.2 0.44 Allowed 'General case' 0 CA--C 1.548 0.887 0 C-N-CA 123.987 0.915 . . . . 62.350000000000001 110.377 172.391 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 85.46 -1.2 88.47 Favored Glycine 0 CA--C 1.533 1.16 0 N-CA-C 115.195 0.838 . . . . 13.140000000000001 115.195 172.774 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 28.5 m -139.74 -90.74 0.18 Allowed 'General case' 0 N--CA 1.478 0.943 0 CA-C-N 118.06 0.93 . . . . 53.399999999999999 110.019 176.02 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 74' ' ' GLY . . . . . 0.464 ' HA2' ' O ' ' A' ' 68' ' ' THR . . . 61.32 60.65 7.93 Favored Glycine 0 C--N 1.356 1.668 0 O-C-N 123.577 0.548 . . . . 24.239999999999998 113.277 -176.905 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 141.36 52.19 0.04 OUTLIER Glycine 0 C--N 1.353 1.518 0 C-N-CA 121.101 -0.571 . . . . 73.219999999999999 113.055 -176.502 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 63.6 pttt -56.8 158.9 4.34 Favored 'General case' 0 N--CA 1.487 1.377 0 C-N-CA 123.406 0.682 . . . . 72.099999999999994 111.896 -179.881 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 71.8 p -98.29 -179.21 4.29 Favored 'General case' 0 CA--C 1.544 0.729 0 C-N-CA 123.338 0.655 . . . . 74.519999999999996 110.92 -176.214 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 78' ' ' ILE . . . . . 0.435 ' HA ' ' HE2' ' A' ' 46' ' ' PHE . 25.4 pt -84.96 -8.18 11.12 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.802 0 C-N-CA 122.936 0.494 . . . . 72.239999999999995 110.569 173.483 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 53.3 m-85 -103.87 12.42 34.44 Favored 'General case' 0 N--CA 1.472 0.669 0 C-N-CA 124.338 1.055 . . . . 64.430000000000007 110.361 -179.992 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 126.42 -134.62 8.62 Favored Glycine 0 C--N 1.348 1.211 0 N-CA-C 110.623 -0.991 . . . . 62.350000000000001 110.623 -179.113 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 36.7 tt0 -81.81 -45.66 15.26 Favored 'General case' 0 N--CA 1.47 0.53 0 N-CA-C 109.042 -0.725 . . . . 72.340000000000003 109.042 173.701 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 82' ' ' LYS . . . . . 0.799 ' HD2' ' HA ' ' A' ' 107' ' ' THR . 22.6 pttm -156.07 165.32 36.78 Favored 'General case' 0 CA--C 1.54 0.561 0 CA-C-N 114.217 -1.356 . . . . 74.400000000000006 110.096 -171.284 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 45.7 p90 -145.76 172.77 12.82 Favored 'General case' 0 N--CA 1.474 0.742 0 C-N-CA 124.177 0.991 . . . . 75.340000000000003 109.821 -178.663 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 12.2 pt-20 -91.9 159.73 15.62 Favored 'General case' 0 N--CA 1.472 0.666 0 C-N-CA 122.668 0.387 . . . . 62.450000000000003 110.614 178.722 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 62.5 m-20 -63.25 124.78 22.11 Favored 'General case' 0 N--CA 1.472 0.668 0 C-N-CA 123.621 0.768 . . . . 71.519999999999996 110.669 -179.767 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 62.1 tt0 -62.72 -48.28 79.91 Favored 'General case' 0 CA--C 1.54 0.566 0 CA-C-N 115.025 -0.989 . . . . 74.409999999999997 111.338 -178.95 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 31.9 p30 -161.65 -162.21 0.85 Allowed 'General case' 0 N--CA 1.474 0.759 0 C-N-CA 124.059 0.944 . . . . 75.239999999999995 108.517 -179.068 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 87.1 m-85 -142.16 46.14 1.64 Allowed 'General case' 0 N--CA 1.492 1.654 0 C-N-CA 123.043 0.537 . . . . 71.400000000000006 110.357 175.494 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 78.3 mt -69.59 -56.67 10.77 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.008 0 CA-C-N 115.764 -0.653 . . . . 42.140000000000001 109.882 176.111 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 90' ' ' LEU . . . . . 0.57 HD11 ' HB2' ' A' ' 25' ' ' PHE . 72.0 mt -87.42 126.69 35.03 Favored 'General case' 0 C--O 1.237 0.434 0 CA-C-N 115.045 -0.979 . . . . 54.119999999999997 109.751 -176.899 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 9.6 mtpm? -119.72 165.58 14.33 Favored 'General case' 0 CA--C 1.542 0.638 0 C-N-CA 124.194 0.998 . . . . 64.129999999999995 110.768 -175.291 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 92' ' ' HIS . . . . . . . . . . . . . 52.1 m-70 -83.73 51.31 1.99 Allowed 'General case' 0 N--CA 1.485 1.297 0 C-N-CA 124.478 1.111 . . . . 74.030000000000001 110.463 -177.326 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 11.6 t -95.94 13.39 27.06 Favored 'General case' 0 N--CA 1.48 1.036 0 C-N-CA 123.706 0.802 . . . . 73.349999999999994 112.242 -170.557 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -161.34 173.18 37.72 Favored Glycine 0 C--N 1.342 0.893 0 CA-C-O 120.027 -0.318 . . . . 64.430000000000007 112.524 179.618 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 98.6 Cg_endo -78.87 157.64 27.46 Favored 'Trans proline' 0 C--N 1.363 1.31 0 C-N-CA 122.68 2.253 . . . . 70.099999999999994 111.737 170.651 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 81.42 10.52 84.45 Favored Glycine 0 CA--C 1.533 1.171 0 CA-C-N 116.143 -0.481 . . . . 72.140000000000001 114.284 179.746 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 97' ' ' ILE . . . . . 0.579 ' HB ' ' HB2' ' A' ' 115' ' ' CYS . 9.8 mm -66.85 111.03 1.69 Allowed 'Isoleucine or valine' 0 CA--C 1.553 1.065 0 C-N-CA 124.36 1.064 . . . . 73.200000000000003 111.775 -176.56 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 98' ' ' LEU . . . . . 0.426 HD22 ' CG ' ' A' ' 22' ' ' PHE . 36.6 tp -92.09 113.98 26.39 Favored 'General case' 0 C--O 1.246 0.897 0 CA-C-O 121.257 0.551 . . . . 70.140000000000001 110.596 178.577 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 36.2 t -137.25 144.2 42.63 Favored 'General case' 0 CA--C 1.545 0.76 0 C-N-CA 124.395 1.078 . . . . 63.130000000000003 108.263 175.167 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 100' ' ' MET . . . . . 0.656 ' HA ' ' HA ' ' A' ' 112' ' ' PHE . 74.1 mtp -78.7 147.03 33.63 Favored 'General case' 0 N--CA 1.483 1.217 0 N-CA-C 109.168 -0.678 . . . . 53.210000000000001 109.168 175.316 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 101' ' ' ALA . . . . . 0.548 ' HB3' ' HB2' ' A' ' 111' ' ' GLN . . . -79.53 164.64 23.72 Favored 'General case' 0 N--CA 1.479 0.985 0 CA-C-O 121.399 0.619 . . . . 54.450000000000003 112.59 -169.875 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 24.2 p-10 -153.98 167.58 29.28 Favored 'General case' 0 N--CA 1.471 0.612 0 CA-C-N 114.82 -1.082 . . . . 71.349999999999994 110.071 -178.591 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -113.63 -7.12 13.35 Favored 'General case' 0 CA--C 1.544 0.747 0 C-N-CA 123.765 0.826 . . . . 72.409999999999997 110.02 167.56 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 171.5 -164.76 37.64 Favored Glycine 0 C--N 1.351 1.374 0 CA-C-O 119.399 -0.667 . . . . 44.329999999999998 111.555 -178.572 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 14.1 Cg_exo -70.69 143.06 45.35 Favored 'Trans proline' 0 C--N 1.37 1.658 0 C-N-CA 123.322 2.682 . . . . 73.200000000000003 111.856 177.952 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 64.4 t30 64.57 16.31 10.21 Favored 'General case' 0 N--CA 1.485 1.29 0 C-N-CA 125.131 1.372 . . . . 73.349999999999994 110.997 -177.174 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 107' ' ' THR . . . . . 0.799 ' HA ' ' HD2' ' A' ' 82' ' ' LYS . 4.6 m -117.26 5.48 12.66 Favored 'General case' 0 CA--C 1.547 0.828 0 C-N-CA 124.162 0.985 . . . . 70.230000000000004 110.042 -178.828 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 53.1 t30 -84.09 133.53 34.63 Favored 'General case' 0 N--CA 1.474 0.753 0 C-N-CA 123.867 0.867 . . . . 71.519999999999996 109.937 -176.842 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 113.12 10.39 15.84 Favored Glycine 0 N--CA 1.472 1.074 0 CA-C-O 120.203 -0.22 . . . . 72.230000000000004 113.181 -176.191 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 46.4 p -104.11 120.91 42.11 Favored 'General case' 0 CA--C 1.542 0.652 0 N-CA-C 107.48 -1.304 . . . . 72.299999999999997 107.48 166.383 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 111' ' ' GLN . . . . . 0.548 ' HB2' ' HB3' ' A' ' 101' ' ' ALA . 46.5 mt-30 66.9 178.01 0.23 Allowed 'General case' 0 N--CA 1.498 1.943 0 C-N-CA 124.567 1.147 . . . . 64.319999999999993 111.533 -172.929 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 112' ' ' PHE . . . . . 0.656 ' HA ' ' HA ' ' A' ' 100' ' ' MET . 45.2 p90 -143.74 161.45 38.56 Favored 'General case' 0 N--CA 1.473 0.708 0 C-N-CA 124.409 1.084 . . . . 64.040000000000006 108.874 173.273 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 113' ' ' PHE . . . . . 0.462 ' HE1' ' SG ' ' A' ' 115' ' ' CYS . 48.0 p90 -153.91 161.71 41.79 Favored 'General case' 0 N--CA 1.464 0.266 0 CA-C-O 121.354 0.597 . . . . 75.420000000000002 111.673 176.423 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 114' ' ' ILE . . . . . 0.611 ' HB ' ' SG ' ' A' ' 62' ' ' CYS . 15.6 mt -119.24 100.7 10.25 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.744 0 CA-C-N 114.31 -1.314 . . . . 64.409999999999997 107.577 175.184 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 115' ' ' CYS . . . . . 0.579 ' HB2' ' HB ' ' A' ' 97' ' ' ILE . 87.0 m -62.23 104.4 0.48 Allowed 'General case' 0 N--CA 1.474 0.769 0 N-CA-C 109.245 -0.65 . . . . 51.329999999999998 109.245 171.612 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 28.0 p -82.05 -0.19 43.33 Favored 'General case' 0 CA--C 1.547 0.853 0 C-N-CA 124.316 1.047 . . . . 73.109999999999999 111.609 -177.059 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -129.8 160.94 31.91 Favored 'General case' 0 C--O 1.245 0.834 0 C-N-CA 123.93 0.892 . . . . 41.340000000000003 109.608 169.471 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 10.3 ptmt -70.66 79.76 0.6 Allowed 'General case' 0 CA--C 1.546 0.82 0 CA-C-O 121.613 0.72 . . . . 50.229999999999997 109.418 171.123 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 119' ' ' THR . . . . . . . . . . . . . 36.6 p -72.35 87.05 1.13 Allowed 'General case' 0 CA--C 1.549 0.931 0 CA-C-O 122.013 0.911 . . . . 72.439999999999998 110.132 -176.161 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 9.5 pt-20 -72.8 -30.8 64.36 Favored 'General case' 0 N--CA 1.477 0.907 0 CA-C-N 114.611 -1.177 . . . . 73.049999999999997 112.307 -169.879 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 121' ' ' TRP . . . . . . . . . . . . . 41.4 p90 -68.39 -21.49 64.69 Favored 'General case' 0 CA--C 1.544 0.746 0 C-N-CA 122.965 0.506 . . . . 75.310000000000002 110.936 176.557 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 52.7 mt -83.41 0.36 46.45 Favored 'General case' 0 N--CA 1.482 1.139 0 C-N-CA 122.882 0.473 . . . . 42.229999999999997 112.254 177.768 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 62.7 m-20 -78.32 119.79 22.17 Favored 'General case' 0 CA--C 1.542 0.656 0 N-CA-C 109.082 -0.71 . . . . 74.349999999999994 109.082 172.728 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 111.02 -25.15 14.7 Favored Glycine 0 C--N 1.346 1.123 0 CA-C-N 115.589 -0.732 . . . . 74.430000000000007 111.279 -168.189 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 125' ' ' LYS . . . . . 0.655 ' HG3' ' H ' ' A' ' 126' ' ' HIS . 0.5 OUTLIER -77.32 -167.13 0.85 Allowed 'General case' 0 CA--C 1.568 1.641 0 C-N-CA 124.512 1.125 . . . . 61.140000000000001 107.984 170.997 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 126' ' ' HIS . . . . . 0.655 ' H ' ' HG3' ' A' ' 125' ' ' LYS . 0.4 OUTLIER -64.57 150.03 47.65 Favored 'General case' 0 C--O 1.248 0.996 0 C-N-CA 123.944 0.898 . . . . 74.239999999999995 112.93 -170.777 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 13.9 p -73.01 145.55 11.7 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.585 0 CA-C-N 114.354 -1.293 . . . . 64.540000000000006 111.906 -169.669 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 46.5 t -81.96 149.43 4.8 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.533 0 CA-C-N 114.379 -1.282 . . . . 74.120000000000005 108.616 172.41 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 129' ' ' PHE . . . . . 0.549 ' HA ' HG21 ' A' ' 29' ' ' VAL . 46.0 p90 -129.33 -9.1 4.7 Favored 'General case' 0 N--CA 1.481 1.086 0 CA-C-N 118.158 0.435 . . . . 72.409999999999997 111.753 179.611 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . -160.92 176.58 37.51 Favored Glycine 0 C--N 1.337 0.59 0 O-C-N 123.371 0.419 . . . . 73.230000000000004 112.67 -177.578 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 34.2 ttpt -151.47 135.86 16.89 Favored 'General case' 0 N--CA 1.467 0.415 0 N-CA-C 108.307 -0.997 . . . . 63.0 108.307 173.977 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 6.4 p -60.8 117.31 2.46 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.921 0 O-C-N 123.557 0.535 . . . . 74.439999999999998 110.661 178.568 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 133' ' ' LYS . . . . . 0.601 ' HD3' HG23 ' A' ' 5' ' ' THR . 22.3 ptmt -102.12 -14.93 16.87 Favored 'General case' 0 N--CA 1.481 1.124 0 C-N-CA 123.835 0.854 . . . . 75.310000000000002 110.609 -178.22 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 3.7 mm-40 -145.36 141.7 28.72 Favored 'General case' 0 N--CA 1.47 0.568 0 C-N-CA 123.11 0.564 . . . . 73.510000000000005 110.263 -177.808 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 135' ' ' GLY . . . . . 0.405 ' O ' HG23 ' A' ' 139' ' ' VAL . . . 71.75 26.47 72.78 Favored Glycine 0 C--N 1.338 0.645 0 O-C-N 123.797 0.686 . . . . 54.100000000000001 112.76 -174.384 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 136' ' ' MET . . . . . . . . . . . . . 7.0 tpt -60.58 -41.96 95.73 Favored 'General case' 0 N--CA 1.481 1.076 0 C-N-CA 123.379 0.672 . . . . 74.109999999999999 109.996 177.223 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 137' ' ' ASN . . . . . . . . . . . . . 12.4 m120 -62.95 -37.08 85.66 Favored 'General case' 0 N--CA 1.477 0.894 0 C-N-CA 123.68 0.792 . . . . 74.400000000000006 110.759 178.733 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 138' ' ' ILE . . . . . 0.53 ' O ' ' HG3' ' A' ' 142' ' ' MET . 49.6 mm -61.0 -51.16 76.43 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.809 0 C-N-CA 123.29 0.636 . . . . 74.510000000000005 109.663 175.922 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 139' ' ' VAL . . . . . 0.463 HG13 ' SG ' ' A' ' 62' ' ' CYS . 94.6 t -54.36 -47.0 70.06 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.138 0 C-N-CA 124.293 1.037 . . . . 74.420000000000002 111.454 179.859 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 38.2 mt-10 -67.24 -29.98 69.77 Favored 'General case' 0 N--CA 1.481 1.079 0 C-N-CA 123.689 0.796 . . . . 73.019999999999996 111.569 -179.222 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -77.59 -35.66 52.71 Favored 'General case' 0 N--CA 1.475 0.786 0 C-N-CA 122.938 0.495 . . . . 42.0 111.513 178.833 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 142' ' ' MET . . . . . 0.53 ' HG3' ' O ' ' A' ' 138' ' ' ILE . 45.3 mtp -80.52 -19.58 45.49 Favored 'General case' 0 N--CA 1.483 1.193 0 C-N-CA 122.693 0.397 . . . . 75.150000000000006 111.106 -178.935 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 24.8 tt0 -54.15 -35.15 61.94 Favored 'General case' 0 CA--C 1.55 0.974 0 C-N-CA 124.445 1.098 . . . . 52.140000000000001 110.847 168.452 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 144' ' ' ARG . . . . . . . . . . . . . 71.9 mtp180 -74.42 -11.91 60.36 Favored 'General case' 0 CA--C 1.542 0.636 0 C-N-CA 124.69 1.196 . . . . 63.439999999999998 112.067 -175.833 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 145' ' ' PHE . . . . . 0.46 ' HD2' ' HA ' ' A' ' 142' ' ' MET . 67.2 m-85 -90.94 -4.89 56.14 Favored 'General case' 0 N--CA 1.479 0.986 0 C-N-CA 122.816 0.446 . . . . 64.040000000000006 110.962 173.541 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . -91.76 173.92 37.18 Favored Glycine 0 C--N 1.343 0.939 0 CA-C-N 116.827 -0.17 . . . . 75.409999999999997 112.714 176.614 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 20.0 m -132.0 167.92 18.84 Favored 'General case' 0 N--CA 1.484 1.259 0 C-N-CA 124.054 0.942 . . . . 73.430000000000007 110.434 -177.491 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 148' ' ' ARG . . . . . . . . . . . . . 19.7 mmm180 -61.77 -32.22 72.47 Favored 'General case' 0 N--CA 1.484 1.235 0 C-N-CA 123.852 0.861 . . . . 52.32 112.246 -173.071 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 149' ' ' ASN . . . . . . . . . . . . . 30.6 p-10 -88.61 -7.2 56.81 Favored 'General case' 0 N--CA 1.483 1.191 0 C-N-CA 123.716 0.806 . . . . 62.130000000000003 111.83 -179.457 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 150' ' ' GLY . . . . . 0.451 ' O ' ' HA ' ' A' ' 55' ' ' ARG . . . 105.29 -3.04 40.21 Favored Glycine 0 C--N 1.34 0.797 0 CA-C-O 119.85 -0.417 . . . . 74.129999999999995 113.421 -178.331 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 84.8 tttt -63.84 112.56 2.95 Favored 'General case' 0 N--CA 1.472 0.626 0 CA-C-O 121.229 0.537 . . . . 73.239999999999995 109.796 -179.212 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 152' ' ' THR . . . . . . . . . . . . . 9.1 m -94.21 109.51 21.31 Favored 'General case' 0 CA--C 1.541 0.604 0 N-CA-C 108.17 -1.048 . . . . 74.219999999999999 108.17 179.542 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 153' ' ' SER . . . . . . . . . . . . . 16.0 m -59.32 -35.5 73.93 Favored 'General case' 0 N--CA 1.478 0.941 0 C-N-CA 124.914 1.285 . . . . 71.430000000000007 112.164 -174.965 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 74.9 mmtt -109.98 137.04 48.31 Favored 'General case' 0 N--CA 1.467 0.379 0 C-N-CA 123.895 0.878 . . . . 74.299999999999997 109.236 -177.475 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 16.7 tppt? -77.52 91.03 3.9 Favored 'General case' 0 CA--C 1.534 0.341 0 N-CA-C 108.418 -0.956 . . . . 73.349999999999994 108.418 176.215 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 156' ' ' ILE . . . . . 0.539 ' HB ' ' HB2' ' A' ' 53' ' ' PHE . 85.6 mt -84.93 130.25 36.38 Favored 'Isoleucine or valine' 0 C--O 1.221 -0.446 0 CA-C-N 115.126 -0.943 . . . . 71.549999999999997 108.726 -175.383 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 157' ' ' THR . . . . . . . . . . . . . 32.3 p -130.55 155.39 46.59 Favored 'General case' 0 N--CA 1.476 0.867 0 C-N-CA 123.922 0.889 . . . . 52.439999999999998 109.934 -176.03 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 158' ' ' ILE . . . . . 0.429 HG23 ' HB3' ' A' ' 8' ' ' PHE . 23.3 mt -88.76 95.3 5.25 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.641 0 N-CA-C 108.598 -0.89 . . . . 72.430000000000007 108.598 171.643 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 159' ' ' ALA . . . . . 0.407 ' HB2' ' HB2' ' A' ' 11' ' ' ALA . . . -59.72 -33.37 71.55 Favored 'General case' 0 N--CA 1.474 0.729 0 C-N-CA 124.102 0.961 . . . . 75.319999999999993 113.023 -175.267 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 160' ' ' ASP . . . . . . . . . . . . . 1.7 t70 -159.34 170.83 20.97 Favored 'General case' 0 N--CA 1.483 1.206 0 CA-C-O 120.765 0.316 . . . . 75.409999999999997 111.496 -175.285 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 161' ' ' CYS . . . . . . . . . . . . . 19.9 p -139.02 -168.83 2.51 Favored 'General case' 0 N--CA 1.481 1.118 0 C-N-CA 125.305 1.442 . . . . 72.25 108.553 -179.463 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 162' ' ' GLY . . . . . . . . . . . . . . . 135.56 56.45 0.06 OUTLIER Glycine 0 N--CA 1.48 1.591 0 CA-C-N 119.294 0.952 . . . . 72.450000000000003 113.562 -170.735 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 163' ' ' GLN . . . . . 0.45 ' HA ' ' H ' ' A' ' 7' ' ' PHE . 49.3 tt0 -44.42 119.87 2.01 Favored 'General case' 0 N--CA 1.484 1.23 0 C-N-CA 125.336 1.454 . . . . 53.310000000000002 113.069 -178.44 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 164' ' ' LEU . . . . . 0.489 ' O ' ' HB ' ' A' ' 5' ' ' THR . 97.8 mt -91.24 107.96 19.56 Favored 'General case' 0 CA--C 1.536 0.43 0 CA-C-N 115.123 -0.944 . . . . 75.150000000000006 110.306 -176.591 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 165' ' ' GLU . . . . . . . . . . . . . 4.4 pt-20 . . . . . 0 CA--C 1.552 1.049 0 N-CA-C 109.196 -0.668 . . . . 73.439999999999998 109.196 175.63 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' B' B ' 216' ' ' PRO . . . . . . . . . . . . . 16.6 Cg_exo . . . . . 0 N--CA 1.489 1.249 0 N-CA-C 110.784 -0.506 . . . . 60.119999999999997 110.784 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' B' B ' 217' ' ' GLU . . . . . . . . . . . . . 39.3 tt0 -142.25 105.88 5.61 Favored Pre-proline 0 CA--C 1.546 0.798 0 N-CA-C 108.272 -1.01 . . . . 51.43 108.272 -175.291 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 218' ' ' PRO . . . . . . . . . . . . . 26.3 Cg_exo -63.2 105.37 0.47 Allowed 'Trans proline' 0 C--N 1.381 2.278 0 C-N-CA 122.73 2.287 . . . . 65.219999999999999 111.732 -179.906 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 219' ' ' GLY . . . . . . . . . . . . . . . 177.95 163.97 30.47 Favored Glycine 0 CA--C 1.525 0.674 0 CA-C-N 115.612 -0.722 . . . . 75.540000000000006 112.407 -179.844 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 220' ' ' PRO . . . . . . . . . . . . . 24.5 Cg_exo -68.09 157.65 60.87 Favored 'Trans proline' 0 N--CA 1.489 1.254 0 C-N-CA 123.5 2.8 . . . . 75.099999999999994 113.264 175.612 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 221' ' ' TYR . . . . . . . . . . . . . 78.4 m-85 -86.59 139.2 31.05 Favored 'General case' 0 N--CA 1.476 0.844 0 C-N-CA 123.365 0.666 . . . . 72.040000000000006 110.04 179.988 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 222' ' ' ALA . . . . . . . . . . . . . . . -103.83 -173.31 2.28 Favored 'General case' 0 N--CA 1.473 0.717 0 C-N-CA 123.934 0.894 . . . . 63.450000000000003 113.15 -167.734 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 223' ' ' GLN . . . . . . . . . . . . . 24.2 pt20 -95.71 108.38 39.76 Favored Pre-proline 0 CA--C 1.56 1.36 0 CA-C-N 114.121 -1.4 . . . . 75.200000000000003 108.974 170.14 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 224' ' ' PRO . . . . . . . . . . . . . 24.0 Cg_exo . . . . . 0 C--N 1.373 1.849 0 C-N-CA 122.863 2.376 . . . . 74.540000000000006 112.131 177.524 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 N--CA 1.476 0.863 0 N-CA-C 109.165 -0.68 . . . . 73.409999999999997 109.165 . . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 9.9 p -79.46 -25.58 12.54 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.948 0 C-N-CA 123.752 0.821 . . . . 72.409999999999997 111.759 -170.9 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 3' ' ' ASN . . . . . 0.496 ' ND2' ' HA ' ' A' ' 25' ' ' PHE . 14.1 m120 -95.79 109.28 45.41 Favored Pre-proline 0 CA--C 1.548 0.884 0 C-N-CA 123.544 0.738 . . . . 74.230000000000004 110.895 -175.123 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 4' ' ' PRO . . . . . 0.49 ' HG2' ' HB2' ' A' ' 24' ' ' LEU . 16.1 Cg_endo -56.39 147.12 69.78 Favored 'Trans proline' 0 C--N 1.386 2.504 0 C-N-CA 123.51 2.807 . . . . 64.409999999999997 114.276 179.111 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 5' ' ' THR . . . . . 0.521 HG23 ' HD3' ' A' ' 133' ' ' LYS . 86.6 m -98.52 116.82 31.58 Favored 'General case' 0 CA--C 1.542 0.637 0 C-N-CA 124.903 1.281 . . . . 73.420000000000002 108.56 178.271 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . 0.454 ' HA ' ' HG3' ' A' ' 163' ' ' GLN . 28.6 t -99.42 119.93 48.11 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.737 0 N-CA-C 108.358 -0.978 . . . . 60.409999999999997 108.358 178.784 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 7' ' ' PHE . . . . . 0.573 ' H ' ' HA ' ' A' ' 163' ' ' GLN . 75.7 t80 -100.76 131.17 46.78 Favored 'General case' 0 C--N 1.324 -0.539 0 N-CA-C 109.439 -0.578 . . . . 75.400000000000006 109.439 -176.712 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 8' ' ' PHE . . . . . 0.48 ' HD2' ' HE2' ' A' ' 22' ' ' PHE . 46.7 m-85 -133.74 165.07 25.81 Favored 'General case' 0 C--O 1.241 0.65 0 C-N-CA 124.584 1.153 . . . . 74.019999999999996 108.949 167.095 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 9' ' ' ASP . . . . . 0.47 ' HB2' ' HB3' ' A' ' 159' ' ' ALA . 27.9 m-20 -112.94 112.62 24.21 Favored 'General case' 0 C--N 1.318 -0.79 0 N-CA-C 106.337 -1.727 . . . . 70.340000000000003 106.337 170.422 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 10' ' ' ILE . . . . . 0.425 HG21 ' SD ' ' A' ' 142' ' ' MET . 43.5 mm -81.51 125.12 39.55 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.213 0 N-CA-C 108.695 -0.854 . . . . 71.420000000000002 108.695 -179.995 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 11' ' ' ALA . . . . . 0.641 ' HB2' ' HB2' ' A' ' 159' ' ' ALA . . . -121.76 123.54 42.07 Favored 'General case' 0 C--O 1.213 -0.847 0 C-N-CA 124.403 1.081 . . . . 73.430000000000007 110.247 -171.405 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . 0.42 HG22 HG12 ' A' ' 156' ' ' ILE . 67.9 t -99.24 131.36 46.68 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.653 0 N-CA-C 107.844 -1.169 . . . . 65.109999999999999 107.844 173.515 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 23.1 m-20 67.87 17.58 9.67 Favored 'General case' 0 N--CA 1.491 1.621 0 C-N-CA 124.418 1.087 . . . . 71.109999999999999 110.582 -173.577 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 82.75 -9.3 59.85 Favored Glycine 0 C--N 1.351 1.364 0 CA-C-O 119.907 -0.385 . . . . 72.230000000000004 113.131 -171.27 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 37.6 mm-40 -97.35 127.48 38.04 Favored Pre-proline 0 CA--C 1.548 0.888 0 C-N-CA 124.329 1.052 . . . . 73.430000000000007 110.209 -178.127 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 18.6 Cg_endo -55.28 112.5 1.06 Allowed 'Trans proline' 0 C--N 1.381 2.282 0 C-N-CA 123.75 2.967 . . . . 70.230000000000004 113.483 -172.995 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . 0.506 HD23 HG23 ' A' ' 138' ' ' ILE . 40.0 tp -79.33 -40.55 30.03 Favored 'General case' 0 N--CA 1.476 0.87 0 C-N-CA 123.469 0.708 . . . . 64.150000000000006 110.087 174.704 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -176.04 -179.36 46.48 Favored Glycine 0 C--N 1.348 1.206 0 CA-C-N 116.212 -0.449 . . . . 52.109999999999999 113.286 -179.813 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 30.5 mtp85 -107.69 125.48 51.42 Favored 'General case' 0 N--CA 1.475 0.792 0 C-N-CA 124.46 1.104 . . . . 74.129999999999995 109.142 -176.967 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 71.9 t -126.0 142.61 42.17 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.804 0 C-N-CA 124.13 0.972 . . . . 71.049999999999997 109.684 -177.903 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 21' ' ' SER . . . . . 0.48 ' HB2' ' HB2' ' A' ' 134' ' ' GLU . 49.4 m -130.64 134.69 47.17 Favored 'General case' 0 CA--C 1.539 0.539 0 C-N-CA 123.579 0.752 . . . . 55.020000000000003 109.556 173.447 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 22' ' ' PHE . . . . . 0.48 ' HE2' ' HD2' ' A' ' 8' ' ' PHE . 73.3 m-85 -100.49 170.28 8.5 Favored 'General case' 0 N--CA 1.467 0.389 0 C-N-CA 125.039 1.336 . . . . 72.219999999999999 108.945 175.32 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . 0.531 ' HB2' ' HD2' ' A' ' 133' ' ' LYS . 35.5 tt0 -137.07 107.15 6.33 Favored 'General case' 0 CA--C 1.539 0.523 0 C-N-CA 122.98 0.512 . . . . 71.140000000000001 109.674 -178.608 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . 0.49 ' HB2' ' HG2' ' A' ' 4' ' ' PRO . 25.5 mt -87.23 126.83 35.06 Favored 'General case' 0 N--CA 1.476 0.83 0 C-N-CA 123.347 0.659 . . . . 64.409999999999997 110.531 -175.734 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 25' ' ' PHE . . . . . 0.496 ' HA ' ' ND2' ' A' ' 3' ' ' ASN . 50.9 m-85 -86.21 67.17 9.87 Favored 'General case' 0 CA--C 1.54 0.594 0 C-N-CA 123.905 0.882 . . . . 75.319999999999993 109.267 178.51 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -66.83 -18.32 65.32 Favored 'General case' 0 N--CA 1.48 1.059 0 C-N-CA 124.323 1.049 . . . . 75.010000000000005 112.923 -173.271 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 12.9 p-10 -79.01 -32.01 44.92 Favored 'General case' 0 CA--C 1.546 0.804 0 C-N-CA 123.441 0.696 . . . . 74.319999999999993 110.672 176.258 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 97.9 mttt -89.94 -41.93 11.48 Favored 'General case' 0 N--CA 1.478 0.933 0 C-N-CA 123.69 0.796 . . . . 65.230000000000004 111.066 -175.703 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 29' ' ' VAL . . . . . 0.499 HG21 ' HA ' ' A' ' 129' ' ' PHE . 17.0 m -137.81 70.24 50.9 Favored Pre-proline 0 CA--C 1.561 1.374 0 C-N-CA 123.879 0.872 . . . . 52.43 110.096 -172.939 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 27.6 Cg_exo -60.93 -35.66 86.96 Favored 'Trans proline' 0 C--N 1.38 2.197 0 C-N-CA 123.169 2.58 . . . . 72.439999999999998 113.599 -170.727 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 22.9 ttmm -59.83 -61.11 2.85 Favored 'General case' 0 N--CA 1.475 0.782 0 C-N-CA 123.617 0.767 . . . . 65.430000000000007 111.725 -178.398 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 3.6 m -74.37 -27.53 60.7 Favored 'General case' 0 CA--C 1.553 1.077 0 CA-C-N 115.235 -0.893 . . . . 73.129999999999995 111.242 -171.059 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -74.2 -52.44 12.43 Favored 'General case' 0 CA--C 1.549 0.933 0 C-N-CA 122.774 0.43 . . . . 73.230000000000004 111.109 177.061 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 27.5 tt0 -61.14 -31.29 71.01 Favored 'General case' 0 N--CA 1.491 1.612 0 C-N-CA 123.305 0.642 . . . . 73.299999999999997 110.763 179.1 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 35' ' ' ASN . . . . . 0.519 ' O ' ' HG ' ' A' ' 39' ' ' LEU . 45.1 t30 -54.1 -66.55 0.38 Allowed 'General case' 0 C--N 1.354 0.797 0 O-C-N 123.97 0.794 . . . . 54.240000000000002 109.47 175.395 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 74.1 t80 -56.95 -38.2 72.62 Favored 'General case' 0 N--CA 1.479 1.011 0 C-N-CA 124.716 1.206 . . . . 70.400000000000006 111.51 -175.941 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 37' ' ' ARG . . . . . 0.566 ' HA ' HE22 ' A' ' 163' ' ' GLN . 14.0 ttm180 -55.24 -58.33 8.14 Favored 'General case' 0 C--N 1.353 0.759 0 CA-C-N 115.372 -0.831 . . . . 74.340000000000003 110.331 173.957 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 38' ' ' ALA . . . . . 0.435 ' HB1' ' HG2' ' A' ' 44' ' ' LYS . . . -74.11 -18.92 60.74 Favored 'General case' 0 N--CA 1.468 0.452 0 C-N-CA 123.785 0.834 . . . . 74.510000000000005 111.899 -171.782 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 39' ' ' LEU . . . . . 0.639 HD22 ' HE2' ' A' ' 48' ' ' TYR . 43.3 mt -71.58 -46.64 58.75 Favored 'General case' 0 CA--C 1.538 0.517 0 N-CA-C 109.371 -0.603 . . . . 72.019999999999996 109.371 173.229 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 33.7 t -68.5 -56.8 7.13 Favored 'General case' 0 CA--C 1.547 0.861 0 C-N-CA 123.797 0.839 . . . . 74.310000000000002 111.411 -179.433 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 41' ' ' THR . . . . . 0.406 ' OG1' ' HG2' ' A' ' 43' ' ' GLU . 71.6 p -76.62 -31.03 57.16 Favored 'General case' 0 N--CA 1.471 0.619 0 C-N-CA 124.075 0.95 . . . . 73.019999999999996 111.442 -174.012 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 85.74 31.92 19.85 Favored Glycine 0 C--N 1.349 1.261 0 CA-C-O 119.908 -0.384 . . . . 50.310000000000002 113.101 -179.022 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 43' ' ' GLU . . . . . 0.406 ' HG2' ' OG1' ' A' ' 41' ' ' THR . 24.5 mm-40 -66.12 -27.87 68.38 Favored 'General case' 0 N--CA 1.483 1.187 0 C-N-CA 122.706 0.402 . . . . 64.329999999999998 111.665 176.709 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 44' ' ' LYS . . . . . 0.435 ' HG2' ' HB1' ' A' ' 38' ' ' ALA . 33.3 mmtp -105.95 18.6 21.85 Favored 'General case' 0 N--CA 1.484 1.269 0 C-N-CA 122.992 0.517 . . . . 72.349999999999994 110.645 175.405 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 79.23 48.39 6.91 Favored Glycine 0 C--N 1.352 1.43 0 N-CA-C 114.803 0.681 . . . . 75.019999999999996 114.803 169.279 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 46' ' ' PHE . . . . . 0.493 ' HE2' ' HA ' ' A' ' 78' ' ' ILE . 25.1 m-85 -130.08 -50.79 1.12 Allowed 'General case' 0 N--CA 1.49 1.545 0 CA-C-N 118.021 0.911 . . . . 75.099999999999994 111.399 -178.557 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 47.87 53.97 12.76 Favored Glycine 0 C--N 1.354 1.547 0 O-C-N 124.593 1.183 . . . . 75.140000000000001 114.687 176.17 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 48' ' ' TYR . . . . . 0.639 ' HE2' HD22 ' A' ' 39' ' ' LEU . 33.5 m-85 -61.55 95.47 0.05 Allowed 'General case' 0 N--CA 1.479 1.001 0 C-N-CA 123.28 0.632 . . . . 65.310000000000002 111.487 -177.803 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 46.9 tptt -98.48 102.42 14.15 Favored 'General case' 0 CA--C 1.537 0.447 0 CA-C-N 114.866 -1.061 . . . . 55.109999999999999 108.925 -175.65 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 50' ' ' GLY . . . . . 0.43 ' HA2' ' O ' ' A' ' 158' ' ' ILE . . . 110.62 22.66 6.27 Favored Glycine 0 C--N 1.346 1.117 0 CA-C-O 119.362 -0.688 . . . . 74.319999999999993 114.651 173.647 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 51' ' ' SER . . . . . 0.42 ' HB2' HD12 ' A' ' 158' ' ' ILE . 19.3 m -53.43 128.35 28.35 Favored 'General case' 0 N--CA 1.484 1.268 0 C-N-CA 123.732 0.813 . . . . 72.120000000000005 111.175 178.005 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 52' ' ' CYS . . . . . 0.53 ' HA ' ' HA ' ' A' ' 157' ' ' THR . 19.4 p -103.25 133.83 47.67 Favored 'General case' 0 N--CA 1.478 0.937 0 N-CA-C 112.59 0.589 . . . . 63.229999999999997 112.59 -168.282 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 53' ' ' PHE . . . . . 0.684 ' HA ' ' HA2' ' A' ' 64' ' ' GLY . 79.4 m-85 -74.05 102.62 4.25 Favored 'General case' 0 N--CA 1.472 0.661 0 C-N-CA 124.069 0.948 . . . . 74.400000000000006 108.665 166.206 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 16.5 p-80 -114.82 -12.93 12.04 Favored 'General case' 0 N--CA 1.481 1.094 0 C-N-CA 123.603 0.761 . . . . 61.229999999999997 112.006 -173.316 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 36.1 ttt180 -128.39 100.82 5.95 Favored 'General case' 0 C--O 1.217 -0.618 0 C-N-CA 122.884 0.474 . . . . 65.209999999999994 109.75 179.13 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 57.9 mt -128.96 125.4 62.82 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.96 0 C-N-CA 122.905 0.482 . . . . 65.530000000000001 110.126 178.375 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 54.7 mt -116.48 114.25 40.38 Favored Pre-proline 0 CA--C 1.557 1.217 0 C-N-CA 124.367 1.067 . . . . 52.100000000000001 109.162 178.228 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 31.8 Cg_exo -60.32 129.88 31.66 Favored 'Trans proline' 0 C--N 1.387 2.582 0 C-N-CA 123.704 2.936 . . . . 71.239999999999995 112.61 178.103 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 81.26 26.17 52.82 Favored Glycine 0 C--N 1.341 0.807 0 O-C-N 123.778 0.674 . . . . 52.439999999999998 112.661 -176.113 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 60' ' ' PHE . . . . . 0.508 ' HB2' HE21 ' B' ' 223' ' ' GLN . 23.1 t80 -151.88 -75.99 0.13 Allowed 'General case' 0 C--O 1.247 0.933 0 C-N-CA 123.016 0.526 . . . . 74.420000000000002 110.685 179.712 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 61' ' ' MET . . . . . 0.481 ' HA ' ' H ' ' A' ' 116' ' ' THR . 22.9 ptt? -165.35 163.62 19.87 Favored 'General case' 0 N--CA 1.485 1.305 0 N-CA-C 112.813 0.672 . . . . 70.310000000000002 112.813 -174.528 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 62' ' ' CYS . . . . . 0.464 ' SG ' ' HB ' ' A' ' 114' ' ' ILE . 20.5 p -115.59 111.68 21.03 Favored 'General case' 0 CA--C 1.545 0.766 0 C-N-CA 124.253 1.021 . . . . 65.439999999999998 108.933 168.572 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 63' ' ' GLN . . . . . 0.561 ' HA ' ' HA ' ' A' ' 113' ' ' PHE . 52.1 tt0 -102.74 116.73 33.16 Favored 'General case' 0 N--CA 1.479 1.014 0 C-N-CA 124.019 0.928 . . . . 74.109999999999999 110.877 -174.955 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 64' ' ' GLY . . . . . 0.684 ' HA2' ' HA ' ' A' ' 53' ' ' PHE . . . -92.36 173.19 35.48 Favored Glycine 0 C--N 1.342 0.896 0 CA-C-N 115.221 -0.899 . . . . 72.129999999999995 112.284 171.362 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 174.29 150.46 7.69 Favored Glycine 0 C--O 1.238 0.344 0 N-CA-C 110.504 -1.038 . . . . 71.409999999999997 110.504 179.379 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 38.8 t70 -79.75 162.0 25.41 Favored 'General case' 0 CA--C 1.547 0.865 0 CA-C-O 121.608 0.718 . . . . 63.020000000000003 112.658 -169.804 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 55.0 t80 -79.95 -40.59 27.73 Favored 'General case' 0 CA--C 1.548 0.871 0 C-N-CA 124.701 1.2 . . . . 73.299999999999997 111.678 -177.281 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 25.3 m -61.16 112.68 2.21 Favored 'General case' 0 N--CA 1.479 0.979 0 C-N-CA 123.757 0.823 . . . . 71.439999999999998 111.681 -172.673 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 36.3 ttm180 55.83 77.03 0.25 Allowed 'General case' 0 N--CA 1.48 1.035 0 C-N-CA 124.852 1.261 . . . . 74.430000000000007 111.19 -178.877 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 12.2 t60 -79.16 -14.55 59.02 Favored 'General case' 0 CA--C 1.546 0.79 0 CA-C-N 115.261 -0.881 . . . . 71.230000000000004 110.806 -179.559 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 16.8 m120 -55.97 93.36 0.01 OUTLIER 'General case' 0 N--CA 1.485 1.279 0 C-N-CA 124.211 1.004 . . . . 74.439999999999998 110.723 178.18 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 70.18 11.25 67.05 Favored Glycine 0 C--N 1.351 1.4 0 CA-C-N 115.45 -0.795 . . . . 73.530000000000001 114.904 176.071 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 21.0 m -143.25 -83.62 0.16 Allowed 'General case' 0 CA--C 1.553 1.075 0 CA-C-N 117.663 0.731 . . . . 63.340000000000003 110.634 -178.578 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 64.4 59.22 8.6 Favored Glycine 0 C--N 1.357 1.731 0 O-C-N 123.301 0.376 . . . . 63.350000000000001 113.117 -177.008 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 134.6 49.07 0.08 OUTLIER Glycine 0 C--N 1.35 1.359 0 CA-C-N 117.05 0.425 . . . . 43.200000000000003 112.475 -176.135 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 14.0 ptmm? -65.59 159.91 23.66 Favored 'General case' 0 N--CA 1.484 1.243 0 C-N-CA 123.64 0.776 . . . . 75.040000000000006 111.454 -178.683 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 79.6 p -105.86 -175.65 2.85 Favored 'General case' 0 N--CA 1.481 1.095 0 N-CA-C 112.666 0.617 . . . . 65.439999999999998 112.666 -162.897 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 78' ' ' ILE . . . . . 0.493 ' HA ' ' HE2' ' A' ' 46' ' ' PHE . 44.3 pt -70.79 -21.08 22.38 Favored 'Isoleucine or valine' 0 C--N 1.358 0.971 0 CA-C-N 115.595 -0.73 . . . . 65.340000000000003 111.254 176.447 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 98.9 m-85 -88.66 33.83 0.77 Allowed 'General case' 0 N--CA 1.475 0.778 0 C-N-CA 123.83 0.852 . . . . 52.340000000000003 109.736 173.564 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 70.23 -99.16 0.69 Allowed Glycine 0 C--N 1.351 1.399 0 CA-C-N 115.403 -0.817 . . . . 74.030000000000001 111.604 -176.744 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 42.8 tt0 -73.03 -60.22 2.34 Favored 'General case' 0 CA--C 1.544 0.744 0 C-N-CA 123.956 0.902 . . . . 63.439999999999998 110.652 -176.498 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 82' ' ' LYS . . . . . 0.75 ' HD2' ' HA ' ' A' ' 107' ' ' THR . 18.8 pttp -169.2 177.37 4.83 Favored 'General case' 0 N--CA 1.482 1.148 0 C-N-CA 123.11 0.564 . . . . 64.140000000000001 111.162 -169.721 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 51.6 p90 -156.19 174.93 14.65 Favored 'General case' 0 N--CA 1.478 0.959 0 C-N-CA 124.204 1.002 . . . . 72.109999999999999 110.852 -177.574 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 13.5 pt-20 -102.76 162.96 12.5 Favored 'General case' 0 N--CA 1.481 1.117 0 C-N-CA 123.223 0.609 . . . . 71.349999999999994 110.872 177.233 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 85' ' ' ASP . . . . . 0.469 ' HB3' HG23 ' A' ' 127' ' ' VAL . 48.0 m-20 -64.71 130.63 44.29 Favored 'General case' 0 N--CA 1.478 0.926 0 CA-C-N 115.687 -0.688 . . . . 74.310000000000002 111.276 -179.993 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 9.3 tp10 -69.12 -61.36 1.82 Allowed 'General case' 0 N--CA 1.474 0.747 0 O-C-N 123.57 0.544 . . . . 72.129999999999995 111.102 -178.836 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 24.3 p-10 -161.2 127.89 3.98 Favored 'General case' 0 N--CA 1.477 0.887 0 C-N-CA 123.054 0.541 . . . . 75.120000000000005 110.325 -171.891 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 86.4 m-85 -88.58 74.11 8.52 Favored 'General case' 0 N--CA 1.476 0.85 0 CA-C-O 121.533 0.682 . . . . 74.150000000000006 110.18 -171.727 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 65.1 mt -88.87 -60.27 2.38 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.637 0 CA-C-N 115.221 -0.9 . . . . 70.120000000000005 108.998 173.453 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 67.4 mt -85.36 131.13 34.45 Favored 'General case' 0 C--O 1.241 0.626 0 CA-C-N 114.372 -1.286 . . . . 60.539999999999999 110.392 -173.05 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 32.2 mtmm -122.46 169.11 11.32 Favored 'General case' 0 N--CA 1.47 0.55 0 C-N-CA 124.933 1.293 . . . . 75.230000000000004 109.479 -174.485 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 92' ' ' HIS . . . . . . . . . . . . . 20.7 m-70 -91.95 36.83 0.97 Allowed 'General case' 0 N--CA 1.481 1.105 0 C-N-CA 123.992 0.917 . . . . 72.109999999999999 110.852 -170.79 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 80.7 p -67.92 -26.08 65.8 Favored 'General case' 0 N--CA 1.474 0.725 0 C-N-CA 124.387 1.075 . . . . 75.510000000000005 112.226 -170.935 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -124.88 175.6 17.17 Favored Glycine 0 C--N 1.344 1.007 0 O-C-N 123.232 0.332 . . . . 72.310000000000002 113.221 -177.067 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 93.0 Cg_endo -80.89 157.49 20.89 Favored 'Trans proline' 0 C--N 1.367 1.546 0 C-N-CA 123.046 2.498 . . . . 53.409999999999997 111.395 169.484 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 89.36 -0.71 81.34 Favored Glycine 0 N--CA 1.472 1.039 0 CA-C-N 116.27 -0.423 . . . . 34.399999999999999 112.971 -177.206 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 97' ' ' ILE . . . . . 0.44 ' HB ' ' HB2' ' A' ' 115' ' ' CYS . 13.9 mm -66.94 114.07 3.5 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.949 0 C-N-CA 124.041 0.936 . . . . 60.32 111.466 -176.591 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 98' ' ' LEU . . . . . 0.489 HD13 HG12 ' A' ' 114' ' ' ILE . 67.2 tp -102.28 113.11 26.13 Favored 'General case' 0 CA--C 1.551 0.999 0 C-N-CA 123.489 0.716 . . . . 74.510000000000005 109.761 177.827 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 42.6 t -131.44 168.77 17.04 Favored 'General case' 0 N--CA 1.479 0.978 0 C-N-CA 124.95 1.3 . . . . 71.140000000000001 108.296 176.533 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 100' ' ' MET . . . . . 0.505 ' HA ' ' HA ' ' A' ' 112' ' ' PHE . 44.4 mtp -101.62 146.59 27.49 Favored 'General case' 0 N--CA 1.491 1.604 0 CA-C-N 118.596 0.635 . . . . 62.119999999999997 110.482 -176.639 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 101' ' ' ALA . . . . . 0.553 ' HB3' ' HB2' ' A' ' 111' ' ' GLN . . . -85.49 167.58 15.32 Favored 'General case' 0 N--CA 1.482 1.151 0 C-N-CA 123.202 0.601 . . . . 64.329999999999998 111.174 -175.649 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 102' ' ' ASN . . . . . 0.593 ' HB3' ' HA ' ' A' ' 108' ' ' ASN . 29.4 p-10 -169.9 170.93 7.46 Favored 'General case' 0 N--CA 1.478 0.961 0 C-N-CA 122.829 0.451 . . . . 63.229999999999997 111.996 -177.111 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 103' ' ' ALA . . . . . 0.476 ' HB3' HG21 ' A' ' 107' ' ' THR . . . -99.59 -22.1 15.59 Favored 'General case' 0 CA--C 1.547 0.865 0 CA-C-N 115.377 -0.829 . . . . 44.030000000000001 111.142 171.55 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -178.15 -177.0 46.56 Favored Glycine 0 C--N 1.357 1.696 0 CA-C-O 119.467 -0.629 . . . . 53.549999999999997 113.053 -178.134 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 32.4 Cg_exo -58.62 136.52 74.55 Favored 'Trans proline' 0 C--N 1.375 1.948 0 C-N-CA 122.791 2.327 . . . . 75.420000000000002 112.908 175.002 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 66.6 t30 69.72 9.94 7.38 Favored 'General case' 0 N--CA 1.486 1.354 0 C-N-CA 124.805 1.242 . . . . 75.129999999999995 111.639 -176.459 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 107' ' ' THR . . . . . 0.75 ' HA ' ' HD2' ' A' ' 82' ' ' LYS . 3.9 m -109.96 5.16 22.11 Favored 'General case' 0 CA--C 1.553 1.087 0 C-N-CA 124.093 0.957 . . . . 71.340000000000003 110.305 178.301 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 108' ' ' ASN . . . . . 0.593 ' HA ' ' HB3' ' A' ' 102' ' ' ASN . 66.4 t30 -80.93 154.36 27.04 Favored 'General case' 0 N--CA 1.478 0.97 0 C-N-CA 123.467 0.707 . . . . 71.530000000000001 111.3 -173.772 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 106.36 -3.47 37.4 Favored Glycine 0 N--CA 1.467 0.725 0 CA-C-O 119.966 -0.352 . . . . 54.140000000000001 112.7 -178.394 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 41.1 p -91.29 119.23 31.16 Favored 'General case' 0 CA--C 1.54 0.563 0 N-CA-C 108.11 -1.07 . . . . 70.019999999999996 108.11 170.329 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 111' ' ' GLN . . . . . 0.572 HE22 ' HG2' ' B' ' 218' ' ' PRO . 35.7 mt-30 66.75 173.19 0.25 Allowed 'General case' 0 N--CA 1.496 1.857 0 C-N-CA 124.208 1.003 . . . . 73.530000000000001 112.093 -177.919 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 112' ' ' PHE . . . . . 0.505 ' HA ' ' HA ' ' A' ' 100' ' ' MET . 32.6 p90 -143.69 133.72 24.18 Favored 'General case' 0 N--CA 1.474 0.737 0 C-N-CA 123.879 0.871 . . . . 72.150000000000006 108.963 177.983 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 113' ' ' PHE . . . . . 0.561 ' HA ' ' HA ' ' A' ' 63' ' ' GLN . 52.2 p90 -116.52 142.06 47.37 Favored 'General case' 0 C--O 1.24 0.603 0 C-N-CA 123.342 0.657 . . . . 74.329999999999998 110.595 176.497 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 114' ' ' ILE . . . . . 0.489 HG12 HD13 ' A' ' 98' ' ' LEU . 15.3 mt -109.01 106.5 20.83 Favored 'Isoleucine or valine' 0 C--O 1.238 0.454 0 N-CA-C 108.066 -1.087 . . . . 74.340000000000003 108.066 175.39 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 115' ' ' CYS . . . . . 0.44 ' HB2' ' HB ' ' A' ' 97' ' ' ILE . 59.7 m -61.69 103.27 0.32 Allowed 'General case' 0 CA--C 1.546 0.823 0 C-N-CA 123.156 0.582 . . . . 64.439999999999998 109.607 173.554 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 116' ' ' THR . . . . . 0.567 HG22 HG12 ' A' ' 139' ' ' VAL . 35.2 p -74.56 -32.71 62.51 Favored 'General case' 0 N--CA 1.474 0.76 0 C-N-CA 124.29 1.036 . . . . 50.119999999999997 109.703 178.87 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -100.0 159.04 15.4 Favored 'General case' 0 C--O 1.243 0.761 0 C-N-CA 124.46 1.104 . . . . 31.34 108.561 171.051 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -71.88 111.98 7.59 Favored 'General case' 0 CA--C 1.543 0.693 0 N-CA-C 107.586 -1.264 . . . . 72.310000000000002 107.586 169.839 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 119' ' ' THR . . . . . . . . . . . . . 52.2 p -101.86 84.57 2.56 Favored 'General case' 0 CA--C 1.539 0.558 0 CA-C-O 122.319 1.057 . . . . 73.129999999999995 109.168 -175.974 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 11.1 pt-20 -77.0 -25.52 52.78 Favored 'General case' 0 N--CA 1.48 1.055 0 CA-C-N 114.543 -1.208 . . . . 71.219999999999999 110.903 -174.314 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 121' ' ' TRP . . . . . . . . . . . . . 43.8 p90 -70.19 -6.82 37.08 Favored 'General case' 0 CA--C 1.55 0.962 0 C-N-CA 123.914 0.886 . . . . 62.109999999999999 111.258 174.517 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 122' ' ' LEU . . . . . 0.422 HD22 ' HG2' ' A' ' 125' ' ' LYS . 42.7 mt -96.86 24.2 6.38 Favored 'General case' 0 CA--C 1.55 0.965 0 C-N-CA 123.32 0.648 . . . . 63.100000000000001 111.45 172.426 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 24.2 m-20 -71.79 133.9 45.83 Favored 'General case' 0 N--CA 1.484 1.247 0 N-CA-C 109.32 -0.622 . . . . 63.439999999999998 109.32 163.107 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 89.08 -13.84 62.22 Favored Glycine 0 C--N 1.345 1.056 0 CA-C-N 115.792 -0.64 . . . . 74.409999999999997 112.528 -173.26 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 125' ' ' LYS . . . . . 0.422 ' HG2' HD22 ' A' ' 122' ' ' LEU . 0.4 OUTLIER -81.63 -169.45 2.33 Favored 'General case' 0 N--CA 1.477 0.877 0 C-N-CA 123.657 0.783 . . . . 64.430000000000007 111.012 -179.02 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 126' ' ' HIS . . . . . . . . . . . . . 24.0 m80 -71.74 146.68 47.98 Favored 'General case' 0 N--CA 1.477 0.924 0 C-N-CA 124.481 1.112 . . . . 63.340000000000003 111.257 -163.059 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 127' ' ' VAL . . . . . 0.469 HG23 ' HB3' ' A' ' 85' ' ' ASP . 62.1 t -63.32 128.14 24.86 Favored 'Isoleucine or valine' 0 C--O 1.242 0.664 0 O-C-N 124.534 1.146 . . . . 75.209999999999994 112.108 -168.724 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 128' ' ' VAL . . . . . 0.408 HG11 HD12 ' A' ' 97' ' ' ILE . 47.6 t -75.5 140.39 17.46 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.356 0 CA-C-N 114.859 -1.064 . . . . 31.52 108.429 170.787 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 129' ' ' PHE . . . . . 0.499 ' HA ' HG21 ' A' ' 29' ' ' VAL . 41.1 p90 -128.13 -20.87 3.7 Favored 'General case' 0 N--CA 1.474 0.756 0 C-N-CA 122.623 0.369 . . . . 74.239999999999995 110.867 -177.475 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . -134.65 168.84 23.4 Favored Glycine 0 C--N 1.34 0.793 0 O-C-N 123.34 0.4 . . . . 62.119999999999997 112.188 -176.488 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 33.2 ttpt -152.26 137.11 17.12 Favored 'General case' 0 N--CA 1.47 0.569 0 C-N-CA 123.838 0.855 . . . . 63.509999999999998 109.091 176.568 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 17.1 t -70.95 111.71 5.03 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.528 0 N-CA-C 109.439 -0.578 . . . . 74.129999999999995 109.439 178.311 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 133' ' ' LYS . . . . . 0.531 ' HD2' ' HB2' ' A' ' 23' ' ' GLU . 20.2 ptmt -94.94 -37.63 11.07 Favored 'General case' 0 CA--C 1.541 0.605 0 C-N-CA 123.242 0.617 . . . . 75.319999999999993 110.19 178.193 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 134' ' ' GLU . . . . . 0.48 ' HB2' ' HB2' ' A' ' 21' ' ' SER . 17.9 mm-40 -124.4 136.4 54.03 Favored 'General case' 0 N--CA 1.474 0.757 0 C-N-CA 123.984 0.913 . . . . 65.239999999999995 109.274 -178.337 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 76.27 28.34 60.21 Favored Glycine 0 C--N 1.342 0.907 0 O-C-N 123.562 0.539 . . . . 42.299999999999997 113.913 175.245 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 136' ' ' MET . . . . . . . . . . . . . 15.3 tpt -63.91 -26.98 68.84 Favored 'General case' 0 N--CA 1.487 1.403 0 CA-C-N 117.418 0.609 . . . . 75.129999999999995 110.303 173.418 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 137' ' ' ASN . . . . . . . . . . . . . 1.7 m-20 -55.77 -46.69 77.84 Favored 'General case' 0 CA--C 1.549 0.927 0 C-N-CA 124.4 1.08 . . . . 74.140000000000001 110.291 171.502 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 138' ' ' ILE . . . . . 0.506 HG23 HD23 ' A' ' 17' ' ' LEU . 48.5 mm -68.17 -33.23 59.59 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.084 0 C-N-CA 123.876 0.871 . . . . 64.400000000000006 111.116 179.622 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 139' ' ' VAL . . . . . 0.567 HG12 HG22 ' A' ' 116' ' ' THR . 78.9 t -65.85 -44.5 92.78 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.072 0 C-N-CA 123.595 0.758 . . . . 71.349999999999994 111.12 178.839 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 45.1 mt-10 -74.34 -20.2 60.18 Favored 'General case' 0 N--CA 1.48 1.041 0 CA-C-N 115.747 -0.661 . . . . 74.010000000000005 110.99 176.919 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -72.16 -40.18 68.18 Favored 'General case' 0 CA--C 1.542 0.654 0 C-N-CA 122.895 0.478 . . . . 63.43 109.732 170.713 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 142' ' ' MET . . . . . 0.425 ' SD ' HG21 ' A' ' 10' ' ' ILE . 72.6 mtm -61.18 -38.81 87.82 Favored 'General case' 0 N--CA 1.484 1.26 0 C-N-CA 123.303 0.641 . . . . 72.140000000000001 110.289 176.744 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 143' ' ' GLU . . . . . 0.408 ' HB2' HG21 ' A' ' 116' ' ' THR . 42.7 tt0 -51.38 -40.31 58.95 Favored 'General case' 0 CA--C 1.552 1.041 0 O-C-N 124.402 1.064 . . . . 72.209999999999994 111.869 176.607 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 144' ' ' ARG . . . . . . . . . . . . . 53.6 mtp180 -71.81 -25.72 62.11 Favored 'General case' 0 CA--C 1.545 0.762 0 C-N-CA 123.47 0.708 . . . . 72.030000000000001 112.034 -178.279 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 145' ' ' PHE . . . . . . . . . . . . . 93.5 m-85 -82.77 2.4 34.09 Favored 'General case' 0 N--CA 1.481 1.118 0 C-N-CA 122.725 0.41 . . . . 74.120000000000005 111.223 175.749 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . -93.43 173.71 34.35 Favored Glycine 0 C--N 1.349 1.301 0 CA-C-N 117.741 0.246 . . . . 63.450000000000003 112.888 176.075 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 35.2 t -135.23 167.39 21.09 Favored 'General case' 0 N--CA 1.477 0.923 0 C-N-CA 123.911 0.884 . . . . 32.509999999999998 110.084 178.797 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 148' ' ' ARG . . . . . . . . . . . . . 23.2 mmt180 -73.6 -26.34 60.75 Favored 'General case' 0 N--CA 1.479 0.988 0 C-N-CA 123.725 0.81 . . . . 65.530000000000001 112.176 -173.352 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 149' ' ' ASN . . . . . . . . . . . . . 29.3 p-10 -77.06 -5.03 47.25 Favored 'General case' 0 N--CA 1.481 1.089 0 C-N-CA 123.17 0.588 . . . . 54.25 111.001 174.745 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . 101.54 -20.01 48.26 Favored Glycine 0 C--N 1.348 1.226 0 CA-C-O 119.959 -0.356 . . . . 63.409999999999997 112.474 177.936 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 34.9 ttpt -71.36 153.39 42.36 Favored 'General case' 0 N--CA 1.48 1.034 0 C-N-CA 122.802 0.441 . . . . 71.439999999999998 110.584 -176.894 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 152' ' ' THR . . . . . . . . . . . . . 72.2 p -94.82 134.05 37.86 Favored 'General case' 0 CA--C 1.543 0.696 0 C-N-CA 123.202 0.601 . . . . 71.150000000000006 109.452 172.484 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 153' ' ' SER . . . . . . . . . . . . . 36.5 m -65.84 -36.07 82.42 Favored 'General case' 0 CA--C 1.544 0.734 0 C-N-CA 123.641 0.776 . . . . 42.0 110.542 171.729 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 26.3 mmtp -122.87 139.47 54.0 Favored 'General case' 0 N--CA 1.479 0.985 0 C-N-CA 123.899 0.879 . . . . 72.109999999999999 109.505 175.222 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 11.7 tppt? -78.79 99.46 6.71 Favored 'General case' 0 CA--C 1.538 0.5 0 C-N-CA 123.101 0.56 . . . . 71.540000000000006 109.774 -178.127 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 156' ' ' ILE . . . . . 0.476 ' HB ' ' HB2' ' A' ' 53' ' ' PHE . 55.7 mt -89.24 126.08 42.24 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.482 0 CA-C-N 115.444 -0.798 . . . . 75.120000000000005 108.863 179.581 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 157' ' ' THR . . . . . 0.53 ' HA ' ' HA ' ' A' ' 52' ' ' CYS . 69.0 p -122.81 170.78 9.73 Favored 'General case' 0 CA--C 1.541 0.614 0 C-N-CA 125.276 1.43 . . . . 72.109999999999999 109.725 179.958 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 158' ' ' ILE . . . . . 0.43 ' O ' ' HA2' ' A' ' 50' ' ' GLY . 75.4 mt -90.83 113.51 26.74 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.685 0 N-CA-C 108.086 -1.079 . . . . 71.319999999999993 108.086 166.274 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 159' ' ' ALA . . . . . 0.641 ' HB2' ' HB2' ' A' ' 11' ' ' ALA . . . -63.84 -52.08 61.75 Favored 'General case' 0 N--CA 1.476 0.871 0 C-N-CA 123.9 0.88 . . . . 32.299999999999997 111.662 177.959 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 160' ' ' ASP . . . . . . . . . . . . . 14.7 t70 -157.36 173.27 17.17 Favored 'General case' 0 N--CA 1.48 1.043 0 C-N-CA 122.881 0.472 . . . . 73.510000000000005 109.823 -174.025 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 161' ' ' CYS . . . . . . . . . . . . . 19.4 p -134.55 -166.99 1.9 Allowed 'General case' 0 N--CA 1.475 0.817 0 C-N-CA 125.309 1.444 . . . . 45.539999999999999 109.101 -173.542 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 162' ' ' GLY . . . . . . . . . . . . . . . 134.92 53.17 0.07 OUTLIER Glycine 0 C--N 1.344 1.005 0 O-C-N 122.173 -0.33 . . . . 71.010000000000005 112.358 -173.163 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 163' ' ' GLN . . . . . 0.573 ' HA ' ' H ' ' A' ' 7' ' ' PHE . 6.6 tt0 -47.33 103.6 0.04 OUTLIER 'General case' 0 N--CA 1.48 1.035 0 C-N-CA 125.101 1.36 . . . . 64.349999999999994 111.614 -179.878 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 164' ' ' LEU . . . . . . . . . . . . . 85.2 mt -71.27 121.85 19.19 Favored 'General case' 0 CA--C 1.538 0.483 0 CA-C-N 114.765 -1.107 . . . . 42.25 110.882 -174.054 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 165' ' ' GLU . . . . . . . . . . . . . 19.0 pt-20 . . . . . 0 C--O 1.249 1.04 0 C-N-CA 124.114 0.965 . . . . 74.430000000000007 109.756 171.89 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' B' B ' 216' ' ' PRO . . . . . . . . . . . . . 10.9 Cg_endo . . . . . 0 N--CA 1.486 1.048 0 N-CA-C 110.449 -0.635 . . . . 63.149999999999999 110.449 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' B' B ' 217' ' ' GLU . . . . . . . . . . . . . 40.6 mt-10 -131.79 142.08 43.91 Favored Pre-proline 0 N--CA 1.483 1.183 0 C-N-CA 123.507 0.723 . . . . 75.140000000000001 110.379 -172.994 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 218' ' ' PRO . . . . . 0.572 ' HG2' HE22 ' A' ' 111' ' ' GLN . 23.8 Cg_endo -62.37 102.69 0.28 Allowed 'Trans proline' 0 C--N 1.381 2.242 0 C-N-CA 122.386 2.058 . . . . 65.299999999999997 111.216 175.845 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 219' ' ' GLY . . . . . . . . . . . . . . . 162.61 160.47 11.18 Favored Glycine 0 CA--C 1.533 1.162 0 CA-C-N 115.032 -0.985 . . . . 74.109999999999999 111.51 -178.197 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 220' ' ' PRO . . . . . . . . . . . . . 27.5 Cg_exo -64.63 169.96 10.58 Favored 'Trans proline' 0 C--N 1.375 1.955 0 C-N-CA 123.492 2.794 . . . . 73.109999999999999 114.308 179.995 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 221' ' ' TYR . . . . . . . . . . . . . 73.1 m-85 -132.66 173.94 10.82 Favored 'General case' 0 N--CA 1.484 1.273 0 C-N-CA 123.949 0.9 . . . . 71.239999999999995 110.987 -174.938 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 222' ' ' ALA . . . . . . . . . . . . . . . -172.29 -175.37 1.39 Allowed 'General case' 0 N--CA 1.477 0.894 0 C-N-CA 124.23 1.012 . . . . 60.509999999999998 111.055 -178.93 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 223' ' ' GLN . . . . . 0.508 HE21 ' HB2' ' A' ' 60' ' ' PHE . 75.3 mt-30 61.71 91.73 0.07 OUTLIER Pre-proline 0 N--CA 1.479 0.997 0 C-N-CA 125.08 1.352 . . . . 61.509999999999998 112.546 168.06 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 224' ' ' PRO . . . . . . . . . . . . . 33.0 Cg_exo . . . . . 0 C--N 1.376 2.021 0 C-N-CA 123.219 2.612 . . . . 52.5 111.936 175.607 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 96.0 mmm . . . . . 0 N--CA 1.472 0.672 0 N-CA-C 110.119 -0.326 . . . . 73.519999999999996 110.119 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 9.1 p -68.03 -21.99 27.39 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.169 0 C-N-CA 123.744 0.818 . . . . 75.209999999999994 110.086 174.064 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 3' ' ' ASN . . . . . 0.541 HD22 ' HA ' ' A' ' 25' ' ' PHE . 16.3 m120 -59.23 119.31 37.73 Favored Pre-proline 0 CA--C 1.549 0.935 0 C-N-CA 124.914 1.286 . . . . 31.550000000000001 110.622 174.402 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 4' ' ' PRO . . . . . 0.62 ' HG2' ' HB2' ' A' ' 24' ' ' LEU . 32.7 Cg_endo -65.2 129.17 22.17 Favored 'Trans proline' 0 C--N 1.38 2.236 0 C-N-CA 122.696 2.264 . . . . 74.239999999999995 111.379 175.102 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 5' ' ' THR . . . . . 0.467 HG23 ' HD3' ' A' ' 133' ' ' LYS . 65.9 m -95.93 122.74 39.07 Favored 'General case' 0 N--CA 1.464 0.257 0 N-CA-C 108.112 -1.07 . . . . 63.240000000000002 108.112 177.44 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 34.7 m -107.15 128.6 61.95 Favored 'Isoleucine or valine' 0 C--O 1.22 -0.478 0 CA-C-O 121.432 0.634 . . . . 75.420000000000002 110.557 -179.018 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 7' ' ' PHE . . . . . 0.664 ' H ' ' HA ' ' A' ' 163' ' ' GLN . 74.6 t80 -116.03 138.79 50.9 Favored 'General case' 0 C--O 1.239 0.532 0 C-N-CA 124.792 1.237 . . . . 52.219999999999999 109.292 -171.579 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 8' ' ' PHE . . . . . 0.483 ' HB3' HG23 ' A' ' 158' ' ' ILE . 63.2 m-85 -141.02 162.68 34.92 Favored 'General case' 0 N--CA 1.47 0.568 0 O-C-N 124.375 1.047 . . . . 74.430000000000007 110.11 172.17 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 11.9 m-20 -108.67 106.8 17.01 Favored 'General case' 0 C--N 1.328 -0.341 0 C-N-CA 125.124 1.369 . . . . 62.210000000000001 107.359 171.523 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 49.5 mm -81.2 130.88 35.11 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.65 0 N-CA-C 108.664 -0.865 . . . . 73.340000000000003 108.664 177.863 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 11' ' ' ALA . . . . . 0.451 ' HB2' ' HB2' ' A' ' 159' ' ' ALA . . . -132.97 139.68 47.41 Favored 'General case' 0 N--CA 1.473 0.696 0 C-N-CA 123.754 0.822 . . . . 73.439999999999998 110.69 -174.256 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . 0.538 HG23 ' HB2' ' A' ' 17' ' ' LEU . 72.0 t -94.67 98.31 7.91 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.596 0 C-N-CA 124.899 1.28 . . . . 70.329999999999998 108.388 175.697 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 22.6 m-20 61.23 31.18 19.51 Favored 'General case' 0 N--CA 1.483 1.182 0 C-N-CA 124.702 1.201 . . . . 73.129999999999995 111.968 -177.993 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 96.14 -8.85 67.57 Favored Glycine 0 C--N 1.348 1.224 0 CA-C-O 119.749 -0.473 . . . . 63.310000000000002 113.302 179.215 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 39.1 mm-40 -85.56 113.38 50.65 Favored Pre-proline 0 N--CA 1.473 0.721 0 CA-C-O 118.418 -0.801 . . . . 73.040000000000006 109.223 173.321 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 19.2 Cg_endo -55.47 106.06 0.18 Allowed 'Trans proline' 0 C--N 1.385 2.491 0 C-N-CA 123.042 2.495 . . . . 50.219999999999999 112.249 -176.381 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . 0.538 ' HB2' HG23 ' A' ' 12' ' ' VAL . 68.9 tp -76.31 -41.37 48.81 Favored 'General case' 0 N--CA 1.476 0.858 0 C-N-CA 123.793 0.837 . . . . 51.049999999999997 109.115 -179.313 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 169.97 -172.98 44.03 Favored Glycine 0 C--N 1.341 0.836 0 CA-C-N 115.376 -0.829 . . . . 55.329999999999998 112.428 176.513 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 56.0 mtm180 -111.84 136.47 51.09 Favored 'General case' 0 C--O 1.239 0.529 0 C-N-CA 124.111 0.965 . . . . 72.010000000000005 109.766 -175.8 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 20' ' ' VAL . . . . . 0.413 ' HA ' ' HA3' ' A' ' 135' ' ' GLY . 61.1 t -129.57 131.98 66.6 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.998 0 C-N-CA 123.644 0.778 . . . . 34.140000000000001 109.522 177.494 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 45.7 m -119.62 123.8 44.75 Favored 'General case' 0 CA--C 1.543 0.673 0 C-N-CA 124.139 0.975 . . . . 74.319999999999993 108.831 174.365 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 14.7 m-85 -99.85 169.09 9.47 Favored 'General case' 0 CA--C 1.541 0.618 0 C-N-CA 123.999 0.92 . . . . 75.430000000000007 109.007 174.886 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . 0.527 ' HB2' ' HD2' ' A' ' 133' ' ' LYS . 34.2 tt0 -125.86 108.58 11.59 Favored 'General case' 0 C--O 1.239 0.532 0 N-CA-C 107.697 -1.223 . . . . 73.239999999999995 107.697 179.404 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . 0.62 ' HB2' ' HG2' ' A' ' 4' ' ' PRO . 15.8 mt -84.89 124.5 31.7 Favored 'General case' 0 C--O 1.238 0.499 0 CA-C-O 120.935 0.398 . . . . 72.310000000000002 110.028 -179.884 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 25' ' ' PHE . . . . . 0.635 ' HB2' HD11 ' A' ' 90' ' ' LEU . 86.1 m-85 -86.04 64.86 8.82 Favored 'General case' 0 CA--C 1.535 0.375 0 CA-C-N 115.66 -0.7 . . . . 61.229999999999997 109.586 174.899 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -72.42 -16.06 61.83 Favored 'General case' 0 N--CA 1.479 0.989 0 CA-C-N 115.383 -0.826 . . . . 72.099999999999994 111.445 -179.11 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 9.8 p-10 -74.15 -23.0 59.21 Favored 'General case' 0 CA--C 1.553 1.068 0 C-N-CA 123.96 0.904 . . . . 51.530000000000001 110.782 173.851 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 58.2 mttp -101.52 -52.33 3.25 Favored 'General case' 0 N--CA 1.478 0.973 0 C-N-CA 123.874 0.87 . . . . 71.209999999999994 110.771 -177.618 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 30.0 m -122.85 74.37 46.57 Favored Pre-proline 0 CA--C 1.559 1.296 0 C-N-CA 124.308 1.043 . . . . 72.299999999999997 109.761 -173.884 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 24.8 Cg_exo -62.29 -43.36 23.62 Favored 'Trans proline' 0 C--N 1.38 2.206 0 C-N-CA 122.726 2.284 . . . . 74.049999999999997 113.136 -169.717 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 31' ' ' LYS . . . . . 0.416 ' HD2' ' HB2' ' A' ' 86' ' ' GLU . 1.5 ttmp? -57.05 -54.73 43.42 Favored 'General case' 0 N--CA 1.484 1.232 0 C-N-CA 123.472 0.709 . . . . 64.129999999999995 111.495 177.476 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 6.4 m -71.21 -36.3 71.84 Favored 'General case' 0 CA--C 1.551 0.993 0 C-N-CA 123.773 0.829 . . . . 71.519999999999996 111.776 -168.932 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 33' ' ' ALA . . . . . 0.414 ' HB1' ' HB3' ' A' ' 24' ' ' LEU . . . -79.85 -48.54 13.35 Favored 'General case' 0 N--CA 1.474 0.77 0 C-N-CA 123.447 0.699 . . . . 41.350000000000001 111.103 -177.792 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 12.6 tp10 -63.47 -28.48 69.99 Favored 'General case' 0 N--CA 1.482 1.141 0 C-N-CA 123.59 0.756 . . . . 63.210000000000001 111.099 -179.491 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 35' ' ' ASN . . . . . 0.543 ' ND2' ' SD ' ' A' ' 100' ' ' MET . 32.6 t30 -52.79 -69.37 0.12 Allowed 'General case' 0 C--N 1.353 0.721 0 O-C-N 123.948 0.78 . . . . 75.239999999999995 110.316 174.239 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 85.5 t80 -66.69 -32.41 73.71 Favored 'General case' 0 N--CA 1.476 0.875 0 C-N-CA 123.501 0.721 . . . . 71.150000000000006 111.296 -173.869 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 56.2 ttt-85 -55.4 -54.33 45.08 Favored 'General case' 0 N--CA 1.474 0.767 0 C-N-CA 124.192 0.997 . . . . 64.150000000000006 110.268 175.803 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 38' ' ' ALA . . . . . 0.426 ' HB1' ' HG2' ' A' ' 44' ' ' LYS . . . -76.2 -24.15 54.67 Favored 'General case' 0 CA--C 1.541 0.623 0 CA-C-N 115.147 -0.933 . . . . 35.409999999999997 112.218 -174.941 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 39' ' ' LEU . . . . . 0.525 HD22 ' HE2' ' A' ' 48' ' ' TYR . 81.7 mt -66.03 -43.16 88.41 Favored 'General case' 0 N--CA 1.482 1.145 0 C-N-CA 123.329 0.651 . . . . 64.549999999999997 110.144 173.794 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 47.4 m -82.55 -37.37 25.25 Favored 'General case' 0 CA--C 1.547 0.838 0 CA-C-N 115.143 -0.935 . . . . 64.439999999999998 112.317 -172.718 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 41' ' ' THR . . . . . 0.421 ' OG1' ' HG2' ' A' ' 43' ' ' GLU . 3.7 p -72.79 -32.06 65.31 Favored 'General case' 0 N--CA 1.485 1.323 0 C-N-CA 122.519 0.328 . . . . 73.239999999999995 110.309 172.664 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 84.85 29.5 28.8 Favored Glycine 0 C--N 1.345 1.059 0 CA-C-N 116.025 -0.534 . . . . 70.049999999999997 112.558 -178.789 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 43' ' ' GLU . . . . . 0.421 ' HG2' ' OG1' ' A' ' 41' ' ' THR . 17.6 mm-40 -63.85 -31.41 72.59 Favored 'General case' 0 N--CA 1.48 1.058 0 C-N-CA 123.266 0.626 . . . . 64.209999999999994 110.793 176.606 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 44' ' ' LYS . . . . . 0.426 ' HG2' ' HB1' ' A' ' 38' ' ' ALA . 71.6 mmtt -95.42 19.25 11.15 Favored 'General case' 0 N--CA 1.48 1.028 0 C-N-CA 123.719 0.807 . . . . 64.439999999999998 110.533 179.012 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 83.72 -15.97 33.77 Favored Glycine 0 C--N 1.353 1.482 0 CA-C-O 119.472 -0.627 . . . . 62.100000000000001 114.486 175.814 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 46' ' ' PHE . . . . . 0.421 ' HE2' ' HA ' ' A' ' 78' ' ' ILE . 23.6 m-85 -76.77 -51.24 11.75 Favored 'General case' 0 N--CA 1.476 0.853 0 CA-C-N 117.508 0.654 . . . . 61.340000000000003 112.686 -166.77 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 48.82 63.3 3.95 Favored Glycine 0 C--N 1.355 1.628 0 O-C-N 123.978 0.799 . . . . 54.329999999999998 114.653 176.302 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 48' ' ' TYR . . . . . 0.525 ' HE2' HD22 ' A' ' 39' ' ' LEU . 30.2 m-85 -70.04 100.2 1.58 Allowed 'General case' 0 N--CA 1.484 1.25 0 CA-C-N 117.763 0.782 . . . . 74.099999999999994 111.332 -175.511 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 49' ' ' LYS . . . . . 0.582 ' HE3' ' HA ' ' A' ' 160' ' ' ASP . 23.5 tptm -107.47 132.32 53.35 Favored 'General case' 0 CA--C 1.534 0.332 0 C-N-CA 124.951 1.301 . . . . 71.430000000000007 109.063 -176.004 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 83.2 21.38 58.93 Favored Glycine 0 C--N 1.348 1.196 0 CA-C-O 119.722 -0.488 . . . . 72.099999999999994 112.958 179.408 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 51' ' ' SER . . . . . 0.73 ' HA ' ' HB2' ' A' ' 67' ' ' PHE . 22.4 t -61.91 114.26 3.26 Favored 'General case' 0 C--N 1.358 0.959 0 C-N-CA 122.937 0.495 . . . . 74.519999999999996 110.601 -179.761 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 52' ' ' CYS . . . . . 0.609 ' HB3' ' HB3' ' A' ' 66' ' ' ASP . 53.5 t -89.89 157.95 17.65 Favored 'General case' 0 C--O 1.24 0.58 0 C-N-CA 123.352 0.661 . . . . 52.520000000000003 111.412 -173.349 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 53' ' ' PHE . . . . . 0.7 ' HA ' ' HA2' ' A' ' 64' ' ' GLY . 14.5 m-85 -105.85 98.0 7.75 Favored 'General case' 0 CA--C 1.535 0.402 0 C-N-CA 124.973 1.309 . . . . 70.239999999999995 107.64 176.263 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 40.8 p-80 -88.22 -27.26 21.91 Favored 'General case' 0 N--CA 1.483 1.206 0 C-N-CA 122.464 0.306 . . . . 74.450000000000003 111.519 -178.068 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 55' ' ' ARG . . . . . 0.501 ' HA ' ' O ' ' A' ' 150' ' ' GLY . 42.4 ttt180 -116.1 104.86 11.97 Favored 'General case' 0 C--O 1.212 -0.917 0 N-CA-C 109.762 -0.458 . . . . 71.329999999999998 109.762 -175.583 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 63.5 mt -132.46 133.39 59.89 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.044 0 N-CA-C 108.963 -0.754 . . . . 74.549999999999997 108.963 174.066 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 57' ' ' ILE . . . . . 0.409 ' HB ' ' HD2' ' A' ' 60' ' ' PHE . 62.0 mt -123.15 123.18 26.73 Favored Pre-proline 0 CA--C 1.558 1.265 0 C-N-CA 124.41 1.084 . . . . 71.0 109.044 176.475 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 55.9 Cg_endo -67.31 144.7 69.22 Favored 'Trans proline' 0 C--N 1.383 2.392 0 C-N-CA 122.983 2.455 . . . . 75.540000000000006 111.798 178.706 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 73.56 13.48 80.15 Favored Glycine 0 CA--C 1.527 0.838 0 CA-C-N 115.46 -0.791 . . . . 71.099999999999994 114.027 -176.409 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 60' ' ' PHE . . . . . 0.409 ' HD2' ' HB ' ' A' ' 57' ' ' ILE . 17.6 t80 -139.73 -75.06 0.35 Allowed 'General case' 0 C--O 1.245 0.859 0 C-N-CA 123.091 0.556 . . . . 65.209999999999994 110.495 -173.964 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 61' ' ' MET . . . . . 0.68 ' SD ' ' HB2' ' A' ' 113' ' ' PHE . 13.9 tmm? -174.62 147.26 1.06 Allowed 'General case' 0 CA--C 1.55 0.957 0 N-CA-C 112.064 0.394 . . . . 71.430000000000007 112.064 -164.827 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 62' ' ' CYS . . . . . 0.527 ' SG ' ' HB ' ' A' ' 114' ' ' ILE . 21.8 p -108.11 112.48 25.04 Favored 'General case' 0 CA--C 1.552 1.053 0 C-N-CA 124.182 0.993 . . . . 51.399999999999999 109.873 172.984 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 63' ' ' GLN . . . . . 0.607 ' HB2' ' SD ' ' A' ' 61' ' ' MET . 49.2 tt0 -104.87 111.33 24.05 Favored 'General case' 0 N--CA 1.487 1.404 0 C-N-CA 124.064 0.946 . . . . 71.150000000000006 111.465 -173.637 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 64' ' ' GLY . . . . . 0.7 ' HA2' ' HA ' ' A' ' 53' ' ' PHE . . . -89.51 -179.6 45.01 Favored Glycine 0 C--N 1.342 0.865 0 CA-C-N 114.952 -1.022 . . . . 55.200000000000003 112.583 173.483 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 99.42 72.22 1.02 Allowed Glycine 0 N--CA 1.444 -0.809 0 N-CA-C 110.491 -1.044 . . . . 45.310000000000002 110.491 -174.334 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 66' ' ' ASP . . . . . 0.609 ' HB3' ' HB3' ' A' ' 52' ' ' CYS . 38.2 t70 -123.88 -4.64 8.06 Favored 'General case' 0 N--CA 1.484 1.256 0 C-N-CA 123.735 0.814 . . . . 72.349999999999994 110.756 175.915 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 67' ' ' PHE . . . . . 0.73 ' HB2' ' HA ' ' A' ' 51' ' ' SER . 56.0 t80 -79.25 -70.58 0.5 Allowed 'General case' 0 CA--C 1.544 0.718 0 CA-C-N 116.082 -0.508 . . . . 74.099999999999994 111.315 -171.402 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 30.9 m -86.28 102.17 13.73 Favored 'General case' 0 N--CA 1.471 0.602 0 C-N-CA 122.484 0.313 . . . . 72.540000000000006 110.954 -171.136 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 81.5 mtp180 52.69 81.94 0.08 Allowed 'General case' 0 N--CA 1.476 0.844 0 C-N-CA 124.518 1.127 . . . . 74.519999999999996 111.335 -178.266 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 27.5 p80 -74.68 26.11 0.09 Allowed 'General case' 0 N--CA 1.495 1.78 0 N-CA-C 113.74 1.015 . . . . 74.400000000000006 113.74 -170.843 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 1.9 m-20 -86.65 45.06 1.21 Allowed 'General case' 0 CA--C 1.555 1.155 0 C-N-CA 124.344 1.058 . . . . 73.219999999999999 109.62 175.436 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 86.79 -7.9 77.99 Favored Glycine 0 C--N 1.353 1.515 0 CA-C-N 116.081 -0.509 . . . . 63.140000000000001 113.459 -176.811 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 73' ' ' THR . . . . . 0.507 ' HA ' ' HB2' ' A' ' 110' ' ' SER . 3.7 m -90.45 -61.57 1.65 Allowed 'General case' 0 N--CA 1.475 0.786 0 CA-C-N 117.499 0.65 . . . . 64.099999999999994 109.35 179.62 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 62.76 10.12 29.91 Favored Glycine 0 CA--C 1.538 1.525 0 N-CA-C 116.585 1.394 . . . . 62.32 116.585 164.772 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 145.44 55.4 0.02 OUTLIER Glycine 0 N--CA 1.471 1.012 0 CA-C-N 118.179 0.99 . . . . 72.230000000000004 111.451 -164.512 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 23.3 pttm -51.13 165.54 0.12 Allowed 'General case' 0 N--CA 1.488 1.428 0 C-N-CA 124.881 1.272 . . . . 75.239999999999995 112.658 179.8 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 77' ' ' SER . . . . . 0.428 ' HA ' HD11 ' A' ' 39' ' ' LEU . 77.0 p -90.65 178.59 6.03 Favored 'General case' 0 CA--C 1.545 0.767 0 C-N-CA 123.386 0.674 . . . . 71.099999999999994 112.446 -169.697 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 78' ' ' ILE . . . . . 0.421 ' HA ' ' HE2' ' A' ' 46' ' ' PHE . 34.7 pt -72.14 -14.57 17.43 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.074 0 C-N-CA 123.935 0.894 . . . . 73.430000000000007 110.663 175.207 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 89.6 m-85 -94.54 16.06 16.37 Favored 'General case' 0 CA--C 1.548 0.872 0 C-N-CA 124.458 1.103 . . . . 73.230000000000004 110.541 175.674 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 89.79 -121.76 6.26 Favored Glycine 0 C--N 1.355 1.587 0 N-CA-C 111.005 -0.838 . . . . 74.129999999999995 111.005 -179.35 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 42.3 tt0 -55.56 -56.4 20.74 Favored 'General case' 0 N--CA 1.48 1.059 0 C-N-CA 125.02 1.328 . . . . 73.109999999999999 111.321 -177.384 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 82' ' ' LYS . . . . . 0.842 ' HD2' ' HA ' ' A' ' 107' ' ' THR . 21.0 pttp -169.79 179.2 3.76 Favored 'General case' 0 N--CA 1.48 1.04 0 C-N-CA 124.322 1.049 . . . . 75.409999999999997 109.895 -174.999 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 53.5 p90 -148.79 173.66 13.03 Favored 'General case' 0 N--CA 1.475 0.817 0 C-N-CA 123.908 0.883 . . . . 75.25 111.269 -177.422 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 13.9 pt-20 -94.8 151.43 19.25 Favored 'General case' 0 CA--C 1.541 0.603 0 CA-C-N 115.009 -0.996 . . . . 74.299999999999997 110.908 178.532 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 85' ' ' ASP . . . . . 0.424 ' HB3' HG23 ' A' ' 127' ' ' VAL . 44.7 m-20 -65.91 136.69 56.46 Favored 'General case' 0 N--CA 1.475 0.813 0 C-N-CA 124.375 1.07 . . . . 75.409999999999997 111.811 -176.93 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 86' ' ' GLU . . . . . 0.416 ' HB2' ' HD2' ' A' ' 31' ' ' LYS . 11.8 tp10 -86.06 -63.54 1.3 Allowed 'General case' 0 CA--C 1.548 0.895 0 CA-C-N 116.106 -0.497 . . . . 63.229999999999997 111.399 -173.144 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 26.0 p-10 -166.71 135.59 2.87 Favored 'General case' 0 N--CA 1.482 1.164 0 C-N-CA 122.936 0.494 . . . . 74.549999999999997 110.194 -173.944 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 25.9 m-85 -95.34 59.83 2.22 Favored 'General case' 0 N--CA 1.478 0.928 0 C-N-CA 123.841 0.856 . . . . 74.099999999999994 110.71 -170.797 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 34.0 mt -75.22 -35.32 33.61 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.17 0 CA-C-N 115.795 -0.639 . . . . 73.049999999999997 110.169 176.004 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 90' ' ' LEU . . . . . 0.635 HD11 ' HB2' ' A' ' 25' ' ' PHE . 78.8 mt -100.1 161.53 13.55 Favored 'General case' 0 N--CA 1.471 0.623 0 C-N-CA 123.798 0.839 . . . . 73.319999999999993 110.61 -179.125 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 91' ' ' LYS . . . . . 0.659 ' HG3' HG22 ' A' ' 93' ' ' THR . 49.3 pttt -159.17 160.37 35.42 Favored 'General case' 0 CA--C 1.547 0.864 0 CA-C-O 121.646 0.736 . . . . 43.039999999999999 111.931 -174.293 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 92' ' ' HIS . . . . . . . . . . . . . 22.9 m-70 -88.93 32.88 0.79 Allowed 'General case' 0 N--CA 1.483 1.195 0 C-N-CA 124.401 1.08 . . . . 73.129999999999995 112.434 -167.877 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 93' ' ' THR . . . . . 0.659 HG22 ' HG3' ' A' ' 91' ' ' LYS . 6.1 t -89.44 68.72 7.92 Favored 'General case' 0 N--CA 1.479 1.003 0 CA-C-O 122.52 1.152 . . . . 74.129999999999995 110.007 -179.217 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 153.12 164.51 12.59 Favored Glycine 0 C--N 1.338 0.64 0 CA-C-N 114.572 -1.195 . . . . 63.130000000000003 111.745 179.245 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 63.6 Cg_endo -76.82 157.37 35.16 Favored 'Trans proline' 0 CA--C 1.554 1.485 0 C-N-CA 122.308 2.006 . . . . 73.400000000000006 112.167 172.965 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 84.16 18.61 62.45 Favored Glycine 0 CA--C 1.532 1.145 0 N-CA-C 114.543 0.577 . . . . 60.329999999999998 114.543 177.506 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 97' ' ' ILE . . . . . . . . . . . . . 37.6 mm -86.48 106.93 16.19 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.311 0 CA-C-N 117.765 0.783 . . . . 71.219999999999999 111.689 -175.07 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 98' ' ' LEU . . . . . 0.449 HD13 HG12 ' A' ' 114' ' ' ILE . 67.2 tp -92.89 119.25 32.0 Favored 'General case' 0 CA--C 1.552 1.055 0 C-N-CA 123.582 0.753 . . . . 73.230000000000004 110.746 -178.614 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 13.5 m -138.0 143.28 40.56 Favored 'General case' 0 N--CA 1.482 1.134 0 C-N-CA 124.744 1.218 . . . . 62.509999999999998 108.774 177.492 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 100' ' ' MET . . . . . 0.649 ' HA ' ' HA ' ' A' ' 112' ' ' PHE . 73.3 mtp -77.95 138.95 39.13 Favored 'General case' 0 N--CA 1.488 1.433 0 CA-C-N 118.616 0.644 . . . . 73.439999999999998 109.335 176.144 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 101' ' ' ALA . . . . . 0.53 ' HB3' ' HB2' ' A' ' 111' ' ' GLN . . . -74.68 160.82 30.3 Favored 'General case' 0 N--CA 1.483 1.178 0 C-N-CA 123.106 0.562 . . . . 74.340000000000003 112.21 -168.281 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 102' ' ' ASN . . . . . 0.439 ' HB3' ' HA ' ' A' ' 108' ' ' ASN . 27.5 p-10 -165.28 164.3 19.94 Favored 'General case' 0 N--CA 1.476 0.839 0 CA-C-N 115.515 -0.766 . . . . 70.299999999999997 110.974 -176.383 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -107.85 10.34 28.63 Favored 'General case' 0 CA--C 1.549 0.91 0 C-N-CA 123.903 0.881 . . . . 64.230000000000004 110.615 171.676 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 148.65 -175.57 27.86 Favored Glycine 0 C--N 1.356 1.669 0 CA-C-O 119.543 -0.587 . . . . 40.520000000000003 112.373 179.666 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 40.4 Cg_exo -59.0 143.94 99.58 Favored 'Trans proline' 0 C--N 1.375 1.955 0 C-N-CA 123.358 2.705 . . . . 64.150000000000006 112.326 174.311 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 65.1 t30 70.56 9.57 6.94 Favored 'General case' 0 N--CA 1.49 1.573 0 C-N-CA 125.27 1.428 . . . . 73.409999999999997 111.245 -177.914 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 107' ' ' THR . . . . . 0.842 ' HA ' ' HD2' ' A' ' 82' ' ' LYS . 4.0 m -121.88 4.65 9.95 Favored 'General case' 0 CA--C 1.556 1.18 0 C-N-CA 123.476 0.711 . . . . 73.430000000000007 110.945 -175.895 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 108' ' ' ASN . . . . . 0.439 ' HA ' ' HB3' ' A' ' 102' ' ' ASN . 48.5 t30 -84.7 140.74 31.08 Favored 'General case' 0 N--CA 1.485 1.324 0 C-N-CA 123.71 0.804 . . . . 72.209999999999994 110.68 -176.682 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 111.98 23.34 5.6 Favored Glycine 0 N--CA 1.474 1.206 0 C-N-CA 122.556 0.122 . . . . 55.030000000000001 113.354 -177.946 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 110' ' ' SER . . . . . 0.507 ' HB2' ' HA ' ' A' ' 73' ' ' THR . 12.2 p -127.77 120.33 27.66 Favored 'General case' 0 CA--C 1.536 0.433 0 N-CA-C 107.334 -1.358 . . . . 62.509999999999998 107.334 171.866 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 111' ' ' GLN . . . . . 0.53 ' HB2' ' HB3' ' A' ' 101' ' ' ALA . 49.4 mt-30 67.65 175.22 0.26 Allowed 'General case' 0 N--CA 1.488 1.436 0 C-N-CA 124.942 1.297 . . . . 74.329999999999998 111.051 -172.82 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 112' ' ' PHE . . . . . 0.649 ' HA ' ' HA ' ' A' ' 100' ' ' MET . 23.7 p90 -149.86 142.18 24.22 Favored 'General case' 0 N--CA 1.477 0.885 0 N-CA-C 108.12 -1.067 . . . . 74.340000000000003 108.12 176.209 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 113' ' ' PHE . . . . . 0.68 ' HB2' ' SD ' ' A' ' 61' ' ' MET . 54.3 p90 -135.27 139.02 44.07 Favored 'General case' 0 C--O 1.239 0.509 0 CA-C-O 121.198 0.523 . . . . 72.530000000000001 111.227 -177.649 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 114' ' ' ILE . . . . . 0.527 ' HB ' ' SG ' ' A' ' 62' ' ' CYS . 11.8 mt -103.17 108.36 24.19 Favored 'Isoleucine or valine' 0 C--O 1.241 0.629 0 N-CA-C 107.475 -1.306 . . . . 73.420000000000002 107.475 176.805 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 115' ' ' CYS . . . . . . . . . . . . . 58.6 m -67.87 103.72 1.52 Allowed 'General case' 0 N--CA 1.467 0.395 0 N-CA-C 109.059 -0.719 . . . . 71.420000000000002 109.059 177.01 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 116' ' ' THR . . . . . 0.609 HG22 HG12 ' A' ' 139' ' ' VAL . 36.6 p -70.9 -32.39 69.33 Favored 'General case' 0 CA--C 1.54 0.584 0 C-N-CA 124.361 1.065 . . . . 64.099999999999994 110.317 179.737 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -110.25 167.91 9.84 Favored 'General case' 0 CA--C 1.543 0.686 0 C-N-CA 124.339 1.056 . . . . 72.329999999999998 109.853 173.92 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 18.2 ptmt -76.83 85.08 3.41 Favored 'General case' 0 N--CA 1.479 0.98 0 C-N-CA 123.427 0.691 . . . . 70.439999999999998 110.568 179.309 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 119' ' ' THR . . . . . 0.656 ' HB ' HD23 ' A' ' 122' ' ' LEU . 73.5 p -77.44 85.33 3.84 Favored 'General case' 0 CA--C 1.552 1.034 0 CA-C-O 122.068 0.937 . . . . 75.140000000000001 110.168 -175.559 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 9.8 pt-20 -81.52 -20.88 39.12 Favored 'General case' 0 N--CA 1.486 1.34 0 C-N-CA 123.691 0.796 . . . . 73.409999999999997 112.247 -167.862 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 121' ' ' TRP . . . . . . . . . . . . . 28.5 p90 -73.06 -8.16 54.49 Favored 'General case' 0 N--CA 1.484 1.23 0 C-N-CA 123.525 0.73 . . . . 74.310000000000002 110.794 174.748 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 122' ' ' LEU . . . . . 0.656 HD23 ' HB ' ' A' ' 119' ' ' THR . 4.2 mm? -84.23 11.48 8.18 Favored 'General case' 0 CA--C 1.554 1.105 0 C-N-CA 124.16 0.984 . . . . 64.129999999999995 111.239 170.932 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 34.5 m-20 -75.92 150.84 37.46 Favored 'General case' 0 N--CA 1.491 1.602 0 CA-C-N 118.804 0.729 . . . . 72.120000000000005 110.744 171.228 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 64.45 13.45 54.88 Favored Glycine 0 C--N 1.352 1.43 0 O-C-N 123.877 0.735 . . . . 55.140000000000001 112.829 -173.827 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -106.76 -166.21 1.15 Allowed 'General case' 0 CA--C 1.547 0.86 0 C-N-CA 124.941 1.296 . . . . 73.310000000000002 108.05 -173.108 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 126' ' ' HIS . . . . . . . . . . . . . 2.1 p80 -66.84 156.79 34.68 Favored 'General case' 0 N--CA 1.476 0.865 0 C-N-CA 124.48 1.112 . . . . 75.319999999999993 113.039 -173.68 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 127' ' ' VAL . . . . . 0.424 HG23 ' HB3' ' A' ' 85' ' ' ASP . 45.9 t -65.74 133.3 30.97 Favored 'Isoleucine or valine' 0 CA--C 1.553 1.084 0 C-N-CA 125.476 1.51 . . . . 73.439999999999998 112.955 -168.894 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 128' ' ' VAL . . . . . 0.509 ' HB ' ' HB2' ' A' ' 90' ' ' LEU . 47.3 t -85.19 158.57 3.41 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.148 0 C-N-CA 124.759 1.224 . . . . 71.129999999999995 108.701 168.813 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 129' ' ' PHE . . . . . 0.417 ' HD2' HD22 ' A' ' 24' ' ' LEU . 36.8 p90 -139.87 -32.53 0.62 Allowed 'General case' 0 N--CA 1.481 1.092 0 CA-C-N 118.422 0.556 . . . . 74.430000000000007 111.936 176.578 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . -117.84 162.41 13.07 Favored Glycine 0 C--N 1.341 0.855 0 CA-C-O 121.071 0.262 . . . . 62.009999999999998 113.427 -173.112 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 131' ' ' LYS . . . . . 0.404 ' HB3' ' HE2' ' A' ' 131' ' ' LYS . 29.6 ttpt -149.51 120.06 7.46 Favored 'General case' 0 N--CA 1.469 0.489 0 C-N-CA 124.717 1.207 . . . . 71.040000000000006 108.796 -179.608 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 34.8 t -61.17 100.78 0.13 Allowed 'Isoleucine or valine' 0 N--CA 1.473 0.7 0 N-CA-C 109.567 -0.531 . . . . 74.120000000000005 109.567 177.266 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 133' ' ' LYS . . . . . 0.527 ' HD2' ' HB2' ' A' ' 23' ' ' GLU . 0.1 OUTLIER -86.25 -28.76 23.61 Favored 'General case' 0 N--CA 1.473 0.68 0 N-CA-C 109.454 -0.573 . . . . 73.310000000000002 109.454 -179.901 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 42.4 mt-10 -144.27 149.83 36.91 Favored 'General case' 0 N--CA 1.478 0.968 0 C-N-CA 124.937 1.295 . . . . 71.5 109.945 176.748 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 135' ' ' GLY . . . . . 0.413 ' HA3' ' HA ' ' A' ' 20' ' ' VAL . . . 85.73 20.21 56.52 Favored Glycine 0 C--N 1.347 1.157 0 CA-C-O 119.822 -0.432 . . . . 51.299999999999997 113.687 176.749 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 136' ' ' MET . . . . . . . . . . . . . 14.4 tpt -67.24 -26.54 66.63 Favored 'General case' 0 N--CA 1.48 1.056 0 C-N-CA 123.156 0.582 . . . . 74.319999999999993 110.867 179.153 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 137' ' ' ASN . . . . . . . . . . . . . 52.9 t-20 -56.88 -44.39 82.22 Favored 'General case' 0 N--CA 1.48 1.07 0 C-N-CA 124.259 1.023 . . . . 65.150000000000006 109.812 172.164 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 138' ' ' ILE . . . . . . . . . . . . . 49.4 mm -71.47 -32.77 47.42 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.748 0 C-N-CA 123.861 0.864 . . . . 71.120000000000005 110.742 -179.08 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 139' ' ' VAL . . . . . 0.609 HG12 HG22 ' A' ' 116' ' ' THR . 93.5 t -67.09 -42.13 87.97 Favored 'Isoleucine or valine' 0 CA--C 1.559 1.317 0 C-N-CA 123.534 0.734 . . . . 54.119999999999997 110.837 177.904 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 39.3 mt-10 -73.92 -28.14 61.38 Favored 'General case' 0 N--CA 1.478 0.949 0 CA-C-N 115.563 -0.744 . . . . 62.509999999999998 110.804 176.747 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -70.43 -44.27 68.2 Favored 'General case' 0 N--CA 1.476 0.847 0 C-N-CA 123.688 0.795 . . . . 63.299999999999997 110.848 178.031 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 142' ' ' MET . . . . . 0.522 ' HB2' HD13 ' A' ' 156' ' ' ILE . 27.7 ptm -73.91 -29.36 62.01 Favored 'General case' 0 N--CA 1.473 0.679 0 CA-C-N 115.567 -0.742 . . . . 74.430000000000007 111.133 -177.975 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 143' ' ' GLU . . . . . 0.447 ' HB2' HG21 ' A' ' 116' ' ' THR . 41.2 tt0 -51.29 -38.44 52.87 Favored 'General case' 0 N--CA 1.478 0.97 0 C-N-CA 124.105 0.962 . . . . 71.540000000000006 111.707 174.189 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 144' ' ' ARG . . . . . . . . . . . . . 39.1 mtp85 -66.92 -22.1 65.97 Favored 'General case' 0 CA--C 1.542 0.667 0 CA-C-N 115.243 -0.889 . . . . 55.130000000000003 112.216 -173.432 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 145' ' ' PHE . . . . . . . . . . . . . 58.4 m-85 -82.35 -5.84 58.87 Favored 'General case' 0 N--CA 1.481 1.106 0 N-CA-C 112.088 0.403 . . . . 74.310000000000002 112.088 -178.181 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . -97.51 173.09 28.16 Favored Glycine 0 C--N 1.35 1.347 0 N-CA-C 112.52 -0.232 . . . . 73.040000000000006 112.52 177.655 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 46.1 m -134.25 172.37 12.96 Favored 'General case' 0 N--CA 1.486 1.328 0 C-N-CA 124.146 0.978 . . . . 72.439999999999998 111.106 -176.164 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 148' ' ' ARG . . . . . 0.422 ' NH1' ' HB3' ' B' ' 223' ' ' GLN . 11.0 mmt180 -57.14 -46.57 82.58 Favored 'General case' 0 N--CA 1.49 1.557 0 C-N-CA 124.697 1.199 . . . . 64.430000000000007 112.567 -178.553 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 149' ' ' ASN . . . . . . . . . . . . . 29.9 p-10 -67.34 -14.16 62.67 Favored 'General case' 0 N--CA 1.479 1.02 0 C-N-CA 123.801 0.841 . . . . 70.230000000000004 111.884 179.136 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 150' ' ' GLY . . . . . 0.501 ' O ' ' HA ' ' A' ' 55' ' ' ARG . . . 102.68 -4.34 50.2 Favored Glycine 0 C--N 1.351 1.372 0 CA-C-O 119.808 -0.44 . . . . 25.34 112.711 -179.732 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 62.3 tttp -69.93 133.56 47.44 Favored 'General case' 0 N--CA 1.475 0.778 0 CA-C-N 117.15 0.475 . . . . 72.010000000000005 110.408 -177.66 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 152' ' ' THR . . . . . . . . . . . . . 24.8 p -102.06 124.68 48.08 Favored 'General case' 0 C--O 1.236 0.38 0 C-N-CA 123.601 0.761 . . . . 73.430000000000007 109.468 174.165 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 153' ' ' SER . . . . . . . . . . . . . 47.7 t -75.15 -8.62 57.08 Favored 'General case' 0 CA--C 1.55 0.952 0 C-N-CA 123.419 0.688 . . . . 71.420000000000002 111.059 174.866 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 74.7 mmtt -133.96 132.42 40.16 Favored 'General case' 0 N--CA 1.475 0.777 0 C-N-CA 124.54 1.136 . . . . 71.299999999999997 109.424 178.489 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 46.1 mtmt -82.31 93.29 7.12 Favored 'General case' 0 N--CA 1.474 0.767 0 N-CA-C 108.085 -1.08 . . . . 73.400000000000006 108.085 173.757 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 156' ' ' ILE . . . . . 0.522 HD13 ' HB2' ' A' ' 142' ' ' MET . 62.6 mt -85.23 104.67 13.45 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.557 0 CA-C-N 115.707 -0.679 . . . . 74.209999999999994 109.886 -175.223 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 157' ' ' THR . . . . . . . . . . . . . 50.1 p -103.93 148.17 26.48 Favored 'General case' 0 N--CA 1.476 0.83 0 C-N-CA 124.44 1.096 . . . . 73.519999999999996 110.712 -173.393 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 158' ' ' ILE . . . . . 0.483 HG23 ' HB3' ' A' ' 8' ' ' PHE . 60.3 mt -74.93 93.43 0.8 Allowed 'Isoleucine or valine' 0 CA--C 1.543 0.706 0 N-CA-C 108.136 -1.061 . . . . 74.340000000000003 108.136 169.264 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 159' ' ' ALA . . . . . 0.451 ' HB2' ' HB2' ' A' ' 11' ' ' ALA . . . -57.29 -40.08 77.07 Favored 'General case' 0 N--CA 1.476 0.838 0 C-N-CA 124.585 1.154 . . . . 73.140000000000001 112.784 -177.335 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 160' ' ' ASP . . . . . 0.582 ' HA ' ' HE3' ' A' ' 49' ' ' LYS . 29.4 t70 -156.15 163.87 39.08 Favored 'General case' 0 N--CA 1.474 0.738 0 O-C-N 123.394 0.434 . . . . 61.32 111.06 -175.862 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 161' ' ' CYS . . . . . . . . . . . . . 18.6 p -131.39 -169.94 2.28 Favored 'General case' 0 CA--C 1.542 0.661 0 C-N-CA 124.976 1.311 . . . . 72.299999999999997 108.729 177.844 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 162' ' ' GLY . . . . . . . . . . . . . . . 131.22 51.69 0.1 OUTLIER Glycine 0 N--CA 1.471 1.008 0 N-CA-C 109.915 -1.274 . . . . 73.349999999999994 109.915 -170.225 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 163' ' ' GLN . . . . . 0.664 ' HA ' ' H ' ' A' ' 7' ' ' PHE . 36.7 mt-30 -54.33 122.19 9.87 Favored 'General case' 0 CA--C 1.546 0.821 0 CA-C-N 112.429 -1.885 . . . . 74.519999999999996 111.927 -175.836 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 164' ' ' LEU . . . . . . . . . . . . . 82.5 mt -71.62 98.8 1.96 Allowed 'General case' 0 N--CA 1.475 0.806 0 C-N-CA 123.377 0.671 . . . . 70.310000000000002 111.377 -168.046 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 165' ' ' GLU . . . . . . . . . . . . . 42.5 mt-10 . . . . . 0 C--O 1.252 1.189 0 N-CA-C 107.742 -1.207 . . . . 73.230000000000004 107.742 173.77 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' B' B ' 216' ' ' PRO . . . . . 0.575 ' N ' ' HH ' ' B' ' 221' ' ' TYR . 24.0 Cg_exo . . . . . 0 N--CA 1.486 1.068 0 N-CA-C 110.361 -0.669 . . . . 64.239999999999995 110.361 . . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 217' ' ' GLU . . . . . . . . . . . . . 11.2 pt-20 -59.89 145.08 85.03 Favored Pre-proline 0 CA--C 1.554 1.097 0 CA-C-N 114.543 -1.208 . . . . 72.109999999999999 112.259 -178.503 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 218' ' ' PRO . . . . . . . . . . . . . 32.4 Cg_exo -61.89 98.17 0.16 Allowed 'Trans proline' 0 C--N 1.374 1.9 0 C-N-CA 122.63 2.22 . . . . 63.200000000000003 111.787 167.861 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 219' ' ' GLY . . . . . . . . . . . . . . . 171.14 152.48 8.27 Favored Glycine 0 C--N 1.339 0.748 0 CA-C-N 115.827 -0.624 . . . . 72.420000000000002 111.865 178.4 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 220' ' ' PRO . . . . . 0.623 ' HB3' HD11 ' A' ' 122' ' ' LEU . 84.5 Cg_endo -77.72 155.52 31.13 Favored 'Trans proline' 0 C--N 1.373 1.852 0 C-N-CA 122.691 2.26 . . . . 61.210000000000001 112.395 179.888 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 221' ' ' TYR . . . . . 0.575 ' HH ' ' N ' ' B' ' 216' ' ' PRO . 54.4 m-85 -114.08 142.88 45.64 Favored 'General case' 0 C--O 1.244 0.777 0 C-N-CA 123.306 0.642 . . . . 74.140000000000001 109.469 -174.799 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 222' ' ' ALA . . . . . . . . . . . . . . . -171.08 161.13 6.71 Favored 'General case' 0 C--O 1.243 0.742 0 C-N-CA 124.457 1.103 . . . . 75.040000000000006 110.198 175.086 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 223' ' ' GLN . . . . . 0.422 ' HB3' ' NH1' ' A' ' 148' ' ' ARG . 76.4 mt-30 60.19 64.31 2.7 Favored Pre-proline 0 CA--C 1.553 1.085 0 C-N-CA 124.725 1.21 . . . . 73.439999999999998 111.572 174.748 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 224' ' ' PRO . . . . . . . . . . . . . 22.1 Cg_exo . . . . . 0 C--N 1.379 2.178 0 C-N-CA 123.411 2.741 . . . . 53.240000000000002 112.399 -176.535 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 60.7 mtt . . . . . 0 N--CA 1.482 1.157 0 N-CA-C 109.075 -0.713 . . . . 65.109999999999999 109.075 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 24.0 t -77.54 72.24 0.5 Allowed 'Isoleucine or valine' 0 N--CA 1.483 1.21 0 CA-C-O 121.915 0.864 . . . . 70.420000000000002 109.099 179.185 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 3' ' ' ASN . . . . . 0.4 ' ND2' ' HA ' ' A' ' 25' ' ' PHE . 16.6 m120 -101.92 105.5 42.14 Favored Pre-proline 0 C--O 1.24 0.588 0 CA-C-N 114.267 -1.333 . . . . 73.349999999999994 110.024 177.179 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 4' ' ' PRO . . . . . 0.451 ' HG2' ' HB2' ' A' ' 24' ' ' LEU . 60.7 Cg_endo -80.04 141.02 14.54 Favored 'Trans proline' 0 C--N 1.362 1.283 0 C-N-CA 122.116 1.877 . . . . 75.340000000000003 111.003 164.518 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 5' ' ' THR . . . . . 0.402 ' HB ' ' O ' ' A' ' 164' ' ' LEU . 50.6 m -96.54 134.0 40.31 Favored 'General case' 0 CA--C 1.533 0.302 0 N-CA-C 108.744 -0.835 . . . . 72.530000000000001 108.744 175.673 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . 0.6 ' HA ' ' HB2' ' A' ' 163' ' ' GLN . 58.2 t -100.47 145.84 10.27 Favored 'Isoleucine or valine' 0 C--O 1.217 -0.645 0 N-CA-C 107.869 -1.16 . . . . 63.210000000000001 107.869 174.593 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 7' ' ' PHE . . . . . 0.443 ' HB2' ' HG ' ' A' ' 164' ' ' LEU . 87.7 t80 -129.26 126.46 39.12 Favored 'General case' 0 C--O 1.239 0.552 0 N-CA-C 109.132 -0.692 . . . . 75.519999999999996 109.132 178.663 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 8' ' ' PHE . . . . . 0.441 ' HE2' ' HZ ' ' A' ' 36' ' ' PHE . 31.0 m-85 -128.16 166.0 19.35 Favored 'General case' 0 C--O 1.238 0.477 0 C-N-CA 124.253 1.021 . . . . 73.409999999999997 109.409 168.8 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 29.1 m-20 -115.16 111.96 21.8 Favored 'General case' 0 C--N 1.326 -0.419 0 N-CA-C 107.291 -1.374 . . . . 75.140000000000001 107.291 170.835 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 10' ' ' ILE . . . . . 0.482 HG21 ' SD ' ' A' ' 142' ' ' MET . 46.8 mm -80.89 125.76 39.5 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.473 0 N-CA-C 108.896 -0.779 . . . . 60.100000000000001 108.896 -179.461 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 11' ' ' ALA . . . . . 0.821 ' HB2' ' HB2' ' A' ' 159' ' ' ALA . . . -114.6 142.82 45.94 Favored 'General case' 0 C--O 1.217 -0.634 0 C-N-CA 124.556 1.142 . . . . 52.210000000000001 110.199 -173.839 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . 0.46 HG22 HG12 ' A' ' 156' ' ' ILE . 60.9 t -123.99 135.12 64.61 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.907 0 N-CA-C 107.237 -1.394 . . . . 64.209999999999994 107.237 172.097 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 25.4 m-20 65.49 20.32 11.68 Favored 'General case' 0 N--CA 1.494 1.73 0 C-N-CA 124.304 1.041 . . . . 75.209999999999994 110.424 -168.841 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 80.36 -5.7 62.93 Favored Glycine 0 C--N 1.358 1.753 0 CA-C-N 116.065 -0.516 . . . . 60.109999999999999 113.757 -173.849 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 30.8 mm-40 -104.77 126.94 29.9 Favored Pre-proline 0 N--CA 1.475 0.823 0 C-N-CA 123.882 0.873 . . . . 75.329999999999998 110.45 -175.52 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 14.8 Cg_endo -51.87 112.94 0.96 Allowed 'Trans proline' 0 C--N 1.385 2.494 0 C-N-CA 123.538 2.826 . . . . 63.520000000000003 112.647 -174.397 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 50.7 tp -76.42 -46.35 27.52 Favored 'General case' 0 N--CA 1.468 0.472 0 CA-C-N 115.007 -0.997 . . . . 52.409999999999997 108.859 175.535 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -169.57 -176.21 39.25 Favored Glycine 0 C--N 1.34 0.781 0 CA-C-N 115.169 -0.923 . . . . 72.340000000000003 112.258 179.777 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 13.5 ptp180 -109.79 144.44 38.21 Favored 'General case' 0 N--CA 1.475 0.786 0 C-N-CA 123.833 0.853 . . . . 54.340000000000003 110.256 -179.536 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 99.3 t -135.55 131.97 51.38 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.733 0 C-N-CA 124.058 0.943 . . . . 74.25 108.918 177.117 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 21' ' ' SER . . . . . 0.473 ' OG ' ' HB2' ' A' ' 134' ' ' GLU . 78.0 p -116.13 130.9 57.02 Favored 'General case' 0 CA--C 1.552 1.021 0 C-N-CA 123.388 0.675 . . . . 75.239999999999995 109.561 173.914 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 22' ' ' PHE . . . . . 0.452 ' CD1' HD22 ' A' ' 98' ' ' LEU . 44.9 m-85 -102.61 169.94 8.34 Favored 'General case' 0 N--CA 1.471 0.575 0 C-N-CA 124.785 1.234 . . . . 64.200000000000003 110.015 178.928 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 6.4 tp10 -130.95 106.31 8.33 Favored 'General case' 0 C--O 1.24 0.57 0 N-CA-C 108.593 -0.891 . . . . 54.439999999999998 108.593 -179.691 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . 0.451 ' HB2' ' HG2' ' A' ' 4' ' ' PRO . 52.1 mt -78.71 124.75 28.52 Favored 'General case' 0 N--CA 1.468 0.448 0 N-CA-C 109.962 -0.384 . . . . 75.150000000000006 109.962 178.383 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 25' ' ' PHE . . . . . 0.483 ' HB2' HD11 ' A' ' 90' ' ' LEU . 36.4 m-85 -85.34 60.0 5.98 Favored 'General case' 0 CA--C 1.545 0.771 0 N-CA-C 108.777 -0.823 . . . . 73.239999999999995 108.777 173.132 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -61.34 -33.41 73.57 Favored 'General case' 0 N--CA 1.483 1.21 0 C-N-CA 123.613 0.765 . . . . 75.420000000000002 111.666 -175.344 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 12.2 p-10 -59.98 -29.59 68.55 Favored 'General case' 0 CA--C 1.549 0.907 0 C-N-CA 124.372 1.069 . . . . 70.040000000000006 111.92 176.765 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 28' ' ' LYS . . . . . 0.579 ' HD2' HD21 ' A' ' 90' ' ' LEU . 40.0 mttm -94.72 -42.29 8.83 Favored 'General case' 0 N--CA 1.482 1.14 0 C-N-CA 123.548 0.739 . . . . 74.239999999999995 110.637 -178.114 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 29' ' ' VAL . . . . . 0.532 HG21 ' HA ' ' A' ' 129' ' ' PHE . 18.9 m -124.58 82.17 59.47 Favored Pre-proline 0 CA--C 1.563 1.473 0 C-N-CA 123.843 0.857 . . . . 74.329999999999998 110.867 -176.369 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 60.7 Cg_exo -53.77 -52.6 8.12 Favored 'Trans proline' 0 C--N 1.386 2.533 0 C-N-CA 123.183 2.589 . . . . 75.030000000000001 113.504 -177.83 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 4.0 ttmp? -66.47 -52.77 42.72 Favored 'General case' 0 N--CA 1.481 1.096 0 C-N-CA 124.252 1.021 . . . . 75.019999999999996 111.975 -177.301 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 32' ' ' THR . . . . . 0.66 HG22 ' HD2' ' A' ' 129' ' ' PHE . 1.4 m -64.55 -38.04 89.63 Favored 'General case' 0 CA--C 1.549 0.925 0 CA-C-N 115.23 -0.895 . . . . 73.030000000000001 110.94 -169.586 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -83.6 -36.44 23.92 Favored 'General case' 0 CA--C 1.548 0.885 0 C-N-CA 122.825 0.45 . . . . 75.439999999999998 112.2 -178.826 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 29.9 tt0 -57.03 -47.42 80.95 Favored 'General case' 0 N--CA 1.492 1.64 0 C-N-CA 123.371 0.668 . . . . 53.109999999999999 110.535 175.439 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 35' ' ' ASN . . . . . 0.499 ' O ' ' HG ' ' A' ' 39' ' ' LEU . 39.8 t30 -49.63 -57.38 7.27 Favored 'General case' 0 C--N 1.349 0.577 0 O-C-N 125.406 1.691 . . . . 73.5 110.474 179.209 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 36' ' ' PHE . . . . . 0.441 ' HZ ' ' HE2' ' A' ' 8' ' ' PHE . 72.3 t80 -62.24 -45.2 94.38 Favored 'General case' 0 CA--C 1.543 0.675 0 O-C-N 124.169 0.918 . . . . 73.129999999999995 112.051 -175.939 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 11.6 ttm180 -54.14 -47.72 71.59 Favored 'General case' 0 N--CA 1.482 1.143 0 O-C-N 123.843 0.714 . . . . 75.439999999999998 111.507 176.123 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 38' ' ' ALA . . . . . 0.522 ' HB1' ' HG2' ' A' ' 44' ' ' LYS . . . -70.44 -30.37 67.19 Favored 'General case' 0 CA--C 1.544 0.724 0 CA-C-N 115.578 -0.737 . . . . 74.030000000000001 111.809 -175.605 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 39' ' ' LEU . . . . . 0.552 HD22 ' HE2' ' A' ' 48' ' ' TYR . 99.7 mt -71.31 -43.64 66.7 Favored 'General case' 0 N--CA 1.477 0.883 0 C-N-CA 123.603 0.761 . . . . 71.129999999999995 110.593 175.161 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 34.9 t -64.56 -52.32 58.29 Favored 'General case' 0 N--CA 1.477 0.924 0 C-N-CA 124.979 1.312 . . . . 70.200000000000003 111.562 -174.843 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 41' ' ' THR . . . . . 0.446 ' OG1' ' HG2' ' A' ' 43' ' ' GLU . 67.4 p -85.18 -31.25 23.33 Favored 'General case' 0 C--O 1.24 0.587 0 CA-C-N 115.096 -0.956 . . . . 74.109999999999999 111.388 -176.054 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 85.99 35.72 10.92 Favored Glycine 0 C--N 1.347 1.16 0 CA-C-N 116.154 -0.476 . . . . 53.240000000000002 112.736 -177.803 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 43' ' ' GLU . . . . . 0.446 ' HG2' ' OG1' ' A' ' 41' ' ' THR . 26.7 mm-40 -62.89 -30.86 71.85 Favored 'General case' 0 N--CA 1.483 1.218 0 C-N-CA 122.92 0.488 . . . . 55.409999999999997 110.606 172.682 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 44' ' ' LYS . . . . . 0.522 ' HG2' ' HB1' ' A' ' 38' ' ' ALA . 31.5 mmmt -100.57 20.19 15.51 Favored 'General case' 0 CA--C 1.548 0.899 0 C-N-CA 123.707 0.803 . . . . 74.530000000000001 111.465 177.353 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 71.17 41.91 59.15 Favored Glycine 0 C--N 1.35 1.334 0 CA-C-O 119.528 -0.595 . . . . 71.230000000000004 114.562 171.896 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 24.1 m-85 -123.19 -48.33 1.98 Allowed 'General case' 0 N--CA 1.486 1.372 0 CA-C-N 117.596 0.698 . . . . 71.420000000000002 111.071 -176.876 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 48.58 62.64 4.3 Favored Glycine 0 C--N 1.356 1.685 0 O-C-N 124.169 0.918 . . . . 15.109999999999999 114.288 171.669 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 48' ' ' TYR . . . . . 0.589 ' CE1' ' HA2' ' A' ' 75' ' ' GLY . 66.1 m-85 -60.78 95.37 0.04 OUTLIER 'General case' 0 N--CA 1.48 1.065 0 CA-C-O 122.108 0.956 . . . . 72.099999999999994 112.751 -174.617 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 28.6 tptp -109.41 131.45 55.05 Favored 'General case' 0 CA--C 1.537 0.457 0 CA-C-N 113.337 -1.756 . . . . 51.530000000000001 109.149 -176.798 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 72.71 20.34 79.64 Favored Glycine 0 C--N 1.346 1.098 0 CA-C-O 119.665 -0.519 . . . . 70.040000000000006 113.793 177.412 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 51' ' ' SER . . . . . 0.485 ' HB3' ' HA2' ' A' ' 65' ' ' GLY . 49.0 m -61.14 114.56 3.2 Favored 'General case' 0 N--CA 1.476 0.858 0 C-N-CA 123.249 0.62 . . . . 63.039999999999999 110.368 -178.29 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 52' ' ' CYS . . . . . . . . . . . . . 53.5 t -92.14 121.44 33.69 Favored 'General case' 0 N--CA 1.474 0.727 0 N-CA-C 113.031 0.752 . . . . 75.209999999999994 113.031 -165.945 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 53' ' ' PHE . . . . . 0.584 ' HB2' ' HB ' ' A' ' 156' ' ' ILE . 76.4 m-85 -69.4 114.57 7.77 Favored 'General case' 0 C--O 1.239 0.517 0 C-N-CA 124.867 1.267 . . . . 75.5 109.816 167.803 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 17.4 p-80 -128.04 -4.5 5.66 Favored 'General case' 0 N--CA 1.481 1.079 0 C-N-CA 123.565 0.746 . . . . 75.400000000000006 112.031 -173.819 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 36.0 ttt180 -135.19 107.37 7.19 Favored 'General case' 0 C--N 1.357 0.928 0 N-CA-C 108.975 -0.75 . . . . 74.230000000000004 108.975 170.756 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 56' ' ' ILE . . . . . 0.494 HG23 ' SG ' ' A' ' 62' ' ' CYS . 71.8 mt -130.62 129.25 64.17 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.694 0 C-N-CA 123.721 0.808 . . . . 64.349999999999994 109.242 177.365 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 57' ' ' ILE . . . . . 0.468 HG12 ' HA2' ' A' ' 150' ' ' GLY . 52.2 mt -117.07 121.54 32.38 Favored Pre-proline 0 CA--C 1.556 1.186 0 C-N-CA 124.584 1.154 . . . . 61.039999999999999 108.725 176.903 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 58' ' ' PRO . . . . . 0.503 ' HA ' ' HG3' ' A' ' 143' ' ' GLU . 24.3 Cg_exo -64.01 146.85 91.67 Favored 'Trans proline' 0 C--N 1.375 1.954 0 C-N-CA 122.792 2.328 . . . . 65.200000000000003 112.63 173.388 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 63.99 31.22 80.08 Favored Glycine 0 C--N 1.345 1.033 0 CA-C-N 115.117 -0.947 . . . . 63.049999999999997 113.284 -176.306 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 40.0 t80 -158.46 -77.77 0.07 Allowed 'General case' 0 CA--C 1.549 0.923 0 CA-C-N 116.814 0.307 . . . . 74.409999999999997 111.653 -174.18 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 48.3 ttm -165.6 157.12 14.32 Favored 'General case' 0 N--CA 1.489 1.49 0 N-CA-C 112.01 0.374 . . . . 70.540000000000006 112.01 -163.433 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 62' ' ' CYS . . . . . 0.494 ' SG ' HG23 ' A' ' 56' ' ' ILE . 61.2 m -131.86 113.37 13.4 Favored 'General case' 0 N--CA 1.471 0.623 0 C-N-CA 124.299 1.04 . . . . 54.219999999999999 109.11 175.772 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 13.4 pt20 -117.6 149.55 40.48 Favored 'General case' 0 N--CA 1.488 1.448 0 CA-C-O 121.396 0.617 . . . . 75.239999999999995 111.556 -177.343 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 64' ' ' GLY . . . . . 0.459 ' CA ' ' HA ' ' A' ' 53' ' ' PHE . . . -162.1 179.4 37.46 Favored Glycine 0 C--N 1.343 0.951 0 CA-C-N 114.536 -1.211 . . . . 60.109999999999999 113.94 -176.492 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . 0.485 ' HA2' ' HB3' ' A' ' 51' ' ' SER . . . 110.04 98.31 2.5 Favored Glycine 0 N--CA 1.447 -0.581 0 N-CA-C 108.91 -1.676 . . . . 74.450000000000003 108.91 -167.277 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 23.7 t70 -124.69 19.95 8.6 Favored 'General case' 0 N--CA 1.483 1.21 0 CA-C-O 121.765 0.793 . . . . 53.409999999999997 109.132 179.353 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 49.1 t80 -81.54 -77.83 0.2 Allowed 'General case' 0 CA--C 1.551 1.004 0 CA-C-N 115.301 -0.863 . . . . 61.420000000000002 111.746 -169.55 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 89.6 m -85.54 107.74 17.61 Favored 'General case' 0 N--CA 1.48 1.068 0 C-N-CA 122.406 0.282 . . . . 73.310000000000002 110.442 -175.348 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 77.9 mtp180 66.44 80.86 0.21 Allowed 'General case' 0 N--CA 1.472 0.672 0 C-N-CA 125.177 1.391 . . . . 74.5 110.468 -179.85 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 7.8 p80 -70.98 73.87 0.61 Allowed 'General case' 0 CA--C 1.558 1.265 0 CA-C-O 122.343 1.068 . . . . 70.310000000000002 110.652 179.709 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 7.4 t30 -153.81 30.39 0.46 Allowed 'General case' 0 CA--C 1.553 1.073 0 C-N-CA 125.066 1.347 . . . . 65.439999999999998 107.587 -172.821 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 92.17 -8.67 77.48 Favored Glycine 0 C--N 1.353 1.507 0 CA-C-N 114.874 -1.057 . . . . 53.409999999999997 113.431 -177.235 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 73' ' ' THR . . . . . 0.608 ' HA ' ' HB2' ' A' ' 110' ' ' SER . 28.7 m -85.09 -67.12 0.82 Allowed 'General case' 0 CA--C 1.546 0.815 0 N-CA-C 108.525 -0.917 . . . . 63.32 108.525 174.458 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 54.92 18.58 11.87 Favored Glycine 0 C--N 1.348 1.242 0 N-CA-C 115.807 1.083 . . . . 71.340000000000003 115.807 167.248 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . 0.589 ' HA2' ' CE1' ' A' ' 48' ' ' TYR . . . 147.84 54.14 0.02 OUTLIER Glycine 0 CA--C 1.494 -1.233 0 O-C-N 121.537 -0.978 . . . . 53.0 111.826 -160.287 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 64.2 pttt -60.18 167.74 2.26 Favored 'General case' 0 CA--C 1.546 0.823 0 O-C-N 124.524 0.779 . . . . 44.140000000000001 111.173 173.782 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 87.1 p -88.78 174.16 8.15 Favored 'General case' 0 C--O 1.241 0.647 0 CA-C-N 115.68 -0.691 . . . . 51.210000000000001 110.607 -177.746 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 29.6 pt -69.77 -21.69 24.44 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.787 0 CA-C-N 115.846 -0.616 . . . . 74.040000000000006 110.557 173.244 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 56.4 m-85 -87.14 0.4 55.36 Favored 'General case' 0 N--CA 1.479 0.989 0 C-N-CA 124.134 0.974 . . . . 63.43 111.636 -178.166 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 125.6 -150.71 17.47 Favored Glycine 0 C--N 1.347 1.172 0 N-CA-C 111.135 -0.786 . . . . 73.129999999999995 111.135 -179.933 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 45.9 tt0 -63.02 -40.73 98.62 Favored 'General case' 0 N--CA 1.476 0.873 0 C-N-CA 123.392 0.677 . . . . 72.25 110.612 175.997 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 82' ' ' LYS . . . . . 0.476 ' HD3' ' HA ' ' A' ' 107' ' ' THR . 11.2 ptpp? -150.66 168.38 24.5 Favored 'General case' 0 CA--C 1.548 0.887 0 CA-C-N 115.637 -0.71 . . . . 73.230000000000004 110.963 -171.727 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 35.5 p90 -159.77 164.33 33.88 Favored 'General case' 0 N--CA 1.477 0.916 0 C-N-CA 124.797 1.239 . . . . 72.230000000000004 109.512 176.065 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 11.6 pt-20 -94.25 159.16 15.26 Favored 'General case' 0 N--CA 1.478 0.931 0 C-N-CA 123.158 0.583 . . . . 74.129999999999995 109.834 173.934 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 63.9 m-20 -67.08 151.36 47.75 Favored 'General case' 0 N--CA 1.475 0.809 0 C-N-CA 124.371 1.069 . . . . 74.129999999999995 113.814 -170.74 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 6.3 tp10 -69.59 -59.33 3.03 Favored 'General case' 0 CA--C 1.55 0.958 0 CA-C-N 114.953 -1.022 . . . . 75.209999999999994 111.12 177.567 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 87' ' ' ASN . . . . . 0.417 ' OD1' HG12 ' A' ' 29' ' ' VAL . 25.8 p-10 -174.2 137.51 0.54 Allowed 'General case' 0 N--CA 1.489 1.508 0 C-N-CA 123.88 0.872 . . . . 75.519999999999996 109.912 -171.639 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 91.9 m-85 -89.12 54.82 3.1 Favored 'General case' 0 N--CA 1.489 1.508 0 CA-C-O 121.468 0.652 . . . . 74.400000000000006 111.685 -171.492 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 49.3 mt -82.47 -46.72 19.26 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.812 0 CA-C-N 115.632 -0.713 . . . . 75.409999999999997 109.16 170.591 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 90' ' ' LEU . . . . . 0.579 HD21 ' HD2' ' A' ' 28' ' ' LYS . 90.2 mt -95.33 110.73 22.7 Favored 'General case' 0 C--O 1.241 0.641 0 CA-C-N 115.445 -0.798 . . . . 53.109999999999999 110.876 -174.728 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 23.5 pttm -107.84 169.52 8.55 Favored 'General case' 0 N--CA 1.474 0.769 0 C-N-CA 124.176 0.99 . . . . 74.409999999999997 109.409 173.503 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 92' ' ' HIS . . . . . 0.463 ' HA ' HG21 ' A' ' 97' ' ' ILE . 17.1 m-70 -87.68 47.07 1.45 Allowed 'General case' 0 N--CA 1.481 1.088 0 C-N-CA 124.045 0.938 . . . . 55.200000000000003 110.371 -173.688 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 9.5 t -83.71 5.32 25.11 Favored 'General case' 0 CA--C 1.552 1.028 0 C-N-CA 124.315 1.046 . . . . 75.450000000000003 111.971 -174.059 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -133.53 153.42 20.82 Favored Glycine 0 C--N 1.347 1.155 0 CA-C-O 119.713 -0.493 . . . . 74.109999999999999 112.067 179.091 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 73.5 Cg_endo -75.89 142.38 25.2 Favored 'Trans proline' 0 C--N 1.367 1.531 0 C-N-CA 122.538 2.158 . . . . 73.019999999999996 110.064 167.258 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 89.13 6.69 71.17 Favored Glycine 0 N--CA 1.467 0.75 0 CA-C-O 120.145 -0.253 . . . . 62.420000000000002 113.121 -175.931 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 97' ' ' ILE . . . . . 0.717 ' HB ' ' SG ' ' A' ' 115' ' ' CYS . 5.9 mm -68.63 120.18 15.67 Favored 'Isoleucine or valine' 0 CA--C 1.552 1.057 0 C-N-CA 123.181 0.593 . . . . 75.340000000000003 110.782 179.191 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 98' ' ' LEU . . . . . 0.452 HD22 ' CD1' ' A' ' 22' ' ' PHE . 56.8 tp -103.4 123.05 46.11 Favored 'General case' 0 CA--C 1.554 1.122 0 C-N-CA 124.4 1.08 . . . . 54.340000000000003 111.038 -177.657 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 99' ' ' SER . . . . . 0.712 ' HB3' ' HA ' ' A' ' 128' ' ' VAL . 11.3 p -152.88 158.39 42.08 Favored 'General case' 0 N--CA 1.473 0.687 0 C-N-CA 124.369 1.067 . . . . 71.409999999999997 109.514 176.212 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 100' ' ' MET . . . . . 0.661 ' HG3' ' HE2' ' A' ' 129' ' ' PHE . 79.7 mtp -77.25 145.83 37.28 Favored 'General case' 0 N--CA 1.487 1.398 0 N-CA-C 109.944 -0.391 . . . . 75.219999999999999 109.944 -179.898 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 101' ' ' ALA . . . . . 0.518 ' HB3' ' HB2' ' A' ' 111' ' ' GLN . . . -76.07 165.85 24.34 Favored 'General case' 0 C--O 1.247 0.943 0 CA-C-O 121.015 0.436 . . . . 65.439999999999998 111.236 -177.681 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 102' ' ' ASN . . . . . 0.475 ' HB3' ' HA ' ' A' ' 108' ' ' ASN . 27.1 p-10 -160.38 156.79 26.74 Favored 'General case' 0 N--CA 1.472 0.631 0 CA-C-N 115.809 -0.632 . . . . 72.409999999999997 111.007 -176.766 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -93.33 -17.23 23.82 Favored 'General case' 0 CA--C 1.545 0.773 0 CA-C-N 115.358 -0.837 . . . . 54.310000000000002 110.674 169.587 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 177.94 -178.75 48.51 Favored Glycine 0 C--N 1.352 1.437 0 CA-C-O 119.445 -0.642 . . . . 64.510000000000005 112.957 178.839 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 50.2 Cg_exo -58.85 141.22 97.82 Favored 'Trans proline' 0 C--N 1.374 1.917 0 C-N-CA 123.22 2.614 . . . . 75.030000000000001 112.439 171.554 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 64.4 t30 66.54 10.55 7.45 Favored 'General case' 0 N--CA 1.485 1.302 0 C-N-CA 125.48 1.512 . . . . 73.230000000000004 111.243 -176.301 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 107' ' ' THR . . . . . 0.476 ' HA ' ' HD3' ' A' ' 82' ' ' LYS . 16.7 m -126.57 18.76 7.42 Favored 'General case' 0 CA--C 1.558 1.273 0 C-N-CA 124.767 1.227 . . . . 60.119999999999997 108.769 -178.828 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 108' ' ' ASN . . . . . 0.475 ' HA ' ' HB3' ' A' ' 102' ' ' ASN . 48.1 t30 -86.13 143.74 27.87 Favored 'General case' 0 N--CA 1.48 1.026 0 C-N-CA 123.827 0.851 . . . . 61.450000000000003 109.206 177.33 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 112.69 26.29 4.24 Favored Glycine 0 N--CA 1.469 0.86 0 C-N-CA 121.18 -0.533 . . . . 40.020000000000003 113.481 -177.566 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 110' ' ' SER . . . . . 0.608 ' HB2' ' HA ' ' A' ' 73' ' ' THR . 31.6 p -129.17 121.06 26.91 Favored 'General case' 0 CA--C 1.539 0.551 0 N-CA-C 107.859 -1.163 . . . . 65.239999999999995 107.859 171.697 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 111' ' ' GLN . . . . . 0.518 ' HB2' ' HB3' ' A' ' 101' ' ' ALA . 48.8 mt-30 66.49 177.21 0.23 Allowed 'General case' 0 N--CA 1.491 1.583 0 C-N-CA 124.536 1.135 . . . . 70.129999999999995 111.271 -171.574 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 112' ' ' PHE . . . . . 0.638 ' HA ' ' HA ' ' A' ' 100' ' ' MET . 3.1 m-85 -131.75 166.92 20.45 Favored 'General case' 0 N--CA 1.477 0.882 0 N-CA-C 107.396 -1.335 . . . . 72.439999999999998 107.396 175.336 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 113' ' ' PHE . . . . . 0.424 ' O ' HD12 ' A' ' 98' ' ' LEU . 48.2 p90 -157.13 160.47 38.85 Favored 'General case' 0 N--CA 1.477 0.916 0 CA-C-O 121.393 0.616 . . . . 73.430000000000007 112.138 170.902 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 114' ' ' ILE . . . . . 0.483 HG21 HG11 ' A' ' 139' ' ' VAL . 20.2 mt -124.51 109.71 23.29 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.821 0 CA-C-N 114.024 -1.444 . . . . 71.319999999999993 107.443 171.845 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 115' ' ' CYS . . . . . 0.717 ' SG ' ' HB ' ' A' ' 97' ' ' ILE . 29.8 p -74.5 105.5 5.66 Favored 'General case' 0 N--CA 1.474 0.769 0 N-CA-C 108.836 -0.802 . . . . 74.040000000000006 108.836 177.464 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 116' ' ' THR . . . . . 0.421 HG22 HG12 ' A' ' 139' ' ' VAL . 24.2 p -71.27 -23.06 61.9 Favored 'General case' 0 N--CA 1.476 0.853 0 C-N-CA 124.396 1.078 . . . . 62.140000000000001 111.601 -174.015 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -107.39 152.89 23.57 Favored 'General case' 0 C--O 1.245 0.839 0 N-CA-C 108.794 -0.817 . . . . 71.299999999999997 108.794 166.775 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 20.3 ptmt -70.69 99.0 1.61 Allowed 'General case' 0 CA--C 1.543 0.676 0 CA-C-O 121.762 0.792 . . . . 75.510000000000005 109.033 172.851 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 119' ' ' THR . . . . . . . . . . . . . 82.2 p -81.7 86.32 6.44 Favored 'General case' 0 CA--C 1.547 0.858 0 CA-C-O 121.963 0.887 . . . . 63.229999999999997 109.656 -175.721 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 12.1 pt-20 -74.28 -29.99 61.9 Favored 'General case' 0 N--CA 1.48 1.057 0 CA-C-N 114.662 -1.153 . . . . 73.140000000000001 111.132 -175.092 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 121' ' ' TRP . . . . . . . . . . . . . 34.5 p90 -64.91 -13.4 56.76 Favored 'General case' 0 N--CA 1.48 1.03 0 C-N-CA 123.987 0.915 . . . . 75.349999999999994 111.57 175.347 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 64.7 mt -99.42 29.08 4.17 Favored 'General case' 0 CA--C 1.551 0.987 0 C-N-CA 123.75 0.82 . . . . 45.119999999999997 111.51 176.125 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 83.4 m-20 -69.45 134.95 49.56 Favored 'General case' 0 N--CA 1.484 1.254 0 N-CA-C 109.651 -0.5 . . . . 63.439999999999998 109.651 166.615 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 81.9 0.86 89.97 Favored Glycine 0 C--N 1.341 0.844 0 CA-C-N 116.223 -0.444 . . . . 34.420000000000002 113.056 -176.209 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 125' ' ' LYS . . . . . 0.46 ' HG3' ' H ' ' A' ' 126' ' ' HIS . 8.5 tppt? -78.43 -170.93 2.23 Favored 'General case' 0 N--CA 1.477 0.915 0 N-CA-C 108.641 -0.874 . . . . 63.439999999999998 108.641 176.96 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 126' ' ' HIS . . . . . 0.46 ' H ' ' HG3' ' A' ' 125' ' ' LYS . 44.7 p-80 -68.57 152.84 44.81 Favored 'General case' 0 CA--C 1.545 0.781 0 O-C-N 122.051 -0.406 . . . . 65.129999999999995 110.022 -175.826 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 48.5 t -79.37 147.42 6.7 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.697 0 C-N-CA 123.631 0.772 . . . . 75.340000000000003 112.452 -164.771 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 128' ' ' VAL . . . . . 0.712 ' HA ' ' HB3' ' A' ' 99' ' ' SER . 61.7 t -83.19 158.81 3.73 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.759 0 C-N-CA 125.103 1.361 . . . . 54.350000000000001 109.933 176.375 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 129' ' ' PHE . . . . . 0.661 ' HE2' ' HG3' ' A' ' 100' ' ' MET . 7.3 p90 -130.62 -24.13 2.51 Favored 'General case' 0 N--CA 1.479 1.023 0 N-CA-C 111.918 0.34 . . . . 72.200000000000003 111.918 173.509 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . -143.23 175.53 23.25 Favored Glycine 0 C--N 1.34 0.765 0 O-C-N 123.31 0.381 . . . . 63.310000000000002 112.588 -172.997 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 34.6 ttpt -161.08 137.9 8.71 Favored 'General case' 0 N--CA 1.466 0.365 0 N-CA-C 108.52 -0.919 . . . . 74.219999999999999 108.52 179.612 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 132' ' ' VAL . . . . . 0.467 HG11 ' HA ' ' A' ' 136' ' ' MET . 40.7 t -61.35 108.45 0.47 Allowed 'Isoleucine or valine' 0 CA--C 1.544 0.72 0 C-N-CA 123.418 0.687 . . . . 64.530000000000001 109.976 177.043 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 21.4 ptmt -85.74 -39.19 17.43 Favored 'General case' 0 CA--C 1.542 0.663 0 N-CA-C 109.689 -0.485 . . . . 53.240000000000002 109.689 177.006 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 134' ' ' GLU . . . . . 0.473 ' HB2' ' OG ' ' A' ' 21' ' ' SER . 53.4 mm-40 -137.81 149.61 46.5 Favored 'General case' 0 N--CA 1.483 1.195 0 C-N-CA 124.302 1.041 . . . . 64.340000000000003 109.253 177.573 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 85.03 20.38 57.67 Favored Glycine 0 N--CA 1.473 1.161 0 O-C-N 123.414 0.446 . . . . 75.340000000000003 112.649 -179.295 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 136' ' ' MET . . . . . 0.467 ' HA ' HG11 ' A' ' 132' ' ' VAL . 15.1 tpt -61.07 -33.89 74.04 Favored 'General case' 0 N--CA 1.483 1.211 0 C-N-CA 123.763 0.825 . . . . 73.209999999999994 110.943 179.662 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 137' ' ' ASN . . . . . . . . . . . . . 11.4 m120 -64.91 -32.67 74.49 Favored 'General case' 0 CA--C 1.546 0.797 0 C-N-CA 123.849 0.86 . . . . 72.400000000000006 111.82 -179.271 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 138' ' ' ILE . . . . . 0.408 ' O ' ' HG3' ' A' ' 142' ' ' MET . 46.8 mm -70.56 -37.8 71.16 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.966 0 C-N-CA 123.143 0.577 . . . . 64.319999999999993 109.868 177.355 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 139' ' ' VAL . . . . . 0.483 HG11 HG21 ' A' ' 114' ' ' ILE . 59.3 t -67.17 -37.39 79.1 Favored 'Isoleucine or valine' 0 CA--C 1.555 1.139 0 C-N-CA 123.829 0.852 . . . . 62.299999999999997 110.963 177.338 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 38.7 mt-10 -70.86 -28.4 64.54 Favored 'General case' 0 N--CA 1.478 0.934 0 CA-C-N 115.792 -0.64 . . . . 54.049999999999997 110.706 176.328 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -68.8 -39.52 80.07 Favored 'General case' 0 N--CA 1.475 0.814 0 C-N-CA 122.876 0.47 . . . . 73.450000000000003 110.278 172.38 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 142' ' ' MET . . . . . 0.482 ' SD ' HG21 ' A' ' 10' ' ' ILE . 76.6 mtp -58.25 -41.65 84.69 Favored 'General case' 0 N--CA 1.485 1.282 0 C-N-CA 123.983 0.913 . . . . 70.450000000000003 111.157 175.654 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 143' ' ' GLU . . . . . 0.503 ' HG3' ' HA ' ' A' ' 58' ' ' PRO . 37.8 tt0 -53.69 -43.3 68.81 Favored 'General case' 0 CA--C 1.546 0.79 0 CA-C-N 114.92 -1.036 . . . . 60.420000000000002 111.69 176.767 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 144' ' ' ARG . . . . . . . . . . . . . 56.2 mtt180 -72.53 -18.58 61.63 Favored 'General case' 0 N--CA 1.475 0.812 0 C-N-CA 124.155 0.982 . . . . 53.009999999999998 111.646 -177.263 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 145' ' ' PHE . . . . . 0.494 ' HB3' ' HB2' ' A' ' 154' ' ' LYS . 24.9 m-85 -86.56 -4.27 59.15 Favored 'General case' 0 N--CA 1.479 0.981 0 C-N-CA 123.398 0.679 . . . . 61.119999999999997 111.359 176.603 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . -97.24 -179.22 34.17 Favored Glycine 0 C--N 1.347 1.192 0 C-N-CA 123.053 0.358 . . . . 74.129999999999995 112.599 175.569 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 21.4 m -134.03 163.13 30.24 Favored 'General case' 0 N--CA 1.482 1.135 0 C-N-CA 124.114 0.966 . . . . 73.310000000000002 110.512 -176.121 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 148' ' ' ARG . . . . . . . . . . . . . 26.6 mmt180 -67.91 -28.18 67.28 Favored 'General case' 0 N--CA 1.486 1.364 0 C-N-CA 123.432 0.693 . . . . 72.209999999999994 112.037 -175.733 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 149' ' ' ASN . . . . . . . . . . . . . 30.8 p-10 -82.39 2.45 32.37 Favored 'General case' 0 N--CA 1.483 1.177 0 C-N-CA 123.644 0.778 . . . . 74.310000000000002 111.358 175.816 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 150' ' ' GLY . . . . . 0.468 ' HA2' HG12 ' A' ' 57' ' ' ILE . . . 93.06 -6.29 76.09 Favored Glycine 0 C--N 1.35 1.34 0 CA-C-O 119.722 -0.488 . . . . 41.119999999999997 113.674 177.02 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 40.7 ttmt -71.04 141.13 50.92 Favored 'General case' 0 N--CA 1.475 0.804 0 CA-C-N 117.315 0.557 . . . . 70.239999999999995 110.651 -177.719 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 152' ' ' THR . . . . . . . . . . . . . 12.5 p -90.35 117.08 28.8 Favored 'General case' 0 C--O 1.237 0.443 0 N-CA-C 108.824 -0.806 . . . . 75.349999999999994 108.824 169.062 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 153' ' ' SER . . . . . . . . . . . . . 22.8 m -66.46 -31.35 72.03 Favored 'General case' 0 CA--C 1.544 0.742 0 CA-C-N 115.679 -0.691 . . . . 73.230000000000004 110.036 171.92 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 154' ' ' LYS . . . . . 0.494 ' HB2' ' HB3' ' A' ' 145' ' ' PHE . 32.2 mmmt -121.13 129.97 53.52 Favored 'General case' 0 N--CA 1.472 0.627 0 CA-C-N 115.469 -0.787 . . . . 74.200000000000003 110.399 -178.96 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 83.3 tttt -67.76 106.36 2.22 Favored 'General case' 0 C--N 1.352 0.691 0 C-N-CA 123.737 0.815 . . . . 73.140000000000001 109.396 171.759 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 156' ' ' ILE . . . . . 0.584 ' HB ' ' HB2' ' A' ' 53' ' ' PHE . 62.0 mt -102.97 131.73 50.63 Favored 'Isoleucine or valine' 0 C--O 1.221 -0.422 0 N-CA-C 108.102 -1.073 . . . . 75.219999999999999 108.102 176.509 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 157' ' ' THR . . . . . . . . . . . . . 33.1 p -127.96 160.83 30.66 Favored 'General case' 0 N--CA 1.481 1.098 0 C-N-CA 123.935 0.894 . . . . 62.229999999999997 109.732 -179.75 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 158' ' ' ILE . . . . . . . . . . . . . 57.1 mt -82.98 97.08 4.17 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.838 0 N-CA-C 108.52 -0.918 . . . . 74.140000000000001 108.52 167.477 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 159' ' ' ALA . . . . . 0.821 ' HB2' ' HB2' ' A' ' 11' ' ' ALA . . . -55.99 -41.72 75.26 Favored 'General case' 0 N--CA 1.481 1.106 0 C-N-CA 124.067 0.947 . . . . 53.020000000000003 112.626 -177.262 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 160' ' ' ASP . . . . . . . . . . . . . 2.7 t70 -165.35 174.56 9.99 Favored 'General case' 0 CA--C 1.549 0.93 0 O-C-N 123.496 0.498 . . . . 62.399999999999999 110.527 -176.68 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 161' ' ' CYS . . . . . . . . . . . . . 24.5 p -130.96 -167.85 1.9 Allowed 'General case' 0 N--CA 1.478 0.959 0 C-N-CA 125.366 1.467 . . . . 65.349999999999994 109.41 -178.55 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 162' ' ' GLY . . . . . . . . . . . . . . . 132.62 53.32 0.08 OUTLIER Glycine 0 C--N 1.351 1.369 0 N-CA-C 112.137 -0.385 . . . . 74.109999999999999 112.137 -175.327 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 163' ' ' GLN . . . . . 0.6 ' HB2' ' HA ' ' A' ' 6' ' ' VAL . 21.2 pt20 -49.44 143.4 6.67 Favored 'General case' 0 N--CA 1.482 1.131 0 C-N-CA 124.421 1.088 . . . . 73.409999999999997 113.1 -174.379 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 164' ' ' LEU . . . . . 0.443 ' HG ' ' HB2' ' A' ' 7' ' ' PHE . 86.0 mt -95.42 116.93 29.48 Favored 'General case' 0 CA--C 1.547 0.843 0 C-N-CA 123.514 0.726 . . . . 74.200000000000003 110.14 -173.365 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 165' ' ' GLU . . . . . . . . . . . . . 14.0 pt-20 . . . . . 0 C--O 1.252 1.226 0 C-N-CA 123.646 0.778 . . . . 72.140000000000001 108.938 179.406 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' B' B ' 216' ' ' PRO . . . . . . . . . . . . . 32.8 Cg_endo . . . . . 0 CA--C 1.546 1.09 0 N-CA-C 110.014 -0.802 . . . . 64.519999999999996 110.014 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' B' B ' 217' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -145.93 94.11 5.06 Favored Pre-proline 0 CA--C 1.554 1.101 0 N-CA-C 106.781 -1.563 . . . . 72.019999999999996 106.781 177.217 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 218' ' ' PRO . . . . . . . . . . . . . 11.7 Cg_endo -91.23 77.87 0.55 Allowed 'Trans proline' 0 C--N 1.378 2.082 0 C-N-CA 123.424 2.75 . . . . 74.230000000000004 111.632 -178.098 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 219' ' ' GLY . . . . . . . . . . . . . . . 176.08 156.04 14.32 Favored Glycine 0 CA--C 1.525 0.71 0 CA-C-N 114.593 -1.185 . . . . 74.430000000000007 111.542 177.711 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 220' ' ' PRO . . . . . . . . . . . . . 60.5 Cg_endo -85.38 -178.97 3.27 Favored 'Trans proline' 0 CA--C 1.553 1.472 0 C-N-CA 122.961 2.441 . . . . 65.140000000000001 112.209 175.459 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 221' ' ' TYR . . . . . . . . . . . . . 43.1 p90 -147.05 178.52 8.3 Favored 'General case' 0 N--CA 1.484 1.242 0 C-N-CA 123.632 0.773 . . . . 75.299999999999997 110.986 179.802 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 222' ' ' ALA . . . . . . . . . . . . . . . 170.21 91.02 0.0 OUTLIER 'General case' 0 N--CA 1.486 1.369 0 C-N-CA 125.683 1.593 . . . . 72.230000000000004 109.976 166.072 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 223' ' ' GLN . . . . . 0.612 ' H ' ' HD2' ' B' ' 224' ' ' PRO . 35.1 mm-40 -120.66 -50.61 0.04 OUTLIER Pre-proline 0 CA--C 1.563 1.446 0 C-N-CA 124.137 0.975 . . . . 74.540000000000006 109.948 168.624 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 224' ' ' PRO . . . . . 0.612 ' HD2' ' H ' ' B' ' 223' ' ' GLN . 52.7 Cg_endo . . . . . 0 C--N 1.394 2.971 0 C-N-CA 121.6 1.533 . . . . 70.010000000000005 111.133 170.181 . . . . . . . . 1 1 . 1 stop_ save_